PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stonis, JR; Remeikis, A; Diskus, A; Orlovskyte, S; Vargas, SA; Solis, MA				Stonis, Jonas R.; Remeikis, Andrius; Diskus, Arunas; Orlovskyte, Svetlana; Vargas, Sergio A.; Solis, Maria Alma			A new leafmining pest of guava: Hesperolyra guajavifoliae sp. nov., with comments on the diagnostics of the endemic Neotropical genus Hesperolyra van Nieukerken (Lepidoptera, Nepticulidae)	ZOOKEYS			English	Article						New species; pygmy moths; guayaba; Psidium guajava; leaf mines; taxonomy; Colombia		We describe a new pest of guava (Psidium guajava L.), Hesperolyra guajavifoliae Stonis & Vargas, sp. nov., that was recently discovered in western Colombia. Hesperolyra van Nieukerken is a small, Neotropical genus of pygmy moths (Nepticulidae). We re-examine and document the complex morphology of the male genitalia of the generic type species, H. diskusi (Puplesis & Robinson). We discuss the diagnostics and composition of the genus and provide a simple pictorial differentiation scheme for all currently known representatives of the genus. The new species is illustrated with photographs of the adults, some of the immature stages, male and female genitalia, and leaf mines. A link to the COI barcodes of H. guajavifoliae sp. nov. is provided and the relationship of Hesperolyra to other genera is discussed.	[Stonis, Jonas R.; Remeikis, Andrius; Diskus, Arunas; Orlovskyte, Svetlana] Inst Ecol, Nat Res Ctr, Akad St 2, LT-08412 Vilnius, Lithuania; [Vargas, Sergio A.] Jardin Botan Bogota Jose Celestine Mutis, Av Calle 63 68-95, Bogota, Colombia; [Vargas, Sergio A.] Pontificia Univ Javeriana, Dept Biol, UNESIS, Lab Entomol, Carrera 7 43-82, Bogota, Colombia; [Solis, Maria Alma] ARS, Systemat Entomol Lab, USDA, Natl Museum Nat Hist,Smithsonian Inst, Washington, DC 20013 USA		Stonis, JR (corresponding author), Inst Ecol, Nat Res Ctr, Akad St 2, LT-08412 Vilnius, Lithuania.	stonis.biotaxonomy@gmail.com		Vargas, Sergio/0000-0002-6716-905X; Diskus, Arunas/0000-0003-0106-5546; Stonis, Jonas Rimantas/0000-0002-8411-3162	Research Council of Lithuania [S-MIP-19-30]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was partially funded by a grant (S-MIP-19-30, "DiagnoStics") from the Research Council of Lithuania. The study was carried out using the research infrastructure of the Nature Research Centre under the Lithuanian open access network initiative.	Auskalnis t, 2014, SELECTED ABSTRACTS P, P65; Diskus A, 2012, LIETUVOS ENDOBIONTIN; Doorenweerd C, 2017, SYST ENTOMOL, V42, P267, DOI 10.1111/syen.12212; Germplasm Resources Information Network GRIN, 2019, PSID GUAJ; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-14998U1.29; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Heuze V, 2017, GUAVA PSIDIUM GUAJAV; Johansson R., 1990, Fauna Entomologica Scandinavica, V23, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuznetzov V.I., 1994, INSECTS MITES PESTS, V3, P12; Nieukerken EJ, 1986, ZOOLOGISCHE VERHANDE, V236, P1; Gutierrez RMP, 2008, J ETHNOPHARMACOL, V117, P1, DOI 10.1016/j.jep.2008.01.025; Puplesis R., 1994, NEPTICULIDAE E EUROP; Puplesis Rimantas, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P19, DOI 10.1017/S0968045402000020; Puplesis Rimantas, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P59, DOI 10.1017/S0968045402000032; Puplesis Rimantas, 2000, Bulletin of the Natural History Museum Entomology Series, V69, P3; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remeikis A., 2017, THESIS; Scoble M.J., 1983, Transvaal Museum Monograph, P1; Stonis J.R., 2014, 1 BALT INT C FIELD E; Stonis JR, 2017, ZOOTAXA, V4338, P489, DOI 10.11646/zootaxa.4338.3.5; Stonis JR, 2016, ZOOTAXA, V4181, P2, DOI 10.11646/zootaxa.4181.1.1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; van Nieukerken EJ, 2016, ZOOKEYS, P65, DOI 10.3897/zookeys.628.9799; van Nieukerken EJ, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.628.9805; Van Nieukerken Erik J., 2011, Entomologisk Tidskrift, V132, P235; World Atlas, 2019, WORLD ATLAS WETTEST	27	4	4	0	4	PENSOFT PUBLISHERS	SOFIA	12 PROF GEORGI ZLATARSKI ST, SOFIA, 1700, BULGARIA	1313-2989	1313-2970		ZOOKEYS	ZooKeys	DEC 31	2019		900					87	110		10.3897/zookeys.900.46332	http://dx.doi.org/10.3897/zookeys.900.46332			24	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	KB3UI	31920425	Green Published, gold			2022-09-04	WOS:000506424400005
J	Guzman, M; Perchy, S; Rueda, C; Valencia, FD				Guzman, Michell; Perchy, Salim; Rueda, Camilo; Valencia, Frank D.			Characterizing right inverses for spatial constraint systems with applications to modal logic	THEORETICAL COMPUTER SCIENCE			English	Article						Constraint systems; Concurrent constraint programming; Concurrency theory; Modal logic; Inverse operators	OPERATORS	Spatial constraint systems are algebraic structures from concurrent constraint programming to specify spatial and epistemic behavior in multi-agent systems. In this paper spatial constraint systems are used to give an abstract characterization of the notion of normality in modal logic and to derive right inverse/reverse operators for modal languages. In particular, a necessary and sufficient condition for the existence of right inverses is identified and the abstract notion of normality is shown to correspond to the preservation of finite suprema. Furthermore, a taxonomy of normal right inverses is provided, identifying the greatest normal right inverse as well as the complete family of minimal right inverses. These results are applied to existing modal languages such as the weakest normal modal logic, Hennessy-Milner logic, and linear-time temporal logic. Some implications of these results are also discussed in the context of modal concepts such as bisimilarity and inconsistency invariance. (C) 2018 Elsevier B.V. All rights reserved.	[Guzman, Michell] Ecole Polytech Paris, INRIA, LIX, Paris, France; [Perchy, Salim] INRIA Grand Est, Loria, Villers Les Nancy, France; [Rueda, Camilo; Valencia, Frank D.] Pontificia Univ Javeriana Cali, Cali, Colombia; [Valencia, Frank D.] Ecole Polytech Paris, CNRS, Paris, France; [Valencia, Frank D.] Ecole Polytech Paris, LIX, Paris, France		Valencia, FD (corresponding author), Pontificia Univ Javeriana Cali, Cali, Colombia.; Valencia, FD (corresponding author), Ecole Polytech Paris, CNRS, Paris, France.; Valencia, FD (corresponding author), Ecole Polytech Paris, LIX, Paris, France.	frank.valencia@gmail.com		Rueda, camilo/0000-0001-8387-9644	Colciencias project [125171250031 CLASSIC]; STIC AmSud [17-STIC-04]; COFINPRO2016 project [4473 CREATE]	Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); STIC AmSud; COFINPRO2016 project	This work has been partially supported by the Colciencias project 125171250031 CLASSIC, STIC AmSud 17-STIC-04 project EPIC, and COFINPRO2016 project 4473 CREATE.	Abramsky S., 1994, HDB LOGIC COMPUTER S, p1s168; Aristizabal A, 2011, LECT NOTES COMPUT SC, V6604, P138, DOI 10.1007/978-3-642-19805-2_10; Blackburn P., 2002, MODAL LOGIC; Blyth T., 1972, INT SERIES MONOGRAPH, V102; Cacciagrano D., 2007, 14 INT WORKSH EXPR C, P58; Chagrov A., 1997, MODAL LOGIC OXFORD L, V35; DEBOER FS, 1995, THEOR COMPUT SCI, V151, P37, DOI 10.1016/0304-3975(95)00047-Z; DENICOLA R, 1995, J ACM, V42, P458, DOI 10.1145/201019.201032; DENICOLA R, 1990, LECT NOTES COMPUT SC, V458, P152; DENICOLA R, 1990, LECT NOTES COMPUT SC, V472, P301; Fages F, 2001, INFORM COMPUT, V165, P14, DOI 10.1006/inco.2000.3002; Fagin R., 1995, REASONING KNOWLEDGE; Gadducci F, 2015, LECT NOTES COMPUT SC, V9037, P133, DOI 10.1007/978-3-319-19282-6_9; GOLTZ U, 1992, LECT NOTES COMPUT SC, V630, P222; Guzman M, 2017, J LOG ALGEBR METHODS, V86, P107, DOI 10.1016/j.jlamp.2016.09.001; Guzman M, 2016, LECT NOTES COMPUT SC, V9965, P214, DOI 10.1007/978-3-319-46750-4_13; Haar S, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL SYMPOSIUM ON PRINCIPLES AND PRACTICE OF DECLARATIVE PROGRAMMING (PPDP 2015), P161, DOI 10.1145/2790449.2790520; HENNESSY M, 1985, J ACM, V32, P137, DOI 10.1145/2455.2460; Hintikka J., 1962, KNOWLEDGE BELIEF; Knight Saleemah E., 2013, THESIS; Knight S, 2012, LECT NOTES COMPUT SC, V7454, P317, DOI 10.1007/978-3-642-32940-1_23; MACNAB DS, 1981, ALGEBRA UNIV, V12, P5, DOI 10.1007/BF02483860; Milner R., 1989, COMMUNICATION CONCUR, V84; Nielsen M., 2002, Nordic Journal of Computing, V9, P145; Palamidessi C, 2006, IEEE S LOG, P59, DOI 10.1109/LICS.2006.39; Phillips I, 2011, ELECTRON P THEOR COM, P104, DOI 10.4204/EPTCS.64.8; Pnueli A., 1992, TEMPORAL LOGIC REACT; POPKORN S, 1994, 1 STEPS MODAL LOGIC; Prior Arthur N, 1967, PRESENT FUTURE, V154; Rety J.-H., 1998, Fundamenta Informaticae, V34, P323; Ryan M., 1997, Journal of Logic, Language and Information, V6, P123, DOI 10.1023/A:1008218502162; SARASWAT VA, 1991, POPL, P333, DOI DOI 10.1145/99583.99627; Vickers S., 1996, TOPOLOGY VIA LOGIC	33	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0304-3975	1879-2294		THEOR COMPUT SCI	Theor. Comput. Sci.	OCT 5	2018	744						56	77		10.1016/j.tcs.2018.05.022	http://dx.doi.org/10.1016/j.tcs.2018.05.022			22	Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	GW6PD		Green Submitted			2022-09-04	WOS:000447080800005
J	Olmos-Vega, FM; Dolmans, DHJM; Guzman-Quintero, C; Stalmeijer, RE; Teunissen, PW				Olmos-Vega, Francisco M.; Dolmans, Diana H. J. M.; Guzman-Quintero, Carlos; Stalmeijer, Renee E.; Teunissen, Pim W.			Unravelling residents' and supervisors' workplace interactions: an intersubjectivity study	MEDICAL EDUCATION			English	Article							EDUCATION RESEARCH; MEDICAL-EDUCATION; ENVIRONMENTS; LEARN; CARE; PARTICIPATION; PERSPECTIVES	ContextSuccessful engagement between residents and supervisors lies at the core of workplace learning, a process that is not exempt from challenge. Clinical encounters have unique learning potential as they offer opportunities to achieve a shared understanding between the resident and supervisor of how to accomplish a common goal. How residents and supervisors develop such a mutual understanding is an issue that has received limited attention in the literature. We used the intersubjectivity' concept as a novel conceptual framework to analyse this issue. MethodsWe conducted a constructivist grounded theory study in an anaesthesiology department in Bogota, Colombia, using focus groups and field observations. Eleven residents of different training levels and 18 supervisors with varying years of teaching experience participated in the study. Through iterative data analysis, collection and constant comparison, we constructed the final results. ResultsWe found that residents and supervisors achieved a shared understanding by adapting to one another in the process of providing patient care. Continuous changes in the composition of resident-supervisor dyads exposed them to many procedural variations, to which they responded by engaging in various adaptation patterns that included compliance by residents with supervisors' directions, negotiation by residents of supervisors' preferences, and the sharing of decision making. In the process, the resident played an increasingly key role as a member of the supervisory dyad. Additionally, experiencing these adaptation patterns repeatedly resulted in the creation of a working repertoire: an attuned working code used by the members of each supervisory dyad to work together as a team. ConclusionsThe development of shared understanding between residents and supervisors entailed experiencing diverse adaptation patterns which resulted in the creation of working repertoires. Seeing supervisory interactions as adaptation processes has essential theoretical and practical implications regarding workplace learning in postgraduate settings. Our findings call for further exploration to understand learning in postgraduate education as a social process. lmos-vega et al. explore how residents and supervisors develop mutual understanding regarding how to accomplish their common goals.	[Olmos-Vega, Francisco M.] Pontificia Univ Javeriana, Fac Med, Dept Anaesthesiol, Bogota, Colombia; [Olmos-Vega, Francisco M.] Hosp Univ San Ignacio, Bogota, Colombia; [Dolmans, Diana H. J. M.; Stalmeijer, Renee E.; Teunissen, Pim W.] Maastricht Univ, Dept Educ Dev & Res, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Guzman-Quintero, Carlos] Pontificia Univ Javeriana, Dept Anthropol, Bogota, Colombia; [Teunissen, Pim W.] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands		Olmos-Vega, FM (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Anaesthesiol, Carrera 7 N 42-00 Fourth Floor, Bogota 110231, Colombia.	folmos@javeriana.edu.co	Stalmeijer, Renee E/AIE-8162-2022	Stalmeijer, Renee E/0000-0001-8690-5326; Olmos-Vega, Francisco M/0000-0003-1629-4309	Pontifical Xavierian University	Pontifical Xavierian University	the study was completely funded by a PhD scholarship awarded to FMO-V from the Pontifical Xavierian University.	Apramian T, 2018, ANN SURG, V268, P385, DOI 10.1097/SLA.0000000000002284; Apramian T, 2016, J SURG EDUC, V73, P339, DOI 10.1016/j.jsurg.2015.10.016; Apramian T, 2015, ACAD MED, V90, pS70, DOI 10.1097/ACM.0000000000000909; Atkinson P., 2007, ETHNOGRAPHY PRINCIPL, V3rd; Balmer DF, 2012, PEDIATRICS, V129, P910, DOI 10.1542/peds.2011-2674; Billett S, 2002, BRIT J EDUC STUD, V50, P457, DOI 10.1111/1467-8527.t01-2-00214; Billett S, 2016, MED EDUC, V50, P124, DOI 10.1111/medu.12848; Billett S, 2010, PROF PRACT-BASED LEA, P1, DOI 10.1007/978-90-481-3939-2_1; Billett SR, 2014, J INTERPROF CARE, V28, P206, DOI 10.3109/13561820.2014.890580; Bleakley A, 2006, MED EDUC, V40, P150, DOI 10.1111/j.1365-2929.2005.02371.x; Brown J, 2018, MED EDUC, V52, P192, DOI 10.1111/medu.13468; Bryant A, 2007, SAGE HDB GROUNDED TH; Burt R.S., 2005, BROKERAGE CLOSURE IN; Cait CA, 2006, CLIN SOC WORK J, V34, P253, DOI 10.1007/s10615-005-0014-4; Charmaz K, 2007, HDB ETHNOGRAPHY, P150; Cope AC, 2015, MED EDUC, V49, P1103, DOI 10.1111/medu.12780; Crossley N., 1996, INTERSUBJECTIVITY FA; Eraut M., 2004, STUD CONTIN EDUC, V26, P247, DOI DOI 10.1080/158037042000225245; Helmich E, 2017, PERSPECT MED EDUC, V6, P127, DOI 10.1007/s40037-017-0329-1; Hui D, 2007, INT J INF COMMUN TEC, V3, P25, DOI 10.4018/jicte.2007070103; Kennedy TJT, 2007, J GEN INTERN MED, V22, P1080, DOI 10.1007/s11606-007-0179-3; Lave J., 1991, LEARNING IN DOING, DOI DOI 10.2307/2804509; Ligorio MB, 2008, J RES TECHNOL EDUC, V40, P339, DOI 10.1080/15391523.2008.10782511; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Olmos-Vega FM, 2017, MED EDUC, V51, P699, DOI 10.1111/medu.13326; Paradis E, 2017, MED EDUC, V51, P31, DOI 10.1111/medu.13122; Piquette D, 2015, ANN AM THORAC SOC, V12, P498, DOI 10.1513/AnnalsATS.201412-565OC; Rogoff B., 1990, APPRENTICESHIP THINK; Sheehan D, 2005, ACAD MED, V80, P302, DOI 10.1097/00001888-200503000-00022; Stalmeijer RE, 2014, MED TEACH, V36, P923, DOI 10.3109/0142159X.2014.917165; Teunissen PW, 2007, MED EDUC, V41, P1050, DOI 10.1111/j.1365-2923.2007.02858.x; Teunissen PW, 2007, MED EDUC, V41, P763, DOI 10.1111/j.1365-2923.2007.02778.x; Teunissen PW, 2015, ADV HEALTH SCI EDUC, V20, P843, DOI 10.1007/s10459-014-9556-y; Varpio L, 2017, MED EDUC, V51, P40, DOI 10.1111/medu.13124; Watling CJ, 2012, MED TEACH, V34, P850, DOI 10.3109/0142159X.2012.704439; Wenger E., 1999, COMMUNITIES PRACTICE; Zlatev Jordan, 2008, SHARED MIND PERSPECT	37	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0308-0110	1365-2923		MED EDUC	Med. Educ.	JUL	2018	52	7					725	735		10.1111/medu.13603	http://dx.doi.org/10.1111/medu.13603			11	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Health Care Sciences & Services	GI5NT	29879305	Green Submitted			2022-09-04	WOS:000434418300009
J	Echeverri, I; Ortega-Avila, JG; Mosquera, M; Castillo, A; Jimenez, E; Suarez-Ortegon, MF; Mateus, JC; Aguilar-de Plata, C				Echeverri, Isabella; Guillermo Ortega-Avila, Jose; Mosquera, Mildrey; Castillo, Andres; Jimenez, Eliecer; Suarez-Ortegon, Milton Fabian; Cesar Mateus, Julio; Aguilar-de Plata, Cecilia			Relationship Between Maternal and Newborn Endothelial Function and Oxidative Stress	AMERICAN JOURNAL OF HUMAN BIOLOGY			English	Article							FLOW-MEDIATED DILATION; NITRIC-OXIDE; VASCULAR DYSFUNCTION; ANTIOXIDANT STATUS; BRACHIAL-ARTERY; BIRTH-WEIGHT; PREGNANCY; BLOOD; EXERCISE; WOMEN	Objective: To evaluate the relationship between maternal and newborn endothelial function and oxidative stress. Methods: Forty-three pregnant women and their offspring were evaluated. As markers of endothelial function, the flow-mediated dilation (FMD) was measured in pregnant women in the second and third trimesters, and nitric oxide (NO) was quantified in the endothelial cells of the umbilical cord vein. Malondialdehyde (MDA), as a marker of oxidative stress, was measured in the maternal plasma (second and third trimesters) and plasma from umbilical cord blood. Gestational age and birth weight were recorded. Correlations between variables were estimated, and adjustments were made for specific gestational week of measurement, gestational age at birth, and complications during pregnancy and/or at delivery. Results: Maternal FMD at second trimester correlated positively with newborn MDA, although with marginal significance (P = 0.090). The change in maternal FMD was positively correlated with newborn NO (P = 0.039), although adjustment for gestational age and specific week of gestation attenuated this relationship (P = 0.070). Maternal MDA at second trimester correlated positively with newborn MDA independently of gestational age at birth, specific week of gestation of the measurement, and having complications during pregnancy or at delivery (P = 0.032). After adjustments, the change in maternal MDA correlated with newborn MDA but marginally (P = 0.077). Conclusion: Study findings suggest that under physiological conditions, enhanced endothelial function and/or oxidative stress in the mother may impact on normal fetal development. Future studies are recommended, employing larger sample sizes, a more extensive set of markers of oxidative stress, and comparisons of complicated versus normal pregnancies. (C) 2015 Wiley Periodicals, Inc.	[Echeverri, Isabella] Univ ICESI, Fac Hlth Sci, Cali, Colombia; [Echeverri, Isabella; Guillermo Ortega-Avila, Jose; Mosquera, Mildrey; Jimenez, Eliecer; Suarez-Ortegon, Milton Fabian; Aguilar-de Plata, Cecilia] Univ Valle, Nutr Grp, Cali, Colombia; [Guillermo Ortega-Avila, Jose] Pontificia Univ Javeriana, Sch Med, Dept Basic Sci, Res Grp Basic & Clin Hlth Sci,Sch Med, Cali, Colombia; [Mosquera, Mildrey; Jimenez, Eliecer; Aguilar-de Plata, Cecilia] Univ Valle, Dept Physiol Sci, Cali, Colombia; [Castillo, Andres] Univ ICESI, Fac Nat Sci, Dept Biol Sci, Cali, Colombia; [Suarez-Ortegon, Milton Fabian] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Suarez-Ortegon, Milton Fabian] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Cesar Mateus, Julio] Univ Valle, Sch Publ Hlth, Cali, Colombia; [Cesar Mateus, Julio] Fdn CES, Cali, Colombia		Echeverri, I (corresponding author), Univ ICESI, Calle 18 122-135,Edificio L, Cali, Colombia.	iecheverri1@icesi.edu.co; Milton.Suarez@ed.ac.uk	Mateus, Julio/Y-9267-2019; Echeverri, Isabella IE/D-4350-2017	Echeverri, Isabella IE/0000-0001-7916-3897; Suarez Ortegon, Milton Fabian/0000-0002-0513-5196; ORTEGA AVILA, JOSE GUILLERMO/0000-0003-2112-3870; Jimenez Charris, Eliecer/0000-0001-6043-1521; Castillo, Andres/0000-0001-9006-6721; Mosquera, Mildrey/0000-0003-0783-5839; Mateus-Solarte, Julio Cesar/0000-0001-7760-7423	Colombian Department for Science and Technology development (COLCIENCIAS) [1106-45921540]	Colombian Department for Science and Technology development (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Contract grant sponsor: Colombian Department for Science and Technology development (COLCIENCIAS); Contract grant number: 1106-45921540.	Adams MR, 2000, ANNU REV MED, V51, P149, DOI 10.1146/annurev.med.51.1.149; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; Al-Saleh I, 2014, INT J HYG ENVIR HEAL, V217, P567, DOI 10.1016/j.ijheh.2013.11.001; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Armstrong L, 2006, ARCH DIS CHILD-FETAL, V91, P342, DOI 10.1136/adc.2005.086744; Babu MS, 2012, CLIN BIOCHEM, V45, P835, DOI 10.1016/j.clinbiochem.2012.04.018; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Calderon TC, 2008, J PERINATOL, V28, P475, DOI 10.1038/jp.2008.29; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Osorio JC, 2011, REPROD TOXICOL, V31, P35, DOI 10.1016/j.reprotox.2010.09.011; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Delisle H, 2002, PROGRAMMING CHRONIC; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Grune T, 2007, CURR OPIN CLIN NUTR, V10, P712, DOI 10.1097/MCO.0b013e3282f0c97c; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Holzhauer Susanne, 2009, Early Hum Dev, V85, P285, DOI 10.1016/j.earlhumdev.2008.11.002; Hung TH, 2010, REPROD SCI, V17, P401, DOI 10.1177/1933719109359704; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Jones H, 2010, AM J PHYSIOL-REG I, V298, pR427, DOI 10.1152/ajpregu.00442.2009; Kamat R, 2011, INT J CARDIOL, V149, P17, DOI 10.1016/j.ijcard.2009.11.034; Kim YJ, 2005, REPROD TOXICOL, V19, P487, DOI 10.1016/j.reprotox.2004.10.007; Koklu E, 2007, J PAEDIATR CHILD H, V43, P667, DOI 10.1111/j.1440-1754.2007.01184.x; Krause BJ, 2011, PLACENTA, V32, P797, DOI 10.1016/j.placenta.2011.06.025; Lazdam M, 2010, HYPERTENSION, V56, P159, DOI 10.1161/HYPERTENSIONAHA.110.150235; Leikert JF, 2001, FEBS LETT, V506, P131, DOI 10.1016/S0014-5793(01)02901-5; Lewis R, 2006, REV GYNECOL PERINAT, V6, P70, DOI DOI 10.1016/J.RIGAPP.2005.12.001; Miyague AH, 2013, HYPERTENS PREGNANCY, V32, P225, DOI 10.3109/10641955.2013.790412; Mullen MJ, 2001, CIRC RES, V88, P145; Ramirez-Velez R, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-60; Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, pH247, DOI 10.1152/ajpheart.01309.2010; Saarelainen H, 2006, CIRC J, V70, P768, DOI 10.1253/circj.70.768; Steghens JP, 2001, FREE RADICAL BIO MED, V31, P242, DOI 10.1016/S0891-5849(01)00578-0; Stoner L, 2012, J ATHEROSCLER THROMB, V19, P589, DOI 10.5551/jat.11973; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Tschakovsky ME, 2005, J APPL PHYSIOL, V99, P1235, DOI 10.1152/japplphysiol.00607.2005; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Weissgerber TL, 2011, CLIN SCI, V121, P355, DOI 10.1042/CS20110008; Yang X, 2012, J MATERN-FETAL NEO M, V25, P884, DOI 10.3109/14767058.2011.601367	46	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-0533	1520-6300		AM J HUM BIOL	Am. J. Hum. Biol.	NOV-DEC	2015	27	6			SI		822	831		10.1002/ajhb.22733	http://dx.doi.org/10.1002/ajhb.22733			10	Anthropology; Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anthropology; Life Sciences & Biomedicine - Other Topics	CX0PC	25945813				2022-09-04	WOS:000365398000010
J	Luna-Acosta, A; Bustamante, P; Budzinski, H; Huet, V; Thomas-Guyon, H				Luna-Acosta, A.; Bustamante, P.; Budzinski, H.; Huet, V.; Thomas-Guyon, H.			Persistent organic pollutants in a marine bivalve on the Marennes-Oleron Bay and the Gironde Estuary (French Atlantic Coast)-Part 2: Potential biological effects	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Crassostrea gigas; Oxidative stress; Immune humoral defences; Polycyclic aromatic hydrocarbons; Persistent organic pollutants; Active biomonitoring	OYSTER CRASSOSTREA-GIGAS; POLYCYCLIC AROMATIC-HYDROCARBONS; MUSSEL MYTILUS-GALLOPROVINCIALIS; SEASONAL-VARIATIONS; ANTIOXIDANT ENZYMES; SUMMER MORTALITY; PACIFIC OYSTERS; POLYCHLORINATED-BIPHENYLS; IMMUNOLOGICAL PARAMETERS; PEROXISOME PROLIFERATION	Contaminant effects on defence responses of ecologically and economically important organisms, such as the Pacific oyster Crassostrea gigas, are likely to influence their ability to resist infectious diseases, particularly at the young stages. The aim of this study was to explore the potential relationships between organic contaminants accumulated in the soft tissues of juvenile oysters, defence responses and physiological condition. Oysters were transplanted during summer and winter periods in different sites in the Marennes-Oleron Bay, the first area of oyster production in France, and in the Gironde Estuary, the biggest estuary in Occidental Europe. Amongst the battery of biochemical and physiological biomarkers applied in the present work [superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), malondyaldehyde (MDA), catecholase, laccase and lysozyme in gills, digestive glands, mantle and haemolymph, glycogen, proteins and lipids in the digestive gland and the condition index at the whole-organism level], MDA and lysozyme in the digestive gland and SOD, GPx and laccase in plasma contributed in order to significantly discriminate the sites in which oysters bioaccumulated different levels of heavy polycyclic aromatic hydrocarbons (HPAHs), polychlorobiphenyls (PCBs), polybromodiphenylethers (PBDEs), dichlorodiphenyltrichloroethanes (DDTs) and lindane. These results strengthen the hypothesis that it is possible to differentiate sites depending on their contamination levels and biological effects by carrying out studies with transplanted juvenile oysters. In addition, correlations were found between antioxidant and immune-defence responses, and PAH and DDT body burdens in the first area of oyster production in France (the Marennes-Oleron Bay) and where considerable oyster mortalities have been reported. This result suggests that the presence of organic chemical contaminants in the Marennes-Oleron Bay may influence defence responses in juveniles of C. gigas, and, therefore, could influence their ability to resist infectious diseases. (C) 2014 Elsevier B.V. All rights reserved.	[Luna-Acosta, A.; Bustamante, P.; Huet, V.; Thomas-Guyon, H.] Univ La Rochelle, UMR CNRS 7266, Littoral Environm & Soc LIENSs, F-17042 Rochelle 01, France; [Budzinski, H.] Univ Bordeaux 1, UMR CNRS 5805, UMR EPOC, Lab Phys ToxicoChim Environm LPTC, F-33405 Talence, France; [Budzinski, H.] Univ Bordeaux 1, CNRS, UMR 5805, EPOC,Lab Phys ToxicoChim Environm LPTC, F-33405 Talence, France		Luna-Acosta, A (corresponding author), Univ Javeriana, Dept Ecol & Terr, Transv 4 42-00, Bogota, Colombia.	aluna1508@yahoo.com	Bustamante, Paco/G-5833-2011	Bustamante, Paco/0000-0003-3877-9390; BUDZINSKI, Helene/0000-0001-5282-9011; Luna-Acosta, Andrea/0000-0002-4712-2721	Conseil General de the Charente-Maritime; Region Poitou-Charentes; Region Aquitaine; Conseil General de la Charente-Maritime; Conseil General de la Gironde; Agence de l'Eau Adour-Garonne; CPER A2E	Conseil General de the Charente-Maritime(Region Nouvelle-Aquitaine); Region Poitou-Charentes(Region Nouvelle-Aquitaine); Region Aquitaine(Region Nouvelle-Aquitaine); Conseil General de la Charente-Maritime(Region Nouvelle-Aquitaine); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Agence de l'Eau Adour-Garonne; CPER A2E	This study was supported by a PhD grant from the Conseil General de the Charente-Maritime for A. Luna-Acosta. Authors wish to thank M. Baudrimont and D. Fichet for supporting this study through the 'Defi Cadmium' project, financed by Region Poitou-Charentes, Region Aquitaine, Conseil General de la Charente-Maritime, Conseil General de la Gironde, and Agence de l'Eau Adour-Garonne. CPER A2E is also acknowledged for financial support. Authors also acknowledge R. Galois and M. Metian for their scientific advice for lipid and glycogen content and condition index analyses, M. Caine, J. Laheux and M. Pelmoine for their assistance during the study, and the Ifremer networks ROCCH and RAZLEC, the 'Site Ifremer consacre a l'environnement littoral' and especially O. Le Moine, P. Soletchnik, S. Guesdon, P-G. Sauriau, P. Miramand and T. Guyot, for data and references from Marennes-Oleron Bay. Authors also acknowledge C. Trichet and D. Vilday for their technical assistance during the study. Authors wish to also warmly thank T. Caquet and P. Legendre for their scientific advice and help in statistical analyses.	Allan IJ, 2006, TALANTA, V69, P302, DOI 10.1016/j.talanta.2005.09.043; Auffret M, 2004, AQUAT LIVING RESOUR, V17, P297, DOI 10.1051/alr:2004035; Baumard P, 1999, MAR ENVIRON RES, V47, P17, DOI 10.1016/S0141-1136(98)00105-6; Besse JP, 2012, TRAC-TREND ANAL CHEM, V36, P113, DOI 10.1016/j.trac.2012.04.004; Bodin N, 2004, COMP BIOCHEM PHYS C, V138, P411, DOI 10.1016/j.cca.2004.04.009; BORG DC, 1984, ISR J CHEM, V24, P38; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Cheney DP, 2000, J SHELLFISH RES, V19, P353; CLARK RB, 1982, PHILOS T ROY SOC B, V297, P185, DOI 10.1098/rstb.1982.0037; Damasio J, 2010, ECOTOXICOLOGY, V19, P1084, DOI 10.1007/s10646-010-0490-3; Davies IM, 2012, 315 ICES; De La Parra AM, 2005, J SHELLFISH RES, V24, P457, DOI 10.2983/0730-8000(2005)24[457:SVOTBC]2.0.CO;2; De Luca-Abbott SB, 2005, MAR POLLUT BULL, V51, P694, DOI 10.1016/j.marpolbul.2005.01.010; DIGIULIO RT, 1989, ENVIRON TOXICOL CHEM, V8, P1103, DOI 10.1002/etc.5620081203; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; ESPIN JC, 1995, ANAL BIOCHEM, V231, P237, DOI 10.1006/abio.1995.1526; FAO, 2010, AQ PROD QUANT 1950 2; Fernandez B, 2010, AQUAT TOXICOL, V99, P186, DOI 10.1016/j.aquatox.2010.04.013; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOSSATI P, 1980, CLIN CHEM, V26, P227; Gabbott P, 1975, EUR MAR BIOL S AB; Galgani F, 2011, ENVIRON MONIT ASSESS, V172, P301, DOI 10.1007/s10661-010-1335-5; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Gauthier-Clerc S, 2002, COMP BIOCHEM PHYS C, V131, P457, DOI 10.1016/S1532-0456(02)00041-8; Geffard A, 2002, COMP BIOCHEM PHYS C, V131, P281, DOI 10.1016/S1532-0456(02)00015-7; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Greenfield R, 2014, MAR POLLUT BULL, V85, P566, DOI 10.1016/j.marpolbul.2014.03.032; Guidi P, 2010, AQUAT TOXICOL, V100, P75, DOI 10.1016/j.aquatox.2010.07.009; Gunther AJ, 1999, MAR POLLUT BULL, V38, P170, DOI 10.1016/S0025-326X(98)00185-4; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hagger JA, 2005, MAR POLLUT BULL, V51, P811, DOI 10.1016/j.marpolbul.2005.06.044; Hedouin L, 2011, WATER RES, V45, P483, DOI 10.1016/j.watres.2010.09.002; Hyoylainen T, 2002, WATER RES, V36, P4497, DOI 10.1016/S0043-1354(02)00156-2; JOHNSTON SA, 1981, ENVIRON MANAGE, V5, P427, DOI 10.1007/BF01866820; Krishnakumar PK, 1995, MAR BIOL, V124, P251, DOI 10.1007/BF00347129; Lacoste A, 2001, APPL ENVIRON MICROB, V67, P2304, DOI 10.1128/AEM.67.5.2304-2309.2001; LAGADIC L, 1994, ECOTOXICOLOGY, V3, P193, DOI 10.1007/BF00117084; Laroche J, 2013, ENVIRON SCI POLLUT R, V20, P738, DOI 10.1007/s11356-012-1276-3; Leps J., 1999, MULTIVARIATE ANAL EC; LIVINGSTONE DR, 1993, J CHEM TECHNOL BIOT, V57, P195; LOBEL PB, 1982, MAR BIOL, V66, P145, DOI 10.1007/BF00397187; Luna-Acosta A, 2015, SCI TOTAL ENVIRON, V514, P500, DOI 10.1016/j.scitotenv.2014.08.071; Luna-Acosta A, 2012, CHEMOSPHERE, V87, P1335, DOI 10.1016/j.chemosphere.2012.02.022; Luna-Acosta A, 2011, WATER RES, V45, P4103, DOI 10.1016/j.watres.2011.05.011; Luna-Acosta A, 2011, COMP BIOCHEM PHYS B, V159, P220, DOI 10.1016/j.cbpb.2011.04.009; Luna-Acosta A, 2010, FISH SHELLFISH IMMUN, V28, P719, DOI 10.1016/j.fsi.2010.01.008; Luna-Acosta A, 2010, ENVIRON SCI POLLUT R, V17, P999, DOI 10.1007/s11356-009-0287-1; Magni P, 2006, ENVIRON POLLUT, V142, P65, DOI 10.1016/j.envpol.2005.09.018; Manduzio H, 2004, AQUAT TOXICOL, V70, P83, DOI 10.1016/j.aquatox.2004.07.003; Miramand P, 2003, J PHYS IV, V108, P3, DOI 10.1051/jp4:20030584; Mourgaud Y, 2002, BIOMARKERS, V7, P479, DOI 10.1080/1354750021000034528; Munaron D, 2006, CAH BIOL MAR, V47, P85; OLIVER LM, 1995, DIS AQUAT ORGAN, V22, P217, DOI 10.3354/dao022217; Orbea A, 2002, AQUAT TOXICOL, V58, P75, DOI 10.1016/S0166-445X(01)00226-0; Orbea A, 2006, ENVIRON TOXICOL CHEM, V25, P1616, DOI 10.1897/04-520R2.1; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Patrick S, 2006, AQUACULTURE, V252, P328, DOI 10.1016/j.aquaculture.2005.07.008; PELLERINMASSICOTTE J, 1994, COMP BIOCHEM PHYS A, V107, P509, DOI 10.1016/0300-9629(94)90033-7; PERDUE J A, 1981, Journal of Shellfish Research, V1, P9; Pigeot J, 2006, MAR ECOL PROG SER, V307, P101, DOI 10.3354/meps307101; PORTE C, 1991, COMP BIOCHEM PHYS C, V100, P183, DOI 10.1016/0742-8413(91)90150-R; Richardson BJ, 2008, MAR POLLUT BULL, V57, P503, DOI 10.1016/j.marpolbul.2008.02.032; Samain JF, 2007, AQUACULTURE, V268, P227, DOI 10.1016/j.aquaculture.2007.04.044; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SOLE M, 1995, SCI TOTAL ENVIRON, V159, P147, DOI 10.1016/0048-9697(95)04182-Z; Soletchnik P, 1999, AQUAT LIVING RESOUR, V12, P131, DOI 10.1016/S0990-7440(99)80022-9; Soudant P, 2004, AQUACULTURE, V229, P401, DOI 10.1016/S0044-8486(03)00352-1; Strady E, 2011, CHEMOSPHERE, V84, P80, DOI 10.1016/j.chemosphere.2011.02.051; Tapie N, 2008, ANAL BIOANAL CHEM, V391, P2169, DOI 10.1007/s00216-008-2148-z; Therond P, 1996, J INVEST DERMATOL, V106, P1325, DOI 10.1111/1523-1747.ep12349055; Thompson S, 2000, INT J ENVIRON AN CH, V76, P49, DOI 10.1080/03067310008034117; WINSTON GW, 1991, COMP BIOCHEM PHYS C, V100, P173, DOI 10.1016/0742-8413(91)90148-M; Zar JH., 1999, BIOSTAT ANAL, V4	76	28	28	2	46	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	MAY 1	2015	514						511	522		10.1016/j.scitotenv.2014.10.050	http://dx.doi.org/10.1016/j.scitotenv.2014.10.050			12	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	CE7RM	25666833	Green Submitted			2022-09-04	WOS:000352039500054
J	Figuls, MRI; Gine-Garriga, M; Rugeles, CG; Perrotta, C				Roque i Figuls, Marta; Gine-Garriga, Maria; Granados Rugeles, Claudia; Perrotta, Carla			Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review						Acute Disease; Bronchiolitis [therapy]; Drainage, Postural; Infant, Newborn; Oxygen Inhalation Therapy; Percussion [methods]; Randomized Controlled Trials as Topic; Respiratory Therapy [methods]; Vibration [therapeutic use]; Humans; Infant	RESPIRATORY SYNCYTIAL VIRUS; CONSENSUS CONFERENCE; RISK-FACTORS; INFANTS; MANAGEMENT; CHILDREN; GUIDELINES; DEATHS; IMPACT; CARE	Background This is an update of the original Cochrane review published in 2005 and updated in 2007. Acute bronchiolitis is the leading cause of medical emergencies during winter in children younger than two years of age. Chest physiotherapy is thought to assist infants in the clearance of secretions and to decrease ventilatory effort. Objectives The main objective was to determine the efficacy of chest physiotherapy in infants aged less than 24 months old with acute bronchiolitis. A secondary objective was to determine the efficacy of different techniques of chest physiotherapy (for example, vibration and percussion and passive forced exhalation). Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 4) which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to November week 3, 2011), MEDLINE in-process and other non-indexed citations (8 December 2011), EMBASE.com (1990 to December 2011), CINAHL (1982 to December 2011), LILACS (1985 to December 2011) and Web of Science (1985 to December 2011). Selection criteria Randomised controlled trials (RCTs) in which chest physiotherapy was compared against no intervention or against another type of physiotherapy in bronchiolitis patients younger than 24 months of age. Data collection and analysis Two review authors independently extracted data. Primary outcomes were respiratory parameters and improvement in severity of disease. Secondary outcomes were length of hospital stay, duration of oxygen supplementation and the use of bronchodilators and steroids. No pooling of data was possible. Main results Nine clinical trials including 891 participants were included comparing physiotherapy with no intervention. Five trials (246 participants) evaluated vibration and percussion techniques and four trials (645 participants) evaluated passive expiratory techniques. We observed no significant differences in the severity of disease (eight trials, 867 participants). Results were negative for both types of physiotherapy. We observed no differences between groups in respiratory parameters (two trials, 118 participants), oxygen requirements (one trial, 50 participants), length of stay (five trials, 222 participants) or severe side effects (two trials, 595 participants). Differences in mild transient adverse effects (vomiting and respiratory instability) have been observed (one trial, 496 participants). Authors' conclusions Since the last publication of this review new good-quality evidence has appeared, strengthening the conclusions of the review. Chest physiotherapy does not improve the severity of the disease, respiratory parameters, or reduce length of hospital stay or oxygen requirements in hospitalised infants with acute bronchiolitis not on mechanical ventilation. Chest physiotherapy modalities (vibration and percussion or forced expiratory techniques) have shown equally negative results.	[Roque i Figuls, Marta] CIBERESP, Inst Biomed Res IIB St Pau, Iberoamer Cochrane Ctr, Barcelona 08041, Catalunya, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain; [Gine-Garriga, Maria] Inst Catala Salut, Dept Phys Act & Hlth, Barcelona, Spain; [Granados Rugeles, Claudia] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perrotta, Carla] UCD Sch Publ Hlth & Populat Sci, Dublin, Ireland		Figuls, MRI (corresponding author), CIBERESP, Inst Biomed Res IIB St Pau, Iberoamer Cochrane Ctr, St Antoni Maria Claret 171,Edifici Casa de Conval, Barcelona 08041, Catalunya, Spain.	mroque@santpau.es	Giné-Garriga, Maria/F-4089-2016; Giné-Garriga, Maria/AAF-9828-2019	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Perrotta, Carla/0000-0001-5986-4581; Granados, Claudia/0000-0002-7120-7530; Roque i Figuls, Marta/0000-0003-0043-1364	Child Health Field, The Cochrane Collaboration; Iberoamerican Cochrane Center, Barcelona, Spain; UCD School of Public Health and Population Sciences, Ireland; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria, Spain [01/A060]	Child Health Field, The Cochrane Collaboration; Iberoamerican Cochrane Center, Barcelona, Spain; UCD School of Public Health and Population Sciences, Ireland; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria, Spain	Zulma Ortiz, co-author of the first version of this review. The first version of the review was developed with the help of: Iberoamerican Cochrane Center, "Centro de Investigaciones Epidemiologicas", Academia Nacional de Medicina de Buenos Aires and with partial funding by the Child Health Field, The Cochrane Collaboration. The authors wish to thank the following people for commenting on versions of the review: Mariano Gallo, Durhane Wong-Rieger, Georges De Bilderling, Sree Nair, Abigail Fraser, Cindy Cai, Martin Chalumeau, Max Bulsara and Hans van der Wouden.; Internal sources; Iberoamerican Cochrane Center, Barcelona, Spain.; UCD School of Public Health and Population Sciences, Ireland.; External sources; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria (01/A060), Spain.	[Anonymous], 2001, ARCH PEDIAT S1, V8, P11; [Anonymous], 2010, EFF CHEST PHYS ACT V; [Anonymous], 91 SIGN; Aviram M, 1992, EUROPEAN RESP J S15, V5, P229; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Beauvois E, 2001, ARCH PEDIATRIE, V8, p128S; Beeby PJ, 1998, J PAEDIATR CHILD H, V34, P60, DOI 10.1046/j.1440-1754.1998.00155.x; BELCASTRO MR, 1984, J AM OSTEOPATH ASSOC, V83, P672; Bernard-Narbonne F, 2003, ARCH PEDIATRIE, V10, P1043, DOI 10.1016/j.arcped.2003.09.033; BIERMAN CW, 1974, PEDIATRICS, V54, P245; Bohe L, 2004, MEDICINA-BUENOS AIRE, V64, P198; Bronchiolitis Guideline Team, 2005, EV BAS CLIN PRACT GU; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Chalumeau M, 2002, PEDIATR RADIOL, V32, P644, DOI 10.1007/s00247-002-0755-y; David M, 2010, ARCH PEDIATRIE, V17, P125, DOI 10.1016/j.arcped.2009.10.022; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Fernandes RM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub3; Gadomski AM, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001266.pub2, 10.1002/14651858.CD001266.pub3]; Gajdos V, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000345; Gonzalez Caballero D, 2001, An Esp Pediatr, V55, P355; de Dios JG, 2010, AN PEDIATR, V72, P4, DOI 10.1016/j.anpedi.2009.10.006; Gonzalez de Dios J, 2010, ANALES PEDIAT BARCEL, V72; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Halna M, 2005, PRESSE MED, V34, P277, DOI 10.1016/S0755-4982(05)83905-3; Harding JE, 1998, J PEDIATR-US, V132, P440, DOI 10.1016/S0022-3476(98)70017-4; Hartling L, 2011, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003123.PUB2, 10.1002/14651858.CD003123.pub2]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RC, 2003, PEDIATR INFECT DIS J, V22, P483, DOI 10.1097/00006454-200306000-00001; Knight DB, 2001, J PAEDIATR CHILD H, V37, P554, DOI 10.1046/j.1440-1754.2001.00706.x; Lanza FD, 2008, MUNDO SAUDE, V32, P183; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liet JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006915.pub2; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mc Millan JA, 1994, OSKIS PEDIAT PRINCIP; Nicholas KJ, 1999, PHYSIOTHERAPY, V85, P669; Panickar JR, 2005, THORAX, V60, P1035, DOI 10.1136/thx.2005.044750; Perrotta C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004873.pub3; Postiaux G, 2008, EUR RESP SOC ANN C B, pE1772; Postiaux G, 2004, P 6 INT M PED NUM S, P117; Postiaux G, 2011, RESP CARE, V56, P989, DOI 10.4187/respcare.00721; Pupin MK, 2009, J BRAS PNEUMOL, V35, P860, DOI 10.1590/S1806-37132009000900007; Quitell LM, 1988, AM REV RESPIR DIS, V137, p406A; Rochat I, 2010, PAEDIAT RESP R S1526, V11, P85; Rochat I, 2011, EUROPEAN J PEDIAT; Sanchez Etxaniz J, 2007, EVID PEDIAT, V3, P88; Schechter MS, 2007, RESP CARE, V52, P1382; Spencer N, 1996, ARCH DIS CHILD, V74, P50, DOI 10.1136/adc.74.1.50; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2; TAL A, 1983, PEDIATRICS, V71, P13; Touzet S, 2007, J EVAL CLIN PRACT, V13, P651, DOI 10.1111/j.1365-2753.2007.00781.x; Umoren R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006435.pub2; Videla C, 1998, CLIN DIAGN VIROL, V10, P17, DOI 10.1016/S0928-0197(98)00017-8; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; Wainwright C, 2010, PAEDIATR RESPIR REV, V11, P39, DOI 10.1016/j.prrv.2009.10.001; Wallis C, 1999, ARCH DIS CHILD, V80, P393, DOI 10.1136/adc.80.4.393; WANG EEL, 1992, AM REV RESPIR DIS, V145, P106, DOI 10.1164/ajrccm/145.1.106; WEBB MSC, 1985, ARCH DIS CHILD, V60, P1078, DOI 10.1136/adc.60.11.1078; Zhang L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006458.pub2	58	42	43	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2012		2							CD004873	10.1002/14651858.CD004873.pub4	http://dx.doi.org/10.1002/14651858.CD004873.pub4			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904ID	22336805				2022-09-04	WOS:000301187200012
J	Lavergne, A; Ruiz-Garcia, M; Catzeflis, F; Lacote, S; Contamin, H; Mercereau-Puijalon, O; Lacoste, V; de Thoisy, B				Lavergne, Anne; Ruiz-Garcia, Manuel; Catzeflis, Francois; Lacote, Sandra; Contamin, Hugues; Mercereau-Puijalon, Odile; Lacoste, Vincent; de Thoisy, Benoit			Phylogeny and Phylogeography of Squirrel Monkeys (Genus Saimiri) Based on Cytochrome b Genetic Analysis	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						cytochrome b; phylogeny; phylogeography; Saimiri	MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; AMAZON RIVER; SPECIATION; TAXONOMY; DIVERSIFICATION; PRIMATES; ALOUATTA; PLATYRRHINI; SEQUENCES	Squirrel monkeys (genus Saimiri) are distributed over a wide area encompassing the Amazon Basin: French Guiana, Suriname, and Guyana, together with Western Panama and Western Costa Rica. The genus Saimiri includes a complex of species and subspecies displaying considerable morphological variation. Taxonomic and systematic studies have identified, in this genus, one to seven species comprising up to 16 subspecies. The phylogenetic relationships between these taxa are poorly understood. Molecular markers have yielded a consistent framework for the systematics of Central and South American Saimiri, identifying four distinct clades: S. oerstedii, S. sciureus, S. boliviensis, and S. ustus. Here, we reconsider the phylogenetic and biogeographic history of Saimiri on the basis of mitochondrial (mtDNA) sequence data, focusing mostly on individuals originating from the Amazon Basin. We studied 32 monkeys with well-defined geographic origins and inferred the phylogenetic relationships between them on the basis of full-length cytochrome b gene nucleotide sequences. The high level of gene diversity observed (0.966) is consistent with the high level of behavioral and morphological variation observed across the geographic range of the genus: 20 mtDNA haplotypes were identified with a maximum divergence of 4.81% between S. b. boliviensis and S. ustus. In addition to confirming the existence of the four clades previously identified on the basis of molecular characters, we suggest several new lineages, including S. s. macrodon, S. s. albigena, S. s. cassiquiarensis, and S. s. collinsi. We also propose new patterns of dispersion and diversification for the genus Saimiri, and discuss the contribution of certain rivers and forest refuges to its structuring. Am. J. Primatol. 72:242-253, 2010. (C) 2009 Wiley-Liss, Inc.	[Lavergne, Anne; Lacote, Sandra; Contamin, Hugues; de Thoisy, Benoit] Inst Pasteur, Serv Primatol, Ctr Primatol, Cayenne 97306, French Guiana; [Lavergne, Anne; Lacoste, Vincent; de Thoisy, Benoit] Inst Pasteur, Lab Interact Virus Hotes, Cayenne 97306, French Guiana; [Ruiz-Garcia, Manuel] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblaciones Mol Biol Evolut, Bogota, Colombia; [Catzeflis, Francois] Univ Montpellier 2, Lab Paleontol Paleobiol & Phylogenie, Inst Sci Evolut, Montpellier, France; [Lacote, Sandra] Inst Pasteur, Unite Biol Infect Virales Emergentes, Lab Jean Merieux P4, Lyon, France; [Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France		de Thoisy, B (corresponding author), Inst Pasteur, Serv Primatol, Ctr Primatol, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.	bdethoisy@pasteur-cayenne.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; LACOSTE, Vincent/V-2321-2019; Ruiz-Garcia, Manuel/AAF-8191-2019	LACOSTE, Vincent/0000-0002-3173-4053; Ruiz-Garcia, Manuel/0000-0003-2820-2950	Institut Pasteur de la Guyane; French Ministry of Education, Research and Technology; International Network of Pasteur Institutes (ACIP)	Institut Pasteur de la Guyane; French Ministry of Education, Research and Technology; International Network of Pasteur Institutes (ACIP)	Contract grant sponsors: Institut Pasteur de la Guyane; French Ministry of Education, Research and Technology; International Network of Pasteur Institutes (ACIP).	Aide TM, 1998, J BIOGEOGR, V25, P695, DOI 10.1046/j.1365-2699.1998.2540695.x; ARCTANDER P, 1995, P ROY SOC B-BIOL SCI, V262, P13, DOI 10.1098/rspb.1995.0170; Avise J.C., 2000, PHYLOGEOGRAPHY HIST; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boinski S, 1999, INT J PRIMATOL, V20, P237, DOI 10.1023/A:1020522519946; BOINSKI S, 1988, AM J PRIMATOL, V14, P329, DOI 10.1002/ajp.1350140403; Bonvicino CR, 2001, CHROMOSOMA, V110, P241, DOI 10.1007/s004120000128; Coates Anthony G., 1996, P21; Coe, 1985, HDB SQUIRREL MONKEY, P191; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Costello Robert K., 1993, P177; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Cropp S, 2000, MOL PHYLOGENET EVOL, V16, P350, DOI 10.1006/mpev.2000.0814; CROPP S, 1998, DISS ABSTR INT B, V58, P6433; Cropp SJ, 1999, AM J PHYS ANTHROPOL, V108, P65, DOI 10.1002/(SICI)1096-8644(199901)108:1<65::AID-AJPA4>3.0.CO;2-4; DASILVA BTF, 1987, INT J PRIMATOL, V8, P528; DASILVA BTF, 1993, AM J PRIMATOL, V29, P183; Dick CW, 2008, EVOLUTION, V62, P2760, DOI 10.1111/j.1558-5646.2008.00506.x; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endler J.A., 1982, P641; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrell J, 2004, THEOR CRIMINOL, V8, P101; FLEAGLE JG, 1983, FOLIA PRIMATOL, V41, P240, DOI 10.1159/000156135; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; HERSHKOVITZ P, 1984, AM J PRIMATOL, V7, P155, DOI 10.1002/ajp.1350070212; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; JANSON CH, 1992, AM J PHYS ANTHROPOL, V88, P483, DOI 10.1002/ajpa.1330880405; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lavergne A, 2003, J MED PRIMATOL, V32, P330, DOI 10.1046/j.1600-0684.2003.00038.x; Lundberg John G., 1998, P13; Medeiros MA, 1997, AM J PRIMATOL, V42, P167, DOI 10.1002/(SICI)1098-2345(1997)42:3<167::AID-AJP1>3.0.CO;2-V; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Mustrangi MA, 1997, PHYLOGEOGRAPHY SYSTE; Nascimento FF, 2005, CYTOGENET GENOME RES, V108, P106, DOI 10.1159/000080808; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nylander JAA, 2004, MRMODELTEST V2 PROGR; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Patton JL, 1998, ENDLESS FORMS, P202; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rambaut A., 2014, TRACER V16; Renno JF, 2006, MOL PHYLOGENET EVOL, V41, P503, DOI 10.1016/j.ympev.2006.05.029; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSENBERGER AL, 1979, NATURE, V279, P416, DOI 10.1038/279416a0; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruiz-Garcia M., 2006, Primate Report, V73, P3; Ruiz-Garcia M, 2007, FOLIA PRIMATOL, V78, P73, DOI 10.1159/000097058; Rull V, 2006, MOL ECOL, V15, P4257, DOI 10.1111/j.1365-294X.2006.03052.x; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Sambrook J., 1989, MOL CLONING LAB MANU; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; STIRTON RA, 1951, B U CALIFORNIA PUBLI, V28, P315; Swofford D., 2002, MAC VERS, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Szalay F.S., 1979, EVOLUTIONARY HIST PR; Tchaicka L, 2007, MOL ECOL, V16, P819, DOI 10.1111/j.1365-294X.2006.03185.x; Thorington R.W. Jr, 1985, P1; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; VANDEBERG JL, 1987, INT J PRIMATOL, V8, P423; VANDEBERG JL, 1990, AM J PRIMATOL, V22, P101, DOI 10.1002/ajp.1350220204; WALKER LC, 1981, AM J PRIMATOL, V1, P379, DOI 10.1002/ajp.1350010403; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; WHITELEY HE, 1987, AM J TROP MED HYG, V37, P1	72	37	40	1	33	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	MAR	2010	72	3					242	253		10.1002/ajp.20773	http://dx.doi.org/10.1002/ajp.20773			12	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	555KF	19937739				2022-09-04	WOS:000274508900005
J	Martinez-Gomez, C; Parraguez-Camus, C				Martinez-Gomez, Ciro; Parraguez-Camus, Carla			Social harm, neoliberalism and the Covid-19 pandemic in Latin America	PAPELES DE POBLACION			English	Article						Neoliberalism; harm; inequality; poverty; privatization; Covid-19 pandemic impact		This article seeks to uncover how harms in Latin America generated under the neoliberal model over more than four decades ago enhance the negative impacts of the Covid-19 pandemic. Taking Santiago and Bogota as examples, the article scrutinizes how neoliberal harms directly impact health systems given the state's incapacity in achieving public health goals and a rise in access segregation to health services due to Covid-19. Higher levels of contagion and deaths and the policies' poor effectiveness are linked to the previous social harms produced by neoliberalism in the region. The links between Covid-19 and inequality and poverty, especially regarding informality, low educational levels, overcrowding, and the limitations on access to services are uncovered.	[Martinez-Gomez, Ciro] ECLAC Santiago, Populat Div, Santiago, Chile; [Martinez-Gomez, Ciro] UNFPA Off, Bogota, Colombia; [Martinez-Gomez, Ciro] Dept Natl Planning Colombia, Populat Div, Bogota, Colombia; [Martinez-Gomez, Ciro] Dept Natl Planning Colombia, Publ Spending Div, Bogota, Colombia; [Martinez-Gomez, Ciro] Dept Stat Colombia, Demog, Bogota, Colombia; [Martinez-Gomez, Ciro] Javeriana Univ, Externado Colombia, Bogota, Colombia; [Martinez-Gomez, Ciro] Nacl Colombia Univ, Externado Colombia, Bogota, Colombia; [Parraguez-Camus, Carla] Univ Birmingham, Social Policy, Birmingham, W Midlands, England		Martinez-Gomez, C (corresponding author), ECLAC Santiago, Populat Div, Santiago, Chile.; Martinez-Gomez, C (corresponding author), UNFPA Off, Bogota, Colombia.	clmgpers@gmail.com; carliparraguez@gmail.com						AFP, 2020, PAND TIEN IMP DEV AT; [Anonymous], 2020, PAIS 0825; [Anonymous], 2020, TIEMPO 0813; [Anonymous], 2020, NEW YORK TIMES 0711; Atria F., 2013, OTRO MODELO ORDEN NE; Atria Fernando, 2013, VEINTE ANOS DESPUES; Barbosa Camargo SF, 2020, CARACTERIZACION PRES; CEPAL, 2010, TIM EQ CLOS GAPS OP; CEPAL, 2019, PANORAMA SOCIAL; CEPAL, 2019, EST EC AM LAT CAR NU; COMISION ECONOMICA PARA AMERICA LATINA Y EL CARIBE (CEPAL), 2020, DOCUMENTOS PROYECTOS; DANE, 2020, B TECN MED POBR MULT; DANE, 2018, ARCH NAC DAT ANDA EN; Dinero, 2020, COR CUANT PRUEB PROC; DNP, 2018, CONT I APP SECT SAL; England K, 2016, HANDBOOK OF NEOLIBERALISM, P50; Foucault Michelle, 2002, DISCIPLINA CASTIGO; Garcia Francy, 2020, REV COLOMB BIOET; Green Duncan, 2003, SILENT REVOLUTION RI, P39; Guerrero Ramiro, 2011, SISTEMA SALUD COLOMB; Harvey D., 2007, BRIEF HIST NEOLIBERA; Hill D, 2016, HANDBOOK OF NEOLIBERALISM, P130; Hillyard P., 2004, CRIMINOLOGY TAKING H; INE, 2020, ENC NAC EMPL; INFOBAE, 2020, INS RAZ QUE PUED ID; INS, 2020, BOL CAS COV 19 COL; Lewis N, 2016, HANDBOOK OF NEOLIBERALISM, P73; Lloyd-Sherlock P, 2009, SOC POLICY ADMIN, V43, P347, DOI 10.1111/j.1467-9515.2009.00667.x; Mayol A., 2012, DERRUMBE MODELO CRIS; Ministerio de Desarrollo Social Chile, 2017, ENC CASEN 2017; Ministerio de Proteccion Social de Colombia, MARC CONC AN SIST SA; Molina Carlos, 1994, GASTO PUBLICO SALUD; Monreal M., 2018, EDUCACIO SOCIAL REV, P39; Moulian T., 1998, CONSUMO ME CONSUME; MUGGAH ROBERT, 2018, CITIZEN SECURITY LAT, P33; OCDE, 2020, DAT SAL; OMS, 2021, DET SOC SAL; OPS, 2020, SIT COV 19 REG AM; OPS-Cepal, 2020, SAL EC CONV NEC ENFR; Organizacion Mundial de la Salud (OMS), 2020, EL ESPANOL; Parraguez Carla, 2017, THESIS U BIRMINGHAM; Peck J., 2010, CONSTRUCTIONS NEOLIB; Pemberton S., 2016, HARMFUL SOC UNDERSTA; Puello-Socarras Jose F., 2015, NEOLIBERALISMO AM LA, P19; RCN, 2020, AS CINC MILL COL EST; RCN, 2020, AN ACC VAR EPS DEM R; Ruiz Carlos, 2013, CONFLICTOS SOCIALES; Ruiz-Tagle Jaime, 2017, ENDEUDAMIENTO ENDEUD; Santa Maria Mauricio, 2009, DIAGNOSTICO GEN SECT; Solimano Andres, 2015, ELITES EC CRISIS CAP; Springer S, 2015, REV RADICAL POL ECON, V47, P5, DOI 10.1177/0486613413518724; Stiglitz Joseph, 2008, WASHINGTON CONSENSUS, P41, DOI DOI 10.1093/ACPROF:OSO/9780199534081.001.0001; Stiglitz Joseph E., 2008, WASHINGTON CONSENSUS, P14, DOI [10.1093/ACPROF:OSO/9780199534081.003.0002, DOI 10.1093/ACPROF:OSO/9780199534081.003.0002]; Taylor M., 2006, PINOCHET 3 WAY NEOLI; Universidad de los Andes, 2020, EF POBR DES COV 19 C, P23; Universidad de los Andes, 2020, PATR SOC COVID CAS B, P20; World Health Organization, 2020, COV 19; Zamora Roberto, 2012, ISAPRES CHILE I JURI	58	0	1	1	1	UNIV AUTONOMA ESTADO MEXICO	TOLUCA	CIUDAD UNIVERSITARIA, TOLUCA, CP 50100, MEXICO	1405-7425			PAPELES POBLAC	Papeles Poblac.	JUL-MAR	2021	27	107					103	137		10.22185/24487147.2021.107.05	http://dx.doi.org/10.22185/24487147.2021.107.05			35	Demography	Social Science Citation Index (SSCI)	Demography	XN0BX		gold			2022-09-04	WOS:000729181600005
J	Fernandez, N; Caicedo, JI				Fernandez, Nicolas; Caicedo, Juan Ignacio			Impact of COVID-19 on the future of pediatric urology practice. Do guidelines apply to medical practice worldwide?	JOURNAL OF PEDIATRIC UROLOGY			English	Letter									[Fernandez, Nicolas] Univ Washington, Seattle Childrens Hosp, Div Urol, Seattle, WA 98195 USA; [Fernandez, Nicolas] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; [Fernandez, Nicolas; Caicedo, Juan Ignacio] Univ Los Andes, Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia		Fernandez, N (corresponding author), Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA.	jnfb@uw.edu.co	Fernandez, Jose Nicolas/C-2188-2015	Fernandez, Jose Nicolas/0000-0002-9675-5963				American Cancer Society, 2020, CANC FACTS FIG, P2020; Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925; Bhatraj PK, 2020, NEW ENGL J MED, P1; Higashi H, 2015, ARCH DIS CHILD, V100, P233, DOI 10.1136/archdischild-2014-306175; PEREZ J, 2014, UROL COLOMB, V29, P16; Van Batavia JP, 2018, UROL CLIN N AM, V45, P623, DOI 10.1016/j.ucl.2018.06.009	6	4	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1477-5131	1873-4898		J PEDIATR UROL	J. Pediatr. Urol	JUN	2020	16	3					291	292		10.1016/j.jpurol.2020.05.001	http://dx.doi.org/10.1016/j.jpurol.2020.05.001			2	Pediatrics; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Urology & Nephrology	MD6SU	32467025	Bronze, Green Published			2022-09-04	WOS:000544102300010
J	Naranjo, A; Colonia, A; Mesa, J; Maury, H; Maury-Ramirez, A				Naranjo, Alejandra; Colonia, Andres; Mesa, Jaime; Maury, Heriberto; Maury-Ramirez, Anibal			State-of-the-Art Green Roofs: Technical Performance and Certifications for Sustainable Construction	COATINGS			English	Review						green roofs; biological coatings; hydraulic performance; thermal performance; sustainable construction certification; LEED; BREEAM; CASBEE; BEAM; ESGB	RUNOFF WATER QUANTITY; THERMAL-BEHAVIOR; QUALITY; MITIGATION; SURFACE; CLIMATE; COST	Green roof systems, a technology which was used in major ancient buildings, are currently becoming an interesting strategy to reduce the negative impact of traditional urban development caused by ground impermeabilization. Only regarding the environmental impact, the application of these biological coatings on buildings has the potential of acting as a thermal, moisture, noise, and electromagnetic barrier. At the urban scale, they might reduce the heat island effect and sewage system load, improve runoff water and air quality, and reconstruct natural landscapes including wildlife. In spite of these significant benefits, the current design and construction methods are not completely regulated by law because there is a lack of knowledge of their technical performance. Hence, this review of the current state of the art presents a proper green roof classification based on their components and vegetation layer. Similarly, a detailed description from the key factors that control the hydraulic and thermal performance of green roofs is given. Based on these factors, an estimation of the impact of green roof systems on sustainable construction certifications is included (i.e., LEED-Leadership in Energy and Environment Design, BREEAM-Building Research Establishment Environmental Assessment Method, CASBEE-Comprehensive Assessment System for Built Environment Efficiency, BEAM-Building Environmental Assessment Method, ESGB-Evaluation Standard for Green Building). Finally, conclusions and future research challenges for the correct implementation of green roofs are addressed.	[Naranjo, Alejandra; Maury-Ramirez, Anibal] Pontificia Univ Javeriana Cali, Dept Civil & Ind Engn, Cali 760031, Colombia; [Colonia, Andres] Dos Mundos, Gerencia, Cali 760050, Colombia; [Mesa, Jaime] Univ Tecnol Bolivar, Dept Mech Engn, Cartagena De Indias 130001, Colombia; [Maury, Heriberto] Univ Norte, Dept Mech Engn, Barranquilla 081007, Colombia; [Maury-Ramirez, Anibal] Univ De La Salle, Engn Fac, Bogota 111711, Colombia		Maury-Ramirez, A (corresponding author), Pontificia Univ Javeriana Cali, Dept Civil & Ind Engn, Cali 760031, Colombia.; Maury-Ramirez, A (corresponding author), Univ De La Salle, Engn Fac, Bogota 111711, Colombia.	alejanaranjo@gmail.com; gerencia@dosmundos.org; jmesa@utb.edu.co; hmaury@uninorte.edu.co; amaury@lasalle.edu.co	Mesa, Jaime A./T-1447-2017; Mesa, Jaime/AAR-4413-2021; Maury, Heriberto/S-8596-2017	Mesa, Jaime A./0000-0001-6034-4671; Mesa, Jaime/0000-0001-6034-4671; Maury, Heriberto/0000-0003-1564-7504				[Anonymous], 2017, SUSTAINABILITY BASEL, DOI [DOI 10.3390/su9020186, DOI 10.3390/SU9020186]; [Anonymous], SCIENCEDAILY; ArchiExpo, SWIRL GREEN ROOF TOP; Bengtsson L, 2005, NORD HYDROL, V36, P259, DOI 10.2166/nh.2005.0019; Berardi U, 2014, APPL ENERG, V115, P411, DOI 10.1016/j.apenergy.2013.10.047; Berndtsson JC, 2010, ECOL ENG, V36, P351, DOI 10.1016/j.ecoleng.2009.12.014; Bliss D.J., 2010, THESIS; Bliss DJ, 2009, ENVIRON ENG SCI, V26, P407, DOI 10.1089/ees.2007.0186; Carter T, 2008, J ENVIRON MANAGE, V87, P350, DOI 10.1016/j.jenvman.2007.01.024; Carter TL, 2006, J AM WATER RESOUR AS, V42, P1261, DOI 10.1111/j.1752-1688.2006.tb05611.x; Collins S, 2017, BUILD ENVIRON, V122, P206, DOI 10.1016/j.buildenv.2017.06.020; Coma J, 2016, RENEW ENERG, V85, P1106, DOI 10.1016/j.renene.2015.07.074; Coutts AM, 2013, BUILD ENVIRON, V70, P266, DOI 10.1016/j.buildenv.2013.08.021; Cuartero Naranjo A., 2017, THESIS; D'Orazio M, 2012, ENERG BUILDINGS, V55, P439, DOI 10.1016/j.enbuild.2012.09.009; DeNardo JC, 2005, T ASAE, V48, P1491, DOI 10.13031/2013.19181; Ecofield, TEJ CESP; EcoInventos, AZ VERD MANH; Eisenman T, 2006, LANDSCAPE ARCHIT, V96, P22; Garcia S, 2011, ACTES RECH SCI SOC, P4; Getter KL, 2006, HORTSCIENCE, V41, P1276, DOI 10.21273/HORTSCI.41.5.1276; Gonzalez Z., 1995, REV AGROPECU, V71, P58; Kok KH, 2016, INT J RIVER BASIN MA, V14, P1, DOI 10.1080/15715124.2015.1048456; Kumar R, 2005, BUILD ENVIRON, V40, P1505, DOI 10.1016/j.buildenv.2004.11.015; Landscape Development and Landscaping Research, 2018, GREEN ROOF GUID GUID, V6th; Lee WL, 2013, ENERG BUILDINGS, V62, P403, DOI 10.1016/j.enbuild.2013.03.014; Lopez C., 2010, MEDELLIN FBPSA, V2010, P22; Masseroni D, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5377-z; MAyEP/GCBA Buenos Aires Ciudad, BUEN AIR CIUD TECH V; Minke G., 2004, TECHOS VERDES PLANIF; Monterusso MA, 2004, ACTA HORTIC, P369, DOI 10.17660/ActaHortic.2004.639.49; Moran A., 2005, P GREEN ROOFS HLTH C; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Ouldboukhitine SE, 2012, BUILD ENVIRON, V56, P78, DOI 10.1016/j.buildenv.2012.02.024; Ovacen, MAN GUIAS CUB VEG; Parizotto S, 2011, ENERG BUILDINGS, V43, P1712, DOI 10.1016/j.enbuild.2011.03.014; Perez G, 2012, APPL ENERG, V97, P347, DOI 10.1016/j.apenergy.2011.11.051; Peri G, 2012, ENERGY, V48, P406, DOI 10.1016/j.energy.2012.02.045; Scholz-Barth K., 2004, FEDERAL TECHNOLOGY A; Silva CM, 2016, ENERG BUILDINGS, V116, P318, DOI 10.1016/j.enbuild.2016.01.012; Stovin V, 2007, 6 INT C SUST TECHN S, P11; Theodosiou T, 2014, INT J SUSTAIN ENERGY, V33, P227, DOI 10.1080/14786451.2013.772616; Van Spengen J., 2010, THESIS; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Villareal E., 2007, HYDROL RES, V38, P99, DOI [10.2166/nh.2007.031, DOI 10.2166/NH.2007.031]; Wachtel J., 2007, BIOCYCLE, V48, P42; Williams NSG, 2010, URBAN FOR URBAN GREE, V9, P245, DOI 10.1016/j.ufug.2010.01.005; Wong NH, 2003, ENERG BUILDINGS, V35, P353, DOI 10.1016/S0378-7788(02)00108-1; Youtech & Associates, URB MATT; Zinco, 2011, REF CUB AJA	50	9	9	12	39	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-6412		COATINGS	Coatings	JAN	2020	10	1							69	10.3390/coatings10010069	http://dx.doi.org/10.3390/coatings10010069			14	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	KL8UU		Green Published, gold			2022-09-04	WOS:000513694500072
J	Valencia, DP; Yate, L; Aperador, W; Li, YG; Coy, E				Valencia, Drochss P.; Yate, Luis; Aperador, Willian; Li, Yanguang; Coy, Emerson			High Electrocatalytic Response of Ultra-refractory Ternary Alloys of Ta-Hf-C Carbide toward Hydrogen Evolution Reaction in Acidic Media	JOURNAL OF PHYSICAL CHEMISTRY C			English	Article							TRANSITION-METAL CARBIDES; HAFNIUM CARBIDE; CATALYTIC-ACTIVITY; EFFICIENT; OXIDATION; ELECTRODE; OXYGEN; NANOCOMPOSITE; HARDNESS; SURFACE	Transition metal carbide alloys are promising materials to replace platinum as electrodes in electrocatalysts toward the hydrogen evolution reaction (HER). Although tantalum hafnium carbides (Ta-Hf-C) have shown outstanding refractory and structural properties, there is no clear role of their electrochemical efficiency. Here we report on the electrochemical activity of such thin films, (Ta2C(100-x)%center dot(Hf2C)( (x)%), x = 100, 70, 30, and 0, deposited by magnetron sputtering. Grazing incidence X-ray diffraction showed no evidence of phase segregation, and XPS confirms the well-controlled stoichiometry of the electrodes. The HER kinetics was studied in strong acidic conditions, and it was found that the (Ta2C)(7)(0%)center dot(Hf2C) (30%) was the most active material toward HER in this acid media and displayed an onset overpotential of -198 mV vs NHE and a Tafel slope of 129 mV center dot dec(-l ). Our results suggest that the strong affinity of Hf-C toward oxygen reduction reaction could be responsible for the high catalytic response and strong oxidation resistance of the ternary carbide alloys. Finally, we show that, in fact, the Ta-Hf-C alloys can be competitive materials toward HER.	[Valencia, Drochss P.] Pontificia Univ Javeriana Cali, Calle 18 118-250, Cali, Colombia; [Yate, Luis] CIC biomaGUNE, Paseo Miramon 182, Donostia San Sebastian 20009, Spain; [Aperador, Willian] Univ Mil Nueva Granada, Dept Ingn, Carrera 1, Bogota 49300, Colombia; [Li, Yanguang] Soochow Univ, Inst Funct Nano & Soft Mat, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China; [Coy, Emerson] Adam Mickiewicz Univ, NanoBioMed Ctr, 85 Umultowska Str, PL-61614 Poznan, Poland		Coy, E (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, 85 Umultowska Str, PL-61614 Poznan, Poland.	coyeme@amu.edu.pl	Valencia, Drochss/AAF-2917-2019; Li, Yanguang/A-2319-2014; Yate, Luis/K-2687-2017; Coy Romero, Luis Emerson/J-1486-2015	Valencia, Drochss/0000-0002-9364-8134; Li, Yanguang/0000-0003-0506-0451; Yate, Luis/0000-0002-0411-4932; Coy Romero, Luis Emerson/0000-0002-4149-9720; Aperador Chaparro, Willian/0000-0001-9006-0020	Vicerrectoria de Investigaciones de la Universidad Militar Nueva Granada [Ing-2630-2018]; Direccion General de Investigaciones USC Project [531-6211116-A33]; National Science Centre of Poland by the SONATA project [UMO-2016/23/D/ST3/02121]	Vicerrectoria de Investigaciones de la Universidad Militar Nueva Granada; Direccion General de Investigaciones USC Project; National Science Centre of Poland by the SONATA project	This research was supported by "Vicerrectoria de Investigaciones de la Universidad Militar Nueva Granada" under contract Ing-2630-2018 and Direccion General de Investigaciones USC Project DGI-COCEIN-No. 531-6211116-A33. The authors acknowledge the partial financial support from the National Science Centre of Poland by the SONATA project number UMO-2016/23/D/ST3/02121	Alhajri NS, 2013, J MATER CHEM A, V1, P12606, DOI 10.1039/c3ta12984e; Ali M, 2013, MATER CHEM PHYS, V138, P944, DOI 10.1016/j.matchemphys.2013.01.005; Andrievskii R.A., 1967, POWDER METALL MET C+, V6, P65, DOI [DOI 10.1007/BF00773385, 10.1007/BF00773385]; Barinov SM, 2001, J MATER SCI LETT, V20, P1485, DOI 10.1023/A:1017970212233; Benck JD, 2014, ACS CATAL, V4, P3957, DOI 10.1021/cs500923c; BOCKRIS JO, 1957, J PHYS CHEM-US, V61, P879, DOI 10.1021/j150553a008; Briggs D., 2003, XPS BASIC PRINCIPLES; Cavallo C, 2017, APPL PHYS A-MATER, V123, DOI 10.1007/s00339-017-0807-7; Chen WF, 2012, ANGEW CHEM INT EDIT, V51, P6131, DOI 10.1002/anie.201200699; Choi JG, 2013, J POROUS MAT, V20, P1059, DOI 10.1007/s10934-013-9687-1; CONWAY BE, 1956, NATURWISSENSCHAFTEN, V43, P446, DOI 10.1007/BF00629510; Coy E, 2017, ACS APPL MATER INTER, V9, P30872, DOI 10.1021/acsami.7b10317; Coy E, 2016, MATER DESIGN, V111, P584, DOI 10.1016/j.matdes.2016.09.030; Cui W, 2015, APPL CATAL B-ENVIRON, V164, P144, DOI 10.1016/j.apcatb.2014.09.016; De Maria G, 2001, J MATER SCI, V36, P929, DOI 10.1023/A:1004811504475; DEADMORE DL, 1965, J AM CERAM SOC, V48, P357, DOI 10.1111/j.1151-2916.1965.tb14760.x; DesmaisonBrut M, 1997, J EUR CERAM SOC, V17, P1325, DOI 10.1016/S0955-2219(96)00235-X; Du SX, 2017, SURF COAT TECH, V328, P378, DOI 10.1016/j.surfcoat.2017.09.006; Esposito DV, 2011, ENERG ENVIRON SCI, V4, P3900, DOI 10.1039/c1ee01851e; Esposito DV, 2010, ANGEW CHEM INT EDIT, V49, P9859, DOI 10.1002/anie.201004718; Gupta S, 2016, APPL CATAL B-ENVIRON, V192, P126, DOI 10.1016/j.apcatb.2016.03.032; Hong QJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.020104; Huang ZP, 2014, NANO ENERGY, V9, P373, DOI 10.1016/j.nanoen.2014.08.013; Hunt ST, 2015, J PHYS CHEM C, V119, P13691, DOI 10.1021/acs.jpcc.5b02922; Hwu HH, 2005, CHEM REV, V105, P185, DOI 10.1021/cr0204606; Kral C, 1998, J ALLOY COMPD, V265, P215, DOI 10.1016/S0925-8388(97)00297-1; Lengauer W, 2000, 7 TRANSITION METAL C, DOI 10.1002/9783527618217; Liang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8992; Lin TW, 2013, APPL CATAL B-ENVIRON, V134, P75, DOI 10.1016/j.apcatb.2013.01.004; Liu DL, 2012, APPL SURF SCI, V261, P214, DOI 10.1016/j.apsusc.2012.07.145; Liu JP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00206-2; Liu YD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22516; LU X, 2017, SCI REP UK, V7; Ma L, 2015, J MATER CHEM A, V3, P8361, DOI 10.1039/c5ta00139k; Ma XM, 2012, J AM CHEM SOC, V134, P1954, DOI 10.1021/ja2093053; Mamtani K, 2018, APPL CATAL B-ENVIRON, V220, P88, DOI 10.1016/j.apcatb.2017.07.086; Meng XY, 2016, CHEM MATER, V28, P1335, DOI 10.1021/acs.chemmater.5b04256; Meng YA, 2018, APPL SURF SCI, V439, P845, DOI 10.1016/j.apsusc.2017.12.181; Meyer S, 2015, INT J HYDROGEN ENERG, V40, P2905, DOI 10.1016/j.ijhydene.2014.12.076; Moulder J.F., 1995, HDB XRAY PHOTOELECTR; Nisar A, 2016, CORROS SCI, V109, P50, DOI 10.1016/j.corsci.2016.03.013; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Regmi YN, 2015, J MATER CHEM A, V3, P10085, DOI 10.1039/c5ta01296a; Rodenbucher C, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4954714; Sathe BR, 2014, CATAL SCI TECHNOL, V4, P2023, DOI 10.1039/c4cy00075g; Schulz BC, 2013, J EUR CERAM SOC, V33, P1219, DOI 10.1016/j.jeurceramsoc.2012.10.029; Sheng WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6848; Sheng WC, 2010, J ELECTROCHEM SOC, V157, pB1529, DOI 10.1149/1.3483106; Shinozaki K, 2015, J ELECTROCHEM SOC, V162, pF1144, DOI 10.1149/2.1071509jes; Singh D, 2016, CATAL SCI TECHNOL, V6, P6605, DOI 10.1039/c6cy01172a; Toth L., 1971, TRANSITION METAL CAR; Tsai MT, 2014, SURF COAT TECH, V259, P213, DOI 10.1016/j.surfcoat.2014.10.063; Tsoncheva T, 2016, CATAL COMMUN, V81, P14, DOI 10.1016/j.catcom.2016.03.014; Voiry D, 2013, NAT MATER, V12, P850, DOI [10.1038/NMAT3700, 10.1038/nmat3700]; Wang K, 2015, J MATER CHEM A, V3, P9415, DOI 10.1039/c5ta01143d; Wang SY, 2017, AIP ADV, V7, DOI 10.1063/1.4978267; Wang S, 2015, APPL SURF SCI, V327, P68, DOI 10.1016/j.apsusc.2014.11.130; Wang XM, 2016, ACS CATAL, V6, P4195, DOI 10.1021/acscatal.6b00497; Xie AZ, 2017, ACS APPL MATER INTER, V9, P4643, DOI 10.1021/acsami.6b14732; Xu SJ, 2015, ADV FUNCT MATER, V25, P1127, DOI 10.1002/adfm.201403863; YATE L, 2017, SCI REP UK, V7; Yate L, 2014, RSC ADV, V4, P61355, DOI 10.1039/c4ra11292j; ZHANG C, 2017, COATINGS, V7; Zhong Y, 2016, ADV SCI, V3, DOI 10.1002/advs.201500286; Zou ML, 2015, J MATER CHEM A, V3, P18090, DOI 10.1039/c5ta04426j	65	12	12	5	48	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1932-7447	1932-7455		J PHYS CHEM C	J. Phys. Chem. C	NOV 8	2018	122	44					25433	25440		10.1021/acs.jpcc.8b08123	http://dx.doi.org/10.1021/acs.jpcc.8b08123			8	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	HA0HM					2022-09-04	WOS:000449888600029
J	Camacho, J; Medina, AM; Landis-Lewis, Z; Douglas, G; Boyce, R				Camacho, Jhon; Medina Ch, Ana Maria; Landis-Lewis, Zach; Douglas, Gerald; Boyce, Richard			Comparing a Mobile Decision Support System Versus the Use of Printed Materials for the Implementation of an Evidence-Based Recommendation: Protocol for a Qualitative Evaluation	JMIR RESEARCH PROTOCOLS			English	Article						practice guideline; implementation science; decision support systems; mhealth; technology acceptance; computer-interpretable clinical guidelines; Colombia	CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE; STRATEGIES; ADOPTION; MHEALTH; COUNTRIES; DISEASES	Background: The distribution of printed materials is the most frequently used strategy to disseminate and implement clinical practice guidelines, although several studies have shown that the effectiveness of this approach is modest at best. Nevertheless, there is insufficient evidence to support the use of other strategies. Recent research has shown that the use of computerized decision support presents a promising approach to address some aspects of this problem. Objective: The aim of this study is to provide qualitative evidence on the potential effect of mobile decision support systems to facilitate the implementation of evidence-based recommendations included in clinical practice guidelines. Methods: We will conduct a qualitative study with two arms to compare the experience of primary care physicians while they try to implement an evidence-based recommendation in their clinical practice. In the first arm, we will provide participants with a printout of the guideline article containing the recommendation, while in the second arm, we will provide participants with a mobile app developed after formalizing the recommendation text into a clinical algorithm. Data will be collected using semistructured and open interviews to explore aspects of behavioral change and technology acceptance involved in the implementation process. The analysis will be comprised of two phases. During the first phase, we will conduct a template analysis to identify barriers and facilitators in each scenario. Then, during the second phase, we will contrast the findings from each arm to propose hypotheses about the potential impact of the system. Results: We have formalized the narrative in the recommendation into a clinical algorithm and have developed a mobile app. Data collection is expected to occur during 2018, with the first phase of analysis running in parallel. The second phase is scheduled to conclude in July 2019. Conclusions: Our study will further the understanding of the role of mobile decision support systems in the implementation of clinical practice guidelines. Furthermore, we will provide qualitative evidence to aid decisions made by low- and middle-income countries' ministries of health about investments in these technologies.	[Camacho, Jhon] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Camacho, Jhon; Douglas, Gerald; Boyce, Richard] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Medina Ch, Ana Maria] Pontificia Univ Javeriana, Inst Envejecimiento, Bogota, Colombia; [Landis-Lewis, Zach] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA		Camacho, J (corresponding author), Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Hosp Univ San Ignacio, Cra 7 40-62,Piso 2, Bogota, Colombia.	jcamacho@javeriana.edu.co	Boyce, Richard/ABD-2925-2021	Boyce, Richard/0000-0002-2993-2085; Landis-Lewis, Zach/0000-0002-9117-9338; Medina Chavez, Ana Maria/0000-0002-9132-0557; Camacho, Jhon/0000-0003-1805-9142; Douglas, Gerald/0000-0003-3333-7251	US National Institute on Aging [K01AG044433]; NATIONAL INSTITUTE ON AGING [K01AG044433] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded in part by the US National Institute on Aging (K01AG044433). We thank Dario Londono, MD, MS, and Olga Milena Garcia, MD, for their support and insights during the guideline formalization. We also thank Rebecca Crowley Jacobson, MD, MS, for comments and insights that greatly improved this protocol.	[Anonymous], 2011, 133142011 ISO; Britten N, 2006, QUALITATIVE RES HLTH; Brusamento S, 2012, HEALTH POLICY, V107, P168, DOI 10.1016/j.healthpol.2012.08.005; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735; Codish Shlomi, 2005, AMIA Annu Symp Proc, P146; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gagliardi AR, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0247-8; Gagnon MP, 2016, J AM MED INFORM ASSN, V23, P212, DOI 10.1093/jamia/ocv052; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Ginsburg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139625; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Ionic, IONIC BUILD AM NAT A; Khong PCB, 2015, CIN-COMPUT INFORM NU, V33, P555, DOI 10.1097/CIN.0000000000000196; King N., 2004, ESSENTIAL GUIDE QUAL, P256, DOI [DOI 10.4135/9781446280119.N21, 10.4135/9781446280119.n21]; Lee PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126191; Londono D, 2014, ACTA MED COLOMB S3, V39, P1; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Mechael PB, 2010, BARRIERS GAPS AFFECT; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mitchell M, 2009, INT J HEALTHC TECHNO, V10, P156, DOI 10.1504/IJHTM.2009.025819; Patel VL, 2001, J BIOMED INFORM, V34, P52, DOI 10.1006/jbin.2001.1002; Peiris D, 2014, J CARDIOVASC TRANSL, V7, P677, DOI 10.1007/s12265-014-9581-5; Peleg M, 2014, CLINICAL DECISION SUPPORT: THE ROAD TO BROAD ADOPTION, 2ND EDITION, P435; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Rambaud-Althaus C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127674; Schweitzer J, 2012, J HEALTH COMMUN, V17, P73, DOI 10.1080/10810730.2011.649158; Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316; Sola I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086065; Spencer R., 2000, P SIGCHI C HUM FACT; U.S. Department of Health and Human Services, FED POL PROT HUM SUB; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Wilson C., 2013, USER INTERFACE INSPE; World Health Organization, 2011, MHEALTH NEW HORIZONS	35	0	0	0	7	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	APR	2018	7	4							e105	10.2196/resprot.9827	http://dx.doi.org/10.2196/resprot.9827			9	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GH7ZH	29653921	gold, Green Published			2022-09-04	WOS:000433882700020
J	Beltran-Pardo, EA; Jonsson, I; Wojcik, A; Haghdoost, S; Harms-Ringdahl, M; Cruz, RMB; Bernal Villegas, JE				Beltran-Pardo, Eliana A.; Jonsson, Ingemar; Wojcik, Andrzej; Haghdoost, Siamak; Harms-Ringdahl, Mats; Bermudez Cruz, Rosa Maria; Bernal Villegas, Jaime E.			Sequence analysis of the DNA-repair gene rad51 in the tardigrades Milnesium cf. tardigradum, Hypsibius dujardini and Macrobiotus cf. harmsworthi	JOURNAL OF LIMNOLOGY			English	Article						Rad51; phylogeny; Tardigrada; recombinase; DNA repair	N-TERMINAL DOMAIN; RADIATION TOLERANCE; IONIZING-RADIATION; PROTEIN; RESISTANCE; EVOLUTION; STRESS; ANHYDROBIOSIS; REPLICATION; EXCHANGE	Tardigrades are known for being resistant to extreme conditions, including tolerance to ionising and UV radiation in both the hydrated and the dehydrated state. It is known that these factors may cause damage to DNA. It has recently been shown that single and double DNA strand breaks occur when tardigrades are maintained for a long time in the anhydrobiotic state. This may suggest that perhaps tardigrades rely on efficient DNA repair mechanisms. Among all proteins that comprise the DNA repair system, recombinases such as RecA or Rad51 have a very important function: DNA exchange activity. This enzyme is used in the homologous recombination and allows repair of the damaged strand using homologous non-damaged strands as a template. In this study, Rad51 induction was evaluated by western blot in Milnesium cf. tardigradum, after exposure to gamma radiation. The Rad51 protein was highly induced by radiation, when compared to the control. The rad51 genes were searched in three tardigrades: Milnesium cf. tardigradum, Hypsibius dujardini and Macrobiotus cf. harmsworthi. The gene sequences were obtained by preparing and sequencing transcriptome libraries for H. dujardini and M. cf. harmsworthi and designing rad51 degenerate primers specific for M. cf. tardigradum. Comparison of Rad51 putative proteins from tardigrades with other organisms showed that they are highly similar to the corresponding sequence from the nematode Trichinella spiralis. A structure-based sequence alignment from tardigrades and other organisms revealed that putative Rad51 predicted proteins from tardigrades contain the expected motifs for these important recombinases. In a cladogram tree based on this alignment, tardigrades tend to cluster together suggesting that they have selective differences in these genes that make them diverge between species. Predicted Rad51 structures from tardigrades were also compared with crystalline structure of Rad51 in Saccharomyces cerevisiae. These results reveal that S. cerevisiae Rad51 structure is very similar to that of the three analysed tardigrades. On the other hand the predicted structure of Rad51 from M. cf. harmsworthi and H. dujardini are closer related to each other, than each of them to that of M. cf. tardigradum.	[Beltran-Pardo, Eliana A.; Bernal Villegas, Jaime E.] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Jonsson, Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Jonsson, Ingemar; Wojcik, Andrzej; Haghdoost, Siamak; Harms-Ringdahl, Mats] Stockholm Univ, Dept Genet Microbiol & Toxicol, Stockholm, Sweden; [Bermudez Cruz, Rosa Maria] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Mexico City 07360, DF, Mexico		Cruz, RMB (corresponding author), CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	roberm@cinvestav.mx; jebernal@javeriana.edu.co	Jönsson, Ingemar K/K-6047-2013	Jönsson, Ingemar K/0000-0002-1732-0372; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143; Levine, Eliana/0000-0002-0609-3944; Bermudez-Cruz, Rosa Maria/0000-0002-5980-0454	Magnus Bergwall Foundation (Sweden); Swedish Space Agency, Department of Genetics, Microbiology & Toxicology, Stockholm University (Sweden); Instituto de Genetica Humana from Pontificia Universidad Javeriana (Colombia); Departamento de Genetica y Biolog a molecular from Centro de Investigacion y Estudios Avanzados del IPN (Mexico)	Magnus Bergwall Foundation (Sweden); Swedish Space Agency, Department of Genetics, Microbiology & Toxicology, Stockholm University (Sweden); Instituto de Genetica Humana from Pontificia Universidad Javeriana (Colombia); Departamento de Genetica y Biolog a molecular from Centro de Investigacion y Estudios Avanzados del IPN (Mexico)	We want to thank Dr. Georg Mayer and Lars Hering from University of Leipzig Institute of Biology, Animal Evolution & Development, Leipzig, Germany, for preparing the transcriptomic library and providing us with the H. dujardini and M. cf. harmsworthi rad51 and xrcc3 sequences. Rotifers were kindly provided by Dr. Chiara Boschetti from the Institute of Biotechnology, Cambridge University. We are thankful for the financial support given by the following Institutions for this study: Magnus Bergwall Foundation (Sweden), Swedish Space Agency, Department of Genetics, Microbiology & Toxicology, Stockholm University (Sweden), Instituto de Genetica Humana from Pontificia Universidad Javeriana (Colombia) and Departamento de Genetica y Biolog a molecular from Centro de Investigacion y Estudios Avanzados del IPN (Mexico).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amunugama R, 2012, J BIOL CHEM, V287, P8724, DOI 10.1074/jbc.M111.239426; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bolus N E, 2001, J Nucl Med Technol, V29, P67; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Datkhile KD, 2009, INT J RADIAT BIOL, V85, P495, DOI 10.1080/09553000902883786; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Dvorak P., 2002, Folia Veterinaria, V46, P195; Dvorak Petr, 2009, Interdiscip Toxicol, V2, P45, DOI 10.2478/v10102-009-0008-0; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grynberg P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029596; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Jeggo P, 2009, INT J RADIAT BIOL, V85, P1061, DOI 10.3109/09553000903261263; JOHNSON TE, 1988, J GERONTOL, V43, pB137, DOI 10.1093/geronj/43.5.B137; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; Kedzierska Sabina, 2006, Postepy Biochem, V52, P330; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Michalczyk L, 2012, ZOOTAXA, P66; Michalczyk L, 2012, ZOOTAXA, P1; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Nilsson EJC, 2010, INT J RADIAT BIOL, V86, P420, DOI 10.3109/09553000903568001; Parashar V, 2008, RADIAT RES, V169, P707, DOI 10.1667/RR1225.1; Petrov NB, 2005, MOL BIOL+, V39, P503, DOI 10.1007/s11008-005-0067-z; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Reuner A, 2010, CELL STRESS CHAPERON, V15, P423, DOI 10.1007/s12192-009-0158-1; Rinaldo C, 2002, GENETICS, V160, P471; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Suzuki AC, 2003, ZOOL SCI, V20, P49, DOI 10.2108/zsj.20.49; Symington LS, 2005, EMBO REP, V6, P512, DOI 10.1038/sj.embor.7400438; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vitold E., 2006, STRUCTURE, V14, P983; von Sonntag C, 1991, Basic Life Sci, V58, P287; Watanabe M, 2006, INT J RADIAT BIOL, V82, P587, DOI 10.1080/09553000600876652; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Zhang XP, 2005, J BIOL CHEM, V280, P26303, DOI 10.1074/jbc.M503244200	69	9	9	2	30	PAGEPRESS PUBL	PAVIA	MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY	1129-5767	1723-8633		J LIMNOL	J. Limnol.		2013	72			1			80	91		10.4081/jlimnol.2013.s1.e10	http://dx.doi.org/10.4081/jlimnol.2013.s1.e10			12	Limnology	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology	258UW		Green Submitted, gold			2022-09-04	WOS:000327485200010
J	Marmolejo-Tejada, JM; De la Roche-Yepes, J; Perez-Lopez, CA; Taborda, JAP; Avila, A; Jaramillo-Botero, A				Marmolejo-Tejada, Juan M.; De la Roche-Yepes, Jhonattan; Perez-Lopez, Carlos A.; Perez Taborda, Jaime A.; Avila, Alba; Jaramillo-Botero, Andres			Understanding the Origin of Enhanced Piezoelectric Response in PVDF Matrices with Embedded ZnO Nanoparticles, from Polarizable Molecular Dynamics Simulations	JOURNAL OF CHEMICAL INFORMATION AND MODELING			English	Article							REACTIVE FORCE-FIELD; ELECTROMECHANICAL PROPERTIES; HYBRID STRUCTURE; NANOFIBERS; PHASE; NANOSTRUCTURES; NANOCOMPOSITE; COMPOSITE; REAXFF	The pervasive use of portable electronic devices, powered from rechargeable batteries, represents a significant portion of the electricity consumption in the world. A sustainable and alternative energy source for these devices would require unconventional power sources, such as harvesting kinetic/potential energy from mechanical vibrations, ultrasound waves, and biomechanical motion, to name a few. Piezoelectric materials transform mechanical deformation into electric fields or, conversely, external electric fields into mechanical motion. Therefore, accurate prediction of elastic and piezoelectric properties of materials, from the atomic structure and composition, is essential for studying and optimizing new piezogenerators. Here, we demonstrate the application of harmonic-covalent and reactive force fields (FF), Dreiding and ReaxFF, respectively, coupled to the polarizable charge equilibration (PQEq) model for predicting the elastic moduli and piezoelectric response of crystalline zinc oxide (ZnO) and polyvinylidene difluoride (PVDF). Furthermore, we parametrized the ReaxFF atomic interactions for Zn-F in order to characterize the interfacial effects in hybrid PVDF matrices with embedded ZnO nanoparticles (NPs). We capture the nonlinear piezoelectric behavior of the PVDF-ZnO system at different ZnO concentrations and the enhanced response that was recently observed experimentally, between 5 and 7 wt % ZnO concentrations. From our simulation results, we demonstrate that the origin of this enhancement is due to an increase in the total atomic stress distribution at the interface between the two materials. This result provides valuable insight into the design of new and improved piezoelectric nanogenerators and demonstrates the practical value of these first-principles based modeling methods in materials science.	[Marmolejo-Tejada, Juan M.; De la Roche-Yepes, Jhonattan; Jaramillo-Botero, Andres] Pontificia Univ Javeriana, Omicas Program, Cali 760031, Colombia; [Marmolejo-Tejada, Juan M.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Perez-Lopez, Carlos A.; Perez Taborda, Jaime A.; Avila, Alba] Univ Los Andes, Ctr Microelect CMUA, Dept Ingn Elect & Elect, Bogota 111711, Colombia; [Jaramillo-Botero, Andres] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA		Jaramillo-Botero, A (corresponding author), Pontificia Univ Javeriana, Omicas Program, Cali 760031, Colombia.; Jaramillo-Botero, A (corresponding author), CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	ajaramil@caltech.edu	PEREZ TABORDA, JAIME ANDRES/O-2632-2013	PEREZ TABORDA, JAIME ANDRES/0000-0002-5202-9708; Avila, Alba/0000-0003-1241-2080; Jaramillo-Botero, Andres/0000-0003-2844-0756; Marmolejo-Tejada, Juan/0000-0002-2363-5100	Colombian Ministry of Science, Technology and Innovation (Minciencias) [808-2018]	Colombian Ministry of Science, Technology and Innovation (Minciencias)	Part of this work was supported by the Colombian Ministry of Science, Technology and Innovation (Minciencias) under Grant 808-2018. A.J.B. would like to thank William A. Goddard III and Saber Naserifar for sharing the PQeq parameters and libraries for LAMMPS. All the data that support the findings of this study are available from the corresponding author upon request. DFT calculations were performed with the Synopsys QuantumATK software, https://www.synopsys.com/silicon/quantumatk.html.MD calculations were performed with a customized version of the LAMMPS software (https://www.lammps.org/) that implements the PQeq method and can be requested to the corresponding authors in The Journal of Chemical Physics 2017, 146, 124117. The pristine PVDF and hybrid PVDF-ZnO structures were prepared with the Maestro's Polymer creation tool, which can be acquired at https://www.schrodinger.com/products/maestro.	Aktulga HM, 2012, PARALLEL COMPUT, V38, P245, DOI 10.1016/j.parco.2011.08.005; Perez-Lopez CA, 2021, ENERGY REP, V7, P896, DOI 10.1016/j.egyr.2021.01.086; [Anonymous], 2021, SCHRODINGER RELEASE; [Anonymous], QUANTUMATK VERSION O; Byutner OG, 2000, MACROMOLECULES, V33, P4264, DOI 10.1021/ma9918295; Chenoweth K, 2008, J PHYS CHEM A, V112, P1040, DOI 10.1021/jp709896w; Choi M, 2017, NANO ENERGY, V33, P462, DOI 10.1016/j.nanoen.2017.01.062; Deng WL, 2019, NANO ENERGY, V55, P516, DOI 10.1016/j.nanoen.2018.10.049; Desai AV, 2007, SENSOR ACTUAT A-PHYS, V134, P169, DOI 10.1016/j.sna.2006.04.046; Devi PI, 2011, J EXP NANOSCI, V6, P281, DOI 10.1080/17458080.2010.497947; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Fakhri P, 2019, RSC ADV, V9, P10117, DOI 10.1039/c8ra10315a; Fan ZY, 2005, J NANOSCI NANOTECHNO, V5, P1561, DOI 10.1166/jnn.2005.182; Gaillac R, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/27/275201; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P71, DOI 10.1016/B978-0-12-375182-9.10004-1; Jana S, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/44/445403; Jaramillo-Botero A, 2014, J CHEM THEORY COMPUT, V10, P1426, DOI 10.1021/ct5001044; KARASAWA N, 1992, MACROMOLECULES, V25, P7268, DOI 10.1021/ma00052a031; Kong XY, 2004, APPL PHYS LETT, V84, P975, DOI 10.1063/1.1646453; Ma J, 2018, MATER RES EXPRESS, V5, DOI 10.1088/2053-1591/aab747; Mansouri S, 2019, J MATER RES TECHNOL, V8, P1608, DOI 10.1016/j.jmrt.2018.07.024; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Naserifar S, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4978891; NEUMANN M, 1983, MOL PHYS, V50, P841, DOI 10.1080/00268978300102721; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Pei Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3574653; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Raabe G, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3600337; Sabry RS, 2019, POLYM TEST, V79, DOI 10.1016/j.polymertesting.2019.106001; Sabry RS, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/ab4296; Satyanarayana KC, 2012, POLYMER, V53, P2927, DOI 10.1016/j.polymer.2012.04.008; Singh HH, 2018, POLYM ADVAN TECHNOL, V29, P143, DOI 10.1002/pat.4096; Smidstrup S, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.195309; Somavat P, 2010, P 1 INT C EN COMP NE, P141, DOI DOI 10.1145/1791314.1791337; Su HB, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064101; Tainter CJ, 2016, J PHYS CHEM C, V120, P2950, DOI 10.1021/acs.jpcc.5b09511; Todd MG, 2005, IEEE T DIELECT EL IN, V12, P601, DOI 10.1109/TDEI.2005.1453466; Ueberschlag P., 2001, Sensor Review, V21, P118, DOI 10.1108/02602280110388315; van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u; Vinogradov A, 1999, FERROELECTRICS, V226, P169, DOI 10.1080/00150199908230298; Wang ZL, 2012, ADV MATER, V24, P4632, DOI 10.1002/adma.201104365; Wang ZL, 2004, MATER TODAY, V7, P26, DOI 10.1016/S1369-7021(04)00286-X; Weintraub B, 2007, J PHYS CHEM C, V111, P10162, DOI 10.1021/jp073806v; Zeng FL, 2015, J PHYS CHEM A, V119, P8359, DOI 10.1021/acs.jpca.5b03783; Zhu GD, 2008, COMP MATER SCI, V44, P224, DOI [10.1016/j.commatsci.2008.03.016, 10.3778/j.issn.1002-8331.2008.33.068]; Zhu R, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/28/285712	47	0	0	10	22	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9596	1549-960X		J CHEM INF MODEL	J. Chem Inf. Model.	SEP 27	2021	61	9					4537	4543		10.1021/acs.jcim.1c00822	http://dx.doi.org/10.1021/acs.jcim.1c00822		SEP 2021	7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science, Information Systems; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry; Computer Science	WB1KV	34519202				2022-09-04	WOS:000703339100037
J	Ferone, D; Hatami, S; Gonzalez-Neira, EM; Juan, AA; Festa, P				Ferone, Daniele; Hatami, Sara; Gonzalez-Neira, Eliana M.; Juan, Angel A.; Festa, Paola			A biased-randomized iterated local search for the distributed assembly permutation flow-shop problem	INTERNATIONAL TRANSACTIONS IN OPERATIONAL RESEARCH			English	Article						permutation flow-shop scheduling; metaheuristic; assembly system; distributed manufacturing system; iterated local search; biased randomization	VEHICLE-ROUTING PROBLEM; KEY GENETIC ALGORITHM; SHOP SCHEDULING PROBLEM; NEIGHBORHOOD SEARCH; MINIMIZE MAKESPAN; GREEDY ALGORITHM; META-HEURISTICS; OPERATIONS; 3-MACHINE; MACHINE	Modern production systems require multiple manufacturing centers-usually distributed among different locations-where the outcomes of each center need to be assembled to generate the final product. This paper discusses the distributed assembly permutation flow-shop scheduling problem, which consists of two stages: the first stage is composed of several production factories, each of them with a flow-shop configuration; in the second stage, the outcomes of each flow-shop are assembled into a final product. The goal here is to minimize the makespan of the entire manufacturing process. With this objective in mind, we present an efficient and parameter-less algorithm that makes use of a biased-randomized iterated local search metaheuristic. The efficiency of the proposed method is evaluated through the analysis of an extensive set of computational experiments. The results show that our algorithm offers excellent performance when compared with other state-of-the-art approaches, obtaining several new best solutions.	[Ferone, Daniele] Univ Milano Bicocca, Dept Informat Syst & Commun DISCo, Milan, Italy; [Hatami, Sara; Juan, Angel A.] Open Univ Catalonia, IN3 Dept Comp Sci, Barcelona, Spain; [Gonzalez-Neira, Eliana M.] Pontificia Univ Javeriana, Dept Ingn Ind, Bogota, Colombia; [Festa, Paola] Univ Napoli FEDERICO II, Dept Math & Applicat, Naples, Italy; [Juan, Angel A.] Euncet Business Sch, Terrassa, Spain		Ferone, D (corresponding author), Univ Milano Bicocca, Dept Informat Syst & Commun DISCo, Milan, Italy.	daniele.ferone@unimib.it; shatami@uoc.edu; eliana.gonzalez@javeriana.edu.co; ajuanp@uoc.edu; paola.festa@unina.it	Ferone, Daniele/ABA-4370-2020; Juan, Angel A./J-7923-2015; Hatami, Sara/ABB-1496-2021; Gonzalez, Eliana/I-5955-2015	Ferone, Daniele/0000-0003-4696-7826; Juan, Angel A./0000-0003-1392-1776; Gonzalez, Eliana/0000-0002-4590-3401	Erasmus+ programme [2018-1-ES01-KA103049767]	Erasmus+ programme	This work has been partially supported by the Erasmus+ programme (2018-1-ES01-KA103049767).	Allahverdi A, 2006, INT J PROD RES, V44, P4713, DOI 10.1080/00207540600621029; Allahverdi A, 2016, J IND PROD ENG, V33, P391, DOI 10.1080/21681015.2016.1151466; Allahverdi A, 2015, J INTELL MANUF, V26, P225, DOI 10.1007/s10845-013-0775-5; Allahverdi A, 2009, COMPUT OPER RES, V36, P2740, DOI 10.1016/j.cor.2008.12.001; Alvarez A, 2018, INT T OPER RES, V25, P1785, DOI 10.1111/itor.12547; Baker K., 1974, INTRO SEQUENCING SCH; Belloso J, 2019, INT T OPER RES, V26, P289, DOI 10.1111/itor.12379; Brandao J, 2018, COMPUT IND ENG, V120, P146, DOI 10.1016/j.cie.2018.04.032; Brandao JS, 2017, INT T OPER RES, V24, P1061, DOI 10.1111/itor.12429; Brandao JS, 2015, INT T OPER RES, V22, P823, DOI 10.1111/itor.12178; Cunha V, 2020, INT T OPER RES, V27, P197, DOI 10.1111/itor.12610; de Armas J, 2017, J OPER RES SOC, V68, P1161, DOI 10.1057/s41274-016-0155-6; Dominguez O, 2016, EUR J OPER RES, V255, P442, DOI 10.1016/j.ejor.2016.05.002; Dong XY, 2009, COMPUT OPER RES, V36, P1664, DOI 10.1016/j.cor.2008.04.001; Du X, 2016, INDOOR BUILT ENVIRON, V10, P1, DOI DOI 10.1177/1420326X16676881; Estrada-Moreno A, 2019, INT T OPER RES, V26, P1293, DOI 10.1111/itor.12625; Estrada-Moreno A, 2019, INT T OPER RES, V26, P2077, DOI 10.1111/itor.12668; Faulin J., 2008, INT T OPER RES, V15, P599, DOI 10.1111/j.1475-3995.2008.00640.x; Faulin J, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P2708, DOI 10.1109/WSC.2008.4736388; Fernandez-Viagas V, 2015, INT J PROD RES, V53, P1111, DOI 10.1080/00207543.2014.948578; Ferone D, 2019, J OPER RES SOC, V70, P1362, DOI 10.1080/01605682.2018.1494527; Ferreira P, 2014, PROC CIRP, V17, P26, DOI 10.1016/j.procir.2014.01.066; Fikar C, 2016, EUR J IND ENG, V10, P323, DOI 10.1504/EJIE.2016.076382; Framinan JM, 2004, J OPER RES SOC, V55, P1243, DOI 10.1057/palgrave.jors.2601784; Goncalves JF, 2016, INT T OPER RES, V23, P25, DOI 10.1111/itor.12109; Grasas A, 2017, COMPUT IND ENG, V110, P216, DOI 10.1016/j.cie.2017.06.019; Grasas A, 2016, J SIMUL, V10, P69, DOI 10.1057/jos.2014.25; Gupta JND, 2006, EUR J OPER RES, V169, P699, DOI 10.1016/j.ejor.2005.02.001; Hariri AMA, 1997, EUR J OPER RES, V103, P547, DOI 10.1016/S0377-2217(96)00312-8; Hatami S, 2015, INT J PROD ECON, V169, P76, DOI 10.1016/j.ijpe.2015.07.027; Hatami S, 2013, INT J PROD RES, V51, P5292, DOI 10.1080/00207543.2013.807955; Hatami S, 2010, INT J ADV MANUF TECH, V50, P1153, DOI 10.1007/s00170-010-2579-5; Hejazi SR, 2005, INT J PROD RES, V43, P2895, DOI 10.1080/0020754050056417; Hu SJ, 2011, CIRP ANN-MANUF TECHN, V60, P715, DOI 10.1016/j.cirp.2011.05.004; Ji MC, 2016, IEEE C EVOL COMPUTAT, P2649, DOI 10.1109/CEC.2016.7744120; Juan AA, 2018, WINT SIMUL C PROC, P3048, DOI 10.1109/WSC.2018.8632464; Juan AA, 2015, INT T OPER RES, V22, P647, DOI 10.1111/itor.12101; Juan AA, 2014, SIMUL MODEL PRACT TH, V46, P101, DOI 10.1016/j.simpat.2014.02.005; Juan AA, 2014, INT T OPER RES, V21, P103, DOI 10.1111/itor.12028; Komaki GM, 2019, INT J PROD RES, V57, P2926, DOI 10.1080/00207543.2018.1550269; Komaki GM, 2017, COMPUT IND ENG, V105, P158, DOI 10.1016/j.cie.2017.01.006; Komaki GM, 2015, J COMPUT SCI-NETH, V8, P109, DOI 10.1016/j.jocs.2015.03.011; LEE CY, 1993, MANAGE SCI, V39, P616, DOI 10.1287/mnsc.39.5.616; Liao CJ, 2015, COMPUT IND ENG, V88, P317, DOI 10.1016/j.cie.2015.07.018; Lin J, 2016, COMPUT IND ENG, V97, P128, DOI 10.1016/j.cie.2016.05.005; Lin SW, 2016, COMPUT IND ENG, V99, P202, DOI 10.1016/j.cie.2016.07.027; Lin SW, 2013, INT J PROD RES, V51, P5029, DOI 10.1080/00207543.2013.790571; Lourenco HR, 2010, INT SER OPER RES MAN, V146, P363, DOI 10.1007/978-1-4419-1665-5_12; Gonzalez-Neira EM, 2017, SIMUL MODEL PRACT TH, V79, P23, DOI 10.1016/j.simpat.2017.09.001; Mladenovic N, 2020, INT T OPER RES, V27, P480, DOI 10.1111/itor.12646; Mozdgir A, 2013, INT J PROD RES, V51, P3625, DOI 10.1080/00207543.2012.756151; Naderi B, 2010, COMPUT OPER RES, V37, P754, DOI 10.1016/j.cor.2009.06.019; Naderi B, 2014, EUR J OPER RES, V239, P323, DOI 10.1016/j.ejor.2014.05.024; NAWAZ M, 1983, OMEGA-INT J MANAGE S, V11, P91, DOI 10.1016/0305-0483(83)90088-9; Pinto BQ, 2018, EUR J OPER RES, V271, P849, DOI 10.1016/j.ejor.2018.05.071; Pollaris H, 2017, NETWORKS, V69, P304, DOI 10.1002/net.21738; POTTS CN, 1995, OPER RES, V43, P346, DOI 10.1287/opre.43.2.346; Quintero-Araujo CL, 2019, INT T OPER RES, V26, P551, DOI 10.1111/itor.12479; Quintero-Araujo CL, 2017, INT T OPER RES, V24, P1079, DOI 10.1111/itor.12322; Reyes A, 2018, INT T OPER RES, V25, P1515, DOI 10.1111/itor.12507; Ruiz R, 2005, EUR J OPER RES, V165, P479, DOI 10.1016/j.ejor.2004.04.017; Ruiz R, 2007, EUR J OPER RES, V177, P2033, DOI 10.1016/j.ejor.2005.12.009; Sang HY, 2019, SWARM EVOL COMPUT, V44, P64, DOI 10.1016/j.swevo.2018.12.001; Shoaardebili N, 2015, INT J PROD RES, V53, P944, DOI 10.1080/00207543.2014.948575; STUTZLE T, 1998, AIDA9804 TU DARMST; Sun X, 2003, EUR J OPER RES, V146, P498, DOI 10.1016/S0377-2217(02)00245-X; Vallada E, 2010, OMEGA-INT J MANAGE S, V38, P57, DOI 10.1016/j.omega.2009.04.002; Wang K, 2016, J OPER RES SOC, V67, P68, DOI 10.1057/jors.2015.50; Wang SY, 2016, IEEE T SYST MAN CY-S, V46, P139, DOI 10.1109/TSMC.2015.2416127; Xiong FL, 2014, INT J PROD RES, V52, P2743, DOI 10.1080/00207543.2014.884290; Zohali H, 2019, COMPUT OPER RES, V104, P127, DOI 10.1016/j.cor.2018.12.008	71	33	36	5	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0969-6016	1475-3995		INT T OPER RES	Int. Trans. Oper. Res.	MAY	2020	27	3					1368	1391		10.1111/itor.12719	http://dx.doi.org/10.1111/itor.12719		SEP 2019	24	Management; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Operations Research & Management Science	KY5SW					2022-09-04	WOS:000486006300001
J	Rojas, D; Moreira, M; Pereira, MJR; Fonseca, C; Davalos, LM				Rojas, Danny; Moreira, Matthew; Ramos Pereira, Maria Joao; Fonseca, Carlos; Davalos, Liliana M.			Updated distribution maps for neotropical bats in the superfamily Noctilionoidea	ECOLOGY			English	Article; Data Paper						extent of occurrence; Furipteridae; Mormoopidae; Noctilionidae; Phyllostomidae; Thyropteridae		The IUCN provides a spatial database for many species, including terrestrial mammals. This database includes shapefiles with taxonomic information and the extent of occurrence for each species, and has been used in hundreds of studies in ecology, biogeography and conservation. Here we provide updated distribution maps that comprise the extent of occurrence of the neotropical bat species in the superfamily Noctilionoidea (Mammalia: Chiroptera) after a thorough research of new records published between January 2008 and March 2018. The main motivation for this update was the inclusion of spatial and climatic variables in explaining the ecological and taxonomic diversity of noctilionoid bats. The core of the superfamily (246 species distributed in five families out of 250 species) occurs in the Neotropics and shows ecological diversity unparalleled among mammals. This clade also shows the only evolutionary shift towards higher speciation rates within the order Chiroptera. Updating the range maps for these bats resulted in the modification of maps of 94 species, and the creation of new maps for 37 species missing from the IUCN database. From the 94 modified maps, 55 species increased their latitudinal range and 38 increased their longitudinal range. These modifications did not change the overall extent of occurrence of the clade. Altogether, modified and new maps represent 53% of Noctilionoidea. No copyright or proprietary restrictions are associated with the use of this data set other than citation of this Data Paper.	[Rojas, Danny] Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia; [Rojas, Danny; Moreira, Matthew; Ramos Pereira, Maria Joao; Fonseca, Carlos] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Rojas, Danny; Moreira, Matthew; Ramos Pereira, Maria Joao; Fonseca, Carlos] Univ Aveiro, Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal; [Ramos Pereira, Maria Joao] Univ Fed Rio Grande do Sul, Inst Biosci, Dept Zool, Porto Alegre, RS, Brazil; [Davalos, Liliana M.] SUNY Stony Brook, Dept Ecol & Evolut, 650 Life Sci Bldg, Stony Brook, NY 11794 USA; [Davalos, Liliana M.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Consortium Interdisciplinary Environm Res, 129 Dana Hall, Stony Brook, NY 11794 USA		Rojas, D (corresponding author), Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia.; Rojas, D (corresponding author), Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal.; Rojas, D (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal.	rojasmartin.cu@gmail.com	Moreira, Matthew Owen/L-4778-2018; Pereira, Maria João Ramos/AAH-9411-2021; Fonseca, Carlos MMS/D-9744-2011; Rojas, Danny/A-7961-2011	Moreira, Matthew Owen/0000-0002-8252-7804; Pereira, Maria João Ramos/0000-0002-9365-5166; Fonseca, Carlos MMS/0000-0001-6559-7133; Rojas, Danny/0000-0002-5835-0324; Davalos, Liliana/0000-0002-4327-7697					0	4	4	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-9658	1939-9170		ECOLOGY	Ecology	SEP	2018	99	9					2131	2131		10.1002/ecy.2404	http://dx.doi.org/10.1002/ecy.2404			1	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	GS3WV	30102420				2022-09-04	WOS:000443558200023
J	Bravo-Balado, A; Castellanos, LT; Rodriguez, AC; Zapata, DG; Hoyos, JJL; Andrade, R; Nino, JP				Bravo-Balado, Alejandra; Torres Castellanos, Lynda; Carrillo Rodriguez, Adriana; Gomez Zapata, Daniel; Lammoglia Hoyos, Juan Javier; Andrade, Rafael; Perez Nino, Jaime			Primary Mediastinal Pure Seminomatous Germ Cell Tumor (Germinoma) as a Rare Cause of Precocious Puberty in a 9-Year-Old Patient	UROLOGY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; BOY	Less than 5%-7% of germ cell tumors are extragonadal, with the central nervous system being the most common location in children, followed by retroperitoneum and mediastinum. Only 10% of mediastinal tumors are malignant and one-third of these are pure seminomas (germinomas). We report the case of a 9-year-old boy with development of secondary sexual characteristics. Beta-human chorionic gonadotropin was elevated and a mediastinal mass was found. Final histology showed a pure seminomatous germ cell tumor. To our knowledge, this is the first report of a boy with precocious puberty secondary to a mediastinal germinoma. (C) 2017 Elsevier Inc.	[Bravo-Balado, Alejandra] Hosp Univ Fdn Santa Fe Bogota, Dept Urol, Carrera 7 118-09,Unidad Renal,Piso 3, Bogota 110111, DC, Colombia; Univ Los Andes, Sch Med, Bogota, DC, Colombia; Hosp Univ San Ignacio, Div Urol, Bogota, DC, Colombia; Pontificia Univ Javeriana, Sch Med, Bogota, DC, Colombia; Univ Nacl Colombia, Pediat Endocrinol, Bogota, DC, Colombia; Pontificia Univ Javeriana, Bogota, DC, Colombia; Hosp Univ Fdn Santa Fe Bogota, Dept Pathol, Bogota, DC, Colombia		Bravo-Balado, A (corresponding author), Hosp Univ Fdn Santa Fe Bogota, Dept Urol, Carrera 7 118-09,Unidad Renal,Piso 3, Bogota 110111, DC, Colombia.; Bravo-Balado, A (corresponding author), Univ Los Andes, Fdn Santa Fe Bogota, Clin Urol, Sch Med, Carrera 7 118-09,Unidad Renal,Piso 3, Bogota 110111, DC, Colombia.	ac.bravo436@uniandes.edu.co		Bravo-Balado, Alejandra/0000-0002-9555-393X; Perez Nino, Jaime/0000-0002-2231-4321				Amory JK, 2008, FERTIL STERIL, V89, P380, DOI 10.1016/j.fertnstert.2007.02.059; Bebb GG, 1998, ANN THORAC SURG, V66, P547, DOI 10.1016/S0003-4975(98)00504-9; Bokemeyer C, 2002, J CLIN ONCOL, V20, P1864, DOI 10.1200/JCO.2002.07.062; Hettinger CA, 2009, J PEDIATR UROL, V5, P412, DOI 10.1016/j.jpurol.2009.05.004; Kim S, 2016, ACM T DES AUTOMAT EL, V21, DOI [10.1145/2856032, 10.6065/apem.2016.21.1.51]; Kumar Manoj, 2015, Indian J Endocrinol Metab, V19, P228, DOI 10.4103/2230-8210.149316; Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0; Moran CA, 1999, PATHOL RES PRACT, V195, P583, DOI 10.1016/S0344-0338(99)80009-0; Moran CA, 1997, CANCER-AM CANCER SOC, V80, P691, DOI 10.1002/(SICI)1097-0142(19970815)80:4<691::AID-CNCR7>3.0.CO;2-Q; MURAI I, 1990, ENDOCRINOLOGY, V126, P3179, DOI 10.1210/endo-126-6-3179; Schwabe J, 2002, ANN ONCOL, V13, P975, DOI 10.1093/annonc/mdf085; Solorzano CMB, 2010, REPRODUCTION, V140, P399, DOI 10.1530/REP-10-0119; Stephen MD, 2010, INT J PEDIATR ENDOCR, DOI 10.1155/2010/184502; Swerdloff RS, 2000, GYNECOMASTIA ETIOLOG; Temes R, 2000, Oncologist, V5, P179, DOI 10.1634/theoncologist.5-3-179	15	0	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	DEC	2017	110						216	219		10.1016/j.urology.2017.08.038	http://dx.doi.org/10.1016/j.urology.2017.08.038			4	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	FM9NX	28888750				2022-09-04	WOS:000415599100047
J	Rubiano, LC; Miranda, MC; Arenas, SM; Montero, LM; Rodriguez-Barraquer, I; Garcerant, D; Prager, M; Osorio, L; Rojas, MX; Perez, M; Nicholls, RS; Saravia, NG				Consuelo Rubiano, Luisa; Consuelo Miranda, Maria; Muvdi Arenas, Sandra; Mery Montero, Luz; Rodriguez-Barraquer, Isabel; Garcerant, Daniel; Prager, Martin; Osorio, Lyda; Ximena Rojas, Maria; Perez, Mauricio; Santiago Nicholls, Ruben; Gore Saravia, Nancy			Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children	JOURNAL OF INFECTIOUS DISEASES			English	Article							RANDOMIZED CLINICAL-TRIAL; PERIDOMESTIC TRANSMISSION; GEOGRAPHIC-DISTRIBUTION; VISCERAL LEISHMANIASIS; ORAL MILTEFOSINE; EFFICACY; VIANNIA; COLOMBIA; EPIDEMIOLOGY; AGENT	Background. Children have a lower response rate to antimonial drugs and higher elimination rate of antimony (Sb) than adults. Oral miltefosine has not been evaluated for pediatric cutaneous leishmaniasis. Methods. A randomized, noninferiority clinical trial with masked evaluation was conducted at 3 locations in Colombia where Leishmania panamensis and Leishmania guyanensis predominated. One hundred sixteen children aged 2-12 years with parasitologically confirmed cutaneous leishmaniasis were randomized to directly observed treatment with meglumine antimoniate (20 mg Sb/kg/d for 20 days; intramuscular) (n = 58) or miltefosine (1.8-2.5 mg/kg/d for 28 days; by mouth) (n = 58). Primary outcome was treatment failure at or before week 26 after initiation of treatment. Miltefosine was noninferior if the proportion of treatment failures was < 15% higher than achieved with meglumine antimoniate (1-sided test, alpha = .05). Results. Ninety-five percent of children (111/116) completed follow-up evaluation. By intention-to-treat analysis, failure rate was 17.2% (98% confidence interval [CI], 5.7%-28.7%) for miltefosine and 31% (98% CI, 16.9%-45.2%) for meglumine antimoniate. The difference between treatment groups was 13.8%, (98% CI, -4.5% to 32%) (P = .04). Adverse events were mild for both treatments. Conclusions. Miltefosine is noninferior to meglumine antimoniate for treatment of pediatric cutaneous leishmaniasis caused by Leishmania (Viannia) species. Advantages of oral administration and low toxicity favor use of miltefosine in children. Clinical Trial Registration. NCT00487253.	[Consuelo Rubiano, Luisa; Consuelo Miranda, Maria; Rodriguez-Barraquer, Isabel; Garcerant, Daniel; Prager, Martin; Perez, Mauricio; Gore Saravia, Nancy] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali 5390, Colombia; [Muvdi Arenas, Sandra] ESE Bogota, Ctr Dermatol Federico Lleras Acosta, Bogota, Colombia; [Mery Montero, Luz] Hosp San Juan, Chaparral, Colombia; [Osorio, Lyda] Univ Valle, GESP, Escuela Salud Publ, Fac Med, Cali, Colombia; [Ximena Rojas, Maria] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Santiago Nicholls, Ruben] Inst Nacl Salud, Bogota, Colombia		Saravia, NG (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Carrera 125 19-225, Cali 5390, Colombia.	saravian@cideim.org.co	Rubiano Perea, Luisa Consuelo/L-8486-2016; Rojas-Reyes, Maria Ximena/AAD-6800-2019	Rubiano Perea, Luisa Consuelo/0000-0001-6655-6843; Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Osorio, Lyda/0000-0002-5121-4741; Rodriguez-Barraquer, Isabel/0000-0001-6784-1021; Miranda Montoya, Maria Consuelo/0000-0001-5730-0723	Colombian national Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [2229-343-19253]; National Institute of Allergy and Infectious Diseases [1 U19AIO65866]; Fogarty Global Infectious Diseases Research Training Program [D43 TW006589]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065866] Funding Source: NIH RePORTER	Colombian national Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty Global Infectious Diseases Research Training Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support. This work was supported by the Colombian national Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) (grant 2229-343-19253). Capacity building for the ethical conduct of clinical trials at the study sites was supported by the National Institute of Allergy and Infectious Diseases International Collaborations in Infectious Disease Research Program (grant 1 U19AIO65866) and Fogarty Global Infectious Diseases Research Training Program (grant D43 TW006589).	[Anonymous], 2002, Wkly Epidemiol Rec, V77, P365; Berman J, 2006, T ROY SOC TROP MED H, V100, pS41, DOI 10.1016/j.trstmh.2006.02.009; Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Bryceson A, 2001, TROP MED INT HEALTH, V6, P928, DOI 10.1046/j.1365-3156.2001.00795.x; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; Chrusciak-Talhari A, 2011, AM J TROP MED HYG, V84, P255, DOI 10.4269/ajtmh.2011.10-0155; CORREDOR A, 1990, AM J TROP MED HYG, V42, P206; Cruz A, 2007, J INFECT DIS, V195, P602, DOI 10.1086/510860; Escobar P, 2002, ACTA TROP, V81, P151, DOI 10.1016/S0001-706X(01)00197-8; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Instituto Nacional de Salud, 2011, GUIA TRAT SEG PAC CO; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912; Mohebali M, 2007, ACTA TROP, V103, P33, DOI 10.1016/j.actatropica.2007.05.005; Muñoz Gerardo, 2006, Biomed., V26, P131; National Cancer Institute, 2006, COMMON TERMINOLOGY C; Palacios R, 2001, AM J TROP MED HYG, V64, P187, DOI 10.4269/ajtmh.2001.64.187; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Rodriguez-Barraquer I, 2008, AM J TROP MED HYG, V78, P276, DOI 10.4269/ajtmh.2008.78.276; Saravia NG, 1998, AM J TROP MED HYG, V59, P86, DOI 10.4269/ajtmh.1998.59.86; Saravia NG, 2002, AM J TROP MED HYG, V66, P738, DOI 10.4269/ajtmh.2002.66.738; Singh Utpal Kant, 2006, Indian Journal of Pediatrics, V73, P1077, DOI 10.1007/BF02763048; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Soto J, 2001, CLIN INFECT DIS, V33, pE57, DOI DOI 10.1086/322689; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; van Thiel PPAM, 2010, CLIN INFECT DIS, V50, P80, DOI 10.1086/648726; Vega Juan Carlos, 2007, Trop Med Int Health, V12, P1540, DOI 10.1111/j.1365-3156.2007.01962.x; Velez I, 2010, AM J TROP MED HYG, V83, P351, DOI 10.4269/ajtmh.2010.10-0060; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; WEIGLE KA, 1993, J INFECT DIS, V168, P709, DOI 10.1093/infdis/168.3.709; Yadon ZE, 2003, AM J TROP MED HYG, V68, P519, DOI 10.4269/ajtmh.2003.68.519; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272	37	65	67	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	FEB 15	2012	205	4					684	692		10.1093/infdis/jir816	http://dx.doi.org/10.1093/infdis/jir816			9	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	885QU	22238470	Green Published, Bronze			2022-09-04	WOS:000299795000023
J	Santander, SP; Hernandez, JF; Cifuentes, C; Aoki, M; Moins-Teisserenc, H; Fiorentino, S				Paola Santander, Sandra; Fredy Hernandez, John; Cifuentes B, Claudia; Aoki, M.; Moins-Teisserenc, H.; Fiorentino, Susana			Immunomodulatory Effects of Aqueous and Organic Fractions from Petiveria alliacea on Human Dendritic Cells	AMERICAN JOURNAL OF CHINESE MEDICINE			English	Article						Petiveria alliacea; Immunomodulation; Dendritic Cells; Cytokines; Gene Expression	GUINEA HEN WEED; GENE-EXPRESSION; SUBSETS; GROWTH	Petiveria alliacea is a plant traditionally known for its anti-inflammatory and antitumor activities; however, the molecular and cellular mechanisms of its immunomodulatory properties are still unknown. Dendritic cells (DC) promote adaptive immune response by activating T lymphocytes, inducing an effector response or tolerance depending on the DC differentiation level. Herein, we evaluated the immunomodulatory activity of aqueous and organic plant fractions from P. alliacea using human monocyte-derived dendritic cells. The phenotype, cytokine secretion and gene expression were estimated after treatment with the plant fractions. We found that P. alliacea aqueous fraction induced morphological changes and co-stimulatory expression of CD86, indicating partial DC maturation. In addition, pro-inflammatory cytokines such as IL-1 beta, IL-6, IL-8, IL-10, IL-12p70, and TNF-alpha were secreted. The fraction also increased NF-kappa B gene expression while down-regulating TGF beta gene expression. These results suggest that the aqueous fraction can induce partial DC activation, a situation that can be relevant in tolerance induction. It is important to state that the organic fraction by itself does not show any immunomodulatory activity. This study provides evidence for possible immunomodulatory activity of P. alliacea extracts which has been used in traditional medicine in Colombia.	[Paola Santander, Sandra; Fredy Hernandez, John; Fiorentino, Susana] Pontificia Univ Javeriana Bogota, Fac Sci, Immunol & Cellular Biol Grp, Bogota, Colombia; [Cifuentes B, Claudia] Pontificia Univ Javeriana Bogota, Fac Sci, Dept Biochem, Bogota, Colombia; [Aoki, M.; Moins-Teisserenc, H.] Univ Paris Diderot, INSERM, U940, Inst Univ Hematol, Paris, France; [Moins-Teisserenc, H.] Hop St Louis, AP HP, Paris, France		Fiorentino, S (corresponding author), Carrera 7 43-82 Ed 53 Of 608, Bogota, Colombia.	susana.fiorentino@javeriana.edu.co	fiorentino, susana/R-8700-2016; Moins-Teisserenc, helene/AAL-1566-2021	fiorentino, susana/0000-0002-4664-0682; Moins-Teisserenc, helene/0000-0003-1602-7534	Fundacion Universitaria Juan N. Corpas; Instituto Colombiano para el Desarrollo de la Ciencia y Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia [324-2007]; France Foundation; COLCIENCIAS	Fundacion Universitaria Juan N. Corpas; Instituto Colombiano para el Desarrollo de la Ciencia y Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia; France Foundation; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors acknowledge Nuala Mooney for her interesting contributions, the Pontificia Universidad Javeriana Science Faculty and the Fundacion Universitaria Juan N. Corpas for their support to the present work and the Instituto Colombiano para el Desarrollo de la Ciencia y Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia, for the financial support, grant number 324-2007. M. A. post doctoral fellow funded by France Foundation. S. P. S. and J.F.H. are PhD students sponsored by COLCIENCIAS.	[Anonymous], 1998, FAO Food Nutr Pap, V66, P1; Asada M, 1999, J AGR FOOD CHEM, V47, P468, DOI 10.1021/jf9802777; Awad AB, 1996, ANTICANCER RES, V16, P2797; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Duharte AB, 2011, B LATINOAM CARIBE PL, V10, P256; Beifuss U., 2002, RECENT RES DEV PHYTO, V6, P13; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Cavalcanti X., 2008, U FEDERAL PERNAMBUCO, V104; Cifuentes C., 2009, U SCI, V14, P2; DELAVEAU P, 1980, PLANTA MED, V40, P49, DOI 10.1055/s-2008-1074941; DELVALLE L, 1993, REV CUB HEMATOL INMU, V9, P134; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ebringerovda A, 2003, FITOTERAPIA, V74, P52, DOI 10.1016/S0367-326X(02)00295-2; Germano D. H. P., 1993, Fitoterapia, V64, P459; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Ishii K, 2005, IMMUNOL LETT, V98, P280, DOI 10.1016/j.imlet.2004.12.002; Kim JY, 2007, INT IMMUNOPHARMACOL, V7, P78, DOI 10.1016/j.intimp.2006.08.017; Lin YL, 2006, MOL PHARMACOL, V70, P637, DOI 10.1124/mol.106.022327; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lopes-Martins RAB, 2002, PHYTOMEDICINE, V9, P245, DOI 10.1078/0944-7113-00118; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Santander SP, 2009, UNIV MED, V50, P284; Quadros PR, 1999, IMMUNOPHARM IMMUNOT, V21, P109, DOI 10.3109/08923979909016397; Queiroz MLS, 2000, IMMUNOPHARM IMMUNOT, V22, P501, DOI 10.3109/08923970009026008; Rosner H, 2001, BBA-MOL CELL RES, V1540, P166, DOI 10.1016/S0167-4889(01)00129-X; Rossi V., 1993, PHARM RES, V1, P111; Ruffa MJ, 2002, CHEMOTHERAPY, V48, P144, DOI 10.1159/000064920; Santander SP, 2011, INT IMMUNOPHARMACOL, V11, P652, DOI 10.1016/j.intimp.2011.01.006; Santander SP, 2007, BIOMEDICA, V27, P18, DOI 10.7705/biomedica.v27i1.245; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Uruena C, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-60; Webster SA, 2008, IN VITRO CELL DEV-PL, V44, P112, DOI 10.1007/s11627-008-9125-2; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Williams LAD, 2007, W INDIAN MED J, V56, P17	37	11	13	0	9	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0192-415X	1793-6853		AM J CHINESE MED	Am. J. Chin. Med.		2012	40	4					833	844		10.1142/S0192415X12500620	http://dx.doi.org/10.1142/S0192415X12500620			12	Integrative & Complementary Medicine; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine; General & Internal Medicine	976NL	22809035				2022-09-04	WOS:000306591500014
J	Fleischman, FD; Boenning, K; Garcia-Lopez, GA; Mincey, S; Schmitt-Harsh, M; Daedlow, K; Lopez, MC; Basurto, X; Fischer, B; Ostrom, E				Fleischman, Forrest D.; Boenning, Kinga; Garcia-Lopez, Gustavo A.; Mincey, Sarah; Schmitt-Harsh, Mikaela; Daedlow, Katrin; Lopez, Maria Claudia; Basurto, Xavier; Fischer, Burney; Ostrom, Elinor			Disturbance, Response, and Persistence in Self-Organized Forested Communities: Analysis of Robustness and Resilience in Five Communities in Southern Indiana	ECOLOGY AND SOCIETY			English	Article						disturbance; intentional communities; response; robustness; social-ecological systems	SOCIAL-ECOLOGICAL SYSTEMS; RESOURCE-MANAGEMENT; INSTITUTIONS; PERSPECTIVE; FRAMEWORK; SUSTAINABILITY; VULNERABILITY; GOVERNANCE; COMPLEXITY	We develop an analytic framework for the analysis of robustness in social-ecological systems (SESs) over time. We argue that social robustness is affected by the disturbances that communities face and the way they respond to them. Using Ostrom's ontological framework for SESs, we classify the major factors influencing the disturbances and responses faced by five Indiana intentional communities over a 15-year time frame. Our empirical results indicate that operational and collective-choice rules, leadership and entrepreneurship, monitoring and sanctioning, economic values, number of users, and norms/social capital are key variables that need to be at the core of future theoretical work on robustness of self-organized systems.	[Fleischman, Forrest D.; Mincey, Sarah; Schmitt-Harsh, Mikaela] Indiana Univ, Sch Publ & Environm Affairs, Ctr Study Inst Populat & Environm Change, Bloomington, IN 47405 USA; [Daedlow, Katrin] Humboldt Univ, LGF, Div Resource Econ, D-1086 Berlin, Germany; [Lopez, Maria Claudia] Univ Javeriana, Fac Estudios Ambientales & Rurales, Bogota, Colombia; [Basurto, Xavier] Duke Univ, Nicholas Sch Environm, Marine Lab, Durham, NC 27706 USA		Fleischman, FD (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Ctr Study Inst Populat & Environm Change, Bloomington, IN 47405 USA.		, IAMO/G-2328-2012	, IAMO/0000-0001-7922-9665	Food and Agriculture Organization of the United Nations; Ford Foundation; MacArthur Foundation; National Science Foundation; Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO); NSF; Gottfried-Wilhelm-Leibniz-Community, Germany	Food and Agriculture Organization of the United Nations; Ford Foundation; MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO); NSF(National Science Foundation (NSF)); Gottfried-Wilhelm-Leibniz-Community, Germany	We are grateful to the members of the five communities who are profiled in this paper for allowing us to study their communities. We owe the existence of this data set to the many IFRI scholars who have participated in data collection for this project over the last 15 years, as well as to the database support of Julie England and Robin Humphrey. Funding for the IFRI research program has been provided by the Food and Agriculture Organization of the United Nations, Ford Foundation, MacArthur Foundation, and National Science Foundation. K. Daedlow's participation was funded through the project Adaptfish granted by the Gottfried-Wilhelm-Leibniz-Community, Germany. Funding for K. Boenning's participation was provided by the Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO). F. Fleischman's participation was funded by an NSF Graduate Research Fellowship. We appreciate helpful comments and conceptual development from three anonymous reviewers; Amy Poteete, Gwen Arnold, and colleagues in the Social-Ecological Systems Working Group at the Workshop in Political Theory and Policy Analysis, Indiana University, Bloomington; as well as editing from Patty Lezotte. A previous version of this paper was presented at the Workshop on the Workshop 4 conference, Indiana University, Bloomington, June 3-6, 2009.	Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Agrawal A., 2007, INT J COMMONS, V1, P111, DOI [10.18352/ijc.10, DOI 10.18352/IJC.10]; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Anderies J. M., 2007, INT J COMMONS, V1, P77; Anderies JM, 2004, ECOL SOC, V9; Basurto X., 2009, POLITICAL RES Q; Basurto X., 2009, ECONOMIA DELLE FONTI, V52, P35, DOI DOI 10.3280/EFE2009-001004; Boyd R., 2005, ORIGIN EVOLUTION CUL; Brady Henry E., 2004, RETHINKING SOCIAL IN; Brown S. L., 2002, INTENTIONAL COMMUNIT; Carlson JM, 2002, P NATL ACAD SCI USA, V99, P2538, DOI 10.1073/pnas.012582499; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Cleaver F, 2000, DEV CHANGE, V31, P361, DOI 10.1111/1467-7660.00158; Coleman EA, 2009, ECOL ECON, V68, P2106, DOI 10.1016/j.ecolecon.2009.02.006; CRAWFORD SES, 1995, AM POLIT SCI REV, V89, P582, DOI 10.2307/2082975; Fabricius C, 2007, ECOL SOC, V12; Fernandez-Gimenez ME, 2008, HUM ORGAN, V67, P137, DOI 10.17730/humo.67.2.008083027273n05q; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Freyfogle E. T., 2007, 0710 U ILL COLL LAW; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Gibson CC, 1998, HUM ECOL, V26, P621, DOI 10.1023/A:1018701525978; HARWELL MA, 1977, ECOLOGY, V58, P660, DOI 10.2307/1939016; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Janzen D. E., 1981, COMMUNAL SOC, V1, P37; Kanter R. M., 1972, COMMITMENT COMMUNITY; Kanter R. M., 1973, COMMUNES CREATING MA; KATES RW, 1971, ECON GEOGR, V47, P438, DOI 10.2307/142820; King G., 1994, DESIGNING SOCIAL INQ; Kitts James., 2000, COMMUNAL SOC, V20, P13; Kitts JA, 2009, SOC FORCES, V87, P1193, DOI 10.1353/sof.0.0173; Laffan B., 1997, COMMUNCAL ORG SOCIAL; Larson AM, 2007, SUSTAIN SCI, V2, P189, DOI 10.1007/s11625-007-0030-0; Ostrom Elinor, 2002, DRAM COMM; North DC, 2005, PRINC ECON HIST W WO, P1; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; OSTROM E, 2000, PEOPLE FORESTS COMMU, P243; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Oved Y., 1999, COMMUNAL SOC, V19, P67; Pickett STA., 1985, ECOLOGY NATURAL DIST; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Poteete AR, 2008, WORLD DEV, V36, P176, DOI 10.1016/j.worlddev.2007.02.012; Poteete AR, 2004, HUM ECOL, V32, P279, DOI 10.1023/B:HUEC.0000028083.29437.ac; Ragin C.C., 2000, FUZZY SET SOCIAL SCI; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Sunderlin W., 2008, EXCLUSION OWNERSHIP; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Walker B., 2008, RESILIENCE THINKING; Wertime M, 2007, INT FORESTRY RESOURC; White A, 2002, WHO OWNS WORLDS FORE; Wollenberg E, 2007, INT FOREST REV, V9, P670, DOI 10.1505/ifor.9.2.670; Zablocki B., 1980, ALIENATION CHARISMA	53	50	50	2	45	RESILIENCE ALLIANCE	WOLFVILLE	ACADIA UNIV, BIOLOGY DEPT, WOLFVILLE, NS B0P 1X0, CANADA	1708-3087			ECOL SOC	Ecol. Soc.		2010	15	4							9					21	Ecology; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	702SW					2022-09-04	WOS:000285917100011
J	Gil, F; Miranda, A; Uribe-Perez, C; Arias-Ortiz, NE; Yepez-Chamorro, MC; Bravo, LM; de Vries, E				Gil, Fabian; Miranda-Filho, Adalberto; Uribe-Perez, Claudia; Arias-Ortiz, N. E.; Yepez-Chamorro, M. C.; Bravo, L. M.; de Vries, Esther			Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries	JOURNAL OF CANCER EPIDEMIOLOGY			English	Article							THYROID-CANCER; SURVEILLANCE; REGISTRATION; TRENDS	Background. Estimation of survival requires follow-up of patients from diagnosis until death ensuring complete and good quality data. Many population-based cancer registries in low- and middle-income countries have difficulties linking registry data with regional or national vital statistics, increasing the chances of cases lost to follow-up. The impact of lost to follow-up cases on survival estimates from small population-based cancer registries (<500 cases) has been understudied, and bias could be larger than in larger registries. Methods. We simulated scenarios based on idealized real data from three population-based cancer registries to assess the impact of loss to follow-up on 1-5-year overall and net survival for stomach, colon, and thyroid cancers-cancer types with very different prognosis. Multiple scenarios with varying of lost to follow-up proportions (1-20%) and sample sizes of (100-500 cases) were carried out. We investigated the impact of excluding versus censoring lost to follow-up cases; punctual and bootstrap confidence intervals for the average bias are presented. Results. Censoring of lost to follow-up cases lead to overestimation of the overall survival, this effect was strongest for cancers with a poor prognosis and increased with follow-up time and higher proportion of lost to follow-up cases; these effects were slightly larger for net survival than overall survival. Excluding cases lost to follow-up did not generate a bias on survival estimates on average, but in individual cases, there were under- and overestimating survival. For gastric, colon, and thyroid cancer, relative bias on 5-year cancer survival with 1% of lost to follow-up varied between 6% and 125%, 2% and 40%, and 0.1% and 1.0%, respectively. Conclusion. Estimation of cancer survival from small population-based registries must be interpreted with caution: even small proportions of censoring, or excluding lost to follow-up cases can inflate survival, making it hard to interpret comparison across regions or countries.	[Gil, Fabian] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, PhD Program Clin Epidemiol, Bogota, Colombia; [Gil, Fabian; de Vries, Esther] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Fac Med, Bogota, Colombia; [Miranda-Filho, Adalberto] Int Agcy Res Canc, Canc Surveillance Branch, Lyon, France; [Uribe-Perez, Claudia] Univ Autonoma Bucaramanga, Genet Study Complex Dis Res Grp, Populat Registry Canc, Metropolitan Area Bucaramanga, Bucaramanga, Colombia; [Arias-Ortiz, N. E.] Univ Caldas, Hlth Promot & Dis Prevent Res Grp, Populat Registry Canc Maniz, Grp Invest Promoc Salud & Prevenc Enfermedad GIPS, Manizales, Colombia; [Yepez-Chamorro, M. C.] Univ Narino, Fac Ciencias Salud, Ctr Estudios Salud CESUN, Canc Registry Pasto, Pasto, Narino, Colombia; [Bravo, L. M.] Univ Narino, Ctr Estudios Salud CESUN, Canc Registry Pasto, Pasto, Narino, Colombia		Gil, F (corresponding author), Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, PhD Program Clin Epidemiol, Bogota, Colombia.; Gil, F (corresponding author), Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Fac Med, Bogota, Colombia.	fgil@javeriana.edu.co; mirandaa@fellows.iarc.fr; curibep@hotmail.com; nelson.arias@ucaldas.edu.co; macych@gmail.com; lume.goyes@gmail.com; estherdevries@javeriana.edu.co	de Vries, Esther/A-6603-2009; Gil, Jacky Fabian/A-3352-2011	de Vries, Esther/0000-0002-5560-2258; Uribe, Claudia/0000-0002-6640-5938; Arias-Ortiz, Nelson/0000-0001-5093-3384; Gil, Jacky Fabian/0000-0001-6444-7248; BRAVO GOYES, LUISA MERCEDES/0000-0002-6440-8289				Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Andersson TML, 2021, BRIT J CANCER, V124, P1026, DOI 10.1038/s41416-020-01196-7; Andersson TML, 2021, CANCER EPIDEMIOL, V71, DOI 10.1016/j.canep.2020.101881; Bittmann F., 2021, BOOTSTRAPPING INTEGR; Bray F, 2021, CANCER-AM CANCER SOC, V127, P3029, DOI 10.1002/cncr.33587; Brenner H, 2009, INT J CANCER, V125, P432, DOI 10.1002/ijc.24344; Cendales R, 2018, COLOMB MEDICA, V49, P121, DOI 10.25100/cm.v49i1.3155; de Vries E, 2016, CANCER EPIDEMIOL, V45, pS13, DOI 10.1016/j.canep.2016.09.014; Departamento Administrativo Nacional de Estadistica (DANE), 2020, EST CAMB DEM; Dickman PW, 2015, STATA J, V15, P186, DOI 10.1177/1536867X1501500112; Font-Gonzalez A, 2013, SALUD PUBLICA MEXICO, V55, P368; Gil F, 2019, REV COLOMB CANCEROL, V23, P56, DOI 10.35509/01239015.60; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koch Adriana, 2020, J Registry Manag, V47, P32; Leal YA, 2016, SALUD PUBLICA MEXICO, V58, P309, DOI 10.21149/spm.v58i2.7802; Li MM, 2021, LANCET DIABETES ENDO, V9, P330, DOI 10.1016/S2213-8587(21)00083-8; Miranda A, 2021, LANCET DIABETES ENDO, V9, P225, DOI 10.1016/S2213-8587(21)00027-9; Moller H, 2011, BRIT J CANCER, V105, P170, DOI 10.1038/bjc.2011.168; Okuyama A, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033510; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Pineros M, 2021, INT J CANCER, V149, P12, DOI 10.1002/ijc.33407; Pineros M, 2017, EPIDEMIOL REV, V39, P161, DOI 10.1093/epirev/mxx003; Pinheiro Paulo S., 2014, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgu016; R Core Team, 2022, R LANG ENV STAT COMP; Rodriguez Garcia J., 2019, GERENCIA POLITICAS S, V18, P1, DOI [10.11144/Javeriana.rgsp18-36.ccmn, DOI 10.11144/JAVERIANA.RGSP18-36.CCMN]; Rutherford MJ, 2013, BRIT J CANCER, V108, P691, DOI 10.1038/bjc.2013.12; StataCorp, 2019, STATA STAT SOFTWARE; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Woods LM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3399; Yepez M.C., 2017, SISTEMA INFORMACION	31	0	0	2	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-8558	1687-8566		J CANCER EPIDEMIOL	J. Cancer Epidemiol.	JAN 30	2022	2022								9068214	10.1155/2022/9068214	http://dx.doi.org/10.1155/2022/9068214			10	Oncology	Emerging Sources Citation Index (ESCI)	Oncology	ZY1DH	35140789	Green Published, gold			2022-09-04	WOS:000772329400001
J	Caviedes-Bucheli, J; Rios-Osorio, N; Usme, D; Jimenez, C; Pinzon, A; Rincon, J; Azuero-Holguin, MM; Zubizarreta-Macho, A; Gomez-Sosa, JF; Munoz, HR				Caviedes-Bucheli, Javier; Rios-Osorio, Nestor; Usme, Diana; Jimenez, Cristian; Pinzon, Adriana; Rincon, Jorge; Azuero-Holguin, Maria M.; Zubizarreta-Macho, Alvaro; Gomez-Sosa, Jose F.; Munoz, Hugo R.			Three-dimensional analysis of the root canal preparation with Reciproc Blue (R), WaveOne Gold (R) and XP EndoShaper (R): a new method in vivo	BMC ORAL HEALTH			English	Article						Cone-beam computed tomography; 3D reconstruction; Root canal preparation; Single-file; Reciproc Blue; WaveOne Gold; XP-EndoShaper		BackgroundThe purpose of this study was to evaluate the changes in canal volume after root canal preparation in vivo with 3 different single-file techniques (Reciproc-Blue (R), WaveOne-Gold (R) and XP-EndoShaper (R)), with a new method using CBCT and 3D reconstruction.MethodsIn this prospective study, thirty human lower premolars from healthy patients were used, in which extraction was indicated for orthodontic reasons. All the teeth used were caries- and restoration-free with complete root development, without signs of periodontal disease or traumatic occlusion, and with only one straight canal (up to 25o curvature). Teeth were randomly divided into three different groups: Reciproc-Blue, WaveOne-Gold and XP-EndoShaper. CBCT scans before root canal preparation were used to create a 3D reconstruction with RHINOCEROS 5.0 software to assess the initial canal volume, and then compared with 3D reconstructions after canal preparation to measure the increase in canal volume. Student's t test for paired data were used to determine statistically significant differences between the before and after canal volumes. Anova test was used to determine statistically significant differences in the percentage of canal volume increase between the groups and Tukey's post-hoc test were used to paired comparison.ResultsReciproc-Blue showed the higher increase in canal volume, followed by WaveOne-Gold and XP-EndoShaper (p=0.003). XP-EndoShaper did not show a statistically significant increase in canal volume after root canal preparation (p=0.06).ConclusionWith this model, Reciproc-Blue showed higher increase in root canal volume, followed by WaveOne-Gold, while XP-EndoShaper did not significantly increase root canal volume during preparation.	[Caviedes-Bucheli, Javier; Azuero-Holguin, Maria M.] Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia; [Rios-Osorio, Nestor; Usme, Diana; Jimenez, Cristian; Pinzon, Adriana; Azuero-Holguin, Maria M.] Inst Univ Colegios Colombia, Postgrad Endodont Dept, Bogota, Colombia; [Zubizarreta-Macho, Alvaro] Alfonso X El Sabio Univ, Fac Hlth Sci, Dept Endodont, Madrid, Spain; [Gomez-Sosa, Jose F.] Cent Univ Venezuela, Postgrad Endodont Dept, Caracas, Venezuela; [Munoz, Hugo R.] Univ San Carlos, Endodont Dept, Guatemala City, Guatemala		Caviedes-Bucheli, J (corresponding author), Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia.	javiercaviedes@gmail.com	Gomez-Sosa, Jose F/AAL-2610-2020	Gomez-Sosa, Jose F/0000-0002-2307-6214				Achguzel M, 2017, J ENDODONT, V43, P623, DOI 10.1016/j.joen.2016.11.021; Amornvit Pokpong, 2020, J Healthc Eng, V2020, P5739312, DOI 10.1155/2020/5739312; [Anonymous], RHINOCEROS; Azim AA, 2017, J ENDODONT, V43, P1532, DOI 10.1016/j.joen.2017.04.022; Bradel Susanne, 2017, Int J Otolaryngol, V2017, P6753604, DOI 10.1155/2017/6753604; Burroughs JR, 2012, J ENDODONT, V38, P1618, DOI 10.1016/j.joen.2012.09.011; Chakroun F, 2018, J MECH BEHAV BIOMED, V85, P175, DOI 10.1016/j.jmbbm.2018.06.007; Chavda R, 2014, J ENDODONT, V40, P1524, DOI 10.1016/j.joen.2014.05.011; Chen H, 2008, AM J ORTHOD DENTOFAC, V134, P393, DOI 10.1016/j.ajodo.2006.10.030; Cotton TP, 2007, J ENDODONT, V33, P1121, DOI 10.1016/j.joen.2007.06.011; Faggion Clovis Mariano Jr, 2012, J Evid Based Dent Pract, V12, P182, DOI 10.1016/j.jebdp.2012.10.001; Giuliani V, 2014, J ENDODONT, V40, P1468, DOI 10.1016/j.joen.2014.02.024; Keskin C, 2017, J ENDODONT, V43, P1360, DOI 10.1016/j.joen.2017.03.036; Lacerda MFLS, 2017, J ENDODONT, V43, P1878, DOI 10.1016/j.joen.2017.06.032; Maeda M, 2006, ORAL SURG ORAL MED O, V102, P382, DOI 10.1016/j.tripleo.2005.10.057; Manker A, 2020, EUR ARCH PAEDIATR DE, V21, P203, DOI 10.1007/s40368-019-00474-0; Moinzadeh A, 2010, INT ENDOD J, V43, P451, DOI 10.1111/j.1365-2591.2010.01729.x; Moraes SLD, 2015, COMPUT METHOD BIOMEC, V18, P689, DOI 10.1080/10255842.2013.820719; Silva EJNL, 2018, J ENDODONT, V44, P168, DOI 10.1016/j.joen.2017.08.033; Orturk BA, 2020, J ENDODONT, V46, P437, DOI 10.1016/j.joen.2019.11.014; Ozyurek T, 2017, J ENDODONT, V43, P805, DOI 10.1016/j.joen.2016.12.010; Paque F, 2010, J ENDODONT, V36, P703, DOI 10.1016/j.joen.2009.12.020; Patel S, 2014, INT ENDOD J, V47, P502, DOI 10.1111/iej.12267; Peters OA, 2001, J ENDODONT, V27, P1, DOI 10.1097/00004770-200101000-00001; Plotino G, 2014, J ENDODONT, V40, P1228, DOI 10.1016/j.joen.2014.01.041; Ponce EH, 2003, J ENDODONT, V29, P214, DOI 10.1097/00004770-200303000-00013; Rossi-Fedele G, 2017, J ENDODONT, V43, P520, DOI 10.1016/j.joen.2016.12.008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Soares PV, 2014, J ORAL REHABIL, V41, P108, DOI 10.1111/joor.12113; Thomas JP, 2020, J ENDODONT, V46, P244, DOI 10.1016/j.joen.2019.11.001; Tyndall DA, 2012, AUST DENT J, V57, P72, DOI 10.1111/j.1834-7819.2011.01654.x; Verri Fellippo Ramos, 2017, Journal of Medical Engineering & Technology, V41, P644, DOI 10.1080/03091902.2017.1385655; Wei Z, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0326-5; Wu MK, 2000, ORAL SURG ORAL MED O, V89, P99, DOI 10.1016/S1079-2104(00)80023-2	34	2	2	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6831			BMC ORAL HEALTH	BMC Oral Health	FEB 25	2021	21	1							88	10.1186/s12903-021-01450-1	http://dx.doi.org/10.1186/s12903-021-01450-1			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	QQ4OR	33632187	gold, Green Published, Green Submitted			2022-09-04	WOS:000624503200004
J	Acevedo-Triana, C; Torres, M; Aguilar-Bustamante, MC; Hurtado-Parrado, C; Silva, LM; Lopez-Lopez, W				Acevedo-Triana, Cesar; Torres, Michelle; Constanza Aguilar-Bustamante, Maria; Hurtado-Parrado, Camilo; Manuel Silva, Luis; Lopez-Lopez, Wilson			Productivity Analysis and Impact of Colombian Psychology Journals between 2000 and 2016	REVISTA LATINOAMERICANA DE PSICOLOGIA			English	Article						Scientometric analysis; Journals of Psychology; Citation and impact	IBERO-AMERICAN PSYCHOLOGY; BIBLIOMETRIC INDICATORS; RESEARCH COLLABORATION; SCIENTIFIC PRODUCTION; BEHAVIORAL-SCIENCES; WEB; COOPERATION; PERFORMANCE; HUMANITIES; VISIBILITY	The growing output of Colombian psychology journals over past decades leads to questions regarding the regional and international relevance and impact of their productivity. Considering the lack of recent efforts to assess the output of these journals across different information sources, the present study analyzed the production, collaboration, and impact of Colombian psychology journals between 2000 and 2016 using information from the following databases: Scopus, Scielo, Redalyc, and Journal Scholar Metrics. We analyzed 3915 articles published across 13 journals. A journal was included in the analysis if it was indexed in several of these databases, which allowed for multiple comparisons. We observed journals' diversification and growth across all the proposed indicators, with different degrees of visibility and quality depending on the criteria used. Although all the journals generally showed similar regional and international results, some excelled across indicators, which in turn challenges other journals to improve their scores. We conclude that Colombian production in psychology is visible on a regional level. Moreover, journals need to increase some of the indicators so they can be compared with other regional and international open-access benchmarks, which is the model in which they were originally conceived. (c) 2018 Fundacion Universitaria Konrad Lorenz.	[Acevedo-Triana, Cesar; Torres, Michelle] Univ Pedag & Tecnol Colombia, Sch Psychol, Tunja, Colombia; [Constanza Aguilar-Bustamante, Maria] Univ Santo Tomas de Aquino, Fac Psychol, Bogota, Colombia; [Hurtado-Parrado, Camilo] Fdn Univ Konrad Lorenz, Fac Psychol, Bogota, Colombia; [Manuel Silva, Luis; Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Fac Psychol, Bogota, Colombia; [Hurtado-Parrado, Camilo] Troy Univ, Dept Psychol, Troy, AL USA		Lopez-Lopez, W (corresponding author), Pontificia Univ Javeriana, Fac Psychol, Bogota, Colombia.	lopezw@javeriana.edu.co	Hurtado-Parrado, Camilo/W-9832-2019; López López, Wilson/AAV-8032-2021; Acevedo-Triana, Cesar/AAR-1536-2020; Silva, Luis M/B-2213-2009	Hurtado-Parrado, Camilo/0000-0001-5923-8054; López López, Wilson/0000-0002-2964-0402; Silva, Luis M/0000-0001-7051-0186; AGUILAR-BUSTAMANTE, MARIA CONSTANZA/0000-0003-2990-9667				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Acevedo-Triana CA, 2014, REV COSTARRIC PSICOL, V33, P155; Aguado Lopez E, 2013, CAPSULAS INVESTIGACI; Aguado-Lopez E, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-2.upci; Allik J, 2013, EUR J PERSONALITY, V27, P5, DOI 10.1002/per.1843; Alperin J. P., 2015, THE WINNOWER, DOI [10.15200/winn.143982.27959, DOI 10.15200/WINN.143982.27959]; Alperin Juan Pablo, 2017, Rev. Interam. Bibliot, V40, P231, DOI 10.17533/udea.rib.v40n3a04; Alperin JP, 2015, ASLIB J INFORM MANAG, V67, P289, DOI 10.1108/AJIM-12-2014-0176; Salvador-Olivan JA, 2015, REV GEN INF DOC, V25, P341, DOI 10.5209/rev_RGID.2015.v25.n2.51241; Bar-Ilan J, 2008, J INFORMETR, V2, P1, DOI 10.1016/j.joi.2007.11.001; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Bjork BC, 2015, PEERJ, V3, DOI 10.7717/peerj.981; Bornmann L., 2017, GEOGRAPHY REFERENCES, P1; Buela-Casal G, 2004, PSICOTHEMA, V16, P680; Buela-Casal G., 2005, REV LATINOAMERICANA, V37, P211; Butler L., 2008, ETHICS SCI ENV POLIT, V8, P83, DOI DOI 10.3354/ESEP00077; Chi RB, 2013, SCIENTOMETRICS, V96, P147, DOI 10.1007/s11192-012-0894-3; Davidson Patricia M, 2014, ScientificWorldJournal, V2014, P135812, DOI 10.1155/2014/135812; Duffy RD, 2011, SCIENTOMETRICS, V89, P207, DOI 10.1007/s11192-011-0452-4; Fetscherin M, 2015, J BUS RES, V68, P380, DOI 10.1016/j.jbusres.2014.06.010; Gallegos Miguel, 2014, Psicoperspectivas, V13, P106, DOI 10.5027/psicoperspectivas-Vol13-Issue3-fulltext-377; Garcia A, 2017, DIVERSITAS-PERSP PSI, V13, P113, DOI [10.15332/s1794-9998.2017.0001.09, 10.15332/s1794-9998.2017.0001.9]; Garcia Agnaldo, 2016, Suma Psicol., V23, P125, DOI 10.1016/j.sumpsi.2016.08.002; Garcia A, 2014, TER PSICOL, V32, P165; Garfield E., 2003, INT J CLIN HLTH PSYC, V3, P363; Garfield E, 1978, METRIC SCI ADVENT SC; Garfield E, 2007, INT MICROBIOL, V10, P65, DOI 10.2436/20.1501.01.10; Gingras Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004048; Sala FG, 2017, SCIENTOMETRICS, V112, P1069, DOI 10.1007/s11192-017-2372-4; Gorraiz J, 2008, J INF SCI, V34, P715, DOI 10.1177/0165551507086991; Guerrero J, 2009, PRODUCCION CIENTIFIC; Heberger AE, 2010, AM J EVAL, V31, P24, DOI 10.1177/1098214009354120; Hernandez-Gonzalez V, 2016, INT J MORPHOL, V34, P1369, DOI 10.4067/S0717-95022016000400032; Avila-Toscano JH, 2014, AV PSICOL LATINOAM, V32, P167, DOI 10.12804/apl32.1.2014.12; Hicks D, 1999, SCIENTOMETRICS, V44, P193, DOI 10.1007/BF02457380; Kliegl R, 2011, SCIENTOMETRICS, V87, P149, DOI 10.1007/s11192-010-0299-0; Koch S, 1992, CENTURY PSYCHOL SCI, P75; Krampen G, 2008, SCIENTOMETRICS, V76, P3, DOI 10.1007/s11192-007-1900-z; Krampen G, 2011, SCIENTOMETRICS, V87, P687, DOI 10.1007/s11192-011-0357-2; Krampen G, 2010, SCIENTOMETRICS, V83, P507, DOI 10.1007/s11192-009-0093-z; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; LAWANI SM, 1986, SCIENTOMETRICS, V9, P13, DOI 10.1007/BF02016604; Leydesdorff L, 2004, SCIENTOMETRICS, V60, P159, DOI 10.1023/B:SCIE.0000027678.31097.e0; Long HY, 2014, CREATIVITY RES J, V26, P353, DOI 10.1080/10400419.2014.929425; LÓPEZ LÓPEZ WILSON, 2010, Act.Colom.Psicol., V13, P35; Lopez WL, 2010, PAPEL PSICOL, V31, P296; Lopez-Lopez W, 2014, U PSYCHOL, V13; Lopez-Lopez W., 2015, INFORM PSICOLOGICA, V109, P2; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; Moed HF, 2008, SCIENTOMETRICS, V74, P153, DOI 10.1007/s11192-008-0108-1; Moed HF, 2010, J INFORMETR, V4, P265, DOI 10.1016/j.joi.2010.01.002; Morales Y. J. G., 2012, REV COLOMB PSICOL, V21, P97; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Mukherjee B, 2009, J AM SOC INF SCI TEC, V60, P581, DOI 10.1002/asi.21003; NAVARRETE-CORTES JOSÉ, 2010, Univ. Psychol., V9, P553; Nederhof AJ, 2006, SCIENTOMETRICS, V66, P81, DOI 10.1007/s11192-006-0007-2; NEDERHOF AJ, 1989, SCIENTOMETRICS, V15, P423, DOI 10.1007/BF02017063; Neto S. C., 2016, ED POLICY ANAL ARCH, V24, P1, DOI [10.14507/epaa.24.2391, DOI 10.14507/EPAA.24.2391]; Nicolaisen J, 2010, J AM SOC INF SCI TEC, V61, P205, DOI 10.1002/asi.21181; Orduna Malea E, 2012, J SCHOLAR ALTERNATIV; Osca-Lluch J, 2005, SCIENTOMETRICS, V65, P189, DOI 10.1007/s11192-005-0267-2; Pérez-Acosta Andrés M., 2018, CES Psicol, V11, P1, DOI 10.21615/cesp.11.1.11; Piwowar Heather, 2018, PeerJ, V6, pe4375, DOI 10.7717/peerj.4375; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Polanco-Carrasco R, 2017, TER PSICOL, V35, P81; Quevedo-Blasco R, 2011, UNIV PSYCHOL, V10, P937, DOI 10.11144/Javeriana.upsy10-3.srip; Robayo-Castro Beatriz, 2016, Univ. Psychol., V15, P1, DOI 10.11144/Javeriana.upsy15-5.icpa; Romero-Torres M, 2013, REV ESP DOC CIENT, V36, DOI 10.3989/redc.2013.1.876; Ruiz-Perez R, 2013, INDICE H REV CIENTIF; Salas Gonzalo, 2017, Psykhe, V26, P1, DOI 10.7764/psykhe.26.1.1205; Salazar-Acosta M., 2013, INFORME PRODUCCION C; Schui G, 2010, INT J BEHAV DEV, V34, P289, DOI 10.1177/0165025409344828; SCImago Research Group, 2007, DESCR SCIMAGO J RANK; Seglen PO, 1997, ALLERGY, V52, P1050, DOI 10.1111/j.1398-9995.1997.tb00175.x; Sistema de Informacion Cientifica Redalyc, 2018, COL REV PSIC RED REV; de Araujo CGS, 2011, REV BRAS MED ESPORTE, V17, P358, DOI 10.1590/S1517-86922011000500013; Suber P., 2015, ACCESO ABIERTO; SUBRAMANYAM K, 1983, J INFORM SCI, V6, P33, DOI 10.1177/016555158300600105; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Torres-Salinas D, 2012, MANIPULAR GOOGLE SCH; Van Noorden R, 2012, NATURE, V487, P285, DOI 10.1038/487285a; Van Noorden R, 2012, NATURE, V486, P166, DOI 10.1038/486166a; Vargas-Quesada B., 2007, VISUALIZING STRUCTUR, DOI [10.1007/3-540-69728-4, DOI 10.1007/3-540-69728-4]; Vera-Villarroel P, 2011, REV LAT AM PSICOL, V43, P95; Yeung AWK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00120; Zou C, 2016, SCIENTOMETRICS, V106, P901, DOI 10.1007/s11192-015-1807-z; Zurita Gustavo, 2016, Proceedings of the World Congress on Engineering 2016, P403	88	2	2	2	6	FOUNDATION ADVANCEMENT PSYCHOLOGY	BOGOTA D C	APARTADO AEREO 92621, BOGOTA D C, COLOMBIA	0120-0534			REV LAT AM PSICOL	Rev. Latinoam. Psicol.	OCT-DEC	2018	50	3					145	159		10.14349/rlp.2018.v50.n3.2	http://dx.doi.org/10.14349/rlp.2018.v50.n3.2			15	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HR5LL		gold, Green Published			2022-09-04	WOS:000463188200002
J	Lasalvia, P; Rosselli, D; Castaneda-Cardona, C; Garzon, J; Hernandez, F; Beltran, C; Rojas, M; Lopez, MC; Sarpong, EM				Lasalvia, P.; Rosselli, D.; Castaneda-Cardona, C.; Garzon, J.; Hernandez, F.; Beltran, C.; Rojas, M.; Lopez, M. C.; Sarpong, E. M.			COST-EFFECTIVENESS OF CEFTOLOZANE/TAZOBACTAM PLUS METRONIDAZOLE AS EMPIRIC THERAPY FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN COLOMBIA	VALUE IN HEALTH			English	Meeting Abstract									[Lasalvia, P.; Castaneda-Cardona, C.; Hernandez, F.] NeuroEconomix, Bogota, Colombia; [Rosselli, D.] Pontificia Univ Javeriana, Bogota, Colombia; [Garzon, J.] Hosp San Ignacio, Bogota, Colombia; [Beltran, C.; Rojas, M.] Merck Sharp & Dohme Ltd, Bogota, Colombia; [Lopez, M. C.] Merck Sharp & Dhome, Bogota, Colombia; [Sarpong, E. M.] MERCK & CO Inc, Rabway, NJ USA										0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2018	21			1		PIN36	S152	S153						2	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	GN0DO					2022-09-04	WOS:000438630000198
J	Lopez, WL; Marin, CP; Sorum, PC; Mullet, E				Lopez Lopez, Wilson; Pineda Marin, Claudia; Sorum, Paul C.; Mullet, Etienne			Prohibition, Regulation or Free Market: A Mapping of Colombian People's Perspectives Regarding National Drug Policies	SOCIAL INDICATORS RESEARCH			English	Article						Drug policy; Public perception; Colombia	ATTITUDES; LEGALIZATION; SUPPORT; VIEWS; WAR	Colombian laypersons' perspectives regarding actual and potential drug policies were examined. Adults (N = 395) aged 18-68 and living in Bogota were presented with 24 vignettes that were composed according to two within-subject orthogonal factor designs: (a) Demand for drugs in the country x Current government policy regarding soft and hard drugs (from "laissez faire" policy for all drugs to complete prohibition of all drugs) and (b) Information campaigns regarding the dangerousness of drugs x Current policy. Participants rated the level of acceptability of each policy. Seven different perspectives were identified that can be grouped into five broad views. The first one (50 % of participants) was called "radical constructionists" because participants considered that all policies were unacceptable. The second one (19 %) was called "cultural conservatives" because only one drug policy was considered fully acceptable: complete prohibition (although half of the members of this group were willing to allow soft drugs to be sold freely). The third one (14 %) was called "progressive prohibitionists" because the preferred policies in this group were either complete prohibition or complete regulation by the government. The fourth one (8 %) was called "free trade libertarians" because the dominant opinion was that the drug market should be free. The last one (5 %) was called "progressive advocates of legalization" because the preferred policy in this group was complete regulation of all substances. In most cases, the presence of information campaigns was highly valued. Methodological implications and implications for decision-makers are discussed.	[Lopez Lopez, Wilson] Pontificia Javeriana Univ, Bogota, Colombia; [Pineda Marin, Claudia] Santo Tomas Univ, Bogota, Colombia; [Sorum, Paul C.] Albany Med Coll, Albany, NY 12208 USA; [Mullet, Etienne] EPHE, Inst Adv Studies, Quefes 17Bis, F-31830 Plaisance, France		Mullet, E (corresponding author), EPHE, Inst Adv Studies, Quefes 17Bis, F-31830 Plaisance, France.	etienne.mullet@wanadoo.fr	López López, Wilson/AAV-8032-2021	López López, Wilson/0000-0002-2964-0402				Agrawal S, 2010, DRUG-EDUC PREV POLIC, V17, P587, DOI 10.3109/09687630902729602; Anderson N. H., 2008, UNIFIED SOCIALI COGN; BBC, 2004, BBC NEWS; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V279, P827, DOI 10.1001/jama.279.11.827; Boyum D, 2001, SOC RES, V68, P865; Bretteville-Jensen AL, 2006, SUBST USE MISUSE, V41, P555, DOI 10.1080/10826080500521565; Bushnell D, 2010, COLOMBIA COUNTRY STU, P101; Camacho A., 2011, DRUG CONSUMPTION COL, P15; Camus J, 2014, SOC INDIC RES, V118, P1191, DOI 10.1007/s11205-013-0454-0; Costes J. M., 2010, TENDANCES, V71, P1; Courtwright David, 1982, DARK PARADISE OPIATE; Departamento Administrativo Nacional de Estadistica (DANE), 2014, DEM POBL; DRCNet, 2001, COL LEG MOV; FRIEDMAN M, 1991, COMMUNICATION; Gamelin A, 2006, QUAL LIFE RES, V15, P429, DOI 10.1007/s11136-005-2830-y; Gaviria A., 2011, ANTIDRUG POLICY COLO; Goode E, 1998, SOCIETY, V35, P18, DOI 10.1007/BF02686378; Heimann M., 2014, J BUSINESS IN PRESS; Hoffmann NG, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n03_01; Hofmans J, 2013, QUAL QUANT, V47, P455, DOI 10.1007/s11135-011-9529-7; Hopwood M, 2010, DRUG ALCOHOL REV, V29, P385, DOI 10.1111/j.1465-3362.2009.00151.x; Human Rights Watch, 2011, WORLD REP 2011 COL; Jelsma M., 2011, DEV INT DRUG CONTROL; Jenner M. S., 2011, INDIANA J GLOBAL LEG, V18, P901; Lambert EG, 2006, J ETHN CRIM JUSTICE, V4, P93, DOI 10.1300/J222v04n01_04; Lopez-Lopez W., 2012, SOCIAL INDICATORS RE, V114, P287; Millhorn M, 2009, J HUM BEHAV SOC ENVI, V19, P125, DOI 10.1080/10911350802687075; Nadelmann E., 2006, REDUCING PROHIBITION; Neto F., 2013, INT PERSPECTIVES PSY, V2, P73, DOI DOI 10.1037/a0032629; Olivari C, 2011, UNIV PSYCHOL, V10, P13; Patino V. M., 1969, CULTIVATED PLANTS DO, V4; Gomez AP, 2013, ADICCIONES, V25, P106, DOI 10.20882/adicciones.57; PLOWMAN T, 1979, J PSYCHEDEL DRUG, V11, P103, DOI 10.1080/02791072.1979.10472095; Thoumi FE, 2002, ANN AM ACAD POLIT SS, V582, P102; Timberlake JM, 2003, POLICY STUD J, V31, P71, DOI 10.1111/1541-0072.00004; Timberlake JM, 2001, SOC SCI QUART, V82, P184, DOI 10.1111/0038-4941.00016; Treloar C, 2007, DRUG ALCOHOL REV, V26, P355, DOI 10.1080/09595230701373867; Trevino RA, 2002, AM J DRUG ALCOHOL AB, V28, P91, DOI 10.1081/ADA-120001283; Uchtenhagen A, 2010, ADDICTION, V105, P29, DOI 10.1111/j.1360-0443.2009.02741.x; *UN OFF DRUGS CRIM, 2009, WORLD DRUG REP 2009; United Kingdom Drug Policy Commission, 2012, FIN REP UK DRUG POL; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REP 2013; Van Laar M., 2007, REPORT EMCDDA REITOX; Werb D., 2010, EFFECT DRUG LAW ENFO; Wood E., 2010, BRIT MED J, V341, P107; Zorro C., 2011, POLITICAS ANTIDROGA, P91; [No title captured]	47	4	4	1	19	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	MAR	2016	126	2					689	710		10.1007/s11205-015-0908-7	http://dx.doi.org/10.1007/s11205-015-0908-7			22	Social Sciences, Interdisciplinary; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	DD8GM					2022-09-04	WOS:000370164000012
J	Luna-Acosta, A; Budzinski, H; Le Menach, K; Thomas-Guyon, H; Bustamante, P				Luna-Acosta, A.; Budzinski, H.; Le Menach, K.; Thomas-Guyon, H.; Bustamante, P.			Persistent organic pollutants in a marine bivalve on the Marennes-Oleron Bay and the Gironde Estuary (French Atlantic Coast)-Part 1: Bioaccumulation	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Polycyclic aromatic hydrocarbons; Persistent organic pollutants; Bivalve; Bioaccumulation; Active biomonitoring	MYTILUS-GALLOPROVINCIALIS; POLYCHLORINATED-BIPHENYLS; SEASONAL-VARIATIONS; MEDITERRANEAN SEA; PAH CONTAMINATION; CRASSOSTREA-GIGAS; SUMMER MORTALITY; BALTIC SEA; FRANCE; OYSTERS	The aim of this study was to determine 1) the relevance of using the Pacific oyster Crassostrea gigas as a sentinel organism, at a juvenile stage, for polycyclic aromatic hydrocarbon (PAH) and persistent organic pollutant (polychlorobiphenyl, PCB, polybromodimethylether, PBDE, and organochlorine pesticide, OCP) contamination, 2) the potential levels of chemical organic contamination in the Marennes-Oleron Bay, and their potential sources and 3) the potential influence of physiological or environmental factors on contaminant body burdens in oysters. To this end, juvenile oysters purchased from an oyster hatchery were transplanted to a reference site, in Bouin, and to different transplantation sites in the Marennes-Oleron Bay, the first oyster production area in France, and in the Gironde Estuary, the biggest estuary in Occidental Europe. Transplantations were done during summer and winter. Whole oyster soft tissues from each site were analysed for PAHs, PCBs, PBDEs and OCPs. Results obtained with a transplantation period of 3 months suggest that C. gigas, at the juvenile stage, is a relevant sentinel organism for short-term assessment of contamination for these contaminants. In addition, no significant effects of physiological factors on contaminant body burdens were observed. Principal component analysis revealed two distinct groups of contaminants (PAHs and OPCs, and PCBs and PBDEs) and three groups of sites: 1) the reference site, 2) Les Palles (LP) and Boyard (BOY) in winter and 3) all the other sites. The group of LP and BOY was clearly defined by the levels of PAHs and OCPs, suggesting higher levels of contamination of these chemical compounds on these sites, potentially due to local contamination sources. In addition, no relevant effects of physiological or environmental factors on contaminant body burdens were observed. Results suggest also a predominance of contaminants related to agricultural activities along the Marennes-Oleron Bay, and therefore, further studies on the presence of pesticides in this region should be considered. (C) 2014 Elsevier B.V. All rights reserved.	[Luna-Acosta, A.; Thomas-Guyon, H.; Bustamante, P.] Univ La Rochelle, UMR CNRS 7266, Littoral Environm & Soc LIENSs, F-17042 La Rochelle 01, France; [Budzinski, H.; Le Menach, K.] Univ Bordeaux 1, UMR CNRS 5805, UMR EPOC, Lab Phys ToxicoChim Environm LPTC, F-33405 Talence, France; [Budzinski, H.; Le Menach, K.] Univ Bordeaux 1, CNRS, UMR 5805, EPOC,Lab Phys ToxicoChim Environm LPTC, F-33405 Talence, France		Luna-Acosta, A (corresponding author), Univ Javeriana, Dept Ecol & Terr, Transv 4 42-00, Bogota, Colombia.	aluna1508@yahoo.com	Bustamante, Paco/G-5833-2011; Thomas-Guyon, Helene/O-9598-2014	Bustamante, Paco/0000-0003-3877-9390; Luna-Acosta, Andrea/0000-0002-4712-2721; Thomas-Guyon, Helene/0000-0002-7932-6841; BUDZINSKI, Helene/0000-0001-5282-9011	Conseil General de the Charente-Maritime; Region Poitou-Charentes,; Region Aquitaine; Conseil General de la Charente-Maritime; Conseil General de la Gironde; Agence de l'Eau Adour-Garonne; CPER A2E	Conseil General de the Charente-Maritime(Region Nouvelle-Aquitaine); Region Poitou-Charentes,(Region Nouvelle-Aquitaine); Region Aquitaine(Region Nouvelle-Aquitaine); Conseil General de la Charente-Maritime(Region Nouvelle-Aquitaine); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Agence de l'Eau Adour-Garonne; CPER A2E	This study was supported by a PhD grant from the Conseil General de the Charente-Maritime for A. Luna-Acosta. Authors wish to thank M. Baudrimont and D. Fichet for supporting this study through the 'Defi Cadmium' project, financed by Region Poitou-Charentes, Region Aquitaine, Conseil General de la Charente-Maritime, Conseil General de la Gironde, and Agence de l'Eau Adour-Garonne. CPER A2E is also acknowledged for financial support. Authors acknowledge also R. Galois for his scientific advice for lipid and glycogen content analyses, C. Trichet, D. Vilday, M. Caille, J. Laheux and M. Pelmoine for their assistance during the study, and the Ifremer networks ROCCH and RAZLEC, the 'Site Ifremer consacre a l'environnement littoral' and especially O. Le Moine, P. Soletchnik, S. Guesdon, P-G. Sauriau, P. Miramand and T. Guyot, for data and references from Marennes-Oleron Bay. Authors wish to warmly thank also T. Caquet for his scientific advice and help in statistical analyses.	Baumard P, 1999, MAR ENVIRON RES, V47, P17, DOI 10.1016/S0141-1136(98)00105-6; Beliaeff B, 1998, ENVIRON MONIT ASSESS, V49, P87, DOI 10.1023/A:1005766321323; Besse JP, 2012, TRAC-TREND ANAL CHEM, V36, P113, DOI 10.1016/j.trac.2012.04.004; Black MC, 1997, P 1997 GEORG WAT RES, P193; Bodin N, 2007, MAR POLLUT BULL, V54, P657, DOI 10.1016/j.marpolbul.2007.01.018; Bodin N, 2004, COMP BIOCHEM PHYS C, V138, P411, DOI 10.1016/j.cca.2004.04.009; Bourgeault A, 2013, SCI TOTAL ENVIRON, V454, P328, DOI 10.1016/j.scitotenv.2013.03.021; Brosse L., 2003, CARACTERISATION HABI; Brown D, 1986, BIOL PROCESSES WASTE, P61; Bustamante P, 2005, SCI TOTAL ENVIRON, V337, P59, DOI 10.1016/j.scitotenv.2004.07.004; Bustamante P, 2012, CHEMOSPHERE, V87, P938, DOI 10.1016/j.chemosphere.2012.01.049; Cheney DP, 2000, J SHELLFISH RES, V19, P353; Davies IM, 2012, 315 ICES; Durrieu G, 2005, ESTUARIES, V28, P581, DOI 10.1007/BF02696069; El-Shahawi MS, 2010, TALANTA, V80, P1587, DOI 10.1016/j.talanta.2009.09.055; European Commission (EC), 2010, 25 EC; FranceAgriMer, 2013, FISH AQ SECT FRANC; Galgani F, 2011, ENVIRON MONIT ASSESS, V172, P301, DOI 10.1007/s10661-010-1335-5; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Geffard A, 2002, COMP BIOCHEM PHYS C, V131, P281, DOI 10.1016/S1532-0456(02)00015-7; Greenfield R, 2014, MAR POLLUT BULL, V85, P566, DOI 10.1016/j.marpolbul.2014.03.032; Gunther AJ, 1999, MAR POLLUT BULL, V38, P170, DOI 10.1016/S0025-326X(98)00185-4; Hong SH, 2009, CHEMOSPHERE, V77, P854, DOI 10.1016/j.chemosphere.2009.07.063; Lacoste A, 2001, APPL ENVIRON MICROB, V67, P2304, DOI 10.1128/AEM.67.5.2304-2309.2001; LOBEL PB, 1982, MAR BIOL, V66, P145, DOI 10.1007/BF00397187; Luna-Acosta A, 2015, SCI TOTAL ENVIRON, V514, P511, DOI 10.1016/j.scitotenv.2014.10.050; Miramand P, 2003, J PHYS IV, V108, P3, DOI 10.1051/jp4:20030584; Munaron D, 2006, CAH BIOL MAR, V47, P85; Orbea A, 2002, AQUAT TOXICOL, V58, P75, DOI 10.1016/S0166-445X(01)00226-0; PERDUE J A, 1981, Journal of Shellfish Research, V1, P9; Pigeot J, 2006, MAR ECOL PROG SER, V307, P101, DOI 10.3354/meps307101; PORTE C, 1994, ARCH ENVIRON CON TOX, V26, P273; Potrykus J, 2003, OCEANOLOGIA, V45, P337; Readman JW, 2002, MAR POLLUT BULL, V44, P48, DOI 10.1016/S0025-326X(01)00189-8; Romeo M, 2003, ENVIRON TOXICOL, V18, P295, DOI 10.1002/tox.10128; Ruiz Y, 2011, ENVIRON POLLUT, V159, P250, DOI 10.1016/j.envpol.2010.08.031; SALAZAR MH, 1991, MAR ENVIRON RES, V32, P131, DOI 10.1016/0141-1136(91)90038-A; SANCHEZ J, 1993, INT J ENVIRON AN CH, V50, P269, DOI 10.1080/03067319308027603; Scanes PR, 1997, MAR FRESHWATER RES, V48, P1, DOI 10.1071/MF96043; Soletchnik P, 1999, AQUAT LIVING RESOUR, V12, P131, DOI 10.1016/S0990-7440(99)80022-9; Tapie N, 2008, ANAL BIOANAL CHEM, V391, P2169, DOI 10.1007/s00216-008-2148-z; Thompson S, 1999, MAR POLLUT BULL, V38, P655, DOI 10.1016/S0025-326X(98)90197-7; Thompson S, 2000, INT J ENVIRON AN CH, V76, P49, DOI 10.1080/03067310008034117; Zar JH., 1999, BIOSTAT ANAL, V4	44	20	20	0	75	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	MAY 1	2015	514						500	510		10.1016/j.scitotenv.2014.08.071	http://dx.doi.org/10.1016/j.scitotenv.2014.08.071			11	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	CE7RM	25440063	Green Submitted			2022-09-04	WOS:000352039500053
J	Zarate, S; Parra, FC; Acevedo-Triana, C; Sarmiento-Bolanos, MJ; Leon, LA				Zarate, Santiago; Cardenas Parra, Fernando; Acevedo-Triana, Cesar; Sarmiento-Bolanos, Maria Jimena; Leon, Laura Andrea			Effects of Stress on Plasticity and Neurogenesis: A Review	UNIVERSITAS PSYCHOLOGICA			Spanish	Article						stress; plasticity; neurogenesis	NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; NEURONAL PROGENITOR CELLS; RANDOMIZED CONTROLLED-TRIAL; MEDIAL PREFRONTAL CORTEX; HOST MODERATOR VARIABLES; NMDA RECEPTOR ACTIVATION; NEUROTROPHIC FACTOR BDNF; LONG-TERM POTENTIATION; SELF-RATING INVENTORY	There is a growing interest in the comprehension of psychobiological mechanisms underlying stress and its relationships with many psychopathologies such as anxiety (i.e. generalized anxiety and panic attacks) or depression. There are several reports on the effects of stress on neurogenesis and plasticity. This review will discuss some of the core concepts on the relation between stress, plasticity and neurogenesis obtained during the last decades from research-mainly based in the use of animal models. The distinguishable effects between acute and chronic stress will also be discussed in relation to other factors as genre and age with an emphasis on behavioral effects. Some current therapeutic approaches will be reviewed as well.	[Zarate, Santiago; Cardenas Parra, Fernando] Univ Los Andes, Lab Neurociencia & Comportamiento, Bogota, Colombia; [Acevedo-Triana, Cesar] Pontificia Univ Javeriana, Fac Psicol, Bogota, Colombia; [Sarmiento-Bolanos, Maria Jimena] Univ Fed Parana, Programa Educ, BR-80060000 Curitiba, Parana, Brazil; [Leon, Laura Andrea] Univ Sao Paulo, Dept Psicol, BR-05508 Sao Paulo, Brazil; [Leon, Laura Andrea] Univ Sao Paulo, Lab Psicofarmacol, Programa Psicobiol, BR-05508 Sao Paulo, Brazil; [Leon, Laura Andrea] Pontificia Univ Catolica Rio de Janeiro, Lab Neurociencia & Comportamento, Dept Psicol, BR-22453 Rio De Janeiro, Brazil		Zarate, S (corresponding author), Univ Los Andes, Lab Neurociencia & Comportamiento, Bogota, Colombia.	lucarden@uniandes.edu.co; cesar.acevedo@javeriana.edu.co		Leon, Laura/0000-0002-5573-7750				Abel JL, 2013, INT J DEV NEUROSCI, V31, P382, DOI 10.1016/j.ijdevneu.2012.11.002; Abush H, 2013, NEUROPSYCHOPHARMACOL, V38, P1521, DOI 10.1038/npp.2013.51; Acevedo-Triana C.A., 2014, REV MEXICANA NEUROCI, V15, P36; Alferi S M, 2001, J Am Med Womens Assoc (1972), V56, P120; Almela M, 2011, STRESS, V14, P117, DOI 10.3109/10253890.2010.514671; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amorapanth P, 1999, LEARN MEMORY, V6, P491, DOI 10.1101/lm.6.5.491; Anderson JW, 2008, AM J HYPERTENS, V21, P310, DOI 10.1038/ajh.2007.65; Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; ANGULO JA, 1991, MOL BRAIN RES, V11, P301, DOI 10.1016/0169-328X(91)90039-Z; ANTONI MH, 1985, J HUM STRESS, V11, P21, DOI 10.1080/0097840X.1985.9936734; ANTONI MH, 1989, J PSYCHOSOM RES, V33, P457, DOI 10.1016/0022-3999(89)90007-X; ANTONI MH, 1988, J PSYCHOSOM RES, V32, P327, DOI 10.1016/0022-3999(88)90075-X; Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Arango C, 2001, SCHIZOPHRENIA BULL, V27, P477, DOI 10.1093/oxfordjournals.schbul.a006888; Arias-Carrion O, 2007, REV NEUROLOGIA, V44, P541, DOI 10.33588/rn.4409.2006426; Armony JL, 1998, J NEUROSCI, V18, P2592; Association AP, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Aydemir O, 2009, TURK PSIKIYATR DERG, V20, P385; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Bandelow B, 2013, DTSCH ARZTEBL INT, V110, P300, DOI 10.3238/arztebl.2013.0300; Barros M, 2008, REV NEUROSCIENCE, V19, P157; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Ben J, 2009, BRAIN RES, V1302, P248, DOI 10.1016/j.brainres.2009.09.013; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; BENSON H, 1980, HARVARD BUS REV, V58, P86; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bertoldi K, 2012, ECOTOX ENVIRON SAFE, V84, P319, DOI 10.1016/j.ecoenv.2012.08.001; Bianchi M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P597; Blair HT, 2005, NEUROSCIENCE, V133, P561, DOI 10.1016/j.neuroscience.2005.02.043; Blaze J, 2013, INT J DEV NEUROSCI, V31, P804, DOI 10.1016/j.ijdevneu.2013.10.001; Blaze J, 2013, DEV NEUROSCI-BASEL, V35, P306, DOI 10.1159/000350716; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; BRANTLEY PJ, 1987, J BEHAV MED, V10, P61, DOI 10.1007/BF00845128; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Bremner J Douglas, 2006, Dialogues Clin Neurosci, V8, P445; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Butkevich IP, 2011, BRAIN RES, V1419, P76, DOI 10.1016/j.brainres.2011.08.068; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cameron HA, 2008, BIOL PSYCHIAT, V63, P650, DOI 10.1016/j.biopsych.2007.09.023; Cannon W.B., 1914, BODILY CHANGES PAIN; CARUGHI A, 1989, J NUTR, V119, P2005, DOI 10.1093/jn/119.12.2005; Carvalho-Netto EF, 2011, PHYSIOL BEHAV, V104, P242, DOI 10.1016/j.physbeh.2011.01.024; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Cerqueira JJ, 2007, CEREB CORTEX, V17, P1998, DOI 10.1093/cercor/bhl108; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chambers R A, 1999, Semin Clin Neuropsychiatry, V4, P274; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; CHAN KB, 1977, SOC SCI MED, V11, P89, DOI 10.1016/0037-7856(77)90004-X; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Cheniaux Elie, 2011, Psychol. Neurosci., V4, P417, DOI 10.3922/j.psns.2011.3.015; Choi DC, 2010, CURR TOP BEHAV NEURO, V2, P279, DOI 10.1007/7854_2009_10; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Cohen MM, 2013, P NATL ACAD SCI USA, V110, P18274, DOI 10.1073/pnas.1310163110; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Cui L, 2009, NEUROBIOL AGING, V30, P903, DOI 10.1016/j.neurobiolaging.2007.09.005; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Davis DM, 2011, PSYCHOTHERAPY, V48, P198, DOI 10.1037/a0022062; DAWKINS J, 1984, HOSP COMMUNITY PSYCH, V35, P56; Delui MH, 2013, OPEN CARDIOVASC MED, V7, P99, DOI 10.2174/1874192401307010099; DEMOOR P, 1961, J CLIN ENDOCR METAB, V21, P106, DOI 10.1210/jcem-21-1-106; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DIAMOND MC, 1972, J NEUROBIOL, V3, P47, DOI 10.1002/neu.480030105; Difede J, 2014, NEUROPSYCHOPHARMACOL, V39, P1052, DOI 10.1038/npp.2013.317; DOBSON CB, 1983, BRIT J EDUC PSYCHOL, V53, P121, DOI 10.1111/j.2044-8279.1983.tb02541.x; DONALD RA, 1975, J CLIN ENDOCR METAB, V41, P1; Doron R, 2014, LIFE SCI, V94, P151, DOI 10.1016/j.lfs.2013.10.025; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Edenfield TM, 2012, PSYCHOL RES BEHAV MA, V5, P131, DOI 10.2147/PRBM.S34937; Elsner VR, 2011, NEUROSCIENCE, V192, P580, DOI 10.1016/j.neuroscience.2011.06.066; Elsner VR, 2013, EXP GERONTOL, V48, P136, DOI 10.1016/j.exger.2012.11.011; Emack J, 2011, HORM BEHAV, V60, P589, DOI 10.1016/j.yhbeh.2011.08.008; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eyre H, 2012, BRAIN BEHAV IMMUN, V26, P251, DOI 10.1016/j.bbi.2011.09.015; FAHRION SL, 1991, PRIMARY CARE, V18, P663; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; Falconer EM, 2003, BRAIN RES, V975, P22, DOI 10.1016/S0006-8993(03)02542-3; Farber NB, 1999, ARCH GEN PSYCHIAT, V56, P13, DOI 10.1001/archpsyc.56.1.13; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Flaxman PE, 2011, CBT DISTINCT FEATURE, P1; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V370, P169, DOI 10.1016/j.bbrc.2008.03.060; Gable G K, 1989, Pa Med, V92, P46; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; GIUFFRE KA, 1988, ENDOCRINOLOGY, V122, P306, DOI 10.1210/endo-122-1-306; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Gorman JM, 2003, J CLIN PSYCHIAT, V64, P24; GOTTSCHALK LA, 1990, J CLIN PSYCHOL, V46, P915, DOI 10.1002/1097-4679(199011)46:6<915::AID-JCLP2270460636>3.0.CO;2-N; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Goustard-Langelier B, 2013, J NUTR BIOCHEM, V24, P380, DOI 10.1016/j.jnutbio.2012.08.001; Graeff Frederico Guilherme, 2011, Psychol. Neurosci., V4, P183, DOI 10.3922/j.psns.2011.2.003; Graeff Frederico Guilherme, 2010, Psychol. Neurosci., V3, P3, DOI 10.3922/j.psns.2010.1.002; Gray JD, 2013, NEUROSCIENCE, V239, P214, DOI 10.1016/j.neuroscience.2012.08.034; GREEN EE, 1975, PSYCHOTHER PSYCHOSOM, V25, P88, DOI 10.1159/000286836; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Guastella AJ, 2007, J PSYCHIATR RES, V41, P466, DOI 10.1016/j.jpsychires.2006.05.006; Guirado R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-5; GUPTA N, 1979, ORGAN BEHAV HUM PERF, V23, P373, DOI 10.1016/0030-5073(79)90004-7; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; Halvorsen J G, 1991, Fam Pract Res J, V11, P255; Happonen AP, 2009, IEEE ENG MED BIO, P312, DOI 10.1109/IEMBS.2009.5333549; Helmich Ingo, 2010, Clin Pract Epidemiol Ment Health, V6, P115, DOI 10.2174/1745017901006010115; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Heszen-Niejodek I, 1999, PSYCHOTHER PSYCHOSOM, V68, P304, DOI 10.1159/000012348; HIRST MA, 1983, J PSYCHOSOM RES, V27, P193, DOI 10.1016/0022-3999(83)90022-3; Holzel BK, 2013, NEUROIMAGE-CLIN, V2, P448, DOI 10.1016/j.nicl.2013.03.011; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Holscher C, 1999, J NEUROSCI RES, V58, P62; HOVENS JE, 1994, ACTA PSYCHIAT SCAND, V90, P172, DOI 10.1111/j.1600-0447.1994.tb01574.x; Hovens JE, 2000, PSYCHOL REP, V87, P735, DOI 10.2466/PR0.87.7.735-737; Huang X, 2012, CNS NEUROSCI THER, V18, P4, DOI 10.1111/j.1755-5949.2011.00276.x; Huang Y, 2013, NEUROSCIENCE, V231, P432, DOI 10.1016/j.neuroscience.2012.11.010; Hulshof HJ, 2012, BEHAV BRAIN RES, V234, P357, DOI 10.1016/j.bbr.2012.07.011; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Ireton H R, 1989, Fam Pract Res J, V8, P62; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Ives-Deliperi VL, 2011, SOC NEUROSCI-UK, V6, P231, DOI 10.1080/17470919.2010.513495; Ivy AS, 2003, PHARMACOL BIOCHEM BE, V75, P81, DOI 10.1016/S0091-3057(03)00044-3; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Jankovski A, 1998, EUR J NEUROSCI, V10, P3853, DOI 10.1046/j.1460-9568.1998.00397.x; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; JEDEMA HP, 1994, J NEUROCHEM, V63, P785, DOI 10.1046/j.1471-4159.1994.63020785.x; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Sarmiento-Bolanos MJ, 2013, AV PSICOL LATINOAM, V31, P140; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kaliman P, 2011, AGEING RES REV, V10, P475, DOI 10.1016/j.arr.2011.05.002; Kang C, 2013, ANN REHABIL MED-ARM, V37, P301, DOI 10.5535/arm.2013.37.3.301; Karten YJG, 2005, TRENDS NEUROSCI, V28, P171, DOI 10.1016/j.tins.2005.01.009; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; KAUFFMAN SL, 1969, DEV BIOL, V20, P146, DOI 10.1016/0012-1606(69)90010-4; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kerr C. E., 2013, FRONT HUM NEUROSCI, V11, P7; Kerr CE, 2011, BRAIN RES BULL, V85, P96, DOI 10.1016/j.brainresbull.2011.03.026; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; KHORRAM O, 1985, ENDOCRINOLOGY, V117, P2483, DOI 10.1210/endo-117-6-2483; Kim DH, 2010, NEUROSCI LETT, V475, P74, DOI 10.1016/j.neulet.2010.03.046; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kong KH, 2010, J TOXICOL ENV HEAL A, V73, P1490, DOI 10.1080/15287394.2010.511572; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kozasa EH, 2012, NEUROIMAGE, V59, P745, DOI 10.1016/j.neuroimage.2011.06.088; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Kudo C, 2003, BIOCHEM PHARMACOL, V66, P289, DOI 10.1016/S0006-2952(03)00235-1; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kumar A, 2013, INDIAN J PHARMACOL, V45, P49, DOI 10.4103/0253-7613.106435; Kupfer DJ, 2002, RES AGENDA DSM 5; Kwon DH, 2013, BIOCHEM BIOPH RES CO, V434, P245, DOI 10.1016/j.bbrc.2013.02.111; Ladea M, 2013, PSYCHIAT DANUB, V25, P128; Lamprecht F, 2004, NEUROSCI RES, V49, P267, DOI 10.1016/j.neures.2004.02.013; Lappalainen P, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2389; Laue L, 1988, Adv Exp Med Biol, V245, P225; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lazarus R. S., 1979, ESTRES PROCESOS COGN; Lennington Jessica B, 2003, Reprod Biol Endocrinol, V1, P99, DOI 10.1186/1477-7827-1-99; Leon LA, 2009, BEHAV BRAIN RES, V205, P259, DOI 10.1016/j.bbr.2009.06.039; LEVINSON H, 1981, HARVARD BUS REV, V59, P73; LEY KF, 1973, BEHAV BIOL, V9, P111, DOI 10.1016/S0091-6773(73)80174-9; Li B, 2010, FEBS LETT, V584, P3359, DOI 10.1016/j.febslet.2010.06.025; Li H, 2005, NEUROSCI LETT, V386, P160, DOI 10.1016/j.neulet.2005.06.009; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Liljequist L, 1998, J PERS ASSESS, V71, P322, DOI 10.1207/s15327752jpa7103_3; Lin YH, 2008, CEREB CORTEX, V18, P2762, DOI 10.1093/cercor/bhn035; LINTON EA, 1985, ENDOCRINOLOGY, V116, P966, DOI 10.1210/endo-116-3-966; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; LIU JK, 2005, RES COMMUN BIOL PSYC, V30, P103; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Lupien SJ, 1997, J CLIN ENDOCR METAB, V82, P2070, DOI 10.1210/jc.82.7.2070; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lutz J., 2013, SOCIAL COGNITIVE AFF; Lyons DM, 2010, P NATL ACAD SCI USA, V107, P14823, DOI 10.1073/pnas.0914568107; MACRAE PG, 1987, PSYCHOPHARMACOLOGY, V92, P236; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Marques-Aleixo I, 2012, PROG NEUROBIOL, V99, P149, DOI 10.1016/j.pneurobio.2012.08.002; Marques-Deak Andrea, 2004, Rev. Bras. Psiquiatr., V26, P143, DOI 10.1590/S1516-44462004000300002; Marshall R D, 2000, Curr Psychiatry Rep, V2, P335, DOI 10.1007/s11920-000-0078-3; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; MATHENY KB, 1993, J CLIN PSYCHOL, V49, P815; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McGinn MJ, 2012, J NEUROSCI RES, V90, P1159, DOI 10.1002/jnr.23012; McGuire JF, 2012, NEUROPSYCHIATRY-LOND, V2, P291, DOI [10.2217/npy.12.38, 10.2217/NPY.12.38]; McIntosh RC, 2013, J AFFECT DISORDERS, V150, P908, DOI 10.1016/j.jad.2013.05.014; Medearis D W, 1973, Utah Nurse, V24, P32; Meichenbaum D., 1985, STRESS INOCULATION T; Meichenbaum D., 1977, COGNITIVE BEHAV MODI, DOI 10.1007/978-1-4757-9739-8; Menon Sukanya B, 2010, Indian J Psychol Med, V32, P136, DOI 10.4103/0253-7176.78512; Mineur YS, 2007, NEUROSCIENCE, V150, P251, DOI 10.1016/j.neuroscience.2007.09.045; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mitoma M., 2008, PROGR NEUROPSYCHOPHA, V32, P679; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Moghaddam B, 2004, NEUROTOX RES, V6, P73, DOI 10.1007/BF03033299; Moghaddam B, 2002, BIOL PSYCHIAT, V51, P775, DOI 10.1016/S0006-3223(01)01362-2; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Nam SM, 2013, NEUROCHEM RES, V38, P2559, DOI 10.1007/s11064-013-1169-y; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Nijdam MJ, 2012, BRIT J PSYCHIAT, V200, P224, DOI 10.1192/bjp.bp.111.099234; O'Dell SJ, 2007, NEUROSCIENCE, V144, P1141, DOI 10.1016/j.neuroscience.2006.10.042; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Pivonello R, 2002, J ENDOCRINOL INVEST, V25, P932, DOI 10.1007/BF03344064; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; POR SB, 1982, BEHAV NEURAL BIOL, V34, P132, DOI 10.1016/S0163-1047(82)91514-X; POWELL TJ, 1975, AM J ORTHOPSYCHIAT, V45, P756, DOI 10.1111/j.1939-0025.1975.tb01204.x; Pratchett LC, 2011, EXPERT OPIN PHARMACO, V12, P2339, DOI 10.1517/14656566.2011.604030; Quan MN, 2011, BRAIN RES BULL, V85, P109, DOI 10.1016/j.brainresbull.2011.03.002; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; RENNER MJ, 1987, DEV PSYCHOBIOL, V20, P19, DOI 10.1002/dev.420200106; Rice AC, 2004, BRAIN RES, V1011, P94, DOI 10.1016/j.brainres.2004.01.091; RICHARDSON JS, 1984, INT J NEUROSCI, V23, P57, DOI 10.3109/00207458408985345; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Roman V, 2005, BRAIN RES, V1065, P53, DOI 10.1016/j.brainres.2005.10.020; Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Rothman SM, 2013, NEUROSCIENCE, V239, P228, DOI 10.1016/j.neuroscience.2012.10.014; Rutten BPF, 2007, NEUROBIOL AGING, V28, P91, DOI 10.1016/j.neurobiolaging.2005.10.019; Samara Z., 2011, FRONT PSYCHIATRY, V2, P4, DOI DOI 10.3389/FPSYT.2011.00004; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Saunders T, 1996, J Occup Health Psychol, V1, P170, DOI 10.1037/1076-8998.1.2.170; Schaefer M, 1974, Public Health Pap, P1; Schaffer DV, 2004, NEUROMOL MED, V5, P1, DOI 10.1385/NMM:5:1:001; Schoenfeld Timothy J, 2013, Curr Top Behav Neurosci, V15, P139, DOI 10.1007/7854_2012_233; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Segovia G, 2006, BRAIN RES BULL, V70, P8, DOI 10.1016/j.brainresbull.2005.11.005; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; SELYE H, 1973, AM SCI, V61, P692; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; SHIMMIN S, 1979, PRACTITIONER, V223, P81; Sigwalt AR, 2011, NEUROSCIENCE, V192, P661, DOI 10.1016/j.neuroscience.2011.05.075; Singleton O, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00033; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Snyder JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048757; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Sonne C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-137; Srivastava Malini, 2011, Complement Ther Clin Pract, V17, P241, DOI 10.1016/j.ctcp.2011.04.007; Steele P, 1990, Nurs Manage, V21, P50, DOI 10.1097/00006247-199012000-00017; Stergiopoulos E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-838; STERLING P, 1981, SOC SCI MED-MED PSYC, V15, P3, DOI 10.1016/0271-5384(81)90061-2; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; SZAFARCZYK A, 1987, ENDOCRINOLOGY, V121, P883, DOI 10.1210/endo-121-3-883; Thijs RD, 2009, J NEUROL, V256, P155, DOI 10.1007/s00415-009-0108-y; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Toriumi K, 2012, NEUROPSYCHOPHARMACOL, V37, P1387, DOI 10.1038/npp.2011.324; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Tsakiris S, 2006, PHARMACOL RES, V53, P386, DOI 10.1016/j.phrs.2006.01.008; Tung A, 2005, NEUROSCIENCE, V134, P721, DOI 10.1016/j.neuroscience.2005.06.008; Tung A, 2008, ANESTH ANALG, V106, P1772, DOI 10.1213/ane.0b013e31816f2004; Ueda S, 2005, NEUROSCIENCE, V135, P395, DOI 10.1016/j.neuroscience.2005.06.065; Uys JD, 2008, CNS NEUROL DISORD-DR, V7, P482, DOI 10.2174/187152708786927868; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Venero C, 1999, EUR J NEUROSCI, V11, P2465, DOI 10.1046/j.1460-9568.1999.00668.x; Veninga R, 1979, Hosp Prog, V60, P45; Villani D, 2013, PSYCHOL SERV, V10, P315, DOI 10.1037/a0026459; von Dawans B, 2012, PSYCHOL SCI, V23, P651, DOI 10.1177/0956797611431576; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Warmuz-Stangierska I, 2010, ENDOKRYNOL POL, V61, P90; WATERS WF, 1993, J PSYCHOSOM RES, V37, P117, DOI 10.1016/0022-3999(93)90078-T; Westenberg HGM, 2009, CNS SPECTRUMS, V14, P24, DOI 10.1017/S1092852900027267; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; *WHO, 1995, GLOB STRAT OCC HLTH; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; Woidneck M. R., BEHAV MODIF IN PRESS; WOLFGANG AP, 1988, PSYCHOL REP, V62, P220, DOI 10.2466/pr0.1988.62.1.220; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Yadav RK, 2012, J ALTERN COMPLEM MED, V18, P662, DOI 10.1089/acm.2011.0265; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Zajac MS, 2010, HIPPOCAMPUS, V20, P621, DOI 10.1002/hipo.20658; ZALEZNIK A, 1977, BEHAV SCI, V22, P151, DOI 10.1002/bs.3830220302; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170; Zusso M, 2008, BIOCHEM PHARMACOL, V76, P391, DOI 10.1016/j.bcp.2008.05.014	345	2	3	1	14	PONTIFICA UNIV JAVERIANA, FAC PSYCH	BOGOTA	CARRERA 5 NUM 39-00, EDIFICIO MANUEL BRICENO, BOGOTA, 00000, COLOMBIA	1657-9267			UNIV PSYCHOL	Univ. Psychol.	JUL-SEP	2014	13	3					1181	1213						33	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	CB4XH		Bronze			2022-09-04	WOS:000349631200030
J	Castro, HE; Briceno, MF; Casas, CP; Rueda, JD				Castro, Hector E.; Fernanda Briceno, Maria; Casas, Claudia P.; David Rueda, Juan			The History and Evolution of the Clinical Effectiveness of Haemophilia Type A Treatment: A Systematic Review	INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION			English	Review						Hemophilia A; Coagulation disorder; Clotting factor disorder	PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; QUALITY-OF-LIFE; SECONDARY PROPHYLAXIS; CLOTTING FACTOR; CURRENT OPTIONS; INHIBITORS; THERAPY; POPULATION; MANAGEMENT	First evidence of cases of haemophilia dates from ancient Egypt, but it was when Queen Victoria from England in the 19th century transmitted this illness to her descendants, when it became known as the "royal disease". Last decades of the 20th century account for major discoveries that improved the life expectancy and quality of life of these patients. The history and evolution of haemophilia healthcare counts ups and downs. The introduction of prophylactic schemes during the 1970s have proved to be more effective that the classic on-demand replacement of clotting factors, nevertheless many patients managed with frequent plasma transfusions or derived products became infected with the Human Immunodeficiency Virus (HIV) and Hepatitis C virus during the 1980s and 1990s. Recombinant factor VIII inception has decreased the risk of blood borne infections and restored back longer life expectancies. Main concerns for haemophilia healthcare are shifting from the pure clinical aspects to the economic considerations of long-term replacement therapy. Nowadays researchers' attention has been placed on the future costs and cost-effectiveness of costly long-term treatment. Equity considerations are relevant as well, and alternative options for less affluent countries are under the scope of further research. The aim of this review was to assess the evidence of different treatment options for haemophilia type A over the past four decades, focusing on the most important technological advances that have influenced the natural course of this "royal disease".	[Castro, Hector E.] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Castro, Hector E.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Fernanda Briceno, Maria; David Rueda, Juan] Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Casas, Claudia P.] Fdn Univ Ciencias Salud, Hosp San Ignacio, Bogota, Colombia; [Casas, Claudia P.] Fdn Univ Ciencias Salud, Hosp San Jose, Bogota, Colombia		Castro, HE (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	dochecj@hotmail.com						Aledort LM, 2007, HAEMOPHILIA, V13, P1, DOI 10.1111/j.1365-2516.2007.01576.x; Aleem A, 2009, HAEMOPHILIA, V15, P210, DOI 10.1111/j.1365-2516.2008.01865.x; Astermark J, 2010, HAEMOPHILIA, V16, P54, DOI 10.1111/j.1365-2516.2010.02294.x; Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Berntorp E, 2009, HAEMOPHILIA, V15, P1219, DOI 10.1111/j.1365-2516.2009.02077.x; Blanchette VS, 2010, HAEMOPHILIA, V16, P181, DOI 10.1111/j.1365-2516.2010.02318.x; Carcao M, 2010, HAEMOPHILIA, V16, P16, DOI 10.1111/j.1365-2516.2009.02198.x; Carcao M, 2010, HAEMOPHILIA, V16, P4, DOI 10.1111/j.1365-2516.2009.02196.x; Carcao MD, 2007, HAEMOPHILIA, V13, P227, DOI 10.1111/j.1365-2516.2007.01457.x; CHORBA TL, 1994, AM J HEMATOL, V45, P112, DOI 10.1002/ajh.2830450204; Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x; Dimichele D, 2007, J THROMB HAEMOST, V5, P143, DOI 10.1111/j.1538-7836.2007.02474.x; DiMichele D, 2004, HAEMOPHILIA, V10, P140, DOI 10.1111/j.1365-2516.2004.00993.x; Dunn AL, 2005, CURR OPIN HEMATOL, V12, P390, DOI 10.1097/01.moh.0000169285.66841.c8; Evatt BL, 2006, J THROMB HAEMOST, V4, P2295, DOI 10.1111/j.1538-7836.2006.02213.x; Farrugia A, 2002, HAEMOPHILIA, V8, P236, DOI 10.1046/j.1365-2516.2002.00596.x; Feldman BM, 2006, J THROMB HAEMOST, V4, P1228, DOI 10.1111/j.1538-7836.2006.01953.x; Franchini M, 2009, HAEMOPHILIA, V15, P578, DOI 10.1111/j.1365-2516.2008.01975.x; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Hoots WK, 2008, HAEMOPHILIA, V14, P466, DOI 10.1111/j.1365-2516.2008.01654.x; Jones ML, 2003, HAEMOPHILIA, V9, P464, DOI 10.1046/j.1365-2516.2003.00782.x; Konkle BA, 2007, J THROMB HAEMOST, V5, P1904, DOI 10.1111/j.1538-7836.2007.02663.x; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; Lee CA, 2009, CLIN MED, V9, P453, DOI 10.7861/clinmedicine.9-5-453; MAKRIS M, 1993, BLOOD, V81, P1898; Mannucci PM, 2003, J THROMB HAEMOST, V1, P2065, DOI 10.1046/j.1538-7836.2003.00483.x; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Miners A, 2009, HAEMOPHILIA, V15, P881, DOI 10.1111/j.1365-2516.2009.02019.x; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Oldenburg J, 2009, HAEMOPHILIA, V15, P2, DOI 10.1111/j.1365-2516.2008.01946.x; Petrini P, 2007, HAEMOPHILIA, V13, P16, DOI 10.1111/j.1365-2516.2007.01501.x; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Prabhu R, 2010, INDIAN J HEMATOL BLO, V26, P124, DOI 10.1007/s12288-010-0036-0; RAGNI MV, 1986, BLOOD, V67, P592; Royal S, 2002, HAEMOPHILIA, V8, P44, DOI 10.1046/j.1365-2516.2002.00581.x; Santagostino E, 2008, HAEMOPHILIA, V14, P16, DOI 10.1111/j.1365-2516.2008.01884.x; Stachnik J, 2010, FORMULARY, V45, P218; Tusell J, 2002, HAEMOPHILIA, V8, P183, DOI 10.1046/j.1365-2516.2002.00619.x; Valentino LA, 2009, HAEMOPHILIA, V15, P5, DOI 10.1111/j.1365-2516.2009.02159.x; Valentino LA, 2004, HAEMOPHILIA, V10, P147, DOI 10.1111/j.1365-2516.2003.00870.x; VANDERPOEL CL, 1991, VOX SANG, V61, P30; Von Depka M, 2005, HAEMOPHILIA, V11, P18; Wight J, 2003, HAEMOPHILIA, V9, P436, DOI 10.1046/j.1365-2516.2003.00781.x; Wong T, 2011, DRUGS, V71, P305, DOI 10.2165/11585340-000000000-00000	45	9	10	0	12	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0971-4502	0974-0449		INDIAN J HEMATOL BLO	Indian J. Hematol. Blood Transfus.	MAR	2014	30	1					1	11		10.1007/s12288-012-0209-0	http://dx.doi.org/10.1007/s12288-012-0209-0			11	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	AB2KY	24554812	Green Accepted, Green Published			2022-09-04	WOS:000331622800001
J	Lucena, F; Ribas, F; Duran, AE; Skraber, S; Gantzer, C; Campos, C; Moron, A; Calderon, E; Jofre, J				Lucena, F.; Ribas, F.; Duran, A. E.; Skraber, S.; Gantzer, C.; Campos, C.; Moron, A.; Calderon, E.; Jofre, J.			Occurrence of bacterial indicators and bacteriophages infecting enteric bacteria in groundwater in different geographical areas	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						bacterial indicators; bacteriophages; coliphages; groundwater	FILTRATION-ELUTION METHOD; SOMATIC COLIPHAGES; MINERAL WATERS; PCR; CONTAMINATION; REPLICATION; CONCENTRATE; ENUMERATION; SEQUENCES; REMOVAL	Aims: The aim of this research was to determine the suitability of coliphages (bacteriophages) for assessing the microbial quality of groundwater. Methods and Results: The number of several bacterial indicators (faecal coliforms, Escherichia coli, enterococci and spores of sulfite-reducing clostridia) and bacteriophages (somatic coliphages, F-specific RNA bacteriophages and bacteriophages infecting Bacteroides fragilis) were determined in groundwater of aquifers in various geographical areas. Results show that the relative abundance, determined as percentages of positive detections, of the bacterial indicators and bacteriophages varies depending on the aquifer. Conclusions: A single bacterial indicator may not be enough to assess microbiological quality in certain aquifers. One bacterial indicator and a bacteriophage parameter provide more information than two bacterial indicators. Significance and Impact of the Study: Coliphages (CPH) provide different information from that provided by bacterial indicators on the microbial quality of groundwater in different geographical areas. Easy, fast and inexpensive methods for the detection of CPH are feasible in both industrialized and developing countries.	Univ Barcelona, Dept Microbiol, E-08028 Barcelona, Spain; AGBAR, Microbiol Lab, Barcelona, Spain; Univ Nancy 1, Equipe Microbiol & Phys, Fac Pharm, Nancy, France; Javeriana Univ, Dept Microbiol, Bogota, Colombia; Univ Buenos Aires, Fac Ingn, Inst Ingn Sanit, Buenos Aires, DF, Argentina		Lucena, F (corresponding author), Univ Barcelona, Dept Microbiol, Diagonal 645, E-08028 Barcelona, Spain.	flucena@ub.edu	Calderon, Enrique j/A-1997-2013; Calderon, Enrique/M-8498-2019; Campos, Claudia/AAF-6493-2019; IBIS, EPIDEMIOLOGIA/O-8791-2015	Calderon, Enrique j/0000-0002-3166-5086; Calderon, Enrique/0000-0002-3166-5086; lucena, francisco/0000-0001-8892-0431; Campos, Claudia/0000-0001-9137-9033				ABBASZADEGAN M, 1998, OCCURRENCE VIRUSES G, P189; ANDERSON Y, 2001, WATER QUALITY GUIDEL; [Anonymous], 2000, 107052 ISO; [Anonymous], 2001, 107054 ISO; [Anonymous], 1995, 107051 ISO; [Anonymous], 2001, GAZETTE OFFICIELLE Q, V24, P3561; Ausland G, 2002, WATER RES, V36, P3507, DOI 10.1016/S0043-1354(02)00060-X; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Borchardt MA, 2003, APPL ENVIRON MICROB, V69, P1172, DOI 10.1128/AEM.69.2.1172-1180.2003; BOSCH A, 1986, J WATER POLLUT CON F, V58, P87; BUFTON A. W. J., 1959, JOUR APPL BACT, V22, P278, DOI 10.1111/j.1365-2672.1959.tb00162.x; Craun GF, 2003, DRINKING WATER AND INFECTIOUS DISEASE: ESTABLISHING THE LINKS, P105; Gassilloud B, 2003, APPL ENVIRON MICROB, V69, P3965, DOI 10.1128/AEM.69.7.3965-3969.2003; Goss MJ, 1998, J CONTAM HYDROL, V32, P267, DOI 10.1016/S0169-7722(98)00054-0; JOFRE J, 2000, 19506 EUR EN OFF OFF; KATZENELSON E, 1976, APPL ENVIRON MICROB, V32, P638, DOI 10.1128/AEM.32.4.638-639.1976; Lamothe GT, 2003, APPL ENVIRON MICROB, V69, P6541, DOI 10.1128/AEM.69.11.6541-6549.2003; LIEBERMAN RJ, 1994, SOURCE WATER MICROBI; Lina B, 1996, J CLIN MICROBIOL, V34, P3002, DOI 10.1128/JCM.34.12.3002-3006.1996; MCFETERS GA, 1974, APPL MICROBIOL, V27, P823, DOI 10.1128/AEM.27.5.823-829.1974; Melian R, 1999, HYDROGEOL J, V7, P188, DOI 10.1007/s100400050191; Mendez J, 2004, J VIROL METHODS, V117, P19, DOI 10.1016/j.jviromet.2003.11.013; Mooijman KA, 2005, J VIROL METHODS, V127, P60, DOI 10.1016/j.jviromet.2005.02.013; Muir P, 1999, J CLIN MICROBIOL, V37, P1409, DOI 10.1128/JCM.37.5.1409-1414.1999; Muniesa M, 2004, ANTON LEEUW INT J G, V86, P65, DOI 10.1023/B:ANTO.0000024909.75523.be; Muniesa M, 2003, ANTON LEEUW INT J G, V83, P305, DOI 10.1023/A:1023384714481; Nuanualsuwan S, 2002, J VIROL METHODS, V104, P217, DOI 10.1016/S0166-0934(02)00089-7; Pekdeger A., 1985, GROUND WATER QUALITY, P472; Powell KL, 2003, WATER RES, V37, P339, DOI 10.1016/S0043-1354(02)00280-4; Quanrud DM, 2003, WATER RES, V37, P753, DOI 10.1016/S0043-1354(02)00393-7; Ramteke PW, 2002, ENVIRON MONIT ASSESS, V79, P121, DOI 10.1023/A:1020278114463; Rice E.W., 2017, STANDARD METHODS EXA, V23rd; ROHLF FJ, 1969, PRINCIPLES PRACTICE; Sanchez G, 2005, APPL ENVIRON MICROB, V71, P2203, DOI 10.1128/AEM.71.4.2203-2205.2005; SIMONART T, 2000, 196201 EUR OFF OFF P; Sinton LW, 2000, NEW ZEAL J MAR FRESH, V34, P175, DOI 10.1080/00288330.2000.9516924; Sinton LW, 1996, J MICROBIOL METH, V25, P257, DOI 10.1016/0167-7012(95)00100-X; SOBSEY M, 1979, APPL ENVIRON MICROB, V47, P319; Sobsey MD, 2004, WATER SCI TECHNOL, V50, P211, DOI 10.2166/wst.2004.0056; SOBSEY MD, 1990, J AM WATER WORKS ASS, V82, P52; *USEPA, 2000, 821R00009 USEPA; *USEPA, 2000, 821R00010 USEPA; 2000, FED REG, V65, P30193; 1997, 78992 ISO	44	34	35	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	JUL	2006	101	1					96	102		10.1111/j.1365-2672.2006.02907.x	http://dx.doi.org/10.1111/j.1365-2672.2006.02907.x			7	Biotechnology & Applied Microbiology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Microbiology	055GO	16834595				2022-09-04	WOS:000238438400010
J	Toyama, M; Godoy-Casasbuenas, N; Olivar, N; Brusco, LI; Carbonetti, F; Diez-Canseco, F; Gomez-Restrepo, C; Heritage, P; Hidalgo-Padilla, L; Uribe, M; Steffen, M; Fung, C; Priebe, S				Toyama, Mauricio; Godoy-Casasbuenas, Natalia; Olivar, Natividad; Brusco, Luis Ignacio; Carbonetti, Fernando; Diez-Canseco, Francisco; Gomez-Restrepo, Carlos; Heritage, Paul; Hidalgo-Padilla, Liliana; Uribe, Miguel; Steffen, Mariana; Fung, Catherine; Priebe, Stefan			Identifying resources used by young people to overcome mental distress in three Latin American cities: a qualitative study	BMJ OPEN			English	Article						mental health; qualitative research; child & adolescent psychiatry; depression & mood disorders	RESILIENCE; HEALTH; DEPRESSION; ADOLESCENTS	Objective To explore which resources and activities help young people living in deprived urban environments in Latin America to recover from depression and/or anxiety. Design A multimethod, qualitative study with 18 online focus groups and 12 online structured group conversations embedded into arts workshops. Setting This study was conducted in Bogota (Colombia), Buenos Aires (Argentina) and Lima (Peru). Participants Adolescents (15-16 years old) and young adults (20-24 years old) with capacity to provide assent/consent and professionals (older than 18 years of age) that had experience of professionally working with young people were willing to share personal experience within a group, and had capacity to provide consent. Results A total of 185 participants took part in this study: 111 participants (36 adolescents, 35 young adults and 40 professionals) attended the 18 focus groups and 74 young people (29 adolescents and 45 young adults) took part in the 12 arts workshops. Eight categories captured the resources and activities that were reported by young people as helpful to overcome mental distress: (1) personal resources, (2) personal development, (3) spirituality and religion, (4) social resources, (5) social media, (6) community resources, (7) activities (subcategorised into artistic, leisure, sports and outdoor activities) and (8) mental health professionals. Personal and social resources as well as artistic activities and sports were the most common resources identified that help adolescents and young adults to overcome depression and anxiety. Conclusion Despite the different contexts of the three cities, young people appear to use similar resources to overcome mental distress. Policies to improve the mental health of young people in deprived urban settings should address the need of community spaces, where young people can play sports, meet and engage in groups, and support community organisations that can enable and facilitate a range of social activities.	[Toyama, Mauricio; Diez-Canseco, Francisco; Hidalgo-Padilla, Liliana] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Godoy-Casasbuenas, Natalia] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Brusco, Luis Ignacio; Carbonetti, Fernando; Diez-Canseco, Francisco] Univ Buenos Aires, Sch Med, Dept Psychiat & Mental Hlth, Buenos Aires, DF, Argentina; [Gomez-Restrepo, Carlos; Uribe, Miguel] Pontificia Univ Javeriana, Dept Psychiat & Mental Hlth, Bogota, Colombia; [Heritage, Paul; Steffen, Mariana] Queen Mary Univ London, Sch English & Drama, London, England; [Fung, Catherine; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England		Godoy-Casasbuenas, N (corresponding author), Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia.	natalia.godoy@javeriana.edu.co		Diez-Canseco, Francisco/0000-0002-7611-8190	Medical Research Council [MR/S03580X/1]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (grant number: MR/S03580X/1).	Adwas A., 2019, S AFR J MED SCI, V2, P80, DOI [10.21203/rs.2.14739/v2, DOI 10.21203/RS.2.14739/V2]; Anderson K, 2021, J ADOLESCENT HEALTH, V69, P689, DOI 10.1016/j.jadohealth.2021.03.035; Ayed N, 2019, PSYCHOL PSYCHOTHER-T, V92, P299, DOI 10.1111/papt.12185; Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [10.1016/j.npls.2016.01.001, DOI 10.1016/J.NPLS.2016.01.001]; Benjet C, 2019, PSYCHIAT RES, V282, DOI 10.1016/j.psychres.2019.112607; Caqueo-Urizar A., BMC PSYCHIATRY, DOI [10.21203/rs.2.14739/v2, DOI 10.21203/RS.2.14739/V2]; Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Gaete J, 2018, CRIM BEHAV MENT HEAL, V28, P13, DOI 10.1002/cbm.2029; Murcia EH, 2009, AV PSICOL LATINOAM, V27, P154; Herrera-Moreno D, 2018, INT J PSYCHOL RES, V11, P56, DOI 10.21500/20112084.3487; Hildebrand NA, 2019, REV SAUDE PUBL, V53, DOI [10.11606/S1518-8787.2019053000391, 10.11606/s1518-8787.2019053000391]; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Kuznesof EA, 2005, J SOC HIST, V38, P859, DOI 10.1353/jsh.2005.0065; Lopez V, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5516-4; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mendez X., 2002, PSICOLOG A CONDUCTUA, V10, P563; Miller-Graff LE, 2020, CHILD ABUSE NEGLECT, V108, DOI 10.1016/j.chiabu.2020.104639; Morgan C, 2014, BRIT J PSYCHIAT, V204, P346, DOI 10.1192/bjp.bp.113.134452; Oxman AD, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1, 10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11]; Parra A, 2015, J FAM ISSUES, V36, P2002, DOI 10.1177/0192513X13507570; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Priebe S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052339; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stapinski LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078323; Suarez EB, 2013, CHILD ABUSE NEGLECT, V37, P200, DOI 10.1016/j.chiabu.2012.09.011; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Thomson LJ, 2020, PERSPECT PUBLIC HEAL, V140, P277, DOI 10.1177/1757913920910443; Uttley L, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19180; Van Ameringen M, 2003, J ANXIETY DISORD, V17, P561, DOI 10.1016/S0887-6185(02)00228-1; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Vera-Bachmann D, 2015, REV MED CHILE, V143, P677, DOI 10.4067/S0034-98872015000500018; World Health Organization, 2013, EUR MENT HLTH ACT PL; Zarobe L, 2017, PERSPECT PUBLIC HEAL, V137, P337, DOI 10.1177/1757913917712283	35	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2022	12	8							e060340	10.1136/bmjopen-2021-060340	http://dx.doi.org/10.1136/bmjopen-2021-060340			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3U2ME	35953250	gold			2022-09-04	WOS:000840807900002
J	Gomez, AM; Henao, DC; Imitola, A; Munoz, OM; Sepulveda, MAR; Kattah, L; Guerrero, JS; Morros, E; Llano, JP; Jaramillo, MG; Leon-Vargas, F				Maria Gomez, Ana; Cristina Henao, Diana; Imitola, Angelica; Mauricio Munoz, Oscar; Rondon Sepulveda, Martin Alonso; Kattah, Laura; Sebastian Guerrero, Juan; Morros, Elly; Pablo Llano, Juan; Garcia Jaramillo, Maira; Leon-Vargas, Fabian			Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend	ENDOCRINOLOGIA DIABETES Y NUTRICION			English	Article						Sensor-augmented pump therapy; Low glucose suspend; Predictive low-glucose suspend; Continuous glucose monitoring; Type 1 diabetes mellitus; Severe hypoglycemia	INSULIN SUSPENSION; HYPOGLYCEMIA; REDUCTION	Background: Sensor-augmented insulin pump therapy (SAPT) with low-glucose suspend (LGS) is an effective and safe alternative for treating patients with type 1 diabetes mellitus (T1DM). New predictive low-glucose management (PLGM) systems decrease the severity and duration of hypoglycemic events. However, evidence of benefits in patients previously treated with SAPTLGS is limited. Methods: A prospective before-after study was conducted in patients with T1DM treated with SAPT-LGS, who were switched to the Minimed (R) 640G system with SmartGuard (R) to assess the impact on A1c levels, severe hypoglycemia (SH), hypoglycemia unawareness (HU), and area under the curve (AUC) <70 mg/dL after three months of follow-up. Results: Fifty-five patients with T1DM with a mean age of 37.9 (IQR 6, 79) years and a mean baseline Alc level of 7.52 +/- 1.11% were enrolled. After three months under PLGM, Al c levels significantly decreased to 7.18 +/- 0.91% (p= 0.004). SH rate decreased from 2.47 (CI 0.44, 4.90) to 0.87 (CI 0.22, 1.52) events/patient-year (Incidence rate ratio 0.353, 95% CI 0.178, 0.637), AUC <70 mg/dL decreased from 0.59 +/- 0.76 to 0.35 +/- 0.65 mg/dL x minute (p = 0.030). HU determined by Clarke questionnaire resolved in 23 out of 30 patients (p = 0.002). Conclusions: This study suggests that SAPT with PLGM decreases the frequency of SH, HU, exposure to glucose levels below 70 mg/dL, and Alc levels. Based on these results, this therapy should be considered in T1DM patients previously treated with SAPT-LGS with persistent SH and HU. Further clinical trials comparing the efficacy and safety of these features are required. (C) 2018 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.	[Maria Gomez, Ana; Imitola, Angelica; Mauricio Munoz, Oscar; Kattah, Laura; Sebastian Guerrero, Juan; Morros, Elly] Pontificia Univ Javeriana, Bogota, Colombia; [Maria Gomez, Ana; Cristina Henao, Diana; Imitola, Angelica; Mauricio Munoz, Oscar; Kattah, Laura] Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia; [Mauricio Munoz, Oscar; Rondon Sepulveda, Martin Alonso] Pontificia Univ Javeriana, Dept Clin Epidemiol, Bogota, Colombia; [Pablo Llano, Juan] Fdn Univ Sanitas, Bogota, Colombia; [Garcia Jaramillo, Maira] Univ EAN, Bogota, Colombia; [Leon-Vargas, Fabian] Univ Antonio Narino, Bogota, Colombia; [Maria Gomez, Ana; Cristina Henao, Diana; Imitola, Angelica; Kattah, Laura] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7,40-62, Bogota, Colombia; [Mauricio Munoz, Oscar] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Clin Epidemiol & Biostat, Dept Internal Med, Carrera 7,40-62, Bogota, Colombia; [Rondon Sepulveda, Martin Alonso] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Carrera 7,40-62, Bogota, Colombia; [Sebastian Guerrero, Juan; Morros, Elly] Pontificia Univ Javeriana, Carrera 7,40-62, Bogota, Colombia; [Pablo Llano, Juan] Fdn Univ Sanitas, Pediat Endocrinol, Bogota, Colombia		Gomez, AM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.; Gomez, AM (corresponding author), Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia.	amgomezm5@gmail.com	Garcia Jaramillo, Maira/AAE-8251-2022; Muñoz, Oscar/Q-2906-2019	Garcia Jaramillo, Maira/0000-0001-6008-9068; Muñoz, Oscar/0000-0001-5401-0018; Leon Vargas, Fabian/0000-0002-1839-2036; Morros Gonzalez, Elly/0000-0002-7946-3379; Guerrero Rey, Juan Sebastian/0000-0002-5187-1397; RONDON, MARTIN/0000-0002-3885-5448; Henao-Carrillo, Diana Cristina/0000-0002-1353-148X				Agrawal P, 2015, DIABETES TECHNOL THE, V17, P316, DOI 10.1089/dia.2014.0257; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Battelino T, 2017, DIABETES CARE, V40, P764, DOI 10.2337/dc16-2584; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bergenstal RM, 2013, DIABETES TECHNOL THE, V15, P198, DOI 10.1089/dia.2013.0051; Biester T, 2017, DIABETES TECHNOL THE, V19, P173, DOI 10.1089/dia.2016.0349; Buckingham BA, 2017, DIABETES TECHNOL THE, V19, P288, DOI 10.1089/dia.2016.0319; Cha SA, 2016, DIABETES METAB J, V40, P202, DOI 10.4093/dmj.2016.40.3.202; Choudhary P, 2016, DIABETES TECHNOL THE, V18, P288, DOI 10.1089/dia.2015.0324; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; Gomez AM, 2016, DIABETES TECHNOL THE, V19, DOI [10.1089/dia.2016.0337, DOI 10.1089/DIA.2016.0337]; Group JDRFCS, 2010, DIABETES CARE, V33; Henriksen MM, 2016, DIABETES SCI TECHNOL, V10, P1230, DOI [10.1177/1932296816664745, DOI 10.1177/1932296816664745]; Hill NR, 2011, DIABETES TECHNOL THE, V13, P921, DOI 10.1089/dia.2010.0247; Jansa M, 2015, MED CLIN-BARCELONA, V144, P440, DOI 10.1016/j.medcli.2013.11.036; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; NICE-National Institute for Health and Care Excellence, 2016, NAT I HEAL CAR EXC G, P1, DOI DOI 10.1177/0748730419830013; Pinsker JE, 2017, PREDICTIVE LOW GLUCO, V19; Weiss R, 2015, DIABETES TECHNOL THE, V17, P542, DOI 10.1089/dia.2014.0306	19	11	11	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2530-0180			ENDOCRINOL DIAB NUTR	Endocrinol. Diabetes Nutr.	OCT	2018	65	8					451	457		10.1016/j.endinu.2018.03.009	http://dx.doi.org/10.1016/j.endinu.2018.03.009			7	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	GU1HR	29914817				2022-09-04	WOS:000445010400006
J	Morkisch, N; Upegui, LD; Cardona, MI; van den Heuvel, D; Rimmele, M; Freiberger, E; Sieber, CC				Morkisch, N.; Upegui, L. D.; Cardona, M. I.; van den Heuvel, D.; Rimmele, M.; Freiberger, E.; Sieber, C. C.			Components of the Transitional Care Model (TCM) to Reduce the Hospital Re-Admission Rate of geriatric Patients - A systematic Review	ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE			German	Meeting Abstract									[Morkisch, N.; Upegui, L. D.; van den Heuvel, D.] Bundesverband Geriatrie eV, Berlin, Germany; [Upegui, L. D.] Univ Klinikum RWTH Aachen, Inst Med Psychol & Med Soziol, Aachen, Germany; [Cardona, M. I.; Rimmele, M.; Freiberger, E.; Sieber, C. C.] Friedrich Alexander Univ Nurnberg Erlangen, Inst Biomed Alterns, Nurnberg, Germany; [Cardona, M. I.] Pontificia Univ Javeriana, Santiago De Cali, Colombia; [Sieber, C. C.] Krankenhaus Barmherzige Bruder Regensburg, Regensburg, Germany										0	0	0	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-6704	1435-1269		Z GERONTOL GERIATR	Z. Gerontol. Geriatr.	AUG	2018	51			1		PO39	121	121						1	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	GS4DH					2022-09-04	WOS:000443583200387
J	Morales-Alvarez, ED; Rivera-Hoyos, CM; Poveda-Cuevas, SA; Reyes-Guzman, EA; Pedroza-Rodriguez, AM; Reyes-Montano, EA; Poutou-Pinales, RA				Morales-Alvarez, Edwin D.; Rivera-Hoyos, Claudia M.; Poveda-Cuevas, Sergio A.; Reyes-Guzman, Edwin A.; Pedroza-Rodriguez, Aura M.; Reyes-Montano, Edgar A.; Poutou-Pinales, Raul A.			Malachite Green and Crystal Violet Decolorization by Ganoderma lucidum and Pleurotus ostreatus Supernatant and by rGlLCC1 and rPOXA 1B Concentrates: Molecular Docking Analysis (vol 183, pg 1, 2017)	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Correction									[Morales-Alvarez, Edwin D.; Pedroza-Rodriguez, Aura M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Microbiol Ambiental & Suelos,GBAI, Carrera 7ma 43-82,Edificio 50 Lab 106, Bogota 11023, DC, Colombia; [Morales-Alvarez, Edwin D.] Univ Caldas, Fac Ciencias Exactas & Nat, Dept Quim, Manizales Caldas, Colombia; [Rivera-Hoyos, Claudia M.; Poutou-Pinales, Raul A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Carrera 7ma 43-82,Edificio 50 Lab 124, Bogota 11023, DC, Colombia; [Poveda-Cuevas, Sergio A.] UPTC, Fac Ciencias Basicas, Escuela Ciencias Biol, Tunja Boyaca, Colombia; [Reyes-Guzman, Edwin A.; Reyes-Montano, Edgar A.] Univ Nacl Colombia UNAL, Fac Ciencias, Grp Invest Prot, Dept Quim, Carrera 30 45-03 Edificio 451,Oficina 458, Bogota 11001, DC, Colombia; [Reyes-Guzman, Edwin A.] Univ Antonio Narino UAN, Fac Ciencias, Dept Quim, Bogota, DC, Colombia		Pedroza-Rodriguez, AM (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Microbiol Ambiental & Suelos,GBAI, Carrera 7ma 43-82,Edificio 50 Lab 106, Bogota 11023, DC, Colombia.; Poutou-Pinales, RA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Carrera 7ma 43-82,Edificio 50 Lab 124, Bogota 11023, DC, Colombia.; Reyes-Montano, EA (corresponding author), Univ Nacl Colombia UNAL, Fac Ciencias, Grp Invest Prot, Dept Quim, Carrera 30 45-03 Edificio 451,Oficina 458, Bogota 11001, DC, Colombia.	apedroza@javeriana.edu.co; eareyesm@unal.edu.co; rpoutou@javeriana.edu.co	Rivera-Hoyos, Claudia M./AAF-2954-2019; Marina, Aura/AAF-7657-2019; Poutou-Piñales, Raúl A./AAF-2962-2019	Poutou-Piñales, Raúl A./0000-0001-8841-2357; Rivera-Hoyos, Claudia Marcela/0000-0003-0915-8229; Morales-Alvarez, Edwin David/0000-0003-2622-2130				Morales-Alvarez ED, 2018, APPL BIOCHEM BIOTECH, V184, P794, DOI 10.1007/s12010-017-2560-y	1	1	1	1	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	DEC	2017	183	4					1540	1541		10.1007/s12010-017-2609-y	http://dx.doi.org/10.1007/s12010-017-2609-y			2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FN6RC	28990133	Bronze			2022-09-04	WOS:000416142200031
J	Prada-Sarmiento, F; Obregon-Neira, N				Prada-Sarmiento, Felipe; Obregon-Neira, Nelson			Forecasting of Monthly Streamflows Based on Artificial Neural Networks	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article								Artificial neural networks (ANN) have experienced a major breakthrough in civil engineering topics throughout the past 15 years, especially in the hydroinformatics field. Fewer attempts have been made to unveil any feasible physical meaning behind the ANN and their probable application for solving day to day engineering problems. This work explores the possibility of linking the weights of simple multilayer perceptrons with some physical characteristics of watersheds, by means of statistical regressions. The procedure is applied to the forecast of monthly streamflows in the central region of Colombia. Nineteen watersheds were delimited within the zone of study, using geographic information system software. Obtained results allow to foresee that watersheds characteristics such as area, length, and slope of the main stream could be connected with the ANN weights. Better results are expected when daily records and other variables such as rain, evaporation, etc. be included.	[Obregon-Neira, Nelson] Univ Javeriana, Dept Civil Engn, Bogota, Colombia; [Obregon-Neira, Nelson] Univ Nacl Colombia, Dept Civil Engn, Bogota, Colombia; [Prada-Sarmiento, Felipe] Univ Karlsruhe, Inst Bodenmech, D-76131 Karlsruhe, Germany; [Prada-Sarmiento, Felipe] Univ Los Andes, Geotech Res Grp, CEIBA Complex, Bogota, Colombia		Obregon-Neira, N (corresponding author), Univ Javeriana, Dept Civil Engn, Calle 40 5-50, Bogota, Colombia.	felipe.prada@ibf.uni-karlsruhe.de; nobregon@javeriana.edu.co	Obregon, Nelson/AAE-8143-2022	Obregon, Nelson/0000-0002-0881-9833; Prada-Sarmiento, Luis Felipe/0000-0003-2439-4828				ABEBE A, 2003, P 30 IAHR C, V1, P303; Birikundavyi S, 2002, J HYDROL ENG, V7, P392, DOI 10.1061/(ASCE)1084-0699(2002)7:5(392); CIGIZOGLU H, 2003, P 30 IAHR C, V1, P311; DASTORANI M, 2002, P 5 INT C HYDR; Govindaraju RS, 2000, J HYDROL ENG, V5, P115; Hilera J. R., 1995, REDES NEURONALES ART; Hopgood A. A, 2001, INTELLIGENT SYSTEMS, Vsecond; Kisi O, 2004, J HYDROL ENG, V9, P60, DOI 10.1061/(ASCE)1084-0699(2004)9:1(60); Liong SY, 2000, J COMPUT CIVIL ENG, V14, P1, DOI 10.1061/(ASCE)0887-3801(2000)14:1(1); Muttiah RS, 1997, J AM WATER RESOUR AS, V33, P625, DOI 10.1111/j.1752-1688.1997.tb03537.x; OBREGONNEIRA N, 2003, P WORKSH ENV DEC SUP; OBREGONNEIRA N, 2002, 2 C COL 1 ENC AND IN; SIVAPRAGASAM C, 2002, P 5 INT C HYDR; Sudheer KP, 2005, J HYDROL ENG, V10, P264, DOI 10.1061/(ASCE)1084-0699(2005)10:4(264); TAWFIK M, 2002, P 5 INT C HYDR; Thandaveswara BS, 2000, J HYDROL ENG, V5, P290, DOI 10.1061/(ASCE)1084-0699(2000)5:3(290)	16	9	9	0	6	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	DEC	2009	14	12					1390	1395		10.1061/(ASCE)1084-0699(2009)14:12(1390)	http://dx.doi.org/10.1061/(ASCE)1084-0699(2009)14:12(1390)			6	Engineering, Civil; Environmental Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Environmental Sciences & Ecology; Water Resources	521HZ					2022-09-04	WOS:000271912900016
J	Roitman, S; Lopez-Londono, T; Pollock, FJ; Ritchie, KB; Galindo-Martinez, CT; Gomez-Campo, K; Gonzalez-Guerrero, LA; Pizarro, V; Lopez-Victoria, M; Iglesias-Prieto, R; Medina, M				Roitman, Sofia; Lopez-Londono, Tomas; Joseph Pollock, F.; Ritchie, Kim B.; Galindo-Martinez, Claudia T.; Gomez-Campo, Kelly; Gonzalez-Guerrero, Luis A.; Pizarro, Valeria; Lopez-Victoria, Mateo; Iglesias-Prieto, Roberto; Medina, Monica			Surviving marginalized reefs: assessing the implications of the microbiome on coral physiology and survivorship	CORAL REEFS			English	Article						Varadero reef; Coral; Microbiome; Resistance; Turbidity	CLIMATE-CHANGE; WATER-QUALITY; CARTAGENA BAY; SP-NOV.; RESILIENCE; DIVERSITY; RESPONSES; SEDIMENT; VARADERO; IMPACTS	Coral reefs are undergoing degradation due to overexploitation, pollution, and climate change. Management and restoration efforts require that we gain a better understanding of the complex interactions between corals, their microbiomes, and their environment. For this purpose, Varadero Reef near Cartagena, Colombia, serves as an informative study system located at the entrance of the Bay of Cartagena adjacent to the Canal del Dique, which carries turbid and polluted water into the bay. Varadero's survival under poor environmental conditions makes it a great study site for investigating the relationship between the microbiome and coral resistance to environmental stressors. To determine whether the microbiomes of Varadero corals differ from those in less impacted sites, we conducted a reciprocal transplant experiment by relocating coral fragments from Varadero as well as a geographically proximate reef that is less affected by plume dynamics (Rosario) across a gradient of turbidity (low, medium, and high). After 6 months of acclimatization, transplanted corals developed site-specific microbiomes that differed significantly from pre-transplant microbiomes, and corals transplanted to the highly impacted site from both Varadero and Rosario site saw higher mortality and an increase in overall microbial diversity. In combination with physiology and survivorship outcomes pointing to a limit in the corals' photoacclimative capacity, our results indicate that, rather than surviving, Varadero Reef is experiencing a slow decline, and its corals are likely on the brink of dysbiosis. With continued anthropogenic interference in marine environments, sites such as Varadero will become increasingly common, and it is imperative that we understand how corals and their microbial symbionts are changing in response to these new environmental conditions.	[Roitman, Sofia; Lopez-Londono, Tomas; Joseph Pollock, F.; Galindo-Martinez, Claudia T.; Gomez-Campo, Kelly; Gonzalez-Guerrero, Luis A.; Iglesias-Prieto, Roberto; Medina, Monica] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Ritchie, Kim B.] Univ South Carolina Beaufort, Dept Nat Sci, 801 Carteret St, Beaufort, SC 29906 USA; [Pizarro, Valeria] Fdn Ecomares, Cali, Colombia; [Pizarro, Valeria] Nature Conservancy, Northern Caribbean Off, Cape Eleuthera Isl Sch, Rock Sound, Bahamas; [Lopez-Victoria, Mateo] Pontificia Univ Javeriana, Dept Nat Sci & Math, Cali, Valle, Colombia		Roitman, S (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sxr410@psu.edu		Galindo-Martinez, Claudia Tatiana/0000-0001-5238-3099; Pollock, Joseph/0000-0001-5467-8499; Gomez-Campo, Kelly/0000-0003-4560-111X	National Science Foundation [NSF OCE 1642311, NSF OCE 1442206]; Penn State grant from the Institute for Energy and the Environment; Penn State grant from the Social Sciences Institute	National Science Foundation(National Science Foundation (NSF)); Penn State grant from the Institute for Energy and the Environment; Penn State grant from the Social Sciences Institute	This study was funded by the National Science Foundation (Grant NSF OCE 1642311 to M. M. and R. I. P, and NSF OCE 1442206 to M. M) and Penn State grants from the Institute for Energy and the Environment and the Social Sciences Institute to M.M. We want to thank professors Gabriel Navas, Adriana Bermudez and Dario Mendez from Universidad de Cartagena for their hospitality and support at their campus. We also want to thank the personnel of the Corales del Rosario y San Bernardo National Natural Park, in particular to Esteban Zarza, for their constant support to our projects within the park. The light system for PE curves was designed and made by Miguel A. Gomez-Reali from Universidad Nacional Autonoma de Mexico UNAM. Lastly, we would like to thank the dive shops Cartagena Divers and Scuba Cartagena, as well as Pablo and Hector Avendano from Bocachica (Tierra Bomba island) for their support during field work. The research was conducted under the collection permit No. 0546 from 2014 issued by the "Autoridad Nacional de Licencias Ambientales ANLA".	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2000, P 9 INT COR REEF S, P239; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bessell-Browne P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11783-z; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Browne NK, 2013, CORAL REEFS, V32, P195, DOI 10.1007/s00338-012-0965-1; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Restrepo JC, 2017, J COASTAL RES, V33, P135, DOI 10.2112/JCOASTRES-D-15-00185.1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Damjanovic K, 2020, CORAL REEFS, V39, P189, DOI 10.1007/s00338-019-01871-z; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Diaz J. M., 2000, INVEMAR SERIE PUBLIC, V5; DiPerna S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203882; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Erftemeijer PLA, 2012, J MAR BIOL ASSOC UK, V92, P741, DOI 10.1017/S0025315411000944; Fisher R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10288-9; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Guest JR, 2018, J APPL ECOL, V55, P2865, DOI 10.1111/1365-2664.13179; Haas AF, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.42, 10.1038/nmicrobiol.2016.42]; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Iluz ID, 2012, ARTIFICIAL PHOTOSYNT, P115, DOI DOI 10.5772/31040; Jackson EJ, 2014, STATUS TRENDS CARIBB, P306; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Kemp DW, 2014, LIMNOL OCEANOGR, V59, P788, DOI 10.4319/lo.2014.59.3.0788; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; Lee STM, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv142; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lewis AM, 2019, J EUKARYOT MICROBIOL, V66, P469, DOI 10.1111/jeu.12692; Lima LFO, 2020, MBIO, V11, DOI 10.1128/mBio.02691-19; Lopez-Victoria M, 2015, CORAL REEFS, V34, P231, DOI 10.1007/s00338-014-1246-y; Mahmoud HM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00204; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morgan KM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00224; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Osinga R, 2012, APPL PHOTOSYNTHESIS, P229, DOI DOI 10.5772/29339; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Peixoto RS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00341; Pinzon JH, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140214; Pizarro V, 2017, PEERJ, V5, DOI 10.7717/peerj.4119; Pollock FJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07275-x; Restrepo JC, 2016, J COASTAL RES, P135; Restrepo JD, 2018, GEOMORPHOLOGY, V302, P92, DOI 10.1016/j.geomorph.2016.11.007; Rothig T, 2016, MOL ECOL; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sarris PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036090; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shaver EC, 2017, ECOLOGY, V98, P830, DOI 10.1002/ecy.1709; Shetty, 2017, TOOLS MICROBIOME ANA; Shlesinger T, 2019, SCIENCE, V365, P1002, DOI 10.1126/science.aax0110; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Sweet M, 2012, CORAL REEFS, P30; Sweet MJ, 2016, OCEANOGR MAR BIOL, V54, P271; Sweet M, 2015, MOL ECOL, V24, P1150, DOI 10.1111/mec.13097; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; van Oppen MJH, 2019, NAT REV MICROBIOL, V17, P557, DOI 10.1038/s41579-019-0223-4; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Vega L, 2013, ING INVEST, V33, P41; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Wang Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104657, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0097907, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0109571]; Wenger AS, 2016, CONSERV BIOL, V30, P142, DOI 10.1111/cobi.12576; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Zaneveld JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.121; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833; Ziegler M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10969-5; Ziegler M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14213	85	7	7	1	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	JUN	2020	39	3			SI		795	807		10.1007/s00338-020-01951-5	http://dx.doi.org/10.1007/s00338-020-01951-5		JUN 2020	13	Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology	ME0AZ		hybrid			2022-09-04	WOS:000541316600001
J	Forero, DA; Gonzalez-Giraido, Y; Castro-Veges, LJ; Barreto, GE				Forero, Diego A.; Gonzalez-Giraido, Yeimy; Castro-Veges, Luis J.; Barreto, George E.			qPCR-based methods for expression analysis of miRNAs	BIOTECHNIQUES			English	Review						expression analysis; microRNAs; molecular assays; non-coding RNAs; real-time PCR	REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; RT-PCR; MICRORNA EXPRESSION; GENE-EXPRESSION; DIGITAL PCR; QUANTIFICATION; NORMALIZATION; ASSAY; IDENTIFICATION	Several approaches for miRNA expression analysis have been developed in recent years. In this article, we provide an updated and comprehensive review of available qPCR-based methods for miRNA expression analysis and discuss their advantages and disadvantages. Existing techniques involve the use of stem-loop reverse transcription-PCR, polyadenylation of RNAs, ligation of adapters or RT with complex primers, using universal or miRNA-specific qPCR primers and/or probes. Many of these methods are oriented towards the expression analysis of mature miRNAs and few are designed for the study of pre-miRNAs and pri-miRNAs. We also discuss findings from articles that compare results from existing methods. Finally, we suggest key points for the improvement of available techniques and for the future development of additional methods.	[Forero, Diego A.] Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Biomed Sci Res Grp, Bogota, Colombia; [Forero, Diego A.] Univ Antonio Narino, Sch Med, PhD Program Hlth Sci, Bogota, Colombia; [Gonzalez-Giraido, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Castro-Veges, Luis J.] INSERM, UMR970, Paris Cardiovasc Res Ctr, Equipe Labellisee Ligue Canc, Paris, France; [Castro-Veges, Luis J.] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France		Forero, DA (corresponding author), Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Biomed Sci Res Grp, Bogota, Colombia.; Forero, DA (corresponding author), Univ Antonio Narino, Sch Med, PhD Program Hlth Sci, Bogota, Colombia.	diego.forero@uan.edu.co	Forero, Diego A./O-9981-2019; Gonzalez, Yeimy/Y-1975-2019; González-Giraldo, Yeimy/Q-5652-2018; Barreto, George E./AAD-7420-2020	Forero, Diego A./0000-0001-9175-3363; Gonzalez, Yeimy/0000-0002-2527-218X; González-Giraldo, Yeimy/0000-0002-2527-218X; Barreto, George E./0000-0002-6644-1971				Androvic P, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx588; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Benes V, 2015, SCI REP-UK, V5, DOI 10.1038/srep11590; Bofill-De Ros X, 2019, BIOCH BIOPHYS ACTA G; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Bustin S, 2015, CLIN CHEM, V61, P202, DOI 10.1373/clinchem.2014.230615; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Chugh P, 2010, J VIS EXP, V46; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Ge QY, 2014, ANAL METHODS-UK, V6, P9101, DOI 10.1039/c4ay01602e; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Honda S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv218; Hsieh CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29146-7; Huang TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120160; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Hunt EA, 2015, ANNU REV ANAL CHEM, V8, P217, DOI 10.1146/annurev-anchem-071114-040343; Jacobsen N, 2011, METHODS MOL BIOL, V732, P39, DOI 10.1007/978-1-61779-083-6_4; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Jung U, 2013, RNA, V19, P1864, DOI 10.1261/rna.040501.113; Juzenas S, 2017, NUCLEIC ACIDS RES, V45, P9290, DOI 10.1093/nar/gkx706; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kim KJ, 2017, ANAL BIOCHEM, V536, P32, DOI 10.1016/j.ab.2017.08.006; Kong W, 2009, J CELL PHYSIOL, V218, P22, DOI 10.1002/jcp.21577; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Kumar P, 2011, RNA, V17, P365, DOI 10.1261/rna.2490111; Lan L, 2019, CHEM SCI, V10, P2034, DOI 10.1039/c8sc04621b; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Leti F, 2018, METHODS MOL BIOL, V1706, P257, DOI 10.1007/978-1-4939-7471-9_14; Li XQ, 2014, RNA, V20, P252, DOI 10.1261/rna.040220.113; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Magee Rogan, 2017, Non-Coding RNA, V3, P18, DOI 10.3390/ncrna3020018; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mohammadian A, 2013, BIOTECHNOL LETT, V35, P843, DOI 10.1007/s10529-013-1150-5; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mou GP, 2013, BIOSCI BIOTECH BIOCH, V77, P1349, DOI 10.1271/bbb.130192; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; Nejad C, 2018, RNA, V24, P332, DOI 10.1261/rna.064550.117; Nejad C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00011; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ouyang TL, 2019, ANAL CHEM, V91, P3179, DOI 10.1021/acs.analchem.8b05909; Panwar B, 2017, BIOINFORMATICS, V33, P1554, DOI 10.1093/bioinformatics/btx019; Paul P, 2018, J CELL PHYSIOL, V233, P2007, DOI 10.1002/jcp.25854; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pillman KA, 2019, RNA, V25, P232, DOI 10.1261/rna.069047.118; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qureshi R, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S14; Redshaw N, 2013, BIOTECHNIQUES, V54, P155, DOI 10.2144/000114002; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Salone V, 2015, METHODS MOL BIOL, V1296, P103, DOI 10.1007/978-1-4939-2547-6_10; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Fausto AKS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174722; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Telonis AG, 2017, NUCLEIC ACIDS RES, V45, P2973, DOI 10.1093/nar/gkx082; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tong L, 2015, MOL BIOTECHNOL, V57, P939, DOI 10.1007/s12033-015-9885-y; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00360; Wang YL, 2018, MOL MED REP, V17, P3690, DOI 10.3892/mmr.2017.8297; Wylie Dennis, 2011, BMC Res Notes, V4, P555, DOI 10.1186/1756-0500-4-555; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yu F, 2017, NUCLEIC ACIDS RES, V45, P11371, DOI 10.1093/nar/gkx788; Zeka F, 2015, METHODS MOL BIOL, V1296, P85, DOI 10.1007/978-1-4939-2547-6_9; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang WC, 2018, ANAL BIOCHEM, V543, P71, DOI 10.1016/j.ab.2017.12.004; Zhang Yu, 2018, Microrna, V7, P4, DOI 10.2174/2211536607666180126163031; Zheng WD, 2013, CLIN BIOCHEM, V46, P1566, DOI 10.1016/j.clinbiochem.2013.06.024; Zollner H, 2014, METHODS MOL BIOL, V1095, P121, DOI 10.1007/978-1-62703-703-7_10; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	89	31	31	5	18	FUTURE SCI LTD	LONDON	UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	OCT	2019	67	4					192	199		10.2144/btn-2019-0065	http://dx.doi.org/10.2144/btn-2019-0065			8	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JG6RN	31560239	gold			2022-09-04	WOS:000492198800010
J	Lapischies, R; Forero, D; Barcellos, A; Salomao, RP				Lapischies, Rita; Forero, Dimitri; Barcellos, Aline; Salomao, Renato P.			A new species of Pyrrhosphodrus (Hemiptera: Heteroptera: Reduviidae) from the Caatinga ecosystem in Brazil, with notes on the genus	ZOOTAXA			English	Article						Assassin bug; dry forest; Harpactorinae; Harpactorini; Neotropical; semi-arid; synonymy	ASSASSIN BUG; MORPHOLOGY; PHYLOGENY; REDUVIOIDEA	A new species of Reduviidae (Hemiptera: Heteroptera) from Caatinga ecosystem, Pyrrhosphodrus caatingensis Lapischies & Forero sp. nov., is described. The new species is distinguished from its congeners by its overall reddish coloration with black areas; by the black legs, with femora with a subapical yellowish broad ring, tibiae with apical and subapical yellowish annuli; and genital characters. Comments about the biology, feeding habits, habitus, genitalic images, and a distribution map of the new species are given. In addition, the following synonymy is proposed: Pyrrhosphodrus militans Stal, 1866 - P theresina (Berg, 1879), syn. nov. A key to separate the known species of Pyrrhosphodrus Stal, 1866 is provided.	[Lapischies, Rita; Barcellos, Aline] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Forero, Dimitri] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, Bogota, Colombia; [Barcellos, Aline] Fdn Zoobot Rio Grande Sul, Museu Ciencias Nat, Porto Alegre, RS, Brazil; [Salomao, Renato P.] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Salomao, Renato P.] Univ Fed Vale Sao Francisco, Ctr Conservacao & Manejo Fauna Caatinga, Petrolina, PE, Brazil		Lapischies, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	rita.lapischies@gmail.com; forero-i@javeriana.edu.co; alinebar.fzb@gmail.com; renatopsalomao3@hotmail.com	dos Santos, Aline Barcellos Prates/F-7493-2012; Salomão, Renato/ABA-4256-2021; Forero, Dimitri/P-4860-2016	dos Santos, Aline Barcellos Prates/0000-0002-0603-926X; Forero, Dimitri/0000-0002-6358-757X; Salomao, Renato/0000-0001-9826-7472	CAPES; CONACYT	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Gunvi Lindberg (NHRS) for photographs of the types; CAPES, to the master's fellowship to RL; Brazilian Ministerio da Integracao Nacional, which gave permission to use data from the "Programa de Integracao do Rio Sao Francisco com bacias hidrograficas do Nordeste Setentrional"; CEMAFAUNA members' Msc. Luiz Pereira and Dr. Patricia Nicola and CONACYT for the scholarship granted to RPS.	Ang YC, 2013, ZOOKEYS, P9, DOI 10.3897/zookeys.355.6013; Berenger Jean-Michel, 2005, Nouvelle Revue d'Entomologie, V22, P369; Berg C, 1879, HEMIPTERA ARGENTINA, DOI [10.5962/bhl.title.36493, DOI 10.5962/BHL.TITLE.36493]; Cobben R. H., 1975, Studies on the Fauna of Curacao and other Caribbean Islands, V48, P1; DAVIS NT, 1966, ANN ENTOMOL SOC AM, V59, P911, DOI 10.1093/aesa/59.5.911; DAVIS NT, 1969, ANN ENTOMOL SOC AM, V62, P74, DOI 10.1093/aesa/62.1.74; Fallou G., 1887, NATURALISTE SERIES, V1, P68; Forattini O. P., 1950, Dusenia Curitiba, V1, P229; Forero D, 2004, ZOOTAXA, P1; Forero Dimitri, 2011, Boletin del Museo Entomologico Francisco Luis Gallego, V3, P9; Forero D, 2012, DEUT ENTOMOL Z, V59, P5, DOI 10.1002/mmnd.201200001; Gil-Santana HR, 2017, ZOOKEYS, P19, DOI 10.3897/zookeys.671.11985; Leal I.R., 2003, ECOLOGIA CONSERVACAO; Maldonado Capriles J., 1990, CARIBB J SCI, DOI [10.1093/aesa/85.4.532, DOI 10.1093/AESA/85.4.532]; Maldonado Capriles Jenaro, 1993, Entomologica Scandinavica, V24, P139; McPherson JE, 2011, ANN ENTOMOL SOC AM, V104, P1285, DOI 10.1603/AN11128; Putshkov V.G., 1988, CATALOGUE ASSASSIN B; Putshkov VG, 1985, CATALOG ASSASSIN BUG; Silva J.M.C., 2017, CAATINGA, V1, P359, DOI DOI 10.1007/978-3-319-68339-3; Stal C., 1866, OFVERSIGT KONGLIGA V, V23, P235; Vasconcellos A, 2010, REV BRAS ENTOMOL, V54, P471, DOI 10.1590/S0085-56262010000300019; Weirauch C., 2014, Canadian Journal of Arthropod Identification, V26, P1; Wygodzinsky P., 1947, ARQUIVOS MUSEU NACL, V41, P3; Wygodzinsky P., 1949, ELENCO SISTEMATICO R; Zhang GY, 2014, CLADISTICS, V30, P339, DOI 10.1111/cla.12049; Zhang GY, 2013, ACTA ZOOL-STOCKHOLM, V94, P1, DOI 10.1111/j.1463-6395.2011.00522.x; Zhang JX, 2016, CLADISTICS, V32, P538, DOI 10.1111/cla.12140	27	2	2	0	3	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	JAN 8	2019	4543	3					388	400		10.11646/zootaxa.4543.3.4	http://dx.doi.org/10.11646/zootaxa.4543.3.4			13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	HG6LE	30647295				2022-09-04	WOS:000455092200004
J	Gomez, AM; Carrillo, DCH; Lucia, T; Dario, P; Rondon, M; Maira, GJ; Mauricio, LVF; Alejandra, RM; Rebolledo, M				Gomez, A. M.; Henao Carrillo, D. C.; Lucia, T.; Dario, P.; Rondon, M.; Maira, G. J.; Fabian Mauricio, L. V.; Maria Alejandra, R.; Rebolledo, M.			FACTORS ASSOCIATED WITH HYPOGLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES AND HIGH RISK OF HYPOGLYMEMIA	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Gomez, A. M.; Henao Carrillo, D. C.; Lucia, T.; Dario, P.; Rondon, M.] Hosp Univ San Ignacio, Endocrinol, Bogota, Colombia; [Maira, G. J.] Univ EAN, Bogota, Colombia; [Fabian Mauricio, L. V.] Univ Antonio Narino, Bogota, Colombia; [Maria Alejandra, R.] Univ Pontificia Javeriana, Endocrinol, Bogota, Colombia; [Rebolledo, M.] Pontificia Univ Javeriana, Endocrinol, Bogota, Colombia					Henao-Carrillo, Diana Cristina/0000-0002-1353-148X; Gomez-Medina, Ana Maria/0000-0002-8907-3470					0	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB	2018	20			1		214	A97	A98						2	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FW0WC					2022-09-04	WOS:000425015800229
J	Gerlein, EA; McGinnity, TM; Belatreche, A; Coleman, S				Gerlein, Eduardo A.; McGinnity, T. M.; Belatreche, Ammar; Coleman, Sonya			Network on Chip Architecture for Multi-Agent Systems in FPGA	ACM TRANSACTIONS ON RECONFIGURABLE TECHNOLOGY AND SYSTEMS			English	Article						Design; Measurement; Performance; Multi-agent systems; network-on-chip; open core protocol; agent-based simulation	SIMULATION; DESIGN	A system of interacting agents is, by definition, very demanding in terms of computational resources. Although multi-agent systems have been used to solve complex problems in many areas, it is usually very difficult to perform large-scale simulations in their targeted serial computing platforms. Reconfigurable hardware, in particular Field Programmable Gate Arrays devices, have been successfully used in High Performance Computing applications due to their inherent flexibility, data parallelism, and algorithm acceleration capabilities. Indeed, reconfigurable hardware seems to be the next logical step in the agency paradigm, but only a few attempts have been successful in implementing multi-agent systems in these platforms. This article discusses the problem of inter-agent communications in Field Programmable Gate Arrays. It proposes a Network-on-Chip in a hierarchical star topology to enable agents' transactions through message broadcasting using the Open Core Protocol as an interface between hardware modules. A customizable router microarchitecture is described and a multi-agent system is created to simulate and analyse message exchanges in a generic heavy traffic load agent-based application. Experiments have shown a throughput of 1.6Gbps per port at 100MHz without packet loss and seamless scalability characteristics.	[Gerlein, Eduardo A.] Pontificia Univ Javeriana, Dept Elect, Bogota, Colombia; [McGinnity, T. M.] Univ Ulster, Intelligent Syst Res Ctr, Coleraine, Londonderry, North Ireland; [McGinnity, T. M.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Belatreche, Ammar] Northumbria Univ, Fac Engn & Environm, Newcastle Upon Tyne, Tyne & Wear, England; [Coleman, Sonya] Ulster Univ, Intelligent Syst Res Ctr, Coleraine, Londonderry, North Ireland; [McGinnity, T. M.] Nottingham Trent Univ, Coll Sci & Technol, Nottingham, England		Gerlein, EA (corresponding author), Pontificia Univ Javeriana, Dept Elect, Bogota, Colombia.	egerlein@javeriana.edu.co; martin.mcginnity@ntu.ac.uk; ammar.belatreche@northumbria.ac.uk; sa.coleman@ulster.ac.uk		Gerlein, Eduardo/0000-0001-6000-6808; Coleman, Sonya/0000-0002-4676-7640; McGinnity, Thomas Martin/0000-0002-9897-4748	University of Ulster, as part of the Capital Markets Engineering project	University of Ulster, as part of the Capital Markets Engineering project	Eduardo Gerlein is supported by a Vice-Chancellor Research Scholarship (VCRS) from the University of Ulster, as part of the Capital Markets Engineering project.	Allan Rob, 2010, DLTR2010007; [Anonymous], 2012, COGNITIVE AGENT ARCH; Baklouti M, 2014, INT J RECONFIGURABLE, V2014, DOI 10.1155/2014/979327; Bellifemine F. L, 2007, DEV MULTIAGENT SYSTE, V7; Benini L, 2002, COMPUTER, V35, P70, DOI 10.1109/2.976921; Bosse S, 2015, SENSORS-BASEL, V15, P4513, DOI 10.3390/s150204513; Bosse S, 2014, IEEE SENS J, V14, P2159, DOI 10.1109/JSEN.2014.2301938; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Carrillo S, 2013, IEEE T PARALL DISTR, V24, P2451, DOI 10.1109/TPDS.2012.289; Chen Edward, 2011, Holonic and Multi-Agent Systems for Manufacturing. Proceedings 5th International Conference on Industrial Applications of Holonic and Multi-Agent Systems (HoloMAS 2011), P94, DOI 10.1007/978-3-642-23181-0_9; Chen XR, 2003, IEEE C COMP INTEL FI, P159, DOI 10.1109/CIFER.2003.1196256; Das R, 2009, INT S HIGH PERF COMP, P175, DOI 10.1109/HPCA.2009.4798252; Ebrahimi M., 2011, 2011 IEEE/IFIP 19th International Conference on VLSI and System-on-Chip, P284, DOI 10.1109/VLSISoC.2011.6081593; Ferber Jacques, 1999, MULTIAGENT SYSTEMS I, V1; Gerlein EA, 2014, AAMAS'14: PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P1497; Gerlein Eduardo A., 2014, P INT C COMP INT FIN; Gokhale M, 2008, COMPUTER, V41, P60, DOI 10.1109/MC.2008.125; Gonzalez E, 2006, ICEIS 2006: PROCEEDINGS OF THE EIGHTH INTERNATIONAL CONFERENCE ON ENTERPRISE INFORMATION SYSTEMS, P75; Gonzalez Enrique, 2003, P PAR DISTR PROC TEC; IEEE, 2012, FDN INT PHYS AG FIPA; Jerger N. D. E., 2009, ON CHIP NETWORKS; Kiasari AE, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2480741.2480755; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Lukovic Slobodan, 2010, P INT WORKSH SEC DEP, V1; Markettos A Theodore, 2014, 2014 24 INT C FPL P 24 INT C FIELD PRO, P1; Meng Y, 2005, IEEE I C EMBED SOFTW, P166; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Minar N., 1996, SWARM SIMULATION SYS; Naji HR, 2004, FUTURE GENER COMP SY, V20, P1055, DOI 10.1016/j.future.2004.02.002; Naji HR, 2004, ADV ENG SOFTW, V35, P401, DOI 10.1016/j.advengsoft.2004.05.008; OCP International Partnership, 2009, OP COR PROT SPEC 3 0, P494; Park S, 2012, DES AUT CON, P398; Pawlaszczyk D, 2009, WINT SIMUL C PROC, P1169; Stroud P, 2007, JASSS-J ARTIF SOC S, V10; Studdert R, 2005, P 2005 ACM S APPL CO, P963; Varghese B, 2014, COMPUT BIOL MED, V48, P28, DOI 10.1016/j.compbiomed.2014.02.005	36	1	1	0	6	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	1936-7406	1936-7414		ACM T RECONFIG TECHN	ACM T. Reconfigurable Technol. Syst.	DEC	2017	10	4							25	10.1145/3121112	http://dx.doi.org/10.1145/3121112			22	Computer Science, Hardware & Architecture	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	FS0DM		Green Published, Green Accepted			2022-09-04	WOS:000419444100001
J	Henwood, PC; Norwood, BR; Genthon, AA; Silva, D; Martinez, YB; Granada, J; Torres, J; Romero, MG; Arbelaez, C				Henwood, P. C.; Norwood, B. R.; Genthon, A. A.; Silva, D.; Martinez, Y. B.; Granada, J.; Torres, J.; Romero, M. G.; Arbelaez, C.			Point of Care Ultrasonography Training in Bogota Emergency Medicine Residencies: The Unmet Need	ANNALS OF EMERGENCY MEDICINE			English	Meeting Abstract	Research Forum of the American-College-of-Emergency-Physicians (ACEP)	OCT 08-09, 2012	Denver, CO	Amer Coll Emergency Phys					[Henwood, P. C.] Brigham & Womens Hosp, Boston, MA 02115 USA; NYU, Sch Med, New York, NY USA; Rosario Univ, Bogota, Colombia; Javeriana Univ, Bogota, Colombia; Asociac Colombiana Especialista Emergencia & Urge, Bogota, Colombia					Torres-Castillo, Jenny-Imelda/0000-0003-2446-4187					0	0	0	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	OCT	2012	60	4		S			S122	S123		10.1016/j.annemergmed.2012.06.322	http://dx.doi.org/10.1016/j.annemergmed.2012.06.322			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	018BX					2022-09-04	WOS:000309636100341
J	Thevenieau, F; Fardeau, ML; Ollivier, B; Joulian, C; Baena, S				Thevenieau, France; Fardeau, Marie-Laure; Ollivier, Bernard; Joulian, Catherine; Baena, Sandra			Desulfomicrobium thermophilum sp nov., a novel thermophilic sulphate-reducing bacterium isolated from a terrestrial hot spring in Colombia	EXTREMOPHILES			English	Article						anaerobe; thermophile; hot spring; sulphate-reducing bacterium; taxonomy	GEN. NOV.; RECLASSIFICATION; PHYLOGENY; DIVERSITY; ESCAMBIUM; COMMUNITY; SULFIDE; RATES	A moderately thermophilic, sulphate-reducing bacterium, designated strain P6-2(T), was isolated from a terrestrial hot spring located at a height of 2,500 m in the Andean region, Colombia (5 degrees 43'69"N, 73 degrees 6'10"W). Cells of strain P6-2(T) were rod-shaped, stained Gram-negative and were motile by means of a single polar flagellum. The strain grew lithotrophically with H-2 as the electron donor and organotrophically on lactate, pyruvate, ethanol, malate, fumarate, n-propanol and succinate in the presence of sulphate as the terminal electron acceptor. Fumarate and pyruvate was fermented. Strain P6-2(T) grew optimally at 55 degrees C (range 37-60 degrees C), pH 6.6 (range 5.8-8.8) in the presence of 0.5% NaCl (range 0-4.5%) with lactate and sulphate and produced acetate, CO2 and H2S as the major end-products. Sulphate, sulphite and thiosulphate could be used as electron acceptors but not elemental sulphur or nitrate. The G + C content of the genomic DNA was 58.7 mol%. The 16S rRNA sequence analysis indicated that strain P6-2(T) was a member of the class Deltaproteobacteria, domain Bacteria with Desulfomicrobium baculatum being the closest relative (similarity value of 94%). Phylogeny of genes encoding alpha- and beta-subunits of the dissimilatory sulphite reductase (dsrAB genes) supported its affiliation to members of the genus Desulfomicrobium. On the basis of this evidence, we propose to assign strain P6-2(T) as new species of the genus Desulfomicrobium, D. thermophilum sp. nov., with strain P6-2(T) as the type strain (= DSM 16697(T) = CCUG 49732(T)).	Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, Bogota, Colombia; Univ Aix Marseille 1, ESIL, IFR,BAIM,IRD, UMR Microbiol & Biotechnol Environm Chauds 180, F-13288 Marseille, France; Univ Mediterranee, ESIL, IFR,BAIM,IRD, UMR Microbiol & Biotechnol Environm Chauds 180, F-13288 Marseille, France; Bur Rech Geol & Minieres, Biotechnol Unit, Environm & Proc Div, F-45060 Orleans, France		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, POB 56710, Bogota, Colombia.	baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019; Ollivier, Bernard/I-6150-2016; Joulian, Catherine/AAL-5443-2020	Joulian, Catherine/0000-0003-3834-2551; Baena, Sandra/0000-0001-5377-9079				Audiffrin C, 2003, INT J SYST EVOL MICR, V53, P1585, DOI 10.1099/ijs.0.02551-0; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Beeder J, 1995, ARCH MICROBIOL, V164, P331, DOI 10.1007/BF02529979; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Blank CE, 2002, APPL ENVIRON MICROB, V68, P5123, DOI 10.1128/AEM.68.10.5123-5135.2002; Castro HF, 2000, FEMS MICROBIOL ECOL, V31, P1, DOI 10.1016/S0168-6496(99)00071-9; Chang YJ, 2001, APPL ENVIRON MICROB, V67, P3149, DOI 10.1128/AEM.67.7.3149-3160.2001; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Fardeau ML, 2000, INT J SYST EVOL MICR, V50, P2141, DOI 10.1099/00207713-50-6-2141; Fauque G., 2004, MICROBIAL DIVER BIOP, P169; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Ferris MJ, 2003, ENVIRON MICROBIOL, V5, P954, DOI 10.1046/j.1462-2920.2003.00494.x; Fishbain S, 2003, APPL ENVIRON MICROB, V69, P3663, DOI 10.1128/AEM.69.6.3663-3667.2003; GENTHNER BRS, 1994, ARCH MICROBIOL, V161, P215; Genthner BRS, 1997, INT J SYST BACTERIOL, V47, P889; GENTHNER BRS, 1996, INT J SYST BACTERIOL, V46, P1189; Goorissen HP, 2003, INT J SYST EVOL MICR, V53, P1223, DOI 10.1099/ijs.0.02476-0; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-14998U1.29; HENRY EA, 1994, ARCH MICROBIOL, V161, P62, DOI 10.1007/BF00248894; Hippe H, 2003, INT J SYST EVOL MICR, V53, P1127, DOI 10.1099/ijs.0.02574-0; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Itoh T, 1999, INT J SYST BACTERIOL, V49, P1157, DOI 10.1099/00207713-49-3-1157; Itoh T, 1998, INT J SYST BACTERIOL, V48, P879, DOI 10.1099/00207713-48-3-879; Jukes T.H., 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Langendijk PS, 2001, INT J SYST EVOL MICR, V51, P1035, DOI 10.1099/00207713-51-3-1035; Liu YT, 1997, INT J SYST BACTERIOL, V47, P615, DOI 10.1099/00207713-47-3-615; LOVE CA, 1993, SYST APPL MICROBIOL, V16, P244; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Mori K, 2003, EXTREMOPHILES, V7, P283, DOI 10.1007/s00792-003-0320-0; POSTGATE JR, 1956, J GEN MICROBIOL, V14, P545, DOI 10.1099/00221287-14-3-545; REES GN, 1995, INT J SYST BACTERIOL, V45, P85, DOI 10.1099/00207713-45-1-85; ROZANOVA E P, 1988, Mikrobiologiya, V57, P634; ROZANOVA EP, 1976, MICROBIOLOGY+, V45, P711; ROZANOVA EP, 1994, INT J SYST BACTERIOL, V44, P370; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sievert SM, 2000, INT J SYST EVOL MICR, V50, P1239, DOI 10.1099/00207713-50-3-1239; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Sonne-Hansen J, 1999, SYST APPL MICROBIOL, V22, P559, DOI 10.1016/S0723-2020(99)80009-5; Stahl DA, 2002, ANTON LEEUW INT J G, V81, P189, DOI 10.1023/A:1020506415921; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; ZEIKUS JG, 1983, J GEN MICROBIOL, V129, P1159	45	35	39	0	15	SPRINGER JAPAN KK	TOKYO	SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	MAR	2007	11	2					295	303		10.1007/s00792-006-0039-9	http://dx.doi.org/10.1007/s00792-006-0039-9			9	Biochemistry & Molecular Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Microbiology	138BB	17136317				2022-09-04	WOS:000244336400011
J	Gavino-Orduna, JF; Caviedes-Bucheli, J; Manzanares-Cespedes, MC; Roman-Richon, S; Martin-Biedma, B; Segura-Egea, JJ; Berastegui-Jimeno, E; Lopez-Lopez, J				Gavino-Orduna, Jose F.; Caviedes-Bucheli, Javier; Manzanares-Cespedes, Maria C.; Roman-Richon, Sophie; Martin-Biedma, Benjamin; Segura-Egea, Juan J.; Berastegui-Jimeno, Esther; Lopez-Lopez, Jose			Dentin Growth after Direct Pulp Capping with the Different Fractions of Plasma Rich in Growth Factors (PRGF) vs. MTA: Experimental Study in Animal Model	JOURNAL OF CLINICAL MEDICINE			English	Article						pulp capping; regenerative endodontics; pulpotomy; plasma rich growth factors; fluorescence microscopy; vital pulp therapy	BETA ISOFORMS 1-3; MIGRATION; TEETH; PROLIFERATION; THERAPY; INCISOR; TISSUE	Background: This study aimed to evaluate the area of dentin growth in rabbit incisors after pulp capping with plasma rich in growth factors (PRGF) compared with mineral trioxide aggregate (MTA) by fluorescence. Methods: twenty-seven upper and lower incisors of rabbits were divided into 4 groups: poor PRGF (F1) (n = 9 teeth), rich PRGF (F2) (n = 8 teeth), ProRoot MTA (positive control, n = 5 teeth), and untreated (NC) (negative control, n = 5). Fluorochrome markers were injected 24 h before surgery and the day before euthanasia, 28 days after the vital pulp therapy (VPT). Two transverse cuts were performed to every tooth: the first cut (A), 1 mm incisal to the gingival margin, and the second cut (B), 5 mm apical to the first cut. The sections were assessed with histomorphometric evaluation by fluorescence microscopy, comparing the dentin area between fluorescence marks and the total mineralized area. Results: The higher percentage of dentin growth was observed in the F2 group (B = 63.25%, A = 36.52%), followed by F1 (B = 57.63%, A = 30,12%) and MTA (B = 38.64%, A = 15.74%). The group with lowest percentage of dentin growth was the NC group (B = 29.22%, A = 7.82%). Significant difference (p < 0.05) was found between F2 group and MTA, also statistically significant difference has been observed comparing dentin growth areas of NC group with F1 and F2 groups. Conclusions: The application of PRGF rich and poor fraction as a pulp capping material stimulated dentin formation more intensively than MTA and NC.	[Gavino-Orduna, Jose F.; Roman-Richon, Sophie; Berastegui-Jimeno, Esther; Lopez-Lopez, Jose] Univ Barcelona, Sch Dent, Dept Odontostomatol, Fac Med & Hlth Sci, Barcelona 08907, Spain; [Caviedes-Bucheli, Javier] Pontificia Univ Javeriana, Ctr Invest Odontol CIO, Bogota 11001000, Colombia; [Manzanares-Cespedes, Maria C.] Univ Barcelona, Sch Dent, Fac Med & Hlth Sci, Human Anat & Embryol Unit,Dept Pathol & Expt Ther, Barcelona 08907, Spain; [Martin-Biedma, Benjamin] Univ Santiago De Compostela, Sch Med & Dent, Unit Dent Pathol & Therapeut 2, Santiago De Compostela 15782, Spain; [Segura-Egea, Juan J.] Univ Seville, Sch Dent, Dept Stomatol, Seville 41009, Spain; [Lopez-Lopez, Jose] Univ Barcelona, Odontol Hosp Univ Barcelona, Serv Surg Med Area, Barcelona 08907, Spain; [Lopez-Lopez, Jose] Univ Barcelona, Oral Hlth & Masticatory Syst Grp IDIBELL, Bellvitge Biomed Res Inst, Barcelona 08907, Spain		Gavino-Orduna, JF; Lopez-Lopez, J (corresponding author), Univ Barcelona, Sch Dent, Dept Odontostomatol, Fac Med & Hlth Sci, Barcelona 08907, Spain.; Lopez-Lopez, J (corresponding author), Univ Barcelona, Odontol Hosp Univ Barcelona, Serv Surg Med Area, Barcelona 08907, Spain.; Lopez-Lopez, J (corresponding author), Univ Barcelona, Oral Hlth & Masticatory Syst Grp IDIBELL, Bellvitge Biomed Res Inst, Barcelona 08907, Spain.	dr.gavino@gmail.com; javiercaviedes@gmail.com; mcmanzanares@ub.edu; sophie.roman@ymail.com; b.martinbiedma@gmail.com; segurajj@us.es; eberastegui@gmail.com; 18575jll@gmail.com	Segura-Egea, Juan J./A-6312-2009; Céspedes, Maria Cristina Manzanares/H-5489-2015	Segura-Egea, Juan J./0000-0002-0427-9059; Céspedes, Maria Cristina Manzanares/0000-0002-4585-4953; lopez-Lopez, Jose/0000-0001-8035-4412; Caviedes-Bucheli, Javier/0000-0003-0407-9847				Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x; Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010; Anitua E, 2015, CLIN ORAL INVEST, V19, P589, DOI 10.1007/s00784-014-1278-2; Anitua E, 2013, ANN ANAT, V195, P461, DOI 10.1016/j.aanat.2013.04.004; Atesci AA, 2020, J ENDODONT, V46, P200, DOI 10.1016/j.joen.2019.10.033; Awawdeh L, 2018, J ENDODONT, V44, P1603, DOI 10.1016/j.joen.2018.08.004; Brucoli M, 2018, ORAL MAXILLOFAC SURG, V22, P309, DOI 10.1007/s10006-018-0712-z; Carvalho P, 2014, BIODENTAL ENGINEERING II, P59; Cassidy N, 1997, ARCH ORAL BIOL, V42, P219, DOI 10.1016/S0003-9969(96)00115-X; Coll JA, 2017, PEDIATR DENT, V39, P16; da Rosa WLO, 2018, INT ENDOD J, V51, P829, DOI 10.1111/iej.12906; Da Silva A.F., 2016, DENT MATER, V32, pE92, DOI [10.1016/j.dental.2016.08.192, DOI 10.1016/J.DENTAL.2016.08.192]; da Rosa WLD, 2017, J BIOMED MATER RES A, V105, P941, DOI 10.1002/jbm.a.35968; Etxebarria J, 2017, ACTA OPHTHALMOL, V95, pe693, DOI 10.1111/aos.13371; Hu CC, 1998, J ENDODONT, V24, P744, DOI 10.1016/S0099-2399(98)80166-0; Keswani D, 2014, J ENDODONT, V40, P599, DOI 10.1016/j.joen.2014.01.009; KOZLOV M., 1960, ORAL SURG ORAL MED AND ORAL PATHOL, V13, P455, DOI 10.1016/0030-4220(60)90351-0; Mohamed RN, 2018, PLATELETS, V29, P440, DOI 10.1080/09537104.2018.1445844; MOHAMMED C. I., 1955, JOUR DENTAL RES, V34, P608, DOI 10.1177/00220345550340041701; Muller J, 2014, J EXP ZOOL PART A, V321, P283, DOI 10.1002/jez.1864; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; Ohya K, 1993, Kokubyo Gakkai Zasshi, V60, P525; Okada H, 2016, J DENT SCI, V11, P245, DOI 10.1016/j.jds.2015.12.001; Orhan EO, 2012, INT ENDOD J, V45, P317, DOI 10.1111/j.1365-2591.2011.01977.x; PERREAULT J. G., 1956, JOUR AMER DENTAL ASSOC, V52, P533; PINZON RD, 1967, J DENT RES, V46, P202, DOI 10.1177/00220345670460011101; RAHN BA, 1971, STAIN TECHNOL, V46, P125, DOI 10.3109/10520297109067836; Rechenberg DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167289; Ricucci D, 2019, J DENT, V86, P41, DOI 10.1016/j.jdent.2019.05.022; Singhrao SK, 2010, MICROSC RES TECHNIQ, V73, P741, DOI 10.1002/jemt.20815; Sloan AJ, 1999, ARCH ORAL BIOL, V44, P149, DOI 10.1016/S0003-9969(98)00106-X; Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426; Wells C., 2019, VITAL PULP THERAPY E; Widbiller M, 2018, J ENDODONT, V44, P956, DOI 10.1016/j.joen.2018.02.011; Wyss F, 2016, J VET DENT, V33, P39, DOI 10.1177/0898756416640956	35	0	0	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	AUG	2021	10	15							3432	10.3390/jcm10153432	http://dx.doi.org/10.3390/jcm10153432			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TV9NF	34362215	Green Published, gold			2022-09-04	WOS:000682040000001
J	Diaz-Cardenas, C; Bernal, LF; Caro-Quintero, A; Lopez, G; Alzate, JD; Gonzalez, LN; Restrepo, S; Shapiro, N; Woyke, T; Kyrpides, NC; Baena, S				Diaz-Cardenas, Carolina; Fernanda Bernal, Luisa; Caro-Quintero, Alejandro; Lopez, Gina; David Alzate, J.; Gonzalez, Laura N.; Restrepo, Silvia; Shapiro, Nicole; Woyke, Tanja; Kyrpides, Nikos C.; Baena, Sandra			Draft genome and description of Consotaella salsifontis gen. nov sp nov., a halophilic, free-living, nitrogen-fixing alphaproteobacterium isolated from an ancient terrestrial saline spring	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article						Saline Spring; Colombian Andes; phylogeny; taxonomy; Alphaproteobacterium	BACTERIUM; ALIGNMENT; DATABASE; ACID; ROOT	A free-living, nitrogen-fixing, mesophilic and facultative aerobe, designated strain USBA 369(T), was isolated from a terrestrial saline spring of the Colombian Andes. The non-sporulating rods (1.5 x 0.8 mu m) with rounded ends stained Gram-negative and were motile by means of lophotrichous flagella. The strain grew optimally at 30 degrees C, at pH 6.9-7.5 and with 1.5% (w/v) NaCl. The major fatty acids detected were C-18 : 1 omega 7c and C-19 : 0 cyclo omega 8c, and the respiratory lipoquinone ubiquinone 10 (Q-10) was present. The genome consisted of 4.65 Mb with a DNA G+C content of 64.3 mol%. A total of 4371 genes were predicted and, of those, 4300 were protein coding genes and 71 were RNA genes. Phylogenetic analysis based on 16S rRNA gene sequence indicated that strain USBA 369(T) formed a different lineage within the class Alphaproteobacteria, order Rhizobiales, and DNA homology studies with the most closely related genera, Aurantimonas, Aureimonas and Rhizobium (95% 16S rRNA gene sequence similarity), showed values of <15 %. The phylogenomic analysis provided evidence for clear phylogenetic divergence between strain USBA 369(T) and the closely related genera. On the basis of the phenotypic, chemotaxonomic and phylogenomic evidence, strain USBA 369(T) is considered to represent a novel genus and a novel species for which the name Consotaella salsifontis gen. nov., sp. nov. is proposed. The type strain is USBA 369(T) (=KCTC 22549(T)=CMPUJ U369(T)).	[Diaz-Cardenas, Carolina; Fernanda Bernal, Luisa; Lopez, Gina; Baena, Sandra] Pontificia Univ Javeriana, Unidad Saneamiento & Biotecnol Ambiental, Dept Biol, POB 56710, Bogota, Colombia; [Caro-Quintero, Alejandro] Corpo Corp Colombiana Invest Agr, Tibaitata, Colombia; [David Alzate, J.; Gonzalez, Laura N.; Restrepo, Silvia] Univ Los Andes, Biol Sci Dept, Cra 1 18A-12, Bogota, Colombia; [Shapiro, Nicole; Woyke, Tanja; Kyrpides, Nikos C.] Dept Energy Joint Genome Inst, Genome Biol Program, Walnut Creek, CA USA		Baena, S (corresponding author), Pontificia Univ Javeriana, Unidad Saneamiento & Biotecnol Ambiental, Dept Biol, POB 56710, Bogota, Colombia.	baena@javeriana.edu.co	López, Gina/AAF-8171-2019; Kyrpides, Nikos C./A-6305-2014; Baena, Sandra/AAF-8165-2019	Kyrpides, Nikos C./0000-0002-6131-0462; Lopez Ramirez, Gina/0000-0002-4210-089X; Gonzalez Garcia, Laura Natalia/0000-0002-4079-8956; Baena, Sandra/0000-0001-5377-9079; Caro-Quintero, Alejandro/0000-0001-8807-671X	Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion); Universidad de los Andes (Colombia); Pontificia Universidad Javeriana (Colombia); MADS [56, 2013]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de los Andes (Colombia); Pontificia Universidad Javeriana (Colombia); MADS; Office of Science of the US Department of Energy(United States Department of Energy (DOE))	The work was supported by a grant from Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion), Universidad de los Andes (Colombia) and Pontificia Universidad Javeriana (Colombia). This was carried out under MADS Research Permit Resolution no. 8 of 31 October 2006, as amended by Resolution no. 168 (02-04-2009] and MADS contract no. 56, 2013 for Access to Genetic Resources. The sequencing genome work was conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDANI VLD, 1980, SOIL BIOL BIOCHEM, V12, P433, DOI 10.1016/0038-0717(80)90021-8; Bauer JS, 1966, AM J CLIN PATHOL, V45, P493; Bushnell B., 2016, BBTOOLS SOFTWARE PAC; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Cho JC, 2003, INT J SYST EVOL MICR, V53, P1853, DOI 10.1099/ijs.0.02644-0; Cho YR, 2015, INT J SYST EVOL MICR, V65, P3564, DOI 10.1099/ijsem.0.000453; Chung EJ, 2016, INT J SYST EVOL MICR, V66, P3917, DOI 10.1099/ijsem.0.001288; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P1437, DOI 10.1099/ijs.0.010926-0; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P850, DOI 10.1099/ijs.0.010835-0; Díaz-Cárdenas Carolina, 2015, Rev. acad. colomb. cienc. exact. fis. nat., V39, P358, DOI 10.18257/raccefyn.199; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garrity G., 2005, BERGEYS MANUAL SYSTE, V2; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gómez-Gómez Javier Antonio, 2015, Univ. Sci., V20, P369, DOI 10.11144/Javeriana.SC20-3.eobp; HUNTEMANN M, 2015, STAND GENOMIC SCI, V0010; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; IMHOFFSTUCKLE D, 1983, ARCH MICROBIOL, V136, P194, DOI 10.1007/BF00409843; JUKES T H, 1969, P21; Jurado V, 2006, INT J SYST EVOL MICR, V56, P2583, DOI 10.1099/ijs.0.64397-0; Khalid R, 2015, ANTON LEEUW INT J G, V107, P281, DOI 10.1007/s10482-014-0326-x; Kim MS, 2008, INT J SYST EVOL MICR, V58, P1142, DOI 10.1099/ijs.0.65421-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Konstantinidis KT, 2009, P NATL ACAD SCI USA, V106, P15909, DOI 10.1073/pnas.0902000106; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liang J, 2015, INT J SYST EVOL MICR, V65, P1127, DOI 10.1099/ijs.0.000067; Liu BB, 2016, INT J SYST EVOL MICR, V66, P4112, DOI 10.1099/ijsem.0.001320; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; PATEL BKC, 1985, ARCH MICROBIOL, V141, P63, DOI 10.1007/BF00446741; Rathsack K, 2011, INT J SYST EVOL MICR, V61, P2722, DOI 10.1099/ijs.0.027029-0; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Rivas R, 2005, INT J SYST EVOL MICR, V55, P955, DOI 10.1099/ijs.0.63438-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Xu L, 2013, ANTON LEEUW INT J G, V103, P559, DOI 10.1007/s10482-012-9840-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	3	3	0	6	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	OCT	2017	67	10					3744	3751		10.1099/ijsem.0.002185	http://dx.doi.org/10.1099/ijsem.0.002185			8	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	FK4RR	28875905	Bronze			2022-09-04	WOS:000413484800009
J	Acaz-Fonseca, E; Avila-Rodriguez, M; Garcia-Segura, LM; Barreto, GE				Acaz-Fonseca, Estefanfa; Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Barreto, George E.			Regulation of astroglia by gonadal steroid hormones under physiological and pathological conditions	PROGRESS IN NEUROBIOLOGY			English	Review						Estradiol; Progesterone; Reactive astrocytes; Sex differences; Testosterone; Steroid	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR MODULATORS; CENTRAL-NERVOUS-SYSTEM; SEX-RELATED DIFFERENCES; INDUCED UP-REGULATION; SPINAL-CORD-INJURY; MICROVASCULAR ENDOTHELIAL-CELLS; INTRACELLULAR CALCIUM-RELEASE; GLIAL GLUTAMATE TRANSPORTERS	In the last years there has been a considerable advance in the knowledge on the regulation of astrocytes by sex steroids under physiological and pathological conditions. By the activation of a variety of nuclear and membrane receptors, sex steroid hormones regulate the functions of astrocytes and their communication with other cell types in the central nervous system. Under physiological conditions astrocytes participate in the neuroendocrine and behavioral actions of gonadal steroids, as well as in the hormonal control of brain tissue homeostasis. Under pathological conditions astrocytes mediate, at least partially, the neuroprotective effects of gonadal steroid hormones; given that sex steroids modulate reactive astrogliosis and reduce the release of pro-inflammatory molecules by these cells. Given the side effects that sex steroids may have when administered systemically, a number of synthetic agonists of the receptors for gonadal steroid hormones in the nervous system have been developed, and may be considered for clinical use after brain injury as potential enhancers of the neuroprotective astrocytic functions. (C) 2016 Elsevier Ltd. All rights reserved.	[Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Acaz-Fonseca, Estefanfa; Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barreto, George E.] Univ Cient Sur, Lima, Peru		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Acaz-Fonseca, E (corresponding author), CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.; Barreto, GE (corresponding author), Univ Cient Sur, Lima, Peru.	estefania.acaz@cajal.csic.es; gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Acaz-Fonseca, Estefania/S-5884-2016; Barreto, George E./B-5747-2014	Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Ministerio de Economia y Competividad, Spain [BFU2014-51836-C2-1-R]; Precipita-FECYT crowfunding program	Ministerio de Economia y Competividad, Spain; Precipita-FECYT crowfunding program	The authors acknowledge support from Ministerio de Economia y Competividad, Spain (BFU2014-51836-C2-1-R) and from Precipita-FECYT crowfunding program.	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Acarin L, 1999, NEUROSCIENCE, V92, P827, DOI 10.1016/S0306-4522(99)00022-6; Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Agapova OA, 2006, EXP EYE RES, V82, P1053, DOI 10.1016/j.exer.2005.10.021; Airas L, 2015, ACTA NEUROL SCAND, V132, P62, DOI 10.1111/ane.12433; Almey A, 2012, ENDOCRINOLOGY, V153, P5373, DOI 10.1210/en.2012-1458; ALTMAN J, 1978, J COMP NEUROL, V182, P995, DOI 10.1002/cne.901820513; Amateau SK, 2002, J NEUROENDOCRINOL, V14, P904, DOI 10.1046/j.1365-2826.2002.00858.x; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Angelova PR, 2015, J NEUROSCI, V35, P10460, DOI 10.1523/JNEUROSCI.0045-15.2015; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Argente-Arizon P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00042; Arias C, 2009, HORM BEHAV, V55, P257, DOI 10.1016/j.yhbeh.2008.10.016; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Arnold AP, 2013, DEV DYNAM, V242, P371, DOI 10.1002/dvdy.23936; Arnold S, 2008, J MOL ENDOCRINOL, V41, P289, DOI 10.1677/JME-08-0085; Astiz M, 2014, NEUROTOX RES, V25, P271, DOI 10.1007/s12640-013-9417-0; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Munoz E, 2014, AGEING RES REV, V18, P29, DOI 10.1016/j.arr.2014.07.004; Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Baroncini M, 2007, J NEUROENDOCRINOL, V19, P691, DOI 10.1111/j.1365-2826.2007.01576.x; Baroncini M, 2010, NEUROIMAGE, V50, P428, DOI 10.1016/j.neuroimage.2009.11.074; Barouk S, 2011, ENDOCRINOLOGY, V152, P1745, DOI 10.1210/en.2010-1290; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Belenichev IF, 2012, NEUROCHEM J+, V6, P202, DOI 10.1134/S181971241203004X; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; BEYER C, 1990, GLIA, V3, P55, DOI 10.1002/glia.440030108; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Biewenga E, 2005, NEUROSCI LETT, V373, P179, DOI 10.1016/j.neulet.2004.09.067; Birey F, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.046; Blain JF, 2006, NEUROBIOL DIS, V21, P505, DOI 10.1016/j.nbd.2005.08.010; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Boulware MI, 2013, J NEUROSCI, V33, P15184, DOI 10.1523/JNEUROSCI.1716-13.2013; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Boyalla SS, 2011, J NEUROSCI RES, V89, P2068, DOI 10.1002/jnr.22669; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruce-Keller AJ, 2001, J NEUROCHEM, V78, P1315, DOI 10.1046/j.1471-4159.2001.00511.x; Burda JE, 2015, EXP NEUROL; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Byne W, 2008, SCHIZOPHR RES, V98, P118, DOI 10.1016/j.schres.2007.09.034; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Cardona-Gomez GP, 2000, NEUROSCIENCE, V99, P751, DOI 10.1016/S0306-4522(00)00228-1; Carswell HVO, 2005, J STEROID BIOCHEM, V96, P89, DOI 10.1016/j.jsbmb.2005.02.016; Caruso D, 2010, J NEUROENDOCRINOL, V22, P1137, DOI 10.1111/j.1365-2826.2010.02064.x; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Castello-Ruiz M, 2014, NEUROSCI LETT, V575, P53, DOI 10.1016/j.neulet.2014.05.024; Catalano MG, 2000, INT J CANCER, V86, P325, DOI 10.1002/(SICI)1097-0215(20000501)86:3<325::AID-IJC4>3.0.CO;2-G; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chai RC, 2013, GLIA, V61, P1748, DOI 10.1002/glia.22555; Charlier TD, 2013, J EXP NEUROSCI, V7, P31, DOI 10.4137/JEN.S11268; Chen C, 2014, ENDOCRINOLOGY, V155, P2976, DOI 10.1210/en.2013-1844; Chen LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084320; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; CHOWEN JA, 1995, NEUROSCIENCE, V69, P519, DOI 10.1016/0306-4522(95)00250-M; Christensen A, 2011, J NEUROSCI, V31, P17583, DOI 10.1523/JNEUROSCI.3030-11.2011; Ciriza I, 2004, J NEUROBIOL, V61, P209, DOI 10.1002/neu.20043; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Clasadonte J., 2012, ASTROCYTES EPILEPSY; Clasadonte J, 2013, P NATL ACAD SCI USA, V110, P17540, DOI 10.1073/pnas.1311967110; Clasadonte Jerome, 2011, Front Endocrinol (Lausanne), V2, P91, DOI 10.3389/fendo.2011.00091; Coers S, 2002, METAB BRAIN DIS, V17, P55, DOI 10.1023/A:1015415226799; COLLADO P, 1995, NEUROSCI LETT, V184, P86, DOI 10.1016/0304-3940(94)11175-I; Conejo NM, 2005, J NEUROSCI RES, V79, P488, DOI 10.1002/jnr.20372; Cordeau P, 2008, STROKE, V39, P935, DOI 10.1161/STROKEAHA.107.501460; Cornil CA, 2013, J NEUROENDOCRINOL, V25, P1070, DOI 10.1111/jne.12062; Correale J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00180; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; D'Ambrosio R, 2002, J NEUROPHYSIOL, V87, P87, DOI 10.1152/jn.00240.2001; Dainese L, 2013, GENE, V515, P376, DOI 10.1016/j.gene.2012.12.065; Day JR, 1998, EXP NEUROL, V151, P343, DOI 10.1006/exnr.1998.6801; DAY JR, 1990, MOL ENDOCRINOL, V4, P1995, DOI 10.1210/mend-4-12-1995; DAY JR, 1993, NEUROSCIENCE, V55, P435, DOI 10.1016/0306-4522(93)90512-E; de Aguiar RB, 2008, BIOGERONTOLOGY, V9, P285, DOI 10.1007/s10522-008-9137-7; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2011, IUBMB LIFE, V63, P140, DOI 10.1002/iub.426; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Dewing P, 2007, J NEUROSCI, V27, P9294, DOI 10.1523/JNEUROSCI.0592-07.2007; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dittrich F, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0128-0; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dluzen DE, 2001, J NEUROENDOCRINOL, V13, P618, DOI 10.1046/j.1365-2826.2001.00675.x; do Rego J. L., 2015, GEN COMP ENDOCR; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; DonCarlos LL, 2006, NEUROSCIENCE, V138, P801, DOI 10.1016/j.neuroscience.2005.06.020; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Durfinova M, 2014, NEUROENDOCRINOL LETT, V35, P666; Dziedzic B, 2003, J NEUROSCI, V23, P915; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Emamian S, 2010, BEHAV BRAIN RES, V208, P30, DOI 10.1016/j.bbr.2009.11.004; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; Saraceno GE, 2010, EXP NEUROL, V223, P615, DOI 10.1016/j.expneurol.2010.02.010; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fang YT, 2016, ARCH TOXICOL, V90, P333, DOI 10.1007/s00204-014-1425-1; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Fester L, 2014, BRAIN RES; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Finley SK, 1999, J NEUROBIOL, V40, P446; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Gabryel B, 2014, CELL BIOL INT, V38, P1086, DOI 10.1002/cbin.10299; Gao TS, 1998, MOL ENDOCRINOL, V12, P654, DOI 10.1210/me.12.5.654; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 2008, J NEUROENDOCRINOL, V20, P705, DOI 10.1111/j.1365-2826.2008.01713.x; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Garcia-Segura LM, 2008, REPRODUCTION, V135, P419, DOI 10.1530/REP-07-0540; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; GARCIASEGURA LM, 1995, J STEROID BIOCHEM, V53, P293, DOI 10.1016/0960-0760(95)00066-9; GARCIASEGURA LM, 1994, PROG NEUROBIOL, V44, P279, DOI 10.1016/0301-0082(94)90042-6; GARCIASEGURA LM, 1994, GLIA, V10, P59, DOI 10.1002/glia.440100108; GarciaSegura LM, 1996, FRONT NEUROENDOCRIN, V17, P180, DOI 10.1006/frne.1996.0005; GARCIASEGURA LM, 1988, BRAIN RES, V456, P357, DOI 10.1016/0006-8993(88)90239-9; Gerics B, 2001, ACTA BIOL HUNG, V52, P29, DOI 10.1556/ABiol.52.2001.1.4; Ghorbanpoor S, 2014, ENDOCRINOLOGY, V155, P4341, DOI 10.1210/en.2014-1158; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gibson CL, 2013, J CEREBR BLOOD F MET, V33, P1355, DOI 10.1038/jcbfm.2013.102; Ginsberg SD, 1996, J NEUROCHEM, V67, P1208; Giraud SN, 2010, P NATL ACAD SCI USA, V107, P8416, DOI 10.1073/pnas.0910627107; GORCZYNSKA E, 1995, ENDOCRINOLOGY, V136, P2052, DOI 10.1210/en.136.5.2052; Grassi D, 2013, ENDOCRINOLOGY, V154, P2092, DOI 10.1210/en.2012-2137; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Gu F, 2003, J NEUROSCI RES, V72, P709, DOI 10.1002/jnr.10603; Gu Q, 1999, ENDOCRINOLOGY, V140, P660, DOI 10.1210/en.140.2.660; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Gulinello M, 2005, BRAIN RES, V1045, P107, DOI 10.1016/j.brainres.2005.03.021; Guo JB, 2012, FREE RADICAL BIO MED, V52, P2151, DOI 10.1016/j.freeradbiomed.2012.03.005; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Habib P, 2014, NEUROENDOCRINOLOGY, V99, P156, DOI 10.1159/000362279; Habib P, 2014, J MOL NEUROSCI, V52, P277, DOI 10.1007/s12031-013-0137-y; Habib P, 2013, J STEROID BIOCHEM, V138, P195, DOI 10.1016/j.jsbmb.2013.06.003; Had-Aissouni L, 2012, AMINO ACIDS, V42, P181, DOI 10.1007/s00726-011-0863-9; Hajos F, 1999, NEUROREPORT, V10, P2229; Hajos F, 2000, BRAIN RES, V862, P43, DOI 10.1016/S0006-8993(00)02065-5; Hakim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086178; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hernangomez M, 2014, CURR PHARM DESIGN, V20, P4707; Herrera JL, 2011, J NEUROCHEM, V116, P820, DOI 10.1111/j.1471-4159.2010.06987.x; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Hirahara Y, 2013, NEUROSCIENCE, V235, P187, DOI 10.1016/j.neuroscience.2012.12.070; HORSTMANN E, 1954, Z ZELLFORSCH MIK ANA, V39, P588, DOI 10.1007/BF00334758; Hosli E, 2001, INT J DEV NEUROSCI, V19, P11, DOI 10.1016/S0736-5748(00)00082-4; Hsu C, 2001, DEV NEUROSCI-BASEL, V23, P399, DOI 10.1159/000048726; HUHTANIEMI I, 1994, EUR J ENDOCRINOL, V130, P25, DOI 10.1530/eje.0.1300025; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; Imura T, 2003, J NEUROSCI, V23, P2824; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Ismailoglu O, 2010, J CLIN NEUROSCI, V17, P1306, DOI 10.1016/j.jocn.2010.01.049; JAKAB RL, 1993, J STEROID BIOCHEM, V44, P481, DOI 10.1016/0960-0760(93)90253-S; Janda E, 2015, AUTOPHAGY, V11, P1063, DOI 10.1080/15548627.2015.1058683; JENSEN EV, 1962, PERSPECT BIOL MED, V6, P47; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jha MK, 2013, BBA-PROTEINS PROTEOM, V1834, P2418, DOI 10.1016/j.bbapap.2012.12.006; Jogia J, 2012, BIPOLAR DISORD, V14, P461, DOI 10.1111/j.1399-5618.2012.01014.x; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Johansson EM, 2012, GLIA, V60, P1815, DOI 10.1002/glia.22399; Johnson RT, 2008, J COMP NEUROL, V511, P599, DOI 10.1002/cne.21859; Johnson RT, 2012, J COMP NEUROL, V520, P2531, DOI 10.1002/cne.23061; Jones KJ, 1997, NEUROCHEM RES, V22, P1359, DOI 10.1023/A:1022019106417; Jones KJ, 1999, J NEUROSCI RES, V57, P817, DOI 10.1002/(SICI)1097-4547(19990915)57:6<817::AID-JNR6>3.3.CO;2-H; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; JUNGTESTAS I, 1991, EXP CELL RES, V193, P12, DOI 10.1016/0014-4827(91)90532-Y; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Juraska JM, 2013, HORM BEHAV, V64, P203, DOI 10.1016/j.yhbeh.2013.05.010; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khan MM, 2015, J STEROID BIOCHEM, V146, P38, DOI 10.1016/j.jsbmb.2014.05.001; Kim HN, 2012, NEUROCHEM INT, V60, P125, DOI 10.1016/j.neuint.2011.11.015; Kim J, 2013, NEUROBIOL DIS, V59, P80, DOI 10.1016/j.nbd.2013.07.011; Kipp M, 2007, J NEUROENDOCRINOL, V19, P819, DOI 10.1111/j.1365-2826.2007.01588.x; Kiyokage E, 2014, J CHEM NEUROANAT, V59-60, P8, DOI 10.1016/j.jchemneu.2014.04.002; KLINTSOVA A, 1995, BRAIN RES, V690, P269, DOI 10.1016/0006-8993(95)00642-4; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; KOHAMA SG, 1995, NEUROSCI LETT, V183, P164, DOI 10.1016/0304-3940(94)11141-5; Korenic A, 2015, NEUROSCI LETT, V595, P128, DOI 10.1016/j.neulet.2015.04.020; Krentzel AA, 2015, FRONT NEUROENDOCRIN, V38, P37, DOI 10.1016/j.yfrne.2015.01.001; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; KUJAWA KA, 1991, J NEUROSCI, V11, P3898; Kuo John, 2010, Biol Sex Differ, V1, P7, DOI 10.1186/2042-6410-1-7; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Kuo YC, 2011, COLLOID SURFACE B, V86, P225, DOI 10.1016/j.colsurfb.2011.04.005; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Lacroix-Fralish ML, 2006, NEURON GLIA BIOL, V2, P227, DOI 10.1017/S1740925X07000385; Lagrange AH, 1997, MOL PHARMACOL, V51, P605, DOI 10.1124/mol.51.4.605; Lam TT, 2003, EUR J NEUROSCI, V17, P1997, DOI 10.1046/j.1460-9568.2003.02637.x; Lam TT, 2003, NEUROSCIENCE, V116, P491, DOI 10.1016/S0306-4522(02)00730-3; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Langlet F, 2014, J NEUROENDOCRINOL, V26, P753, DOI 10.1111/jne.12191; Langlet F, 2013, J COMP NEUROL, V521, P3389, DOI 10.1002/cne.23355; Lavaque E, 2006, NEUROSCIENCE, V138, P741, DOI 10.1016/j.neuroscience.2005.05.060; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee E, 2013, NEUROTOX RES, V23, P124, DOI 10.1007/s12640-012-9347-2; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lei DL, 2003, NEUROSCIENCE, V121, P659, DOI 10.1016/S0306-4522(03)00245-8; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; Lewis DK, 2008, J NEUROIMMUNOL, V195, P47, DOI 10.1016/j.jneuroim.2008.01.006; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Liu MY, 2008, J NEUROSCI METH, V171, P214, DOI 10.1016/j.jneumeth.2008.03.002; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Liu Z., 2015, PROG NEUROBIOL; Llorente R, 2008, DEV NEUROBIOL, V68, P1334, DOI 10.1002/dneu.20666; Llorente R, 2009, INT J DEV NEUROSCI, V27, P233, DOI 10.1016/j.ijdevneu.2009.01.002; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lopez-Gallardo M, 2012, NEUROSCIENCE, V204, P90, DOI 10.1016/j.neuroscience.2011.09.063; Lopez-Hidalgo M, 2014, CURR OPIN NEUROBIOL, V24, P176, DOI 10.1016/j.conb.2013.11.001; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; Lorenz B, 2005, J COMP NEUROL, V492, P456, DOI 10.1002/cne.20763; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Herrera JL, 2011, STEROIDS, V76, P840, DOI 10.1016/j.steroids.2011.02.014; LUQUIN S, 1993, J NEUROBIOL, V24, P913, DOI 10.1002/neu.480240705; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Ma YL, 2014, BRAIN RES, V1569, P1, DOI 10.1016/j.brainres.2014.04.036; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; Martin R, 2015, SCIENCE, V349, P730, DOI 10.1126/science.aaa7945; Martinez FG, 2006, BRAIN RES, V1108, P117, DOI 10.1016/j.brainres.2006.06.014; Martini L, 1996, CELL MOL NEUROBIOL, V16, P271, DOI 10.1007/BF02088095; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCarthy MM, 2002, BIOL REPROD, V67, P691, DOI 10.1095/biolreprod.102.003251; Mecha M, 2015, BRAIN BEHAV IMMUN, V49, P233, DOI 10.1016/j.bbi.2015.06.002; Medina JM, 1999, ADV EXP MED BIOL, V468, P361; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi RC, 1999, J NEUROSCI RES, V56, P349, DOI 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H; Melcangi RC, 2001, HORM BEHAV, V40, P210, DOI 10.1006/hbeh.2001.1678; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Melcangi RC, 2010, HORM BEHAV, V57, P2, DOI 10.1016/j.yhbeh.2009.06.001; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Meyer M, 2013, J NEUROENDOCRINOL, V25, P235, DOI 10.1111/jne.12004; Meyer M, 2010, CELL MOL NEUROBIOL, V30, P123, DOI 10.1007/s10571-009-9437-8; Micevych P., 2003, LUTEINIZING HORMONE; Micevych P, 2008, ENDOCRINOLOGY, V149, P2739, DOI 10.1210/en.2008-0011; Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568; Micevych PE, 2007, ENDOCRINOLOGY, V148, P782, DOI 10.1210/en.2006-0774; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Mickley KR, 2004, NEUROENDOCRINOLOGY, V79, P305, DOI 10.1159/000079710; Miller VM, 2010, INT J DEV NEUROSCI, V28, P553, DOI 10.1016/j.ijdevneu.2010.07.237; Milner TA, 2001, J COMP NEUROL, V429, P355; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Mong JA, 1996, HORM BEHAV, V30, P553, DOI 10.1006/hbeh.1996.0058; Mong JA, 2002, DEV BRAIN RES, V139, P151, DOI 10.1016/S0165-3806(02)00541-2; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10288, 10.1002/glia.10238]; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Morizawa Y, 2012, CELL MOL NEUROBIOL, V32, P953, DOI 10.1007/s10571-012-9829-z; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Nathan BP, 2004, ENDOCRINOLOGY, V145, P3065, DOI 10.1210/en.2003-1707; Nevzati Edin, 2015, Acta Neurochir Suppl, V120, P141, DOI 10.1007/978-3-319-04981-6_24; Nilsen J, 2002, NEUROREPORT, V13, P825, DOI 10.1097/00001756-200205070-00018; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A., 2015, BRAIN RES; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nogueira MI, 2009, NEUROCHEM RES, V34, P1355, DOI 10.1007/s11064-009-9915-x; Nwosu I, 2008, NEUROSCI LETT, V441, P282, DOI 10.1016/j.neulet.2008.05.117; O'Connell K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-146; O'Neill K, 2004, EXP NEUROL, V188, P268, DOI 10.1016/j.expneurol.2004.01.014; O'Shaughnessy PJ, 2006, INT J ANDROL, V29, P90, DOI 10.1111/j.1365-2605.2005.00555.x; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; Ojeda SR, 2008, J NEUROENDOCRINOL, V20, P732, DOI 10.1111/j.1365-2826.2008.01712.x; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pan Y, 2005, BRAIN RES, V1043, P195, DOI 10.1016/j.brainres.2005.02.078; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; PARDUCZ A, 1993, NEUROSCIENCE, V53, P395, DOI 10.1016/0306-4522(93)90203-R; Parducz A, 2002, EUR J NEUROSCI, V16, P665, DOI 10.1046/j.1460-9568.2002.02127.x; Parkash J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7385; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PATEL AJ, 1989, NEUROCHEM INT, V15, P239, DOI 10.1016/0197-0186(89)90107-1; Patel R, 2013, BRAIN PATHOL, V23, P462, DOI 10.1111/bpa.12029; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Pawlak J, 2005, GLIA, V50, P270, DOI 10.1002/glia.20162; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7; Pekny M., 2015, BIOCH BIOPHYS ACTA M; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Penfield W, 1924, BRAIN, V47, P430, DOI 10.1093/brain/47.4.430; Peng L, 2014, CURR NEUROPHARMACOL, V12, P303, DOI 10.2174/1570159X12999140829152550; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Pereira GJS, 2013, NEUROCHEM RES, V38, P2418, DOI 10.1007/s11064-013-1154-5; PEREZ J, 1993, BRAIN RES, V608, P38, DOI 10.1016/0006-8993(93)90771-E; Peterson RS, 2007, DEV NEUROBIOL, V67, P1867, DOI 10.1002/dneu.20548; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pietranera L, 2014, J NEUROENDOCRINOL, V26, P310, DOI 10.1111/jne.12151; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Platania P, 2005, NEUROBIOL DIS, V20, P461, DOI 10.1016/j.nbd.2005.03.025; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Prange-Kiel J, 2004, EUR J NEUROSCI, V19, P309, DOI 10.1111/j.0953-816X.2003.03124.x; Prevot V, 2010, J NEUROENDOCRINOL, V22, P639, DOI 10.1111/j.1365-2826.2010.02033.x; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; PUY L, 1995, J STEROID BIOCHEM, V55, P197, DOI 10.1016/0960-0760(95)00165-V; Qiu J, 2003, J NEUROSCI, V23, P9529; Quesada A, 2007, J COMP NEUROL, V503, P198, DOI 10.1002/cne.21358; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rage F, 1997, J NEUROSCI, V17, P9145; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rasia AA, 2002, BRAIN RES BULL, V58, P67, DOI 10.1016/S0361-9230(02)00758-X; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rhodes ME, 2004, EPILEPSIA, V45, P1531, DOI 10.1111/j.0013-9580.2004.16504.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rubio N, 2014, J NEUROVIROL, V20, P485, DOI 10.1007/s13365-014-0273-3; Rubio N, 2011, IMMUNOLOGY, V133, P360, DOI 10.1111/j.1365-2567.2011.03448.x; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Ruiz-Palmero I, 2013, MOL CELL ENDOCRINOL, V372, P105, DOI 10.1016/j.mce.2013.03.018; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Rutkowsky JM, 2011, AM J PHYSIOL-CELL PH, V301, pC204, DOI 10.1152/ajpcell.00399.2010; Rutzel H., 1980, CELL TISSUE RES, V211; Sakakibara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079437; Sakuma S, 2009, NEUROPATHOLOGY, V29, P55, DOI 10.1111/j.1440-1789.2008.00946.x; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Savic I, 2014, EXP NEUROL, V259, P38, DOI 10.1016/j.expneurol.2014.04.009; Schillaci MA, 2005, TROP MED INT HEALTH, V10, P1305, DOI 10.1111/j.1365-3156.2005.01524.x; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Seredynski AL, 2015, J NEUROSCI, V35, P13110, DOI 10.1523/JNEUROSCI.2056-15.2015; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; Sinchak K, 2003, DEV NEUROSCI-BASEL, V25, P343, DOI 10.1159/000073511; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Sortino MA, 2004, ENDOCRINOLOGY, V145, P5080, DOI 10.1210/en.2004-0973; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; STALLCUP WB, 1983, COLD SPRING HARB SYM, V48, P761, DOI 10.1101/SQB.1983.048.01.078; Stanic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090451; Steindler DA, 2003, GLIA, V43, P62, DOI 10.1002/glia.10242; STEINSAPIR J, 1991, BIOCHEM BIOPH RES CO, V179, P90, DOI 10.1016/0006-291X(91)91338-D; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Stone DJ, 1998, ENDOCRINOLOGY, V139, P3202, DOI 10.1210/en.139.7.3202; Storer PD, 2003, EXP NEUROL, V184, P939, DOI 10.1016/S0014-4886(03)00339-X; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; SUAREZ I, 1991, J ANAT, V178, P79; SUAREZ I, 1992, GLIA, V5, P10, DOI 10.1002/glia.440050103; Suuronen T, 2005, INFLAMM RES, V54, P194, DOI 10.1007/s00011-005-1343-z; Swamydas M, 2009, J NEUROSCI RES, V87, P3306, DOI 10.1002/jnr.21943; Tabatadze N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100628; Tabori NE, 2005, NEUROSCIENCE, V130, P151, DOI 10.1016/j.neuroscience.2004.08.048; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tamrakar P, 2015, NEUROSCIENCE, V292, P34, DOI 10.1016/j.neuroscience.2015.02.019; Tamrakar P, 2015, BRAIN RES BULL, V110, P47, DOI 10.1016/j.brainresbull.2014.12.002; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; Theodosis DT, 2006, AM J PHYSIOL-REG I, V290, pR1175, DOI 10.1152/ajpregu.00755.2005; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas SC, 2015, J NUTR HEALTH AGING, V19, P58, DOI 10.1007/s12603-014-0511-7; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; TOFT D, 1966, P NATL ACAD SCI USA, V55, P1574, DOI 10.1073/pnas.55.6.1574; Tokuhara D, 2005, ACTA NEUROPATHOL, V110, P411, DOI 10.1007/s00401-005-1071-z; Tomas-Camardiel M, 2005, J NEUROSCI RES, V80, P235, DOI 10.1002/jnr.20443; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; TORP R, 1995, EXP BRAIN RES, V103, P51; TORRESALEMAN I, 1992, GLIA, V6, P180, DOI 10.1002/glia.440060305; Tournell CE, 2006, NEUROSCIENCE, V141, P1327, DOI 10.1016/j.neuroscience.2006.05.004; TRANQUE PA, 1987, BRAIN RES, V406, P348, DOI 10.1016/0006-8993(87)90805-5; Vaknin-Dembinsky A, 2014, J AUTOIMMUN, V54, P93, DOI 10.1016/j.jaut.2014.05.004; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vest RS, 2013, HORM BEHAV, V63, P301, DOI 10.1016/j.yhbeh.2012.04.006; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; Wang HJ, 2012, CELL TISSUE RES, V350, P261, DOI 10.1007/s00441-012-1478-5; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Waters EM, 2008, J COMP NEUROL, V511, P34, DOI 10.1002/cne.21826; Webb P, 2000, J BIOL CHEM, V275, P37552, DOI 10.1074/jbc.M007435200; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655; WILSON SS, 1981, DEV BIOL, V83, P146, DOI 10.1016/S0012-1606(81)80017-6; WITKIN JW, 1991, ENDOCRINOLOGY, V129, P1083, DOI 10.1210/endo-129-2-1083; Wong AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120530; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu X, 2013, J MOL NEUROSCI, V49, P499, DOI 10.1007/s12031-012-9875-5; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yague JG, 2004, NEUROSCI LETT, V368, P279, DOI 10.1016/j.neulet.2004.07.010; Yague JG, 2008, BRAIN RES, V1209, P115, DOI 10.1016/j.brainres.2008.02.061; Yague JG, 2010, BRAIN RES, V1315, P41, DOI 10.1016/j.brainres.2009.09.111; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang L, 2002, MOL BRAIN RES, V103, P1; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980; Zuo W, 2013, EUR J PHARMACOL, V711, P73, DOI 10.1016/j.ejphar.2013.04.024; Zupanc GKH, 2014, J NEUROPHYSIOL, V111, P1646, DOI 10.1152/jn.00750.2013; Zwain IH, 2002, NEUROENDOCRINOLOGY, V75, P375, DOI 10.1159/000059434; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	501	74	75	0	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-0082	1873-5118		PROG NEUROBIOL	Prog. Neurobiol.	SEP	2016	144				SI		5	26		10.1016/j.pneurobio.2016.06.002	http://dx.doi.org/10.1016/j.pneurobio.2016.06.002			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ1ME	27283249				2022-09-04	WOS:000385601700002
J	Ripoll, JD; Mejia, SM; Mills, MJL; Villa, AL				Ripoll, Juan D.; Mejia, Sol M.; Mills, Matthew J. L.; Villa, Aida L.			Understanding the azeotropic diethyl carbonate-water mixture by structural and energetic characterization of DEC(H2O)(n) heteroclusters	JOURNAL OF MOLECULAR MODELING			English	Article						Oxygenated fuel-water azeotrope; Non-covalent interaction; Stochastic exploration; Electron density topology; Cooperative effect	CENTER-DOT-O; AB-INITIO; MOLECULAR-INTERACTIONS; DIMETHYL CARBONATE; BINDING-ENERGIES; MATRIX-ISOLATION; ETHANOL; CLUSTERS; CONFORMATIONS; COMPLEXES	Diethyl carbonate (DEC) is an oxygenated fuel additive. During its synthesis through a promising green process, a DEC-water azeotrope is formed, which decreases DEC production efficiency in the gas phase. Molecular information about this system is scarce but could be of benefit in understanding (and potentially improving) the synthetic process. Therefore, we report a detailed computational study of the conformers of DEC, and their microsolvation with up to four water molecules, with the goal of understanding the observed 1:3 DEC:H2O molar ratio. The most stable DEC conformers (with mutual energy differences < 1.5 kcal mol(-1)) contribute to the energetic and structural properties of the complexes. An exhaustive stochastic exploration of each potential energy surface of DEC-(H2O)(n), (where n=1, 2, 3, 4) heteroclusters discovered 3, 8, 7, and 4 heterodimers, heterotrimers, heterotetramers, and heteropentamers, respectively, at the MP2/6-311++G(d,p) level of theory. DEC conformers and energies of the most stable structures at each heterocluster size were refined using CCSD(T)/6-311++G(d,p). Energy decomposition, electron density topology, and cooperative effects analyses were carried out to determine the relationship between the geometrical features of the heteroclusters and the non-covalent interaction types responsible for their stabilization. Our findings show that electrostatic and exchange energies are responsible for heterocluster stabilization, and also suggest a mutual weakening among hydrogen bonds when more than three water molecules are present. All described results are complementary and suggest a structural and energetic explanation at the molecular level for the experimental molar ratio of 1:3 (DEC:H2O) for the DEC-water azeotrope.	[Ripoll, Juan D.; Villa, Aida L.] Univ Antioquia, Fac Engn, Dept Chem Engn, Environm Catalysis Res Grp, Medellin, Colombia; [Mejia, Sol M.] Pontificia Univ Javeriana, GIFUJ, Dept Quim, Fac Ciencias, Bogota, DC, Colombia; [Mills, Matthew J. L.] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Mills, Matthew J. L.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA		Mejia, SM (corresponding author), Pontificia Univ Javeriana, GIFUJ, Dept Quim, Fac Ciencias, Carrera 7 40-62, Bogota, DC, Colombia.	sol.mejia@javeriana.edu.co	Chica, Sol Milena Mejía/AAE-7711-2019	Chica, Sol Milena Mejía/0000-0001-5664-0558; Villa, Aida Luz/0000-0002-3770-3223	Universidad de Antioquia; Pontifica Universidad Javeriana; Colciencias	Universidad de Antioquia; Pontifica Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors would like to thank the Universidad de Antioquia (Sustainability Strategy 2013-2014) and the Pontifica Universidad Javeriana for financial support of this work. J.D.R. thanks "Colciencias" and the Universidad de Antioquia for his PhD scholarship. Additionally, great gratitude is due to Professor Albeiro Restrepo for permission to use the ASCEC program.	Al-Amer AM, 2000, IND ENG CHEM RES, V39, P3901, DOI 10.1021/ie0000515; [Anonymous], 1985, ACCOUNTS CHEM RES, DOI [10.1002/0470845015.caa012, DOI 10.1021/AR00109A003]; Arango IC, 2013, FLUID PHASE EQUILIBR, V339, P31, DOI 10.1016/j.fluid.2012.11.026; Arbelaez O, 2012, TOP CATAL, V55, P668, DOI 10.1007/s11244-012-9849-4; Arteconi A, 2011, WATER AIR SOIL POLL, V221, P405, DOI 10.1007/s11270-011-0804-y; Balasubramaniyan K., 2013, INT J SCI ENG TECHNO, V2, P2031; Barr-David F., 1959, J CHEM ENG DATA, V4, P107; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Contreras-Garcia J, 2011, J CHEM THEORY COMPUT, V7, P625, DOI 10.1021/ct100641a; Gonzalez JD, 2013, J MOL MODEL, V19, P1763, DOI 10.1007/s00894-012-1716-5; de Lima GF, 2013, J PHYS CHEM C, V117, P4124, DOI 10.1021/jp312323b; De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; Deepanraj B., 2011, ENGINEERING, V3, P1132, DOI [10.4236/eng.2011.311141, DOI 10.4236/ENG.2011.311141]; FANG HL, 1984, CHEM PHYS LETT, V105, P5, DOI 10.1016/0009-2614(84)80404-2; Frisch M. J., 2010, GAUSSIAN 09 REV E01; Gee IL, 1998, CHEMOSPHERE, V36, P2497, DOI 10.1016/S0045-6535(97)10217-X; Gu YL, 1999, J AM CHEM SOC, V121, P9411, DOI 10.1021/ja991795g; Guerra D, 2014, J COMPUT METHODS SCI, V14, P93, DOI 10.3233/JCM-140487; HERRON WJ, 1992, J AM CHEM SOC, V114, P3684, DOI 10.1021/ja00036a017; Hincapie G, 2010, J PHYS CHEM A, V114, P7809, DOI 10.1021/jp103683m; Ibarguen C, 2014, RSC ADV, V4, P58217, DOI 10.1039/c4ra09430a; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; Kar BP, 2014, J MOL STRUCT, V1072, P61, DOI 10.1016/j.molstruc.2014.04.044; Kar BP, 2012, J MOL STRUCT, V1024, P84, DOI 10.1016/j.molstruc.2012.05.007; Kar T, 2004, J PHYS CHEM A, V108, P9161, DOI [10.1021/jp048546l, 10.1021/jp0485461]; KIM KS, 1992, J CHEM PHYS, V97, P6649, DOI 10.1063/1.463669; KITAURA K, 1976, INT J QUANTUM CHEM, V10, P325, DOI 10.1002/qua.560100211; Lapuerta M, 2008, PROG ENERG COMBUST, V34, P198, DOI 10.1016/j.pecs.2007.07.001; Lyktey MMY, 2000, J PHYS CHEM A, V104, P5197, DOI 10.1021/jp000872n; May E, 2001, J AM CHEM SOC, V123, P12248, DOI 10.1021/ja010316m; McQuarrie D.A., 2000, STAT MECH; Mejia SM, 2007, J PHYS CHEM A, V111, P8250, DOI 10.1021/jp073168g; Mejia SM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3701563; Mejia SM, 2011, INT J QUANTUM CHEM, V111, P3080, DOI 10.1002/qua.22664; Mejia SM, 2011, PHYS CHEM CHEM PHYS, V13, P7821, DOI 10.1039/c0cp02869j; Mejia SM, 2009, J MOL STRUC-THEOCHEM, V901, P186, DOI 10.1016/j.theochem.2009.01.027; Mendonca S, 2013, INT J SCI RES PUBL, V3, P1; Nedic M, 2011, PHYS CHEM CHEM PHYS, V13, P14050, DOI 10.1039/c1cp20182d; Nielsen IMB, 1999, J CHEM PHYS, V110, P9435, DOI 10.1063/1.478908; NISHI N, 1988, J AM CHEM SOC, V110, P5246, DOI 10.1021/ja00224a002; Noskov SY, 2005, J PHYS CHEM B, V109, P6705, DOI 10.1021/jp045438q; Pacheco MA, 1997, ENERG FUEL, V11, P2, DOI 10.1021/ef9600974; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Perez J. F., 2008, ASCEC V 01 ANNEALING; Perez JF, 2008, INT J QUANTUM CHEM, V108, P1653, DOI 10.1002/qua.21615; PERRY R, 1995, SCI TOTAL ENVIRON, V169, P149, DOI 10.1016/0048-9697(95)04643-F; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Roh NS, 2003, FUEL PROCESS TECHNOL, V83, P27, DOI 10.1016/S0378-3820(03)00079-1; Romero J, 2011, PHYS CHEM CHEM PHYS, V13, P15264, DOI 10.1039/c1cp20903e; Rozas I, 2007, PHYS CHEM CHEM PHYS, V9, P2782, DOI 10.1039/b618225a; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Su PF, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3159673; Thomsen DL, 2013, J PHYS CHEM A, V117, P10260, DOI 10.1021/jp405512y; Tuma C, 1999, PHYS CHEM CHEM PHYS, V1, P3939, DOI 10.1039/a904357h; Uragami T, 2004, BIOMACROMOLECULES, V5, P1567, DOI 10.1021/bm0498880; Wakisaka A, 2006, J MOL LIQ, V129, P25, DOI 10.1016/j.molliq.2006.08.010; Watson JG, 2001, ATMOS ENVIRON, V35, P1567, DOI 10.1016/S1352-2310(00)00461-1; XANTHEAS SS, 1994, J CHEM PHYS, V100, P7523, DOI 10.1063/1.466846; Yang DP, 2013, J CLUST SCI, V24, P485, DOI 10.1007/s10876-012-0514-7; Zapata-Escobar A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874258	60	3	3	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1610-2940	0948-5023		J MOL MODEL	J. Mol. Model.	APR	2015	21	4							93	10.1007/s00894-015-2593-5	http://dx.doi.org/10.1007/s00894-015-2593-5			13	Biochemistry & Molecular Biology; Biophysics; Chemistry, Multidisciplinary; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer Science	CE0ER	25786831				2022-09-04	WOS:000351477800027
J	Lucci, P; Pacetti, D; Calzuola, I; Marsili, V; Perni, S; Giavarini, F; Frega, NG; Gianfranceschi, GL				Lucci, Paolo; Pacetti, Deborah; Calzuola, Isabella; Marsili, Valeria; Perni, Stefano; Giavarini, Flavio; Frega, Natale Giuseppe; Gianfranceschi, Gian Luigi			Characterization of Phospholipid Molecular Species and Peptide Molecules in Wheat Sprout Hydroalcoholic Extract	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						functional food; molecular species; peptide molecules; EPA-rich phospholipid; phospholipid domains; phospholipid-peptide complexes; LC-ESI-MS; hydroalcoholic extract; sprouts; wheat	TANDEM MASS-SPECTROMETRY; APOLIPOPROTEIN-A-I; ANTIOXIDATIVE ACTIVITY; OXIDATIVE STABILITY; IDENTIFICATION; PURIFICATION; SEPARATION; CAPACITY; DELIVERY; COMPLEX	The phospholipid molecular species and the main peptide molecules of wheat sprout hydroalcoholic extract have been fully characterized by normal-phase high performance liquid chromatography coupled online with positive electrospray ionization tandem mass spectrometry. The extract that resulted was rich in phospholipid molecular species formed by the combination of the two essential fatty acids (alpha-linoleic and alpha-linolenic). These species accounted for 51.7% of total phosphatidic acid, 47.3% of total phosphatidylethanolamine, 37.7% of total phosphatidylcholine, and 14.1% of total phosphatidylinositol. The last one showed the highest amounts of species containing palmitic acid, thus representing the most saturated phospholipid class. The extract was also shown to contain several peptide sequences with both potential antioxidant domains and interaction sites for phospholipids (i.e., H-Ala-Gly-Ser-Met-Met-Cys-NH2, H-Tyr-Met-Thr-Val-Val-Ala-Cys-NH2, etc.); this latter finding can have a highly positive impact on the poor peptides bioavailability. Because of the presence of essential fatty acids-rich phospholipids and bioactive peptides, wheat sprout hydroalcoholic extract can be considered a potential functional food ingredient.	[Lucci, Paolo] Pontificia Univ Javeriana, Dept Nutr & Biochem, Fac Sci, Bogota, Distrito Capita, Colombia; [Pacetti, Deborah; Frega, Natale Giuseppe] Univ Politecn Marche, Dept Agr Food & Environm Sci, I-60131 Ancona, Italy; [Calzuola, Isabella; Marsili, Valeria; Perni, Stefano; Gianfranceschi, Gian Luigi] NPP Nutraceut & Phytochem Prod, Pantalla Di Todi, PG, Italy; [Marsili, Valeria] Univ Perugia, Dept Cellular & Environm Biol, I-06123 Perugia, Italy; [Giavarini, Flavio] Univ Milan, Dept Pharmaceut Sci, Lab Mass Spectrometry, I-20133 Milan, Italy		Pacetti, D (corresponding author), Univ Politecn Marche, Dept Agr Food & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.	d.pacetti@univpm.it	Marsili, Valeria/F-9772-2014; Perni, Stefano/M-1925-2016	Perni, Stefano/0000-0002-0591-4376; Lucci, Paolo/0000-0002-3659-132X				Amici M, 2008, BIOCHIMIE, V90, P790, DOI 10.1016/j.biochi.2007.12.001; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonfili L, 2009, BIOCHIMIE, V91, P1131, DOI 10.1016/j.biochi.2009.06.001; Boselli E, 2008, MEAT SCI, V78, P305, DOI 10.1016/j.meatsci.2007.06.017; Boselli E, 2012, J AGR FOOD CHEM, V60, P3234, DOI 10.1021/jf205159a; Bruni R, 2005, J PEPT SCI, V11, P225, DOI 10.1002/psc.595; Burri L, 2012, INT J MOL SCI, V13, P15401, DOI 10.3390/ijms131115401; Calzuola I, 2005, PEPTIDES, V26, P2074, DOI 10.1016/j.peptides.2005.04.008; Calzuola I, 2004, J AGR FOOD CHEM, V52, P5201, DOI 10.1021/jf0307752; Cheng Y, 2010, J FOOD SCI, V75, pC760, DOI 10.1111/j.1750-3841.2010.01864.x; Choe E., 2007, FOOD LIPIDS CHEM NUT, P449; Cui F, 2006, J CONTROL RELEASE, V114, P242, DOI 10.1016/j.jconrel.2006.05.013; Demoor L, 1996, EUR J BIOCHEM, V239, P74, DOI 10.1111/j.1432-1033.1996.0074u.x; Diao L, 2013, CLIN PHARMACOKINET, V52, P855, DOI 10.1007/s40262-013-0079-0; Donkor ON, 2012, FOOD CHEM, V135, P950, DOI 10.1016/j.foodchem.2012.05.058; Espin JC, 2000, J AGR FOOD CHEM, V48, P648, DOI 10.1021/jf9908188; Falcioni G, 2002, J FOOD SCI, V67, P2918, DOI 10.1111/j.1365-2621.2002.tb08838.x; Frega NG, 2012, TANDEM MASS SPECTROSCOPY - APPLICATIONS AND PRINCIPLES, P637; Gundermann KJ, 2011, PHARMACOL REP, V63, P643, DOI 10.1016/S1734-1140(11)70576-X; Han XL, 1996, BIOCHEMISTRY-US, V35, P5822, DOI 10.1021/bi952927v; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hidalgo FJ, 2005, J AGR FOOD CHEM, V53, P659, DOI 10.1021/jf0483220; Hidalgo FJ, 2006, J AGR FOOD CHEM, V54, P5461, DOI 10.1021/jf060848s; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; Koehler P, 2007, J AGR FOOD CHEM, V55, P4678, DOI 10.1021/jf0633037; Koprivnjak O, 2008, FOOD CHEM, V111, P121, DOI 10.1016/j.foodchem.2008.03.045; Kumar NSS, 2011, PEPTIDES, V32, P1496, DOI 10.1016/j.peptides.2011.05.020; Le Grandois J, 2009, J AGR FOOD CHEM, V57, P6014, DOI 10.1021/jf900903e; Li Y, 2005, ANAL CHEM, V77, P1556, DOI 10.1021/ac040084k; Liu R, 2010, PEPTIDES, V31, P786, DOI 10.1016/j.peptides.2010.02.016; Marton M., 2010, Acta Universitatis Sapientiae - Alimentaria, V3, P81; Mendez MA, 2008, ANAL CHEM, V80, P9499, DOI 10.1021/ac801651f; Pacetti D, 2007, J CHROMATOGR A, V1150, P241, DOI 10.1016/j.chroma.2006.10.022; Perni S, 2011, J PEPT SCI, V17, P744, DOI 10.1002/psc.1397; Plaza L, 2003, EUR FOOD RES TECHNOL, V216, P138, DOI 10.1007/s00217-002-0640-9; Saito H, 1997, J AM OIL CHEM SOC, V74, P1531, DOI 10.1007/s11746-997-0072-6; Sanders WS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002101; Lopez DRS, 2013, THER DELIV, V4, P479, DOI [10.4155/TDE.13.5, 10.4155/tde.13.5]; Shaji J, 2008, INDIAN J PHARM SCI, V70, P269, DOI 10.4103/0250-474X.42967; Suetsuna K, 2000, MAR BIOTECHNOL, V2, P5; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tabet F, 2010, ARTERIOSCL THROM VAS, V30, P246, DOI 10.1161/ATVBAHA.109.200196; VANLOO B, 1995, J LIPID RES, V36, P1686	44	7	8	3	41	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	NOV 27	2013	61	47					11453	11459		10.1021/jf4034392	http://dx.doi.org/10.1021/jf4034392			7	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Chemistry; Food Science & Technology	263MK	24156493				2022-09-04	WOS:000327812500027
J	Dennis, RJ; Roa, JH; Villadiego, J; Mendez, F; Vieda, E; Restrepo, H				Dennis, Rodolfo J.; Roa, Jairo H.; Villadiego, Juan; Mendez, Freddy; Vieda, Elias; Restrepo, Hector			Venous thromboembolism prophylaxis in Colombian surgical and medical patients: Results for Colombia of the ENDORSE study	BIOMEDICA			Spanish	Article						venous thromboembolism/epidemiology; thrombosis/prevention & control; risk management; general surgery; drug prescriptions	PREVENTION; PLACEBO; THROMBOPROPHYLAXIS	Introduction. More information is needed on the risk of venous thromboembolism in the hospital setting, and on patterns of use of thromboprophylaxis, as advocated in consensus guidelines. ENDORSE was an international study aimed at evaluating hospital venous thromboembolism prevention practices in medical and surgical patientes. Objectives. The risk of venous thromboembolism was evaluated along with the use of thromboprophylaxis in hospitalized medical and surgical subjects; these data were compared with the international sample from the ENDORSE study. Materials and methods. Participating institutions in Colombia were selected arbitrarily. The medical charts for medical and surgical patients were evaluated randomly. The 2004 American College of Chest Physician guidelines were used to evaluate risk of venous thromboembolism and adherence to recommended thromboprophylaxis regimens. Results. The study included 761 subjects (218 surgical, 543 medical) located in five acute care hospitals; 49% of these subjects were considered at risk of venous thromboembolism (40% medical, 72% surgical), compared with 52% in the international sample. Prophylaxis use was higher in medical patients at risk (63.7%, n=137) than in surgical patients (48.4%, n=76; p=0.01). Compared with the international sample, the use of prophylaxis in Colombia was greater in medical patients (63.7% vs. 39.5%, p=0.003), but lower in surgical patients (48.4% vs. 58.5%, p=0.02). Conclusions. Participating Colombian centers treat patients at risk of venous thromboembolism similarly to other participant countries, but appropriate prophylaxis was prescribed more frequently to medical patients. Greater efforts are needed, both in Colombia and around the world, to improve rates of appropriate venous thromboembolism prophylaxis in at-risk subjects.	[Dennis, Rodolfo J.] Fdn Cardioinfantil, Dept Med Interna, Inst Cardiol, Bogota, DC, Colombia; [Dennis, Rodolfo J.] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestat, Bogota, DC, Colombia; [Roa, Jairo H.] Fdn Santafe Bogota, Dept Med Interna, Bogota, DC, Colombia; [Villadiego, Juan] Clin Rafael Uribe Uribe, Dept Med Interna, Cali, Colombia; [Mendez, Freddy] Clin Soma, Dept Med Interna, Medellin, Colombia; [Vieda, Elias] Hosp Univ Valle, Dept Med Interna, Unidad Terapia Intens, Cali, Colombia; [Dennis, Rodolfo J.; Restrepo, Hector] Fdn Cardioinfantil, Dept Invest, Inst Cardiol, Bogota, DC, Colombia		Dennis, RJ (corresponding author), Fdn Cardioinfantil, Dept Invest, Inst Cardiol, Carrera 13B 163-85,Torre H, Bogota, DC, Colombia.	rdennis@cardioinfantil.org		RESTREPO, HECTOR FABIO/0000-0003-4327-3693; Dennis, Rodolfo J/0000-0003-3215-9721				Abuabara J, 2005, ACTA MED COLOMB, V30, P241; Agnelli G, 2004, NEW ENGL J MED, V351, P2015; Chopard P, 2005, J INTERN MED, V257, P352, DOI 10.1111/j.1365-2796.2005.01455.x; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Dennis R, 1996, ACTA MED COLOMB, V21, P55; Dennis Rodolfo J, 2009, Acta Med Colomb, V34, P11; Dennis Rodolfo José, 2008, Acta Med Colomb, V33, P111; Douketis JD, 2008, CURR OPIN PULM MED, V14, P381, DOI 10.1097/MCP.0b013e3283043dcf; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Hernández Blanco Javier, 2009, Acta Med Colomb, V34, P4; Kahn SR, 2007, THROMB RES, V119, P145, DOI 10.1016/j.thromres.2006.01.011; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Labarere J, 2007, INT J QUAL HEALTH C, V19, P301, DOI 10.1093/intqhc/mzm034; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Menajovsky LB, 2004, CLEV CLIN J MED, V71, P947, DOI 10.3949/ccjm.71.12.947; Millar JA, 2009, INTERN MED J, V39, P606, DOI 10.1111/j.1445-5994.2008.01796.x; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Pham DQ, 2008, INT J CLIN PRACT, V62, P134, DOI 10.1111/j.1742-1241.2007.01578.x; Piazza G, 2009, AM J MED, V122, P230, DOI 10.1016/j.amjmed.2008.09.037; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Scaglione L, 2005, HAEMATOLOGICA, V90, P678; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993	24	3	8	0	1	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	JUN	2011	31	2					200	208		10.7705/biomedica.v31i2.304	http://dx.doi.org/10.7705/biomedica.v31i2.304			9	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	829HV	22159536	gold, Green Published			2022-09-04	WOS:000295570100007
J	Vargas, LFC; Pedraza, M; Rincon, FA; Pulido, JA; Mendoza-Zuchini, A; Gomez, D; Moreno-Villamizar, MD; Ferrada, P; Lopez, P; Di Saverio, S				Vargas, Luis Felipe Cabrera; Pedraza, Mauricio; Rincon, Francisco Alejandro; Pulido, Jean Andre; Mendoza-Zuchini, Andres; Gomez, Daniel; Moreno-Villamizar, Maria Daniela; Ferrada, Paula; Lopez, Paula; Di Saverio, Salomone			Fully therapeutic laparoscopy for penetrating abdominal trauma in stable patients	AMERICAN JOURNAL OF SURGERY			English	Editorial Material									[Vargas, Luis Felipe Cabrera] Pontificia Univ Javeriana, Hosp Univ San Ignacio Bogota, Dept Surg, Bogota, Colombia; [Vargas, Luis Felipe Cabrera] Univ Mil Nueva Granada, Dept Vasc Surg, Bogota, Colombia; [Pedraza, Mauricio] Univ El Bosque, Dept Gen Surg, Bogota, Colombia; [Rincon, Francisco Alejandro; Pulido, Jean Andre; Moreno-Villamizar, Maria Daniela] Univ El Bosque, Dept Med, Bogota, Colombia; [Mendoza-Zuchini, Andres] Univ El Bosque, Dept Gen Surg, Cobos Med Ctr, Bogota, Colombia; [Gomez, Daniel] Univ Mil Nueva Granada, Dept Gen Surg, Bogota, Colombia; [Ferrada, Paula] Virginia Commonwealth Univ, Dept Surg, Med Ctr, West Hosp, 16th Floor,1200 E Broad St, Richmond, VA 23219 USA; [Lopez, Paula] Univ El Bosque, Dept Gen Surg, Ave Cra 9 131a 20, Bogota, Colombia; [Di Saverio, Salomone] Cambridge Colorectal Unit, Cambridge, England		Pedraza, M (corresponding author), Univ El Bosque, Dept Gen Surg, Bogota, Colombia.	Luis.felipe.cabrera@hotmail.com; mpedrazape@unbosque.edu.co; frinconc@unbosque.edu.co; japs1493@gmail.com; andreszuchini@hotmail.com; vesalius0216@yahoo.com; Daniela_moreno_villa@hotmail.com; pferrada@mcvh-vcu.edu; Paulitalopezm@hotmail.com; salomone.disaverio@gmail.com		Mendoza Zuchini, Andres/0000-0002-0727-8430				Agbroko Solomon, 2019, Niger J Surg, V25, P167, DOI 10.4103/njs.NJS_2_19; Arnscheidt C, 2015, ADV TRAUMA LIFE SUPP; Bain K, 2019, SURG ENDOSC, V33, P1618, DOI 10.1007/s00464-018-6436-1; Cardi M, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0272-z; Di Saverio S, 2019, J TRAUMA ACUTE CARE, V86, P344, DOI 10.1097/TA.0000000000002130; Di Saverio S, 2014, J TRAUMA ACUTE CARE, V77, P338, DOI 10.1097/TA.0000000000000288; Justin V, 2017, CURR TRAUMA REP, V3, P43, DOI 10.1007/s40719-017-0076-0; Shamim AA, 2020, SURG ENDOSC, V34, P4072, DOI 10.1007/s00464-019-07169-z; Spaner Shelley Jane, BRIEF HIST ENDOSCOPY, V7	9	0	0	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2022	223	1					206	207		10.1016/j.amjsurg.2021.07.008	http://dx.doi.org/10.1016/j.amjsurg.2021.07.008		DEC 2021	2	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XQ6JZ	34294385				2022-09-04	WOS:000731653700037
J	Baez-Jurado, E; Guio-Vega, G; Hidalgo-Lanussa, O; Gonzalez, J; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Mitochondrial Neuroglobin Is Necessary for Protection Induced by Conditioned Medium from Human Adipose-Derived Mesenchymal Stem Cells in Astrocytic Cells Subjected to Scratch and Metabolic Injury (vol 56, 5167, 2019)	MOLECULAR NEUROBIOLOGY			English	Correction									[Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	Gonzalez Santos, Janneth/AAB-9948-2020	Gonzalez Santos, Janneth/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971				Baez-Jurado E, 2019, MOL NEUROBIOL, V56, P5167, DOI 10.1007/s12035-018-1442-9	1	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2022	59	2					1347	1348		10.1007/s12035-021-02618-0	http://dx.doi.org/10.1007/s12035-021-02618-0		DEC 2021	2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZD0FK	34882290	Bronze			2022-09-04	WOS:000728429200001
J	Pulido, N; Guevara-Morales, JM; Rodriguez-Lopez, A; Pulido, A; Diaz, J; Edrada-Ebel, RA; Echeverri-Pena, OY				Pulido, Ninna; Guevara-Morales, Johana M.; Rodriguez-Lopez, Alexander; Pulido, Alvaro; Diaz, Jhon; Edrada-Ebel, Ru Angelie; Echeverri-Pena, Olga Y.			H-1-Nuclear Magnetic Resonance Analysis of Urine as Diagnostic Tool for Organic Acidemias and Aminoacidopathies	METABOLITES			English	Article						metabolism; Inborn Errors of Metabolism; organic acidemia; aminoacidopathy; nuclear magnetic resonance	COA DEHYDROGENASE-DEFICIENCY; FALSE DISCOVERY RATE; INBORN-ERRORS; NMR; METABOLISM; SPECTROSCOPY; H-1-NMR; ACIDS; METABOLOMICS; ACIDURIA	The utility of low-resolution H-1-NMR analysis for the identification of biomarkers provided evidence for rapid biochemical diagnoses of organic acidemia and aminoacidopathy. H-1-NMR, with a sensitivity expected for a field strength of 400 MHz at 64 scans was used to establish the metabolomic urine sample profiles of an infant population diagnosed with small molecule Inborn Errors of Metabolism (smIEM) compared to unaffected individuals. A qualitative differentiation of the H-1-NMR spectral profiles of urine samples obtained from individuals affected by different organic acidemias and aminoacidopathies was achieved in combination with GC-MS. The smIEM disorders investigated in this study included phenylalanine metabolism; isovaleric, propionic, 3-methylglutaconicm and glutaric type I acidemia; and deficiencies in medium chain acyl-coenzyme and holocarboxylase synthase. The observed metabolites were comparable and similar to those reported in the literature, as well as to those detected with higher-resolution NMR. In this study, diagnostic marker metabolites were identified for the smIEM disorders. In some cases, changes in metabolite profiles differentiated post-treatments and follow-ups while allowing for the establishment of different clinical states of a biochemical disorder. In addition, for the first time, a H-1-NMR-based biomarker profile was established for holocarboxylase synthase deficiency spectrum.	[Pulido, Ninna] San Ignacio Univ Hosp, Bogota 4665684, Colombia; [Pulido, Ninna; Guevara-Morales, Johana M.; Echeverri-Pena, Olga Y.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Sch Sci, Cra 7,43-82,Edificio 54,Lab 303A, Bogota 4665684, Colombia; [Rodriguez-Lopez, Alexander] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota 4665684, Colombia; [Rodriguez-Lopez, Alexander; Diaz, Jhon] Pontificia Univ Javeriana, Sch Sci, Chem Dept, Bogota 4665684, Colombia; [Pulido, Alvaro] Univ Nacl Colombia, Elect & Elect Dept, Bogota 4665684, Colombia; [Edrada-Ebel, Ru Angelie] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Nat Prod Metabol Grp, Fac Sci, John Arbuthnott Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland		Echeverri-Pena, OY (corresponding author), Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Sch Sci, Cra 7,43-82,Edificio 54,Lab 303A, Bogota 4665684, Colombia.; Edrada-Ebel, RA (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Nat Prod Metabol Grp, Fac Sci, John Arbuthnott Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	nfpulido@husi.org.co; johana.guevara@javeriana.edu.co; rodriguez.edwin@javeriana.edu.co; apulidoa@unal.edu.co; diaz.john@javeriana.edu.co; ruangelie.edrada-ebel@strath.ac.uk; oyecheve@javeriana.edu.co	Rodriguez-Lopez, Alexander/E-6650-2015; Edrada-Ebel, RuAngelie/G-6127-2015	Rodriguez-Lopez, Alexander/0000-0001-5409-3466; Diaz, John/0000-0002-8447-307X; Edrada-Ebel, RuAngelie/0000-0003-2420-1117; Pulido-Ochoa, Ninna/0000-0002-1628-930X	Hospital Universitario San Ignacio; Pontificia Universidad Javeriana [SIAP 6733]	Hospital Universitario San Ignacio; Pontificia Universidad Javeriana	For this research, Ninna Pulido was supported by the grant: "Primera convocatoria de becas condonables para formacion avanzada en investigacion 2014", Hospital Universitario San Ignacio. Olga Y. Echeverri-Pena and Johana M. Guevara Morales were supported by the grant number SIAP 6733, Pontificia Universidad Javeriana.	Aygen S, 2014, JIMD REP, V16, P101, DOI 10.1007/8904_2014_326; BALES JR, 1984, CLIN CHEM, V30, P426; Bamforth FJ, 1999, J INHERIT METAB DIS, V22, P297, DOI 10.1023/A:1005531432766; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Baumgartner MR, 2012, INBORN METABOLIC DIS, P375; Beale DJ, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1449-2; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Blasco H, 2010, ANAL BIOANAL CHEM, V396, P1205, DOI 10.1007/s00216-009-3280-0; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Carragher FM, 2003, ANN CLIN BIOCHEM, V40, P313, DOI 10.1258/000456303766476968; CHALMERS RA, 1976, CLIN CHEM, V22, P1288; Cowart S.L., 1990, CLIN METHODS HIST PH, V3rd; De Castro M, 2015, JIMD REP, V20, P1, DOI 10.1007/8904_2014_367; Dercksen M, 2013, METABOLOMICS, V9, P765, DOI 10.1007/s11306-013-0501-5; Donti TR, 2016, MOL GENET METAB REP, V7, P40, DOI 10.1016/j.ymgmr.2016.03.007; Eduardo S.P.d.N., 2011, AN LISE METABOL MICA; Embade N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49685-x; Emwas AH, 2019, METABOLITES, V9, DOI 10.3390/metabo9070123; Engelke UFH, 2006, NMR BIOMED, V19, P271, DOI 10.1002/nbm.1018; Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Eriksson L, 2002, J COMPUT AID MOL DES, V16, P711, DOI 10.1023/A:1022450725545; Ferreira CR, 2019, GENET MED, V21, P102, DOI 10.1038/s41436-018-0022-8; FOXALL PJD, 1995, ARCH DIS CHILD-FETAL, V73, pF153, DOI 10.1136/fn.73.3.F153; Garg U., 2017, BIOMARKERS INBORN ER, P1, DOI [10.1016/b978-0-12-802896-4.00001-8, DOI 10.1016/B978-0-12-802896-4.00001-8]; Gebregiworgis T, 2012, COMB CHEM HIGH T SCR, V15, P595, DOI 10.2174/138620712802650522; Gryff-Keller A, 2012, ACTA BIOCHIM POL, V59, P613; Guerrero RB, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.11.05; Gunnerson K.J., 2011, MEDSCAPE REF; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; ILES RA, 1985, CLIN CHEM, V31, P1795; Ismail IT, 2019, METABOLITES, V9, DOI 10.3390/metabo9100242; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kobayashi H, 2007, J CHROMATOGR B, V855, P80, DOI 10.1016/j.jchromb.2006.12.010; KODAMA S, 1991, Acta Paediatrica Japonica, V33, P139; Kumps A, 2002, CLIN CHEM, V48, P708; LAWSON AM, 1976, CLIN CHEM, V22, P1283; LEHNERT W, 1986, EUR J PEDIATR, V145, P260, DOI 10.1007/BF00439397; LEHNERT W, 1983, CLIN CHIM ACTA, V134, P207, DOI 10.1016/0009-8981(83)90198-5; Mardhiah M, 2020, MOL GENET METAB REP, V22, DOI 10.1016/j.ymgmr.2019.100548; Markley JL, 2017, CURR OPIN BIOTECH, V43, P34, DOI 10.1016/j.copbio.2016.08.001; Merritt J.L., 2019, MEDIUM CHAIN ACYL CO; Miller MJ, 2021, GENET MED, V23, P249, DOI 10.1038/s41436-020-00990-1; Miller MJ, 2015, J INHERIT METAB DIS, V38, P1029, DOI 10.1007/s10545-015-9843-7; Moolenaar S., 2002, HEILBRONN SHS INT; Moolenaar SH, 2003, ANN CLIN BIOCHEM, V40, P16, DOI 10.1258/000456303321016132; Morava E, 2015, J INHERIT METAB DIS, V38, P1003, DOI 10.1007/s10545-015-9893-x; Morrone A, 2002, AM J MED GENET, V111, P10, DOI 10.1002/ajmg.10532; Nadal-Desbarats L, 2014, ANALYST, V139, P3460, DOI 10.1039/c4an00552j; Norusis M. J., 2010, PASW STAT 18 GUIDE D; Phipps WS, 2019, ADV CLIN CHEM, V92, P59, DOI 10.1016/bs.acc.2019.04.001; Procopio D, 2016, J PEDIATR BIOCHEM, V6, P11, DOI 10.1055/s-0036-1582237; Rafter J.E., 1990, MEDIUM CHAIN ACYL CO; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Roland D, 2017, MOL GENET METAB, V121, P111, DOI 10.1016/j.ymgme.2017.03.006; Sachse D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161123; Saudubray JM, 2019, J INHERIT METAB DIS, V42, P706, DOI 10.1002/jimd.12086; Saudubray JM, 2006, J INHERIT METAB DIS, V29, P261, DOI 10.1007/s10545-006-0358-0; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; SCHMIDTSOMMERFELD E, 1992, PEDIATR RES, V31, P545, DOI 10.1203/00006450-199206000-00002; Sgaravatti AM, 2003, BBA-MOL BASIS DIS, V1639, P232, DOI 10.1016/j.bbadis.2003.09.010; Shoemaker R., 2008, MESTRENOVA MESTRELAB, V5, P66; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Soler-Alfonso C, 2016, RES REP NEONATOL, V6, P1, DOI 10.2147/RRN.S60617; Strovel Erin T, 2017, Genet Med, V19, DOI 10.1038/gim.2017.84; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vaidyanathan K., 2018, NOVEL BIOMARKERS INB; Vaidyanathan K, 2011, INDIAN J CLIN BIOCHE, V26, P319, DOI 10.1007/s12291-011-0134-2; van Wegberg AMJ, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0685-2; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; Vernon HJ, 2015, JAMA PEDIATR, V169, P778, DOI 10.1001/jamapediatrics.2015.0754; Villani GRD, 2017, CLIN EXP MED, V17, P305, DOI 10.1007/s10238-016-0435-0; Watanabe Miki, 2012, J Mol Biomark Diagn, V3; Waters D, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.021102; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wolf B, 2016, BIOTINIDASE DEFICIEN; Wortmann SB, 2012, J INHERIT METAB DIS, V35, P13, DOI 10.1007/s10545-010-9210-7; Wu Z., 2010, HDB PARTIAL LEAST SQ, P757, DOI DOI 10.1007/978-3-540-32827-8_33; Xiao CN, 2009, ANALYST, V134, P916, DOI 10.1039/b818802e; Yamada K, 2012, BRAIN DEV-JPN, V34, P92, DOI 10.1016/j.braindev.2011.08.004; Zuppi C, 1997, CLIN CHIM ACTA, V265, P85, DOI 10.1016/S0009-8981(97)00110-1	86	0	0	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-1989		METABOLITES	Metabolites	DEC	2021	11	12							891	10.3390/metabo11120891	http://dx.doi.org/10.3390/metabo11120891			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	XW9VJ	34940649	Green Accepted, Green Published, gold			2022-09-04	WOS:000735956900001
J	Bautista-Molano, W; Gonzalez, L; Fernandez-Avila, D; Cardozo, R; Ruiz, O				Bautista-Molano, Wilson; Gonzalez, Liza; Fernandez-Avila, Daniel; Cardozo, Rosa; Ruiz, Oscar			Frequency of positivity of the tuberculin intradermorreaction test in a cohort of patients with rheumatoid arthritis	BIOMEDICA			Spanish	Article						Arthritis; rheumatoid/epidemiology; tuberculosis; risk; biological therapy	TUMOR-NECROSIS-FACTOR; RELEASE ASSAYS; RISK; PREVALENCE; DIAGNOSIS; SOCIETY	Introduction: Rheumatoid arthritis is an autoimmune, chronic, and deforming condition associated with disability. Patients are immunosuppressed and at high risk of developing tuberculosis. The tuberculin skin test is used to screen candidates for biological therapy. Objective: To evaluate the frequency of positivity of the tuberculin skin test in a cohort of Colombian patients with rheumatoid arthritis. Materials and methods: We conducted a descriptive cross-sectional study including patients with rheumatoid arthritis receiving the tuberculin skin test prior to the start or at the time of the change of biological therapy. The patients' condition was moderate or severe and they were candidates for initiation or change of biological therapy. We defined the value of >= 6 mm as the cut-off point for a positive tuberculin skin test and performed a descriptive analysis for each of the variables considered. Results: In total, 261 patients with rheumatoid arthritis were included, 92 % of whom were women; the average age was 55 years (SD=13.92) and the time from diagnosis, 12.3 years (SD=8.54). The frequency of positive tuberculin skin tests was 15.71% (n=41). Of the 41 positive patients, nine had previously had the test (1 to 6 years before), all of them with negative results; 18 of these were receiving glucocorticoids (43.9%) and all of them (100%) were being treated with methotrexate. Conclusions: The frequency of positivity of the tuberculin skin test in these Colombian patients diagnosed with rheumatoid arthritis was around 16%. We reco0mmend optimizing strategies aimed at an optimal detection of this condition and the timely initiation of treatment to reduce the risk of tuberculosis reactivation.	[Bautista-Molano, Wilson; Cardozo, Rosa; Ruiz, Oscar] Org Sanitas Int Colsanitas, Ave Calle 100 11B-67, Bogota, DC, Colombia; [Bautista-Molano, Wilson] Univ Mil Nueva Granada, Fac Med, Bogota, DC, Colombia; [Bautista-Molano, Wilson] Univ El Bosque, Fac Med, Bogota, DC, Colombia; [Gonzalez, Liza] Fdn Univ Sanitas, Fac Med, Bogota, DC, Colombia; [Fernandez-Avila, Daniel] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Med Interna, Bogota, DC, Colombia		Bautista-Molano, W (corresponding author), Org Sanitas Int Colsanitas, Ave Calle 100 11B-67, Bogota, DC, Colombia.	wilson.bautista@gmail.com	Bautista-Molano, Wilson/Y-8316-2019	Bautista-Molano, Wilson/0000-0003-0684-9542				Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Bautista-Molano W, 2018, J RHEUMATOL, V45, P206, DOI 10.3899/jrheum.170520; Bautista-Molano W, 2016, REUMATOL CLIN, V12, P313, DOI 10.1016/j.reuma.2015.11.009; Chaparro Pablo Enrique, 2004, Biomed., V24, P102; Chung TT, 2020, RHEUMATOL INT, V40, P983, DOI 10.1007/s00296-020-04583-8; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DANNENBERG AM, 1991, IMMUNOL TODAY, V12, P228, DOI 10.1016/0167-5699(91)90035-R; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Ehlers S, 2005, CLIN INFECT DIS, V41, pS199, DOI 10.1086/429998; Forero Elias, 2016, Rev.Colomb.Reumatol., V23, P50, DOI 10.1016/j.rcreu.2016.02.004; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Kaufmann SHE, 2004, ANN RHEUM DIS, V63, P50, DOI 10.1136/ard.2004.028258; Lopez-Perez M, INFORME EVENTO TUBER; Lopez-Perez M, 2014, INFORME FINAL; Tamborenea MN, 2010, RHEUMATOL INT, V30, P613, DOI 10.1007/s00296-009-1027-z; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Perez C, 2007, REV COLOMB NEUMOL, V19, P11; Raviglione M., GLOBAL TUBERCULOSIS; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Sharma S, 2020, PPD SKIN TEST; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Zafari P, 2021, IUBMB LIFE, V73, P26, DOI 10.1002/iub.2413; Zar HJ, 2013, THORAX, V68, P283, DOI 10.1136/thoraxjnl-2012-203127	28	0	0	0	0	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	SEP	2021	41	3					472	480		10.7705/biomedica.5416	http://dx.doi.org/10.7705/biomedica.5416			9	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	XC0PB	34559494	gold, Green Published			2022-09-04	WOS:000721721400010
J	Lopez, WL; Tortosa, F; Santolaya, F; Tortosa, M; de Oliver, JSP; Aguilar-Bustamante, MC				Lopez Lopez, Wilson; Tortosa, Francisco; Santolaya, Francisco; Tortosa, Macarena; Prego de Oliver, Jesus Santolaya; Constanza Aguilar-Bustamante, Maria			HISTORY, DIFFICULTIES, AND CHALLENGES OF THE IBERO-AMERICAN FEDERATION OF PSYCHOLOGY ASSOCIATIONS	PAPELES DEL PSICOLOGO			Spanish	Article						FIAP; Scientific organizations; Professional organizations; Globalization; Ibero-American psychology		The main aim of the article is to present and describe the main foundational elements, as well as the iconic events and mission, of the Ibero-American Federation of Psychology Associations (FIAP). The contributions and tasks of this organization are described, as well as the difficulties of building an organized psychology, vulnerable to the fragilities and diversities of the socio-economic and socio-political realities of the region. The final purpose is to discuss the role of the FIAP within the organization and representation of the psychology profession, as well as its shortcomings, challenges, and tasks, in order to continue to promote the positioning and internationalization of the psychological science and profession in Spanish and Portuguese speaking countries.	[Lopez Lopez, Wilson] Pontificia Univ Javeriana, Bogota, Colombia; [Tortosa, Francisco] Univ Valencia, Valencia, Spain; [Santolaya, Francisco] Consejo Gen Psicol Espana, Madrid, Spain; [Tortosa, Macarena] Univ Int Valencia VIU, Valencia, Spain; [Prego de Oliver, Jesus Santolaya] Univ Europea Valencia, Valencia, Spain; [Constanza Aguilar-Bustamante, Maria] Univ Catolica Colombia, Bogota, Colombia		Lopez, WL (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	lopezlopezwilson@gmail.com	López López, Wilson/AAV-8032-2021	López López, Wilson/0000-0002-2964-0402				Adair JG, 2010, INT J PSYCHOL, V45, P155, DOI 10.1080/00207590903157221; Alvarado CS, 2017, J SCI EXPLORATION, V31, P255; American Psychological Association, 1968, 17 INT C PSYCH MOSC; [Anonymous], 2019, INFOCOPONLINE; [Anonymous], 2008, INFOCOP; [Anonymous], 1885, REV PHILOS FRANCE ET, V19, P591; ASH MG, 1980, CENT EUR HIST, V13, P255, DOI 10.1017/S0008938900009602; Becerril A., 2019, 22 INT C EL PUBL REV, P41; Benjamin L, 2012, OXFORD HDB HIST PSYC; Botero M, 2002, RED FACULTADES DEPAR; Botero M, 2004, RED IBEROAMERICANA F; Buela-Casal G., 2005, REV LATINOAMERICANA, V37, P211; Bullock M., 2012, HDB PSYCHOL, P562; Carpintero H., 2020, INT ASS APPL PSYCHOL; CAUTLEY PW, 1992, PSYCHOLOGY IN INTERNATIONAL PERSPECTIVE, P3; COMPTON BE, 1967, SCIENCE, V155, P1648, DOI 10.1126/science.155.3770.1648; Consejo General de la Psicologia de Espana, 2020, MEM GEST AN COP 2019; COON DJ, 1992, AM PSYCHOL, V47, P143, DOI 10.1037/0003-066X.47.2.143; Fernberger SW, 1932, PSYCHOL BULL, V29, P1, DOI 10.1037/h0075733; FIAP, 2002, MEM 1 ENC IB DEC PSI; FIAP, 2002, DECL BOG 2002 RED FA; Freeman RPJ, 2011, EUR PSYCHOL, V16, P90, DOI 10.1027/1016-9040/a000085; Gallegos M., 2018, REV MEX PSICOL, V35, P1313, DOI [10.1080/00207594.2013.840965, DOI 10.1080/00207594.2013.840965]; Gallegos M, 2013, INT J PSYCHOL, V48, P1313, DOI 10.1080/00207594.2013.840965; Garcia A, 2019, REV IBEROAM PSICOL S, V10, P37, DOI 10.23923/j.rips.2018.02.024; Garcia Agnaldo, 2016, Suma Psicol., V23, P125, DOI 10.1016/j.sumpsi.2016.08.002; Garcia Agnaldo, 2015, Psykhe, V24, P1, DOI 10.7764/psykhe.24.2.765; Gielen U., 2017, INTERNATIONALIZING T; Gonzalez M, 2012, INFOCOPONLINE; Gonzalez M., 1998, CONGRESOS INT PSICOL; Gundlach H, 2004, PSYCHOL RUNDSCH, V55, P12, DOI 10.1026/0033-3042.55.S1.12; Gundlach H, 1998, APPL PSYCHOL, V1; Klappenbach H., 2004, HDB INT PSYCHOL, P129; Loewenberg P, 2012, 100 YEARS IPA CENTEN; López López Wilson, 2018, Univ. Psychol., V17, P1; López Wilson López, 2011, Estud. psicol. (Natal), V16, P17, DOI 10.1590/S1413-294X2011000100003; Lopez-Lopez W., TEACHING PSYCHOL WOR, V4, P53; Lopez-Lopez W, 2019, EUL FOC NETW EC SEM; Lopez-Lopez W., 2019, UNIV PSYCHOL, V18, P1; Lopez-Lopez W., 2016, CATALOGO REVISTAS PS; Lopez-Lopez W, 2010, UNIV PSYCHOL, V9, P609; Lopez-Lopez W, 2013, APA PSYCHOL INT; Lopez-Lopez W., 2015, PSICOLOGIA IBEROAMER, P1; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; Lovie A. D., 2001, PSYCHOL BRITAIN HIST, P95; Lunt I, 1996, EUR PSYCHOL, V1, P60, DOI 10.1027/1016-9040.1.1.60; Maluf MR, 2012, REV PSICOL-LIMA, V30, P215; McCarthy S., 2007, TEACHING PSYCHOL WOR, V1; Merenda P, 1995, WORLD PSYCHOL, V1, P27; Montoro L., 1983, REV HIST PSICOLOGIA, V4, P43; MUCCHIELLI L., 1998, Annals of Science, V55, P263; PAWLIK K, 1994, INT J PSYCHOL, V29, P665, DOI 10.1080/00207599408246556; Pickren W., 2012, HDB PSYCHOL, V1, P597; Pickren W. E., 2018, 125 YEARS AM PSYCHOL; Poole Randall A., 2003, PROBLEMS IDEALISM ES; Poole Randall A., 1996, THESIS U NOTRE DAME; Poortinga YH, 2011, EUR PSYCHOL, V16, P111, DOI 10.1027/1016-9040/a000088; Psicofundacion, PAG WEB RIPE RED IB; Rich G., 2020, TEACHINGPPSYCHOLOGY, V5; Rosenzweig M. R., 2000, HIST INT UNION PSYCH; Rossi L., 2014, HIST PSICOLOGIA AM S, P28; Sabourin M, 2014, INT J PSYCHOL, V49, P222, DOI 10.1002/ijop.12071; Sanchez-Ron J, 1991, REV OCCIDENTE, V122-123, P93; Santolaya F, 2001, PAPEL PSICOL, V80, P71; Sommer A, 2013, CROSSING BOUNDARIES; Steinberg H, 1961, BRIT PSYCHOL SOC 190; Tibana-Herrera G, 2018, PROF INFORM, V27, P1082, DOI 10.3145/epi.2018.sep.12; Tortosa M., 2019, THESIS U VALENCIA; Tortosa M., 2020, ESTRATEGIA POSICIONA; Tortosa-Perez M, 2020, AN PSICOL-SPAIN, V36, P12, DOI [10.6018/analesps.36.1.388691, 10.6018/analesps.388691]; Tortosa-Perez M, 2019, AN PSICOL-SPAIN, V35, P332, DOI 10.6018/analesps.35.2.332171; TROMBETTA C, 1998, REV HIST PSICOLOGIA, V19, P173; van de Vijver FJK, 2013, AM PSYCHOL, V68, P761, DOI 10.1037/a0033762; Zuniga M. F., 2008, QUORUM REV PENSAMIEN, P149	74	2	2	0	1	CONSEJO GENERAL PSICOLOGIA DE ESPANA	MADRID	CONDE PENALVER, 45, 5O IZQUIERDA, MADRID, 28006, SPAIN	0214-7823	1886-1415		PAPEL PSICOL	Papel. Psicol.	JAN-APR	2021	42	1					67	78		10.23923/pap.psicol2021.2951	http://dx.doi.org/10.23923/pap.psicol2021.2951			12	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	RU4MG		gold			2022-09-04	WOS:000645122400008
J	Baez-Villanueva, OM; Zambrano-Bigiarini, M; Ribbe, L; Nauditt, A; Giraldo-Osorio, JD; Thinh, NX				Manuel Baez-Villanueva, Oscar; Zambrano-Bigiarini, Mauricio; Ribbe, Lars; Nauditt, Alexandra; Diego Giraldo-Osorio, Juan; Nguyen Xuan Thinh			Temporal and spatial evaluation of satellite rainfall estimates over different regions in Latin-America	ATMOSPHERIC RESEARCH			English	Article						CHIRPSv2; MSWEPv2; Precipitation; Satellite; Upscaling influence; Validation of SREs	PRECIPITATION PRODUCTS; MERGING GAUGE; RESOLUTION; DATABASE; VALIDATION; SCENARIOS; DATASETS; CMORPH; BRAZIL	In developing countries, an accurate representation of the spatio-temporal variability of rainfall is currently severely limited, therefore, satellite-based rainfall estimates (SREs) are promising alternatives. In this work, six state-of-the-art SREs (TRMM 3B42v7, TRMM 3B42RT, CHIRPSv2, CMORPHv1, PERSIANN-CDR, and MSWEPv2) are evaluated over three different basins in Latin-America, using a point-to-pixel comparison at daily, monthly, and seasonal timescales. Three continuous (root mean squared error, modified Kling-Gupta efficiency, and percent bias) and three categorical (probability of detection, false alarm ratio, and frequency bias) indices are used to evaluate the performance of the different SREs, and to assess if the upscaling procedure used, in CHIRPSv2 and MSWEPv2, to enable a consistent point-to-pixel comparison affects the evaluation of the SREs performance at different time scales. Our results show that for Paraiba do Sul in Brazil, MSWEPv2 presented the best performance at daily and monthly time scales, while CHIRPSv2 performed the best at these timescales over the Magdalena River Basin in Colombia. In the Imperial River Basin in Chile, MSWEPv2 and CHIRPSv2 performed the best at daily and monthly time scales, respectively. When the basins were evaluated at seasonal scale, CMORPHv1 performed the best for DJF and SON, TRMM 3B42v7 for MAM, and PERSIANN-CDR for JJA over Imperial Basin. MSWEPv2 performed the best over Paraiba do Sul Basin for all seasons and CHIRPSv2 showed the best performance over Magdalena Basin. The Modified Kling-Gupta efficiency (KGE') proved to be a useful evaluation index because it decomposes the performance of the SREs into linear correlation, bias, and variability parameters, while the Root Mean Squared Error (RMSE) is not recommended for evaluating SREs performance because it gives more weight to high rainfall events and its results are not comparable between areas with different precipitation regimes. On the other hand, CHIRPSv2 and MSWEPv2 presented different performance, for some study areas and time scales, when evaluated with their original spatial resolution (0.05 degrees and 0.1, respectively) with respect to the evaluation resulting after applying the spatial upscaling (to a unified 0.25), showing that the upscaling procedure might impact the SRE performance. We finally conclude that a site-specific validation is needed before using any SRE, and we recommend to evaluate the SRE performance before and after applying any upscaling procedure in order to select the SRE that best represents the spatio-temporal precipitation patterns of a site.	[Manuel Baez-Villanueva, Oscar; Ribbe, Lars; Nauditt, Alexandra] Technol Arts Sci TH Koln, Inst Technol & Resources Management Trop & Subtro, Cologne, Germany; [Zambrano-Bigiarini, Mauricio] Univ La Frontera, Dept Civil Engn, Temuco, Chile; [Zambrano-Bigiarini, Mauricio] Univ Chile, Ctr Climate & Resilience Res, Santiago, Chile; [Diego Giraldo-Osorio, Juan] Pontificia Univ Javeriana, Bogota, Colombia; [Manuel Baez-Villanueva, Oscar; Nguyen Xuan Thinh] TU Dortmund Univ, Fac Spatial Planning, Dortmund, Germany		Baez-Villanueva, OM (corresponding author), Technol Arts Sci TH Koln, Inst Technol & Resources Management Trop & Subtro, Cologne, Germany.	obaezvil@th-koeln.de; mauricio.zambrano@ufrontera.cl; lars.ribbe@th-koeln.de; alexandra.nauditt@th-koeln.de; j.giraldoo@javeriana.edu.co; nguyen.thinh@tu-dortmund.de	Giraldo-Osorio, Juan Diego/F-8969-2016; Zambrano-Bigiarini, Mauricio/C-7855-2012; Baez-Villanueva, Oscar Manuel/ABG-1929-2020	Giraldo-Osorio, Juan Diego/0000-0001-6205-3341; Zambrano-Bigiarini, Mauricio/0000-0002-9536-643X; Nauditt, Alexandra/0000-0002-9780-5280; Ribbe, Lars/0000-0003-3052-1782	FONDECYT [11150861]; Centers for Natural Resources and Development (CNRD) Ph.D. program	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centers for Natural Resources and Development (CNRD) Ph.D. program	The authors thank FONDECYT (11150861) for partially funding the collaboration between the Universidad de la Frontera (Temuco, Chile) and the Institute for Technology and Resources Management in the Tropics and Subtropics (Koln, Germany). The authors also thank the Centers for Natural Resources and Development (CNRD) Ph.D. program for the financial support to the main author (Ph.D. scholarship).	[Anonymous], T AM GEOPHYS UNION; Ashouri H, 2015, B AM METEOROL SOC, V96, P69, DOI 10.1175/BAMS-D-13-00068.1; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P6201, DOI 10.5194/hess-21-6201-2017; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P589, DOI 10.5194/hess-21-589-2017; Berndt C, 2014, J HYDROL, V508, P88, DOI 10.1016/j.jhydrol.2013.10.028; Ceccherini G, 2015, REMOTE SENS-BASEL, V7, P6454, DOI 10.3390/rs70506454; dos Reis JBC, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121240; Delahaye F, 2015, J HYDROL, V527, P292, DOI 10.1016/j.jhydrol.2015.04.012; Dinku T, 2010, J APPL METEOROL CLIM, V49, P1004, DOI 10.1175/2009JAMC2260.1; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Gebremichael M, 2010, J AM WATER RESOUR AS, V46, P361, DOI 10.1111/j.1752-1688.2010.00428.x; Guo H, 2015, REMOTE SENS-BASEL, V7, P7181, DOI 10.3390/rs70607181; Gupta HV, 2009, J HYDROL, V377, P80, DOI 10.1016/j.jhydrol.2009.08.003; Haberlandt U, 2007, J HYDROL, V332, P144, DOI 10.1016/j.jhydrol.2006.06.028; Hijmans R.J., 2017, RASTER GEOGRAPHIC DA; Hsu KL, 1997, J APPL METEOROL, V36, P1176, DOI 10.1175/1520-0450(1997)036<1176:PEFRSI>2.0.CO;2; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Instituto de Hidrologia Meteorologia y Estudios Ambientales y Corporacion Autonoma Regional del Rio Grande de la Magdalena-Cormagdalena., 2001, EST AMB CUENC MAGD C; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kling H, 2012, J HYDROL, V424, P264, DOI 10.1016/j.jhydrol.2012.01.011; Melo DDD, 2015, J GEOPHYS RES-ATMOS, V120, P9426, DOI 10.1002/2015JD023797; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Restrepo JD, 2006, J HYDROL, V316, P213, DOI 10.1016/j.jhydrol.2005.05.002; Rivera N.R., 2004, Inf. tecnol., V15, P89, DOI 10.4067/S0718-07642004000500013; Rogelis MC, 2013, J HYDROMETEOROL, V14, P85, DOI 10.1175/JHM-D-11-0150.1; Salio P, 2015, ATMOS RES, V163, P146, DOI 10.1016/j.atmosres.2014.11.017; Schuster G, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-8; Silva W.M., 2014, INT J GEOSCI, V5, P408, DOI [10.4236/ijg.2014.54039, DOI 10.4236/IJG.2014.54039]; Simoes SJ, 2007, MANAG ENVIRON QUAL, V18, P263, DOI 10.1108/14777830710731734; Soares PV, 2012, ENVIRON EARTH SCI, V67, P1685, DOI 10.1007/s12665-012-1610-6; Sorooshian S, 2000, B AM METEOROL SOC, V81, P2035, DOI 10.1175/1520-0477(2000)081<2035:EOPSSE>2.3.CO;2; Team  R. Development Core, 2011, R LANG ENV STAT COMP; Thiemig V, 2012, J HYDROMETEOROL, V13, P1760, DOI 10.1175/JHM-D-12-032.1; Villar JCE, 2009, INT J CLIMATOL, V29, P1574, DOI 10.1002/joc.1791; Woldemeskel FM, 2013, J HYDROL, V499, P167, DOI 10.1016/j.jhydrol.2013.06.039; Xie PP, 2017, J HYDROMETEOROL, V18, P1617, DOI [10.1175/JHM-D-16-0168.1, 10.1175/jhm-d-16-0168.1]; Zambrano-Bigiarini M., 2017, HYDROTSM TIME SERIES; Zambrano-Bigiarini M, 2017, HYDROL EARTH SYST SC, V21, P1295, DOI 10.5194/hess-21-1295-2017; Zambrano-Bigiarini Mauricio, 2017, HYDROGOF GOODNESS OF	41	57	60	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0169-8095	1873-2895		ATMOS RES	Atmos. Res.	NOV 15	2018	213						34	50		10.1016/j.atmosres.2018.05.011	http://dx.doi.org/10.1016/j.atmosres.2018.05.011			17	Meteorology & Atmospheric Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Meteorology & Atmospheric Sciences	GR0AW					2022-09-04	WOS:000442169800004
J	Parra, M; Herrera, D; Calvo-Calle, JM; Stern, LJ; Parra-Lopez, CA; Butcher, E; Franco, M; Angel, J				Parra, Miguel; Herrera, Daniel; Calvo-Calle, J. Mauricio; Stern, Lawrence J.; Parra-Lopez, Carlos A.; Butcher, Eugene; Franco, Manuel; Angel, Juana			Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors alpha 4 beta 7 and CCR9	VIROLOGY			English	Article						Rotavirus (RV); T cells; Intestinal homing receptors; MHC class II tetramers	MAJOR HISTOCOMPATIBILITY COMPLEX; ANTHRAX VACCINE; CHILDREN; MEMORY; PROTECTION; INFECTION; EPITOPES; IMMUNITY; PEPTIDE; PROTEIN	Using a consensus epitope prediction approach, three rotavirus (RV) peptides that induce cytokine secretion by CD4 T cells from healthy volunteers were identified. The peptides were shown to bind HLA-DRB1*0101 and then used to generate MHC II tetramers. RV specific T cell lines specific for one of the three peptides studied were restricted by MHC class II molecules and contained T cells that bound the tetramer and secreted cytokines upon activation with the peptide. The majority of RV and Flu tetramer(+) CD4 T cells in healthy volunteers expressed markers of antigen experienced T cells, but only RV specific CD4 T cells expressed intestinal homing receptors. CD4 T cells from children that received a RV vaccine, but not placebo recipients, were stained with the RV-VP6 tetramer and also expressed intestinal homing receptors. Circulating RV-specific CD4 T cells represent a unique subset that expresses intestinal homing receptors. (C) 2014 Elsevier Inc. All rights reserved.	[Parra, Miguel; Herrera, Daniel; Franco, Manuel; Angel, Juana] Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia; [Calvo-Calle, J. Mauricio; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Parra-Lopez, Carlos A.] Univ Nacl Colombia, Dept Microbiol, Fac Med, Bogota, Colombia; [Butcher, Eugene] Stanford Univ, Dept Pathol, Sch Med, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA		Angel, J (corresponding author), Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Carrera 7 40-62, Bogota, Colombia.	jangel@javeriana.edu.co	Angel, Juana/O-2908-2014; CORTES, Manuel Antonio FRANCO/M-7517-2014	Angel, Juana/0000-0001-6623-5337; CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; PARRA LOPEZ, CARLOS ALBERTO/0000-0002-6084-8981; Parra, Miguel/0000-0002-1457-3614	Colciencias [1203-408-20481]; Pontificia Universidad Javeriana [ID5195]; NIH [U19-AI057319];  [R37-AI047822];  [RC1-AI087257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, R37AI047822, RC1AI087257] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work Was financed by grants from Colciencias 1203-408-20481 and the Pontificia Universidad Javeriana (ID5195). LJS and JMCC received support from NIH grant U19-AI057319 and EB funding from R37-AI047822 and RC1-AI087257 also from the NIH, which funded Ab production. Miguel Parra was funded by a scholarship from Colciencias.	Angel J, 2012, CURR OPIN VIROL, V2, P419, DOI 10.1016/j.coviro.2012.05.003; Banos DM, 1997, J VIROL, V71, P419; Blutt SE, 2012, MUCOSAL IMMUNOL, V5, P712, DOI 10.1038/mi.2012.51; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Cameron TO, 2002, J IMMUNOL METHODS, V268, P51, DOI 10.1016/S0022-1759(02)00200-4; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Danke NA, 2003, J IMMUNOL, V171, P3163, DOI 10.4049/jimmunol.171.6.3163; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Glass Roger I, 2012, Trans Am Clin Climatol Assoc, V123, P36; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; Honeyman MC, 2010, J IMMUNOL, V184, P2204, DOI 10.4049/jimmunol.0900709; Jaimes MC, 2002, J VIROL, V76, P4741, DOI 10.1128/JVI.76.10.4741-4749.2002; Kwok WW, 2008, INFECT IMMUN, V76, P4538, DOI 10.1128/IAI.00324-08; Laughlin EM, 2007, INFECT IMMUN, V75, P1852, DOI 10.1128/IAI.01814-06; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mesa MC, 2010, VIROLOGY, V399, P77, DOI 10.1016/j.virol.2009.12.016; Nastke MD, 2012, J VIROL, V86, P4776, DOI 10.1128/JVI.06573-11; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Parra-Lopez C, 2006, J BIOL CHEM, V281, P14907, DOI 10.1074/jbc.M511571200; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Quah BJ, 2010, J VIS EXP, V44, pe2259; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Rojas OL, 2003, VIROLOGY, V314, P671, DOI 10.1016/S0042-6822(03)00507-5; Rojas OL, 2007, VIRAL IMMUNOL, V20, P300, DOI 10.1089/vim.2006.0105; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Rott LS, 1997, J CLIN INVEST, V100, P1204, DOI 10.1172/JCI119633; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schuler Mathias M., 2007, V409, P75; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vollers SS, 2008, IMMUNOLOGY, V123, P305, DOI 10.1111/j.1365-2567.2007.02801.x; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Zhao Wei, 2008, Virology (Auckl), V1, P9	42	16	19	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	MAR	2014	452						191	201		10.1016/j.virol.2014.01.014	http://dx.doi.org/10.1016/j.virol.2014.01.014			11	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	AD1NJ	24606696	Bronze, Green Accepted			2022-09-04	WOS:000333000400021
J	Arauz, A; Rodriguez-Agudelo, Y; Sosa, AL; Chavez, M; Paz, F; Gonzalez, M; Coral, J; Diaz-Olavarrieta, C; Roman, GC				Arauz, Antonio; Rodriguez-Agudelo, Yaneth; Luisa Sosa, Ana; Chavez, Mireya; Paz, Francisco; Gonzalez, Margarita; Coral, Juliana; Diaz-Olavarrieta, Claudia; Roman, Gustavo C.			Vascular Cognitive Disorders and Depression After First-Ever Stroke: The Fogarty-Mexico Stroke Cohort	CEREBROVASCULAR DISEASES			English	Article						Mexico; Post-stroke depression; Stroke; Vascular cognitive disorders; Vascular cognitive impairment; Vascular dementia	EXECUTIVE DYSFUNCTION SYNDROME; DIAGNOSTIC-CRITERIA; FOLLOW-UP; CEREBROVASCULAR-DISEASE; CLINICAL DETERMINANTS; POSTSTROKE DEPRESSION; DEMENTIA; FREQUENCY; IMPAIRMENT; PREVALENCE	Background and Purpose: Stroke is the major cause of vascular behavior and cognitive disorders worldwide. In developing countries, there is a dearth of information regarding the public health magnitude of stroke. The aim of the Fogarty-Mexico cohort was to assess the prevalence of vascular behavioral and cognitive disorders, ranging from mild vascular cognitive impairment (VCI) to vascular dementia (VaD), in a cohort of acute first-ever symptomatic stroke patients in Mexico. Methods: A total of 165 consecutive, first-ever stroke patients admitted to the National Institute of Neurology and Neurosurgery in Mexico City, were included in the cohort. Patients were eligible if they had an ischemic stroke, primary intracerebral hemorrhage, or cerebral venous thrombosis (CVT). Stroke diagnosis required the presence of an acute focal deficit lasting more than 24 h, confirmed by a corresponding lesion on CT/MRI. Stroke severity was established with the NIH Stroke Scale. The pre-stroke functional status was determined by the IQCODE. Three months after the occurrence of stroke, 110 survivor patients returned for follow-up and were able to undergo functional outcome (modified Rankin scale, Barthel index), along with neurological, psychiatric, neuropsychological, laboratory, and imaging assessments. We compared depression, demographic, and clinical and imaging features between patients with and without dementia, and between patients with VCI and those with intact cognition. Results: Of the 110 patients (62% men, mean age 56 +/- 17.8, education 7.7 +/- 5.2 years) 93 (84%) had ischemic strokes, 14 (13%) intracerebral hemorrhage, and 3 (3%) CVT. The main risk factors were hypertension (50%), smoking (40%), hypercholesterolemia (29%), hyperhomocysteinemia (24%), and diabetes (22%). Clinical and neuropsychological evaluations demonstrated post-stroke depression in 56%, VCI in 41%, and VaD in 12%; 17% of the latter had pre-stroke functional impairment (IQCODE > 3.5). Cognitive deficits included executive function in 69%, verbal memory in 49%, language in 38%, perception in 36%, and attention in 38%. Executive dysfunction occurred in 36% of non-demented subjects, 65% of them with mild-moderate deficits in daily living activities. Female gender (p <= 0.054), older age (mean age 65.6 years vs. 49.3, p < 0.001), diabetes (p <= 0.004), illiteracy and lower education (p <= 0.001), and PSD (p = 0.03) were significantly higher in VCI-VaD compared with cognitively intact post-stroke subjects. We could not demonstrate an association with lesion site and distribution of the cognitive deficits. Conclusions: The Fogarty-Mexico cohort recruited relatively young acute stroke patients, compared with other Mexican stroke cohorts. PSD and VCI occurred frequently but prevalence of VaD (12%) was lower than expected. A high prevalence of treatable stroke risk factors suggests that preventive interventions are advisable. (C) 2014 S. Karger AG, Basel	[Arauz, Antonio; Rodriguez-Agudelo, Yaneth; Luisa Sosa, Ana; Chavez, Mireya; Paz, Francisco; Gonzalez, Margarita; Diaz-Olavarrieta, Claudia] Natl Inst Neurol & Neurosurg Mexico, Mexico City 14269, DF, Mexico; [Coral, Juliana] Pontificia Univ Javeriana, Bogota, Colombia; [Roman, Gustavo C.] Methodist Neurol Inst, Houston, TX USA; [Roman, Gustavo C.] Weill Cornell Med Coll, Houston, TX USA		Arauz, A (corresponding author), Natl Inst Neurol & Neurosurg, Stroke Clin, Insurgentes 3877, Mexico City 14269, DF, Mexico.	antonio.arauz@prodigy.net.mx	Ortiz, Ana Luisa Sosa/AAU-9376-2021; Oliveros, Mireya Chávez -/AAU-3898-2020; Paz, Francisco/AAG-1381-2019	Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Oliveros, Mireya Chávez -/0000-0002-1064-2096; Paz, Francisco/0000-0003-4424-7067	National Institutes of Health (NIH), Fogarty Center [1R21TW06786-01]; FOGARTY INTERNATIONAL CENTER [R21TW006786] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Fogarty Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Fogarty-Mexico Stroke Cohort study was funded by a grant from the National Institutes of Health (NIH), Fogarty Center grant # 1R21TW06786-01 'Brain Disorders in the Developing World: Research Across the Lifespan.' The authors wish to thank patients and caregivers in Mexico City for participating in the study. Dr. Erika Mariana Longoria Ibarrola provided excellent editorial assistance.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; American Psychiatric Association (APA), 1994, AM PSYCHIATR ASSOC, V4th; Arauz A, 2006, CEREBROVASC DIS, V22, P150, DOI 10.1159/000093244; Arauz A, 2010, STROKE, V41, P717, DOI 10.1161/STROKEAHA.109.568790; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Cantu-Brito C, 2010, STROKE, V41, P878, DOI 10.1161/STROKEAHA.109.577726; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Jurado S, 1998, SALUD MENT, V21, P26; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, V4th; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Miralbell J, 2013, CEREBROVASC DIS, V36, P98, DOI 10.1159/000352059; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Paolo AM, 1997, J CLIN EXP NEUROPSYC, V19, P220, DOI 10.1080/01688639708403853; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Robinson RG, 2010, CAN J PSYCHIAT, V55, P341, DOI 10.1177/070674371005500602; Rockwood K, 2000, NEUROLOGY, V54, P447, DOI 10.1212/WNL.54.2.447; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; Roman GC, 2012, ALZ DIS ASSOC DIS, V26, P295, DOI 10.1097/WAD.0b013e31825cbc4b; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Serrano S, 2007, STROKE, V38, P105, DOI 10.1161/01.STR.0000251804.13102.c0; Sibolt G, 2013, CEREBROVASC DIS, V36, P336, DOI 10.1159/000355145; Teng EL, 1999, MANUAL COGNITIVE ABI; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Vataja R, 2005, AM J GERIAT PSYCHIAT, V13, P99, DOI 10.1176/appi.ajgp.13.2.99; Verdelho A, 2004, NEUROLOGY, V62, P905, DOI 10.1212/01.WNL.0000115107.66957.8C; Wechsler D., 2003, ESCALA WECHSLER INTE; WHO, 2013, WORLD HLTH STAT; Willis KJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00013	40	25	30	2	21	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.		2014	38	4					284	289		10.1159/000366471	http://dx.doi.org/10.1159/000366471			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	AW4QD	25412708	Bronze			2022-09-04	WOS:000346264800008
J	Stewart, DE; Dorado, LM; Diaz-Granados, N; Rondon, M; Saavedra, J; Posada-Villa, J; Torres, Y				Stewart, Donna E.; Dorado, Linda M.; Diaz-Granados, Natalia; Rondon, Marta; Saavedra, Javier; Posada-Villa, Jose; Torres, Yolanda			Examining gender equity in health policies in a low- (Peru), middle- (Colombia), and high- (Canada) income country in the Americas	JOURNAL OF PUBLIC HEALTH POLICY			English	Article						equity; gender; women; health policy; public health; evaluation	VIOLENCE; SEX; OPPORTUNITIES; INDICATORS; CHALLENGES	Gender inequities in health prevail in most countries despite ongoing attempts to eliminate them. Assessment of gender-sensitive health policies can be used to identify country specific progress as well as gaps and issues that need to be addressed to meet health equity goals. This study selected and measured the existence of gender-sensitive health policies in a low- (Peru), middle- (Colombia), and high (Canada)- income country in the Americas. Investigators selected 10 of 20 gender-sensitive health policy indicators and found eight to be feasible to measure in all three countries, although the wording and scope varied. The results from this study inform policy makers and program planners who aim to develop, improve, implement, and monitor national gender-sensitive health policies. Future studies should assess the implementation of policy indicators within countries and assess their performance in increasing gender equity. Journal of Public Health Policy (2009) 30, 439-454. doi: 10.1057/jphp.2009.40	[Stewart, Donna E.; Dorado, Linda M.; Diaz-Granados, Natalia] Univ Hlth Network Womens Hlth Program, Toronto, ON M5G 2C4, Canada; [Rondon, Marta] Univ Peruana Cayetano Heredia, Lima 11, Peru; [Saavedra, Javier] Inst Nacl Salud Mental, Lima 31, Peru; [Posada-Villa, Jose] Univ Javeriana, Bogota, Colombia; [Torres, Yolanda] Univ CES, Medellin 054591, Colombia		Stewart, DE (corresponding author), Univ Hlth Network Womens Hlth Program, 200 Elizabeth St,EN 7-229, Toronto, ON M5G 2C4, Canada.		Posada-Villa, José/AAA-2355-2019; Stewart, Donna Eileen E/J-2844-2016	Posada-Villa, José/0000-0001-5840-3118; Stewart, Donna Eileen E/0000-0002-8157-7746; Rondon, Marta/0000-0001-8459-6785; Saavedra, Javier Esteban/0000-0001-8403-5363	Canadian Institutes of Health Research, Institute of Gender and Health	Canadian Institutes of Health Research, Institute of Gender and Health(Canadian Institutes of Health Research (CIHR))	We thank the Canadian Institutes of Health Research, Institute of Gender and Health for support for this study.	Beck T., 1999, USING GENDER SENSITI; Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181; *CAN I HLTH RES, 2008, GLOB HLTH HLTH CAN H; *CAN MORTG, 2006, RES HIGHL SOC SER, P1; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Doyal L, 2003, INT J HEALTH SERV, V33, P569, DOI 10.2190/CWK2-U7R6-VCE0-E47P; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Doyal L, 2000, SOC SCI MED, V51, P931, DOI 10.1016/S0277-9536(00)00072-1; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Grace Sherry L, 2004, BMC Womens Health, V4 Suppl 1, pS15, DOI 10.1186/1472-6874-4-S1-S15; *HOSP REP RES COLL, 2001, HOSP REP 2001 PREL S, V2; *ILO, 2000, TRAD UN INF SECT COM; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; LIN V, 2003, COMP EVALUATION INDI, P1; Lin V, 2007, INT J PUBLIC HEALTH, V52, pS19, DOI 10.1007/s00038-006-6050-1; Lin V, 2007, INT J PUBLIC HEALTH, V52, pS27, DOI 10.1007/s00038-006-6049-7; Moss NE, 2002, SOC SCI MED, V54, P649, DOI 10.1016/S0277-9536(01)00115-0; *PAHO, 2001, EPIDEMIOLOGICAL B, V22; *PAHO, 2005, BAS IND GEND EQ AN H, P1; *PAHO, 2005, GEND HLTH DEV AM BAS; Phillips Susan P, 2005, Int J Equity Health, V4, P11, DOI 10.1186/1475-9276-4-11; Sen G, 2008, Glob Public Health, V3 Suppl 1, P1, DOI 10.1080/17441690801900795; Theobald S, 2005, HEALTH POLICY PLANN, V20, P141, DOI 10.1093/heapol/czi019; World Health Organisation:Promoting Mental Health, 2004, PHARM ENS SAF US MED, P1	26	9	10	0	8	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0197-5897	1745-655X		J PUBLIC HEALTH POL	J. Public Health Policy	DEC	2009	30	4					439	454		10.1057/jphp.2009.40	http://dx.doi.org/10.1057/jphp.2009.40			16	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	539EB	20029433				2022-09-04	WOS:000273235300009
J	Aliev, G; Palacios, HH; Walrafen, B; Lipsitt, AE; Obrenovich, ME; Morales, L				Aliev, Gjumrakch; Palacios, Hector H.; Walrafen, Brianna; Lipsitt, Amanda E.; Obrenovich, Mark E.; Morales, Ludis			Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Review						Alzheimer disease; Brain hypoperfusion; Mitochondrial failure; Neurodegeneration; Oxidative stress	ACETYL-L-CARNITINE; AMYLOID-PRECURSOR-PROTEIN; ALPHA-LIPOIC-ACID; CEREBRAL VESSEL WALLS; VASCULAR RISK-FACTORS; OXIDATIVE DAMAGE; NEURODEGENERATIVE DISEASES; APOLIPOPROTEIN-E; TRANSGENIC MICE; BETA-PROTEIN	Alzheimer's disease (AD) and cerebrovascular accidents are two leading causes of age-related dementia. Increasing evidence supports the idea that chronic hypoperfusion is primarily responsible for the pathogenesis that underlies both disease processes. In this regard, hypoperfusion appears to induce oxidative stress (OS), which is largely due to reactive oxygen species (ROS), and over time initiates mitochondrial failure which is known as an initiating factor of AD. Recent evidence indicates that chronic injury stimulus induces hypoperfusion seen in vulnerable brain regions. This reduced regional cerebral blood flow (CBF) then leads to energy failure within the vascular endothelium and associated brain parenchyma, manifested by damaged mitochondrial ultrastructure (the formation of large number of immature, electron-dense "hypoxic" mitochondria) and by overproduction of mitochondrial DNA(mtDNA) deletions. Additionally, these mitochondrial abnormalities co-exist with increased redox metal activity, lipid peroxidation, and RNA oxidation. Interestingly, vulnerable neurons and glial cells show mtDNA deletions and oxidative stress markers only in the regions that are closely associated with damaged vessels, and, moreover, brain vascular wall lesions linearly correlate with the degree of neuronal and glial cell damage. We summarize the large body of evidence which indicates that sporadic, late-onset AD results from a vascular etiology by briefly reviewing mitochondrial damage and vascular risk factors associated with the disease and then we discuss the cerebral microvascular changes reason for the energy failure that occurs in normal aging and, to a much greater extent, AD. (C) 2009 Elsevier Ltd. All rights reserved.	[Aliev, Gjumrakch; Palacios, Hector H.; Walrafen, Brianna] Univ Texas San Antonio, Dept Biol, Coll Sci, San Antonio, TX 78249 USA; [Aliev, Gjumrakch; Palacios, Hector H.; Walrafen, Brianna] Univ Texas San Antonio, Electron Microscopy Res Ctr, Coll Sci, San Antonio, TX 78249 USA; [Aliev, Gjumrakch; Morales, Ludis] Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, DC, Colombia; [Lipsitt, Amanda E.] Univ Texas Hlth Sci Ctr San Antonio, Div Infect Dis, Dept Med, San Antonio, TX 78229 USA; [Obrenovich, Mark E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA		Aliev, G (corresponding author), Univ Texas San Antonio, Dept Biol, Coll Sci, 1 UTSA Circle, San Antonio, TX 78249 USA.	aliev03@gmail.com	Aliev, Gjumrakch/K-7302-2017; Morales, Ludis/AAZ-7053-2020; Aliev, Gjumrakch/AAE-7734-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Morales-Alvarez, Ludis/0000-0002-8541-9729	Philip Morris USA Research Management	Philip Morris USA Research Management	Supported by the Philip Morris USA Research Management.	Acuna-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Aliev G., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P225; Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x; Aliev G, 2002, BRAIN PATHOL, V12, P21; ALIEV G, 1993, MICROVASC RES, V46, P65, DOI 10.1006/mvre.1993.1035; Aliev G, 1998, HISTOL HISTOPATHOL, V13, P797, DOI 10.14670/HH-13.797; ALIEV G, INT C ALZH IN PRESS; ALIEV G, 2000, SOC NEUROSCI ABS BOO, V30; Aliev G, 2008, NAT CLIN PRACT CARD, V5, P590, DOI 10.1038/ncpcardio1295; Aliev G, 2002, J ALZHEIMERS DIS, V4, P513; Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608; Aliev G, 2009, J CELL MOL MED, V13, P320, DOI 10.1111/j.1582-4934.2008.00324.x; Aliev G, 2008, MINI-REV MED CHEM, V8, P1395, DOI 10.2174/138955708786369582; Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040; Ames BN, 2004, ANN NY ACAD SCI, V1033, P108, DOI 10.1196/annals.1320.010; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Ames BN, 2004, J ALZHEIMERS DIS, V6, P117; Arancibia S., 2008, BRAIN RES REV; BATES KA, 2008, MOL PSYCHIAT; Beach TG, 2008, NEURODEGENER DIS, V5, P143, DOI 10.1159/000113685; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x; Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X; Bishop GM, 2002, NEUROBIOL AGING, V23, P1101, DOI 10.1016/S0197-4580(02)00050-7; Blass JP, 2002, NEUROBIOL AGING, V23, P1077, DOI 10.1016/S0197-4580(02)00036-2; Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0; Bragin Valentin, 2005, Am J Alzheimers Dis Other Demen, V20, P21, DOI 10.1177/153331750502000103; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; CIRILLO R, 1994, PHARMACOL RES, V29, P293, DOI 10.1016/1043-6618(94)80053-7; CIRILLO R, 1992, J CARDIOVASC PHARM, V20, P969, DOI 10.1097/00005344-199212000-00018; CORIA F, 1988, LAB INVEST, V58, P454; Cormier A, 2001, BRAIN RES, V900, P72, DOI 10.1016/S0006-8993(01)02254-5; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crawford JG, 1998, MED HYPOTHESES, V50, P25, DOI 10.1016/S0306-9877(98)90173-6; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606; de la Torre JC, 2008, J ALZHEIMERS DIS, V14, P353; de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681; de la Torre JC, 2006, NEUROL RES, V28, P637, DOI 10.1179/016164106X130362; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, NEUROBIOL AGING, V21, P331, DOI 10.1016/S0197-4580(00)00111-1; DeJong GI, 1997, ANN NY ACAD SCI, V826, P56; delaTorre JC, 1997, ANN NY ACAD SCI, V826, P75; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Etiene Dannie, 1998, J Alzheimers Dis, V1, P119; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; FRISTON KJ, 1991, ELECTROEN CLIN NEURO, P355; GALLE J, 1995, CIRCULATION, V92, P1582, DOI 10.1161/01.CIR.92.6.1582; Gandy S, 2005, LANCET NEUROL, V4, P452, DOI 10.1016/S1474-4422(05)70124-1; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; GRANGER DN, 1989, AM J PHYSIOL, V257, pG683, DOI 10.1152/ajpgi.1989.257.5.G683; Grant W.B., 1997, ALZHEIMERS DIS REV, V2, P42; Greenberg SM, 2003, NAT MED, V9, P389, DOI 10.1038/nm847; Hill JM, 2007, EXP EYE RES, V84, P801, DOI 10.1016/j.exer.2006.08.001; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Iwamoto N, 1997, ACTA NEUROPATHOL, V93, P334, DOI 10.1007/s004010050624; JAGUST WJ, 1988, NEUROLOGY, V38, P909, DOI 10.1212/WNL.38.6.909; Jakobovits A, 2000, METH MOL B, V136, P435; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; KAWAI M, 1990, AM J PATHOL, V137, P1435; Kisilevsky R, 1998, NAT MED, V4, P772, DOI 10.1038/nm0798-772; Kulnane LS, 2001, NEUROBIOL DIS, V8, P982, DOI 10.1006/nbdi.2001.0446; KUMAR A, 1990, J PSYCHIAT RES, V24, P97, DOI 10.1016/0022-3956(90)90050-Z; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Lee HG, 2006, AM J PATHOL, V169, P738, DOI 10.2353/ajpath.2006.060633; Letenneur L, 2004, BIOL RES, V37, P189, DOI 10.4067/S0716-97602004000200003; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINSEMAN DA, 2008, ANTIOXID REDOX SIGNA; Liu JK, 2004, ANN NY ACAD SCI, V1033, P117, DOI 10.1196/annals.1320.011; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; LONG J, 2008, NEUROCHEM RES; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; Mas E, 2006, DEMENT GERIATR COGN, V21, P198, DOI 10.1159/000090868; Matz RL, 2000, PHYSIOL RES, V49, P11; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Milgram NW, 2007, FASEB J, V21, P3756, DOI 10.1096/fj.07-8531com; Montine TJ, 1997, AM J PATHOL, V151, P1571; Moretra PI, 2007, J NEUROPATH EXP NEUR, V66, P525, DOI 10.1097/01.jnen.0000240476.73532.b0; Natte R, 1999, BRAIN RES, V828, P179, DOI 10.1016/S0006-8993(99)01361-X; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nunomura A, 1999, ANN NY ACAD SCI, V893, P362, DOI 10.1111/j.1749-6632.1999.tb07855.x; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Obrenovich ME, 2006, NEUROTOX RES, V10, P43, DOI 10.1007/BF03033333; Octave JN, 1995, ACTA NEUROL BELG, V95, P197; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Perry G, 1998, BRAIN RES, V791, P63, DOI 10.1016/S0006-8993(98)00006-7; Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; Rao AV, 2002, NUTR NEUROSCI, V5, P291, DOI 10.1080/1028415021000033767; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reddy PH, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31372; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Reid PC, 2007, J CELL MOL MED, V11, P383, DOI 10.1111/j.1582-4934.2007.00054.x; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; ROSES AD, 1995, EXP NEUROL, V132, P149, DOI 10.1016/0014-4886(95)90019-5; Sala A, 1996, BLOOD, V87, P1824; SALVATICO E, 1994, J CARDIOVASC PHARM, V24, P638, DOI 10.1097/00005344-199410000-00015; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SHENK JC, 2009, J NEUROL SCI; Shi J, 2002, J NUCL MED, V43, P1044; Smith JD, 1997, J INTERN MED, V242, P99, DOI 10.1046/j.1365-2796.1997.00197.x; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Smith MA, 1997, J NEUROSCI, V17, P2653; Smith MA, 1996, MOL CHEM NEUROPATHOL, V28, P41, DOI 10.1007/BF02815203; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Smith MA, 1998, FREE RADICAL BIO MED, V25, P898, DOI 10.1016/S0891-5849(98)00119-1; SMITH MA, 2000, BIOCHIM BIOPHYS ACTA, V1501, P139; SMITH MA, 1997, ALZHEIMER DIS REV, V2, P58; SMITH MA, 1996, ALZHEIMER DIS REV, V1, P63; Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; STEWART PA, 1992, LAB INVEST, V67, P734; STEWARTLEE AL, 1995, J CARDIOVASC PHARM, V25, P906, DOI 10.1097/00005344-199506000-00008; TAGLIAVINI F, 1990, LAB INVEST, V62, P761; Thomas AJ, 2000, ANN NY ACAD SCI, V903, P83, DOI 10.1111/j.1749-6632.2000.tb06353.x; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; VINTERS HV, 1988, ANN INTERN MED, V109, P41, DOI 10.7326/0003-4819-109-1-41; Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	160	82	85	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	OCT	2009	41	10			SI		1989	2004		10.1016/j.biocel.2009.03.015	http://dx.doi.org/10.1016/j.biocel.2009.03.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501AZ	19703659				2022-09-04	WOS:000270351100026
J	Ruiz-Garcia, M; Escobar-Armel, P; Alvarez, D; Mudry, M; Ascunce, M; Gutierrez-Espeleta, G; Shostell, JM				Ruiz-Garcia, M.; Escobar-Armel, P.; Alvarez, D.; Mudry, M.; Ascunce, M.; Gutierrez-Espeleta, G.; Shostell, J. M.			Genetic variability in four Alouatta species measured by means of nine DNA microsatellite markers: Genetic structure and recent bottlenecks	FOLIA PRIMATOLOGICA			English	Article						Alouatta; DNA microsatellites; bottlenecks; genetic structure	HOWLER MONKEYS ALOUATTA; F-STATISTICS; POPULATION; DIFFERENTIATION; DIVERSITY; POLYMORPHISMS; PATTERNS; GENUS	We used microsatellite DNA to study the population genetics of 4 Alouatta species from Central and South America. Our main findings include the following: ( 1) A. seniculus had the highest level of microsatellite variability while A. caraya and A. palliata had the lowest mean number of alleles per locus and the lowest expected heterozygosity, respectively; ( 2) the samples of A. seniculus and A. palliata came from different regions and were not in Hardy- Weinberg equilibrium ( HWE) which may indicate a Wahlund effect and differentiated gene pools - in contrast, A. macconnelli and A. caraya were in HWE; ( 3) the microsatellite genetic heterogeneity of the 4 Alouatta species was similar to the karyotype divergence found among these Alouatta species; the species pair with the lowest level of heterogeneity ( genetic differentiation) was A. seniculus/ A. caraya, while the Central American species, A. palliata, was highly differentiated from the other 3 South American species; ( 4) we recommend the establishment of a conservation plan to help protect A. caraya because the Cornuet and Luikart procedure demonstrated a recent bottleneck for this species. Copyright (C) 2007 S. Karger AG, Basel	Pontifica Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Genet,Grp Genet Poblaciones Biol Evolut, Bogota, DC, Colombia; Univ Buenos Aires, Fac Ciencias Exactas, Dept Biol, GIBE, RA-1053 Buenos Aires, DF, Argentina; Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; Penn State Univ, Dept Biol, Uniontown, PA USA		Ruiz-Garcia, M (corresponding author), Pontifica Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Genet,Grp Genet Poblaciones Biol Evolut, Cra 7A 43-82, Bogota, DC, Colombia.	mruiz@javeriana.edu.co	Ruiz-Garcia, Manuel/AAF-8191-2019; Alvarez, Diana/AAF-8172-2019; Ascunce, Marina/AAW-2139-2020	Ruiz-Garcia, Manuel/0000-0003-2820-2950; Alvarez, Diana/0000-0001-6700-8101				ARCHIE JW, 1985, EVOLUTION, V39, P623, DOI [10.1111/j.1558-5646.1985.tb00399.x, 10.2307/2408657]; Bonvicino CR, 2001, CHROMOSOMA, V110, P241, DOI 10.1007/s004120000128; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Cornuet JM, 1996, GENETICS, V144, P2001; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; DELIMA MMC, 1991, CYTOGENET GENOME RES, V57, P151; Ellsworth JA, 1998, MOL ECOL, V7, P657; Figueiredo Wilsea B., 1998, Neotropical Primates, V6, P73; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 1996, GENETICS, V144, P1933; Groves C. P., 2001, PRIMATE TAXONOMY; Hernandez-Camacho J., 1976, P35; James RA, 1997, AM J PHYS ANTHROPOL, V102, P329, DOI 10.1002/(SICI)1096-8644(199703)102:3<329::AID-AJPA3>3.0.CO;2-Q; Luikart G, 1998, J HERED, V86, P319; MALGREM LA, 1978, RECENT ADV PRIMATOL, P283; MALGREM LA, 1979, THESIS U CONNECTICUT; MELO ACA, 1992, PRIMATES, V33, P217, DOI 10.1007/BF02382751; Michalakis Y, 1996, GENETICS, V142, P1061; NASCIMENTO FF, 2005, CYTOGENET GENOME RES, V108, P78; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rogers J, 1996, AM J PRIMATOL, V38, P157, DOI 10.1002/(SICI)1098-2345(1996)38:2<157::AID-AJP4>3.0.CO;2-Y; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; Rousset F, 1997, GENETICS, V145, P1219; Ruiz-Garcia M., 2005, Primate Report, V71, P27; RUIZGARCIA M, IN PRESS PRIMATE REP; Rylands AB, 1997, PRIMATE CONSERVATION, V17, P46; Rylands Anthony B., 2000, Neotropical Primates, V8, P61; Sambrook J., 1989, MOL CLONING LAB MANU; Sampaio I, 1996, PRIMATES, V37, P65, DOI 10.1007/BF02382921; SAMPAIO MIC, 1991, INT J PRIMATOL, V12, P389, DOI 10.1007/BF02547619; SLATKIN M, 1995, GENETICS, V139, P457; Spong G, 2000, MOL ECOL, V9, P1773, DOI 10.1046/j.1365-294x.2000.01067.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.1111/j.1558-5646.1984.tb05657.x, 10.2307/2408641]; Witte SM, 1999, AM J PRIMATOL, V47, P75, DOI 10.1002/(SICI)1098-2345(1999)47:1<75::AID-AJP9>3.3.CO;2-T; WOLFHEIM JH, 1983, PRIMATES NEW WORLD D; WRIGHT S, 1951, ANN EUGENIC, V15, P323	40	19	23	0	15	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0015-5713	1421-9980		FOLIA PRIMATOL	Folia Primatol.		2007	78	2					73	87		10.1159/000097058	http://dx.doi.org/10.1159/000097058			15	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	173GQ	17303937				2022-09-04	WOS:000246861900001
J	Ruiz-Marvez, E; Ramirez, CA; Rodriguez, ER; Florez, MM; Delgado, G; Guzman, F; Gomez-Puertas, P; Requena, JM; Puerta, CJ				Ruiz-Marvez, Elizabeth; Augusto Ramirez, Cesar; Rocio Rodriguez, Eliana; Mellisa Florez, Magda; Delgado, Gabriela; Guzman, Fanny; Gomez-Puertas, Paulino; Maria Requena, Jose; Puerta, Concepcion J.			Molecular Characterization of Tc964, A Novel Antigenic Protein from Trypanosoma cruzi	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						chagas disease; leishmaniasis; Leishmania major; Trypanosoma cruzi; molecular modelling; serodiagnosis	SIGNAL RECOGNITION PARTICLE; B-CELL EPITOPES; CHAGAS-DISEASE; DIFFERENTIAL SERODIAGNOSIS; RECOMBINANT ANTIGEN; HEART-FAILURE; PREDICTION; LEISHMANIA; INFECTIONS; DIAGNOSIS	The Tc964 protein was initially identified by its presence in the interactome associated with the LYT1 mRNAs, which code for a virulence factor of Trypanosoma cruzi. Tc964 is annotated in the T. cruzi genome as a hypothetical protein. According to phylogenetic analysis, the protein is conserved in the different genera of the Trypanosomatidae family; however, recognizable orthologues were not identified in other groups of organisms. Therefore, as a first step, an in-depth molecular characterization of the Tc946 protein was carried out. Based on structural predictions and molecular dynamics studies, the Tc964 protein would belong to a particular class of GTPases. Subcellular fractionation analysis indicated that Tc964 is a nucleocytoplasmic protein. Additionally, the protein was expressed as a recombinant protein in order to analyze its antigenicity with sera from Chagas disease (CD) patients. Tc964 was found to be antigenic, and B-cell epitopes were mapped by the use of synthetic peptides. In parallel, the Leishmania major homologue (Lm964) was also expressed as recombinant protein and used for a preliminary evaluation of antigen cross-reactivity in CD patients. Interestingly, Tc964 was recognized by sera from Chronic CD (CCD) patients at different stages of disease severity, but no reactivity against this protein was observed when sera from Colombian patients with cutaneous leishmaniasis were analyzed. Therefore, Tc964 would be adequate for CD diagnosis in areas where both infections (CD and leishmaniasis) coexist, even though additional assays using larger collections of sera are needed in order to confirm its usefulness for differential serodiagnosis.	[Ruiz-Marvez, Elizabeth; Augusto Ramirez, Cesar; Rocio Rodriguez, Eliana; Puerta, Concepcion J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Invest Enfermedades Infecciosas, Carrera 7 40-62, Bogota, Colombia; [Mellisa Florez, Magda; Delgado, Gabriela] Univ Nacl Colombia, Fac Ciencias, Dept Farm, Grp Invest Inmunotoxicol, Carrera 30 45-01, Bogota, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma NBC, Ave Univ, Valparaiso 2373223, Chile; [Gomez-Puertas, Paulino] Univ Autonoma Madrid CBMSO, Ctr Biol Mol Severo Ochoa, Microbes Hlth & Welf Dept, CSIC UAM,Grp Modelado Mol, Madrid 28049, Spain; [Maria Requena, Jose] Univ Autonoma Madrid CBMSO, Grp Regulac Expres Gen Leishmania, Mol Biol Dept, CSIC UAM,Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Invest Enfermedades Infecciosas, Carrera 7 40-62, Bogota, Colombia.	elizabeth.ruiz@javeriana.edu.co; Ramirez-Segura.Cesar@mayo.edu; erodriguezg@javeriana.edu.co; mmflorezm@unal.edu.co; lgdelgadom@unal.edu.co; fanny.guzman@pucv.cl; pagomez@cbm.csic.es; jmrequena@cbm.csic.es; cpuerta@javeriana.edu.co	Gomez-Puertas, Paulino/G-8821-2014	Gomez-Puertas, Paulino/0000-0003-3131-729X; Ramirez, Cesar Augusto/0000-0002-2687-9880; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Ruiz Marvez, Elizabeth/0000-0003-1949-4736; Florez, Magda Melissa/0000-0002-5751-9773; Guzman Quimbayo, Fanny/0000-0002-7829-0568	Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias); Pontificia Universidad Javeriana [PPTA 120356933228]; Vicerrectoria de Investigacion from the Pontificia Universidad Javeriana [120813F0401200]; FEDER; Spanish Ministerio de Ciencia, Innovacion y Universidades/Agencia Estatal de Investigacion [RTC-2017-6494-1, RTI2018-094434-B-I00]; Minciencias convocatoria doctorados nacionales [647-2014]; convocatoria jovenes investigadores e innovadores [706-2015]; Network of Tropical Diseases Research RICET (Instituto de Salud Carlos III) [RD16/0027/0008]	Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias); Pontificia Universidad Javeriana; Vicerrectoria de Investigacion from the Pontificia Universidad Javeriana; FEDER(European Commission); Spanish Ministerio de Ciencia, Innovacion y Universidades/Agencia Estatal de Investigacion(Spanish Government); Minciencias convocatoria doctorados nacionales; convocatoria jovenes investigadores e innovadores; Network of Tropical Diseases Research RICET (Instituto de Salud Carlos III)(Instituto de Salud Carlos III)	This research was funded by Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias) and Pontificia Universidad Javeriana, research project ID PPTA 120356933228 granted to C.J.P. The article publication was funded by the Vicerrectoria de Investigacion from the Pontificia Universidad Javeriana, code 120813F0401200. The Network of Tropical Diseases Research RICET (RD16/0027/0008, Instituto de Salud Carlos III and co-funded by FEDER) to J.M.R., and grants from the Spanish Ministerio de Ciencia, Innovacion y Universidades/Agencia Estatal de Investigacion RTC-2017-6494-1 and RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) to P.G.-P., E.R.-M and E.R.R. were supported by Minciencias convocatoria doctorados nacionales 647-2014 and convocatoria jovenes investigadores e innovadores 706-2015, respectively.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Hernandez DA., 2018, REV MED HOSP GEN M X, V81, P154, DOI [10.1016/j.hgmx.2016.09.010, DOI 10.1016/J.HGMX.2016.09.010]; Andrew S.M., 2001, Curr. Protoc. Toxicol., V10; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; [Anonymous], PYMOL MOL GRAPH SYST; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Balouz V, 2017, ADV PARASIT, V97, P1, DOI 10.1016/bs.apar.2016.10.001; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Benabdellah K, 2007, MOL MICROBIOL, V65, P1559, DOI 10.1111/j.1365-2958.2007.05892.x; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Berna L, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000177; Bottino CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-568; Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI [10.1590/S0074-02761909000200008, DOI 10.1590/S0074-02761909000200008]; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9; Daltro RT, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00762-19, 10.1128/jcm.00762-19]; Das P, 2018, J MED CHEM, V61, P5664, DOI 10.1021/acs.jmedchem.8b00565; de la Vega Michelle, 2011, Small GTPases, V2, P192; Dumonteil E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005422; Egea PF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003619; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001; Flechas ID, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-186; Franzen O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-531; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001283; Fu XK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051445; Goody RS, 2017, BIOL CHEM, V398, P565, DOI 10.1515/hsz-2016-0274; Grisard EC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01114-13; Gupta I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26532-z; Guzman F, 2019, MAR DRUGS, V17, DOI 10.3390/md17080453; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Instituto Nacional de Salud, INF EV ENF CHAG COL; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson AP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-594; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lasso P, 2015, J IMMUNOL, V195, P3748, DOI 10.4049/jimmunol.1500459; Lobo M, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007245; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; MALCHIODI EL, 1994, CLIN EXP IMMUNOL, V97, P417, DOI 10.1111/j.1365-2249.1994.tb06104.x; Manning-Cela R, 2001, INFECT IMMUN, V69, P3916, DOI 10.1128/IAI.69.6.3916-3923.2001; Maslov DA, 2019, PARASITOLOGY, V146, P1, DOI 10.1017/S0031182018000951; Florez MM, 2017, PROTEIN PEPTIDE LETT, V24, P982, DOI 10.2174/0929866524666170728143924; Messenger LA, 2015, EXPERT REV ANTI-INFE, V13, P995, DOI 10.1586/14787210.2015.1056158; Meymandi S, 2018, CURR TREAT OPT INFEC, V10, P373, DOI 10.1007/s40506-018-0170-z; Minchin EA, 1910, NATURE, V84, P142, DOI 10.1038/084142a0; Montgomery SP, 2014, AM J TROP MED HYG, V90, P814, DOI 10.4269/ajtmh.13-0726; Mucci J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005972; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820; Organizacion Panamericana de la Salud, GUIA DIAGN TRAT ENF; Passos VMA, 1997, MEM I OSWALDO CRUZ, V92, P791, DOI 10.1590/S0074-02761997000600011; Pereira-da Silva L. H., 1953, Folia Clinica et Biologica Sao Paulo, V20, P191; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Ramirez C.A., 2017, P S OM TECHN RES INF, DOI [10.13140/RG.2.2.10639.94888, DOI 10.13140/RG.2.2.10639.94888]; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Ruíz Elizabeth, 2018, Univ. Sci., V23, P267, DOI 10.11144/javeriana.sc23-2.cotm; Ruiz-Marvez E., PROTEINS ASS UTRS LY; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wild K, 2004, MOL MICROBIOL, V53, P357, DOI 10.1111/j.1365-2958.2004.04139.x; Wild K, 2016, J MOL BIOL, V428, P2880, DOI 10.1016/j.jmb.2016.05.015; World Health Organization, CHAG DIS AM TRYP; Xu Lizhong, 2010, Curr Biol, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yancy CW, 2017, J AM COLL CARDIOL, V70, P776, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152; Zhang X., 2012, THESIS, DOI [10.1007/978-1-4419-7808-0, DOI 10.1007/978-1-4419-7808-0]	81	0	0	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2020	21	7							2432	10.3390/ijms21072432	http://dx.doi.org/10.3390/ijms21072432			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LR3DN	32244527	Green Published, gold			2022-09-04	WOS:000535574200174
J	Rudas, J; Martinez, D; Castellanos, G; Demertzi, A; Martial, C; Carriere, M; Aubinet, C; Soddu, A; Laureys, S; Gomez, F				Rudas, Jorge; Martinez, Darwin; Castellanos, Gabriel; Demertzi, Athena; Martial, Charlotte; Carriere, Manon; Aubinet, Charlene; Soddu, Andrea; Laureys, Steven; Gomez, Francisco			Time-Delay Latency of Resting-State Blood Oxygen Level-Dependent Signal Related to the Level of Consciousness in Patients with Severe Consciousness Impairment	BRAIN CONNECTIVITY			English	Article						disorders of consciousness; functional connectivity; latency; midcingulate cortex; resting-state networks; time delay	POSTERIOR CINGULATE CORTEX; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; CEREBRAL METABOLISM; CORTICAL ACTIVITY; VEGETATIVE STATE; BRAIN-INJURY; FMRI; DISORDERS; PRECISION	Recent evidence on resting-state functional magnetic resonance imaging (rs-fMRI) suggests that healthy human brains have a temporal organization represented in a widely complex time-delay structure. This structure seems to underlie brain communication flow, integration/propagation of brain activity, as well as information processing. Therefore, it is probably linked to the emergence of highly coordinated complex brain phenomena, such as consciousness. Nevertheless, possible changes in this structure during an altered state of consciousness remain poorly investigated. In this work, we hypothesized that due to a disruption in high-order functions and alterations of the brain communication flow, patients with disorders of consciousness (DOC) might exhibit changes in their time-delay structure of spontaneous brain activity. We explored this hypothesis by comparing the time-delay projections from fMRI resting-state data acquired in resting state from 48 patients with DOC and 27 healthy controls (HC) subjects. Results suggest that time-delay structure modifies for patients with DOC conditions when compared with HC. Specifically, the average value and the directionality of latency inside the midcingulate cortex (mCC) shift with the level of consciousness. In particular, positive values of latency inside the mCC relate to preserved states of consciousness, whereas negative values change proportionally with the level of consciousness in patients with DOC. These results suggest that the mCC may play a critical role as an integrator of brain activity in HC subjects, but this role vanishes in an altered state of consciousness.	[Rudas, Jorge] Univ Nacl Colombia, Inst Biotechnol, Bogota, Colombia; [Martinez, Darwin] Univ Nacl Colombia, Dept Comp Sci, Bogota, Colombia; [Martinez, Darwin] Univ Cent Colombia, Dept Comp Sci, Bogota, Colombia; [Castellanos, Gabriel] Pontificia Univ Javeriana, Dept Physiol Sci, Fac Med, Bogota, Colombia; [Demertzi, Athena] Univ Liege, Physiol Cognit Res Lab, GIGA Consciousness, GIGA Inst, Liege, Belgium; [Martial, Charlotte; Carriere, Manon; Aubinet, Charlene; Laureys, Steven] Univ Liege, Coma Sci Grp, GIGA Consciousness, Liege, Belgium; [Soddu, Andrea] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Gomez, Francisco] Univ Nacl Colombia, Dept Math, St 45 26-85, Bogota 111311, Colombia		Gomez, F (corresponding author), Univ Nacl Colombia, Dept Math, St 45 26-85, Bogota 111311, Colombia.	fagomezj@unal.edu.co	Martial, Charlotte/O-6703-2016; castellanos, gabriel/G-3358-2016; Demertzi, Athena/I-1251-2019; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Martial, Charlotte/0000-0001-6291-3460; castellanos, gabriel/0000-0001-8121-1552; Demertzi, Athena/0000-0001-8021-3759; Laureys, Steven/0000-0002-3096-3807; Aubinet, Charlene/0000-0001-5095-5583	James McDonnell Foundation; BIAL Foundation; Belgian National Funds for Scientific Research (FRS-FNRS); European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant [785907, SGA2, EU-H2020fetopenga686764]; European Space Agency, Mind Science Foundation; French Speaking Community Concerted Research Action; Public Utility Foundation; Fondazione Europea di Ricerca Biomedica; University Hospital of Lie'ge; department of Magdalena [55796]	James McDonnell Foundation; BIAL Foundation(Bial Foundation); Belgian National Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant; European Space Agency, Mind Science Foundation; French Speaking Community Concerted Research Action; Public Utility Foundation; Fondazione Europea di Ricerca Biomedica; University Hospital of Lie'ge; department of Magdalena	This work was supported by the James McDonnell Foundation, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 785907 (Human Brain Project SGA2), the Luminous project (EU-H2020fetopenga686764), the European Space Agency, Mind Science Foundation, the French Speaking Community Concerted Research Action, the Belgian inter-university attraction pole, the Public Utility Foundation ``Universite ' Europe ' enne du Travail,'' ``Fondazione Europea di Ricerca Biomedica,'' and the University and University Hospital of Lie ' ge. In addition, this work was further supported by the agreement between theGobernacio ' n del Magdalena and COLCIENCIAS (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologi ' a) for the education of high-quality human capital in the department of Magdalena, the project titled ``A functional activity maps for 1.5T fMRI data in resting-state'' at Universidad Nacional de Colombia and the project ``Caracterizacio ' n de la conectividad estructural y funcional del sistema reticular ascendente por medio de resonancia magne ' tica con tractografi ' a y BOLD, para la prediccio ' n del estado de conciencia en pacientes posreanimacio ' n o con lesio ' n cerebral trauma ' tica'' (Code: 55796) from programa nacional de ciencia, tecnologi ' a e innovacio ' n en salud of COLCIENCIAS 744.	Abrol A, 2017, NEUROIMAGE, V163, P160, DOI 10.1016/j.neuroimage.2017.09.020; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Basar E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00275; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Boerwinkle VL, 2019, NEUROL-CLIN PRACT, V9, pE33, DOI 10.1212/CPJ.0000000000000596; BRAAK H, 1976, BRAIN RES, V109, P219, DOI 10.1016/0006-8993(76)90526-6; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Buxton RB, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/9/096601; Caruana F, 2018, BRAIN, V141, P3035, DOI 10.1093/brain/awy219; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Crone JS, 2015, NEUROIMAGE, V110, P101, DOI 10.1016/j.neuroimage.2015.01.037; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davey CG, 2016, NEUROIMAGE, V132, P390, DOI 10.1016/j.neuroimage.2016.02.022; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Duggento A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23996-x; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Englot DJ, 2017, J NEUROL NEUROSUR PS, V88, P925, DOI 10.1136/jnnp-2017-315732; Eslami Taban, 2018, High Throughput, V7, DOI 10.3390/ht7020011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Georgiopoulos C, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101946; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goulden N, 2014, NEUROIMAGE, V99, P180, DOI 10.1016/j.neuroimage.2014.05.052; Havlicek M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00616; Imperatori LS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45289-7; Jin F, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1070; Konishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132209; Krieger-Redwood K, 2016, NEUROIMAGE, V141, P366, DOI 10.1016/j.neuroimage.2016.07.060; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lewis SM, 2005, EXP BRAIN RES, V165, P447, DOI 10.1007/s00221-005-2336-4; Lin P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46088; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lottman KK, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101959; Madsen KH, 2017, HUM BRAIN MAPP, V38, P882, DOI 10.1002/hbm.23425; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Marino S, 2016, BRAIN IMAGING BEHAV, V10, P604, DOI 10.1007/s11682-015-9417-1; Martinez DE, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1476; Martinez M, 2016, HUM BRAIN MAPP, V37, P1722, DOI 10.1002/hbm.23131; Mazaika P, 2009, METHODS SOFTWARE FMR; Meszlenyi RJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00075; Mitra A, 2014, J NEUROPHYSIOL, V111, P2374, DOI 10.1152/jn.00804.2013; Mitra A, 2018, NEURON, V98, P297, DOI 10.1016/j.neuron.2018.03.015; Mitra A, 2018, SCAND J PSYCHOL, V59, P83, DOI 10.1111/sjop.12422; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mitra A, 2015, ELIFE, V4, DOI 10.7554/eLife.10781; Mitra A, 2015, P NATL ACAD SCI USA, V112, pE2235, DOI 10.1073/pnas.1503960112; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Naci L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31525-z; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nikolic D, 2007, J COMPUT NEUROSCI, V22, P5, DOI 10.1007/s10827-006-9441-7; Palomero-Gallagher N, 2009, HUM BRAIN MAPP, V30, P2336, DOI 10.1002/hbm.20667; Persuh M, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00078; Pistoia F, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040047; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rincon AL, 2016, J NEUROSCI METH, V274, P94, DOI 10.1016/j.jneumeth.2016.09.011; Rudas J, 2014, IEEE ENG MED BIO, P2793, DOI 10.1109/EMBC.2014.6944203; Schiefer J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006056; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Siegel JS, 2016, J CEREBR BLOOD F MET, V36, P2162, DOI 10.1177/0271678X15614846; Sinitsyn DO, 2018, HUM BRAIN MAPP, V39, P2929, DOI 10.1002/hbm.24050; Sitaram R, 2019, BRAIN COGNITION, V131, P10, DOI 10.1016/j.bandc.2018.11.007; Tak S, 2018, J NEUROSCI METH, V305, P36, DOI 10.1016/j.jneumeth.2018.05.002; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vodrahalli K, 2018, NEUROIMAGE, V180, P223, DOI 10.1016/j.neuroimage.2017.06.042; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Weng YF, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00218; You YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064509; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zimmermann M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213371	84	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	MAR 1	2020	10	2					83	94		10.1089/brain.2019.0716	http://dx.doi.org/10.1089/brain.2019.0716			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB8RL	32195610	Green Submitted			2022-09-04	WOS:000524897600004
J	Boltz, M; Chort, I				Boltz, Marie; Chort, Isabelle			The Risk of Polygamy and Wives' Saving Behavior	WORLD BANK ECONOMIC REVIEW			English	Article						Polygamy; savings; intra-household resource allocation; consumption; survival analysis	POLYGYNY; ECONOMICS; DIVORCE; HAZARDS; AFRICA	In a polygamous society, all monogamous women are potentially at risk of polygamy. However, both the anthropological and economic literatures are silent on the potential impact of the risk of polygamy on economic decisions of monogamous wives. We explore this issue for Senegal using individual panel data. We first estimate a Cox model for the probability of transition to polygamy. Second, we estimate the impact of the predicted risk of polygamy on monogamous wives' savings. We find a positive impact of the risk of polygamy on female savings entrusted to formal or informal institutions suggestive of self-protective strategies. This increase in savings comes at the cost of reduced consumption, both in terms of household food expenditures and wives' private nonfood expenses.	[Boltz, Marie] Pontificia Univ Javeriana, Dept Business Adm, Bogota, Colombia; [Chort, Isabelle] PSL Res Univ, Univ Paris Dauphine, IRD, LEDa,DIAL, F-75016 Paris, France		Chort, I (corresponding author), PSL Res Univ, Univ Paris Dauphine, IRD, LEDa,DIAL, F-75016 Paris, France.	marie_boltz@javeriana.edu.co; isabelle.chort@dauphine.fr			European Union under the 7th Research Framework Programme [290752, SSH. 2011.1]	European Union under the 7th Research Framework Programme	Marie Boltz is with the Department of Business Administration, Pontificia Universidad Javeriana, Bogota, Colombia; her e-mail address is marie_boltz@javeriana.edu.co.Isabelle Chort (corresponding author) is with the Universite Paris-Dauphine, PSL Research University, IRD, LEDa, DIAL, 75016 Paris, France; her e-mail address isisabelle.chort@dauphine.fr.We would like to thank the editor Andrew Foster, three anonymous referees, Luc Arrondel, Jean-Marie Baland, Xavier Gine, Laurent Gobillon, Marc Gurgand, Sergei Guriev, Kenneth Houngbedji, Elise Huillery, Alain de Janvry, Sylvie Lambert, Karine Marazyan, Joan Monras, Pauline Rossi, Elisabeth Sadoulet, and Denni Tommasi for precious comments and suggestions, and Philippe De Vreyer and Sylvie Lambert for providing us with the PSF data. This research is part of the NOPOOR project, which is funded by the European Union under the 7th Research Framework Programme (Theme SSH. 2011.1) - Grant Agreement No. 290752. We are also grateful to participants to the 2015 DIAL Development Conference at the Universite Paris-Dauphine, the 2015 German Economic Association, the Research Group on Development Economics Conference in Kiel, the 2015 Journeesde Microeconomie Appliquee in Montpellier, the 2015 Annual Conference of the Royal Economic Society in Manchester, the 2015 CSAE Conference in Oxford, the 2015 Annual Doctoral Conference of the Association for the Development of Research in Economics and Statistics at the Centre d'Economie de la Sorbonne in Paris, the 2014 Northeast Universities Development Consortium Conference at Boston University, the 2014 Jamboree conference of the European Doctoral Program in Quantitative Economics at the Paris School of Economics, the 2014 5th GRETHA International Conference on Economic Development in Bordeaux, and the audience to seminar presentations at the Paris School of Economics. A supplementary online appendix to this article is available at https://academic.oup.com/wber.	Anderson S, 2002, Q J ECON, V117, P963, DOI 10.1162/003355302760193931; Antoine P, 2002, DT200206 DIAL; Ashraf N, 2009, AM ECON REV, V99, P1245, DOI 10.1257/aer.99.4.1245; Becker G, 1974, EC FAMILY MARRIAGE C, P299, DOI DOI 10.2307/2780254; Boltz M, 2016, PSE WORKING PAPERS; Boltz-Laemmel M, 2013, AUTREPART, P67; Bove R, 2009, SOC SCI MED, V68, P21, DOI 10.1016/j.socscimed.2008.09.045; Browning M, 2000, SCAND J ECON, V102, P235, DOI 10.1111/1467-9442.00197; Castilla C, 2013, GENDER ROLES A UNPUB; Dauphin A, 2001, ECON LETT, V71, P211, DOI 10.1016/S0165-1765(01)00373-1; Dauphin A, 2013, 1323 CIRPEE; De Laiglesia J. R., 2008, OECD DEV CTR WORKING, V267; Fenske J, 2015, J DEV ECON, V117, P58, DOI 10.1016/j.jdeveco.2015.06.005; Gonzalez L, 2013, J HUM RESOUR, V48, P404; GROSSBARD A, 1976, CURR ANTHROPOL, V17, P701, DOI 10.1086/201804; Grossbard A.S., 1980, RES POPUL ECOL, V2, P321; Grossbard S., 2014, MARRIAGE MOTIVE PRIC; GROSSBARDSHECHTMAN A, 1986, J ECON BEHAV ORGAN, V7, P415, DOI 10.1016/0167-2681(86)90014-4; JACOBY HG, 1995, J POLIT ECON, V103, P938, DOI 10.1086/262009; Jacoby HG, 2002, AM ECON REV, V92, P1420, DOI 10.1257/000282802762024575; Kureishi W, 2013, REV ECON HOUSEHOLD, V11, P681, DOI 10.1007/s11150-013-9191-z; Lambert S, 2015, WORKING PAPER; Lambert S, 2014, J DEV ECON, V110, P327, DOI 10.1016/j.jdeveco.2014.05.007; LOCOH T, 1995, POPULATION, V50, P61, DOI 10.2307/1533793; Madhavan S, 2002, ETHNOLOGY, V41, P69, DOI 10.2307/4153021; Papps K. L, 2006, 2395 IZA; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sangeetha Madhavan, 2001, Culture, Health & Sexuality, V3, P451, DOI 10.1080/13691050110074219; Sylla M., 2008, STATECO, V102, P5; Tertilt M, 2005, J POLIT ECON, V113, P1341, DOI 10.1086/498049; Udry C, 1996, J POLIT ECON, V104, P1010, DOI 10.1086/262050	31	3	3	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0258-6770	1564-698X		WORLD BANK ECON REV	World Bank Econ. Rev.	FEB	2019	33	1					209	230		10.1093/wber/lhw054	http://dx.doi.org/10.1093/wber/lhw054			22	Business, Finance; Development Studies; Economics	Social Science Citation Index (SSCI)	Business & Economics; Development Studies	HU0HB		Green Submitted			2022-09-04	WOS:000464950900010
J	Easton, JF; Stephens, CR; Roman-Sicilia, H; Cesari, M; Perez-Zepeda, MU				Easton, Jonathan F.; Stephens, Christopher R.; Roman-Sicilia, Heriberto; Cesari, Matteo; Ulises Perez-Zepeda, Mario			Anthropometric measurements and mortality in frail older adults	EXPERIMENTAL GERONTOLOGY			English	Article						Frailty; Mortality; Body mass index; Anthropometric measures	BODY-MASS INDEX; MEXICAN HEALTH; TERM; OBESITY; PEOPLE; CARE	Background: As the number of older adults increases, so does the number of frail older adults. Although anthropometry has been widely used as a way to stratify the overall mortality risk of a person, the significance of these measurements becomes blurred in the case of frail older adults who have changes in body composition. Therefore, the aim of this study is to determine the association of anthropometric measurements (body mass index, knee-adjusted height body mass index, waist-to-hip ratio and calf circumference) with mortality risk in a group of older Mexican adults. Methods: This is a longitudinal analysis of the Mexican Health and Aging sub-sample (with biomarkers, n = 2573) from the first wave in 2001, followed-up to the last available wave in 2015. Only frail 50-year or older adults (Frailty Index with a cut-off value of 0.21 or higher, was used) were considered for this analysis (n = 1298). A survival analysis was performed with Kaplan-Meier curves and Cox regression models (unadjusted and adjusted for confounding). Socio-demographic, health risks, physical activity and comorbidities were variables used for adjusting the multivariate models. Results: From the total sample of 1298 older adults, 32.5% (n = 422) died during follow-up. The highest hazard ratio in the adjusted model was for calf circumference 1.31 (95% confidence interval 1.02-1.69, p = 0.034). Other measurements were not significant. Conclusions: Anthropometric measurements have different significance in frail older adults, and these differences could have implications on adverse outcomes. Calf circumference has a potential value in predicting negative health outcomes.	[Easton, Jonathan F.; Stephens, Christopher R.; Roman-Sicilia, Heriberto] Univ Nacl Autonoma Mexico, C3, Ciudad De Mexico, Mexico; [Easton, Jonathan F.; Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad De Mexico, Mexico; [Cesari, Matteo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy; [Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Mexico City, DF, Mexico; [Cesari, Matteo] Univ Milan, Dept Clin Sci & Community, Milan, Italy; [Ulises Perez-Zepeda, Mario] Pontificia Univ Javeriana, Fac Med, Inst Envejecimiento, Bogota, Colombia		Perez-Zepeda, MU (corresponding author), Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Res Unit, Av Contreras 428, Mexico City, DF, Mexico.	mperez@inger.gob.mx	Cesari, Matteo/A-4649-2008; Perez-Zepeda, Mario/B-7265-2011	Cesari, Matteo/0000-0002-0348-3664; Perez-Zepeda, Mario/0000-0003-4374-976X; Easton, Jonathan F./0000-0002-4871-872X	NIH [R01 AG018016]; CONACYT Fronteras [FC-2015-2/1093]; NATIONAL INSTITUTE ON AGING [R01AG018016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACYT Fronteras; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Mexican Health and Aging Study was partially funded by NIH R01 AG018016 (PI Rebeca Wong). The manuscript was supported by CONACYT Fronteras grant FC-2015-2/1093.	Aalen OO, 2015, INT J EPIDEMIOL, V44, P1408, DOI 10.1093/ije/dyu192; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Cesari M, 2011, J NUTR HEALTH AGING, V15, P663, DOI 10.1007/s12603-011-0336-6; Cesari M, 2016, J AM MED DIR ASSOC, V17, P448, DOI 10.1016/j.jamda.2016.02.007; Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016; Dent E, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12130; Easton Jonathan F, 2017, BMC Obes, V4, P16, DOI 10.1186/s40608-017-0152-6; Easton JF, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00012; Easton JF, 2014, COMPUT BIOL MED, V54, P199, DOI 10.1016/j.compbiomed.2014.09.003; Elder JP, 2013, SALUD PUBLICA MEXICO, V55, pS355; Carrillo-Vega MF, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-016-0297-9; Garcia-Gonzalez J. J., 2009, BMC Geriatrics, V9; Garcia-Pena C, 2016, EXP GERONTOL, V79, P55, DOI 10.1016/j.exger.2016.03.016; Guigoz Y, 1997, Ther Umsch, V54, P345; Gutierrez-Robledo LM, 2002, J GERONTOL A-BIOL, V57, pM162, DOI 10.1093/gerona/57.3.M162; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Hogan David B, 2003, Aging Clin Exp Res, V15, P1; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Jung HW, 2014, J AM GERIATR SOC, V62, P2110, DOI 10.1111/jgs.13107; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; Lustgarten MS, 2011, J NUTR HEALTH AGING, V15, P368, DOI 10.1007/s12603-011-0049-x; Mendoza-Nunez VM, 2002, AM J HUM BIOL, V14, P351, DOI 10.1002/ajhb.10029; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Organization W. H, 2017, OB DAT; Salud S. D, 2017, MAS VALE PREVENIR CH; Salud S. D, 1998, NORMA OFICIAL MEXICA; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; Zunzunegui MV, 2012, J AGING HEALTH, V24, P29, DOI 10.1177/0898264311408419; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; Wong Rebeca, 2007, Salud pública Méx, V49, ps436; Wong R, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyu263; Zaslavsky O, 2016, J AM GERIATR SOC, V64, P277, DOI 10.1111/jgs.13930	36	13	14	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	SEP	2018	110						61	66		10.1016/j.exger.2018.05.011	http://dx.doi.org/10.1016/j.exger.2018.05.011			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	GR2HA	29775746	Green Accepted			2022-09-04	WOS:000442386400009
J	Visca, J; Gallegos, M; Lopez, WL; Polanco, R; Cervigni, M				Visca, Jorge; Gallegos, Miguel; Lopez Lopez, Wilson; Polanco, Roberto; Cervigni, Mauricio			THE JOURNALS OF PSYCHOLOGY IN ARGENTINA: HISTORICAL REVIEW AND CURRENT SITUATION	REVISTA ARGENTINA DE CLINICA PSICOLOGICA			Spanish	Review						Psychology in Argentina; Journal of Psychology; History of Psychology	IMPACT FACTOR; AMERICA	This paper examined the most common publishing journals of psychology in Argentina. The databases of the National Council for Scientific and Technological Information (Consejo Nacional de Investigaciones Cientificas y Tecnicas) were used to identify the significant journals in the fields of humanities and social sciences. The Council proposes specific guidelines for publications following the Bill 2249/14. As such, the journals of psychology go through a three level category systematic process. Results comprised of 49 psychology journals. Journals were further analyzed examining their index criteria, publishing characteristics and the editorial management. It is considered that even when the edition of psychology journals in Argentina has an important trajectory throughout the twentieth century, it was just in the 1990s, when it was possible to project several journals with sufficient solidity and editorial maturity.	[Visca, Jorge] UNMdP, Mar Del Plata, Buenos Aires, Argentina; [Gallegos, Miguel] Univ Catolica Maule, Curico, Chile; [Lopez Lopez, Wilson] Univ Javeriana, Bogota, Colombia; [Polanco, Roberto] Asociac Chilena Revistas Cient Psicol, Santiago, Chile; [Cervigni, Mauricio] Univ Nacl Rosario, Rosario, Santa Fe, Argentina		Visca, J (corresponding author), UNMdP, Mar Del Plata, Buenos Aires, Argentina.		López López, Wilson/AAV-8032-2021; Gallegos, Miguel/AAX-6132-2020	López López, Wilson/0000-0002-2964-0402; Gallegos, Miguel/0000-0001-6891-7833; Polanco-Carrasco, Roberto/0000-0002-5064-9049				Alarcon R., 2002, ESTUDIOS PSICOLOGIA; Alarcon R., 2004, REV INTERAM PSICOL, V38, P307; Amil A, 2005, ACTA PSIQUIATRICA PS, V51; Ardila R., 2003, PERSPECTIVAS PSICOLO, V3-4, P7; Ardila R., 1986, PSICOLOGIA AM LATINA; Ardila R., 2004, REV INTERAMERICANA P, V38, P317; Ávila-Toscano José Hernando, 2016, Psicol. caribe, V33, P66, DOI 10.14482/psdc.33.1.8063; Barletta A. M., 2011, ARCHIVOS CIENCIAS ED, V5, P17; Berra M., 2012, CUADERNOS SOCIALES, V12, P123; Bregman C, 2015, TER PSICOL, V33, P205, DOI 10.4067/S0718-48082015000300005; Buela-Casal G, 2004, PSICOTHEMA, V16, P680; Buela-Casal G, 2003, PSICOTHEMA, V15, P23; Buela-Casal G., 2005, REV LATINOAMERICANA, V37, P211; Caan W, 2011, J PUBLIC MENT HEALTH, V10, P190, DOI 10.1108/jpmh.2011.10.3.190.1; CARDOSO SAMPAIO MARIA IMACULADA, 2012, Rev. colomb. psicol., V21, P111; Dagfal Alejandro, 2009, ENTRE PARIS BUENOS A; Di Dom?nico C., 2011, PSICOLATINA, V22, P1; Foradori A., 1954, PSICOLOGIA AM; Gallegos M, 2005, REV LAT AM PSICOL, V37, P641; Gallegos M, 2010, 2 C INT INV PRACT PR, V3, P84; Gallegos M., 2016, ENSENANZA INVESTIGAC, V21, P319; Gallegos M., 2016, HIST LOCAL PSICOLOGI, P303; Gallegos Miguel, 2017, Rev. psicol., V26, P166, DOI 10.5354/0719-0581.2017.46511; Gallegos Miguel, 2014, Psicoperspectivas, V13, P106, DOI 10.5027/psicoperspectivas-Vol13-Issue3-fulltext-377; GALLEGOS MIGUEL, 2010, Univ. Psychol., V9, P911; Gentile A., 2003, ENSAYOS HIST PSICOAN; Gonzalez E. N., 2015, UNIV PSYCHOL, V14, P15; GUTIÉRREZ GERMÁN, 2012, Rev. colomb. psicol., V21, P7; Gutierrez G, 2009, REV LAT AM PSICOL, V41, P413; Avila-Toscano JH, 2014, AV PSICOL LATINOAM, V32, P167, DOI 10.12804/apl32.1.2014.12; Kirsch U., 2005, 12 JORN INV, V3, P209; Klappenbach H, 2000, REV LAT AM PSICOL, V32, P419; Klappenbach H., 1999, ACTA PSIQUIATRICA PS, V45, P303; Klappenbach H, 2000, PSIQUIATRIA PSICOLOG, P269; Klappenbach H., 2011, REV ARGENTINA PSICOL, V50, P44; Klappenbach H., 2008, REV PSICOLOGIA LA PL, V10, P13; KLAPPENBACH HA, 1994, REV LAT AM PSICOL, V26, P445; Klappenbach H, 2015, UNIV PSYCHOL, V14, P937, DOI 10.11144/Javeriana.upsy14-3.fupa; Klappenbach Hugo, 2003, Psicol. Estud., V8, P3, DOI 10.1590/S1413-73722003000200002; Klappenbach Hugo, 2012, REV INTERAMERICANA P, V46, P181; Liberatore G., 2008, REV INTERAM PSICOL, V42, P507; Liberatore G., 2009, 1 C INT INV PRACT PR; Liberatore G., 2014, PERSPECTIVAS PSICOLO, V11, P6; Liberatore G, 2006, PERSPECTIVAS PSICOLO, V3, P44; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; López-López Wilson, 2010, Univ. Psychol., V9, P607; Marinelarena-Dondena L, 2010, PSICODEBATE-PSICOL C, V10, P9, DOI 10.18682/pd.v10i0.386; Morales Y. J. G., 2012, REV COLOMB PSICOL, V21, P97; Navarlaz V.E., 2008, REV ANUARIO INVESTIG, V15, P151; Gonzalez EN, 2008, REV ARGENT CLIN PSIC, V17, P277; PAPINI MR, 1976, REV LAT AM PSICOL, V8, P319; Plotkin Mariano, 2003, FREUD EN LAS PAMPAS; Polanco-Carrasco R., 2016, CUADERNOS NEUROPSICO, V10, P10, DOI [10.7714/CNPS/10.3.101, DOI 10.7714/CNPS/10.3.101]; Polanco-Carrasco R, 2017, TER PSICOL, V35, P81; Polanco-Carrasco R, 2015, CUAD NEUROPSICOL, V9, P10; Quevedo-Blasco R, 2013, PSICOTHEMA, V25, P93, DOI 10.7334/psicothema2012.282; Ravelo E. L, 2016, ACTA COLOMB PSICOL, V19, P281, DOI DOI 10.14718/ACP.2016.19.2.12; Rojas Breu G., 2005, 12 JORN INV, V3, P221; Rossi L., 2013, DISCURSO PSICOLOGICO; Rossi L., 2004, ANU INVEST, V12, P299; Rossi L. A., 2008, ANU INVEST, V15, P161; Rossi Lucía A., 2007, Anu. investig., V14; Salas Gonzalo, 2017, Psykhe, V26, P1, DOI 10.7764/psykhe.26.1.1205; SCImago journal Rank, 2015, RANK REV PSIC LAT SE; Sosa JJS, 2001, INT J PSYCHOL, V36, P384, DOI 10.1080/00207590143000216; Garcia-Martinez AT, 2012, UNIV PSYCHOL, V11, P699; Vilanova A, 1999, PSICOLOGIA CONO DATO; Vilanova A, 1999, FORMACION PSICOLOGOS; Vilanova A., 2001, ACTA PSIQUIATRICA PS, V47, P73; Villalobos-Galvis F, 2007, REV LAT AM PSICOL, V39, P593; Weismann P, 1999, CUARENTA CINCO ANOS; Ynoub R.C., 2004, INVESTIGACIONES PSIC, V1, P129; Zych I, 2010, UNIV PSYCHOL, V9, P27, DOI 10.11144/Javeriana.upsy9-1.irpm	73	2	5	0	8	FUNDACION AIGLE	BUENOS AIRES	VIRREY OLAGUER FELIU 2679, BUENOS AIRES, 00000, ARGENTINA	0327-6716			REV ARGENT CLIN PSIC	Rev. Argent. Clin. Psicol.	SEP	2018	27	3					478	491		10.24205/03276716.2018.1076	http://dx.doi.org/10.24205/03276716.2018.1076			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GS9BD		Green Published			2022-09-04	WOS:000444009200011
J	Kosenko, EA; Tikhonova, LA; Montoliu, C; Barreto, GE; Aliev, G; Kaminsky, YG				Kosenko, Elena A.; Tikhonova, Lyudmila A.; Montoliu, Carmina; Barreto, George E.; Aliev, Gjumrakch; Kaminsky, Yury G.			Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease	FRONTIERS IN NEUROSCIENCE			English	Review						Alzheimer's disease; amyloid beta; erythrocytes; metabolic dysfunction; multilayered pathology; clinical manifestation	AMYLOID-BETA-PROTEIN; RED-BLOOD-CELLS; TRAUMATIC BRAIN-INJURY; REDUCED GLUCOSE-TRANSPORTER; NEURONAL OXIDATIVE STRESS; D-ASPARTATE RECEPTOR; SPINAL-CORD TRAUMA; HEALTHY OLD-PEOPLE; A-BETA; PRECURSOR PROTEIN	Alzheimer's disease (AD) is a slowly progressive, neurodegenerative disorder of uncertain etiology. According to the amyloid cascade hypothesis, accumulation of non-soluble amyloid beta peptides (A beta) in the Central Nervous System (CNS) is the primary cause initiating a pathogenic cascade leading to the complex multilayered pathology and clinical manifestation of the disease. It is, therefore, not surprising that the search for mechanisms underlying cognitive changes observed in AD has focused exclusively on the brain and A beta-inducing synaptic and dendritic loss, oxidative stress, and neuronal death. However, since A beta depositions were found in normal non-demented elderly people and in many other pathological conditions, the amyloid cascade hypothesis was modified to claim that intraneuronal accumulation of soluble A beta oligomers, rather than monomer or insoluble amyloid fibrils, is the first step of a fatal cascade in AD. Since a characteristic reduction of cerebral perfusion and energy metabolism occurs in patients with AD it is suggested that capillary distortions commonly found in AD brain elicit hemodynamic changes that alter the delivery and transport of essential nutrients, particularly glucose and oxygen to neuronal and glial cells. Another important factor in tissue oxygenation is the ability of erythrocytes (red blood cells, RBC) to transport and deliver oxygen to tissues, which are first of all dependent on the RBC antioxidant and energy metabolism, which finally regulates the oxygen affinity of hemoglobin. In the present review, we consider the possibility that metabolic and antioxidant defense alterations in the circulating erythrocyte population can influence oxygen delivery to the brain, and that these changes might be a primary mechanism triggering the glucose metabolism disturbance resulting in neurobiological changes observed in the AD brain, possibly related to impaired cognitive function. We also discuss the possibility of using erythrocyte biochemical aberrations as potential tools that will help identify a risk factor for AD.	[Kosenko, Elena A.; Tikhonova, Lyudmila A.; Kaminsky, Yury G.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Russia; [Montoliu, Carmina] INCLIVA Inst Invest Sanit, Fdn Invest Hosp Clin, Valencia, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Inst Inc, San Antonio, TX 78229 USA		Kosenko, EA (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Inst Inc, San Antonio, TX 78229 USA.	eakos@rambler.ru; aliev03@gmail.com	Tikhonova, Lyudmila A/N-3194-2017; Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020; Montoliu, Carmina/ABB-1904-2021; Kosenko, Elena A/N-3224-2017	Tikhonova, Lyudmila A/0000-0001-6310-0242; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Kosenko, Elena A/0000-0002-3293-652X	RFBR; Moscow region [17-44-500561]	RFBR(Russian Foundation for Basic Research (RFBR)); Moscow region	The reported study was funded by RFBR and Moscow region according to the research project No 17-44-500561.	ACKERMAN WJ, 1974, WESTERN J MED, V121, P428; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Ajmani RS, 2003, CLIN HEMORHEOL MICRO, V28, P29; Ajmani RS, 1998, GERONTOLOGY, V44, P111, DOI 10.1159/000021993; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; ALEXANDER MP, 1980, NEUROLOGY, V30, P1193, DOI 10.1212/WNL.30.11.1193; Alexandrovich YG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5849593; Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Aliev G, 2003, J BIOMED BIOTECHNOL, P162; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Aliev G, 2011, CNS NEUROL DISORD-DR, V10, P147, DOI 10.2174/187152711794480492; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ARAI H, 1992, BRAIN RES, V585, P386, DOI 10.1016/0006-8993(92)91242-7; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Atkins R, 1878, Br Med J, V2, P96; Atkins R., 1875, DUBLIN J MED SCI, V60, P314, DOI [10.1007/BF02975691, DOI 10.1007/BF02975691, 10.1007/BF0297569]; Attems J, 2004, ACTA NEUROPATHOL, V107, P83, DOI 10.1007/s00401-003-0796-9; Atwood CS, 2002, J ALZHEIMERS DIS, V4, P203, DOI 10.3233/JAD-2002-4310; Atwood CS, 2003, BRAIN RES REV, V43, P1, DOI 10.1016/S0165-0173(03)00174-7; AUER R, 1985, ACTA NEUROPATHOL, V67, P279, DOI 10.1007/BF00687813; AUER RN, 1993, BAILLIERE CLIN ENDOC, V7, P611, DOI 10.1016/S0950-351X(05)80210-1; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Baez E, 2017, NEUROTOX RES, V32, P163, DOI 10.1007/s12640-017-9733-x; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Bagnara GP, 2000, J GERONTOL A-BIOL, V55, pB61; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; BAKER RF, 1967, NATURE, V215, P424, DOI 10.1038/215424a0; Balin B J, 2001, J Am Osteopath Assoc, V101, pS1; Bapat R D, 1983, J Postgrad Med, V29, P29; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1991, J NEUROCHEM, V57, P1068, DOI 10.1111/j.1471-4159.1991.tb08258.x; BEUTLER E, 1969, TRANSFUSION, V9, P109, DOI 10.1111/j.1537-2995.1969.tb05527.x; Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; Blass JP, 2003, NEUROL RES, V25, P556, DOI 10.1179/016164103101201995; Blass JP, 2002, INT REV NEUROBIOL, V51, P325, DOI 10.1016/S0074-7742(02)51010-2; BLASS JP, 1991, REV NEUROL, V147, P513; Blocq PO, 1892, SEIMANE MED, V12, P445; BONSIGNORE A, 1964, J CLIN INVEST, V43, P834, DOI 10.1172/JCI104969; BOSMAN GJCGM, 1991, NEUROBIOL AGING, V12, P13, DOI 10.1016/0197-4580(91)90033-G; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRECHER G, 1972, BLOOD-J HEMATOL, V40, P333, DOI 10.1182/blood.V40.3.333.333; BREWER GJ, 1974, ANN NY ACAD SCI, V241, P513, DOI 10.1111/j.1749-6632.1974.tb21907.x; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Bruce DG, 2009, DIABETOLOGIA, V52, P1808, DOI 10.1007/s00125-009-1437-1; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P143; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Chang CY, 2007, MICROCIRCULATION, V14, P627, DOI 10.1080/10739680701411056; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chibber S, 2016, CNS NEUROL DISORD-DR, V15, P250, DOI 10.2174/1871527315666160202121809; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Cholevas V, 2008, EUR J PEDIATR, V167, P211, DOI 10.1007/s00431-007-0464-5; CONNOLLY AM, 1990, CLIN PERINATOL, V17, P371, DOI 10.1016/S0095-5108(18)30573-6; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; DANON D, 1992, EXP GERONTOL, V27, P275, DOI 10.1016/0531-5565(92)90055-5; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9; de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606; de la Torre JC, 2017, J ALZHEIMERS DIS, V57, P353, DOI 10.3233/JAD-161266; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; de la Torre JC, 2000, ALZ DIS ASSOC DIS, V14, pS72, DOI 10.1097/00002093-200000001-00012; DELATORRE JC, 1993, NEUROL RES, V15, P146; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dodds C, 1998, BRIT J ANAESTH, V81, P449, DOI 10.1093/bja/81.3.449; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; DUHM J, 1971, PFLUG ARCH EUR J PHY, V326, P341, DOI 10.1007/BF00586998; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fita IG, 2011, ROM J MORPHOL EMBRYO, V52, P975; Funato H, 1998, AM J PATHOL, V152, P1633; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GIBSON GE, 1981, AM J MED, V70, P1247, DOI 10.1016/0002-9343(81)90834-2; Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson; GIBSON GE, 1975, BIOCHEM J, V148, P17, DOI 10.1042/bj1480017; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Globerson A, 1999, EXP GERONTOL, V34, P137, DOI 10.1016/S0531-5565(98)00069-2; Godfrin Y, 2012, EXPERT OPIN BIOL TH, V12, P127, DOI 10.1517/14712598.2012.631909; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gonzalez J, 2015, INT J NEUROSCI, V125, P315, DOI 10.3109/00207454.2014.940941; Gonzalez-Reyes RE, 2016, CURR PHARM DESIGN, V22, P812, DOI 10.2174/1381612822666151209152013; GOODALL HB, 1994, DIS MARKERS, V12, P23, DOI 10.1155/1994/493810; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hachinski V, 1997, ANN NY ACAD SCI, V826, P1, DOI 10.1111/j.1749-6632.1997.tb48456.x; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; HAMASAKI N, 1981, TRANSFUSION, V21, P391, DOI 10.1046/j.1537-2995.1981.21481275994.x; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HODES JE, 1985, ANESTHESIOLOGY, V63, P633, DOI 10.1097/00000542-198512000-00013; HOYER S, 1988, J NEUROL, V235, P143, DOI 10.1007/BF00314304; Hoyer S, 1996, ACTA NEUROL SCAND, V93, P18; Hoyer S, 2000, EXP GERONTOL, V35, P1363, DOI 10.1016/S0531-5565(00)00156-X; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOBST KA, 1992, J NEUROL NEUROSUR PS, V55, P190, DOI 10.1136/jnnp.55.3.190; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; KALARIA RN, 1995, NEUROREPORT, V6, P477, DOI 10.1097/00001756-199502000-00018; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaminsky Y, 2012, AM J NEUROPROTECT NE, V4, P73, DOI DOI 10.1166/AJNN.2012.1039; Kaminsky YG, 2012, B EXP BIOL MED+, V153, P406, DOI 10.1007/s10517-012-1727-3; Kaminsky YG, 2013, AGING DIS, V4, P244, DOI 10.14336/AD.2013.0400244; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kasa P, 2001, BRAIN RES, V909, P159, DOI 10.1016/S0006-8993(01)02679-8; Kiefmann R, 2008, BLOOD, V111, P5205, DOI 10.1182/blood-2007-09-113902; Kiko T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049620; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Kontush A, 2001, FREE RADICAL BIO MED, V30, P119, DOI 10.1016/S0891-5849(00)00458-5; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; Korol DL, 1998, AM J CLIN NUTR, V67, p764S, DOI 10.1093/ajcn/67.4.764S; KOSENKO E, 1994, J NEUROCHEM, V63, P2172; Kosenko E A, 2009, Bioorg Khim, V35, P172; Kosenko E A, 2008, Bioorg Khim, V34, P654; Kosenko EA, 2016, CNS NEUROL DISORD-DR, V15, P113, DOI 10.2174/1871527314666150821103444; Kosenko EA, 2012, CNS NEUROL DISORD-DR, V11, P926; Kosenko EA, 2008, BIOCHEM CELL BIOL, V86, P469, DOI 10.1139/O08-134; KOWLURU R, 1989, P NATL ACAD SCI USA, V86, P3327, DOI 10.1073/pnas.86.9.3327; Kucukatay V, 2009, TOXICOL MECH METHOD, V19, P19, DOI 10.1080/15376510802175788; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Kuo YM, 1996, J BIOL CHEM, V271, P4077; KUYPERS FA, 1990, J LAB CLIN MED, V116, P535; KYLES AE, 1993, AM J VET RES, V54, P1483; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lan J, 2015, AGE AGEING, V44, P458, DOI 10.1093/ageing/afv009; Lang E, 2016, CELL PHYSIOL BIOCHEM, V39, P668, DOI 10.1159/000445657; Lang F, 2015, EXPERT OPIN THER TAR, V19, P1219, DOI 10.1517/14728222.2015.1051306; Larsen VH, 1996, SCAND J CLIN LAB INV, V56, P83, DOI 10.3109/00365519609088626; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P109; Llansola M, 2007, METAB BRAIN DIS, V22, P321, DOI 10.1007/s11011-007-9067-0; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luo Y, 1996, NEUROSCI LETT, V217, P125, DOI 10.1016/0304-3940(96)13087-1; MACDONALD R, 1977, ANAESTHESIA, V32, P544, DOI 10.1111/j.1365-2044.1977.tb10002.x; Manikandan S, 2006, NEUROSCI LETT, V399, P17, DOI 10.1016/j.neulet.2006.01.037; MANN DMA, 1992, ACTA NEUROPATHOL, V83, P415, DOI 10.1007/BF00713534; MARCUS DL, 1989, ANN NEUROL, V26, P91, DOI 10.1002/ana.410260114; Marcus DL, 1997, ANN NY ACAD SCI, V826, P248, DOI 10.1111/j.1749-6632.1997.tb48476.x; Martin-Jimenez CA, 2017, PROG NEUROBIOL, V158, P45, DOI 10.1016/j.pneurobio.2017.08.001; Martin-Jimenez CA, 2017, MOL NEUROBIOL, V54, P7096, DOI 10.1007/s12035-016-0193-8; Martindale JL, 2010, J EMERG MED, V39, P491, DOI 10.1016/j.jemermed.2010.03.021; MASUDA J, 1988, STROKE, V19, P205, DOI 10.1161/01.STR.19.2.205; Matsumoto Y, 1995, Masui, V44, P342; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 1997, BRAIN RES, V771, P147, DOI 10.1016/S0006-8993(97)00824-X; McCully K, 1999, MUSCLE NERVE, V22, P621, DOI 10.1002/(SICI)1097-4598(199905)22:5<621::AID-MUS11>3.0.CO;2-D; MCGEER EG, 1990, J NEUROSCI RES, V27, P612, DOI 10.1002/jnr.490270422; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MeierRuge W, 1996, REV NEUROSCIENCE, V7, P1; MEIERRUGE W, 1984, ARCH GERONTOL GERIAT, V3, P161, DOI 10.1016/0167-4943(84)90007-4; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Mohanty JG, 2008, ADV EXP MED BIOL, V614, P29, DOI 10.1007/978-0-387-74911-2_4; MOORE GL, 1981, TRANSFUSION, V21, P723, DOI 10.1046/j.1537-2995.1981.21682085764.x; Moreira PI, 2006, BIOL RES, V39, P7, DOI 10.4067/S0716-97602006000100002; Morishima-Kawashima M, 2000, AM J PATHOL, V157, P2093, DOI 10.1016/S0002-9440(10)64847-X; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Murr L E, 2006, Int J Environ Res Public Health, V3, P48, DOI 10.3390/ijerph2006030007; Nakamura J, 1995, EUR J PHARMACOL, V294, P207, DOI 10.1016/0014-2999(95)00531-5; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nicolay JP, 2007, CELL PHYSIOL BIOCHEM, V19, P175, DOI 10.1159/000099205; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pankowska Ewa, 2005, Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, V11, P207; Papassotiriou I, 1998, EXP HEMATOL, V26, P922; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; PARIKH SS, 1995, ANESTH ANALG, V80, P1223, DOI 10.1097/00000539-199506000-00027; Pascual JM, 2004, EUR J ENDOCRINOL, V150, P627, DOI 10.1530/eje.0.1500627; Perry G, 1998, BRAIN RES, V791, P63, DOI 10.1016/S0006-8993(98)00006-7; Perry G, 2003, NEUROCHEM RES, V28, P1549, DOI 10.1023/A:1025678510480; Perry RT, 2008, NEUROBIOL AGING, V29, P185, DOI 10.1016/j.neurobiolaging.2006.10.017; Pfeifer LA, 2002, NEUROLOGY, V58, P1629, DOI 10.1212/WNL.58.11.1629; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Plum F, 1972, Contemp Neurol Ser, V10, P1; Ponizovsky AM, 2003, HARVARD REV PSYCHIAT, V11, P317, DOI 10.1080/10673220390264258; Pretorius E, 2016, BLOOD REV, V30, P263, DOI 10.1016/j.blre.2016.01.001; Quastel JH, 1932, LANCET, V2, P1417; Rabini RA, 1997, EUR J CLIN INVEST, V27, P327, DOI 10.1046/j.1365-2362.1997.1130652.x; Ravi LB, 2004, NEUROL RES, V26, P579, DOI 10.1179/016164104225016227; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; RESNICK LM, 1994, AM J MED SCI, V307, pS66; Richards RS, 2007, ARCH MED RES, V38, P94, DOI 10.1016/j.arcmed.2006.06.008; RICHARDSON JTE, 1990, NEUROSCI BIOBEHAV R, V14, P385, DOI 10.1016/S0149-7634(05)80060-0; Riegel B, 2002, AM J CRIT CARE, V11, P520, DOI 10.4037/ajcc2002.11.6.520; Rifkind JM, 1998, LIFE SCI, V64, P237, DOI 10.1016/S0024-3205(98)00559-1; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Ronquist G, 2003, J INTERN MED, V254, P517, DOI 10.1111/j.1365-2796.2003.01235.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; ROTHSTEIN G, 1993, BLOOD, V82, P2601; SAKUTA S, 1981, STROKE, V12, P824, DOI 10.1161/01.STR.12.6.824; Samaja M, 2003, EUR J APPL PHYSIOL, V90, P351, DOI 10.1007/s00421-003-0954-8; SANSONI P, 1993, BLOOD, V82, P2767; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Scholz W, 1938, Z GESAMTE NEUROL PSY, V162, P694, DOI 10.1007/BF02890989; SEEMAN P, 1973, J CELL BIOL, V56, P519, DOI 10.1083/jcb.56.2.519; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2007, NUTR REV, V65, pS239, DOI [10.1111/j.1753-4887.2007.tb00370.x, 10.1301/nr.2007.dec.S239-S243]; Shevtsova EF, 2017, CNS NEUROL DISORD-DR, V16, P677, DOI 10.2174/1871527316666170424114444; Shi J, 1997, BRAIN RES, V772, P247, DOI 10.1016/S0006-8993(97)00827-5; Shinozuka Takao, 1994, Tokai Journal of Experimental and Clinical Medicine, V19, P53; SIMPSON IA, 1994, ANN NEUROL, V36, P800, DOI 10.1002/ana.410360522; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; SIMPSON PJ, 1988, J PHARMACOL EXP THER, V244, P619; SINGH VK, 1994, BRAIN RES, V660, P353, DOI 10.1016/0006-8993(94)91313-7; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 2002, NEUROCHEM INT, V40, P527, DOI 10.1016/S0197-0186(01)00123-1; Smith MA, 2002, FREE RADICAL BIO MED, V33, P1194, DOI 10.1016/S0891-5849(02)01021-3; Smith MA, 2000, ANN NY ACAD SCI, V924, P35; Solerte SB, 2000, NEUROBIOL AGING, V21, P271, DOI 10.1016/S0197-4580(00)00105-6; STOREY E, 1992, J NEUROCHEM, V58, P1975, DOI 10.1111/j.1471-4159.1992.tb10080.x; Tabaton M, 2005, INT J EXP PATHOL, V86, P139, DOI 10.1111/j.0959-9673.2005.00428.x; Tabaton M, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P127; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; Thal DR, 2009, NEUROBIOL AGING, V30, P1936, DOI 10.1016/j.neurobiolaging.2008.01.017; Thal DR, 2002, J NEUROPATH EXP NEUR, V61, P282, DOI 10.1093/jnen/61.3.282; Thanvi B, 2006, AGE AGEING, V35, P565, DOI 10.1093/ageing/afl108; Tikhonova LA, 2014, AM J ALZHEIMERS DIS, V29, P685, DOI 10.1177/1533317514534757; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; TSIRKA A, 1990, ACTA PAEDIATR SCAND, V79, P763, DOI 10.1111/j.1651-2227.1990.tb11552.x; Urbach H, 2011, Clin Neuroradiol, V21, P43, DOI 10.1007/s00062-011-0063-8; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VALERI CR, 1969, J LAB CLIN MED, V73, P722; van der Zwaluw CS, 2011, J STROKE CEREBROVASC, V20, P549, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.009; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vanhanen M, 1997, NEUROREPORT, V8, P1527, DOI 10.1097/00001756-199704140-00041; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; VORA S, 1987, BIOMED BIOCHIM ACTA, V46, pS285; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Webster MT, 1998, J NEURAL TRANSM, V105, P839, DOI 10.1007/s007020050098; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WILLIAMS LH, 1986, EXP HEMATOL, V14, P827; Wimo A, 2010, WORLD ALZHEIMER REPO; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; WISNIEWSKI HM, 1994, ACTA NEUROPATHOL, V87, P233; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2004, NEURODEGENER DIS, V1, P29, DOI 10.1159/000076667; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039	282	16	16	1	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 5	2018	11								728	10.3389/fnins.2017.00728	http://dx.doi.org/10.3389/fnins.2017.00728			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FR9GZ	29354027	Green Published, gold			2022-09-04	WOS:000419383200001
J	Cespedes, N; Valencia, A; Echeverry, CA; Arce-Plata, MI; Colon, C; Castineiras, DE; Hurtado, PM; Cocho, JA; Herrera, S; Arevalo-Herrera, M				Cespedes, Nora; Valencia, Angela; Echeverry, Carlos Alberto; Arce-Plata, Maria Isabel; Colon, Cristobal; Castineiras, Daisy E.; Margarita Hurtado, Paula; Angel Cocho, Jose; Herrera, Socrates; Arevalo-Herrera, Myriam			Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use In newborn screening In southwest Colombia	COLOMBIA MEDICA			English	Article						Neonatal screenings; inborn errors; amino acids; acylcarnitines; succinylacetone; mass spectrometry; tandem	DRIED BLOOD SPOTS; FAST ATOM BOMBARDMENT; INBORN-ERRORS; QUANTITATIVE-ANALYSIS; BRITISH-COLUMBIA; METABOLISM; SPECIMENS; IDENTIFICATION; HEMATOCRIT; INFANTS	Introduction: Inborn errors of metabolism (IEM) represent an important public health problem due to current diagnosis and treatment limitations, poor life quality of affected patients, and consequent untimely child death. In contrast to classical methods, tandem mass spectrometry (MS/MS) has allowed simultaneous evaluation of multiple metabolites associated with IEM offering higher sensitivity, low false positive rates and high throughput. Aims: Determine concentration levels for amino acids and acylcarnitines in blood of newborns from Colombia, to establish reference values for further use in diagnosis of IEM. Methods: Implementation of a method to determine amino acids, acylcarnitines and succinylacetone in newborn dried blood spots using MS/MS, and its application in a cross-sectional study conducted in 891 healthy neonates from Cali and Quibdo cities is described. Results: fifty-seven analytes that allow the diagnosis of more than 40 different pathologies were tested. The method showed to be linear, precise and accurate. Healthy neonates 1-18 days of age were included, 523 from Cali and 368 from Quibdo; 52% male and 48% female. Age-related differences on the concentration levels of amino acids and acylcarnitines were observed whereas no significant differences by gender were found. Conclusion: The study has contributed to reveal the usual concentration levels of amino acids, acylcarnitines and succinylacetone that could be used as reference for the establishment of a newborn metabolic screening program in Colombia.	[Cespedes, Nora; Valencia, Angela; Echeverry, Carlos Alberto; Arce-Plata, Maria Isabel; Herrera, Socrates; Arevalo-Herrera, Myriam] Malaria Vaccine & Drug Dev Ctr MVDC, Carrera 37 2Bis 5E-08, Cali, Colombia; [Colon, Cristobal; Castineiras, Daisy E.; Angel Cocho, Jose] Hosp Clin Univ Santiago, Lab Metabolopatias, Santiago De Compostela, Spain; [Margarita Hurtado, Paula] Pontificia Univ Javeriana, Fac Ciencias Salud, Cali, Colombia; [Margarita Hurtado, Paula] Ctr Med Imbanaco, Cali, Colombia; [Arevalo-Herrera, Myriam] Asoclin Inmunol Ltda, Cali, Colombia; [Arevalo-Herrera, Myriam] Univ Valle, Fac Salud, Cali, Colombia		Arevalo-Herrera, M (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Carrera 37 2Bis 5E-08, Cali, Colombia.	marevalo@inmuno.org	Cocho de Juan, José Ángel/ABF-8750-2021; Villa, Paula Margarita Hurtado/O-2543-2014	Villa, Paula Margarita Hurtado/0000-0003-3822-7780; Echeverry-Gonzalez, Carlos/0000-0003-4519-0090; Colon, Cristobal/0000-0002-9711-2812	Colciencias [766-2013]; Pontificia Universidad Javeriana Cali [O.-J.079-09]; Fundacion Centro Internacional de Vacunas	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana Cali; Fundacion Centro Internacional de Vacunas	This work was funded by Colciencias (Contract 766-2013), Fundacion Centro Internacional de Vacunas and Pontificia Universidad Javeriana Cali (cooperation agreement O.-J.079-09)	Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; Berry SA, 2010, GENET MED, V12, pS215, DOI [10.1097/GIM.0b013e3181fe5d23, 10.1097/GIM.0b013e3181fea476]; Borrajo GJC, 2007, J INHERIT METAB DIS, V30, P466, DOI 10.1007/s10545-007-0669-9; Hernandez DC, 2010, REV PANAM SALUD PUBL, V27, P309; Cavedon CT, 2005, CLIN CHEM, V51, P745, DOI 10.1373/clinchem.2004.043646; Chace DH, 1998, CLIN CHEM, V44, P2405; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chace DH, 1997, CLIN CHEM, V43, P2106; Chace DH, 2001, CLIN CHEM, V47, P1166; Chace DH, 2009, CLIN CHIM ACTA, V407, P6, DOI 10.1016/j.cca.2009.06.017; Cifuentes C Yolanda, 2007, rev.fac.med., V55, P126; CLSI, 2013, NBS01A6 CLSI; CLSI, 2010, NBS04 CLSI; DANE, 2015, REND CUENT 2014 2015; de Cespedes C, 2003, PREVENCION RETARDO M; Torres-Sepulveda MD, 2008, SALUD PUBLICA MEXICO, V50, P200; Dhillon KS, 2011, CLIN CHIM ACTA, V412, P873, DOI 10.1016/j.cca.2010.12.028; Golbahar J, 2014, J MED SCREEN, V21, P5, DOI 10.1177/0969141314525367; Gong Zhen-hua, 2010, Zhonghua Er Ke Za Zhi, V48, P922; Guidance for Industry, 2001, GUID IND BIOAN METH; Holub M, 2006, CLIN CHIM ACTA, V373, P27, DOI 10.1016/j.cca.2006.04.013; Jensen UG, 2001, CLIN CHEM, V47, P1364; Lawson AJ, 2016, J MED SCREEN, V23, P7, DOI 10.1177/0969141315593571; Couce ML, 2011, MOL GENET METAB, V104, P470, DOI 10.1016/j.ymgme.2011.09.021; MILLINGTON DS, 1984, BIOMED MASS SPECTROM, V11, P236, DOI 10.1002/bms.1200110508; MILLINGTON DS, 1989, ANAL BIOCHEM, V180, P331, DOI 10.1016/0003-2697(89)90441-7; NCCLS, 2000, C28A2 NCCLS, V2nd; Raghuveer TS, 2006, AM FAM PHYSICIAN, V73, P1981; Rosselli D, 2014, PEDIATRIA, V47, P68; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002; van Karnebeek CDM, 2014, PAED CHILD HEALT-CAN, V19, P469, DOI 10.1093/pch/19.9.469; Wagner M, 2016, MASS SPECTROM REV, V35, P361, DOI 10.1002/mas.21441	33	8	9	0	2	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	JUL-SEP	2017	48	3					112	118						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK9BD	29213153	Green Published			2022-09-04	WOS:000413804800002
J	Buman, MP; Floegel, TA; Florez-Pregonero, A; Hekler, EB				Buman, Matthew P.; Floegel, Theresa A.; Florez-Pregonero, Alberto; Hekler, Eric B.			Validation of Consumer-Based Activity Monitors in Older Adults with Varied Ambulatory Abilities	JOURNAL OF AGING AND PHYSICAL ACTIVITY			English	Meeting Abstract									[Buman, Matthew P.; Floegel, Theresa A.; Florez-Pregonero, Alberto; Hekler, Eric B.] Arizona State Univ, Phoenix, AZ USA; [Floegel, Theresa A.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Florez-Pregonero, Alberto] Pontificia Univ Javeriana, Dept Formac, Bogoto, Colombia			matthew.buman@asu.edu; albertoflorezp@asu.edu; eric.hekler@asu.edu	Buman, Matthew/AAJ-4447-2020	Buman, Matthew/0000-0002-5130-3162					0	0	0	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1063-8652	1543-267X		J AGING PHYS ACTIV	J. Aging Phys. Act.	JUN	2016	24			S			S98	S99						2	Geriatrics & Gerontology; Gerontology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Sport Sciences	DT5WR					2022-09-04	WOS:000381554400252
J	Salazar, M; Villalba, G; Mateus, H; Villegas, V; Fonseca, D; Nunez, F; Caicedo, V; Pachon, S; Bernal, JE				Salazar, Marleny; Villalba, Guiovanny; Mateus, Heidi; Villegas, Victoria; Fonseca, Dora; Nunez, Federico; Caicedo, Victor; Pachon, Sonia; Bernal, Jaime E.			Analysis of microdeletions in 22q11 in Colombian patients with congenital heart disease	INVESTIGACION CLINICA			Spanish	Article						congenital heart diseases; microdeletion 22q11; multiplex PCR; densitometry; TUPLE 1; Tetralogy of Fallot; atrial septal defects	VENTRICULAR SEPTAL-DEFECT; CARDIOVASCULAR ANOMALIES; CONOTRUNCAL DEFECTS; PULMONARY-ATRESIA; DELETION SYNDROME; PREVALENCE; TETRALOGY; FREQUENCY; DIGEORGE; PHENOTYPE	Cardiac defects are the most frequent congenital malformations, with an incidence estimated between 4 and 12 per 1000 newborns. Their etiology is multifactorial and might be attributed to genetic predispositions and environmental factors. Since 1990 these types of pathologies have been associated with 22q11 microdeletion. In this study, the frequency of microdeletion 22q11 was determined in 61 patients with non-syndromic congenital heart disease. DNA was extracted from peripheral blood and TUPLE1 and STR D10S2198 genes were amplified by multiplex PCR and visualized in agarose gels. Gene content was quantified by densitometry. Three patients were found with microdeletion 22q11, representing a 4.9% frequency. This microdeletion was associated with two cases of Tetralogy of Fallot and a third case with atrial septal defect (ASD). In conclusion, the frequency for microdeletion 22q11 in the population analyzed was 4.9%. The cases that presented Teratology of Fallot had a frequency for this microdeletion of 7.4% and for ASD of 11.1%.	[Salazar, Marleny] Univ Quindio, Programa Licenciatura Biol & Educ Ambiental, Armenia, Quindio, Colombia; [Villalba, Guiovanny] Univ Los Andes, Bogota, Colombia; [Mateus, Heidi; Villegas, Victoria; Fonseca, Dora] Univ Rosario, Escuela Med, Fac Ciencias Salud, Bogota, Colombia; [Nunez, Federico; Caicedo, Victor; Pachon, Sonia] Fdn Clin Shaio, Bogota, Colombia; [Bernal, Jaime E.] Pontificia Univ Javeriana, Inst Genet Humana, Fac Ciencias Salud, Bogota, Colombia		Salazar, M (corresponding author), Univ Quindio, Programa Licenciatura Biol & Educ Ambiental, Ave Bolivar Calle 12N,Carrera 15, Armenia, Quindio, Colombia.	masasa@uniquindio.edu.co	Villegas, Victoria E./G-8125-2016; Fonseca, Dora/K-3286-2016	Villegas, Victoria E./0000-0003-4149-2307; Fonseca, Dora/0000-0002-7323-6570; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143				Aglony M, 2004, REV MED CHILE, V132, P26; AMATI F, 1995, HUM GENET, V95, P479; Anaclerio Silvia, 2004, Ital Heart J, V5, P624; Beauchesne LM, 2005, J AM COLL CARDIOL, V45, P595, DOI 10.1016/j.jacc.2004.10.056; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Braunw AL, 2000, QUINTA ED, VI; Braunw AL, 2000, QUINTA ED, VII; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; Carotti A, 2008, DEV DISABIL RES REV, V14, P35, DOI 10.1002/ddrr.6; Cohen E, 1999, AM J MED GENET, V86, P359, DOI 10.1002/(SICI)1096-8628(19991008)86:4<359::AID-AJMG10>3.0.CO;2-V; Debrus S, 1996, HUM GENET, V97, P138, DOI 10.1007/BF02265254; Diez Tomas JJ, 1989, AN ESP PEDIATR, V31, P229; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Ferenz C, 1998, J PEDIAT, V114, P79; Fernandez L, 2005, CLIN GENET, V68, P373, DOI 10.1111/j.1399-0004.2005.00493.x; Fokstuen S, 1998, CLIN GENET, V53, P63, DOI 10.1034/j.1399-0004.1998.531530113.x; Garcia-Minaur S, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.10.e62; Gioli-Pereira L, 2010, INT J CARDIOL, V138, P261, DOI 10.1016/j.ijcard.2008.08.035; GLOVER TW, 1995, NAT GENET, V10, P257, DOI 10.1038/ng0795-257; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hu YL, 2009, CARDIOL YOUNG, V19, P179, DOI 10.1017/S1047951109003667; Icardo J, 2002, REV ESP CARDIOL, V9, P962; Iserin L, 1998, EUR J PEDIATR, V157, P881, DOI 10.1007/s004310050959; JEDELE KB, 1992, PEDIATRICS, V89, P915; Jiang LH, 2005, INT J CARDIOL, V105, P216, DOI 10.1016/j.ijcard.2005.01.012; Johnson MC, 1996, J PEDIATR-US, V129, P1; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kazuma N, 1997, PEDIATR CARDIOL, V18, P149, DOI 10.1007/s002469900138; Khositseth A, 2005, PEDIATR CARDIOL, V26, P570, DOI 10.1007/s00246-004-0775-5; Lammer EJ, 2009, BIRTH DEFECTS RES A, V85, P30, DOI 10.1002/bdra.20541; Marino B, 2001, GENET MED, V3, P45, DOI 10.1097/00125817-200101000-00010; Matsuoka R, 1998, HUM GENET, V103, P70, DOI 10.1007/s004390050786; McDonald-McGinn DM, 1997, GENET TEST, V1, P99, DOI 10.1089/gte.1997.1.99; McElhinney DB, 2003, PEDIATRICS, V112, pE472, DOI 10.1542/peds.112.6.e472; Miller CF, 2009, SEX ROLES, V60, P870, DOI 10.1007/s11199-009-9584-x; Momma K, 1996, J AM COLL CARDIOL, V27, P198, DOI 10.1016/0735-1097(95)00415-7; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; MOTZKIN B, 1993, J PEDIATR-US, V123, P406, DOI 10.1016/S0022-3476(05)81740-8; Rauch R, 2010, J MED GENET, V47, P321, DOI 10.1136/jmg.2009.070391; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Shen Lei, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P25; Shprintzen RJ, 2005, CURR OPIN PEDIATR, V17, P725, DOI 10.1097/01.mop.0000184465.73833.0b; van Engelen K, 2010, HEART, V96, P621, DOI 10.1136/hrt.2009.182642; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Ziolkowska L, 2008, EUR J PEDIATR, V167, P1135, DOI 10.1007/s00431-007-0645-2	50	0	1	0	5	INST INVESTIGACION CLINICA	MARACAIBO	APARTADO 23, MARACAIBO 4001-A, VENEZUELA	0535-5133			INVEST CLIN	Invest. Clin.	DEC	2011	52	4					334	343						10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	881PO	22523843				2022-09-04	WOS:000299498800005
J	Torres, D; Rashid, MU; Seidel-Renkert, A; Weitzel, JN; Briceno, I; Hamann, U				Torres, Diana; Rashid, Muhammad U.; Seidel-Renkert, Antje; Weitzel, Jeffrey N.; Briceno, Ignacio; Hamann, Ute		Colombian Breast Canc Study Grp	Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics	BREAST CANCER RESEARCH AND TREATMENT			English	Letter						BRCA1; Genomic rearrangements; Exon 9-12 deletion; Ethnic groups	OVARIAN-CANCER; ETHNIC-DIFFERENCES; HEREDITARY BREAST; FOUNDER MUTATIONS; INCREASED RISK; REARRANGEMENTS; POPULATION; PREVALENCE; WOMEN; GENE		[Rashid, Muhammad U.; Seidel-Renkert, Antje; Hamann, Ute] Deutsch Krebsforschungszentrum, Res Grp Mol Genet Breast Canc, D-69120 Heidelberg, Germany; [Torres, Diana; Briceno, Ignacio] Univ Sabana, Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Rashid, Muhammad U.] Shaukat Khanum Mem Canc Hosp & Res Ctr, Lahore, Pakistan; [Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Dept Clin Canc Genet, Duarte, CA 91010 USA		Hamann, U (corresponding author), Deutsch Krebsforschungszentrum, Res Grp Mol Genet Breast Canc, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	u.hamann@dkfz-heidelberg.de	Gil, Fabian/A-3352-2011; Briceno Balcazar, Ignacio/N-3337-2017	Gil, Fabian/0000-0001-6444-7248; Rashid, Muhammad Usman/0000-0002-7684-3122; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Briceno Balcazar, Ignacio/0000-0001-7300-6401				Casilli F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040212; Croyle R T, 1999, J Natl Cancer Inst Monogr, P59; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Gad S, 2002, ONCOGENE, V21, P6841, DOI 10.1038/sj.onc.1205685; Hamann U, 2002, J Med Genet, V39, pE12, DOI 10.1136/jmg.39.3.e12; Hamann U, 1997, J MED GENET, V34, P884, DOI 10.1136/jmg.34.11.884; Hamann U, 1997, GENE CHROMOSOME CANC, V18, P126, DOI 10.1002/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.0.CO;2-4; Hughes C, 1997, PATIENT EDUC COUNS, V32, P51, DOI 10.1016/S0738-3991(97)00064-5; Hughes C, 1996, BREAST CANCER RES TR, V40, P25, DOI 10.1007/BF01806000; Jara L, 2006, CANCER GENET CYTOGEN, V166, P36, DOI 10.1016/j.cancergencyto.2005.08.019; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Weitzel JN, 2007, CANCER EPIDEM BIOMAR, V16, P1615, DOI 10.1158/1055-9965.EPI-07-0198; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072	17	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	OCT	2009	117	3					679	681		10.1007/s10549-009-0383-4	http://dx.doi.org/10.1007/s10549-009-0383-4			3	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	495TA	19333752	Green Submitted			2022-09-04	WOS:000269916700027
J	Camacho, J; Zanoletti-Mannello, M; Landis-Lewis, Z; Kane-Gill, SL; Boyce, RD				Camacho, Jhon; Zanoletti-Mannello, Manuela; Landis-Lewis, Zach; Kane-Gill, Sandra L.; Boyce, Richard D.			A Conceptual Framework to Study the Implementation of Clinical Decision Support Systems (BEAR): Literature Review and Concept Mapping	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Review						clinical decision support system; computerized decision support system; implementation science; technology acceptance; barriers; facilitators; determinants; decision support system	USER ACCEPTANCE; TECHNOLOGY; ADOPTION; OUTCOMES; MODELS	Background: The implementation of clinical decision support systems (CDSSs) as an intervention to foster clinical practice change is affected by many factors. Key factors include those associated with behavioral change and those associated with technology acceptance. However, the literature regarding these subjects is fragmented and originates from two traditionally separate disciplines: implementation science and technology acceptance. Objective: Our objective is to propose an integrated framework that bridges the gap between the behavioral change and technology acceptance aspects of the implementation of CDSSs. Methods: We employed an iterative process to map constructs from four contributing frameworks-the Theoretical Domains Framework (TDF); the Consolidated Framework for Implementation Research (CFIR); the Human, Organization, and Technology-fit framework (HOT-fit); and the Unified Theory of Acceptance and Use of Technology (UTAUT)-and the findings of 10 literature reviews, identified through a systematic review of reviews approach. Results: The resulting framework comprises 22 domains . agreement with the decision algorithm; attitudes; behavioral regulation; beliefs about capabilities; beliefs about consequences; contingencies; demographic characteristics; effort expectancy; emotions; environmental context and resources; goals; intentions; intervention characteristics; knowledge; memory, attention, and decision processes; patient-health professional relationship; patient's preferences; performance expectancy; role and identity; skills, ability, and competence; social influences; and system quality. We demonstrate the use of the framework providing examples from two research projects. Conclusions: We proposed BEAR (BEhavior and Acceptance fRamework), an integrated framework that bridges the gap between behavioral change and technology acceptance, thereby widening the view established by current models.	[Camacho, Jhon; Boyce, Richard D.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA USA; [Camacho, Jhon] I&E Meaningful Res, Calle 119a 70-31, Bogota 111121, Colombia; [Zanoletti-Mannello, Manuela] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Landis-Lewis, Zach] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA; [Kane-Gill, Sandra L.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA		Camacho, J (corresponding author), I&E Meaningful Res, Calle 119a 70-31, Bogota 111121, Colombia.	jjcamachosanchez@gmail.com	Boyce, Richard/ABD-2925-2021	Boyce, Richard/0000-0002-2993-2085; Kane-GIll, Sandra/0000-0001-7523-4846; Camacho, Jhon/0000-0003-1805-9142; Landis-Lewis, Zach/0000-0002-9117-9338	US National Institute on Aging [K01AG044433]	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded in part by the US National Institute on Aging (K01AG044433). We thank Socorro Moreno, Ps, MSc, and Maria Fernanda Parra, Ps, for their comments and insights regarding preliminary versions of the framework.	Akrani G., 2013, WHAT IS PRODUCT QUAL; [Anonymous], 2020, GROSS DOMESTIC R EXP; Baig MM, 2019, HEALTH INFORM J, V25, P1091, DOI 10.1177/1460458217740722; Blank A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-44; Borum C, 2018, CIN-COMPUT INFORM NU, V36, P177, DOI 10.1097/CIN.0000000000000413; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carter J, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0954-1; Chan WV, 2017, CIRCULATION, V135, pE122, DOI 10.1161/CIR.0000000000000481; Codish Shlomi, 2005, AMIA Annu Symp Proc, P146; Cox JL, 2018, AM HEART J, V201, P149, DOI 10.1016/j.ahj.2018.04.008; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; Eberhardt J, 2012, J SURG ONCOL, V105, P502, DOI 10.1002/jso.23053; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gagnon MP, 2016, J AM MED INFORM ASSN, V23, P212, DOI 10.1093/jamia/ocv052; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Holroyd BR, 2007, ACAD EMERG MED, V14, P942, DOI 10.1197/j.aem.2007.06.023; Hussain MI, 2019, J AM MED INFORM ASSN, V26, P1141, DOI 10.1093/jamia/ocz095; Kane-Gill SL, 2017, CRIT CARE MED, V45, P1481, DOI 10.1097/CCM.0000000000002580; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khairat S, 2018, JMIR MED INF, V6, P25, DOI 10.2196/medinform.8912; Khong PCB, 2015, CIN-COMPUT INFORM NU, V33, P555, DOI 10.1097/CIN.0000000000000196; Kilsdonk E, 2017, INT J MED INFORM, V98, P56, DOI 10.1016/j.ijmedinf.2016.12.001; Landry CA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.e19585; LAU R, 2016, IMPLEMENT SCI, V11, DOI DOI 10.1186/S13012-016-0396-4; Lee PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126191; Martinez-Perez B, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0004-y; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mickan S, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-56; Miller K, 2018, J AM MED INFORM ASSN, V25, P585, DOI 10.1093/jamia/ocx118; Moja L, 2014, AM J PUBLIC HEALTH, V104, pE12, DOI 10.2105/AJPH.2014.302164; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Murphy Elizabeth V., 2014, Yale Journal of Biology and Medicine, V87, P187; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; O'Reilly-Shah VN, 2018, PEDIATR ANESTH, V28, P167, DOI 10.1111/pan.13305; Pearson SA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-154; Peleg M, 2014, CLINICAL DECISION SUPPORT: THE ROAD TO BROAD ADOPTION, 2ND EDITION, P435; Reis WC, 2017, PHARM PRACT-GRANADA, V15, DOI [10.18549/PharmPract.2017.04.1036, 10.18549/pharmpract.2017.04.1036]; Ross Jamie, 2016, Implement Sci, V11, P146; Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316; Soufi MD, 2018, INT J MED INFORM, V114, P35, DOI 10.1016/j.ijmedinf.2018.03.008; Souza NM, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-87; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Van Dort BA, 2019, INT J MED INFORM, V129, P285, DOI 10.1016/j.ijmedinf.2019.06.024; VandenBos G.R., 2007, APA DICT PSYCHOL; Vecchio N, 2018, INT J MED INFORM, V114, P76, DOI 10.1016/j.ijmedinf.2018.03.016; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Vernooij RWM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-3; Ward R, 2013, HEALTH POLICY TECHN, V2, P222, DOI 10.1016/j.hlpt.2013.07.002; Yusof MM, 2008, INT J MED INFORM, V77, P386, DOI 10.1016/j.ijmedinf.2007.08.011	51	4	5	1	9	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	AUG 6	2020	22	8							e18388	10.2196/18388	http://dx.doi.org/10.2196/18388			15	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	NW5MG	32759098	Green Published, gold			2022-09-04	WOS:000575055400005
J	Duarte, C; Salazar, A; Strasser-Weippl, K; de Vries, E; Wiesner, C; Krush, L; Goss, PE				Duarte, C.; Salazar, A.; Strasser-Weippl, K.; de Vries, E.; Wiesner, C.; Krush, L.; Goss, P. E.			Breast cancer in Colombia: A growing challenge for the health care system	CANCER RESEARCH			English	Meeting Abstract	San Antonio Breast Cancer Symposium	DEC 04-08, 2018	San Antonio, TX						Inst Nacl Cancerol, Bogota, Colombia; Wilhelminen Hosp, Vienna, Austria; Pontificia Univ Javeriana, Bogota, Colombia; Global Canc Inst, Boston, MA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA										0	0	0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	FEB	2019	79	4		S		P5-13-12				10.1158/1538-7445.SABCS18-P5-13-12	http://dx.doi.org/10.1158/1538-7445.SABCS18-P5-13-12			2	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Oncology	IN4WF					2022-09-04	WOS:000478677002141
J	Hurtado-de-Mendoza, D; Loaiza-Bonilla, A; Bonilla-Reyes, PA; Tinoco, G; Alcorta, R				Hurtado-de-Mendoza, David; Loaiza-Bonilla, Arturo; Bonilla-Reyes, Paula A.; Tinoco, Gabriel; Alcorta, Rodrigo			Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives	CUREUS			English	Review						cancer treatment; cardiac dysfunction; cardiotoxicity; cardio-oncology; cardiovascular events	ENDOTHELIAL GROWTH-FACTOR; PHASE-II TRIAL; ARTERIAL THROMBOEMBOLIC EVENTS; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; LEFT-VENTRICULAR DYSFUNCTION; UBIQUITIN-PROTEASOME SYSTEM; PACLITAXEL PLUS BEVACIZUMAB	Cardio-oncology is a medical discipline that identifies, prevents, and treats the cardiovascular complications related to cancer therapy. Due to the remarkable proliferation of new cancer therapies causing cardiovascular complications, such as hypertension, heart failure, vascular complications, and cardiac arrhythmia, we provide an extensive, comprehensive revision of the most up-to-date scientific information available on the cardiovascular complications associated with the use of newer, novel chemotherapeutic agents, including their reported incidence, suggested pathophysiology, clinical manifestations, potential treatment, and prevention. The authors consider this topic to be relevant for the clinicians since cardiovascular complications associated with the administration of recently approved drugs are relatively underappreciated. The purpose of this article is to provide a state-of-the-art review of cardiovascular complications associated with the use of newer, novel chemotherapeutic agents and targeted therapies, including their reported incidence, suggested pathophysiology, clinical manifestations, potential treatment, and prevention. Ongoing efforts are needed to provide a better understanding of the frequency, mechanisms of disease, prevention, and treatment of cardiovascular complications induced by the newer, novel chemotherapeutic agents. Development of a cardio-oncology discipline is warranted in order to promote task forces aimed at the creation of oncology patient-centered guidelines for the detection, prevention, and treatment of potential cardiovascular side effects associated with newer cancer therapies.	[Hurtado-de-Mendoza, David] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Coral Gables, FL 33124 USA; [Loaiza-Bonilla, Arturo] Canc Treatment Ctr Amer, Med Hematol & Oncol, Boca Raton, FL USA; [Bonilla-Reyes, Paula A.] Pontificia Univ Javeriana, Fac Med, Cali, Colombia; [Tinoco, Gabriel] Ohio State, Dept Internal Med, Columbus, OH USA; [Alcorta, Rodrigo] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru		Hurtado-de-Mendoza, D (corresponding author), Univ Miami, Miller Sch Med, Jackson Mem Hosp, Coral Gables, FL 33124 USA.	arturolbmd@gmail.com	Tinoco, Gabriel/ABD-2204-2021	Tinoco, Gabriel/0000-0002-2565-6124; Loaiza-Bonilla, Arturo/0000-0002-3655-9602; Alcorta Proano, Rodrigo/0000-0002-5222-8491				Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 2009, ARZERRA OFATUMUMAB F; [Anonymous], 2009, FDA FINAL LABELING T; [Anonymous], 2015, TOR TEMS HIGHL PRESC; [Anonymous], 2016, PRODUCT MONOGRAPH XA; [Anonymous], 2009, VECTIBIX PANITUMUMAB; [Anonymous], 2012, AF EV HIGHL PRESCR I; [Anonymous], 2013, REVLIMID LENALIDOMID; [Anonymous], 2010, FDA FINAL LABELING T; [Anonymous], 2010, RAP SIR HIGHL PRESCR; [Anonymous], 2017, CARDIOTOXICITY RAD T; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Azad NS, 2008, J CLIN ONCOL, V26, P3709, DOI 10.1200/JCO.2007.10.8332; Bagnes C, 2010, CURR DRUG SAF, V5, P93, DOI 10.2174/157488610789869111; Baliga RR, 2008, MANAGEMENT HEART FAI, V1, DOI [10.1007/978-1-84800-102-2, DOI 10.1007/978-1-84800-102-2]; Baselga J, 2006, ONCOLOGIST, V11, P4, DOI 10.1634/theoncologist.11-90001-4; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Bennett CL, 2002, AM J MED, V113, P603, DOI 10.1016/S0002-9343(02)01300-1; Bria E, 2008, BREAST CANCER RES TR, V109, P231, DOI 10.1007/s10549-007-9663-z; Brummendorf TH, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.3135.3135; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Burotto M, 2015, ONCOLOGIST, V20, P400, DOI 10.1634/theoncologist.2014-0154; Burtness B, 2005, J CLIN ONCOL, V23, P5440, DOI 10.1200/JCO.2005.02.002; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Center for Drug Evaluation and Research, 2012, RISK ASS RISK MIT RE; Center for Drug Evaluation and Research, 2012, CROSS DISC TEAM LEAD; Cersosimo RJ, 2003, AM J HEALTH-SYST PH, V60, P1531, DOI 10.1093/ajhp/60.15.1531; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clerk A, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu082.37; Cobleigh MA, 2003, SEMIN ONCOL, V30, P117, DOI 10.1053/j.seminoncol.2003.08.013; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Costa A, 2016, BLOOD, V128, P1793; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; D'Adamo DR, 2005, J CLIN ONCOL, V23, P7135, DOI 10.1200/JCO.2005.16.139; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Davis PJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1250, DOI 10.1152/ajpcell.00410.2010; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Dillman RO, 2002, J CLIN ONCOL, V20, P3545, DOI 10.1200/JCO.2002.02.126; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Engur S, 2016, IMMUNOPHARM IMMUNOT, V38, P87, DOI 10.3109/08923973.2015.1122616; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; Esparis-Ogando A, 2005, INT J CANCER, V114, P665, DOI 10.1002/ijc.20793; Ewer M.S., 2013, CANC HEART; Ewer MS, 2005, J CLIN ONCOL, V23, P7820, DOI 10.1200/JCO.2005.13.300; Felmeden DC, 2003, AM J HYPERTENS, V16, P11, DOI 10.1016/S0895-7061(02)03149-7; Fiedler W, 2005, BLOOD, V105, P986, DOI 10.1182/blood-2004-05-1846; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Friehs I, 2006, CIRCULATION, V114, pI290, DOI 10.1161/CIRCULATIONAHA.105.001289; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Geiger S, 2010, ANTI-CANCER DRUG, V21, P578, DOI 10.1097/CAD.0b013e3283394624; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Ghatalia P, 2015, BRIT J CANCER, V112, P296, DOI 10.1038/bjc.2014.564; Ghobrial Irene M, 2003, J Support Oncol, V1, P194; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Gille L, 1997, FREE RADICAL BIO MED, V23, P775, DOI 10.1016/S0891-5849(97)00025-7; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Gore SD, 2002, CLIN CANCER RES, V8, P963; Gridelli C, 2007, ONCOLOGIST, V12, P191, DOI 10.1634/theoncologist.12-2-191; Guevremont C, 2009, CURR ONCOL, V16, pS29; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Hacihanefioglu A, 2008, INT J HEMATOL, V88, P219, DOI 10.1007/s12185-008-0139-7; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Horning SJ, 2005, J CLIN ONCOL, V23, P712, DOI 10.1200/JCO.2005.07.040; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jacene H, 2017, MOL IMAGING BIOL, V19, P429, DOI 10.1007/s11307-016-1019-9; Janas E, 2005, CLIN EXP IMMUNOL, V139, P439, DOI 10.1111/j.1365-2249.2005.02720.x; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Kaneda R, 2009, GENES CELLS, V14, P69, DOI 10.1111/j.1365-2443.2008.01252.x; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Karp JE, 2004, CLIN CANCER RES, V10, P3577, DOI 10.1158/1078-0432.CCR-03-0627; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kelly PA, 1997, PHARMACOTHERAPY, V17, P1148; Kenigsberg B., 2016, CLIN PHARMACOL THER, V8, DOI [10.1211/CP.2016.20201651, DOI 10.1211/CP.2016.20201651]; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Khakoo AY, 2008, NAT CLIN PRACT ONCOL, V5, P655, DOI 10.1038/ncponc1225; Khakoo AY, 2008, CANCER RES, V68, P9112, DOI 10.1158/0008-5472.CAN-08-0851; Khakoo AY, 2008, CANCER-AM CANCER SOC, V112, P2500, DOI 10.1002/cncr.23460; Kilickap S, 2008, MED ONCOL, V25, P437, DOI 10.1007/s12032-008-9062-2; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Kloth JSL, 2015, BRIT J CANCER, V112, P1011, DOI 10.1038/bjc.2015.82; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Le Tourneau Christophe, 2007, Ther Clin Risk Manag, V3, P341, DOI 10.2147/tcrm.2007.3.2.341; Lenihan DJ, 2004, BLOOD, V104, P655, DOI 10.1182/blood-2003-07-2345; Leon-Mateos L, 2015, REDOX BIOL, V6, P421, DOI 10.1016/j.redox.2015.09.007; Lipshultz SE, 2002, J CLIN ONCOL, V20, P4517, DOI 10.1200/JCO.2002.12.102; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lu Z, 2012, SCI TRANSL MED, V4, P131, DOI DOI 10.1126/SCITRANSLMED.3003623; Luke JJ, 2013, ONCOLOGIST, V18, P717, DOI 10.1634/theoncologist.2012-0391; Lund MB, 1996, HEART, V75, P591, DOI 10.1136/hrt.75.6.591; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallarkey G, 2015, THER ADV DRUG SAF, V6, P4, DOI 10.1177/2042098614560737; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Mego M, 2007, ANN ONCOL, V18, P1906, DOI 10.1093/annonc/mdm489; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nair A, 2015, CLIN CANCER RES, V21, P5205, DOI 10.1158/1078-0432.CCR-15-1377; Nakamae H, 2005, CANCER-AM CANCER SOC, V104, P2492, DOI 10.1002/cncr.21478; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Noon JP, 1997, J CLIN INVEST, V99, P1873, DOI 10.1172/JCI119354; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Pande A, 2007, ANTICANCER RES, V27, P3465; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peng XY, 2010, CIRC RES, V106, P1022, DOI 10.1161/CIRCRESAHA.109.211276; Perez EA, 2004, J CLIN ONCOL, V22, P322, DOI 10.1200/JCO.2004.01.120; Perez EA, 2008, MAYO CLIN PROC, V83, P679, DOI 10.4065/83.6.679; Perik PJ, 2008, ANN ONCOL, V19, P359, DOI 10.1093/annonc/mdm468; Perik PJ, 2007, EUR J HEART FAIL, V9, P173, DOI 10.1016/j.ejheart.2006.05.010; Petrelli F, 2012, ANN ONCOL, V23, P1672, DOI 10.1093/annonc/mdr592; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; PRESS MF, 1993, CANCER RES, V53, P4960; Presta LG, 1997, CANCER RES, V57, P4593; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rixe O, 2007, ANN ONCOL, V18, P1117, DOI 10.1093/annonc/mdm184; Robak T, 2008, EXPERT REV ANTICANC, V8, P1033, DOI 10.1586/14737140.8.7.1033; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosato RR, 2005, EXPERT OPIN THER TAR, V9, P809, DOI 10.1517/14728222.9.4.809; Ryan CW, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1047; Sablin MP, 2007, J CLIN ONCOL, V25; Sanford D, 2015, HAEMATOLOGICA, V100, pE494, DOI 10.3324/haematol.2015.132845; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schmidinger M, 2008, J CLIN ONCOL, V26, P5204, DOI 10.1200/JCO.2007.15.6331; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Senderowicz AM, 2007, ONCOLOGY-NY, V21, P1696; Sengupta PP, 2008, MAYO CLIN PROC, V83, P197, DOI 10.4065/83.2.197; Shah RR, 2015, DRUG SAFETY, V38, P693, DOI 10.1007/s40264-015-0300-1; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Siegel AB, 2008, J CLIN ONCOL, V26, P2992, DOI 10.1200/JCO.2007.15.9947; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; Smith J, 2014, US PHARM, V39, pHS2; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Sugrue MM, 2007, J CLIN ONCOL, V25; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Syrigou E, 2009, ANTI-CANCER DRUG, V20, P1, DOI 10.1097/CAD.0b013e32831961b3; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Telli ML, 2008, ANN ONCOL, V19, P1613, DOI 10.1093/annonc/mdn168; Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073; Vaklavas C, 2010, ONCOLOGIST, V15, P130, DOI 10.1634/theoncologist.2009-0252; van Hees HWH, 2008, AM J PHYSIOL-LUNG C, V294, pL1260, DOI 10.1152/ajplung.00035.2008; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Veinot JP, 1996, HUM PATHOL, V27, P766, DOI 10.1016/S0046-8177(96)90447-5; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503; Voortman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-129; Wamique S, 2008, CURR PROB CARDIOLOGY, V33, P163, DOI 10.1016/j.cpcardiol.2008.01.002; Wehrle J, 2014, RECENT RESULTS CANC, V201, P99, DOI 10.1007/978-3-642-54490-3_5; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu SH, 2008, LANCET ONCOL, V9, P117, DOI 10.1016/S1470-2045(08)70003-2; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yang HJ, 2009, EXPERT OPIN INV DRUG, V18, P957, DOI 10.1517/13543780903002074; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zecchina G, 2007, CLIN LUNG CANCER, V8, P264, DOI 10.3816/CLC.2007.n.004; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang X, 2016, EXPERT REV CLIN PHAR, V9, P1109, DOI 10.1080/17512433.2016.1190269; Zhang Y, 2016, ONCOL LETT, V12, P3241, DOI 10.3892/ol.2016.5081; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; 2006, HIGHLIGHTS PRESCRIBI	194	8	9	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAY	2017	9	5							e1258	10.7759/cureus.1258	http://dx.doi.org/10.7759/cureus.1258			29	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HE7MJ	28649481	Green Submitted, Green Published, gold			2022-09-04	WOS:000453621500056
J	Lopez, G; Chow, J; Bongen, P; Lauinger, B; Pietruszka, J; Streit, WR; Baena, S				Lopez, Gina; Chow, Jennifer; Bongen, Patrick; Lauinger, Benjamin; Pietruszka, Joerg; Streit, Wolfgang R.; Baena, Sandra			A novel thermoalkalostable esterase from Acidicaldus sp. strain USBA-GBX-499 with enantioselectivity isolated from an acidic hot springs of Colombian Andes	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Acidic hot spring; Thermoacidophile; Thermoalkalostable esterase; Enantioselectivity	HORMONE-SENSITIVE LIPASE; THERMOSTABLE ESTERASE; THERMOACIDOPHILIC ARCHAEON; BACILLUS-ACIDOCALDARIUS; THERMOPHILIC ESTERASE; SEQUENCE SIMILARITY; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GEN. NOV.; PURIFICATION	Several thermo- and mesoacidophilic bacterial strains that revealed high lipolytic activity were isolated from water samples derived from acidic hot springs in Los Nevados National Natural Park (Colombia). A novel lipolytic enzyme named 499EST was obtained from the thermoacidophilic alpha-Proteobacterium Acidicaldus USBA-GBX-499. The gene estA encoded a 313-amino-acid protein named 499EST. The deduced amino acid sequence showed the highest identity (58 %) with a putative alpha/beta hydrolase from Acidiphilium sp. (ZP_08632277.1). Sequence alignments and phylogenetic analysis indicated that 499EST is a new member of the bacterial esterase/lipase family IV. The esterase reveals its optimum catalytic activity at 55 A degrees C and pH 9.0. Kinetic studies showed that 499EST preferentially hydrolyzed middle-length acyl chains (C6-C8), especially p-nitrophenyl (p-NP) caproate (C6). Its thermostability and activity were strongly enhanced by adding 6 mM FeCl3. High stability in the presence of water-miscible solvents such as dimethyl sulfoxide and glycerol was observed. This enzyme also exhibits stability under harsh environmental conditions and enantioselectivity towards naproxen and ibuprofen esters, yielding the medically relevant (S)-enantiomers. In conclusion, according to our knowledge, 499EST is the first thermoalkalostable esterase derived from a Gram-negative thermoacidophilic bacterium.	[Lopez, Gina; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, Bogota, DC, Colombia; [Lopez, Gina; Baena, Sandra] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, DC, Colombia; [Chow, Jennifer; Streit, Wolfgang R.] Univ Hamburg, Dept Microbiol & Biotechnol, Bioctr Klein Flottbek, Hamburg, Germany; [Bongen, Patrick; Lauinger, Benjamin; Pietruszka, Joerg] Univ Dusseldorf, Res Ctr Juelich, Inst Bioorgan Chem, Julich, Germany		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, POB 56710, Bogota, DC, Colombia.	wolfgang.streit@uni-hamburg.de; baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019; Streit, Wolfgang/S-3049-2019; Pietruszka, Jörg/G-5731-2013; López, Gina/AAF-8171-2019; Streit, Wolfgang R/K-1366-2012	Streit, Wolfgang/0000-0001-7617-7396; Pietruszka, Jörg/0000-0002-9819-889X; Baena, Sandra/0000-0001-5377-9079; Lopez Ramirez, Gina/0000-0002-4210-089X; Chow, Jennifer/0000-0002-7499-5325	Colciencias-SENA [6570-392-19990]; MAVDT [15]	Colciencias-SENA(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MAVDT	This work was funded by Colciencias-SENA (6570-392-19990) and was carried out under MAVDT Contract No. 15, 2008 for access to genetic resources and UAESPNN Research Permit No. DTNO-N-20/2007.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antranikian G, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P361; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Atomi H, 2004, TETRAHEDRON-ASYMMETR, V15, P2729, DOI 10.1016/j.tetasy.2004.07.054; Auernik KS, 2008, CURR OPIN BIOTECH, V19, P445, DOI 10.1016/j.copbio.2008.08.001; Berekaa MM, 2009, WORLD J MICROB BIOT, V25, P287, DOI 10.1007/s11274-008-9891-3; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Chang YF, 2001, TETRAHEDRON-ASYMMETR, V12, P177, DOI 10.1016/S0957-4166(01)00017-9; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; Chen CKM, 2009, J MOL BIOL, V390, P672, DOI 10.1016/j.jmb.2009.05.017; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Cieslinski H, 2007, ARCH MICROBIOL, V188, P27, DOI 10.1007/s00203-007-0220-2; DARLAND G, 1971, J GEN MICROBIOL, V67, P9, DOI 10.1099/00221287-67-1-9; De Santi C, 2010, BIOCHIMIE, V92, P949, DOI 10.1016/j.biochi.2010.04.001; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P1437, DOI 10.1099/ijs.0.010926-0; Ejima K, 2004, J BIOSCI BIOENG, V98, P445, DOI 10.1263/jbb.98.445; Elend C, 2006, APPL ENVIRON MICROB, V72, P3637, DOI 10.1128/AEM.72.5.3637-3645.2006; FELLER G, 1991, DNA CELL BIOL, V10, P381, DOI 10.1089/dna.1991.10.381; Fucinos P, 2005, BIOTECHNOL PROGR, V21, P1198, DOI 10.1021/bp050080g; FUSEK M, 1990, J BIOL CHEM, V265, P1496; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gaur R, 2008, PROCESS BIOCHEM, V43, P1040, DOI 10.1016/j.procbio.2008.05.007; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Hasan F, 2009, BIOTECHNOL ADV, V27, P782, DOI 10.1016/j.biotechadv.2009.06.001; Hausmann S., 2010, HDB HYDROCARBON LIPI, P1099, DOI DOI 10.1007/978-3-540-77587-4_77; Hess M, 2008, TRENDS MICROBIOL, V16, P414, DOI 10.1016/j.tim.2008.06.001; Hotta Y, 2002, APPL ENVIRON MICROB, V68, P3925, DOI 10.1128/AEM.68.8.3925-3931.2002; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Isobe K, 1997, J GEN APPL MICROBIOL, V43, P151, DOI 10.2323/jgam.43.151; Itoh T, 2003, INT J SYST EVOL MICR, V53, P1149, DOI 10.1099/ijs.0.02580-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jiang XW, 2012, ARCH MICROBIOL, V194, P207, DOI 10.1007/s00203-011-0745-2; Kadar Z, 2003, APPL BIOCHEM BIOTECH, V105, P557; Kim S, 2004, BIOSCI BIOTECH BIOCH, V68, P2289, DOI 10.1271/bbb.68.2289; Kim SB, 2008, J MICROBIOL, V46, P100, DOI 10.1007/s12275-007-0185-5; Kroutil W, 1997, TETRAHEDRON-ASYMMETR, V8, P3263, DOI 10.1016/S0957-4166(97)00429-1; Kumar L, 2012, PROCESS BIOCHEM, V47, P983, DOI 10.1016/j.procbio.2012.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manco G, 2000, ARCH BIOCHEM BIOPHYS, V373, P182, DOI 10.1006/abbi.1999.1497; Manco G, 1998, BIOCHEM J, V332, P203, DOI 10.1042/bj3320203; Mandrich L, 2004, J MOL BIOL, V335, P357, DOI 10.1016/j.jmb.2003.10.038; Mandrich L., 2011, CURR CHEM BIOL, V5, P17, DOI [10.2174/187231311793564351, DOI 10.2174/187231311793564351]; Mandrich L, 2008, PROTEINS, V71, P1721, DOI 10.1002/prot.21877; Mandrich L, 2009, PROTEIN PEPTIDE LETT, V16, P1189; Metin K, 2006, J BASIC MICROB, V46, P400, DOI 10.1002/jobm.200510121; Morana A, 2002, GENE, V283, P107, DOI 10.1016/S0378-1119(01)00879-4; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; Rao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060645; Rao L, 2011, BBA-PROTEINS PROTEOM, V1814, P1695, DOI 10.1016/j.bbapap.2011.08.013; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd; San Martin-Uriz P, 2011, J BACTERIOL, V193, P5585, DOI 10.1128/JB.05386-11; Serour E, 2002, ANTON LEEUW INT J G, V81, P73, DOI 10.1023/A:1020525525490; Sharma A, 2012, EXTREMOPHILES, V16, P1, DOI 10.1007/s00792-011-0402-3; Sharma A, 2011, J BIOSCI BIOENG, V111, P550, DOI 10.1016/j.jbiosc.2011.01.004; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Soliman NA, 2007, PROCESS BIOCHEM, V42, P1090, DOI 10.1016/j.procbio.2007.05.005; Stingl U, 2008, MICROB ECOL, V55, P395, DOI 10.1007/s00248-007-9284-4; Suzuki Y, 2004, FEMS MICROBIOL LETT, V236, P97, DOI 10.1016/j.femsle.2004.05.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tekedar HC, 2011, EXTREMOPHILES, V15, P203, DOI 10.1007/s00792-010-0344-1; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Zhao DT, 2011, BIOTECHNOL BIOPROC E, V16, P638, DOI 10.1007/s12257-011-0007-9	71	23	29	0	32	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2014	98	20					8603	8616		10.1007/s00253-014-5775-7	http://dx.doi.org/10.1007/s00253-014-5775-7			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7HZ	24818691				2022-09-04	WOS:000343751400016
J	Langa, GPJ; Dantas, PPD; Lemus, GMR; Silva, CGB; Meza-Mauricio, J; Muniz, FWMG				Jose Langa, Gerson Pedro; de Almeida Dantas, Pedro Paulo; Ramirez Lemus, Gloria Marcela; Benitez Silva, Carlos Guillermo; Meza-Mauricio, Jonathan; Mustafa Gomes Muniz, Francisco Wilker			Effectiveness of interdental cleaning devices with active substances: a systematic review	CLINICAL ORAL INVESTIGATIONS			English	Review						Dental devices; Home care; Gingival diseases; Oral health; Oral hygiene	GINGIVAL INFLAMMATION; PERIODONTAL-DISEASE; SUPRAGINGIVAL BIOFILM; ORAL-HEALTH; ADULTS; EFFICACY; PREVALENCE; PREVENTION; SEVERITY	Objectives To systematically review the literature on the efficacy of interdental cleaning devices (ICDs) used with active substances, as adjuncts to toothbrushing, in comparison with toothbrushing alone or with ICDs without active substances. Materials and methods Searches for randomized clinical trials were performed in PubMed, Embase, Scopus, Cochrane (CENTRAL), and Web of Science. Two independent researchers performed study selection, data extraction, and risk-of-bias assessment; a third one resolved any disagreement. Meta-analysis was not feasible, and a narrative approach was used to synthesize the evidence. Results Seven studies were included. Dental floss with chlorhexidine was used in five studies, whereas interdental brushes with chlorhexidine and cetylpyridinium chloride were used in one study each. ICDs with active substances resulted in significantly higher antiplaque and antigingivitis efficacies than without ICDs (n = 3). ICDs with and without active substances demonstrated contrasting results. For this comparison, six studies were included for each outcome. Significantly higher antigingivitis efficacy of ICDs with active substances was noted in four studies, whereas significantly higher antiplaque efficacy of ICDs with active substances was reported in three studies. All comparisons demonstrated a very low certainty of evidence. Conclusions There is no robust evidence for the additional clinical efficacy of ICDs with active substances regarding their antiplaque and antigingivitis efficacies. These devices may have additional clinical efficacy when compared with the absence of interproximal hygiene.	[Jose Langa, Gerson Pedro] Univ Fed Rio Grande do Sul, Sch Dent, Dept Periodontol, Porto Alegre, RS, Brazil; [de Almeida Dantas, Pedro Paulo] Univ Fed Pelotas, Sch Dent, Pelotas, RS, Brazil; [Ramirez Lemus, Gloria Marcela] Pontificia Univ Javeriana, Sch Dent, Dept Periodontol, Bogota, Colombia; [Benitez Silva, Carlos Guillermo] Latin Amer Oral Hlth Assoc LAOHA, Sao Paulo, Brazil; [Meza-Mauricio, Jonathan] Univ Guarulhos, Dept Periodontol, Dent Res Div, Sao Paulo, Brazil; [Mustafa Gomes Muniz, Francisco Wilker] Univ Fed Pelotas, Sch Dent, Dept Periodontol, Rua Goncalves Chaves 457, BR-96015560 Pelotas, RS, Brazil		Muniz, FWMG (corresponding author), Univ Fed Pelotas, Sch Dent, Dept Periodontol, Rua Goncalves Chaves 457, BR-96015560 Pelotas, RS, Brazil.	wilkermustafa@gmail.com	Muniz, Francisco/K-3411-2014	Muniz, Francisco/0000-0002-3945-1752; Meza Mauricio, Jonathan/0000-0002-4878-9835	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES). The authors self-funded the other part of the study.	Abusleme L, 2021, PERIODONTOL 2000, V86, P57, DOI 10.1111/prd.12362; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P158, DOI 10.1177/003335491012500202; Brunette DM., 2008, CAN J DENT HYG, V42, P8; Carr MP, 2000, AM J DENT, V13, P212; Carvajal P, 2016, J APPL ORAL SCI, V24, P524, DOI 10.1590/1678-775720160178; Chapple ILC, 2015, J CLIN PERIODONTOL, V42, pS71, DOI 10.1111/jcpe.12366; Elias-Boneta AR, 2018, P R HEALTH SCI J, V37, P115; Figuero E, 2020, J CLIN PERIODONTOL, V47, P125, DOI 10.1111/jcpe.13244; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haas AN, 2016, J DENT, V55, P7, DOI 10.1016/j.jdent.2016.09.001; HUGOSON A, 1979, SWED DENT J, V3, P69; Jakubovics NS, 2021, PERIODONTOL 2000, V86, P32, DOI 10.1111/prd.12361; James P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008676.pub2; Jonsson B, 2020, PERIODONTOL 2000, V84, P134, DOI 10.1111/prd.12334; Langa GPJ, 2021, J EVID-BASED DENT PR, V21, DOI 10.1016/j.jebdp.2021.101548; Joseph S, 2021, PERIODONTOL 2000, V86, P201, DOI 10.1111/prd.12377; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.005; KINANE DF, 1992, J PERIODONTOL, V63, P757, DOI 10.1902/jop.1992.63.9.757; Kotsakis GA, 2018, J PERIODONTOL, V89, P558, DOI 10.1002/JPER.17-0368; Langa GPJ, 2021, CLIN ORAL INVEST, V25, P745, DOI 10.1007/s00784-020-03661-2; Lee Ying C., 1996, New Zealand Dental Journal, V92, P13; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marchesan JT, 2018, J DENT RES, V97, P773, DOI 10.1177/0022034518759915; Muniz FWMG, 2015, INT J DENT HYG, V13, P117, DOI 10.1111/idh.12112; Muniz FWMG, 2018, J INVESTIG CLIN DENT, V9, DOI 10.1111/jicd.12280; Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72; Page MJ, 2021, J CLIN EPIDEMIOL, V134, P178, DOI 10.1016/j.jclinepi.2021.03.001; Pal M, 2020, OPEN ACCESS MAC J ME, V8, P118; Salzer S, 2020, PERIODONTOL 2000, V84, P35, DOI 10.1111/prd.12332; Salvi GE, 2009, ORAL HLTH PREV DENT, V7, P383; Scannapieco FA, 2020, PERIODONTOL 2000, V84, P9, DOI 10.1111/prd.12330; Schmidt B, 2015, ORAL HLTH PREV DENT, V13, P205, DOI 10.3290/j.ohpd.a32680; Slot D E, 2008, Int J Dent Hyg, V6, P253, DOI 10.1111/j.1601-5037.2008.00330.x; Slot DE, 2020, J CLIN PERIODONTOL, V47, P107, DOI 10.1111/jcpe.13275; U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, 2015 2020 DIET GUID, V8th ed.; Worthington HV, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012018.pub2; Zanatta FB, 2011, AM J ORTHOD DENTOFAC, V140, P812, DOI 10.1016/j.ajodo.2011.06.028	41	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	MAR	2022	26	3					2253	2267		10.1007/s00784-021-04327-3	http://dx.doi.org/10.1007/s00784-021-04327-3		JAN 2022	15	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	ZN4QM	34999990				2022-09-04	WOS:000740380400001
J	Echeverri-Pena, OY; Salazar-Barreto, DA; Rodriguez-Lopez, A; Gonzalez, J; Almeciga-Diaz, CJ; Verano-Guevara, CH; Barrera, LA				Echeverri-Pena, Olga Y.; Salazar-Barreto, Diego A.; Rodriguez-Lopez, Alexander; Gonzalez, Janneth; Almeciga-Diaz, Carlos J.; Verano-Guevara, Cristian H.; Barrera, Luis A.			Use of a neuron-glia genome-scale metabolic reconstruction to model the metabolic consequences of the Arylsulphatase a deficiency through a systems biology approach	HELIYON			English	Article						Metachromatic leukodystrophy; System biology; Arylsulphatase A; Myelin sheath	CONSTRAINT-BASED MODELS; CARNOSINE; MYELIN; CELL; COMMUNICATION; HOMOCARNOSINE; GLYCOGEN	Metachromatic leukodystrophy (MLD) is a human neurodegenerative disorder characterized by progressive damage on the myelin band in the nervous system. MLD is caused by the impaired function of the lysosomal enzyme Arylsulphatase A (ARSA). The physiopathology mechanisms and the biochemical consequences in the brain of ARSA deficiency are not entirely understood. In recent years, the use of genome-scale metabolic (GEM) models has been explored as a tool for the study of the biochemical alterations in MLD. Previously, we modeled the metabolic consequences of different lysosomal storage diseases using single GEMs. In the case of MLD, using a glia GEM, we previously predicted that the metabolism of glycosphingolipids and neurotransmitters was altered. The results also suggested that mitochondrial metabolism and amino acid transport were the main reactions affected. In this study, we extended the modeling of the metabolic consequences of ARSA deficiency through the integration of neuron and glial cell metabolic models. Cell-specific models were generated from Recon2, and these were used to create a neuron-glial bi-cellular model. We propose a workflow for the integration of this type of model and its subsequent study. The results predicted the impairment pathways involved in the transport of amino acids, lipids metabolism, and catabolism of purines and pyrimidines. The use of this neuron-glial GEM metabolic reconstruction allowed to improve the prediction capacity of the metabolic consequences of ARSA deficiency, which might pave the way for the modeling of the biochemical alterations of other inborn errors of metabolism with central nervous system involvement.	[Echeverri-Pena, Olga Y.; Rodriguez-Lopez, Alexander; Almeciga-Diaz, Carlos J.; Barrera, Luis A.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Fac Sci, Bogota, Colombia; [Salazar-Barreto, Diego A.] Univ Andes, Dept Ind Engn, Fac Engn, Ctr Optimizac & Probabilidad Aplicada COPA, Bogota, Colombia; [Salazar-Barreto, Diego A.; Gonzalez, Janneth] Pontificia Univ Javeriana, Fac Sci, Dept Nutr & Biochem, Grp Bioquim Computac Estruct & Bioinform, Bogota, Colombia; [Barrera, Luis A.] Hosp Univ San Ignacio, Clin Errores Innatos Metab, Bogota, Colombia; [Rodriguez-Lopez, Alexander; Verano-Guevara, Cristian H.] Univ Dist Francisco Jose de Caldas, Licenciatura Quim, Bogota, Colombia; [Rodriguez-Lopez, Alexander] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia		Echeverri-Pena, OY; Almeciga-Diaz, CJ (corresponding author), Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Fac Sci, Bogota, Colombia.	oyecheve@javeriana.edu.co; cjalmeciga@javeriana.edu.co	GONZALEZ, JANNETH/AAB-9948-2020; Alméciga-Díaz, Carlos J/A-2494-2017	GONZALEZ, JANNETH/0000-0003-4482-256X; Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Echeverri-Pena, Olga Y/0000-0001-9704-6387	Pontificia Universidad Javeriana [SIAP 4197]	Pontificia Universidad Javeriana	Olga Y. Echeverri-Pena and Luis A. Barrera were supported by the grant number SIAP 4197, Pontificia Universidad Javeriana.	Alabovsky VV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P77; Alfardan J, 2010, MOL GENET METAB, V100, P333, DOI 10.1016/j.ymgme.2010.04.014; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Aubert A, 2007, GLIA, V55, P1272, DOI 10.1002/glia.20360; Ben Achour S, 2012, NEUROCHEM RES, V37, P2464, DOI 10.1007/s11064-012-0807-0; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bonora M, 2015, ONCOGENE, V34, P1608, DOI [10.1038/onc.2014.462, 10.1038/onc.2014.96]; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cairella M, 1969, Clin Ter, V51, P439; Cakir T, 2004, BIOSYSTEMS, V78, P49, DOI 10.1016/j.biosystems.2004.06.004; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Chen EP, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3098-5; Cook DJ, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1393; De Luca C., 2020, INT J MOL SCI, V21; Deconinck N, 2008, EUR J PAEDIATR NEURO, V12, P46, DOI 10.1016/j.ejpn.2007.05.004; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5; Ferdinandusse S, 2010, J NEUROL NEUROSUR PS, V81, P310, DOI 10.1136/jnnp.2009.176255; Gieselmann V., 2014, ONLINE METABOLIC MOL; GOODRUM JF, 1995, J NEUROCHEM, V65, P1752; Jolivet R, 2010, J CEREBR BLOOD F MET, V30, P1982, DOI 10.1038/jcbfm.2010.132; Kohlschutter A, 2013, HAND CLINIC, V113, P1611, DOI 10.1016/B978-0-444-59565-2.00029-0; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li Zheng-Hao, 2017, Shengli Xuebao, V69, P817, DOI 10.13294/j.aps.2017.0083; Lieven C, 2020, NAT BIOTECHNOL, V38, P272, DOI 10.1038/s41587-020-0446-y; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; NAKAI M, 1989, JPN J VET SCI, V51, P521; Olarte-Avellaneda S, 2014, MOL BIOL REP, V41, P7073, DOI 10.1007/s11033-014-3383-3; Olga Y.E, 2016, CENT NERV SYST AGENT, V16, P1; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Pfau T, 2016, BRIEF BIOINFORM, V17, P1060, DOI 10.1093/bib/bbv100; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Rich LR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01176; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Salazar DA, 2016, MOL GENET METAB, V117, P129, DOI 10.1016/j.ymgme.2015.08.001; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schoen P, 2003, CLIN CHEM, V49, P1930, DOI 10.1373/clinchem.2003.019398; Sertbas M, 2014, FEBS OPEN BIO, V4, P542, DOI 10.1016/j.fob.2014.05.006; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tan MAF, 2010, MOL GENET METAB, V99, P142, DOI 10.1016/j.ymgme.2009.09.006; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Toepfer CN, 2019, CIRC RES, V124, P1172, DOI 10.1161/CIRCRESAHA.118.314505; Tress O, 2012, J NEUROSCI, V32, P7499, DOI 10.1523/JNEUROSCI.0392-12.2012; Uhl ~en M, 2015, SCIENCE, V347; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Rappard DF, 2015, BEST PRACT RES CL EN, V29, P261, DOI 10.1016/j.beem.2014.10.001; Wade JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029445; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297	56	1	1	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	JUL	2021	7	7							e07671	10.1016/j.heliyon.2021.e07671	http://dx.doi.org/10.1016/j.heliyon.2021.e07671		JUL 2021	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3QE	34381909	gold, Green Published			2022-09-04	WOS:000680264800007
J	Fernandez, N; Prada, S; Avansino, J; Chavarriaga, J; Hermida, E; Perez, J				Fernandez, Nicolas; Prada, Stefania; Avansino, Jeffrey; Chavarriaga, Julian; Hermida, Eduardo; Perez, Jaime			Risk-based stratification triaging system in pediatric urology: what COVID-19 pandemic has taught us	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Enhanced recovery after surgery; Pediatrics; COVID-19 pandemic; SARS-COV-2 pandemic		Introduction and objective SARS-COV-2 pandemic has affected the population worldwide requiring social distancing, quarantine and isolation as strategies to control virus propagation. Initial measures to reduce the burden to the health care system during the pandemic included deferring elective surgery. These damage control measures did not take into account the mid- and long-term implications. Management of congenital anomalies can be time sensitive with delays resulting in permanent disability, morbidity and increased costs to the healthcare system. This study reports the results of using a novel scoring system that enables triage of time sensitive congenital anomalies and pediatric surgical conditions and how implementation of Enhanced Recovery After Surgery (ERAS (R)) principles allowed optimization of resources and reduced the burden to the system while allowing for appropriate care of pediatric patients with urgent urologic surgical conditions. Methods We present a prospective case series of patients with congenital urological conditions scheduled and taken to surgery during COVID-19 pandemic. All pediatric urology cases that were pending and or scheduled for surgery at the moment the pandemic struck as well as all cases that presented to the emergency department with urological conditions were triaged and included for analysis using a modified Medically Necessary, Time-Sensitive Procedures: Scoring System (MeNTS). A modified MeNTS was implemented for pediatric patients, giving more priority to the impact of deferring surgical intervention on patient's prognosis. An individualized evaluation using this scoring system was applied to each patient. Intra- and postoperative ERAS(R) principles were applied to all cases operated during the pandemic between March 20th and April 24th to reduce the burden to the healthcare system. Results A total of 49 patients were triaged and included for analysis with a mean age of 6.47 years of age. Adjusted MeNTS showed that all clinically emergent cases had a score of 12 or less. Cases that could be postponed for 2 weeks but no longer had a score between 13 and 15. The ones that could wait 6 weeks or longer had scores higher than 16. Score results were not the same for similar procedures and individualized assessments resulted in scores based on an individual patient's conditions. From the total cases, implementation of ERAS(R) principles increased outpatient procedures from 68 to 90.4%. Conclusion Our results provide a novel triaging method to rank pediatric urological surgical management based on individualized patient's clinical conditions. Cutoff values of 12 and 16 allowed appropriate triage preventing the postponement of urgent urologic cases during the COVID-19 pandemic. Implementation of ERAS(R) principles allowed for these procedures to be done in the outpatient setting, preserving valuable healthcare resources. Type of study Prospective cohort study.	[Fernandez, Nicolas] Univ Washington, Seattle Childrens Hosp, Div Urol, 4800 Sand Point Way NE, Seattle, WA 98105 USA; [Prada, Stefania; Chavarriaga, Julian; Perez, Jaime] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; [Avansino, Jeffrey] Univ Washington, Dept Surg, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Perez, Jaime] Univ Los Andes, Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia; [Hermida, Eduardo] Univ Los Andes, Fdn Santa Fe Bogota, Dept Anesthesia, Bogota, Colombia		Fernandez, N (corresponding author), Univ Washington, Seattle Childrens Hosp, Div Urol, 4800 Sand Point Way NE, Seattle, WA 98105 USA.	jnfb@uw.edu		Prada, Stefania/0000-0003-4297-6215; Perez Nino, Jaime/0000-0002-2231-4321				[Anonymous], SURGEONS AC COVID 19; Azhar RA, 2016, EUR UROL, V70, P176, DOI 10.1016/j.eururo.2016.02.051; Beverly Anair, 2017, Anesthesiol Clin, V35, pe115, DOI 10.1016/j.anclin.2017.01.018; Campi R, 2020, EUR UROL, V78, P11, DOI 10.1016/j.eururo.2020.03.054; Chan MC, 2020, EUR UROL, V78, pE38, DOI 10.1016/j.eururo.2020.03.004; Cini C, 2020, J PEDIATR UROL, V16, P295, DOI 10.1016/j.jpurol.2020.04.023; Fernandez N, 2020, J PEDIATR UROL, V16, P291, DOI 10.1016/j.jpurol.2020.05.001; Mattioli G, 2009, J LAPAROENDOSC ADV S, V19, pS7, DOI 10.1089/lap.2008.0121.supp; Penchaszadeh V, COMMUN GENET, V5, P61; Poenaru D, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0125-5; Poenaru D, 2015, WORLD J SURG, V39, P2198, DOI 10.1007/s00268-015-3103-8; Prachand VN, 2020, J AM COLL SURGEONS, V231, P281, DOI 10.1016/j.jamcollsurg.2020.04.011; Qiu H, LANCET INFECT DIS; Quaedackers JSLT, 2020, J PEDIATR UROL, V16, P284, DOI 10.1016/j.jpurol.2020.04.007; Reismann M, 2007, J PEDIATR SURG, V42, P234, DOI 10.1016/j.jpedsurg.2006.09.022; Reismann M, 2009, LANGENBECK ARCH SURG, V394, P529, DOI 10.1007/s00423-008-0440-1; Rove KO, 2018, PEDIATR ANESTH, V28, P482, DOI 10.1111/pan.13380; Schukfeh N, 2014, EUR J PEDIATR SURG, V24, P419, DOI 10.1055/s-0033-1352528; Short HL, 2018, J PEDIATR SURG, V53, P688, DOI 10.1016/j.jpedsurg.2017.05.004; Simpson JC, 2019, CLIN COLON RECT SURG, V32, P121, DOI 10.1055/s-0038-1676477; Spinoit AF, 2020, EUR UROL, V78, P122, DOI 10.1016/j.eururo.2020.04.019; Stensland KD, 2020, EUR UROL, V77, P663, DOI 10.1016/j.eururo.2020.03.027; Vrecenak JD, 2014, J PEDIATR SURG, V49, P99, DOI 10.1016/j.jpedsurg.2013.09.038; Wick EC, 2017, JAMA SURG, V152, P691, DOI 10.1001/jamasurg.2017.0898; Zeng L, JAMA PEDIATR	25	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	JUN	2021	37	6					827	833		10.1007/s00383-021-04868-4	http://dx.doi.org/10.1007/s00383-021-04868-4		FEB 2021	7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	SA6CS	33638662	Green Published, Bronze			2022-09-04	WOS:000622665600001
J	Rodriguez-Lopez, M; Vergara-Sanchez, C; Crispi, F; Cepeda, IL				Rodriguez-Lopez, Merida; Vergara-Sanchez, Carlos; Crispi, Fatima; Cepeda, Ivan Leonardo			Sources of heterogeneity when studying the cardiovascular effects of fetal growth restriction: an overview of the issues	JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE			English	Review						Fetal growth retardation; fetal programing; prevention; cardiovascular diseases; statistical analysis; heterogeneity	ORIGINS; STANDARDS; DISEASE; WEIGHT; BIAS	Intrauterine growth restriction (IUGR) has been repeatedly identified as a risk factor for cardiovascular disease (CVD). A possible explanation for this association is the effect of IUGR on cardiovascular structure and function. However, the specific changes observed are not consistent among studies. In this paper, we analyze several sources of heterogeneity within and between studies related to exposure, outcome and co-variables. A broad IUGR definition might include different phenotypes, expressing heterogeneity as an outcome. Outcome heterogeneity may also be the result of the postnatal effect modification that can be explored within studies. In order to do so, it is important to move beyond mean differences between groups, for example using unsupervised, stratified or interaction analysis. Different definitions of IUGR and the inclusion of different postnatal variables as confounders are potential sources of heterogeneity between studies. Researchers should be aware that postnatal variables may play different roles throughout a person's life and are not limited to behave as confounders. Therefore, their inclusion in the statistical model needs to be carefully considered. We discuss when sources of heterogeneity need to be controlled, and when they need to be identified and shown as a result.	[Rodriguez-Lopez, Merida; Vergara-Sanchez, Carlos; Cepeda, Ivan Leonardo] Pontificia Univ Javeriana, Cali, Colombia; [Rodriguez-Lopez, Merida; Vergara-Sanchez, Carlos] Pontificia Univ Javeriana, Ctr Interdisciplinary Hlth Studies, Cali, Colombia; [Crispi, Fatima] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp Clin,Fetal Med Res Ctr, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Crispi, Fatima] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp St Joan de Deu,Inst Clin Ginecol Obstet & Ne, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain		Rodriguez-Lopez, M (corresponding author), Pontificia Univ Javeriana Cali, Ctr Interdisciplinary Hlth Studies, Calle 18 118-250 Tercer Piso Edificio Raul Posada, Cali, Valle Del Cauca, Colombia.	merida.rdguez@gmail.com	Rodriguez-Lopez, Merida/N-9273-2017	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Crispi, Fatima/0000-0002-7422-5240; Cepeda, Ivan Leonardo/0000-0001-9696-4047				Al Lwan A, 2010, GLOBAL STATUS REPORT; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Arnott C, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000265; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Bjarnegard N, 2013, ULTRASOUND OBST GYN, V41, P177, DOI 10.1002/uog.12314; Chiossi G, 2017, ULTRASOUND OBST GYN, V50, P156, DOI 10.1002/uog.17381; Cinar B, 2015, CARDIOL YOUNG, V25, P301, DOI 10.1017/S1047951113002199; Cohen E, 2018, ACTA PAEDIATR, V107, P450, DOI 10.1111/apa.14144; Cohen E, 2016, PEDIATR RES, V79, P821, DOI 10.1038/pr.2016.24; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Crispi F, 2018, AM J OBSTET GYNECOL, V218, pS869, DOI 10.1016/j.ajog.2017.12.012; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Fouzas S, 2014, PEDIATR RES, V75, P651, DOI 10.1038/pr.2014.22; Gardosi J, 2004, SEMIN PERINATOL, V28, P33, DOI 10.1053/j.semperi.2003.12.002; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Holt Richard I G, 2002, Semin Vasc Med, V2, P33, DOI 10.1055/s-2002-23094; Iliodromiti S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002228; Kimm SYS., 2004, CURR OPIN ENDOCRINOL, V11, P192, DOI [10.1097/01.med.0000140938.39925.4c, DOI 10.1097/01.MED.0000140938.39925.4C]; Leeson P, 2017, J AM COLL CARDIOL, V69, P2643, DOI 10.1016/j.jacc.2017.03.574; Luque-Fernandez MA, 2016, EUR J EPIDEMIOL, V31, P613, DOI 10.1007/s10654-016-0139-5; Miyague NI, 1997, EARLY HUM DEV, V48, P93, DOI 10.1016/S0378-3782(96)01840-3; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; Papageorghiou AT, 2018, AM J OBSTET GYNECOL, V218, pS630, DOI 10.1016/j.ajog.2018.01.011; Rodriguez-Lopez M, 2017, ULTRASOUND OBST GYN, V50, P207, DOI 10.1002/uog.17365; Rodriguez-Lopez M, 2016, PEDIATR RES, V79, P100, DOI 10.1038/pr.2015.182; Sarvari SI, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005270; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Szklo M, EPIDEMIOLOGIA INTERM; Tzeng CR, 2014, FERTIL STERIL, V101, P1404, DOI 10.1016/j.fertnstert.2014.01.023; VanderWeele TJ, 2013, EPIDEMIOLOGY, V24, P224, DOI 10.1097/EDE.0b013e318281a64e; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Vayssiere C, 2015, EUR J OBSTET GYN R B, V193, P10, DOI 10.1016/j.ejogrb.2015.06.021; VEILLE JC, 1993, AM J PERINAT, V10, P275, DOI 10.1055/s-2007-994739; Yiallourou SR, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx048	40	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1476-7058	1476-4954		J MATERN-FETAL NEO M	J. Matern.-Fetal Neonatal Med.	APR 3	2022	35	7					1379	1385		10.1080/14767058.2020.1749592	http://dx.doi.org/10.1080/14767058.2020.1749592		APR 2020	7	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	ZO3BS	32228109				2022-09-04	WOS:000526263700001
J	Rodriguez, FM; Perez, MV				Malaver Rodriguez, Florentino; Vargas Perez, Marisela			Bogota-Region in the OECD scenario. Prisms and innovation indicators	CUADERNOS DE ECONOMIA			Spanish	Article						innovation indicators; innovation policies; innovation; RIS		Colombia's accession to the OECD has raised positive expectations. It would induce greater international comparison of its performance in science, technology and innovation, and better policies. The text discusses the readings made possible by the OECD indicators and the European Union's Regional Innovation Index (RIS), and the evidence provided by its application in Bogota-Region. This reveals: a growing backwardness vis-a-vis developed country regions and Latin American capitals; a more comprehensive and inclusive perspective on RIS; and the need for indicators to capture regional specificities and explain results that are at odds with those recorded in developed countries.	[Malaver Rodriguez, Florentino] Univ Nacl Colombia, Econ, Bogota, Colombia; [Malaver Rodriguez, Florentino] Univ Pedag & Tecnol Colombia, Tunja, Colombia; [Malaver Rodriguez, Florentino; Vargas Perez, Marisela] Pontificia Univ Javeriana, Fac Ciencias Econ & Adm, Dept Adm Empresas, Bogota, Colombia; [Malaver Rodriguez, Florentino; Vargas Perez, Marisela] Grp Invest CINNCO, Conocimiento, Innovac, Competitividad, Medellin, Colombia; [Vargas Perez, Marisela] Univ Nacl Colombia, Ciencias Econ, Bogota, Colombia; [Vargas Perez, Marisela] Univ Andes, Bogota, Colombia		Rodriguez, FM (corresponding author), Pontificia Univ Javeriana, Fac Ciencias Econ & Adm, Dept Adm Empresas, Bogota, Colombia.; Rodriguez, FM (corresponding author), Grp Invest CINNCO, Conocimiento, Innovac, Competitividad, Medellin, Colombia.	fmalaver@javeriana.edu.co; marisela.vargas@javeriana.edu.co		Vargas Perez, Marisela/0000-0002-1032-8785				Ajmone G., 2011, OECD REGIONAL DEV WO; Arundel A., 2006, WORKING PAPER; Arundel A., 2008, NEGLECTED INNOVATORS; Charum J., 2009, ENCUESTAS DATOS DESC, P15; COOKE P, 1992, GEOFORUM, V23, P365, DOI 10.1016/0016-7185(92)90048-9; Dini M., 2014, PROMESA SUSPIRAR POL, P9; Dosi G, 2012, HBK ECON, V1, P51, DOI 10.1016/S0169-7218(10)01003-8; Edquist Ch, 2013, OXFORD HDB INNOVATIO, P1, DOI [DOI 10.1093/OXFORDHB/9780199286805.003.0007, 10.1093/oxfordhb/9780199286805.003.0007]; European Commission, 2014, REG INN SCOR 2014; European Commission, 2012, INN UN SCOR 2011; European Commission, 2010, EL SETT HEADL IND IN; European Commission, 2012, REGIONAL INNOVATION; European Commission, 2014, INN UN SCOR 2014; Ferrari C., 2018, REV JAVERIANA, V847, P16; FREEMAN C., 1987, TECHNOLOGY POLICY EC; Gault F, 2013, ELGAR ORIG REF, P441; Gault F, 2013, ELGAR ORIG REF, P3; Glaude M., 2008, 32 CEIES SEM INN IND, P21; Hodgson GM, 2006, J ECON ISSUES, V40, P1, DOI 10.1080/00213624.2006.11506879; Hollanders H., 2009, INN IND LAT AM WORKS; Hollanders H, 2011, INNOVATION UNION SCO; Hollanders H, 2013, ELGAR ORIG REF, P279; Jaramillo H., 2001, NORMALIZACION INDICA; Jensen MB, 2007, RES POLICY, V36, P680, DOI 10.1016/j.respol.2007.01.006; Kline S., 1986, POSITIVE SUM STRATEG, P275, DOI DOI 10.1108/14601069810368485; Lundvall A, 1985, PRODUCT INNOVATION U; Lundvall B., 2005, OXFORD HDB INNOVATIO, P599, DOI DOI 10.1093/OXFORDHB/9780199286805.001.0001; Malaver F., 2014, SET CORE INDICADORES; Malaver F., 2019, FIRM HETEROGENEITY I; Malaver F., 2004, ACADEMIA, V33, P5; Malaver Rodríguez Florentino, 2005, Cuad. Adm., V18, P39; Meyer J., 1983, ORG ENV RITUAL RATIO; Nelson R. R, 1993, NATL INNOVATION SYST, V1st; NELSON RR, 2001, REV EC I, V0003, P00017; OECD, 2015, GUID COLL REP DAT RE; OECD, 1963, FRASC MAN 1963 PROP; OECD, 2014, OECD SCI TECHN IND O, DOI [10.1787/sti_outlook-2014-en, DOI 10.1787/STI_OUTLOOK-2014-EN]; OECD, 2005, OSLO MANUAL GUIDELIN; OECD, 1992, OSLO MANUAL GUIDELIN; Raffols I., 2016, OECD BLUE SKY C 14 M; TETHER B, 2002, 11 U MANCH CTR RES I; Vargas M., 2013, CUADERNOS EC, V32, P537; Vargas Pérez Marisela, 2018, Innovar, V28, P75, DOI 10.15446/innovar.v28n67.68614; Vega-Jurado Jaider, 2017, Cuad. Adm., V30, P7, DOI 10.11144/javeriana.cao30-55.bcica; Yoguel G, 2017, REV BRAS INOV, V16, P381, DOI 10.20396/rbi.v16i2.8650116	45	1	1	0	0	UNIV NAC COLOMBIA, FAC CIENCIAS ECONOMICAS, CUADERNOS ECONOMIA	BOGOTA	CARRERA 30 N 45-03., EDIFICIO 310, OFICINA 115, BOGOTA, 055051, COLOMBIA	0121-4772	2248-4337		CUAD ECON-BOGOTA	Cuad. Econ.	JAN-JUN	2020	39	79					103	138		10.15446/cuad.econ.v39n79.75783	http://dx.doi.org/10.15446/cuad.econ.v39n79.75783			36	Economics	Emerging Sources Citation Index (ESCI)	Business & Economics	JZ0XC		gold, Green Submitted			2022-09-04	WOS:000504828800004
J	Baez-Jurado, E; Hidalgo-Lanussa, O; Barrera-Bailon, B; Sahebkar, A; Ashraf, GM; Echeverria, V; Barreto, GE				Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Barrera-Bailon, Biviana; Sahebkar, Amirhossein; Ashraf, Ghulam Md; Echeverria, Valentina; Barreto, George E.			Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies	MOLECULAR NEUROBIOLOGY			English	Review						Mesenchymal stem cells; Paracrine factors; Pathologies; Therapeutics; Secretome; Brain	UMBILICAL-CORD BLOOD; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL PROGENITOR CELLS; HUMAN ADIPOSE-TISSUE; STROMAL CELLS; CONDITIONED MEDIUM; BONE-MARROW; IN-VITRO; REGENERATIVE MEDICINE; CLINICAL-APPLICATIONS	Previous studies have indicated that mesenchymal stem cells (MSCs) have a fundamental role in the repair and regeneration of damaged tissues. There is strong evidence showing that much of the beneficial effects of these cells are due to the secretion of bioactive molecules-besides microRNAs, hormones, and neurotrophins-with anti-inflammatory, immunoregulatory, angiogenic, and trophic effects. These factors have been reported by many studies to possess protective effects on the nervous tissue. Although the beneficial effects of the secretory factors of MSCs have been suggested for various neurological diseases, their actions on astrocytic cells are not well understood. Hence, it is important to recognize the specific effects of MSCs derived from adipose tissue, in addition to the differences presented by the secretome, depending on the source and methods of analysis. In this paper, the different sources of MSCs and their main characteristics are described, as well as the most significant advances in regeneration and protection provided by the secretome of MSCs. Also, we discuss the possible neuroprotective mechanisms of action of the MSC-derived biomolecules, with special emphasis on the effect of MSCs derived from adipose tissue and their impact on glial cells and brain pathologies.	[Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Barrera-Bailon, Biviana; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018; Ashraf, Ghulam Md/H-9485-2012; Barrera-Bailon, Biviana/K-6107-2017	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Barrera-Bailon, Biviana/0000-0001-8607-5174; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ grant [7115]; Vicerrectoria Academica of PUJ	PUJ grant; Vicerrectoria Academica of PUJ	This work was in part funded by PUJ grant (ID no. 7115) to GEB. We also acknowledge scholarships for doctoral studies granted by the Vicerrectoria Academica of PUJ to Baez-Jurado E and Hidalgo-Lanussa O.	Ahn SY, 2017, CELL TRANSPLANT, V26, P145, DOI 10.3727/096368916X692861; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Ali F, 2014, EXP NEUROL, V260, P3, DOI 10.1016/j.expneurol.2012.12.017; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Assuncao-Silva RC, 2018, BIOCHIMIE, V155, P83, DOI 10.1016/j.biochi.2018.07.026; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Barile L, 2017, PHARMACOL THERAPEUT, V174, P63, DOI 10.1016/j.pharmthera.2017.02.020; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bartolucci J, 2017, CIRC RES, V121, P1192, DOI 10.1161/CIRCRESAHA.117.310712; Behrstock Soshana, 2006, ELS, DOI DOI 10.1038/NPG.ELS.0005765; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bongso A, 2005, STEM CELLS, P588, DOI [10. 1142/5729, DOI 10.1142/5729]; Brick RM, 2018, STEM CELL TRANSL MED, V7, P45, DOI 10.1002/sctm.17-0108; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Brunt KR, 2012, CAN J PHYSIOL PHARM, V90, P327, DOI [10.1139/Y2012-007, 10.1139/y2012-007]; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Burrello J, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00083; Caccia D, 2013, BBA-PROTEINS PROTEOM, V1834, P2442, DOI 10.1016/j.bbapap.2013.01.039; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cao W, 2015, IMMUNOL LETT, V168, P147, DOI 10.1016/j.imlet.2015.06.003; Caplan AI, 2015, STEM CELL TRANSL MED, V4, P695, DOI 10.5966/sctm.2014-0291; Caron I, 2016, BIOMATERIALS, V75, P135, DOI 10.1016/j.biomaterials.2015.10.024; Castro-Manrreza ME, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/394917; Chagastelles Pedro Cesar, 2010, Science Progress, V93, P113, DOI 10.3184/003685010X12708175591515; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen YX, 2015, J RADIAT RES, V56, P700, DOI 10.1093/jrr/rrv026; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Cizkova D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030870; Cohen SP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7656; Cruz-Martinez P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.130; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; da Silva AF, 2015, CELL TRANSPLANT, V24, P2657, DOI 10.3727/096368915X687534; Dahbour S, 2017, CNS NEUROSCI THER, V23, P866, DOI 10.1111/cns.12759; Dang XT, 2016, GENE, V575, P377, DOI 10.1016/j.gene.2015.08.067; Datta I, 2012, CELL BIOL INT, V36, P617, DOI 10.1042/CBI20110602; Day AJ, 2018, MATRIX BIOL, DOI [10. 1016/j. matbio. 2018. 01. 011, DOI 10.1016/J.MATBI0.2018.01.011]; de Aro AA, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090127; de Deus GC, 2012, EINSTEIN-SAO PAULO, V10, P296, DOI 10.1590/S1679-45082012000300007; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; De la Rosa MB, 2018, ADV EXP MED BIOL, V1119, P41, DOI 10.1007/5584_2018_254; de Pedro-Cuesta J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137342; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; De-Miguel MP, 2009, INT J DEV BIOL, V53, P1529, DOI 10.1387/ijdb.072413md; DeLany JP, 2005, MOL CELL PROTEOMICS, V4, P731, DOI 10.1074/mcp.M400198-MCP200; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; DiNunzio JC, 2008, DRUG DEV IND PHARM, V34, P1141, DOI [10.1080/03639040802020536, 10.1080/03639040802020536 ]; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dong L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3738071; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Duan XH, 2017, INT J NANOMED, V12, P6705, DOI 10.2147/IJN.S146742; Endres M, 2003, ADV EXPT MED BIOL, P455; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Farinazzo A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25676-2; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gama KB, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8179013; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gardner OFW, 2015, METHODS MOL BIOL, V1340, P41, DOI 10.1007/978-1-4939-2938-2_3; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Golchin A, 2018, J CELL BIOCHEM, V119, P5043, DOI 10.1002/jcb.26706; Guadix JA, 2017, MED CLIN-BARCELONA, V148, P408, DOI 10.1016/j.medcli.2016.11.033; Hampel U, 2013, ENDOCRINOLOGY, V154, P2034, DOI 10.1210/en.2012-2201; Han YX, 2019, J NEUROSURG, V131, P290, DOI 10.3171/2018.2.JNS171475; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; Harrell CR, 2018, ADV EXP MED BIOL, V1089, P47, DOI 10.1007/5584_2018_219; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heo SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16895; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hiwatashi N, 2014, LARYNGOSCOPE, V124, pE461, DOI 10.1002/lary.24816; Hoban DB, 2015, NEUROSCIENCE, V303, P402, DOI 10.1016/j.neuroscience.2015.07.014; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang LB, 2016, OCUL IMMUNOL INFLAMM, V24, P684, DOI 10.3109/09273948.2015.1071405; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Jha KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072016; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kawai T, 2015, CYTOTHERAPY, V17, P369, DOI 10.1016/j.jcyt.2014.11.009; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim DH, 2018, BIOCHEM BIOPH RES CO, V504, P933, DOI 10.1016/j.bbrc.2018.09.012; Kim DH, 2015, STEM CELLS DEV, V24, P2378, DOI 10.1089/scd.2014.0487; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Kim Hee Jin, 2015, Alzheimers Dement (N Y), V1, P95, DOI 10.1016/j.trci.2015.06.007; Kim HY, 2014, STEM CELLS, V32, P2724, DOI 10.1002/stem.1770; Kim HS, 2017, STEM CELLS, V35, P248, DOI 10.1002/stem.2401; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim N, 2013, KOREAN J INTERN MED, V28, P387, DOI 10.3904/kjim.2013.28.4.387; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Kim WS, 2009, EXPERT OPIN BIOL TH, V9, P879, DOI 10.1517/14712590903039684; Kim WS, 2009, J DERMATOL SCI, V53, P96, DOI 10.1016/j.jdermsci.2008.08.007; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kokai LE, 2014, TRANSL RES, V163, P399, DOI 10.1016/j.trsl.2013.11.009; Koniusz S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00109; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lafourcade C, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S39916; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lai WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057876; Lankford KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190358; Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017; Lee HY, 2017, CANCER SCI, V108, P1939, DOI 10.1111/cas.13334; Lee TH, 2008, J CLIN NEUROSCI, V15, P907, DOI 10.1016/j.jocn.2007.03.016; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li MR, 2017, INT WOUND J, V14, P64, DOI 10.1111/iwj.12551; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Liang CM, 2014, CYTOTHERAPY, V16, P1371, DOI 10.1016/j.jcyt.2014.05.015; Lim JS, 2010, J KOREAN MED SCI, V25, P746, DOI 10.3346/jkms.2010.25.5.746; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liras A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-131; Liu YW, 2018, NAT BIOTECHNOL, V36, P597, DOI 10.1038/nbt.4162; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011; Lunyak VV, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00220; Ma L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0091-4; Machado Cíntia de Vasconcellos, 2013, Rev. Bras. Hematol. Hemoter., V35, P62, DOI 10.5581/1516-8484.20130017; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; Mahmoudifar N, 2015, METHODS MOL BIOL, V1340, P53, DOI 10.1007/978-1-4939-2938-2_4; Makridakis M, 2013, BBA-PROTEINS PROTEOM, V1834, P2380, DOI 10.1016/j.bbapap.2013.01.032; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marinkovic M, 2016, MATRIX BIOL, V52-54, P426, DOI 10.1016/j.matbio.2016.01.004; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Martins LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03592-1; Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189; Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Mochizuki Hideki, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS128, DOI 10.1016/S1353-8020(13)70031-2; Mokarizadeh A, 2012, IMMUNOL LETT, V147, P47, DOI 10.1016/j.imlet.2012.06.001; Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005; Mukai T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00466; Mukai T, 2017, NEUROSCIENCE, V355, P175, DOI 10.1016/j.neuroscience.2017.05.006; Nakamura Y, 2015, FEBS LETT, V589, P1257, DOI 10.1016/j.febslet.2015.03.031; Nakano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24805; Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Neymotin SA, 2015, ENCY COMPUTATIONAL N, P437; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Olson SD, 2012, MOL NEUROBIOL, V45, P87, DOI 10.1007/s12035-011-8219-8; Ooi YY, 2015, NEUROIMMUNOMODULAT, V22, P233, DOI 10.1159/000365483; Oses C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178011; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.tea.2011.0325, 10.1089/ten.TEA.2011.0325]; Otsuka T, 2018, STEM CELLS DEV, V27, P1287, DOI 10.1089/scd.2017.0299; Palomares T, 2018, MOL NEUROBIOL, V55, P13, DOI 10.1007/s12035-017-0714-0; Papazian I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030651; Park EH, 2018, STEM CELL TRANSL MED, V7, P636, DOI 10.1002/sctm.18-0031; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Paul G, 2013, BIOCHIMIE, V95, P2246, DOI 10.1016/j.biochi.2013.07.013; Petrou P, 2016, JAMA NEUROL, V73, P337, DOI 10.1001/jamaneurol.2015.4321; Phan J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1522236; Phelps J, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/9415367; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Quijano MC, 2012, COLOMBIA, V10, P11; Rani S, 2016, ADV MATER, V28, P5542, DOI 10.1002/adma.201504009; Rani S, 2015, MOL THER, V23, P812, DOI 10.1038/mt.2015.44; Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109; Ridge SM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0597-8; Rigotti G, 2009, AESTHET PLAST SURG, V33, P271, DOI 10.1007/s00266-009-9339-7; Rojas M, 2012, INT J MORPHOL, V30, P1243, DOI 10.4067/S0717-95022012000400001; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Savatier P, 2017, STEM CELL RES, V19, P104, DOI 10.1016/j.scr.2017.01.008; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seo M, 2018, STEM CELLS INT, V2018; Shabbir A, 2009, AM J PHYSIOL-HEART C, V296, pH1888, DOI 10.1152/ajpheart.00186.2009; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Shen CY, 2015, MOL MED REP, V12, P20, DOI 10.3892/mmr.2015.3409; Shiue SJ, 2019, PAIN, V160, P210, DOI 10.1097/j.pain.0000000000001395; Shoichet Molly S., 2008, P221; Shologu N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102996; Silva NA, 2013, STEM CELLS DEV, V22, P1232, DOI 10.1089/scd.2012.0524; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Song SY, 2010, EXPERT OPIN BIOL TH, V10, P1529, DOI 10.1517/14712598.2010.522987; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Srinageshwar B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020199; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Sugitani S, 2013, EXP EYE RES, V116, P254, DOI 10.1016/j.exer.2013.09.013; Sun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083523; Szekiova E, 2018, NEUROL RES, V40, P258, DOI 10.1080/01616412.2018.1432266; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Tan B, 2011, NEUROSCIENCE, V181, P40, DOI 10.1016/j.neuroscience.2011.02.038; Tani K, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.32; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Teixeira FG, 2015, STEM CELL REV REP, V11, P288, DOI 10.1007/s12015-014-9576-2; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Tsai MJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-5; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Ul Hassan W, 2014, WOUND REPAIR REGEN, V22, P313, DOI 10.1111/wrr.12173; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Um S, 2017, CELL TISSUE RES, V368, P551, DOI 10.1007/s00441-017-2581-4; Venugopal C, 2018, CURR GENE THER, V18, P307, DOI 10.2174/1566523218666180913152615; Vessey CJ, 2001, PATHOLOGY, V33, P130; Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852; Volarevic V, 2018, INT J MED SCI, V15, P36, DOI 10.7150/ijms.21666; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Whone AL, 2012, BRAIN RES, V1431, P86, DOI 10.1016/j.brainres.2011.10.038; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu L, 2012, CELL PROLIFERAT, V45, P311, DOI 10.1111/j.1365-2184.2012.00823.x; Wu PP, 2018, CYTOTHERAPY, V20, P291, DOI 10.1016/j.jcyt.2017.11.002; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Xin HQ, 2017, CELL TRANSPLANT, V26, P243, DOI 10.3727/096368916X693031; Yagi Hiroshi, 2013, Frontiers in Genetics, V4, P261, DOI 10.3389/fgene.2013.00261; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/109389; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908; Zemel'ko V I, 2013, Tsitologiia, V55, P101; Zhang B, 2015, STEM CELLS, V33, P2158, DOI 10.1002/stem.1771; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhao K, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2153629; Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39; Zhou BR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519126; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504; Zhu YQ, 2018, J CELL PHYSIOL, V233, P6414, DOI 10.1002/jcp.26414	265	25	27	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	OCT	2019	56	10					6902	6927		10.1007/s12035-019-1570-x	http://dx.doi.org/10.1007/s12035-019-1570-x			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX9LQ	30941733				2022-09-04	WOS:000486010800017
J	Rojas, D; Pereira, MJR; Fonseca, C; Davalos, LM				Rojas, Danny; Pereira, Maria Joao Ramos; Fonseca, Carlos; Davalos, Liliana M.			Eating down the food chain: generalism is not an evolutionary dead end for herbivores	ECOLOGY LETTERS			English	Article						Bayesian phylogenetic mixed models; macroevolution; Noctilionoidea; path-wise rates; specialisation; speciation; trophic level; variable-rates model	LEAF-NOSED BATS; ADAPTIVE RADIATION; R PACKAGE; SPECIES DIVERSIFICATION; SPECIALIZATION; SPECIATION; DIVERSITY; PHYLOGENIES; DYNAMICS; SPECIALISTS	The role of trophic specialisation in taxonomic diversification remains unclear. Plant specialists diversify faster than omnivores and animalivores, but at shorter macroevolutionary scales this pattern sometimes reverses. Here, we estimate the effect of diet diversification on speciation rates in noctilionoid bats, controlling for tree shape, rate heterogeneity and macroevolutionary regimes. We hypothesise that niche subdivision among herbivores positively relates to speciation rates, differing between macroevolutionary regimes. We found the rate at which new herbivorous lineages originate decreases as rates of diet evolution increase. Herbivores experience higher speciation rates, but generalist herbivores and predominantly herbivorous omnivores speciate faster than specialised herbivores, omnivores and animalivores. Generalised herbivory is not a dead end. We show that analysing ecological traits and diversification requires accounting for macroevolutionary regimes and within- and between-clade variation in evolutionary rates. Our approach overcomes the high false-positive rates of other methods and illuminates the roles of herbivory and specialisation in speciation.	[Rojas, Danny] Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia; [Rojas, Danny; Pereira, Maria Joao Ramos; Fonseca, Carlos] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Rojas, Danny; Pereira, Maria Joao Ramos; Fonseca, Carlos] Univ Aveiro, Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal; [Pereira, Maria Joao Ramos] Univ Fed Rio Grande do Sul, Inst Biosci, Porto Alegre, RS, Brazil; [Davalos, Liliana M.] SUNY Stony Brook, Dept Ecol & Evolut, 650 Life Sci Bldg, Stony Brook, NY 11794 USA; [Davalos, Liliana M.] SUNY Stony Brook, Consortium Interdisciplinary Environm Res, Sch Marine & Atmospher Sci, 129 Dana Hall, Stony Brook, NY 11794 USA		Rojas, D (corresponding author), Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia.; Rojas, D (corresponding author), Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal.; Rojas, D (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal.; Davalos, LM (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, 650 Life Sci Bldg, Stony Brook, NY 11794 USA.; Davalos, LM (corresponding author), SUNY Stony Brook, Consortium Interdisciplinary Environm Res, Sch Marine & Atmospher Sci, 129 Dana Hall, Stony Brook, NY 11794 USA.	rojasmartin.cu@gmail.com; liliana.davalos-alvarez@stonybrook.edu	Rojas, Danny/A-7961-2011; Pereira, Maria João Ramos/AAH-9411-2021; Fonseca, Carlos MMS/D-9744-2011	Rojas, Danny/0000-0002-5835-0324; Pereira, Maria João Ramos/0000-0002-9365-5166; Fonseca, Carlos MMS/0000-0001-6559-7133; Davalos, Liliana/0000-0002-4327-7697	National Science Foundation [DEB-0949759, DEB-1442142, 1531492]; Foundation for Science and Technology, Portugal [SFRH/BPD/97707/2013]; Portuguese Foundation for Science and Technology [UID/AMB/50017]; Portuguese Foundation for Science and Technology through FEDER funds [UID/AMB/50017]; Direct For Biological Sciences [1442142, 1442314] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology through FEDER funds; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DEB-0949759 and DEB-1442142) to LMD. DR was supported by Foundation for Science and Technology, Portugal (www.fct.pt), fellowship SFRH/BPD/97707/2013. The Portuguese Foundation for Science and Technology supported CESAM RU (UID/AMB/50017) through national funds and FEDER funds, within the PT2020 Partnership Agreement. We also thank Kevin Healy, Thomas Guillerme, and Heather Lynch for assistance with the Bayesian phylogenetic mixed models, and Kevin Arbuckle and an anonymous reviewer for their useful comments and suggestions. The authors thank Stony Brook Research Computing and Cyberinfrastructure, and the Institute for Advanced Computational Science at Stony Brook University for access to the high-performance LIred and SeaWulf computing systems, the latter of which was made possible by a $1.4M National Science Foundation grant (1531492).	Baker J, 2015, P NATL ACAD SCI USA, V112, P5093, DOI 10.1073/pnas.1419823112; Beaulieu J. M., 2016, OUWIE ANAL EVOLUTION; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Burin G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11250; Cantalapiedra JL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2746; Davis MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-38; Day EH, 2016, J EVOLUTION BIOL, V29, P1257, DOI 10.1111/jeb.12867; Dumont ER, 2014, EVOLUTION, V68, P1436, DOI 10.1111/evo.12358; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Ferrarezzi Hebert, 1996, Journal of Comparative Biology, V1, P75; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Fleming TH., 2013, ORNAMENTS LIFE COEVO; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.ecolsys.19.1.207; Givnish TJ, 2015, NEW PHYTOL, V207, P297, DOI 10.1111/nph.13482; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Marten-Rodriguez S, 2010, NEW PHYTOL, V188, P403, DOI 10.1111/j.1469-8137.2010.03330.x; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Price SA, 2012, P NATL ACAD SCI USA, V109, P7008, DOI 10.1073/pnas.1117133109; Rabosky DL, 2015, SYST BIOL, V64, P340, DOI 10.1093/sysbio/syu131; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rex K, 2010, ECOSCIENCE, V17, P37, DOI 10.2980/17-1-3294; Rojas D, 2016, SYST BIOL, V65, P432, DOI 10.1093/sysbio/syw011; Rojas D, 2012, J BIOGEOGR, V39, P1948, DOI 10.1111/j.1365-2699.2012.02709.x; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Rosenblum EB, 2012, EVOL BIOL, V39, P255, DOI 10.1007/s11692-012-9171-x; Saldana-Vazquez RA, 2014, MAMMAL REV, V44, P215, DOI 10.1111/mam.12024; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shi JJ, 2015, EVOLUTION, V69, P1528, DOI 10.1111/evo.12681; Simpson GG., 1953, MAJOR FEATURES EVOLU; Stroud JT, 2016, ANNU REV ECOL EVOL S, V47, P507, DOI 10.1146/annurev-ecolsys-121415-032254; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Wiens JJ, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600128; Wiens JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9370; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702	50	16	16	0	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1461-023X	1461-0248		ECOL LETT	Ecol. Lett.	MAR	2018	21	3					402	410		10.1111/ele.12911	http://dx.doi.org/10.1111/ele.12911			9	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	FV9ER	29341410				2022-09-04	WOS:000424890900010
J	Florez-Pregonero, A; Fulton, JE; Dorn, JM; Ainsworth, BE				Florez-Pregonero, Alberto; Fulton, Janet E.; Dorn, Joan M.; Ainsworth, Barbara E.			Feasibility of using pedometers in a state-based surveillance system: 2014 Arizona Behavioral Risk Factor Surveillance System	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Assessment; Measurement; Physical activity; Public health	PHYSICAL-ACTIVITY; UNITED-STATES; ADULTS; WALKING; STEPS	Background: Despite their utility in accessing ambulatory movement, pedometers have not been used consistently to monitor physical activity in U.S. surveillance systems. This study was designed to determine the feasibility of using pedometers to assess daily steps taken in a sub-sample of adults from Maricopa County who completed the 2014 Arizona Behavioral Risk Factor Surveillance System Survey. Methods: Respondents were sent an Omron HJ324U pedometer, a logbook to record steps taken, and a walking questionnaire. The pedometer was worn for 7 days. Feasibility was assessed for acceptability (interest in study), demand (procedures followed correctly), implementation (time to complete study), and practicality (cost). Results: Acceptability was modest with 23.9% (830/3476) agreeing to participate. Among those participating (92.9%; 771/830), 50.1% (386/771) returned the logbook. Demand was modest with 39.3% (303/771) of logbooks returned with valid data. Implementation represented 5 months to recruit participants. The cost to obtain valid step-count data was USD61.60 per person. An average of 6363 +/- 3049 steps/day were taken with most participants classified as sedentary (36.0%) or low active (35.6%). Conclusion: The feasibility of using pedometers in a state-based surveillance system is modest at best. Feasibility may potentially be improved with easy-to-use pedometers where data can be electronically downloaded. (c) 2018 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND license.	[Florez-Pregonero, Alberto; Ainsworth, Barbara E.] Arizona State Univ, Coll Hlth Solut, Sch Nutr & Hlth Promot, Phoenix, AZ 85004 USA; [Florez-Pregonero, Alberto] Pontificia Univ Javeriana, Bogota 110231, Colombia; [Fulton, Janet E.] US Ctr Dis Control & Prevent, Ctr Chron Dis Prevent & Hlth Promot, Div Nutr Phys Act & Obes, Phys Activ & Hlth Branch, Atlanta, GA 30340 USA; [Dorn, Joan M.] CUNY, Sch Med, Dept Community Hlth & Social Med, New York, NY 10031 USA		Ainsworth, BE (corresponding author), Arizona State Univ, Coll Hlth Solut, Sch Nutr & Hlth Promot, Phoenix, AZ 85004 USA.	Barbara.ainsworth@asu.edu	Flórez-Pregonero, Alberto/C-8804-2012	Flórez-Pregonero, Alberto/0000-0003-1907-3173	McKing Consulting [4568]; U.S. Centers for Disease Control and Prevention [200-2012-F-53729]	McKing Consulting; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was partially supported under a contract from McKing Consulting (#4568) with the U.S. Centers for Disease Control and Prevention (200-2012-F-53729) to assist with pedometer distribution. We are grateful to Omron Inc. for donating the pedometers used in the study and to Judy Bass and her staff from the Arizona Department of Health Services for her assistance in making this study possible.	Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Berrigan David, 2012, Morbidity and Mortality Weekly Report, V61, P595; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Fulton JE, 2016, MED SCI SPORT EXER, V48, P2057, DOI 10.1249/MSS.0000000000000989; Inoue S, 2006, J PHYS ACT HEALTH, V9, P1117; Link M., 2006, J OFF STAT, V22, P293; Matthiessen J, 2015, SCAND J PUBLIC HEALT, V43, P525, DOI 10.1177/1403494815578321; Rosenberg M, 2010, PHYS ACTIVITY LEVELS; Tudor-Locke C, 2004, MED SCI SPORT EXER, V36, P1567, DOI 10.1249/01.MSS.0000139806.53824.2E; Tudor-Locke C, 2004, FIELD METHOD, V16, P422; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2009, SPORTS MED, V39, P981, DOI 10.2165/11319600-000000000-00000; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; U.S. Centers for Disease Control and Prevention, 2015, SURV SYST; U.S. Department of Health and Human Services, 2015, STEP IT SURG GEN CAL; US Centers for Disease Control and Prevention PHSBP, 2015, BEH RISK FACT SURV S; Wyatt HR, 2005, MED SCI SPORT EXER, V37, P724, DOI 10.1249/01.MSS.0000161750.84096.D4	17	2	2	0	0	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	JAN	2018	7	1					34	41		10.1016/j.jshs.2017.11.003	http://dx.doi.org/10.1016/j.jshs.2017.11.003			8	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	FX2XL	30356482	Green Published, gold			2022-09-04	WOS:000425929600007
J	Granados-Beltran, C				Granados-Beltran, Carlo			Editorial	GIST-EDUCATION AND LEARNING RESEARCH JOURNAL			English	Editorial Material									[Granados-Beltran, Carlo] Univ Santo Tomas, Educ, Manila, Philippines; [Granados-Beltran, Carlo] UNICA, BA Bilingual Educ, Bogota, Colombia; [Granados-Beltran, Carlo] Univ Cent, Language Dept, Bogota, Colombia; [Granados-Beltran, Carlo] Univ Pedag Nacl, BA Programme Spanish, Bogota, Colombia; [Granados-Beltran, Carlo] Univ Pedag Nacl, BA Programme Languages & Spanish & English, Bogota, Colombia; [Granados-Beltran, Carlo] Univ Javeriana, BA Modern Languages, Bogota, Colombia; [Granados-Beltran, Carlo] UPTC, MA Language Teaching, Sogamoso, Colombia		Granados-Beltran, C (corresponding author), Univ Santo Tomas, Educ, Manila, Philippines.; Granados-Beltran, C (corresponding author), UNICA, BA Bilingual Educ, Bogota, Colombia.; Granados-Beltran, C (corresponding author), Univ Cent, Language Dept, Bogota, Colombia.; Granados-Beltran, C (corresponding author), Univ Pedag Nacl, BA Programme Spanish, Bogota, Colombia.; Granados-Beltran, C (corresponding author), Univ Pedag Nacl, BA Programme Languages & Spanish & English, Bogota, Colombia.; Granados-Beltran, C (corresponding author), Univ Javeriana, BA Modern Languages, Bogota, Colombia.; Granados-Beltran, C (corresponding author), UPTC, MA Language Teaching, Sogamoso, Colombia.								0	0	0	0	0	INST UNIV COLOMBO AMERICANA-UNICA	BOGOTA	CALLE 19 NO 2A-49 SEGUNDO PISO, BOGOTA, 00000, COLOMBIA	1692-5777			GIST-EDUC LEARN RES	GIST-Educ. Learn. Res. J.	JAN-JUN	2017		14					4	5						2	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	FP1XG					2022-09-04	WOS:000417407600001
J	Montenegro, M; Cardenas, C; Cuervo, C; Bernal, C; Grisard, EC; Thomas, MC; Lopez, MC; Puerta, CJ				Montenegro, M.; Cardenas, C.; Cuervo, C.; Bernal, C.; Grisard, E. C.; Thomas, M. C.; Lopez, M. C.; Puerta, C. J.			Molecular characterization of calcineurin B from the non-virulent Trypanosoma rangeli kinetoplastid indicates high gene conservation	MOLECULAR BIOLOGY REPORTS			English	Article						Calcineurin; Calcineurin B; Trypanosoma rangeli; EF-hand; Calcium binding; Protein structural homology model	PROTEIN-STRUCTURE; SWISS-MODEL; 3-DIMENSIONAL STRUCTURES; I-TASSER; CRUZI; RECOGNITION; ENVIRONMENT; TEJERA; ERRORS; WEB	Calcineurin B, the regulatory subunit of calcineurin, a serine/threonine protein phosphatase, is highly conserved throughout the evolutionary scale including trypanosomatids such as Trypanosoma cruzi, and Leishmania major. Thus, in these flagellates the protein is required for mammalian host cell invasion and virulence and stress responses. With the aim of determining the presence of calcineurin B in Trypanosoma rangeli, a non-virulent trypanosome for mammals, the respective gene was amplified by PCR, cloned and sequenced. Two sequences of 531 bp in length showing a nucleotide polymorphism (314A > C) were obtained in spite of a single-copy gene was revealed by Southern blot. These sequences, probably the alleles from the gene, showed a 79 % of identity with those from T. cruzi and clustered as the sister group of this trypanosome species in a Maximum Parsimony analysis. Deduced amino acid sequence comparison with trypanosomatids and other organisms through the phylogenetic scale as well as the obtained protein structural homology model suggested the presence of the four potential EF-hand regions and the corresponding calcium binding sites of the last three of these domains. Having assessed the expression of this protein in T. rangeli epimastigotes, and taking into account the following facts: (i) calcineurin inhibitors have inhibitory effect on the in vitro replication of T. cruzi, (ii) L. major promastigote growth is inhibited by chelating agents, and (iii) T. rangeli does not seem to productively infect mammalian cells, it is hypothesized herein that the function of this protein in T. rangeli is required for epimastigote growth.	[Montenegro, M.; Cuervo, C.; Bernal, C.; Puerta, C. J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Parasitol Mol, Bogota, Colombia; [Cardenas, C.] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Grisard, E. C.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Lab Protozool & Bioinformat, BR-88040900 Florianopolis, SC, Brazil; [Thomas, M. C.; Lopez, M. C.] CSIC, IPBLN, Granada 18100, Spain		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Parasitol Mol, Carrera 7 43-82, Bogota, Colombia.	cpuerta@javeriana.edu.co	Lopez, Manuel/Z-5641-2019; Cuervo, Claudia/AAF-8180-2019; Puerta, Concepcion J/AAG-4912-2019; Thomas, María Carmen PhD/D-9065-2016; Grisard, Edmundo C/A-7338-2015	Grisard, Edmundo C/0000-0001-8916-8296; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Lopez, Manuel Carlos/0000-0003-0002-3678; Thomas, M Carmen/0000-0003-3586-9657; Cuervo, Claudia/0000-0002-3494-6481	Colciencias Research project [RC-595-2009]; program Jovenes Investigadores e Innovadores from Colciencias; PAI (Junta de Andalucia) [P08-CVI-04037]; Plan Nacional I+D+i (MICINN) [BFU2010-1670, SAF2012-35777]; ISCIII-RETIC (MICINN), Spain [RD12/008/0021]; FEDER	Colciencias Research project; program Jovenes Investigadores e Innovadores from Colciencias; PAI (Junta de Andalucia)(Junta de Andalucia); Plan Nacional I+D+i (MICINN)(Spanish Government); ISCIII-RETIC (MICINN), Spain(Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission)	This work was financially supported by Colciencias Research project No. RC-595-2009. CAB and MM, were supported by the program Jovenes Investigadores e Innovadores 2010 and 2011 from Colciencias. MC Lopez and MC Thomas, were supported by Grants P08-CVI-04037 from PAI (Junta de Andalucia), BFU2010-1670 and SAF2012-35777 from Plan Nacional I+D+i (MICINN) and RD12/008/0021 from ISCIII-RETIC (MICINN), Spain and FEDER.	Urrea DA, 2011, ACTA TROP, V120, P59, DOI 10.1016/j.actatropica.2011.05.016; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Araya JE, 2008, MICROBES INFECT, V10, P892, DOI 10.1016/j.micinf.2008.05.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Barton N, 2007, EVOLUTION, P619; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bua J, 2004, BIOORG MED CHEM LETT, V14, P4633, DOI 10.1016/j.bmcl.2004.07.003; Cuba CA, 1999, REV SOC BRAS MED TRO, V31, P207; Cuervo C, 2006, INFECT GENET EVOL, V6, P401, DOI 10.1016/j.meegid.2006.01.005; Deschamps P, 2011, MOL BIOL EVOL, V28, P53, DOI 10.1093/molbev/msq289; Diez H, 2005, PARASITOLOGY, V130, P643, DOI 10.1017/S0031182004006936; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eger-Mangrich I, 2001, PARASITOL RES, V87, P505, DOI 10.1007/s004360000356; Grisard EC, 1999, MEM I OSWALDO CRUZ, V94, P203, DOI 10.1590/S0074-02761999000200015; Grisard EC, 2010, MOL BIOCHEM PARASIT, V174, P18, DOI 10.1016/j.molbiopara.2010.06.008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guhl F, 2003, MEM I OSWALDO CRUZ, V98, P435, DOI 10.1590/S0074-02762003000400001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; McGuffin LJ, 2010, BIOINFORMATICS, V26, P182, DOI 10.1093/bioinformatics/btp629; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Moreno VR, 2007, ACTA TROP, V101, P80, DOI 10.1016/j.actatropica.2006.11.008; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; Nei M., 2000, MOL EVOLUTION PHYLOG; Pavia PX, 2012, EXP PARASITOL, V132, P144, DOI 10.1016/j.exppara.2012.06.007; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Puerta CJ, 2005, PRACTICAS BIOL MOL; Puerta CJ, 2009, VECTOR-BORNE ZOONOT, V9, P449, DOI 10.1089/vbz.2008.0017; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urrea D. A., 2005, Infection Genetics and Evolution, V5, P123, DOI 10.1016/j.meegid.2004.07.005; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	4	4	0	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	AUG	2013	40	8					4901	4912		10.1007/s11033-013-2590-7	http://dx.doi.org/10.1007/s11033-013-2590-7			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	191DH	23677712				2022-09-04	WOS:000322392300028
J	Giraldo, NA; Bolanos, NI; Cuellar, A; Roa, N; Cucunuba, Z; Rosas, F; Velasco, V; Puerta, CJ; Gonzalez, JM				Giraldo, Nicolas A.; Bolanos, Natalia I.; Cuellar, Adriana; Roa, Nubia; Cucunuba, Zulma; Rosas, Fernando; Velasco, Victor; Puerta, Concepcion J.; Gonzalez, John M.			T Lymphocytes from Chagasic Patients Are Activated but Lack Proliferative Capacity and Down-Regulate CD28 and CD3 zeta	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CRUZI KMP-11 PROTEIN; TRYPANOSOMA-CRUZI; PERIPHERAL-BLOOD; CD4(+) T; IMMUNOSUPPRESSIVE FACTOR; CELL DIFFERENTIATION; HUMAN INFECTION; HUMAN EFFECTOR; HLA-DR; EXPRESSION	Background: Chronic persistent infections have been associated with T lymphocytes functional impairment. The aim of this study was to compare the activation status, the proliferative potential and the expression of CD28 and CD3 zeta chain on T lymphocytes between chronic chagasic patients and uninfected controls. Methodology/Principal Findings: Forty-two chronic chagasic patients, 28 healthy individuals and 32 non-chagasic cardiomyopathy donors were included. Peripheral blood was marked for CD3, CD4, CD8, HLA-DR, CD28, CD38 and intracellular CD3 zeta. Peripheral blood mononuclear cells were stained with carboxyfluorescein diacetate succinimidylester and incubated with T. cruzi lysate or phytohemagglutinin for five days. Cells from 3 healthy controls were incubated with T. cruzi trypomastigotes separated with transwells; and the expression of CD3 zeta chain and proliferation index was determined. Heart-infiltrating cells from two chronic chagasic patients were tested for the aforementioned cellular markers. Chagasic patients displayed higher frequencies of CD4+/HLA-DR+/CD38+ (8.1%+/- 6.1) and CD8+/HLA-DR+/CD38+ (19.8 +/- 8.9) T cells in comparison with healthy (1.6 +/- 1.0; 10.6 +/- 8.0) and non-chagasic cardiomyopathy donors (2.9 +/- 2.9; 5.8 +/- 6.8). Furthermore, the percentage of CD4+ activated T cells was higher in chagasic patients with cardiac involvement. CD8+ T cells proliferation index in chagasic donors (1.7 +/- 0.3) was lower when compared with healthy (2.3 +/- 0.3) and non-chagasic cardiomyopathy individuals (3.1 +/- 1.1). The frequencies of CD4+/CD28+ and CD8+/CD28+ T cells, as well as the CD3 zeta(bright)/CD3 zeta(dim)% ratios in CD4+ and CD8+ were lower in chagasic patients when compared with both control groups. The CD3 zeta(bright)/CD3 zeta(dim)% ratio and proliferative indexes for CD4+ and CD8+ T lymphocytes decreased gradually in those cells cultivated with parasites and displayed lower values than those incubated with medium alone. Finally, heart-infiltrating T cells from two T. cruzi infected patients also expressed activation markers and down-regulate CD28 and CD3 zeta. Conclusions: CD8+ T lymphocytes from chagasic donors displayed reduced proliferative capacity, which might be associated with CD3 zeta down-regulation and diminished CD28 expression on CD4 T cells.	[Giraldo, Nicolas A.; Bolanos, Natalia I.; Gonzalez, John M.] Univ Los Andes, Grp Ciencias Basicas Med, Fac Med, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Fac Ciencias, Bogota, Colombia; [Roa, Nubia] Pontificia Univ Javeriana, Grp Trasplante, Fac Med, Bogota, Colombia; [Roa, Nubia] Hosp Univ San Ignacio, Bogota, Colombia; [Cucunuba, Zulma] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Rosas, Fernando; Velasco, Victor] Fdn Clin Abood Shaio, Bogota, Colombia; [Puerta, Concepcion J.] Pontificia Univ Javeriana, Lab Parasitol Mol, Dept Microbiol, Fac Ciencias, Bogota, Colombia		Giraldo, NA (corresponding author), Univ Los Andes, Grp Ciencias Basicas Med, Fac Med, Bogota, Colombia.	johgonza@uniandes.edu.co	Cucunuba, Zulma M/X-5670-2019; Cucunuba, Zulma M./L-4076-2016; Giraldo, Nicolas/U-6521-2017; Puerta, Concepcion J/AAG-4912-2019; Cuellar, Adriana/AAF-2958-2019; Zaky, Mohammad/I-3187-2017	Cucunuba, Zulma M/0000-0002-8165-3198; Cucunuba, Zulma M./0000-0002-8165-3198; Giraldo, Nicolas/0000-0002-7452-1103; Zaky, Mohammad/0000-0003-3547-2588; Mursalin, Adi/0000-0002-1867-0868; Cuellar, Adriana/0000-0003-0834-8442; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Vicerrectoria de Investigaciones, Universidad de los Andes	Vicerrectoria de Investigaciones, Universidad de los Andes	This project was funded by the Vicerrectoria de Investigaciones, Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Arguello RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035966; Castro AM, 2002, PARASITOL RES, V88, P894, DOI 10.1007/s00436-002-0679-3; Castro C, 1999, Rev Soc Bras Med Trop, V32, P157, DOI 10.1590/S0037-86821999000200007; Albareda MC, 2010, AM J TROP MED HYG, V82, P861, DOI 10.4269/ajtmh.2010.09-0604; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Choi BS, 2002, CLIN EXP IMMUNOL, V127, P137, DOI 10.1046/j.1365-2249.2002.01732.x; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Crawford TQ, 2011, J VIROL, V85, P12343, DOI 10.1128/JVI.05682-11; Cuellar A, 2009, IMMUNOL CELL BIOL, V87, P149, DOI 10.1038/icb.2008.76; Diaz-Benitez CE, 2009, J CLIN IMMUNOL, V29, P532, DOI 10.1007/s10875-009-9279-7; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Dutra WO, 1996, SCAND J IMMUNOL, V43, P88, DOI 10.1046/j.1365-3083.1996.d01-9.x; DUTRA WO, 1994, INT IMMUNOL, V6, P499, DOI 10.1093/intimm/6.4.499; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Giraldo NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001294; HO HN, 1993, J IMMUNOL, V150, P3070; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Kierszenbaum F, 1998, MOL BIOCHEM PARASIT, V92, P133, DOI 10.1016/S0166-6851(97)00240-5; KIERSZENBAUM F, 1990, J IMMUNOL, V144, P4000; Krishnan S, 2001, BLOOD, V97, P3851, DOI 10.1182/blood.V97.12.3851; Kumar A, 1998, CLIN EXP IMMUNOL, V114, P78; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Lindgren T, 2011, J VIROL, V85, P10252, DOI 10.1128/JVI.05548-11; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; Liossis SNC, 1998, J CLIN INVEST, V101, P1448, DOI 10.1172/JCI1457; Lynne JE, 1998, J INFECT DIS, V177, P1083, DOI 10.1086/517400; MALECKAR JR, 1983, J IMMUNOL, V130, P908; Martins GA, 2004, MICROBES INFECT, V6, P1133, DOI 10.1016/j.micinf.2004.07.002; Matsuda M, 1998, SCAND J IMMUNOL, V47, P254; Menezes CAS, 2004, CLIN EXP IMMUNOL, V137, P129, DOI 10.1111/j.1365-2249.2004.02479.x; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; Mittrucker HW, 2001, J IMMUNOL, V167, P5620, DOI 10.4049/jimmunol.167.10.5620; Miyahira Y, 2003, INFECT IMMUN, V71, P3131, DOI 10.1128/IAI.71.6.3131-3137.2003; MOSCA W, 1991, MEM I OSWALDO CRUZ, V86, P147, DOI 10.1590/S0074-02761991000200002; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Ostrowski SR, 2003, J INFECT DIS, V187, P1726, DOI 10.1086/375239; Piedras J, 1997, CYTOMETRY, V30, P28, DOI 10.1002/(SICI)1097-0320(19970215)30:1<28::AID-CYTO4>3.0.CO;2-B; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Sanchez G, 2002, REV MED CHILE, V130, P363; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Shen T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-310; Trimble LA, 2000, BLOOD, V96, P1021, DOI 10.1182/blood.V96.3.1021.015k37_1021_1029; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Villegas EN, 1999, J IMMUNOL, V163, P3344; Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x; Vitelli-Avelar DM, 2005, SCAND J IMMUNOL, V62, P297, DOI 10.1111/j.1365-3083.2005.01668.x; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Yoshimoto K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/509021; Zea AH, 1998, INFECT IMMUN, V66, P499, DOI 10.1128/IAI.66.2.499-504.1998	57	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2013	7	1							e2038	10.1371/journal.pntd.0002038	http://dx.doi.org/10.1371/journal.pntd.0002038			11	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	081ZB	23383358	Green Published, Green Submitted, gold			2022-09-04	WOS:000314360200056
J	Mosquera-Guerra, F; Trujillo, F; Perez-Torres, J; Mantilla-Meluk, H; Franco, N; Valderrama, MJ; Acosta-Lugo, E; Torres-Forero, P; Oviedo, JSU; Barreto, S; Armenteras-Pascual, D				Mosquera-Guerra, Federico; Trujillo, Fernando; Perez-Torres, Jairo; Mantilla-Meluk, Hugo; Franco, Nicole; Jimena Valderrama, Maria; Acosta-Lugo, Estefany; Torres-Forero, Paula; Usma Oviedo, Jose Saulo; Barreto, Sebastian; Armenteras-Pascual, Dolors			Identifying habitat preferences and core areas of Amazon River dolphin activity using spatial ecology analysis	LANDSCAPE ECOLOGY			English	Article						Amazonas River; Habitat use; Home range; Kernel density; Orinoco Basin; Spatiotemporal distribution; Satellite telemetry	HOME-RANGE USE; INIA-GEOFFRENSIS; TURSIOPS-TRUNCATUS; SEASONAL MOVEMENTS; ANIMAL MOVEMENT; SELECTION; CONSERVATION; CETACEA; POPULATION; PATTERNS	Context Identifying the habitat preferences and core areas of Inia geoffrensis activity is essential to designing effective strategies for the management and conservation of Amazon River dolphins and their habitats in the Colombian Amazonas River and Orinoco basin. Objectives Quantify the differential use of habitat that Amazon River dolphins exhibit and identify core areas of activity during seasons of rising waters in the Colombian Amazonas River and five major rivers in the Orinoco basin. Methods Based on processed satellite images from Landsat 8 (2018-2021), we classified habitat types used by I. geoffrensis as reported in the literature as follows: (1) main river, (2) confluences, (3) tributaries, (4) channels, (5) islands, (6) bays, and (7) lagoons. We combined this dataset with GPS location data obtained from 17 tagged Amazon River dolphins to quantify the proportion of habitat types used. We used kernel density estimate (KDE) analysis to identify both areas used (K-95) and core areas (K-50) in the habitat types for the satellite-monitored individuals. Results Satellite tracking of I. geoffrensis individuals reported 16,098 locations classified into seven habitat types. For the analyzed period (rising waters) main habitat types used were as follow: (1) main river (n = 9144, 57%); (2) confluences (n = 932, 6%); (3) tributaries (n = 1423, 9%); (4) channels (n = 1597, 10%); (5) islands (n = 738, 5%); (6) bays (n = 1096, 7%), and (7) lagoons (n = 1168, 7%). Home range size (K-95) for the satellite-monitored I. geoffrensis individuals ranged from 6 to 116 km(2) (mean = 40 +/- 33); and the largest core areas (K-50) or core area of activity were recorded in the main river, confluences, channels, bays, lagoons, and tributaries. Conclusions Our results demonstrated the importance of spatial ecology analysis of Amazon River dolphins for the definition of protected areas, quantifying the use of ecosystems within these areas, and the location of priority areas for the implementation of management plans for the species and habitats.	[Mosquera-Guerra, Federico; Perez-Torres, Jairo] Pontificia Univ Javeriana, Dept Biol, Lab Ecol Func, Bogota 110231, Colombia; [Mosquera-Guerra, Federico; Trujillo, Fernando; Franco, Nicole; Jimena Valderrama, Maria; Torres-Forero, Paula] Fdn Omacha, Bogota 111211, Colombia; [Mosquera-Guerra, Federico; Barreto, Sebastian; Armenteras-Pascual, Dolors] Univ Nacl Colombia, Dept Biol, Grp Ecol Paisaje & Modelac Ecosistemas ECOLMOD, Bogota 111321, Colombia; [Mosquera-Guerra, Federico; Mantilla-Meluk, Hugo] Univ Quindio, Programa Biol, Grp Invest Desarrollo & Estudio Recurso Hidr & Am, Armenia 630004, Qui, Colombia; [Mantilla-Meluk, Hugo] Univ Quindio, Ctr Estudios Alta Montana, Armenia 630004, Qui, Colombia; [Acosta-Lugo, Estefany] Univ Mil Nueva Granada, Fac Ciencias Basicas & Aplicadas, Dept Biol Aplicada Semillero Ecol & Conservac SEC, Bogota 250247, Colombia; [Usma Oviedo, Jose Saulo] World Wildlife Fund WWF, Bogota 1196, Colombia		Mosquera-Guerra, F (corresponding author), Pontificia Univ Javeriana, Dept Biol, Lab Ecol Func, Bogota 110231, Colombia.	federico.mosqueraguerra@gmail.com			Fundacion Omacha; Pontificia Universidad Javeriana [20389]	Fundacion Omacha; Pontificia Universidad Javeriana	This work was funded by the Fundacion Omacha and the Postdoctoral Fellowship from Pontificia Universidad Javeriana (ID Project: 20389 to 2021).	Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; Aliaga-Rossel Enzo, 2002, Aquatic Mammals, V28, P312; Aliaga-Rossel Enzo, 2020, Therya, V11, P459, DOI 10.12933/therya-20-977; Anderson EP, 2019, FRONT ECOL ENVIRON, V17, P521, DOI 10.1002/fee.2114; Aragon-Noriega EA, 2010, INT J SUST DEV WORLD, V17, P410, DOI 10.1080/13504509.2010.500823; Banguera-Hinestroza E, 2002, J HERED, V93, P312, DOI 10.1093/jhered/93.5.312; Barthem RB, 2017, SCI REP-UK, V7, DOI 10.1038/srep41784; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Best R. C., 1989, HDB MARINE MAMMALS, V4, P1; Bjorge Arne, 2001, P63; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bolger DT, 2008, ECOL LETT, V11, P63; Brum S, 2021, AQUAT CONSERV, V31, P1068, DOI 10.1002/aqc.3590; Buskirk S, 2004, SCIENCE, V306, P238, DOI 10.1126/science.1104480; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Chulick GS., 2002, GEOL SOC AM BULL, V33, P2478; Crampton WGR, 1999, ESTRATEGIAS MANEJO R, P10; CROOKS KR, 2006, CONSERV BIOL SER, V14, P1; Da Silva V, 2018, INIA GEOFFRENSIS ASS; da Silva V.M.F., 2014, P364; da Silva VMF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P26; Da Silva VMF, 1983, ECOLOGIA ALIMENTAR G; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Oshima JED, 2010, J MAR BIOL ASSOC UK, V90, P1641, DOI 10.1017/S0025315410001311; Defran RH, 1999, MAR MAMMAL SCI, V15, P381, DOI 10.1111/j.1748-7692.1999.tb00808.x; Denkinger J., 2010, AV CIENC ING, V2, pB91; Di Bitetti MS, 2001, J ZOOL, V253, P33, DOI 10.1017/S0952836901000048; Di Blanco YE, 2017, J MAMMAL, V98, P1118, DOI 10.1093/jmammal/gyx019; Dolton HR, 2020, ENDANGER SPECIES RES, V41, P209, DOI 10.3354/esr01018; Environmental Systems Research Institute, 2020, ARCGIS PRORELEASE 28; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Gomez-Salazar C, 2012, ECOL INDIC, V23, P19, DOI 10.1016/j.ecolind.2012.02.034; Gomez-Salazar C, 2012, MAR MAMMAL SCI, V28, pE124, DOI 10.1111/j.1748-7692.2011.00496.x; Gomez-Salazar C, 2011, AQUAT MAMM, V37, P472, DOI 10.1578/AM.37.4.2011.472; GONZALEZ FT, 1994, MAR MAMMAL SCI, V10, P348, DOI 10.1111/j.1748-7692.1994.tb00489.x; Gowans S, 2001, ANIM BEHAV, V62, P369, DOI 10.1006/anbe.2001.1756; Gravena W, 2019, PEERJ, V7, DOI 10.7717/peerj.6692; Gravena W, 2014, CONSERV GENET, V15, P619, DOI 10.1007/s10592-014-0565-4; Gubbins C, 2002, J MAMMAL, V83, P178, DOI 10.1644/1545-1542(2002)083<0178:UOHRBR>2.0.CO;2; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jaramillo-Legorreta A, 2017, CONSERV BIOL, V31, P183, DOI 10.1111/cobi.12789; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kenward R.E., 2001, MANUAL WILDLIFE RADI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Klar N, 2008, BIOL CONSERV, V141, P308, DOI 10.1016/j.biocon.2007.10.004; Knight CM, 2009, WILDLIFE RES, V36, P213, DOI 10.1071/WR08032; Kong DJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5105; Loseto LL, 2006, CAN J ZOOL, V84, P1743, DOI 10.1139/Z06-160; MacLeod C.D, 2013, INTRO USING GIS MARI; Martin AR, 2022, ORYX, V56, P587, DOI 10.1017/S0030605320001350; Martin AR, 2018, BIOL J LINN SOC, V123, P666, DOI 10.1093/biolinnean/bly005; Martin AR, 2006, MAR MAMMAL SCI, V22, P25, DOI 10.1111/j.1748-7692.2006.00003.x; Martin AR, 2006, MAR MAMMAL SCI, V22, P17, DOI 10.1111/j.1748-7692.2006.00002.x; Martin AR, 2004, CAN J ZOOL, V82, P1307, DOI 10.1139/Z04-109; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Martin AR, 1998, MAR TECHNOL SOC J, V32, P82; McGuire TL, 2007, BIOTROPICA, V39, P129, DOI 10.1111/j.1744-7429.2006.00221.x; McGuire Tamara L., 2007, Aquatic Mammals, V33, P359, DOI 10.1578/AM.33.3.2007.359; McGuire TL, 1998, BIOTROPICA, V30, P625, DOI 10.1111/j.1744-7429.1998.tb00102.x; Mintzer VJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00191; Mintzer VJ, 2016, MAR MAMMAL SCI, V32, P664, DOI 10.1111/mms.12298; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morris DW, 2003, WILDLIFE RES, V30, P303, DOI 10.1071/WR02028; Mosquera-Guerra F, 2019, ECOHEALTH, V16, P743, DOI 10.1007/s10393-019-01451-1; Mosquera-Guerra F, 2018, SC; Mosquera-Guerra F, 2022, FRONT MAR SCI, V9, DOI 10.3389/fmars.2022.838988; Mosquera-Guerra F, 2021, ENDANGER SPECIES RES, V45, P269, DOI 10.3354/esr01133; Mosquera-Guerra Federico, 2020, Therya, V11, P9, DOI 10.12933/therya-20-854; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Newmark WD, 2012, MAMM BIOL, V77, P293, DOI 10.1016/j.mambio.2012.03.007; Oliveira JSF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1912; Oliveira-da-Costa M, 2020, ORYX, V54, P696, DOI 10.1017/S0030605319000279; Ouellette M, 2011, CHELONIAN CONSERV BI, V10, P259, DOI 10.2744/CCB-0847.1; Pavanato HJ, 2016, ENDANGER SPECIES RES, V31, P47, DOI 10.3354/esr00751; Pivari D, 2021, J NAT CONSERV, V64, DOI 10.1016/j.jnc.2021.126082; Powell RA, 2000, METH C CONS, P65; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Preisler HK, 2006, J APPL ECOL, V43, P164, DOI 10.1111/j.1365-2664.2005.01123.x; R Development Core Team, 2008, R LANG ENV STAT COMP; Rako-Gospic N, 2017, MAR POLLUT BULL, V124, P234, DOI 10.1016/j.marpolbul.2017.07.040; Rayment W, 2009, MAR MAMMAL SCI, V25, P537, DOI 10.1111/j.1748-7692.2008.00271.x; Reeves RR., 2003, DOLPHINS WHALES PORP, DOI [10.2305/IUCN.CH.2003.SSC-AP.2.en, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.EN]; Revenga C., 2000, PILOT ANAL GLOBAL EC; Reyers B, 2009, ECOL SOC, V14; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Sevigny J, 2021, LANDSCAPE ECOL, V36, P1685, DOI 10.1007/s10980-021-01238-2; Sioli H., 1984, AMAZON ITS MAIN AFFL, V56, P127, DOI [DOI 10.1007/978-94-009-6542-3_5, 10.1007/978-94-009-6542-3_5]; Soule ME, 1999, CONTINENTAL CONSERVA; Sprogis KR, 2016, MAR MAMMAL SCI, V32, P287, DOI 10.1111/mms.12260; Stahl P, 2001, J APPL ECOL, V38, P674, DOI 10.1046/j.1365-2664.2001.00625.x; Trujillo F, 2000, THESIS U ABERDEEN; Trujillo F., 2010, GLOBAL ECOL BIOGEOGR, V23, P1; Trujillo-González Fernando, 2019, Rev. acad. colomb. cienc. exact. fis. nat., V43, P199, DOI 10.18257/raccefyn.765; Tucker MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1105, DOI 10.1111/geb.12194; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; van Toor ML, 2018, LANDSCAPE ECOL, V33, P879, DOI 10.1007/s10980-018-0637-9; Viana DS, 2018, MOV ECOL, V6, DOI 10.1186/s40462-017-0119-8; Vila M, 2010, TECTONOPHYSICS, V490, P152, DOI 10.1016/j.tecto.2010.05.003; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wells RS, 2017, ENDANGER SPECIES RES, V33, P159, DOI 10.3354/esr00732; Whitehead H, 2000, CETACEAN SOCIETIES, P154; Williams R, 2016, BIOL CONSERV, V195, P136, DOI 10.1016/j.biocon.2015.12.037; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yamamoto Y, 2016, MAR MAMMAL SCI, V32, P220, DOI 10.1111/mms.12252; Zhang LW, 2015, LANDSCAPE ECOL, V30, P535, DOI 10.1007/s10980-014-0106-z	114	0	0	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-2973	1572-9761		LANDSCAPE ECOL	Landsc. Ecol.	AUG	2022	37	8					2099	2119		10.1007/s10980-022-01470-4	http://dx.doi.org/10.1007/s10980-022-01470-4		JUN 2022	21	Ecology; Geography, Physical; Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Physical Geography; Geology	3I9QU					2022-09-04	WOS:000815412200001
J	Gaitan-Duarte, HG; Alvarez-Moreno, C; Rincon-Rodriguez, CJ; Yomayusa-Gonzalez, N; Cortes, JA; Villar, JC; Bravo-Ojeda, JS; Garcia-Pena, A; Adarme-Jaimes, W; Rodriguez-Romero, VA; Villate-Soto, SL; Buitrago, G; Chacon-Sarmiento, J; Macias-Quintero, M; Vaca, CP; Gomez-Restrepo, C; Rodriguez-Malagon, N				Gaitan-Duarte, H. G.; Alvarez-Moreno, C.; Rincon-Rodriguez, C. J.; Yomayusa-Gonzalez, N.; Cortes, J. A.; Villar, J. C.; Bravo-Ojeda, J. S.; Garcia-Pena, A.; Adarme-Jaimes, W.; Rodriguez-Romero, V. A.; Villate-Soto, S. L.; Buitrago, G.; Chacon-Sarmiento, J.; Macias-Quintero, M.; Vaca, C. P.; Gomez-Restrepo, C.; Rodriguez-Malagon, N.			Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial	ECLINICALMEDICINE			English	Article							STATINS	Background The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The objective of this study was to assess the effectiveness and safety of rosuvastatin plus colchicine, emtricitabine/tenofovir, and their combined use in these patients. Methods This was a randomized, controlled, open-label, multicentre, parallel, pragmatic study conducted in six referral hospitals in Bogota, Colombia. The study enrolled hospitalized patients over 18 years of age with a confirmed diagnosis of COVID-19 complicated with pneumonia, not on chronic treatment with the study medications, and with no contraindications for their use. Patients were assigned I:I:I:I. I) emtricitabine with tenofovir disoproxil fumarate (FTC/TDF, 200/300 mg given orally for 10 days); 2) colchicine plus rosuvastatin (COLCH+ROSU, 0.5 mg and 40 mg given orally for 14 days); 3) emtricitabine with tenofovir disoproxil plus colchicine and rosuvastatin at the same doses and for the same period of time (FTC/TDF+COLCH+ROSU); or 4) the Colombian consensus standard of care, including a corticosteroid (SOC). The primary endpoint was 28-day all-cause mortality. A modified intention-to-treat analysis was used together with a usefulness analysis to determine which could be the best treatment. Findings Out of 994 candidates considered between August 2020 and March 2021, 649 (65.3%) patients agreed to participate and were enrolled in this study; among them, 633 (97.5%) were included in the analysis. The mean age was 55.4 years (SD +/- 12.8 years), and 428 (68%) were men; 28-day mortality was significantly lower in the FTC/TDF+COLCH+ROSUV group than in the SOC group, 10.7% (17/159) vs. 17.4% (28/161) (hazard ratio [HR] 0.53; 95% CI 0.29 to 0.96). Mortality in the FTC/TDF group was 13.8% (22/160, HR o.68, 95% CI 0.39 to 1.20) and 14.4% in the COLCH+ROSU group (22/153) (HR o.78, 95% CI 0.44 to 1.36). A lower need for invasive mechanical ventilation was observed in the FTC/TDF+COLCH+ROSUV group than in the SOC group (risk difference [RD] - 0.08, 95% CI 0.11 to 0.04). Three patients presented severe adverse events, one severe diarrhoea in the COLCH +ROSU and one in the FTC/TDF+COLCH+ROSU group and one general exanthema in the FTC/TDF group. Interpretation The combined use of FTC/TDF+COLCH+ROSU reduces the risk of 28-day mortality and the need for invasive mechanical ventilation in hospitalized patients with pulmonary compromise from COVID-19. More randomized controlled trials are needed to compare the effectiveness and cost of treatment with this combination versus other drugs that have been shown to reduce mortality from SARS-CoV-2 infection and its usefulness in patients with chronic statin use. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Gaitan-Duarte, H. G.] Univ Nacl Colombia, Hosp Univ Nacl Colombia, Clin Res Inst, Bogota, Colombia; [Alvarez-Moreno, C.] Univ Nacl Colombia, Clin Univ Colombia, Clin Colsanitas, Internal Med Dept, Bogota, Colombia; [Rincon-Rodriguez, C. J.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Yomayusa-Gonzalez, N.] Fdn Univ Sanitas, Global Inst Clin Excellence Translat Res Grp, Clin Reina Sofia, Clin Colsanitas, Bogota, Colombia; [Cortes, J. A.] Univ Nacl Colombia, Hosp Univ Nacl Colombia, Infect Dis Serv, Internal Med Dept, Bogota, Colombia; [Villar, J. C.] Fdn Cardioinfantil, Inst Cardiol, Res Dept, Bogota, Colombia; [Bravo-Ojeda, J. S.] Clin Colsanitas, Clin Santa Maria del Lago, Bogota, Colombia; [Garcia-Pena, A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Internal Med Dept, Bogota, Colombia; [Adarme-Jaimes, W.] Univ Nacl Colombia, Sch Engn, SEPRO Grp, Bogota, Colombia; [Rodriguez-Romero, V. A.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Villate-Soto, S. L.] Univ Nacl Colombia, Clin Res Inst, Bogota, Colombia; [Buitrago, G.] Univ Nacl Colombia, Hosp Univ Nacl Colombia, Clin Res Inst, Bogota, Colombia; [Chacon-Sarmiento, J.] Fdn Univ Sanitas, Clin Colsanitas, Clin Reina Sofia, Bogota, Colombia; [Macias-Quintero, M.] Univ Nacl Colombia, Bogota, Colombia; [Vaca, C. P.] Univ Nacl Colombia, Pharm Dept, Bogota, Colombia; [Gomez-Restrepo, C.; Rodriguez-Malagon, N.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia		Gaitan-Duarte, HG (corresponding author), Univ Nacl Colombia, Unidad Camilo Torres, Univ Nacl Colombia, Clin Res Inst, Cl 44 45-99,Modulo C Oficina 601, Bogota, Colombia.	hggaitand@unal.edu.co		Cortes, Jorge/0000-0002-0882-9652; Rodriguez, Viviana/0000-0001-8487-0676	Colombian Ministry of Science and Technology [374-2020]; Universidad Nacional de Colombia; Pontificia Universidad Javeriana	Colombian Ministry of Science and Technology; Universidad Nacional de Colombia; Pontificia Universidad Javeriana	This project was supported by grant 374-2020 from the Colombian Ministry of Science and Technology to Universidad Nacional de Colombia. Additionally, this was supported by Universidad Nacional de Colombia and Pontificia Universidad Javeriana.	[Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Chien MC, 2020, J PROTEOME RES, V19, P4690, DOI [10.1021/acs.jproteome.0c00392, 10.1101/2020.03.18.997585]; Clososki GC, 2020, J BRAZIL CHEM SOC, V31, P1552, DOI 10.21577/0103-5053.20200106; Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136; del Amo J, 2020, ANN INTERN MED, V173, P536, DOI 10.7326/M20-3689; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Melchjorsen J, 2011, JAIDS-J ACQ IMM DEF, V57, P265, DOI 10.1097/QAI.0b013e3182185276; Minz MM, 2020, DIABETES METAB SYND, V14, P2063, DOI 10.1016/j.dsx.2020.10.021; Neant N, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017962118; Parienti JJ, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.100993; Perico N, 1996, J AM SOC NEPHROL, V7, P594; Permana H, 2021, PHARMACOL REP, V73, P769, DOI 10.1007/s43440-021-00233-3; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Saavedra-Trujillo CH, 2020, INFECTIO, V24, P262; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tardif JC, 2021, LANCET RESP MED, V9, P924, DOI 10.1016/S2213-2600(21)00222-8; Vahedian-Azimi A, 2021, ARCH MED SCI, V17, P579, DOI 10.5114/aoms/132950; Vickerstaff V, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0754-4; Vitiello A, 2021, RESP MED, V178, DOI 10.1016/j.rmed.2021.106322; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; Xing Kai, 2021, Zhongguo Dang Dai Er Ke Za Zhi, V23, P221; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570	35	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-5370		ECLINICALMEDICINE	EClinicalMedicine	JAN	2022	43								101242	10.1016/j.eclinm.2021.101242	http://dx.doi.org/10.1016/j.eclinm.2021.101242		DEC 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YO3NT	34957385	Green Published			2022-09-04	WOS:000747850800038
J	Parra, DC; Adlakha, D; Pinzon, JD; Van Zandt, A; Brownson, RC; Gomez, LF				Parra, Diana C.; Adlakha, Deepti; Pinzon, Jose D.; Van Zandt, Alexandria; Brownson, Ross C.; Gomez, Luis F.			Geographic Distribution of the Ciclovia and Recreovia Programs by Neighborhood SES in Bogota: How Unequal is the Geographic Access Assessed Via Distance-based Measures?	JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE			English	Article						recreational inequalities; Ciclovia; Recreovia; Bogota	PHYSICAL-ACTIVITY PROGRAMS; OPEN STREETS INITIATIVES; HEALTH; PARTICIPATION; TRANSPORTATION; RECREATIVA; POLICY; ADULTS	Ciclovia, also known as Open Streets initiatives in other countries, are city streets that are closed to motorized traffic and opened during certain times to residents for engaging in physical activity (PA). These initiatives are viewed by policy makers and health and community advocates as being beneficial to social, environmental, and community health. This study explores the geographic distribution of Ciclovia and Recreovia and the differences in geographic access assessed via distance-based measures, based on the socioeconomic status (SES) of the area. Results from this study show that the median distance to the Ciclovia according to SES ranges from 2930 m for SES 1 (most disadvantaged) to 482 m for SES 6 (wealthiest). The median distance to the Recreovia sites ranges from 5173 m for SES 1 to 3869 m for SES 6. This study found revealing urban inequities in the distribution of Ciclovia, whereas there was less inequalities within the Recreovia sites. This study shows that urban interventions are needed to promote recreational activity and reduce health disparities in under resourced, low SES areas.	[Parra, Diana C.; Brownson, Ross C.] Washington Univ, Prevent Res Ctr St Louis, Brown Sch, One Brookings Dr,Campus,Box 1196 St, St Louis, MO 63130 USA; [Adlakha, Deepti] Queens Univ Belfast, Sch Nat & Built Environm, Belfast, Antrim, North Ireland; [Pinzon, Jose D.] Univ Andes, Grp EpiAndes, Cra 1 18A 12, Bogota, Colombia; [Van Zandt, Alexandria] Washington Univ, Program Phys Therapy, Sch Med, 4444 Forest Pk Ave, St Louis, MO 63130 USA; [Brownson, Ross C.] Washington Univ, Sch Med, Div Publ Hlth Sci, Dept Surg, St Louis, MO 63130 USA; [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63130 USA; [Gomez, Luis F.] Pontificia Univ Javeriana, Sch Med, Transversal 4 42-00 Piso 3, Bogota, Colombia		Parra, DC (corresponding author), Washington Univ, Prevent Res Ctr St Louis, Brown Sch, One Brookings Dr,Campus,Box 1196 St, St Louis, MO 63130 USA.	dparrape34@gmail.com; d.adlakha@qub.ac.uk; josed.pinzon@gmail.com; aevanzandt@wustl.edu; luisefe64@yahoo.com	; Parra, Diana/D-7633-2013	Adlakha, Deepti/0000-0002-1720-6780; Parra, Diana/0000-0002-9797-6231	Institute for Public Health at Washington University in St. Louis	Institute for Public Health at Washington University in St. Louis	This project was supported in part by funds from the Institute for Public Health at Washington University in St. Louis.	Abolghasem S, 2018, SOCIO-ECON PLAN SCI, V61, P90, DOI 10.1016/j.seps.2017.03.005; [Anonymous], 2019, ENC NAC SIT NUTR; Barreto L, 2018, BOGOTA, V6, P2018; Beiler MO, 2017, J URBAN PLAN DEV, V143, DOI 10.1061/(ASCE)UP.1943-5444.0000351; Bernatchez AC, 2015, J TRANSP HEALTH, V2, P360, DOI 10.1016/j.jth.2015.04.005; [Bogota Cd Bogota AMd], 2015, PROYECTO ACUERDO 478; CATASTRO, 2018, MAP REF; Cohen D, 2016, PREV MED, V90, P26, DOI 10.1016/j.ypmed.2016.06.009; CONPES, 1997, ESTRATIFICACION SOCI; DANE, 2005, PROYECC POBL; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; del Castillo AD, 2017, PREV MED, V103, pS41, DOI 10.1016/j.ypmed.2016.08.028; Dlaz-del-Castillo A., 2011, BRAZIL TRANSL BEHAV, V1, P350, DOI DOI 10.1007/s13142-011-0038-y; Engelberg JK, 2014, PREV MED, V69, pS66, DOI 10.1016/j.ypmed.2014.10.005; Gomez LF, 2015, CAD SAUDE PUBLICA, V31, pS257, DOI 10.1590/0102-311X00086814; Gomez LF, 2015, SOC SCI MED, V131, P18, DOI 10.1016/j.socscimed.2015.02.042; Gonzalez S, 2014, BIOMEDICA, V34, P447, DOI [10.7705/biomedica.v34i3.2258, 10.1590/S0120-41572014000300014]; Herens M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2327; Hipp JA, 2017, PREV MED, V103, pS15, DOI 10.1016/j.ypmed.2016.10.014; Hipp JA, 2014, AM J HEALTH PROMOT, V28, pS114, DOI 10.4278/ajhp.28.3s.S114; Hipp JA, 2013, J URBAN HEALTH, V90, P1010, DOI 10.1007/s11524-012-9759-6; IDRD, 2017, HIST CICLOVIA BOGOTA; IDRD, 2017, CICL BOG; Kuhlberg JA, 2014, J PHYS ACT HEALTH, V11, P1468, DOI 10.1123/jpah.2012-0376; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Meisel Jose D, 2014, Am J Health Promot, V28, pe127, DOI 10.4278/ajhp.120912-QUAN-443; Montero S, 2017, LAT AM PERSPECT, V44, P111, DOI 10.1177/0094582X16668310; Montes F, 2012, J URBAN HEALTH, V89, P153, DOI 10.1007/s11524-011-9628-8; Mosquera J, 2012, J PHYS ACT HEALTH, V9, P776, DOI 10.1123/jpah.9.6.776; Paez DC, 2015, TRANSL BEHAV MED, V5, P1, DOI 10.1007/s13142-014-0275-y; Parra D.C., 2018, CITIES HLTH, V2, P60, DOI [10.1080/23748834.2018.1507068, DOI 10.1080/23748834.2018.1507068]; Parra D, 2007, INDOOR BUILT ENVIRON, V16, P344, DOI 10.1177/1420326X07080462; Perry CK, 2017, J PUBLIC HEALTH MAN, V23, P360, DOI 10.1097/PHH.0000000000000555; Reis RS, 2014, MED SCI SPORT EXER, V46, P92, DOI 10.1249/MSS.0b013e3182a365ae; Rodrigues DE, 2018, J URBAN HEALTH, V95, P727, DOI 10.1007/s11524-018-0293-z; Rojas F, 2019, POT PENALOSA MOVILID; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Sarmiento OL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060633; Sarmiento OL, 2017, PREV MED, V103, pS34, DOI 10.1016/j.ypmed.2016.07.028; Shahid R, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-200; Teunissen T, 2015, INT J SUSTAIN TRANSP, V9, P457, DOI 10.1080/15568318.2013.808388; Torres Andrea, 2013, Am J Public Health, V103, pe23, DOI 10.2105/AJPH.2012.301142; UN-Habitat, 2012, STAT LAT AM CAR CIT, P2012; Uribe C., 2006, PAP POLITICO, V1, P69; Vasquez EE, 2019, GLOB PUBLIC HEALTH, V14, P777, DOI 10.1080/17441692.2019.1601752; Wilcox S, 2006, AM J PUBLIC HEALTH, V96, P1201, DOI 10.2105/AJPH.2005.074690; Zieff SG, 2016, CHILD YOUTH SERV REV, V70, P95, DOI 10.1016/j.childyouth.2016.09.014; Zieff SG, 2013, J PUBLIC HEALTH MAN, V19, pS74, DOI 10.1097/PHH.0b013e3182841982	49	2	2	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1099-3460	1468-2869		J URBAN HEALTH	J. Urban Health	FEB	2021	98	1					101	110		10.1007/s11524-020-00496-w	http://dx.doi.org/10.1007/s11524-020-00496-w		NOV 2020	10	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	QF4JI	33236318	Green Published, Green Accepted			2022-09-04	WOS:000592191100001
J	Osorio, D; Pinzon, A; Martin-Jimenez, C; Barreto, GE; Gonzalez, J				Osorio, Daniel; Pinzon, Andres; Martin-Jimenez, Cynthia; Barreto, George E.; Gonzalez, Janneth			Multiple Pathways Involved in Palmitic Acid-Induced Toxicity: A System Biology Approach	FRONTIERS IN NEUROSCIENCE			English	Article						tibolone; astrocytes; inflammatory response; flux balance analysis; palmitic acid; genome-scale reconstruction; systems biology	OXIDATIVE STRESS; ACTIVATED ASTROCYTES; METABOLISM; TIBOLONE; CELLS; BRAIN; INFLAMMATION; DIFFERENTIATION; EXPRESSION; HISTIDINE	Inflammation is a complex biological response to injuries, metabolic disorders or infections. In the brain, astrocytes play an important role in the inflammatory processes during neurodegenerative diseases. Recent studies have shown that the increase of free saturated fatty acids such as palmitic acid produces a metabolic inflammatory response in astrocytes generally associated with damaging mechanisms such as oxidative stress, endoplasmic reticulum stress, and autophagic defects. In this aspect, the synthetic neurosteroid tibolone has shown to exert protective functions against inflammation in neuronal experimental models without the tumorigenic effects exerted by sexual hormones such as estradiol and progesterone. However, there is little information regarding the specific mechanisms of tibolone in astrocytes during inflammatory insults. In the present study, we performed a genome-scale metabolic reconstruction of astrocytes that was used to study astrocytic response during an inflammatory insult by palmitate through Flux Balance Analysis methods and data mining. In this aspect, we assessed the metabolic fluxes of human astrocytes under three different scenarios: healthy (normal conditions), induced inflammation by palmitate, and tibolone treatment under palmitate inflammation. Our results suggest that tibolone reduces the L-glutamate-mediated neurotoxicity in astrocytes through the modulation of several metabolic pathways involved in glutamate uptake. We also identified a set of reactions associated with the protective effects of tibolone, including the upregulation of taurine metabolism, gluconeogenesis, cPPAR and the modulation of calcium signaling pathways. In conclusion, the different scenarios studied in our model allowed us to identify several metabolic fluxes perturbed under an inflammatory response and the protective mechanisms exerted by tibolone.	[Osorio, Daniel] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Pinzon, Andres] Univ Nacl Colombia, Lab Bioinformat & Biol Sistemas, Bogota, Colombia; [Martin-Jimenez, Cynthia; Gonzalez, Janneth] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		Osorio, D (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.; Martin-Jimenez, C; Gonzalez, J (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	dcosorioh@tamu.edu; martin.c@javeriana.edu.co; janneth.gonzalez@javeriana.edu.co	martin, cynthia/AAC-6016-2021; GONZALEZ, JANNETH/AAB-9948-2020; Hurtado, Daniel Camilo Osorio/AAF-3138-2019; Barreto, George E./AAD-7420-2020	GONZALEZ, JANNETH/0000-0003-4482-256X; Hurtado, Daniel Camilo Osorio/0000-0003-4424-8422; Barreto, George E./0000-0002-6644-1971; Pinzon, Andres/0000-0002-4133-810X	Pontificia Universidad Javeriana, Bogota, Colombia; Colciencias [7425, 7714, 7740]	Pontificia Universidad Javeriana, Bogota, Colombia; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research is the result of the master's thesis presented by DO. This work was supported by the Pontificia Universidad Javeriana, Bogota, Colombia, and Colciencias IDs 7425, 7714, and 7740 to JG.	Ahlemeyer B, 2002, J NEUROCHEM, V82, P504, DOI 10.1046/j.1471-4159.2002.00994.x; Amen-Ra N, 2006, MED HYPOTHESES, V66, P978, DOI 10.1016/j.mehy.2005.11.013; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Badaut J, 2012, BRAIN RES, V1473, P19, DOI 10.1016/j.brainres.2012.07.041; Banos DT, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0507-0; Barnard ND, 2014, NEUROBIOL AGING, V35, pS65, DOI 10.1016/j.neurobiolaging.2014.02.030; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Belenichev IF, 2012, NEUROCHEM J+, V6, P202, DOI 10.1134/S181971241203004X; Bhowmick Rupa, 2015, Syst Synth Biol, V9, P159, DOI 10.1007/s11693-015-9183-9; Botero K., 2016, EXP2FLUX CONVERT GEN; Bruce-Keller AJ, 2001, J NEUROCHEM, V78, P1315, DOI 10.1046/j.1471-4159.2001.00511.x; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Colditz G. A., 1995, OBSTET GYNECOL SURV, V50, P789, DOI [10.1097/00006254-199511000-00017, DOI 10.1097/00006254-199511000-00017]; Core Team R., 2019, LANG ENV STAT COMP R; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fernando H, 2013, TOXICOL APPL PHARM, V266, P470, DOI 10.1016/j.taap.2012.11.017; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Frago LM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00330; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; Genazzani Andrea Riccardo, 2006, Neuropsychiatr Dis Treat, V2, P299, DOI 10.2147/nedt.2006.2.3.299; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gonzalez-Giraldo Y, 2019, MOL CELL ENDOCRINOL, V486, P65, DOI 10.1016/j.mce.2019.02.017; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Greenwood PM, 2018, NEUROPSYCHOLOGY, V32, P973, DOI 10.1037/neu0000470; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Hausen J, 2015, ENVIRON SCI POLLUT R, V22, P16384, DOI 10.1007/s11356-015-5019-0; Heimann G, 2017, CEREB CORTEX, V27, P4213, DOI 10.1093/cercor/bhx112; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Hornik K, 2012, WIRES COMPUT STAT, V4, P394, DOI 10.1002/wics.1212; Jha MK, 2016, CURR ALZHEIMER RES, V13, P387, DOI 10.2174/1567205013666151116124755; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kulkarni J, 2015, MOL PSYCHIATR, V20, P695, DOI 10.1038/mp.2014.33; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Le Foll C, 2016, AM J PHYSIOL-REG I, V310, pR1186, DOI 10.1152/ajpregu.00113.2016; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; Little JP, 2012, J ALZHEIMERS DIS, V30, pS179, DOI 10.3233/JAD-2011-111262; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Martin-Jimenez CA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00023; Mast N, 2017, J BIOL CHEM, V292, P4913, DOI 10.1074/jbc.M116.774760; Melo HM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00265; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; MURPHY S, 1988, GLIA, V1, P241, DOI 10.1002/glia.440010402; Nagahara M, 2010, RHEUMATOLOGY, V49, P898, DOI 10.1093/rheumatology/keq028; Najafi A, 2014, CURR GENOMICS, V15, P130, DOI 10.2174/1389202915666140319002221; Niu YC, 2012, BRIT J NUTR, V108, P57, DOI 10.1017/S0007114511005289; Okada M, 2010, INT J MOL SCI, V11, P4114, DOI 10.3390/ijms11104114; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osorio D, 2017, R J, V9, P114; Panov A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472459; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Petrelli F, 2016, CURR OPIN PHARMACOL, V26, P138, DOI 10.1016/j.coph.2015.11.010; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Rael LT, 2004, BIOCHEM BIOPH RES CO, V319, P847, DOI 10.1016/j.bbrc.2004.04.200; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reichelt AC, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00096; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; RYMER J, 1994, OSTEOPOROSIS INT, V4, P314, DOI 10.1007/BF01622189; Rymer JM, 1998, GYNECOL ENDOCRINOL, V12, P213, DOI 10.3109/09513599809015548; Sa JV, 2017, NEUROCHEM RES, V42, P244, DOI 10.1007/s11064-016-1907-z; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Seeger DR, 2016, PROSTAG LEUKOTR ESS, V110, P16, DOI 10.1016/j.plefa.2016.05.003; Sertbas M, 2014, FEBS OPEN BIO, V4, P542, DOI 10.1016/j.fob.2014.05.006; Shi M, 2009, NEUROBIOL DIS, V35, P157, DOI 10.1016/j.nbd.2008.09.004; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Son DO, 2005, FEBS LETT, V579, P4671, DOI 10.1016/j.febslet.2005.07.038; Souza DG, 2019, SEMIN CELL DEV BIOL, V95, P142, DOI 10.1016/j.semcdb.2019.04.002; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Varemo L, 2015, CELL REP, V11, P921, DOI 10.1016/j.celrep.2015.04.010; Velde AAT, 2008, EUR J GASTROEN HEPAT, V20, P555, DOI 10.1097/MEG.0b013e3282f45751; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; Wojtal K, 2006, PHARMACOL REP, V58, P335	100	7	7	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 31	2020	13								1410	10.3389/fnins.2019.01410	http://dx.doi.org/10.3389/fnins.2019.01410			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN1JF	32076395	Green Published, gold			2022-09-04	WOS:000514595100001
J	Torres, D; Bermejo, JL; Mesa, KG; Gilbert, M; Briceno, I; Pohl-Zeidler, S; Silos, RG; Boekstegers, F; Plass, C; Hamann, U				Torres, Diana; Bermejo, Justo Lorenzo; Mesa, Karen Garcia; Gilbert, Michael; Briceno, Ignacio; Pohl-Zeidler, Svenja; Silos, Rosa Gonzalez; Boekstegers, Felix; Plass, Christoph; Hamann, Ute			Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women	INTERNATIONAL JOURNAL OF CANCER			English	Article						breast cancer; Hispanics; risk factors; genetic ancestry; Colombia	GENOME-WIDE ASSOCIATION; HISPANIC WHITE WOMEN; RISK-FACTORS; FUNCTIONAL VARIANTS; MUTATION CARRIERS; LOCUS; ADMIXTURE; REPLICATION; POPULATIONS; PREDICTION	Latino women show lower incidences of breast cancer (BC) than non-Hispanic whites. Large-scale genetic association studies have identified variants robustly associated with BC risk in European women. We examine here the relevance of these variants to Colombian BC and possible interactions with genetic ancestry. Native American, European and African proportions were estimated for 1022 Colombian BC cases and 1023 controls. Logistic regression was applied to assess the association between 78 variants and BC risk and interactions between the variants and ancestry proportions. We constructed a multifactorial risk score combining established BC risk factors, associated risk variants and individual ancestry proportions. Each 1% increase in the Native American proportion translated into a 2.2% lower BC risk (95% CI: 1.4-2.9). Thirteen variants were associated with BC in Colombian women, with allele frequencies and risk effects partially different from European women. Ancestry proportions moderated the risk effects of two variants. The ability of Native American proportions to separate Colombian cases and controls (area-under-the-curve (AUC) = 0.61) was similar to the discriminative ability of family history of BC in first-degree female relatives (AUC = 0.58) or the combined effect of all 13 associated risk variants (AUC = 0.57). Our findings demonstrate ample potential for individualized BC prevention in Hispanic women taking advantage of individual Native American proportions, information on established susceptibility factors and recently identified common risk variants.	[Torres, Diana; Mesa, Karen Garcia; Gilbert, Michael; Pohl-Zeidler, Svenja; Hamann, Ute] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Torres, Diana; Briceno, Ignacio] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Bermejo, Justo Lorenzo; Mesa, Karen Garcia; Silos, Rosa Gonzalez; Boekstegers, Felix] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Briceno, Ignacio] Univ Sabana, Bogota, Colombia; [Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany		Hamann, U (corresponding author), German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany.	u.hamann@dkfz-heidelberg.de	Briceno Balcazar, Ignacio/N-3337-2017	Briceno Balcazar, Ignacio/0000-0001-7300-6401	Deutsches Krebsforschungszentrum; Pontificia Universidad Javeriana	Deutsches Krebsforschungszentrum(Helmholtz Association); Pontificia Universidad Javeriana	Deutsches Krebsforschungszentrum; Grant sponsor: Pontificia Universidad Javeriana	Amadou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079695; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Banegas MP, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw215; Barnholtz-Sloan Jill S., 2011, Frontiers in Genetics, V2, P37, DOI 10.3389/fgene.2011.00037; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Connor AE, 2016, J WOMENS HEALTH, V25, P299, DOI 10.1089/jwh.2015.5502; Dipierri JE, 1998, HUM BIOL, V70, P1001; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elgazzar S, 2012, J HUM GENET, V57, P766, DOI 10.1038/jhg.2012.108; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6260; Fejerman L, 2013, CARCINOGENESIS, V34, P1787, DOI 10.1093/carcin/bgt110; Fejerman L, 2012, HUM MOL GENET, V21, P1907, DOI 10.1093/hmg/ddr617; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Gonzalez-Andrade F, 2007, HUM BIOL, V79, P51, DOI 10.1353/hub.2007.0024; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hemminki K, 2007, CARCINOGENESIS, V28, P648, DOI 10.1093/carcin/bgl182; Hines LM, 2010, CANCER-AM CANCER SOC, V116, P3215, DOI 10.1002/cncr.25154; Huesing A, 2012, J MED GENET, V49, P601, DOI 10.1136/jmedgenet-2011-100716; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Lecarpentier J, 2017, J CLIN ONCOL, V35, P2240, DOI 10.1200/JCO.2016.69.4935; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Orr N, 2015, HUM MOL GENET, V24, P2966, DOI 10.1093/hmg/ddv035; Pardo C, 2009, BIOMEDICA, V29, P437, DOI 10.7705/biomedica.v29i3.2; Prentice RL, 2009, CANCER EPIDEM BIOMAR, V18, P3079, DOI 10.1158/1055-9965.EPI-09-0611; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Sans M, 2000, HUM BIOL, V72, P155; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Slattery ML, 2012, CARCINOGENESIS, V33, P1512, DOI 10.1093/carcin/bgs163; Slattery ML, 2011, BREAST CANCER RES TR, V129, P531, DOI 10.1007/s10549-011-1498-y; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Torres D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05056-y; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092	62	6	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7136	1097-0215		INT J CANCER	Int. J. Cancer	MAY 1	2019	144	9					2181	2191		10.1002/ijc.32023	http://dx.doi.org/10.1002/ijc.32023			11	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology	HN7BP	30485434				2022-09-04	WOS:000460343700015
J	Hernandez-Vasquez, A; Alarcon-Ruiz, CA; Bendezu-Quispe, G; Comande, D; Rosselli, D				Hernandez-Vasquez, Akram; Alarcon-Ruiz, Christoper A.; Bendezu-Quispe, Guido; Comande, Daniel; Rosselli, Diego			A bibliometric analysis of the global research on biosimilars	JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE			English	Article						Biosimilar pharmaceuticals; Bibliometrics; Biomedical research (source: MeSH NLM)		Background: Biosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars research. Methods: We performed a bibliometric analysis using documents about biosimilars published until December 2016 in journals indexed in Scopus. We extracted the annual research, languages, countries, journals, authors, institutions, citation frequency, and the metrics of journals. The data were quantitatively and qualitatively analyzed using Microsoft Excel 2013. Additional information about authors' participation was obtained using the R-package Bibliometrix. Publication activity was adjusted for the countries by population size. Also, author co-citation analysis and a term co-occurrence analysis with the terms included in the title and abstract of publications was presented as network visualization maps using VOSviewer. Results: A total of 2330 biosimilar-related documents identified in the Scopus database, most of them were articles (1452; 62.32%). The number of documents published had an exponential increased between 2004 and 2016 (p <0.001). The United States was the country with the highest production with 685 (29.40%) documents followed by Germany and UK with 293 (12.58%) and 248 (10.64%), respectively. Switzerland (11.05), Netherlands (5.85) and UK (3.83) showed the highest per capita ratio. The highest citation/article ratio were for the Netherlands (28.06), Spain (24.23), and France (20.11). Gabi Journal published 73 (3.13%) documents; both Biopharm International and Pharmaceutical Technology and Mabs, 41 (1.76%). Three out of top ten journals were Trade publications. Amgen Incorporated from the USA was the most prolific institution with 51 documents followed by Pfizer Inc. with 48. Terms about specific diseases and drugs were found in recent years, compared with terms such as legislation, structure, protein, dose and generic in the early years. Conclusions: Research production and publication of documents on biosimilars are increasing. The majority of publications came from high-income countries. The trends in terminology use are according to state of the art in the topic, and reflects the interest in the utilization of biosimilars in diseases who are expected to obtain benefits of its use.	[Hernandez-Vasquez, Akram] Univ Privada Norte, Lima, Peru; [Alarcon-Ruiz, Christoper A.] Univ Ricardo Palma, Fac Med, Lima, Peru; [Bendezu-Quispe, Guido] Univ Peruana Cayetano Heredia, Lima, Peru; [Comande, Daniel] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Rosselli, Diego] Pontificia Univ Javeriana, Fac Med, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia		Hernandez-Vasquez, A (corresponding author), Univ Privada Norte, Lima, Peru.	akram.hernandez.v@upch.pe	Bendezu-Quispe, Guido/H-7415-2014; Alarcon-Ruiz, Christoper A./S-1679-2019; Hernández-Vásquez, Akram/AAM-4868-2021	Bendezu-Quispe, Guido/0000-0002-5140-0843; Alarcon-Ruiz, Christoper A./0000-0003-3907-2784; Hernández-Vásquez, Akram/0000-0003-1431-2526; Rosselli, Diego/0000-0003-0960-9480; Comande, Daniel/0000-0002-7111-5169				Agarwal A, 2016, ASIAN J ANDROL, V18, P296, DOI 10.4103/1008-682X.171582; Becciolini A, 2017, DRUG DES DEV THER, V11, P1969, DOI 10.2147/DDDT.S138515; Beck M, 2017, MABS-AUSTIN, V9, P384, DOI 10.1080/19420862.2016.1267087; Bennett S, 2017, WHO BEGIN PILOT PREQ; Biosimilars approved in Europe, 2017, BIOS APPR EUR; Blackstone Erwin A, 2012, Biotechnol Healthc, V9, P24; Boccia R, 2017, CANCER MANAG RES, V9, P197, DOI 10.2147/CMAR.S133442; Cheng T, 2013, RHEUMATOLOGY, V52, P1630, DOI 10.1093/rheumatology/ket008; Cohen H, 2017, ADV THER, V33, P2160, DOI 10.1007/s12325-016-0431-5; Declerck P, 2017, DRUGS, V77, P671, DOI 10.1007/s40265-017-0717-1; Eleryan MG, 2016, CLIN COSMET INVESTI, V9, P135, DOI 10.2147/CCID.S91691; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Farhat F, 2017, ONCOLOGIST, V22, P1; Garcia R, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0564-1; Gyawali Bishal, 2017, Recenti Progressi in Medicina, V108, P172, DOI 10.1701/2681.27452; Jacobs I, 2017, BIODRUGS, V31, P1, DOI 10.1007/s40259-016-0207-0; Jacobs I, 2016, PATIENT PREFER ADHER, V10, P937, DOI 10.2147/PPA.S104891; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Li Q, 2012, AM J EMERG MED, V30, P1530, DOI 10.1016/j.ajem.2011.12.023; Liang ZM, 2015, ARTHROSCOPY, V31, P1452, DOI 10.1016/j.arthro.2015.03.009; Luo XY, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0070-0; McKeage K, 2014, BIODRUGS, V28, P313, DOI 10.1007/s40259-014-0094-1; Nabhan C, 2018, JAMA ONCOL, V4, P241, DOI 10.1001/jamaoncol.2017.2004; Oklahoma State University, 2016, ART TYP IND TRAD PUB; Olteanu R, 2017, ACTA DERMATOVENER CR, V25, P57; Prince FHM, 2013, PEDIATR DRUGS, V15, P271, DOI 10.1007/s40272-013-0023-7; Rein P, 2017, RHEUMATOL THER, V4, P247, DOI 10.1007/s40744-017-0073-3; Schulz M, 2016, CURR OPIN HEMATOL, V23, P61, DOI 10.1097/MOH.0000000000000204; Sullivan PM, 2017, AM J HEALTH-SYST PH, V74, P568, DOI 10.2146/ajhp150971; Sweileh WM, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0116-1; Sweileh WM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2801-5; US Food and Drug Administration, 2017, PURPL BOOK LISTS LIC; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; van Overbeeke E, 2017, BIODRUGS, V31, P447, DOI 10.1007/s40259-017-0244-3; Van Raan A., 2003, TECHNIKFOLGENABSCHAT, V12, P20, DOI [10.14512/tatup.12.1.20, DOI 10.14512/TATUP.12.1.20]; Ventola C Lee, 2013, P T, V38, P270; Wang YR, 2017, ONCOTARGET, V8, P48460, DOI 10.18632/oncotarget.17223; Wei MY, 2016, EUR SPINE J, V25, P976, DOI 10.1007/s00586-016-4442-3; Zhang WJ, 2013, ANN PLAS SURG, V70, P231, DOI 10.1097/SAP.0b013e3182309982; Zhao XY, 2015, ENDOKRYNOL POL, V66, P434, DOI 10.5603/EP.2015.0054	40	18	18	3	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2052-3211		J PHARM POLICY PRACT	J. Pharm. Policy Pract.	MAR 27	2018	11	1							6	10.1186/s40545-018-0133-2	http://dx.doi.org/10.1186/s40545-018-0133-2			8	Health Policy & Services; Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Pharmacology & Pharmacy	VJ3GO	29599984	Green Published, gold			2022-09-04	WOS:000577156400001
J	Ahcar, J; Siroen, JM				Ahcar, Jaime; Siroen, Jean-Marc			Deep Integration: Considering the Heterogeneity of Free Trade Agreements	JOURNAL OF ECONOMIC INTEGRATION			English	Article						Deep Integration; Gravity Model; Regional Trade Agreements; Trade Liberalization; International Trade	INTERNATIONAL-TRADE; INDUSTRIAL-POLICY; MARKET ACCESS; GRAVITY; COUNTRIES; ANATOMY; WTO	Regional Trade Agreements have emerged in an environment of stalled multilateral trade negotiations. Although the impact of Regional Trade Agreements on international trade has been well documented, scant attention has been paid to empirical studies exploring their heterogeneity from the point of view of deep integration. We set out to determine whether deeper Regional Trade Agreements promote trade more effectively than less ambitious ones. We generate credible deep integration indicators using two recently available datasets from the World Trade Organization and the World Trade Institute. We then test the effect of depth on trade using a gravity model. We treat additive indicators as factor variables and use multiple correspondence analysis to obtain distilled indicators of deep integration to offer new insights and confirm recent deep integration findings. We find that deeper Regional Trade Agreements increase trade more than shallow agreements do, irrespective of whether the provisions they contain are within or beyond the competence of the World Trade Organization.	[Ahcar, Jaime] Pontificia Univ Javeriana, Econ Dept, Calle 18 118-250, Cali 760031, Colombia; [Siroen, Jean-Marc] Univ Paris 09, PSL, IRD, LEDa,UMR 225,DIAL, Paris, France; [Siroen, Jean-Marc] Univ Paris 09, PSL Res Univ, Pl Marechal de Tassigny, F-75775 Paris 16, France; [Siroen, Jean-Marc] Univ Paris 09, DIAL, Pl Marechal de Tassigny, F-75775 Paris 16, France		Ahcar, J (corresponding author), Pontificia Univ Javeriana, Econ Dept, Calle 18 118-250, Cali 760031, Colombia.	jahcar@javerianacali.edu.co; siroen@dauphine.fr	Ahcar, Jaime Rafael/J-9277-2016	Ahcar, Jaime Rafael/0000-0002-9483-369X				Ahcar J., 2014, DIALDT201425 IRD U P; Anderson JE, 2011, ANNU REV ECON, V3, P133, DOI 10.1146/annurev-economics-111809-125114; Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; [Anonymous], 1962, SHAPING WORLD EC SUG; Baier SL, 2007, J INT ECON, V71, P72, DOI 10.1016/j.jinteco.2006.02.005; Baldwin R, 2011, AM ECON J-MICROECON, V3, P60, DOI 10.1257/mic.3.2.60; Baler SL, 2014, J INT ECON, V93, P339, DOI 10.1016/j.jinteco.2014.03.005; Booysen F, 2008, WORLD DEV, V36, P1113, DOI 10.1016/j.worlddev.2007.10.008; Boughanmi H, 2016, J ECON INTEGR, V31, P206, DOI 10.11130/jei.2016.31.2.206; Bourgeois J., 2007, COMP ANAL SELE UNPUB; Cahuzac E., 2008, STATA J; Dur A, 2014, REV INT ORGAN, V9, P353, DOI 10.1007/s11558-013-9179-8; Dunteman G.H., 1989, QUANTITATIVE APPL SO, V69; Fally T, 2015, J INT ECON, V97, P76, DOI 10.1016/j.jinteco.2015.05.005; GHONEIM A.F., 2012, 13 MEDPRO; Harrison A, 2010, HBK ECON, V5, P4039, DOI 10.1016/B978-0-444-52944-2.00001-X; Head K, 2014, HBK ECON, P131, DOI 10.1016/B978-0-444-54314-1.00003-3; Hoekman B., 2001, ZEI STUDIES EUROPEAN, V4, P171; Horn H, 2010, WORLD ECON, V33, P1565, DOI 10.1111/j.1467-9701.2010.01273.x; Khor M., 2008, BILATERAL REGIONAL F; Kleimann D, 2014, J WORLD TRADE, V48, P629; Kohl T, 2016, WORLD ECON, V39, P97, DOI 10.1111/twec.12272; Kohl T, 2014, REV WORLD ECON, V150, P443, DOI 10.1007/s10290-014-0188-3; Le Roux Brigitte, 2010, SERIES QUANTITATIVE, V163; Marquez-Ramos L, 2011, OPEN ECON REV, V22, P479, DOI 10.1007/s11079-009-9132-x; Martinez-Zarzoso I, 2013, APPL ECON, V45, P311, DOI 10.1080/00036846.2011.599786; Martinez-Zarzoso I, 2009, N AM J ECON FINANC, V20, P46, DOI 10.1016/j.najef.2008.10.001; Orefice G, 2014, WORLD ECON, V37, P106, DOI 10.1111/twec.12076; Peridy N, 2013, J ECON INTEGR, V28, P580, DOI 10.11130/jei.2013.28.4.580; Rodrik D, 2004, J ECON GROWTH, V9, P131, DOI 10.1023/B:JOEG.0000031425.72248.85; Rose AK, 2004, AM ECON REV, V94, P98, DOI 10.1257/000282804322970724; Shadlen KC, 2005, REV INT POLIT ECON, V12, P750, DOI 10.1080/09692290500339685; Shahid S, 2011, COMM SYST NETW COMSN, P1; Silva JMCS, 2006, REV ECON STAT, V88, P641, DOI 10.1162/rest.88.4.641; Silva JMCS, 2011, ECON LETT, V112, P220, DOI 10.1016/j.econlet.2011.05.008; Vicard V, 2009, REV WORLD ECON, V145, P167, DOI 10.1007/s10290-009-0010-9; World Bank WB, 2017, GLOB EC PROSP; World Trade Organization, 2011, WORLD TRAD REP 2011	38	6	7	5	18	SEJONG UNIV, CENTER INT ECONOMICS	SEOUL	KUNJA-DONG, KWANGJIN-GU, SEOUL, 143-747, SOUTH KOREA	1225-651X	1976-5525		J ECON INTEGR	J. Econ. Integr.	SEP	2017	32	3					615	659		10.11130/jei.2017.32.3.615	http://dx.doi.org/10.11130/jei.2017.32.3.615			45	Economics	Emerging Sources Citation Index (ESCI)	Business & Economics	FF3JY		Bronze, Green Published			2022-09-04	WOS:000408792500004
J	Biswas, I; Bruzzo, U; Otero, BG; Lo Giudice, A				Biswas, Indranil; Bruzzo, Ugo; Grana Otero, Beatriz; Lo Giudice, Alessio			YANG-MILLS-HIGGS CONNECTIONS ON CALABI-YAU MANIFOLDS	ASIAN JOURNAL OF MATHEMATICS			English	Article						Calabi-Yau manifold; approximate Hermitian-Yang-Mills structures; Hermitian-Yang-Mills metrics; polystability; Higgs field	EQUATION	Let X be a compact connected Kahler-Einstein manifold with c(1)(TX) >= 0. If there is a semistable Higgs vector bundle (E, theta) on X with. theta not equal 0, then we show that c(1)(TX) = 0; any X satisfying this condition is called a Calabi-Yau manifold, and it admits a Ricci-flat Kahler form [Ya]. Let (E, theta) be a polystable Higgs vector bundle on a compact Ricci-flat Kahler manifold X. Let h be an Hermitian structure on E satisfying the Yang-Mills-Higgs equation for (E, theta). We prove that h also satisfies the Yang-Mills-Higgs equation for (E, 0). A similar result is proved for Hermitian structures on principal Higgs bundles on X satisfying the Yang-Mills-Higgs equation.	[Biswas, Indranil] Tata Inst Fundamental Res, Sch Math, Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Bruzzo, Ugo] Univ Fed Santa Catarina, Dept Matemat, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil; [Bruzzo, Ugo] Ist Nazl Fis Nucl, Sez Trieste, Frascati, RM, Italy; [Grana Otero, Beatriz] Pontificia Univ Javeriana, Dept Matemat, Cra 7ma 40-62, Bogota, Colombia; [Lo Giudice, Alessio] IMECC UNICAMP, Dept Matemat, Rua Sergio Buarque Holanda,651,Cidade Univ, BR-13083859 Campinas, SP, Brazil		Biswas, I (corresponding author), Tata Inst Fundamental Res, Sch Math, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	indranil@math.tifr.res.in; bruzzo@sissa.it; bgrana@javeriana.edu.co; alessiologiudic@gmail.com	Graña Otero, Beatriz/B-4597-2017; Bruzzo, Ugo/AAC-2462-2020	Graña Otero, Beatriz/0000-0003-1666-2685; 	J. C. Bose Fellowship; Pontificia Universidad Javeriana, Bogota [PRY 6777]; PRIN "Geometry of Algebraic Varieties"; GNSAGA-INDAM; FAPESP post-doctoral grant [2013/20617-2]	J. C. Bose Fellowship(Department of Science & Technology (India)); Pontificia Universidad Javeriana, Bogota; PRIN "Geometry of Algebraic Varieties"; GNSAGA-INDAM; FAPESP post-doctoral grant	We thank the referee for pointing out several misprints. I.B. is supported by a J. C. Bose Fellowship. B.G.O. is supported by Project ID PRY 6777 of the Pontificia Universidad Javeriana, Bogota. U.B. is supported by PRIN "Geometry of Algebraic Varieties" and GNSAGA-INDAM. A. L. was supported by the FAPESP post-doctoral grant number 2013/20617-2.	Atiyah M. F., 1957, T AMS, V85, P181, DOI 10.2307/1992969; Biswas I, 2009, INT J MATH, V20, P541, DOI 10.1142/S0129167X09005406; Bruzzo U, 2016, ASIAN J MATH, V20, P399, DOI 10.4310/AJM.2016.v20.n3.a1; HITCHIN NJ, 1987, P LOND MATH SOC, V55, P59; Simpson C., 1992, I HAUTES ETUDES SCI, V75, P5; Simpson C. T., 1988, J AM MATH SOC, V1, P867; YAU ST, 1978, COMMUN PUR APPL MATH, V31, P339, DOI 10.1002/cpa.3160310304	7	3	3	0	4	INT PRESS BOSTON, INC	SOMERVILLE	PO BOX 43502, SOMERVILLE, MA 02143 USA	1093-6106	1945-0036		ASIAN J MATH	Asian J. Math.		2016	20	5					989	1000		10.4310/AJM.2016.v20.n5.a8	http://dx.doi.org/10.4310/AJM.2016.v20.n5.a8			12	Mathematics, Applied; Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	EL3XG		Green Submitted			2022-09-04	WOS:000394552000008
J	Bolnick, DA; Diaz-Matallana, M; Mata-Miguez, J; Pintar, E; Martinez, JG				Bolnick, Deborah A.; Diaz-Matallana, Marcela; Mata-Miguez, Jaime; Pintar, Elizabeth; Martinez, Jorge G.			Ancient DNA from Early to Mid-Holocene burials in Northwestern Argentina: Implications for understanding the colonization and early populations of South America	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	83rd Annual Meeting of the American-Association-of-Physical-Anthropologists	APR 08-12, 2014	Calgary, CANADA	Amer Assoc Phys Anthropologists					[Bolnick, Deborah A.; Mata-Miguez, Jaime] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Bolnick, Deborah A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Diaz-Matallana, Marcela] Pontificia Univ Javeriana, Human Genet Inst, Bogota, Colombia; [Pintar, Elizabeth] Austin Community Coll, Dept Anthropol, Austin, TX USA; [Martinez, Jorge G.] Univ Nacl Tucuman, Fac Ciencias Nat, Inst Arqueol & Museo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Martinez, Jorge G.] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina										0	0	3	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2014	153			58	SI		81	81						1	Anthropology; Evolutionary Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Anthropology; Evolutionary Biology	AA6RH					2022-09-04	WOS:000331225100077
J	Diaz, C; Baena, S; Patel, BKC; Fardeau, ML				Diaz, C.; Baena, S.; Patel, B. K. C.; Fardeau, M. L.			PEPTIDOLYTIC MICROBIAL COMMUNITY OF METHANOGENIC REACTORS FROM TWO MODIFIED UASBS OF BREWERY INDUSTRIES	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						anaerobic peptide-degrading bacteria; MPN; UASB; 16S rRNA gene	SULFATE-REDUCING BACTERIUM; ACID-DEGRADING BACTERIUM; WASTE-WATER TREATMENT; SP-NOV.; GEN. NOV.; DATABASE	We studied the peptide-degrading anaerobic communities of methanogenic reactors from two mesophilic full-scale modified upflow anaerobic sludge blanket (UASB) reactors treating brewery wastewater in Colombia. Most probable number (MPN) counts varied between 7.1 x 10(8) and 6.6 x 10(9) bacteria/g volatile suspended solids VSS (Methanogenic Reactor 1) and 7.2 x 10(6) and 6.4 x 10(7) bacteria/g (VSS) (Methanogenic Reactor 2). Metabolites detected in the highest positive MPN dilutions in both reactors were mostly acetate, propionate, isovalerate and, in some cases, negligible concentrations of butyrate. Using the highest positive dilutions of MPN counts, 50 dominant strains were isolated from both reactors, and 12 strains were selected for sequencing their 16S rRNA gene based on their phenotypic characteristics. The small-subunit rRNA gene sequences indicated that these strains were affiliated to the families Propionibacteriaceae, Clostridiaceae and Syntrophomonadaceae in the low G + C gram-positive group and Desulfovibrio spp. in the class delta-Proteobacteria. The main metabolites detected in the highest positive dilutions of MPN and the presence of Syntrophomonadaceae indicate the effect of the syntrophic associations on the bioconversion of these substrates in methanogenic reactors. Additionally, the potential utilization of external electron acceptors for the complete degradation of amino acids by Clostridium strains confirms the relevance of these acceptors in the transformation of peptides and amino acids in these systems.	[Diaz, C.; Baena, S.] Pontificia Univ Javeriana, Dept Biol, USBA, Bogota, Colombia; [Patel, B. K. C.] Griffith Univ, Fac Sci, Sch Biomol & Biomed Sci, Microbial Res Discovery Unit, Brisbane, Qld 4111, Australia; [Fardeau, M. L.] Univ Aix Marseille 1, ESIL, IFR BAIM, IRD, F-13288 Marseille 09, France; [Fardeau, M. L.] Univ Mediterranee, ESIL, F-13288 Marseille 09, France		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, USBA, POB 56710, Bogota, Colombia.	baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019; Patel, Bharat KC/H-8050-2015	Patel, Bharat KC/0000-0002-5332-1858; Baena, Sandra/0000-0001-5377-9079	IFS (International Foundation for Science); COLCIENCIAS (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia)	IFS (International Foundation for Science)(International Foundation for Science); COLCIENCIAS (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported by IFS (International Foundation for Science) and COLCIENCIAS (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia). We thank Eng. Juan Carlos Hoyos of Cerveceria Bavaria for providing the physicochemical data of the two treatment systems, and Dr. Caroline Plugge of the Laboratory of Microbiology, Wageningen University, for allowing us to evaluate the metabolism of strain GELA in her lab.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APHA-AWWA-WPCF, 1995, STAND METH EX WAT WA; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Baena S, 1998, SYST APPL MICROBIOL, V21, P498, DOI 10.1016/S0723-2020(98)80061-1; Baena S, 2000, INT J SYST EVOL MICR, V50, P259, DOI 10.1099/00207713-50-1-259; Baena S, 1999, INT J SYST BACTERIOL, V49, P975, DOI 10.1099/00207713-49-3-975; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Delbes C, 2000, ENVIRON MICROBIOL, V2, P506, DOI 10.1046/j.1462-2920.2000.00132.x; Demirel B, 2006, BIORESOURCE TECHNOL, V97, P1201, DOI 10.1016/j.biortech.2005.05.009; Diaz C, 2007, INT J SYST EVOL MICR, V57, P1914, DOI 10.1099/ijs.0.63614-0; Diaz EE, 2006, APPL ENVIRON MICROB, V72, P4942, DOI 10.1128/AEM.02985-05; FAUDON C, 1995, CURR MICROBIOL, V31, P152, DOI 10.1007/BF00293546; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez N, 2008, MICROB ECOL, V56, P121, DOI 10.1007/s00248-007-9330-2; Ganesan A, 2008, INT J SYST EVOL MICR, V58, P2003, DOI 10.1099/ijs.0.65645-0; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-14998U1.29; Hernandez-Eugenio G, 2000, ANAEROBE, V6, P305, DOI 10.1006/anae.2000.0354; Hernandez-Eugenio G, 2002, INT J SYST EVOL MICR, V52, P1461, DOI [10.1099/ijs.0.01946-0, 10.1099/00207713-52-5-1461]; Hungate RE, 1969, METHODS MICROBIOLO B, V3; Jukes T.H., 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Liu WT, 2002, WATER RES, V36, P1767, DOI 10.1016/S0043-1354(01)00377-3; Magot M, 1997, INT J SYST BACTERIOL, V47, P818, DOI 10.1099/00207713-47-3-818; McHugh S, 2003, FEMS MICROBIOL LETT, V219, P297, DOI 10.1016/S0378-1097(03)00055-7; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Plugge CM, 2002, INT J SYST EVOL MICR, V52, P401, DOI 10.1099/00207713-52-2-401; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; REDBURN AC, 1993, FEMS MICROBIOL LETT, V113, P81, DOI 10.1111/j.1574-6968.1993.tb06492.x; Roest K, 2005, SYST APPL MICROBIOL, V28, P175, DOI 10.1016/j.syapm.2004.10.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Sekiguchi Y, 1998, MICROBIOL-UK, V144, P2655, DOI 10.1099/00221287-144-9-2655; Sekiguchi Y., 2006, MICROBES ENVIRON, V21, P1, DOI [10.1264/ jsme2.21.1, DOI 10.1264/JSME2.21.1]; Spanevello MD, 2002, INT J SYST EVOL MICR, V52, P795, DOI [10.1099/ijs.0.01959-0, 10.1099/00207713-52-3-795]; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Sun YJ, 2008, J ENVIRON SCI, V20, P626, DOI 10.1016/S1001-0742(08)62104-X; Tang YQ, 2005, J BIOSCI BIOENG, V99, P150, DOI 10.1263/jbb.99.150; Thabet OB, 2004, ANAEROBE, V10, P185, DOI 10.1016/j.anaerobe.2004.04.002; VandePeer Y, 1997, NUCLEIC ACIDS RES, V25, P111, DOI 10.1093/nar/25.1.111; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Woo THS, 1997, FEMS MICROBIOL LETT, V155, P169, DOI 10.1016/S0378-1097(97)00383-2; Wu JH, 2001, MICROBIOL-UK, V147, P373, DOI 10.1099/00221287-147-2-373; ZINDEL U, 1988, ARCH MICROBIOL, V150, P254, DOI 10.1007/BF00407789	45	6	6	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	JUL-OCT	2010	41	3					707	717		10.1590/S1517-83822010000300022	http://dx.doi.org/10.1590/S1517-83822010000300022			11	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	612BW	24031547	Green Submitted, Green Published, gold			2022-09-04	WOS:000278872800022
J	Corredor-Silva, C; Gomez-Rodriguez, C; Aluja-Jaramillo, F				Corredor-Silva, Carlos; Gomez-Rodriguez, Carolina; Aluja-Jaramillo, Felipe			Implementation of Social Distancing in Radiology and Diagnostic Imaging Education	UNIVERSITAS MEDICA			Spanish	Review						education; medical; education department; hospital; education; medical; graduate; radiology department; hospital	COVID-19; MANAGEMENT; STRATEGY	This paper outlines how the Radiology and Diagnostic imagery program at the Pontificia Universidad Javeriana adapted itself to deal with the fallout of the SARS-CoV-2 epidemic. In-person lectures and seminars were migrated online using telepresence tools; whilst hand-on professional training and supervised practice were staged and performed in reduced groups to comply with person-to-person distancing policies to contain the spread of the virus. This was particularly challenging as the program makes emphasis on constructivist learning and social engagement. After six months, the effects of changes in lecturing were assessed through a poll which showed that there was widespread acceptance within the whole academic community. Particularly it was observed that use of remote presence tools enhanced engagement, improved knowledge appropriation and allowed for more flexibility. Therefore, there is support for making the implemented actions permanent. Consequently, it is an interesting test case for the application of flipped classroom and other akin virtual education strategies for developing skills in health care, thus contributing to making education more efficient, flexible, inclusive and, sustainable.	[Corredor-Silva, Carlos; Gomez-Rodriguez, Carolina; Aluja-Jaramillo, Felipe] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Radiol, Bogota, Colombia; [Corredor-Silva, Carlos] Univ La Sabana, Educ Med, Chia, Colombia; [Gomez-Rodriguez, Carolina] Univ Andes, Adm Empresas, Bogota, Colombia; [Gomez-Rodriguez, Carolina] Univ Antioquia, Telesalud, Medellin, Colombia		Gomez-Rodriguez, C (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Radiol, Bogota, Colombia.; Gomez-Rodriguez, C (corresponding author), Univ Andes, Adm Empresas, Bogota, Colombia.; Gomez-Rodriguez, C (corresponding author), Univ Antioquia, Telesalud, Medellin, Colombia.	c.gomezr@javeriana.edu.co		Aluja-Jaramillo, Felipe/0000-0002-3093-2509; Gomez, Carolina/0000-0001-9154-2072				Berman JD, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139864; Chen K, 2020, LANCET PLANET HEALTH, V4, pE210, DOI 10.1016/S2542-5196(20)30107-8; England E, 2020, ACAD RADIOL, V27, P1140, DOI 10.1016/j.acra.2020.05.001; Kaska K., 2019, HUAWEI 5G CHINA SECU; Knapper C, 2017, LIFELONG LEARNING HI; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Li CH, 2020, ACAD RADIOL, V27, P872, DOI 10.1016/j.acra.2020.04.028; Lo-Iacono-Ferreira VG, 2018, J CLEAN PROD, V178, P846, DOI 10.1016/j.jclepro.2017.12.184; Poli P, 2020, SCI REP-UK, V10, P9404, DOI 10.1038/s41598-020-66368-0; Prabhakar AM, 2020, J AM COLL RADIOL, V17, P730, DOI 10.1016/j.jacr.2020.04.004; UK Cabinet Office, 2020, TRANSMISSION SARS CO; Unesco-Iesalc, 2020, COV 19 EDU SUP EF IN; van Dijk J, 2020, THE DIGITAL DIVIDE; Warhadpande S, 2020, ACAD RADIOL, V27, P868, DOI 10.1016/j.acra.2020.04.024; Wilson B. G., 1996, CONSTRUCTIVIST LEARN; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1	16	0	0	2	4	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.	APR-JUN	2021	62	2								10.11144/Javeriana.umed62-2.dist	http://dx.doi.org/10.11144/Javeriana.umed62-2.dist			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TD5YU					2022-09-04	WOS:000669402900006
J	Stonis, JR; Remeikis, A; Diskus, A; Vargas, SA; Solis, MA				Stonis, Jonas R.; Remeikis, Andrius; Diskus, Arunas; Vargas, Sergio A.; Solis, M. Alma			OPOSTEGIDAE (LEPIDOPTERA) OF THE AMERICAS: UPDATED CATALOG, DIAGNOSTICS, AND NEW SPECIES DESCRIPTIONS	PROCEEDINGS OF THE ENTOMOLOGICAL SOCIETY OF WASHINGTON			English	Article						antennal scape; COI barcodes; distribution; Neopostega; Pseudopostega; tropical habitats		We list 102 currently known Opostegidae species from the Americas, designate one new species group, and revise and provide pictorial diagnostics for the twelve Pseudopostega Kozlov species groups. Five new species are described: Neopostega dondavisi Stonis and Remeikis, new species, Pseudopostega cucullata Stonis and Vargas, new species, Pseudopostega bogotensis Vargas, new species, Pseudopostega bifida Stonis and Remeikis, new species, and Pseudopostega spinosa Stonis and Dgkus, new species. We provide new distributional data and the first photographic documentation of Pseudopostega ovatula Davis and Stonis, P. monstruosa Davis and Stonis, P. sacculata (Meyrick), P. fumida Davis and Stonis, P. paraplicatella Davis and Stonis, P. apotoma Davis and Stonis, P. diskusi Davis and Stonis, P. sublobata Davis and Stonis, P. didyma Davis and Stonis, P. denticulata Davis and Stonis, P. ecuadoriana Davis and Stonis, and P. venticola (Walsingham). We briefly discuss available molecular data, history of species descriptions, and provide species numbers for countries in the Western Hemisphere.	[Stonis, Jonas R.; Remeikis, Andrius; Diskus, Arunas] Nat Res Ctr, Inst Ecol, Akademijos St 2, LT-08412 Vilnius, Lithuania; [Vargas, Sergio A.] Jardin Bot Bogota Jose Celestino Mutis, Av Calle 63 68-95, Bogota, Colombia; [Vargas, Sergio A.] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, UNESIS, Carrera 7 43-82, Bogota, Colombia; [Solis, M. Alma] USDA, Systemat Entomol Lab, Beltsville Agr Res Ctr, Agr Res Ctr,Natl Museum Nat Hist,Smithsonian Inst, Washington, DC 20013 USA		Stonis, JR (corresponding author), Nat Res Ctr, Inst Ecol, Akademijos St 2, LT-08412 Vilnius, Lithuania.	stonis.biotaxonomy@gmail.com		Stonis, Jonas Rimantas/0000-0002-8411-3162; Diskus, Arunas/0000-0003-0106-5546	Research Council of Lithuania [S-MIP-19-30]; Lithuanian Research Council	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Lithuanian Research Council(Research Council of Lithuania (LMTLT))	We are indebted to our Ecuadorian scientific partners, including those who participated in the initial 1999 project by R. Puplesis, S. R. Hill, and Professor Giovanni Onore, former professor at the Pontifical Catholic University of Ecuador, Quito, Ecuador. We are very grateful to Professor Dr. Igor Dimitri Forero Fuentes, Coordinator of the Biological Collections (Departamento de Biologia, Pontificia Universidad Javeriana, Bogota, Colombia), for facilitating a permit to collect material in Colombia and for his previous scientific collaboration. We thank the Consejo Nacional de Areas Protegidas (CONAP) Guatemala, C.A. for the Licencia de Collecta o Aprovechamiento de Vida Silvestre (No. 12900) and the Autoridad Nacional de Licencias Ambientales, Bogota, Colombia, for Collecting Permit No. 2019007511-1-000. Julia PuplesyteChambers and Jonas R. Stonis thank the Environmental Programme at the Andes Office of NGO DAR Peru for permission for Julia Puplesyte-Chambers to attend training courses and fieldwork on the project "Rapid assessment of biodiversity plots of critical value in the provinces Chanchamayo and Satipo, Peru", in cooperation with the Baltic-American Biotaxonomy Institute in 2017-2018.; The first and final authors thank Dr. Michael Gates, Research Leader, of the Systematic Entomology Laboratory, ARS, USDA, for supporting MAS participation in this research. The first author also thanks Vladimir Riaskov (Ukraine) for assistance during the last stage of the manuscript preparation, and Simon R. Hill (U.K.) for companionship during the 2018 fieldwork; This research was partially funded by a grant (S-MIP-19-30, "DiagnoStics") from the Research Council of Lithuania. Andrius Remeikis is grateful to the Lithuanian Research Council for the research stipend he was awarded in 2019.	Braun Annette F., 1918, Entomological News Philadelphia, V29; Busck A., 1900, Proceedings United States Museum, Vxxiii, P225; Chambers V. T., 1881, J CINCINNATI SOC NAT, V3, P289; Chambers V. T, 1875, CINCINNATI Q J SCI, V2, P97; Clemens B, 1862, P ENTOMOLOGICAL SOC, V1, P131; Clemens M. D., 1872, TINEINA N AM; Davis D. R., 2007, SMITHSONIAN CONTRIBU, V625; Davis D.R., 1989, SMITHSON CONTRIB ZOO, V478, DOI [10.5479/si.00810282.478, DOI 10.5479/SI.00810282.478]; Davis Donald R., 1999, Handbuch der Zoologie (Berlin), V4, P65; EYER JOHN R., 1967, FLA ENTOMOL, V50, P39, DOI 10.2307/3493205; Frey H., 1876, ENTOMOLOGISCHE ZEITU, V37, P209; Grossenbacher J.G., 1910, NEW YORK AGR EXPT ST, V15, P49; Heppner J.B., 2009, Lepidoptera Novae, V2, P31; Hubners J., 1796, SAMMLUNG EUROPAISCHE; KOZLOV M. V., 1985, T ZOOL I LENINGR, V135, P49; Kuroko H., 1982, MOTHS JAPAN, V1; Kuroko H., 1982, MOTHS JAPAN, V2; Lord Walsingham, 1914, BIOL CENTRALI AM, V4, P225; MEYRICK E., 1931, Exotic Microlepidoptera, V4, P161; Meyrick E, 1915, T ENTOMOLOGICAL SOC, V1915, P201, DOI [DOI 10.1111/J.1365-2311.1915.TB02527.X, 10.1111/j.1365-2311.1915.tb02527.x]; Meyrick E., 1920, EXOTIC MICROLEPIDOPT, V2, P353; MEYRICK EDWARD, 1935, EXOTIC MICROLEPIDOPTERA, V4, P545; Puplesis R., 2003, NEPTICULOIDEA TISCHE; Puplesis Rimantas, 1999, Bulletin of the Natural History Museum Entomology Series, V68, P1; Remeikis Andrius, 2009, Acta Zoologica Lituanica, V19, P278, DOI 10.2478/v10043-009-0034-3; Stonis J.R., 2014, 1 BALT INT C FIELD E; Stonis JR, 2019, ZOOKEYS, P87, DOI 10.3897/zookeys.900.46332; van Nieukerken EJ, 2016, ZOOKEYS, P65, DOI 10.3897/zookeys.628.9799; Walsingham The Lord, 1897, Proceedings of the Zoological Society of London, P54	29	3	3	0	0	ENTOMOL SOC WASHINGTON	WASHINGTON	SMITHSONIAN INSTITUTION DEPT ENTOMOLOGY, WASHINGTON, DC 20560 USA	0013-8797			P ENTOMOL SOC WASH	Proc. Entomol. Soc. Wash.	OCT	2020	122	4					929	972		10.4289/0013-8797.122.4.929	http://dx.doi.org/10.4289/0013-8797.122.4.929			44	Entomology	Science Citation Index Expanded (SCI-EXPANDED)	Entomology	ON5NN					2022-09-04	WOS:000586747600016
J	Mendoza-Leon, R; Puentes, J; Uriza, LF; Hoyos, MH				Mendoza-Leon, Ricardo; Puentes, John; Felipe Uriza, Luis; Hernandez Hoyos, Marcela			Single-slice Alzheimer's disease classification and disease regional analysis with Supervised Switching Autoencoders	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Alzheimer disease; Supervised autoencoder; Supervised switching autoencoder; Convolutional neural networks; Representation learning; Magnetic resonance imaging	ATROPHY; MRI; REPRESENTATION; BIOMARKERS; DIAGNOSIS; PATHOLOGY; PATTERNS	Background: Alzheimer's disease (AD) is a difficult to diagnose pathology of the brain that progressively impairs cognitive functions. Computer-assisted diagnosis of AD based on image analysis is an emerging tool to support AD diagnosis. In this article, we explore the application of Supervised Switching Autoencoders (SSAs) to perform AD classification using only one structural Magnetic Resonance Imaging (sMRI) slice. SSAs are revised supervised autoencoder architectures, combining unsupervised representation and supervised classification as one unified model. In this work, we study the capabilities of SSAs to capture complex visual neurodegeneration patterns, and fuse disease semantics simultaneously. We also examine how regions associated to disease state can be discovered by SSAs following a local patch-based approach. Methods: Patch-based SSAs models are trained on individual patches extracted from a single 2D slice, independently for Axial, Coronal, and Sagittal anatomical planes of the brain at selected informative locations, exploring different patch sizes and network parameterizations. Then, models perform binary class prediction - healthy (CDR = 0) or AD-demented (CDR > 0) - on test data at patch level. The final subject classification is performed employing a majority rule from the ensemble of patch predictions. In addition, relevant regions are identified, by computing accuracy densities from patch-level predictions, and analyzed, supported by Atlas-based regional definitions. Results: Our experiments employing a single 2D T1-w sMRI slice per subject show that SSAs perform similarly to previous proposals that rely on full volumetric information and feature-engineered representations. SSAs classification accuracy on slices extracted along the Axial, Coronal, and Sagittal anatomical planes from a balanced cohort of 40 independent test subjects was 87.5%, 90.0%, and 90.0%, respectively. A top sensitivity of 95.0% on both Coronal and Sagittal planes was also obtained. Conclusions: SSAs provided well-ranked accuracy performance among previous classification proposals, including feature-engineered and feature learning based methods, using only one scan slice per subject, instead of the whole 3D volume, as it is conventionally done. In addition, regions identified as relevant by SSAs' were, in most part, coherent or partially coherent in regard to relevant regions reported on previous works. These regions were also associated with findings from medical knowledge, which gives value to our methodology as a potential analytical aid for disease understanding.	[Mendoza-Leon, Ricardo; Hernandez Hoyos, Marcela] Univ Los Andes, Sch Engn, Syst & Comp Engn Dept, Bogota, Colombia; [Mendoza-Leon, Ricardo; Puentes, John] IMT Atlantique, Lab STICC, UMR CNRS 6285, F-29238 Brest, France; [Felipe Uriza, Luis] Hosp Univ San Ignacio, Dept Radiol & Imagenes Diagnost, Bogota, Colombia; [Felipe Uriza, Luis] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Mendoza-Leon, R (corresponding author), IMT Atlantique, Dept Image & Traitement Informat, 655 Ave Technopole, F-29280 Plouzane, France.	ra.mendoza35@uniandes.edu.co		Uriza Carrasco, Luis Felipe/0000-0002-1923-3934; Hernandez Hoyos, Marcela/0000-0002-9723-5417	Fundacion CEIBA; Alcaldia Mayor de Bogota (Colombia)	Fundacion CEIBA; Alcaldia Mayor de Bogota (Colombia)	The authors wish to thank Fundacion CEIBA and Alcaldia Mayor de Bogota (Colombia), for the financial support of Ricardo Mendoza's PhD studies through the scholarship program "Becas Rodolfo antis", and team DECIDE - Lab-STICC UMR CNRS 6285, for providing valuable computing resources for the completion of this work.	Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Backstrom K, 2018, I S BIOMED IMAGING, P149, DOI 10.1109/ISBI.2018.8363543; Bakkour A, 2013, NEUROIMAGE, V76, P332, DOI 10.1016/j.neuroimage.2013.02.059; Bangen KJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00159; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bron EE, 2015, IEEE J BIOMED HEALTH, V19, P1617, DOI 10.1109/JBHI.2015.2432832; Bron EE, 2015, NEUROIMAGE, V111, P562, DOI 10.1016/j.neuroimage.2015.01.048; Cai KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170875; Caso F, 2015, RADIOLOGY, V277, P162, DOI 10.1148/radiol.2015142766; Choi H, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00212; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dahl GE, 2013, INT CONF ACOUST SPEE, P8609, DOI 10.1109/ICASSP.2013.6639346; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Dong WS, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1603; Eliasova I, 2014, J NEUROL SCI, V346, P318, DOI 10.1016/j.jns.2014.08.036; Eskildsen SF, 2015, NEUROBIOL AGING, V36, pS23, DOI 10.1016/j.neurobiolaging.2014.04.034; Falahati F, 2014, J ALZHEIMERS DIS, V41, P685, DOI 10.3233/JAD-131928; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Gao SH, 2015, IEEE T INF FOREN SEC, V10, P2108, DOI 10.1109/TIFS.2015.2446438; Garcia-Sebastian M, 2009, LECT NOTES COMPUT SC, V5517, P957, DOI 10.1007/978-3-642-02478-8_120; Glozman T, 2017, J ALZHEIMERS DIS, V56, P287, DOI 10.3233/JAD-160900; Gupta A., 2013, P 30 INT C INT C MAC, V28, pIII; Hon M, 2017, IEEE INT C BIOINFORM, P1166, DOI 10.1109/BIBM.2017.8217822; Hosseini-Asl E, 2016, IEEE IMAGE PROC, P126, DOI 10.1109/ICIP.2016.7532332; Islam Jyoti, 2018, Brain Inform, V5, P2, DOI 10.1186/s40708-018-0080-3; Jha D, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/9060124; Kang K, 2013, J NEUROL SCI, V334, P55, DOI 10.1016/j.jns.2013.07.014; Lama RK, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/5485080; Landin-Romero R., 2017, NEUROIMAGE SC, V151, P72; Lehericy S, 2007, EUR RADIOL, V17, P347, DOI 10.1007/s00330-006-0341-z; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Li RJ, 2014, LECT NOTES COMPUT SC, V8675, P305, DOI 10.1007/978-3-319-10443-0_39; Li T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171749; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mendoza-Leon E., 2016, INT J COMPUT ASSI S1, V11, pS39; Mendoza-Leon R, 2016, I S BIOMED IMAGING, P24, DOI 10.1109/ISBI.2016.7493202; Moller C, 2015, J ALZHEIMERS DIS, V44, P635, DOI 10.3233/JAD-141230; Moradi E, 2017, NEUROIMAGE-CLIN, V13, P415, DOI 10.1016/j.nicl.2016.12.011; Toro CAO, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061752; Prince M., 2016, WORLD ALZHEIMER REPO, DOI 10.1073/pnas.1611243113; Pulido A, 2013, INT WORKSHOP PATTERN, P152, DOI 10.1109/PRNI.2013.47; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Quiroz YT, 2013, J NEUROL NEUROSUR PS, V84, P556, DOI 10.1136/jnnp-2012-303299; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Rueda Andrea, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P559, DOI 10.1007/978-3-642-33275-3_69; Sam Deepak Babu, 2017, CVPR; Samper-Gonzalez J, 2018, NEUROIMAGE, V183, P504, DOI 10.1016/j.neuroimage.2018.08.042; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Simic G, 2009, NEUROPATH APPL NEURO, V35, P532, DOI 10.1111/j.1365-2990.2009.01038.x; Simoes R, 2014, NEURORADIOLOGY, V56, P709, DOI 10.1007/s00234-014-1385-4; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; Steketee RME, 2016, EUR RADIOL, V26, P244, DOI 10.1007/s00330-015-3789-x; Suk HI, 2015, BRAIN STRUCT FUNCT, V220, P841, DOI 10.1007/s00429-013-0687-3; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Tabatabaei-Jafari H, 2017, HUM BRAIN MAPP, V38, P3141, DOI 10.1002/hbm.23580; Teipel SJ, 2014, J ALZHEIMERS DIS, V41, P69, DOI 10.3233/JAD-131829; Termenon M, 2012, NEURAL PROCESS LETT, V35, P1, DOI 10.1007/s11063-011-9200-2; Turchenko V, 2017, PROCEEDINGS OF THE 2017 9TH IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT DATA ACQUISITION AND ADVANCED COMPUTING SYSTEMS: TECHNOLOGY AND APPLICATIONS (IDAACS), VOL 2, P651, DOI 10.1109/IDAACS.2017.8095172; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Wang SH, 2017, CNS NEUROL DISORD-DR, V16, P11, DOI 10.2174/1871527315666161111123024; Yuasa T., 2016, ALZHEIMERS DEMENT, V12, pP1106; Zhang YD, 2018, J ALZHEIMERS DIS, V65, P855, DOI 10.3233/JAD-170069; Zhang YD, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00066; Zhao Y, 2017, NEUROIMAGE, V148, P296, DOI 10.1016/j.neuroimage.2016.12.026	68	9	9	2	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JAN	2020	116								103527	10.1016/j.compbiomed.2019.103527	http://dx.doi.org/10.1016/j.compbiomed.2019.103527			14	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	KM2TU	31765915				2022-09-04	WOS:000513976500012
J	Rustagi, T; Iwanaga, J; Sardi, JP; Alonso, F; Oskouian, RJ; Tubbs, RS				Rustagi, Tarush; Iwanaga, Joe; Sardi, Juan P.; Alonso, Fernando; Oskouian, Rod J.; Tubbs, R. Shane			Anatomic Variations of the Anterior Atlantodental Joint and Relations to the Apical and Alar Ligaments in a Geriatric Population	WORLD NEUROSURGERY			English	Article						Anatomic variation; Anatomy; Arthritis; Cadaver; Cervical vertebrae; Dens axis; Ligament	CROWNED DENS SYNDROME; ACUTE NECK PAIN; CERVICAL-SPINE; RETROODONTOID PSEUDOTUMOR; RHEUMATOID-ARTHRITIS; OSTEOARTHRITIS; CALCIFICATION; ETIOLOGY	K BACKGROUND: Degenerative changes in the upper cervical spine may be age related degeneration or a pathological process such as rheumatoid arthritis. However, to our knowledge, the relationship between the apical and alar ligaments and these anomalies has not been discussed. We present anatomical variations of the anterior atlantodental joint observed during cadaveric dissection of adult craniovertebral junctions, the relationship with the alar and apical ligaments and discuss possible origins and clinical implications. METHODS: The upper cervical spine including part of the occiput was dissected from cadavers whose mean age at death was 78.9 years-old. The anterior atlantodental joint and apical and alar ligaments were observed and any atypical findings were noted. RESULTS: In eleven specimens, seven had a dens corona, three had an os odontoideum and one had a dens aureola, which arose from the upper part of the anterior arch of the atlas. Only four specimens had an apical ligament. CONCLUSIONS: The possible etiologies and the clinical applications of these craniovertebral anomalies in a geriatric population should be appreciated by the clinician treating patients with disease in this area or interpreting imaging in the region.	[Rustagi, Tarush; Iwanaga, Joe; Alonso, Fernando; Oskouian, Rod J.; Tubbs, R. Shane] Seattle Sci Fdn, Seattle, WA 98122 USA; [Rustagi, Tarush; Alonso, Fernando; Oskouian, Rod J.] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA 98122 USA; [Rustagi, Tarush] Indian Spinal Injuries Ctr, Dept Spine Surg, New Delhi, India; [Iwanaga, Joe] Kurume Univ, Dept Anat, Sch Med, Kurume, Fukuoka, Japan; [Sardi, Juan P.] Pontificia Univ Javeriana, Bogota, Colombia; [Tubbs, R. Shane] St Georges Univ, Dept Anat Sci, True Blue, Grenada		Rustagi, T (corresponding author), Seattle Sci Fdn, Seattle, WA 98122 USA.; Rustagi, T (corresponding author), Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA 98122 USA.; Rustagi, T (corresponding author), Indian Spinal Injuries Ctr, Dept Spine Surg, New Delhi, India.	tarush.rustagi@gmail.com	Iwanaga, Joe/ABC-7040-2021; Sardi, Juan Pablo/ABD-9875-2020	Iwanaga, Joe/0000-0002-8502-7952; Sardi, Juan Pablo/0000-0002-0696-9213				Bouchaud-Chabot A, 2002, JOINT BONE SPINE, V69, P141, DOI 10.1016/S1297-319X(02)00361-5; BOUVET JP, 1985, ARTHRITIS RHEUM, V28, P1417, DOI 10.1002/art.1780281215; Child Z, 2016, SPINE J; Gehweiler D, J ORTHOP RES; Goel A, 2010, J NEUROSURG-SPINE, V12, P592, DOI 10.3171/2009.12.SPINE0999; Goto S, 2007, J BONE JOINT SURG AM, V89A, P2732, DOI 10.2106/JBJS.F.01322; Johal J, 2017, CUREUS, V9, DOI 10.7759/cureus.981; Klimo P, 2007, NEUROSURG CLIN N AM, V18, P463, DOI 10.1016/j.nec.2007.04.005; Kobayashi Y, 2001, SKELETAL RADIOL, V30, P295, DOI 10.1007/s002560100325; Lakshmanan P, 2005, EUR SPINE J, V14, P78, DOI 10.1007/s00586-004-0743-z; Raimondi AJ, 1989, THE PEDIAT SPINE; Sankar WN, 2006, SPINE, V31, P979, DOI 10.1097/01.brs.0000214935.70868.1c; Sardi JP, 2017, WORLD NEUROSURG, V101, DOI 10.1016/j.wneu.2017.03.066; Schmidt H, 1993, BORDERLANDS NORMAL E; Sekijima Y, 2010, J NEUROL SCI, V296, P79, DOI 10.1016/j.jns.2010.05.028; Shah A, 2016, WORLD NEUROSURG, V91, P419, DOI 10.1016/j.wneu.2016.04.050; Soubai RB, 2012, PAN AFR MED J, V13; Stulik J, 2007, ACTA CHIR ORTHOP TR, V74, P189; Takizawa N, 2016, J RHEUMATOL, V43, P177, DOI 10.3899/jrheum.150905; Tobari Y, 2014, J ORTHOP SURG-HONG K, V22, P430, DOI 10.1177/230949901402200333; Tubbs RS, 2015, CLIN ANAT, V28, P602, DOI 10.1002/ca.22563; Younes M, 2009, JOINT BONE SPINE, V76, P361, DOI 10.1016/j.jbspin.2008.10.010; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c	23	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						506	510		10.1016/j.wneu.2017.08.039	http://dx.doi.org/10.1016/j.wneu.2017.08.039			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	28823669				2022-09-04	WOS:000415860500069
J	Sanabria-Pulido, P; Rubaii, N; Puron, G				Sanabria-Pulido, Pablo; Rubaii, Nadia; Puron, Gabriel			Public affairs graduate education in Latin America: Emulation or identity?	POLICY AND SOCIETY			English	Article						Public affairs education; Latin America; Policy transfer	ADMINISTRATION EDUCATION; MANAGEMENT; PROGRAMS; POLICY; CHALLENGES; SERVICE	In this paper, we explore the state of the art of public affairs education in Latin America and compare it with the evolution and current character of MPA/MPP education in the United States. In doing so, we are able to identify ways in which there is a Latin American model (or at least identifiable patterns) of public affairs education in sharp contrast to what might be expected in terms of emulation of international programs, particularly from the United States and Europe. As the basis for our analysis, we rely on three main sources of information. We use extensive data gathered from a survey of nearly 50 programs of public affairs in Latin America, which we administered in 2015 in order to identify patterns and trends in public affairs education in the region. Then, we compare our data with two data bases: (1) the Atlas of Public Policy and Management (Carleton University and the University of Toronto), which provides an international profile of programs, and (2) NASPAA's Data Center, which summarizes the characteristics of NASPAA-member programs based on Annual Survey data. This comparison allows us to establish to what degree there is a phenomenon of isomorphism in public affairs education between countries in Latin America and similar programs in North America. We finish this article exploring the implications of such results, for the quality and appropriateness of education in government affairs in Latin American countries. (C) 2016 Policy and Society Associates (APSS). Published by Elsevier Ltd. All rights reserved.	[Sanabria-Pulido, Pablo] Univ Los Andes, Alberto Lleras Camargo Sch Govt, Bogota, Colombia; [Sanabria-Pulido, Pablo] Pontificia Univ Javeriana Cali, Cali, Colombia; [Rubaii, Nadia] SUNY Binghamton, Binghamton, NY 13902 USA; [Puron, Gabriel] CIDE, Mexico City, DF, Mexico		Sanabria-Pulido, P (corresponding author), Univ Los Andes, Alberto Lleras Camargo Sch Govt, Bogota, Colombia.	psanabri@uniandes.edu.co; nadia.rubaii@binghamton.edu; gabriel.puron@cide.edu	Puron-Cid, Gabriel/AAY-5661-2021					Appe S, 2013, J PUBLIC AFF EDUC, V19, P591, DOI 10.1080/15236803.2013.12001755; Benavides AD, 2013, J PUBLIC AFF EDUC, V19, P615, DOI 10.1080/15236803.2013.12001756; Bryman A., 2008, SOCIAL RES METHODS; Careaga M., 2014, ENSENANZA APRENDIZAJ, P149; Dabene O., 2009, SCI PO SERIES INT RE; Dolowitz DP, 2000, GOVERNANCE, V13, P5, DOI 10.1111/0952-1895.00121; Ewoh AIE, 2014, J PUBLIC AFF EDUC, V20, P455, DOI 10.1080/15236803.2014.12001801; Frumkin P, 2004, J PUBL ADM RES THEOR, V14, P283, DOI 10.1093/jopart/muh028; Geva-May I, 2008, J POLICY ANAL MANAG, V27, P187, DOI 10.1002/pam.20314; Geva-May I, 2006, J PUBLIC AFF EDUC, V12, P413, DOI 10.1080/15236803.2006.12001449; Haruna PF, 2013, J PUBLIC AFF EDUC, V19, P493, DOI 10.1080/15236803.2013.12001748; Haruna PF, 2014, J PUBLIC AFF EDUC, V20, P451, DOI 10.1080/15236803.2014.12001800; Jarvis DSL, 2014, POLICY SOC, V33, P237, DOI 10.1016/j.polsoc.2014.09.003; Neuby BL, 2012, J PUBLIC AFF EDUC, V18, P683, DOI 10.1080/15236803.2012.12001708; Oliveira FB, 2013, J PUBLIC AFF EDUC, V19, P635, DOI 10.1080/15236803.2013.12001757; Onder M, 2013, J PUBLIC AFF EDUC, V19, P117, DOI 10.1080/15236803.2013.12001723; Rubaii N., 2016, J COMP POLICY ANAL R; Rubaii N, 2016, J PUBLIC AFF EDUC, V22, P467, DOI 10.1080/15236803.2016.12002261; Rubaii NM, 2013, J PUBLIC AFF EDUC, V19, P585, DOI 10.1080/15236803.2013.12001754; Sanabria P., 2012, THESIS; Stone Diane., 2001, 6901 CTR STUD GLOB R; Subban M, 2014, J PUBLIC AFF EDUC, V20, P499, DOI 10.1080/15236803.2014.12001804; Ye L, 2009, J PUBLIC AFF EDUC, V15, P203, DOI 10.1080/15236803.2009.12001554; Yildiz M, 2011, J PUBLIC AFF EDUC, V17, P343, DOI 10.1080/15236803.2011.12001649	24	5	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1449-4035	1839-3373		POLICY SOC	Policy Soc.	DEC	2016	35	4					315	331		10.1016/j.polsoc.2016.11.004	http://dx.doi.org/10.1016/j.polsoc.2016.11.004			17	Political Science; Public Administration	Social Science Citation Index (SSCI)	Government & Law; Public Administration	EN2OC					2022-09-04	WOS:000395848800003
J	Mendoza, C; Barreto, GE; Avila-Rodriguez, M; Echeverria, V				Mendoza, Cristhian; Barreto, George E.; Avila-Rodriguez, Marco; Echeverria, Valentina			Role of neuroinflammation and sex hormones in war-related PTSD	MOLECULAR AND CELLULAR ENDOCRINOLOGY			English	Review						Sex hormones; Fear; Stress; Trauma; Neuroinflammation; Combat PTSD	POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; RECEPTOR MESSENGER-RNA; GENOME-WIDE ASSOCIATION; CENTRAL-NERVOUS-SYSTEM; VETERANS SEEKING HELP; GROWTH-FACTOR-ALPHA; GENDER-DIFFERENCES; PREFRONTAL CORTEX	The susceptibility to develop posttraumatic stress disorder (PTSD) is greatly influenced by both innate and environmental risk factors. One of these factors is gender, with women showing higher incidence of trauma-related mental health disorders than their male counterparts. The evidence so far links these differences in susceptibility or resilience to trauma to the neuroprotective actions of sex hormones in reducing neuroinflammation after severe stress exposure. In this review, we discuss the impact of war related trauma on the incidence of PTSD in civilian and military populations as well as differences associated to gender in the incidence and recovery from PTSD. In addition, the mutually influencing role of inflammation, genetic, and sex hormones in modulating the consequences derived from exposure to traumatic events are discussed in light of current evidence. Published by Elsevier Ireland Ltd.	[Mendoza, Cristhian; Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Neurobiol Lab, Lientur 1457, Concepcion 4080871, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Ctr Biomed Res, Carlos Antunez 1920, Santiago, Chile; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Ibague, Colombia; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA		Echeverria, V (corresponding author), 10,000 Bay Pines Blvd, Bay Pines, FL 33744 USA.	echeverria.valentina@gmail.com	Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Avila-Rodriguez, Marco/0000-0003-4612-3236; Mendoza, Cristhian/0000-0002-5038-0991				Al-Krenawi A, 2009, BRIT J PSYCHIAT, V195, P427, DOI 10.1192/bjp.bp.108.050393; Altemus M, 1997, NEUROPSYCHOPHARMACOL, V17, P100; ANSEL JC, 1987, J INVEST DERMATOL, V89, P32, DOI 10.1111/1523-1747.ep12580362; Antov MI, 2014, PSYCHONEUROENDOCRINO, V49, P106, DOI 10.1016/j.psyneuen.2014.06.022; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; BANKI CM, 1987, AM J PSYCHIAT, V144, P873; Barnum CJ, 2008, BRAIN BEHAV IMMUN, V22, P517, DOI 10.1016/j.bbi.2007.10.004; Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; Beckham JC, 1999, J PSYCHOACTIVE DRUGS, V31, P103, DOI 10.1080/02791072.1999.10471731; Beckham JC, 1997, J CLIN PSYCHOL, V53, P859, DOI 10.1002/(SICI)1097-4679(199712)53:8<859::AID-JCLP11>3.3.CO;2-U; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; BINGAMAN EW, 1994, NEUROENDOCRINOLOGY, V59, P228, DOI 10.1159/000126663; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; Boasso AM, 2015, J TRAUMA STRESS, V28, P73, DOI 10.1002/jts.21988; Bosson Julia Vigna, 2011, Clin Schizophr Relat Psychoses, V5, P147, DOI 10.3371/CSRP.5.3.5; Bremner J Douglas, 2002, Semin Clin Neuropsychiatry, V7, P104, DOI 10.1053/scnp.2002.31787; Bremner JD, 2003, CHILD ADOL PSYCH CL, V12, P271, DOI 10.1016/S1056-4993(02)00098-6; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Cain KC, 2009, DIGEST DIS SCI, V54, P1542, DOI 10.1007/s10620-008-0516-3; Calhoun PS, 2000, J CONSULT CLIN PSYCH, V68, P923, DOI 10.1037/0022-006X.68.5.923; Calhoun PS, 2002, AM J PSYCHIAT, V159, P2081, DOI 10.1176/appi.ajp.159.12.2081; Carbone DL, 2013, NEUROSCIENCE, V239, P295, DOI 10.1016/j.neuroscience.2012.10.073; Carvalho-Netto EF, 2011, PHYSIOL BEHAV, V104, P242, DOI 10.1016/j.physbeh.2011.01.024; Chang FC, 2000, AM J PHYSIOL-REG I, V279, pR793, DOI 10.1152/ajpregu.2000.279.3.R793; Cheung J, 2013, NEUROBIOL LEARN MEM, V106, P87, DOI 10.1016/j.nlm.2013.07.005; Chiu S, 2011, PUBLIC HEALTH REP, V126, P201, DOI 10.1177/003335491112600211; Cohen E, 2011, J FAM PSYCHOL, V25, P688, DOI 10.1037/a0024065; Cucurachi L, 2006, NEUROL SCI, V27, P47, DOI 10.1007/s10072-006-0564-4; CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171; CUNNINGHAM ET, 1991, ENDOCRINOLOGY, V128, P2666, DOI 10.1210/endo-128-5-2666; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; Dalla C, BASIC CLIN PHARM TOX, V106, P226; De Bellis MD, 2003, NEUROSCI BIOBEHAV R, V27, P103, DOI 10.1016/S0149-7634(03)00013-7; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; DIAMOND MC, 1983, EXP NEUROL, V81, P1, DOI 10.1016/0014-4886(83)90153-X; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Dubow EF, 2012, J CLIN CHILD ADOLESC, V41, P837, DOI 10.1080/15374416.2012.675571; Dubow EF, 2012, J CLIN CHILD ADOLESC, V41, P402, DOI 10.1080/15374416.2012.684274; Dubow EF, 2010, J CLIN CHILD ADOLESC, V39, P103, DOI 10.1080/15374410903401153; Engel CC, 1999, J OCCUP ENVIRON MED, V41, P384, DOI 10.1097/00043764-199905000-00006; Fantuzzi G, 2001, ACTA PHYSIOL SCAND, V173, P5, DOI 10.1046/j.1365-201X.2001.00879.x; Felmingham KL, 2012, PSYCHONEUROENDOCRINO, V37, P1896, DOI 10.1016/j.psyneuen.2012.03.026; Felmingham KL, 2012, BIOL PSYCHOL, V89, P539, DOI 10.1016/j.biopsycho.2011.12.006; Fenchel D, 2015, EUR NEUROPSYCHOPHARM, V25, P944, DOI 10.1016/j.euroneuro.2015.02.004; Ferree NK, 2011, CONSCIOUS COGN, V20, P1154, DOI 10.1016/j.concog.2011.02.003; FLEMING DE, 1986, BRAIN RES BULL, V16, P395, DOI 10.1016/0361-9230(86)90062-6; Fontana A, 1997, AM J PUBLIC HEALTH, V87, P169, DOI 10.2105/AJPH.87.2.169; Fontana A, 2000, J NERV MENT DIS, V188, P163, DOI 10.1097/00005053-200003000-00006; Fontana A, 1998, PSYCHIATR SERV, V49, P658, DOI 10.1176/ps.49.5.658; Freedman SA, 2002, J TRAUMA STRESS, V15, P407, DOI 10.1023/A:1020189425935; GASKIN JH, 1971, ENDOCRINOLOGY, V89, P1047, DOI 10.1210/endo-89-4-1047; GASKIN JH, 1970, ENDOCRINOLOGY, V87, P779, DOI 10.1210/endo-87-4-779; Gil S, 2016, PSYCHOL TRAUMA-US, V8, P49, DOI 10.1037/tra0000063; Gil S, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.316; Glatt SJ, 2013, AM J MED GENET B, V162B, P313, DOI 10.1002/ajmg.b.32167; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Gold PW, 2013, MOL PSYCHIATR, V18, P632, DOI 10.1038/mp.2013.5; GOLD PW, 1985, PSYCHONEUROENDOCRINO, V10, P401, DOI 10.1016/0306-4530(85)90080-0; GOLD PW, 1984, AM J PSYCHIAT, V141, P619; Goldmann E, 2012, ANN EPIDEMIOL, V22, P71, DOI 10.1016/j.annepidem.2011.11.003; Goldzweig CL, 2006, J GEN INTERN MED, V21, pS82, DOI 10.1111/j.1525-1497.2006.00380.x; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Guffanti G, 2013, PSYCHONEUROENDOCRINO, V38, P3029, DOI 10.1016/j.psyneuen.2013.08.014; Guidetti V, 2009, FUNCT NEUROL, V24, P29; Hamama-Raz Y, 2008, J TRAUMA STRESS, V21, P521, DOI 10.1002/jts.20376; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Handa RJ, 2013, BRAIN RES, V1529, P74, DOI 10.1016/j.brainres.2013.07.021; Handa Robert J, 2011, Front Endocrinol (Lausanne), V2, P65, DOI 10.3389/fendo.2011.00065; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2012, NEUROPHARMACOLOGY, V62, P705, DOI 10.1016/j.neuropharm.2011.11.007; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Isgor C, 1998, HORM BEHAV, V34, P183, DOI 10.1006/hbeh.1998.1477; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Jackowski AP, 2009, PSYCHIAT CLIN NEUROS, V63, P1, DOI 10.1111/j.1440-1819.2008.01906.x; Jacobson IG, 2015, J PSYCHIATR RES, V68, P30, DOI 10.1016/j.jpsychires.2015.05.015; Jones HE, 1997, BRAIN RES BULL, V42, P341, DOI 10.1016/S0361-9230(96)00293-6; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Jones ME, 2015, NEUROPSYCHOPHARMACOL, V40, P1289, DOI 10.1038/npp.2014.317; Karlovic D, 2012, NEUROPSYCHOBIOLOGY, V65, P90, DOI 10.1159/000329556; Karstoft KI, 2013, J CLIN PSYCHIAT, V74, pE1163, DOI [10.4088/JCP.13m08428, 10.4088/JCP.13.m08482]; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; Kavushansky A, 2006, J NEUROSCI RES, V84, P1580, DOI 10.1002/jnr.21058; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; Kirby AC, 2012, VIOLENCE VICTIMS, V27, P777, DOI 10.1891/0886-6708.27.5.777; Kirby Sarah E, 2008, Psychol Health Med, V13, P257, DOI 10.1080/13548500701402928; Krupnick JL, 2010, PSYCHIATRY, V73, P234, DOI 10.1521/psyc.2010.73.3.234; Laufer A, 2009, J INTERPERS VIOLENCE, V24, P959, DOI 10.1177/0886260508319367; Liu F. F., 2015, MOL NEUROBIOL; MARETH TR, 1985, MIL MED, V150, P186, DOI 10.1093/milmed/150.4.186; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; MINAMI M, 1991, NEUROSCI LETT, V123, P254, DOI 10.1016/0304-3940(91)90944-O; Minkowski A, 2000, ACTA PAEDIATR, V89, P378, DOI 10.1080/080352500750028032; Mitev YA, 2003, FASEB J, V17, P518, DOI 10.1096/fj.02-0513fje; Mitev YA, 2003, NEUROSCIENCE, V120, P541, DOI 10.1016/S0306-4522(03)00287-2; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Mouthaan J, 2014, PSYCHONEUROENDOCRINO, V45, P179, DOI 10.1016/j.psyneuen.2014.04.001; Nagaya N, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00205; Nagaya N, 2015, BIOL PSYCHIAT, V78, P152, DOI 10.1016/j.biopsych.2015.06.010; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Nievergelt CM, 2015, PSYCHONEUROENDOCRINO, V51, P459, DOI 10.1016/j.psyneuen.2014.10.017; Nishi D, 2015, NEUROPSYCHOBIOLOGY, V71, P196, DOI 10.1159/000382021; Nugent NR, 2010, J TRAUMA STRESS, V23, P282, DOI 10.1002/jts.20517; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; OPARA EI, 1995, NEUROREPORT, V6, P750, DOI 10.1097/00001756-199503270-00011; OPP MR, 1988, AM J PHYSIOL, V255, pR914, DOI 10.1152/ajpregu.1988.255.6.R914; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pace TWW, 2012, BRAIN BEHAV IMMUN, V26, P13, DOI 10.1016/j.bbi.2011.07.232; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Palgi Y, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.7165; PATCHEV VK, 1995, FASEB J, V9, P419, DOI 10.1096/fasebj.9.5.7896013; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Philbert J, 2015, BEHAV BRAIN RES, V279, P41, DOI 10.1016/j.bbr.2014.11.006; Pierce PF, 1997, AVIAT SPACE ENVIR MD, V68, P317; PLATASALAMAN CR, 1992, PHYSIOL BEHAV, V51, P1277, DOI 10.1016/0031-9384(92)90321-R; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Qouta S, 2003, EUR CHILD ADOLES PSY, V12, P265, DOI 10.1007/s00787-003-0328-0; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; REDEI E, 1994, NEUROENDOCRINOLOGY, V60, P113, DOI 10.1159/000126741; Reijnen A, 2015, PSYCHONEUROENDOCRINO, V51, P525, DOI 10.1016/j.psyneuen.2014.07.017; Richardson JD, 2006, J CLIN PSYCHIAT, V67, P1240, DOI 10.4088/JCP.v67n0810; Richardson JD, 2010, CAN FAM PHYSICIAN, V56, P430; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Richert KA, 2006, DEPRESS ANXIETY, V23, P17, DOI 10.1002/da.20131; Rivera JC, 2015, CLIN ORTHOP RELAT R, V473, P2448, DOI 10.1007/s11999-015-4180-6; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Rosen CS, 2011, J NERV MENT DIS, V199, P879, DOI 10.1097/NMD.0b013e3182349ea5; Rusiecki Jennifer A, 2013, Front Psychiatry, V4, P56, DOI 10.3389/fpsyt.2013.00056; Schneider B., 2007, PSYCHOANAL REV, V94, P336; Schneider Beverly, 2007, Psychoanal Rev, V94, P333, DOI 10.1521/prev.2007.94.2.333; Shalev AY, 2009, PSYCHIAT CLIN N AM, V32, P687, DOI 10.1016/j.psc.2009.06.001; Shansky Rebecca M, 2006, Behav Brain Funct, V2, P8, DOI 10.1186/1744-9081-2-8; Shansky RM, 2015, NEUROBIOL STRESS, V1, P60, DOI 10.1016/j.ynstr.2014.09.005; Shansky RM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00123; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shansky Rebecca M, 2009, Stress, V12, P457, DOI 10.1080/10253890802520988; Shansky RM, 2009, EXPERT REV NEUROTHER, V9, P967, DOI [10.1586/ern.09.46, 10.1586/ERN.09.46]; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shansky RM, 2004, MOL PSYCHIATR, V9, P531, DOI 10.1038/sj.mp.4001435; SHINTANI F, 1995, MOL NEUROBIOL, V10, P47, DOI 10.1007/BF02740837; SHINTANI F, 1995, J NEUROSCI, V15, P1961, DOI 10.1523/JNEUROSCI.15-03-01961.1995; Singareddy R, 2012, SLEEP MED, V13, P346, DOI 10.1016/j.sleep.2011.10.033; Smid GE, 2015, PSYCHONEUROENDOCRINO, V51, P534, DOI 10.1016/j.psyneuen.2014.07.010; SOLOMON SD, 1992, JAMA-J AM MED ASSOC, V268, P633, DOI 10.1001/jama.268.5.633; SOLOMON Z, 1987, J CONSULT CLIN PSYCH, V55, P577, DOI 10.1037/0022-006X.55.4.577; SOLOMON Z, 1988, J ABNORM PSYCHOL, V97, P302, DOI 10.1037/0021-843X.97.3.302; SOLOMON Z, 1989, PSYCHIATRY, V52, P428, DOI 10.1080/00332747.1989.11024467; SOLOMON Z, 1988, PSYCHIATRY, V51, P323, DOI 10.1080/00332747.1988.11024407; Solomon Z, 2008, FAM PROCESS, V47, P261, DOI 10.1111/j.1545-5300.2008.00252.x; Spivak B, 2003, NEUROPSYCHOBIOLOGY, V47, P57, DOI 10.1159/000070009; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Steenkamp MM, 2014, AM PSYCHOL, V69, P706, DOI 10.1037/a0037360; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Stein NR, 2013, AM J ORTHOPSYCHIAT, V83, P528, DOI 10.1111/ajop.12044; Stevens Sally J, 2003, Child Maltreat, V8, P46, DOI 10.1177/1077559502239611; Street AE, 2015, PSYCHOL MED, V45, P717, DOI 10.1017/S003329171400258X; SUNDAR SK, 1990, J NEUROSCI, V10, P3701; SUSSKIND BM, 1987, J IMMUNOL, V139, P905; Thabet AAM, 1999, J CHILD PSYCHOL PSYC, V40, P385, DOI 10.1111/1469-7610.00456; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; Thomaes K, 2012, PSYCHOL MED, V42, P2337, DOI 10.1017/S0033291712000499; Usta MB, 2016, NORD J PSYCHIAT, V70, P116, DOI 10.3109/08039488.2015.1056752; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Wasserman D, 2008, GENES BRAIN BEHAV, V7, P14, DOI 10.1111/j.1601-183X.2007.00310.x; Wasserman D, 2010, EUR PSYCHIAT, V25, P278, DOI 10.1016/j.eurpsy.2009.12.016; Wasserman D, 2009, GENES BRAIN BEHAV, V8, P72, DOI 10.1111/j.1601-183X.2008.00446.x; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; Yehuda R, 1998, PSYCHIAT CLIN N AM, V21, P359, DOI 10.1016/S0193-953X(05)70010-1; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P881, DOI 10.1016/S0893-133X(01)00301-3; Zohar J, 2009, J CLIN PSYCHIAT, V70, P1629, DOI 10.4088/JCP.08m04378blu	185	24	26	2	26	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0303-7207			MOL CELL ENDOCRINOL	Mol. Cell. Endocrinol.	OCT 15	2016	434	C					266	277		10.1016/j.mce.2016.05.016	http://dx.doi.org/10.1016/j.mce.2016.05.016			12	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology; Endocrinology & Metabolism	DU5TJ	27216917				2022-09-04	WOS:000382273900025
J	Romero-Sanchez, C; Gomez-Gutierrez, A; Gomez, PE; Casas-Gomez, MC; Briceno, I				Romero-Sanchez, Consuelo; Gomez-Gutierrez, Alberto; Elena Gomez, Piedad; Consuelo Casas-Gomez, Maria; Briceno, Ignacio			C677t (rs1801133) MTFHR gene polymorphism frequency in a colombian population	COLOMBIA MEDICA			English	Article						Methotrexate; genotype; alleles; polymorphism; metylentetrahidrofolate-reductase	METHYLENETETRAHYDROFOLATE REDUCTASE GENE; RHEUMATOID-ARTHRITIS; MTHFR POLYMORPHISMS; PREGNANCY LOSS; CARDIA CANCER; RISK-FACTOR; METHOTREXATE; SUSCEPTIBILITY; HOMOCYSTEINE; ESOPHAGEAL	Introduction: Abnormal levels of the enzyme methylenetetrahydrofolate reductase (MTHFR) are associated with an increased risk of both cardiovascular and cerebrovascular disease and higher concentrations of homocysteine. Abnormal levels are also related to birth defects, pregnancy complications, cancer and toxicity to methotrexate (MTX). Polymorphisms of MTHFR affect the activity of the enzyme. Genetic associations have been related to treatment efficacy. Objective: To establish the frequency of the C>T polymorphism at nucleotide 677 of the MTHFR gene in a group of Colombian individuals. Methods: Data from pharmacogenetic microarrays that include MTX sensibility-associated polymorphisms were retrospectively collected (Pathway Genomics (R)). The frequency of the C>T MTHFR rs1801133 marker polymorphism was analyzed. Results: Microarray data from 68 men and 84 women were analyzed. Comparisons of genotype C/C vs. C/T and T/T were statistically significantly different (p= 0.00, p= 0.026, respectively), as were C/T and T/T (p= 0.0001). Conclusions: Results for the C/C and C/T genotypes in a Colombian population are similar to other previously studied groups of healthy subjects. Subjects from our population might be at risk of developing diseases associated with MTHFR polymorphisms and might present toxicity and adverse effects if treated with MTX, which suggests the need to evaluate therapeutic alternatives based on individual pharmacogenetic studies.	[Romero-Sanchez, Consuelo; Gomez-Gutierrez, Alberto; Elena Gomez, Piedad; Consuelo Casas-Gomez, Maria; Briceno, Ignacio] Inst Referencia Andino, Bogota, Colombia; [Gomez-Gutierrez, Alberto; Briceno, Ignacio] Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia; [Briceno, Ignacio] Univ La Sabana, Fac Med, Bogota, Colombia; [Romero-Sanchez, Consuelo] Hosp Mil, Serv Reumatol & Inmunol, Bogota, Colombia; [Romero-Sanchez, Consuelo] Univ El Bosque, Inst UIBO Unidad Invest Basico Oral, Bogota, Colombia		Romero-Sanchez, C (corresponding author), UIBO, Bogota, Colombia.	romeromaria@unbosque.edu.co	; Briceno Balcazar, Ignacio/N-3337-2017	Romero-Sanchez, Consuelo/0000-0002-6973-7639; Briceno Balcazar, Ignacio/0000-0001-7300-6401				Alluri RV, 2005, EUR J NEUROL, V12, P40, DOI 10.1111/j.1468-1331.2004.00938.x; ANDERSEN PA, 1985, ANN INTERN MED, V103, P489, DOI 10.7326/0003-4819-103-4-489; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Baum L, 2004, CLIN CHEM LAB MED, V42, P1370, DOI 10.1515/CCLM.2004.256; Bermúdez Marta, 2006, Colomb. Med., V37, P46; Brinker RR, 2010, CLIN EXP RHEUMATOL, V28, pS33; Cardona H, 2008, NUTR HOSP, V23, P277; Delgado-Enciso I, 2006, REV INVEST CLIN, V58, P462; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Finnell RH, 1998, CRIT REV ORAL BIOL M, V9, P38, DOI 10.1177/10454411980090010201; Fisher MC, 2009, J RHEUMATOL, V36, P539, DOI 10.3899/jrheum.080576; Fodil-Cornu N, 2009, GENES IMMUN, V10, P662, DOI 10.1038/gene.2009.50; Garcia-Robles R, 2011, UNIV MED, V52, P269; González-Galofre Zaniah N., 2010, Rev. Cienc. Salud, V8, P07; GUBNER R, 1951, AM J MED SCI, V221, P176, DOI 10.1097/00000441-195102000-00009; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1993, CIRCULATION, V88, P1463, DOI 10.1161/01.CIR.88.4.1463; Kim SK, 2006, J RHEUMATOL, V33, P1266; Li DH, 2005, CANCER EPIDEM BIOMAR, V14, P1470, DOI 10.1158/1055-9965.EPI-04-0894; Meadows DN, 2014, HUM MUTAT, V35, P594, DOI 10.1002/humu.22533; Meshkin Brian, 2007, Drug Metab Lett, V1, P55, DOI 10.2174/187231207779814319; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Semmler Alexander, 2011, BMC Res Notes, V4, P439, DOI 10.1186/1756-0500-4-439; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Stolzenberg-Solomon RZ, 2003, CANCER EPIDEM BIOMAR, V12, P1222; Sun L, 2008, EUR J CANCER PREV, V17, P446, DOI 10.1097/CEJ.0b013e328305a140; Taniguchi A, 2007, PHARMACOGENET GENOM, V17, P383, DOI 10.1097/01.fpc.0000236326.80809.b1; Tian HH, 2007, BULL HOSP JT DIS, V65, P168; Torres JD, 2006, AM J HEMATOL, V81, P933, DOI 10.1002/ajh.20733; van Ede AE, 2001, ARTHRITIS RHEUM, V44, P2525, DOI 10.1002/1529-0131(200111)44:11<2525::AID-ART432>3.0.CO;2-B; Wang LD, 2005, DIS ESOPHAGUS, V18, P177, DOI 10.1111/j.1442-2050.2005.00492.x; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401	34	12	13	0	3	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	APR-JUN	2015	46	2					75	79						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8JP	26309343				2022-09-04	WOS:000360140100006
J	Castillo, RE; Merentes, N; Rafeiro, H				Erlin Castillo, Rene; Merentes, Nelson; Rafeiro, Humberto			Bounded Variation Spaces with p-Variable	MEDITERRANEAN JOURNAL OF MATHEMATICS			English	Article						Bounded variation; variable exponent spaces; total variation	IMAGE; EXPONENT	In this paper, we introduce bounded variation spaces in the Wiener sense with p-variable and study some of its basic properties.	[Erlin Castillo, Rene] Univ Nacl Colombia, Dept Matemat, Bogota, Colombia; [Merentes, Nelson] Univ Cent Venezuela Caracas, Dept Matemat, Caracas, Venezuela; [Rafeiro, Humberto] Pontificia Univ Javeriana, Dept Matemat, Bogota, Colombia; [Rafeiro, Humberto] Inst Super Tecn, Ctr CEAF, Dept Matemat, P-1049001 Lisbon, Portugal		Castillo, RE (corresponding author), Univ Nacl Colombia, Dept Matemat, Cra 45 26-85 Ed Uriel Gutierrez, Bogota, Colombia.	recastillo@unal.edu.co; nmerucv@gmail.com; hrafeiro@gmail.com	Rafeiro, Humberto/AAK-4908-2020	Rafeiro, Humberto/0000-0002-5304-8572	Pontificia Universidad Javeriana under the research project "Study of variable bounded variation spaces"	Pontificia Universidad Javeriana under the research project "Study of variable bounded variation spaces"	H. Rafeiro was partially supported by Pontificia Universidad Javeriana under the research project "Study of variable bounded variation spaces".	Aboulaich R, 2008, COMPUT MATH APPL, V56, P874, DOI 10.1016/j.camwa.2008.01.017; Aboulaich R, 2007, CR MATH, V345, P425, DOI 10.1016/j.crma.2007.09.009; Acerbi E, 2002, CR MATH, V334, P817, DOI 10.1016/S1631-073X(02)02337-3; Acerbi E, 2002, ARCH RATION MECH AN, V164, P213, DOI 10.1007/s00205-002-0208-7; Antontsev SN., 2006, ANN U FERRARA, V52, P19, DOI [10.1007/s11565-006-0002-9, DOI 10.1007/S11565-006-0002-9]; Blomgren P, 1997, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL III, P384, DOI 10.1109/ICIP.1997.632128; Bollt EM, 2009, ADV COMPUT MATH, V31, P61, DOI 10.1007/s10444-008-9082-7; Chen YM, 2008, INVERSE PROBL IMAG, V2, P205; Chen YM, 2006, SIAM J APPL MATH, V66, P1383, DOI 10.1137/050624522; Diening L, 2011, LECT NOTES MATH, V2017, P1, DOI 10.1007/978-3-642-18363-8; Castillo RE, 2008, REAL ANAL EXCH, V34, P49; Fan XL, 2010, NONLINEAR ANAL-THEOR, V72, P4148, DOI 10.1016/j.na.2010.01.047; Harjulehto P, 2010, NONLINEAR ANAL-THEOR, V72, P4551, DOI 10.1016/j.na.2010.02.033; Hudjaev S.I., 1985, MECH ANAL, V8; Jordan C., 1881, CR HEBD ACAD SCI, V2, P228; Kozlowski WM, 1988, MONOGRAPHS TXB PURE, V122; Love E. R., 1951, J LOND MATH SOC, V26, P1; Love E.R., 1936, FUND MATH, V28, P243; Mingione G., 2006, APPL MATH, V51, P355, DOI [DOI 10.1007/s10778-006-0110-3, 10.1007/s10778-006-0110-3]; MUSIELAK J, 1983, LECT NOTES MATH, V1034, P1; Musielak J., 1959, STUDIA MATH, V18, P11; Musielak J., 1959, STUD MATH, V18, P49, DOI DOI 10.4064/SM-18-1-49-65; Nakano H., 1950, MODULARED SEMIORDERE; RAFEIRO H., 2011, J MATH SCI N Y, V172, P143; Rika M., 2004, APPL MATH, V49, P565, DOI [10.1007/s10492-004-6432-8, DOI 10.1007/S10492-004-6432-8]; Ruzicka M, 2000, LECT NOTES MATH, V1748, P1; Wiener N., 1924, MASSACHUSETTS J MATH, V3, P72, DOI DOI 10.1002/SAPM19243272; Wunderli T, 2010, J MATH ANAL APPL, V364, P591, DOI 10.1016/j.jmaa.2009.10.064	28	4	4	1	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1660-5446	1660-5454		MEDITERR J MATH	Mediterr. J. Math.	NOV	2014	11	4					1069	1079		10.1007/s00009-013-0342-5	http://dx.doi.org/10.1007/s00009-013-0342-5			11	Mathematics, Applied; Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	AR9GX					2022-09-04	WOS:000343882300003
J	Suarez, DR; Weinans, H; van Keulen, F				Suarez, Daniel R.; Weinans, Harrie; van Keulen, Fred			Bone remodelling around a cementless glenoid component	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Glenoid; Bone remodelling; Cementless implant; Finite element analysis; Shoulder	TOTAL SHOULDER ARTHROPLASTY; FINITE-ELEMENT ANALYSIS; TOTAL HIP-ARTHROPLASTY; STRESS-ANALYSES; INGROWTH; DENSITY; PROSTHESIS; MECHANISM; TISSUE; MODEL	Post-operative change in the mechanical loading of bone may trigger its (mechanically induced) adaptation and hamper the mechanical stability of prostheses. This is especially important in cementless components, where the final fixation is achieved by the bone itself. The aim of this study is, first, to gain insight into the bone remodelling process around a cementless glenoid component, and second, to compare the possible bone adaptation when the implant is assumed to be fully bonded (best case scenario) or completely loose (worst case scenario). 3D finite element models of a scapula with and without a cementless glenoid component were created. 3D geometry of the scapula, material properties, and several physiological loading conditions were acquired from or estimated for a specific cadaver. Update of the bone density after implantation was done according to a node-based bone remodelling scheme. Strain energy density for different loading conditions was evaluated, weighted according to their frequencies in activities of daily life and used as a mechanical stimulus for bone adaptation. The average bone density in the glenoid increased after implantation. However, local bone resorption was significant in some regions next to the bone-implant interface, regardless of the interface condition (bonded or loose). The amount of bone resorption was determined by the condition imposed to the interface, being slightly larger when the interface was loose. An ideal screw, e.g. in which material fatigue was not considered, was enough to keep the interface micromotions small and constant during the entire bone adaptation simulation.	[Suarez, Daniel R.] Pontificia Univ Javeriana, Bogota, Colombia; [Suarez, Daniel R.] Leiden Univ MC, Dept Orthopaed, Leiden, Netherlands; [Suarez, Daniel R.; van Keulen, Fred] Delft Univ Technol, Fac 3mE, NL-2628 CD Delft, Netherlands; [Weinans, Harrie] Erasmus MC, Orthopaed Res Lab, NL-3000 CA Rotterdam, Netherlands		Suarez, DR (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	d-suarez@javeriana.edu.co		Suarez, Daniel R./0000-0001-6264-2250; van Keulen, Fred/0000-0003-2634-0110; Weinans, Harrie/0000-0002-2275-6170	Dutch Arthritis Association	Dutch Arthritis Association	The authors thank to Prof. Piet M. Rozing and Dr. Edward R. Valstar for their valuable feedback and discussions during the elaboration of this manuscript. This research was supported by a long-term grant of the Dutch Arthritis Association.	Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Bohsali KI, 2006, J BONE JOINT SURG AM, V88A, P2279, DOI 10.2106/JBJS.F.00125; BOISSONNAT JD, 1988, COMPUT VISION GRAPH, V44, P1, DOI 10.1016/S0734-189X(88)80028-8; Botha C, 2008, SIMVIS, P309; CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3; Clement ND, 2010, J SHOULDER ELB SURG, V19, P749, DOI 10.1016/j.jse.2009.11.005; Coley B, 2008, GAIT POSTURE, V28, P581, DOI 10.1016/j.gaitpost.2008.04.014; Couteau B, 2001, CLIN BIOMECH, V16, P566, DOI 10.1016/S0268-0033(01)00029-8; Fernandes PR, 2002, J BIOMECH, V35, P167, DOI 10.1016/S0021-9290(01)00204-4; Folgado J, 2009, COMPUT METHOD BIOMEC, V12, P135, DOI [10.1080/10255840903081123, 10.1080/10255840802546754]; FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327; Frost HM., 1964, LAWS BONE STRUCTURE, V1; Gupta S, 2004, J BIOMECH, V37, P1777, DOI 10.1016/j.jbiomech.2004.02.001; Gupta S, 2004, CLIN BIOMECH, V19, P292, DOI 10.1016/j.clinbiomech.2003.12.002; HARRIS WH, 1983, CLIN ORTHOP RELAT R, P7; Hart R, 2001, BONE MECH HDB, V1; HOLLISTER SJ, 1994, J BIOMECH, V27, P433, DOI 10.1016/0021-9290(94)90019-1; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; JACOBS CR, 1995, J BIOMECH, V28, P449, DOI 10.1016/0021-9290(94)00087-K; Kalouche I, 2010, CLIN BIOMECH, V25, P292, DOI 10.1016/j.clinbiomech.2009.12.009; Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3; Lacroix D, 2000, J BIOMECH ENG-T ASME, V122, P430, DOI 10.1115/1.1286318; Lehtinen JT, 2004, J SHOULDER ELB SURG, V13, P344, DOI 10.1016/j.jse.2004.01.012; MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martin SD, 2005, J BONE JOINT SURG AM, V87A, P1284, DOI 10.2106/JBJS.C.00947; Maurel N, 2002, J BIOMECH, V35, P1071, DOI 10.1016/S0021-9290(02)00065-9; MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503; ORR TE, 1988, CLIN ORTHOP RELAT R, P217; Pelletier MH, 2008, J SHOULDER ELB SURG, V17, P779, DOI 10.1016/j.jse.2008.01.138; Popinet S, 2006, GTS GNU TRIANGULATED; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Stone KD, 1999, J SHOULDER ELB SURG, V8, P151, DOI 10.1016/S1058-2746(99)90009-5; Suarez DR, 2009, P I MECH ENG H, V223, P795, DOI 10.1243/09544119JEIM545; Suarez DR, 2009, MED BIOL ENG COMPUT, V47, P507, DOI 10.1007/s11517-009-0475-7; Tammachote N, 2007, J SHOULDER ELB SURG, V16, p102S, DOI 10.1016/j.jse.2006.03.012; Torchia ME, 1997, J SHOULDER ELB SURG, V6, P495, DOI 10.1016/S1058-2746(97)90081-1; VANDERHELM FCT, 1992, J BIOMECH, V25, P129, DOI 10.1016/0021-9290(92)90270-B; VANDERHELM FCT, 1994, J BIOMECH, V27, P551, DOI 10.1016/0021-9290(94)90065-5; VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U; VANRIETBERGEN B, 2001, BONE MECH HDB; VEEGER HEJ, 1991, J BIOMECH, V24, P615, DOI 10.1016/0021-9290(91)90294-W; WEINANS H, 1993, J ORTHOPAED RES, V11, P500, DOI 10.1002/jor.1100110405; Wirth MA, 1996, J BONE JOINT SURG AM, V78A, P603, DOI 10.2106/00004623-199604000-00018; Yeh LR, 1998, SKELETAL RADIOL, V27, P500, DOI 10.1007/s002560050427; Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269	47	15	15	0	15	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959			BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUL	2012	11	6					903	913		10.1007/s10237-011-0360-9	http://dx.doi.org/10.1007/s10237-011-0360-9			11	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	952TA	22109099	Green Published, hybrid			2022-09-04	WOS:000304814100013
J	Kozhevnikova, I; Shveikina, V; Dominguez, E				Kozhevnikova, I.; Shveikina, V.; Dominguez, E.			Modelling fluctuations of Caspian Sea levels using a mixed probability distribution	JOURNAL OF FLOOD RISK MANAGEMENT			English	Article						Caspian Sea; hydrological modelling; mixed probability distribution; stochastic processes	CLIMATE	By applying a nonlinear regression root analysis, this paper evaluates the significance of an emerging third stable steady state for the Caspian Sea level. A theoretical probability density function (PDF) is built and fitted to empirical data by mixing three different normal distributions. From this mixed probability distribution, a drift coefficient is obtained for the corresponding diffusive process. A stochastic model is then proposed, which uses the derived drift coefficient. This model demonstrates better performance than that exhibited by polynomial approximations and open possibilities for hydrological risk assessment of systems with several stable steady states.	[Dominguez, E.] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia; [Shveikina, V.] Russian Acad Sci, Inst Water Problems, Moscow, Russia; [Kozhevnikova, I.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Dominguez, E.] CeiBA Complejidad, Bogota, Colombia		Dominguez, E (corresponding author), Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota Transversal 4 42-00,Edificio J Rafael Arbo, Bogota, Colombia.	e.dominguez@javeriana.edu.co	Domínguez, Efraín/AAD-7485-2019; Domínguez, Efraín/B-1083-2008	Domínguez, Efraín/0000-0001-5487-9661; 				Aivazyan S. A., 1968, STAT STUDY RELATIONS; Asarin A. E., 1997, HYDROTECNICAL CONSTR, V31, P645; DAGOSTIN.RB, 1972, BIOMETRIKA, V59, P219, DOI 10.2307/2334638; Dolgonosov BM, 2007, WATER RESOUR+, V34, P624, DOI 10.1134/S0097807807060036; Elguindi N, 2007, CLIM DYNAM, V28, P365, DOI 10.1007/s00382-006-0185-x; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Hald A., 1952, STAT THEORY ENG APPL; Isaenko O. K., 1976, SEPARATION MIXED PRO; KAPITZA SP, 1992, MATH MODELLING, V4, P65; Kozhevnikova IA, 2008, WATER RESOUR, V35, P297, DOI 10.1134/S0097807808030056; Naidenov V. I., 2005, RUSS METEOROL HYDROL, V12, P31; Naidenov V. I, 1992, WATER RESOUR, V6, P5; Naidenov VI, 2001, DOKL PHYS, V46, P340, DOI 10.1134/1.1378099; Seber GAF., 1977, LINEAR REGRESSION AN; Shiriaev A. N., 2007, PROBABILITY; Siegert S, 1998, PHYS LETT A, V243, P275, DOI 10.1016/S0375-9601(98)00283-7; SVESHNIKOV AA, 1968, PROBLEMS PROBABILITY; WALTON TL, 1990, J WATERW PORT C-ASCE, V116, P664, DOI 10.1061/(ASCE)0733-950X(1990)116:6(664)	18	0	1	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1753-318X			J FLOOD RISK MANAG	J. Flood Risk Manag.	MAR	2012	5	1					3	13		10.1111/j.1753-318X.2011.01116.x	http://dx.doi.org/10.1111/j.1753-318X.2011.01116.x			11	Environmental Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Water Resources	889AP					2022-09-04	WOS:000300046200003
J	Santander, SP; Hernandez, JF; Barreto, CC; Masayuki, A; Moins-Teisserenc, H; Fiorentino, S				Paola Santander, Sandra; Fredy Hernandez, John; Cifuentes Barreto, Claudia; Masayuki, Aoki; Moins-Teisserenc, Helene; Fiorentino, Susana			Immunomodulatory Effects of Aqueous and Organic Fractions from Petiveria alliacea on Human Dendritic Cells (vol 40, pg 833, 2012)	AMERICAN JOURNAL OF CHINESE MEDICINE			English	Correction									[Paola Santander, Sandra; Fredy Hernandez, John; Fiorentino, Susana] Pontificia Univ Javeriana Bogota, Immunol & Cellular Biol Grp, Fac Sci, Bogota, Colombia; [Cifuentes Barreto, Claudia] Pontificia Univ Javeriana Bogota, Dept Biochem, Fac Sci, Bogota, Colombia; [Moins-Teisserenc, Helene] Univ Paris Diderot, INSERM, U940, Inst Univ Hematol, Paris, France; [Moins-Teisserenc, Helene] Hop St Louis, AP HP, Paris, France		Santander, SP (corresponding author), Pontificia Univ Javeriana Bogota, Immunol & Cellular Biol Grp, Fac Sci, Bogota, Colombia.		fiorentino, susana/R-8700-2016; Moins-Teisserenc, helene/AAL-1566-2021	fiorentino, susana/0000-0002-4664-0682; Moins-Teisserenc, helene/0000-0003-1602-7534				Santander SP, 2012, AM J CHINESE MED, V40, P833, DOI 10.1142/S0192415X12500620	1	0	0	0	9	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0192-415X			AM J CHINESE MED	Am. J. Chin. Med.		2012	40	6					1325	1325		10.1142/S0192415X12920024	http://dx.doi.org/10.1142/S0192415X12920024			1	Integrative & Complementary Medicine; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine; General & Internal Medicine	052PN		Bronze			2022-09-04	WOS:000312210400019
J	Cruz, RHB; Sanchez, MM; Dominguez-Sanchez, MA; Barreto, GE; Lancheros, D; Reynolds, J				Bustos Cruz, Rosa Helena; Sanchez, Magdy M.; Andrea Dominguez-Sanchez, Maria; Barreto, George E.; Lancheros, Daniel; Reynolds, Jorge			Nanotechnology in Neurosciences: An Approach	CURRENT PHARMACEUTICAL DESIGN			English	Review						Biosensors; nanotechnology; nanosensors; neuroregeneration; glial cells; neurosciences	REAL-TIME MEASUREMENT; IN-VITRO; MAGNETIC NANOPARTICLES; ELECTROCHEMICAL BIOSENSORS; OXIDE NANOPARTICLES; NEURON REGENERATION; PARKINSONS-DISEASE; ENSHEATHING CELLS; EXTRACELLULAR ATP; OLFACTORY SYSTEM	The use of nanotechnology in neurosciences has been evolving since new treatments, diagnoses and biomolecule monitoring are needed to find safer treatments for central nervous system diseases (CNDs). Nanotechnology employs devices that interact with biological systems allowing molecular interactions with a high degree of specificity. This review considers concepts associated with nanotechnology and leading areas of neurosciences with nanotechnology research.	[Bustos Cruz, Rosa Helena] Univ La Sabana, Therapeut Evidence Grp, Fac Med, Bogota, Colombia; [Sanchez, Magdy M.; Andrea Dominguez-Sanchez, Maria] Univ Nacl Colombia, Fac Med, Maestria Neurociencias, Bogota, Colombia; [Andrea Dominguez-Sanchez, Maria] Univ La Sabana, Grp Invest Movimiento Corporal Humano, Programa Fisioterapia, Fac Enfermeria & Rehabil, Bogota, Colombia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Lancheros, Daniel; Reynolds, Jorge] Clin Shaio, Dept Elect & Nanoelect, Bogota, Colombia		Cruz, RHB (corresponding author), Univ La Sabana, Evidence Based Therapeut Grp, Bogota, Colombia.	rosa.bustos@unisabana.edu.co	Barreto, George E./AAD-7420-2020; Bustos, Helena/R-5723-2019; Bustos, Rosa Helena/P-2742-2018	Barreto, George E./0000-0002-6644-1971; Bustos, Helena/0000-0003-0243-2299; Bustos, Rosa Helena/0000-0003-0243-2299				Abou DS, 2011, NUCL MED BIOL, V38, P675, DOI 10.1016/j.nucmedbio.2010.12.011; Ajetunmobi A, 2014, PROG NEUROBIOL, V123, P18, DOI 10.1016/j.pneurobio.2014.09.004; Alfonso A, 2014, TOXINS, V6, P96, DOI 10.3390/toxins6010096; Alonso-Sarduy L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103674; Alvarez Mar, 2009, V504, P51, DOI 10.1007/978-1-60327-569-9_4; Amiri-Aref M, 2015, BIOSENS BIOELECTRON, V74, P518, DOI 10.1016/j.bios.2015.07.001; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arruda IG, 2014, J NANOSCI NANOTECHNO, V14, P6658, DOI 10.1166/jnn.2014.9351; Bafadir E.B., 2014, ARTIF CELL NANOMED B, V44, P1; Battiston FM, 2001, SENSOR ACTUAT B-CHEM, V77, P122, DOI 10.1016/S0925-4005(01)00683-9; Bergeret A., 2004, 13 SEM ING BIOM UR; Berube D, 2005, NANOHYPE TRUTH NANOT; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bungart BL, 2014, NANOMED-NANOTECHNOL, V10, P15, DOI 10.1016/j.nano.2013.10.007; Bustos R., 2010, DEV NOVEL REAL TIME; BYKOV NP, 1976, FARMAKOL TOKSIKOL, V39, P451; Cady WG, 1964, PIEZOELECTRICITY; Carlinia L, 2013, REV NANOSCI NANOTECH, V2, P42; Carrascosa LG, 2006, TRENDS ANAL CHEM, V25; Casemiro L, 2015, SURFACE PLASMON RESO; Charkhkar H, 2012, SENSOR ACTUAT B-CHEM, V161, P655, DOI 10.1016/j.snb.2011.10.086; Chen X, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105104; Chen XY, 2004, EUR J NUCL MED MOL I, V31, P1081, DOI 10.1007/s00259-003-1452-2; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Cheran LE, 2007, ANALYST, V132, P242, DOI 10.1039/b615476j; Cheung SL, 2011, ANALYST, V136, P4412, DOI 10.1039/c1an15534b; Cheung SL, 2011, ANALYST, V136, P2786, DOI 10.1039/c1an15166e; Cheung S, 2010, ANALYST, V135, P289, DOI 10.1039/b919430b; Chirea M, 2005, J PHYS CHEM B, V109, P21808, DOI 10.1021/jp0537815; Cho WJ, 2009, CELL BIOL INT, V33, P224, DOI 10.1016/j.cellbi.2008.11.008; Choi JH, 2014, J NANOSCI NANOTECHNO, V14, P5658, DOI 10.1166/jnn.2014.8830; Choi Soonwook, 2014, Front Synaptic Neurosci, V6, P2, DOI 10.3389/fnsyn.2014.00002; Ciber bbn, 2013, CTR INV BIOM RED BIO; CIBER-BBN I, BIOING BIOM NAN; Castro VHC, 2014, CURR NEUROPHARMACOL, V12, P490, DOI 10.2174/1570159X13666141223223657; Cordeiro CA, 2015, BIOSENS BIOELECTRON, V67, P677, DOI 10.1016/j.bios.2014.09.101; Crivianu-Gaita V, 2015, BIOSENS BIOELECTRON, V70, P167, DOI 10.1016/j.bios.2015.03.032; Cui GH, 2014, NAT PROTOC, V9, P1213, DOI 10.1038/nprot.2014.080; Depry C, 2013, PFLUG ARCH EUR J PHY, V465, P373, DOI 10.1007/s00424-012-1175-y; Derkus B, 2016, BIOSENS BIOELECTRON, V79, P901, DOI 10.1016/j.bios.2016.01.033; Elbayoumi TA, 2006, EUR J NUCL MED MOL I, V33, P1196, DOI 10.1007/s00259-006-0139-x; Erdogan S, 2006, MOL PHARMACEUT, V3, P525, DOI 10.1021/mp060055t; Ereifej ES, 2013, J BIOMED MATER RES A, V101, P1743, DOI 10.1002/jbm.a.34480; Fernandes AR, 2014, INTEGR BIOL-UK, V6, P855, DOI 10.1039/c4ib00085d; Fink AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041434; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a; Gilbert J W, 1992, ASAIO J, V38, P82, DOI 10.1097/00002480-199204000-00003; Gofflot S, 2005, CLIN CHEM, V51, P1605, DOI 10.1373/clinchem.2005.050120; Golgi C., 1870, SOSTANZA CONNETTIVA; Gonzalez V, 2005, INFORME VIGILANCIA T; Graham AHD, 2011, SENSORS-BASEL, V11, P4943, DOI 10.3390/s110504943; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GRAZIADEI PPC, 1980, J NEUROCYTOL, V9, P145, DOI 10.1007/BF01205155; Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704; Grover A, 2014, AAPS PHARMSCITECH, V15, P1562, DOI 10.1208/s12249-014-0165-0; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; HAMM B, 1994, JMRI-J MAGN RESON IM, V4, P659, DOI 10.1002/jmri.1880040508; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hasan A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/307519; Hu L, 2015, BIOSENS BIOELECTRON, V66, P572, DOI 10.1016/j.bios.2014.12.019; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutten A, 2004, J BIOTECHNOL, V112, P47, DOI 10.1016/j.jbiotec.2004.04.019; Jenkins SI, 2015, NANOMED-NANOTECHNOL, V11, P77, DOI 10.1016/j.nano.2014.07.010; Serramia MJ, 2015, J CONTROL RELEASE, V200, P60, DOI 10.1016/j.jconrel.2014.12.042; Jun Y-w, 2007, BIOAPPLICATIONS NANO; Kabiri M, 2015, EXCLI J, V14, P851, DOI 10.17179/excli2015-282; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khun K, 2014, J NANOSCI NANOTECHNO, V14, P6646, DOI 10.1166/jnn.2014.9367; Kirsch J, 2013, CHEM SOC REV, V42, P8733, DOI 10.1039/c3cs60141b; Kobayashi T, 2014, BIOSENS BIOELECTRON, V53, P31, DOI 10.1016/j.bios.2013.09.033; Kogan MJ, 2006, NANO LETT, V6, P110, DOI 10.1021/nl0516862; Koss KM, 2016, ACTA BIOMATER, V35, P127, DOI 10.1016/j.actbio.2016.02.001; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kruss S, 2014, J AM CHEM SOC, V136, P713, DOI 10.1021/ja410433b; Kuo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022382; Kurtulus O, 2012, IEEE ENG MED BIO, P6568, DOI 10.1109/EMBC.2012.6347499; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lee P, 2012, INT J NANOMED, V7, P731, DOI 10.2147/IJN.S28783; Lee SM, 2015, J BIOMED MATER RES A, V103, P365, DOI 10.1002/jbm.a.35174; Lennarz S, 2015, ANGEW CHEM INT EDIT, V54, P5369, DOI 10.1002/anie.201409597; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Luka G, 2015, SENSORS-BASEL, V15, P30011, DOI 10.3390/s151229783; Ma SH, 2005, LAB CHIP, V5, P74, DOI 10.1039/b405713a; Mahmoudifard M, 2016, MAT SCI ENG C-MATER, V58, P586, DOI 10.1016/j.msec.2015.09.007; Malhotra B, 2003, ADV BIOSENSORS; Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013; Masaeli E, 2014, NANOMED-NANOTECHNOL, V10, P1559, DOI 10.1016/j.nano.2014.04.008; Massicotte G, 2016, IEEE T BIOMED CIRCUI; Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961; Meininger M, 2016, MAT SCI ENG C-MATER, V61, P351, DOI 10.1016/j.msec.2015.12.075; Milowska K, 2011, INT J BIOL MACROMOL, V48, P742, DOI 10.1016/j.ijbiomac.2011.02.021; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Miyazaki CM, 2016, MAT SCI ENG C-MATER, V58, P310, DOI 10.1016/j.msec.2015.08.042; Moraes ML, 2014, J NANOSCI NANOTECHNO, V14, P6638, DOI 10.1166/jnn.2014.9361; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P881, DOI 10.1109/TBME.2004.827465; Mundt AP, 2009, NEUROIMAGE, V46, P367, DOI 10.1016/j.neuroimage.2009.01.067; Muthmann JO, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00028; Nagarah JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00384; Nayak BB, 2012, APPL PHYS A-MATER, V106, P99, DOI 10.1007/s00339-011-6565-z; Nayak P, 2015, J NANOSCI NANOTECHNO, V15, P4855, DOI 10.1166/jnn.2015.9812; O'Brien KB, 2007, BIOSENS BIOELECTRON, V22, P2994, DOI 10.1016/j.bios.2006.12.020; Oku N, 2011, INT J PHARMACEUT, V403, P170, DOI 10.1016/j.ijpharm.2010.10.001; Oliveira L, 2015, SURFACE PLASMON RESO; Pan LB, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00032; Pancrazio JJ, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/732913; Pancrazio JJ, 2008, NANOMEDICINE-UK, V3, P823, DOI 10.2217/17435889.3.6.823; Pantic I, 2015, REV ADV MATER SCI, V40, P257; Papa S, 2013, ACS NANO, V7, P9881, DOI 10.1021/nn4036014; Park S, 2013, INT J BIOL SCI, V9, P702, DOI 10.7150/ijbs.6473; Parpura V, 2013, BBA-MOL CELL RES, V1833, P1625, DOI 10.1016/j.bbamcr.2012.11.023; Piliarik M, 2009, OPT EXPRESS, V17, P16505, DOI 10.1364/OE.17.016505; Pohanka M, 2008, J APPL BIOMED, V6, P57, DOI 10.32725/jab.2008.008; Polyak A, 2013, INT J PHARMACEUT, V449, P10, DOI 10.1016/j.ijpharm.2013.03.049; Poncin-Epaillard F, 2012, J BIOMAT SCI-POLYM E, V23, P1879, DOI [10.1163/156856211X598247, 10.1163/156856211x598247]; Provenzale J, 2010, CURRENT ISSUES NANOM, V6, P12; Qin MY, 2015, NANOSCALE; Ramirez N., 2005, CIENCIAS BIOL, V36; Raspa A, 2016, NANOSCALE, V8, P253, DOI 10.1039/c5nr03698d; Ravalli A, 2015, J NANOSCI NANOTECHNO, V15, P3307, DOI 10.1166/jnn.2015.10038; Regatos D., 2012, BIOSENSORES OPTICOS; Rekas A, 2009, MACROMOL BIOSCI, V9, P230, DOI 10.1002/mabi.200800242; Ren JQ, 2016, FASEB J, V30, P612, DOI 10.1096/fj.15-280677; RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874; Roychoudhury A, 2015, BIOSENS BIOELECTRON; Rudolf V., 1858, CELLULARPATHOLOGIE I; Sadana A., 2015, BIOMARKERS BIOSENSOR; Sadana A., 2002, ENG BIOSENSORS; Santos RM, 2015, BIOSENS BIOELECTRON, V69, P83, DOI 10.1016/j.bios.2015.02.003; Scacca C., 2009, NANOTECHNOLOGY ITS M; Schneider SW, 1999, P NATL ACAD SCI USA, V96, P12180, DOI 10.1073/pnas.96.21.12180; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sedaghati T, 2014, NEW BIOTECHNOL, V31, P203, DOI 10.1016/j.nbt.2014.01.002; Seeger C., 2014, REVEALING SECRETS SY; Shantilatha P, 2003, ADV IS BIOSENSORS; Shineman Diana W, 2009, BMC Neurol, V9 Suppl 1, pI1, DOI 10.1186/1471-2377-9-S1-I1; Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827; Silva GA, 2005, CURR NANOSCI, V1, P225, DOI 10.2174/157341305774642975; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Silva GA, 2010, ANN NY ACAD SCI, V1199, P221, DOI 10.1111/j.1749-6632.2009.05361.x; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Silva TR, 2016, ANALYST, V141, P216, DOI 10.1039/c5an01784j; Song QX, 2014, ACS NANO, V8, P2345, DOI 10.1021/nn4058215; Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/NNANO.2012.265, 10.1038/nnano.2012.265]; Srivatsan A, 2014, ADV CARCER RES; Steinmetz KL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S2; Stewart AJ, 2015, ANAL CHEM, V87, P11847, DOI 10.1021/acs.analchem.5b03345; Stoeckli ET, 2012, EUR J NEUROSCI, V35, P1811, DOI 10.1111/j.1460-9568.2012.08171.x; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Takado Y, 2015, NANOMED-NANOTECHNOL, V11, P239, DOI 10.1016/j.nano.2014.09.007; Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1081/AL-100103209; Thomson M., 2013, SENSOR TECHNOLOGY NE; Tiwari JN, 2016, ACS NANO, V10, P46, DOI 10.1021/acsnano.5b05690; Toft A, 2013, GLIA, V61, P513, DOI 10.1002/glia.22452; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Tropea D, 2010, J NEUROSCI, V30, P11086, DOI 10.1523/JNEUROSCI.1661-10.2010; Tunc AT, 2015, ARTIF CELL NANOMED B, P1; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Vidu R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00091; Wang C, 2013, BIOSENS BIOELECTRON, V43, P355, DOI 10.1016/j.bios.2012.12.027; Wang JJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2764463; Wang YM, 2015, BIOSENS BIOELECTRON, V66, P338, DOI 10.1016/j.bios.2014.11.025; Watanabe H, 2009, ELECTR COMMUN JPN, V92, P29, DOI 10.1002/ecj.10058; Weiss DG, 2011, NEUROMETHODS, V56, P467, DOI 10.1007/978-1-61779-077-5_24; Weng B, 2016, NANOSCALE, V8, P3416, DOI 10.1039/c5nr08631k; Williams L, 2007, NANOTECHNOLOGY DEMYS; Withers GS, 2006, J NEUROBIOL, V66, P1183, DOI 10.1002/neu.20298; Wu M, 2009, J RECEPT SIG TRANSD, V29, P202, DOI 10.1080/10799890903068474; Xue X, 2014, NANO LETT, V14, P5110, DOI 10.1021/nl501839q; Yasmin Z, 2015, BIOSENS BIOELECTRON, V64, P676, DOI 10.1016/j.bios.2014.09.078; Ye C, 2016, BIOSENS BIOELECTRON, V79, P34, DOI 10.1016/j.bios.2015.11.096; Yi GQ, 2014, TUMOR BIOL, V35, P2445, DOI 10.1007/s13277-013-1324-8; Zachek MK, 2008, J ELECTROANAL CHEM, V614, P113, DOI 10.1016/j.jelechem.2007.11.007; Zaman M, 2014, INT J NANOMED, V9, P899, DOI 10.2147/IJN.S54171; Zhang J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035101; Zhang L, 2014, J BIOMED NANOTECHNOL, V10, P1713, DOI 10.1166/jbn.2014.1896; Zhao F, 2015, J NANOSCI NANOTECHNO, V15, P7871, DOI 10.1166/jnn.2015.11220; Zhao Yuling, 2011, J Nanomed Nanotechnol, VS4; Zheng KY, 2015, NEURON, V88, P277, DOI 10.1016/j.neuron.2015.09.043; Ziemba KS, 2008, J NEUROSCI, V28, P340, DOI 10.1523/JNEUROSCI.3819-07.2008; Ziv-Polat O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/267808; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	192	3	3	3	24	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2017	23	28					4154	4169		10.2174/1381612823666170816115452	http://dx.doi.org/10.2174/1381612823666170816115452			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FL6PC	28814235				2022-09-04	WOS:000414366900010
J	Faccini-Martinez, AA; Botero-Garcia, CA; Hidalgo, M				Faccini-Martinez, Alvaro A.; Botero-Garcia, Carlos A.; Hidalgo, Marylin			CONTRIBUTIONS TO RICKETTSIOSES RESEARCH IN COLOMBIA (1917-1943), LUIS B. PATINO CAMARGO	REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO			English	Review						Rickettsia infections; Colombia; Rickettsia rickettsii; Rickettsia prowazekii; Rickettsia typhi	SP STRAIN COLOMBIANENSI; MOUNTAIN-SPOTTED-FEVER; BORNE RICKETTSIOSES; MOLECULAR-DETECTION; RURAL AREA; INFECTION; CALDAS; FELIS; TICKS; ANTIBODIES	Colombian physician Luis Benigno Patino Camargo was one of the pioneers in the study of rickettsioses in South America, demonstrating for the first time in Colombia the presence of Rickettsia rickettsii as the etiological agent of a highly deadly exanthematic febrile syndrome in the 1930s. However, Patino-Camargo performed other investigations from 1917-1943, which represent the first descriptions and scientific evidence of the presence of R. prowazekii and R. typhi in Colombia. Almost 60 years after the latest research conducted by Dr. Patino-Camargo, rickettsioses were again a matter of interest and research. In the last decade over 20 research studies have been published, showing new endemic areas for R. rickettsii, as well as the description of new rickettsial species in Colombia.	[Faccini-Martinez, Alvaro A.] SAI, Calle 50 13-62, Bogota, DC, Colombia; [Faccini-Martinez, Alvaro A.] Univ La Sabana, Fac Med, Bogota, Colombia; [Faccini-Martinez, Alvaro A.] Int Soc Chemotherapy, Working Grp Zoonoses, Aberdeen, Scotland; [Faccini-Martinez, Alvaro A.] Assoc Colombiana Infectol ACIN, Comite Zoonosis & Fiebres Hemorrag, Bogota, Colombia; [Botero-Garcia, Carlos A.] Univ Mil Nueva Granada, Fac Med, Bogota, Colombia; [Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Bogota, Colombia		Faccini-Martinez, AA (corresponding author), SAI, Calle 50 13-62, Bogota, DC, Colombia.	afaccini@gmail.com	Hidalgo, Marylin/AAF-5736-2019	Faccini-Martinez, Alvaro A./0000-0002-1127-0132; Hidalgo, Marylin/0000-0001-8960-0616				Acosta J., 2006, Informe Quincenal - Epidemiologico Nacional, V11, P177; Arroyave E, 2013, BIOMEDICA, V33, P99, DOI 10.7705/biomedica.v33i0.734; Barrera Samia, 2015, Infect., V19, P75, DOI 10.1016/j.infect.2015.02.001; Quintero JC, 2013, BIOMEDICA, V33, P38, DOI 10.7705/biomedica.v33i0.735; Faccini-Martinez AA, 2015, EMERG INFECT DIS, V21, P537, DOI 10.3201/eid2013.140721; Faccini-Martinez AA, 2014, INT J INFECT DIS, V28, P126, DOI 10.1016/j.ijid.2014.05.025; Faccini-Martinez AA, 2013, BIOMEDICA, V33, P9, DOI 10.7705/biomedica.v33i0.723; Hidalgo M, 2008, AM J TROP MED HYG, V78, P321, DOI 10.4269/ajtmh.2008.78.321; Hidalgo M, 2007, AM J TROP MED HYG, V77, P378, DOI 10.4269/ajtmh.2007.77.378; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Hidalgo M, 2013, BIOMEDICA, V33, P161, DOI 10.7705/biomedica.v33i0.1466; Hidalgo M, 2013, VECTOR-BORNE ZOONOT, V13, P289, DOI 10.1089/vbz.2012.1173; Hidalgo M, 2011, MEM I OSWALDO CRUZ, V106, P117, DOI 10.1590/S0074-02762011000100019; Hidalgo M, 2009, AM J TROP MED HYG, V80, P1029, DOI 10.4269/ajtmh.2009.80.1029; Lombana-Barreneche JM, 1901, REV MED-BOGOTA, V256, P127; Londono AF, 2014, TICKS TICK-BORNE DIS, V5, P672, DOI 10.1016/j.ttbdis.2014.04.018; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Miranda AM, 2002, INF QUINC EPIDEMIOL, V7, P71; Miranda J, 2014, TICKS TICK-BORNE DIS, V5, P208, DOI 10.1016/j.ttbdis.2013.10.008; Miranda J, 2012, J MED ENTOMOL, V49, P960, DOI 10.1603/ME11195; Miranda J, 2011, BIOMEDICA, V31, P216, DOI 10.1590/S0120-41572011000200009; Pacheco O., 2008, INF QUINC EPIDEMIOL, V13, P145; Padmanabha H, 2009, VECTOR-BORNE ZOONOT, V9, P483, DOI 10.1089/vbz.2008.0092; Patino JF, 2011, BIOMEDICA, V31, P13; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; PATINO-CAMARGO L., 1943, Rev. Facul. de Mea., V11, P503; Patino-Camargo L., 1942, REV FAC MED-CARACAS, V11, P13, DOI [10.15446/revfacmed, DOI 10.15446/REVFACMED]; Patino-Camargo L., 1941, REV FAC MED-CARACAS, V10, P425, DOI [10.15446/revfacmed, DOI 10.15446/REVFACMED]; Patino-Camargo L, 1939, SCIENCE, V89, P681; Patino-Camargo L., 1922, TIFO NEGRO EXANTEMAT; PATINO-CAMARGO Luis, 1941, Boletin de la Oficina Sanitaria Panamericana, V20, P1112; Patino-Nino JA, 2015, INFECTIO; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; Ramirez N, 2007, INVESTIG ANDINA, V9, P5; Ramirez-Hernandez A, 2013, AM J TROP MED HYG, V89, P453, DOI 10.4269/ajtmh.12-0698; Rios R, 2008, INFECTIO, V12, P318; Szabo MPJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00027	37	3	3	0	2	INST MEDICINA TROPICAL SAO PAULO	SAO PAULO	AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000, BRAZIL	0036-4665	1678-9946		REV INST MED TROP SP	Rev. Inst. Med. Trop. Sao Paulo		2016	58								33	10.1590/S1678-9946201658033	http://dx.doi.org/10.1590/S1678-9946201658033			8	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	DS3JX	27074327	Green Published, Green Submitted, gold			2022-09-04	WOS:000380680200021
J	Vesga-Jimenez, DJ; Martin-Jimenez, CA; Rodriguez, AG; Aristizabal-Pachon, AF; Pinzon, A; Barreto, GE; Ramirez, D; Gonzalez, J				Vesga-Jimenez, Diego Julian; Martin-Jimenez, Cynthia A.; Grismaldo Rodriguez, Adriana; Felipe Aristizabal-Pachon, Andres; Pinzon, Andres; Barreto, George E.; Ramirez, David; Gonzalez, Janneth			Tibolone Pre-Treatment Ameliorates the Dysregulation of Protein Translation and Transport Generated by Palmitic Acid-Induced Lipotoxicity in Human Astrocytes: A Label-Free MS-Based Proteomics and Network Analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mass spectrometry; human astrocytes; tibolone; palmitic acid; obesity; neuroprotection; proteomics; network analysis	INDUCED UP-REGULATION; GLUTAMATE TRANSPORTERS; ENDOPLASMIC-RETICULUM; ELONGATION ARREST; NUCLEAR IMPORT; FATTY-ACIDS; RECEPTOR; MECHANISM; NEURONS; BETA	Excessive accumulation and release of fatty acids (FAs) in adipose and non-adipose tissue are characteristic of obesity and are associated with the leading causes of death worldwide. Chronic exposure to high concentrations of FAs such as palmitic acid (pal) is a risk factor for developing different neurodegenerative diseases (NDs) through several mechanisms. In the brain, astrocytic dysregulation plays an essential role in detrimental processes like metabolic inflammatory state, oxidative stress, endoplasmic reticulum stress, and autophagy impairment. Evidence shows that tibolone, a synthetic steroid, induces neuroprotective effects, but its molecular mechanisms upon exposure to pal remain largely unknown. Due to the capacity of identifying changes in the whole data-set of proteins and their interaction allowing a deeper understanding, we used a proteomic approach on normal human astrocytes under supraphysiological levels of pal as a model to induce cytotoxicity, finding changes of expression in proteins related to translation, transport, autophagy, and apoptosis. Additionally, tibolone pre-treatment showed protective effects by restoring those same pal-altered processes and increasing the expression of proteins from cell survival processes. Interestingly, ARF3 and IPO7 were identified as relevant proteins, presenting a high weight in the protein-protein interaction network and significant differences in expression levels. These proteins are related to transport and translation processes, and their expression was restored by tibolone. This work suggests that the damage caused by pal in astrocytes simultaneously involves different mechanisms that the tibolone can partially revert, making tibolone interesting for further research to understand how to modulate these damages.	[Vesga-Jimenez, Diego Julian; Martin-Jimenez, Cynthia A.] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30329 USA; [Grismaldo Rodriguez, Adriana; Felipe Aristizabal-Pachon, Andres; Gonzalez, Janneth] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia; [Pinzon, Andres] Univ Nacl Colombia, Lab Bioinformat & Biol Sistemas, Bogota 111321, Colombia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick V94 T9PX, Ireland; [Ramirez, David] Univ Concepcion, Fac Ciencias Biol, Dept Farmacol, Concepcion 4030000, Chile		Gonzalez, J (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia.	vesgad@javeriana.edu.co; cmart51@emory.edu; mgrismaldo@javeriana.edu.co; andres_aristizabal@javeriana.edu.co; ampinzonv@unal.edu.co; george.barreto@ul.ie; dramirers@udec.cl; janneth.gonzalez@javeriana.edu.co	Ramirez, David/Q-9537-2018; Aristizabal-Pachon, Andres Felipe/J-3046-2015	Ramirez, David/0000-0003-0002-1189; Aristizabal-Pachon, Andres Felipe/0000-0003-3004-4867; Pinzon, Andres/0000-0002-4133-810X; Gonzalez, Janneth/0000-0003-2009-3374	MINCIENCIAS [7425, 8845, 20302]; Pontificia Universidad Javeriana	MINCIENCIAS; Pontificia Universidad Javeriana	The experiments and analysis of this study were funded by MINCIENCIAS grants 7425, 8845, and 20302 by Pontificia Universidad Javeriana.	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Anderson G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215500; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Lopez-Rodriguez AB, 2015, ESTROGEN EFFECTS ON TRAUMATIC BRAIN INJURY: MECHANISMS OF NEUROPROTECTION AND REPAIR, P73, DOI 10.1016/B978-0-12-801479-0.00006-1; Bogie JFJ, 2020, ADV DRUG DELIVER REV, V159, P198, DOI 10.1016/j.addr.2020.01.004; Boye E, 2020, CURR GENET, V66, P293, DOI 10.1007/s00294-019-01026-1; Braverman N, 2009, ENCY NEUROSCIENCE, P579; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Cakir I, 2019, TRENDS ENDOCRIN MET, V30, P163, DOI 10.1016/j.tem.2019.01.002; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; De Aguilar JLG, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00284; De Vos KJ, 2017, NEUROBIOL DIS, V105, P283, DOI 10.1016/j.nbd.2017.02.004; Deshpande P, 2020, FASEB J, V34, P14217, DOI 10.1096/fj.202001046R; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dietrich AK, 2015, MOL CELL ENDOCRINOL, V406, P19, DOI 10.1016/j.mce.2015.02.013; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Dozio V, 2022, J NEUROSCI RES, V100, P220, DOI 10.1002/jnr.24731; Dozio V, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1371-6; Dupree EJ, 2020, PROTEOMES, V8, DOI 10.3390/proteomes8030014; Elo LL, 2008, IEEE ACM T COMPUT BI, V5, P423, DOI 10.1109/TCBB.2007.1078; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Evans HT, 2019, EMBO J, V38, DOI 10.15252/embj.2018101174; Flores-Leon M, 2021, MOL NEUROBIOL, DOI 10.1007/s12035-021-02434-6; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Gartner W, 2003, CELL MOTIL CYTOSKEL, V56, P79, DOI 10.1002/cm.10136; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; Gonzalez-Giraldo Y, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12768; Gonzalez-Giraldo Y, 2019, MOL CELL ENDOCRINOL, V486, P65, DOI 10.1016/j.mce.2019.02.017; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Grotwinkel JT, 2014, SCIENCE, V344, P101, DOI 10.1126/science.1249094; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Herland A, 2020, ADV BIOSYST, V4, DOI 10.1002/adbi.201900230; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hickson-Bick DLM, 2002, AM J PHYSIOL-HEART C, V282, pH656, DOI 10.1152/ajpheart.00726.2001; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Kar AN, 2013, J NEUROSCI, V33, P7165, DOI 10.1523/JNEUROSCI.2040-12.2013; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Korbecki J, 2019, INFLAMM RES, V68, P915, DOI 10.1007/s00011-019-01273-5; Laakkonen EK, 2017, AGING CELL, V16, P1276, DOI 10.1111/acel.12661; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HG, 2022, NAT REV DRUG DISCOV, V21, P339, DOI 10.1038/s41573-022-00390-x; Lee JH, 2005, BIOTECHNOL LETT, V27, P1011, DOI 10.1007/s10529-005-7869-x; Liddelow SA, 2019, NAT NEUROSCI, V22, P512, DOI 10.1038/s41593-019-0367-6; LIN A, 1983, J BIOL CHEM, V258, P664; Liu AW, 2011, CLIN CANCER RES, V17, P710, DOI 10.1158/1078-0432.CCR-10-0331; Liu L, 2013, EXP NEUROL, V248, P482, DOI 10.1016/j.expneurol.2013.08.004; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Lushchak OV, 2014, REDOX REP, V19, P8, DOI 10.1179/1351000213Y.0000000073; Martin-Jimenez C, 2020, NEUROTOX RES, V38, P585, DOI 10.1007/s12640-020-00247-4; Mary C, 2010, RNA, V16, P969, DOI 10.1261/rna.2040410; McArdle AJ, 2021, ARCH DIS CHILDHOOD-E, V106, P178, DOI 10.1136/archdischild-2019-317434; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Melo HM, 2020, CELL REP, V30, P2180, DOI 10.1016/j.celrep.2020.01.072; Melo HM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00265; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Moon SL, 2018, TRENDS MOL MED, V24, P575, DOI 10.1016/j.molmed.2018.04.001; Obinata H, 2019, INT IMMUNOL, V31, P617, DOI 10.1093/intimm/dxz037; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ortiz-Rodriguez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072479; Ortiz-Rodriguez A, 2019, MOL NEUROBIOL, V56, P1665, DOI 10.1007/s12035-018-1183-9; Del Rio JP, 2020, TRENDS ENDOCRIN MET, V31, P742, DOI 10.1016/j.tem.2020.04.007; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Quijano C, 2016, REDOX BIOL, V8, P28, DOI 10.1016/j.redox.2015.11.010; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Rocchio F, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1264-8; Rocha-Perugini V, 2017, ADV EXP MED BIOL, V1006, P271, DOI 10.1007/978-4-431-56550-5_15; Rodriguez Maria, 2022, Nutr Neurosci, V25, P1509, DOI 10.1080/1028415X.2021.1872990; Schonfeld P, 2021, NEUROCHEM INT, V148, DOI 10.1016/j.neuint.2021.105050; Shamim A., 2018, CLIN NUTR EXP, V20, P1, DOI [10.1016/j.yclnex.2018.05.001, DOI 10.1016/J.YCLNEX.2018.05.001]; Shang Y, 2014, BIOCHEM BIOPH RES CO, V446, P387, DOI 10.1016/j.bbrc.2014.02.124; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Staples CJ, 2014, J CELL SCI, V127, P2910, DOI 10.1242/jcs.147785; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Storey J, 2020, QVALUE Q VALUE ESTIM; Suomi T, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005562; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Valikangas T, 2018, BRIEF BIOINFORM, V19, P1344, DOI 10.1093/bib/bbx054; van Horssen J, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.050; Vesga-Jimenez DJ, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23052577; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; WHO, OB OB OV; Wong KL, 2014, PHARMACOL REP, V66, P1106, DOI 10.1016/j.pharep.2014.07.009; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yang W, 2019, INT J ONCOL, V55, P439, DOI 10.3892/ijo.2019.4833; Yu J, 2014, DEV CELL, V29, P277, DOI 10.1016/j.devcel.2014.03.016; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	110	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2022	23	12							6454	10.3390/ijms23126454	http://dx.doi.org/10.3390/ijms23126454			23	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	2N1CS	35742897	Green Published, gold			2022-09-04	WOS:000818126900001
J	Arango-Londono, D; Sanchez, VF; Castillo, M; Castro-Aristizabal, G				Arango-Londono, David; Farkas Sanchez, Valentina; Castillo, Maribel; Castro-Aristizabal, Geovanny			GEOREFERENCING EDUCATIONAL QUALITY IN CALI, COLOMBIA IN 2018, WITH A FOCUS ON ACADEMIC AGGLOMERATION AND SEGREGATION	CUADERNOS DE ECONOMIA			English	Article						Analysis of education; education and inequality; panel data models; spatio temporal models		Our findings confirm the existence of educational quality agglomeration in Cali (Moran's Index = 0.311). High educational quality is concentrated in schools in the south of the city (commune 22), while low educational quality is found in schools located in the east (communes 13, 14 and 15). Our study also confirms the importance of the determinants for school performance identified in the previous literature. The main contribution of this study is the finding that crime negatively affects educational quality. When the number of homicides in the neighbourhood in which a school is located increases by one percentage point, the quality of education decreases, on average, by 0.63 points.	[Arango-Londono, David] Pontificia Univ Javeriana, Dept Nat Sci & Math, Cali, Colombia; [Farkas Sanchez, Valentina] Univ Valle, Cali, Colombia; [Castillo, Maribel] CINDE, Social Sci Children & Youth, Hamilton, ON, Canada; [Castillo, Maribel] Univ Manizales, Manizales, Colombia; [Castillo, Maribel] Pontificia Univ Javeriana, Dept Econ, Cali, Colombia; [Castillo, Maribel] Pontificia Univ Javeriana, Res Grp Econ Management & Hlth ECGESA, Cali, Colombia; [Castro-Aristizabal, Geovanny] Univ Zaragoza, Econ, Zaragoza, Spain; [Castro-Aristizabal, Geovanny] Univ Autonoma Bucaramanga, Bucaramanga, Colombia; [Castro-Aristizabal, Geovanny] Univ Autonoma Bucaramanga, Sectoral Dynam Res Grp, Bucaramanga, Colombia		Arango-Londono, D (corresponding author), Pontificia Univ Javeriana, Dept Nat Sci & Math, Cali, Colombia.	david.arango@javerianacali.edu.co; valentina.farkas@correouni-valle.edu.co; mabelcas@jave-rianacali.edu.co; gcastro793@unab.edu.co						Aguerre T. F., 2002, REV MEX INVESTIG EDU, V7, P501; Ayala J., 2011, EC REGION, V5, P43; Carcamo C., 2012, EC REGION, V6, P133; Aristizabal GC, 2017, REV EDUC-MADRID, P33, DOI 10.4438/1988-592X-RE-2017-376-343; Castro G., 2018, REV CEPAL CHILE, V124, P35; Correa J., 2011, REV SOC ECON, V6, P81; Direccion de Estratificacion de Bogota y Departamento de Estadistica Uni- versidad Nacional, 2016, ESTR BOG IMP SOC ALT; Duarte J., 2012, BANCO INTERAMERICANO; Fujita M., 1999, SPATIAL EC CITIES RE; Instituto Colombiano para la Evaluacion de la Educacion (ICFES), 2016, SABER BREV, V5; Iregui A. M., 2007, REV EC ROSARIO, V10, P21; Murillo FJ, 2017, MAGIS, V9, P11, DOI 10.11144/Javeriana.m9-19.emse; Jola A. F., 2011, REV COYUNTURA ECONOM, V41, P25; Kaztman R., 2011, INFANCIA AM LATINA P; Kaztman R., 2010, COHESION SOCIAL AM L, P39; Lajaunie C., 1991, LOCAL RISK ESTIMATIO, V1; Ministerio de Educacion Nacional Colombia, 2006, AL TABLERO; OCDE, 2016, ED COL REV NAT POL E; Rubia F. A., 2013, FORUM ARAGON, V10, P47; Rubiano M., 2017, SEGREGACION SOCIOESP; Sabatini F., 2006, SEGREGACION SOCIAL E; Sanchez A, 2011, ETNIA DESEMPENO ACAD, V156; Vazquez E., 2018, SEGREGACION SOCIOECO; Velez J. E, 2009, REV EC ADMINISTRACIO, V6, P59; Vivas H., 2007, EDUCACION BACKGROUND	25	0	0	0	0	UNIV NAC COLOMBIA, FAC CIENCIAS ECONOMICAS, CUADERNOS ECONOMIA	BOGOTA	CARRERA 30 N 45-03., EDIFICIO 310, OFICINA 115, BOGOTA, 055051, COLOMBIA	0121-4772	2248-4337		CUAD ECON	Cuad. Econ.		2022	41	86					109	128		10.15446/cuad.econ.v41n86.85723	http://dx.doi.org/10.15446/cuad.econ.v41n86.85723			20	Economics	Emerging Sources Citation Index (ESCI)	Business & Economics	3I4TY					2022-09-04	WOS:000832712500004
J	Lopez-Lopez, W; Ossa, JC; Cudina, JN; Bustamante, MCA; Torres, M; Acevedo-Triana, C; Salas, G				Lopez-Lopez, Wilson; Cesar Ossa, Julio; Nikola Cudina, Jean; Aguilar Bustamante, Maria Constanza; Torres, Michelle; Acevedo-Triana, Cesar; Salas, Gonzalo			Analysis of production and collaboration networks in doctoral programs in psychology in Colombia	ACTA COLOMBIANA DE PSICOLOGIA			Spanish	Article						academic production; doctoral training programs; Colombia	IBERO-AMERICAN PSYCHOLOGY; SCIENTIFIC PRODUCTION; IMPACT PAPERS; JOURNALS; PUBLICATION; CHALLENGES; VISIBILITY; HISTORY; INTERNATIONALIZATION; BIBLIOMETRICS	The objective of doctoral training is the generation and dissemination of new knowledge; however, it is not clear how doctoral programs in Colombia relate to this type of production. Based on this, this study presents the general panorama of academic production across Colombian higher education institutions that offer doctoral training programs in psychology. The academic production was obtained from the Scopus database in a sample of 13 universities. After this search, 1345 documents were found with which an analysis was made regarding productivity indicators and the collaboration networks within the discipline in the country were identified. Subsequently, this information was contrasted with the national information registered in the Latin American and Caribbean Curriculum Vitae system (CvLAC) of 193 professors associated with the universities offering doctoral programs. As a result, when comparing national and international academic production, a greater correlation is found between the supervision of graduate theses and publication in national journals. In this sense, it is found that the impact of doctoral training on the generation of new knowledge is relative and has a limited scope, being mainly national journals the means of dissemination of this knowledge. It is recommended to evaluate the impact of products associated with postgraduate training and international visibility, with emphasis on indexed journals in international databases.	[Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Cra 5 39-00,Piso 2,Edificio Manuel Briceno, Bogota, Colombia; [Cesar Ossa, Julio] Fdn Univ Popayan, Popayan, Colombia; [Nikola Cudina, Jean] Fdn Univ Lumen Gentium, Cali, Colombia; [Aguilar Bustamante, Maria Constanza] Univ Catolica Colombia, Bogota, Colombia; [Torres, Michelle; Acevedo-Triana, Cesar] Univ Pedag & Tecnol Colombia, Tunja, Boyaca, Colombia; [Salas, Gonzalo] Univ Catolica Maule, Talca, Chile		Lopez-Lopez, W (corresponding author), Pontificia Univ Javeriana, Cra 5 39-00,Piso 2,Edificio Manuel Briceno, Bogota, Colombia.	lopezw@javeriana.edu.co	Ossa, Julio Cesar/ABT-8122-2022	Ossa, Julio Cesar/0000-0002-3079-3318; Salas, Gonzalo/0000-0003-0707-8188; Lopez-Lopez, Wilson/0000-0002-2964-0402; Acevedo-Triana, Cesar/0000-0002-1296-9957; AGUILAR-BUSTAMANTE, MARIA CONSTANZA/0000-0003-2990-9667; Cudina, Jean Nikola/0000-0003-4004-7615				Abdill RJ, 2020, ELIFE, V9, DOI 10.7554/eLife.58496; Abramo G, 2011, J INFORMETR, V5, P659, DOI 10.1016/j.joi.2011.06.004; Acevedo-Triana C, 2018, REV LAT AM PSICOL, V50, P145, DOI 10.14349/rlp.2018.v50.n3.2; Aguado-Lopez E., 2017, REV INTERAM PSICOL, V51, P268; Aguado-Lopez E, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-2.upci; Aguado-Lopez E, 2009, CONVERGENCIA, V16, P225; Aguilar Bustamante M. C., 2018, DIVERSITAS PERSP PSI, V14, P11; Aguilar-Bustamante María Constanza, 2018, Divers.: Perspect. Psicol., V14, P163, DOI 10.15332/s1794-9998.2018.0001.12; Alperin J. P., 2015, THE WINNOWER, DOI [10.15200/winn.143982.27959, DOI 10.15200/WINN.143982.27959]; Alperin Juan Pablo, 2017, Rev. Interam. Bibliot, V40, P231, DOI 10.17533/udea.rib.v40n3a04; Alperin JP, 2015, ASLIB J INFORM MANAG, V67, P289, DOI 10.1108/AJIM-12-2014-0176; Alperin JP, 2014, NATURE, V511, P155, DOI 10.1038/511155c; Ana J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001315; Orozco LA, 2013, COLCIENCIAS CUARENTA ANOS: ENTRE LA LEGITIMIDAD, LA NORMATIVIDAD Y LA PRACTICA, P635; Ardila R., 2019, HIST PSICOLOGIA COLO, V2; Armayones M, 2015, PAPEL PSICOL, V36, P153; Avila-Toscano J. H., 2020, AV PSICOL LATINOAM, V38, P1, DOI [10.12804/revistas.urosario.edu.co/apl/a.8133, DOI 10.12804/REVISTAS.UROSARIO.EDU.CO/APL/A.8133]; Avila-Toscano J. H., 2019, REV GEN INFORMA CION, V29, P209; Ayodele FO, 2019, SCI ENG ETHICS, V25, P357, DOI 10.1007/s11948-017-9941-z; Bajwa NU, 2019, SCIENTOMETRICS, V120, P1147, DOI 10.1007/s11192-019-03180-2; Banco Mundial, 2021, US; Chacon JWB, 2013, INVESTIG BIBLIOTECOL, V27, P83; Bautista-Puig N, 2020, SCIENTOMETRICS, V124, P2551, DOI 10.1007/s11192-020-03546-x; Bornmann L., 2021, MAPPING IMPACT PAPER; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; Brown P., 2001, HIGH SKILLS GLOBALIZ; Bucheli V, 2012, SCIENTOMETRICS, V91, P369, DOI 10.1007/s11192-012-0627-7; Bustos-Gonzalez A, 2019, PROF INFORM, V28, DOI 10.3145/epi.2019.jul.22; CALDERÓN-PRADA SERGIO, 2012, Rev. colomb. psicol., V21, P125; Carlsson B, 2006, RES POLICY, V35, P56, DOI 10.1016/j.respol.2005.08.003; Chavarro D., 2010, INVESTIGACION UNIAND, P107; Confalonieri Linda, 2012, ISRN Neurol, V2012, P613595, DOI 10.5402/2012/613595; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097.abs; Cudina JN., 2017, REV INTERAM PSICOL, V51, P282; De-Moya-Anegon F., 2011, PRODUCCION CIENTIFIC; Di Bitetti MS, 2017, AMBIO, V46, P121, DOI 10.1007/s13280-016-0820-7; Fernandez MT, 1998, INTERCIENCIA, V23, P328; Forero DA, 2020, INT J NEUROSCI, V130, P398, DOI 10.1080/00207454.2019.1692837; Franco-Suarez O, 2017, PSIENCIA-REV LATINOA, V9, DOI 10.5872/psiencia/9.4.22; Frenken K., 2002, ECON SYST RES, V14, P345; Gallegos M, 2020, INTERDISCIPLINARIA, V37, P95, DOI 10.16888/interd.2020.37.2.6; Gallegos Miguel, 2014, Psicoperspectivas, V13, P106, DOI 10.5027/psicoperspectivas-Vol13-Issue3-fulltext-377; Garcia A, 2017, DIVERSITAS-PERSP PSI, V13, P113, DOI [10.15332/s1794-9998.2017.0001.09, 10.15332/s1794-9998.2017.0001.9]; Garcia Agnaldo, 2015, Psykhe, V24, P1, DOI 10.7764/psykhe.24.2.765; Garcia A, 2014, TER PSICOL, V32, P165; GARFIELD E, 1992, CURR CONTENTS, V41, P5; Giraldo B., 2000, SUMA PSICOL, V7, P275; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Godin B, 2000, RES POLICY, V29, P273, DOI 10.1016/S0048-7333(99)00065-7; Gómez Campo Víctor Manuel, 2009, rev.estud.soc., P106; GÓMEZ MORALES YURI JACK, 2012, Rev. colomb. psicol., V21, P97; Gómez-Morales Yuri Jack, 2017, Rev. colomb. antropol., V53, P15; Sala FG, 2017, SCIENTOMETRICS, V112, P1069, DOI 10.1007/s11192-017-2372-4; Gonzalez-Zabala M. P., 2017, REV VIRTUAL UNIV CAT, V38, P23; Graddy-Reed A, 2021, RES POLICY, V50, DOI 10.1016/j.respol.2021.104224; Guerrero J, 2009, PRODUCCION CIENTIFIC; Gutierrez G., 2018, PSYCHOL LATIN AM CUR, P7, DOI [10.1007/978-3-319-93569-0_2, DOI 10.1007/978-3-319-93569-0_2]; Harzing AW, 2008, EUR J INT MANAG, V2, P115, DOI 10.1504/EJIM.2008.017763; Hayes N, 1996, EUR PSYCHOL, V1, P130, DOI 10.1027/1016-9040.1.2.130; Avila-Toscano JH, 2014, AV PSICOL LATINOAM, V32, P167, DOI 10.12804/apl32.1.2014.12; Horta H, 2018, STUD HIGH EDUC, V43, P542, DOI 10.1080/03075079.2016.1185406; Jaraba-Barrios B, 2011, AV PSICOL LATINOAM, V29, P354; Jonkers K, 2008, SCIENTOMETRICS, V77, P309, DOI 10.1007/s11192-007-1971-x; Kamler B, 2008, STUD HIGH EDUC, V33, P283, DOI 10.1080/03075070802049236; Klappenbach H, 2015, UNIV PSYCHOL, V14, P937, DOI 10.11144/Javeriana.upsy14-3.fupa; Krabel S, 2012, J TECHNOL TRANSFER, V37, P192, DOI 10.1007/s10961-010-9182-7; Krampen G, 2008, SCIENTOMETRICS, V76, P3, DOI 10.1007/s11192-007-1900-z; Lafont P, 2014, PROCD SOC BEHV, V116, P570, DOI 10.1016/j.sbspro.2014.01.259; Liberatore G., 2008, REV INTERAM PSICOL, V42, P507; Lopez WL, 2021, PAPEL PSICOL, V42, P67, DOI 10.23923/pap.psicol2021.2951; Lopez WL, 2019, UNIV PSYCHOL, V18, DOI 10.11144/Javeriana.upsy18-1.ccpp; López López Wilson, 2018, Univ. Psychol., V17, P1; LÓPEZ LÓPEZ WILSON, 2010, Act.Colom.Psicol., V13, P35; Lopez-Lopez W., 2018, TEACHING PSYCHOL WOR, V4, P53; Lopez-Lopez W, 2020, UNIV PSYCHOL, V19, DOI 10.11144/Javeriana.upsy19.pchi; Lopez-Lopez W, 2019, UNIV PSYCHOL, V18, DOI 10.11144/Javeriana.upsy18-4.ecal; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106; Rivera-Garzon DM, 2008, UNIV PSYCHOL, V7, P917; Alzate-Medina GM, 2008, UNIV PSYCHOL, V7, P425; Benavente JM, 2012, RES POLICY, V41, P1461, DOI 10.1016/j.respol.2012.04.007; Miguel S, 2012, INFORM RES, V17; Minciencias, 2017, PROGR COL CIENT AP D; Minciencias, 2021, CONV FOND CIENC TECN; Minciencias, 2021, OBJ PROGR FORM ALT N; Ministerio de Educacion, 2019, SIST AS CAL ED SUP; Cudina JN, 2016, INFORM SOC-ESTUD, V26, P137; Ossa J. C., 2016, REV GUI LLERMO OCKHA, V14, P7, DOI [10.21500/22563202.2720, DOI 10.21500/22563202.2720]; Otte E, 2002, J INF SCI, V28, P441, DOI 10.1177/016555102762202123; Packalen M, 2020, P NATL ACAD SCI USA, V117, P12011, DOI 10.1073/pnas.1910160117; Pena-Correal T., 1993, HIST SOCIAL CIENCIA, P95; Piwowar H, 2018, PEERJ, V6, DOI 10.7717/peerj.4375; Polanco F., 2017, REV INTERAM PSICOL, V51, P297, DOI [10.30849/rip/ijp.v51i3.910, DOI 10.30849/RIP/IJP.V51I3.910]; Polanco-Carrasco R, 2017, TER PSICOL, V35, P81; PUCHE-NAVARRO REBECA, 2012, Rev. colomb. psicol., V21, P79; Ravelo-Contreras EL, 2020, ACTA COLOMB PSICOL, V23, P188, DOI [10.14718/ACP.2020.23.2.8, 10.14718/acp.2020.23.2.8]; revistas.usantotomas, IND PHP DIV ART VIEW; Robayo-Castro B, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-5.icpa; Romero-Torres M, 2013, REV ESP DOC CIENT, V36, DOI 10.3989/redc.2013.1.876; Russell JM, 2007, REV ESP DOC CIENT, V30, P180, DOI DOI 10.3989/redc.2007.v30.i2.378; Salas G, 2019, REV LAT AM PSICOL, V51, P123, DOI 10.14349/rlp.2019.v51.n2.7; Salazar-Acosta M., 2013, INFORM PRODUCCION CI, V1; Garcia-Martinez AT, 2012, UNIV PSYCHOL, V11, P699; Torka M, 2018, MINERVA, V56, P59, DOI 10.1007/s11024-018-9342-8; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Vasconcelos S, 2009, EMBO REP, V10, P677, DOI 10.1038/embor.2009.134; Vasconcelos SMR, 2008, EMBO REP, V9, P700, DOI 10.1038/embor.2008.143; Velez-Cuartas G, 2014, REV ESP DOC CIENT, V37, DOI 10.3989/redc.2014.3.1133; Vera-Villarroel P, 2011, REV LAT AM PSICOL, V43, P95; Vessuri H, 2014, REV ESTUD SOC, P167, DOI 10.7440/res50.2014.16; WHITE MJ, 1977, AM PSYCHOL, V32, P301, DOI 10.1037/0003-066X.32.5.301	111	0	0	3	3	UNIV CATOLICA COLOMBIA, FAC DISENO	BOGOTA D C	CARRERA 13 NO 47-49, BOGOTA D C, 00000, COLOMBIA	0123-9155	1909-9711		ACTA COLOMB PSICOL	Acta Colomb. Psicol.	JAN-JUN	2022	25	1					151	182		10.14718/ACP.2022.25.1.11	http://dx.doi.org/10.14718/ACP.2022.25.1.11			32	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	1P7KG		Green Submitted, gold			2022-09-04	WOS:000802183200010
J	Parra-Murillo, M; Lowery, CM; Gomez, LF; Mora-Plazas, M; Taillie, LS; Carpentier, FDR				Parra-Murillo, Maria; Lowery, Caitlin M.; Gomez, Luis F.; Mora-Plazas, Mercedes; Taillie, Lindsey Smith; Dillman Carpentier, Francesca R.			Claims on Ready-to-Eat Cereals: Are Those With Claims Healthier?	FRONTIERS IN NUTRITION			English	Article						marketing claims; breakfast cereal; claims; cereal bars; ready-to-eat food; marketing and advertising; critical nutrient content	NEW-ZEALAND; BREAKFAST CEREALS; NUTRITIONAL QUALITY; CHILDREN; OBESITY; CONSUMPTION; PURCHASES; PRODUCTS; BURDEN; LABELS	Background: The use of advertising content strategies that suggest consuming a product will confer nutrient- and health-related benefits influences household food purchasing decisions, which increases consumption of energy-dense, nutrient-poor products. We examined the presence of marketing claims regarding nutrient content, health and nature in ready-to-eat (RTE) cereal packages in relation to the products' nutritional quality.Methods: A cross-sectional content analysis was conducted on 178 RTE cereal packages available in the six largest supermarket chains in four Colombian cities from August to November 2018. The nutritional quality of products was assessed through the nutrient profile model established by the Chilean Law of Food Labeling and Advertising law.Results: All products sampled exceeded the regulation threshold for at least one nutrient of concern (e.g., high-in calories and/or sugar). The majority (66.3%) of packages had claims related to nature, 57.3% had nutrient-content claims, and 15.7% had health benefit or risk avoidance claims. Most products with nature, nutrient-content, and health claims were high in energy (99.2, 98.0, and 92.9%, respectively) and sugar (88.1, 87.3, and 92.9%, respectively).Conclusion: RTE cereal products offered in major Colombian supermarket chains are heavily marketed using nutrition- and nature-related claims. Nearly all products with claims are high in energy and sugar, despite the messages conveyed by the claims to consumers. Results support the implementation of mandatory regulations restricting claims on food and beverage products high in nutrients of concern.	[Parra-Murillo, Maria; Gomez, Luis F.] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Lowery, Caitlin M.; Taillie, Lindsey Smith] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Mora-Plazas, Mercedes] Univ Nacl Colombia, Fac Med, Dept Nutr Humana, Bogota, Colombia; [Taillie, Lindsey Smith] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Dillman Carpentier, Francesca R.] Univ North Carolina Chapel Hill, Hussman Sch Journalism & Media, Chapel Hill, NC USA		Parra-Murillo, M (corresponding author), Pontificia Univ Javeriana, Fac Med, Bogota, Colombia.	mparram@javeriana.edu.co	Lowery, Caitlin/AHE-3317-2022	Lowery, Caitlin/0000-0001-7450-6248				Acton RB, 2018, PUBLIC HEALTH NUTR, V21, P3354, DOI 10.1017/S1368980018002550; Adams J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2391; Albertson AM, 2009, J AM DIET ASSOC, V109, P1557, DOI 10.1016/j.jada.2009.06.363; Angelino D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112827; Anker T., 2016, TRUTH MARKETING THEO, V1st ed.; Australian government's Healthy Food Partnership, 2016, READ TO EAT BREAKF C; Baker P, 2020, OBES REV, V21, DOI 10.1111/obr.13126; Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017; Castetbon K, 2012, PUBLIC HEALTH NUTR, V15, P1456, DOI 10.1017/S1368980011003065; Correa T, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0781-x; Corvalan C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802; Devi A, 2014, APPETITE, V81, P253, DOI 10.1016/j.appet.2014.06.019; Dixon H, 2011, PUBLIC HEALTH NUTR, V14, P1071, DOI 10.1017/S1368980010003691; Duffy EW, 2021, J ACAD NUTR DIET, V121, P36, DOI [10.1016/j.jand.2020.08.009, 10.1016/j.j.2020.08.009]; Dunckel M., 2020, NATURAL ORGANIC LABE, P1; Euromonitor, 2020, BREAKF CER PER; Euromonitor International, 2019, BREAKFAST CEREALS CO; FAST R., 2000, MANUFACTURING TECHNO, V2nd, P17; Federal Register., 2016, USE TERM NATURAL LAB, P5; Franco-Arellano Beatriz, 2017, BMC Nutr, V3, P74, DOI 10.1186/s40795-017-0192-9; Gamboa-Gamboa T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112738; Garcia AL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030856; Garcia AL, 2019, ARCH DIS CHILD, V104, P541, DOI 10.1136/archdischild-2018-315870; Gorton D, 2010, AUST NZ J PUBL HEAL, V34, P57, DOI 10.1111/j.1753-6405.2010.00474.x; Guarnizo-Peralta D., 2017, SIN REGLAS NI CONTRO, P1; Hall KD, 2019, CELL METAB, V30, P226, DOI 10.1016/j.cmet.2019.05.020; Harris JL, 2011, PEDIATRICS, V127, P71, DOI 10.1542/peds.2010-0864; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hughner RS, 2006, J MARKET MANAG-UK, V22, P929, DOI 10.1362/026725706778935600; IBM Corp, 2019, IBM SPSS STAT WIND V; Kanter R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010052; Kanter R, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001016; Khandpur N, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054001176; Kim K, 2009, INT J ADVERT, V28, P527, DOI 10.2501/S0265048709200722; Kosti RI, 2010, NUTR RES REV, V23, P314, DOI 10.1017/S095442241000020X; Lane MM, 2021, OBES REV, V22, DOI 10.1111/obr.13146; Lowery Caitlin M., 2020, Nutrients, V12, P3260, DOI 10.3390/nu12113260; Martinez X, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061594; Martini D, 2021, FOODS, V10, P2225, DOI 10.3390/foods10092225; Maschkowski G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1178; McGinnis J.M., 2006, FOOD MARKETING CHILD; McLean R, 2012, PUBLIC HEALTH NUTR, V15, P783, DOI 10.1017/S1368980011003508; Mhurchu CN, 2007, AUST NZ J PUBL HEAL, V31, P105, DOI 10.1111/j.1753-6405.2007.00026.x; Milosavljevic M, 2011, JUDGM DECIS MAK, V6, P520; Ministerio de salud-Subsecretaria de salud publica, 2012, LEY 20 606 COMP NUTR; Montenegro-Bethancourt G, 2009, NUTR RES, V29, P335, DOI 10.1016/j.nutres.2009.05.003; Mora-Plazas M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051011; Nestle M, 2010, JAMA-J AM MED ASSOC, V303, P771, DOI 10.1001/jama.2010.179; Nieto C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080884; Pan American Health Organization, 2016, PAN AM HLTH ORG NUTR, P1; Perron J, 2021, PUBLIC HEALTH NUTR, V24, P2397, DOI 10.1017/S1368980021001361; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4; Priebe MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164931; Rodrigues VM, 2016, BRIT J NUTR, V115, P2047, DOI 10.1017/S0007114516001021; RStudio Team, 2020, RSTUDIO INT DEV R; Schuldt JP, 2013, HEALTH COMMUN, V28, P814, DOI 10.1080/10410236.2012.725270; Schuldt JP, 2012, SOC PSYCHOL PERS SCI, V3, P581, DOI 10.1177/1948550611431643; Soo J, 2016, INT J OBESITY, V40, P39, DOI 10.1038/ijo.2015.161; Stoltze FM, 2021, APPETITE, V163, DOI 10.1016/j.appet.2021.105229; Stoltze FM, 2020, CURR DEV NUTR, V4, P1723; Sussman RL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071604; Taillie LS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020569; The Food and Drug Administration, 2016, US TERM NAT FOOD LAB; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Williams PG, 2014, ADV NUTR, V5, p636S, DOI 10.3945/an.114.006247	66	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	NOV 26	2021	8								770489	10.3389/fnut.2021.770489	http://dx.doi.org/10.3389/fnut.2021.770489			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	XQ6XB	34901117	gold, Green Published			2022-09-04	WOS:000731688200001
J	Vasquez, D; Castrillon, MS; Vega, MG; Henck, CG; Aguillon, D; Garcia-Cifuentes, E; Jaramillo-Jimenez, A; Velez, JE; Madrigal, L; Lopera, F				Vasquez, Daniel; Castrillon, Melissa Sierra; Vega, Manuela Gomez; Henck, Clara Gomez; Aguillon, David; Garcia-Cifuentes, Elkin; Jaramillo-Jimenez, Alberto; Velez, Juan Esteban; Madrigal, Lucia; Lopera, Francisco			Quality of life in early-onset Alzheimer's disease due to a PSEN1-E280A mutation	NEUROLOGICAL SCIENCES			English	Article						Familial Alzheimer disease (FAD); Early-onset Alzheimer disease; Dominant Alzheimer disease; Quality of life; Dementia		Purpose The present study aims to explore the association between the quality of life (QoL) score and the clinical and sociodemographic variables in patients with the PSEN1-E280A mutation. We also seek to evaluate the differences between the QoL reported by the patients (P-QoL) and the scores reported by the caregivers (C-QoL). Methods An analysis of 75 patients with the PSEN1-E280A mutation with mild cognitive impairment and dementia was performed. We used the Quality of Life in Alzheimer Disease (QoL-AD) survey to evaluate QoL as an outcome and evaluated its association with sociodemographic, lifestyle, clinical, and past medical history variables. Results The largest difference in the median of the QoL-AD score was in those who needed help to eat, those with moderate or severe dementia, those classified as frail or pre-frail, those with moderate social risk, and those with depression. Also, C-QoL was lower than the P-QoL, and the QoL-AD of individuals with severe dementia was lower than for milder forms of the disease. Not needing help to eat, not having a stressful situation in the past 3 months, and the years of education were positively correlated with QoL-AD in the linear model. Conclusion As studies in similar populations with AD, factors with more impact on QoL are those related to loss of functionality and independence. These factors are also associated with variables related to the current literature with the burden of the disease for the caregivers.	[Vasquez, Daniel; Vega, Manuela Gomez; Henck, Clara Gomez; Aguillon, David; Garcia-Cifuentes, Elkin; Jaramillo-Jimenez, Alberto; Velez, Juan Esteban; Madrigal, Lucia; Lopera, Francisco] Univ Antioquia, Fac Med, Grp Neurociencias Antioquia, Medellin, Colombia; [Vasquez, Daniel] Univ CES, Grp Invest Epidemiol & Bioestadist, Medellin, Colombia; [Castrillon, Melissa Sierra] Univ Antioquia, Fac Ciencias Sociales & Humanas, Dept Psicol, Medellin, Colombia; [Castrillon, Melissa Sierra; Vega, Manuela Gomez; Aguillon, David; Jaramillo-Jimenez, Alberto] Univ Antioquia, Fac Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Garcia-Cifuentes, Elkin] Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Garcia-Cifuentes, Elkin] Hosp Univ San Ignacio, Unidad Neurol, Bogota, Colombia; [Jaramillo-Jimenez, Alberto] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway		Vasquez, D (corresponding author), Univ Antioquia, Fac Med, Grp Neurociencias Antioquia, Medellin, Colombia.; Vasquez, D (corresponding author), Univ CES, Grp Invest Epidemiol & Bioestadist, Medellin, Colombia.	danielvasquezb96@gmail.com	LOPERA, FRANCISCO/AAR-5968-2021; Garcia-Cifuentes, Elkin/AAC-6077-2021	Garcia-Cifuentes, Elkin/0000-0003-4214-0266; Gomez Vega, Manuela/0000-0002-2000-4901; Velez-Hernandez, Juan/0000-0002-0800-5709; Jaramillo-Jimenez, Alberto/0000-0001-5374-6410; Aguillon Nino, David Fernando/0000-0003-2283-536X; Vasquez, Daniel/0000-0002-2586-162X; Lopera, Francisco/0000-0003-3986-1484	NIA; Genentech/Roche; anonymous foundation to develop the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease - API ADAD - Registry	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Genentech/Roche(Roche HoldingGenentech); anonymous foundation to develop the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease - API ADAD - Registry	This study did not receive any financial contribution to carry it out. However, the base registry fromwhich the patients were recruited has been sponsored by the NIA, Genentech/Roche, and an anonymous foundation to develop the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease - API ADAD - Registry.	da Camara SMA, 2013, GERIATR GERONTOL INT, V13, P421, DOI 10.1111/j.1447-0594.2012.00920.x; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Disease International, 2015, GLOBAL IMPACT DEMENT; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596.x00diagnosticclassification; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; Barbe C, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0855-7; Barbe C, 2017, AGING MENT HEALTH, V21, P571, DOI 10.1080/13607863.2015.1132674; BERNDT S, 1993, PAIN, V52, P331, DOI 10.1016/0304-3959(93)90167-N; Custodio Nilton, 2017, CES Med., V31, P14, DOI 10.21615/cesmedicina.31.1.2; EISDORFER C, 1992, AM J PSYCHIAT, V149, P190; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garz?n M, 2013, CES MED, V4; Gomez-Gallego M, 2012, NEUROLOGIA, V27, P4, DOI 10.1016/j.nrl.2011.03.006; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Lacey L, 2015, VALUE HEALTH, V18, P638, DOI 10.1016/j.jval.2015.03.1787; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Logsdon Rebecca G, 2007, Alzheimers care today, V8, P309; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Logsdon RG., 1999, J MENTAL HLTH AGING, V5, P21, DOI [10.1037/t03352-000, DOI 10.1037/T03352-000]; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Megari K, 2013, HEALTH PSYCHOL RES, V1, P141, DOI [10.4082/hpr.2013.e27, 10.4081/hpr.2013.e27]; Mendez Mario F, 2019, Continuum (Minneap Minn), V25, P34, DOI 10.1212/CON.0000000000000687; Merchant, 1999, J MENTAL HLTH AGING, V5, P49; Naglie G, 2007, CAN J NEUROL SCI, V34, pS57, DOI 10.1017/S0317167100005588; Patterson C, 2018, WORLD ALZHEIMER REPO; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Rios-Romenets S, 2017, ALZHEIMERS DEMENT, V13, P602, DOI 10.1016/j.jalz.2016.09.010; Sainfort F, 1996, AM J PSYCHIAT, V153, P497; Savva GM, 2013, J GERONTOL A-BIOL, V68, P441, DOI 10.1093/gerona/gls190; Sheehan B, 2012, THER ADV NEUROL DISO, V5, P349, DOI 10.1177/1756285612455733; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Soysal P, 2019, J AM MED DIR ASSOC, V20, P183, DOI 10.1016/j.jamda.2018.07.016; Stites SD, 2018, ALZ DIS ASSOC DIS, V32, P276, DOI 10.1097/WAD.0000000000000262; Stites SD, 2017, J GERONTOL B-PSYCHOL, V72, P974, DOI 10.1093/geronb/gbx100; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Torisson G, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0493-8; Torres VL, 2021, APPL NEUROPSYCH-ADUL, V28, P230, DOI 10.1080/23279095.2019.1627357; Vadikolias K, 2012, BRAIN BEHAV, V2, P620, DOI 10.1002/brb3.88; Vale Francisco A.C., 2012, Dement. neuropsychol., V6, P212, DOI 10.1590/S1980-57642012DN06040004; Weiss CO, 2014, J GEN INTERN MED, V29, P653, DOI 10.1007/s11606-013-2660-5; Wenger GC, 2007, J GERONTOL; Weyerer S., 2003, ASSESSMENT QUALITY L, DOI [10.1017/S1041610203009475, DOI 10.1017/S1041610203009475]; Woods RT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-94; World Health Organisation, 2017, GLOB ACT PLAN PUBL H	46	0	0	1	3	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2021	42	11					4637	4645		10.1007/s10072-021-05136-y	http://dx.doi.org/10.1007/s10072-021-05136-y		MAR 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WH4LQ	33675003				2022-09-04	WOS:000625578100001
J	Mejia-Vergara, AJ; Restrepo-Jimenez, P; Pelak, VS				Mejia-Vergara, Alvaro J.; Restrepo-Jimenez, Paula; Pelak, Victoria S.			Optical Coherence Tomography in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis	FRONTIERS IN NEUROLOGY			English	Review						Alzheimer&apos; s disease; mild cognitive impairment; optical coherence tomography; retina; biomarker; systematic review; meta&#8211; analysis	NERVE-FIBER LAYER; ALZHEIMERS-DISEASE; RETINAL THICKNESS; RECOMMENDATIONS; DIAGNOSIS	Purpose: The use of optical coherence tomography (OCT) of the retina to detect inner retinal degeneration is being investigated as a potential biomarker for mild cognitive impairment (MCI) and Alzheimer's disease (AD), and an overwhelming body of evidence indicates that discovery of disease-modifying treatments for AD should be aimed at the pre-dementia clinical stage of AD, i.e., MCI. We aimed to perform a systematic review and meta-analysis on retinal OCT in MCI. Methods: We performed a systematic review of the English literature in three databases (PubMed, Embase, and Latindex) for studies that measured retinal thickness using OCT in people with MCI and healthy controls, age 50 or older, between 1 January 2000 and 31 July 2019. Only cohort and case-control studies were reviewed, and independent extraction of quality data and established objective data was performed. We calculated the effect size for studies in the review that met the following criteria: (1) a statistically significant difference between MCI subjects and normal controls for several OCT variables, (2) use of spectral domain OCT, and (3) use of APOSTEL recommendations for OCT reporting. Weighted Hedges' g statistic was used to calculate the pooled effect size for four variables: ganglion cell layer-inner plexiform layer (GCL-IPL) complex thickness in micrometers (mu m), circumpapillary retinal nerve fiber layer (pRNFL) thickness in mu m, macular thickness in mu m, and macular volume in mu m(3). For variables with high heterogeneity, a multivariate meta-regression was performed. We followed the PRISMA guidelines for systematic reviews. Results: Fifteen articles met the inclusion criteria. A total of 58.9% of MCI patients had statistically significant thinning of the pRNFL compared with normal subjects, while 61.6% of all MCI patients who had macular volume measured had a statistically significant reduction in volume compared with controls, and 50.0% of the macular GCL-IPL complexes measured demonstrated significant thinning in MCI compared with normal controls. Meta-analysis demonstrated a large effect size for decreased macular thickness in MCI subjects compared with normal controls, but there was a substantial heterogeneity for macular thickness results. The other variables did not demonstrate a significant difference and also had substantial heterogeneity. Meta-regression analysis did not reveal an explanation for the heterogeneity. Conclusions: A better understanding of the cause of retina degeneration and longitudinal, standardized studies are needed to determine if optical coherence tomography can be used as a biomarker for mild cognitive impairment due to Alzheimer's disease.	[Mejia-Vergara, Alvaro J.] Univ Calif Los Angeles, Stein & Doheny Eye Inst, Dept Neuroophthalmol, Pasadena, CA 91125 USA; [Mejia-Vergara, Alvaro J.; Restrepo-Jimenez, Paula] Pontificia Univ Javeriana, San Ignacio Univ Hosp, Sch Med, Ophthalmol Dept, Bogota, Colombia; [Pelak, Victoria S.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Pelak, Victoria S.] Univ Colorado, Sch Med, Dept Ophthalmol, Aurora, CO USA		Mejia-Vergara, AJ (corresponding author), Univ Calif Los Angeles, Stein & Doheny Eye Inst, Dept Neuroophthalmol, Pasadena, CA 91125 USA.; Mejia-Vergara, AJ (corresponding author), Pontificia Univ Javeriana, San Ignacio Univ Hosp, Sch Med, Ophthalmol Dept, Bogota, Colombia.	alvaro.mejia@javeriana.edu.co	Mejia-Vergara, Alvaro Jose/AAU-7053-2021	Mejia-Vergara, Alvaro Jose/0000-0002-5145-1413				Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Almeida ALM, 2019, ALZH DEMENT-DADM, V11, P659, DOI 10.1016/j.dadm.2019.08.006; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Bell C.C., 1994, JAMA-J AM MED ASSOC, V272, P828, DOI 10.1001/jama.1994.03520100096046; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Cass SP, 2017, CURR SPORT MED REP, V16, P19, DOI 10.1249/JSR.0000000000000332; Chan VTT, 2019, OPHTHALMOLOGY, V126, P497, DOI 10.1016/j.ophtha.2018.08.009; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Collie A, 2002, AUST NZ J PSYCHIAT, V36, P133, DOI 10.1046/j.1440-1614.2002.00972.x; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; de la Torre JC, 2014, J ALZHEIMERS DIS, V42, pS327, DOI 10.3233/JAD-141800; den Haan J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0516-x; den Haan Jurre, 2019, Alzheimers Dement (Amst), V11, P463, DOI 10.1016/j.dadm.2019.05.002; den Haan Jurre, 2017, Alzheimers Dement (Amst), V6, P162, DOI 10.1016/j.dadm.2016.12.014; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ferrari L, 2017, J ALZHEIMERS DIS, V56, P1101, DOI 10.3233/JAD-160886; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Castejon DG, 2016, NEURO-OPHTHALMOLOGY, V40, P16, DOI 10.3109/01658107.2015.1118516; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jiang H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192154; Kardon RH, 2011, J NEURO-OPHTHALMOL, V31, P353, DOI 10.1097/WNO.0b013e318238b9cb; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Knoll Brianna, 2016, Alzheimers Dement (Amst), V4, P85; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Kwon Jin Young, 2017, Korean J Ophthalmol, V31, P548, DOI 10.3341/kjo.2016.0118; La Morgia C, 2016, ANN NEUROL, V79, P90, DOI 10.1002/ana.24548; Lad EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192646; Liu D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1869-6; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; McGuinness LA, 2021, RES SYNTH METHODS, V12, P55, DOI 10.1002/jrsm.1411; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; O'Bryhim BE, 2018, JAMA OPHTHALMOL, V136, P1242, DOI 10.1001/jamaophthalmol.2018.3556; Oktem EO, 2015, NEUROL SCI, V36, P1141, DOI 10.1007/s10072-014-2055-3; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2007, EUR J NEUROL, V14, P627, DOI 10.1111/j.1468-1331.2007.01795.x; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P1828; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Parisi V, 2001, OPHTHALMOLOGY, V108, P905, DOI 10.1016/S0161-6420(00)00644-8; Pelak VS, 2018, NEURODEGENER DIS MAN, V8, P49, DOI 10.2217/nmt-2017-0030; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pillai J, 2013, ALZHEIMERS DEMENT, V1, P214, DOI [10.1016/j.jalz.2013.05.403, DOI 10.1016/J.JALZ.2013.05.403]; Pillai JA, 2016, AM J ALZHEIMERS DIS, V31, P430, DOI 10.1177/1533317515628053; Querques G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37271-6; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Shao Y, 2018, J ALZHEIMERS DIS, V64, P1261, DOI 10.3233/JAD-180070; Shen Y, 2014, CURR ALZHEIMER RES, V11, P259, DOI 10.2174/1567205011666140131114418; Tricco AC, 2013, CAN MED ASSOC J, V185, P1393, DOI 10.1503/cmaj.130451; Uchida A, 2018, INVEST OPHTH VIS SCI, V59, P2768, DOI 10.1167/iovs.17-23240; van de Kreeke JA, 2020, BRIT J OPHTHALMOL, V104, P157, DOI 10.1136/bjophthalmol-2019-314127; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wu J, 2020, ACTA OPHTHALMOL, V98, pE781, DOI 10.1111/aos.14381; Wu Y, 2018, INT J NEUROSCI, V128, P849, DOI 10.1080/00207454.2018.1438428; Yoon SP, 2019, OSLI RETINA, V50, P709, DOI 10.3928/23258160-20191031-06; Yoon SP, 2019, OPHTHALMOL RETINA, V3, P489, DOI 10.1016/j.oret.2019.02.002; Zhang YS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214685	59	5	5	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 16	2020	11								578698	10.3389/fneur.2020.578698	http://dx.doi.org/10.3389/fneur.2020.578698			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OK5QC	33178120	Green Published, gold			2022-09-04	WOS:000584703900001
J	Bernal, CAA; Pedroza, MT				Bernal, Carlos Andres Arroyave; Pedroza, Marlin Tellez			Patient-Physicians: Identities and Expertise Brought Into the Light of Diagnosis and Treatment	JOURNAL OF PATIENT EXPERIENCE			English	Article						patient; physician; identity; expertise; diagnosis; treatment	DOCTOR; INSTITUTION	Researchers continue establishing a clear-cut division between identities of doctors and patients, but the perspective of the physician in the event that they became a patient is seldom analyzed. This article shows empirical evidence of the discursive construction of identities and expertise in the accounts of 24 patient-physicians diagnosed and treated for acute or chronic disease in the city of Bogota, Colombia (2009-2015). An approach to these accounts from Science and Technology Studies, which is a perspective emerged among the field of social sciences during the 1970s that has achieved in our time a broader understanding of expertise, leads to the questioning of stereotypes about who doctors are and who patients are, and to illustrate the difficulty of drawing boundaries between experts and laypeople. Finally, it was concluded that identities and expertise are reconfigured in interaction, in a contingent and situated way, when considering diagnosis and treatment. New meanings of the relationship between doctor and patient were proposed, from a more symmetrical stance.	[Bernal, Carlos Andres Arroyave] Univ El Bosque, Dept Humanidades, Bogota, Colombia; [Bernal, Carlos Andres Arroyave] FHISCIS Grp Filosofia Hist & Sociol Ciencias, Bogota, Colombia; [Pedroza, Marlin Tellez] Univ Nacl Colombia, Dept Salud Colect, Bogota, Colombia; [Pedroza, Marlin Tellez] GESCTM Grp Estudios Sociales Ciencia & Tecnol Med, Bogota, Colombia		Pedroza, MT (corresponding author), Pontificia Univ Javeriana, Fac Enfermeria, Dept Enfermeria Salud Colect, Bogota, Colombia.; Pedroza, MT (corresponding author), Grp Proc Sociales & Salud, Bogota, Colombia.	matellez@javeriana.edu.co		Tellez, Marlin/0000-0003-3148-6827; Arroyave Bernal, Carlos Andres/0000-0002-4390-5008				Antaki C, 1998, IDENTITIES TALK, P224; ARMSTRONG D, 1984, SOC SCI MED, V18, P737, DOI 10.1016/0277-9536(84)90099-6; BLAXTER M, 1983, SOC SCI MED, V17, P59, DOI 10.1016/0277-9536(83)90356-8; Boiron C, 2009, PSYCHO-ONCOLOGIE, V3, P147, DOI 10.1007/s11839-009-0141-1; BOWES D, 1984, CAN MED ASSOC J, V131, P1343; Collins HM, 2002, SOC STUD SCI, V32, P235, DOI 10.1177/0306312702032002003; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; FREIDSON E., 1978, PROFESION MED ESTUDI; Fromme E, 2003, JAMA-J AM MED ASSOC, V290, P2048, DOI 10.1001/jama.290.15.2048; Goffman E, 2004, ENSAYOS SITUACION SO; HORTONSALWAY M, 1998, MIND BODY DISCURSIVE; Jovell A, 2008, CANC BIOGRAFIA SUPER; Klitzman R, 2007, PATIENT EDUC COUNS, V66, P147, DOI 10.1016/j.pec.2006.10.005; Mandell H, 1987, DOCTORS GET SICK; Myers G, 2004, MATTERS OPINION, P255; Nova Cristina, 2007, Recenti Progressi in Medicina, V98, P79; PARSONS T, 1984, SISTEMA SOCIAL; Pill R, 1981, HLTH PROMOTION RES, P187; SACKS H, 1992, LECT CONVERSATION, V1; SACKS H, 1992, LECT CONVERSATION, V2; Sacks O., 1984, A LEG TO STAND ON; Salcedo H., 2002, U EXTERN COLOMB CUAD, V4, P85; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; Strauss Anselm L., 1975, CHRONIC ILLNESS QUAL; Tierney WM, 2002, MED CARE, V40, P20; Vallejo Najera JA, 1990, PUERTA ESPERANZA; Waldron HA, 1996, ANN OCCUP HYG, V40, P391, DOI 10.1093/annhyg/40.4.391; Widdicombe S, 1995, LANGUAGE YOUTH SUBCU, P250; ZOLA IK, 1972, SOCIOL REV, V20, P487, DOI 10.1111/j.1467-954X.1972.tb00220.x	29	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2374-3743	2374-3735		J PATIENT EXPERIENCE	J. Patient Experience	APR	2020	7	2					245	250		10.1177/2374373519836468	http://dx.doi.org/10.1177/2374373519836468			6	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	LM6KP	32851147	gold, Green Published			2022-09-04	WOS:000532358700018
J	Tipton, PW; Soto-Beasley, AI; Walton, RL; Soler-Rangel, S; Romero-Osorio, O; Diaz, C; Moreno-Lopez, CL; Ross, OA; Wszolek, ZK; Cerquera-Cleves, C				Tipton, Philip W.; Soto-Beasley, Alexandra I.; Walton, Ronald L.; Soler-Rangel, Silvia; Romero-Osorio, Oscar; Diaz, Cindy; Lucia Moreno-Lopez, Claudia; Ross, Owen A.; Wszolek, Zbigniew K.; Cerquera-Cleves, Catalina			Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations	PARKINSONISM & RELATED DISORDERS			English	Letter						Parkinson's disease; Genetics; GBA; Gaucher's disease	GLUCOCEREBROSIDASE MUTATIONS	We aimed to replicate a recent study that found a high frequency of the GBA p.K198E mutant in Colombian patients with PD. We identified the p.K198E substitution at a lower frequency in our cohort of Colombians with PD (2.1%), and this was not significantly different than controls (1.7%, P = 0.86) emphasizing the need for larger genetic studies in Latin America.	[Tipton, Philip W.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, 4500 San Pablo Rd,Mangurian Bldg, Jacksonville, FL 32224 USA; [Soto-Beasley, Alexandra I.; Walton, Ronald L.; Ross, Owen A.] Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Soler-Rangel, Silvia; Romero-Osorio, Oscar; Diaz, Cindy; Lucia Moreno-Lopez, Claudia; Cerquera-Cleves, Catalina] Hosp Univ San Ignacio, Movement Disorders Clin, Bogota, Colombia; [Soler-Rangel, Silvia; Romero-Osorio, Oscar; Diaz, Cindy; Cerquera-Cleves, Catalina] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Lucia Moreno-Lopez, Claudia] Fdn Cardioinfantil, Bogota, Colombia; [Ross, Owen A.] Mayo Clin, Dept Clin Genom, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Cerquera-Cleves, Catalina] Clin Univ Colombia, Bogota, Colombia		Wszolek, ZK (corresponding author), Mayo Clin, Dept Neurol, 4500 San Pablo Rd,Mangurian Bldg, Jacksonville, FL 32224 USA.	Wszolek.Zbigniew@mayo.edu		Cerquera, Catalina/0000-0002-3874-0261	NINDS NIH HHS [R01 NS078086, P50 NS072187, U54 NS100693, U54 NS110435] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Eblan MJ, 2006, MOVEMENT DISORD, V21, P282, DOI 10.1002/mds.20766; Orvisky E, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9024; Pineda-Trujillo N, 2006, AM J MED GENET B, V141B, P885, DOI 10.1002/ajmg.b.30375; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Velez-Pardo C, 2019, PARKINSONISM RELAT D, V63, P204, DOI 10.1016/j.parkreldis.2019.01.030	5	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	APR	2020	73						16	18		10.1016/j.parkreldis.2020.03.008	http://dx.doi.org/10.1016/j.parkreldis.2020.03.008			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ3XP	32197197	Green Accepted			2022-09-04	WOS:000541161700005
J	Orduna, JFG; Garcia, MG; Dominguez, P; Bucheli, JC; Biedma, BM; Sans, FA; Cespedes, MCM				Gavino Orduna, J. F.; Garcia Garcia, M.; Dominguez, P.; Caviedes Bucheli, J.; Martin Biedma, B.; Abella Sans, F.; Manzanares Cespedes, M. C.			Successful pulp revascularization of an autotransplantated mature premolar with fragile fracture apicoectomy and plasma rich in growth factors: a 3-year follow-up	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						autotransplanted tooth; fragile fracture apicoectomy; plasma-rich growth factors; pulp revascularization	HUMAN DENTAL-PULP; COMPLETE ROOT-FORMATION; LONG-TERM; PROGNOSTIC-FACTORS; APICAL DIAMETER; 3RD MOLARS; TEETH; SURVIVAL; TRANSPLANTATION; REGENERATION	Aim This case report demonstrates a positive outcome of the adjuvant use of fragile fracture (FF), which is a technique used to harvest dental pulp stem cells (DPSCs), and platelet-rich plasma (PRP) in a mandibular premolar (tooth 44) with a completely formed root that was transplanted into a surgically created socket and which maintained pulp vitality and function. After virtual surgical planning, a 3D tooth replica of tooth 44 was fabricated. A surgical socket was created in the position of tooth 14; then, tooth 44 was extracted and the root dentine was abraded using a turbine diamond bur 3 mm from the apex until a circular groove was prepared around the outer circumference of the root; and then, an FF was performed without damaging the pulp tissue. PRP was placed in the socket, after which the donor tooth was inserted in the recipient area. At 2 weeks post-treatment, orthodontic traction was applied. At 3-year follow-up, the tooth had adequate alignment and was asymptomatic. Response to pulp testing was positive, and the presence of pulp canal obliteration was observed as a sign of pulpal healing. Key learning points Autotransplantation is a good alternative for replacing missing teeth, with repair of tissues and pulp revascularization. Revascularization of an autotransplanted mature tooth using the fragile fracture technique and PRP scaffold is a feasible option and might have positive effects on the long-term outcome of the procedure. Including completely formed teeth as donors in autotransplantation, maintaining vitality and their functions is an option that warrants further study.	[Gavino Orduna, J. F.; Garcia Garcia, M.; Dominguez, P.; Manzanares Cespedes, M. C.] Univ Barcelona, Sch Dent, Dept Odontostomatol, Barcelona, Spain; [Caviedes Bucheli, J.] Univ Javeriana, CIO Pontificia, Bogota, Colombia; [Martin Biedma, B.] Univ Santiago de Compostela, Sch Med & Dent, Unit Dent Pathol & Therapeut 2, Santiago De Compostela, Spain; [Abella Sans, F.] Univ Int Catalunya, Dept Endodont, Barcelona, Spain; [Manzanares Cespedes, M. C.] Univ Barcelona, Sch Med, Dept Expt Pathol & Therapeut, Barcelona, Spain		Orduna, JFG (corresponding author), Sch Dent, Dept Odontoestomatol, Bellvitge Univ Campus,C Feixa LLarga S-N, Barcelona 08907, Spain.	dr.gavino@gmail.com	Garcia Garcia, Marta/AFX-6542-2022; Assis, Antônio Victor Almeida/AAA-3840-2021; Manzanares Cespedes, Maria Cristina/H-5489-2015	Garcia Garcia, Marta/0000-0002-8052-1505; Manzanares Cespedes, Maria Cristina/0000-0002-4585-4953; Abella Sans, Fransesc/0000-0002-3500-3039; Caviedes-Bucheli, Javier/0000-0003-0407-9847				Abd-Elmeguid A, 2015, DENT TRAUMATOL, V31, P437, DOI 10.1111/edt.12199; Almpani K, 2015, CLIN ORAL INVEST, V19, P1157, DOI 10.1007/s00784-015-1473-9; ALTONEN M, 1978, INT J ORAL MAXILLOF, V7, P434, DOI 10.1016/S0300-9785(78)80034-9; ANDREASEN JO, 1990, EUR J ORTHODONT, V12, P14, DOI 10.1093/ejo/12.1.14; Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x; Anitua E, 2017, DENT TRAUMATOL, V33, P414, DOI 10.1111/edt.12354; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Aoyama S, 2012, OR SURG OR MED OR PA, V114, pS216, DOI 10.1016/j.oooo.2011.09.037; Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Bae JH, 2010, J ENDODONT, V36, P1422, DOI 10.1016/j.joen.2010.04.028; Bauss O, 2009, EUR J ORTHODONT, V31, P121, DOI 10.1093/ejo/cjn084; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Caviedes-Bucheli J, 2017, INT ENDOD J, V50, P339, DOI 10.1111/iej.12627; Caviedes-Bucheli J, 2009, INT ENDOD J, V42, P686, DOI 10.1111/j.1365-2591.2009.01568.x; Caviedes-Bucheli J, 2011, J ENDODONT, V37, P934, DOI 10.1016/j.joen.2011.03.035; Chung WC, 2014, J CLIN PERIODONTOL, V41, P412, DOI 10.1111/jcpe.12228; Assuncao LRD, 2011, J PERIODONTOL, V82, P758, DOI 10.1902/jop.2010.100448; Denys D, 2013, EUR J ORTHODONT, V35, P680, DOI 10.1093/ejo/cjs112; Derringer KA, 1998, EUR J ORTHODONT, V20, P357, DOI 10.1093/ejo/20.4.357; Derringer KA, 2004, ARCH ORAL BIOL, V49, P631, DOI 10.1016/j.archoralbio.2004.02.011; Fang YJ, 2018, J ENDODONT, V44, P414, DOI 10.1016/j.joen.2017.10.007; Fang Y, 2016, J ENDODONT, V42, P198, DOI 10.1016/j.joen.2015.10.021; Orduna JFG, 2017, J ENDODONT, V43, P1294, DOI 10.1016/j.joen.2017.04.010; Gonzalez-Ocasio J, 2017, J ORAL MAXIL SURG, V75, DOI 10.1016/j.joms.2017.04.018; Hasegawa T, 2007, CELL TISSUE RES, V329, P259, DOI 10.1007/s00441-007-0424-4; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]; Jonsson T, 2004, AM J ORTHOD DENTOFAC, V125, P668, DOI 10.1016/j.ajodo.2003.12.002; Kallu R, 2005, INT J ORAL MAX SURG, V34, P745, DOI 10.1016/j.ijom.2005.03.009; KLING M, 1986, Endodontics and Dental Traumatology, V2, P83; Laureys WGM, 2013, J ENDODONT, V39, P759, DOI 10.1016/j.joen.2013.02.004; Lee Seung-Jong, 2012, Restor Dent Endod, V37, P136, DOI 10.5395/rde.2012.37.3.136; Lu L, 2013, J ZHEJIANG UNIV-SC B, V14, P1025, DOI 10.1631/jzus.B1300062; Lundberg T, 1996, BRIT J ORAL MAX SURG, V34, P181, DOI 10.1016/S0266-4356(96)90374-5; Marques-Ferreira M, 2011, MED ORAL PATOL ORAL, V16, pC984, DOI 10.4317/medoral.16926; Mattuella LG, 2007, J ENDODONT, V33, P524, DOI 10.1016/j.jeon.2007.01.003; Mejare B, 2004, ORAL SURG ORAL MED O, V97, P231, DOI 10.1016/S1079-2104(03)00461-X; Moraschini V, 2015, INT J ORAL MAX SURG, V44, P377, DOI 10.1016/j.ijom.2014.10.023; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013; Paganelli C, 2014, BIODENTAL ENGINEERING III, P249; Rombouts C, 2017, J DENT RES, V96, P137, DOI 10.1177/0022034516671688; Saghiri MA, 2015, J ENDODONT, V41, P797, DOI 10.1016/j.joen.2014.12.019; Simonis P, 2010, CLIN ORAL IMPLAN RES, V21, P772, DOI 10.1111/j.1600-0501.2010.01912.x; SKOGLUND A, 1978, ORAL SURG ORAL MED O, V45, P17, DOI 10.1016/0030-4220(78)90217-7; Skoglund A, 1981, J Endod, V7, P309, DOI 10.1016/S0099-2399(81)80097-0; Tran-Hung L, 2008, ARCH ORAL BIOL, V53, P9, DOI 10.1016/j.archoralbio.2007.07.001; Tsukiboshi M, 2002, DENT TRAUMATOL, V18, P157, DOI 10.1034/j.1600-9657.2002.00118.x; Verweij JP, 2016, J CLIN PERIODONTOL, V43, P167, DOI 10.1111/jcpe.12492; Yang Y, 2012, J PERIODONTOL, V83, P235, DOI 10.1902/jop.2011.110099; Yilmaz SG, 2019, ACTA ODONTOL SCAND, V77, P107, DOI 10.1080/00016357.2018.1510137; Yu HJ, 2017, INT J ORAL MAX SURG, V46, P531, DOI 10.1016/j.ijom.2016.12.007	51	8	8	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	MAR	2020	53	3					421	433		10.1111/iej.13230	http://dx.doi.org/10.1111/iej.13230		NOV 2019	13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KK0XF	31587320				2022-09-04	WOS:000493768500001
J	Garcia-Melo, JE; Oliveira, C; Silva, GJD; Ochoa-Orrego, LE; Pereira, LHG; Maldonado-Ocampo, JA				Garcia-Melo, Jorge E.; Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.; Garcia Pereira, Luiz Henrique; Maldonado-Ocampo, Javier A.			Species delimitation of neotropical Characins (Stevardiinae): Implications for taxonomy of complex groups	PLOS ONE			English	Article							GENUS BRYCONAMERICUS TELEOSTEI; CHARACIFORMES CHARACIDAE; MAGDALENA BASIN; RIVER; OSTARIOPHYSI; PHYLOGENY; REVISION; MODELS; CLADE; FISH	Accurate species delimitation is crucial for studies of phylogeny, phylogeography, ecology, conservation and biogeography. The limits of species and genera in the Characidae family are controversial due to its uncertain phylogenetic relationships, high level of morphological homoplasy and the use of ambiguous morphological characters for descriptions. Here we establish species boundaries for Bryconamericus, Hemibrycon, Knodus and Eretmobrycon (Stevardiinae: Characidae), previously diagnosed with morphology, using three different barcoding approaches (GMYC, PTP, ABGD). Results revealed that species delimitation was successful by the use of a single-gene approach and by following a workflow in the context of integrative taxonomy, making evident problems and mistakes in the cataloging of Characidae species. Hence, it was possible to infer boundaries at genus level for clusters in the trees (GMYC and PTP) and automatic partitions (ABGD) which were consistent with some of recent taxonomic changes proposed in Characidae. We found that discordance cases between methods were linked to limitations of the methods and associated to putative species cluster closely related, some historically problematic in their diagnosis and identification. Furthermore, we suggested taxonomic changes and possibly new species, revealing a high degree of hidden diversity. Finally, we propose a workflow as a fast, accurate and objective way to delimit species from mitochondrial DNA sequences and to help clarify the classification of this group.	[Garcia-Melo, Jorge E.; Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia; [Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.] Univ Estadual Paulista UNESP, Dept Morfol, Inst Biociencias, Campus Botucatu, Botucatu, SP, Brazil; [Da Costa Silva, Guilherme Jose] Univ Santo Amaro, Rua Prof Eneas de Siqueira Neto, Sao Paulo, SP, Brazil; [Garcia Pereira, Luiz Henrique] Univ Fed Integracao Latino Amer UNILA, Ctr Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil; [Garcia-Melo, Jorge E.] Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia		Garcia-Melo, JE (corresponding author), Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia.; Garcia-Melo, JE (corresponding author), Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia.	jgarcia-m@javeriana.edu.co	Oliveira, Claudio/D-7713-2012; García-Melo, Jorge E/AAU-3289-2020; Garcia Pereira, Luiz Henrique/S-4710-2017	Oliveira, Claudio/0000-0002-7010-8880; García-Melo, Jorge E/0000-0003-2885-5652; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Ochoa, Luz/0000-0003-4205-8510; Garcia Pereira, Luiz Henrique/0000-0001-9435-6347	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO) [567/2012]; Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana [00006552]; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17009-2, 2014/26502-3]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306054/2006-0]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO); Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JEGM was supported by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO, doctoral fellowship grant 567/2012) (www.colciencias.gov.co).JEGM and JAMO were supported by Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana (Project No 00006552) (www.javeriana.edu.co).CO was also financially supported by the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #2010/17009-2 and 2014/26502-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant #306054/2006-0) (www.fapesp.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210166; Bagley JC, 2015, MULTILOCUS SPECIES D, P1, DOI [10.1371/journal.pone.0121139, DOI 10.1371/JOURNAL.PONE.0121139]; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P737, DOI 10.1590/S1679-62252010000400005; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Casciotta JR, 2002, REV SUISSE ZOOL, V109, P155, DOI 10.5962/bhl.part.79584; Core Team R., 2019, LANG ENV STAT COMP R; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Silva José Francisco Pezzi da, 2004, Neotrop. ichthyol., V2, P55, DOI 10.1590/S1679-62252004000200002; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dellicour S, 2018, MOL ECOL RESOUR, V18, P1234, DOI 10.1111/1755-0998.12908; Dos Santos AR, 2012, HEREDITAS, V149, P24, DOI 10.1111/j.1601-5223.2011.02234.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2012, GENEIOUS V4 8 5; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eschmeyer W. N., 2018, CATALOG FISHES GENER; Eschmeyer WN, 2018, CATALOG FISHES CALIF; Escobar-Camacho D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135569; Ezard T, 2009, SPLITS SPECIES LIMIT, P1; Ferreira KM, 2007, ANALISE FILOGENETICA; FINK W L, 1976, Proceedings of the Biological Society of Washington, V88, P331; Fischer Johanne, 2013, FAO Fisheries and Aquaculture Technical Paper, V585, P3; Fricke, 2020, ESCHMEYERS CATALOG F; Fujisawa T, 2016, SYST BIOL, V65, P759, DOI 10.1093/sysbio/syw028; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Melo JE, 2018, J FISH BIOL, V92, P1929, DOI 10.1111/jfb.13634; Gery J, 1977, CHARACOIDS WORLD; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-14998U1.29; Han ZL, 2012, 2012 INTERNATIONAL CONFERENCE ON OPTICAL MEMS AND NANOPHOTONICS (OMN), P27, DOI 10.1109/OMEMS.2012.6318785; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Jacobs SJ, 2018, MOL ECOL, V27, P2397, DOI 10.1111/mec.14590; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larson ER, 2016, PEERJ, V4, DOI 10.7717/peerj.1915; Lima FCT, 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Malabarba Luiz R., 2000, Ichthyological Exploration of Freshwaters, V11, P315; Malabarba Luiz R., 2003, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V16, P67; Malabarba MCSL, 1995, P BIOL SOC WASH, V108, P1; Maldonado-Ocampo J.A., 2005, PECES ANDES COLOMBIA; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mazeti Camila Montoro, 2013, Acta Scientiarum Biological Sciences, V35, P241, DOI 10.4025/actascibiolsci.v35i2.11451; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Miquelarena AM, 1999, P BIOL SOC WASH, V112, P523; Miquelarena Amalia M., 1995, Revista Brasileira de Biologia, V55, P559; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; O'Connell KA, 2019, MOL PHYLOGENET EVOL, V134, P1, DOI 10.1016/j.ympev.2019.01.021; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paintner-Marques TR, 2002, HEREDITAS, V137, P107, DOI 10.1034/j.1601-5223.2002.01651.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pereira LHG, 2013, ANALISE DIVERSIDADE; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Piscor D, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-13; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Roman-Valencia C, 2014, ANIM BIODIV CONSERV, V37, P107; Roman-Valencia C, 2013, ANIM BIODIV CONSERV, V36, P123; Roman-Valencia C, 2010, ANIM BIODIV CONSERV, V33, P195; Roman-Valencia C, 2002, REV BIOL TROP, V50, P173; Roman-Valencia C, 2000, REV BIOL TROP, V48, P449; Roman-Valencia C., 2008, Animal Biodiversity and Conservation, V31, P15; Roman-Valencia C., 2003, MEMORIAS FUNDACION S, V2003, P31; Roman-Valencia C., 2005, MEMORIA FUNDACION SA, V163, P27; Roman-Valencia C., 2003, B MUS REG SCI NAT TO, V31, P447; Roman-Valencia C., 2001, B MUSEUM REGIONALLI, V18, P469; Roman-Valencia C., 2003, REV ASOCIACION COLOM, P17; Roman-Valencia C, 2017, REV INVESTIG, V29, P38, DOI 10.33975/riuq.vol29n1.13; Roman-Valencia C, 2011, REV MEX BIODIVERS, V82, P844; Roman-Valencia C, 2010, REV BIOL TROP, V58, P339; Roman-Valencia C, 2009, CALDASIA, V31, P393; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P465; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P455; Roman-Valencia Cesar, 2003, Dahlia, V6, P7; Roman-Valencia C, 2008, REV BIOL TROP, V56, P1749; Roman-Valencia Cesar, 2004, Dahlia, V7, P23; Roman-Valencia Cesar, 1999, Actualidades Biologicas (Medellin), V20, P109; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Serra JP, 2006, BIOTA NEOTROP, P6; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Song C, 2018, ZOOL SCR, V47, P311, DOI 10.1111/zsc.12284; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Taphorn D.C, 1992, BIOLLANIA EDICION ES, V4, P1; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; VARI RP, 1990, P BIOL SOC WASH, V103, P516; White BP, 2014, FRESHW SCI, V33, P338, DOI 10.1086/674982; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	111	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216786	10.1371/journal.pone.0216786	http://dx.doi.org/10.1371/journal.pone.0216786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166941	Green Published, gold, Green Submitted			2022-09-04	WOS:000470087800013
J	Mendoza, C; Perez-Urrutia, N; Alvarez-Ricartes, N; Barreto, GE; Perez-Ordas, R; Iarkov, A; Echeverria, V				Mendoza, Cristhian; Perez-Urrutia, Nelson; Alvarez-Ricartes, Nathalie; Barreto, George E.; Perez-Ordas, Raquel; Iarkov, Alex; Echeverria, Valentina			Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress	FRONTIERS IN NEUROSCIENCE			English	Article						depression; cotinine; anxiety; restraint stress; krill oil; astrocytes	IMPAIRS SPATIAL MEMORY; PREFRONTAL CORTEX; RECEPTOR EXPRESSION; NEUROTROPHIC FACTOR; ANIMAL-MODELS; OPEN-FIELD; DISORDER; VOLUME; ANXIETY; FEMALE	Restraint stress (RS) is a condition affecting millions of people worldwide. The investigation of new therapies to alleviate the consequences of prolonged RS is much needed. Cotinine, a nicotine-derivative, has shown to prevent the decrease in cerebral synaptic density, working memory deficits, anxiety, and depressive-like behavior after prolonged restraint stress (RS) in mice. Furthermore, post-treatment with cotinine reduced the adverse effects of chronic RS on astrocyte survival and architecture. On the other hand, the nutritional supplement krill oil (KO), has shown to be beneficial in decreasing depressive-like behavior and oxidative stress. In this study, in the search for effective preventative treatments to be used in people subjected to reduced mobility, the effect of co-treatment with cotinine plus KO in mice subjected to prolonged RS was investigated. The results show that cotinine plus KO prevented the loss of astrocytes, the appearance of depressive-like behavior and cognitive impairment induced by RS. The use of the combination of cotinine plus KO was more effective than cotinine alone in preventing the depressive-like behavior in the restrained mice. The potential use of this combination to alleviate the psychological effects of reduced mobility is discussed.	[Mendoza, Cristhian; Perez-Urrutia, Nelson; Alvarez-Ricartes, Nathalie; Iarkov, Alex; Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Concepcion, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Perez-Ordas, Raquel] Univ Pablo de Olavide, Fac Ciencias Actividad Fis & Deporte, Seville, Spain; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA		Echeverria, V (corresponding author), Univ San Sebastian, Fac Cs Salud, Concepcion, Chile.; Echeverria, V (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA.	echeverria.valentina@gmail.com	Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Perez Ordas, Raquel/0000-0001-7839-0350; Perez Urrutia, Nelson/0000-0001-9009-671X; Mendoza, Cristhian/0000-0002-5038-0991	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile [1150194]; Universidad San Sebastian, Chile	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile; Universidad San Sebastian, Chile	This work was supported by the Fondo de Ciencia y Tecnologia (FONDECYT) de Chile, (grant 1150194) and the Universidad San Sebastian, Chile.	Abidin I, 2004, INT J NEUROSCI, V114, P683, DOI 10.1080/00207450490430543; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Barros MP, 2014, NUTRIENTS, V6, P1293, DOI 10.3390/nu6031293; Bauer ME, 2001, PHYSIOL BEHAV, V73, P525, DOI 10.1016/S0031-9384(01)00503-0; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Belzung C, 2001, Curr Opin Investig Drugs, V2, P1108; Belzung C, 2001, BEHAV PHARMACOL, V12, P451, DOI 10.1097/00008877-200111000-00005; Bennett MR, 2014, PROG NEUROBIOL, V112, P80, DOI 10.1016/j.pneurobio.2013.10.005; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Cherian SB, 2009, INDIAN J EXP BIOL, V47, P893; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Conrad CD, 2004, PHARMACOL BIOCHEM BE, V78, P569, DOI 10.1016/j.pbb.2004.04.025; Conrad CD, 2010, PROG BRAIN RES, V182, P31, DOI 10.1016/S0079-6123(10)82002-3; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dalla C, 2010, BASIC CLIN PHARMACOL, V106, P226, DOI 10.1111/j.1742-7843.2009.00516.x; de Andrade JS, 2012, BEHAV BRAIN RES, V232, P20, DOI 10.1016/j.bbr.2012.03.034; de Bruin N, 2006, PHARMACOL BIOCHEM BE, V85, P253, DOI 10.1016/j.pbb.2006.08.007; de Filippis L, 2011, HISTOL HISTOPATHOL, V26, P1093, DOI 10.14670/HH-26.1093; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Filipovic BR, 2011, CENT EUR NEUROSURG, V72, P133, DOI 10.1055/s-0030-1253349; Franklin K.B.J., 1997, MOUSE BRAIN STEREOTA, DOI [10.1111/j.1469-7580.2004.00264.x, DOI 10.1111/J.1469-7580.2004.00264.X]; Garzon D, 2016, J MOL NEUROSCI, V58, P483, DOI 10.1007/s12031-016-0719-6; Gonul AS, 2011, WORLD J BIOL PSYCHIA, V12, P110, DOI 10.3109/15622975.2010.507786; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Hammen C, 2003, J AFFECT DISORDERS, V74, P49, DOI 10.1016/S0165-0327(02)00430-5; Hayase T, 2011, J TOXICOL SCI, V36, P31, DOI 10.2131/jts.36.31; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jaggi AS, 2011, NEUROL SCI, V32, P993, DOI 10.1007/s10072-011-0770-6; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Kassem MS, 2013, MOL NEUROBIOL, V47, P645, DOI 10.1007/s12035-012-8365-7; Kleen JK, 2006, BEHAV NEUROSCI, V120, P842, DOI 10.1037/0735-7044.120.4.842; Lee Y, 2013, J PSYCHIATR NEUROSCI, V38, P183, DOI 10.1503/jpn.120024; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Luine VN, 2007, J NEUROENDOCRINOL, V19, P743, DOI 10.1111/j.1365-2826.2007.01594.x; Luine V, 2016, J STEROID BIOCHEM, V160, P189, DOI 10.1016/j.jsbmb.2015.07.022; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; McEwen BS, 1997, EUR NEUROPSYCHOPHARM, V7, P323, DOI 10.1016/S0924-977X(97)00064-3; Mika A, 2012, BEHAV NEUROSCI, V126, P605, DOI 10.1037/a0029642; Moreira PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163245; Muscatelli S, 2017, J ORTHOP TRAUMA, V31, P47, DOI 10.1097/BOT.0000000000000664; Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Perez-Urrutia N, 2017, EXP NEUROL, V295, P211, DOI 10.1016/j.expneurol.2017.06.016; Polotow TG, 2015, MAR DRUGS, V13, P6117, DOI 10.3390/md13106117; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Reagan LP, 2008, EUR J PHARMACOL, V585, P64, DOI 10.1016/j.ejphar.2008.02.050; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Scharfman HE, 2014, NEUROPHARMACOLOGY, V76, P696, DOI 10.1016/j.neuropharm.2013.04.029; Schmitz C, 2002, MOL PSYCHIATR, V7, P810, DOI 10.1038/sj.mp.4001118; SCHOUSBOE A, 1992, PROG BRAIN RES, V94, P199; Serchov T, 2016, BIOL CHEM, V397, P207, DOI 10.1515/hsz-2015-0267; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Tafet GE, 2003, PROG NEURO-PSYCHOPH, V27, P893, DOI 10.1016/S0278-5846(03)00162-3; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Tymen SD, 2013, BRAIN BEHAV IMMUN, V28, P207, DOI 10.1016/j.bbi.2012.07.013; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; Zschocke J, 2005, J BIOL CHEM, V280, P34924, DOI 10.1074/jbc.M502581200	77	7	7	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 17	2018	12								952	10.3389/fnins.2018.00952	http://dx.doi.org/10.3389/fnins.2018.00952			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE4WM	30618579	Green Published, gold			2022-09-04	WOS:000453369800001
J	Lopez, G; Diaz-Cardenas, C; Alzate, JD; Gonzalez, LN; Shapiro, N; Woyke, T; Kyrpides, NC; Restrepo, S; Baena, S				Lopez, G.; Diaz-Cardenas, C.; Alzate, J. David; Gonzalez, L. N.; Shapiro, N.; Woyke, T.; Kyrpides, N. C.; Restrepo, S.; Baena, S.			Description of Alicyclobacillus montanus sp nov., a mixotrophic bacterium isolated from acidic hot springs	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article						16S rRNA; gyrB; Firmicutes; Alicyclobacillaceae; Alicyclobacillus montanus	SULFATE-REDUCING BACTERIUM; GEN. NOV.; THERMOPHILIC BACTERIUM; OXIDIZING BACTERIUM; EMENDED DESCRIPTION; FATTY-ACIDS; SOIL; MINE; PROPOSAL; GENOME	Three morphologically similar thermo-acidophilic strains, USBA-GBX-501, USBA-GBX-502 and USBA-GBX-503(T), were isolated from acidic thermal springs at the National Natural Park Los Nevados (Colombia). All isolates were spore-forming, Gram-stain-positive and motile, growing aerobically at 25-55 degrees C (optimum similar to 45 degrees C) and at pH 1.5-4.5 (optimum pH similar to 3.0). Phylogenetic analysis of the 16S rRNA gene sequences of these isolates showed an almost identical sequence (99.0% similarity) and they formed a robust cluster with the closest relative Alicyclobacillus tolerans DSM 16297(T) with a sequence similarity of 99.0 %. Average similarity to other species of the genus Alicyclobacillus was 93.0% and average similarity to species of the genus Effusibacillus was 90 %. In addition, the level of DNA-DNA hybridization between strain USBA-GBX-503(T) and Alicyclobacillus tolerans DSM 16297(T) was 31.7 %. The genomic DNA G+C content of strain USBA-GBX-503(T) was 44.6 mol %. The only menaquinone was MK-7 (100.0 %). No omega-alicyclic fatty acids were detected in strain USBA-GBX-503(T), and the major cellular fatty acids were C-18:(1)omega 7c, anteiso- C-17:0 and iso-C-17:0. Based on phenotypic and chemotaxonomic characteristics, phylogenetic analysis and DNA-DNA relatedness values, along with low levels of identity at the whole genome level (ANIb and ANIm values of <67.0 and < 91.0 %, respectively), it can be concluded that strain USBA-GBX-503(T) represents a novel species of the genus Alicyclobacillus, for which the name Alicyclobacillus montanus sp. nov. is proposed. The type strain is USBA-GBX-503(T) (=CMPUJ UGB U503(T) = CBMAI1927(T)).	[Lopez, G.; Diaz-Cardenas, C.; Baena, S.] Pontificia Univ Javeriana, Dept Biol, USBA, POB 56710, Bogota, Colombia; [Lopez, G.; Baena, S.] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, DC, Colombia; [Alzate, J. David; Gonzalez, L. N.; Restrepo, S.] Univ Los Andes, Biol Sci Dept, Cra 1 18A-12, Bogota, Colombia; [Shapiro, N.; Woyke, T.; Kyrpides, N. C.] Joint Genome Inst, Dept Energy, Genome Biol Program, Walnut Creek, CA USA		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, USBA, POB 56710, Bogota, Colombia.; Baena, S (corresponding author), Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, DC, Colombia.	baena@javeriana.edu.co	López, Gina/AAF-8171-2019; Kyrpides, Nikos C./A-6305-2014; Baena, Sandra/AAF-8165-2019	Kyrpides, Nikos C./0000-0002-6131-0462; Lopez Ramirez, Gina/0000-0002-4210-089X; Gonzalez Garcia, Laura Natalia/0000-0002-4079-8956; Baena, Sandra/0000-0001-5377-9079	Pontificia Universidad Javeriana; Universidad de los Andes; Colciencias-Sena [6570-392-199990]; MAVDT [76]; Office of Science of the U.S. Department of Energy [DEAC02-05CH11231]	Pontificia Universidad Javeriana; Universidad de los Andes; Colciencias-Sena(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MAVDT; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This research was funded by Pontificia Universidad Javeriana, Universidad de los Andes and Colciencias-Sena (Project 6570-392-199990). It was done under the Access to Genetic Resources (AGR) contract MAVDT No. 76, 2013 and research permit No. DTNO-N-20/2007. The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported by the Office of Science of the U.S. Department of Energy under Contract No. DEAC02-05CH11231. Special thanks to Professor Claudia Parra for her valuable assistance with the MALDI-TOF analysis.	Albuquerque L, 2000, INT J SYST EVOL MICR, V50, P451, DOI 10.1099/00207713-50-2-451; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baena S, 2011, INT J SYST EVOL MICR, V61, P732, DOI 10.1099/ijs.0.020586-0; Bevilacqua A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141228; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINK ROBERT H., 1960, SOIL SCI, V89, P157, DOI 10.1097/00010694-196003000-00006; Bushnell B., 2016, BBTOOLS SOFTWARE PAC; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003; Delgado-Serrano L, 2014, FEMS MICROBIOL ECOL, V89, P56, DOI 10.1111/1574-6941.12333; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P1437, DOI 10.1099/ijs.0.010926-0; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goto K, 2003, INT J SYST EVOL MICR, V53, P1537, DOI 10.1099/ijs.0.02546-0; Goto K, 2002, INT J SYST EVOL MICR, V52, P109, DOI 10.1099/00207713-52-1-109; Goto K, 2007, INT J SYST EVOL MICR, V57, P1276, DOI 10.1099/ijs.0.64692-0; Guo X, 2009, INT J SYST EVOL MICR, V59, P2415, DOI 10.1099/ijs.0.008870-0; Hungate RE., 1979, METHOD MICROBIOL, P117; Huntemann M, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0077-y; IMHOFFSTUCKLE D, 1983, ARCH MICROBIOL, V136, P194, DOI 10.1007/BF00409843; Itoh T, 2003, INT J SYST EVOL MICR, V53, P1149, DOI 10.1099/ijs.0.02580-0; Jiang CY, 2008, INT J SYST EVOL MICR, V58, P2898, DOI 10.1099/ijs.0.2008/000562-0; Karavaiko GI, 2005, INT J SYST EVOL MICR, V55, P941, DOI 10.1099/ijs.0.63300-0; Karavaiko GI, 2001, MICROBIOLOGY+, V70, P245, DOI 10.1023/A:1010463007138; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kusube M, 2014, INT J SYST EVOL MICR, V64, P2257, DOI 10.1099/ijs.0.061440-0; MANNING HL, 1975, APPL MICROBIOL, V30, P1010, DOI 10.1128/AEM.30.6.1010-1016.1975; Matsubara H, 2002, INT J SYST EVOL MICR, V52, P1681, DOI [10.1099/ijs.0.02169-0, 10.1099/00207713-52-5-1681]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584, DOI 10.1128/JCM.16.3.584-586.1982; Nakano C, 2015, INT J SYST EVOL MICR, V65, P716, DOI 10.1099/ijs.0.068957-0; Nicolaus B, 1998, POLAR BIOL, V19, P133, DOI 10.1007/s003000050224; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Rubiano-Labrador C, 2013, INT J SYST EVOL MICR, V63, P1396, DOI 10.1099/ijs.0.037937-0; Schleifer K. -H., 2009, BERGEYS MANUAL SYSTE, P19; Simbahan J, 2004, INT J SYST EVOL MICR, V54, P1703, DOI 10.1099/ijs.0.03012-0; Slobodkin AI, 1999, INT J SYST BACTERIOL, V49, P1471, DOI 10.1099/00207713-49-4-1471; TINDALL BJ, 1990, SYST APPL MICROBIOL, V13, P128, DOI 10.1016/S0723-2020(11)80158-X; Tsuruoka N, 2003, INT J SYST EVOL MICR, V53, P1081, DOI 10.1099/ijs.0.02409-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263; Zhang B, 2015, INT J SYST EVOL MICR, V65, P4915, DOI 10.1099/ijsem.0.000695	43	8	8	4	26	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	MAY	2018	68	5					1608	1615		10.1099/ijsem.0.002718	http://dx.doi.org/10.1099/ijsem.0.002718			8	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	GH1OA	29557767	Bronze			2022-09-04	WOS:000433171000031
J	Perez-Anton, E; Egui, A; Thomas, MC; Puerta, CJ; Gonzalez, JM; Cuellar, A; Segovia, M; Lopez, MC				Perez-Anton, Elena; Egui, Adriana; Carmen Thomas, M.; Puerta, Concepcion J.; Mario Gonzalez, John; Cuellar, Adriana; Segovia, Manuel; Carlos Lopez, Manuel			Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4(+) CD8(+) T cells in chronic Chagas disease patients	PLOS NEGLECTED TROPICAL DISEASES			English	Article							IMMUNE-RESPONSE; CHRONIC PHASE; EXHAUSTION; EXPRESSION; PERFORIN; GAMMA; MAINTENANCE; LYMPHOCYTES; PHENOTYPE; MOLECULES	Background Chagas disease is caused by Trypanosoma cruzi. The persistence of the parasite is associated with the disease chronicity and the impairment of the cellular immune response. It has been reported that the CD4(+)CD8(+) T cell population expands in chronic Chagas disease patients. Few studies have focused on this subset of cells, and very little is known about the impact of antiparasitic treatment on this population. Methodology Thirty-eight chronic Chagas disease patients (20 asymptomatic and 18 symptomatic) and twelve healthy controls were enrolled in this study. Peripheral blood mononuclear cells were stimulated with soluble T. cruzi antigens to analyze the production of cytokines and cytotoxic molecules by CD4(+)CD8(+) T cells before and after benznidazole treatment. Additionally, expression and co-expression of five inhibitory receptors in these patients after treatment were studied using a multiparameter flow cytometry technique. Principal findings The frequency of CD4(+)CD8(+) T cells was higher in chronic Chagas disease patients compared with healthy donors. Furthermore, a higher ratio of CD4(+)CD8(low)/CD4(+)CD8(high) sub populations was observed in chronic Chagas disease patients than in healthy donors. Additionally, CD4(+)CD8(+) T cells from these patients expressed and co-expressed higher levels of inhibitory receptors in direct proportion to the severity of the pathology. Benznidazole treatment reduced the frequency of CD4(+)CD8(+) T cells and decreased the ratio of CD4(+)CD8(low)/CD4(+)CD8(high) subpopulations. The co-expression level of the inhibitory receptor was reduced after treatment simultaneously with the enhancement of the multifunctional capacity of CD4(+)CD8(+) T cells. After treatment, an increase in the frequency of T. cruzi antigen -specific CD4(+)CD8(+) T cells expressing IL-2 and TNF-alpha was also observed. Conclusions CD4(+)CD8(+) T cells could play an important role in the control of T. cruzi infection since they were able to produce effector molecules for parasite control. Benznidazole treatment partially reversed the exhaustion process caused by T. cruzi infection in these cells with an improvement in the functional response of the T. cruziantigen-specific CD4(+)CD8(+) T cells.	[Perez-Anton, Elena; Egui, Adriana; Carmen Thomas, M.; Carlos Lopez, Manuel] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Puerta, Concepcion J.] Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia; [Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol, Bogota, Colombia; [Segovia, Manuel] Hosp Virgen Arrixaca, Unidad Reg Med Trop, Murcia, Spain		Lopez, MC (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mclopez@ipb.csic.es	Thomas, María Carmen PhD/D-9065-2016; Pérez-Antón, elena/AAU-9102-2021; Egui, Adriana/AAA-5983-2019; Lopez, Manuel/Z-5641-2019; Cuellar, Adriana/AAF-2958-2019; Puerta, Concepcion J/AAG-4912-2019	Pérez-Antón, elena/0000-0002-9397-3914; Egui, Adriana/0000-0002-3038-0468; Thomas, M Carmen/0000-0003-3586-9657; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Lopez, Manuel Carlos/0000-0003-0002-3678	Programa Estatal I+D+i (MINECO) [SAF2016-81003-R, SAF2016-80998-R]; Network of Tropical Diseases Research - RICET (Instituto de Salud Carlos III) [RD16/0027/0005, RD16/0027/0016]; FEDER	Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research - RICET (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); FEDER(European Commission)	This study was supported by the grants SAF2016-81003-R and SAF2016-80998-R from the Programa Estatal I+D+i (MINECO); The Network of Tropical Diseases Research - RICET (Instituto de Salud Carlos III), grants RD16/0027/0005 and RD16/0027/0016 and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002575; Arguello RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035966; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; BLUE ML, 1985, J IMMUNOL, V134, P2281; Bustamante JM, 2007, INT J ANTIMICROB AG, V29, P733, DOI 10.1016/j.ijantimicag.2007.01.014; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Chauhan NK, 2012, J MED VIROL, V84, P845, DOI 10.1002/jmv.23289; Clenet ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11926-2; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; de Melo AS, 2012, CYTOKINE, V58, P207, DOI 10.1016/j.cyto.2012.01.008; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fragata AA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004508; Frebel H, 2010, EUR J IMMUNOL, V40, P654, DOI 10.1002/eji.200940102; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Giraldo NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001294; Jordan KA, 2010, EXP PARASITOL, V126, P318, DOI 10.1016/j.exppara.2010.05.008; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Lasso P, 2015, J IMMUNOL, V195, P3748, DOI 10.4049/jimmunol.1500459; Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332; Mateus J, 2017, J IMMUNOL, V198, P3170, DOI 10.4049/jimmunol.1602095; Mateus J, 2013, BIOMEDICA, V33, P660, DOI 10.7705/biomedica.v33i4.1709; Muller U, 2003, EUR J IMMUNOL, V33, P70, DOI 10.1002/immu.200390009; Murcia L, 2010, J ANTIMICROB CHEMOTH, V65, P1759, DOI 10.1093/jac/dkq201; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Nascimbeni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020145; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Perez AR, 2012, ANN NY ACAD SCI, V1262, P27, DOI 10.1111/j.1749-6632.2012.06627.x; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Peters NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004538; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Pinazo MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001965; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; Pombo C, 2015, J INFECT DIS, V212, P1376, DOI 10.1093/infdis/jiv226; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; Silverio JC, 2010, INT J EXP PATHOL, V91, P72, DOI 10.1111/j.1365-2613.2009.00670.x; da Silva GMS, 2014, ANTIMICROB AGENTS CH, V58, P6371, DOI 10.1128/AAC.02842-14; Sullivan YB, 2001, IMMUNOLOGY, V103, P270, DOI 10.1046/j.1365-2567.2001.01243.x; Tarleton RL, 2015, SEMIN IMMUNOPATHOL, V37, P233, DOI 10.1007/s00281-015-0481-9; TARLETON RL, 1991, RES IMMUNOL, V142, P130, DOI 10.1016/0923-2494(91)90022-B; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Tu TC, 2015, J EXP MED, V212, P415, DOI 10.1084/jem.20131601; Vallejo A, 2016, ACTA TROP, V164, P117, DOI 10.1016/j.actatropica.2016.09.010; Vigano S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004380; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; Walker LSK, 2017, IMMUNOL LETT, V184, P43, DOI 10.1016/j.imlet.2017.02.007; Waterhouse NJ, 2006, J CELL BIOL, V173, P133, DOI 10.1083/jcb.200510072; Weiss L, 1998, J INFECT DIS, V178, P1158, DOI 10.1086/515674; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHO, 2002, CONTR CHAG DIS; Xie DX, 2009, CELL IMMUNOL, V259, P157, DOI 10.1016/j.cellimm.2009.06.011	66	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2018	12	5							e0006480	10.1371/journal.pntd.0006480	http://dx.doi.org/10.1371/journal.pntd.0006480			22	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	GH9WW	29750791	Green Published, Green Submitted, gold			2022-09-04	WOS:000434021900035
J	Poncela, P; Senra, E; Sierra, L				Poncela, Pilar; Senra, Eva; Paola Sierra, Lya			Long-term links between raw materials prices, real exchange rate and relative de-industrialization in a commodity-dependent economy: empirical evidence of "Dutch disease" in Colombia	EMPIRICAL ECONOMICS			English	Article						Dutch disease; Commodity prices; Cointegration analysis	CAPITAL INFLOWS; BOOMING SECTOR; COINTEGRATION; ADJUSTMENT; SHOCKS; COFFEE; TRADE; MONEY; OIL	The term Dutch disease appears in relation to the Netherlands discovery of large gas deposits in the North Sea and its harmful effects on the country industrial sector. The sudden increase in the country's wealth created an inflow of capital never seen before, which led to an appreciation of its currency and, therefore, a loss of competiveness in the non-energy exporting sector. The purpose of this article is to provide empirical evidence of Dutch disease in Colombia. This country is different from other economies analyzed for Dutch disease since it has been dependent on two different commodities, coffee first and oil lately. Hence, we focus on the long-run analysis and test by means of a vector error correction model whether commodity prices are related to the real exchange rate and the relative manufacturing output. The long-run relations as well as the impulse response analysis clearly show that commodity prices are positively related to the real exchange rate. Thus, increases in commodity prices have a negative effect on the competitiveness of the country. Our result also shows that public spending is a major source of pressure on the Colombian real exchange rate.	[Poncela, Pilar] Univ Autonoma Madrid, Dept Anal Econ Economia Cuantitat, C Francisco,Tomas & Valiente 5, E-28049 Madrid, Spain; [Senra, Eva] Univ Alcala, Dept Econ, Plaza Victoria 2, Madrid 28802, Spain; [Paola Sierra, Lya] Pontificia Univ Javeriana, Dept Econ, Calle 18 118-250 Av Canasgordas, Cali, Colombia; [Poncela, Pilar] European Commiss, Joint Res Ctr, Ispra, Italy		Sierra, L (corresponding author), Pontificia Univ Javeriana, Dept Econ, Calle 18 118-250 Av Canasgordas, Cali, Colombia.	lyap@javerianacali.edu.co	Poncela, Pilar/AAB-1726-2019; Sierra, Lya/J-5607-2016; Senra, Eva/L-3535-2014	Poncela, Pilar/0000-0002-0848-3997; Sierra, Lya/0000-0002-8909-8977; Senra, Eva/0000-0003-4422-7648	Spanish Ministry of Economy and Competitiveness [ECO2012-32854, ECO2014-56676C2-2-P]; Pontificia Universidad Javeriana Cali	Spanish Ministry of Economy and Competitiveness(Spanish Government); Pontificia Universidad Javeriana Cali	We thank the participants of the XVI Applied Economics Meeting, EEA, for their useful comments. Moreover, we thank Sebastian Voigt for commenting this article at the 20th European Association of Environmental and Resource Economist, EAERE. The first and second authors acknowledge financial support from Spanish Ministry of Economy and Competitiveness, Projects Numbers ECO2012-32854 and ECO2014-56676C2-2-P, respectively. Support from the Pontificia Universidad Javeriana Cali to the third author is gratefully acknowledged.	Acosta PA, 2009, J INT ECON, V79, P102, DOI 10.1016/j.jinteco.2009.06.007; Aizenman J, 2012, J INT MONEY FINANC, V31, P1990, DOI 10.1016/j.jimonfin.2012.05.003; Alberola E, 2003, 0309 BANK SPAIN; Algieri B, 2011, ECON CHANG RESTRUCT, V44, P243, DOI 10.1007/s10644-011-9101-4; Arellano C, 2005, WP05119 IMF; Beine M, 2012, RESOUR ENERGY ECON, V34, P468, DOI 10.1016/j.reseneeco.2012.05.002; Benassy-Quere A, 2004, 13 CEPII RES CTR; Benedictow A, 2013, ECON MODEL, V32, P400, DOI 10.1016/j.econmod.2013.02.016; BRUNO M, 1982, REV ECON STUD, V49, P845, DOI 10.2307/2297191; Buiter WH, 1983, EC INTERDEPENDENCE F; CHATTERJI M, 1988, OXFORD ECON PAP, V40, P302, DOI 10.1093/oxfordjournals.oep.a041854; Corden W.M., 1994, EC POLICY EXCHANGE R; CORDEN WM, 1984, OXFORD ECON PAP, V36, P359, DOI 10.1093/oxfordjournals.oep.a041643; CORDEN WM, 1982, ECON J, V92, P825, DOI 10.2307/2232670; Corden WM, 2002, SENSATIONAL CHOICE E; Coudert V, 2011, WORLD ECON, V34, P1557, DOI 10.1111/j.1467-9701.2011.01400.x; DAVIS GA, 1995, WORLD DEV, V23, P1765, DOI 10.1016/0305-750X(95)00071-J; DeLoach S., 2001, REV INT ECON, V9, P336; EDWARDS S, 1984, WORLD DEV, V12, P1107, DOI 10.1016/0305-750X(84)90005-6; Edwards S, 1989, REAL EXCHANGE RATES; Egert B, 2008, OPEN ECON REV, V19, P147, DOI 10.1007/s11079-007-9051-7; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Guha P, 2013, ECON MODEL, V33, P292, DOI 10.1016/j.econmod.2013.04.016; Ismail K., 2010, INT MONETARY FUND, DOI DOI 10.5089/9781455200627.001; JOHANSEN S, 1991, ECONOMETRICA, V59, P1551, DOI 10.2307/2938278; Johansen Soren, 1995, LIKELIHOOD BASED INF; KAMAS L, 1986, WORLD DEV, V14, P1177, DOI 10.1016/0305-750X(86)90119-1; Kang SJ, 2011, WORLD ECON, V34, P313, DOI 10.1111/j.1467-9701.2010.01324.x; KRUGMAN P, 1987, J DEV ECON, V27, P41, DOI 10.1016/0304-3878(87)90005-8; Lartey EKK, 2007, J INT TRADE ECON DEV, V16, P337, DOI 10.1080/09638190701526667; Lartey EKK, 2011, REV DEV ECON, V15, P556, DOI 10.1111/j.1467-9361.2011.00627.x; Lartey EKK, 2008, INT FINANC, V11, P131, DOI 10.1111/j.1468-2362.2008.01222.x; Mackinnon JG, 1999, J APPL ECONOM, V14, P563, DOI 10.1002/(SICI)1099-1255(199909/10)14:5<563::AID-JAE530>3.0.CO;2-R; Meisel A, 1998, CUADERNOS HIST EC EM; Morshed AKMM, 2004, J INT ECON, V63, P147, DOI 10.1016/S0022-1996(03)00038-2; NEARY JP, 1982, SCAND J ECON, V84, P229, DOI 10.2307/3439637; NEARY JP, 1988, AM ECON REV, V78, P210; Nkusu M, 2004, WP0449 IMF; Otero J, 2000, ECON LETT, V67, P5, DOI 10.1016/S0165-1765(99)00245-1; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Prati A, 2005, WP06145 IMF; Puyana A., 2000, INT J POLITICS CULT, V14, P205; Raju SS, 2003, J POLICY MODEL, V25, P963, DOI 10.1016/j.jpolmod.2003.09.001; Salter W, 1959, ECON REC, V238, P35; Stokke HE, 2008, ECON MODEL, V25, P148, DOI 10.1016/j.econmod.2007.05.005; Suescun R, 1997, SUBGERENCIA ESTUDIOS; Swan T.W., 1960, ECON REC, V36, P51, DOI DOI 10.1111/ECOR.1960.36.ISSUE-73; van der Ploeg F, 2011, J ECON LIT, V49, P366, DOI 10.1257/jel.49.2.366	48	9	14	0	27	PHYSICA-VERLAG GMBH & CO	HEIDELBERG	PO BOX 10 52 80, 69042 HEIDELBERG, GERMANY	0377-7332	1435-8921		EMPIR ECON	Empir. Econ.	MAR	2017	52	2					777	798		10.1007/s00181-016-1083-7	http://dx.doi.org/10.1007/s00181-016-1083-7			22	Economics; Social Sciences, Mathematical Methods	Social Science Citation Index (SSCI)	Business & Economics; Mathematical Methods In Social Sciences	EM1FS					2022-09-04	WOS:000395064100014
J	Lizarazo, NE; Munoz-Martinez, AM; Santos, MM; Kanter, JW				Esparza Lizarazo, Natalia; Munoz-Martinez, Amanda M.; Santos, Maria M.; Kanter, Jonathan W.			A Within-Subjects Evaluation of the Effects of Functional Analytic Psychotherapy on In-Session and Out-of-Session Client Behavior	PSYCHOLOGICAL RECORD			English	Article						Functional Analytic Psychotherapy; Clinically relevant behaviors; Daily life problems; Therapeutic rules; Behavior change	DEPRESSION	Previous research has shown the effect of the five rules of Functional Analytic Psychotherapy (FAP) on target behaviors, but has not isolated the effects of FAP's hypothesized mechanism of contingent responding with reinforcement to in-session behavior (Rule 3) from evoking the behavior (Rule 2). The current study demonstrates the effects of FAP on in-session clinically relevant behaviors (CRBs) and out-of-session client behaviors, or daily life problems (DLPs) in an A/A + B design in which the A phase controlled for evoking CRB (Rule 2) and the A + B phase introduced contingent responding to CRB with reinforcement (Rule 3). Three clients presenting with emotional expression difficulties participated in this study. As per previous research, trained, reliable coders analyzed CRBs by rating session recordings with the FAP Rating Scale (FAPRS), and clients completed self-monitoring templates weekly to track out-of-session behaviors. Results showed FAP-phase-related improvements in CRBs and out-of-session behaviors in two of the three clients, with improvements maintained for one client for whom follow-up data were collected over a brief period. While earlier investigations have not explored the sustainability of behavioral improvements, the present study provides findings that are suggestive of this effect. Some recommendations to improve the reliability and generalization of these outcomes are discussed.	[Esparza Lizarazo, Natalia] Pontificia Univ Javeriana, Dept Psychol, Bogota, Colombia; [Munoz-Martinez, Amanda M.] Fdn Univ Konrad Lorenz, Bogota, Colombia; [Santos, Maria M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Kanter, Jonathan W.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA		Kanter, JW (corresponding author), Univ Washington, Dept Psychol, Box 351525, Seattle, WA 98195 USA.	jonkan@uw.edu		Kanter, Jonathan/0000-0001-5317-5152; MUNOZ, AMANDA/0000-0001-5558-4355				Busch AM, 2010, J CONTEMP PSYCHOTHER, V40, P11, DOI 10.1007/s10879-009-9122-8; Busch AM, 2009, BEHAV THER, V40, P280, DOI 10.1016/j.beth.2008.07.003; Callaghan G., 2008, BEHAV ANAL TODAY, V9, P57; Callaghan G. C., 2015, CURRENT OPINION PSYC; Callaghan G. M., 2006, BEHAV ANAL TODAY, V7, P357, DOI DOI 10.1037/H0100160; Callaghan G.M., 2008, BEHAV ANALYST TODAY, V9, P98, DOI [10.1037/h0100648, DOI 10.1037/H0100648]; Callaghan G. M., 2003, J CONTEMP PSYCHOTHER, V33, P321, DOI DOI 10.1023/B:J0CP.0000004502.55597.81; Kanter JW, 2006, J APPL BEHAV ANAL, V39, P463, DOI 10.1901/jaba.2006.21-06; Kazdin A. E., 2013, BEHAV MODIFICATION A; Kohlenberg R. J., 1991, FUNCTIONAL ANAL PSYC; Kohlenberg RJ, 2002, COGN BEHAV PRACT, V9, P213, DOI 10.1016/S1077-7229(02)80051-7; Kratochwill TR, 2014, J SCHOOL PSYCHOL, V52, P231, DOI 10.1016/j.jsp.2014.01.003; Landes SJ, 2013, J CONTEXTUAL BEHAV S, V2, P49, DOI 10.1016/j.jcbs.2013.03.004; Mangabeira V., 2012, INT J BEHAV CONSULTA, V7, P78, DOI [10.1037/h0100941, DOI 10.1037/H0100941]; Munoz-Martinez A. M., 2012, INT J BEHAV CONSULTA, V7, P96; Munoz-Martinez AM, 2011, UNIV PSYCHOL, V10, P501; Oshiro C.K.B., 2012, INT J BEHAV CONSULTA, V7, P111, DOI [DOI 10.1037/H0100945, https://doi.org/10.1037/h0100945]; Rodriguez-Naranjo C, 1998, PSICOTHEMA, V10, P85; Rush AJ., 1979, COGNITIVE THERAPY DE; Valdivia S., 2007, INT J PSYCHOL PSYCHO, V7, P347; Weeks CE, 2012, BEHAV MODIF, V36, P87, DOI 10.1177/0145445511422830	21	18	20	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-2933	2163-3452		PSYCHOL REC	Psychol. Rec.	SEP	2015	65	3					463	474		10.1007/s40732-015-0122-7	http://dx.doi.org/10.1007/s40732-015-0122-7			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	CN8DH					2022-09-04	WOS:000358667600005
J	Hoy, D; Geere, JA; Davatchi, F; Meggitt, B; Barrero, LH				Hoy, Damian; Geere, Jo-Anne; Davatchi, Fereydoun; Meggitt, Belinda; Barrero, Lope H.			A time for action: Opportunities for preventing the growing burden and disability from musculoskeletal conditions in low- and middle-income countries	BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY			English	Article						Musculoskeletal; Rheumatology; Burden; Disability; Low income; Middle income; Developing; Prevention	LOW-BACK-PAIN; RANDOMIZED CONTROLLED-TRIAL; ALEXANDER TECHNIQUE LESSONS; ROAD TRAFFIC INJURIES; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; CHRONIC DISEASES; MASSAGE ATEAM; RISK-FACTORS; NECK PAIN	Musculoskeletal (MSK) conditions cause an enormous global burden, and this is dramatically increasing in developing countries, particularly due to rapidly ageing populations and increasing obesity. Many of the global non-communicable disease (NCD) initiatives need to expand beyond the traditional 'top four' NCD groups by incorporating MSK diseases. It is critical that MSK initiatives in developing countries integrate well with health systems, rather than being stand-alone. A better inclusion of MSK conditions will avoid doubling of efforts and wasting of resources, and will help to promote a more streamlined, cost-effective approach. Other key opportunities for action include the following: ensuring the principles of 'development effectiveness' are met; strengthening leadership and commitment; building the research, information and evidence base; and reducing the incidence and disability of MSK conditions through better prevention. Each of these elements is necessary to mitigate and reduce the growing burden from the MSKs. (C) 2014 Elsevier Ltd. All rights reserved.	[Hoy, Damian] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Geere, Jo-Anne] Univ E Anglia, Sch Rehabil Sci, Norwich NR4 7TJ, Norfolk, England; [Davatchi, Fereydoun] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran 74177, Iran; [Davatchi, Fereydoun] Shariati Hosp, Dept Internal Med, Div Rheumatol, Tehran 74177, Iran; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia		Hoy, D (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	damehoy@yahoo.com.au; jo.geere@uea.ac.uk; fddh@davatchi.net; bmeggitt@gmail.com; lopehugo@javeriana.edu.co	Davatchi, Fereydoun/L-9490-2016	Davatchi, Fereydoun/0000-0003-0508-7013; Barrero, Lope/0000-0003-1503-0264				Adebajo A, 2010, ARTHRIT CARE RES, V62, P439, DOI 10.1002/acr.20032; Akhter E, 2011, RHEUMATOL INT, V31, P849, DOI 10.1007/s00296-011-1820-3; [Anonymous], 2014, GLOB ALL CHRON DIS; Bachani AM, 2012, TRAFFIC INJ PREV, V13, P24, DOI 10.1080/15389588.2011.633136; Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013; Black C, 2008, WORKING HEALTHIER TO; Boardman Allison, 2011, Iowa Orthop J, V31, P30; Bunning K, 2013, SURVEY REHABILITATIO; Cassels A, 1998, LANCET, V352, P1777, DOI 10.1016/S0140-6736(98)05350-1; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Croucher R, 2013, INT LIT REV; Department of population and social affairs, 2012, POP AG DEV 2012; Doyel L., 2009, CONTIN MED ED, V27, P456; Dye C, 2013, WORLD HLTH REP 2013; Faller G, 2009, BEST PRACT RES CL RH, V23, P643, DOI 10.1016/j.berh.2009.07.006; Francavilla F, 2003, HOUSEHOLD CHORES CHI; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Geere JAL, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-52; Gona JK, 2013, RURAL REMOTE HEALTH, V13; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Gray G, 2007, PAIN, V132, pS13, DOI 10.1016/j.pain.2007.10.009; Haldeman S, 2012, BEST PRACT RES CL RH, V26, P263, DOI 10.1016/j.berh.2012.03.006; Haldeman S, 2009, J MANIP PHYSIOL THER, V32, pS7, DOI 10.1016/j.jmpt.2008.11.005; Hartley S, 2009, LANCET, V374, P1803, DOI 10.1016/S0140-6736(09)62036-5; Hartley SE, 2006, CBR PART COMMUNITY D; Hartvigsen J, 2001, SPINE, V26, P1788, DOI 10.1097/00007632-200108150-00011; Hemson D, 2007, POLICY FUTURES EDUC, V5, P315, DOI 10.2304/pfie.2007.5.3.315; Heneweer H, 2012, EUR SPINE J, V21, P1265, DOI 10.1007/s00586-011-2097-7; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; High Level Forum on Aid Effectiveness, 2008, HIGH LEVEL FORUM AID; High Level Forum on Aid Effectiveness, 2005, HIGH LEVEL FORUM AID; High Level Forum on Aid Effectiveness, 2011, HIGH LEV FOR AID EFF; Hollinghurst Sandra, 2008, BMJ, V337, pa2656, DOI 10.1136/bmj.a2656; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2003, LANCET, V361, P225, DOI 10.1016/S0140-6736(03)12254-4; Hoy D, 2014, ANN RHEUM DIS; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hoy DG, 2014, ANN RHEUM DIS, V73, P982, DOI 10.1136/annrheumdis-2013-204344; Hoy DG, 2010, DISABIL REHABIL, V32, P1373, DOI 10.3109/09638280903524803; Hoy DG, 2010, J PHYSIOTHER, V56, P49, DOI 10.1016/S1836-9553(10)70054-0; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS STUD 2; International League of Associations for Rheumatology and World Health Organisation, 2014, COMM OR PROGR CONTR; Joshi T K, 2001, Int J Occup Environ Health, V7, P217; Kalla AA, 2003, BEST PRACT RES CL RH, V17, P863, DOI 10.1016/S1521-6942(03)00047-0; Katz David L., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khani GMK, 2012, PREHOSP DISASTER MED, V27, P489, DOI 10.1017/S1049023X12001161; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P325; Kunda R, 2013, J OCCUP HEALTH, V55, P211, DOI 10.1539/joh.11-0175-FS; Lavy C, 2005, BRIT MED J, V331, P46, DOI 10.1136/bmj.331.7507.46; Lea CS, 1999, AM J EPIDEMIOL, V150, P1099, DOI 10.1093/oxfordjournals.aje.a009935; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Matheson JIDM, 2011, WORLD J SURG, V35, P2635, DOI 10.1007/s00268-011-1293-2; Messing K, 2006, GENDER EQUALITY WORK, P46; Mody GM, 2012, BEST PRACT RES CL RH, V26, P237, DOI 10.1016/j.berh.2012.03.002; Morales-Torres J, 2007, CLIN RHEUMATOL, V26, P139, DOI 10.1007/s10067-006-0314-2; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Ngo AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-561; Nugent RA, 2010, 228 CTR GLOB DEV; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Ojoawo A., 2011, J PHYS THER, V3, P45; Porter G, 2013, SOC SCI MED, V88, P90, DOI 10.1016/j.socscimed.2013.04.010; Rischewski D, 2008, T ROY SOC TROP MED H, V102, P608, DOI 10.1016/j.trstmh.2008.02.023; Saidu IA, 2011, INT J OCCUP SAF ERGO, V17, P99; Sanchez-Riera L, 2014, ANN RHEUM DIS, V73, P1635, DOI 10.1136/annrheumdis-2013-204320; Schwab K., 2013, WORLD EC FORUM; Sealetsa OJ, 2011, WORK, V38, P279, DOI 10.3233/WOR-2011-1131; Secretariat of the Pacific Community, 2013, PAC NCD SURV OP RES; Shakur H, 2012, LANCET, V380, P2062, DOI 10.1016/S0140-6736(12)62037-6; Smith E, 2014, ANN RHEUM DIS, V73, P1470, DOI 10.1136/annrheumdis-2013-204647; Smith E, 2014, ANN RHEUM DIS, V73, P1462, DOI 10.1136/annrheumdis-2013-204680; Spiegel DA, 2008, CLIN ORTHOP RELAT R, V466, P2297, DOI 10.1007/s11999-008-0411-4; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; The World Bank, 2011, POP PROJ; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; United Nations, 2011, DRAFT POL DECL HIGH; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; van Vuuren B, 2007, J OCCUP REHABIL, V17, P409, DOI 10.1007/s10926-007-9092-1; Vandyck E, 2012, INT J CONSUM STUD, V36, P486, DOI 10.1111/j.1470-6431.2011.01066.x; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walsh NE, 2003, B WORLD HEALTH ORGAN, V81, P665; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2013, STRENGTH ROAD SAF LE; Woolf AD, 2006, ANN RHEUM DIS, V65, P1401, DOI 10.1136/ard.2006.058172; World Health Organisation, 2002, WORLD REPORT VIOLENC; World Health Organization. (WHO), 2013, STEPWISE APPR SURV S; World Health Organization (WHO), 2004, WORLD REPORT ROAD TR; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	98	81	82	2	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-6942	1521-1770		BEST PRACT RES CL RH	Best Pract. Res. Clin. Rheumatol.	JUN	2014	28	3					377	393		10.1016/j.berh.2014.07.006	http://dx.doi.org/10.1016/j.berh.2014.07.006			17	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rheumatology	AY5BT	25481422				2022-09-04	WOS:000347589100004
J	Ocampo-Duque, W; Juraske, R; Kumar, V; Nadal, M; Domingo, J; Schuhmacher, M				Ocampo-Duque, William; Juraske, Ronnie; Kumar, Vikas; Nadal, Marti; Domingo, Jose Luis; Schuhmacher, Marta			A concurrent neuro-fuzzy inference system for screening the ecological risk in rivers	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Fuzzy inference systems; Self-organizing maps; Ecological risk assessment; Water quality; Ebro River (Spain)	WATER-QUALITY; IMPACT ASSESSMENT; SEDIMENT QUALITY; MODEL; NETWORK; CLASSIFICATION; POTENTIALS; POLLUTANTS; TOXICITY; CHINA	A conceptual model to assess water quality in river basins was developed here. The model was based on ecological risk assessment principles, and incorporated a novel ranking and scoring system, based on self-organizing maps, to account for the likely ecological hazards posed by the presence of chemical substances in freshwater. This approach was used to study the chemical pollution in the Ebro River basin (Spain), whose currently applied environmental indices must be revised in terms of scientific accuracy. Ecological hazard indexes for chemical substances were calculated by pattern recognition of persistence, bioaccumulation, and toxicity properties. A fuzzy inference system was proposed to compute ecological risk points (ERP), which are a combination of the ecological hazard to aquatic sensitive organisms and environmental concentrations. By aggregating ERP, changes in water quality over time were estimated. The proposed concurrent neuro-fuzzy model was applied to a comprehensive dataset of the network controlling the levels of dangerous substances, such as metals, pesticides, and polycyclic aromatic hydrocarbons, in the Ebro river basin. The approach was verified by comparison versus biological monitoring. The results showed that water quality in the Ebro river basin is affected by presence of micro-pollutants. The ERP approach is suitable to analyze overall trends of potential threats to freshwater ecosystems by anticipating the likely impacts from multiple substances, although it does not account for synergies among pollutants. Anyhow, the model produces a convenient indicator to search for pollutant levels of concern.	[Schuhmacher, Marta] Univ Rovira & Virgili, Dept Engn Quim, Tarragona 43007, Catalonia, Spain; [Nadal, Marti; Domingo, Jose Luis] Univ Rovira & Virgili, IISPV, Sch Med, Lab Toxicol & Environm Hlth, E-43201 Reus, Catalonia, Spain; [Ocampo-Duque, William] Pontificia Univ Javeriana, Fac Engn, Cali, Colombia; [Juraske, Ronnie] Swiss Fed Inst Technol, Inst Environm Engn, CH-8093 Zurich, Switzerland; [Kumar, Vikas] Univ Sheffield, Catchment Sci Ctr, Sheffield S3 7HQ, S Yorkshire, England		Schuhmacher, M (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Av Paisos Catalans 26, Tarragona 43007, Catalonia, Spain.	marta.schuhmacher@urv.cat	Domingo, Jose L/E-8327-2014; Schuhmacher, Marta/F-4902-2017; Nadal, Martí/B-8807-2017; Kumar, Vikas/M-2306-2014	Schuhmacher, Marta/0000-0003-4381-2490; Nadal, Martí/0000-0002-0217-4827; Domingo, Jose L/0000-0001-6647-9470; Kumar, Vikas/0000-0002-9795-5967	Program Alban [E04D028890CO]; Obra Social Caixa Sabadell; Spanish Ministry of Science and Innovation [CSD2009-00065]	Program Alban; Obra Social Caixa Sabadell; Spanish Ministry of Science and Innovation(Spanish Government)	This research has been supported by the Program Alban (scholarship E04D028890CO), Obra Social Caixa Sabadell, and the Spanish Ministry of Science and Innovation through the project Consolider-Ingenio 2010 CSD2009-00065. The authors thank Susana Cortes for her valuable collaboration in providing the required database.	Alvarez-Guerra M, 2008, ENVIRON INT, V34, P782, DOI 10.1016/j.envint.2008.01.006; Annas S, 2007, ECOL INFORM, V2, P159, DOI 10.1016/j.ecoinf.2007.04.001; [Anonymous], 2000, SOM TOOLBOX MATLAB 5; Aronson D, 2006, CHEMOSPHERE, V63, P1953, DOI 10.1016/j.chemosphere.2005.09.044; Batra R, 2009, IEEE INT ADV COMP C, P453; Bunke D, 2005, ENVIRON SCI POLLUT R, V12, P310, DOI 10.1065/espr2005.08.285; Camusso M, 2002, WATER RES, V36, P2491, DOI 10.1016/S0043-1354(01)00485-7; Chau KW, 2002, EXPERT SYST APPL, V22, P321, DOI 10.1016/S0957-4174(02)00020-9; Chau KW, 2006, MAR POLLUT BULL, V52, P726, DOI 10.1016/j.marpolbul.2006.04.003; CHE, 2005, RED INT RED REF RED; CHE, 2002, INF FIN RED DIAT CUE; DEPA, 2004, 94 DEPA; Goma J, 2004, VIE MILIEU, V54, P81; Howard P. H., 1991, HDB ENV DEGRADATION; Huang F, 2010, WATER RES, V44, P1562, DOI 10.1016/j.watres.2009.11.003; Huijbregts MAJ, 2005, CHEMOSPHERE, V61, P1495, DOI 10.1016/j.chemosphere.2005.04.046; Huijbregts MAJ, 2000, CHEMOSPHERE, V41, P541, DOI 10.1016/S0045-6535(00)00030-8; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jassar S, 2011, APPL SOFT COMPUT, V11, P2935, DOI 10.1016/j.asoc.2010.11.011; Juraske R, 2007, ENVIRON INT, V33, P886, DOI 10.1016/j.envint.2007.04.005; Knekta E, 2004, CHEMOSPHERE, V57, P1495, DOI 10.1016/j.chemosphere.2004.07.056; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Legrand H, 2006, CAH BIOL MAR, V47, P39; Lopez E, 2008, ENVIRON SCI POLLUT R, V15, P278, DOI 10.1065/espr2007.02.390; Lyons G, 2006, ENVIRON HEALTH PERSP, V114, P142, DOI 10.1289/ehp.8070; Mari M, 2010, ENVIRON SCI TECHNOL, V44, P3162, DOI 10.1021/es1000165; Meylan WM, 1999, ENVIRON TOXICOL CHEM, V18, P664, DOI 10.1002/etc.5620180412; Muttil N, 2007, ENG APPL ARTIF INTEL, V20, P735, DOI 10.1016/j.engappai.2006.11.016; Muttil N, 2006, INT J ENVIRON POLLUT, V28, P223, DOI 10.1504/IJEP.2006.011208; Nadal M, 2006, CHEMOSPHERE, V64, P1526, DOI 10.1016/j.chemosphere.2005.11.078; Ocampo-Duque W, 2008, CHEMOSPHERE, V72, P715, DOI 10.1016/j.chemosphere.2008.03.055; Ocampo-Duque W, 2007, ENVIRON POLLUT, V148, P634, DOI 10.1016/j.envpol.2006.11.027; Ocampo-Duque W, 2006, ENVIRON INT, V32, P733, DOI 10.1016/j.envint.2006.03.009; Otermann K., 1994, 679101014 NAT I PUBL; Payet J, 2004, THESIS ECOLE POLYTEH; Pennington DW, 2001, RISK ANAL, V21, P897, DOI 10.1111/0272-4332.215160; Posthuma L, 2006, ENVIRON TOXICOL CHEM, V25, P1094, DOI 10.1897/05-305R.1; Prygiel J, 2002, J APPL PHYCOL, V14, P27, DOI 10.1023/A:1015277207328; RAIS, 2007, EC BENCHM TOOL; Roig N, 2011, ENVIRON INT, V37, P671, DOI 10.1016/j.envint.2011.01.007; Ross T.J., 2004, FUZZY LOGIC ENG APPL, V2nd; Schmitt-Jansen M, 2005, ESTUAR COAST SHELF S, V62, P539, DOI 10.1016/j.ecss.2004.09.016; Swanson MB, 1997, CHEM RANKING SCORING; Terrado M, 2006, TALANTA, V70, P691, DOI 10.1016/j.talanta.2006.05.041; Tomlin CDS, 2002, E PESTICIDE MANUAL V; Tsakovski S, 2010, J CHEMOMETR, V24, P694, DOI 10.1002/cem.1333; USDOE, 1999, AQ TOX REF VAL; USEPA, 2011, EC RISK ASS FRESHW S; USEPA, 2011, EST PROGR INT SUIT E; [USEPA] US Environmental Protection Agency, 2000, WAST MIN PRIOR TOOL; USGS, 2004, WAT QUAL BENCHM NAWQ; Vighi M, 2006, ENVIRON SCI POLLUT R, V13, P9, DOI 10.1065/espr2006.01.003; Wang XZ, 2005, J NETW COMPUT APPL, V28, P147, DOI 10.1016/j.jnca.2004.01.006; Wu CL, 2006, INT J ENVIRON POLLUT, V28, P534, DOI 10.1504/IJEP.2006.011227; Xie JX, 2006, INT J ENVIRON POLLUT, V28, P364, DOI 10.1504/IJEP.2006.011217; Zhao MY, 2006, INT J ENVIRON POLLUT, V28, P448, DOI 10.1504/IJEP.2006.011222; Zhu D, 2009, LAND DEGRAD DEV, V20, P654, DOI 10.1002/ldr.956; [No title captured]	58	13	13	0	23	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344			ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	MAY	2012	19	4			SI		983	999		10.1007/s11356-011-0595-0	http://dx.doi.org/10.1007/s11356-011-0595-0			17	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	935UO	22544552				2022-09-04	WOS:000303547200007
J	Ito, PMM; Carvalho, TP; Pavanelli, CS; Vanegas-Rios, JA; Malabarba, LR				Ito, Priscila Madoka M.; Carvalho, Tiago P.; Pavanelli, Carla S.; Vanegas-Rios, James A.; Malabarba, Luiz R.			Phylogenetic relationships and description of two new species of Diapoma (Characidae: Stevardiinae) from the La Plata River basin	NEOTROPICAL ICHTHYOLOGY			English	Article						Diapomini; Gill gland; Identification key; Iguacu River; Negro River	RIO PARANA BASIN; GLANDULOCAUDINE FISHES TELEOSTEI; CHARACIFORMES CHARACIDAE; MOLECULAR PHYLOGENY; GENUS; MORPHOLOGY; EIGENMANN; SUBFAMILY; GLANDS; BRAZIL	Herein we describe two new species of Diapoma, one from the Negro River, a tributary of the Uruguay River in Brazil and Uruguay, and one from the Iguacu River, in Brazil and Argentina. The new species from the Negro River basin is distinguished from its congeners by the following combination of characters: a black narrow and conspicuous line restricted to the body horizontal septum, incomplete lateral line, tricuspid teeth in the inner series of the premaxilla, and a lower body depth at vertical through the dorsal-fin origin (29.3-32.8% SL in males and 27.7-33.3% SL in females). The new species from the Iguacu River basin is distinguished from its congeners by the following combination of characters: a discontinuous lateral line, adipose fin hyaline, longer anal-fin base (26.5-32.4% SL), and a longitudinal black stripe along the median region of caudal-fin rays. Additionally, we updated the molecular phylogeny of the genus, including new sequences from these two new species and Diapoma thauma. An identification key for species of Diapoma is presented, modified from previous study.	[Ito, Priscila Madoka M.; Carvalho, Tiago P.; Malabarba, Luiz R.] Univ Fed Rio Grande do Sul UFRGS, Dept Zool, Lab Ictiol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil; [Carvalho, Tiago P.] Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Carrera 7 43-82, Bogota, DC, Colombia; [Pavanelli, Carla S.] Univ Estadual Maringa UFM, Colecao Ictiol, Nucleo Pesquisas Limnol Ictiol & Aquicultura NUPE, Av Colombo 5790, BR-87020900 Maringa, Parana, Brazil; [Vanegas-Rios, James A.] UNLP, Div Zool Vertebrados, Fac Ciencias Nat & Museo, CONICET, Edificio Anexo,Gabinete 104, La Plata, Buenos Aires, Argentina		Ito, PMM (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Dept Zool, Lab Ictiol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.	blindyami@gmail.com; pitiago@javeriana.edu.com; carlasp@nupelia.uem.br; anyelovr@fcnym.unlp.edu.ar; malabarb@ufrgs.br	Pavanelli, Carla/G-6399-2012; Malabarba, Luiz/I-3225-2012	Pavanelli, Carla/0000-0003-4059-984X; Ito, Priscila Madoka Miyake/0000-0002-4446-8532; Carvalho, Tiago/0000-0001-5901-1634; Malabarba, Luiz/0000-0002-9607-3735	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307890/2016-3, 401204/2016-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FONCyT [BID-PICT 1938-2017, BID-PICT 2019-02419]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FONCyT(FONCyT)	We thank curators for loan of material and assistance during visits to collections: G. Chiaramonte and R. Ferriz (MACN); Roberto E. Reis and Carlos A. S. Lucena (MCP); Sonia Fisch-Muller and Rafael Covain (MHNG); D. Nadalin, Jorge R. Casciotta and Adriana E. Almiron (MLP), and Juliana M. Wingert (UFRGS). The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq process #307890/2016-3 and 401204/2016-2 to LRM), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, past PNPD fellowship to TPC), and FONCyT (BID-PICT 1938-2017 to JAVR and BID-PICT 2019-02419 to JAVR).	[Anonymous], 2019, STAND PET SUBC GUID; Baumgartner Dirceu, 2006, Check List, V2, P1; Baumgartner G., 2012, PEIXES BAIXO RIO IGU, DOI [10.7476/9788576285861, DOI 10.7476/9788576285861]; Benine RC, 2015, ZOOTAXA, V3956, P1, DOI 10.11646/zootaxa.3956.1.1; Bertaco VA, 2016, ZOOTAXA, V4138, P401, DOI 10.11646/zootaxa.4138.3.1; Betancur-R R, 2019, EVOLUTION, V73, P329, DOI 10.1111/evo.13649; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Burns JR, 1996, COPEIA, P627; BURNS JR, 1995, J MORPHOL, V224, P131, DOI 10.1002/jmor.1052240203; Bushmann PJ, 2002, J MORPHOL, V253, P187, DOI 10.1002/jmor.1120; Carvalho FR, 2013, NEOTROP ICHTHYOL, V11, P525, DOI 10.1590/S1679-62252013000300006; Casciotta Jorge, 2016, Historia Natural (Corrientes), V6, P5; Casciotta J, 2012, ZOOTAXA, P39; Cope E. D., 1894, American Naturalist, Vxlviii, P67; Cope E. D., 1894, Proceedings of the American Philosophical Society, Vxxxiii, P84; de Oliveira CLC, 2012, NEOTROP ICHTHYOL, V10, P349, DOI 10.1590/S1679-62252012005000005; Delariva RL, 2013, NEOTROP ICHTHYOL, V11, P891, DOI 10.1590/S1679-62252013000400017; Depra GD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196291; Doyle J.J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI [10.2307/4119796, DOI 10.2307/4119796]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eigenmann C. H., 1910, Reports of the Princeton University Expeditions to Patagonia 1896-1899 Princeton NJ, V3; Eigenmann C. H., 1909, REPORTS PRINCETON U, P225; Eigenmann C. H., 1914, INDIANA U STUD, V20, P32; Ferreira KM, 2021, J ZOOL SYST EVOL RES, V59, P2060, DOI 10.1111/jzs.12517; Ferreira KM, 2011, NEOTROP ICHTHYOL, V9, P281, DOI 10.1590/S1679-62252011000200005; Marinho MMF, 2021, NEOTROP ICHTHYOL, V19, DOI 10.1590/1982-0224-2020-0118; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Fricke R, 2022, ESCHMEYERS CATALOG F; Ingenito Leonardo Ferreira da Silva, 2004, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V7, P23; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larentis C, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2015-0117; Malabarba LR, 1995, P BIOL SOC WASH, V108, P679; Malabarba Luiz R., 2003, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V16, P67; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Melo BF, 2016, MOL PHYLOGENET EVOL, V94, P709, DOI 10.1016/j.ympev.2015.10.022; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Menezes NA, 2003, P BIOL SOC WASH, V116, P557; Menezes NA, 2009, NEOTROP ICHTHYOL, V7, P295, DOI 10.1590/S1679-62252009000300002; Menezes Naércio A., 2011, Pap. Avulsos Zool., V51, P59; Mezzaroba L, 2021, BIOTA NEOTROP, V21, DOI [10.1590/1676-0611-bn-2020-1083, 10.1590/1676-0611-BN-2020-1083]; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Netto-Ferreira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052098; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palumbi Stephen R., 1996, P205; Rambaut A, 2018, TRACER V1 6; Rambaut A., 2013, TREEANNOTATOR V1 70; Rambaut A, 2014, FIGTREE TREE FIGURE; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russo Mcircia Regina, 2004, Acta Scientiarum Biological Sciences, V26, P431; Tagliacollo VA, 2012, MOL PHYLOGENET EVOL, V64, P297, DOI 10.1016/j.ympev.2012.04.007; TAYLOR W R, 1985, Cybium, V9, P107; Teran GE, 2020, ZOOL J LINN SOC-LOND, V190, P1217, DOI 10.1093/zoolinnean/zlaa019; Teran GE, 2015, ACTA ZOOL-STOCKHOLM, V96, P335, DOI 10.1111/azo.12081; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Vanegas-Rios JA, 2020, J ZOOL SYST EVOL RES, V58, P387, DOI 10.1111/jzs.12346; Vanegas-Rios JA, 2018, J FISH BIOL, V93, P830, DOI 10.1111/jfb.13786; Weitzman S.H., 1988, P379; WEITZMAN S H, 1985, Smithsonian Contributions to Zoology, P1; Weitzman Stanley H., 2005, Neotrop. ichthyol., V3, P329, DOI 10.1590/S1679-62252005000300002; Weitzman Stanley H., 1998, P171; Zawadzki CH, 1999, REV SUISSE ZOOL, V106, P91, DOI 10.5962/bhl.part.80072	65	1	1	0	0	SOC BRASILEIRA ICTIOLOGIA	SAO PAULO	UNIV SAO PAULO, DEPT FISIOLOGIA-IB, RUA DO MATAO, TRAVESSA 14 N 321, SAO PAULO, SP 05508-900, BRAZIL	1679-6225			NEOTROP ICHTHYOL	Neotrop. Ichthyol.		2022	20	1							e210115	10.1590/1982-0224-2021-0115	http://dx.doi.org/10.1590/1982-0224-2021-0115			30	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	ZX3QG		gold			2022-09-04	WOS:000771812800001
J	Kerry, SJ; Aguilar, OM; Penny, W; Crinion, JT; Leff, AP; Woodhead, ZVJ				Kerry, Sheila J.; Aguilar, Oscar M.; Penny, William; Crinion, Jennifer T.; Leff, Alex P.; Woodhead, Zoe V. J.			How Does iReadMore Therapy Change the Reading Network of Patients with Central Alexia?	JOURNAL OF NEUROSCIENCE			English	Article						alexia; aphasia; DCM; MEG; reading; stroke	LANGUAGE REORGANIZATION; EVOKED-RESPONSES; WORD RECOGNITION; MECHANISMS; RECOVERY; DYNAMICS; ANOMIA; MODEL; MEG; COMPREHENSION	Central alexia (CA) is an acquired reading disorder co-occurring with a generalized language deficit (aphasia). The roles of perilesional and ipsilesional tissue in recovery from poststroke aphasia are unclear. We investigated the impact of reading training (using iReadMore, a therapy app) on the connections within and between the right and left the misphere\of the reading network of patients with CA. In patients with pure alexia, iReadMore increased feedback from left inferior frontal gyrus (IFG) region to the left occipital (OCC) region. We aimed to identify whether iReadMore therapy was effective through a similar mechanism in patients with CA. Participants with chronic poststroke CA(n = 23) completed 35 h of iReadMore training over 4 weeks. Reading accuracy for trained and untrained words was assessed before and after therapy. The neural response to reading trained and untrained words in the left and right OCC, ventral occipitotemporal, and IFG regions was examined using event-related magnetoencephalography. The training-related modulation in effective connectivity between regions was modeled at the group level with dynamic causal modeling. iReadMore training improved participants' reading accuracy by an average of 8.4% (range, -2.77 to 31.66) while accuracy for untrained words was stable. Training increased regional sensitivity in bilateral frontal and occipital regions, and strengthened feedforward connections within the left hemisphere. Our data suggest that iReadMore training in these patients modulates lower-order visual representations, as opposed to higher-order, more abstract representations, to improve word-reading accuracy.	[Kerry, Sheila J.; Crinion, Jennifer T.; Leff, Alex P.] UCL, Inst Cognit Neurosci, London WC1N 3AZ, England; [Aguilar, Oscar M.; Leff, Alex P.; Woodhead, Zoe V. J.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London WC1N 3BG, England; [Aguilar, Oscar M.; Leff, Alex P.] UCL, Wellcome Ctr Human Neuroimaging, London WC1N 3BG, England; [Aguilar, Oscar M.] Pontificia Univ Javeriana, Fac Psicol, Bogota 110311, Colombia; [Penny, William] Univ East Anglia, Sch Psychol, Norwich NR4 7TJ, Norfolk, England; [Woodhead, Zoe V. J.] Univ Oxford, Dept Expt Psychol, Oxford OX2 6GG, England		Kerry, SJ (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AZ, England.	zoe.woodhead@psy.ox.ac.uk	Crinion, Jennifer/A-1992-2019	Crinion, Jennifer/0000-0001-8080-6562; Aguilar, Oscar/0000-0001-8189-8286; Leff, Alexander/0000-0002-0831-3541	Medical Research Council [MR/K022563/1]; ESRC [ES/J003174/1] Funding Source: UKRI; MRC [MR/K022563/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This trial was supported by the Medical Research Council (Grant MR/K022563/1). The trial was registered at www.clinicaltrials.gov, reference NCT02062619. We thank Gareth Barnes for his guidance regarding the MEG study design and analysis for this project.	Abel S, 2015, BRAIN, V138, P1097, DOI 10.1093/brain/awv022; Abel S, 2014, NEUROPSYCHOLOGIA, V57, P154, DOI 10.1016/j.neuropsychologia.2014.03.010; Adair JC, 2000, NEUROPSY NEUROPSY BE, V13, P303; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bonilha L, 2016, NEUROREHAB NEURAL RE, V30, P266, DOI 10.1177/1545968315593808; Brookshire CE, 2014, APHASIOLOGY, V28, P1464, DOI 10.1080/02687038.2014.945389; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Carreiras M, 2014, TRENDS COGN SCI, V18, P90, DOI 10.1016/j.tics.2013.11.005; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Crinion JT, 2015, CURR OPIN NEUROL, V28, P330, DOI 10.1097/WCO.0000000000000217; Crisp J, 2006, J COGNITIVE NEUROSCI, V18, P348, DOI 10.1162/jocn.2006.18.3.348; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dejerine J., 1891, MEMOIRES SOC BIOL, V43, P197; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Drakesmith M, 2015, NEUROPSYCHOBIOLOGY, V72, P46, DOI 10.1159/000379752; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fridriksson J, 2010, J NEUROSCI, V30, P11558, DOI 10.1523/JNEUROSCI.2227-10.2010; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hartwigsen G, 2019, NEUROIMAGE, V190, P14, DOI 10.1016/j.neuroimage.2017.11.056; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Hoffman P, 2015, P NATL ACAD SCI USA, V112, pE3719, DOI 10.1073/pnas.1502032112; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Kiebel SJ, 2008, NEUROIMAGE, V39, P728, DOI 10.1016/j.neuroimage.2007.09.005; Kiebel SJ, 2007, NEUROIMAGE, V36, P332, DOI 10.1016/j.neuroimage.2007.02.046; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Kurland J, 2008, BRAIN IMAGING BEHAV, V2, P147, DOI 10.1007/s11682-008-9027-2; Lee YS, 2017, NEUROPSYCHOLOGIA, V94, P52, DOI 10.1016/j.neuropsychologia.2016.11.010; Leff A., 2013, ALEXIA DIAGNOSIS TRE; Leski JM, 2002, IEEE T BIO-MED ENG, V49, P796, DOI 10.1109/TBME.2002.800757; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Meinzer M, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-28; Mohr B, 2016, NEUROPSYCHOLOGIA, V93, P413, DOI 10.1016/j.neuropsychologia.2016.04.006; Naeser MA, 2011, BRAIN LANG, V119, P206, DOI 10.1016/j.bandl.2011.07.005; Nagel IE, 2008, NEUROIMAGE, V43, P801, DOI 10.1016/j.neuroimage.2008.07.017; Nardo D, 2017, BRAIN, V140, P3039, DOI 10.1093/brain/awx234; NAZIR TA, 1992, PERCEPT PSYCHOPHYS, V52, P315, DOI 10.3758/BF03209148; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Perea M, 2003, MEM COGNITION, V31, P829, DOI 10.3758/BF03196438; Perrone-Bertolotti M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00325; Pillay SB, 2018, J COGNITIVE NEUROSCI, V30, P514, DOI 10.1162/jocn_a_01214; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; Richter M, 2008, BRAIN, V131, P1391, DOI 10.1093/brain/awn043; Robson H, 2012, NEUROPSYCHOLOGIA, V50, P276, DOI 10.1016/j.neuropsychologia.2011.11.022; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rueckl JG, 2015, P NATL ACAD SCI USA, V112, P15510, DOI 10.1073/pnas.1509321112; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schneider W., 2002, E PRIME VERSION 20 C; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Seghier ML, 2016, NEUROIMAGE, V124, P1208, DOI 10.1016/j.neuroimage.2015.03.083; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tsapkini K, 2011, NEUROIMAGE, V55, P1357, DOI 10.1016/j.neuroimage.2010.12.024; Turkeltaub PE, 2012, CORTEX, V48, P1179, DOI 10.1016/j.cortex.2011.06.010; Turkeltaub PE, 2011, NEUROLOGY, V76, P1726, DOI 10.1212/WNL.0b013e31821a44c1; van Hees S, 2014, BRAIN LANG, V129, P47, DOI 10.1016/j.bandl.2013.12.004; Vartiainen J, 2009, NEUROIMAGE, V47, P2064, DOI 10.1016/j.neuroimage.2009.06.002; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Whitworth A, 2016, COGNITIVE NEUROPSYCH; Woodhead ZVJ, 2014, CEREB CORTEX, V24, P817, DOI 10.1093/cercor/bhs365; Woodhead ZVJ, 2018, BRAIN, V141, P2127, DOI 10.1093/brain/awy138; Woodhead ZVJ, 2013, BRAIN, V136, P2579, DOI 10.1093/brain/awt186; Xu M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603309; Zhou W, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.683; Zweig E, 2009, LANG COGNITIVE PROC, V24, P412, DOI 10.1080/01690960802180420	82	1	2	2	10	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 17	2019	39	29					5719	5727		10.1523/JNEUROSCI.1426-18.2019	http://dx.doi.org/10.1523/JNEUROSCI.1426-18.2019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IJ2YZ	31085605	Green Published, Green Accepted, Bronze			2022-09-04	WOS:000475772200009
J	Vaca-Gonzalez, JJ; Escobar, JF; Guevara, JM; Hata, YA; Ferrer, GG; Garzon-Alvarado, DA				Vaca-Gonzalez, J. J.; Escobar, J. F.; Guevara, J. M.; Hata, Y. A.; Gallego Ferrer, G.; Garzon-Alvarado, D. A.			Capacitively coupled electrical stimulation of rat chondroepiphysis explants: A histomorphometric analysis	BIOELECTROCHEMISTRY			English	Article						Growth plate; Electric fields; Columnar organization; Hypertrophy; Histomorphometric	GROWTH-PLATE CHONDROCYTES; ARTICULAR CHONDROCYTES; CARTILAGE EXPLANTS; BONE; TRANSLOCATION; EXPRESSION; PHYSIOLOGY; AGGRECAN; RESPOND; FIELDS	The growth plate is a cartilaginous layer present from the gestation period until the end of puberty where it ossifies joining diaphysis and epiphysis. During this period several endocrine, autocrine, and paracrine processes within the growth plate are carried out by chondrocytes; therefore, a disruption in cellular functions may lead to pathologies affecting bone development. It is known that electric fields impact the growth plate; however, parameters such as stimulation time and electric field intensity are not well documented. Accordingly, this study presents a histomorphometrical framework to assess the effect of electric fields on chondroepiphysis ex-plants. Bones were stimulated with 3.5 and 7 mV/cm, and for each electric field two exposure times were tested for 30 days (30 min and 1 h). Results evidenced that electric fields increased the hypertrophic zones compared with controls. In addition, a stimulation of 3.5 mV/cm applied for 1 h preserved the columnar cell density and its orientation. Moreover, a pre-hypertrophy differentiation in the center of the chondroepiphysis was observed when explants were stimulated during 1 h with both electric fields. These findings allow the understanding of the effect of electrical stimulation over growth plate organization and how the stimulation modifies chondrocytes morphophysiology. (C) 2018 Elsevier B.V. All rights reserved.	[Vaca-Gonzalez, J. J.; Escobar, J. F.; Hata, Y. A.; Garzon-Alvarado, D. A.] Univ Nacl Colombia, Inst Biotechnol, Biomimet Lab, Bogota, Colombia; [Vaca-Gonzalez, J. J.; Escobar, J. F.; Hata, Y. A.; Garzon-Alvarado, D. A.] Univ Nacl Colombia, Numer Methods & Modeling Res Grp GNUM, Bogota, Colombia; [Guevara, J. M.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota, Colombia; [Vaca-Gonzalez, J. J.; Gallego Ferrer, G.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn CBIT, Camino Vera S-N, E-46022 Valencia, Spain; [Gallego Ferrer, G.] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Valencia, Spain		Garzon-Alvarado, DA (corresponding author), Carrera 30 N 45-03 Edificio 407,Oficina 202A, Bogota, Colombia.	dagarzona@unal.edu.co	Hata, Yoshie/AAS-2276-2021; Garzon-Alvarado, Diego/AAD-6607-2019; GUEVARA-MORALES, JOHANA M./AAF-9014-2019; Gallego-Ferrer, Gloria/H-6690-2015	Hata, Yoshie/0000-0001-9203-0829; Gallego-Ferrer, Gloria/0000-0002-2428-0903; Garzon, Diego/0000-0003-0072-3738; Escobar Huertas, Juan Felipe/0000-0002-9934-2523	COLCIENCIAS Administrative Department of Science, Technology and Innovation [712-2015, 50457]	COLCIENCIAS Administrative Department of Science, Technology and Innovation	Research reported in this publication was supported by COLCIENCIAS Administrative Department of Science, Technology and Innovation (Announcement 712-2015 Grant No 50457).	Amini S, 2010, J BIOMECH, V43, P2582, DOI 10.1016/j.jbiomech.2010.05.010; ARMSTRONG PF, 1988, J ORTHOP RES, V6, P265, DOI 10.1002/jor.1100060214; ARMSTRONG PF, 1986, J ORTHOP RES, V4, P446, DOI 10.1002/jor.1100040407; Ballock RT, 2003, J BONE JOINT SURG AM, V85A, P715, DOI 10.2106/00004623-200304000-00021; BRIGHTON C T, 1983, Journal of Orthopaedic Research, V1, P42, DOI 10.1002/jor.1100010106; Brighton CT, 2008, J BONE JOINT SURG AM, V90A, P833, DOI 10.2106/JBJS.F.01437; Brighton CT, 2006, BIOCHEM BIOPH RES CO, V342, P556, DOI 10.1016/j.bbrc.2006.01.171; BRIGHTON CT, 1989, J ORTHOPAED RES, V7, P759, DOI 10.1002/jor.1100070519; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Cancel M, 2009, BONE, V44, P306, DOI 10.1016/j.bone.2008.09.005; Chao PHG, 2000, J BIOMECH ENG-T ASME, V122, P261, DOI 10.1115/1.429661; Fioravanti A, 2002, ANN RHEUM DIS, V61, P1032, DOI 10.1136/ard.61.11.1032; FORGON M, 1985, ARCH ORTHOP TRAUM SU, V104, P121, DOI 10.1007/BF00454252; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel C., 1996, ENV HEAL, P21; Guevara J. M., 2016, J MECH MED BIOL, V16, P1; Ham A., 1987, BONE HAMS HISTOLOGY; Hochberg Z, 2002, BEST PRACT RES CL EN, V16, P399, DOI 10.1053/beem.2002.0208; Honda K, 2000, EUR J CELL BIOL, V79, P601, DOI 10.1078/0171-9335-00089; Kandzierski G, 2012, INT ORTHOP, V36, P2513, DOI 10.1007/s00264-012-1699-y; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; LAMMI MJ, 1994, BIOCHEM J, V304, P723, DOI 10.1042/bj3040723; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li YW, 2011, DEVELOPMENT, V138, P359, DOI 10.1242/dev.052324; Lieben L, 2012, FRONT ENDOCRINOL, V3, P1; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lu C, 2013, BONE, V53, P566, DOI 10.1016/j.bone.2012.12.016; Ma XW, 2015, SCI REP-UK, V4, DOI 10.1038/srep09918; MACGINITIE LA, 1994, J ORTHOPAED RES, V12, P151, DOI 10.1002/jor.1100120202; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Matta C., 2015, CURR RHEUMATOL REP, V17; Moncayo M., 2014, ESTUDIO ENTORNO MECA; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nakasuji S., 2009, AS PAC C MAT MECH 20, V1, P13; Niehoff A, 2004, BONE, V35, P899, DOI 10.1016/j.bone.2004.06.006; Ohashi N, 2002, J BONE MINER RES, V17, P284, DOI 10.1359/jbmr.2002.17.2.284; SATO O, 1989, ARCH ORTHOP TRAUM SU, V109, P9, DOI 10.1007/BF00441903; Sergerie K, 2011, J ORTHOP RES, V29, P473, DOI 10.1002/jor.21282; Stokes IA, 2002, J BONE JOINT SURG AM, V84A, P1842, DOI 10.2106/00004623-200210000-00016; Stokes IAF., 2008, ALTERATIONS GROWTH P, V41, P197; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Taghian T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0153; Vaca-Gonzalez JJ, 2016, CELL MOL BIOENG, V9, P116, DOI 10.1007/s12195-015-0419-2; Valteau B, 2011, BONE, V49, P996, DOI 10.1016/j.bone.2011.07.008; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Wang W, 2004, CLIN ORTHOP RELAT R, pS163, DOI 10.1097/01.blo.0000143837.53434.5c; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001	49	7	7	0	15	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1567-5394	1878-562X		BIOELECTROCHEMISTRY	Bioelectrochemistry	APR	2019	126						1	11		10.1016/j.bioelechem.2018.11.004	http://dx.doi.org/10.1016/j.bioelechem.2018.11.004			11	Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Biophysics; Electrochemistry	HK8GB	30471483				2022-09-04	WOS:000458226300001
J	DoNascimiento, C; Herrera-Collazos, EE; Herrera-R, GA; Ortega-Lara, A; Villa-Navarro, FA; Oviedo, JSU; Maldonado-Ocampo, JA				DoNascimiento, Carlos; Esteban Herrera-Collazos, Edgar; Herrera-R, Guido A.; Ortega-Lara, Armando; Villa-Navarro, Francisco A.; Usma Oviedo, Jose Saulo; Maldonado-Ocampo, Javier A.			Checklist of the freshwater fishes of Colombia: a Darwin Core alternative to the updating problem	ZOOKEYS			English	Article						Aquatic ecosystems; conservation; endemic; richness; South America	RIO-MAGDALENA BASIN; CHARACIFORMES CHARACIDAE STEVARDIINAE; TRICHOMYCTERUS SILURIFORMES TRICHOMYCTERIDAE; GENUS LEPORINUS-SPIX; SOUTH-AMERICA PISCES; ORINOCO RIVER-BASIN; HEMIBRYCON CHARACIFORMES; TELEOSTEI CHARACIFORMES; MOLECULAR PHYLOGENY; TAXONOMIC REVISION	The present work is part of a process to create a Catalogue of the Freshwater Fishes of Colombia and consisted in the depuration and updating of the taxonomic and geographic components of the checklist of the freshwater fishes of Colombia. An exhaustive revision of the 1435 species recorded in 2008 was necessary to: 1. Add new species described since 2009 and species originally described from Colombia but inadvertently omitted in 2008; 2. Add new records of already described species; 3. Delete species whose presence in Colombia was not supported by voucher specimens in ichthyological collections; and 4. Revise the geographic distribution of the species listed in 2008. This process resulted in the following numbers: 1. Total number of freshwater fish species in Colombia: 1494; 2. Number of species recorded by hydrographic region - Amazon: 706, Orinoco: 663, Caribbean: 223, Magdalena-Cauca: 220, Pacific: 130; and 3. Number of endemic species: 374 (76% from the trans-Andean region). Updating the current checklist is a fundamental requirement to ensure its incorporation in the decision-making process with regard to the conservation of Colombian aquatic species and ecosystems, which are facing transformation processes as a result of activities such as mining, construction of hydroelectric plants, expansion of the agricultural frontier and subsequent deforestation, industrial and domestic pollution, development of waterways, introduction of exotic species, and climate change.	[DoNascimiento, Carlos] Inst Invest Recursos Biol Alexander von Humboldt, Villa De Leyva, Colombia; [Esteban Herrera-Collazos, Edgar; Herrera-R, Guido A.; Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS,Lab Ictiol, Bogota, DC, Colombia; [Ortega-Lara, Armando] Fdn Invest & Desarrollo Sostenible FUNINDES, Grp Invest Peces Neotropicales, Cali, Colombia; [Villa-Navarro, Francisco A.] Univ Tolima, Fac Ciencias, Grp Invest Zool, Ibague, Colombia; [Usma Oviedo, Jose Saulo] WWF Colombia, Programa Ecosistemas Agua Dulce, Cali, Colombia		DoNascimiento, C (corresponding author), Inst Invest Recursos Biol Alexander von Humboldt, Villa De Leyva, Colombia.; Maldonado-Ocampo, JA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS,Lab Ictiol, Bogota, DC, Colombia.	cdonascimiento@humboldt.org.co; maldonadoj@javeriana.edu.co	DoNascimiento, Carlos/W-2661-2019	DoNascimiento, Carlos/0000-0002-8680-7942; Herrera-R, Guido A/0000-0001-5686-6362; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X	Asociacion Colombiana de Ictiologos (ACICTIOS); Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt; Nature Conservancy; Conservation International Colombia; WWF Colombia; Universidad de Antioquia; Pontificia Universidad Javeriana; Oficina de Investigaciones y Desarrollo Cientifico de la Universidad del Tolima; CORTOLIMA; Grupo de Investigacion en Zoologia de la Universidad del Tolima	Asociacion Colombiana de Ictiologos (ACICTIOS); Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt; Nature Conservancy; Conservation International Colombia; WWF Colombia; Universidad de Antioquia; Pontificia Universidad Javeriana; Oficina de Investigaciones y Desarrollo Cientifico de la Universidad del Tolima; CORTOLIMA; Grupo de Investigacion en Zoologia de la Universidad del Tolima	We thank the Asociacion Colombiana de Ictiologos (ACICTIOS), Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt, The Nature Conservancy, Conservation International Colombia, WWF Colombia, Universidad de Antioquia, and Pontificia Universidad Javeriana for the support and funds provided throughout the project: "Catalogue of the Freshwater Fishes of Colombia". For comments and grammar corrections on the manuscript we thank D. C. Taphorn. We gratefully acknowledge F. C. T. Lima and Sven O. Kullander who made a thorough revision of the Characidae and Bryconidae (FCTL) and Cyprinodontiformes and Cichliformes sections (SOK) of the checklist. We are indebted to A. Acosta (CIACOL), J. G. Albornoz-Garzon (CZUT-IC), and S. Prada-Pedreros and A. Urbano-Bonilla (MPUJ) for facilitating information of records in their respective collections. FAVN thanks the Oficina de Investigaciones y Desarrollo Cientifico de la Universidad del Tolima, CORTOLIMA, and Grupo de Investigacion en Zoologia de la Universidad del Tolima for funding, logistic, and technical support.	Acero A, 2006, CYBIUM, V30, P215; Acosta-Santos A, 2016, SERIE EDITORIAL RECU, P361; Agudelo-Cordoba E, 2012, LIBRO ROJO PECES DUL, P92; Agudelo-Zamora Henry D., 2014, Pap. Avulsos Zool. (São Paulo), V54, P195, DOI 10.1590/0031-1049.2014.54.15; Agudelo-Zamora Henry D, 2010, Bol. Cient. Mus. Hist. Nat. Univ. Caldas, V14, P129; AgudeloCordoba, 2013, SERIE EDITORIAL RECU; AHL E., 1925, SITZUNGSBERICHTE GES, P106; Ajiaco-Martinez RE, 2012, LIBRO ROJO PECES DUL, P82; Albert J.S., 2003, CHECK LIST FRESHWATE, P494; Albert James S., 2003, Zootaxa, V287, P1; [Anonymous], 2003, CHECK LIST FRESHWATE; [Anonymous], 2012, LIBRO ROJO PECES DUL; [Anonymous], 2003, CHECK LIST FRESHWATE; Villa-Navarro FA, 2017, ZOOTAXA, V4299, P337, DOI 10.11646/zootaxa.4299.3.2; Vanegas-Rios JA, 2013, NEOTROP ICHTHYOL, V11, P275, DOI 10.1590/S1679-62252013000200005; Vanegas-Rios JA, 2013, REV MEX BIODIVERS, V84, P384, DOI 10.7550/rmb.29591; Aquino AE, 2002, COPEIA, P374; AQUINO AE, 2010, B AM MUSEUM NATURAL, V0336, P00001, DOI DOI 10.1206/336.1; Arbelaez F, 2004, AMAZONIANA, V18, P95; Ardila R. C., 2008, DAHLIA, V10, P27; Ardila Rodriguez C.A., 2011, DAHLIA, V11, P3; Ardila Rodriguez C.A., 2008, DAHLIA, V10, P33; Ardila Rodriguez C.A., 2006, DAHLIA, V9, P3; Ardila Rodriguez CA, 2006, PECES DEP SANTANDER, V2, P1; Ardila Rodriguez CA, 2013, PECES DEP SANTANDER, V6, P1; Ardila Rodriguez CA, 2017, PECES DEP SANTANDER, V9, P1; Ardila Rodriguez CA, 2017, TRICHOMYCTERUS CASIT, V3, P1; Ardila Rodriguez CA, 2014, TRICHOMYCTERUS NIETO; Ardila Rodriguez CA, 2015, ASTROBLEPUS VERAI SP, V7, P1; Ardila Rodriguez CA, 1994, REV UNIMETRO, V10, P1; Ardila Rodriguez CA, 2001, REV UNIMETRO, V13, P1; Ardila Rodriguez CA, 2016, 5 NUEVAS ESPECIES PE, V2, P1; Ardila Rodriguez CA, 2011, DAHLIA, V11, P23; Ardila Rodriguez CA, 2016, PECES DEP SANTANDER, V8, P1; Ardila Rodriguez CA, 2012, PECES DEP SANTANDER, V5, P1; Ardila Rodriguez Carlos A., 2011, Dahlia, V11, P13; Ardila Rodriguez Carlos A., 2008, Dahlia, V10, P17; Ardila Rodriguez Carlos A., 2002, Dahlia, V5, P11; Ardila-Rodriguez C. A., 2010, PECES DEP CHOCO, V1, P1; Ardila-Rodriguez CA, 2007, PECES DEP SANTANDER, V3, P1; Ardilla C., 2015, REV ASOCIACI N COLOM, V27, P124; Armbruster JW, 2007, ZOOTAXA, P59; Armbruster Jonathan W., 2005, Neotrop. ichthyol., V3, P549, DOI 10.1590/S1679-62252005000400013; Armbruster JW, 2006, NEOTROP ICHTHYOL, V4, P401, DOI 10.1590/S1679-62252006000400003; Armbruster JW, 2015, ZOOKEYS, P97, DOI 10.3897/zookeys.480.6540; Armbruster JW, 2008, ZOOTAXA, P1; Ballen GA, 2016, ICHTHYOL EXPLOR FRES, V27, P325; Ballen GA, 2016, ZOOTAXA, V4105, P181, DOI 10.11646/zootaxa.4105.2.6; Ballen GA, 2014, ZOOTAXA, V 3765, P134, DOI 10.11646/zootaxa.3765.2.2; Ballen GA, 2012, NEOTROP ICHTHYOL, V10, P499, DOI 10.1590/S1679-62252012000300003; Ballen Gustavo A., 2011, Pap. Avulsos Zool. (São Paulo), V51, P383, DOI 10.1590/S0031-10492011002600001; Bean Barton A., 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V33; Bejarano I, 2001, DISTRIBUCION C UNPUB; Benine RC, 2015, ZOOTAXA, V3956, P1, DOI 10.11646/zootaxa.3956.1.1; Benine RC, 2010, ZOOTAXA, P59; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P737, DOI 10.1590/S1679-62252010000400005; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Birindelli JLO, 2012, ZOOTAXA, P55; Birindelli JLO, 2011, P ACAD NAT SCI PHILA, V161, P117, DOI 10.1635/053.161.0109; Birindelli JLO, 2011, NEOTROP ICHTHYOL, V9, P515, DOI 10.1590/S1679-62252011000300006; Bockmann F.A., 2003, CHECK LIST FRESHWATE, P406; Bockmann FA, 2008, ZOOTAXA, P1; Bogota-Gregory Juan D., 2005, Dahlia, V8, P61; Bogota-Gregory Juan David, 2006, Biota Colombiana, V7, P301; Bogota-Gregory Juan David, 2016, Check List, V12, P1954; Bogota-Gregory Juan David, 2006, Biota Colombiana, V7, P55; BOHLKE J., 1951, STANFORD ICHTHYOL BULL, V4, P38; BOHLKE JAMES, 1955, NOTULAE NATURAE [PHILADELPHIA], V278, P1; BOHLKE JE, 1980, P ACAD NAT SCI PHILA, V132, P150; Boulenger G. A., 1887, Annals of Natural History, V(5), P348; Boulenger G. A., 1895, Annals of Natural History, Vxvi, P480; Boulenger GA, 1911, ANN MAGAZINE NATURAL, V8, P212; Britski HA, 2008, NEOTROP ICHTHYOL, V6, P45, DOI 10.1590/S1679-62252008000100005; Britski HA, 2011, ZOOTAXA, P59; BUCKUP PA, 1992, COPEIA, P1066; Buckup PA., 2003, CHECK LIST FRESHWATE, P87; Buckup Paulo Andreas, 1993, Ichthyological Exploration of Freshwaters, V4, P97; Buhrnheim CM, 2007, NEOTROP ICHTHYOL, V5, P1, DOI 10.1590/S1679-62252007000100001; Buitrago-Suarez UA, 2007, ZOOTAXA, P1; Burns MD, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160166; Caires RA, 2011, ZOOTAXA, P39; Cala P, 1977, LOZANIA, V24, P1; Calderon CM, 2001, ESTRUCTURA ESP UNPUB; Cardoso A.R., 2008, THESIS; Casatti L, 2005, ZOOTAXA, P39; Casatti Lilian, 2002, Zootaxa, V26, P1; Castellanos-Morales C. A., 2011, BIOTA COLOMBIANA, V11, P33; Castellanos-Morales CA, 2008, NEOTROP ICHTHYOL, V6, P307, DOI 10.1590/S1679-62252008000300003; Castellanos-Morales CA, 2007, ZOOTAXA, P49; Castro D, 1988, B FAC BIOL MAR, V8, P7; Castro D.M., 1987, B ECOTROPICA, V16, P23; Castro D. M., 1986, B ECOTROPICA, V15, P33; Castro DM, 1987, B FACULTAD BIOL MARI, V7, P8; Castro Ricardo M.C., 2004, Smithsonian Contributions to Zoology, V622, P1; CHERNOFF B, 1994, COPEIA, P238; Cipamocha CA, 2002, CARACTERIZACIO UNPUB; Correa Sandra B., 2003, Dahlia, V6, P59; Costa W. J. E. M., 2003, CHECK LIST FRESHWATE, P526; Costa WJEM, 2015, VERTEBR ZOOL, V65, P27; Covain R, 2016, MOL PHYLOGENET EVOL, V94, P492, DOI 10.1016/j.ympev.2015.10.018; da Silva JPCB, 2011, NEOTROP ICHTHYOL, V9, P209, DOI 10.1590/S1679-62252011000100021; Dahl G., 1961, Novedades Colombianas, V1, P483; Dahl G., 1958, Stanford Ichthyological Bulletin, V7, P42; Dahl G., 1960, Caldasia, V8, P353; DAHL G., 1960, CALDASIA, V8, P451; Dahl G., 1943, Kungliga Fysiografiska Sallskapets i Lund Forhandlingar, V12, P215; Dahl G, 1955, REV LINNEANA, V1, P11; Dahl G, 1942, FORHANDLINGAR KUNGL, V11, P80; Dahl G., 1960, NOVEDADES COLOMBIANA, V1, P302; Dahl G, 1964, INFORME FAUNA ACUATI; de Pinna M, 2003, P BIOL SOC WASH, V116, P873; de Pinna MCC, 2003, CHECK LIST FRESHWATE, P70; De Santana CD, 2011, ZOOL J LINN SOC-LOND, V163, P1096, DOI 10.1111/j.1096-3642.2011.00736.x; de Santana CD, 2007, ICHTHYOL EXPLOR FRES, V18, P117; Santana CD, 2013, ZOOL J LINN SOC-LOND, V168, P564, DOI 10.1111/zoj.12022; De Santana CD, 2010, ZOOL J LINN SOC-LOND, V159, P223, DOI 10.1111/j.1096-3642.2009.00588.x; de Santana CD, 2009, COPEIA, P233, DOI 10.1643/CI-08-082; de Santana CD, 2005, ICHTHYOL EXPLOR FRES, V16, P223; De Santana CD, 2004, ZOOTAXA, P1; DoNascimiento C, 2014, NEOTROP ICHTHYOL, V12, P717, DOI 10.1590/1982-0224-20140005; DoNascimiento C, 2014, NEOTROP ICHTHYOL, V12, P707, DOI 10.1590/1982-0224-20130236; Duplain RR, 2012, COPEIA, P541, DOI 10.1643/CI-11-155; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V23; Eigenmann C. H., 1917, Philadelphia Proceedings of the American Philosophical Society, V56; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V25; Eigenmann C. H., 1911, Annals & Magazine of Natural History Series 8, V7; Eigenmann C. H., 1922, Memoirs of the Carnegie Museum, V9, P1; Eigenmann C. H., 1910, Reports of the Princeton University Expeditions to Patagonia 1896-1899 Princeton NJ, V3; Eigenmann C. H., 1905, Proceedings of the Washington Academy, Vvii, P159; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V19; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V24; Eigenmann C.H., 1921, Memoirs Museum of Comparative Zoology Cambridge Mass, V43, P209; Eigenmann C. H., 1907, P US NATL MUS, V33, P1, DOI [10.5479/si.00963801.33-1556.1, DOI 10.5479/SI.00963801.33-1556.1]; Eigenmann C. H., 1918, P AM PHILOS SOC, V56, P673; Eigenmann C. H., 1915, MEMOIRS CARNEGIE MUS, V7, P1, DOI [10.5962/bhl.title.46579, DOI 10.5962/BHL.TITLE.46579]; Eigenmann C.H., 1913, INDIANA U STUDIES, V18, P1; Eigenmann C. H., 1918, MEM CARNEGIE MUS, V7, P259, DOI DOI 10.5962/BHL.TITLE.43951; Eigenmann C.H., 1912, INDIANA U STUDIES, V16, P1; EIGENMANN CH, 1916, ANN CARNEGIE MUS, V10, P77; Eigenmann CH., 1917, MEMOIRS CARNEGIE MUS, V7, P229; Eigenmann CH, 1916, ANN CARNEGIE MUS, V10, P87; Evans KM, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160168; Fernandez L, 2005, COPEIA, P68; Fernandez L, 2009, COPEIA, P195, DOI 10.1643/CI-08-083; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Ferraris CJ, 1999, ZOOL J LINN SOC-LOND, V126, P387, DOI 10.1111/j.1096-3642.1999.tb00156.x; Ferraris Jr CJ, 2005, NEOTROP ICHTHYOL, V3, P81; Ferreira KM, 2006, COPEIA, P630; Ferrer J, 2013, NEOTROP ICHTHYOL, V11, P217, DOI 10.1590/S1679-62252013000200001; Fisch-Muller S., 2003, CHECK LIST FRESHWATE, P373; Fowler H. W., 1919, Proceedings of the Academy of Natural Sciences of Philadelphia, V71; Fowler H. W., 1944, Proceedings of the Academy of Natural Sciences of Philadelphia, V96, P227; Fowler H. W., 1907, P ACAD NAT SCI PHILA, V58, P431; FOWLER HENRY W., 1941, NOTULAE NATURAE [PHILADELPHIA], V73, P1; Fowler Henry W., 1945, PROC ACAD NAT SCI PHILADELPHIA, V97, P93; Fowler Henry W., 1943, PROC ACAD NAT SCI PHILADELPHIA, V95, P223; FOWLER HENRY W., 1950, NOTULAE NATURAE [PHILADELPHIA], V222, P1; FOWLER HENRY W., 1939, NOTULAE NATURAE [PHILADELPHIA], V33, P1; Friel JP, 2008, NEOTROP ICHTHYOL, V6, P293, DOI 10.1590/S1679-62252008000300001; Friel JP, 2016, ZOOTAXA, V4088, P531, DOI 10.11646/zootaxa.4088.4.4; Friel JP, 2003, CHECK LIST FRESHWATE, P261; Galvis G, 2007, PECES ORINOQUIA COLO; Galvis G., 2007, PECES AMAZONIA COLOM; Galvis G, 2006, SERIE GUIAS TROPICAL, V5, P548; Garavello J. C., 2003, CHECK LIST FRESHWATE, P71; GARAVELLO JC, 1988, P ACAD NAT SCI PHILA, V140, P143; Garavello JC, 2014, NEOTROP ICHTHYOL, V12, P317, DOI 10.1590/1982-0224-20130114; Garcfa-Aizate Carlos A., 2015, Cuadernos de Investigación UNED, V7, P89; Garcia-Alzate C. A., 2008, Animal Biodiversity and Conservation, V31, P11; Garcia-Alzate C.A., 2010, BRENESIA, V70, P33; Garcia-Alzate CA, 2008, ZOOTAXA, P42, DOI 10.11646/zootaxa.1813.1.4; Garcia-Alzate CA, 2017, ZOOKEYS, P123, DOI 10.3897/zookeys.668.11489; Garcia-Alzate CA, 2015, CALDASIA, V37, P221, DOI 10.15446/caldasia.v37n1.51228; Garcia-Alzate CA, 2010, ZOOTAXA, P55; Garcia-Alzate CA, 2013, REV BIOL TROP, V61, P181; Garcia-Alzate CA, 2010, CALDASIA, V32, P443; Garcia-Melo LJ, 2016, ZOOTAXA, V4117, P226, DOI 10.11646/zootaxa.4117.2.6; Gery J., 1961, Tropical Fish Hobbyist, VNo.9, P26; GERY J, 1972, Revue Suisse de Zoologie, V79, P931; Gery J., 1986, Tropical Fish Hobbyist, V34; Gery J., 1964, Tropical Fish Hobbyist, V12, P25; Gery J., 1964, Tropical Fish Hobbyist, V13, P11; GERY JACQUES, 1966, ICHTHYOL AQUARIUM J, V37, P211; GERY JACQUES, 1966, ICHTHYOL AQUARIUM J, V37, P111; Henn A. W., 1916, ANN CARNEGIE MUSEUM, V10, P93; Herrera G, 2015, AREAS ALTO GRADO END; Hrbek T, 2005, ZOOTAXA, P1; HUBER J H, 1985, Cybium, V9, P315; Hulen KG, 2005, SYST BIODIVERS, V3, P407, DOI 10.1017/S1477200005001726; Humboldt A. von, 1805, VOYAGE HUMBOLDT BONP, P17; IDEAM MinAmbiente, 2015, EST NAC AG 2014; Isbrucker I.J.H., 1988, Revue Francaise d'Aquariologie Herpetologie, V15, P13; ISBRUCKER IJH, 1979, BIJDR DIERKD, V48, P191, DOI 10.1163/26660644-04802008; ISBRUCKER IJH, 1979, REV FRANCAISE AQUARI, V5, P86; Isbrucker IJH, 1999, AQUARIEN TERRARIEN Z, V52, P38; Jegu M, 2001, CYBIUM, V25, P119; Jegu M, 2003, CHECK LIST FRESHWATE, P182, DOI DOI 10.5962/BHL.PART.80216; Kullander S.O., 1983, REVISION S AM CICHLI; Kullander S. O., 2003, CHECK LIST FRESHWATE, P39; KULLANDER SO, 1989, J NAT HIST, V23, P225, DOI 10.1080/00222938900770131; KULLANDER SO, 1991, REV SUISSE ZOOL, V98, P407, DOI 10.5962/bhl.part.79799; KULLANDER SO, 1989, ZOOL SCR, V18, P447, DOI 10.1111/j.1463-6409.1989.tb00139.x; KULLANDER SO, 1979, ZOOL SCR, V8, P69, DOI 10.1111/j.1463-6409.1979.tb00620.x; Kullander SO, 1986, CICHLID FISHES AMAZO, P1; Kullander SO, 2006, ICHTHYOL EXPLOR FRES, V17, P289; Kullander SO, 2015, COPEIA, V103, P512, DOI 10.1643/CI-14-169; Kullander Sven O., 2004, Ichthyological Exploration of Freshwaters, V15, P41; Kullander Sven O., 1996, Ichthyological Exploration of Freshwaters, V7, P149; Langeani F, 2003, CHECK LIST FRESHWATE, P96; LASSO C.A., 2011, SERIE EDITORIAL RECU; Lasso C.A., 2004, MEMORIA FUNDACION SA, V159-160, P5; Lasso CA, 2012, SERIE EDITORIAL RECU; Lasso CA, 2011, BIODIVERSIDAD CUENCA, VII; Lasso Carlos A., 2004, Biota Colombiana, V5, P95; Lasso Carlos A., 2011, Biota Colombiana, V11, P173; Lasso Carlos A., 2009, Biota Colombiana, V10, P89; Lehmann P, 2006, NEOTROP ICHTHYOL, V4, P379, DOI 10.1590/S1679-62252006000400001; Lehmann AP, 2015, NEOTROP ICHTHYOL, V13, P47, DOI 10.1590/1982-0224-20140113; Hernandez CL, 2015, COPEIA, V103, P563, DOI 10.1643/CI-14-145; Lima F.C.T., 2013, PEIXES RIO MADEIRA, V1, P212; Lima FCT, 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Lima FCT, 2017, ZOOTAXA, V4222, P1, DOI 10.11646/zootaxa.4222.1.1; Lima Flavio C. T., 2016, Aqua, V22, P123; Lima R.S., 2003, CHECKLIST FRESHWATER, P197; Littmann MW, 2007, ZOOTAXA, P1; Littmann MW, 2015, P ACAD NAT SCI PHILA, V164, P159, DOI 10.1635/053.164.0115; Littmann Michael W., 2001, Ichthyological Exploration of Freshwaters, V12, P1; Littmann MW, 2000, P BIOL SOC WASH, V113, P900; Londono-Burbano A, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150120; Londono-Burbano A, 2011, NEOTROP ICHTHYOL, V9, P709, DOI 10.1590/S1679-62252011000400003; Lopez-Fernandez Hernan, 2003, Ichthyological Exploration of Freshwaters, V14, P193; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lovejoy NR, 2003, CHECK LIST FRESHWATE, P586; Lucena C. A. S., 2003, ZOOLOGIA, V93, P283; Lucena CAS, 2003, CHECK LIST FRESHWATE, P200; Lujan NK, 2015, COPEIA, V103, P664, DOI 10.1643/CI-14-194; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lujan NK, 2010, COPEIA, P676, DOI 10.1643/CI-09-185; Lujan NK, 2009, COPEIA, P50, DOI 10.1643/CI-07-187; Lundberg J. G., 2003, CHECK LIST FRESHWATE, V1, P432; Lundberg JG, 2008, NEOTROP ICHTHYOL, V6, P439, DOI 10.1590/S1679-62252008000300018; Mago-Leccia F., 1985, CONTRIB SCI NAT HIST, V358, P1; Malabarba Maria Claudia S. L., 2004, Neotrop. ichthyol., V2, P167, DOI 10.1590/S1679-62252004000400001; Maldonado-Ocampo J. A., 2013, PECES DULCEACUICOLAS; Maldonado-Ocampo J.A., 2005, PECES ANDES COLOMBIA; Maldonado-Ocampo J. A., 2004, FAUNA ACUATICA ORINO, P303; Maldonado-Ocampo JA, 2004, ZOOTAXA, P1; Maldonado-Ocampo JA, 2007, CARACTERIZACION BIOL, P237; Maldonado-Ocampo JA, 2001, REV ASOCIACION COLOM, V4, P61; Maldonado-Ocampo Javier A., 2013, Biota Colombiana, V14, P114; Maldonado-Ocampo Javier A., 2008, Biota Colombiana, V9, P143; Maldonado-Ocampo Javier Alejandro, 2003, Biota Colombiana, V4, P147; Maldonado-Ocampo Javier Alejandro, 2006, Biota Colombiana, V7, P113; Maldonado-Ocampo Javier-Alejandro, 2006, Biota Colombiana, V7, P143; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Marinho MMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183069; Marinho MMF, 2015, ZOOTAXA, V3931, P568, DOI 10.11646/zootaxa.3931.4.6; Mattox GMT, 2014, NEOTROP ICHTHYOL, V12, P343, DOI 10.1590/1982-0224-20130174; Mautari KC, 2006, NEOTROP ICHTHYOL, V4, P27, DOI 10.1590/S1679-62252006000100002; Mees G.F., 1974, Zoologische Verh Leiden, VNo. 132, P1; MEES GF, 1989, P K NED AKAD C BIOL, V92, P379; Menezes NA, 2014, NEOTROP ICHTHYOL, V12, P193, DOI 10.1590/1982-0224-20130175; Mesa SLM, 2011, SERIE EDITORIAL RECU; Meyer Manfred K., 2002, Zoologische Abhandlungen (Dresden), V52, P49; Miles C., 1945, Caldasia Bogota, V3, P453; Miles C., 1943, ESTUDIO EC ECOLOGICO; MILES C, 1947, PECES RIO MAGDALENA; Miles Cecil, 1942, CALDASIA, V5, P55; Mojica J. I., 2005, BIOTA COLOMBIANA, V6, P191; Mojica JI, 2004, COLOMBIA DIVERSIDAD, P725; Mojica Jose Ivan, 2006, Biota Colombiana, V7, P129; Mojica Jose Ivan, 2000, Caldasia, V22, P353; Mojica Jose Ivan, 2006, Biota Colombiana, V7, P23; Mojica-C. Jose Ivan, 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P547; Mol JH, 2012, CYBIUM, V36, P263; Musilova Z, 2009, J ZOOL SYST EVOL RES, V47, P234, DOI 10.1111/j.1439-0469.2009.00528.x; Myers G. S., 1960, Stanford Ichthyological Bulletin, V7, P98; Myers G. S., 1927, Bulletin of the Museum of Comparative Zoology, V68, P107; MYERS GEORGE S., 1930, PROC BIOL SOC WASHINGTON, V43, P65; MYERS GS, 1966, J ZOOL, V149, P277; Myers GS, 1932, COPEIA, V1932, P137; Nelson JS., 2016, FISHES WORLD, V5, DOI 10.1002/9781119174844; Nijssen H., 1988, Revue Francaise d'Aquariologie Herpetologie, V15, P33; NIJSSEN H, 1983, Beaufortia, V33, P53; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Ormerod SJ, 2014, AQUAT CONSERV, V24, P147, DOI 10.1002/aqc.2452; ORTEGA-LARA A., 2012, BIOTA COLOMB, V13, P71; Ortega-Lara A, 2016, SERIE RECURSOS PESQU; Ortega-Lara A, 2006, NEOTROP ICHTHYOL, V4, P147, DOI 10.1590/S1679-62252006000200002; Ortega-Lara A, 2011, NEOTROP ICHTHYOL, V9, P777, DOI 10.1590/S1679-62252011000400009; Ortega-Lara Armando, 2006, Biota Colombiana, V7, P39; OrtegaLara A., 2015, SERIE RECURSOS PESQU; Ota RP, 2015, ZOOTAXA, V3948, P218, DOI 10.11646/zootaxa.3948.2.4; Ota RP, 2010, THESIS; Pavanelli CS, 2015, ICHTHYOL EXPLOR FRES, V26, P193; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Perez MHS, 2008, P ACAD NAT SCI PHILA, V157, P189; Perez MHS, 2014, P ACAD NAT SCI PHILA, V163, P133, DOI 10.1635/053.163.0102; Piorski NM, 2008, NEOTROP ICHTHYOL, V6, P481, DOI 10.1590/S1679-62252008000300021; Ploeg A., 1991, THESIS; Poeser FN, 2003, P BIOL SOC WASH, V116, P356; Poeser FN, 2003, THESIS, P130; Portocarrero-Aya M, 2016, AQUAT CONSERV, V26, P350, DOI 10.1002/aqc.2582; Posada A, 1909, ESTUDIOS CIENTIFICOS, P285; Prada-Pedreros SP, 1997, CALDASIA, V19, P353; Prieto EF, 2000, ESTUDIO ICTIOL UNPUB; Provenzano RF, 2017, ZOOTAXA, V4294, P522, DOI 10.11646/zootaxa.4294.5.2; Radda A.C., 1987, Aquaria (St Gallen), V34, P169; Ramirez-Gil H, 2012, LIBRO ROJO PECES DUL, P86; Ramos R.T.C., 2003, ICHTHYOL EXPLOR FRES, V14, P97; RAMOS RTC, 2003, CHECK LIST FRESHWATE, P666; Ray CK, 2016, ZOOTAXA, V4072, P501, DOI 10.11646/zootaxa.4072.5.1; Regan C. T., 1913, Annals & Magazine of Natural History, V12; Regan C. T., 1903, Annals of Natural History, Vxii, P621; Regan C. T., 1912, ANN MAGAZINE NATURAL, V10, P209; Regan CT, 1912, P ZOOL SOC LOND, V1912, P666; Regan CT, 1907, P ZOOL SOC LOND, V1907, P795; Regan CT, 1905, P ZOOL SOC LOND, V1905, P152; Regan CT, 1912, ANN MAGAZINE NATURAL, V9, P505; Regan CT, 1912, ANN MAGAZINE NATURAL, V10, P387; Regan CT., 1904, T ZOOL SOC LONDON, V17, P191, DOI DOI 10.1111/J.1096-3642.1904.TB00040.X; Regan CT, 1914, ANN MAGAZINE NATURAL, V14, P31, DOI DOI 10.1080/00222931408693538; Reis R. E., 2003, CHECK LIST FRESHWATE, P291; Reis RE, 2003, CHECK LIST FRESHWATE; Reis RE, 2006, COPEIA, P412; Reis Roberto E., 2014, Arquivos de Zoologia (Sao Paulo), V45, P41; Rendahl H., 1941, Arkiv for Zoologi Stockholm, V33A, P1; Retzer ME, 2005, ZOOTAXA, P1; Retzer ME, 1997, P ACAD NAT SCI PHILA, V147, P33; Ribeiro FRV, 2017, J FISH BIOL, V90, P1388, DOI 10.1111/jfb.13246; Roa-Fuentes Camilo Andres, 2010, Check List, V6, P485; Rodrigues C., 2011, PECES DEP SANTANDER, P1; RODRIGUES Cristiano, 2013, ASTROBLEPUS MARTINEZ, P1; Rodrigues-Silva C, 2016, ENVIRON SCI POLLUT R, P1, DOI DOI 10.1080/10400435.2016.1171810; Rodriguez Carolina, 2011, ASTROBLEPUS ITAE AST, P1; Roman-Valencia C, 2014, ANIM BIODIV CONSERV, V37, P107; Roman-Valencia C, 2010, ANIM BIODIV CONSERV, V33, P195; Roman-Valencia C., 2009, Animal Biodiversity and Conservation, V32, P77; Roman-Valencia C, 2000, REV BIOL TROP, V48, P449; Roman-Valencia C., 2008, Animal Biodiversity and Conservation, V31, P67; Roman-Valencia C., 2003, MEMORIAS FUNDACION S, V2003, P31; Roman-Valencia C, 2003, B MUSEO REGIONALE SC, V20, P1; Roman-Valencia C., 2001, B MUSEUM REGIONALLI, V18, P469; Roman-Valencia C, 1999, ACTUAL BIOL, V20, P109; ROMAN-VALENCIA C., 2003, MEM FUND SALLE CIENC, V155, P51; ROMÁN-VALENCIA CÉSAR, 2007, Caldasia, V29, P121; Roman-Valencia Cesar, 1999, Dahlia, V3, P53; Roman-Valencia Cesar, 2003, Dahlia, V6, P17; Roman-valencia C, 2009, REV INVESTIG, V19, P144; Roman-Valencia C, 2014, ZOOKEYS, DOI 10.3897/zookeys.454.6954; Roman-Valencia C, 2013, REV BIOL TROP, V61, P1365; Roman-Valencia C, 2012, NEOTROP ICHTHYOL, V10, P519, DOI 10.1590/S1679-62252012000300004; Roman-Valencia C, 2010, VERTEBR ZOOL, V60, P99; Roman-Valencia C, 2010, ICHTHYOL EXPLOR FRES, V21, P87; Roman-Valencia C, 2010, REV BIOL TROP, V58, P339; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P455; Roman-Valencia C, 2008, REV BIOL TROP, V56, P1749; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Roxo FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105564; Sabaj M. H., 2016, STANDARD SYMBOLIC CO; Sabaj Mark Henry, 2005, Neotrop. ichthyol., V3, P637, DOI 10.1590/S1679-62252005000400020; Salazar Lina M. Mesa, 2011, Biota Colombiana, V12, P19; de Lucena CAS, 2007, IHERINGIA SER ZOOL, V97, P117, DOI 10.1590/S0073-47212007000200001; Santos M, 2000, ASPECTOS ECOLO UNPUB; Sarmento-Soares LM, 2008, NEOTROP ICHTHYOL, V6, P495, DOI 10.1590/S1679-62252008000300022; Schaefer SA, 1996, COPEIA, P913; Schaefer SA, 2003, CHECKLIST FRESHWATER, P312; Schaefer SA, 2011, ZOOL J LINN SOC-LOND, V162, P90, DOI 10.1111/j.1096-3642.2010.00673.x; Schindler Ingo, 2008, Vertebrate Zoology, V58, P67; Schultz L., 1944, COPEIA, V1944, P155; SCHULTZ LEONARD P., 1966, ICHTHYOLOGICA AQUARIUM J, V37, P25; Schultz Leonard P, 1944, JOUR WASHINGTON ACAD SCI, V34, P93; Schultz Leonard P., 1944, JOUR WASHINGTON ACAD SCI, V34, P410; Schultz Leonard P., 1943, JOUR WASHINGTON ACAD SCI, V33, P273; de Lucena ZMS, 2010, ZOOLOGIA-CURITIBA, V27, P263, DOI 10.1590/S1984-46702010000200014; Shibatta OA, 2003, CHECK LIST FRESHWATE, P401; Shibatta OA, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160132; Sidlauskas B, 2006, ICHTHYOL RES, V53, P24, DOI 10.1007/s10228-005-0310-6; Sidlauskas BL, 2007, COPEIA, P711; Steindachner F., 1879, DENKSCHRIFTEN AKAD W, V39, P19; Steindachner F., 1879, MATH NATURWISSENSCHA, V80, P119; Steindachner F., 1878, ANZEIGER KAISERLI MN, V15, P88; Steindachner F., 1900, ANZEIGER AKAD WISSEN, V37, P206; Steindachner F., 1911, ANZEIGER KAISERLI MN, V48, P369; Steindachner F., 1915, DENKSCHRIFTEN KAI MN, V52, P217; Steindachner F., 1880, MATH NATURWISSENSCHA, V42, P55; Steindachner F., 1876, MATH NATURWISSENSCHA, V72, P551; Steindachner F, 1879, ANZEIGER KAISERLICHE, V80, P119; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sullivan JP, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.327.5427; Sullivan JP, 2013, P ACAD NAT SCI PHILA, V162, P89, DOI 10.1635/053.162.0106; Sullivan JP, 2009, P ACAD NAT SCI PHILA, V158, P183, DOI 10.1635/053.158.0109; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; Taphorn D., 1992, BIOLLANIA, V4, P537; TAPHORN D C, 1978, Acta Biologica Venezuelica, V9, P377; TAPHORN DC, 1980, COPEIA, P335; Taphorn DC, 2010, ZOOTAXA, P19, DOI 10.11646/zootaxa.2345.1.2; Taphorn DC, 2013, ZOOTAXA, V3641, P343, DOI 10.11646/zootaxa.3641.4.2; Tellez P, 2011, PORTAFOLIO CONSERVAC; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Thomerson Jamie E., 1993, Ichthyological Exploration of Freshwaters, V4, P57; Tognelli M.F., 2016, ESTADO CONSERVACI N, V1st; Toledo-Piza M, 2000, ICHTHYOL EXPLOR FRES, V11, P289; Toledo-Piza Monica, 1996, American Museum Novitates, V3160, P1; Toledo-Piza M, 2007, ZOOL J LINN SOC-LOND, V151, P691, DOI 10.1111/j.1096-3642.2007.00355.x; Toledo-Piza Monica, 2000, American Museum Novitates, V3286, P1, DOI 10.1206/0003-0082(2000)286<0001:TNFSCT>2.0.CO;2; Torres-Mejia M, 2005, COPEIA, P812; Torres-Mejia M, 2012, COPEIA, P501, DOI 10.1643/CI-10-160; Urbano-Bonilla Alexander, 2009, Biota Colombiana, V10, P149; Usma JS, 2009, PLAN NACL ESPECIES M, P103; Usma Oviedo JS, 2013, Guía de las Especies Migratorias de la Biodiversidad en Colombia. Peces, V2, P215; Usma S, 2002, LIBRO ROJO PECES DUL, P166; Valdesalici S, 2016, ZOOTAXA, V4085, P279, DOI 10.11646/zootaxa.4085.2.8; Vanegas-Rios JA, 2017, J FISH BIOL, V90, P2344, DOI 10.1111/jfb.13317; Vanegas-Rios JA, 2016, ZOOTAXA, V4100, P1, DOI 10.11646/zootaxa.4100.1.1; Vanegas-Rios JA, 2015, ICHTHYOL EXPLOR FRES, V26, P171; Vari R.P., 1984, Smithsonian Contributions to Zoology, P1; VARI R P, 1982, Smithsonian Contributions to Zoology, P1; Vari R.P., 2003, CHECK LIST FRESHWATE, P85; Vari R. P., 1992, SMITHSON CONTRIB ZOO, V529, P1, DOI DOI 10.5479/SI.00810282.529; Vari R. P., 1994, SMITHSONIAN CONTRIBU, V551, P1, DOI DOI 10.5479/SI.00810282.551; Vari Richard P., 2005, Neotrop. ichthyol., V3, P127, DOI 10.1590/S1679-62252005000200001; Vari Richard P., 1995, Smithsonian Contributions to Zoology, V577, P1; Vari RP, 2006, COPEIA, P168, DOI 10.1643/0045-8511(2006)6[168:TCGTA]2.0.CO;2; Vari RP, 2003, COPEIA, P583; Vari RP., 1991, SM C ZOOL, V507, P1; Vari RP., 1995, SMITHSON CONTRIB ZOO, V564, P1, DOI 10.5479/si.00810282.564; VARI RP, 1989, SMITHSONIAN CONTRIBU, V481, P1, DOI [10.5479/si.00810282.481, DOI 10.5479/SI.00810282.481]; Vari RP., 1992, SM C ZOOL, V533, P1; Vari RP, 2003, CHECK LIST FRESHWATE, P51; VARI RP, 1989, SMITHSONIAN CONTRIBU, V474, P1, DOI DOI 10.5479/SI.00810282.474; Vejarano S, 2000, ICTIOFAUNA LAG UNPUB; Vermeulen F.M.B., 2013, KILLI DATA SERIES, V2013, P47; Vilardy S., 2014, PRINCIPIOS CRITERIOS; Villa-Navarro F, 2011, BIODIVERSIDAD CASANA, P121; von Humboldt FHA, 1821, VOYAGE HUMBOLDT BO 2, P145; Weber C., 2003, CHECK LIST FRESHWATE, P351, DOI DOI 10.1016/J.NEULET.2009.06.076; Weitzman M., 2003, EDIPUCRS, V729p, P241; WEITZMAN S, 1978, Proceedings of the Biological Society of Washington, V91, P158; Weitzman S. H., 1960, Stanford Ichthyological Bulletin, V7, P217; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; WEITZMAN S H, 1971, Beaufortia, V19, P57; WEITZMAN S H, 1976, Proceedings of the Biological Society of Washington, V89, P325; WEITZMAN S H, 1977, Proceedings of the Biological Society of Washington, V90, P348; Weitzman S. H., 1970, BEAUFORTIA, V18, P119; WEITZMAN SH, 1987, P BIOL SOC WASH, V100, P640; Weitzman SH., 2003, CHECK LIST FRESHWATE, P222; Weitzman SH, 1975, SMITHSONIAN CONTRIBU, V186, P1; Weitzman Stanley H., 2005, Neotrop. ichthyol., V3, P329, DOI 10.1590/S1679-62252005000300002; Weitzman Stanley H., 1997, Ichthyological Exploration of Freshwaters, V7, P209; WEITZMAN STANLEY H., 1966, PROC U S NAT MUS, V119, P1; Zanata AM, 2004, ZOOL J LINN SOC-LOND, V140, P103, DOI 10.1111/j.1096-3642.2004.00090.x; Zapata LA, 2013, GUIA ESPECIES MIGRAT, V2; Zarske Axel, 2002, Aquarium (Bornheim), V391, P22; Zarske A, 2015, VERTEBR ZOOL, V65, P3; Zarske A, 2011, VERTEBR ZOOL, V61, P13; Zuniga-Upegui P. T. Z.-U., 2006, BIOTA COLOMBIANA, V7, P3, DOI DOI 10.21068/BC.V7I1.162	458	41	53	0	6	PENSOFT PUBLISHERS	SOFIA	12 PROF GEORGI ZLATARSKI ST, SOFIA, 1700, BULGARIA	1313-2989	1313-2970		ZOOKEYS	ZooKeys		2017		708					25	138		10.3897/zookeys.708.13897	http://dx.doi.org/10.3897/zookeys.708.13897			114	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	FK0VB	29118633	Green Published, gold, Green Submitted			2022-09-04	WOS:000413197300003
J	Arango, CM; Parra, DC; Gomez, LF; Lema, L; Lobelo, F; Ekelund, U				Arango, Carlos M.; Parra, Diana C.; Gomez, Luis F.; Lema, Lucia; Lobelo, Felipe; Ekelund, Ulf			Screen time, cardiorespiratory fitness and adiposity among school-age children from Monteria, Colombia	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sedentary lifestyle; Physical fitness; Abdominal fat; Adolescent; Developing countries	PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; MEDIA USE; TELEVISION; ADOLESCENTS; OBESITY; YOUTH	Objectives: To explore the association between electronic media exposure (television viewing time, personal computer/video game use, total screen time), and waist circumference and body mass index, and study whether this association is independent of cardiorespiratory fitness, in a representative sample of adolescents from Monteria, Colombia. Design: Cross-sectional study analyzing data from 546 students aged 11-18 years, from fourteen randomly selected schools. Z-scores for WC and BMI were calculated. Methods: The physical activity module of the Global School Health Survey 2007 was used to determine EME, and the shuttle run test was used to assess CRF. Linear regression models adjusted by age, school location, physical activity level, type of institution (public or private), consumption of sweetened beverages, fast food, and fried food were used. Results: Among boys, independently of cardiorespiratory fitness, high television viewing time (>= 2 h/day) (beta = +0.22; p<0.02), was positively associated with waist circumference. High total screen time (>3 h/day) was positively associated with waist circumference (beta = +0.34; p<0.01), and body mass index (beta = +0.39; p<0.01). Among girls, sedentary behavior was not associated with adiposity, but cardiorespiratory fitness (beta = -0.04; p<0.02) was negatively associated with body mass index. Conclusions: These findings support the evidence on the negative impact of excessive electronic media exposure and low cardiorespiratory fitness, and highlight the need for interventions, and prevention strategies. (C) 2013 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Arango, Carlos M.; Parra, Diana C.] Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Gomez, Luis F.] Pontificia Univ Javeriana, Dept Med Prevent & Social, Bogota, Colombia; [Lema, Lucia] Univ Cordoba, Dept Cultura Fis, Cordoba, Colombia; [Lobelo, Felipe] Ctr Dis Control & Prevent, Global Hlth Promot Off, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Ekelund, Ulf] Dept Sport Med, Oslo, Norway; [Ekelund, Ulf] Inst Metab Sci, MRC, Epidemiol Unit, Tehran, Iran		Arango, CM (corresponding author), Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63130 USA.	carangopaternina@go.wustl.edu	Lobelo, R.L Felipe/AAB-2264-2021; Parra, Diana C/B-7761-2015; Ekelund, Ulf/AAE-8471-2019	Lobelo, R.L Felipe/0000-0003-4185-7193; Parra, Diana C/0000-0002-9797-6231; Ekelund, Ulf/0000-0003-2115-9267; Arango-Paternina, Carlos Mario/0000-0002-5263-3139; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012	Medical Research Council [MC_U106179473] Funding Source: Medline; MRC [MC_UU_12015/3, MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_UU_12015/3] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson DR, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00121; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; Arango CM, 2011, J PHYS ACT HEALTH, V8, pS171, DOI 10.1123/jpah.8.s2.s171; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Centers for Disease Control and Prevention, 2011, GLOB SCH BAS STUD HL; Delmas C, 2007, OBESITY, V15, P2495, DOI 10.1038/oby.2007.296; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Ortega-Montes JE, 2008, CUAD VIVIENDA URBAN, V1, P96; Giammattei J, 2003, ARCH PEDIAT ADOL MED, V157, P882, DOI 10.1001/archpedi.157.9.882; Grund A, 2001, PUBLIC HEALTH NUTR, V4, P1245, DOI 10.1079/PHN2001178; Institut Brasileiro de Geografia e Estatistica, 2010, POP 2008 2009 DESN P; Institut Colombiano de Bienestar Familiar y Profamilia, 2011, ENC NACL SIT NUTR CO; KLESGES RC, 1993, PEDIATRICS, V91, P281; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Lobelo F, 2010, J ADOLESCENT HEALTH, V47, P352, DOI 10.1016/j.jadohealth.2010.04.012; Marshall SJ, 2011, AM J LIFESTYLE MED, V5, P518, DOI 10.1177/1559827610395487; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Ministerio de Salud, 1993, RESOLUCION 008430 19; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Organizacion Panamericana de la Salud, 2005, SAL DESPL COL MONT; Ortega FB, 2007, OBESITY, V15, P1589, DOI 10.1038/oby.2007.188; Popkin Barry M, 2003, Forum Nutr, V56, P262; Raymond SU, 2006, CURR OPIN CLIN NUTR, V9, P111, DOI 10.1097/01.mco.0000214568.52192.91; Roberts DF, 2008, FUTURE CHILD, V18, P11, DOI 10.1353/foc.0.0000; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization (WHO), 2011, CHRON DIS HLTH PROM	30	28	30	1	30	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2014	17	5					491	495		10.1016/j.jsams.2013.09.010	http://dx.doi.org/10.1016/j.jsams.2013.09.010			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AP9MZ	24211150				2022-09-04	WOS:000342405200009
J	Rodriguez, JM; Medina, MH; Campuzano, JC; Bangdiwala, SI; Villaveces, A				Rodriguez, Jorge M.; Medina, Martha Hijar; Campuzano, Julio Cesar; Bangdiwala, Shrikant I.; Villaveces, Andres			Methodological proposal for implementing an intervention to prevent pedestrian injuries, a multidisciplinary approach: the case of Cuernavaca, Morelos, Mexico	INJURY PREVENTION			English	Article							ROAD-TRAFFIC INJURIES; MOTOR-VEHICLE; AREA	Objective To describe the process for implementing an intervention to prevent pedestrian injuries in Cuernavaca, Mexico, using a multidisciplinary and evidence-based approach. Methodology This study included two phases with several stages. The first was an overall assessment of pedestrian mortality in Cuernavaca that included a comparison of pedestrian mortality between Cuernavaca and the rest of Morelos State (1998-2007), an analysis and geocoding of pedestrian injuries (2008-2009), and a description of techniques for selecting and analysing clustered events using road audits. The second phase focused on selecting an intervention through a review of the literature seeking the best evidence' adaptable to the local context and a methodological evaluation for implementation including techniques for cluster randomisation and for the evaluation of possible effects of the intervention. Results Between 2008 and 2009, in Cuernavaca there were 620 pedestrian injury events: 59.4% were men, the mean age was 36.3 years, 70% occurred during daylight hours, 55% had mild severity and there were no differences by sex (p>0.05). We generated evidence, that when combined with the results from a systematic search of the literature, provided sufficient information for the implementation of a pedestrian injury prevention intervention. Conclusions A combination of strategies and disciplines makes it possible to comprehensively address this public health problem, allowing interventions to strengthen aspects of pedestrian safety while accounting for characteristics of the local context; the promotion of local measures, of low cost and high impact, with modifications to the road infrastructure, are more effective in addressing pedestrian vulnerabilities.	[Rodriguez, Jorge M.; Medina, Martha Hijar; Campuzano, Julio Cesar] Natl Inst Publ Hlth Mexico, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Rodriguez, Jorge M.] Univ Javeriana, Ctr Proyectos Desarrollo Cendex, Bogota, Capital Distric, Colombia; [Bangdiwala, Shrikant I.] Univ N Carolina, UNC Injury Prevent Res Ctr, Chapel Hill, NC USA; [Bangdiwala, Shrikant I.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Villaveces, Andres] Univ Valle, Cisalva Inst, Cali 25360, Velle, Colombia		Villaveces, A (corresponding author), Univ Valle, Cisalva Inst, Oficina 114,San Fernando Calle 4B 36-00, Cali 25360, Valle, Colombia.	avillavec@yahoo.com		Rodriguez, Jorge Martin/0000-0002-7301-7706; Villaveces, Andres/0000-0002-3725-2741	National Council of Science and Technology (CONACYT) of Mexico [114657]; National Institute of Public Health of Mexico; National Center for Injury Prevention and Control (NCIPC) [R149 CE000196]	National Council of Science and Technology (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Public Health of Mexico; National Center for Injury Prevention and Control (NCIPC)	This work was funded by the National Council of Science and Technology (CONACYT) of Mexico under project 114657 and also received partial support from the National Institute of Public Health of Mexico. Partial support for AV and SIB came from a grant of the National Center for Injury Prevention and Control (NCIPC), to the UNC Injury Prevention Research Center under grant R149 CE000196.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; Campbell BJ, 2004, REV PEDESTRIAN SAFET, P150; Cayuela L., 2009, MODELOS LINEALES GEN; Celis A, 1999, Gac Med Mex, V135, P353; Franco Arias C., 2010, AMBIENTE SEGURO INTE, P38; Hayes RJ, 2009, INTERD STAT, P3; Hernandez M, 2007, EPIDEMIOLOGIA DESENO, P253, DOI Mexico; Hidalgo-Solorzano E, 2010, SALUD PUBLICA MEXICO, V52, P502, DOI 10.1590/S0036-36342010000600004; Hijar M, 2004, ACCIDENT ANAL PREV, V36, P37, DOI 10.1016/S0001-4575(02)00112-4; Hijar M, 2003, SOC SCI MED, V57, P2149, DOI 10.1016/S0277-9536(03)00067-4; Hijar Martha, 2003, Inj Control Saf Promot, V10, P37, DOI 10.1076/icsp.10.1.37.14108; Hijar-Medina MC, 2000, SALUD PUBLICA MEXICO, V42, P188, DOI 10.1590/S0036-36342000000300004; Instituto Nacional de Estadistica y Geografia, 2007, URB MARG MEX; Instituto Nacional de Estadistica y Geografia, 2008, DAT REC MORT EXT CAU; Kennedy J.F., 2008, ESTIMATING PEDESTRIA; Koepsell T, 2002, JAMA-J AM MED ASSOC, V288, P2136, DOI 10.1001/jama.288.17.2136; Kraschnewski JL, 2010, PREV CHRONIC DIS, V7; Kwan I, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003438.pub2; Lwanga S.K., 1991, SAMPLE SIZE DETERMIN; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Morency P, 2006, INJURY PREV, V12, P360, DOI 10.1136/ip.2006.013326; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; National Population Council, 2008, POP PROJ MEX 1995 20; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Peden M, 2004, WORLD REPORT ROAD TR, P41; Peek-Asa C, 2003, EPIDEMIOL REV, V25, P77, DOI 10.1093/epirev/mxg006; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; Rodríguez-Hernández Jorge M, 2010, Rev. salud pública, V12, P497; Salinas-Rodriguez A, 2009, SALUD PUBLICA MEXICO, V51, P397; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Tiwari G, 1998, ACCIDENT ANAL PREV, V30, P207, DOI 10.1016/S0001-4575(97)00082-1; Villaveces A, 2003, AM J EPIDEMIOL, V157, P131, DOI 10.1093/aje/kwf186; World Health Organization (WHO), 2010, INT STAT CLASS DIS R	36	3	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2014	20	1							e1	10.1136/injuryprev-2013-040776	http://dx.doi.org/10.1136/injuryprev-2013-040776			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AA6EG	23606527				2022-09-04	WOS:000331191000001
J	Angarita, FA; Rodriguez, JL; Meek, E; Sanchez, JO; Tawil, M; Torregrosa, L				Angarita, Fernando A.; Rodriguez, Jorge L.; Meek, Eugenio; Sanchez, Jesus O.; Tawil, Mauricio; Torregrosa, Lilian			Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature	WORLD JOURNAL OF SURGICAL ONCOLOGY			English	Review						Breast neoplasm; Neuroendocrine tumor; Chromogranin A; Synaptophysin	SMALL-CELL CARCINOMA; NEEDLE-ASPIRATION-CYTOLOGY; ENDOCRINE-CELLS; APOCRINE DIFFERENTIATION; PROGNOSTIC-SIGNIFICANCE; GENE-EXPRESSION; TUMOR; FEATURES; CHROMOGRANIN; MARKER	Background: Primary neuroendocrine carcinoma of the breast is a heterogeneous group of rare tumors with positive immunoreactivity to neuroendocrine markers in at least 50% of cells. Diagnosis also requires that other primary sites be ruled out and that the same tumor show histological evidence of a breast in situ component. Primary neuroendocrine carcinoma of the breast rarely presents as locally advanced disease and less frequently with such widespread metastatic disease as described herein. The review accompanying this case report is the first to provide an overview of all the cases of primary neuroendocrine carcinoma of the breast published in the literature and encompasses detailed information regarding epidemiology, histogenesis, clinical and histologic diagnosis criteria, classification, surgical and adjuvant treatment, as well as prognosis. We also provide recommendations for common clinical and histologic pitfalls associated with this tumor. Case presentation: We describe a case of a 51-year-old Hispanic woman initially diagnosed with locally-advanced invasive ductal carcinoma that did not respond to neodjuvant treatment. After undergoing modified radical mastectomy the final surgical pathology showed evidence of alveolar-type primary neuroendocrine carcinoma of the breast. The patient was treated with cisplatin/etoposide followed by paclitaxel/carboplatinum. Thirteen months after surgery the patient is alive, but developed pulmonary, bone, and hepatic metastasis. Conclusion: The breast in situ component of primary neuroendocrine carcinoma of the breast may prevail on a core biopsy samples increasing the probability of underdiagnosing this tumor preoperatively. Being aware of the existence of this disease allows for timely diagnosis and management. Optimal treatment requires simultaneous consideration of both the neuroendocrine and breast in situ tumor features.	[Angarita, Fernando A.; Tawil, Mauricio; Torregrosa, Lilian] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Surg, Bogota, Colombia; [Rodriguez, Jorge L.; Meek, Eugenio] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Pathol, Bogota, Colombia; [Sanchez, Jesus O.] Ctr Javeriano Oncol, Dept Oncol, Bogota, Colombia; [Tawil, Mauricio; Torregrosa, Lilian] Ctr Javeriano Oncol, Breast & Soft Tissue Clin, Bogota, Colombia; [Angarita, Fernando A.] Univ Hlth Network, Div Expt Therapeut, Toronto Gen Res Inst, Toronto, ON, Canada; [Angarita, Fernando A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada		Torregrosa, L (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Surg, Carrera 7 40-62,Oficina 718, Bogota, Colombia.	lilian.torregrosa@javeriana.edu.co	Angarita, Fernando A./AAI-9245-2020	Angarita, Fernando A./0000-0002-8546-7309; Rodriguez Sarmiento, Jorge Luis/0000-0002-0084-0339; Torregrosa Almonacid, Lilian/0000-0002-5392-7083; Meek, Eugenio/0000-0002-3564-6763				Adegbola T, 2005, J CLIN PATHOL, V58, P775, DOI 10.1136/jcp.2004.020792; Alkaied H, 2012, MED ONCOL, V29, P2613, DOI 10.1007/s12032-012-0222-z; AZZOPARDI JG, 1982, HISTOPATHOLOGY, V6, P549, DOI 10.1111/j.1365-2559.1982.tb02750.x; Bergman S, 2004, AM J CLIN PATHOL, V121, P117, DOI 10.1309/737Y07JNP8GQQJJY; Berruti A, 2004, BREAST, V13, P527, DOI 10.1016/j.breast.2004.06.007; Bigotti G, 2004, J EXP CLIN CANC RES, V23, P691; BUSSOLATI G, 1985, AM J PATHOL, V120, P186; Christie M, 2010, INT J CLIN EXP PATHO, V3, P629; CHUA RS, 1997, ACTA CYTOL S4, P13; CUBILLA AL, 1977, AM J SURG PATHOL, V1, P283, DOI 10.1097/00000478-197712000-00001; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Ellis IO., 2003, PATHOLOGY GENETICS T, P32; Ersahin C, 2009, INT J SURG PATHOL, V17, P368, DOI 10.1177/1066896909340275; Eyden B., 2002, Journal of Submicroscopic Cytology and Pathology, V34, P27; FEYRTER F, 1963, Frankf Z Pathol, V73, P24; FRANCOIS A, 1995, AM J CLIN ONCOL-CANC, V18, P133, DOI 10.1097/00000421-199504000-00008; Fujimoto Yasuhisa, 2007, Breast Cancer, V14, P250, DOI 10.2325/jbcs.889; Fukunaga M, 1998, PATHOL INT, V48, P744, DOI 10.1111/j.1440-1827.1998.tb03976.x; Gunhan-Bilgen I, 2003, EUR RADIOL, V13, P788, DOI 10.1007/s00330-002-1567-z; Hoang MP, 2001, HUM PATHOL, V32, P753, DOI 10.1053/hupa.2001.25603; Honami H., 2011, BREAST CANC; HULL MT, 1987, ULTRASTRUCT PATHOL, V11, P29, DOI 10.3109/01913128709023180; Hwang H, 2008, BREAST J, V14, P201, DOI 10.1111/j.1524-4741.2007.00557.x; Jablon LK, 1998, ANN SURG ONCOL, V5, P261, DOI 10.1007/BF02303783; Jochems L, 2004, EUR J OBSTET GYN R B, V115, P231, DOI 10.1016/j.ejogrb.2003.12.013; JUNDT G, 1984, VIRCHOWS ARCH A, V404, P213, DOI 10.1007/BF00704065; Kawanishi N, 2011, DIAGN CYTOPATHOL, V39, P527, DOI 10.1002/dc.21494; Kawasaki T, 2008, HISTOPATHOLOGY, V53, P288, DOI 10.1111/j.1365-2559.2008.03093.x; Kawasaki T, 2012, BREAST, V21, P652, DOI 10.1016/j.breast.2012.01.016; Kim JW, 2008, J KOREAN MED SCI, V23, P1118, DOI 10.3346/jkms.2008.23.6.1118; Kinoshita S, 2008, SURG TODAY, V38, P734, DOI 10.1007/s00595-007-3716-0; Latif N, 2010, BREAST J, V16, P647, DOI 10.1111/j.1524-4741.2010.00974.x; Lopez-Bonet E, 2008, ONCOL REP, V20, P1369, DOI 10.3892/or_00000154; Makretsov N, 2003, HUM PATHOL, V34, P1001, DOI 10.1053/S0046-8177(03)00411-8; McIntire M, 2008, DIAGN CYTOPATHOL, V36, P887, DOI [10.1002/dc.20946, 10.1002/dc.20753]; Miremadi A, 2002, HISTOPATHOLOGY, V40, P215, DOI 10.1046/j.1365-2559.2002.01336.x; Miura K, 2012, PATHOL INT, V62, P331, DOI 10.1111/j.1440-1827.2012.02786.x; Ng WK, 2002, ACTA CYTOL, V46, P325, DOI 10.1159/000326729; Nozoe T, 2011, SURG TODAY, V41, P829, DOI 10.1007/s00595-010-4351-8; Ooi A, 1988, SURG PATHOL, V1, P277; PAGANI A, 1994, VIRCHOWS ARCH, V425, P459; PAGANI A, 1990, AM J PATHOL, V136, P319; PAPOTTI M, 1989, SEMIN DIAGN PATHOL, V6, P174; PAPOTTI M, 1992, VIRCHOWS ARCH A, V420, P103, DOI 10.1007/BF01605991; PAPOTTI M, 1993, ULTRASTRUCT PATHOL, V17, P115, DOI 10.3109/01913129309015404; Richter-Ehrenstein C, 2010, BREAST CANCER RES TR, V124, P413, DOI 10.1007/s10549-010-1178-3; Righi L, 2010, SEMIN DIAGN PATHOL, V27, P69, DOI 10.1053/j.semdp.2009.12.003; RINDI G, 1986, HISTOCHEMISTRY, V85, P19, DOI 10.1007/BF00508649; ROVERA F, 2008, INT J SURG S1, pS113; Salmo EN, 2001, HISTOPATHOLOGY, V38, P277, DOI 10.1046/j.1365-2559.2001.01068.x; Samli B, 2000, ARCH PATHOL LAB MED, V124, P296; Sapino A, 2000, SEMIN DIAGN PATHOL, V17, P127; Sapino A, 2002, HISTOPATHOLOGY, V40, P211, DOI 10.1046/j.1365-2559.2002.01327.x; Sapino A, 2001, MODERN PATHOL, V14, P768, DOI 10.1038/modpathol.3880387; Shin SJ, 2000, AM J SURG PATHOL, V24, P1231, DOI 10.1097/00000478-200009000-00006; Sridhar P, 2004, BREAST, V13, P149, DOI 10.1016/j.breast.2003.07.001; Stita W, 2009, CAN J SURG, V52, pE289; Su CH, 2012, ANTICANCER RES, V32, P183; Tang F, 2011, HISTOPATHOLOGY, V59, P106, DOI 10.1111/j.1365-2559.2011.03880.x; Tang WH, 2002, ACTA CYTOL, V46, P835, DOI 10.1159/000327056; Tian Z, 2011, HUM PATHOL, V42, P1169, DOI 10.1016/j.humpath.2010.11.014; Tsang WYW, 1996, AM J SURG PATHOL, V20, P921, DOI 10.1097/00000478-199608000-00002; Valdes EK, 2006, AM SURGEON, V72, P185; van Krimpen C, 2004, BREAST, V13, P329, DOI 10.1016/j.breast.2003.11.008; WADE MP, 1983, CANCER, V52, P121; Wei B, 2010, CANCER-AM CANCER SOC, V116, P4463, DOI 10.1002/cncr.25352; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407; Yamaguchi R, 2009, MED MOL MORPHOL, V42, P58, DOI 10.1007/s00795-008-0432-9; Yamamoto J, 2004, ONCOL REP, V11, P825; Yamasaki T, 2000, PATHOL INT, V50, P914, DOI 10.1046/j.1440-1827.2000.01126.x; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zekioglu O, 2003, BREAST, V12, P251, DOI 10.1016/S0960-9776(03)00059-6; Zhang JY, 2011, SURG TODAY, V41, P1575, DOI 10.1007/s00595-010-4516-5	73	26	31	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7819		WORLD J SURG ONCOL	World J. Surg. Oncol.	JUN 5	2013	11								128	10.1186/1477-7819-11-128	http://dx.doi.org/10.1186/1477-7819-11-128			11	Oncology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Surgery	164CS	23734899	Green Published, gold			2022-09-04	WOS:000320387000001
J	Wachs, TD; Posada, G; Carbonell, OA; Creed-Kanashiro, H; Gurkas, P				Wachs, Theodore D.; Posada, German; Carbonell, Olga A.; Creed-Kanashiro, Hillary; Gurkas, Pinar			Infant Nutrition and 12 and 18 Months Secure Base Behavior: An Exploratory Study	INFANCY			English	Article							MOTHER-CHILD INTERACTION; IRON-DEFICIENCY; ATTACHMENT SECURITY; Q-SORT; PATTERNS; ANEMIA	A notable omission in studies of developmental links to early nutritional deficiencies is infant attachment. In those few studies investigating associations between infant nutrition and attachment, nutrition was defined solely by physical growth, and infants had moderate-severe growth retardation. In this study, we utilized multiple markers of infant nutrition. Our sample consisted of 172 12-month-old Peruvian infants and their mothers from low-income families, with a follow-up assessment on 77 infants at 18 months. Infants were not severely malnourished, but did have micronutrient deficiencies. Anthropometry, dietary intake, and iron status were used as measures of infant nutrition. Based on infant behavior in a structured laboratory situation, Q-sort techniques were used to rate three attachment markers: infant secure base behavior, interaction quality, and negative emotionality with mother. At 12 months, infant weight was positively related to interaction quality. At 18 months, infant iron status was positively related to secure base behavior. This pattern of findings remained even after statistically controlling for family socioeconomic status and maternal education. Our findings indicate that infant nutritional status is associated with markers of infant attachment and these associations are not restricted just to severely malnourished infants.	[Wachs, Theodore D.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Posada, German] Purdue Univ, Dept Child Dev & Family Studies, W Lafayette, IN 47907 USA; [Carbonell, Olga A.] Pontificia Univ Javeriana, Dept Psychol, Bogota, Colombia; [Gurkas, Pinar] Columbus State Univ, Dept Psychol & Sociol, Columbus, GA USA		Wachs, TD (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	wachs@psych.purdue.edu		Creed-Kanashiro, Hilary/0000-0001-8282-0835				Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2008, J NUTR, V138, P2534, DOI 10.1093/jn/138.12.2534; Bost KK, 1998, CHILD DEV, V69, P192; Bowlby J., 1971, ATTACHMENT LOSS LOSS; Cassidy J, 1999, HDB ATTACHMENT THEOR, P3; CHAVEZ A, 1975, FED PROC, V34, P1574; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corapci F, 2006, J DEV BEHAV PEDIATR, V27, P371, DOI 10.1097/00004703-200610000-00001; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Elicker J., 1992, FAMILY PEER RELATION, P77, DOI DOI 10.1370/AFM.2473; Finkel D, 1998, BEHAV GENET, V28, P1, DOI 10.1023/A:1021448429653; GOMEZ F, 1954, ADV PEDIATR, V7, P131; GRAVES PL, 1978, AM J CLIN NUTR, V31, P541, DOI 10.1093/ajcn/31.3.541; GRAVES PL, 1976, AM J CLIN NUTR, V29, P305, DOI 10.1093/ajcn/29.3.305; GREENBERG MT, 1993, DEV PSYCHOPATHOL, V5, P191, DOI 10.1017/S095457940000434X; Hubbs-Tait L, 2008, J AM DIET ASSOC, V108, P1154, DOI 10.1016/j.jada.2008.04.008; Hurtado EK, 1999, AM J CLIN NUTR, V69, P115; Johnson RA, 1982, APPL MULTIVARIATE ST; Kerns KA, 1998, MERRILL PALMER QUART, V44, P504; Lay KL, 1995, MONOGR SOC RES CHILD, V60, P179, DOI 10.2307/1166178; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Martone D J, 1988, J Obstet Gynecol Neonatal Nurs, V17, P212, DOI 10.1111/j.1552-6909.1988.tb00427.x; Pederson DR, 1995, MONOGR SOC RES CHILD, V60, P111, DOI 10.2307/1166174; Perez EM, 2005, J NUTR, V135, P850, DOI 10.1093/jn/135.4.850; POLLITT E, 1993, MONOGR SOC RES CHILD, V58, pR5; Posada G, 2004, DEV PSYCHOL, V40, P508, DOI 10.1037/0012-1649.40.4.508; Posada G, 2002, DEV PSYCHOL, V38, P67, DOI 10.1037//0012-1649.38.1.67; Roisman GI, 2008, DEV PSYCHOL, V44, P831, DOI 10.1037/0012-1649.44.3.831; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Sigman M, 1998, PAHO SCI P, P91; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; STOLTZFUS RJ, 2005, COMP QUANTIFICATION, P163; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5th; Tomlinson M, 2005, CHILD DEV, V76, P1044, DOI 10.1111/j.1467-8624.2005.00896.x; UNICEF, 2004, STAT WORLDS CHILDR 2; VALENZUELA M, 1990, CHILD DEV, V61, P1984, DOI 10.1111/j.1467-8624.1990.tb03580.x; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; WACHS TD, 1992, INT J BEHAV DEV, V15, P1; Wachs TD, 2005, J NUTR, V135, P2179, DOI 10.1093/jn/135.9.2179; Wachs TD, 2003, ADV CHILD DEV BEHAV, V31, P363; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Waters E, 2000, CHILD DEV, V71, P164, DOI 10.1111/1467-8624.00130; Waters E, 1999, ATTACHMENT DISORGANIZATION, P265; Waters E, 1995, MONOGR SOC RES CHILD, V60, pR9; Zaslow M, 2009, MATERN CHILD HLTH J, V13, P66, DOI 10.1007/s10995-008-0329-1; Zemel BS, 1997, ANNU REV NUTR, V17, P211, DOI 10.1146/annurev.nutr.17.1.211; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	59	2	2	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1525-0008	1532-7078		INFANCY	Infancy		2011	16	1					91	111		10.1111/j.1532-7078.2010.00040.x	http://dx.doi.org/10.1111/j.1532-7078.2010.00040.x			21	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	693EE	32693480				2022-09-04	WOS:000285206600008
J	Blair, KJ; Valderrama-Beltran, SL; Bautista-Arredondo, S; Juillard, C; Amaya, LJL				Blair, Kevin J.; Liliana Valderrama-Beltran, Sandra; Bautista-Arredondo, Sergio; Juillard, Catherine; Lombana Amaya, Luis Jorge			Anal cancer screening in low-income and middleincome countries	LANCET GASTROENTEROLOGY & HEPATOLOGY			English	Letter							MEN; SEX		[Blair, Kevin J.] Univ Calif Los Angeles, South Amer Program HIV Prevent Res, Los Angeles, CA 90095 USA; [Blair, Kevin J.; Juillard, Catherine] Univ Calif Los Angeles, Program Adv Surg Equ, Dept Surg, Los Angeles, CA 90095 USA; [Liliana Valderrama-Beltran, Sandra] Hosp Univ San Ignacio, Dept Med Interna, Unidad Infectol, Bogota, Colombia; [Liliana Valderrama-Beltran, Sandra; Lombana Amaya, Luis Jorge] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Bautista-Arredondo, Sergio] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Hlth Econ & Hlth Syst Innovat, Cuernavaca, Morelos, Mexico; [Lombana Amaya, Luis Jorge] Hosp Univ San Ignacio, Dept Cirugia Gen, Unidad Coloproctol, Bogota, Colombia		Blair, KJ (corresponding author), Univ Calif Los Angeles, South Amer Program HIV Prevent Res, Los Angeles, CA 90095 USA.; Blair, KJ (corresponding author), Univ Calif Los Angeles, Program Adv Surg Equ, Dept Surg, Los Angeles, CA 90095 USA.	kevin.james.blair@gmail.com			University of California, Los Angeles' South American Program in HIV Prevention Research (National Institute of Mental Health) [R25MH087222]; University of California, Los Angeles Center for HIV Identification, Prevention, and Treatment Services (National Institute of Mental Health) [P30MH58107]	University of California, Los Angeles' South American Program in HIV Prevention Research (National Institute of Mental Health); University of California, Los Angeles Center for HIV Identification, Prevention, and Treatment Services (National Institute of Mental Health)	We declare no competing interests. Our ongoing work to establish an anal cancer screening programme in Bogota, Colombia, is funded by the University of California, Los Angeles' South American Program in HIV Prevention Research (National Institute of Mental Health grant R25MH087222) and the University of California, Los Angeles Center for HIV Identification, Prevention, and Treatment Services (National Institute of Mental Health grant P30MH58107). The content of this Correspondence is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque A, 2021, LANCET GASTROENTEROL, V6, P327, DOI 10.1016/S2468-1253(20)30304-6; Berry JM, 2009, DIS COLON RECTUM, V52, P1860, DOI 10.1097/01.dcr.0000361970.30352.e0; Clifford GM, 2021, INT J CANCER, V148, P38, DOI 10.1002/ijc.33185; Howard K, 2012, SEX HEALTH, V9, P610, DOI 10.1071/SH12017; Nowak RG, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00102	5	0	0	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA		2468-1253		LANCET GASTROENTEROL	Lancet Gastroenterol. Hepatol.	JUL	2021	6	7					S26	S26						1	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	SR9CL					2022-09-04	WOS:000661341800013
J	Baez-Jurado, E; Guio-Vega, G; Hidalgo-Lanussa, O; Gonzalez, J; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Mitochondrial Neuroglobin Is Necessary for Protection Induced by Conditioned Medium from Human Adipose-Derived Mesenchymal Stem Cells in Astrocytic Cells Subjected to Scratch and Metabolic Injury	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Scratch assay; Mesenchymal stem cells; Inflammation; Conditioned medium; Neuroglobin	HUMAN BONE-MARROW; OXYGEN-GLUCOSE DEPRIVATION; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; IN-VITRO; OXIDATIVE STRESS; GROWTH-FACTOR; SIGNALING PATHWAY; STROMAL CELLS; GLUTAMATE EXCITOTOXICITY	Astrocytes are specialized cells capable of regulating inflammatory responses in neurodegenerative diseases or traumatic brain injury. In addition to playing an important role in neuroinflammation, these cells regulate essential functions for the preservation of brain tissue. Therefore, the search for therapeutic alternatives to preserve these cells and maintain their functions contributes in some way to counteract the progress of the injury and maintain neuronal survival in various brain pathologies. Among these strategies, the conditioned medium from human adipose-derived mesenchymal stem cells (CM-hMSCA) has been reported with a potential beneficial effect against several neuropathologies. In this study, we evaluated the potential effect of CM-hMSCA in a model of human astrocytes (T98G cells) subjected to scratch injury. Our findings demonstrated that CM-hMSCA regulates the cytokines IL2, IL-6, IL-8, IL-10, GM-CSF, and TNF-a, downregulates calcium at the cytoplasmic level, and regulates mitochondrial dynamics and the respiratory chain. These actions are accompanied by modulation of the expression of different proteins involved in signaling pathways such as AKT/pAKT and ERK1/2/pERK, and may mediate the localization of neuroglobin (Ngb) at the cellular level. We also confirmed that Ngb mediated the protective effects of CM-hMSCA through regulation of proteins involved in survival pathways and oxidative stress. In conclusion, regulation of brain inflammation combined with the recovery of fundamental cellular aspects in the face of injury makes CM-hMSCA a promising candidate for the protection of astrocytes in brain pathologies.	[Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012; Sahebkar, Amirhossein/B-5124-2018	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [6260, 7115, 6278]; Vicerrectoria Academica of PUJ	PUJ; Vicerrectoria Academica of PUJ	The authors thank Dr. Jorge Andres Afanador and the staff of the cosmetic surgery Clinic DHARA in Bogota, Colombia, for the adipose tissue samples. This work was supported in part by grants PUJ IDs 6260 and 7115 to GEB and 6278 to JG and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to EB.	Alarifi S, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S82050; Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Anderson CNG, 1999, J NEUROSCI, V19, P664; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Bhela S, 2017, J IMMUNOL, V199, P1342, DOI 10.4049/jimmunol.1700520; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bravo-Sagua R, 2017, COMPR PHYSIOL, V7, P623, DOI 10.1002/cphy.c160013; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chaudhry H, 2013, IN VIVO, V27, P669; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Chen XL, 2018, INT IMMUNOPHARMACOL, V59, P287, DOI 10.1016/j.intimp.2018.04.020; Chen YX, 2015, J RADIAT RES, V56, P700, DOI 10.1093/jrr/rrv026; CHENG B, 1995, J NEUROCHEM, V65, P2525; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; de Oliveira MR, 2015, CHEM-BIOL INTERACT, V242, P396, DOI 10.1016/j.cbi.2015.11.003; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Dimitrov D.H., 2014, ADV PSYCHIAT, P1; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Eisner V, 2018, NAT CELL BIOL, V1; El-Sayed KMF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7154327; Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fiocchetti M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154959; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Gao F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.327; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; GIJBELS K, 1990, EUR J IMMUNOL, V20, P233, DOI 10.1002/eji.1830200134; Gimeno ML, 2017, STEM CELL TRANSL MED, V6, P161, DOI 10.5966/sctm.2016-0014; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Gorgun FM, 2014, INHAL TOXICOL, V26, P361, DOI 10.3109/08958378.2014.902147; Guida E, 1998, CELL PHYSIOL BIOCHEM, V8, P75, DOI 10.1159/000016272; Guillen MI, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00661; Guo ZY, 2015, NEURAL REGEN RES, V10, P651, DOI 10.4103/1673-5374.155442; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Helleringer R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00349; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; HOLLIDAY J, 1993, BRAIN RES, V621, P233, DOI 10.1016/0006-8993(93)90111-Y; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SH, 2014, MAR DRUGS, V12, P4602, DOI 10.3390/md12084602; Jiang CL, 1998, BIOL SIGNAL RECEPT, V7, P148; Jiang T, 2014, AGING CELL, V13, P1059, DOI 10.1111/acel.12268; Jiang Y, 2008, NEUROBIOL DIS, V32, P125, DOI 10.1016/j.nbd.2008.06.017; Jin KL, 2012, NEUROSCI LETT, V519, P47, DOI 10.1016/j.neulet.2012.05.018; Johnson GG, 2014, NEURO-ONCOLOGY, V16, P1086, DOI 10.1093/neuonc/nou012; Kane MS, 2017, J CELL MOL MED, V21, P2284, DOI 10.1111/jcmm.13149; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le Thuc O, 2015, ANN NY ACAD SCI, V1351, P127, DOI 10.1111/nyas.12855; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Lotfinia M, 2016, STEM CELLS DEV, V25, P1898, DOI 10.1089/scd.2016.0244; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Mekhemar MK, 2018, CELL IMMUNOL, V326, P60, DOI 10.1016/j.cellimm.2017.01.007; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Morales AP, 2011, NEUROCHEM RES, V36, P829, DOI 10.1007/s11064-011-0411-8; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Ogunbileje JO, 2016, AM J PHYSIOL-ENDOC M, V311, pE436, DOI 10.1152/ajpendo.00535.2015; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Papazian I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030651; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Pedraza-Alva G, 2015, IMMUNOL REV, V265, P231, DOI 10.1111/imr.12294; Phuagkhaopong S, 2017, NEUROTOXICOLOGY, V60, P82, DOI 10.1016/j.neuro.2017.03.001; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pokrzywinski KL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45102; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Reyes RC, 2008, J NEUROSCI, V28, P9682, DOI 10.1523/JNEUROSCI.3484-08.2008; Rothhammer V, 2015, SEMIN IMMUNOPATHOL, V37, P625, DOI 10.1007/s00281-015-0515-3; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Shinotsuka T, 2014, BIOCHEM BIOPH RES CO, V444, P171, DOI 10.1016/j.bbrc.2014.01.035; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Trubiani O, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0253-4; Ulusoy C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0451-0; Valencia J, 2016, CYTOTHERAPY, V18, P1297, DOI 10.1016/j.jcyt.2016.07.006; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Voloboueva LA, 2010, J NEUROSCI, V30, P12242, DOI 10.1523/JNEUROSCI.1752-10.2010; Vomelova I, 2009, FOLIA BIOL-PRAGUE, V55, P243; Voulgari-Kokota A, 2012, EXP NEUROL, V236, P161, DOI 10.1016/j.expneurol.2012.04.011; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Xia W, 2015, NEURAL REGEN RES, V10, P610, DOI 10.4103/1673-5374.155436; Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908; Zhang Q, 2011, MOLECULES, V16, P10146, DOI 10.3390/molecules161210146; Zhao J, 2015, CNS NEUROSCI THER, V21, P61, DOI 10.1111/cns.12334; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zhu LH, 2017, NEUROSCI LETT, V650, P12, DOI 10.1016/j.neulet.2017.03.024	170	12	12	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2019	56	7					5167	5187		10.1007/s12035-018-1442-9	http://dx.doi.org/10.1007/s12035-018-1442-9			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT8VJ	30536184				2022-09-04	WOS:000483159700044
J	Yaribeygi, H; Butler, AE; Barreto, GE; Sahebkar, A				Yaribeygi, Habib; Butler, Alexandra E.; Barreto, George E.; Sahebkar, Amirhossein			Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						antidiabetic medications; diabetes; diabetic nephropathy (DN); oxidative stress; vascular dysfunction	INDUCED OXIDATIVE STRESS; GLUCAGON-LIKE PEPTIDE-1; ANALOG LIRAGLUTIDE PROTECTS; METFORMIN-TREATED PATIENTS; OXYGEN SPECIES PRODUCTION; GLUCOSE-LOWERING DRUGS; BETA-CELL LINE; INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; NAD(P)H OXIDASE	Many vascular complications are related to exposure of tissues to elevated levels of glucose, a condition that promotes oxidative stress. The primary goal of antidiabetic medication is for normalization of blood glucose. However, antidiabetic medications may have antioxidant effects that go beyond their hypoglycemic influences. Therefore, antidiabetic drugs may be doubly beneficial in preventing diabetic complications. Vascular dysfunction due to uncontrolled diabetes is a serious complication of the disease and one which has a severe impact on quality of life. Readjustment of the oxidative balance in subjects with diabetes, and the positive effects thereof is a topic of intense interest at present. In the current review, we highlight the antioxidant effects of antidiabetic medications which may prevent or delay the onset of vascular dysfunction.	[Yaribeygi, Habib] Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran, Iran; [Butler, Alexandra E.] Antidoping Lab Qatar, Life Sci Res Div, Doha, Qatar; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran		Yaribeygi, H (corresponding author), Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Iran.	habib.yari@yahoo.com; sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Yaribeygi, Habib/R-8998-2019; Barreto, George E./AAD-7420-2020	Yaribeygi, Habib/0000-0002-1706-6212; Barreto, George E./0000-0002-6644-1971				Ahmad S., 2016, INT J OPHTHALMOLOGY, V4, P220; Ahren B, 2005, DIABETES CARE, V28, P1936, DOI 10.2337/diacare.28.8.1936; Ahren B, 2007, BEST PRACT RES CL EN, V21, P517, DOI 10.1016/j.beem.2007.07.005; Akbar DH, 2013, J RENIN-ANGIO-ALDO S, V14, P103, DOI 10.1177/1470320312460881; Alam MA, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0095-3; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Alsharidah M, 2018, SAUDI PHARM J, V26, P1, DOI 10.1016/j.jsps.2017.11.007; Anan F, 2009, HYPERTENS RES, V32, P299, DOI 10.1038/hr.2009.8; Anedda A, 2008, J ENDOCRINOL, V199, P33, DOI 10.1677/JOE-08-0278; Avogaro A, 2014, DIABETES CARE, V37, P2884, DOI 10.2337/dc14-0865; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Batchuluun B, 2014, ATHEROSCLEROSIS, V232, P156, DOI 10.1016/j.atherosclerosis.2013.10.025; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Brussee V, 2004, DIABETES, V53, P1824, DOI 10.2337/diabetes.53.7.1824; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Ceriello A, 2016, NUTR METAB CARDIOVAS, V26, P285, DOI 10.1016/j.numecd.2016.01.006; Chakraborty A, 2011, DIABETES RES CLIN PR, V93, P56, DOI 10.1016/j.diabres.2010.11.030; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chaturvedi N, 2001, DIABETES CARE, V24, P284, DOI 10.2337/diacare.24.2.284; Cho YN, 2014, YONSEI MED J, V55, P700, DOI 10.3349/ymj.2014.55.3.700; Chugh S N, 2001, J Assoc Physicians India, V49, P803; Courreges JP, 2008, DIABETIC MED, V25, P1129, DOI 10.1111/j.1464-5491.2008.02484.x; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Davidson Mayer B, 2015, Clin Diabetes, V33, P123, DOI 10.2337/diaclin.33.3.123; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dhindsa P, 2003, BRIT J CLIN PHARMACO, V55, P616, DOI 10.1046/j.1365-2125.2003.01781.x; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group, 2016, DIABETES CARE; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Feldman EL, 2003, J CLIN INVEST, V111, P431, DOI 10.1172/JCI200317863; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; FISCHER Y, 1995, ENDOCRINOLOGY, V136, P412, DOI 10.1210/en.136.2.412; Gault VA, 2015, DIABETES OBES METAB, V17, P403, DOI 10.1111/dom.12432; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goya K, 2006, J DIABETES COMPLICAT, V20, P336, DOI 10.1016/j.jdiacomp.2005.08.003; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; Gumieniczek A, 2005, J BIOMED SCI, V12, P531, DOI 10.1007/s11373-005-6733-2; Gumieniczek A, 2003, LIFE SCI, V74, P553, DOI 10.1016/j.lfs.2003.03.004; Haluzik M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/895102; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hatanaka T, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.239; Hendarto H, 2012, METABOLISM, V61, P1422, DOI 10.1016/j.metabol.2012.03.002; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Imano E, 1998, DIABETES CARE, V21, P2135, DOI 10.2337/diacare.21.12.2135; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Inoue T, 2006, DIABETES, V55, pA38; Inoue T, 2015, ATHEROSCLEROSIS, V240, P250, DOI 10.1016/j.atherosclerosis.2015.03.026; Ishibashi Y, 2016, HORM METAB RES, V48, P191, DOI 10.1055/s-0035-1555791; Jennings PE, 2000, METABOLISM, V49, P23, DOI 10.1016/S0026-0495(00)80081-5; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Jin HY, 2014, ENDOCRINE, V47, P772, DOI 10.1007/s12020-014-0198-x; Joubert M, 2017, DIABETES, V66, P1030, DOI 10.2337/db16-0733; Kadiiska MB, 2012, DIABETES, V61, P586, DOI 10.2337/db11-1091; Kamezaki M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22229-5; Kawanami D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051083; Khemka V. K, ASS SERUM MALONDIALD; Khunti K, 2016, DIABETES OBES METAB, V18, P401, DOI 10.1111/dom.12626; Kim NH, 2018, DIABETES METAB, V44, P361, DOI 10.1016/j.diabet.2018.03.004; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Kosiborod M, 2017, CIRCULATION, V136, P249, DOI 10.1161/CIRCULATIONAHA.117.029190; Krentz A, 2009, DIABETES-METAB RES, V25, P112, DOI 10.1002/dmrr.937; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Kuru Karabas Munire, 2013, ISRN Endocrinol, V2013, P858690, DOI 10.1155/2013/858690; Landman GWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082880; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Loke Yoon Kong, 2011, BMJ, V342, pd1309, DOI 10.1136/bmj.d1309; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Moreto F, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/505368; Nesti L, 2017, NUTR METAB CARDIOVAS, V27, P657, DOI 10.1016/j.numecd.2017.04.009; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Nystrom T, 2017, DIABETES OBES METAB, V19, P831, DOI 10.1111/dom.12889; Oelze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112394; Oh YS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010026; Okon UA, 2017, J INTEGR MED-JIM, V15, P302, DOI 10.1016/S2095-4964(17)60332-7; Osorio H, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/542042; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Pujadas G, 2017, ENDOCRINE, V56, P509, DOI 10.1007/s12020-016-1052-0; Qiang XL, 1998, METABOLISM, V47, P977, DOI 10.1016/S0026-0495(98)90354-7; Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Ruige JB, 1998, CIRCULATION, V97, P996; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sawada F, 2008, METABOLISM, V57, P1038, DOI 10.1016/j.metabol.2008.01.038; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Shokrzadeh M, 2017, IRAN J BASIC MED SCI, V20, P497, DOI 10.22038/IJBMS.2017.8673; Siddique M., 2016, DIABETES CASE REPORT, V1, P2; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Sironi AM, 1997, CLIN PHARMACOL THER, V62, P194, DOI 10.1016/S0009-9236(97)90068-0; SIRTORI CR, 1994, PHARMACOL RES, V30, P187, DOI 10.1016/1043-6618(94)80104-5; Sola D, 2015, ARCH MED SCI, V11, P840, DOI 10.5114/aoms.2015.53304; Steven S, 2017, REDOX BIOL, V13, P370, DOI 10.1016/j.redox.2017.06.009; Sugizaki T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0012-0; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Triggle CR, 2014, THER ADV CHRONIC DIS, V5, P245, DOI 10.1177/2040622314546125; Tsubouchi H, 2005, BIOCHEM BIOPH RES CO, V326, P60, DOI 10.1016/j.bbrc.2004.10.201; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Wang XXX, 2017, J BIOL CHEM, V292, P5335, DOI 10.1074/jbc.M117.779520; Yanagawa T, 2004, METABOLISM, V53, P353, DOI 10.1016/j.metabol.2003.10.025; YARIBEYGI H, 2018, COMP CLIN PATHOL, V27, P691, DOI DOI 10.1007/s00580-018-2652-2; Yaribeygi H., 2016, RAZAVI INT J MED, V4; Yaribeygi H, 2018, METABOLISM, V87, P48, DOI 10.1016/j.metabol.2018.07.001; Yaribeygi H, 2018, CNS NEUROL DISORD-DR, V17, P207, DOI 10.2174/1871527317666180425122557; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P6080, DOI 10.1002/jcb.26806; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P2990, DOI 10.1002/jcb.26450; Yaribeygi H, 2018, BIOMED PHARMACOTHER, V98, P333, DOI 10.1016/j.biopha.2017.12.077; Yi QY, 2016, AM J TRANSL RES, V8, P3947; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; YOSHIOKA S, 1993, METABOLISM, V42, P75, DOI 10.1016/0026-0495(93)90175-N; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	132	42	43	0	66	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAR	2019	234	3					2436	2446		10.1002/jcp.27278	http://dx.doi.org/10.1002/jcp.27278			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HC2FU	30191997				2022-09-04	WOS:000451618500042
J	Vega-Vela, NE; Osorio, D; Avila-Rodriguez, M; Gonzalez, J; Garcia-Segura, LM; Echeverria, V; Barreto, GE				Vega-Vela, Nelson E.; Osorio, Daniel; Avila-Rodriguez, Marco; Gonzalez, Janneth; Miguel Garcia-Segura, Luis; Echeverria, Valentina; Barreto, George E.			L-Type Calcium Channels Modulation by Estradiol	MOLECULAR NEUROBIOLOGY			English	Review						Voltage-gated calcium channels; Estradiol; Calcium signaling; Estrogen receptor-independent mechanisms; Estrogen non-genomic actions; DHP binding site	ESTROGEN-RECEPTOR-BETA; POTENTIAL INITIATION MECHANISM; CORTICAL SPREADING DEPRESSION; NON-GENOMIC ACTIONS; SYNAPTIC PLASTICITY; CA2+ CHANNELS; NEURONAL EXCITABILITY; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; ASTROCYTIC CELLS	Voltage-gated calcium channels are key regulators of brain function, and their dysfunction has been associated with multiple conditions and neurodegenerative diseases because they couple membrane depolarization to the influx of calcium-and other processes such as gene expression-in excitable cells. L-type calcium channels, one of the three major classes and probably the best characterized of the voltage-gated calcium channels, act as an essential calcium binding proteins with a significant biological relevance. It is well known that estradiol can activate rapidly brain signaling pathways and modulatory/regulatory proteins through non-genomic (or non-transcriptional) mechanisms, which lead to an increase of intracellular calcium that activate multiple kinases and signaling cascades, in the same way as L-type calcium channels responses. In this context, estrogens-L-type calcium channels signaling raises intracellular calcium levels and activates the same signaling cascades in the brain probably through estrogen receptor-independent modulatory mechanisms. In this review, we discuss the available literature on this area, which seems to suggest that estradiol exerts dual effects/modulation on these channels in a concentration-dependent manner (as a potentiator of these channels in pM concentrations and as an inhibitor in nM concentrations). Indeed, estradiol may orchestrate multiple neurotrophic responses, which open a new avenue for the development of novel estrogen-based therapies to alleviate different neuropathologies. We also highlight that it is essential to determine through computational and/or experimental approaches the interaction between estradiol and L-type calcium channels to assist these developments, which is an interesting area of research that deserves a closer look in future biomedical research.	[Vega-Vela, Nelson E.; Osorio, Daniel; Avila-Rodriguez, Marco; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Echeverria, Valentina] Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; GONZALEZ, JANNETH/AAB-9948-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./B-5747-2014; Hurtado, Daniel Camilo Osorio/AAF-3138-2019	Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; GONZALEZ, JANNETH/0000-0003-4482-256X; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Hurtado, Daniel Camilo Osorio/0000-0003-4424-8422; Avila-Rodriguez, Marco/0000-0003-4612-3236; Vega, Nelson/0000-0003-2404-6858	PUJ [5544, 5608, 6243, 5619, 6371]	PUJ	This work was in part funded by PUJ grants #5544 and 5608 to GEB, and #6243, 5619 and 6371 to JG.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; AMEDEE T, 1991, J PHYSIOL-LONDON, V441, P35, DOI 10.1113/jphysiol.1991.sp018737; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; BARRES BA, 1989, J NEUROSCI, V9, P3169; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2011, HUM EXP TOXICOL, V30, P1737, DOI 10.1177/0960327111398676; Lopez-Rodriguez AB, 2015, ESTROGEN EFFECTS ON TRAUMATIC BRAIN INJURY: MECHANISMS OF NEUROPROTECTION AND REPAIR, P73, DOI 10.1016/B978-0-12-801479-0.00006-1; Berger S, 2014, CELL TISSUE RES, V357, P463, DOI 10.1007/s00441-014-1936-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Beyer C, 1998, EUR J NEUROSCI, V10, P255, DOI 10.1046/j.1460-9568.1998.00045.x; Bird MD, 2008, CELL IMMUNOL, V252, P57, DOI 10.1016/j.cellimm.2007.09.007; BOLT HM, 1979, PHARMACOL THERAPEUT, V4, P155, DOI 10.1016/0163-7258(79)90018-4; Boon WC, 2010, PROG BRAIN RES, V181, P209, DOI 10.1016/S0079-6123(08)81012-6; Boutros C, 2012, SURG ONCOL, V21, pE183, DOI 10.1016/j.suronc.2012.08.002; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Brinton RD, 2004, CNS DRUGS, V18, P405, DOI 10.2165/00023210-200418070-00001; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Bulun SE, 2009, ANN NY ACAD SCI, V1155, P121, DOI 10.1111/j.1749-6632.2009.03705.x; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carreau S, 2003, FOLIA HISTOCHEM CYTO, V41, P107; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Catterall W A, 1991, Curr Opin Neurobiol, V1, P5, DOI 10.1016/0959-4388(91)90004-Q; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Catterall WA, 2015, MOL PHARMACOL, V88, P141, DOI 10.1124/mol.114.097659; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Charlier TD, 2010, BBA-GEN SUBJECTS, V1800, P1094, DOI 10.1016/j.bbagen.2009.12.010; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Crider A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-46; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Deitmer JW, 1998, CELL CALCIUM, V24, P405, DOI 10.1016/S0143-4160(98)90063-X; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dye Richelin V, 2012, Int J Alzheimers Dis, V2012, P258454, DOI 10.1155/2012/258454; Ellem S J, 2006, Minerva Endocrinol, V31, P1; Ertel E.A., 2004, CALCIUM CHANNEL PHAR, P183; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fatehi M, 2008, NEUROPSYCHOPHARMACOL, V33, P1354, DOI 10.1038/sj.npp.1301523; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Foy M, 2004, NEURON GLIA BIOL, V1, P327, DOI 10.1017/S1740925X05000165; Foy MR, 2010, VITAM HORM, V82, P219, DOI 10.1016/S0083-6729(10)82012-6; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006; Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Glasser SP, 1998, J CLIN PHARMACOL, V38, P659, DOI 10.1002/j.1552-4604.1998.tb04804.x; Grimm A, 2012, MOL NEUROBIOL, V46, P151, DOI 10.1007/s12035-012-8281-x; Ha DM, 2007, NEUROBIOL AGING, V28, P1936, DOI 10.1016/j.neurobiolaging.2006.08.007; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Lanussa OH, 2016, CNS NEUROL DISORD-DR, V15, P242, DOI 10.2174/1871527315666160202122032; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; Hodis HN, 2014, J STEROID BIOCHEM, V142, P68, DOI 10.1016/j.jsbmb.2013.06.011; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Holinka CF, 2008, J STEROID BIOCHEM, V110, P138, DOI 10.1016/j.jsbmb.2008.03.027; Ingle JN, 2002, BREAST CANCER RES, V4, P133, DOI 10.1186/bcr436; Ito H, 1997, MOL PHARMACOL, V52, P735, DOI 10.1124/mol.52.4.735; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kulkarni J, 2013, INT J ENDOCRINOL MET, V11, P129, DOI 10.5812/ijem.6615; Kulkarni J, 2012, CNS DRUGS, V26, P549, DOI 10.2165/11630660-000000000-00000; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lanussa OH, 2016, CNS NEUROL DISORD DR; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lipscombe D, 2002, CIRC RES, V90, P933, DOI 10.1161/01.RES.0000019740.52306.92; Ludwig A, 1997, J NEUROSCI, V17, P1339; Luine VN, 2014, HORM BEHAV, V66, P602, DOI 10.1016/j.yhbeh.2014.08.011; MacLusky NJ, 2005, ENDOCRINOLOGY, V146, P287, DOI 10.1210/en.2004-0730; Maia H, 2012, INT J WOMENS HEALTH, V4, P61, DOI 10.2147/IJWH.S29154; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Markou Athina, 2005, Hormones (Athens), V4, P9; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; McEwen BS, 2012, BEHAV NEUROSCI, V126, P4, DOI 10.1037/a0026708; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Michael T., 2011, GOODMAN GILMANS PHAR, P745; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nelles JL, 2011, EXPERT REV ENDOCRINO, V6, P437, DOI 10.1586/EEM.11.20; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Ogiue-Ikeda M, 2008, BRAIN RES REV, V57, P363, DOI 10.1016/j.brainresrev.2007.06.010; Oh William K, 2002, Clin Prostate Cancer, V1, P81, DOI 10.3816/CGC.2002.n.009; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Ortner NJ, 2016, CHANNELS, V10, P7, DOI 10.1080/19336950.2015.1048936; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Russell JF, 2014, GENETIC STEROID DISORDERS, P165, DOI 10.1016/B978-0-12-416006-4.00012-0; Sak K, 2004, J STEROID BIOCHEM, V88, P323, DOI 10.1016/j.jsbmb.2004.01.004; Sampson K, 2006, GOODMAN GILMANS PHAR, P815; Sanchez JC, 2014, NEUROENDOCRINOL LETT, V35, P724; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Savage L, 2008, JNCI-J NATL CANCER I, V100, P519, DOI DOI 10.1093/JNCI/DJN137; Segars JH, 2002, TRENDS ENDOCRIN MET, V13, P349, DOI 10.1016/S1043-2760(02)00633-1; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Sinnegger MJ, 1997, J BIOL CHEM, V272, P27686, DOI 10.1074/jbc.272.44.27686; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Striessnig Jorg, 2014, Wiley Interdiscip Rev Membr Transp Signal, V3, P15; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Ticconi C, 2013, PULM PHARMACOL THER, V26, P617, DOI 10.1016/j.pupt.2013.08.004; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Torrente D, 2014, NEUROSCI LETT, V558, P87, DOI 10.1016/j.neulet.2013.11.004; Triggle David J., 1998, American Journal of Hypertension, V11, p80S, DOI 10.1016/S0895-7061(98)00004-1; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P115, DOI 10.1016/S0014-2999(02)01835-6; Weick JP, 2003, J NEUROSCI, V23, P3446; Weiser MJ, 2008, BRAIN RES REV, V57, P309, DOI 10.1016/j.brainresrev.2007.05.013; Wend Korinna, 2012, Front Endocrinol (Lausanne), V3, P19, DOI 10.3389/fendo.2012.00019; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wittliff JL, 2014, ENCY TOXICOL, P462; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Xu C, 2008, ENDOCRINOLOGY, V149, P2459, DOI 10.1210/en.2007-1178; Yang XP, 2011, CURR OPIN NEPHROL HY, V20, P133, DOI 10.1097/MNH.0b013e3283431921; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yue W, 2013, STEROIDS, V78, P161, DOI 10.1016/j.steroids.2012.11.001; Zadran S, 2009, P NATL ACAD SCI USA, V106, P21936, DOI 10.1073/pnas.0912558106; Zhao L, 2005, NEUROSCIENCE, V132, P299, DOI 10.1016/j.neuroscience.2004.11.054	140	25	25	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2017	54	7					4996	5007		10.1007/s12035-016-0045-6	http://dx.doi.org/10.1007/s12035-016-0045-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC0BO	27525676				2022-09-04	WOS:000406503500013
J	Granger, A; Sardi, JP; Iwanaga, J; Wilson, TJ; Yang, L; Loukas, M; Oskouian, RJ; Tubbs, RS				Granger, Andre; Sardi, Juan P.; Iwanaga, Joe; Wilson, Thomas J.; Yang, Lynda; Loukas, Marios; Oskouian, Rod J.; Tubbs, R. Shane			Osborne's Ligament: A Review of its History, Anatomy, and Surgical Importance	CUREUS			English	Review						pain; peripheral neuropathy; entrapment neuropathy; surgical anatomy; history; ulnar nerve; osborne's ligament	ULNAR NERVE; CUBITAL TUNNEL; ELBOW; DECOMPRESSION	When discussing the pathophysiology of ulnar neuropathy, Geoffrey Vaughan Osborne described a fibrous band that can be responsible for the symptoms seen in this disorder. In this paper, we take a glimpse at the life of Osborne and review the anatomy and surgical significance of Osborne's ligament. This band of tissue connects the two heads of the flexor carpi ulnaris and thus forms the roof of the cubital tunnel. To our knowledge, no prior publication has reviewed the history of this ligament, and very few authors have studied its anatomy in any detail. Therefore, the aim of the present paper is to elucidate this structure that is often implicated and surgically transected to decompress the ulnar nerve at the elbow.	[Granger, Andre; Loukas, Marios] St Georges Univ, Dept Anat Sci, Sch Med, St Georges, Grenada; [Sardi, Juan P.] Pontificia Univ Javeriana, Neurociencias, Bogota, Colombia; [Iwanaga, Joe] Seattle Sci Fdn, Seattle, WA USA; [Wilson, Thomas J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Yang, Lynda] Univ Michigan, Neurosurg, Ann Arbor, MI 48109 USA; [Oskouian, Rod J.] Swedish Neurosci Inst, Neurosurg, Complex Spine, Seattle, WA USA; [Tubbs, R. Shane] Seattle Sci Fdn, Neurosurg, Seattle, WA USA		Sardi, JP (corresponding author), Pontificia Univ Javeriana, Neurociencias, Bogota, Colombia.	jsardi2@hotmail.com	Iwanaga, Joe/ABC-7040-2021; Sardi, Juan Pablo/ABD-9875-2020; Granger, Andre/AAN-1815-2020	Iwanaga, Joe/0000-0002-8502-7952; Sardi, Juan Pablo/0000-0002-0696-9213; Granger, Andre/0000-0003-0928-9368				Adkinson JM, 2014, HAND CLIN, V30, P63, DOI 10.1016/j.hcl.2013.08.019; [Anonymous], 1999, PART MILL OR HIST PR; Bartels RHMA, 2001, NEUROSURGERY, V49, P391, DOI 10.1097/00006123-200108000-00023; Beddows H, 2004, GEOFFREY VAUGHAN OSB; Brown Justin M, 2010, Hand (N Y), V5, P141, DOI 10.1007/s11552-009-9225-4; Cheng CJ, 2008, J HAND SURG-AM, V33A, P1518, DOI 10.1016/j.jhsa.2008.05.022; Davidge Kristen M, 2015, Hand (N Y), V10, P388, DOI 10.1007/s11552-014-9721-z; De Maeseneer M, 2015, EUR J RADIOL, V84, P671, DOI 10.1016/j.ejrad.2014.12.007; DELLON AL, 1986, J HAND SURG-BRIT EUR, V11B, P175; Gonzalez MH, 2001, J HAND SURG-BRIT EUR, V26, P142, DOI 10.1054/jhsb.2000.0532; Granata G, 2013, CLIN NEUROPHYSIOL, V124, P1689, DOI 10.1016/j.clinph.2012.12.051; HARDINGE K, 1982, J BONE JOINT SURG BR, V64, P17, DOI 10.1302/0301-620X.64B1.7068713; Hunt JR, 1930, BMJ-BRIT MED J, V1930, P642, DOI 10.1136/bmj.2.3641.642; Husarik DB, 2009, RADIOLOGY, V252, P148, DOI 10.1148/radiol.2521081614; IYER KM, 1981, HAND, V13, P246, DOI 10.1016/S0072-968X(81)80004-6; Jacobson JA, 2001, RADIOLOGY, V220, P601, DOI 10.1148/radiol.2202001723; James J, 2011, J HAND SURG-AM, V36A, P1988, DOI 10.1016/j.jhsa.2011.09.014; Karatas A, 2009, J SHOULDER ELB SURG, V18, P627, DOI 10.1016/j.jse.2009.03.004; Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993; Macchi V, 2014, J ANAT, V225, P262, DOI 10.1111/joa.12206; Mahan MA, 2015, J NEUROSURG, V123, P1216, DOI 10.3171/2014.10.JNS141379; Martinoli C, 2000, RADIOGRAPHICS, V20, pS199, DOI 10.1148/radiographics.20.suppl_1.g00oc08s199; Miller TT, 2010, AM J ROENTGENOL, V195, P585, DOI 10.2214/AJR.10.4817; ODRISCOLL SW, 1991, J BONE JOINT SURG BR, V73, P613, DOI 10.1302/0301-620X.73B4.2071645; Osborne G, 1966, J Bone Joint Surg Br, V48, P340; Osborne G, 1970, Hand, V2, P10; OSBORNE G, 1959, Postgrad Med J, V35, P392; OSBORNE GV, 1950, J BONE JOINT SURG BR, V32, P148, DOI 10.1302/0301-620X.32B2.148; SEDDON HJ, 1952, J BONE JOINT SURG BR, V34, P386, DOI 10.1302/0301-620X.34B3.386; Silver JR, 2009, J ROY COLL PHYS EDIN, V39, P79; Simonson S, 2010, SEMIN ROENTGENOL, V45, P180, DOI 10.1053/j.ro.2010.01.002; Thiyam Rajesh, 2015, J Clin Orthop Trauma, V6, P137, DOI 10.1016/j.jcot.2014.12.004; Vanderpool D W, 1968, J Bone Joint Surg Br, V50, P792; Waugh RP, 2007, HAND CLIN, V23, P319, DOI 10.1016/j.hcl.2007.06.001; WEISL H, 1964, J BONE JOINT SURG BR, V46, P297, DOI 10.1302/0301-620X.46B2.297	35	16	17	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR	2017	9	3							e1080	10.7759/cureus.1080	http://dx.doi.org/10.7759/cureus.1080			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HE7LV	28405530	Green Published, Green Submitted, gold			2022-09-04	WOS:000453620000018
J	Piquet, H; Bhosle, S; Diez, R; Cousineau, M; Djibrillah, M; Le Thanh, D; Dagang, AN; Zissis, G				Piquet, H.; Bhosle, S.; Diez, R.; Cousineau, M.; Djibrillah, M.; Le Thanh, D.; Dagang, A. N.; Zissis, G.			Control of the UV flux of a XeCl dielectric barrier discharge excilamp through its current variation	QUANTUM ELECTRONICS			English	Article						dielectric barrier discharge; exciplex; current regime; power supply; static converter; UV	EXCIMER LAMPS; MODEL; DESIGN; POWER	The efficiency of the electrical power transfer to the gas mixture of a XeCl dielectric barrier discharge (DBD) exciplex lamp is analysed. An equivalent circuit model of the DBD is considered. It is shown that the excilamp power can be controlled by applying current to the lamp. This highly desired property is ensured by means of a specific power supply topology, whose concepts and design are discussed. The experimental prototype of a current-mode converter operating in the pulsed regime at pulse repetition rate of 50 kHz is presented and its capability to control the amount of energy transferred during each current pulse is demonstrated. The capability of this power supply to maintain specific operating conditions for the DBD lamp, with a very stable behaviour (even at a very low current, in the regime of a single discharge channel), is illustrated. The experimental results of a combined use of this converter and a XeCl excilamp are presented. The influence of the supply parameters on the 308-nm XeCl excilamp is analysed. The shape of the UV pulse of the lamp is experimentally shown to be similar to that of the current, which actually flows into the gas mixture. The UV radiation power is demonstrated to be tightly correlated to the current injected into the gas and controlled by the available degrees of freedom offered by the power supply. The measured UV output characteristics and performance of the system are discussed. Time resolved UV imaging of a XeCl DBD excilamp is used to analyse the mechanisms involved in the production of exciplexes at various power supply regimes. It is shown that a pulsed voltage source leads to formation of short high intensity UV peaks, while current pulses lead to formation of sustained discharge filaments. Based on the results of modelling of the above-mentioned operation conditions, the two power supply regimes are compared and analysed from the point of view of the UV power and radiative control.	[Piquet, H.; Cousineau, M.; Djibrillah, M.; Le Thanh, D.; Dagang, A. N.; Zissis, G.] Univ Toulouse, LAPLACE, UMR CNRS INPT UPS, F-31071 Toulouse, France; [Bhosle, S.] OLISCIE, F-31600 Lherm, France; [Diez, R.] Pontificia Univ Javeriana, Dept Elect, Bogota, Colombia		Piquet, H (corresponding author), Univ Toulouse, LAPLACE, UMR CNRS INPT UPS, 2 Rue Camichel, F-31071 Toulouse, France.	Hubert.Piquet@laplace.univ-tlse.fr	Zissis, Georges/J-1646-2015; Piquet, Hubert/D-4396-2013; Dagang, Ahmad Nazri/C-7961-2018	Zissis, Georges/0000-0002-7582-5686; Piquet, Hubert/0000-0002-3736-2676; Dagang, Ahmad Nazri/0000-0003-3215-6977; Diez, Rafael/0000-0002-8107-2844	Dermoptics (Quantel Group); ECOS-Nord/COLCENCIAS/ICETEX	Dermoptics (Quantel Group); ECOS-Nord/COLCENCIAS/ICETEX	The authors thank Dermoptics (Quantel Group) for their support in providing their patented lamp for the experimental part of the work. Part of this work is a French-Colombian cooperation, supported by the ECOS-Nord/COLCENCIAS/ICETEX program.	Bhosle S., 2006, P IEEE IAS C, V4, P1784; Bhosle S., 2006, P 16 INT C GAS DISCH; Bhosle S., 2008, P 11 INT S HIGH PRES; Borisov VM, 1998, QUANTUM ELECTRON+, V28, P297, DOI 10.1070/QE1998v028n04ABEH001195; *CPAT KIN SOFTW, 1995, SIGL DAT; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez R., 2008, P IEEE ISIE, V1, P62; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Lomaev MI, 2006, INSTRUM EXP TECH+, V49, P595, DOI 10.1134/S0020441206050010; Mildren RP, 2001, J PHYS D APPL PHYS, V34, pL1, DOI 10.1088/0022-3727/34/1/101; Oda A, 2000, J PHYS D APPL PHYS, V33, P1507, DOI 10.1088/0022-3727/33/12/313; Oda A, 1999, J PHYS D APPL PHYS, V32, P2726, DOI 10.1088/0022-3727/32/21/304; Piquet H, 2008, P SOC PHOTO-OPT INS, V6938, P93810, DOI 10.1117/12.785662; Sosnin EA, 2002, INSTRUM EXP TECH+, V45, P838, DOI 10.1023/A:1021403810878; Vongphouthone S, 2001, EUR PHYS J-APPL PHYS, V15, P123, DOI 10.1051/epjap:2001173	15	3	3	0	6	TURPION LTD	BRISTOL	C/O TURPION LTD, IOP PUBLISHING, TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6HG, ENGLAND	1063-7818	1468-4799		QUANTUM ELECTRON+	Quantum Electron.		2012	42	2					157	164		10.1070/QE2012v042n02ABEH014266	http://dx.doi.org/10.1070/QE2012v042n02ABEH014266			8	Engineering, Electrical & Electronic; Quantum Science & Technology; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Physics	905TP					2022-09-04	WOS:000301298100012
J	McAlpine, CA; Etter, A; Fearnside, PM; Seabrook, L; Laurance, WF				McAlpine, C. A.; Etter, A.; Fearnside, P. M.; Seabrook, L.; Laurance, W. F.			Increasing world consumption of beef as a driver of regional and global change: A call for policy action based on evidence from Queensland (Australia), Colombia and Brazil	GLOBAL ENVIRONMENTAL CHANGE-HUMAN AND POLICY DIMENSIONS			English	Review						Beef consumption; Carbon credits; Deforestation; Ecosystem degradation; Exotic grasses; Greenhouse gases; Market forces; New consumers; Regrowth forests; Soybeans	GREENHOUSE-GAS EMISSIONS; RAIN-FOREST FRAGMENTATION; LAND-COVER; TROPICAL DEFORESTATION; AGRICULTURAL LAND; AMAZON; CARBON; PATTERNS; LIVESTOCK; SAVANNA	While the global community is seeking to reduce fossil fuel consumption, a parallel but equally important issue is the environmental impacts of increased world consumption of beef. We provide a comparative analysis and synthesis of the expansion of beef cattle production and its regional and global environmental impacts for Queensland (Australia), Colombia and Brazil. Evidence assembled indicates that rising beef consumption is a major driver of regional and global change, and warrants greater policy attention. We propose four policy imperatives to help mitigate escalating environmental impacts of beef: stop subsidising beef production and promoting beef consumption; control future expansion of soybeans and extensive grazing; protect and restore regrowth forests in grazing lands; and allocate resources to less environmentally damaging alternative land uses. (C) 2008 Elsevier Ltd. All rights reserved.	[McAlpine, C. A.; Seabrook, L.] Univ Queensland, Sch Geog Planning & Architecture, Ctr Remote Sensing & Spatial Informat Sci, St Lucia, Qld 4072, Australia; [Etter, A.] Javeriana Univ, Dept Ecol & Terr, Bogota, Colombia; [Fearnside, P. M.] Natl Inst Res Amazon INPA, BR-69011970 Manaus, Amazonas, Brazil; [Laurance, W. F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama		McAlpine, CA (corresponding author), Univ Queensland, Sch Geog Planning & Architecture, Ctr Remote Sensing & Spatial Informat Sci, St Lucia, Qld 4072, Australia.	c.mcalpine@uq.edu.au	McAlpine, Clive A/A-3907-2010; Seabrook, Leonie M K/D-2992-2009; Laurance, William F/B-2709-2012; Fearnside, Philip M/GQA-6023-2022; Etter, Andrés/E-1860-2011; Fearnside, Philip M/D-6559-2011	Seabrook, Leonie M K/0000-0001-5602-5168; Laurance, William F/0000-0003-4430-9408; Fearnside, Philip M/0000-0003-3672-9082; Etter, Andrés/0000-0003-0665-9300; Fearnside, Philip M/0000-0003-3672-9082; McAlpine, Clive/0000-0003-0457-8144				Andersen L., 2002, DYNAMICS DEFORESTATI; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Arango N., 1998, INFORME NACL ESTADO; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; *AUSTR BUR STAT, 2007, 7123355001 AGR STAT; *AUSTR GREENH OFF, 2006, QUEENSL GREENH GAS I; Barbosa Reinaldo Imbrozio, 2000, Acta Amazonica, V30, P601; Barbosa RI, 2005, FOREST ECOL MANAG, V204, P371, DOI 10.1016/j.foreco.2004.09.011; Barbosa RI, 2005, FOREST ECOL MANAG, V216, P295, DOI 10.1016/j.foreco.2005.05.042; Barlow J, 2002, BIOL CONSERV, V105, P157, DOI 10.1016/S0006-3207(01)00177-X; Baruch Z, 2000, BIOL INVASIONS, V2, P123, DOI [10.1023/A:1010040524588, DOI 10.1023/A:1010040524588]; Baumert K. A., 2005, NAVIGATING NUMBERS G; BETTS R, 2008, NATURE REPORTS CLIMA, V801, P7; Binning C, 2001, NATURAL ASSETS INVEN; Boadi DA, 2004, CAN J ANIM SCI, V84, P445, DOI 10.4141/A03-079; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; BROWN LR, 2006, FEEDING 7 BILLION WE; Butler Don W., 2003, Ecological Management & Restoration, V4, P120, DOI 10.1046/j.1442-8903.2003.00146.x; CARDENAS F, 2000, DESARROLLO SOSTENIBL; Chaves M. E., 2004, INFORME AVANCE CONOC; Chen XY, 2003, OECOLOGIA, V137, P405, DOI 10.1007/s00442-003-1358-5; Chomitz KM., 2001, GEOGRAPHIC PATTERNS; Coomes OT, 2008, ECOL ECON, V65, P207, DOI 10.1016/j.ecolecon.2007.12.028; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; Covacevich J. A., 1998, Memoirs of the Queensland Museum, V42, P475; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Crowley Gabriel M., 1998, Pacific Conservation Biology, V4, P132; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; DeFries R., 2004, GeoJournal, V61, P345, DOI 10.1007/s10708-004-5051-y; Dinerstein E., 1995, CONSERVATION ASSESSM; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Etter A, 2006, J ENVIRON MANAGE, V79, P74, DOI 10.1016/j.jenvman.2005.05.017; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Etter A, 2000, MT RES DEV, V20, P236, DOI 10.1659/0276-4741(2000)020[0236:AFAFSI]2.0.CO;2; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Etter A, 2006, GLOBAL CHANGE BIOL, V12, P1409, DOI 10.1111/j.1365-2486.2006.01168.x; Fairfax RJ, 2000, BIOL CONSERV, V94, P11, DOI 10.1016/S0006-3207(99)00169-X; FAO, 2002, WORLD AGR 2015 2030; FAO, 1997, STAT WORLDS FOR 1997; *FAO, 2006, FOOD AGR STAT GLOB O; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Fearnside PM, 1998, FOREST ECOL MANAG, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fearnside PM, 1997, ENVIRON CONSERV, V24, P271, DOI 10.1017/S0376892997000350; Fearnside PM, 1997, ECOL ECON, V20, P53, DOI 10.1016/S0921-8009(96)00066-3; Fearnside PM, 2001, WORLD DEV, V29, P1361, DOI 10.1016/S0305-750X(01)00039-0; Fearnside PM, 2003, AMBIO, V32, P343, DOI 10.1639/0044-7447(2003)032[0343:DCIMGA]2.0.CO;2; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Fearnside PM, 2000, ADV SOIL S, P231; FEARNSIDE PM, 1990, ENVIRON CONSERV, V17, P213, DOI 10.1017/S0376892900032355; FEARNSIDE PM, 1989, 5 CNPQ; Fearnside PM, 2004, CIENCIA HOJE, V34, P63; Foley JA, 2003, FRONT ECOL ENVIRON, V1, P38, DOI 10.2307/3867963; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Gerbens-Leenes PW, 2002, ECOL ECON, V42, P185, DOI 10.1016/S0921-8009(02)00049-6; Gifford R.M., 2001, ENVIRON SCI POLICY, V4, P59, DOI DOI 10.1016/S1462-9011(00)00109-X; Hannah D, 2007, AUSTRAL ECOL, V32, P261, DOI 10.1111/j.1442-9993.2007.01683.x; HECHT SB, 1993, BIOSCIENCE, V43, P687, DOI 10.2307/1312340; Henry BK, 2002, RANGELAND J, V24, P112, DOI 10.1071/RJ02006; HOBBS RJ, 1990, P ECOL SOC AUST, V16, P93; Hoffmann WA, 2008, AUSTRAL ECOL, V33, P29, DOI 10.1111/j.1442-9993.2007.01787.x; HOWDEN SM, 1994, CLIMATIC CHANGE, V27, P49, DOI 10.1007/BF01098473; Howden SM, 2001, ENVIRON INT, V27, P161, DOI 10.1016/S0160-4120(01)00077-0; Keyzer MA, 2005, ECOL ECON, V55, P187, DOI 10.1016/j.ecolecon.2004.12.002; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Laurance WF, 2005, SCIENCE, V307, P1046, DOI 10.1126/science.307.5712.1046; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2001, SCIENCE, V292, P1652; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Ludwig John A., 2000, Pacific Conservation Biology, V6, P254; McAlpine CA, 2002, RANGELAND J, V24, P36, DOI 10.1071/RJ02002; Mertens B, 2002, AGR ECON, V27, P269, DOI 10.1016/S0169-5150(02)00076-2; Mistry J, 2005, BIOTROPICA, V37, P439, DOI 10.1111/j.1744-7429.2005.00058.x; MORAN EF, 1993, HUM ECOL, V21, P1, DOI 10.1007/BF00890069; Perz Stephen G., 2005, Environment Development and Sustainability, V7, P23, DOI 10.1007/s10668-003-6977-9; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pielke RA, 2007, AGR FOREST METEOROL, V142, P234, DOI 10.1016/j.agrformet.2006.06.012; Ramankutty N, 1999, GLOBAL ECOL BIOGEOGR, V8, P381, DOI 10.1046/j.1365-2699.1999.00141.x; Rijsberman FR, 2006, AGR WATER MANAGE, V80, P5, DOI 10.1016/j.agwat.2005.07.001; Rolfe J, 2002, RANGELAND J, V24, P152, DOI 10.1071/RJ02008; Santilli M, 2005, CLIMATIC CHANGE, V71, P267, DOI 10.1007/s10584-005-8074-6; Seabrook L, 2006, LANDSCAPE URBAN PLAN, V78, P373, DOI 10.1016/j.landurbplan.2005.11.007; Sharp BR, 2003, J BIOGEOGR, V30, P783, DOI 10.1046/j.1365-2699.2003.00840.x; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; Silveira JP, 2001, SCIENCE, V292, P1651, DOI 10.1126/science.292.5522.1651c; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Steinfeld H, 2007, ANNU REV ENV RESOUR, V32, P271, DOI 10.1146/annurev.energy.32.041806.143508; Steininger MK, 2001, ENVIRON CONSERV, V28, P127, DOI 10.1017/S0376892901000133; Subak S, 1999, ECOL ECON, V30, P79, DOI 10.1016/S0921-8009(98)00100-1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Woinarski JCZ, 2002, AUSTRAL ECOL, V27, P311, DOI 10.1046/j.1442-9993.2002.01182.x; WRIGHT A, 2007, COMMONWEALTH AUSTR	102	157	162	4	150	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-3780	1872-9495		GLOBAL ENVIRON CHANG	Glob. Environ. Change-Human Policy Dimens.	FEB	2009	19	1					21	33		10.1016/j.gloenvcha.2008.10.008	http://dx.doi.org/10.1016/j.gloenvcha.2008.10.008			13	Environmental Sciences; Environmental Studies; Geography	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Geography	425RS		Green Accepted			2022-09-04	WOS:000264655400005
J	Dennis, RJ; Perez, A; Rowan, K; Londono, D; Metcalfe, A; Gomez, C; McPherson, K				Dennis, RJ; Perez, A; Rowan, K; Londono, D; Metcalfe, A; Gomez, C; McPherson, K			Factors associated with hospital mortality in patients admitted to the intensive care unit in Colombia	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Article						intensive care; invasive ventilation; APACHE; mortality, prediction	SOCIETY APACHE-II; CASE-MIX; PREDICTION; ADVANTAGES; SURVIVAL; OUTCOMES; IRELAND; BRITAIN	OBJECTIVES: To describe the demographic features, reasons for hospital admission and factors associated with hospital mortality in patients admitted to intensive care in Colombia. METHOD: A cohort study of patients admitted to intensive care units (ICUs). Of 89 ICUs identified in Colombia, 20 in ten cities were invited to gather information on 200 consecutive patients admitted to each ICU. RESULTS: Three thousand sixty-six patient cases were available for analysis. The mean age was 53 years and 43% were women (men vs. women, p < 0.001). The most frequent cause of admission was medical (63.9%), acute myocardial infarction patients (7.1%) comprising the largest group. Severity of disease measured as APACHE II and III was a mean 14.0 (SD 6.9) and 48.3 (SD 23.5), respectively. Multivariate analysis, independent of adjustment for severity (APACHE II or III), showed that the factors associated with hospital death were the need for mechanical ventilation, pupillary response, transfer from a medical ward, and management by the ICU team prior to admission (p < 0.01). CONCLUSION: The most common reason for admission to an ICU in Colombia was myocardial infarction. Besides severity of disease, other variables related to medical care in Colombia are associated with hospital mortality, such as invasive ventilation. Although these variables may be artifacts related to disease severity, they are more likely to be related to quality of care.	Hosp Univ San Ignacio, Oficina Med Interna, Dept Med Interna, Unidades Neumol & Cuidados Intensivos, Bogota, Colombia; Pontificia Univ Javeriana, Fac Med, Unidad Epidemiol Clin & Bioestadist, Bogota, Colombia; Hosp Univ San Ignacio, Dept Psiquiatria, Bogota, Colombia; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc & Publ Hlth Unit, London WC1, England; Natl Audit & Res Ctr, London, England		Dennis, RJ (corresponding author), Hosp Univ San Ignacio, Oficina Med Interna, Dept Med Interna, Unidades Neumol & Cuidados Intensivos, Ctra 7,70-62,5 Piso, Bogota, Colombia.	rdennis@javercol.javeriana.edu.co		Perez, Adriana/0000-0002-6859-9916; Dennis, Rodolfo J/0000-0003-3215-9721				Bach PB, 1998, AM J RESP CRIT CARE, V158, P1410, DOI 10.1164/ajrccm.158.5.9804042; Bastos PG, 1996, INTENS CARE MED, V22, P564, DOI 10.1007/s001340050131; CHANG RWS, 1988, CRIT CARE MED, V16, P34, DOI 10.1097/00003246-198801000-00007; CHANG RWS, 1989, LANCET, V2, P143; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; DENNIS R, 1995, ACTA MED COLOMB, V20, P64; Dennis R. J., 2000, ACTA MED COLOMB, V25, P211; Donabedian A., 1985, EXPLORATIONS QUALITY, VIII; Ely EW, 1999, INTENS CARE MED, V25, P581, DOI 10.1007/s001340050906; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Hosmer D., 1989, APPL LOGISTIC REGRES; *ICNARC, 1997, ICMPDS CAS MIX PROGR; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; LEMESHOW S, 1988, CRIT CARE MED, V16, P470, DOI 10.1097/00003246-198805000-00002; MARTINEZ CE, 1998, REV COLOMB NEUMOL, V10, P83; MARTINEZ CE, 1997, REV COLOMB NEUMOL, V9, P78; MIRANDA DR, 1998, UPDATE INTENS CARE E, V29, P38; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; Nelson HS, 1998, CHEST, V113, P1264, DOI 10.1378/chest.113.5.1264; Nickas G, 2000, ARCH INTERN MED, V160, P541, DOI 10.1001/archinte.160.4.541; Qureshi AI, 2000, CRIT CARE MED, V28, P1383, DOI 10.1097/00003246-200005000-00020; ROWAN KM, 1993, BRIT MED J, V307, P977, DOI 10.1136/bmj.307.6910.977; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; Shortell S M, 1992, QRB Qual Rev Bull, V18, P150; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Singh N, 1998, J GASTROENTEROL, V33, P73, DOI 10.1007/s005350050047; VASILYEV S, 1995, CHEST, V107, P1083, DOI 10.1378/chest.107.4.1083	32	6	8	0	2	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0300-2896	1579-2129		ARCH BRONCONEUMOL	Arch. Bronconeumol.	MAR	2002	38	3					117	122		10.1016/S0300-2896(02)75168-5	http://dx.doi.org/10.1016/S0300-2896(02)75168-5			6	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	539PZ	11900688				2022-09-04	WOS:000174880800004
J	Guzman, CPC; Cordoba, MA; Godoy, N; Castano, A; Ribeiro, KB; Moreno, F; de Vries, E				Guzman, Paula Carolina C.; Adelaida Cordoba, Maria; Godoy, Natalia; Castano, Alexandra; Ribeiro, Karina Braga; Moreno, Florencia; de Vries, Esther			Childhood cancer in Latin America: from detection to palliative care and survivorship	CANCER EPIDEMIOLOGY			English	Article								Background: Treatment options for childhood cancer have improved substantially, although in many low-and middle-income countries survival is lagging behind. Integral childhood cancer care involves the whole spectrum from detection and diagnosis to palliative and survivorship care. Methods: Based on a literature review and expert opinions, we summarized current practice and recommendations on the following aspects of childhood cancer in Latin America: diagnostic processes and time to diagnosis, stage at diagnosis, treatments and complications, survivorship programs and palliative care and end-of-life services. Results: Latin America is a huge and heterogeneous continent. Identified barriers show similar problems between countries, both logistically (time and distance to centers, treatment interruptions) and financially (cost of care, cost of absence from work). Governmental actions in several countries improved the survival of children with cancer, but difficulties persist in timely diagnosis and providing adequate treatment to all childhood cancer patients in institutions with complete infrastructure. Treatment abandonment is still common, although the situation is improving. Cancer care in the region has mostly focused on acute treatment of the disease and has not adequately considered palliative and end-of-life care and monitoring of survivors. Conclusions: Decentralizing diagnostic activities and centralizing specialized treatment will remain necessary; measures to facilitate logistics and costs of transportation of the child and caretakers should be implemented. Twinning actions with specialized centers in high income countries for help in diagnosis, treatment and education of professionals and family members have been shown to work. Palliative and end-of-life care as well as childhood cancer survivorship plans are needed.	[Guzman, Paula Carolina C.] Univ Mil Nueva Granada, Hosp Mil Cent, Pediat Dept, Trasversal 3 49-02, Bogota, Colombia; [Guzman, Paula Carolina C.] Univ Mil Nueva Granada, Fac Med, Trasversal 3 49-02, Bogota, Colombia; [Adelaida Cordoba, Maria] Hosp Univ Fdn Santa Fe Bogota, Hosp La Misericordia, Pediat Palliat Care Unit, Av Caracas 1-65,Carrera 7 117 15, Bogota, Colombia; [Adelaida Cordoba, Maria] Hosp Mil Cent, Av Caracas 1-65,Carrera 7 117 15, Bogota, Colombia; [Godoy, Natalia] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, PhD Program Clin Epidemiol, Carrera 7 40 62, Bogota, Colombia; [Castano, Alexandra] Hosp Univ Fdn Santa Fe Bogota, Pediat Dept, Carrera 7 117-15, Bogota, Colombia; [Ribeiro, Karina Braga] Fac Ciencias Med Santa Casa Sao Paulo, Dept Collect Hlth, Rua Doutor Cesario Motta Jr 61, Sao Paulo, SP, Brazil; [Moreno, Florencia] Natl Canc Inst, Argentinian Pediat Oncol Registry, Minist Hlth, JA Roca 781 Piso 11 CABA, Buenos Aires, DF, Argentina; [de Vries, Esther] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Carrera 7 40 62, Bogota, Colombia		de Vries, E (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Carrera 7 40 62, Bogota, Colombia.	paulacarolinaguzmanc@gmail.com; maria.cordoba@fsfb.org.co; natalia.godoy@javeriana.edu.co; alexandracastano81@gmail.com; kbribeiro@gmail.com; roha@inc.gob.ar; estherdevries@javeriana.edu.co	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258; Cordoba Nunez, Maria Adelaida/0000-0001-8130-5647				Abu Arja MH, 2019, CHILD NERV SYST, V35, P257, DOI 10.1007/s00381-018-4000-x; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Alvarez E, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26560; Arias-Casais N, 2020, J PAIN SYMPTOM MANAG, V60, P746, DOI 10.1016/j.jpainsymman.2020.04.028; Bernada M, 2005, SALUDARTE, V13, P35; Bray F., 2019, CANC ATLAS, V3rd; Brown AEC, 2014, J PALLIAT MED, V17, P1369, DOI 10.1089/jpm.2014.0095; CampbellBull M, 2005, REV PED ELEC, V2, P1; de la Lanza CC, 2015, GAC MEX ONCOL, V14, P181, DOI 10.1016/j.gamo.2015.07.006; Chantada Guillermo L, 2016, J Glob Oncol, V2, P347, DOI 10.1200/JGO.2015.002782; Cuenta de alto costo,, 2019, SITUACI CANC POBLACI; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Mattosinho CCD, 2019, PEDIATR HEMAT ONCOL, V36, P55, DOI 10.1080/08880018.2019.1605432; Delgado E, 2008, PALLIATIVE END LIFE; Fajardo-Gutierrez A, 2002, MED PEDIATR ONCOL, V39, P25, DOI 10.1002/mpo.10100; Fedorovsky JM, 2017, REV PANAM SALUD PUBL, V41, DOI [10.26633/rpsp.2017.152, 10.26633/RPSP.2017.152]; Ferman S, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27724; Florencia M, 2015, CANCER EPIDEMIOL, V39, P505, DOI 10.1016/j.canep.2015.04.010; Fonseca A., 2017, HOS PAL MED INT JNL, V1, P54, DOI [10.15406/hpmij.2017.01.00012, DOI 10.15406/HPMIJ.2017.01.00012]; Frenk J, 2018, ARCH MED RES, V49, P79, DOI 10.1016/j.arcmed.2018.06.002; Germ R.M, 2012, PEDIAT PALLIAT CARE, P405, DOI [10.1007/978-94-007-2570-6, DOI 10.1007/978-94-007-2570-6]; GomezGarcia W C, 2020, IAHPC PUBL, V21; Grynszpancholc E, 2019, MEDICINA-BUENOS AIRE, V79, P349; GuzmanCruz P, 2017, U MEDICA, V58, DOI [10.11144/Javeriana.umed58-4.espm, DOI 10.11144/JAVERIANA.UMED58-4.ESPM]; Hopkins J, 2013, J Cancer Policy, V1, pE8, DOI 10.1016/j.jcpo.2013.06.001; Howard S, 2012, PEDIATR BLOOD CANCER, V59, P993; Howard Scott C, 2007, Pediatr Blood Cancer, V48, P364, DOI 10.1002/pbc.21003; Howard SC, 2008, CANCER, V112, P461, DOI 10.1002/cncr.23205; Howard SC, 2007, PEDIATR BLOOD CANCER, V48, P486, DOI 10.1002/pbc.20989; Howard SC, 2018, LANCET ONCOL, V19, pE252, DOI 10.1016/S1470-2045(18)30123-2; Hsu SC, 2007, PEDIATR BLOOD CANCER, V49, P139, DOI 10.1002/pbc.20883; Jacobs LA, 2017, LANCET ONCOL, V18, pE19, DOI 10.1016/S1470-2045(16)30386-2; Knapp C, 2011, PEDIATR BLOOD CANCER, V57, P361, DOI 10.1002/pbc.23100; Lago P, 2010, PEDIAT PALLIATIVE CA, P417, DOI [10.1007/978-94-007-2570-6_23., DOI 10.1007/978-94-007-2570-6_23]; Lam CG, 2019, SCIENCE, V363, P1182, DOI 10.1126/science.aaw4892; Landier W, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.77.0180; Leander C, 2007, PEDIATR BLOOD CANCER, V49, P817, DOI 10.1002/pbc.21052; Lins MM, 2012, J PEDIAT HEMATOL ONC, V34, pE271, DOI 10.1097/MPH.0b013e3182580bea; Lucena Januária Nunes, 2018, Rev. paul. pediatr., V36, P254, DOI 10.1590/1984-0462/;2018;36;3;00007; Luna-Fineman S, 2019, J CLIN ONCOL, V37, P2875, DOI 10.1200/JCO.18.00141; Maestre Mattos C, 2018, PROTOCOLO VIGILANCIA; Moreno F, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26533; Moreno F, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28583; Moreno F, 2016, PEDIATR BLOOD CANCER, V63, P1362, DOI 10.1002/pbc.25987; Moreno F, 2014, PEDIATR BLOOD CANCER, V61, P1610, DOI 10.1002/pbc.25048; Moreno F, 2013, EUR J CANCER, V49, P465, DOI 10.1016/j.ejca.2012.08.001; Naves R., 2016, IARC 50 ANN C GLOB C; Oeffinger KC, 2008, PEDIATR CLIN N AM, V55, P251, DOI 10.1016/j.pcl.2007.10.009; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Osorio DS, 2018, NEURO-ONCOLOGY, V20, P47; PaezAguirre S, 2012, PEDIAT PALLIATIVE CA, P345, DOI 10.1007/978-94-007-2570-6; Pan American Health Organization World Health Organisation, 2014, DIAGNOSTICO TEMPRANO; Pastrana T, 2014, PALLIATIVE MED, V28, P1231, DOI 10.1177/0269216314538893; Pastrana T, 2013, CURR OPIN SUPPORT PA, V7, P411, DOI 10.1097/SPC.0000000000000008; Pena-Hernandez A, 2019, PEDIATR BLOOD CANCER, V66, P27621, DOI 10.1002/pbc.27621; Perez V, 2018, JAMA OPHTHALMOL, V136, P747, DOI 10.1001/jamaophthalmol.2018.1501; Perez-Cuevas R, 2013, PEDIATR BLOOD CANCER, V60, P196, DOI 10.1002/pbc.24265; Phillips SM, 2015, CANCER EPIDEM BIOMAR, V24, P653, DOI 10.1158/1055-9965.EPI-14-1418; Pineros M, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/RPSP.2017.2; Quesada-Tristan L, 2012, PEDIAT PALLIAT CARE, P323, DOI [10.1007/978-94-007-2570-6, DOI 10.1007/978-94-007-2570-6]; Ramirez O, 2018, PEDIAT HEMATOL ONCOL, V3, P79, DOI [DOI 10.1016/J.PHOJ.2019.01.001, 10.1016/j.phoj.2019.01.001]; Ribeiro K., 2018, BRAZIL PEDIAT BLOOD, V65, pS283; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; Robb SL, 2014, CANCER NURS, V37, pE1, DOI 10.1097/NCC.0000000000000095; Rodriguez Zamora N, 2014, MED PALIATIVA, V21, P15, DOI [10.1016/j. medipa.2012.07.005, DOI 10.1016/J.MEDIPA.2012.07.005]; Rodriguez-Galindo C, 2015, J CLIN ONCOL, V33, P3065, DOI 10.1200/JCO.2014.60.6376; Salaverria C, 2015, PEDIATR BLOOD CANCER, V62, P1609, DOI 10.1002/pbc.25557; Samudio A., 2018, J GLOB ONCOL, V4, p70S, DOI [10.1200/jgo.18.40200, DOI 10.1200/JGO.18.40200]; Samudio A, 2015, J PEDIAT HEMATOL ONC, V37, P383, DOI 10.1097/MPH.0000000000000338; Santiago Teresa, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.17.00187; Santiago TC, 2012, PEDIATR BLOOD CANCER, V59, P221, DOI 10.1002/pbc.24071; Schwartz C L, 1999, Oncologist, V4, P45; Selistre SGA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0579-9; ShalkowKlincovstein J, 2016, COMP EP OG CAN; Skinner R, 2007, ARCH DIS CHILD, V92, P257, DOI 10.1136/adc.2006.095513; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; SKION, 2014, GUIDELINES FOLLOW UP; Snaman J, 2020, J CLIN ONCOL, V38, P954, DOI 10.1200/JCO.18.02331; Spence D, 2019, LANCET ONCOL, V20, pE522, DOI 10.1016/S1470-2045(19)30516-9; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Suarez A, 2011, REV COLOMB CANCEROL, V15, P22, DOI 10.1016/S0123-9015(11)70077-4; Mattos AS, 2018, COLOMB MEDICA, V49, P97, DOI 10.25100/cm.v49i1.3377; Tonorezos ES, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.5180; Parra DU, 2020, CANCER EPIDEMIOL, V64, DOI 10.1016/j.canep.2019.101645; Vasquez L, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28180; Vasquez L, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27007; Vasquez L, 2016, PEDIATR BLOOD CANCER, V63, P1959, DOI 10.1002/pbc.26134; Waldman E, 2013, NAT REV CLIN ONCOL, V10, P100, DOI 10.1038/nrclinonc.2012.238; Weaver MS, 2015, PEDIATR BLOOD CANCER, V62, pS829, DOI 10.1002/pbc.25695; Winther JF, 2015, ACTA ONCOL, V54, P655, DOI 10.3109/0284186X.2015.1008648; World Health Organization, ESTRATEGIA ATENCION	91	7	7	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1877-7821	1877-783X		CANCER EPIDEMIOL	Cancer Epidemiol.	APR	2021	71		B		SI				101837	10.1016/j.canep.2020.101837	http://dx.doi.org/10.1016/j.canep.2020.101837		MAR 2021	11	Oncology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Public, Environmental & Occupational Health	RC2IM	33121936				2022-09-04	WOS:000632627700006
J	Olaya, M; Garrido, M; Franco, JA; Rodriguez, JL; Vargas, MJ; Aula-Olivar, A; Quintero, L; Cajal, SRY				Olaya-C, Mercedes; Garrido, Marta; Franco, Jorge Andres; Rodriguez, Jorge Luis; Vargas, Magda Jimena; Aula-Olivar, Ana; Quintero, Laura; Cajal, Santiago Ramon Y.			Spiral Arteries in Second Trimester of Pregnancy: When Is It Possible to Define Expected Physiological Remodeling as Abnormal?	REPRODUCTIVE SCIENCES			English	Article						Spiral arteries; Vascular remodeling; Endovascular trophoblast; Trophoblast invasion; Preeclampsia	ENDOVASCULAR TROPHOBLAST INVASION; PREECLAMPSIA	After undergoing remodeling, uterine spiral arteries turn into wide, flexible tubes, with low resistance. If remodeling does not occur, spontaneous abortions, intrauterine growth restriction, and pregnancy-related hypertensive disorders can ensue. Arterial transformation begins at a very early gestational stage; however, second quarter pregnancy histopathological samples have yet to pinpoint the exact moment when abnormal remodeling transpires. We examined 100 samples, taken from consecutive abortions at 12-23 gestational weeks. Following Pijnenborg and Smith guidelines, blinded pathologists analyzed clinical data on remodeling stages. Lab results showed that arterial remodeling is not synchronic in all vessels; a single sample can include various remodeling stages; neither is remodeling homogenous in a single vessel: change may be occurring in one part of the vessel, but not in another. To our knowledge, no one has published this finding. In the examined age group, Smith stage IV predominates; around week 14, substantial muscle and endothelium loss takes place. After week 17, endovascular or fibrin trophoblast does not usually occur. Although scant consensus exists on what defines preeclampsia etiology, it is clear that it involves abnormal remodeling in decidua vessels. Improved understanding requires further knowledge on both the physiological and pathological aspects of the remodeling process. We observed that muscle and endothelial tissues disappear from weeks 14-17, after which time reendothelization predominates. We list the expected proportion of spiral artery changes for each gestational age which, to date, has not been available.	[Olaya-C, Mercedes; Rodriguez, Jorge Luis; Vargas, Magda Jimena] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Med Sch, Fac Med,Inst Human Genet,Dept Pathol, Kra 7a 40-62, Bogota, Colombia; [Garrido, Marta; Aula-Olivar, Ana; Cajal, Santiago Ramon Y.] Vall Hebron Hosp, Pathol Dept, Barcelona 08035, Spain; [Franco, Jorge Andres] Pontificia Univ Javeriana, Fac Med, Dept Morphol, Kra 7a 40-62, Bogota, Colombia; [Quintero, Laura] Pontificia Univ Javeriana, Fac Med, Kra 7a 40-62, Bogota, Colombia; [Cajal, Santiago Ramon Y.] Univ Autonoma Barcelona, Vall Hebron Res Inst VHIR, Translat Mol Pathol, Passeig Vall Hebron 119-129, Barcelona 08035, Spain; [Cajal, Santiago Ramon Y.] Spanish Biomed Res Network Ctr Oncol CIBER ONCnc, Barcelona, Spain		Olaya, M (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Med Sch, Fac Med,Inst Human Genet,Dept Pathol, Kra 7a 40-62, Bogota, Colombia.	olaya.m@javeriana.edu.co; magarrido@vhebron.net; jafrancoz@javeriana.edu.co; jlrodriguez@javeriana.edu.co; magda_vargas@javeriana.edu.co; Aaula@vhebron.net; quintero_laura@javeriana.edu.co; sramon@vhebron.net	Ramon y Cajal, Santiago/H-4955-2016; OLAYA-C, MERCEDES/AGC-7209-2022	Ramon y Cajal, Santiago/0000-0002-3867-1390; OLAYA-C, MERCEDES/0000-0002-7147-425X; Rodriguez Sarmiento, Jorge Luis/0000-0002-0084-0339; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; Franco Zuluaga, Jorge Andres/0000-0002-0446-0042	San Ignacio University Hospital of the Pontificia Universidad Javeriana in Bogota, Colombia [PPTA 00008214]; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain [PPTA 00008214]	San Ignacio University Hospital of the Pontificia Universidad Javeriana in Bogota, Colombia; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain	This study constitutes part of the research project entitled "Arterias espirales, ?cuando decir que la remodelacion fisiologica es anormal?" (ID PPTA 00008214) financed by the San Ignacio University Hospital of the Pontificia Universidad Javeriana in Bogota, Colombia, and the Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain.	Albrecht ED, 2020, REPROD SCI, V27, P1932, DOI 10.1007/s43032-020-00212-8; Avagliano L, 2011, J CLIN PATHOL, V64, P1064, DOI 10.1136/jclinpath-2011-200092; Barker DJP, 2013, PLACENTA, V34, P841, DOI 10.1016/j.placenta.2013.07.063; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brosens I, 2019, AM J OBSTET GYNECOL, V221, P437, DOI 10.1016/j.ajog.2019.05.044; Brosens I, 2019, AM J OBSTET GYNECOL, V221, P219, DOI 10.1016/j.ajog.2019.01.239; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Cartwright JE, 2010, REPRODUCTION, V140, P803, DOI 10.1530/REP-10-0294; Chen CP, 2009, TAIWAN J OBSTET GYNE, V48, P3, DOI 10.1016/S1028-4559(09)60028-0; De Wolf F, 1982, Contrib Gynecol Obstet, V9, P86; Dhariwal Nerlyne K, 2017, Anesthesiol Clin, V35, P95, DOI 10.1016/j.anclin.2016.09.009; Ernst LM, 2018, MATERNAL VASCULAR MA, V126; Geusens N, 2008, PLACENTA, V29, P614, DOI 10.1016/j.placenta.2008.04.005; Gyselaers W, 2020, AM J OBSTET GYNECOL, V222, P633, DOI 10.1016/j.ajog.2019.12.274; Harris LK, 2019, AM J OBSTET GYNECOL, V221, P457, DOI 10.1016/j.ajog.2019.07.010; Hirano Hiroshi, 2002, Kobe Journal of Medical Sciences, V48, P13; Jauniaux E, 2006, PLACENTA, V27, P468, DOI 10.1016/j.placenta.2005.04.010; Kaplan C., 2007, COLOR ATLAS GROSS PL, P12; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; KHONG TY, 1991, ARCH PATHOL LAB MED, V115, P722; Khong TY, 2016, ARCH PATHOLOGY LAB M; Lu HQ, 2019, SCAND J IMMUNOL, V90, DOI 10.1111/sji.12756; Lyall F, 2005, PLACENTA, V26, pS31, DOI 10.1016/j.placenta.2005.02.010; Naicker T, 2003, ACTA OBSTET GYN SCAN, V82, P722, DOI 10.1034/j.1600-0412.2003.00220.x; Naruse K, 2019, PLACENTA, V84, P69, DOI 10.1016/j.placenta.2019.02.009; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Rainey A, 2010, PLACENTA, V31, P602, DOI 10.1016/j.placenta.2010.04.005; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Spinillo A, 2019, ACTA OBSTET GYN SCAN, V98, P1585, DOI 10.1111/aogs.13699; Vesce F, 1997, GYNECOL OBSTET INVES, V44, P107, DOI 10.1159/000291497; Wang Y, 2010, VASCULAR BIOL PLACEN	34	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	APR	2021	28	4					1185	1193		10.1007/s43032-020-00403-3	http://dx.doi.org/10.1007/s43032-020-00403-3		NOV 2020	9	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	QS6LD	33237514				2022-09-04	WOS:000592542100005
J	Riascos-Ortiz, D; Mosquera-Espinosa, AT; De Agudelo, FV; de Oliveira, CMG; Munoz-Florez, JE				Riascos-Ortiz, Donald; Teresa Mosquera-Espinosa, Ana; Varon De Agudelo, Francia; Goncalves de Oliveira, Claudio Marcelo; Eduardo Munoz-Florez, Jaime			An integrative approach to the study of Helicotylenchus (Nematoda: Hoplolaimidae) Colombian and Brazilian populations associated with Musa crops	JOURNAL OF NEMATOLOGY			English	Article						Banana; Helicotylenchus; H. multicinctus; H. dihystera; H. erythrinae; H. californicus; Plantain; Taxonomy	PLANT-PARASITIC NEMATODES; MOLECULAR CHARACTERIZATION; TYLENCHIDA HOPLOLAIMIDAE; PSEUDOROBUSTUS STEINER; 1914 GOLDEN; BANANA; MULTICINCTUS; ROOTS; SOIL; RHIZOSPHERE	In total, 10 populations of Helicotylenchus associated with Musa spp., six from Colombia, and four from Brazil were identified to the species level. Morphological and morphometric data were recorded for each population, performed a principal components analysis (PCA), a conglomerate, along with consensus sequences of D2 to D3 expansion segment of the large subunit of ribosomal DNA (28S) for different populations. Identify of species were performed using the basic local alignment search tool (BLAST), and the evolutionary relationships of species were explored using a phylogeny study. Four species of Helicotylenchus were identified based on morphological and morphometric data: H. multicinctus, H. dihystera, H. erythrinae, and H. californicus. PCA and conglomerate analysis clearly separated these species. BLAST and phylogenetic analysis confirmed the presence of these species associated with Musa spp. crops. This is the first report of these species in Colombia through integrative taxonomy.	[Riascos-Ortiz, Donald] Univ Nacl Colombia, Fac Ciencias Agr, Palmira, Colombia; [Riascos-Ortiz, Donald] Univ Pacifico, Programa Agron, Buenaventura, Colombia; [Teresa Mosquera-Espinosa, Ana; Eduardo Munoz-Florez, Jaime] Pontificia Univ Javeriana, Dept Ciencias Nat & Matemat, Cali, Colombia; [Varon De Agudelo, Francia] Ctr Invest Palma Aceite Cenipalma, Bogota, Colombia; [Goncalves de Oliveira, Claudio Marcelo] Inst Biol, Lab Nematol, Campinas, SP, Brazil		Riascos-Ortiz, D (corresponding author), Univ Nacl Colombia, Fac Ciencias Agr, Palmira, Colombia.; Riascos-Ortiz, D (corresponding author), Univ Pacifico, Programa Agron, Buenaventura, Colombia.	dhriascoso@unal.edu.co			Colciencias (Departamento Administrativo de Ciencias, Tecnologia e Innovacion) [727-2015]; Sistema General de Regalias - SGR of Colombia	Colciencias (Departamento Administrativo de Ciencias, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Sistema General de Regalias - SGR of Colombia	We would like to thanks to Colciencias (Departamento Administrativo de Ciencias, Tecnologia e Innovacion) for the financial support to the first author for his studies of the Doctorate program, his internship, and the research (announcement 727-2015). The project named `Tecnologias innovadoras para el Manejo Integrado de plagas y enfermedades limitantes de platano y banana en el Valle del Cauca', supported by the Sistema General de Regalias - SGR of Colombia, by the financial support for the collection of roots and soil samples in different farms and the acquisition of reagents. The Molecular Biology Laboratory of the Universidad Nacional de Colombia in Palmira, Valle del Cauca - Colombia and Nematology Laboratory of Instituto Biologico in Campinas, Sao Paulo - Brasil for the scientific support for the register of molecular, morphological, and morphometric data. Universidad del Pacifico in Buenaventura, Colombia. Peter Ramley for his collaboration in the grammar checking of manuscript. To PhD Angel Vale and PhD Danny Rojas for their assistance with the bioinformatics analyses and manuscript revision and CIPRES by bioinformatics support.	Araya M, 2004, ACTA OECOL, V26, P137, DOI 10.1016/j.actao.2004.03.010; Araya Vargas Mario, 2011, Fitosanidad, V15, P163; Barekye A, 2000, ANN APPL BIOL, V137, P273, DOI 10.1111/j.1744-7348.2000.tb00068.x; BOAG B, 1985, SYST PARASITOL, V7, P47, DOI 10.1007/BF00010161; Campos V.P., 1987, Sociedade Brasileira de Nematologia Publicacao, V11, P226; Castillo P., 1993, Nematologia Mediterranea, V21, P45; Crozzoli Renato, 2009, V4, P63, DOI 10.1007/978-1-4020-9858-1_2; Daneel M, 2015, NEMATROPICA, V45, P118; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; Dias-Arieira CR, 2010, REV BRAS FRUTIC, V32, P1064, DOI 10.1590/S0100-29452010005000119; FORTUNER R, 1984, Revue de Nematologie, V7, P245; FORTUNER R, 1984, Revue de Nematologie, V7, P121; FORTUNER R, 1979, Revue de Nematologie, V2, P197; FORTUNER R, 1981, Revue de Nematologie, V4, P235; FORTUNER R, 1991, Revue de Nematologie, V14, P165; Fortuner R, 2018, NEMATOLOGY, V20, P423, DOI 10.1163/15685411-00003148; Godefroid M, 2017, APPL SOIL ECOL, V113, P63, DOI 10.1016/j.apsoil.2017.01.012; Golden A., 1956, BULLETIN, VA-85; GOODEY T., 1940, JOUR HELMINTHOL, V18, P21, DOI 10.1017/S0022149X00031357; Guzman-Piedrahita O. A., 2011, Agronomia, V19, P19; Guzman-Piedrahita Oscar Adrian, 2004, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V28, P295; Kamira M, 2013, NEMATROPICA, V43, P216; Karakas M, 2007, BIOLOGIA, V62, P320, DOI 10.2478/s11756-007-0054-z; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan Matiyar Rahaman, 2010, Journal of Plant Protection Research, V50, P263, DOI 10.2478/v10045-010-0046-9; Krall EL., 1990, ROOT PARASITIC NEMAT; Lara Posadas S.V., 2016, Rev. mex. fitopatol, V34, P116, DOI 10.18781/R.MEX.FIT.1507-7; MCSORLEY R, 1986, NEMATROPICA, V16, P73; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Mizukubo Takayuki, 1992, Japanese Journal of Nematology, V22, P26; Munera GE, 2009, NEMATOLOGY, V11, P799, DOI 10.1163/156854109X415524; Nath RC, 1998, FUND APPL NEMATOL, V21, P353; Nguyen Ngoc Chau, 1998, International Journal of Nematology, V7, P122; ORBIN DP, 1973, J NEMATOL, V5, P37; Perry V., 1959, RES B COLL AGR LIFE, P207; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ravichandra N.G., 2014, HORTICULTURAL NEMATO, DOI [10.1007/978-81-322-1841-8, DOI 10.1007/978-81-322-1841-8]; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy K., 2014, Journal of Crop and Weed, V10, P375; Selvaraj S, 2014, BIOCONTROL, V59, P345, DOI 10.1007/s10526-014-9569-8; Sher S. A., 1961, Nematalogica, V6, P155; SHER SA, 1966, NEMATOLOGICA, V12, P1, DOI 10.1163/187529266X00013; Siddiqi M.R., 1972, HELICOTYLENCHUS DIHY; Singh S. K., 2013, Bulletin OEPP, V43, P334, DOI 10.1111/epp.12050; Speijer PR, 1999, NEMATROPICA, V29, P185; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subbotin SA, 2015, NEMATOLOGY, V17, P27, DOI 10.1163/15685411-00002850; Subbotin SA, 2011, NEMATOLOGY, V13, P333, DOI 10.1163/138855410X520936; Torrado-Jaime Mayary, 2009, Agron. colomb., V27, P237; Tzortzakakis EA, 2017, J NEMATOL, V49, P233, DOI 10.21307/jofnem-2017-068; Uzma I., 2015, Pakistan Journal of Nematology, V33, P115; Van den Berg E., 2003, African Plant Protection, V9, P31; Van Den Berg E., 1975, S AFRICAN HOPLOLAIMI, V4; Villegas C., 1989, RESUMENES ANALITICOS, P275; WOUTS WM, 1994, NEW ZEAL J ZOOL, V21, P213, DOI 10.1080/03014223.1994.9517988; [肖雅敏 Xiao Yamin], 2014, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V43, P573; ZUNIGA G, 1979, Fitopatologia Colombiana, V8, P40	58	1	2	2	3	SOC NEMATOLOGISTS	MARCELINE	PO BOX 311, MARCELINE, MO 64658 USA	0022-300X			J NEMATOL	J. Nematol.		2020	52								e2020-54	10.21307/jofnem-2020-054	http://dx.doi.org/10.21307/jofnem-2020-054			19	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	MJ0EE	32628821	gold, Green Published			2022-09-04	WOS:000547768300001
J	Nunez, MX; Henriquez, MA; Escaf, LJ; Ventura, BV; Srurs, M; Newball, L; Espaillat, A; Centurion, VA				Nunez, Maria X.; Henriquez, Maria A.; Escaf, Luis J.; Ventura, Bruna V.; Srurs, Miguel; Newball, Lyle; Espaillat, Arnaldo; Centurion, Virgilio A.			Consensus on the management of astigmatism in cataract surgery	CLINICAL OPHTHALMOLOGY			English	Article						management of astigmatism; astigmatism correction during cataract surgery; cataract patients with astigmatism; measurement and treatment of astigmatism; consensus on managing astigmatism	TORIC INTRAOCULAR-LENS; RESIDUAL REFRACTIVE ERROR; TOTAL CORNEAL ASTIGMATISM; IN-SITU KERATOMILEUSIS; LIMBAL RELAXING INCISIONS; CLASSIFICATION-SYSTEM III; RETINAL-DETACHMENT; ROTATIONAL STABILITY; FEMTOSECOND LASER; PREEXISTING ASTIGMATISM	This project was aimed at achieving consensus on the management of astigmatism during cataract surgery by ophthalmologists from Latin America using modified Delphi technique. Relevant peer-reviewed literature was identified, and 21 clinical research questions associated with the definition, classification, measurement, and treatment of astigmatism during cataract surgery were formulated. Twenty participants were divided into seven groups, and each group was assigned three questions to which they had to respond in written form, after thoroughly reviewing the literature. The assigned questions with corresponding responses by each group were discussed with other participants in round 4 - presentation of findings. The consensus was achieved if approval was obtained from at least 80% of participants. The present paper provides several agreements and recommendations for management of astigmatism during cataract surgery, which could potentially minimize the variability in practice patterns and help ophthalmologists adopt optimal practices for cataract patients with astigmatism and improve patient satisfaction.	[Nunez, Maria X.] Univ Javeriana, Unit Cornea Cataract & Refract Surg, Grp Invest Vis Sana, Clin Oftalmol Cali, Cali, Colombia; [Henriquez, Maria A.] Oftalmosalud Inst Ojos, Dept Cataract, Dept Res, Lima, Peru; [Escaf, Luis J.] Univ Javeriana, Clin Oftalmol Caribe Cofca, Barranquilla, Colombia; [Ventura, Bruna V.] HOPE Eye Hosp, Altino Ventura Fdn, Dept Cataract, Recife, PE, Brazil; [Srurs, Miguel] Univ Los Andes, Ctr Vis, Filial Clin Las Condes, Santiago, Chile; [Newball, Lyle] Lynd Newball Clin, San Andres Islas, Colombia; [Espaillat, Arnaldo] Espaillat Cabral Inst, Cataract & Refract Surg Serv, Santo Domingo, Dominican Rep; [Centurion, Virgilio A.] IMO, Cataract Serv, Sao Paulo, Brazil		Nunez, MX (corresponding author), Univ Javeriana, Grp Invest Vis Sana, Clin Oftalmol Cali, Cra 47 Sur 8c-94, Cali, Colombia.	ximena@visionsana.com		IZQUIERDO Jr, LUIS/0000-0002-9405-4581; Srur, Miguel/0000-0001-8281-6641; Centurion, Virgilio/0000-0003-0750-9013; Henriquez, Maria A./0000-0001-9392-5536	Colombian Association of Cataract and Refractive Surgeons (ASOCCYR); Alcon - a Novartis Division - through the Colombian Association of Cataract and Refractive Surgeons (ASOCCYR)	Colombian Association of Cataract and Refractive Surgeons (ASOCCYR); Alcon - a Novartis Division - through the Colombian Association of Cataract and Refractive Surgeons (ASOCCYR)	The authors thank the Colombian Association of Cataract and Refractive Surgeons (ASOCCYR) for its support and Omar Salamanca, the epidemiologist who participated in the bibliographic search for evidence. Raman Bedi, MD, critically reviewed the manuscript, and IrisARC - Analytics, Research & Consulting (Chandigarh, India) provided editorial assistance in the preparation of the manuscript. This project was primarily funded by an educational grant by Alcon - a Novartis Division - through the Colombian Association of Cataract and Refractive Surgeons (ASOCCYR). The funding body had no role in the design, contents, implementation, or interpretation of the results of this project. This funding defrayed the cost of epidemiologist, statistical analysis, rounds of the Delphi Panels, printed materials, portfolio, supplements, questionnaires, and travel of panelists to the presentation of findings in Cali, Colombia, and potential publication expenses.	Abulafia A, 2016, J CATARACT REFR SURG, V42, P663, DOI 10.1016/j.jcrs.2016.02.038; Abulafia A, 2015, J REFRACT SURG, V31, P699, DOI 10.3928/1081597X-20150928-03; Agresta B, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-41; Ahmed IIK, 2010, J CATARACT REFR SURG, V36, P609, DOI 10.1016/j.jcrs.2009.10.044; Alfonso JF, 2008, AM J OPHTHALMOL, V146, P244, DOI 10.1016/j.ajo.2008.03.022; Alfonso JF, 2014, J CATARACT REFR SURG, V40, P51, DOI 10.1016/j.jcrs.2013.06.026; Algvere PV, 1999, GRAEF ARCH CLIN EXP, V237, P137, DOI 10.1007/s004170050208; Alio J, 2005, OPHTHALMOLOGY, V112, P1997, DOI 10.1016/j.ophtha.2005.06.024; Alio JL, 2015, CURR OPIN OPHTHALMOL, V26, P50, DOI 10.1097/ICU.0000000000000111; Alio JL, 2011, BRIT J OPHTHALMOL, V95, P301, DOI 10.1136/bjo.2010.186429; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Alpins NA, 1997, J CATARACT REFR SURG, V23, P1503, DOI 10.1016/S0886-3350(97)80021-1; ALPINS NA, 1993, J CATARACT REFR SURG, V19, P524, DOI 10.1016/S0886-3350(13)80617-7; Alpins N, 2016, J REFRACT SURG, V32, P598, DOI 10.3928/1081597X-20160608-01; Alpins N, 2015, J REFRACT SURG, V31, P182, DOI 10.3928/1081597X-20150224-02; Alpins N, 2014, J CATARACT REFR SURG, V40, P283, DOI 10.1016/j.jcrs.2013.06.029; Altan-Yaycioglu R, 2007, J REFRACT SURG, V23, P515, DOI 10.3928/1081-597X-20070501-16; Amesbury EC, 2009, CURR OPIN OPHTHALMOL, V20, P19, DOI 10.1097/ICU.0b013e328319c27a; [Anonymous], 2016, EYE NET; Anton A, 2014, GRAEF ARCH CLIN EXP, V252, P539, DOI 10.1007/s00417-014-2565-y; Aramberri J, 2012, J CATARACT REFR SURG, V38, P1934, DOI 10.1016/j.jcrs.2012.06.049; Asena L, 2017, INT OPHTHALMOL, V37, P391, DOI 10.1007/s10792-016-0274-8; Asua Batarrita José, 2005, Gac Sanit, V19, P65; Ayala MJ, 2001, J REFRACT SURG, V17, P12; BARRAQUER C, 1994, ARCH OPHTHALMOL-CHIC, V112, P336, DOI 10.1001/archopht.1994.01090150066025; Barraquer RI, 2017, OPHTHALMIC RES, V57, P247, DOI 10.1159/000456720; BARRETT GD, 1993, J CATARACT REFR SURG, V19, P713, DOI 10.1016/S0886-3350(13)80339-2; Bazzazi Noushin, 2008, J Ophthalmic Vis Res, V3, P87; Belovay GW, 2010, CURR OPIN OPHTHALMOL, V21, P25, DOI 10.1097/ICU.0b013e328332f814; Borasio E, 2006, J CATARACT REFR SURG, V32, P2030, DOI 10.1016/j.jcrs.2006.09.010; Browne AW, 2014, J REFRACT SURG, V30, P67, DOI 10.3928/1081597X-20131217-07; Buckhurst PJ, 2010, CLIN EXP OPTOM, V93, P409, DOI 10.1111/j.1444-0938.2010.00515.x; Carvalho MJ, 2007, J REFRACT SURG, V23, P499; Chang DF, 2009, J CATARACT REFR SURG, V35, P1445, DOI 10.1016/j.jcrs.2009.04.027; Chang DF, 2003, J CATARACT REFR SURG, V29, P935, DOI 10.1016/S0886-3350(02)01843-6; Cheung CYL, 2011, INVEST OPHTH VIS SCI, V52, P1314, DOI 10.1167/iovs.10-5427; Chiam PJ, 2016, INT J OPHTHALMOL-CHI, V9, P699, DOI 10.18240/ijo.2016.05.10; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Comez AT, 2012, ASTIGMATISM OPTICS P; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; Davison JA, 2017, CLIN OPHTHALMOL, V11, P923, DOI 10.2147/OPTH.S135659; Davison JA, 2015, CLIN OPHTHALMOL, V9, P1511, DOI 10.2147/OPTH.S88693; de Vries NE, 2011, J CATARACT REFR SURG, V37, P859, DOI 10.1016/j.jcrs.2010.11.032; Delrivo M, 2014, J REFRACT SURG, V30, P49, DOI 10.3928/1081597X-20131217-06; Dominguez-Vicent A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149249; Elhofi AH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001618; Epitropoulos AT, 2015, J CATARACT REFR SURG, V41, P1672, DOI 10.1016/j.jcrs.2015.01.016; Fernandez-Vega L, 2003, OPHTHALMOLOGY, V110, P2349, DOI 10.1016/S0161-6420(03)00794-2; Ferreira TB, 2017, J REFRACT SURG, V33, P794, DOI 10.3928/1081597X-20171004-03; Ferreira TB, 2017, J CATARACT REFR SURG, V43, P340, DOI 10.1016/j.jcrs.2016.12.031; Ferrer-Blasco T, 2009, J CATARACT REFR SURG, V35, P70, DOI 10.1016/j.jcrs.2008.09.027; Gil MA, 2014, EUR J OPHTHALMOL, V24, P44, DOI 10.5301/ejo.5000335; Goggin M, 2015, J REFRACT SURG, V31, P98, DOI 10.3928/1081597X-20150122-04; Grewal DS, 2009, OPHTHALMOLOGY, V116, P1436, DOI 10.1016/j.ophtha.2009.03.002; Gris O, 1996, J CATARACT REFR SURG, V22, P686, DOI 10.1016/S0886-3350(96)80303-8; Gundersen Kjell G, 2016, Clin Ophthalmol, V10, P2141; Guyatt G, 2008, USERS GUIDES MED LIT, V2; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; Hall NF, 1999, BRIT J OPHTHALMOL, V83, P1159, DOI 10.1136/bjo.83.10.1159; Hamer CA, 2016, CLIN EXP OPTOM, V99, P583, DOI 10.1111/cxo.12329; Hashemi H, 2016, CURR OPIN OPHTHALMOL, V27, P58, DOI 10.1097/ICU.0000000000000223; Hashemi H, 2015, J CATARACT REFR SURG, V41, P1065, DOI 10.1016/j.jcrs.2014.08.043; Hatch KM, 2015, J REFRACT SURG, V31, P237, DOI 10.3928/1081597X-20150319-03; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; He L, 2011, J CATARACT REFR SURG, V37, P1313, DOI 10.1016/j.jcrs.2010.12.061; Hida WT, 2009, ARQ BRAS OFTALMOL, V72, P526, DOI 10.1590/S0004-27492009000400017; Hirnschall N, 2014, J CATARACT REFR SURG, V40, P354, DOI 10.1016/j.jcrs.2013.08.049; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Ho JD, 2009, AM J OPHTHALMOL, V147, P788, DOI 10.1016/j.ajo.2008.12.020; Hoffmann PC, 2014, CURR EYE RES, V39, P1178, DOI 10.3109/02713683.2014.898376; Holladay JT, 2001, J CATARACT REFR SURG, V27, P61, DOI 10.1016/S0886-3350(00)00796-3; Holladay JT, 1998, J CATARACT REFR SURG, V24, P57, DOI 10.1016/S0886-3350(98)80075-8; Holland E, 2010, OPHTHALMOLOGY, V117, P2104, DOI 10.1016/j.ophtha.2010.07.033; Ichhpujani Parul, 2013, J Curr Glaucoma Pract, V7, P54, DOI 10.5005/jp-journals-10008-1138; Jasvinder S, 2011, EYE, V25, P717, DOI 10.1038/eye.2011.28; Jendritza BB, 2008, J REFRACT SURG, V24, P274, DOI 10.3928/1081597X-20080301-09; Jimenez-Alfaro I, 1998, J CATARACT REFR SURG, V24, P1310, DOI 10.1016/S0886-3350(98)80220-4; Jin GJC, 2008, J CATARACT REFR SURG, V34, P562, DOI 10.1016/j.jcrs.2007.11.040; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kanellopoulos AJ, 2015, CORNEA, V34, P937, DOI 10.1097/ICO.0000000000000476; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Khan MI, 2011, J CATARACT REFR SURG, V37, P1751, DOI 10.1016/j.jcrs.2011.04.026; Khokhar S, 2006, J CATARACT REFR SURG, V32, P1432, DOI 10.1016/j.jcrs.2006.04.010; Kim P, 2005, J CATARACT REFR SURG, V31, P979, DOI 10.1016/j.jcrs.2004.08.054; Klijn S, 2016, AM J OPHTHALMOL, V167, P72, DOI 10.1016/j.ajo.2016.04.011; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Kuo IC, 2005, J CATARACT REFR SURG, V31, P2104, DOI 10.1016/j.jcrs.2005.08.023; Lane SS, 2009, J REFRACT SURG, V25, P899, DOI 10.3928/1081597X-20090617-05; Lee H, 2015, CURR OPIN OPHTHALMOL, V26, P34, DOI 10.1097/ICU.0000000000000119; Lee KH, 1996, J CATARACT REFR SURG, V22, P1411, DOI 10.1016/S0886-3350(96)80139-8; Lever J, 2000, J CATARACT REFR SURG, V26, P803, DOI 10.1016/S0886-3350(00)00378-3; Li HQ, 2010, IEEE T BIO-MED ENG, V57, P1690, DOI 10.1109/TBME.2010.2041454; Lois N, 2003, SURV OPHTHALMOL, V48, P467, DOI 10.1016/S0039-6257(03)00083-3; Lyhne N, 1998, J CATARACT REFR SURG, V24, P1647, DOI 10.1016/S0886-3350(98)80358-1; Macsai MS, 2008, CURR OPIN OPHTHALMOL, V19, P18, DOI 10.1097/ICU.0b013e3282f14d9f; Magalhaes FP, 2011, ARQ BRAS OFTALMOL, V74, P110, DOI 10.1590/S0004-27492011000200008; Masket S, 2009, J REFRACT SURG, V25, P21, DOI 10.3928/1081597X-20090101-04; Mencucci R, 2014, J CATARACT REFR SURG, V40, P1479, DOI 10.1016/j.jcrs.2013.12.024; Michelitsch M, 2017, OPHTHALMOLOGE, V114, P247, DOI 10.1007/s00347-016-0323-8; Mingo-Botin D, 2010, J CATARACT REFR SURG, V36, P1700, DOI 10.1016/j.jcrs.2010.04.043; Moshirfar M, 2014, EXPERT REV OPHTHALMO, V9, P529, DOI 10.1586/17469899.2014.966817; Mozayan E, 2014, CURR OPIN OPHTHALMOL, V25, P286, DOI 10.1097/ICU.0000000000000068; Naeser K, 2008, ACTA OPHTHALMOL, V86, P349, DOI 10.1111/j.1755-3768.2008.01287.x; Nanavaty MA, 2017, AM J OPHTHALMOL, V180, P165, DOI 10.1016/j.ajo.2017.06.007; Nemeth G, 2014, CORNEA, V33, P1214, DOI 10.1097/ICO.0000000000000238; Neuhann IM, 2008, J CATARACT REFR SURG, V34, P1644, DOI 10.1016/j.jcrs.2008.06.022; Nichamin Louis D., 2003, International Ophthalmology Clinics, V43, P53; Onishi H, 2016, JPN J OPHTHALMOL, V60, P142, DOI 10.1007/s10384-016-0432-6; Ouchi M, 2010, J REFRACT SURG, V26, P594, DOI 10.3928/1081597X-20091015-01; Guedes RAP, 2011, J FR OPHTALMOL, V34, P387, DOI 10.1016/j.jfo.2011.02.003; Patel CK, 1999, OPHTHALMOLOGY, V106, P2190, DOI 10.1016/S0161-6420(99)90504-3; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Popovic M, 2016, OPHTHALMOLOGY, V123, P2113, DOI 10.1016/j.ophtha.2016.07.005; Popp N, 2012, J CATARACT REFR SURG, V38, P2094, DOI 10.1016/j.jcrs.2012.07.039; Pucci V, 2001, J CATARACT REFR SURG, V27, P896, DOI 10.1016/S0886-3350(01)00858-6; Ravalico G, 2003, J CATARACT REFR SURG, V29, P39, DOI 10.1016/S0886-3350(02)01508-0; Read SA, 2007, CLIN EXP OPTOM, V90, P5, DOI 10.1111/J.1444-0938.2007.00112.x; Reinstein DZ, 2012, J REFRACT SURG, V28, P509, DOI 10.3928/1081597X-20120620-02; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Rubenstein JB, 2013, CURR OPIN OPHTHALMOL, V24, P30, DOI 10.1097/ICU.0b013e32835ac853; Ruckl T, 2013, J CATARACT REFR SURG, V39, P528, DOI 10.1016/j.jcrs.2012.10.043; Sanchez-Galeana CA, 2001, J REFRACT SURG, V17, P299; Savini G, 2015, INVEST OPHTH VIS SCI, V56, P827, DOI 10.1167/iovs.14-15903; Savini G, 2014, J CATARACT REFR SURG, V40, P1645, DOI 10.1016/j.jcrs.2014.01.046; Scialdone A, 2013, J CATARACT REFR SURG, V39, P906, DOI 10.1016/j.jcrs.2013.01.037; Shah GD, 2012, J CATARACT REFR SURG, V38, P54, DOI 10.1016/j.jcrs.2011.08.028; Shirayama M, 2010, CORNEA, V29, P1136, DOI 10.1097/ICO.0b013e3181d3d689; Shirayama M, 2009, AM J OPHTHALMOL, V148, P528, DOI 10.1016/j.ajo.2009.04.028; Simon GJB, 2005, GRAEF ARCH CLIN EXP, V243, P321, DOI 10.1007/s00417-004-1035-3; Srivannaboon S, 2012, J CATARACT REFR SURG, V38, P2088, DOI 10.1016/j.jcrs.2012.07.024; Teichman JC, 2010, CURR OPIN OPHTHALMOL, V21, P135, DOI 10.1097/ICU.0b013e3283365154; Tejedor J, 2005, AM J OPHTHALMOL, V139, P767, DOI 10.1016/j.ajo.2004.12.057; Thibos LN, 2001, J CATARACT REFR SURG, V27, P80, DOI 10.1016/S0886-3350(00)00797-5; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Trikha S, 2013, EYE, V27, P461, DOI 10.1038/eye.2012.293; Venter JA, 2015, J CATARACT REFR SURG, V41, P585, DOI 10.1016/j.jcrs.2014.06.035; Ventura BV, 2015, J CATARACT REFR SURG, V41, P2242, DOI 10.1016/j.jcrs.2015.11.003; Ventura BV, 2014, ARQ BRAS OFTALMOL, V77, P125, DOI 10.5935/0004-2749.20140032; Villegas EA, 2014, J CATARACT REFR SURG, V40, P13, DOI 10.1016/j.jcrs.2013.09.010; Wang L, 2003, J CATARACT REFR SURG, V29, P712, DOI 10.1016/S0886-3350(02)01838-2; Woodward MA, 2009, J CATARACT REFR SURG, V35, P992, DOI 10.1016/j.jcrs.2009.01.031; Yokogawa H, 2017, CORNEA, V36, P269, DOI 10.1097/ICO.0000000000001124; Zhang L, 2015, J CATARACT REFR SURG, V41, P84, DOI 10.1016/j.jcrs.2014.04.033; Zheng TY, 2016, J CATARACT REFR SURG, V42, P84, DOI 10.1016/j.jcrs.2015.07.037; Zhu XJ, 2016, BRIT J OPHTHALMOL, V100, P263, DOI 10.1136/bjophthalmol-2015-306656	146	16	18	2	5	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-5483			CLIN OPHTHALMOL	Clin. Ophthalmol.		2019	13						311	324		10.2147/OPTH.S178277	http://dx.doi.org/10.2147/OPTH.S178277			14	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	HK9LQ	30809088	Green Submitted, Green Published, gold			2022-09-04	WOS:000458313400001
J	Hernandez-Fernandez, J; Pinzon, A; Marino-Ramirez, L				Hernandez-Fernandez, Javier; Pinzon, Andres; Marino-Ramirez, Leonardo			De novo transcriptome assembly of loggerhead sea turtle nesting of the Colombian Caribbean	GENOMICS DATA			English	Article; Data Paper						Caretta caretta turtle; Trinity; RNAseq; Illumina; N50		Loggerhead sea turtle Caretta caretta is widely distributed in the oceans of tropical and subtropical latitude. This turtle is an endangered species due to anthropic and natural factors that have decreased their population levels. In this study, RNA sequencing and de-novo assembly of genes expressed in blood were performed. The raw FASTQ files have been deposited on NCBI's SRA database with accession number SRX2629512. A total of 5.4 Gb raw sequence data were obtained, corresponding to 48,257,019 raw reads. Trinity pipeline was used to perform a de-novo assembly, we were able to identify 64,930 transcripts for female loggerhead turtle transcriptome with an N50 of 1131 bp. The obtained transcriptome data will be useful for further studies of the physiology, biochemistry and evolution in this species.	[Hernandez-Fernandez, Javier] Univ Jorge Tadeo Lozano, Dept Nat & Environm Sci, Mol Biol & Bioinformat Lab, Genet, Cra 4 22-61 Modulo 7 Piso 6, Bogota, DC, Colombia; [Hernandez-Fernandez, Javier] Pontificia Univ Javeriana, Fac Ciencias, Bogota, Colombia; [Pinzon, Andres] Univ Nacl Colombia, Bioinformat & Syst Biol Grp, Bogota, Colombia; [Marino-Ramirez, Leonardo] NCBI, NLM, NIH Computat Biol Branch, Bldg 38A,Room 6S614M 8600 Rockville Pike,MSC 6075, Bethesda, MD 20894 USA		Hernandez-Fernandez, J (corresponding author), Univ Jorge Tadeo Lozano, Dept Nat & Environm Sci, Mol Biol & Bioinformat Lab, Genet, Cra 4 22-61 Modulo 7 Piso 6, Bogota, DC, Colombia.	javier.hernandez@utadeo.edu.co	Fernandez, Javier A Hernandez/K-9794-2016; Mariño-Ramírez, Leonardo/N-5395-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Hernandez Fernandez, Javier Adolfo/0000-0001-8442-9266; Pinzon, Andres/0000-0002-4133-810X	Office of Research, Creation and Extension of the Universidad Jorge Tadeo Lozano [693-12-15]; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Office of Research, Creation and Extension of the Universidad Jorge Tadeo Lozano; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Office of Research, Creation and Extension of the Universidad Jorge Tadeo Lozano (693-12-15). We are grateful to CEINER Oceanarium on the island of St. Martin Pajares for their collaboration in obtaining and providing sample of Caretta caretta for the development of this study. Samples were obtained under a research permit that was granted by the Ministry of Environment and Territorial Development (# 24 of June 22, 2012) and Contract for Access to Genetic Resources (# 64 of April 23, 2013).	Azanza-Ricardo J, 2006, REV INVESTIGACIONES, V27, P69; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Ceballos-Fonseca Claudia, 2004, Bol. Invest. Mar. Cost., V33, P79; Dodd Jr C.K., 1988, US FISH WILDL SERV B, V88, P1; Dutton P.H., 1996, P INT S SEA TURTL CO; Eckert K. L., 2000, UNION INT CONSERVACI; European Council, 2009, COUNCIL CONCLUSIONS, P2; FRAZIER J, 1984, BIOL CONSERV, V30, P41, DOI 10.1016/0006-3207(84)90019-3; FWC, 2015, STAT AN TRENDS FLOR; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hobza R, 2008, MOL ECOL RESOUR, V8, P1274, DOI 10.1111/j.1755-0998.2008.02344.x; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Lancheros-Piliego Daniel, 2013, Univ. Sci., V18, P321; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linnaeus C., 1758, SYSTEMA NATURAE SIVE, P1; Machado A, 2012, ESTADO CONSERVACION; Pritchard P. C. H., 2004, CONV INT PROT CONS T; Pritchard Peter C.H., 1999, P21; SWOT, 2012, 7 SWOT, V7, P48; UICN, 2017, IUCN RED LIST THREAT	21	5	6	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-5960			GENOM DATA	Genom. Data	SEP	2017	13						18	20		10.1016/j.gdata.2017.06.005	http://dx.doi.org/10.1016/j.gdata.2017.06.005			3	Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Genetics & Heredity	FN3XW	28649496	Green Published, Green Accepted, gold			2022-09-04	WOS:000415937000007
J	Jimenez, JF; Bekrar, A; Zambrano-Rey, G; Trentesaux, D; Leitao, P				Jimenez, Jose-Fernando; Bekrar, Abdelghani; Zambrano-Rey, Gabriel; Trentesaux, Damien; Leitao, Paulo			Pollux: a dynamic hybrid control architecture for flexible job shop systems	INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH			English	Article						flexible job shop; hybrid production system; dynamic scheduling; switching mechanism	MANUFACTURING EXECUTION SYSTEMS; REACTIVE CONTROL; MECHANISM; EVOLUTION; ADACOR; FMS	Nowadays, manufacturing control systems can respond more effectively to exigent market requirements and real-time demands. Indeed, they take advantage of changing their structural and behavioural arrangements to tailor the control solution from a diverse set of feasible configurations. However, the challenge of this approach is to determine efficient mechanisms that dynamically optimise the configuration between different architectures. This paper presents a dynamic hybrid control architecture that integrates a switching mechanism to control changes at both structural and behavioural level. The switching mechanism is based on a genetic algorithm and strives to find the most suitable operating mode of the architecture with regard to optimality and reactivity. The proposed approach was tested in a real flexible job shop to demonstrate the applicability and efficiency of including an optimisation algorithm in the switching process of a dynamic hybrid control architecture.	[Jimenez, Jose-Fernando; Bekrar, Abdelghani; Trentesaux, Damien] UVHC, LAMIH, UMR CNRS 8201, Valenciennes, France; [Jimenez, Jose-Fernando; Zambrano-Rey, Gabriel] Univ Javeriana, Ind Engn Dept Pontificia, Bogota, Colombia; [Leitao, Paulo] Polytech Inst Braganca, Dept Elect Engn, Campus Santa Apolonia, Braganca, Portugal; [Leitao, Paulo] LIACC Artificial Intelligence & Comp Sci Lab, Oporto, Portugal		Jimenez, JF (corresponding author), UVHC, LAMIH, UMR CNRS 8201, Valenciennes, France.; Jimenez, JF (corresponding author), Univ Javeriana, Ind Engn Dept Pontificia, Bogota, Colombia.	j-jimenez@javeriana.edu.co	trentesaux, damien/D-2791-2009; Jimenez, Jose Fernando/AAX-8877-2020; Leitao, Paulo/A-8390-2011	trentesaux, damien/0000-0003-2489-6203; Leitao, Paulo/0000-0002-2151-7944	Colombian scholarship programme of department of science - COLCIENCIAS [Convocatoria 568]; Pontificia Universidad Javeriana under grant 'Programa de Formacion de posgrados del Profesor Javeriano'	Colombian scholarship programme of department of science - COLCIENCIAS; Pontificia Universidad Javeriana under grant 'Programa de Formacion de posgrados del Profesor Javeriano'	This work was supported by the Colombian scholarship programme of department of science - COLCIENCIAS under grant 'Convocatoria 568 - Doctorados en el exterior' and the Pontificia Universidad Javeriana under grant 'Programa de Formacion de posgrados del Profesor Javeriano'.	[Anonymous], HIGH PERF MATH OPT E; Baker AD, 1998, J MANUF SYST, V17, P297, DOI 10.1016/S0278-6125(98)80077-0; Barbosa J, 2015, COMPUT IND, V66, P99, DOI 10.1016/j.compind.2014.10.011; Bohnlein D, 2011, INT J PROD ECON, V131, P146, DOI 10.1016/j.ijpe.2010.04.006; Bongaerts L, 2000, COMPUT IND, V43, P123, DOI 10.1016/S0166-3615(00)00062-2; Borangiu T, 2015, INT J PROD RES, V53, P1950, DOI 10.1080/00207543.2014.935825; Cardin O, 2017, J INTELL MANUF, V28, P1503, DOI 10.1007/s10845-015-1139-0; DILTS DM, 1991, J MANUF SYST, V10, P79, DOI 10.1016/0278-6125(91)90049-8; Gunasekaran A, 2012, INT J PROD ECON, V135, P687, DOI 10.1016/j.ijpe.2011.11.002; Herrera C, 2014, PROD MANUF RES, V2, P756, DOI 10.1080/21693277.2014.949895; Holland J. H., 1992, ADAPTATION NATURAL A; Holvoet T, 2009, INT CONF SELF SELF, P1, DOI 10.1109/SASO.2009.31; Jimenez JF, 2016, INT J PROD RES, V54, P7027, DOI 10.1080/00207543.2016.1177237; Jimenez JF, 2015, IFAC PAPERSONLINE, V48, P1093, DOI 10.1016/j.ifacol.2015.06.229; Lee CKM, 2013, INT J PROD RES, V51, P2652, DOI 10.1080/00207543.2012.738943; Leitao P, 2006, COMPUT IND, V57, P121, DOI 10.1016/j.compind.2005.05.005; Novas JM, 2013, SERVICE ORIENTATION, P3, DOI DOI 10.1007/978-3-642-35852-4_1; Pach C, 2012, CONTROL ENG PRACT, V20, P1293, DOI 10.1016/j.conengprac.2012.07.005; Pach C, 2014, COMPUT IND, V65, P706, DOI 10.1016/j.compind.2014.02.005; Pan Y., 2011, 2011 IEEE International Conference on Computer Science and Automation Engineering (CSAE), P405, DOI 10.1109/CSAE.2011.5952878; Raileanu S, 2012, STUD COMPUT INTELL, V402, P265; Rey GZ, 2014, INT J PROD RES, V52, P3688, DOI 10.1080/00207543.2014.881575; Saharidis GK, 2006, RAIRO-OPER RES, V40, P113, DOI 10.1051/ro:2006017; Trentesaux D, 2013, CONTROL ENG PRACT, V21, P1204, DOI 10.1016/j.conengprac.2013.05.004; Trentesaux D, 2009, ENG APPL ARTIF INTEL, V22, P971, DOI 10.1016/j.engappai.2009.05.001; Valckenaers P, 2007, J MANUF SYST, V26, P75, DOI 10.1016/j.jmsy.2007.12.003; Wilensky U., 1999, NETLOGO CTR CONNECTE; Zambrano Rey G., 2014, THESIS	28	23	24	0	43	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7543	1366-588X		INT J PROD RES	Int. J. Prod. Res.		2017	55	15					4229	4247		10.1080/00207543.2016.1218087	http://dx.doi.org/10.1080/00207543.2016.1218087			19	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Operations Research & Management Science	EV0WN		Green Published			2022-09-04	WOS:000401467300001
J	Perni, S; Calzuola, I; Gianfranceschi, GL; Giavarini, F; Lucci, P; Pacetti, D; Frega, NG; Marsili, V				Perni, Stefano; Calzuola, Isabella; Gianfranceschi, Gian Luigi; Giavarini, Flavio; Lucci, Paolo; Pacetti, Deborah; Frega, Natale Giuseppe; Marsili, Valeria			Biochemical and mass spectrometry recognition of phospholipid-peptide complexes in wheat sprouts extract	JOURNAL OF PEPTIDE SCIENCE			English	Article						bioactive peptides; peptide-phospholipid complex; phospholipids; wheat sprout	LIPID-BASED FORMULATIONS; APOLIPOPROTEIN-A-I; ACIDIC PEPTIDES; DELIVERY; PLASMA; ANTIOXIDANTS; CHROMATIN; PROTEIN; EFFLUX; CELLS	Total hydroalcoholic extract of wheat sprouts was treated with 90% cold acetone as a preliminary step directed to separate antioxidant peptides from antioxidant polyphenols. Surprisingly, the addition of acetone causes the formation of a yellow buoyant gelatinous drop that prevailingly contains peptides and phospholipids. In this context, evidences have been presented that support the hypothesis that peptides (and perhaps other active molecules) are complexed with phospholipids. In fact, the MS/MS analysis of some main ions, present in RPHPLC fractions of wheat sprout extract, generates several ions that correspond to molecular weight of phospholipids or phospholipid fragments. Moreover, several ions were detected that correspond to lysophosphatidylcholine or phosphatidylcholine-peptide complexes. The possibility that phospholipids can be complexed with peptides has been discussed in the light of potential involvement in the peptide bioavailability. Copyright (C) 2011 European Peptide Society and John Wiley & Sons, Ltd.	[Perni, Stefano; Marsili, Valeria] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06123 Perugia, Italy; [Calzuola, Isabella; Gianfranceschi, Gian Luigi] Ctr Eccellenza Mat Innovativi Strutturati CEMIN, I-06123 Perugia, Italy; [Giavarini, Flavio] Univ Milan, Dipartimento Sci Farmacol, Lab Spettrometria Massa, I-20133 Milan, Italy; [Lucci, Paolo] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Pacetti, Deborah; Frega, Natale Giuseppe] Univ Politecn Marche, Dipartimento SAIFET, Sez Sci & Tecnol Alimentari, I-60131 Ancona, Italy		Marsili, V (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, Via Pascoli, I-06123 Perugia, Italy.	vmarsili@unipg.it	Marsili, Valeria/F-9772-2014; Perni, Stefano/M-1925-2016	Perni, Stefano/0000-0002-0591-4376; Lucci, Paolo/0000-0002-3659-132X				Amici M, 2008, BIOCHIMIE, V90, P790, DOI 10.1016/j.biochi.2007.12.001; Bonfili L, 2009, BIOCHIMIE, V91, P1131, DOI 10.1016/j.biochi.2009.06.001; Bruni R, 2005, J PEPT SCI, V11, P225, DOI 10.1002/psc.595; Calzuola I, 2005, PEPTIDES, V26, P2074, DOI 10.1016/j.peptides.2005.04.008; Calzuola I, 2004, J AGR FOOD CHEM, V52, P5201, DOI 10.1021/jf0307752; Calzuola I, 2006, INT J FOOD SCI NUTR, V57, P168, DOI 10.1080/09637480600658328; Chen S, 2007, BBA-MOL CELL BIOL L, V1771, P1319, DOI 10.1016/j.bbalip.2007.08.001; Cui F, 2006, J CONTROL RELEASE, V114, P242, DOI 10.1016/j.jconrel.2006.05.013; de Brouwer APM, 2002, BIOCHEMISTRY-US, V41, P8013, DOI 10.1021/bi016055a; Fricker G, 2010, PHARM RES-DORDR, V27, P1469, DOI 10.1007/s11095-010-0130-x; Labeur C, 1997, ARTERIOSCL THROM VAS, V17, P580, DOI 10.1161/01.ATV.17.3.580; Li Y, 2004, RAPID COMMUN MASS SP, V18, P135, DOI 10.1002/rcm.1288; Li Y, 2005, ANAL CHEM, V77, P1556, DOI 10.1021/ac040084k; Liu AC, 2006, J PHARMACEUT BIOMED, V40, P720, DOI 10.1016/j.jpba.2005.09.032; Malavolta M, 2004, J CHROMATOGR B, V810, P173, DOI 10.1016/j.jchromb.2004.07.001; Mancinelli L, 1999, BIOL CHEM, V380, P31, DOI 10.1515/BC.1999.004; Mancinelli L, 2009, MOL CANCER, V55, P31; Marsili V, 2004, J CLIN GASTROENTEROL, V38, pS123, DOI 10.1097/01.mcg.0000128933.46296.0a; Mendez MA, 2008, ANAL CHEM, V80, P9499, DOI 10.1021/ac801651f; Pacetti D, 2007, J CHROMATOGR A, V1150, P241, DOI 10.1016/j.chroma.2006.10.022; Pan WH, 2010, CELL PHYSIOL BIOCHEM, V25, P623, DOI 10.1159/000315081; Provinciali M, 2007, CANCER RES, V67, P2022, DOI 10.1158/0008-5472.CAN-06-2601; Shaji J, 2008, INDIAN J PHARM SCI, V70, P269, DOI 10.4103/0250-474X.42967; Tabet F, 2010, ARTERIOSCL THROM VAS, V30, P246, DOI 10.1161/ATVBAHA.109.200196; Tu H, 2010, FASEB J, V24, P2281, DOI 10.1096/fj.09-143487; VANLOO B, 1995, J LIPID RES, V36, P1686; Wang T, 2010, EUR J PHARM SCI, V39, P373, DOI 10.1016/j.ejps.2010.01.006; Xiong J, 2008, DRUG DEV IND PHARM, V34, P65, DOI [10.1080/03639040701508292, 10.1080/03639040701508292 ]	28	5	5	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	NOV	2011	17	11					744	750		10.1002/psc.1397	http://dx.doi.org/10.1002/psc.1397			7	Biochemistry & Molecular Biology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	841DV	21919132				2022-09-04	WOS:000296493600005
J	Caicedo-Martinez, M; Fernandez-Deaza, G; Ordonez-Reyes, C; Olejua, P; Nuche-Berenguer, B; Mello, MB; Murillo, R				Caicedo-Martinez, Maria; Fernandez-Deaza, Ginna; Ordonez-Reyes, Camila; Olejua, Peter; Nuche-Berenguer, Bernardo; Mello, Maeve B.; Murillo, Raul			High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis	INTERNATIONAL JOURNAL OF STD & AIDS			English	Review						human papillomavirus; HIV; AIDS; uterine cervical neoplasms; Latin America	CERVICAL-CANCER; POSITIVE WOMEN; HPV INFECTION; HIGH PREVALENCE; LESIONS; COHORT; NEOPLASIA; GENOTYPES; HIV/AIDS	We carried out a systematic review to summarize available data regarding prevalence of high-risk human papillomavirus (HR-HPV) among women living with HIV (WLHIV) in Latin America and the Caribbean (LAC). A literature search in PubMed and LILACS was conducted and supplemented with cross-referencing and grey literature. The primary outcome was prevalence of HR-HPV by age as a major determinant of HPV infection. Pooled prevalence and weighted averages were obtained. A random effects meta-analysis conducted for HPV- and HIV-associated factors. In total, 6157 women from 19 cross-sectional studies were included. Weighted prevalence of HR-HPV in WLHIV was 51.0% (95% CI 42.8-59.1, I-2 = 97.4%) with a bimodal trend by age. No association between antiretroviral therapy and HR-HPV prevalence was observed, but low CD4 cell count was associated (PR 1.64, 95% CI 1.07-2.52). Although not significant, a higher HR-HPV prevalence was observed with Hybrid Capture 2 versus PCR. The high prevalence of HR-HPV among WLHIV in LAC underlines the need for improved cervical cancer prevention and early detection in this vulnerable population. Moreover, the high prevalence across age groups, and particularly in young women, deserves careful consideration for defining target populations of HPV-based screening and HPV immunization programs.	[Caicedo-Martinez, Maria; Fernandez-Deaza, Ginna; Ordonez-Reyes, Camila; Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Carrera 7 40-62, Bogota 110231, Colombia; [Olejua, Peter] Hosp Univ San Ignacio, Oficina Invest, Bogota, Colombia; [Nuche-Berenguer, Bernardo; Mello, Maeve B.] Pan Amer Hlth Org, Washington, DC USA; [Murillo, Raul] Pontif Univ Javeriana, Fac Med, Bogota, Colombia; [Murillo, Raul] Int Agcy Res Canc, Early Detect Prevent & Infect Branch, Lyon, France		Murillo, R (corresponding author), Hosp Univ San Ignacio, Ctr Javeriano Oncol, Carrera 7 40-62, Bogota 110231, Colombia.	rmurillo@husi.org.co			Pan American Health Organization	Pan American Health Organization	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was funded by the Pan American Health Organization.	Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; [Anonymous], 2018, CRIT APPR NOT CHECKL; Boos CJ, 2019, INT J VASC MED, V2019, DOI 10.1155/2019/9849465; Bruni L., 2019, SUMMARY REPORT; Martinez MC, 2020, UNIV MED, V61, DOI [10.11144/Javeriana.umed61-4.ccep, 10.11144/javeriana.umed61-4.ccep]; Camargo M, 2018, TROP MED INT HEALTH, V23, P1259, DOI 10.1111/tmi.13142; Carvalho AZ., 2016, ESTUDO SOCIOEPIDEMIO; Castilho JL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1486-4; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2017, CLIN INFECT DIS, V64, P1228, DOI 10.1093/cid/cix135; Correa CM, 2011, REV ASSOC MED BRAS, V57, P425, DOI 10.1590/S0104-42302011000400017; da Silva L, 2015, BRAZ J INFECT DIS, V19, P557, DOI 10.1016/j.bjid.2015.07.001; Dames DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085429; Dartell M, 2013, SEX TRANSM DIS, V40, P737, DOI 10.1097/OLQ.0000000000000005; de Salud Ministerio, 2013, GUIA CLIN AUGE SINDR; Denslow SA, 2014, INT J STD AIDS, V25, P163, DOI 10.1177/0956462413491735; Downes MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011458; Entiauspe LG, 2014, BRAZ J INFECT DIS, V18, P643, DOI 10.1016/j.bjid.2014.07.005; Fedrizzi, 2011, J BRAS DOENCAS SEXUA, V23, P205, DOI DOI 10.5533/2177-8264-201123410; Gobierno de la Repblica de Honduras SecretarYa de Salud, 2017, MAN AT INT AD AD CON; Goncalves MAG, 1999, INT J STD AIDS, V10, P803, DOI 10.1258/0956462991913583; Grinsztejn B, 2009, INT J INFECT DIS, V13, P72, DOI 10.1016/j.ijid.2008.03.031; Grinsztejn B, 2006, INT J STD AIDS, V17, P473, DOI 10.1258/095646206777689071; Instituto Nacional de COncer, 2016, DIR BRAS RASTR CANC, P118; International Agency for Research on Cancer, 2018, GLOBAL CANC OBSERVAT; Kelly H, 2018, LANCET HIV, V5, pE45, DOI 10.1016/S2352-3018(17)30149-2; Kelly HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174117; Koliopoulos G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008587.pub2; Levi JE, 2002, J CLIN MICROBIOL, V40, P3341, DOI 10.1128/JCM.40.9.3341-3345.2002; Levi José E., 2002, Braz J Infect Dis, V6, P129, DOI 10.1590/S1413-86702002000300005; Liu G, 2018, AIDS, V32, P795, DOI [10.1097/QAD.0000000000001765, 10.1097/qad.0000000000001765]; Maiman M, 1997, OBSTET GYNECOL, V89, P76, DOI 10.1016/S0029-7844(96)00378-X; Mandavilli A., 2020, FEDERAL OFFICIALS TU; Mbulawa ZZA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1181-8; Miles UNAIDS, 2018, GO RESP HIV LAT AM G; Miranda AE, 2017, J MED VIROL, V89, P2217, DOI 10.1002/jmv.24906; Mohammed DY, 2018, INT J WOMENS HEALTH, V10, P83, DOI 10.2147/IJWH.S153003; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Murillo R, 2019, INT J GYNECOL CANCER, V29, P1317, DOI 10.1136/ijgc-2019-000582; Murillo R, 2016, CANCER EPIDEMIOL, V44, pS121, DOI 10.1016/j.canep.2016.07.015; Ortiz AP, 2017, PAPILLOMAVIRUS RES, V4, P39, DOI 10.1016/j.pvr.2017.06.006; PAHO, 2016, PLAN ACT PREV CONTR; Pan American Health Organization, 2018, PLAN ACT CERV CANC P; Teixeira NCP, 2012, BRAZ J INFECT DIS, V16, P164, DOI [10.1590/S1413-86702012000200010, 10.1016/S1413-8670(12)70299-4]; Peyton CL, 1998, J CLIN MICROBIOL, V36, P3248, DOI 10.1128/JCM.36.11.3248-3254.1998; Rama CH, 2008, REV SAUDE PUBL, V42, P123, DOI 10.1590/S0034-89102008000100016; Rohner E, 2020, INT J CANCER, V146, P601, DOI 10.1002/ijc.32260; Martins AES, 2014, MEM I OSWALDO CRUZ, V109, P738, DOI 10.1590/0074-0276140070; Stelzle D, 2021, LANCET GLOB HEALTH, V9, pE161, DOI 10.1016/S2214-109X(20)30459-9; Taku O, 2020, INT J INFECT DIS, V95, P176, DOI 10.1016/j.ijid.2020.02.051; The R Foundation for Statistical Computing, 2020, PLATF X86 64 PC LIN; UNAIDS, 2019, HIV EST 1990 PRES; United Nations General Assembly, POL DECL HIV AIDS FA; de Andrade ACV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018297; Volkow P, 2001, GYNECOL ONCOL, V82, P27, DOI 10.1006/gyno.2001.6244; Weldegebreal F, 2019, CANCER CONTROL, V26, DOI 10.1177/1073274819845872; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	60	0	0	1	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	DEC	2021	32	14					1278	1289	09564624211037498	10.1177/09564624211037498	http://dx.doi.org/10.1177/09564624211037498		SEP 2021	12	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	XK6GA	34488503				2022-09-04	WOS:000693383000001
J	Stonis, JR; Remeikis, A; Diskus, A; Forero, D; Torres, NC				Stonis, Jonas R.; Remeikis, Andrius; Diskus, Arunas; Forero, Dimitri; Cumbicus Torres, Nixon			A report on Lamiaceae-feeding Nepticulidae (Lepidoptera) from South America	ZOOTAXA			English	Article						Andes; Lamiaceae; leaf mines; Nepticulidae; new species; Salvia; Scutellaria; South America; Stigmella	LEAF-MINING NEPTICULIDAE; PLANT GENUS; 1ST DESCRIPTION; HOST-PLANT; ASTERACEAE; QUERCUS; ACALYPTRIS; DISCOVERY; ARGENTINA; COMPLEX	We provide a report on Nepticulidae feeding on Lamiaceae plants in South America and describe two new species from the Andes: Stigmella lamiacifoliae Remeikis & Stonis, sp. nov., feeding on Salvia palifolia in Colombia, and S. scutellariae Remeikis & Stonis, sp. nov., feeding on Scutellaria volubilis in Ecuador. The leaf mines, adults, genitalia, and habitats of the new species are illustrated.	[Stonis, Jonas R.; Diskus, Arunas] Lithuanian Univ Educ Sci, Studentu St 39, LT-08106 Vilnius, Lithuania; [Stonis, Jonas R.; Diskus, Arunas] Balt Amer Biotaxon Inst, Studentu St 39, LT-08106 Vilnius, Lithuania; [Remeikis, Andrius] Nat Res Ctr, Akad St 2, LT-08412 Vilnius, Lithuania; [Forero, Dimitri] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, UNESIS, Carrera 7,43-82, Bogota, Colombia; [Forero, Dimitri] Balt Amer Biotaxon Inst, Carrera 7,43-82, Bogota, Colombia; [Cumbicus Torres, Nixon] Univ Tecn Particular Loja, San Cayetano Alto S-N, Loja, Ecuador; [Cumbicus Torres, Nixon] Balt Amer Biotaxon Inst, San Cayetano Alto S-N, Loja, Ecuador		Stonis, JR (corresponding author), Lithuanian Univ Educ Sci, Studentu St 39, LT-08106 Vilnius, Lithuania.	stonis@leu.lt	Forero, Dimitri/P-4860-2016	Forero, Dimitri/0000-0002-6358-757X	Research Foundation of the Lithuanian University of Educational Sciences	Research Foundation of the Lithuanian University of Educational Sciences(Research Council of Lithuania (LMTLT))	This study was supported in part by the Research Foundation of the Lithuanian University of Educational Sciences (2017). Andrius Remeikis is grateful for the research stipend received from the Research Foundation of the Research Council of Lithuania	Diskus A., 2012, LEAF MINING INSECTS; Johansson R., 1990, Fauna Entomologica Scandinavica, V23, P1; NEWTON PJ, 1982, SYST ENTOMOL, V7, P367, DOI 10.1111/j.1365-3113.1982.tb00455.x; Nieukerken EJ, 1986, ZOOLOGISCHE VERHANDE, V236, P1; Puplesis R., 1994, NEPTICULIDAE E EUROP; Puplesis R., 2003, NEPTICULOIDEA TISCHE; Puplesis Rimantas, 2000, Bulletin of the Natural History Museum Entomology Series, V69, P3; Remeikis A., 2016, BIOLOGIJA, V62, P207, DOI [10.6001/biologija.v62i4.3411, DOI 10.6001/BIOLOGIJA.V62I4.3411]; Remeikis A., 2017, INT C SMART BIO 18 2, P22; Remeikis A, 2015, ZOOTAXA, V4057, P409, DOI 10.11646/zootaxa.4057.3.7; Scoble M.J., 1983, Transvaal Museum Monograph, P1; Stonis J. R., 2014, 1 INT THEOR PRACT C, P114; Stonis J.R., 2014, 1 BALT INT C FIELD E; Stonis J. R., 2016, BIOLOGIJA, V62, P215, DOI DOI 10.6001/BIOLOGIJA.V62I4.3412; Stonis JR, 2017, ZOOTAXA, V4272, P1, DOI 10.11646/zootaxa.4272.1.1; Stonis JR, 2017, ZOOTAXA, V4257, P1, DOI [10.11646/zootaxa.4257.1, 10.11646/zootaxa.4257.1.1]; Stonis JR, 2016, ZOOTAXA, V4200, P561, DOI 10.11646/zootaxa.4200.4.7; Stonis JR, 2016, ZOOTAXA, V4181, P2, DOI 10.11646/zootaxa.4181.1.1; Stonis Jonas R., 2016, Biologija, V62, P83; Stonis Jonas R., 2015, Biologija, V61, P123; Stonis JR, 2016, ZOOTAXA, V4136, P309, DOI 10.11646/zootaxa.4136.2.3; Stonis JR, 2016, ZOOTAXA, V4136, P101, DOI 10.11646/zootaxa.4136.1.4; Stonis JR, 2016, ZOOTAXA, V4061, P119, DOI 10.11646/zootaxa.4061.2.2; Stonis JR, 2015, ZOOTAXA, V4057, P79, DOI 10.11646/zootaxa.4057.1.4; Stonis JR, 2015, ZOOTAXA, V4040, P576, DOI 10.11646/zootaxa.4040.5.6; Stonis JR, 2014, ZOOTAXA, V3887, P321, DOI 10.11646/zootaxa.3887.3.3; Stonis JR, 2013, ZOOTAXA, V 3737, P201, DOI 10.11646/zootaxa.3737.3.1; Stonis JR, 2013, ZOOTAXA, V 3737, P101, DOI 10.11646/zootaxa.3737.2.1; Stonis JR, 2013, ZOOTAXA, V 3737, P1, DOI 10.11646/zootaxa.3737.1.1; Stonis JR, 2013, ZOOTAXA, V3609, P223, DOI 10.11646/zootaxa.3609.2.8; van Nieukerken EJ, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.628.9805; Wilkinson C., 1985, INSECTA MANSUMURANA, V32, P1	32	3	3	0	6	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	OCT 24	2017	4338	1					128	140		10.11646/zootaxa.4338.1.6	http://dx.doi.org/10.11646/zootaxa.4338.1.6			13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	FK4ZN	29245730				2022-09-04	WOS:000413506800006
J	Jaramillo, A; Contreras, A; Lafaurie, GI; Duque, A; Ardila, CM; Duarte, S; Osorio, L				Jaramillo, Adriana; Contreras, Adolfo; Ines Lafaurie, Gloria; Duque, Andres; Martin Ardila, Carlos; Duarte, Silvia; Osorio, Lyda			Association of metabolic syndrome and chronic periodontitis in Colombians	CLINICAL ORAL INVESTIGATIONS			English	Article						Chronic periodontitis; Metabolic syndrome; Insulin resistance; Subgingival microbiota	DISEASE; PREVALENCE; POPULATION; OBESITY; CARMELA; RISK	Metabolic syndrome (MetS) is a common chronic condition that increases the cardiovascular disease risk and is also linked to periodontitis. The study aim was to determine if a relationship exists between MetS and chronic periodontitis in adult Colombians. Participants were 220 healthy-gingivitis subjects and 431 periodontitis patients coming from the three largest Colombian cities. Periodontal status and MetS were determined in subjects. Univariate analysis and odds ratio were calculated within the 95 % confidence intervals and chi(2) test compared the groups. Variables were compared among the clinical periodontal groups and MetS by Wilcoxon and multivariate analysis, and logistic regression was performed for MetS and periodontitis. MetS had higher prevalence in periodontitis group (6.3 %) versus controls (3.2 %). In multivariate analysis, periodontitis was associated with MetS (adjusted OR = 2.72, 95 % CI 1.09-6.79), glucose intolerance with another component of MetS (adjusted OR = 1.78, 1.16 to 2.72), glucose resistance (adjusted OR = 11.46, 95 % CI 1.41-92.88), smoking (OR = 1.72, 95 % CI 1.09-2.71), and city of origin (2.69, 95 % CI 1.79-4.04). The study confirmed the positive association between MetS and periodontitis, being glucose sensitivity the strongly associated component. MetS must be taken into account by the dentist when evaluating risk factors for periodontitis, being useful for dentists to evaluate glycemia, lipidic profile, central obesity, and high blood pressure in patients. Interdisciplinary treatment must be recommended when a patient with MetS and periodontitis is being treated.	[Jaramillo, Adriana; Contreras, Adolfo] Univ Valle, Sch Dent, Periodontal Med Grp, Cali, Colombia; [Ines Lafaurie, Gloria] Univ El Bosque, Sch Dent, Unit Oral Basic Invest UIBO, Bogota, Colombia; [Duque, Andres] Univ CES, Medellin, Colombia; [Martin Ardila, Carlos] Univ Antioquia, Dept Periodontol, Medellin, Colombia; [Duarte, Silvia] Pontificia Univ Javeriana, Dent Res Ctr CIO, Bogota, Colombia; [Osorio, Lyda] Univ Valle, Sch Publ Hlth, Cali, Colombia		Jaramillo, A (corresponding author), Univ Valle, Sch Dent, Periodontal Med Grp, Cali, Colombia.	adriana_jaramillo_echeverri@hotmail.com	Jaramillo, Adriana/R-5672-2019; Ardila, Carlos M./AAG-4846-2019; Ardila, Carlos/AAH-2083-2019	Jaramillo, Adriana/0000-0002-1917-468X; Ardila, Carlos M./0000-0002-3663-1416; Osorio, Lyda/0000-0002-5121-4741	Colciencias [1308-459-21661]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was funded by Colciencias (grant number 1308-459-21661).	Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Bascones-Martinez A, 2011, MED ORAL PATOL ORAL, V16, pE722, DOI 10.4317/medoral.17032; Benguigui C, 2010, J CLIN PERIODONTOL, V37, P601, DOI 10.1111/j.1600-051X.2010.01571.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; D'Aiuto F, 2008, J CLIN ENDOCR METAB, V93, P3989, DOI 10.1210/jc.2007-2522; Borges PKO, 2007, CAD SAUDE PUBLICA, V23, P657, DOI 10.1590/S0102-311X2007000300024; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Han DH, 2010, J CLIN PERIODONTOL, V37, P609, DOI 10.1111/j.1600-051X.2010.01580.x; Kushiyama M, 2009, J PERIODONTOL, V80, P1610, DOI 10.1902/jop.2009.090218; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Lafaurie GI, 2007, J PERIODONTOL, V78, P629, DOI 10.1902/jop.2007.060187; Li P, 2009, J PERIODONTOL, V80, P541, DOI 10.1902/jop.2009.080387; Lopez NJ, 2012, J PERIODONTOL, V83, P267, DOI 10.1902/jop.2011.110227; Morita T, 2009, J PUBLIC HEALTH DENT, V69, P248, DOI 10.1111/j.1752-7325.2009.00130.x; OLIVER RC, 1994, J PERIODONTOL, V65, P530, DOI 10.1902/jop.1994.65.5s.530; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Ramirez JH, 2014, AUST DENT J, V59, P29, DOI 10.1111/adj.12139; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089	24	14	17	1	15	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JUN	2017	21	5					1537	1544		10.1007/s00784-016-1942-9	http://dx.doi.org/10.1007/s00784-016-1942-9			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	EV8DU	27535794				2022-09-04	WOS:000402011500013
J	Puentes-Cardenas, IJ; Chavez-Camarillo, GM; Flores-Ortiz, CM; Cristiani-Urbina, MD; Netzahuatl-Munoz, AR; Salcedo-Reyes, JC; Pedroza-Rodriguez, AM; Cristiani-Urbina, E				Johanna Puentes-Cardenas, Ingrid; Ma. Chavez-Camarillo, Griselda; Mateo Flores-Ortiz, Cesar; del Carmen Cristiani-Urbina, Maria; Rosa Netzahuatl-Munoz, Alma; Carlos Salcedo-Reyes, Juan; Marina Pedroza-Rodriguez, Aura; Cristiani-Urbina, Eliseo			Adsorptive Removal of Acid Blue 80 Dye from Aqueous Solutions by Cu-TiO2	JOURNAL OF NANOMATERIALS			English	Article							PHOTOCATALYTIC DEGRADATION; THIN-FILMS; DOPED TIO2; METHYLENE-BLUE; AMARANTH DYE; RHODAMINE-B; BIOSORPTION; EQUILIBRIUM; SURFACE; COMPOSITE	The adsorption performance of a Cu-TiO2 composite for removing acid blue 80 (AB80) dye from aqueous solutions was investigated in terms of kinetics, equilibrium, and thermodynamics. The effect of operating variables, such as solution pH, initial dye concentration, contact time, and temperature, on AB80 adsorption was studied in batch experiments. AB80 adsorption increased with increasing contact time, initial dye concentration, and temperature and with decreasing solution pH. Modeling of adsorption kinetics showed good agreement of experimental data with the pseudo-second-order kinetics model. The experimental equilibrium data for AB80 adsorption were evaluated for compliance with different two-parameter, three-parameter, and four-parameter isotherm models. The Langmuir isotherm model best described the AB80 adsorption equilibrium data. The thermodynamic data revealed that the AB80 adsorption process was endothermic and nonspontaneous. Kinetics, equilibrium, and thermodynamic results indicate that Cu-TiO2 adsorbs AB80 by a chemical sorption reaction.	[Johanna Puentes-Cardenas, Ingrid; Ma. Chavez-Camarillo, Griselda; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Prolongac Carpio & Plan Ayala S-N, Mexico City 11340, DF, Mexico; [Mateo Flores-Ortiz, Cesar] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Ave Barrios 1, Tlalnepantla 54090, Mex, Mexico; [del Carmen Cristiani-Urbina, Maria] Univ Autonoma Chiapas, Blvd Belisario Dominguez,Kilometro 1081,S-N, Tuxtla Gutierrez 29000, Chis, Mexico; [Rosa Netzahuatl-Munoz, Alma] Univ Politecn Tlaxcala, Ave Univ Politecn 1, Tepeyanco 90180, Tlax, Mexico; [Carlos Salcedo-Reyes, Juan; Marina Pedroza-Rodriguez, Aura] Pontificia Univ Javeriana, Fac Ciencias, Carrera 7 40-62, Bogota 11001000, Colombia		Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Prolongac Carpio & Plan Ayala S-N, Mexico City 11340, DF, Mexico.	ecristianiu@yahoo.com.mx	Muñoz, Alma Rosa Netzahuatl/ABC-9252-2020; Salcedo-Reyes, Juan Carlos/AAC-3347-2020; Marina, Aura/AAF-7657-2019	Muñoz, Alma Rosa Netzahuatl/0000-0003-1963-8357; Salcedo-Reyes, Juan Carlos/0000-0002-6209-0502; Cristiani-Urbina, Eliseo/0000-0002-8470-0711; Flores, Cesar M./0000-0002-5837-799X	scientific staff of the Central Laboratories of Spectroscopy; Biotechnology and Molecular Biology at ENCB-IPN; Secretaria de Investigacion y Posgrado, IPN, Mexico; Pontificia Universidad Javeriana, Bogota, Colombia [6272]; CONACyT	scientific staff of the Central Laboratories of Spectroscopy; Biotechnology and Molecular Biology at ENCB-IPN; Secretaria de Investigacion y Posgrado, IPN, Mexico; Pontificia Universidad Javeriana, Bogota, Colombia; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge the support provided by the scientific staff of the Central Laboratories of Spectroscopy, and Biotechnology and Molecular Biology at ENCB-IPN, as well as the financial support provided by the Secretaria de Investigacion y Posgrado, IPN, Mexico, and the Pontificia Universidad Javeriana (Research Project 6272), Bogota, Colombia. The CONACyT awarded a graduate scholarship to one of the coauthors (Ingrid Johanna Puentes-Cardenas). Eliseo Cristiani-Urbina is a holder of grants from COFAA-IPN, EDI-IPN, and SNI-CONACyT.	Arana J, 2005, CATAL TODAY, V101, P261, DOI 10.1016/j.cattod.2005.03.006; Basha S, 2008, IND ENG CHEM RES, V47, P980, DOI 10.1021/ie071210o; Basha S, 2007, PROCESS BIOCHEM, V42, P1521, DOI 10.1016/j.procbio.2007.08.004; Belessi V, 2009, J HAZARD MATER, V170, P836, DOI 10.1016/j.jhazmat.2009.05.045; Ben-Tal N, 2000, BIOPHYS J, V79, P1180, DOI 10.1016/S0006-3495(00)76372-7; Bhatnagar A, 2010, ENVIRON TECHNOL, V31, P97, DOI 10.1080/09593330903370000; Bourikas K, 2005, LANGMUIR, V21, P9222, DOI 10.1021/la051434g; Carvalho HWP, 2010, J HAZARD MATER, V184, P273, DOI 10.1016/j.jhazmat.2010.08.033; Celekli A, 2012, CHEM ENG J, V191, P228, DOI 10.1016/j.cej.2012.03.007; Chen G., 2007, ENV SCI, V2, P56; Condon J. B., 2006, MEASUREMENTS THEORY; Devi LG, 2012, APPL SURF SCI, V261, P137, DOI 10.1016/j.apsusc.2012.07.121; Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155; Du YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108647; Dutta S, 2009, CHEM ENG J, V155, P674, DOI 10.1016/j.cej.2009.08.026; El-Mekkawi D, 2013, J HYDRO-ENVIRON RES, V7, P219, DOI 10.1016/j.jher.2013.02.003; Environment Canada and Health Canada, 2008, SCREEN ASS CHALL BEN; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Franca AS, 2014, ENVIRON ENG MANAG J, V13, P3025, DOI 10.30638/eemj.2014.341; Gautam RK, 2013, J ENVIRON CHEM ENG, V1, P1283, DOI 10.1016/j.jece.2013.09.021; GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5; Flores-Garnica JG, 2013, BIORESOURCE TECHNOL, V136, P635, DOI 10.1016/j.biortech.2013.02.059; Grover IS, 2013, APPL SURF SCI, V280, P366, DOI 10.1016/j.apsusc.2013.04.163; Guerrero-Coronilla I, 2015, J ENVIRON MANAGE, V152, P99, DOI 10.1016/j.jenvman.2015.01.026; Guerrero-Coronilla I, 2014, ENVIRON ENG MANAG J, V13, P1917; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; Hasan SH, 2010, BIORESOURCES, V5, P563; Hernandez A., 2012, P 19 INT C PHOT CONV; Hernandez-Estevez A, 2014, ENVIRON MONIT ASSESS, V186, P7987, DOI 10.1007/s10661-014-3981-5; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Hwang KJ, 2010, CURR APPL PHYS, V10, pS184, DOI 10.1016/j.cap.2009.11.068; Jain R, 2007, J ENVIRON MANAGE, V85, P956, DOI 10.1016/j.jenvman.2006.11.002; Jiang YH, 2013, APPL SURF SCI, V273, P448, DOI 10.1016/j.apsusc.2013.02.061; Puentes-Cardenas IJ, 2012, ENVIRON ENG MANAG J, V11, P1741; Karunakaran C, 2010, J COLLOID INTERF SCI, V352, P68, DOI 10.1016/j.jcis.2010.08.012; Kim TY, 2013, MEASUREMENT, V46, P1692, DOI 10.1016/j.measurement.2013.01.008; Kordouli E, 2015, CATAL TODAY, V252, P128, DOI 10.1016/j.cattod.2014.09.010; Li JJ, 2013, APPL SURF SCI, V279, P400, DOI 10.1016/j.apsusc.2013.04.127; Li WJ, 2008, J PHYS CHEM C, V112, P14943, DOI 10.1021/jp8049075; Li WJ, 2014, RSC ADV, V4, P36959, DOI 10.1039/C4RA04768K; Liang CH, 2008, DYES PIGMENTS, V76, P477, DOI 10.1016/j.dyepig.2006.10.006; Liao DL, 2009, COLLOID SURFACE A, V348, P270, DOI 10.1016/j.colsurfa.2009.07.036; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Mahmoodi NM, 2011, DESALINATION, V275, P93, DOI 10.1016/j.desal.2011.02.034; Marugan J, 2007, IND ENG CHEM RES, V46, P7605, DOI 10.1021/ie070093u; Mathews NR, 2009, SOL ENERGY, V83, P1499, DOI 10.1016/j.solener.2009.04.008; Muthirulan P., 2013, ARABIAN J CHEM; Pauporte T, 2007, J PHYS CHEM C, V111, P7639, DOI 10.1021/jp071465f; Pihosh Y, 2009, APPL SURF SCI, V256, P937, DOI 10.1016/j.apsusc.2009.05.155; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Sharma P, 2011, ENVIRON MONIT ASSESS, V183, P151, DOI 10.1007/s10661-011-1914-0; Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003; Su YY, 2009, REACT KINET CATAL L, V98, P227, DOI 10.1007/s11144-009-0059-4; Villamieva-Jaramillo C., 2012, P 19 INT C PHOT CONV; Yan H, 2013, CHEM ENG J, V223, P402, DOI 10.1016/j.cej.2013.02.113; Yang XJ, 2015, T NONFERR METAL SOC, V25, P504, DOI 10.1016/S1003-6326(15)63631-7; Yola ML, 2014, CHEM ENG J, V242, P333, DOI 10.1016/j.cej.2013.12.086; Zhao JC, 1998, ENVIRON SCI TECHNOL, V32, P2394, DOI 10.1021/es9707926	58	12	12	1	20	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-4110	1687-4129		J NANOMATER	J. Nanomater.		2016	2016								3542359	10.1155/2016/3542359	http://dx.doi.org/10.1155/2016/3542359			15	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	DD1SA		gold, Green Submitted			2022-09-04	WOS:000369700800001
J	Vanegas, JC; Afeiche, MC; Gaskins, AJ; Minguez-Alarcon, L; Williams, PL; Wright, DL; Toth, TL; Hauser, R; Chavarro, JE				Vanegas, Jose C.; Afeiche, Myriam C.; Gaskins, Audrey J.; Minguez-Alarcon, Lidia; Williams, Paige L.; Wright, Diane L.; Toth, Thomas L.; Hauser, Russ; Chavarro, Jorge E.			Soy food intake and treatment outcomes of women undergoing assisted reproductive technology	FERTILITY AND STERILITY			English	Article						Cohort studies; isoflavones; phytoestrogens; soy foods; assisted reproductive techniques	ESTROGEN-RECEPTOR-ALPHA; DIETARY PATTERNS; RANDOMIZED-TRIAL; SEMEN QUALITY; MEN; PHYTOESTROGEN; INFERTILITY; CELLS; PREGNANCY; AGONIST	Objective: To study the relation of dietary phytoestrogens intake and clinical outcomes of women undergoing infertility treatment with the use of assisted reproductive technology (ART). Design: Prospective cohort study. Setting: Fertility center. Patient(s): A total of 315 women who collectively underwent 520 ART cycles from 2007 to 2013. Intervention(s): None. Main Outcome Measure(s): Implantation, clinical pregnancy, and live birth rates per initiated cycle. Result(s): Soy isoflavones intake was positively related to live birth rates in ART. Compared with women who did not consume soy isoflavones, the multivariable-adjusted odds ratios of live birth (95% confidence interval) for women in increasing categories of soy isoflavones intake were 1.32 (0.76-2.27) for women consuming 0.54-2.63 mg/d, 1.87 (1.12-3.14) for women consuming 2.64-7.55 mg/d, and 1.77 (1.03-3.03) for women consuming 7.56-27.89 mg/d. Conclusion(s): Dietary soy intake was positively related to the probability of having a live birth during infertility treatment with ART. ((c) 2015 by American Society for Reproductive Medicine.)	[Vanegas, Jose C.] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Afeiche, Myriam C.; Minguez-Alarcon, Lidia; Hauser, Russ] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Gaskins, Audrey J.; Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Gaskins, Audrey J.; Hauser, Russ; Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Williams, Paige L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wright, Diane L.; Toth, Thomas L.; Hauser, Russ] Massachusetts Gen Hosp, Vincent Obstet & Gynecol, Boston, MA 02114 USA; [Wright, Diane L.; Toth, Thomas L.; Hauser, Russ; Chavarro, Jorge E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chavarro, Jorge E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA		Chavarro, JE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	jchavarr@hsph.harvard.edu	Chavarro, Jorge E/AAE-5665-2021; Gaskins, Audrey/K-6246-2019	Chavarro, Jorge E/0000-0002-4436-9630; 	National Institutes of Health [ES022955, R01ES009718, R01ES000002, P30DK46200, T32DK007703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022955, P30ES000002, R01ES009718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants ES022955, R01ES009718, R01ES000002, P30DK46200, and T32DK007703.	Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P70, DOI 10.1111/j.1751-0813.1946.tb06451.x; Bennetts HW, 1947, AUST VET J, V23, P10; Chavarro JE, 2008, HUM REPROD, V23, P2584, DOI 10.1093/humrep/den243; Chun OK, 2009, J AM DIET ASSOC, V109, P245, DOI 10.1016/j.jada.2008.10.055; Gaskins AJ, 2014, OBSTET GYNECOL, V124, P801, DOI 10.1097/AOG.0000000000000477; Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298; Habito RC, 2000, BRIT J NUTR, V84, P557, DOI 10.1017/S0007114500001872; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Kyselova Vendula, 2003, Reprod Biol Endocrinol, V1, P30, DOI 10.1186/1477-7827-1-30; Lee Y, 2003, J STEROID BIOCHEM, V84, P463, DOI 10.1016/S0960-0760(03)00067-0; Mei H, 2011, REPRODUCTION, V141, P357, DOI 10.1530/REP-10-0432; Messina M, 2006, NUTR CANCER, V55, P1, DOI 10.1207/s15327914nc5501_1; MEYER EP, 1970, AUST VET J, V46, P305, DOI 10.1111/j.1751-0813.1970.tb07904.x; Mitchell JH, 2001, CLIN SCI, V100, P613, DOI 10.1042/CS20000212; Mok-Lin E, 2010, INT J ANDROL, V33, P385, DOI 10.1111/j.1365-2605.2009.01014.x; Mueller SO, 2003, TOXICOL LETT, V142, P89, DOI 10.1016/S0378-4274(03)00016-X; Mumford SL, 2014, J NUTR, V144, P352, DOI 10.3945/jn.113.184820; Nagata C, 2001, CANCER EPIDEM BIOMAR, V10, P179; Oliva LL, 2014, HORM METAB RES, V46, P120, DOI 10.1055/s-0033-1361165; Pearce V, 2003, J STEROID BIOCHEM, V84, P431, DOI 10.1016/S0960-0760(03)00064-5; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Seppen J, 2012, TOXICOL APPL PHARM, V264, P335, DOI 10.1016/j.taap.2012.09.013; Shahin AY, 2008, REPROD BIOMED ONLINE, V16, P580, DOI 10.1016/S1472-6483(10)60465-8; Unfer V, 2004, FERTIL STERIL, V82, P1509, DOI 10.1016/j.fertnstert.2004.07.934; USDA, 2007, USDA IOW STAT U DAT; Xia YK, 2013, ENVIRON INT, V59, P161, DOI 10.1016/j.envint.2013.06.009; Xu X, 2000, J NUTR, V130, P798, DOI 10.1093/jn/130.4.798	28	26	27	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	MAR	2015	103	3					749	U467		10.1016/j.fertnstert.2014.12.104	http://dx.doi.org/10.1016/j.fertnstert.2014.12.104			9	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	CE8QN	25577465	Green Accepted			2022-09-04	WOS:000352109000029
J	Vannucchi, H; Berezovsky, MW; Masson, L; Cortes, Y; Sifontes, Y; Bourges, H				Vannucchi, Hello; Weingarten Berezovsky, Mariela; Masson, Lilian; Cortes, Yadira; Sifontes, Yaritza; Bourges, Hector			Proposal for the harmonization of the values of reference for nutritional labeling in Latin America (NVR - LA).	ARCHIVOS LATINOAMERICANOS DE NUTRICION			Spanish	Article						Nutritional labeling; nutritional reference values; recommended daily intake; Latin-America		Proposal for the harmonization of the values of reference for nutritional labeling in Latin America (NVR-LA). The values of recommendation of intake of nutrients, important for nutritional labeling, present variations among the countries of Latin America. The aim of the NVR project is to establish consensually harmonized nutritional labeling values to be adopted among the Latin American countries. From the search and analysis of the different values of recommendations used in the countries of Latin America, was defined by consensus a proposal to a total of 36 nutrient values. The expectation of everyone involved with the project is to take its accessible results and encourage the countries of the region to adopt the proposal, with the support of scientific organizations, Governments and Academia. Thus labeling will be simpler, easy understanding and help the consumer a better selection of products.	[Vannucchi, Hello] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil; Univ Chile, Santiago, Chile; Pontificia Univ Javeriana, Bogota, Colombia; Cent Univ Venezuela, Fdn Bengoa, Caracas, Venezuela; Minist Salud Mexico, Mexico City, DF, Mexico		Vannucchi, H (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.		Vannucchi, Helio/B-8060-2013	Vannucchi, Helio/0000-0003-4161-3228; Cortes, Lilia Yadira/0000-0003-2789-3219; Sifontes, Yaritza/0000-0002-9291-2933				[Anonymous], 1963, FAO WHO FOOD STAND; Ashwell M, 2008, EUROPEAN J NUTR S1, V47; Camara MCC, 2008, REV PANAM SALUD PUBL, V23; Celeste RK, 2001, REV SAUDE PUBL, V35, P217, DOI 10.1590/S0034-89102001000300001; Cozzolino, 2001, USOS APLICACOES DIET; Cozzolino SMF, 2009, SERIE PUBLICACOES IL; Ferraz RG, 2001, THESIS U FEDERAL VIC; Ferreira AB, 2007, REV NUTR, V20, P83, DOI 10.1590/S1415-52732007000100009; Institute of Medicine, 1999, DIET REF INT; Kimbrell E., 2000, AgBioForum, V3, P197; Marins BR, 2008, CIENCIA TECNOL ALIME, V28, P579, DOI 10.1590/S0101-20612008000300012; Tee E, 2005, MONOGRAPH SERIES; Yoshizawa N., 2003, Boletim do Centro de Pesquisa e Processamento de Alimentos, V21, P169; [No title captured]; [No title captured]	15	4	4	0	2	ARCHIVOS LATINOAMERICANOS NUTRICION	CARACAS	APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA	0004-0622	2309-5806		ARCH LATINOAM NUTR	Arch. Latinoam. Nutr.	DEC	2011	61	4					347	352						6	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	021PD	23094516				2022-09-04	WOS:000309896900002
J	Bahamon, AMZ; Rivera, JCP; Rojas, J; Lopez, VG; Vargas, V; Arevalo, MR				Zarante Bahamon, Ana Maria; Prieto Rivera, Juan Carlos; Rojas, Jorge; Gonzalez Lopez, Vladimir; Vargas, Victor; Rosero Arevalo, Melissa			Clinical Variability of Hypophosphatasia in Colombian Patients: Case Reports	JOURNAL OF ENDOCRINOLOGY AND METABOLISM			English	Article						Short stature; Skeletal deformities; Alkaline phosphatase; Mutation; Hypomineralization		Hypophosphatasia (HPP) is a rare inherited disorder characterized by low serum alkaline phosphatase. It affects bone and tooth mineralization, although extra-skeletal manifestations are frequent. HPP is caused by loss-of-function mutations in the ALPL gene, encoding the protein tissue-nonspecific alkaline phosphatase. The phenotype is broadly variable, from a subtype with exclusive odontological compromise (odontohypophosphatasia) to five subtypes with systemic involvement, classified according to the age of onset at fast symptoms. We present seven cases of HPP, in order to perform the clinical, biochemistry and radiological description of these Colombian patients, as well as to show the clinical variability of the disease in patients who present the same mutation or genetic defect.	[Zarante Bahamon, Ana Maria; Vargas, Victor] Inst Roosevelt, Bogota, Colombia; [Zarante Bahamon, Ana Maria] Lab Biotecnol & Genet, Bogota, Colombia; [Prieto Rivera, Juan Carlos; Rojas, Jorge] Pontificia Univ Javeriana, Bogota, Colombia; [Gonzalez Lopez, Vladimir] Secretaria Dist Salud Bogota, Subred Integrada Serv Salud Suroccidente, Bogota, Colombia; [Vargas, Victor] Hosp Infantil Univ San Jose, Bogota, Colombia; [Rosero Arevalo, Melissa] Fdn Clin Infantil Club Noel, Cali, Colombia; [Rosero Arevalo, Melissa] Clin Imbanaco, Cali, Colombia		Bahamon, AMZ (corresponding author), Inst Roosevelt, Bogota, Colombia.; Rivera, JCP (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	anazarante@gmail.com; jcprieto@javeriana.edu.co		Vargas Martinez, Victor Alejandro/0000-0002-1313-8848	Alexion	Alexion	We are requesting a sponsorship of Alexion.	Choida V, 2019, THER ADV MUSCULOSKEL, V11, DOI 10.1177/1759720X19863997; Chou Yen-Yin, 2005, Kaohsiung Journal of Medical Sciences, V21, P134; del Angel G, 2020, HUM MUTAT, V41, P1250, DOI 10.1002/humu.24010; GORODISCHER R, 1976, PEDIATR RES, V10, P650, DOI 10.1203/00006450-197610070-00004; Kishnani PS, 2017, MOL GENET METAB, V122, P4, DOI 10.1016/j.ymgme.2017.07.010; Lefever E, 2020, J CLIN DENSITOM, V23, P340, DOI 10.1016/j.jocd.2018.12.006; Mao XJ, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1800-4; Matsushita M, 2014, PEDIATR RADIOL, V44, P340, DOI 10.1007/s00247-013-2805-z; Mori Mari, 2016, Bone Rep, V5, P228, DOI 10.1016/j.bonr.2016.08.004; Mornet E, 2007, GENE REV; Mornet E, 2011, ANN HUM GENET, V75, P439, DOI 10.1111/j.1469-1809.2011.00642.x; Mumm S, 2001, J BONE MINER RES, V16, P1724, DOI 10.1359/jbmr.2001.16.9.1724; ORIMO H, 1994, HUM MOL GENET, V3, P1683, DOI 10.1093/hmg/3.9.1683; RATHBUN JC, 1948, AM J DIS CHILD, V75, P822, DOI 10.1001/archpedi.1948.02030020840003; Szabo SM, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1062-0; Taketani T, 2014, ARCH DIS CHILD, V99, P211, DOI 10.1136/archdischild-2013-305037; Tenorio J, 2017, AM J MED GENET A, V173, P601, DOI 10.1002/ajmg.a.37991; Whyte MP, 2015, BONE, V75, P229, DOI 10.1016/j.bone.2015.02.022; Bahamon AMZ, 2018, CLIN CASES MINER BON, V15, P364	19	0	0	0	0	ELMER PRESS INC	Ontario	9225 LESLIE ST, STE 201, Ontario, RICHMOND HILL, CANADA	1923-2861	1923-287X		J ENDOCRINOL METAB	J. Endocrinol. Metab.	APR	2021	11	2					56	64		10.14740/jem711	http://dx.doi.org/10.14740/jem711			9	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	RT7UE		gold			2022-09-04	WOS:000644662100006
J	Esteban, TM; Prado, CC; Jimenez, SG; Chagas, A				Esteban, Tulande-M; Camilo Prado, Cesar; Galvis Jimenez, Sebastian; Chagas, Amazonas, Jr.			A remarkable Newportia from the Colombian Andes, with the proposition of a new subgenus (Scolopendromorpha, Scolopocryptopidae, Newportiinae)	ZOOTAXA			English	Article						Andes; Andeocryptops; new species; Newportiinae; soil fauna	CENTIPEDE; CHAMBERLIN; CHILOPODA; GENUS	A new monotypic subgenus New portia (Andeocryptops) subgen. n is described based on 18 specimens of N. (A.) shelleyi sp. n. This form is endemic to the Colombian Andes showing the following unique combination of morphological features: very short and thin, a cylindrical and not segmented ultimate tarsus 2, a "spinning-spur" (see below) on the ultimate tarsus 1, short paramcdian sutures close to the anterior and posterior margins of cephalic plate, a tibial lateral spur and a glandular pore fields in the ultimate femur. An identification key to the Newportia subgenera, as well as a key to the Ectonocryptops, Ectonocryptoides and Andeocryptops species are included.	[Esteban, Tulande-M] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Escuela Restaurac Ecol, Carrara 7, Bogota 438245, Colombia; [Camilo Prado, Cesar] Univ Dist Francisco Jose Caldas, Fac Ciencias & Educ, Bogota, Colombia; [Galvis Jimenez, Sebastian] Univ Nacl Colombia, Inst Ciencias Nat, Sede Bogota, Bogota, Colombia; [Chagas, Amazonas, Jr.] Univ Fed Mato Grosso, Inst Biociencias, Dept Biol & Zool, Lab Sistemat & Taxon Artropodes Terr, Ave Fernando Correa Costa 2367, BR-78060900 Cuiabai, MT, Brazil		Esteban, TM (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Escuela Restaurac Ecol, Carrara 7, Bogota 438245, Colombia.	etulandem@javeriana.edu.co; polydesmida@gmail.com; sgalvisjimenez@gmail.com; amazonaschagas@gmail.com		Tulande-M, Esteban/0000-0001-7754-9518	Corporacion Autonoma Regional de Cundinamarca (CAR); Pontificia Universidad Javeriana (PUJ)	Corporacion Autonoma Regional de Cundinamarca (CAR); Pontificia Universidad Javeriana (PUJ)	This study was supported by the Corporacion Autonoma Regional de Cundinamarca (CAR) and Pontificia Universidad Javeriana (PUJ) to Jose Ignacio Barrera-Catano and Sofia Basto. We acknowledge Dr. Giovanny Fagua (PUJ) and Dimitri Forero (PUJ) for his help on photo shooting, Carolina Moreno (PUJ) for botanical identifications, Dr. Arkady Schileyko and Dr. Daniel Chirivi-Joya for valuable comments, Julian Jimenez for English corrections, and last but not least Daniel F. Jimenez for photo and plate edition and last but not least Dr. Thomas Wesener for Manuscript editing.	Adis J., 2002, P555; de Oliveira MPA, 2019, APPL SOIL ECOL, V143, P181, DOI 10.1016/j.apsoil.2019.07.012; Anderson J.M, 1993, TROPICAL SOIL BIOL F, V2nd; Bonato L., 2016, CHILOBASE VERSION 2; Bonato L, 2010, ZOOKEYS, P17, DOI 10.3897/zookeys.69.737; Chagas A, 2018, ZOOTAXA, V4403, P154, DOI 10.11646/zootaxa.4403.1.9; Chagas-Jr A., 2003, ZOOTAXA, V379, P1; Chagas-Junior Amazonas, 2011, International Journal of Myriapodology, V5, P63, DOI 10.3897/ijm.5.1649; Chamberlin R.V., 1921, OCCAS PAP MUS ZOOL U, V97, P1; CRABILL RE, 1977, P ENTOMOL SOC WASH, V79, P346; Edgecombe G, 2011, TREATISE ZOOLOGY ANA, V1, P392, DOI DOI 10.1163/9789004188266_; Edgecombe GD, 2015, ZOOKEYS, P65, DOI 10.3897/zookeys.510.8573; Ferlian O, 2014, OIKOS, V123, P1182, DOI 10.1111/j.1600-0706.2013.00848.x; Gervais P., 1847, HIST NATURELLE INSEC, V4, P298; Kenning M, 2017, PEERJ, V5, DOI 10.7717/peerj.4023; Klarner B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180915; Koch L., 1862, MYRIAPODENGATTUNG LI; Koch Markus, 2010, International Journal of Myriapodology, V3, P51, DOI 10.1163/187525410X12578602960344; Lewis John G. E., 2005, African Invertebrates, V46, P115; Pocock P.I., 1895, BIOL CENTRALI AM, P1; Porta A.O., 2016, REV SOC ENTOMOLOGICA, V75, P3; Schileyko A., 1999, ARTHROPODA SEL, V7, P265; Schileyko AA, 2020, ZOOTAXA, V4825, P1, DOI 10.11646/zootaxa.4825.1.1; Schileyko AA, 2013, ZOOKEYS, P39, DOI 10.3897/zookeys.276.4876; Schileyko Arkady A., 2009, Soil Organisms, V81, P519; Shelley RM, 2005, ZOOTAXA, P25, DOI 10.11646/zootaxa.1094.1.2; Shelley RM, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1824.1.7; Shelley RM, 2009, WEST N AM NATURALIST, V69, P138, DOI 10.3398/064.069.0108; Vahtera V, 2013, INVERTEBR SYST, V27, P578, DOI 10.1071/IS13035; Villani MG, 1999, ANNU REV ENTOMOL, V44, P233, DOI 10.1146/annurev.ento.44.1.233; Zanella A, 2018, APPL SOIL ECOL, V122, P10, DOI 10.1016/j.apsoil.2017.07.004	31	0	0	1	2	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	OCT 6	2020	4859	2					228	238		10.11646/zootaxa.4859.2.3	http://dx.doi.org/10.11646/zootaxa.4859.2.3			11	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	OC7XP	33056197				2022-09-04	WOS:000579371200003
J	Gomez, RM; Dominguez-Sanchez, MA; Sanchez, MY; Barreto, GE				Gomez, Rosa M.; Andrea Dominguez-Sanchez, Maria; Sanchez, Magdy Y.; Barreto, George E.			Neuroglial Cell Cryopreservation in Appropriate Inductive Conditions	CURRENT PHARMACEUTICAL DESIGN			English	Review						Cryopreservation; cell therapy; stem cell; neuroglia cell; cryoprotectant; neuroregeneration	EMBRYONIC STEM-CELLS; LONG-TERM CULTURES; PLASMA-MEMBRANE; HYDROXYETHYL STARCH; HIPPOCAMPAL-NEURONS; PROGENITOR CELLS; LOW-TEMPERATURE; CYTOCHALASIN-B; BRAIN-INJURY; GLIAL-CELLS	An ability to store cells (if they cannot be used fresh) reduces cell wastage, thereby increasing the supply of transplantable material. Cell storage is also valuable in scientific research, allowing material to be archived and experiments to be repeated from the same tissue source and facilitating research collaboration by allowing stored samples to be distributed. Cryopreservation is currently considered the most promising and successful, long-term biological conservation method. Its use has led to optimizing survival, improving protocols and stem cell and neuroglia viability, thereby assuring its future use in neuroregeneration and restoration regarding cell therapy. The success of conservation processes in ensuring cell viability depends on aspects such as the characteristics, cells' cryobiological behavior, isolation methodologies, cell freezing, the use and choice of cryoprotectants and such aspects' influence on intra-and extra-cellular dynamics. This review deals with cells' cryobiological behavior, cryopreservation and cryoprotectants, emphasizing on stem cell and neuroglial populations as therapeutic target regarding nervous system diseases.	[Gomez, Rosa M.; Sanchez, Magdy Y.] Neuroregenerat Fdn Colombia, NeuroRec Res Grp, Bogota, Colombia; [Andrea Dominguez-Sanchez, Maria; Sanchez, Magdy Y.] Univ Nacl Colombia, Fac Med, Master Neurosci Programme, Bogota, Colombia; [Andrea Dominguez-Sanchez, Maria] Univ La Sabana, Nursing & Rehabil Fac, Physiotherapy Programme, Human Body Movement Grp, Chia, Colombia; [Sanchez, Magdy Y.] Univ La Sabana, Nursing & Rehabil Fac, Physiotherapy Programme, Chia, Colombia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Gomez, RM (corresponding author), Neuroregenerat Fdn Colombia, NeuroRec Res Grp, Bogota, Colombia.	rosa.gomez.b1@gmail.com	Bustos, Rosa Helena/P-2742-2018; Forero, Diego A./O-9981-2019; Valentina Echeverria Moran, BCh/E-7765-2013	Bustos, Rosa Helena/0000-0003-0243-2299; Forero, Diego A./0000-0001-9175-3363; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971				Abir R, 2016, HUM REPROD, V31, P750, DOI 10.1093/humrep/dew007; Al-Azawi T, 2013, MIDDLE EAST FERTIL S, V18, P223, DOI 10.1016/j.mefs.2012.10.008; [Anonymous], 2005, CONG BACT FACT QUE I, P3; ASHWOODSMITH MJ, 1975, ANN NY ACAD SCI, V243, P246, DOI 10.1111/j.1749-6632.1975.tb25363.x; Ávila-Portillo Luz Mabel, 2006, Rev Colomb Obstet Ginecol, V57, P291; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Benavides F. J., 2003, MANUAL GENETICA ROED; Benson EE, 2008, PLANT CRYOPRESERVATI; Benson Erica E., 2008, P15, DOI 10.1007/978-0-387-72276-4_2; Biedermann B, 2002, J NEUROSCI METH, V120, P173, DOI 10.1016/S0165-0270(02)00195-4; Boiso I., 2001, 1 C ASEBIR, P18; Broxmeyer HE, 1997, CLIN EXP IMMUNOL, V107, P45; CAFFREY M, 1987, BIOCHIM BIOPHYS ACTA, V896, P123, DOI 10.1016/0005-2736(87)90365-8; Cai R S, 1993, J Tongji Med Univ, V13, P138; CALCOTT PH, 1976, CAN J MICROBIOL, V22, P106, DOI 10.1139/m76-015; Capicciotti CJ, 2015, CRYOBIOLOGY, V70, P79, DOI 10.1016/j.cryobiol.2015.01.002; CAUDA R, 1994, CLIN IMMUNOL IMMUNOP, V70, P198, DOI 10.1006/clin.1994.1029; Chaytor JL, 2012, GLYCOBIOLOGY, V22, P123, DOI 10.1093/glycob/cwr115; Coopman K, 2011, BIOTECHNOL PROGR, V27, P1511, DOI 10.1002/btpr.680; DELATORRE JC, 1981, SPINE, V6, P315, DOI 10.1097/00007632-198107000-00001; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Farstad W, 1996, ANIM REPROD SCI, V42, P251, DOI 10.1016/0378-4320(96)01483-2; Franco M, 2006, IN VITRO CELL DEV-AN, V42, P40, DOI 10.1007/s11626-006-0010-1; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; Garcia J, 1984, BIOL CLIN HEMATOL, V6, P219; GOLLAN F, 1967, ANN NY ACAD SCI, V141, P63, DOI 10.1111/j.1749-6632.1967.tb34866.x; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Hancock CR, 2000, BIOCHEM BIOPH RES CO, V271, P418, DOI 10.1006/bbrc.2000.2631; HARRISON ARTHUR P., 1956, ANTONIE VAN LEEU WENHOEK JOUR MICROBIOL AND SEROL, V22, P407, DOI 10.1007/BF02538353; Hashimoto A, 2000, RES VET SCI, V69, P39, DOI 10.1053/rvsc.2000.0382; He XM, 2008, CRYOBIOLOGY, V56, P223, DOI 10.1016/j.cryobiol.2008.03.005; Herschler SWJaR, 2010, PHARM DMSO DEP SURG; Higgins AZ, 2011, J NEUROSCI METH, V201, P9, DOI 10.1016/j.jneumeth.2011.06.033; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Inden M, 2005, NEUROSCI LETT, V387, P151, DOI 10.1016/j.neulet.2005.06.029; Janz FD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/649353; JUN F, 1992, CRYOBIOLOGY, V29, P267, DOI 10.1016/0011-2240(92)90025-W; Kashuba CM, 2014, CRYOBIOLOGY, V68, P176, DOI 10.1016/j.cryobiol.2013.12.003; Kobylka P, 1998, TRANSPLANTATION, V65, P1275, DOI 10.1097/00007890-199805150-00024; LIM R, 1975, ANN NY ACAD SCI, V243, P358, DOI 10.1111/j.1749-6632.1975.tb25376.x; Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1007/BF03206624; Liu Y, 2010, BIOTECHNOL PROGR, V26, P1635, DOI 10.1002/btpr.464; Lotan R, 1981, ADV CELL BIOL; LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V10, P414, DOI 10.1016/0006-3002(53)90273-X; LUO KH, 1994, CRYOBIOLOGY, V31, P349, DOI 10.1006/cryo.1994.1042; Malpique R, 2012, BIOTECHNOL PROGR, V28, P1079, DOI 10.1002/btpr.1572; MANDELBAUM J, 1987, HUM REPROD, V2, P709, DOI 10.1093/oxfordjournals.humrep.a136619; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1966, CRYOBIOLOGY, V2, P181, DOI 10.1016/S0011-2240(66)80165-7; MAZUR P, 1965, ANN NY ACAD SCI, V125, P658, DOI 10.1111/j.1749-6632.1965.tb45420.x; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; McLellan M R, 1995, Methods Mol Biol, V38, P1; Mendoza JA, 2000, CRYOBIOLOGY, V41, P319, DOI 10.1006/cryo.2000.2287; Michelmann H. W., 2006, Cell and Tissue Banking, V7, P135, DOI 10.1007/s10561-005-0877-1; Milosevic J, 2005, STEM CELLS, V23, P681, DOI 10.1634/stemcells.2004-0135; Mitchell PD, 2014, TISSUE ENG PART C-ME, V20, P941, DOI [10.1089/ten.tec.2013.0595, 10.1089/ten.TEC.2013.0595]; Moore AI, 2005, CRYOBIOLOGY, V51, P241, DOI 10.1016/j.cryobiol.2005.07.004; Nazareth L, 2015, MOL CELL NEUROSCI, V65, P92, DOI 10.1016/j.mcn.2015.03.005; Negishi T, 2002, NEUROSCI LETT, V328, P21, DOI 10.1016/S0304-3940(02)00433-0; Negishi T, 2002, EXP ANIM TOKYO, V51, P383, DOI 10.1538/expanim.51.383; NICOTERA P, 1986, FEBS LETT, V209, P139, DOI 10.1016/0014-5793(86)81099-7; Otto F, 2003, J NEUROSCI METH, V128, P173, DOI 10.1016/S0165-0270(03)00186-9; Paulenz H., 1993, NORW J VET MED, P1135; Paynter SJ, 2009, CRYOBIOLOGY, V58, P308, DOI 10.1016/j.cryobiol.2009.02.008; Paynter SJ, 2008, BRAIN RES BULL, V75, P1, DOI 10.1016/j.brainresbull.2007.08.004; PETITE D, 1995, BRAIN RES, V669, P263, DOI 10.1016/0006-8993(94)01269-N; PICKERING SJ, 1990, FERTIL STERIL, V54, P102; POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0; PRATHER RS, 1986, J EXP ZOOL, V239, P37, DOI 10.1002/jez.1402390106; Purdy PH, 2004, CRYOBIOLOGY, V48, P36, DOI 10.1016/j.cryobiol.2003.12.001; Ragoonanan V, 2013, CRYOBIOLOGY, V66, P96, DOI 10.1016/j.cryobiol.2012.10.008; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Ray B, 1973, CRC Crit Rev Clin Lab Sci, V4, P161, DOI 10.3109/10408367309151556; SANDBORN EB, 1975, ANN NY ACAD SCI, V243, P122, DOI 10.1111/j.1749-6632.1975.tb25351.x; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Seo JM, 2011, CRYOBIOLOGY, V62, P167, DOI 10.1016/j.cryobiol.2011.02.003; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shen JL, 2012, CRYOBIOLOGY, V64, P167, DOI 10.1016/j.cryobiol.2012.01.004; Shufaro Y, 2010, ANN NY ACAD SCI, V1205, P220, DOI 10.1111/j.1749-6632.2010.05651.x; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Spurr EE, 2002, CRYOBIOLOGY, V44, P210, DOI 10.1016/S0011-2240(02)00027-5; STEPONKUS PL, 1989, J BIOENERG BIOMEMBR, V21, P21, DOI 10.1007/BF00762210; STIFF PJ, 1987, BLOOD, V70, P974; STOUGHTO.RB, 1965, ARCH DERMATOL, V91, P657, DOI 10.1001/archderm.1965.01600120089022; Takamatsu H, 2005, J BIOMECH, V38, P117, DOI 10.1016/j.jbiomech.2004.03.011; Thammavongs B, 2004, J MICROBIOL METH, V57, P181, DOI 10.1016/j.mimet.2004.01.003; Valbuena D, 2008, REPROD BIOMED ONLINE, V17, P127, DOI 10.1016/S1472-6483(10)60302-1; WEISSMAN.G, 1967, ANN NY ACAD SCI, V141, P326, DOI 10.1111/j.1749-6632.1967.tb34897.x; Xue T, 2009, INT J PEDIATR OTORHI, V73, P969, DOI 10.1016/j.ijporl.2009.03.017; Yan Ping-Di, 2003, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V19, P306	95	1	1	2	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2017	23	28					4145	4153		10.2174/1381612823666170406113501	http://dx.doi.org/10.2174/1381612823666170406113501			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FL6PC	28814236				2022-09-04	WOS:000414366900009
J	Otalvaro, IF; Neto, MPC; Delage, P; Caicedo, B				Otalvaro, Ivan Fernando; Cordao Neto, Manoel Porfirio; Delage, Pierre; Caicedo, Bernardo			Relationship between soil structure and water retention properties in a residual compacted soil	ENGINEERING GEOLOGY			English	Article						Mercury intrusion porosimetry; Water retention curve; Pore size density	HYDRAULIC CONDUCTIVITY; MECHANICAL-BEHAVIOR; MICROSTRUCTURE; CLAY; FEATURES; POROSITY; CURVE; FORM	Soil structure, especially the soil pore size distribution, is a fundamental property that describes the hydro mechanical behavior of soils. The volume change behavior, shear strength, water retention capacity and hydraulic conductivity of soil are controlled by the pore size distribution. However, research on soil structure has been limited due to the associated expenses and specialized instruments, such as environmental scanning electron microscopes and mercury intrusion porosimeters (MIPs). In this study, the relationship between the soil water retention curve (WRC) along a drying path and the pore size distribution obtained through an MIP method was reviewed. The WRC for a compacted tropical soil was converted into a soil air injection curve and then used to estimate the pore size density (PSD) function. Relative to the data collected from MIP methods, the results showed an acceptable prediction of the PSD function based on a soil air injection curve. Finally, a series of adjustments to the air injection curve were performed to improve the accuracy of the PSD prediction based on the water retention curve. (C) 2016 Published by Elsevier B.V.	[Otalvaro, Ivan Fernando] Univ Javeriana, Cali, Colombia; [Cordao Neto, Manoel Porfirio] Univ Brasilia, Fac Tecnol, Dept Engn Civil & Ambiental, Campus Darcy Ribeiro,Asa Norte SG-12, BR-70910900 Brasilia, DF, Brazil; [Delage, Pierre] Ecole Ponts ParisTech Navier CERMES, 6-8 Av B Pascal, F-77455 Marne La Vallee 2, France; [Caicedo, Bernardo] Univ Los Andes, Bogota, Colombia; [Caicedo, Bernardo] Cra 1 Este 19 A-40, Bogota, Colombia		Neto, MPC (corresponding author), Univ Brasilia, Fac Tecnol, Dept Engn Civil & Ambiental, Campus Darcy Ribeiro,Asa Norte SG-12, BR-70910900 Brasilia, DF, Brazil.	otalvaro.calle@gmail.com; mporfirio76@gmail.com; delage@cermes.enpc.fr; bcaicedo@uniandes.edu.co	Caicedo, Bernardo/R-2965-2016; Cordão Neto, Manoel Porfirio/AAT-5746-2021; Cordão-Neto, Manoel/AAB-2999-2022	Caicedo, Bernardo/0000-0003-4344-0914; Cordão Neto, Manoel Porfirio/0000-0003-0618-4376; Otalvaro, Ivan/0000-0003-3665-4244; Delage, Pierre/0000-0002-2101-5522	European Commission [PIRSES-GA-2013-612665]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank the "Conselho Nacional de Desenvolvimento Cientifico e Tec-nologico" CNPq of Brazil and the Department of Civil and Environmental Engineering at the Los Andes University. The authors wish to acknowledge the support of the European Commission via the Marie Curie IRSES project GREAT (PIRSES-GA-2013-612665).The first author sincerely thank Dr. Jose Camapum de Carvalho for providing the opportunity to discuss tropical soil features.	Alonso EE, 2011, GEOTECHNIQUE, V61, P329, DOI 10.1680/geot.2011.61.4.329; Alonso EE, 2010, GEOTECHNIQUE, V60, P913, DOI 10.1680/geot.8.P.002; Alonso EE, 1999, ENG GEOL, V54, P173, DOI 10.1016/S0013-7952(99)00079-4; [Anonymous], 2000, D69800A ASTM; Aung K.K., 2001, GEOTECH GEOL ENG, V19, P401, DOI [10.1023/A:1013125600962, DOI 10.1023/A:1013125600962, 10.1007/978-94-015-9775-3_9, DOI 10.1007/978-94-015-9775-3_9]; Casini F, 2012, ACTA GEOTECH, V7, P139, DOI 10.1007/s11440-012-0159-6; CHANDLER RJ, 1992, P I CIVIL ENG-CIV EN, V92, P82, DOI 10.1680/icien.1992.18771; COLLINS K, 1974, GEOTECHNIQUE, V24, P223, DOI 10.1680/geot.1974.24.2.223; Delage P, 1996, CAN GEOTECH J, V33, P150, DOI 10.1139/t96-030; Delage P, 2009, GEOTECHNIQUE, V59, P75, DOI 10.1680/geot.2008.59.1.75; DELAGE P, 1984, CAN GEOTECH J, V21, P21, DOI 10.1139/t84-003; Delage P., 1995, P 9 EUR C SOIL MECH, P43; Delgado A.K.C., 2002, THESIS U BRASILIA; Di Stefano C, 2010, BIOSYST ENG, V106, P205, DOI 10.1016/j.biosystemseng.2010.03.013; DIAMOND S, 1970, CLAY CLAY MINER, V18, P7, DOI 10.1346/CCMN.1970.0180103; DURNER W, 1994, WATER RESOUR RES, V30, P211, DOI 10.1029/93WR02676; Farulla CA, 2010, CAN GEOTECH J, V47, P688, DOI 10.1139/T09-138; Feuerharmel C, 2006, GEOTECH TEST J, V29, P419; Fies JC, 1998, EUR J SOIL SCI, V49, P557, DOI 10.1046/j.1365-2389.1998.4940557.x; Freitas-Silva F.H., 1998, DISTRIC FEDERAL GEOL; Futai MM, 2005, GEOTECHNIQUE, V55, P201, DOI 10.1680/geot.55.3.201.61520; FUTAI MM, 2002, THESIS FEDERAL U RIO; Guimaraes RC, 2002, THESIS U BRASILIA; Koliji A, 2010, CAN GEOTECH J, V47, P297, DOI 10.1139/T09-089; Marinho FAM, 2006, GEOTECH TEST J, V29, P250; Martins E.S., 2004, GEOMORPHOLOGIC DISTR; Mascarenha M.M.A., 2010, UNSATURATED SOILS, DOI [10.1201/9781003026365, DOI 10.1201/9781003026365]; Miguel MG, 2012, GEOTECH GEOL ENG, V30, P1405, DOI 10.1007/s10706-012-9545-y; Miguel MG, 2009, CAN GEOTECH J, V46, P1084, DOI 10.1139/T09-039; Mitchell J.K., 2005, FUNDAMENTAL SOIL BEH, V3, P415; Otalvaro I.F., 2015, TRANSPORTATION UNPUB; Pham HQ, 2011, CAN GEOTECH J, V48, P280, DOI [10.1139/T10-061, 10.1139/t10-061]; PRAPAHARAN S, 1985, J GEOTECH ENG-ASCE, V111, P1139, DOI 10.1061/(ASCE)0733-9410(1985)111:9(1139); Romero E, 2011, GEOTECHNIQUE, V61, P313, DOI 10.1680/geot.2011.61.4.313; Romero E, 1999, ENG GEOL, V54, P117, DOI 10.1016/S0013-7952(99)00067-8; Romero E.E., 1999, THESIS U POLITECNICA; Romero E, 2008, GEOTECH GEOL ENG, V26, P705, DOI 10.1007/s10706-008-9204-5; Santamarina J.C., 2011, ENERGY GEOTECHNOLOGY; Santamarina JC, 2002, CAN GEOTECH J, V39, P233, DOI 10.1139/T01-077; Silva, 2007, THESIS U BRASILIA; Simms PH, 2001, CAN GEOTECH J, V38, P741, DOI 10.1139/cgj-38-4-741; Sridharan A., 1971, ASCEJ SOIL MECH FDN, V97, P771, DOI DOI 10.1061/JSFEAQ.0001595; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Zhang LM, 2010, J GEOTECH GEOENVIRON, V136, P1425, DOI 10.1061/(ASCE)GT.1943-5606.0000348; Zhang LM, 2005, J GEOTECH GEOENVIRON, V131, P666, DOI 10.1061/(ASCE)1090-0241(2005)131:5(666)	45	41	43	5	76	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0013-7952	1872-6917		ENG GEOL	Eng. Geol.	APR 29	2016	205						73	80		10.1016/j.enggeo.2016.02.016	http://dx.doi.org/10.1016/j.enggeo.2016.02.016			8	Engineering, Geological; Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Geology	DK8GV					2022-09-04	WOS:000375166100008
J	Lopez-Ramos, HE; Garcia-Perdomo, H; Prieto-Martinez, V; Rosselli, D; Cortes, V				Lopez-Ramos, H. E.; Garcia-Perdomo, H.; Prieto-Martinez, V; Rosselli, D.; Cortes, V			COST-EFFECTIVENESS OF MID-URETHRAL TAPE COMPARED TO CONVENTIONAL TREATMENT OF FEMALE URINARY STRESS INCONTINENCE IN COLOMBIA	VALUE IN HEALTH			Spanish	Meeting Abstract									[Lopez-Ramos, H. E.] Univ Rosario, Bogota, Colombia; [Garcia-Perdomo, H.] Univ Valle, Cali, Colombia; [Prieto-Martinez, V] Univ Nacl Colombia, Bogota, Colombia; [Rosselli, D.] Pontificia Univ Javeriana, Bogota, Colombia; [Cortes, V] Clin Colsubsidio, Bogota, Colombia				García-Perdomo, Herney A/G-9701-2013; Lopez Ramos, Hugo Enrique/D-3527-2017	García-Perdomo, Herney A/0000-0001-6945-8261; Lopez Ramos, Hugo Enrique/0000-0002-5895-3029					0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	NOV	2013	16	7					A710	A710		10.1016/j.jval.2013.08.2181	http://dx.doi.org/10.1016/j.jval.2013.08.2181			1	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	242MY		Bronze			2022-09-04	WOS:000326247603258
J	Gomez, G; Botero-Rodriguez, F; Misas, JD; Garcia-Cifuentes, E; Sulo, S; Brunton, C; Venegas-Sanabria, LC; Gracia, DA; Gutierrez, CAC				Gomez, Gabriel; Botero-Rodriguez, Felipe; Misas, Juan Diego; Garcia-Cifuentes, Elkin; Sulo, Suela; Brunton, Cory; Venegas-Sanabria, Luis Carlos; Gracia, Daniela Alejandra; Gutierrez, Carlos Alberto Cano			A nutritionally focused program for community-living older adults resulted in improved health and well-being	CLINICAL NUTRITION			English	Article						Nutrition; Older adults; Oral nutritional supplement; Activities of daily living; Functionality; Quality of life	MINI-MENTAL-STATE; NURSING-HOME; MALNUTRITION; IMPACT; CARE; REHABILITATION; INTERVENTION; ASSOCIATION; MANAGEMENT; DEMENTIA	Objectives: Among older adults, malnutrition is common and is associated with increased risk for impaired health and functionality, conditions further associated with poorer quality of life. In this study of community-living older adults, our objective was to quantify outcome changes following identification and treatment of malnutrition or its risk. Design: Our intervention was a nutritional quality improvement program (QIP). The nutritional QIP included: (i) education of participants about the importance of complete and balanced macro- and micronutrient intake plus physical exercise, (ii) nutritional intervention with dietary counseling; and (iii) provision of oral nutritional supplements (ONS) for daily intake over 60 days. Follow-up measurements took place 30 days after ONS treatment ended, i.e., 90 days after start of intervention. Setting and participants: We recruited 618 transitional-care, chronically ill, older adults ( 60 years) with malnutrition/risk (per Mini Nutrition Assessment-Short Form, MNA-SF) from the outpatient clinic of Hospital Universitario San Ignacio, in Bogota???, Colombia. Methods: For pre-post comparisons, we examined cognition (Mini-Mental State Exam, MMSE), physical abilities (Barthel Activities of Daily Living, ADL; Short Physical Performance Battery, SPPB), affective disorder status (Global Depression Scale, GDS), and quality of life (QoL; EuroQoL-5D-3L, EQ-5D-3L; EuroQoL-Visual Analog Scale, EQ-VAS). Results: Participants were mean age 74.1 ?? 8.7 y, female majority (69.4%), and had an average of 2.6 comorbidities with cardiovascular and respiratory diseases predominant (28.5%). QIP-based nutritional intervention led to significant improvements in cognitive (MMSE) and physical functions (ADL and SPPB), affective disorder status (GDS), and health-related quality of life (EQ-VAS); all differences (P < 0.001). Self-reported QoL (EQ-5D-3L) also improved. Conclusions and implications: Over 90 days, the nutritional QIP led to improvements in all measured outcomes, thus highlighting the importance of addressing malnutrition or its risk among communityliving older adults. From a patient's perspective, maintaining mental and physical function are important and further linked with quality of life.	[Gomez, Gabriel; Botero-Rodriguez, Felipe; Misas, Juan Diego; Gracia, Daniela Alejandra] Abbott Labs, Bogota, Colombia; [Garcia-Cifuentes, Elkin; Gutierrez, Carlos Alberto Cano] Pontificia Univ Javeriana, Ageing Inst, Sch Med, Bogota, Colombia; [Botero-Rodriguez, Felipe; Garcia-Cifuentes, Elkin; Gutierrez, Carlos Alberto Cano] Hosp Univ San Ignacio, Carrera 7 40-62, Bogota, Colombia; [Sulo, Suela] Abbott Labs, Abbott Pk, IL USA; [Brunton, Cory] Abbott Labs, Columbus, OH USA; [Venegas-Sanabria, Luis Carlos] Univ Rosario, Inst Rosarista el Estudio Envejecimiento & Longev, Bogota, Colombia; [Venegas-Sanabria, Luis Carlos] Hosp Univ Mayor Mederi, Bogota, Colombia		Gutierrez, CAC (corresponding author), Hosp Univ San Ignacio, Carrera 7 40-62, Bogota, Colombia.	ccano@javeriana.edu.co		Brunton, Cory/0000-0002-3799-3742; Botero-Rodriguez, Felipe/0000-0003-1537-5211	Abbott [HA38]	Abbott(Abbott Laboratories)	This study was supported by a research grant (HA38) from Abbott to the Hospital Universitario San Ignacio, Bogota, Colombia.	Agarwal E, 2013, MATURITAS, V76, P296, DOI 10.1016/j.maturitas.2013.07.013; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Chavarro-Carvajal DA, 2022, CLIN NUTR ESPEN, V48, P291, DOI 10.1016/j.clnesp.2022.01.032; [Anonymous], 2021, THEWORLD HLTH ORG RA; Beard JR, 2022, J GERONTOL A-BIOL, V77, P94, DOI 10.1093/gerona/glab226; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Chew STH, 2021, CLIN NUTR, V40, P1879, DOI 10.1016/j.clnu.2020.10.015; Correia MITD, 2014, J AM MED DIR ASSOC, V15, P544, DOI 10.1016/j.jamda.2014.05.011; Correia MITD, 2017, CLIN NUTR, V36, P958, DOI 10.1016/j.clnu.2016.06.025; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gale SA, 2018, AM J MED, V131, P1161, DOI 10.1016/j.amjmed.2018.01.022; Garcia RS, 2013, EINSTEIN-SAO PAULO, V11, P147, DOI 10.1590/S1679-45082013000200002; Graham J, 2017, J AGING RES HEALTHC, V1, P18; Guest JF, 2011, CLIN NUTR, V30, P422, DOI 10.1016/j.clnu.2011.02.002; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Halaweh Hadeel, 2018, J Aging Res, V2018, P9858252, DOI 10.1155/2018/9858252; Hamirudin AH, 2016, ARCH GERONTOL GERIAT, V62, P9, DOI 10.1016/j.archger.2015.09.007; Holyday M, 2012, J NUTR HEALTH AGING, V16, P562, DOI 10.1007/s12603-012-0022-3; Hong K, 2021, J PRIM CARE COMMUNIT, V12; Hopman-Rock M, 2019, AGING CLIN EXP RES, V31, P917, DOI 10.1007/s40520-018-1034-6; Correia MI, 2016, JPEN-PARENTER ENTER, V40, P319, DOI 10.1177/0148607115581373; Kaiser MJ, 2011, J AM GERIATR SOC, V59, P2124, DOI 10.1111/j.1532-5415.2011.03659.x; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Kok RM, 2017, JAMA-J AM MED ASSOC, V317, P2114, DOI 10.1001/jama.2017.5706; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Maresova P, 2015, CURR ALZHEIMER RES, V12, P903, DOI 10.2174/156720501209151019111448; Marshall S, 2014, J HUM NUTR DIET, V27, P133, DOI 10.1111/jhn.12167; McKeever L, 2019, J AGING RES CLIN PRA, V8, P7; Pirlich M, 2003, DIGEST DIS, V21, P245, DOI 10.1159/000073342; Prado CM, 2020, J CACHEXIA SARCOPENI, V11, P366, DOI 10.1002/jcsm.12525; Prado CM, 2018, ANN MED, V50, P675, DOI 10.1080/07853890.2018.1511918; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Riley K, 2020, JPEN-PARENTER ENTER, V44, P58, DOI 10.1002/jpen.1606; Rodda J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5219; Rodríguez Magda Ginnette, 2019, Biomed., V39, P663, DOI 10.7705/biomedica.4733; Salva Casanovas Antoni, 2012, Rev Esp Geriatr Gerontol, V47, P245, DOI 10.1016/j.regg.2012.10.001; Sanders C, 2016, J ALZHEIMERS DIS, V52, P33, DOI 10.3233/JAD-150528; Sheean P, 2019, PUBLIC HEALTH NUTR, V22, P894, DOI 10.1017/S1368980018002902; Smith TR, 2020, NUTRIENTS, V12; Sriram K, 2018, JPEN-PARENTER ENTER, V42, P1093, DOI 10.1002/jpen.1040; Sulo S, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720922716; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Leeuwen KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213263; Villafane JH, 2016, J PHYS THER SCI, V28, P607, DOI 10.1589/jpts.28.607; Wadas-Enright M, 2015, J COMMUN HEALTH NURS, V32, P1, DOI 10.1080/07370016.2015.991658; Wade D T, 1988, Int Disabil Stud, V10, P64; Wei JM, 2018, PUBLIC HEALTH NUTR, V21, P3129, DOI 10.1017/S1368980018002227; Wolters M, 2019, CLIN NUTR, V38, P2389, DOI 10.1016/j.clnu.2018.10.020; World Health Organization, 2020, DEC HLTH AG 2020 203; World Health Organization, 2017, OPERATIONALISING CON; World Health Organization (WHO), 2017, INT CAR OLD PEOPL GU; World Health Organization (WHO), 2015, WORLD REP AG HLTH; Yu Wuhan, 2021, Psychogeriatrics, V21, P80, DOI 10.1111/psyg.12631	56	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	JUL	2022	41	7					1549	1556		10.1016/j.clnu.2022.05.003	http://dx.doi.org/10.1016/j.clnu.2022.05.003			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	2T3RN	35667271	hybrid			2022-09-04	WOS:000822396200010
J	Alvarez-Moreno, C; Valderrama-Beltran, S; Rodriguez-Morales, AJ				Alvarez-Moreno, Carlos; Valderrama-Beltran, Sandra; Rodriguez-Morales, Alfonso J.			Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America	ANTIBIOTICS-BASEL			English	Editorial Material							COUNTRIES		[Alvarez-Moreno, Carlos] Univ Nacl Colombia, Fac Med, Bogota 111176, Colombia; [Alvarez-Moreno, Carlos] Clin Univ Colombia, Clin Colsanitas Grp Keralty, Bogota 111176, Colombia; [Valderrama-Beltran, Sandra] Hosp Univ San Ignacio, Bogota 110231, Colombia; [Valderrama-Beltran, Sandra] Pontificia Univ Javeriana, Dept Microbiol, Bogota 110231, Colombia; [Rodriguez-Morales, Alfonso J.] Fdn Univ Autonoma Ias Amer, Fac Med, Grp Invest Biomed, Pereira 660003, Risaralda, Colombia; [Rodriguez-Morales, Alfonso J.] Latin Amer Network COVID 19 Res LANCOVID, Pereira 660003, Risaralda, Colombia		Alvarez-Moreno, C (corresponding author), Univ Nacl Colombia, Fac Med, Bogota 111176, Colombia.; Alvarez-Moreno, C (corresponding author), Clin Univ Colombia, Clin Colsanitas Grp Keralty, Bogota 111176, Colombia.; Rodriguez-Morales, AJ (corresponding author), Fdn Univ Autonoma Ias Amer, Fac Med, Grp Invest Biomed, Pereira 660003, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Latin Amer Network COVID 19 Res LANCOVID, Pereira 660003, Risaralda, Colombia.	caalvarezmo@unal.edu.co; sandra.valderama@gmail.com; alfonso.rodriguez@uam.edu.co	Rodriguez-Morales, Alfonso J./R-9765-2016	Rodriguez-Morales, Alfonso J./0000-0001-9773-2192; Valderrama-Beltran, Sandra Liliana/0000-0003-1833-1599; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; alvarez Moreno, carlos Arturo/0000-0001-5419-4494				Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Government of Honduras, GOBIERNO ENV A PRIME; Klein EY, 2021, LANCET INFECT DIS, V21, P107, DOI 10.1016/S1473-3099(20)30332-7; Labarca JA, 2016, CRIT REV MICROBIOL, V42, P276, DOI 10.3109/1040841X.2014.940494; Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016; O' Neil J, REV ANTIBIOTIC RESIS; Rawson TM, 2020, J ANTIMICROB CHEMOTH, V75, P1681, DOI 10.1093/jac/dkaa194; Rosenthal VD, 2020, AM J INFECT CONTROL, V48, P423, DOI 10.1016/j.ajic.2019.08.023; Seas C, 2018, J ANTIMICROB CHEMOTH, V73, P212, DOI 10.1093/jac/dkx350; Stewardson A, 2019, LANCET INFECT DIS, V19, P601, DOI 10.1016/S1473-3099(18)30792-8; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Vaughn VM, 2021, CLIN INFECT DIS, V72, pE533, DOI 10.1093/cid/ciaa1239	12	4	4	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2079-6382			ANTIBIOTICS-BASEL	Antibiotics-Basel	MAR	2021	10	3							328	10.3390/antibiotics10030328	http://dx.doi.org/10.3390/antibiotics10030328			3	Infectious Diseases; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Pharmacology & Pharmacy	RD2BM	33804758	Green Published, gold			2022-09-04	WOS:000633290400001
J	Phillips, HRP; Halley, JM; Urbina-Cardona, JN; Purvis, A				Phillips, Helen R. P.; Halley, John M.; Urbina-Cardona, J. Nicolas; Purvis, Andy			The effect of fragment area on site-level biodiversity	ECOGRAPHY			English	Article							PLANT-SPECIES RICHNESS; HABITAT FRAGMENTATION; FOREST FRAGMENTS; EXTINCTION DEBT; LAND-USE; TERRESTRIAL BIODIVERSITY; ISLAND BIOGEOGRAPHY; LANDSCAPE; DIVERSITY; RESPONSES	Habitat fragmentation accompanies habitat loss, and drives additional biodiversity change; but few global biodiversity models explicitly analyse the effects of both fragmentation and loss. Here we propose and test the hypothesis that, as fragment area increases, species density (the number of species in a standardised plot) will scale with an exponent given by the difference between the exponents of the species-area relationships for islands (z similar to 0.25) and in contiguous habitat (z similar to 0.15), and test whether scaling varies between land uses. We also investigate the scaling of overall abundance and rarefaction-based richness, as some mechanisms make different predictions about how fragment area should affect them. The relevant data from the taxonomically and geographically broad PREDICTS database were used to model the three diversity measures, testing their scaling with fragment area and whether the scaling exponent varied among land uses (primary forest, secondary forest, plantation forest, cropland and pasture). In addition, the consistency of the response of species density to fragment area was tested across three well represented taxa (Magnoliopsida, Hymenoptera and herptiles'). Species density and total abundance showed area-scaling exponents of 0.07 and 0.16, respectively, and these exponents did not vary significantly among land uses; rarefaction-based richness by contrast did not increase consistently with area. These results suggest that the area-scaling of species density is driven by the area-scaling of total abundance, with additive edge effects (species moving into the small fragments from the surroundings) opposing - but not fully overcoming - the effect of fragment area on overall density of individuals. The interaction between fragment area and higher taxon (plants, vertebrates and invertebrates), which remained in the rarefied richness model, indicates that mechanisms may vary among groups.	[Phillips, Helen R. P.; Purvis, Andy] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Phillips, Helen R. P.; Purvis, Andy] Nat Hist Museum, Dept Life Sci, London, England; [Phillips, Helen R. P.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, Ioannina, Greece; [Urbina-Cardona, J. Nicolas] Pontificia Univ Javeriana, Sch Rural & Environm Studies, Dept Ecol & Terr, Bogota, Colombia		Phillips, HRP (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.; Phillips, HRP (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Phillips, HRP (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.	helen.phillips@idiv.de	Urbina-Cardona, J. Nicolas/B-5447-2008; Purvis, Andy/A-7529-2008; Halley, John M/AAP-3004-2020	Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Purvis, Andy/0000-0002-8609-6204; Phillips, Helen/0000-0002-7435-5934	Hans Rausing Foundation; UK Natural Environment Research Council (NERC) [NE/J011193/2]; NERC [NE/J011193/2] Funding Source: UKRI; Natural Environment Research Council [NE/J011193/2] Funding Source: researchfish	Hans Rausing Foundation; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to the Hans Rausing Foundation (PhD studentship to HRPP) and the UK Natural Environment Research Council (NERC; grant number NE/J011193/2 to AP) for financial support.	Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; [Anonymous], 2005, EC HUM WELL BEING BI; Armbrecht I, 2006, ECOL ENTOMOL, V31, P403, DOI 10.1111/j.1365-2311.2006.00802.x; Azovsky AI, 2011, ECOGRAPHY, V34, P18, DOI 10.1111/j.1600-0587.2010.06288.x; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Barton K., 2018, MUMIN MULTIMODEL INF; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Bragagnolo C, 2007, BIOL CONSERV, V139, P389, DOI 10.1016/j.biocon.2007.07.008; Brummitt NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135152; Brunet J, 2011, FOREST ECOL MANAG, V262, P1863, DOI 10.1016/j.foreco.2011.08.007; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Cagle NL, 2008, BIOL CONSERV, V141, P744, DOI 10.1016/j.biocon.2008.01.003; Cam E, 2002, ECOLOGY, V83, P1118, DOI 10.1890/0012-9658(2002)083[1118:DSAEEU]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Cook WM, 2002, ECOL LETT, V5, P619, DOI 10.1046/j.1461-0248.2002.00366.x; Crawley M.J., 2012, R BOOK, V2nd; Cronk Q, 2016, SCIENCE, V353, P446, DOI 10.1126/science.aag1794; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dominguez-Haydar Y, 2011, RESTOR ECOL, V19, P178, DOI 10.1111/j.1526-100X.2010.00735.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Ducatez S, 2017, CONSERV LETT, V10, P186, DOI 10.1111/conl.12258; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2015, AGR ECOSYST ENVIRON, V200, P219, DOI 10.1016/j.agee.2014.11.018; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fernandez IC, 2013, URBAN ECOSYST, V16, P377, DOI 10.1007/s11252-012-0272-1; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Franzen M, 2008, ECOGRAPHY, V31, P698, DOI 10.1111/j.1600-0587.2008.05110.x; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Giladi I, 2014, J BIOGEOGR, V41, P1055, DOI 10.1111/jbi.12299; Haarmeyer DH, 2010, BIOL CONSERV, V143, P588, DOI 10.1016/j.biocon.2009.11.008; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Halley JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12283; Halley JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P113, DOI 10.1111/geb.12098; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Hamback PA, 2007, P NATL ACAD SCI USA, V104, P8368, DOI 10.1073/pnas.0611462104; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hendrix SD, 2010, BIODIVERS CONSERV, V19, P1699, DOI 10.1007/s10531-010-9797-x; HILL JL, 1994, GLOBAL ECOL BIOGEOGR, V4, P97, DOI 10.2307/2997435; HOLT RD, 1992, THEOR POPUL BIOL, V41, P354, DOI 10.1016/0040-5809(92)90034-Q; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Hudson LN, 2017, ECOL EVOL, V7, P145, DOI 10.1002/ece3.2579; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; IPBES, 2016, SECR INT SCIENC PLAT; Julier HE, 2009, J ECON ENTOMOL, V102, P563, DOI 10.1603/029.102.0214; Karger DN, 2014, J BIOGEOGR, V41, P250, DOI 10.1111/jbi.12209; Koh LP, 2010, CONSERV BIOL, V24, P994, DOI 10.1111/j.1523-1739.2010.01464.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lachat T, 2006, BIODIVERS CONSERV, V15, P3, DOI 10.1007/s10531-004-1234-6; Lasky JR, 2010, J TROP ECOL, V26, P67, DOI 10.1017/S0266467409990368; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Leal IR, 2012, BIODIVERS CONSERV, V21, P1687, DOI 10.1007/s10531-012-0271-9; MAC ARTHUR ROBERT H., 1967; MacSwiney MC, 2007, BIOL CONSERV, V136, P499, DOI 10.1016/j.biocon.2006.12.021; Magurran AE., 2004, MEASURING BIOL DIVER; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Murphy GEP, 2014, ECOL EVOL, V4, P91, DOI 10.1002/ece3.909; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Naoe S, 2012, J FOREST RES-JPN, V17, P219, DOI 10.1007/s10310-011-0296-z; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T, 2016, ECOGRAPHY, V39, P1151, DOI 10.1111/ecog.01932; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Norton DA, 2006, NEW ZEAL J ECOL, V30, P335; Nyeko P, 2009, BIOTROPICA, V41, P476, DOI 10.1111/j.1744-7429.2009.00499.x; O'Connor TG, 2005, J APPL ECOL, V42, P975, DOI 10.1111/j.1365-2664.2005.01065.x; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Paritsis J, 2008, FOREST ECOL MANAG, V255, P1575, DOI 10.1016/j.foreco.2007.11.015; Pereira H. M., 2013, ENCY BIODIVERSITY, P321; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Phillips H. R. P., 2017, NATURAL HIST MUSEUMS, DOI [10. 5519/0089190, DOI 10.5519/0089190<GREATERTHAN>]; Qian H, 2007, AM NAT, V170, P690, DOI 10.1086/521960; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Ross KA, 2002, J BIOGEOGR, V29, P749, DOI 10.1046/j.1365-2699.2002.00722.x; Sam K, 2014, J FIELD ORNITHOL, V85, P152, DOI 10.1111/jofo.12057; Savage J, 2011, WETLANDS, V31, P125, DOI 10.1007/s13157-010-0133-8; Schneider-Maunoury L, 2016, BIOL CONSERV, V200, P207, DOI 10.1016/j.biocon.2016.06.011; Schoereder JH, 2004, J BIOGEOGR, V31, P1219, DOI 10.1111/j.1365-2699.2004.01113.x; Schon NL, 2008, APPL SOIL ECOL, V40, P218, DOI 10.1016/j.apsoil.2008.04.007; Smith AB, 2013, ECOLOGY, V94, P2392, DOI 10.1890/12-2109.1; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; Summerville KS, 2006, ECOL APPL, V16, P891, DOI 10.1890/1051-0761(2006)016[0891:STAPOL]2.0.CO;2; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Wade TG, 2003, CONSERV ECOL, V7; Watling JI, 2006, CONSERV BIOL, V20, P1016, DOI 10.1111/j.1523-1739.2006.00482.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wilcove D.S., 1986, P237; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zuur Alain F., 2009, P1	117	20	20	3	51	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	JUL	2018	41	7					1220	1231		10.1111/ecog.02956	http://dx.doi.org/10.1111/ecog.02956			12	Biodiversity Conservation; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	GL1IO					2022-09-04	WOS:000436854100015
J	Baez, E; Echeverria, V; Cabezas, R; Avila-Rodriguez, M; Garcia-Segura, LM; Barreto, GE				Baez, Eliana; Echeverria, Valentina; Cabezas, Ricardo; Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Barreto, George E.			Protection by Neuroglobin expression in Brain Pathologies	FRONTIERS IN NEUROLOGY			English	Article						astrocytes; neuroglobin; mitochondria; neuroprotection; brain injury	OXYGEN-GLUCOSE DEPRIVATION; MOUSE CORTICAL-NEURONS; OXIDATIVE STRESS; PARKINSONS-DISEASE; MITOCHONDRIAL-FUNCTION; CEREBRAL MALARIA; UP-REGULATION; NITRIC-OXIDE; IN-VIVO; ASTROCYTE MITOCHONDRIA	Astrocytes play an important role in physiological, metabolic, and structural functions, and when impaired, they can be involved in various pathologies including Alzheimer, focal ischemic stroke, and traumatic brain injury. These disorders involve an imbalance in the blood flow and nutrients such as glucose and lactate, leading to biochemical and molecular changes that cause neuronal damage, which is followed by loss of cognitive and motor functions. Previous studies have shown that astrocytes are more resilient than neurons during brain insults as a consequence of their more effective antioxidant systems, transporters, and enzymes, which made them less susceptible to excitotoxicity. In addition, astrocytes synthesize and release different protective molecules for neurons, including neuroglobin, a member of the globin family of proteins. After brain injury, neuroglobin expression is induced in astrocytes. Since neuroglobin promotes neuronal survival, its increased expression in astrocytes after brain injury may represent an endogenous neuroprotective mechanism. Here, we review the role of neuroglobin in the central nervous system, its relationship with different pathologies, and the role of different factors that regulate its expression in astrocytes.	[Baez, Eliana; Cabezas, Ricardo; Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Madrid, Spain.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./B-5747-2014	Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Pontificia Universidad Javeriana	Pontificia Universidad Javeriana	GB's work is supported by Pontificia Universidad Javeriana.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2012, INT J NEUROSCI, V122, P223, DOI 10.3109/00207454.2011.648292; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Jurado-Coronel JC, 2016, CURR PHARM DESIGN, V22, P1305, DOI 10.2174/138161282210160304112133; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Chen XM, 2015, NEUROSCI LETT, V606, P194, DOI 10.1016/j.neulet.2015.09.002; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Dugan LL, 2004, J BIOENERG BIOMEMBR, V36, P317, DOI 10.1023/B:JOBB.0000041761.61554.44; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Gotting M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12284; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Gouix E, 2014, PHARMACOL RES, V87, P8, DOI 10.1016/j.phrs.2014.06.002; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Guglielmotto M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00147; Guo Y, 2015, BRAIN RES, V1600, P1, DOI 10.1016/j.brainres.2014.12.046; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hu Y, 2015, INT J MOL SCI, V16, P24895, DOI 10.3390/ijms161024895; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Jayaraman T, 2011, J BIOL CHEM, V286, P42679, DOI 10.1074/jbc.M111.271973; Jin KL, 2012, NEUROSCI LETT, V519, P47, DOI 10.1016/j.neulet.2012.05.018; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Jing L, 2015, INT J BIOL SCI, V11, P59, DOI 10.7150/ijbs.10174; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Kubik LL, 2015, TOXICOL SCI, V144, P7, DOI 10.1093/toxsci/kfu254; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lechauve C, 2009, J MOL BIOL, V388, P968, DOI 10.1016/j.jmb.2009.03.047; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lee VY, 2002, J BIOL CHEM, V277, P16067, DOI 10.1074/jbc.M111177200; Li Y, 2016, J MOL NEUROSCI, V58, P28, DOI 10.1007/s12031-015-0645-z; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lin Y, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-110; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Liu N, 2013, NEUROSCI LETT, V534, P333, DOI 10.1016/j.neulet.2012.11.025; Liu ZF, 2015, INT J CLIN EXP MED, V8, P5351; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magistretti P.J., 2002, NEUROPSYCHOPHARMACOL; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Medina-Ceja L, 2007, REV NEUROLOGIA, V45, P341, DOI 10.33588/rn.4506.2005647; Meir JU, 2009, J EXP BIOL, V212, P3330, DOI 10.1242/jeb.033761; Mohideen SS, 2013, J OCCUP HEALTH, V55, P29, DOI 10.1539/joh.12-0118-OA; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Oliveira K, 2015, METAB BRAIN DIS, V30, P1401, DOI 10.1007/s11011-015-9718-5; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Picotti P, 2009, FEBS J, V276, P7027, DOI 10.1111/j.1742-4658.2009.07416.x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Purushothuman S, 2015, BRAIN RES, V1601, P52, DOI 10.1016/j.brainres.2015.01.003; Qin HJ, 2012, BRAIN TUMOR PATHOL, V29, P10, DOI 10.1007/s10014-011-0066-9; Qiu Xin Yao, 2014, Biomol Concepts, V5, P195, DOI 10.1515/bmc-2014-0011; Quijano María Cristina, 2012, Rev. Cienc. Salud, V10, P21; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Rappold PM, 2010, NEUROTHERAPEUTICS, V7, P413, DOI 10.1016/j.nurt.2010.07.001; Raychaudhuri S, 2008, BIOPHYS J, V95, P3559, DOI 10.1529/biophysj.108.135483; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Reuss S, 2016, MOL NEUROBIOL, V53, P1461, DOI 10.1007/s12035-014-9082-1; Schneuer M, 2012, NEUROSCIENCE, V223, P35, DOI 10.1016/j.neuroscience.2012.07.052; Shang AJ, 2015, MOL MED REP, V12, P1693, DOI 10.3892/mmr.2015.3593; Sharlin DS, 2010, J NEUROENDOCRINOL, V22, P153, DOI 10.1111/j.1365-2826.2009.01947.x; Shelby M, 2004, REPROD TOXICOL, V18, P303, DOI 10.1016/j.reprotox.2003.10.013; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Simon R, 2013, NEUROSCI LETT, V549, P1, DOI 10.1016/j.neulet.2013.05.016; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song X, 2014, INT J CLIN EXP PATHO, V7, P2163; Steele ML, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.018; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Van Leuven W, 2013, BBA-PROTEINS PROTEOM, V1834, P1764, DOI 10.1016/j.bbapap.2013.04.015; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x; Wang TH, 2015, CLIN TOXICOL, V53, P823, DOI 10.3109/15563650.2015.1064939; Watanabe S, 2012, J BIOL CHEM, V287, P30128, DOI 10.1074/jbc.M112.373381; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Wystub S, 2003, NEUROSCI LETT, V346, P114, DOI 10.1016/S0304-3940(03)00563-9; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; Yu ZL, 2014, NEUROSCIENCE, V270, P158, DOI 10.1016/j.neuroscience.2014.04.013; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Yue X, 2014, NEUROSCIENCE, V258, P385, DOI 10.1016/j.neuroscience.2013.11.038; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhong ZX, 2013, TOXICOLOGY, V306, P16, DOI 10.1016/j.tox.2013.01.022; Zhou D, 2008, EUR J PEDIATR, V167, P1169, DOI 10.1007/s00431-007-0653-2; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	138	44	44	0	20	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 12	2016	7								146	10.3389/fneur.2016.00146	http://dx.doi.org/10.3389/fneur.2016.00146			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV6AT	27672379	Green Published, gold			2022-09-04	WOS:000383013600002
J	Ruiz-Garcia, M; Castellanos, A; Bernal, LA; Pinedo-Castro, M; Kaston, F; Shostell, JM				Ruiz-Garcia, Manuel; Castellanos, Armando; Agueda Bernal, Luz; Pinedo-Castro, Myreya; Kaston, Franz; Shostell, Joseph M.			Mitogenomics of the mountain tapir (Tapirus pinchaque, Tapiridae, Perissodactyla, Mammalia) in Colombia and Ecuador: Phylogeography and insights into the origin and systematics of the South American tapirs	MAMMALIAN BIOLOGY			English	Article						Tapirus pinchaque; Mitochondrial DNA; Genetic diversity; Spatial genetic structure; Phylogenetic analyses	EVOLUTIONARY TREES; PLEISTOCENE TAPIR; PHYLOGENETICS; SPECIATION; SOFTWARE; GENETICS; MODEL	We sampled 45 Andean mountain tapirs (Tapirus pinchaque) from Colombia and Ecuador and sequenced 15 mitochondrial genes (two rRNA and 13 protein codifying genes) making up 13,939 base pairs, approximately 83.1% of the total mitochondrial DNA's length. The overall sample had low to medium levels of nucleotide diversity with diversity slightly higher for the Colombian population. Both populations experienced high historical gene flow and our genetic heterogeneity analyses revealed a low genetic differentiation between them. Therefore, we did not detect any molecular subspecies, or significantly different evolutionary units for T. pinchaque. This species experienced a population expansion in the last 100,000 years but this expansion was more pronounced in the Ecuadorian population especially in the last 10,000 years, whereas the Colombian population underwent a strong bottleneck in the last 5,000 years. There was no significant spatial trend in genetic structure for the mountain tapir in Colombia and Ecuador. Phylogenetic analyses did not detect any important geographic Glade within this species. Temporal split between T. pinchaque and T. terrestris might have occurred around 7-1.5 million years ago (MYA). T. pinchaque and T. terrestris +T. kabomani are two monophyletic clades, suggesting that T. kabomani is not a full species. (C) 2015 Deutsche Gesellschaft fur Saugetierkunde. Published by Elsevier GmbH. All rights reserved.	[Ruiz-Garcia, Manuel; Agueda Bernal, Luz; Pinedo-Castro, Myreya] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Biol Evolut, Cra 7A 43-82, Bogota, DC, Colombia; [Castellanos, Armando] Andean Bear Fdn, La Isla, Quito, Ecuador; [Kaston, Franz] Fdn Nativa, Apartado Aereo 59199, Bogota, DC, Colombia; [Shostell, Joseph M.] Univ Minnesota Crookston, Dept Math Sci & Technol, Crookston, MN 56716 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Biol Evolut, Cra 7A 43-82, Bogota, DC, Colombia.	mruizgar@yahoo.es	Ruiz-Garcia, Manuel/AAF-8191-2019; Castro, Myreya Pinedo/AAF-8450-2019	Ruiz-Garcia, Manuel/0000-0003-2820-2950				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashley Mary V., 1996, Journal of Mammalian Evolution, V3, P315, DOI 10.1007/BF02077448; Barongi R. A., 1993, International Zoo Yearbook, V32, P7; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benton M., 1991, THE RISE OF MAMMALS; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Brooks D.M., 1997, TAPIR STATUS SURVEY; Bush G.L., 1981, P201; Cavelier J., 2010, TROPICAL MONTANE CLO, P172; Cozzuol MA, 2013, J MAMMAL, V94, P1331, DOI 10.1644/12-MAMM-A-169.1; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Downer CC, 2001, J ZOOL, V254, P279, DOI 10.1017/S0952836901000796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferrero BS, 2007, J VERTEBR PALEONTOL, V27, P504, DOI 10.1671/0272-4634(2007)27[504:ANUPTF]2.0.CO;2; Frison GC, 1998, P NATL ACAD SCI USA, V95, P14576, DOI 10.1073/pnas.95.24.14576; HAFFER J, 1970, Caldasia, V10, P603; Hershkovitz P., 1966, ECTOPARASITES PANAMA, P725; Hershkovitz P, 1954, P US NATL MUS, V103, P465, DOI DOI 10.5479/SI.00963801.103-3329.465; Holanda EC, 2011, J MAMMAL, V92, P111, DOI 10.1644/10-MAMM-A-144.1; Holanda EC, 2013, J MAMM EVOL, V20, P33, DOI 10.1007/s10914-012-9196-z; Houck ML, 2000, CYTOGENET CELL GENET, V89, P110, DOI 10.1159/000015587; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hulbert R, 2005, J VERTEBR PALEONTOL, V25, p72A; Hulbert Richard C. Jr., 2010, Bulletin of the Florida Museum of Natural History, V49, P67; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KING M, 1993, SPECIES EVOLUTION; LEWIS H, 1966, SCIENCE, V152, P167, DOI 10.1126/science.152.3719.167; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lizcano D.J., 2006, SERIE LIBROS ROJOS E; Lizcano DJ, 2002, J BIOGEOGR, V29, P7, DOI 10.1046/j.1365-2699.2002.00654.x; MANTEL N, 1967, CANCER RES, V27, P209; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; Mau B, 1996, BAYESIAN PHYLOGENETI; Norman JE, 2000, J MOL EVOL, V50, P11, DOI 10.1007/s002399910002; Pinho G.M., 2013, 1 C LAT TAP 8 11 MAY; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Rothlisberger F., 1987, 10000 JAHRE GLETSCHE, P1; Ruiz-Garcia M, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P83; Ruiz-Garcia M, 2016, MITOCHONDRIAL DNA A, V27, P2334, DOI 10.3109/19401736.2015.1022766; SCHAUENBERG P, 1969, Revue Suisse de Zoologie, V76, P211; Simpson BB, 1979, MONOGRAPH MUSEUM NAT, P157; SOKAL RR, 1981, BIOMETRY; Swofford DL, 2002, PAUP PHYLOGENETIC AN, P1, DOI DOI 10.1007/BF02198856; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Tirira D.G, 2011, PUBLICACION ESPECIAL, V8; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Van der Hammen T., 1992, ERDKUNDE, V46, P252; Van der Hammen T, 2001, DIVERSIDADE BIOL CUL, P19; VANGEEL B, 1973, PALAEOGEOGR PALAEOCL, V14, P9, DOI 10.1016/0031-0182(73)90064-3; Voss RS, 2014, J MAMMAL, V95, P893, DOI 10.1644/14-MAMM-A-054; White M. J. D., 1978, MODES SPECIATION; WHITE MJD, 1968, SCIENCE, V159, P1065, DOI 10.1126/science.159.3819.1065; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zachos F.E., 2015, MAMMAL BIOL IN PRESS	62	11	14	0	29	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-5047	1618-1476		MAMM BIOL	Mamm. Biol.	MAR	2016	81	2					163	175		10.1016/j.mambio.2015.11.001	http://dx.doi.org/10.1016/j.mambio.2015.11.001			13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	DG9CD					2022-09-04	WOS:000372379500007
J	Acuna, SA; Angarita, FA; Escallon, J; Tawil, M; Torregrosa, L				Acuna, Sergio A.; Angarita, Fernando A.; Escallon, Jaime; Tawil, Mauricio; Torregrosa, Lilian			Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice	BMC SURGERY			English	Article						Breast surgery; Surgical site infection; Prophylactic antibiotic	SURGICAL SITE INFECTIONS; WOUND-INFECTION; COMPLICATIONS; CHEMOTHERAPY; MORBIDITY; MASTECTOMY; HOSPITALS; BIOPSY; WOMEN; COST	Background: Prophylactic antibiotics (PAs) are beneficial to breast cancer patients undergoing surgery because they prevent surgical site infection (SSI), but limited information regarding their use has been published. This study aims to determine the use of PAs prior to breast cancer surgery amongst breast surgeons in Colombia. Methods: An online survey was distributed amongst the breast surgeon members of the Colombian Association of Mastology, the only breast surgery society of Colombia. The scope of the questions included demographics, clinical practice characteristics, PA prescription characteristics, and the use of PAs in common breast surgical procedures. Results: The survey was distributed amongst eighty-eight breast surgeons of whom forty-seven responded (response rate: 53.4%). Forty surgeons (85.1%) reported using PAs prior to surgery of which >60% used PAs during mastectomy, axillary lymph node dissection, and/or breast reconstruction. Surgeons reported they targeted the use of PAs in cases in which patients had any of the following SSI risk factors: diabetes mellitus, drains in situ, obesity, and neoadjuvant therapy. The distribution of the self-reported PA dosing regimens was as follows: single preoperative fixed-dose (27.7%), single preoperative dose followed by a second dose if the surgery was prolonged (44.7%), single preoperative dose followed by one or more postoperative doses for >24 hours (10.6%), and single preoperative weight-adjusted dose (2.1%). Conclusion: Although this group of breast surgeons is aware of the importance of PAs in breast cancer surgery there is a discrepancy in how they use it, specifically with regards to prescription and timeliness of drug administration. Our findings call for targeted quality-improvement initiatives, such as standardized national guidelines, which can provide sufficient evidence for all stakeholders and therefore facilitate best practice medicine for breast cancer surgery.	[Acuna, Sergio A.; Angarita, Fernando A.; Tawil, Mauricio; Torregrosa, Lilian] Pontificia Univ Javeriana, Dept Surg, Hosp Univ San Ignacio, Bogota, Colombia; [Escallon, Jaime] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Escallon, Jaime] Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M4X 1K9, Canada; [Tawil, Mauricio; Torregrosa, Lilian] Ctr Javeriano Oncol, Breast & Soft Tissue Clin, Bogota, Colombia		Torregrosa, L (corresponding author), Pontificia Univ Javeriana, Dept Surg, Hosp Univ San Ignacio, Bogota, Colombia.	lilian.torregrosa@javeriana.edu.co	Acuna, Sergio A./H-7783-2013; Angarita, Fernando A./AAI-9245-2020	Acuna, Sergio A./0000-0002-6266-2136; Angarita, Fernando A./0000-0002-8546-7309				BARBER GR, 1995, ARCH SURG-CHICAGO, V130, P1042; BEATTY JD, 1983, ARCH SURG-CHICAGO, V118, P1421; Bergkvist L., 2007, World Journal of Surgery, V31, P2300, DOI 10.1007/s00268-007-9247-4; Bertin ML, 1998, AM J INFECT CONTROL, V26, P61, DOI 10.1016/S0196-6553(98)70062-8; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005360.pub3; Canavese G, 1997, EUR J SURG ONCOL, V23, P10, DOI 10.1016/S0748-7983(97)80135-7; CHEN J, 1991, J HOSP INFECT, V17, P61, DOI 10.1016/0195-6701(91)90078-M; Codina C, 1999, INFECT CONT HOSP EP, V20, P436, DOI 10.1086/501650; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; D'Amico DF, 2001, J CHEMOTHERAPY, V13, P108, DOI 10.1179/joc.2001.13.Supplement-2.108; DANFORTH DN, 1990, AM SURGEON, V56, P6; DELLINGER EP, 1994, INFECT CONT HOSP EP, V15, P182; ELDIN AB, 1989, EUR J SURG ONCOL, V15, P486; Felippe WAB, 2007, WORLD J SURG, V31, P2293, DOI 10.1007/s00268-007-9248-3; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hall JC, 2000, J HOSP INFECT, V46, P165, DOI [10.1053/jhin.2000.0834, 10.1016/S0195-6701(00)90834-X]; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Hauck RM, 2011, ANN PLAST SURG; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Lipshy KA, 1996, ANN SURG ONCOL, V3, P290, DOI 10.1007/BF02306285; MANGRAM AJ, 1950, INFECT CONT HOSP EP, V20, P250; McDonald AHN, 1999, AUST NZ J SURG, V69, P514, DOI 10.1046/j.1440-1622.1999.01614.x; Namias N, 1999, J AM COLL SURGEONS, V188, P225, DOI 10.1016/S1072-7515(98)00287-7; Ng D, 2007, BREAST, V16, P68, DOI 10.1016/j.breast.2006.06.004; Nicolas P, 2007, J SURG ONCOL, V96, P124, DOI 10.1002/jso.20796; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; Penel N, 2004, B CANCER, V91, P445; PLATT R, 1990, NEW ENGL J MED, V322, P153, DOI 10.1056/NEJM199001183220303; Recht A, 1996, NEW ENGL J MED, V334, P1356, DOI 10.1056/NEJM199605233342102; Rodriguez-Caravaca G, 2011, ENFERM INFEC MICR CL, V29, P415, DOI 10.1016/j.eimc.2011.02.002; ROTSTEIN C, 1992, INFECT CONT HOSP EP, V13, P207; Sheridan R L, 1994, Adv Surg, V27, P43; Smyth STM, 2000, J HOSP INFECT, V45, P173, DOI 10.1053/jhin.2000.0736; Tejirian T, 2006, J AM COLL SURGEONS, V203, P729, DOI 10.1016/j.jamcollsurg.2006.07.013; Thomas R, 1999, CHEMOTHERAPY, V45, P217, DOI 10.1159/000007186; Throckmorton AD, 2010, SURG INFECT, V11, P355, DOI 10.1089/sur.2009.029; Tran CL, 2003, AM SURGEON, V69, P852; Vilar-Compte D, 2004, WORLD J SURG, V28, P242, DOI 10.1007/s00268-003-7193-3; Vilar-Compte D, 2009, AM J INFECT CONTROL, V37, P674, DOI 10.1016/j.ajic.2009.02.010; Vitug AF, 2007, SURG CLIN N AM, V87, P431, DOI 10.1016/j.suc.2007.01.005; WAGMAN LD, 1990, SURG GYNECOL OBSTET, V170, P12; WEDGWOOD KR, 1992, ANN ROY COLL SURG, V74, P314; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X; Witt A, 2003, OBSTET GYNECOL, V101, P745, DOI 10.1016/S0029-7844(03)00044-9	44	9	10	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2482			BMC SURG	BMC Surg.	AUG 31	2012	12								18	10.1186/1471-2482-12-18	http://dx.doi.org/10.1186/1471-2482-12-18			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	040PP		gold, Green Published			2022-09-04	WOS:000311335200001
J	Astor, A; Akhtar, T; Matallana, MA; Muthuswamy, V; Olowu, FA; Tallo, V; Lie, RK				Astor, A; Akhtar, T; Matallana, MA; Muthuswamy, V; Olowu, FA; Tallo, V; Lie, RK			Physician migration: views from professionals in Colombia, Nigeria, India, Pakistan and the Philippines	SOCIAL SCIENCE & MEDICINE			English	Article						physician migration; health policy; developing countries; India; Pakistan; Nigeria; Columbia; The Philippines	BRAIN-DRAIN; HEALTH-PROFESSIONALS; DOCTORS	There has been much debate recently about several issues related to the migration of physicians from developing to developed countries. However, few studies have been conducted to address these issues in a systematic fashion. In an attempt to begin the process of generating systematic data, we designed and- distributed a questionnaire addressing several core issues surrounding physician migration to respondents selected on the basis of their special expertise or experience in India, Nigeria, Pakistan, Colombia, and the Philippines. The issues addressed relate to the reasons physicians migrate to developed countries, how migration is related to the structure of medical education, the effect that migration has on the health care infrastructure of developing countries, and various policy options for dealing with physician migration. Though responses varied somewhat by country, a desire for increased income, greater access to enhanced technology, an atmosphere of general security and stability, and improved prospects for one's children were the primary motivating factors for physician migration. A majority of respondents believed that physicians in developing counties are provided with highly specialized skills that they can better utilize in developed countries, but respondents were ambivalent with respect to the utility of educational reform. Responses varied significantly by country with regard to whether physician migration results in physician shortages, but there was widespread agreement that it exacerbates shortages in rural and public settings. With respect to policy options, increasing physician income, improving working conditions, requiring physicians to work in their home countries for a period following graduation from medical school, and creating increased collaboration between health ministries in developed and developing countries found the most favor with respondents. (c) 2005 Elsevier Ltd. All rights reserved.	NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA; Pakistan Med Res Council, Islamabad, Pakistan; Pontif Univ Javeriana, Cendex, Bogota, Colombia; Indian Council Med Res, New Delhi, India; Intellfit Africa Training Ctr, Lagos, Nigeria		Lie, RK (corresponding author), NIH, Dept Clin Bioeth, Room 1C118,Bldg 10, Bethesda, MD 20892 USA.	rlie@cc.nih.gov	Astor, Avi/I-1318-2015	Astor, Avi/0000-0002-4720-1841				BARNETT JR, 1988, SOC SCI MED, V26, P1049, DOI 10.1016/0277-9536(88)90223-7; Bateman C, 2001, S AFR MED J, V91, P544; BUNDRED P, 2000, LANCET, P356; Buske L, 2002, CAN MED ASSOC J, V166, P1320; Chanda R, 2002, B WORLD HEALTH ORGAN, V80, P158; CROASDALE M, 2004, AM MED NEWS     1101; *DEP HLTH, 2001, COD PRACT NHS EMPL I; DUBLIN T, 1972, NEW ENGL J MED, P286; Forcier Melanie Bourassa, 2004, Hum Resour Health, V2, P12, DOI 10.1186/1478-4491-2-12; GISH O, 1979, SOC SCI MED-MED ECON, V13, P1, DOI 10.1016/0160-7995(79)90020-0; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Hilary J, 2002, BRIT MED J, V325, P220; HORN J, 1977, INT J HLTH SERVICES, V7; LAURENCE L, 2003, BRIT MED J, V327, P170; *NRMP, 2002, NAT RES MATCH PROGR; Nullis-Kapp C, 2005, B WORLD HEALTH ORGAN, V83, P84; Oslak O, 1973, Educ Med Salud, V7, P316; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Patel V, 2003, BRIT MED J, V327, P926, DOI 10.1136/bmj.327.7420.926; Pizurki Helena, 1979, PHYS NURSE MIGRATION; PORTES A, 1976, J INTERAM STUD WORLD, V18, P395, DOI 10.2307/174989; Rosselli D, 2001, MED EDUC, V35, P809, DOI 10.1046/j.1365-2923.2001.1014f.x; Stein DI, 2002, BRIT MED J, V325, P219, DOI 10.1136/bmj.325.7357.219; Stilwell Barbara, 2003, Hum Resour Health, V1, P8, DOI 10.1186/1478-4491-1-8; Vujicic Marko, 2004, Hum Resour Health, V2, P3, DOI 10.1186/1478-4491-2-3; World Bank, 1993, WORLD DEV REP 1993 I, V1	26	99	104	0	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	DEC	2005	61	12					2492	2500		10.1016/j.socscimed.2005.05.003	http://dx.doi.org/10.1016/j.socscimed.2005.05.003			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	987DO	15953667				2022-09-04	WOS:000233498800003
J	Lopez-Lopez, W; Vega-Arce, M; Salas, G; Urzua, A; Torres-Fernandez, I; Ho, YS				Lopez-Lopez, Wilson; Vega-Arce, Maribel; Salas, Gonzalo; Urzua, Alfonso; Torres-Fernandez, Ivelisse; Ho, Yuh-Shan			Bibliometric analysis of COVID-19 editorial materials in the beginning stage of the pandemic	MALAYSIAN JOURNAL OF LIBRARY & INFORMATION SCIENCE			English	Article						COVID-19; SARS-CoV-2; Bibliometric Analysis; Web of Science Core Collection; Editorial Material	CORONAVIRUS OUTBREAK; CITATION-INDEX; HEALTH; THREAT; MANAGEMENT; SCIENCE; CHINA	Editorial materials express the opinions of the scientific community and guides the publication foci; thus, providing insight into the dynamics of the knowledge ecosystem in a scenario that impacts innovation and public policies. The purpose of this bibliometric analysis was to identify the main characteristics of the editorial materials published at the beginning stage of the COVID-19 pandemic, published between 2019 and April 30, 2020 and indexed in the Web of Science Core Collection. A total of 537 editorial materials were written by 1,455 authors, primarily in English, and in the general and internal medicine category. The majority of these editorial materials were published in the British Medical Journal and Lancet. The United States, China, and United Kingdom had the most editorial materials, with Harvard Medical School, Imperial College, and Oxford University were the leading universities. Richard Horton was the most prolific author and the editorial material by Hui et al. (2020) was the most cited. in the initial stage of COVID-19, editorial materials reflected contingent aspects of the course of the infection at the global, regional, and national levels. In the emerging and rapidly developing crisis of COWD-19, editorial materials allow the scientific community to engage in the ongoing discussions. Analysis of editorial materials fosters the understanding of the dynamics of the knowledge ecosystem.	[Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Carrera 5 39-00 Edificio Manuel Briseno,Piso 2, Bogota, Colombia; [Vega-Arce, Maribel; Salas, Gonzalo] Univ Catolica Maule, Avn San Miguel 3605, Talca, Chile; [Urzua, Alfonso] Univ Catolica Norte, Avda Angamos 0610, Antofagasta, Chile; [Torres-Fernandez, Ivelisse] Carlos Bizu Univ, San Juan, PR USA; [Ho, Yuh-Shan] Asia Univ, Trend Res Ctr, Taichung 41354, Taiwan		Ho, YS (corresponding author), Asia Univ, Trend Res Ctr, Taichung 41354, Taiwan.	lopezw@javeriana.edu.co; mvega@ucm.cl; gsalas@ucm.cl; alurzua@ucn.cl; itorres@albizu.edu; ysho@asia.edu.tw	Urzúa, Alfonso/A-1208-2012; López López, Wilson/AAV-8032-2021	Urzúa, Alfonso/0000-0002-0882-2194; López López, Wilson/0000-0002-2964-0402				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30823-0; [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2010, J ROY SOC MED, V103, P207, DOI 10.1258/jrsm.2010.10k002; [Anonymous], 2014, EUROPEAN SCI EDITING; [Anonymous], 2020, AM J RESP CRIT CARE, DOI DOI 10.1164/RCCM.2014P7; Bhutta ZA, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1190; Brown A, 2020, LANCET, V395, P1099, DOI 10.1016/S0140-6736(20)30742-X; Carinci F, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m799; Carletti F, 2020, J MED VIROL, V92, P1404, DOI 10.1002/jmv.25833; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Chiu WT, 2005, SCIENTOMETRICS, V63, P3, DOI 10.1007/s11192-005-0201-7; Chiu WT, 2004, SCIENTOMETRICS, V61, P69, DOI 10.1023/B:SCIE.0000037363.49623.28; Chuang KY, 2011, SCIENTOMETRICS, V87, P551, DOI 10.1007/s11192-011-0365-2; Clarivate Analytics, 2020, MAST J LIST; Cohen J, 2020, SCIENCE, V367, P492, DOI 10.1126/science.367.6477.492; Daniels JP, 2020, LANCET, V395, P1023, DOI 10.1016/S0140-6736(20)30718-2; Fu HZ, 2012, J COLLOID INTERF SCI, V379, P148, DOI 10.1016/j.jcis.2012.04.051; Galetsi P, 2020, HEALTH INFO LIBR J, V37, P5, DOI 10.1111/hir.12286; Garfield E., 1987, CURRENT CONTENTS CLI, V2, P7; Gomez-Jauregui V, 2014, INT J INFORM MANAGE, V34, P257, DOI 10.1016/j.ijinfomgt.2014.01.002; Gonzalez L, 2007, J AM SOC INF SCI TEC, V58, P252, DOI 10.1002/asi.20424; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Hall KS, 2020, LANCET, V395, P1175, DOI 10.1016/S0140-6736(20)30801-1; Han JS, 2011, NEUROSCI BIOBEHAV R, V35, P680, DOI 10.1016/j.neubiorev.2010.08.006; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Ho YS, 2016, INORG CHEM COMMUN, V73, P174, DOI 10.1016/j.inoche.2016.10.023; Horton R, 2020, LANCET, V395, P1022, DOI 10.1016/S0140-6736(20)30727-3; Horton R, 2020, LANCET, V395, P935, DOI 10.1016/S0140-6736(20)30669-3; Horton R, 2020, LANCET, V395, P400, DOI 10.1016/S0140-6736(20)30299-3; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Ippolito G, 2020, LANCET RESP MED, V8, P230, DOI 10.1016/S2213-2600(20)30070-9; Isidro G, 2019, TELEMATIQUE, V18, P1; Jacobsen KH, 2020, LANCET, V395, P1013, DOI 10.1016/S0140-6736(20)30559-6; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Kamerow D, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1260; Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241; Knight S., 2020, NEW YORKER; Lei J., 2020, RADIOLOGY, V295, P18, DOI [DOI 10.1148/RADIOL.2020200236, 10.1148/radiol.2020200236]; Li Guangdi, 2020, Nat Rev Drug Discov, V19, P149, DOI 10.1038/d41573-020-00016-0; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Lopez I., 2017, TEKNOKULTURA, V14, P13, DOI 10.5209/TEKN.54142; Lopez-Lopez W, 2020, UNIV PSYCHOL, V19, DOI 10.11144/Javeriana.upsy19.pchi; Lopez-Lopez W, 2019, UNIV PSYCHOL, V18, DOI 10.11144/Javeriana.upsy18-5.acdu; McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4; Mendonca S, 2018, SCIENTOMETRICS, V117, P1513, DOI 10.1007/s11192-018-2909-1; Metz I, 2012, PERS REV, V41, P283, DOI 10.1108/00483481211212940; Campanario JM, 2006, SCIENTOMETRICS, V69, P365, DOI 10.1007/s11192-006-0158-1; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Ram Shri, 2020, Science & Technology Libraries, V39, DOI 10.1080/0194262X.2020.1742270; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sayburn A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1297; Schiariti V, 2020, DEV MED CHILD NEUROL, V62, P661, DOI 10.1111/dmcn.14526; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; van Leeuwen T, 2013, SCIENTOMETRICS, V95, P817, DOI 10.1007/s11192-012-0904-5; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Yang LY, 2012, SCIENTOMETRICS, V93, P497, DOI 10.1007/s11192-012-0695-8; Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/ncomms14542, 10.1038/s41467-017-01968-5]; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5	69	2	2	5	15	UNIV MALAYA, FAC COMPUTER SCIENCE & INFORMATION TECH	KUALA LUMPUR	UNIV MALAYA, FAC COMPUTER SCIENCE & INFORMATION TECH, KUALA LUMPUR, 50603, MALAYSIA	1394-6234			MALAYS J LIBR INF SC	Malays. J. Libr. Sci.		2021	26	1					103	116		10.22452/mjlis.vol26no1.6	http://dx.doi.org/10.22452/mjlis.vol26no1.6			14	Information Science & Library Science	Social Science Citation Index (SSCI)	Information Science & Library Science	RZ7JE		Bronze			2022-09-04	WOS:000648776900006
J	Springer, AE; Evans, AE; Ortuno, J; Salvo, D; Arevalo, MTV				Springer, Andrew E.; Evans, Alexandra E.; Ortuno, Jaquelin; Salvo, Deborah; Varela Arevalo, Maria Teresa			Health by Design: Interweaving Health Promotion into Environments and Settings	FRONTIERS IN PUBLIC HEALTH			English	Article						context; health and place; environments; settings; health promotion; health planning	PHYSICAL-ACTIVITY; COMPLEX INTERVENTIONS; VEGETABLE CONSUMPTION; BUILT ENVIRONMENT; SEX WORKERS; COMMUNITY; IMPLEMENTATION; CHILDREN; OBESITY; SCHOOL	The important influence of the environmental context on health and health behavior-which includes place, settings, and the multiple environments within place and settings-has directed health promotion planners from a focus solely on changing individuals, toward a focus on harnessing and changing context for individual and community health promotion. Health promotion planning frameworks such as Intervention Mapping provide helpful guidance in addressing various facets of the environmental context in health intervention design, including the environmental factors that influence a given health condition or behavior, environmental agents that can influence a population's health, and environmental change methods. In further exploring how to harness the environmental context for health promotion, we examine in this paper the concept of interweaving of health promotion into context, defined as weaving or blending together health promotion strategies, practices, programs, and policies to fit within, complement, and build from existing settings and environments. Health promotion interweaving stems from current perspectives in health intervention planning, improvement science and complex systems thinking by guiding practitioners from a conceptualization of context as a backdrop to intervention, to one that recognizes context as integral to the intervention design and to the potential to directly influence health outcomes. In exploring the general approach of health promotion interweaving, we examine selected theoretical and practice-based interweaving concepts in relation to four key environments (the policy environment, the information environment, the social/cultural/organizational environment, and the physical environment), followed by evidence-based and practice-based examples of health promotion interweaving from the literature. Interweaving of health promotion into context is a common practice for health planners in designing health promotion interventions, yet one which merits further intentionality as a specific health promotion planning design approach.	[Springer, Andrew E.; Evans, Alexandra E.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth Austin, Hlth Promot & Behav Sci, Michael & Susan Dell Ctr Hlth Living, Austin, TX 78701 USA; [Ortuno, Jaquelin] St Edwards Univ, Austin, TX 78704 USA; [Ortuno, Jaquelin] Univ Texas Hlth Sci Ctr Houston, Michael & Susan Dell Ctr Hlth Living, Sch Publ Hlth Austin, Austin, TX USA; [Salvo, Deborah] Univ Texas Sch Publ Hlth Austin, Michael & Susan Dell Ctr Hlth Living, Epidemiol Human Genet & Environm Sci, Austin, TX USA; [Salvo, Deborah] Inst Nacl Salud Publ, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Varela Arevalo, Maria Teresa] Pontificia Univ Javeriana Cali, Dept Ciencias Sociales, Cali, Colombia		Springer, AE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth Austin, Hlth Promot & Behav Sci, Michael & Susan Dell Ctr Hlth Living, Austin, TX 78701 USA.	andrew.e.springer@uth.tmc.edu	Varela, Maria Teresa/P-7043-2018	Varela, Maria Teresa/0000-0001-6034-7127; Salvo, Deborah/0000-0002-9726-0882	Michael & Susan Dell Foundation	Michael & Susan Dell Foundation	This paper was supported in part by a community health grant from the Michael & Susan Dell Foundation, which provides funding for the Michael & Susan Dell Center for Healthy Living/UTHealth School of Public Health-Austin where four of the five authors are based.	Akol A, 2014, GLOB HEALTH-SCI PRAC, V2, P472, DOI 10.9745/GHSP-D-14-00085; Andersen HB, 2017, AM J PREV MED, V53, pE81, DOI 10.1016/j.amepre.2017.03.010; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bartholomew Eldredge L. K., 2016, PLANNING HLTH PROMOT; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Carlton TA, 2017, PREV MED, V95, pS10, DOI 10.1016/j.ypmed.2016.08.037; Carson V, 2015, PEDIATR EXERC SCI, V27, P151, DOI 10.1123/pes.2014-0022; Center for Training and Research Translation (Center TRT), 2017, TEX MOTH FRIENDL WOR; Centers for Disease Control and Prevention, 2015, SOC EC MOD; Centers for Disease Control and Prevention, 2014, HLTH HLTH PLACES; Cerin E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0471-5; ChangeLab Solutions, 2017, WHAT IS SHAR US; Chawla L, 2015, J PLAN LIT, V30, P433, DOI 10.1177/0885412215595441; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; Child ST, 2016, AM J HEALTH PROMOT, V30, P634, DOI 10.4278/ajhp.140307-ARB-99; City of Austin, 2016, CORRIDOR PROGRAM IMP; Coleman J, 1994, FDN SOCIAL THEORY, P300; Collaboration for Change, 2017, DEV COMM AG; Cummings T.G., 2014, ORG DEV CHANGE; Dannenberg AL, 2008, AM J PREV MED, V34, P241, DOI 10.1016/j.amepre.2007.11.015; de Brun T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1587-z; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Falbe J, 2016, AM J PREV MED, V51, pE45, DOI 10.1016/j.amepre.2016.02.010; Flood J, 2015, HEALTH EDUC BEHAV, V42, P654, DOI 10.1177/1090198115577372; Francis J, 2012, SOC SCI MED, V74, P1570, DOI 10.1016/j.socscimed.2012.01.032; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Glanz K, 2016, SSM-POPUL HLTH, V2, P24, DOI 10.1016/j.ssmph.2016.02.002; Goetzel RZ, 2014, J OCCUP ENVIRON MED, V56, P927, DOI 10.1097/JOM.0000000000000276; Hawe P, 2015, ANNU REV PUBL HEALTH, V36, P307, DOI 10.1146/annurev-publhealth-031912-114421; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; HIEBERT EH, 1981, READ RES QUART, V16, P236, DOI 10.2307/747558; Hodder RK, 2017, PREV MED, V100, P248, DOI 10.1016/j.ypmed.2017.04.003; Holt-Lunstad J., 2015, HLTH BEHAV THEORY RE, P183, DOI DOI 10.3928/01484834-20140325-04; Ickes MJ, 2013, J PHYS ACT HEALTH, V10, P910, DOI 10.1123/jpah.10.6.910; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; King DK, 2010, AM J PUBLIC HEALTH, V100, P2076, DOI 10.2105/AJPH.2009.190959; Kok G, 2016, HEALTH PSYCHOL REV, V10, P297, DOI 10.1080/17437199.2015.1077155; Largo-Wight E, 2011, INT J ENVIRON HEAL R, V21, P41, DOI 10.1080/09603123.2010.499452; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Liss S., 2016, HLTH CLIN COMING MET; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; May CR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0506-3; McAlister A, 2000, J MASS COMMUN Q, V77, P143, DOI 10.1177/107769900007700111; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Miller RL, 2005, AM J COMMUN PSYCHOL, V35, P169, DOI 10.1007/s10464-005-3395-1; MINKLER M, 1989, HEALTH EDUC QUART, V16, P17, DOI 10.1177/109019818901600105; Mitchell C, 2016, GLOB PUBLIC HEALTH, V11, P651, DOI 10.1080/17441692.2016.1165720; Mode NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154535; Moos R.H., 1979, HLTH PSYCHOL HDB, P523; National Collaborative on Childhood Obesity Research (NCCOR), 2017, HLTH BEHAV DES BUILT; Neumann MM, 2014, EARLY CHILD RES Q, V29, P310, DOI 10.1016/j.ecresq.2014.03.005; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; O'Reilly-de Brun M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-015-1247-8; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pfadenhauer LM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0552-5; Preskill H, 2017, FACILITATING INTENTI; Puckrein GA, 2015, ETHNIC DIS, V25, P521, DOI 10.18865/ed.25.4.521; Reininger BM, 2015, SOC SCI MED, V143, P98, DOI 10.1016/j.socscimed.2015.08.029; Reininger BM, 2010, HEALTH PROMOT PRACT, V11, P347, DOI 10.1177/1524839908321486; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Robert Wood Johnson Foundation, 2017, BUILT ENV; Rudolph L, 2013, HLTH ALL POLICIES GU; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Sallis J.F., 2008, HLTH BEHAV HLTH ED T, P465, DOI DOI 10.7326/0003-4819-116-4-350_1; Sallis JF, 2016, LANCET, V388, P2936, DOI 10.1016/S0140-6736(16)30068-X; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2003, AM J PREV MED, V24, P209, DOI 10.1016/S0749-3797(02)00646-3; Salvo D, 2017, PREV MED, V103, pS27, DOI 10.1016/j.ypmed.2016.09.007; Salvo D, 2017, J URBAN HEALTH, V94, P470, DOI 10.1007/s11524-017-0167-9; Schuster MA, 2012, NEW ENGL J MED, V367, P735, DOI 10.1056/NEJMsa1114353; Shangani S, 2017, AIDS CARE, V29, P1003, DOI 10.1080/09540121.2017.1282105; Sharifi M, 2016, PREV MED, V91, P103, DOI 10.1016/j.ypmed.2016.07.009; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Simons-Morton BG, 2006, ACCIDENT ANAL PREV, V38, P907, DOI 10.1016/j.aap.2006.03.001; Slater MD, 2006, HEALTH EDUC RES, V21, P157, DOI 10.1093/her/cyh056; Slater SJ, 2013, AM J PREV MED, V44, P164, DOI 10.1016/j.amepre.2012.10.015; Springer AE, 2016, HEALTH PROMOT PERSPE, V6, P111, DOI 10.15171/hpp.2016.19; Springer AE, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/1479-5868-12-S1-S8; Springer AE, 2012, J PHYS ACT HEALTH, V9, P739, DOI 10.1123/jpah.9.5.739; Street Plans Collaborative, 2011, TACT URB SHORT TERM; Sustainable Food Center, 2017, DOUBL DOLL; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Texas Department of State Health Services, 2017, OLE TEX; Torres A, 2017, PREV MED, V103, pS51, DOI 10.1016/j.ypmed.2016.11.005; Torres Andrea, 2013, Am J Public Health, V103, pe23, DOI 10.2105/AJPH.2012.301142; Valente TW., 2015, HLTH BEHAV THEORY RE, P205; Van Vliet-Brown CE, 2018, HEALTH PROMOT INT, V33, P713, DOI 10.1093/heapro/dax008; VanEpps EM, 2016, CURR OBES REP, V5, P72, DOI 10.1007/s13679-016-0193-z; Williams AF, 2002, INJ PREV, V8, P293, DOI 10.1136/ip.8.4.293; Willows N, 2016, HEALTH SOC CARE COMM, V24, P567, DOI 10.1111/hsc.12229; World Health Organization (WHO), 2013, FRAM STAT C IN PRESS; Younan D, 2016, J AM ACAD CHILD PSY, V55, P591, DOI 10.1016/j.jaac.2016.05.002	98	11	11	4	16	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	SEP 29	2017	5								268	10.3389/fpubh.2017.00268	http://dx.doi.org/10.3389/fpubh.2017.00268			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FN0OB	29043248	Green Published, gold			2022-09-04	WOS:000415676600001
J	Liu, N; Tobon, L; Tang, YF; Liu, QH				Liu, Na; Tobon, Luis; Tang, Yifa; Liu, Qing Huo			Mixed Spectral Element Method for 2D Maxwell's Eigenvalue Problem	COMMUNICATIONS IN COMPUTATIONAL PHYSICS			English	Article						Maxwell eigenvalues; spectral element method; spurious eigenvalues	FINITE-ELEMENTS; SPURIOUS MODES	It is well known that conventional edge elements in solving vector Maxwell's eigenvalue equations by the finite element method will lead to the presence of spurious zero eigenvalues. This problem has been addressed for the first order edge element by Kikuchi by the mixed element method. Inspired by this approach, this paper describes a higher order mixed spectral element method (mixed SEM) for the computation of two-dimensional vector eigenvalue problem of Maxwell's equations. It utilizes Gauss-Lobatto-Legendre (GLL) polynomials as the basis functions in the finite-element framework with a weak divergence condition. It is shown that this method can suppress all spurious zero and nonzero modes and has spectral accuracy. A rigorous analysis of the convergence of the mixed SEM is presented, based on the higher order edge element interpolation error estimates, which fully confirms the robustness of our method. Numerical results are given for homogeneous, inhomogeneous, L-shape, coaxial and dual-inner-conductor cavities to verify the merits of the proposed method.	[Liu, Na] Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China; [Tobon, Luis; Liu, Qing Huo] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Tobon, Luis] Pontificia Univ Javeriana, Dept Ciencias & Ingn Comp, Cali, Colombia; [Tang, Yifa] Chinese Acad Sci, Acad Math & Syst Sci, ICMSEC, LSEC, Beijing 100190, Peoples R China		Liu, QH (corresponding author), Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China.	liuna@xmu.edu.cn; let12@duke.edu; tyf@lsec.cc.ac.cn; qhliu@duke.edu	Liu, Qing Huo/AFR-9899-2022; Liu, Qing Huo/AFO-6814-2022; TOBON, LUIS E/N-4459-2016	Liu, Qing Huo/0000-0001-5286-4423; Liu, Qing Huo/0000-0001-5286-4423; TOBON, LUIS E/0000-0003-2500-0982	Academy of Mathematics and Systems Science, Chinese Academy of Sciences; National Natural Science Foundation of China [11371357, 60931002, 41390453, 61301008]; Fujian Province Natural Science Foundation [2013J05060]	Academy of Mathematics and Systems Science, Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province)	We would also like to thank Dr. Yanmin Zhao, Mr. Qiang Ren and other research group members for helpful discussions. The research work in this paper was carried out while the first author was visiting Department of Electrical and Computer Engineering, Duke University under the support of Academy of Mathematics and Systems Science, Chinese Academy of Sciences. The research is also partially supported by supported by National Natural Science Foundation of China (Grant Nos. 11371357, 60931002, 41390453, and 61301008), and by Fujian Province Natural Science Foundation (Grant No. 2013J05060).	ADAM S, 1997, 275 ETH ZUR I SCI CO; BESPALOV AN, 1988, SOV J NUMER ANAL MAT, V3, P163; Boffi D., 1997, ANN SCUOLA NORM SU S, V25, P131; Boffi D, 2006, NUMER MATH, V105, P249, DOI 10.1007/s00211-006-0037-y; Boffi D, 2010, ACTA NUMER, V19, P1, DOI 10.1017/S0962492910000012; Brenner SC, 2008, SIAM J NUMER ANAL, V46, P1190, DOI 10.1137/060671760; Brenner SC, 2009, J SCI COMPUT, V40, P51, DOI 10.1007/s10915-008-9266-9; Cendes Z. J., 1986, DEV NEW METHODS PRED; Graglia RD, 2004, IEEE T ANTENN PROPAG, V52, P1672, DOI 10.1109/TAP.2004.831292; Hiptmair R, 2002, ACT NUMERIC, V11, P237; Hiptmair R, 2005, INT J NUMER METH ENG, V62, P1652, DOI 10.1002/nme.1241; KIKUCHI F, 1987, COMPUT METHOD APPL M, V64, P509; KOBELANSKY AJ, 1986, ELECTRON LETT, V22, P569, DOI 10.1049/el:19860387; Lee JH, 2006, IEEE T MICROW THEORY, V54, P437, DOI 10.1109/TMTT.2005.860502; Liu N., 2013, IEEE INT S ANT PROP; Luo M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026705; MONK P, 1994, J COMPUT APPL MATH, V53, P117, DOI 10.1016/0377-0427(92)00127-U; Monk P., 2003, NUMERICAL MATH SCI C; MUR G, 1994, IEEE T MAGN, V30, P3552, DOI 10.1109/20.312706; NEDELEC JC, 1980, NUMER MATH, V35, P315, DOI 10.1007/BF01396415; NEDELEC JC, 1986, NUMER MATH, V50, P57, DOI 10.1007/BF01389668; Pantic-Tanner Z, 1998, IEEE T MICROW THEORY, V46, P178, DOI 10.1109/22.660984; Peverini OA, 2011, IEEE T MICROW THEORY, V59, P1685, DOI 10.1109/TMTT.2011.2144991; RAHMAN BMA, 1984, IEEE T MICROW THEORY, V32, P922, DOI 10.1109/TMTT.1984.1132789; Silvester P., 1969, ALTA FREQ, V38, P313; SUN D, 1995, IEEE ANTENNAS PROPAG, V37, P12, DOI 10.1109/74.475860; SURI M, 1990, MATH COMPUT, V54, P1; WINKLER JR, 1984, J COMPUT PHYS, V56, P1, DOI 10.1016/0021-9991(84)90079-2	28	10	12	3	13	GLOBAL SCIENCE PRESS	WANCHAI	ROOM 3208, CENTRAL PLAZA, 18 HARBOUR RD, WANCHAI, HONG KONG 00000, PEOPLES R CHINA	1815-2406	1991-7120		COMMUN COMPUT PHYS	Commun. Comput. Phys.	FEB	2015	17	2					458	486		10.4208/cicp.230113.140814a	http://dx.doi.org/10.4208/cicp.230113.140814a			29	Physics, Mathematical	Science Citation Index Expanded (SCI-EXPANDED)	Physics	CH0EY					2022-09-04	WOS:000353693400006
J	Ruiz-Garcia, M; Vasquez, C; Camargo, E; Leguizamon, N; Galvez, H; Vallejo, A; Pinedo, M; Castellanos-Mora, L; Shostell, J; Alvarez, D				Ruiz-Garcia, Manuel; Vasquez, Catalina; Camargo, Emily; Leguizamon, Norberto; Galvez, Hugo; Vallejo, Adriana; Pinedo, Myreya; Castellanos-Mora, Luisa; Shostell, Joseph; Alvarez, Diana			Molecular Phylogenetics of Aotus (Platyrrhini, Cebidae)	INTERNATIONAL JOURNAL OF PRIMATOLOGY			English	Article						Aotus; Colombia; Microsatellites; mtCOII gene; Peru; Phylogenetic analyses	PERUVIAN OWL MONKEY; NEW-WORLD MONKEYS; GENUS AOTUS; NIGHT MONKEYS; DNA; EVOLUTION; PRIMATES; PHYLOGEOGRAPHY; DIVERSITY; COII	The accurate identification of taxa of Aotus is essential for 1) the development of precise biomedical assays, 2) the determination of potential illegal traffic of this genus, and 3) conservation. Although many studies have contributed to what we know about the phylogenetics of Aotus, none used a sufficiently large number of samples to clarify its complexity. To address this need, we sequenced 696 base pairs of the mitochondrial cytochrome-oxidase II gene (mtCOII) in 69 specimens of 7 taxa of Aotus. We also analyzed 8 microsatellite loci in 136 individuals of 6 taxa. In contrast to previous studies, we sampled only wild individuals and have a precise geographical origin for each one. The mtDNA results showed that: 1) the northern gray-necked group of Aotus is genetically more homogeneous than the polyphyletic red-necked group of Aotus; 2) the ancestors of Aotus vociferans seem to be the original species candidate for the current Aotus; 3) Aotus azarae azarae and A. a. boliviensis are the most differentiated taxa, likely a result of extreme genetic drift during stasipatric speciation; 4) the first genetic splits found among taxa of Aotus occurred during the Pliocene (or even Miocene) while the most recent ones happened during the Pleistocene, when forest refugia may have played an important role in speciation. The mean number of microsatellite alleles was 3-5.33 alleles per locus. We found some private alleles that could be useful in helping to identify illegal trade, although a larger sample size is needed to ensure that these alleles are really private to the relevant taxa. These new findings increase our understanding of the phylogeny of Aotus and the level of genetic diversity within different taxa of Aotus.	[Ruiz-Garcia, Manuel; Vasquez, Catalina; Camargo, Emily; Vallejo, Adriana; Pinedo, Myreya; Alvarez, Diana] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota, DC, Colombia; [Leguizamon, Norberto] Secretaria Distrital Ambiental, Bogota, DC, Colombia; [Galvez, Hugo] Inst Vet Invest Trop & Altura, Estn Expt, Iquitos, Peru; [Castellanos-Mora, Luisa] Fdn Omacha, Bogota, DC, Colombia; [Shostell, Joseph] Penn State Univ Fayette, Dept Biol, Uniontown, PA 15401 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota, DC, Colombia.	mruiz@javeriana.edu.co	Alvarez, Diana/AAF-8172-2019; Ruiz-Garcia, Manuel/AAF-8191-2019; Galvez, Hugo HG/J-2227-2017	Alvarez, Diana/0000-0001-6700-8101; Ruiz-Garcia, Manuel/0000-0003-2820-2950	SDA	SDA	We thank the SDA for the project entitled "Fortalecimiento del control y prevencion del trafico ilegal de fauna silvestre, especialmente de Primates, a traves de la determinacion de zonas sometidas a extraccion ilegal utilizando pruebas de genetica molecular de poblaciones," which allowed us to obtain the necessary financial resources to conduct the current study. We thank P. Escobar-Armel and A. Rodriguez for their help in obtaining samples of Aotus during the last 7 years. We thank the Bolivian and Peruvian Ministry of Environment; the Direccion General de Biodiversidad; the Wildlife Conservation Society and CITES from Bolivia; the PRODUCE, Direccion Nacional de Extraccion and Procesamiento Pesquero from Per; and the Consejo Nacional del Ambiente and the Instituto Nacional de Recursos Naturales (INRENA) for their role in facilitating the obtainment of the collection permits. Special thanks go to the Coleccion Boliviana de Fauna (Dr. Julieta Vargas) in La Paz (Bolivia). We also thank the Ticuna, Yucuna, Yaguas, Witoto, and Cocama Indian communities in the Colombian Amazon, Bora, Ocaina, Shipibo-Comibo, Capanahua, Angoteros, Orejon, Cocama, Kishuarana, and Alama in the Peruvian Amazon, and the Movima, Moxeno, Siriono, Canichana, Cayubaba, and Chacobo Indian communities in Bolivia. M. Ruiz-Garc a also thanks Drs. Thomas Defler and Sara Bennet for their continuous encouragement to conduct molecular genetic analyses of Neotropical primates. In addition, M. Ruiz-Garc a thanks Dr. Angela Maldonado and the referees for their reviews of this manuscript. This manuscript serves as tribute to all those Aotus sacrificed "in the name of science."	ADKINS RM, 1994, J MOL EVOL, V38, P215; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; ASHLEY MV, 1995, INT J PRIMATOL, V16, P793, DOI 10.1007/BF02735720; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barroso CML, 1997, INT J PRIMATOL, V18, P651, DOI 10.1023/A:1026371408379; BUSH GL, 1981, EVOLUTION SPECIATION; Chung WK, 2008, INT J PRIMATOL, V29, P1341, DOI 10.1007/s10764-008-9303-4; Collins AC, 2000, INT J PRIMATOL, V21, P381, DOI 10.1023/A:1005435718241; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Defler Thomas R., 2001, Neotropical Primates, V9, P37; Defler Thomas R., 2007, Primate Conservation, V22, P55, DOI 10.1896/052.022.0104; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ellsworth JA, 1998, MOL ECOL, V7, P657; Ford Susan M., 1994, P1; GALBREATH GJ, 1983, AM J PRIMATOL, V4, P245, DOI 10.1002/ajp.1350040303; Groves C. P., 2001, PRIMATE TAXONOMY; Haffer J., 1982, P6; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; HARRISON T, 1987, J HUM EVOL, V16, P41, DOI 10.1016/0047-2484(87)90060-1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hernandez-Camacho J., 1976, P35; HERSHKOVITZ P, 1983, AM J PRIMATOL, V4, P209, DOI 10.1002/ajp.1350040302; HERSHKOVITZ P, 1949, MUSEUM, V98, P323; Hershkovitz P., 1977, LIVING NEW WORLD MON; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau J, 2004, CONSERV GENET, V5, P727, DOI 10.1007/s10592-004-1851-3; Lavergne A, 2010, AM J PRIMATOL, V72, P242, DOI 10.1002/ajp.20773; Lonnberg Einar, 1941, ARKIV ZOOL [STOCKHOLM], V33A, P1; Lundberg John G., 1998, P13; MA NSF, 1980, J HERED, V71, P336, DOI 10.1093/oxfordjournals.jhered.a109382; MA NSF, 1982, IMMUNOGENETICS, V15, P1, DOI 10.1007/BF00375497; MA NSF, 1985, AM J PRIMATOL, V9, P333, DOI 10.1002/ajp.1350090409; MA NSF, 1981, AM J PHYS ANTHROPOL, V54, P293, DOI 10.1002/ajpa.1330540302; Maldonado Angela M., 2010, Endangered Species Research, V9, P143, DOI 10.3354/esr00209; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nei M., 2000, MOL EVOLUTION PHYLOG; PIECZARKA JC, 1988, AM J PRIMATOL, V14, P255, DOI 10.1002/ajp.1350140306; PIECZARKA JC, 1993, PRIMATES, V34, P197, DOI 10.1007/BF02381390; Plautz HL, 2009, MOL PHYLOGENET EVOL, V51, P382, DOI 10.1016/j.ympev.2009.01.005; Rambaut A., 2014, TRACER V16; RENDFORD R, 2002, ORIGENES EVOLUCION C; Ruiz-Garcia M., 2006, Primate Report, V73, P3; Ruiz-Garcia M, 2007, FOLIA PRIMATOL, V78, P73, DOI 10.1159/000097058; Ruiz-Garcia M., 2005, Primate Report, V71, P27; Ruiz-Garcia M, 2010, MOL POPULATION GENET; Ruiz-Garcia M, 2010, FOLIA PRIMATOL, V81, P109, DOI 10.1159/000315070; Ruiz-Garcia M, 2010, REV BIOL TROP, V58, P1049; RUIZGARCIA M, 2010, GENETICA UNPUB; RUIZGARCIA M, 2011, MOL ECOLOGY IN PRESS; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Torres OM, 1998, AM J PRIMATOL, V44, P255, DOI 10.1002/(SICI)1098-2345(1998)44:4<255::AID-AJP2>3.0.CO;2-V; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; White M. J. D., 1978, MODES SPECIATION; WHITE MJD, 1968, SCIENCE, V159, P1065, DOI 10.1126/science.159.3819.1065; WHITMORE TC, 1987, OXFORD MONOGRAPHS BI, V3	68	15	20	0	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0164-0291	1573-8604		INT J PRIMATOL	Int. J. Primatol.	OCT	2011	32	5					1218	1241		10.1007/s10764-011-9539-2	http://dx.doi.org/10.1007/s10764-011-9539-2			24	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	857UL					2022-09-04	WOS:000297747200013
J	Cordoba-Rodriguez, DP; Iglesia, I; Gomez-Bruton, A; Miguel-Berges, ML; Flores-Barrantes, P; Casajus, JA; Moreno, LA; Rodriguez, G				Cordoba-Rodriguez, Diana Paola; Iglesia, Iris; Gomez-Bruton, Alejandro; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Casajus, Jose Antonio; Moreno, Luis A.; Rodriguez, Gerardo			Associations between Spanish children's physical activity and physical fitness with lean body mass: The CALINA study	JOURNAL OF SPORTS SCIENCES			English	Article						Lean body mass; muscle cross-sectional area; physical activity; physical fitness; schoolchildren	BONE-MINERAL DENSITY; DIET QUALITY INDEX; FAT-FREE MASS; PRESCHOOL-CHILDREN; TRABECULAR BONE; MUSCLE MASS; ADOLESCENTS; STRENGTH; HEALTH; VALIDATION	The present study investigated the associations between physical activity (PA) and physical fitness (PF) with lean body mass (LBM) and evaluated whether PA mediates the association between PF and LBM. 279 children (150 boys) aged 7.5 +/- 0.3 years participated in the study. PA was assessed by accelerometry and PF with handgrip and the standing long jump test. Total lean soft tissue mass index (TLSTMI), muscle cross-sectional area index (MCSAI), and fat-free mass index (FFMI) were evaluated using dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and bioimpedance analysis, respectively. Total (beta = 0.247) and vigorous PA (beta = 0.143) were associated with TLSTMI in girls. In boys, total (beta = 0.337), light (beta = 0.290), vigorous (beta = 0.200), and moderate-vigorous PA (beta = 0.189) were associated with TLSTMI. Total PA was associated with FFMI (beta = 0.299). Handgrip strength does not mediate the relationship between total PA and TLSTMI. Positive associations were found between handgrip strength and TLSTMI, MCSAI, and FFMI in both girls and boys. In children, there is a positive association between total and vigorous PA with TLSTMI. Handgrip strength does not mediate the relationship between total PA and TLSTMI. It was associated with TLSTMI, MCSAI, and FFMI.	[Cordoba-Rodriguez, Diana Paola] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Iglesia, Iris; Gomez-Bruton, Alejandro; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Casajus, Jose Antonio; Moreno, Luis A.] Univ Zaragoza, Inst Agroalimentario Aragon Ia2, Growth Exercise Nutr & Dev Genud Res Grp, Zaragoza, Spain; [Iglesia, Iris; Casajus, Jose Antonio; Moreno, Luis A.; Rodriguez, Gerardo] Inst Invest Sanitaria Aragon Iis Aragon, Zaragoza, Spain; [Iglesia, Iris; Rodriguez, Gerardo] Inst Salud Carlos III, Red Salud Materno Infantil & Desarrollo Samid, Madrid, Spain; [Gomez-Bruton, Alejandro; Casajus, Jose Antonio] Univ Zaragoza, Dept Fisiatria & Enfermeria, Fac Ciencias Salud & Deporte Fcsd, Zaragoza, Spain; [Gomez-Bruton, Alejandro; Casajus, Jose Antonio; Moreno, Luis A.] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Rodriguez, Gerardo] Univ Zaragoza, Area Pediat, Zaragoza, Spain		Gomez-Bruton, A (corresponding author), Univ Zaragoza, Growth Exercise Nutr & Dev Genud Res Grp, Zaragoza, Spain.	bruton@unizar.es	Bruton, Alejandro Gomez/L-5724-2018; Rodriguez, Gerardo/AAG-9855-2020; Cordoba-Rodriguez, Diana Paola/AAG-7457-2019	Bruton, Alejandro Gomez/0000-0002-0520-1640; Rodriguez, Gerardo/0000-0002-7985-9912; Cordoba-Rodriguez, Diana Paola/0000-0002-7034-8796; Casajus Mallen, Jose Antonio/0000-0002-7215-6931	Instituto de Salud Carlos III [PI08/0559, PI13/02359, RD16/0022]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Instituto de Salud Carlos III, Award Number: PI08/0559 | Recipient: Gerardo RodriguezInstituto de Salud Carlos III, Award Number: PI13/02359 | Recipient: Gerardo RodriguezInstituto de Salud Carlos III, Award Number: RD16/0022 | Recipient: Gerardo RodriguezCarolina Foundation, Award Number: Ph.D. Grants | Recipient: Diana Paola Cordoba-Rodriguez	[Anonymous], 2012, INT STAND CLASS ED I; Bammann K, 2011, INT J OBESITY, V35, pS79, DOI 10.1038/ijo.2011.38; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter-Jones ADG, 2008, J APPL PHYSIOL, V105, P734, DOI 10.1152/japplphysiol.00869.2007; Bazzocchi A, 2016, EUR J RADIOL, V85, P1481, DOI 10.1016/j.ejrad.2016.04.004; Boisseau N, 2000, SPORTS MED, V30, P405, DOI 10.2165/00007256-200030060-00003; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Burrows R, 2017, PEDIATR DIABETES, V18, P895, DOI 10.1111/pedi.12505; Carson V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071417, 10.1371/journal.pone.0056700]; Carver A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-126; Centers for Disease Control and Prevention,, 2013, NATL HLTH NUTR EXAMI; Crabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Deheeger M, 1997, INT J OBESITY, V21, P372, DOI 10.1038/sj.ijo.0800415; Dorsey KB, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-41; Dotan R, 2012, PEDIATR EXERC SCI, V24, P2, DOI 10.1123/pes.24.1.2; Espana-Romero V, 2008, J HAND SURG-AM, V33A, P378, DOI 10.1016/j.jhsa.2007.11.013; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Foo LH, 2007, BRIT J NUTR, V98, P1281, DOI 10.1017/S0007114507787421; Lopez-Gil JF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020567; Frank-Wilson AW, 2015, BONE, V75, P49, DOI 10.1016/j.bone.2015.01.016; Fraser Brooklyn J., 2020, Journal of Sports Sciences, V38, DOI 10.1080/02640414.2019.1679575; Gomez-Bruton A, 2014, NUTR HOSP, V30, P399, DOI 10.3305/nh.2014.30.2.7603; Gonzalez-Aguero A, 2013, OSTEOPOROSIS INT, V24, P1035, DOI 10.1007/s00198-012-2041-7; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Gracia-Marco L, 2016, PROG CARDIOVASC DIS, V58, P555, DOI 10.1016/j.pcad.2015.11.002; Guglielmi G, 2016, AGING CLIN EXP RES, V28, P1047, DOI 10.1007/s40520-016-0589-3; Hao G, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12471; Heelan Kate A, 2006, J Phys Act Health, V3, P200, DOI 10.1123/jpah.3.2.200; Henriksson P, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080473; Heymsfield SB, 2015, P NUTR SOC, V74, P355, DOI 10.1017/S0029665115000129; Huybrechts I, 2010, BRIT J NUTR, V104, P135, DOI 10.1017/S0007114510000231; Iglesia I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030642; Isganaitis E, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1170-1; Jimenez-Pavon D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-667; Jurimae T, 2009, HOMO, V60, P225, DOI 10.1016/j.jchb.2008.05.004; Kim JH, 2016, NUTR RES, V36, P1423, DOI 10.1016/j.nutres.2016.09.013; Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153383; Kim S, 2015, OBES RES CLIN PRACT, V9, P125, DOI 10.1016/j.orcp.2014.05.002; Kulkarni B, 2014, NUTR REV, V72, P190, DOI 10.1111/nure.12097; Kuriyan R, 2018, INDIAN J MED RES, V148, P648, DOI 10.4103/ijmr.IJMR_1777_18; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; Larque E, 2019, NAT REV ENDOCRINOL, V15, P456, DOI 10.1038/s41574-019-0219-1; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; Leppanen MH, 2016, INT J OBESITY, V40, P1126, DOI 10.1038/ijo.2016.54; Leppanen MH, 2017, MED SCI SPORT EXER, V49, P2078, DOI 10.1249/MSS.0000000000001313; Liu Junting, 2019, J Cachexia Sarcopenia Muscle, V10, P155, DOI 10.1002/jcsm.12361; Moliner-Urdiales D, 2010, EUR J APPL PHYSIOL, V109, P1119, DOI 10.1007/s00421-010-1457-z; Mouratidou T, 2019, NUTRITION, V65, P60, DOI 10.1016/j.nut.2019.03.003; Organization  W.H, 2020, WHO GUID PHYS ACT SE; Orsso CE, 2019, CLIN NUTR, V38, P2002, DOI 10.1016/j.clnu.2019.04.012; Ortega FB, 2015, SPORTS MED, V45, P533, DOI 10.1007/s40279-014-0281-8; Suarez BO, 2014, AN PEDIATR, V81, P32, DOI 10.1016/j.anpedi.2013.09.008; Cordoba-Rodriguez DP, 2021, ANN HUM BIOL, V48, P93, DOI 10.1080/03014460.2021.1877352; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Ramires VV, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0430-6; Rennie KL, 2005, AM J CLIN NUTR, V82, P13, DOI 10.1093/ajcn/82.1.13; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Roggen I, 2015, CALCIFIED TISSUE INT, V96, P527, DOI 10.1007/s00223-015-9988-2; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Santos DA, 2019, MED SCI SPORT EXER, V51, P323, DOI 10.1249/MSS.0000000000001785; Scheurer JM, 2018, NEONATOLOGY, V114, P169, DOI 10.1159/000487915; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Sioen I, 2016, CALCIFIED TISSUE INT, V99, P557, DOI 10.1007/s00223-016-0183-x; Tanita Corporation, BODY COMPOSITION ANA; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P47, DOI [10.1139/H11-009, 10.1139/H11-010]; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; UNESCO, 1997, INT STANDARD CLASSIF; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Vicente-Rodriguez G, 2004, MED SCI SPORT EXER, V36, P1789, DOI 10.1249/01.MSS.0000142311.75866.D7; Vyncke K, 2013, BRIT J NUTR, V109, P2067, DOI 10.1017/S000711451200414X; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Westerterp Klaas R, 2021, Am J Clin Nutr, V114, P1583, DOI 10.1093/ajcn/nqab260; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Wyszynska J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041210	77	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	FEB 16	2022	40	4					401	412		10.1080/02640414.2021.1994728	http://dx.doi.org/10.1080/02640414.2021.1994728		OCT 2021	12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ZS6SY	34720058				2022-09-04	WOS:000713489500001
J	Lin, L; Xie, JK; Sanchez, OF; Bryan, C; Freeman, JL; Yuan, CL				Lin, Li F.; Xie, Junkai; Sanchez, Oscar F.; Bryan, Chris; Freeman, Jennifer L.; Yuan, Chongli			Low dose lead exposure induces alterations on heterochromatin hallmarks persisting through SH-SY5Y cell differentiation	CHEMOSPHERE			English	Article						Lead exposure; 5 mC; H3K9me3; H3K27me3; Epigenetic persistence	DNA METHYLATION; PB EXPOSURE; LEVEL; SEX; TRANSCRIPTION; OUTGROWTH; CRIME; WATER; RISK	Lead (Pb) is a commonly found heavy metal due to its historical applications. Recent studies have associated early-life Pb exposure with the onset of various neurodegenerative disease. The molecular mechanisms of Pb conferring long-term neurotoxicity, however, is yet to be elucidated. In this study, we explored the persistency of alteration in epigenetic marks that arise from exposure to low dose of Pb using a combination of image-based and gene expression analysis. Using SH-SY5Y as a model cell line, we observed significant alterations in global 5-methycytosine (5 mC) and histone 3 lysine 27 tri-methylation (H3K27me3) and histone 3 lysine 9 tri-methylation (H3K9me3) levels in a dose-dependent manner immediately after Pb exposure. The changes are partially associated with alterations in epigenetic enzyme expression levels. Long term culturing (14 days) after cease of exposure revealed persistent changes in 5 mC, partial recovery in H3K9me3 and overcompensation in H3K27me3 levels. The observed alterations in H3K9me3 and H3K27me3 are reversed after neuronal differentiation, while reduction in 5 mC levels are amplified with significant changes in patterns as identified via texture clustering analysis. Moreover, correlation analysis demonstrates a strong positive correlation between trends of 5 mC alteration after differentiation and neuronal morphology. Collectively, our results suggest that exposure to low dose of Pb prior to differentiation can result in persistent epigenome alterations that can potentially be responsible for the observed phenotypic changes. Our work reveals that Pb induced changes in epigenetic repressive marks can persist through neuron differentiation, which provides a plausible mechanism underlying long-term neurotoxicity associated with developmental Pb-exposure. (C) 2020 Elsevier Ltd. All rights reserved.	[Lin, Li F.; Xie, Junkai; Yuan, Chongli] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA; [Sanchez, Oscar F.] Pontificia Univ Javeriana, Dept Nutr & Biochem, Bogota 110231, Colombia; [Bryan, Chris] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Freeman, Jennifer L.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Freeman, Jennifer L.; Yuan, Chongli] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Lin, Li F.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94704 USA		Yuan, CL (corresponding author), Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.	cyuan@purdue.edu	Sanchez, Oscar/A-5612-2013	Sanchez, Oscar/0000-0003-2237-0945; Freeman, Jennifer/0000-0002-3669-9111; Yuan, Chongli/0000-0003-3765-0931	National Science Foundation [CBET-1512285, CBET-1705560, EF-1935226]	National Science Foundation(National Science Foundation (NSF))	This workwas supported by National Science Foundation [CBET-1512285, CBET-1705560 & EF-1935226].	ANNEST JL, 1983, NEW ENGL J MED, V308, P1373, DOI 10.1056/NEJM198306093082301; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Bellinger DC, 2018, ADV NEUROTOXICOL, V2, P1, DOI 10.1016/bs.ant.2018.03.009; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bihaqi SW, 2017, NEUROTOXICOLOGY, V62, P218, DOI 10.1016/j.neuro.2017.07.029; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P178, DOI 10.1016/j.neuro.2012.01.010; Cecil KM, 2011, ENVIRON HEALTH PERSP, V119, P403, DOI 10.1289/ehp.1002176; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Cedar H, 2017, INT J DEV BIOL, V61, P137, DOI 10.1387/ijdb.160270hc; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chilton J.K., 2007, INTRACELLULAR MECH N, P57; Coon S, 2006, ENVIRON HEALTH PERSP, V114, P1872, DOI 10.1289/ehp.9102; Crumpton T, 2001, NEUROTOXICOLOGY, V22, P49, DOI 10.1016/S0161-813X(00)00008-5; Davidovics Z, 2005, J NEUROSCI RES, V80, P817, DOI 10.1002/jnr.20539; Deng WB, 2001, TOXICOL APPL PHARM, V174, P235, DOI 10.1006/taap.2001.9219; Dignam T., 2019, J PUBL HLTH MANAG PR, V25; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Eid Aseel, 2016, Alzheimers Dement (Amst), V2, P123, DOI 10.1016/j.dadm.2016.02.002; Fanti Z, 2008, IEEE ENG MED BIO, P1196, DOI 10.1109/IEMBS.2008.4649377; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Perez MF, 2019, NAT CELL BIOL, V21, P143, DOI 10.1038/s41556-018-0242-9; Gu XZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1912-7; Hauptman M, 2017, CLIN PEDIATR EMERG M, V18, P181, DOI 10.1016/j.cpem.2017.07.010; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jarvis P, 2018, SCI TOTAL ENVIRON, V644, P1346, DOI 10.1016/j.scitotenv.2018.07.064; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Keniry A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0064-6; Kim Y, 2013, NEUROTOXICOLOGY, V35, P15, DOI 10.1016/j.neuro.2012.11.006; Kribelbauer JF, 2017, CELL REP, V19, P2383, DOI 10.1016/j.celrep.2017.05.069; Kungulovski G, 2014, GENOME RES, V24, P1842, DOI 10.1101/gr.170985.113; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2018, LANCET PUBLIC HEALTH, V3, pE177, DOI 10.1016/S2468-2667(18)30025-2; Lee J, 2017, J APPL TOXICOL, V37, P400, DOI 10.1002/jat.3372; Li CP, 2011, TOXICOL LETT, V203, P48, DOI 10.1016/j.toxlet.2011.03.002; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li YY, 2012, ENVIRON TOXICOL, V27, P495, DOI 10.1002/tox.20666; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/tit.1982.1056489; LU XH, 2016, NAT COMMUN, V7, DOI DOI 10.1145/2883816; Mansouri MT, 2009, ENVIRON TOXICOL PHAR, V27, P307, DOI 10.1016/j.etap.2009.01.003; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; Meyer DN, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125527; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Nevin R, 2000, ENVIRON RES, V83, P1, DOI 10.1006/enrs.1999.4045; Nevin R, 2007, ENVIRON RES, V104, P315, DOI 10.1016/j.envres.2007.02.008; Nicetto D, 2019, SCIENCE, V363, P294, DOI 10.1126/science.aau0583; NRIAGU JO, 1990, SCI TOTAL ENVIRON, V92, P13, DOI 10.1016/0048-9697(90)90318-O; Nye MD, 2015, TOXICOL IN VITRO, V29, P544, DOI 10.1016/j.tiv.2015.01.002; Obeng-Gyasi E, 2019, REV ENVIRON HEALTH, V34, P25, DOI 10.1515/reveh-2018-0037; Pieper KJ, 2018, ENVIRON SCI TECHNOL, V52, P8124, DOI 10.1021/acs.est.8b00791; Ramsawhook AH, 2017, JOVE-J VIS EXP, DOI 10.3791/56318; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanchez OF, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113712; Sanchez OF, 2019, ACS OMEGA, V4, P13250, DOI 10.1021/acsomega.9b01413; Sanchez OF, 2017, METALLOMICS, V9, P149, DOI 10.1039/c6mt00198j; Schneider JS, 2016, NEUROTOXICOLOGY, V54, P65, DOI 10.1016/j.neuro.2016.03.016; Shefa ST, 2017, TOXICOL LETT, V280, P232, DOI 10.1016/j.toxlet.2017.08.015; Shenoda BB, 2018, J PAIN RES, V11, P935, DOI 10.2147/JPR.S159458; Shipley Mackenzie M, 2016, J Vis Exp, P53193, DOI 10.3791/53193; Singh G, 2018, TOXICOL LETT, V290, P63, DOI 10.1016/j.toxlet.2018.03.021; Stefanovski D, 2017, ONCOTARGET, V8, P57278, DOI 10.18632/oncotarget.18985; Sun H, 2017, 2017 INTERNATIONAL CONFERENCE ON COMPUTER NETWORK, ELECTRONIC AND AUTOMATION (ICCNEA), P12, DOI 10.1109/ICCNEA.2017.15; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Triantafyllidou S, 2009, GLOBAL NEST J, V11, P341; Triantafyllidou S, 2013, ENVIRON MONIT ASSESS, V185, P1355, DOI 10.1007/s10661-012-2637-6; Tyssowski K, 2014, NEUROSCIENCE, V264, P4, DOI 10.1016/j.neuroscience.2013.10.008; Watanabe T, 2000, SCI TOTAL ENVIRON, V247, P1, DOI 10.1016/S0048-9697(99)00416-7; Weisskopf MG, 2010, ENVIRON HEALTH PERSP, V118, P1609, DOI 10.1289/ehp.1002339; Wilson N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-1; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Xiao J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0719-8; Xicoy H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0149-0; Yan D, 2008, NEUROSCIENCE, V153, P436, DOI 10.1016/j.neuroscience.2008.02.016; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Zenk F, 2017, SCIENCE, V357, P212, DOI 10.1126/science.aam5339; Zou RX, 2020, TOXICOL IN VITRO, V63, DOI 10.1016/j.tiv.2019.104742	83	8	8	3	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	FEB	2021	264		1						128486	10.1016/j.chemosphere.2020.128486	http://dx.doi.org/10.1016/j.chemosphere.2020.128486			12	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	PG6AZ	33032221	Green Submitted			2022-09-04	WOS:000599817400069
J	Barbosa, JQ; Figueroa, APC; Salas, SS; Camargo, H; Sanchez, A; Tobon, J; Ortiz, D; Schachtebeck, E; Gutierrez, MF				Quintero Barbosa, Juan; Corredor Figueroa, Adriana P.; Salas, Sandra S.; Camargo, Hugo; Sanchez, Alfredo; Tobon, Julio; Ortiz, Diego; Schachtebeck, Eric; Fernanda Gutierrez, Maria			High prevalence of persistently infected animals from bovine viral diarrhea in Colombian cattle	BMC VETERINARY RESEARCH			English	Article						Bovine viral diarrhea virus; Persistently infected animals; Genotype	HOBI-LIKE; MOLECULAR CHARACTERIZATION; VIRUS; PESTIVIRUSES; RHINOTRACHEITIS; IDENTIFICATION; DIVERSITY; ASSAYS; PCR	BackgroundBovine Viral Diarrhea Virus (BVDV) is associated with gastrointestinal, respiratory and reproductive diseases of livestock across the world that causes continuous economic losses in the cattle industry. This virus can establish a persistent infection (PI) in calves after the fetal infection, making BVDV positive catle carriers and primary reservoirs which will constantly transmit the virus to healthy and new-born animals. For this reason, the detection of the PI animals in herds is the first line of prevention of the viral infection.ResultsIn this study, PI animals were detected in five different regions of Colombia through RT-PCR techniques and confirmed by sequencing. BVDV genotypes were determined using one fragment of the 5'UTR. It was found a 7% BVDV prevalence in animals and 22% in farms; and genotype 1 was identified as a single genotype for all of the samples. All samples were BVDV 1a.ConclusionThis is the first report in Colombia with higher prevalence rates compared with other places in the world, turned out to be of great importance for the ranchers, the vaccine producers and animal health control parties.	[Quintero Barbosa, Juan; Fernanda Gutierrez, Maria] Univ Ind Santander, Escuela Biol, Carrera 27 Calle 9,Ed 45, Bucaramanga, Colombia; [Corredor Figueroa, Adriana P.; Salas, Sandra S.] Pontificia Univ Javeriana, Dept Microbiol, Carrera 7 40-62, Bogota, Colombia; [Camargo, Hugo; Sanchez, Alfredo; Tobon, Julio] Empresa Colombiana Prod Vet VECOL, Av Eldorado 82-93, Bogota, Colombia; [Ortiz, Diego] Corp Colombiana Invest Agr CORPOICA, Km 14,Via Mosquera Bogota, Mosquera, Colombia; [Schachtebeck, Eric] Univ Antonio Narino, Fac Vet, Carrera 3 Este 47 A-15, Bogota, Colombia		Gutierrez, MF (corresponding author), Univ Ind Santander, Escuela Biol, Carrera 27 Calle 9,Ed 45, Bucaramanga, Colombia.	mfgutier@javeriana.edu.co	Gutierrez, Maria/AAF-2966-2019	Tobon Torreglosa, Julio Cesar/0000-0003-2705-3770; Gutierrez, Maria Fernanda/0000-0003-0767-3737; ORTIZ ORTEGA, DIEGO/0000-0002-7042-2829	Pontificia Universidad Javeriana and Vecol	Pontificia Universidad Javeriana and Vecol	This work was supported by the Pontificia Universidad Javeriana and Vecol.	Brodersen BW, 2014, VET PATHOL, V51, P453, DOI 10.1177/0300985813520250; Chernick A, 2018, INFECT GENET EVOL, V58, P218, DOI 10.1016/j.meegid.2018.01.002; Ebranati E, 2018, INFECT GENET EVOL, V58, P258, DOI 10.1016/j.meegid.2018.01.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Factor C, 2017, VET REC OPEN, V3, P1; Giammarioli M, 2015, BIOLOGICALS, V43, P220, DOI 10.1016/j.biologicals.2015.05.009; Gunn GJ, 2005, PREV VET MED, V72, P149, DOI 10.1016/j.prevetmed.2005.08.012; Haider N, 2014, TRANSBOUND EMERG DIS, V61, P193, DOI 10.1111/tbed.12218; Hanon JB, 2014, TRANSBOUND EMERG DIS, V61, P156, DOI 10.1111/tbed.12011; Houe H, 2006, J VET DIAGN INVEST, V18, P427, DOI 10.1177/104063870601800501; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; Huaman JC, 2007, REV INVESTIG VET PER, V18, P141; ICTV, 2015, ICTV VIR TAX; Kameyama K, 2016, J VET MED SCI, V78, P1329, DOI 10.1292/jvms.15-0555; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Maya L, 2016, ARCH VIROL, V161, P529, DOI 10.1007/s00705-015-2688-4; Mishra N, 2014, VET MICROBIOL, V174, P239, DOI 10.1016/j.vetmic.2014.09.017; Newcomer BW, 2016, VET CLIN N AM-FOOD A, V32, P425, DOI 10.1016/j.cvfa.2016.01.011; O'Brien E, 2017, RES VET SCI, V111, P14, DOI 10.1016/j.rvsc.2016.10.017; Pecora A, 2014, RES VET SCI, V96, P204, DOI 10.1016/j.rvsc.2013.11.004; Pizarro-Lucero J, 2006, VET MICROBIOL, V115, P208, DOI 10.1016/j.vetmic.2006.02.009; Ramos AE, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0324-2; Ridpath JF, 2010, VET CLIN N AM-FOOD A, V26, P105, DOI 10.1016/j.cvfa.2009.10.007; Sandvik T, 2005, PREV VET MED, V72, P3, DOI 10.1016/j.prevetmed.2005.08.015; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Silveira S, 2018, TRANSBOUND EMERG DIS, V65, pe113, DOI 10.1111/tbed.12689; Smith DB, 2017, J GEN VIROL, V98, P2106, DOI 10.1099/jgv.0.000873; Tajima M, 2001, VIRUS RES, V76, P31, DOI 10.1016/S0168-1702(01)00244-1; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Vargas DS, 2009, REV COLOMB CIENC PEC, V22, P677; VILCEK S, 1994, J CLIN MICROBIOL, V32, P2225, DOI 10.1128/JCM.32.9.2225-2231.1994; Walz PH, 2010, J VET INTERN MED, V24, P476, DOI 10.1111/j.1939-1676.2010.0502.x; Weber MN, 2015, INFECT GENET EVOL, V30, P219, DOI 10.1016/j.meegid.2014.12.032; Workman AM, 2016, J VET DIAGN INVEST, V28, P519, DOI 10.1177/1040638716654943; Wu ZW, 2003, AIDS RES HUM RETROV, V19, P201, DOI 10.1089/088922203763315704; Xue WZ, 2011, VACCINE, V29, P4657, DOI 10.1016/j.vaccine.2011.04.129; Yesilbag K, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060128	37	2	2	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1746-6148			BMC VET RES	BMC Vet. Res.	JAN 10	2019	15								23	10.1186/s12917-018-1769-5	http://dx.doi.org/10.1186/s12917-018-1769-5			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	HH1PQ	30630483	Green Published, gold			2022-09-04	WOS:000455492500001
J	Lopez, WL; Alvarado, GS; Rodriguez, S; Ruiz, C; Leon, JD; Pineda-Marin, C; Mullet, E				Lopez Lopez, Wilson; Sandoval Alvarado, Gonzalo; Rodriguez, Sebastian; Ruiz, Camila; David Leon, Juan; Pineda-Marin, Claudia; Mullet, Etienne			Forgiving Former Perpetrators of Violence and Reintegrating Them into Colombian Civil Society: Noncombatant Citizens' Positions	PEACE AND CONFLICT-JOURNAL OF PEACE PSYCHOLOGY			English	Article						forgiveness; reintegration; Colombia; paramilitary forces; guerrilla	INTERGROUP FORGIVENESS; NORTHERN-IRELAND; RECONCILIATION SENTIMENT; COLLECTIVE GUILT; PTSD SYMPTOMS; MENTAL-HEALTH; CONFLICT; IMPACT; ASSOCIATION; GENOCIDE	The study examined Colombian people's positions on forgiving former actors in the armed civil conflict and on reintegrating them into society. A convenience sample of 550 adults living in Bogota was presented with 12 realistic stories depicting a former perpetrator of violence (a member of the guerillas, the paramilitary, or the military) who begged a victim's family for forgiveness. The vignettes were created by combining the levels of 4 factors-Identity X Apologies (has apologized and offered compensation or not) X Type of Crime (murder or destruction of property) X Level of Responsibility (mere agent or organizer)-in a Latin square design. Three different rating scales were used: a willingness to forgive scale, an acceptance in the neighborhood scale, and an acceptance as a coworker scale. Through cluster analysis, 4 personal positions regarding forgiveness were found: a never forgive under any circumstances position (29%), a hesitant position (23%), an always forgive position (18%), and a depends on circumstances position (13%). Few participants adopted positions showing that at least minimal deliberation (weighing the pros and the cons) had taken place before responding. In addition, 17% of the sample was totally undetermined. Ninety-two percent of the participants who were hostile to forgiveness or hesitant were unwilling to have former perpetrators live in their neighborhoods, and 94% were unwilling to have them as coworkers. The corresponding figures were 62% and 66%, respectively, for participants holding an always forgive position. The gut reaction to former perpetrators found regarding the possibility of forgiving extended to the issue of reintegration. Overall, and despite the fact that, from a practical viewpoint, reintegrating people into society does not imply full forgiveness, Colombian people's views on reintegration are not more favorable than are their views on forgiveness. Public Significance Statement During the past few years, and possibly as a result of the development of the peace process, Colombian citizens have become more open to the idea of forgiveness to perpetrators of violence. This change has not yet manifested itself in a visible way, however. Rather, some people who were, in the recent past, hostile to the idea of forgiveness are now in a state of indetermination. To be successful, the reintegration of former perpetrators into society must be done with care, on a voluntary basis. Some citizens are blatantly hostile to the idea of living and working in the same places as former perpetrators; it would be difficult to impose perpetrators' presence on them in these places. A minority of citizens, however, is open to this idea: The process of reintegration is, therefore, not necessarily blocked everywhere.	[Lopez Lopez, Wilson] Pontificia Javeriana Univ, Dept Psychol, Bogota, Colombia; [Sandoval Alvarado, Gonzalo; Rodriguez, Sebastian; Ruiz, Camila; David Leon, Juan] Univ Santo Tomas, Bogota, Colombia; [Pineda-Marin, Claudia] Fdn Univ Konrad Lorenz, Bogota, Colombia; [Pineda-Marin, Claudia] Univ Jean Jaures, Toulouse, France; [Mullet, Etienne] Inst Adv Studies EPHE, Lab Eth, Paris, France		Mullet, E (corresponding author), Rue Quefes,17bis, F-31830 Plaisance, France.; Lopez, WL (corresponding author), Carrera 66 97-35,Torre 3,Apto 304, Bogota 111511, Colombia.	lopezw@javeriana.edu.co; etienne.mullet@wanadoo.fr	López López, Wilson/AAV-8032-2021	López López, Wilson/0000-0002-2964-0402				Ahmed RA, 2007, CONFLICT MANAG PEACE, V24, P159, DOI 10.1080/07388940701468385; Alipanga B., 2014, J PSYCHIAT, V17, P6, DOI [10.4172/Psychiatry.1000161, DOI 10.4172/PSYCHIATRY.1000161]; Allan A, 2006, BEHAV SCI LAW, V24, P87, DOI 10.1002/bsl.689; Anderson N. H., 2017, MORAL SCI; Anderson N.H., 2008, UNIFIED SOCIAL COGNI; [Anonymous], 2016, NY TIMES; [Anonymous], 2016, BBC NEWS; [Anonymous], 2016, SEMANA; [Anonymous], 2013, EL ESPECTADOR; Azar F, 1999, J PEACE RES, V36, P169, DOI 10.1177/0022343399036002003; AZAR F, 2001, INT J GROUP TENSIONS, V30, P161, DOI DOI 10.1023/A:1005204408575; Bayer CP, 2007, JAMA-J AM MED ASSOC, V298, P555, DOI 10.1001/jama.298.5.555; Brown RP, 2008, PERS SOC PSYCHOL B, V34, P1406, DOI 10.1177/0146167208321538; Cardozo BL, 2003, J TRAUMA STRESS, V16, P351, DOI 10.1023/A:1024413918346; Cehajic S, 2008, POLIT PSYCHOL, V29, P351, DOI 10.1111/j.1467-9221.2008.00634.x; Cohrs JC, 2015, PEACE CONFL, V21, P634, DOI 10.1037/pac0000141; Conejero S, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.9; Cortes A, 2016, PSYCHOSOC INTERV, V25, P19, DOI 10.1016/j.psi.2015.09.004; El Pais, 2016, PAIS; Enright R.D., 2000, HELPING CLIENTS FORG; Fehr R, 2010, PSYCHOL BULL, V136, P894, DOI 10.1037/a0019993; Gibson JL, 2007, SOC INDIC RES, V81, P257, DOI 10.1007/s11205-006-9010-5; Govier Trudy, 2002, FORGIVENESS REVENGE; Haidt Jonathan, 2013, RIGHTEOUS MIND; Heim L, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-37; Hofmans J, 2013, QUAL QUANT, V47, P455, DOI 10.1007/s11135-011-9529-7; Human Rights Watch, 2017, COL; Junne G., 2005, POSTCONFLICT DEV M N; Kaufman SJ, 2006, J PEACE RES, V43, P201, DOI 10.1177/0022343306060622; Kira IA, 2009, PEACE CONFL, V15, P385, DOI 10.1080/10781910903158669; Kirchhoff J, 2014, PEACE CONFL, V20, P430, DOI 10.1037/pac0000064; Klar Y, 2015, GROUP PROCESS INTERG, V18, P624, DOI 10.1177/1368430215570502; Kpanake L, 2011, CONFL RESOLUT Q, V28, P291, DOI 10.1002/crq.20024; Leonard MA, 2015, PEACE CONFL, V21, P155, DOI 10.1037/pac0000055; Lopez-Lopez W, 2013, SOC INDIC RES, V114, P287, DOI 10.1007/s11205-012-0146-1; Moeschberger SL, 2005, PEACE CONFL, V11, P199, DOI 10.1207/s15327949pac1102_5; Mukashema I., CLOSE RELATIONSHIPS; Mukashema I, 2013, SOC INDIC RES, V113, P121, DOI 10.1007/s11205-012-0085-x; Mukashema I, 2010, SOC INDIC RES, V99, P25, DOI 10.1007/s11205-009-9563-1; Mullet E, 2000, FORGIVENESS, P111; Mullet E, 2007, AM J PSYCHOL, V120, P25, DOI 10.2307/20445380; Mullet E, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-3.fmf; Myers E, 2009, POLIT PSYCHOL, V30, P269, DOI 10.1111/j.1467-9221.2008.00691.x; Nadler A, 2006, PERS SOC PSYCHOL B, V32, P459, DOI 10.1177/0146167205276431; Nateghian S, 2015, J LOSS TRAUMA, V20, P123, DOI 10.1080/15325024.2013.831262; Neto F, 2007, J PEACE RES, V44, P711, DOI 10.1177/0022343307082067; Noor M, 2008, PERS SOC PSYCHOL B, V34, P819, DOI 10.1177/0146167208315555; Noor M, 2015, GROUP PROCESS INTERG, V18, P644, DOI 10.1177/1368430215586604; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Quezada SA, 2006, LAT AM PERSPECT, V33, P56, DOI 10.1177/0094582X05286085; Reed A, 2003, J PERS SOC PSYCHOL, V84, P1270, DOI 10.1037/0022-3514.84.6.1270; Regalia C, 2015, GROUP PROCESS INTERG, V18, P609, DOI 10.1177/1368430215570503; Rettberg A, 2016, SECUR DIALOGUE, V47, P517, DOI 10.1177/0967010616671858; Rye MS, 2002, J CLIN PSYCHOL, V58, P419, DOI 10.1002/jclp.1153; Staub E, 2005, J SOC CLIN PSYCHOL, V24, P297, DOI 10.1521/jscp.24.3.297.65617; Stein DJ, 2008, SOC PSYCH PSYCH EPID, V43, P462, DOI 10.1007/s00127-008-0350-0; Tam T, 2007, GROUP PROCESS INTERG, V10, P119, DOI 10.1177/1368430207071345; Tavuchis N., 1991, MEA CULPA SOCIOLOGY; Vargas Andres R., 2009, GUERRA VIOLENCIAS CO, P27; Voci A, 2015, GROUP PROCESS INTERG, V18, P589, DOI 10.1177/1368430215577001; Wilson D. S., 2002, DARWINS CATHEDRAL EV, DOI [10.7208/chicago/9780226901374.001.0001, DOI 10.7208/CHICAGO/9780226901374.001.0001]; Wohl MJA, 2005, J PERS SOC PSYCHOL, V88, P288, DOI 10.1037/0022-3514.88.2.288; Worthington E. L., 2005, HDB FORGIVENESS; Worthington EL, 2000, J MARITAL FAM THER, V26, P93, DOI 10.1111/j.1752-0606.2000.tb00279.x; Worthington EL, 2000, J PSYCHOL THEOL, V28, P3, DOI 10.1177/009164710002800101	65	21	22	1	24	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1078-1919	1532-7949		PEACE CONFL	Peace Confl.	MAY	2018	24	2					201	215		10.1037/pac0000295	http://dx.doi.org/10.1037/pac0000295			15	Psychology, Social	Emerging Sources Citation Index (ESCI)	Psychology	GH1HA					2022-09-04	WOS:000433152600008
J	Ventre-Lespiaucq, AB; Delgado, JA; Ospina-Calderon, NH; Otero, JT; Escudero, A; Sanchez, MA; Balaguer, L; Flanagan, NS				Ventre-Lespiaucq, Agustina B.; Delgado, Juan A.; Ospina-Calderon, Nhora H.; Otero, Joel T.; Escudero, Adrian; Sanchez, Maria A.; Balaguer, Luis; Flanagan, Nicola S.			A tropical epiphytic orchid uses a low-light interception strategy in a spatially heterogeneous light environment	BIOTROPICA			English	Article						Cauca Valley; Colombia; intra-individual trait variation; intra-specific trait variation; leaf angles; light interception strategy; Orchidaceae; plant size; Rodriguezia granadensis; vascular epiphytes	FOREST UNDERSTORY PLANTS; PHYSIOLOGICAL ECOLOGY; VASCULAR EPIPHYTES; CROWN ARCHITECTURE; VEGETATIVE GROWTH; CARBON GAIN; SIZE; CAPTURE; PHOTOSYNTHESIS; SIMULATION	Light is considered a non-limiting factor for vascular epiphytes. Nevertheless, an epiphyte's access to light may be limited by phorophyte shading and the spatio-temporal environmental patchiness characteristic of epiphytic habitats. We assessed the extent to which potential light interception in Rodriguezia granadensis, an epiphytic orchid, is determined by individual factors (plant size traits and leaf traits), or environmental heterogeneity (light patchiness) within the crown of the phorophyte, or both. We studied 104 adult plants growing on Psidium guajava trees in two habitats with contrasting canopy cover: a dry tropical forest edge, and isolated trees in a pasture. We recorded the number of leaves and the leaf area, the leaf position angles, and the potential exposure of the leaf surface to direct irradiance (silhouette area of the leaf blade), and the potential irradiance incident on each plant. We found the epiphytes experience a highly heterogeneous light environment in the crowns of P.guajava. Nonetheless, R.granadensis plants displayed a common light interception strategy typical of low-light environments, resembling terrestrial, forest understory plants. Potential exposure of the total leaf surface to direct irradiance correlated positively with plant size and within-plant variation in leaf orientation. In many-leaved individuals, within-plant variation in leaf angles produced complementary leaf positions that enhanced potential light interception. This light interception strategy suggests that, in contrast to current wisdom, enhancing light capture is important for vascular epiphytes in canopies with high spatio-temporal heterogeneity in light environments.	[Ventre-Lespiaucq, Agustina B.; Delgado, Juan A.] Univ Complutense Madrid, Dept Ecol, C Jose Antonio Novais 2, E-28040 Madrid, Spain; [Ospina-Calderon, Nhora H.; Flanagan, Nicola S.] Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Calle 18 118-250, Cali, Colombia; [Otero, Joel T.] Univ Nacl Colombia, Dept Biol Sci, Palmira Campus,Carrera 32 12-00, Palmira, Colombia; [Escudero, Adrian] Univ Rey Juan Carlos, Dept Biol & Geol, Calle Tulipan S-N, Mostoles 28933, Spain; [Sanchez, Maria A.] Fdn Univ Popayan, Fac Ecol, Km 8 Via Panamer Sur, Popayan, Colombia; [Balaguer, Luis] Univ Complutense Madrid, Dept Plant Biol 1, C Jose Antonio Novais 2, E-28040 Madrid, Spain		Ventre-Lespiaucq, AB (corresponding author), Univ Complutense Madrid, Dept Ecol, C Jose Antonio Novais 2, E-28040 Madrid, Spain.	aguslespiaucq@gmail.com	Otero, J. Tupac/A-7413-2010; Ventre-Lespiaucq, Agustina/AAB-1460-2019; Delgado, Juan Antonio/P-2398-2019; Flanagan, Nicola S./AAN-2272-2020; Escudero, Adrian/H-5046-2015	Otero, J. Tupac/0000-0002-0810-183X; Ventre-Lespiaucq, Agustina/0000-0002-6068-1851; Delgado, Juan Antonio/0000-0002-8075-4704; Flanagan, Nicola S./0000-0002-4909-8710; Escudero, Adrian/0000-0002-1427-5465	Spanish Ministry of Science and Education [CROWN CONCERT CGL2009-10392, MOUNTAINS CGL2012-38427]; Madrid Regional Govt [REMEDINAL-3, S2013/MAE-2719]; Asociacion Universitaria Iberoamericana de Posgrado	Spanish Ministry of Science and Education(Spanish Government); Madrid Regional Govt; Asociacion Universitaria Iberoamericana de Posgrado	We thank Federico Gonzalez-Soto for field assistance, Valentin Hidalgo for logistic support at the RNBY, Julie Messier for sharing the R script for the variance components analyses, Sandra Magro for her useful suggestions, Marcelino de la Cruz for statistical advice, Marcos Mendez for kindly drawing Fig. 4 and reviewing the manuscript; and two anonymous reviewers for critically reviewing the manuscript. This research was funded by the Spanish Ministry of Science and Education (CROWN CONCERT CGL2009-10392; MOUNTAINS CGL2012-38427); the Madrid Regional Govt. (REMEDINAL-3, S2013/MAE-2719); and a mobility grant from Asociacion Universitaria Iberoamericana de Posgrado to A.B.V.L.	Adams SR, 1997, ANN BOT-LONDON, V79, P219, DOI 10.1006/anbo.1996.0347; [Anonymous], 1978, TROPICAL TREES FORES; Bennett B.C, 1986, SELBYANA, V9, P70; BENZING DH, 1987, ANN MO BOT GARD, V74, P183, DOI 10.2307/2399394; Benzing DH, 1990, VASCULAR EPIPHYTES; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calderon-Saenz E, 2007, LIBRO ROJO PLANTAS C, V6; CARTER GA, 1985, PLANT PHYSIOL, V79, P1038, DOI 10.1104/pp.79.4.1038; Cescatti A, 2004, ECOL STU AN, V178, P42; CHASE M W, 1987, Selbyana, V10, P24; CHASE MW, 1986, SYST BOT, V11, P477, DOI 10.2307/2419085; CHAZDON RL, 1991, BIOSCIENCE, V41, P760, DOI 10.2307/1311725; Chazdon Robin L., 1996, P5; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Dressler R.L., 1990, ORCHIDS NATURAL HIST; Duursma RA, 2012, NEW PHYTOL, V193, P397, DOI 10.1111/j.1469-8137.2011.03943.x; Ehleringer J, 1986, EC PLANT FORM FUNCT, P57; ESCOBAR E., 2001, PRESENTACION YOTOCO; Escribano-Rocafort AG, 2016, ANN BOT-LONDON, V117, P643, DOI 10.1093/aob/mcw004; Escribano-Rocafort AG, 2014, METHODS ECOL EVOL, V5, P132, DOI 10.1111/2041-210X.12141; Falster DS, 2003, NEW PHYTOL, V158, P509, DOI 10.1046/j.1469-8137.2003.00765.x; Gibson D. J., 2002, METHOD COMP PLANT PO; Granado-Yela C, 2011, PLANT CELL ENVIRON, V34, P800, DOI 10.1111/j.1365-3040.2011.02283.x; Guzman JA, 2015, BOTANY, V93, P151, DOI 10.1139/cjb-2014-0157; Kuppers M., 1994, ECOPHYSIOL PROCESS B, P111; Laube S, 2003, FUNCT ECOL, V17, P598, DOI 10.1046/j.1365-2435.2003.00760.x; Lin MJ, 2004, J PLANT PHYSIOL, V161, P1259, DOI 10.1016/j.jplph.2004.05.009; Luttge U., 1989, VASCULAR PLANTS EPIP; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; NIKLAS KJ, 1988, EVOLUTION, V42, P1, DOI 10.1111/j.1558-5646.1988.tb04103.x; NORMAN JM, 1974, J APPL ECOL, V11, P375, DOI 10.2307/2402028; OKERBLOM P, 1988, FOREST SCI, V34, P894; Ospina-Calderón Nhora H, 2015, Lankesteriana, V15, P129; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parveaud CE, 2008, TREES-STRUCT FUNCT, V22, P87, DOI 10.1007/s00468-007-0172-9; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Pearcy RW, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P45; Pearcy RW, 1998, FUNCT ECOL, V12, P543, DOI 10.1046/j.1365-2435.1998.00234.x; R Core Team, 2021, R LANG ENV STAT COMP; Rascher U, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00117; Reina-Rodriguez G. A., 2011, GUIA ILUSTRADA ORQUI; Sarkar D, 2018, R PACKAGE VERSION, DOI DOI 10.4018/978-1-4666-7244-4.CH001; Schmidt G, 2001, PLANT ECOL, V153, P65, DOI 10.1023/A:1017521204284; Takenaka A, 2001, FUNCT ECOL, V15, P660, DOI 10.1046/j.0269-8463.2001.00562.x; TERSTEEGE H, 1989, BIOTROPICA, V21, P331, DOI 10.2307/2388283; Valladares F, 1999, ANN BOT-LONDON, V83, P459, DOI 10.1006/anbo.1998.0843; Valladares F, 1998, OECOLOGIA, V114, P1, DOI 10.1007/s004420050413; Valladares F, 2002, AM J BOT, V89, P1275, DOI 10.3732/ajb.89.8.1275; Ventre-Lespiaucq AB, 2016, TREES-STRUCT FUNCT, V30, P995, DOI 10.1007/s00468-015-1328-7; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Zotz G, 2011, PLANT BIOLOGY, V13, P902, DOI 10.1111/j.1438-8677.2011.00460.x; Zotz G, 2002, ANN BOT-LONDON, V90, P437, DOI 10.1093/aob/mcf208; Zotz G, 2001, J EXP BOT, V52, P2051, DOI 10.1093/jexbot/52.363.2051; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067; Zotz Gerhard, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P19, DOI 10.1078/1433-8319-00002	57	5	9	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3606	1744-7429		BIOTROPICA	Biotropica	MAY	2017	49	3					318	327		10.1111/btp.12425	http://dx.doi.org/10.1111/btp.12425			10	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	ET5CL					2022-09-04	WOS:000400301500005
J	Loizzo, MR; Pacetti, D; Lucci, P; Nunez, O; Menichini, F; Frega, NG; Tundis, R				Loizzo, Monica R.; Pacetti, Deborah; Lucci, Paolo; Nunez, Oscar; Menichini, Francesco; Frega, Natale Giuseppe; Tundis, Rosa			Prunus persica var. platycarpa (Tabacchiera Peach): Bioactive Compounds and Antioxidant Activity of Pulp, Peel and Seed Ethanolic Extracts	PLANT FOODS FOR HUMAN NUTRITION			English	Article						Prunus persica L. Stokes ex Batsch var. platycarpa; Phenols; HPLC-ESI-MS/MS; Dietary antioxidants	L. BATSCH PROGENY; PHENOLIC-COMPOUNDS; NECTARINE; CAROTENOIDS; CULTIVARS; CAPACITY; POLYPHENOLS; SOLVENTS; FRUITS; ASSAY	A comparative analysis of ethanol extracts from peel, pulp and seed of Prunus persica var. platycarpa (Tabacchiera peach) was done. The total phenol, flavonoid and carotenoid content as well as the antioxidant properties by using different in vitro assays (DPPH, ABTS, FRAP, Fe-chelating, beta-carotene bleaching test) were evaluated. Pulp extract was subjected to liquid chromatography-electrospray-tandem mass spectrometry (HPLC-ESI-MS/MS). Gallic acid, protocatechuic acid, protocatechualdehyde, chlorogenic acid, p-coumaric acid, and ferulic acid were identified as main constituents. Pulp extract was characterized by the highest total phytonutrients content and exhibited the highest antioxidant activity in all in vitro assays (IC50 values of 2.2 mu g/mL after 60 min of incubation by using beta-carotene bleaching test and 2.9 mu g/mL by using Fe-chelating assay). Overall, the obtained results suggest that P. persica var. platycarpa displays a good antioxidant activity and its consumption could be promoted.	[Loizzo, Monica R.; Menichini, Francesco; Tundis, Rosa] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy; [Pacetti, Deborah; Frega, Natale Giuseppe] Politecn Marche Univ, Dept Food Sci, I-60131 Ancona, Italy; [Lucci, Paolo] Pontificia Univ Javeriana, Dept Biochem & Nutr, Fac Sci, Bogota, DC, Colombia; [Nunez, Oscar] Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Spain; [Nunez, Oscar] Generalitat Catalunya, Catalunya, Spain		Tundis, R (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.	tundis@unical.it	Núñez, Oscar/D-7912-2014	Núñez, Oscar/0000-0001-5850-8972; Menichini, Francesco/0000-0002-4584-4405; Tundis, Rosa/0000-0002-3713-4403; Lucci, Paolo/0000-0002-3659-132X	Spanish Ministry of Economy and Competitiveness [CTQ2012-30836]; Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain) [2014 SGR-539]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain)	The authors are grateful to Dr. D. Sturino, Department of Pharmacy, Health and Nutritional Science, University of Calabria, for English revision of the manuscript. The authors are also grateful to the Spanish Ministry of Economy and Competitiveness (project CTQ2012-30836), and to the Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain) (Project 2014 SGR-539).	Abidi W, 2015, J SCI FOOD AGR, V95, P351, DOI 10.1002/jsfa.6727; Abidi W, 2011, INT J MOL SCI, V12, P6919, DOI 10.3390/ijms12106919; Alothman M, 2009, FOOD CHEM, V115, P785, DOI 10.1016/j.foodchem.2008.12.005; Antolovich M, 2002, ANALYST, V127, P183, DOI 10.1039/b009171p; AOAC, 1995, OFFICIAL METHODS ANA, V16th; AOAC, 2007, OFFICIAL METHODS ANA; Bendary E., 2013, Annals of Agricultural Science (Cairo), V58, P173, DOI 10.1016/j.aoas.2013.07.002; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Campbell OE, 2013, FOOD RES INT, V54, P448, DOI 10.1016/j.foodres.2013.07.016; Cantin CM, 2009, J AGR FOOD CHEM, V57, P4586, DOI 10.1021/jf900385a; Cevallos-Casals BA, 2006, FOOD CHEM, V96, P273, DOI 10.1016/j.foodchem.2005.02.032; Di Vaio C, 2008, EUR FOOD RES TECHNOL, V227, P1225, DOI 10.1007/s00217-008-0840-z; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Gao XQ, 2000, J AGR FOOD CHEM, V48, P1485, DOI 10.1021/jf991072g; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Hong YP, 2008, PLANT FOOD HUM NUTR, V63, P200, DOI 10.1007/s11130-008-0088-6; Ismail A, 2004, FOOD CHEM, V87, P581, DOI 10.1016/j.foodchem.2004.01.010; Kchaou W, 2013, IND CROP PROD, V45, P262, DOI 10.1016/j.indcrop.2012.12.028; Legua P, 2011, J FOOD SCI, V76, pC729, DOI 10.1111/j.1750-3841.2011.02165.x; Loizzo MR, 2012, J FOOD COMPOS ANAL, V25, P179, DOI 10.1016/j.jfca.2011.09.002; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Puigventos L, 2015, ANAL BIOANAL CHEM, V407, P597, DOI 10.1007/s00216-014-8298-2; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Schreiner M, 2013, SCI HORTIC-AMSTERDAM, V163, P63, DOI 10.1016/j.scienta.2013.09.027; Tavarini S, 2008, INT J FOOD SCI TECH, V43, P810, DOI 10.1111/j.1365-2621.2007.01520.x; Tomas-Barberan FA, 2001, J AGR FOOD CHEM, V49, P4748, DOI 10.1021/jf0104681; Vizzotto M, 2007, J AM SOC HORTIC SCI, V132, P334, DOI 10.21273/JASHS.132.3.334	30	31	32	2	52	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-9668	1573-9104		PLANT FOOD HUM NUTR	Plant Food Hum. Nutr.	SEP	2015	70	3					331	337		10.1007/s11130-015-0498-1	http://dx.doi.org/10.1007/s11130-015-0498-1			7	Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Chemistry; Food Science & Technology; Nutrition & Dietetics	CP5TX	26138775	Green Accepted			2022-09-04	WOS:000359948600015
J	Minguez-Alarcon, L; Afeiche, MC; Chiu, YH; Vanegas, JC; Williams, PL; Tanrikut, C; Toth, TL; Hauser, R; Chavarro, JE				Minguez-Alarcon, L.; Afeiche, M. C.; Chiu, Y. -H.; Vanegas, J. C.; Williams, P. L.; Tanrikut, C.; Toth, T. L.; Hauser, R.; Chavarro, J. E.			Male soy food intake was not associated with invitro fertilization outcomes among couples attending a fertility center	ANDROLOGY			English	Article						epidemiology; ICSI; IVF; male reproductive health; soy intake	ESTROGEN-RECEPTOR-ALPHA; FREQUENCY QUESTIONNAIRE; SEMEN QUALITY; US ADULTS; MEN; PHYTOESTROGEN; WOMEN; INFERTILITY; REPRODUCIBILITY; VALIDITY	Male factor etiology may be a contributing factor in up to 60% of infertility cases. Dietary intake of phytoestrogens has been related to abnormal semen quality and hormone levels. However, its effect on couple fecundity is still unclear. Intake of soy products was assessed in 184 men from couples undergoing infertility treatment with invitro fertilization. Couples were recruited between February 2007 and May 2014 and prospectively followed to document treatment outcomes including fertilization, implantation, clinical pregnancy and live birth. Multivariate generalized linear mixed models with random intercepts, binomial distribution and logit link function were used to examine this relation while accounting for repeated treatment cycles and adjusting for potential confounders. Male partner's intake of soy foods and soy isoflavones was unrelated to fertilization rates, the proportions of poor quality embryos, accelerated or slow embryo cleavage rate, and implantation, clinical pregnancy and live birth. The adjusted live birth rates per initiated cycle (95% CI) for partners of men in increasing categories of soy food intake were 0.36 (0.28-0.45), 0.42 (0.29-0.56), 0.36 (0.24-0.51), and 0.37 (0.24-0.52), respectively. Soy food intake in men was not related to clinical outcomes among couples presenting at an infertility clinic. Data on the relation between phytoestrogens and male reproductive potential remain scarce and additional research is required to clarify its role in human reproduction.	[Minguez-Alarcon, L.; Afeiche, M. C.; Hauser, R.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Chiu, Y. -H.; Chavarro, J. E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Vanegas, J. C.] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Williams, P. L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Williams, P. L.; Hauser, R.; Chavarro, J. E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tanrikut, C.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Tanrikut, C.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Toth, T. L.; Hauser, R.] Massachusetts Gen Hosp, Vincent Obstet & Gynecol, Boston, MA 02114 USA; [Toth, T. L.; Hauser, R.; Chavarro, J. E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chavarro, J. E.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA		Minguez-Alarcon, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	lminguez@hsph.harvard.edu	Chavarro, Jorge E/AAE-5665-2021	Chavarro, Jorge E/0000-0002-4436-9630	NIH from NIEHS [R01-ES009718]; NIH from NIDDK [P30 DK046200]; NIDDK [T32 DK 007703-16]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, T32DK007703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009718] Funding Source: NIH RePORTER	NIH from NIEHS; NIH from NIDDK; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the study participants whose continued dedication and commitment make this work possible and the research nurses Jennifer B. Ford, B.S.N., R.N. and Myra G. Keller, R.N.C., B.S.N. and senior research assistant Ramace Dadd. This work was supported by NIH grants R01-ES009718 from NIEHS, P30 DK046200 from NIDDK. MA was supported by a Ruth L. Kirschstein National Research Service Award T32 DK 007703-16 from NIDDK.	[Anonymous], 2017, FUNDAMENTALS BIOSTAT; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P70, DOI 10.1111/j.1751-0813.1946.tb06451.x; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; Chavarro JE, 2008, HUM REPROD, V23, P2584, DOI 10.1093/humrep/den243; Chun OK, 2009, J AM DIET ASSOC, V109, P245, DOI 10.1016/j.jada.2008.10.055; Frankenfeld CL, 2003, AM J CLIN NUTR, V77, P674, DOI 10.1093/ajcn/77.3.674; Frankenfeld CL, 2002, J AM DIET ASSOC, V102, P1407, DOI 10.1016/S0002-8223(02)90313-5; Gaskins AJ, 2014, HUM REPROD, V29, P2575, DOI 10.1093/humrep/deu212; GASKINS AJ, 2013, BRIT J SPORT MED, V49, P265, DOI DOI 10.1136/bjsports-2012-091644; Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298; Habito RC, 2000, BRIT J NUTR, V84, P557, DOI 10.1017/S0007114500001872; Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7; Hauser R, 2006, SEMIN REPROD MED, V24, P156, DOI 10.1055/s-2006-944422; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; Kirk P, 1999, J AM DIET ASSOC, V99, P558, DOI 10.1016/S0002-8223(99)00139-X; Kyselova Vendula, 2003, Reprod Biol Endocrinol, V1, P30, DOI 10.1186/1477-7827-1-30; Lee Y, 2003, J STEROID BIOCHEM, V84, P463, DOI 10.1016/S0960-0760(03)00067-0; Mei H, 2011, REPRODUCTION, V141, P357, DOI 10.1530/REP-10-0432; MEYER EP, 1970, AUST VET J, V46, P305, DOI 10.1111/j.1751-0813.1970.tb07904.x; Mitchell JH, 2001, CLIN SCI, V100, P613, DOI 10.1042/CS20000212; Mueller SO, 2003, TOXICOL LETT, V142, P89, DOI 10.1016/S0378-4274(03)00016-X; Mumford SL, 2014, J NUTR, V144, P352, DOI 10.3945/jn.113.184820; Nagata C, 2001, CANCER EPIDEM BIOMAR, V10, P179; Pearce V, 2003, J STEROID BIOCHEM, V84, P431, DOI 10.1016/S0960-0760(03)00064-5; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Seppen J, 2012, TOXICOL APPL PHARM, V264, P335, DOI 10.1016/j.taap.2012.09.013; Sermondade N, 2012, ARCH INTERN MED, V172, P440, DOI 10.1001/archinternmed.2011.1382; Song G, 2006, FERTIL STERIL, V86, pS49, DOI 10.1016/j.fertnstert.2006.07.134; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; USDA, 2007, USDA IOW STAT U DAT; Vanegas JC, 2015, FERTIL STERIL, V103, P749, DOI 10.1016/j.fertnstert.2014.12.104; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wong WY, 2000, FERTIL STERIL, V73, P435, DOI 10.1016/S0015-0282(99)00551-8; Xia YK, 2013, ENVIRON INT, V59, P161, DOI 10.1016/j.envint.2013.06.009; Xu X, 2000, J NUTR, V130, P798, DOI 10.1093/jn/130.4.798	39	21	21	0	25	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-2919	2047-2927		ANDROLOGY-US	Andrology	JUL	2015	3	4					702	708		10.1111/andr.12046	http://dx.doi.org/10.1111/andr.12046			7	Andrology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CN3LZ	26097060	Green Accepted			2022-09-04	WOS:000358329300010
J	Andabaka, T; Nickerson, JW; Rojas-Reyes, MX; Rueda, JD; Vrca, VB; Barsic, B				Andabaka, Tea; Nickerson, Jason W.; Ximena Rojas-Reyes, Maria; David Rueda, Juan; Vrca, Vesna Bacic; Barsic, Bruno			Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review							COST-EFFECTIVENESS ANALYSIS; PREMATURE-INFANTS; POTENTIAL IMPACT; YOUNG-CHILDREN; ECONOMIC-EVALUATION; PRETERM INFANTS; PALIVIZUMAB PROPHYLAXIS; PASSIVE-IMMUNIZATION; GESTATIONAL-AGE; RSV PROPHYLAXIS	Background Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections in children. It results in about 3.4 million hospitalisations annually in children under five. Palivizumab is an anti-RSV monoclonal antibody, administered intramuscularly at a dose of 15 mg/kg once every 30 days. The efficacy and safety of palivizumab has been evaluated in multicentre, randomised controlled trials (RCTs) and a large number of economic evaluations (EEs) have tested its cost-effectiveness. Objectives To assess the effectiveness and safety of palivizumab prophylaxis compared with placebo, or another type of prophylaxis, in reducing the risk of complications (hospitalisation due to RSV infection) in high-risk infants and children. To assess the cost-effectiveness (or cost-utility) of palivizumab prophylaxis compared with no prophylaxis in infants and children in different risk groups. Search methods We searched CENTRAL 2012, Issue 7, MEDLINE (1996 to July week 4, 2012), EMBASE (1996 to August 2012), CINAHL (1996 to August 2012) and LILACS (1996 to August 2012) for studies of effectiveness and safety. We searched the NHS Economic Evaluations Database (NHS EED 2012, Issue 4), Health Economics Evaluations Database (HEED, 9 August 2012) and Paediatric Economic Database Evaluations (PEDE, 1980 to 2009), MEDLINE (1996 to July week 4, 2012) and EMBASE (1996 to August 2012) for economic evaluations. Selection criteria We included RCTs comparing palivizumab prophylaxis with a placebo, no prophylaxis or another type of prophylaxis in preventing serious lower respiratory tract disease caused by RSV in paediatric patients at high risk. We included cost-effectiveness analyses and cost-utility analyses comparing palivizumab prophylaxis with no prophylaxis. Data collection and analysis Two review authors independently assessed risk of bias for the included studies and extracted data for both the RCTs and EEs. We calculated risk ratios (RRs) and their associated 95% confidence intervals (CIs) for dichotomous outcomes and for adverse events (AEs). We provided a narrative summary of results for continuous outcomes, due to missing data on standard deviations. We performed fixed-effect meta-analyses for the estimation of pooled effects whenever there was no indication of heterogeneity between included RCTs. We summarised the results reported in included EEs, such as incremental costs, incremental effectiveness, and incremental cost-effectiveness and/or cost-utility ratios (ICERs), and we calculated ICER present values in 2011 Euros for all studies. Main results Of the seven available RCTs, three compared palivizumab with a placebo in a total of 2831 patients, and four compared palivizumab with motavizumab in a total of 8265 patients. All RCTs were sponsored by the drug manufacturing company. The overall quality of RCTs was good, but for most of the outcomes assessed only data from two studies contributed to the analysis. Palivizumab prophylaxis was associated with a statistically significant reduction in RSV hospitalisations (RR 0.49, 95% CI 0.37 to 0.64) when compared to placebo. When compared to motavizumab, palivizumab recipients showed a non-significant increase in the risk of RSV hospitalisations (RR 1.36, 95% CI 0.97 to 1.90). In both cases, the proportion of children with any AE or any AE related to the study drug was similar between the two groups. In terms of economic evidence, we included 34 studies that reported cost-effectiveness and/or cost-utility data for palivizumab prophylaxis compared with no prophylaxis, in high-risk children with different underlying medical conditions. The overall quality of EEs was good, but the variations in modelling approaches were considerable across the studies, leading to big differences in cost-effectiveness results. The cost-effectiveness of palivizumab prophylaxis depends on the consumption of resources taken into account by the study authors; and on the cost-effectiveness threshold set by the healthcare sector in each country. Authors' conclusions There is evidence that palivizumab prophylaxis is effective in reducing the frequency of hospitalisations due to RSV infection, i.e. in reducing the incidence of serious lower respiratory tract RSV disease in children with chronic lung disease, congenital heart disease or those born preterm. Results from economic evaluations of palivizumab prophylaxis are inconsistent, implying that economic findings must be interpreted with caution. ICER values varied considerably across studies, from highly cost-effective to not cost-effective. The availability of low-cost palivizumab would reduce its inequitable distribution, so that RSV prophylaxis would be available to the poorest countries where children are at greatest risk.	[Andabaka, Tea] Univ Split, Sch Med, Split 21000, Croatia; [Nickerson, Jason W.] Inst Populat Hlth, Ottawa, ON, Canada; [Ximena Rojas-Reyes, Maria] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Fac Med, Bogota, Colombia; [David Rueda, Juan] Pontificia Univ Javeriana, Dept Cirugia, Bogota, Colombia; [Vrca, Vesna Bacic] Univ Hosp Dubrava, Dept Hosp Pharm, Zagreb, Croatia; [Barsic, Bruno] Univ Zagreb, Sch Med, Dept Intens Care, Hosp Infect Dis, Zagreb 41001, Croatia		Andabaka, T (corresponding author), Univ Split, Sch Med, Soltanska 2, Split 21000, Croatia.	Tea.Andabaka@gmail.com	Rojas-Reyes, Maria Ximena/AAD-6800-2019; Vrca, Vesna Bacic/W-7934-2019; Nickerson, Jason/AAP-6026-2021; Nickerson, Jason/B-8035-2014	Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Nickerson, Jason/0000-0003-3692-999X; Nickerson, Jason/0000-0003-3692-999X				Abarca K, 2009, PEDIATR INFECT DIS J, V28, P267, DOI 10.1097/INF.0b013e31818ffd03; American Academy of Pediatrics, 2012, RED BOOK 2012 REPORT; [Anonymous], NTR1023; Arms JL, 2008, CLIN PEDIATR, V47, P953, DOI 10.1177/0009922808320699; Banerji A, 2009, PEDIATR INFECT DIS J, V28, P702, DOI 10.1097/INF.0b013e31819df78e; Bentley A, 2011, THORAX, V66, pA136, DOI 10.1136/thoraxjnl-2011-201054c.170; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Brozek J, 2008, GRADEPRO 3 2 WINDOWS; Buckley BC, 2010, J MANAGE CARE PHARM, V16, P15, DOI 10.18553/jmcp.2010.16.1.15; Carbonell-Estrany Xavier, 2009, Paediatr Respir Rev, V10 Suppl 1, P12, DOI 10.1016/S1526-0542(09)70006-5; Carbonell-Estrany X, 2010, PEDIATRICS, V125, pE35, DOI 10.1542/peds.2008-1036; Chan PWK, 2003, ACTA PAEDIATR, V92, P481, DOI 10.1111/j.1651-2227.2003.tb00582.x; Chirico G, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-4; Chiroli S, 2005, ITAL J PEDIATR, V31, P188; Clark SJ, 2000, ARCH DIS CHILD, V83, P313, DOI 10.1136/adc.83.4.313; Datar M, 2012, VALUE HEALTH, V15, pA58, DOI 10.1016/j.jval.2012.03.323; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Domachowske JB, 1999, CLIN MICROBIOL REV, V12, P298, DOI 10.1128/CMR.12.2.298; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; ElHassan NO, 2006, ARCH PEDIAT ADOL MED, V160, P1070, DOI 10.1001/archpedi.160.10.1070; Embleton Nicholas D, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P445, DOI 10.1586/14737167.7.5.445; Farina D, 2002, PEDIATR INFECT DIS J, V21, P287, DOI 10.1097/00006454-200204000-00006; FDA 2010 United States Food, BACKGR PACK BLA 1252; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Feltes TF, 2011, PEDIATR RES, V70, P186, DOI 10.1203/PDR.0b013e318220a553; Fernandez P, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-38; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; Garcia-Altes A, 2010, PEDIAT CATALANA, V70, P57; Glanville J, 2009, INT J TECHNOL ASSESS, V25, P522, DOI 10.1017/S0266462309990523; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1979, AM J DIS CHILD, V133, P798, DOI 10.1001/archpedi.1979.02130080038006; Hall CB, 2010, MANDELL DOUGLAS BENN, V2, P2207; Hall CB, 2009, TXB PEDIAT INFECT DI, V2, P2462; Hampp C, 2009, VALUE HEALTH, V12, pA301, DOI 10.1016/S1098-3015(10)74479-X; Hampp C, 2011, ARCH PEDIAT ADOL MED, V165, P498, DOI 10.1001/archpediatrics.2010.298; Harris KC, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2010.12.064; Hascoet JM, 2008, ARCH PEDIATRIE, V15, P1739, DOI 10.1016/j.arcped.2008.09.024; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Human DG, 2010, CARDIOLOGY YOUNG S1, V20, P30; Jacobson PD, 2001, J HEALTH POLIT POLIC, V26, P291, DOI 10.1215/03616878-26-2-291; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kang HY, 2009, VALUE HEALTH, V12, pA424, DOI 10.1016/S1098-3015(10)75096-8; Korbal Piotr, 2003, Ginekol Pol, V74, P1154; Krilov LR, 2010, VALUE HEALTH, V13, P77, DOI 10.1111/j.1524-4733.2009.00586.x; Lanctot KL, 2008, CURR MED RES OPIN, V24, P3223, DOI [10.1185/03007990802484234, 10.1185/03007990802484234 ]; Lapena Lopez de Armentia S, 2003, An Pediatr (Barc), V59, P328; Lazaro y de Mercado P, 2006, An Pediatr (Barc), V65, P316; Lazaro y de Mercado P, 2007, PHARMACOECONOMICS SP, V4, P57; Lee S L, 2001, Paediatr Child Health, V6, P525; Lefebvre C, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Lolfand JH, 2000, CLIN THER, V22, P1357, DOI 10.1016/S0149-2918(00)83032-5; Lozano JM, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006602.pub2, DOI 10.1002/14651858.CD006602.PUB2]; Marchetti A, 1999, CLIN THER, V21, P752, DOI 10.1016/S0149-2918(00)88326-5; Marques T, 2010, EARLY HUMAN DEV S, V86, P123; Martínez M. José Luis, 2002, Rev. chil. pediatr., V73, P9; Mayen-Herrera E, 2011, VALUE HEALTH, V14, pA565, DOI 10.1016/j.jval.2011.08.1698; McCormick J, 2002, PEDIATR PULM, V34, P262, DOI 10.1002/ppul.10169; Meberg A, 2006, ACTA PAEDIATR, V95, P404, DOI 10.1080/08035250500447944; Meissner HC, 1999, ANTIMICROB AGENTS CH, V43, P1183, DOI 10.1128/AAC.43.5.1183; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Mutuc Jeffry D., 2011, Morbidity and Mortality Weekly Report, V60, P1203; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Neovius K, 2010, ACTA PAEDIATR, V99, P96; Neovius K, 2011, ACTA PAEDIATR, V100, P1306, DOI 10.1111/j.1651-2227.2011.02309.x; Nuijten Mark, 2009, J Med Econ, V12, P291, DOI 10.3111/13696990903316961; Nuijten Mark, 2009, J Med Econ, V12, P301, DOI 10.3111/13696990903347172; Nuijten MJ, 2010, EUR J HEALTH ECON, V11, P105, DOI 10.1007/s10198-009-0206-x; Nuijten MJC, 2007, PHARMACOECONOMICS, V25, P55, DOI 10.2165/00019053-200725010-00006; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Numa A, 2000, J PAEDIATR CHILD H, V36, P422, DOI 10.1046/j.1440-1754.2000.00303.x; Parmigiani S, 2001, Acta Biomed Ateneo Parmense, V72, P109; Purcell K, 2004, PEDIATR INFECT DIS J, V23, P418, DOI 10.1097/01.inf.0000126273.27123.33; Rackham OJ, 2005, CARDIOL YOUNG, V15, P251, DOI 10.1017/S1047951105000533; Ralston S, 2009, J PEDIATR-US, V155, P728, DOI 10.1016/j.jpeds.2009.04.063; Ravasio R, 2006, PHARMACOECONOMICS IT, V8, P105; Raya Ortega L, 2006, SEVILLA ANDALUSIAN A, V14, P1; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P253, DOI 10.1111/j.1440-1754.2006.00850.x; Resch B, 2008, CLIN THER, V30, P749, DOI 10.1016/j.clinthera.2008.03.014; Resch B, 2012, PEDIATR INFECT DIS J, V31, pE1, DOI 10.1097/INF.0b013e318235455b; Rietveld E, 2010, ARCH DIS CHILD, V95, P493, DOI 10.1136/adc.2008.155556; Robinson KA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007743.pub3; Rodriguez SP, 2008, PEDIATR INFECT DIS J, V27, P660, DOI 10.1097/INF.0b013e3181691753; Roeckl-Wiedmann I, 2003, EUR J PEDIATR, V162, P237, DOI 10.1007/s00431-002-1106-6; Salinas-Escudero G, 2012, SALUD PUBLICA MEXICO, V54, P47; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Shireman TI, 2002, ARCH PEDIAT ADOL MED, V156, P1251, DOI 10.1001/archpedi.156.12.1251; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Smart Kelly A, 2010, J Med Econ, V13, P705, DOI 10.3111/13696998.2010.535577; Stevens TP, 2000, ARCH PEDIAT ADOL MED, V154, P55; Strutton DR, 2003, J PEDIATR-US, V143, pS157, DOI 10.1067/S0022-3476(03)00512-2; Subramanian KNS, 1998, PEDIATR INFECT DIS J, V17, P110, DOI 10.1097/00006454-199802000-00006; Takeuchi Y, 2002, JAPANESE J CHEMOTHER, V50, P215; Tam Derrick Y, 2009, J Med Econ, V12, P361, DOI 10.3111/13696990903442155; The Nordic Cochrane Centre, 2012, REV MAN REVMAN 5 2; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; US Food and Drug Administration, SAF AL HUM MED PROD; Vann JJ, 2007, PHARMACOECONOMICS, V25, P793, DOI 10.2165/00019053-200725090-00007; Vogel AM, 2002, J PAEDIATR CHILD H, V38, P352, DOI 10.1046/j.1440-1754.2002.00790.x; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; Wang D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15050; Wang D, 2009, CLIN GOVERNANCE INT, V14, P156; Wang EEL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001725.pub2; Wegner S, 2004, PEDIATRICS, V114, P1612, DOI 10.1542/peds.2004-0959; Weiner Leonard B, 2012, J Med Econ, V15, P997, DOI 10.3111/13696998.2012.672942; Wendel B, 2010, J AM PHARM ASSOC, V50, P231; Yount LE, 2004, PEDIATRICS, V114, P1606, DOI 10.1542/peds.2004-0224	109	114	118	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2013		4							UNSP CD006602	10.1002/14651858.CD006602.pub4	http://dx.doi.org/10.1002/14651858.CD006602.pub4			135	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167SJ	23633336				2022-09-04	WOS:000320654400032
J	Vargas, E; de Deugd, R; Villegas, VE; Gil, F; Mora, L; Viana, LF; Bruges, R; Gonzalez, A; Galvis, JC; Hamann, U; Torres, D				Vargas, Elizabeth; de Deugd, Robert; Villegas, Victoria E.; Gil, Fabian; Mora, Lina; Fernando Viana, Luis; Bruges, Ricardo; Gonzalez, Alejandro; Carlos Galvis, Juan; Hamann, Ute; Torres, Diana			Prevalence of BRCA1 and BRCA2 Germline Mutations in Patients of African Descent with Early-Onset and Familial Colombian Breast Cancer	ONCOLOGIST			English	Article						BRCA1; 2; breast cancer; germline mutation; Afro-Colombian	OVARIAN-CANCER; HEREDITARY BREAST; FOUNDER MUTATIONS; MORTALITY	Background Pathogenic germline mutations in the BRCA1 and BRCA2 (BRCA1/2) genes contribute to hereditary breast/ovarian cancer (OC) in White/mestizo Colombian women. As there is virtually no genetic data on breast cancer (BC) in Colombians of African descent, we conducted a comprehensive BRCA1/2 mutational analysis of 60 Afro-Colombian families affected by breast/OC. Materials and Methods Mutation screening of the complete BRCA1/2 genes for small-scale mutations and large genomic alterations was performed in these families using next-generation sequencing and multiplex ligation-dependent probe amplification analysis. Results Four pathogenic germline mutations, including one novel mutation, were identified, comprising 3 in BRCA1 and one in BRCA2. The prevalence of BRCA1/2 mutations, including one BRCA1 founder mutation (c.5123C>A) previously identified in this sample set, was 3.9% (2/51) in female BC-affected families and 33.3% (3/9) in those affected by both breast and OC. Haplotype analysis of 2 BRCA2_c.2701delC carriers (one Afro-Colombian and one previously identified White/mestizo Colombian patient with BC) suggested that the mutation arose in a common ancestor. Conclusion Our data showed that 2/5 (40%) mutations (including the one previously identified in this sample set) are shared by White/mestizo Colombian and Afro-Colombian populations. This suggests that these 2 populations are closely related. Nevertheless, variations in the BRCA1/2 mutational spectrum among Afro-Colombian subgroups from different regions of the country were observed, suggesting that specific genetic risk assessment strategies need to be developed. Pathogenic germline mutations in the BRCA1 and BRCA2 (BRCA1/2) genes contribute to hereditary breast and ovarian cancer in white/mestizo Colombian women, but there is virtually no genetic data on breast cancer in Colombians of African descent. This article provides a comprehensive BRCA1/2 mutational analysis of 60 Afro-Colombian families affected by breast or ovarian.	[Vargas, Elizabeth; Mora, Lina; Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Vargas, Elizabeth; Hamann, Ute; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [de Deugd, Robert] CENTOGENE GmbH, Rostock, Germany; [Villegas, Victoria E.] Univ Rosario, Fac Ciencias Nat, Ctr Invest Microbiol & Biotecnol UR CIMBIUR, Bogota, Colombia; [Gil, Fabian] Pontificia Univ Javeriana, Unit Clin Epidemiol & Biostat, Bogota, Colombia; [Fernando Viana, Luis] Canc League, Cartagena, Colombia; [Bruges, Ricardo; Gonzalez, Alejandro; Carlos Galvis, Juan] Pontificia Univ Javeriana, Ctr Javeriano Oncol, Bogota, Colombia		Torres, D (corresponding author), Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia.; Villegas, VE (corresponding author), Univ Rosario, Fac Ciencias Nat, Ctr Invest Microbiol & Biotecnol UR CIMBIUR, Bogota, Colombia.	victoria.villegas@urosario.edu.co			Pontificia Universidad Javeriana [6601]; AstraZeneca [D0810L00012]; Universidad del Rosario; Ministerio de Ciencia Tecnologia e Innovacion (Minciencias) from Colombia; Alexander von Humboldt Foundation; Deutsches Krebsforschungszentrum (DKFZ), from Germany; CENTOGENE	Pontificia Universidad Javeriana; AstraZeneca(AstraZeneca); Universidad del Rosario; Ministerio de Ciencia Tecnologia e Innovacion (Minciencias) from Colombia; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsches Krebsforschungszentrum (DKFZ), from Germany; CENTOGENE	This study was supported by the Pontificia Universidad Javeriana (Project No. 6601); AstraZeneca (Project No. D0810L00012); Universidad del Rosario and Ministerio de Ciencia Tecnologia e Innovacion (Minciencias) Ph.D. scholarship (Convocatoria 757 de 2016-Doctorados Nacionales) from Colombia, as well as the Alexander von Humboldt Foundation (return fellowship to D.M.T.L.) and the Deutsches Krebsforschungszentrum (DKFZ), from Germany and by CENTOGENE.	[Anonymous], 2005, EVOLUTION GENETICS L; Churpek JE, 2015, BREAST CANCER RES TR, V149, P31, DOI 10.1007/s10549-014-3195-0; Cock-Rada AM, 2018, FAM CANCER, V17, P23, DOI 10.1007/s10689-017-0004-z; DANE, 2020, EST VIT EEVV NAC DEF, V69; Dutil J, 2015, BREAST CANCER RES TR, V154, P441, DOI 10.1007/s10549-015-3629-3; Esteban J., 2014, HERED CANCER CLIN PR, V12, P1; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Gao Q, 2000, HUM GENET, V107, P186, DOI 10.1007/s004390000290; Hall MJ, 2009, CANCER-AM CANCER SOC, V115, P2222, DOI 10.1002/cncr.24200; Hansen TV, 2009, BREAST CANCER RES TR, V115, P315, DOI 10.1007/s10549-008-0088-0; Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0122-z, 10.1038/s41572-019-0111-2]; Jara L, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0139-2; Kanaan Y, 2003, HUM GENET, V113, P452, DOI 10.1007/s00439-003-0999-0; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Lizcano Fernández Francisco, 2005, Convergencia, V12, P185; Ministerio de Cultura. Republica de Colombia, 2000, MINIST CULT, V2010, P1; Miramar MD, 2008, BREAST CANCER RES TR, V112, P353, DOI 10.1007/s10549-007-9868-1; Moreno-Estrada A., 2013, PLOS GENET, V9, P1, DOI [10.1371/journal.pgen.1003925, DOI 10.1371/J0URNAL.PGEN.1003925]; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Palmer-Young EC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20369-2; Pardo C., 2017, ATLAS MORTALIDAD CAN, P1; Pardo C, 2018, COLOMB MEDICA, V49, P16, DOI 10.25100/cm.v49i1.3596; Rodriguez AO, 2012, GYNECOL ONCOL, V124, P236, DOI 10.1016/j.ygyno.2011.10.027; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Torres D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05056-y; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Tuazon AMD, 2020, BREAST CANCER RES, V22, P108, DOI 10.1186/s13058-020-01341-3; Vargas E, 2019, ONCOLOGIST, V24, pE475, DOI 10.1634/theoncologist.2018-0346; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037	30	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1083-7159	1549-490X		ONCOLOGIST	Oncologist	MAR 4	2022	27	2					E151	E157		10.1093/oncolo/oyab026	http://dx.doi.org/10.1093/oncolo/oyab026			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	ZM3LX	35641219	Green Published, gold			2022-09-04	WOS:000764264500016
J	Garcia-Cifuentes, E; Botero-Rodriguez, F; Velandia, FR; Iragorri, A; Marquez, I; Gelvis-Ortiz, G; Acosta, MF; Jaramillo-Jimenez, A; Lopera, F; Cano-Gutierrez, CA				Garcia-Cifuentes, Elkin; Botero-Rodriguez, Felipe; Ramirez Velandia, Felipe; Iragorri, Angela; Marquez, Isabel; Gelvis-Ortiz, Geronimo; Acosta, Maria-Fernanda; Jaramillo-Jimenez, Alberto; Lopera, Francisco; Cano-Gutierrez, Carlos Alberto			Muscular Function as an Alternative to Identify Cognitive Impairment: A Secondary Analysis From SABE Colombia	FRONTIERS IN NEUROLOGY			English	Article						gait speed; handgrip strength; cognitive impairment; biomarker; pre-clinical dementia; motor dysfunction	DUAL-TASK GAIT; INSTRUMENTAL ACTIVITIES; OLDER-ADULTS; DECLINE; SPEED; DEMENTIA; DYSFUNCTION; PREDICTORS; LANGUAGE; HEALTH	BackgroundIdentification of cognitive impairment is based traditionally on the neuropsychological tests and biomarkers that are not available widely. This study aimed to establish the association between motor function (gait speed and handgrip strength) and cognitive performance in the Mini-Mental State Examination, globally and by domains. A secondary goal was calculating a cut-off point for gait speed and handgrip strength to classify older adults as cognitively impaired. MethodsThis is a secondary analysis of SABE Colombia (Salud, Bienestar & Envejecimiento), a survey that was conducted in 2015 on health, wellbeing, and aging in Colombia. This study used linear regression models to search for an association between motor function and cognitive performance. The accuracy of motor function measurements in identifying cognitive impairment was assessed with receiver operating characteristic (ROC) curves. This study also analyzed other clinical and sociodemographical variables. ResultsGait speed was associated with orientation (r(2) = 0.16), language (r(2) = 0.15), recall memory (r(2) = 0.14), and counting (r(2) = 0.08). Similarly, handgrip strength was associated with orientation (r(2) = 0.175), language (r(2) = 0.164), recall memory (r(2) = 0.137), and counting (r(2) = 0.08). To differentiate older adults with and without cognitive impairment, a gait speed cut-off point of 0.59 m/s had an area under the curve (AUC) of 0.629 (0.613-0.646), and a weak handgrip (strength below 17.5 kg) had an AUC of 0.653 (0.645-0.661). The cut-off points for handgrip strength and gait speed were significantly higher in male participants. ConclusionsGait speed and handgrip strength are similarly associated with the cognitive performance, exhibiting the most extensive association with orientation and language domains of the Mini-Mental State Examination. Gait speed and handgrip strength can easily be measured by any clinician, and they prove to be useful screening tools to detect cognitive impairment.	[Garcia-Cifuentes, Elkin; Ramirez Velandia, Felipe; Marquez, Isabel; Gelvis-Ortiz, Geronimo; Acosta, Maria-Fernanda; Cano-Gutierrez, Carlos Alberto] Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Garcia-Cifuentes, Elkin; Iragorri, Angela] Hosp Univ San Ignacio, Unidad Neurol, Bogota, Colombia; [Botero-Rodriguez, Felipe] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestat, Bogota, Colombia; [Jaramillo-Jimenez, Alberto; Lopera, Francisco] Univ Antioquia, Grp Neurociencias Antioquia, Fac Med, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Jaramillo-Jimenez, Alberto] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Fac Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Semillero Invest SINAPSIS, Fac Med, Medellin, Colombia; [Cano-Gutierrez, Carlos Alberto] Hosp Univ San Ignacio, Unidad Geriatr, Bogota, Colombia		Garcia-Cifuentes, E (corresponding author), Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia.; Garcia-Cifuentes, E (corresponding author), Hosp Univ San Ignacio, Unidad Neurol, Bogota, Colombia.	elkingarciaci@gmail.com		Botero-Rodriguez, Felipe/0000-0003-1537-5211	Colciencias; Ministerio de Salud y la Proteccion Social; Colombian Ministry of Health and Social Protection [764]; Colciencias - Pontificia Universidad Javeriana [829]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministerio de Salud y la Proteccion Social; Colombian Ministry of Health and Social Protection; Colciencias - Pontificia Universidad Javeriana	This study is part of a larger project funded by Colciencias and the Ministerio de Salud y la Proteccion Social, the Colombian Ministry of Health and Social Protection (The SABE Study, ID 2013, no. 764). Contract of financing RC No. 829 of 2018, Colciencias - Pontificia Universidad Javeriana.	Adamo DE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232021; ADI, 2019, WORLD ALZHEIMER REPO; Ahman HB, 2019, J ALZHEIMERS DIS, V71, pS75, DOI 10.3233/JAD-181265; Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; [Anonymous], SABE Colombia 2015: Estudio Nacional de Salud Bienestar y Envejecimiento. Resumen Ejecutivo. Ministerio de Salud y Proteccion Social de Colombia; Arevalo-Rodriguez I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010783.pub2; Beason-Held LL, 2013, J NEUROSCI, V33, P18008, DOI 10.1523/JNEUROSCI.1402-13.2013; Beauchet O, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-12; Beauchet O, 2009, GERONTOLOGY, V55, P702, DOI 10.1159/000235905; Bender F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9521; Buchman AS, 2011, EXPERT REV NEUROTHER, V11, P665, DOI [10.1586/ern.11.57, 10.1586/ERN.11.57]; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Chou MY, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1199-7; Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2; Cuellar Segura CM., DOCUMENTO METODOLOGI; De Cock AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178566; Dumurgier J, 2017, J GERONTOL A-BIOL, V72, P655, DOI 10.1093/gerona/glw110; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritz NE, 2017, AGEING RES REV, V35, P112, DOI 10.1016/j.arr.2017.01.004; Garcia-Cifuentes E, 2017, J FRALITY AGING, V6, P141, DOI 10.14283/jfa.2017.17; Garcia-Cifuentes E, 2021, DEMENT GERIATR COGN, V49, P565, DOI 10.1159/000510494; Garcia-Pena C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069849; Gomez F., 2016, CURRENT GERONTOLOGY, V2016, P7910205, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Ismail Z, 2020, ALZHEIMERS DEMENT, V16, P1182, DOI 10.1002/alz.12105; Jin Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23123229; Krumpoch S, 2021, AGING CLIN EXP RES, V33, P141, DOI 10.1007/s40520-020-01703-z; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; MacAulay RK, 2017, J INT NEUROPSYCH SOC, V23, P493, DOI 10.1017/S1355617717000261; MAHONEY F I, 1965, Md State Med J, V14, P61; Mancioppi G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86579-3; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Montero-Odasso M, 2016, EUR J NEUROL, V23, P437, DOI 10.1111/ene.12908; Montero-Odasso M, 2020, AGE AGEING, V49, P995, DOI 10.1093/ageing/afaa106; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; Montero-Odasso M, 2014, NEUROL SCI, V35, P601, DOI 10.1007/s10072-013-1613-4; Montero-Odasso Manuel, 2009, BMC Geriatr, V9, P41, DOI 10.1186/1471-2318-9-41; Montero-Odasso MM, 2017, JAMA NEUROL, V74, P857, DOI 10.1001/jamaneurol.2017.0643; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Parraga-Montilla JA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073428; R Core Team, 2021, R LANG ENV STAT COMP; Ramirez-Velez R, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00052; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Reilly J, 2010, J COMMUN DISORD, V43, P438, DOI 10.1016/j.jcomdis.2010.04.011; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Sakurai R., 2018, J GERONTOL A, V5, P1, DOI [10.1093/geroni/igx004.2077, DOI 10.1093/GERONI/IGX004.2077]; Sakurai R, 2017, GERIATR GERONTOL INT, V17, P1873, DOI 10.1111/ggi.12982; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Tian Q, 2016, INT J GERONTOL, V10, P232, DOI 10.1016/j.ijge.2016.03.010; Torres VL, 2021, APPL NEUROPSYCH-ADUL, V28, P230, DOI 10.1080/23279095.2019.1627357; Vaz-Patto M, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0178-2; Veronese N, 2016, EXP GERONTOL, V81, P110, DOI 10.1016/j.exger.2016.05.008; Wirtshafter HS, 2019, CURR BIOL, V29, P3177, DOI 10.1016/j.cub.2019.07.089	59	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 18	2022	13								695253	10.3389/fneur.2022.695253	http://dx.doi.org/10.3389/fneur.2022.695253			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ZP6GB	35250796	gold, Green Published			2022-09-04	WOS:000766517900001
J	Mateus, C; Acosta, AM; Baquero, MM; Gomez, P; Lalinde, JD; Cubillos, JE; Martinez, RA; Fajardo, AP; Ospina, JC				Mateus, Carolina; Maria Acosta, Ana; Baquero, Maria M.; Gomez, Paola; Lalinde, Juan D.; Cubillos, Javier E.; Martinez, Rodolfo A.; Fajardo, Angelica P.; Camilo Ospina, Juan			First EXIT (exuterus intapartum treatment) in San Ignacio University Hospital: Case Report	UNIVERSITAS MEDICA			Spanish	Article						EXIT (ex-uterus intrapartum treatment); congenital cervical malformation, airway	UTERO INTRAPARTUM TREATMENT; ANESTHESIA	The present article is the report of the first Ex Utero Intrapartum (EXIT) procedure, carried out at the San Ignacio University Hospital, by an interdisciplinary group (anesthesiologist, pediatric otolaryngologist, neonatologist and obstetrician). The need for an EXIT strategy is rare. Its objective is to secure the newborn's airway during childbirth when there is a risk of airway obstruction tha may be caused by secondary compression from cervical or mediastinal masses, congenital craniofacial or airway malformations. The aim of the surgery is to reduce the risk of mortality of the newborn. We present a 33 years old patient with a gestational age of 38 weeks and a diagnosis of cervical cystic lesion in the fetus by gestational week 25. The delivery was performed by securing the neonate's airway with orotracheal intubation. In this case, a vascular macrocystic lymphatic malformation was confirmed. The objective of the article is to emphasize that proper planning and prenatal diagnosis of cervical malformations significantly improves the patient's prognosis, both in the short and the long term results. intrapartum	[Mateus, Carolina; Baquero, Maria M.; Gomez, Paola; Lalinde, Juan D.; Martinez, Rodolfo A.] Pontificia Univ Javeriana, Bogota, Colombia; [Mateus, Carolina; Baquero, Maria M.] Hosp Univ San Ignacio, Dept Cirugia, Unidad Otorrinolaringol, Bogota, Colombia; [Maria Acosta, Ana] Univ Javeriana, Hosp Univ San Ignacio, Dept Cirugia, Otorrinolaringol,Fac Med,Unidad Otorrinolaringol, Bogota, Colombia; [Gomez, Paola; Fajardo, Angelica P.] Hosp Univ San Ignacio, Dept Anestesia, Bogota, Colombia; [Lalinde, Juan D.; Martinez, Rodolfo A.] Hosp Univ San Ignacio, Dept Ginecol & Obstet, Bogota, Colombia; [Cubillos, Javier E.] London Hlth Sci Ctr, London, England; [Cubillos, Javier E.] Western Univ, Dept Anesthesia & Perioperat Med, London, ON, Canada; [Camilo Ospina, Juan] Univ British Columbia, Vancouver, BC, Canada; [Camilo Ospina, Juan] Pontificia Univ Javeriana, Fac Med, Unidad Otorrinolaringol, Dept Cirugia,Hosp Univ San Ignacio, Bogota, Colombia		Acosta, AM (corresponding author), Univ Javeriana, Hosp Univ San Ignacio, Dept Cirugia, Otorrinolaringol,Fac Med,Unidad Otorrinolaringol, Bogota, Colombia.	anamaria.acostar@gmail.com		Fajardo Escolar, Angelica Paola/0000-0003-2166-9048; acosta, ana/0000-0002-3959-6601; Baquero Hoyos, Maria Monica/0000-0003-4732-6529; Ospina, Juan/0000-0001-7806-5355				Cox JA, 2014, SEMIN PLAST SURG, V28, P58, DOI 10.1055/s-0034-1376263; Dighe MK, 2011, RADIOGRAPHICS, V31, P511, DOI 10.1148/rg.312105108; Garcia PJ, 2011, ANESTHESIOLOGY, V114, P1446, DOI 10.1097/ALN.0b013e31821b173e; George RB, 2007, CAN J ANAESTH, V54, P218, DOI 10.1007/BF03022643; Hedrick Holly L, 2003, Semin Pediatr Surg, V12, P190, DOI 10.1016/S1055-8586(03)00026-X; Hubbard AM, 1998, AM J PERINAT, V15, P253, DOI 10.1055/s-2007-993937; Laje P, 2012, J PEDIATR SURG, V47, P1208, DOI 10.1016/j.jpedsurg.2012.03.027; Marwan Ahmad, 2006, Semin Pediatr Surg, V15, P107, DOI 10.1053/j.sempedsurg.2006.02.008; Oliveira E, 2015, REV BRAS ANESTESIOL, V65, P529, DOI [10.1016/j.bjane.2013.07.020, 10.1016/j.bjan.2015.08.001]; Ospina-García Juan Camilo, 2012, Rev Colomb Obstet Ginecol, V63, P155; Richter GT, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/645678; Sviggum HP, 2013, CLIN PERINATOL, V40, P413, DOI 10.1016/j.clp.2013.05.012	12	0	0	0	1	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.	JUL-SEP	2020	61	3								10.11144/Javeriana.umed61-3.exit	http://dx.doi.org/10.11144/Javeriana.umed61-3.exit			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LJ4ID		gold			2022-09-04	WOS:000530129100008
J	Jamebozorgi, K; Taghizadeh, E; Rostami, D; Pormasoumi, H; Barreto, GE; Hayat, SMG; Sahebkar, A				Jamebozorgi, Khosro; Taghizadeh, Eskandar; Rostami, Daryoush; Pormasoumi, Hosein; Barreto, George E.; Hayat, Seyed Mohammad Gheibi; Sahebkar, Amirhossein			Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives	MOLECULAR NEUROBIOLOGY			English	Article						Parkinson's disease; Transplantation therapy; Molecular mechanisms; L-dopa; Gene therapy	TARGETING ALPHA-SYNUCLEIN; EMBRYONIC STEM-CELLS; GENE-THERAPY; DOPAMINE NEURONS; NATURAL-PRODUCTS; RAT MODEL; MONOCLONAL-ANTIBODY; RNA INTERFERENCE; SIRNA DELIVERY; PRIMATE MODEL	Parkinson's disease is a neurodegenerative disorder accompanied by depletion of dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible for the motor and non-motor symptoms in this disease. The main drug prescribed for Parkinsonian patients is L-dopa, which can be converted to dopamine by passing through the blood-brain barrier. Although Ldopa is able to improve motor function and improve the quality of life in the patients, there is inter-individual variability and some patients do not achieve the therapeutic effect. Variations in treatment response and side effects of current drugs have convinced scientists to think of treating Parkinson's disease at the cellular and molecular level. Molecular and cellular therapy for Parkinson's disease include (i) cell transplantation therapy with human embryonic stem (ES) cells, human induced pluripotent stem (iPS) cells and human fetal mesencephalic tissue, (ii) immunological and inflammatory therapy which is done using antibodies, and (iii) gene therapy with AADC-TH-GCH gene therapy, viral vector-mediated gene delivery, RNA interferencebased therapy, CRISPR-Cas9 gene editing system, and alternative methods such as optogenetics and chemogenetics. Although these methods currently have a series of challenges, they seem to be promising techniques for Parkinson's treatment in future. In this study, these prospective therapeutic approaches are reviewed.	[Jamebozorgi, Khosro; Pormasoumi, Hosein] Zabol Univ Med Sci, Fac Med, Zabol, Iran; [Taghizadeh, Eskandar] Yasuj Univ Med Sci, Cellular & Mol Res Ctr, Yasuj, Iran; [Taghizadeh, Eskandar] Mashhad Univ Med Sci, Fac Med, Dept Med Genet, Mashhad, Razavi Khorasan, Iran; [Rostami, Daryoush] Zabol Univ Med Sci, Dept Sch Allied, Zabol, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Hayat, Seyed Mohammad Gheibi] Shahid Sadoughi Univ Med Sci, Sch Med, Dept Genet, Yazd, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Taghizadeh, Eskandar/AAY-5149-2020; Sahebkar, Amirhossein/B-5124-2018; Gheibihayat, Seyed Mohammad ./T-7187-2017; rostami, daryoush/B-5964-2018; Barreto, George E./AAD-7420-2020	Taghizadeh, Eskandar/0000-0002-7394-2539; Gheibihayat, Seyed Mohammad ./0000-0002-1378-118X; Barreto, George E./0000-0002-6644-1971; rostami, daryoush/0000-0002-4698-4944; pourmasoomi, hoseyn/0000-0002-8662-3529				Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Aono H, 2017, GLIA, V65, P1833, DOI 10.1002/glia.23199; Areiza-Mazo N, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00276; Axelsen TM, 2018, J PARKINSON DIS, P1; Azzouz M, 2002, J NEUROSCI, V22, P10302; BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Bartus RT, 2014, MOL THER, V22, P487, DOI 10.1038/mt.2013.281; Basu S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45883; Belin AC, 2008, FEBS J, V275, P1377, DOI 10.1111/j.1742-4658.2008.06301.x; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blaylock Russell L, 2017, Surg Neurol Int, V8, P65, DOI 10.4103/sni.sni_441_16; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Cabezas R, 2019, MOL NEUROBIOL, V56, P2339, DOI 10.1007/s12035-018-1203-9; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carta M, 2008, PROG BRAIN RES, V172, P465, DOI 10.1016/S0079-6123(08)00922-9; Caudle WM, 2008, TRENDS NEUROSCI, V31, P303, DOI 10.1016/j.tins.2008.02.010; Cenci MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00242; Chan AK, 2014, JAMA NEUROL, V71, P291, DOI 10.1001/jamaneurol.2013.5798; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Chin-Chan M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00124; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Coune PG, 2012, COLD SPRING HARB PER, V2; Cui Z, 2018, HUM MOL GENET; de Tassigny XD, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00010; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; De Andrade DVG, 2008, BRAIN RES, V1198, P188, DOI 10.1016/j.brainres.2008.01.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; Dehay B, 2016, MOVEMENT DISORD, V31, P882, DOI 10.1002/mds.26568; Dehay B, 2015, LANCET NEUROL, V14, P855, DOI 10.1016/S1474-4422(15)00006-X; Delamarre A, 2017, PRESSE MED, V46, P175, DOI 10.1016/j.lpm.2017.01.001; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Fitzpatrick KM, 2009, ANTIOXID REDOX SIGN, V11, P2189, DOI [10.1089/ars.2009.2654, 10.1089/ARS.2009.2654]; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 2011, NEUROTHERAPEUTICS, V8, P549, DOI 10.1007/s13311-011-0082-9; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Fu MH, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1400-1; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GODWINAURB, 1969, LANCET, V2, P165; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Gonzalez C, 2016, CURR STEM CELL RES T, V11, P561, DOI 10.2174/1574888X10666150531172612; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hadaczek P, 2010, MOL THER, V18, P1458, DOI 10.1038/mt.2010.106; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Hallett PJ, 2014, CELL REP, V7, P1755, DOI 10.1016/j.celrep.2014.05.027; Hauser RA, 2009, MOVEMENT DISORD, V24, P564, DOI 10.1002/mds.22402; Haussecker D, 2014, J CONTROL RELEASE, V195, P49, DOI 10.1016/j.jconrel.2014.07.056; Helmschrodt C, 2017, MOL THER-NUCL ACIDS, V9, P57, DOI 10.1016/j.omtn.2017.08.013; Hoang QQ, 2014, P NATL ACAD SCI USA, V111, P2402, DOI 10.1073/pnas.1324284111; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Hornykiewicz O, 1975, MINIREVIEWS NEUROSCI, P421; Hutz MH, 2018, FUTURE MED; Jain S, 2005, CLIN SCI, V109, P355, DOI 10.1042/CS20050106; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jankovic J, 2018, PARKINSONISM RELAT D, V46, pE25; Jankovic J, 2018, FUTURE MED; Jarraya B, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000130; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Kalinderi K, 2016, ACTA NEUROL SCAND, V134, P314, DOI 10.1111/ane.12563; Kikuchi T, 2017, NATURE, V548, P592, DOI 10.1038/nature23664; Kikuchi T, 2011, J PARKINSON DIS, V1, P395, DOI 10.3233/JPD-2011-11070; Kim HJ, 2011, BBA-MOL BASIS DIS, V1812, P1, DOI 10.1016/j.bbadis.2010.08.006; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirik D, 2017, NEUROBIOL DIS, V97, P179, DOI 10.1016/j.nbd.2016.09.008; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lawand NB, 2015, EXPERT OPIN THER TAR, V19, P1351, DOI 10.1517/14728222.2015.1062877; Lee JS, 2016, J MOV DISORD, V9, P14, DOI 10.14802/jmd.15059; Li C, 2010, NEUROCHEM RES, V35, P1546, DOI 10.1007/s11064-010-0214-3; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; LINDVALL O, 1987, ANN NEUROL, V22, P457, DOI 10.1002/ana.410220403; LINDVALL O., 2015, PHIL T R SOC, V370, P1680; Lindvall O, 2013, MOVEMENT DISORD, V28, P268, DOI 10.1002/mds.25378; Liu YY, 2014, CNS NEUROSCI THER, V20, P76, DOI 10.1111/cns.12176; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Maiti P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0099-z; Man JHK, 2018, J CONTROL RELEASE, V286, P114, DOI 10.1016/j.jconrel.2018.07.017; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Marin B, 2018, NEUROEPIDEMIOLOGY IN TROPICAL HEALTH, P167, DOI 10.1016/B978-0-12-804607-4.00013-7; Marizzoni M, 2017, CURR OPIN NEUROL, V30, P630, DOI 10.1097/WCO.0000000000000496; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masserdotti G, 2016, DEVELOPMENT, V143, P2494, DOI 10.1242/dev.092163; Mastrangelo L, 2017, ADV GENET, V98, P43, DOI 10.1016/bs.adgen.2017.08.001; Mazo NA, 2017, CURR PHARM DESIGN, V23, P4180, DOI 10.2174/1381612823666170316142803; McSwiggen J, 2004, GOOGLE PATENTS; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Muramatsu SI, 2010, ANN NEUROSCI, V17, P92, DOI 10.5214/ans.0972-7531.1017209; Obeso JA, 2017, MOVEMENT DISORD, V32, P1264, DOI 10.1002/mds.27115; Oertel W, 2016, J NEUROCHEM, V139, P325, DOI 10.1111/jnc.13750; Oh SM, 2015, EMBO MOL MED; Olanow CW, 2015, ANN NEUROL, V78, P248, DOI 10.1002/ana.24436; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002; Parmar M, 2018, EUR J NEUROSCI; PESCHANSKI M, 1994, BRAIN, V117, P487, DOI 10.1093/brain/117.3.487; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Pienaar IS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0044-5; Pienaar IS, 2015, BRAIN STRUCT FUNCT, V220, P479, DOI 10.1007/s00429-013-0669-5; Pinna A, 2014, EXP NEUROL, V253, P180, DOI 10.1016/j.expneurol.2013.12.021; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rath A, 2013, CELL TRANSPLANT, V22, P1281, DOI 10.3727/096368912X654984; Reichmann H, 2016, J NEURAL TRANSM, V123, P73, DOI 10.1007/s00702-015-1441-1; Rios JL, 2016, PLANTA MED, V82, P942, DOI 10.1055/s-0042-107081; Roybon L, 2004, CELL TISSUE RES, V318, P261, DOI 10.1007/s00441-004-0946-y; Sahin C, 2017, BIOPHYS CHEM, V220, P34, DOI 10.1016/j.bpc.2016.11.002; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanders TH, 2016, NEUROBIOL DIS, V95, P225, DOI 10.1016/j.nbd.2016.07.021; Santos G, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00097; Schenk DB, 2017, MOVEMENT DISORD, V32, P211, DOI 10.1002/mds.26878; Seidel K, 2015, BRAIN PATHOL, V25, P121, DOI 10.1111/bpa.12168; Solayman M, 2017, CURR DRUG METAB, V18, P50, DOI 10.2174/1389200217666160709204826; Spencer B, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0410-8; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sulzer D, 2017, NATURE, V550, P292, DOI 10.1038/nature23896; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Sveinbjornsdottir S, 2016, J NEUROCHEM, V139, P318, DOI 10.1111/jnc.13691; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Tambasco N, 2016, J NEURAL TRANSM, V123, P1301, DOI 10.1007/s00702-016-1578-6; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; WADE LA, 1975, LIFE SCI, V17, P131, DOI 10.1016/0024-3205(75)90248-9; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Weihofen A, 2017, NEURODEGENER DIS; Weintraub D, 2015, MOVEMENT DISORD, V30, P919, DOI 10.1002/mds.26170; Witoelar A, 2017, JAMA NEUROL, V74, P780, DOI 10.1001/jamaneurol.2017.0469; Yang YX, 2009, NEUROREPORT, V20, P150, DOI 10.1097/WNR.0b013e32831c50df; Zhang HJ, 2017, EUR J MED CHEM, V141, P257, DOI 10.1016/j.ejmech.2017.09.068; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	157	22	21	1	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2019	56	7					4799	4811		10.1007/s12035-018-1419-8	http://dx.doi.org/10.1007/s12035-018-1419-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT8VJ	30397850				2022-09-04	WOS:000483159700015
J	Pregonero, AF; Gomez, LF; Parra, DC; Cohen, DD; Paternina, CMA; Lobelo, F				Florez Pregonero, Alberto; Fernando Gomez, Luis; Parra, Diana C.; Cohen, Daniel D.; Arango Paternina, Carlos Mario; Lobelo, Felipe			Time spent traveling in motor vehicles and its association with overweight and abdominal obesity in Colombian adults who do not own a car	PREVENTIVE MEDICINE			English	Article						Obesity; Motor vehicles; Sedentary behaviors; Travel time	PHYSICAL-ACTIVITY; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SEDENTARY TIME; SITTING TIME; RISK; MORTALITY	Objective. This study examined associations between time spent traveling in motor vehicles per week (TSTMV) and BMI and abdominal obesity (AO) among Colombian adults residing in urban areas who do not own car. Method. Secondary data analysis of the 2005 National Nutrition Survey of Colombia was conducted. TSTMV was assessed using the long International Physical Activity Questionnaire. Body composition was measured in 7900 adults. Polytomous and binary logistic regressions were conducted, stratified by gender and adjusted for confounders, including physical activity (PA). Results. Forty-two percent of participants were either overweight or obese according to their BM!, and 22.4% had AO. Males in the middle (10 to 149 min) and highest (>150 min) TSTMV tertiles were more likely to be overweight (POR = 1.58, 95% CI = 1.13-2.21 and POR = 1.55, 95% CI = 1.12-2.15 respectively, p-trend = 0.012), obese (POR = 2.39, 95% CI = 1.43-3.99 and POR = 1.93, 95% CI = 1.22-3.08 respectively, p trend = 0.019) and to have AO (POR = 1.81, 95% CI = 1.18-2.78 and POR = 1.73, 95% CI = 1.18-2.54 respectively, p-trend = 0.009). Associations were not significant in females. Conclusions. TSTMV was positively associated with overweight and AO in adult Colombian males even after adjusting for PA. These findings highlight the potential deleterious health effects of sedentary behaviors such as prolonged traveling time, independently of having met PA recommendations. (C) 2012 Elsevier Inc. All rights reserved.	[Florez Pregonero, Alberto] Pontificia Univ Javeriana, Fac Educ, Dept Formac, Bogota, Colombia; [Fernando Gomez, Luis] Pontificia Univ Javeriana, Fac Med, Dept Med Prevent & Social, Bogota, Colombia; [Parra, Diana C.; Arango Paternina, Carlos Mario] Washington Univ, George Warren Brown Sch, Prevent Res Ctr St Louis, St Louis, MO USA; [Cohen, Daniel D.] London Metropolitan Univ, Fac Life Sci, London, England; [Cohen, Daniel D.] Concordia Univ, Ctr Res Human Dev, Montreal, PQ, Canada; [Lobelo, Felipe] Ctr Dis Control & Prevent, Global Hlth Promot Off, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA		Pregonero, AF (corresponding author), Carrera 7,40-62 Edificio,25 Piso 4, Bogota, Colombia.	floreza@javeriana.edu.co	Flórez-Pregonero, Alberto/C-8804-2012; Lobelo, R.L Felipe/AAB-2264-2021; lobelo, felipe/B-9148-2013; Parra, Diana C/B-7761-2015; Parra, Diana C/D-7633-2013	Flórez-Pregonero, Alberto/0000-0003-1907-3173; Lobelo, R.L Felipe/0000-0003-4185-7193; Parra, Diana C/0000-0002-9797-6231; Parra, Diana C/0000-0002-9797-6231; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012; Arango-Paternina, Carlos Mario/0000-0002-5263-3139				Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Distrital D.A.D.P, 2005, ESTR BOG DC EST REL; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Gao X, 2007, DIABETES CARE, V30, P694, DOI 10.2337/dc06-1835; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Instituto Colombiano de Bienestar Familiar ICBF, 2005, ENC NAC SIT NUTR COL; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Medina-Lezama J, 2010, DIABETES CARE, V33, P1385, DOI 10.2337/dc09-2353; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parra DC, 2009, PREV MED, V49, P179, DOI 10.1016/j.ypmed.2009.07.010; Rogat J., 2009, C INT ENV TRANSP CON; StataCorp LP, 2007, STAT STAT SOFTW; US Department of Health and Human Services, 2018, PHYS ACT GUID AM; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wen LM, 2006, INT J OBESITY, V30, P782, DOI 10.1038/sj.ijo.0803199	22	17	17	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435			PREV MED	Prev. Med.	JUN	2012	54	6					402	404		10.1016/j.ypmed.2012.04.002	http://dx.doi.org/10.1016/j.ypmed.2012.04.002			3	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	960HP	22521998				2022-09-04	WOS:000305378900006
J	Ruiz-Garcia, M; Vasquez, JYA; Restrepo, H; Caceres-Martinez, CH; Shostell, JM				Ruiz-Garcia, Manuel; Arias Vasquez, Jessica Yanina; Restrepo, Hector; Herney Caceres-Martinez, Carlos; Mark Shostell, Joseph			The genetic structure of the spectacled bear (Tremarctos ornatus; Ursidae, Carnivora) in Colombia by means of mitochondrial and microsatellite markers	JOURNAL OF MAMMALOGY			English	Article						Colombian Andean Cordilleras; gene flow; genetic heterogeneity; microsatellites; mitochondrial genes; Pleistocene and Holocene demographic changes; spatial autocorrelation; spectacled bear; Tremarrtos ornatus	ANDEAN BEAR; STATISTICAL TESTS; POPULATION-GROWTH; GLACIAL SEQUENCE; RARE ALLELES; DNA; NEUTRALITY; EVOLUTION; PATTERNS; HISTORY	The spectacled bear (Ursidae: Tremarctos ornatus) is an emblematic umbrella species and one of the top carnivores in the Andean mountains. It is also listed as vulnerable by IUCN and as endangered by CITES. We analyzed the genetic structure of this species in nine geographical regions representing the three Andean Cordilleras in Colombia. We sequenced six mitochondrial genes in 115 spectacled bears; a subset of these specimens (n = 61) were genotyped at seven nuclear microsatellites. We addressed three objectives: 1) determine the genetic diversity and historical demographic changes of the spectacled bear in Colombia; 2) determine phylogeographic patterns of genetic divergence among spectacled bear populations in Colombia; and 3) estimate the levels of gene flow among different regions of Colombia. Our analyses show evidence of high mitochondrial genetic diversity in spectacled bears, both in Colombia as well as in each of the nine regions, most particularly Norte de Santander, Narino, and Antioquia-Cordoba. In addition, we detected population expansion in Colombia that occurred around 24,000 years ago, followed by a population decrease during the last 7,000 years, and a sudden expansion in the last 300 years. Phylogenetic analyses showed few well-supported Glades, with some haplotypes detected in all the departments and Colombian Andean Cordilleras, and other haplotypes restricted to certain geographical areas (Antioquia, None de Santander, Cundinamarca, and Narino). We detected significant genetic heterogeneity among some departments and among the three Colombian Andean Cordilleras for both mitochondrial and nuclear genes. Nevertheless, the moderate levels of gene flow estimated from F-ST. statistics suggest that geographical barriers have not been definitive obstacles to the dispersion of the spectacled bear throughout Colombia. Despite these gene flow estimates, significant spatial autocorrelation was detected for spectacled bear in Colombia, where two kinds of spatial patterns were discovered: genetic patches of 144 km of diameter, and isolation by distance among bears separated from 578 to 800 km. The two most northern spectacled bear populations of Colombia (Norte de Santander and Antioquia) also were the two most differentiated. Their distinctiveness may qualify them as distinct Management Units (MUs) in the context of conservation policies for the spectacled bear in Colombia.	[Ruiz-Garcia, Manuel; Arias Vasquez, Jessica Yanina] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut,Unidad Genet, Cra 7A 43-82, Bogota 110231, DC, Colombia; [Restrepo, Hector] Fdn Wii, Bogota 110121, DC, Colombia; [Herney Caceres-Martinez, Carlos] Univ Nacl Colombia, Sede Medellin, Grp Invest Ecol & Conservac Fauna Silvestre, Medellin 050034, Colombia; [Mark Shostell, Joseph] Univ Minnesota Crookston, Math Sci & Technol Dept, 2900 Univ Ave, Crookston, MN 56716 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut,Unidad Genet, Cra 7A 43-82, Bogota 110231, DC, Colombia.	mruizgar@yahoo.es		Caceres Martinez, Carlos Herney/0000-0002-5329-3914; Ruiz-Garcia, Manuel/0000-0003-2820-2950	Pontificia Universidad Javeriana of Bogota (Colombia); Corponarino at Pasto (Narino, Colombia)	Pontificia Universidad Javeriana of Bogota (Colombia); Corponarino at Pasto (Narino, Colombia)	The authors express their gratitude to collaborators who obtained some samples directly from wild: Sergio Sandoval, Franz Kaston, Daniel Rodriguez, and Pedro Moreno. We are indebted to the Academic Vice-Rectory of the Pontificia Universidad Javeriana of Bogota (Colombia) and to Corponarino (Aida Delgado, Diana Ocana Saltikova) at Pasto (Narino, Colombia) for providing financial support to carry out this research. We are also grateful to the Instituto von Humboldt (Colombian government), and the regional corporations Corpoguavio, Corantioquia, and Corponarino for their role in facilitating the obtainment of the collection and care permits in different Departments of Colombia.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allendorf FW., 2007, CONSERV GENET; Ameghino F., 1889, ACTAS ACAD NACL CIEN, V6, P1, DOI DOI 10.5962/BHL.TITLE.121288; Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Bebbington A, 2008, WORLD DEV, V36, P2888, DOI 10.1016/j.worlddev.2007.11.016; Bowen D. Q., 1978, QUATERNARY GEOLOGY S; Castellanos A., 1998, INFORM FINAL PROYECT; Castellanos A, 2011, URSUS, V22, P65, DOI 10.2192/URSUS-D-10-00006.1; Correal Urrego G., 1990, AGUAZUQUE EVIDENCIAS; Cosse M, 2014, URSUS, V25, P163, DOI 10.2192/URSUS-D-14-00020.1; Cueva DF, 2018, URSUS, V29, P43, DOI 10.2192/URSUS-D-17-00020.2; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Del Moral Sachetti J. Fernando, 2011, Rev. Mus. Argent. Cienc. Nat., V13, P7; Dollfus O, 1999, HIST GEN AM LATINA S, V1, P29; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Ellegren H, 1997, MOL BIOL EVOL, V14, P854, DOI 10.1093/oxfordjournals.molbev.a025826; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Del Moral J. Fernando, 2009, Rev. Mus. Argent. Cienc. Nat., V11, P69; Figueroa J., 2009, OSO ANDINO ALCANCES; Figueroa Judith, 2012, Acta Zool. Mex, V28, P594; Flores Y., 1975, SEM HIST RUR AND LIM; Florez A., 1986, THESIS; Florez A., 1992, ANALISIS GEOGRAFICOS, V22, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forasiepi A., 2007, BESTIARIO FOSIL MAMI; Frankham R, 2017, GENETIC MANAGEMENT OF FRAGMENTED ANIMAL AND PLANT POPULATIONS, P1; Frankham Richard, 2009, P371, DOI 10.1002/9781444312034.ch17; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Garcia-Rangel S, 2012, MAMMAL REV, V42, P85, DOI 10.1111/j.1365-2907.2011.00207.x; GOLDMAN D, 1989, EVOLUTION, V43, P282, DOI 10.1111/j.1558-5646.1989.tb04228.x; Gonzales Fiorella N, 2016, Rev. peru biol., V23, P61, DOI 10.15381/rpb.v23i1.11834; Guhl E., 1975, COLOMBIA BOSQUEJO GE, V1; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Helmens K. F., 1984, THESIS; HELMENS KF, 1988, PALAEOGEOGR PALAEOCL, V67, P263, DOI 10.1016/0031-0182(88)90156-3; Herd D, 1982, PUBL GEOL ESPEC INGE, V8, P1; Hershkovitz P., 1957, Saugetierkundliche Mitteilungen, V5, P122; Hooghiemstra H., 1984, QUATERNARY COLOMBIA, V5, P62; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kattan G, 2004, ORYX, V38, P155, DOI 10.1017/S0030605304000298; KUHRY P., 1988, DISSERTATIONES BOT, V116, P1; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/srep46487; Kurten B., 1967, ACTA ZOOL FENN, V117, P1; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOZADA R, 1989, PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON THE SPECTACLED BEAR, P28; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mitchell KJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0062; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; NASH WG, 1987, CYTOGENET CELL GENET, V45, P206, DOI 10.1159/000132455; OBRIEN SJ, 1987, NATURE, V325, P758, DOI 10.1038/325758a0; Ojeda M. C., 2006, THESIS; Orejuela Jorge, 1999, P168; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Paisley S, 2006, J ZOOL, V268, P25, DOI 10.1111/j.1469-7998.2005.00019.x; Pena G. A., 1996, MAMIFEROS MAS COMUNE, V6; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Peyton B, 1998, URSUS-SERIES, V10, P87; Peyton Bernard, 1999, P157; Portillo-Quintero CA, 2012, APPL GEOGR, V35, P152, DOI 10.1016/j.apgeog.2012.06.015; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Rodriguez ED, 2003, ECOREGIONAL STRATEGY; Rodriguez ED, 1986, MANABA, V2, P1; Rodriguez-Paez S. A., 2016, OSO ANDINO GUARDIAN; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rostworowski M, 1981, COLECCION HIST ANDIN; Ruiz-Garcia M, 2005, GENES GENET SYST, V80, P57, DOI 10.1266/ggs.80.57; Ruiz-Garcia M, 2003, HEREDITAS, V138, P81, DOI 10.1034/j.1601-5223.2003.01578.x; Ruiz-Garcia M., 2020, MAMMALIAN CONSERVATI, P165; Ruiz-Garcia M, 2013, MOL POPULATION GENET, P129; Ruiz-Garcia M, 2006, AVANCES PROGRAMA NAC, P19; Ruiz-Garcia Manuel, 2007, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V102, P99; Ruiz-Garcia M, 2020, MITOCHONDRIAL DNA A, V31, P190, DOI 10.1080/24701394.2020.1769088; Ruiz-Garcia Manuel, 2003, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V98, P135; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sambrook J., 1989, MOL CLONING LAB MANU; Sanchez-Mercado A., 2010, CIENCIA CONSERVACION, P137; Sanchez-Mercado A, 2008, ORYX, V42, P437, DOI 10.1017/S0030605308006996; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIMONSEN KL, 1995, GENETICS, V141, P413; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Soibelzon L., 2007, MONOGRAPHIE SOC HIST, V12, P5; Soibelzon L. H., 2002, THESIS; Soibelzon Leopoldo Hector, 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P105; Soibelzon LH, 2013, MOL POPULATION GENET, P509; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stucchi M, 2009, URSUS, V20, P63, DOI 10.2192/08GR017R1.1; TAJIMA F, 1989, GENETICS, V123, P585; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Van Der Hammen T., 1963, B GEOLOGICO, V11, P189; VANDERHAMMEN T, 1985, J GEOL SOC LONDON, V142, P483, DOI 10.1144/gsjgs.142.3.0483; VANDERHAMMEN T, 1981, PALAEOGEOGR PALAEOCL, V32, P247; Velez-Liendo X, 2014, URSUS, V25, P172, DOI 10.2192/URSUS-D-14-00012.1; Viteri MP, 2009, URSUS, V20, P102, DOI 10.2192/09GR004.1; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Waits LP, 1999, MOL PHYLOGENET EVOL, V13, P82, DOI 10.1006/mpev.1999.0637; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Webb SD, 2006, ANN MO BOT GARD, V93, P245; WIJMSTRA T A, 1974, Geologie en Mijnbouw, V53, P386; wooding J.B., 1994, INT C BEAR RES MANAG, V9, P349; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1943, GENETICS, V28, P114; Yerena E, 1998, URSUS-SERIES, V10, P101; Yerena E., 1987, U SIM BOL DEP EST AM; Yerena E, 2007, PLAN ACCION CONSERVA; Yu L, 2004, MOL PHYLOGENET EVOL, V32, P480, DOI 10.1016/j.ympev.2004.02.015; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; ZHANG YP, 1993, P NATL ACAD SCI USA, V90, P9557, DOI 10.1073/pnas.90.20.9557; ZHANG YP, 1994, MOL PHYLOGENET EVOL, V3, P351, DOI 10.1006/mpev.1994.1041	126	2	3	2	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2372	1545-1542		J MAMMAL	J. Mammal.	AUG 31	2020	101	4					1072	1090		10.1093/jmammal/gyaa082	http://dx.doi.org/10.1093/jmammal/gyaa082			19	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	OX0HX					2022-09-04	WOS:000593258300016
J	Muniz, J; Romero, J; Holubiec, M; Barreto, G; Gonzalez, J; Saint-Martin, M; Blanco, E; Cavicchia, JC; Castilla, R; Capani, F				Muniz, Javier; Romero, Juan; Holubiec, Mariana; Barreto, George; Gonzalez, Janneth; Saint-Martin, Madeleine; Blanco, Eduardo; Carlos Cavicchia, Juan; Castilla, Rocio; Capani, Francisco			Neuroprotective effects of hypothermia on synaptic actin cytoskeletal changes induced by perinatal asphyxia	BRAIN RESEARCH			English	Article						Neostriatum; Perinatal asphyxia; Neuroprotection; Hypothermia; Actin cytoskeleton	CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; F-ACTIN; CEREBRAL-ISCHEMIA; DENDRITIC SPINE; BRAIN-INJURY; RAT-BRAIN; POSTSYNAPTIC DENSITIES; BIRTH ASPHYXIA; PROTEIN	Cerebral hypoxia ischemia damages synaptic proteins, resulting in cytoskeletal alterations, protein aggregation and neuronal death. In the previous works, we have shown neuronal and synaptic changes in rat neostriatum subjected to hypoxia that leads to ubi-protein accumulation. Recently, we also showed that, changes in F-actin organization could be related to early alterations induced by hypoxia in the Central Nervous System. However, little is known about effective treatment to diminish the damage. The main aim of this work is to study the effects of birth hypothermia on the actin cytoskeleton of neostriatal post-synaptic densities (PSD) in 60 days olds rats by immunohistochemistry, photooxidation and western blot. We used 2 different protocols of hypothermia: (a) intrahypoxic hypothermia at 15 degrees C and (b) post-hypoxia hypothermia at 32 degrees C. Consistent with previous data at 30 days, staining with phalloidin-Alexa(488) followed by confocal microscopy analysis showed an increase of F-actin fluorescent staining in the neostriatum of hypoxic animals. Correlative photooxidation electron microscopy confirmed these observations showing an increment in the number of mushroom-shaped F-actin staining spines in neostriatal excitatory synapses in rats subjected to hypoxia. In addition, western blot revealed beta-actin increase in PSDs in hypoxic animals. The optic relative density measurement showed a significant difference between controls and hypoxic animals. When hypoxia was induced under hypothermic conditions, the changes observed in actin cytoskeleton were blocked. Post-hypoxic hypothermia showed similar answer but actin cytoskeleton modifications were not totally reverted as we observed at 15 degrees C. These data suggest that the decrease of the body temperature decreases the actin modifications in dendritic spines preventing the neuronal death. (C) 2014 Elsevier B.V. All rights reserved.	[Muniz, Javier; Romero, Juan; Holubiec, Mariana; Saint-Martin, Madeleine; Blanco, Eduardo; Castilla, Rocio; Capani, Francisco] UBA, CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal, Buenos Aires, DF, Argentina; [Barreto, George; Gonzalez, Janneth] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr Bioquim, Bogota, DC, Colombia; [Blanco, Eduardo] Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain; [Carlos Cavicchia, Juan] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol Dr Mario H Burgos IHEM CONI, RA-5500 Mendoza, Argentina; [Capani, Francisco] Univ Argentina John F Kennedy, Dept Biol, Buenos Aires, DF, Argentina		Capani, F (corresponding author), UBA, CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal, Marcelo T Alvear 2270,C1122AAJ, Buenos Aires, DF, Argentina.	fcapani@fmed.uba.ar	GONZALEZ, JANNETH/AAB-9948-2020; capani, Francisco/D-9781-2016; Calvo, Eduardo Blanco/H-5805-2013; Barreto, George E./AAD-7420-2020	GONZALEZ, JANNETH/0000-0003-4482-256X; Calvo, Eduardo Blanco/0000-0003-0357-1151; Barreto, George E./0000-0002-6644-1971; Capani, Francisco/0000-0003-0342-0628; Holubiec, Mariana/0000-0002-7532-8890; Romero, Juan Ignacio/0000-0003-2323-0864	CONICET [11420100100135]; Universidad de Buenos Aires (UBACyT) [20020090100118]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires)	This research has been supported by a grant to FC from the CONICET (PIP 2011-2013, #11420100100135) and the Universidad de Buenos Aires (UBACyT 20-2012, #20020090100118).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aggoun-Zouaoui D, 1998, APOPTOSIS, V3, P133, DOI 10.1023/A:1009653126347; AMIELTISON C, 1986, DEV MED CHILD NEUROL, V28, P671; Bae J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034514; BJELKE B, 1991, BRAIN RES, V543, P1, DOI 10.1016/0006-8993(91)91041-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capani F, 1997, BRAIN RES, V775, P11, DOI 10.1016/S0006-8993(97)00714-2; Capani F, 2003, INT J NEUROSCI, V113, P641, DOI 10.1080/00207450390200099; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; Capani F, 2001, BRAIN RES, V914, P204, DOI 10.1016/S0006-8993(01)02781-0; Capani F, 2008, BIOCELL, V32, P1; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Clark DL, 2009, EXP NEUROL, V220, P391, DOI 10.1016/j.expneurol.2009.10.002; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; Dorfman VB, 2006, LIFE SCI, V78, P1529, DOI 10.1016/j.lfs.2005.06.045; Dunah AW, 2003, J NEUROCHEM, V85, P935, DOI 10.1046/j.1471-4159.2003.01744.x; Dunah AW, 1996, J NEUROCHEM, V67, P2335; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Engidawork E, 2001, EXP BRAIN RES, V138, P375, DOI 10.1007/s002210100710; Saraceno GE, 2010, EXP NEUROL, V223, P615, DOI 10.1016/j.expneurol.2010.02.010; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gisselsson L, 2010, BRAIN RES, V1316, P92, DOI 10.1016/j.brainres.2009.11.087; Gisselsson LL, 2005, J CEREBR BLOOD F MET, V25, P1346, DOI 10.1038/sj.jcbfm.9600131; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HILL A, 1981, ANN NEUROL, V10, P109, DOI 10.1002/ana.410100202; Hof PR, 2000, J CHEM NEUROANAT, V20, P3, DOI 10.1016/S0891-0618(00)00072-7; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Li DD, 2007, EXP NEUROL, V206, P280, DOI 10.1016/j.expneurol.2007.05.017; Liu CL, 2004, J CEREBR BLOOD F MET, V24, P1219, DOI 10.1097/01.WCB.0000136706.77918.21; Liu JJ, 2006, NEUROREPORT, V17, P1691, DOI 10.1097/01.wnr.0000236868.83970.79; Loidl CF, 1997, MOL CHEM NEUROPATHOL, V31, P301; Loidl CF, 2000, PHYSIOL BEHAV, V68, P263, DOI 10.1016/S0031-9384(99)00125-0; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Luo LD, 1996, J ANDROL, V17, P509; Martone ME, 1999, J NEUROSCI, V19, P1988; McGuire William, 2006, Clin Evid, P511; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Ouyang Y, 2005, EUR J NEUROSCI, V22, P2995, DOI 10.1111/j.1460-9568.2005.04521.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sameshima H, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/659374; Saraceno GE, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/873532; Saraceno GE, 2012, SYNAPSE, V66, P9, DOI 10.1002/syn.20978; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Shankaran S, 2009, J NEUROTRAUM, V26, P437, DOI 10.1089/neu.2008.0678; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Soll RF, 2013, NEONATOLOGY, V104, P260, DOI 10.1159/000353681; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; van Bel F, 2008, NEONATOLOGY, V94, P203, DOI 10.1159/000143723; Van de Berg WDJ, 2003, NEUROSCIENCE, V117, P83, DOI 10.1016/S0306-4522(02)00787-X; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; WANG P, 1995, PROTEIN EXPRES PURIF, V6, P528, DOI 10.1006/prep.1995.1070; WEIBEL HP, 1978, ARCH OHREN NASEN KEH, V219, P413, DOI 10.1007/BF00463862; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031	64	9	9	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 14	2014	1563						81	90		10.1016/j.brainres.2014.03.023	http://dx.doi.org/10.1016/j.brainres.2014.03.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH7XF	24685534				2022-09-04	WOS:000336348000009
J	Perez, GF; Nino, CL; Rodriguez-Martinez, C; Gutierrez, M; Huseni, S; Nino, G				Perez, Geovanny F.; Nino, C. L.; Rodriguez-Martinez, C.; Gutierrez, M.; Huseni, S.; Nino, G.			High-Throughput Signal Processing of Polysomnography Identifies Airflow-Independent Respiratory Features of OSA in Adults	JOURNAL OF INVESTIGATIVE MEDICINE			English	Meeting Abstract	Eastern Regional Meeting of the American-Federation-for-Medical-Research (AFMR)	APR 16-17, 2013	Washington, DC	Amer Federat Med Res (AFMR)					[Perez, Geovanny F.; Huseni, S.; Nino, G.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Nino, C. L.] Javeriana Univ, Bogota, Colombia; [Rodriguez-Martinez, C.] Univ Nacl Colombia, Bogota, Colombia; [Gutierrez, M.] Penn State Univ, Coll Med, Hershey, PA USA										0	0	0	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1081-5589			J INVEST MED	J. Invest. Med.	MAR	2013	61	3					669	670						2	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Research & Experimental Medicine	097GU					2022-09-04	WOS:000315462800055
J	Diaz-Soto, JC; Lasso, P; Guzman, F; Forero-Shelton, M; Thomas, MD; Lopez, MC; Guhl, F; Cuellar, A; Puerta, CJ; Gonzalez, JM				Camilo Diaz-Soto, Juan; Lasso, Paola; Guzman, Fanny; Forero-Shelton, Manu; del Carmen Thomas, Maria; Carlos Lopez, Manuel; Guhl, Felipe; Cuellar, Adriana; Judith Puerta, Concepcion; Gonzalez, John M.			Rabbit serum against K1 peptide, an immunogenic epitope of the Trypanosoma cruzi KMP-11, decreases parasite invasion to cells	ACTA TROPICA			English	Article						Trypanosoma cruzi; Anti-peptide antibodies; Chagas disease	KINETOPLASTID MEMBRANE PROTEIN-11; ACUTE CHAGAS-DISEASE; METACYCLIC FORMS; ANTIBODIES; INFECTION; INHIBITION; MICE; SUSCEPTIBILITY; SURFACE; BRUCEI	KMP-11 is a highly conserved protein of Trypanosoma cruzi implicated in parasite's motility. Here we show that K1, a peptide derived from KMP-11, induced polyclonal antibodies capable of decreasing T. cruzi infection in vitro. Rabbit sera rose against K1 peptide showed recognition of the recombinant protein by ELISA and Western blot and also of the native protein in both epimastigotes and trypomastigotes as evaluated by immunofluorescence test and flow cytometry. Invasion assays showed a significant reduction of trypomastigotes infection of eukaryotic cells when parasites were pre-incubated with anti-K1 rabbit serum. Computational modeling predicted that the K1 sequence conserved its alpha-helical configuration into the protein, and some of the amino acid residues appear accessible for recognition by antibodies in vivo. Taken together, these results support the idea that the K1 peptide induces antibodies than can have a potential role in protective immunity in Chagas disease. (C) 2012 Elsevier B.V. All rights reserved.	[Camilo Diaz-Soto, Juan; Gonzalez, John M.] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, DC, Colombia; [Lasso, Paola; Judith Puerta, Concepcion] Pontifica Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Bogota, DC, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Forero-Shelton, Manu] Univ Los Andes, Fac Ciencias, Grp Biofis, Bogota, DC, Colombia; [del Carmen Thomas, Maria; Carlos Lopez, Manuel] CSIC, Dept Biol Mol, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Guhl, Felipe] Univ Los Andes, Ctr Invest Microbiol & Parasitol Trop CIMPAT, Bogota, DC, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Fac Ciencias, Grp Inmunobiol, Bogota, DC, Colombia		Gonzalez, JM (corresponding author), Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Carrera 1 18A-10, Bogota, DC, Colombia.	johgonza@uniandes.edu.co	Puerta, Concepcion J/AAG-4912-2019; Thomas, María Carmen PhD/D-9065-2016; Cuellar, Adriana/AAF-2958-2019; Guzman, Fanny fg/K-5592-2013; Lopez, Manuel/Z-5641-2019	Guzman, Fanny fg/0000-0003-1537-0904; Thomas, M Carmen/0000-0003-3586-9657; Cuellar, Adriana/0000-0003-0834-8442; Guhl, Felipe/0000-0001-7180-7125; Forero-Shelton, Manu/0000-0002-7989-0311; Lopez, Manuel Carlos/0000-0003-0002-3678; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Gonzalez, John M./0000-0001-6925-0620	Vicerrectoria de Investigaciones, Universidad de los Andes; VRA, Pontificia Universidad Javeriana [003333]; COLCIENCIAS [640-2009]; Programa PAI de la Junta de Andalucia [P08-CVI-04037]; Programa RETIC del ISCIII-MICINN [RD06/0021/0014]	Vicerrectoria de Investigaciones, Universidad de los Andes; VRA, Pontificia Universidad Javeriana; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Programa PAI de la Junta de Andalucia(Junta de Andalucia); Programa RETIC del ISCIII-MICINN	This project was funded by an associate professor grant (JMG) from the Vicerrectoria de Investigaciones, Universidad de los Andes; and also received financial support from VRA, Pontificia Universidad Javeriana project No. 003333. PL was supported by COLCIENCIAS project No. 640-2009; and MCT and MCL were supported by grants No. P08-CVI-04037 (Programa PAI de la Junta de Andalucia) and No. RD06/0021/0014 (Programa RETIC del ISCIII-MICINN). The sponsors did not have any participation in the study design, data analysis or paper writing.	de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Costales J, 2005, J PARASITOL, V91, P950, DOI 10.1645/GE-429R.1; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; Cuellar A, 2009, IMMUNOL CELL BIOL, V87, P149, DOI 10.1038/icb.2008.76; de Souza W, 2010, INT J CELL BIOL; Diez H, 2007, PEPTIDES, V28, P1520, DOI 10.1016/j.peptides.2007.06.017; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Diez H, 2008, VECTOR-BORNE ZOONOT, V8, P93, DOI 10.1089/vbz.2006.0650; Flechas ID, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-186; Franchin G, 1997, INFECT IMMUN, V65, P2548, DOI 10.1128/IAI.65.7.2548-2554.1997; Guhl F, 2007, MEM I OSWALDO CRUZ, V102, P29, DOI 10.1590/S0074-02762007005000099; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LH, 2003, NUCLEIC ACIDS RES, V31, P3296, DOI 10.1093/nar/gkg541; Barrera YK, 2008, BIOMEDICA, V28, P616; KIERSZENBAUM F, 1983, AM J TROP MED HYG, V32, P1236, DOI 10.4269/ajtmh.1983.32.1236; KRETTLI AU, 1976, J IMMUNOL, V116, P755; KRETTLI AU, 1982, J IMMUNOL, V128, P2009; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; LIMAMARTINS MVC, 1985, PARASITE IMMUNOL, V7, P367, DOI 10.1111/j.1365-3024.1985.tb00083.x; Milei J, 2009, AM HEART J, V157, P22, DOI 10.1016/j.ahj.2008.08.024; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROCHA A, 1994, AM J TROP MED HYG, V50, P261, DOI 10.4269/ajtmh.1994.50.261; RODRIGUEZ AM, 1981, INFECT IMMUN, V31, P524, DOI 10.1128/IAI.31.2.524-529.1981; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; TARLETON RL, 1990, J IMMUNOL, V144, P717; Thomas MC, 2000, DNA CELL BIOL, V19, P47, DOI 10.1089/104454900314708; Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x; WIRTH JJ, 1987, INT J PARASITOL, V17, P841, DOI 10.1016/0020-7519(87)90067-1; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	38	2	3	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	SEP	2012	123	3					224	229		10.1016/j.actatropica.2012.05.015	http://dx.doi.org/10.1016/j.actatropica.2012.05.015			6	Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology; Tropical Medicine	978TP	22687575				2022-09-04	WOS:000306769000013
J	Ogier, A; Franco, MA; Charpilienne, A; Cohen, J; Pothier, P; Kohli, E				Ogier, A; Franco, MA; Charpilienne, A; Cohen, J; Pothier, P; Kohli, E			Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						B cells; alpha 4 beta 7; intranasal immunization; rotavirus; flow cytometry assay	HEAT-LABILE TOXIN; CHOLERA-TOXIN; PROTECTIVE EFFICACY; LYMPHOID-TISSUE; VP6 PROTEIN; EXPRESSION; INFECTION; IMMUNITY; MICE; IGA	Virus-like particles containing the rotavirus (RV) internal proteins VP2 and VP6 (2/6-VLP) have been shown to induce serum and fecal antibodies as well as protection in mice after intranasal administration with a mutant of E. coli toxin, LT-R192G. To better understand the origin of fecal IgA induced by this protocol, we studied the RV-specific B cell response in systemic and mucosal lymphoid tissues using a flow cytometry assay that allows quantification and phenotypic characterization of RV-specific B lymphocytes. We also assessed the RV-specific antibody-secreting cells in the spleen and intestinal lamina propria (ILP). A remarkably high frequency of RV-specific B cells was found in the respiratory lymphoid tissues and spleen, of which only a minority expressed the alpha 4 beta 7 integrin (intestinal homing receptor). In contrast, but in accordance with alpha 4 beta 7 expression at the induction site, a very low response was observed in intestinal lymphoid tissues (mesenteric lymph nodes and ILP), which did not increase after a second immunization. Thus, intranasal immunization with a nonreplicating antigen does not induce an important number of RV-specific B cells with an intestinal homing profile.	UFRs Med & Pharm, Microbiol Med & Mol, F-21079 Dijon, France; Lab Virol CHU, Dijon, France; Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; CNRS, INRA, UMR, Virol Mol & Struct, Gif Sur Yvette, France		Kohli, E (corresponding author), UFRs Med & Pharm, Microbiol Med & Mol, 7 Blvd Jeanne Arc, F-21079 Dijon, France.	evelyne.kohli@chu-dijon.fr	CORTES, Manuel Antonio FRANCO/M-7517-2014; Kohli, Evelyne/A-7612-2011	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Kohli, Evelyne/0000-0002-9383-6573				Bertolotti-Ciarlet A, 2003, VACCINE, V21, P3885, DOI 10.1016/S0264-410X(03)00308-6; Blutt SE, 2004, J VIROL, V78, P6974, DOI 10.1128/JVI.78.13.6974-6981.2004; Blutt SE, 2002, J IMMUNOL, V168, P5716, DOI 10.4049/jimmunol.168.11.5716; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Ciarlet M, 1998, J VIROL, V72, P9233, DOI 10.1128/JVI.72.11.9233-9246.1998; Coffin SE, 2001, VIROLOGY, V291, P235, DOI 10.1006/viro.2001.1180; Estes MK., 2001, FIELDS VIROLOGY, P1747; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Fromantin C, 2001, J VIROL, V75, P11010, DOI 10.1128/JVI.75.22.11010-11016.2001; Gonzalez AM, 2003, VIROLOGY, V305, P93, DOI 10.1006/viro.2002.1708; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Jaimes MC, 2004, J VIROL, V78, P10967, DOI 10.1128/JVI.78.20.10967-10976.2004; Kuklin NA, 2001, J IMMUNOL, V166, P1894, DOI 10.4049/jimmunol.166.3.1894; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Lynch M, 2000, CURR OPIN INFECT DIS, V13, P495, DOI 10.1097/00001432-200010000-00011; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; O'Neal CM, 1998, J VIROL, V72, P3390; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parez N, 2004, J VIROL, V78, P12489, DOI 10.1128/JVI.78.22.12489-12496.2004; QUILINGJABRINK M, 1997, J CLIN INVEST, V99, P1281; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Schwartz-Cornil I, 2002, J VIROL, V76, P8110, DOI 10.1128/JVI.76.16.8110-8117.2002; Shimoda M, 2001, J EXP MED, V194, P1597, DOI 10.1084/jem.194.11.1597; Siadat-Pajouh M, 2001, VIRAL IMMUNOL, V14, P31, DOI 10.1089/08828240151061365; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173; Yuan LJ, 2000, J VIROL, V74, P8843, DOI 10.1128/JVI.74.19.8843-8853.2000; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	32	14	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	JUL	2005	35	7					2122	2130		10.1002/eji.200526059	http://dx.doi.org/10.1002/eji.200526059			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	948VY	15948217				2022-09-04	WOS:000230745000013
J	Scott, J; Hockey, S; Pinillos, LO; Doraiswamy, PM; Alvarez-Jimenez, M; Hickie, I				Scott, Jan; Hockey, Samuel; Pinillos, Laura Ospina; Doraiswamy, P. Murali; Alvarez-Jimenez, Mario; Hickie, Ian			Research to Clinical Practice-Youth seeking mental health information online and its impact on the first steps in the patient journey	ACTA PSYCHIATRICA SCANDINAVICA			English	Article; Early Access						adolescents; help-seeking behaviour; Internet; mental health; online	WORLD-WIDE-WEB; INTERNET USE; SOCIAL MEDIA; YOUNG-ADULTS; QUALITY; HELP; METAANALYSIS; PERCEPTIONS; EXPERTISE; BEHAVIOR	Background Online searches about anxiety and depression are recorded every 3-5 s. As such, information and communication technologies (ICT) have enormous potential to enable or impair help-seeking and patient-professional interactions. Youth studies indicate that ICT searches are undertaken before initial mental health consultations, but no publications have considered how this online activity affects the first steps of the patient journey in youth mental health settings. Methods State-of-the-art review using an iterative, evidence mapping approach to identify key literature and expert consensus to synthesize and prioritise clinical and research issues. Results Adolescents and young adults are more likely to seek health advice via online search engines or social media platforms than from a health professional. Young people not only search user-generated content and social media to obtain advice and support from online communities but increasingly contribute personal information online. Conclusions A major clinical challenge is to raise professional awareness of the likely impact of this activity on mental health consultations. Potential strategies range from modifying the structure of clinical consultations to ensure young people are able to disclose ICT activities related to mental health, through to the development and implementation of 'internet prescriptions' and a youth-focused 'toolkit'.	[Scott, Jan] Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia; [Hockey, Samuel] Univ Sydney, Brain & Mind Ctr, Translat Res Collect, Sydney, NSW, Australia; [Pinillos, Laura Ospina] Pontificia Univ Javeriana, Fac Med, Dept Psiquiatria & Salud Mental, Bogota, Colombia; [Doraiswamy, P. Murali] Duke Univ, Behav Med & Neurosci, Psychiat & Behav Sci, Durham, NC USA; [Alvarez-Jimenez, Mario] Univ Melbourne, Digital Mental Hlth, Melbourne, Vic, Australia; [Hickie, Ian] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia		Scott, J (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia.	jan.scott@newcastle.ac.uk			National Health and Medical Research Council [APP1177235]; University of Melbourne	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	National Health and Medical Research Council, Grant/Award Number: APP1177235; Dame Kate Campbell Fellowship from The University of Melbourne	Ahmad F, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e22; Alvarez-Jimenez M, 2021, WORLD PSYCHIATRY, V20, P233, DOI 10.1002/wps.20858; Aref-Adib G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0952-0; Barker G., 2012, ADOLESCENTS SOCIAL S, P64; Bates M. J., 2002, New Review of Information Behaviour Research, V3, P1; Bauer R, 2013, NORD J PSYCHIAT, V67, P185, DOI 10.3109/08039488.2012.700734; Beaunoyer E, 2017, PATIENT EDUC COUNS, V100, P183, DOI 10.1016/j.pec.2016.08.028; Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934; Bell J, 2018, ARCH SUICIDE RES, V22, P263, DOI 10.1080/13811118.2017.1334609; Berger M, 2005, SOC SCI MED, V61, P1821, DOI 10.1016/j.socscimed.2005.03.025; Bernstam EV, 2005, INT J MED INFORM, V74, P13, DOI 10.1016/j.ijmedinf.2004.10.001; Berry N, 2018, ACTA PSYCHIAT SCAND, V138, P558, DOI 10.1111/acps.12953; Best P, 2016, QUAL HEALTH RES, V26, P1067, DOI 10.1177/1049732316648128; Birnbaum ML, 2017, EARLY INTERV PSYCHIA, V11, P290, DOI 10.1111/eip.12237; Birnbaum ML, 2016, EARLY INTERV PSYCHIA, V10, P397, DOI 10.1111/eip.12179; Booth RG, 2018, JMIR MENT HEALTH, V5, DOI 10.2196/mental.8808; Brown RC, 2020, FRONT PSYCHIATRY, V11, P274, DOI 10.3389/fpsyt.2020.00274; Burns JM, 2010, MED J AUSTRALIA, V192, pS22, DOI 10.5694/j.1326-5377.2010.tb03688.x; Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865; Downie, UK SEARCHES GOOGLE S; Ebert DD, 2019, INT J METH PSYCH RES, V28, DOI 10.1002/mpr.1754; Edwards L, 2014, J MED INTERNET RES, V16, P154, DOI 10.2196/jmir.3257; Egan KG, 2013, ISSUES MENT HEALTH N, V34, P46, DOI 10.3109/01612840.2012.718044; Employer News, 2021, EMPLOYER NEWS; Eysenbach G, 2002, AM J MED, V113, P763, DOI 10.1016/S0002-9343(02)01473-0; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Fergie, 2015, THESIS U GLASGOW; Fergie G, 2016, HEALTH EXPECT, V19, P1324, DOI 10.1111/hex.12430; Fisher KE, 2003, P ASIST ANNU, V40, P298, DOI 10.1002/meet.1450400137; Flint M, 2022, EARLY INTERV PSYCHIA, V16, P643, DOI 10.1111/eip.13209; Fox S, 2013, HLTH ONLINE 2013, V2013, P1; Freckelton IR, 2020, MED LAW REV, V28, P502, DOI 10.1093/medlaw/fwaa008; Gkotsis G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45141; Gould MS, 2002, J AM ACAD CHILD PSY, V41, P1182, DOI 10.1097/00004583-200210000-00007; Gowen LK, 2013, J TECHNOL HUMAN SERV, V31, P97, DOI 10.1080/15228835.2013.765533; Gray Nicola J, 2005, J Adolesc Health, V37, P243; Greenberg L, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e18; Grohol JM, 2014, CYBERPSYCH BEH SOC N, V17, P216, DOI 10.1089/cyber.2013.0258; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Haller DM, 2008, J ADOLESCENT HEALTH, V42, P436, DOI 10.1016/j.jadohealth.2007.09.013; Hasty RT, 2014, J AM OSTEOPATH ASSOC, V114, P368, DOI 10.7556/jaoa.2014.035; Hetrick SE, 2010, J EVAL CLIN PRACT, V16, P1025, DOI 10.1111/j.1365-2753.2008.01112.x; Hickie IB, 2019, MED J AUSTRALIA, V211, pS3, DOI 10.5694/mja2.50349; Hollis C, 2018, LANCET PSYCHIAT, V5, P845, DOI 10.1016/S2215-0366(18)30296-7; Ipser Jonathan C, 2007, Curr Psychiatry Rep, V9, P303, DOI 10.1007/s11920-007-0037-3; Iverson SA, 2008, J AM OSTEOPATH ASSOC, V108, P699; Ivie EJ, 2020, J AFFECT DISORDERS, V275, P165, DOI 10.1016/j.jad.2020.06.014; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Kalckreuth S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0368-7; Kauer SD, 2014, J MED INTERNET RES, V16, P314, DOI 10.2196/jmir.3103; Khazaal Yasser, 2008, Psychiatr Q, V79, P301, DOI 10.1007/s11126-008-9083-1; Khazaal Y, 2012, PSYCHIAT QUART, V83, P15, DOI 10.1007/s11126-011-9179-x; Khazaal Y, 2009, PATIENT EDUC COUNS, V77, P33, DOI 10.1016/j.pec.2009.02.016; Kim Y, 2016, HEALTH INFORM J, V22, P355, DOI 10.1177/1460458214559432; Kitchens B, 2014, DECIS SUPPORT SYST, V57, P454, DOI 10.1016/j.dss.2012.10.050; Koch-Weser S, 2010, J HEALTH COMMUN, V15, P279, DOI 10.1080/10810730.2010.522700; Lal S, 2018, EARLY INTERV PSYCHIA, V12, P324, DOI 10.1111/eip.12317; Lavis A, 2020, J CHILD PSYCHOL PSYC, V61, P842, DOI 10.1111/jcpp.13245; Lee K, 2009, GLOB INST, P1; Lee K, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3706; Ma T, 2017, TELEMAT INFORM, V34, P472, DOI 10.1016/j.tele.2016.09.009; Marcus MA, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1868; Mars B, 2015, J AFFECT DISORDERS, V185, P239, DOI 10.1016/j.jad.2015.06.001; MCGINNIES E, 1980, PERS SOC PSYCHOL B, V6, P467, DOI 10.1177/014616728063023; McKinley CJ, 2014, COMPUT HUM BEHAV, V34, P101, DOI 10.1016/j.chb.2014.01.038; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Metzger MJ, 2010, J COMMUN, V60, P413, DOI 10.1111/j.1460-2466.2010.01488.x; Mohr DC, 2018, JAMA PSYCHIAT, V75, P113, DOI 10.1001/jamapsychiatry.2017.3838; Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/cpb.2004.7.497; Myrick JG, 2017, COMPUT HUM BEHAV, V68, P422, DOI 10.1016/j.chb.2016.11.071; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9; O'Reilly M, 2019, HEALTH PROMOT INT, V34, P981, DOI 10.1093/heapro/day056; O'Reilly M, 2018, CLIN CHILD PSYCHOL P, V23, P601, DOI 10.1177/1359104518775154; OECD, GROW EXP DIG EC INT; OECD, 2021, ICT ACC US HOUS IND, DOI [10.1787/b9823565-en, DOI 10.1787/B9823565-EN]; Pavlova A, 2022, HEALTH COMMUN, V37, P637, DOI 10.1080/10410236.2020.1862396; Powell J, 2006, BRIT J PSYCHIAT, V189, P273, DOI 10.1192/bjp.bp.105.017319; Pretorius C, 2019, J MED INTERNET RES, V21, DOI 10.2196/13873; Pretorius C, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/13524; Provost M, 2006, INT J MED INFORM, V75, P42, DOI 10.1016/j.ijmedinf.2005.07.034; Read J, 2013, ACTA PSYCHIAT SCAND, V128, P422, DOI 10.1111/acps.12146; Rickwood D, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.5988; Rickwood DJ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0429-6; Ridout B, 2018, J MED INTERNET RES, V20, DOI 10.2196/12244; Rijo R., 2016, INFORM COMMUNICATION, P606; Robillard JM, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0668-9; Rowlands IJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4048; Ruan S, 2021, HEALTH COMMUN, V36, P764, DOI 10.1080/10410236.2020.1712522; Scott J., 2001, BECOMING EXPERT YOUR, P247; Scott J, 2021, ACTA PSYCHIAT SCAND, V143, P377, DOI 10.1111/acps.13290; Shenton AK, 2003, J LIBR INF SCI, V35, P219, DOI 10.1177/0961000603035004002; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Skiba DJ, 2010, NURS EDUC PERSPECT, V31, P251; Smailhodzic E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1691-0; Society for Participatory Medicine, 2011, BRING TOG E PAT HLTH; Swire-Thompson B, 2020, ANNU REV PUBL HEALTH, V41, P433, DOI 10.1146/annurev-publhealth-040119-094127; Tan SSL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5729; Thapa DK, 2021, PATIENT EDUC COUNS, V104, P770, DOI 10.1016/j.pec.2020.11.016; Torous J, 2020, WORLD PSYCHIATRY, V19, P308, DOI 10.1002/wps.20805; Torous J, 2019, WORLD PSYCHIATRY, V18, P97, DOI 10.1002/wps.20592; Valdagno M, 2014, CNS SPECTRUMS, V19, P479, DOI 10.1017/S1092852913000916; Valentine L, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/18990; Wang XH, 2021, HEALTH COMMUN, V36, P1163, DOI 10.1080/10410236.2020.1748829; Weiser EB, 2001, CYBERPSYCHOL BEHAV, V4, P723, DOI 10.1089/109493101753376678; Wetterlin Felicia M, 2014, J Med Internet Res, V16, pe293, DOI 10.2196/jmir.3526; Wicks P, 2012, J MENT HEALTH, V21, P332, DOI 10.3109/09638237.2012.682268; Wilson TD, 1999, J DOC, V55, P249, DOI 10.1108/EUM0000000007145; Winter S, 2010, COGNITION IN FLUX, P802; Wong K, 2021, J AFFECT DISORDERS, V292, P21, DOI 10.1016/j.jad.2021.05.056; World Economic Forum, 2019, WMA STAT SOL CONF, P28; Yi MY, 2013, DECIS SUPPORT SYST, V55, P284, DOI 10.1016/j.dss.2013.01.029; Yonker LM, 2015, J MED INTERNET RES, V17, DOI [/jmir.3692, 10.2196/jmir.3692]; Zhang Y, 2014, J ASSOC INF SCI TECH, V65, P911, DOI 10.1002/asi.23023	113	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-690X	1600-0447		ACTA PSYCHIAT SCAND	Acta Psychiatr. Scand.												10.1111/acps.13390	http://dx.doi.org/10.1111/acps.13390		DEC 2021	14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XV0UC	34923619				2022-09-04	WOS:000734667100001
J	Rodriguez-Patarroyo, M; Torres-Quintero, A; Vecino-Ortiz, AI; Hallez, K; Franco-Rodriguez, AN; Barrera, EAR; Puerto, S; Gibson, DG; Labrique, AB; Pariyo, GW; Ali, J				Rodriguez-Patarroyo, Mariana; Torres-Quintero, Angelica; Vecino-Ortiz, Andres, I; Hallez, Kristina; Natalia Franco-Rodriguez, Aixa; Rueda Barrera, Eduardo A.; Puerto, Stephanie; Gibson, Dustin G.; Labrique, Alain B.; Pariyo, George W.; Ali, Joseph			Informed Consent for Mobile Phone Health Surveys in Colombia: A Qualitative Study	JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS			English	Article						bioethics; informed consent; mobile phone survey; mHealth; non-communicable diseases; Colombia	ETHICAL-ISSUES; PARTICIPATION	Public health surveys deployed through automated mobile phone calls raise a set of ethical challenges, including succinctly communicating information necessary to obtain respondent informed consent. This study aimed to capture the perspectives of key stakeholders, both experts and community members, on consent processes and preferences for participation in automated mobile phone surveys (MPS) of non-communicable disease risk factors in Colombia. We conducted semi-structured interviews with ethics and digital health experts and focus group discussions with community representatives. There was meaningful disagreement within both groups regarding the necessity of consent, when the purpose of a survey is to contribute to the formulation of public policies. Respondents who favored consent emphasized that consent communications ought to promote understanding and voluntariness, and implicitly suggested that information disclosure conform to areasonable personstandard. Given the automated and unsolicited nature of the phone calls and concerns regarding fraud, trust building was emphasized as important, especially for national MPS deployment. Community sensitization campaigns that provide relevant contextual information (such as the name of the administering institution) were thought to support trust-building. Additional ways to achieve the goals of consent while building trust in automated MPS for disease surveillance should be evaluated in order to inform ethical and effective practice.	[Rodriguez-Patarroyo, Mariana; Natalia Franco-Rodriguez, Aixa] Pontificia Univ Javeriana, Inst Bioeth, Bogota, Colombia; [Torres-Quintero, Angelica; Puerto, Stephanie] Pontificia Univ Javeriana, Inst Publ Hlth, Bogota, Colombia; [Vecino-Ortiz, Andres, I; Gibson, Dustin G.; Labrique, Alain B.; Pariyo, George W.; Ali, Joseph] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Hallez, Kristina] Univ Calif Berkeley, Ctr Effect Global Act, Berkeley, CA 94720 USA; [Rueda Barrera, Eduardo A.] Int Network Biolaw, Bogota, Colombia; [Ali, Joseph] Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave,Rm 208, Baltimore, MD 21205 USA		Ali, J (corresponding author), Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave,Rm 208, Baltimore, MD 21205 USA.	jali@jhu.edu		Torres-Quintero, Angelica/0000-0001-9577-6415; Gibson, Dustin/0000-0002-9073-3376; Rueda Barrera, Eduardo Alfonso/0000-0002-3512-6872; Vecino-Ortiz, Andres I./0000-0002-8089-2488; Labrique, Alain/0000-0003-2502-7819	Bloomberg Philanthropies	Bloomberg Philanthropies	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was conducted as part of research and development activities under the non-communicable diseases mobile phone survey component of the Bloomberg Philanthropies Data for Health Initiative, supported by the Bloomberg Philanthropies. The paper does not necessarily reflect the views of Bloomberg Philanthropies.	Ali J, 2019, GLOB PUBLIC HEALTH, V14, P1167, DOI 10.1080/17441692.2019.1566482; Ali J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7326; Balestra M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5662; Barbosa JD, 2018, REV AGRIC NEOTROP, V5, P13, DOI 10.32404/rean.v5i2.1872; Bloomberg, 2019, DAT HLTH; Bok S., 2017, HUMAN EXPT RES, P147; Carter A, 2015, JMIR MHEALTH UHEALTH, V3, P99, DOI 10.2196/mhealth.4538; Corneli A, 2017, J EMPIR RES HUM RES, V12, P14, DOI 10.1177/1556264616682550; Cyr J, 2016, SOCIOL METHOD RES, V45, P231, DOI 10.1177/0049124115570065; Declaration of Helsinki, 2013, DECL HELS ETH PRINC; Doerr M, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6521; Firchow P, 2020, SOCIOL METHOD RES, V49, P133, DOI 10.1177/0049124117729702; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Fuller Theodore, 1993, SUCCESSFUL FOCUS GRO, P89; Garrett SB, 2017, J EMPIR RES HUM RES, V12, P326, DOI 10.1177/1556264617731869; Gibson DG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7428; Gibson DG, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7534; He Dongjing, 2014, AMIA Annu Symp Proc, V2014, P645; Henderson GE, 2011, AM J MED SCI, V342, P267, DOI 10.1097/MAJ.0b013e31822a6c47; Hennink M., 2010, QUALITATIVE RES METH; Hunter RF, 2018, AM J PUBLIC HEALTH, V108, P343, DOI [10.2105/ajph.2017.304249, 10.2105/AJPH.2017.304249]; King N., 2010, INTERVIEWS QUALITATI, P142; Kongsholm NCH, 2017, BIOETHICS, V31, P432, DOI 10.1111/bioe.12342; Marshall PA, 2006, AM J PUBLIC HEALTH, V96, P1989, DOI 10.2105/AJPH.2005.076232; Millett L. I., 2001, CHI 2001 Conference Proceedings. Conference on Human Factors in Computing Systems, P46; Moore S, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7014; Pariyo GW, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7302; Parker M, 2012, J MOB TECHNOL MED, V1, P50, DOI [10.7309/jmtm.23, DOI 10.7309/JMTM.23]; Perrault EK, 2018, J EMPIR RES HUM RES, V13, P50, DOI 10.1177/1556264617738846; Petrini C, 2015, ANN I SUPER SANITA, V51, P270, DOI 10.4415/ANN_15_04_05; Simon CM, 2018, J EMPIR RES HUM RES, V13, P338, DOI 10.1177/1556264618773883; Slegers C, 2015, J BIOETHIC INQ, V12, P227, DOI 10.1007/s11673-015-9611-2; Wilbanks J, 2018, J LAW MED ETHICS, V46, P110, DOI 10.1177/1073110518766025; Wolff B., 1993, SUCCESSFUL FOCUS GRO, P118, DOI DOI 10.4135/9781483349008.N8	34	1	1	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1556-2646	1556-2654		J EMPIR RES HUM RES	J. Empir. Res. Hum. Res. Ethics	FEB	2021	16	1-2					24	34	1556264620958606	10.1177/1556264620958606	http://dx.doi.org/10.1177/1556264620958606		SEP 2020	11	Ethics; Medical Ethics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics	RL0OM	32975157	hybrid, Green Published			2022-09-04	WOS:000573522400001
J	Toro-Urrego, N; Vesga-Jimenez, DJ; Herrera, MI; Luaces, JP; Capani, F				Toro-Urrego, Nicolas; Julian Vesga-Jimenez, Diego; Ines Herrera, Maria; Pablo Luaces, Juan; Capani, Francisco			Neuroprotective Role of Hypothermia in Hypoxic-ischemic Brain Injury: Combined Therapies using Estrogen	CURRENT NEUROPHARMACOLOGY			English	Review						Hypoxic-ischemic brain injury; neuroprotective treatments; selective estrogen receptor modulators; selective tissue estrogenic activity regulators; therapeutic hypothermia; combined therapies	OXYGEN-GLUCOSE DEPRIVATION; INDUCIBLE FACTOR-I; FOCAL CEREBRAL-ISCHEMIA; RECEPTOR MODULATORS SERMS; INDUCED NEURONAL DAMAGE; GROWTH-FACTOR PROTECTS; INDUCED UP-REGULATION; WHITE-MATTER DAMAGE; MILD HYPOTHERMIA; NORMOBARIC HYPEROXIA	Hypoxic-ischemic brain injury is a complex network of factors, which is mainly characterized by a decrease in levels of oxygen concentration and blood flow, which lead to an inefficient supply of nutrients to the brain. Hypoxic-ischemic brain injury can be found in perinatal asphyxia and ischemic-stroke, which represent one of the main causes of mortality and morbidity in children and adults worldwide. Therefore, knowledge of underlying mechanisms triggering these insults may help establish neuroprotective treatments. Selective Estrogen Receptor Modulators and Selective Tissue Estrogenic Activity Regulators exert several neuroprotective effects, including a decrease of reactive oxygen species, maintenance of cell viability, mitochondria) survival, among others. However, these strategies represent a traditional approach of targeting a single factor of pathology without satisfactory results. Hence, combined therapies, such as the administration of therapeutic hypothermia with a complementary neuroprotective agent, constitute a promising alternative. In this sense, the present review summarizes the underlying mechanisms of hypoxic-ischemic brain injury and compiles several neuroprotective strategies, including Selective Estrogen Receptor Modulators and Selective Tissue Estrogenic Activity Regulators, which represent putative agents for combined therapies with therapeutic hypothermia.	[Toro-Urrego, Nicolas; Ines Herrera, Maria; Pablo Luaces, Juan; Capani, Francisco] Univ Buenos Aires, Inst Invest Cardiol, Lab Citoarquitectura & Plasticidad Neuronal, CONICET, Buenos Aires, DF, Argentina; [Julian Vesga-Jimenez, Diego] Pontificia Univ Javeriana Bogota, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Dc, Colombia; [Ines Herrera, Maria; Capani, Francisco] Univ Catolica Argentina, Fac Psicol & Psicopedag, Ctr Invest Psicol & Psicopedag, Buenos Aires, DF, Argentina; [Capani, Francisco] Univ Catolica Argentina, Fac Psicol & Psicopedag, Buenos Aires, DF, Argentina; [Capani, Francisco] Univ Argentina JF Kennedy, Dept Biol, Buenos Aires, DF, Argentina; [Capani, Francisco] Univ Autonoma Chile, Santiago, Chile		Toro-Urrego, N (corresponding author), Univ Buenos Aires, Inst Invest Cardiol, Lab Citoarquitectura & Plasticidad Neuronal, CONICET, Buenos Aires, DF, Argentina.	Nicolas.toro3@gmail.com		Vesga Jimenez, Diego Julian/0000-0003-1531-3862				Abdelhamid R, 2011, ACS CHEM NEUROSCI, V2, P256, DOI 10.1021/cn100106a; Al Okail MS, 2010, J SAUDI CHEM SOC, V14, P197, DOI 10.1016/j.jscs.2010.02.005; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Anju TR, 2013, BIOCHEM CELL BIOL, V91, P350, DOI 10.1139/bcb-2012-0102; Anju TR, 2011, NEUROSCI LETT, V502, P129, DOI 10.1016/j.neulet.2011.05.236; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Bae S, 2012, INT J MOL MED, V30, P1180, DOI 10.3892/ijmm.2012.1115; Barreto G, 2015, ESTROGEN EFFECTS ON TRAUMATIC BRAIN INJURY: MECHANISMS OF NEUROPROTECTION AND REPAIR, P113, DOI 10.1016/B978-0-12-801479-0.00008-5; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Baud O, 2004, BRAIN PATHOL, V14, P1; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Lopez-Rodriguez AB, 2015, ESTROGEN EFFECTS ON TRAUMATIC BRAIN INJURY: MECHANISMS OF NEUROPROTECTION AND REPAIR, P73, DOI 10.1016/B978-0-12-801479-0.00006-1; Berger HR, 2017, DEV NEUROSCI-BASEL, V39, P36, DOI 10.1159/000472709; Bordt EA, 2018, NEUROTOXICOLOGY, V66, P213, DOI 10.1016/j.neuro.2017.10.008; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Charriaut-Marlangue C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010061; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5; Cilio MR, 2010, SEMIN FETAL NEONAT M, V15, P293, DOI 10.1016/j.siny.2010.02.002; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Cui XY, 2018, NEUROL RES, V40, P391, DOI 10.1080/01616412.2018.1447318; de Aguiar RB, 2008, BIOGERONTOLOGY, V9, P285, DOI 10.1007/s10522-008-9137-7; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Derrick M, 2009, INT J DEV NEUROSCI, V27, P549, DOI 10.1016/j.ijdevneu.2009.06.008; Derugin N, 1998, NEUROSCI RES, V32, P349, DOI 10.1016/S0168-0102(98)00096-0; Descloux C, 2015, INT J DEV NEUROSCI, V45, P75, DOI 10.1016/j.ijdevneu.2015.06.008; Dominguez R, 2018, J STROKE CEREBROVASC, V27, P1743, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.030; Dong YF, 2018, J CELL MOL MED, V22, P3159, DOI 10.1111/jcmm.13596; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Drury PP, 2014, CLIN PERINATOL, V41, P161, DOI 10.1016/j.clp.2013.10.005; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Dwyer DS, 2002, INT REV NEUROBIOL, V51, P159, DOI 10.1016/S0074-7742(02)51005-9; Ek CJ, 2015, J CEREBR BLOOD F MET, V35, P818, DOI 10.1038/jcbfm.2014.255; Elkordy A, 2018, J NEUROCHEM, V146, P560, DOI 10.1111/jnc.14321; Elstner A, 2007, CLIN EXP METASTAS, V24, P57, DOI 10.1007/s10585-007-9057-y; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Feng SJ, 2018, FOLIA NEUROPATHOL, V56, P49, DOI 10.5114/fn.2018.74659; Fernandez SM, 2008, J NEUROSCI, V28, P8660, DOI 10.1523/JNEUROSCI.1968-08.2008; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Galbiati M, 2002, J NEUROENDOCRINOL, V14, P829, DOI 10.1046/j.1365-2826.2002.00852.x; Gao XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07091; Gao YF, 2017, J HEALTHC ENG, V2017, P1, DOI 10.1155/2017/1425102; Garzon D, 2016, J MOL NEUROSCI, V58, P483, DOI 10.1007/s12031-016-0719-6; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; Gressens P, 2018, NEUROPATHOL APPL NEU, V22, P498; Guillamon-Vivancos T, 2015, NEUROLOGIA, V30, P119, DOI 10.1016/j.nrl.2012.12.007; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Guo C, 2016, EXP NEUROL, V280, P13, DOI 10.1016/j.expneurol.2016.03.016; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Hammes SR, 2015, BEST PRACT RES CL EN, V29, P581, DOI 10.1016/j.beem.2015.04.001; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Harvey BJ, 2001, NEWS PHYSIOL SCI, V16, P174; He WL, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00006; Helmy MM, 2011, ANN NEUROL, V69, P493, DOI 10.1002/ana.22223; Herrera MI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00145; Hirayama Y, 2018, NEUROSCI RES, V126, P53, DOI 10.1016/j.neures.2017.11.013; Hishikawa T, 2008, NEUROSURGERY, V62, P232, DOI 10.1227/01.NEU.0000311082.88766.33; Hojo Y, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00183; Hu YY, 2017, NEUROSCI LETT, V653, P105, DOI 10.1016/j.neulet.2016.11.050; Huang BW, 2014, CELL SIGNAL, V26, P2702, DOI 10.1016/j.cellsig.2014.08.018; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Herrera MI, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/3436943; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobson J, 2002, J CELL SCI, V115, P1175; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin XC, 2013, EXP NEUROL, V240, P9, DOI 10.1016/j.expneurol.2012.11.018; Jones SM, 2013, NEUROSCIENCE, V252, P420, DOI 10.1016/j.neuroscience.2013.07.060; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010; Kaneko Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047583; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Khan MM, 2015, J STEROID BIOCHEM, V146, P38, DOI 10.1016/j.jsbmb.2014.05.001; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Kida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068877; Kim H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8638294; Kim M, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0033-1; KIRSCHNER PB, 1995, J CEREBR BLOOD F MET, V15, P619, DOI 10.1038/jcbfm.1995.76; Laptook A R, 1988, NMR Biomed, V1, P74, DOI 10.1002/nbm.1940010204; Leaw B, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00199; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lee Kim Mai, 2015, World J Virol, V4, P42, DOI 10.5501/wjv.v4.i2.42; Lee WLA, 2017, DEV NEUROSCI-BASEL, V39, P49, DOI 10.1159/000467392; Li B, 2017, PROG NEUROBIOL, V159, P50, DOI 10.1016/j.pneurobio.2017.10.006; Li LH, 2014, AM J TRANSL RES, V6, P377; Li Y. W., 2018, CLIN RES PRACT, V3, P1; Liang LJ, 2016, MED GAS RES, V6, P33, DOI 10.4103/2045-9912.179343; Lin EP, 2014, ANESTH ANALG, V119, P1158, DOI 10.1213/ANE.0000000000000262; Liu J, 2013, ANESTHESIOLOGY, V119, P1120, DOI 10.1097/ALN.0b013e31829c2d90; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; MALLARD EC, 1994, AM J OBSTET GYNECOL, V170, P206; Marin F., 2006, SELECTIVE ESTROGEN R, P71; Mehrabani M, 2015, CELL PROLIFERAT, V48, P532, DOI 10.1111/cpr.12209; Meldrum DR, 2007, AM J PATHOL, V170, P1148, DOI 10.2353/ajpath.2007.070025; Millar LJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00078; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mu DZ, 2005, EXP NEUROL, V195, P407, DOI 10.1016/j.expneurol.2005.06.001; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Mucci S, 2017, CURR PHARM DESIGN, V23, P3899, DOI 10.2174/1381612823666170727145422; Muller AS, 2018, J ENDODONT, V44, P1263, DOI 10.1016/j.joen.2018.04.010; Nakai A, 2001, DEV BRAIN RES, V128, P1, DOI 10.1016/S0165-3806(01)00138-9; Nelson ER, 2013, BONE, V53, P42, DOI 10.1016/j.bone.2012.11.011; Nonaka Y, 2008, NEUROSCI LETT, V441, P224, DOI 10.1016/j.neulet.2008.06.033; Nonaka Y, 2009, J PHARMACOL EXP THER, V330, P13, DOI 10.1124/jpet.109.151548; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; NOZAKI K, 1993, J CEREBR BLOOD F MET, V13, P221, DOI 10.1038/jcbfm.1993.27; Nunez J, 2007, EXP NEUROL, V208, P269, DOI 10.1016/j.expneurol.2007.08.020; Oh JS, 2013, AM J EMERG MED, V31, P154, DOI 10.1016/j.ajem.2012.06.033; Ouyang YB, 2004, CELL CALCIUM, V36, P303, DOI 10.1016/j.ceca.2004.02.015; Pabon MM, 2013, FUTUR NEUROL, V8, P193, DOI 10.2217/FNL.12.85; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Paterni I, 2014, STEROIDS, V90, P13, DOI 10.1016/j.steroids.2014.06.012; Paternotte E, 2008, BIO-MED MATER ENG, V18, P295, DOI 10.3233/BME-2008-0541; Piironen K, 2014, STROKE, V45, P486, DOI 10.1161/STROKEAHA.113.003180; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Pupo M, 2016, METHODS MOL BIOL, V1366, P471, DOI 10.1007/978-1-4939-3127-9_37; Qiu J, 2003, J NEUROSCI, V23, P9529; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Rey M, 2015, NEURAL REGEN RES, V10, P17, DOI 10.4103/1673-5374.150640; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Rocha-Ferreira E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00056; Rodriguez-Alvarez N, 2015, NEUROBIOL DIS, V83, P100, DOI 10.1016/j.nbd.2015.08.023; Romero J, 2014, NEUROSCI LETT, V565, P42, DOI 10.1016/j.neulet.2013.10.046; Ruiz-Palmero I, 2013, MOL CELL ENDOCRINOL, V372, P105, DOI 10.1016/j.mce.2013.03.018; Rzemieniec J, 2018, MOL CELL ENDOCRINOL, V461, P64, DOI 10.1016/j.mce.2017.08.014; Rzemieniec J, 2015, J STEROID BIOCHEM, V146, P26, DOI 10.1016/j.jsbmb.2014.05.005; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sampath D, 2015, NEUROSCI LETT, V607, P46, DOI 10.1016/j.neulet.2015.09.005; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song J, 2016, ANN NEUROL, V80, P24, DOI 10.1002/ana.24677; Stark J, 2015, GYNECOL ENDOCRINOL, V31, P31, DOI 10.3109/09513590.2014.943727; Sullivan SM, 2010, BRAIN RES, V1319, P164, DOI 10.1016/j.brainres.2010.01.010; TAN WKM, 1992, ANN NEUROL, V32, P677, DOI 10.1002/ana.410320511; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Tian T, 2018, EXP BIOL MED, V243, P78, DOI 10.1177/1535370217737983; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Tozzi A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.0010, 10.3389/fncel.2015.00192]; Traudt CM, 2013, DEV NEUROSCI-BASEL, V35, P491, DOI 10.1159/000355460; Tuem KB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00442; van der Kooij MA, 2009, NEUROSCI LETT, V451, P109, DOI 10.1016/j.neulet.2008.12.013; Vavilis T, 2016, CELL MOL NEUROBIOL, V36, P701, DOI 10.1007/s10571-015-0250-2; WANG GL, 1993, BLOOD, V82, P3610; Wang K, 2018, J INT MED RES, V46, P675, DOI 10.1177/0300060517734460; Wang Z, 2018, J CELL PHYSIOL, V233, P4864, DOI 10.1002/jcp.26294; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weng YF, 2018, ONCOTARGET, V9, P4511, DOI 10.18632/oncotarget.23391; Wenger RH, 1997, BIOL CHEM, V378, P609; Woo MS, 2012, ANN NEUROL, V72, P961, DOI 10.1002/ana.23727; Wu QF, 2015, DRUG DISCOV TODAY, V20, P1372, DOI 10.1016/j.drudis.2015.09.001; Xia MH, 2009, TOXICOL SCI, V112, P153, DOI 10.1093/toxsci/kfp123; Yang D, 2014, J NEUROSCI, V34, P16467, DOI 10.1523/JNEUROSCI.2582-14.2014; Yang XH, 2018, FRONT MED-PRC, V12, P307, DOI 10.1007/s11684-017-0547-2; Yao QQ, 2016, ACS APPL MATER INTER, V8, P32450, DOI 10.1021/acsami.6b10538; Yin XC, 2018, ULTRASON SONOCHEM, V43, P15, DOI 10.1016/j.ultsonch.2017.12.039; Zeng HL, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-32; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zhao X, 2018, J CELL BIOCHEM, V119, P4548, DOI 10.1002/jcb.26597; Zhou TE, 2018, CRYOBIOLOGY, V80, P55, DOI 10.1016/j.cryobiol.2017.12.004; Ziemka-Nalecz M, 2017, J NEUROPATH EXP NEUR, V76, P644, DOI 10.1093/jnen/nlx046	181	2	2	1	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.		2019	17	9					874	890		10.2174/1570159X17666181206101314	http://dx.doi.org/10.2174/1570159X17666181206101314			17	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	IS5UD	30520375	Green Published			2022-09-04	WOS:000482217100007
J	Baig, MH; Ahmad, K; Saeed, M; Alharbi, AM; Barreto, GE; Ashraf, GM; Choi, I				Baig, Mohammad Hassan; Ahmad, Khurshid; Saeed, Mohd; Alharbi, Ahmed M.; Barreto, George E.; Ashraf, Ghulam Md; Choi, Inho			Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases	BIOMEDICINE & PHARMACOTHERAPY			English	Review						Neurodegenerative disorders; Anti-Cancer; Enzymes; Peptides; Peptide based vaccine; Stability	VASOACTIVE-INTESTINAL-PEPTIDE; GLUCAGON-LIKE PEPTIDE-1; ANTIMICROBIAL PEPTIDE; ANTIBACTERIAL PEPTIDES; CLINICAL UTILITY; BREAST-CANCER; L-CARNOSINE; CELL-DEATH; C-PEPTIDE; IN-VITRO	Bioactive peptides are actively involved in different biological functions and importantly contribute to human health, and the use of peptides as therapeutics has a long successful history in disease management. A number of peptides have wide-ranging therapeutic effects, such as antioxidant, antimicrobial, and antithrombotic effects. Neurodegenerative diseases are typically caused by abnormal aggregations of proteins or peptides, and the depositions of these aggregates in or on neurons, disrupt signaling and eventually kill neurons. During recent years, research on short peptides has advanced tremendously. This review offers a brief introduction to peptide based therapeutics and their application in disease management and provides an overview of peptide vaccines, and toxicity related issues. In addition, the importance of peptides in the management of different neuro-degenerative diseases and their therapeutic applications is discussed. The present review provides an understanding of peptides and their applications for the management of different diseases, but with focus on neuro-degenerative diseases. The role of peptides as anti-cancer, antimicrobial and antidiabetic agents has also been discussed.	[Baig, Mohammad Hassan; Ahmad, Khurshid; Choi, Inho] Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan, Gyeongbuk, South Korea; [Saeed, Mohd; Alharbi, Ahmed M.] Univ Hail, Dept Clin Lab Sci, Coll Appl Med Sci, Hail, Saudi Arabia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Baig, MH; Choi, I (corresponding author), Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan, Gyeongbuk, South Korea.	mohdhassanbaig@gmail.com; inhochoi@ynu.ac.kr	Ahmad, Khurshid/M-4676-2014; saeed, mohd/AAG-3896-2020; Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012	Ahmad, Khurshid/0000-0002-1095-8445; saeed, mohd/0000-0003-3443-386X; Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Baig, Mohd Hassan/0000-0001-8227-4838				Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Ahmad A, 2006, J BIOL CHEM, V281, P22029, DOI 10.1074/jbc.M602378200; Akhtar MS, 2005, J NUCL MED, V46, P567; Baig M, 2017, SEMIN CANC BIOL; Baig M. H., 2017, CURR NEUROPHARMACOL; Baig MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112456; Bancovik J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1022-6; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Benson N, 2012, ADV EXP MED BIOL, V736, P607, DOI 10.1007/978-1-4419-7210-1_36; Bernhardt SL, 2006, BRIT J CANCER, V95, P1474, DOI 10.1038/sj.bjc.6603437; Bieler S, 2004, CURR DRUG TARGETS, V5, P553; Boakye A. A., 2016, CARNOSINE THERAPEUTI; Bodyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1157, DOI 10.1023/A:1012441215506; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Brunsvig PF, 2006, CANCER IMMUNOL IMMUN, V55, P1553, DOI 10.1007/s00262-006-0145-7; Cararo JH, 2015, AGING DIS, V6, P369, DOI 10.14336/AD.2015.0616; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; CHATTERJEE S, 1992, J ANTIBIOT, V45, P832, DOI 10.7164/antibiotics.45.832; Chen F, 2012, AMINO ACIDS, V43, P499, DOI 10.1007/s00726-011-1095-8; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; Collins JE, 2008, J NUTR, V138, P2284, DOI 10.3945/jn.108.096347; Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Crawford E David, 2004, Rev Urol, V6 Suppl 7, pS3; CULLOR JS, 1990, ARCH OPHTHALMOL-CHIC, V108, P861, DOI 10.1001/archopht.1990.01070080105044; Danho W, 2009, ADV EXP MED BIOL, V611, P467, DOI 10.1007/978-0-387-73657-0_201; Delgado M, 2013, AMINO ACIDS, V45, P25, DOI 10.1007/s00726-011-1184-8; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Dubois VDJP, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009493.pub2; Dudkowiak R, 2013, ADV CLIN EXP MED, V22, P585; Dukic-Stefanovic S, 2001, BIOGERONTOLOGY, V2, P19, DOI 10.1023/A:1010052800347; Ellert-Miklaszewska A, 2017, FUTURE MED CHEM, V9, P199, DOI 10.4155/fmc-2016-0189; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Fabisiak A, 2016, PHARMACOL REP, V68, P802, DOI 10.1016/j.pharep.2016.03.015; Fahrenkrug J, 2007, J MOL NEUROSCI, V31, P139, DOI 10.1385/JMN/31:02:139; Fernandez-Montesinos R, 2010, J MOL NEUROSCI, V41, P114, DOI 10.1007/s12031-009-9300-x; Ferrari CKB, 2004, BIOGERONTOLOGY, V5, P275, DOI 10.1007/s10522-004-2566-z; Filichia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32656; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Fourcade J, 2014, CANCER RES, V74, P1045, DOI 10.1158/0008-5472.CAN-13-2908; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Ganz Tomas, 2016, Rinsho Ketsueki, V57, P1913; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gautam A, 2014, NUCLEIC ACIDS RES, V42, pD444, DOI 10.1093/nar/gkt1008; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Goldberg AL, 1997, BIOL CHEM, V378, P131; Gonzalez-Montoya M, 2018, FOOD CHEM, V242, P75, DOI 10.1016/j.foodchem.2017.09.035; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; GOSSRAU R, 1990, Z MIKROSK ANAT FORSC, V104, P385; Gupta S, 2015, METHODS MOL BIOL, V1268, P143, DOI 10.1007/978-1-4939-2285-7_7; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/0968-0004(96)10012-8; Hipkiss AR, 2001, MECH AGEING DEV, V122, P1431, DOI 10.1016/S0047-6374(01)00272-X; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Horswill AR, 2004, P NATL ACAD SCI USA, V101, P15591, DOI 10.1073/pnas.0406999101; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Irwin JJ, 2006, CURR OPIN CHEM BIOL, V10, P352, DOI 10.1016/j.cbpa.2006.06.003; JACKSON MC, 1991, CLIN CHIM ACTA, V196, P193, DOI 10.1016/0009-8981(91)90073-L; Jiang HM, 2017, NAT CHEM BIOL, V13, P994, DOI [10.1038/NCHEMBIO.2442, 10.1038/nchembio.2442]; Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; Jones RM, 2000, CURR PHARM DESIGN, V6, P1249, DOI 10.2174/1381612003399653; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Kang JH, 2003, MOL CELLS, V15, P87; Katzenback Barbara A., 2015, Biology-Basel, V4, P607, DOI 10.3390/biology4040607; Ke ZP, 2016, BIOMED PHARMACOTHER, V78, P272, DOI 10.1016/j.biopha.2016.01.021; Kolesanova E.F., 2013, INT J PEPT PROT RES, V2013, P197317, DOI [10.1155/2013/197317, DOI 10.1155/2013/197317]; Korkmaz OT, 2010, J MOL NEUROSCI, V41, P278, DOI 10.1007/s12031-009-9307-3; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Krensky AM, 2000, BIOCHEM PHARMACOL, V59, P317, DOI 10.1016/S0006-2952(99)00177-X; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kyte JA, 2009, CANCER IMMUNOL IMMUN, V58, P1609, DOI 10.1007/s00262-009-0670-2; Lau J.L, 2017, BIOORG MED CHEM; Lausted C, 2014, ANNU REV PHARMACOL, V54, P457, DOI 10.1146/annurev-pharmtox-011613-135928; Leecharoenkiat K, 2016, ASIAN PAC J TROP MED, V9, P1013, DOI 10.1016/j.apjtm.2016.07.035; LEHRER RI, 1985, J VIROL, V54, P467, DOI 10.1128/JVI.54.2.467-472.1985; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Lipsky BA, 2008, CLIN INFECT DIS, V47, P1537, DOI 10.1086/593185; Liu XS, 2017, J CLIN INVEST, V127, P2007, DOI 10.1172/JCI92284; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu YL, 2015, INTEGR BIOL-UK, V7, P534, DOI 10.1039/c4ib00243a; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Manandhar B, 2015, J MED CHEM, V58, P1020, DOI 10.1021/jm500810s; Mandal SM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00105; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Martins NM, 2010, TOXICON, V56, P86, DOI 10.1016/j.toxicon.2010.03.014; Matsumoto S, 2006, HANDB EXP PHARM, V173, P197; Maynard LM, 2001, J NUTR, V131, P287, DOI 10.1093/jn/131.2.287; McMichael JW, 2005, INFECT IMMUN, V73, P3609, DOI 10.1128/IAI.73.6.3609-3617.2005; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; MILLER WR, 1985, NATURE, V313, P231, DOI 10.1038/313231a0; Morell Mara, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P323; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nilsson AC, 2015, ANTIMICROB AGENTS CH, V59, P145, DOI 10.1128/AAC.03513-14; Okuyama R, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27010; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Oscherwitz J, 2010, J IMMUNOL, V185, P3661, DOI 10.4049/jimmunol.1001749; Pace BT, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5186904; Petroff OAC, 2001, EPILEPSIA, V42, P543, DOI 10.1046/j.1528-1157.2001.18800.x; Popiel H. A., 2011, J AMINO ACIDS, V2011; Prokopieva VD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2939087; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Quintana FJ, 2006, ANN NY ACAD SCI, V1070, P500, DOI 10.1196/annals.1317.069; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Reinholz M, 2012, ANN DERMATOL, V24, P126, DOI 10.5021/ad.2012.24.2.126; Ruiz-Torres V., 2017, MOL CELL PROBES, V22; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schaalan M. F., 2017, J CELL PHYSL; Schally AV, 2000, PROSTATE, V45, P158, DOI 10.1002/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Shima F, 2014, J BIOMAT SCI-POLYM E, V25, P203, DOI 10.1080/09205063.2013.848328; Silberberg D, 2011, NEUROLOGY, V77, P307, DOI 10.1212/WNL.0b013e3182285da9; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Smolarczyk R, 2009, POSTEP HIG MED DOSW, V63, P360; Solares A. M., 2011, ISRN OBSTET GYNECOL; Soliman K, 2001, COMP BIOCHEM PHYS B, V129, P157, DOI 10.1016/S1096-4959(01)00332-3; Song C, 2013, P NATL ACAD SCI USA, V110, P4586, DOI 10.1073/pnas.1214739110; Soudy R, 2017, MINI-REV MED CHEM, V17, P1696, DOI 10.2174/1389557516666160219121836; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Stvolinsky SL, 1999, CELL MOL NEUROBIOL, V19, P45, DOI 10.1023/A:1006960407008; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Suzuki Y, 2011, INT J CLIN EXP PATHO, V4, P378; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004; Tarradas J, 2011, VACCINE, V29, P4422, DOI 10.1016/j.vaccine.2011.03.095; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Thiel R, 2005, MED HYPOTHESES, V64, P524, DOI 10.1016/j.mehy.2004.08.020; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Tiwari SK, 2014, CURR MED CHEM, V21, P2610, DOI 10.2174/0929867321666140217125857; Tomonaga S, 2004, BRAIN RES BULL, V63, P75, DOI 10.1016/j.brainresbull.2004.01.002; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tuncel N, 2005, PEPTIDES, V26, P827, DOI 10.1016/j.peptides.2004.12.019; Nguyen VS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13600-z; Vlad A, 2004, Rom J Intern Med, V42, P333; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; VOLPINA OM, 1993, FEBS LETT, V333, P175, DOI 10.1016/0014-5793(93)80399-F; Wang Chang Yi, 2017, Alzheimers Dement (N Y), V3, P262, DOI 10.1016/j.trci.2017.03.005; Wang S., 2017, COLD SPRING HARB PER, V7; Webb TR, 2005, CURR OPIN DRUG DISC, V8, P303; White CM, 2010, CNS NEUROL DISORD-DR, V9, P661; Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785; Yu HG, 2013, J BIOL CHEM, V288, P12270, DOI 10.1074/jbc.M112.411884; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zeth K, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00086; Zhang Bai-Yu, 2013, Zoological Research, V34, P27, DOI 10.3724/SP.J.1141.2013.01027; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	154	53	54	1	43	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	JUL	2018	103						574	581		10.1016/j.biopha.2018.04.025	http://dx.doi.org/10.1016/j.biopha.2018.04.025			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GH3UW	29677544				2022-09-04	WOS:000433328800070
J	Romero-Sanchez, C; Chila-Moreno, L; Gomez, A; Casas, GMC; Bautista-Molano, W; Briceno, I; Rueda, JC; de Avila, J; Londono, J; Valle-Onate, R				Romero-Sanchez, Consuelo; Chila-Moreno, Lorena; Gomez, Alberto; Consuelo Casas, Maria G.; Bautista-Molano, Wilson; Briceno, Ignacio; Rueda, Juan C.; de Avila, Juliette; Londono, John; Valle-Onate, Rafael			The Frequency of HLA-B27 in a Colombian Population with Signs of Spondyloarthritis	CURRENT RHEUMATOLOGY REVIEWS			English	Article						Flow cytometry; HLA-B27; polymerase chain reaction; ankylosing spondylitis; autoimmune diseases; population	ANKYLOSING-SPONDYLITIS; ASSOCIATION	Background: The strong association between HLA-B27 and spondyloarthritis (SpA) has demonstrated that typing the HLA-B27 antigen is a crucial step in diagnosis and aids in defining the progression and severity of disease. Objective: To describe the frequency of HLA-B27 in Colombian individuals with clinical manifestations associated with SpA. Materials and Methodology: We retrospectively analyzed 4109 HLA-B27 typing requests to the Hospital Militar Central and the Instituto de Referencia Andino from Colombian individuals with clinical signs suggestive of SpA between 2009 and 2012. We used basic digital cytometry followed by Polymerase Chain Reaction with sequence specific primers when confirmation was needed. We determined the frequency of HLA-B27 in the population and levels of association of HLA-B27 with SpA. Results: Our population included 1585 men (36.8%) and 2524 women (61.4%). The predominant age range was between 19 and 45 years (49.9%). The majority (95.4%) of the study population came from the Andean region and eastern plains. The most frequent clinical manifestations were peripheral. Only a small fraction (12.1%) of the 4109 subjects was HLA-B27 positive. Of those, 56.9% were male, and 54.7% were between 19 and 45 years old. In contrast, when rheumatologists referred the HLA B27, 64% were found to be positive. Conclusion: The frequency of the HLA-B27 allele in individuals with clinical signs suggestive of SpA was low, in accordance with the lower prevalence found in Colombian patients diagnosed with SpA compared to American and European population.	[Romero-Sanchez, Consuelo; Valle-Onate, Rafael] Hosp Mil Cent, Spondyloarthropaty Grp, Div Rheumatol, Bogota, Colombia; [Romero-Sanchez, Consuelo; Chila-Moreno, Lorena; de Avila, Juliette] Univ Bosque, UIBO Inst, Oral Basic Res Unit, Bogota, Colombia; [Romero-Sanchez, Consuelo; Gomez, Alberto; Consuelo Casas, Maria G.] Inst Referencia Andino, Bogota, Colombia; [Londono, John] Univ Sabana, Div Rheumatol & Immunol, Hosp Mil Cent, Spondyloarthropaty Group, Bogota, Colombia; [Gomez, Alberto; Briceno, Ignacio] Pontificia Univ Javeriana, Inst Human Genet, Fac Med, Bogota, Colombia; [Bautista-Molano, Wilson; Valle-Onate, Rafael] Univ Mil Nueva Granada, Fac Med, Bogota, Colombia; [Briceno, Ignacio; Rueda, Juan C.; Londono, John] Univ Sabana, Fac Med, Bogota, Colombia		Romero-Sanchez, C (corresponding author), Univ Mil Nueva Granada, Univ Bosque, Inst Referencia Andino,Fac Med,UIBO Inst Oral Bas, Spondyloarthropaty Grp,Div Rheumatol,Hosp Mil Cen, Bogota, Colombia.	spacolombia@hotmail.com	Bautista-Molano, Wilson/Y-8316-2019; Rueda, Juan C./W-6274-2019; Briceno Balcazar, Ignacio/N-3337-2017	Bautista-Molano, Wilson/0000-0003-0684-9542; Rueda, Juan C./0000-0002-6263-2914; Romero-Sanchez, Consuelo/0000-0002-6973-7639; De Avila, Juliette/0000-0002-2441-7084; Gomez, Alberto/0000-0002-5592-3844; Briceno Balcazar, Ignacio/0000-0001-7300-6401; Chila, Lorena/0000-0002-1911-2892				Bautista-Molano Wilson A., 2011, Rev.Colomb.Reumatol., V18, P34; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 2009, CURR OPIN RHEUMATOL, V21, P318, DOI 10.1097/BOR.0b013e32832b3795; Carpeta S, 2001, ACTA BIOL COLOMB, V6, P26; Citera G., 2009, REV ARGENT REUMATOL, V20, P26; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; KHAN MA, 1992, RHEUM DIS CLIN N AM, V18, P837; Londono J, 2012, REV BRAS REUMATOL, V52, P529, DOI 10.1590/S0482-50042012000400006; Londoo J, 2005, REV COLOMB REUMATOL, V12, P195; Martinez B, 1999, REV INVEST CLIN, V51, P221; Mrquez J, 2010, REV COLOMB REUMATOL, V17, P80; Paredes M, 2003, FORENSIC SCI INT, V137, P67, DOI 10.1016/S0379-0738(03)00271-8; Velasquez EP, 2012, BIOMEDICA, V32, P43, DOI 10.1590/S0120-41572012000100006; Romero-Sanchez C, 2012, RHEUMATOL INT, V32, P2195, DOI 10.1007/s00296-011-1883-1; Romero-Sanchez C, 2011, CLIN EXP RHEUMATOL, V29, P828; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Valle-Onate R, 2011, AM J MED SCI, V341, P293, DOI 10.1097/MAJ.0b013e31820f8cdb; Vergara M P, 2009, REV CHIL REUMATOL, V25, P88	18	5	6	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-3971	1875-6360		CURR RHEUMATOL REV	Curr. Rheumatol. Rev.		2018	14	3					246	250		10.2174/1573397113666170329121552	http://dx.doi.org/10.2174/1573397113666170329121552			5	Rheumatology	Emerging Sources Citation Index (ESCI)	Rheumatology	HD1WU	28356051				2022-09-04	WOS:000452303900008
J	Lopez, G; Canas-Duarte, SJ; Pinzon-Velasco, AM; Vega-Vela, NE; Rodriguez, M; Restrepo, S; Baena, S				Lopez, G.; Canas-Duarte, S. J.; Pinzon-Velasco, A. M.; Vega-Vela, N. E.; Rodriguez, M.; Restrepo, S.; Baena, S.			Description of a new anaerobic thermophilic bacterium, Thermoanaerobacterium butyriciformans sp nov	SYSTEMATIC AND APPLIED MICROBIOLOGY			English	Article						Thermoanaerobacterium; New species; Hot springs; Taxonomic; Genomic relatedness indexes	GENUS THERMOANAEROBACTERIUM; SPECIES DEFINITION; DNA HYBRIDIZATION; HOT-SPRINGS; CLOSTRIDIUM; EMENDATION; TOOL	Strain USBA-019(T), an anaerobic and thermophilic strain, was identified as a new member of the genus Thermoanaerobacterium. USBA-019T cells are gram-positive, strictly anaerobic, thermophilic, chemoorganotrophic, moderately acidophilic, non-motile, endospore-forming, slightly curved, and rod shaped. Cells measure 0.4 x 3.0-7.0 mu.m. Optimal growth occurs at 50-55 degrees C (35-65 degrees C). Optimum pH is 5.0-5.5 (4.0-8.5). Thiosulfate, elemental sulfur and nitrate were utilized as electron acceptors. Fermentation of glucose, lactose, cellobiose, galactose, arabinose, xylose, starch and xylan primarily produced acetate and butyrate. Xylan, starch and cellobiose produced ethanol and starch, cellobiose, galactose, arabinose and mannose produced lactic acid. Phylogenetic analyses based on 16S rRNA gene sequence comparison and genomic relatedness indices show the close relation of USBA-019T to Thermoanaerobacterium thermostercoris and Thermoanaerobacterium aotearoense (similarity value: 99%). Hybridization of USBA-019T, Th. thermostercoris DSM22141(T) and Th. aotearoense DMS10170(T) found DNA-DNA relatedness of 33.2% and 18.2%, respectively. Based on phenotypic, chemotaxonomic and phylogenetic evidence, along with low identity at whole genome level, USBA-019T is a novel species of the genus Thermoanaerobacterium which we propose to name Thermoanaerobacterium butyriciformans sp. nov. The type strain is USBA-019(T) (=CMPUJ U-019T = DSM 101588(T)). (C) 2016 Elsevier GmbH. All rights reserved.	[Lopez, G.; Baena, S.] Pontificia Univ Javeriana, Dept Biol, POB 56710, Bogota, Colombia; [Canas-Duarte, S. J.; Restrepo, S.] Univ Los Andes, Dept Biol Sci, Cra 1 18A-12, Bogota, Colombia; [Canas-Duarte, S. J.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Pinzon-Velasco, A. M.] Univ Nacl Colombia, Inst Genet, Grp Invest Bioinformat & Biol Sistemas, Bogota, Colombia; [Vega-Vela, N. E.; Rodriguez, M.] Ctr Bioinformat & Biol Computac Colombia BIOS, Manizales, Colombia		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, POB 56710, Bogota, Colombia.	baena@javeriana.edu.co	López, Gina/AAF-8171-2019; Baena, Sandra/AAF-8165-2019	Vega, Nelson/0000-0003-2404-6858; Lopez Ramirez, Gina/0000-0002-4210-089X; Pinzon, Andres/0000-0002-4133-810X; Canas-Duarte, Silvia J/0000-0001-5705-0023; Baena, Sandra/0000-0001-5377-9079	Universidad de los Andes; BIOS; Pontificia Universidad Javeriana and Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) [0641]; MAVDT Contract [33]	Universidad de los Andes; BIOS; Pontificia Universidad Javeriana and Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion); MAVDT Contract	This research was funded by Universidad de los Andes, BIOS, Pontificia Universidad Javeriana and Colciencias (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) ID Project 0641 Estudio de la diversidad microbiana de ambientes extremofilos en aguas minerales termales de Boyaca, Colombia, and done under Research Permit No. 0102-2003 and MAVDT Contract No. 33 for access to genetic resources.	Bosma E. F., 2015, APPL ENV MICROBIOL; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Delgado-Serrano L, 2014, FEMS MICROBIOL ECOL, V89, P56, DOI 10.1111/1574-6941.12333; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; KOLBELBOELKE J, 1988, MICROB ECOL, V16, P17, DOI 10.1007/BF02097402; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kublanov IV, 2007, INT J SYST EVOL MICR, V57, P260, DOI 10.1099/ijs.0.64633-0; LEE YE, 1993, INT J SYST BACTERIOL, V43, P41, DOI 10.1099/00207713-43-1-41; Liu SY, 1996, INT J SYST BACTERIOL, V46, P388, DOI 10.1099/00207713-46-2-388; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romano I, 2010, EXTREMOPHILES, V14, P233, DOI 10.1007/s00792-010-0303-x; Rubiano-Labrador C, 2013, INT J SYST EVOL MICR, V63, P1396, DOI 10.1099/ijs.0.037937-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thevenieau F, 2007, EXTREMOPHILES, V11, P295, DOI 10.1007/s00792-006-0039-9; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079	22	3	3	0	4	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0723-2020			SYST APPL MICROBIOL	Syst. Appl. Microbiol.	MAR	2017	40	2					86	91		10.1016/j.syapm.2016.11.006	http://dx.doi.org/10.1016/j.syapm.2016.11.006			6	Biotechnology & Applied Microbiology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Microbiology	EM9DA	28057375				2022-09-04	WOS:000395610300003
J	Castellanos, LT; Bencardino, MCM; Bravo-Balado, A; Mayorga, CAG; Manrique, IV; Fernandez, N				Castellanos, Lynda Torres; Bencardino, Maria Camila Moreno; Bravo-Balado, Alejandra; Mayorga, Carlos Andres Garcia; Manrique, Isis Vargas; Fernandez, Nicolas			Evaluation of the Efficacy and Safety of Laser versus Cold Knife Urethrotomy in the Management of Patients with Urethral Strictures: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	UROLOGIA INTERNATIONALIS			English	Review						Urethra; Urethral stricture; Urethral stenosis; Laser; Cold knife; Urethrotomy; Urethral reconstruction; Efficacy; Safety; Recurrence rate	INTERNAL URETHROTOMY; ETIOLOGY; DILATION	Introduction: Urethral strictures generate great morbidity. Two procedures have been described for their management - laser and cold knife techniques - which are still widely used. We aim to assess the safety and efficacy of laser versus cold knife urethrotomy. Materials and Methods: We conducted a systematic search of the literature using MEDLINE, EMBASE, LILACS and Cochrane databases and gray literature. Primary outcomes were urethral stricture recurrence, time-to-recurrence and complication rate. Secondary outcomes were quality of life and maximum urinary flow rate (Qmax). Data analysis was obtained using Review Manager 5.2. Results: Out of 137 publications, 4 articles were included in the meta-analysis. At 3 months, the recurrence rate was similar in both groups (0.55, 95% CI 0.18-1.66), but at 6 and 12 months, it was significantly lower in the laser urethrotomy group (0.39, 95% CI 0.19-0.81 and 0.44, 95% CI 0.26-0.75). The analysis of Qmax at 6 months post-intervention suggested a greater improvement in the laser urethrotomy group. A qualitative analysis showed that complications in both procedures were minor and infrequent. Conclusions: Laser urethrotomy has a lower recurrence rate at 6 and 12 months compared to cold knife urethrotomy. Complications in both procedures are minor and infrequent. Results should be interpreted cautiously, since they were evaluated only for a short term. (C) 2017 S. Karger AG, Basel	[Castellanos, Lynda Torres; Bencardino, Maria Camila Moreno; Mayorga, Carlos Andres Garcia; Manrique, Isis Vargas; Fernandez, Nicolas] Hosp Univ San Ignacio, Dept Urol, Carrera 7 40-62,Piso 8, Bogota 110111, Colombia; [Castellanos, Lynda Torres; Bencardino, Maria Camila Moreno; Mayorga, Carlos Andres Garcia; Manrique, Isis Vargas; Fernandez, Nicolas] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Bravo-Balado, Alejandra] Hosp Univ Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia; [Bravo-Balado, Alejandra] Univ Los Andes, Sch Med, Bogota, Colombia; [Fernandez, Nicolas] Pontificia Univ Javeriana, Human Genet Inst, Bogota, Colombia; [Fernandez, Nicolas] Hosp SickKids, Div Urol, Toronto, ON, Canada		Castellanos, LT (corresponding author), Hosp Univ San Ignacio, Dept Urol, Carrera 7 40-62,Piso 8, Bogota 110111, Colombia.; Castellanos, LT (corresponding author), Pontificia Univ Javeriana, Unidad Urol, Carrera 7 40-62,Piso 8, Bogota 110111, Colombia.	lynda_torres@javeriana.edu.co		Bravo-Balado, Alejandra/0000-0002-9555-393X				Atak M, 2011, KAOHSIUNG J MED SCI, V27, P503, DOI 10.1016/j.kjms.2011.06.013; Brandes SB., 2014, ADV MALE URETHRAL GE, V2, P759; Buckley JC, 2014, UROLOGY, V83, pS18, DOI 10.1016/j.urology.2013.08.075; Bullock TL, 2007, J UROLOGY, V177, P685, DOI 10.1016/j.juro.2006.09.052; Carreno G, 2016, C SCU; Dutkiewicz SA, 2012, INT UROL NEPHROL, V44, P717, DOI 10.1007/s11255-011-0094-8; Gallegos Maxx A, 2016, F1000Res, V5, P2913, DOI 10.12688/f1000research.9741.1; Greenwell TJ, 2004, J UROLOGY, V172, P275, DOI 10.1097/01.ju.0000132156.76403.8f; Jablonowski Z, 2010, PHOTOMED LASER SURG, V28, P239, DOI 10.1089/pho.2009.2516; Jain SK, 2014, UROL ANNALS, V6, P328, DOI 10.4103/0974-7796.140997; Jin T, 2010, CHINESE MED J-PEKING, V123, P1589, DOI 10.3760/cma.j.issn.0366-6999.2010.12.020; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Ogbonna BC, 1998, BRIT J UROL, V81, P741; Santucci RA, 2007, J UROLOGY, V177, P1667, DOI 10.1016/j.juro.2007.01.041; Tritschler S, 2013, DTSCH ARZTEBL INT, V110, P220, DOI 10.3238/arztebl.2013.0220; VICENTE J, 1990, EUR UROL, V18, P166; Wein A.J., 2016, CAMPBELL WALSH UROLO, V11th; Wessells H, 2017, J UROLOGY, V197, P182, DOI 10.1016/j.juro.2016.07.087; Xue JD, 2016, UROL INT, V96, P231, DOI 10.1159/000442994; Zhou SK, 2016, UROL INT, V97, P386, DOI 10.1159/000444592	20	8	9	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0042-1138	1423-0399		UROL INT	Urol.Int.		2017	99	4					453	459		10.1159/000478026	http://dx.doi.org/10.1159/000478026			7	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	FO5DO	28697506	Bronze			2022-09-04	WOS:000416870900011
J	Albarracin, SL; Baldeon, ME; Sangronis, E; Petruschina, AC; Reyes, FGR				Albarracin, Sonia Luz; Baldeon, Manuel E.; Sangronis, Elba; Petruschina, Alexandra Cucufate; Reyes, Felix G. R.			L-glutamate: a key amino acid for sensory and metabolic functions	ARCHIVOS LATINOAMERICANOS DE NUTRICION			Spanish	Article						Glutamate; monosodium glutamate; ionotropic receptors and metabotropics receptors; umami taste	SYNTHETASE; ABSORPTION; PROTEIN	Glutamic acid or its ionic form L-glutamate (GLU) is one of the most abundant amino acids in nature and it plays important functions at the cellular and systemic levels. For instance, in the intestine and liver, GLU is a source of energy and is the precursor of key biological molecules. At the central nervous system of mammals, GLU acts as an excitatory neurotransmitter due to the interaction with specific receptors. In addition, GLU has been related with short-and long-term potentiation, memory and the learning. Furthermore, consumption of GLU or its monosodium salt (monosodium glutamate, MSG) as a food additive is responsible for the umami taste. The consumption of MSG has been considered safe for different agencies responsible for the evaluation of the safe use of food additives, which have establish an Acceptable Daily Intake (ADI) "not specified", or classified as Generally Recognized Safe Substance (GRAS). This review focuses on important metabolic aspects of GLU and its role in food tasting and MSG safety.	[Albarracin, Sonia Luz] Pontificia Univ javeriana, Fac Ciencias, Bogota, Colombia; Univ Amer, Ctr Invest Traslac, Quito, Ecuador; Univ Simon Bolivar, Div Ciencias Biol, Caracas, Venezuela; Univ Peruana Ciencias Aplicadas, Fac Ciencias Salud, Lima, Peru; Univ Estadual Campinas, Fac Ingn Alimentos, Sao Paulo, Brazil		Albarracin, SL (corresponding author), Pontificia Univ javeriana, Fac Ciencias, Bogota, Colombia.		Albarracin, Sonia Luz/AAM-7372-2020; Reyes, Felix Guillermo Reyes/U-1743-2019; Reyes, Reyes/J-3044-2017	Reyes, Felix Guillermo Reyes/0000-0003-0126-3817; Reyes, Reyes/0000-0003-0126-3817				Albarracin SL, 2012, THESIS; Amaya-Farfan J, 2013, EDITORA PLEIADE, P91; [Anonymous], 2006, 192 FAOWHO CODEX ALI; Baldeon ME, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-104; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Bos C, 2005, AM J CLIN NUTR, V81, P87; Butterworth RF, 2014, MOL GENET METAB, V113, P113, DOI 10.1016/j.ymgme.2014.06.003; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; EC (European Commission), 2008, OFFICIAL J EUROPEA L, V354; FAO/WHO, 1971, WHO TECHN REP SER, V48; FAO/WHO, 1974, FAO NUTR M REP SER, V53; *FAO WHO, 1974, FAO NUTR M REP SER, V53; FAO/WHO, 1987, WHO TECHN REP SER, V759; FAO/WHO, 1988, WHO FOOD ADD SER, V22, P97; FAO/WHO, 1971, WHO TECHN REP SER, V48; *FAO WHO, 2005, WHO TECHN REP SER, V928; Federation of American Societies for Experimental Biology (FASEB), 1995, AN ADV REACT MON GLU; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Flores-Soto ME, 2012, NEUROLOGIA, V27, P301, DOI 10.1016/j.nrl.2011.10.014; Janeczko MJ, 2007, J NUTR, V137, P2384, DOI 10.1093/jn/137.11.2384; Kandel E, 2000, PRINCIPLES NEURAL SC, P1321; Kinnamon SC, 2009, AM J CLIN NUTR, V90, p753S, DOI 10.3945/ajcn.2009.27462K; Kurihara K, 2009, AM J CLIN NUTR, V90, p719S, DOI 10.3945/ajcn.2009.27462D; Liu XX, 2014, AM J PHYSIOL-GASTR L, V307, pG459, DOI 10.1152/ajpgi.00400.2013; Loliger J, 2000, J NUTR, V130, p915S, DOI 10.1093/jn/130.4.915S; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martinez Sarrasague M, 2006, ACTA BIOQUIM CLIN L, V40, P208; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; MEISTER A, 1985, METHOD ENZYMOL, V113, P185; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nilius B, 2011, EMBO REP, V12, P1094, DOI 10.1038/embor.2011.200; Reyes FGR, 2013, UMAMI GLUTAMATO ASPE, P401; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; ROIG JC, 1995, JPEN-PARENTER ENTER, V19, P179, DOI 10.1177/0148607195019003179; Rowley NM, 2012, NEUROCHEM INT, V61, P546, DOI 10.1016/j.neuint.2012.02.013; Sabatini BL, 2007, NATURE, V450, P1173, DOI 10.1038/4501173a; San Gabriel A, 2012, NATUREOUTLOOK, V486, pS44; SCF (Scientific Committee for Food), 1991, REP SCI COMM FOOD; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; US FDA, 1969, REP MON GLUT REV FOO; VAUGELADE P, 1994, P SOC EXP BIOL MED, V207, P309, DOI 10.3181/00379727-207-43821; Verkhratsky A, 2012, NEUROCHEM RES, V37, P2326, DOI 10.1007/s11064-012-0765-6	44	4	5	1	26	ARCHIVOS LATINOAMERICANOS NUTRICION	CARACAS	APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA	0004-0622	2309-5806		ARCH LATINOAM NUTR	Arch. Latinoam. Nutr.	JUN	2016	66	2					101	112						12	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	DY0AT	29737666				2022-09-04	WOS:000384759900002
J	Ballen, GA; Urbano-Bonilla, A; Maldonado-Ocampo, JA				Ballen, Gustavo A.; Urbano-Bonilla, Alexander; Maldonado-Ocampo, Javier A.			Description of a new species of the genus Chaetostoma from the Orinoco River drainage with comments on Chaetostoma milesi Fowler, 1941 (Siluriformes: Loricariidae)	ZOOTAXA			English	Article						Ancistrini; taxonomy; Hemiancistrus platyrhynchus; Andes; northern South America	ARMORED CATFISHES; HYPOSTOMINAE; GENERA	Chaetostoma joropo n. sp. is described from the piedmont of the Orinoco River drainage in Colombia. The new species has been long confused with Chaetostoma milesi, a species with similar overall morphology and color pattern that is restricted to the Magdalena-Cauca River Basin. We diagnose the new species on the basis of morphology as well as a precise description of the color pattern. Chaetostoma joropo n. sp. is also easily distinguished from C. formosae the most similar species and other species inhabiting the Orinoco River drainage in Colombia. Data on ontogenetic variation and sexual dimorphism are provided, as well as natural history notes and remarks on the usage of the name Chaetostoma milesi for specimens from both the Orinoco and Magdalena-Cauca drainages. A discussion on the usage of the name Chaetostoma platyrhynchus is also provided given its current instability in the literature.	[Ballen, Gustavo A.] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Ballen, Gustavo A.] Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Ancon, Panama; [Ballen, Gustavo A.; Urbano-Bonilla, Alexander; Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Ictiol, Bogota, Colombia; [Urbano-Bonilla, Alexander] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS, Bogota, Colombia		Ballen, GA (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil.; Ballen, GA (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Ancon, Panama.; Ballen, GA; Urbano-Bonilla, A; Maldonado-Ocampo, JA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Ictiol, Bogota, Colombia.; Urbano-Bonilla, A (corresponding author), Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia.; Maldonado-Ocampo, JA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS, Bogota, Colombia.	gaballench@gmail.com; bio.ictiologia@gmail.com; maldonadoj@javeriana.edu.co		/0000-0002-0190-8913; Ballen, Gustavo/0000-0001-5424-8608; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X	Pontificia Universidad Javeriana [5211411]; University Vienna, Department of Integrative Zoology; Department of Morphology, Universidade Estadual Paulista-UNESP-; Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt; Oleoducto Bicentenario [4400000166]; FAPESP [2014/11558-5]	Pontificia Universidad Javeriana; University Vienna, Department of Integrative Zoology; Department of Morphology, Universidade Estadual Paulista-UNESP-; Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt; Oleoducto Bicentenario; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding to conduct field work along the Orinoco River Basin piedmont was provided by the Pontificia Universidad Javeriana (project No 5211411), University Vienna, Department of Integrative Zoology, and Department of Morphology, Universidade Estadual Paulista-UNESP-, Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt and Oleoducto Bicentenario (project No. 4400000166); and through a doctoral grant by FAPESP to GAB (process 2014/11558-5). John Lundberg (ANSP), Saul Prada (MPUJ), and Francisco Villa (CZUT) are acknowledged for the access to collections or loan of specimens. GAB acknowledges Sandra Reinales and Carlos Sarmiento for their skillful advice on data analysis, and Tulio Teixeira for information about collections of Chaetostoma from Peru housed at MZUSP. AU-B acknowledges fishermen Juan de Dios Ocampo and Josue Ocampo, Anton Lamboj and Oliver Lucanus who facilitated and participated in the fieldwork at the Serrania de La Macarena. The comments from two anonymous reviewers are also acknowledged for helping to improve the quality of the manuscript. Donald Taphorn is acknowledged for kindly reviewing the English of the manuscript.	Armbruster JW, 2008, ZOOTAXA, P1; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Armbruster JW, 2003, ZOOTAXA, V344, P1, DOI 10.11646/zootaxa.344.1.1; Ballen GA, 2012, NEOTROP ICHTHYOL, V10, P499, DOI 10.1590/S1679-62252012000300003; Ballen Gustavo A., 2011, Pap. Avulsos Zool. (São Paulo), V51, P383, DOI 10.1590/S0031-10492011002600001; Burgess Warren E., 1996, Tropical Fish Hobbyist, V45, P163; Caeiro F., 2014, Randtests: Testing Randomness in R, R Package; Curran-Everett D, 2013, ADV PHYSIOL EDUC, V37, P213, DOI 10.1152/advan.00053.2013; Dragulescu AA, 2018, XLSX READ WRITE FORM; FOWLER HENRY W., 1941, NOTULAE NATURAE [PHILADELPHIA], V73, P1; Fowler Henry W., 1943, PROC ACAD NAT SCI PHILADELPHIA, V95, P223; Geerinckx T, 2007, J MORPHOL, V268, P254, DOI 10.1002/jmor.10515; Geerinckx T, 2006, ZOOLOGY, V109, P287, DOI 10.1016/j.zool.2006.04.001; Hettmansperger T.P., 2010, ROBUST NONPARAMETRIC; Husson F, 2015, FACTOMINER MULTIVARI; Isbrucker I. J., 1980, VERSLAGEN TECHNISCHE, V22, P1; Isbrucker I.J.H., 2001, DATZ SONDERHEFT HARN, V2, P17; Jolliffe I.T., 2002, PRINCIPAL COMPONENT; Kassambara A., 2015, FACTOEXTRA EXTRACT V; Kloke J., 2014, NONPARAMETRIC STAT M; Kloke J.D., 2014, NPSM PACKAGE NONPARA; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Lasso Carlos A., 2004, Biota Colombiana, V5, P95; Lujan NK, 2015, COPEIA, V103, P651, DOI 10.1643/CI-15-246; Lujan NK, 2015, COPEIA, V103, P664, DOI 10.1643/CI-14-194; Lujan NK, 2012, J MORPHOL, V273, P24, DOI 10.1002/jmor.11003; Lujan NK, 2011, COPEIA, P216, DOI 10.1643/CI-10-008; Maldonado-Ocampo Javier A., 2013, Biota Colombiana, V14, P114; Maldonado-Ocampo Javier A., 2008, Biota Colombiana, V9, P143; Muller K., 2015, R PACKAGE VERSION 0; Ortega-Lara A, 2011, NEOTROP ICHTHYOL, V9, P777, DOI 10.1590/S1679-62252011000400009; R Core Development Team, 2012, R LANG ENV STAT COMP; Rapp Py-Daniel L.H., 1991, Ichthyological Exploration of Freshwaters, V2, P239; Rodriguez-Olarte D, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P243; Sabaj-Perez M, 2022, STANDARD SYMBOLIC CO; Salcedo NJ, 2006, COPEIA, P60, DOI 10.1643/0045-8511(2006)006[0060:NSOCSL]2.0.CO;2; Salcedo NJ, 2006, ICHTHYOL EXPLOR FRES, V17, P207; Schaefer SA, 1997, P ACAD NAT SCI PHILA, V148, P1; Tan MT, 2012, ZOOTAXA, P52; TAYLOR W R, 1985, Cybium, V9, P107; Todeschini R., 2008, HDB MOL DESCRIPTORS, V11; Urbano-Bonilla Alexander, 2014, Biota Colombiana, V15, P52; Urbano-Bonilla Alexander, 2009, Biota Colombiana, V10, P149; VAN DER LOO M. P. J., 2010, EXTREMEVALUES R PACK; Zamudio J., 2008, DAHLIA, V10, P43	45	7	8	0	2	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	APR 20	2016	4105	2					181	197		10.11646/zootaxa.4105.2.6	http://dx.doi.org/10.11646/zootaxa.4105.2.6			17	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	DK9SR	27394772				2022-09-04	WOS:000375272100006
J	Witjes, S; Ahlstrom, H; Vildasen, S; Ramos-Mejia, M				Witjes, Sjors; Ahlstrom, Hanna; Vildasen, Sigurd; Ramos-Mejia, Monica			Academics for sustainable development: Exploring consequences and dilemmas of transdisciplinary research approaches	SUSTAINABLE DEVELOPMENT			English	Editorial Material							SCIENCE		[Witjes, Sjors] Radboud Univ Nijmegen, Inst Management Res, Nijmegen, Netherlands; [Ahlstrom, Hanna] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden; [Vildasen, Sigurd] Norwegian Univ Sci & Technol, Sintef Mfg, Trondheim, Norway; [Vildasen, Sigurd] Norwegian Univ Sci & Technol, Dept Ind Econ & Technol Management, Trondheim, Norway; [Ramos-Mejia, Monica] Pontificia Univ Javeriana, Dept Business Adm, Bogota, Colombia		Witjes, S (corresponding author), Radboud Univ Nijmegen, Inst Management Res, Nijmegen, Netherlands.	sjors.witjes@ru.nl						Ahlstrom H, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120691; Albert C., 2021, SUSTAIN DEV; Arnold MG, 2022, SUSTAIN DEV, V30, P326, DOI 10.1002/sd.2277; Biswas S, 2022, SUSTAIN DEV, V30, P293, DOI 10.1002/sd.2275; Blyton, 2013, RES SUSTAINABILITY G; Bulten E, 2021, SUSTAIN SCI, V16, P1269, DOI 10.1007/s11625-021-00938-7; Care O, 2021, SUSTAIN SCI, V16, P703, DOI 10.1007/s11625-021-00909-y; Carew AL, 2010, FUTURES, V42, P1146, DOI 10.1016/j.futures.2010.04.025; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Chambers JM, 2021, NAT SUSTAIN, V4, P983, DOI 10.1038/s41893-021-00755-x; Cockburn J., 2018, THESIS RHODES U GRAH; Cockburn J, 2022, SUSTAIN DEV, V30, P358, DOI 10.1002/sd.2279; Fahy F., 2013, METHODS SUSTAINABILI; Hakkarainen V, 2022, SUSTAIN DEV, V30, P309, DOI 10.1002/sd.2276; Hessels LK, 2008, RES POLICY, V37, P740, DOI 10.1016/j.respol.2008.01.008; Jahn S, 2022, SUSTAIN DEV, V30, P343, DOI 10.1002/sd.2278; Keitsch, 2021, TRANSDISCIPLINARITY, P179; Laasch O, 2020, J BUS ETHICS, V162, P735, DOI 10.1007/s10551-020-04440-5; Milkoreit M, 2015, ENVIRON SCI POLICY, V53, P87, DOI 10.1016/j.envsci.2014.08.003; Norstrom AV, 2020, NAT SUSTAIN, V3, P182, DOI 10.1038/s41893-019-0448-2; Polk M, 2015, FUTURES, V65, P110, DOI 10.1016/j.futures.2014.11.001; Schaltegger S, 2013, BUS STRATEG ENVIRON, V22, P219, DOI 10.1002/bse.1772; Sellberg M.M., 2018, THESIS STOCKHOLM U S; Sellberg MM, 2021, ECOSYST PEOPLE, V17, P292, DOI 10.1080/26395916.2021.1931452; Soderbaum P, 2009, SUSTAIN DEV, V17, P70, DOI 10.1002/sd.404; Stirling, 2021, CHALLENGING RES SUST; Tengo M, 2014, AMBIO, V43, P579, DOI 10.1007/s13280-014-0501-3; Thompson MA, 2017, ENVIRON SCI POLICY, V74, P30, DOI 10.1016/j.envsci.2017.04.006; Vermeulen, 2020, TRANSDISCIPLINARITY; Vermeulen W.J.V., 2021, TRANSDISCIPLINARITY, P6; Wardani J, 2022, SUSTAIN DEV, V30, P375, DOI 10.1002/sd.2280; Wiek A, 2014, RES EVALUAT, V23, P117, DOI 10.1093/reseval/rvt031; Witjes S., 2021, TRANSDISCIPLINARY RE, P27; Wittmayer JM, 2014, SUSTAIN SCI, V9, P483, DOI 10.1007/s11625-014-0258-4	34	1	1	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0968-0802	1099-1719		SUSTAIN DEV	Sustain. Dev.	APR	2022	30	2			SI		289	292		10.1002/sd.2254	http://dx.doi.org/10.1002/sd.2254		NOV 2021	4	Development Studies; Green & Sustainable Science & Technology; Regional & Urban Planning	Social Science Citation Index (SSCI)	Development Studies; Science & Technology - Other Topics; Public Administration	0M8JD		Green Published			2022-09-04	WOS:000723232200001
J	Yaribeygi, H; Simental-Mendia, LE; Barreto, GE; Sahebkar, A				Yaribeygi, Habib; Simental-Mendia, Luis E.; Barreto, George E.; Sahebkar, Amirhossein			Metabolic effects of antidiabetic drugs on adipocytes and adipokine expression	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						adipocyte; adipokine; adiponectin; antidiabetic agent; diabetes mellitus; inflammation; thiazolidinedione	TYPE-2 DIABETES-MELLITUS; HUMAN ADIPOSE-TISSUE; IMPROVES INSULIN SENSITIVITY; ADIPONECTIN LEVELS; SKELETAL-MUSCLE; DIPEPTIDYL PEPTIDASE-4; PLASMA ADIPONECTIN; AEROBIC EXERCISE; PEPTIDE-1 ANALOG; OXIDATIVE STRESS	Several classes of antidiabetic agents have been developed that achieve their hypoglycemic outcomes via various molecular mechanisms. Adipose tissue is a major metabolic and energy-storing tissue and plays an important role in many metabolic pathways, including insulin signaling and insulin sensitivity. Adipose tissue monitors and regulates whole body homeostasis via production and release of potent proteins, such as adipokine and adiponectin, into the circulation. Therefore, any agent that can modulate adipocyte metabolism can, in turn, affect metabolic and glucose homeostatic pathways. Antidiabetic drugs are not only recognized primarily as hypoglycemic agents but may also alter adipose tissue itself, as well as adipocyte-derived adipokine expression and secretion. In the current review, we present the major evidence concerning routinely used antidiabetic agents on adipocyte metabolism and adipokine expression.	[Yaribeygi, Habib] Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, POB 196151178, Tehran, Iran; [Simental-Mendia, Luis E.] Inst Mexicano Seguro Social, Delegac Durango, Unidad Invest Biomed, Mexico City, DF, Mexico; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Yaribeygi, H (corresponding author), Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, POB 196151178, Tehran, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Dept Med Biotechnol, Neurogen Inflammat Res Ctr, Sch Med, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	habib.yari@yahoo.com; sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Barreto, George E./AAD-7420-2020; Yaribeygi, Habib/R-8998-2019	Barreto, George E./0000-0002-6644-1971; Yaribeygi, Habib/0000-0002-1706-6212				Adeghate E, 2008, CURR MED CHEM, V15, P1851, DOI 10.2174/092986708785133004; Aguirre L, 2014, J CLIN ENDOCR METAB, V99, P3290, DOI 10.1210/jc.2013-3200; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; BAILEY CJ, 1992, DIABETES CARE, V15, P755, DOI 10.2337/diacare.15.6.755; Bamford NJ, 2016, EQUINE VET J, V48, P368, DOI 10.1111/evj.12434; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bluher M, 2014, MOL METAB, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Bolinder J, 2012, J CLIN ENDOCR METAB, V97, P1020, DOI 10.1210/jc.2011-2260; Cai Run-Ce, 2009, Zhonghua Yi Xue Za Zhi, V89, P381; Cherneva RV, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-5; Chiba Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150756; Chu CS, 2006, AM J CARDIOL, V97, P646, DOI 10.1016/j.amjcard.2005.09.101; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Corriere M, 2013, CURR DIABETES REP, V13, P805, DOI 10.1007/s11892-013-0425-5; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Derosa G, 2012, ARCH MED SCI, V8, P899, DOI 10.5114/aoms.2012.31621; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Dyck DJ, 2006, ACTA PHYSIOL, V186, P5, DOI 10.1111/j.1748-1716.2005.01502.x; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; El Husseny MWA, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8095926; Fadaei R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168773; Fadini GP, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0529-3; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gao HT, 2015, BIOL PHARM BULL, V38, P694, DOI 10.1248/bpb.b14-00505; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Garvey WT, 2018, METABOLISM, V85, P32, DOI 10.1016/j.metabol.2018.02.002; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Geloneze B, 2017, DRUGS, V77, P493, DOI 10.1007/s40265-017-0706-4; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hall J. E, 2021, GUYTON HALL TXB MED; Hammarstedt A, 2006, J CLIN ENDOCR METAB, V91, P1181, DOI 10.1210/jc.2005-1395; Hansen JB, 2014, ACTA PHYSIOL, V210, P717, DOI 10.1111/apha.12256; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hausman G J, 2008, J Anim Sci, V86, pE236; Hoelmkjaer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154727; Ikeda Y, 2013, FEBS J, V280, P5884, DOI 10.1111/febs.12514; Itoh N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00107; Kadoglou NPE, 2013, DIABETIC MED, V30, pE41, DOI 10.1111/dme.12055; Kanda Y, 2008, DIABETES RES CLIN PR, V81, P13, DOI 10.1016/j.diabres.2008.01.031; Kim EK., 2016, MEDIATORS INFLAMM, V2016, P1, DOI DOI 10.1155/2016/5813030; Kim G, 2018, INT J OBESITY, V42, P542, DOI 10.1038/ijo.2017.222; Kim HJ, 2008, DIABETES RES CLIN PR, V81, P42, DOI 10.1016/j.diabres.2008.02.001; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; Kong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140565; Kwon H., 2018, TXB ENERGY BALANCE N, P225; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee S, 2013, AM J PHYSIOL-ENDOC M, V305, pE1222, DOI 10.1152/ajpendo.00285.2013; Li CJ, 2014, GENET EPIGENETICS, V6, P1, DOI 10.4137/GEG.S14176; Li XS, 2015, 2015 INTERNATIONAL CONFERENCE ON INDUSTRIAL INFORMATICS - COMPUTING TECHNOLOGY, INTELLIGENT TECHNOLOGY, INDUSTRIAL INFORMATION INTEGRATION (ICIICII), P1, DOI 10.1109/ICIICII.2015.88; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Li Y, 2011, COMPR PHYSL, V7, P863; Liao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep32887; Liu X, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0372-7; Loh RKC, 2018, DIABETOLOGIA, V61, P220, DOI 10.1007/s00125-017-4479-9; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Makino H, 2016, DIABETIC MED, V33, P1737, DOI 10.1111/dme.13151; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; McGee KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020287; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; Nagasaka S, 2003, DIABETES CARE, V26, P2215, DOI 10.2337/diacare.26.7.2215; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nicholson T, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0185-8; Nishitani S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27181-y; Otto C, 2006, J ENDOCRINOL INVEST, V29, P231, DOI 10.1007/BF03345545; Papatheodorou K, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3086167; Pastel E, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.44; PEDERSEN O, 1991, American Journal of Medicine, V90, p22S, DOI 10.1016/0002-9343(91)90414-S; Punthakee Z, 2014, DIABETIC MED, V31, P1086, DOI 10.1111/dme.12512; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rehman K, 2017, CRIT REV EUKAR GENE, V27, P229, DOI 10.1615/CritRevEukaryotGeneExpr.2017019712; Rizvi AA, 2014, METAB SYNDR RELAT D, V12, P1, DOI 10.1089/met.2013.0090; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Sahebkar A, 2016, CURR MED CHEM, V23, P1356, DOI 10.2174/0929867323666160405111354; Sato T, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-017-0658-8; Saukkonen T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31144-8; Sawada Y, 2017, BIOCHEM BIOPH RES CO, V493, P40, DOI 10.1016/j.bbrc.2017.09.081; Schmid PM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-46; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shi H, 1999, FASEB J, V13, P1833, DOI 10.1096/fasebj.13.13.1833; Shimizu H, 2006, DIABETIC MED, V23, P253, DOI 10.1111/j.1464-5491.2006.01776.x; Shirakawa J, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0138-4; Storgaard H, 2016, BASIC CLIN PHARMACOL, V118, P168, DOI 10.1111/bcpt.12457; Tan B., 2009, ENDOCRINE ABSTRACTS, V19, pOC23; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tarkun I, 2010, EUR CYTOKINE NETW, V21, P272, DOI 10.1684/ecn.2010.0217; Teranishi T, 2007, METABOLISM, V56, P1418, DOI 10.1016/j.metabol.2007.06.005; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tokubuchi I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171293; Trnovska J, 2015, ATHEROSCLEROSIS, V241, pE46, DOI 10.1016/j.atherosclerosis.2015.04.165; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; von Bibra H, 2008, DIABETES VASC DIS RE, V5, P310, DOI 10.3132/dvdr.2008.045; Wang AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169469; Wang Q. A., 2018, MOL CELL BIOL; Wang SQ, 2017, BRAZ ORAL RES, V31, DOI [10.1590/1807-3107BOR-2017.vol31.0090, 10.1590/1807-3107bor-2017.vol31.0090]; Wintrob ZAP, 2017, CYTOKINE, V89, P45, DOI 10.1016/j.cyto.2016.10.017; Wolk R, 2016, EUR J PREV CARDIOL, V23, P50, DOI 10.1177/2047487314544046; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Xu L., 2018, ADV MATER SCI ENG, V2018, P1, DOI [10.5194/acp-2017-1109, DOI 10.5194/ACP-2017-1109]; Xu L., 2010, INCRETINS DPP 4 INHI; Xu L, 2017, EBIOMEDICINE, V20, P137, DOI 10.1016/j.ebiom.2017.05.028; Yang Lu, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P353, DOI 10.3881/j.issn.1000-503X.2013.03.021; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P5674, DOI 10.1002/jcp.27427; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8286, DOI 10.1002/jcp.27699; Yaribeygi H, 2018, METABOLISM, V87, P48, DOI 10.1016/j.metabol.2018.07.001; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P1300, DOI 10.1002/jcp.27164; Yaribeygi H, 2019, DRUG DISCOV TODAY, V24, P256, DOI 10.1016/j.drudis.2018.08.005; Yaribeygi H, 2018, DRUG RES, V68, P355, DOI 10.1055/s-0043-121143; Yokoyama H, 2004, DIABETES CARE, V27, P1756, DOI 10.2337/diacare.27.7.1756; Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281; Zeng J., 2011, J CHENGDU MED COLL, V1, P029; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918; Zhang XW, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005945; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Zhu JJ, 2017, ENDOCRINE, V56, P73, DOI 10.1007/s12020-016-1203-3; Zillssen P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23074; Zulian A, 2011, OBESITY FACTS, V4, P27, DOI 10.1159/000324582	136	12	13	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	OCT	2019	234	10					16987	16997		10.1002/jcp.28420	http://dx.doi.org/10.1002/jcp.28420			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	IH7ML	30825205				2022-09-04	WOS:000474688200026
J	Macchi, M; Festa, S; Vega-Vela, NE; Morelli, IS; Coppotelli, BM				Macchi, Marianela; Festa, Sabrina; Vega-Vela, Nelson E.; Morelli, Irma S.; Coppotelli, Bibiana M.			Assessing interactions, predicting function, and increasing degradation potential of a PAH-degrading bacterial consortium by effect of an inoculant strain	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Inoculation; invasion; Bacterial consortia; Degradation potential; Invasion; Predicted functions; PICRUSt; Proteome	MICROBIAL CONSORTIA; PHENANTHRENE; BIODEGRADATION; COMMUNITY; SPHINGOMONAS; SOIL; ENVIRONMENT; SPHINGOBIUM; DIVERSITY; HYDROCARBONS	A natural phenanthrene-degrading consortium CON was inoculated with an exogenous strain Sphingobium sp. (ex Sp. paucimobilis) 20006FA yielding the consortium called I-CON, in order to study ecological interactions into the bacterial community. DGGE and proteomic profiles and analyses by HTS (High-Throughput Sequencing) technologies demonstrated inoculant establishment and changes on CON composition. Inoculation increased degradation efficiency in I-CON and prevented intermediate HNA accumulation. This could be explained not only by the inoculation, but also by enrichment in Achromobacter genus at expense of a decrease in Klebsiella genus. After inoculation, cooperation between Sphingobium and Achromobacter genera were improved, thereby, some competition could have been generated, and as a consequence, species in minor proportion (cheaters), as Inquilinus sp. and Luteibacter sp., were not detected. Sequences of Sphingobium (corresponding to the inoculated strain) did not vary. PICRUSt predicted a network with bacterial phylotypes connected with enzymes, showing functional redundancy in the phenanthrene pathway, with exception of the first enzymes biphenyl-2,3-diol 1,2-dioxygenase and protocatechuate 4,5-dioxygenase that were only encoded in Sphingobium sp. This is the first report where a natural consortium that has been characterized by HTS technologies is inoculated with an exogenous strain in order to study competitiveness and interactions.	[Macchi, Marianela; Festa, Sabrina; Morelli, Irma S.; Coppotelli, Bibiana M.] UNLP, CINDEFI, Ctr Invest & Desarrollo Fermentac Ind, St 50 N 227, RA-1900 La Plata, Buenos Aires, Argentina; [Macchi, Marianela; Festa, Sabrina; Morelli, Irma S.; Coppotelli, Bibiana M.] Consejo Nacl Invest Cient & Tecn, CCT La Plata, St 50 227, RA-1900 La Plata, Buenos Aires, Argentina; [Vega-Vela, Nelson E.] Pontificia Univ Javeriana, Bogota, Colombia; [Vega-Vela, Nelson E.] Univ Bogota Jorge Tadeo Lozano, Bogota, Colombia; [Morelli, Irma S.] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina		Coppotelli, BM (corresponding author), UNLP, CINDEFI, Ctr Invest & Desarrollo Fermentac Ind, St 50 N 227, RA-1900 La Plata, Buenos Aires, Argentina.; Coppotelli, BM (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT La Plata, St 50 227, RA-1900 La Plata, Buenos Aires, Argentina.	bibicoppotelli@gmail.com		Coppotelli, Bibiana/0000-0003-3439-5170; Macchi, Marianela/0000-0002-7339-3795	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2013-0103]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was partially supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2013-0103). Festa S. and Macchi M. have doctoral and postdoctoral fellowships supported by CONICET. Morelli I.S. is a research member of CIC-PBA. Coppotelli B.M. is a research member of CONICET.	Balashova NV, 2001, BIODEGRADATION, V12, P179, DOI 10.1023/A:1013126723719; Baldrian P, 2013, LAB ENV MICROBIOLOGY, V8, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1371/J0URNAL.P0NE.0057923; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerniglia Carl E., 1993, Current Opinion in Biotechnology, V4, P331, DOI 10.1007/BF00129093; CERNIGLIA CE, 1984, APPL ENVIRON MICROB, V47, P119, DOI 10.1128/AEM.47.1.119-124.1984; Chiu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100014; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Coppotelli BM, 2008, MICROB ECOL, V55, P173, DOI 10.1007/s00248-007-9265-7; Coppotelli BM, 2010, MICROB ECOL, V59, P266, DOI 10.1007/s00248-009-9563-3; de Lorenzo V, 2013, ENVIRON MICROBIOL, V15, P6, DOI 10.1111/j.1462-2920.2012.02896.x; De Roy K, 2014, ENVIRON MICROBIOL, V16, P1472, DOI 10.1111/1462-2920.12343; Desai C, 2010, BIORESOURCE TECHNOL, V101, P1558, DOI 10.1016/j.biortech.2009.10.080; Dressler MD, 2017, FRONT CHEM SCI ENG, V11, P3, DOI 10.1007/s11705-016-1605-z; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Festa S, 2016, APPL SOIL ECOL, V98, P8, DOI 10.1016/j.apsoil.2015.08.025; Festa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184505; Festa S, 2013, INT BIODETER BIODEGR, V85, P42, DOI 10.1016/j.ibiod.2013.06.006; Friedman Jonathan, 2017, Current Opinion in Systems Biology, V1, P114, DOI 10.1016/j.coisb.2016.12.001; Gotelli NJ, 2013, MEASURING ESTIMATING, V5; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hoek TA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002540; Hua XF, 2010, CHEMOSPHERE, V80, P951, DOI 10.1016/j.chemosphere.2010.05.002; Kazunga C, 2000, APPL ENVIRON MICROB, V66, P1917, DOI 10.1128/AEM.66.5.1917-1922.2000; Khara P, 2014, FEBS OPEN BIO, V4, P290, DOI 10.1016/j.fob.2014.03.001; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Macchi M, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-017-2391-6; Madueno L, 2011, INT BIODETER BIODEGR, V65, P345, DOI 10.1016/j.ibiod.2010.12.008; Mallon CA, 2015, TRENDS MICROBIOL, V23, P719, DOI 10.1016/j.tim.2015.07.013; McCully AL, 2017, MBIO, V8, DOI 10.1128/mBio.01620-17; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Mercier C, 2013, SUMATRA SUMACLUSTFAS; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Pavlopoulos GA, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy014; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Quast C., 2012, NUCLEIC ACIDS RES, V41, P590, DOI DOI 10.1093/NAR/GKS1219; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stadie J, 2013, FOOD MICROBIOL, V35, P92, DOI 10.1016/j.fm.2013.03.009; Stolz A, 2009, APPL MICROBIOL BIOT, V81, P793, DOI 10.1007/s00253-008-1752-3; Su ZG, 2018, MAR POLLUT BULL, V131, P481, DOI 10.1016/j.marpolbul.2018.04.052; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Tao KY, 2017, BIORESOURCE TECHNOL, V224, P327, DOI 10.1016/j.biortech.2016.10.073; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Toledo FL, 2008, BIORESOURCE TECHNOL, V99, P8470, DOI 10.1016/j.biortech.2007.08.055; VECCHIOLI GI, 1990, ENVIRON POLLUT, V67, P249, DOI 10.1016/0269-7491(90)90190-N; Waigi MG, 2015, INT BIODETER BIODEGR, V104, P333, DOI 10.1016/j.ibiod.2015.06.008; Waite AJ, 2012, P NATL ACAD SCI USA, V109, P19079, DOI 10.1073/pnas.1210190109; Wanapaisan P, 2018, J HAZARD MATER, V342, P561, DOI 10.1016/j.jhazmat.2017.08.062; Wickham H, 2016, USE R, V174, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4]; Wrenn BA, 1996, CAN J MICROBIOL, V42, P252, DOI 10.1139/m96-037; Yang TJ, 2017, ENVIRON MICROBIOL, V19, P2984, DOI 10.1111/1462-2920.13708; Yuan SY, 2000, CHEMOSPHERE, V41, P1463, DOI 10.1016/S0045-6535(99)00522-6; Zafra G, 2017, CHEMOSPHERE, V172, P120, DOI 10.1016/j.chemosphere.2016.12.038; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao HP, 2008, J HAZARD MATER, V152, P1293, DOI 10.1016/j.jhazmat.2007.08.008; Zhao JK, 2016, J HAZARD MATER, V318, P90, DOI 10.1016/j.jhazmat.2016.06.055; Zhao Q, 2017, SCI TOTAL ENVIRON, V609, P1238, DOI 10.1016/j.scitotenv.2017.07.249	67	1	1	7	53	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	SEP	2019	26	25					25932	25944		10.1007/s11356-019-05760-4	http://dx.doi.org/10.1007/s11356-019-05760-4			13	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	IU6LT	31273663	Green Published			2022-09-04	WOS:000483698500045
J	Ullah, MF; Ahmad, A; Bhat, SH; Abu-Duhier, FM; Barreto, GE; Ashraf, GM				Ullah, Mohammad Fahad; Ahmad, Aamir; Bhat, Showket Hussain; Abu-Duhier, Faisel M.; Barreto, George E.; Ashraf, Ghulam Md			Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Review						Neurodegenerative disorders; Cognitive impairment; Gender bias; Alzheimer's disease; Parkinson's disease; Huntington's disease; Multiple sclerosis	AMYLOID PRECURSOR PROTEIN; MULTIPLE-SCLEROSIS MECHANISMS; CAG REPEAT INSTABILITY; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; GENE-EXPRESSION; NEUROLOGICAL DISORDERS; ASTROCYTE ACTIVATION	The impact of neurodegenerative disorders in humans has multiple consequences because of the progressive decline in cognitive and physical performances. These disorders have diverse manifestations and are influenced by genetic and lifestyle factors, concurrent health conditions as well as un-modifiable predisposing risk factors, including gender and advanced age. Accumulating evidence indicates a gender-dependent natural bias of neurodegenerative diseases, such as, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, with the ratio of male to female prevalence as well as the severity of the disease differing significantly between the two sexes. This observation has recently garnered much attention and it is now being realized that understanding the sex as a biological variable in the etiology of the neurodegenerative diseases may advance the status of the pathophysiology and treatment strategies while improving the associated decline in cognitive and functional abilities. This review highlights the influence of gender in neurodegenerative disorders and further discusses the sex-specific pre-determined microenvironments that are critical in predisposing the individuals to such disorders.	[Ullah, Mohammad Fahad; Bhat, Showket Hussain; Abu-Duhier, Faisel M.] Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk 71491, Saudi Arabia; [Ahmad, Aamir] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia		Ullah, MF (corresponding author), Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk 71491, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.	m.ullah@ut.edu.sa; gashraf@kau.edu.sa	Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012; Ullah, Mohammad Fahad/AGH-2871-2022	Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Bhat, Ramesa Shafi/0000-0003-2149-6239; Bhat, Dr. Shijaatt Hussain/0000-0002-8735-6792				Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Airas L, 2012, OBSTET MED, V5, P94, DOI 10.1258/om.2012.110014; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer A., 1910, HISTOLOGISCHE HISTOP, P401; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arnold AP, 2003, ANN NY ACAD SCI, V1007, P176, DOI 10.1196/annals.1286.018; Aziz NA, 2011, EUR J MED GENET, V54, pE413, DOI 10.1016/j.ejmg.2011.04.002; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Barth C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00037; Beinhoff U, 2008, J NEUROL, V255, P117, DOI 10.1007/s00415-008-0726-9; Bergamaschi R, 2007, INT REV NEUROBIOL, V79, P423, DOI 10.1016/S0074-7742(07)79019-0; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Bruyn GW, 1968, HDB CLIN NEUROLOGY, V16, P298; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burns A, 2002, LANCET, V360, P1963, DOI 10.1016/S0140-6736(02)11920-9; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Carcaillon L, 2014, ALZHEIMERS DEMENT, V10, pS306, DOI 10.1016/j.jalz.2013.06.006; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chene G, 2015, ALZHEIMERS DEMENT, V11, P310, DOI 10.1016/j.jalz.2013.10.005; Cordeau P, 2008, STROKE, V39, P935, DOI 10.1161/STROKEAHA.107.501460; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Czech DP, 2012, J NEUROCHEM, V122, P260, DOI 10.1111/j.1471-4159.2012.07782.x; de Vries GJ, 2009, HORM BEHAV, V55, P589, DOI 10.1016/j.yhbeh.2009.03.012; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dorsey ER, 2013, NEUROLOGY, V80, P1989, DOI 10.1212/WNL.0b013e318293e2ce; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eldar-Geva T, 1998, HUM REPROD, V13, P9, DOI 10.1093/humrep/13.1.9; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; FORNO LS, 1992, PROG BRAIN RES, V94, P429; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gaignard P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00406; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Georgiev D, 2017, ACTA NEUROL SCAND, V136, P570, DOI 10.1111/ane.12796; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Gillies GE, 2014, NEUROSCIENCE, V282, P69, DOI 10.1016/j.neuroscience.2014.05.033; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; GRADY KL, 1965, J COMP PHYSIOL PSYCH, V59, P176, DOI 10.1037/h0021824; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hall JR, 2013, J ALZHEIMERS DIS, V35, P363, DOI 10.3233/JAD-122359; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039; Hara Y, 2015, PHYSIOL REV, V95, P785, DOI 10.1152/physrev.00036.2014; Harbo HF, 2013, THER ADV NEUROL DISO, V6, P237, DOI 10.1177/1756285613488434; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hong Y, 2016, INT IMMUNOPHARMACOL, V33, P83, DOI 10.1016/j.intimp.2016.02.002; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Irvine K, 2012, J CLIN EXP NEUROPSYC, V34, P989, DOI 10.1080/13803395.2012.712676; Jaber SM, 2018, NEUROCHEM INT, V117, P82, DOI 10.1016/j.neuint.2017.09.003; Joel D, 2017, NEUROPSYCHOPHARMACOL, V42, P379, DOI 10.1038/npp.2016.79; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kancheva R, 2011, NEUROSCIENCE, V191, P22, DOI 10.1016/j.neuroscience.2011.05.054; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Karussis D, 2014, J AUTOIMMUN, V48-49, P134, DOI 10.1016/j.jaut.2014.01.022; Khalid R, 2014, IMMUNOL LETT, V162, P223, DOI 10.1016/j.imlet.2014.09.004; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kovtun IV, 2004, J BIOL CHEM, V279, P9389, DOI 10.1074/jbc.M313080200; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; KREMER B, 1995, AM J HUM GENET, V57, P343; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lemus HN, 2018, NEUROL CLIN, V36, P1, DOI 10.1016/j.ncl.2017.08.002; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Li RN, 2014, MOL CELL ENDOCRINOL, V389, P13, DOI 10.1016/j.mce.2013.12.018; Lin Katherine A, 2015, Alzheimers Dement (N Y), V1, P103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu S, 2013, NEURAL REGEN RES, V8, P2800, DOI 10.3969/j.issn.1673-5374.2013.30.002; LOBO A, NEUROLOGY S5, V54, pS; Luchetti S, 2014, J NEUROPATH EXP NEUR, V73, P123, DOI 10.1097/NEN.0000000000000037; Neto JL, 2017, GENETICS, V205, P503, DOI 10.1534/genetics.116.195578; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maejima T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00040; Mani ST, 2006, BRAIN RES, V1067, P43, DOI 10.1016/j.brainres.2005.10.006; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Maylor EA, 2007, ARCH SEX BEHAV, V36, P235, DOI 10.1007/s10508-006-9155-y; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2017, J NEUROSCI RES, V95, P24, DOI 10.1002/jnr.23809; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Muller CM, 2005, J NEUROPATH EXP NEUR, V64, P623; Munro CA, 2006, BIOL PSYCHIAT, V59, P966, DOI 10.1016/j.biopsych.2006.01.008; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1602/neurorx.1.2.255; Nitkowska M, 2015, ACTA NEUROL SCAND, V131, P411, DOI 10.1111/ane.12334; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Osborn LM, 2016, PROG NEUROBIOL, V144, P121, DOI 10.1016/j.pneurobio.2016.01.001; Palmer K, 2003, BRIT MED J, V326, P245, DOI 10.1136/bmj.326.7383.245; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Paus T, 2010, PROG BRAIN RES, V186, P13, DOI 10.1016/B978-0-444-53630-3.00002-6; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Peper JS, 2009, EUR J ENDOCRINOL, V160, P739, DOI 10.1530/EJE-08-0915; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pidgeon C, 2013, BEHAV NEUROL, V26, P245, DOI [10.1155/2013/705373, 10.3233/BEN-2012-120267]; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Pozzilli C, 2003, EUR J NEUROL, V10, P95, DOI 10.1046/j.1468-1331.2003.00519.x; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Prothero KE, 2009, CHROMOSOME RES, V17, P637, DOI 10.1007/s10577-009-9063-9; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; Putnam K, 2005, J CLIN ENDOCR METAB, V90, P4224, DOI 10.1210/jc.2004-2525; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RAJPUT AH, 1984, ANN NEUROL, V16, P278, DOI 10.1002/ana.410160303; Ramien C, 2016, NEUROSCI BIOBEHAV R, V67, P137, DOI 10.1016/j.neubiorev.2015.12.015; Rawlins MD, 2016, NEUROEPIDEMIOLOGY, V46, P144, DOI 10.1159/000443738; Riccardi P, 2011, SYNAPSE, V65, P99, DOI 10.1002/syn.20822; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Sharma J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-9; Simunovic F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008856; Sintzel MB, 2018, NEUROL THER, V7, P59, DOI 10.1007/s40120-017-0086-4; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Thompson AJ, 2018, LANCET, V391, P1622, DOI 10.1016/S0140-6736(18)30481-1; Tinbergen N., 1951, STUDY INSTINCT; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Uitti RJ, 2005, PARKINSONISM RELAT D, V11, P139, DOI 10.1016/j.parkreldis.2004.10.007; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; Wexler NS, 2012, ANNU REV MED, V63, P1, DOI 10.1146/annurev-med-050710-134457; Wheeler VC, 2007, J MED GENET, V44, P695, DOI 10.1136/jmg.2007.050930; Wong KK, 2012, J CLIN NEUROSCI, V19, P183, DOI 10.1016/j.jocn.2011.05.013; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yokomaku D, 2003, MOL ENDOCRINOL, V17, P831, DOI 10.1210/me.2002-0314; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zagni Emanuela, 2016, Neurosci J, V2016, P2827090, DOI 10.1155/2016/2827090; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zielonka D, 2008, CESK SLOV NEUROL N, V71, P688; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012	164	34	34	4	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	JUL	2019	102						95	105		10.1016/j.neubiorev.2019.04.003	http://dx.doi.org/10.1016/j.neubiorev.2019.04.003			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	IE1EF	30959072				2022-09-04	WOS:000472128000006
J	Muelle, CE; Martinez, AQ				Esguerra Muelle, Camila; Quintana Martinez, Alejandra			"YOUR LIFE IS ALSO MY LAND": DISSONANT SEXUALITIES AND GENDER FUGUES IN LILIANA FELIPE AND JESUSA RODRIGUEZ	CUADERNOS DE MUSICA ARTES VISUALES Y ARTES ESCENICAS			Spanish	Article						multimodal discourse; performativity; heterosexual regime; cisgenerism; exile; artistic practices		This article seeks to do a reflection both on the vital, artistic and political practices of Liliana Felipe and Jesusa Rodriguez and on their experiences of disobedience to the regimes of sexuality and gender, which are articulated to regimes of terror in Mexico and Argentina. The methodology used in order to make this reflection was a Multimodal Critical Discourse Analysis from both an intersectional and decolonial perspective. This methodology implies the analysis of contexts, texts, subtexts and textures that make up the work and life of these artists. From this epistemological position, the performative and musical work of Liliana and Jesusa is seen as a collection of multimodal discourses. Creation, experience - understood as a political locus-and the collective proposals of Liliana and Jesusa are put into play in a field of performative struggle where their disobedient discourses propose ways of resistance to colonial-modern-capitalist regimes of gender and sexuality. Jesusa and Liliana propose a multimodal and multimedial work that fissures the limits of the discursive genres, the musical genres, the grammatical gender and the gender sex system, which deserves an undisciplined look. This article proposes an original approach insofar as it approaches the experience and work of these two women not from a disciplinary view, but from a transdisciplinary, intersectional and decolonial point of view, that assumes artistic production as a political commitment in where the boundaries between the personal and the public are erased.	[Esguerra Muelle, Camila] Univ Nacl Colombia, Bogota, Colombia; [Esguerra Muelle, Camila] Univ Utrecht, Genero & Etnicidad, Utrecht, Netherlands; [Esguerra Muelle, Camila] Univ Carlos III Madrid, Humanidades, Getafe, Spain; [Esguerra Muelle, Camila] Univ Los Andes, Ctr Interdisciplinario Estudios Desarrollo, Santiago, Chile; [Quintana Martinez, Alejandra] Pontificia Univ Javeriana, Mus Enfasis Hist, Bogota, Colombia; [Quintana Martinez, Alejandra] Pontificia Univ Javeriana, Bogota, Colombia		Muelle, CE (corresponding author), Univ Nacl Colombia, Bogota, Colombia.; Muelle, CE (corresponding author), Univ Utrecht, Genero & Etnicidad, Utrecht, Netherlands.; Muelle, CE (corresponding author), Univ Carlos III Madrid, Humanidades, Getafe, Spain.; Muelle, CE (corresponding author), Univ Los Andes, Ctr Interdisciplinario Estudios Desarrollo, Santiago, Chile.							Alzate Gaston A., 2013, LECT GENRE, V11, P86; ANZALDUA GLORIA, 1987, BORDERLANDS; Austin John, 1982, COMO HACER COSAS CON; Boswell John, 1993, CRISTIANISMO TOLERAN; Bradford Marcus, 2000, EVENING SALON MEXICO; Bradley K., 1998, ESCLAVITUD SOC ROMA; Bradley K. R., 1991, DISCOVERING ROMAN FA; Brouillet Pierre Andre, 1887, LECCION CLIN SALPETR; Crenshaw Kimberle, 1994, PUBLIC NATURE PRIVAT, P93, DOI DOI 10.3917/CDGE.039.0051; Cusick S., 1994, QUEERING PITCH NEW G, P67; De Lauretis Teresa, 2004, PENAR GENERO, P202; Didi-Huberman G., 2007, INVENCION HISTERIA C; Dixon Suzanne, 1992, THE ROMAN FAMLY; Doty Alexander, 1997, DEBATE FEMINISTA RAR, V16, P98; Echeverria B., 2010, MODERNIDAD BLANQUITU; Echeverria Bolivar, 1998, MODERNIDAD BARROCO; Encuentro, 2013, HIST DEB L FEL; Espinosa Minoso Y, 2010, APROXIMACIONES CRITI; Femenías María Luisa, 2007, Rev. Estud. Fem., V15, P11; Garcia Canclini N., 1990, CULTURAS H BRIDAS ES; Gargallo Cellentani Francesca, 2012, FEMINISMOS ABYA YALA; Guy Donna, 1994, SEXO PELIGROSO PROST; Hall S, 1997, REPRESENTATION; KRESS Gunther, 2001, MULTIMODAL DISCOURSE; Lazar MM, 2008, HANDB APPL LINGUIST, V4, P89; Liliana Felipe, 2005, TANGACHOS; Liliana Felipe, 1983, LILIANA 2 CON ORQUES; Liliana Felipe, 2010, REV N           1210; Liliana Felipe, 2010, ABSENTA MUSICAL BAND, V1, P11; Liliana Felipe, 2001, NACION; Liliana Felipe, 2006, MATAR O NO MATAR; Liliana Felipe, 2006, LA VOZ ONLINE   0312; Liliana Felipe, 2002, TRUCHO; LUGONES MARÍA, 2008, Tabula Rasa, P73; Margulis Mario, 1977, DEMOGRAFIA EC, V11, P326; Mbembe A, 2003, PUBLIC CULTURE, V15, P11, DOI 10.1215/08992363-15-1-11; McClary Susan, 1991, FEMININE ENDINGS GEN; Molina Ramirez Tania, 2009, LA JORNADA      0905; Montiel Martos, 1996, LESBOS CON AMOR HOMO; Nielsen C. S., 2005, INT STUDIES MANAGEME, V35, P8, DOI DOI 10.1080/00208825.2005.11043741; Parker SB, 2008, STUD MUSICOL, V49, P407, DOI 10.1556/SMus.49.2008.3-4.10; Rivera Cusicanqui S., 2010, CHIXINAKAX UTXIWA RE; Rodriguez Jesusa, 2008, NEW WORLD THEAT INT; Salisbury Joyce S., 1994, PADRES IGLESIA VIRGE; Savigliano Marta E., 1995, TANGO POLITICAL EC P; Segato Rita Laura, 2013, CIUDAD JUAREZ TERRIT, P11; The White House, 2001, COMMUNICATION; van Dijk T., 1999, ANALISIS CRITICO DIS; VAN DIJK Teun A., 2001, METODOS ANALISIS CRI, P143; Wittig Monique, 1992, STRAIGHT MIND OTHER; [No title captured]	51	0	0	0	0	PONTIFICIA UNIV JAVERIANA, FAC ARTES	BOGOTA	CARRERA 7 NO 40-62, EDIF PABLO VI PISO 2, BOGOTA, 00000, COLOMBIA	1794-6670	2215-9959		CUAD MUSIC ARTES ESC	Cuad. Music Artes Escen.	JAN-JUN	2018	13	1					61	84		10.11144/javeriana.mavae13-1.tvte	http://dx.doi.org/10.11144/javeriana.mavae13-1.tvte			24	Humanities, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Arts & Humanities - Other Topics	GI3VB		Green Submitted, Bronze			2022-09-04	WOS:000434298600004
J	Florez, D; Diez, R; Piquet, H				Florez, David; Diez, Rafael; Piquet, Hubert			Optimizing the Operation of DBD Excilamps	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Current control; dielectric barrier discharge (DBD); excimer lamp; ultraviolet (UV)	DIELECTRIC BARRIER DISCHARGE; POWER; LAMP; EFFICIENCY; VOLTAGE; IDENTIFICATION; PARAMETERS; EXCITATION; RADIATION; EXCIPLEX	Dielectric barrier discharge (DBD) excimer lamps are efficient and environmentally friendly sources of ultraviolet (UV). One of the challenges for this technology to be massively adopted is the optimization and effective management of the overall lamp-supply system. Accordingly, a methodology to study the impact of the operating point over the performance and operation of a DBD UV excilamp is developed and experimentally validated. The DBD operating point is parametrically adjusted by means of the power supply current with three independent variables: intensity, frequency, and duty cycle. This methodology allows the determination of the optimal operating point for the particular excilamp under study. These supplying conditions will be later achieved by means of a dedicated electrical generator, which has to be especially designed according to these specifications. It is found that an increment in the current intensity has a positive impact on the lamp efficiency and also leads to the existence of more filamentary discharges. Also, a relation between the energy of the pulse supplied to the DBD and the reactor efficiency can be established. For certain levels of UV power, energy savings on the reactor higher than 50% are attained by proper selection of the operating point.	[Florez, David] Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota 110221, Colombia; [Diez, Rafael] Pontificia Univ Javeriana, Dept Elect Engn, Bogota 110231, Colombia; [Piquet, Hubert] Univ Toulouse 3, Inst Natl Polytech Toulouse, CNRS, Lab Plasma & Convers Energie, F-31071 Toulouse, France		Florez, D (corresponding author), Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota 110221, Colombia.	david.florez@usa.edu.co; rdiez@javeriana.edu.co; hubert.piquet@laplace.univ-tlse.fr	Piquet, Hubert/D-4396-2013	Piquet, Hubert/0000-0002-3736-2676; Diez, Rafael/0000-0002-8107-2844	Colciencias [663-2015]; ECOS Nord Program [C16P01]; Pontificia Universidad Javeriana [6794]; Universidad Sergio Arboleda [IN.BG.086.16.013]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ECOS Nord Program; Pontificia Universidad Javeriana; Universidad Sergio Arboleda	This work was supported in part by Colciencias under Project 663-2015, in part by the ECOS Nord Program under Project C16P01, in part by the Pontificia Universidad Javeriana under Project 6794, and in part by the Universidad Sergio Arboleda under Project IN.BG.086.16.013.	Amjad M, 2013, IEEE T POWER ELECTR, V28, P650, DOI 10.1109/TPEL.2012.2202130; Boichenko AM, 2004, LASER PHYS, V14, P1036; Bonnin X, 2013, EUR PHYS J-APPL PHYS, V64, DOI 10.1051/epjap/2013130080; Carman RJ, 2003, J PHYS D APPL PHYS, V36, P19, DOI 10.1088/0022-3727/36/1/304; Carman RJ, 2004, J PHYS D APPL PHYS, V37, P2399, DOI 10.1088/0022-3727/37/17/010; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez R., 2009, P 35 ANN C IEEE IND, P3500; Florez D., 2014, THESIS; Florez D, 2015, IEEE T IND ELECTRON, V62, P1451, DOI 10.1109/TIE.2014.2361601; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Gouri R, 2013, IEEE T DIELECT EL IN, V20, P1540, DOI 10.1109/TDEI.2013.6633681; Guivan MM, 2010, IEEE T PLASMA SCI, V38, P1972, DOI 10.1109/TPS.2010.2044588; Hoft H, 2014, IEEE T PLASMA SCI, V42, P2336, DOI 10.1109/TPS.2014.2309595; Jeong J, 2007, CHEMOSPHERE, V68, P2007, DOI 10.1016/j.chemosphere.2007.01.044; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Doanh LT, 2013, IEEE T IND APPL, V49, P331, DOI 10.1109/TIA.2012.2228835; Lomaev MI, 2012, J OPT TECHNOL+, V79, P498, DOI 10.1364/JOT.79.000498; Lomaev MI, 2012, PROG QUANT ELECTRON, V36, P51, DOI 10.1016/j.pquantelec.2012.03.003; Lomaev MI, 2003, PHYS-USP+, V46, P193, DOI 10.1070/PU2003v046n02ABEH001308; Lopez AM, 2013, IEEE T PLASMA SCI, V41, P2335, DOI 10.1109/TPS.2013.2273462; Monge-Dauge C, 2012, IEEE T PLASMA SCI, V40, P2254, DOI 10.1109/TPS.2012.2207407; Panousis E, 2009, IEEE T DIELECT EL IN, V16, P734, DOI 10.1109/TDEI.2009.5128513; Park SH, 2009, IEEE T PLASMA SCI, V37, P1611, DOI 10.1109/TPS.2009.2025170; Piquet H, 2010, IEEE T PLASMA SCI, V38, P2531, DOI 10.1109/TPS.2010.2060735; Plaksin VY, 2008, J KOREAN PHYS SOC, V53, P2607, DOI 10.3938/jkps.53.2607; Razhev AM, 2008, QUANTUM ELECTRON+, V38, P1005, DOI 10.1070/QE2008v038n11ABEH013762; Zhang C, 2010, IEEE T PLASMA SCI, V38, P1517, DOI 10.1109/TPS.2010.2045660	27	5	6	1	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	JUL	2016	44	7					1160	1168		10.1109/TPS.2016.2568461	http://dx.doi.org/10.1109/TPS.2016.2568461			9	Physics, Fluids & Plasmas	Science Citation Index Expanded (SCI-EXPANDED)	Physics	DR6TQ		Green Submitted			2022-09-04	WOS:000380034600015
J	Moreno, CA; Rosenthal, VD; Olarte, N; Gomez, WV; Sussmann, O; Agudelo, JG; Rojas, C; Osorio, L; Linares, C; Valderrama, A; Mercado, PG; Bernate, PHA; Vergara, GR; Pertuz, AM; Mojica, BE; Navarrete, MDPT; Romero, ASA; Henriquez, D				Moreno, Carlos Alvarez; Rosenthal, Victor D.; Olarte, Narda; Gomez, Wilmer Villamil; Sussmann, Otto; Agudelo, Julio Garzon; Rojas, Catherine; Osorio, Laline; Linares, Claudia; Valderrama, Alberto; Mercado, Patricia Garrido; Bernate, Patrick Hernan Arrieta; Vergara, Guillermo Ruiz; Pertuz, Alberto Marrugo; Mojica, Beatriz Eugenia; Navarrete, Maria del Pilar Torres; Romero, Ana Sofia Alonso; Henriquez, Daibeth			Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: Findings of the international nosocomial infection control consortium	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							BLOOD-STREAM INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; URINARY-TRACT-INFECTION; PERFORMANCE FEEDBACK; ATTRIBUTABLE MORTALITY; CONTROL PROGRAM; SURVEILLANCE; LENGTH; STAY; ARGENTINA	objective. To perform active targeted prospective surveillance to measure device-associated infection (DAI) rates, attributable mortality due to DAI, and the microbiological and antibiotic resistance profiles of infecting pathogens at 10 intensive care units (ICUs) in 9 hospitals in Colombia, all of which are members of the International Infection Control Consortium. methods. We conducted prospective surveillance of healthcare-associated infection in 9 hospitals by using the definitions of the US Centers for Disease Control and Prevention National Nosocomial Surveillance System (NNIS). DAI rates were calculated as the number of infections per 100 ICU patients and per 1,000 device-days. results. During the 3-year study, 2,172 patients hospitalized in an ICU for an aggregate duration of 14,603 days acquired 266 DAIs, for an overall DAI rate of 12.2%, or 18.2 DAIs per 1,000 patient-days. Central venous catheter ( CVC) - related bloodstream infection ( BSI) (47.4% of DAIs; 11.3 cases per 1,000 catheter-days) was the most common DAI, followed by ventilator-associated pneumonia (VAP) ( 32.3% of DAIs; 10.0 cases per 1,000 ventilator-days) and catheter-associated urinary tract infection (CAUTI) (20.3% of DAIs; 4.3 cases per 1,000 catheter-days). Overall, 65.4% of all Staphylococcus aureus infections were caused by methicillin-resistant strains; 40.0% of Enterobacteriaceae isolates were resistant to ceftriaxone and 28.3% were resistant to ceftazidime; and 40.0% of Pseudomonas aeruginosa isolates were resistant to fluoroquinolones, 50.0% were resistant to ceftazidime, 33.3% were resistant to piperacillin-tazobactam, and 19.0% were resistant to imipenem. The crude unadjusted attributable mortality was 16.9% among patients with VAP ( relative risk [RR], 1.93; 95% confidence interval [CI], 1.24- 3.00;); 18.5 among those with CVC- associated BSI ( RR, 2.02; 95% CI, 1.42- 2.87;); and 10.5% among Pp. 002 P = .002 those with CAUTI ( R, 1.58; 95% CI, 0.78- 3.18;). Pp. 19 conclusion. The rates of DAI in the Colombian ICUs were lower than those published in some reports from other Latin American countries and were higher than those reported in US ICUs by the NNIS. These data show the need for more-effective infection control interventions in Colombia.	Coll Med, RA-1405 Buenos Aires, DF, Argentina; Univ Simon Bolivar, Bogota, Colombia; Pontificia Javeriana Univ, San Ignacio Hosp, Bogota, Colombia; Tunal ESE Hosp, Bogota, Colombia; La Nueva Med Ctr, Bogota, Colombia; La Nueva Med Ctr, Bogota, Colombia; Videlmed Med Ctr, Bogota, Colombia; Olaya Med Ctr, Bogota, Colombia; Dept Infect Control & Epidemiol, Bogota, Colombia; Santa Maria Med Ctr, Sucre, Colombia		Rosenthal, VD (corresponding author), Coll Med, Arengreen 1366, RA-1405 Buenos Aires, DF, Argentina.	victor_rosenthal@fibertel.com.ar	Moreno, carlos Arturo alvarez/P-6678-2016	Moreno, carlos Arturo alvarez/0000-0001-5419-4494; ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; Arias CA, 2003, J ANTIMICROB CHEMOTH, V51, P59, DOI 10.1093/jac/dkg002; BERG DE, 1995, CLIN INFECT DIS, V21, P588, DOI 10.1093/clinids/21.3.588; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Diener J R, 1996, Rev Assoc Med Bras (1992), V42, P205; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1994, INFECT CONT HOSP EP, V15, P428; FREEMAN R, 1991, J HOSP INFECT, V18, P299, DOI 10.1016/0195-6701(91)90036-8; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gastmeier P, 1998, J HOSP INFECT, V38, P51, DOI 10.1016/S0195-6701(98)90174-8; GOMEZ WV, PROGR ABSTR ASS PROF; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; HIGUERA MRF, 2005, P ABSTR 15 ANN SOC H; HUGHES JM, 1988, CHEMOTHERAPY, V34, P553, DOI 10.1159/000238624; Hugonnet S, 2004, CURR OPIN INFECT DIS, V17, P329, DOI 10.1097/01.qco.0000136931.83167.d2; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Kurlat I, 1998, J HOSP INFECT, V40, P149, DOI 10.1016/S0195-6701(98)90094-9; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; Lopes JMM, 2002, AM J INFECT CONTROL, V30, P1, DOI 10.1067/mic.2002.117039; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; Martinez-Aguilar G, 2001, SALUD PUBLICA MEXICO, V43, P515, DOI 10.1590/S0036-36342001000600001; Mittal Nalini, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P365; O'Grady NP, 2002, AM J INFECT CONTROL, V30, P476, DOI 10.1067/mic.2002.129427; OROPEZA MS, 2005, PROGR ABSTR 15 ANN S; Orsi GB, 2002, INFECT CONT HOSP EP, V23, P190, DOI 10.1086/502034; PITTET D, 1994, SCHWEIZ MED WSCHR, V124, P227; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; PITTET D, 1996, CURR INFECT DIS REP, V153, P684; Reed CS, 2003, J HOSP INFECT, V54, P267, DOI 10.1016/S0195-6701(03)00148-8; Rezende EM, 1998, INFECT CONT HOSP EP, V19, P872, DOI 10.1086/647751; Richards MJ, 1998, AM J CARDIOL, V82, P789, DOI 10.1016/S0002-9149(98)00450-0; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016/j.ajic.2005.11.002; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P157, DOI 10.1016/j.ajic.2004.08.008; Rosenthal VD, 2004, AM J INFECT CONTROL, V32, P135, DOI 10.1016/j.ajic.2003.12.002; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P47, DOI 10.1086/502291; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P85, DOI 10.1067/mic.2003.63; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; SALOMAO R, 2005, PROGR ABSTR ASS PROF; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tinoco JC, 1997, SALUD PUBLICA MEXICO, V39, P25, DOI 10.1590/S0036-36341997000100005; Velasco E, 1997, AM J INFECT CONTROL, V25, P458, DOI 10.1016/S0196-6553(97)90067-5; VILLANOVA P, 1997, M7A4 NAT COMM CLIN L; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639	54	84	94	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	APR	2006	27	4					349	356		10.1086/503341	http://dx.doi.org/10.1086/503341			8	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	204IB	16622811				2022-09-04	WOS:000249036100005
J	Mejia-Arango, S; Garcia-Cifuentes, E; Samper-Ternent, R; Borda, MG; Cano-Gutierrez, CA				Mejia-Arango, Silvia; Garcia-Cifuentes, Elkin; Samper-Ternent, Rafael; Borda, Miguel G.; Cano-Gutierrez, Carlos A.			Socioeconomic Disparities and Gender Inequalities in Dementia: a Community-Dwelling Population Study from a Middle-Income Country	JOURNAL OF CROSS-CULTURAL GERONTOLOGY			English	Article						Colombia; Dementia; Gender-based; Gender disparity; Latin America; Socioeconomic disparity	MONTREAL COGNITIVE ASSESSMENT; ALZHEIMERS-DISEASE; INSTRUMENTAL ACTIVITIES; CARDIOVASCULAR HEALTH; SEX-DIFFERENCES; SCREENING TOOL; LATIN-AMERICA; AIR-POLLUTION; PREVALENCE; ASSOCIATION	The proportion of the world's older adults and of its dementia cases is increasing in low and middle-income countries. This is particularly true in Colombia. There, the number of individuals with dementia may increase five-fold by 2050. Yet research is lacking on dementia in such settings. This work estimates the prevalence of dementia in a community-dwelling population in Colombia. It also assesses how gender-based differences in cardiovascular conditions and socioeconomic disparities affect dementia. This work analyzes data on 2000 respondents at least 60 years of age in the Health, Well-Being, And Aging (SABE) study in Bogota. Respondents with dementia are those who have cognitive impairment and at least two limitations in instrumental activities of daily living. The SABE study finds 8.4% of respondents have dementia. Age, cardiovascular risks, and socioeconomic disparities contributed to higher odds of dementia. The contributors to dementia can differ for men and women. For example, socioeconomic disparities were a larger contributor to dementia for women than men. The findings support the cognitive reserve hypothesis on dementia. This holds that pre-existing cognitive processes and compensatory mechanisms influence dementia. Women in Latin America are more likely to suffer from socioeconomic disparities that limit their cognitive reserve. This research points to several policy implications that can help offset these disparities and reduce the prevalence of dementia.	[Mejia-Arango, Silvia] Colegio Frontera Norte, Dept Populat Studies, Carretera Escenica Km 18-5 San Antonio del Mar, Tijuana 22560, Baja California, Mexico; [Garcia-Cifuentes, Elkin; Borda, Miguel G.; Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Bogota, Colombia; [Garcia-Cifuentes, Elkin; Borda, Miguel G.; Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Samper-Ternent, Rafael] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Borda, Miguel G.; Cano-Gutierrez, Carlos A.] Hosp Univ San Ignacio, Unidad Geriatria, Bogota, Colombia; [Borda, Miguel G.] Stavanger Univ Hosp, Ctr Age Related Dis, Stavanger, Norway		Mejia-Arango, S (corresponding author), Colegio Frontera Norte, Dept Populat Studies, Carretera Escenica Km 18-5 San Antonio del Mar, Tijuana 22560, Baja California, Mexico.	smejia@colef.mx	Borda, Miguel German/AHB-5593-2022; Garcia-Cifuentes, Elkin/AAC-6077-2021	Borda, Miguel German/0000-0001-5832-0603; Garcia-Cifuentes, Elkin/0000-0003-4214-0266; Samper-Ternent, Rafael/0000-0002-2250-9401; Mejia, Silvia/0000-0002-6416-1159	Administrative Department of Science, Technology and Innovation in Colombia [Colciencias] [12035431692]; Pontificia Universidad Javeriana	Administrative Department of Science, Technology and Innovation in Colombia [Colciencias]; Pontificia Universidad Javeriana	Research was completed with funding from the Administrative Department of Science, Technology and Innovation in Colombia [Colciencias]. Code 12035431692 and the Pontificia Universidad Javeriana.	Ailshire JA, 2014, AM J EPIDEMIOL, V180, P359, DOI 10.1093/aje/kwu155; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Alvarado BE, 2002, AGING CLIN EXP RES, V14, P132, DOI 10.1007/BF03324426; ALZATE Maria Cristina, 2006, ESTRATIFICACION SOCI; Andrianopoulos Vasileios, 2017, Breathe (Sheff), V13, pe1, DOI 10.1183/20734735.001417; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Babulal GM, 2019, ALZHEIMERS DEMENT, V15, P292, DOI 10.1016/j.jalz.2018.09.009; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Borda MB, 2015, J NEUROL SCI, V357, pE121, DOI 10.1016/j.jns.2015.08.390; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Cano Sara M, 2016, Rev. Fac. Nac. Salud Pública, V34, P48, DOI 10.17533/udea.rfnsp.v34n1a06; Crimmins EM, 2018, J GERONTOL B-PSYCHOL, V73, pS20, DOI 10.1093/geronb/gbx135; Custodio N, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00221; Diaz-Cabezas R, 2006, REV NEUROLOGIA, V43, P646, DOI 10.33588/rn.4311.2005774; ECLAC/ILO (Economic Commission for Latin America and the Caribbean/International Labour Organization), 2018, EMPL SIT LAT AM CAR; Estrada A, 2017, USO ESTUFAS EFICIENT; Feng Z., 2019, ENCY GERONTOLOGY POP; Gatto NM, 2014, NEUROTOXICOLOGY, V40, P1, DOI 10.1016/j.neuro.2013.09.004; Gil L, 2015, INT J GERIATR PSYCH, V30, P655, DOI 10.1002/gps.4199; Golub E., 2014, ENV WATER RESOURCES; Gutierrez C.A.C., 2010, ACTA NEUROL COLOMB, V26, P112; Jayachandran S, 2015, ANNU REV ECON, V7, P63, DOI 10.1146/annurev-economics-080614-115404; Kim Dasom, 2018, Chronic Dis Transl Med, V4, P75, DOI 10.1016/j.cdtm.2018.03.003; Koyanagi A, 2018, J AM GERIATR SOC, V66, P721, DOI 10.1111/jgs.15288; Kulshreshtha A, 2019, CURR EPIDEMIOL REP, V6, P347, DOI 10.1007/s40471-019-00210-8; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liu S, 2010, PUBLIC HEALTH REV, V32, P489, DOI 10.1007/BF03391613; Llibre R., 2008, LANCET, V372, P464, DOI DOI 10.1016/S0140-6736(08)61002-8; Maestre GE, 2012, CURR NEUROL NEUROSCI, V12, P511, DOI 10.1007/s11910-012-0300-9; Mazure CM, 2016, LANCET NEUROL, V15, P451, DOI 10.1016/S1474-4422(16)00067-3; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Mendez DM, 2015, REV CS CIENC SOC, V15, P142, DOI 10.18046/recs.i15.1963; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430; Oudin A, 2016, ENVIRON HEALTH PERSP, V124, P306, DOI 10.1289/ehp.1408322; Parker S., 2000, GENDER DIFFERENCES E; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Pot A., 2013, BUPA ADI REPORT IMPR; Pradilla Ardila Gustavo, 2002, Rev. méd. Chile, V130, P191; PRADILLA G, 2003, REV PANAM SALUD PUBL, V14, P2, DOI DOI 10.1590/S1020-49892003000700005; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Saenz JL, 2018, J EPIDEMIOL COMMUN H, V72, P21, DOI 10.1136/jech-2017-209704; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Samper-Ternent R, 2017, AGING CLIN EXP RES, V29, P265, DOI 10.1007/s40520-016-0561-2; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2017, BRAIN IMAGING BEHAV, V11, P410, DOI 10.1007/s11682-016-9566-x; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Subramanian M, 2014, NATURE, V509, P548, DOI 10.1038/509548a; UPME, 2019, PROGR SUST PROGR LEN; Yaffe K, 2018, JAMA INTERN MED, V178, P281, DOI 10.1001/jamainternmed.2017.7299; Zunzunegui MV, 2009, SOC SCI MED, V68, P235, DOI 10.1016/j.socscimed.2008.10.031	56	4	4	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0169-3816	1573-0719		J CROSS-CULT GERONTO	J. Cross-Cult. Gerontol.	MAR	2021	36	1					105	118		10.1007/s10823-020-09418-4	http://dx.doi.org/10.1007/s10823-020-09418-4		NOV 2020	14	Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	QP6MY	33247379				2022-09-04	WOS:000593413100001
J	Garcia-Perdomo, HA; Echeverria-Garcia, F; Lopez, H; Fernandez, N; Manzano-Nunez, R				Garcia-Perdomo, H. A.; Echeverria-Garcia, F.; Lopez, H.; Fernandez, N.; Manzano-Nunez, R.			Pharmacologic interventions to treat renal colic pain in acute stone episodes: Systematic review and meta-analysis	PROGRES EN UROLOGIE			English	Review						Renal colic; Pain; Pain management; Urology	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DOUBLE-BLIND; EMERGENCY-DEPARTMENT; DICLOFENAC SODIUM; KETOROLAC; PETHIDINE; MORPHINE; MANAGEMENT; DIPYRONE; ANALGESIA	Objective. - To assess effectiveness of pharmacologic interventions to relieve pain in patients suffering an acute stone episode. Methods. - Relevant trials that included patients with acute renal colic and radiological findings of urinary stones were identified in four databases. The main outcome was pain relief evaluated by Visual Analogue Scale score (VAS). Results. - In overall, diclofenac was superior to other NSAIDs for pain relief (MD of -12.57 [95% CI: -19.26, -5.88]). Paracetamol was superior to morphine for pain reduction at 30 minutes (MD of -3.92 [95% CI: -6.41, -1.43]) and also to placebo at 15 minutes (MD of -24.77 [95% CI: -33.19, -16.35]) and at 30 minutes (MD of 16 [95% CI:-29, -2.96]) after drug administration. Finally, diclofenac was superior to paracetamol for pain reduction at 60 (MD of 6.60 [95% CI: 4.37, 8.83]) and 90 minutes (MD of 3.4 [95% CI: 2.01, 4.79]). Conclusions. - Diclofenac was superior to other NSAIDs and paracetamol for diminishing pain in patients suffering an acute stone episode. Paracetamol was superior to morphine and placebo for short pain relief. Future trials should address the role of paracetamol in the management of pain in patients suffering an acute stone episode. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Garcia-Perdomo, H. A.; Echeverria-Garcia, F.] Univ Valle, Calle 13 100-00, Cali, Colombia; [Garcia-Perdomo, H. A.] Univ Libre Cali, Diagonal 37A 3-29, Cali, Colombia; [Manzano-Nunez, R.] Fdn Valle Lili, Cra 98 18-49, Cali, Colombia; [Lopez, H.] Univ Rosario, Calle 12C 6-25, Bogota, Colombia; [Fernandez, N.] Univ Javeriana, Carrera 7 40-62, Bogota, Colombia		Manzano-Nunez, R (corresponding author), 760001 Fdn Valle Lili, Cra 98 18-49, Cali, Colombia.	ramiro.manzano@correounivalle.edu.co	García-Perdomo, Herney A/G-9701-2013; Lopez Ramos, Hugo Enrique/D-3527-2017	García-Perdomo, Herney A/0000-0001-6945-8261; Manzano Nunez, Ramiro/0000-0001-7444-9634; Lopez Ramos, Hugo Enrique/0000-0002-5895-3029				Altay B, 2007, UROL INT, V79, P73, DOI 10.1159/000102918; Azizkhani R, 2013, J RES MED SCI, V18, P772; Bektas F, 2009, ANN EMERG MED, V54, P568, DOI 10.1016/j.annemergmed.2009.06.501; Bovill JG, 1997, EUR J ANAESTH, V14, P9, DOI 10.1097/00003643-199705001-00003; Cohen E, 1998, EUR J CLIN PHARMACOL, V54, P455, DOI 10.1007/s002280050492; Cordell WH, 1996, ANN EMERG MED, V28, P151, DOI 10.1016/S0196-0644(96)70055-0; Diniz DHMP, 2007, BRAZ J MED BIOL RES, V40, P949, DOI 10.1590/S0100-879X2007000700009; Diniz DHMP, 2007, NEPHRON CLIN PRACT, V106, P91, DOI 10.1159/000102995; Diniz DHMP, 2006, J UROLOGY, V176, P2483, DOI 10.1016/j.juro.2006.07.156; El Khebir M, 2009, PROG UROL, V19, P462, DOI 10.1016/j.purol.2009.03.005; FINLAY IG, 1982, BMJ-BRIT MED J, V284, P1830, DOI 10.1136/bmj.284.6332.1830; Fraga A, 2003, CLIN DRUG INVEST, V23, P701, DOI 10.2165/00044011-200323110-00002; Gagnier JJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-111; Glina S, 2011, INT BRAZ J UROL, V37, P697, DOI 10.1590/S1677-55382011000600003; Graham A, 2011, EMERG MED CLIN N AM, V29, P519, DOI 10.1016/j.emc.2011.04.007; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Higgins J., 2011, JOHN WILEY SONS; Holdgate A, 2004, BRIT MED J, V328, P1401, DOI 10.1136/bmj.38119.581991.55; Hozo S.P., 2005, BMC MED RES METHODOL, V5, P13, DOI [DOI 10.1186/1471-2288-5-13, 10.1186/1471-2288-5-13]; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; MARTHAK KV, 1991, CURR MED RES OPIN, V12, P366, DOI 10.1185/03007999109111506; McGettigan P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001388; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; OOSTERLINCK W, 1990, J CLIN PHARMACOL, V30, P336, DOI 10.1002/j.1552-4604.1990.tb03603.x; Pasero C, 2012, PAIN MANAG NURS, V13, P107, DOI [10.1016/j.pmn.2012.03.002, 10.1016/j.pmn.2012.63.002]; Pathan SA, 2016, LANCET, V387, P1999, DOI 10.1016/S0140-6736(16)00652-8; Phillips E, 2009, J ENDOUROL, V23, P1021, DOI 10.1089/end.2008.0615; Picard P, 1997, PAIN, V73, P401, DOI 10.1016/S0304-3959(97)00128-0; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Preminger Glenn M, 2007, AM UROL ASS, P1; Safdar B, 2006, ANN EMERG MED, V48, P173, DOI 10.1016/j.annemergmed.2006.03.013; Sanchez-Carpena J, 2003, CLIN DRUG INVEST, V23, P139, DOI 10.2165/00044011-200323030-00001; Sanchez-Carpena J, 2007, EUR J CLIN PHARMACOL, V63, P751, DOI 10.1007/s00228-007-0322-4; SANDHU DPS, 1994, BRIT J UROL, V74, P690, DOI 10.1111/j.1464-410X.1994.tb07107.x; Serinken M, 2012, EMERG MED J, V29, P902, DOI 10.1136/emermed-2011-200165; SOMMER P, 1989, BRIT J UROL, V63, P4, DOI 10.1111/j.1464-410X.1989.tb05112.x; STANKOV G, 1994, WORLD J UROL, V12, P155; Supervia A, 1998, BRIT J UROL, V81, P27; Trinchieri Alberto, 2008, Arch Ital Urol Androl, V80, P1; Turk C, 2016, EUR ASS UROL; WALDEN M, 1993, SCAND J UROL NEPHROL, V27, P323, DOI 10.3109/00365599309180441; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wook Jin Choi M.D., 2011, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V22, P151; Wright PJ, 2002, BMJ-BRIT MED J, V325, P1408, DOI 10.1136/bmj.325.7377.1408	44	9	9	0	9	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	1166-7087	2405-5131		PROG UROL	Prog. Urol.	OCT	2017	27	12					654	665		10.1016/j.purol.2017.05.011	http://dx.doi.org/10.1016/j.purol.2017.05.011			12	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	FL0FT	28651994				2022-09-04	WOS:000413887700008
J	Blair, MW; Herrera, AL; Sandoval, TA; Caldas, GV; Filleppi, M; Sparvoli, F				Blair, Matthew W.; Herrera, Andrea Lorena; Alejandro Sandoval, Tito; Caldas, Gina Viviana; Filleppi, Marizia; Sparvoli, Francesca			Inheritance of seed phytate and phosphorus levels in common bean (Phaseolus vulgaris L.) and association with newly-mapped candidate genes	MOLECULAR BREEDING			English	Article						Phytates; IP6; Phytic acid; Total seed phosphorus; QTL; MIPSs; MIPSv; IPKs; ITPK	PHYTIC ACID MUTANT; MOLECULAR CHARACTERIZATION; NUTRITIONAL QUALITY; MINERAL-CONTENT; QTL ANALYSIS; GLYCINE-MAX; ZINC; IRON; LINKAGE; BIOAVAILABILITY	Common bean (Phaseolus vulgaris L.) is an important, high-quality staple food that provides large amounts of protein and mineral micronutrients to the diets of people in many countries. Phytates are a storage form of organic phosphorus which is used by the plant in various stages of growth and development but can have certain anti-nutrient properties due to chelation of minerals such as iron and zinc. At the same time, phytates provide certain health benefits and therefore are the subject of both mutagenesis and breeding programs for functional foods. The objective of this study was to evaluate the quantitative trait loci (QTL) associated with seed phytate and seed phosphorus concentration and content on a per-seed basis and to develop functional molecular markers for genes from the phytic acid synthesis pathway. We used a well-characterized mapping population, DOR364 x G19833, in three field experiments with three repetitions each and two levels of soil phosphorus fertilization, as well as a large set of previously and newly developed primer pairs for the genes myo-inositol (3)P-1 synthase, myo-inositol kinase and various inositol kinases. We identified an association of phytate concentration QTL with one of two paralogs of the myo-inositol (3)P-1 synthase gene family, located on linkage group b01 and expressed in common bean seed rather than in vegetative tissues. We also identified QTL for phytate concentration on linkage group b06 and phytate content on linkage groups b03, b04 and b10. We provide a synteny analysis based on common bean versus soybean genome comparisons of all the phytic acid pathway genes that were genetically mapped and indicate flanking markers that can be used for marker-assisted selection when the genes themselves are not polymorphic as PCR amplicons. We can conclude that natural variability in phytate levels is controlled by the seed-expressed myo-inositol (3)P-1 synthase gene (MIPS) as well as other loci in the common bean genome. This means that breeding of phytate levels in common bean must take into account allele variability at certain candidate genes, such as this seed MIPS gene, a recently cloned ABC trasnporter and additional QTL for the trait, which underlie the oligogenic inheritance for phytate concentration in common bean.	[Blair, Matthew W.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Herrera, Andrea Lorena] Ohio State Univ, Dept Agron, Wooster, OH USA; [Alejandro Sandoval, Tito] Univ Javeriana, Dept Biol, Bogota, Colombia; [Caldas, Gina Viviana] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Filleppi, Marizia; Sparvoli, Francesca] CNR, Inst Biol & Biotecnol Agr, Milan, Italy		Blair, MW (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, 242 Emerson Hall, Ithaca, NY 14853 USA.	mwblair2011@gmail.com	Sparvoli, Francesca/G-8372-2015	Sparvoli, Francesca/0000-0002-3304-7548; Sandoval Medina, Tito/0000-0003-2705-5282				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariza-Nieto M, 2007, J AGR FOOD CHEM, V55, P7950, DOI 10.1021/jf070023y; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2009, CROP SCI, V49, P237, DOI 10.2135/cropsci2008.05.0246; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Bouis HE, 2003, P NUTR SOC, V62, P403, DOI 10.1079/PNS2003262; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campion B, 2009, THEOR APPL GENET, V118, P1211, DOI 10.1007/s00122-009-0975-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Cichy KA, 2005, CROP SCI, V45, P864, DOI 10.2135/cropsci2004.0104; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; Coelho Cileide Maria Medeiros, 2002, Braz. J. Plant Physiol., V14, P51, DOI 10.1590/S1677-04202002000100007; Fileppi M, 2010, MOL BREEDING, V25, P453, DOI 10.1007/s11032-009-9344-1; Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI [10.1002/(SICI)1097-0010(20000515)80:7<861::AID-JSFA601>3.0.CO;2-P, 10.1002/(SICI)1097-0010(20000515)80:7&lt;861::AID-JSFA601&gt;3.0.CO;2-P]; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Galeano CH, 2009, CROP SCI, V49, P381, DOI 10.2135/cropsci2008.07.0413; Gelin JP, 2007, CROP SCI, V47, P1361, DOI 10.2135/cropsci2006.08.0510; Graham RD, 2001, ADV AGRON, V70, P77, DOI 10.1016/S0065-2113(01)70004-1; Grusak MA, 2002, J AM COLL NUTR, V21, p178S, DOI 10.1080/07315724.2002.10719263; Guzman-Maldonado SH, 2003, CROP SCI, V43, P1029, DOI 10.2135/cropsci2003.1029; Guzman-Maldonado SH, 2000, J SCI FOOD AGR, V80, P1874, DOI [10.1002/1097-0010(200010)80:13<1874::AID-JSFA722>3.0.CO;2-X, 10.1002/1097-0010(200010)80:13&lt;1874::AID-JSFA722&gt;3.0.CO;2-X]; Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI 10.1104/pp.128.2.650; Israel DW, 2006, CROP SCI, V46, P67, DOI 10.2135/cropsci2005.0076; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Larson SR, 2000, CROP SCI, V40, P1397, DOI 10.2135/cropsci2000.4051397x; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Lolas G, 1975, J AGR FOOD CHEM, V23, P1094; Lott JNA, 2000, SEED SCI RES, V10, P11, DOI 10.1017/S0960258500000039; Murray J, 2002, GENOME, V45, P1013, DOI [10.1139/g02-069, 10.1139/G02-069]; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Ochoa IE, 2006, CROP SCI, V46, P1609, DOI 10.2135/cropsci2005.12-0446; Oltmans SE, 2005, CROP SCI, V45, P593, DOI 10.2135/cropsci2005.0593; Panzeri D, 2011, NEW PHYTOL, V191, P70, DOI 10.1111/j.1469-8137.2011.03666.x; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Petry N, 2010, J NUTR, V140, P1977, DOI 10.3945/jn.110.125369; Pilu R, 2003, THEOR APPL GENET, V107, P980, DOI 10.1007/s00122-003-1316-y; Raboy V, 2001, J PLANT PHYSIOL, V158, P489, DOI 10.1078/0176-1617-00361; RABOY V, 1993, CROP SCI, V33, P1300, DOI 10.2135/cropsci1993.0011183X003300060036x; RABOY V, 1984, CROP SCI, V24, P431, DOI 10.2135/cropsci1984.0011183X002400030001x; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2002, J NUTR, V132, p503S, DOI 10.1093/jn/132.3.503S; RABOY V, 1984, PLANT PHYSIOL, V75, P1094, DOI 10.1104/pp.75.4.1094; Raboy V., 2009, MODIFICATION SEED CO, V51, P177, DOI [DOI 10.2134/AGRONMONOGR51.C8, 10.2134/agronmonogr51.c8]; Raboy Victor, 2006, V39, P71; Raboy V, 2007, NAT BIOTECHNOL, V25, P874, DOI 10.1038/nbt0807-874; Sandberg AS, 1999, AM J CLIN NUTR, V70, P240; Stangoulis JCR, 2007, EUPHYTICA, V154, P289, DOI 10.1007/s10681-006-9211-7; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Tar'an B, 2002, CROP SCI, V42, P544, DOI 10.2135/cropsci2002.0544; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walker DR, 2006, CROP SCI, V46, P390, DOI 10.2135/cropsci2005.0245; Wang TL, 2003, PLANT PHYSIOL, V131, P886, DOI 10.1104/pp.102.017665; Welch RM, 2000, J AGR FOOD CHEM, V48, P3576, DOI 10.1021/jf0000981; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	55	23	24	1	42	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2012	30	3					1265	1277		10.1007/s11032-012-9713-z	http://dx.doi.org/10.1007/s11032-012-9713-z			13	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Plant Sciences; Genetics & Heredity	014BH					2022-09-04	WOS:000309349600003
J	Nigenda, GG; Machado, MH; Ruiz, FF; Carrasco, VV; Moline, PP; Girardi, SS				Nigenda, Gustavo G., Jr.; Machado, Maria H.; Ruiz, Fernando F.; Carrasco, Victor V.; Moline, Patricia P.; Girardi, Sabado S.			Towards the construction of health workforce metrics for Latin America and the Caribbean	HUMAN RESOURCES FOR HEALTH			English	Article								Introduction: One of the components of the Health Observatory for Latin American and the Caribbean (HO-LAC) is the design and implementation of metrics for human resources for health. Under the HO-LAC initiative, researchers from nine countries in the region formed the Collaborative Community on Human Resources for Health in Latin America and the Caribbean to identify common metrics applicable to the field of human resources for health (HRH). Case description: The case description comprises three stages: a) the origins of an initiative in which a non-governmental organization brings together researchers involved in HRH policy in LAC, b) a literature search to identify initiatives to develop methods and metrics to assess the HRH field in the region, and c) subsequent discussions held by the group of researchers regarding the possibilities of identifying an appropriate set of metrics and indicators to assess HRH throughout the region. Discussion and evaluation: A total of 101 documents produced between 1985 and 2008 in the LAC region were identified. Thirty-three of the papers included a variety of measurements comprising counts, percentages, proportions, indicators, averages and metrics, but only 13 were able to fully describe the methods used to identify these metrics and indicators. Of the 33 articles with measurements, 47% addressed labor market issues, 25% were about working conditions, 23% were on HRH training and 5% addressed regulations. Based on these results, through iterative discussions, metrics were defined into three broad categories (training, labor market and working conditions) and available sources of information for their estimation were proposed. While only three of the countries have data on working conditions, all countries have sufficient data to measure at least one aspect of HRH training and the HRH labor market. Conclusions: Information gleaned from HRH metrics makes it possible to carry out comparisons on a determined experience in space and time, in a given country and/or region. The results should then constitute evidence for policy formulation and HRH planning and programs, with improved health system performance ultimately contributing to improved population health. The results of this study are expected to guide decision making by incentivizing the construction of metrics that provide information about HRH problems in LAC countries.	[Nigenda, Gustavo G., Jr.] Natl Inst Publ Hlth, Hlth Serv & Syst Innovat, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico; [Machado, Maria H.] Osvaldo Cruz Fdn, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Ruiz, Fernando F.] Pontificia Univ Javeriana, Ctr Project Dev, Bogota, Colombia; [Carrasco, Victor V.] Cayetano Heredia Peruvian Univ, Carlos Vidal Layseca Sch Publ Hlth & Adm, Lima, Peru; [Moline, Patricia P.] Plenitud Fdn, Santo Domingo, Dominican Rep; [Girardi, Sabado S.] Univ Fed Minas Gerais, Ctr Publ Hlth Studies, Belo Horizonte, MG, Brazil		Nigenda, GG (corresponding author), Natl Inst Publ Hlth, Hlth Serv & Syst Innovat, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico.	gnigenda@insp.mx		Carrasco Cortez, Victor Ruperto/0000-0002-7238-6622; Machado, Maria Helena/0000-0002-5209-2424				Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; ARROYO J, 2005, SISTEMAS DESCENTRADO; Bloor K, 2003, INT COMP REV; CARRASCO V, 2007, ANALISIS ACTUAL PROS; Diallo Khassoum, 2003, Hum Resour Health, V1, P3, DOI 10.1186/1478-4491-1-3; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; FEITOSA J, 2004, PRECARIZACION TRABAJ; FRENK J, 1988, PSICOLOGIA SALUD, V1, P31; *MIN SAL NIC, 2007, MAN PROC PLAN PROGR; Nigenda G, 2006, SALUD PUBLICA MEXICO, V48, P22, DOI 10.1590/S0036-36342006000100005; Nigenda G, 2010, FORMACION EMPLEO REG; Nigenda Gustavo, 2005, Hum Resour Health, V3, P3, DOI 10.1186/1478-4491-3-3; Novick M., 2006, DESAFIOS GESTION REC; *OPS OMS, 2006, LLAM ACC TOR 2006 20, P1; *ORG PAN SAL, 2000, OBS REC HUM SAL QUIT; *PAHO, 2006, HLTH HUM RES TRENDS; RUIZ F, 2007, RECURSOS HUMANOS SAL; SIMOENS S, 2003, OECD HLTH WORKING PA, V21; WHO, 2006, COL SAL INF SAL MUND, P135; OBSERVATORIO RECURSO; METRICAS SALUD; DEV REGIONAL HRH IND	22	5	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1478-4491			HUM RESOUR HEALTH	Hum. Resour. Health	OCT 14	2011	9								24	10.1186/1478-4491-9-24	http://dx.doi.org/10.1186/1478-4491-9-24			9	Health Policy & Services; Industrial Relations & Labor	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Business & Economics	847MQ	21999239	gold, Green Published			2022-09-04	WOS:000296977400001
J	Salas, G; Santander, P; Precht, A; Scholten, H; Moretti, R; Lopez-Lopez, W				Salas, Gonzalo; Santander, Priscilla; Precht, Andrea; Scholten, Hernan; Moretti, Renato; Lopez-Lopez, Wilson			COVID-19: Psychosocial Impact on School in Chile. Inequalities and Challenges for Latin America	AVANCES EN PSICOLOGIA LATINOAMERICANA			Spanish	Article						COVID-19; School; psychosocial impact; Chile; Latin America	TEACHERS; CHILDREN	The Coronavirus-19 (COVID-19) pandemic has exceeded five million cases worldwide, and its consequences have been devastating for health and society in general. As part of the health protocols that seek to mitigate the pandemic's effects, school closures were implemented in most countries, where Chile was no exception. In the framework of this article, we seek to give an account of the psychosocial impact of this initiative on Chilean schools and to broaden the reflection to the rest of Latin America. In this sense, we analyze government decisions since the creation of the Aprendo en Linea [I Learn Online] program and propose a contextualization and a contrast with the measures adopted in other countries. We then explore the conditions of the exercise of the teaching activity, its consequences in the family context, and the impact on the relationship between families and schools. This allows us to visualize, once again, not only the structural inequality of the Chilean education system but also its maintenance and eventual deepening. The discussions and measures to be implemented in the current situation pose challenges that, beyond the context of Chile, can be extended to other Latin American countries.	[Salas, Gonzalo; Precht, Andrea] Univ Catolica Maule, Talca, Chile; [Santander, Priscilla] Univ Cent Chile, Santiago, Chile; [Scholten, Hernan] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Moretti, Renato] Univ Alberto Hurtado, Santiago, Chile; [Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Bogota, Colombia		Salas, G (corresponding author), Univ Catolica Maule, Dept Psicol, Av San Miguel 3605, Talca, Chile.	gsalas@ucm.cl	Precht, Andrea/H-4506-2015; López López, Wilson/AAV-8032-2021	Precht, Andrea/0000-0002-2435-5565; López López, Wilson/0000-0002-2964-0402				Ali I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138861; Asmundson GJG, 2020, J ANXIETY DISORD, V70, DOI 10.1016/j.janxdis.2020.102196; Avalos B, 2016, INT J EDUC DEV, V49, P279, DOI 10.1016/j.ijedudev.2016.03.012; Bayham J, 2020, LANCET PUBLIC HEALTH, V5, pE271, DOI 10.1016/S2468-2667(20)30082-7; Bellei C., 2020, CASA ESCUELA PROPUES; Bercht A., 2018, REFLEXIONES EXPERIEN, P119; Bott S, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.26; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Burman E., 2016, DECONSTRUCTING DEV P, V3rd; Cabello P, 2021, J CHILD MEDIA, V15, P183, DOI 10.1080/17482798.2020.1744176; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Carrasco D., 2017, MIDEVIDENCIAS, V11, P1; Cavieres Fernández Eduardo, 2014, Rev. Bras. Educ., V19, P1033, DOI 10.1590/S1413-24782014000900011; Centers for Disease Control and Prevention, 2020, PEOPL WHO AR HIGH RI; Centro de Estudios Mineduc, 2020, MATR AL; CEPAL, 2019, PAN SOC AM LAT; Chavez P., 2017, SER NINO NINA CHILE; Claro M., 2019, REFORMA TRANSFORMACI, P217; Colegio de Profesores de Chile, 2020, CART AB TEL ED CRIS; Coronavirus Resource Center, 2020, COV 19 DASHB CTR SYS; DiBartolo I., 2016, APEGO COMO NUESTROS; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Faircloth, 2013, PARENTING GLOBAL PER; Faircloth C, 2015, J FAM ISSUES, V36, P1115, DOI 10.1177/0192513X14533546; Falabella Alejandra, 2016, Estud. pedagóg., V42, P395; Falabella Alejandra, 2016, Estud. pedagóg., V42, P107; Fretwell N., 2020, GENEALOGY, V4, P1; Furedi F., 2001, PARANOID PARENTING A; Gaete Silva Alfredo, 2017, Estud. pedagóg., V43, P123; Gallegos Miguel, 2014, Psicoperspectivas, V13, P106, DOI 10.5027/psicoperspectivas-Vol13-Issue3-fulltext-377; Garces M, 2019, J LAT AM CULT STUD, V28, P483, DOI 10.1080/13569325.2019.1696289; Garcia-Huidobro J., 2007, PENSAMIENTO ED, V40, P65; Gobierno de Argentina, 2020, SEG ED MIN ED PRES P; Gomez Espino JM, 2013, CHILDHOOD, V20, P22, DOI 10.1177/0907568212445225; Gonzalez R, 2020, INT J SOCIOL, V50, P227, DOI 10.1080/00207659.2020.1752499; Goodall J., 2019, ECOL EVOL, P1; Gutierrez M, 2018, UNIV PSYCHOL, V17, DOI 10.11144/Javeriana.upsy17-5.aspn; Hernández-Silva Carla, 2017, Educ. Educ., V20, P434, DOI 10.5294/edu.2017.20.3.6; Human Rights Watch, 2020, INF MUND 2020 CHIL; Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013; Kim JK, 2014, SMART MEMBRANES AND SENSORS: SYNTHESIS, CHARACTERIZATION, AND APPLICATIONS, P53; Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500; Lee E. J., 2014, PARENTING CULTURE ST; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lu XX, 2020, PEDIAT ALLERG IMM-UK, V31, P449, DOI 10.1111/pai.13267; Madrid R, 2019, REV ELECTRON INTERUN, V22, P1, DOI 10.6018/reifop.22.3.389801; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1140; Criado EM, 2017, CUAD RELAC LABOR, V35, P305, DOI 10.5209/CRLA.56777; Ministerio de Desarrollo Social y Familia, 2017, RES ENC CAS 2017; Ministerio de Educaci6n, 2020, APR CAS; Ministerio de Educacion de Chile, 2020, APR TV BLOQ ED MIN T; Ministerio de Educacion de Chile, 2020, APR LIN; Ministerio de Educacion de Colombia, 2020, GOB NAC EXP NORM MAR; Ministerio de Educacion de Costa Rica, 2020, APR CAS; Ministerio de Tecnologias de la Informacion y las Comunicaciones de Colombia, 2019, COL 50 HOG TIEN INT; Ministry of Education of the People's Republic of China, 2020, GUID ORG MAN ONL TEA; Naguy A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102050; Ochoa-Angrino S, 2018, UNIV PSYCHOL, V17, DOI 10.11144/Javeriana.upsy17-5.phrr; Paredes N., 2020, CORONAVIRUS CONFINAM; Parra V., 2020, TIEMPOS CRISIS REPOS; Patrick SL, 2020, HEALTH BEHAV POLICY, V7, P165, DOI 10.14485/HBPR.7.2.10; Precht A., 2016, PATHOS ETHOS LINEAS, P129; Precht Andrea, 2016, Estud. pedagóg., V42, P165; Ruf B., 2012, PEDAGOGIA EMERGENCIA; Ruffinelli Vargas Andrea, 2016, Estud. pedagóg., V42, P261; Salas G., 2015, ROSTROS MALESTAR CRI, P89; Salas G, 2019, TER PSICOL, V37, P317; Schiariti V, 2020, DEV MED CHILD NEUROL, V62, P661, DOI 10.1111/dmcn.14526; Scholten H., 2020, REV INTERAMERICANA P, V54, pe1287, DOI [10.30849/ripijp.v54i1.1287, DOI 10.30849/RIPIJP.V54I1.1287]; Sepulveda Mauricio., 2019, SUBJECTIVITY, V12, P371, DOI 10.1057/s41286-019-00084-7; Subsecretaria de Telecomunicaciones de Chile, 2020, INF AN SECT TEL 2019; Superintendencia de Seguridad Social-SUSESO, 2019, INF AN EST 2018 SEG; The Alliance for Child Protection in Humanitarian Action, 2020, TECHN NOT PROT CHILD; The New York City Departament of Education, 2020, COR UPD; Tian H., 2020, IMPACT TRANSMISSION, DOI 10.1101/2020.01.30.20019844; Trevino E., 2019, REFORMA TRANSFORMACI, P173; UNDP, 2017, DES OR CAMB DES BREC; UNESCO, 2020, IMP COVID 19 ED; Unicef, 2020, COVID 19 MAS 95 CIEN; Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Voela, 2016, WE NEED TALK FAMILY; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X; Wobmann L., 2020, WIRTSCHAFTSDIENST, V4, P228, DOI [10.1007/s10273-020-2618-2, DOI 10.1007/S10273-020-2618-2]; Zhang WN, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030055	85	6	13	3	16	UNIV ROSARIO	BOGOTA	PROGRAMA PSICOLOGIA, FAC MED, CARRERA 24 63 C-69 QUINTA DE MUTIS, BOGOTA, 00000, COLOMBIA	1794-4724	2145-4515		AV PSICOL LATINOAM	Av. Psicol. Latinoam.		2020	38	2								10.12804/revistas.urosario.edu.co/apl/a.9404	http://dx.doi.org/10.12804/revistas.urosario.edu.co/apl/a.9404			17	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	PC7WG					2022-09-04	WOS:000597206200002
J	Gorabi, AM; Kiaie, N; Barreto, GE; Read, MI; Tafti, HA; Sahebkar, A				Gorabi, Armita Mahdavi; Kiaie, Nasim; Barreto, George E.; Read, Morgayn, I; Tafti, Hossein Ahmadi; Sahebkar, Amirhossein			The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases	MOLECULAR NEUROBIOLOGY			English	Article						Stem cell; Central nervous system; Regeneration; Neuroprotection; Exosome; Neurodegenerative diseases	STROMAL CELLS; IN-VITRO; NEUROVASCULAR PLASTICITY; MEDIATED ENDOCYTOSIS; TRANSFERRIN RECEPTOR; FUNCTIONAL RECOVERY; MIMETIC PEPTIDES; NEURAL CELLS; SPINAL-CORD; BRAIN	Neurologic complications are commonly regarded as irreversible impairments that stem from limited potential of regeneration of the central nervous system (CNS). On the other side, the regenerative potential of stem cells has been evaluated in basic research, as well as in preclinical studies. Mesenchymal stem cells (MSCs) have been regarded as candidate cell sources for therapeutic purposes of various neurological disorders, because of their self-renewal ability, plasticity in differentiation, neurotrophic characteristics, and immunomodulatory properties. Exosomes are extracellular vesicles which can deliver biological information over long distances and thereby influencing normal and abnormal processes in cells and tissues. The therapeutic capacity of exosomes relies on the type of cell, as well as on the physiological condition of a given cell. Therefore, based on tissue type and physiological condition of CNS, exosomes may function as contributors or suppressors of pathological conditions in this tissue. When it comes to the therapeutic viewpoint, the most promising cellular source of exosomes is considered to be MSCs. The aim of this review article is to discuss the current knowledge around the potential of stem cells and MSC-derived exosomes in the treatment of neurodegenerative diseases.	[Gorabi, Armita Mahdavi; Kiaie, Nasim; Tafti, Hossein Ahmadi] Univ Tehran Med Sci, Res Ctr Adv Technol Cardiovasc Med, Tehran Heart Ctr, Tehran, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Read, Morgayn, I] Univ Otago, Sch Med Sci, Dept Pharmacol, Dunedin, New Zealand; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad 9177948564, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Tehran, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Med, Tehran, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad 9177948564, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Tehran, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Tehran, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; ahmadi, hossein/AAH-9202-2021; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Aryani A, 2016, MOL NEUROBIOL, V53, P818, DOI 10.1007/s12035-014-9054-5; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Barchet TM, 2009, EXPERT OPIN DRUG DEL, V6, P211, DOI 10.1517/17425240902758188; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bonafede R, 2016, EXP CELL RES, V340, P150, DOI 10.1016/j.yexcr.2015.12.009; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Cabezas R, 2019, MOL NEUROBIOL, V56, P2339, DOI 10.1007/s12035-018-1203-9; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Chiquet-Ehrismann R, 2014, MATRIX BIOL, V37, P112, DOI 10.1016/j.matbio.2014.01.007; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Farinazzo A, 2015, CYTOTHERAPY, V17, P571, DOI 10.1016/j.jcyt.2015.01.005; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Ferhat L, 1996, J NEUROCYTOL, V25, P535, DOI 10.1007/BF02284821; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heng YHE, 2015, CEREB CORTEX, V25, P3758, DOI 10.1093/cercor/bhu253; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hurley JH, 2012, NAT CELL BIOL, V14, P654, DOI 10.1038/ncb2530; Jarmalaviciute A, 2013, J MOL NEUROSCI, V51, P307, DOI 10.1007/s12031-013-0046-0; Jarmalaviciute A, 2015, CYTOTHERAPY, V17, P932, DOI 10.1016/j.jcyt.2014.07.013; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim MY, 2012, MOL CELLS, V33, P71, DOI 10.1007/s10059-012-2214-4; Kiraly M, 2009, NEUROCHEM INT, V55, P323, DOI 10.1016/j.neuint.2009.03.017; Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Lee HK, 2014, STEM CELLS DEV, V23, P2851, DOI 10.1089/scd.2014.0146; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Lopez-Verrilli MA, 2016, NEUROSCIENCE, V320, P129, DOI 10.1016/j.neuroscience.2016.01.061; Lopez-Verrilli MA, 2013, BIOL RES, V46, P5, DOI 10.4067/S0716-97602013000100001; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Marconi S, 2013, NEUROSCIENCE, V248, P333, DOI 10.1016/j.neuroscience.2013.05.034; Mazzio EA, 2004, BRAIN RES, V1004, P29, DOI 10.1016/j.brainres.2003.12.034; Menon S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010141; Mercier F, 2001, J COMP NEUROL, V431, P88, DOI 10.1002/1096-9861(20010226)431:1<88::AID-CNE1057>3.0.CO;2-D; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Patterson M, 2014, STEM CELL REP, V3, P758, DOI 10.1016/j.stemcr.2014.08.015; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pivoraite U, 2015, INFLAMMATION, V38, P1933, DOI 10.1007/s10753-015-0173-6; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Pusic AD, 2014, J NEUROIMMUNOL, V266, P12, DOI 10.1016/j.jneuroim.2013.10.014; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schwarz JM, 2015, JOVE-J VIS EXP, DOI 10.3791/52537; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Soares AR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13243; Somoza R, 2010, BIOL BLOOD MARROW TR, V16, P1530, DOI 10.1016/j.bbmt.2010.06.006; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor AR, 2007, DEV NEUROBIOL, V67, P1815, DOI 10.1002/dneu.20559; Tfilin M, 2010, MOL PSYCHIATR, V15, P1164, DOI 10.1038/mp.2009.110; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang Chong, 2010, Front Biosci (Elite Ed), V2, P127, DOI 10.2741/e74; Wideman JG, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016998; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-290; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194; Zhu J, 2015, NEUROSCIENCE, V290, P288, DOI 10.1016/j.neuroscience.2015.01.038; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	128	59	62	4	35	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2019	56	12					8157	8167		10.1007/s12035-019-01663-0	http://dx.doi.org/10.1007/s12035-019-01663-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JK5CI	31197655				2022-09-04	WOS:000494860800018
J	Vargas-Luna, A; Crosato, A; Anders, N; Hoitink, AJF; Keesstra, SD; Uijttewaal, WSJ				Vargas-Luna, Andres; Crosato, Alessandra; Anders, Niels; Hoitink, Antonius J. F.; Keesstra, Saskia D.; Uijttewaal, Wim S. J.			Morphodynamic effects of riparian vegetation growth after stream restoration	EARTH SURFACE PROCESSES AND LANDFORMS			English	Article						stream restoration; stream dynamics; vegetation modelling; seasonal variation; Lunterse Beek; Delft3D	RIVER RESTORATION; GRAVEL-BED; SEDIMENT TRANSPORT; FLUVIAL LANDFORMS; WAAL RIVER; CHANNEL; FLOW; BANK; PATTERNS; EROSION	The prediction of the morphological evolution of renaturalized streams is important for the success of restoration projects. Riparian vegetation is a key component of the riverine landscape and is therefore essential for the natural rehabilitation of rivers. This complicates the design of morphological interventions, since riparian vegetation is influenced by and influences the river dynamics. Morphodynamic models, useful tools for project planning, should therefore include the interaction between vegetation, water flow and sediment processes. Most restoration projects are carried out in USA and Europe, where rivers are highly intervened and where the climate is temperate and vegetation shows a clear seasonal cycle. Taking into account seasonal variations might therefore be relevant for the prediction of the river morphological adaptation. This study investigates the morphodynamic effects of riparian vegetation on a re-meandered lowland stream in the Netherlands, the Lunterse Beek. The work includes the analysis of field data covering 5years and numerical modelling. The results allow assessment of the performance of a modelling tool in predicting the morphological evolution of the stream and the relevance of including the seasonal variations of vegetation in the computations. After the establishment of herbaceous plants on its banks, the Lunterse Beek did not show any further changes in channel alignment. This is here attributed to the stabilizing effects of plant roots together with the small size of the stream. It is expected that the morphological restoration of similarly small streams may result in important initial morphological adaptation followed by negligible changes after full vegetation establishment. Copyright (c) 2018 John Wiley & Sons, Ltd.	[Vargas-Luna, Andres] Pontificia Univ Javeriana, Cra 7 40-62, Bogota 74062, Colombia; [Vargas-Luna, Andres; Crosato, Alessandra; Uijttewaal, Wim S. J.] Delft Univ Technol, Fac Civil Engn & Geosci, Rivers Ports Waterways & Dredging Works Sect, POB 5048, NL-2600 GA Delft, Netherlands; [Crosato, Alessandra] UNESCO IHE, Dept Water Engn, POB 3015, NL-2601 DA Delft, Netherlands; [Anders, Niels; Hoitink, Antonius J. F.; Keesstra, Saskia D.] Wageningen Univ, Dept Environm Sci, Hydrol & Quantitat Water Management, Droevendaalsesteeg 4, NL-6708 PB Wageningen, Netherlands; [Anders, Niels] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 94248, NL-1090 GE Amsterdam, Netherlands		Vargas-Luna, A (corresponding author), Pontificia Univ Javeriana, Cra 7 40-62, Bogota 74062, Colombia.	avargasl@javeriana.edu.co	keesstra, saskia/Z-5477-2019; Uijttewaal, Wim/ABC-8328-2021; Uijttewaal, Wim/GNP-7281-2022; Uijttewaal, Wim S.J./G-1244-2010; Anders, Niels/C-4020-2008; Crosato, Alessandra/C-6734-2009	Uijttewaal, Wim/0000-0002-6043-8026; Anders, Niels/0000-0003-3453-8717; Crosato, Alessandra/0000-0001-9531-005X; Keesstra, Saskia/0000-0003-4129-9080; Hoitink, Ton/0000-0003-4996-185X; Vargas-Luna, Andres/0000-0002-5317-8975	COLCIENCIAS (Colombian Administrative Department of Science, Technology and Innovation); Pontificia Universidad Javeriana	COLCIENCIAS (Colombian Administrative Department of Science, Technology and Innovation); Pontificia Universidad Javeriana	The authors are grateful to J.P.C. Eekhout (Wageningen University), R. Fraaije (Utrecht University), CycloMedia (www.cyclomedia.com), Slagboom en Peeters Luchtfotografie (www.slagboomenpeeters.com), the Dutch cadastre office (www.kadaster.nl), and the Water board Vallei en Veluwe (www.vallei-veluwe.nl) for the information provided on the Lunterse Beek to conduct this study. The authors also would like to express their gratitude to the Dutch national e-infrastructure with the support of SURF Cooperative (https://userinfo.surfsara.nl/systems/lisa/description) in the computational resources provided for the numerical modelling carried out in this work. This research has also benefited from cooperation within the network of the Netherlands Centre for River studies. Andres Vargas Luna is grateful to COLCIENCIAS (Colombian Administrative Department of Science, Technology and Innovation), and to Pontificia Universidad Javeriana, the institutions that support financially his studies in the Netherlands.	Anders NS, 2011, REMOTE SENS ENVIRON, V115, P2976, DOI 10.1016/j.rse.2011.05.007; Arboleda AM, 2010, HYDROL PROCESS, V24, P3661, DOI 10.1002/hyp.7804; Arroyave JAV, 2010, P I CIVIL ENG-WAT M, V163, P457, DOI 10.1680/wama.900023; Asahi K, 2013, J GEOPHYS RES-EARTH, V118, P2208, DOI 10.1002/jgrf.20150; Augustijn D., 2008, 4 INT C FLUV HYDR RI; Baatz M., 2014, ADV REMOTE SENS, V2, P12; Barenbold F, 2016, WATER RESOUR RES, V52, P1070, DOI 10.1002/2015WR017492; Bagnold R. A, 1966, 4 USGEOLOGICAL SURV, DOI [10.1017/s0016756800049074, DOI 10.1017/S0016756800049074]; Baptist M, 2005, THESIS; Baptist MJ, 2007, J HYDRAUL RES, V45, P435, DOI 10.1080/00221686.2007.9521778; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Berendse F, 2015, ECOSYSTEMS, V18, P881, DOI 10.1007/s10021-015-9869-6; Bernhardt ES, 2007, RESTOR ECOL, V15, P482, DOI 10.1111/j.1526-100X.2007.00244.x; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bertoldi W, 2014, GEOPHYS RES LETT, V41, P7167, DOI 10.1002/2014GL061666; Brachet C., 2015, HDB MANAGEMENT RESTO; Braudrick CA, 2009, P NATL ACAD SCI USA, V106, P16936, DOI 10.1073/pnas.0909417106; Brookes A., 1988, CHANNELIZED RIVERS P; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; Camporeale C, 2013, REV GEOPHYS, V51, P379, DOI 10.1002/rog.20014; Champion PD, 2000, HYDROBIOLOGIA, V441, P1, DOI 10.1023/A:1017517303221; Corenblit D, 2007, EARTH-SCI REV, V84, P56, DOI 10.1016/j.earscirev.2007.05.004; Corenblit D, 2011, EARTH-SCI REV, V106, P307, DOI 10.1016/j.earscirev.2011.03.002; Corenblit D, 2009, EARTH SURF PROC LAND, V34, P1790, DOI 10.1002/esp.1876; Cotton JA, 2006, GEOMORPHOLOGY, V77, P320, DOI 10.1016/j.geomorph.2006.01.010; Crosato A, 2011, EARTH SURF PROC LAND, V36, P711, DOI 10.1002/esp.2088; Crouzy B, 2016, ADV WATER RESOUR, V93, P156, DOI 10.1016/j.advwatres.2015.07.011; desJong J, 2005, THESIS; Dufour S, 2009, RIVER RES APPL, V25, P568, DOI 10.1002/rra.1239; Edmaier K, 2015, J GEOPHYS RES-BIOGEO, V120, P1812, DOI 10.1002/2014JG002898; Edmaier K., 2011, HYDROL EARTH SYST SC, P1365, DOI [10.5194/hessd-8-1365-2011, DOI 10.5194/HESSD-8-1365-2011]; Eekhout JPC, 2015, WATER RESOUR RES, V51, P3339, DOI 10.1002/2014WR016539; Eekhout JPC, 2014, EARTH SURF DYNAM, V2, P279, DOI 10.5194/esurf-2-279-2014; Eekhout JPC, 2015, ADV WATER RESOUR, V81, P161, DOI 10.1016/j.advwatres.2014.10.008; Eke E, 2014, J GEOPHYS RES-EARTH, V119, P1455, DOI 10.1002/2013JF003020; Engelund F, 1967, MONOGRAPH SEDIMENT T, V4; Facchini E, 2009, ECRR CIRF, V2, P67; FRIEDMAN JM, 1995, ENVIRON MANAGE, V19, P547, DOI 10.1007/BF02471966; Geerling GW, 2008, GEOMORPHOLOGY, V99, P317, DOI 10.1016/j.geomorph.2007.11.011; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Gonzalez E, 2015, J ENVIRON MANAGE, V158, P85, DOI 10.1016/j.jenvman.2015.04.033; Goodwin CN, 1997, RESTOR ECOL, V5, P4, DOI 10.1111/j.1526-100X.1997.00004.x; Gorla L, 2015, WATER RESOUR RES, V51, P1758, DOI 10.1002/2014WR015543; Gorla L, 2015, ECOL ENG, V77, P297, DOI 10.1016/j.ecoleng.2015.01.019; Gran K, 2001, WATER RESOUR RES, V37, P3275, DOI 10.1029/2000WR000203; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Gurnell AM, 2006, J VEG SCI, V17, P665, DOI 10.1111/j.1654-1103.2006.tb02490.x; Gurnell A, 2014, EARTH SURF PROC LAND, V39, P4, DOI 10.1002/esp.3397; Gurnell AM, 2006, ENVIRON MANAGE, V38, P580, DOI 10.1007/s00267-005-0190-6; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; Gyssels G, 2005, PROG PHYS GEOG, V29, P189, DOI 10.1191/0309133305pp443ra; Hauer C, 2008, ENVIRON MANAGE, V42, P279, DOI 10.1007/s00267-008-9118-2; HICKIN EJ, 1984, CAN GEOGR-GEOGR CAN, V28, P111, DOI 10.1111/j.1541-0064.1984.tb00779.x; Hobbs RJ, 2005, RESTOR ECOL, V13, P239, DOI 10.1111/j.1526-100X.2005.00030.x; IKEDA S, 1982, J HYDR ENG DIV-ASCE, V108, P1369; Jankowska E, 2014, ESTUAR COAST SHELF S, V139, P159, DOI 10.1016/j.ecss.2014.01.003; Jesse P, 2003, ARCH HYDROBIOLOGIE S, V15, P359, DOI [10. 1127/lr/15/2003/359, DOI 10.1127/LR/15/2003/359]; Keesstra SD, 2007, EARTH SURF PROC LAND, V32, P49, DOI 10.1002/esp.1360; Keesstra SD, 2012, NETH J GEOSCI, V91, P245, DOI 10.1017/S0016774600001633; Koch F.G., 1981, P 19 IAHR C NEW DELH; Kondolf GM, 2006, ECOL SOC, V11; Kondolf GM, 2011, GEOPHYS MONOGR SER, V194, P29, DOI 10.1029/2010GM001020; Kondolf GM, 2013, HYDROBIOLOGIA, V719, P527, DOI 10.1007/s10750-012-1363-y; KONDOLF GM, 1995, ENVIRON MANAGE, V19, P1, DOI 10.1007/BF02471999; Kondolf GM, 2001, ENVIRON MANAGE, V28, P761, DOI 10.1007/s002670010260; Lane SN, 2003, EARTH SURF PROC LAND, V28, P249, DOI 10.1002/esp.483; Madsen S., 2006, RIVER RESTORATION DE; Marion A, 2014, J HYDRAUL RES, V52, P744, DOI 10.1080/00221686.2014.968887; Milan DJ, 2011, GEOMORPHOLOGY, V125, P160, DOI 10.1016/j.geomorph.2010.09.012; Mohl A., 2004, LIFE RIVER RESTORATI, P17; Murray AB, 2003, EARTH SURF PROC LAND, V28, P131, DOI 10.1002/esp.428; Neary VS, 2012, J HYDRAUL ENG, V138, P765, DOI 10.1061/(ASCE)HY.1943-7900.0000168; Nepf HM, 2012, ANNU REV FLUID MECH, V44, P123, DOI 10.1146/annurev-fluid-120710-101048; Nicholas AP, 2013, EARTH SURF PROC LAND, V38, P1187, DOI 10.1002/esp.3431; Nienhuis PH, 2001, HYDROBIOLOGIA, V444, P85, DOI 10.1023/A:1017509410951; Nones M, 2016, RIVER SEDIMENTATION, V56; Nones M, 2016, GEOPLANET-EARTH PLAN, P167, DOI 10.1007/978-3-319-27750-9_14; O'Donnell J, 2016, SCI TOTAL ENVIRON, V542, P591, DOI 10.1016/j.scitotenv.2015.10.118; Ormerod SJ, 2004, AQUAT CONSERV, V14, P543, DOI 10.1002/aqc.663; Ortiz AC, 2013, J GEOPHYS RES-EARTH, V118, P2585, DOI 10.1002/2013JF002858; Owens PN, 2005, RIVER RES APPL, V21, P693, DOI 10.1002/rra.878; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Parker G, 2004, P ASCE WORLD WAT ENV; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perona P, 2014, EARTH SURF PROC LAND, V39, P1651, DOI 10.1002/esp.3614; Perucca E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005234; Piegay H, 2005, RIVER RES APPL, V21, P773, DOI 10.1002/rra.881; Poggi D, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2565528; Poggi D, 2007, AGR FOREST METEOROL, V144, P1, DOI 10.1016/j.agrformet.2007.01.009; Pollen-Bankhead N, 2010, GEOMORPHOLOGY, V116, P353, DOI 10.1016/j.geomorph.2009.11.013; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Roni P, 2005, 484 FAO UN; Schirmer M, 2014, HYDROL EARTH SYST SC, V18, P2449, DOI 10.5194/hess-18-2449-2014; Simon A, 2004, WATER SCI APPL, V8, P1; Solari L, 2016, RIVER RES APPL, V32, P164, DOI 10.1002/rra.2910; STRUIKSMA N, 1985, J HYDRAUL RES, V23, P57, DOI 10.1080/00221688509499377; Tal M, 2007, GEOLOGY, V35, P347, DOI 10.1130/G23260A.1; Tal M, 2010, EARTH SURF PROC LAND, V35, P1014, DOI 10.1002/esp.1908; TALMON AM, 1995, J HYDRAUL RES, V33, P495, DOI 10.1080/00221689509498657; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Thorne C.R., 1990, VEGETATION EROSION, P125; van der Wegen M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003983; van Oorschot M, 2016, EARTH SURF PROC LAND, V41, P791, DOI 10.1002/esp.3864; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vargas-Luna A, 2016, ADV WATER RESOUR, V93, P205, DOI 10.1016/j.advwatres.2015.10.004; Vargas-Luna A, 2015, EARTH SURF PROC LAND, V40, P157, DOI 10.1002/esp.3633; Walker Lawrence R., 2007, P1, DOI 10.1007/978-0-387-35303-6_1; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Yager EM, 2013, J GEOPHYS RES-EARTH, V118, P1585, DOI 10.1002/jgrf.20085	109	16	16	3	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-9337	1096-9837		EARTH SURF PROC LAND	Earth Surf. Process. Landf.	JUN 30	2018	43	8					1591	1607		10.1002/esp.4338	http://dx.doi.org/10.1002/esp.4338			17	Geography, Physical; Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physical Geography; Geology	GJ3YO					2022-09-04	WOS:000435270900003
J	Stapleton, M; Sawamoto, K; Almeciga-Diaz, CJ; Mackenzie, WG; Mason, RW; Orii, T; Tomatsu, S				Stapleton, Molly; Sawamoto, Kazuki; Almeciga-Diaz, Carlos J.; Mackenzie, William G.; Mason, Robert W.; Orii, Tadao; Tomatsu, Shunji			Development of Bone Targeting Drugs	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						bone targeting drugs; osteoporosis; metabolic skeletal dysplasia; bisphosphonates; nanoparticles	STEM-CELLS; ADIPOGENIC DIFFERENTIATION; RHEUMATOID-ARTHRITIS; TISSUE REGENERATION; PLGA NANOPARTICLES; DELIVERY-SYSTEM; BISPHOSPHONATES; MORQUIO; INTERFERENCE; OLIGOPEPTIDE	The skeletal system, comprising bones, ligaments, cartilage and their connective tissues, is critical for the structure and support of the body. Diseases that affect the skeletal system can be difficult to treat, mainly because of the avascular cartilage region. Targeting drugs to the site of action can not only increase efficacy but also reduce toxicity. Bone-targeting drugs are designed with either of two general targeting moieties, aimed at the entire skeletal system or a specific cell type. Most bone-targeting drugs utilize an affinity to hydroxyapatite, a major component of the bone matrix that includes a high concentration of positively-charged Ca2+. The strategies for designing such targeting moieties can involve synthetic and/or biological components including negatively-charged amino acid peptides or bisphosphonates. Efficient delivery of bone-specific drugs provides significant impact in the treatment of skeletal related disorders including infectious diseases (osteoarthritis, osteomyelitis, etc.), osteoporosis, and metabolic skeletal dysplasia. Despite recent advances, however, both delivering the drug to its target without losing activity and avoiding adverse local effects remain a challenge. In this review, we investigate the current development of bone-targeting moieties, their efficacy and limitations, and discuss future directions for the development of these specific targeted treatments.	[Stapleton, Molly; Mason, Robert W.; Tomatsu, Shunji] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Stapleton, Molly; Sawamoto, Kazuki; Mackenzie, William G.; Mason, Robert W.; Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota 110231, Colombia; [Orii, Tadao; Tomatsu, Shunji] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011193, Japan; [Tomatsu, Shunji] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA		Tomatsu, S (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.; Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA.; Tomatsu, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011193, Japan.; Tomatsu, S (corresponding author), Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA.	mstaple@udel.edu; kazuki.sawamoto@nemours.org; cjalmeciga@javeriana.edu.co; william.mackenzie@nemours.org; robert.mason@nemours.org; orii.tadao@camel.plala.or.jp; shunji.tomatsu@nemours.org	Alméciga-Díaz, Carlos J/A-2494-2017	Alméciga-Díaz, Carlos J/0000-0001-6484-1173	International Morquio Organization (Carol Ann Foundation); Japanese Mucopolysaccharidosis Family Society; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH [P30GM114736]; Austrian Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114736] Funding Source: NIH RePORTER	International Morquio Organization (Carol Ann Foundation); Japanese Mucopolysaccharidosis Family Society; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH; Austrian Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Austrian Mucopolysaccharidosis Society and International Morquio Organization (Carol Ann Foundation). This work was also supported by Japanese Mucopolysaccharidosis Family Society. Robert William Mason and Shunji Tomatsu were supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH under grant number P30GM114736. The content of the article has not been influenced by the sponsors.	Allgrove J., 2007, PAEDIAT CHILD HLTH, V17, P253; Bassit A. C. F., 2015, J NANOMED NANOTECHNO, V6, P1; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Chen F, 2012, BIOMATERIALS, V33, P6447, DOI 10.1016/j.biomaterials.2012.05.059; Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003; Cong YY, 2015, J BIOMAT SCI-POLYM E, V26, P629, DOI 10.1080/09205063.2015.1053170; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95; Edwards JR, 2012, DISCOV MED, V13, P201; Feng XB, 2016, CURR PHARM DESIGN, V22, P6330, DOI 10.2174/1381612822666160708223353; Ferreira DD, 2015, INT J NANOMED, V10, P2441, DOI 10.2147/IJN.S76168; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; FLEISCH H, 1969, SCIENCE, V165, P1262, DOI 10.1126/science.165.3899.1262; Fleisher KE, 2010, ORAL SURG ORAL MED O, V110, P509, DOI 10.1016/j.tripleo.2010.04.023; FRAME B, 1972, ANN INTERN MED, V77, P655, DOI 10.7326/0003-4819-77-4-655; Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0; Harris P.E., 2014, METABOLIC BONE DIS E, P243; Harwood Paul J, 2005, Expert Opin Drug Saf, V4, P75, DOI 10.1517/14740338.4.1.75; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; Hengst V, 2007, INT J PHARMACEUT, V331, P224, DOI 10.1016/j.ijpharm.2006.11.024; Holmberg AR, 2010, INT J ONCOL, V37, P563, DOI 10.3892/ijo_00000705; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Iannazzo D., 2015, BIOMIMETIC APPROACHE, P1; Jeon OH, 2016, DRUG DELIV TRANSL RE, V6, P105, DOI 10.1007/s13346-015-0266-7; Katsumi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135966; Katsumi H, 2011, J PHARM SCI-US, V100, P3783, DOI 10.1002/jps.22620; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Kokkola R, 2002, ARTHRITIS RHEUM, V46, P2598, DOI 10.1002/art.10540; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Liang C, 2015, NAT MED, V21, P288, DOI 10.1038/nm.3791; Liu J, 2015, BIOMATERIALS, V52, P148, DOI 10.1016/j.biomaterials.2015.02.007; Liu XL, 2016, J BIOMED RES, V30, P264, DOI 10.7555/JBR.30.20150110; Martin J, 2000, AUSTI PRESER, V23, P130; Mays S., 2008, ADV HUMAN PALAEOPATH, P215; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Ossipov DA, 2015, EXPERT OPIN DRUG DEL, V12, P1443, DOI 10.1517/17425247.2015.1021679; Pillinger G, 2016, ONCOTARGET, V7, P39784, DOI 10.18632/oncotarget.9289; Pistone A, 2017, ENGINEERING-PRC, V3, P55, DOI 10.1016/J.ENG.2017.01.007; Pistone A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/42/425701; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Rawat P, 2016, INT J PHARMACEUT, V506, P253, DOI 10.1016/j.ijpharm.2016.04.049; Rehman FU, 2016, NANO RES, V9, P3305, DOI 10.1007/s12274-016-1208-5; Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720; Reszka Alfred A, 2003, Curr Rheumatol Rep, V5, P65, DOI 10.1007/s11926-003-0085-6; Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Salerno M, 2010, CURR CANCER DRUG TAR, V10, P649, DOI 10.2174/156800910793605767; Sawamoto K, 2016, EXPERT OPIN ORPHAN D, V4, P941, DOI 10.1080/21678707.2016.1214572; Sedghizadeh P. P., 2017, J MED CHEM, P1; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shen CH, 2016, NANOMED-NANOTECHNOL, V12, P487, DOI 10.1016/j.nano.2015.12.119; Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111; Smith MR, 2008, UROL ONCOL-SEMIN ORI, V26, P420, DOI 10.1016/j.urolonc.2007.11.004; Sun Y, 2016, ACS NANO, V10, P5759, DOI 10.1021/acsnano.5b07828; Takahashi T, 2008, PHARM RES-DORDR, V25, P2881, DOI 10.1007/s11095-008-9605-4; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65, DOI 10.2147/RRED.S37278; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; Wang G., 2016, INSIGHTS STEM CELLS, V2, P2, DOI DOI 10.1155/2016/1736024; Wang H, 2015, INT J NANOMED, V10, P5671, DOI 10.2147/IJN.S88798; Wang XL, 2015, CURR PHARM DESIGN, V21, P1575, DOI 10.2174/1381612821666150115152841; Whyte MP, 2016, NAT REV ENDOCRINOL, V12, P233, DOI 10.1038/nrendo.2016.14; Xie H, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6493241; Yang F, 2009, MOL THER, V17, P1959, DOI 10.1038/mt.2009.146; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228; Zhang Y, 2014, J DENT RES, V93, P1095, DOI 10.1177/0022034514552676; Zhang YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26925; Zhang YF, 2015, J BONE MINER RES, V30, P286, DOI 10.1002/jbmr.2322	71	50	51	3	32	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUL	2017	18	7							1345	10.3390/ijms18071345	http://dx.doi.org/10.3390/ijms18071345			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	FF2SJ	28644392	Green Submitted, Green Published, gold			2022-09-04	WOS:000408746800017
J	Nair, V; Pathi, S; Jutooru, I; Sreevalsan, S; Basha, R; Abdelrahim, M; Samudio, I; Safe, S				Nair, Vijayalekshmi; Pathi, Satya; Jutooru, Indira; Sreevalsan, Sandeep; Basha, Riyaz; Abdelrahim, Maen; Samudio, Ismael; Safe, Stephen			Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors	CARCINOGENESIS			English	Article							MTOR COMPLEX 1; NF-KAPPA-B; BREAST-CANCER; SPECIFICITY PROTEIN-1; ANTIDIABETIC DRUG; DIABETIC-PATIENTS; FACTOR EXPRESSION; AMPK-ACTIVATION; IN-VITRO; DEGRADATION	Metformin is a widely used antidiabetic drug, and epidemiology studies for pancreatic and other cancers indicate that metformin exhibits both chemopreventive and chemotherapeutic activities. Several metformin-induced responses and genes are similar to those observed after knockdown of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 by RNA interference, and we hypothesized that the mechanism of action of metformin in pancreatic cancer cells was due, in part, to downregulation of Sp transcription factors. Treatment of Panc1, L3.6pL and Panc28 pancreatic cancer cells with metformin downregulated Sp1, Sp3 and Sp4 proteins and several pro-oncogenic Sp-regulated genes including bcl-2, survivin, cyclin D1, vascular endothelial growth factor and its receptor, and fatty acid synthase. Metformin induced proteasome-dependent degradation of Sps in L3.6pL and Panc28 cells, whereas in Panc1 cells metformin decreased microRNA-27a and induced the Sp repressor, ZBTB10, and disruption of miR-27a: ZBTB10 by metformin was phosphatase dependent. Metformin also inhibited pancreatic tumor growth and downregulated Sp1, Sp3 and Sp4 in tumors in an orthotopic model where L3.6pL cells were injected directly into the pancreas. The results demonstrate for the first time that the anticancer activities of metformin are also due, in part, to downregulation of Sp transcription factors and Sp-regulated genes.	[Nair, Vijayalekshmi; Pathi, Satya; Jutooru, Indira; Sreevalsan, Sandeep; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Basha, Riyaz; Abdelrahim, Maen] MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL 32827 USA; [Samudio, Ismael] Pontifica Univ Javeriana, Fac Sci, Dept Nutr & Biochem, Bogota, Colombia; [Safe, Stephen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA		Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Samudio, Ismael/D-3581-2013	Samudio, Ismael/0000-0001-8676-1035; Basha, Riyaz/0000-0002-4071-0993	National Institutes of Health [R01CA136571]; Texas AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (R01CA136571); Texas AgriLife Research.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Jan HJ, 2009, CANCER LETT, V277, P141, DOI 10.1016/j.canlet.2008.11.033; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Murtola TJ, 2008, AM J EPIDEMIOL, V168, P925, DOI 10.1093/aje/kwn190; Nonn L, 2007, CARCINOGENESIS, V28, P1188, DOI 10.1093/carcin/bgl241; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tan BK, 2011, J CLIN ENDOCR METAB, V96, P808, DOI 10.1210/jc.2010-1803; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	44	70	73	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	DEC	2013	34	12					2870	2879		10.1093/carcin/bgt231	http://dx.doi.org/10.1093/carcin/bgt231			10	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	269XX	23803693	Green Published, Bronze			2022-09-04	WOS:000328278900021
J	Mueller, NT; Pereira, MA; Buitrago-Lopez, A; Rodriguez, DC; Duran, AE; Ruiz, AJ; Rueda-Clausen, CF; Villa-Roel, C				Mueller, Noel T.; Pereira, Mark A.; Buitrago-Lopez, Adriana; Rodriguez, Diana C.; Duran, Alvaro E.; Ruiz, Alvaro J.; Rueda-Clausen, Christian F.; Villa-Roel, Cristina			Adiposity indices in the prediction of insulin resistance in prepubertal Colombian children	PUBLIC HEALTH NUTRITION			English	Article						Insulin resistance; Obesity; Body fat distribution; Skinfold thickness; Waist circumference; Waist-to-height ratio; Growth; Anthropometry	METABOLIC SYNDROME; WAIST CIRCUMFERENCE; BODY-COMPOSITION; CHILDHOOD OBESITY; FAT DISTRIBUTION; SENSITIVITY; TISSUE; MASS; PREVALENCE; OVERWEIGHT	Objective: To compare BMI with abdominal skinfold thickness (ASF), waist circumference and waist-to-height ratio in the prediction of insulin resistance (IR) in prepubertal Colombian children. Design: We calculated age-and sex-specific Z-scores for BMI, ASF, waist circumference, waist-to-height ratio and three other skinfold-thickness sites. Logistic regression with stepwise selection (P=0.80 for entry and P=0.05 for retention) was performed to identify predictors of IR and extreme IR, which were determined by age-and sex-specific Z-scores to identify the >= 90th and >= 95th percentile of homeostasis model assessment (HOMA(IR)), respectively. We used receiver operating characteristic curves to compare the area under the curve between models. Setting: Bucaramanga, Colombia. Subjects: Children (n 1261) aged 6-10 years in Tanner stage 1 from a population-based study. Results: A total of 127 children (seventy girls and fifty-seven boys) were classified with IR, including sixty-three children (thirty-three girls and thirty boys) classified with extreme IR. Only ASF and BMI Z-scores were retained as predictors of IR by stepwise selection. Adding ASF Z-score to BMI Z-score improved the area under the curve from 0.794 (95% CI 0.752, 0.837) to 0.811 (95% CI 0.770, 0.851; P for contrast=0.01). In predicting extreme IR, the addition of ASF Z-score to BMI Z-score improved the area under the curve from 0.837 (95% CI 0.790, 0.884) to 0.864 (95% CI 0.823, 0.905; P for contrast=0.01). Conclusions: ASF Z-score predicted IR independent of BMI Z-score in our population of prepubertal children. ASF and BMI Z-scores together improved IR risk stratification compared with BMI Z-score alone, opening new perspectives in the prediction of cardiometabolic risk in prepubertal children.	[Mueller, Noel T.; Pereira, Mark A.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Buitrago-Lopez, Adriana] Erasmus MC, Netherlands Inst Hlth Sci, Rotterdam, Netherlands; [Rodriguez, Diana C.; Duran, Alvaro E.] Fdn Cardiovasc Colombia, Pediat Res Area, Santander, Colombia; [Ruiz, Alvaro J.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Rueda-Clausen, Christian F.] Univ Alberta, Dept Med, Shing Ctr Hlth Res Innovat, Edmonton, AB, Canada; [Villa-Roel, Cristina] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada		Mueller, NT (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, 1300 S 2nd St,Suite 300, Minneapolis, MN 55454 USA.	muel0266@umn.edu	Buitrago-Lopez, Adriana/AAD-6697-2019; Ruiz, Alvaro/AAD-5422-2019; Rueda-Clausen, Christian/S-2428-2019	Buitrago-Lopez, Adriana/0000-0002-2840-0781; Ruiz, Alvaro/0000-0001-6528-4268; Rueda-Clausen, Christian/0000-0002-4077-6159; Mueller, Noel/0000-0002-7412-8352	Colombian Institute for the Development of Science and Technology [COLCIENCIAS 65660418215]; National Heart, Lung, and Blood Institute of the National Institutes of Health [T32HL007779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007779] Funding Source: NIH RePORTER	Colombian Institute for the Development of Science and Technology; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Source of funding: The present study was supported by the Colombian Institute for the Development of Science and Technology (COLCIENCIAS 65660418215). Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL007779. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bennett B, 2012, OBESITY, V20, P371, DOI 10.1038/oby.2011.264; Cameron N, 2009, EUR J CLIN NUTR, V63, P1065, DOI 10.1038/ejcn.2009.26; CAMERON N, 1994, AM J PHYS ANTHROPOL, V93, P307, DOI 10.1002/ajpa.1330930304; *CDCP, 2006, BMI CHILDR TEENS; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; De Ferranti Sarah D, 2007, Diab Vasc Dis Res, V4, P285, DOI 10.3132/dvdr.2007.055; Demura SI, 2007, TOHOKU J EXP MED, V213, P51, DOI 10.1620/tjem.213.51; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Goran MI, 1999, AM J HUM BIOL, V11, P201, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;201::AID-AJHB8&gt;3.0.CO;2-R; GORAN MI, 1995, INT J OBESITY, V19, P279; Goran MI, 1998, INT J OBESITY, V22, P549, DOI 10.1038/sj.ijo.0800624; Goran MI, 1998, CORONARY ARTERY DIS, V9, P483, DOI 10.1097/00019501-199809080-00003; Gower BA, 1998, AM J CLIN NUTR, V67, P821, DOI 10.1093/ajcn/67.5.821; Lawrence JM, 2009, DIABETES CARE, V32, pS123, DOI 10.2337/dc09-S204; Lee MS, 2007, ASIA PAC J CLIN NUTR, V16, P594; Lee S, 2006, J PEDIATR-US, V148, P188, DOI 10.1016/j.jpeds.2005.10.001; Liem ET, 2009, EUR J CLIN NUTR, V63, P835, DOI 10.1038/ejcn.2008.57; Maffeis C, 2008, J CLIN ENDOCR METAB, V93, P2122, DOI 10.1210/jc.2007-2089; Masuccio FG, 2009, J PEDIATR ENDOCR MET, V22, P695; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; McCarthy HD, 2006, P NUTR SOC, V65, P385, DOI 10.1079/PNS2006514; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Moreno LA, 2002, ACTA PAEDIATR, V91, P1307, DOI 10.1080/08035250216112; Mueller W, 1988, ANTHROPOMETRIC STAND; National Health and Nutrition Examination Survey, 2000, ANTHR PROC MAN; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Pereira MA, 2003, CLIN CHEM, V49, P540, DOI 10.1373/49.4.540; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; REAVEN GM, 1991, AM HEART J, V121, P1283, DOI 10.1016/0002-8703(91)90434-J; Reilly JJ, 2010, OBES REV, V11, P645, DOI 10.1111/j.1467-789X.2009.00709.x; Semiz S, 2008, INDIAN PEDIATR, V45, P457; Sievenpiper JL, 2001, AM J CLIN NUTR, V73, P567; Tukey John W, 1977, CONCISE ENCY STAT, V2; Tybor DJ, 2008, INT J PEDIATR OBES, V3, P148, DOI 10.1080/17477160802068957; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Villa-Roel C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-28; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Yanovski JA, 1996, AM J CLIN NUTR, V64, P833, DOI 10.1093/ajcn/64.6.833	45	13	15	0	8	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1368-9800	1475-2727		PUBLIC HEALTH NUTR	Public Health Nutr.	FEB	2013	16	2					248	255		10.1017/S136898001200393X	http://dx.doi.org/10.1017/S136898001200393X			8	Public, Environmental & Occupational Health; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Nutrition & Dietetics	076RT	22916737	Green Accepted, Bronze			2022-09-04	WOS:000313976100009
J	Marsch, LA; Gomez-Restrepo, C; Bartels, SM; Bell, K; Camblor, PM; Castro, S; Charry, MPC; Cepeda, M; Cubillos, L; John, D; Jassir, MP; Lemley, SM; Suarez-Obando, F; Torrey, WC; Uribe, JM; Williams, MJ				Marsch, Lisa A.; Gomez-Restrepo, Carlos; Bartels, Sophie M.; Bell, Kathleen; Camblor, Pablo Martinez; Castro, Sergio; Cardenas Charry, Maria Paula; Cepeda, Magda; Cubillos, Leonardo; John, Deepak; Jassir, Maria Paula; Lemley, Shea M.; Suarez-Obando, Fernando; Torrey, William C.; Miguel Uribe, Jose; Williams, Makeda J.			Scaling Up Science-Based Care for Depression and Unhealthy Alcohol Use in Colombia: An Implementation Science Project	PSYCHIATRIC SERVICES			English	Article							LOW-INCOME WOMEN; MENTAL-DISORDERS; MOBILE TECHNOLOGY; HEALTH; BURDEN; INTERVENTIONS; CHALLENGES; QUESTIONS; ADDICTION; SANTIAGO	Background: Mental disorders are a major cause of the global burden of disease and significantly contribute to disability and death. This challenge is particularly evident in low-and middle-income countries (LMICs), where >85% of the world's population live. Latin America is one region comprising LMICs where the burden of mental disorders is high and the availability of mental health services is low. This is particularly evident in Colombia, a country with a long-standing history of violence and associated mental health problems. Methods: This article describes the design of a multisite implementation science project, "Scaling Up Science Based Mental Health Interventions in Latin America" (also known as the DIADA project), that is being conducted in six primary care systems in Colombia. This project, funded via a cooperative agreement from the National Institute of Mental Health, seeks to implement and assess the impact of a new model for promoting widespread access to mental health care for depression and unhealthy alcohol use within primary care settings and building an infrastructure to support research capacity and sustainability of the new service delivery model in Colombia. This care model centrally harnesses mobile health technology to increase the reach of science-based mental health care for depression and unhealthy alcohol use. Results: This initiative offers great promise to increase capacity for providing and sustaining evidence-based treatment for depression and unhealthy alcohol use in Colombia. Next steps: This project may inform models of care that can extend to other regions of Latin America or other LMICs.	[Marsch, Lisa A.; Bartels, Sophie M.; Bell, Kathleen; Camblor, Pablo Martinez; Cubillos, Leonardo; John, Deepak; Lemley, Shea M.; Torrey, William C.] Dartmouth Coll, Ctr Technol & Behav Hlth, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Gomez-Restrepo, Carlos; Castro, Sergio; Cardenas Charry, Maria Paula; Cepeda, Magda; Jassir, Maria Paula; Suarez-Obando, Fernando; Miguel Uribe, Jose] Pontificia Univ Javeriana, Dept Psychiat, Bogota, Colombia; [Gomez-Restrepo, Carlos; Suarez-Obando, Fernando] Hosp Univ San Ignacio, Bogota, Colombia; [Cubillos, Leonardo; Torrey, William C.] Dartmouth Hitchcock, Dept Psychiat, Lebanon, NH USA; [Williams, Makeda J.] NIMH, NIH, Bethesda, MD 20892 USA		Marsch, LA (corresponding author), Dartmouth Coll, Ctr Technol & Behav Hlth, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	lisa.a.marsch@dartmouth.edu		Castro Diaz, Sergio/0000-0001-6820-8711; Suarez-Obando, Fernando/0000-0001-6336-5347	National Institute of Mental Health (NIMH) of the National Institutes of Health [U19 MH-109988]	National Institute of Mental Health (NIMH) of the National Institutes of Health	The research reported in this study was supported by the National Institute of Mental Health (NIMH) of the National Institutes of Health (award U19 MH-109988; principal investigators Drs. Marsch and Gomez-Restrepo).	Alarcon Renato D, 2003, World Psychiatry, V2, P54; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; [Anonymous], 2016, NAT SURV MENT HLTH; [Anonymous], 2014, PLAN ACT MENT HLTH 2; [Anonymous], 2008, SCAL CAR MENT NEUR S; [Anonymous], 2018, BURD MENT DIS REG AM; [Anonymous], 2010, PAN CONS; [Anonymous], 2012 2021 10 YEAR PU; [Anonymous], 2018, NONCOMMUNICABLE DIS; [Anonymous], Research Partnerships for Scaling UpMentalHealth Interventions in Low- and Middle-Income Countries; [Anonymous], 2013, BRAS CONS; [Anonymous], 2019, SCAL SCI BAS MENT HL; [Anonymous], 2018, WHO LAUNCH SAFER ALC; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Balon R, 2016, ACAD PSYCHIATR, V40, P643, DOI 10.1007/s40596-016-0574-3; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bhavnani SP, 2016, EUR HEART J, V37, P1428, DOI 10.1093/eurheartj/ehv770; Bloom D. E., 2011, GLOBAL EC BURDEN NON; Brown C. A., 2006, BMC MED RES METHODOL, V6, P54, DOI [DOI 10.1186/1471-2288-6-54, 10.1186/1471-2288-6-54]; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun A, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130185; Campbell ANC, 2014, AM J PSYCHIAT, V171, P683, DOI 10.1176/appi.ajp.2014.13081055; Cardenas P, 2020, QUAL HEALTH RES, V30, P906, DOI 10.1177/1049732320902460; Castro SM, 2020, ADM POLICY MENT HLTH, V47, P435, DOI 10.1007/s10488-019-01002-4; Chaskel Roberto, 2015, BJPsych Int, V12, P95; Cheung MWL, 2009, STRUCT EQU MODELING, V16, P28, DOI 10.1080/10705510802561295; Cheung MWL, 2005, PSYCHOL METHODS, V10, P40, DOI 10.1037/1082-989X.10.1.40; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Cruz A, 2015, POOR MENTAL HLTH OBS; Dallery J., 2014, BEHAV HLTH CARE TECH; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Gómez-Restrepo Carlos, 2016, rev.colomb.psiquiatr., V45, P58, DOI 10.1016/j.rcp.2016.04.009; Heron KE, 2010, BRIT J HEALTH PSYCH, V15, P1, DOI 10.1348/135910709X466063; Hopko D. R., 2006, BEHAV ANAL TODAY, V7, P212, DOI [10.1037/h0100084, DOI 10.1037/H0100084]; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lewis CC, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-014-0193-x; Luke DA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130184; Marsch LA., 2018, 6 EDITION ASAM PRINC; Marsch LA, 2012, J ADDICT DIS, V31, P313, DOI 10.1080/10550887.2012.694606; Marsch LA, 2012, PSYCHIAT CLIN N AM, V35, P481, DOI 10.1016/j.psc.2012.03.009; Martinez V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-309; McBain RK, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000134; Murray LK, 2014, INTERVENTION, V12, P94, DOI 10.1097/WTF.0000000000000070; Naslund JA, 2017, LANCET PSYCHIAT, V4, P486, DOI 10.1016/S2215-0366(17)30096-2; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Pinto Masís Diana, 2010, rev.colomb.psiquiatr., V39, P465; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rathod S, 2017, HEALTH SERV INSIGHTS, V10, P1, DOI 10.1177/1178632917694350; Rehm J, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-0997-0; Roy M, 2008, SUBST USE MISUSE, V43, P2116, DOI 10.1080/10826080802347586; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schell SF, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-15; Schueller SM., 2014, BEHAV HLTH CARE TECH; Silver L., 2019, SMARTPHONE OWNERSHIP; Simon SS, 2015, INT J GERIATR PSYCH, V30, P223, DOI 10.1002/gps.4239; Smith JE, 2001, AM J ADDICTION, V10, P51, DOI 10.1080/10550490150504137; Spates C.R., 2006, BEHAV ANAL TODAY, V7, P508; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stryiak J, 2019, MOBILE EC ASIA PACIF; Suarez-Obando F, REV COLOMB PSIQUIATR; Torrey WC, 2020, PSYCHIAT SERV, V71, P678, DOI 10.1176/appi.ps.201900457; Trautmann S, 2016, EMBO REP, V17, P1245, DOI 10.15252/embr.201642951; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Valle CG., 2014, BEHAV HLTH CARE TECH; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wigginton C., 2017, GLOBAL MOBILE CONSUM; Zullig LH., 2014, BEHAV HLTH CARE TECH	73	0	0	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	FEB	2022	73	2					196	205		10.1176/appi.ps.202000041	http://dx.doi.org/10.1176/appi.ps.202000041			10	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	0N4VZ	34347504				2022-09-04	WOS:000782838400011
J	Bavarsad, K; Riahi, MM; Saadat, S; Barreto, G; Atkin, SL; Sahebkar, A				Bavarsad, Kowsar; Riahi, Maryam Matbou; Saadat, Saeideh; Barreto, George; Atkin, Stephen L.; Sahebkar, Amirhossein			Protective effects of curcumin against ischemia-reperfusion injury in the liver	PHARMACOLOGICAL RESEARCH			English	Review						Ischemia-reperfusion injury; Curcumin; Liver; Transplantation	NITRIC-OXIDE SYNTHASE; HEPATIC ISCHEMIA/REPERFUSION INJURY; KAPPA-B ACTIVATION; BIOLOGICAL-ACTIVITIES; MOLECULAR-MECHANISMS; GENE-EXPRESSION; IN-VIVO; CYANIDIN 3-O-BETA-D-GLUCOSIDE; NEUTROPHIL CHEMOATTRACTANT; SUPEROXIDE-DISMUTASE	Liver ischemia/reperfusion (I/R) injury is a major complication of hepatic surgery and transplantation. It is one of the leading causes of morbidity and mortality because of post-surgery hepatic dysfunction. Several studies have suggested different mechanisms are involved in the pathogenesis of I/R injury in the liver that includes oxidative stress, inflammation, mitochondria dysfunction, liver Kupffer cells (KCs) activation, vascular cell adhesion molecule overexpression, and facilitation of polymorphonuclear neutrophil injury. Curcumin is a natural product extracted from Curcuma longa that is known to suppress these pathways and as a result reduces liver ischemia-reperfusion injury. This paper gives an overview of the protective effects of curcumin against I/R injury in the liver and discusses the studies that have linked biological functions of curcumin with liver I/R injury improvement.	[Bavarsad, Kowsar; Saadat, Saeideh] Mashhad Univ Med Sci, Dept Physiol, Fac Med, Mashhad, Iran; [Riahi, Maryam Matbou] Isfahan Univ Med Sci, Cardiovasc Res Inst, Heart Failure Res Ctr, Esfahan, Iran; [Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Atkin, Stephen L.] Weill Cornell Med Qatar, Doha, Qatar; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Bavarsad, Kowsar/AAW-9150-2020; Saadat, Saeideh/Z-1064-2019; Atkin, stephen/ABE-7047-2020; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971	cancer research center of cancer institute of Iran (Shams cancer charity) [37312-202-01-97]; National Institute for Medical Research Development (NIMAD) of Iran [965464]	cancer research center of cancer institute of Iran (Shams cancer charity); National Institute for Medical Research Development (NIMAD) of Iran	This project has been conduct by a grant from cancer research center of cancer institute of Iran (Shams cancer charity, Grant No: 37312-202-01-97) and the National Institute for Medical Research Development (NIMAD) of Iran (code 965464).	Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Adam R, 1998, Transpl Int, V11 Suppl 1, pS168, DOI 10.1007/s001470050453; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Arai N, 2001, LIVER TRANSPLANT, V7, P292; Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Aydin MS, 2014, INT J SURG, V12, P601, DOI 10.1016/j.ijsu.2014.04.013; Behroozi-Lak T, 2018, REV ASSOC MED BRAS, V64, P22, DOI 10.1590/1806-9282.64.01.22; Ben-Ari Z, 2012, CELL PHYSIOL BIOCHEM, V30, P489, DOI 10.1159/000341432; BROUET I, 1995, BIOCHEM BIOPH RES CO, V206, P533, DOI 10.1006/bbrc.1995.1076; Bucak MN, 2012, ANDROLOGIA, V44, P102, DOI 10.1111/j.1439-0272.2010.01146.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Caldwell CC, 2005, AM J PHYSIOL-GASTR L, V289, pG969, DOI 10.1152/ajpgi.00223.2005; Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2; Chen CG, 2006, TRANSPLANTATION, V82, P931, DOI 10.1097/01.tp.0000232674.52951.ff; Chi XW, 2017, EUR J PHARM SCI, V100, P94, DOI 10.1016/j.ejps.2016.12.042; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.5114/aoms.2017.69326, 10.1093/nutrit/nux047]; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Dcodhar S., 2013, INDIAN J MED RES, V138, P1; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; de Rougemont O, 2009, ANN SURG, V250, P674, DOI 10.1097/SLA.0b013e3181bcb1ee; deVera ME, 1996, HEPATOLOGY, V24, P1238; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Eser A, 2015, BIOMED REP, V3, DOI 10.3892/br.2015.515; Fan Z, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/191624; Farmer D. G., 2000, TRANSPLANT REV, V14, P106, DOI DOI 10.1053/TR.2000.4651; FERREIRA LAF, 1992, TOXICON, V30, P1211, DOI 10.1016/0041-0101(92)90437-A; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gaddipati JP, 2003, SHOCK, V19, P150, DOI 10.1097/00024382-200302000-00011; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Gehrau RC, 2013, TRANSPLANTATION, V96, P926, DOI 10.1097/TP.0b013e3182a20398; Ghoneim AI, 2002, PHARMACOL RES, V46, P273, DOI 10.1016/S1043-6618(02)00123-8; Guan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Harbrecht B. G., 1995, SHOCK AUGUSTA GA, V3, P31; HECKER M, 1995, FEBS LETT, V359, P251, DOI 10.1016/0014-5793(95)00039-C; Hines IN, 2003, AM J PHYSIOL-GASTR L, V284, pG536, DOI 10.1152/ajpgi.00400.2002; Husted TL, 2006, CURR PHARM DESIGN, V12, P2867, DOI 10.2174/138161206777947597; IKEDA T, 1992, HEPATOLOGY, V16, P454, DOI 10.1002/hep.1840160226; Iranshahi M, 2010, PHYTOMEDICINE, V17, P269, DOI 10.1016/j.phymed.2009.05.020; Ismail A. F. M., 2016, Journal of Chemical and Pharmaceutical Research, V8, P773; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jacob A, 2007, PPAR RES, V2007, DOI 10.1155/2007/89369; JAESCHKE H, 1992, J LEUKOCYTE BIOL, V52, P377, DOI 10.1002/jlb.52.4.377; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jaeschke  H., 1990, METHOD ENZYMOL, P752; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Jayaprakasha GK, 2005, TRENDS FOOD SCI TECH, V16, P533, DOI 10.1016/j.tifs.2005.08.006; Johnston TD, 1999, TRANSPLANTATION, V67, pS652, DOI 10.1097/00007890-199905150-00463; Kakkar  V., 2013, CURCUMIN LOADED SOLI; Kalani A, 2016, INT J BIOCHEM CELL B, V79, P360, DOI 10.1016/j.biocel.2016.09.002; Kalani A, 2015, NEURAL REGEN RES, V10, P1565, DOI 10.4103/1673-5374.165305; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Kato K, 1998, CELL STRESS CHAPERON, V3, P152, DOI 10.1379/1466-1268(1998)003<0152:SOTSIE>2.3.CO;2; Ke BB, 2010, MOL THER, V18, P1019, DOI 10.1038/mt.2009.285; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069; Liang R, 2009, TRANSPL INT, V22, P1100, DOI 10.1111/j.1432-2277.2009.00925.x; Lin CM, 2012, TRANSPL P, V44, P974, DOI 10.1016/j.transproceed.2012.01.081; Liu AC, 2006, J PHARMACEUT BIOMED, V40, P720, DOI 10.1016/j.jpba.2005.09.032; Liu JF, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/638153; LIU PT, 1994, CIRC SHOCK, V43, P64; Liu W, 1996, HEPATOLOGY, V24, P157, DOI 10.1002/hep.510240126; Liu Y, 2018, INT IMMUNOPHARMACOL, V62, P270, DOI 10.1016/j.intimp.2018.07.013; Lu TF, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e24; Madan B, 2003, SHOCK, V19, P91, DOI 10.1097/00024382-200301000-00017; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Manipuri  P., 2013, J BIOANAL BIOMED, V5; Mendes-Braz  M., 2012, J BIOMED BIOTECHNOL, V2012, P20; Mendes-Braz  M., 2012, BIOMED RES INT, V2012; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Mirzaei H, 2017, BIOMED PHARMACOTHER, V85, P102, DOI 10.1016/j.biopha.2016.11.098; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Montesino NL, 2015, MOLECULES, V20, P14118, DOI 10.3390/molecules200814118; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Moussavian MR, 2011, LANGENBECK ARCH SURG, V396, P231, DOI 10.1007/s00423-010-0668-4; Nickkholgh A, 2008, SURG ENDOSC, V22, P122, DOI 10.1007/s00464-007-9386-6; Notarbartolo M, 2005, CANCER LETT, V224, P53, DOI 10.1016/j.canlet.2004.10.051; Oguz A, 2013, EUR REV MED PHARMACO, V17, P457; Oguz  A., 2013, EFFECTS CURCUMIN LIV; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Pan SH, 2013, MOL NUTR FOOD RES, V57, P1218, DOI 10.1002/mnfr.201300010; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Pantazi E, 2016, EXPERT OPIN PHARMACO, V17, P169, DOI 10.1517/14656566.2016.1115015; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Rogers NM, 2012, BRIT J PHARMACOL, V166, P194, DOI 10.1111/j.1476-5381.2011.01590.x; Sahebkar A, 2016, PAIN MED, V17, P1192, DOI 10.1093/pm/pnv024; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Sahebkar A, 2014, CLIN NUTR, V33, P406, DOI 10.1016/j.clnu.2013.09.012; Sahebkar A, 2010, FERTIL STERIL, V94, pE75, DOI 10.1016/j.fertnstert.2010.07.1071; Saidi SA, 2018, BIOPHARM DRUG DISPOS, V39, P18, DOI 10.1002/bdd.2108; Sak ME, 2013, INT J SURG, V11, P967, DOI 10.1016/j.ijsu.2013.06.007; SCHOENIGER LO, 1994, GASTROENTEROLOGY, V106, P177, DOI 10.1016/S0016-5085(94)95209-4; Scotter MJ, 2011, FOOD ADDIT CONTAM A, V28, P527, DOI 10.1080/19440049.2011.555844; Shahed AR, 2001, TRANSPLANT P, V33, P2988, DOI 10.1016/S0041-1345(01)02283-7; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Shen SQ, 2007, WORLD J GASTROENTERO, V13, P1953, DOI 10.3748/wjg.v13.i13.1953; Shen XD, 2012, AM J TRANSPLANT, V12, P1730, DOI 10.1111/j.1600-6143.2012.04021.x; Shen XD, 2011, LIVER TRANSPLANT, V17, P201, DOI 10.1002/lt.22214; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; Sood A, 2001, BIOCHEM BIOPH RES CO, V283, P36, DOI 10.1006/bbrc.2001.4749; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tapuria N, 2016, WORLD J GASTROENTERO, V22, P7518, DOI 10.3748/wjg.v22.i33.7518; Teow SY, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/2853045; Thangapazham RL, 2007, ADV EXP MED BIOL, V595, P343; Thuillier R, 2014, AM J TRANSPLANT, V14, P1073, DOI 10.1111/ajt.12661; Tokac M, 2017, TURK J PHARM SCI, V14, P257, DOI 10.4274/tjps.49369; Tsuda T, 1999, ARCH BIOCHEM BIOPHYS, V368, P361, DOI 10.1006/abbi.1999.1311; Tsuda T, 2002, J NUTR SCI VITAMINOL, V48, P134, DOI 10.3177/jnsv.48.134; Tvrda  Eva, 2016, INT J BIOL BIOMOL AG; Wang L, 2017, ONCOTARGET, V8, P65414, DOI 10.18632/oncotarget.18676; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wang ZY, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0511-1; Wei SM, 2009, FERTIL STERIL, V91, P271, DOI 10.1016/j.fertnstert.2007.10.082; Wu NC, 2014, TRANSPL P, V46, P1135, DOI 10.1016/j.transproceed.2013.12.020; Xu Y, 2016, ONCOTARGET, V7, P87390, DOI 10.18632/oncotarget.13626; Yabe Y, 2001, J PHARMACOL EXP THER, V298, P894; Yeh CH, 2005, J SURG RES, V125, P109, DOI 10.1016/j.jss.2004.11.009; Yin DP, 1998, TRANSPLANTATION, V66, P152, DOI 10.1097/00007890-199807270-00002; Yoshidome H, 2000, J HEPATOL, V33, P59, DOI 10.1016/S0168-8278(00)80160-9; Zabihi NA, 2017, CURR PHARM DESIGN, V23, P969, DOI 10.2174/1381612822666161010115235; Zaki HF, 2013, CAN J PHYSIOL PHARM, V91, P1064, DOI 10.1139/cjpp-2013-0097; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225; Zheng WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148677; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou WH, 2001, HEPATOLOGY, V33, P902, DOI 10.1053/jhep.2001.23073	141	37	38	1	16	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618	1096-1186		PHARMACOL RES	Pharmacol. Res.	MAR	2019	141						53	62		10.1016/j.phrs.2018.12.014	http://dx.doi.org/10.1016/j.phrs.2018.12.014			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HO5VT	30562571				2022-09-04	WOS:000460997000005
J	Forouzanfar, F; Butler, AE; Banach, M; Barreto, GE; Sahbekar, A				Forouzanfar, Fatemeh; Butler, Alexandra E.; Banach, Maciej; Barreto, George E.; Sahbekar, Amirhossein			Modulation of heat shock proteins by statins	PHARMACOLOGICAL RESEARCH			English	Review						Statin; Heat shock proteins; HMG-CoA; Atherogenesis	CONTRAST-INDUCED NEPHROPATHY; CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; 27 ANTIBODY-TITERS; NITRIC-OXIDE; REPERFUSION INJURY; HEME OXYGENASE-1; GROWTH-FACTOR; UP-REGULATION; CARDIOVASCULAR-DISEASE	Heat shock proteins (HSP or stress proteins) are intracellular molecules that participate in physiological cell metabolism and growth, although they are known to be involved in many stress conditions. Statins inhibit the action of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA), which is important in the synthesis of cholesterol and essential isoprenoid intermediates, thereby lowering circulating low-density lipoprotein cholesterol (LDL), a major risk factor for cardiovascular disease (CVD). This review provides new insights into the mechanisms of action of statins in the regulation of HSPs. A better understanding of this involvement can help in development of new and more effective treatment strategies for CVD.	[Forouzanfar, Fatemeh] Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Iran; [Butler, Alexandra E.] Antidoping Lab Qatar, Life Sci Res Div, Sports City Rd, Doha, Qatar; [Banach, Maciej] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Zeromskiego 113, Lodz, Poland; [Banach, Maciej] PMMHRI, Lodz, Poland; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahbekar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahbekar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran; [Sahbekar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran		Sahbekar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Iran.	sahebkara@mums.ac.ir	Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018; Banach, Maciej/A-1271-2009	Barreto, George E./0000-0002-6644-1971; Banach, Maciej/0000-0001-6690-6874				Acunzo J, 2014, CURR DRUG TARGETS, V15, P423, DOI 10.2174/13894501113146660230; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Arianpour R, 2014, J PHARM SCI, V20, P46; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Azarpazhooh MR, 2010, ANGIOLOGY, V61, P607, DOI 10.1177/0003319709360524; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Banach M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0459-4; Banach M, 2015, PHARMACOL RES, V99, P329, DOI 10.1016/j.phrs.2015.07.008; Banach M, 2015, MAYO CLIN PROC, V90, P24, DOI 10.1016/j.mayocp.2014.08.021; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bellosta S, 2018, EXPERT OPIN DRUG SAF, V17, P25, DOI 10.1080/14740338.2018.1394455; Bielecka-Dabrowa A, 2018, TRENDS PHARMACOL SCI, V39, P331, DOI 10.1016/j.tips.2018.02.003; Bielecka-Dabrowa A, 2009, EXPERT OPIN THER TAR, V13, P307, DOI [10.1517/14728220902725149, 10.1517/14728220902725149 ]; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bobryshev YV, 2002, J VASC SURG, V35, P368, DOI 10.1067/mva.2002.121067; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Buhlin K, 2003, EUR HEART J, V24, P2099, DOI 10.1016/j.ehj.2003.09.016; Burma O, 2014, CARDIOVASC J AFR, V25, P212, DOI 10.5830/CVJA-2014-038; Chrusciel P, 2016, ATHEROSCLEROSIS, V253, P194, DOI 10.1016/j.atherosclerosis.2016.07.897; Ciocca DR, 2003, CELL STRESS CHAPERON, V8, P26, DOI 10.1379/1466-1268(2003)8<26:HAHIRT>2.0.CO;2; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Dapper JD, 2013, NEUROBIOL DIS, V59, P26, DOI 10.1016/j.nbd.2013.07.001; Derosa G, 2016, DRUGS, V76, P947, DOI 10.1007/s40265-016-0591-2; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferretti G, 2015, PROG LIPID RES, V60, P50, DOI 10.1016/j.plipres.2015.08.003; Forouzanfar F, 2016, PHYTOTHER RES, V30, P1954, DOI 10.1002/ptr.5701; Fu Q, 2008, CIRC RES, V103, P369, DOI 10.1161/CIRCRESAHA.108.174607; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Ghayour-Mobarhan M, 2005, ANGIOLOGY, V56, P61, DOI 10.1177/000331970505600108; Ghayour-Mobarhan M, 2008, INT J EXP PATHOL, V89, P209, DOI 10.1111/j.1365-2613.2008.00586.x; Ghayour-Mobarhan M, 2012, CLIN CHIM ACTA, V413, P15, DOI 10.1016/j.cca.2011.04.005; Ghazavi H, 2017, STEM CELL REV REP, V13, P670, DOI 10.1007/s12015-017-9755-z; Goradel NH, 2018, J CELL PHYSIOL, V233, P2902, DOI 10.1002/jcp.26029; Gueler F, 2007, AM J PATHOL, V170, P1192, DOI 10.2353/ajpath.2007.060782; Guisasola MC, 2009, LIPIDS, V44, P317, DOI 10.1007/s11745-008-3265-3; Ham A, 2014, KIDNEY INT, V85, P807, DOI 10.1038/ki.2013.345; He XY, 2017, MOL MED REP, V15, P1963, DOI 10.3892/mmr.2017.6251; He XY, 2016, J PHARMACOL SCI, V131, P18, DOI 10.1016/j.jphs.2016.03.006; Heidari-Bakavoli AR, 2012, ANGIOLOGY, V63, P12, DOI 10.1177/0003319711406104; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jones SE, 1998, NEUROREPORT, V9, P4161, DOI 10.1097/00001756-199812210-00030; Kavalipati Narasaraju, 2015, Indian J Endocrinol Metab, V19, P554, DOI 10.4103/2230-8210.163106; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee SJ, 2014, BRIT J CANCER, V111, P497, DOI 10.1038/bjc.2014.283; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li ML, 2013, MOL CELL BIOL, V33, P2315, DOI 10.1128/MCB.00931-12; Li Y, 2003, INVEST OPHTH VIS SCI, V44, P1299, DOI 10.1167/iovs.02-0235; Li Y, 2013, INT J BIOL MACROMOL, V57, P259, DOI 10.1016/j.ijbiomac.2013.03.035; Li Z., 2004, CURRENT PROTOCOLS IM; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Liu CC, 2013, EUR REV MED PHARMACO, V17, P2103; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu Y, 2002, EUR J VASC ENDOVASC, V24, P269, DOI 10.1053/ejvs.2002.1690; Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004; Madden J, 2010, CELL BIOL TOXICOL, V26, P215, DOI 10.1007/s10565-009-9134-x; Manjili MH, 2002, CANCER RES, V62, P1737; Manucha W, 2011, EUR J PHARMACOL, V650, P487, DOI 10.1016/j.ejphar.2010.09.059; Margaritis M, 2014, ANTIOXID REDOX SIGN, V20, P1198, DOI 10.1089/ars.2013.5430; Matsumoto T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126229; Matusiak A, 2016, ARCH MED SCI, V12, P45, DOI 10.5114/aoms.2015.50772; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Garcia IM, 2012, NITRIC OXIDE-BIOL CH, V27, P95, DOI 10.1016/j.niox.2012.05.006; Michalska-Kasiczak M, 2015, INT J CARDIOL, V178, P111, DOI 10.1016/j.ijcard.2014.10.118; Moohebati M, 2011, CLIN BIOCHEM, V44, P192, DOI 10.1016/j.clinbiochem.2010.09.016; Moser C, 2012, ANTICANCER RES, V32, P2551; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Muntean DM, 2017, DRUG DISCOV TODAY, V22, P85, DOI 10.1016/j.drudis.2016.09.001; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parizadeh SMR, 2011, LIPIDS, V46, P333, DOI 10.1007/s11745-010-3517-x; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pirillo A, 1997, BIOCHEM BIOPH RES CO, V231, P437, DOI 10.1006/bbrc.1997.6117; Pockley A. G., 2000, Immunology, V101, P39; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Ramkumar S, 2016, ACTA CARDIOL SIN, V32, P631, DOI 10.6515/ACS20160611A; Rashid M, 2009, CIRC J, V73, P361, DOI 10.1253/circj.CJ-08-0817; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; ROBINSON GA, 1995, MOL BRAIN RES, V30, P61, DOI 10.1016/0169-328X(94)00277-L; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sadeghnia HR, 2017, FOLIA NEUROPATHOL, V55, P206, DOI 10.5114/fn.2017.70485; Sadeghnia HR, 2017, IRAN J BASIC MED SCI, V20, P594, DOI 10.22038/IJBMS.2017.8847; Sahebkar A, 2016, INT J CARDIOL, V212, P160, DOI 10.1016/j.ijcard.2016.03.010; Sahebkar A, 2016, AUTOIMMUN REV, V15, P344, DOI 10.1016/j.autrev.2015.12.007; Sahebkar A, 2016, PHARMACOL RES, V103, P17, DOI 10.1016/j.phrs.2015.10.013; Sahebkar A, 2015, METABOLISM, V64, P1466, DOI 10.1016/j.metabol.2015.08.002; Sahebkar A, 2015, THROMB HAEMOSTASIS, V114, P546, DOI 10.1160/TH14-11-0937; Sahebkar A, 2015, ATHEROSCLEROSIS, V241, P433, DOI 10.1016/j.atherosclerosis.2015.05.022; Sahebkar A, 2011, CLIN BIOCHEM, V44, P1390, DOI 10.1016/j.clinbiochem.2011.09.011; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; Serban C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09902; Shin YO, 2006, INT HEART J, V47, P671, DOI 10.1536/ihj.47.671; Soran H, 2018, ARCH MED SCI, V14, P1, DOI 10.5114/aoms.2018.72238; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Tao X, 2015, NEUROL RES, V37, P229, DOI 10.1179/1743132814Y.0000000427; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Uchiyama T, 2006, ATHEROSCLEROSIS, V188, P265, DOI 10.1016/j.atherosclerosis.2005.10.045; UDONO H, 1994, J IMMUNOL, V152, P5398; Vrtovec B, 2008, J CARD FAIL, V14, P140, DOI 10.1016/j.cardfail.2007.10.013; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3; Wang XY, 2001, J IMMUNOL, V166, P490, DOI 10.4049/jimmunol.166.1.490; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Xu QB, 1999, CIRCULATION, V100, P1169, DOI 10.1161/01.CIR.100.11.1169; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110; Zhu JH, 2001, CIRCULATION, V103, P1071, DOI 10.1161/01.CIR.103.8.1071	127	7	7	0	4	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	AUG	2018	134						134	144		10.1016/j.phrs.2018.06.020	http://dx.doi.org/10.1016/j.phrs.2018.06.020			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GR5UX	29935271				2022-09-04	WOS:000442708500013
J	Tomatsu, S; Sawamoto, K; Shimada, T; Bober, MB; Kubaski, F; Yasuda, E; Mason, RW; Khan, S; Almeciga-Diaz, CJ; Barrera, LA; Mackenzie, WG; Orii, T				Tomatsu, Shunji; Sawamoto, Kazuki; Shimada, Tsutomu; Bober, Michael B.; Kubaski, Francyne; Yasuda, Eriko; Mason, Robert W.; Khan, Shaukat; Almeciga-Diaz, Carlos J.; Barrera, Luis A.; Mackenzie, William G.; Orii, Tadao			Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations	EXPERT OPINION ON ORPHAN DRUGS			English	Review						Chondroitin-6-sulfate; enzyme replacement therapy; keratan sulfate; mucopolysaccharidosis IVA; skeletal dysplasia	N-ACETYLGALACTOSAMINE 4-SULFATASE; DRUG-DELIVERY SYSTEM; II HUNTER-SYNDROME; BONE-MARROW-TRANSPLANTATION; TANDEM MASS-SPECTROMETRY; MAROTEAUX-LAMY-SYNDROME; SURROGATE END-POINTS; 6-MINUTE WALK TEST; KERATAN-SULFATE; OPEN-LABEL	Introduction: Following a Phase III, randomized, double-blind, placebo (PBO)-controlled, multinational study in subjects with mucopolysaccharidosis IVA (MPS IVA), enzyme replacement therapy (ERT) of elosulfase alfa has been approved in several countries. The study was designed to evaluate safety and efficacy of elosulfase alfa in patients with MPS IVA aged 5 years and older.Areas covered: Outcomes of clinical trials for MPS IVA have been described. Subjects received either 2.0 mg/kg/week, 2.0 mg/kg/every other week, or PBO, for 24 weeks. The primary endpoint was the change from baseline 6-min walk test (6MWT) distance compared to PBO. The 6MWT results improved in patients receiving 2 mg/kg weekly compared to PBO. The every other week regimen resulted in walk distances comparable to PBO. There was no change from baseline in the 3 Min Stair Climb Test in both treatment groups. Following completion of the initial study, patients, who continued to receive elosulfase alfa 2 mg/kg weekly (QW) for another 48 weeks (for a total of up to 72-week exposure), did not show additional improvement on 6MWT.Expert opinion: We suggest that ERT is a therapeutic option for MPS IVA, providing a modest effect and the majority of the effects are seen in the soft tissues.	[Tomatsu, Shunji; Sawamoto, Kazuki; Shimada, Tsutomu; Bober, Michael B.; Kubaski, Francyne; Yasuda, Eriko; Mason, Robert W.; Khan, Shaukat; Mackenzie, William G.] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19899 USA; [Tomatsu, Shunji; Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan; [Shimada, Tsutomu; Yasuda, Eriko] Kanazawa Univ, Grad Sch Med Sci, Dept Med Informat, Kanazawa, Ishikawa, Japan; [Kubaski, Francyne] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Almeciga-Diaz, Carlos J.; Barrera, Luis A.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Sch Sci, Bogota, Colombia		Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia Ctr, Nemours Biomed Res, Wilmington, DE 19899 USA.	stomatsu@nemours.org	Kubaski, Francyne/M-2410-2017; Alméciga-Díaz, Carlos J/A-2494-2017; Bober, Michael/AAH-4553-2021	Kubaski, Francyne/0000-0002-9330-0154; Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Bober, Michael/0000-0002-6178-1264	Austrian MPS Society; Bennett Foundation; International Morquio Organization (Carol Ann Foundation); Japanese MPS Family Society; Biomarin; National institute of General Medical Sciences of NIH [P20GM103464]; National Institutes of Health [R01HD065767]; Conselho Nacional dc Desenvolvimento Cientifico e Tecnologico from Brazil (CNPq); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114736, P20GM103464] Funding Source: NIH RePORTER	Austrian MPS Society; Bennett Foundation; International Morquio Organization (Carol Ann Foundation); Japanese MPS Family Society; Biomarin; National institute of General Medical Sciences of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional dc Desenvolvimento Cientifico e Tecnologico from Brazil (CNPq); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This review article was supported by grants from the Austrian MPS Society, The Bennett Foundation, and International Morquio Organization (Carol Ann Foundation). This work was also supported by Japanese MPS Family Society. WG MacKenzie is a clinical consultant for Biomarin, and MB Bober was a Principal investigator in the Biomarin sponsored MOR-004 and 005 trials and is also a clinical consultant for the company. RW Mason and S Tomatsu were supported by an institutional Development Award (IDeA) from the National institute of General Medical Sciences of NIH under grant number P20GM103464, S Tomatsu was supported by National Institutes of Health grant R01HD065767. F Kubaski was supported by Conselho Nacional dc Desenvolvimento Cientifico e Tecnologico from Brazil (CNPq). The content of the article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other sponsors. Editorial assistance to the manuscript was provided by Michelle Stofa at Nemours/Alfred I. duPont Hospital for Children. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.	[Anonymous], EL ALF MUC TYP IVA; Aronson JK, 2012, BRIT J CLIN PHARMACO, V73, P900, DOI 10.1111/j.1365-2125.2012.04234.x; Aronson JK, 2005, BRIT J CLIN PHARMACO, V59, P491, DOI 10.1111/j.1365-2125.2005.02435.x; BECK M, 1992, PRENATAL DIAG, V12, P1019, DOI 10.1002/pd.1970121207; BECK M, 1986, CLIN GENET, V29, P325; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Chinen Y, 2014, MOLEC GENET METAB RE, V1, P31, DOI 10.1016/j.ymgmr.2013.11.002; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Connock M, 2006, HEALTH TECHNOL ASSES, V10, P1; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Donida B, 2015, BBA-MOL BASIS DIS, V1852, P1012, DOI 10.1016/j.bbadis.2015.02.004; Dorfman A, 1976, Adv Exp Med Biol, V68, P261; Dvorak-Ewell M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012194; Elloumi M, 2011, PHYSIOTHER RES INT, V16, P32, DOI 10.1002/pri.470; Espejo-Mojica AJ, 2015, MOL GENET METAB; FUJIMOTO A, 1983, AM J MED GENET, V15, P265, DOI 10.1002/ajmg.1320150210; Fujisaki J, 1998, J DRUG TARGET, V5, P129, DOI 10.3109/10611869808995866; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gulmans VAM, 1996, PEDIATR PULM, V22, P85, DOI 10.1002/(SICI)1099-0496(199608)22:2<85::AID-PPUL1>3.0.CO;2-I; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Harmatz P, 2013, MOL GENET METAB, V109, P54, DOI 10.1016/j.ymgme.2013.01.021; Hendriks CJ, 2014, MOL GENET METAB; Hendriksz C, 2012, MOL GENET METAB, V105, pS35, DOI 10.1016/j.ymgme.2011.11.076; Hendriksz CJ, 2014, J INHERIT METAB DIS, V37, P979, DOI 10.1007/s10545-014-9715-6; Hendriksz CJ, 2013, J INHERIT METAB DIS, V36, P309, DOI 10.1007/s10545-012-9459-0; Hintze JP, 2011, BIOMARK INSIGHTS, V6, P69, DOI 10.4137/BMI.S7451; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Lau AA, 2013, JIMD REP, V8, P121, DOI 10.1007/8904_2012_169; Martell LA, 2011, BIOANALYSIS, V3, P1855, DOI [10.4155/BIO.11.172, 10.4155/bio.11.172]; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; NAGATA T, 1991, BIOCHEM J, V274, P513, DOI 10.1042/bj2740513; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI 10.1111/j.1651-2227.2009.01134.x; Oikawa H, 2014, J INHERIT METAB DIS, V37, P309, DOI 10.1007/s10545-013-9646-7; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Orii T., 1971, BONE METAB, V5, P72; Orii T, 1981, CONNECT TISSUE RES, V13, P169; Paciotti S, 2012, CLIN CHIM ACTA, V413, P1827, DOI 10.1016/j.cca.2012.07.011; Parveen S, 2006, CLIN PHARMACOKINET, V45, P965, DOI 10.2165/00003088-200645100-00002; Patel P, 2014, MOLEC GENET METAB RE, V1, P5, DOI 10.1016/j.ymgmr.2013.10.001; Patel P, 2014, MOLEC GENET METAB RE, V1, P184, DOI 10.1016/j.ymgmr.2014.04.001; Preedy V.R., 2012, HDB GROWTH GROWTH MO, P2091, DOI DOI 10.1007/978-1-4419-1795-9_126; Qi YL, 2014, CLIN PHARMACOKINET, V53, P1137, DOI 10.1007/s40262-014-0173-y; Rodriguez A, 2010, J IND MICROBIOL BIOT, V37, P1193, DOI 10.1007/s10295-010-0766-x; Rodriguez ME, 2010, PEDIATR PULM, V45, P679, DOI 10.1002/ppul.21246; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Rowan DJ, 2012, MOL GENET METAB, V107, P161, DOI 10.1016/j.ymgme.2012.07.002; SANDS MS, 1993, LAB INVEST, V68, P676; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0; Shimada T, 2014, J INHERIT M IN PRESS; Shimada T, 2014, JIMD REP, V16, P15, DOI 10.1007/8904_2014_311; Soper BW, 2001, BLOOD, V97, P1498, DOI 10.1182/blood.V97.5.1498; Tanjuakio J., 2014, MOL GENET METAB; Theroux MC, 2012, PEDIATR ANESTH, V22, P901, DOI 10.1111/j.1460-9592.2012.03904.x; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; Tomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; Tomatsu S., 2014, MOL GENET METAB; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Tomatsu S, 2014, PEDIATR ENDOCR REV P, V12, P141; Tomatsu S, 2013, EXPERT OPIN ORPHAN D, V1, P805, DOI 10.1517/21678707.2013.846853; Tomatsu S, 2010, J INHERIT METAB DIS, V33, pS35, DOI 10.1007/s10545-009-9013-x; Tomatsu S, 2013, MOL GENET METAB, V110, P42, DOI 10.1016/j.ymgme.2013.06.007; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65, DOI 10.2147/RRED.S37278; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Dung VC, 2013, MOL GENET METAB, V110, P129, DOI 10.1016/j.ymgme.2013.06.008; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228	84	37	38	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2167-8707			EXPERT OPIN ORPHAN D	Exp. Opin. Orphan Drugs	NOV 2	2015	3	11					1279	1290		10.1517/21678707.2015.1086640	http://dx.doi.org/10.1517/21678707.2015.1086640			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CV8QN	26973801	Green Accepted			2022-09-04	WOS:000364552900003
J	Runzer-Colmenares, FM; Samper-Ternent, R; Al Snih, S; Ottenbacher, KJ; Parodi, JF; Wong, R				Runzer-Colmenares, Fernando M.; Samper-Ternent, Rafael; Al Snih, Soham; Ottenbacher, Kenneth J.; Parodi, Jose F.; Wong, Rebeca			Prevalence and factors associated with frailty among Peruvian older adults	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Frailty; Peru; Older Veterans; Risk factors; Prevalence	CLOCK-DRAWING TEST; MEXICAN-AMERICANS; COGNITIVE IMPAIRMENT; VALIDITY; WOMEN; MEN; DISABILITY; PHENOTYPE; MORTALITY	The objective of this study is to examine the prevalence and factors associated with frailty in Peruvian Navy Veteran's older adults and family members. A total of 311 non-institutionalized men and women aged 60 years and older, from the Geriatrics Service of the Peruvian Navy Medical Center (Centro Medico Naval "Cirujano Mayor Santiago Tavara") were assessed between May and October 2010. Frailty was defined as having two or more of the following components: (1) unintentional weight-loss, (2) weakness (lowest 20% in grip-strength), (3) self-reported exhaustion, and (4) slow walking speed (lowest 20% 8-m walk-time in seconds). Additionally, information on socio-demographic factors, medical conditions, depressive symptoms, disability, and cognitive function were obtained. Of the 311 participants, 78 (25.1%) were not frail, 147 (47.3%) were pre-frail, and 86 (27.8%) were frail. Using logistic regression analysis, we found that older age, being married, falls in the last year and disability were factors significantly associated with being frail. We conclude that prevalence of pre-frail and frail status in Peruvian Navy Veterans and family members is high. Our data reports risk factors for frailty that have been reported in the past in other population groups. A larger sample and longitudinal follow-up are needed to design and implement comprehensive geriatric interventions that can benefit Peruvian Navy Veteran's older adults at risk of becoming frail. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Runzer-Colmenares, Fernando M.; Parodi, Jose F.] Univ San Martin de Porres, Aging Investigat Ctr, Lima, Peru; [Runzer-Colmenares, Fernando M.] Peruvian Naval Med Ctr, Callao, Peru; [Samper-Ternent, Rafael] Univ Javeriana, Hosp San Ignacio, Bogota, Colombia; [Al Snih, Soham; Ottenbacher, Kenneth J.; Wong, Rebeca] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Al Snih, Soham; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Al Snih, Soham] Univ Texas Med Branch, Dept Internal Med, Div Geriatr, Galveston, TX 77555 USA		Runzer-Colmenares, FM (corresponding author), Geriatr Dept Off, Bamboo Seniors Hlth Serv Bldg,Caminos Inca Ave 55, Lima, Peru.	Fernandorunzer@gmail.com; soalsnih@utmb.edu	Samper-Ternent, Rafael Antonio/C-1453-2012; Runzer-Colmenares, Fernando M./K-7924-2019; Snih, Soham Al/ABC-2882-2020; Parodi, Jose Francisco/N-8299-2017	Samper-Ternent, Rafael Antonio/0000-0002-2250-9401; Parodi, Jose Francisco/0000-0002-0336-0584; Al Snih, Soham/0000-0002-0681-4641; /0000-0003-4045-0260; Ottenbacher, Kenneth/0000-0001-5990-3982	National Institute on Aging of the National Institutes of Health [P30-AG024832, R03-AG029959, R24-HD065702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, R03AG029959] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the National Institute on Aging of the National Institutes of Health (P30-AG024832 Older Americans Independence Center, R03-AG029959 and R24-HD065702). Infrastructure support provided by the WHO/PAHO Collaborating Center on Aging and Health in the Sealy Center on Aging at the University of Texas Medical Branch. Study sponsors had no role in the study design, data collection, analysis or interpretation of the data. Study sponsors did not have any role in the writing of the manuscript or the submission to a journal.	Al Snih S, 2009, J REHABIL MED, V41, P892, DOI 10.2340/16501977-0424; Alvarado BE, 2008, J GERONTOL A-BIOL, V63, P1399, DOI 10.1093/gerona/63.12.1399; Andela RM, 2010, INT J NURS PRACT, V16, P14, DOI 10.1111/j.1440-172X.2009.01807.x; Avila-Funes JA, 2009, J AM GERIATR SOC, V57, P453, DOI 10.1111/j.1532-5415.2008.02136.x; Borges LL, 2011, REV CLIN GERONTOL, V21, P67, DOI 10.1017/S0959259810000304; Borson S, 1999, J GERONTOL A-BIOL, V54, pM534, DOI 10.1093/gerona/54.11.M534; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Bowers D., 2008, MED STAT SCRATCH; Boyle PA, 2010, J AM GERIATR SOC, V58, P248, DOI 10.1111/j.1532-5415.2009.02671.x; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Ensrud KE, 2009, J AM GERIATR SOC, V57, P2085, DOI 10.1111/j.1532-5415.2009.02490.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022; Kinsella K., 2009, AGING WORLD 2008 INT; Lawrence RH, 1996, J GERONTOL B-PSYCHOL, V51, pS173, DOI 10.1093/geronb/51B.4.S173; MAHONEY F I, 1965, Md State Med J, V14, P61; McNicoll G., 2002, WORLD POPULATION AGE; Nishiwaki Y, 2004, AM J EPIDEMIOL, V160, P797, DOI 10.1093/aje/kwh288; Ottenbacher KJ, 2009, AM J PUBLIC HEALTH, V99, P673, DOI 10.2105/AJPH.2008.143958; Ottenbacher KJ, 2005, J AM GERIATR SOC, V53, P1524, DOI 10.1111/j.1532-5415.2005.53511.x; PAHO, 2002, HLTH AM, V2; Rolfson DB, 2006, AGE AGEING, V35, P526, DOI 10.1093/ageing/afl041; Rothman MD, 2008, J AM GERIATR SOC, V56, P2211, DOI 10.1111/j.1532-5415.2008.02008.x; Royall DR, 2008, INT J GERIATR PSYCH, V23, P821, DOI 10.1002/gps.1990; Royall DR, 2003, INT J GERIATR PSYCH, V18, P135, DOI 10.1002/gps.804; Samper-Ternent R, 2008, J AM GERIATR SOC, V56, P1845, DOI 10.1111/j.1532-5415.2008.01947.x; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Syddall H, 2010, AGE AGEING, V39, P197, DOI 10.1093/ageing/afp204; Varela L., 2004, PROFILE OLDER ADULTS; Varela-Pinedo L, 2008, REV SOC PERU MED INT, V21, P11	33	44	57	1	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2014	58	1					69	73		10.1016/j.archger.2013.07.005	http://dx.doi.org/10.1016/j.archger.2013.07.005			5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	238XG	23978328	Green Submitted, Green Accepted			2022-09-04	WOS:000325984500012
J	Caraballo, RH; Ruggieri, V; Gonzalez, G; Cersosimo, R; Gamboni, B; Rey, A; Poveda, JCP; Bernardina, BD				Horacio Caraballo, Roberto; Ruggieri, Victor; Gonzalez, Gabriel; Cersosimo, Ricardo; Gamboni, Beatriz; Rey, Andrea; Perez Poveda, Juan Carlos; Dalla Bernardina, Bernardo			Infantile spams without hypsarrhythmia: A study of 16 cases	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Childhood; Cluster; Encephalopathy; Epileptic spasms; Infantile spasms; Hypsarrhythmia	ONSET EPILEPTIC SPASMS; SEIZURES; ENCEPHALOPATHY	In this study, we present the electroclinical features and evolution of patients with epileptic spasms (ES) in clusters without hypsarrhythmia and with or without focal or generalized paroxysmal discharges on the interictal EEG. We also discuss how to nosologically define these cases. Methods: Between February 1, 1990, and December, 2009, sixteen patients met the electroclinical diagnostic criteria of ES in clusters without hypsarrhythmia. Results: ES were cryptogenic in thirteen patients and symptomatic in three. Age at onset of ES was between 4 months and 30 months, with a mean age of 9 months and a median age of 7 months. Seven patients had seizures before the onset of ES. Focal spikes were observed in seven patients, bilateral spikes and spikes and waves in five, multifocal spikes in two, and two patients had a normal EEG. The ictal EEG recording showed diffuse high-amplitude slow waves in ten patients, diffuse slow waves followed by voltage attenuation in four patients, and diffuse fast rhythms in two. ES were cured in five patients. Mean follow-up was 6 years. Neuropsychological development has been normal in the five latter patients. Eleven patients continue with seizures refractory to antiepileptic drugs after a mean follow-up of 10 years. Of these eleven patients, five have severe mental retardation, three have moderate mental retardation, and two have mild mental retardation. All of them show behavioral disturbances. Conclusion: The patients in this series may be considered to have a variant of West syndrome rather than an electroclinically distinct epileptic syndrome. (C) 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Horacio Caraballo, Roberto; Ruggieri, Victor; Cersosimo, Ricardo] Hosp Nacl Pediat Prof Dr Juan P Garrahan, Buenos Aires, DF, Argentina; [Gonzalez, Gabriel; Rey, Andrea] Ctr Hosp Pereira Rossell, Catedra Neuropediat, Fac Med, Montevideo, Uruguay; [Gamboni, Beatriz] Hosp Pediat, Mendoza, Argentina; [Perez Poveda, Juan Carlos] Pontificia Univ Javeriana, Bogota, Colombia; [Dalla Bernardina, Bernardo] Univ Verona, Osped Gianbattista Rossi, I-37100 Verona, Italy		Caraballo, RH (corresponding author), Hosp Pediat Prof Dr Juan P Garrahan, Dept Neurol, Combate de los Pozos 1881, Buenos Aires, DF, Argentina.	rhcaraballo@arnet.com.ar		Perez Poveda, Juan Carlos/0000-0001-5360-5650				Auvin S, 2010, EPILEPSIA, V51, P1290, DOI 10.1111/j.1528-1167.2010.02534.x; Bednarek N, 1998, EPILEPSIA, V39, P55, DOI 10.1111/j.1528-1157.1998.tb01274.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Capote Gabriela, 2009, Arch. Pediatr. Urug., V80, P118; Caraballo RH, 2003, EPILEPTIC DISORD, V5, P109; DREIFUSS F, 1992, EPILEPSIA, V33, P195; Dulac O, 1994, MISCELLANEOUS CAUSES, P226; Eisermann MM, 2006, EPILEPSIA, V47, P1035, DOI 10.1111/j.1528-1167.2006.00518.x; FUSCO L, 1993, EPILEPSIA, V34, P671, DOI 10.1111/j.1528-1157.1993.tb00445.x; GOBBI G, 1987, DEV MED CHILD NEUROL, V29, P766; Goldstein J, 2008, J CHILD NEUROL, V23, P407, DOI 10.1177/0883073807309230; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; Nordli DR, 2007, EPILEPSIA, V48, P206; Oguni H, 2005, EPILEPSIA, V46, P709, DOI 10.1111/j.1528-1167.2005.37504.x; RamachandranNair R, 2008, EPILEPSY RES, V78, P216, DOI 10.1016/j.eplepsyres.2007.12.007; RUGGIERI V, 1989, PEDIATR NEUROL, V5, P327, DOI 10.1016/0887-8994(89)90029-5; Vigevano F, 2001, BRAIN DEV-JPN, V23, P467, DOI 10.1016/S0387-7604(01)00284-4; Watanabe Y, 2007, BRAIN DEV-JPN, V29, P571, DOI 10.1016/j.braindev.2007.03.006	18	38	39	0	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	APR	2011	20	3					197	202		10.1016/j.seizure.2010.11.018	http://dx.doi.org/10.1016/j.seizure.2010.11.018			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	742GL	21167750	Bronze			2022-09-04	WOS:000288929200003
J	Cordoba-Rodriguez, DP; Iglesia, I; Gomez-Bruton, A; Sauras, MLA; Miguel-Berges, ML; Flores-Barrantes, P; Casajus, JA; Moreno, LA; Rodriguez, G				Paola Cordoba-Rodriguez, Diana; Iglesia, Iris; Gomez-Bruton, Alejandro; Alvarez Sauras, Maria Luisa; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Antonio Casajus, Jose; Moreno, Luis A.; Rodriguez, Gerardo			Early Life Factors Associated with Lean Body Mass in Spanish Children: CALINA Study	CHILDREN-BASEL			English	Article						lean body mass; muscle cross-sectional area; perinatal factors; schoolchildren	BIRTH-WEIGHT; PHYSICAL-FITNESS; FAT DISTRIBUTION; EARLY-CHILDHOOD; STYLE FACTORS; MUSCLE MASS; GROWTH; SMOKING; OBESITY; BONE	Early life is critical for the programming of body composition. The literature links perinatal factors with fat mass development and its future effects (e.g., obesity); however, little evidence exists between early life factors and lean body mass (LBM). This study follows up on a cohort of 416 Spanish children at ages six to eight, previously evaluated at birth in the CALINA study. Here, we studied the association between early life factors, LBM, and limb strength. Parental origin/nutritional status, maternal smoking during pregnancy, gestational diabetes/weight gain/age, birth weight (BW), early feeding, and rapid weight gain (RWG) were collected from primary care records. Bioimpedance analysis, dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and a handgrip/standing long jump test were used to assess fat-free mass index (FFMI), total lean soft tissue mass index (TLSTMI), muscle cross-sectional area index (MCSAI), and limb strength, respectively. In girls, maternal smoking, gestational age, and BW were positively associated with FFM/LSTM. In boys, the parents' BMI, BW, and RWG were positively associated with FFM/LSTM. BW was associated with handgrip strength in both. Maternal BMI in girls and RWG in boys were negatively associated with the standing long jump. Early life programming plays a key role in determining LBM in children.	[Paola Cordoba-Rodriguez, Diana] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia; [Iglesia, Iris; Gomez-Bruton, Alejandro; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Antonio Casajus, Jose; Moreno, Luis A.; Rodriguez, Gerardo] Univ Zaragoza, Inst Agroalimentario Arago6n IA2, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza 50009, Spain; [Iglesia, Iris; Alvarez Sauras, Maria Luisa; Antonio Casajus, Jose; Moreno, Luis A.; Rodriguez, Gerardo] Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza 50009, Spain; [Iglesia, Iris; Rodriguez, Gerardo] Inst Salud Carlos III, Red Salud Materno Infantil & Desarrollo SAMID, Madrid 28029, Spain; [Iglesia, Iris] Inst Salud Carlos III, Primary Care Intervent Prevent Maternal & Child C, Madrid 28029, Spain; [Gomez-Bruton, Alejandro; Antonio Casajus, Jose] Univ Zaragoza, Fac Ciencias Salud & Deporte FCSD, Dept Fisiatria & Enfermeria, Zaragoza 50009, Spain; [Gomez-Bruton, Alejandro; Antonio Casajus, Jose; Moreno, Luis A.] Inst Salud Carlos III Madrid, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid 28029, Spain; [Rodriguez, Gerardo] Univ Zaragoza, Area Pediat, Zaragoza 50009, Spain		Iglesia, I (corresponding author), Univ Zaragoza, Inst Agroalimentario Arago6n IA2, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza 50009, Spain.; Iglesia, I (corresponding author), Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza 50009, Spain.; Iglesia, I (corresponding author), Inst Salud Carlos III, Red Salud Materno Infantil & Desarrollo SAMID, Madrid 28029, Spain.; Iglesia, I (corresponding author), Inst Salud Carlos III, Primary Care Intervent Prevent Maternal & Child C, Madrid 28029, Spain.	d.cordoba@javeriana.edu.co; iglesia@unizar.es; bruton@unizar.es; mlalvarez@iisaragon.es; mlmiguel@unizar.es; pfloba@unizar.es; joseant@unizar.es; lmoreno@unizar.es; gerard@unizar.es	Rodriguez, Gerardo/AAG-9855-2020; Gomez-Bruton, Alejandro/L-5724-2018	Rodriguez, Gerardo/0000-0002-7985-9912; Moreno Aznar, Luis A./0000-0003-0454-653X; Casajus Mallen, Jose Antonio/0000-0002-7215-6931; Cordoba Rodriguez, Diana Paola/0000-0002-7034-8796; Gomez-Bruton, Alejandro/0000-0002-0520-1640; Flores Barrantes, Paloma/0000-0002-2135-900X; Miguel-Berges, Maria L/0000-0002-2411-9538	Instituto de Salud Carlos III [PI08/0559, PI13/02359]; PN I + D+I 2008-2011 (Spain) [RD16/0022/0013]; ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF); Aragon's Regional Government (Diputacion General de Aragon, DGA); Carolina Foundation; Recovery, Transformation and Resilience Plan, ISCIII; European Union-Next Generation EU [RD21/0012/0012]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); PN I + D+I 2008-2011 (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); Aragon's Regional Government (Diputacion General de Aragon, DGA); Carolina Foundation; Recovery, Transformation and Resilience Plan, ISCIII; European Union-Next Generation EU	This research was supported by three grants from the Instituto de Salud Carlos III: the PI08/0559 Aragon Health Sciences Institute for the Growth and Feeding in Infants from Aragon (CALINA) project, the PI13/02359 Environmental factors influencing early development of obesity during childhood and body composition programming, and the RD16/0022/0013 Maternal, Child Health, and Development Network (Retic SAMID) RETICS, funded by the PN I + D+I 2008-2011 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion, and the European Regional Development Fund (ERDF). P.F.-B. received financial support by a grant from the Aragon's Regional Government (Diputacion General de Aragon, DGA). Additionally, we thank the Carolina Foundation Ph.D. Grants for supporting first author in producing this manuscript. RICORS funded by the Recovery, Transformation and Resilience Plan 2017-2020, ISCIII, and by the European Union-Next Generation EU, ref. RD21/0012/0012.	Abe T, 2015, AGE, V37, DOI 10.1007/s11357-014-9741-1; Ahlqvist VH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46200-0; [Anonymous], 2012, INT STANDARD CLASSIF, P1; [Anonymous], 2010, J LIFE SCI; [Anonymous], 1997, INT STANDARD CLASSIF, P1; Arisaka O, 2020, CLIN PEDIATR ENDOCRI, V29, P135, DOI 10.1297/cpe.29.135; Baker J, 2010, AM J HUM BIOL, V22, P206, DOI 10.1002/ajhb.20979; Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Bielemann RM, 2016, NUTRITION, V32, P228, DOI 10.1016/j.nut.2015.08.014; Brown LD, 2014, J ENDOCRINOL, V221, pR13, DOI 10.1530/JOE-13-0567; Bruckner M, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00061; Burrows R, 2017, PEDIATR DIABETES, V18, P895, DOI 10.1111/pedi.12505; Cadenas-Sanchez C, 2017, EUR J CLIN NUTR, V71, P1200, DOI 10.1038/ejcn.2017.62; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Centers for Disease Control and Prevention,, 2013, NATL HLTH NUTR EXAMI; Cordoba-Rodriguez DP, 2022, BMC PEDIATR, V22, DOI 10.1186/s12887-021-03041-z; Magalhaes EID, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023852; Dahly DL, 2018, INT J EPIDEMIOL, V47, P131, DOI 10.1093/ije/dyx221; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Devakumar D, 2016, AM J HUM BIOL, V28, P524, DOI 10.1002/ajhb.22825; Dorsey KB, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-41; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Espana-Romero V, 2008, J HAND SURG-AM, V33A, P378, DOI 10.1016/j.jhsa.2007.11.013; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Lopez-Gil JF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020567; Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284; Gill SV, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-29; Lopez GG, 2019, APUNTS-MED ESPORT, V54, P119, DOI 10.1016/j.apunts.2019.07.005; Gomez-Bruton A, 2014, NUTR HOSP, V30, P399, DOI 10.3305/nh.2014.30.2.7603; Gonzalez-Aguero A, 2013, OSTEOPOROSIS INT, V24, P1035, DOI 10.1007/s00198-012-2041-7; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Grunnet LG, 2017, DIABETES CARE, V40, P1746, DOI 10.2337/dc17-0514; Huang P, 2016, BRIT J NUTR, V116, P132, DOI 10.1017/S0007114516001720; Isganaitis E, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1170-1; Kearney M, 2018, CLIN OBES, V8, P81, DOI 10.1111/cob.12237; Kim JH, 2016, NUTR RES, V36, P1423, DOI 10.1016/j.nutres.2016.09.013; Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153383; Kim S, 2015, OBES RES CLIN PRACT, V9, P125, DOI 10.1016/j.orcp.2014.05.002; Kwon Eun Jin, 2017, Obstet Gynecol Sci, V60, P506, DOI 10.5468/ogs.2017.60.6.506; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; Larque E, 2019, NAT REV ENDOCRINOL, V15, P456, DOI 10.1038/s41574-019-0219-1; Lau EY, 2014, J OBES, V2014, DOI 10.1155/2014/524939; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Lindsay CA, 1997, AM J OBSTET GYNECOL, V177, P1124, DOI 10.1016/S0002-9378(97)70027-9; Liu Junting, 2019, J Cachexia Sarcopenia Muscle, V10, P155, DOI 10.1002/jcsm.12361; Liu JX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222141; Mangrio E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-891; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Moreno-Villares José-Manuel, 2019, Nutr. Hosp., V36, P218, DOI 10.20960/nh.02453; Morrison KM, 2021, PEDIATR RES, V89, P996, DOI 10.1038/s41390-020-1012-5; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Suarez BO, 2014, AN PEDIATR, V81, P32, DOI 10.1016/j.anpedi.2013.09.008; Petersen AMW, 2007, AM J PHYSIOL-ENDOC M, V293, pE843, DOI 10.1152/ajpendo.00301.2007; Pruszkowska-Przybylska P, 2019, ANTHROPOL ANZ, V76, P409, DOI 10.1127/anthranz/2019/0955; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rasmussen K.M., 2009, WEIGHT GAIN PREGNANC; Rillamas-Sun E, 2012, OBESITY, V20, P463, DOI 10.1038/oby.2011.138; Rom O, 2015, ADDICTION, V110, P326, DOI 10.1111/add.12761; Rotevatn TA, 2020, EUR J PUBLIC HEALTH, V30, P703, DOI 10.1093/eurpub/ckz140; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Scheurer JM, 2018, NEONATOLOGY, V114, P169, DOI 10.1159/000487915; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Sioen I, 2016, CALCIFIED TISSUE INT, V99, P557, DOI 10.1007/s00223-016-0183-x; SPADY DW, 1986, PEDIATR RES, V20, P716, DOI 10.1203/00006450-198608000-00003; Stutte S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020124; Tambalis KD, 2020, PEDIATR EXERC SCI, V32, P165, DOI 10.1123/pes.2020-0004; UNICEF, 2021, IND ASS INF YOUNG CH, P1; van Beijsterveldt IALP, 2021, OBESITY, V29, P1899, DOI 10.1002/oby.23271; van Deutekom AW, 2015, INT J OBESITY, V39, P593, DOI 10.1038/ijo.2014.204; Wells JCK, 2014, INT J EPIDEMIOL, V43, P772, DOI 10.1093/ije/dyu055; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; WILCOX AJ, 1992, AM J PUBLIC HEALTH, V82, P378, DOI 10.2105/AJPH.82.3.378; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	76	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	MAY	2022	9	5							585	10.3390/children9050585	http://dx.doi.org/10.3390/children9050585			17	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	1P4GW	35626762	Green Published, gold			2022-09-04	WOS:000801970200001
J	Caviedes-Bucheli, J; Lopez-Moncayo, LF; Munoz-Alvear, HD; Hernandez-Acosta, F; Pantoja-Mora, M; Rodriguez-Guerrero, AS; Lopez-Ordonez, A; Diaz, LE; Gomez-Sosa, JF; Munoz, HR				Caviedes-Bucheli, Javier; Lopez-Moncayo, Luis F.; Munoz-Alvear, Hernan Dario; Hernandez-Acosta, Francisco; Pantoja-Mora, Melissa; Rodriguez-Guerrero, Angie S.; Lopez-Ordonez, Alexander; Diaz, Luis E.; Gomez-Sosa, Jose Francisco; Munoz, Hugo R.			Expression of early angiogenesis indicators in mature versus immature teeth	BMC ORAL HEALTH			English	Article						Angiogenesis; Human dental pulp; HIF-1&#945; ANG1; ANG2; TIE2	HUMAN DENTAL-PULP; ENDOTHELIAL GROWTH-FACTOR; MECHANISMS; TIE2	Background Proper oxygen balance in the dental pulp is essential for cell metabolism. Angiogenesis in the pulp is a constant process during the life of the tooth. Hypoxia indicators in a tissue, such as HIF-1 alpha, as well as vascular destabilization markers, such as ANG2 and its receptor TIE2, are necessary for angiogenesis. Therefore the purpose of this study is to evaluate the expression of HIF-1 alpha, ANG1, ANG2 and TIE2 in dental pulp as early angiogenesis indicators in teeth with complete and incomplete root development. Methods Forty human dental pulps were obtained from freshly extracted third molars divided into two groups: incomplete (n = 20) and complete (n = 20) root development. Dental pulps were stored at - 80 degrees C, defrosted in an ice bath and re-frozen with their respective thaws to disintegrate the tissue. Three sonication cycles were performed until the tissues were homogenized, then thaw were centrifuged and the supernatant was collected for the detection of the markers to be studied. The samples were processed for the ELISA test using the ELISA-sandwich principle. Student t and Mann-Whitney U tests were performed to determine statistically significant differences between groups. Results In the complete root development, HIF-1 alpha, ANG1, ANG2 and TIE2 expressions were significantly higher than their expression in the incomplete root development group. Conclusions The angiogenic process seems to be a physiological process in the dental pulp. Angiogenic activity is higher in teeth with mature than immature apex teeth.	[Caviedes-Bucheli, Javier] Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia; [Caviedes-Bucheli, Javier; Lopez-Moncayo, Luis F.; Munoz-Alvear, Hernan Dario; Hernandez-Acosta, Francisco; Pantoja-Mora, Melissa; Rodriguez-Guerrero, Angie S.; Lopez-Ordonez, Alexander] Univ Cooperat Colombia, Endodont Dept, Pasto, Colombia; [Diaz, Luis E.] Univ La Sabana, Engineer Sch, Chia, Colombia; [Gomez-Sosa, Jose Francisco] Univ Cent Venezuela, Postgrad Endodont Dept, Caracas, Venezuela; [Munoz, Hugo R.] Univ San Carlos, Endodont Dept, Guatemala City, Guatemala		Caviedes-Bucheli, J (corresponding author), Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia.	javiercaviedes@gmail.com	Barrera, Luis Eduardo Díaz/U-2706-2019; Gomez-Sosa, Jose F/AAL-2610-2020	Barrera, Luis Eduardo Díaz/0000-0002-9588-9935; Gomez-Sosa, Jose F/0000-0002-2307-6214; MUNOZ ALVEAR, HERNAN DARIO/0000-0002-4327-4242; Caviedes-Bucheli, Javier/0000-0003-0407-9847				Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Balamurugan K, 2016, INT J CANCER, V138, P1058, DOI 10.1002/ijc.29519; Caviedes-Bucheli J, 2017, INT ENDOD J, V50, P339, DOI 10.1111/iej.12627; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Derringer KA, 2003, ARCH ORAL BIOL, V48, P285, DOI 10.1016/S0003-9969(03)00008-6; Gomez-Sosa JF, 2019, INT ENDOD J, V52, P1716, DOI 10.1111/iej.13188; Kim HB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15754-2; Li JY, 2017, DEVELOPMENT, V144, P374, DOI 10.1242/dev.137216; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mattuella LG, 2007, J ENDODONT, V33, P1408, DOI 10.1016/i.joen.2007.08.019; Mattuella LG, 2007, J ENDODONT, V33, P524, DOI 10.1016/j.jeon.2007.01.003; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Murakami M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/293641; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3; Sakdee JB, 2009, J ENDODONT, V35, P818, DOI 10.1016/j.joen.2009.03.001; Vallee A, 2018, REV NEUROSCIENCE, V29, P71, DOI 10.1515/revneuro-2017-0032; Wei FL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/215761; Xue CL, 2018, STEM CELLS DEV, V27, P456, DOI 10.1089/scd.2017.0296; Zhou J, 2020, J BIOCHEM MOL TOXIC, V34, DOI 10.1002/jbt.22436; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	21	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6831			BMC ORAL HEALTH	BMC Oral Health	NOV 12	2020	20	1							324	10.1186/s12903-020-01313-1	http://dx.doi.org/10.1186/s12903-020-01313-1			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	OX7MV	33183306	gold, Green Published			2022-09-04	WOS:000593745200002
J	Chavarriaga, J; Fernandez, N; Campo, MAO; Bolivar, J; Patino, G; Perez, J				Chavarriaga, Julian; Fernandez, Nicolas; Campo, Maria A. O.; Bolivar, John; Patino, German; Perez, Jaime			Self-perception, quality of life and ease of catheterization in patients with continent urinary diversion with the mitrofanoff principle	INTERNATIONAL BRAZ J UROL			English	Article						Urinary Diversion; Quality of Life; Urinary Bladder; Neurogenic	VQZ-PLASTY; BLADDER; STOMA; APPENDICOVESICOSTOMY; CONDUIT	Purpose: Continent urinary diversion (CUD) with the Mitrofanoff principle stands as an alternative to urethral catheterization by a route other than the urethra. The aim of the study was to determine self-perception of health-related quality of life (HRQoL), ease of catheterization and global and cosmetic outcomes in patient's dependent on Mitrofanoff catheterization. Materials and methods: Records of all patients who underwent CUD with the Mitrofanoff principle between 2012 to 2018 were reviewed. Data were collected and analysed retrospectively from medical charts. We assessed HRQoL with the EuroQol EQ-5D-3L questionnaire, cosmetic and global satisfaction with a questionnaire designed by the reconstructive urology board and ease of catheterization with a Likert questionnaire adapted from the Intermittent Catheterization Difficulty Questionnaire (ICDQ) validated in patients reliant on retrograde CIC. Results: A total of 25 patients requiring CUD with the Mitrofanoff principle between 2012 and 2018 were assessed, the group was composed mainly of: appendiceal conduits 18 patients (72%) and 7 ileal conduits (Yang-Monti) and three of those requiring Casale (Monti Spiral) and 1 a double Monti technique. Median follow-up was 57 months, median age was 30 years. Visual Analogue Scale (VAS) of the EQ-5D-3L reported a Global health score of 86.5%. Fifty nine percent of the patients had no pain or bleeding with catheterizations. Regarding global satisfaction and cosmetic perception 91 % were satisfied with their CUD. Conclusions: CUD is associated with good HRQoL, global satisfaction, ease and painless catheterization, adequate self-perception of cosmetic outcomes and a low complication rate, remaining a safe and viable option.	[Chavarriaga, Julian; Fernandez, Nicolas; Campo, Maria A. O.; Bolivar, John; Patino, German; Perez, Jaime] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Carrera 7-40-62, Bogota, Colombia; [Fernandez, Nicolas; Perez, Jaime] Fdn Santa Fe Bogota, Div Urol, Bogota, Colombia; [Fernandez, Nicolas] Univ Toronto, Hosp SickKids, Div Urol, Toronto, ON, Canada; [Patino, German] Univ Calif San Francisco, Div Urol, San Francisco, CA 94143 USA		Chavarriaga, J (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Carrera 7-40-62, Bogota, Colombia.	chavarriagaj@javeriana.edu.co		Chavarriaga, Julian/0000-0003-0158-504X; Patino, German/0000-0002-7495-5139; Perez Nino, Jaime/0000-0002-2231-4321				Berrettini A, 2008, UROLOGY, V72, P1073, DOI 10.1016/j.urology.2008.06.061; Cain MP, 1999, J UROLOGY, V162, P1749, DOI 10.1016/S0022-5347(05)68230-4; Cortes S.T., 1947, REV FAC MED-CARACAS, V15, P577; England RJ, 2007, J UROLOGY, V178, P2607, DOI 10.1016/j.juro.2007.08.030; Farrugia MK, 2010, J PEDIATR UROL, V6, P330, DOI 10.1016/j.jpurol.2010.01.015; Fumincelli L, 2017, WORLDV EVID-BASED NU, V14, P324, DOI 10.1111/wvn.12231; Gowda BDR, 2008, BJU INT, V102, P1688, DOI 10.1111/j.1464-410X.2008.07885.x; Harris CF, 2000, J UROLOGY, V163, P1922, DOI 10.1016/S0022-5347(05)67599-4; Herdman M, 2001, Aten Primaria, V28, P425; Itesako T, 2011, J PEDIATR UROL, V7, P433, DOI 10.1016/j.jpurol.2010.05.012; Landau EH, 2008, J UROLOGY, V180, P1765; Landau EH, 2008, J UROLOGY, V180, P1761, DOI 10.1016/j.juro.2008.04.070; Lapides J, 2017, J UROLOGY, V197, pS122, DOI 10.1016/j.juro.2016.10.097; Liard A, 2001, J UROLOGY, V165, P2394, DOI 10.1016/S0022-5347(05)66213-1; Lima DX, 2015, INT BRAZ J UROL, V41, P542, DOI 10.1590/S1677-5538.IBJU.2014.0150; McAndrew HF, 2002, BJU INT, V89, P86, DOI 10.1046/j.1464-4096.2001.01828.x; Ramanan V, 1997, UROL INT, V58, P108, DOI 10.1159/000282961; Sahadevan K, 2008, BJU INT, V102, P236, DOI 10.1111/j.1464-410X.2008.07467.x; Santos M, 2016, MED DECIS MAKING, V36, P253, DOI 10.1177/0272989X15613521; Siegel S, 2015, NEUROUROL URODYNAM, V34, P224, DOI 10.1002/nau.22544; Smith GM, 2011, EUR J PEDIATR SURG, V21, P263, DOI 10.1055/s-0031-1275748	21	7	7	0	2	BRAZILIAN SOC UROL	RIO DE JANEIRO	RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL	1677-5538	1677-6119		INT BRAZ J UROL	Int. Braz J Urol	SEP-OCT	2020	46	5					743	751		10.1590/S1677-5538.IBJU.2019.0388	http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0388			9	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	MC7OM	32648414	Green Published, gold			2022-09-04	WOS:000543471400007
J	Corredor-Figueroa, AP; Salas, S; Olaya-Galan, NN; Quintero, JS; Fajardo, A; Sonora, M; Moreno, P; Cristina, J; Sanchez, A; Tobon, J; Ortiz, D; Gutierrez, MF				Patricia Corredor-Figueroa, Adriana; Salas, Sandra; Nathalia Olaya-Galan, Nury; Sebastian Quintero, Juan; Fajardo, Alvaro; Sonora, Martin; Moreno, Pilar; Cristina, Juan; Sanchez, Alfredo; Tobon, Julio; Ortiz, Diego; Fernanda Gutierrez, Maria			Prevalence and molecular epidemiology of bovine leukemia virus in Colombian cattle	INFECTION GENETICS AND EVOLUTION			English	Article						Enzootic bovine leukosis; Viral genotypes; Prevalence; BLV	BLV; INFECTION; REVEALS; DNA	Bovine leukemia virus (BLV) is one of the five agents considered most significant for cattle. It is important to determine the prevalence and molecular epidemiology of BLV throughout the country in order to gain a more thorough understanding of the current situation of BLV and to reveal the possibility of masked genotypes that the primers used by OIE are unable to identify. Blood samples were collected at random from 289 cows distributed in 75 farms across the country. PCR amplification of env, gag and tax gene segments was performed. The obtained amplicons were sequenced and then subjected to phylogenetic analyses. A total of 62% of the cows present at 92% of the farms were BLV-positive for gag fragment. Genotype 1 was exclusively detected by env gene segment when analyzed using previously reported primers. However, tax gene analysis revealed circulation of genotype 6 variants, which were also detected based on env gene analysis with newly designed primers. These results indicate that current genotyping approaches based on partial env sequencing may bias BLV genetic variability approaches and underestimate the diversity of the detected BLV genotypes. This report is one of the first molecular and epidemiological studies of BLV conducted in Colombia, which contributes to the global epidemiology of the virus; it also highlights the substantial impact of BLV on the country's livestock and thus is a useful resource for farmers and government entities.	[Patricia Corredor-Figueroa, Adriana] Univ ECCI, Cra 19,49-20, Bogota 111311, Colombia; [Patricia Corredor-Figueroa, Adriana; Salas, Sandra; Nathalia Olaya-Galan, Nury; Sebastian Quintero, Juan; Fernanda Gutierrez, Maria] Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Carrera 7,40 62, Bogota 11001000, Colombia; [Nathalia Olaya-Galan, Nury] Univ Rosario, PhD Programme Biomed & Biol Sci, Carrera 24,63C-69, Bogota 112111, Colombia; [Fajardo, Alvaro; Sonora, Martin; Moreno, Pilar; Cristina, Juan] Univ Republ Uruguay, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Mataojo 2055, Montevideo 11400, Uruguay; [Sanchez, Alfredo; Tobon, Julio] Empresa Colombiana Prod Vet VECOL, Av Eldorado 82-93, Bogota 110931, Colombia; [Ortiz, Diego] Agrosavia, Km 14 Via Mosquera Bogota, Mosquera 250047, Colombia		Gutierrez, MF (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Carrera 7,40 62, Bogota 11001000, Colombia.	acorredorf@ecci.edu.co; s.salas@javeriana.edu.co; juan.quintero5@correo.uis.edu.co; afajardo@cin.edu.uy; msonora@pasteur.edu.uy; pmoreno@cin.edu.uy; Julio.Tobon@vecol.com.co; mfgutier@javeriana.edu.co	; Olaya-Galan, Nury-Nathalia/L-9782-2016	Corredor Figueroa, Adriana Patricia/0000-0001-9839-6151; Tobon Torreglosa, Julio Cesar/0000-0003-2705-3770; ORTIZ ORTEGA, DIEGO/0000-0002-7042-2829; Olaya-Galan, Nury-Nathalia/0000-0002-4282-4951; Fajardo, Alvaro/0000-0003-3998-6703	Pontificia Universidad Javeriana, Colciencias [657/2014]; Vecol	Pontificia Universidad Javeriana, Colciencias; Vecol	This work was supported by Pontificia Universidad Javeriana, Colciencias in call of grants 657/2014 and Vecol.	Ababneh MM, 2012, ARCH VIROL, V157, P2343, DOI 10.1007/s00705-012-1447-z; Awasthi P, 2018, PEDIATR ANESTH CRIT, V6, P61, DOI 10.14587/paccj.2018.10; Barez PY, 2015, VIRUSES-BASEL, V7, P6080, DOI 10.3390/v7112929; Bazzucchi M, 2019, ARCH VIROL, V164, P1697, DOI 10.1007/s00705-019-04255-4; Benavides Bibiana, 2017, Rev. Med. Vet., P67, DOI 10.19052/mv.4054; Buehring GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179367; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Fechner H, 1997, VIROLOGY, V237, P261, DOI 10.1006/viro.1997.8784; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; Frie MC, 2015, VET IMMUNOL IMMUNOP, V163, P103, DOI 10.1016/j.vetimm.2014.11.014; Gillet NA, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0308-3; GIOVANNA M., 2013, OPEN J MED MICROBIOL, V3, P84, DOI [DOI 10.4236/OJMM.2013.31013, https://doi.org/10.4236/ojmm.2013.31013]; Huelsenbeck J.P., 2015, COMMAND REFERENCE MR; Kelly TR, 2017, PREV VET MED, V137, P112, DOI 10.1016/j.prevetmed.2016.11.023; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Lee J, 2005, J KOREAN MED SCI, V20, P603, DOI 10.3346/jkms.2005.20.4.603; Lendez P.A., 2018, MULTIDISCIP CANC INV, V2, P16, DOI 10.30699/acadpub.mci.4.16; Murakami H, 2011, VIRUS RES, V156, P107, DOI 10.1016/j.virusres.2011.01.004; Nekoei S, 2015, POL J VET SCI, V18, P703, DOI 10.1515/pjvs-2015-0091; Ochirkhuu N, 2016, ARCH VIROL, V161, P985, DOI 10.1007/s00705-015-2676-8; OIE, 2018, LEUC BOV INF MAN TER; Olaya N., 2016, J MED SURG PATHOL, V1; Olaya-Galan N., 2017, EPIDEMIOL INFECT, P1; Ortiz C, 2016, J SPORT HEALTH RES, V8, P35; Corredor AP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199397; Polat M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0876-4; Polat M, 2017, ARCH VIROL, V162, P425, DOI 10.1007/s00705-016-3118-y; Polat M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0239-z; Ramos AE, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0324-2; Richter V, 2017, VET J, V220, P80, DOI 10.1016/j.tvjl.2017.01.005; Robinson SM, 2016, BRIT J CANCER, V115, DOI 10.1038/bjc.2016.268; Rosewick N, 2013, P NATL ACAD SCI USA, V110, P2306, DOI 10.1073/pnas.1213842110; Schwingel D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39834-7; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Trono KG, 2001, VET MICROBIOL, V83, P235, DOI 10.1016/S0378-1135(01)00420-5; Usuga-Monroy C, 2018, REV MEX CIENC PECU, V9, P387, DOI 10.22319/rmcp.v9i2.4232; Yu CQ, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1863-3; Zhang R, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0763-8	39	9	11	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	JUN	2020	80								104171	10.1016/j.meegid.2020.104171	http://dx.doi.org/10.1016/j.meegid.2020.104171			8	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	LD0XO	31904555	hybrid, Green Published			2022-09-04	WOS:000525757000004
J	Pardo, LM; van der Leest, RJT; de Vries, E; Soerjomataram, I; Nijsten, T; Hollestein, LM				Pardo, L. M.; van der Leest, R. J. T.; de Vries, E.; Soerjomataram, I.; Nijsten, T.; Hollestein, L. M.			Comparing survival of patients with single or multiple primary melanoma in the Netherlands: 1994-2009	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							RISK		[Pardo, L. M.; van der Leest, R. J. T.; de Vries, E.; Nijsten, T.; Hollestein, L. M.] Erasmus MC Canc Inst, Dept Dermatol, Rotterdam, Netherlands; [de Vries, E.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Soerjomataram, I.] Int Agcy Res Canc, Sect Canc Surveillance, Lyon, France; [Hollestein, L. M.] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands		Hollestein, LM (corresponding author), Erasmus MC Canc Inst, Dept Dermatol, Rotterdam, Netherlands.	l.hollestein@erasmusmc.nl	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258				Doubrovsky A, 2003, ARCH DERMATOL, V139, P1013, DOI 10.1001/archderm.139.8.1013; Fong ZV, 2014, BRIT J DERMATOL, V170, P20, DOI 10.1111/bjd.12687; Hollestein LM, 2012, ANN ONCOL, V23, P524, DOI 10.1093/annonc/mdr128; Kricker A, 2013, JAMA DERMATOL, V149, P921, DOI 10.1001/jamadermatol.2013.4581; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Oncoline, CANC CLIN PRACT GUID; Turrisi R, 2015, JAMA DERMATOL, V151, P945, DOI 10.1001/jamadermatol.2015.0690; van der Leest RJT, 2015, J EUR ACAD DERMATOL, V29, P1053, DOI 10.1111/jdv.12887; Vuong K, 2014, INT J CANCER, V134, P2735, DOI 10.1002/ijc.28603; Youlden DR, 2016, J INVEST DERMATOL, V136, P2270, DOI 10.1016/j.jid.2016.03.014	10	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	FEB	2017	176	2					531	533		10.1111/bjd.14846	http://dx.doi.org/10.1111/bjd.14846			3	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	EL6TM	27377396	Green Published			2022-09-04	WOS:000394755100059
J	Fernandez-Villegas, A; Thomas, MC; Carrilero, B; Lasso, P; Egui, A; Murcia, L; Segovia, M; Alonso, C; Lopez, MC				Fernandez-Villegas, Ana; Carmen Thomas, M.; Carrilero, Bartolome; Lasso, Paola; Egui, Adriana; Murcia, Laura; Segovia, Manuel; Alonso, Carlos; Carlos Lopez, Manuel			A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							TERM FOLLOW-UP; BENZNIDAZOLE; BIOMARKERS; INFECTION; EVOLUTION; PROTEIN; ADULTS	Objectives: The objective was to characterize a Trypanosoma cruzi repetitive amino acid sequence that can be used as a marker of therapeutic drug efficacy in patients with chronic Chagas' disease. Methods: Reactivities to the 3973 peptide were measured in 85 patients with Chagas' disease (41 in the asymptomatic stage and 44 in the cardiomyopathy stage) before and 9 and 24 months after benznidazole administration. Additionally, the levels of IL-6 and C-reactive protein were measured in serum samples from patients with cardiomyopathy. Results: In 85% of the asymptomatic patients and 73% of the symptomatic chronic patients, modifications of the reactivity to the 3973 peptide were observed at 9 and 24 months post-benznidazole treatment. Significant variations in reactivities to the total antigens of T. cruzi were not observed at these times. Significant decreases in the reactivity to the 3973 peptide were observed after treatment in 20 of 41 (49%) asymptomatic patients and 15 of 44 (34%) cardiac chagasicpatients (P<0.001). In these patients, the decreases in reactivity at 24 months post-treatment were at least 40% lower than those detected before treatment. No correlations were found of the detected modifications in reactivity to the 3973 peptide after treatment with the levels of C-reactive protein or IL-6. Conclusions: Decreases in reactivity to the 3973 peptide may be relevant in the post-treatment follow-up of chronic chagasic patients.	[Fernandez-Villegas, Ana; Carmen Thomas, M.; Lasso, Paola; Egui, Adriana; Carlos Lopez, Manuel] Consejo Super Invest Cient IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, PTS Granada, Avda Conocimiento S-N, Granada 18100, Spain; [Carrilero, Bartolome; Murcia, Laura; Segovia, Manuel] Hosp Virgen Arrixaca, Unidad Reg Med Trop, Cra Cartagena S-N El Palmar, Murcia 30120, Spain; [Lasso, Paola] Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia; [Alonso, Carlos] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain		Lopez, MC (corresponding author), Consejo Super Invest Cient IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, PTS Granada, Avda Conocimiento S-N, Granada 18100, Spain.	mclopez@ipb.csic.es	Lopez, Manuel/Z-5641-2019; Murcia, Laura/AAD-7100-2021; Thomas, María Carmen PhD/D-9065-2016; Egui, Adriana/AAA-5983-2019	Murcia, Laura/0000-0001-7768-0989; Lopez, Manuel Carlos/0000-0003-0002-3678; Thomas, M Carmen/0000-0003-3586-9657; Carrilero Fernandez, Bartolome/0000-0002-0110-603X; Fernandez-Villegas, Ana/0000-0002-9766-8722; Egui, Adriana/0000-0002-3038-0468	Programa Estatal I+D+i (MINECO) [SAF2012-35777, SAF2013-48527-R, RTC-2014-2130]; Network of Tropical Diseases Research RICET [RD12/0018/0021, RD12/0018/0018, RD12/0018/0009]; FEDER	Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET; FEDER(European Commission)	This work was supported by grants SAF2012-35777, SAF2013-48527-R and RTC-2014-2130 from the Programa Estatal I+D+i (MINECO), the Network of Tropical Diseases Research RICET (RD12/0018/0021, RD12/0018/0018 and RD12/0018/0009) and FEDER.	Britto C, 2001, MEM I OSWALDO CRUZ, V96, P823, DOI 10.1590/S0074-02762001000600014; BUSCHIAZZO A, 1992, MOL BIOCHEM PARASIT, V54, P125, DOI 10.1016/0166-6851(92)90105-S; Cardoni RL, 1997, MEDICINA-BUENOS AIRE, V57, P227; Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Fabbro D, 2013, REV INST MED TROP SP, V55, P167, DOI 10.1590/S0036-46652013000300005; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fernandez-Villegas A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-206; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lopez L, 2006, REV ESP CARDIOL, V59, P50, DOI 10.1157/13083649; Murcia L, 2013, CLIN INFECT DIS, V56, P496, DOI 10.1093/cid/cis910; Pinazo MJ, 2015, MEM I OSWALDO CRUZ, V110, P422, DOI 10.1590/0074-02760140435; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Porras AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003697; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2013, EXPERT REV ANTI-INFE, V11, P957, DOI 10.1586/14787210.2013.824718; Negrette OS, 2008, CLIN VACCINE IMMUNOL, V15, P297, DOI 10.1128/CVI.00106-07; VIOTTI R, 1994, AM HEART J, V127, P151, DOI 10.1016/0002-8703(94)90521-5; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; WHO, 2002, TECH REP SER, V905, P1	20	7	7	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	JUL	2016	71	7					2005	2009		10.1093/jac/dkw090	http://dx.doi.org/10.1093/jac/dkw090			5	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	DV9FP	27073267	Bronze			2022-09-04	WOS:000383246000033
J	Munns, CH; Chung, MK; Sanchez, YE; Arnzel, LM; Caterina, MJ				Munns, Clare H.; Chung, Man-Kyo; Sanchez, Yuly E.; Arnzel, L. Mario; Caterina, Michael J.			Role of the Outer Pore Domain in Transient Receptor Potential Vanilloid 1 Dynamic Permeability to Large Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(2) CHANNEL PERMEABILITY; ION-PERMEATION PATHWAY; CAPSAICIN RECEPTOR; POTASSIUM CHANNEL; TRP CHANNEL; MOLECULAR-BASIS; PAIN PATHWAY; ACTIVATION; SELECTIVITY; DILATION	Transient receptor potential vanilloid 1 (TRPV1) has been shown to alter its ionic selectivity profile in a time- and agonist-dependent manner. One hallmark of this dynamic process is an increased permeability to large cations such as N-methyl-D-glucamine (NMDG). In this study, we mutated residues throughout the TRPV1 pore domain to identify loci that contribute to dynamic large cation permeability. Using resiniferatoxin (RTX) as the agonist, we identified multiple gain-of-function substitutions within the TRPV1 pore turret (N628P and S629A), pore helix (F638A), and selectivity filter (M644A) domains. In all of these mutants, maximum NMDG permeability was substantially greater than that recorded in wild type TRPV1, despite similar or even reduced sodium current density. Two additional mutants, located in the pore turret (G618W) and selectivity filter (M644I), resulted in significantly reduced maximum NMDG permeability. M644A and M644I also showed increased and decreased minimum NMDG permeability, respectively. The phenotypes of this panel of mutants were confirmed by imaging the RTX-evoked uptake of the large cationic fluorescent dye YO-PROL Whereas none of the mutations selectively altered capsaicin-induced changes in NMDG permeability, the loss-of-function phenotypes seen with RTX stimulation of G618W and M644I were recapitulated in the capsaicin-evoked YO-PRO1 uptake assay. Curiously, the M644A substitution resulted in a loss, rather than a gain, in capsaicin-evoked YO-PRO1 uptake. Modeling of our mutations onto the recently determined TRPV1 structure revealed several plausible mechanisms for the phenotypes observed. We conclude that side chain interactions at a few specific loci within the TRPV1 pore contribute to the dynamic process of ionic selectivity.	[Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Biol Chem, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Sanchez, Yuly E.; Arnzel, L. Mario] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Chung, Man-Kyo] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Sanchez, Yuly E.] Univ Nacl Colombia, Fac Ciencias, Dept Fis, Bogota 111321, Colombia; [Sanchez, Yuly E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia		Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, 725 N Wolfe St, Baltimore, MD 21205 USA.	caterina@jhmi.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148; Amzel, L. Mario/0000-0002-0129-9572	National Institutes of Health from NINDS [NS054902]; National Institutes of Health from NIDCR [DE023846]; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054902] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from NIDCR; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS054902 from NINDS (to M. J. C.), Grant DE023846 from NIDCR (to M. K. C.) by funding from the Neurosurgery Pain Research Institute and Blaustein Pain Research Fund at Johns Hopkins School of Medicine (to M. J. C.), and a John J. Bonica Fellowship from the International Association for the Study of Pain (to C. H. M.). Dr. Caterina is an inventor on a patent on the use of products related to TRPV1, which is licensed through UCSF and Merck. This conflict is being managed by the Johns Hopkins Office on Policy Coordination.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chao CC, 2010, J PHYSIOL SCI, V60, P441, DOI 10.1007/s12576-010-0111-1; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Jansson ET, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-1; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/NCHEMBIO.1428, 10.1038/nchembio.1428]; Wang ZR, 2009, J GEN PHYSIOL, V133, P361, DOI 10.1085/jgp.200810139; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795	49	33	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5707	5724		10.1074/jbc.M114.597435	http://dx.doi.org/10.1074/jbc.M114.597435			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568328	hybrid, Green Published			2022-09-04	WOS:000350044200039
J	Macias, F; Malmusi, D; Borrell, C				Macias, Felipe; Malmusi, Davide; Borrell, Carme			Different Patterns by Age-Group and Gender of Socioeconomic Inequalities in Smoking in Colombia	NICOTINE & TOBACCO RESEARCH			English	Article							CESSATION; COUNTRIES; SMOKERS; CONSUMPTION; PREVALENCE; INITIATION; ARGENTINA; BEHAVIOR; QUIT; RISK	Introduction: Evidence on socioeconomic inequalities in smoking from low-and middle-income countries has shown some inconsistency between countries. We have studied the socioeconomic inequalities in current smoking, ever smoking, and smoking cessation in Colombia by age-group and gender. Methods: Sixty thousand, three hundred and forty-nine Colombian men and women aged 12-69 years were selected at random from the results of a national survey. We used Pearson's chi-square and Robust Poisson regression analyses to estimate adjusted prevalence ratios between smoking behaviors and 2 indicators of socioeconomic position; individuals' educational level and household socioeconomic stratum. Results: In men aged 45-69 years, higher socioeconomic stratum and higher education were associated with a lower rate of current smoking (PR = 0.49 [95% CI, 0.32-0.73] and PR = 0.64 [95% CI, 0.47-0.86], respectively), a history of smoking (PR = 0.67 [95% CI, 0.53-0.85] and PR = 0.75 [95% CI, 0.63-0.90], respectively), or a higher rate of smoking cessation (PR = 1.37 [95% CI, 1.09-1.72] and PR = 0.18 [95% CI, 0.99-1.72], respectively). In men aged 18-44 years, higher education was associated with lower odds of current and history of smoking (PR = 0.75 [95% CI, 0.61-0.92 and PR = 0.81 [95% CI, 0.67-0.98], respectively). Results in women and adolescents were mixed. Conclusions: In Colombia, the overall declining prevalence of smoking in men seems to be accompanied by a narrowing of smoking inequalities in successive birth cohorts, suggesting a favorable evolution of the tobacco epidemic. Further research will be required to identify factors that have contributed these optimal circumstances in tobacco control.	[Macias, Felipe] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Macias, Felipe; Malmusi, Davide; Borrell, Carme] Agencia Salut Publ Barcelona, Barcelona 08023, Spain; [Macias, Felipe; Borrell, Carme] Univ Pompeu Fabra, Barcelona, Spain; [Malmusi, Davide; Borrell, Carme] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Malmusi, Davide; Borrell, Carme] Inst Biomed Res IIB St Pau, Barcelona, Spain		Macias, F (corresponding author), Agencia Salut Publ Barcelona, Pl Lesseps 1, Barcelona 08023, Spain.	fmacias@aspb.cat		Borrell, Carme/0000-0002-1170-2505; Malmusi, Davide/0000-0003-1877-3581	ERACOL, Erasmus Mundus Action 2 Partnership, European Commission	ERACOL, Erasmus Mundus Action 2 Partnership, European Commission	None of the authors received direct financial support for this specific article. The indirect sponsor did not review the article prior to submission and had no editorial influence. Felipe Macias Acuna was awarded a grant from ERACOL, Erasmus Mundus Action 2 Partnership, European Commission, to pursue his PhD in Biomedicine.	Bacigalupe A, 2013, EUR J PUBLIC HEALTH, V23, P552, DOI 10.1093/eurpub/cks104; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Broms U, 2004, NICOTINE TOB RES, V6, P447, DOI 10.1080/14622200410001696637; Buttenheim AM, 2010, GLOB PUBLIC HEALTH, V5, P413, DOI 10.1080/17441690902756062; Fernandez E, 2001, PREV MED, V32, P218, DOI 10.1006/pmed.2000.0794; Fleischer NL, 2012, AM J EPIDEMIOL, V175, P167, DOI 10.1093/aje/kwr314; Fleischer NL, 2011, NICOTINE TOB RES, V13, P894, DOI 10.1093/ntr/ntr090; Gilmore AB, 2012, TOB CONTROL, V21, P119, DOI 10.1136/tobaccocontrol-2011-050397; Harwood GA, 2007, PUBLIC HEALTH NURS, V24, P361, DOI 10.1111/j.1525-1446.2007.00645.x; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hiscock R, 2011, J PUBLIC HEALTH-UK, V33, P39, DOI 10.1093/pubmed/fdq097; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042843; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Kim S, 2007, SUBST USE MISUSE, V42, P1455, DOI 10.1080/10826080701212501; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Linetzky B, 2012, NICOTINE TOB RES, V14, P1092, DOI 10.1093/ntr/nts004; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI DOI 10.1136/TC.3.3.242; Marqueta A, 2013, GAC SANIT, V27, P26, DOI 10.1016/j.gaceta.2011.12.011; McKinnon B., 2012, CANCER CAUSE CONTROL, P1; Mina L., 2004, ECON DESARR-CUBA, V3, P53; Ministerio de Salud, 1999, EST NAC FACT RIESG E, VII, P48; Nagelhout GE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-303; Osler M, 1998, TOB CONTROL, V7, P262, DOI 10.1136/tc.7.3.262; Pardo C., 2010, BIOMEDICA, V4, P509; Peualoza E., 2009, ENCUESTA NACL SALUD; Reid JL, 2010, NICOTINE TOB RES, V12, pS20, DOI 10.1093/ntr/ntq051; Schaap MM, 2008, NICOTINE TOB RES, V10, P359, DOI 10.1080/14622200701825098; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Siahpush M, 2009, ADDICTION, V104, P1382, DOI 10.1111/j.1360-0443.2009.02599.x; Storr CL, 2008, ADDICT BEHAV, V33, P412, DOI 10.1016/j.addbeh.2007.10.003; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294	34	5	6	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	OCT	2013	15	10					1745	1755		10.1093/ntr/ntt055	http://dx.doi.org/10.1093/ntr/ntt055			11	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	252AR	23645609				2022-09-04	WOS:000326977100014
J	Bustos, SS; Kuruoglu, D; Yan, M; Bustos, VP; Forte, AJ; Ciudad, P; Kim, EA; Del Corral, GA; Manrique, OJ				Bustos, Samyd S.; Kuruoglu, Doga; Yan, Maria; Bustos, Valeria P.; Forte, Antonio J.; Ciudad, Pedro; Kim, Esther A.; Del Corral, Gabriel A.; Manrique, Oscar J.			Nipple-areola complex reconstruction in transgender patients undergoing mastectomy with free nipple grafts: a systematic review of techniques and outcomes	ANNALS OF TRANSLATIONAL MEDICINE			English	Review						Transgender persons; nipples; chest wall; plastic surgery; masculinity	TO-MALE TRANSSEXUALS; GENDER-AFFIRMING SURGERY; WALL CONTOURING SURGERY; SUBCUTANEOUS MASTECTOMY; CHEST RECONSTRUCTION	Nipple-areola complex (NAC) reconstruction in transgender and gender non-binary (TGNB) individuals undergoing chest wall masculinization surgery is critical for adequate satisfaction and aesthetic results. Here, we conducted a systematic review to find the various techniques and outcomes of NAC reconstruction in double-incision mastectomy and free nipple grafts (DIM-FNG). A comprehensive search of several databases was conducted based on PRISMA guidelines. We included studies that described the NAC reconstruction technique after DIM-FNG, and evaluated the surgical outcomes, or satisfaction, or aesthetic results after a minimum duration of follow-up of 6 months. Studies were assessed for risk of bias. A qualitative synthesis was performed. A total of 19 studies, comprising 1,587 patients (3,174 breasts), were included. There was a total of 14 studies using the conventional FNG technique, 4 describing new approaches for NAC reconstruction in FNG and 1 study comparing the conventional FNG technique to another alternative technique. A total of 1,347 patients underwent DIM-FNG with conventional FNG and 240 underwent alternative techniques for NAC reconstruction after DIM-FNG. Postoperative complications were low, and satisfaction was high for conventional and alternative techniques. Newer techniques aim to reshape the new NACs in an oval shape, reduce nipple size and place the NACs using the pectoralis major lateral and inferior borders as reference. In addition, a horizontal oval incision at the recipient site may avoid an undesired vertical NAC.	[Bustos, Samyd S.; Kuruoglu, Doga; Yan, Maria; Manrique, Oscar J.] Mayo Clin, Div Plast & Reconstruct Surg, Rochester, MN 55905 USA; [Bustos, Samyd S.; Manrique, Oscar J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA; [Bustos, Valeria P.] Pontificia Univ Javeriana, Fac Med, Bogota, DC, Colombia; [Forte, Antonio J.] Mayo Clin, Div Plast & Reconstruct Surg, Jacksonville, FL 32224 USA; [Ciudad, Pedro] Arzobispo Loayza Natl Hosp, Dept Plast Reconstruct & Burn Surg, Lima, Peru; [Kim, Esther A.] Univ Calif San Francisco, Div Plast & Reconstruct Surg, San Francisco, CA 94143 USA; [Del Corral, Gabriel A.] MedStar Georgetown Univ Hosp, Plast & Reconstruct Surg, Washington, DC USA		Manrique, OJ (corresponding author), Mayo Clin, Div Plast & Reconstruct Surg, Rochester, MN 55905 USA.	oscarj.manrique@gmail.com	Forte, Antonio/I-2970-2019	Forte, Antonio/0000-0003-2004-7538				Agarwal CA, 2017, AESTHET PLAST SURG, V41, P1305, DOI 10.1007/s00266-017-0935-7; Beer GM, 2001, PLAST RECONSTR SURG, V108, P1947, DOI 10.1097/00006534-200112000-00015; Berry MG, 2012, J PLAST RECONSTR AES, V65, P711, DOI 10.1016/j.bjps.2011.11.053; Black CK, 2020, PRS-GLOB OPEN, V8, DOI 10.1097/GOX.0000000000002356; Bluebond-Langner R, 2017, PLAST RECONSTR SURG, V139, DOI 10.1097/PRS.0000000000003225; Bustos SS, 2020, AESTHET PLAST SURG, V44, P1478, DOI 10.1007/s00266-020-01803-1; Claes KEY, 2018, CLIN PLAST SURG, V45, P369, DOI 10.1016/j.cps.2018.03.010; Cregten-Escobar P, 2012, J SEX MED, V9, P3148, DOI 10.1111/j.1743-6109.2012.02939.x; Donato DP, 2017, ANN PLAS SURG, V79, P259, DOI 10.1097/SAP.0000000000001099; Frederick MJ, 2017, ANN PLAS SURG, V78, P249, DOI 10.1097/SAP.0000000000000882; Frey JD, 2018, PLAST RECONSTR SURG, V142, P331, DOI 10.1097/PRS.0000000000004551; HAGE JJ, 1995, PLAST RECONSTR SURG, V96, P386, DOI 10.1097/00006534-199508000-00019; HAGE JJ, 1995, ANN PLAS SURG, V34, P59, DOI 10.1097/00000637-199501000-00012; Kaariainen M, 2017, SCAND J SURG, V106, P74, DOI 10.1177/1457496916645964; Knox ADC, 2017, PLAST RECONSTR SURG, V139, p1260E, DOI 10.1097/PRS.0000000000003388; KORNSTEIN AN, 1992, AESTHET PLAST SURG, V16, P331, DOI 10.1007/BF01570696; Kuhn S, 2019, ARCH PLAST SURG-APS, V46, P433, DOI 10.5999/aps.2018.01214; Lane M, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001738; Lewin R, 2016, AESTHET PLAST SURG, V40, P724, DOI 10.1007/s00266-016-0684-z; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136, 10.1136/bmj.b2700]; Lindsay W R, 1979, Ann Plast Surg, V3, P39; Lo Russo G, 2017, AESTHET PLAST SURG, V41, P369, DOI 10.1007/s00266-017-0796-0; McEvenue G, 2018, AESTHET SURG J, V38, P49, DOI 10.1093/asj/sjx116; Monstrey S, 2008, PLAST RECONSTR SURG, V121, P849, DOI 10.1097/01.prs.0000299921.15447.b2; Morselli PG, 2019, ANN PLAS SURG, V83, P629, DOI 10.1097/SAP.0000000000002119; Nelson L, 2009, J PLAST RECONSTR AES, V62, P331, DOI 10.1016/j.bjps.2007.10.049; Newfield E, 2006, QUAL LIFE RES, V15, P1447, DOI 10.1007/s11136-006-0002-3; NIH, STUD QUAL ASS TOOLS; Rothenberg KA, 2018, ANN PLAS SURG, V81, P642, DOI 10.1097/SAP.0000000000001617; Shulman O, 2001, PLAST RECONSTR SURG, V108, P348, DOI 10.1097/00006534-200108000-00010; van de Grift TC, 2019, J SEX MARITAL THER, V45, P201, DOI 10.1080/0092623X.2018.1500405; Vigneswaran N, 2013, J PLAST RECONSTR AES, V66, P1805, DOI 10.1016/j.bjps.2013.06.052; Whitehead DM, 2018, ANN PLAS SURG, V81, P353, DOI 10.1097/SAP.0000000000001536; Wilson SC, 2018, ANN PLAS SURG, V80, P679, DOI 10.1097/SAP.0000000000001354; Wolter A, 2015, J PLAST RECONSTR AES, V68, P184, DOI 10.1016/j.bjps.2014.10.016; Wolter A, 2018, J PLAST RECONSTR AES, V71, P344, DOI 10.1016/j.bjps.2017.09.003; Yue D, 2018, AESTHET SURG J, V38, P742, DOI 10.1093/asj/sjx245	37	1	1	0	1	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	APR	2021	9	7							612	10.21037/atm-20-4522	http://dx.doi.org/10.21037/atm-20-4522			13	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	SM0SI	33987310	Green Published, gold			2022-09-04	WOS:000657322500039
J	Wiesner, A; Diez, R; Florez, D; Piquet, H				Wiesner, A.; Diez, R.; Florez, D.; Piquet, H.			System for experimental investigation of DBD excilamps in view of control and optimization of UV emission	MATHEMATICS AND COMPUTERS IN SIMULATION			English	Article						DBD; Power converters; Current-mode; Interleaved converters	DIELECTRIC-BARRIER-DISCHARGE; POWER; LAMP; DESIGN; IDENTIFICATION; GENERATION; EFFICIENCY; CONVERTER; FREQUENCY; SURFACE	This paper presents the design of a system aimed at characterizing a diverse set of dielectric barrier discharge UV lamps. This experimental bench allows the study of the lamps performances regarding UV emission maximization and energy conversion optimization. It includes a current-mode pulsed power supply for the lamps, the design of which is detailed. This converter presents 3 degrees of freedom (DOF) can control and adjust independently the frequency, amplitude and duration of the current pulses injected into the lamps. Theoretical modeling of the lamps, by means of equivalent electrical circuits, is used to define the most interesting operating points to be explored, as well as for the converter's design; these models are afterwards validated by experimental tests on the entire set of lamps. The operation of the bench is controlled by a supervising program: the latter manages the data acquisition and performs sweeps of the DOFs of the pulsed current. Examples of analyzes, oriented toward optimization of electric to UV energy conversion, are shown. (C) 2019 International Association for Mathematics and Computers in Simulation (IMACS). Published by Elsevier B.V. All rights reserved.	[Wiesner, A.; Diez, R.; Florez, D.] Pontificia Univ Javeriana, Carrera 7,40-62, Bogota 110231, Colombia; [Wiesner, A.; Piquet, H.] Univ Toulouse, LAPLACE, CNRS, INPT,UPS, 2 Rue Charles Camichel, F-31071 Toulouse, France; [Florez, D.] Univ Sergio Arboleda, Calle 74,14-14, Bogota 110221, Colombia		Wiesner, A (corresponding author), Pontificia Univ Javeriana, Carrera 7,40-62, Bogota 110231, Colombia.	awiesner@javeriana.edu.co; rdiez@javeriana.edu.co	Piquet, Hubert/D-4396-2013	Piquet, Hubert/0000-0002-3736-2676; Diez, Rafael/0000-0002-8107-2844; WIESNER HERNANDEZ, Arnold/0000-0003-4012-9645	Universidad Sergio Arboleda, Colombia [IN.BG.086.16.013]; COLCENCIAS/COLFUTURO; Colciencias, Colombia [663-2015, 294-2016, C16P01]	Universidad Sergio Arboleda, Colombia; COLCENCIAS/COLFUTURO; Colciencias, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors acknowledge specially to ECOS-Nord/COLCENCIAS/ICETEX French-Colombian cooperation program, ECOS Nord Program under Project C16P01, by Colciencias, Colombia under contracts 663-2015 and 294-2016 and by Universidad Sergio Arboleda, Colombia under Project IN. BG.086.16.013 and COLCENCIAS/COLFUTURO because part of this work is supported by them.	Akashi H, 2008, IEEE T PLASMA SCI, V36, P1336, DOI 10.1109/TPS.2008.920313; Garcia-Guerrero EA, 2018, IEEE T PLASMA SCI, V46, P2425, DOI 10.1109/TPS.2018.2824825; Bendali M, 2015, IET ELECTR SYST TRAN, V5, P53, DOI 10.1049/iet-est.2013.0045; Viejo CB, 2011, IEEE T IND APPL, V47, P1983, DOI 10.1109/TIA.2011.2155014; Bozhko IV, 2017, IEEE T PLASMA SCI, V45, P3064, DOI 10.1109/TPS.2017.2760888; Carman RJ, 2004, J PHYS D APPL PHYS, V37, P2399, DOI 10.1088/0022-3727/37/17/010; Cheng KY, 2016, IEEE T PLASMA SCI, V44, P3183, DOI 10.1109/TPS.2016.2606485; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez R, 2008, IEEE POWER ELECTRON, P2485, DOI 10.1109/PESC.2008.4592314; Diez R, 2015, IEEE T PLASMA SCI, V43, P452, DOI 10.1109/TPS.2014.2370796; Erofeev MV, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/04/045403; Esteki M, 2015, IET POWER ELECTRON, V8, P2352, DOI 10.1049/iet-pel.2014.0976; Florez D, 2018, IEEE T PLASMA SCI, V46, P140, DOI 10.1109/TPS.2017.2777835; Florez D, 2016, IEEE T PLASMA SCI, V44, P1160, DOI 10.1109/TPS.2016.2568461; Florez D, 2015, IEEE T IND ELECTRON, V62, P1451, DOI 10.1109/TIE.2014.2361601; Gnapowski E, 2016, IEEE T PLASMA SCI, V44, P2079, DOI 10.1109/TPS.2016.2541459; Guo TT, 2014, IET POWER ELECTRON, V7, P2857, DOI 10.1049/iet-pel.2013.0840; Huang GM, 2016, IEEE T PLASMA SCI, V44, P2111, DOI 10.1109/TPS.2016.2570758; Doanh LT, 2013, IEEE T IND APPL, V49, P331, DOI 10.1109/TIA.2012.2228835; Lomaev MI, 2012, PROG QUANT ELECTRON, V36, P51, DOI 10.1016/j.pquantelec.2012.03.003; Lomaev MI, 2003, PHYS-USP+, V46, P193, DOI 10.1070/PU2003v046n02ABEH001308; Lopez AM, 2013, IEEE T PLASMA SCI, V41, P2335, DOI 10.1109/TPS.2013.2273462; Manley T. C., 1943, 84 GEN M NEW YORK, P83; Meisser M., 2013, RESONANT BEHAV PULSE; Nassour K, 2018, IEEE T DIELECT EL IN, V25, P428, DOI 10.1109/TDEI.2017.006600; Oda A, 1999, J PHYS D APPL PHYS, V32, P2726, DOI 10.1088/0022-3727/32/21/304; Pipa V., 2012, SCI INSTRUM, V83; Roth J. Reece, 1995, DARK ELECT DISCHARGE, V1, P251	28	0	0	2	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4754	1872-7166		MATH COMPUT SIMULAT	Math. Comput. Simul.	NOV	2019	165						92	106		10.1016/j.matcom.2019.02.021	http://dx.doi.org/10.1016/j.matcom.2019.02.021			15	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Mathematics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematics	IC0RA		Green Published, Green Accepted, Bronze			2022-09-04	WOS:000470666400006
J	Nair, LB; Diochon, PF; Lassu, RA; Tilleman, SG				Nair, Lakshmi Balachandran; Fatien Diochon, Pauline; Lassu, Reka Anna; Tilleman, Suzanne G.			Let's Perform and Paint! The Role of Creative Mediums in Enhancing Management Research Representation	JOURNAL OF MANAGEMENT INQUIRY			English	Article						creativity; innovation; communication	MODEL	The limited reach of management research results in missed opportunities to support the decision-making processes of business professionals and policy makers. To strengthen the impact of management research and overcome barriers posed by text-heavy representation, we advocate for the use of creative mediums (e.g., collage, film, poetry) to showcase the product of an inquiry, either alone or as a supplement to traditional reporting. We provide a rationale for how these mediums trigger interest, foster a multisensory experience, convey complex meaning, and spark contemporary, inclusive dialogues. Each of the four rationales is discussed by showing an example of previous use, and explaining how the respective barrier to research representation is overcome. We finally offer recommendations for how management researchers can employ creative mediums to enhance the fertility of their work.	[Nair, Lakshmi Balachandran] Univ Utrecht, Utrecht, Netherlands; [Fatien Diochon, Pauline] Pontificia Univ Javeriana, Bogota, Colombia; [Lassu, Reka Anna] Univ Cent Florida, Orlando, FL 32816 USA; [Tilleman, Suzanne G.] Univ Montana, Missoula, MT 59812 USA		Tilleman, SG (corresponding author), Univ Montana, Dept Management & Mkt, 32 Campus Dr, Missoula, MT 59812 USA.	suzanne.tilleman@umontana.edu	Diochon, Pauline Fatien/ABH-5859-2020; NAIR, LAKSHMI/U-6228-2019	Diochon, Pauline Fatien/0000-0001-7255-5361; NAIR, LAKSHMI/0000-0003-3693-7922; Tilleman, Suzanne/0000-0003-0938-8622				Adler NJ, 2018, J MANAGE INQUIRY, V27, P119, DOI 10.1177/1056492617710758; Aguinis H, 2010, ORGAN RES METHODS, V13, P515, DOI 10.1177/1094428109333339; [Anonymous], 1995, KNOWLEDGE CREATION C; [Anonymous], 2014, ELECT J BUS RES METH; Banks M., 2000, INTERNET ARCHAEOLOGY, V8, DOI [10.11141/ia.8.8, DOI 10.11141/IA.8.8]; Baron T., 2012, ARTS BASED RES; Bartunek JM, 2006, ACAD MANAGE J, V49, P9; Beavan K., 2017, 33 EGOS C COP DENM; Bohannon J., 2017, SCIENCE, DOI [10.1126/science.aan6888, DOI 10.1126/SCIENCE.AAN6888]; Brearley L., 2004, ANN AUSTR ASS RES ED; Bresler L, 2009, BRIT J MUSIC EDUC, V26, P7, DOI 10.1017/S0265051708008243; Caulley DN, 2008, QUAL INQ, V14, P424, DOI 10.1177/1077800407311961; Champoux JE, 1999, J MANAGE INQUIRY, V8, P206, DOI 10.1177/105649269982016; Chenail RJ, 2008, QUAL REP, V13, P7; Furman R., 2006, INT J QUAL METH, V5, P24, DOI [DOI 10.1177/160940690600500305, 10.1177/160940690600500305]; Gerstenblatt P, 2013, INT J QUAL METH, V12, P294, DOI 10.1177/160940691301200114; Hall J., 2013, HOPE HOPE SCOTTISH S; HAMBRICK DC, 1994, ACAD MANAGE REV, V19, P11, DOI 10.2307/258833; Hatch MJ, 2018, J MANAGE INQUIRY, V27, P138, DOI 10.1177/1056492617711600; Hughes T, 2011, ACAD MANAG LEARN EDU, V10, P40, DOI 10.5465/AMLE.2011.59513272; Jepsen K., 2013, SYMMETRY MAGAZI 0609; Knowles JG., 2008, HDB ARTS QUALITATIVE; Korchagina N., 2016, 74 ACAD MAN AN CA; Leavy P, 2015, METHOD MEETS ART ART; Liddicoat P., 2012, SUPER ALLOY IS BORN; Meisiek S., 2008, ORG LEARNING KNOWLED; Miller D., 1993, QUASI POLITICAL EXPL; Mohrman SA, 2001, ACAD MANAGE J, V44, P357, DOI 10.2307/3069461; Morrison K. F., 2014, YOU HERMENEUTICS EMP; Natale N., 2011, MARC SPARFELTHE EURO; Newman J, 2016, PUBLIC ADMIN REV, V76, P24, DOI 10.1111/puar.12464; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Parker I., 2004, QUALITATIVE RES PSYC, V1, P95, DOI [10.1191/1478088704qp010oa, DOI 10.1191/1478088704QP0100A]; QUALMAN E., 2010, SOCIALNOMICS SOCIAL; Rolling JH, 2010, STUD ART EDUC, V51, P102, DOI 10.1080/00393541.2010.11518795; Romme AGL, 2015, BRIT J MANAGE, V26, P544, DOI 10.1111/1467-8551.12110; Rosling H., 2017, ROSLING DIAGNOSED WO; Rosling H., 2006, TED TALK BEST STATS; Rousseau DM, 2006, ACAD MANAGE REV, V31, P256, DOI 10.5465/AMR.2006.20208679; Rynes SL, 2001, ACAD MANAGE J, V44, P340, DOI 10.2307/3069460; Shepard G. H., 2012, MISS KAYAPO FILMING; SHRIVASTAVA P, 1984, ACAD MANAGE REV, V9, P18, DOI 10.2307/258228; Silverman D., 2013, VERY SHORT FAIRLY IN, V2nd; Spencer JW, 2001, ACAD MANAGE J, V44, P432, DOI 10.2307/3069465; Thackeray R, 2009, HEALTH PROMOT PRACT, V10, P171, DOI 10.1177/1524839908330729	45	4	4	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1056-4926	1552-6542		J MANAGE INQUIRY	J. Manage. Inq.	JUL	2018	27	3					301	308		10.1177/1056492618760723	http://dx.doi.org/10.1177/1056492618760723			8	Management	Social Science Citation Index (SSCI)	Business & Economics	GK3LB					2022-09-04	WOS:000436045600003
J	Bachurin, SO; Gavrilova, SI; Samsonova, A; Barreto, GE; Aliev, G				Bachurin, Sergey O.; Gavrilova, Svetlana I.; Samsonova, Anna; Barreto, George E.; Aliev, Gjumrakch			Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention	PHARMACOLOGICAL RESEARCH			English	Review						Neurodegenerative disease; Alzheimer's disease; Multitargeting compounds; Disease-modifying drugs; Repositioning of old drugs; Clinical trial and AD treatment	OXIDASE INHIBITOR; DRUG; TOMM40; GENOTYPE; TARGETS; PROTEIN; MODEL; TRIAL; RATS	Alzheimer disease (AD) and related forms of dementia are among the main medical and social problems in the economically developed countries. It is connected with significant increase in human life span in these regions and with the absence of efficient medicines for treatment and prevention of such diseases. Lack of positive results in the developing of novel drugs for AD treatment stimulates special attention on problem of early diagnosis and drug discovery for pharmacotherapy on the very early stages of dementia, in particular, on mild cognitive impairments (MCI) due to AD. Here we review the state of art in the field of MCI diagnostics and analyze the data on the pharmacological agents developed for MCI treatment, which currently are in preclinical and clinical trials. The conclusion was made that only the agents that act on the very early pathogenetic stages of the disease, when the damage of cholinergic neurons is not observed, can be efficient for pharmacotherapeutic intervention of MCI. Therefore, the focused search and design of "disease-modifying" medicines should be accepted as the most (and may be the only) efficient strategy for treatment and prevention of MCI. (C) 2017 Published by Elsevier Ltd.	[Bachurin, Sergey O.; Samsonova, Anna; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 1142432, Moscow Region, Russia; [Gavrilova, Svetlana I.] Mental Hlth Res Ctr, 34Kashirskoyeshosse, Moscow 115522, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Bachurin, SO (corresponding author), Russian Acad Sci, Inst Physiologically Act Cpds, Severny Pr 1, Chernogolovka 142432, Russia.	aliev03@gmail.com	Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020; Sergey, Bachurin/I-1708-2018; Gavrilova, Svetlana/B-4548-2016	Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Gavrilova, Svetlana/0000-0001-6683-0240	Russian Science Foundation [17-23-00013] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF))		Afshar F., 2017, J PREV ALZHEIMERS DI, V4, P404; Alessenko A. V., 2013, Biomeditsinskaya Khimiya, V59, P25; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2017, ALZH TREATM; Bachurin S, 1999, ANN NY ACAD SCI, V890, P155, DOI 10.1111/j.1749-6632.1999.tb07990.x; Bachurin S., 2013, FLUORINE CONTAINING; Bar-Am O, 2009, J MOL NEUROSCI, V37, P135, DOI 10.1007/s12031-008-9139-6; Bazenet C, 2012, BIOMARK MED, V6, P441, DOI [10.2217/BMM.12.48, 10.2217/bmm.12.48]; Bharadwaj P R, 2013, Transl Psychiatry, V3, pe332, DOI 10.1038/tp.2013.97; Brinton L.S., 2017, ALZHEIMERS DEMENTI S, V13, P939; Calsolaro V, 2015, CNS DRUGS, V29, P1023, DOI 10.1007/s40263-015-0301-8; Cardinali Daniel P, 2012, Am J Neurodegener Dis, V1, P280; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Dodel A., 2011, ALZHEIMERS DEMENT, V7, pe55; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Ellis R, 2016, NEUROTHERAPEUTICS, V13, P471, DOI 10.1007/s13311-016-0454-2; Gavrilova SI, 2010, ZH NEVROL PSIKHIATR, V110, P62; Green RC, 2006, NEUROLOGY, V67, pS2, DOI 10.1212/WNL.67.9_suppl_3.S2; Guan J, 2010, BEHAV BRAIN RES, V210, P221, DOI 10.1016/j.bbr.2010.02.039; Hake A.M., 2017, ALZHEIMERS DEMENTI S, V13, P250; He HW, 2010, CURR NEUROPHARMACOL, V8, P211, DOI 10.2174/157015910792246137; Hoekman M., 2012, Patent No. [PCT/US12/27754, 1227754]; Howley E, 2017, NEUROCHEM RES, V42, P3279, DOI 10.1007/s11064-017-2367-9; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jayarajan P, 2016, ALZHEIMERS DEMENT, V7, P823, DOI [10.1016/j.jalz.2016.06.1673, DOI 10.1016/J.JALZ.2016.06.1673]; Jayarajan R., 2015, ALZHEIMERS DEMENT, V11, pP472; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Khan A, 2017, EXPERT REV NEUROTHER, V17, P683, DOI 10.1080/14737175.2017.1326818; Kikuchi K, 2017, J CELL BIOCHEM, V118, P4183, DOI 10.1002/jcb.26129; Kimura Y., 2017, ALZHEIMERS DEMENTI S, V13, P624; Kumar A, 2012, PHARMACOL BIOCHEM BE, V103, P43, DOI 10.1016/j.pbb.2012.07.015; Lahmy V, 2013, NEUROPSYCHOPHARMACOL, V38, P1706, DOI 10.1038/npp.2013.70; Langen B, 2011, EUR NEUROPSYCHOPHARM, V21, pS335, DOI 10.1016/S0924-977X(11)70533-8; Lin CH, 2014, BIOL PSYCHIAT, V75, P678, DOI 10.1016/j.biopsych.2013.08.010; Liu J, 2016, DRUG AGING, V33, P685, DOI 10.1007/s40266-016-0406-x; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Maher MP, 2009, COMB CHEM HIGH T SCR, V12, P64, DOI 10.2174/138620709787048028; Matijevic H., 2015, ALZHEIMERS DEMENT, V11, pP841; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Modgil A, 2017, NEUROPHARMACOLOGY, V113, P314, DOI 10.1016/j.neuropharm.2016.10.010; Muddana R., 2014, ALZHEIMERS DEMENT, V10, pP460; Nirogi K., 2017, ALZHEIMERS DEMENTI S, V13, P617; Nirogi P., 2009, ALZHEIMERS DEMENT, V5, pP337; Peters OM, 2013, J ALZHEIMERS DIS, V33, P1041, DOI 10.3233/JAD-2012-121732; Petersen RC, 2000, NEUROL CLIN, V18, P789, DOI 10.1016/S0733-8619(05)70226-7; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Porrini V, 2015, NEUROSCIENCE, V302, P112, DOI 10.1016/j.neuroscience.2014.10.029; Pradier L., 2013, ALZHEIMERS DEMENT, V9, pP808; Relkin NR, 2017, NEUROLOGY, V88, P1768, DOI 10.1212/WNL.0000000000003904; Ritchie S., 2016, ALZHEIMERS DEMENTI S, V12, P1186; Rosenberg G.I., 2005, Patent W0, Patent No. [2005016229A3, 2005016229]; Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88; Sanz-Blasco S, 2016, NEUROREPORT, V27, P705, DOI 10.1097/WNR.0000000000000601; Smith G., 2013, Patent, Patent No. 2014144801; Spilman P, 2014, BRAIN RES, V1551, P25, DOI 10.1016/j.brainres.2013.12.029; Strawn JR, 2017, J CHILD ADOL PSYCHOP, V27, P29, DOI 10.1089/cap.2016.0132; Strekalova T., 2017, MOL NEUROBIOL; Strohle A, 2015, AM J GERIAT PSYCHIAT, V23, P1234, DOI 10.1016/j.jagp.2015.07.007; Toba J, 2016, BIOCHEM BIOPH RES CO, V473, P1039, DOI 10.1016/j.bbrc.2016.04.012; Tucker S, 2015, J ALZHEIMERS DIS, V43, P575, DOI 10.3233/JAD-140741; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Webster SP, 2017, BRIT J PHARMACOL, V174, P396, DOI 10.1111/bph.13699; Xiao R, 2016, CURR TOP MED CHEM, V16, P565, DOI 10.2174/1568026615666150813144603; Yu Zhong-Hai, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P287; Zhu JY, 2017, J MED CHEM, V60, P7863, DOI 10.1021/acs.jmedchem.7b00996; Zhuravin I А, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P110, DOI 10.17116/jnevro2015115112110-117	72	39	45	0	31	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	MAR	2018	129						216	226		10.1016/j.phrs.2017.11.021	http://dx.doi.org/10.1016/j.phrs.2017.11.021			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GA1UJ	29170097				2022-09-04	WOS:000428102600022
J	dos Santos, AB; Kohlmeier, KA; Rocha, ME; Barreto, GE; Barreto, JA; de Souza, ACA; Bezerra, MA				dos Santos, Altair B.; Kohlmeier, Kristi A.; Rocha, Marcelo E.; Barreto, George E.; Barreto, Jeferson A.; de Souza, Ana Carla A.; Bezerra, Marcos A.			Hair in Parkinson's disease patients exhibits differences in Calcium, Iron and Zinc concentrations measured by flame atomic absorption spectrometry - FAAS	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Neurochemistry; Neurotoxicity; Metals unbalance; Neurodegenerative disease; Analytical methods	OCCUPATIONAL-EXPOSURE; METALS; COPPER; ALZHEIMERS; BLOOD; TRACE; SERUM; RISK	Imbalances in metals have emerged as playing a role in the pathophysiology of Parkinson's Disease (PD). Monitoring of metal levels could serve as a biomarker of presence, or future development, of this disease. To this end, we evaluated the ability of flame atomic absorption spectrometry (FAAS) to assess the concentrations of Ca, Fe and Zn in hair of PD patients and to investigate if there was an association with age and disease duration. Hair samples were collected from 26 clinically-diagnosed PD patients, and 33 healthy individuals. Concentrations of Ca and Fe were lower in PD patients when compared to control, whereas, a higher concentration of Zn was detected in PD patients. Levels of Ca and Fe did not vary with age nor with the duration of PD. While Zn did not present variation with duration of the disease, there was a correlation with age as PD patients older than 65 years exhibited a higher concentration of Zn than controls. We conclude that FAAS is useful for detecting differences in Fe, Ca and Zn in hair samples of patients with PD. Hair samples required for this method are easy to collect, and the technique relies on a simple method of digestion of the organic matrix. The ease of use of FAAS should allow for more frequent monitoring of metallic levels in patients in a variety of small clinical situations, thereby offering the hope of allowing systematic tracking of metal levels as the disease progresses, or prior to the defining motor symptoms.	[dos Santos, Altair B.; Rocha, Marcelo E.; Barreto, Jeferson A.; Bezerra, Marcos A.] Univ Estadual Sudoeste Bahia, Dept Ciencias & Tecnol, Av Jose Moreira Sobrinho S-N, BR-45206190 Jequie, BA, Brazil; [dos Santos, Altair B.; Kohlmeier, Kristi A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [de Souza, Ana Carla A.] Univ Fed Sergipe, Dept Physiol, Aracaju, Brazil		Bezerra, MA (corresponding author), Univ Estadual Sudoeste Bahia, Dept Ciencias & Tecnol, Av Jose Moreira Sobrinho S-N, BR-45206190 Jequie, BA, Brazil.	mbezerra@uesb.edu.br	Barreto, George E./AAD-7420-2020; Barreto, Jeferson Alves/AAV-4175-2020; Barreto, Jeferson Alves/S-3160-2019	Barreto, George E./0000-0002-6644-1971; Kohlmeier, Kristi A./0000-0003-0183-3816; Barreto, Jeferson Alves/0000-0002-7595-3207	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [99999.012934/2013-05]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. Grant numbers (99999.012934/2013-05).	Altschuler E, 1999, MED HYPOTHESES, V53, P22, DOI 10.1054/mehy.1997.0701; Korn MDA, 2008, APPL SPECTROSC REV, V43, P67, DOI 10.1080/05704920701723980; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bocca B, 2006, J NEUROL SCI, V248, P23, DOI 10.1016/j.jns.2006.05.007; Burguera M, 1998, ANAL CHIM ACTA, V366, P63, DOI 10.1016/S0003-2670(97)00661-2; CHATTERJEE J, 1994, BIOL TRACE ELEM RES, V46, P211, DOI 10.1007/BF02789298; Chen Pan, 2016, F1000Res, V5, DOI 10.12688/f1000research.7431.1; D'Ilio S, 2000, MICROCHEM J, V67, P343, DOI 10.1016/S0026-265X(00)00086-2; Forte G, 2005, J TRACE ELEM MED BIO, V19, P195, DOI 10.1016/j.jtemb.2005.08.003; Forte G, 2004, J NEURAL TRANSM, V111, P1031, DOI 10.1007/s00702-004-0124-0; Fukushima Tetsuhito, 2013, Fukushima J Med Sci, V59, P76; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Isaev NK, 2012, BRAIN RES BULL, V87, P80, DOI 10.1016/j.brainresbull.2011.10.017; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; KLEVAY LM, 1987, AM J CLIN NUTR, V46, P233, DOI 10.1093/ajcn/46.2.233; Kobayashi S, 1989, Prog Clin Biol Res, V317, P1095; Le Couteur DG, 1999, BIOMED PHARMACOTHER, V53, P122, DOI 10.1016/S0753-3322(99)80077-8; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Miyake Y, 2011, J NEUROL SCI, V306, P98, DOI 10.1016/j.jns.2011.03.035; Pande MBS, 2005, COMPUT BIOL MED, V35, P475, DOI 10.1016/j.compbiomed.2004.04.003; Rahman MA, 2009, BIOL TRACE ELEM RES, V127, P102, DOI 10.1007/s12011-008-8230-8; Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010; RYBICKI BA, 1993, MOVEMENT DISORD, V8, P87, DOI 10.1002/mds.870080116; Senofonte O, 2000, J TRACE ELEM MED BIO, V14, P6, DOI 10.1016/S0946-672X(00)80017-6; Squitti R, 2002, NEUROLOGY, V59, P1153, DOI 10.1212/WNL.59.8.1153; Stelmashook EV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P391, DOI 10.1134/S0006297914050022; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; ZAYED J, 1990, CAN J NEUROL SCI, V17, P286, DOI 10.1017/S0317167100030584; Zhao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083060	31	9	9	0	12	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0946-672X	1878-3252		J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.		2018	47						134	139		10.1016/j.jtemb.2018.02.003	http://dx.doi.org/10.1016/j.jtemb.2018.02.003			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GB9MC	29544800				2022-09-04	WOS:000429396900017
J	Faccini-Martinez, AA; Ramirez-Hernandez, A; Barreto, C; Forero-Becerra, E; Millan, D; Valbuena, E; Sanchez-Alfonso, AC; Imbacuan-Pantoja, WO; Cortes-Vecino, JA; Polo-Teran, LJ; Yaya-Lancheros, N; Jacome, J; Palomar, AM; Santibanez, S; Portillo, A; Oteo, JA; Hidalgo, M				Faccini-Martinez, Alvaro A.; Ramirez-Hernandez, Alejandro; Barreto, Christian; Forero-Becerra, Elkin; Millan, Diego; Valbuena, Elkin; Sanchez-Alfonso, Andrea C.; Imbacuan-Pantoja, Wilson O.; Cortes-Vecino, Jesus A.; Polo-Teran, Luis J.; Yaya-Lancheros, Nestor; Jacome, Jorge; Palomar, Ana M.; Santibanez, Sonia; Portillo, Aranzazu; Oteo, Jose A.; Hidalgo, Marylin			Epidemiology of Spotted Fever Group Rickettsioses and Acute Undifferentiated Febrile Illness in Villeta, Colombia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SP STRAIN COLOMBIANENSI; MOLECULAR-DETECTION; RURAL AREA; TICKS; ACARI; EHRLICHIA; IXODIDAE; HUMANS; IDENTIFICATION; LEPTOSPIROSIS	Etiology of acute undifferentiated febrile syndrome (AUFS) is often unknown, leading to inaccurate diagnosis and treatment. Villeta town has been identified as an endemic area for spotted fever group (SFG) rickettsioses but little is known about possible amplifier hosts and other Rickettsia species different from Rickettsia rickettsii. Besides, few studies have approached other AUFS etiologies in the region. We investigated the role of dengue, leptospirosis, rickettsioses, human anaplasmosis, and Q fever as possible causes of AUFS in patients from Villeta. Sera specimens and ticks from animals as well as ticks from vegetation were studied for the presence of different Rickettsia spp. Among 104 sera from patients with AUFS, 16.4%, 24.0%, and 2.9% patients seroconverted to dengue, Leptospira, and SFG Rickettsia, respectively, with a case of probable coinfection or cross-reaction with Anaplasma phagocytophilum. None of the samples were reactive for Coxiella burnetii. Sera samples from 74 horses, 118 dogs, and 62 bovines were collected and showed 33.8%, 14.4%, and 50.0% of seroprevalence for SFG Rickettsia, respectively. A total of 1,287 ixodid ticks were collected from animals/vegetation and processed in pools for polymerase chain reaction. Among them, 1.7% was positive for Rickettsia genes, and Rickettsia amblyommii, R. rickettsii, and Rickettsia spp. were found. These results confirm the circulation of dengue, different SFG Rickettsia species and the relevance of other etiologies like leptospirosis and human anaplasmosis. Further studies must identify different epidemiological variables to establish proper surveillance and control programs.	[Faccini-Martinez, Alvaro A.; Barreto, Christian; Millan, Diego; Valbuena, Elkin; Sanchez-Alfonso, Andrea C.; Hidalgo, Marylin] Pontificia Univ Javeriana, Dept Microbiol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Faccini-Martinez, Alvaro A.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Spain; [Ramirez-Hernandez, Alejandro; Imbacuan-Pantoja, Wilson O.; Cortes-Vecino, Jesus A.; Polo-Teran, Luis J.] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Grp Parasitol Vet, Bogota, Colombia; [Ramirez-Hernandez, Alejandro] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, SP, Brazil; [Forero-Becerra, Elkin] Univ Fed Vicosa, Dept Med Vet, Vicosa, MG, Brazil; [Polo-Teran, Luis J.; Yaya-Lancheros, Nestor] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Dept Salud Anim, Grp Salud Publ Vet, Bogota, Colombia; [Jacome, Jorge] Pontificia Univ Javeriana, Dept Biol, Bogota, Colombia; [Palomar, Ana M.; Santibanez, Sonia; Portillo, Aranzazu; Oteo, Jose A.] Hosp San Pedro CIBIR, Ctr Rickettsiosis & Enfermedades Transmitidas Art, Dept Enfermedades Infecciosas, Logrono, Spain; [Imbacuan-Pantoja, Wilson O.; Cortes-Vecino, Jesus A.] Univ Nacl Colombia, Grp Parasitol Vet, Ciudad Univ, Bogota, Colombia; [Palomar, Ana M.; Santibanez, Sonia; Portillo, Aranzazu; Oteo, Jose A.] Hosp San Pedro CIBIR, Ctr Rickettsioses & Arthropod Borne Dis, Dept Infect Dis, Logrono, Spain		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Fac Ciencias, Cra 7a 43-82, Bogota, Colombia.	afaccini@gmail.com; aramirezhe@unal.edu.co; davidbarreto_02@hotmail.com; egforerob@unal.edu.co; dmillan19@hotmail.com; notengokorreo8@hotmail.com; asanchez-a@javeriana.edu.co; woimbacuanp@unal.edu.c; jacortesv@unal.edu.co; luijpolot@unal.edu.co; nyayal@unal.edu.co; jacomej@javeriana.edu.co; ampalomar@riojasalud.es; ssantibanez@riojasalud.es; aportillo@riojasalud.es; jaoteo@riojasalud.es; hidalgo.m@javeriana.edu.co	Portillo, Arantza/ABH-7807-2020; Jácome, Jorge/AAF-8178-2019; Hernandez, Alejandro Ramirez/U-1567-2019; Santibáñez, Sonia/AAM-8816-2021; Oteo, Jose A./AAB-3134-2020; Hidalgo, Marylin/AAF-5736-2019; Palomar, Ana M/ABF-7245-2020	Portillo, Arantza/0000-0002-2055-1825; Jácome, Jorge/0000-0003-0972-3056; Hernandez, Alejandro Ramirez/0000-0001-8689-5930; Santibáñez, Sonia/0000-0002-4996-288X; Oteo, Jose A./0000-0001-7080-6542; Palomar, Ana M/0000-0002-5461-5874; Cortes-Vecino, Jesus A./0000-0003-2641-604X; Hidalgo, Marylin/0000-0001-8960-0616	Departamento Administrativo de Ciencia, Tecnologia e Innovacion from Colombia (COLCIENCIAS) [120351929098]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion from Colombia (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The study was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion from Colombia (COLCIENCIAS, Code: 120351929098). Regulatory permits for this work were Permit in scientific research in biodiversity No. 005 of June 19, 2012, given by Corporacion Autonoma Regional (CAR) de Cundinamarca and contract for access to genetic resources for scientific research without commercial interest No. 85 of 2013, given by Ministerio de Ambiente y Desarrollo Sostenible from Colombia.	Acosta J., 2006, Informe Quincenal - Epidemiologico Nacional, V11, P177; Arroyave E, 2013, BIOMEDICA, V33, P99, DOI 10.7705/biomedica.v33i0.734; Barros-Battesti DM, 2006, CARRAPATOS IMPORTANC; Bello S, 2013, BIOMEDICA, V33, P153, DOI 10.7705/biomedica.v33i0.1608; Bermudez SE, 2009, J MED ENTOMOL, V46, P856, DOI 10.1603/033.046.0417; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Blanton LS, 2014, VECTOR-BORNE ZOONOT, V14, P557, DOI 10.1089/vbz.2014.1575; Campos Sabrina Destri Emmerick, 2016, Vet Med Int, V2016, P2430945, DOI 10.1155/2016/2430945; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Delisle J, 2016, AM J TROP MED HYG, V94, P1212, DOI 10.4269/ajtmh.15-0372; Direccion de Vigilancia y Analisis del Riesgo en Salud Publica Instituto Nacional deSalud (INS), 2015, B EP SEM SEM EP NUM; Eremeeva ME, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00055; Estrada-Pena A, 2004, ANN TROP MED PARASIT, V98, P283, DOI 10.1179/000349804225003316; Faccini-Martinez AA, 2016, VECTOR-BORNE ZOONOT, V16, P85, DOI 10.1089/vbz.2015.1841; Faccini-Martinez AA, 2015, EMERG INFECT DIS, V21, P537, DOI 10.3201/eid2013.140721; Faccini-Martinez AA, 2014, INT J INFECT DIS, V28, P126, DOI 10.1016/j.ijid.2014.05.025; Guglielmone AA, 2006, EXP APPL ACAROL, V40, P83, DOI 10.1007/s10493-006-9027-0; Hidalgo M, 2007, AM J TROP MED HYG, V77, P378, DOI 10.4269/ajtmh.2007.77.378; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Hidalgo M, 2013, VECTOR-BORNE ZOONOT, V13, P289, DOI 10.1089/vbz.2012.1173; Hidalgo M, 2009, AM J TROP MED HYG, V80, P1029, DOI 10.4269/ajtmh.2009.80.1029; Londono AF, 2014, TICKS TICK-BORNE DIS, V5, P672, DOI 10.1016/j.ttbdis.2014.04.018; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Máttar Salim, 2006, Rev.MVZ Cordoba, V11, P781; Merhej V, 2014, INFECT GENET EVOL, V25, P122, DOI 10.1016/j.meegid.2014.03.014; Miranda J, 2014, TICKS TICK-BORNE DIS, V5, P208, DOI 10.1016/j.ttbdis.2013.10.008; Miranda J, 2012, J MED ENTOMOL, V49, P960, DOI 10.1603/ME11195; Monje LD, 2016, J MED ENTOMOL, V53, P660, DOI 10.1093/jme/tjv250; Ogrzewalska M, 2012, PARASITOLOGY, V139, P1283, DOI 10.1017/S0031182012000546; Pacheco O., 2008, INF QUINC EPIDEMIOL, V13, P145; PATERNINA LUIS E, 2009, Acta biol.Colomb., V14, P154; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; PATINO-CAMARGO Luis, 1941, Boletin de la Oficina Sanitaria Panamericana, V20, P1112; Pesquera C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0662-3; Ramirez-Hernandez A, 2013, ACTA MED COSTARRIC, V55, P83; Ramirez-Hernandez A, 2013, AM J TROP MED HYG, V89, P453, DOI 10.4269/ajtmh.12-0698; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Rivas JJ, 2015, TICKS TICK-BORNE DIS, V6, P805, DOI 10.1016/j.ttbdis.2015.07.008; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Santos HA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-348; Thompson CN, 2015, AM J TROP MED HYG, V92, P875, DOI 10.4269/ajtmh.14-0709; Walker DH, 2016, AM J TROP MED HYG, V94, P3, DOI 10.4269/ajtmh.15-0762; WELLS EA, 1981, J WILDLIFE DIS, V17, P153, DOI 10.7589/0090-3558-17.1.153; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011	46	13	17	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	3					782	788		10.4269/ajtmh.16-0442	http://dx.doi.org/10.4269/ajtmh.16-0442			7	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	FT5OM	28722568	Green Published			2022-09-04	WOS:000423202900032
J	Ruiz, GO; Osorio, J; Valderrama, S; Alvarez, D; Diaz, RE; Calderon, J; Ballesteros, D; Franco, A				Ortiz Ruiz, G.; Osorio, J.; Valderrama, S.; Alvarez, D.; Elias Diaz, R.; Calderon, J.; Ballesteros, D.; Franco, A.			Risk factors for candidemia in non-neutropenic critical patients in Colombia	MEDICINA INTENSIVA			Spanish	Article						Candida; Risk factors; Mortality; Intensive care; Invasive candidiasis	CLINICAL-PREDICTION RULES; INTENSIVE-CARE-UNIT; INVASIVE CANDIDIASIS; ILL PATIENTS; ATTRIBUTABLE MORTALITY; EPIDEMIOLOGY; SCORE; MULTICENTER; VALIDATION; COLONIZATION	Objectives: Due to the increase in isolation of Candida spp. in critically ill patients, and the high mortality and economic costs which this infection entails, a study was made of the risk factors associated to candidemia in critically ill patients from 7 intensive care units in Colombia. Materials and methods: A multicenter matched case-control study was conducted in 7 intensive care units of 3 university hospitals. Data on overall length of hospital stay (including both general wards and the intensive care unit) were recorded. Results: A total of 243 subjects (81 cases and 162 controls) between January 2008 and December 2012 were included. In order of frequency, C. albicans, C. tropicalis and C. parapsilosis were isolated. The main identified risk factors were: overall length of hospital stay > 25 days (OR 5.33, 95% CI 2.6-10.9), use of meropenem (OR 3.75, 95% CI 1.86-7.5), abdominal surgery (OR 2.9, 95% CI 1.39-6.06) and hemodialysis (OR 3.35, 95% CI 1.5-7.7). No differences in mortality between patients with candidemia and controls were found (39.5 vs. 36.5%, respectively, P=.66) were found. Conclusions: In Colombia, a long hospital stay, abdominal surgery, the use of meropenem and hemodialysis were identified as risk factors for candidemia. (C) 2015 Elsevier Espana, S.L.U. and SEMICYUC. All rights reserved.	[Ortiz Ruiz, G.] Univ Bosquec, Hosp Santa Clara, Dept Cuidados Intens, Bogota, Colombia; [Osorio, J.] Univ Dept Med Interna Surcolombiana, Neiva, Colombia; [Valderrama, S.] Pontificia Univ Javeriana, Dept Med Interna, Bogota, Colombia; [Alvarez, D.] Univ Pittsburgh, Med Ctr, Dept Med Interna Pittsburgh, Pittsburgh, PA 15260 USA; [Elias Diaz, R.] Dept Med Interna Fdn Clin Shaio, Bogota, Colombia; [Calderon, J.] Hosp Univ Neiva, Dept Med Interna Neiva, Neiva, Colombia; [Ballesteros, D.] Hosp Santa Clara, Dept Med Interna, Bogota, Colombia; [Franco, A.] Hosp Santa Clara, Dept Cuidados Intens, Bogota, Colombia		Ruiz, GO (corresponding author), Univ Bosquec, Hosp Santa Clara, Dept Cuidados Intens, Bogota, Colombia.	ortiz_guillermo@hotmail.com		Valderrama-Beltran, Sandra Liliana/0000-0003-1833-1599				Cortes JA, 2011, REV IBEROAM MICOL, V28, P74, DOI 10.1016/j.riam.2010.12.002; Barberino Maria Goreth, 2006, Braz J Infect Dis, V10, P36, DOI 10.1590/S1413-86702006000100008; Chow JK, 2008, CLIN INFECT DIS, V46, P1206, DOI 10.1086/529435; Darouiche RO, 2009, CLIN CHEST MED, V30, P287, DOI 10.1016/j.ccm.2009.02.013; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; de Molina FJG, 2012, CRIT CARE, V16, DOI 10.1186/cc11388; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hermsen ED, 2011, CRIT CARE, V15, DOI 10.1186/cc10366; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z; Ostrosky-Zeichner L, 2011, CRIT CARE, V15, DOI 10.1186/cc10422; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pasero D, 2011, INTERACT CARDIOV TH, V12, P374, DOI 10.1510/icvts.2010.257931; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Playford EG, 2009, INTENS CARE MED, V35, P2141, DOI 10.1007/s00134-009-1619-9; Shorr AF, 2009, CRIT CARE, V13, DOI 10.1186/cc8110	21	16	19	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	APR	2016	40	3					139	144		10.1016/j.medin.2015.08.001	http://dx.doi.org/10.1016/j.medin.2015.08.001			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2BL	26725105				2022-09-04	WOS:000374719500001
J	Corcellas, C; Feo, ML; Torres, JP; Malm, O; Ocampo-Duque, W; Eljarrat, E; Barcelo, D				Corcellas, Cayo; Luisa Feo, Maria; Paulo Torres, Joao; Malm, Olaf; Ocampo-Duque, William; Eljarrat, Ethel; Barcelo, Damia			Pyrethroids in human breast milk: Occurrence and nursing daily intake estimation	ENVIRONMENT INTERNATIONAL			English	Article						Cypermethrin; Esfenvalerate; Fenvalerate; Lambda-cyhalothrin; Permethrin	REPRODUCTIVE TOXICITY; INSECTICIDES; PERMETHRIN; CYPERMETHRIN; POPULATIONS; METABOLISM; RESISTANCE; RESIDUES; EXPOSURE	There is an assumption that pyrethroid pesticides are converted to non-toxic metabolites by hydrolysis in mammals. However, some recent works have shown their bioaccumulation in human breast milk collected in areas where pyrethroids have been widely used for agriculture or malaria control. In this work, thirteen pyrethroids have been studied in human breast milk samples coming from areas without pyrethroid use for malaria control, such as Brazil, Colombia and Spain. The concentrations of pyrethroids ranged from 1.45 to 24.2 ng g(-1) lw. Cypermethrin, lambda-cyhalothrin, permethrin and esfenvalerate/fenvalerate were present in all the studied samples. The composition of pyrethroid mixture depended on the country of origin of the samples, bifenthrin being the most abundant in Brazilian samples, lambda-cyhalothrin in Colombian and permethrin in Spanish ones. When the pyrethroid concentrations were confronted against the number of gestations, an exponential decay was observed. Moreover, a time trend study was carried out in Brazil, where additional archived pool samples were analyzed, corresponding to years when pyrethroids were applied for dengue epidemic control. In these cases, total pyrethroid levels reached up to 128 ng g(-1) lw, and concentrations decreased when massive use was not allowed. Finally, daily intake estimation of nursing infants was calculated in each country and compared to acceptable WHO levels. The estimated daily intakes for nursing infants were always below the acceptable daily intake levels, nevertheless in certain samples the detected concentrations were very close to the maximum acceptable levels. (C) 2012 Elsevier Ltd. All rights reserved.	[Corcellas, Cayo; Luisa Feo, Maria; Eljarrat, Ethel; Barcelo, Damia] CSIC, Dep Environm Chem, IDAEA, ES-08034 Barcelona, Spain; [Paulo Torres, Joao; Malm, Olaf] Inst Biophys, Lab Radioisotopes, Rio De Janeiro, Brazil; [Ocampo-Duque, William] Pontificia Univ Javeriana, Fac Engn, Cali, Colombia; [Barcelo, Damia] Univ Girona, Catalan Inst Water Res ICRA, Girona, Spain		Eljarrat, E (corresponding author), CSIC, Dep Environm Chem, IDAEA, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	eeeqam@cid.csic.es	torres, joao/AAI-8390-2021; torres, joao pm/H-4950-2012; BARCELO, DAMIA/O-4558-2016; Malm, Olaf/H-1724-2012	torres, joao/0000-0002-2510-1612; torres, joao pm/0000-0002-2510-1612; BARCELO, DAMIA/0000-0002-8873-0491; Corcellas, Cayo/0000-0003-4088-5563; ELJARRAT, ETHEL/0000-0002-0814-6579	Spanish Ministry of Economy and Competitiveness through the project CEMAGUA [CGL2007-64551/HID]	Spanish Ministry of Economy and Competitiveness through the project CEMAGUA	We thank all the women for their participation in the study. We also thank Alexandra Jelic for their assistance in revising the manuscript. This research work was funded by the Spanish Ministry of Economy and Competitiveness through the project CEMAGUA (CGL2007-64551/HID).	[Anonymous], 2003, TCD INS MARK TRENDS, P105; Barcelo D, 2010, TRENDS ANAL CHEM, V29, P7; Bouwman H, 2006, ENVIRON POLLUT, V144, P902, DOI 10.1016/j.envpol.2006.02.002; Chambers J, 1980, Residue Rev, V73, P101; Cox C., 1996, Journal of Pesticide Reform, V16, P2; da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017; DEMOUTE JP, 1989, PESTIC SCI, V27, P375, DOI 10.1002/ps.2780270406; Feo ML, 2011, RAPID COMMUN MASS SP, V25, P869, DOI 10.1002/rcm.4936; Feo ML, 2010, J HYDROL, V393, P156, DOI 10.1016/j.jhydrol.2010.08.012; Feo ML, 2012, ENVIRON INT, V38, P67, DOI 10.1016/j.envint.2011.08.008; George J, 2011, PROTEOMICS, V11, P4411, DOI 10.1002/pmic.201100233; Godin SJ, 2007, DRUG METAB DISPOS, V35, P1664, DOI 10.1124/dmd.107.015388; Gosselin R.E., 1984, CLIN TOXICOLOGY COMM, V5; Haraguchi K, 2009, ENVIRON INT, V35, P1072, DOI 10.1016/j.envint.2009.06.003; Jin YX, 2012, ENVIRON INT, V42, P144, DOI 10.1016/j.envint.2011.05.020; LaKind JS, 2009, ENVIRON HEALTH PERSP, V117, P1625, DOI 10.1289/ehp.0900876; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu J, 2011, TOXICOLOGY, V290, P42, DOI 10.1016/j.tox.2011.08.016; Ministerio da Saude Fundacao Nacional de Saude., 2002, PROGR NAC CONTR DENG; Nakamura Y, 2007, TOXICOLOGY, V235, P176, DOI 10.1016/j.tox.2007.03.016; Sereda B, 2009, J TOXICOL ENV HEAL A, V72, P842, DOI 10.1080/15287390902800447; Tanabe S, 2007, ENVIRON POLLUT, V146, P400, DOI 10.1016/j.envpol.2006.07.003; US Environmental Protection Agency, 2002, CHILD SPEC EXP FACT, V11, P20; US Environmental Protection Agency, 2002, CHILD SPEC EXP FACT, V2, P20; WHO FAO, 1962, PRINC GOV CONS SAF R; Zehringer M, 2001, EUR FOOD RES TECHNOL, V212, P247, DOI 10.1007/s002170000223; Zhang SY, 2008, TOXICOLOGY, V248, P136, DOI 10.1016/j.tox.2008.03.018	27	95	98	4	80	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	OCT 15	2012	47						17	22		10.1016/j.envint.2012.05.007	http://dx.doi.org/10.1016/j.envint.2012.05.007			6	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	996AS	22717642				2022-09-04	WOS:000308057000003
J	Cordoba-Rodriguez, DP; Iglesia, I; Gomez-Bruton, A; Miguel-Berges, ML; Flores-Barrantes, P; Casajus, JA; Moreno, LA; Rodriguez, G				Paola Cordoba-Rodriguez, Diana; Iglesia, Iris; Gomez-Bruton, Alejandro; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Antonio Casajus, Jose; Moreno, Luis A.; Rodriguez, Gerardo			Quantitative peripheral computed tomography to measure muscle area and assess lean soft tissue mass in children	ANNALS OF HUMAN BIOLOGY			English	Article						Dual-energy X-ray absorptiometry; lean soft tissue mass; muscle cross-sectional area; peripheral quantitative computed tomography	X-RAY ABSORPTIOMETRY; BODY-COMPOSITION; CHILDHOOD OBESITY; TRABECULAR BONE; YOUDEN INDEX; PQCT; DXA; FAT; OVERWEIGHT; ADOLESCENTS	Background Skeletal muscle is one of the main components of lean soft tissue mass (LSTM). Low levels in children affect locomotion, posture, and increase the risk of metabolic syndrome. Aim (1) To evaluate the association between muscle cross-sectional area (MCSA) of the lower left leg measured by peripheral quantitative computed tomography (pQCT) and total LSTM; namely, total left leg and left lower leg LSTM assessed by dual-energy X-ray absorptiometry (DXA) in a group of children, (2) to examine if MCSA is a predictor of LSTM, (3) to determine the ability of pQCT to identify children with low LSTM. Subjects and methods Lower left leg MCSA and LSTM were measured using pQCT and DXA, respectively, in 396 children. Results Statistically significant positive correlations were found between the lower leg MCSA - total LSTM (r(2) = 0.789), total leg LSTM (r(2) = 0.79), and lower leg LSTM (r(2) = 0.791) (p < .01). MCSA explained 64-68% of the variance in LSTM. Receiver operator characteristic (ROC) curves determined the capacity of the lower left leg MCSA to identify low LSTM in girls (AUC 0.95) and boys (AUC 0.87). Conclusions Our results showed that lower left leg MCSA, measured using pQCT, could be a tool to predict low LSTM in children.	[Paola Cordoba-Rodriguez, Diana] Pontificia Univ Javeriana, Fac Sci, Food Nutr & Hlth Res Grp, Carrera 7 40 62, Bogota, DC, Colombia; [Iglesia, Iris; Gomez-Bruton, Alejandro; Miguel-Berges, Maria L.; Flores-Barrantes, Paloma; Antonio Casajus, Jose; Moreno, Luis A.; Rodriguez, Gerardo] Univ Zaragoza, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Iglesia, Iris; Rodriguez, Gerardo] Inst Invest Sanitaria Aragon IIS Aragon, Inst Agroalimentario Aragon IA2, Zaragoza, Spain; [Iglesia, Iris; Rodriguez, Gerardo] Inst Salud Carlos III, Red Salud Materno Infantil & Desarrollo SAMID, Madrid, Spain; [Gomez-Bruton, Alejandro; Antonio Casajus, Jose; Moreno, Luis A.] Univ Zaragoza, Fac Hlth & Sport Sci FCSD, Dept Physiatry & Nursing, Zaragoza, Spain; [Gomez-Bruton, Alejandro; Moreno, Luis A.; Rodriguez, Gerardo] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Rodriguez, Gerardo] Univ Zaragoza, Dept Pediat, Zaragoza, Spain		Cordoba-Rodriguez, DP (corresponding author), Pontificia Univ Javeriana, Fac Sci, Food Nutr & Hlth Res Grp, Carrera 7 40 62, Bogota, DC, Colombia.	d.cordoba@javeriana.edu.co	Cordoba-Rodriguez, Diana Paola/AAG-7457-2019; Rodriguez, Gerardo/AAG-9855-2020; Bruton, Alejandro Gomez/L-5724-2018	Cordoba-Rodriguez, Diana Paola/0000-0002-7034-8796; Rodriguez, Gerardo/0000-0002-7985-9912; Bruton, Alejandro Gomez/0000-0002-0520-1640; Moreno Aznar, Luis A./0000-0003-0454-653X; Casajus Mallen, Jose Antonio/0000-0002-7215-6931; Miguel-Berges, Maria L/0000-0002-2411-9538; Flores Barrantes, Paloma/0000-0002-2135-900X				Abe T, 2015, AGE, V37, DOI 10.1007/s11357-014-9741-1; Al-Sallami HS, 2015, CLIN PHARMACOKINET, V54, P1169, DOI 10.1007/s40262-015-0277-z; Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; Ashby RL, 2009, OSTEOPOROSIS INT, V20, P1337, DOI 10.1007/s00198-008-0800-2; Bazzocchi A, 2016, EUR J RADIOL, V85, P1481, DOI 10.1016/j.ejrad.2016.04.004; Blew RM, 2018, J CLIN DENSITOM, V21, P583, DOI 10.1016/j.jocd.2018.03.002; Brion MA, 2007, J HUM HYPERTENS, V21, P283, DOI 10.1038/sj.jhh.1002152; Brown LD, 2014, J ENDOCRINOL, V221, pR13, DOI 10.1530/JOE-13-0567; Codner PA., 2016, CURR NUTR REP, V5, P191; Crabtree NJ., 2016, ACQUISITION DXA CHIL, P89; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Ducher G, 2009, ANN HUM BIOL, V36, P705, DOI 10.3109/03014460903055139; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Evans WJ, 2019, J CACHEXIA SARCOPENI, V10, P14, DOI 10.1002/jcsm.12390; Faigenbaum AD, 2018, CURR SPORT MED REP, V17, P45, DOI 10.1249/JSR.0000000000000450; Farr JN, 2011, J BONE MINER RES, V26, P2217, DOI 10.1002/jbmr.414; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Frank-Wilson AW, 2015, BONE, V75, P49, DOI 10.1016/j.bone.2015.01.016; Gomez-Bruton A, 2014, NUTR HOSP, V30, P399, DOI 10.3305/nh.2014.30.2.7603; Gomez-Bruton A, 2020, SPORTS HEALTH, V12, P431, DOI 10.1177/1941738120913645; Gonzalez-Aguero A, 2013, OSTEOPOROSIS INT, V24, P1035, DOI 10.1007/s00198-012-2041-7; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Gracia-Marco L, 2016, PROG CARDIOVASC DIS, V58, P555, DOI 10.1016/j.pcad.2015.11.002; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Guglielmi G, 2016, AGING CLIN EXP RES, V28, P1047, DOI 10.1007/s40520-016-0589-3; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Hangartner TN, 2013, J CLIN DENSITOM, V16, P520, DOI 10.1016/j.jocd.2013.08.007; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; Lohman TG, 2013, PEDIATR EXERC SCI, V25, P573, DOI 10.1123/pes.25.4.573; Ramos RML, 2012, RADIOLOGIA-MADRID, V54, P410, DOI 10.1016/j.rx.2011.09.023; Marfell-Jones M., 2012, ISAK; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; Moon RJ, 2015, BONE, V75, P105, DOI 10.1016/j.bone.2015.02.015; Mukaka MM, 2012, MALAWI MED J, V24, P69; National Health and Nutrition Examination Survey, 2012, BOD COMP PROC MAN, P1; Suarez BO, 2014, AN PEDIATR, V81, P32, DOI 10.1016/j.anpedi.2013.09.008; Park HW, 2012, J KOREAN MED SCI, V27, P1385, DOI 10.3346/jkms.2012.27.11.1385; Prado CMM, 2014, JPEN-PARENTER ENTER, V38, P940, DOI 10.1177/0148607114550189; Rathnayake N, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0179-5; Reid KF, 2008, J NUTR HEALTH AGING, V12, P493, DOI 10.1007/BF02982711; Roggen I, 2015, CALCIFIED TISSUE INT, V96, P527, DOI 10.1007/s00223-015-9988-2; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sherk VD, 2014, J MUSCULOSKEL NEURON, V14, P411; Sherk VD, 2011, PHYSIOL MEAS, V32, pN65, DOI 10.1088/0967-3334/32/12/N01; Swinford RR, 2010, OSTEOPOROSIS INT, V21, P1863, DOI 10.1007/s00198-009-1151-3; Wang Z, 2008, Int J Body Compos Res, V6, P173; Weber David R, 2012, Pediatr Endocrinol Rev, V10, P130; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2008, ARCH DIS CHILD, V93, P168, DOI 10.1136/adc.2007.115741; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	51	1	1	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0301-4460	1464-5033		ANN HUM BIOL	Ann. Hum. Biol.	FEB 17	2021	48	2					93	100		10.1080/03014460.2021.1877352	http://dx.doi.org/10.1080/03014460.2021.1877352			8	Anthropology; Biology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anthropology; Life Sciences & Biomedicine - Other Topics; Public, Environmental & Occupational Health	SN7ZJ	33470135				2022-09-04	WOS:000658505600002
J	Lopez, AP; Duarte-Abadia, B; Boelens, R				Prieto Lopez, Ana; Duarte-Abadia, Bibiana; Boelens, Rutgerd			Territory in conflict: land dispossession, water grabbing and mobilization for environmental justice in southern Spain	INTERNATIONAL JOURNAL OF WATER RESOURCES DEVELOPMENT			English	Article						Land dispossession; political ecology; tourism development; water grabbing; hydrosocial territories; environmental justice		This paper analyses the socio-territorial conflict prompted by Los Merinos: a residential-tourism project constructed in an ecological reserve that is vital to Andalusian livelihoods. It examines disputes concerning discourses, authorities and rules in order to understand the struggle over land and water. Using the echelons of rights analysis (ERA) framework, the paper scrutinizes the multiscale forces and strategies adopted by business and opposing movement networks in order to shape territory, thereby engaging local and supra-local governments. The authors' political-ecology lens on environmental justice and territorialization enhances the understanding of the relevance of social movements in contesting the misappropriation of socio-natural environments.	[Prieto Lopez, Ana; Boelens, Rutgerd] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands; [Duarte-Abadia, Bibiana; Boelens, Rutgerd] Univ Amsterdam, CEDLA Ctr Latin Amer Res & Documentat, Amsterdam, Netherlands; [Duarte-Abadia, Bibiana] Pontificia Univ Javeriana, Res Grp Inst & Rural Dev, Fac Environm & Rural Studies, Bogota, Colombia; [Boelens, Rutgerd] Pontificia Univ Catolica Peru, Dept Social Sci, Lima, Peru; [Boelens, Rutgerd] Univ Cent Ecuador, Fac Agr Sci, Ciudadela Univ, Quito, Ecuador		Lopez, AP (corresponding author), Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands.	prietolopez.ana@gmail.com		Duarte Abadia, Bibiana/0000-0003-4203-050X				Achterhuis H, 2010, OUT OF THE MAINSTREAM: WATER RIGHTS, POLITICS AND IDENTITY, P27; Agencia Andaluza del Agua, 2005, INFORM COMPATIBILID; Aguilar Conde, 2011, MERINOS NORTE PHENOM; ALLAN T, 2015, INT J WATER RESOUR D, V31; [Anonymous], 2012, EL OBSERVADOR; Aud S.A., 1990, RONDA PLAN ESPECIAL; Baud M, 2019, ESTUD ATACAMENOS, P195, DOI 10.22199/issn.0718-1043-2019-0033; Bebbington A, 2000, ANN ASSOC AM GEOGR, V90, P495, DOI 10.1111/0004-5608.00206; Bebbington A, 2010, OUT OF THE MAINSTREAM: WATER RIGHTS, POLITICS AND IDENTITY, P307; Bebbington A, 2009, LAT AM RES REV, V44, P177; Boelens R., 2005, B LAT AM RES, V24, DOI 10.1111/j.0261-3050.2005.00137.x; BOELENS R, 2016, WATER INT, V41; BOELENS R, 2014, COSUST, V11; Boelens R., 2015, WATER POWER IDENTITY; Campesino A.J., 2015, REV CUATRIMESTRAL GE, V97, DOI 10.17811/er.97.2015.173-188; Chiara E.C., 2004, INFORME CONSUMO AGUA; Crespo J.M., 2010, COLLECTION EDYTEM CA, P113, DOI [10.3406/edyte.2010.1119, DOI 10.3406/EDYTE.2010.1119]; De Stefano L, 2015, INT J WATER RESOUR D, V31, P640, DOI 10.1080/07900627.2014.938260; De Vega B.G., 2014, EL MUNDO; De Vos H, 2006, INT J WATER RESOUR D, V22, P37, DOI 10.1080/07900620500405049; Del Romero-Renau L., 2015, DOCUMENTS D AN LISI, V61, P369, DOI [10.5565/rev/dag.230, DOI 10.5565/REV/DAG.230]; Delgado M., 2016, MEGAPROYECTOS ANDALU; DESTEFANO L, 2018, REG ENVIRON CHANGE, V18; Duarte-Abadia Bibiana, 2019, Water International, V44, P148, DOI 10.1080/02508060.2019.1578080; Duarte-Abadia B, 2016, WATER INT, V41, P15, DOI 10.1080/02508060.2016.1117271; Duarte-Abaduia B., 2020, THESIS U AMSTERDAM; Dupuits E, 2019, ECOL SOC, V24, DOI 10.5751/ES-10857-240220; Escobar A., 2008, TERRITORIES DIFFEREN; Escobar Arturo, 2018, DESIGNS PLURIVERSE R; Feindt P.H., 2005, J ENVIRON POL PLAN, V7, DOI 10.1080/15239080500339638; Sanudo MF, 2016, DESAFIOS, V28, P367, DOI 10.12804/desafios28.2.2016.10; FerruYndiz 48 G.I.A S.L. y Mayoral, 2004, ESTUDIO HIDROGEOL GI; Fletcher R, 2017, GEOFORUM, V85, P311, DOI 10.1016/j.geoforum.2017.06.009; Flores J., 2019, M LAGA HOY; Foucault Michel, 1980, POWER KNOWLEDGE SELE; Fraga, 1995, PROYECTO REFUNDIDO P; Fraser N, 2000, NEW LEFT REV, P107; Gil, 2009, ESTUDIO GEOL GICO HI; HOOGESTEGER J, 2016, WATER INT, V41; Hoogesteger J, 2015, GEOFORUM, V62, P13, DOI 10.1016/j.geoforum.2015.03.013; Horowitz L.S., 2012, CAPITALISM NATURE SO, V23, DOI 10.1080/10455752.2012.702868; Huertas I.T., 2005, ALEGACIONES DELEGACI; Jackson S, 2018, WIRES WATER, V5, DOI 10.1002/wat2.1314; Jan C., 2004, PA S; Jimunez, 2008, PUEBLO TIERRA; Junta de Andalucuia, 2020, LEY IMPULSO SOSTENIB; LaVanchy GT, 2015, INT J WATER RESOUR D, V31, P765, DOI 10.1080/07900627.2014.985819; Malpica A., 1995, AGUA MITOS RITOS REA, P359; Martinez-Alier J., 2002, ENV POOR; Melgar V., 2016, DIARIO; Navarrete, 2005, HIST CONT, V30, P49; Nello O., 2007, INFORGEO; Observatorio Turuistico de la Costa del Sol-MuYlaga, 2018, OBSERVATORIO TUR STI; PAERREGAARD K, 2017, WILEY INTERDISCIPLIN, V5; Plan General de OrdenaciuEn Urbanuistica [General Urban Development Plan], 1991, JUNTA ANDALUC A; Poma A., 2015, CAPITALISM NATURE SO, V26, DOI 10.1080/10455752.2014.995688; Prieto, 2017, THESIS WAGENINGEN U; Prieto Del Pino, 2008, CUADERNOS PENALES JO, V5, P91; Purez F.J., 2011, PA S; Purez F.J., 2006, PA S; Rebaque J.I.G., 2016, CIUDADES, V19, P191; Ricart S, 2019, INT J WATER RESOUR D, V35, P491, DOI 10.1080/07900627.2018.1447911; Rico E., 2017, BIBLIO 3W REV BIBLIO, V22, P742, DOI [10.1344/b3w.0.2017.26442, DOI 10.1344/B3W.0.2017.26442]; Lopez RR, 2019, GEOFORUM, V102, P202, DOI 10.1016/j.geoforum.2019.04.012; Rodriguez-de-Francisco JC, 2019, WATER-SUI, V11, DOI 10.3390/w11061143; Romero J, 2010, CUAD GEOGR, V47, P17; Roth D, 2015, J LEG PLUR UNOFF LAW, V47, P456, DOI 10.1080/07329113.2015.1111502; Ruiz-Villaverde A, 2010, INT J WATER RESOUR D, V26, P653, DOI 10.1080/07900627.2010.519497; Sanchis-Ibor C, 2017, GEOFORUM, V87, P38, DOI 10.1016/j.geoforum.2017.10.002; Sauri D, 2020, INT J WATER RESOUR D, V36, P909, DOI 10.1080/07900627.2019.1634999; Schlosberg D, 2004, ENVIRON POLIT, V13, P517, DOI 10.1080/0964401042000229025; SCHMIDT JJ, 2014, WILEY INTERDISCIPLIN, V1; Shah E, 2021, J PEASANT STUD, V48, P1008, DOI 10.1080/03066150.2019.1669566; Swyngedouw E., 2015, LIQUID POWER CONTEST; Trottier J, 2019, INT J WATER RESOUR D, pNIL_1, DOI 10.1080/07900627.2019.1617679; Tur AA, 2008, ARBOR, V184, P99; United Nations World Tourism Organization, 2019, INT TOURISM HIGHLIGH, DOI 10.18111/9789284421152; Van der Ploeg J.D., 2008, NEW PEASANTRIES STRU; VILLAMAYORTOMAS S, 2018, GLOBAL ENVIRON CHANG, V5311; ViuCdez J., 2011, PA S; Vos, 2018, WATER JUSTICE, P115, DOI DOI 10.1017/9781316831847.008; Vos J., 2018, WATER JUSTICE, P59; Vos J, 2020, ECOL ECON, V173, DOI 10.1016/j.ecolecon.2020.106651; WILSON N, 2019, GEOFORUM, V104; Zwarteveen MZ, 2014, WATER INT, V39, P143, DOI 10.1080/02508060.2014.891168	85	4	4	4	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0790-0627	1360-0648		INT J WATER RESOUR D	Int. J. Water Resour. Dev.	NOV 2	2021	37	6					996	1020		10.1080/07900627.2020.1854693	http://dx.doi.org/10.1080/07900627.2020.1854693		JAN 2021	25	Water Resources	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Water Resources	UZ9WH		Green Published, hybrid			2022-09-04	WOS:000607236700001
J	Ashraf, GM; Athanasios, A; Barreto, GE; Uddin, MS				Ashraf, Ghulam Md; Athanasios, Alexiou; Barreto, George E.; Uddin, Md Sahab			Neuroproteomics on the Rise (Part II)	CURRENT PROTEIN & PEPTIDE SCIENCE			English	Editorial Material									[Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Athanasios, Alexiou] Novel Global Community Educ Fdn, Hebersham, NSW, Australia; [Athanasios, Alexiou] AFNP Med Austria, Haidingergasse 29, A-1030 Vienna, Austria; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Uddin, Md Sahab] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Uddin, Md Sahab] Pharmakon Neurosci Res Network, Dhaka, Bangladesh		Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	ashraf.gm@gmail.com; alextha@yahoo.gr; gesbarreto@gmail.com; msu-neuropharma@hotmail.com	Ashraf, Ghulam Md/H-9485-2012	Ashraf, Ghulam Md/0000-0002-9820-2078				Ahmad F, 2021, CURR PROTEIN PEPT SC, V22, P479, DOI 10.2174/1389203722666210618110233; Uddin MS, 2021, CURR PROTEIN PEPT SC, V22, P449, DOI 10.2174/1389203722666210322151627; Uddin MS, 2021, CURR PROTEIN PEPT SC, V22, P442, DOI 10.2174/1389203722666210122144437; Ullah N, 2021, CURR PROTEIN PEPT SC, V22, P470, DOI 10.2174/1389203722666210325110231; Yadav N, 2021, CURR PROTEIN PEPT SC, V22, P458, DOI 10.2174/1389203721999201111195512	5	0	0	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-2037	1875-5550		CURR PROTEIN PEPT SC	Curr. Protein Pept. Sci.		2021	22	6					441	441						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	XG2EY	34814815				2022-09-04	WOS:000724572500001
J	Garrido-Arevalo, AR; Agudelo-Otalora, LM; Obregon-Neira, N; Garrido-Arevalo, V; Quinones-Bolanos, EE; Naraei, P; Mehrvar, M; Bustillo-Lecompte, CF				Rafael Garrido-Arevalo, Augusto; Mauricio Agudelo-Otalora, Luis; Obregon-Neira, Nelson; Garrido-Arevalo, Victor; Eduardo Quinones-Bolanos, Edgar; Naraei, Parisa; Mehrvar, Mehrab; Fernando Bustillo-Lecompte, Ciro			Application of Artificial Neural Network and Information Entropy Theory to Assess Rainfall Station Distribution: A Case Study from Colombia	WATER			English	Article						hydrology; rainfall; artificial neural networks; information entropy; clustering process	MAXIMUM-ENTROPY; HOMOGENEOUS REGIONS; PRECIPITATION; DESIGN; RIVER; IDENTIFICATION; OPTIMIZATION; WIND	An assessment of the rainfall station distribution in the mountainous area of the Regional Autonomous Corporation of Cundinamarca (CAR, for its acronym in Spanish), Colombia, was conducted by applying concepts from information entropy and artificial neural networks (ANNs). This study was divided into two phases: first, a classification of the meteorological stations using two-dimensional self-organizing maps; second, the evaluation of the performance of the ANN by applying concepts of information entropy. Three scenarios were raised for the classification of the meteorological stations by adjusting the number of neurons in the output layer. A high number of neurons in the output layer were obtained, causing the model to over-fit while emphasizing differences amid patterns. When comparing the results of the scenarios, the permanence of certain characteristics and features was found in the system, validating the model classification. Subsequently, the results of the first scenario were used to evaluate the entropy of the historical series. Finally, the results show that the area of study presents a lack of information due to the uncertainty associated with the probabilistic arrangement, which can be corrected with the developed model. Consequently, some recommendations for the redesign of the rainfall are provided.	[Rafael Garrido-Arevalo, Augusto; Mauricio Agudelo-Otalora, Luis] Univ La Sabana, Fac Engn, Bogota 140013, Colombia; [Obregon-Neira, Nelson] Pontificia Univ Javeriana, Fac Engn, Bogota 110231, Colombia; [Garrido-Arevalo, Victor] Univ Tecnolog Bolivar, Fac Engn, Cartagena 131001, Colombia; [Eduardo Quinones-Bolanos, Edgar] Univ Cartagena, Fac Engn, Cartagena 130015, Colombia; [Naraei, Parisa] Ryerson Univ, Dept Comp Sci, Toronto, ON M5B 2K3, Canada; [Mehrvar, Mehrab] Ryerson Univ, Dept Chem Engn, Toronto, ON M5B 2K3, Canada; [Fernando Bustillo-Lecompte, Ciro] Ryerson Univ, Grad Program Environm Appl Sci, Toronto, ON M5B 2K3, Canada; [Fernando Bustillo-Lecompte, Ciro] Ryerson Univ, Grad Program Management, Toronto, ON M5B 2K3, Canada		Bustillo-Lecompte, CF (corresponding author), Ryerson Univ, Grad Program Environm Appl Sci, Toronto, ON M5B 2K3, Canada.; Bustillo-Lecompte, CF (corresponding author), Ryerson Univ, Grad Program Management, Toronto, ON M5B 2K3, Canada.	augustoga@unisabana.edu.co; mauricio.agudelo@unisabana.edu.co; nobregon@javeriana.edu.co; vgarrido@utb.edu.co; equinonesb@unicartagena.edu.co; parisa.naraei@ryerson.ca; mmehrvar@ryerson.ca; ciro.lecompte@ryerson.ca	Lecompte, Ciro Fernando Bustillo/O-9614-2015; Obregon, Nelson/AAE-8143-2022; Naraei, Parisa/GNW-5894-2022	Lecompte, Ciro Fernando Bustillo/0000-0001-5262-7743; Obregon, Nelson/0000-0002-0881-9833	Universidad de La Sabana; Pontificia Universidad Javeriana; Universidad Tecnologica de Bolivar; Universidad de Cartagena; Ryerson University	Universidad de La Sabana; Pontificia Universidad Javeriana; Universidad Tecnologica de Bolivar; Universidad de Cartagena; Ryerson University	The financial support of Universidad de La Sabana, Pontificia Universidad Javeriana, Universidad Tecnologica de Bolivar, Universidad de Cartagena, and Ryerson University is appreciated.	Acosta OEC, 2002, ING HIDRAUL MEX, V17, P5; Adib H, 2013, J NAT GAS SCI ENG, V10, P14, DOI 10.1016/j.jngse.2012.09.001; [Anonymous], 2010, SICLICA SIST INF CLI, VCAR; Asimakopoulou FE, 2013, ELECTR POW SYST RES, V94, P113, DOI 10.1016/j.epsr.2012.07.018; Aurbacher J, 2011, AGR SYST, V104, P470, DOI 10.1016/j.agsy.2011.03.004; CAR, 2012, 2012 2015 MAST PLAN; CAR, 2016, 2016 2019 MAST PLAN; Chang TK, 2017, J HYDROL, V545, P100, DOI 10.1016/j.jhydrol.2016.12.024; Chen YC, 2008, HYDROL PROCESS, V22, P340, DOI 10.1002/hyp.6292; Chowdhury M, 2010, STOCH ENV RES RISK A, V24, P1, DOI 10.1007/s00477-008-0296-5; DALEZIOS NR, 1989, J HYDROL, V109, P25, DOI 10.1016/0022-1694(89)90004-8; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dursun M, 2014, COMPUT ELECTRON AGR, V102, P120, DOI 10.1016/j.compag.2014.01.008; Elshorbagy A, 2010, HYDROL EARTH SYST SC, V14, P1931, DOI 10.5194/hess-14-1931-2010; Farsadnia F, 2014, J HYDROL, V509, P387, DOI 10.1016/j.jhydrol.2013.11.050; Fukushima K, 2013, NEURAL NETWORKS, V37, P103, DOI 10.1016/j.neunet.2012.09.016; Garrido-Arevalo A. R., 2020, Journal of Physics: Conference Series, V1448, DOI 10.1088/1742-6596/1448/1/012008; Gonzalez-Alvarez A, 2019, WATER-SUI, V11, DOI 10.3390/w11020358; González-Cuéllar Federico, 2013, Ing. Univ., V17, P311; Hamzehie ME, 2015, J NAT GAS SCI ENG, V24, P106, DOI 10.1016/j.jngse.2015.03.014; Hurtado-Montoya Andrés Felipe, 2014, Dyna rev.fac.nac.minas, V81, P251, DOI 10.15446/dyna.v81n186.40419; Johansson B, 2003, INT J CLIMATOL, V23, P1523, DOI 10.1002/joc.951; Kar AK, 2015, J HYDROL-REG STUD, V4, P313, DOI 10.1016/j.ejrh.2015.07.003; Karabacak K, 2014, RENEW SUST ENERG REV, V29, P804, DOI 10.1016/j.rser.2013.08.070; Lin GF, 2006, J HYDROL, V324, P1, DOI 10.1016/j.jhydrol.2005.09.009; Liu QJ, 2013, GEOMORPHOLOGY, V186, P181, DOI 10.1016/j.geomorph.2013.01.012; Lohani AK, 2012, J HYDROL, V442, P23, DOI 10.1016/j.jhydrol.2012.03.031; Mallela UK, 2016, THIN WALL STRUCT, V102, P158, DOI 10.1016/j.tws.2016.01.025; Mishra AK, 2009, J HYDROL, V370, P139, DOI 10.1016/j.jhydrol.2009.03.006; Mohajerani M, 2012, SEP PURIF TECHNOL, V90, P173, DOI 10.1016/j.seppur.2012.02.025; Najafabadi ATP, 2012, INSUR MATH ECON, V51, P216, DOI 10.1016/j.insmatheco.2011.08.010; Noonan JP, 2007, KYBERNETES, V36, P52, DOI 10.1108/03684920710741143; OAS, 2010, MAN DES INST OP MAIN; Rojas Polanco M. I., 2009, Revista Forestal Venezolana, V53, P9; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Turlapaty AC, 2010, PATTERN RECOGN LETT, V31, P1184, DOI 10.1016/j.patrec.2009.12.033; Vinod HD, 2006, J ASIAN ECON, V17, P955, DOI 10.1016/j.asieco.2006.09.001; Wang WQ, 2018, J HYDROL, V559, P136, DOI 10.1016/j.jhydrol.2018.02.010; Weber TC, 2011, FOREST ECOL MANAG, V261, P779, DOI 10.1016/j.foreco.2010.12.009; Wei C, 2014, ENTROPY-SWITZ, V16, P4626, DOI 10.3390/e16084626; Xie L, 2016, COMPUT GEOSCI-UK, V89, P252, DOI 10.1016/j.cageo.2015.12.015; Zoppou C, 2001, ENVIRON MODELL SOFTW, V16, P195, DOI 10.1016/S1364-8152(00)00084-0	42	0	0	1	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4441		WATER-SUI	Water	JUL	2020	12	7							1973	10.3390/w12071973	http://dx.doi.org/10.3390/w12071973			18	Environmental Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Water Resources	MV4YC		Green Published, gold			2022-09-04	WOS:000556364500001
J	Martinez-Ruiz, DM; Fandino-Losada, A; de Leon, AP; Arango-Londono, D; Mateus, JC; Jaramillo-Molina, C; Bonilla-Escobar, FJ; Vivase, H; Vanlaar, W; Gutierrez-Martinez, MI				Marcela Martinez-Ruiz, Diana; Fandino-Losada, Andres; de Leon, Antonio Ponce; Arango-Londono, David; Cesar Mateus, Julio; Jaramillo-Molina, Ciro; Javier Bonilla-Escobar, Francisco; Vivase, Harvy; Vanlaar, Ward; Isabel Gutierrez-Martinez, Maria			Impact evaluation of camera enforcement for traffic violations in Cali, Colombia, 2008-2014	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Camera enforcement; Photo enforcement; Traffic violations; Fixed traffic camera; Road injuries; Quasi-experimental; Mixed model	FIXED SPEED CAMERAS; SAFETY; PREVALENCE; ACCIDENTS; INJURIES	Introduction: Cameras for detecting traffic violations have been used as a measure to improve road safety in different countries around the world. In Cali, Colombia, fixed cameras were installed in March 2012 on a number of roads and intersections. All camera devices are capable of detecting simultaneously the following traffic violations: driving over the speed limit, running a red light or stop sign, violation of the traffic ban schedule, and blocking the pedestrian crosswalk. Objective: To evaluate the impact of camera enforcement of traffic violations in Cali, Colombia. Methods: A quasi-experimental difference-in-differences study with before and after measurements and a comparison group was conducted. We observed 38 intervention areas and 50 comparison areas (250 m radius), during 42 months before and 34 months after the installation of cameras. Effects were estimated with mixed negative binomial regression models. Results: In intervention areas, after 12 months, there was a reduction of 19.2% of all crashes and a 24.7% reduction of injury and fatal crashes. In comparison areas, this reduction was 15.0% for all crashes and 20.1% for injury and fatal crashes. After adjusted comparisons, intervention sites outperformed comparison sites with an additional yearly reduction of 5.3% (p = 0.045) for all crashes. Conclusions: The use of cameras for detecting traffic violations seems to have a positive effect on the reduction of crashes in intervention areas. A beneficial spillover effect was found as well in comparison areas; but more evaluations are needed.	[Marcela Martinez-Ruiz, Diana; Fandino-Losada, Andres; Arango-Londono, David; Javier Bonilla-Escobar, Francisco; Isabel Gutierrez-Martinez, Maria] Univ Valle, Cisalva Inst, Cali, Colombia; [Fandino-Losada, Andres; Cesar Mateus, Julio; Isabel Gutierrez-Martinez, Maria] Univ Valle, Sch Publ Hlth, Cali, Colombia; [Cesar Mateus, Julio] Univ Valle, Sch Hlth, Doctoral Program Hlth, Cali, Colombia; [Jaramillo-Molina, Ciro] Univ Valle, Sch Engn, GITTV Res Grp, Cali, Colombia; [Vivase, Harvy] Univ Valle, Sch Social Sci & Econ, GERA Res Grp, Cali, Colombia; [de Leon, Antonio Ponce] Univ Estado Rio de Janeiro, Social Med Inst, Rio De Janeiro, RJ, Brazil; [Arango-Londono, David] Pontificia Univ Javeriana, Sch Nat Sci & Math, Cali, Colombia; [Vanlaar, Ward] Traff Injury Res Fdn, Ottawa, ON, Canada; [Javier Bonilla-Escobar, Francisco] Univ Pittsburgh, Inst Clin Res Educ, Pittsburgh, PA USA		Fandino-Losada, A (corresponding author), Univ Valle, Calle 4B 36-00 Edif 135 Piso 3, Cali 760043, Colombia.	diana.martinez.ruiz@correounivalle.edu.co; carlos.fandino@correounivalle.edu.co; antonio.ponce.leon@gmail.com; david.arango@javerianacali.edu.co; julio.mateus@correounivalle.edu.co; ciro.jaramillo@correounivalle.edu.co; fjbonillaescobar@gmail.com; harvy.vivas@correounivalle.edu.co; wardv@tirf.ca; maria.gutierrez@correounivalle.edu.co	Jaramillo, Ciro/AFG-8310-2022; Bonilla-Escobar, Francisco Javier/AAK-8367-2020; Fandiño-Losada, Andrés/AAI-4945-2020; Mateus, Julio/Y-9267-2019; de Leon, Antonio C M Ponce/G-5730-2012; Jaramillo, Ciro/AAF-1779-2022; Jaramillo, Ciro/B-9863-2011	Jaramillo, Ciro/0000-0002-8820-2314; Bonilla-Escobar, Francisco Javier/0000-0002-0224-3482; Fandiño-Losada, Andrés/0000-0002-3385-7380; de Leon, Antonio C M Ponce/0000-0002-0704-5215; Jaramillo, Ciro/0000-0002-8820-2314; Mateus-Solarte, Julio Cesar/0000-0001-7760-7423	Universidad del Valle (Colombia); COLCIENCIAS (Colombia)	Universidad del Valle (Colombia); COLCIENCIAS (Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was funded by an institutional research grant by the Universidad del Valle (Colombia). Additionally, COLCIENCIAS (Colombia) financed the academic interchange between Universidad del Valle (Colombia) and the Universidade do Estado do Rio de Janeiro (Brazil); and also it financed the young researcher scholarship for the first author.	Ahmed MM, 2015, TRANSPORT RES C-EMER, V50, P130, DOI 10.1016/j.trc.2014.07.012; [Anonymous], 2012, PAIS; Blais E, 2015, J SAFETY RES, V55, P135, DOI 10.1016/j.jsr.2015.08.007; Bonilla-Escobar FJ, 2016, INT J INJ CONTROL SA, V23, P179, DOI 10.1080/17457300.2014.966120; Brown H, 2014, APPL MIXED MODELS ME, V3rd; Departamento Administrativo de Planeacian, 2016, CAL EN CIFR 2016; Dickerson A, 2000, ECONOMICA, V67, P101, DOI 10.1111/1468-0335.00198; Duranton G, 2011, AM ECON REV, V101, P2616, DOI 10.1257/aer.101.6.2616; Elvik R, 2009, HANDBOOK OF ROAD SAFETY MEASURES, 2ND EDITION, P1; Escuela Colombiana de Ingenierla Julio Garavito, 2014, INFORME FINAL; Gomez-Salazar GS, 2017, INT J INJ CONTROL SA, V24, P158, DOI 10.1080/17457300.2015.1080730; Gomez-Suarez A., 2016, TRIUNFO PARADOJA EMO; Gonzalez J. F., 2016, DESARROLLO SOC, V77, P131; Hess S., 2005, COCHRANE DB SYST REV, V18, P1465; Hong D., 2005, P E ASIA SOC TRANSPO; Hoye A, 2015, ACCIDENT ANAL PREV, V82, P263, DOI 10.1016/j.aap.2015.06.001; Hoye A, 2014, ACCIDENT ANAL PREV, V73, P200, DOI 10.1016/j.aap.2014.09.001; Instituto Nacional de Medicina Legal y Ciencias Forenses, 2018, FORENSIS 2017; Bonilla-Escobar FJ, 2014, COLOMB MEDICA, V45, P132; Jiang Z., 2017, SPILLOVER EFFECT EC; Ko M, 2017, J SAFETY RES, V62, P117, DOI 10.1016/j.jsr.2017.06.010; Li HJ, 2016, ACCIDENT ANAL PREV, V97, P153, DOI 10.1016/j.aap.2016.09.007; Maisel M. S, 2013, J LAW PUBLIC POLICY, V10, P401; Martinez S., 2017, EVALUACION IMPACTO P, V2nd; Ministerio de Salud y Proteccion Social, 2020, ANALISIS SITUACION S; Novoa AM, 2010, INJURY PREV, V16, P12, DOI 10.1136/ip.2008.021485; Observatorio de Seguridad Alcaldfa de Santiago de Cali (Colombia)., 2017, INF AN TRANS SANT CA; Osorio-Cuellar GV, 2017, INT J INJ CONTROL SA, V24, P145, DOI 10.1080/17457300.2015.1061563; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Perez K, 2007, AM J PUBLIC HEALTH, V97, P1632, DOI 10.2105/AJPH.2006.093195; Pilkington P, 2005, BMJ-BRIT MED J, V330, P331, DOI 10.1136/bmj.38324.646574.AE; Restrepo J., 2014, EVALUACION IMPACTO C; Secretarfa de Salud Pablica Municipal de Cali, 2016, AN SIT INT SAL ASIS; Tay R, 2010, J TRANSP ECON POLICY, V44, P247; Vanlaar W, 2014, ACCIDENT ANAL PREV, V62, P238, DOI 10.1016/j.aap.2013.09.023; Wilson C, 2010, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD004607.PUB3; World Health Organization, 2015, GLOBAL STATUS REPORT; World Health Organization (WHO), 2017, MAN SPEED	38	13	13	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	APR	2019	125						267	274		10.1016/j.aap.2019.02.002	http://dx.doi.org/10.1016/j.aap.2019.02.002			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	HP2WN	30802777				2022-09-04	WOS:000461536200032
J	Abdi, TA; Peiro, JM; Ayala, Y; Zappala, S				Abdi, Tariku Ayana; Peiro, Jose M.; Ayala, Yarid; Zappala, Salvatore			Four Wellbeing Patterns and their Antecedents in Millennials at Work	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						health; job satisfaction; wellbeing; wellbeing misalignment; Millennials	BEST-PRACTICE RECOMMENDATIONS; JOB-SATISFACTION; ROLE-CONFLICT; ROLE STRESS; LIFE SATISFACTION; PERFORMANCE; HEALTH; AMBIGUITY; OVEREDUCATION; AMBIVALENCE	Literature suggests that job satisfaction and health are related to each other in a synergic way. However, this might not always be the case, and they may present misaligned relationships. Considering job satisfaction and mental health as indicators of wellbeing at work, we aim to identify four patterns (i.e., satisfied-healthy, unsatisfied-unhealthy, satisfied-unhealthy, and unsatisfied-healthy) and some of their antecedents. In a sample of 783 young Spanish employees, a two-step cluster analysis procedure showed that the unsatisfied-unhealthy pattern was the most frequent (33%), followed by unsatisfied-healthy (26.6%), satisfied-unhealthy (24.8%) and, finally, the satisfied-healthy pattern (14.3%). Moreover, as hypothesized, discriminant analysis suggests that higher levels of job importance and lower levels of role ambiguity mainly differentiate the satisfied-healthy pattern, whereas overqualification and role overload differentiate, respectively, the unsatisfied-healthy and satisfied-unhealthy patterns. Contrary to our expectations, role conflict also characterizes the satisfied-unhealthy pattern. We discuss the practical and theoretical implications of these findings.	[Abdi, Tariku Ayana] Univ Campania, Dept Psychol, I-8100 Caserta, Italy; [Peiro, Jose M.] Univ Valencia, IVIE, Valencia 46010, Spain; [Peiro, Jose M.] Univ Valencia, IDOCAL, Valencia 46010, Spain; [Ayala, Yarid] Pontificia Univ Javeriana, Dept Econ & Management, Bogota 110111, Colombia; [Zappala, Salvatore] Univ Bologna, Dept Psychol, I-40126 Bologna, Italy; [Zappala, Salvatore] Financial Univ Govt Russian Federat, Dept Human Resource Management & Psychol, Moscow 125993, Russia		Ayala, Y (corresponding author), Pontificia Univ Javeriana, Dept Econ & Management, Bogota 110111, Colombia.	tarikuayana.abdi@unicampania.it; jose.m.peiro@uv.es; ayala.christianyarid@javeriana.edu.co; salvatore.zappala@unibo.it	Zappala, Salvatore/AAK-4850-2020; Ayana, Tariku/AAS-3078-2021; PEIRO, JOSE M./B-3388-2011	Ayana, Tariku/0000-0001-7069-2389; PEIRO, JOSE M./0000-0001-5293-0355; Zappala', Salvatore/0000-0002-8679-1063; AYALA, YARID/0000-0002-8033-040X	MINECO/FEDER [PSI2015-64862-R]; GV [PROMETEO/2016/138]; National Council on Science and Technology of Mexico (CONACYT) [CVU 326153]	MINECO/FEDER(Spanish Government); GV; National Council on Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The present study has been prepared with the support of the project PSI2015-64862-R (MINECO/FEDER). It was also supported by the PROGRAM PROMETEO/2016/138 of the GV. The third author has received a pre-doctoral scholarship, CVU 326153, from the National Council on Science and Technology of Mexico (CONACYT).	Aguinis H, 2013, ORGAN RES METHODS, V16, P270, DOI 10.1177/1094428112470848; Agut S, 2009, J CAREER DEV, V36, P159, DOI 10.1177/0894845308327738; Akkermans J, 2009, CAREER DEV INT, V14, P671, DOI 10.1108/13620430911005717; [Anonymous], 2015, 70 C 2015; Ashforth BE, 2014, ORGAN SCI, V25, P1453, DOI 10.1287/orsc.2014.0909; Ayala Y, 2017, J HAPPINESS STUD, V18, P1377, DOI 10.1007/s10902-016-9778-1; Babin BJ, 1996, J RETAILING, V72, P57, DOI 10.1016/S0022-4359(96)90005-6; BANKS MH, 1983, PSYCHOL MED, V13, P349, DOI 10.1017/S0033291700050972; BEEHR TA, 1976, J APPL PSYCHOL, V61, P41, DOI 10.1037/0021-9010.61.1.41; BEHRMAN DN, 1984, J MARKETING, V48, P9, DOI 10.2307/1251506; Bernerth JB, 2016, PERS PSYCHOL, V69, P229, DOI 10.1111/peps.12103; Buchel F, 2002, ECON EDUC REV, V21, P263, DOI 10.1016/S0272-7757(01)00020-6; Cass MH, 2003, STRESS HEALTH, V19, P79, DOI 10.1002/smi.959; COOKE RA, 1984, J APPL PSYCHOL, V69, P252, DOI 10.1037/0021-9010.69.2.252; Danna K, 1999, J MANAGE, V25, P357, DOI 10.1177/014920639902500305; Dawson C, 2017, ECON IND DEMOCRACY, V38, P69, DOI 10.1177/0143831X14559781; De Cuyper N, 2006, J OCCUP ORGAN PSYCH, V79, P395, DOI 10.1348/096317905X53660; De Hauw S, 2010, J BUS PSYCHOL, V25, P293, DOI 10.1007/s10869-010-9162-9; Di Pietro G, 2006, APPL ECON, V38, P79, DOI 10.1080/00036840500215303; ENGLAND GW, 1983, J INT BUS STUD, V14, P49, DOI 10.1057/palgrave.jibs.8490518; Erdogan B, 2011, IND ORGAN PSYCHOL-US, V4, P215, DOI 10.1111/j.1754-9434.2011.01330.x; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Fichman M, 2003, ORGAN RES METHODS, V6, P282, DOI 10.1177/1094428103255532; Fong CT, 2006, ACAD MANAGE J, V49, P1016, DOI 10.5465/AMJ.2006.22798182; Frone M R, 1996, J Occup Health Psychol, V1, P57, DOI 10.1037/1076-8998.1.1.57; Grant AM, 2007, ACAD MANAGE PERSPECT, V21, P51, DOI 10.5465/AMP.2007.26421238; HEADEY B, 1993, SOC INDIC RES, V29, P63, DOI 10.1007/BF01136197; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; Hu J, 2015, J APPL PSYCHOL, V100, P1228, DOI 10.1037/apl0000008; Ilies R, 2007, EUR J WORK ORGAN PSY, V16, P326, DOI 10.1080/13594320701363712; ILO, 2020, WORLD EMPL SOC OUTL; International Labour Organization, 2013, GLOB EMPL TRENDS YOU; IRIS B, 1972, J APPL PSYCHOL, V56, P301, DOI 10.1037/h0033095; JACKSON SE, 1985, ORGAN BEHAV HUM DEC, V36, P16, DOI 10.1016/0749-5978(85)90020-2; Johnson GJ, 2000, J PSYCHOL, V134, P537, DOI 10.1080/00223980009598235; KELLER RT, 1975, PERS PSYCHOL, V28, P57, DOI 10.1111/j.1744-6570.1975.tb00391.x; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Luksyte A, 2011, J OCCUP HEALTH PSYCH, V16, P279, DOI 10.1037/a0022709; Maynard DC, 2006, J ORGAN BEHAV, V27, P509, DOI 10.1002/job.389; MCFARLIN DB, 1992, J ORGAN BEHAV, V13, P41, DOI 10.1002/job.4030130105; McGowan J, 2006, NEW ZEAL J PSYCHOL, V35, P92; MCINTYRE RM, 1980, MULTIVAR BEHAV RES, V15, P225, DOI 10.1207/s15327906mbr1502_7; MILES RH, 1976, ACAD MANAGE J, V19, P25, DOI 10.2307/255445; Nielsen K, 2017, WORK STRESS, V31, P101, DOI 10.1080/02678373.2017.1304463; Nordenmark M, 2004, ACTA SOCIOL, V47, P115, DOI 10.1177/0001699304043823; Peiro J.M, 2018, P 29 INT C APPL PSYC; Peiro JM, 2010, J APPL SOC PSYCHOL, V40, P666, DOI 10.1111/j.1559-1816.2010.00592.x; PETERSON MF, 1995, ACAD MANAGE J, V38, P429, DOI 10.2307/256687; Pouliakas K., 2015, SAFEGUARDING ED INVE; Raykov T, 2012, INTRO APPL MULTIVARI; RIZZO JR, 1970, ADMIN SCI QUART, V15, P150, DOI 10.2307/2391486; SIEBER SD, 1974, AM SOCIOL REV, V39, P567, DOI 10.2307/2094422; Sinclair R. R., 2012, RES METHODS OCCUPATI; Thompson CA, 2006, J OCCUP HEALTH PSYCH, V11, P100, DOI 10.1037/1076-8998.10.4.100; van de Voorde K., 2014, WELL BEING PERFORMAN, P95; WARR P, 1979, J OCCUP PSYCHOL, V52, P129, DOI 10.1111/j.2044-8325.1979.tb00448.x; Warr P., 2013, RES METHODS OCCUPATI, P76, DOI DOI 10.4324/9780203095249; Warr PB, 2011, WORK HAPPINESS UNHAP; Ziegler R, 2012, J APPL SOC PSYCHOL, V42, P2019, DOI 10.1111/j.1559-1816.2012.00929.x	59	4	4	3	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JAN 1	2019	16	1							25	10.3390/ijerph16010025	http://dx.doi.org/10.3390/ijerph16010025			17	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HM0BZ	30583531	gold, Green Published			2022-09-04	WOS:000459111400025
J	Gomez-Quintero, CH; Faccini-Martinez, AA; Botero-Garcia, CA; Lozano, M; Sanchez-Lerma, L; Miranda, J; Mattar, S; Hidalgo, M				Gomez-Quintero, Carlos H.; Faccini-Martinez, Alvaro A.; Botero-Garcia, Carlos A.; Lozano, Marcela; Sanchez-Lerma, Liliana; Miranda, Jorge; Mattar, Salim; Hidalgo, Marylin			Probable case of spotted fever group rickettsial infection in a new suspected endemic area, Colombia	JOURNAL OF INFECTION AND PUBLIC HEALTH			English	Article						Rickettsia; Rickettsia infections; Spotted fever group; Colombia		Spoted fever group (SFG) rickettsioses are actually considered as emerging and re-emerging zoonotic diseases, caused by pathogenic bacteria of the spotted fever group rickettsiae (SFGR). Recently, serologic studies in human and animals conducted in Colombian Orinoquia, showed a high seroprevalence against SFGR. In June 2015, a 50-year-old male was admitted to a hospital in Bogota, Colombia, with two days of malaise and temperature of 39 degrees C, associated to generalized rash 24 h after the onset of fever. He referred a work visit and outdoor activities in rural area of the Department of Meta 15 days prior the onset of symptoms. The patient was transferred to the intensive care unit with supplementary oxygen, inotropic support and was assessed by the infectious diseases department, indicating the addition of Doxycycline. After seven days of antibiotic treatment the patient was discharged with no evidence of new symptoms or sequels. Retrospectively, two serum samples collected during the acute and convalescent phase were evaluated; there was four fold rise in titer against SFGR. With the foregoing, associated with the recent serological evidence that suggests the circulation of SFGR species in the Colombian Orinoquia, we consider to recognize this region as a new endemic area for SFG Rickettsioses. (C) 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Gomez-Quintero, Carlos H.; Lozano, Marcela] Clin De La Mujer, Grp Enfermedades Infecciosas, Bogota, Colombia; [Faccini-Martinez, Alvaro A.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Doencas Infecciosas, Vitoria, Brazil; [Botero-Garcia, Carlos A.] Univ Militar Nueva Granada, Sch Med, Bogota, Colombia; [Sanchez-Lerma, Liliana] Univ Cooperat Colombia, Fac Med, Villavicencio, Colombia; [Miranda, Jorge; Mattar, Salim] Inst Invest Biol Trop, Monteria, Colombia; [Hidalgo, Marylin] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia		Faccini-Martinez, AA (corresponding author), Univ Fed Espirito Santo, Ave Marechal Campos 1468, Vitoria, ES, Brazil.	afaccini@gmail.com	Miranda, Jorge L/K-8943-2013; Gomez Quintero, Carlos Hernando/AHE-8226-2022; Hidalgo, Marylin/AAF-5736-2019	Miranda, Jorge L/0000-0002-7110-7791; Gomez Quintero, Carlos Hernando/0000-0002-8987-9351; Sanchez Lerma, Liliana/0000-0001-7024-3874; Faccini-Martinez, Alvaro A./0000-0002-1127-0132; Hidalgo, Marylin/0000-0001-8960-0616				Acosta J., 2006, Informe Quincenal - Epidemiologico Nacional, V11, P177; Biggs HM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6502a1; Faccini-Martinez AA, 2015, EMERG INFECT DIS, V21, P537, DOI 10.3201/eid2013.140721; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Hidalgo M, 2011, MEM I OSWALDO CRUZ, V106, P117, DOI 10.1590/S0074-02762011000100019; Miranda J.L., 2011, BIOMEDICA, V31, P103; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; Rivera-Paez FA, 2016, TICKS TICK-BORNE DIS, V7, P842, DOI 10.1016/j.ttbdis.2016.03.020; Riveros-Pinilla DA, 2015, REV MVZ CORDOBA, V20, P5004, DOI 10.21897/rmvz.14	10	6	6	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1876-0341	1876-035X		J INFECT PUBLIC HEAL	J. Infect. Public Health	MAY-JUN	2017	10	3					353	356		10.1016/j.jiph.2016.08.012	http://dx.doi.org/10.1016/j.jiph.2016.08.012			4	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	EW4IY	27614577	gold			2022-09-04	WOS:000402466400016
J	Mucci, S; Herrera, MI; Barreto, GE; Kolliker-Frers, R; Capani, F				Mucci, Sofia; Herrera, Maria Ines; Barreto, George E.; Kolliker-Frers, Rodolfo; Capani, Francisco			Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells	CURRENT PHARMACEUTICAL DESIGN			English	Review						brain injury; hypoxia-ischemia; pharmacological treatments; glial cells; neuroprotection	ACETYLCHOLINE-RECEPTOR AGONIST; OXYGEN-GLUCOSE DEPRIVATION; TRANSIENT GLOBAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; ACID AMIDE HYDROLASE; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NITRIC-OXIDE; RAT-BRAIN; IN-VITRO	Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.	[Mucci, Sofia; Herrera, Maria Ines; Kolliker-Frers, Rodolfo; Capani, Francisco] UBA, CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal,Fac M, Buenos Aires, DF, Argentina; [Herrera, Maria Ines; Capani, Francisco] Univ Catolica Argentina, Fac Psicol, Ctr Invest Psicol & Psicopedag, Buenos Aires, DF, Argentina; [Barreto, George E.] Pontificia Univ Javeriana Bogota, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Capani, Francisco] Univ Argentina JF Kennedy, Dept Biol, Buenos Aires, DF, Argentina; [Capani, Francisco] Univ Autonoma Chile, Santiago, Chile; [Capani, Francisco] Univ Catolica Argentina, Fac Psicol, Buenos Aires, DF, Argentina		Capani, F (corresponding author), UBA, CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal,Fac M, Buenos Aires, DF, Argentina.	franciscoca-pani@hotmail.com	capani, Francisco/D-9781-2016; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971				Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Amantea D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00147; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Benito C, 2012, BRIT J PHARMACOL, V166, P1474, DOI 10.1111/j.1476-5381.2012.01889.x; Bi J, 2008, NEUROSCI LETT, V442, P224, DOI 10.1016/j.neulet.2008.07.029; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Brifault C, 2015, STROKE, V46, P520, DOI 10.1161/STROKEAHA.114.006864; Cao X, 2010, BRAIN RES, V1347, P142, DOI 10.1016/j.brainres.2010.05.072; Capani F, 1997, BRAIN RES, V775, P11, DOI 10.1016/S0006-8993(97)00714-2; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Chao HM, 2013, J OCUL PHARMACOL TH, V29, P539, DOI 10.1089/jop.2012.0179; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Chen W, 2009, EXP NEUROL, V216, P7, DOI 10.1016/j.expneurol.2008.10.016; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Correa F, 2011, BRAIN BEHAV IMMUN, V25, P736, DOI 10.1016/j.bbi.2011.01.020; Donega V, 2014, EXP NEUROL, V261, P53, DOI 10.1016/j.expneurol.2014.06.009; Duan YL, 2011, NEUROSCIENCE, V192, P81, DOI 10.1016/j.neuroscience.2011.06.067; Saraceno GE, 2010, EXP NEUROL, V223, P615, DOI 10.1016/j.expneurol.2010.02.010; Findlay VJ, 2005, BIOMED PHARMACOTHER, V59, P374, DOI 10.1016/j.biopha.2005.07.003; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Furukawa S, 2014, BRAIN RES, V1562, P52, DOI 10.1016/j.brainres.2014.03.028; Furukawa S, 2013, BRAIN DEV-JPN, V35, P607, DOI 10.1016/j.braindev.2012.10.006; Gaire BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120203; George S, 2011, DEV NEUROSCI-BASEL, V33, P280, DOI 10.1159/000329923; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; Guo JB, 2012, FREE RADICAL BIO MED, V52, P2151, DOI 10.1016/j.freeradbiomed.2012.03.005; Gupta K, 2013, BRIT J CLIN PHARMACO, V75, P907, DOI 10.1111/bcp.12022; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu X, 2016, BRAIN RES BULL, V125, P1, DOI 10.1016/j.brainresbull.2016.03.017; Hua SS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718769; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Ichinose M, 2014, J NEUROSCI RES, V92, P1270, DOI 10.1002/jnr.23418; Ionov M, 2011, NEUROSCIENCE, V180, P229, DOI 10.1016/j.neuroscience.2011.02.045; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Krishnan G, 2012, GLIA, V60, P1629, DOI 10.1002/glia.22380; Kumar V, 2010, ROBBINS COTRAN PATHO, VEighth; Lee Kim Mai, 2015, World J Virol, V4, P42, DOI 10.5501/wjv.v4.i2.42; Li DQ, 2004, NEUROSCI RES, V50, P169, DOI 10.1016/j.neures.2004.06.009; Li F, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-111; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Li YC, 2008, INT J DEV NEUROSCI, V26, P309, DOI 10.1016/j.ijdevneu.2008.01.006; Lu Q, 2015, REDOX BIOL, V6, P516, DOI 10.1016/j.redox.2015.06.016; Lu Q, 2015, REDOX BIOL, V6, P112, DOI 10.1016/j.redox.2015.06.007; Lukersmith S, 2016, DISABIL HEALTH J, V9, P272, DOI 10.1016/j.dhjo.2015.09.006; Lv MH, 2016, INFLAMM RES, V65, P551, DOI 10.1007/s00011-016-0939-9; Makarov PR, 2002, BRAIN RES, V933, P91, DOI 10.1016/S0006-8993(02)02246-1; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Mato S, 2013, GLIA, V61, P750, DOI 10.1002/glia.22470; Matsui T, 2014, FOLIA NEUROPATHOL, V52, P151, DOI 10.5114/fn.2014.43786; Mifsud G, 2014, CNS NEUROSCI THER, V20, P603, DOI 10.1111/cns.12263; Moon JM, 2013, J CEREBR BLOOD F MET, V33, P1976, DOI 10.1038/jcbfm.2013.157; Morales P, 2011, EPMA J, V2, P211, DOI 10.1007/s13167-011-0100-3; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Ni JS, 2015, BRAIN BEHAV IMMUN, V49, P75, DOI 10.1016/j.bbi.2015.04.014; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Ouyang YB, 2013, GLIA, V61, P1784, DOI 10.1002/glia.22556; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Pathipati P, 2013, DEV NEUROSCI-BASEL, V35, P241, DOI 10.1159/000346159; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perea G, FRONT CELL NEUROSCI, V8, P378; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00098; Ronca RD, 2015, LIFE SCI, V138, P72, DOI 10.1016/j.lfs.2015.05.005; Seo M, 2012, ELECTROPHORESIS, V33, P3835, DOI 10.1002/elps.201200331; Singh S, 2016, INT J NEUROSCI, P1; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Skaper SD, 2011, CNS NEUROL DISORD-DR, V10, P44; Stary CM, 2015, NEUROCHEM RES, V40, P301, DOI 10.1007/s11064-014-1373-4; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Sun J, 2013, ACTA PHARMACOL SIN, V34, P119, DOI 10.1038/aps.2012.141; Swamy M, 2010, INT J MED SCI, V7, P147; Talwar T, 2014, ANN INDIAN ACAD NEUR, V17, P1, DOI 10.4103/0972-2327.128519; Ternianov A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.012; Vazquez C, 2015, NEUROBIOL DIS, V79, P41, DOI 10.1016/j.nbd.2015.04.005; Vijayakumar NT, 2016, MOL NEUROBIOL, V53, P2579, DOI 10.1007/s12035-015-9278-z; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Wang D, 2013, NEUROSCIENCE, V237, P130, DOI 10.1016/j.neuroscience.2013.01.056; Xiong M, 2013, EXP NEUROL, V247, P720, DOI 10.1016/j.expneurol.2013.03.015; Xiong M, 2013, DEV NEUROSCI-BASEL, V35, P17, DOI 10.1159/000346324; Xu JJ, 2014, J NEUROTRAUM, V31, P1343, DOI 10.1089/neu.2013.3222; Xu M, 2014, GLIA, V62, P855, DOI 10.1002/glia.22645; Xu ZX, 2015, INT IMMUNOPHARMACOL, V25, P528, DOI 10.1016/j.intimp.2015.02.033; Yang D, 2014, J NEUROSCI, V34, P16467, DOI 10.1523/JNEUROSCI.2582-14.2014; Yang JS, 2014, J NEUROCHEM, V131, P383, DOI 10.1111/jnc.12819; Zeng KW, 2015, EUR J PHARMACOL, V748, P18, DOI 10.1016/j.ejphar.2014.12.013; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404; Zhang ZY, 2015, CELL MOL NEUROBIOL, V35, P147, DOI 10.1007/s10571-014-0106-1; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; Zhou KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108454; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zhou YC, 2015, INT J MOL MED, V36, P43, DOI 10.3892/ijmm.2015.2205; Zhu J, 2012, NEUROSCIENCE, V202, P342, DOI 10.1016/j.neuroscience.2011.11.070	104	3	3	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2017	23	26					3899	3906		10.2174/1381612823666170727145422	http://dx.doi.org/10.2174/1381612823666170727145422			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FI9LS	28748754				2022-09-04	WOS:000412330000012
J	Rey, GZ; Bekrar, A; Trentesaux, D; Zhou, BH				Rey, Gabriel Zambrano; Bekrar, Abdelghani; Trentesaux, Damien; Zhou, Bing-Hai			Solving the flexible job-shop just-in-time scheduling problem with quadratic earliness and tardiness costs	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Flexible job shop scheduling; Just-in-time; Release times; Genetic algorithms; Particle swarm optimization	MEAN SQUARED DEVIATION; COMMON DUE-DATE; GENETIC-ALGORITHM; PARTICLE SWARM; COMPLETION TIMES; OPTIMIZATION; RELEASE; OPERATORS; MODELS	The flexible job-shop scheduling problem is known to be an (Non-deterministic Polynomial-time hard) combinatorial problem and has become a challenge in optimization and manufacturing control. Although flexibility is important in order to respond effectively to higher product variety, shorter lead times, and smaller batch sizes, industrialists also require just-in-time scheduling strategies to increase customer satisfaction. The aim of this paper is to find adequate job release times to meet production demands in relation to specific due dates. Since large deviations in job completion times are undesirable, the scheduling objective for just-in-time production is translated into the minimization of the mean-square due date deviation (MSD), quadratically penalizing inventory (earliness) costs and backlogging (tardiness) costs. Given the computational complexity of the problem, two meta-heuristics are proposed: a genetic algorithm (GA) and particle swarm optimization (PSO), as well as two different approaches to handle job release times. In the GA, job release times are treated as dependent variables, whereas the PSO enables the integration of job release times as independent variables within the particle encoding. These meta-heuristic approaches were compared using three benchmarks, two adapted from the literature and one inspired from a real manufacturing cell. The simulation results show that the GA and PSO attained similar performances, each one with advantages and disadvantages for constrained and unconstrained MSD problems.	[Rey, Gabriel Zambrano] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Rey, Gabriel Zambrano; Bekrar, Abdelghani; Trentesaux, Damien] Univ Lille Nord France, F-59000 Lille, France; [Rey, Gabriel Zambrano; Bekrar, Abdelghani; Trentesaux, Damien] UVHC, LAMIH UMR CNRS 8201, F-59313 Valenciennes, France; [Zhou, Bing-Hai] Tongji Univ, Sch Mech Engn, Inst Ind Engn, Shanghai 200092, Peoples R China		Rey, GZ (corresponding author), Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia.	gzambrano@javeriana.edu.co	trentesaux, damien/D-2791-2009	trentesaux, damien/0000-0003-2489-6203	scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS; Javeriana University (Bogota, Colombia)	scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS; Javeriana University (Bogota, Colombia)	The corresponding author was supported financially by the scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS and Javeriana University (Bogota, Colombia), where he is currently an associate professor.	Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P57, DOI 10.1109/ICEC.1994.350042; BAGCHI U, 1987, MANAGE SCI, V33, P894, DOI 10.1287/mnsc.33.7.894; Bagheri A, 2010, FUTURE GENER COMP SY, V26, P533, DOI 10.1016/j.future.2009.10.004; Bergamaschi D, 1997, INT J PROD RES, V35, P399, DOI 10.1080/002075497195821; Bessaou M, 2001, STRUCT MULTIDISCIP O, V23, P63, DOI 10.1007/s00158-001-0166-y; Brandimarte P., 1993, Annals of Operations Research, V41, P157, DOI 10.1007/BF02023073; Bratton D, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P120, DOI 10.1109/SIS.2007.368035; Cevikcan E, 2014, COMPUT IND ENG, V76, P318, DOI 10.1016/j.cie.2014.08.012; Cheng RW, 1996, COMPUT IND ENG, V30, P983, DOI 10.1016/0360-8352(96)00047-2; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; Eberhart R., 1995, P 6 INT S MICR MACH, P39, DOI 10.1109/MHS.1995.494215; Eberhart RC, 2001, IEEE C EVOL COMPUTAT, P81, DOI 10.1109/CEC.2001.934374; Eiben AE, 2007, STUD COMPUT INTELL, V54, P19; Ennigrou M, 2008, AUTON AGENT MULTI-AG, V17, P270, DOI 10.1007/s10458-008-9031-3; Fallah-Jamshidi S, 2011, EXPERT SYST APPL, V38, P13549, DOI 10.1016/j.eswa.2011.04.065; Fattahi P, 2007, J INTELL MANUF, V18, P331, DOI 10.1007/s10845-007-0026-8; Fattahi P, 2010, CIRP J MANUF SCI TEC, V2, P114, DOI 10.1016/j.cirpj.2009.10.001; Gao J, 2006, J INTELL MANUF, V17, P493, DOI 10.1007/s10845-005-0021-x; GOLDBERG DE, 1991, FDN GENETIC ALGORITH; Gomes MC, 2013, INT J PROD RES, V51, P5120, DOI 10.1080/00207543.2013.793428; Grupe F. H., 2004, Information Management & Computer Security, V12, P288, DOI 10.1108/09685220410542624; Guo ZX, 2008, INT J ADV MANUF TECH, V36, P156, DOI 10.1007/s00170-006-0818-6; Gutierrez A L, 2011, 2011 5th European Conference on Antennas and Propagation (EuCAP), P965; He Y, 2007, CHEM ENG SCI, V62, P1504, DOI 10.1016/j.ces.2006.11.049; Henchiri Abir, 2013, Advances in Swarm Intelligence. 4th International Conference, ICSI 2013. Proceedings, P385, DOI 10.1007/978-3-642-38715-9_46; Holland J. H., 1992, ADAPTATION NATURAL A; Hu XH, 2004, IEEE C EVOL COMPUTAT, P90, DOI 10.1109/CEC.2004.1330842; Hussain MF, 1998, IEEE SYS MAN CYBERN, P2225, DOI 10.1109/ICSMC.1998.724986; Jaszkiewicz A, 2004, EUR J OPER RES, V158, P418, DOI 10.1016/j.ejor.2003.06.015; Jia ZH, 2007, PROCEEDINGS OF 2007 IEEE INTERNATIONAL CONFERENCE ON GREY SYSTEMS AND INTELLIGENT SERVICES, VOLS 1 AND 2, P1584; Jozefowska J, 2007, INT SER OPER RES MAN, V106, P1, DOI 10.1007/978-0-387-71718-0; Kacem I, 2002, IEEE T SYST MAN CY C, V32, P1, DOI 10.1109/TSMCC.2002.1009117; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P162, DOI 10.1109/SIS.2007.368041; Kianfar K, 2012, COMPUT OPER RES, V39, P2978, DOI 10.1016/j.cor.2012.03.004; Kim JG, 2012, INT J PROD RES, V50, P6040, DOI 10.1080/00207543.2011.644591; Kuo RJ, 2013, INT J ADV MANUF TECH, V67, P59, DOI 10.1007/s00170-013-4753-z; Lauff V, 2004, MATH COMPUT MODEL, V40, P637, DOI 10.1016/j.mcm.2003.05.019; Li J, 2010, INT J COMPUT THEORY, V2, P1793, DOI DOI 10.7763/IJ(.1'H.2010.V2.139; Mati Y, 2011, INT J PROD RES, V49, P2169, DOI 10.1080/00207541003733775; Mattfeld DC, 2004, EUR J OPER RES, V155, P616, DOI 10.1016/S0377-2217(03)00016-X; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI 10.1109/tevc.2004.826074; Moslehi G, 2011, INT J PROD ECON, V129, P14, DOI 10.1016/j.ijpe.2010.08.004; Nearchou AC, 2004, INT J PROD ECON, V88, P191, DOI 10.1016/S0925-5273(03)00184-1; Nie L, 2013, J INTELL MANUF, V24, P763, DOI 10.1007/s10845-012-0626-9; Niu Q, 2008, APPL MATH COMPUT, V205, P148, DOI 10.1016/j.amc.2008.05.086; Nouiri M, 2013, PROCEEDINGS OF 2013 INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND SYSTEMS MANAGEMENT (IEEE-IESM 2013), P29; Oosterman B, 2000, INT J PROD ECON, V68, P107, DOI 10.1016/S0925-5273(99)00141-3; Pach C, 2012, CONTROL ENG PRACT, V20, P1293, DOI 10.1016/j.conengprac.2012.07.005; Pezzella F, 2008, COMPUT OPER RES, V35, P3202, DOI 10.1016/j.cor.2007.02.014; Prabhu VV, 2003, IEEE T ROBOTIC AUTOM, V19, P142, DOI 10.1109/TRA.2002.807552; Rabiee M, 2012, INT J PROD RES, V50, P7327, DOI 10.1080/00207543.2011.648280; Rey GZ, 2014, INT J PROD RES, V52, P3688, DOI 10.1080/00207543.2014.881575; Roshanaei V, 2013, INT J PROD RES, P1; Sabuncuoglu I, 1999, INT J PROD ECON, V62, P259, DOI 10.1016/S0925-5273(98)00248-5; Sevaux M., 2004, Q J BELGIAN FRENCH I, V2, P129; Shao XY, 2013, INT J ADV MANUF TECH, V67, P2885, DOI 10.1007/s00170-012-4701-3; Sourd F, 2005, COMPUT OPER RES, V32, P1849, DOI 10.1016/j.cor.2003.12.002; Srirangacharyulu B, 2013, EUR J OPER RES, V231, P547, DOI 10.1016/j.ejor.2013.06.017; Su LH, 2009, COMPUT OPER RES, V36, P461, DOI 10.1016/j.cor.2007.09.013; Sun W, 2010, J MECH SCI TECHNOL, V24, P2119, DOI 10.1007/s12206-010-0526-x; Thurer M, 2011, INT J PROD RES, V49, P6905, DOI 10.1080/00207543.2010.519000; Trentesaux D, 2013, CONTROL ENG PRACT, V21, P1204, DOI 10.1016/j.conengprac.2013.05.004; Valente JMS, 2011, INT J ADV MANUF TECH, V54, P251, DOI 10.1007/s00170-010-2921-y; van den Bergh F, 2004, IEEE T EVOLUT COMPUT, V8, P225, DOI 10.1109/tevc.2004.826069; Vilcot G, 2011, INT J PROD RES, V49, P6963, DOI 10.1080/00207543.2010.526016; Vincent T, 2011, INT J PROD RES, V49, P3191, DOI 10.1080/00207541003733783; Weng MX, 2008, INT J PROD RES, V46, P2197, DOI 10.1080/00207540600969758; Weng W, 2011, IN C IND ENG ENG MAN, P318, DOI 10.1109/IEEM.2011.6117930; Wu ZB, 2005, IEEE T SYST MAN CY B, V35, P293, DOI 10.1109/TSMCB.2004.842412; Xia WJ, 2005, COMPUT IND ENG, V48, P409, DOI 10.1016/j.cie.2005.01.018; Yin HL, 2013, 2013 9TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P298, DOI 10.1109/CIS.2013.70; Rey GZ, 2012, STUD COMPUT INTELL, V402, P115; Zhang GH, 2011, EXPERT SYST APPL, V38, P3563, DOI 10.1016/j.eswa.2010.08.145; Zhang GH, 2009, COMPUT IND ENG, V56, P1309, DOI 10.1016/j.cie.2008.07.021; Zhang Q, 2012, COMPUT OPER RES, V39, P1713, DOI 10.1016/j.cor.2011.10.007; Zhou W, 2014, CHIN CONT DECIS CONF, P1031, DOI 10.1109/CCDC.2014.6852316	77	5	6	1	46	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	DEC	2015	81	9-12					1871	1891		10.1007/s00170-015-7347-0	http://dx.doi.org/10.1007/s00170-015-7347-0			21	Automation & Control Systems; Engineering, Manufacturing	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Engineering	CW8BR					2022-09-04	WOS:000365224400036
J	Requena, JM; Chicharro, C; Garcia, L; Parrado, R; Puerta, CJ; Canavate, C				Requena, Jose M.; Chicharro, Carmen; Garcia, Lineth; Parrado, Rudy; Puerta, Concepcion J.; Canavate, Carmen			Sequence analysis of the 3 '-untranslated region of HSP70 (type I) genes in the genus Leishmania: its usefulness as a molecular marker for species identification	PARASITES & VECTORS			English	Article						Leishmania; HSP70; 3 ' UTR; Sequence analysis; Microsatellites; Phylogenetic analysis	NEIGHBOR-JOINING METHOD; DONOVANI COMPLEX; WORLD LEISHMANIA; HEAT-SHOCK; OLD-WORLD; CUTANEOUS LEISHMANIASIS; GENOMIC ORGANIZATION; TRYPANOSOMA-CRUZI; MESSENGER-RNA; DNA	Background: The Leishmaniases are a group of clinically diverse diseases caused by parasites of the genus Leishmania. To distinguish between species is crucial for correct diagnosis and prognosis as well as for treatment decisions. Recently, sequencing of the HSP70 coding region has been applied in phylogenetic studies and for identifying of Leishmania species with excellent results. Methods: In the present study, we analyzed the 3'-untranslated region (UTR) of Leishmania HSP70-type I gene from 24 strains representing eleven Leishmania species in the belief that this non-coding region would have a better discriminatory capacity for species typing than coding regions. Results: It was observed that there was a remarkable degree of sequence conservation in this region, even between species of the subgenus Leishmania and Viannia. In addition, the presence of many microsatellites was a common feature of the 3'-UTR of HSP70-I genes in the Leishmania genus. Finally, we constructed dendrograms based on global sequence alignments of the analyzed Leishmania species and strains, the results indicated that this particular region of HSP70 genes might be useful for species (or species complex) typing, improving for particular species the discrimination capacity of phylogenetic trees based on HSP70 coding sequences. Given the large size variation of the analyzed region between the Leishmania and Viannia subgenera, direct visualization of the PCR amplification product would allow discrimination between subgenera, and a HaeIII-PCR-RFLP analysis might be used for differentiating some species within each subgenera. Conclusions: Sequence and phylogenetic analyses indicated that this region, which is readily amplified using a single pair of primers from both Old and New World Leishmania species, might be useful as a molecular marker for species discrimination.	[Requena, Jose M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Chicharro, Carmen; Canavate, Carmen] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, WHO Collaborating Ctr Leishmaniasis, Madrid 28220, Spain; [Parrado, Rudy] UMSS, Fac Med, Inst Invest Med, Cochabamba, Bolivia; [Puerta, Concepcion J.] Pontificia Univ Javeriana, Fac Ciencias, Lab Parasitol Mol, Bogota, Colombia		Requena, JM (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain.	jmrequena@cbm.uam.es	Requena, Jose M/I-2022-2019; Puerta, Concepcion J/AAG-4912-2019	Requena, Jose M/0000-0001-7550-0198; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Chicharro, Carmen/0000-0003-1297-1376	Ministerio de Ciencia y Tecnologia [BFU2009-08986]; Fondo de Investigaciones Sanitarias [ISCIII-RETIC RD06/0021/0008-FEDER, ISCIII-RETIC RD06/0021/0009-FEDER]; Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID) [A/024740/09]; Fundacion Ramon Areces	Ministerio de Ciencia y Tecnologia(Spanish GovernmentEuropean Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID); Fundacion Ramon Areces	The authors would like to thank J. P. Dedet and Francine Pratlong (Centre National de Reference des Leishmania, Montpellier, France) who kindly donated some of the strains used in this study. We gratefully acknowledge assistance from our technician (Virginia Franco) and a Master's student (Marta Truchado), who contributed to the cloning step. The careful revision of two anonymous reviewers and their comments and suggestions are also appreciated. This work was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2009-08986), the Fondo de Investigaciones Sanitarias (ISCIII-RETIC RD06/0021/0008-FEDER and ISCIII-RETIC RD06/0021/0009-FEDER), and Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID, A/024740/09). Also, an institutional grant from Fundacion Ramon Areces is acknowledged.	Asato Y, 2009, EXP PARASITOL, V121, P352, DOI 10.1016/j.exppara.2008.12.013; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003; Cao DP, 2011, PARASITOL RES, V109, P163, DOI 10.1007/s00436-010-2239-6; Croan D, 1996, MOL BIOCHEM PARASIT, V79, P97, DOI 10.1016/0166-6851(96)02629-1; Croan DG, 1997, MOL BIOCHEM PARASIT, V89, P149, DOI 10.1016/S0166-6851(97)00111-4; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; da Silva LA, 2010, INFECT GENET EVOL, V10, P77, DOI 10.1016/j.meegid.2009.11.001; de Lima ACS, 2011, PARASITOL RES, V108, P1525, DOI 10.1007/s00436-010-2208-0; Fakhar M, 2008, PARASITOLOGY, V135, P567, DOI 10.1017/S0031182008004186; Folgueira C, 2007, PARASITOLOGY, V134, P369, DOI 10.1017/S0031182006001570; Folgueira C, 2007, FEMS MICROBIOL REV, V31, P359, DOI 10.1111/j.1574-6976.2007.00069.x; Fraga J, 2010, INFECT GENET EVOL, V10, P238, DOI 10.1016/j.meegid.2009.11.007; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Haralambous C, 2008, DIAGN MICR INFEC DIS, V60, P33, DOI 10.1016/j.diagmicrobio.2007.07.019; Hide M, 2007, PARASITOLOGY, V134, P379, DOI 10.1017/S0031182006001600; Ibrahim ME, 2001, INFECT GENET EVOL, V1, P61, DOI 10.1016/S1567-1348(01)00009-0; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kieleczawa Jan, 2010, J Biomol Tech, V21, P97; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Lee MGS, 1998, NUCLEIC ACIDS RES, V26, P4025, DOI 10.1093/nar/26.17.4025; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Montalvo AM, 2010, PARASITOLOGY, V137, P1159, DOI 10.1017/S0031182010000089; Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13; Odiwuor SOC, 2011, EUR J CLIN MICROBIOL, V30, P209, DOI 10.1007/s10096-010-1071-3; Martinez LP, 2010, PARASITOL RES, V106, P647, DOI 10.1007/s00436-009-1712-6; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Quijada L, 1997, J BIOL CHEM, V272, P4493, DOI 10.1074/jbc.272.7.4493; Quijada L, 1996, PARASITOLOGY, V112, P277, DOI 10.1017/S0031182000065793; Quispe-Tintaya KW, 2005, J INFECT DIS, V192, P685, DOI 10.1086/432077; Ramirez CA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-166; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; REQUENA JM, 1988, NUCLEIC ACIDS RES, V16, P1393, DOI 10.1093/nar/16.4.1393; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rodrigues DC, 2010, EXP PARASITOL, V126, P245, DOI 10.1016/j.exppara.2010.05.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Stevenson LG, 2010, DIAGN MICR INFEC DIS, V66, P432, DOI 10.1016/j.diagmicrobio.2009.11.005; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI [10.1093/molbev/msm092, 10.1093/molbev/msr121]; Tsukayama P, 2009, INT J PARASITOL, V39, P355, DOI 10.1016/j.ijpara.2008.08.004; Van der Auwera G, 2011, TRENDS PARASITOL, V27, P49, DOI 10.1016/j.pt.2010.11.007; Waki K, 2007, EUKARYOT CELL, V6, P198, DOI 10.1128/EC.00282-06; WHO, 2010, CONTR LEISHM; Zemanova E, 2007, INT J PARASITOL, V37, P149, DOI 10.1016/j.ijpara.2006.08.008	49	21	22	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 28	2012	5								87	10.1186/1756-3305-5-87	http://dx.doi.org/10.1186/1756-3305-5-87			9	Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology; Tropical Medicine	993CB	22541251	gold, Green Published, Green Accepted			2022-09-04	WOS:000307831000002
J	Santander, SP; Aoki, M; Hernandez, JF; Pombo, M; Moins-Teisserenc, H; Mooney, N; Fiorentino, S				Santander, S. P.; Aoki, M.; Hernandez, J. F.; Pombo, M.; Moins-Teisserenc, H.; Mooney, N.; Fiorentino, S.			Galactomannan from Caesalpinia spinosa induces phenotypic and functional maturation of human dendritic cells	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Dendritic cells; Immunomodulation; Gene expression; Galactomannan; Polysaccharide; Caesalpinia spinosa	IN-VITRO; RECEPTOR; BINDING; MACROPHAGES; EXPRESSION; LIPOPOLYSACCHARIDE; INDUCTION; CYTOKINE; COMPLEX; CONIDIA	Plant polysaccharides present an interesting potential as immunomodulators, particularly in the induction of antitumoral responses, principally because of their molecular complexity and low in vivo toxicity. Activation of dendritic cells (DCs) could improve antitumoral responses usually diminished in cancer patients, and natural adjuvants provide a possibility of inducing this activation. Herein, we investigated the immunomodulatory activity of a neutral plant polysaccharide Galactomannan on human monocyte-derived DCs (MDDC). MDDCs were stimulated with Galactomannan (GLM) from Caesalpinia spinosa and both phenotypic and functional activities were assessed by flow cytometry and real-time PCR. The phagocytic ability of MDDCs was determined by using E-coli pHrodo particles and induction of T-lymphocyte allostimulation was determined after T-cell staining with carboxyfluorescein succinimidyl ester (CFSE). In MDDCs, purified Galactomannan induced phenotypic maturation revealed by increased expression of CD83, CD86, CD206, and HLA-DR. Functional experiments showed the loss of particulate antigen uptake in Galactomannan-stimulated DCs and increased alloantigen presentation capacity. Finally, Galactomannan increased protein and mRNA levels of pro-inflammatory cytokines including IL-1 beta, IL-6, IL-8, IL-12p70, and TNF-alpha. These data reveal that Galactomannan obtained from Caesalpinia spinosa promotes effective activation of MDDCs. This adjuvant-like activity may have therapeutic applications in clinical settings where immune responses need boosting. (C) 2011 Elsevier B.V. All rights reserved.	[Santander, S. P.; Hernandez, J. F.; Fiorentino, S.] Pontificia Univ Javeriana Bogota, Fac Sci, Immunol & Cellular Biol Grp, Bogota, Colombia; [Pombo, M.] Fdn Univ Juan N Corpas, Bogota, Colombia; [Aoki, M.; Moins-Teisserenc, H.; Mooney, N.] Univ Paris 07, INSERM, Inst Univ Hematol, U940, Paris, France; [Moins-Teisserenc, H.] Hop St Louis, AP HP, Paris, France			susana.fiorentino@javeriana.edu.co	fiorentino, susana/R-8700-2016; Moins-Teisserenc, helene/AAL-1566-2021	fiorentino, susana/0000-0002-4664-0682; Moins-Teisserenc, helene/0000-0003-1602-7534; Mooney, Nuala/0000-0002-3516-6882; Pombo, Luis Miguel/0000-0002-7277-1838	Instituto Colombian para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia [324-2007 Cod 1203408204]; Fondation de France	Instituto Colombian para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fondation de France(Fondation de France)	Financial support was provided by the Instituto Colombian para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" (COLCIENCIAS) Bogota, Colombia, Grant number 324-2007 Cod 1203408204 (S. Fiorentino). M.A. was a postdoctoral fellow funded by Fondation de France. S.P.S. and J.F.H. are PhD student funded by COLCIENCIAS.	Adler HS, 2007, EUR J DERMATOL, V17, P476; Apte SH, 2010, J IMMUNOL, V185, P998, DOI 10.4049/jimmunol.0903372; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Cerqueira MA, 2009, CARBOHYD POLYM, V75, P408, DOI 10.1016/j.carbpol.2008.07.036; CHIHARA G, 1969, Nature (London), V222, P687; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; CORREA J, 1990, SECAB, V3, P231; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Duncan CJG, 2002, J AGR FOOD CHEM, V50, P5683, DOI 10.1021/jf020267c; Fan J, 2002, J IMMUNOL, V168, P5252, DOI 10.4049/jimmunol.168.10.5252; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kim GY, 2006, BIOL PHARM BULL, V29, P354, DOI 10.1248/bpb.29.354; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; LOMBARD Y, 1994, J IMMUNOL METHODS, V174, P155, DOI 10.1016/0022-1759(94)90018-3; Lu MC, 2009, FOOD CHEM, V113, P1049, DOI 10.1016/j.foodchem.2008.08.089; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Noleto GR, 2002, MOL CELL BIOCHEM, V233, P73, DOI 10.1023/A:1015566312032; Ono L, 2003, ANTIVIR RES, V60, P201, DOI 10.1016/S0166-3542(03)00175-X; PASCUAL D, 2002, VACCINE S2, V24; Persat F, 2003, CLIN EXP IMMUNOL, V133, P370, DOI 10.1046/j.1365-2249.2003.02222.x; Ramesh HP, 2002, CARBOHYD POLYM, V50, P79, DOI 10.1016/S0144-8617(01)00377-0; RONCERO V, 2001, U POLITECNICA CATALU; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Sheng KC, 2006, IMMUNOLOGY, V118, P372, DOI 10.1111/j.1365-2567.2006.02384.x; Sittikijyothin W, 2005, CARBOHYD POLYM, V59, P339, DOI 10.1016/j.carbpol.2004.10.005; Srivastava M, 2005, CHEM BIODIVERS, V2, P295, DOI 10.1002/cbdv.200590013; Tevyashova AN, 2007, RUSS J BIOORG CHEM+, V33, P139, DOI 10.1134/S1068162007010153; TIZARD I R, 1989, Molecular Biotherapy, V1, P290; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; WAKSMUNDAHAJNOS M, 2008, THIN LAYER CHROMATOG, P267; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; ZHANGA M, 2007, TRENDS FOOD SCI TECH, V18	45	21	25	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	JUN	2011	11	6					652	660		10.1016/j.intimp.2011.01.006	http://dx.doi.org/10.1016/j.intimp.2011.01.006			9	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	776AC	21255695				2022-09-04	WOS:000291505900003
J	Lasso, P; Mesa, D; Cuellar, A; Guzman, F; Bolanos, N; Rosas, F; Velasco, V; Thomas, MD; Lopez, MC; Gonzalez, JM; Puerta, CJ				Lasso, P.; Mesa, D.; Cuellar, A.; Guzman, F.; Bolanos, N.; Rosas, F.; Velasco, V.; Del Carmen Thomas, M.; Lopez, M. C.; Gonzalez, J. M.; Puerta, C. J.			Frequency of specific CD8+T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patients	PARASITE IMMUNOLOGY			English	Article						CD8(+) T cell; Chagas' disease; HLA-A2 supertype; Trypanosoma cruzi	CD8(+) T-CELLS; KINETOPLASTID MEMBRANE PROTEIN-11; CLASS-I SUPERTYPES; TRANSGENIC MICE; CENTRAL-MEMORY; HLA-A; IDENTIFICATION; ANTIGEN; DISEASE; INFECTION	The K1 peptide is a CD8+T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein. We have previously shown that this peptide induces IFN-gamma secretion by CD8+T cells. The aim of this study was to characterize the frequency of K1-specific CD8+T cells in chagasic patients. Nineteen HLA-A2+individuals were selected from 50 T. cruzi infected patients using flow cytometry and SSP-PCR assays. Twelve HLA-A*0201+noninfected donors were included as controls. Peripheral blood mononuclear cells were stained with HLA-A2-K1 tetramer, showing that 15 of 19 infected patients have K1-specific CD8+T cells (0 center dot 09-0 center dot 34% frequency) without differences in disease stages or severity. Of note, five of these responders were A*0205, A*0222, A*0226, A*0259 and A*0287 after molecular typing. Thus, a phenotypic and functional comparison of K1-specific CD8+T cells from non-HLA-A*0201 and HLA-A*0201+infected patients was performed. The results showed that both non-HLA-A*0201 and HLA-A*0201+individuals have a predominant effector memory CD8+T cell phenotype (CCR7-, CD62L-). Moreover, CD8+T cells from non-HLA-A*0201 and HLA-A*0201+individuals expressed IL-2, IFN-gamma and perforin without any differences. These findings support that K1 peptide is a promiscuous epitope presented by HLA-A2 supertype molecules and is highly recognized by chagasic patients.	[Puerta, C. J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Bogota, Colombia; [Cuellar, A.] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Guzman, F.] Pontificia Univ Catolica Valparaiso, Lab Genet & Inmunol Mol, Valparaiso, Chile; [Bolanos, N.; Gonzalez, J. M.] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Rosas, F.; Velasco, V.] Fdn Clin Abood Shaio, Bogota, Colombia; [Del Carmen Thomas, M.; Lopez, M. C.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Cra 7A 43-82,Ed 52,Of 608, Bogota, Colombia.	cpuerta@javeriana.edu.co	Thomas, María Carmen PhD/D-9065-2016; Zaky, Mohammad/I-3187-2017; Lopez, Manuel/Z-5641-2019; Puerta, Concepcion J/AAG-4912-2019; Cuellar, Adriana/AAF-2958-2019; Guzman, Fanny fg/K-5592-2013	Zaky, Mohammad/0000-0003-3547-2588; Guzman, Fanny fg/0000-0003-1537-0904; Cuellar, Adriana/0000-0003-0834-8442; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Gonzalez, John M./0000-0001-6925-0620; Thomas, M Carmen/0000-0003-3586-9657; Lopez, Manuel Carlos/0000-0003-0002-3678; Mursalin, Adi/0000-0002-1867-0868	Colciencias Research [1203-333-18692]; PAI (Junta de Andalucia) [P06-CTS-02242];  [RICET-RD06/0021-0014]	Colciencias Research; PAI (Junta de Andalucia)(Junta de Andalucia); 	The HLA-A2/K1 and HLA-A2/Flu-MP* tetramers were generated and kindly provided by the NIH Tetramer Facility. This work was supported by Colciencias Research project No. 1203-333-18692. We thank Zulma Cucunuba from Instituto Nacional de Salud, and Hugo Diez from Laboratorio de Parasitologia Molecular, Pontificia Universidad Javeriana for their collaboration with contacting patients. MCT and MCL were supported by P06-CTS-02242 Grant from PAI (Junta de Andalucia) and RICET-RD06/0021-0014, Spain.	Alvarez MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000288; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bixby LM, 2008, J IMMUNOL, V181, P2644, DOI 10.4049/jimmunol.181.4.2644; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Diez H, 2007, PEPTIDES, V28, P1520, DOI 10.1016/j.peptides.2007.06.017; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Fiuza JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000512; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Garcia F, 2003, MICROBES INFECT, V5, P351, DOI 10.1016/S1286-4579(03)00044-3; Harari A, 2009, J VIROL, V83, P2862, DOI 10.1128/JVI.02528-08; Kumar S, 1998, PARASITE IMMUNOL, V20, P207, DOI 10.1046/j.1365-3024.1998.00154.x; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Leavey JK, 2003, J IMMUNOL, V170, P2264, DOI 10.4049/jimmunol.170.5.2264; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Martin DL, 2005, J IMMUNOL, V174, P1594, DOI 10.4049/jimmunol.174.3.1594; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; Rodriguez Pilar, 2002, Biomedica, V22, P263; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; Tarleton RL, 1996, INT IMMUNOL, V8, P13, DOI 10.1093/intimm/8.1.13; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Thomas MC, 2000, DNA CELL BIOL, V19, P47, DOI 10.1089/104454900314708; Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835; World Health Organization (WHO), 2002, WHO TECH REP SER, V905, P1; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	48	24	26	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	JUL	2010	32	7					494	502		10.1111/j.1365-3024.2010.01206.x	http://dx.doi.org/10.1111/j.1365-3024.2010.01206.x			9	Immunology; Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Parasitology	608ZL	20591120				2022-09-04	WOS:000278624400004
J	Fonseca, FAH; Ruiz, A; Cardona-Munoz, EG; Silva, JM; Fuenmayor, N; Marotti, M				Fonseca, FAH; Ruiz, A; Cardona-Munoz, EG; Silva, JM; Fuenmayor, N; Marotti, M		DISCOVERY PENTA investigators	The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C value - an Evaluation of Rosuvastatin therapY compared with atorvastatin	CURRENT MEDICAL RESEARCH AND OPINION			English	Article						atorvastatin; cardiovascular disease; coronary heart disease; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; rosuvastatin; triglycerides	CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; LIPID-LOWERING-THERAPY; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; HIGH-RISK; MULTICENTER; PRAVASTATIN; AVERAGE; EVENTS	Background. International guidelines emphasize the need to achieve recommended low-density lipoprotein cholesterol (LDL-C) levels in order to reduce morbidity and mortality associated with coronary heart disease (CHD). However, many patients with hypercholesterolemia fail to achieve LDL-C goals on treatment. Objective: The primary objective was to compare the efficacy of rosuvastatin and atorvastatin for enabling patients to achieve National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) LDL-C goals. Secondary objectives were European LDL-C goal achievement, changes in the lipid profile, and safety. Research design and methods: This 12-week, multicenter, multinational, randomized, open-label trial compared the efficacy and safety of rosuvastatin 10 mg with atorvastatin 10 mg in statin-naive and switched patients with primary hypercholesterolemia from Brazil, Colombia, Mexico, Portugal, and Venezuela. Results: A total of 1124 patients with similar baseline characteristics were randomized to the two treatment groups. After 12 weeks of treatment, a significantly greater percentage of patients receiving rosuvastatin 10mg compared with atorvastatin 10 mg achieved NCEP ATP III LDL-C goals (71.2% vs 61.4%, p < 0.001), 1998 European LDL-C goals (73.5% vs 59.2%, p < 0.001) and 2003 European LDL-C goals (58.9% vs 44.6%, p < 0.001). Rosuvastatin treatment was associated with significant reductions in LDL-C and total cholesterol (TC) and, in statin-naive patients, a significant increase in high-density lipoprotein cholesterol (HDL-C) compared with atorvastatin treatment. Both treatments were well tolerated with a similar incidence of adverse events. Clinically significant elevations in creatinine, creatine kinase or hepatic transaminases were low and similar between treatment groups. Conclusions: Rosuvastatin 10 mg is significantly more effective at achieving NCEP ATP III and European LDL-C goals, lowering LDL-C and TC in both naive and switched patients and increasing HDL-C in naive patients than atorvastatin 10 mg, with a similar safety and tolerability profile. This study also provides evidence regarding the comparative effects of rosuvastatin versus atorvastatin in Latin American and Portuguese populations.	Univ Fed Sao Paulo, Sao Paulo, Brazil; Pontificia Univ Javeriana, Med Interna & Epidemiol Clin, Bogota, Colombia; Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; Univ Coimbra, Serv Med 2, P-3000 Coimbra, Portugal; Hosp Miguel Perez Carreno, Serv Nefrol Dialisis & Transplante, Caracas, Venezuela; AstraZeneca, Macclesfield, Cheshire, England		Fonseca, FAH (corresponding author), Univ Fed Sao Paulo, Rua Pedro Toledo,458, Sao Paulo, Brazil.	fahfonseca@terra.com.br	Fonseca, Francisco A H/A-6480-2010; Ruiz, Alvaro/AAD-5422-2019	Fonseca, Francisco A H/0000-0002-9911-4598; Ruiz, Alvaro/0000-0001-6528-4268; CARDONA MUNOZ, ERNESTO GERMAN/0000-0001-7868-667X; da Silva Franco, Roberto Jorge/0000-0001-9787-4393				Assmann G, 1997, Eur J Med Res, V2, P237; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; BARTER P, 2005, ATHEROSCLEROSIS S, V6; BOTS SFE, 2004, TIJDSCHR HUISARTSGEN, V21, P29; Brewer HB, 2003, AM J CARDIOL, V92, p23K, DOI 10.1016/S0002-9149(03)00779-3; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Deedwania PC, 2005, AM J CARDIOL, V95, P360, DOI 10.1016/j.amjcard.2004.09.034; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FELLSTROM B, 2003, NEPHROL DIAL TRANS S, V18; Foley KA, 2003, AM J CARDIOL, V92, P79, DOI 10.1016/S0002-9149(03)00474-0; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kendrach MG, 2004, ANN PHARMACOTHER, V38, P1286, DOI 10.1345/aph.1D391; KJEKSHUS J, 2004, EUR I HEALTHC DEEP I; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; McKenney JM, 2003, CURR MED RES OPIN, V19, P689, DOI 10.1185/030079903125002405; McTaggart F, 2001, AM J CARDIOL, V87, p28B; MIDDLETON A, 2005, PCCS ANN M AGM 3 4 O; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schuster H, 2004, AM HEART J, V147, P705, DOI 10.1016/j.ahj.2003.10.004; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shepherd J, 2004, AM J CARDIOL, V94, P882, DOI 10.1016/j.amjcard.2004.06.049; Strandberg TE, 2004, CLIN THER, V26, P1821, DOI 10.1016/j.clinthera.2004.11.015; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WILSON PWF, 1991, AM J MED, V90, P11, DOI 10.1016/0002-9343(91)90500-W; Wood D, 1998, EUR HEART J, V19, P1434	39	20	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-7995	1473-4877		CURR MED RES OPIN	Curr. Med. Res. Opin.	AUG	2005	21	8					1307	1315		10.1185/030079905X56529	http://dx.doi.org/10.1185/030079905X56529			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	958SU	16083541				2022-09-04	WOS:000231469300021
J	Colonia, CB; Ramirez-Hernandez, A; Gil-Mora, J; Agudelo, JC; Villa, GJC; Pino, C; Betancourt-Ruiz, P; Cardenas, JEP; Blanton, LS; Hidalgo, M				Colonia, Carol B.; Ramirez-Hernandez, Alejandro; Gil-Mora, Juliana; Agudelo, Juan C.; Castano Villa, Gabriel Jaime; Pino, Camilo; Betancourt-Ruiz, Paola; Perez Cardenas, Jorge E.; Blanton, Lucas S.; Hidalgo, Marylin			Flea-borne Rickettsia species in fleas, Caldas department, Colombia	JOURNAL OF INFECTION IN DEVELOPING COUNTRIES			English	Article						Rickettsia felis; Rickettsia asembonensis; RFLP; vector-borne diseases; zoonotic diseases	MURINE TYPHUS; CTENOCEPHALIDES-FELIS; CAT FLEAS; MOLECULAR-DETECTION; 1ST REPORT; ASEMBOENSIS; BARTONELLA; ECOLOGY; TRANSMISSION; INFECTIONS	Introduction: Rickettsioses are zoonotic diseases caused by pathogenic bacteria of the genus Rickettsia and transmitted to man by means of arthropod vectors such as ticks, fleas, mites and lice. Historically, Caldas Department has reported a significant number of cases of murine typhus to the Colombian national health surveillance system, and consequent studies of flea-borne rickettsiosis identified the circulation of Rickettsia typhi and Rickettsia felis in multiple municipalities. Our aim was to genotype species of Rickettsia detected in fleas collected from domestic and wild mammals in Caldas. Methodology: Flea samples were taken by convenience sampling from dogs, cats and wild mammals (rodents and marsupials) in 26 municipalities. Specimens were classified by current taxonomic keys and pooled for DNA extraction and molecular screening for Rickettsia spp. by PCR amplification of gltA, htrA and sca5 genes. Positive samples were genotyped by enzyme digestion (htrA) and sequencing. Results: A total of 1388 flea samples were collected. Rickettsia DNA was amplified in 818 (gltA), 883 (htrA) and 424 (sca5) flea pools. Alignment analysis with available Rickettsia DNA sequences showed greater similarity with R. asembonensis (gltA) and with R. felis (sca5 and htrA). Restriction pattern was compatible with R. felis. R. typhi was not identified. Conclusion: The present study confirms the presence and high prevalence of R. asembonensis and R. felis in fleas from domestic and wild animals in different municipalities from Caldas Department.	[Colonia, Carol B.; Gil-Mora, Juliana; Betancourt-Ruiz, Paola; Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Grp Enfermedades Infecciosas, Bogota, Colombia; [Ramirez-Hernandez, Alejandro] Univ Nacl Colombia, Grp Parasitol Vet, Fac Med Vet & Zootecnia, Bogota, Colombia; [Ramirez-Hernandez, Alejandro] Univ Texas Med Branch, Dept Pathol, Rickettsial & Ehrlichial Dis Res, Galveston, TX 77555 USA; [Agudelo, Juan C.] Univ Caldas, Fac Ciencias Agr, Manizales, Caldas, Colombia; [Castano Villa, Gabriel Jaime] Univ Caldas, Grp Invest GEBIOME, Dept Desarrollo Rural & Recursos Nat, Fac Ciencias Agr, Manizales, Caldas, Colombia; [Pino, Camilo] Univ Nacl Colombia, Fac Ingn, Lab Invest Sistemas Inteligentes, Bogota, Colombia; [Perez Cardenas, Jorge E.] Univ Caldas, Fac Ciencias Salud, Manizales, Caldas, Colombia; [Blanton, Lucas S.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA		Hidalgo, M (corresponding author), Fac Ciencias, Dept Microbiol, Cra 7a 43-82 Edificio 53 Lab 401, Bogota, Colombia.	hidalgo.m@javeriana.edu.co	Hernandez, Alejandro Ramirez/U-1567-2019	Hernandez, Alejandro Ramirez/0000-0001-8689-5930	Colciencias [112765740609]; Fogarty International Center of the National Institutes of Health [D43TW010331]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by Colciencias (Code: 112765740609) and was supported by a grant from the Fogarty International Center of the National Institutes of Health, "Research Training Program on the Impact of Zoonotic and Vectorborne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses" (grant D43TW010331). We must thank Alejandra Cedeno, Stefanny Diaz and Claudia Cuervo for their contributions during different study phases. We acknowledge Dr. David H. Walker for their valuable contributions through manuscript editing. Finally, we acknowledge Pontificia Universidad Javeriana and University of Caldas for physical and human resources provided.	Abramowicz KF, 2012, MED VET ENTOMOL, V26, P458, DOI 10.1111/j.1365-2915.2012.01017.x; Acosta Roxana, 2003, Acta Zool. Mex, P39; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; ADAMS WH, 1970, AM J TROP MED HYG, V19, P311, DOI 10.4269/ajtmh.1970.19.311; Aung AK, 2014, AM J TROP MED HYG, V91, P451, DOI 10.4269/ajtmh.14-0191; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Badiaga S, 2012, COMP IMMUNOL MICROB, V35, P39, DOI 10.1016/j.cimid.2011.09.008; Bicho C. L., 1998, Revista Brasileira de Parasitologia Veterinaria, V7, P47; Billeter SA, 2017, J MED ENTOMOL, V54, P4, DOI 10.1093/jme/tjw179; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Blanton LS, 2019, VECTOR-BORNE ZOONOT, V19, P637, DOI 10.1089/vbz.2018.2428; Blanton LS, 2017, AM J TROP MED HYG, V96, P53, DOI 10.4269/ajtmh.16-0537; Blanton LS, 2016, AM J TROP MED HYG, V95, P457, DOI 10.4269/ajtmh.16-0197; Blanton LS, 2015, EMERG INFECT DIS, V21, P484, DOI 10.3201/eid2103.140716; Bolanos-Rivero M, 2011, INT J INFECT DIS, V15, pE481, DOI 10.1016/j.ijid.2011.03.019; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Brown Lisa D, 2016, Curr Trop Med Rep, V3, P27; Capelli G, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S8; Chaliotis G, 2012, INT J INFECT DIS, V16, pE591, DOI 10.1016/j.ijid.2012.03.010; Christou C, 2010, AM J TROP MED HYG, V83, P1301, DOI 10.4269/ajtmh.2010.10-0118; Dall'Agnol B, 2017, ACTA TROP, V167, P18, DOI 10.1016/j.actatropica.2016.12.008; de Sousa R, 2006, AM J TROP MED HYG, V75, P727, DOI 10.4269/ajtmh.2006.75.727; Denisov GA, 2004, Google Patents, Patent No. [US6681186B1, 6681186]; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Faccini-Martinez AA, 2016, VECTOR-BORNE ZOONOT, V16, P85, DOI 10.1089/vbz.2015.1841; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Gikas A, 2009, CLIN MICROBIOL INFEC, V15, P211, DOI 10.1111/j.1469-0691.2008.02133.x; Gillespie JJ, 2015, GENOME BIOL EVOL, V7, P35, DOI 10.1093/gbe/evu262; Hidalgo M, 2008, AM J TROP MED HYG, V78, P321, DOI 10.4269/ajtmh.2008.78.321; Hidalgo M, 2013, VECTOR-BORNE ZOONOT, V13, P289, DOI 10.1089/vbz.2012.1173; Horta MC, 2014, AM J TROP MED HYG, V91, P96, DOI 10.4269/ajtmh.13-0699; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; Jima DD, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00018-15; Jones SL, 2004, MED J AUSTRALIA, V180, P482, DOI 10.5694/j.1326-5377.2004.tb06032.x; Kamani J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002246; Kho KL, 2018, J MED ENTOMOL, V56, P526; Kim BJ, 2013, VECTOR-BORNE ZOONOT, V13, P457, DOI 10.1089/vbz.2012.1115; Kitts PA, 2016, NUCLEIC ACIDS RES, V44, pD73, DOI 10.1093/nar/gkv1226; Kocher C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004843; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Legendre KP, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2040064; Leulmi H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003152; Loftis AD, 2006, AM J TROP MED HYG, V75, P41, DOI 10.4269/ajtmh.2006.75.41; Loyola S, 2018, EMERG INFECT DIS, V24, P931, DOI 10.3201/eid2405.170323; Luce-Fedrow A, 2015, VECTOR-BORNE ZOONOT, V15, P268, DOI 10.1089/vbz.2014.1744; Maina AN, 2016, INT J SYST EVOL MICR, V66, P4512, DOI 10.1099/ijsem.0.001382; Mediannikov O., 2015, New Microbes and New Infections, V3, P24, DOI 10.1016/j.nmni.2014.10.005; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Oteo JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0455-0; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; PATINO-CAMARGO Luis, 1942, Revista de la Facultad de Medicina, V11, P13; Ramirez-Hernandez A, 2013, AM J TROP MED HYG, V89, P453, DOI 10.4269/ajtmh.12-0698; Reeves WK, 2005, J VECTOR ECOL, V30, P310; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Silva AB, 2017, ACTA TROP, V172, P44, DOI 10.1016/j.actatropica.2017.04.004; Spitalska E, 2015, PARASITOL RES, V114, P4333, DOI 10.1007/s00436-015-4713-7; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wall R., 2001, VET ECTOPARASITES BI; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x	64	2	2	1	2	J INFECTION DEVELOPING COUNTRIES	TRAMANIGLIO	JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY	1972-2680			J INFECT DEV COUNTR	J. Infect. Dev. Ctries.	OCT	2020	14	10					1155	+		10.3855/jidc.12524	http://dx.doi.org/10.3855/jidc.12524			11	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	OS6HJ	33175711	gold			2022-09-04	WOS:000590262200014
J	Corredor-Acosta, A; Cortes-Chong, N; Acosta, A; Pizarro-Koch, M; Vargas, A; Medellin-Mora, J; Saldias, GS; Echeverry-Guerra, V; Gutierrez-Fuentes, J; Betancur-Turizo, S				Corredor-Acosta, Andrea; Cortes-Chong, Nayade; Acosta, Alberto; Pizarro-Koch, Matias; Vargas, Andres; Medellin-Mora, Johanna; Saldias, Gonzalo S.; Echeverry-Guerra, Valentina; Gutierrez-Fuentes, Jairo; Betancur-Turizo, Stella			Spatio-Temporal Variability of Chlorophyll-A and Environmental Variables in the Panama Bight	REMOTE SENSING			English	Article						satellite chlorophyll-a; nutrients; sea surface temperature; photosynthetically available radiation; geostrophic circulation; wind stress; Ekman pumping; Panama Bight	EASTERN TROPICAL PACIFIC; OCEAN-COLOR; EL-NINO; PHYTOPLANKTON PHENOLOGY; MEDITERRANEAN SEA; RIVER PLUMES; MIXED-LAYER; TEMPERATURE; SHELF; SIZE	The analysis of synoptic satellite data of total chlorophyll-a (Chl-a) and the environmental drivers that influence nutrient and light availability for phytoplankton growth allows us to understand the spatio-temporal variability of phytoplankton biomass. In the Panama Bight Tropical region (PB; 1-9 degrees N, 79-84 degrees W), the spatial distribution of Chl-a is mostly related to the seasonal wind patterns and the intensity of localized upwelling centers. However, the association between the Chl-a and different physical variables and nutrient availability is still not fully assessed. In this study, we evaluate the relationship between the Chl-a and multiple physical (wind, Ekman pumping, geostrophic circulation, mixed layer depth, sea level anomalies, river discharges, sea surface temperature, and photosynthetically available radiation) and chemical (nutrients) drivers in order to explain the spatio-temporal Chl-a variability in the PB. We used satellite data of Chl-a and physical variables, and a re-analysis of a biogeochemical product for nutrients (2002-2016). Our results show that at the regional scale, the Chl-a varies seasonally in response to the wind forcing and sea surface temperature. However, in the coastal areas (mainly Gulf of Panama and off central-southern Colombia), the maximum non-seasonal Chl-a values are found in association with the availability of nutrients by river discharges, localized upwelling centers and the geostrophic circulation field. From this study, we infer that the interplay among these physical-chemical drivers is crucial for supporting the phytoplankton growth and the high biodiversity of the PB region.	[Corredor-Acosta, Andrea; Saldias, Gonzalo S.] Ctr FONDAP Invest Dinam Ecosistemas Marinos Altas, Valdivia 5110566, Chile; [Corredor-Acosta, Andrea; Saldias, Gonzalo S.] Univ Bio Bio, Dept Fis, Fac Ciencias, Concepcion 4051381, Chile; [Cortes-Chong, Nayade; Acosta, Alberto; Echeverry-Guerra, Valentina] Pontificia Univ Javeriana, Unidad Ecol & Sistemat UNESIS, Dept Biol, Bogota 110231, Colombia; [Pizarro-Koch, Matias; Medellin-Mora, Johanna] Univ Concepcion, Inst Milenio Oceanog, Dept Oceanog, Concepcion 4030000, Chile; [Pizarro-Koch, Matias] Univ Concepcion, Programa Postgrad Oceanog, Dept Oceanog, Fac Ciencias Nat &Oceanog, Concepcion 4030000, Chile; [Vargas, Andres] Pontificia Univ Javeriana, Dept Matemat, Bogota 110231, Colombia; [Medellin-Mora, Johanna] Ecoreef Ltda, Dept Invest Innovac & Desarrollo, Calle 174A 49B-46, Bogota 111166, Colombia; [Gutierrez-Fuentes, Jairo] Inst Fomento Pesquero, Blanco 839, Valparaiso 2340000, Chile; [Betancur-Turizo, Stella] Ctr Invest Oceanog & Hidrog CIOH, Area Protecc Medio Marino, Cartagena 130001, Colombia		Corredor-Acosta, A (corresponding author), Ctr FONDAP Invest Dinam Ecosistemas Marinos Altas, Valdivia 5110566, Chile.; Corredor-Acosta, A (corresponding author), Univ Bio Bio, Dept Fis, Fac Ciencias, Concepcion 4051381, Chile.	gsaldias@ubiobio.cl; cortes.nayade@javeriana.edu.co; laacosta@javeriana.edu.co; matiaspizarro@udec.cl; a.vargasd@javeriana.edu.co; johanna.medellin@imo-chile.cl; gsaldias@ubiobio.cl; vecheverry@javeriana.edu.co; jairo.gutierrez@ifop.cl; sbetancur@dimar.mil.co		Betancur-Turizo, Stella Patricia/0000-0002-3440-9184; Medellin, Johanna/0000-0003-4864-1694; Acosta, Alberto/0000-0001-9269-1547; Echeverry-Guerra, Valentina/0000-0003-2836-8942	Pontificia Universidad Javeriana, Bogota, Colombia [PRY 8891]; FONDAP IDEAL [15150003]; FONDECYT [1190805]; Millennium Nucleus Center for the Study of Multiple Drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON [NC120028]	Pontificia Universidad Javeriana, Bogota, Colombia; FONDAP IDEAL; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus Center for the Study of Multiple Drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON	This research was funded by the Pontificia Universidad Javeriana, Bogota, Colombia (ID PRY 8891). A.C.-A. has been supported by FONDAP IDEAL (Program 15150003). G.S.S. has been partially supported by FONDECYT 1190805 and the Millennium Nucleus Center for the Study of Multiple Drivers on Marine Socio-Ecological Systems (MUSELS) funded by MINECON NC120028.	Akaike H, 1973, P 2 INT S INFORM THE; Amador JA, 2006, PROG OCEANOGR, V69, P101, DOI 10.1016/j.pocean.2006.03.007; Anderson M.J., 2008, GUIDE SOFTWARE STAT; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Atlas R, 2011, B AM METEOROL SOC, V92, P157, DOI 10.1175/2010BAMS2946.1; Aurin D, 2013, REMOTE SENS ENVIRON, V137, P212, DOI 10.1016/j.rse.2013.06.018; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Bellacicco M, 2016, REMOTE SENS ENVIRON, V184, P595, DOI 10.1016/j.rse.2016.08.004; Brewin RJW, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00104; Brewin RJW, 2015, REMOTE SENS ENVIRON, V168, P437, DOI 10.1016/j.rse.2015.07.004; Castillo F.A., 1992, B CIENT CIOH, P13, DOI 10.26640/22159045.47; CCCP, 2002, COMP OC CUENC PAC CO, P1; Chelton DB, 2000, MON WEATHER REV, V128, P1993, DOI 10.1175/1520-0493(2000)128<1993:SOOTWJ>2.0.CO;2; Chin TM, 2017, REMOTE SENS ENVIRON, V200, P154, DOI 10.1016/j.rse.2017.07.029; Christian JR, 2001, DEEP-SEA RES PT II, V49, P509; Clarke AJ, 2014, ANNU REV MAR SCI, V6, P79, DOI 10.1146/annurev-marine-010213-135026; Clarke K, 2006, GETTING STARTED PRIM; Corredor-Acosta A, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060834; Corredor-Acosta A, 2015, J GEOPHYS RES-OCEANS, V120, P813, DOI 10.1002/2014JC010330; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; DeMaster DJ, 2019, ENCYCLOPEDIA OF OCEAN SCIENCES, VOL 1: MARINE BIOGEOCHEMISTRY, 3RD EDITION, P473, DOI 10.1016/B978-0-12-409548-9.10799-7; Devis-Morales A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035172; Dominguez-Hernandez G, 2020, ADV SPACE RES, V65, P2595, DOI 10.1016/j.asr.2020.02.019; ECMWF, COP PROD QUAL ASS RE; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Garcia CAE, 2008, CONT SHELF RES, V28, P1568, DOI 10.1016/j.csr.2007.08.010; Gierach MM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051103; Halsey KH, 2015, ANNU REV MAR SCI, V7, P265, DOI 10.1146/annurev-marine-010814-015813; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Hopkinson BM, 2008, LIMNOL OCEANOGR, V53, P1303, DOI 10.4319/lo.2008.53.4.1303; INVEMAR-ANH Especies, 2010, ENS PAIS BLOQ MAR SU, P226; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Johnson GC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007651; Kessler WS, 2002, J PHYS OCEANOGR, V32, P2457, DOI 10.1175/1520-0485-32.9.2457; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; Legendre, 2012, NUMERICAL ECOLOGY, P512; Levy M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07059-3; LONSDALE P, 1977, DEEP-SEA RES, V24, P1065, DOI 10.1016/0146-6291(77)90514-8; Mahadevan A, 2016, ANNU REV MAR SCI, V8, P161, DOI 10.1146/annurev-marine-010814-015912; Maranon E., 2009, PHYTOPLANKTON SIZE S, P1; Maranon E, 2018, ISME J, V12, P1836, DOI 10.1038/s41396-018-0105-1; Marrari M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00372; McGillicuddy DJ, 2016, ANNU REV MAR SCI, V8, P125, DOI 10.1146/annurev-marine-010814-015606; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Messie M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007938; Milliman J.D., 2011, RIVER DISCHARGE COAS, V1, P384; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Montagnes DJS, 2001, LIMNOL OCEANOGR, V46, P2008, DOI 10.4319/lo.2001.46.8.2008; Navarra A, 2010, GUIDE TO EMPIRICAL ORTHOGONAL FUNCTIONS FOR CLIMATE DATA ANALYSIS, P107, DOI 10.1007/978-90-481-3702-2_7; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; Poveda G, 2000, GEOPHYS RES LETT, V27, P1675, DOI 10.1029/1999GL006091; POVEDA G, 1999, REV ACAD COLOMB CIEN, V23, P517; Racault MF, 2017, SURV GEOPHYS, V38, P277, DOI 10.1007/s10712-016-9391-1; Racault MF, 2014, J PLANKTON RES, V36, P621, DOI 10.1093/plankt/fbu016; Racault MF, 2012, ECOL INDIC, V14, P152, DOI 10.1016/j.ecolind.2011.07.010; Radenac MH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007841; Radenac MH, 2001, J GEOPHYS RES-OCEANS, V106, P26879, DOI 10.1029/2000JC000546; Ramirez Diego G., 2006, Investigaciones Marinas Universidad Catolica de Valparaiso, V34, P211; Restrepo J., 2006, B CIENTIFICO CCCP, V13, P17; Restrepo JD, 2004, ENVIRONM SCI, P169; Rivera-Gomez M, 2019, J EXP MAR BIOL ECOL, V516, P1, DOI 10.1016/j.jembe.2019.04.002; Rodriguez-Rubio E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016794; Rodriguez-Rubio E, 2002, P INDIAN AS-EARTH, V111, P227; Romero-Torres M, 2020, GLOBAL CHANGE BIOL, V26, P3880, DOI 10.1111/gcb.15126; Rueda O. A., 2006, METEOROL COL, P132; Saldias GS, 2016, PROG OCEANOGR, V146, P212, DOI 10.1016/j.pocean.2016.07.007; Salgado-Hernanz PM, 2019, REMOTE SENS ENVIRON, V221, P50, DOI 10.1016/j.rse.2018.10.036; Sathyendranath S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194285; Schmidtko S, 2013, J GEOPHYS RES-OCEANS, V118, P1658, DOI 10.1002/jgrc.20122; Sharma P, 2019, GEOPHYS RES LETT, V46, P5987, DOI 10.1029/2018GL080689; Sigman D.M., 2012, NAT ED KNOWL, V3, P1; Sogamoso E.A., 2008, B CIENTIFICO CCCP, V15, P105, DOI 10.26640/01213423.15.105_122; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tchantsev V., 1998, B CIENT CCCP, P7, DOI 10.26640/01213423.7.7_19; Tyrrell T, 2019, ENCYCLOPEDIA OF OCEAN SCIENCES, VOL 1: MARINE BIOGEOCHEMISTRY, 3RD EDITION, P461, DOI 10.1016/B978-0-12-409548-9.11281-3; Villegas N., 2016, REV MUTIS, V6, P82, DOI [10.21789/22561498.1153, DOI 10.21789/22561498.1153]; Wang CZ, 2000, J CLIMATE, V13, P488, DOI 10.1175/1520-0442(2000)013<0488:TENOER>2.0.CO;2; Ward BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135581; Willett CS, 2006, PROG OCEANOGR, V69, P218, DOI 10.1016/j.pocean.2006.03.010; Woods HA, 1999, AM ZOOL, V39, P244; WOOSTER WARREN S., 1959, BULL AMER MUS NAT HIST, V118, P113; Yokomizo H, 2010, THEOR ECOL-NETH, V3, P53, DOI 10.1007/s12080-009-0053-5; Zapata FA, 2007, J BIOGEOGR, V34, P38, DOI 10.1111/j.1365-2699.2006.01586.x	88	4	4	2	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-4292		REMOTE SENS-BASEL	Remote Sens.	JUL	2020	12	13							2150	10.3390/rs12132150	http://dx.doi.org/10.3390/rs12132150			26	Environmental Sciences; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Geology; Remote Sensing; Imaging Science & Photographic Technology	MT4QT		gold, Green Submitted			2022-09-04	WOS:000554957700001
J	Baig, MH; Rashid, I; Srivastava, P; Ahmad, K; Jan, AT; Rabbani, G; Choi, D; Barreto, GE; Ashraf, GM; Lee, EJ; Choi, I				Baig, Mohammad Hassan; Rashid, Iliyas; Srivastava, Prachi; Ahmad, Khurshid; Jan, Arif Tasleem; Rabbani, Gulam; Choi, Dukhwan; Barreto, George E.; Ashraf, Ghulam Md; Lee, Eun Ju; Choi, Inho			NeuroMuscleDB: a Database of Genes Associated with Muscle Development, Neuromuscular Diseases, Ageing, and Neurodegeneration	MOLECULAR NEUROBIOLOGY			English	Article						Database; Genes; Myogenesis; Skeletal muscle; Ageing; Neuromuscular dystrophies; Neurodegenerative disorders	SATELLITE CELLS; RESOURCES; AGE	Skeletal muscle is a highly complex, heterogeneous tissue that serves a multitude of biological functions in living organisms. With the advent of methods, such as microarrays, transcriptome analysis, and proteomics, studies have been performed at the genome level to gain insight of changes in the expression profiles of genes during different stages of muscle development and of associated diseases. In the present study, a database was conceived for the straightforward retrieval of information on genes involved in skeletal muscle formation, neuromuscular diseases (NMDs), ageing, and neurodegenerative disorders (NDs). The resulting database named NeuroMuscleDB (http://yu-mbl-muscledb.com/NeuroMuscleDB) is the result of a wide literature survey, database searches, and data curation. NeuroMuscleDB contains information of genes in Homo sapiens, Mus musculus, and Bos Taurus, and their promoter sequences and specified roles at different stages of muscle development and in associated myopathies. The database contains information on similar to 1102 genes, 6030 mRNAs, and 5687 proteins, and embedded analytical tools that can be used to perform tasks related to gene sequence usage. The authors believe NeuroMuscleDB provides a platform for obtaining desired information on genes related to myogenesis and their associations with various diseases (NMDs, ageing, and NDs). NeuroMuscleDB is freely available on the web at http://yu-mbl-muscledb.com/NeuroMuscleDB and supports all major browsers.	[Baig, Mohammad Hassan; Ahmad, Khurshid; Rabbani, Gulam; Choi, Dukhwan; Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Dept Med Biotechnol, Gyongsan 38541, South Korea; [Rashid, Iliyas; Srivastava, Prachi] Amity Univ, Amity Inst Biotechnol, Lucknow 226028, Uttar Pradesh, India; [Jan, Arif Tasleem] Baba Ghulam Shah Badshah Univ, Sch Biosci & Biotechnol, Rajouri 185236, India; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Lee, EJ; Choi, I (corresponding author), Yeungnam Univ, Dept Med Biotechnol, Gyongsan 38541, South Korea.	gorapadoc0315@hanmail.net; inhochoi@ynu.ac.kr	Rabbani, Gulam/AAE-5629-2022; Jan, Arif Tasleem/AAX-6531-2020; Ashraf, Ghulam Md/H-9485-2012; Rashid, Iliyas/AAW-9086-2020; Barreto, George E./AAD-7420-2020; Ahmad, Khurshid/M-4676-2014	Rabbani, Gulam/0000-0002-5293-8231; Jan, Arif Tasleem/0000-0002-3607-543X; Ashraf, Ghulam Md/0000-0002-9820-2078; Rashid, Iliyas/0000-0001-7186-8200; Barreto, George E./0000-0002-6644-1971; Ahmad, Khurshid/0000-0002-1095-8445; Baig, Mohd Hassan/0000-0001-8227-4838; Srivastava, Prachi/0000-0003-4138-5464	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1C1B1011478]; Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea [SF316001A]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (#2016R1C1B1011478) and by the Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do and Gyeongbuk Science and Technology Promotion Center of Korea (#SF316001A).	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; D'Alessandro A, 2013, J PROTEOMICS, V78, P558, DOI 10.1016/j.jprot.2012.10.023; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; GUNNING P, 1991, FASEB J, V5, P3064, DOI 10.1096/fasebj.5.15.1835946; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hocquette JF, 2007, ANIMAL, V1, P159, DOI 10.1017/S1751731107658042; Jan Arif Tasleem, 2016, Journal of Animal Science and Technology, V58, P18, DOI 10.1186/s40781-016-0100-x; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kaplan JC, 2015, NEUROMUSCULAR DISORD, V25, P991, DOI 10.1016/j.nmd.2015.10.010; Krauss RS, 2010, EXP CELL RES, V316, P3042, DOI 10.1016/j.yexcr.2010.05.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee EJ, 2016, FASEB J, V30, P2708, DOI 10.1096/fj.201500133R; Listrat Anne, 2016, ScientificWorldJournal, V2016, P3182746, DOI 10.1155/2016/3182746; Malik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133597; Manini TM, 2013, CURR OPIN CLIN NUTR, V16, P21, DOI 10.1097/MCO.0b013e32835b5880; Manzoni C, 2018, BRIEF BIOINFORM, V19, P286, DOI 10.1093/bib/bbw114; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Nagpure NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136711; Nagpure NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-630; Pinero J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav028; Rashid I, 2017, SCI REP-UK, V7, DOI 10.1038/srep42346; Sharma S, 2015, J FOOD SCI TECH MYS, V52, P7599, DOI 10.1007/s13197-015-1972-3; Skalsky AJ, 2012, PHYS MED REH CLIN N, V23, P675, DOI 10.1016/j.pmr.2012.06.009; Stelzer G, 2016, CURR PROTOC BIOINFOR, V54, DOI 10.1002/cpbi.5; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vigodarzere GC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00362; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zou D, 2015, GENOM PROTEOM BIOINF, V13, P55, DOI 10.1016/j.gpb.2015.01.006	39	7	7	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2019	56	8					5835	5843		10.1007/s12035-019-1478-5	http://dx.doi.org/10.1007/s12035-019-1478-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ1QK	30684219				2022-09-04	WOS:000475673100041
J	Bachurin, SO; Gavrilova, SI; Samsonova, A; Barreto, GE; Aliev, G				Bachurin, Sergey O.; Gavrilova, Svetlana I.; Samsonova, Anna; Barreto, George E.; Aliev, Gjumrakch			Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention (vol 129, pg 216, 2018)	PHARMACOLOGICAL RESEARCH			English	Correction									[Bachurin, Sergey O.; Samsonova, Anna; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Severny Pr 1, Chernogolovka 1142432, Moscow Region, Russia; [Gavrilova, Svetlana I.] Mental Hlth Res Ctr, 34 Kashirskoyeshosse, Moscow 115522, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Bachurin, SO (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Severny Pr 1, Chernogolovka 1142432, Moscow Region, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	bachurin@ipac.ac.ru; aliev03@gmail.com	Sergey, Bachurin/I-1708-2018; Barreto, George E./AAD-7420-2020; Gavrilova, Svetlana/B-4548-2016; Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020	Barreto, George E./0000-0002-6644-1971; Gavrilova, Svetlana/0000-0001-6683-0240; Aliev, Gjumrakch/0000-0001-7373-3182				Bachurin SO, 2018, PHARMACOL RES, V129, P216, DOI 10.1016/j.phrs.2017.11.021	1	0	0	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	JUN	2018	132						245	245		10.1016/j.phrs.2018.03.006	http://dx.doi.org/10.1016/j.phrs.2018.03.006			1	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GL1ZY	29555151				2022-09-04	WOS:000436914000026
J	Pizarro, V; Rodriguez, SC; Lopez-Victoria, M; Zapata, FA; Zea, S; Galindo-Martinez, CT; Iglesias-Prieto, R; Pollock, J; Medina, M				Pizarro, Valeria; Rodriguez, Sara C.; Lopez-Victoria, Mateo; Zapata, Fernando A.; Zea, Sven; Galindo-Martinez, Claudia T.; Iglesias-Prieto, Roberto; Pollock, Joseph; Medina, Monica			Unraveling the structure and composition of Varadero Reef, an improbable and imperiled coral reef in the Colombian Caribbean	PEERJ			English	Article						Caribbean coral reefs; Coral reef biodiversity; Reef dredging; Paradoxical reef; Resistance	NUTRIENT ENRICHMENT; ENVIRONMENTS; ECOSYSTEMS; AUSTRALIA; PATTERNS; COASTAL	Coral reefs are commonly associated with oligotrophic, well-illuminated waters. In 2013, a healthy coral reef was discovered in one of the least expected places within the Colombian Caribbean: at the entrance of Cartagena Bay, a highly-polluted system that receives industrial and sewage waste, as well as high sediment and freshwater loads from an outlet of the Magdalena River (the longest and most populated river basin in Colombia). Here we provide the first characterization of Varadero Reef's geomorphology and biological diversity. We also compare these characteristics with those of a nearby reference reef, Baru Reef, located in an area much less influenced by the described polluted system. Below the murky waters, we found high coral cover of 45.1% (+/- 3.9; up to 80% in some sectors), high species diversity, including 42 species of scleractinian coral, 38 of sponge, three of lobster, and eight of sea urchin; a fish community composed of 61 species belonging to 24 families, and the typical zonation of a Caribbean fringing reef. All attributes found correspond to a reef that, according to current standards should be considered in "good condition''. Current plans to dredge part of Varadero threaten the survival of this reef. There is, therefore, an urgent need to describe the location and characteristics of Varadero as a first step towards gaining acknowledgement of its existence and garnering inherent legal and environmental protections.	[Pizarro, Valeria] Ecomares NGO, Cali, Valle, Colombia; [Rodriguez, Sara C.; Lopez-Victoria, Mateo] Pontifica Univ Javeriana, Dept Nat Sci & Math, Cali, Valle, Colombia; [Zapata, Fernando A.] Univ Valle, Dept Biol, Cali, Valle, Colombia; [Zea, Sven] Univ Nacl Colombia, Ctr Estudios Ciencias Mar CECIMAR, Sede Caribe, Santa Marta, Magdalena, Colombia; [Galindo-Martinez, Claudia T.; Iglesias-Prieto, Roberto; Pollock, Joseph; Medina, Monica] Penn State Univ, Dept Biol, State Coll, PA USA		Pizarro, V (corresponding author), Ecomares NGO, Cali, Valle, Colombia.	valeria.pizarro@ecomares.org		Galindo-Martinez, Claudia Tatiana/0000-0001-5238-3099; Pollock, Joseph/0000-0001-5467-8499	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation for the project "Coral robustness: lessons from an 'improbable' reef". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado E.M., 2011, FORMACIONES ARRECIFA; Andersen Per K, 2012, STAT MODELS BASED CO; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Bayraktarov E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080536; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Burke L., 2011, REEFS RISK REVISITED; Restrepo JC, 2017, J COASTAL RES, V33, P135, DOI 10.2112/JCOASTRES-D-15-00185.1; Chaves-Fonnegra Andia, 2007, Bol. Invest. Mar. Cost., V36, P63; Claro Rodolfo, 2003, Atoll Research Bulletin, V496, P278; de Bakker DM, 2017, CORAL REEFS, V36, P355, DOI 10.1007/s00338-016-1534-9; Diaz JM, 2000, AREAS CORALINAS COL3; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geister J., 1977, Proceedings int Coral Reef Symp, V3, P23; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081172; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Martinez JI, 2010, J S AM EARTH SCI, V29, P214, DOI 10.1016/j.jsames.2009.08.010; Inoue S, 2013, NATURE CLIMATE CHANG, V3, P638, DOI [10.1038/ndimate1892, DOI 10.1038/NDIMATE1892]; Jackson J.B.C., 2014, STATUS TRENDS CARIBB; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P100; LIDDELL WD, 1987, B MAR SCI, V40, P311; Lonin S, 2004, B CIENTIFICO CIOH, V22, P77, DOI DOI 10.26640/22159045.130; Lopez-Victoria M, 2015, CORAL REEFS, V34, P231, DOI 10.1007/s00338-014-1246-y; Malaio R, 2008, MAR BIOL, V154, P841, DOI [10.1007/s00227-008-0977-0, DOI 10.1007/S00227-008-0977-0]; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mogollon JV, 2013, CANAL DIQUE HIST DEA; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pattengill-Semmens Christy V., 2003, Atoll Research Bulletin, V496, P226; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Pollock FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102498; Restrepo JD, 2006, GLOBAL PLANET CHANGE, V50, P33, DOI 10.1016/j.gloplacha.2005.09.002; Rezai Hamid, 2004, P155; Riegl B.M., 2012, CORAL REEFS GULF, V3, P1, DOI DOI 10.1007/978-94-007-3008-3_1; Roberts DA, 2012, ENVIRON INT, V40, P230, DOI 10.1016/j.envint.2011.11.013; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Santodomingo N, 2013, MAR BIODIVERS, V43, P7, DOI 10.1007/s12526-012-0131-6; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Smithers S, 2003, CORAL REEFS, V22, P499, DOI 10.1007/s00338-003-0344-z; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Valderrama Diego, 2003, Bol. Invest. Mar. Cost., V32, P37; Van Oppen MJH, 2017, GLOBAL CHANGE BIOL, V23, P3437, DOI 10.1111/gcb.13647; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006; Wenger AS, 2017, FISH FISH, V18, P967, DOI 10.1111/faf.12218; Wilkinson C., 2008, STATUS CORAL REEFS W; Zea S., 2001, REV ACAD COLOMB CIEN, V25, P597; Zea S., 1987, CATALOGO CIENTIFICO, P1; Zea S, 2014, SPONGE GUIDE PICTURE	58	14	15	0	8	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	DEC 14	2017	5								e4119	10.7717/peerj.4119	http://dx.doi.org/10.7717/peerj.4119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6EN	29259841	Green Submitted, gold, Green Published			2022-09-04	WOS:000418456700001
J	Delgado-Serrano, MD; Vanwildemeersch, P; London, S; Ortiz-Guerrero, CE; Semerena, RE; Rojas, M				del Mar Delgado-Serrano, Maria; Vanwildemeersch, Pieter; London, Silvia; Ortiz-Guerrero, Cesar E.; Escalante Semerena, Roberto; Rojas, Mara			Adapting prospective structural analysis to strengthen sustainable management and capacity building in community-based natural resource management contexts	ECOLOGY AND SOCIETY			English	Article						Argentina; Colombia; Latin America; local knowledge; Mexico; participatory techniques; social-ecological systems; strategic foresight	SOCIAL-ECOLOGICAL-SYSTEMS; ENVIRONMENTAL-MANAGEMENT; FRAMEWORK; ADAPTATION; KNOWLEDGE; FISHERIES; ACTORS	Local communities collectively managing common pool resources can play an important role in sustainable management, but they often lack the skills and context-specific tools required for such management. The complex dynamics of social-ecological systems (SES), the need for management capacities, and communities' limited empowerment and participation skills present challenges for community-based natural resource management (CBNRM) strategies. We analyzed the applicability of prospective structural analysis (PSA), a strategic foresight tool, to support decision making and to foster sustainable management and capacity building in CBNRM contexts and the modifications necessary to use the tool in such contexts. By testing PSA in three SES in Colombia, Mexico, and Argentina, we gathered information regarding the potential of this tool and its adaptation requirements. The results suggest that the tool can be adapted to these contexts and contribute to fostering sustainable management and capacity building. It helped identify the systems' dynamics, thus increasing the communities' knowledge about their SES and informing the decision-making process. Additionally, it drove a learning process that both fostered empowerment and built participation skills. The process demanded both time and effort, and required external monitoring and facilitation, but community members could be trained to master it. Thus, we suggest that the PSA technique has the potential to strengthen CBNRM and that other initiatives could use it, but they must be aware of these requirements.	[del Mar Delgado-Serrano, Maria; Vanwildemeersch, Pieter] Univ Cordoba, Dept Agr Econ Sociol & Policy, E-14071 Cordoba, Spain; [London, Silvia; Rojas, Mara] UNS CONICET, IIESS, Bahia Blanca, Buenos Aires, Argentina; [London, Silvia; Rojas, Mara] UNS, Dept Econ, Bahia Blanca, Buenos Aires, Argentina; [Ortiz-Guerrero, Cesar E.] Pontificia Univ Javeriana, Bogota, Colombia; [Escalante Semerena, Roberto] Univ Nacl Autonoma Mexico, Fac Econ, Mexico City, DF, Mexico		Delgado-Serrano, MD (corresponding author), Univ Cordoba, Dept Agr Econ Sociol & Policy, E-14071 Cordoba, Spain.		del mar delgado-serrano, maria/B-7581-2011	del mar delgado-serrano, maria/0000-0003-0171-6097; London, Silvia/0000-0002-4597-0233	Seventh Framework Program of the European Commission in the frame of the Project "Community-based management of environmental challenges in Latin America" [FP7-ENV2011-282845 COMET-LA]	Seventh Framework Program of the European Commission in the frame of the Project "Community-based management of environmental challenges in Latin America"	To Manolo Delgado dagger, whose support and inspiration made the impossible possible. This research has been financed by the Seventh Framework Program of the European Commission in the frame of the Project "Community-based management of environmental challenges in Latin America" (FP7-ENV2011-282845 COMET-LA). Authors are very grateful to all the researchers, community members, and stakeholders in Colombia, Mexico, and Argentina who have collaborated in this research, especially to M<SUP>a</SUP> Adelaida Farah, Diana Maya, Pablo Ramos, Bryann Avendano, and Lina Pinzon, for their support in the Colombian methodological development and fieldwork. Authors also recognized the contributions of the anonymous reviewers and subject editors to improve the manuscript.	AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Anderies JM, 2004, ECOL SOC, V9; Arcade J., 1992, STRUCTURAL ANAL MICM; Armitage D, 2005, ENVIRON MANAGE, V35, P703, DOI 10.1007/s00267-004-0076-z; Avendano B., 2013, STAKEHOLDER VISION P; Benassouli P., 2005, REV FUTURIBLES, V203, P37; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.2307/2641280; Berkes F., 1998, LINKING SOCIAL ECOLO; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Brondizio ES, 2009, ANNU REV ENV RESOUR, V34, P253, DOI 10.1146/annurev.environ.020708.100707; Chapuy P, 2010, TECHNOL FORECAST SOC, V77, P1540, DOI 10.1016/j.techfore.2010.06.025; Cox M, 2010, ECOL SOC, V15; Davidson-Hunt IJ, 2007, SOC NATUR RESOUR, V20, P291, DOI 10.1080/08941920601161312; De Jouvenel H., 1994, CATALOGNE HORIZON 20; Delgado-Serrano MD, 2015, CUAD DESARRO RURAL, V12, P35, DOI 10.11144/Javeriana.cdr12-76.epsa; Delgado-Serrano MD, 2015, ECOL SOC, V20, DOI 10.5751/ES-07965-200424; Delgado-Serrano MD, 2015, INT J COMMONS, V9, P808, DOI 10.18352/ijc.567; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Escalante Semerena R. I., 2013, STAKEHOLDER VISION P; European Commission, 2014, EUR FOR PLATF; Fabricius C., 2007, Water Policy, V9, P83; Fabricius C, 2007, ECOL SOC, V12; Flannery Tim, 2006, WEATHER MAKERS MAN I; GODET M, 1986, FUTURES, V18, P134, DOI 10.1016/0016-3287(86)90094-7; Godet M, 1994, ANTICIPATION ACTION, P83; Godet M., 2001, CREATING FUTURES SCE; Gomez-Limon JA, 2009, FUTURES, V41, P313, DOI 10.1016/j.futures.2008.11.007; Huntington HP, 2002, ENVIRON MANAGE, V30, P778, DOI 10.1007/s00267-002-2749-9; Kelly R., 2004, Foresight, V6, P80, DOI 10.1108/14636680410537547; Lafourcade B, 2000, TECHNOL FORECAST SOC, V65, P67, DOI 10.1016/S0040-1625(99)00128-6; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Constantino PDL, 2012, ECOL SOC, V17, DOI 10.5751/ES-05164-170422; London S., 2013, STAKEHOLDER VISION P; London S., 2015, INT ASS FUZZY SET MA; Luttrell W, 2010, VISUAL STUD, V25, P224, DOI 10.1080/1472586X.2010.523274; MAYERS J, 2005, POWER TOOL SERIES; MEA (Millennium Ecosystem Assessment), 2005, EC HUM WELL BEING; Murphree M., 1993, INT I ENV DEV GAT SE, V36; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Ostrom Elinor, 2007, ANN M AM ASS ADV SCI; Parrott L, 2012, ECOL SOC, V17, DOI 10.5751/ES-04936-170332; Raymond CM, 2010, J ENVIRON MANAGE, V91, P1766, DOI 10.1016/j.jenvman.2010.03.023; Reed MS, 2007, LAND DEGRAD DEV, V18, P249, DOI 10.1002/ldr.777; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Shackleton CM, 2010, ENVIRON CONSERV, V37, P1, DOI 10.1017/S0376892910000366; Soviana S, 2013, INT J ENVIRON SUSTAI, V12, P86, DOI 10.1504/IJESD.2013.051731; Stratigea A., 2013, J MANAGEMENT STRATEG, V4, P1, DOI DOI 10.5430/JMS.V4N2P1; Stringer L. C., 2006, ECOLOGY SOC, V11, P22, DOI [10.5751/ES-01896-110239, DOI 10.5751/ES-01896-110239]; Trimble M, 2013, J ENVIRON MANAGE, V128, P768, DOI 10.1016/j.jenvman.2013.06.032; Van Laerhoven F, 2014, COMMUNITY DEV J, V49, pI118, DOI 10.1093/cdj/bsu005; Waylen KA, 2015, ECOL SOC, V20, DOI 10.5751/ES-07926-200428; Wiber M, 2009, MAR POLICY, V33, P172, DOI 10.1016/j.marpol.2008.05.009	54	13	15	0	22	RESILIENCE ALLIANCE	WOLFVILLE	ACADIA UNIV, BIOLOGY DEPT, WOLFVILLE, NS B0P 1X0, CANADA	1708-3087			ECOL SOC	Ecol. Soc.		2016	21	2							36	10.5751/ES-08505-210236	http://dx.doi.org/10.5751/ES-08505-210236			13	Ecology; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	DR6ZF		Green Published, Green Submitted, gold			2022-09-04	WOS:000380049100045
J	Rodriguez-Leguizamon, G; Fiori, A; Lopez, LF; Gomez, BL; Parra-Giraldo, CM; Gomez-Lopez, A; Suarez, CF; Ceballos, A; Van Dijck, P; Patarroyo, MA				Rodriguez-Leguizamon, Giovanni; Fiori, Alessandro; Lopez, Luisa F.; Gomez, Beatriz L.; Parra-Giraldo, Claudia M.; Gomez-Lopez, Arley; Suarez, Carlos F.; Ceballos, Andres; Van Dijck, Patrick; Patarroyo, Manuel A.			Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogota, Colombia	BMC MICROBIOLOGY			English	Article						Candida albicans/Candida africana; Atypical Candida albicans; MALDI TOF-MS; Chlamydospores	DESORPTION IONIZATION-TIME; MASS-SPECTROMETRY; MOLECULAR CHARACTERIZATION; AFRICANA; DUBLINIENSIS; IDENTIFICATION; EPIDEMIOLOGY; YEASTS; PREVALENCE; SUSCEPTIBILITY	Background: Candida species are the most frequently found fungal pathogens causing nosocomial disease in a hospital setting. Such species must be correctly identified to ensure that appropriate control measures are taken and that suitable treatment is given for each species. Candida albicans is causing most fungal disease burden worldwide; the challenge lies in differentiating it from emerging atypical, minor and related species such as Candida dubliniensis and Candida africana. The purpose of this study was to compare identification based on MALDI-TOF MS to standard identification systems using a set of nosocomial isolates. Methods: Eleven nosocomial samples were collected from 6 third-level hospitals in Bogota, Colombia. All the samples were identified by combining MALDI-TOF MS with morphological characters, carbohydrate assimilation and molecular markers (D1/D2 and HWP1). Results: The present work describes the first collection of atypical Colombian Candida clinical isolates; these were identified as Candida albicans/Candida africana by their MALDI-TOF MS profile. Phenotypical characteristics showed that they were unable to produce chlamydospores, assimilate trehalose, glucosamine, N-acetyl-glucosamine and barely grew at 42 degrees C, as would be expected for Candida africana. The molecular identification of the D1/D2 region of large subunit ribosomal RNA and HWP1 hyphal cell wall protein 1 sequences from these isolates was consistent with those for Candida albicans. The mass spectra obtained by MALDI-TOF MS were analysed by multi-dimensional scaling (MDS) and cluster analysis, differences being revealed between Candida albicans, Candida africana, Candida dubliniensis reference spectra and two clinical isolate groups which clustered according to the clinical setting, one of them being clearly related to C. albicans. Conclusion: This study highlights the importance of using MALDI-TOF MS in combination with morphology, substrate assimilation and molecular markers for characterising Candida albicans-related and atypical C. albicans species, thereby overcoming conventional identification methods. This is the first report of hospital-obtained isolates of this type in Colombia; the approach followed might be useful for gathering knowledge regarding local epidemiology which could, in turn, have an impact on clinical management. The findings highlight the complexity of distinguishing between typical and atypical Candida albicans isolates in hospitals.	[Rodriguez-Leguizamon, Giovanni; Gomez, Beatriz L.; Suarez, Carlos F.; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Rodriguez-Leguizamon, Giovanni; Fiori, Alessandro; Van Dijck, Patrick] VIB Dept Mol Microbiol, Leuven, Belgium; [Rodriguez-Leguizamon, Giovanni; Fiori, Alessandro; Van Dijck, Patrick] KU Leuven Lab Mol Cell Biol, Leuven, Belgium; [Lopez, Luisa F.; Gomez, Beatriz L.] CIB, Med & Expt Mycol Unit, Medellin, Colombia; [Parra-Giraldo, Claudia M.; Ceballos, Andres] Pontificia Univ Javeriana, Dept Microbiol, Infect Dis Res Grp, Bogota, Colombia; [Gomez-Lopez, Arley; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Suarez, Carlos F.] Fdn Inst Inmunol Colombia FIDIC, Dept Biomath, Bogota, Colombia		Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia.	mapatarr.fidic@gmail.com	Martínez, Carlos Fernando Suárez/ABH-7784-2020; Patarroyo, Manuel A/I-8046-2016; Giraldo, Claudia Marcela Parra/AAG-3047-2019; Suárez Martínez, Carlos/L-9787-2016; CEBALLOS, Andres/AAN-8908-2021; Rodriguez-Leguizamon, Giovanni/J-6027-2016; Gomez, Beatriz L./D-2612-2018	Martínez, Carlos Fernando Suárez/0000-0001-8423-408X; Patarroyo, Manuel A/0000-0002-4751-2500; Giraldo, Claudia Marcela Parra/0000-0003-1302-5429; Suárez Martínez, Carlos/0000-0001-8423-408X; CEBALLOS, Andres/0000-0003-2129-1399; Rodriguez-Leguizamon, Giovanni/0000-0002-5683-8414; Gomez, Beatriz L./0000-0002-6641-1924; Ceballos-Garzon, Andres/0000-0002-0743-6857	Erasmus Mundus Eracol programme; KU Leuven Research Fund; Fund for Scientific Research Flanders [FWO WO.026.11 N, G.0804.11]; Universidad del Rosario; Fundacion Instituto de Inmunologia de Colombia (FIDIC)	Erasmus Mundus Eracol programme; KU Leuven Research Fund(KU Leuven); Fund for Scientific Research Flanders(FWO); Universidad del Rosario; Fundacion Instituto de Inmunologia de Colombia (FIDIC)	This work was financed by the Erasmus Mundus Eracol programme, by the KU Leuven Research Fund, by the Fund for Scientific Research Flanders (FWO WO.026.11 N and G.0804.11), by the Universidad del Rosario and by the Fundacion Instituto de Inmunologia de Colombia (FIDIC). We greatly acknowledge technical-scientific support from the Fundacion Instituto de Inmunologia de Colombia (FIDIC) and Anna Kolecka and Teun Boekhout at CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands, for carrying out and analysing the MALDI spectra and their productive comments. We would like to thank Ilse Palmans, Marina Munoz and Diego Garzon for their technical support, Edna Zamora from the Unidad de Investigacion en Proteomica y Micosis Humanas, Pontificia Universidad Javeriana and the Grupo de Investigacion en Micosis Humanas del Hospital Universitario San Ignacio in Bogota for providing the additional isolates. We would like to thank Professor Francisco Javier Peman Garcia from the Servicio de Microbiologia, Hospital Universitario la Fe, Valencia, Spain for generously providing the reference C. africana ATCC 2669 strain. We would like to thank Jason Garry for translating and revising the manuscript.	Alberti-Segui C, 2004, YEAST, V21, P285, DOI 10.1002/yea.1061; Alonso-Vargas R, 2008, MED MYCOL, V46, P167, DOI 10.1080/13693780701633101; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Borman AM, 2013, J CLIN MICROBIOL, V51, P967, DOI 10.1128/JCM.02816-12; Brandt ME, 2012, CURR FUNGAL INFECT R, V6, P170, DOI 10.1007/s12281-012-0094-x; Cendejas-Bueno E, 2012, J CLIN MICROBIOL, V50, P3641, DOI 10.1128/JCM.02248-12; Coleman D, 1997, Oral Dis, V3 Suppl 1, pS96; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Criseo G, 2015, J MICROBIOL METH, V111, P50, DOI 10.1016/j.mimet.2015.02.004; Cuetara M. Soledad, 2006, Revista Iberoamericana de Micologia, V23, P4; De Carolis E, 2014, J CLIN MICROBIOL, V52, P1453, DOI 10.1128/JCM.03355-13; Dieng Y, 2012, J MYCOL MED, V22, P335, DOI 10.1016/j.mycmed.2012.07.052; Bosco-Borgeat ME, 2011, MYCOPATHOLOGIA, V172, P407, DOI 10.1007/s11046-011-9450-6; Maubon D, 2014, INTENS CARE MED, V40, P1241, DOI 10.1007/s00134-014-3404-7; Ngouana TK, 2015, MYCOSES, V58, P33, DOI 10.1111/myc.12266; Nnadi NE, 2012, MED MYCOL, V50, P765, DOI 10.3109/13693786.2012.662598; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; PETERSON SW, 1991, SYST APPL MICROBIOL, V14, P124, DOI 10.1016/S0723-2020(11)80289-4; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Romeo O, 2008, DIAGN MICR INFEC DIS, V62, P230, DOI 10.1016/j.diagmicrobio.2008.05.014; Romeo O, 2013, CURR FUNGAL INFECT R, V7, P192, DOI 10.1007/s12281-013-0142-1; Romeo O, 2011, MYCOSES, V54, P475, DOI 10.1111/j.1439-0507.2010.01939.x; Romeo O, 2009, J CLIN MICROBIOL, V47, P212, DOI 10.1128/JCM.01540-08; Romeo O, 2009, MYCOSES, V52, P454, DOI 10.1111/j.1439-0507.2008.01630.x; Rosenvinge FS, 2013, MYCOSES, V56, P229, DOI 10.1111/myc.12000; Segal E, 2005, MYCOSES, V48, P3, DOI 10.1111/j.1439-0507.2005.01103.x; Shan YY, 2014, MED MYCOL, V52, P636, DOI 10.1093/mmy/myu003; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Sydnor ERM, 2011, CLIN MICROBIOL REV, V24, P141, DOI 10.1128/CMR.00027-10; Taj-Aldeen SJ, 2014, INFECTION, V42, P393, DOI 10.1007/s15010-013-0570-4; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tietz HJ, 2001, MYCOSES, V44, P437, DOI 10.1046/j.1439-0507.2001.00707.x; van Belkum A, 2012, J CLIN MICROBIOL, V50, P1513, DOI 10.1128/JCM.00420-12; Vlek A, 2014, J CLIN MICROBIOL, V52, P3023, DOI 10.1128/JCM.00563-14; Wahab AA, 2014, INT J INFECT DIS, V24, P14, DOI 10.1016/j.ijid.2014.03.1380; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	40	13	14	4	21	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2180			BMC MICROBIOL	BMC Microbiol.	OCT 5	2015	15								199	10.1186/s12866-015-0535-0	http://dx.doi.org/10.1186/s12866-015-0535-0			10	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	CS7GF	26438104	Green Published, gold			2022-09-04	WOS:000362251400003
J	Rey, GZ; Bekrar, A; Prabhu, V; Trentesaux, D				Rey, Gabriel Zambrano; Bekrar, Abdelghani; Prabhu, Vittaldas; Trentesaux, Damien			Coupling a genetic algorithm with the distributed arrival-time control for the JIT dynamic scheduling of flexible job-shops	INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH			English	Article						genetic algorithms; manufacturing control; arrival time control; dynamic scheduling; flexible job-shop; Just-in-Time	ONE-MACHINE; TARDINESS; EARLINESS; SIMULATION; SYSTEM; COMMON; RULES	In order to increase customer satisfaction and competitiveness, manufacturing systems need to combine flexibility with Just-in-Time (JIT) production. Until now, research on JIT scheduling problems has been mostly limited to high volume assembly lines rather than job-shop-like systems, due to their combinatorial complexity. In this paper, we propose a generic strategy for dynamically controlling task schedules by coupling genetic algorithms and distributed arrival-time control to optimise JIT performance. We explore two such hybrid approaches: a sequential approach where the two algorithms work separately and an integrated approach where the distributed arrival time control is embedded into the genetic algorithm. Performance of these approaches is benchmarked with quadratic linear programme solutions to get a gauge of their relative strengths in a static environment. Results from applying these approaches to a job-shop-like automated cell verify their effectiveness for JIT manufacturing under realistic dynamically changing environment.	[Rey, Gabriel Zambrano; Bekrar, Abdelghani; Trentesaux, Damien] Univ Lille Nord France, Lille, France; [Rey, Gabriel Zambrano; Bekrar, Abdelghani; Trentesaux, Damien] TEMPO Lab, Prod Serv & Informat Team, Valenciennes, France; [Rey, Gabriel Zambrano] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Prabhu, Vittaldas] Penn State Univ, Marcus Dept Ind & Mfg Engn, University Pk, PA 16802 USA		Rey, GZ (corresponding author), Univ Lille Nord France, Lille, France.	gzambrano@javeriana.edu.co	trentesaux, damien/D-2791-2009	trentesaux, damien/0000-0003-2489-6203	scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS; Javeriana University (Bogota, Colombia)	scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS; Javeriana University (Bogota, Colombia)	Gabriel Zambrano Rey is supported financially by the scholarship program, "Francisco Jose de Caldas - Generacion del Bicentenario" of the Administrative Department of Science, Technology and Innovation - COLCIENCIAS and Javeriana University (Bogota, Colombia), where he is currently an assistant professor.	[Anonymous], 2003, THEORY SCHEDULING; Arzi Y, 1999, IIE TRANS, V31, P217, DOI 10.1023/A:1007645721482; BAGCHI U, 1987, MANAGE SCI, V33, P894, DOI 10.1287/mnsc.33.7.894; BAKER KR, 1990, OPER RES, V38, P22, DOI 10.1287/opre.38.1.22; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; DU JZ, 1990, MATH OPER RES, V15, P483, DOI 10.1287/moor.15.3.483; Fattahi P, 2007, J INTELL MANUF, V18, P331, DOI 10.1007/s10845-007-0026-8; Fattahi P, 2010, CIRP J MANUF SCI TEC, V2, P114, DOI 10.1016/j.cirpj.2009.10.001; Gholami M, 2009, J INTELL MANUF, V20, P481, DOI 10.1007/s10845-008-0150-0; Girden E.R., 1992, ANOVA REPEATED MEASU; Hong J, 2003, INT J PROD RES, V41, P4357, DOI 10.1080/0020754031000156123; Hussain MF, 1998, IEEE SYS MAN CYBERN, P2225, DOI 10.1109/ICSMC.1998.724986; Jeong KC, 1998, INT J PROD RES, V36, P2609, DOI 10.1080/002075498192733; Joseph OA, 2011, INT J ADV MANUF TECH, V56, P291, DOI 10.1007/s00170-011-3158-0; Jozefowska J, 2007, INT SER OPER RES MAN, V106, P1, DOI 10.1007/978-0-387-71718-0; Kim JG, 2012, INT J PROD RES, V50, P6040, DOI 10.1080/00207543.2011.644591; Lu H, 2013, APPL SOFT COMPUT, V13, P2790, DOI 10.1016/j.asoc.2012.10.001; Mattfeld DC, 2004, EUR J OPER RES, V155, P616, DOI 10.1016/S0377-2217(03)00016-X; Metan G, 2010, INT J PROD RES, V48, P6909, DOI 10.1080/00207540903307581; Nie L, 2013, J INTELL MANUF, V24, P763, DOI 10.1007/s10845-012-0626-9; Pfeiffer A, 2008, INT J COMPUT INTEG M, V21, P206, DOI 10.1080/09511920701607717; Prabhu V., 1995, CIRP ANN-MANUF TECHN, V44, P425, DOI [10.1016/S0007-8506(07)62356-7, DOI 10.1016/S0007-8506(07)62356-7]; Prabhu V.V., 1996, CIRP ANN-MANUF TECHN, V45, P445, DOI DOI 10.1016/S0007-8506(07)63099-6; Prabhu VV, 2003, IEEE T ROBOTIC AUTOM, V19, P142, DOI 10.1109/TRA.2002.807552; Rajabinasab A, 2011, INT J ADV MANUF TECH, V54, P1091, DOI 10.1007/s00170-010-2986-7; Rocha M, 1999, LECT NOTES ARTIF INT, V1611, P127; Sels V, 2012, INT J PROD RES, V50, P4255, DOI 10.1080/00207543.2011.611539; Sethi A. K., 1990, International Journal of Flexible Manufacturing Systems, V2, P289; Shnits B, 2012, INT J PROD RES, V50, P6111, DOI 10.1080/00207543.2012.657805; Sourd F, 2005, COMPUT OPER RES, V32, P1849, DOI 10.1016/j.cor.2003.12.002; Sourd F, 2003, J SCHEDULING, V6, P533, DOI 10.1023/A:1026224610295; Su LH, 2009, COMPUT OPER RES, V36, P461, DOI 10.1016/j.cor.2007.09.013; Trentesaux D, 1998, ARTIF INTELL ENG, V12, P49, DOI 10.1016/S0954-1810(96)00052-0; Trentesaux D, 2013, CONTROL ENG PRACT, V21, P1204, DOI 10.1016/j.conengprac.2013.05.004; Trentesaux D, 2009, ENG APPL ARTIF INTEL, V22, P971, DOI 10.1016/j.engappai.2009.05.001; Vivo-Truyols G, 2001, CHEMOMETR INTELL LAB, V59, P107, DOI 10.1016/S0169-7439(01)00149-6; We Y, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON INTEGRATION TECHNOLOGY, PROCEEDINGS, P281; Wu ZB, 2005, IEEE T SYST MAN CY B, V35, P293, DOI 10.1109/TSMCB.2004.842412; Xiang W, 2008, ENG APPL ARTIF INTEL, V21, P73, DOI 10.1016/j.engappai.2007.03.008; Yang HH, 2003, INT J COMPUT INTEG M, V16, P382, DOI 10.1080/0951192031000077870; Yu TB, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS, VOLS 1-6, P2014, DOI 10.1109/ICAL.2008.4636493; Yu XF, 2006, INT J PROD RES, V44, P4793, DOI 10.1080/00207540600621094	42	19	19	5	95	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7543	1366-588X		INT J PROD RES	Int. J. Prod. Res.	JUN 18	2014	52	12					3688	3709		10.1080/00207543.2014.881575	http://dx.doi.org/10.1080/00207543.2014.881575			22	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Operations Research & Management Science	AE3OG					2022-09-04	WOS:000333885200014
J	Navas, GCG; Martinez, JDT; Bermudez, JDF				Gordillo Navas, Gladys Cecilia; Trujillo Martinez, Javier David; Filizzola Bermudez, Juan David			Simulation Strategy for the Application of SPIKES Protocol in the Communication of Bad News	UNIVERSITAS MEDICA			Spanish	Article						simulation; communication; heatlh education; simulated patient; bad news; SPIKES protocol	POSTGRADUATE RESIDENTS; SKILLS; PERCEPTIONS	Bad news in the health care environment are defined as pieces of information delivered to patients, that can drastically (and often negatively) modify their life course and expectations for the future. Even though communicating bad news has great relevance in the clinical scenario, the training health care professionals need to acquire this skill is often deficient or overlooked. Skilfull delivery of bad news can provide confort for patients and their families, while poor communication of such information can generate negative emotional reactions, wrong perspectives about clinical prognosis and even lead to legal troubles for practitioners. Many protocols and tools for successfully delivering bad news have been described in literature, as well as diverse academic strategies for teaching such tools. The present article proposes a reflection about the use of simulated scenarios for training of health care professionals in bad news delivery, using the SPIKES protocol.	[Gordillo Navas, Gladys Cecilia] Univ Pedagog & Tecnol Colombia, Tunja, Colombia; [Gordillo Navas, Gladys Cecilia] Pontificia Univ Javeriana, Honorem, Bogota, Colombia; [Gordillo Navas, Gladys Cecilia] ESE Hosp Univ San Rafael Tunja, Gest Acad, Tunja, Colombia; [Gordillo Navas, Gladys Cecilia; Trujillo Martinez, Javier David] ESE Hosp Univ San Rafael Tunja, Grp Invest Salud San Rafael, Tunja, Colombia; [Trujillo Martinez, Javier David] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, Colombia; [Trujillo Martinez, Javier David] UDCA, Semillero Invest Salud Familiar, Bogota, Colombia; [Filizzola Bermudez, Juan David] Pontificia Univ Javeriana Bogota, Med, Bogota, Colombia; [Filizzola Bermudez, Juan David] Hosp Univ San Ignacio, Semillero Bioet Clin, Bogota, Colombia; [Filizzola Bermudez, Juan David] Pontificia Univ Javeriana, Dept Psiquiatria, Semillero Mente, Bogota, Colombia		Navas, GCG (corresponding author), Univ Pedagog & Tecnol Colombia, Tunja, Colombia.; Navas, GCG (corresponding author), Pontificia Univ Javeriana, Honorem, Bogota, Colombia.; Navas, GCG (corresponding author), ESE Hosp Univ San Rafael Tunja, Gest Acad, Tunja, Colombia.; Navas, GCG (corresponding author), ESE Hosp Univ San Rafael Tunja, Grp Invest Salud San Rafael, Tunja, Colombia.	cedmedica@hospitalsanrafaeltunja.gov.co						Abbas S Q, 2004, J Pak Med Assoc, V54, P195; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; BEIGZADEH A, 2016, J EMERG PRACT TRAUMA, V2, P25, DOI [10.15171/jept.2015.05, DOI 10.15171/JEPT.2015.05]; Berkey FJ, 2018, AM FAM PHYSICIAN, V98, P99; Brown VA, 2011, EUR J CANCER CARE, V20, P56, DOI 10.1111/j.1365-2354.2009.01156.x; Camargo Nicole Cavalari, 2019, Rev. Bioét., V27, P326, DOI 10.1590/1983-80422019272317; Cleland JA, 2009, MED TEACH, V31, P477, DOI 10.1080/01421590903002821; Dosanjh S, 2001, MED EDUC, V35, P197, DOI 10.1046/j.1365-2923.2001.00766.x; Eid A, 2009, J CANCER EDUC, V24, P154, DOI 10.1080/08858190902854848; da Silveira FJF, 2017, SAO PAULO MED J, V135, P323, DOI 10.1590/1516-3180.20160221270117; Flores-Funes D., 2020, EDUC MED-BARCELONA, V21, P118, DOI [10.1016/j.edumed.2018.07.005, DOI 10.1016/J.EDUMED.2018.07.005]; Herrera A, 2014, REV MED CHILE, V142, P1306, DOI 10.4067/S0034-98872014001000011; Jameel A, 2012, J PAK MED ASSOC, V62, P585; Kaplonyi J, 2017, MED EDUC, V51, P1209, DOI 10.1111/medu.13387; Karam VY, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0374-7; Laughey W, 2018, MED EDUC, V52, P664, DOI 10.1111/medu.13547; León-Amenero Deborah, 2019, An. Fac. med., V80, P86, DOI 10.15381/anales.v80i1.15471; Martin Hernandez I, 2009, REV LATINOAM BIOET, V9, P77; Negri EC, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.1807.2916; Nielsen PE, 2012, CLIN J ONCOL NURS, V22, P23; Oikonomidou D, 2017, HEALTH COMMUN, V32, P657, DOI 10.1080/10410236.2016.1167991; Parvan K, 2018, EDUC HEALTH, V31, P32, DOI [10.4103/1357-6283.239044, 10.4103/efh.EfH_60_17]; Payan C., 2012, CIRUPED, V2, P35; Ramirez-Ibanez MT, 2015, ATENCION FAM, V22, P95; Rat A, 2018, JMIR MED ED, V4, P1; Sarwar MZ, 2019, J PAK MED ASSOC, V69, P695; Wallace J., 2002, ADV PSYCHIAT TREAT, V8, P342, DOI [10.1192/apt.8.5.342, DOI 10.1192/APT.8.5.342]	27	0	0	0	3	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.	JUL-SEP	2020	61	3								10.11144/Javeriana.umed61-3.spik	http://dx.doi.org/10.11144/Javeriana.umed61-3.spik			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LJ4ID		gold			2022-09-04	WOS:000530129100006
J	Velasco, C; Salgado-Montejo, A; Elliot, AJ; Woods, AT; Alvarado, J; Spence, C				Velasco, Carlos; Salgado-Montejo, Alejandro; Elliot, Andrew J.; Woods, Andy T.; Alvarado, Jorge; Spence, Charles			The shapes associated with approach/avoidance words	MOTIVATION AND EMOTION			English	Article						Symmetry; Curvature; Approach; Avoidance; Motivation; Valence	FLUCTUATING ASYMMETRY; LONGITUDINAL DATA; SEXUAL ORNAMENTS; SYMMETRY; PREFERENCE; VALENCE; BEAUTY; LINES; AESTHETICS; CURVATURE	People prefer curved and symmetrical shapes to their angular and asymmetrical counterparts. While it is known that stimulus valence is central to approach and avoidance motivation, the exact nature of the relationship between curvature/symmetry and approach/avoidance motivation still needs to be clarified. Experiment 1 was designed to investigate whether simple shapes are associated with approach and avoidance words. Participants found it easier to match more symmetrical shapes with approach words. In Experiment 2, symmetry was differentially associated with approach words and was rated significantly higher on the approach dimension than asymmetry. Next, we assessed whether object valence and object curvature (Experiment 3) or symmetry (Experiment 4) would lead to different associations to approach and avoidance words. Only object valence had a significant influence on participants' ratings, with the positively-valenced objects being more closely associated with approach words than their negatively-valenced counterparts. These results highlight the complex relation between visual properties of objects, their valence, and appetitive and aversive categories.	[Velasco, Carlos; Salgado-Montejo, Alejandro; Woods, Andy T.; Spence, Charles] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford, England; [Velasco, Carlos] Imagineering Inst, Iskandar, Malaysia; [Salgado-Montejo, Alejandro] Univ La Sabana, Chia, Colombia; [Elliot, Andrew J.] Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY USA; [Woods, Andy T.] Xperiment, Surrey, England; [Alvarado, Jorge] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia		Velasco, C (corresponding author), Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford, England.; Velasco, C (corresponding author), Imagineering Inst, Iskandar, Malaysia.	carlosvelasco@protonmail.com		Salgado Montejo, Alejandro/0000-0001-6325-6183; Velasco, Carlos/0000-0002-4864-2315; Woods, Andy/0000-0003-3797-3845; Alvarado, Jorge/0000-0001-8331-2031				Apthorp D, 2015, CURR BIOL, V25, pR267, DOI 10.1016/j.cub.2015.02.017; Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Barca L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116193; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Carbon CC, 2010, ACTA PSYCHOL, V134, P233, DOI 10.1016/j.actpsy.2010.02.004; Chatterjee A., 2014, AESTHETIC BRAIN WE E, DOI [10.1093/acprof:oso/9780199811809.001.0001, DOI 10.1093/ACPROF:OSO/9780199686520.003.0003]; Chatterjee A, 2014, TRENDS COGN SCI, V18, P370, DOI 10.1016/j.tics.2014.03.003; Cliff N, 1996, MULTIVAR BEHAV RES, V31, P331, DOI 10.1207/s15327906mbr3103_4; Collier GL, 1996, MOTIV EMOTION, V20, P1, DOI 10.1007/BF02251005; Dazkir SS, 2012, ENVIRON BEHAV, V44, P722, DOI 10.1177/0013916511402063; Elliot AJ, 2013, EMOT REV, V5, P308, DOI 10.1177/1754073913477517; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Enquist M, 1997, P ROY SOC B-BIOL SCI, V264, P1345, DOI 10.1098/rspb.1997.0186; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Fetterman AK, 2013, MOTIV EMOTION, V37, P33, DOI 10.1007/s11031-012-9306-5; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Gomez-Puerto G, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00712; Gordon K., 1909, ESTHETICS; Hair H., 1995, B COUN RES MUSIC ED, V127, P99; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2012, GEN ESTIMATING EQUAT; HOPKINS JR, 1976, CHILD DEV, V47, P1166, DOI 10.1111/j.1467-8624.1976.tb02300.x; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Jadva V, 2010, ARCH SEX BEHAV, V39, P1261, DOI 10.1007/s10508-010-9618-z; Jansson L, 2002, ANIM BEHAV, V63, P617, DOI 10.1006/anbe.2001.1936; Jennions MD, 1998, ANIM BEHAV, V55, P61, DOI 10.1006/anbe.1997.0579; Kawase H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02106; Krieglmeyer R, 2010, PSYCHOL SCI, V21, P607, DOI 10.1177/0956797610365131; Larson CL, 2012, MOTIV EMOTION, V36, P404, DOI 10.1007/s11031-011-9249-2; Leder H, 2005, APPL COGNITIVE PSYCH, V19, P603, DOI 10.1002/acp.1088; Leder H, 2011, PERCEPTION, V40, P649, DOI 10.1068/p6845; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lundholm H, 1921, PSYCHOL REV, V28, P43, DOI 10.1037/h0072647; Magnuson JS, 2005, P NATL ACAD SCI USA, V102, P9995, DOI 10.1073/pnas.0504413102; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; MOLLER AP, 1990, ANIM BEHAV, V40, P1185, DOI 10.1016/S0003-3472(05)80187-3; Munar E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141106; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; OAKES EJ, 1994, ANIM BEHAV, V48, P937, DOI 10.1006/anbe.1994.1319; Palmer SE, 2013, ANNU REV PSYCHOL, V64, P77, DOI 10.1146/annurev-psych-120710-100504; Palumbo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140043; Poffenberger AT, 1924, J APPL PSYCHOL, V8, P187, DOI 10.1037/h0073513; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rodriguez I, 2004, NATURWISSENSCHAFTEN, V91, P374, DOI 10.1007/s00114-004-0537-5; Salgado-Montejo A, 2015, PSYCHOL MARKET, V32, P771, DOI 10.1002/mar.20817; Sasaki Y, 2005, P NATL ACAD SCI USA, V102, P3159, DOI 10.1073/pnas.0500319102; Shen X, 2015, FOOD QUAL PREFER, V44, P26, DOI 10.1016/j.foodqual.2015.03.015; Shepherd K, 2011, PERCEPTION, V40, P1254, DOI 10.1068/p7057; Silvia PJ, 2009, PSYCHOL AESTHET CREA, V3, P48, DOI 10.1037/a0014632; Silvia PJ., 2009, EMPIR STUD ARTS, V27, P25, DOI [DOI 10.2190/EM.27.1.B, 10.2190/EM.27.1.b]; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Stewart I., 2013, SYMMETRY VERY SHORT; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Tinio PPL, 2009, ACTA PSYCHOL, V130, P241, DOI 10.1016/j.actpsy.2009.01.001; Vartanian O, 2013, P NATL ACAD SCI USA, V110, P10446, DOI 10.1073/pnas.1301227110; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5; Westerman SJ, 2012, PSYCHOL MARKET, V29, P595, DOI 10.1002/mar.20546	63	20	20	2	16	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0146-7239	1573-6644		MOTIV EMOTION	Motiv. Emot.	OCT	2016	40	5					689	702		10.1007/s11031-016-9559-5	http://dx.doi.org/10.1007/s11031-016-9559-5			14	Psychology, Experimental; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	DV2MR		Green Submitted			2022-09-04	WOS:000382755200004
J	Makhaeva, GF; Lushchekina, SV; Boltneva, NP; Sokolov, VB; Grigoriev, VV; Serebryakova, OG; Vikhareva, EA; Aksinenko, AY; Barreto, GE; Aliev, G; Bachurin, SO				Makhaeva, Galina F.; Lushchekina, Sofya V.; Boltneva, Natalia P.; Sokolov, Vladimir B.; Grigoriev, Vladimir V.; Serebryakova, Olga G.; Vikhareva, Ekaterina A.; Aksinenko, Alexey Yu.; Barreto, George E.; Aliev, Gjumrakch; Bachurin, Sergey O.			Conjugates of gamma-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease	SCIENTIFIC REPORTS			English	Article							CRESYL SALIGENIN PHOSPHATE; BETA-AMYLOID PEPTIDE; CHOLINESTERASE-INHIBITORS; METHYLENE-BLUE; HUMAN CARBOXYLESTERASES; MULTIFACTORIAL NATURE; SYMPTOMATIC TREATMENT; DRUG-METABOLISM; RAT-BRAIN; ACETYLCHOLINESTERASE	Alzheimer disease is a multifactorial pathology and the development of new multitarget neuroprotective drugs is promising and attractive. We synthesized a group of original compounds, which combine in one molecule.-carboline fragment of dimebon and phenothiazine core of methylene blue (MB) linked by 1-oxo- and 2-hydroxypropylene spacers. Inhibitory activity of the conjugates toward acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and structurally close to them carboxylesterase (CaE), as well their binding to NMDA-receptors were evaluated in vitro and in silico. These newly synthesized compounds showed significantly higher inhibitory activity toward BChE with IC50 values in submicromolar and micromolar range and exhibited selective inhibitory action against BChE over AChE and CaE. Kinetic studies for the 9 most active compounds indicated that majority of them were mixed-type BChE inhibitors. The main specific protein-ligand interaction is p-p stacking of phenothiazine ring with indole group of Trp82. These compounds emerge as promising safe multitarget ligands for the further development of a therapeutic approach against aging-related neurodegenerative disorders such as Alzheimer and/or other pathological conditions.	[Makhaeva, Galina F.; Lushchekina, Sofya V.; Boltneva, Natalia P.; Sokolov, Vladimir B.; Grigoriev, Vladimir V.; Serebryakova, Olga G.; Vikhareva, Ekaterina A.; Aksinenko, Alexey Yu.; Bachurin, Sergey O.] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow 119334, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Vikhareva, Ekaterina/ABA-4151-2020; Makhaeva, Galina/A-9412-2014; Sergey, Bachurin/I-1708-2018; Barreto, George E./AAD-7420-2020; Lushchekina, Sofya/F-8469-2010; Aksinenko, Alexey/AAB-4616-2021; Aliev, Gjumrakch/K-7302-2017; Grigoriev, Vladimir/ABA-7052-2020; Serebryakova, Olga/ABA-4175-2020; Barreto, George E./B-5747-2014	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Lushchekina, Sofya/0000-0002-6922-020X; Aksinenko, Alexey/0000-0002-7281-9467; Serebryakova, Olga/0000-0002-0313-1423; Barreto, George E./0000-0002-6644-1971; Boltneva, Natalia/0000-0002-7171-8832	Russian Science Foundation [14-23-00160]; "Dynasty" foundation	Russian Science Foundation(Russian Science Foundation (RSF)); "Dynasty" foundation	The study was supported by the grant of the Russian Science Foundation (project number 14-23-00160). S.V. Lushchekina is grateful to the "Dynasty" foundation for the scholarship (a support of the computer-modeling part of this study).	Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; Bachurin S. O., 2014, Russia patent, Patent No. 2529899; Bachurin S. O., 2014, Russia patent, Patent No. 2530881; Bachurin SO, 2001, VOP MED KHIM, V47, P155; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bharadwaj P R, 2013, Transl Psychiatry, V3, pe332, DOI 10.1038/tp.2013.97; Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118; Cacabelos R, 1999, INT J GERIATR PSYCH, V14, P3, DOI 10.1002/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7; Calza L, 2013, CURR TOP MED CHEM, V13, P1843, DOI 10.2174/15680266113139990140; Canas PM, 2014, NEUROPHARMACOLOGY, V76, P51, DOI 10.1016/j.neuropharm.2013.08.026; Cano-Cuenca N, 2014, J ALZHEIMERS DIS, V38, P155, DOI 10.3233/JAD-130872; Carreiras MC, 2013, CURR TOP MED CHEM, V13, P1745, DOI 10.2174/15680266113139990135; Coughenour LL, 2001, J PHARMACOL EXP THER, V296, P150; DANA C, 1991, NEUROSCI LETT, V125, P45, DOI 10.1016/0304-3940(91)90127-F; Darvesh S, 2005, BIOORGAN MED CHEM, V13, P211, DOI 10.1016/j.bmc.2004.09.059; Darvesh S, 2008, J MED CHEM, V51, P4200, DOI 10.1021/jm8002075; Darvesh S, 2007, BIOORGAN MED CHEM, V15, P6367, DOI 10.1016/j.bmc.2007.06.060; Darvesh S, 2010, BIOORGAN MED CHEM, V18, P2232, DOI 10.1016/j.bmc.2010.01.066; Eisen A, 2009, J CLIN NEUROSCI, V16, P505, DOI 10.1016/j.jocn.2008.07.072; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Francis PT, 2012, EXPERT REV NEUROTHER, V12, P1351, DOI [10.1586/ERN.12.124, 10.1586/ern.12.124]; Geldenhuys WJ, 2013, CURR MED CHEM, V20, P1662; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Greig NH, 2001, CURR MED RES OPIN, V17, P159; Grigor'ev VV, 2003, B EXP BIOL MED+, V136, P474, DOI 10.1023/B:BEBM.0000017097.75818.14; Grossberg GT, 2006, J CLIN PHARMACOL, V46, p17S, DOI 10.1177/0091270006288735; Guzior N, 2015, CURR MED CHEM, V22, P373; HEYMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P609, DOI 10.1515/bchm2.1967.348.1.609; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Kamal MA, 2008, NEUROCHEM RES, V33, P745, DOI 10.1007/s11064-007-9490-y; Laizure SC, 2013, PHARMACOTHERAPY, V33, P210, DOI 10.1002/phar.1194; Lane RM, 2006, INT J NEUROPSYCHOPH, V9, P101, DOI 10.1017/S1461145705005833; Lushchekina SV, 2013, RUSS CHEM B+, V62, P2527, DOI 10.1007/s11172-013-0366-9; Macdonald IR, 2014, J ALZHEIMERS DIS, V42, P379, DOI 10.3233/JAD-140219; Makhaeva GF, 2012, SAR QSAR ENVIRON RES, V23, P627, DOI 10.1080/1062936X.2012.679690; Makhaeva GF, 2013, CHEM-BIOL INTERACT, V203, P231, DOI 10.1016/j.cbi.2012.10.012; Martinez A, 2006, EXPERT OPIN INV DRUG, V15, P1, DOI 10.1517/13543784.15.1.1; Masson P, 2013, BIOCHEM J, V454, P387, DOI 10.1042/BJ20130389; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1841, DOI 10.1063/1.1740589; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Nordberg A, 2009, CURR ALZHEIMER RES, V6, P4, DOI 10.2174/156720509787313961; NOWAK G, 1993, J PHARMACOL EXP THER, V265, P1380; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Rodda J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2986; Rosini M, 2014, NEUROCHEM RES, V39, P1914, DOI 10.1007/s11064-014-1250-1; Salomone S, 2012, BRIT J CLIN PHARMACO, V73, P504, DOI 10.1111/j.1365-2125.2011.04134.x; Samadi A, 2013, EUR J MED CHEM, V67, P64, DOI 10.1016/j.ejmech.2013.06.021; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sezgin Z, 2013, ARCH BIOCHEM BIOPHYS, V532, P32, DOI 10.1016/j.abb.2013.01.003; Simeon-Rudolf V, 2001, CROAT CHEM ACTA, V74, P173; Steele JW, 2013, AUTOPHAGY, V9, P617, DOI 10.4161/auto.23487; STERRI SH, 1985, BIOCHEM PHARMACOL, V34, P2779, DOI 10.1016/0006-2952(85)90579-9; Tsurkan LG, 2013, CHEM-BIOL INTERACT, V203, P226, DOI 10.1016/j.cbi.2012.10.018; Wang L, 2014, EUR J MED CHEM, V80, P543, DOI 10.1016/j.ejmech.2014.04.078; Weinstock M, 2008, CHEM-BIOL INTERACT, V175, P216, DOI 10.1016/j.cbi.2008.03.014; Wilkinson DG, 2004, DRUG AGING, V21, P453, DOI 10.2165/00002512-200421070-00004; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042; Youdim Moussa B H, 2010, Exp Neurobiol, V19, P1, DOI 10.5607/en.2010.19.1.1; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	63	63	64	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 18	2015	5								13164	10.1038/srep13164	http://dx.doi.org/10.1038/srep13164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VH	26281952	Green Published, gold			2022-09-04	WOS:000359664000001
J	Carranza, H; Cardona, AF; Vargas, C; Otero, JM; Sanchez, JO; Carrasco-Chaumel, E; Reveiz, L; Torres, D; Castro, C; Gonzalez-Angulo, AM				Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.			Trastuzumab (H) treatment in patients (pts) with metastatic breast cancer (MBC): An observational retrospective study in four hospitals from Bogota, Colombia (ONCOLGroup study)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	45th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 29-JUN 02, 2009	Orlando, FL	Amer Soc Clin Oncol					[Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] Fdn Santa Fe Bogota, Bogota, Colombia; [Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] Catalan Inst Oncol, Barcelona, Spain; [Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] Inst Natl Cancerol, Bogota, Colombia; [Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] Cochrane Colombian Grp, Bogota, Colombia; [Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] Pontificia Univ Javeriana, Bogota, Colombia; [Carranza, H.; Cardona, A. F.; Vargas, C.; Otero, J. M.; Sanchez, J. O.; Carrasco-Chaumel, E.; Reveiz, L.; Torres, D.; Castro, C.; Gonzalez-Angulo, A. M.] MD Anderson Canc Ctr, Houston, TX USA										0	0	0	0	1	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X			J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2009	27	15		S		e12016								2	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Oncology	582OF					2022-09-04	WOS:000276606602082
J	Burgos-Ravanal, R; Campos, A; Diaz-Vesga, MC; Gonzalez, MF; Leon, D; Lobos-Gonzalez, L; Leyton, L; Kogan, MJ; Quest, AFG				Burgos-Ravanal, Renato; Campos, America; Diaz-Vesga, Magda C.; Gonzalez, Maria Fernanda; Leon, Daniela; Lobos-Gonzalez, Lorena; Leyton, Lisette; Kogan, Marcelo J.; Quest, Andrew F. G.			Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications	CANCERS			English	Review						extracellular vesicles; hallmarks of cancer; drug resistance; theranostics	CELL-DERIVED EXOSOMES; TISSUE FACTOR; DRUG-RESISTANCE; GASTRIC-CANCER; TUMOR-GROWTH; IN-VITRO; BIOLOGICAL SIGNIFICANCE; SIGNALING PATHWAY; GENE-EXPRESSION; POTENTIAL ROLE	Simple Summary Cancer is the second leading cause of death in humans, and in 2020, 9.8 million cancer-related deaths were reported worldwide. In the last 20 years, it has become apparent that small vesicles released by cancer cells, referred to as extracellular vesicles (EVs), are key players in cell-cell communication in the tumor environment, and as a consequence, research in this area has increased dramatically. This review summarizes the recent advances in our understanding of how EVs serve as mediators of communication between cancer cells and with their surroundings in order to promote the acquisition of specific characteristics that permit their aberrant behavior. In addition, we dwell on how EVs aid in the development of drug resistance, which is a frequent cause of treatment failure in chemotherapy. Finally, we discuss an exciting new area of research that envisions harnessing the unique characteristics of EVs for therapeutic and diagnostic purposes (theranostics). Taken together, the available literature suggests that advances in our understanding of EV biology in the next decades will likely be critical to achieving more effective treatments in cancer patients. Cancer remains a leading cause of death worldwide despite decades of intense efforts to understand the molecular underpinnings of the disease. To date, much of the focus in research has been on the cancer cells themselves and how they acquire specific traits during disease development and progression. However, these cells are known to secrete large numbers of extracellular vesicles (EVs), which are now becoming recognized as key players in cancer. EVs contain a large number of different molecules, including but not limited to proteins, mRNAs, and miRNAs, and they are actively secreted by many different cell types. In the last two decades, a considerable body of evidence has become available indicating that EVs play a very active role in cell communication. Cancer cells are heterogeneous, and recent evidence reveals that cancer cell-derived EV cargos can change the behavior of target cells. For instance, more aggressive cancer cells can transfer their "traits" to less aggressive cancer cells and convert them into more malignant tumor cells or, alternatively, eliminate those cells in a process referred to as "cell competition". This review discusses how EVs participate in the multistep acquisition of specific traits developed by tumor cells, which are referred to as "the hallmarks of cancer" defined by Hanahan and Weinberg. Moreover, as will be discussed, EVs play an important role in drug resistance, and these more recent advances may explain, at least in part, why pharmacological therapies are often ineffective. Finally, we discuss literature proposing the use of EVs for therapeutic and prognostic purposes in cancer.	[Burgos-Ravanal, Renato; Campos, America; Diaz-Vesga, Magda C.; Gonzalez, Maria Fernanda; Leyton, Lisette; Quest, Andrew F. G.] Univ Chile, Fac Med, Ctr Estudios Ejercicio Metab & Canc CEMC, Lab Comunicac Celulares,Programa Biol Celular & M, Santiago 8380453, Chile; [Burgos-Ravanal, Renato; Campos, America; Diaz-Vesga, Magda C.; Gonzalez, Maria Fernanda; Leon, Daniela; Leyton, Lisette; Kogan, Marcelo J.; Quest, Andrew F. G.] Ctr Avanzado Estudios Enfermedades Cron ACCDIS, Santiago 8380453, Chile; [Campos, America] Univ Queensland, Royal Brisbane & Womens Hosp, Ctr Clin Diagnost, UQ Ctr Clin Res,Exosome Biol Lab, Brisbane, Qld 4029, Australia; [Diaz-Vesga, Magda C.] Pontificia Univ Javeriana Cali, Grp Invest Ciencias Basicas & Clin Salud, Cali 760008, Colombia; [Leon, Daniela; Kogan, Marcelo J.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santos Dumt 964, Santiago 8380494, Chile; [Lobos-Gonzalez, Lorena] Univ Desarrollo Clin Alemana, Fac Med, Ctr Med Regenerat, Santiago 7590943, Chile		Quest, AFG (corresponding author), Univ Chile, Fac Med, Ctr Estudios Ejercicio Metab & Canc CEMC, Lab Comunicac Celulares,Programa Biol Celular & M, Santiago 8380453, Chile.; Kogan, MJ; Quest, AFG (corresponding author), Ctr Avanzado Estudios Enfermedades Cron ACCDIS, Santiago 8380453, Chile.; Kogan, MJ (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santos Dumt 964, Santiago 8380494, Chile.	raburgos@uc.cl; ame.campos@ug.uchile.cl; magdiaz@ug.uchile.cl; mariagonzalez1@ug.uchile.cl; daniela.leon92@ucuenca.ec; llobos@udd.cl; lleyton@med.uchile.cl; mkogan@ciq.uchile.cl; aquest@med.uchile.cl	; Quest, Andrew/A-7782-2008	Kogan, Marcelo/0000-0003-0608-5087; Diaz Vesga, Magda Carolina/0000-0002-7807-2050; Gonzalez, Maria Fernanda/0000-0001-7435-6497; Quest, Andrew/0000-0001-8755-1590	Fondecyt [1210644, 1200836, 1211223]; FONDAP [15130011]; ANID postdoctoral fellowship award Becas Chile; ANID PhD fellowship [21200147, 21191341, 21170292]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; ANID postdoctoral fellowship award Becas Chile; ANID PhD fellowship	Research in the laboratories was supported by Fondecyt grants 1210644 (A.F.G.Q.), 1200836 (L.L.), 1211223 (L.L.-G.), FONDAP grant 15130011 (A.F.G.Q., M.J.K., L.L., L.L.-G.), ANID postdoctoral fellowship award Becas Chile 2019 (AC), ANID PhD fellowship awards 21200147 (R.B.-R.), 21191341 (M.C.D.-V.), 21170292 (M.F.G.).	Abdouh M, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1248-2; Abels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-z; Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Aheget H, 2021, CANCERS, V13, DOI 10.3390/cancers13010084; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Al-Mayah AHJ, 2017, RADIAT RES, V187, P98, DOI 10.1667/RR14201.1; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Aleckovic M, 2015, BBA-REV CANCER, V1855, P24, DOI 10.1016/j.bbcan.2014.10.005; Allegra A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020448; Anand Sushma, 2021, Subcell Biochem, V97, P89, DOI 10.1007/978-3-030-67171-6_5; Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Armstrong D, 2018, J PATHOL TRANSL MED, V52, P1, DOI 10.4132/jptm.2017.05.21; Aspe JR, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23244; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Augimeri G, 2020, INT J MOL SCI, V21, P5841, DOI 10.3390/ijms21165841; Aung T, 2011, P NATL ACAD SCI USA, V108, P15336, DOI 10.1073/pnas.1102855108; Baran J, 2010, CANCER IMMUNOL IMMUN, V59, P841, DOI 10.1007/s00262-009-0808-2; Batista IA, 2021, CANCERS, V13, DOI 10.3390/cancers13030473; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bhandari V, 2019, NAT GENET, V51, P308, DOI 10.1038/s41588-018-0318-2; Bhattacharya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114409; Bigagli E, 2016, CANCER BIOL THER, V17, P1062, DOI 10.1080/15384047.2016.1219815; Bijnsdorp IV, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22097; Boopathy GTK, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00049; Bowling S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04167-y; Buscail E, 2019, CANCERS, V11, DOI 10.3390/cancers11111656; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Caivano A, 2015, TUMOR BIOL, V36, P9739, DOI 10.1007/s13277-015-3741-3; Campos A, 2018, NANOMEDICINE-UK, V13, P2597, DOI 10.2217/nnm-2018-0094; Cappellesso R, 2014, CANCER CYTOPATHOL, V122, P685, DOI 10.1002/cncy.21442; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Carvalho AS, 2020, FRONT BIOSCI-LANDMRK, V25, P398, DOI 10.2741/4811; Catalano M, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1703244; CHARGAFF E, 1946, J BIOL CHEM, V166, P189; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Choi DY, 2014, PROTEOMICS, V14, P1845, DOI 10.1002/pmic.201400008; Choi DS, 2015, MASS SPECTROM REV, V34, P474, DOI 10.1002/mas.21420; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Cooks T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03224-w; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Dai GY, 2018, B CANCER, V105, P336, DOI 10.1016/j.bulcan.2017.12.009; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; Dillekas H, 2019, CANCER MED-US, V8, P5574, DOI 10.1002/cam4.2474; Ding XQ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01113; El Kharbili M, 2017, ONCOTARGET, V8, P17140, DOI 10.18632/oncotarget.15084; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Gangadaran P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31998-y; Gardiner C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26901; Garofalo M, 2019, THERANOSTICS, V9, P5681, DOI 10.7150/thno.34824; Georgantzoglou N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052744; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Gheldof D, 2014, THROMB RES, V133, P433, DOI 10.1016/j.thromres.2013.11.008; Giusti I, 2016, TUMOR BIOL, V37, P12743, DOI 10.1007/s13277-016-5165-0; Giusti I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/703048; Gomez CD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00092; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Grilz E, 2018, HAEMATOLOGICA, V103, P1549, DOI 10.3324/haematol.2018.192419; GROSSHANS CA, 1989, BIOCHEMISTRY-US, V28, P6888, DOI 10.1021/bi00443a017; Guo DJ, 2019, INT J CANCER, V144, P3070, DOI 10.1002/ijc.32064; Gutkin A, 2016, ONCOTARGET, V7, P59173, DOI 10.18632/oncotarget.10384; Haderk F, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5509; Hakulinen J, 2008, J CELL BIOCHEM, V105, P1211, DOI 10.1002/jcb.21923; Hallal S, 2019, MOL NEUROBIOL, V56, P4566, DOI 10.1007/s12035-018-1385-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao S., 2006, Experimental Oncology, V28, P126; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He JL, 2020, INT J CANCER, V146, P1052, DOI 10.1002/ijc.32543; He LQ, 2019, THERANOSTICS, V9, P8206, DOI 10.7150/thno.37455; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; Hernandez-Oller L, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12121146; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hisada Y, 2017, J THROMB HAEMOST, V15, P2208, DOI 10.1111/jth.13809; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hong CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14661-w; Hood JL, 2016, NANOMEDICINE-UK, V11, P1745, DOI 10.2217/nnm-2016-0102; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hsu YL, 2017, ONCOGENE, V36, P4929, DOI 10.1038/onc.2017.105; Hu LZ, 2015, MAGN RESON MED, V74, P266, DOI 10.1002/mrm.25376; Huang J, 2019, AM J TRANSL RES, V11, P1711; Huang Ming-Bo, 2019, J Cancer Ther, V10, P382, DOI 10.4236/jct.2019.105032; Huang RX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0763-x; Huang T, 2019, INT J BIOL SCI, V15, P1, DOI 10.7150/ijbs.27796; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Huang Z, 2017, ONCOL RES, V25, P651, DOI 10.3727/096504016X14752792816791; Jadli AS, 2020, MOL CELL BIOCHEM, V467, P77, DOI 10.1007/s11010-020-03703-z; Jia G, 2018, BIOMATERIALS, V178, P302, DOI 10.1016/j.biomaterials.2018.06.029; Jiang XY, 2018, NANOTECHNOLOGY, V29, DOI 10.1088/1361-6528/aaaf14; Jung KO, 2018, BIOMATERIALS, V177, P139, DOI 10.1016/j.biomaterials.2018.05.048; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Katoh M, 2005, ONCOL REP, V14, P1583; Kawamura S, 2019, J HEPATO-BIL-PAN SCI, V26, P63, DOI 10.1002/jhbp.601; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Khoo XH, 2019, CANCERS, V11, DOI 10.3390/cancers11081166; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Kim MS, 2018, NANOMED-NANOTECHNOL, V14, P195, DOI 10.1016/j.nano.2017.09.011; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Ko SY, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0609-x; Kobayashi M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-4; Koch R, 2016, CLIN CANCER RES, V22, P395, DOI 10.1158/1078-0432.CCR-15-0577; Koga K, 2005, ANTICANCER RES, V25, P3703; Kooijmans SAA, 2016, PHARMACOL RES, V111, P487, DOI 10.1016/j.phrs.2016.07.006; Kooijmans SAA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31053; Kreger BT, 2016, CANCERS, V8, DOI 10.3390/cancers8120111; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lai CP, 2014, METHODS MOL BIOL, V1098, P249, DOI 10.1007/978-1-62703-718-1_19; Lara P, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111022; Lara P, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-0573-0; Lazar I, 2016, CANCER RES, V76, P4051, DOI 10.1158/0008-5472.CAN-16-0651; Lazaro-Ibanez E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3087-x; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Lei L, 2020, CANCER BIOL THER, V21, P717, DOI 10.1080/15384047.2020.1764318; Li B, 2012, ONCOGENE, V31, P4740, DOI 10.1038/onc.2011.636; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Li XX, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0269-y; Li YY, 2018, EBIOMEDICINE, V36, P209, DOI 10.1016/j.ebiom.2018.09.006; Li YH, 2012, ADV DRUG DELIVER REV, V64, P29, DOI 10.1016/j.addr.2011.04.006; Li ZH, 2018, ONCOGENE, V37, P3822, DOI 10.1038/s41388-018-0237-9; Limkin EJ, 2017, ANN ONCOL, V28, P1191, DOI 10.1093/annonc/mdx034; Liu SH, 2014, INT J CLIN EXP PATHO, V7, P4857; Liu T, 2017, ACTA BIOCH BIOPH SIN, V49, P808, DOI 10.1093/abbs/gmx078; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Liu YF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027472; Liu Y, 2016, CELL RES, V26, P149, DOI 10.1038/cr.2015.153; Liu ZJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.225714; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lubin JA, 2018, NEUROSURGERY, V83, pE98, DOI 10.1093/neuros/nyy295; Lucero R, 2020, CELL REP, V30, P2065, DOI 10.1016/j.celrep.2020.01.073; Ludwig N, 2018, EXPERT OPIN THER TAR, V22, P409, DOI 10.1080/14728222.2018.1464141; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Ma Q, 2020, INT J ONCOL, V56, P1025, DOI 10.3892/ijo.2020.4986; Maacha S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0965-7; Madan E, 2019, NATURE, V572, P260, DOI 10.1038/s41586-019-1429-3; Matsumoto A, 2017, CANCER SCI, V108, P1803, DOI 10.1111/cas.13310; McAndrews KM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0963-9; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meng WR, 2020, DRUG DELIV, V27, P585, DOI 10.1080/10717544.2020.1748758; Meng XD, 2018, TRANSL CANCER RES, V7, pS226, DOI 10.21037/tcr.2017.09.17; Menon JU, 2013, THERANOSTICS, V3, P152, DOI 10.7150/thno.5327; Messenger SW, 2018, J CELL BIOL, V217, P2877, DOI 10.1083/jcb.201710132; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mir B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071601; Momen-Heravi Fatemeh, 2018, Oncotarget, V9, P34838, DOI 10.18632/oncotarget.26208; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Ozawa PMM, 2018, BREAST CANCER RES TR, V172, P713, DOI 10.1007/s10549-018-4925-5; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nielsen T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210835; Ning YL, 2018, IMMUNOL LETT, V199, P36, DOI 10.1016/j.imlet.2018.05.002; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ohyashiki JH, 2016, CURR OPIN HEMATOL, V23, P268, DOI 10.1097/MOH.0000000000000235; Osataphan S, 2021, BLOOD ADV, V5, P2055, DOI 10.1182/bloodadvances.2020004118; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pal T, 2008, CANCER-AM CANCER SOC, V113, P733, DOI 10.1002/cncr.23601; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Pascucci L, 2014, J CONTROL RELEASE, V192, P262, DOI 10.1016/j.jconrel.2014.07.042; Pavlakis E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249648; PAZZAGLIA UE, 1988, ARCH ORTHOP TRAUM SU, V107, P20; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petrovcikova E, 2018, BIOLOGIA, V73, P437, DOI 10.2478/s11756-018-0047-0; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Pritchard A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051303; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Qu JL, 2009, ACTA ONCOL, V48, P1173, DOI 10.3109/02841860903032817; Qu Z, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0430-z; Radeghieri A, 2017, BIOCHEM BIOPH RES CO, V483, P706, DOI 10.1016/j.bbrc.2016.12.077; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Richardson JJ, 2019, CHEM MATER, V31, P2191, DOI 10.1021/acs.chemmater.9b00050; Rijpma SR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-359; Rodrigues G, 2019, NAT CELL BIOL, V21, P1403, DOI 10.1038/s41556-019-0404-4; Rousseau A, 2017, INT J ONCOL, V51, P1793, DOI 10.3892/ijo.2017.4170; Roy S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061349; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sato Y, 2017, ONCOTARGET, V8, P39345, DOI 10.18632/oncotarget.16996; Savina A, 2002, J CELL SCI, V115, P2505; Schlienger S, 2014, MOL BIOL CELL, V25, P17, DOI 10.1091/mbc.E13-06-0335; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Shah S, 2021, DISEASES-BASEL, V9, DOI 10.3390/diseases9020034; Shang D, 2020, J CELL MOL MED, V24, P588, DOI 10.1111/jcmm.14766; Shao CC, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0869-y; Shao HL, 2018, CHEM REV, V118, P1917, DOI 10.1021/acs.chemrev.7b00534; Sharma P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56542-4; Shedden K, 2003, CANCER RES, V63, P4331; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singh P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071979; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skryabin GO, 2020, BIOCHEMISTRY-MOSCOW+, V85, P177, DOI 10.1134/S0006297920020054; Steidel C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020790; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Surman M, 2019, CURR PHARM DESIGN, V25, P132, DOI 10.2174/1381612825666190306153318; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Takahasi K, 2018, J HEPATO-BIL-PAN SCI, V25, P155, DOI 10.1002/jhbp.524; Tan CF, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051320; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Tarsounas M, 2020, NAT REV MOL CELL BIO, V21, P284, DOI 10.1038/s41580-020-0218-z; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thomas GM, 2015, J THROMB HAEMOST, V13, P1310, DOI 10.1111/jth.13002; Thomas GM, 2009, J EXP MED, V206, P1913, DOI 10.1084/jem.20082297; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Torreggiani E, 2016, INT J ONCOL, V49, P189, DOI 10.3892/ijo.2016.3509; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tripisciano C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03262-2; Tsering T, 2020, CANCERS, V12, DOI 10.3390/cancers12102923; Uchihara T, 2020, CANCER RES, V80, P3222, DOI 10.1158/0008-5472.CAN-19-3803; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vella LJ, 2017, NEOPLASIA, V19, P932, DOI 10.1016/j.neo.2017.07.002; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Wang JG, 2012, BLOOD, V119, P5543, DOI 10.1182/blood-2012-01-402156; Wang J, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201707360; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wang M, 2021, ONCOGENE, V40, P2296, DOI 10.1038/s41388-021-01722-8; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Wang X, 2015, ONCOL REP, V33, P2445, DOI 10.3892/or.2015.3843; Wang XK, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1114-z; Wheatley SP, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223826; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Willms E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00738; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Wu BR, 2019, ONCOL REP, V42, P2528, DOI 10.3892/or.2019.7361; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Wu LJ, 2016, TUMOR BIOL, V37, P12169, DOI 10.1007/s13277-016-5071-5; Xavier CPR, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051141; Xia Y, 2017, ONCOTARGET, V8, P37783, DOI 10.18632/oncotarget.16354; Xie FT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1074-3; Yamashita T, 2013, PHARMAZIE, V68, P969, DOI 10.1691/ph.2013.3599; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang HO, 2018, MOL THER, V26, P2466, DOI 10.1016/j.ymthe.2018.07.023; Yang L, 2013, MOL MED REP, V8, P1272, DOI 10.3892/mmr.2013.1634; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Yang ZY, 2020, CELL ONCOL, V43, P123, DOI 10.1007/s13402-019-00476-6; Yoshii S, 2019, CANCER SCI, V110, P2396, DOI 10.1111/cas.14084; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00518; Zhang HY, 2018, NAT CELL BIOL, V20, P332, DOI 10.1038/s41556-018-0040-4; Zhang J., 2017, PROTEOMICS, V17, P1; Zhang Q, 2021, GASTROENTEROLOGY, V160, P958, DOI 10.1053/j.gastro.2020.09.042; Zhang Q, 2019, CELL REP, V27, P940, DOI 10.1016/j.celrep.2019.01.009; Zhao JG, 2019, CANCERS, V11, DOI 10.3390/cancers11060874; Zhao L, 2015, ACTA BIOMATER, V20, P155, DOI 10.1016/j.actbio.2015.03.036; Zhou BT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00258-9; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zijlstra A, 2018, NAT CELL BIOL, V20, P228, DOI 10.1038/s41556-018-0049-8; Zong SF, 2018, NANOTECHNOLOGY, V29, DOI 10.1088/1361-6528/aaa375	272	5	5	2	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	JUL	2021	13	13							3324	10.3390/cancers13133324	http://dx.doi.org/10.3390/cancers13133324			36	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	TG2RC	34283059	Green Published, gold			2022-09-04	WOS:000671256300001
J	Cubillos, L; Bartels, SM; Torrey, WC; Naslund, J; Uribe-Restrepo, JM; Gaviola, C; Diaz, SC; John, DT; Williams, MJ; Cepeda, M; Gomez-Restrepo, C; Marsch, LA				Cubillos, Leonardo; Bartels, Sophia M.; Torrey, William C.; Naslund, John; Uribe-Restrepo, Jose Miguel; Gaviola, Chelsea; Diaz, Sergio Castro; John, Deepak T.; Williams, Makeda J.; Cepeda, Magda; Gomez-Restrepo, Carlos; Marsch, Lisa A.			The effectiveness and cost-effectiveness of integrating mental health services in primary care in low- and middle-income countries: systematic review	BJPSYCH BULLETIN			English	Review						Mental health integration; depression; alcohol use; primary care; provision of services	BRIEF PSYCHOLOGICAL TREATMENT; RANDOMIZED CONTROLLED-TRIAL; SUBSTANCE USE DISORDERS; REDUCE ALCOHOL-USE; BRIEF INTERVENTION; ANXIETY DISORDERS; SOUTH-AFRICA; DEPRESSION; INDIA; PROGRAM	Aims and method This systematic review examines the effectiveness and cost-effectiveness of behavioural health integration into primary healthcare in the management of depression and unhealthy alcohol use in low- and middle-income countries. Following PRISMA guidelines, this review included research that studied patients aged >= 18 years with unhealthy alcohol use and/or depression of any clinical severity. An exploration of the models of integration was used to characterise a typology of behavioural health integration specific for low- and middle-income countries. Results Fifty-eight articles met inclusion criteria. Studies evidenced increased effectiveness of integrated care over treatment as usual for both conditions. The economic evaluations found increased direct health costs but cost-effective estimates. The included studies used six distinct behavioural health integration models. Clinical implications Behavioural health integration may yield improved health outcomes, although it may require additional resources. The proposed typology can assist decision-makers to advance the implementation of integrated models.	[Cubillos, Leonardo; Bartels, Sophia M.; Torrey, William C.; Gaviola, Chelsea; John, Deepak T.; Marsch, Lisa A.] Geisel Sch Med Dartmouth, Ctr Technol & Behav Hlth, Hanover, NH 03755 USA; [Cubillos, Leonardo; Torrey, William C.; Marsch, Lisa A.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA; [Torrey, William C.; Marsch, Lisa A.] Geisel Sch Med Dartmouth, Dartmouth Inst, Hanover, NH USA; [Naslund, John] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Uribe-Restrepo, Jose Miguel; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Dept Psychiat & Mental Hlth, Bogota, Colombia; [Diaz, Sergio Castro; Cepeda, Magda; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Williams, Makeda J.] NIMH, Ctr Global Mental Hlth Res, Bethesda, MD 20892 USA		Cubillos, L (corresponding author), Geisel Sch Med Dartmouth, Ctr Technol & Behav Hlth, Hanover, NH 03755 USA.; Cubillos, L (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA.	leonardo.cubillos@dartmouth.edu		Uribe Restrepo, Jose Miguel/0000-0003-4284-7886; Gaviola, Chelsea/0000-0002-1020-1098; Castro Diaz, Sergio/0000-0001-6820-8711; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Cubillos, Leonardo/0000-0003-1436-1854; Cepeda-Gil, Magda/0000-0003-4579-6033	National Institute of Mental Health of the National Institutes of Health (NIH) [1U19MH109988]	National Institute of Mental Health of the National Institutes of Health (NIH)	Research reported in this publication was funded by the National Institute of Mental Health of the National Institutes of Health (NIH) under award number 1U19MH109988 (multiple Principal Investigators: Lisa A. Marsch, PhD, Dartmouth College, USA; Carlos Gomez-Restrepo, MD, Pontificia Universidad Javeriana, Colombia). The contents are solely the opinion of the authors and do not necessarily represent the views of the NIH or the United States Government.	Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Assanangkornchai S, 2015, ASIAN J PSYCHIATR, V18, P75, DOI 10.1016/j.ajp.2015.09.003; Barbui C, 2006, EPIDEMIOL PSICHIAT S, V15, P276, DOI 10.1017/S1121189X00002165; Lima AFBD, 2011, REV BRAS PSIQUIATR, V33, P245, DOI 10.1590/S1516-44462011000300007; Berbesi Dedsy, 2010, Rev. Fac. Nac. Salud Pública, V28, P48; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Butler M, 2008, INTEGRATION MENTAL H; Buttorff C, 2012, B WORLD HEALTH ORGAN, V90, P813, DOI 10.2471/BLT.12.104133; Chen SL, 2015, LANCET PSYCHIAT, V2, P332, DOI 10.1016/S2215-0366(15)00002-4; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Cuijpers P, 2018, WORLD PSYCHIATRY, V17, P90, DOI 10.1002/wps.20493; Cuijpers P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002542; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Degenhardt L, 2017, WORLD PSYCHIATRY, V16, P299, DOI 10.1002/wps.20457; Lara-Munoz MD, 2010, SALUD MENT, V33, P301; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Drummond M. F., 2015, METHODS EC EVALUATIO; Fairall LR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002178; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Ford JD, 2009, HARVARD BUS REV, V87, P99; Gillies D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007193.pub2; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Husain N, 2014, BEHAV COGN PSYCHOTH, V42, P693, DOI 10.1017/S1352465813000441; James S, 2002, INT J SOC PSYCHIATR, V48, P163, DOI 10.1177/002076402128783217; Jenkins R, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-25; Joint Commission, 2018, SENT EV POL; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Kaner EFS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Katon W, 2012, AM J PREV MED, V42, P550, DOI 10.1016/j.amepre.2012.01.017; Kazungu JS, 2018, INT J HEALTH PLAN M, V33, pE892, DOI 10.1002/hpm.2565; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; L'Engle KL, 2014, JAIDS-J ACQ IMM DEF, V67, P446, DOI 10.1097/QAI.0000000000000335; Malakouti Seyed Kazem, 2015, Med J Islam Repub Iran, V29, P208; Mertens JR, 2014, ALCOHOL ALCOHOLISM, V49, P430, DOI 10.1093/alcalc/agu030; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Nadkarni A, 2017, LANCET, V389, P186, DOI 10.1016/S0140-6736(16)31590-2; National Institute of Mental Health (NIMH), 2019, SCALING MENTAL HLTH; Noknoy S, 2010, ALCOHOL ALCOHOLISM, V45, P263, DOI 10.1093/alcalc/agq013; Papas RK, 2011, ADDICTION, V106, P2156, DOI 10.1111/j.1360-0443.2011.03518.x; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Patel V, 2010, WORLD PSYCHIATRY, V9, P169; Peltzer K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-699; Petersen I, 2012, COMMUNITY MENT HLT J, V48, P336, DOI 10.1007/s10597-011-9429-2; Pradeep J, 2014, INDIAN J MED RES, V139, P236; Rahman A, 2016, JAMA-J AM MED ASSOC, V316, P2609, DOI 10.1001/jama.2016.17165; Ramarumo M, 2016, J PSYCHOL AFR, V26, P78, DOI 10.1080/14330237.2015.1101282; Rendall-Mkosi K, 2013, ADDICTION, V108, P725, DOI 10.1111/add.12081; Richards DA, 2012, CAN J PSYCHIAT, V57, P210, DOI 10.1177/070674371205700403; Rojas G, 2014, REV MED CHILE, V142, P1142, DOI 10.4067/S0034-98872014000900008; Rotheram-Borus MJ, 2015, AM J PREV MED, V49, P715, DOI 10.1016/j.amepre.2015.05.004; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Seidman G, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0200-9; Simon GE, 2001, AM J PSYCHIAT, V158, P1638, DOI 10.1176/appi.ajp.158.10.1638; Siskind D, 2010, BRIT J PSYCHIAT, V197, P291, DOI 10.1192/bjp.bp.109.068957; Sorsdahl K, 2015, COMMUNITY MENT HLT J, V51, P962, DOI 10.1007/s10597-015-9853-9; Stokes J, 2018, HEALTH POLICY, V122, P963, DOI 10.1016/j.healthpol.2018.07.003; Struckmann V., 2017, EUROPEAN OBSERVATORY; Substance Abuse and Mental Health Services Administration (SAMSHA), 2013, STANDARD FRAMEWORK L; Thavorncharoensap M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-323; Tice JA, 2015, INTEGRATING BEHAV HL; Uribe Jose Miguel, 2017, Value Health Reg Issues, V14, P15, DOI 10.1016/j.vhri.2017.03.001; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Wagstaff A., 2018, 2018 HLTH EQUITY FIN; Weiss WM, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0622-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Bank, WORLD BANK COUNTRY L; World Health Organisation, 2017, DEPR OTH COMM MENT D; World Health Organisation, 2008, TASK SHIFTING GLOBAL; World Health Organization, 2016, MHGAP INTERVENTION G; World Health Organization, 2003, WHO GUIDE COST EFFEC; World Health Organization, 2018, WORLD HLTH STAT; World Health Organization (WHO), 2018, VISION PRIMARY HLTH; World Health Organization World Organisation of National Colleges Academies and Academic Associations of General Practitioners/Family Physicians, 2008, INTEGRATING MENTAL H	81	10	10	0	3	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	2056-4694	2056-4708		BJPSYCH BULL	BJPsych Bull.	FEB	2021	45	1					40	52	PII S2056469420000352	10.1192/bjb.2020.35	http://dx.doi.org/10.1192/bjb.2020.35			13	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	PY9GD	32321610	Green Published, gold			2022-09-04	WOS:000612347900009
J	Perez-Sousa, MA; Venegas-Sanabria, LC; Chavarro-Carvajal, DA; Cano-Gutierrez, CA; Izquierdo, M; Correa-Bautista, JE; Ramirez-Velez, R				Perez-Sousa, Miguel A.; Carlos Venegas-Sanabria, Luis; Andres Chavarro-Carvajal, Diego; Alberto Cano-Gutierrez, Carlos; Izquierdo, Mikel; Enrique Correa-Bautista, Jorge; Ramirez-Velez, Robinson			Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Article						Gait speed; Sarcopenia; Elderly; Functional Capacity; Latin-American	WALKING SPEED; OLDER-ADULTS; MUSCLE MASS; INCIDENT DISABILITY; CALF CIRCUMFERENCE; EXERCISE; FRAILTY; INDEPENDENCE; PERFORMANCE; PREVALENCE	Background Sarcopenia in older adults is strongly associated with an increase in dependency in activities of daily living (ADL) and with a decline in gait speed. Interestingly, gait speed has been shown to independently predict mortality. In this context, our study aimed to explore the mediator role of gait speed on the relationship between sarcopenia and dependency in ADL. Methods A cross-sectional study was conducted in Colombia, 19 705 older adults with a mean age of 70 years, 55.6% women, 16.1% with sarcopenia, and 14.7% mild, moderate, or severe dependency in ADL, according to 'SABE Survey 2015'. Sarcopenia was assessed by calf circumference and ADL dependence through the Barthel Index. Gait speed was measured over a distance of 3 m. The association between sarcopenia condition and gait speed and dependency level was analysed by linear regression adjusted by covariates. To examine whether gait speed mediated the association between sarcopenia and dependence components of physical function, simple mediation models were generated using ordinary least squares with the macro PROCESS version 3.2, adjusted for age, sex, and body mass index (BMI). Results Significant differences (P < 0.05) were found in gait speed and dependency in ADL between the sarcopenia and non-sarcopenia groups after adjusting for age, sex, and BMI. BMI was significantly higher in the non-sarcopenia group whereas dependency was significantly higher in the sarcopenia group (19.6% vs. 13.8%). Results from mediation model regression analysis indicated a significant and direct detrimental effect of sarcopenia on dependency in ADL (beta = -0.05; P < 0.001), and a significant indirect effect of gait speed on the direct effect (-0.009 to -0.004). Conclusions The negative effect of sarcopenia on functional dependence was mediated by the gait speed. Therefore, gait speed may positively influence the detrimental effect of sarcopenia for dependency, after adjusting for age, gender, and BMI. Consequently, physical exercise should be promoted and focused to circumvent the gait speed decline associated with age in older people with sarcopenia.	[Perez-Sousa, Miguel A.] Univ Huelva, Fac Sport Sci, Huelva, Spain; [Carlos Venegas-Sanabria, Luis; Andres Chavarro-Carvajal, Diego; Alberto Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Aging Inst, Bogota, Colombia; [Izquierdo, Mikel; Enrique Correa-Bautista, Jorge; Ramirez-Velez, Robinson] Univ Publ Navarra, Inst Salud Carlos III, Dept Hlth Sci, Navarrabiomed,CIBER Frailty & Hlth Aging CIBERFES, Pamplona, Spain		Izquierdo, M (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Av De Baranain S-N, Pamplona 31008, Navarra, Spain.	mikel.izquierdo@gmail.com	Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Ramírez-Vélez, Robinson/D-5311-2016; Perez-Sousa, Miguel A./M-5931-2019; Chavarro-Carvajal, Diego Andres/F-5659-2019	Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Perez-Sousa, Miguel A./0000-0003-4392-6850; Chavarro-Carvajal, Diego Andres/0000-0002-8584-3191; Venegas-Sanabria, Luis Carlos/0000-0001-8260-9108; Cano-Gutierrez, Carlos/0000-0001-5680-7880				Auyeung TW, 2014, GERIATR GERONTOL INT, V14, P76, DOI 10.1111/ggi.12213; Bernaola-Sagardui I, 2018, ENFERM CLIN, V28, P210, DOI [10.1016/j.enfcli.2017.12.001, 10.1016/j.enfcli.2017.17.001]; Bravo-Jose P, 2018, CLIN NUTR ESPEN, V27, P113, DOI 10.1016/j.clnesp.2018.05.008; Cadore EL, 2015, AGE, V37, DOI 10.1007/s11357-015-9800-2; Cesari M, 2015, J GERONTOL A-BIOL, V70, P457, DOI 10.1093/gerona/glu181; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Diaz Villegas Gregory Mishell, 2015, Rev Esp Geriatr Gerontol, V50, P22, DOI 10.1016/j.regg.2014.06.002; dos Santos L, 2017, J CACHEXIA SARCOPENI, V8, P245, DOI 10.1002/jcsm.12160; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fuggle N, 2017, BEST PRACT RES CL RH, V31, P218, DOI 10.1016/j.berh.2017.11.007; Gomez F., 2016, CURRENT GERONTOLOGY, V2016, P7910205, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Graham JE, 2010, PHYS THER, V90, P1591, DOI 10.2522/ptj.20100018; Hayes AF., 2018, INTRO MEDIATION MODE, V2nd ed.; Hsu B, 2018, J AM MED DIR ASSOC, V19, P216, DOI 10.1016/j.jamda.2017.08.018; Hsu WC, 2016, CLIN NUTR, V35, P735, DOI 10.1016/j.clnu.2015.05.017; Kawakami R, 2015, GERIATR GERONTOL INT, V15, P969, DOI 10.1111/ggi.12377; Kim Seong-Kyu, 2018, J Korean Med Sci, V33, pe188, DOI 10.3346/jkms.2018.33.e188; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lopez-Teros T, 2014, J FRALITY AGING, V3, P109, DOI 10.14283/jfa.2014.10; Lustosa LP, 2017, CLIN INTERV AGING, V12, P1183, DOI 10.2147/CIA.S139579; Manikandan S, 2010, J PHARMACOL PHARMACO, V1, P126, DOI 10.4103/0976-500X.72373; Masanes Toran F, 2010, SEMIN FUND ESP REUMA, V11, P14; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Mlinac ME, 2016, ARCH CLIN NEUROPSYCH, V31, P506, DOI 10.1093/arclin/acw049; Nicklas BJ, 2009, EXERC SPORT SCI REV, V37, P165, DOI 10.1097/JES.0b013e3181b7b3d9; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Samper-Ternent R, 2017, AGING CLIN EXP RES, V29, P265, DOI 10.1007/s40520-016-0561-2; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; Verghese J, 2011, J GERONTOL A-BIOL, V66, P1083, DOI 10.1093/gerona/glr099; Veronese N, 2018, J AM MED DIR ASSOC, V19, P981, DOI 10.1016/j.jamda.2018.06.007; von Haehling S, 2017, J CACHEXIA SARCOPENI, V8, P1081, DOI 10.1002/jcsm.12261; Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006; Yoo SZ, 2018, J EXERC REHABIL, V14, P551, DOI 10.12965/jer.1836268.134	42	33	33	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Cachexia Sarcopenia Muscle	OCT	2019	10	5					1009	1015		10.1002/jcsm.12444	http://dx.doi.org/10.1002/jcsm.12444			7	Geriatrics & Gerontology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; General & Internal Medicine	JH8MW	31066999	Green Published, gold			2022-09-04	WOS:000493023300007
J	McEniry, M; Samper-Ternent, R; Florez, CE; Cano-Gutierrez, C				McEniry, Mary; Samper-Ternent, Rafael; Elisa Florez, Carmen; Cano-Gutierrez, Carlos			Early Life Displacement Due to Armed Conflict and Violence, Early Nutrition, and Older Adult Hypertension, Diabetes, and Obesity in the Middle-Income Country of Colombia	JOURNAL OF AGING AND HEALTH			English	Article						early life; displacement due to violence; hypertension; diabetes; obesity; middle-income countries	BLOOD-PRESSURE; HEALTH; RISK; HEIGHT; PREVALENCE; MORTALITY; BURDEN	Objective: We examine the importance of early life displacement and nutrition on hypertension (HTN) and diabetes in older Colombian adults (60+ years) exposed to rapid demographic, epidemiological, and nutritional transitions, and armed conflict. We compare early life nutritional status and adult health in other middle- and high-income countries. Method: In Colombia (Survey of Health, Wellbeing and Aging [SABE]-Bogota), we estimate the effects of early life conditions (displacement due to armed conflict and violence, hunger, low height, and not born in the capital city) and obesity on adult health; we compare the effects of low height on adult health in Mexico, South Africa (Study on Global Ageing and Adult Health [SAGE]), the United States, and England (Health and Retirement Study [HRS], English Longitudinal Study of Ageing [ELSA]). Results: Early life displacement, early poor nutrition, and adult obesity increase the risk of HTN and diabetes in Colombia. Being short is most detrimental for HTN in Colombian males. Discussion: Colombian data provide new evidence into how early life conditions and adult obesity contribute to older adult health.	[McEniry, Mary] Univ Wisconsin Madison, Madison, WI USA; [Samper-Ternent, Rafael] Univ Texas Med Branch, Galveston, TX USA; [Elisa Florez, Carmen] Univ Rosario, Bogota, Colombia; [Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Bogota, Colombia		McEniry, M (corresponding author), Univ Wisconsin Madison, Ctr Demog & Ecol, Madison, WI 53706 USA.	mmceniry@ssc.wisc.edu		Samper-Ternent, Rafael/0000-0002-2250-9401; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Mary, McEniry/0000-0003-2636-0250	NIA NIH HHS [P30 AG059301, R01 AG018016, P30 AG024832, P30 AG017266] Funding Source: Medline; NICHD NIH HHS [P2C HD047873] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018016, P30AG017266, P30AG024832] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albala C, 1997, REV MED CHILE, V125, P719; [Anonymous], 2016, URB POP TOT; Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Barker DJP, 1998, MOTHERS BABIES HLTH; Bateson P., 2011, PLASTICITY ROBUSTNES; Cano-Gutierrez C., 2016, MARKERS VIOLENCE OLD; Carrillo-Larco RM, 2016, INT J OBESITY, V40, P181, DOI 10.1038/ijo.2015.140; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Crimmins EM, 2010, INT DIFFERENCES MORT, P68, DOI [DOI 10.17226/12945, 10.17226/12945]; Dubow, 1995, SEGREGATION APARTHEI; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; FAO, 2016, FOOD BALANCE SHEETS; FAO, 1946, WORLD FOOD SURV; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Florez C. E., 2016, WORKING PAPER; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; GLUCKMAN P, 2005, FETAL MATRIX EVOLUTI; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Gomez F, 2009, J AM GERIATR SOC, V57, P1692, DOI 10.1111/j.1532-5415.2009.02341.x; Gordon JE, 1968, INTERACTIONS NUTR IN, P40; Haden A., 2000, WORLD HLTH REP 2000; Hebert JR, 1998, JNCI-J NATL CANCER I, V90, P1637, DOI 10.1093/jnci/90.21.1637; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Internal Displacement Monitoring Center, 2015, GLOB OV 2015 PEOPL I; Janghorbani M, 2012, OBES REV, V13, P1172, DOI 10.1111/j.1467-789X.2012.01030.x; Korhonen PE, 2017, J HYPERTENS, V35, P1170, DOI 10.1097/HJH.0000000000001300; Kowal P, 2016, AGING WORLD 2015 INT; Kuh D., 2004, LIFE COURSE APPROACH, P371, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; McEniry M, 2013, J DEV ORIG HLTH DIS, V4, P10, DOI 10.1017/S2040174412000499; McEniry M, 2009, 200904 CDE U WISC MA; McEniry M. C., 2015, ICPSR34241V1; Palloni A, 2013, DEMOGR RES, V29, P543, DOI 10.4054/DemRes.2013.29.21; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Raghunathan T. E., 2003, J OFF STAT, V19, P1, DOI DOI 10.1515/J0S-2015-0006; Riley J. C., 2005, BIBLIO WORKS PROVIDI; Rodriguez de Romo A. C., 1998, HIST CIENC SAUDE-MAN, VV, P290, DOI [10.1590/S0104-59701998000200002, DOI 10.1590/S0104-59701998000200002]; Samper-Ternent R, 2012, SALUD PUBLICA MEXICO, V54, P487, DOI 10.1590/S0036-36342012000500005; Schmidhuber J., 2005, ACTA AGR SCAND C, V2, P150, DOI DOI 10.1080/16507540500534812; Song LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep39480; Taylor SE, 2010, P NATL ACAD SCI USA, V107, P8507, DOI 10.1073/pnas.1003890107; The World Bank Group, 2017, GINI IND WORLD BANK; Timaeus I. M., 2006, AGING SUBSAHARAN AFR, P250; United Nations High Commissioner for Refugees, 2017, GLOBAL TRENDS FORCED; United Nations Statistical Office & the Department of Economic and Social Affairs, 1958, STAT YB, V10; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Vargas-Uricoechea H, 2015, ANN GLOB HEALTH, V81, P742, DOI 10.1016/j.aogh.2015.11.001; Wilson DK, 2004, CURR HYPERTENS REP, V6, P321, DOI 10.1007/s11906-004-0028-2; World Bank Group, 2017, GNI PER CAP ATL METH; World Health Organization, 2016, GLOB REP PSOR, DOI DOI 10.1093/eurheartj/ehz300; World Health Organization, 2015, WORLD HLTH STAT 2015; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	55	2	2	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0898-2643	1552-6887		J AGING HEALTH	J. Aging Health	SEP	2019	31	8					1479	1502		10.1177/0898264318778111	http://dx.doi.org/10.1177/0898264318778111			24	Gerontology; Health Policy & Services	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Health Care Sciences & Services	IR5EF	29916766	Green Accepted			2022-09-04	WOS:000481455100007
J	McEniry, M; Samper-Ternent, R; Florez, CE; Pardo, R; Cano-Gutierrez, C				McEniry, Mary; Samper-Ternent, Rafael; Elisa Florez, Carmen; Pardo, Renata; Cano-Gutierrez, Carlos			Patterns of SES Health Disparities Among Older Adults in Three Upper Middle- and Two High-Income Countries	JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES			English	Article						Diabetes; Health disparities; Hypertension; Middle-income countries; Obesity; Socioeconomic status	UNITED-STATES; SOCIOECONOMIC INEQUALITIES; EDUCATIONAL-ATTAINMENT; SOUTH-AFRICA; OBESITY; MORTALITY; HYPERTENSION; PREVALENCE; NUTRITION; POPULATION	Objectives: To examine the socioeconomic status (SES) health gradient for obesity, diabetes, and hypertension within a diverse group of health outcomes and behaviors among older adults (60+) in upper middle-income countries benchmarked with high-income countries. Method: We used data from three upper middle-income settings (Colombia-SABE-Bogota, Mexico-SAGE, and South Africa-SAGE) and two high-income countries (England-ELSA and US-HRS) to estimate logistic regression models using age, gender, and education to predict health and health behaviors. Results: The sharpest gradients appear in middle-income settings but follow expected patterns found in high-income countries for poor self-reported health, functionality, cognitive impairment, and depression. However, weaker gradients appear for obesity, hypertension, diabetes, and other chronic conditions in Colombia and Mexico and the gradient reverses in South Africa. Strong disparities exist in risky health behaviors and in early nutritional status in the middle-income settings. Discussion: Rapid demographic and nutritional transitions, urbanization, poor early life conditions, social mobility, negative health behavior, and unique country circumstances provide a useful framework for understanding the SES health gradient in middle-income settings. In contrast with high-income countries, the increasing prevalence of obesity, an important risk factor for chronic conditions and other aspects of health, may ultimately change the SES gradient for diseases in the future.	[McEniry, Mary] Univ Wisconsin, Ctr Demog & Ecol, Madison, WI 53706 USA; [Samper-Ternent, Rafael] Univ Texas Med Branch, Dept Internal Med, Div Geriatr, Galveston, TX 77555 USA; [Elisa Florez, Carmen] Univ Rosario, Dept Econ, Bogota, Colombia; [Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Fac Med, Inst Aging, Bogota, Colombia		McEniry, M (corresponding author), Univ Wisconsin, Ctr Demog & Ecol, Madison, WI 53706 USA.	mmceniry@ssc.wisc.edu		Cano-Gutierrez, Carlos/0000-0001-5680-7880; Samper-Ternent, Rafael/0000-0002-2250-9401	Fulbright Commission in Colombia; Colombian Department of Science, Technology, and Innovation (Colciencias); Aging Institute at the Pontificia Universidad Javeriana, Bogota; National Institute of Health [P2C HD047873]; Center for Demography of Health and Aging, University of Wisconsin [P30 AG017266]; Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Claude D. Pepper OAIC [P30-AG024832]; National Institutes of Health/National Institute on Aging [R01AG018016]; NATIONAL INSTITUTE ON AGING [P30AG017266, P30AG024832] Funding Source: NIH RePORTER	Fulbright Commission in Colombia; Colombian Department of Science, Technology, and Innovation (Colciencias); Aging Institute at the Pontificia Universidad Javeriana, Bogota; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Demography of Health and Aging, University of Wisconsin; Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Claude D. Pepper OAIC; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Fulbright Commission in Colombia, the Colombian Department of Science, Technology, and Innovation (Colciencias), and the Aging Institute at the Pontificia Universidad Javeriana, Bogota, within the framework of the Fulbright U.S. Scholar program, Cohort 2016-17. University of Wisconsin-Madison researchers are supported by National Institute of Health core grants to the Center for Demography and Ecology, University of Wisconsin (P2C HD047873); and the Center for Demography of Health and Aging, University of Wisconsin (P30 AG017266). Dr. Samper-Ternent was supported by the Sealy Center on Aging at the University of Texas Medical Branch in Galveston, Claude D. Pepper OAIC (P30-AG024832) and The Mexican Health and Aging Study (R01AG018016) from grants of the National Institutes of Health/National Institute on Aging.	Agyemang C, 2010, AM J HYPERTENS, V23, P639, DOI 10.1038/ajh.2010.39; Alaba O, 2014, INT J ENV RES PUB HE, V11, P3387, DOI 10.3390/ijerph110303387; Anand A, 2014, BEHAV HLTH, V1, P1; [Anonymous], 2016, P95161 US CENS BUR; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Barker DJP, 1998, MOTHERS BABIES HLTH; Bateson P., 2011, PLASTICITY ROBUSTNES; Beltran-Sanchez H, 2016, DEMOGRAPHY, V53, P1555, DOI 10.1007/s13524-016-0508-4; Bhorat H., 2009, 09138 DPRU TRAD IND, DOI [10.2139/ssrn.1474271, DOI 10.2139/SSRN.1474271]; Carrillo-Larco RM, 2016, INT J OBESITY, V40, P181, DOI 10.1038/ijo.2015.140; CHDS, 2008, CLOS GAP GEN HLTH EQ; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Dubow, 1995, SEGREGATION APARTHEI; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; FAO, 2017, FOOD BALANCE SHEETS; FAO, 1946, WORLD FOOD SURV; Florez C. E., 2016, WORKING PAPER; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Franco R., 2007, STRATIFICATION SOCIA; GLUCKMAN P, 2005, FETAL MATRIX EVOLUTI; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Goldman N, 2011, SOC SCI MED, V72, P307, DOI 10.1016/j.socscimed.2010.11.004; Hebert JR, 1998, JNCI-J NATL CANCER I, V90, P1637, DOI 10.1093/jnci/90.21.1637; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; Kuh D., 2004, LIFE COURSE APPROACH, P371, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lopez-Alonso M, 2007, J LAT AM STUD, V39, P81, DOI 10.1017/S0022216X06002045; Malambo P, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0167-3; Martorell R, 2001, J NUTR, V131, p874S, DOI 10.1093/jn/131.3.874S; McEniry M. C., 2015, ICPSR34241, DOI [10.3886/ICPSR34241.v2, DOI 10.3886/ICPSR34241.V2]; McEniry M. C., 2014, EARLY LIFE CONDITION, DOI [10.1007/078-94-007-6979-3, DOI 10.1007/078-94-007-6979-3]; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Montez JK, 2012, DEMOGRAPHY, V49, P315, DOI 10.1007/s13524-011-0082-8; Palloni A, 2013, DEMOGR RES, V29, P543, DOI 10.4054/DemRes.2013.29.21; Pampel FC, 2012, SOC SCI MED, V74, P1073, DOI 10.1016/j.socscimed.2011.12.028; Payne CF, 2017, J GERONTOL B-PSYCHOL, V72, P665, DOI 10.1093/geronb/gbx030; Popkin B., 2001, NUTR TRANSITION DIET; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riley J. C., 2005, BIBLIO WORKS PROVIDI; Rodriguez de Romo A C, 1998, Hist Cienc Saude Manguinhos, V5, P293; Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004; Schmidhuber J., 2005, 97 SEM EUR ASS AGR E; SMITH GD, 2004, LIFE COURSE APPROACH, P77, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; Smith KV, 2007, SOC SCI MED, V65, P1372, DOI 10.1016/j.socscimed.2007.05.023; The World Bank Group, 2017, GINI IND WORLD BANK; Timaeus I. M., 2006, AGING SUBSAHARAN AFR, P250; United Nations Development Programme, 2018, HUMAN DEV REPORT 201; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Vargas-Uricoechea H, 2015, ANN GLOB HEALTH, V81, P742, DOI 10.1016/j.aogh.2015.11.001; Vellakkal S, 2015, J EPIDEMIOL COMMUN H, V69, P218, DOI 10.1136/jech-2014-204621; Wilkinson RG., 1996, UNHEALTHY SOC AFFLIC; World Bank Group, 2017, GNI PER CAP ATL METH; World Bank Group, 2017, LAC EQ LAB INC IN UR; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2015, WORLD HLTH STAT 2015; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	59	2	2	4	18	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5014	1758-5368		J GERONTOL B-PSYCHOL	J. Gerontol. Ser. B-Psychol. Sci. Soc. Sci.	SEP	2019	74	6					E25	E37		10.1093/geronb/gby050	http://dx.doi.org/10.1093/geronb/gby050			13	Geriatrics & Gerontology; Gerontology; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychology	JI3PF	29684199	Green Published			2022-09-04	WOS:000493377400003
J	Rodriguez-Lopez, A; Pimentel-Vera, LN; Espejo-Mojica, AJ; Van Hecke, A; Tiels, P; Tomatsu, S; Callewaert, N; Almeciga-Diaz, CJ				Rodriguez-Lopez, Alexander; Pimentel-Vera, Luisa N.; Espejo-Mojica, Angela J.; Van Hecke, Annelies; Tiels, Petra; Tomatsu, Shunji; Callewaert, Nico; Almeciga-Diaz, Carlos J.			Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Morquio A; mucopolysaccharidosis IV A; GALNS; Pichia pastoris; glycosylations	ACID ALPHA-GLUCOSIDASE; REPLACEMENT THERAPY; ELOSULFASE ALPHA; LYSOSOMAL-ENZYMES; MANNOSE RECEPTOR; PROTEIN GLYCOSYLATION; MEDIATED DELIVERY; CELLULAR UPTAKE; MORQUIO; DISEASE	Mucopolysaccharidosis IVA (MPS IVA or Morquio A syndrome) is a lysosomal storage disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), leading to lysosomal storage of keratan sulfate and chondroitin-6-sulfate. Currently, enzyme replacement therapy using an enzyme produced in CHO cells represents the main treatment option for MPS IVA patients. As an alternative, we reported the production of an active GALNS enzyme produced in the yeast Pichia pastoris (prGALNS), which showed internalization by cultured cells through a potential receptor-mediated process and similar post-translational processing as human enzyme. In this study, we further studied the therapeutic potential of prGALNS through the characterization of the N-glycosylation structure, in vitro cell uptake and keratan sulfate reduction, and in vivo biodistribution and generation of anti-prGALNS antibodies. Taken together, these results represent an important step in the development of a P. pastoris-based platform for production of a therapeutic GALNS for MPS IVA enzyme replacement therapy. (C) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.	[Rodriguez-Lopez, Alexander; Pimentel-Vera, Luisa N.; Espejo-Mojica, Angela J.; Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Sch Sci, Inst Study Inborn Errors Metab, Bogota, Colombia; [Rodriguez-Lopez, Alexander] Pontificia Univ Javeriana, Sch Sci, Chem Dept, Bogota, Colombia; [Rodriguez-Lopez, Alexander; Van Hecke, Annelies; Tiels, Petra; Callewaert, Nico] VIB Ctr Med Biotechnol, Ghent, Belgium; [Rodriguez-Lopez, Alexander; Van Hecke, Annelies; Tiels, Petra; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [Tomatsu, Shunji] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA; [Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia, Dept Orthoped, Wilmington, DE 19803 USA; [Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia, Dept BioMed, Wilmington, DE 19803 USA		Almeciga-Diaz, CJ (corresponding author), Pontificia Univ Javeriana, Sch Sci, Inst Study Inborn Errors Metab, Bogota, Colombia.	cjalmeciga@javeriana.edu.co	Alméciga-Díaz, Carlos J/A-2494-2017; Espejo, Angela/AAF-9020-2019; Rodriguez-Lopez, Alexander/E-6650-2015	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Van Hecke, Annelies/0000-0002-3010-8034; Rodriguez-Lopez, Alexander/0000-0001-5409-3466	Pontificia Universidad Javeriana [7204, 7520]; COLCIENCIAS [5174, 120356933205, 5170, 120356933427]	Pontificia Universidad Javeriana; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	A.R.L. received a doctoral scholarship from Pontificia Universidad Javeriana. A.J.E.M. received a doctoral scholarship from COLCIENCIAS. C.J.A.D. was supported by Pontificia Universidad Javeriana [Grant ID 7204 and 7520] and COLCIENCIAS [Grant ID 5174 -contract No. 120356933205, and Grant ID 5170 -contract No. 120356933427]. The authors declare that they have no competing interests. Data are available on request from the authors.	[Anonymous], 2018, MUCOPOLYSACCHARIDOSE; Ben Turkia H, 2013, AM J HEMATOL, V88, P179, DOI 10.1002/ajh.23382; Boer E, 2007, APPL MICROBIOL BIOT, V77, P513, DOI 10.1007/s00253-007-1209-0; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Clerc F, 2016, GLYCOCONJUGATE J, V33, P309, DOI 10.1007/s10719-015-9626-2; Connock M, 2006, HEALTH TECHNOL ASSES, V10, P1; Coutinho MF, 2012, MOL GENET METAB, V107, P257, DOI 10.1016/j.ymgme.2012.07.012; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dittmer F, 1999, J CELL SCI, V112, P1591; Dooley K C, 1980, J Inherit Metab Dis, V3, P145, DOI 10.1007/BF02312548; Du H, 2005, AM J HUM GENET, V77, P1061, DOI 10.1086/498652; Du H, 2001, HUM MOL GENET, V10, P1639, DOI 10.1093/hmg/10.16.1639; Du H, 2008, J LIPID RES, V49, P1646, DOI 10.1194/jlr.M700482-JLR200; Dvorak-Ewell M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012194; Espejo-Mojica A, 2013, MOL GENET METAB, V108, pS38, DOI 10.1016/j.ymgme.2012.11.082; Espejo-Mojica AJ, 2015, MOL GENET METAB, V116, P13, DOI 10.1016/j.ymgme.2015.06.001; Espejo-Mojica AJ, 2014, MOL GENET METAB, V111, pS42, DOI 10.1016/j.ymgme.2013.12.083; Friedman BA, 1999, BLOOD, V93, P2807; Fuller M, 1998, BBA-MOL BASIS DIS, V1406, P283, DOI 10.1016/S0925-4439(98)00011-8; Grubb JH, 2010, REJUV RES, V13, P229, DOI 10.1089/rej.2009.0920; Hagymasi Krisztina, 2004, Acta Pharm Hung, V74, P51; Hendriksz CJ, 2015, MOL GENET METAB, V114, P178, DOI 10.1016/j.ymgme.2014.08.012; Hendriksz CJ, 2014, J INHERIT METAB DIS, V37, P979, DOI 10.1007/s10545-014-9715-6; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jung JW, 2016, J BIOTECHNOL, V226, P44, DOI 10.1016/j.jbiotec.2016.03.031; Kreer C, 2017, ONCOTARGET, V8, P6857, DOI 10.18632/oncotarget.14314; Kubaski F, 2017, MOL GENET METAB, V120, P67, DOI 10.1016/j.ymgme.2016.09.005; Kubaski F, 2017, J INHERIT METAB DIS, V40, P151, DOI 10.1007/s10545-016-9981-6; Lalonde ME, 2017, J BIOTECHNOL, V251, P128, DOI 10.1016/j.jbiotec.2017.04.028; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Laukens B, 2015, FUTURE MICROBIOL, V10, P21, DOI 10.2217/fmb.14.104; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Limkul J, 2016, PLANT BIOTECHNOL J, V14, P1682, DOI 10.1111/pbi.12529; Liu YL, 2005, MOL THER, V11, P35, DOI 10.1016/j.ymthe.2004.08.027; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Melton AC, 2017, J IMMUNOL METHODS, V440, P41, DOI 10.1016/j.jim.2016.10.006; Mosquera A, 2012, PROCESS BIOCHEM, V47, P2097, DOI 10.1016/j.procbio.2012.07.028; Olarte-Avellaneda S, 2014, MOL BIOL REP, V41, P7073, DOI 10.1007/s11033-014-3383-3; Ou L, 2018, MOL GENET METAB, V123, P105, DOI 10.1016/j.ymgme.2017.11.013; Pimentel N, 2018, BIOTECHNOL APPL BIOC, V65, P655, DOI 10.1002/bab.1660; Puckett Y, 2017, EXPERT OPIN ORPHAN D, V5, P741, DOI 10.1080/21678707.2017.1366900; RICHARDS SM, 1993, BLOOD, V82, P1402; Rodriguez-Lopez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29329; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Sanford M, 2014, DRUGS, V74, P713, DOI 10.1007/s40265-014-0210-z; Sawamoto K, 2016, EXPERT OPIN ORPHAN D, V4, P941, DOI 10.1080/21678707.2016.1214572; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweighardt B, 2015, CLIN THER, V37, P1012, DOI 10.1016/j.clinthera.2014.11.005; Shen JS, 2016, J INHERIT METAB DIS, V39, P293, DOI 10.1007/s10545-015-9886-9; Shirley M, 2015, DRUGS, V75, P1935, DOI 10.1007/s40265-015-0479-6; Stratton J, 1998, METH MOL B, V103, P107; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; Teh SH, 2011, GENET MOL BIOL, V34, P464, DOI 10.1590/S1415-47572011005000022; Tekoah  Y., 2013, BIOSCI REP, V33; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2007, MOL GENET METAB, V91, P69, DOI 10.1016/j.ymgme.2007.01.004; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65, DOI 10.2147/RRED.S37278; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Vera M, 2013, PEDIATR RES, V74, P712, DOI 10.1038/pr.2013.158; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	68	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	AUG	2019	108	8					2534	2541		10.1016/j.xphs.2019.03.034	http://dx.doi.org/10.1016/j.xphs.2019.03.034			8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	IM1MO	30959056				2022-09-04	WOS:000477754400004
J	Forero, AJ; Munoz, M; Camargo, M; Soto-De Leon, SC; Rios-Chaparro, DI; Birchenall, C; Pinilla, D; Pardo, JM; Josa, DF; Patarroyo, MA; Ramirez, JD				Forero, Alex J.; Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Rios-Chaparro, Dora I.; Birchenall, Claudia; Pinilla, Dario; Pardo, Juan M.; Josa, Diego F.; Patarroyo, Manuel A.; Ramirez, Juan D.			High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogota, Colombia	GUT PATHOGENS			English	Article						Clostridium perfringens; Clostridium difficile; Diarrhea; Community-onset; Health care facility onset	INFECTION; TOXINS; TCDB	BackgroundThe aim of this study was to evaluate the frequency of toxigenic C. difficile and C. perfringens infections at health care facility-onset (HCFO) and community-onset (CO), in two health care centers (HCC) in Bogota, Colombia. A total of 220 stool samples from patients presenting diarrhea acquired at HCFO or CO were analyzed by several PCR tests.ResultsWe found that 65.5% (n=144) of the population had C. difficile infection, followed by toxigenic C. difficile with 57.3% (n=126), and finally toxigenic C. perfringens with a frequency of 32.7% (n=72).ConclusionsThis study is the first molecular detection and characterization of C. difficile and C. perfringens in HCFO and CO in Latin America and demonstrates a relevant frequency of these two species, including coinfection and strikingly diverse toxigenic profiles, especially in the CO.	[Forero, Alex J.; Munoz, Marina; Rios-Chaparro, Dora I.; Ramirez, Juan D.] Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Carrera 24 63C-69, Bogota, Colombia; [Forero, Alex J.] Pontificia Univ Javeriana, Especializac Microbiol Med, Bogota, Colombia; [Munoz, Marina] Univ Nacl Colombia, Fac Ciencias, Posgrad Interfac Doctorado Biotecnol, Bogota, Colombia; [Camargo, Milena; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Soto-De Leon, Sara C.] Univ Sinu, Fac Ciencias Salud, Lab Invest Biomed & Biol Mol, Monteria, Cordoba, Colombia; [Birchenall, Claudia; Pinilla, Dario; Pardo, Juan M.] Hosp Univ Mayor Mederi, Bogota, Colombia; [Josa, Diego F.] Fdn Clin Shaio, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia		Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Carrera 24 63C-69, Bogota, Colombia.	juand.ramirez@urosario.edu.co	De León, Sara Cecilia Soto/AAF-6301-2021; Pardo-Oviedo, Juan Mauricio/F-9140-2016; Leon, Sara Cecilia Soto-De/ABD-3186-2020; Josa, Diego/AAF-5868-2019; Patarroyo, Manuel A/I-8046-2016	De León, Sara Cecilia Soto/0000-0003-4515-6749; Pardo-Oviedo, Juan Mauricio/0000-0003-0084-3449; Josa, Diego/0000-0003-0870-7257; Patarroyo, Manuel A/0000-0002-4751-2500; Camargo, Milena/0000-0003-0246-0716	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) [617]; DIRECCION DE INVESTIGACION E INNOVACION from Universidad del Rosario	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); DIRECCION DE INVESTIGACION E INNOVACION from Universidad del Rosario	The Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) financed the PhD program to MM within the framework of the National Program for Promoting Research Training (sponsorship call 617). This work was funded By DIRECCION DE INVESTIGACION E INNOVACION from Universidad del Rosario.	Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Du PC, 2014, J CLIN MICROBIOL, V52, P3264, DOI 10.1128/JCM.03487-13; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Leslie JL, 2015, CURR OPIN MICROBIOL, V23, P121, DOI 10.1016/j.mib.2014.11.010; Navarro MA, 2018, TOXINS, V10, DOI 10.3390/toxins10050212; Persson S, 2011, J CLIN MICROBIOL, V49, P4299, DOI 10.1128/JCM.05161-11; Rineh A, 2014, EXPERT REV ANTI-INFE, V12, P131, DOI 10.1586/14787210.2014.866515; Rood JI, 2018, ANAEROBE, V53, P5, DOI 10.1016/j.anaerobe.2018.04.011; Roussan DA, 2012, POULTRY SCI, V91, P3080, DOI 10.3382/ps.2012-02368; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1111/j.1574-6968.2000.tb09122.x; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	14	3	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-4749			GUT PATHOG	Gut Pathogens	JUN 3	2019	11								27	10.1186/s13099-019-0308-7	http://dx.doi.org/10.1186/s13099-019-0308-7			6	Gastroenterology & Hepatology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Microbiology	IB3DM	31171939	Green Published, gold			2022-09-04	WOS:000470148200001
J	Nino, CL; Perez, GF; Isaza, N; Gutierrez, MJ; Gomez, JL; Nino, G				Nino, Cesar L.; Perez, Geovanny F.; Isaza, Natalia; Gutierrez, Maria J.; Gomez, Jose L.; Nino, Gustavo			Characterization of Sex-Based Dna Methylation Signatures in the Airways During Early Life	SCIENTIFIC REPORTS			English	Article							X-CHROMOSOME INACTIVATION; OBSTRUCTIVE PULMONARY-DISEASE; PRIMARY IMMUNODEFICIENCY; PREMATURE-INFANTS; GENE-EXPRESSION; ESCAPE; VARIABILITY; DIAGNOSIS; RESPONSES; SEVERITY	Human respiratory conditions are largely influenced by the individual's sex resulting in overall higher risk for males. Sex-based respiratory differences are present at birth suggesting a strong genetic component. Our objective was to characterize early life sex-based genomic signatures determined by variable X-chromosome methylation in the airways. We compared male versus female genome-wide DNA methylation in nasal airway samples from newborns and infants aged 1-6 months (N = 12). We analyzed methylation signals across CpG sites mapped to each X-linked gene using an unsupervised classifier (principal components) followed by an internal evaluation and an exhaustive cross-validation. Results were validated in an independent population of children (N = 72) following the same algorithm. X-linked genes with significant sex-based differential methylation in the nasal airway of infants represented only about 50% of the unique protein coding transcripts. X-linked genes without significant sex-based differential methylation included genes with evidence of escaping X-inactivation and female-biased airway expression. These genes showed similar methylation patterns in males and females suggesting unbalanced X-chromosome dosage. In conclusion, we identified that the human airways have already sex-based DNA methylation signatures at birth. These early airway epigenomic marks may determine sex-based respiratory phenotypes and overall predisposition to develop respiratory disorders later in life.	[Nino, Cesar L.] Pontificia Univ Javeriana, Dept Elect Engn, Bogota, Colombia; [Perez, Geovanny F.; Nino, Gustavo] Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA; [Perez, Geovanny F.; Nino, Gustavo] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Perez, Geovanny F.; Nino, Gustavo] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA; [Isaza, Natalia] Childrens Natl Med Ctr, Div Neonatol, Washington, DC 20010 USA; [Gutierrez, Maria J.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Gomez, Jose L.] Yale Univ, Sch Med, Div Pulm Crit Care & Sleep Med, New Haven, CT USA		Nino, G (corresponding author), Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA.; Nino, G (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Nino, G (corresponding author), Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA.	gnino@childrensnational.org	Gutierrez, Maria/AAK-2528-2021	Gutierrez, Maria Jimena/0000-0001-5494-5841; Perez, Geovanny/0000-0003-2843-6837; Gomez, Jose/0000-0002-6521-6318	NIH National Center for Advancing Translational Sciences [NIAID/AI130502-01A1, NHLBI/HL090020, NHLBI/HL125474-03, NICHC/HD001399, NCATS/UL1TR000075 KL2TR000076]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000076] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125474, K12HL090020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI130502] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIAID/AI130502-01A1, NHLBI/HL090020, NHLBI/HL125474-03, NICHC/HD001399, NCATS/UL1TR000075 KL2TR000076 Awards from the NIH National Center for Advancing Translational Sciences.	Ali S, 2003, GENE, V321, P25, DOI 10.1016/j.gene.2003.08.006; Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Ariumi Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00423; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Balaton BP, 2016, TRENDS GENET, V32, P348, DOI 10.1016/j.tig.2016.03.007; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Berletch JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005079; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, P1186, DOI 10.1016/j.jaci.2015.04.049; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Dugo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167460; Falagas ME, 2007, RESP MED, V101, P1845, DOI 10.1016/j.rmed.2007.04.011; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; James G., 2013, INTRO STAT LEARNING, DOI 10.1007/978-1-0716-1418-1.pdf; Kelley J, 2005, GENOMICS, V85, P503, DOI 10.1016/j.ygeno.2005.01.009; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Liptzin DR, 2015, PEDIATR PULM, V50, P1159, DOI 10.1002/ppul.23178; Luo FM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-26; Marsland S., 2015, MACHINE LEARNING ALG; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Mi H, 2016, NUCL ACIDS RES; Okumura K, 2008, HAEMOPHILIA, V14, P1088, DOI 10.1111/j.1365-2516.2008.01786.x; Pancham K, 2015, PEDIATR RES, V78, P389, DOI 10.1038/pr.2015.113; Payer B, 2016, SEMIN CELL DEV BIOL, V56, P88, DOI 10.1016/j.semcdb.2016.04.014; Peeters SB, 2014, BIOESSAYS, V36, P746, DOI 10.1002/bies.201400032; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373; Yang IV, 2016, J ALLERGY CLIN IMMUN; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148	35	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 3	2018	8								5526	10.1038/s41598-018-23063-5	http://dx.doi.org/10.1038/s41598-018-23063-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3ZK	29615635	Green Published, gold			2022-09-04	WOS:000428999200062
J	Orduna, JFG; Caviedes-Bucheli, J; Cespedes, MCM; Jimeno, EB; Biedma, BM; Segura-Egea, JJ; Lopez-Lopez, J				Gavino Orduna, Jose Francisco; Caviedes-Bucheli, Javier; Manzanares Cespedes, Maria C.; Berastegui Jimeno, Esther; Martin Biedma, Benjamin; Jose Segura-Egea, Juan; Lopez-Lopez, Jose			Use of Platelet-rich Plasma in Endodontic Procedures in Adults: Regeneration or Repair? A Report of 3 Cases with 5 Years of Follow-up	JOURNAL OF ENDODONTICS			English	Article						Adult regenerative endodontic procedure; apical periodontitis; open apex necrotic tooth; plasma-rich growth factors	IMMATURE PERMANENT TEETH; STEM-CELLS; PULP REVASCULARIZATION; APICAL PERIODONTITIS; CALCIUM HYDROXIDE; GROWTH-FACTORS; DOG TEETH; PAPILLA; TOOTH; SURVIVAL	Introduction: Regenerative endodontic procedures (REP) are a promising alternative for necrotic immature teeth in adolescents and children, but very little evidence is available on this alternative in long-lasting necrotic teeth with open apices in adults. REPs are designed to replace damaged structures of the pulp dentin complex, but no regeneration has been obtained in any of the cases described in necrotic immature permanent teeth with apical periodontitis with histologic results. The results are limited to periapical tissue repair with increasing root length, thickening of the root walls, and apical closure in young patients. In this series of cases, we report on the outcomes of the adjuvant use of autologous platelet-rich plasma (PRP) in endodontic therapy in adults by monitoring periapical tissue healing with periodic periapical radiographs and cone-beam computed tomographic scanning. Methods: Three teeth with apical periodontitis and open apices in 3 different patients from 21 to 35 years-old were evaluated. An REP was performed with the adjuvant use of PRP. Results: At controls, complete disappearance of the radiolucent lesions and the presence of calcified structures forming bridges occupying the pulp lumen were observed but not an ostensible thickening of root walls with a regeneration of pulp-dentin complex. Conclusions: The repair of periapical tissues with REPs of open apex teeth with apical periodontitis and in nonsurgical endodontic retreatment appears to be feasible in adults, but no regeneration was obtained in any of the present cases. The use of PRP may be a good choice as an autologous matrix because of its stability and induction; it contains growth factors and bioactive molecules like transforming growth factor beta, bone morphogenic proteins, insulinlike growth factors, and angiogenetic growth factors, which stimulate collagen production, angiogenesis, and cell differentiation. Anti-inflammatory and antibacterial properties have also been reported for this preparation, which are involved in all processes of repair.	[Gavino Orduna, Jose Francisco; Berastegui Jimeno, Esther] Univ Barcelona, Sch Dent, Dept Odonto Stomatol, Barcelona, Spain; [Manzanares Cespedes, Maria C.] Univ Barcelona, Fac Dent, Barcelona, Spain; [Caviedes-Bucheli, Javier] Pontificia Univ Javeriana, CIO, Bogota, Colombia; [Martin Biedma, Benjamin] Univ Santiago Compostela, Unit Dent Pathol & Therapeut II Sch Med & Dent, Santiago De Compostela, Spain; [Jose Segura-Egea, Juan] Univ Seville, Sch Dent, Dept Stomatol, Seville, Spain; [Lopez-Lopez, Jose] Univ Barcelona, Hosp Llobregat, Sch Dent,Oral Hlth & Masticatory Syst Grp, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain		Orduna, JFG (corresponding author), Hosp Llobregat, Sch Dent, Dept Odontoestomatol, Bellvitge Univ Campus,Pabellon Gobierno C Feixa L, Barcelona 08907, Spain.	dr.gavino@gmail.com	Céspedes, Maria Cristina Manzanares/H-5489-2015; Caviedes, Javier/O-5271-2019; Sánchez-Margalet, Victor/AAB-9986-2021; Segura-Egea, Juan J./A-6312-2009	Céspedes, Maria Cristina Manzanares/0000-0002-4585-4953; Caviedes, Javier/0000-0003-0407-9847; Sánchez-Margalet, Victor/0000-0001-8638-8680; Segura-Egea, Juan J./0000-0002-0427-9059; Martin Biedma, Benjamin/0000-0002-4297-4220				Abe S, 2008, BIOCHEM BIOPH RES CO, V371, P90, DOI 10.1016/j.bbrc.2008.04.016; Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x; Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x; Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003; Cehreli ZC, 2011, J ENDODONT, V37, P1327, DOI 10.1016/j.joen.2011.05.033; Chrepa V, 2015, J DENT RES, V94, P1653, DOI 10.1177/0022034515596527; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Diogenes A, 2013, ENDOD TOP, V28, P2, DOI [10.1111/etp.12040, DOI 10.1111/ETP.12040]; Garcia-Godoy F, 2012, DENT TRAUMATOL, V28, P33, DOI 10.1111/j.1600-9657.2011.01044.x; Holden DT, 2008, J ENDODONT, V34, P812, DOI 10.1016/j.joen.2008.04.003; Hoshino E, 1996, INT ENDOD J, V29, P125, DOI 10.1111/j.1365-2591.1996.tb01173.x; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001; Jadhav G, 2012, J ENDODONT, V38, P1581, DOI 10.1016/j.joen.2012.09.010; Jeeruphan T, 2012, J ENDODONT, V38, P1330, DOI 10.1016/j.joen.2012.06.028; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kim JH, 2010, J ENDODONT, V36, P1086, DOI 10.1016/j.joen.2010.03.031; Kishen Anil, 2016, J Conserv Dent, V19, P199, DOI 10.4103/0972-0707.181925; Latham J, 2016, J ENDODONT, V42, P1218, DOI 10.1016/j.joen.2016.05.004; Liao J, 2011, J ENDODONT, V37, P1217, DOI 10.1016/j.joen.2011.05.022; Lin LM, 2011, INT ENDOD J, V44, P889, DOI 10.1111/j.1365-2591.2011.01915.x; Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; Patel S, 2014, INT ENDOD J, V47, P502, DOI 10.1111/iej.12267; Reynolds K, 2009, INT ENDOD J, V42, P84, DOI 10.1111/j.1365-2591.2008.01467.x; Rodriguez-Benitez S, 2015, J ENDODONT, V41, P1299, DOI 10.1016/j.joen.2015.05.002; Rodriguez-Benitez Soledad, 2014, J Clin Exp Dent, V6, pe357, DOI 10.4317/jced.51475; Ruparel NB, 2012, J ENDODONT, V38, P1372, DOI 10.1016/j.joen.2012.06.018; Sato I, 1996, INT ENDOD J, V29, P118, DOI 10.1111/j.1365-2591.1996.tb01172.x; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shimizu E, 2012, J ENDODONT, V38, P1293, DOI 10.1016/j.joen.2012.06.017; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Starnbolsky C, 2016, ARCH ORAL BIOL, V71, P122, DOI 10.1016/j.archoralbio.2016.07.007; Thibodeau B, 2007, J ENDODONT, V33, P680, DOI 10.1016/j.joen.2007.03.001; Thomson A, 2010, AUST DENT J, V55, P446, DOI 10.1111/j.1834-7819.2010.01268.x; Torabinejad M, 2012, J ENDODONT, V38, P864, DOI 10.1016/j.joen.2012.03.006; Trevino EG, 2011, J ENDODONT, V37, P1109, DOI 10.1016/j.joen.2011.05.013; Vijayaraghavan R, 2012, J PHARM BIOALLIED SC, V4, pS230, DOI 10.4103/0975-7406.100214; Wang XJ, 2010, J ENDODONT, V36, P56, DOI 10.1016/j.joen.2009.09.039; Yasa B, 2015, CLIN ORAL INVEST, V19, P1437, DOI 10.1007/s00784-014-1364-5; Zhang DD, 2014, J ENDODONT, V40, P1388, DOI 10.1016/j.joen.2014.03.020	43	15	16	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	AUG	2017	43	8					1294	1301		10.1016/j.joen.2017.04.010	http://dx.doi.org/10.1016/j.joen.2017.04.010			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FE1NU	28662879				2022-09-04	WOS:000407985700013
J	Nunez, O; Gallart-Ayala, H; Martins, CPB; Lucci, P; Busquets, R				Nunez, Oscar; Gallart-Ayala, Hector; Martins, Claudia P. B.; Lucci, Paolo; Busquets, Rosa			State-of-the-art in fast liquid chromatography-mass spectrometry for bio-analytical applications	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Review						Bio-analysis; UHPLC column technology; MIP and RAM technology; Turbulent flow chromatography; On-line SPE; High resolution mass spectrometry	SOLID-PHASE EXTRACTION; TURBULENT-FLOW CHROMATOGRAPHY; MOLECULARLY IMPRINTED POLYMER; HIGH-THROUGHPUT ANALYSIS; UHPLC-MS/MS METHOD; BIOLOGICAL SAMPLES; SELECTIVE EXTRACTION; HUMAN PLASMA; HUMAN URINE; QUANTITATIVE-DETERMINATION	There is an increasing need of new bio-analytical methodologies with enough sensitivity, robustness and resolution to cope with the analysis of a large number of analytes in complex matrices in short analysis time. For this purpose, all steps included in any bio-analytical method (sampling, extraction, clean-up, chromatographic analysis and detection) must be taken into account to achieve good and reliable results with cost-effective methodologies. The purpose of this review is to describe the state-of-the-art of the most employed technologies in the period 2009-2012 to achieve fast analysis with liquid chromatography coupled to mass spectrometry (LC-MS) methodologies for bio-analytical applications. Current trends in fast liquid chromatography involve the use of several column technologies and this review will focus on the two most frequently applied: sub-2 mu m particle size packed columns to achieve ultra high pressure liquid chromatography (UHPLC) separations and porous-shell particle packed columns to attain high efficiency separations with reduced column back-pressures. Additionally, recent automated sample extraction and clean-up methodologies to reduce sample manipulation, variability and total analysis time in bio-analytical applications such as on-line solid phase extraction coupled to HPLC or UHPLC methods, or the use of other approaches such as molecularly imprinted polymers, restricted access materials, and turbulent flow chromatography will also be addressed. The use of mass spectrometry and high or even ultra-high resolution mass spectrometry to reduce sample manipulation and to solve ion suppression or ion enhancement and matrix effects will also be presented. The advantages and drawbacks of all these methodologies for fast and sensitive analysis of biological samples are going to be discussed by means of relevant applications. (C) 2013 Elsevier B.V. All rights reserved.	[Nunez, Oscar] Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Spain; [Gallart-Ayala, Hector] Lab Etud Residus & Contaminants Aliments LABERCA, ONIRIS, F-44307 Nantes, France; [Martins, Claudia P. B.] Thermo Fisher Sci, F-91963 Courtaboeuf, France; [Lucci, Paolo] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, DC, Colombia; [Busquets, Rosa] Univ Brighton, Fac Sci & Engn, Nanosci & Nanotechnol Grp, Brighton BN2 4GJ, E Sussex, England		Nunez, O (corresponding author), Univ Barcelona, Dept Analyt Chem, Marti & Franques 1-11, E-08028 Barcelona, Spain.	oscar.nunez@ub.edu	Núñez, Oscar/D-7912-2014	Núñez, Oscar/0000-0001-5850-8972; Gallart-Ayala, Hector/0000-0003-2333-0646; Busquets, Rosa/0000-0001-9033-4757; Lucci, Paolo/0000-0002-3659-132X	FP7-PEOPLE IEF Marie Curie project Polar Clean [274985]	FP7-PEOPLE IEF Marie Curie project Polar Clean	R. Busquets acknowledges the FP7-PEOPLE-2010 IEF Marie Curie project Polar Clean (project number 274985).	Amoako AA, 2010, J CHROMATOGR B, V878, P3231, DOI 10.1016/j.jchromb.2010.09.024; Antignac JP, 2011, TRAC-TREND ANAL CHEM, V30, P292, DOI 10.1016/j.trac.2010.11.003; Ardjomand-Woelkart K, 2011, ANAL BIOANAL CHEM, V400, P2371, DOI 10.1007/s00216-010-4618-3; Ayrton J, 1997, RAPID COMMUN MASS SP, V11, P1953, DOI 10.1002/(SICI)1097-0231(199712)11:18<1953::AID-RCM102>3.0.CO;2-Z; Baecher S, 2012, CLIN BIOCHEM, V45, P1491, DOI 10.1016/j.clinbiochem.2012.06.030; Baumgarten S, 2012, BIOMED CHROMATOGR, V26, P1529, DOI 10.1002/bmc.2727; Beltran A, 2009, J CHROMATOGR A, V1216, P2248, DOI 10.1016/j.chroma.2009.01.024; Beste KY, 2012, CLIN CHIM ACTA, V413, P240, DOI 10.1016/j.cca.2011.09.042; BOOS KS, 1995, FRESEN J ANAL CHEM, V352, P684, DOI 10.1007/BF00323048; Borges NC, 2009, J CHROMATOGR B, V877, P3601, DOI 10.1016/j.jchromb.2009.08.048; Bouchet S, 2011, CLIN CHIM ACTA, V412, P1060, DOI 10.1016/j.cca.2011.02.023; Bowen CL, 2010, J CHROMATOGR B, V878, P3125, DOI 10.1016/j.jchromb.2010.09.020; Breaud AR, 2010, CLIN CHIM ACTA, V411, P825, DOI 10.1016/j.cca.2010.02.067; Brouwers JF, 2011, BBA-MOL CELL BIOL L, V1811, P763, DOI 10.1016/j.bbalip.2011.08.001; Bui BTS, 2010, ANAL CHEM, V82, P4420, DOI 10.1021/ac100128c; Bunch DR, 2010, J CHROMATOGR B, V878, P3255, DOI 10.1016/j.jchromb.2010.10.003; Bunch DR, 2009, CLIN CHEM LAB MED, V47, P1565, DOI 10.1515/CCLM.2009.342; Bussche JV, 2010, J CHROMATOGR A, V1217, P4285, DOI 10.1016/j.chroma.2010.04.030; Cassiano NM, 2009, BIOANALYSIS, V1, P577, DOI 10.4155/BIO.09.39; Chang MS, 2007, RAPID COMMUN MASS SP, V21, P64, DOI 10.1002/rcm.2808; Chapuis-Hugon F, 2009, J SEP SCI, V32, P3301, DOI 10.1002/jssc.200900247; Chaves AR, 2011, J CHROMATOGR A, V1218, P3376, DOI 10.1016/j.chroma.2010.11.039; Chiuminatto U, 2010, ANAL CHEM, V82, P5636, DOI 10.1021/ac100607v; Couchman L, 2012, ANAL BIOANAL CHEM, V403, P1685, DOI 10.1007/s00216-012-5970-2; Couchman L, 2012, BIOMED CHROMATOGR, V26, P892, DOI 10.1002/bmc.2769; Cunliffe JM, 2011, BIOANALYSIS, V3, P735, DOI 10.4155/BIO.11.17; D'Orazio G, 2012, J CHROMATOGR A, V1228, P213, DOI 10.1016/j.chroma.2011.05.053; de Jong WHA, 2010, J CHROMATOGR B, V878, P1506, DOI 10.1016/j.jchromb.2010.03.050; de Jong WHA, 2010, ANAL BIOANAL CHEM, V396, P2609, DOI 10.1007/s00216-010-3466-5; de Jong WHA, 2009, J CHROMATOGR B, V877, P603, DOI 10.1016/j.jchromb.2009.01.015; Dhillon K, 2011, CLIN CHIM ACTA, V412, P2076, DOI 10.1016/j.cca.2011.07.009; Ding SJ, 2010, ANAL BIOANAL CHEM, V398, P779, DOI 10.1007/s00216-010-3993-0; Du H, 2011, FOOD CHEM, V129, P1320, DOI 10.1016/j.foodchem.2011.05.054; Dufield DR, 2010, ANAL BIOCHEM, V406, P113, DOI 10.1016/j.ab.2010.06.044; Duy SV, 2009, J CHROMATOGR B, V877, P1101, DOI 10.1016/j.jchromb.2009.02.068; Eckert E, 2012, J CHROMATOGR B, V889, P69, DOI 10.1016/j.jchromb.2012.01.032; El-Shahat MF, 2010, J HAZARD MATER, V177, P1054, DOI 10.1016/j.jhazmat.2010.01.027; Emary WB, 2011, BIOANALYSIS, V3, P2485, DOI [10.4155/bio.11.245, 10.4155/BIO.11.245]; Emotte C, 2012, J CHROMATOGR B, V895, P1, DOI 10.1016/j.jchromb.2012.02.025; Emotte C, 2012, J PHARMACEUT BIOMED, V58, P102, DOI 10.1016/j.jpba.2011.09.021; de Mendoza AEH, 2009, J CHROMATOGR B, V877, P4035, DOI 10.1016/j.jchromb.2009.10.020; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fekete S, 2011, TALANTA, V84, P416, DOI 10.1016/j.talanta.2011.01.053; Fekete S, 2011, J PHARMACEUT BIOMED, V54, P482, DOI 10.1016/j.jpba.2010.09.021; Fekete S, 2009, J PHARMACEUT BIOMED, V49, P64, DOI 10.1016/j.jpba.2008.10.009; Ferreiro-Vera C, 2011, ANAL BIOANAL CHEM, V399, P1093, DOI 10.1007/s00216-010-4400-6; Figueiredo EC, 2011, ANALYST, V136, P3753, DOI 10.1039/c1an15198c; Fontanals N, 2010, TRAC-TREND ANAL CHEM, V29, P765, DOI 10.1016/j.trac.2010.03.015; Fung EN, 2011, J CHROMATOGR B, V879, P2919, DOI 10.1016/j.jchromb.2011.08.025; Ganz N, 2012, J CHROMATOGR B, V885, P50, DOI 10.1016/j.jchromb.2011.12.012; GIDDINGS JC, 1965, ANAL CHEM, V37, P60, DOI 10.1021/ac60220a012; Gosetti F, 2010, J CHROMATOGR A, V1217, P7864, DOI 10.1016/j.chroma.2010.10.049; Gritti F, 2007, J CHROMATOGR A, V1157, P289, DOI 10.1016/j.chroma.2007.05.030; Gu YC, 2009, J CHROMATOGR B, V877, P3181, DOI 10.1016/j.jchromb.2009.08.009; Guillarme D, 2010, TRAC-TREND ANAL CHEM, V29, P15, DOI 10.1016/j.trac.2009.09.008; Guiochon G, 2006, J CHROMATOGR A, V1126, P6, DOI 10.1016/j.chroma.2006.07.032; HAGESTAM IH, 1986, J CHROMATOGR, V368, P77, DOI 10.1016/S0021-9673(00)91048-3; Hanold KA, 2004, ANAL CHEM, V76, P2842, DOI 10.1021/ac035442i; Harlan R, 2010, CLIN CHIM ACTA, V411, P1728, DOI 10.1016/j.cca.2010.07.013; Hartmann A, 2008, J VET PHARMACOL THER, V31, P87, DOI 10.1111/j.1365-2885.2007.00932.x; Harun N, 2010, ANAL BIOANAL CHEM, V396, P2449, DOI 10.1007/s00216-009-3404-6; He X, 2012, ANAL BIOANAL CHEM, V402, P3003, DOI 10.1007/s00216-012-5768-2; Heideloff C, 2010, THER DRUG MONIT, V32, P102, DOI 10.1097/FTD.0b013e3181c324c8; Heinig K, 2011, J PHARMACEUT BIOMED, V54, P742, DOI 10.1016/j.jpba.2010.10.003; Heinisch S, 2009, J CHROMATOGR A, V1216, P642, DOI 10.1016/j.chroma.2008.11.079; Holcapek M, 2012, J CHROMATOGR A, V1259, P3, DOI 10.1016/j.chroma.2012.08.072; Hooff GP, 2011, ANAL BIOANAL CHEM, V400, P3473, DOI 10.1007/s00216-011-5050-z; Hou HW, 2012, J PHARMACEUT BIOMED, V63, P17, DOI 10.1016/j.jpba.2012.01.028; Hu CW, 2010, CLIN CHIM ACTA, V411, P1218, DOI 10.1016/j.cca.2010.04.029; International Conference on Harmonization (ICH) Guidelines, 2005, US FDA FED REG   NOV; Ismaiel OA, 2011, J CHROMATOGR B, V879, P2081, DOI 10.1016/j.jchromb.2011.05.039; Ivanova M, 2011, CLIN CHEM LAB MED, V49, P1151, DOI 10.1515/CCLM.2011.192; Jackson R, 2010, ANAL METHODS-UK, V2, P552, DOI 10.1039/b9ay00251k; Jayatilaka NK, 2011, ARCH ENVIRON CON TOX, V61, P59, DOI 10.1007/s00244-010-9593-3; Giron AJ, 2012, ANAL CHIM ACTA, V721, P137, DOI 10.1016/j.aca.2012.02.002; Jones RL, 2012, J CHROMATOGR B, V881-82, P42, DOI 10.1016/j.jchromb.2011.11.036; Josep L.H., 2010, 27 MONTR S LC MS MON; Kadi A, 2011, ANALYST, V136, P591, DOI 10.1039/c0an00381f; Karakosta TD, 2012, TALANTA, V88, P561, DOI 10.1016/j.talanta.2011.11.034; Kato K, 2011, J CHROMATOGR A, V1218, P2133, DOI 10.1016/j.chroma.2010.10.051; Kaufmann A, 2006, RAPID COMMUN MASS SP, V20, P3566, DOI 10.1002/rcm.2762; Kirchhoff F, 2010, CLIN CHEM LAB MED, V48, P1647, DOI 10.1515/CCLM.2010.310; Kirkland JJ, 2007, AM LAB, V39, P18; Kloos D, 2012, J CHROMATOGR A, V1232, P19, DOI 10.1016/j.chroma.2011.07.095; KNOX JH, 1977, J CHROMATOGR SCI, V15, P352, DOI 10.1093/chromsci/15.9.352; Kohler C, 2011, ANAL BIOANAL CHEM, V400, P17, DOI 10.1007/s00216-010-4466-1; Konig S, 2011, ANAL BIOANAL CHEM, V400, P9, DOI 10.1007/s00216-011-4708-x; Kole PL, 2011, BIOMED CHROMATOGR, V25, P199, DOI 10.1002/bmc.1560; Kong WJ, 2011, J SEP SCI, V34, P260, DOI 10.1002/jssc.201000757; Korfmacher W, 2011, BIOANALYSIS, V3, P1169, DOI [10.4155/BIO.11.98, 10.4155/bio.11.98]; Krebber R, 2009, ANAL CHIM ACTA, V637, P208, DOI 10.1016/j.aca.2008.11.006; Kwok WH, 2010, J CHROMATOGR A, V1217, P3289, DOI 10.1016/j.chroma.2010.01.023; Leon-Gonzalez Z, 2011, J CHROMATOGR A, V1218, P3013, DOI 10.1016/j.chroma.2011.03.045; Li J, 2012, J CHROMATOGR B, V895, P83, DOI 10.1016/j.jchromb.2012.03.018; Liao HT, 2011, J CHROMATOGR B, V879, P1961, DOI 10.1016/j.jchromb.2011.05.028; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Liu GW, 2009, ANAL CHEM, V81, P9225, DOI 10.1021/ac901316w; Liu HY, 2012, J CHROMATOGR B, V889, P55, DOI 10.1016/j.jchromb.2012.01.030; Liu YK, 2010, TALANTA, V82, P1212, DOI 10.1016/j.talanta.2010.06.038; Lovgren U, 2010, J PHARMACEUT BIOMED, V53, P537, DOI 10.1016/j.jpba.2010.03.024; Lucci P., 2012, CHROMATOGRAPHY; Lucci P, 2011, J CHROMATOGR A, V1218, P4828, DOI 10.1016/j.chroma.2011.02.007; Lucci P, 2010, ANAL CHIM ACTA, V672, P15, DOI 10.1016/j.aca.2010.03.010; Magiera S, 2012, TALANTA, V89, P47, DOI 10.1016/j.talanta.2011.11.055; Mallett DN, 2009, J PHARMACEUT BIOMED, V49, P100, DOI 10.1016/j.jpba.2008.09.041; Mayatra SJ, 2010, J PHARMACEUT BIOMED, V52, P410, DOI 10.1016/j.jpba.2009.05.033; McWhinney BC, 2010, J CHROMATOGR B, V878, P2863, DOI 10.1016/j.jchromb.2010.08.044; Michopoulos F, 2010, J SEP SCI, V33, P1472, DOI 10.1002/jssc.200900789; Moehring T., 2007, 367 THERM SCI; Mora P, 2008, GRAEF ARCH CLIN EXP, V246, P1047, DOI 10.1007/s00417-008-0825-4; Mosch C, 2010, J CHROMATOGR B, V878, P2652, DOI 10.1016/j.jchromb.2010.01.015; Mottier P, 2008, J AGR FOOD CHEM, V56, P35, DOI 10.1021/jf072934d; Mueller DM, 2012, J CHROMATOGR B, V883, P189, DOI 10.1016/j.jchromb.2011.08.022; Mueller DM, 2011, ANAL BIOANAL CHEM, V400, P89, DOI 10.1007/s00216-010-4560-4; Mueller DM, 2010, J CHROMATOGR B, V878, P1007, DOI 10.1016/j.jchromb.2010.02.029; Novakova L, 2011, J CHROMATOGR A, V1218, P7971, DOI 10.1016/j.chroma.2011.08.096; Nunez O, 2008, J CHROMATOGR A, V1191, P231, DOI 10.1016/j.chroma.2008.02.029; Nunez O, 2012, J CHROMATOGR A, V1228, P298, DOI 10.1016/j.chroma.2011.10.091; Oxelbark J, 2007, J CHROMATOGR A, V1160, P215, DOI 10.1016/j.chroma.2007.05.057; Perez F, 2012, ANAL BIOANAL CHEM, V402, P2369, DOI 10.1007/s00216-011-5660-5; Pozo OJ, 2006, TRAC-TREND ANAL CHEM, V25, P1030, DOI 10.1016/j.trac.2006.06.012; Prasad B, 2010, J PHARMACEUT BIOMED, V52, P377, DOI 10.1016/j.jpba.2009.07.014; Pyrzynska K., 2011, HERBICIDES THEORY AP; Radovnikovic A, 2011, J CHROMATOGR B, V879, P159, DOI 10.1016/j.jchromb.2010.11.036; Fernandez MDR, 2009, J CHROMATOGR B, V877, P2153, DOI 10.1016/j.jchromb.2009.04.047; Ramirez-Fernandez M.M., 2010, J CHROMATOGR B, V878, P1616; Rodriguez-Gonzalo E, 2010, J CHROMATOGR A, V1217, P40, DOI 10.1016/j.chroma.2009.11.002; Rodriguez-Gonzalo E, 2011, J CHROMATOGR A, V1218, P9055, DOI 10.1016/j.chroma.2011.10.016; Gonzalez RR, 2011, J NEUROSCI METH, V198, P187, DOI 10.1016/j.jneumeth.2011.03.023; Rudewicz PJ, 2011, BIOANALYSIS, V3, P1663, DOI [10.4155/BIO.11.137, 10.4155/bio.11.137]; Saba A, 2009, J MASS SPECTROM, V44, P541, DOI 10.1002/jms.1530; Saber AL, 2009, TALANTA, V78, P295, DOI 10.1016/j.talanta.2008.11.016; Scheffler K., 2011, GIT LABOR FACHZ, V55, P516; Schettgen T, 2012, TALANTA, V98, P211, DOI 10.1016/j.talanta.2012.06.074; Schurmann A, 2009, RAPID COMMUN MASS SP, V23, P1196, DOI 10.1002/rcm.3982; Severino P, 2012, J PHARM ANA, V2, P29, DOI 10.1016/j.jpha.2011.10.006; Shah KA, 2011, J PHARMACEUT BIOMED, V54, P368, DOI 10.1016/j.jpba.2010.09.001; Shentu J., 2012, J PHARM BIOMED ANAL, DOI DOI 10.1016/JJPBA.2012.06.014; Song W, 2009, J PHARMACEUT BIOMED, V50, P491, DOI 10.1016/j.jpba.2009.05.011; Sparidans RW, 2012, J CHROMATOGR B, V895, P174, DOI 10.1016/j.jchromb.2012.03.021; Stevens J, 2010, J CHROMATOGR B, V878, P969, DOI 10.1016/j.jchromb.2010.02.024; Stolker AAM, 2010, ANAL BIOANAL CHEM, V397, P2841, DOI 10.1007/s00216-010-3660-5; Strano-Rossi S, 2011, ANAL BIOANAL CHEM, V401, P609, DOI 10.1007/s00216-011-5108-y; Sturm S, 2010, J CHROMATOGR B, V878, P2726, DOI 10.1016/j.jchromb.2010.08.013; Szultka M, 2012, ANAL BIOANAL CHEM, V403, P785, DOI 10.1007/s00216-012-5901-2; Tan GG, 2011, CHROMATOGRAPHIA, V74, P341, DOI 10.1007/s10337-011-2072-9; Teutenberg T, 2009, ANAL CHIM ACTA, V643, P1, DOI 10.1016/j.aca.2009.04.008; Thibeault D, 2012, J CHROMATOGR B, V883, P120, DOI 10.1016/j.jchromb.2011.12.021; Thibert V, 2012, TALANTA, V88, P412, DOI 10.1016/j.talanta.2011.11.009; Thomas A, 2012, ANAL BIOANAL CHEM, V403, P1279, DOI 10.1007/s00216-011-5655-2; Trufelli H, 2011, MASS SPECTROM REV, V30, P491, DOI 10.1002/mas.20298; Tuffal G, 2011, THROMB HAEMOSTASIS, V105, P696, DOI 10.1160/TH10-09-0582; Uliyanchenko E, 2011, J CHROMATOGR A, V1218, P1509, DOI 10.1016/j.chroma.2011.01.053; Van Deemters JJ, 1956, J CHEM ENG SCI, V5, P272; Vera-Avila LE, 2012, TALANTA, V88, P553, DOI 10.1016/j.talanta.2011.11.032; Verdirame M, 2010, J PHARMACEUT BIOMED, V51, P834, DOI 10.1016/j.jpba.2009.10.005; Vickova H, 2011, J PHARMACEUT BIOMED, V55, P301, DOI 10.1016/j.jpba.2011.01.025; Vlckova H, 2012, TALANTA, V90, P22, DOI 10.1016/j.talanta.2011.12.043; Wang CJ, 2010, TALANTA, V82, P1434, DOI 10.1016/j.talanta.2010.07.015; Wang QQ, 2010, J CHROMATOGR B, V878, P1893, DOI 10.1016/j.jchromb.2010.05.015; Wang Y, 2012, J MAGN MAGN MATER, V324, P410, DOI 10.1016/j.jmmm.2011.07.058; Wilson I.D., 2003, HDB ANAL SEPARATIONS, V4; Wong CHF, 2012, J CHROMATOGR A, V1232, P257, DOI 10.1016/j.chroma.2011.12.095; Wu NJ, 2007, J SEP SCI, V30, P1167, DOI 10.1002/jssc.200700026; Xin GZ, 2010, J CHROMATOGR B, V878, P435, DOI 10.1016/j.jchromb.2009.12.027; Xu RNX, 2007, J PHARMACEUT BIOMED, V44, P342, DOI 10.1016/j.jpba.2007.02.006; Xu WJ, 2010, J CHROMATOGR A, V1217, P7198, DOI 10.1016/j.chroma.2010.09.035; Ye L, 2012, J CHROMATOGR A, V1244, P46, DOI 10.1016/j.chroma.2012.04.075; You YW, 2010, CHROMATOGRAPHIA, V72, P1097, DOI 10.1365/s10337-010-1784-6; Yuan C, 2012, CLIN CHEM LAB MED, V50, P95, DOI 10.1515/CCLM.2011.739; Zeng W, 2008, J PHARMACEUT BIOMED, V46, P534, DOI 10.1016/j.jpba.2007.11.003; Zhang WD, 2011, J CHROMATOGR B, V879, P3735, DOI 10.1016/j.jchromb.2011.10.022; Zhu XC, 2011, ANAL CHEM, V83, P9516, DOI 10.1021/ac202280f	173	43	44	1	164	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	MAY 15	2013	927				SI		3	21		10.1016/j.jchromb.2012.12.031	http://dx.doi.org/10.1016/j.jchromb.2012.12.031			19	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	140PS	23375883	Green Submitted, Green Accepted			2022-09-04	WOS:000318668000002
J	Jensen, AB; Olmeo, N; Wynne, C; Ramirez, G; Lebrecht, A; Mehta, A; He, W; Song, Y; Berd, Y; Lombardi, A				Jensen, A. B.; Olmeo, N.; Wynne, C.; Ramirez, G.; Lebrecht, A.; Mehta, A.; He, W.; Song, Y.; Berd, Y.; Lombardi, A.			Effect of cathepsin k inhibition on suppression of bone resorption in women with breast cancer and established bone metastases in a 4-week, double-blind, randomized controlled trial	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract									Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Azienda Osped Sassari, Sassari, Italy; Christchurch Clin Studies Trust, Christchurch, New Zealand; Javeriana Univ, Bogota, Colombia; Johannes Gutenberg Univ Mainz, Mainz, Germany; Merck Res Labs, Rahway, NJ USA				Lebrecht, Antje/F-6456-2014	Lebrecht, Antje/0000-0002-8442-6505					0	13	13	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X			J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2008	26	15		S		1023				10.1200/jco.2008.26.15_suppl.1023	http://dx.doi.org/10.1200/jco.2008.26.15_suppl.1023			1	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	V25CZ					2022-09-04	WOS:000208457400287
J	Mancera, J; Vergara, A; Cadena, ME; Lozada-Martinez, ID; Guardo-Carmona, D; Cabrera-Vargas, LF; Ataullah, AHM				Mancera, Juliana; Vergara, Arturo; Cadena, Manuel E.; David Lozada-Martinez, Ivan; Guardo-Carmona, Daniela; Felipe Cabrera-Vargas, Luis; Ataullah, A. H. M.			Metastasis of the abdominal wall in a patient with diagnosis of pulmonary adenocarcinoma: An interesting finding	RESPIRATORY MEDICINE CASE REPORTS			English	Article						Adenocarcinoma of lung; Neoplasm metastasis; Abdominal wall; Rare diseases	DESMOID TUMOR; LUNG; PATTERNS	Tumors of the abdominal wall are rare, divided into benign and malignant lesions that are composed of primary tumors and by the parietal invasion of intra-abdominal tumors and metastatic parietal implants. In the case of metastases in the abdominal wall, the most frequent are metastases from neoplasms of colonic origin. The case described below is that of a 68-year-old patient with a history of stage IIA left lung adenocarcinoma who received partial response radiotherapy with an indication for chemotherapy, which she refused and lost follow-up.	[Mancera, Juliana] Pontificia Univ Javeriana, Dept Surg, Bogota, Colombia; [Vergara, Arturo; Cadena, Manuel E.] Fdn Santa Fe Bogota, Dept Surg, Bogota, Colombia; [Vergara, Arturo; Cadena, Manuel E.] Univ los Andes, Sch Med, Dept Surg, Bogota, Colombia; [David Lozada-Martinez, Ivan; Guardo-Carmona, Daniela; Felipe Cabrera-Vargas, Luis] Colombian Surg Assoc, Med & Surg Res Ctr, Future Surg Chapter, Bogota, Colombia; [Felipe Cabrera-Vargas, Luis] Univ Bosque, Dept Surg, Bogota, Colombia; [Ataullah, A. H. M.] Sher E Bangla Med Coll Hosp, Dept Med, Barishal, Bangladesh		Ataullah, AHM (corresponding author), Sher E Bangla Med Coll Hosp, Dept Med, Barishal, Bangladesh.	ataullah_cox@yahoo.com		Lozada Martinez, Ivan David/0000-0002-1960-7334; Ataullah, Dr. A. H. M./0000-0002-6625-3655				Berger A, 1999, AM J GASTROENTEROL, V94, P1884, DOI 10.1111/j.1572-0241.1999.01224.x; Choi JH, 2021, ADV ANAT PATHOL, V28, P44, DOI 10.1097/PAP.0000000000000284; Gloster HM, 1996, J AM ACAD DERMATOL, V35, P355, DOI 10.1016/S0190-9622(96)90597-6; Herrera R. Ortega, 2012, PROGRESOS OBSTET GIN, V55, P367; Horton JD, 2008, AM J SURG, V196, P207, DOI 10.1016/j.amjsurg.2007.07.035; Kikuchi Isao, 2011, Gan To Kagaku Ryoho, V38, P2372; Koskenvuo L, 2016, J SURG ONCOL, V113, P209, DOI 10.1002/jso.24117; Koyama R, 2019, CASE REP GASTROENTER, V13, P78, DOI 10.1159/000497098; Kwas Hamida H, 2013, Asian Cardiovasc Thorac Ann, V21, P741, DOI 10.1177/0218492312470571; Mankin HJ, 2010, J SURG ONCOL, V102, P380, DOI 10.1002/jso.21433; Mundra V, 2012, AM J CASE REP, V13, P177, DOI 10.12659/AJCR.883323; Pop D, 2009, J THORAC ONCOL, V4, P1236, DOI 10.1097/JTO.0b013e3181b24509; REITAMO JJ, 1982, AM J CLIN PATHOL, V77, P665; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Pedraza TS, 2014, MEDISUR-REV CIENC ME, V12, P670; Seo JB, 2001, RADIOGRAPHICS, V21, P403, DOI 10.1148/radiographics.21.2.g01mr17403; Stojadinovic A, 2001, ARCH SURG-CHICAGO, V136, P70, DOI 10.1001/archsurg.136.1.70	17	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-0071			RESPIR MED CASE REP	Respir. Med. Case Rep.		2022	38								101703	10.1016/j.rmcr.2022.101703	http://dx.doi.org/10.1016/j.rmcr.2022.101703			4	Respiratory System	Emerging Sources Citation Index (ESCI)	Respiratory System	3H5HN	35879972	gold, Green Published			2022-09-04	WOS:000832067200001
J	Duarte, C; Salazar, A; Strasser-Weippl, K; de Vries, E; Wiesner, C; Arango-Gutierrez, A; Krush, L; Goss, PE				Duarte, Carlos; Salazar, Alejandro; Strasser-Weippl, Kathrin; de Vries, Esther; Wiesner, Carolina; Arango-Gutierrez, Angelica; Krush, Lindsay; Goss, Paul E.			Breast cancer in Colombia: a growing challenge for the healthcare system	BREAST CANCER RESEARCH AND TREATMENT			English	Review						Breast cancer; Colombia; Public health; Screening; Health policies; Access to health		Aim To provide a comprehensive overview of breast cancer in Colombia. Methods Data on breast cancer in Colombia are scarce. We present incidence data from population-based cancer registries that represent 4 distinct regions of the country. Other data originate from non-governmental institutions and healthcare providers within Colombia, official sources, expert opinion, Colombian legislation, and the Cancer Mortality Atlas publishes by Colombian National Cancer Institute. Results In Colombia, the age-standardized incidence rate remained relatively stable between 2012 and 2020 (43.1 to 47.8 cases per 100,000 women-years); Additionally, survival since 1995 has presented a substantial improvement from 65.7 to 72.1. In 33% of cases, the diagnosis of breast cancer was made in advanced stages, stage III or higher. The health demography survey conducted in 2015 showed that the participation in mammography screening in women aged 40 to 69 remains low 48.1%. Some limitations regarding access to early detection and diagnosis include economic strata, health insurance coverage, origin, and accessibility. On average, a 90-day period was reported from onset of symptoms to diagnosis of breast cancer. Conclusion The first action towards improving outcomes in breast cancer should be to improve stage at diagnosis and timely access to care.	[Duarte, Carlos; Wiesner, Carolina] Inst Nacl Cancerol, Bogota, DC, Colombia; [Salazar, Alejandro] Oncol Occidente, Manizales, Caldas, Colombia; [Strasser-Weippl, Kathrin] Wilhelminen Hosp, Vienna, Austria; [de Vries, Esther; Arango-Gutierrez, Angelica] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, DC, Colombia; [Krush, Lindsay; Goss, Paul E.] Global Canc Inst, Boston, MA 02215 USA; [Krush, Lindsay; Goss, Paul E.] Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA		Goss, PE (corresponding author), Global Canc Inst, Boston, MA 02215 USA.; Goss, PE (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	cduarte@cancer.gov.co; pgoss@partners.org	Gutièrrez, Angèlica Marìa Arango/AAN-2218-2021; de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258; DUARTE, CARLOS/0000-0002-2069-5642; Arango Gutierrez, Angelica Maria/0000-0002-2980-6847	Instituto Nacional de Cancerologia, Colombia; Global Cancer Institute, Boston Massachusetts	Instituto Nacional de Cancerologia, Colombia; Global Cancer Institute, Boston Massachusetts	Instituto Nacional de Cancerologia, Colombia and Global Cancer Institute, Boston Massachusetts.	Calderon CAA, 2011, CIENC SAUDE COLETIVA, V16, P2817, DOI 10.1590/S1413-81232011000600020; Alejo-Martinez H., 2013, RADIOL M XICO, V12, P164; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; American Sociey of Clinical Oncology (ASCO), 2018, KEY TRENDS TRACKING; [Anonymous], 2020, VOLKSGEZONDHEIDENZOR; BMJ (Clinical research ed) Screening and Immunisations Team NHS Digital, BREAST SCREENING PRO; Bray F, 2017, CANC INCIDENCE 5 CON, VXI; Céspedes-Londoño Juan Eduardo, 2002, Cad. Saúde Pública, V18, P1003, DOI 10.1590/S0102-311X2002000400008; Yepez MC, 2018, COLOMB MEDICA, V49, P42, DOI 10.25100/cm.v49i1.3616; Velasquez-De Charry L, 2009, SALUD PUBLICA MEXICO, V51, pS246, DOI 10.1590/S0036-36342009000800015; Cuenta de alto costo, 2019, SITUACI N C NCER POB; De Pineda VG, 1968, FAMILIA CULTURA COLO, P415; de Vries E, 2018, J Cancer Policy, V15, P104, DOI 10.1016/j.jcpo.2018.01.003; de Vries E, 2016, REV COLOMB CANCEROL, V20, P45, DOI 10.1016/j.rccan.2016.02.001; de Vries E, 2015, J EPIDEMIOL COMMUN H, V69, P408, DOI 10.1136/jech-2014-204650; Defensoria del Pueblo de Colombia, 2019, TUTELA DERECHOS SALU, P1; Departamento Administrativo Nacional de Estadistica, 2020, ESTADISTICAS TEMA SA; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Diaz S., 2005, REV COLOMBIANA CANCE, V9, P93; Bravo LE, 2018, COLOMB MEDICA, V49, P9, DOI 10.25100/cm.v49i1.3877; Arias-Ortiz NE, 2018, COLOMB MEDICA, V49, P63, DOI 10.25100/cm.v49i1.3629; Eslava-Schmalbach J., 2013, INEQUIDAD MORTALIDAD, P255; Facultad de Salud Universidad del Valle, RPCC REGISTRO POBLAC; Fejerman L, 2013, CANCER RES, V73, P7243, DOI 10.1158/0008-5472.CAN-13-2014; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Ferlay J., 2020, GLOBAL CANC OBSERVAT; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; Heinze-Martin G, 2018, GAC MED MEX, V154, P342, DOI 10.24875/GMM.18003770; Henriquez G, 2017, REV COLOMB CANCEROL, V21, P104, DOI 10.1016/j.rccan.2017.04.002; IARC, 2019, WHO CANC MORTALITY D; Instituto Nacional de Cancerologia ESE, 2017, SITUACI N C NCER COL; Killelea BK, 2019, ANN SURG ONCOL, V26, P3052, DOI 10.1245/s10434-019-07546-x; Methodology S., 2020, SURVEILLANCE RES PRO; Ministerio de Salud y Proteccion Social, 2020, PORTAL SISPRO; Ministerio de Salud y Proteccion Social Instituto de Evaluacion Tecnologica en Salud Instituto Nacional de Cancerologia, 2017, GU A PR CTICA 150 NI; Ministerio de Salud y Proteccion Social Instituto Nacional de Cancerologia ESE, 2012, PLAN DECENAL CONTROL; Ministerio de Salud y Proteccion Social & Profamilia, 2017, ENCUESTA NACL DEMOGR; Ministry of Finance and Economic Planning, 2000, RESOLUCI N 3384 29 D, P1; MinSalud Profamilia, 2017, ENCUESTA NACL DEMOGR, V2; Murcia E, 2018, COLOMB MEDICA, V49, P89, DOI 10.25100/cm.v49i1.3620; Murillo R, 2015, MINISTERIO SALUD PRO; Pardo C, 2017, ATLAS MORTALIDAD C N; Pardo C, 2015, CANC COLOMBIA 2007 2, P1; Pineros M., 2011, COLOMBIA SALUD P BLI, V53, P478; PNUD, 2019, INFORME DESARROLLO H; Profamilia, 2011, ENCUESTA NACL DEMOGR; Puerto D, 2018, AN LISIS CONCORDANCI, V40, P181; Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239; RUSHTON L, 1992, BRIT J OBSTET GYNAEC, V99, P239, DOI 10.1111/j.1471-0528.1992.tb14506.x; SERNANP & ANECAP, 2019, DOC TRAB 35 MOD COG; Garcia LS, 2018, COLOMB MEDICA, V49, P109, DOI 10.25100/cm.v49i1.3853; Perez CJU, 2018, COLOMB MEDICA, V49, P73, DOI 10.25100/cm.v49i1.3632; Velasco S, 2014, REV COLOMB CANCEROL, V18, P101, DOI 10.1016/j.rccan.2014.06.001; Weiss M., 2013, COLOMB CRIS RENEW; Wild CP, 2020, OESOPHAGEAL CANC TAL	56	1	1	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	FEB	2021	186	1					15	24		10.1007/s10549-020-06091-6	http://dx.doi.org/10.1007/s10549-020-06091-6		FEB 2021	10	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	QT6MK	33611666				2022-09-04	WOS:000620116500003
J	Betancourt-Ruiz, P; Martinez-Diaz, HC; Gil-Mora, J; Ospina, C; Olaya, LA; Benavides, E; Bolanos, E; Cuervo, C; Blanton, L; Hidalgo, M				Betancourt-Ruiz, Paola; Martinez-Diaz, Heidy-C; Gil-Mora, Juliana; Ospina, Catalina; Olaya-M, Luz-Adriana; Benavides, Efrain; Bolanos, Eliana; Cuervo, Claudia; Blanton, Lucas; Hidalgo, Marylin			Candidatus Rickettsia senegalensis in Cat Fleas (Siphonaptera: Pulicidae) Collected from Dogs and Cats in Cauca, Colombia	JOURNAL OF MEDICAL ENTOMOLOGY			English	Article						Rickettsia asemboensis; Rickettsia spp; Rickettsia senegalensis; Ctenocephalides felis; flea-borne rickettsioses	MURINE TYPHUS; CTENOCEPHALIDES-FELIS; BORNE RICKETTSIOSES; SPOTTED-FEVER; INFECTION; OPOSSUMS; ECOLOGY; CALDAS	Rickettsia typhi and Rickettsia felis (Rickettsiales: Rickettsiaceae) are flea-transmitted pathogens. They are important causes of acute febrile illness throughout the world. We, therefore, sought to identify the rickettsial species present in the fleas of dogs and cats in the department of Cauca, Colombia. In this study, we collected 1,242 fleas from 132 dogs and 43 fleas from 11 cats. All fleas were morphologically identified as Ctenocephalides felis (Bouche) adults and organized in pools for DNA extraction (234 pools from dogs and 11 from cats). The gltA gene from rickettsiae was targeted for screening amplification using conventional PCR. In total, 144 of the 245 pools (58.7%) were positive. The positive samples were then processed for the amplification of the 17kDa antigen gene (144/144; 100% positive) and sca5 gene (140/144; 97.2% positive). In addition, restriction enzyme length polymorphism analysis using NlaIV on the amplified product of the sca5 gene demonstrated several organisms: 21/140 (15%) were R. felis, 118/140 (84.3%) were Rickettsia asemboensis, and 1/140 (0.7%) were Candidatus Rickettsia senegalensis. Subsequent sequencing confirmed Candidatus Rickettsia senegalensis in C. felis collected from dogs the first reported from Colombia.	[Betancourt-Ruiz, Paola; Martinez-Diaz, Heidy-C; Gil-Mora, Juliana; Cuervo, Claudia; Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Grp Enfermedades Infecciosas, Bogota, Colombia; [Ospina, Catalina; Benavides, Efrain] Univ La Salle, Fac Ciencias Agr, Grp Epidemiol & Salud Publ, Bogota, Colombia; [Olaya-M, Luz-Adriana] Univ Libre, Cali, Colombia; [Olaya-M, Luz-Adriana] Secc Cali, Cali, Colombia; [Bolanos, Eliana] Secretaria Dept Salud, Cauca, Colombia; [Blanton, Lucas] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Grp Enfermedades Infecciosas, Bogota, Colombia.	hidalgo.m@javeriana.edu.co	; Ospina Pinto, Maria Catalina/B-6796-2019	Martinez-Diaz, Heidy-Carolina/0000-0001-7239-6428; Gil-Mora, Juliana/0000-0001-9834-1281; Betancourt-Ruiz, Paola/0000-0003-3287-2762; /0000-0003-3706-3542; Cuervo, Claudia/0000-0002-3494-6481; Benavides, Efrain/0000-0002-8894-5441; Ospina Pinto, Maria Catalina/0000-0001-9083-9536	COLCIENCIAS [120374455209]; Pontificia Universidad Javeriana [7277]	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana	This research was funded by the COLCIENCIAS (code 120374455209). Regulatory permission for this work was: Framework Permission for Collection of Specimens of Wild Species of Biological Diversity for the Purpose of Non-Commercial Scientific Research No. 01364 of August 21, 2018 given by Ministerio de Ambiente y Desarrollo Sostenible from Colombia. We acknowledge Pontificia Universidad Javeriana ID: 7277 for physical and human resources provided.	ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; Billeter SA, 2016, VECTOR-BORNE ZOONOT, V16, P151, DOI 10.1089/vbz.2015.1869; Blanton LS, 2019, VECTOR-BORNE ZOONOT, V19, P637, DOI 10.1089/vbz.2018.2428; Blanton LS, 2016, AM J TROP MED HYG, V95, P457, DOI 10.4269/ajtmh.16-0197; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Brown Lisa D, 2016, Curr Trop Med Rep, V3, P27; Cevidanes A, 2018, J MED ENTOMOL, V55, P1659, DOI 10.1093/jme/tjy141; Chandra S, 2017, VET PARASITOL, V234, P25, DOI 10.1016/j.vetpar.2016.12.017; DUBREUIL RM, 1993, PCR METH APPL, V3, P57; Faccini-Martinez AA, 2016, VECTOR-BORNE ZOONOT, V16, P85, DOI 10.1089/vbz.2015.1841; Faccini-Martinez AA, 2013, BIOMEDICA, V33, P9, DOI 10.7705/biomedica.v33i0.723; Fang R, 2017, CLIN LAB MED, V37, P383, DOI 10.1016/j.cll.2017.01.009; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Galvez R, 2017, MED VET ENTOMOL, V31, P107, DOI 10.1111/mve.12204; Hall TA., 1999, NUCL ACIDS S SER, V41, P95; Hidalgo M, 2013, VECTOR-BORNE ZOONOT, V13, P289, DOI 10.1089/vbz.2012.1173; Hornok S., 2018, New Microbes and New Infections, V25, P3, DOI 10.1016/j.nmni.2018.05.001; Khan SA, 2016, T ROY SOC TROP MED H, V110, P487, DOI 10.1093/trstmh/trw052; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legendre KP, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2040064; Linardi PM, 2012, REV BRAS PARASITOL V, V21, P345, DOI 10.1590/S1984-29612012000400002; Maina AN, 2016, INT J SYST EVOL MICR, V66, P4512, DOI 10.1099/ijsem.0.001382; Mediannikov O., 2015, New Microbes and New Infections, V3, P24, DOI 10.1016/j.nmni.2014.10.005; Noden BH, 2017, J MED ENTOMOL, V54, P1093, DOI 10.1093/jme/tjx069; Palacios-Salvatierra Rosa, 2018, Rev. perú. med. exp. salud publica, V35, P630, DOI 10.17843/rpmesp.2018.354.3646; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Ramirez-Hernandez A, 2013, AM J TROP MED HYG, V89, P453, DOI 10.4269/ajtmh.12-0698; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; SCHRIEFER ME, 1994, J MED ENTOMOL, V31, P681, DOI 10.1093/jmedent/31.5.681; Silva AB, 2017, ACTA TROP, V172, P44, DOI 10.1016/j.actatropica.2017.04.004; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; WEBB L, 1990, J CLIN MICROBIOL, V28, P530, DOI 10.1128/JCM.28.3.530-534.1990	35	4	4	1	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2585	1938-2928		J MED ENTOMOL	J. Med. Entomol.	MAR	2020	57	2					382	387		10.1093/jme/tjz177	http://dx.doi.org/10.1093/jme/tjz177			6	Entomology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Entomology; Veterinary Sciences	KS8IS	31617911				2022-09-04	WOS:000518550900007
J	Shoaib, A; Badruddeen; Dixit, RK; Ganash, M; Barreto, G; Ashraf, GM; Siddiqui, HH				Shoaib, Ambreen; Badruddeen; Dixit, Rakesh Kumar; Ganash, Magdah; Barreto, George; Ashraf, Ghulam Md; Siddiqui, Hefazat Hussain			Beneficial effects of n-hexane bark extract of Onosma echioides L. on diabetic peripheral neuropathy	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						behavioral effect; diabetic neuropathy; histopathology; Onosma echioides; oxidative biomarkers	GABAPENTIN; PREGABALIN; MODEL; STZ	Onosma echioides Linn (Boraginaceae) is the most frequently used curative herb widely used for kidney obstruction, sciatic pain, and gout. The present study was designed to investigate the therapeutic effects of n-hexane bark extract of O. echioides (OE) L. root in vivo against Streptozotocin-induced diabetic neuropathy in SD rats. For in vivo activity, the experiment was categorized into five different groups (n = 5). Group-I was considered as nondiabetic/normal control (NC) treated with 0.5% carboxymethyl cellulose (CMC), Group II as diabetic control, Group-III, IV, and V served as diabetic treated with OE 50, OE 100, and pregabalin at a dose of 50, 100, and 10 mg/kg body weight, orally, respectively. Body weight, blood glucose, oral glucose tolerance test, behavioral studies (motor coordination test, thermal hyperalgesia, cold allodynia, locomotor activity, oxidative biomarkers (thio barbituric acid reactive substances [TBARS], superoxide dismutase [SOD], glutathione [GSH], and catalase), and histopathology of the sciatic nerve were performed. Treatment with OE showed a dose-dependent increase in neuroprotective activity by improving the myelination and decreasing the axonal swelling of nerve fibers. The verdicts of behavioral activities showed a remarkable effect on animals after the treatment of extract and standard drug pregabalin. In conclusion, our findings supported the traditional application of OE and explored its importance in the management of diabetic neuropathy. Additional clinical experiments may provide novel therapeutic drugs for diabetes and its complications.	[Shoaib, Ambreen; Badruddeen; Siddiqui, Hefazat Hussain] Integral Univ, Dept Pharmacol, Fac Pharm, Lucknow 226026, Uttar Pradesh, India; [Dixit, Rakesh Kumar] King George Med Univ, Dept Pharmacol, Lucknow, Uttar Pradesh, India; [Ganash, Magdah] King Abdulaziz Univ, Dept Biol, Fac Sci, Jeddah, Saudi Arabia; [Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia		Siddiqui, HH (corresponding author), Integral Univ, Dept Pharmacol, Fac Pharm, Lucknow 226026, Uttar Pradesh, India.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia.	ashraf.gm@gmail.com; hefazathussainsiddiqui@gmail.com	Shoaib, ambreen/AAE-4601-2020; Ashraf, Ghulam Md/H-9485-2012; Ganash, Magdah/AAY-6666-2020; Shoaib, Ambreen/AAD-6789-2020; Barreto, George E./AAD-7420-2020	Ashraf, Ghulam Md/0000-0002-9820-2078; Ganash, Magdah/0000-0003-3709-0487; Shoaib, Ambreen/0000-0002-6562-8945; Barreto, George E./0000-0002-6644-1971				AEBI H, 1984, METHOD ENZYMOL, V105, P121; [Anonymous], J TROP LIFE SCI; [Anonymous], 2011, NEPAL J SCI TECHNOL; [Anonymous], J CHEM PHARM RES; Badruddeen, 2012, J CLIN DIAGN RES, V6, P1356; Bairagi N, 2005, INDIAN J FIBRE TEXT, V30, P196; Balaha M, 2018, BIOMED PHARMACOTHER, V101, P821, DOI 10.1016/j.biopha.2018.02.135; Baral SR, 2006, COMPENDIUM MED PLANT, P534; Bhattacharyya S, 2006, J BIOMED NANOTECHNOL, V2, P36, DOI 10.1166/jbn.2006.008; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chopra RN, 1956, GLOSSARY INDIAN MED; Field MJ, 1999, PAIN, V80, P391, DOI 10.1016/S0304-3959(98)00239-5; Grover J, INDIAN J EXP BIOL, V40, P273; Kumar Neeraj, 2013, Pharmacogn Rev, V7, P140, DOI 10.4103/0973-7847.120513; Lee HW, 2003, BIOL PHARM BULL, V26, P1100; Mangaiarkkarasi A, 2015, J CLIN DIAGN RES, V9, pFF11, DOI 10.7860/JCDR/2015/13373.5955; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Muthuraman A, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-24; Nasiry D, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1983-x; Nikita G, 2015, NAT PROD RES, V29, P1584, DOI 10.1080/14786419.2014.986126; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Prince PSM, 1999, J ETHNOPHARMACOL, V65, P277, DOI 10.1016/S0378-8741(98)00164-0; Roeder E, 2009, PHARMAZIE, V64, P699, DOI 10.1691/ph.2009.9653; Saini AK, 2007, EUR J PHARMACOL, V568, P164, DOI 10.1016/j.ejphar.2007.04.016; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sharma G. K., 2000, Journal of the Tennessee Academy of Science, V75, P38; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Sharma S, 2004, LIFE SCI, V75, P2391, DOI 10.1016/j.lfs.2004.04.030; Shoaib Ambreen, 2020, Journal of Dietary Supplements, V17, P110, DOI 10.1080/19390211.2018.1484406; Shoaib A, 2019, NAT PROD RES, V33, P2699, DOI 10.1080/14786419.2018.1460838; Shortall SE, 2016, ADDICT BIOL, V21, P1127, DOI 10.1111/adb.12283; Smith A Gordon, 2012, Continuum (Minneap Minn), V18, P60, DOI 10.1212/01.CON.0000411568.34085.3e; Solanki ND, 2015, INDIAN J PHARMACOL, V47, P610, DOI 10.4103/0253-7613.169579; Subramanian R, 2008, ACTA BIOCHIM POL, V55, P391, DOI 10.18388/abp.2008_3087; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774	35	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	OCT	2019	120	10					16524	16532		10.1002/jcb.28912	http://dx.doi.org/10.1002/jcb.28912			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IU4IQ	31099436				2022-09-04	WOS:000483551100021
J	Naeini, MB; Momtazi, AA; Jaafari, MR; Johnston, TP; Barreto, G; Banach, M; Sahebkar, A				Naeini, Mehri Bemani; Momtazi, Amir Abbas; Jaafari, Mahmoud Reza; Johnston, Thomas P.; Barreto, George; Banach, Maciej; Sahebkar, Amirhossein			Antitumor effects of curcumin: A lipid perspective	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						curcumin; enzyme; lipid; metabolism; tumor	FATTY-ACID SYNTHASE; ATP-CITRATE LYASE; HMG-COA REDUCTASE; SYSTEMIC OXIDATIVE STRESS; INDUCED HEPATIC STEATOSIS; COENZYME-A REDUCTASE; BREAST-CANCER CELLS; X-RECEPTOR; INSULIN-RESISTANCE; PIPERINE COMBINATION	Lipid metabolism plays an important role in cancer development due to the necessities of rapidly dividing cells to increase structural, energetic, and biosynthetic demands for cell proliferation. Basically, obesity, type 2 diabetes, and other related diseases, and cancer are associated with a common hyperactivated lipogenic state. Recent evidence suggests that metabolic reprogramming and overproduction of enzymes involved in the synthesis of fatty acids are the new hallmarks of cancer, which occur in an early phase of tumorigenesis. As the first evidence to confirm dysregulated lipid metabolism in cancer cells, the overexpression of fatty acid synthase (FAS) was observed in breast cancer patients and demonstrated the role of FAS in cancer. Other enzymes of fatty acid synthesis have recently been found to be dysregulated in cancer, including ATP-dependent citrate lyase and acetyl-CoA carboxylase, which further underscores the connection of these metabolic pathways with cancer cell survival and proliferation. The degree of overexpression of lipogenic enzymes and elevated lipid utilization in tumors is closely associated with cancer progression. The question that arises is whether the progression of cancer can be suppressed, or at least decelerated, by modulating gene expression related to fatty acid metabolism. Curcumin, due to its effects on the regulation of lipogenic enzymes, might be able to suppress, or even cause regression of tumor growth. This review discusses recent evidence concerning the important role of lipogenic enzymes in the metabolism of cancer cells and whether the inhibitory effects of curcumin on lipogenic enzymes is therapeutically efficacious.	[Naeini, Mehri Bemani; Momtazi, Amir Abbas; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO 64110 USA; [Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Banach, Maciej] PMMHRI, Lodz, Poland; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Banach, Maciej/A-1271-2009; Barreto, George E./AAD-7420-2020; Momtazi-Borojeni, Amir Abaas/AAC-6972-2019; Sahebkar, Amirhossein/B-5124-2018	Banach, Maciej/0000-0001-6690-6874; Barreto, George E./0000-0002-6644-1971; Momtazi-Borojeni, Amir Abaas/0000-0002-4376-1083; 				Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Bjarnadottir O, 2013, BREAST CANCER RES TR, V138, P499, DOI 10.1007/s10549-013-2473-6; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Corominas-Faja B, 2014, ONCOTARGET, V5, P8306, DOI 10.18632/oncotarget.2059; Deng YT, 2012, J AGR FOOD CHEM, V60, P1059, DOI 10.1021/jf204496f; Ding LL, 2016, TOXICOL APPL PHARM, V304, P99, DOI 10.1016/j.taap.2016.05.011; Dong SZ, 2011, MOL CELL BIOCHEM, V358, P281, DOI 10.1007/s11010-011-0978-z; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; El Akri K., 2013, OPEN J MED CHEM, V3, P100; Fan HJ, 2016, ONCOL REP, V35, P2651, DOI 10.3892/or.2016.4682; Fan HJ, 2014, TARGET ONCOL, V9, P279, DOI 10.1007/s11523-013-0286-5; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Ghanbarzadeh F., 2013, J SHAHID SADOUGHI U, V21, P482; Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hopperton KE, 2014, EXP CELL RES, V320, P302, DOI 10.1016/j.yexcr.2013.10.016; Horiguchi A, 2008, J UROLOGY, V180, P1137, DOI 10.1016/j.juro.2008.04.135; Hung CM, 2012, J AGR FOOD CHEM, V60, P8427, DOI 10.1021/jf302754w; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Iranshahi M, 2010, PHYTOMEDICINE, V17, P269, DOI 10.1016/j.phymed.2009.05.020; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Kim BH, 2016, YONSEI MED J, V57, P664, DOI 10.3349/ymj.2016.57.3.664; Kim JH, 2010, J CELL PHYSIOL, V223, P771, DOI 10.1002/jcp.22093; Kim T, 2009, BIOCHEM BIOPH RES CO, V388, P377, DOI 10.1016/j.bbrc.2009.08.018; Kuo JJ, 2012, INT J MOL MED, V30, P673, DOI 10.3892/ijmm.2012.1049; Lamouille S, 2011, CELLS TISSUES ORGANS, V193, P8, DOI 10.1159/000320172; LaPensee CR, 2016, ENDOCRINOLOGY, V157, P1775, DOI 10.1210/en.2015-2052; Le Lay S, 2004, ADIPOCYTE CHOLESTERO; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Liu LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-154; Lone J, 2016, J NUTR BIOCHEM, V27, P193, DOI 10.1016/j.jnutbio.2015.09.006; Lu CF, 2015, IUBMB LIFE, V67, P645, DOI 10.1002/iub.1409; Luo DX, 2012, RECENT PAT ANTI-CANC, V7, P168, DOI 10.2174/157489212799972918; Maithilikarpagaselvi N, 2016, PHARM BIOL, V54, P2857, DOI 10.1080/13880209.2016.1187179; MALTESE WA, 1985, J CLIN INVEST, V76, P1748, DOI 10.1172/JCI112165; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Migita T, 2013, AM J PATHOL, V182, P1800, DOI 10.1016/j.ajpath.2013.01.048; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Mohammadi A, 2013, PHYTOTHER RES, V27, P374, DOI 10.1002/ptr.4715; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Murata S, 2010, CANCER SCI, V101, P1861, DOI 10.1111/j.1349-7006.2010.01596.x; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Narisawa T, 1996, JPN J CANCER RES, V87, P798, DOI 10.1111/j.1349-7006.1996.tb02103.x; ODLE J, 1995, J NUTR, V125, P2541; Oh GS, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0037-x; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Panahi Y, 2016, NUTRITION, V32, P1116, DOI 10.1016/j.nut.2016.03.018; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P209, DOI 10.3109/19390211.2015.1008611; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Panahi Y, 2015, PHYTOTHER RES, V29, P17, DOI 10.1002/ptr.5211; Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006; Panahi Y, 2014, PHYTOTHER RES, V28, P1625, DOI 10.1002/ptr.5174; Pandey P. R., 2012, ROLES LIPOGENESIS BR; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Parizadeh SMR, 2011, LIPIDS, V46, P333, DOI 10.1007/s11745-010-3517-x; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Peck B, 2016, FEBS J, V283, P2767, DOI 10.1111/febs.13681; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Raju J, 2007, CANCER LETT, V255, P194, DOI 10.1016/j.canlet.2007.04.011; Rashid A, 1997, AM J PATHOL, V150, P201; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Reddy BS, 2006, CANCER RES, V66, P4542, DOI 10.1158/0008-5472.CAN-05-4428; Rogers MA, 2015, J STEROID BIOCHEM, V151, P102, DOI 10.1016/j.jsbmb.2014.09.008; Rotondo D, 2011, CURR OPIN LIPIDOL, V22, P428, DOI 10.1097/MOL.0b013e32834b0d7f; Sahebkar Amirhossein, 2014, Nat Rev Cardiol, V11, P123, DOI 10.1038/nrcardio.2013.140-c1; Sahebkar A, 2016, INTEGR CANCER THER, V15, P333, DOI 10.1177/1534735415624139; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2016, THROMB HAEMOSTASIS, V115, P520, DOI 10.1160/TH15-08-0620; Sahebkar A, 2015, THROMB HAEMOSTASIS, V114, P546, DOI 10.1160/TH14-11-0937; Sahebkar A, 2015, ATHEROSCLEROSIS, V241, P433, DOI 10.1016/j.atherosclerosis.2015.05.022; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045; Saraon P, 2014, PROSTATE, V74, P372, DOI 10.1002/pros.22758; Saxena NK, 2010, CELL ADHES MIGR, V4, P358, DOI 10.4161/cam.4.3.11541; Sbiera S, 2015, ENDOCRINOLOGY, V156, P3895, DOI 10.1210/en.2015-1367; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Serban C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09902; Shanmugam MK, 2015, MOLECULES, V20, P2728, DOI 10.3390/molecules20022728; Shieh JM, 2013, J AGR FOOD CHEM, V61, P6366, DOI 10.1021/jf4012455; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Skiba-Cassy S, 2007, COMP BIOCHEM PHYS B, V147, P278, DOI 10.1016/j.cbpb.2007.01.007; Swamy MV, 2002, INT J ONCOL, V20, P753; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Um MY, 2013, BASIC CLIN PHARMACOL, V113, P152, DOI 10.1111/bcpt.12076; Wang CY, 2003, J CLIN ENDOCR METAB, V88, P3021, DOI 10.1210/jc.2002-021834; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057; Zhang YZ, 2010, CIRCULATION, V121, P1347, DOI 10.1161/CIRCULATIONAHA.109.897330; Zhao JO, 2011, MOL CELL BIOCHEM, V351, P19, DOI 10.1007/s11010-010-0707-z; Zhou YL, 2012, MOL BIOL REP, V39, P9733, DOI 10.1007/s11033-012-1838-y; Zingg JM, 2013, BIOFACTORS, V39, P1, DOI 10.1002/biof.1050	130	19	19	0	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	SEP	2019	234	9					14743	14758		10.1002/jcp.28262	http://dx.doi.org/10.1002/jcp.28262			16	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	IB3NM	30741424				2022-09-04	WOS:000470174200030
J	Restrepo-Cardona, JS; Marin-C, D; Sanchez-Bellaiza, DM; Rodriguez-Villamil, DR; Berrio, S; Vargas, L; Mikkola, H				Sebastian Restrepo-Cardona, Juan; Marin-C, David; Sanchez-Bellaiza, Diana M.; Rodriguez-Villamil, David R.; Berrio, Sebastian; Vargas, Leandro; Mikkola, Heimo			DIET OF BARN OWL (TYTO ALBA), SPECTACLED OWL (PULSATRIX PERSPICILLATA) AND RUFOUS-BANDED OWL (STRIX ALBITARSIS) IN THE WESTERN ANDES OF COLOMBIA	ORNITOLOGIA NEOTROPICAL			English	Article						Antioquia; Biomass; Food niche; Neotropical owls; Strigiformes	STRIGIDAE	Dietary studies are one of the most developed research areas in biology and ecology studies of Neotropical owls, but most of these studies have focused on few species. Our study describes the diet of Barn Owl (Tyto alba), Spectacled Owl (Pulsatrix perspicillata), and Rufous-banded Owl (Strix albitarsis) in Jardin and Ciudad Bolivar, western Andes of Colombia. The diet of T. alba, based on 495 prey items consisted 98.6% of vertebrates, the main food items being rodents (66%) and shrews (21.4%). Out of 142 prey items identified from P. perspicillata fractured pellets, the main prey species were Artibeus lituratus (23.9%), Rattus norvegicus (21.8%), and Didelphis sp. (16.1%), species of small and medium-sized mammals that tolerate environmental changes and often live in urban areas. Pulsatrix perspicillata preyed also on at least 14 bird species including hummingbirds and migratory birds. Based on 165 prey items S. albitarsis consumed more invertebrates (57.7%) than vertebrates (42.3%). Among the insects, the main preys were Coleoptera beetles and Orthoptera crickets. Among the vertebrates, the main prey species included mammals such as Thomasomys aureus, Marmosops sp., Marmosa sp., and Reithrodontomys mexicanus. These scansorial species are likely to be vulnerable to aerial predators such as S. albitarsis which hunt from a perchs. According to standardized Levins index values T. alba was the most selective in its food habits, P. perspicillata had intermediate values, while S. albitarsis showed the least selective diet.	[Sebastian Restrepo-Cardona, Juan] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia; [Marin-C, David] Univ Antioquia, Grp Mastozool & Colecc Teriol, Medellin, Colombia; [Sanchez-Bellaiza, Diana M.] Univ Quindio, Programa Biol, Armenia, Colombia; [Rodriguez-Villamil, David R.] Univ Pedag Nacl, Grp Ornitol, Bogota, Colombia; [Berrio, Sebastian] Univ Antioquia, Programa Biol, Medellin, Colombia; [Vargas, Leandro] COTINGA Birders, Grp Observ Aves de Jardin, Medellin, Colombia; [Mikkola, Heimo] Univ Eastern Finland, Dept Biol, Kuopio Campus, Kuopio, Finland		Restrepo-Cardona, JS (corresponding author), Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia.	jsrestrepoc@gmail.com	Mikkola, Heimo/AAJ-4202-2021					Aliabadian M, 2016, BIOL J LINN SOC, V119, P904, DOI 10.1111/bij.12824; Bó María Susana, 2007, Hornero, V22, P97; Cadena-Ortiz H, 2013, ORNITOL NEOTROP, V24, P469; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Daza Juan D., 2017, Cuad. herpetol., V31, P37; de Silva HG, 1997, J RAPTOR RES, V31, P385; Delgado V, 2007, B SAO, V17, P114; Delgado V., 2005, ORNITOL COLOMB, V3, P100; Delgado VCA, 2007, B SAO, V17, P94; Delgado-V CA, 2004, ORNITOL NEOTROP, V15, P413; Delgado-V. Carlos A., 2009, Ornitologia Colombiana, V8, P88; Donadio E, 2009, ORNITOL NEOTROP, V20, P137; Dunning J. B., 2008, CRC HDB AVIAN BODY M; Enriquez P. L., 2006, CURRENT RAPTOR STUDI, P254; Greeney Harold F., 2003, Lundiana, V4, P67; Marin-Gomez OH, 2017, NORTH-WEST J ZOOL, V13, P368; JIMENEZ JE, 1989, WILSON BULL, V101, P377; Konig C., 2008, OWLS WORLD; Krebs C.J, 1999, ECOLOGICAL METHODOLO; LEVINS RICHARD, 1968; Lloyd H, 2003, J FIELD ORNITHOL, V74, P376, DOI 10.1648/0273-8570-74.4.376; Lopez L., 2007, GUIA FLAMENCO; Marks J.S., 1999, HDB BIRDS WORLD VOL, P76; Marti C.D., 1987, RAPTOR RES MANAGEMEN, V10, P69; Marti Carl D., 2007, P129; Raimilla V, 2012, REV CHIL HIST NAT, V85, P469, DOI 10.4067/S0716-078X2012000400009; Ramírez-Chaves Héctor E, 2011, Bol. Cient. Mus. Hist. Nat. Univ. Caldas, V15, P139; Rashid Scott, 1999, Journal of the Colorado Field Ornithologists, V33, P94; Rivera-Rivera E, 2012, REV MEX BIODIVERS, V83, P742, DOI 10.7550/rmb.21364; Sanchez-Londono JD, 2014, IMAMA MAMIFEROS SILV; Sazima I, 2015, REV BRAS ORNITOL, V23, P12; Trejo A, 2005, ORNITOL NEOTROP, V16, P539; Voirin James Bryson, 2009, Edentata, V8-10, P15	33	2	3	0	18	NEOTROPICAL ORNITHOLOGICAL SOC, USGS PATUXENT WILDLIFE RESEARCH CTR	ATHENS	UNIV GEORGIA, WARNELL SCH FOREST RESOURCES, ATHENS, GA 30602-2152 USA	1075-4377			ORNITOL NEOTROP	ORNITOL. NEOTROP.	AUG 20	2018	29						193	198						6	Ornithology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	HH3UI					2022-09-04	WOS:000455644800001
J	Mugabo, Y; Zhao, SG; Seifried, A; Gezzar, S; Al-Mass, A; Zhang, DW; Lamontagne, J; Attane, C; Poursharifi, P; Iglesias, J; Joly, E; Peyot, ML; Gohla, A; Madiraju, SRM; Prentki, M				Mugabo, Yves; Zhao, Shangang; Seifried, Annegrit; Gezzar, Sari; Al-Mass, Anfal; Zhang, Dongwei; Lamontagne, Julien; Attane, Camille; Poursharifi, Pegah; Iglesias, Jose; Joly, Erik; Peyot, Marie-Line; Gohla, Antje; Madiraju, S. R. Murthy; Prentki, Marc			Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic beta-cells and hepatocytes	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						glycerol-3-phosphate phosphatase; gluconeogenesis; glucolipotoxicity; type 2 diabetes; glucose-stimulated insulin secretion	STIMULATED INSULIN-SECRETION; FREE FATTY-ACIDS; GLYCEROL SYNTHESIS; ADIPOSE-TISSUE; GLUCOSE-METABOLISM; LIPID-METABOLISM; RAINBOW SMELT; OBESE MICE; DYSFUNCTION; MASS	Obesity, and the associated disturbed glycerolipid/fatty acid (GL/FA) cycle, contribute to insulin resistance, islet beta-cell failure, and type 2 diabetes. Flux through the GL/FA cycle is regulated by the availability of glycerol-3-phosphate (Gro3P) and fatty acyl-CoA. We describe here amammalian Gro3P phosphatase (G3PP), which was not known to exist in mammalian cells, that can directly hydrolyze Gro3P to glycerol. We identified that mammalian phosphoglycolate phosphatase, with an uncertain function, acts in fact as a G3PP. We found that G3PP, by controlling Gro3P levels, regulates glycolysis and glucose oxidation, cellular redox and ATP production, gluconeogenesis, glycerolipid synthesis, and fatty acid oxidation in pancreatic islet beta-cells and hepatocytes, and that glucose stimulated insulin secretion and the response tometabolic stress, e.g., glucolipotoxicity, in beta-cells. In vivo overexpression of G3PP in rat liver lowers body weight gain and hepatic glucose production from glycerol and elevates plasma HDL levels. G3PP is expressed at various levels in different tissues, and its expression varies according to the nutritional state in some tissues. As Gro3P lies at the crossroads of glucose, lipid, and energy metabolism, control of its availability by G3PP adds a key level of metabolic regulation in mammalian cells, and G3PP offers a potential target for type 2 diabetes and cardiometabolic disorders.	[Mugabo, Yves; Zhao, Shangang; Gezzar, Sari; Zhang, Dongwei; Lamontagne, Julien; Attane, Camille; Poursharifi, Pegah; Iglesias, Jose; Joly, Erik; Peyot, Marie-Line; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Dept Nutr, Montreal, PQ H1W 4A4, Canada; [Mugabo, Yves; Zhao, Shangang; Gezzar, Sari; Zhang, Dongwei; Lamontagne, Julien; Attane, Camille; Poursharifi, Pegah; Iglesias, Jose; Joly, Erik; Peyot, Marie-Line; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Dept Biochem, Montreal, PQ H1W 4A4, Canada; [Mugabo, Yves; Zhao, Shangang; Gezzar, Sari; Zhang, Dongwei; Lamontagne, Julien; Attane, Camille; Poursharifi, Pegah; Iglesias, Jose; Joly, Erik; Peyot, Marie-Line; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; [Seifried, Annegrit; Gohla, Antje] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97080 Wurzburg, Germany; [Seifried, Annegrit; Gohla, Antje] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Al-Mass, Anfal] Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; [Al-Mass, Anfal] McGill Univ, Dept Expt Med, Montreal, PQ H3A 0G1, Canada; [Zhang, Dongwei] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing 100029, Peoples R China; [Iglesias, Jose] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Cra 7,43-82,Edf Carlos Ortiz, Bogota, Colombia		Madiraju, SRM; Prentki, M (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Dept Nutr, Montreal, PQ H1W 4A4, Canada.; Madiraju, SRM; Prentki, M (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Dept Biochem, Montreal, PQ H1W 4A4, Canada.; Madiraju, SRM; Prentki, M (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada.	murthy.madiraju@crchum.qc.ca; marc.prentki@umontreal.ca	Poursharifi, Pegah/K-4420-2019; ZHao, Shangang/H-5730-2019; Zhang, Dongwei/AAS-8384-2020	Poursharifi, Pegah/0000-0002-7804-4359; Zhang, Dongwei/0000-0002-7793-1482; Zhao, Shangang/0000-0002-9209-8206; Gohla, Antje/0000-0002-7442-1487	Canadian Institutes of Health Research; NIH [R01-DK19514]; Deutsche Forschungsgemeinschaft [SFB688]; Forschungszentrum Grant [FZ82]; Fond de Recherche Sante Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum Grant; Fond de Recherche Sante Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Metabolomics Core Facility of the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal for performing the metabolite determinations. This study was supported by grants from Canadian Institutes of Health Research (to M.P. and S.R.M.M.), NIH Grant R01-DK19514 (to M.P. and Neil Ruderman, Boston University), Deutsche Forschungsgemeinschaft Grant SFB688 (to A.G.), Forschungszentrum Grant FZ82 (to A.G.), and a fellowship from Fond de Recherche Sante Quebec (to Y.M.). M.P. holds the Canada Research Chair in Diabetes and Metabolism.	BARDELL D, 1977, MICROBIOS, V20, P139; Berry M, 1991, ISOLATED HEPATOCYTES; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Caparros-Martin JA, 2014, PLANTA, V240, P479, DOI 10.1007/s00425-014-2102-6; Chen BZ, 2007, CHEM RES TOXICOL, V20, P1701, DOI 10.1021/tx700164y; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; DEGROOT MJM, 1994, PFLUG ARCH EUR J PHY, V427, P96, DOI 10.1007/BF00585947; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Ditlecadet D, 2014, FISH PHYSIOL BIOCHEM, V40, P257, DOI 10.1007/s10695-013-9841-3; Ditlecadet D, 2013, AM J PHYSIOL-REG I, V304, pR304, DOI 10.1152/ajpregu.00468.2012; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Fan JJ, 2005, FEMS MICROBIOL LETT, V245, P107, DOI 10.1016/j.femsle.2005.02.031; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Green CD, 2009, ENDOCRINOLOGY, V150, P2637, DOI 10.1210/en.2008-1039; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Knight J, 2012, ANAL BIOCHEM, V421, P121, DOI 10.1016/j.ab.2011.10.041; Lahiri SD, 2006, BIOORG CHEM, V34, P394, DOI 10.1016/j.bioorg.2006.09.007; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Larrouy-Maumus G, 2013, P NATL ACAD SCI USA, V110, P11320, DOI 10.1073/pnas.1221597110; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; MAUGHAN RJ, 1982, CLIN CHIM ACTA, V122, P231, DOI 10.1016/0009-8981(82)90282-0; Mehta A, 1998, J CHROMATOGR B, V719, P9, DOI 10.1016/S0378-4347(98)00403-4; Merlen G, 2014, J HEPATOL, V60, P152, DOI 10.1016/j.jhep.2013.08.025; Moriyama M, 2015, BBA-MOL BASIS DIS, V1852, P1787, DOI 10.1016/j.bbadis.2015.04.023; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; PHILLIPS JW, 1995, EUR J BIOCHEM, V227, P352, DOI 10.1111/j.1432-1033.1995.tb20396.x; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; ROSE ZB, 1981, ARCH BIOCHEM BIOPHYS, V208, P602, DOI 10.1016/0003-9861(81)90549-X; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang CB, 2013, CLIN LIPIDOL, V8, P659, DOI 10.2217/clp.13.67; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003	51	60	62	2	22	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JAN 26	2016	113	4					E430	E439		10.1073/pnas.1514375113	http://dx.doi.org/10.1073/pnas.1514375113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6IJ	26755581	Green Published, Bronze			2022-09-04	WOS:000368617900007
J	Diaz, JDP; Llano, RC; Lombana, LJ; Restrepo, JI; Gomez, G				Puerta Diaz, J. D.; Castao Llano, R.; Lombana, L. J.; Restrepo, J. I.; Gomez, G.			Use of the gluteus maximus muscle as the neosphincter for restoration of anal function after abdominoperineal resection	TECHNIQUES IN COLOPROCTOLOGY			English	Article						Abdominoperineal resection; Colostomy; Fecal incontinence; Gluteus maximus transposition	TOTAL ANORECTAL RECONSTRUCTION; RECTAL-CANCER; FECAL INCONTINENCE; PERINEAL COLOSTOMY; SPHINCTER; GRACILOPLASTY; EXPERIENCE; EXCISION; ANASTOMOSIS; CONTINENCE	Our aim was to evaluate complications and long-term functional outcome in patients who had sphincter reconstruction using the gluteus maximus muscle as the neosphincter after abdominoperineal resection for rectal cancer treatment. Seven patients underwent reconstruction from 2000 to 2010. First, the sigmoid colon was brought down to the perineum as a perineal colostomy, with the procedure protected by a loop ileostomy. Reconstruction of the sphincter mechanism using the gluteus maximus took place 3 months later, and after another 8-12 weeks, the loop ileostomy was closed. We studied the functional outcome of these interventions with follow-up interviews of patients and objectively assessed anorectal function using manometry and the Cleveland Clinic Florida (Jorge-Wexner) fecal incontinence score. The mean follow-up was 56 months (median 47; range 10-123 months). One patient had a perianal wound infection and another had fibrotic stricture in the colocutaneous anastomosis that required several digital dilatations. Anorectal manometry at 3-month follow-up showed resting pressures from 10 to 18 mm Hg and voluntary contraction pressures from 68 to 187 mm Hg. Four patients had excellent sphincter function (Jorge-Wexner scores a parts per thousand currency sign5). Our preliminary results show that sphincter reconstruction by means of gluteus maximus transposition can be effective in restoring gastrointestinal continuity and recovering fecal continence in patients who have undergone APR with permanent colostomy for rectal cancer. Furthermore, the reconstruction procedure can be performed 2-4 years after the APR.	[Puerta Diaz, J. D.] Univ Pontificia Bolivariana, Clin Amer, Dept Gen Surg, Medellin, Colombia; [Castao Llano, R.] Univ Antioquia, Dept Gastrointestinal Surg & Endoscopy, Medellin, Colombia; [Castao Llano, R.] Univ Pontificia Bolivariana, Hosp Pablo Tobon Uribe, Medellin, Colombia; [Lombana, L. J.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Gen Surg, Bogota, Colombia; [Restrepo, J. I.] Univ CES, Hosp Pablo Tobon Uribe, Dept Gen Surg, Medellin, Colombia; [Restrepo, J. I.] Univ CES, Hosp Pablo Tobon Uribe, Dept Coloproctol, Medellin, Colombia; [Restrepo, J. I.] Clin Vegas, Medellin, Colombia; [Gomez, G.] Clin Saludcoop, Medellin, Colombia		Diaz, JDP (corresponding author), Univ Pontificia Bolivariana, Clin Amer, Dept Gen Surg, Diagonal 75B 2A 80-308, Medellin, Colombia.	puerta58@gmail.com		Lombana Amaya, Luis Jorge/0000-0002-7165-2124				Altomare DF, 1997, INT J COLORECTAL DIS, V12, P308, DOI 10.1007/s003840050112; Altomare DF, 2005, RECTAL CANC NEW FRON; BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646; Bordeianou L, 2008, DIS COLON RECTUM, V51, P1010, DOI 10.1007/s10350-008-9230-7; Breukink S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005200.pub2; Cavina E, 1996, DIS COLON RECTUM, V39, P182, DOI 10.1007/BF02068073; Cavina E, 1998, DIS COLON RECTUM, V41, P1010, DOI 10.1007/BF02237392; Cera Susan M, 2005, Clin Colon Rectal Surg, V18, P46, DOI 10.1055/s-2005-864081; CHETWOOD CH, 1902, MED REC, V61, P529; Chittenden AS, 1930, ANN SURG, V92, P152; Devesa J M, 2005, Tech Coloproctol, V9, P149, DOI 10.1007/s10151-005-0215-4; DEVESA JM, 1992, DIS COLON RECTUM, V35, P339, DOI 10.1007/BF02048111; DRAKE DB, 1987, ANN SURG, V206, P600; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hirche C, 2010, DIS COLON RECTUM, V53, P1272, DOI 10.1007/DCR.0b013e3181e74c1f; Ho KS, 2005, INT J COLORECTAL DIS, V20, P38, DOI 10.1007/s00384-004-0622-4; Kirzin S, 2010, DIS COLON RECTUM, V53, P1265, DOI 10.1007/DCR.0b013e3181e2c489; Latkauskas T, 2010, COLORECTAL DIS, V12, P1075, DOI 10.1111/j.1463-1318.2009.02015.x; Madoff RD, 1999, GASTROENTEROLOGY, V116, P549, DOI 10.1016/S0016-5085(99)70176-9; Marchal F, 2005, GASTROEN CLIN BIOL, V29, P425, DOI 10.1016/S0399-8320(05)80797-3; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Marwan K, 2010, DIS COLON RECTUM, V53, P1645, DOI 10.1007/DCR.0b013e3181f46485; PARKS AG, 1982, BRIT J SURG, V69, P301, DOI 10.1002/bjs.1800690602; Puerta J, 2001, REV COLOMB CIR, V16, P225; Puerta J, 1998, REV COLOMB GASTROENT, V13, P9; Romano G, 2003, DIS COLON RECTUM, V46, P730, DOI 10.1007/s10350-004-6649-3; SIMONSEN OS, 1976, BRIT J SURG, V63, P389, DOI 10.1002/bjs.1800630514; Tilney HS, 2008, ANN SURG, V247, P77, DOI 10.1097/SLA.0b013e31816076c3; Violi V, 2004, INT J COLORECTAL DIS, V19, P219, DOI 10.1007/s00384-003-0528-6; WILLIAMS NS, 1990, DIS COLON RECTUM, V33, P561, DOI 10.1007/BF02052207	30	1	2	0	7	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1123-6337	1128-045X		TECH COLOPROCTOL	Tech. Coloproctology	AUG	2013	17	4					425	429		10.1007/s10151-012-0961-z	http://dx.doi.org/10.1007/s10151-012-0961-z			5	Gastroenterology & Hepatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Surgery	184TF	23242561				2022-09-04	WOS:000321915700015
J	Huseni, S; Gutierrez, M; Rodriguez-Martinez, C; Nino, CL; Perez, GF; Nino, G				Huseni, Shehlanoor; Gutierrez, Maria; Rodriguez-Martinez, Carlos; Nino, Cesar L.; Perez, Geovanny F.; Nino, Gustavo			Upper and Lower Airway Inflammation Modulate the Phenotypical Expression of OSA in Children	JOURNAL OF INVESTIGATIVE MEDICINE			English	Meeting Abstract	Eastern Regional Meeting of the American-Federation-for-Medical-Research (AFMR)	APR 16-17, 2013	Washington, DC	Amer Federat Med Res					[Huseni, Shehlanoor; Perez, Geovanny F.; Nino, Gustavo] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Gutierrez, Maria] Penn State Univ, Coll Med, Hershey, PA USA; [Rodriguez-Martinez, Carlos] Univ Nacl Colombia, Bogota, Colombia; [Nino, Cesar L.] Javeriana Univ, Bogota, Colombia										0	0	0	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	MAR	2013	61	3					665	665						1	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Research & Experimental Medicine	097GU					2022-09-04	WOS:000315462800040
J	Cisneros-Heredia, DF; Venecas, PJ; Rada, M; Schulte, R				Cisneros-Heredia, Diedo F.; Venecas, Pablo J.; Rada, Marco; Schulte, Rainer			A NEW SPECIES OF GLASSFROG (ANURA: CENTROLENIDAE) FROM THE FOOTHILL ANDEAN FORESTS OF ECUADOR AND PERU	HERPETOLOGICA			English	Article						Amphibia; Centrolenidae; Cochranella mediarmidi new species; Contrafuerte de Tzunatza; Cordillera del Condor; Cordillera Oriental; Ecuador; Nymphargus posadae; Peru	FROGS	We describe a new species of glassfrog assigned to the genus Cochranella (Amphibia: Anura; Athesphatanura: Centrolenidae) from the Foothill Evergreen forests on the southeastern Andean slopes of Ecuador and northeastern Andean slopes of Peru. The new species is characterized by its moderate-sized body (25.4-26.9 mm in adult males), medium-sized eyes (eye diameter/third disc width = 1.4-1.9), distinctive coloration in life (olive green with light spots) and in preservative (grayish lavender with pale spots), dorsal skin covered with flat warts and low turbercles, parietal peritoneum mostly white (covered by iridophores), thick ulnar folds, and extensive hand and foot webbing. In addition, we, provide the first record of Nymphargus posadae from Peru, found in sympatry with the new species at the Cordillera del Condor.	[Cisneros-Heredia, Diedo F.] Kings Coll London, Dept Geog, Strand, London WC2R 2LS, England; [Cisneros-Heredia, Diedo F.] Univ San Francisco Quito, Quito, Ecuador; [Cisneros-Heredia, Diedo F.] Museo Ecuatoriano Ciencias Nat, Quito, Ecuador; [Venecas, Pablo J.] Invest Asociado, Ctr Ornitol & Biodiversidad CORBIDI, Lima, Peru; [Rada, Marco] Conservac Int Anfibios & Reptiles, Botota, Colombia; [Rada, Marco] Pontificia Univ Javeriana, Lab Herpetol, Botota, Colombia; [Schulte, Rainer] INIBICO, Tarapoto, Peru		Cisneros-Heredia, DF (corresponding author), Kings Coll London, Dept Geog, Strand, London WC2R 2LS, England.	diegofrancisco_cisneros@yahoo.com	Rada, Marco/F-9306-2015; Cisneros-Heredia, Diego F./D-1744-2011	Cisneros-Heredia, Diego F./0000-0002-6132-2738	Conservacion Internacional-Colombia; Fondo para la Accion Ambiental y la Ninez; Darwin Initiative; Smithsonian Women's Committee; National Museum of Natural History Smithsonian Institution; King's College London; Universidad San Francisco de Quito; Conservation International; Word Wildlife Fund WWF; "Fernando Ortiz-Crespo" Endangered Species Program	Conservacion Internacional-Colombia; Fondo para la Accion Ambiental y la Ninez; Darwin Initiative; Smithsonian Women's Committee; National Museum of Natural History Smithsonian Institution(Smithsonian InstitutionSmithsonian National Museum of Natural History); King's College London; Universidad San Francisco de Quito; Conservation International; Word Wildlife Fund WWF; "Fernando Ortiz-Crespo" Endangered Species Program	For the access to specimens, provision of working space and hospitality, we thank: M. H. Yanez-Munoz (DHMECN); J. D. Lynch (ICN); L. Trueb, W. Duellman, and J. M. Guayasamin (KU); J. Hanken and J. Rosado (MCZ); L. A. Coloma (QCAZ); C. Aguilar, M. Medina Muller, and K. Siu Ting Salvatierra (MUSM); and R. W. McDiarmid, G. R. Zug, and W. R. Heyer (USNM). We are grateful to D. Almeida-Reinoso, J. A. Campbell, L. A. Coloma, J. M. Guayasamin, M. B. Harvey, J. D. Lynch, F. Nogales, J. E. Simmons, E. Wild, F. Burbrink and two anonymous reviewers for their helpful comments, enlightened discussions, and provision of useful literature; and to S. Cruz, J. Snarez-Segovia, and J. J. Mueses-Cisneros for permissions to use their photographs. MR's research was supported by Conservacion Internacional-Colombia, the Fondo para la Accion Ambiental y la Ninez, and the Darwin Initiative ("Jorge Hernandez-Camacho" Endangered Species Program). DFCH's research was supported by M. E. Heredia and L. Heredia, the Smithsonian Women's Committee, the 2002 Research Training Program at the National Museum of Natural History Smithsonian Institution, King's College London, Universidad San Francisco de Quito, Conservation International, the Russel E. Train Education for Nature Program of the Word Wildlife Fund WWF, and the "Fernando Ortiz-Crespo" Endangered Species Program managed by EcoCiencia and Conservation International. DFCH is grateful to R. W. McDiarmid, G. R. Zug, W. R. Heyer, R. P. Reynolds, K. A. Tighe, S. W. Gotte, C. C. Baldwin, and M. Sangrey for their continuous support during his work at the USNM; to R. W. McDiarmid and G. A. Wyngaard and to Guayasamin and E. Bonaccorso for their hospitality during his visits to Washington, D.C., and Lawrence, respectively; and to J. Arellano, M. O. Borja, S. Cruz, M. E. Heredia, A. Leon-Reyes, D. Proano, and T. Sugahara for their friendship, field companionship, and laboratory assistance.	Acosta-Galvis Andres Rymel, 2000, Biota Colombiana, V1, P289; Aguayo R, 2006, HERPETOLOGICA, V62, P323, DOI 10.1655/0018-0831(2006)62[323:ANGOTC]2.0.CO;2; Cisneros-Heredia Diego F., 2007, Herpetozoa, V20, P27; Cisneros-Heredia DF, 2007, ZOOTAXA, P3; Cisneros-Heredia DF, 2007, ZOOTAXA, P33, DOI 10.11646/zootaxa.1485.1.3; Cisneros-Heredia Diego F., 2005, Check List, V1, P18; Cisneros-Heredia DF, 2006, ZOOTAXA, P1; Cisneros-Heredia DF, 2006, ZOOTAXA, P21, DOI 10.11646/zootaxa.1361.1.2; DUELLMAN WE, 1993, OCCASIONAL PAPERS MU, V155, P1; FHOST DR, 2006, B AM MUS NAT HIST, V297, P1; FROST DR, 2007, AMPHIBIAN SPECIES WO; Guayasamin JM, 2006, ZOOL J LINN SOC-LOND, V147, P489, DOI 10.1111/j.1096-3642.2006.00223.x; HAYES M P, 1980, Bulletin Southern California Academy of Sciences, V79, P89; Lynch J.D., 1973, Occasional Papers Mus Nat Hist Univ Kans, VNo. 16, P1; Rodriguez L.O. J. H., 1993, PUBLICACIONES MUSEO, V45, P1; Ruiz-Carranza Pedro M., 1995, Lozania, V62, P1; Ruiz-Carranza Pedro M., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P541; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; Savage Jay M., 1997, Herpetological Review, V28, P131; SCHWALM PA, 1980, J MORPHOL, V163, P37, DOI 10.1002/jmor.1051630106; Senaris JC., 2005, REVISION TAXONOMICA; Sierra R, 1999, PROPUESTA PRELIMINAR; TAYLOR EDWARD H., 1951, PROC BIOL SOC WASHINGTON, V64, P33; Torres-Gastello Claudia P., 2007, Journal of the National Museum Prague Natural History Series, V176, P1; WILD ER, 1994, J HERPETOL, V28, P299, DOI 10.2307/1564528; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809	26	9	10	0	6	HERPETOLOGISTS LEAGUE	LAWRENCE	C/O ALLEN PRESS, PO BOX 7065, LAWRENCE, KS 66044 USA	0018-0831	1938-5099		HERPETOLOGICA	Herpetologica	SEP	2008	64	3					341	353		10.1655/06-078.1	http://dx.doi.org/10.1655/06-078.1			13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	376ZX					2022-09-04	WOS:000261222600007
J	Zubizarreta-Macho, A; Alonso-Ezpeleta, O; Martinez, AA; Matoses, VF; Brucheli, JC; Agustin-Panadero, R; Alvarez, JM; Martinez-Berganza, FV				Zubizarreta-Macho, Alvaro; Alonso-Ezpeleta, Oscar; Albaladejo Martinez, Alberto; Faus Matoses, Vicente; Caviedes Brucheli, Javier; Agustin-Panadero, Ruben; Mena Alvarez, Jesus; Vizmanos Martinez-Berganza, Fernando			Novel Electronic Device to Quantify the Cyclic Fatigue Resistance of Endodontic Reciprocating Files after Using and Sterilization	APPLIED SCIENCES-BASEL			English	Article						endodontics; cyclic fatigue; time of use; sterilization cycles; reciprocating movement	AUTOCLAVE STERILIZATION; ROTARY INSTRUMENTS; TITANIUM; DEFORMATION	Background: The aim of this study was to analyze the effects of the time of use (TU) and sterilization cycles (SC) of endodontic reciprocating files on cyclic fatigue resistance. Methods: One-hundred-and-twenty (120) Procodile NiTi endodontic reciprocating instruments were selected at random and distributed into the following study groups: A: 0 sterilization cycles/0s time of use (n= 10); B: 0/60 (n= 10); C: 0/120 (n= 10); D: 1/0 (n= 10); E: 1/60 (n= 10); F: 1/120 (n= 10); G: 5/0 (n= 10); H: 5/60 (n= 10); I: 5/120 (n= 10); J: 10/0 (n= 10); K: 10/60 (n= 10); and L: 10/120 (n= 10). A dynamic cyclic fatigue device was designed using computer-aided design/computer-aided engineering (CAD/CAE) technology and created with a 3D printer to simulate the pecking motion performed by the clinician. Failure of the endodontic rotary instrument was detected by a light-emitting diode-light-dependent resistor (LED-LDR) system controlled by an Arduino driver complex and management software. The results were analyzed using the ANOVA test. Results: All pairwise comparisons presented statistically significant differences between the time to failure, number of cycles to failure and number of cycles of in-and-out movement for the time of use study groups (p< 0.001), but not in the number of sterilization cycles (p> 0.05). Conclusions: The time of use of NiTi endodontic reciprocating files negatively affects dynamic cyclic fatigue resistance. Dynamic cyclic resistance is not affected by the number of sterilization cycles.	[Zubizarreta-Macho, Alvaro; Mena Alvarez, Jesus; Vizmanos Martinez-Berganza, Fernando] Alfonso X El Sabio Univ, Fac Hlth Sci, Dept Endodont, Madrid 28691, Spain; [Alonso-Ezpeleta, Oscar] Univ Zaragoza, Sch Hlth Sci, Dept Endodont, Zaragoza 22006, Spain; [Albaladejo Martinez, Alberto] Univ Salamanca, Sch Med, Dept Dent, Salamanca 37008, Spain; [Faus Matoses, Vicente; Agustin-Panadero, Ruben] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia 46010, Spain; [Caviedes Brucheli, Javier] Pontificia Univ Javeriana, Ctr Invest Odontol CIO, Bogota 1101, Colombia		Agustin-Panadero, R (corresponding author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia 46010, Spain.	amacho@uax.es; lalonezp@unizar.es; albertoalbaladejo@hotmail.com; vfaus@clinicafaus.com; javiercaviedes@gmail.com; ruben.agustin@uv.es; jmenaalvarez@gmail.com; fvizmmar@myuax.com	ALVAREZ, JESUS MENA/R-7942-2019; Agustín-Panadero, Rubén/R-9296-2018; Faus-Matoses, Vicente/AAN-4547-2020	ALVAREZ, JESUS MENA/0000-0003-0533-9065; Agustín-Panadero, Rubén/0000-0003-2757-6619; Faus-Matoses, Vicente/0000-0003-2452-4135; Caviedes-Bucheli, Javier/0000-0003-0407-9847				Alapati SB, 2005, J ENDODONT, V31, P40, DOI 10.1097/01.DON.0000132301.87637.4A; Alazemi MA, 2015, INT ENDOD J, V48, P593, DOI 10.1111/iej.12353; Arias A, 2020, CLIN ORAL INVEST, V24, P3113, DOI 10.1007/s00784-019-03185-4; Casper RB, 2011, J ENDODONT, V37, P1572, DOI 10.1016/j.joen.2011.07.008; Champa C, 2017, J Conserv Dent, V20, P194, DOI 10.4103/0972-0707.218307; De-Deus G, 2014, J ENDODONT, V40, P575, DOI 10.1016/j.joen.2013.10.013; Di Nardo Dario, 2019, J Clin Exp Dent, V11, pe231, DOI 10.4317/jced.55487; Dioguardi M, 2019, MATERIALS, V12, DOI 10.3390/ma12132190; Ferreira F, 2017, INT ENDOD J, V50, P143, DOI 10.1111/iej.12613; Gavini G, 2018, BRAZ ORAL RES, V32, P44, DOI 10.1590/1807-3107bor-2018.vol32.0067; Generali L, 2020, INT ENDOD J, V53, P250, DOI 10.1111/iej.13214; Grassi FR, 2012, INT J MED SCI, V9, P642, DOI 10.7150/ijms.4998; Hilfer PB, 2011, J ENDODONT, V37, P72, DOI 10.1016/j.joen.2010.09.011; Hlsmann M, 2019, INT ENDOD J, V52, P1427, DOI 10.1111/iej.13182; Keles A, 2019, INT ENDOD J, V52, P880, DOI 10.1111/iej.13073; Kim JW, 2014, J ENDODONT, V40, P1671, DOI 10.1016/j.joen.2014.06.002; Laneve E, 2019, INT J DENT, V2019, DOI 10.1155/2019/6507286; Olcay K, 2019, NIGER J CLIN PRACT, V22, P1335, DOI 10.4103/njcp.njcp_655_18; Ozyurek Taha, 2017, Restor Dent Endod, V42, P301, DOI 10.5395/rde.2017.42.4.301; Pedulla E, 2018, J ENDODONT, V44, P648, DOI 10.1016/j.joen.2017.12.011; Plotino G, 2012, J ENDODONT, V38, P222, DOI 10.1016/j.joen.2011.10.017; Pruett JP, 1997, J ENDODONT, V23, P77, DOI 10.1016/S0099-2399(97)80250-6; Raju T B V G, 2013, J Int Oral Health, V5, P108; Rubio J, 2019, ACTA STOMATOL CROAT, V53, P28, DOI 10.15644/asc53/1/3; SCHNEIDER SW, 1971, ORAL SURG ORAL MED O, V32, P271, DOI 10.1016/0030-4220(71)90230-1; Scott R, 2019, AUST ENDOD J, V45, P400, DOI 10.1111/aej.12374; Seago ST, 2015, J ENDODONT, V41, P725, DOI 10.1016/j.joen.2015.01.011; Shen Y, 2011, J ENDODONT, V37, P1566, DOI 10.1016/j.joen.2011.08.005; Sheth Nomal Chintan, 2017, J Conserv Dent, V20, P346, DOI 10.4103/JCD.JCD_253_16; Spagnuolo G, 2012, INT ENDOD J, V45, P1148, DOI 10.1111/j.1365-2591.2012.02088.x; Testarelli L, 2011, J ENDODONT, V37, P1293, DOI 10.1016/j.joen.2011.05.023; Topcuoglu HS, 2018, INT ENDOD J, V51, P1053, DOI 10.1111/iej.12915; Valois CRA, 2008, J ENDODONT, V34, P859, DOI 10.1016/j.joen.2008.02.028; Yang Y J, 2018, Beijing Da Xue Xue Bao Yi Xue Ban, V50, P882; Zhao D, 2016, INT ENDOD J, V49, P990, DOI 10.1111/iej.12550; Zubizarreta-Macho A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010045	36	3	3	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	JUL	2020	10	14							4962	10.3390/app10144962	http://dx.doi.org/10.3390/app10144962			14	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	MS2GJ		Green Published, gold			2022-09-04	WOS:000554101200001
J	Guzman-Tordecilla, DN; Vecino-Ortiz, AI; Lucumi, D; Mentz, G				Nicolas Guzman-Tordecilla, Deivis; Ignacio Vecino-Ortiz, Andres; Lucumi, Diego; Mentz, Graciela			Chronic stress as a mediator of the relationship between socioeconomic status and pharmacological adherence in hypertensive patients	BIOMEDICA			Spanish	Article						Stress; psychological; hypertension; treatment adherence and compliance; medication adherence; social class; Colombia	BLOOD-PRESSURE; PERCEIVED STRESS; GLOBAL BURDEN; JOB STRAIN; HEALTH; PREVALENCE; METAANALYSIS; ASSOCIATION; DISPARITIES; CORTISOL	Introduction: High blood pressure is a public health problem worldwide. In Colombia, its prevalence is 25% with a high mortality rate. The psychosocial factors affecting pharmacological adherence among patients have not been sufficiently studied and despite international evidence on their impact, in Colombia, there is a paucity of research on the role of chronic stress in the relationship between socioeconomic status and pharmacological adherence. Objective: To examine the role of chronic stress in the relationship between socioeconomic status and pharmacological adherence in hypertensive patients aged 45 to 70 years old in three Colombian cities between 2015 and 2016. Materials and methods: We conducted a cross-sectional study in a population of hypertensive patients. Data for this study came from the first wave of longitudinal study aimed at examining social factors associated with the control of hypertension in Bogota, Medellin, and Quibdo. Patients with hypertension were selected randomly from a sample of those participating in the hypertension control program De todo corazon. For the statistical analysis of the data, we used factorial analysis and multivariate regressions. Results: We found a positive association between socioeconomic status and the degree of pharmacological adherence and a negative one with chronic stress. Besides, evidence was found that stress has a negative association with the degree of adherence. Conclusions: The results suggest that stress is not a likely mediator between socioeconomic status and the pharmacological adherence of hypertensive patients in Colombia. Additional studies are required to confirm these relationships with a larger sample.	[Nicolas Guzman-Tordecilla, Deivis; Lucumi, Diego] Univ Los Andes, Escuela Gobierno, Bogota, DC, Colombia; [Ignacio Vecino-Ortiz, Andres] Pontificia Univ Javeriana, Inst Salud Publ, Bogota, DC, Colombia; [Ignacio Vecino-Ortiz, Andres] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Mentz, Graciela] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA		Guzman-Tordecilla, DN (corresponding author), Carrera 5 18-26,Piso 301, Bogota, DC, Colombia.	deivy-gt@hotmail.com		Guzman-Tordecilla, Deivis Nicolas/0000-0002-9419-7056; Vecino-Ortiz, Andres I./0000-0002-8089-2488; Lucumi Cuesta, Diego Ivan/0000-0003-1834-7937				Acock A. C., 2012, GENTLE INTRO STATA; Adler N, MACARTHUR SCALE SUBJ; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Bastos-Barbosa RG, 2012, ARQ BRAS CARDIOL, V99, P636, DOI 10.1590/S0066-782X2012005000054; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Baysak B, 2015, PROCD SOC BEHV, V207, P79, DOI 10.1016/j.sbspro.2015.10.159; Camacho PA, 2016, J HYPERTENS, V34, P2344, DOI 10.1097/HJH.0000000000001115; Campo José Ernesto, 2006, Colomb. Med., V37, P21; Campo-Arias A, 2009, AQUICHAN, V9, P271; Casas Piedrahíta María Cristina, 2013, Hacia promoc. Salud, V18, P81; Castaño-Castrillón José Jaime, 2012, rev.fac.med., V60, P179; Cha SH, 2012, J EPIDEMIOL, V22, P425, DOI 10.2188/jea.JE20110132; Chacón Javier, 2015, Rev Chil Cardiol, V34, P18; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Cortes D, INEQUIDAD REGIONAL C; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Departamento Administrativo Nacional de Estadistica, CENS GEN 2005; FREEDMAN LS, 1992, AM J EPIDEMIOL, V136, P1148, DOI 10.1093/oxfordjournals.aje.a116581; Fritz MS, 2008, BEHAV RES METHODS, V40, P55, DOI 10.3758/BRM.40.1.55; Garay J, 2007, PSICOL IBEROAM, V15, P22; Gasperin D, 2009, CAD SAUDE PUBLICA, V25, P715, DOI 10.1590/S0102-311X2009000400002; Glei DA, 2013, STRESS, V16, P411, DOI 10.3109/10253890.2013.789015; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Guarín-Loaiza Gloria Mercedes, 2016, rev.fac.med., V64, P651, DOI 10.15446/revfacmed.v64n4.52217; Herrera E., 2012, AV ENFERM, V30, P67; Instituto Nacional de Salud Observatorio Nacional de Salud, QUINT INF ONS CARG E; Carlos Alberto Isaza, 2004, Biomed., V24, P273; Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kershaw KN, 2017, AM J HYPERTENS, V30, P75, DOI 10.1093/ajh/hpw103; Kretchy IA, 2014, PAN AFR MED J, V17, P1; Landsbergis PA, 2003, SCAND J WORK ENV HEA, V29, P206, DOI 10.5271/sjweh.723; Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2012.301153; Legido-Quigley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122112; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Liu MY, 2017, NEUROL RES, V39, P573, DOI 10.1080/01616412.2017.1317904; London N. E., 2012, INT J PSYCHOL RES, V5, P142, DOI DOI 10.21500/20112084.770; LucumiCuesta DI, 2018, DISPARITIES HYPERTEN; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Mena-Díaz Fernanda Carolina, 2018, Hacia promoc. Salud, V23, P67, DOI 10.17151/hpsal.2018.23.2.5; Ministerio de Educacion, POBL COLO MUI BAJ NI; Ministerio de Salud y Proteccion Social, AN SIT SAL AS COL 20; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; O'Brien KM, 2013, STRESS HEALTH, V29, P337, DOI 10.1002/smi.2475; Patton Michael Q., 1990, QUALITATIVE EVALUATI, P277; Perez LH, 2001, EUR J EPIDEMIOL, V17, P275, DOI 10.1023/A:1017975925554; Perez-Escamilla B, 2015, PATIENT PREFER ADHER, V9, P569, DOI 10.2147/PPA.S76139; Ramos Morales Luisa Estela, 2015, Rev Cubana Angiol Cir Vasc, V16, P175; Rodríguez Lopez Mérida R, 2015, Rev. Fac. Nac. Salud Pública, V33, P192, DOI 10.17533/udea.rfnsp.v33n2a06; Rolnick SJ, 2013, CLIN MED RES, V11, P54, DOI 10.3121/cmr.2013.1113; Sandoval D, 2014, REV MED CHILE, V142, P1245, DOI 10.4067/S0034-98872014001000003; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Secretaria de Salud del Choco, AN SIT SAL AS MOD DE; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tang KL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010137; Trujano R, 2012, ALTER PSICOL, V16, P78; Val A, 1992, ATEN PRIM, V10, P767; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; World Health Organization. Department of Health Statistics and Infromatics, CAUS DEATH 2008 DAT; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	65	2	2	1	1	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	JUN	2020	40	2					243	256		10.7705/biomedica.4780	http://dx.doi.org/10.7705/biomedica.4780			14	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	MC6DL	32673454	gold, Green Published			2022-09-04	WOS:000543375000005
J	Rizvi, SMD; Hussain, T; Ahmed, ABF; Alshammari, TM; Moin, A; Ahmed, MQ; Barreto, GE; Kamal, MA; Ashraf, GM				Rizvi, Syed Mohd Danish; Hussain, Talib; Ahmed, Abo Bakr Fathy; Alshammari, Thamir M.; Moin, Afrasim; Ahmed, Mohammed Qumani; Barreto, George E.; Kamal, Mohammad Ajmal; Ashraf, Ghulam Md			Gold nanoparticles: A plausible tool to combat neurological bacterial infections in humans	BIOMEDICINE & PHARMACOTHERAPY			English	Review						Nanotechnology; Gold nanoparticles; Neurological bacterial infections; Bacterial meningitis; Blood brain barrier; Drug delivery	BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; GROUP-B STREPTOCOCCUS; MICROVASCULAR ENDOTHELIAL-CELLS; DRUG-DELIVERY; IN-VIVO; NEISSERIA-MENINGITIDIS; SILVER NANOPARTICLES; BIOMEDICAL APPLICATIONS; INTRACELLULAR SURVIVAL	Management of bacterial infections of central nervous system is a major challenge for the scientists all over the world. Despite the development of various potential drugs, the issue of central nervous system infections persists in the society. The main constraint is the delivery of drugs across the blood brain barrier and only a few drugs after meeting the stringent criteria could cross the blood brain barrier. On the other hand, certain bacterial pathogens could easily enter the brain by using several factors and mechanisms by crossing the blood brain barriers. Interestingly, in the recent past, gold nanoparticles have shown immense potential to overcome the issues associated with the treatment of central nervous system infections, especially due to their inherent ability to cross the blood brain barrier. Initially, the present review summarized the recent updates on the pathogenesis and factors involved in neurological bacterial infections, including the mechanism used by bacterial pathogens to cross the blood brain barriers. Thereafter, the emphasis of the review was on providing current information on gold nanoparticles pertinent to their applicability for the treatment of neurological infections. After discussing the background of neurological bacterial infections, the characteristic features, antibacterial properties, mechanisms of antibacterial action and ability to cross the blood brain barrier of gold nanoparticles have been summarized. Some of the features of gold nanoparticles that make them an ideal candidate for brain delivery are biocompatibity, stability, ability to get synthesized in different sizes with facile methods, surface affinity towards various functional groups, spontaneous crossing of blood brain barrier without applying any external field and most importantly, easy non- invasive tracing by CT imaging. The current updates on the development of gold nanoparticles based therapeutic strategies for the prevention and treatment of central nervous system infections have been discussed in the present study. However, further investigation would be required to translate these preclinical outcomes into clinical applications. Nevertheless, we could safely state that the information gathered and discussed in the present review would benefit the scientists working in the field of neuro-nanotechnology.	[Rizvi, Syed Mohd Danish; Hussain, Talib] Univ Hail, Dept Pharmacol & Toxicol, Coll Pharm, Hail, Saudi Arabia; [Ahmed, Abo Bakr Fathy; Moin, Afrasim] Univ Hail, Dept Pharmaceut, Coll Pharm, Hail, Saudi Arabia; [Alshammari, Thamir M.] Univ Hail, Dept Clin Pharm, Coll Pharm, Hail, Saudi Arabia; [Ahmed, Mohammed Qumani] Univ Hail, Dept Pharmacol, Coll Med, Hail, Saudi Arabia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Kamal, Mohammad Ajmal] Enzymoics, 7 Peterlee Pl, Kishinev 277028, Moldova; [Kamal, Mohammad Ajmal] Novel Global Community Educ Fdn, Sydney, NSW, Australia; [Kamal, Mohammad Ajmal; Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia		Rizvi, SMD (corresponding author), Univ Hail, Dept Pharmacol & Toxicol, Coll Pharm, Hail, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia.	syedrizvi10@yahoo.com; gashraf@kau.edu.sa	Ahmed, Abo Bakr F./AAA-8171-2020; Barreto, George E./AAD-7420-2020; Kamal, Mohammad Amjad/J-2918-2014; moin, afrasim/A-9254-2012; Hussain, Talib/I-4624-2014; Rizvi, Syed Mohd Danish/AAC-4452-2020; li, jian/AAD-5811-2019; Alshammari, Thamir M/AAV-6891-2020; Ashraf, Ghulam Md/H-9485-2012	Barreto, George E./0000-0002-6644-1971; Kamal, Mohammad Amjad/0000-0003-0088-0565; moin, afrasim/0000-0002-3902-1162; Hussain, Talib/0000-0002-5138-8223; Rizvi, Syed Mohd Danish/0000-0002-3106-4707; Alshammari, Thamir M/0000-0002-5630-2468; Ashraf, Ghulam Md/0000-0002-9820-2078				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abrahao AL, 2005, WORLD J BIOL PSYCHIA, V6, P44, DOI 10.1080/15622970510030063; Akhtar MS, 2013, ACS SUSTAIN CHEM ENG, V1, P591, DOI 10.1021/sc300118u; Alam MI, 2010, EUR J PHARM SCI, V40, P385, DOI 10.1016/j.ejps.2010.05.003; Amin M, 2013, CARBOHYD POLYM, V92, P1896, DOI 10.1016/j.carbpol.2012.11.056; Robles-Garcia MA, 2016, J NANOSCI NANOTECHNO, V16, P8188, DOI 10.1166/jnn.2016.12925; Arda B, 2008, MED PRIN PRACT, V17, P76, DOI 10.1159/000109595; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Arvizo R, 2010, EXPERT OPIN DRUG DEL, V7, P753, DOI 10.1517/17425241003777010; Ortiz-Benitez EA, 2015, METALLOMICS, V7, P1173, DOI 10.1039/c5mt00044k; Bagga P, 2017, CURR DRUG DELIV, V14, P1114, DOI 10.2174/1567201814666170316113432; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bao G, 2013, ANNU REV BIOMED ENG, V15, P253, DOI 10.1146/annurev-bioeng-071812-152409; Barichello T, 2013, REV BRAS PSIQUIATR, V35, P81, DOI 10.1016/j.rbp.2012.11.003; Barichello T, 2012, ARQ NEURO-PSIQUIAT, V70, P366, DOI 10.1590/S0004-282X2012000500011; Barichello T, 2010, BRAIN RES BULL, V82, P243, DOI 10.1016/j.brainresbull.2010.04.015; Batarseh KI, 2004, J ANTIMICROB CHEMOTH, V54, P546, DOI 10.1093/jac/dkh349; Bauer LA, 2004, J MATER CHEM, V14, P517, DOI 10.1039/b312655b; Bobadilla K, 2013, IMMUNOLOGY, V138, P34, DOI 10.1111/imm.12010; Borase HP, 2017, BIOPROC BIOSYST ENG, V40, P1437, DOI 10.1007/s00449-017-1801-3; Brandenberger C, 2010, TOXICOL APPL PHARM, V242, P56, DOI 10.1016/j.taap.2009.09.014; Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07; Braun JS, 2002, J CLIN INVEST, V109, P19; Brown AN, 2012, APPL ENVIRON MICROB, V78, P2768, DOI 10.1128/AEM.06513-11; Burygin GL, 2009, NANOSCALE RES LETT, V4, P794, DOI 10.1007/s11671-009-9316-8; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carrero JA, 2012, ADV IMMUNOL, V113, P157, DOI 10.1016/B978-0-12-394590-7.00001-4; Chandran K, 2019, ARAB J CHEM, V12, P1994, DOI 10.1016/j.arabjc.2014.11.041; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Cheng Y, 2014, SMALL, V10, P5137, DOI 10.1002/smll.201400654; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chithrani DB, 2010, MOL MEMBR BIOL, V27, P299, DOI 10.3109/09687688.2010.507787; Choi SJ, 2013, MOL CELL TOXICOL, V9, P205, DOI 10.1007/s13273-013-0026-z; Choi Y, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-103; Chong HT, 2005, NEUROL ASIA, V10, P7; Chueh PJ, 2014, J HAZARD MATER, V264, P303, DOI 10.1016/j.jhazmat.2013.11.031; Comim CM, 2010, NEUROTOX RES, V17, P279, DOI 10.1007/s12640-009-9101-6; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Carabineiro SAC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050857; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; CUNDELL DR, 1995, INFECT IMMUN, V63, P757, DOI 10.1128/IAI.63.3.757-761.1995; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Curry T, 2014, CONTRAST MEDIA MOL I, V9, P53, DOI 10.1002/cmmi.1563; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Denora N, 2009, CURR TOP MED CHEM, V9, P182, DOI 10.2174/156802609787521571; Doran KS, 2016, ACTA NEUROPATHOL, V131, P185, DOI 10.1007/s00401-015-1531-z; Drevets DA, 2004, CLIN MICROBIOL REV, V17, P323, DOI 10.1128/CMR.17.2.323-347.2004; Dykman LA, 2011, ACTA NATURAE, V3, P34, DOI 10.32607/20758251-2011-3-2-34-56; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; Eugene E, 2002, J CELL SCI, V115, P1231; FEIGIN R D, 1977, Clinics in Perinatology, V4, P103; FINKELSTEIN AE, 1976, ANN RHEUM DIS, V35, P251, DOI 10.1136/ard.35.3.251; Flores-Cordero JM, 2003, INTENS CARE MED, V29, P1967, DOI 10.1007/s00134-003-1935-4; Fratoddi I, 2015, NANO RES, V8, P1771, DOI 10.1007/s12274-014-0697-3; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Gerber A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-32; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; GOLDSTEIN GW, 1986, SCI AM, V255, P74, DOI 10.1038/scientificamerican0986-74; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Gromnicova R, 2016, NANOMEDICINE-UK, V11, P617, DOI 10.2217/nnm.15.215; Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z; Hainfeld JF, 2013, NANOMEDICINE-UK, V8, P1601, DOI [10.2217/NNM.12.165, 10.2217/nnm.12.165]; Hartono D, 2010, BIOMATERIALS, V31, P3008, DOI 10.1016/j.biomaterials.2010.01.003; Heath PT, 2011, ADV EXP MED BIOL, V719, P11, DOI 10.1007/978-1-4614-0204-6_2; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Hur YE, 2014, MATER LETT, V129, P185, DOI 10.1016/j.matlet.2014.05.032; Iovino F, 2014, INFECT IMMUN, V82, P3555, DOI 10.1128/IAI.00046-14; Iram F, 2014, CARBOHYD POLYM, V104, P29, DOI 10.1016/j.carbpol.2014.01.002; Jain KK, 2012, NANOMEDICINE-UK, V7, P1225, DOI 10.2217/nnm.12.86; Jain SK, 2006, J INFECT DIS, V193, P1287, DOI 10.1086/502631; Jiang S, 2013, NANOSCALE, V5, P3127, DOI 10.1039/c3nr34005h; Jo MR, 2015, NANOMATERIALS-BASEL, V5, P835, DOI 10.3390/nano5020835; Joh DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062425; JONSSON S, 1985, J INFECT DIS, V152, P4, DOI 10.1093/infdis/152.1.4; Julayanont P., 2016, SW RESP CRIT CARE CH, V4, P5; Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651; Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018; Khan MS, 2013, ADV COLLOID INTERFAC, V199, P44, DOI 10.1016/j.cis.2013.06.003; Khan NA, 2012, MICROB PATHOGENESIS, V53, P269, DOI 10.1016/j.micpath.2012.07.001; Khan S, 2015, MATER LETT, V159, P373, DOI 10.1016/j.matlet.2015.06.118; Khan S, 2017, J PHOTOCH PHOTOBIO B, V174, P150, DOI 10.1016/j.jphotobiol.2017.07.011; Kharissova OV, 2013, TRENDS BIOTECHNOL, V31, P240, DOI 10.1016/j.tibtech.2013.01.003; Kihara M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-79; Kim BJ, 2015, J CLIN INVEST, V125, P2473, DOI 10.1172/JCI74159; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; KIM KS, 1992, J CLIN INVEST, V90, P897, DOI 10.1172/JCI115965; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kim KS, 2006, INT J PARASITOL, V36, P607, DOI 10.1016/j.ijpara.2006.01.013; Klinman DM, 2016, WIRES NANOMED NANOBI, V8, P631, DOI 10.1002/wnan.1382; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kodiha M, 2014, CELL MOL LIFE SCI, V71, P4259, DOI 10.1007/s00018-014-1622-3; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Krol S., 2011, US Patent, Patent No. [2011/0111040 A1, 20110111040]; Kumar D, 2013, EXPERT OPIN DRUG DEL, V10, P397, DOI 10.1517/17425247.2013.749854; Kwon SG, 2008, ACCOUNTS CHEM RES, V41, P1696, DOI 10.1021/ar8000537; Lam GY, 2012, ADV IMMUNOL, V113, P7, DOI 10.1016/B978-0-12-394590-7.00008-7; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Legname G.A., 2011, US Patent, Patent No. [2011/0262546 A1, 20110262546]; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Li XN, 2014, ACS NANO, V8, P10682, DOI 10.1021/nn5042625; Liao HW, 2006, NANOMEDICINE-UK, V1, P201, DOI 10.2217/17435889.1.2.201; Lipka J, 2010, BIOMATERIALS, V31, P6574, DOI 10.1016/j.biomaterials.2010.05.009; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; Lopez-Castejon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035936; Luan JJ, 2016, CURR DRUG TARGETS, V17, P467, DOI 10.2174/1389450116666150416120224; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Majzik A, 2009, GOLD BULL, V42, P113, DOI 10.1007/BF03214921; Marques AH, 2007, REV BRAS PSIQUIATR, V29, pS27, DOI 10.1590/S1516-44462007000500006; Maughan CN, 2015, J PHARM PHARMACOL, V67, P426, DOI 10.1111/jphp.12352; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mitchell L, 2004, J INFECT DIS, V190, P2039, DOI 10.1086/425520; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Mocan L, 2013, BMBN, V1, P1; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Mu HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18877; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; National Institute of Neurological Disorders and Strokes, 2018, MEN ENC FACT SHEET; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Pardridge W. M, 2001, BRAIN DRUG TARGETING; Pardridge William M, 2005, NeuroRx, V2, P3; Park S, 2016, MAT SCI ENG C-MATER, V58, P1160, DOI 10.1016/j.msec.2015.09.068; Park Y, 2011, IET NANOBIOTECHNOL, V5, P69, DOI 10.1049/iet-nbt.2010.0033; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Payne JN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00607; Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prud'homme RK, 2012, NANOSTRUCT SCI TECHN, P1, DOI 10.1007/978-1-4614-2305-8_1; Pusponegoro H.D., 1988, PAEDIAT INFECT DIS J, V17, pS176; Qu YH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025007; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f; Rai M, 2013, IET NANOBIOTECHNOL, V7, P117, DOI 10.1049/iet-nbt.2012.0031; Raymond J, 2012, ARCH PEDIATRIE, V19, pS55, DOI 10.1016/S0929-693X(12)71274-5; Reuveni T, 2011, INT J NANOMED, V6, P2859, DOI 10.2147/IJN.S25446; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Rodriguez-Del Rio E, 2015, VACCINE, V33, P1465, DOI 10.1016/j.vaccine.2015.01.062; Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024; Roos Karen L, 2010, Handb Clin Neurol, V96, P51, DOI 10.1016/S0072-9752(09)96004-3; Sadauskas E, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-16; Safari D, 2012, NANOMEDICINE-UK, V7, P651, DOI [10.2217/NNM.11.151, 10.2217/nnm.11.151]; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939; Schleh C, 2012, NANOTOXICOLOGY, V6, P36, DOI 10.3109/17435390.2011.552811; Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P3218, DOI 10.1002/1521-3773(20020902)41:17<3218::AID-ANIE3218>3.0.CO;2-P; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805; Sela H, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0133-1; Sellner Johann, 2010, Handb Clin Neurol, V96, P1, DOI 10.1016/S0072-9752(09)96001-8; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Sethi N, 2006, INFECT IMMUN, V74, P6408, DOI 10.1128/IAI.00538-06; Shah M, 2014, FRONT BIOSCI-LANDMRK, V19, P1320, DOI 10.2741/4284; Shah M, 2014, J NANOSCI NANOTECHNO, V14, P344, DOI 10.1166/jnn.2014.8900; Shaikh S, 2017, J CELL BIOCHEM, V118, P2802, DOI 10.1002/jcb.25929; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Shan CS, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/28/285601; Shedbalkar U, 2014, ADV COLLOID INTERFAC, V209, P40, DOI 10.1016/j.cis.2013.12.011; Shilo M, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0075-7; Shilo M, 2014, NANOSCALE, V6, P2146, DOI 10.1039/c3nr04878k; Shilo M, 2012, NANOMEDICINE-UK, V7, P257, DOI [10.2217/nnm.11.190, 10.2217/NNM.11.190]; Short, 2000, Curr Infect Dis Rep, V2, P327, DOI 10.1007/s11908-000-0011-2; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Somand D, 2009, EMERG MED CLIN N AM, V27, P89, DOI 10.1016/j.emc.2008.07.004; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; Stanier C., 2010, ADV SCI NEWS; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Sundar S, 2012, CURR MED CHEM, V19, P3196; Sung RYT, 1997, J PAEDIATR CHILD H, V33, P296, DOI 10.1111/j.1440-1754.1997.tb01603.x; Tang LM, 1999, QJM-MON J ASSOC PHYS, V92, P719, DOI 10.1093/qjmed/92.12.719; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Tillotson GS, 2013, F1000PRIME REP, V5, P51, DOI [DOI 10.12703/P5-51, 10.12703/P5-51]; Tiwari PM, 2011, NANOMATERIALS-BASEL, V1, P31, DOI 10.3390/nano1010031; Trono JD, 2011, J RADIAT RES, V52, P103, DOI 10.1269/jrr.10068; Tsai CJ, 2008, CLIN INFECT DIS, V46, P1664, DOI 10.1086/587897; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van Rooy I, 2011, PHARM RES-DORDR, V28, P456, DOI 10.1007/s11095-010-0291-7; Versiani AF, 2016, FUTURE VIROL, V11, P293, DOI 10.2217/fvl-2015-0010; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Voliani V., 2012, RECENT PAT NANOMED, V2, P34, DOI DOI 10.2174/1877912311202010034; Wadhwani P, 2017, BIOMATER SCI-UK, V5, P817, DOI 10.1039/c7bm00069c; Wang H, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-190; Wei XL, 2007, COLLOID SURFACE B, V59, P100, DOI 10.1016/j.colsurfb.2007.04.016; Weiss PS, 2008, ACCOUNTS CHEM RES, V41, P1772, DOI 10.1021/ar8001443; Wilder-Smith E, 2000, AUST NZ J MED, V30, P462, DOI 10.1111/j.1445-5994.2000.tb02052.x; Yah CS, 2013, BIOMED RES-INDIA, V24, P400; Zhang GD, 2009, BIOMATERIALS, V30, P1928, DOI 10.1016/j.biomaterials.2008.12.038; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428; Zhang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25794; Zhang Y, 2015, J ENVIRON SCI HEAL C, V33, P286, DOI 10.1080/10590501.2015.1055161; Zhao YY, 2013, NANOSCALE, V5, P8340, DOI 10.1039/c3nr01990j; Zhou C, 2013, EXP BIOL MED, V238, P1199, DOI 10.1177/1535370213505825	215	13	14	2	48	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	NOV	2018	107						7	18		10.1016/j.biopha.2018.07.130	http://dx.doi.org/10.1016/j.biopha.2018.07.130			12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GU1PC	30075371				2022-09-04	WOS:000445036200002
J	Ruiz, A; Misas, JD; Gomez, G; Sulo, S; Dennis, RJ; Buitrago, G; Rodriguez, N; Gomez, C; Alba, M; Chaves, W; Araque, C				Ruiz, A.; Misas, J. D.; Gomez, G.; Sulo, S.; Dennis, R. J.; Buitrago, G.; Rodriguez, N.; Gomez, C.; Alba, M.; Chaves, W.; Araque, C.			ASSESSING THE BURDEN OF DISEASE -ASSOCIATED MALNUTRITION AMONG HOSPITALIZED MALNOURISHED COLOMBIAN PATIENTS WITH HEART AND LUNG DISEASE	VALUE IN HEALTH			English	Meeting Abstract									[Ruiz, A.; Buitrago, G.; Rodriguez, N.] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Misas, J. D.; Gomez, G.] Abbott, Bogota, Colombia; [Sulo, S.] Abbott Nutr, Abbott Pk, IL USA; [Dennis, R. J.] Fdn Cardioinfantil, Bogota, Colombia; [Gomez, C.] Pontificia Univ Javeriana, Bogota, Colombia; [Alba, M.] Fdn Univ Ciencias Salud, Bogota, Colombia; [Chaves, W.] Hosp Univ San Jose, Bogota, Colombia; [Araque, C.] Hosp Univ Infantil San Jose, Bogota, Colombia				Ruiz, Alvaro/AAD-5422-2019	Ruiz, Alvaro/0000-0001-6528-4268					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2018	21			1		PHP84	S100	S101		10.1016/j.jval.2018.04.678	http://dx.doi.org/10.1016/j.jval.2018.04.678			2	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	GM0KQ		Bronze			2022-09-04	WOS:000437739100544
J	van der Leest, RJT; Hollestein, LM; Liu, L; Nijsten, T; de Vries, E				van der Leest, R. J. T.; Hollestein, L. M.; Liu, L.; Nijsten, T.; de Vries, E.			Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							SUBSEQUENT CUTANEOUS MALIGNANCY; INCIDENCE RATES; CANCER; TRENDS; METAANALYSIS; NETHERLANDS; SINGLE	BackgroundSkin cancer patients are primarily at increased risk of developing subsequent skin cancers of the same type. Shared risk factors might also increase the occurrence of a different type of subsequent skin cancer. ObjectiveTo investigate risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). MethodsAll melanoma and SCC patients included in the national Netherlands Cancer Registry (NCR) and all BCC patients included in the regional Eindhoven Cancer Registry (ECR) between 1989 and 2009 were followed until diagnosis of a subsequent different skin cancer (melanoma, SCC or BCC), date of death or end of study. Cumulative risks, standardized incidence ratios (SIR) and absolute excess risks (AER) of subsequent skin cancers were calculated. ResultsA total of 50 510 melanoma patients and 64 054 patients with a SCC of the skin were included (national data NCR). The regional data of the ECR consisted of 5776 melanoma patients, 5749 SCC patients and 41 485 BCC patients. The 21-year cumulative risk for a subsequent melanoma after a first SCC or BCC was respectively 1.7% and 1.3% for males and 1.3% and 1.2% for females; SCC after melanoma or BCC was 4.6% and 9.3% (males) and 2.6% and 4.1% (females); BCC after melanoma or SCC was respectively 13.2% and 27.8% (males) and 14.9% and 21.1% (females). SIRs and AERs remained elevated up to 21 years after the first melanoma, SCC or BCC. ConclusionThis large population-based study investigating risks of developing a different subsequent cutaneous malignancy showed high-cumulative risks of mainly KC and markedly increased relative and absolute risks of all tumour combinations. These estimates confirm a common carcinogenesis and can serve as a base for follow-up guidelines and patient education aiming for an early detection of the subsequent cancers.	[van der Leest, R. J. T.; Hollestein, L. M.; Nijsten, T.; de Vries, E.] Erasmus MC Canc Inst, Dept Dermatol, Rotterdam, Netherlands; [Hollestein, L. M.] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands; [Liu, L.; de Vries, E.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Liu, L.] EORTC, Dept Stat, Brussels, Belgium; [de Vries, E.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Fac Med, Bogota, Colombia		Hollestein, LM (corresponding author), Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands.	l.hollestein@erasmusmc.nl	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258	Netherlands Organization for Health Research and Development ZonMw [VIDI 91711315]	Netherlands Organization for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development)	The Netherlands Organization for Health Research and Development ZonMw, VIDI 91711315.	Asgari MM, 2014, J AM ACAD DERMATOL, V71, P521, DOI 10.1016/j.jaad.2014.04.019; Balmain Allan, 2014, J Invest Dermatol, V134, pE2, DOI 10.1038/skinbio.2014.2; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Dominguez-Cruz JJ, 2014, BRIT J DERMATOL, V170, P716, DOI 10.1111/bjd.12675; Flohil SC, 2011, BRIT J DERMATOL, V165, P874, DOI 10.1111/j.1365-2133.2011.10488.x; Flohil SC, 2013, EUR J CANCER, V49, P2365, DOI 10.1016/j.ejca.2013.03.010; Flohil SC, 2013, J INVEST DERMATOL, V133, P913, DOI 10.1038/jid.2012.431; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hollestein LM, 2012, EUR J CANCER, V48, P2046, DOI 10.1016/j.ejca.2012.01.003; Hollestein LM, 2012, ANN ONCOL, V23, P524, DOI 10.1093/annonc/mdr128; Holterhues C, 2012, J EUR ACAD DERMATOL, V26, P1389, DOI 10.1111/j.1468-3083.2011.04297.x; Jung GW, 2014, BRIT J DERMATOL, V170, P136, DOI 10.1111/bjd.12694; Keim U, 2015, J INVEST DERMATOL, V135, P728, DOI 10.1038/jid.2014.410; Kiiski V, 2010, ARCH DERMATOL, V146, P848, DOI 10.1001/archdermatol.2010.155; Murali R, 2012, ANN SURG ONCOL, V19, P1024, DOI 10.1245/s10434-011-2058-8; Paradisi A, 2011, BRIT J DERMATOL, V165, P782, DOI 10.1111/j.1365-2133.2011.10403.x; Rees JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099674; Robsahm TE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-210; Siskind V, 2011, J INVEST DERMATOL, V131, P461, DOI 10.1038/jid.2010.298; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Soerjomataram Isabelle, 2009, V471, P85, DOI 10.1007/978-1-59745-416-2_5; Song FJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001433; Tessari G, 2010, ARCH DERMATOL, V146, P294, DOI 10.1001/archdermatol.2009.377; Toth V, 2013, PATHOL ONCOL RES, V19, P805, DOI 10.1007/s12253-013-9647-8; van der Leest RJT, 2015, J EUR ACAD DERMATOL, V29, P1053, DOI 10.1111/jdv.12887; van der Leest RJT, 2012, BRIT J DERMATOL, V167, P1321, DOI 10.1111/j.1365-2133.2012.11123.x; van der Leest RJT, 2015, EUR J CANCER, V51, P2833, DOI 10.1016/j.ejca.2015.09.008; Verkouteren JAC, 2015, J INVEST DERMATOL, V135, P2649, DOI 10.1038/jid.2015.244; Viros A, 2014, PIGM CELL MELANOMA R, V27, P1009, DOI 10.1111/pcmr.12305; Wehner MR, 2015, JAMA DERMATOL, V151, P382, DOI 10.1001/jamadermatol.2014.3307; Wehner MR, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5909; Wu PA, 2015, JAMA DERMATOL, V151, P369, DOI 10.1001/jamadermatol.2014.3827	32	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	MAR	2018	32	3					382	389		10.1111/jdv.14587	http://dx.doi.org/10.1111/jdv.14587			8	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	FZ3IW	28898461				2022-09-04	WOS:000427481900034
J	Casals, E; Gonzalez, E; Puntes, VF				Casals, E.; Gonzalez, E.; Puntes, V. F.			Reactivity of inorganic nanoparticles in biological environments: insights into nanotoxicity mechanisms	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Review							AMBIENT AIR-POLLUTION; PROTEIN CORONA; SILVER NANOPARTICLES; GOLD NANOPARTICLES; CARBON NANOTUBES; OXIDATIVE STRESS; MAGNETIC CHARACTERIZATION; CELLULAR TOXICITY; IRON-OXIDE; CYTOTOXICITY	A deeper understanding of the behaviour of inorganic nanoparticles in biological media is needed not only to fully control and develop the potential of these materials but also to increase knowledge of the physical chemistry of inorganic materials when their morphology approaches that of molecular entities. Although this knowledge and control is not yet entirely acquired, industry and society are already using nanomaterials in greater quantities and in consumer products. As normally happens when something new arrives in society, the interest in the broader implications of this emerging technology has grown together with unfounded 'nanoeuphoria' and 'nanoscares'. In this context, only by understanding the mechanisms of the nano-bio interaction will it be possible to safely develop nanotechnology. In this review, we discuss on how nanoparticles behave once they are naturally or intentionally produced and are exposed to humans and the environment. The response of nanoparticles inside organisms or released to the environment is complex and diverse, and depends on a variety of parameters involved. Mainly, they may (i) be aggregated into microscopic particles or embedded in exposed materials; (ii) the surfaces of the nanoparticles, which determine their bioactivity, experience constant modifications; and (iii) nanoparticles may corrode and dissolve or they can suffer morphological modifications.	[Casals, E.; Gonzalez, E.; Puntes, V. F.] Catalan Inst Nanotechnol, CIN2 ICN CSIC, Bellaterra 08193, Barcelona, Spain; [Casals, E.; Gonzalez, E.; Puntes, V. F.] Univ Autonoma Barcelona, Bellaterra 08193, Barcelona, Spain; [Gonzalez, E.] Pontificia Univ Javeriana, Fac Ingn, Inst Geofis, Bogota 110231, Colombia; [Puntes, V. F.] ICREA, Barcelona, Spain		Casals, E (corresponding author), Catalan Inst Nanotechnol, CIN2 ICN CSIC, Campus UAB,Edifici Q, Bellaterra 08193, Barcelona, Spain.	victor.puntes@icn.cat	Puntes, Victor/AAL-6081-2021; Puntes, Víctor F./F-8407-2013; Casals, Eudald/P-2382-2016	Puntes, Victor/0000-0001-8996-9499; Puntes, Víctor F./0000-0001-8996-9499; Casals, Eudald/0000-0002-2900-7295; Gonzalez, Edgar E/0000-0003-3103-3959	ICREA Funding Source: Custom	ICREA(ICREA)		Akaighe N, 2011, ENVIRON SCI TECHNOL, V45, P3895, DOI 10.1021/es103946g; Alaeddine S, 1995, PROTEINS INTERFACES; Allen BL, 2008, NANO LETT, V8, P3899, DOI 10.1021/nl802315h; Alvarez-Puebla RA, 2007, ANALYST, V132, P1210, DOI 10.1039/b711361g; [Anonymous], 2008, CONTRIB SCI, DOI DOI 10.2436/20.7010.01.52; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; Balogh L, 2007, NANOMED-NANOTECHNOL, V3, P281, DOI 10.1016/j.nano.2007.09.001; Banfield JF, 2001, REV MINERAL GEOCHEM, V44, P1, DOI 10.2138/rmg.2001.44.01; Bastus NG, 2008, NANOTOXICOLOGY, V2, P99, DOI 10.1080/17435390802217830; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Brash J. L., 1995, PROTEINS INTERFACES, VII; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Buseck PR, 1999, P NATL ACAD SCI USA, V96, P3372, DOI 10.1073/pnas.96.7.3372; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Casals E, 2008, TRAC-TREND ANAL CHEM, V27, P672, DOI 10.1016/j.trac.2008.06.004; Casals E, 2011, SMALL, V7, P3479, DOI 10.1002/smll.201101511; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; CHAVANY C, 1994, PHARM RES-DORDR, V11, P1370, DOI 10.1023/A:1018923301967; Colomban P, 2009, J NANO RES-SW, V8, P109, DOI 10.4028/www.scientific.net/JNanoR.8.109; Cui ZR, 2005, MOL PHARMACEUT, V2, P22, DOI 10.1021/mp049907k; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Donlin MJ, 1998, J CHEM EDUC, V75, P437, DOI 10.1021/ed075p437; Dubas ST, 2008, MATER LETT, V62, P2661, DOI 10.1016/j.matlet.2008.01.033; EBBESEN P, 1972, J IMMUNOL, V109, P1296; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Evelyn A, 2003, NANO LETT, V3, P63, DOI 10.1021/nl025803u; Faunce TA, 2008, NANOMEDICINE-UK, V3, P859, DOI 10.2217/17435889.3.6.859; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Gessner A, 2000, INT J PHARM, V196, P245, DOI 10.1016/S0378-5173(99)00432-9; Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Goy-Lopez S, 2012, LANGMUIR, V28, P9113, DOI 10.1021/la300402w; Gupta VK, 2007, DEV ENVIRONM SCI, V5, P33, DOI 10.1016/S1474-8177(07)05003-6; Gutierrez L, 2006, J INORG BIOCHEM, V100, P1790, DOI 10.1016/j.jinorgbio.2006.06.010; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Hochella MF, 2008, SCIENCE, V319, P1631, DOI 10.1126/science.1141134; Hoet PHM, 2001, TOXICOL APPL PHARM, V175, P184, DOI 10.1006/taap.2001.9247; Hough RM, 2008, GEOLOGY, V36, P571, DOI 10.1130/G24749A.1; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Ito A, 2001, MAT SCI ENG C-BIO S, V17, P161, DOI 10.1016/S0928-4931(01)00329-0; Ji ZX, 2010, ENVIRON SCI TECHNOL, V44, P7309, DOI 10.1021/es100417s; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Joo SH, 2004, ENVIRON SCI TECHNOL, V38, P2242, DOI 10.1021/es035157g; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/nnano.2010.44, 10.1038/NNANO.2010.44]; Klavins M, 2010, ECOL CHEM ENG S, V17, P351; Kretzschmar R, 2001, ROY SOC CH, P153, DOI 10.1039/9781847551085-00153; Krumov N, 2009, CHEM ENG TECHNOL, V32, P1026, DOI 10.1002/ceat.200900046; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Larsen A, 2008, HISTOCHEM CELL BIOL, V130, P681, DOI 10.1007/s00418-008-0448-1; Larsen A, 2007, HISTOCHEM CELL BIOL, V128, P1, DOI 10.1007/s00418-007-0295-5; Lazaro FJ, 2005, BBA-MOL BASIS DIS, V1740, P434, DOI 10.1016/j.bbadis.2004.11.020; LEONARD A, 1980, MUTAT RES, V76, P227, DOI 10.1016/0165-1110(80)90018-4; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Lim SI, 2010, NANO LETT, V10, P964, DOI 10.1021/nl100032c; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Matsunaga T, 2000, BIOTECHNOL BIOENG, V70, P704, DOI 10.1002/1097-0290(20001220)70:6<704::AID-BIT14>3.0.CO;2-E; Matsunaga T, 2000, J BIOSCI BIOENG, V90, P1; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Moreau JW, 2007, SCIENCE, V316, P1600, DOI 10.1126/science.1141064; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Murr LE, 2004, J MATER SCI-MATER M, V15, P237, DOI 10.1023/B:JMSM.0000015483.06136.68; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; O'Shaughnessy J. A., 2003, 26 ANN SAN ANT BREAS; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oostingh GJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-8; Ostwald W., 1896, LEHRBUCH ALLGEMEIN 1, V2; Pal T, 1997, LANGMUIR, V13, P1481, DOI 10.1021/la960834o; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Puntes V, 2010, INT C NANAX 4 NAN NA; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Rancan F, 2002, J PHOTOCH PHOTOBIO B, V67, P157, DOI 10.1016/S1011-1344(02)00320-2; Reith F, 2006, GEOCHIM COSMOCHIM AC, V70, P1421, DOI 10.1016/j.gca.2005.11.013; Robidoux A, 2006, BREAST CANCER RES TR, V100, pS147; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Sahoo B, 2007, CHEM PHYS LETT, V445, P217, DOI 10.1016/j.cplett.2007.07.075; Sanchez A, 2011, TRAC-TREND ANAL CHEM, V30, P507, DOI 10.1016/j.trac.2010.11.011; Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586; Schueler D., 2002, International Microbiology, V5, P209; Silin V, 1997, J COLLOID INTERF SCI, V185, P94, DOI 10.1006/jcis.1996.4586; Slack SM, 1995, ACS SYM SER, V602, P112; Southam G, 2009, ELEMENTS, V5, P303, DOI 10.2113/gselements.5.5.303; Stack AG, 2012, J AM CHEM SOC, V134, P11, DOI 10.1021/ja204714k; Sun SH, 1999, J APPL PHYS, V85, P4325, DOI 10.1063/1.370357; Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wiltschko W, 2002, J EXP BIOL, V205, P3031; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zheng XO, 2011, ENVIRON SCI TECHNOL, V45, P2826, DOI 10.1021/es2000744	110	56	56	1	121	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	NOV 7	2012	45	44							443001	10.1088/0022-3727/45/44/443001	http://dx.doi.org/10.1088/0022-3727/45/44/443001			15	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	028TO					2022-09-04	WOS:000310446200002
J	Moratorio, G; Martinez, M; Gutierrez, MF; Gonzalez, K; Colina, R; Lopez-Tort, F; Lopez, L; Recarey, R; Schijman, AG; Moreno, MP; Garcia-Aguirre, L; Manascero, AR; Cristina, J				Moratorio, Gonzalo; Martinez, Mariela; Gutierrez, Maria F.; Gonzalez, Katiuska; Colina, Rodney; Lopez-Tort, Fernando; Lopez, Lilia; Recarey, Ricardo; Schijman, Alejandro G.; Moreno, Maria P.; Garcia-Aguirre, Laura; Manascero, Aura R.; Cristina, Juan			Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region	VIROLOGY JOURNAL			English	Article							QUASI-SPECIES PRESENT; SEQUENCE ALIGNMENT; CELL-TYPE; TRANSLATION; INFECTION; DIVERSIFICATION; HETEROGENEITY; TRANSMISSION; REPLICATION; ARGENTINA	Background: Hepatitis C virus (HCV) has been the subject of intense research and clinical investigation as its major role in human disease has emerged. Previous and recent studies have suggested a diversification of type I HCV in the South American region. The degree of genetic variation among HCV strains circulating in Bolivia and Colombia is currently unknown. In order to get insight into these matters, we performed a phylogenetic analysis of HCV 5' non-coding region (5'NCR) sequences from strains isolated in Bolivia, Colombia and Uruguay, as well as available comparable sequences of HCV strains isolated in South America. Methods: Phylogenetic tree analysis was performed using the neighbor-joining method under a matrix of genetic distances established under the Kimura-two parameter model. Signature pattern analysis, which identifies particular sites in nucleic acid alignments of variable sequences that are distinctly representative relative to a background set, was performed using the method of Korber & Myers, as implemented in the VESPA program. Prediction of RNA secondary structures was done by the method of Zuker & Turner, as implemented in the mfold program. Results: Phylogenetic tree analysis of HCV strains isolated in the South American region revealed the presence of a distinct genetic lineage inside genotype I. Signature pattern analysis revealed that the presence of this lineage is consistent with the presence of a sequence signature in the 5'NCR of HCV strains isolated in South America. Comparisons of these results with the ones found for Europe or North America revealed that this sequence signature is characteristic of the South American region. Conclusion: Phylogentic analysis revealed the presence of a sequence signature in the 5'NCR of type I HCV strains isolated in South America. This signature is frequent enough in type I HCV populations circulating South America to be detected in a phylogenetic tree analysis as a distinct type I sub-population. The coexistence of distinct type I HCV subpopulations is consistent with quasispecies dynamics, and suggests that multiple coexisting subpopulations may allow the virus to adapt to its human host populations.	Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Montevideo 11400, Uruguay; Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Virol Lab, Bogota, Colombia; Univ Mayor San Andres, Fac Ciencias Med & Bioquim, La Paz, Bolivia; Grp CentraLab, Mol Biol Lab, Buenos Aires, DF, Argentina; Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada		Cristina, J (corresponding author), Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.	gmora@cin.edu.uy; marie@cin.edu.uy; mfgutier@javeriana.edu.co; katiuskagg@hotmail.com; rcolina@cin.edu.uy; flopez@cin.edu.uy; llopez@cin.edu.uy; rrecarey@cin.edu.uy; schijman@dna.uba.ar; pmoreno@cin.edu.uy; lgarcia@cin.edu.uy; mfgutier@javeriana.edu.co; cristina@cin.edu.uy	Gutierrez, Maria/AAF-2966-2019	Colina, Rodney/0000-0003-3731-5383; Moreno, Pilar/0000-0001-6155-7206				Biswas S, 2006, VET MICROBIOL, V116, P187, DOI 10.1016/j.vetmic.2006.03.001; Burke B, 2006, VIROLOGY, V355, P138, DOI 10.1016/j.virol.2006.07.026; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; CHAN SW, 1992, J GEN VIROL, V73, P1131, DOI 10.1099/0022-1317-73-5-1131; Colina R, 1999, J GEN VIROL, V80, P1377, DOI 10.1099/0022-1317-80-6-1377; Cristina Juan, 2005, J Clin Virol, V34 Suppl 2, pS1; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; Feliu A, 2004, LIVER TRANSPLANT, V10, P1131, DOI 10.1002/lt.20206; FELSENSTEIN J, 1993, PHYLOGENY INTERFEREN; Gismondi MI, 2006, J CLIN MICROBIOL, V44, P2229, DOI 10.1128/JCM.02569-05; Gismondi MI, 2004, J CLIN MICROBIOL, V42, P1298, DOI 10.1128/JCM.42.3.1298-1301.2004; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Laporte J, 2000, J VIROL, V74, P10827, DOI 10.1128/JVI.74.22.10827-10833.2000; Laporte J, 2003, BLOOD, V101, P52, DOI 10.1182/blood-2002-03-0818; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Lerat H, 2000, J VIROL, V74, P7024, DOI 10.1128/JVI.74.15.7024-7031.2000; Lu M, 2000, ARCH VIROL, V145, P2201, DOI 10.1007/s007050070050; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pawlotsky JM, 2003, CURR OPIN INFECT DIS, V16, P587, DOI 10.1097/00001432-200312000-00012; PESSTOVA TV, 1998, GENE DEV, V12, P6783; Pistello M, 2004, J CLIN VIROL, V30, P11, DOI 10.1016/j.jcv.2003.08.008; Rijnbrand RCA, 2000, CURR TOP MICROBIOL, V242, P85; San Roman M, 2002, ARCH VIROL, V147, P2239, DOI 10.1007/s00705-002-0869-4; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Leeuwen HC, 2004, J GEN VIROL, V85, P1859, DOI 10.1099/vir.0.79924-0; Vega I, 2001, ARCH VIROL, V146, P1623, DOI 10.1007/s007050170084; Yepes A, 2002, Gastroenterol Hepatol, V25, P334; You SY, 2004, J VIROL, V78, P1352, DOI 10.1128/JVI.78.3.1352-1366.2004	37	6	10	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-422X			VIROL J	Virol. J.	AUG 2	2007	4								79	10.1186/1743-422X-4-79	http://dx.doi.org/10.1186/1743-422X-4-79			12	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	208CV	17683527	Green Published, gold			2022-09-04	WOS:000249298300001
J	Morillo, LE; Diaz, J; Estevez, E; Costa, A; Mendez, H; Davila, H; Medero, N; Rodriguez, N; Chaves, M; Vinueza, R; Ortiz, J; Glasser, D				Morillo, LE; Diaz, J; Estevez, E; Costa, A; Mendez, H; Davila, H; Medero, N; Rodriguez, N; Chaves, M; Vinueza, R; Ortiz, J; Glasser, D			Prevalence of erectile dysfunction in Colombia, Ecuador, and Venezuela: a population-based study (DENSA)	INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH			English	Article						erectile dysfunction; Latin America; prevalence; risk factors	SEXUAL DYSFUNCTION; DEPRESSIVE SYMPTOMS; CIGARETTE-SMOKING; RISK-FACTOR; IMPOTENCE; MEN; EPIDEMIOLOGY; AGE	The purpose of this study was to estimate the prevalence of erectile dysfunction (ED) in Colombia, Ecuador, and Venezuela. A 49-item questionnaire was completed by 1946 men aged 40 years and older. The age-adjusted combined prevalence of minimal, moderate, and complete ED for all three countries was 53.4%, with 19.8% of all men reporting moderate to complete ED. Age was the variable most strongly linked to ED; the prevalence of complete ED increased markedly in men older than 79 y of age (31.9%) and 70-79 y (17.2%) compared with men aged 40-49 y (<3%). Several medical conditions, such as hypertension, benign prostatic hyperplasia, and diabetes, and the use of medications to treat these conditions were correlated with the prevalence of ED. This study corroborates earlier studies demonstrating that ED is very common, increases dramatically with age, and has multiple correlates, including some that are also risk factors for cardiovascular disease.	Pontificia Univ Javeriana, Fac Med, Bogota, DC, Colombia; Univ Cent Ecuador, Quito, Ecuador; Soc Ecuatoriana Urol, Quito, Ecuador; Fundacredesa, Caracas, Venezuela; Soc Venezolana Urol, Caracas, Venezuela; Pfizer Inc, Bogota, Colombia; Pfizer Inc, New York, NY USA		Morillo, LE (corresponding author), Hosp San Igancio, Unidad Epidemiol Clin, Carrera 7 40-62,Segundo Piso, Bogota, Colombia.			ESTEVEZ M., Edmundo/0000-0001-7865-5099; Rodriguez, Nelcy/0000-0003-4320-695X; Saenz, Klever/0000-0003-0356-2730				Ansong KS, 2000, ANN EPIDEMIOL, V10, P293, DOI 10.1016/S1047-2797(00)00050-8; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; BANSAL S, 1988, HYPERTENSION, V12, P1; BENET AE, 1995, UROL CLIN N AM, V22, P699; Blanker MH, 2001, UROLOGY, V57, P763, DOI 10.1016/S0090-4295(00)01091-8; Bortolotti A, 2001, EUR UROL, V40, P392, DOI 10.1159/000049805; Bosch Ruud, 1999, Journal of Urology, V161, P178; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Dunn KM, 1998, FAM PRACT, V15, P519, DOI 10.1093/fampra/15.6.519; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; GIULIANO FA, 1996, EUR UROL SUPPL, V30, P250; GLASSER DB, 1998, 8 WORLD M IMP RES 25; JONLER M, 1995, BRIT J UROL, V75, P651, DOI 10.1111/j.1464-410X.1995.tb07426.x; Kayigil O., 1996, International Urology and Nephrology, V28, P717, DOI 10.1007/BF02552171; Kongkanand A, 2000, INT J ANDROL, V23, P77, DOI 10.1046/j.1365-2605.2000.00022.x; Koskimaki J, 2000, J UROLOGY, V164, P367, DOI 10.1016/S0022-5347(05)67362-4; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Macfarlane GJ, 1996, J CLIN EPIDEMIOL, V49, P1171, DOI 10.1016/0895-4356(96)00213-2; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Martin-Morales A, 2001, J UROLOGY, V166, P569, DOI 10.1016/S0022-5347(05)65986-1; Marumo K, 2001, INT J UROL, V8, pS50, DOI 10.1046/j.1442-2042.2001.00335.x; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; MENDEZ H, 1994, SOC ESTR CAR VEN; Moreira ED, 2001, UROLOGY, V58, P583, DOI 10.1016/S0090-4295(01)01274-2; MULLIGAN T, 1988, J AM GERIATR SOC, V36, P520, DOI 10.1111/j.1532-5415.1988.tb04022.x; MULLIGAN T, 1991, ARCH SEX BEHAV, V20, P17, DOI 10.1007/BF01543004; Rimm Eric B., 2000, Journal of Urology, V163, P241; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; SCHIAVI RC, 1995, UROL CLIN N AM, V22, P711; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; Shirai M., 1987, IMPOTENCE, V2, P67; SLAG MF, 1983, JAMA-J AM MED ASSOC, V249, P1736, DOI 10.1001/jama.249.13.1736; Tengs TO, 2001, PREV MED, V32, P447, DOI 10.1006/pmed.2001.0830; WABREK AJ, 1980, ARCH SEX BEHAV, V9, P69, DOI 10.1007/BF01541402	37	36	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0955-9930	1476-5489		INT J IMPOT RES	Int. J. Impot. Res.	AUG	2002	14			2			S10	S18		10.1038/sj.ijir.3900893	http://dx.doi.org/10.1038/sj.ijir.3900893			9	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	584AT	12161763				2022-09-04	WOS:000177445600003
J	Silva-Ramos, CR; Montoya-Ruiz, C; Faccini-Martinez, AA; Rodas, JD				Silva-Ramos, Carlos Ramiro; Montoya-Ruiz, Carolina; Faccini-Martinez, Alvaro A.; Rodas, Juan David			An updated review and current challenges of Guanarito virus infection, Venezuelan hemorrhagic fever	ARCHIVES OF VIROLOGY			English	Review							GUINEA-PIGS; PIRITAL VIRUSES; ETIOLOGIC AGENT; MACHUPO VIRUS; Z PROTEINS; RIG-I; ARENAVIRUS; JUNIN; PHYLOGENY; ARGENTINE	Guanarito virus (GTOV) is a member of the family Arenaviridae and has been designated a category A bioterrorism agent by the US Centers for Disease Control and Prevention. It is endemic to Venezuela's western region, and it is the etiological agent of "Venezuelan hemorrhagic fever" (VHF). Similar to other arenaviral hemorrhagic fevers, VHF is characterized by fever, mild hemorrhagic signs, nonspecific symptoms, thrombocytopenia, and leukopenia. Patients with severe disease usually develop signs of internal bleeding. Due to the absence of reference laboratories that can handle GTOV in endemic areas, diagnosis is primarily clinical and epidemiological. No antiviral therapies are available; thus, treatment includes only supportive analgesia and fluids. GTOV is transmitted by contact with the excreta of its rodent reservoir, Zygodontomys brevicauda. The main reasons for the emergence of the disease may be the increase in the human population, migration, and changes in land use patterns in rural areas. Social and environmental changes could make VHF an important cause of underdiagnosed acute febrile illnesses in regions near the endemic areas. Although there is evidence that GTOV circulates among rodents in different Venezuelan states, VHF cases have only been reported in the states of Portuguesa and Barinas. However, due to the increased frequency of invasions by humans into wildlife habitats, it is probable that VHF could become a public health problem in the nearby regions of Colombia and Brazil. The current Venezuelan political crisis is causing an increase in the migration of people and livestock, representing a risk for the redistribution and re-emergence of infectious diseases.	[Silva-Ramos, Carlos Ramiro] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Montoya-Ruiz, Carolina] Univ Nacl Colombia, Fac Ciencias, Carrera 65,59a,110, Medellin, Colombia; [Faccini-Martinez, Alvaro A.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Faccini-Martinez, Alvaro A.] Asociac Colombiana Infectol, Com Med Trop Zoonosis Med Viajero, Bogota, Colombia; [Rodas, Juan David] Univ Antioquia, Grp Invest Ciencias Veterinarias Centauro, Medellin, Colombia		Montoya-Ruiz, C (corresponding author), Univ Nacl Colombia, Fac Ciencias, Carrera 65,59a,110, Medellin, Colombia.	cmontoyru@unal.edu.co			Pontificia Universidad Javeriana; Universidad Nacional de Colombia sede Medellin; Universidad de Antioquia; Fogarty International Center; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [D43 TW010331]	Pontificia Universidad Javeriana; Universidad Nacional de Colombia sede Medellin; Universidad de Antioquia; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Pontificia Universidad Javeriana, Universidad Nacional de Colombia sede Medellin, and Universidad de Antioquia provided funding. At the time of this work, Alvaro A. Faccini-Martinez was supported by the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, under Award Number D43 TW010331. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health.	Azim Kazi Faizul, 2021, Heliyon, V7, pe07022, DOI 10.1016/j.heliyon.2021.e07022; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Cajimat MNB, 2004, VIRUS RES, V102, P199, DOI 10.1016/j.virusres.2004.01.032; Castellar A, 2017, BIOMEDICA, V37, P75, DOI 10.7705/biomedica.v37i2.3226; Clark LE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04271-z; Casabona JC, 2009, J VIROL, V83, P7029, DOI 10.1128/JVI.00329-09; de Manzione N, 1998, CLIN INFECT DIS, V26, P308, DOI 10.1086/516299; Eichler R, 2004, VIRUS RES, V100, P249, DOI 10.1016/j.virusres.2003.11.017; Fajfr M, 2014, EPIDEMIOL MIKROBI IM, V63, P238; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Frank MG, 2021, INT J INFECT DIS, V105, P505, DOI 10.1016/j.ijid.2021.02.046; Fukushi S, 2012, VIRUSES-BASEL, V4, P2097, DOI 10.3390/v4102097; Fulhorst CF, 1997, AM J TROP MED HYG, V56, P548; Fulhorst CF, 1999, J INFECT DIS, V180, P966, DOI 10.1086/315029; Fulhorst CF, 1999, AM J TROP MED HYG, V61, P325, DOI 10.4269/ajtmh.1999.61.325; Fulhorst CF, 2008, VIROLOGY, V378, P205, DOI 10.1016/j.virol.2008.05.014; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Golden JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04889-x; Golden JW, 2016, J VIROL, V90, P3515, DOI 10.1128/JVI.02969-15; GONZALEZ JP, 1995, AM J TROP MED HYG, V53, P1; Grant A, 2012, VIRUSES-BASEL, V4, P2317, DOI 10.3390/v4102317; Hall WC, 1996, AM J TROP MED HYG, V55, P81, DOI 10.4269/ajtmh.1996.55.81; Hallam SJ, 2020, PLOS NEGLECT TROP D, V14, P8555, DOI 10.1371/journal.pntd.0008555; Hallam SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01751; Helguera G, 2012, J VIROL, V86, P4024, DOI 10.1128/JVI.06397-11; Janosko K, 2016, JOVE-J VIS EXP, DOI 10.3791/52317; Koma T, 2016, J VIROL, V90, P1290, DOI 10.1128/JVI.02615-15; Kotturi Maya F, 2010, Immunome Res, V6, P4, DOI 10.1186/1745-7580-6-4; Kotturi MF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000695; Lee AM, 2008, J BIOL CHEM, V283, P18734, DOI 10.1074/jbc.M802089200; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Lindahl Johanna F., 2015, Infection Ecology & Epidemiology, V5, P30048, DOI 10.3402/iee.v5.30048; Martin VK, 2010, J VIROL, V84, P1176, DOI 10.1128/JVI.01625-09; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Mattar S, 2011, EMERG INFECT DIS, V17, P1315, DOI 10.3201/eid1707.101961; Mendenhall M, 2011, ANTIMICROB AGENTS CH, V55, P782, DOI 10.1128/AAC.01219-10; Milazzo ML, 2011, EMERG INFECT DIS, V17, P2209, DOI 10.3201/eid1712.110393; Noad RJ, 2019, VACCINE, V37, P6241, DOI 10.1016/j.vaccine.2019.09.009; Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635; Parsy ML, 2013, J VIROL, V87, P13070, DOI 10.1128/JVI.02298-13; Pasquato A, 2011, ANTIVIR RES, V90, pA62, DOI 10.1016/j.antiviral.2011.03.122; Patterson M, 2014, CURR OPIN VIROL, V5, P82, DOI 10.1016/j.coviro.2014.02.007; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Radoshitzky SR, 2019, J GEN VIROL, V100, P1200, DOI 10.1099/jgv.0.001280; Radoshitzky SR, 2012, EXPERT OPIN DRUG DIS, V7, P613, DOI 10.1517/17460441.2012.687719; Rodriguez-Morales AJ, 2021, NEW MICROB NEW INFEC, V44, DOI 10.1016/j.nmni.2021.100945; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Rosenke K, 2018, EMERG INFECT DIS, V24, P1696, DOI 10.3201/eid2409.180233; SALAS R, 1991, LANCET, V338, P1033, DOI 10.1016/0140-6736(91)91899-6; Shao JJ, 2015, PATHOGENS, V4, P283, DOI 10.3390/pathogens4020283; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; TESH RB, 1993, AM J TROP MED HYG, V49, P227, DOI 10.4269/ajtmh.1993.49.227; TESH RB, 1994, AM J TROP MED HYG, V50, P452, DOI 10.4269/ajtmh.1994.50.452; Tesh Robert B, 2002, Biomedica, V22, P287; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077; Urata S, 2009, J VIROL, V83, P12651, DOI 10.1128/JVI.01012-09; Ure AE, 2008, J MED VIROL, V80, P2127, DOI 10.1002/jmv.21265; Veliziotis I, 2020, EMERG INFECT DIS, V26, P1562, DOI 10.3201/eid2607.200275; Weaver SC, 2000, VIROLOGY, V266, P189, DOI 10.1006/viro.1999.0067; Xing JJ, 2015, J VIROL, V89, P2944, DOI 10.1128/JVI.03349-14; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhirnov I V, 2015, Bioorg Khim, V41, P54	65	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	SEP	2022	167	9					1727	1738		10.1007/s00705-022-05453-3	http://dx.doi.org/10.1007/s00705-022-05453-3		MAY 2022	12	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	3P7HM	35579715	Green Published, Bronze			2022-09-04	WOS:000796784200002
J	Olmedo, I; Pino, G; Riquelme, JA; Aranguiz, P; Diaz, MC; Lopez-Crisosto, C; Lavandero, S; Donoso, P; Pedrozo, Z; Sanchez, G				Olmedo, Ivonne; Pino, Gonzalo; Riquelme, Jaime A.; Aranguiz, Pablo; Diaz, Magda C.; Lopez-Crisosto, Camila; Lavandero, Sergio; Donoso, Paulina; Pedrozo, Zully; Sanchez, Gina			Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Ischemia/reperfusion; Mitofusin-2; Proteasome; Mitochondria	MYOCARDIAL-ISCHEMIA; DEGRADATION; AUTOPHAGY; HEART; FISSION; FUSION; ROLES; TRANSPORT; DYNAMICS; MIRO	Cardiomyocyte loss is the main cause of myocardial dysfunction following an ischemia-reperfusion (IR) injury. Mitochondrial dysfunction and altered mitochondrial network dynamics play central roles in cardiomyocyte death. Proteasome inhibition is cardioprotective in the setting of IR; however, the mechanisms underlying this protection are not well-understood. Several proteins that regulate mitochondrial dynamics and energy metabolism, including Mitofusin-2 (Mfn2), are degraded by the proteasome. The aim of this study was to evaluate whether proteasome inhibition can protect cardiomyocytes from IR damage by maintaining Mfn2 levels and preserving mitochondrial network integrity. Using ex vivo Langendorff-perfused rat hearts and in vitro neonatal rat ventricular myocytes, we showed that the proteasome inhibitor MG132 reduced IR-induced cardiomyocyte death. Moreover, MG132 preserved mitochondrial mass, prevented mitochondrial network fragmentation, and abolished IR-induced reductions in Mfn2 levels in heart tissue and cultured cardiomyocytes. Interestingly, Mfn2 overexpression also prevented cardiomyocyte death. This effect was apparently specific to Mfn2, as overexpression of Miro1, another protein implicated in mitochondrial dynamics, did not confer the same protection. Our results suggest that proteasome inhibition protects cardiomyocytes from IR damage. This effect could be partly mediated by preservation of Mfn2 and therefore mitochondrial integrity.	[Olmedo, Ivonne; Sanchez, Gina] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiopatol, Santiago 8380453, Chile; [Pino, Gonzalo; Diaz, Magda C.; Donoso, Paulina; Pedrozo, Zully] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Santiago 8380453, Chile; [Riquelme, Jaime A.; Diaz, Magda C.; Lopez-Crisosto, Camila; Lavandero, Sergio; Pedrozo, Zully] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile; [Riquelme, Jaime A.; Diaz, Magda C.; Lopez-Crisosto, Camila; Lavandero, Sergio; Pedrozo, Zully] Univ Chile, Fac Med, Santiago 8380492, Chile; [Riquelme, Jaime A.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santiago 8380492, Chile; [Aranguiz, Pablo] Univ Andres Bello, Fac Med, Escuela Quim & Farm, Vina Del Mar 2520000, Chile; [Diaz, Magda C.] Pontificia Univ Javeriana Cali, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia; [Lavandero, Sergio] Corp Ctr Estudios Cient Enfermedades Cron CECEC, Santiago 7680201, Chile; [Lavandero, Sergio] Univ Texas Southwestern Med Ctr Dallas, Cardiol Div, Dept Internal Med, Dallas, TX 75390 USA		Pedrozo, Z; Sanchez, G (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Santiago 8380453, Chile.	zpedrozo@med.uchile.cl; gisanchez@med.uchile.cl	Pedrozo, Zully/AAN-5350-2021; Riquelme, Jaime A/ABG-7889-2020; Aranguiz, Pablo/U-9353-2019	Riquelme, Jaime A/0000-0003-0517-5697; Aranguiz, Pablo/0000-0002-4379-2429; Diaz Vesga, Magda Carolina/0000-0002-7807-2050	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile): Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130407, 1180613, 11170962, 1160704, 1200490, 11181000, 3190546, 3160549]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) [15130011]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile): Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by grants from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile): Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants 1130407 to G.S, 1180613 to Z.P., 11170962 to I.O., 1160704 to P.D., 1200490 to S.L., 11181000 to J.A.R., 3190546 to C.L C., and 3160549 to P.A.; and Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) grant 15130011 to S.L., J.A.R., and Z.P. We thank Dr. A. Zorzano that kindly provided the adenovirus AsMfn2.	Ali S, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010015; Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Carreira RS, 2011, CURR PHARM DESIGN, V17, P2017; Chen GY, 2015, MOL MED REP, V12, P7595, DOI 10.3892/mmr.2015.4337; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; Cordova-Casanova A, 2018, BBA-MOL CELL RES, V1865, P289, DOI 10.1016/j.bbamcr.2017.11.001; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Dong Y, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0578-x; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017; Guo CX, 2016, FREE RADICAL BIO MED, V94, P17, DOI 10.1016/j.freeradbiomed.2016.02.011; Hall AR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.139; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Huang L, 2016, J CARDIOVASC PHARM T, V21, P70, DOI 10.1177/1074248415581177; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Kane LA, 2010, J MOL MED, V88, P971, DOI 10.1007/s00109-010-0674-6; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH812, DOI 10.1152/ajpheart.00335.2017; Luss H, 2002, CARDIOVASC RES, V54, P140, DOI 10.1016/S0008-6363(02)00232-8; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896; Maneechote C, 2017, J CELL MOL MED, V21, P2643, DOI 10.1111/jcmm.13330; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340; Pashevin DO, 2015, PATHOBIOLOGY, V82, P290, DOI 10.1159/000440982; Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005; Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Przyklenk K, 2012, CARDIOVASC RES, V94, P197, DOI 10.1093/cvr/cvr358; Rehni AK, 2010, BIOL PHARM BULL, V33, P1953, DOI 10.1248/bpb.33.1953; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Riquelme JA, 2016, EXPERT REV CARDIOVAS, V14, P1007, DOI 10.1080/14779072.2016.1202760; Sanchez G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161068; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schlossarek S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00484; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Tahrir FG, 2019, J CELL PHYSIOL, V234, P8122, DOI 10.1002/jcp.27597; Tang BL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010001; Tang H, 2017, INT J BIOCHEM CELL B, V88, P55, DOI 10.1016/j.biocel.2017.05.006; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Xiong WJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00411; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu J, 2016, PEERJ, V4, DOI 10.7717/peerj.2659; Yu XC, 2005, AM J PHYSIOL-HEART C, V289, pH1960, DOI 10.1152/ajpheart.00328.2005; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071; Zhang J, 2016, AM J PHYSIOL-HEART C, V310, pH29, DOI 10.1152/ajpheart.00926.2014; Zhu AF, 2017, J CARDIOVASC PHARM, V69, P170, DOI 10.1097/FJC.0000000000000454; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zorov DB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020175	72	8	9	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY 1	2020	1866	5							165659	10.1016/j.bbadis.2019.165659	http://dx.doi.org/10.1016/j.bbadis.2019.165659			10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	LG2PL	31891806	Bronze			2022-09-04	WOS:000527949200016
J	Shurin, JB; Aranguren-Riano, N; Negro, DD; Lopez, DE; Jones, NT; Laverde-R, O; Neu, A; Ramos, AP				Shurin, Jonathan B.; Aranguren-Riano, Nelson; Duque Negro, Daniel; Echeverri Lopez, David; Jones, Natalie T.; Laverde-R, Oscar; Neu, Alexander; Pedroza Ramos, Adriana			Ecosystem effects of the world's largest invasive animal	ECOLOGY			English	Article						eutrophication; exotic species; hippopotamus; lakes; productivity; water resources	PLEISTOCENE; CHALLENGES; PHOSPHORUS; NUTRIENTS; MEGAFAUNA	The keystone roles of mega-fauna in many terrestrial ecosystems have been lost to defaunation. Large predators and herbivores often play keystone roles in their native ranges, and some have established invasive populations in new biogeographic regions. However, few empirical examples are available to guide expectations about how mega-fauna affect ecosystems in novel environmental and evolutionary contexts. We examined the impacts on aquatic ecosystems of an emerging population of hippopotamus (Hippopotamus amphibus) that has been growing in Colombia over the last 25 yr. Hippos in Africa fertilize lakes and rivers by grazing on land and excreting wastes in the water. Stable isotopes indicate that terrestrial sources contribute more carbon in Colombian lakes containing hippo populations, and daily dissolved oxygen cycles suggest that their presence stimulates ecosystem metabolism. Phytoplankton communities were more dominated by cyanobacteria in lakes with hippos, and bacteria, zooplankton, and benthic invertebrate communities were similar regardless of hippo presence. Our results suggest that hippos recapitulate their role as ecosystem engineers in Colombia, importing terrestrial organic matter and nutrients with detectable impacts on ecosystem metabolism and community structure in the early stages of invasion. Ongoing range expansion may pose a threat to water resources.	[Shurin, Jonathan B.; Jones, Natalie T.; Neu, Alexander] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Aranguren-Riano, Nelson; Duque Negro, Daniel; Pedroza Ramos, Adriana] Univ Pedag & Tecnol Colombia, Unidad Ecol Sistemas Acuat UDESA, Ave Cent Norte 39-115, Tunja, Boyaca, Colombia; [Echeverri Lopez, David] Corp Autonoma Reg Cuencas Rios Negros & Nare CORN, Calle 13,9-29, Municipio De La Union, Antioquia, Colombia; [Jones, Natalie T.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Laverde-R, Oscar] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Bogota, DC, Colombia		Shurin, JB (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	jshurin@ucsd.edu		Neu, Alexander/0000-0003-0833-1704; Aranguren-Riano, Nelson J./0000-0003-0117-1015; Jones, Natalie/0000-0001-5114-7123; Laverde-R., Oscar/0000-0003-0447-4724	National Geographic Waitt Grant [W448-16]; Fulbright Colombia U.S. Scholar Fellowship; National Science Foundation (NSF-DEB) [1457737]	National Geographic Waitt Grant(National Geographic Society); Fulbright Colombia U.S. Scholar Fellowship; National Science Foundation (NSF-DEB)(National Science Foundation (NSF))	We thank Andrea Barrera, Luis Antonio Gonzalez Montana, Nestor Torres, and Zahia Merchan for help in the field; and Jorge Caro Lopez and Hacienda Napoles Park for access to field sites and logistical assistance. Funding was provided by National Geographic Waitt Grant (W448-16), Fulbright Colombia U.S. Scholar Fellowship and National Science Foundation (NSF-DEB Award 1457737).	Beever EA, 2019, FRONT ECOL ENVIRON, V17, P117, DOI 10.1002/fee.2000; Bernardo-Madrid R, 2019, ECOL LETT, V22, P1297, DOI 10.1111/ele.13321; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dawson J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37359; Dembitzer J, 2017, ISR J ECOL EVOL, V63, P5, DOI 10.1163/22244662-06303002; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Doughty CE, 2016, P NATL ACAD SCI USA, V113, P868, DOI 10.1073/pnas.1502549112; Dutton CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04391-6; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Faurby S, 2015, DIVERS DISTRIB, V21, P1155, DOI 10.1111/ddi.12369; Fry B., 2006, STABLE ISOTOPE ECOLO; Galetti M, 2018, BIOL REV, V93, P845, DOI 10.1111/brv.12374; Galetti M, 2017, PERSPECT ECOL CONSER, V15, P245, DOI 10.1016/j.pecon.2017.10.002; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Hewitt N, 2011, BIOL CONSERV, V144, P2560, DOI 10.1016/j.biocon.2011.04.031; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Aranguren-Riano NJ, 2018, AQUAT SCI, V80, DOI 10.1007/s00027-018-0588-x; Kalff J, 2002, LIMNOLOGY; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Lundgren EJ, 2018, ECOGRAPHY, V41, P857, DOI 10.1111/ecog.03430; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; McCauley DJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00514.1; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Oksanen J., 2019, R PACKAGE VERSION, V2, P5, DOI DOI 10.4135/9781412971874.N145; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Schoelynck J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0395; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Stears K, 2018, P NATL ACAD SCI USA, V115, pE5028, DOI 10.1073/pnas.1800407115; Subalusky AL, 2019, BIOL REV, V94, P517, DOI 10.1111/brv.12465; Subalusky AL, 2018, ECOLOGY, V99, P2558, DOI 10.1002/ecy.2509; Subalusky AL, 2015, FRESHWATER BIOL, V60, P512, DOI 10.1111/fwb.12474; Utermohl H, 1958, MITTEILUNGEN INT VER, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Winslow LA, 2016, INLAND WATERS, V6, P622, DOI 10.5268/IW-6.4.883; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	37	15	15	4	57	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-9658	1939-9170		ECOLOGY	Ecology	MAY	2020	101	5							e02991	10.1002/ecy.2991	http://dx.doi.org/10.1002/ecy.2991		FEB 2020	9	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	LL8PR	31994172				2022-09-04	WOS:000514046800001
J	Ucros, S; Granados, C; Parejo, K; Ortega, F; Guillen, F; Restrepo, S; Gil, F; Guillen, M				Ucros, Santiago; Granados, Claudia; Parejo, Karem; Ortega, Fausto; Guillen, Fernando; Restrepo, Sonia; Gil, Fabian; Guillen, Miriam			Oxygen saturation, periodic breathing, and sleep apnea in infants aged 1-4 months old living at 3200 meters above sea level	ARCHIVOS ARGENTINOS DE PEDIATRIA			Spanish	Article							HIGH-ALTITUDE; NEWBORNS; BORN; TERM		[Ucros, Santiago] Fdn Santa Fe Bogota, Dept Pediat, Bogota, Colombia; [Granados, Claudia] Pontificia Univ Javeriana, Dept Pediat, Bogota, Colombia; [Granados, Claudia; Gil, Fabian] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Parejo, Karem] Fdn Clin Shaio, Dept Neurol & Lab Sueno, Bogota, Colombia; [Ortega, Fausto] Hosp Luis Fernando Martinez, Dept Pediat, Canar, Ecuador; [Guillen, Fernando] Univ Azuay, Dept Pediat, Hosp Rio, Cuenca, Ecuador; [Restrepo, Sonia] Hosp La Misericordia, Dept Pediat, Bogota, Colombia; [Restrepo, Sonia] Univ Los Andes, Fdn Santa Fe Bogota, Bogota, Colombia; [Guillen, Miriam] Univ Azuay, Estudiante Med, Cuenca, Ecuador		Ucros, S (corresponding author), Fdn Santa Fe Bogota, Dept Pediat, Bogota, Colombia.	santiago_ucros@yahoo.com	Gil, Fabian/A-3352-2011	Gil, Fabian/0000-0001-6444-7248; UCROS, SANTIAGO/0000-0003-3468-0895; Granados, Claudia/0000-0002-7120-7530				Aldashev AA, 2002, AM J RESP CRIT CARE, V166, P1396, DOI 10.1164/rccm.200204-345OC; Alduncin José, 2005, Arch. argent. pediatr., V103, P14; Brockmann PE, 2013, SLEEP MED, V14, P1323, DOI 10.1016/j.sleep.2013.07.016; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Duenas-Meza E, 2015, CHEST, V148, P120, DOI 10.1378/chest.14-3207; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Gonzales GF, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-46; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; NIERMEYER S, 1993, J PEDIATR-US, V123, P767, DOI 10.1016/S0022-3476(05)80857-1; Salas AA, 2008, ANN TROP PAEDIATR, V28, P275, DOI 10.1179/146532808X375431; Schluter B., 2001, SOMNOLOGIE, V5, P3, DOI [DOI 10.1046/J.1439-054X.2001.01148.X, 10.1046/j.1439-054x.2001.01148.x]; Torres Y, 1999, AVANCES PEDIAT, V1, P2; Ucros S, 2015, ARCH ARGENT PEDIATR, V113, P341, DOI [10.5546/aap.2015.341, 10.5546/aap.2015.eng.341]	13	10	10	1	1	SOC ARGENTINA PEDIATRIA	CAP FED BUENO AIRES	AV COLONEL DIAZ 1971-75-C1425DQF, CAP FED BUENO AIRES, 00000, ARGENTINA	0325-0075	1668-3501		ARCH ARGENT PEDIATR	Arch. Argent. Pediatr.	FEB	2017	115	1					54	57		10.5546/aap.2017.54	http://dx.doi.org/10.5546/aap.2017.54			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EO3WC	28097841	gold			2022-09-04	WOS:000396624200010
J	Latz, A; Llano, M; Pavia, P; Puerta, C; Florez, AC; Cucunuba, Z; Cuellar, A; Gonzalez, J; Licda, AR; Roche, I; Zamora, DMB				Latz, A.; Llano, M.; Pavia, P.; Puerta, C.; Florez, A. C.; Cucunuba, Z.; Cuellar, A.; Gonzalez, J.; Licda, A. R.; Roche, I.; Zamora, D. M. B.			Performance evaluation of enzyme linked immunosorbent assay and lineblot for serological diagnosis of Chagas (Trypanosoma cruzi) disease	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Latz, A.] NovaTec Immundiagnost GmbH, Dietzenbach, Germany; [Llano, M.; Pavia, P.; Puerta, C.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Parasitol Mol, Bogota, Colombia; [Florez, A. C.; Cucunuba, Z.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Cuellar, A.] Pontificia Univ Javeriana, Fac Ciencias, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Gonzalez, J.] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Licda, A. R.; Roche, I.] San Carlos Univ Guatemala, Sch Chem & Pharmaceut Sci, Guatemala City, Guatemala; [Zamora, D. M. B.] Univ San Carlos, Escuela Biol, Guatemala City, Guatemala				Cuellar, Adriana/AAF-2958-2019; Cucunuba, Zulma M/X-5670-2019; Puerta, Concepcion J/AAG-4912-2019	Cucunuba, Zulma M/0000-0002-8165-3198; 					0	0	0	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		131	131						1	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	213BS					2022-09-04	WOS:000324029000351
J	Castillo, D; Bousquet, F; Janssen, MA; Worrapimphong, K; Cardenas, JC				Castillo, Daniel; Bousquet, Francois; Janssen, Marco A.; Worrapimphong, Kobchai; Camillo Cardenas, Juan			Context matters to explain field experiments: Results from Colombian and Thai fishing villages	ECOLOGICAL ECONOMICS			English	Article						Field experiments; Role games; Fisheries; Rules; Cooperation; Trust		During the last decade, field experiments regarding the study of common pool resource governance have been performed that replicated earlier findings of laboratory experiments. One of the questions is how the decisions made by participants in rural communities are influenced by their experience. This paper presents the results of field experiments in Colombia and Thailand on fishery resources. Context information is derived from the communities via in-depth interviews, surveys and role playing exercises. The use of different methodological tools allowed to link decisions in field experiments with contextual variables for two fishery villages. Explanation of core variables in social dilemmas is given, the degree of cooperation levels, preferred rules, rule compliance and enforcement. Main findings include: i) fishermen made decisions in the field experiments that reflected their own experience and context, ii) agreements for rule crafting are possible only under specific conditions that guarantees livelihoods and sustainability, iii) the broader context determines cooperation levels at a local level, iv) inequalities in the sanctioning of rule breakers decrease the possibilities of reaching cooperation agreements, and v) high levels of trust among local fishermen is not a sufficient condition for resource sustainability, when trust in external rule makers and enforcers is low. (C) 2011 Elsevier B.V. All rights reserved.	[Castillo, Daniel] Univ Javeriana, Sch Environm & Rural Studies, Inst & Rural Dev Res Grp, Bogota, Colombia; [Bousquet, Francois] CIRAD, UPRGREEN, F-34398 Montpellier 5, France; [Janssen, Marco A.] Arizona State Univ, Ctr Study Inst Divers, Tempe, AZ 85287 USA; [Worrapimphong, Kobchai] Chulalongkorn Univ, Fac Sci, Dept Biol, Pathumwan Bangkok 10330, Thailand; [Camillo Cardenas, Juan] Univ Los Andes, Dept Econ, Bogota, Colombia		Castillo, D (corresponding author), Transv 4 42-00,Piso 8, Bogota, Colombia.	d.castillo@javeriana.edu.co	Bousquet, Francois/G-3605-2010; Bousquet, Francois/Y-7904-2019; Castillo Brieva, Daniel/C-4104-2015; cardenas, juan-camilo/B-4658-2009	Bousquet, Francois/0000-0002-4552-3724; Castillo Brieva, Daniel/0000-0001-9251-6124; cardenas, juan-camilo/0000-0003-0005-7595	National Science Foundation [BCS 0601320]	National Science Foundation(National Science Foundation (NSF))	The support of the National Science Foundation (Grant number BCS 0601320) made it possible to carry out this research which is part of the project "Dynamics of Rules in Commons Dilemmas". We want to thank all the people, students, researchers, friends and relatives that helped with the field work in Colombian and Thai fishery sites driven by their interest in innovative tools for understanding and solving problems in rural communities and natural resources. We want to acknowledge all the people in Colombia and Thailand, students and villagers that participated in experiments, role games, interviews and surveys. They shared with us their knowledge and experience with natural resources, but did not always see the benefits of scientific work in their daily life. We are permanently indebted to them. Thank you to Deb Cleland and Luis Garcia Barrios for their careful reading and useful comments. Finally, we want to thank the careful reading and comments of two anonymous reviewers.	Acheson JM., 2003, CAPTURING COMMONS DE; Barreteau O, 2003, JASSS-J ARTIF SOC S, V6; Basurto X, 2008, ECOL SOC, V13; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Berkes F., 1998, LINKING SOCIAL ECOLO; BERKES F, 2001, MANAGING SMALL SCALE; Bousquet F, 2002, COMPLEXITY AND ECOSYSTEM MANAGEMENT, P248; Bousquet F., 2005, COMPANION MODELING M; *C REP COL, 1990, DIARIO OFICIAL, V39, P143; CARDENAS JC, 2005, ARTEFACTUAL FIELD EX, V22; Herbert A, 2010, SIMULAT GAMING, V41, P681, DOI 10.1177/1046878109334009; HERNANDEZ J, 1990, NUEVOS PARQUESNACION; IGAC (Instituto Geografico Agustin Codazzi), 2002, ATL COL, V5ta; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janssen Marco A., HDB EXPT EC IN PRESS; Kato F, 2010, SIMULAT GAMING, V41, P694, DOI 10.1177/1046878109334010; Kopainsky B, 2010, SIMULAT GAMING, V41, P641, DOI 10.1177/1046878109332280; Kriz WC, 2010, SIMULAT GAMING, V41, P663, DOI 10.1177/1046878108319867; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Ostrom E., 1994, RULES GAMES COMMON P; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pak MV, 2010, ENVIRON MODELL SOFTW, V25, P1322, DOI 10.1016/j.envsoft.2010.03.015; Pineda I.J., 2006, PLAN MANEJO PARQUE N; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; SMITH V, 2010, J EC BEHAV ORG, V73; Sterman, 2010, BUSINESS DYNAMICS; Suchman L, 2002, BRIT J SOCIOL, V53, P163, DOI 10.1080/00071310220133287	30	62	63	1	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	JUL 15	2011	70	9			SI		1609	1620		10.1016/j.ecolecon.2011.05.011	http://dx.doi.org/10.1016/j.ecolecon.2011.05.011			12	Ecology; Economics; Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Business & Economics	793EN					2022-09-04	WOS:000292803300008
J	Luna-Meza, A; Godoy-Casasbuenas, N; Calvache, JA; Diaz-Amado, E; Rueda, FEG; Morales, O; Leal, F; Gomez-Restrepo, C; de Vries, E				Luna-Meza, Angela; Godoy-Casasbuenas, Natalia; Andres Calvache, Jose; Diaz-Amado, Eduardo; Gempeler Rueda, Fritz E.; Morales, Olga; Leal, Fabian; Gomez-Restrepo, Carlos; de Vries, Esther			Decision making in the end-of-life care of patients who are terminally ill with cancer - a qualitative descriptive study with a phenomenological approach from the experience of healthcare workers	BMC PALLIATIVE CARE			English	Article						Neoplasms; Terminal care; Palliative care; Death; Colombia	PALLIATIVE CARE; SEDATION; AFRICA	Background In Colombia, recent legislation regarding end-of-life decisions includes palliative sedation, advance directives and euthanasia. We analysed which aspects influence health professionals ' decisions regarding end-of-life medical decisions and care for cancer patients. Methods Qualitative descriptive-exploratory study based on phenomenology using semi-structured interviews. We interviewed 28 oncologists, palliative care specialists, general practitioners and nurses from three major Colombian institutions, all involved in end-of-life care of cancer patients: Hospital Universitario San Ignacio and Instituto Nacional de Cancerologia in Bogota and Hospital Universitario San Jose in Popayan. Results When making decisions regarding end-of-life care, professionals consider: 1. Patient's clinical condition, cultural and social context, in particular treating indigenous patients requires special skills. 2. Professional skills and expertise: training in palliative care and experience in discussing end-of-life options and fear of legal consequences. Physicians indicate that many patients deny their imminent death which hampers shared decision-making and conversations. They mention frequent ambiguity regarding who initiates conversations regarding end-of-life decisions with patients and who finally takes decisions. Patients rarely initiate such conversations and the professionals normally do not ask patients directly for their preferences. Fear of confrontation with family members and lawsuits leads healthcare workers to carry out interventions such as initiating artificial feeding techniques and cardiopulmonary resuscitation, even in the absence of expected benefits. The opinions regarding the acceptability of palliative sedation, euthanasia and use of medications to accelerate death without the patients ' explicit request vary greatly. 3. Conditions of the insurance system: limitations exist in the offer of oncology and palliative care services for important proportions of the Colombian population. Colombians have access to opioid medications, barriers to their application are largely in delivery by the health system, the requirement of trained personnel for intravenous administration and ambulatory and home care plans which in Colombia are rare. Conclusions To improve end-of-life decision making, Colombian healthcare workers and patients need to openly discuss wishes, needs and care options and prepare caregivers. Promotion of palliative care education and development of palliative care centres and home care plans is necessary to facilitate access to end-of-life care. Patients and caregivers' perspectives are needed to complement physicians' perceptions and practices.	[Luna-Meza, Angela; Gomez-Restrepo, Carlos; de Vries, Esther] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Luna-Meza, Angela; Gempeler Rueda, Fritz E.; Morales, Olga; Leal, Fabian; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Godoy-Casasbuenas, Natalia] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, PhD Programme Clin Epidemiol, Bogota, Colombia; [Andres Calvache, Jose] Univ Cauca, Dept Anesthesiol, Popayan, Colombia; [Andres Calvache, Jose] Erasmus Univ MC Rotterdam, Dept Anesthesiol, Rotterdam, Netherlands; [Diaz-Amado, Eduardo] Pontificia Univ Javeriana, Inst Bioeth, Bogota, Colombia; [Gempeler Rueda, Fritz E.; Morales, Olga; Leal, Fabian; Gomez-Restrepo, Carlos] Hosp Univ San Ignacio, Bogota, Colombia; [Morales, Olga; Leal, Fabian] Pontificia Univ Javeriana, Fac Med, Dept Anesthestiol, Serv Dolor & Cuidados Paliativos, Bogota, Colombia; [Leal, Fabian] Inst Nacl Cancerol, Bogota, Colombia		de Vries, E (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia.	estherdevries@javeriana.edu.co	Calvache, Jose Andres/V-7932-2019; de Vries, Esther/A-6603-2009	Calvache, Jose Andres/0000-0001-9421-3717; de Vries, Esther/0000-0002-5560-2258; Gomez-Restrepo, Carlos/0000-0002-9013-5384	Colciencias	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was financed by Colciencias, in the framework of the "777-2017 Convocatoria para proyectos de ciencia, tecnologia e innovacion en Salud 2017", project CT-826-2018 - Decisiones medicas al final de la vida en pacientes oncologicos en Colombia".	Agarwal R, 2018, SEMIN ONCOL NURS, V34, P316, DOI 10.1016/j.soncn.2018.06.012; Albert RH, 2017, AM FAM PHYSICIAN, V95, P356; Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Calvache JA., 2020, COLOMBIAN J ANESTHES, V0408; Clark D, 2007, J PAIN SYMPTOM MANAG, V33, P698, DOI 10.1016/j.jpainsymman.2006.09.033; Congreso de la Republica de Colombia, LEY 1733 CONSUELO DE; Coulter A, 2001, HEALTH AFFAIR, V20, P244, DOI 10.1377/hlthaff.20.3.244; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; de Vogel-Voogt E, 2007, PALLIATIVE MED, V21, P243, DOI 10.1177/0269216307077352; de Vries E, 2021, MED DECISIONS END LI; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Fraser BA, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2017.010090; Gerber K, 2019, PALLIATIVE MED, V33, P802, DOI 10.1177/0269216319845794; Giger Joyce Newman, 2006, J Cult Divers, V13, P3; Groenewald T., 2004, INT J QUAL METH, V3, P42, DOI [10.1177/160940690400300104, DOI 10.1177/160940690400300104]; Hales S, 2008, ARCH INTERN MED, V168, P912, DOI 10.1001/archinte.168.9.912; Hepburn A., 2004, QUALITATIVE RES PRAC, P180, DOI DOI 10.4135/9781848608191.D16; Heyland DK, 2006, CAN MED ASSOC J, V174, P627, DOI 10.1503/cmaj.050626; Jimenez G, 2018, J PAIN SYMPTOM MANAG, V56, P436, DOI 10.1016/j.jpainsymman.2018.05.016; Larson DG, 2000, JAMA-J AM MED ASSOC, V284, P1573, DOI 10.1001/jama.284.12.1573; Manalo Maria Fidelis C, 2013, Palliat Care, V7, P1, DOI 10.4137/PCRT.S10796; Materstvedt LJ, 2012, BMJ SUPPORT PALLIAT, V2, P9, DOI 10.1136/bmjspcare-2011-000040; Ministerio de salud y proteccion social, 2016, GUIA PRACT CLIN AT P; Ministerio de Salud y Proteccion Social, 2015, PROT APL PROC EUT CO, P7; Neil DA, 2007, J MED ETHICS, V33, P721, DOI 10.1136/jme.2006.017137; Ntizimira CR, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.493; Onyeka TC, 2013, EUR J CANCER CARE, V22, P597, DOI 10.1111/ecc.12064; Raijmakers NJH., 2013, THESIS ERASMUS U ROT; Rainsford S, 2017, PALLIATIVE MED, V31, P895, DOI 10.1177/0269216316685234; Salloch S, 2018, J EVAL CLIN PRACT, V24, P180, DOI 10.1111/jep.12840; Sarmiento Medina M, 2015, REV SALUD BOSQUE, V1, P23, DOI [10.18270/rsb.v1i2.93, DOI 10.18270/RSB.V1I2.93]; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; Sepulveda C, 2003, BRIT MED J, V327, P209, DOI 10.1136/bmj.327.7408.209; Shahid S, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0325-1; Shen MJ, 2019, PALLIAT SUPPORT CARE, V17, P374, DOI 10.1017/S1478951518000834; Vargas-Lorenzo Ingrid, 2010, Rev. salud pública, V12, P701; Willig C., 2008, INTRO QUALITATIVE RE, P52; Zadeh RS, 2018, AM J HOSP PALLIAT ME, V35, P411, DOI 10.1177/1049909117711997	39	4	5	2	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-684X			BMC PALLIAT CARE	BMC Palliat. Care	MAY 28	2021	20	1							76	10.1186/s12904-021-00768-5	http://dx.doi.org/10.1186/s12904-021-00768-5			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	SJ9PN	34049535	Green Submitted, gold, Green Published			2022-09-04	WOS:000655857700001
J	Garcia-Diaz, C; Peli, G; van Witteloostuijn, A				Garcia-Diaz, Cesar; Peli, Gabor; van Witteloostuijn, Arjen			The coevolution of the firm and the product attribute space	PLOS ONE			English	Article							DEVELOPMENT EXTERNALITIES; COMPLEX DYNAMICS; LINE LENGTH; MODEL; COMPETITION; OLIGOPOLY; INDUSTRY; DUOPOLY; INTERDEPENDENCY; DIMENSIONALITY	Traditionally, firm competition has been studied in contexts where the dimensionality of the product attribute space is given, and firms deploy their strategies constrained by this space. However, firms may exert influence on the local structure of the product attribute space by offering product variants with new attributes. As a result, the geometry of the product attribute space would change endogenously through firms' actions, and this emergent new geometry modifies the conditions for subsequent firm behavior. By focusing on this interplay between actors and conditions, we explore the co-evolution of the firm and the product attribute space. Through a multi-variant Cournot competition framework, we develop a computational model in which firms invest to differentiate their products from other variants, but as minimally as possible so that demand from closely similar existing variants can be stolen. We introduce the fraction dimensionality of the attribute space as our critical independent variable, to reflect saturation of the space with product varieties. The simulation reveals that while new product variants are typically introduced by firms with scale economies, their performance gap with firms without scale economies reduces as fraction dimensionality increases. This indicates that space geometry evolution may favor small-scale players, even when their large-scale competitors are the driving force behind attribute space changes.	[Garcia-Diaz, Cesar] Pontificia Univ Javeriana, Dept Business Adm, Bogota, Colombia; [Peli, Gabor] Hungarian Acad Sci Ctr Excellence, Ctr Social Sci, Budapest, Hungary; [Peli, Gabor] Karoli Gaspar Univ Reformed Church Hungary, Inst Social & Commun Sci, Budapest, Hungary; [van Witteloostuijn, Arjen] Vrije Univ Amsterdam, Sch Business & Econ, Amsterdam, Netherlands; [van Witteloostuijn, Arjen] Antwerp Management Sch, Fac Business & Econ, Antwerp, Belgium		Garcia-Diaz, C (corresponding author), Pontificia Univ Javeriana, Dept Business Adm, Bogota, Colombia.	ce.garciad@javeriana.edu.co	; Garcia-Diaz, Cesar/R-1559-2017	Peli, Gabor/0000-0003-1839-6915; Garcia-Diaz, Cesar/0000-0002-5395-5324; van Witteloostuijn, A./0000-0002-0287-5965	"Vicerrectoria de Investigacion/Facultad de Ciencias Economicas y Administrativas" of Pontificia Universidad Javeriana [9546]	"Vicerrectoria de Investigacion/Facultad de Ciencias Economicas y Administrativas" of Pontificia Universidad Javeriana	This project has been financially supported by the "Vicerrectoria de Investigacion/Facultad de Ciencias Economicas y Administrativas" of Pontificia Universidad Javeriana (Project ID: 9546; Dr. Cesar Garcia-Diaz).	Abolhassani M, 2014, P 10 INT C WEB INT E; Adner R, 2014, MANAGE SCI, V60, P2794, DOI 10.1287/mnsc.2014.1978; Agliari A, 2016, APPL MATH COMPUT, V281, P1, DOI 10.1016/j.amc.2016.01.045; [Anonymous], 2002, COMPOS STRUCT, V58, P83; [Anonymous], 2008, STRATEG MANAG; [Anonymous], 2007, LOGICS ORG THEORY AU; Artinger F, 2015, J ORGAN BEHAV, V36, pS33, DOI 10.1002/job.1950; Barnett W.P., 2008, RED QUEEN ORG COMPET; Barnett WP, 1997, ADMIN SCI QUART, V42, P128, DOI 10.2307/2393811; Barroso A, 2013, STRATEGIC MANAGE J, V34, P1435, DOI 10.1002/smj.2079; Bayus BL, 1999, MARKET SCI, V18, P137, DOI 10.1287/mksc.18.2.137; Berger P. L., 1966, SOCIAL CONSTRUCTION; Bimpikis K, 2019, MANAGE SCI, V65, P2467, DOI 10.1287/mnsc.2018.3061; Bischi GI, 2015, J ECON BEHAV ORGAN, V116, P219, DOI 10.1016/j.jebo.2015.04.024; Bischi GI, 2012, MATH COMPUT SIMULAT, V84, P66, DOI 10.1016/j.matcom.2012.09.001; Bischi GI, 2012, MATH COMPUT SIMULAT, V84, P51, DOI 10.1016/j.matcom.2012.08.006; Blau P.M., 1977, AM J SOCIOL, V83, P26, DOI 10.1086/226505; Boone C, 2002, AM SOCIOL REV, V67, P408, DOI 10.2307/3088964; Bruggeman J, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500533; Cao YX, 2019, INT J BIFURCAT CHAOS, V29, DOI 10.1142/S0218127419300313; Carroll GR, 2002, RES ORGAN BEHAV, V24, P1, DOI 10.1016/S0191-3085(02)24002-2; Chang MH, 2015, COMPUTATIONAL MODEL; Dawid H, 2014, J ECON BEHAV ORGAN, V105, P158, DOI 10.1016/j.jebo.2014.03.004; Dobrev SD, 2000, ORGAN STUD, V21, P383, DOI 10.1177/0170840600212004; Downs Anthony, 1957, J PUBLIC ECON THEORY; Draganska M, 2005, J ECON MANAGE STRAT, V14, P1, DOI 10.1111/j.1430-9134.2005.00032.x; Fanti L, 2012, ECON MODEL, V29, P421, DOI 10.1016/j.econmod.2011.11.010; Felin T, 2014, STRATEG ENTREP J, V8, P269, DOI 10.1002/sej.1184; FREEMAN LC, 1983, SOC NETWORKS, V5, P139, DOI 10.1016/0378-8733(83)90022-9; Garcia-Diaz C, 2008, ADV COMPLEX SYST, V11, P231, DOI 10.1142/S0219525908001593; Garcia-Diaz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144574; Garcia-Diaz C, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500197; Gavetti G, 2017, STRATEG SCI, V2, P194, DOI 10.1287/stsc.2017.0036; Giachetti C, 2014, STRATEGIC MANAGE J, V35, P1398, DOI 10.1002/smj.2154; Gourville JT, 2005, MARKET SCI, V24, P382, DOI 10.1287/mksc.1040.0109; Irmen A, 1998, J ECON THEORY, V78, P76, DOI 10.1006/jeth.1997.2348; Kim J, 2007, J ECONOMETRICS, V138, P208, DOI 10.1016/j.jeconom.2006.05.020; Lacourbe P, 2009, PROD OPER MANAG, V18, P315, DOI [10.1111/j.1937-5956.2009.01020.x, 10.3401/poms.1080.1020]; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Laver M., 2012, PARTY COMPETITION AG; Lenox MJ, 2007, MANAGE SCI, V53, P599, DOI 10.1287/mnsc.1060.0679; Lenox MJ, 2006, MANAGE SCI, V52, P757, DOI 10.1287/mnsc.1050.0495; Mandelbrot B.B., 1983, FRACTAL GEOMETRY NAT, DOI 10.1119/1.13295; McPherson M, 2004, IND CORP CHANGE, V13, P263, DOI 10.1093/icc/13.1.263; MCPHERSON M, 1983, AM SOCIOL REV, V48, P519, DOI 10.2307/2117719; Ofek E., 2008, HDB NEW PRODUCT DEV, V1st ed., P49; Peli G, 1999, AM J SOCIOL, V104, P1132, DOI 10.1086/210138; Peli G, 2009, MANAG DECIS ECON, V30, P1, DOI 10.1002/mde.1428; Sanchez SM, 2006, P 2006 WINT SIM C 20; Scott W. Richard, 1995, I ORG IDEAS INTEREST; Thomadsen R, 2012, J MARKETING RES, V49, P349, DOI 10.1509/jmr.10.0164; Thomas L, 2000, STRATEGIC MANAGE J, V21, P897; Vallee T, 2009, J ECON BEHAV ORGAN, V72, P670, DOI 10.1016/j.jebo.2009.07.007; Van Valen L., 1973, EVOL THEORY, V1, P1; Van Witteloostuijn A, 2006, ACAD MANAGE REV, V31, P409; VANWITTELOOSTUIJN A, 1990, J ECON PSYCHOL, V11, P183, DOI 10.1016/0167-4870(90)90003-R; Waltman L, 2008, J ECON DYN CONTROL, V32, P3275, DOI 10.1016/j.jedc.2008.01.003; Yi QG, 2015, CHAOS SOLITON FRACT, V76, P231, DOI 10.1016/j.chaos.2015.04.008; Yu ZY, 2011, SYSTEMS ENG, V14, P441, DOI 10.1002/sys.20188; Zhang YH, 2018, NONLINEAR DYNAM, V91, P819, DOI 10.1007/s11071-017-3912-4; Zhou J, 2019, APPL MATH COMPUT, V341, P358, DOI 10.1016/j.amc.2018.09.004; Zhou W, 2019, DISCRETE DYN NAT SOC, V2019, DOI 10.1155/2019/2369898	62	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234007	10.1371/journal.pone.0234007	http://dx.doi.org/10.1371/journal.pone.0234007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530953	gold, Green Published, Green Accepted			2022-09-04	WOS:000542037200018
J	Caviedes-Bucheli, J; Rios-Osorio, N; Rey-Rojas, M; Laguna-Rivero, F; Azuero-Holguin, MM; Diaz, LE; Curtidor, H; Castaneda-Ramirez, JJ; Munoz, HR				Caviedes-Bucheli, J.; Rios-Osorio, N.; Rey-Rojas, M.; Laguna-Rivero, F.; Azuero-Holguin, M. M.; Diaz, L. E.; Curtidor, H.; Castaneda-Ramirez, J. J.; Munoz, H. R.			Substance P and Calcitonin gene-related peptide expression in human periodontal ligament after root canal preparation with Reciproc Blue, WaveOne Gold, XP EndoShaper and hand files	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						Calcitonin gene-related peptide; human periodontal ligament; neurogenic inflammation; neuropeptides; Reciproc Blue; Substance P; symptomatic apical periodontitis; WaveOne Gold; XP-EndoShaper	HUMAN DENTAL-PULP; DRIVEN INSTRUMENTATION TECHNIQUES; CYCLIC FATIGUE RESISTANCE; APICAL EXTRUSION; IRREVERSIBLE PULPITIS; SINGLE-FILE; ENDO SHAPER; SYSTEMS; DEBRIS; TISSUE	Aim To quantify Substance P (SP) and Calcitonin gene-related peptide (CGRP) expression in healthy human periodontal ligament from premolars after root canal preparation with Reciproc Blue, WaveOne Gold, XP EndoShaper and hand files. Methodology Results A total of 50 human periodontal ligament samples were obtained from healthy mandibular premolars where extraction was indicated for orthodontic reasons. Prior to extraction, 40 of these premolars were equally divided into four groups, and root canals were prepared using four different systems: Reciproc Blue, WaveOne Gold, XP EndoShaper and a hand instrumentation technique. The remaining 10 healthy premolars were extracted without treatment and served as a negative control group. All periodontal ligament samples were processed, and SP and CGRP were measured by radioimmunoassay. The Kruskal-Wallis test was used to establish significant differences between groups and LSD post hoc comparisons were also performed. Greater SP and CGRP values were found in the hand instrumentation group, followed by the XP EndoShaper, WaveOne Gold and the Reciproc groups. The lower SP and CGRP values were for the healthy periodontal ligament group. The Kruskal-Wallis test revealed significant differences between groups (P < 0.05). Post hoc Least Significant Difference (LSD) tests revealed significant differences (P < 0.05) in SP and CGRP expression between all the comparisons except for the Reciproc Blue and WaveOne Gold group (P > 0.05). Conclusion All the root canal preparation techniques tested increased SP and CGRP expression in human periodontal ligament, with hand files and XP EndoShaper instruments being associated with greater neuropeptide release compared to Reciproc Blue and WaveOne Gold files.	[Caviedes-Bucheli, J.; Azuero-Holguin, M. M.] Pontificia Univ Javeriana, Ctr Invest Odontol, Cra 13A 89-53,Of 603, Bogota, Colombia; [Rios-Osorio, N.; Rey-Rojas, M.; Laguna-Rivero, F.; Azuero-Holguin, M. M.] Inst Univ Colegios Colombia, Postgrad Endodont Dept, Bogota, Colombia; [Diaz, L. E.] Univ La Sabana, Engineer Sch, Chia, Colombia; [Curtidor, H.] Univ Rosario, Bogota, Colombia; [Castaneda-Ramirez, J. J.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Munoz, H. R.] Univ San Carlos, Postgrad Endodont Dept, Guatemala City, Guatemala		Caviedes-Bucheli, J (corresponding author), Pontificia Univ Javeriana, Ctr Invest Odontol, Cra 13A 89-53,Of 603, Bogota, Colombia.	javiercaviedes@gmail.com	Barrera, Luis Eduardo Díaz/U-2706-2019; Curtidor, Hernando/I-7997-2016; Caviedes, Javier/O-5271-2019	Barrera, Luis Eduardo Díaz/0000-0002-9588-9935; Curtidor, Hernando/0000-0002-6556-7812; Caviedes, Javier/0000-0003-0407-9847				Awawdeh L, 2002, INT ENDOD J, V35, P30, DOI 10.1046/j.1365-2591.2002.00451.x; Azim AA, 2017, J ENDODONT, V43, P1532, DOI 10.1016/j.joen.2017.04.022; Bayram HM, 2017, J ENDODONT, V43, P1166, DOI 10.1016/j.joen.2017.02.005; Bowles WR, 2003, J ENDODONT, V29, P265, DOI 10.1097/00004770-200304000-00009; Caviedes-Bucheli J, 2016, INT ENDOD J, V49, P255, DOI 10.1111/iej.12452; Caviedes-Bucheli J, 2013, INT ENDOD J, V46, P419, DOI 10.1111/iej.12005; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P945, DOI 10.1016/j.joen.2008.05.011; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P773, DOI 10.1016/j.joen.2008.03.010; Caviedes-Bucheli J, 2011, J ENDODONT, V37, P627, DOI 10.1016/j.joen.2011.02.013; Caviedes-Bucheli J, 2010, J ENDODONT, V36, P1938, DOI 10.1016/j.joen.2010.08.043; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P1462, DOI 10.1016/j.joen.2008.09.013; Caviedes-Bucheli J, 2009, J ENDODONT, V35, P631, DOI 10.1016/j.joen.2008.12.020; De-Deus G, 2017, J ENDODONT, V43, P462, DOI 10.1016/j.joen.2016.10.039; Dentsply International Inc, 2017, SURF CAN CONF WAVEON; Elnaghy AM, 2018, INT ENDOD J, V51, P572, DOI 10.1111/iej.12815; Er K, 2005, INT ENDOD J, V38, P871, DOI 10.1111/j.1365-2591.2005.01029.x; Ferraz CCR, 2001, INT ENDOD J, V34, P354, DOI 10.1046/j.1365-2591.2001.00394.x; FKG Swiss Endo, 2017, XP ENDOSHAPER ON SHA; Hargreaves KM, 2003, J ENDODONT, V29, P397, DOI 10.1097/00004770-200306000-00004; Ismail AAA, 2014, ADV CLIN CHEM, V66, P241, DOI 10.1016/B978-0-12-801401-1.00007-4; Keskin C, 2017, J ENDODONT, V43, P1360, DOI 10.1016/j.joen.2017.03.036; Kim HC, 2012, J ENDODONT, V38, P541, DOI 10.1016/j.joen.2011.11.014; Lacerda MFLS, 2017, J ENDODONT, V43, P1878, DOI 10.1016/j.joen.2017.06.032; MIZUTANI T, 1992, J ENDODONT, V18, P344, DOI 10.1016/S0099-2399(06)80486-3; Ozyurek T, 2016, J ENDODONT, V42, P1536, DOI 10.1016/j.joen.2016.06.019; Peters OA, 2004, J ENDODONT, V30, P559, DOI 10.1097/01.DON.0000129039.59003.9D; Peters Ove Andreas, 2017, Dent Clin North Am, V61, P37, DOI 10.1016/j.cden.2016.08.002; Ricucci D, 1998, INT ENDOD J, V31, P384; Siqueira JF, 2002, J ENDODONT, V28, P457, DOI 10.1097/00004770-200206000-00010; Somma F, 2012, INT ENDOD J, V45, P552, DOI 10.1111/j.1365-2591.2011.02010.x; VDW, 2017, REC BLUE INSTR; Walker VM, 2017, INT J EPIDEMIOL, V46, P1627, DOI 10.1093/ije/dyx090; Webber J., 2011, ROOTS, V1, P28	33	6	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	DEC	2018	51	12					1358	1366		10.1111/iej.12952	http://dx.doi.org/10.1111/iej.12952			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	GZ9MA	29772080				2022-09-04	WOS:000449822300005
J	Sawamoto, K; Chen, HH; Almeciga-Diaz, CJ; Mason, RW; Tomatsu, S				Sawamoto, Kazuki; Chen, Hui-Hsuan; Almeciga-Diaz, Carlos J.; Mason, Robert W.; Tomatsu, Shunji			Gene therapy for Mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Review						Mucopolysaccharidoses; Gene therapy; Adeno-associated virus; Glycosaminoglycans	CENTRAL-NERVOUS-SYSTEM; STEM-CELL TRANSPLANTATION; BLOOD-BRAIN-BARRIER; ENZYME-REPLACEMENT THERAPY; ADENOASSOCIATED VIRUS VECTOR; RECOMBINANT AAV VECTORS; RATE-LIMITING STEP; MOUSE MODEL; LYSOSOMAL STORAGE; IN-VIVO	Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders (LSDs) caused by a deficiency of lysosomal enzymes, leading to a wide range of various clinical symptoms depending upon the type of MPS or its severity. Enzyme replacement therapy (ERT), hematopoietic stem cell transplantation (HSCT), substrate reduction therapy (SRT), and various surgical procedures are currently available for patients with MPS. However, there is no curative treatment for this group of disorders. Gene therapy should be a one-time permanent therapy, repairing the cause of enzyme deficiency. Preclinical studies of gene therapy for MPS have been developed over the past three decades. Currently, clinical trials of gene therapy for some types of MPS are ongoing in the United States, some European countries, and Australia. Here, in this review, we summarize the development of gene therapy for MPS in preclinical and clinical trials.	[Sawamoto, Kazuki; Chen, Hui-Hsuan; Mason, Robert W.; Tomatsu, Shunji] Nemours Alfred L duPont Hosp Children, 1600 Rockland Rd, Wilmington, DE 19899 USA; [Chen, Hui-Hsuan] Univ Delaware, Dept Med Lab Sci, Newark, DE USA; [Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota, Colombia; [Tomatsu, Shunji] Gifu Univ, Dept Pediat, Gifu, Japan; [Tomatsu, Shunji] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA		Tomatsu, S (corresponding author), Nemours Alfred L duPont Hosp Children, 1600 Rockland Rd, Wilmington, DE 19899 USA.	stomatsu@nemours.org	Alméciga-Díaz, Carlos J/A-2494-2017	Alméciga-Díaz, Carlos J/0000-0001-6484-1173	National MPS Society; Austrian MPS Society; International Morquio Organization (Carol Ann Foundation); Japanese MPS Family Society; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of National Institutes of Health (NIH) [P30GM114736]; NIH [1R01HD065767]; Fulbright Colombia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114736] Funding Source: NIH RePORTER	National MPS Society; Austrian MPS Society; International Morquio Organization (Carol Ann Foundation); Japanese MPS Family Society; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Colombia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National MPS Society, the Austrian MPS Society, and International Morquio Organization (Carol Ann Foundation). This work was also supported by Japanese MPS Family Society. R.W.M. and S.T. were supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of National Institutes of Health (NIH) under grant number P30GM114736. S.T. was supported by NIH grant 1R01HD065767. The content of the article has not been influenced by the sponsors. C.J.A-D. was supported by Fulbright Colombia.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Aldenhoven M, 2015, BIOL BLOOD MARROW TR, V21, P1106, DOI 10.1016/j.bbmt.2015.02.011; Barth AL, 2017, MOL GENET METAB REP, V12, P62, DOI 10.1016/j.ymgmr.2017.05.010; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bey K, 2017, GENE THER, V24, P325, DOI 10.1038/gt.2017.18; Bosch A, 2000, MOL THER, V1, P63, DOI 10.1006/mthe.1999.0005; Boutin S., 2010, GENE THER, V21; Bucher T, 2014, GENE THER, V21, P522, DOI 10.1038/gt.2014.16; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chen YH, 2012, MOL THER, V20, P1393, DOI 10.1038/mt.2012.100; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Cotugno G, 2011, MOL THER, V19, P461, DOI 10.1038/mt.2010.257; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Dekeler R., 2017, 13 INT C INB ERR MET; Desmaris N, 2004, ANN NEUROL, V56, P68, DOI 10.1002/ana.20150; Doi Knayo, 2015, Virus (Nagoya), V65, P27, DOI 10.2222/jsv.65.27; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Feria R., 2015, GENE THER, V26, P145; Ferla R, 2013, HUM GENE THER, V24, P163, DOI 10.1089/hum.2012.179; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fraldi A, 2007, HUM MOL GENET, V16, P2693, DOI 10.1093/hmg/ddm223; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Fu H, 2002, MOL THER, V5, P42, DOI 10.1006/mthe.2001.0514; Fu HY, 2017, MOL THER, V25, P792, DOI 10.1016/j.ymthe.2016.12.025; Fu HY, 2016, CURR OPIN VIROL, V21, P87, DOI 10.1016/j.coviro.2016.08.006; Fu HY, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.36; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Ghodsi A, 1998, HUM GENE THER, V9, P2331, DOI 10.1089/hum.1998.9.16-2331; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gruber K, 2012, LANCET, V380, pE10, DOI 10.1016/S0140-6736(12)61992-8; Gurda BL, 2016, MOL THER, V24, P206, DOI 10.1038/mt.2015.189; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Handa A, 2000, J GEN VIROL, V81, P2077, DOI 10.1099/0022-1317-81-8-2077; Hinderer C, 2016, HUM GENE THER, V27, P906, DOI 10.1089/hum.2016.101; Hinderer C, 2016, MOL GENET METAB, V119, P124, DOI 10.1016/j.ymgme.2016.06.006; Hinderer C, 2014, MOL THER, V22, P2018, DOI 10.1038/mt.2014.135; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kamata Y, 2003, GENE THER, V10, P406, DOI 10.1038/sj.gt.3301869; Kanaji A, 2003, MOL THER, V8, P718, DOI 10.1016/j.ymthe.2003.07.004; Khan S, 2017, MOL GENET METAB, V120, P78, DOI 10.1016/j.ymgme.2016.11.007; Kitazawa T, 2017, TRANSPL P, V49, P4, DOI 10.1016/j.transproceed.2016.10.007; Kubaski F, 2017, BIOL BLOOD MARROW TR, V23, P1795, DOI 10.1016/j.bbmt.2017.06.020; Kurian KM, 2000, J CLIN PATHOL-MOL PA, V53, P173, DOI 10.1136/mp.53.4.173; Laoharawee K, 2017, HUM GENE THER, V28, P626, DOI 10.1089/hum.2016.184; Majhail NS, 2013, BONE MARROW TRANSPL, V48, P294, DOI 10.1038/bmt.2012.133; Manfredsson FP, 2009, MOL THER, V17, P403, DOI 10.1038/mt.2009.15; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Meadows AS, 2015, HUM GENE THER CL DEV, V26, P228, DOI 10.1089/humc.2015.132; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Motas S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86696; Murrey DA, 2014, HUM GENE THER CL DEV, V25, P72, DOI 10.1089/humc.2013.208; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Parks RJ, 2000, CLIN GENET, V58, P1, DOI 10.1034/j.1399-0004.2000.580101.x; Peters AHFM, 2001, MOL THER, V4, P603, DOI 10.1006/mthe.2001.0500; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; Ruzo A, 2012, HUM GENE THER, V23, P1237, DOI 10.1089/hum.2012.029; Ruzo A, 2012, MOL THER, V20, P254, DOI 10.1038/mt.2011.220; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Samaranch L, 2013, HUM GENE THER, V24, P526, DOI 10.1089/hum.2013.005; Sawamoto K, 2016, EXPERT OPIN ORPHAN D, V4, P941, DOI 10.1080/21678707.2016.1214572; Schuster DJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00042; Sferra TJ, 2000, HUM GENE THER, V11, P507, DOI 10.1089/10430340050015707; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Shi J, 2009, CURR OPIN MOL THER, V11, P547; Skorupa AF, 1999, EXP NEUROL, V160, P17, DOI 10.1006/exnr.1999.7176; Sorrentino NC, 2016, MOL THER, V24, P276, DOI 10.1038/mt.2015.212; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tardieu M, 2017, LANCET NEUROL, V16, P712, DOI 10.1016/S1474-4422(17)30169-2; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Tessitore A, 2008, MOL THER, V16, P30, DOI 10.1038/sj.mt.6300325; Tomatsu S, 2015, EXPERT OPIN ORPHAN D, V3, P1279, DOI 10.1517/21678707.2015.1086640; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65, DOI 10.2147/RRED.S37278; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Turbeville S, 2011, MOL GENET METAB, V102, P111, DOI 10.1016/j.ymgme.2010.09.010; Vance M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22131; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Wang JM, 2016, BIOL BLOOD MARROW TR, V22, P2104, DOI 10.1016/j.bbmt.2016.08.015; Willyard C, 2012, NAT MED, V18, P328, DOI 10.1038/nm0312-328; Winner LK, 2016, HUM GENE THER, V27, P363, DOI 10.1089/hum.2015.170; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Yabe H, 2016, MOL GENET METAB, V117, P84, DOI 10.1016/j.ymgme.2015.09.011; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	98	34	37	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2018	123	2					59	68		10.1016/j.ymgme.2017.12.434	http://dx.doi.org/10.1016/j.ymgme.2017.12.434			10	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	FW0EI	29295764	Green Accepted			2022-09-04	WOS:000424963800420
J	Camargo, ID; Nattero, J; Careaga, SA; Nunez-Farfan, J				Dario Camargo, Ivan; Nattero, Julieta; Careaga, Sonia A.; Nunez-Farfan, Juan			Flower-level developmental plasticity to nutrient availability in Datura stramonium: implications for the mating system	ANNALS OF BOTANY			English	Article						Datura stramonium; flower-level developmental reaction norms; nutrient availability; within-individual variation; herkogamy; population variation; probability of self; and cross-fertilized flowers; complete selfing; mating system; reproductive assurance	SELF-FERTILIZING WEED; PHENOTYPIC PLASTICITY; FLORAL TRAITS; GEOGRAPHICAL VARIATION; INBREEDING DEPRESSION; EVOLUTIONARY ECOLOGY; GENETIC-VARIATION; OUTCROSSING RATE; PLANT TOLERANCE; POLLINATION	Background and Aims Studies of phenotypic plasticity in plants have mainly focused on (1) the effect of environmental variation on whole-plant traits related to the number of modules rather than on (2) the phenotypic consequences of environmental variation in traits of individual modules. Since environmental and developmental factors can produce changes in traits related to the mating system, this study used the second approach to investigate whether within-individual variation in herkogamy-related traits is affected by the environment during plant development in two populations of Datura stramonium, an annual herb with a hypothesized persistent mixed mating system, and to determine which morphological traits may promote self-fertilization. Methods Full-sib families of two Mexican populations of D. stramonium, with contrasting ecological histories, were grown under low, mid and high nutrient availability to investigate the effects of genetic, environmental and within-plant flower position on flower size, corolla, stamen and pistil lengths, and herkogamy. Key Results Populations showed differences in familial variation, plasticity and familial differences in plasticity in most floral traits analysed. In one population (Ticuman), the effect of flower position on trait variation varied among families, whereas in the other (Pedregal) the effect of flower position interacted with the nutrient environment. Flower size varied with the position of flowers, but in the opposite direction between populations in low nutrients; a systematic within-plant trend of reduction in flower size, pistil length and herkogamy with flower position increased the probability of self-fertilization in the Pedregal population. Conclusions Besides genetic variation in floral traits between and within populations, environmental variation affects phenotypic floral trait values at the whole-plant level, as well as among flower positions. The interaction between flower position and nutrient environment can affect the plant's mating system, and this differs between populations. Thus, reductions in herkogamy with flower positions may be expected in environments with either low pollinator abundance or low nutrients.	[Dario Camargo, Ivan; Nunez-Farfan, Juan] Univ Nacl Autonoma Mexico, Lab Genet Ecol & Evoluc, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Dario Camargo, Ivan] Pontificia Univ Javeriana, Dept Ecol & Terr, Fac Estudios Ambientales & Rurales, Bogota 110231594, Colombia; [Nattero, Julieta] UBA, Inst Ecol Genet & Evoluc Buenos Aires, CONICET, EGE,FCEyN, C1428EGA, Buenos Aires, DF, Argentina; [Careaga, Sonia A.] CONABIO, Comis Nacl Conocimiento & Uso Biodiversidad, Mexico City 14010, DF, Mexico; [Nunez-Farfan, Juan] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA		Nunez-Farfan, J (corresponding author), Univ Nacl Autonoma Mexico, Lab Genet Ecol & Evoluc, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.; Nunez-Farfan, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	farfan@unam.mx	Núñez-Farfán, Juan/D-3379-2018	Camargo, Ivan/0000-0002-7305-2309	Harvard University; CONACyT; UNAM; Red de Macrouniversidades	Harvard University; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico); Red de Macrouniversidades	This paper is dedicated to the memory of Professor Fahkri A. Bazzaz. We thank Carl D. Schlichting, David Ackerly and Peter Wayne for valuable criticisms and insights. We extend our appreciation to Professor D. Levin and three anonymous reviewers for valuable comments to improve this manuscript. Financial support (J.N.-F.) was provided by Harvard University, CONACyT and UNAM. I.D.C. acknowledges the scholarship of CONACyT for doctoral studies at the Posgrado en Ciencias Biologicas UNAM, and J.N. was supported by a Scholarship from the Red de Macrouniversidades.	ALLARD RW, 1968, ADV GENET, V14, P55, DOI 10.1016/S0065-2660(08)60425-3; [Anonymous], 1978, TROPICAL TREES FORES; Armbruster WS, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P23; Baker RH, 2003, EVOLUTION, V57, P87; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; BARRETT SCH, 1992, J EVOLUTION BIOL, V5, P83, DOI 10.1046/j.1420-9101.1992.5010083.x; Barrett SCH, 2009, NEW PHYTOL, V183, P546, DOI 10.1111/j.1469-8137.2009.02937.x; Bissell EK, 2008, INT J PLANT SCI, V169, P225, DOI 10.1086/523875; Boyd A, 2000, SYSTEMATIC BOT, V27, P116; BRADSHAW AD, 1989, BIOL J LINN SOC, V37, P137, DOI 10.1111/j.1095-8312.1989.tb02099.x; BULL JJ, 1987, EVOLUTION, V41, P303, DOI 10.1111/j.1558-5646.1987.tb05799.x; Cano-Santana Z., 1996, CIENCIAS, V41, P58; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Cuevas E, 1996, THESIS; Darwin C., 1862, VARIOUS CONTRIVANCES; Darwin C., 1878, EFFECTS CROSS SELF F; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; Diggle PK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0253; Diggle PK, 1997, INT J PLANT SCI, V158, pS99, DOI 10.1086/297510; Diggle PK, 2003, REGNUM VEG, V141, P63; Dominguez CA, 1998, AM J BOT, V85, P637, DOI 10.2307/2446532; Elle E, 2004, PLANT ADAPTATION: MOLECULAR GENETICS AND ECOLOGY, P111; Elle E, 2002, FUNCT ECOL, V16, P79, DOI 10.1046/j.0269-8463.2001.00599.x; Engelmann KE, 2005, AM J BOT, V92, P101, DOI 10.3732/ajb.92.1.101; Fenster CB, 1997, INT J PLANT SCI, V158, pS121, DOI 10.1086/297512; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Fornoni J, 2000, EVOLUTION, V54, P789, DOI 10.1111/j.0014-3820.2000.tb00080.x; Fornoni J, 2003, EVOL ECOL RES, V5, P1049; Gianoli E, 2004, INT J PLANT SCI, V165, P825, DOI 10.1086/422050; Gonzalez AV, 2004, ACTA OECOL, V26, P185, DOI 10.1016/j.actao.2004.05.001; Goodspeed TH, 1915, AM J BOT, V2, P332, DOI 10.2307/2435145; Gorsuch R.L., 1983, FACTOR ANAL, V2nd ed.; GRANT V, 1983, BOT GAZ, V144, P280, DOI 10.1086/337374; Hair J. F, 1998, MULTIVARIATE DATA AN, V5th; Harman H.H, 1960, MODERN FACTOR ANAL; Herrera C. M, 2009, MULTIPLICITY UNITY P; Herrera CM, 2002, J EVOLUTION BIOL, V15, P108, DOI 10.1046/j.1420-9101.2002.00365.x; HOLTSFORD TP, 1992, EVOLUTION, V46, P216, DOI 10.1111/j.1558-5646.1992.tb01996.x; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; Johnson SD, 1997, BOT J LINN SOC, V123, P225, DOI 10.1006/bojl.1996.0082; Johnson SD, 1997, EVOLUTION, V51, P45, DOI [10.2307/2410959, 10.1111/j.1558-5646.1997.tb02387.x]; Kagaya M, 2009, AM J BOT, V96, P1808, DOI 10.3732/ajb.0800327; Kawamura K, 2010, ECOL RES, V25, P733, DOI 10.1007/s11284-009-0688-0; Kawasaki M. L., 1991, BRITTONIA, V43, P145, DOI [10.2307/2807042, DOI 10.2307/2807042]; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; LANDE R, 1985, EVOLUTION, V39, P24, DOI 10.1111/j.1558-5646.1985.tb04077.x; Levin DA, 2010, J ECOL, V98, P1276, DOI 10.1111/j.1365-2745.2010.01715.x; LEWIS OAM, 1978, NEW PHYTOL, V81, P519, DOI 10.1111/j.1469-8137.1978.tb01625.x; Lloyd D.G., 1992, EVOLUTION FUNCTION H, P179; LLOYD DG, 1984, BIOL J LINN SOC, V21, P357, DOI 10.1111/j.1095-8312.1984.tb01600.x; Marshall C, 1996, VEGETATIO, V127, P9, DOI 10.1007/BF00054842; Masco M, 2004, PLANT SYST EVOL, V244, P77, DOI 10.1007/s00606-003-0083-1; Moeller DA, 2005, EVOLUTION, V59, P786, DOI 10.1554/04-656; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; MOTTEN AF, 1992, AM J BOT, V79, P419, DOI 10.2307/2445154; Motten AF, 2000, AM J BOT, V87, P339, DOI 10.2307/2656629; Nattero J, 2007, BIOL J LINN SOC, V90, P657, DOI 10.1111/j.1095-8312.2007.00756.x; NUNEZFARFAN J, 1994, EVOLUTION, V48, P423, DOI [10.2307/2410102, 10.1111/j.1558-5646.1994.tb01321.x]; NunezFarfan J, 1996, AM J BOT, V83, P1041, DOI 10.2307/2445993; Perez F, 2007, J EVOLUTION BIOL, V20, P1730, DOI 10.1111/j.1420-9101.2007.01393.x; Pigliucci M, 1997, AM J BOT, V84, P887, DOI 10.2307/2446278; Pigliucci M, 1997, J ECOL, V85, P265, DOI 10.2307/2960500; PIGLIUCCI M, 1995, ECOLOGY, V76, P2134, DOI 10.2307/1941688; Pigliucci M, 2006, EVOL ECOL RES, V8, P415; Pigliucci M., 2001, SYN ECO EVO; PLATT SG, 1982, PLANT CELL PHYSIOL, V23, P917; Preston KA, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P80; RICK CM, 1978, PLANT SYST EVOL, V129, P31, DOI 10.1007/BF00988982; SCHLICHTING CD, 1984, AM J BOT, V71, P252, DOI 10.2307/2443753; Schmalhausen I, 1949, FACTORS EVOLUTION TH; SCHOEN DJ, 1982, EVOLUTION, V36, P352, DOI 10.1111/j.1558-5646.1982.tb05051.x; SHARMA M, 1972, Journal of Palynology, V8, P17; Sinnott EW, 1921, AM NAT, V55, P385, DOI 10.1086/279823; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stone JL, 2002, EVOLUTION, V56, P2187, DOI 10.1111/j.0014-3820.2002.tb00143.x; SULTAN SE, 1987, EVOL BIOL, V21, P127; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Vallejo-Marin M, 2009, ANN BOT-LONDON, V103, P951, DOI 10.1093/aob/mcp015; Valverde PL, 2001, J EVOLUTION BIOL, V14, P424, DOI 10.1046/j.1420-9101.2001.00295.x; Vogler DW, 1999, AM J BOT, V86, P482, DOI 10.2307/2656809; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; WEAVER SE, 1984, CAN J PLANT SCI, V64, P979, DOI 10.4141/cjps84-132; WEBB CJ, 1986, NEW ZEAL J BOT, V24, P163, DOI 10.1080/0028825X.1986.10409726; WELLS H, 1979, EVOLUTION, V33, P252, DOI 10.1111/j.1558-5646.1979.tb04679.x; WHITE J, 1979, ANNU REV ECOL SYST, V10, P109, DOI 10.1146/annurev.es.10.110179.000545; Winn AA, 1996, J EVOLUTION BIOL, V9, P737, DOI 10.1046/j.1420-9101.1996.9060737.x; YAHARA T, 1992, EVOLUTION, V46, P557, DOI 10.1111/j.1558-5646.1992.tb02059.x; Zhang XS, 2005, EVOLUTION, V59, P1237	92	9	9	2	32	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	OCT	2017	120	4					603	615		10.1093/aob/mcx093	http://dx.doi.org/10.1093/aob/mcx093			13	Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences	FK3QG	28981570	Green Published, Bronze			2022-09-04	WOS:000413400400015
J	Floegel, TA; Florez-Pregonero, A; Hekler, EB; Buman, MP				Floegel, Theresa A.; Florez-Pregonero, Alberto; Hekler, Eric B.; Buman, Matthew P.			Validation of Consumer-Based Hip and Wrist Activity Monitors in Older Adults With Varied Ambulatory Abilities	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Physical activity; Exercise; Pedometer; Accelerometer; Accuracy	PHYSICAL-ACTIVITY; ACTIVITY TRACKERS; ACCELEROMETER; DISABILITY; EXERCISE; MOBILITY	Background: The accuracy of step detection in consumer-based wearable activity monitors in older adults with varied ambulatory abilities is not known. Methods: We assessed the validity of two hip-worn (Fitbit One and Omron HJ-112) and two wrist-worn (Fitbit Flex and Jawbone UP) activity monitors in 99 older adults of varying ambulatory abilities and also included the validity results from the ankle-worn StepWatch as a comparison device. Nonimpaired, impaired (Short Physical Performance Battery Score < 9), cane-using, or walker-using older adults (62 and older) ambulated at a self-selected pace for 100 m wearing all activity monitors simultaneously. The criterion measure was directly observed steps. Intraclass correlation coefficients (ICC), mean percent error and mean absolute percent error, equivalency, and Bland-Altman plots were used to assess accuracy. Results: Nonimpaired adults steps were underestimated by 4.4% for StepWatch (ICC = 0.87), 2.6% for Fitbit One (ICC = 0.80), 4.5% for Omron HJ-112 (ICC = 0.72), 26.9% for Fitbit Flex (ICC = 0.15), and 2.9% for Jawbone UP (ICC = 0.55). Impaired adults steps were underestimated by 3.5% for StepWatch (ICC = 0.91), 1.7% for Fitbit One (ICC = 0.96), 3.2% for Omron HJ-112 (ICC = 0.89), 16.3% for Fitbit Flex (ICC = 0.25), and 8.4% for Jawbone UP (ICC = 0.50). Cane-user and walker-user steps were underestimated by StepWatch by 1.8% (ICC = 0.98) and 1.3% (ICC = 0.99), respectively, where all other monitors underestimated steps by > 11.5% (ICCs < 0.05). Conclusions: StepWatch, Omron HJ-112, Fitbit One, and Jawbone UP appeared accurate at measuring steps in older adults with nonimpaired and impaired ambulation during a self-paced walking test. StepWatch also appeared accurate at measuring steps in cane-users.	[Floegel, Theresa A.] Univ North Carolina Chapel Hill, Sch Nursing, Chapel Hill, NC USA; [Floegel, Theresa A.; Florez-Pregonero, Alberto; Hekler, Eric B.; Buman, Matthew P.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Florez-Pregonero, Alberto] Pontificia Univ Javeriana, Dept Formac, Bogota, Colombia		Buman, MP (corresponding author), Coll Hlth Solut, Sch Nutr & Hlth Promot, 500 North 3rd St, Phoenix, AZ 85004 USA.	matthew.buman@asu.edu	Buman, Matthew/AAJ-4447-2020; Flórez-Pregonero, Alberto/C-8804-2012	Buman, Matthew/0000-0002-5130-3162; Flórez-Pregonero, Alberto/0000-0003-1907-3173	Aliphcom; National Institutes of Nursing Research Grant T32 Interventions for Preventing and Managing Chronic Illness [5T32NR007091]; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR007091] Funding Source: NIH RePORTER	Aliphcom; National Institutes of Nursing Research Grant T32 Interventions for Preventing and Managing Chronic Illness; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported in part by Aliphcom, and data were collected as a subset of a larger study. Aliphcom is the parent company of Jawbone and did not have any input in the study design, analysis, or interpretation of data. Manuscript development was supported by the National Institutes of Nursing Research Grant T32 Interventions for Preventing and Managing Chronic Illness (5T32NR007091).	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Farren L, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150027; Gill TM, 2006, J AM GERIATR SOC, V54, P248, DOI 10.1111/j.1532-5415.2005.00586.x; Gillison FB, 2009, SOC SCI MED, V68, P1700, DOI 10.1016/j.socscimed.2009.02.028; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hart TL, 2011, RES Q EXERCISE SPORT, V82, P600, DOI 10.1080/02701367.2011.10599796; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Kelley GA, 2009, J APPL GERONTOL, V28, P369, DOI 10.1177/0733464808327456; Koizumi D, 2009, J PHYS ACT HEALTH, V6, P467, DOI 10.1123/jpah.6.4.467; Lauritzen J, 2013, STUD HEALTH TECHNOL, V192, P759, DOI 10.3233/978-1-61499-289-9-759; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; O'Brien T, 2015, GERIATR NURS, V36, pS21, DOI 10.1016/j.gerinurse.2015.02.019; Preusse K., 2016, J APPL GERONTOL, P1; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Storm FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118723; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tucker WJ, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0008-7; Tudor-Locke C, 2013, J GERONTOL A-BIOL, V68, P1426, DOI 10.1093/gerona/glt116; Valenti G, 2014, INT J OBESITY, V38, P1011, DOI 10.1038/ijo.2013.195	21	56	57	0	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	FEB	2017	72	2					229	236		10.1093/gerona/glw098	http://dx.doi.org/10.1093/gerona/glw098			8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	EP2EC	27257217	Bronze, Green Published			2022-09-04	WOS:000397194800011
J	Lucas, M; Forero, D; Basset, Y				Lucas, Maxime; Forero, Dimitri; Basset, Yves			Diversity and recent population trends of assassin bugs (Hemiptera: Reduviidae) on Barro Colorado Island, Panama	INSECT CONSERVATION AND DIVERSITY			English	Article						Assassin bug; light trap; monitoring; Panstrongylus geniculatus; predation; rainfall; temperature; Triatominae	BIODIVERSITY LOSS; RAIN-FORESTS; ASSEMBLAGES; ABUNDANCE; IMPACTS	1. In tropical rainforests, most assassin bugs (Hemiptera: Reduviidae) represent important predators preying on other arthropods. Apart from the hematophagous Triatominae of medical importance, Reduviidae remain poorly known. 2. Here, we address the importance of Reduviidae for long-term monitoring of secondary consumers in tropical rainforests, using data from Barro Colorado Island (BCI), Panama. First, we demonstrate that light traps allow catching a wide and representative diversity of Reduviidae, and are more efficient than other collection methods tested. 3. Second, we present one of the very first checklists of Reduviidae for a tropical locality, including 118 species. These baseline data will be necessary for interpreting any long-term changes in reduviid populations on BCI. 4. Last, we show that the low abundance of Reduviidae collected at light remains challenging for statistical analyses of long-term population trends. During a 7-year period (2009-2015), we observed no significant changes in the short-term population dynamics of most reduviid taxa, although these results do not account for the complexity of the intra-annual population dynamics of each species. In particular, the population of the rather abundant Panstrongylus geniculatus, which is a known vector of Chagas' disease, appears to be fluctuating but so far is stable. 5. Daily maximum temperature and rainfall were negatively correlated with the overall abundance of Reduviidae during light traps surveys. During the past 25 years, global warming has induced significant increases in annual temperature and rainfall in Panama. Therefore, we conclude that reduviid populations on BCI may be vulnerable in the future to these global effects.	[Lucas, Maxime] AgroParisTech, Gest Environm Ecosyst & Forets Trop, 648,Rue Jean Francois Breton,BP 7355, F-34086 Montpellier 4, France; [Forero, Dimitri] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, UNESIS, Bogota, Colombia; [Basset, Yves] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Basset, Yves] Univ Panama, Maestria Entomol, Panama City, Panama; [Basset, Yves] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic		Lucas, M (corresponding author), AgroParisTech, Gest Environm Ecosyst & Forets Trop, 648,Rue Jean Francois Breton,BP 7355, F-34086 Montpellier 4, France.	max.lucasdc@gmail.com	Forero, Dimitri/P-4860-2016; Basset, Yves F/B-6642-2014	Forero, Dimitri/0000-0002-6358-757X; Basset, Yves F/0000-0002-1942-5717	Czech Science Foundation GACR grant [14-36098G]	Czech Science Foundation GACR grant	We thank Hector Barrios and Donald Windsor for granting us access to their Malaise trap data. Grants from the Smithsonian Institution Barcoding Opportunity FY012 and FY013 and in-kind help from the Canadian Centre for DNA Barcoding via Paul Hebert and Alex Borisenko at the Biodiversity Institute of Ontario allowed to sequence many of reduviid specimens collected recently on BCI. YB was supported by Czech Science Foundation GACR grant 14-36098G and is a member of the Sistema Nacional de Investigacion, SENACYT, Panama.	Abad-Franch F, 2000, T ROY SOC TROP MED H, V94, P629, DOI 10.1016/S0035-9203(00)90213-X; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; [Anonymous], 2004, TROPICAL FOREST DIVE; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136623; Basset Y, 2013, INSECT CONSERV DIVER, V6, P223, DOI 10.1111/j.1752-4598.2012.00205.x; Bestelmeyer Brandon T., 2000, P122; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castro-Huertas A.V., 2010, THESIS; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Colwell R.K, 2013, ESTIMATES VERSION 9; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dornelas M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1931; Dougherty V, 1995, T AM ENTOMOL SOC, V121, P173; Fairchild G. B., 1943, AMER JOUR TROP MED, V23, P569; Froeschner R.C., 1999, TRUE BUGS HETEROPTE; Gil-Santana HR, 2015, ENTOMOL FOCUS, V2, P307, DOI 10.1007/978-94-017-9861-7_12; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Grotan V, 2012, J ANIM ECOL, V81, P714, DOI 10.1111/j.1365-2656.2011.01950.x; Guilbert E, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2157.1.2; Hawking JH, 2002, J INSECT CONSERV, V6, P171, DOI 10.1023/A:1023231325756; HODKINSON ID, 1991, BIOL J LINN SOC, V43, P101, DOI 10.1111/j.1095-8312.1991.tb00587.x; HOOD WG, 1990, PHYSIOL ENTOMOL, V15, P23, DOI 10.1111/j.1365-3032.1990.tb00489.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hwang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045523; Kaspari M, 2001, ECOL ENTOMOL, V26, P245, DOI 10.1046/j.1365-2311.2001.00320.x; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kitching RL, 2001, BIODIVERS CONSERV, V10, P793, DOI 10.1023/A:1016627220773; Kuria SK, 2010, AFR ENTOMOL, V18, P87, DOI 10.4001/003.018.0109; Leidner AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009534; Leigh Jr E. G, 1999, TROPICAL FOREST ECOL; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Magurran AE., 2004, MEASURING BIOL DIVER; MILLER N. C. E., 1953, TRANS ZOOL SOC LONDON, V27, P541; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542695; Oksanen J., 2009, THE VEGAN PACKAGE; Pannekoek J., 2005, TRIM 3 MANUAL TRENDS; Pellegrino A. C., 2013, PLOS ONE, V8, P1; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Sahayaraj K., 2007, PEST CONTROL MECH RE; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Srygley RB, 2014, BIOTROPICA, V46, P90, DOI 10.1111/btp.12081; Stocker T. F., 2013, WORKING GROUP 1 CONT, V1535; STORK NE, 1991, J TROP ECOL, V7, P161, DOI 10.1017/S0266467400005319; TANAKA LK, 1982, BIOTROPICA, V14, P114, DOI 10.2307/2387740; ter Braak CJF, 1998, CANOCO RELEASE 4 REF; TOWNES H, 1972, Entomological News, V83, P239; Valente VC, 1998, J MED ENTOMOL, V35, P99, DOI 10.1093/jmedent/35.2.99; van Doesburg P.H., 2012, ZOOLOGISCHE MEDEDELI, V86, P516; Weirauch C., 2014, Canadian Journal of Arthropod Identification, V26, P1; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Windsor D.M., 1990, CLIMATE MOISTURE VAR; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	60	8	9	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-458X	1752-4598		INSECT CONSERV DIVER	Insect. Conserv. Divers.	NOV	2016	9	6					546	558		10.1111/icad.12191	http://dx.doi.org/10.1111/icad.12191			13	Biodiversity Conservation; Entomology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Entomology	EA1MC					2022-09-04	WOS:000386355400007
J	Plata, M; Zuluaga, L; Santander, J; Salazar, M; Castano, JC; Benavides-Martinez, JA; Garzon, DL; Schlesinger, R; Serrano, B; Echeverry, M; Silva, JM; Varela, D; Carvajal, A; Azuero, J				Plata, Mauricio; Zuluaga, Laura; Santander, Jessica; Salazar, Milton; Castano, Juan Carlos; Benavides-Martinez, Johana A.; Garzon, Diana L.; Schlesinger, Ricardo; Serrano, Brigitte; Echeverry, Mariana; Silva, Jose M.; Varela, Daniela; Carvajal, Alejandro; Azuero, Julian			Performance of the artificial urinary sphincter implantation in men with urinary incontinence: Results from a contemporary long-term real-world nationwide analysis	NEUROUROLOGY AND URODYNAMICS			English	Article						artificial urinary sphincter; extrusion; patients reported outcomes; urinary incontinence	OF-LIFE OUTCOMES; FUNCTIONAL OUTCOMES; DEVICE SURVIVAL; DURABILITY; EFFICACY; PATIENT	Purpose The artificial urinary sphincter (AUS) is one of the most effective surgical treatments for male urinary incontinence regardless of its severity. Current knowledge comes from high-volume centers, but little is known about the performance of this surgery from community practices. This study aims to report contemporary AUS performance in a nationwide observational study in Colombia. Methods Male patients who underwent AUS surgery with AMS 800 (TM) between 2000 and 2020 in more than 17 centers and four cities were identified. Pre, intra, and postoperative characteristics were evaluated, mainly addressing patient reported outcomes measurements in the postoperative period. Retrospective and prospective data collection and descriptive analysis were completed. Kaplan-Meier analysis was used to determine AUS survival rate. Results Out of an initial 667 cases, a total of 215 patients met inclusion and exclusion criteria and were included. Mean age was 67 +/- 9.4 years, and mean follow-up was 6.0 +/- 4.4 years with maximum range of 14 years. The etiology of urinary incontinence was prostate cancer surgery in 141 (81%) of the cases. The rest of the cases were related to benign prostatic disease or spinal cord injury. It is noteworthy that out of 115 patients, only 59 (51.3%) reported previous formal pelvic floor rehabilitation. Subjective severity of urinary incontinence determined by a visual analog scale showed a decrease in 4.5 points after sphincter implantation. Sphincter removal was required in 50 (23.2%) cases. The main reasons for implant removal were urethral erosion and infection. The sphincter survival rate at 2, 5, 8, 10, and 14 years was 76%, 70%, 60%, 57%, and 17%, respectively. Of the subjects at the last follow-up with the device still in place, 80.7% defined their urinary condition as "does not cause or causes minor discomfort," and 99% would recommend the device to a friend or relative in the same condition. Conclusions This series from a community-based practice shows the lack of adherence to clinical practice guidelines and the lack of standardized data collection. In contrast, this study provides real-world data on explantation and revision rates, allows physicians to inform patients and to have clear metrics for a shared decision-making process before the procedure.	[Plata, Mauricio; Zuluaga, Laura; Santander, Jessica; Azuero, Julian] Hosp Univ Fdn Santa Fe Bogota, Dept Urol, Carrera 7 118 09,Piso 3, Bogota 110111, Colombia; [Plata, Mauricio; Zuluaga, Laura; Santander, Jessica; Azuero, Julian] Univ los Andes, Sch Med, Bogota 110111, Colombia; [Salazar, Milton; Garzon, Diana L.] Clin FOSCAL, Dept Urol, Bucaramanga, Colombia; [Castano, Juan Carlos; Benavides-Martinez, Johana A.; Carvajal, Alejandro] Clin CES, Dept Urol, Medellin, Colombia; [Schlesinger, Ricardo; Echeverry, Mariana] Hosp Mil Cent, Dept Urol, Bogota, Colombia; [Serrano, Brigitte] Clin Marly, Dept Urol, Bogota, Colombia; [Silva, Jose M.; Varela, Daniela] Pontificia Univ Javeriana, Sch Med, Hosp Univ San Ignacio, Dept Urol, Bogota, Colombia		Plata, M (corresponding author), Hosp Univ Fdn Santa Fe Bogota, Dept Urol, Carrera 7 118 09,Piso 3, Bogota 110111, Colombia.; Plata, M (corresponding author), Univ los Andes, Sch Med, Bogota 110111, Colombia.; Plata, M (corresponding author), Univ los Andes, Sch Med, Unidad Renal, Clin Urol,Fdn Santa Fe Bogota, Carrera 7 118 09,Piso 3, Bogota 110111, Colombia.	mplata@uniandes.edu.co			Boston Scientific Corporation	Boston Scientific Corporation(Boston Scientific)	Boston Scientific Corporation	Biardeau X, 2016, NEUROUROL URODYNAM, V35, pS5, DOI 10.1002/nau.23001; Boswell TC, 2020, TRANSL ANDROL UROL, V9, P56, DOI 10.21037/tau.2019.08.02; Dalkin BL, 2003, J UROLOGY, V169, P237, DOI 10.1016/S0022-5347(05)64076-1; Gousse AE, 2001, J UROLOGY, V166, P1755, DOI 10.1016/S0022-5347(05)65668-6; Gulpinar O, 2013, KOREAN J UROL, V54, P373, DOI 10.4111/kju.2013.54.6.373; Hussain M, 2005, J UROLOGY, V174, P418, DOI 10.1097/01.ju.0000165345.11199.98; Kim SP, 2008, J UROLOGY, V179, P1912, DOI 10.1016/j.juro.2008.01.048; Klovning A., 2010, VALIDATIONS RES METH; Kretschmer A, 2017, EUR UROL FOCUS, V3, P364, DOI 10.1016/j.euf.2017.11.007; Leon P, 2015, BJU INT, V115, P951, DOI 10.1111/bju.12848; MacDonald S, 2017, UROLOGY, V108, P175, DOI 10.1016/j.urology.2017.04.055; Myles PS, 2017, BRIT J ANAESTH, V118, P424, DOI 10.1093/bja/aew466; O'connor RC, 2008, UROLOGY, V71, P90, DOI 10.1016/j.urology.2007.08.017; Queissert F, 2020, NEUROUROL URODYNAM, V39, P1856, DOI 10.1002/nau.24444; Queissert F, 2019, INT NEUROUROL J, V23, P219, DOI 10.5213/inj.1938032.016; Rocha FT, 2008, UROLOGY, V71, P85, DOI 10.1016/j.urology.2007.09.009; Sandhu JS, 2019, J UROLOGY, V202, P369, DOI 10.1097/JU.0000000000000314; Sandhu JS, 2011, EUR UROL, V60, P1285, DOI 10.1016/j.eururo.2011.05.048; SCOTT FB, 1974, J UROLOGY, V112, P75, DOI 10.1016/S0022-5347(17)59647-0; Thuroff JW, 2011, EUR UROL, V59, P387, DOI 10.1016/j.eururo.2010.11.021; Van der Aa F, 2013, EUR UROL, V63, P681, DOI 10.1016/j.eururo.2012.11.034; Walsh IK, 2002, BJU INT, V89, P364, DOI 10.1046/j.1464-4096.2001.01759.x; Yafi FA, 2017, J UROLOGY, V197, P759, DOI 10.1016/j.juro.2016.08.107	23	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	SEP	2022	41	7					1573	1581		10.1002/nau.25002	http://dx.doi.org/10.1002/nau.25002		JUL 2022	9	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	3Z2DR	35866192				2022-09-04	WOS:000829812300001
J	Castellanos, DB; Martin-Jimenez, CA; Pinzon, A; Barreto, GE; Padilla-Gonzalez, GF; Aristizabal, A; Zuluaga, M; Santos, JG				Baez Castellanos, Daniel; Martin-Jimenez, Cynthia A.; Pinzon, Andres; Barreto, George E.; Federico Padilla-Gonzalez, Guillermo; Aristizabal, Andres; Zuluaga, Martha; Gonzalez Santos, Janneth			Metabolomic Analysis of Human Astrocytes in Lipotoxic Condition: Potential Biomarker Identification by Machine Learning Modeling	BIOMOLECULES			English	Article						astrocytes; lipotoxicity; neurodegenerative diseases; obesity; metabolomics	ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; PALMITATE; CELLS; NEURODEGENERATION; PATHOGENESIS; RESISTANCE; OXIDATION; GLUTAMINE; APOPTOSIS	The association between neurodegenerative diseases (NDs) and obesity has been well studied in recent years. Obesity is a syndrome of multifactorial etiology characterized by an excessive accumulation and release of fatty acids (FA) in adipose and non-adipose tissue. An excess of FA generates a metabolic condition known as lipotoxicity, which triggers pathological cellular and molecular responses, causing dysregulation of homeostasis and a decrease in cell viability. This condition is a hallmark of NDs, and astrocytes are particularly sensitive to it, given their crucial role in energy production and oxidative stress management in the brain. However, analyzing cellular mechanisms associated with these conditions represents a challenge. In this regard, metabolomics is an approach that allows biochemical analysis from the comprehensive perspective of cell physiology. This technique allows cellular metabolic profiles to be determined in different biological contexts, such as those of NDs and specific metabolic insults, including lipotoxicity. Since data provided by metabolomics can be complex and difficult to interpret, alternative data analysis techniques such as machine learning (ML) have grown exponentially in areas related to omics data. Here, we developed an ML model yielding a 93% area under the receiving operating characteristic (ROC) curve, with sensibility and specificity values of 80% and 93%, respectively. This study aimed to analyze the metabolomic profiles of human astrocytes under lipotoxic conditions to provide powerful insights, such as potential biomarkers for scenarios of lipotoxicity induced by palmitic acid (PA). In this work, we propose that dysregulation in seleno-amino acid metabolism, urea cycle, and glutamate metabolism pathways are major triggers in astrocyte lipotoxic scenarios, while increased metabolites such as alanine, adenosine, and glutamate are suggested as potential biomarkers, which, to our knowledge, have not been identified in human astrocytes and are proposed as candidates for further research and validation.	[Baez Castellanos, Daniel; Aristizabal, Andres; Gonzalez Santos, Janneth] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110311, Colombia; [Martin-Jimenez, Cynthia A.] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30329 USA; [Pinzon, Andres] Univ Nacl Colombia, Lab Bioinformat & Biol Sistemas, Bogota 111321, Colombia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick V94 T9PX, Ireland; [Federico Padilla-Gonzalez, Guillermo] Royal Bot Gardens, London TW9 3AE, England; [Zuluaga, Martha] Univ Nacl Abierta & Distancia, Escuela Ciencias Basicas Tecnol & Ingenierias, Dosquebradas 661001, Colombia		Santos, JG (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110311, Colombia.	baez.daniel@javeriana.edu.co; cmart51@emory.edu; ampinzonv@unal.edu.co; george.barreto@ul.ie; federicopg@gmail.com; andres_aristizabal@javeriana.edu.co; martha.zuluaga@unad.edu.co; janneth.gonzalez@javeriana.edu.co	; Aristizabal-Pachon, Andres Felipe/J-3046-2015	Zuluaga, Martha/0000-0003-1720-8476; Aristizabal-Pachon, Andres Felipe/0000-0003-3004-4867	Pontificia Universidad Javeriana (Bogota, Colombia); Ministerio de Ciencia Tecnologia e Innovacion (MINCIENCIAS) [20304, 9307, 8845]	Pontificia Universidad Javeriana (Bogota, Colombia); Ministerio de Ciencia Tecnologia e Innovacion (MINCIENCIAS)	This research was funded by Pontificia Universidad Javeriana (Bogota, Colombia) and Ministerio de Ciencia Tecnologia e Innovacion (MINCIENCIAS), grant numbers 20304, 9307, and 8845 to J.G.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004; [Anonymous], WHO OBESITY OVERWEIG; Azizi SA, 2013, METHODS MOL BIOL, V1078, P89, DOI 10.1007/978-1-62703-640-5_8; Castellanos DB, 2021, FRONT NEUROENDOCRIN, V61, DOI 10.1016/j.yfrne.2021.100899; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Burkov A., 2019, 100 PAGE MACHINE LEA; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Cho H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-9; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; de Zwaan M, 2002, OBES RES, V10, P1143, DOI 10.1038/oby.2002.155; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; GRAY CW, 1995, BRAIN RES, V691, P169, DOI 10.1016/0006-8993(95)00669-H; Gropman AL, 2007, J INHERIT METAB DIS, V30, P865, DOI 10.1007/s10545-007-0709-5; Guillamon-Vivancos T, 2015, NEUROLOGIA, V30, P119, DOI 10.1016/j.nrl.2012.12.007; Haffar T, 2016, CELL PHYSIOL BIOCHEM, V40, P969, DOI 10.1159/000453154; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Hines DJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0594; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Jones OAH, 2014, METABOLOMICS AND SYSTEMS BIOLOGY IN HUMAN HEALTH AND MEDICINE, P1, DOI 10.1079/9781780642000.0000; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kien CL, 2005, AM J CLIN NUTR, V82, P320, DOI 10.1093/ajcn/82.2.320; Kim AY, 2019, NEUROCHEM RES, V44, P147, DOI 10.1007/s11064-018-2467-1; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Lammerhofer M., 2013, METABOLOMICS PRACTIC; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Manzoni AG, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106217; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Osorio D, 2020, FRONT NEUROSCI-SWITZ, V13, P1410, DOI 10.3389/fnins.2019.01410; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Pioro EP, 1999, NEUROLOGY, V53, P71, DOI 10.1212/WNL.53.1.71; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stegman LD, 1998, HUM GENE THER, V9, P185, DOI 10.1089/hum.1998.9.2-185; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P134, DOI 10.1016/S0753-3322(03)00035-0; Trepanier G, 1996, NEUROSCIENCE, V75, P231, DOI 10.1016/0306-4522(96)00222-9; Trezzi JP, 2017, MOVEMENT DISORD, V32, P1401, DOI 10.1002/mds.27132; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Waagepetersen HS, 2000, J NEUROCHEM, V75, P471, DOI 10.1046/j.1471-4159.2000.0750471.x; Weckwerth W., 2007, METABOLOMICS METHODS; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhao CG, 2015, J PHARMACEUT BIOMED, V115, P48, DOI 10.1016/j.jpba.2015.06.028	68	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	JUL	2022	12	7							986	10.3390/biom12070986	http://dx.doi.org/10.3390/biom12070986			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3J3FM	35883542	Green Published, gold			2022-09-04	WOS:000833284300001
J	Hernandez-Fernandez, J; Pinzon-Velasco, A; Lopez, EA; Rodriguez-Becerra, P; Marino-Ramirez, L				Hernandez-Fernandez, Javier; Pinzon-Velasco, Andres; Anne Lopez, Ellie; Rodriguez-Becerra, Pilar; Marino-Ramirez, Leonardo			Transcriptional Analyses of Acute Exposure to Methylmercury on Erythrocytes of Loggerhead Sea Turtle	TOXICS			English	Article						Caretta caretta; RNA-seq; differential expression; methylmercury; transcriptomics		To understand changes in enzyme activity and gene expression as biomarkers of exposure to methylmercury, we exposed loggerhead turtle erythrocytes (RBCs) to concentrations of 0, 1, and 5 mg L-1 of MeHg and de novo transcriptome were assembled using RNA-seq. The analysis of differentially expressed genes (DEGs) indicated that 79 unique genes were dysregulated (39 upregulated and 44 downregulated genes). The results showed that MeHg altered gene expression patterns as a response to the cellular stress produced, reflected in cell cycle regulation, lysosomal activity, autophagy, calcium regulation, mitochondrial regulation, apoptosis, and regulation of transcription and translation. The analysis of DEGs showed a low response of the antioxidant machinery to MeHg, evidenced by the fact that genes of early response to oxidative stress were not dysregulated. The RBCs maintained a constitutive expression of proteins that represented a good part of the defense against reactive oxygen species (ROS) induced by MeHg.	[Hernandez-Fernandez, Javier; Rodriguez-Becerra, Pilar] Jorge Tadeo Lozano Univ, Fac Sci & Engn, Genet Mol Biol & Bioinformat Res Grp GENBIMOL, Marine Biol Program,Dept Nat & Environm Sci, Cra 4 22-61, Bogota 110311, Colombia; [Hernandez-Fernandez, Javier] Pontificia Univ Javeriana, Fac Sci, Dept Biol, Calle 45,Cra 7, Bogota 110231, Colombia; [Pinzon-Velasco, Andres] Univ Nacl Colombia, Bioinformat & Biol Sistemas, Calle 45,Cra 30, Bogota 111321, Colombia; [Anne Lopez, Ellie] Sergio Arboleda Univ, Inst Environm Studies & Serv, IDEASA Res Grp Environm & Sustainabil, Bogota 111711, Colombia; [Marino-Ramirez, Leonardo] NLM, NCBI, NIH, Computat Biol Branch, Bldg 38A,Room 6S614M 8600 Rockville Pike,MSC 6075, Bethesda, MD 20894 USA		Hernandez-Fernandez, J (corresponding author), Jorge Tadeo Lozano Univ, Fac Sci & Engn, Genet Mol Biol & Bioinformat Res Grp GENBIMOL, Marine Biol Program,Dept Nat & Environm Sci, Cra 4 22-61, Bogota 110311, Colombia.; Hernandez-Fernandez, J (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Biol, Calle 45,Cra 7, Bogota 110231, Colombia.	javier.hernandez@utadeo.edu.co; ampinzonv@unal.edu.co; ellie.lopez@usa.edu.co; mariad.rodriguezb@utadeo.edu.co; marino@ncbi.nlm.nih.gov	; Marino-Ramirez, Leonardo/I-5759-2013	Lopez, Ellie/0000-0002-4195-6354; Hernandez Fernandez, Javier Adolfo/0000-0001-8442-9266; Rodriguez Becerra, Maria del Pilar/0000-0003-3843-1490; Pinzon, Andres/0000-0002-4133-810X; Marino-Ramirez, Leonardo/0000-0002-5716-8512	Office of Research, Creation, and Innovation of the Universidad Jorge Tadeo Lozano [340-07-10]; Intramural Research Program of the United States National Institutes of Health (NIH), National Library of Medicine (NLM), National Center for Biotechnology Information (NCBI) [ZIA LM082713-06]	Office of Research, Creation, and Innovation of the Universidad Jorge Tadeo Lozano; Intramural Research Program of the United States National Institutes of Health (NIH), National Library of Medicine (NLM), National Center for Biotechnology Information (NCBI)	This work was supported by the Office of Research, Creation, and Innovation of the Universidad Jorge Tadeo Lozano (340-07-10). This research was supported in part by the Intramural Research Program of the United States National Institutes of Health (NIH), National Library of Medicine (NLM), National Center for Biotechnology Information (NCBI) ZIA LM082713-06.	Ackermann A., 2019, INT J ONCOL, V2019, P1; Ajsuvakova OP, 2020, COORDIN CHEM REV, V417, DOI 10.1016/j.ccr.2020.213343; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin Shorash, 2014, BMC Research Notes, V7, P488, DOI 10.1186/1756-0500-7-488; Ancora S, 2002, ARCH ENVIRON CON TOX, V42, P348, DOI 10.1007/s00244-001-0005-6; Andrews S., 2018, FASTQC QUALITY CONTR; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; ATCHISON WD, 1994, FASEB J, V8, P622, DOI 10.1096/fasebj.8.9.7516300; BALLA G, 1992, J BIOL CHEM, V267, P18148; Bhattacharya R, 2004, MOL BIOL CELL, V15, P3123, DOI 10.1091/mbc.E04-01-0060; Bohn J., 2021, G3 BETHESDA, V11, P1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bridges CC, 2017, ARCH TOXICOL, V91, P63, DOI 10.1007/s00204-016-1803-y; Burger J, 2004, ENVIRON RES, V96, P239, DOI 10.1016/j.envres.2003.12.001; Cairns, 2003, HDB ECOTOXICOLOGY; Chang SH, 2013, J TOXICOL SCI, V38, P823; Chatterjee S, 2014, TOXICOL IND HEALTH, V30, P611, DOI 10.1177/0748233712462442; Chen N, 2019, J INORG BIOCHEM, V190, P67, DOI 10.1016/j.jinorgbio.2018.10.007; Cherok E, 2017, MOL BIOL CELL, V28, P396, DOI 10.1091/mbc.E16-04-0208; Chowdhury D, 2019, CELL STRESS CHAPERON, V24, P393, DOI 10.1007/s12192-019-00974-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Dare E, 2001, FREE RADICAL BIO MED, V30, P1347, DOI 10.1016/S0891-5849(01)00526-3; Davies AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06172-7; Day RD, 2007, ENVIRON HEALTH PERSP, V115, P1421, DOI 10.1289/ehp.9918; Dohmen E, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-1591-0; dos Santos AA, 2018, TOXICS, V6, DOI 10.3390/toxics6030047; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; ERIKSSON P, 1995, MOL MICROBIOL, V17, P95, DOI 10.1111/j.1365-2958.1995.mmi_17010095.x; FACEMIRE C, 1995, WATER AIR SOIL POLL, V80, P923, DOI 10.1007/BF01189745; Fang YT, 2016, ARCH TOXICOL, V90, P333, DOI 10.1007/s00204-014-1425-1; Fernandez A, 2007, MAR POLLUT BULL, V54, P1681, DOI 10.1016/j.marpolbul.2007.08.007; Ferrelli F, 2015, ACTA DIABETOL, V52, P55, DOI 10.1007/s00592-014-0600-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finlayson KA, 2020, SCI TOTAL ENVIRON, V747, DOI 10.1016/j.scitotenv.2020.142095; Finlayson KA, 2019, SCI TOTAL ENVIRON, V664, P958, DOI 10.1016/j.scitotenv.2019.02.052; Finlayson KA, 2016, ENVIRON INT, V94, P113, DOI 10.1016/j.envint.2016.05.013; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Gadhia SR, 2012, TOXICOL LETT, V212, P169, DOI 10.1016/j.toxlet.2012.05.013; Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058; Gardner SC, 2006, N P TOX ENV, P1; Gaudet M, 2011, TREE PHYSIOL, V31, P1309, DOI 10.1093/treephys/tpr088; Grab Jessica, 2019, Microbiol Insights, V12, p1178636119864594, DOI 10.1177/1178636119864594; Grillitsch B, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P337, DOI 10.1201/EBK1420064162-c12; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guisande C, 2014, RWIZARD SOFTWARE; Gytz H, 2019, FEBS J, V286, P1319, DOI 10.1111/febs.14731; Haas B.J., 2019, TRANSDECODER 550; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartung T, 2017, CHEM RES TOXICOL, V30, P870, DOI 10.1021/acs.chemrestox.7b00003; He F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134777; Henny CJ, 2002, ECOTOXICOLOGY, V11, P213, DOI 10.1023/A:1016327602656; Hernandez-Fernandez J, 2020, APPL SCI-BASEL, V10, pNIL_5151, DOI 10.3390/app10103602; Hou YQ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0356; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Jeong KH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020556; Jin X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06718-7; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kemena C, 2019, NUCLEIC ACIDS RES, V47, pW507, DOI 10.1093/nar/gkz366; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Kumar A, 2013, PROTOPLASMA, V250, P965, DOI 10.1007/s00709-013-0488-9; Lamming DW, 2019, TRAFFIC, V20, P27, DOI 10.1111/tra.12617; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YJ, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020182; Ley-Quinonez C, 2011, MAR POLLUT BULL, V62, P1979, DOI 10.1016/j.marpolbul.2011.06.022; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao EC, 2000, DEVELOPMENT, V127, P5123; Liu Q, 2013, ECOTOXICOLOGY, V22, P740, DOI 10.1007/s10646-013-1066-9; Love M., 2014, GENOME BIOL, V15, P10; Mahapatra CT, 2012, NEUROTOXICOL TERATOL, V34, P387, DOI 10.1016/j.ntt.2012.04.007; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Matte A, 2013, FREE RADICAL BIO MED, V55, P27, DOI 10.1016/j.freeradbiomed.2012.10.543; McElwee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-698; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Ochi T, 2002, TOXICOLOGY, V175, P111, DOI 10.1016/S0300-483X(02)00070-7; Oliveira CS, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00425; Oliveira CS, 2017, ADV NEUROBIOL, V18, P53, DOI DOI 10.1007/978-3-319-60189-2_4; Oliveros J. C., 2007, INTERACTIVE TOOL COM; Ondovcik SL, 2012, TOXICOL SCI, V128, P272, DOI 10.1093/toxsci/kfs138; Onishchenko N, 2008, J NEUROCHEM, V106, P1378, DOI 10.1111/j.1471-4159.2008.05484.x; Parran DK, 2004, DEV BRAIN RES, V149, P53, DOI 10.1016/j.devbrainres.2003.10.017; Patterson M.C., 2014, HEXOSAMINIDASE DEFIC, V2, P564; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piccoli BC, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114632; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramanathan G, 2011, NEUROTOXICOLOGY, V32, P742, DOI 10.1016/j.neuro.2011.07.007; Rand MD, 2008, TOXICOL SCI, V104, P163, DOI 10.1093/toxsci/kfn060; Rangan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep31721; Raza U, 2016, ONCOTARGET, V7, P49859, DOI 10.18632/oncotarget.10489; REISCHL E, 1986, COMP BIOCHEM PHYS B, V85, P723, DOI 10.1016/0305-0491(86)90167-7; Reischl E, 2007, COMP BIOCHEM PHYS C, V146, P22, DOI 10.1016/j.cbpc.2006.07.015; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Reyes LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06367-w; Roos D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/248764; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu HW, 2015, TOX RESEARCH, V31, P1, DOI 10.5487/TR.2015.31.1.001; Sakai H, 2000, ARCH ENVIRON CON TOX, V39, P378; Shariati L, 2018, J CELL BIOCHEM, V119, P9357, DOI 10.1002/jcb.27253; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Smith R, 2009, HUM MOL GENET, V18, P3942, DOI 10.1093/hmg/ddp336; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; Sorensen DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193228; Spiller HA, 2018, CLIN TOXICOL, V56, P313, DOI 10.1080/15563650.2017.1400555; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Storelli MM, 2005, ENVIRON POLLUT, V135, P163, DOI 10.1016/j.envpol.2004.09.005; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Takanezawa Y, 2016, TOXICOL LETT, V262, P135, DOI 10.1016/j.toxlet.2016.09.007; Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Touma J, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00720; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; VOGEL DG, 1985, TOXICOL APPL PHARM, V80, P473, DOI 10.1016/0041-008X(85)90392-8; Waldmann T, 2017, CHEM RES TOXICOL, V30, P905, DOI 10.1021/acs.chemrestox.6b00259; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Webb SJ, 2014, ENVIRON SCI TECHNOL, V48, P14728, DOI 10.1021/es504182e; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Wilke RA, 2003, NEUROTOXICOLOGY, V24, P369, DOI 10.1016/S0161-813X(03)00032-9; Wolfe MF, 1998, ENVIRON TOXICOL CHEM, V17, P146, DOI [10.1002/etc.5620170203, 10.1897/1551-5028(1998)017&lt;0146:EOMOWA&gt;2.3.CO;2]; Won EJ, 2012, COMP BIOCHEM PHYS C, V155, P344, DOI 10.1016/j.cbpc.2011.10.002; Won EJ, 2011, COMP BIOCHEM PHYS C, V154, P82, DOI 10.1016/j.cbpc.2011.03.008; Wyatt LH, 2017, DNA REPAIR, V52, P31, DOI 10.1016/j.dnarep.2017.02.005; Yadetie F, 2013, AQUAT TOXICOL, V126, P314, DOI 10.1016/j.aquatox.2012.09.013; Yang LX, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125586; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin ZB, 2007, BRAIN RES, V1131, P1, DOI 10.1016/j.brainres.2006.10.070; Yipel M, 2017, MAR POLLUT BULL, V125, P487, DOI 10.1016/j.marpolbul.2017.08.011; Young JL, 2015, COMP BIOCHEM PHYS C, V178, P145, DOI 10.1016/j.cbpc.2015.09.013; Yuan YK, 2007, MOL PHARMACOL, V71, P1109, DOI 10.1124/mol.106.031286; Zhang HC, 2020, ECOTOXICOLOGY, V29, P295, DOI 10.1007/s10646-020-02173-9; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhao CJ, 2016, J MOL HISTOL, V47, P297, DOI 10.1007/s10735-016-9678-z; Zhao ZH, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06885-4; Zheng CP, 2020, EUR J MED CHEM, V189, DOI 10.1016/j.ejmech.2020.112065; Zhu FY, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0337-0; Zhu J, 2019, RSC ADV, V9, P10766, DOI 10.1039/c9ra00770a	148	1	1	1	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2305-6304		TOXICS	Toxics	APR	2021	9	4							70	10.3390/toxics9040070	http://dx.doi.org/10.3390/toxics9040070			29	Environmental Sciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Toxicology	RS2RK	33805397	gold, Green Published			2022-09-04	WOS:000643628900001
J	Rey, GZ; Bonte, T; Prabhu, V; Trentesaux, D				Rey, Gabriel Zambrano; Bonte, Therese; Prabhu, Vittaldas; Trentesaux, Damien			Reducing myopic behavior in FMS control: A semi-heterarchical simulation-optimization approach	SIMULATION MODELLING PRACTICE AND THEORY			English	Article						Myopic behavior; Heterarchical control architectures; Simulation-optimization; FMS control	MANUFACTURING SYSTEMS; NEGOTIATION PROTOCOLS; CONTROL ARCHITECTURES; DISPATCHING RULES; TIME; PERFORMANCE; DESIGN; BENCHMARKING; AGILE	Heterarchical FMS control architectures localize decisional capabilities in each entity, resulting in highly reactive, low complexity control architectures. Unfortunately, these architectures present myopic behavior since decisional entities have limited visibility of other decisional entities' behavior and the alignment of an entity's decision with the system's global objective. In this paper, we propose a semi-heterarchical architecture in which a supervisor tackles different kinds of myopic decisions using simulation-optimization mechanisms and the current conditions of a flexible manufacturing system (FMS). The supervisor uses simulation results to calculate local and global performances and to evolve the solutions proposed by the optimization mechanisms. The approach proposed was configured to control a real assembly cell with highly heterarchical approaches. The completion time variance was used as the performance measure for myopic behavior reduction. The simulation results showed that the semi-heterarchical architecture can reduce myopic behavior whereby it strikes a balance between the ability to react to disturbances and maintaining low complexity, thus making it suitable for production control. (C) 2014 Elsevier B.V. All rights reserved.	[Rey, Gabriel Zambrano; Bonte, Therese; Trentesaux, Damien] Univ Lille Nord France, F-59000 Lille, France; [Rey, Gabriel Zambrano; Bonte, Therese; Trentesaux, Damien] UVHC, TEMPO Lab, Prod Serv & Informat Team, F-59313 Valenciennes, France; [Rey, Gabriel Zambrano] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Prabhu, Vittaldas] Penn State Univ, Marcus Dept Ind & Mfg Engn, University Pk, PA 16802 USA		Rey, GZ (corresponding author), UVHC, TEMPO Lab, Prod Serv & Informat Team, F-59313 Valenciennes, France.	gzambrano@javeriana.edu.co	trentesaux, damien/D-2791-2009	trentesaux, damien/0000-0003-2489-6203; Zambrano Rey, Gabriel/0000-0002-1590-6839; Bonte, Therese/0000-0003-2750-5589				Adam E, 2009, LECT NOTES COMPUT SC, V5696, P145; Baker AD, 1998, J MANUF SYST, V17, P297, DOI 10.1016/S0278-6125(98)80077-0; Barbosa J., 2011, 2011 IEEE 20th International Symposium on Industrial Electronics (ISIE 2011), P1773, DOI 10.1109/ISIE.2011.5984425; Barbosa J, 2012, ADV INTEL SOFT COMPU, V156, P9; Baykasoglu A, 2010, INT J PROD ECON, V124, P369, DOI 10.1016/j.ijpe.2009.11.032; Boccalatte A, 2004, IEEE SYS MAN CYBERN, P5548; Bongaerts L, 2000, COMPUT IND, V43, P123, DOI 10.1016/S0166-3615(00)00062-2; Borangiu T, 2009, STUD COMPUT INTELL, V243, P489; Brandimarte P., 1993, Annals of Operations Research, V41, P157, DOI 10.1007/BF02023073; Brennan RW, 2000, ROBOT CIM-INT MANUF, V16, P191, DOI 10.1016/S0736-5845(00)00007-7; Cardin O, 2009, ENG APPL ARTIF INTEL, V22, P1025, DOI 10.1016/j.engappai.2009.01.006; Cavalieri S, 2000, COMPUT IND, V43, P139, DOI 10.1016/S0166-3615(00)00063-4; DILTS DM, 1991, J MANUF SYST, V10, P79, DOI 10.1016/0278-6125(91)90049-8; Duffie NA, 1996, INT J COMP INTEG M, V9, P270, DOI 10.1080/095119296131562; ElMaraghy HA, 2005, INT J FLEX MANUF SYS, V17, P261, DOI 10.1007/s10696-006-9028-7; ElMaraghy W, 2012, CIRP ANN-MANUF TECHN, V61, P793, DOI 10.1016/j.cirp.2012.05.001; Habchi G, 2003, SIMUL MODEL PRACT TH, V11, P21, DOI 10.1016/S1569-190X(02)00097-7; Hadeli, 2006, LECT NOTES ARTIF INT, P232; Ho NB, 2005, IEEE C EVOL COMPUTAT, P2848; Hong LJ, 2009, WINT SIMUL C PROC, P75, DOI 10.1109/WSC.2009.5429321; Jeong KC, 1998, INT J PROD RES, V36, P2609, DOI 10.1080/002075498192733; Jernigan SR, 1997, SIMULATION, V68, P377, DOI 10.1177/003754979706800603; Joseph OA, 2011, INT J ADV MANUF TECH, V56, P273, DOI 10.1007/s00170-011-3153-5; Joseph OA, 2011, INT J ADV MANUF TECH, V56, P291, DOI 10.1007/s00170-011-3158-0; Klemmt A, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P2041, DOI 10.1109/WSC.2008.4736300; Korytkowski P, 2013, SIMUL MODEL PRACT TH, V35, P69, DOI 10.1016/j.simpat.2013.03.006; Krothapalli NKC, 1999, INT J PROD RES, V37, P1601, DOI 10.1080/002075499191157; KUBIAK W, 1995, DISCRETE APPL MATH, V58, P157, DOI 10.1016/0166-218X(93)E0125-I; Kutanoglu E, 2001, J MANUF SYST, V20, P264, DOI 10.1016/S0278-6125(01)80046-7; Law AM, 2002, PROCEEDINGS OF THE 2002 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P41, DOI 10.1109/WSC.2002.1172866; Leitao P, 2006, COMPUT IND, V57, P121, DOI 10.1016/j.compind.2005.05.005; Leitao P, 2012, ENG APPL ARTIF INTEL, V25, P934, DOI 10.1016/j.engappai.2011.09.025; Leitao P, 2011, INT J PROD RES, V49, P1269, DOI 10.1080/00207543.2010.518735; Leitao P, 2009, ENG APPL ARTIF INTEL, V22, P979, DOI 10.1016/j.engappai.2008.09.005; Lemessi M, 2011, WINT SIMUL C PROC, P2346, DOI 10.1109/WSC.2011.6147945; Li XY, 2010, EXPERT SYST APPL, V37, P1256, DOI 10.1016/j.eswa.2009.06.014; Lim MK, 2009, ENG APPL ARTIF INTEL, V22, P1068, DOI 10.1016/j.engappai.2008.12.003; Lima RM, 2006, INT J PROD RES, V44, P3693, DOI 10.1080/00207540600788992; LIN GYJ, 1992, IIE TRANS, V24, P57, DOI 10.1080/07408179208964224; Maione G., 2002, 2002 IEEE International Conference on Systems, Man and Cybernetics. Conference Proceedings (Cat. No.02CH37349), DOI 10.1109/ICSMC.2002.1173342; Maione G, 2003, IEEE T SYST MAN CY A, V33, P573, DOI 10.1109/TSMCA.2003.817389; Marik V, 2007, CONTROL ENG PRACT, V15, P1364, DOI 10.1016/j.conengprac.2006.10.001; Metan G, 2010, INT J PROD RES, V48, P6909, DOI 10.1080/00207540903307581; Monostori L, 2010, ANNU REV CONTROL, V34, P118, DOI 10.1016/j.arcontrol.2010.02.007; Mouelhi-Chibani W, 2010, COMPUT IND ENG, V58, P249, DOI 10.1016/j.cie.2009.03.008; Nejad HTN, 2011, INT J PROD RES, V49, P1373, DOI 10.1080/00207543.2010.518741; O'Keefe R. M., 1992, International Journal of Flexible Manufacturing Systems, V4, P113, DOI 10.1007/BF01313696; Ouelhadj D, 2009, J SCHEDULING, V12, P417, DOI 10.1007/s10951-008-0090-8; Pach C, 2012, CONTROL ENG PRACT, V20, P1293, DOI 10.1016/j.conengprac.2012.07.005; Papakostas N, 2012, INT J COMPUT INTEG M, V25, P509, DOI 10.1080/0951192X.2011.637963; Pfeiffer A, 2008, INT J COMPUT INTEG M, V21, P206, DOI 10.1080/09511920701607717; Prabhu V., 1995, CIRP ANN-MANUF TECHN, V44, P425, DOI [10.1016/S0007-8506(07)62356-7, DOI 10.1016/S0007-8506(07)62356-7]; Prabhu V.V., 1996, CIRP ANN-MANUF TECHN, V45, P445, DOI DOI 10.1016/S0007-8506(07)63099-6; Reaidy J, 2006, INT J PROD ECON, V99, P117, DOI 10.1016/j.ijpe.2004.12.011; Rey GZ, 2013, ENG APPL ARTIF INTEL, V26, P800, DOI 10.1016/j.engappai.2012.08.011; Rossi A, 2007, ROBOT CIM-INT MANUF, V23, P503, DOI 10.1016/j.rcim.2006.06.004; Ruiz MC, 2009, J LOGIC ALGEBR PROGR, V78, P260, DOI 10.1016/j.jlap.2008.11.002; Seleim A, 2012, PROC CIRP, V3, P179, DOI 10.1016/j.procir.2012.07.032; Sels V, 2012, INT J PROD RES, V50, P4255, DOI 10.1080/00207543.2011.611539; Shen WM, 2006, ADV ENG INFORM, V20, P415, DOI 10.1016/j.aei.2006.05.004; Siebers P, 2010, J SIMUL, V4, P204, DOI 10.1057/jos.2010.14; Smith JS, 2003, J MANUF SYST, V22, P157, DOI 10.1016/S0278-6125(03)90013-6; SMITH RG, 1980, IEEE T COMPUT, V29, P1104; Sousa P, 1998, J INTELL MANUF, V9, P107, DOI 10.1023/A:1008807726981; Tekin E, 2004, IIE TRANS, V36, P1067, DOI 10.1080/07408170490500654; Trentesaux D, 2013, CONTROL ENG PRACT, V21, P1204, DOI 10.1016/j.conengprac.2013.05.004; Trentesaux D, 2009, ENG APPL ARTIF INTEL, V22, P971, DOI 10.1016/j.engappai.2009.05.001; Valckenaers P, 2006, ADV ENG INFORM, V20, P261, DOI 10.1016/j.aei.2006.01.007; Van Brussel H, 1998, COMPUT IND, V37, P255, DOI 10.1016/S0166-3615(98)00102-X; Wang LC, 2009, COMPUT IND ENG, V57, P620, DOI 10.1016/j.cie.2009.05.015; Weigert G, 2006, INT J PROD RES, V44, P3677, DOI 10.1080/00207540600851774; Wilensky U, 1997, NETLOGO; Wong TN, 2006, EXPERT SYST APPL, V31, P486, DOI 10.1016/j.eswa.2005.09.073; Zambrano G., 2011, 2011 IEEE 20th International Symposium on Industrial Electronics (ISIE 2011), P1767, DOI 10.1109/ISIE.2011.5984424; Rey GZ, 2012, STUD COMPUT INTELL, V402, P115; Zbib N, 2012, J INTELL MANUF, V23, P1649, DOI 10.1007/s10845-010-0467-3; Zhang DZ, 2007, IEEE T SYST MAN CY A, V37, P824, DOI 10.1109/TSMCA.2007.897710	77	28	28	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1569-190X	1878-1462		SIMUL MODEL PRACT TH	Simul. Model. Pract. Theory	AUG	2014	46				SI		53	75		10.1016/j.simpat.2014.01.005	http://dx.doi.org/10.1016/j.simpat.2014.01.005			23	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	AL4YX		Green Submitted			2022-09-04	WOS:000339141800005
J	Ruiz, M; Plata, E; Castillo, JJ; Ortiz, CC; Lopez, G; Baena, S; Torres, R; Fernandez-Lafuente, R				Ruiz, Monica; Plata, Esteban; Castillo, John J.; Ortiz, Claudia C.; Lopez, Gina; Baena, Sandra; Torres, Rodrigo; Fernandez-Lafuente, Roberto			Modulation of the Biocatalytic Properties of a Novel Lipase from Psychrophilic Serratia sp. (USBA-GBX-513) by Different Immobilization Strategies	MOLECULES			English	Article						lipase from psychrophilic microorganism; immobilization; interfacial activation; hyperactivation; USBA-GBX-513	DIVINYLSULFONE ACTIVATED AGAROSE; CANDIDA-ANTARCTICA LIPASE; ENZYME IMMOBILIZATION; INTERFACIAL ACTIVATION; OCTYL-AGAROSE; SUPPORT MATERIALS; CRYSTAL-STRUCTURE; CYANOGEN-BROMIDE; OPEN FORM; FISH-OIL	In this work, the effect of different immobilization procedures on the properties of a lipase obtained from the extremophilic microorganism Serratia sp. USBA-GBX-513, which was isolated from Paramo soils of Los Nevados National Natural Park (Colombia), is reported. Different Shepharose beads were used: octyl-(OC), octyl-glyoxyl-(OC-GLX), cyanogen bromide (BrCN)-, and Q-Sepharose. The performance of the different immobilized extremophile lipase from Serratia (ESL) was compared with that of the lipase B from Candida antarctica (CALB). In all immobilization tests, hyperactivation of ESL was observed. The highest hyperactivation (10.3) was obtained by immobilization on the OC support. Subsequently, the thermal stability at pH 5, 7, and 9 and the stability in the presence of 50% (v/v) acetonitrile, 50% dioxane, and 50% tetrahydrofuran solvents at pH 7 and 40 degrees C were evaluated. ESL immobilized on octyl-Sepharose was the most stable biocatalyst at 90 degrees C and pH 9, while the most stable preparation at pH 5 was ESL immobilized on OC-GLX-Sepharose supports. Finally, in the presence of 50% (v/v) tetrahydrofuran (THF) or dioxane at 40 degrees C, ESL immobilized on OC-Sepharose was the most stable biocatalyst, while the immobilized preparation of ESL on Q-Sepharose was the most stable one in 40% (v/v) acetonitrile.	[Ruiz, Monica; Plata, Esteban; Castillo, John J.] Univ Ind Santander, Grp Invest Bioquim & Microbiol GIBIM, Escuela Quim, Edificio Camilo Torres 210, Bucaramanga 680001, Colombia; [Ortiz, Claudia C.] Univ Ind Santander, Escuela Microbiol, Bucaramanga 680001, Colombia; [Lopez, Gina; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental USBA, Bogota 11001000, Colombia; [Torres, Rodrigo] ECOPETROL, Lab Biotecnol, Inst Colombiano Petr, Piedecuesta 681012, Colombia; [Fernandez-Lafuente, Roberto] ICP CSIC, Dept Biocatalisis, Campus UAM CSIC Cantoblanco, Madrid 28049, Spain; [Fernandez-Lafuente, Roberto] King Abdulaziz Univ, External Sci Advisory Acad Board, Ctr Excellence Bionanosci Res, Jeddah 21589, Saudi Arabia		Fernandez-Lafuente, R (corresponding author), ICP CSIC, Dept Biocatalisis, Campus UAM CSIC Cantoblanco, Madrid 28049, Spain.; Fernandez-Lafuente, R (corresponding author), King Abdulaziz Univ, External Sci Advisory Acad Board, Ctr Excellence Bionanosci Res, Jeddah 21589, Saudi Arabia.	icmonicaruiz@gmail.com; stbnplata29@gmail.com; jcasleon@uis.edu.co; ortizc@uis.edu.co; ginalopezr@gmail.com; baena@javeriana.edu.co; rodrigo.torres@ecopetrol.com.co; rfl@icp.csic.es		Torres, Rodrigo/0000-0003-1113-3020; Lopez Ramirez, Gina/0000-0002-4210-089X; Torres, Rodrigo/0000-0001-6627-5929; castillo, john/0000-0002-6751-2305	Colciencias [FP 44842-076-2016]; Universidad Industrial de Santander (Vicerrectoria de Investigacion y Extension) [8854]; Spanish Ministerio de Ciencia e Innovacion [CTQ2017-86170-R]; Universidad Pontificia Javeriana [DTNO-N-20/2007]; contract MAVDT [15]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Industrial de Santander (Vicerrectoria de Investigacion y Extension); Spanish Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIISpanish Government); Universidad Pontificia Javeriana; contract MAVDT	This research was funded by Colciencias, project number FP 44842-076-2016, Universidad Industrial de Santander (Vicerrectoria de Investigacion y Extension, project number 8854), Spanish Ministerio de Ciencia e Innovacion, grant number CTQ2017-86170-R, contract MAVDT No. 15, 2008 for genetic resources access (GRA) and the research authorization No. DTNO-N-20/2007 of Universidad Pontificia Javeriana	Aggarwal S, 2021, INT J BIOL MACROMOL, V167, P962, DOI 10.1016/j.ijbiomac.2020.11.052; Aloulou A, 2006, BBA-MOL CELL BIOL L, V1761, P995, DOI 10.1016/j.bbalip.2006.06.009; Amutha B, 1998, BBA-GEN SUBJECTS, V1425, P300, DOI 10.1016/S0304-4165(98)00081-6; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; Arana-Pena S, 2020, CATALYSTS, V10, DOI 10.3390/catal10060605; Arana-Pena S, 2020, FRONT BIOENG BIOTECH, V8, P36, DOI 10.3389/fbioe.2020.00036; Arana-Pena S, 2018, CATALYSTS, V8, DOI 10.3390/catal8110511; Arana-Pena S, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2735; Atalah J, 2019, BIORESOURCE TECHNOL, V280, P478, DOI 10.1016/j.biortech.2019.02.008; Barbosa O, 2015, BIOTECHNOL ADV, V33, P435, DOI 10.1016/j.biotechadv.2015.03.006; Benassi VM, 2013, J MOL CATAL B-ENZYM, V89, P93, DOI 10.1016/j.molcatb.2012.12.010; Bernal C, 2014, LANGMUIR, V30, P3557, DOI 10.1021/la4047512; Bharathi D, 2019, BIOCATAL AGR BIOTECH, V22, DOI 10.1016/j.bcab.2019.101368; Bolivar JM, 2020, CURR OPIN GREEN SUST, V25, DOI 10.1016/j.cogsc.2020.04.010; Bolivar JM, 2013, TRENDS BIOTECHNOL, V31, P194, DOI 10.1016/j.tibtech.2013.01.004; Boniello C, 2010, BIOTECHNOL BIOENG, V106, P528, DOI 10.1002/bit.22694; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Canganella F, 2011, NATURWISSENSCHAFTEN, V98, P253, DOI 10.1007/s00114-011-0775-2; Coelho ALS, 2021, CRIT REV FOOD SCI, V61, P1689, DOI 10.1080/10408398.2020.1764489; Cowan DA, 2011, ENZYME MICROB TECH, V49, P326, DOI 10.1016/j.enzmictec.2011.06.023; Cygler M, 1999, BBA-MOL CELL BIOL L, V1441, P205, DOI 10.1016/S1388-1981(99)00152-3; de Miranda AS, 2015, BIOTECHNOL ADV, V33, P372, DOI 10.1016/j.biotechadv.2015.02.015; DEREWENDA U, 1994, J LIPID RES, V35, P524; dos Santos JCS, 2015, ENZYME MICROB TECH, V77, P1, DOI 10.1016/j.enzmictec.2015.05.001; dos Santos JCS, 2015, PROCESS BIOCHEM, V50, P918, DOI 10.1016/j.procbio.2015.03.018; dos Santos JCS, 2015, RSC ADV, V5, P35801, DOI 10.1039/c5ra03798k; dos Santos JCS, 2015, CHEMCATCHEM, V7, P2413, DOI 10.1002/cctc.201500310; Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003; Facin BR, 2019, IND ENG CHEM RES, V58, P5358, DOI 10.1021/acs.iecr.9b00448; Fernandez-Lopez L, 2018, BIOCATAL BIOTRANSFOR, V36, P47, DOI 10.1080/10242422.2016.1278212; Fernandez-Lopez L, 2017, ENZYME MICROB TECH, V98, P18, DOI 10.1016/j.enzmictec.2016.12.002; Filice M, 2011, BIOTECHNOL PROGR, V27, P961, DOI 10.1002/btpr.635; Frock AD, 2012, CURR OPIN CHEM ENG, V1, P363, DOI 10.1016/j.coche.2012.07.003; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; Goncalves D, 2019, APPL MICROBIOL BIOT, V103, P7399, DOI 10.1007/s00253-019-10027-6; Gotor, 2007, IND ENZYMES STRUCTUR, P301; GROCHULSKI P, 1993, J BIOL CHEM, V268, P12843; Han HW, 2019, BIORESOURCE TECHNOL, V279, P350, DOI 10.1016/j.biortech.2019.01.087; Ismail AR, 2020, INT J BIOL MACROMOL, V163, P1624, DOI 10.1016/j.ijbiomac.2020.09.021; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; JAEGER KE, 1993, FEBS LETT, V332, P143, DOI 10.1016/0014-5793(93)80501-K; JENNISSEN HP, 1995, J MOL RECOGNIT, V8, P116, DOI 10.1002/jmr.300080121; Jesionowski T, 2014, ADSORPTION, V20, P801, DOI 10.1007/s10450-014-9623-y; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Kohli I, 2020, CURR GENOMICS, V21, P96, DOI 10.2174/1389202921666200401105908; Kumar A, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0033-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMED RJ, 1981, BIOCHEM J, V195, P183, DOI 10.1042/bj1950183; Lima RN, 2019, MOL CATAL, V466, P75, DOI 10.1016/j.mcat.2019.01.007; Liu DM, 2020, PROCESS BIOCHEM, V92, P464, DOI 10.1016/j.procbio.2020.02.005; Liu J, 2020, ANAL CHIM ACTA, V1101, P9, DOI 10.1016/j.aca.2019.11.073; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Manoel EA, 2015, ENZYME MICROB TECH, V71, P53, DOI 10.1016/j.enzmictec.2015.02.001; Marciello M, 2012, CATAL SCI TECHNOL, V2, P1531, DOI 10.1039/c2cy20125a; Oliart-Ros RM, 2016, CIENCIAUAT, V11, P79, DOI 10.29059/cienciauat.v11i1.556; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Mehrotra S, 2008, BBA-PROTEINS PROTEOM, V1784, P2019, DOI 10.1016/j.bbapap.2008.08.008; Mokhtar NF, 2020, CATALYSTS, V10, DOI 10.3390/catal10070744; Ortiz C, 2019, CATAL SCI TECHNOL, V9, P2380, DOI 10.1039/c9cy00415g; OWUSU RK, 1989, ENZYME MICROB TECH, V11, P568, DOI 10.1016/0141-0229(89)90084-7; Palomo JM, 2003, BIOMACROMOLECULES, V4, P1, DOI 10.1021/bm025729+; Palomo JM, 2002, J MOL CATAL B-ENZYM, V19, P279, DOI 10.1016/S1381-1177(02)00178-9; Peirce S, 2016, MOLECULES, V21, DOI 10.3390/molecules21060751; Pereira MG, 2015, PROCESS BIOCHEM, V50, P561, DOI 10.1016/j.procbio.2014.12.027; Pinto GB, 2020, MINI-REV ORG CHEM, V17, P701, DOI 10.2174/1570193X16666190913181530; Pronk S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4034; Ramirez L.P., COMPOSICI N DIVERSID; Reed CJ, 2013, ARCHAEA, V2013, DOI 10.1155/2013/373275; REGAN DL, 1974, BIOTECHNOL BIOENG, V16, P1081, DOI 10.1002/bit.260160808; Rios NS, 2019, BBA-PROTEINS PROTEOM, V1867, P741, DOI 10.1016/j.bbapap.2019.06.005; Rodrigues RC, 2019, BIOTECHNOL ADV, V37, P746, DOI 10.1016/j.biotechadv.2019.04.003; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Rueda N, 2015, RSC ADV, V5, P11212, DOI 10.1039/c4ra13338b; Salameh M, 2007, ADV APPL MICROBIOL, V61, P253, DOI 10.1016/S0065-2164(06)61007-1; Sanchez A, 2016, RSC ADV, V6, P27329, DOI 10.1039/c6ra03627a; Sarmah N, 2018, BIOTECHNOL PROGR, V34, P5, DOI 10.1002/btpr.2581; SCHNAPP J, 1976, BIOCHEM BIOPH RES CO, V70, P8, DOI 10.1016/0006-291X(76)91101-3; Shames AI, 2000, APPL MAGN RESON, V18, P515, DOI 10.1007/BF03162298; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Sharma S, 2014, SCI WORLD J, DOI 10.1155/2014/625258; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Shen L, 2007, CHEM ENG SCI, V62, P3748, DOI 10.1016/j.ces.2007.03.041; Singh BK, 2010, TRENDS BIOTECHNOL, V28, P111, DOI 10.1016/j.tibtech.2009.11.006; Suescun A, 2015, PROCESS BIOCHEM, V50, P1211, DOI 10.1016/j.procbio.2015.05.010; Tsai SW, 2016, J MOL CATAL B-ENZYM, V127, P98, DOI 10.1016/j.molcatb.2014.07.010; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Urrutia P, 2018, INT J BIOL MACROMOL, V108, P674, DOI 10.1016/j.ijbiomac.2017.12.062; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Virgen-Ortiz JJ, 2017, ENZYME MICROB TECH, V96, P30, DOI 10.1016/j.enzmictec.2016.09.010; Wahab RA, 2020, REACT FUNCT POLYM, V152, DOI 10.1016/j.reactfunctpolym.2020.104613; Zhong L, 2020, INT J BIOL MACROMOL, V152, P207, DOI 10.1016/j.ijbiomac.2020.02.258	94	2	2	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	MAR	2021	26	6							1574	10.3390/molecules26061574	http://dx.doi.org/10.3390/molecules26061574			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	RU8PT	33809323	Green Published, gold			2022-09-04	WOS:000645403900001
J	Hernandez-Fernandez, J; Lopez-Barrera, EA; Marino-Ramirez, L; Rodriguez-Becerra, P; Pinzon-Velasco, A				Hernandez-Fernandez, Javier; Lopez-Barrera, Ellie Anne; Marino-Ramirez, Leonardo; Rodriguez-Becerra, Pilar; Pinzon-Velasco, Andres			Oxidative Stress Biomarkers in Erythrocytes of Captive Pre-Juvenile Loggerhead Turtles Following Acute Exposure to Methylmercury	APPLIED SCIENCES-BASEL			English	Article						Cytotoxicity; erythrocytes; methylmercury; malondialdehyde; in vitro; superoxide dismutase	CARETTA-CARETTA; SEA-TURTLES; CHELONIA-MYDAS; MERCURY; BLOOD; THIOREDOXIN; PEROXIREDOXINS; MODEL; SYSTEM; VALUES	This study describes the use of erythrocytes (RBCs) of loggerhead turtles as in vitro models for evaluating their toxicity to methylmercury. Blood samples of loggerhead turtles that were born in the Colombian Caribbean were used. The LC50 of RBCs to methylmercury was determined at 96 h using methylmercury concentrations of 0.5-100 mg L-1. Next, the viability of the RBCs and the activity of the enzymes superoxide dismutase (SOD), glutathione S-transferase (GST), and lipid peroxidation by malondialdehyde (MDA) at 6 and 12 h of exposure to acute concentrations of 0, 1, and 5 mg L-1 were evaluated. The LC50 for loggerhead turtle RBCs was 8.32 mg L-1. The cell viability bioassay of RBCs exposed for 12 h only showed 100% cell viability. Increasing in vitro MeHg concentrations caused a corresponding increase in MDA concentration as well as decreases in the activities of SOD and GST. The RBCs represent an excellent model for ecotoxicological studies and SOD, GST, and MDA are biomarkers of environmental pollution and oxidative stress in loggerhead turtles. This was the first study conducted on loggerhead turtle where the response of RBCs to MeHg-induced oxidative stress is evaluated.	[Hernandez-Fernandez, Javier; Rodriguez-Becerra, Pilar] Jorge Tadeo Lozano Univ, Dept Nat & Environm Sci, Fac Sci & Engn, Genet Mol Biol & Bioinformat Res Grp GENBIMOL, Cra 4 22-61, Bogota 110311, Colombia; [Hernandez-Fernandez, Javier] Pontificia Univ Javeriana, Fac Sci, Dept Biol, Calle 45,Cra 7, Bogota 110231, Colombia; [Lopez-Barrera, Ellie Anne] Sergio Arboleda Univ, Inst Environm Studies & Serv, IDEASA Res Grp IDEASA, Bogota 111711, Colombia; [Marino-Ramirez, Leonardo] NLM, NCBI, NIH, Computat Biol Branch, Bldg 38A,Room 6S614M 8600 Rockville Pike,MSC 6075, Bethesda, MD 20894 USA; [Pinzon-Velasco, Andres] Univ Nacl Colombia, Bioinformat & Syst Biol Grp, Calle 45 Cra 30, Bogota 111321, Colombia		Hernandez-Fernandez, J (corresponding author), Jorge Tadeo Lozano Univ, Dept Nat & Environm Sci, Fac Sci & Engn, Genet Mol Biol & Bioinformat Res Grp GENBIMOL, Cra 4 22-61, Bogota 110311, Colombia.; Hernandez-Fernandez, J (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Biol, Calle 45,Cra 7, Bogota 110231, Colombia.	javier.hernandez@utadeo.edu.co; ellie.lopez@usa.edu.co; marino@ncbi.nlm.nih.gov; mariad.rodriguezb@utadeo.edu.co; ampinzonv@unal.edu.co	Fernandez, Javier A Hernandez/K-9794-2016; Marino-Ramirez, Leonardo/I-5759-2013	Marino-Ramirez, Leonardo/0000-0002-5716-8512; Pinzon, Andres/0000-0002-4133-810X; Rodriguez Becerra, Maria del Pilar/0000-0003-3843-1490; Lopez, Ellie/0000-0002-4195-6354	Office of Research, Creation and Innovation of the Universidad Jorge Tadeo Lozano [340-07-10]; Intramural Research Program of the National Institutes of Health (NIH, USA); National Library of Medicine (USA); National Center for Biotechnology Information (NCBI) [ZIA LM082713-06]	Office of Research, Creation and Innovation of the Universidad Jorge Tadeo Lozano; Intramural Research Program of the National Institutes of Health (NIH, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information (NCBI)	This work was supported by the Office of Research, Creation and Innovation of the Universidad Jorge Tadeo Lozano (340-07-10). Additional funding came from the Intramural Research Program of the National Institutes of Health (NIH, USA), National Library of Medicine (USA), National Center for Biotechnology Information (NCBI) ZIA LM082713-06. There was no additional external funding received for this study.	AGRAWAL D, 1991, FOOD CHEM TOXICOL, V29, P459, DOI 10.1016/0278-6915(91)90091-K; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Amorocho Diego, 2003, Marine Turtle Newsletter, V101, P8; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Maniero MA, 2020, J TRACE ELEM MED BIO, V58, DOI 10.1016/j.jtemb.2019.126441; Barraza AD, 2019, CHEMOSPHERE, V223, P342, DOI 10.1016/j.chemosphere.2019.01.107; Berntssen MHG, 2003, AQUAT TOXICOL, V65, P55, DOI 10.1016/S0166-445X(03)00104-8; Beyer W.N., 1996, ENV CONTAMINANTS WIL, P1, DOI [10.1201/b10598, DOI 10.1201/B10598]; Bjorndal KA, 2000, MAR ECOL PROG SER, V202, P265, DOI 10.3354/meps202265; Branco V, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/359879; Burger J, 2004, ENVIRON RES, V96, P239, DOI 10.1016/j.envres.2003.12.001; Burgos-Aceves MA, 2019, SCI TOTAL ENVIRON, V670, P1170, DOI 10.1016/j.scitotenv.2019.03.275; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Carvalho CML, 2011, FASEB J, V25, P370, DOI 10.1096/fj.10-157594; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cocci P, 2017, ENVIRON RES, V158, P616, DOI 10.1016/j.envres.2017.07.024; Corduk N, 2019, ACTA ZOOL BULGAR, V71, P219; Cortes-Gomez AA, 2017, ENVIRON POLLUT, V229, P567, DOI 10.1016/j.envpol.2017.06.077; Cortes-Gutierrez EI, 2019, BIOTECH HISTOCHEM, V94, P600, DOI 10.1080/10520295.2019.1618495; Day RD, 2007, ENVIRON HEALTH PERSP, V115, P1421, DOI 10.1289/ehp.9918; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Dutton P.H., 1996, P INT S SEA TURTL CO; Farina Marcelo, 2017, Adv Neurobiol, V18, P267, DOI 10.1007/978-3-319-60189-2_13; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Farina M, 2009, TOXICOL SCI, V112, P416, DOI 10.1093/toxsci/kfp219; Figueres J., 2015, ESTUDIO SANITARIO TO, P1; Finlayson KA, 2019, SCI TOTAL ENVIRON, V664, P958, DOI 10.1016/j.scitotenv.2019.02.052; Finlayson KA, 2019, AQUAT TOXICOL, V207, P13, DOI 10.1016/j.aquatox.2018.11.022; Finlayson KA, 2016, ENVIRON INT, V94, P113, DOI 10.1016/j.envint.2016.05.013; FINNEY D J, 1971, P333; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Franco R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8020046; GABRYELAK T, 1983, COMP BIOCHEM PHYS C, V75, P383, DOI 10.1016/0742-8413(83)90210-4; Goodchild CG, 2020, PHYSIOL BIOCHEM ZOOL, V93, P129, DOI 10.1086/707920; Guisande C, 2014, RWIZARD SOFTWARE; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hammami N, 2019, J FOOD MEAS CHARACT, V13, P2705, DOI 10.1007/s11694-019-00191-8; HIROTA Y, 1980, TOXICOL APPL PHARM, V53, P174, DOI 10.1016/0041-008X(80)90394-4; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Isaji Y, 2009, BIOCHEM ENG J, V43, P178, DOI 10.1016/j.bej.2008.09.016; Joshi D, 2014, J ENVIRON PATHOL TOX, V33, P167, DOI 10.1615/JEnvironPatholToxicolOncol.2014010291; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Kampalath R, 2006, MAR POLLUT BULL, V52, P1816, DOI 10.1016/j.marpolbul.2006.09.019; Kaska Yakup, 2001, Zoology in the Middle East, V24, P127; Kelly TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115739; Kotnik J, 2017, MAR CHEM, V193, P8, DOI 10.1016/j.marchem.2017.03.002; Krivoruchko A, 2010, BBA-GEN SUBJECTS, V1800, P662, DOI 10.1016/j.bbagen.2010.03.015; Kumagai Y, 1997, APPL ORGANOMET CHEM, V11, P635; Labrada-Martagon V, 2011, COMP BIOCHEM PHYS C, V154, P65, DOI 10.1016/j.cbpc.2011.02.006; Lancheros-piliego D., 2013, U SCI, V18, DOI [10.11144/Javeriana.SC18-3.apit, DOI 10.11144/JAVERIANA.SC18-3.APIT]; Ley-Quinonez C, 2011, MAR POLLUT BULL, V62, P1979, DOI 10.1016/j.marpolbul.2011.06.022; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu DL, 2016, INT IMMUNOPHARMACOL, V41, P82, DOI 10.1016/j.intimp.2016.10.025; Lund B., 2017, BIOCHMDCAL PHAMWCOLO, V45, P2017; Lutz P.L., 1971, FISH B, V85, P37; Martins RD, 2009, FOOD CHEM TOXICOL, V47, P645, DOI 10.1016/j.fct.2008.12.020; Massarsky A, 2014, COMP BIOCHEM PHYS C, V159, P10, DOI 10.1016/j.cbpc.2013.09.008; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; Messer RLW, 2005, J BIOMED MATER RES B, V75B, P257, DOI 10.1002/jbm.b.30263; Morcillo P, 2016, FISH SHELLFISH IMMUN, V54, P77, DOI 10.1016/j.fsi.2016.03.164; NAGANUMA A, 1980, TOXICOL APPL PHARM, V54, P405, DOI 10.1016/0041-008X(80)90167-2; Olivero-Verbel J, 2009, INT J ENVIRON HEAL R, V19, P343, DOI 10.1080/09603120902749090; Orson R., 1973, J FISH RES BOARD CAN, V30, P1293, DOI [10.1139/f73-209, DOI 10.1139/F73-209]; Pagano M, 2015, CELL BIOCHEM FUNCT, V33, P351, DOI 10.1002/cbf.3135; Panghal A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03431; Parra J.P., 2011, EVOLUCION ESTADO CON, P1; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perrault JR, 2014, HARMFUL ALGAE, V37, P194, DOI 10.1016/j.hal.2014.06.007; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; R Development Core Team R., 2017, LANG ENV STAT COMP, P900051; Robitaille S, 2016, TOXICOL LETT, V256, P1, DOI 10.1016/j.toxlet.2016.05.013; Rodríguez M., 2017, Rev. vet., V28, P157; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Ruggiero MG, 2014, J EXP ZOOL PART A, V321, P144, DOI 10.1002/jez.1844; Sakuragui MM, 2019, TOXICON, V169, P18, DOI 10.1016/j.toxicon.2019.08.002; Salvarani PI, 2018, ENVIRON SCI POLLUT R, V25, P23809, DOI 10.1007/s11356-018-2404-5; Schara M, 2001, CELL MOL BIOL LETT, V6, P299; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; Shinyashiki M, 1996, ENVIRON TOXICOL PHAR, V2, P359, DOI 10.1016/S1382-6689(96)00070-1; Stier A, 2015, EXP GERONTOL, V71, P118, DOI 10.1016/j.exger.2015.09.001; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; STRICKS W, 1953, J AM CHEM SOC, V75, P5673, DOI 10.1021/ja01118a060; Tan FX, 2010, CELL BIOL TOXICOL, V26, P255, DOI 10.1007/s10565-009-9130-1; TANAKA R, 1977, JPN J PHARMACOL, V27, P413, DOI 10.1254/jjp.27.413; Tong J, 2016, J ENVIRON SCI, V41, P138, DOI 10.1016/j.jes.2015.04.036; Tosic M, 2019, ESTUAR COAST SHELF S, V216, P187, DOI 10.1016/j.ecss.2017.08.013; Toyama T, 2007, BIOCHEM BIOPH RES CO, V363, P645, DOI 10.1016/j.bbrc.2007.09.017; Velando A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38535-5; Venables W.N., 2002, MODERN APPL STAT S, VFourth edition; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Walsh CJ, 2019, ECOTOXICOLOGY, V28, P1085, DOI 10.1007/s10646-019-02110-5; Wataha JC, 2008, DENT MATER, V24, P765, DOI 10.1016/j.dental.2007.09.002; WEED R, 1962, J GEN PHYSIOL, V45, P395, DOI 10.1085/jgp.45.3.395; Winterbourn C.C., 2013, BIOL CHEM HYDROGEN P, V528; Xu JH, 2016, FISH SHELLFISH IMMUN, V56, P417, DOI 10.1016/j.fsi.2016.07.032; Yang LX, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125586; Yang T, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coy079; Yarsan E., 2013, J MOL BIOMARK DIAG S, VS1, P1, DOI DOI 10.4172/2155-9929.S1-003; YEE S, 1994, EXP MOL PATHOL, V60, P188, DOI 10.1006/exmp.1994.1017; Yipel M, 2017, MAR POLLUT BULL, V125, P487, DOI 10.1016/j.marpolbul.2017.08.011; Young JL, 2015, COMP BIOCHEM PHYS C, V178, P145, DOI 10.1016/j.cbpc.2015.09.013; ZAMAN K, 1994, ARCH ENVIRON CON TOX, V26, P114, DOI 10.1007/BF00212802; Zapata LM, 2016, ECOTOX ENVIRON SAFE, V127, P108, DOI 10.1016/j.ecoenv.2016.01.016; Zhang YY, 2019, DEV COMP IMMUNOL, V101, DOI 10.1016/j.dci.2019.103456	108	5	5	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	MAY	2020	10	10								10.3390/app10103602	http://dx.doi.org/10.3390/app10103602			21	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	LZ7ZE		Green Published, gold			2022-09-04	WOS:000541440000263
J	Kosenko, EA; Tikhonova, LA; Alilova, GA; Montoliu, C; Barreto, GE; Aliev, G; Kaminsky, YG				Kosenko, Elena A.; Tikhonova, Lyudmila A.; Alilova, Gubidat A.; Montoliu, Carmina; Barreto, George E.; Aliev, Gjumrakch; Kaminsky, Yury G.			Portacaval shunting causes differential mitochondrial superoxide production in brain regions	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Ammonia; Superoxide radical; Carbonylated proteins; Antioxidant enzymes; Brain regions; Cerebellum; Mitochondria; Nitric oxide synthase; Portacaval anastomosis	ACUTE AMMONIA INTOXICATION; NITRIC-OXIDE SYNTHASE; PHOSPHATE-ACTIVATED GLUTAMINASE; FULMINANT HEPATIC-FAILURE; OXIDATIVE STRESS; CEREBRAL-CORTEX; PERMEABILITY TRANSITION; ANTIOXIDANT ENZYMES; NMDA RECEPTOR; CELL-DEATH	The portacaval shunting (PCS) prevents portal hypertension and recurrent bleeding of esophageal varices. On the other hand, it can induce chronic hyperammonemia and is considered to be the best model of mild hepatic encephalopathy (HE). Pathogenic mechanisms of HE and dysfunction of the brain in hyperammonemia are not fully elucidated, but it was originally suggested that the pathogenetic defect causes destruction of antioxidant defense which leads to an increase in the production of reactive oxygen species (ROS) and the occurrence of oxidative stress. In order to gain insight into the pathogenic mechanisms of HE in the brain tissue, we investigated the effects of PCS in rats on free radicals production and activity levels of antioxidant and prooxidant enzymes in mitochondria isolated from different brain areas. We found that O-2(center dot-) production, activities of Mnsuperoxide dismutase (Mn-SOD), glutathione peroxidase (GPx), glutathione reductase (GR), glutathione transferase (GT), nitric oxide synthase (NOS), and levels of carbonylated proteins differed between the four brain regions both in the amount and response to PCS. In PCS rats, Mn-SOD activity in the cerebellum was significantly decreased, and remained unchanged in the neocortex, hippocampus and striatum compared with that in sham-operated animals. Among the four brain regions in control rats, the levels of the carbonyl groups in mitochondrial proteins were maximal in the cerebellum. 4 weeks after PCS, the content of carbonylated proteins were higher only in mitochondria of this brain region. Under control conditions, O-2(center dot-) production by submitochondrial particles in the cerebellum was significantly higher than in other brain regions, but was significantly increased in each brain region from PCS animals. Indeed, the production of O-2(center dot-) by submitochondrial particles correlated with mitochondrial ammonia levels in the four brain regions of control and PCS-animals. These findings are the first to suggest that in vivo levels of ammonia in the brain directly affect the rate of mitochondrial O-2(center dot-) production.	[Kosenko, Elena A.; Tikhonova, Lyudmila A.; Alilova, Gubidat A.; Kaminsky, Yury G.] Inst Theoret & Expt Biophys, Pushchino, Russia; [Montoliu, Carmina] Fdn Invest Hosp Clin, Inst Invest Sanitaria INCLIVA, Valencia, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Inst Inc, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA		Kosenko, EA; Aliev, G (corresponding author), Inst Theoret & Expt Biophys, Pushchino, Russia.; Kosenko, EA; Aliev, G (corresponding author), GALLY Int Biomed Res Inst Inc, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	gieraki@mail.ru; cobalt55@gallyinternational.com	Barreto, George E./AAD-7420-2020; Montoliu, Carmina/ABB-1904-2021; Alilova, Gubidat/AAO-1363-2020; Tikhonova, Lyudmila A/N-3194-2017; Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Kosenko, Elena A/N-3224-2017	Barreto, George E./0000-0002-6644-1971; Tikhonova, Lyudmila A/0000-0001-6310-0242; Aliev, Gjumrakch/0000-0001-7373-3182; Kosenko, Elena A/0000-0002-3293-652X; Alilova, Gubidat/0000-0001-8789-1712				ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ASSAL JP, 1971, Z GES EXP MED, V154, P87, DOI 10.1007/BF02048382; Audet RM, 1998, METAB BRAIN DIS, V13, P69, DOI 10.1023/A:1020683013238; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bemeur C, 2010, METAB BRAIN DIS, V25, P3, DOI 10.1007/s11011-010-9177-y; Bergmeyer H.U., 1985, METHOD ENZYMAT AN, P454; Bosoi CR, 2012, FREE RADICAL BIO MED, V52, P1228, DOI 10.1016/j.freeradbiomed.2012.01.006; BUTTERWORTH RF, 1992, DIGEST DIS SCI, V37, P321, DOI 10.1007/BF01307722; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; BUTTERWORTH RF, 1988, J NEUROCHEM, V51, P486, DOI 10.1111/j.1471-4159.1988.tb01064.x; Butterworth RF, 2007, METAB BRAIN DIS, V22, P309, DOI 10.1007/s11011-007-9072-3; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carbonero-Aguilar P, 2011, LIVER INT, V31, P964, DOI 10.1111/j.1478-3231.2011.02515.x; Chinopoulos C, 2011, METHODS MOL BIOL, V793, P311, DOI 10.1007/978-1-61779-328-8_20; COOPER AJL, 1985, J NEUROCHEM, V44, P1716, DOI 10.1111/j.1471-4159.1985.tb07159.x; Desjardins P, 1999, METAB BRAIN DIS, V14, P273, DOI 10.1023/A:1020741226752; DYKENS JA, 1994, J NEUROCHEM, V63, P584; Felipo V, 2002, NEUROCHEM INT, V40, P487, DOI 10.1016/S0197-0186(01)00119-X; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; Frings M, 2004, LEARN MEMORY, V11, P347, DOI 10.1101/lm.66904; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; GIRARD G, 1993, METAB BRAIN DIS, V8, P207, DOI 10.1007/BF01001062; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Hadjihambi A., 2017, HEPATOL INT; Haussinger Dieter, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS256, DOI 10.1046/j.1440-1746.17.s3.10.x; Hawkins PA, 1996, J APPL PHYSIOL, V80, P885, DOI 10.1152/jappl.1996.80.3.885; Heaton MB, 2000, ALCOHOL CLIN EXP RES, V24, P512, DOI 10.1097/00000374-200004000-00026; HINDFELT B, 1977, J CLIN INVEST, V59, P386, DOI 10.1172/JCI108651; HOYER S, 1990, NEUROSCI LETT, V117, P358, DOI 10.1016/0304-3940(90)90691-2; KAMINSKY YG, 1987, IZV AN SSSR BIOL+, P196; Kaminsky YG, 2014, NEUROCHEM J+, V8, P289, DOI 10.1134/S1819712414030064; Kaur P, 2007, TOXICOLOGY, V230, P164, DOI 10.1016/j.tox.2006.11.058; KITANI K, 1994, ANN NY ACAD SCI, V717, P60, DOI 10.1111/j.1749-6632.1994.tb12073.x; Kosenko E, 1997, METAB BRAIN DIS, V12, P69, DOI 10.1007/BF02676355; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; Kosenko E, 2004, J NEUROCHEM, V89, P1101, DOI 10.1111/j.1471-4159.2004.02426.x; KOSENKO E, 1994, J NEUROCHEM, V63, P2172; Kosenko E, 2003, BRAIN RES, V981, P193, DOI 10.1016/S0006-8993(03)03035-X; KOSENKO E, 1993, BIOCHIM BIOPHYS ACTA, V1180, P321, DOI 10.1016/0925-4439(93)90057-8; Kosenko E, 2001, BRAIN RES PROTOC, V7, P248, DOI 10.1016/S1385-299X(01)00071-X; Kosenko E, 1997, FREE RADICAL RES, V27, P637, DOI 10.3109/10715769709097867; Kosenko E, 2007, J NEUROSCI RES, V85, P2491, DOI 10.1002/jnr.21385; Kosenko EA, 2014, CNS NEUROL DISORD-DR, V13, P1089, DOI 10.2174/1871527313666140806155929; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Lalonde R, 2003, CEREBELLUM, V2, P300, DOI 10.1080/14734220310017456; LAVOIE J, 1987, METAB BRAIN DIS, V2, P283, DOI 10.1007/BF00999698; LEE SH, 1961, SURGERY, V50, P668; LIPPITT B, 1972, J BIOL CHEM, V247, P4688; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manda K, 2007, BEHAV BRAIN RES, V177, P7, DOI 10.1016/j.bbr.2006.11.013; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Norenberg MD, 2004, METAB BRAIN DIS, V19, P313, DOI 10.1023/B:MEBR.0000043978.91675.79; OCONNOR JE, 1990, ADV EXP MED BIOL, V272, P183; Oja SS, 2017, NEUROCHEM RES, V42, P713, DOI 10.1007/s11064-016-2014-x; Rao KVR, 2012, NEUROCHEM INT, V60, P697, DOI 10.1016/j.neuint.2011.09.007; Rao KVR, 2005, NEUROCHEM INT, V47, P31, DOI 10.1016/j.neuint.2005.04.004; Rao VLR, 1997, BRAIN RES, V765, P169, DOI 10.1016/S0006-8993(97)00652-5; Rao VLR, 2002, NEUROCHEM INT, V41, P161, DOI 10.1016/S0197-0186(02)00038-4; RATNAKUMARI L, 1993, NEUROSCI LETT, V161, P37, DOI 10.1016/0304-3940(93)90134-7; Reddy PVB, 2004, NEUROSCI LETT, V368, P15, DOI 10.1016/j.neulet.2004.06.046; Renovell A., 2001, INT J DEV BIOL, V40, pS193; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Romero-Gomez M, 2005, METAB BRAIN DIS, V20, P319, DOI 10.1007/s11011-005-7913-5; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P2406, DOI 10.3748/wjg.v12.i15.2406; Sathyasaikumar KV, 2007, NEUROCHEM RES, V32, P517, DOI 10.1007/s11064-006-9265-x; Satoh T, 1998, J NEUROCHEM, V70, P316; Scorziello A, 2001, J NEUROSCI RES, V63, P20, DOI 10.1002/1097-4547(20010101)63:1<20::AID-JNR3>3.0.CO;2-N; Shevtsova EF, 2017, CNS NEUROL DISORD-DR, V16, P677, DOI 10.2174/1871527316666170424114444; Singh S, 2008, NEUROCHEM RES, V33, P103, DOI 10.1007/s11064-007-9422-x; von Frerichs F. T., 1860, CLIN TREATISE DIS LI; Vornov JJ, 1998, EXP NEUROL, V149, P109, DOI 10.1006/exnr.1997.6673; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; WARHOLM M, 1985, METHOD ENZYMOL, V113, P499; Widmer R, 2007, ARCH BIOCHEM BIOPHYS, V464, P1, DOI 10.1016/j.abb.2007.03.027; Wilde GJC, 1997, J NEUROCHEM, V69, P883; Yang XL, 2010, METAB BRAIN DIS, V25, P11, DOI 10.1007/s11011-010-9174-1; ZIEVE L, 1987, METAB BRAIN DIS, V2, P147, DOI 10.1007/BF00999607	79	16	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2017	113						109	118		10.1016/j.freeradbiomed.2017.09.023	http://dx.doi.org/10.1016/j.freeradbiomed.2017.09.023			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	FN2FP	28964916				2022-09-04	WOS:000415806800010
J	Ramirez, AM; Rodriguez-Lopez, A; Ardila, A; Beltran, L; Patarroyo, CA; Melendez, AD; Sanchez, OF; Almeciga-Diaz, CJ				Maria Ramirez, Aura; Rodriguez-Lopez, Alexander; Ardila, Andrea; Beltran, Laura; Andres Patarroyo, Camilo; Del Pilar Melendez, Adelina; Fernando Sanchez, Oscar; Javier Almeciga-Diaz, Carlos			Production of human recombinant phenylalanine hydroxylase in Lactobacillus plantarum for gastrointestinal delivery	EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Phenylketonuria; Lactobacilli; Phenylalanine hydroxylase; Caco-2 cells	LACTIC-ACID BACTERIA; CELL-TARGETING NANOPARTICLES; ENZYME REPLACEMENT THERAPY; LACTOCOCCUS-LACTIS; AMMONIA-LYASE; ORAL DELIVERY; INTESTINAL BARRIER; PROTEIN SECRETION; SIGNAL PEPTIDES; FUSION PROTEINS	Phenylketonuria (PKU) is an autosomal recessive disorder caused by a defective phenylalanine hydroxylase (PAH), which catalyzes the hydroxylation of L-phenylalanine (L-Phe) to L-tyrosine (L-Tyr) in presence of the cofactor tetrahydrobiopterin (BH4). Defective PAH causes accumulation of phenylalanine, which has neurotoxic effects and leads to dermatological, behavioral, and neurocognitive problems. Treatments for this disease consist in life-long diets that are hard for patients to keep, or supplementation with BH4. In this study, we propose a system where a probiotic lactic acid bacteria (LAB) can be used as vehicle to express in situ an engineered human PAH. Engineered PAHs contain a secretion peptide, a gastrointestinal signal (GI), the human PAH, and a flexible glycine linker followed by the fluorescence protein mEGFP. Engineered constructs were successfully transformed, expressed, and secreted in Lactobacillus plantarum CM_PUJ411. PAH construct containing either the signal peptide GI1 or GI2 were transported through a Caco-2 cell monolayer. Nevertheless, the one containing GI1 allowed the highest transport through the cell monolayer. Co-culture of L. plantarum and Caco-2 cells showed that engineered PAH is produced in-situ and transported through the cell monolayer. Finally, the activity test showed that the engineered PAH secreted by L. plantarum CM_PUJ411 is active, leading to a reduction in L-Phe and an increase in L-Tyr levels, respectively. These results show the potential of this system as a new therapeutic alternative for the treatment of PKU patients.	[Maria Ramirez, Aura; Rodriguez-Lopez, Alexander; Beltran, Laura; Andres Patarroyo, Camilo; Javier Almeciga-Diaz, Carlos] Pontificia Univ Javeriana, Sch Sci, Inst Study Inborn Errors Metab, Bogota, Colombia; [Rodriguez-Lopez, Alexander] Pontificia Univ Javeriana, Sch Sci, Chem Dept, Bogota, Colombia; [Ardila, Andrea] Hosp Univ San Ignacio, Inborn Errors Metab Sect, Clin Lab, Bogota, Colombia; [Del Pilar Melendez, Adelina] Univ Nacl Colombia, Pharm Dept, Bogota, Colombia; [Fernando Sanchez, Oscar] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA		Sanchez, OF (corresponding author), Purdue Univ, Sch Chem Engn, Forney Hall Chem Engn,480 Stadium Mall Dr, W Lafayette, IN 47907 USA.; Almeciga-Diaz, CJ (corresponding author), Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Prot Express & Purificat Lab, Kra 7 43-82 Bldg 54,Room 305A, Bogota, Colombia.	sancheo@purdue.edu; cjalmeciga@javeriana.edu.co	Alméciga-Díaz, Carlos J/A-2494-2017; Rodriguez-Lopez, Edwin Alexander/E-6650-2015; Sanchez, Oscar/A-5612-2013	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Rodriguez-Lopez, Edwin Alexander/0000-0001-5409-3466; Cardona Ramirez, Carolina/0000-0003-4572-956X; Patarroyo, Camilo/0000-0002-3124-1910; ARDILA GOMEZ, YUDY ANDREA/0000-0003-0508-6168; Sanchez, Oscar/0000-0003-2237-0945	Departamento Administrativo de Ciencia y Tecnologia Colciencias [05174, 120356933205, 5170, 120356933427]; Departamento Administrativo de Ciencia y Tecnologia Colciencias	Departamento Administrativo de Ciencia y Tecnologia Colciencias; Departamento Administrativo de Ciencia y Tecnologia Colciencias	The authors want to thank Dr. Lars Axelsson, Norwegian Food Research Institute (Osloveien, Norway), for providing the pSIP503 plasmid. We also thank to Dr. Alfonso Barreto, Pontificia Universidad Javeriana, for providing the Caco-2 cells. LB received a Young Researcher scholarship from Departamento Administrativo de Ciencia y Tecnologia Colciencias. This work was supported by Departamento Administrativo de Ciencia y Tecnologia Colciencias [Grant ID 05174, contract No. 120356933205; and Grant ID 5170, contract No. 120356933427].	Agarwal P, 2014, PHARM RES-DORDR, V31, P3404, DOI 10.1007/s11095-014-1430-3; Alegre MT, 2004, FEMS MICROBIOL LETT, V241, P73, DOI 10.1016/j.femsle.2004.10.006; BARTHOLOME K, 1975, PEDIATR RES, V9, P899, DOI 10.1203/00006450-197509120-00006; Berlec A, 2012, PHARMAZIE, V67, P891, DOI 10.1691/ph.2012.1705; Bermudez-Brito M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0408-6; Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; Cotugno G, 2011, ACTA PAEDIATR, V100, P1144, DOI 10.1111/j.1651-2227.2011.02227.x; Ding Z, 2006, GENE THER, V13, P587, DOI 10.1038/sj.gt.3302684; Dobrowolski SF, 2009, J INHERIT METAB DIS, V32, P10, DOI 10.1007/s10545-008-0942-6; Duerr DM, 2004, J VIROL METHODS, V116, P177, DOI 10.1016/j.jviromet.2003.11.012; Eavri R, 2007, J BIOL CHEM, V282, P23402, DOI 10.1074/jbc.M703367200; Fan TT, 2014, EUR J PHARM BIOPHARM, V88, P518, DOI 10.1016/j.ejpb.2014.06.011; Gamez A, 2004, MOL THER, V9, P124, DOI 10.1016/j.ymthe.2003.11.002; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; Harding CO, 2010, J INHERIT METAB DIS, V33, P681, DOI 10.1007/s10545-010-9099-1; HASHIMOTO K, 1993, CYTOTECHNOLOGY, V13, P175, DOI 10.1007/BF00749813; Heintz C, 2012, MOL GENET METAB, V105, P559, DOI 10.1016/j.ymgme.2011.12.025; Howland J. L., 1996, SHORT PROTOCOLS MOL, P836; Jin Y, 2012, BIOMATERIALS, V33, P1573, DOI 10.1016/j.biomaterials.2011.10.075; Jurecki E., 2008, PKU NEWS, V20, P1; Kang SK, 2008, J BIOTECHNOL, V135, P210, DOI 10.1016/j.jbiotec.2008.01.021; Kang TS, 2010, MOL GENET METAB, V99, P4, DOI 10.1016/j.ymgme.2009.09.002; Karlskas IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091125; Kim W, 2004, MOL THER, V10, P220, DOI 10.1016/j.ymthe.2004.05.001; Kwon KC, 2016, MOL THER, V24, P1342, DOI 10.1038/mt.2016.115; Li HS, 2015, VACCINE, V33, P1959, DOI 10.1016/j.vaccine.2015.02.061; Li X, 2015, PHARM RES-DORDR, V32, P1017, DOI 10.1007/s11095-014-1513-1; Longo N, 2014, LANCET, V384, P37, DOI 10.1016/S0140-6736(13)61841-3; Ortega LFM, 2009, ACTA BIOQUIM CLIN L, V43, P647; Mathiesen G, 2008, J APPL MICROBIOL, V105, P215, DOI 10.1111/j.1365-2672.2008.03734.x; Ng DTW, 2013, APPL ENVIRON MICROB, V79, P347, DOI 10.1128/AEM.02667-12; Oh Y, 2007, ORAL MICROBIOL IMMUN, V22, P140, DOI 10.1111/j.1399-302X.2007.00338.x; Ohlsson A., 2016, SPECTRUM PAH MUTATIO; OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730, DOI 10.1128/AEM.59.8.2730-2733.1993; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35794; Pusch O, 2005, JAIDS-J ACQ IMM DEF, V40, P512, DOI 10.1097/01.qai.0000187446.76579.d3; Qiu Y, 2017, AMINO ACIDS, V49, P75, DOI 10.1007/s00726-016-2327-8; Rossi L, 2014, J CONTROL RELEASE, V194, P37, DOI 10.1016/j.jconrel.2014.08.012; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sanchez-Navarro M, 2016, ADV DRUG DELIVER REV, V106, P355, DOI 10.1016/j.addr.2016.04.031; Sarkissian CN, 2011, MOL GENET METAB, V104, P249, DOI 10.1016/j.ymgme.2011.06.016; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Sarkissian CN, 2005, MOL GENET METAB, V86, pS22, DOI 10.1016/j.ymgme.2005.06.016; Sasikumar P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/280432; Shao J, 2004, INT J PHARMACEUT, V286, P117, DOI 10.1016/j.ijpharm.2004.08.004; Shi Z, 2012, PROTEINS, V80, P61, DOI 10.1002/prot.23159; Sirtori LR, 2005, BBA-MOL BASIS DIS, V1740, P68, DOI 10.1016/j.bbadis.2005.02.005; Skory CD, 2015, APPL MICROBIOL BIOT, V99, P10001, DOI 10.1007/s00253-015-6854-0; Sorvig E, 2003, FEMS MICROBIOL LETT, V229, P119, DOI 10.1016/S0378-1097(03)00798-5; Sulzbacher A, 1998, INT J CLIN PHARM TH, V36, P86; van Spronsen FJ, 2010, MOL GENET METAB, V99, pS90, DOI 10.1016/j.ymgme.2009.10.008; van Vliet D, 2015, MOL GENET METAB, V114, P29, DOI 10.1016/j.ymgme.2014.11.009; VANASSELDONK M, 1990, GENE, V95, P155, DOI 10.1016/0378-1119(90)90428-T; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zhang J, 2014, MOL PHARMACEUT, V11, P1520, DOI 10.1021/mp400685v	56	9	10	2	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-0987	1879-0720		EUR J PHARM SCI	Eur. J. Pharm. Sci.	NOV 15	2017	109						48	55		10.1016/j.ejps.2017.07.033	http://dx.doi.org/10.1016/j.ejps.2017.07.033			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FK2PV	28768147				2022-09-04	WOS:000413325000006
J	Florez, D; Diez, R; Piquet, H; Harb, AKH				Florez, David; Diez, Rafael; Piquet, Hubert; Hay Harb, Abdel Karim			Square-Shape Current-Mode Supply for Parametric Control of the DBD Excilamp Power	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Current control; dielectric; dielectric barrier discharge (DBD); excimer lamp (excilamp); ultraviolet (UV)	DIELECTRIC BARRIER DISCHARGE; LAMP; CONVERTER; EXCIMER; UV; INACTIVATION; DESIGN	With the aim of providing a power supply for the study of dielectric barrier discharge (DBD) excimer lamps (excilamps), a current-mode converter that allows for an accurate adjustment of the electrical power injected into one of those lamps is designed and implemented. Starting from the electrical model of the DBD lamps, the convenience of using a current-mode supply to control the lamp power is demonstrated. With the proposed converter, the current supplied to the lamp has a trapezoidal almost-square shape controlled by means of three parameters, namely, amplitude, duty cycle, and frequency, which provides full control of the lamp electrical power. Implementation is made considering a step-up transformer interfacing the high-voltage lamp with the converter. Experiments demonstrate the operating principle of this converter, including ultraviolet power measurements for a DBD XeCl excilamp. The capabilities of the converter are used to analyze the lamp behavior under different combinations of these three parameters, illustrating its capabilities for finding the optimal operating point of a DBD reactor.	[Florez, David; Diez, Rafael; Hay Harb, Abdel Karim] Pontificia Univ Javeriana, Dept Elect Engn, Bogota 11001000, Colombia; [Florez, David; Piquet, Hubert] Univ Toulouse, Univ Toulouse 3, CNRS,Unite Mixte Rech 5213, Inst Natl Polytech Toulouse,Lab Plasma & Convers, F-31071 Toulouse 7, France; [Florez, David; Hay Harb, Abdel Karim] Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota, Colombia		Florez, D (corresponding author), Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota, Colombia.	david.florez@usa.edu.co; rdiez@javeriana.edu.co; hubert.piquet@laplace.univ-tlse.fr; karim.hay@usa.edu.co	Piquet, Hubert/D-4396-2013	Piquet, Hubert/0000-0002-3736-2676; Diez, Rafael/0000-0002-8107-2844	Colciencias [120352128205]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported in part by Colciencias through Project 120352128205.	Alonso J., 2009, P 13 EUR C POW EL AP, P1; Amjad M, 2014, IEEE T IND ELECTRON, V61, P753, DOI 10.1109/TIE.2013.2251733; Bhosle S, 2006, IEEE IND APPLIC SOC, P1784; Blajan M, 2013, IEEE T IND APPL, V49, P714, DOI 10.1109/TIA.2013.2244543; Bonnin X., 2013, P 15 EUR C POW EL AP, P1; Bonnin X, 2013, EUR PHYS J-APPL PHYS, V64, DOI 10.1051/epjap/2013130080; Borage M, 2007, IEEE T IND ELECTRON, V54, P741, DOI 10.1109/TIE.2007.892254; Bossche A., 2005, INDUCTORS TRANFORMER, P289; Christofi N, 2008, CHEMOSPHERE, V73, P717, DOI 10.1016/j.chemosphere.2008.06.059; Cousineau M, 2012, IEEE T IND ELECTRON, V59, P1920, DOI 10.1109/TIE.2011.2116761; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez R, 2012, IEEE T IND ELECTRON, V59, P1912, DOI 10.1109/TIE.2011.2126536; El-Deib AA, 2011, IEEE T IND APPL, V47, P1971, DOI 10.1109/TIA.2011.2155015; Florez D, 2013, BRAZIL POWER ELECTR, P1171, DOI 10.1109/COBEP.2013.6785263; Florez D, 2014, IEEE T IND APPL, V50, P86, DOI 10.1109/TIA.2013.2271216; Florez D, 2012, P INT CONF OPTIM EL, P1346, DOI 10.1109/OPTIM.2012.6231836; Fukushima T, 2012, IEEE T ELECTRON DEV, V59, P2956, DOI 10.1109/TED.2012.2212709; Gacio D, 2011, IEEE T IND ELECTRON, V58, P589, DOI 10.1109/TIE.2010.2046578; Guivan MM, 2010, IEEE T PLASMA SCI, V38, P1972, DOI 10.1109/TPS.2010.2044588; Kirsten AL, 2013, IEEE T IND ELECTRON, V60, P608, DOI 10.1109/TIE.2012.2205363; Komurcugil H, 2010, IEEE T IND ELECTRON, V57, P1026, DOI 10.1109/TIE.2009.2025297; Kuroki T, 2013, IEEE T IND APPL, V49, P293, DOI 10.1109/TIA.2012.2228612; Le Than D., 2013, IEEE T IND APPL, V49, P331; Lomaev MI, 2012, PROG QUANT ELECTRON, V36, P51, DOI 10.1016/j.pquantelec.2012.03.003; Lomaev MI, 2003, PHYS-USP+, V46, P193, DOI 10.1070/PU2003v046n02ABEH001308; Manlet T C, 1943, T ELECTROCHEM SOC, V84, P83, DOI DOI 10.1149/1.3071556; Matafonova G, 2012, CHEMOSPHERE, V89, P637, DOI 10.1016/j.chemosphere.2012.06.012; Piquet H, 2010, IEEE T PLASMA SCI, V38, P2531, DOI 10.1109/TPS.2010.2060735; Rao JF, 2013, IEEE T PLASMA SCI, V41, P564, DOI 10.1109/TPS.2012.2228885; Schoenbach KH, 2012, IEEE J QUANTUM ELECT, V48, P768, DOI 10.1109/JQE.2012.2185686; Sosnin EA, 2006, J PHOTOCH PHOTOBIO C, V7, P145, DOI 10.1016/j.jphotochemrev.2006.12.002; Stankovic AV, 2012, IEEE T IND ELECTRON, V59, P1815, DOI 10.1109/TIE.2011.2141094; Taleghani AS, 2012, IEEE T PLASMA SCI, V40, P1434, DOI 10.1109/TPS.2012.2187683; Zhang S, 2013, IEEE T PLASMA SCI, V41, P350, DOI 10.1109/TPS.2012.2231965	34	16	17	0	22	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	MAR	2015	62	3					1451	1460		10.1109/TIE.2014.2361601	http://dx.doi.org/10.1109/TIE.2014.2361601			10	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Engineering; Instruments & Instrumentation	CB5OI					2022-09-04	WOS:000349676900013
J	Tomatsu, S; Mackenzie, W; Theroux, M; Mason, R; Thacker, M; Shaffer, T; Montano, A; Almeciga-Diaz, C; Barrera, L; Chinen, Y; Suzuki, Y; Orii, T				Tomatsu, Shunji; Mackenzie, William; Theroux, Mary; Mason, Robert; Thacker, Mihir; Shaffer, Thomas; Montano, Adriana; Almeciga-Diaz, Carlos; Barrera, Luis; Chinen, Yasutsugu; Suzuki, Yasuyuki; Orii, Tadao			Current and emerging treatments and surgical interventions for Morquio A syndrome: A review	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	9th Annual World Symposium of the Lysosomal-Disease-Network (LDN)	FEB 12-15, 2013	Orlando, FL	Lysosomal Dis Network (LDN)					[Tomatsu, Shunji; Mackenzie, William; Theroux, Mary; Mason, Robert; Thacker, Mihir; Shaffer, Thomas] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Montano, Adriana] St Louis Univ, Dept Pediat, St Louis, MO 63103 USA; [Almeciga-Diaz, Carlos; Barrera, Luis] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota, Colombia; [Chinen, Yasutsugu] Univ Ryukyus, Fac Med, Dept Pediat, Nishihara, Okinawa 90301, Japan; [Suzuki, Yasuyuki] Gifu Univ, Med Educ Dev Ctr, Gifu, Japan; [Orii, Tadao] Gifu Univ, Pediat 7Dept, Gifu, Japan				Montano, Adriana/AHE-8741-2022; Thacker, Mihir/AAN-6014-2020; Alméciga-Díaz, Carlos J/A-2494-2017	Alméciga-Díaz, Carlos J/0000-0001-6484-1173					0	0	0	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192			MOL GENET METAB	Mol. Genet. Metab.	FEB	2013	108	2				234	S91	S91		10.1016/j.ymgme.2012.11.248	http://dx.doi.org/10.1016/j.ymgme.2012.11.248			1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	086FW		Green Published, Green Accepted			2022-09-04	WOS:000314670500236
J	Pacheco, P; Aguilar-Stoen, M; Borner, J; Etter, A; Putzel, L; Diaz, MDV				Pacheco, Pablo; Aguilar-Stoen, Mariel; Boerner, Jan; Etter, Andres; Putzel, Louis; Diaz, Maria del Carmen Vera			Landscape Transformation in Tropical Latin America: Assessing Trends and Policy Implications for REDD	FORESTS			English	Article						drivers; land-use change; landscapes; Latin America; REDD	LAND-USE; BRAZILIAN AMAZON; ENVIRONMENTAL SERVICES; LEVEL EVIDENCE; DEFORESTATION; FORESTS; CONSERVATION; AGRICULTURE; EXPANSION; EMISSIONS	Important transformations are underway in tropical landscapes in Latin America with implications for economic development and climate change. Landscape transformation is driven not only by national policies and markets, but also by global market dynamics associated with an increased role for transnational traders and investors. National and global trends affect a disparate number of social, political and economic interactions taking place at the local level, which ultimately shapes land-use and socio-economic change. This paper reviews five different trajectories of landscape change in tropical Latin America, and discusses their implications for development and conservation: (1) Market-driven growth of agribusiness; (2) expansion and modernization of traditional cattle ranching; (3) slow growth of peasant agriculture; (4) logging in production forest frontiers; and (5) resurgence of agro-extractive economies. Contrasting trade-offs between economic development and forest conservation emerge across these landscapes, calling for nuanced policy responses to manage them in the context of climate change. This discussion sets the background to assess how reduction of emissions from deforestation and forest degradation and enhancing carbon stocks (REDD+) aims should be better aligned with current landscape trajectories and associated actors to better address climate-change mitigation in forest landscapes with effective and equitable outcomes.	[Pacheco, Pablo; Putzel, Louis] Jalan CIFOR Situ Gede, Ctr Int Forestry Res CIFOR, Bogor Barat 16115, Indonesia; [Aguilar-Stoen, Mariel] Univ Oslo, Ctr Dev & Environm, N-0855 Oslo, Norway; [Boerner, Jan] CIFOR, BR-22210010 Rio De Janeiro, Brazil; [Etter, Andres] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia; [Diaz, Maria del Carmen Vera] Tufts Univ, Global Dev & Environm Inst GDAE, Medford, MA 02155 USA		Pacheco, P (corresponding author), Jalan CIFOR Situ Gede, Ctr Int Forestry Res CIFOR, Bogor Barat 16115, Indonesia.	p.pacheco@cgiar.org; m.c.a.stoen@sum.uio.no; j.borner@cgiar.org; aetter@javeriana.edu.co; l.putzel@cgiar.org; mariadelcarmenveradiaz@gmail.com	Börner, Jan/ABF-8775-2021; Börner, Jan JB/I-2139-2015; Pacheco, Pablo/I-7090-2019; Pacheco, Pablo/D-9851-2013; Etter, Andrés/E-1860-2011	Börner, Jan/0000-0003-3034-5360; Pacheco, Pablo/0000-0001-7192-6861; Pacheco, Pablo/0000-0001-7192-6861; Etter, Andrés/0000-0003-0665-9300; Aguilar-Stoen, Mariel/0000-0001-8709-4713				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 2010, GLOB FOR RES ASS 201; Arias T., 2009, FEEDSTOCK PRODUCTION; Armas A., 2009, PAGOS SERVICIOS AMBI; Baker M.M., 2004, EIR, V45, P46; Barham B. L., 1999, Unasylva (English ed.), V50, P34; Boerner J, 2007, ECOL ECON, V64, P356, DOI 10.1016/j.ecolecon.2007.03.001; Borner J, 2010, ECOL ECON, V69, P1272, DOI 10.1016/j.ecolecon.2009.11.003; Bradley AV, 2008, ECOL SOC, V13; Bray D.B., 2005, COMMUNITY FORESTS ME; Bray DB, 2002, SOC NATUR RESOUR, V15, P429, DOI 10.1080/08941920252866783; Browder JO, 2004, HUM ECOL, V32, P197, DOI 10.1023/B:HUEC.0000019763.73998.c9; Cadier C., 2004, THESIS ESCOLA INT CO; Carr DL, 2009, POPUL ENVIRON, V30, P222, DOI 10.1007/s11111-009-0090-4; Chape S., 2003, UN LIST PROTECTED AR; Chomitz K, 2007, OVERVIEW LOGGERHEADS; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Cronkleton P., 2009, REFORMAS TENENCIA FO; de Janvry A, 2010, WORLD DEV, V38, P1328, DOI 10.1016/j.worlddev.2010.02.008; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Deininger K. W., 2003, LAND POLICIES GROWTH, DOI DOI 10.1596/0-8213-5071-4; Eakin H, 2006, GEOGR J, V172, P156, DOI 10.1111/j.1475-4959.2006.00195.x; EMBRAPA SOJA, 2008, TECN PROD SOJ REG CE, P262; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Etter A, 2006, LANDSCAPE URBAN PLAN, V77, P240, DOI 10.1016/j.landurbplan.2005.03.002; Etter A, 2006, GLOBAL CHANGE BIOL, V12, P1409, DOI 10.1111/j.1365-2486.2006.01168.x; Faminow MD, 1997, CAN J AGR ECON, V45, P179, DOI 10.1111/j.1744-7976.1997.tb00203.x; FAMINOW MD, 1998, CATTLE DEFORESTATION, P253; FAOSTAT, STAT DAT; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2009, ENVIRON CONSERV, V36, P177, DOI 10.1017/S0376892909990294; Fredericksen TS, 2003, J FOREST, V101, P37; Galford GL, 2010, P NATL ACAD SCI USA, V107, P19649, DOI 10.1073/pnas.1000780107; Gasques E., 2003, DESEMPENHO CRESCIMEN, P45; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Grau HR, 2005, ENVIRON CONSERV, V32, P140, DOI 10.1017/S0376892905002092; Grunwald M., 2008, TIME MAGAZINE; Gwynne R., 2000, LATIN AM TRANSFORMED; Gwynne Robert, 2004, LATIN AM TRANSFORMED; HECHT S, 1992, CONSERVATION NEOTROP; Hecht S. B., 1989, FATE FOREST DEV DEST; Hecht SB, 2006, WORLD DEV, V34, P308, DOI 10.1016/j.worlddev.2005.09.005; Hecht SB, 2005, DEV CHANGE, V36, P375, DOI 10.1111/j.0012-155X.2005.00415.x; Hecht S, 2010, LAND USE POLICY, V27, P161, DOI 10.1016/j.landusepol.2009.08.010; IBGE, 2008, CENS AGR 2006; IBGE, 2010, PESQ AGR MUN 2009; Jaffee D, 2007, BREWING JUSTICE: FAIR TRADE COFFEE, SUSTAINABILITY, AND SURVIVAL, P1; Kaimowitz D, 2008, INT FOREST REV, V10, P485, DOI 10.1505/ifor.10.3.485; Kaimowitz D., 2004, HAMBURGER CONNECTION, P9; KAIMOWITZ D, 1995, 9 EPTD INT FOOD POL; Kaimowitz D., 2003, REV FORESTAL CENTROA, V39-40, P13; Kay C, 2002, THIRD WORLD Q, V23, P1073, DOI 10.1080/0143659022000036649; KAY C, 1995, CAPITAL POWER INEQUA; Killeen TJ, 2008, ECOL SOC, V13; Killeen TJ, 2007, PERFECT STORM AMAZON; Lambin EF, 2003, ENVIRONMENT, V45, P22, DOI 10.1080/00139157.2003.10544695; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Larson A. M., 2008, TENURE RIGHTS COMMUN; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lee D., 2001, TRADEOFFS SYNERGIES; LeGrand Catherine, 1988, COLONIZACION PROTEST; Margulis S., 2004, 22 WORLD BANK; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; MORAN EF, 1984, FRONTIER EXPANSION A, P285; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nelson M., 1977, APROVECHAMIENTO TIER; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pacheco P., 2009, Environment and History, V15, P493, DOI 10.3197/096734009X12532652872072; Pacheco P, 2008, FORESTS GOVERNANCE P; Pacheco P., 1998, ESTILOS DESARROLLO D, P389; Pacheco P., 2008, 12 BIENN C INT ASS S; Pacheco P, 2006, LAND USE POLICY, V23, P205, DOI 10.1016/j.landusepol.2004.09.004; Pacheco P, 2009, WORLD DEV, V37, P1337, DOI 10.1016/j.worlddev.2008.08.019; Pacheco P, 2009, HUM ECOL, V37, P27, DOI 10.1007/s10745-009-9220-y; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pascual U, 2010, ECOL ECON, V69, P1237, DOI 10.1016/j.ecolecon.2009.11.004; Perz SG, 2002, WORLD DEV, V30, P1009, DOI 10.1016/S0305-750X(02)00024-4; PICHON F, 2003, PATTERNS PROCESSES L; Poccard-Chapuis R, 2004, RESEAUX CONQUETE FIL; Pokorny B., 2008, COMMUNITY FORESTRY A; Ponette-Gonzalez AG, 2007, HUM ECOL, V35, P289, DOI 10.1007/s10745-006-9091-4; Putzel L., 2009, 13 WORLD FOR C BUEN; Quijandria B., 2001, ASSESSMENT RURAL POV; Redo D, 2009, APPL GEOGR, V29, P91, DOI 10.1016/j.apgeog.2008.07.007; Grau HR, 2008, ECOL SOC, V13; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Rigg J, 2006, WORLD DEV, V34, P180, DOI 10.1016/j.worlddev.2005.07.015; Riquelme Q., 2006, PARAGUAY SOJERO SOY; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Rodriguez-Medel J.G., 2009, ENV HUMAN DIMENSIONS; Roldan R., 2004, MODELS RECOGNIZING I; Rudel T.K., 1993, TROPICAL DEFORESTATI, P234; Salo M, 2009, ENVIRON MANAGE, V44, P609, DOI 10.1007/s00267-009-9343-3; Schmink M., 1992, CONTESTED FRONTIERS; Silva C.A.B., 1999, ESTUDO EFICIENCIA EC, P226; Stoian D., 2000, THESIS U FREIBURG FR; Takasaki Y., 2000, STAFF PAPER SERIES, V434; Tourrand J.F., 2004, EXPANSAO TRAJETORIAS, P161; UNCTAD (United Nations Conference on Trade and Development), 2009, WORLD INV REP 2009 T; Uriarte M, 2010, BIOTROPICA, V42, P1, DOI 10.1111/j.1744-7429.2009.00580.x; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; van Gelder J.W., 2005, RAINFOREST CHICKEN B; Vinnova, 2014, VINNV PROGR REN MOV; Vosti S., 2003, AGR INTENSIFICATION; Walker R, 2000, WORLD DEV, V28, P683, DOI 10.1016/S0305-750X(99)00149-7; Walker R, 2002, INT REGIONAL SCI REV, V25, P169, DOI 10.1177/016001702762481230; Walker R, 2009, GEOFORUM, V40, P732, DOI 10.1016/j.geoforum.2008.10.009; Wertz-Kanounnikoff S., 2009, REALISING REDD NATL; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010	118	60	60	1	37	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4907		FORESTS	Forests	MAR	2011	2	1					1	29		10.3390/f2010001	http://dx.doi.org/10.3390/f2010001			29	Forestry	Science Citation Index Expanded (SCI-EXPANDED)	Forestry	V28BT		gold, Green Submitted			2022-09-04	WOS:000208657000001
J	Brochero, H; Li, C; Wilkerson, R; Conn, JE; Ruiz-Garcia, M				Brochero, Helena; Li, Cong; Wilkerson, Richard; Conn, Jan E.; Ruiz-Garcia, Manuel			Genetic Structure of Anopheles (Nyssorhynchus) marajoara (Diptera: Culicidae) in Colombia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							HUMAN-POPULATION EXPANSION; AEDES-AEGYPTI DIPTERA; ALBITARSIS COMPLEX; MITOCHONDRIAL-DNA; F-STATISTICS; RARE ALLELES; MICROSATELLITE; GAMBIAE; DIFFERENTIATION; VECTOR	Five Anopheles marajoara Galvao and Damasceno populations. representing diverse ecological conditions. were sampled throughout Colombia and analyzed using nine hypervariable DNA microsatellite loci The overall genetic diversity (H = 0 58) was lower than that determined for some Brazilian populations using the same markers The Caqueta population (Colombia) had the lowest gene diversity (H = 0.48), and it was the only population at Hardy-Wemberg equilibrium. Hardy-Wemberg disequilibrium in the remaining four populations was probably caused by the Wahlund effect. The assignment analyses showed two incompletely isolated gene pools separated by the Eastern Andean cordillera However. other possible geographical barriers (rivers and other mountains) did not play any role in the moderate genetic heterogeneity found among these populations (F-SI = 0 069) These results are noteworthy. because this species is a putative malaria vector in Colombia.	[Ruiz-Garcia, Manuel] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut,Unidad Genet, Bogota, DC, Colombia; [Brochero, Helena] Univ Nacl Colombia, Fac Agron, Bogota, DC, Colombia; [Li, Cong; Wilkerson, Richard] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA; [Conn, Jan E.] NYSDOH, Wadsworth Ctr, Griffin Lab, Slinger Lands, NY USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut,Unidad Genet, Cra 7th 43-82, Bogota, DC, Colombia.		Ruiz-Garcia, Manuel/AAF-8191-2019	Conn, Jan/0000-0002-5301-7020; Ruiz-Garcia, Manuel/0000-0003-2820-2950	Walter Reed Army Institute of Research; Colombian National Health Institute 13; National Institutes of Health [AI R0154139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054139] Funding Source: NIH RePORTER	Walter Reed Army Institute of Research; Colombian National Health Institute 13; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank technical personnel from Health Department of Magdalena (Katiuska Atiza). Antioquia (Armando Galeano). Caqueta (Albeit Polania). Norte de Santander (Euhdes Pabon and Panfilo Lobo). and Meta (Luz Stella Buitrago) This research was performed with institutional support provided by both Walter Reed Army Institute of Research and the Colombian National Health Institute 13:until support was provided by National Institutes of Health Grant AI R0154139 to J E C and Colciencias to B Logistical support was obtained from the Pontificia Universidad Javeriana at Bogota DC, Colombia. to M R -G to early out the population genetics analyses and write the present manuscript	ARCHIE JW, 1985, EVOLUTION, V39, P623, DOI [10.1111/j.1558-5646.1985.tb00399.x, 10.2307/2408657]; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Beaumont MA, 1999, GENETICS, V153, P2013; Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434; Brochero HHL, 2007, AM J TROP MED HYG, V76, P1113, DOI 10.4269/ajtmh.2007.76.1113; Brochero HL, 2005, J AM MOSQUITO CONTR, V21, P182, DOI 10.2987/8756-971X(2005)21[182:BAABSO]2.0.CO;2; COLLINS WE, 1985, J PARASITOL, V71, P771, DOI 10.2307/3281711; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Conn JE, 2002, AM J TROP MED HYG, V66, P18, DOI 10.4269/ajtmh.2002.66.18; Conn JE, 1997, J HERED, V88, P98, DOI 10.1093/oxfordjournals.jhered.a023084; Cornuet JM, 1999, GENETICS, V153, P1989; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; CROW JF, 1984, P NATL ACAD SCI-BIOL, V81, P6073, DOI 10.1073/pnas.81.19.6073; De Sousa GB, 1999, J MED ENTOMOL, V36, P400, DOI 10.1093/jmedent/36.3.400; deSousa GB, 1996, J MED ENTOMOL, V33, P894, DOI 10.1093/jmedent/33.6.894; DinardoMiranda LL, 1996, J MED ENTOMOL, V33, P726, DOI 10.1093/jmedent/33.5.726; dos Santos JMM, 2003, MEM I OSWALDO CRUZ, V98, P247, DOI 10.1590/S0074-02762003000200014; ESTRADAFRANCO JG, 1993, AM J TROP MED HYG, V49, P735, DOI 10.4269/ajtmh.1993.49.735; FARAN M E, 1981, Mosquito Systematics, V13, P1; Garcia-Franco F, 2002, AM J TROP MED HYG, V66, P594, DOI 10.4269/ajtmh.2002.66.594; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; HERRERA S, 1987, PLASMODIUM COLOMB ME, V18, P57; Kamau L, 2002, J MED ENTOMOL, V39, P78, DOI 10.1603/0022-2585-39.1.78; Kamau L, 1999, INSECT MOL BIOL, V8, P287, DOI 10.1046/j.1365-2583.1999.820287.x; Kimmel M, 1998, GENETICS, V148, P1921; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehr MA, 2005, ANN ENTOMOL SOC AM, V98, P908, DOI 10.1603/0013-8746(2005)098[0908:CSITAN]2.0.CO;2; Li C, 2005, MEM I OSWALDO CRUZ, V100, P495, DOI 10.1590/S0074-02762005000500009; Li C, 2005, MOL ECOL NOTES, V5, P65, DOI 10.1111/j.1471-8286.2004.00835.x; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; MENDOZA M, 2000, SITUACION MALARIA CO; *MIN PROT SOC I NA, 2009, INFORM QUINCENAL EPI, V14, P47; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; Molina-Cruz A, 2004, AM J TROP MED HYG, V71, P350, DOI 10.4269/ajtmh.2004.71.350; Motoki MT, 2009, MEM I OSWALDO CRUZ, V104, P823, DOI 10.1590/S0074-02762009000600004; NARANG SK, 1993, BIOCHEM GENET, V31, P97, DOI 10.1007/BF02399823; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Onyabe DY, 2001, HEREDITY, V87, P647, DOI 10.1046/j.1365-2540.2001.00957.x; POSSO G CARMEN ELISA, 2006, Rev. Colomb. Entomol., V32, P49; Pritchard JK, 2000, GENETICS, V155, P945; QUINONES ML, 1990, J AM MOSQUITO CONTR, V6, P602; Ravel S, 2001, ACTA TROP, V78, P241, DOI 10.1016/S0001-706X(01)00083-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Reich DE, 1999, MOL BIOL EVOL, V16, P453, DOI 10.1093/oxfordjournals.molbev.a026127; Rongnoparut P, 1999, AM J TROP MED HYG, V60, P508, DOI 10.4269/ajtmh.1999.60.508; Rousset F, 1997, GENETICS, V145, P1219; RubioPalis Y, 1997, J MED ENTOMOL, V34, P499, DOI 10.1093/jmedent/34.5.499; Ruiz-Garcia M, 2006, RUSS J GENET+, V42, P752, DOI 10.1134/S102279540607009X; Ruiz-Garcia M, 2000, GENES GENET SYST, V75, P269, DOI 10.1266/ggs.75.269; Ruiz-Garcia M, 1998, ACTA THERIOL, V43, P39, DOI 10.4098/AT.arch.98-4; Ruiz-Garcia Manuel, 2003, Genetics and Molecular Research, V2, P229; RUIZGARCIA M, 1993, J HERED, V84, P173, DOI 10.1093/oxfordjournals.jhered.a111312; Scarpassa VM, 2000, GENET MOL BIOL, V23, P71, DOI 10.1590/S1415-47572000000100013; *SEM, 1957, PLAN ERR MAL COL, V1; SEM (Servicio de Erradicacion de la Malaria. Ministerio de Salud Publica. Republica de Colombia), 1957, PLAN ERR MAL COL, VII; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; TAKAHATA N, 1983, GENETICS, V104, P497; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.1111/j.1558-5646.1984.tb05657.x, 10.2307/2408641]; Wilkerson R.C., 1993, Insect Molecular Biology, V1, P205, DOI 10.1111/j.1365-2583.1993.tb00093.x; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354	76	10	11	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2010	83	3					585	595		10.4269/ajtmh.2010.09-0482	http://dx.doi.org/10.4269/ajtmh.2010.09-0482			11	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	645SZ	20810825	Green Published			2022-09-04	WOS:000281487800026
J	Jimenez-Sierra, DA; Quintero-Olaya, DA; Alvear-Munoz, JC; Benitez-Restrepo, HD; Florez-Ospina, JF; Chanussot, J				Jimenez-Sierra, David Alejandro; Quintero-Olaya, David Alfredo; Alvear-Munoz, Juan Carlos; Benitez-Restrepo, Hernan Dario; Florez-Ospina, Juan Felipe; Chanussot, Jocelyn			Graph Learning Based on Signal Smoothness Representation for Homogeneous and Heterogeneous Change Detection	IEEE TRANSACTIONS ON GEOSCIENCE AND REMOTE SENSING			English	Article						Feature extraction; Kernel; Synthetic aperture radar; Data models; Computational modeling; Satellites; Remote sensing; Change detection (CD); graph signal processing (GSP); graphs; smoothness; spectral filtering	UNSUPERVISED CHANGE DETECTION; OF-THE-ART; IMAGE FUSION; FRAMEWORK	Graph-based methods are promising approaches for traditional and modern techniques in change detection (CD) applications. Nonetheless, some graph-based approaches omit the existence of useful priors that account for the structure of a scene, and the inter- and intra-relationships between the pixels are analyzed. To address this issue, in this article, we propose a framework for CD based on graph fusion and driven by graph signal smoothness representation. In addition to modifying the graph learning stage, in the proposed model, we apply a Gaussian mixture model for superpixel segmentation (GMMSP) as a downsampling module to reduce the computational cost required to learn the graph of the entire images. We carry out tests on 14 real cases of natural disasters, farming, and construction. The dataset contains homogeneous cases with multispectral (MS) and synthetic aperture radar (SAR) images, along with heterogeneous cases that include MS/SAR images. We compare our approach against probabilistic thresholding, unsupervised learning, deep learning, and graph-based methods. In terms of Cohen's kappa coefficient, our proposed model based on graph signal smoothness representation outperformed state-of-the-art approaches in ten out of 14 datasets.	[Jimenez-Sierra, David Alejandro; Quintero-Olaya, David Alfredo; Alvear-Munoz, Juan Carlos; Benitez-Restrepo, Hernan Dario] Pontificia Univ Javeriana Secc Cali, Dept Elect & Ciencias Comp, Cali 760031, Colombia; [Florez-Ospina, Juan Felipe] Univ Delaware, Multimodal Imaging & Spectroscopy Lab, Newark, DE 19716 USA; [Chanussot, Jocelyn] Univ Grenoble Alpes, CNRS, Grenoble INP, GIPSA Lab, F-38000 Grenoble, France		Jimenez-Sierra, DA (corresponding author), Pontificia Univ Javeriana Secc Cali, Dept Elect & Ciencias Comp, Cali 760031, Colombia.	davidjimenez@javerianacali.edu.co; quintero98@javerianacali.edu.co; juanca970816@javerianacali.edu.co; hbenitez@javerianacali.edu.co; jfflorez@udel.edu; jocelyn.chanussot@grenobleinp.fr	Florez-Ospina, Juan Felipe/GPG-3868-2022	Chanussot, Jocelyn/0000-0003-4817-2875; Quintero Olaya, David Alfredo/0000-0002-6325-5719; Jimenez Sierra, David Alejandro/0000-0002-5403-9547	OMICAS Program: "Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar)"; Colombian Scientific Ecosystem by The World Bank; Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Tourism; ICETEX [FP44842-217-2018]; OMICAS [79261187]; PROGRAMA ECOS-NORD INTERCAMBIO DE INVESTIGADORES COLOMBIA-FRANCIA 2021 - MINCIENCIAS, The Ministere de l'Europe et des Affaires etrangeres (MEAE); Le Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI); MIAI@Grenoble Alpes [ANR-19-P3IA-0003]	OMICAS Program: "Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar)"; Colombian Scientific Ecosystem by The World Bank; Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Tourism; ICETEX; OMICAS; PROGRAMA ECOS-NORD INTERCAMBIO DE INVESTIGADORES COLOMBIA-FRANCIA 2021 - MINCIENCIAS, The Ministere de l'Europe et des Affaires etrangeres (MEAE); Le Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI); MIAI@Grenoble Alpes	This work was funded by the OMICAS Program: "Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar)," anchored at the Pontificia Universidad Javeriana in Cali and funded within the Colombian Scientific Ecosystem by The World Bank, the Colombian Ministry of Science, Technology and Innovation, the Colombian Ministry of Education, the Colombian Ministry of Industry and Tourism, and ICETEX, under Grant ID: FP44842-217-2018 and OMICAS Award ID: 79261187. This research also received funding from PROGRAMA ECOS-NORD INTERCAMBIO DE INVESTIGADORES COLOMBIA-FRANCIA 2021, supported by MINCIENCIAS, The Ministere de l'Europe et des Affaires etrangeres (MEAE), and Le Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI). This work has been partially supported by MIAI@Grenoble Alpes, (ANR-19-P3IA-0003).	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Jimenez-Sierra DA, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12172683; Ban ZH, 2018, IEEE T IMAGE PROCESS, V27, P4105, DOI 10.1109/TIP.2018.2836306; Chen H, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12101662; Ding MT, 2010, IEEE GEOSCI REMOTE S, V7, P761, DOI 10.1109/LGRS.2010.2047241; Dong XW, 2019, IEEE SIGNAL PROC MAG, V36, P44, DOI 10.1109/MSP.2018.2887284; Ghosh A, 2011, INFORM SCIENCES, V181, P699, DOI 10.1016/j.ins.2010.10.016; Gong MG, 2012, IEEE T IMAGE PROCESS, V21, P2141, DOI 10.1109/TIP.2011.2170702; He F, 2020, IEEE T NEUR NET LEAR, V31, P626, DOI 10.1109/TNNLS.2019.2908504; Hong DF, 2021, IEEE T GEOSCI REMOTE, V59, P5966, DOI 10.1109/TGRS.2020.3015157; Hong DF, 2021, IEEE T GEOSCI REMOTE, V59, P4340, DOI 10.1109/TGRS.2020.3016820; Iyer G, 2021, IEEE T GEOSCI REMOTE, V59, P4419, DOI 10.1109/TGRS.2020.2971395; Jimenez-Sierra David Alejandro, 2021, 2021 IEEE International Geoscience and Remote Sensing Symposium IGARSS, P2895, DOI 10.1109/IGARSS47720.2021.9555107; Kalofolias V., 2019, P 7 INT C LEARN REPR; Kalofolias V, 2016, JMLR WORKSH CONF PRO, V51, P920; Khan SH, 2017, IEEE T GEOSCI REMOTE, V55, P5407, DOI 10.1109/TGRS.2017.2707528; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; Krylov VA, 2016, IEEE T IMAGE PROCESS, V25, P4704, DOI 10.1109/TIP.2016.2593340; Lehoucq Richard B, 1998, ARPACK USERS GUIDE S, V6; Lei T, 2019, IEEE T IMAGE PROCESS, V28, P5510, DOI 10.1109/TIP.2019.2920514; Lei T, 2019, IEEE GEOSCI REMOTE S, V16, P982, DOI 10.1109/LGRS.2018.2889307; Liu SC, 2017, PROC SPIE, V10198, DOI 10.1117/12.2263024; Liu Z, 2018, IEEE T IMAGE PROCESS, V27, P1822, DOI 10.1109/TIP.2017.2784560; Luppino L. T., 2022, IEEE T GEOSCI ELECT, V60, P1; Luppino LT, 2019, IEEE T GEOSCI REMOTE, V57, P9960, DOI 10.1109/TGRS.2019.2930348; Ma L, 2019, ISPRS J PHOTOGRAMM, V152, P166, DOI 10.1016/j.isprsjprs.2019.04.015; Marcos D, 2016, PROC CVPR IEEE, P5091, DOI 10.1109/CVPR.2016.550; Mateos G, 2019, IEEE SIGNAL PROC MAG, V36, P16, DOI 10.1109/MSP.2018.2890143; MIAN A, 2019, PROCESS, V67, P520; Mura MD, 2015, P IEEE, V103, P1585, DOI 10.1109/JPROC.2015.2462751; Niu XD, 2019, IEEE GEOSCI REMOTE S, V16, P45, DOI 10.1109/LGRS.2018.2868704; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perraudin N., 2014, ARXIV14085781; Saboksayr SS, 2021, SIGNAL PROCESS, V186, DOI 10.1016/j.sigpro.2021.108101; Serviansky H., 2020, P ADV NEUR INF PROC, V33, P22080; Seydi ST, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12122010; Shekkizhar S, 2020, IEEE IMAGE PROC, P1956, DOI 10.1109/ICIP40778.2020.9191232; Shi WZ, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12101688; Song M, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101664; Sun YL, 2022, IEEE T GEOSCI REMOTE, V60, P221, DOI 10.1109/TGRS.2021.3053571; Sun YL, 2021, IEEE T IMAGE PROCESS, V30, P6277, DOI 10.1109/TIP.2021.3093766; Sun YL, 2021, PATTERN RECOGN, V109, DOI 10.1016/j.patcog.2020.107598; Touati R, 2020, IEEE T IMAGE PROCESS, V29, P757, DOI 10.1109/TIP.2019.2933747; Tran DQ, 2020, PLANT PROD SCI, V23, P129, DOI 10.1080/1343943X.2019.1682462; Tuia D, 2016, ISPRS J PHOTOGRAMM, V120, P1, DOI 10.1016/j.isprsjprs.2016.07.004; Vakalopoulou Maria, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P61, DOI 10.1109/CVPRW.2015.7301384; Zanetti M, 2018, IEEE T GEOSCI REMOTE, V56, P1129, DOI 10.1109/TGRS.2017.2759663; Zanetti M, 2015, IEEE T IMAGE PROCESS, V24, P5004, DOI 10.1109/TIP.2015.2474710; Zhang CX, 2020, ISPRS J PHOTOGRAMM, V166, P183, DOI 10.1016/j.isprsjprs.2020.06.003; Zhang M, 2020, IEEE T GEOSCI REMOTE, V58, P7232, DOI 10.1109/TGRS.2020.2981051; Zhang R, 2022, IEEE T NEUR NET LEAR, V33, P1355, DOI 10.1109/TNNLS.2020.3042330; ZhiYong L, 2022, IEEE GEOSC REM SEN M, V10, P44, DOI 10.1109/MGRS.2021.3088865	52	1	1	8	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0196-2892	1558-0644		IEEE T GEOSCI REMOTE	IEEE Trans. Geosci. Remote Sensing		2022	60								4410416	10.1109/TGRS.2022.3168126	http://dx.doi.org/10.1109/TGRS.2022.3168126			16	Geochemistry & Geophysics; Engineering, Electrical & Electronic; Remote Sensing; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Geochemistry & Geophysics; Engineering; Remote Sensing; Imaging Science & Photographic Technology	1D7GB					2022-09-04	WOS:000793964300015
J	Morales, AR; Higa, C; Ramos, M; Alonso, O; Cobos, L; Funes, D; Cocarelli, T				Ruiz Morales, A.; Higa, C.; Ramos, M.; Alonso, O.; Cobos, L.; Funes, D.; Cocarelli, T.			REAL-LIFE EFFECTIVENESS AND SAFETY OF FIXED COMBINATION AMLODIPINE/IRBESARTAN IN THE MANAGEMENT OF HYPERTENSION IN LATIN AMERICA: RESULTS FROM THE PARCERIA STUDY	JOURNAL OF HYPERTENSION			English	Meeting Abstract	28th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH)	JUN 08-11, 2018	Barcelona, SPAIN	AIM Grp Int, Rome Off, European Soc Hypertens					[Ruiz Morales, A.] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Higa, C.] Hosp Aleman, Buenos Aires, DF, Argentina; [Ramos, M.] Hosp San Jose Satelite, Naucaplan De Juarez, Mexico; [Alonso, O.] Hosp Univ Esperanza, Guatemala City, Guatemala; [Cobos, L.] Hosp El Pino, Santiago, Chile; [Funes, D.] Sanofi Argentina, San Isidro, Argentina; [Cocarelli, T.] Consultoria Estatist, Sao Paulo, Brazil										0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	JUN	2018	36			1			E148	E149		10.1097/01.hjh.0000539395.12451.7d	http://dx.doi.org/10.1097/01.hjh.0000539395.12451.7d			2	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology	HH3BM					2022-09-04	WOS:000455593900443
J	Hidalgo, M; Carvajal, LP; Rincon, S; Faccini-Martinez, AA; Palacios, AAT; Mercado, M; Paloma, SL; Rayo, LX; Acevedo, JA; Reyes, J; Panesso, D; Garcia-Padilla, P; Alvarez, C; Arias, CA				Hidalgo, Marylin; Carvajal, Lina P.; Rincon, Sandra; Faccini-Martinez, Alvaro A.; Tres Palacios, Alba A.; Mercado, Marcela; Paloma, Sandra L.; Rayo, Leidy X.; Acevedo, Jessica A.; Reyes, Jinnethe; Panesso, Diana; Garcia-Padilla, Paola; Alvarez, Carlos; Arias, Cesar A.			Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogota, Colombia	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; SOFT-TISSUE INFECTIONS; NASAL COLONIZATION; RISK-FACTORS; CARRIAGE; EVOLUTION; SKIN; IDENTIFICATION; PREVALENCE; PERSISTENT	We aimed to determine the prevalence of MRSA colonization and examine the molecular characteristics of colonizing isolates in patients receiving hemodialysis and HIV-infected in a Colombian hospital. Patients on hemodialysis and HIV-infected were prospectively followed between July 2011 and June 2012 in Bogota, Colombia. Nasal and axillary swabs were obtained and cultured. Colonizing S. aureus isolates were identified by standard and molecular techniques. Molecular typing was performed by using pulse-field gel electrophoresis and evaluating the presence of lukF-PV/lukS-PV by PCR. A total of 29% (n = 82) of HIV-infected and 45.5% (n = 15) of patients on hemodialysis exhibited S. aureus colonization. MSSA/MRSA colonization was observed in 28% and 3.6% of the HIV patients, respectively and in 42.4% and 13.3% of the hemodialysis patients, respectively. Staphylococcal cassette chromosome mec typing showed that four MRSA isolates harbored the type IV cassette, and one type I. In the hemodialysis group, two MRSA isolates were classified as belonging to the USA300-LV genetic lineage. Conversely, in the HIV infected group, no colonizing isolates belonging to the USA300-Latin American Variant (UDA300-LV) lineage were identified. Colonizing isolates recovered from the HIV-infected group belonged to the prevalent hospital-associated clones circulating in Latin America (Chilean [n = 1] and Pediatric [n = 2]). The prevalence of MRSA colonization in the study groups was 3.6% (HIV) and 13.3% (hemodialysis). Surveillance programs should be implemented in this group of patients in order to understand the dynamics of colonization and infection in high-risk patients.	[Hidalgo, Marylin; Faccini-Martinez, Alvaro A.; Tres Palacios, Alba A.; Paloma, Sandra L.; Rayo, Leidy X.; Acevedo, Jessica A.] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia; [Carvajal, Lina P.; Rincon, Sandra; Reyes, Jinnethe; Panesso, Diana; Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Mercado, Marcela] Inst Nacl Salud, Direcc Vigilancia & Anal Riesgo Salud Publ, Bogota, Colombia; [Panesso, Diana; Arias, Cesar A.] Univ Texas Med Sch Houston, Div Infect Dis, Dept Internal Med, Houston, TX USA; [Garcia-Padilla, Paola; Alvarez, Carlos] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia.	hidalgo.m@javeriana.edu.co	Moreno, carlos Arturo alvarez/P-6678-2016; Hidalgo, Marylin/AAF-5736-2019	Moreno, carlos Arturo alvarez/0000-0001-5419-4494; Garcia Padilla, Paola Karina/0000-0001-9852-749X; Hidalgo, Marylin/0000-0001-8960-0616; Faccini-Martinez, Alvaro A./0000-0002-1127-0132; Rincon, Sandra/0000-0002-8482-4554; TRESPALACIOS RANGEL, ALBA ALICIA/0000-0002-7540-5868	Pontificia Universidad Javeriana [4553]; NIH [R01 AI093749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093749] Funding Source: NIH RePORTER	Pontificia Universidad Javeriana; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Pontificia Universidad Javeriana provided financial support for the project "Colonizacion por Staphylococcus aureus en una cohorte de pacientes con riesgo de adquirir una infeccion (VIH y hemodialisis)", code 4553. CAA is supported by NIH grant R01 AI093749.	Aktas E, 2011, AM J INFECT CONTROL, V39, P421, DOI 10.1016/j.ajic.2010.06.012; Alexander EL, 2011, DIAGN MICR INFEC DIS, V70, P37, DOI 10.1016/j.diagmicrobio.2010.12.005; Alvarez CA, 2006, EMERG INFECT DIS, V12, P2000; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Bettin A, 2012, BRAZ J INFECT DIS, V16, P329, DOI 10.1016/j.bjid.2012.06.017; Bogut A, 2007, NEW MICROBIOL, V30, P149; Carrillo RG, 2011, CLIN NEPHROL, V75, P174, DOI 10.5414/CN106479; Cenizal MJ, 2008, JAIDS-J ACQ IMM DEF, V48, P567, DOI 10.1097/QAI.0b013e31817e9b79; Cole J, 2013, CURR HIV-AIDS REP, V10, P244, DOI 10.1007/s11904-013-0161-0; Creech CB, 2010, ARCH PEDIAT ADOL MED, V164, P615, DOI 10.1001/archpediatrics.2010.93; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FitzGerald F, 2011, J HOSP INFECT, V79, P218, DOI 10.1016/j.jhin.2011.06.015; Foster TJ, 2004, NAT MED, V10, P447, DOI 10.1038/nm0504-447a; Friedel David, 2007, Curr Infect Dis Rep, V9, P201, DOI 10.1007/s11908-007-0032-1; Ghazvini Kiarash, 2007, Iran J Kidney Dis, V1, P21; Giarola LB, 2012, BRAZ J MICROBIOL, V43, P923, DOI [10.1590/S1517-83822012000300011, 10.1590/S1517-838220120003000011]; Hidron Alicia I, 2010, Infect Drug Resist, V3, P73; Imaz A, 2013, J INFECTION, V66, P199, DOI 10.1016/j.jinf.2012.10.013; Imaz A, 2010, AIDS REV, V12, P153; Institute CaLS, 2013, PERF STAND ANT SUSC; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Lai CF, 2013, J FORMOS MED ASSOC, V112, P365, DOI 10.1016/j.jfma.2012.07.009; Melles DC, 2008, MICROBES INFECT, V10, P151, DOI 10.1016/j.micinf.2007.10.017; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Padoveze MC, 2008, AM J INFECT CONTROL, V36, P187, DOI 10.1016/j.ajic.2007.05.012; Planet PJ, 2015, J INFECT DIS; Popovich KJ, 2013, CLIN INFECT DIS, V56, P1067, DOI 10.1093/cid/cit010; Popovich KJ, 2012, CLIN INFECT DIS, V54, P1296, DOI 10.1093/cid/cis030; Popovich KJ, 2010, CLIN INFECT DIS, V50, P979, DOI 10.1086/651076; Reyes J, 2014, 54 INT C ANT AG CHEM; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Song YH, 2012, VACCINE, V30, P3675, DOI 10.1016/j.vaccine.2012.03.031; Sowash MG, 2013, METHODS MOL BIOL, V185, P25, DOI 10.1007/978-1-62703-664-1_2; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Uehara Y, 2013, J HOSP INFECT, V84, P81, DOI 10.1016/j.jhin.2013.01.004; Uhlemann AC, 2012, GENOME BIOL EVOL, V4, P1275, DOI 10.1093/gbe/evs094; Verhoeven PO, 2014, EXPERT REV ANTI-INFE, V12, P75, DOI 10.1586/14787210.2014.859985; Wang CY, 2012, J FORMOS MED ASSOC, V111, P14, DOI 10.1016/j.jfma.2012.01.001; Wang SH, 2015, J CLIN MICROBIOL, V53, P1599, DOI 10.1128/JCM.03147-14; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004	45	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140748	10.1371/journal.pone.0140748	http://dx.doi.org/10.1371/journal.pone.0140748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474075	Green Submitted, gold, Green Published			2022-09-04	WOS:000363185500099
J	Pantoja, A; Nava, EM; Quijano, N				Pantoja, Andres; Mojica Nava, Eduardo; Quijano, Nicanor			Sum of squares decomposition: theory and applications in control	INGENIERIA E INVESTIGACION			English	Article						sum of squares (SOS); stability analysis; nonlinear systems; switched systems	LOCAL STABILITY ANALYSIS; SYSTEMS	The sum of squares (SOS) decomposition technique allows numerical methods such as semidefinite programming to be used for proving the positivity of multivariable polynomial functions. It is well known that it is not an easy task to find Lyapunov functions for stability analysis of nonlinear systems. An algorithmic tool is used in this work for solving this problem. This approach is presented as SOS programming and solutions were obtained with a Matlab toolbox. Simple examples of SOS concepts, stability analysis for nonlinear polynomial and rational systems with uncertainties in parameters are presented to show the use of this tool. Besides these approaches, an alternative stability analysis for switched systems using a polynomial approach is also presented.	[Pantoja, Andres] Univ Nacl Colombia, Sede Manizales, Colombia; [Pantoja, Andres] Univ Narino, Pasto, Colombia; [Mojica Nava, Eduardo] Univ Ind Santander, Santander, Colombia; [Mojica Nava, Eduardo] Univ Catolica, Bogota, Colombia; [Quijano, Nicanor] Pontificia Univ Javeriana, Bogota, Colombia; [Quijano, Nicanor] Univ Los Andes, Bogota, Colombia		Pantoja, A (corresponding author), Univ Nacl Colombia, Sede Manizales, Colombia.	ad.pantoja24@uniandes.edu.co; ea.mojica70@uniandes.edu.co; nquijano@uniandes.edu.co	Quijano, Nicanor/B-4730-2011	Quijano, Nicanor/0000-0002-8688-3195				Anjos MF, 2008, SIAM J OPTIMIZ, V18, P1310, DOI 10.1137/06066847X; Burden R., 1985, NUMERICAL ANAL PWS; Ebenbauer C., 2004, 6th IFAC Symposium on Nonlinear Control Systems (NOLCOS 2004), P1025; Ebenbauer C, 2006, COMPUT CHEM ENG, V30, P1590, DOI 10.1016/j.compchemeng.2006.05.014; Franze G, 2009, LECT NOTES CONTR INF, V384, P491; Khalil H., 2000, NONLINEAR SYSTEMS, V3rd; Mojica-Nava E, 2010, SYST CONTROL LETT, V59, P98, DOI 10.1016/j.sysconle.2009.12.004; Pantoja AD, 2008, P AMER CONTR CONF, P3390, DOI 10.1109/ACC.2008.4587016; Papachristodoulou A, 2004, P AMER CONTR CONF, P4153; Papachristodoulou A, 2002, IEEE DECIS CONTR P, P3482, DOI 10.1109/CDC.2002.1184414; Parrilo P.A., 2000, THESIS CALTECH; Parrilo PA, 2003, MATH PROGRAM, V96, P293, DOI 10.1007/s10107-003-0387-5; Prajna S., 2004, 2004 IEEE International Symposium on Computer Aided Control Systems Design (IEEE Cat. No.04TH8770), P315, DOI 10.1109/CACSD.2004.1393895; Prajna S., SOSTOOLS SUM SQUARES, P91125; Reznick B., 2000, CONTEMP MATH, V253, P251, DOI [10.1090/conm/253/03936, DOI 10.1090/CONM/253/03936]; Topcu U, 2008, AUTOMATICA, V44, P2669, DOI 10.1016/j.automatica.2008.03.010; Topcu U, 2009, IEEE T AUTOMAT CONTR, V54, P1042, DOI 10.1109/TAC.2009.2017157; Zhang LJ, 2007, J MATH ANAL APPL, V334, P414, DOI 10.1016/j.jmaa.2006.12.065; Zhao J, 2008, SYST CONTROL LETT, V57, P158, DOI 10.1016/j.sysconle.2007.08.011	19	0	0	1	3	UNIV NAC COLOMBIA, FAC INGENIERIA	BOGOTA	CARRERA 30 NO 45-03, EDIFICIO 408 CADE, BOGOTA, DC 00000, COLOMBIA	0120-5609	2248-8723		ING INVEST	Ing. Invest.	DEC	2010	30	3					57	70						14	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	V28FS					2022-09-04	WOS:000208667300006
J	Villar, LA; Valbuena, G; Hidalgo, M; Gonzalez, M; Rey, G; Martinez, R; Coronel, C; Tiga, D; Diaz, F; Agudelo, P				Villar, Luis A.; Valbuena, Gustavo; Hidalgo, Marylin; Gonzalez, Martha; Rey, Gloria; Martinez, Ruth; Coronel, Carolina; Tiga, Diana; Diaz, Fredi; Agudelo, Piedad			ETIOLOGY OF NONSPECIFIC ACUTE FEBRILE SYNDROME IN A DENGUE ENDEMIC URBAN AREA IN COLOMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	59th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 03-07, 2010	Atlanta, GA	Amer Soc Trop Med & Hyg (ASTMH)					[Villar, Luis A.; Martinez, Ruth; Coronel, Carolina; Tiga, Diana; Diaz, Fredi] Univ Ind Santander, Bucaramanga, Colombia; [Valbuena, Gustavo] Univ Texas Galveston, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA; [Hidalgo, Marylin] Pontificia Univ Javeriana, Bogota, Colombia; [Gonzalez, Martha; Rey, Gloria] Inst Nacl Salud, Bogota, Colombia; [Agudelo, Piedad] Inst Colombiano Med Trop, Medellin, Colombia										0	0	0	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2010	83	5		S		900	269	269						1	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Tropical Medicine	832QF					2022-09-04	WOS:000295819701268
J	Diez, H; Lopez, MC; Thomas, MD; Guzman, F; Rosas, F; Velazco, V; Gonzalez, JM; Puerta, C				Diez, H; Lopez, MC; Thomas, MD; Guzman, F; Rosas, F; Velazco, V; Gonzalez, JM; Puerta, C			Evaluation of IFN-gamma production by CD8(+) T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi	PARASITE IMMUNOLOGY			English	Article						CD8(+) T lymphocytes; Chagas disease; HLA-A*0201 epitope; KMP-11; Trypanosoma cruzi	KINETOPLASTID MEMBRANE PROTEIN-11; CHAGAS-DISEASE; LEISHMANIA-DONOVANI; IMMUNE-RESPONSE; TRANSGENIC MICE; CELLS; IDENTIFICATION; ANTIGEN; IMMUNIZATION; EPITOPES	The cellular response mediated by MHC class I restricted CD8(+)T cells has been shown to be crucial in the control of Chagas disease. The K1 peptide derived from T. cruzi KMP-11 protein has a high binding affinity to the HLA-A*0201 molecule. Nevertheless, it is not known whether this peptide is processed and displayed as an MHC class I epitope during natural infection by T. cruzi. The aim of this study was to evaluate, by ELISPOT assay, the ability of K1 peptide to activate CD8(+)T lymphocytes to produce IFN-gamma. Therefore, CD8(+)T lymphocytes from 22 HLA-A*0201(+)individuals, 12 chronic chagasic patients and 10 uninfected controls, were analysed. The results revealed that two of the chagasic patients had IFN-gamma-secreting CD8(+)T cells that were able to respond to K1 peptide with a relative frequency of 110 and 230 per million CD8(+)T cells. In contrast, none of HLA-A*0201(+)uninfected controls responded to K1 peptide. Responses to HLA-A*0201 restricted peptide from the influenza matrix protein were found in six chagasic patients and four uninfected controls with an average frequency of 175 and 111 cells per million CD8(+)T cells, respectively. Moreover, a flow cytometric assay for degranulation showed that chagasic responders had K1-specific cytotoxic CD8(+) T cells. It is shown here for the first time that the K1 peptide is efficiently processed, presented and recognized by CD8(+)T lymphocytes during the natural course of Chagas disease.	Pontificia Univ Javeriana, Mol Parasitol Lab, Dept Microbiol, Fac Ciencias, Bogota, Colombia; CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; Univ Nacl Colombia, Fac Med, Bogota, Colombia; Fdn Clin Shaio, Bogota, Colombia; Univ So Calif, Dept Neurol, Keck Sch Med, Los Angeles, CA USA		Puerta, C (corresponding author), Pontificia Univ Javeriana, Mol Parasitol Lab, Dept Microbiol, Fac Ciencias, Bogota, Colombia.	cpuerta@javeriana.edu.co	DIEZ, HUGO/AAF-5743-2019; Thomas, María Carmen PhD/D-9065-2016; Zaky, Mohammad/I-3187-2017; Guzman, Fanny fg/K-5592-2013; Lopez, Manuel/Z-5641-2019; Puerta, Concepcion J/AAG-4912-2019	DIEZ, HUGO/0000-0002-3412-5691; Zaky, Mohammad/0000-0003-3547-2588; Guzman, Fanny fg/0000-0003-1537-0904; Lopez, Manuel Carlos/0000-0003-0002-3678; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Thomas, M Carmen/0000-0003-3586-9657; Gonzalez, John M./0000-0001-6925-0620; Mursalin, Adi/0000-0002-1867-0868				Andrade ALSS, 2004, AM J TROP MED HYG, V71, P594, DOI 10.4269/ajtmh.2004.71.594; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BRODSKYN CI, 1989, IMMUNOL CELL BIOL, V67, P343, DOI 10.1038/icb.1989.50; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Cervetta L, 2002, ACTA PARASITOL, V47, P73; DosReis GA, 1997, PARASITOL TODAY, V13, P335, DOI 10.1016/S0169-4758(97)01073-9; Fleischhauer K, 1998, TISSUE ANTIGENS, V51, P204; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Garcia F, 2003, MICROBES INFECT, V5, P351, DOI 10.1016/S1286-4579(03)00044-3; Gonzalez JM, 2000, PARASITE IMMUNOL, V22, P501, DOI 10.1046/j.1365-3024.2000.00331.x; Jensen ATR, 1998, SCAND J IMMUNOL, V48, P103; Kumar S, 2001, J IMMUNOL, V166, P4596, DOI 10.4049/jimmunol.166.7.4596; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; Mukhopadhyay S, 1999, VACCINE, V17, P291, DOI 10.1016/S0264-410X(98)90017-2; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; Ramirez JR, 2001, VACCINE, V20, P455, DOI 10.1016/S0264-410X(01)00341-3; Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x; TOLSON DL, 1994, INFECT IMMUN, V62, P4893, DOI 10.1128/IAI.62.11.4893-4899.1994; *WHO, 1991, WHO TECH REP SER, V811, P1; *WHO, 2002, WHO TECHN REP SER, V905, P82	26	30	31	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	MAR	2006	28	3					101	105		10.1111/j.1365-3024.2005.00815.x	http://dx.doi.org/10.1111/j.1365-3024.2005.00815.x			5	Immunology; Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Parasitology	007QW	16441508				2022-09-04	WOS:000234985400006
J	Morvaridzadeh, M; Nachvak, SM; Agah, S; Sepidarkish, M; Dehghani, F; Rahimlou, M; Pizarro, AB; Heshmati, J				Morvaridzadeh, Mojgan; Nachvak, Seyed Mostafa; Agah, Shahram; Sepidarkish, Mahdi; Dehghani, Fereshteh; Rahimlou, Mehran; Beatriz Pizarro, Ana; Heshmati, Javad			Effect of soy products and isoflavones on oxidative stress parameters: A systematic review and meta-analysis of randomized controlled trials	FOOD RESEARCH INTERNATIONAL			English	Review						Soy; Isoflavones; Malondialdehyde; Oxidative stress	SOYBEAN ISOFLAVONES; INSULIN-RESISTANCE; ANTIOXIDANT STATUS; MILK CONSUMPTION; GENISTEIN SUPPLEMENTATION; POSTMENOPAUSAL WOMEN; LIPID-PEROXIDATION; DIABETIC-PATIENTS; BLOOD-PRESSURE; NITRIC-OXIDE	Soy products and isoflavones intake have been shown to exert antioxidant effects. There are several randomized control trials (RCTs) that evaluated the effect of soy products intake on oxidative stress (OS) parameters. The aim of the present systematic review and meta-analysis was to summarize the results of RCTs evaluating the effect of soy products and isoflavones intake on OS parameters. Randomized trials that assessed the effect of soy products and isoflavones intake on OS parameters in adults were identified through searching in electronic databases: Cochrane clinical trial center, Embase, PubMed, Scopus, and Web of Sciences up to April 2020. Random effects model was used to calculate the effects sizes of soy intake on OS parameters. Twenty-four trials with 1,852 participants were eligible and were included in the meta-analysis which measured OS parameters. Soy intake compared to control group significantly reduced MDA levels (SMD: -0.53; 95% CI: -0.86, -0.19; I-2 = 88.3%), increased GSH levels (SMD: 0.51; 95% CI: 0.13, 0.88; I-2 = 72.4%), SOD activity (SMD: 0.53; 95% CI: 0.08, 0.99; I-2 = 84.1%), TAC (SMD: 0.54; 95% CI: 0.27, 0.82; I-2 = 49.3%) and TRAP (SMD: 1.74; 95% CI: 0.82, 2.65; I-2 = 81.3%) significantly compared to control group. Soy products and isoflavones intake are effective in improving OS parameters in adults compared with controls; thus, it could be a valuable advise to control OS progress in chronic diseases.	[Morvaridzadeh, Mojgan; Nachvak, Seyed Mostafa; Heshmati, Javad] Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Kermanshah, Iran; [Agah, Shahram] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Sepidarkish, Mahdi] Babol Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Babol, Iran; [Dehghani, Fereshteh] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran, Iran; [Rahimlou, Mehran] Ahvaz Jundishapour Univ Med Sci, Fac Paramed, Nutr Dept, Ahvaz, Iran; [Beatriz Pizarro, Ana] Pontificia Univ Javeriana, Dept Epidemiol & Biostat, Bogota, Colombia		Heshmati, J (corresponding author), Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Fac Nutr Sci & Food Technol, Isar Sq, Kermanshah 6715847141, Iran.	a.pizarro@javeriana.edu.co; javad.heshmati@gmail.com	Pizarro, Ana Beatriz/AAC-8021-2022; Morvaridzadeh, Mojgan/GLU-6418-2022; heshmati, javad/H-6812-2019; Rahimlou, Mehran/AAL-4902-2021; sepidarkish/N-6176-2019	Pizarro, Ana Beatriz/0000-0003-4089-454X; Morvaridzadeh, Mojgan/0000-0002-1771-4697; heshmati, javad/0000-0002-2676-0185; Rahimlou, Mehran/0000-0002-7861-8287				Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Amanat S, 2018, CLIN NUTR, V37, P1210, DOI 10.1016/j.clnu.2017.05.028; Babajafari S, 2018, BURNS, V44, P140, DOI 10.1016/j.burns.2017.05.014; Bahls LD, 2011, ARQ BRAS ENDOCRINOL, V55, P399, DOI 10.1590/S0004-27302011000600006; Bajkacz S, 2017, TALANTA, V168, P329, DOI 10.1016/j.talanta.2017.02.065; Bakhtiari A, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0441-y; Bakhtiari A, 2017, BIOMED REP, V7, P331, DOI 10.3892/br.2017.964; Beavers KM, 2009, NUTR RES, V29, P616, DOI 10.1016/j.nutres.2009.09.002; Bodaghi M. N., 2019, Tehran University Medical Journal, V76, P748; Bondonno CP, 2016, CRIT REV FOOD SCI, V56, P2036, DOI 10.1080/10408398.2013.811212; Brandao LC, 2009, BIOL RES, V42, P281, DOI [/S0716-97602009000300002, 10.4067/S0716-97602009000300002]; Braxas H, 2019, CAN J DIABETES, V43, P490, DOI 10.1016/j.jcjd.2019.04.007; Chowdhury P, 2002, ANN CLIN LAB SCI, V32, P188; de Santana MB, 2008, NUTRITION, V24, P562, DOI 10.1016/j.nut.2008.02.007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duchnik E, 2019, POSTEP DERM ALERGOL, V36, P760, DOI 10.5114/ada.2019.87280; Farah C, 2018, NAT REV CARDIOL, V15, P292, DOI 10.1038/nrcardio.2017.224; Fritz KL, 2003, NUTR RES, V23, P479, DOI 10.1016/S0271-5317(03)00005-8; Ghahari S, 2017, CURR MICROBIOL, V74, P522, DOI 10.1007/s00284-016-1188-4; Giles D, 1997, NUTR CANCER, V29, P77, DOI 10.1080/01635589709514605; Giolo JS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040424; Hematdar Z, 2018, J DIABETES METAB DIS, V17, P111, DOI 10.1007/s40200-018-0346-6; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Illesca PG, 2017, BIOMED PHARMACOTHER, V88, P1008, DOI 10.1016/j.biopha.2017.01.153; Incir S, 2016, LIFE SCI, V158, P57, DOI 10.1016/j.lfs.2016.06.014; Jamilian M, 2016, J CLIN ENDOCR METAB, V101, P3386, DOI 10.1210/jc.2016-1762; Jamilian M, 2015, J CLIN ENDOCR METAB, V100, P4654, DOI 10.1210/jc.2015-3454; Janaszewska A, 2002, SCAND J CLIN LAB INV, V62, P231, DOI 10.1080/003655102317475498; Javanbakht MH, 2014, NEFROLOGIA, V34, P483, DOI 10.3265/Nefrologia.pre2014.Jun.12051; Kangari Parisa, 2018, Asian Pac J Cancer Prev, V19, P3511; Karamali M, 2018, J HUM NUTR DIET, V31, P533, DOI 10.1111/jhn.12545; Khan TH, 2012, INT J PHARMACOL, V8, P30, DOI 10.3923/ijp.2012.30.38; Kurzer MS, 2002, J NUTR, V132, p570S, DOI 10.1093/jn/132.3.570S; Kwak JH, 2013, HYPERTENS RES, V36, P1060, DOI 10.1038/hr.2013.79; Lemasters JJ, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P714; Lepetsos P, 2016, BBA-MOL BASIS DIS, V1862, P576, DOI 10.1016/j.bbadis.2016.01.003; Li Robert, 2016, React Oxyg Species (Apex), V1, P9, DOI 10.20455/ros.2016.803; Li Y, 2017, FOOD FUNCT, V8, P2935, DOI 10.1039/c7fo00342k; Liu YT, 2016, J FUNCT FOODS, V26, P135, DOI 10.1016/j.jff.2016.07.011; Lu MP, 2008, NUTR METAB CARDIOVAS, V18, P618, DOI 10.1016/j.numecd.2007.05.003; Luo QH, 2019, MOLECULES, V24, DOI 10.3390/molecules24162966; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maleki Z, 2019, COMPLEMENT THER MED, V44, P44, DOI 10.1016/j.ctim.2019.02.020; Martin-Gallan P, 2003, FREE RADICAL BIO MED, V34, P1563, DOI 10.1016/S0891-5849(03)00185-0; Miraghajani MS, 2012, DIABETES CARE, V35, P1981, DOI 10.2337/dc12-0250; Mohammad-Shahi M, 2016, NUTR DIET, V73, P139, DOI 10.1111/1747-0080.12174; Moradi M, 2020, CRIT REV FOOD SCI, V60, P3414, DOI 10.1080/10408398.2019.1689097; Nachvak SM, 2019, J ACAD NUTR DIET, V119, P1483, DOI 10.1016/j.jand.2019.04.011; Nematgorgani S, 2017, J HERB MED, V9, P32, DOI 10.1016/j.hermed.2017.05.002; Nikander E, 2003, J CLIN ENDOCR METAB, V88, P5180, DOI 10.1210/jc.2003-030362; Pusparini, 2013, ASIA PAC J CLIN NUTR, V22, P357, DOI 10.6133/apjcn.2013.22.3.13; Rawat S, 2019, EXCLI J, V18, P950, DOI 10.17179/excli2019-1847; Reimann M, 2006, J NUTR, V136, P100, DOI 10.1093/jn/136.1.100; Sahin K, 2010, FOOD CHEM TOXICOL, V48, P2670, DOI 10.1016/j.fct.2010.06.038; Sattarahmady N, 2015, GALEN MED J, V4, P62; Schmitz ID, 2019, MOL BIOL REP, V46, P2285, DOI 10.1007/s11033-019-04684-z; Sedaghat A, 2019, DIABETES METAB SYND, V13, P1387, DOI 10.1016/j.dsx.2019.01.057; Seo WD, 2017, FOOD SCI BIOTECHNOL, V26, P339, DOI 10.1007/s10068-017-0046-x; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; Szymczak G, 2017, J FOOD COMPOS ANAL, V57, P40, DOI 10.1016/j.jfca.2016.12.015; Taleb A, 2018, BIOMED PHARMACOTHER, V102, P689, DOI 10.1016/j.biopha.2018.03.140; Tehrani SS, 2018, J CELL BIOCHEM, V119, P223, DOI 10.1002/jcb.26217; Teixeira CP, 2019, GYNECOL ENDOCRINOL, V35, P586, DOI 10.1080/09513590.2018.1559287; Uifalean A, 2016, MOLECULES, V21, DOI 10.3390/molecules21010013; Vega-Lopez S, 2005, AM J CLIN NUTR, V81, P43; Wang B, 2017, EXP THER MED, V14, P276, DOI 10.3892/etm.2017.4469; Yamagata K, 2019, J CARDIOVASC PHARM, V74, P201, DOI 10.1097/FJC.0000000000000708; Yaribeygi H, 2018, CNS NEUROL DISORD-DR, V17, P207, DOI 10.2174/1871527317666180425122557; Zemel MB, 2010, AM J CLIN NUTR, V91, P16, DOI 10.3945/ajcn.2009.28468; Zhang R, 2012, J CELL BIOCHEM, V113, P1987, DOI 10.1002/jcb.24068; Zhang X., 2019, IEEE SENS J, P1, DOI DOI 10.1109/JSEN.2019.2911431	71	11	11	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	NOV	2020	137								109578	10.1016/j.foodres.2020.109578	http://dx.doi.org/10.1016/j.foodres.2020.109578			11	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	OY0PP	33233189				2022-09-04	WOS:000593956500013
J	Stonis, JR; Diskus, A; Remeikis, A; Vargas, SA; Solis, MA				Stonis, Jonas R.; Diskus, Arunas; Remeikis, Andrius; Vargas, Sergio A.; Solis, M. Alma			Diagnostics and updated catalogue of Acalyptris Meyrick, the second largest genus of Nepticulidae (Lepidoptera) in the Americas	ZOOTAXA			English	Article						distribution; leaf mines; new species; pygmy moths; Neotropics; North America; South America; species groups	COMPLEX LEPIDOPTERA; REVISION; PERU	We list all 56 currently known Acalyptris Meyrick species from North and South America, designate five new species groups, and provide pictorial diagnostics for all nine revised species groups of the American fauna. We describe seven new species: A. marmor Stonis & Diskus, sp. nov., A. barbudo Stonis & Remeikis, sp. nov., A. jareki Stonis & Diskus, sp. nov., A. hilli Stonis & Diskus, sp. nov., A. mortalis Diskus & Stonis, sp. nov., A. hyacinthum Stonis & Vargas, sp. nov., and A. extremus Stonis & Diskus, sp. nov. We provide new data on morphology, biology or distribution for the following species: A. murex Diskus & Stonis, A. hispidus Puplesis & Robinson, A. frifidus Puplesis & Robinson, A. bifidus Puplesis & Robinson, A. terrificus Simkeviciute & Stonis, and particularly A. yucatani Remeikis & Stonis. We transfer Fomoria miranda Diskus & Stonis to Acalyptris and provide the first photographic documentation of A. novenarius Puplesis & Robinson, A. fortis Puplesis & Robinson, A. martinheringi Puplesis & Robinson, A. basihastatus Puplesis & Diskus, A. pseudohastatus Puplesis & Diskus, A. articulosus Puplesis & Diskus, A. bovicorneus Puplesis & Diskus, andA. insolentis Puplesis & Diskus. We also comment on the re-deposition of some type series to the collection of the Zoological Museum of the Natural History Museum of Denmark, Copenhagen.	[Stonis, Jonas R.; Diskus, Arunas; Remeikis, Andrius] Nat Res Ctr, Inst Ecol, Akad St 2, LT-08412 Vilnius, Lithuania; [Stonis, Jonas R.; Diskus, Arunas; Remeikis, Andrius] Baltic Amer Biotaxon Inst, Akad St 2, LT-08412 Vilnius, Lithuania; [Vargas, Sergio A.] Jardin Bot Bogota Jose Celestino Mutis, Av Calle 63 68-95, Bogota, Colombia; [Vargas, Sergio A.] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, Carrera 7,43-82, Bogota, Colombia; [Solis, M. Alma] ARS, Systemat Entomol Lab, USDA, Natl Museum Nat Hist,Smithsonian Inst, Washington, DC 20013 USA		Stonis, JR (corresponding author), Nat Res Ctr, Inst Ecol, Akad St 2, LT-08412 Vilnius, Lithuania.; Stonis, JR (corresponding author), Baltic Amer Biotaxon Inst, Akad St 2, LT-08412 Vilnius, Lithuania.	stonis.biotaxonomy@gmail.com		Vargas, Sergio/0000-0002-6716-905X; Diskus, Arunas/0000-0003-0106-5546; Stonis, Jonas Rimantas/0000-0002-8411-3162	Research Council of Lithuania [S-MIP-19-30]; Lithuanian Research Council; Consejo Nacional de Areas Protegidas (CONAP) Guatemala, C.A. [12900]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Lithuanian Research Council(Research Council of Lithuania (LMTLT)); Consejo Nacional de Areas Protegidas (CONAP) Guatemala, C.A.	We are indebted to our Ecuadorian scientific partners, including to those who participated in the initial project in 1999 by R. Puplesis, S. R. Hill, and Professor Giovanni Onore, former professor at the Pontifical Catholic University of Ecuador, Quito, Ecuador. We thank the Consejo Nacional de Areas Protegidas (CONAP) Guatemala, C.A. for the Licencia de Colecta o Aprovechamiento de Vida Silvestre (No. 12900) and the Autoridad Nacional de Licencias Ambientales, Bogota, Colombia, for Collecting Permit No. 2019007511-1-000. Julia Puplesyte-Chambers and Jonas R. Stonis thank the Environmental Programme at the Andes Office of NGO DAR Peru for permission for Julia Puplesyte-Chambers to attend training courses and fieldwork on the project "Rapid assessment of biodiversity plots of critical value in the provinces Chanchamayo and Satipo, Peru," in cooperation with the Baltic-American Biotaxonomy Institute in 2017-2018.; This research was partially funded by a grant (S-MIP-19-30, "DiagnoStics") from the Research Council of Lithuania. Andrius Remeikis is grateful to the Lithuanian Research Council for the research stipend he was awarded in 2019.	Braun A. F., 1925, Transactions of the American Entomological Society, V51, P183; Braun Annette F., 1910, Entomological News Philadelphia, V21; Braun Annette P., 1917, Transactions of the American Entomological Society, V43; Chambers VT, 1873, CAN ENTOMOL, V5, P124, DOI DOI 10.4039/ENT5124-7; Chambers VT, 1876, CAN ENTOMOL, V8, P158, DOI [10.4039/Ent8158-8, DOI 10.4039/ENT8158-8]; DAVIS DR, 1978, FLA ENTOMOL, V61, P209, DOI 10.2307/3494210; Diskus A., 2012, LEAF MINING INSECTS; Johansson R., 1990, Fauna Entomologica Scandinavica, V23, P1; Kaila L, 2015, ZOOTAXA, V3980, P301, DOI 10.11646/zootaxa.3980.3.1; Kaila L, 2015, ZOOTAXA, V3963, P517, DOI 10.11646/zootaxa.3963.4.3; Kaila L, 2011, MONOGR AUST LEPIDOPT, V11, P7; Meyrick, 1921, EXOTIC MICROLEPIDOPT, V2, P385, DOI DOI 10.1136/BMJ.2.3167.416; MULLER-RUTZ J., 1934, MITTEIL SCHWEIZER ENT GES, V16, P118; Nieukerken EJ, 1986, ZOOLOGISCHE VERHANDE, V236, P1; Pohl GR, 2018, ANNOTATED CHECKLIST; Puplesis R., 2003, MONOGRAPH; Puplesis R., 1994, NEPTICULIDAE E EUROP; Puplesis Rimantas, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P19, DOI 10.1017/S0968045402000020; Puplesis Rimantas, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P59, DOI 10.1017/S0968045402000032; Puplesis Rimantas, 2000, Bulletin of the Natural History Museum Entomology Series, V69, P3; Scoble M.J., 1983, Transvaal Museum Monograph, P1; Simkeviciute Agne, 2009, Acta Zoologica Lituanica, V19, P268, DOI 10.2478/v10043-009-0037-0; Stonis J.R., 2014, 1 BALT INT C FIELD E; Stonis JR, 2019, ZOOKEYS, P87, DOI 10.3897/zookeys.900.46332; Stonis Jonas R., 2018, Biologija, V64, P191; Stonis JR, 2018, P ENTOMOL SOC WASH, V120, P842, DOI 10.4289/0013-8797.120.4.842; Stonis JR, 2018, ZOOTAXA, V4469, P1, DOI 10.11646/zootaxa.4469.1.1; Stonis JR, 2018, ZOOTAXA, V4392, P458, DOI 10.11646/zootaxa.4392.3.2; Stonis JR, 2017, ZOOTAXA, V4338, P489, DOI 10.11646/zootaxa.4338.3.5; Stonis JR, 2017, ZOOTAXA, V4272, P1, DOI 10.11646/zootaxa.4272.1.1; Stonis JR, 2017, ZOOTAXA, V4257, P1, DOI [10.11646/zootaxa.4257.1, 10.11646/zootaxa.4257.1.1]; Stonis JR, 2016, ZOOTAXA, V4200, P561, DOI 10.11646/zootaxa.4200.4.7; Stonis JR, 2015, ZOOTAXA, V4057, P79, DOI 10.11646/zootaxa.4057.1.4; Stonis JR, 2014, ZOOTAXA, V3887, P321, DOI 10.11646/zootaxa.3887.3.3; Stonis JR, 2013, ZOOTAXA, V 3737, P201, DOI 10.11646/zootaxa.3737.3.1; Stonis JR, 2013, ZOOTAXA, V 3737, P101, DOI 10.11646/zootaxa.3737.2.1; Stonis JR, 2013, ZOOTAXA, V3609, P223, DOI 10.11646/zootaxa.3609.2.8; Van Nieukerken EJ, 2007, ZOOTAXA, P1; van Nieukerken EJ, 2016, ZOOKEYS, P65, DOI 10.3897/zookeys.628.9799; van Nieukerken EJ, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.628.9805; WAGNER DL, 1987, PAN-PAC ENTOMOL, V63, P278; WILKINSON C, 1979, Tijdschrift voor Entomologie, V122, P59; WILKINSON C, 1979, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm111107fv	43	3	3	1	2	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	MAR 6	2020	4748	2					201	247		10.11646/zootaxa.4748.2.1	http://dx.doi.org/10.11646/zootaxa.4748.2.1			47	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	KT0CL	32230072				2022-09-04	WOS:000518678100001
J	Ruiz-Garcia, M; Albino, A; Pinedo-Castro, M; Zeballos, H; Bello, A; Leguizamon, N; Shostell, JM				Ruiz-Garcia, Manuel; Albino, Aymara; Pinedo-Castro, Myreya; Zeballos, Horacio; Bello, Aurita; Leguizamon, Norberto; Shostell, Joseph Mark			First Molecular Phylogenetic Analysis of the Lagothrix Taxon Living in Southern Peru and Northern Bolivia: Lagothrix lagothricha tschudii (Atelidae, Primates), a New Subspecies	FOLIA PRIMATOLOGICA			English	Article						Lagothrix lagothricha tschudii; Mitochondrial genes; Phylogenetic analyses; Andean mountains; Pleistocene; Peru	WORLD MONKEYS PLATYRRHINI; POPULATION-GENETICS; CAT POPULATIONS; MAXIMUM-LIKELIHOOD; STATISTICAL TESTS; AOTUS PLATYRRHINI; WOOLLY MONKEYS; PHYLOGEOGRAPHY; COII; NEUTRALITY	We sequenced mitochondrial COI and COII genes (1,377 base pairs) of 166 woolly monkeys (Lagothrix) to determine the phylogenetic relationships of tschudii in reference to the other taxa within the genus Lagothrix, to provide the first genetic diversity level estimates for tschudii, and to reconstruct the historical demographic evolution of this taxon. The sample set included, for the first time, 10 individuals of the elusive tschudii taxon sensu Groves from southern Peru and northern Bolivia. Our phylogenetic analyses showed that these 10 exemplars formed a statistically significant and differentiated (molecularly and morphologically) monophyletic clade relative to other traditional subspecies of Lagothrix lagothricha. Therefore, tschudii should be recognized as a fifth subspecies: Lagothrix lagothricha tschudii. The temporal divergence of the ancestors of tschudii and L. l. cana was estimated to have occurred around 1.8 million years ago (MYA). Additionally, mitochondrial diversification within tschudii started no later than 0.96 MYA (Bayesian Inference) or 0.88 MYA (Median Joining -Network), respectively. In contrast to the phylogenetic trees, the FST statistic and the gene flow estimates showed L. l. lugens to be the least differentiated taxon of L. lagothricha from L. l. tschudii. Based on genetic distances, L. l. tschudii had the smallest average genetic distance from the other subspecies of L. lagothricha. It was also the taxon within L. lagothricha that had the smallest genetic distance from L. flavicauda. It should be related to L. l. tschudii as the first original taxon in L. lagothricha. Furthermore, the Andean mountains were extremely important in the original diversification of the Lagothrix genus and in the original diversification of L. lagothricha. Although L. l. tschudii has the smallest geographical range of all the taxa of L. lagothricha, its genetic diversity is even higher than in other taxa with wider geographical ranges, such as L. l. lagothricha and L. l. cana. L. l. tschudii showed a very slight demographic increase during the Pleistocene with a decrease of females in the last 10,000 Y, similar to that found for L. l. lugens in a previous study. (C) 2019 S. Karger AG, Basel	[Ruiz-Garcia, Manuel; Albino, Aymara; Pinedo-Castro, Myreya] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Genet,Lab Genet Poblac Biol Evolut, Bogota, Colombia; [Zeballos, Horacio] Univ Nacl San Agustin Arequipa MUSA, Museo Hist Nat, Arequipa, Peru; [Zeballos, Horacio] Pontificia Univ Catolica Peru PUCP, Inst Ciencias Nat, Terr & Energias Renovables, Lima, Peru; [Bello, Aurita; Leguizamon, Norberto] SDA, Bogota, Colombia; [Shostell, Joseph Mark] Univ Minnesota, Math Sci & Technol Dept, Crookston, MN USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Genet, Fac Ciencias, Cra 7A 43-82, Bogota, Colombia.	mruizgar@yahoo.es	Castro, Myreya Pinedo/AAF-8450-2019; Ruiz-Garcia, Manuel/AAF-8191-2019; Ponce-Soto, Luis Alberto/B-1328-2017	Ponce-Soto, Luis Alberto/0000-0001-5976-2913				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen JA, 1900, B AM MUS NAT HIST, V13, P219; Andrews TD, 2000, J MOL EVOL, V50, P562, DOI 10.1007/s002390010059; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; ASHLEY MV, 1995, INT J PRIMATOL, V16, P793, DOI 10.1007/BF02735720; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Botero S, 2015, MOL PHYLOGENET EVOL, V82, P511, DOI 10.1016/j.ympev.2014.05.019; Botero S, 2014, DEV PRIMATOL-PROG PR, V39, P17, DOI 10.1007/978-1-4939-0697-0_2; Botero S, 2010, AM J PRIMATOL, V72, P1131, DOI 10.1002/ajp.20878; Burrell AS, 2009, MOL PHYLOGENET EVOL, V51, P340, DOI 10.1016/j.ympev.2009.02.004; Caviedes CN, 1975, J GLACIOL, V14, P155; Chung WK, 2008, INT J PRIMATOL, V29, P1341, DOI 10.1007/s10764-008-9303-4; Clapperton C. M., 1981, REV CTR INTERAMERICA, V6, P93; Clark PU, 2002, SCIENCE, V298, DOI 10.1126/science.298.5591.7; Collins AC, 2000, INT J PRIMATOL, V21, P381, DOI 10.1023/A:1005435718241; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Cossios D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-68; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Di Fiore A, 2015, MOL PHYLOGENET EVOL, V82, P495, DOI 10.1016/j.ympev.2014.03.028; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elliot DG, 1909, ANN MAGAZINE NATURAL, V8, P244; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fooden J., 1963, Journal of Mammalogy, V44, P213, DOI 10.2307/1377454; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Geoffroy Saint Hilaire E., 1812, ANN MUS HIST NAT PAR, V19, P85, DOI DOI 10.5962/BHL.TITLE.46654; Geoffroyi I, 1851, CATALOGUE METHODIQUE, P1; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Groves C. P., 2001, PRIMATE TAXONOMY; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; International Commission on Stratigraphy, 2007, INT STRAT CHART; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Kiesling NMJ, 2015, MOL PHYLOGENET EVOL, V82, P386, DOI 10.1016/j.ympev.2014.03.027; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Levi T, 2013, BIOL CONSERV, V163, P99, DOI 10.1016/j.biocon.2013.03.016; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MACFADDEN BJ, 1990, J HUM EVOL, V19, P7, DOI 10.1016/0047-2484(90)90010-9; MacNeish R.S., 1979, PRELLANO CULTURES AM, P1; Maslin MA, 2000, SCIENCE, V290, P2285; Meireles CM, 1999, MOL PHYLOGENET EVOL, V12, P10, DOI 10.1006/mpev.1998.0574; Mercer JH, 1984, ZENTRALBLATT GEOLOGI, V11, P1661; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nascimento FF, 2015, J BIOGEOGR, V42, P1349, DOI 10.1111/jbi.12448; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nylander J.A.A, 2004, MRMODELTEST V2 PROGR; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Plautz HL, 2009, MOL PHYLOGENET EVOL, V51, P382, DOI 10.1016/j.ympev.2009.01.005; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pucheran J, 1857, REV MAGASIN ZOOLOGIE, V2, P289; Rambaut A., 2014, TRACER V16; Rambaut A, 2013, TREEANNOTATOR V1 8 0; Rambaut A., 2012, FIGTREE VERSION 140; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rodbell DT, 2000, QUATERNARY RES, V54, P328, DOI 10.1006/qres.2000.2177; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rosenberger AL, 2002, CAM S BIO EVOL ANTHR, V33, P151; Ruiz-Garcia M, 2010, MOL PHYLOGENET EVOL, V57, P1049, DOI 10.1016/j.ympev.2010.09.002; Ruiz-Garcia M, 2000, GENES GENET SYST, V75, P269, DOI 10.1266/ggs.75.269; Ruiz-Garcia M, 1999, GENET MOL BIOL, V22, P493, DOI 10.1590/S1415-47571999000400006; Ruiz-Garcia M, 2013, MOL POPULATION GENET, P97; Ruiz-Garcia M, 2018, MAMM BIOL, V93, P153, DOI 10.1016/j.mambio.2018.09.004; Ruiz-Garcia M, 2017, FOLIA PRIMATOL, V88, P421, DOI 10.1159/000480502; Ruiz-Garcia M, 2015, PRIMATES, V56, P145, DOI 10.1007/s10329-014-0452-0; Ruiz-Garcia M, 2014, MOL PHYLOGENET EVOL, V79, P179, DOI 10.1016/j.ympev.2014.05.034; Ruiz-Garcia M, 2011, INT J PRIMATOL, V32, P1218, DOI 10.1007/s10764-011-9539-2; Ruiz-Garcia M, 2010, FOLIA PRIMATOL, V81, P109, DOI 10.1159/000315070; RUIZGARCIA M, 1993, J HERED, V84, P173, DOI 10.1093/oxfordjournals.jhered.a111312; RUIZGARCIA M, 1994, GENET SEL EVOL, V26, P39, DOI 10.1051/gse:19940104; RuizGarcia M, 1997, J GENET, V76, P1, DOI 10.1007/BF02931765; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Sambrook J., 1989, MOL CLONING LAB MANU; Slack JH, 1863, P NATIONAL ACADEMY S, V1862, P507; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STROBECK C, 1987, GENETICS, V117, P149; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI [10.1093/molbev/msm092, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thomas O., 1880, Proceedings of the Zoological Society, P393; Thomas O., 1920, P US NATL MUS, V58, P217, DOI DOI 10.5479/SI.00963801.58-2333.217; Thomas O, 1899, ANN MAGAZINE NATUR 7, V7, P40, DOI DOI 10.1080/00222939908678073; Thomas O, 1901, ANN MAGAZINE NATURAL, V7, P178; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; VANDERHAMMEN T, 1985, J GEOL SOC LONDON, V142, P483, DOI 10.1144/gsjgs.142.3.0483; VANDERHAMMEN T, 1992, HIST ECOLOGIA VEGETA; Wallace Robert B., 1999, Neotropical Primates, V7, P111; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019	100	4	6	2	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0015-5713	1421-9980		FOLIA PRIMATOL	Folia Primatol.		2019	90	4					215	239		10.1159/000497251	http://dx.doi.org/10.1159/000497251			25	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	IE7IU					2022-09-04	WOS:000472548500002
J	Figueroa-Lara, A; Aguirre-Perez, T; Tapetado-Rodriguez, F; Puente-Maestu, L; Fernando-Cifuentes, L; Canas-Arboleda, A; Cangelosi, MJ				Figueroa-Lara, A.; Aguirre-Perez, T.; Tapetado-Rodriguez, F.; Puente-Maestu, L.; Fernando-Cifuentes, L.; Canas-Arboleda, A.; Cangelosi, M. J.			COST-EFFECTIVENESS ANALYSIS OF BRONCHIAL THERMOPLASTY VERSUS PHARMACOLOGICAL THERAPIES IN PATIENTS WITH SEVERE ASTHMA IN MEXICO, COLOMBIA AND SPAIN	VALUE IN HEALTH			English	Meeting Abstract									[Figueroa-Lara, A.] Boston Sci Mexico, Mexico City, DF, Mexico; [Aguirre-Perez, T.] Inst Mexicano Enfermedades Resp, Mexico City, DF, Mexico; [Tapetado-Rodriguez, F.] Boston Sci Iber, Madrid, Spain; [Puente-Maestu, L.] Hosp Gregorio Maranon, Madrid, Spain; [Fernando-Cifuentes, L.] Boston Sci Colombia, Bogota, Colombia; [Canas-Arboleda, A.] Pontificia Univ Javeriana, Bogota, Colombia; [Cangelosi, M. J.] Boston Sci Corp, Marlborough, MA USA				Figueroa-Lara, Alejandro/AAH-5978-2021; Cangelosi, Michael/AAJ-9249-2021						0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2018	21			1		PMD51	S167	S167		10.1016/j.jval.2018.04.1129	http://dx.doi.org/10.1016/j.jval.2018.04.1129			1	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	GN0DO		Bronze			2022-09-04	WOS:000438630000280
J	Lasso, P; Beltran, L; Guzman, F; Rosas, F; Thomas, MC; Lopez, MC; Gonzalez, JM; Cuellar, A; Puerta, CJ				Lasso, Paola; Beltran, Lina; Guzman, Fanny; Rosas, Fernando; Carmen Thomas, M.; Carlos Lopez, Manuel; Mario Gonzalez, John; Cuellar, Adriana; Puerta, Concepcion J.			Promiscuous Recognition of a Trypanosoma cruzi CD8(+) T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients	PLOS ONE			English	Article							CLASS-I SUPERTYPES; KMP-11 PROTEIN; PEPTIDE; ANTIGEN; MICE; IDENTIFICATION; SPECIFICITY; DEFINITION; RESPONSES; SUSCEPTIBILITY	Background TcTLE is a nonamer peptide from Trypanosoma cruzi KMP-11 protein that is conserved among different parasite strains and that is presented by different HLA-A molecules from the A2 supertype. Because peptides presented by several major histocompatibility complex (MHC) supertypes are potential targets for immunotherapy, the aim of this study was to determine whether MHC molecules other than the A2 supertype present the TcTLE peptide. Methodology/Principal Findings From 36 HLA-A2-negative chagasic patients, the HLA-A genotypes of twenty-eight patients with CD8(+) T cells that recognized the TcTLE peptide using tetramer (twenty) or functional (eight) assays, were determined. SSP-PCR was used to identify the A locus and the allelic variants. Flow cytometry was used to analyze the frequency of TcTLE-specific CD8(+) T cells, and their functional activity (IFN-gamma, TNF alpha, IL-2, perforin, granzyme and CD107a/b production) was induced by exposure to the TcTLE peptide. All patients tested had TcTLE-specific CD8(+) T cells with frequencies ranging from 0.07-0.37%. Interestingly, seven of the twenty-eight patients had HLA-A homozygous alleles: A*24 (5 patients), A*23 (1 patient) and A*01 (1 patient), which belong to the A24 and A1 supertypes. In the remaining 21 patients with HLA-A heterozygous alleles, the most prominent alleles were A24 and A68. The most common allele sub-type was A*2402 (sixteen patients), which belongs to the A24 supertype, followed by A*6802 (six patients) from the A2 supertype. Additionally, the A*3002/A*3201 alleles from the A1 supertype were detected in one patient. All patients presented CD8(+) T cells producing at least one cytokine after TcTLE peptide stimulation. Conclusion/Significance These results show that TcTLE is a promiscuous peptide that is presented by the A24 and A1 supertypes, in addition to the A2 supertype, suggesting its potential as a target for immunotherapy.	[Lasso, Paola; Beltran, Lina; Puerta, Concepcion J.] Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia; [Lasso, Paola; Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Lasso, Paola; Carmen Thomas, M.; Carlos Lopez, Manuel] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, NBC, Valparaiso, Chile; [Rosas, Fernando] Fdn Clin Abood Shaio, Inst Arritmias Joseph Brugada, Bogota, Colombia; [Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia.	cpuerta@javeriana.edu.co	Zaky, Mohammad/I-3187-2017; Lopez, Manuel/Z-5641-2019; Guzman, Fanny fg/K-5592-2013; Puerta, Concepcion J/AAG-4912-2019; Thomas, María Carmen PhD/D-9065-2016; Cuellar, Adriana/AAF-2958-2019	Zaky, Mohammad/0000-0003-3547-2588; Guzman, Fanny fg/0000-0003-1537-0904; Cuellar, Adriana/0000-0003-0834-8442; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Mursalin, Adi/0000-0002-1867-0868; Thomas, M Carmen/0000-0003-3586-9657; Lopez, Manuel Carlos/0000-0003-0002-3678	Pontificia Universidad Javeriana [00004536]; Colciencias [120349326159]; Programa Estatal I+D+i (MINECO) [SAF2012-35777, SAF2013-48527-R, RTC-2014-2130]; Network of Tropical Diseases Research RICET [RD12/0018/0021]; FEDER	Pontificia Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET; FEDER(European Commission)	This work was supported by the grants "Analisis de la respuesta inmune celular frente a epitopos analogos del peptido K1 de Trypanosoma cruzi" and "Estados de activacion y actividad funcional de linfocitos T CD8+ en pacientes chagasicos con diferentes grados de severidad de la enfermedad" from Pontificia Universidad Javeriana (ID propuesta No. 00004536) and Colciencias (Code No. 120349326159), respectively. The authors are grateful to the Programa de Jovenes Investigadores e Innovadores of the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Colciencias, Bogota, Colombia. MCT and MCL were supported by grants SAF2012-35777, SAF2013-48527-R and RTC-2014-2130 from Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET, grants RD12/0018/0021 and FEDER.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P519; Arrunategui Ana María, 2013, Acta Med Colomb, V38, P16; Axelsson-Robertson R, 2011, CLIN VACCINE IMMUNOL, V18, P125, DOI 10.1128/CVI.00302-10; Bardi Marlene Silva, 2012, Rev. Bras. Hematol. Hemoter., V34, P25, DOI 10.5581/1516-8484.20120010; Beltran M, 2001, MANUAL PROCEDIMIENTO, P32; BF A., 2010, ADAPTIVE IMMUNITY; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; Burrows SR, 2003, J IMMUNOL, V171, P1407, DOI 10.4049/jimmunol.171.3.1407; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Diez H, 2005, PARASITOLOGY, V130, P643, DOI 10.1017/S0031182004006936; Doytchinova I, 2003, ORG BIOMOL CHEM, V1, P2648, DOI 10.1039/b300707c; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Giraldo NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001294; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; KUBO RT, 1994, J IMMUNOL, V152, P3913; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Lasso P, 2015, J IMMUNOL, V195, P3748, DOI 10.4049/jimmunol.1500459; Lasso P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-198; Liu J, 2012, J VIROL, V86, P13281, DOI 10.1128/JVI.01841-12; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Maranon C, 2011, MICROBES INFECT, V13, P1025, DOI 10.1016/j.micinf.2011.05.010; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Martinez-Laso J, 2006, EUR J MED GENET, V49, P169, DOI 10.1016/j.ejmg.2005.04.005; Mohamed ER, 2009, INT J ONCOL, V34, P529, DOI 10.3892/ijo_00000178; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Moscoso J, 2006, MOL IMMUNOL, V43, P1881, DOI 10.1016/j.molimm.2005.10.013; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Pereira IR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004594; Arias-Murillo YR, 2010, COLOMB MEDICA, V41, P336; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; TARLETON RL, 1990, J IMMUNOL, V144, P717; Terasaki Y, 2009, CANCER IMMUNOL IMMUN, V58, P1879, DOI 10.1007/s00262-009-0699-2; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150996	10.1371/journal.pone.0150996	http://dx.doi.org/10.1371/journal.pone.0150996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974162	Green Published, gold, Green Submitted			2022-09-04	WOS:000372570600040
J	Galvez, JF; Sanches, M; Bauer, IE; Sharma, AN; Hamilton, J; Mwangi, B; Quevedo, J; Zunta-Soares, G; Soares, JC				Galvez, Juan F.; Sanches, Marsal; Bauer, Isabelle E.; Sharma, Ajaykumar N.; Hamilton, Jane; Mwangi, Benson; Quevedo, Joao; Zunta-Soares, Giovana; Soares, Jair C.			Premorbid obesity and metabolic disturbances as promising clinical targets for the prevention and early screening of bipolar disorder	MEDICAL HYPOTHESES			English	Article							BODY-MASS INDEX; PITUITARY-ADRENAL AXIS; MOOD DISORDERS; CARDIOVASCULAR-DISEASE; PSYCHIATRIC-DISORDERS; VAL66MET POLYMORPHISM; INFLAMMATORY MARKERS; NEUROTROPHIC FACTOR; ANXIETY DISORDERS; BARIATRIC SURGERY	Recent evidence shows an important relationship between metabolic disturbances and bipolar disorder (BD). However, it is still unclear whether such metabolic disturbances are only a consequence or to some extent the precipitating factors for health problems and maladaptive behaviors observed in BD. Because both metabolic disturbances and BD are medical conditions sharing common alterations in multiple biomarkers, it is plausible to hypothesize that metabolic disturbances may be considered to some extent as a major vulnerability factor in the latent phase of BD for some young adults. In line with this hypothesis, obesity may be regarded as a major driving force for prevalent cardio-metabolic disorders encountered within the early stages of BD. Likewise, premorbid metabolic disturbances as a whole may be considered as a potential source for vulnerability to develop BD. In addition, a synergistic relationship between obesity and metabolic disturbances associated with a premorbid disruption of biological rhythms may also lead to BD. Therefore, we postulate that metabolic disturbances may serve as a specific marker of premorbid illness activity in some people at risk for BD. Future prospective studies should focus on validating metabolic disturbances as vulnerability factors within the staging model of BD. (c) 2015 Published by Elsevier Ltd.	[Galvez, Juan F.; Sanches, Marsal; Bauer, Isabelle E.; Sharma, Ajaykumar N.; Hamilton, Jane; Mwangi, Benson; Zunta-Soares, Giovana; Soares, Jair C.] Univ Texas Hlth Sci Ctr Houston, UTCEMD, Houston, TX 77030 USA; [Galvez, Juan F.] Pontificia Univ, Javeriana Sch Med, Dept Psychiat, Bogota, Colombia; [Sharma, Ajaykumar N.; Quevedo, Joao] Univ Texas Med Sch Houston, Ctr Expt Models Psychiat, Dept Psychiat & Behav Sci, Houston, TX USA; [Quevedo, Joao] Univ Southern Santa Catarina, Lab Neurosci, Grad Program Hlth Sci, Hlth Sci Unit, Criciuma, SC, Brazil		Soares, JC (corresponding author), UTCEMD, BBSB,1941 East Rd Suite 3208, Houston, TX 77054 USA.	Juan.F.GalvezFlorez@uth.tmc.edu; Jair.C.Soare-s@uth.tmc.edu	Bauer, Isabelle Esther/C-5839-2015; Sanches, Marsal/ABE-5446-2020; de Quevedo, João Luciano/E-5491-2013	Bauer, Isabelle Esther/0000-0001-9613-9354; de Quevedo, João Luciano/0000-0003-3114-6611; Soares, Jair C./0000-0002-5466-5628; Mwangi, Benson/0000-0002-1717-4395; Sanches, Marsal/0000-0002-6993-6822	Pat Rutherford, Jr. Endowed Chair in Psychiatry [73C-1-8585]	Pat Rutherford, Jr. Endowed Chair in Psychiatry	Supported in part by the Pat Rutherford, Jr. Endowed Chair in Psychiatry 73C-1-8585.	Andreazza AC, 2010, J PSYCHIATR RES, V44, P775, DOI 10.1016/j.jpsychires.2010.01.015; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150; Bechdolf A, 2012, CURR PHARM DESIGN, V18, P358, DOI 10.2174/138161212799316226; Berk M, 2011, BIPOLAR DISORD, V13, P87, DOI 10.1111/j.1399-5618.2011.00889.x; Biernacka JM, 2012, J AFFECT DISORDERS, V136, pE21, DOI 10.1016/j.jad.2011.05.038; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Bond DJ, 2011, BIOL PSYCHIAT, V70, P381, DOI 10.1016/j.biopsych.2011.02.025; Bond DJ, 2010, BIPOLAR DISORD, V12, P616, DOI 10.1111/j.1399-5618.2010.00855.x; Bond DJ, 2013, BIOL PSYCHIAT; Bradford DW, 2013, J CLIN PSYCHIAT, V74, pE754, DOI 10.4088/JCP.12r07666; Buchowski MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047079; Cai DS, 2013, REV ENDOCR METAB DIS, V14, P309, DOI 10.1007/s11154-013-9278-0; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cai DS, 2012, ENDOCRINOLOGY, V153, P1010, DOI 10.1210/en.2011-2183; Calkin C, 2009, BIPOLAR DISORD, V11, P650, DOI 10.1111/j.1399-5618.2009.00730.x; Castilla-Puentes R, 2013, J NERV MENT DIS, V201, P1060, DOI 10.1097/NMD.0000000000000052; Dadic-Hero E, 2010, PSYCHIAT DANUB, V22, P381; Danquah I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-96; Das U N, 2005, J Assoc Physicians India, V53, P472; Queiroz AID, 2013, MED HYPOTHESES, V80, P259, DOI 10.1016/j.mehy.2012.11.043; Desbriere R, 2006, OBESITY, V14, P794, DOI 10.1038/oby.2006.92; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Duffy A, 2012, J AFFECT DISORDERS, V142, P57, DOI 10.1016/j.jad.2012.04.010; Duffy A, 2012, EARLY INTERV PSYCHIA, V6, P128, DOI 10.1111/j.1751-7893.2011.00323.x; Duffy A, 2009, BRIT J PSYCHIAT, V195, P457, DOI 10.1192/bjp.bp.108.062810; Fagiolini A, 2008, CNS DRUGS, V22, P655, DOI 10.2165/00023210-200822080-00004; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fiedorowicz JG, 2008, ANN CLIN PSYCHIATRY, V20, P131, DOI 10.1080/10401230802177722; Frank S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042570; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Giglio LMF, 2009, SLEEP BREATH, V13, P169, DOI 10.1007/s11325-008-0215-5; Gil FP, 2002, AM J PSYCHIAT, V159, P1111, DOI 10.1176/appi.ajp.159.7.1111; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Goldstein BI, 2013, BIPOLAR DISORD, V15, P284, DOI 10.1111/bdi.12035; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Goldstein BI, 2009, BIPOLAR DISORD, V11, P657, DOI 10.1111/j.1399-5618.2009.00735.x; Gomes F, 2010, ARQ BRAS CARDIOL, V94, P273, DOI 10.1590/S0066-782X2010000200021; Grande I, 2014, ACTA PSYCHIAT SCAND, V129, P393, DOI 10.1111/acps.12192; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2009, CLIN PSYCHOL-SCI PR, V16, P256, DOI 10.1111/j.1468-2850.2009.01164.x; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Husse J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052983; Ising Marcus, 2006, Dialogues Clin Neurosci, V8, P433; Jiang HY, 2013, NEUROSCI LETT, V549, P191, DOI 10.1016/j.neulet.2013.05.065; Jimenez A, 2013, OBES SURG, V23, P494, DOI 10.1007/s11695-012-0817-7; Kapczinski F, 2008, NEUROSCI BIOBEHAV R, V32, P675, DOI 10.1016/j.neubiorev.2007.10.005; Kapczinski F, 2009, EXPERT REV NEUROTHER, V9, P957, DOI [10.1586/ern.09.31, 10.1586/ERN.09.31]; Kaplan DR, 2007, NEURON, V55, P1, DOI 10.1016/j.neuron.2007.06.025; Kemp DE, 2010, BIPOLAR DISORD, V12, P404, DOI 10.1111/j.1399-5618.2010.00823.x; Konarski JZ, 2008, BIPOLAR DISORD, V10, P1, DOI 10.1111/j.1399-5618.2008.00435.x; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kremeyer B, 2006, AM J MED GENET B, V141B, P435, DOI 10.1002/ajmg.b.30354; Kretschmer E, 1921, BODY STRUCTURE CHARA; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Leopold K, 2014, J AFFECT DISORDERS, V152, P427, DOI 10.1016/j.jad.2013.10.009; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Lima MMO, 2013, OBESITY, V21, pE182, DOI 10.1002/oby.20030; Limberg JK, 2013, AM J PHYSIOL-HEART C, V305, pH1230, DOI 10.1152/ajpheart.00291.2013; Lohoff FW, 2005, AM J MED GENET B, V139B, P51, DOI 10.1002/ajmg.b.30215; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Malhi GS, 2014, BIPOLAR DISORD, V16, P455, DOI 10.1111/bdi.12133; Mattsson C, 2009, J CLIN ENDOCR METAB, V94, P1347, DOI 10.1210/jc.2008-2054; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; McIntyre RS, 2010, J AFFECT DISORDERS, V126, P366, DOI 10.1016/j.jad.2010.04.012; McIntyre RS, 2004, HUM PSYCHOPHARM CLIN, V19, P369, DOI 10.1002/hup.612; McIntyre RS, 2013, BIPOLAR DISORD; Megna JL, 2011, ANN CLIN PSYCHIATRY, V23, P131; Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007; Oda E, 2012, ACTA DIABETOL, V49, P89, DOI 10.1007/s00592-011-0309-6; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Petersson H, 2010, BRIT J NUTR, V104, P1357, DOI 10.1017/S000711451000228X; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Ramsey CM, 2013, J AFFECT DISORDERS, V151, P337, DOI 10.1016/j.jad.2013.06.019; Rao SR, 2012, INFLAMM RES, V61, P789, DOI 10.1007/s00011-012-0473-3; Rodriguez-Hernandez H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/678159; Sala M, 2014, DIABETES CARE, V37, P493, DOI 10.2337/dc13-1160; Schneider R, 2001, AM J PHYSIOL-RENAL, V301, P997; Segura B, 2009, NEUROLOGY, V73, P438, DOI 10.1212/WNL.0b013e3181b163cd; Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Soczynska JK, 2011, NEUROMOL MED, V13, P93, DOI 10.1007/s12017-010-8140-8; Soreca I, 2008, J PSYCHIATR RES, V42, P956, DOI 10.1016/j.jpsychires.2007.10.009; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Stote KS, 2012, EUR J CLIN NUTR, V66, P1153, DOI 10.1038/ejcn.2012.101; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006847; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wakai T, 2011, NEUROREPORT, V22, P385, DOI 10.1097/WNR.0b013e328346be84; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wang TY, 2014, INT J NEUROPSYCHOPH, V17, P211, DOI 10.1017/S1461145713001296; Winham SJ, 2013, MOL PSYCHIAT; Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y; Yau PL, 2012, PEDIATRICS, V130, pE856, DOI 10.1542/peds.2012-0324; Zhang AH, 2014, CLIN CHIM ACTA, V429, P106, DOI 10.1016/j.cca.2013.11.037	112	10	10	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	APR	2015	84	4					285	293		10.1016/j.mehy.2015.01.016	http://dx.doi.org/10.1016/j.mehy.2015.01.016			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CE2PE	25678233				2022-09-04	WOS:000351656700001
J	Huseni, S; Gutierrez, M; Rodriguez-Martinez, C; Nino, CL; Perez, GF; Nino, G				Huseni, S.; Gutierrez, M.; Rodriguez-Martinez, C.; Nino, C. L.; Perez, G. F.; Nino, G.			Upper And Lower Airway Inflammation Modulate The Phenotypical Expression Of Osa In Children	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Meeting Abstract									[Huseni, S.; Perez, G. F.; Nino, G.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Gutierrez, M.] Penn State Univ, Coll Med, Hershey, PA USA; [Rodriguez-Martinez, C.] Univ Nacl Colombia, Bogota, Colombia; [Nino, C. L.] Javeriana Univ, Bogota, Colombia										0	0	0	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.		2013	187					A5197								1	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	V45TH					2022-09-04	WOS:000209838402025
J	Nino, CL; Rodriguez-Martinez, CE; Gutierrez, M; Nino, G				Nino, C. L.; Rodriguez-Martinez, C. E.; Gutierrez, M.; Nino, G.			Magnitude Coherence Spectrum (mcs) Identifies Airflow-Independent Respiratory Features Of Osa In Adults	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Meeting Abstract									[Nino, C. L.] Javeriana Univ, Bogota, Colombia; [Rodriguez-Martinez, C. E.] Univ Nacl Colombia, Bogota, Colombia; [Gutierrez, M.] Penn State Univ, Coll Med, Hershey, PA USA; [Nino, G.] Childrens Natl Med Ctr, Washington, DC 20010 USA			gnino@cnmcresearch.org							0	0	0	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.		2013	187					A3762								1	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	V45TH					2022-09-04	WOS:000209838400215
J	Dehghani, F; Morvaridzadeh, M; Pizarro, AB; Rouzitalab, T; Khorshidi, M; Izadi, A; Shidfar, F; Omidi, A; Heshmati, J				Dehghani, Fereshteh; Morvaridzadeh, Mojgan; Pizarro, Ana B.; Rouzitalab, Tohid; Khorshidi, Masoud; Izadi, Azimeh; Shidfar, Farzad; Omidi, Amirhosein; Heshmati, Javad			Effect of extra virgin olive oil consumption on glycemic control: A systematic review and meta-analysis	NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES			English	Review						Extra virgin olive oil; Glycemic control; Insulin; Fasting blood sugar	LIPID PROFILE; PHENOLIC-COMPOUNDS; FATTY-ACIDS; DIET; RICH; GUIDELINES; EXPRESSION; GENES	Aims: Several health benefits are contributed to extra virgin olive oil (EVOO). The polyphenol fraction of EVOO may be responsible for its cardioprotective impacts. This systematic review and meta-analysis aimed to investigate the effect of EVOO intake on glycemic parameters. Electronic literature searched through 1 September 2020 across MEDLINE/PubMed, Web of Science, and SCOPUS databases to find all clinical trials that reported the effect of EVOO intake on glycemic parameters [FBS(fasting blood glucose), insulin, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) and HbA1c (glycated hemoglobin A1c)] vs. control. Data synthesis: We pooled standardized mean differences (SMD) and 95% confidence intervals (CIs) from randomized clinical trials (RCTs) using random-effects models. Heterogeneity was assessed by Cochran Q-statistic and quantified (I-2). We found 13 related trials comprising a total of 633 subjects. In pooled analysis, EVOO intake had no effect on FBS (SMD: -0.07; 95% CI: -0.20, 0.07; I-2 = 0.0%), insulin (SMD: -0.32; 95% CI: -0.70, 0.06; I-2 = 38.0%), and HOMA-IR (SMD: -0.32; 95% CI: -0.75, 0.10; I-2 = 51.0%). However, a decreasing trend was observed in these effects. Subgroup analysis based on age, health status, dose, and EVOO intake duration also did not significantly change results. Conclusion: Although EVOO seems a promising hypoglycemic effects, we did not find any significant evidence that EVOO consumption impacts glucose homeostasis. Furthermore, well-designed RCTs with longer durations are still needed to evaluate the EVOO's efficacy on glycemic parameters. (C) 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.	[Dehghani, Fereshteh; Khorshidi, Masoud; Shidfar, Farzad; Heshmati, Javad] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Shahid Hemmat Highway,POB 14665-354, Tehran 1449614535, Iran; [Morvaridzadeh, Mojgan; Omidi, Amirhosein; Heshmati, Javad] Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Kermanshah, Iran; [Pizarro, Ana B.] Pontificia Univ Javeriana, Bogota, Colombia; [Rouzitalab, Tohid; Izadi, Azimeh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Biochem & Diet therapy, Tabriz, Iran; [Khorshidi, Masoud] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Gastroenterol Hepatol & Nutr Res Ctr, Tehran, Iran		Shidfar, F; Heshmati, J (corresponding author), Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Shahid Hemmat Highway,POB 14665-354, Tehran 1449614535, Iran.; Heshmati, J (corresponding author), Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Kermanshah, Iran.	shidfar.f@iums.ac.ir; javad.heshmati@gmail.com	heshmati, javad/H-6812-2019; Morvaridzadeh, Mojgan/GLU-6418-2022; Pizarro, Ana Beatriz/AAC-8021-2022	heshmati, javad/0000-0002-2676-0185; Morvaridzadeh, Mojgan/0000-0002-1771-4697; Pizarro, Ana Beatriz/0000-0003-4089-454X				Amirkalali B, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.24723; Aranceta J, 2012, BRIT J NUTR, V107, pS8, DOI 10.1017/S0007114512001444; Bozzetto L, 2019, CLIN NUTR, V38, P2645, DOI 10.1016/j.clnu.2018.11.015; Cabou Cendrine, 2011, Rev Diabet Stud, V8, P418, DOI 10.1900/RDS.2011.8.418; Candido FG, 2018, EUR J NUTR, V57, P2445, DOI 10.1007/s00394-017-1517-9; Carnevale R, 2017, CLIN NUTR, V36, P782, DOI 10.1016/j.clnu.2016.05.016; Cheng C, 2019, INT J FOOD SCI NUTR, V70, P355, DOI 10.1080/09637486.2018.1504009; D'Amore S, 2016, BBA-MOL CELL BIOL L, V1861, P1671, DOI 10.1016/j.bbalip.2016.07.003; Daneshzad E, 2018, J CARDIOVASC THORAC, V10, P153, DOI 10.15171/jcvtr.2018.25; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Anderson-Vasquez HE, 2015, NUTR HOSP, V31, P2561, DOI 10.3305/nh.2015.31.6.8732; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fernandes J, 2020, NUTRITION, V69, DOI 10.1016/j.nut.2019.110559; Ferrara LA, 2000, ARCH INTERN MED, V160, P837, DOI 10.1001/archinte.160.6.837; Heshmati Javad, 2019, Journal of Dietary Supplements, V16, P357, DOI 10.1080/19390211.2018.1440685; Heshmati J, 2018, HORM METAB RES, V50, P193, DOI 10.1055/s-0044-101835; Imamura F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002087; Jurado-Ruiz E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47904-z; Kamel, 2016, BIOSCI BIOTECH RES A, V5, P59; Khaw KT, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020167; Lombardo GE, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00116; Martin-Pelaez S, 2017, EUR J NUTR, V56, P663, DOI 10.1007/s00394-015-1110-z; Muros JJ, 2015, J PHYS ACT HEALTH, V12, P1245, DOI 10.1123/jpah.2014-0236; Oliveras-Lopez MJ, 2008, J NUTR, V138, P1074, DOI 10.1093/jn/138.6.1074; Oliveras-Lopez MJ, 2013, ARCH GERONTOL GERIAT, V57, P234, DOI 10.1016/j.archger.2013.04.002; Perez Banasco V, 2007, NEFROLOGIA, V27, P472; Rozati M, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0022-5; SAEEDI P, 2019, DIABETES RES CLIN PR, V157, DOI DOI 10.1016/J.DIABRES.2019.107843; Santangelo C, 2016, J ENDOCRINOL INVEST, V39, P1295, DOI 10.1007/s40618-016-0506-9; Schwingshackl L, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.12; Schwingshackl L, 2011, ANN NUTR METAB, V58, P290, DOI 10.1159/000331214; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Taheri E, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-3; Vafa M, 2016, J MATERN-FETAL NEO M, V29, P461, DOI 10.3109/14767058.2015.1004052; van der Stelt I, 2015, J FUNCT FOODS, V14, P702, DOI 10.1016/j.jff.2015.02.040; Venturini D, 2015, NUTRITION, V31, P834, DOI 10.1016/j.nut.2014.12.016; Violi F, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.23; Wijayanthie N., 2019, INT J APPL PHARM, V11, DOI [10.22159/ijap.2019.v11s6.33540, DOI 10.22159/IJAP.2019.V11S6.33540]; Yubero-Serrano EM, 2019, EUR J CLIN NUTR, V72, P8, DOI 10.1038/s41430-018-0304-x; Zhao ZH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123005; Zulkiply SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220877	41	2	2	2	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0939-4753	1590-3729		NUTR METAB CARDIOVAS	Nutr. Metab. Carbiovasc. Dis.	JUN 30	2021	31	7					1953	1961		10.1016/j.numecd.2021.02.017	http://dx.doi.org/10.1016/j.numecd.2021.02.017		JUN 2021	9	Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Endocrinology & Metabolism; Nutrition & Dietetics	TC0QX	33941427				2022-09-04	WOS:000668351100003
J	Guzman-Perez, V; Bumke-Vogt, C; Schreiner, M; Mewis, I; Borchert, A; Pfeiffer, AFH				Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga; Borchert, Andrea; Pfeiffer, Andreas F. H.			Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION PATHWAYS; TYPE-2 DIABETIC-PATIENTS; BLIND CLINICAL-TRIAL; HIGH-FAT DIET; OXIDATIVE STRESS; BROCCOLI SPROUTS; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; IN-VITRO	Nasturtium (Tropaeolum majus L.) contains high concentrations of benzylglcosinolate. We found that a hydrolysis product of benzyl glucosinolate-the benzyl isothiocyanate (BITC)modulates the intracellular localization of the transcription factor Forkhead box O 1 (FOXO1). FoxO transcription factors can antagonize insulin effects and trigger a variety of cellular processes involved in tumor suppression, longevity, development and metabolism. The current study evaluated the ability of BITC-extracted as intact glucosinolate from nasturtium and hydrolyzed with myrosinase-to modulate i) the insulin-signaling pathway, ii) the intracellular localization of FOXO1 and, iii) the expression of proteins involved in gluconeogenesis, antioxidant response and detoxification. Stably transfected human osteosarcoma cells (U-2 OS) with constitutive expression of FOXO1 protein labeled with GFP (green fluorescent protein) were used to evaluate the effect of BITC on FOXO1. Human hepatoma HepG2 cell cultures were selected to evaluate the effect on gluconeogenic, antioxidant and detoxification genes and protein expression. BITC reduced the phosphorylation of protein kinase B (AKT/PKB) and FOXO1; promoted FOXO1 translocation from cytoplasm into the nucleus antagonizing the insulin effect; was able to down-regulate the gene and protein expression of gluconeogenic enzymes; and induced the gene expression of antioxidant and detoxification enzymes. Knockdown analyses with specific siRNAs showed that the expression of gluconeogenic genes was dependent on nuclear factor (erythroid derived)-like2 (NRF2) and independent of FOXO1, AKT and NAD-dependent deacetylase sirtuin-1 (SIRT1). The current study provides evidence that BITC might have a role in type 2 diabetes T2D by reducing hepatic glucose production and increasing antioxidant resistance.	[Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Borchert, Andrea; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany; [Guzman-Perez, Valentina] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Bumke-Vogt, Christiane; Pfeiffer, Andreas F. H.] Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Qual, Erfurt, Germany		Guzman-Perez, V (corresponding author), German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany.; Guzman-Perez, V (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia.	vguzman@javeriana.edu.co	Guzmán-Pérez, Valentina/AAB-5471-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Schreiner, Monika/0000-0002-5629-4429; Guzman-Perez, Valentina/0000-0002-6668-3161	"Investitionsbank Berlin" (IBB) [10140311]; "German Academic Exchange Service" (DAAD); Pontificia Universidad Javeriana Bogota DC (Colombia) [A/09/72490]	"Investitionsbank Berlin" (IBB); "German Academic Exchange Service" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Pontificia Universidad Javeriana Bogota DC (Colombia)	CB-V was in part funded by "Investitionsbank Berlin" (IBB): http://www.ibb.de/Foerderangebote.aspx Project Titel: "Entwicklung einer biotechnologischen Methode zur Identifikation gesundheitlich vorteilhafter Pflanzeninhaltsstoffe zur Pravention von Diabetes Typ 2", Ref-No: 10140311. VG was funded by the "German Academic Exchange Service" (DAAD) and Pontificia Universidad Javeriana Bogota DC (Colombia): https://www.daad.de/de/index.html, Ref-No: A/09/72490, http://www.javeriana.edu.co/home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2008, EUR J CLIN NUTR, V62, P324, DOI 10.1038/sj.ejcn.1602750; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bahadoran Z, 2011, EUR J CLIN NUTR, V65, P972, DOI 10.1038/ejcn.2011.59; Bahadoran Z, 2013, J MED FOOD, V16, P375, DOI 10.1089/jmf.2012.2559; Bahadoran Z, 2012, INT J FOOD SCI NUTR, V63, P767, DOI 10.3109/09637486.2012.665043; Bahadoran Z, 2012, DIABETES RES CLIN PR, V96, P348, DOI 10.1016/j.diabres.2012.01.009; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanschen FS, 2014, ANGEW CHEM INT EDIT, DOI [10.1002/anie, 10.1002/ijc.24555, DOI 10.1002/ANIE.2009/07/09]; Jiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041168; Ju YH, 2014, INT J ONCOL, V44, P1284, DOI 10.3892/ijo.2014.2269; Kim DH, 2013, J DIABETES, V5, P233, DOI 10.1111/1753-0407.12027; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Krajka-Kuzniak V, 2015, J PHYSIOL BIOCHEM, V71, P227, DOI 10.1007/s13105-015-0401-4; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lacroix IME, 2014, MOL NUTR FOOD RES, V58, P61, DOI 10.1002/mnfr.201300223; Lippmann D, 2014, FOOD FUNCT, V5, P1073, DOI 10.1039/c3fo60676g; Liu BN, 2013, CELL BIOCHEM BIOPHYS, V66, P81, DOI 10.1007/s12013-012-9456-9; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Schreiner M, 2009, INNOV FOOD SCI EMERG, V10, P93, DOI 10.1016/j.ifset.2008.10.001; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Steinbrecher A, 2009, INT J CANCER, V125, P2179, DOI 10.1002/ijc.24555; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Xiao D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046874, 10.1371/journal.pone.0032597]; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yun H, 2014, FEBS J, V281, P4421, DOI 10.1111/febs.12949; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhu Y, 2013, ASIAN PAC J CANCER P, V14, P2607, DOI 10.7314/APJCP.2013.14.4.2607	67	25	26	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162397	10.1371/journal.pone.0162397	http://dx.doi.org/10.1371/journal.pone.0162397			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622707	Green Published, Green Submitted, gold			2022-09-04	WOS:000383681000030
J	Chin, KJ; Cubillos, JE; Alakkad, H				Chin, Ki Jinn; Cubillos, Javier E.; Alakkad, Husni			Single, double or multiple-injection techniques for non-ultrasound guided axillary brachial plexus block in adults undergoing surgery of the lower arm	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review						Brachial Plexus; Anesthetics, Local [administration & dosage]; Axilla [innervation]; Elbow [surgery]; Forearm [surgery]; Hand [surgery]; Intraoperative Complications [prevention & control]; Nerve Block [methods]; Pain [prevention & control]; Randomized Controlled Trials as Topic; Tourniquets [adverse effects]; Wrist [surgery]; Adult; Humans	PERIPHERAL-NERVE STIMULATOR; MEPIVACAINE 1-PERCENT; FUNCTIONAL-ANATOMY; SUCCESS RATE; 60 ML; TRANSARTERIAL; TRIPLE; NEUROSTIMULATION; ANESTHESIA; IMPROVES	Background Regional anaesthesia comprising axillary block of the brachial plexus is a common anaesthetic technique for distal upper limb surgery. This is an update of a review first published in 2006 and previously updated in 2011 and 2013. Objectives To compare the relative effects (benefits and harms) of three injection techniques (single, double and multiple) of axillary block of the brachial plexus for distal upper extremity surgery. We considered these effects primarily in terms of anaesthetic effectiveness; the complication rate (neurological and vascular); and pain and discomfort caused by performance of the block. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3), MEDLINE (1946 to AprilWeek 1 2016), Embase (1947 to April 18 2016) and reference lists of trials. We contacted trial authors. The date of the last search was April 2016 (updated from March 2013). Selection criteria We included randomized controlled trials that compared double with single-injection techniques, multiple with single-injection techniques, or multiple with double-injection techniques for axillary block in adults undergoing surgery of the distal upper limb. We excluded trials using ultrasound-guided techniques. Data collection and analysis Independent study selection, 'Risk of bias' assessment and data extraction were performed by at least two investigators. We undertook meta-analysis. Main results We included one new trial involving 45 participants in this updated review. In total we included 22 trials involving a total of 2193 participants who received regional anaesthesia for hand, wrist, forearm or elbow surgery. 'Risk of bias' assessment indicated that trial design and conduct were generally adequate; the most common areas of weakness were in blinding and allocation concealment. Nine trials comparing double versus single injections showed a statistically significant decrease in primary anaesthesia failure (risk ratio (RR) 0.55, 95% confidence interval (CI) 0.34 to 0.89, high-quality evidence). Subgroup analysis by method of nerve location showed that the effect size was greater when neurostimulation was used rather than the transarterial technique. Nine trials comparing multiple with single injections showed a statistically significant decrease in primary anaesthesia failure (RR 0.25, 95% CI 0.14 to 0.42, high-quality evidence). Pooled data from five trials also showed a significant decrease in incomplete motor block (RR 0.61, 95% CI 0.39 to 0.96, high-quality evidence) in the multiple-injection group. Twelve trials comparing multiple versus double injections showed a statistically significant decrease in primary anaesthesia failure (RR 0.27, 95% CI 0.19 to 0.39, high-quality evidence). Pooled data from six trials also showed a significant decrease in incomplete motor block (RR 0.55, 95% CI 0.36 to 0.85, high-quality evidence) in the multiple injection group. Tourniquet pain was significantly reduced with multiple injections compared with double injections (RR 0.53, 95% CI 0.33 to 0.84, high-quality evidence). Otherwise there were no statistically significant differences between groups in any of the three comparisons on secondary analgesia failure, complications and patient discomfort. Compared with multiple injections, the time for block performance was significantly shorter for single injection (MD 3.33 minutes, 95% CI 2.76 to 3.90) and double injections (MD 1.54 minutes, 95% CI 0.80 to 2.29); however there was no difference in time to readiness for surgery. Authors' conclusions This review provides evidence that multiple-injection techniques using nerve stimulation for axillary plexus block produce more effective anaesthesia than either double or single-injection techniques. However, there was insufficient evidence to draw any definitive conclusions regarding differences in other outcomes, including safety.	[Chin, Ki Jinn] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Cubillos, Javier E.] Hosp Univ San Ignacio, Dept Anesthesiol, Bogota, Colombia; [Cubillos, Javier E.] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Cubillos, Javier E.] Hosp Univ Fdn Santa Fe Bogota, Dept Anesthesia, Bogota, Colombia; [Alakkad, Husni] Univ Dammam, Dept Anesthesia, Dammam, Saudi Arabia		Chin, KJ (corresponding author), Univ Toronto, Toronto Western Hosp, Dept Anesthesia, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	gasgenie@gmail.com	Chin, Ki Jinn/ABA-9450-2021		Department of Anesthesia, University of Toronto, Toronto, Canada; Department of Anaesthesia and Operative Services, HOC, Rigshospital, Copenhagen, Denmark	Department of Anesthesia, University of Toronto, Toronto, Canada; Department of Anaesthesia and Operative Services, HOC, Rigshospital, Copenhagen, Denmark	Internal sources; Department of Anesthesia, University of Toronto, Toronto, Canada.; Department of Anaesthesia and Operative Services, HOC, Rigshospital, Copenhagen, Denmark.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BARANOWSKI AP, 1990, ANAESTHESIA, V45, P362, DOI 10.1111/j.1365-2044.1990.tb14776.x; Bernucci F, 2012, REGION ANESTH PAIN M, V37, P473, DOI 10.1097/AAP.0b013e3182576b6f; Bloc S, 2010, EUR J ANAESTH, V27, P628, DOI 10.1097/EJA.0b013e328333fc0a; Bouaziz H, 1997, ANESTH ANALG, V84, P1058, DOI 10.1097/00000539-199705000-00019; BURNHAM PJ, 1958, ANESTHESIOLOGY, V19, P281; Carre P, 2000, PAEDIATR ANAESTH, V10, P35, DOI 10.1046/j.1460-9592.2000.00424.x; Chin KJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003842.pub4; Chin KJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003842.pub3; Coleman MM, 2000, CAN J ANAESTH, V47, P192, DOI 10.1007/BF03018863; Coventry DM, 2001, BRIT J ANAESTH, V86, P80, DOI 10.1093/bja/86.1.80; Coventry DM, 2004, COMMUNICATION; DEJONG RH, 1961, ANESTHESIOLOGY, V22, P215; Fanelli G, 1999, ANESTH ANALG, V88, P847, DOI 10.1097/00000539-199904000-00031; Geier Karl Otto, 2006, Rev. Bras. Anestesiol., V56, P202, DOI 10.1590/S0034-70942006000200013; Gianesello L, 2010, J CLIN ANESTH, V22, P7, DOI 10.1016/j.jclinane.2009.02.010; GOLDBERG ME, 1987, ANESTHESIOLOGY, V66, P814, DOI 10.1097/00000542-198706000-00017; GRADE Working Group, 2014, GRADEPRO GDT; Handoll HHG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003842.pub2; HICKEY R, 1993, REGION ANESTH, V18, P335; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huynh D, 2012, REG AN PAIN MED C 31; Imasogie N, 2010, ANESTH ANALG, V110, P1222, DOI 10.1213/ANE.0b013e3181cb6791; Imbelloni Luiz Eduardo, 2005, Rev. Bras. Anestesiol., V55, P40, DOI 10.1590/S0034-70942005000100005; Inberg P, 1999, REGION ANESTH PAIN M, V24, P509, DOI 10.1016/S1098-7339(99)90040-8; Kjelstrup T, 2006, ACTA ANAESTH SCAND, V50, P112, DOI 10.1111/j.1399-6576.2006.00874.x; Kjelstrup T, 2014, EUR J ANAESTH, V31, P611, DOI 10.1097/EJA.0000000000000122; Koscielniak-Nielsen ZJ, 1998, ACTA ANAESTH SCAND, V42, P570, DOI 10.1111/j.1399-6576.1998.tb05168.x; Koscielniak-Nielsen ZJ, 1999, CAN J ANAESTH, V46, P658, DOI 10.1007/BF03013954; Koscielniak-Nielsen ZJ, 2000, ACTA ANAESTH SCAND, V44, P274, DOI 10.1034/j.1399-6576.2000.440309.x; Koscielniak-Nielsen ZJ, 1999, ACTA ANAESTH SCAND, V43, P398, DOI 10.1034/j.1399-6576.1999.430406.x; Koscielniak-Nielsen ZJ., 2004, COMMUNICATION; Koscielniak-Nielsen ZJ., 2000, THESIS; KoscielniakNielsen ZJ, 1997, EUR J ANAESTH, V14, P164, DOI 10.1046/j.1365-2346.1997.00093.x; LANG SA, 1992, CAN J ANAESTH, V39, P1118, DOI 10.1007/BF03008387; Lassale B, 1984, B SOC CHIRURG PARIS, V9, P57; LAVOIE J, 1992, CAN J ANAESTH, V39, P583, DOI 10.1007/BF03008322; Liu Fu-Chao, 2005, Chang Gung Med J, V28, P396; PARTRIDGE BL, 1987, ANESTHESIOLOGY, V66, P743, DOI 10.1097/00000542-198706000-00006; PERE P, 1993, BRIT J ANAESTH, V70, P276, DOI 10.1093/bja/70.3.276; Ramirez-Gomez M, 2010, REV MEXICANA ANESTES, V33, P9; Rodriguez J, 2005, REGION ANESTH PAIN M, V30, P324, DOI 10.1016/j.rapm.2005.04.001; Rodriguez J, 2008, J CLIN ANESTH, V20, P253, DOI 10.1016/j.jclinane.2007.11.004; Serradell Catalan A, 2001, Rev Esp Anestesiol Reanim, V48, P356; Serradell Catalan A., 2005, COMMUNICATION; Sia S, 2001, REGION ANESTH PAIN M, V26, P12, DOI 10.1053/rapm.2001.19638; Sia S, 2001, REGION ANESTH PAIN M, V26, P499, DOI 10.1053/rapm.2001.25896; Sia S, 2010, REGION ANESTH PAIN M, V35, P22, DOI 10.1097/AAP.0b013e3181c6f395; SINGELYN FJ, 1992, REGION ANESTH, V17, P148; Sites BD, 2006, ACTA ANAESTH SCAND, V50, P678, DOI 10.1111/j.1399-6576.2006.01042.x; STAN TC, 1995, REGION ANESTH, V20, P486; The Nordic Cochrane Centre, 2018, REVMAN 5 3 US GUID; THOMPSON GE, 1983, ANESTHESIOLOGY, V59, P117, DOI 10.1097/00000542-198308000-00009; Tran DQH, 2012, REGION ANESTH PAIN M, V37, P248, DOI 10.1097/AAP.0b013e31824611bf; TUOMINEN MK, 1987, ANAESTHESIA, V42, P20, DOI 10.1111/j.1365-2044.1987.tb02939.x; Turkan H, 2002, MIL MED, V167, P723, DOI 10.1093/milmed/167.9.723; URBAN MK, 1994, REGION ANESTH, V19, P175; VESTERANDERSEN T, 1986, ACTA ANAESTH SCAND, V30, P231, DOI 10.1111/j.1399-6576.1986.tb02403.x; VESTERANDERSEN T, 1984, ACTA ANAESTH SCAND, V28, P99, DOI 10.1111/j.1399-6576.1984.tb02020.x; VESTERANDERSEN T, 1984, ACTA ANAESTH SCAND, V28, P95, DOI 10.1111/j.1399-6576.1984.tb02019.x; VESTERANDERSEN T, 1984, ACTA ANAESTH SCAND, V28, P612, DOI 10.1111/j.1399-6576.1984.tb02131.x; VESTERANDERSEN T, 1986, ACTA ANAESTH SCAND, V30, P18, DOI 10.1111/j.1399-6576.1986.tb02359.x; YOUSSEF MS, 1988, BRIT J ANAESTH, V60, P841, DOI 10.1093/bja/60.7.841; Yu Wei-Ping, 2007, Zhonghua Yi Xue Za Zhi, V87, P740	65	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2016		9							CD003842	10.1002/14651858.CD003842.pub5	http://dx.doi.org/10.1002/14651858.CD003842.pub5			124	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE4TR	27589694	Green Published			2022-09-04	WOS:000389598700011
J	Maldonado-Ocampo, JA; Lopez-Fernandez, H; Taphorn, DC; Bernard, CR; Crampton, WGR; Lovejoy, NR				Maldonado-Ocampo, Javier A.; Lopez-Fernandez, Hernan; Taphorn, Donald C.; Bernard, Calvin R.; Crampton, William G. R.; Lovejoy, Nathan R.			Akawaio penak, a new genus and species of Neotropical electric fish (Gymnotiformes, Hypopomidae) endemic to the upper Mazaruni River in the Guiana Shield	ZOOLOGICA SCRIPTA			English	Article							GUAYANA HIGHLANDS; DIVERSIFICATION; TELEOSTEI; SYSTEM	Akawaio penak, a new genus and species, is described from the upper Mazaruni River, Guyana. The new species is diagnosed from all other species of Hypopomidae by several anatomical traits. The phylogenetic affinities of the new genus were inferred using data from one nuclear (rag2) and two mitochondrial (COI and cyt b) genes. The phylogenetic analyses indicate that Akawaio is the sister taxon of a clade that includes Brachyhypopomus, Hypopomus, Microsternarchus and Racenisia. These results provide evidence for the phylogenetic composition of Hypopomidae supported by previous molecular studies and support the position of the Steatogenini (Hypopygus+Steatogenys) as the sister group of Rhamphichthys+Gymnorhamphichthys. The description of this new electric knifefish increases the total number of endemic genera and species in the upper Mazaruni, a region that is suffering freshwater habitat degradation as consequence of gold-mining activities.	[Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Dept Biol, Fac Ciencias, Unidad Ecol & Sistemat UNESIS, Bogota, DC, Colombia; [Lopez-Fernandez, Hernan] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Lopez-Fernandez, Hernan; Lovejoy, Nathan R.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Bernard, Calvin R.] Univ Guyana, Ctr Study Biodivers, Georgetown, Guyana; [Crampton, William G. R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Lovejoy, Nathan R.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada		Maldonado-Ocampo, JA (corresponding author), Carrera 7 43-82, Bogota, DC, Colombia.	maldonadoj@javeriana.edu.co; hernanl@rom.on.ca; taphorn@gmail.com; calrber@gol.net.gy; crampton@mail.ucf.edu; lovejoy@utsc.utoronto.ca	Crampton, William/AAP-3608-2020	Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Lopez-Fernandez, Hernan/0000-0003-0270-1671	TWAS-CNPq; NSERC; NSF [DEB 0516831, DEB-0614334, DEB-1146374]; Royal Ontario Museum	TWAS-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Royal Ontario Museum	For museum and technical support and/or loan of material, we thank Erling Holm, Don Stacey, Mary Burridge and Marg Zur (ROM), Mary Anne Rogers (FMNH), Marcelo Rocha (INPA) and Fernando Forero and Carlos Montana (IAvH-P). JAMO is grateful to TWAS-CNPq Postgraduate Fellowships programme for support during this project. For their invaluable help in the field, we are grateful to El-ford Liverpool, Shannon Refvik, June Enright, Clydon Thierens and Kelly, George and Mary Kramer. We are grateful to the Akawaio communities of Kamarang, Kako, Jawalla and Phillipai in the upper Mazaruni for granting us permission to do research in their lands. Permits for field collections in the Mazaruni were granted by the Environmental Protection Agency of Guyana. Tissue samples donated at MCP were exported from Brazil under Material Transfer Agreement MTA #02/2008-PUCRS. Funding for this research was provided by an NSERC Discovery Grant to HLF, NSF Grant DEB 0516831 to K.O. Winemiller, R.L. Honeycutt and HLF, a Schad Conservation Grant from the Royal Ontario Museum to HLF, NSF Grants DEB-0614334 and DEB-1146374 to WGRC, and an NSERC Discovery Grant to NRL. This is publication number 8 in collaboration between the Royal Ontario Museum and the Centre for the Study of Biodiversity, University of Guyana, to describe the fishes of Guyana.	Albert J.S., 2003, CHECK LIST FRESHWATE, P494; Albert J.S., 2001, MISCELLANEOUS PUBLIC, V190, P1; Albert James S., 1998, P419; Alofs K. M., 2013, DIVERSITY D IN PRESS; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; Armbruster JW, 2011, COPEIA, P46, DOI 10.1643/CI-08-187; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; Brosse S, 2011, BIODIVERS CONSERV, V20, P1013, DOI 10.1007/s10531-011-0011-6; Cardoso AL, 2011, REV FISH BIOL FISHER, V21, P613, DOI 10.1007/s11160-010-9196-0; Drummond AJ, 2012, GENEIOUS V5 5 6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fricke R, 2012, GUIDE FISH COLLECTIO; Gery Jacques, 2002, Zoologische Abhandlungen (Dresden), V52, P35; Hammond DS, 2007, AMBIO, V36, P661, DOI 10.1579/0044-7447(2007)36[661:CACOAT]2.0.CO;2; Howard J, 2011, ENVIRON MONIT ASSESS, V179, P555, DOI 10.1007/s10661-010-1762-3; Kullander S.O., 1990, Ichthyological Exploration of Freshwaters, V1, P3; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2012, NEOTROP ICHTHYOL, V10, P465, DOI 10.1590/S1679-62252012000300001; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Lovejoy NR, 2001, COPEIA, P324, DOI 10.1643/0045-8511(2001)001[0324:PRONWN]2.0.CO;2; Lujan NK, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P211; Mago-Leccia F., 1994, ELECT FISHES CONTINE; Miller JR, 2003, WATER AIR SOIL POLL, V148, P139, DOI 10.1023/A:1025465800121; Palumbi SR., 1991, SIMPLE FOOLS GUIDE P; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Presswell Bronwen, 2000, Ichthyological Exploration of Freshwaters, V11, P175; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rull V, 2005, J BIOGEOGR, V32, P921, DOI 10.1111/j.1365-2699.2005.01252.x; Rull V, 2007, BIOTROPICA, V39, P31, DOI 10.1111/j.1744-7429.2006.00215.x; Salerno PE, 2012, EVOLUTION, V66, P3000, DOI 10.1111/j.1558-5646.2012.01666.x; Schmitt R, 2005, THESIS U FEDERAL AMA; Sullivan J.P., 1997, THESIS DUKE U DURHAM; Swofford D., 2002, MAC VERS, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; TAYLOR W R, 1985, Cybium, V9, P107; Triques Mauro Luis, 1993, Comunicacoes do Museu de Ciencias da PUCRS Serie Zoologia, V6, P85; Vari Richard P., 2009, Bulletin of the Biological Society of Washington, V17, P9	38	18	21	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-3256	1463-6409		ZOOL SCR	Zool. Scr.	JAN	2014	43	1					24	33		10.1111/zsc.12035	http://dx.doi.org/10.1111/zsc.12035			10	Evolutionary Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Evolutionary Biology; Zoology	263QD					2022-09-04	WOS:000327822200002
J	Otero, JM; Cardona, AF; Carrasco-Chaumel, E; Carranza, H; Vargas, C; Carlos, C; Diana, T; Ludovic, R; Reguart, N; Cuello, M				Otero, J. M.; Cardona, A. F.; Carrasco-Chaumel, E.; Carranza, H.; Vargas, C.; Carlos, C.; Diana, T.; Ludovic, R.; Reguart, N.; Cuello, M.			Survival of patients (pts) with advanced lung adenocarcinoma (ALA) treated in four hospitals from Bogota DC, Colombia, and report of a novel alteration in the epidermal growth factor receptor (EGFR) (ONCOLGroup study)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	45th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 29-JUN 02, 2009	Orlando, FL	Amer Soc Clin Oncol					Fdn Santa Fe Bogota, Inst Oncol, Bogota, Colombia; Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; Fdn Santa Fe Bogota, Bogota, Colombia; Pontificia Univ Javeriana, Bogota, Colombia; Cochrane Colombian Grp, Bogota, Colombia; Hosp Clin Barcelona, Barcelona, Spain; Clin Dexeus, Barcelona, Spain										0	0	0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X			J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2009	27	15		S		e19097								2	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Oncology	582OF					2022-09-04	WOS:000276606605402
J	Rivadeneira, F; van Meurs, JBJ; Kant, J; Zillikens, MC; Stolk, L; Beck, TJ; Arp, P; Schuit, SCE; Hofman, A; Houwing-Duistermaat, JJ; van Duijn, CM; van Leeuwen, JPTM; Pols, HAP; Uitterlinden, AG				Rivadeneira, Fernando; van Meurs, Joyce B. J.; Kant, Jojanneke; Zillikens, M. Carola; Stolk, Lisette; Beck, Thomas J.; Arp, Pascal; Schuit, Stephanie C. E.; Hofman, Albert; Houwing-Duistermaat, Jeanine J.; van Duijn, Cornelia M.; van Leeuwen, Johannes P. T. M.; Pols, Huibert A. P.; Uitterlinden, Andr G.			Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						estrogen receptor; single nucleotide polymorphisms; association; growth factors; osteoporosis	BONE-MINERAL DENSITY; GENE PROMOTER POLYMORPHISM; ER-BETA; OSTEOPOROTIC FRACTURES; MYOCARDIAL-INFARCTION; I-ALPHA-1 GENE; CHINESE WOMEN; FEMORAL-NECK; ASSOCIATION; MEN	Introduction: Osteoporosis is a complex disease with strong genetic influence, but the genes involved are ill-defined. We examined estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants in relation to the risk of osteoporotic fracture, BMD, and bone geometry. Materials and Methods: In the Rotterdam study, a prospective population-based cohort of elderly white individuals, we studied six single nucleotide polymorphisms (SNPs). in ESR2 (n = 6343, 60% women). We analyzed the genetic variants in the form of haplotypes reconstructed by a statistical method. Results refer to the most frequent ESR2 haplotype I estimated from two SNPs in intron 2 and the 3'-untranslated region (UTR). Outcomes included vertebral and incident nonvertebral fractures, BMD, and hip structural analysis (HSA). We also studied the interaction with (the most frequent) ESR1 haplotype I estimated from the PvuII and XbaI polymorphisms and an IGF1 promoter CA-repeat. Results: Compared with ESR2 haplotype I noncarriers, female homozygous carriers had a 1.8- and 1.4-fold increased-risk of vertebral and fragility fractures. HSA showed that ESR2 haplotype I homozygote women had 2.6% thinner cortices, 1.0% increased neck width, and 4.3% higher bone instability (buckling ratios).. For testing the gene interaction, we assumed a recessive model of ESR2 haplotype 1. Female homozygous carriers of ESR2 haplotype I and noncarriers of ESR1 haplotype I had a 3.5- and 1.8-fold increased risk of vertebral and fragility fractures (P-interaction = 0-10). Such effects and interactions were stronger in women homozygous for the IGF1 192-bp allele, with 9.3-fold increased risk (p(interaction) 0.002) for vertebral and 4.0-fold increased risk (P-interaction = 0.01) for fragility fractures. Multilocus interaction analyses of fracture endured correction for multiple testing using Monte-Carlo simulations (p(interaction) = 0.02 for vertebral and P-interaction = 0.02 for fragility fractures). Similar patterns of interaction were observed for BMD, cortical thickness, bone strength (section modulus), and instability (buckling ratio). In men, no such effects were observed. Conclusions: Variants of ESR2 alone and in interaction with ESR1 and IGF1 influence the risk of fracture in postmenopausal women. These findings reinforce the polygenic and complex character of osteoporosis.	Erasmus Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; Leiden Univ, Ctr Med, Dept Med Stat, Leiden, Netherlands		Rivadeneira, F (corresponding author), Erasmus Med Ctr, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	f.rivadeneira@erasmusmc.nl	Houwing-Duistermaat, Jeanne/V-9048-2018; Rivadeneira, Fernando/O-5385-2015; van Leeuwen, Johannes/D-5015-2014	Rivadeneira, Fernando/0000-0001-9435-9441; van Leeuwen, Johannes/0000-0002-2282-4006; Van Duijn, Cornelia/0000-0002-2374-9204; van Meurs, Joyce/0000-0001-6245-2123; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137				Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Arko B, 2002, J STEROID BIOCHEM, V81, P147, DOI 10.1016/S0960-0760(02)00061-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Becker T, 2005, GENET EPIDEMIOL, V29, P313, DOI 10.1002/gepi.20096; Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Fang Y, 2003, J BONE MINER RES, V18, P1632, DOI 10.1359/jbmr.2003.18.9.1632; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P5921, DOI 10.1210/jc.2004-2253; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; Jarvinen TL, 2003, J BONE MINER RES, V18, P1921, DOI 10.1359/jbmr.2003.18.11.1921; Kaptoge S, 2003, BONE, V32, P561, DOI 10.1016/S8756-3282(03)00055-3; Khosla S, 2004, J CLIN ENDOCR METAB, V89, P1808, DOI 10.1210/jc.2003-031448; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lau HHL, 2002, BONE, V31, P276, DOI 10.1016/S8756-3282(02)00827-X; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Liu MM, 2002, J BIOL CHEM, V277, P24353, DOI 10.1074/jbc.M201829200; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Mendez P, 2005, J ENDOCRINOL, V185, P11, DOI 10.1677/joe.1.06058; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Ogawa S, 2000, BIOCHEM BIOPH RES CO, V269, P537, DOI 10.1006/bbrc.2000.2285; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Rivadeneira F, 2004, J BONE MINER RES, V19, P1280, DOI 10.1359/JBMR.040405; Rivadeneira F, 2003, J CLIN ENDOCR METAB, V88, P3878, DOI 10.1210/jc.2002-021813; Rosenkranz K, 1998, J CLIN ENDOCR METAB, V83, P4524, DOI 10.1210/jc.83.12.4524; Saxon LK, 2005, BONE, V36, P185, DOI 10.1016/j.bone.2004.08.003; Scariano JK, 2004, CALCIFIED TISSUE INT, V74, P501, DOI 10.1007/s00223-003-0170-x; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Schuit SCE, 2004, J CLIN ENDOCR METAB, V89, P303, DOI 10.1210/jc.2003-031095; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Seeman E, 2003, J APPL PHYSIOL, V95, P2142, DOI 10.1152/japplphysiol.00564.2003; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shearman AM, 2004, J BONE MINER RES, V19, P773, DOI 10.1359/JBMR.0301258; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379; Uitterlinden AG, 2001, OSTEOPOROSIS, P639; Vaessen N, 2001, DIABETES, V50, P637, DOI 10.2337/diabetes.50.3.637; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Westberg L, 2001, J CLIN ENDOCR METAB, V86, P2562, DOI 10.1210/jc.86.6.2562; Zheng SL, 2003, CANCER RES, V63, P7624	65	63	69	0	7	AMER SOC BONE & MINERAL RES	WASHINGTON	2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	SEP	2006	21	9					1443	1456		10.1359/JBMR.060605	http://dx.doi.org/10.1359/JBMR.060605			14	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	079EY	16939403				2022-09-04	WOS:000240159500013
J	Eadie, A; Vasquez, IC; Liang, XF; Wang, XH; Souders, CL; El Chehouri, J; Hoskote, R; Feswick, A; Cowie, AM; Loughery, JR; Martyniuk, CJ				Eadie, Ashley; Cristina Vasquez, Isabel; Liang, Xuefang; Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Feswick, April; Cowie, Andrew M.; Loughery, Jennifer R.; Martyniuk, Christopher J.			Residual molecular and behavioral effects of the phenylpyrazole pesticide fipronil in larval zebrafish (Danio rerio) following a pulse embryonic exposure	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS			English	Article						Behavior; Oxidative respiration; Pesticide; Transcriptome networks; Recovery	SULFONE METABOLITE; ENVIRONMENTAL FATE; GENE-EXPRESSION; TOXICITY; GABA; INSECTICIDE; DIELDRIN; MODEL	Pesticides are typically applied to crops as acute applications, and residual effects of such intermittent exposures are not often characterized in developing fish. Fipronil is an agricultural pesticide that inhibits gamma-amino-butyric acid (GABA) gated chloride channels. In this study, zebrafish (Danio rerio) embryos were exposed for 48 h (starting at similar to 3 h post fertilization, hpf) to various concentrations of fipronil (0.02 mu g/L up to 4000 mu g/L). Following this acute exposure, a subset of fish was transferred to clean water for a 7-day depuration phase. We hypothesized that a pulse exposure to fipronil during critical periods of central nervous system development would adversely affect fish later in life. After a 48 hour pulse exposure, survival was reduced in embryos exposed to 2 mu g fipronil/L or greater. However, there was no further mortality during the depuration phase, nor were there changes in body length nor notochord length in larvae 9 dpf (days post-fertilization) compared to controls. Additional experiments were carried out at higher concentrations over 96 h (up to 4 dpf) to also elucidate developmental effects and teratogenicity of fipronil (43.7 mu g/L up to 4370 mu g/L). Fipronil at these higher concentrations significantly impacted the development of zebrafish, and the following morphometric and teratogenic effects were observed in 4 dpf fish; reduced body length, yolk sac and pericardial edema, reduced midbrain length, reduced optic and otic diameter, and truncation of the lower jaw. In depurated fish, we hypothesized that there would exist residual effects of exposure at the molecular level. Transcriptome profiling was therefore conducted on 9 dpf depurated larvae exposed initially for 48 h to one dose of either 0.2 mu g/L, 200 mu g/L or 2000 mu g/L fipronil. The expression of gene networks associated with glycogen and omega-3-fatty acid metabolism were decreased in larvae exposed to each of the three concentrations of fipronil, suggesting metabolic disruption. Moreover, transcriptomics revealed that fipronil suppressed gene networks related to light-dark adaptation, photoperiod sensing, and circadian rhythm. Based on these data, we tested fish for altered behavioral responses in a Light-Dark preference test. Larvae exposed to > 200 mu g fipronil/L as embryos showed fewer number of visits (20-30% less) to the dark zone compared to controls. Larvae also spent a lower amount of time in the dark zone compared to controls, suggesting that fipronil strengthened dark avoidance behavior which is indicative of anxiety. This study demonstrates that a short pulse exposure to fipronil can affect transcriptome networks for metabolism, circadian rhythm, and response to light in fish after depuration, and these molecular responses are hypothesized to be related to aberrant behavioral effects observed in the light-dark preference test.	[Eadie, Ashley; Feswick, April; Cowie, Andrew M.; Loughery, Jennifer R.; Martyniuk, Christopher J.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada; [Cristina Vasquez, Isabel] Pontificia Univ Javeriana, Fac Med, Dept Ciencias Fisiol, Bogota, Colombia; [Liang, Xuefang] Inner Mongolia Univ, Sch Ecol & Environm, Inner Mongolia Key Lab Environm Pollut Control &, Hohhot 010021, Peoples R China; [Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Martyniuk, Christopher J.] Univ Florida, Genet Inst, Coll Vet Med, Dept Physiol Sci,Interdisciplinary Program Biomed, Gainesville, FL 32611 USA; [Martyniuk, Christopher J.] Canadian Rivers Inst, Fredericton, NB, Canada; [Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Martyniuk, Christopher J.] Univ Florida, Genet Inst, Coll Vet Med, Ctr Environm & Human Toxicol,Interdisciplinary Pr, Gainesville, FL 32611 USA		Martyniuk, CJ (corresponding author), Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.	cmartyn@ufl.edu	Eadie, Ashley/AAH-7415-2019	Vasquez Velez, Isabel Cristina/0000-0003-3744-6383; Martyniuk, Christopher J./0000-0003-0921-4796; El Chehouri, Jana/0000-0001-5480-4862	Natural Sciences and Engineering Research Council of Canada [386275-2010]; Canada Research Chair awards; University of Florida; College of Veterinary Medicine; China Scholarship Council; Graduate School Fellowship (GSF)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair awards(Canada Research Chairs); University of Florida(University of Florida); College of Veterinary Medicine; China Scholarship Council(China Scholarship Council); Graduate School Fellowship (GSF)	We thank Edward Flynn for zebrafish husbandry and technical support. This research was supported by the Natural Sciences and Engineering Research Council of Canada [Discovery grant no. 386275-2010 to CJM], and Canada Research Chair awards to CJM. This research was also funded by the University of Florida and the College of Veterinary Medicine (CJM) start-up funding, China Scholarship Council (XW) and a Graduate School Fellowship (GSF) (KS). The graphical abstract was generated with Biorender.com.	Bai Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0298-z; Beggel S, 2012, SCI TOTAL ENVIRON, V426, P160, DOI 10.1016/j.scitotenv.2012.04.005; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Cao FJ, 2019, ECOTOX ENVIRON SAFE, V170, P227, DOI 10.1016/j.ecoenv.2018.11.110; Cao FJ, 2019, SCI TOTAL ENVIRON, V646, P595, DOI 10.1016/j.scitotenv.2018.07.331; Chaulet FD, 2019, ARCH ENVIRON CON TOX, V77, P443, DOI 10.1007/s00244-019-00644-7; Chen TH, 2011, AQUAT TOXICOL, V102, P162, DOI 10.1016/j.aquatox.2011.01.010; Chueh TC, 2017, ENVIRON TOXICOL, V32, P1548, DOI 10.1002/tox.22376; COLE LM, 1993, PESTIC BIOCHEM PHYS, V46, P47, DOI 10.1006/pest.1993.1035; Cowie AM, 2017, J PROTEOMICS, V157, P71, DOI 10.1016/j.jprot.2017.02.003; Cryder Z, 2019, ENVIRON POLLUT, V250, P754, DOI 10.1016/j.envpol.2019.04.060; Gan J, 2012, ENVIRON SCI TECHNOL, V46, P1489, DOI 10.1021/es202904x; Gant DB, 1998, PESTICIDES AND THE FUTURE, P147; Glinski DA, 2018, CHEMOSPHERE, V209, P496, DOI 10.1016/j.chemosphere.2018.06.116; Gormley KL, 2003, ECOTOX ENVIRON SAFE, V54, P330, DOI 10.1016/S0147-6513(02)00005-2; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02; Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konwick BJ, 2006, ENVIRON SCI TECHNOL, V40, P2930, DOI 10.1021/es0600678; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Loughery JR, 2019, ENVIRON SCI TECHNOL, V53, P10435, DOI 10.1021/acs.est.9b01493; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Park H, 2020, J HAZARD MATER, V385, DOI 10.1016/j.jhazmat.2019.121531; Perez-Rodriguez V, 2019, COMP BIOCHEM PHYS C, V217, P87, DOI 10.1016/j.cbpc.2018.11.017; Pitton BJL, 2016, J ENVIRON MANAGE, V180, P10, DOI 10.1016/j.jenvman.2016.05.011; Qian Y, 2019, ENVIRON POLLUT, V249, P362, DOI 10.1016/j.envpol.2019.03.038; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Sadoul B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13301-7; Sarty KI, 2017, COMP BIOCHEM PHYS C, V194, P37, DOI 10.1016/j.cbpc.2017.01.010; Schlenk D, 2001, ARCH ENVIRON CON TOX, V41, P325, DOI 10.1007/s002440010255; Sprague LA, 2008, ENVIRON TOXICOL CHEM, V27, P288, DOI 10.1897/07-276R.1; Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185; Stewart A, 2011, NEUROMETHODS, V51, P157, DOI 10.1007/978-1-60761-953-6_13; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Testa C, 2019, J ENVIRON SCI HEAL B, V54, P441, DOI 10.1080/03601234.2019.1607133; Vera-Chang MN, 2018, P NATL ACAD SCI USA, V115, pE12435, DOI 10.1073/pnas.1811695115; Wang C, 2016, ENVIRON POLLUT, V211, P252, DOI 10.1016/j.envpol.2016.01.016; Wang XH, 2018, TOXICOL LETT, V283, P13, DOI 10.1016/j.toxlet.2017.10.022; Weis JS, 2014, TOXICS, V2, P165, DOI 10.3390/toxics2020165; Wu HH, 2014, PESTIC BIOCHEM PHYS, V115, P9, DOI 10.1016/j.pestbp.2014.07.010; Xu C, 2019, ENVIRON POLLUT, V246, P876, DOI 10.1016/j.envpol.2018.12.096; Xu HQ, 2018, SCI TOTAL ENVIRON, V639, P550, DOI 10.1016/j.scitotenv.2018.05.159; Yan L, 2016, ENVIRON TOXICOL PHAR, V48, P39, DOI 10.1016/j.etap.2016.10.002; Zhao XL, 2005, J PHARMACOL EXP THER, V314, P363, DOI 10.1124/jpet.104.077891; Zheng N, 2014, J AGR FOOD CHEM, V62, P10646, DOI 10.1021/jf503851z	49	4	4	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1744-117X	1878-0407		COMP BIOCHEM PHYS D	Comp. Biochem. Physiol. D-Genomics Proteomics	DEC	2020	36								100743	10.1016/j.cbd.2020.100743	http://dx.doi.org/10.1016/j.cbd.2020.100743			12	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	OV0ND	32977147				2022-09-04	WOS:000591917000006
J	Coral, W; Rossi, C; Curet, OM; Castro, D				Coral, William; Rossi, Claudio; Curet, Oscar M.; Castro, Diego			Design and assessment of a flexible fish robot actuated by shape memory alloys	BIOINSPIRATION & BIOMIMETICS			English	Article						shape memory alloys; smart materials; fish-like robot; soft robotics; underwater robotics; locomotion	LOCOMOTION; PERFORMANCE	In this paper, we present a fish-like underwater robot inspired by the black bass fish. This robot is composed of a deformable structure and muscle-like linear actuators based on shape memory alloy wires. Such actuators are used to bend a continuous structure representing the backbone of the fish. The prototype is also equipped with a bio-inspired synthetic skin made of liquid silicone rubber and Lycra microfiber mesh. We present the mechatronics of the prototype and its control scheme, which take advantage of flex sensors for proprioception. Experiments under different conditions (in air and in water) assess the effectiveness of the mechatronics design and demonstrate that a relatively simple PID controller provides high precision of the muscles' position control. Here, the implementation of biomimetic kinematics and silent actuation technology in bio-inspired underwater robotics are demonstrated. Progress in this technology could provide multiple applications, including fish farming, coastal protection and live animal monitoring where silent robotics are necessary.	[Coral, William] Corp Univ Huila, Dept Mechatron Engn, Huila, Colombia; [Coral, William; Rossi, Claudio] Univ Politecn Madrid, CSIC, Ctr Automat & Robot, Madrid, Spain; [Coral, William; Curet, Oscar M.] Florida Atlantic Univ, Dept Ocean & Mech Engn, Boca Raton, FL 33431 USA; [Castro, Diego] Pontificia Univ Javeriana, Sch Engn, Bogota, Colombia		Coral, W (corresponding author), Corp Univ Huila, Dept Mechatron Engn, Huila, Colombia.; Coral, W (corresponding author), Univ Politecn Madrid, Ctr Automat & Robot, CSIC, Madrid, Spain.; Coral, W (corresponding author), Florida Atlantic Univ, Dept Ocean & Mech Engn, Boca Raton, FL 33431 USA.	william.coral@corhuila.edu.co	ROSSI, CLAUDIO/E-4558-2019	ROSSI, CLAUDIO/0000-0002-8740-2453; Castro, Diego/0000-0003-0022-8868; Curet, Oscar/0000-0002-3202-6841; Coral, William/0000-0002-3971-9536	RoboCity2030-III-CM project [S2013/MIT-2748]; Programas de Actividades I + D en la Comunidad de Madrid; Structural Funds of the EU; Administrative Department of Science, Technology and Innovation ('COLCIENCIAS') [568 2013]; Foundation for the Future of Colombia ('COLFUTURO') of Colombia	RoboCity2030-III-CM project; Programas de Actividades I + D en la Comunidad de Madrid; Structural Funds of the EU; Administrative Department of Science, Technology and Innovation ('COLCIENCIAS')(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Foundation for the Future of Colombia ('COLFUTURO') of Colombia	This work has been partially funded by the RoboCity2030-III-CM project (S2013/MIT-2748), funded by the Programas de Actividades I + D en la Comunidad de Madrid and co-funded by the Structural Funds of the EU. The first author acknowledges the support of the Administrative Department of Science, Technology and Innovation ('COLCIENCIAS', grant call 568 2013) and of the Foundation for the Future of Colombia ('COLFUTURO', grant call 2012) of Colombia.	Alvarado PVY, 2006, J DYN SYST-T ASME, V128, P3, DOI 10.1115/1.2168476; Anderson JM, 2002, INTEGR COMP BIOL, V42, P118, DOI 10.1093/icb/42.1.118; Aureli M, 2010, IEEE-ASME T MECH, V15, P603, DOI 10.1109/TMECH.2009.2030887; Bartolini T, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/2/026003; Butail S, 2015, SPR TRACTS MECH ENG, P359, DOI 10.1007/978-3-662-46870-8_12; Colorado J, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036006; Coral W, 2012, SMART ACTUATION AND SENSING SYSTEMS - RECENT ADVANCES AND FUTURE CHALLENGES, P53, DOI 10.5772/50209; HAWKES JW, 1974, CELL TISSUE RES, V149, P159, DOI 10.1007/BF00222271; Herbert NA, 2013, SWIMMING PHYSL FISH, P377; Hu H., 2006, P IEEE SMC UK RI CHA, P3; Katzschmann RK, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P3048, DOI 10.1109/IROS.2016.7759472; Lambert TR, 2017, SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa5485; Lauder GV, 2011, MAR TECHNOL SOC J, V45, P41, DOI 10.4031/MTSJ.45.4.8; Liu HL, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aacd26; Low KH, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/046002; Meier H., 2009, EUR S MART TRANSF; Morgansen KA, 2007, IEEE T ROBOT, V23, P1184, DOI 10.1109/LED.2007.911625; Nguyen QS, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/3/035030; Nguyen QS, 2011, J BIONIC ENG, V8, P158, DOI 10.1016/S1672-6529(11)60019-X; Rediniotis OK, 2002, J INTEL MAT SYST STR, V13, P35, DOI 10.1106/104538902028534; Rossi C, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/045005; Rossi C., 2013, SWIMMING PHYSL FISH, P407, DOI [10.1007/978-3-642-31049-2_17, DOI 10.1007/978-3-642-31049-2_17]; Rossi C, 2011, IEEE INT CONF ROBOT; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shen Q, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/7/075035; Suleman A, 2008, COMPUT STRUCT, V86, P491, DOI 10.1016/j.compstruc.2007.02.007; Teh YH, 2008, INT J ROBOT RES, V27, P595, DOI 10.1177/0278364908090951; Wang Z., 2008, SMART MATER STRUCT, V17, P25; Wang ZL, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO 2009), VOLS 1-4, P1809, DOI 10.1109/ROBIO.2009.5420423; Wen L, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046013; Xiang CQ, 2017, SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa5b03; Xu C, 2009, IEEE INT CONF ROBOT, P69; Zhang YH, 2008, J BIONIC ENG, V5, P13, DOI 10.1016/S1672-6529(08)60002-5; Zhang YH, 2005, 2005 IEEE International Conference on Mechatronics and Automations, Vols 1-4, Conference Proceedings, P1878; Zhang ZY, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/9/094017	35	29	30	13	201	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-3182	1748-3190		BIOINSPIR BIOMIM	Bioinspir. Biomim.	SEP	2018	13	5							056009	10.1088/1748-3190/aad0ae	http://dx.doi.org/10.1088/1748-3190/aad0ae			12	Engineering, Multidisciplinary; Materials Science, Biomaterials; Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science; Robotics	GP1MF	29968572				2022-09-04	WOS:000440579500003
J	Romero-Torres, M; Treml, EA; Acosta, A; Paz-Garcia, DA				Romero-Torres, Mauricio; Treml, Eric A.; Acosta, Alberto; Paz-Garcia, David A.			The Eastern Tropical Pacific coral population connectivity and the role of the Eastern Pacific Barrier	SCIENTIFIC REPORTS			English	Article							LONG-DISTANCE DISPERSAL; NINO-SOUTHERN OSCILLATION; EL-NINO; COMMUNITY STRUCTURE; LARVAL DISPERSAL; LOCAL RETENTION; STONY CORALS; REEF CORALS; GENE FLOW; POCILLOPORA	Long-distance dispersal is believed to strongly influence coral reef population dynamics across the Tropical Pacific. However, the spatial scale and strength at which populations are potentially connected by dispersal remains uncertain. To determine the patterns in connectivity between the Eastern (ETP) and Central Tropical Pacific (CTP) ecoregions, we used a biophysical model incorporating ocean currents and larval biology to quantify the seascape-wide dispersal potential among all population. We quantified the likelihood and determined the oceanographic conditions that enable the dispersal of coral larvae across the Eastern Pacific Barrier (EP-Barrier) and identified the main connectivity pathways and their conservation value for dominant reef-building corals. Overall, we found that coral assemblages within the CTP and ETP are weakly connected through dispersal. Although the EP-Barrier isolates the ETP from the CTP ecoregion, we found evidence that the EP-Barrier may be breached, in both directions, by rare dispersal events. These rare events could explain the evolutionary genetic similarity among populations of pocilloporids in the ecoregions. Moreover, the ETP may function as a stronger source rather than a destination, providing potential recruits to CTP populations. We also show evidence for a connectivity loop in the ETP, which may positively influence long-term population persistence in the region. Coral conservation and management communities should consider eight-key stepping stone ecoregions when developing strategies to preserve the long-distance connectivity potential across the ETP and CTP.	[Romero-Torres, Mauricio; Acosta, Alberto] Pontificia Univ Javeriana, Unidad Ecol & Sistemat UNESIS, Dept Biol, Carrera 7 40-62, Bogota, Colombia; [Treml, Eric A.] Deakin Univ, Sch Life & Environm Sci, Waurn Ponds, Vic 3216, Australia; [Treml, Eric A.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Paz-Garcia, David A.] Louisiana State Univ, Dept Biol Sci, Marine Speciat & Mol Evolut Lab, Baton Rouge, LA 70803 USA; [Paz-Garcia, David A.] Ctr Invest Biol Noroeste CIBNOR, Lab Necton & Ecol Arrecifes, Calle IPN 195, La Paz 23096, Bcs, Mexico		Romero-Torres, M (corresponding author), Pontificia Univ Javeriana, Unidad Ecol & Sistemat UNESIS, Dept Biol, Carrera 7 40-62, Bogota, Colombia.	mauricio_romero@javeriana.edu.co	Paz-García, David A./H-7142-2019; Acosta, Alberto/D-3254-2011; Romero-Torres, Mauricio/I-2660-2019; Treml, Eric/C-7580-2013	Paz-García, David A./0000-0002-1228-5221; Romero-Torres, Mauricio/0000-0003-3282-0372; Acosta, Alberto/0000-0001-9269-1547; Treml, Eric/0000-0003-4844-4420	Colciencias-Colfuturo [528]; Pontificia Universidad Javeriana, Facultad de Ciencias [ID PPTA 4135, 4159]; CONACYT [250126]	Colciencias-Colfuturo; Pontificia Universidad Javeriana, Facultad de Ciencias; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We gratefully acknowledge the financial support provided by Colciencias-Colfuturo (Scholarship for Doctoral Studies 528) and the Pontificia Universidad Javeriana, Facultad de Ciencias (ID PPTA 4135 and 4159). We thank Treml's Marine Spatial Ecology and Conservation Lab, Steve Swearer's Group, and the High-Performance computing cluster (Edward) at the School of Biosciences University of Melbourne. DAPG received a CONACYT fellowship during the development of this study (250126). Also, Maria Claudia Diazgranados at Conservation International Colombia for ideas on ETP connectivity. M.R-T thanks Princeton University and the Smithsonian Tropical Research Institute - Panama for practice as teaching assistant in Coiba's Island. Likewise, we thank the members of the Strategic Marine Ecosystems Laboratory in the Javeriana University. Andrea Acosta for helping with Matlab code. The comments of Maria Echeverry, Fernando Zapata, Elvira Alvarado, Jurgen Guerrero, Hector Reyes and Juan Sanchez greatly improved this work.	Artzy-Randrup Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000876; Baums IB, 2012, MOL ECOL, V21, P5418, DOI 10.1111/j.1365-294X.2012.05733.x; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; BRIGGS JC, 1961, EVOLUTION, V15, P545, DOI 10.1111/j.1558-5646.1961.tb03184.x; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Carlton JT, 2017, SCIENCE, V357, P1402, DOI 10.1126/science.aao1498; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cortes J, 1997, CORAL REEFS, V16, pS39, DOI 10.1007/s003380050240; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowman PF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1541; Cunning R, 2013, CORAL REEFS, V32, P795, DOI 10.1007/s00338-013-1036-y; DANA TF, 1975, MAR BIOL, V33, P355, DOI 10.1007/BF00390574; Davies SW, 2015, MOL ECOL, V24, P70, DOI 10.1111/mec.13005; Devis-Morales A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035172; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Fong P, 2017, CORAL REEFS WORLD, V8, P339, DOI 10.1007/978-94-017-7499-4_11; Gerber LR, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00336.1; Glynn PW, 2014, MAR ECOL PROG SER, V495, P233, DOI 10.3354/meps10594; Glynn PW, 2007, PAC SCI, V61, P67, DOI 10.1353/psc.2007.0005; Glynn PW, 2017, CORAL REEFS WORLD, V8, P251, DOI 10.1007/978-94-017-7499-4_8; Glynn PW, 2017, CORAL REEFS WORLD, V8, P107, DOI 10.1007/978-94-017-7499-4_5; Glynn PW, 1996, CORAL REEFS, V15, P71; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; GRIGG RW, 1992, SCIENCE, V255, P172, DOI 10.1126/science.255.5041.172; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; GUZMAN HM, 1988, REV BIOL TROP, V36, P163; Guzman HM, 2001, B MAR SCI, V69, P133; Hastings A., 2000, ZOOL J LINN SOC-LOND, V128, P319, DOI [10.1006/zjls.1998.0196, DOI 10.1006/ZJLS.1998.0196]; Hata T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02402-y; Hellberg ME, 2016, J BIOGEOGR, V43, P2147, DOI 10.1111/jbi.12792; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Kenyon JC, 2008, PAC SCI, V62, P569, DOI 10.2984/1534-6188(2008)62[569:AASRSA]2.0.CO;2; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Kurczyn JA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007970; LEIS J M, 1984, Oceanographie Tropicale, V19, P181; Lessios HA, 2017, CORAL REEFS WORLD, V8, P477, DOI 10.1007/978-94-017-7499-4_16; Lopez-Perez A, 2017, CORAL REEFS WORLD, V8, P39, DOI 10.1007/978-94-017-7499-4_2; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Manzello DP, 2014, GEOPHYS RES LETT, V41, P9001, DOI 10.1002/2014GL062501; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Mizrahi D, 2014, CORAL REEFS, V33, P443, DOI 10.1007/s00338-014-1135-4; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Paz-Garcia DA, 2012, PAC SCI, V66, P43, DOI 10.2984/66.1.3; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Reyes-Bonilla H, 2002, CORAL REEFS, V21, P368, DOI 10.1007/s00338-002-0255-4; Reyes-Hernandez C, 2016, CONT SHELF RES, V114, P1, DOI 10.1016/j.csr.2015.12.012; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Robertson DR, 1996, CORAL REEFS, V15, P121, DOI 10.1007/s003380050032; RODRIGUEZ-RAMIREZ A, 2008, STATUS CORAL REEFS W, P281; Rogers A, 2015, GLOBAL CHANGE BIOL, V21, P504, DOI 10.1111/gcb.12725; Romero-Torres M, 2017, ICES J MAR SCI, V74, P613, DOI 10.1093/icesjms/fsw218; Saavedra-Sotelo NC, 2013, ECOL EVOL, V3, P4070, DOI 10.1002/ece3.734; Schill SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144199; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Smith TB, 2017, CORAL REEFS WORLD, V8, P501, DOI 10.1007/978-94-017-7499-4_17; Treml EA, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0045-6; Treml EA, 2015, DIVERS DISTRIB, V21, P465, DOI 10.1111/ddi.12307; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Treml EricA., 2018, SEASCAPE ECOLOGY, P293; Truelove NK, 2017, CORAL REEFS, V36, P233, DOI 10.1007/s00338-016-1516-y; UNEP-WCMC WorldFishCentre., 2005, GLOB DISTR WARM WAT; von Prahl H, 1985, ACTUAL BIOL, V14, P26; Walther-Mendoza M, 2016, REV MEX BIODIVERS, V87, P417, DOI 10.1016/j.rmb.2016.03.007; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12571; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Wren JLK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167626; Zapata Fernando A., 2017, Rev. acad. colomb. cienc. exact. fis. nat., V41, P306, DOI 10.18257/raccefyn.486	80	19	19	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 19	2018	8								9354	10.1038/s41598-018-27644-2	http://dx.doi.org/10.1038/s41598-018-27644-2			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7AH	29921956	Green Published, gold			2022-09-04	WOS:000435536100030
J	Ramirez, SR; Hernandez, C; Link, A; Lopez-Uribe, MM				Ramirez, Santiago R.; Hernandez, Carlos; Link, Andres; Lopez-Uribe, Margarita M.			Seasonal cycles, phylogenetic assembly, and functional diversity of orchid bee communities	ECOLOGY AND EVOLUTION			English	Article						Biodiversity patterns; euglossini; orchid bees; pollinators	MALE EUGLOSSINE BEES; BIODIVERSITY; APIDAE; CONSERVATION; POLLINATORS; HYMENOPTERA; PATTERNS	Neotropical rainforests sustain some of the most diverse terrestrial communities on Earth. Euglossine (or orchid) bees are a diverse lineage of insect pollinators distributed throughout the American tropics, where they provide pollination services to a staggering diversity of flowering plant taxa. Elucidating the seasonal patterns of phylogenetic assembly and functional trait diversity of bee communities can shed new light into the mechanisms that govern the assembly of bee pollinator communities and the potential effects of declining bee populations. Male euglossine bees collect, store, and accumulate odoriferous compounds (perfumes) to subsequently use during courtship display. Thus, synthetic chemical baits can be used to attract and monitor euglossine bee populations. We conducted monthly censuses of orchid bees in three sites in the Magdalena valley of Colombia - a region where Central and South American biotas converge - to investigate the structure, diversity, and assembly of euglossine bee communities through time in relation to seasonal climatic cycles. In particular, we tested the hypothesis that phylogenetic community structure and functional trait diversity changed in response to seasonal rainfall fluctuations. All communities exhibited strong to moderate phylogenetic clustering throughout the year, with few pronounced bursts of phylogenetic overdispersion that coincided with the transition from wet-to-dry seasons. Despite the heterogeneous distribution of functional traits (e.g., body size, body mass, and proboscis length) and the observed seasonal fluctuations in phylogenetic diversity, we found that functional trait diversity, evenness, and divergence remained constant during all seasons in all communities. However, similar to the pattern observed with phylogenetic diversity, functional trait richness fluctuated markedly with rainfall in all sites. These results emphasize the importance of considering seasonal fluctuations in community assembly and provide a glimpse to the potential effects that climatic alterations may have on both pollinator communities and the ecosystem services they provide.	[Ramirez, Santiago R.] Univ Calif Davis, Davis, CA 95616 USA; [Hernandez, Carlos] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol, Bogota, Colombia; [Link, Andres] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Lopez-Uribe, Margarita M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA		Ramirez, SR (corresponding author), Univ Calif Davis, One Shields Ave, Davis, CA 95616 USA.	sanram@ucdavis.edu	Lopez-Uribe, Margarita/I-7112-2015	Link, Andres/0000-0003-3125-249X	Packard Fellowship	Packard Fellowship(The David & Lucile Packard Foundation)	Packard Fellowship.	Abrahamczyk S, 2014, ECOGRAPHY, V37, P500, DOI 10.1111/j.1600-0587.2013.00417.x; Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; Abrahamczyk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027115; ACKERMAN JD, 1983, ECOLOGY, V64, P274, DOI 10.2307/1937075; Aldana Ana Maria, 2008, Neotropical Primates, V15, P46, DOI 10.1896/044.015.0203; Armenteras D, 2011, REG ENVIRON CHANGE, V11, P693, DOI 10.1007/s10113-010-0200-y; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bonilla-Gomez Maria Argenis, 1992, Caldasia, V17, P149; Brehm G, 2013, ECOGRAPHY, V36, P1247, DOI 10.1111/j.1600-0587.2013.00030.x; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Darveau CA, 2005, J EXP BIOL, V208, P3593, DOI 10.1242/jeb.01777; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; DUDLEY R, 1995, J EXP BIOL, V198, P1065; Eltz T, 1999, J CHEM ECOL, V25, P157, DOI 10.1023/A:1020897302355; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; GENTRY AH, 1992, OIKOS, V63, P19, DOI 10.2307/3545512; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hedstrom I, 2006, REV BIOL TROP, V54, P965; HEITHAUS ER, 1979, ECOLOGY, V60, P190, DOI 10.2307/1936480; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Link A., 2013, PRIMATES COLOMBIANOS, P88; Lopez-Uribe MM, 2008, APIDOLOGIE, V39, P410, DOI 10.1051/apido:2008023; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nemesio A, 2007, NEOTROP ENTOMOL, V36, P874, DOI 10.1590/S1519-566X2007000600008; Nemesio A, 2013, BIODIVERS CONSERV, V22, P1647, DOI 10.1007/s10531-013-0500-x; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramirez Santiago, 2002, Biota Colombiana, V3, P7; Ramirez SR, 2011, SCIENCE, V333, P1742, DOI 10.1126/science.1209175; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Roubik D. W., 1992, ECOLOGY NATURAL HIST; Roubik DW, 2001, CONSERV ECOL, V5; Roubik DW., 2004, ORCHID BEES TROPICAL; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Villanueva-G R, 2005, BEE WORLD, V86, P35, DOI 10.1080/0005772X.2005.11099651; Vogel S., 1963, OSTERR BOT Z, V110, P308, DOI DOI 10.1007/BF01373137; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Williams N. H., 1982, Orchid biology: reviews and perspectives. II., P119; WILLIAMS NH, 1983, BIOL BULL, V164, P355, DOI 10.2307/1541248; Willmer P, 2011, POLLINATION FLORAL E; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	64	21	21	6	79	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	MAY	2015	5	9					1896	1907		10.1002/ece3.1466	http://dx.doi.org/10.1002/ece3.1466			12	Ecology; Evolutionary Biology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Evolutionary Biology	CH7IP	26140205	Green Published, gold			2022-09-04	WOS:000354209800013
J	Bailey, CJ; Aschner, P; Del Prato, S; LaSalle, J; Ji, LN; Matthaei, S				Bailey, Clifford J.; Aschner, Pablo; Del Prato, Stefano; LaSalle, James; Ji, Linong; Matthaei, Stephan		Global Partnership Effective Diabe	Individualized glycaemic targets and pharmacotherapy in type 2 diabetes	DIABETES & VASCULAR DISEASE RESEARCH			English	Review						Glycaemic targets; HbA(1c); type 2 diabetes; individualized therapy; Global Partnership	GLUCOSE CONTROL; CARDIOVASCULAR OUTCOMES; SEVERE HYPOGLYCEMIA; ORAL MEDICATIONS; FOLLOW-UP; RECOMMENDATIONS; MANAGEMENT; MELLITUS; THERAPY; ASSOCIATION	The Global Partnership for Effective Diabetes Management, established to provide practical guidance to improve patient outcomes in diabetes, has developed and modified recommendations to improve glycaemic control in type 2 diabetes. The Global Partnership advocates an individualized therapeutic approach and, as part of the process to customize therapy, has previously identified specific type 2 diabetes patient subgroups that require special consideration. This article builds on earlier publications, expanding the scope of practical guidance to include newly diagnosed individuals with complications and women with diabetes in pregnancy. Good glycaemic control remains the cornerstone of managing type 2 diabetes, and plays a vital role in preventing or delaying the onset and progression of diabetic complications. Individualizing therapeutic goals and treatments to meet glycaemic targets safely and without delay remains paramount, in addition to a wider programme of care to reduce cardiovascular risk factors and improve patient outcomes.	[Bailey, Clifford J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Aschner, Pablo] Javeriana Univ, Endocrinol Unit, Sch Med, Bogota, Colombia; [Del Prato, Stefano] Univ Pisa, Sch Med, I-56100 Pisa, Italy; [LaSalle, James] Med Arts Res Collaborat, Excelsior Springs, MO USA; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Matthaei, Stephan] Diabet Zentrum Quakenbruck, Quakenbruck, Germany		Bailey, CJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	c.j.bailey@aston.ac.uk	Del+Prato, Stefano/AAC-9197-2021; Del Prato, Stefano/K-3405-2016; Linong, Ji/AAB-6543-2020	Del Prato, Stefano/0000-0002-5388-0270; Bailey, Clifford J/0000-0002-6998-6811	Bristol-Myers Squibb; AstraZeneca LP; Novartis Pharma AG	Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca LP(AstraZeneca); Novartis Pharma AG	The Global Partnership for Effective Diabetes Management, including the development of this article, is supported by an unrestricted educational grant from Bristol-Myers Squibb and AstraZeneca LP, and also Novartis Pharma AG.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Aschner PJ, 2012, DIABETES TECHNOL THE, V14, pS68, DOI 10.1089/dia.2012.0012; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Bailey CJ, 2009, DIABETES VASC DIS RE, V6, P283, DOI 10.1177/1479164109341691; Bakris GL, 2011, MAYO CLIN PROC, V86, P444, DOI 10.4065/mcp.2010.0713; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bennett WL, 2012, ANN INTERN MED, V156, P27, DOI 10.7326/0003-4819-156-1-201201030-00005; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Brunetti P, 2007, INT J CLIN PRACT, V61, P3, DOI 10.1111/j.1742-1241.2007.01359.x; Del Prato S, 2005, INT J CLIN PRACT, V59, P1345, DOI 10.1111/j.1742-1241.2005.00674.x; Del Prato S, 2010, INT J CLIN PRACT, V64, P295, DOI 10.1111/j.1742-1241.2009.02227.x; Del Prato S, 2009, DIABETOLOGIA, V52, P1219, DOI 10.1007/s00125-009-1352-5; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Flint A, 2011, DIABETES CARE, V34, pS177, DOI 10.2337/dc11-s215; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI 10.2337/dc11-s220; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Leguizamon G, 2007, OBSTET GYN CLIN N AM, V34, P225, DOI 10.1016/j.ogc.2007.04.002; Mann DM, 2009, ARCH INTERN MED, V169, P1718, DOI 10.1001/archinternmed.2009.296; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Miccoli R, 2011, DIABETES CARE, V34, pS231, DOI 10.2337/dc11-s235; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; Sheth Bhavna P, 2002, Curr Diab Rep, V2, P327, DOI 10.1007/s11892-002-0022-5; Sinharoy Keshab, 2008, J Indian Med Assoc, V106, P747; Tieu J, 2010, COCHRANE DATABASE SY, V10; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	43	25	25	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1479-1641	1752-8984		DIABETES VASC DIS RE	Diabetes Vasc. Dis. Res.	SEP	2013	10	5					397	409		10.1177/1479164113490765	http://dx.doi.org/10.1177/1479164113490765			13	Endocrinology & Metabolism; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Cardiovascular System & Cardiology	201AR	23711582	Bronze			2022-09-04	WOS:000323113600002
J	Velasquez, A; Mora-Plazas, M; Gomez, LF; Taillie, LS; Carpentier, FRD				Velasquez, Alcides; Mora-Plazas, Mercedes; Gomez, Luis Fernando; Taillie, Lindsey S.; Carpentier, Francesca R. Dillman			Extent and nutritional quality of foods and beverages to which children are exposed in Colombian TV food advertising	PUBLIC HEALTH NUTRITION			English	Article						Food marketing; Television; Food advertising; Childhood obesity; Nutritional profile	ULTRA-PROCESSED FOODS; CONSUMPTION; OBESITY; ASSOCIATIONS; ADOLESCENTS; PROFILES; PRODUCTS; HEALTH	Objective: To examine children's exposure to food and beverage advertising across a year of Colombian television based on whether products exceed Pan-American Health Organization (PAHO)-defined nutrient thresholds. Design: Nutritional information was obtained for all foods and beverages advertised and used to categorise each product according to the product category (e.g. beverage, snack food) and nutritional quality based on the PAHO model for identifying products in excess of free sugars, Na or saturated fat or containing non-caloric sweeteners or trans-fat. Television audience ratings data were used to derive the average child audience (unique child viewers) per ad and the number of times ads were seen by children in a single week (weekly impressions) based on product category and nutritional quality. Setting: All food and beverage ads on cable and over-the-air TV in Colombia in 2017. Participants: N/A. Results: Of all instances of TV ads, 89 center dot 3 % were of unhealthy products. A larger proportion of male and female children, as well as children from low (88 center dot 01 %), mid (89 center dot 10 %) and high (89 center dot 10 %) socio-economic status, are exposed to advertising of unhealthy products, but no significant difference was found between these proportions. Conclusion: The majority of foods and beverages advertised to Colombian children are unhealthy. These findings highlight a need to implement statutory measures to reduce children's exposure to unhealthy food advertising in Colombia, as obesity and overweight have been increasing among school-age children in Colombia, and exposure to television advertising of unhealthy foods is a known contributor to children's food intake and obesity.	[Velasquez, Alcides] Univ Kansas, Dept Commun Studies, Lawrence, KS 66045 USA; [Mora-Plazas, Mercedes] Univ Nacl Colombia, Dept Nutr Humana, Bogota, Colombia; [Gomez, Luis Fernando] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Taillie, Lindsey S.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC USA; [Taillie, Lindsey S.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA; [Carpentier, Francesca R. Dillman] Univ North Carolina Chapel Hill, Hussman Sch Journalism & Media, CB 3365, Chapel Hill, NC 27599 USA		Carpentier, FRD (corresponding author), Univ North Carolina Chapel Hill, Hussman Sch Journalism & Media, CB 3365, Chapel Hill, NC 27599 USA.	francesca@unc.edu		Dillman Carpentier, Francesca/0000-0001-5361-635X	Bloomberg Philanthropies; Clinical and Translational Science Award program of the Division of Research Resources, National Institutes of Health [UL1TR002489]	Bloomberg Philanthropies; Clinical and Translational Science Award program of the Division of Research Resources, National Institutes of Health	Support comes from Bloomberg Philanthropies and from the Clinical and Translational Science Award program of the Division of Research Resources, National Institutes of Health (UL1TR002489). Funders had no role in the study design, data collection, analysis or interpretation.	Andreyeva T, 2011, ECON HUM BIOL, V9, P221, DOI 10.1016/j.ehb.2011.02.004; Arnas YA, 2006, PEDIATR INT, V48, P138, DOI 10.1111/j.1442-200X.2006.02180.x; Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bleakley A, 2013, PEDIATRICS, V132, pE364, DOI 10.1542/peds.2012-3415; Buitrago-Lopez A, 2015, J EPIDEMIOL COMMUN H, V69, P580, DOI 10.1136/jech-2014-204992; Castillo-Lancellotti C, 2010, REV ESP NUTR COMUNIT, V16, P90, DOI 10.1016/S1135-3074(10)70022-3; Congreso de la Republica de Colombia Camara de Representantes [Congress of the Republic of Colombia House of Representatives], 2020, GACETAS C; Connell PM, 2014, J CONSUM RES, V41, P119, DOI 10.1086/675218; Cornwell B, 2018, PUBLIC HEALTH NUTR, V21, P142, DOI 10.1017/S1368980017000891; Correa T, 2019, PUBLIC HEALTH NUTR, V22, P1113, DOI 10.1017/S1368980018003130; Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018; Departamento Administrativo Nacional de Estadistica (DANE) [National Administrative Department of Statistics], 2020, ESTR SOC; Departamento Administrativo Nacional de Estadistica (DANE) [National Administrative Department of Statistics], 2019, B TECN ENC NAC CAL V; Carpentier FRD, 2020, PUBLIC HEALTH NUTR, V23, P747, DOI 10.1017/S1368980019003355; Folkvord F, 2016, CURR OPIN BEHAV SCI, V9, P26, DOI 10.1016/j.cobeha.2015.11.016; Gaitan Charry DA., 2020, PUBLIC HEALTH NUTR, pE1; Gobierno de Colombia  Universidad Nacional de Colombia  Instituto Nacional de Salud [Government of Colombia National University of Colombia National Institute of Health], 2019, ENCUESTA NACL SITUAC; Gonzalez-Casanova I, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140065; Gunderson MD, 2014, APPETITE, V73, P1, DOI 10.1016/j.appet.2013.10.009; Halfon N, 2013, ACAD PEDIATR, V13, P6, DOI 10.1016/j.acap.2012.10.007; Halford JCG, 2004, APPETITE, V42, P221, DOI 10.1016/j.appet.2003.11.006; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hawkes C., 2004, MARKETING FOOD CHILD; Helm AF, 2019, SLEEP HEALTH, V5, P241, DOI 10.1016/j.sleh.2019.02.009; Kantar IBOPE Media-Colombia, 2018, TEL SIG SIEND PANT F; Kasper NM, 2014, PUBLIC HEALTH NUTR, V17, P2398, DOI 10.1017/S1368980013003418; Kelly B, 2019, OBES REV, V20, P116, DOI 10.1111/obr.12840; Kunkel D, 2013, J HEALTH COMMUN, V18, P1084, DOI 10.1080/10810730.2013.768732; Lindsay AC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091923; Diaz DMM, 2014, NUTR HOSP, V29, P858, DOI 10.3305/nh.2014.29.4.7214; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Mora-Plazas M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051011; Morrison KM, 2015, J AFFECT DISORDERS, V172, P18, DOI 10.1016/j.jad.2014.09.014; Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006; Pan American Health Organization (PAHO), 2016, PAHO NUTR PROF MOD; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001; Taillie LS, 2019, NUTR REV, V77, P787, DOI 10.1093/nutrit/nuz021; Tiempo CEE, 2018, TEL MED MAS CONS POB; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Wood CT, 2019, ACAD PEDIATR, V19, P529, DOI 10.1016/j.acap.2019.04.002	44	1	1	0	2	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1368-9800	1475-2727		PUBLIC HEALTH NUTR	Public Health Nutr.	MAR	2021	24	4					706	716	PII S1368980020004784	10.1017/S1368980020004784	http://dx.doi.org/10.1017/S1368980020004784			11	Public, Environmental & Occupational Health; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nutrition & Dietetics	QK9BA	33234185				2022-09-04	WOS:000620672200014
J	Ghasemi, F; Bagheri, H; Barreto, GE; Read, MI; Sahebkar, A				Ghasemi, Faezeh; Bagheri, Hossein; Barreto, George E.; Read, Morgayn I.; Sahebkar, Amirhossein			Effects of Curcumin on Microglial Cells	NEUROTOXICITY RESEARCH			English	Review						Curcumin; Microglia; neuroinflammation; Neuroprotection; Neurodegenerative diseases	CENTRAL-NERVOUS-SYSTEM; FATTY LIVER-DISEASE; I CLINICAL-TRIAL; NF-KAPPA-B; OXIDATIVE DAMAGE; INFLAMMATORY RESPONSES; PIPERINE COMBINATION; SIGNALING PATHWAY; DOPAMINERGIC-NEURONS; METABOLIC SYNDROME	Microglia are innate immune system cells which reside in the central nervous system (CNS). Resting microglia regulate the homeostasis of the CNS via phagocytic activity to clear pathogens and cell debris. Sometimes, however, to protect neurons and fight invading pathogens, resting microglia transform to an activated-form, producing inflammatory mediators, such as cytokines, chemokines, iNOS/NO and cyclooxygenase-2 (COX-2). Excessive inflammation, however, leads to damaged neurons and neurodegenerative diseases (NDs), such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Curcumin is a phytochemical isolated from Curcuma longa. It is widely used in Asia and has many therapeutic properties, including antioxidant, anti-viral, anti-bacterial, anti-mutagenic, anti-amyloidogenic and anti-inflammatory, especially with respect to neuroinflammation and neurological disorders (NDs). Curcumin is a pleiotropic molecule that inhibits microglia transformation, inflammatory mediators and subsequent NDs. In this mini-review, we discuss the effects of curcumin on microglia and explore the underlying mechanisms.	[Ghasemi, Faezeh] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran; [Bagheri, Hossein] Arak Univ Med Sci, Dept Biotechnol, Fac Med, Arak, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Read, Morgayn I.] Univ Otago, Sch Med Sci, Dept Pharmacol, Dunedin, New Zealand; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971				Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; Akaishi T, 2018, EUR J PHARMACOL, V819, P190, DOI 10.1016/j.ejphar.2017.12.008; Alexiou A, 2019, MOL NEUROBIOL, V56, P4530, DOI 10.1007/s12035-018-1397-x; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Ameruoso A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01411; Bavarsad K, 2019, MOL NEUROBIOL, V56, P1391, DOI 10.1007/s12035-018-1169-7; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bhattacharjee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150211; Bianconi V, 2018, CURR CARDIOL REP, V20, DOI 10.1007/s11886-018-0994-7; Cabezas R, 2019, MOL NEUROBIOL, V56, P2339, DOI 10.1007/s12035-018-1203-9; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Canales-Aguirre AA, 2012, NUTR NEUROSCI, V15, P62, DOI 10.1179/1476830511Y.0000000034; Chen GL, 2018, CELL MOL NEUROBIOL, V38, P1465, DOI 10.1007/s10571-018-0616-3; Chen HY, 2018, RESTOR NEUROL NEUROS, V36, P583, DOI 10.3233/RNN-180834; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chiu SS, 2011, ANTICANCER RES, V31, P907; Choi DK, 2011, MOLECULES, V16, P1021, DOI 10.3390/molecules16021021; Cianciulli A, 2016, INT IMMUNOPHARMACOL, V36, P282, DOI 10.1016/j.intimp.2016.05.007; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.5114/aoms.2017.69326, 10.1093/nutrit/nux047]; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Ding FJ, 2016, EXP THER MED, V12, P823, DOI 10.3892/etm.2016.3413; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Eun CS, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1880-3; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605; Ghosh S, 2015, FOOD CHEM TOXICOL, V83, P111, DOI 10.1016/j.fct.2015.05.022; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Hamzehzadeh L, 2018, J CELL PHYSIOL, V233, P6530, DOI 10.1002/jcp.26620; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; He GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147721; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; He LF, 2010, BRAIN RES, V1339, P60, DOI 10.1016/j.brainres.2010.04.014; Hesari A, 2018, J CELL BIOCHEM, V119, P7898, DOI 10.1002/jcb.26829; Lanussa OH, 2016, CNS NEUROL DISORD-DR, V15, P242, DOI 10.2174/1871527315666160202122032; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Hoppe JB, 2013, NEUROBIOL LEARN MEM, V106, P134, DOI 10.1016/j.nlm.2013.08.001; Hosseini S, 2018, REP BIOCHEM MOL BIOL, V6, P137; Hu SX, 2015, EXPERT REV NEUROTHER, V15, P629, DOI 10.1586/14737175.2015.1044981; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Iranshahi M, 2009, EUR J CANCER PREV, V18, P412, DOI 10.1097/CEJ.0b013e32832c389e; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jacob A, 2007, PPAR RES, V2007, DOI 10.1155/2007/89369; Karimian MS, 2017, CURR PHARM DESIGN, V23, P2462, DOI 10.2174/1381612823666170222122822; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Kaur H, 2015, NEUROCHEM INT, V89, P40, DOI 10.1016/j.neuint.2015.07.009; Keihanian F, 2018, J CELL PHYSIOL, V233, P4497, DOI 10.1002/jcp.26249; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kodali M, 2018, BRAIN BEHAV IMMUN, V69, P499, DOI 10.1016/j.bbi.2018.01.009; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Lee KH, 2012, INT J MOL SCI, V13, P2985, DOI 10.3390/ijms13032985; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Liang G, 2008, BIOORG MED CHEM LETT, V18, P1525, DOI 10.1016/j.bmcl.2007.12.068; Liu WX, 2016, NEUROCHEM INT, V100, P164, DOI 10.1016/j.neuint.2016.09.014; Liu ZJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00233; Liu ZJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00261; Lund H, 2018, NAT IMMUNOL, V19, P435, DOI 10.1038/s41590-018-0091-5; Maiti P, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0406-3; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2014, F1000PRIME REP, V6, DOI 10.12703/P6-13; Mazzolani F, 2013, CLIN OPHTHALMOL, V7, P939, DOI 10.2147/OPTH.S45820; Miobedzka J, 1910, GESELLSCHAFT, V43, P2163; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Mokhtari-Zaer A, 2019, J CELL PHYSIOL, V234, P214, DOI 10.1002/jcp.26848; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Momtazi AA, 2016, MOL DIAGN THER, V20, P335, DOI 10.1007/s40291-016-0202-7; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Mukherjee S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0792-5; Mukherjee S, 2016, INT J CANCER, V139, P2838, DOI 10.1002/ijc.30398; Naeimi R, 2018, NEUROSCI LETT, V674, P1, DOI 10.1016/j.neulet.2018.03.018; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Niskanen J, 2016, NANOMEDICINE-UK, V11, P447, DOI 10.2217/nnm.15.214; Panahi Y, 2018, DRUG RES, V68, P403, DOI 10.1055/s-0044-101752; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006; Parada E, 2015, MOL NUTR FOOD RES, V59, P1690, DOI 10.1002/mnfr.201500279; Parsamanesh N, 2018, PHARMACOL RES, V136, P181, DOI 10.1016/j.phrs.2018.09.012; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Riazi K, 2015, J NEUROSCI, V35, P4942, DOI 10.1523/JNEUROSCI.4485-14.2015; Rossi F, 2018, NAT NEUROSCI, V21, P455, DOI 10.1038/s41593-018-0123-3; Saeidinia A, 2018, PHARMACOL RES, V131, P112, DOI 10.1016/j.phrs.2018.03.009; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Sahebkar A, 2010, FERTIL STERIL, V94, pE75, DOI 10.1016/j.fertnstert.2010.07.1071; Sales SS, 2018, ANN ONCOL, V29; Sawikr Y, 2017, ADV PROTEIN CHEM STR, V108, P33, DOI 10.1016/bs.apcsb.2017.02.001; Shakeri A, 2019, CURR VASC PHARMACOL, V17, P262, DOI 10.2174/1570161116666180209113014; Shakeri A, 2016, J NEUROSCI RES, V94, P111, DOI 10.1002/jnr.23696; Sharma N, 2017, INFLAMMOPHARMACOLOGY, V25, P351, DOI 10.1007/s10787-017-0346-z; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shi XL, 2015, NEUROSCI LETT, V594, P105, DOI 10.1016/j.neulet.2015.03.045; Sorrenti V, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00183; Sousa C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00198; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Tegenge MA, 2014, EXP NEUROL, V253, P102, DOI 10.1016/j.expneurol.2013.12.016; Teymouri M, 2017, BIOFACTORS, V43, P331, DOI 10.1002/biof.1344; Tocharus J, 2012, J NAT MED-TOKYO, V66, P400, DOI 10.1007/s11418-011-0599-6; Tripanichkul W, 2013, EUR REV MED PHARMACO, V17, P1360; Tripanichkul W, 2012, INT J NEUROSCI, V122, P263, DOI 10.3109/00207454.2011.648760; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Vainchtein ID, 2014, GLIA, V62, P1724, DOI 10.1002/glia.22711; Valverde Y, 2016, HAEMATOLOGICA, V101, pE44, DOI 10.3324/haematol.2015.137489; Venigalla M, 2016, NEUROCHEM INT, V95, P63, DOI 10.1016/j.neuint.2015.10.011; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang YH, 2017, CELL PHYSIOL BIOCHEM, V44, P479, DOI 10.1159/000485085; Xu MX, 2016, BRAIN BEHAV IMMUN, V58, P69, DOI 10.1016/j.bbi.2016.01.001; Yang SF, 2008, NEUROCHEM RES, V33, P2044, DOI 10.1007/s11064-008-9675-z; Yu Y, 2018, FRONT PHARM, V9; Yuan J, 2017, J SURG RES, V207, P85, DOI 10.1016/j.jss.2016.08.090; Yue YK, 2014, J OCUL PHARMACOL TH, V30, P657, DOI 10.1089/jop.2014.0022; Zabihi NA, 2017, CURR PHARM DESIGN, V23, P969, DOI 10.2174/1381612822666161010115235; Zhang LJ, 2010, INT IMMUNOPHARMACOL, V10, P331, DOI 10.1016/j.intimp.2009.12.004; Zhang ZY, 2017, MOL NEUROBIOL, V54, P1, DOI 10.1007/s12035-015-9635-y; Zhou JJ, 2017, INFLAMM RES, V66, P177, DOI 10.1007/s00011-016-1004-4; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Zusso M, 2017, BRIT J PHARMACOL, V174, P1090, DOI 10.1111/bph.13746	132	31	31	4	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	JUL	2019	36	1					12	26		10.1007/s12640-019-00030-0	http://dx.doi.org/10.1007/s12640-019-00030-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID4OI	30949950				2022-09-04	WOS:000471655800002
J	Moncaleano-Nino, AM; Barrios-Latorre, SA; Poloche-Hernandez, JF; Becquet, V; Huet, V; Villamil, L; Thomas-Guyon, H; Ahrens, MJ; Luna-Acosta, A				Moncaleano-Nino, Angela M.; Barrios-Latorre, Sergio A.; Poloche-Hernandez, Javier F.; Becquet, Vanessa; Huet, Valerie; Villamil, Luisa; Thomas-Guyon, Helene; Ahrens, Michael J.; Luna-Acosta, Andrea			Alterations of tissue metallothionein and vitellogenin concentrations in tropical cup oysters (Saccostrea sp.) following short-term (96 h) exposure to cadmium	AQUATIC TOXICOLOGY			English	Article						Saccostrea sp; Biomarkers; Metallothioneins; Vitellogenin; Sub-lethal; Cadmium	SYDNEY ROCK OYSTER; MUSSELS MYTILUS-GALLOPROVINCIALIS; METAL CONTAMINATION; CRASSOSTREA-GIGAS; DIGESTIVE GLAND; REPRODUCTIVE TOXICITY; ESTROGENIC COMPOUNDS; GENE-EXPRESSION; AQUATIC INVERTEBRATES; DREISSENA-POLYMORPHA	Metallothioneins and vitellogenins are low molecular weight proteins that have been used widely in environmental monitoring as biomarkers of exposure and damage to metals and estrogenic compounds, respectively. In the present study, the responses of metallothionein and vitellogenin tissue concentrations were measured following acute (96 h) aqueous exposures to cadmium in Saccostrea sp., a tropical cup oyster native to the Western Pacific Ocean that has recently established itself in the Caribbean Sea. Adult oysters (1.5-5.0 cm shell length) collected from the municipal marina of Santa Marta, Colombia (Caribbean Sea) and acclimated for 5 days in the laboratory, were exposed to Cd at five concentrations (0, 1, 10, 100 and 1000 mu g/L) and their tissues (gills, digestive gland and adductor muscle) were analyzed in pools of 5 individuals (3 replicates per concentration). Metallothioneins in digestive glands of oysters exposed to Cd concentrations >= 100 mu g/L showed a significant increase, from 8.0 to 14.8 mu g MT/mg total protein, whereas metallothionein concentrations in gills increased to lesser extent, and no differences were observed in adductor muscle. Metallothionein concentrations in digestive gland and gills correlated directly with whole soft tissue Cd concentrations (ranging from 2 to 297 mu g/g dw Cd). Vitellogenin in homogenates of oyster gonad tissue, after 96 h of exposure to 1000 mu g/L Cd, were significantly lower (0.04 mg P/g gonad) compared to control oysters (0.68 mg P/g gonad), suggestive of an anti-estrogenic effect of Cd at high concentrations, whereas no significant changes in vitellogenin concentrations were observed at intermediate Cd exposure concentrations. This study confirms acute responses of metallothionein and vitellogenin concentrations in tissues of Saccostrea sp. exposed to high concentrations of cadmium (Cd >= 100 mu g/L, 96 h). The present results are first step towards validating the use of these two proteins as biomarkers of metal exposure in this species. (C) 2017 Elsevier B.V. All rights reserved.	[Moncaleano-Nino, Angela M.; Barrios-Latorre, Sergio A.; Poloche-Hernandez, Javier F.; Villamil, Luisa; Ahrens, Michael J.; Luna-Acosta, Andrea] Univ Bogota Jorge Tadeo Lozano, Dept Biol Sci, Carrera 4 22-61, Bogota, Colombia; [Becquet, Vanessa; Huet, Valerie; Thomas-Guyon, Helene] Univ La Rochelle, CNRS, Littoral Environm & Soc LIENSs UMR 7266, Batiment ILE 2,Rue Olympe Gouges, F-17000 La Rochelle, France; [Villamil, Luisa] Univ La Sabana, Biociencias, Campus Puente Comtin,Km 7, Autopista Norte De Bogot, Chia, Colombia; [Luna-Acosta, Andrea] Pontificia Univ javeriana, Fac Environm & Rural Studies, Dept Ecol & Terr, Transversal 4 42-00, Bogota, Colombia		Ahrens, MJ (corresponding author), Univ Bogota Jorge Tadeo Lozano, Dept Biol Sci, Carrera 4 22-61, Bogota, Colombia.	michael.ahrens@utadeo.edu.co	Villamil, Luisa/GQA-5483-2022; Ahrens, Michael J/F-2315-2013	Ahrens, Michael J/0000-0003-3556-006X; Barrios Latorre, Sergio Alejandro/0000-0003-1924-5318; Moncaleano Nino, Angela Margarita/0000-0002-7397-5664; Villamil Diaz, Luisa Marcela/0000-0003-2188-5453	Jorge Tadeo Lozano University [006-15]; COLCIENCIAS	Jorge Tadeo Lozano University; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	We thank A.Devia-Barros for valuable technical support during the collection, maintenance and exposure of oysters, A. Franco for facilitating the use of the laboratory facilities of the Jorge Tadeo Lozano University campus in Santa Marta, and S. Caballero (Universidad de Los Andes) for invaluable help with analysis and interpretation of molecular identification results. We, furthermore, thank the staff at the LIENSs laboratory (Littoral Environnement et Societe's) for performing metal analysis of oyster tissues.Constructive comments by two anonymous reviewers greatly improved the manuscript. Funding for this study was kindly provided by research grant 006-15 from Jorge Tadeo Lozano University and COLCIENCIAS (PhD scholarship to A. Moncaleano).	Aceto S, 2011, MAR GENOM, V4, P61, DOI 10.1016/j.margen.2011.01.001; Ahrens M.J., 2014, 4 C COL ZOOL DEC; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Andrew MN, 2010, ECOTOXICOLOGY, V19, P1440, DOI 10.1007/s10646-010-0529-5; Andrew-Priestley MN, 2012, AQUAT TOXICOL, V120, P99, DOI 10.1016/j.aquatox.2012.03.020; Arcos FG, 2009, AQUAC RES, V40, P644, DOI 10.1111/j.1365-2109.2008.02138.x; BEBIANNO MJ, 1993, AQUAT TOXICOL, V27, P315, DOI 10.1016/0166-445X(93)90061-5; Bernal-Hernandez YY, 2010, ECOTOXICOLOGY, V19, P819, DOI 10.1007/s10646-009-0459-2; Blaise C, 1999, ENVIRON TOXICOL, V14, P455, DOI 10.1002/(SICI)1522-7278(199912)14:5<455::AID-TOX2>3.0.CO;2-8; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustamante P, 2002, MAR ENVIRON RES, V53, P227, DOI 10.1016/S0141-1136(01)00108-8; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Cavaleiro NP, 2013, MOL BIOL REP, V40, P7039, DOI 10.1007/s11033-013-2823-9; Cravo A, 2012, MAR ENVIRON RES, V75, P23, DOI 10.1016/j.marenvres.2011.09.012; De Schamphelaere KAC, 2004, AQUAT TOXICOL, V70, P233, DOI 10.1016/j.aquatox.2004.09.008; DEPLEDGE MH, 1994, NONDESTRUCTIVE BIOMARKERS IN VERTEBRATES, P271; Domingos FXV, 2007, ENVIRON RES, V105, P350, DOI 10.1016/j.envres.2007.06.003; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENGEL DW, 1979, ENVIRON HEALTH PERSP, V28, P81, DOI 10.2307/3428908; Gagne F, 2011, COMP BIOCHEM PHYS C, V153, P99, DOI 10.1016/j.cbpc.2010.09.002; Gagne F, 1999, B ENVIRON CONTAM TOX, V62, P723, DOI 10.1007/s001289900933; Galloway TS, 2006, MAR POLLUT BULL, V53, P606, DOI 10.1016/j.marpolbul.2006.08.013; Geffard A, 2001, BIOMARKERS, V6, P91, DOI 10.1080/13547500010000860; Geret F, 2002, AQUAT LIVING RESOUR, V15, P61, DOI 10.1016/S0990-7440(01)01147-0; Gold-Bouchot Gerardo, 2007, International Journal of Environment and Health, V1, P171, DOI 10.1504/IJENVH.2007.014630; Gomiero A, 2011, MAR POLLUT BULL, V62, P2483, DOI 10.1016/j.marpolbul.2011.08.015; Gonzalez-Fernandez C, 2015, AQUAT TOXICOL, V167, P90, DOI 10.1016/j.aquatox.2015.07.007; Guo XM, 1998, EVOLUTION, V52, P394, DOI [10.2307/2411076, 10.1111/j.1558-5646.1998.tb01640.x]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hook SE, 2002, MAR ENVIRON RES, V53, P161, DOI 10.1016/S0141-1136(01)00118-0; Hook SE, 2001, MAR BIOL, V138, P1131, DOI 10.1007/s002270000533; Hurtado MA, 2012, COMP BIOCHEM PHYS B, V163, P172, DOI 10.1016/j.cbpb.2012.05.011; Isani G, 2000, CELL MOL BIOL, V46, P311; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Jenny MJ, 2004, EUR J BIOCHEM, V271, P1702, DOI 10.1111/j.1432-1033.2004.04071.x; Kimbrough K.L., 2008, 74 NOAA NOS NCCOS, P105; KLUYTMANS JH, 1988, MAR ENVIRON RES, V24, P189, DOI 10.1016/0141-1136(88)90296-6; KNAUER GA, 1973, LIMNOL OCEANOGR, V18, P597, DOI 10.4319/lo.1973.18.4.0597; Komesli OT, 2015, CHEM ENG J, V277, P202, DOI 10.1016/j.cej.2015.04.115; Lam K, 2006, J MOLLUS STUD, V72, P235, DOI 10.1093/mollus/eyl002; Lam PKS, 2003, MAR POLLUT BULL, V46, P182, DOI 10.1016/S0025-326X(02)00449-6; LAUMOND F, 1984, MAR CHEM, V15, P251, DOI 10.1016/0304-4203(84)90021-5; Lazoski C, 2011, MAR ECOL PROG SER, V426, P197, DOI 10.3354/meps09035; LEE RF, 1995, MAR ENVIRON RES, V39, P151, DOI 10.1016/0141-1136(94)00052-Q; Leinio S, 2005, COMP BIOCHEM PHYS C, V140, P408, DOI 10.1016/j.cca.2005.04.005; Li Q, 1998, INVERTEBR REPROD DEV, V33, P87, DOI 10.1080/07924259.1998.9652345; Lohan KMP, 2015, MAR BIOL, V162, P957, DOI 10.1007/s00227-015-2637-5; Luo LZ, 2014, FISH SHELLFISH IMMUN, V38, P318, DOI 10.1016/j.fsi.2014.03.029; MACKAY EA, 1993, EUR J BIOCHEM, V218, P183, DOI 10.1111/j.1432-1033.1993.tb18364.x; Marie V, 2006, ENVIRON TOXICOL CHEM, V25, P412, DOI 10.1897/05-114R.1; Marie V, 2006, CHEMOSPHERE, V65, P609, DOI 10.1016/j.chemosphere.2006.01.074; Marie V, 2006, BIOMETALS, V19, P399, DOI 10.1007/s10534-005-4064-4; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Marin MG, 2004, MAR POLLUT BULL, V48, P835, DOI 10.1016/j.marpolbul.2004.02.037; Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008; McComb Jacqueline, 2014, J Bioremediat Biodegrad, V5; MITRA A, 1993, MAR POLLUT BULL, V26, P521, DOI 10.1016/0025-326X(93)90471-U; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Morthorst JE, 2014, COMP BIOCHEM PHYS C, V166, P88, DOI 10.1016/j.cbpc.2014.07.008; Neubert D, 1997, REGUL TOXICOL PHARM, V26, P9, DOI 10.1006/rtph.1997.1149; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; OLSSON PE, 1995, BIOCHEM J, V307, P197, DOI 10.1042/bj3070197; Oropesa A., 2008, OBSERVATORIO MEDIOAM, V11, P63; PALMER BD, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432407; Pampanin DM, 2005, ENVIRON POLLUT, V136, P103, DOI 10.1016/j.envpol.2004.12.010; PEREIRA JJ, 1993, ARCH ENVIRON CON TOX, V24, P427, DOI 10.1007/BF01146157; POVLSEN AE, 1990, AQUAT TOXICOL, V17, P253, DOI 10.1016/0166-445X(90)90067-Y; Prabal Barua, 2011, Environmental Research Journal, V5, P121, DOI 10.3923/erj.2011.121.130; Prego R, 2004, ANAL CHIM ACTA, V524, P23, DOI 10.1016/j.aca.2004.03.032; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Puyana M., 1995, B INVEST MAR COST, V24, P29; Quinn B, 2004, AQUAT TOXICOL, V66, P279, DOI 10.1016/j.aquatox.2003.10.007; QUIRÓS R JORGE ALEXANDER, 2013, Acta biol.Colomb., V18, P329; Raspor B, 2004, SCI TOTAL ENVIRON, V333, P99, DOI 10.1016/j.scitotenv.2004.05.008; Ricciardi F, 2008, MAR POLLUT BULL, V57, P365, DOI 10.1016/j.marpolbul.2008.02.023; RIDLINGTON JW, 1979, CHEM-BIOL INTERACT, V25, P127, DOI 10.1016/0009-2797(79)90041-3; Riffeser M, 2002, COMP BIOCHEM PHYS C, V132, P75, DOI 10.1016/S1532-0456(02)00048-0; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; ROESIJADI G, 1994, MAR ENVIRON RES, V38, P147, DOI 10.1016/0141-1136(94)90005-1; Roesijadi G, 1997, COMP BIOCHEM PHYS C, V118, P267, DOI 10.1016/S0742-8413(97)00179-5; Roesijadi G., 1996, P515; SAFE SH, 1995, PHARMACOL THERAPEUT, V67, P247, DOI 10.1016/0163-7258(95)00017-B; Sappington TW, 1998, J MOL EVOL, V46, P476, DOI 10.1007/PL00006328; Sarkar A, 2006, ECOTOXICOLOGY, V15, P333, DOI 10.1007/s10646-006-0069-1; Scanes P, 1996, MAR POLLUT BULL, V33, P226, DOI 10.1016/S0025-326X(96)00172-5; Sekino M, 2013, FISHERIES SCI, V79, P61, DOI 10.1007/s12562-012-0577-2; Silva CAR, 2003, HYDROBIOLOGIA, V501, P199, DOI 10.1023/A:1026242417427; Sinaie M, 2010, FISH PHYSIOL BIOCHEM, V36, P1235, DOI 10.1007/s10695-010-9403-x; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Taylor DA, 2015, ENVIRON TOXICOL, V30, P989, DOI 10.1002/tox.21972; Taylor DA, 2013, ENVIRON POLLUT, V178, P65, DOI 10.1016/j.envpol.2013.02.027; Thompson EL, 2012, ENVIRON POLLUT, V170, P102, DOI 10.1016/j.envpol.2012.06.015; Thompson EL, 2012, AQUAT TOXICOL, V109, P202, DOI 10.1016/j.aquatox.2011.09.018; Thompson EL, 2011, AQUAT TOXICOL, V103, P241, DOI 10.1016/j.aquatox.2011.03.004; Thompson Raymond J., 1996, P335; UNEP United Nations Environment Programme, 1999, MAP TECHNICAL REPORT, V120; UNGER ME, 1991, BIOCHIM BIOPHYS ACTA, V1074, P371, DOI 10.1016/0304-4165(91)90087-W; Velez Anibal, 1991, P117; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Viarengo A, 1997, MAR ENVIRON RES, V44, P69, DOI 10.1016/S0141-1136(96)00103-1; VIARENGO A, 1985, MAR ENVIRON RES, V16, P23, DOI 10.1016/0141-1136(85)90018-2; Viloria Maestre Efrain, 2012, Boletin de Investigaciones Marinas y Costeras, V41, P399; Vivas-Aguas L, 2014, SER PUBL PER INV, V4; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; Zanette J, 2006, COMP BIOCHEM PHYS C, V143, P187, DOI 10.1016/j.cbpc.2006.02.001; Zar JH., 1999, BIOSTAT ANAL, V4	108	12	12	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	APR	2017	185						160	170		10.1016/j.aquatox.2017.02.011	http://dx.doi.org/10.1016/j.aquatox.2017.02.011			11	Marine & Freshwater Biology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Toxicology	ER2VG	28222366				2022-09-04	WOS:000398651300017
J	Figuls, MRI; Gine-Garriga, M; Rugeles, CG; Perrotta, C; Vilaro, J				Roque i Figuls, Marta; Gine-Garriga, Maria; Granados Rugeles, Claudia; Perrotta, Carla; Vilaro, Jordi			Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review						Acute Disease; Albuterol [therapeutic use]; Bronchiolitis [therapy]; Bronchodilator Agents [therapeutic use]; Drainage, Postural; Oxygen Inhalation Therapy [methods]; Percussion [methods]; Randomized Controlled Trials as Topic; Respiratory Therapy [methods]; Sodium Chloride [therapeutic use]; Vibration [therapeutic use]; Humans; Infant; Infant; Newborn	RESPIRATORY SYNCYTIAL VIRUS; ACUTE VIRAL BRONCHIOLITIS; PHYSICAL-THERAPY; CONSENSUS CONFERENCE; RIB FRACTURES; RISK-FACTORS; DOUBLE-BLIND; INFANTS; GUIDELINES; QUALITY	Background This Cochrane review was first published in 2005 and updated in 2007, 2012 and now 2015. Acute bronchiolitis is the leading cause of medical emergencies during winter in children younger than two years of age. Chest physiotherapy is sometimes used to assist infants in the clearance of secretions in order to decrease ventilatory effort. Objectives To determine the efficacy of chest physiotherapy in infants aged less than 24 months old with acute bronchiolitis. A secondary objective was to determine the efficacy of different techniques of chest physiotherapy (for example, vibration and percussion and passive forced exhalation). Search methods We searched CENTRAL (2015, Issue 9) (accessed 8 July 2015), MEDLINE (1966 to July 2015), MEDLINE in-process and other non-indexed citations (July 2015), EMBASE (1990 to July 2015), CINAHL (1982 to July 2015), LILACS (1985 to July 2015), Web of Science (1985 to July 2015) and Pedro (1929 to July 2015). Selection criteria Randomised controlled trials (RCTs) in which chest physiotherapy was compared against no intervention or against another type of physiotherapy in bronchiolitis patients younger than 24 months of age. Data collection and analysis Two review authors independently extracted data. Primary outcomes were change in the severity status of bronchiolitis and time to recovery. Secondary outcomes were respiratory parameters, duration of oxygen supplementation, length of hospital stay, use of bronchodilators and steroids, adverse events and parents' impression of physiotherapy benefit. No pooling of data was possible. Main results We included 12 RCTs (1249 participants), three more than the previous Cochrane review, comparing physiotherapy with no intervention. Five trials (246 participants) evaluated conventional techniques (vibration and percussion plus postural drainage), and seven trials (1003 participants) evaluated passive flow-oriented expiratory techniques: slow passive expiratory techniques in four trials, and forced passive expiratory techniques in three trials. Conventional techniques failed to show a benefit in the primary outcome of change in severity status of bronchiolitis measured by means of clinical scores (five trials, 241 participants analysed). Safety of conventional techniques has been studied only anecdotally, with one case of atelectasis, the collapse or closure of the lung resulting in reduced or absent gas exchange, reported in the control arm of one trial. Slow passive expiratory techniques failed to show a benefit in the primary outcomes of severity status of bronchiolitis and in time to recovery (low quality of evidence). Three trials analysing 286 participants measured severity of bronchiolitis through clinical scores, with no significant differences between groups in any of these trials, conducted in patients with moderate and severe disease. Only one trial observed a transient significant small improvement in the Wang clinical score immediately after the intervention in patients with moderate severity of disease. There is very low quality evidence that slow passive expiratory techniques seem to be safe, as two studies (256 participants) reported that no adverse effects were observed. Forced passive expiratory techniques failed to show an effect on severity of bronchiolitis in terms of time to recovery (two trials, 509 participants) and time to clinical stability (one trial, 99 participants analysed). This evidence is of high quality and corresponds to patients with severe bronchiolitis. Furthermore, there is also high quality evidence that these techniques are related to an increased risk of transient respiratory destabilisation (risk ratio (RR) 10.2, 95% confidence interval (CI) 1.3 to 78.8, one trial) and vomiting during the procedure (RR 5.4, 95% CI 1.6 to 18.4, one trial). Results are inconclusive for bradycardia with desaturation (RR 1.0, 95% CI 0.2 to 5.0, one trial) and bradycardia without desaturation (RR 3.6, 95% CI 0.7 to 16.9, one trial), due to the limited precision of estimators. However, in mild to moderate bronchiolitis patients, forced expiration combined with conventional techniques produced an immediate relief of disease severity (one trial, 13 participants).	[Roque i Figuls, Marta] CIBERESP, Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, Dept Phys Act & Sport Sci, FPCEE Blanquerna, Barcelona, Spain; [Granados Rugeles, Claudia] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perrotta, Carla] Hosp Italiano Buenos Aires, Family Med, Buenos Aires, DF, Argentina; [Vilaro, Jordi] Ramon Lull Univ, Dept Hlth Sci, Padilla 326-332, Barcelona 08025, Spain		Vilaro, J (corresponding author), Ramon Lull Univ, Dept Hlth Sci, Padilla 326-332, Barcelona 08025, Spain.	jordivc@blanquerna.url.edu	Giné-Garriga, Maria/AAF-9828-2019; Giné-Garriga, Maria/F-4089-2016	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Perrotta, Carla/0000-0001-5986-4581; Roque i Figuls, Marta/0000-0003-0043-1364; Granados, Claudia/0000-0002-7120-7530	Iberoamerican Cochrane Center, Barcelona, Spain; UCD School of Public Health and Population Sciences, Ireland; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria, Spain [01/A060]	Iberoamerican Cochrane Center, Barcelona, Spain; UCD School of Public Health and Population Sciences, Ireland; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria, Spain	Internal sources; Iberoamerican Cochrane Center, Barcelona, Spain.; UCD School of Public Health and Population Sciences, Ireland.; External sources; Instituto de Salud Carlos III Subdireccion General de Investigacion Sanitaria (01/A060), Spain.	[Anonymous], 2001, ARCH PEDIAT S1, V8, P11; Aviram M, 1992, EUROPEAN RESP J S15, V5, P229; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Beauvois E, 2001, ARCH PEDIATRIE, V8, p128S; Beeby PJ, 1998, J PAEDIATR CHILD H, V34, P60, DOI 10.1046/j.1440-1754.1998.00155.x; BELCASTRO MR, 1984, J AM OSTEOPATH ASSOC, V83, P672; Bella Lisboa A., 2008, CHEST PHYSIOTHERAPY; Bernard-Narbonne F, 2003, ARCH PEDIATRIE, V10, P1043, DOI 10.1016/j.arcped.2003.09.033; BIERMAN CW, 1974, PEDIATRICS, V54, P245; Bohe L, 2004, MEDICINA-BUENOS AIRE, V64, P198; Bourke T, 2011, CLIN EVIDENCE, V4, P1; Branchereau E, 2013, ARCH PEDIATRIE, V20, P1369, DOI 10.1016/j.arcped.2013.09.028; Bronchiolitis Guideline Team, 2005, EV BAS CLIN PRACT GU; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Castro-Rodriguez JA, 2014, ACTA PAEDIATR, V103, pE326, DOI 10.1111/apa.12670; Castro-Rodriguez JA, 2014, ACTA PAEDIATR, V103, P518, DOI 10.1111/apa.12578; Chalumeau M, 2002, PEDIATR RADIOL, V32, P644, DOI 10.1007/s00247-002-0755-y; Chaneliere C, 2006, ARCH PEDIATRIE, V13, P1410, DOI 10.1016/j.arcped.2006.06.022; David M, 2010, ARCH PEDIATRIE, V17, P125, DOI 10.1016/j.arcped.2009.10.022; Dick KJ, 1991, THESIS QUEEN MARGARE; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Farley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub4; Fernandes RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub4; Gadomski AM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001266.pub4; Gajdos V, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000345; Girardi G, 2001, REV CHIL PEDIATR, V72, P292; Gomes ELFD, 2012, BRAZ J PHYS THER, V16, P241, DOI 10.1590/S1413-35552012005000018; Gonzalez Caballero D, 2001, An Esp Pediatr, V55, P355; de Dios JG, 2010, AN PEDIATR, V72, P4, DOI 10.1016/j.anpedi.2009.10.006; Gonzalez de Dios J, 2010, ANALES PEDIAT BARCEL, V72; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Halna M, 2005, PRESSE MED, V34, P277, DOI 10.1016/S0755-4982(05)83905-3; Harding JE, 1998, J PEDIATR-US, V132, P440, DOI 10.1016/S0022-3476(98)70017-4; Hartling L, 2011, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003123.PUB2, 10.1002/14651858.CD003123.pub2]; Higgins J. P. T., 2011, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RC, 2003, PEDIATR INFECT DIS J, V22, P483, DOI 10.1097/00006454-200306000-00001; Knight DB, 2001, J PAEDIATR CHILD H, V37, P554, DOI 10.1046/j.1440-1754.2001.00706.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lanza FD, 2008, MUNDO SAUDE, V32, P183; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liet JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006915.pub2; Lopez Galbany N., COMMUNICATION; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MCCONNOCHIE KM, 1983, AM J DIS CHILD, V137, P11, DOI 10.1001/archpedi.1983.02140270007003; McMaster University (developed by Evidence Prime), 2019, GRADEPRO GDT; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Nicholas KJ, 1999, PHYSIOTHERAPY, V85, P669; Panickar JR, 2005, THORAX, V60, P1035, DOI 10.1136/thx.2005.044750; Perrotta C, 2005, Cochrane Database Syst Rev, pCD004873; Postiaux G, 2008, EUR RESP SOC ANN C B, pE1772; Postiaux G, 2004, P 6 INT M PED NUM S, P117; Postiaux G, 2011, RESP CARE, V56, P989, DOI 10.4187/respcare.00721; Pupin MK, 2009, J BRAS PNEUMOL, V35, P860, DOI 10.1590/S1806-37132009000900007; Quitell LM, 1988, AM REV RESPIR DIS, V137, p406A; Ralston S, 2014, PEDIATRICS, V134, P571, DOI 10.1542/peds.2014-1036; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Remondini R, 2014, EINSTEIN-SAO PAULO, V12, P452, DOI 10.1590/S1679-45082014AO3230; Rochat I, 2010, PAEDIAT RESP R S1526, V11, P85; Rochat I, 2011, EUROPEAN J PEDIAT; Figuls MRI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004873.pub4; Bayle MS, 2012, AN PEDIATR, V77, P5, DOI 10.1016/j.anpedi.2011.11.026; Sanchez Etxaniz J, 2007, EVID PEDIAT, V3, P88; Schechter MS, 2007, RESP CARE, V52, P1382; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; SILVERMAN WA, 1956, PEDIATRICS, V17, P1; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Spencer N, 1996, ARCH DIS CHILD, V74, P50, DOI 10.1136/adc.74.1.50; TAL A, 1983, PEDIATRICS, V71, P13; The Nordic Cochrane Centre, 2018, REVMAN 5 3 US GUID; Touzet S, 2007, J EVAL CLIN PRACT, V13, P651, DOI 10.1111/j.1365-2753.2007.00781.x; Umoren R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006435.pub2; Verstraete M, 2014, ARCH PEDIATRIE, V21, P53, DOI 10.1016/j.arcped.2013.10.020; Videla C, 1998, CLIN DIAGN VIROL, V10, P17, DOI 10.1016/S0928-0197(98)00017-8; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; Wainwright C, 2010, PAEDIATR RESPIR REV, V11, P39, DOI 10.1016/j.prrv.2009.10.001; WANG EEL, 1992, AM REV RESPIR DIS, V145, P106, DOI 10.1164/ajrccm/145.1.106; WEBB MSC, 1985, ARCH DIS CHILD, V60, P1078, DOI 10.1136/adc.60.11.1078; WOOD DW, 1972, AM J DIS CHILD, V123, P227, DOI 10.1001/archpedi.1972.02110090097011; Zhang LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006458.pub3	82	36	39	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2016		2							CD004873	10.1002/14651858.CD004873.pub5	http://dx.doi.org/10.1002/14651858.CD004873.pub5			55	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI1VP	26833493	Green Published			2022-09-04	WOS:000373285000014
J	Londono, AF; Diaz, FJ; Valbuena, G; Gazi, M; Labruna, MB; Hidalgo, M; Mattar, S; Contrera, V; Rodas, JD				Londono, Andres F.; Diaz, Francisco J.; Valbuena, Gustavo; Gazi, Michal; Labruna, Marcelo B.; Hidalgo, Marylin; Mattar, Salim; Contrera, Veronica; Rodas, Juan D.			Infection of Amblyomma ovale by Rickettsia sp strain Atlantic rainforest, Colombia	TICKS AND TICK-BORNE DISEASES			English	Article						Rickettsia sp strain Atlantic rainforest; Colombia; Amblyomma ovale; Rodents	SPOTTED-FEVER RICKETTSIOSIS; TICKS ACARI IXODIDAE; STATE	Our goal was to understand rickettsial spotted fevers' circulation in areas of previous outbreaks reported from 2006 to 2008 in Colombia. We herein present molecular identification and isolation of Rickettsia sp. Atlantic rainforest strain from Amblyomma ovate ticks, a strain shown to be pathogenic to humans. Infected ticks were found on dogs and a rodent in Antioquia and Cordoba Provinces. This is the first report of this rickettsia outside Brazil, which expands its known range considerably. (C) 2014 Elsevier GmbH. All rights reserved.	[Londono, Andres F.; Rodas, Juan D.] Univ Antioquia, Grp Invest Ciencias Vet, Medellin, Colombia; [Diaz, Francisco J.] Univ Antioquia, Grp Inmunovirol, Medellin, Colombia; [Valbuena, Gustavo; Gazi, Michal] Univ Texas Med Branch, Galveston, TX USA; [Labruna, Marcelo B.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil; [Hidalgo, Marylin] Pontificia Univ Javeriana, Bogota, Colombia; [Mattar, Salim; Contrera, Veronica] Univ Cordoba, Inst Invest Biol Trop, Monteria, Colombia		Rodas, JD (corresponding author), Univ Antioquia, Grp Invest Ciencias Vet, Calle 70 52-21, Medellin, Colombia.	juandavid.rodas@gmail.com	Labruna, Marcelo B/B-6241-2013; GONZALEZ, JUAN DAVID RODAS/AAU-7011-2020; Hidalgo, Marylin/AAF-5736-2019; Barbarán, Andrés Felipe F Londoño/O-9746-2016; Rodas, Juan David/AAM-6382-2020; Barbarán, Andrés Felipe Londoño/AAB-8250-2020	Labruna, Marcelo B/0000-0002-9675-3132; GONZALEZ, JUAN DAVID RODAS/0000-0002-7054-9918; Barbarán, Andrés Felipe F Londoño/0000-0002-4703-1387; Barbarán, Andrés Felipe Londoño/0000-0002-4703-1387; Hidalgo, Marylin/0000-0001-8960-0616; Contreras Cogollo, Veronica/0000-0001-5380-2347	Colciencias [111549326228]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	We thank the community leaders and human health units in Las Changas, Alto de Mulatos, and Los Cordobas for their cooperation to obtain animals and vector samples. We thank Dr. Sergio Solari, professor of the Instituto de Biologia, and his students, Daisy Gomez, Edwin Osorio, and Laura Vargas, all from the Mastozoology group at the Universidad de Antioquia, for their assistance in identifying the rodents. We thank also the Universidad de Antioquia program "Sostenibilidad 2013/2014". We are indebted to Colciencias for its financial support through grant No. 111549326228 ("Estudio ecologic de endemicidad por Rickettsia en Colombia").	Acosta J., 2006, INF QUINC EPIDEMIOL, V11, P161; Barros-Battesti D.M.B., 2006, CARRAPATOS IMPORTANC; Quintero JC, 2013, BIOMEDICA, V33, P38, DOI 10.7705/biomedica.v33i0.735; Guedes E, 2005, MEM I OSWALDO CRUZ, V100, P841, DOI 10.1590/S0074-02762005000800004; Guglielmone AA, 2006, EXP APPL ACAROL, V40, P83, DOI 10.1007/s10493-006-9027-0; Hidalgo M., 2007, I NAC SALUD, V12, P371; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Medeiros AP, 2011, MEM I OSWALDO CRUZ, V106, P926, DOI 10.1590/S0074-02762011000800005; Pacheco O., 2008, INF QUINC EPIDEMIOL, V13, P145; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; Sabatini GS, 2010, J MED ENTOMOL, V47, P913, DOI 10.1603/ME10073; Silva N, 2011, EMERG INFECT DIS, V17, P275, DOI 10.3201/eid1702.100859; Spolidorio MG, 2010, EMERG INFECT DIS, V16, P521, DOI 10.3201/eid1603.091338; Szabo MPJ, 2013, PARASITOLOGY, V140, P719, DOI 10.1017/S0031182012002065	17	44	44	0	3	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	1877-959X	1877-9603		TICKS TICK-BORNE DIS	Ticks Tick-Borne Dis.		2014	5	6					672	675		10.1016/j.ttbdis.2014.04.018	http://dx.doi.org/10.1016/j.ttbdis.2014.04.018			4	Infectious Diseases; Microbiology; Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Parasitology	AR2AG	25090976				2022-09-04	WOS:000343385100012
J	Sethi, B; Comlekci, A; Gomez-Peralta, F; Landgraf, W; Dain, MP; Pilorget, V; Aschner, P				Sethi, B.; Comlekci, A.; Gomez-Peralta, F.; Landgraf, W.; Dain, M. -P.; Pilorget, V.; Aschner, P.			Relationship between glycaemic control and hypoglycaemia using insulin glargine versus premixed insulin in type 2 diabetes: a subanalysis of GALAPAGOS	DIABETOLOGIA			English	Meeting Abstract	49th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 23-27, 2013	Barcelona, SPAIN	European Assoc Study Diabet					[Sethi, B.] CARE Hosp, Hyderabad, Andhra Pradesh, India; [Comlekci, A.] Dokuz Eylul Univ, Sch Med, Izmir, Turkey; [Gomez-Peralta, F.] Hosp Gen Segovia, Unit Endocrinol & Nutr, Segovia, Spain; [Landgraf, W.] Sanofi, Frankfurt, Germany; [Dain, M. -P.; Pilorget, V.] Sanofi, Paris, France; [Aschner, P.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia				Landgraf, Wolfgang/AAD-2624-2019	Landgraf, Wolfgang/0000-0001-5321-7164					0	0	0	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2013	56			1		587	S240	S240						1	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism	282TQ					2022-09-04	WOS:000329196901245
J	Gomez, AM; Henao, DC; Munoz, OM; Lucero, OD; Jaramillo, MG; Aldea, A; Martin, C; Hortua, LMR				Gomez, Ana Maria; Henao, Diana Cristina; Munoz, Oscar Mauricio; Lucero, Oscar David; Jaramillo, Maira Garcia; Aldea, Arantza; Martin, Clare; Hortua, Luis Miguel Rodriguez			Efficacy of the mHealth application in patients with type 2 diabetes transitioning from inpatient to outpatient care: A randomized controlled clinical trial	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Type 2 diabetes; Telemedicine; mHealth; ClouDi; Hospital	MOBILE PHONE; META-REGRESSION; TELEMEDICINE; SYSTEM; HYPOGLYCEMIA; METAANALYSIS; HEALTH; IMPACT	Introduction: No studies have assessed the efficacy of telemedicine using a platform for recording and adjusting insulin doses in patients with diabetes mellitus type 2 (DM2) transitioning from inpatient to outpatient care. This study aimed to assess, in a population of patients with DM2, discharged from a tertiary referral hospital, whether treatment based on the use of an mHealth application was associated with better glycemic control at the 3-month follow-up, than standard care. Methods: This open, randomized, controlled clinical trial included adult DM2 patients who were transitioning from inpatient to outpatient care. The efficacy and safety of patient management with and without mHealth was compared at the 3-month follow-up. The primary outcome was the change in the Glycosylated hemoglobin (HbA1c) levels. The secondary outcomes were the rates of hypoglycemic and hyperglycemic events and treatment satisfaction measured using the Insulin Treatment Satisfaction Questionnaire (ITSQ). Results: In total, 86 patients (41 using mHealth) were included in the clinical trial. HbA1c levels showed a significant decrease in both groups. The mean HbA1c level was significantly lower in the mHealth group. Patients using mHealth showed decreased incidence rate ratios of hypoglycemia 3.0 mmol/L [<54 mg/dl], hypoglycemia ranging from 3.0 to 3.8 mmol/L [54 to 70 mg/dl] and severe hypoglycemia. The level of satisfaction assessed using the ITSQ was higher in the mHealth group. Conclusion: Using mHealth in patients with DM2 transitioning from inpatient to outpatient care improves metabolic control and may reduce the hypoglycemia rates.	[Gomez, Ana Maria; Henao, Diana Cristina; Lucero, Oscar David] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7,40-62, Bogota, Colombia; Univ Antonio Narino, Calle 22S 12D-81, Bogota, Colombia; [Munoz, Oscar Mauricio] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Internal Med Dept, Carrera 7,40-62, Bogota, Colombia; [Jaramillo, Maira Garcia] Univ EAN, Calle 79,11-45, Bogota, Colombia; [Aldea, Arantza; Martin, Clare] Oxford Brookes Univ, Wheatley Campus, Oxford OX33 1HX, Oxon, England; [Hortua, Luis Miguel Rodriguez] Pontificia Univ Javeriana, Carrera 7,40-62, Bogota, Colombia; Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7,40-62, Bogota, Colombia; Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Carrera 7,40-62, Bogota, Colombia		Gomez, AM (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7,40-62, Bogota, Colombia.	amgomezm5@gmail.com; o.munoz@javeriana.edu.co; odlucero@husi.org.co; magarcia@universidadean.edu.co; aaldea@brookes.ac.uk; cemartin@brookes.ac.uk; ro.luis@javeriana.edu.co		Lucero Pantoja, Oscar David/0000-0002-4100-3529				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8; Andres Emmanuel, 2019, J Med Life, V12, P203, DOI 10.25122/jml-2019-0006; [Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc19-SINT01]; Aschner P, 2020, DIABETOLOGIA, V63, P711, DOI 10.1007/s00125-019-05078-3; Bonoto BC, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6309; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Chakranon P, 2020, DIABETIC MED, V37, P1966, DOI 10.1111/dme.14156; Cho JH, 2006, DIABETES CARE, V29, P2625, DOI 10.2337/dc05-2371; Cho JH, 2009, J TELEMED TELECARE, V15, P77, DOI 10.1258/jtt.2008.080412; Choudhary P, 2021, DIABETES THER, V12, P2311, DOI 10.1007/s13300-021-01132-9; Chudasama YV, 2020, DIABETES METAB SYND, V14, P965, DOI 10.1016/j.dsx.2020.06.042; Cui MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166718; Eberle C, 2021, JMIR MHEALTH UHEALTH, V9, DOI 10.2196/23477; Faruque LI, 2017, CAN MED ASSOC J, V189, pE341, DOI 10.1503/cmaj.150885; Mateo GF, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4836; Geddes J, 2007, DIABETES CARE, V30, P1868, DOI 10.2337/dc06-2556; He QY, 2022, J ADV NURS, V78, P348, DOI 10.1111/jan.14993; Hou C, 2018, DIABETES OBES METAB, V20, P2009, DOI 10.1111/dom.13307; Hu YL, 2019, J TELEMED TELECARE, V25, P402, DOI 10.1177/1357633X18776823; Idris Iskandar, 2020, JMIR Diabetes, V5, pe15189, DOI 10.2196/15189; Koot D, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12965; Leon-Vargas F, 2021, COMPUT METH PROG BIO, V208, DOI 10.1016/j.cmpb.2021.106205; Lim S, 2016, ACTA DIABETOL, V53, P189, DOI 10.1007/s00592-015-0754-8; Nagrebetsky Alexander, 2013, J Diabetes Sci Technol, V7, P123; Park SH, 2019, HEALTHC INFORM RES, V25, P12, DOI 10.4258/hir.2019.25.1.12; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Rodriguez-Idigoras MI, 2009, DIABETES TECHNOL THE, V11, P431, DOI 10.1089/dia.2008.0114; Rossi MC, 2013, DIABETES TECHNOL THE, V15, P670, DOI 10.1089/dia.2013.0021; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Wang YF, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15400; Wu C, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012962; Wu IXY, 2018, OBES REV, V19, P825, DOI 10.1111/obr.12669; Wu Y, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6522; Yoo HJ, 2009, DIABETIC MED, V26, P628, DOI 10.1111/j.1464-5491.2009.02732.x	36	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	JUL	2022	189								109948	10.1016/j.diabres.2022.109948	http://dx.doi.org/10.1016/j.diabres.2022.109948			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	2M8UM	35700926	Green Published, hybrid			2022-09-04	WOS:000817968000002
J	Mesa, J; Pierce, J; Zuniga, J; Esparragoza, I; Maury, H				Mesa, Jaime; Pierce, James; Zuniga, Jorge; Esparragoza, Ivan; Maury, Heriberto			Sustainable manufacture of scalable product families based on modularity	CIRP JOURNAL OF MANUFACTURING SCIENCE AND TECHNOLOGY			English	Article						Product family; Modularity; Product design; Sustainability; Circular economy; Manufacturing	DESIGN APPROACH; EMERGENCE	This article presents a redesign methodology based on modularity to minimize resource consumption and reuse components, avoiding the need to replace a whole product with another with higher functional performance. The method employs two decision algorithms to modularize product families that offer the same functionality in different levels (i.e., scalable functions) based on design parameters such as geometry, size, and functional relationships among components. The proposed approach's benefits are demonstrated through a case study of a family of upper limb prostheses. Significant improvements in the manufacturing stage, such as raw material and energy consumption, manufacturing cost, and complexity, were obtained from implementing the method. Other benefits in the use stage were also obtained from modularization, increasing the product family's reuse of components. (c) 2021 CIRP.	[Mesa, Jaime] Pontificia Univ Javeriana, Dept Ind Engn, Bogota 110231, Colombia; [Mesa, Jaime; Maury, Heriberto] Univ Norte, Dept Mech Engn, Barranquilla 080001, Colombia; [Pierce, James; Zuniga, Jorge] Univ Nebraska, Dept Biomech, Omaha, NE 68007 USA; [Zuniga, Jorge] Univ Autanoma Chile, Fac Ciencias Salud, Santiago 7591538, Chile; [Esparragoza, Ivan] Penn State Univ, Dept Engn, Media, PA 19063 USA		Mesa, J (corresponding author), Pontificia Univ Javeriana, Cra 7 40-62, Bogota, Colombia.	mesajaime@javeriana.edu.co	Mesa, Jaime A./T-1447-2017; Mesa, Jaime/AAR-4413-2021; Maury, Heriberto/S-8596-2017	Mesa, Jaime A./0000-0001-6034-4671; Mesa, Jaime/0000-0001-6034-4671; Maury, Heriberto/0000-0003-1564-7504; Pierce III, James/0000-0001-5971-126X	COLCIENCIASthrough the Ph.D. National Scholarship Program [61702, UN-OJ-2014-24072]; office of the Engineering Technology and Commonwealth Engineering at Penn State University	COLCIENCIASthrough the Ph.D. National Scholarship Program; office of the Engineering Technology and Commonwealth Engineering at Penn State University	This work was supported by COLCIENCIASthrough the Ph.D. National Scholarship Program No 61702. Contract UN-OJ-2014-24072and the office of the Engineering Technology and Commonwealth Engineering at Penn State University.	Mesa JA, 2020, INT J SUSTAIN ENG, V13, P108, DOI 10.1080/19397038.2019.1634157; Ashby M.F, 2011, MAT SELECTION MECH D, Vfourth; Bataglin M, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.122198; Despeisse M, 2012, PROD PLAN CONTROL, V23, P354, DOI 10.1080/09537287.2011.555425; Esmaeilian B, 2016, J MANUF SYST, V39, P79, DOI 10.1016/j.jmsy.2016.03.001; Giret A, 2015, J MANUF SYST, V37, P126, DOI 10.1016/j.jmsy.2015.08.002; Halstenberg FA, 2015, PROC CIRP, V29, P603, DOI 10.1016/j.procir.2015.02.166; Kim S, 2019, J INTELL MANUF, V30, P383, DOI [10.1007/s10845-016-1253-7, 10.17856/jahs.2016.09.136.1]; Ko YT, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083351; Ma JF, 2016, INT J ADV MANUF TECH, V85, P741, DOI 10.1007/s00170-015-7979-0; Malek J, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120345; Malek J, 2019, J CLEAN PROD, V226, P589, DOI 10.1016/j.jclepro.2019.04.056; Massimi E, 2020, INT J ADV MANUF TECH, V108, P1997, DOI 10.1007/s00170-020-05366-y; Mesa J, 2015, INT J ADV MANUF TECH, V80, P221, DOI 10.1007/s00170-015-6951-3; Mihelcic JR, 2003, ENVIRON SCI TECHNOL, V37, P5314, DOI 10.1021/es034605h; Miyajima S., 2019, J ADV MANUF TECHNOL, V13, P119; Mutingi M, 2017, PROCEDIA MANUF, V8, P471, DOI 10.1016/j.promfg.2017.02.060; Nair SB, 2011, J OBSTET GYN INDIA, V61, P683, DOI 10.1007/s13224-012-0120-5; Rajput S, 2019, INT J INFORM MANAGE, V49, P98, DOI 10.1016/j.ijinfomgt.2019.03.002; Schischke K., 2017, ELECT GOES GREEN 201, P1, DOI [10.1109/EGG.2016.7829810, DOI 10.1109/EGG.2016.7829810]; Seliger G, 2008, CIRP ANN-MANUF TECHN, V57, P133, DOI 10.1016/j.cirp.2008.03.031; Sheng ZQ, 2017, P I MECH ENG C-J MEC, V231, P1981, DOI 10.1177/0954406215625679; Sonego M, 2018, J CLEAN PROD, V176, P196, DOI 10.1016/j.jclepro.2017.12.106; Tan AR, 2010, CIRP J MANUF SCI TEC, V3, P90, DOI 10.1016/j.cirpj.2010.01.001; Wenyuan Wang, 2011, International Journal of Product Lifecycle Management, V5, P164, DOI 10.1504/IJPLM.2011.043186; Yan JH, 2014, CLEAN TECHNOL ENVIR, V16, P95, DOI 10.1007/s10098-013-0597-3; Yang MG, 2011, INT J PROD ECON, V129, P251, DOI 10.1016/j.ijpe.2010.10.017; Zuniga Jorge, 2015, BMC Res Notes, V8, P10, DOI 10.1186/s13104-015-0971-9; Zuniga JM, 2019, EXPERT REV MED DEVIC, V16, P257, DOI 10.1080/17434440.2019.1572506; Zuniga JM, 2019, DISABIL REHABIL-ASSI, V14, P68, DOI 10.1080/17483107.2017.1398279	30	1	1	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1755-5817			CIRP J MANUF SCI TEC	CIRP J. Manuf. Sci. Technol.	NOV	2021	35						80	95		10.1016/j.cirpj.2021.05.011	http://dx.doi.org/10.1016/j.cirpj.2021.05.011		JUN 2021	16	Engineering, Manufacturing	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WD2FV					2022-09-04	WOS:000704764200008
J	Perez, J; Chavarriaga, J; Ortiz, A; Orrego, P; Rueda, S; Quiroga, W; Fernandez, N; Patino, G; Tobar, V; Villareal, N; Prada, J; Barco, C; Sarmiento, G				Perez, Jaime; Chavarriaga, Julian; Ortiz, Ana; Orrego, Paola; Rueda, Sandra; Quiroga, William; Fernandez, Nicolas; Patino, German; Tobar, Veronica; Villareal, Nicolas; Prada, Juan; Barco, Catalina; Sarmiento, Guillermo			Oncological and Functional Outcomes After Organ-Sparing Plastic Reconstructive Surgery for Penile Cancer	UROLOGY			English	Article							GLANS; MANAGEMENT; RESECTION	OBJECTIVE To describe oncological and functional outcomes in patients treated with reconstructive organsparing surgery (OSS) for squamous cell carcinoma of the penis. Plastic reconstructive OSS of the penis with a split thickness skin graft has been proposed as a treatment option for penile cancer, with the objective being preservation of physiological voiding and sexual function without comprising oncological control. MATERIALS AND METHODS Multicenter study reporting clinicopathological data of 57 patients with malignant lesions of the penis treated with OSS and plastic reconstructive surgery with split thickness skin graft from 2007 to 2019. Health related quality of life (HRQoL) was assessed with EuroQoL-5D-3L, urinary symptoms with the International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms, and erectile function with the International Index of erectile function (IIEF)-5. RESULTS Fifty-seven patients underwent OSS reconstructive surgery. Twenty underwent glans resurfacing, 23 partial penectomy, and 14 glansectomy. Median age was 55.1 years (interquartile range [IQR] 29-90), median follow-up 55.7 months (3-149). At the time of data analysis, 6 patients had died of Squamous Cell Carcinoma (SCC) (12.5%) and 10 (17.8%) had progressed. Kaplan-Meier estimates showed a 5-year survival rate of 87.5% and a 5-year progression-free survival of 83%. We assessed HRQoL and functional outcomes in 32 patients. EuroQol 5D-3L showed a mean health status of 82.5%, median Voiding score of the ICIQ-MLTUS was 4 (IQR 1-15), and median IIEF-5 19 (IQR 10.75-25). CONCLUSION OSS of the penis remains a safe and viable option for the treatment of SCC, ensuring a favorable appearance of the penis, preserving urinary and sexual function, with good HRQoL and without comprising oncological safety in selected cases. (C) 2020 Elsevier Inc.	[Perez, Jaime; Chavarriaga, Julian; Fernandez, Nicolas; Patino, German; Prada, Juan] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Carrera 7 40-62, Bogota, Colombia; [Fernandez, Nicolas; Barco, Catalina] Fdn Santa Fe, Dept Urol, Bogota, Colombia; [Ortiz, Ana; Rueda, Sandra; Tobar, Veronica; Villareal, Nicolas; Sarmiento, Guillermo] Univ Autonoma Bucaramanga, Div Urol, Fdn Oftalmol Santander Clin Ardila Lull, Bucaramanga, Colombia; [Orrego, Paola; Quiroga, William] Univ Mil Nueva Granada, Hosp Mil Cent, Div Urol, Bogota, Colombia; Univ Toronto, Hosp SickKids, Div Urol, Toronto, ON, Canada		Chavarriaga, J (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Carrera 7 40-62, Bogota, Colombia.	chavarriagaj@javeriana.edu.co	Barco-Castillo, Catalina/A-5153-2019	Patino, German/0000-0002-7495-5139; Barco-Castillo, Catalina/0000-0002-5137-944X; Perez Nino, Jaime/0000-0002-2231-4321; Chavarriaga, Julian/0000-0003-0158-504X				Acosta-Guevara C, 2017, UROL COLOMB, V26, P144; Ancona LD, 1997, LIFE PARTIAL PENECTO, P593; Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029; Bracka A, 2010, BJU INT, V105, P136, DOI 10.1111/j.1464-410X.2009.09087.x; Cui Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21862; Djajadiningrat RS, 2014, J UROLOGY, V192, P120, DOI 10.1016/j.juro.2013.12.038; Gomez-Ferrer A, 2011, ACTAS UROL ESP, V35, P180, DOI [10.1016/j.acuro.2010.09.007, 10.1016/S2173-5786(11)70046-4]; Hadway P, 2006, BJU INT, V98, P532, DOI 10.1111/j.1464-410X.2006.06368.x; Heyns CF, 2010, UROLOGY, V76, pS43, DOI 10.1016/j.urology.2010.03.001; Huang WN, 2019, LUTS, V11, P189, DOI 10.1111/luts.12260; Jackson MJ, 2011, EUR UROL, V60, P60, DOI 10.1016/j.eururo.2011.03.003; Janssen MF, 2019, EUR J HEALTH ECON, V20, P205, DOI 10.1007/s10198-018-0955-5; Kamel MH, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2017.10.017; Kamel MH, 2017, J UROLOGY, V198, P770, DOI 10.1016/j.juro.2017.01.088; Li J, 2011, UROLOGY, V78, P1121, DOI 10.1016/j.urology.2011.08.006; Lindner AK, 2020, WORLD J UROL, V38, P417, DOI 10.1007/s00345-019-02793-9; Maddineni Satish B, 2009, BMC Urol, V9, P8, DOI 10.1186/1471-2490-9-8; Minhas S, 2005, BJU INT, V96, P1040, DOI 10.1111/j.1464-410X.2005.05769.x; National Industrial Chemicals Notification and Assessment Scheme, 2019, NAT SPAC WEATH STRAT, P1; Nino P, 2008, RECONSTRUCCION PENE, VXVII, P62; Perez-Nino J, 2014, ACTAS UROL ESP, V38, P62, DOI 10.1016/j.acuro.2013.04.005; Scarberry K, 2015, SEX MED-UK, V3, P62, DOI 10.1002/sm2.56; Sedigh O, 2015, CUAJ-CAN UROL ASSOC, V9, pE423, DOI 10.5489/cuaj.2801; Tillett JW, 2006, UROLOGY, V67, DOI 10.1016/j.urology.2005.12.023; Zegarra Luis, 2011, Rev. perú. med. exp. salud publica, V28, P477	25	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-4295	1527-9995		UROLOGY	Urology	AUG	2020	142						161	+		10.1016/j.urology.2020.03.058	http://dx.doi.org/10.1016/j.urology.2020.03.058			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	MN9BZ	32380155				2022-09-04	WOS:000551136500046
J	Tipton, PW; Jaramillo-Koupermann, G; Soto-Beasley, AI; Walton, RL; Soler-Rangel, S; Romero-Osorio, O; Diaz, C; Moreno-Lopez, CL; Ross, OA; Wszolek, ZK; Cerquera-Cleves, C; Alarcon, F				Tipton, Philip W.; Jaramillo-Koupermann, Gabriela; Soto-Beasley, Alexandra I.; Walton, Ronald L.; Soler-Rangel, Silvia; Romero-Osorio, Oscar; Diaz, Cindy; Lucia Moreno-Lopez, Claudia; Ross, Owen A.; Wszolek, Zbigniew K.; Cerquera-Cleves, Catalina; Alarcon, Fernando			Genetic characterization of Parkinson's disease patients in Ecuador and Colombia	PARKINSONISM & RELATED DISORDERS			English	Letter						Parkinson's disease; Genetics; Latin America		To help address the scarcity of studies on the genetics of Parkinson's disease (PD) in Latin America, we screened 426 Ecuadorians with PD and 80 Colombians (PD = 55, Control = 26) for mutations within several PD-related genes. Among Colombians, we identified several variants within PARKIN and PINK1 genes.	[Tipton, Philip W.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Mangurian Bldg, Jacksonville, FL 32224 USA; [Jaramillo-Koupermann, Gabriela] Hosp Eugenio Especjo, Dept Pathol, Quito, Ecuador; [Soto-Beasley, Alexandra I.; Walton, Ronald L.; Romero-Osorio, Oscar; Diaz, Cindy; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Soler-Rangel, Silvia; Romero-Osorio, Oscar; Diaz, Cindy; Lucia Moreno-Lopez, Claudia; Cerquera-Cleves, Catalina] Hosp Univ San Ignacio, Movement Disorders Clin, Bogota, Colombia; [Soler-Rangel, Silvia; Cerquera-Cleves, Catalina] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Lucia Moreno-Lopez, Claudia] Fdn Cardioinfantil, Bogota, Colombia; [Ross, Owen A.] Mayo Clin, Dept Clin Genom, Jacksonville, FL 32224 USA; [Cerquera-Cleves, Catalina] Clin Univ Colombia, Bogota, Colombia; [Alarcon, Fernando] Hosp Eugenio Especjo, Dept Neurol, Movement Disorders Unit, Quito, Ecuador		Wszolek, ZK (corresponding author), Mayo Clin, Dept Neurol, Mangurian Bldg, Jacksonville, FL 32224 USA.	Wszolek.Zbigniew@mayo.edu		Cerquera, Catalina/0000-0002-3874-0261				Cornejo-Olivas M, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0020-6; Duque AF, 2015, COLOMB MEDICA, V46, P117; Mata IF, 2009, PARKINSONISM RELAT D, V15, P370, DOI 10.1016/j.parkreldis.2008.09.002; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Velez-Pardo C, 2019, PARKINSONISM RELAT D, V63, P204, DOI 10.1016/j.parkreldis.2019.01.030	5	2	3	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUN	2020	75						27	29		10.1016/j.parkreldis.2020.05.005	http://dx.doi.org/10.1016/j.parkreldis.2020.05.005			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MW7JW	32447234				2022-09-04	WOS:000557209100006
J	Sharma, AN; Fries, GR; Galvez, JF; Valvassori, SS; Soares, JC; Carvalho, AF; Quevedo, J				Sharma, Ajaykumar N.; Fries, Gabriel R.; Galvez, Juan F.; Valvassori, Samira S.; Soares, Jair C.; Carvalho, Andre F.; Quevedo, Joao			Modeling mania in preclinical settings: A comprehensive review	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Review						Mood disorders; Mania; Neuroprogression; Preclinical models; Animal models; Psychiatry; Treatment-resistance	INDUCED BEHAVIORAL SENSITIZATION; CELLULAR PLASTICITY CASCADES; DEEP BRAIN-STIMULATION; MEDIAL TEMPORAL-LOBE; PROTEIN-KINASE-C; ANIMAL-MODEL; BIPOLAR DISORDER; OXIDATIVE STRESS; MOUSE MODEL; NEUROTROPHIC FACTOR	The current pathophysiological understanding of mechanisms leading to onset and progression of bipolar manic episodes remains limited. At the same time, available animal models for mania have limited face, construct, and predictive validities. Additionally, these models fail to encompass recent pathophysiological frameworks of bipolar disorder (BD), e.g. neuroprogression. Therefore, there is a need to search for novel preclinical models for mania that could comprehensively address these limitations. Herein we review the history, validity, and caveats of currently available animal models for mania. We also review new genetic models for mania, namely knockout mice for genes involved in neurotransmission, synapse formation, and intracellular signaling pathways. Furthermore, we review recent trends in preclinical models for mania that may aid in the comprehension of mechanisms underlying the neuroprogressive and recurring nature of BD. In conclusion, the validity of animal models for mania remains limited. Nevertheless, novel (e.g. genetic) animal models as well as adaptation of existing paradigms hold promise. (C) 2015 Elsevier Inc. All rights reserved.	[Sharma, Ajaykumar N.; Fries, Gabriel R.; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Ctr Translat Psychiat, 1941 East Rd,Suite 3140, Houston, TX 77054 USA; [Sharma, Ajaykumar N.; Soares, Jair C.; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Ctr Excellence Mood Disorders, Houston, TX 77054 USA; [Galvez, Juan F.] Pontificia Univ Javeriana, Sch Med, Dept Psychiat, Bogota, Colombia; [Valvassori, Samira S.; Quevedo, Joao] Univ Southern Santa Catarina, Hlth Sci Unit, Grad Program Hlth Sci, Lab Neurosci, Criciuma, SC, Brazil; [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil; [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil		Quevedo, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Ctr Translat Psychiat, 1941 East Rd,Suite 3140, Houston, TX 77054 USA.	Joao.L.DeQuevedo@uth.tmc.edu	Fries, Gabriel R/C-1521-2009; de Quevedo, João Luciano/E-5491-2013; Fries, Gabriel R/P-8810-2014	Fries, Gabriel R/0000-0002-5468-2612; de Quevedo, João Luciano/0000-0003-3114-6611; Fries, Gabriel R/0000-0002-5468-2612; Soares, Jair C./0000-0002-5466-5628	CNPq (Brazil) [475719/2012-3, 552485/2011-0]; NIH [R01 MH085667]; National Institutes of Health (NIH) [NIH RO1 MH085667]; Stanley Medical Research Institute; John S. Dunn Foundation; Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston; FAPESC; CNPq [475719/2012-3, 552485/2011-0]; Pat Rutherford, Jr. Endowed Chair in Psychiatry; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085667] Funding Source: NIH RePORTER	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; John S. Dunn Foundation; Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston; FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pat Rutherford, Jr. Endowed Chair in Psychiatry; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the financial support of the CNPq (Brazil) process numbers 475719/2012-3 and 552485/2011-0 (J.Q.) and the NIH R01 MH085667 (J.C.S.).; The Center of Excellence on Mood Disorders (USA) is funded by Pat Rutherford, Jr. Endowed Chair in Psychiatry (J.C.S.), National Institutes of Health (NIH RO1 MH085667 to J.C.S.), Stanley Medical Research Institute, and The John S. Dunn Foundation. The Center for Translational Psychiatry (USA) is funded by Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston. Laboratory of Neurosciences (Brazil) is a center of the National Institute for Molecular Medicine (INCT-MM) funded by CNPq. Laboratory of Neurosciences is one of the members of the Center of Excellence in Applied Neurosciences of Santa Catarina (NENASC) funded by FAPESC. AFC and JQ are recipients of research fellowship awards from CNPq (levels II and IA, respectively; process numbers 475719/2012-3 and 552485/2011-0).	Adamec R E, 1990, Neuroreport, V1, P255, DOI 10.1097/00001756-199011000-00022; Agam G, 2009, BIOCHEM SOC T, V37, P1121, DOI 10.1042/BST0371121; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, P947; Arban R, 2005, BEHAV BRAIN RES, V158, P123, DOI 10.1016/j.bbr.2004.08.015; Arent CO, 2011, MOL NEUROBIOL, V43, P207, DOI 10.1007/s12035-011-8178-0; Arey R, 2012, BEHAV PHARMACOL, V23, P392, DOI 10.1097/FBP.0b013e32835651fd; Armani F, 2014, PSYCHOPHARMACOLOGY, V231, P639, DOI 10.1007/s00213-013-3397-x; Armani F, 2012, CNS NEUROSCI THER, V18, P119, DOI 10.1111/j.1755-5949.2010.00224.x; Bachevalier J, 1996, J AUTISM DEV DISORD, V26, P217, DOI 10.1007/BF02172015; Banerjee U, 2012, PROG NEURO-PSYCHOPH, V37, P56, DOI 10.1016/j.pnpbp.2011.12.006; Bannerman DM, 2001, EXP BRAIN RES, V138, P100, DOI 10.1007/s002210100687; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BAPTISTA T, 1993, EUR J PHARMACOL, V236, P39, DOI 10.1016/0014-2999(93)90224-6; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Benedetti F., 2015, CHRONOBIOL INT, P1; Benedetti F, 2008, BEHAV BRAIN RES, V187, P221, DOI 10.1016/j.bbr.2007.09.012; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; BERGGREN U, 1978, PSYCHOPHARMACOLOGY, V59, P41, DOI 10.1007/BF00428028; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Berk M, 2009, INT J NEUROPSYCHOPH, V12, P441, DOI 10.1017/S1461145708009498; Bersudsky Y, 2008, BEHAV PHARMACOL, V19, P217, DOI 10.1097/FBP.0b013e3282feb099; Brocardo PS, 2010, BIPOLAR DISORD, V12, P414, DOI 10.1111/j.1399-5618.2010.00827.x; Bruning CA, 2012, PROG NEURO-PSYCHOPH, V38, P168, DOI 10.1016/j.pnpbp.2012.03.005; Budni J, 2013, REV BRAS PSIQUIATR, V35, P1, DOI 10.1016/j.rbp.2013.01.001; CAPPELIEZ P, 1990, PROG NEURO-PSYCHOPH, V14, P347, DOI 10.1016/0278-5846(90)90023-A; Cassidy F, 1999, AM J PSYCHIAT, V156, P1417; Cechinel-Recco K, 2012, J PSYCHOPHARMACOL, V26, P1594, DOI 10.1177/0269881112463124; Chen C, 2014, BIPOLAR DISORD, V16, P790, DOI 10.1111/bdi.12255; Chiu CT, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu102; CHRISTO PJ, 1993, MED HYPOTHESES, V41, P378, DOI 10.1016/0306-9877(93)90089-9; Coque L, 2011, NEUROPSYCHOPHARMACOL, V36, P1478, DOI 10.1038/npp.2011.33; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; D'Aquila PS, 2006, EUR J PHARMACOL, V535, P208, DOI 10.1016/j.ejphar.2006.02.016; D'Aquila PS, 2000, EUR J PHARMACOL, V395, P157, DOI 10.1016/S0014-2999(00)00189-8; D'Aquila PS, 2001, EUR J PHARMACOL, V416, P107, DOI 10.1016/S0014-2999(01)00876-7; Damri O, 2015, EUR NEUROPSYCHOPHARM, V25, P425, DOI 10.1016/j.euroneuro.2014.06.012; DAVIES C, 1974, PSYCHOPHARMACOLOGIA, V36, P263, DOI 10.1007/BF00421808; Dencker D, 2010, BEHAV BRAIN RES, V207, P78, DOI 10.1016/j.bbr.2009.09.040; Dickerson F, 2012, BIPOLAR DISORD, V14, P547, DOI 10.1111/j.1399-5618.2012.01028.x; Dzirasa K, 2012, ANN NY ACAD SCI, V1265, P36, DOI 10.1111/j.1749-6632.2012.06669.x; Dzirasa K, 2011, J NEUROSCI, V31, P6449, DOI 10.1523/JNEUROSCI.6144-10.2011; Einat H, 2005, BEHAV BRAIN RES, V165, P172, DOI 10.1016/j.bbr.2005.06.012; Einat H, 2007, NEUROSCI BIOBEHAV R, V31, P850, DOI 10.1016/j.neubiorev.2006.12.001; Einat H, 2007, BEHAV GENET, V37, P244, DOI 10.1007/s10519-006-9093-4; Einat H, 2006, J PSYCHOPHARMACOL, V20, P714, DOI 10.1177/0269881106060241; Einat H, 2006, BIOL PSYCHIAT, V59, P1160, DOI 10.1016/j.biopsych.2005.11.004; Einat H, 2014, HARVARD REV PSYCHIAT, V22, P348, DOI 10.1097/HRP.0000000000000059; Einat H, 2014, PHARMACOL REP, V66, P722, DOI 10.1016/j.pharep.2014.03.013; Einat H, 2011, CURR TOP BEHAV NEURO, V5, P69, DOI 10.1007/7854_2010_49; El-Mallakh RS, 2006, PROG NEURO-PSYCHOPH, V30, P1261, DOI 10.1016/j.pnpbp.2006.04.003; El-Mallakh RS, 2003, BIPOLAR DISORD, V5, P362, DOI 10.1034/j.1399-5618.2003.00053.x; ELMALLAKH RS, 1995, PROG NEURO-PSYCHOPH, V19, P955, DOI 10.1016/0278-5846(95)00123-D; ELMALLAKH RS, 1995, BIOL PSYCHIAT, V37, P235, DOI 10.1016/0006-3223(94)00201-D; Ene HM, 2015, BEHAV PHARMACOL, V26, P331, DOI 10.1097/FBP.0000000000000128; Engel SR, 2009, MOL PSYCHIATR, V14, P448, DOI 10.1038/sj.mp.4002135; Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; Flaisher-Grinberg Shlomit, 2010, Front Psychiatry, V1, P10, DOI 10.3389/fpsyt.2010.00010; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; FRATTA W, 1987, EUR J PHARMACOL, V142, P437, DOI 10.1016/0014-2999(87)90084-7; Frey BN, 2006, J PSYCHIATR NEUROSCI, V31, P326; Frey BN, 2006, LIFE SCI, V79, P281, DOI 10.1016/j.lfs.2006.01.002; Fries G.R., 2015, J PSYCHIAT RES; Fries GR, 2012, CURR PSYCHIAT REP, V14, P667, DOI 10.1007/s11920-012-0319-2; Frye MA, 2006, BIPOLAR DISORD, V8, P677, DOI 10.1111/j.1399-5618.2006.00370.x; Galvez JF, 2015, MED HYPOTHESES, V84, P285, DOI 10.1016/j.mehy.2015.01.016; Gao YL, 2011, PSYCHIAT RES, V188, P366, DOI 10.1016/j.psychres.2010.12.030; GARDNER R, 1982, ARCH GEN PSYCHIAT, V39, P1436; Gazal M, 2014, EUR J PHARMACOL, V724, P132, DOI 10.1016/j.ejphar.2013.12.028; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; GESSA GL, 1995, ADV BIOCHEM PSYCHOPH, V49, P43; Geyer MA, 2008, NEUROTOX RES, V14, P71, DOI 10.1007/BF03033576; Ghedim FV, 2012, J PSYCHIATR RES, V46, P1569, DOI 10.1016/j.jpsychires.2012.08.010; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goldstein I, 2012, EUR NEUROPSYCHOPHARM, V22, P72, DOI 10.1016/j.euroneuro.2011.05.007; Gould TJ, 2001, BEHAV BRAIN RES, V118, P95, DOI 10.1016/S0166-4328(00)00318-1; Gould TD, 2007, NEUROSCI BIOBEHAV R, V31, P825, DOI 10.1016/j.neubiorev.2007.05.007; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Hamani C, 2012, BIOL PSYCHIAT, V72, P916, DOI 10.1016/j.biopsych.2012.05.024; Hamani C, 2010, EUR J NEUROSCI, V32, P1109, DOI 10.1111/j.1460-9568.2010.07414.x; Hamid H, 2009, PROG NEURO-PSYCHOPH, V33, P1103, DOI 10.1016/j.pnpbp.2009.06.002; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hannah-Poquette C, 2011, BEHAV BRAIN RES, V223, P222, DOI 10.1016/j.bbr.2011.04.047; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hattori Satoko, 2012, Front Behav Neurosci, V6, P58, DOI 10.3389/fnbeh.2012.00058; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Henry BL, 2010, NEUROSCI BIOBEHAV R, V34, P1296, DOI 10.1016/j.neubiorev.2010.04.002; HICKS RA, 1979, PHYSIOL BEHAV, V22, P1097, DOI 10.1016/0031-9384(79)90263-4; Hoertel N, 2013, EXPERT OPIN DRUG DIS, V8, P907, DOI 10.1517/17460441.2013.804057; Hougland MT, 2008, PSYCHIAT RES-NEUROIM, V164, P166, DOI 10.1016/j.pscychresns.2008.01.004; Huff MO, 2010, J AFFECT DISORDERS, V123, P303, DOI 10.1016/j.jad.2009.09.018; Jornada LK, 2011, J PSYCHIATR RES, V45, P162, DOI 10.1016/j.jpsychires.2010.05.011; Jornada LK, 2010, J PSYCHIATR RES, V44, P506, DOI 10.1016/j.jpsychires.2009.11.002; Kalinichev M, 2011, INT J NEUROPSYCHOPH, V14, P1051, DOI 10.1017/S1461145710001495; Kalynchuk LE, 2000, NEUROSCI BIOBEHAV R, V24, P691, DOI 10.1016/S0149-7634(00)00031-2; Kapczinski F, 2014, ACTA PSYCHIAT SCAND, V130, P354, DOI 10.1111/acps.12305; Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015; Kapczinski F, 2009, EXPERT REV NEUROTHER, V9, P957, DOI [10.1586/ern.09.31, 10.1586/ERN.09.31]; Kaplan KA, 2013, AM J PSYCHIAT, V170, P716, DOI 10.1176/appi.ajp.2013.12050708; Kara NZ, 2013, CELL TISSUE RES, V354, P191, DOI 10.1007/s00441-013-1594-x; Katayama T, 2009, PHARMACOGENOMICS, V10, P1967, DOI [10.2217/pgs.09.147, 10.2217/PGS.09.147]; Kehoe P, 1998, BEHAV NEUROSCI, V112, P116, DOI 10.1037/0735-7044.112.1.116; KIMBLE DP, 1963, J COMP PHYSIOL PSYCH, V56, P273, DOI 10.1037/h0048903; Kirshenbaum GS, 2014, NEUROSCIENCE, V260, P195, DOI 10.1016/j.neuroscience.2013.12.011; Kirshenbaum GS, 2012, GENES BRAIN BEHAV, V11, P436, DOI 10.1111/j.1601-183X.2012.00800.x; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; Kirshenbaum GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060141; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Kittel-Schneider S, 2015, PHARMACOPSYCHIATRY, V48, P145, DOI 10.1055/s-0035-1549946; Kofman O, 1998, PHARMACOL BIOCHEM BE, V59, P191, DOI 10.1016/S0091-3057(97)00410-3; Koukopoulos A, 2009, EUR PSYCHIAT, V24, P125, DOI 10.1016/j.eurpsy.2008.07.006; Kozikowski AP, 2007, J AM CHEM SOC, V129, P8328, DOI 10.1021/ja068969w; Kupfer DJ, 2005, JAMA-J AM MED ASSOC, V293, P2528, DOI 10.1001/jama.293.20.2528; KUROIWA T, 1991, NEUROSCI LETT, V122, P141, DOI 10.1016/0304-3940(91)90842-H; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; LEGRAND R, 1973, J COMP PHYSIOL PSYCH, V82, P501, DOI 10.1037/h0034127; Levy NA, 2000, BIPOLAR DISORD, V2, P108, DOI 10.1034/j.1399-5618.2000.020204.x; Li R, 1997, MOL CHEM NEUROPATHOL, V31, P65, DOI 10.1007/BF02815161; Li Y, 1997, BEHAV BRAIN RES, V84, P285, DOI 10.1016/S0166-4328(96)00158-1; Lien R, 2008, PHARMACOL REP, V60, P490; Macedo DS, 2013, PROG NEURO-PSYCHOPH, V43, P230, DOI 10.1016/j.pnpbp.2013.01.007; Macedo DS, 2012, BIPOLAR DISORD, V14, P707, DOI 10.1111/j.1399-5618.2012.01046.x; Machado-Vieira R, 2004, PROG NEURO-PSYCHOPH, V28, P209, DOI 10.1016/j.pnpbp.2003.10.015; Machado-Vieira R, 2007, NEUROSCI LETT, V421, P33, DOI 10.1016/j.neulet.2007.05.016; Maeng SH, 2008, P NATL ACAD SCI USA, V105, P8766, DOI 10.1073/pnas.0803736105; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Malatynska E, 2007, J NEUROSCI METH, V165, P175, DOI 10.1016/j.jneumeth.2007.05.035; Maletic V, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00098; Malkesman O, 2009, DIS MODEL MECH, V2, P238, DOI 10.1242/dmm.001628; Malkoff-Schwartz S, 1998, ARCH GEN PSYCHIAT, V55, P702, DOI 10.1001/archpsyc.55.8.702; Mansell W, 2008, CLIN PSYCHOL REV, V28, P494, DOI 10.1016/j.cpr.2007.07.010; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; McInnes LA, 2001, P NATL ACAD SCI USA, V98, P11485, DOI 10.1073/pnas.191519098; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MICZEK KA, 1978, PSYCHOPHARMACOLOGY, V57, P47, DOI 10.1007/BF00426957; Milhiet Vanessa, 2014, Front Biosci (Schol Ed), V6, P120; Mitchell PJ, 2005, EUR J PHARMACOL, V526, P147, DOI 10.1016/j.ejphar.2005.09.029; MORDEN B, 1968, PSYCHOPHYSIOLOGY, V5, P241; Moretti M, 2011, BEHAV PHARMACOL, V22, P766, DOI 10.1097/FBP.0b013e32834d0f1b; NAKANE H, 1995, NEUROSCI LETT, V188, P151, DOI 10.1016/0304-3940(95)11417-U; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Paszti-Gere E, 2013, CELL BIOCHEM BIOPHYS, V66, P831, DOI 10.1007/s12013-013-9608-6; Perez J, 1999, ARCH GEN PSYCHIAT, V56, P248, DOI 10.1001/archpsyc.56.3.248; POST RM, 1989, J CLIN PSYCHIAT, V50, P23; Post RM, 1996, MOL NEUROBIOL, V13, P33, DOI 10.1007/BF02740751; Post RM, 1998, BIOL PSYCHIAT, V44, P193, DOI 10.1016/S0006-3223(98)00144-9; POST RM, 1992, PHARMACOPSYCHIATRY, V25, P41, DOI 10.1055/s-2007-1014386; Post RM, 2001, DEV PSYCHOPATHOL, V13, P581, DOI 10.1017/S0954579401003091; POST RM, 1982, J NERV MENT DIS, V170, P717, DOI 10.1097/00005053-198212000-00002; Post RM, 2007, NEUROSCI BIOBEHAV R, V31, P858, DOI 10.1016/j.neubiorev.2007.04.003; Post RM, 2013, BRIT J PSYCHIAT, V202, P172, DOI 10.1192/bjp.bp.112.116855; Powell SB, 2008, BEHAV PHARMACOL, V19, P562, DOI 10.1097/FBP.0b013e32830dc110; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Queiroz A.I., 2015, METAB BRAIN DIS; Ralph-Williams RJ, 2003, BIOL PSYCHIAT, V53, P352, DOI 10.1016/S0006-3223(02)01489-0; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; Rao JS, 2012, J AFFECT DISORDERS, V136, P63, DOI 10.1016/j.jad.2011.08.017; Razafsha M, 2013, NEUROSCIENCE, V240, P204, DOI 10.1016/j.neuroscience.2013.02.045; Redrobe JP, 2009, BEHAV BRAIN RES, V198, P481, DOI 10.1016/j.bbr.2008.12.027; Rezin GT, 2014, MOL NEUROBIOL, V49, P877, DOI 10.1007/s12035-013-8566-8; Ricke AK, 2011, BIOL PSYCHIAT, V70, pE13, DOI 10.1016/j.biopsych.2011.02.030; Riegel RE, 2010, INT J DEV NEUROSCI, V28, P233, DOI 10.1016/j.ijdevneu.2010.02.002; Riegel RE, 2009, NEUROCHEM INT, V55, P491, DOI 10.1016/j.neuint.2009.05.003; ROBINSON TE, 1985, BRAIN RES, V343, P374, DOI 10.1016/0006-8993(85)90760-7; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Ruktanonchai DJ, 1998, PHYSIOL BEHAV, V63, P403, DOI 10.1016/S0031-9384(97)00457-5; Rygula R, 2015, PSYCHOPHARMACOLOGY, V232, P651, DOI 10.1007/s00213-014-3707-y; Saul MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038128; SCHAEFFER JC, 1976, J PHARM SCI, V65, P122, DOI 10.1002/jps.2600650128; Scheuing L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00249; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Serra G, 2015, J CLIN PSYCHIAT, V76, pE91, DOI 10.4088/JCP.13m08956; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Shaldubina A, 2002, J NEURAL TRANSM, V109, P433, DOI 10.1007/s007020200035; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Sharma AN, 2014, PROG NEURO-PSYCHOPH, V54, P289, DOI 10.1016/j.pnpbp.2014.06.005; Sidor M.M., 2015, MOL PSYCHIAT, V5; Steckert AV, 2013, NEUROCHEM INT, V62, P425, DOI 10.1016/j.neuint.2013.02.001; Stertz L, 2014, REV BRAS PSIQUIATR, V36, P39, DOI 10.1590/1516-4446-2013-1094; Sui L, 2013, J NEURAL TRANSM, V120, P1191, DOI 10.1007/s00702-013-0973-5; Swerdlow NR, 2001, BRAIN RES BULL, V55, P71, DOI 10.1016/S0361-9230(01)00492-0; Szabo ST, 2009, NEUROPHARMACOLOGY, V56, P47, DOI 10.1016/j.neuropharm.2008.08.015; Takuma K, 2014, BEHAV BRAIN RES, V272, P269, DOI 10.1016/j.bbr.2014.07.005; Teixeira AL, 2013, REV BRAS PSIQUIATR, V35, pS73, DOI 10.1590/1516-4446-2013-1182; Toker L, 2014, NEUROPSYCHOPHARMACOL, V39, P319, DOI 10.1038/npp.2013.194; Trevizol F, 2013, PROG NEURO-PSYCHOPH, V45, P215, DOI 10.1016/j.pnpbp.2013.06.007; Valvassori SS, 2014, PSYCHIAT RES, V215, P483, DOI 10.1016/j.psychres.2013.11.016; Valvassori SS, 2013, REV BRAS PSIQUIATR, V35, pS121, DOI 10.1590/1516-4446-2013-1168; van Enkhuizen J, 2014, NEUROPSYCHOPHARMACOL, V39, P3112, DOI 10.1038/npp.2014.170; van Enkhuizen J, 2013, INT J NEUROPSYCHOPH, V16, P1021, DOI 10.1017/S1461145712001198; Vassout A, 2000, REGUL PEPTIDES, V96, P7, DOI 10.1016/S0167-0115(00)00194-4; Verwer RWH, 1996, J COMP NEUROL, V376, P75, DOI 10.1002/(SICI)1096-9861(19961202)376:1<75::AID-CNE5>3.0.CO;2-L; WANG D, 1990, BRAIN RES, V533, P78, DOI 10.1016/0006-8993(90)91798-L; WEEKE A, 1987, J AFFECT DISORDERS, V13, P287, DOI 10.1016/0165-0327(87)90049-8; WILKINSON LS, 1993, BEHAV BRAIN RES, V55, P143, DOI 10.1016/0166-4328(93)90110-C; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Wolterink G, 2001, EUR NEUROPSYCHOPHARM, V11, P51, DOI 10.1016/S0924-977X(00)00138-3; Wong PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051455; Yang CR, 2015, NEUROTOX RES, V27, P129, DOI 10.1007/s12640-014-9498-4; Young JW, 2007, NEUROSCI BIOBEHAV R, V31, P882, DOI 10.1016/j.neubiorev.2007.05.009; Young JW, 2011, BRIT J PHARMACOL, V164, P1263, DOI 10.1111/j.1476-5381.2011.01318.x; Young JW, 2011, J PSYCHOPHARMACOL, V25, P934, DOI 10.1177/0269881111400646; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982; Zugno AI, 2015, LIFE SCI, V121, P65, DOI 10.1016/j.lfs.2014.11.025; Zugno AI, 2015, METAB BRAIN DIS, V30, P1043, DOI 10.1007/s11011-015-9671-3	211	28	28	0	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	APR 3	2016	66						22	34		10.1016/j.pnpbp.2015.11.001	http://dx.doi.org/10.1016/j.pnpbp.2015.11.001			13	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	DC3CK	26545487	Green Accepted			2022-09-04	WOS:000369096700003
J	Gallego, J; Gallego, GS; Daza, C; Molina, R; Barrault, J; Batiot-Dupeyat, C; Mondragon, F				Gallego, Jaime; Sierra Gallego, German; Daza, Carlos; Molina, Rafael; Barrault, Joel; Batiot-Dupeyat, Catherine; Mondragon, Fanor			PRODUCTION OF CARBON NANOTUBES AND HYDROGEN BY CATALYTIC ETHANOL DECOMPOSITION	DYNA-COLOMBIA			English	Article						Carbon nanotubes; perovskites; nickel; hydrogen; ethanol decomposition	GROWTH	This work reports the synthesis of multiwall carbon nanotubes (MWCNTs) by the catalytic decomposition of ethanol using the perovskite-type oxide LaNiO3 as catalyst precursor. The carbon nanotubes were characterized by transmission electronic microscopy (TEM), scanning electronic microscopy (SEM) and thermogravimetric analysis (TGA). TEM micrographs show that the carbon nanotubes were multi-walled with inner diameters ranging from 3 nm to 12 nm and outer diameters up to 42 nm. The yield of CNT and H-2 were 3.5 g(CNT).(g(cat).h)(-1) and 39 L-H2.(g.h)(-1) respectively at 700 degrees C. TGA data show that nanotube carbon purity was about 95 % by weight and the oxidation temperature was around 620 degrees C.	[Gallego, Jaime; Mondragon, Fanor] Univ Antioquia, Inst Quim, Medellin, Colombia; [Sierra Gallego, German] Univ Nacl Colombia, Fac Minas, Escuela Ingn Mat, Medellin, Colombia; [Daza, Carlos] Pontificia Univ Javeriana, Dept Quim, Bogota, Colombia; [Molina, Rafael] Univ Nacl Colombia, Dept Quim, Bogota, Colombia; [Barrault, Joel; Batiot-Dupeyat, Catherine] Univ Poitiers, ENSIP, CNRS, IC2MP,UMR 7285, F-86022 Poitiers, France		Gallego, J (corresponding author), Univ Antioquia, Inst Quim, Medellin, Colombia.	jaimegallegomarin@yahoo.es; geasierraga@unal.edu.co; carlosenriquedaza@hotmail.com; ramolinag@unal.edu.co; joel.barrault@univ-poitiers.fr; catherine.batiot.dupeyrat@univ-poitiers.fr; fmondra@gmail.com		BATIOT-DUPEYRAT, Catherine/0000-0003-2174-0166; Molina, Rafael/0000-0002-8676-7039; Daza, Carlos/0000-0002-9521-9499; Gallego Marin, Jaime Andres/0000-0003-0349-2170	ECOS-Nord/Colciencias program; University of Antioquia; Colciencias	ECOS-Nord/Colciencias program; University of Antioquia; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors are grateful to the ECOS-Nord/Colciencias program for the financial support given. F. Mondragon, J. Gallego and G. Sierra acknowledge the University of Antioquia for the financial support of the "Sostenibilidad" Program 2013-2014. J. Gallego C. Daza and G. Sierra would like to thank Colciencias and the University of Antioquia (JG and GS) for the PhD scholarship.	CHICK LA, 1990, MATER LETT, V10, P6, DOI 10.1016/0167-577X(90)90003-5; De Jong KP, 2000, CATAL REV, V42, P481, DOI 10.1081/CR-100101954; de Lima SM, 2008, CATAL LETT, V124, P195, DOI 10.1007/s10562-008-9484-7; Djaidja A, 2006, CATAL TODAY, V113, P194, DOI 10.1016/j.cattod.2005.11.066; Gallego GS, 2008, CATAL TODAY, V133, P200, DOI 10.1016/j.cattod.2007.12.075; Gallego GS, 2008, APPL CATAL A-GEN, V334, P251, DOI 10.1016/j.apcata.2007.10.010; Gallego J, 2011, APPL CATAL A-GEN, V397, P73, DOI 10.1016/j.apcata.2011.02.017; Govindaraj A, 2006, CARBON NANOTECHNOLOGY: RECENT DEVELOPMENTS IN CHEMISTRY, PHYSICS, MATERIALS SCIENCE AND DEVICE APPLICATIONS, P15, DOI 10.1016/B978-044451855-2/50005-X; Harris PJF, 2007, CARBON, V45, P229, DOI 10.1016/j.carbon.2006.09.023; Kuras M, 2011, CARBON, V49, P1453, DOI 10.1016/j.carbon.2010.12.015; Moshkalev SA, 2007, J APPL PHYS, V102, DOI 10.1063/1.2769354; Musumeci AW, 2007, J THERM ANAL CALORIM, V88, P885, DOI 10.1007/s10973-006-7563-9; Pan ZW, 1999, CHEM PHYS LETT, V299, P97, DOI 10.1016/S0009-2614(98)01240-8; Porro S, 2007, PHYSICA E, V37, P58, DOI 10.1016/j.physe.2006.07.014; Sierra G., 2010, DYNA, V163, P141; Gallego GS, 2006, APPL CATAL A-GEN, V311, P164, DOI 10.1016/j.apcata.2006.06.024; Gallego GS, 2008, IND ENG CHEM RES, V47, P9272, DOI 10.1021/ie800281t	17	3	4	0	10	UNIV NAC COLOMBIA, FAC NAC MINAS	MEDELLIN	APARTADO AEREO 3840, MEDELLIN, 00000, COLOMBIA	0012-7353			DYNA-COLOMBIA	Dyna-Colombia	APR	2013	80	178					78	85						8	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	145QL					2022-09-04	WOS:000319031800011
J	Obrenovich, ME; Morales, LA; Cobb, CJ; Shenk, JC; Mendez, GM; Fischbach, K; Smith, MA; Qasimov, EK; Perry, G; Aliev, G				Obrenovich, Mark E.; Morales, Ludis A.; Cobb, Celia J.; Shenk, Justin C.; Mendez, Gina M.; Fischbach, Kathryn; Smith, Mark A.; Qasimov, Eldar K.; Perry, George; Aliev, Gjumrakch			Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Review						GRK2; Alzheimer disease; cerebrovascular disease	PROTEIN-COUPLED RECEPTOR; METABOTROPIC GLUTAMATE RECEPTORS; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; KINASE 2; OXIDATIVE STRESS; VASCULAR HYPOPERFUSION; BETA-GAMMA; A-BETA; EXPRESSION	Alzheimer disease (AD) and stroke are two leading causes of age-associated dementia. Increasing evidence points to vascular damage as an early contributor to the development of AD and AD-like pathology. In this review, we discuss the role of G protein-coupled receptor kinase 2 (GRK2) as it relates to individuals affected by AD and how the cardiovasculature plays a role in AD pathogenesis. The possible involvement of GRKs in AD pathogenesis is an interesting notion, which may help bridge the gap in our understanding of the heart-brain connection in relation to neurovisceral damage and vascular complications in AD, since kinases of this family are known to regulate numerous receptor functions both in the brain, myocardium, and elsewhere. The aim of this review is to discuss our findings of overexpression of GRK2 in the context of the early pathogenesis of AD, because increased levels of GRK2 immunoreactivity were found in vulnerable neurons of AD patients as well as in a two-vessel occlusion (2-VO) mammalian model of ischaemia. Also, we consider the consequences for this overexpression as a loss of G-protein coupled receptor (GPCR) regulation, as well as suggest a potential role for GPCRs and GRKs in a unifying theory of AD pathogenesis, particularly in the context of cerebrovascular disease. We synthesize this newer information and attempt to put it into context with GRKs as regulators of diverse physiological cellular functions that could be appropriate targets for future pharmacological intervention.	[Aliev, Gjumrakch] Univ Texas San Antonio, Coll Sci, Dept Biol, San Antonio, TX 78249 USA; [Obrenovich, Mark E.; Smith, Mark A.; Perry, George] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Morales, Ludis A.; Mendez, Gina M.] Javeriana Univ, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Cobb, Celia J.; Shenk, Justin C.; Fischbach, Kathryn; Aliev, Gjumrakch] Univ Texas San Antonio, Coll Sci, Electron Microscopy Res Ctr, San Antonio, TX 78249 USA; [Qasimov, Eldar K.] Azerbaijan Med Univ, Dept Cytol Histol & Embryol, Baku, Azerbaijan		Aliev, G (corresponding author), Univ Texas San Antonio, Coll Sci, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	aliev03@gmail.com	Perry, George/A-8611-2009; Aliev, Gjumrakch/AAE-7734-2020; Morales, Ludis/AAZ-7053-2020; Aliev, Gjumrakch/K-7302-2017	Perry, George/0000-0002-6547-0172; Aliev, Gjumrakch/0000-0001-7373-3182; Morales-Alvarez, Ludis/0000-0002-8541-9729; Gasimov, Eldar/0000-0002-5104-4260	Philip Morris USA Research Management Group; Alzheimer Association (IIRG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060655] Funding Source: NIH RePORTER	Philip Morris USA Research Management Group; Alzheimer Association (IIRG)(Alzheimer's Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Philip Morris USA Research Management Group and Alzheimer Association (IIRG).	Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x; Aliev G, 2002, BRAIN PATHOL, V12, P21; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; Boucher M, 2004, EUR J PHARMACOL, V495, P185, DOI 10.1016/j.ejphar.2004.05.040; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; DELATORRE JC, 1995, J NEUROSCI RES, V41, P238, DOI 10.1002/jnr.490410211; DELATORRE JC, 1992, NEUROL RES, V14, P177, DOI 10.1080/01616412.1992.11740045; Durand D, 2008, NEUROPHARMACOLOGY, V55, P577, DOI 10.1016/j.neuropharm.2008.06.022; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Erdtmann-Vourliotis M, 2001, MOL BRAIN RES, V95, P129, DOI 10.1016/S0006-8993(01)03046-3; Feldman RD, 2002, MOL PHARMACOL, V61, P707, DOI 10.1124/mol.61.4.707; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Ge JA, 1996, EUR J PHARMACOL, V297, P299, DOI 10.1016/0014-2999(95)00762-8; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; Haga K, 1998, EUR J BIOCHEM, V255, P363, DOI 10.1046/j.1432-1327.1998.2550363.x; Hagen SA, 2003, ANESTHESIOLOGY, V98, P343, DOI 10.1097/00000542-200302000-00012; Harris CA, 2001, BASIC RES CARDIOL, V96, P364, DOI 10.1007/s003950170044; Hata Jonathan A, 2003, Mol Interv, V3, P264, DOI 10.1124/mi.3.5.264; Heininger K, 2000, HUM PSYCHOPHARM CLIN, V15, P1, DOI 10.1002/(SICI)1099-1077(200001)15:1<1::AID-HUP153>3.0.CO;2-1; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Iaccarino G, 2005, EUR HEART J, V26, P1752, DOI 10.1093/eurheartj/ehi429; Iaccarino G, 2003, ASSAY DRUG DEV TECHN, V1, P347, DOI 10.1089/154065803321204484; Iacovelli L, 1999, MOL PHARMACOL, V56, P316, DOI 10.1124/mol.56.2.316; Kwon S, 2004, J PHARMACOL SCI, V95, P267, DOI 10.1254/jphs.FPJ03091X; Lea PM, 2003, DRUG NEWS PERSPECT, V16, P513, DOI 10.1358/dnp.2003.16.8.829350; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Mayor F, 1998, TRENDS CARDIOVAS MED, V8, P234, DOI 10.1016/S1050-1738(98)00008-5; Nistor A, 2007, NEUROBIOL AGING, V28, P1493, DOI 10.1016/j.neurobiolaging.2006.06.023; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Obrenovich M.E., 2003, CELL CYCLE MECH NEUR, P71; OBRENOVICH MA, 2005, CELL CYCLE ACTIVATIO, P1; Obrenovich ME, 2006, NEUROTOX RES, V10, P43, DOI 10.1007/BF03033333; Obrenovich ME, 2002, NEUROBIOL AGING, V23, P1097, DOI 10.1016/S0197-4580(02)00038-6; Pappas BA, 1996, BRAIN RES, V708, P50, DOI 10.1016/0006-8993(95)01267-2; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Penela P, 2000, EUR J BIOCHEM, V267, P4390, DOI 10.1046/j.1432-1327.2000.01484.x; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Raina AK, 2001, ACTA NEUROPATHOL, V101, P305; RAINA AK, 2006, INT J NEUROPROTEC NE, V2, P80; Ramos-Ruiz R, 2000, CIRCULATION, V101, P2083, DOI 10.1161/01.CIR.101.17.2083; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; RODER HM, 1993, BIOCHEM BIOPH RES CO, V193, P639, DOI 10.1006/bbrc.1993.1672; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Shahid G, 2007, J BIOL CHEM, V282, P20612, DOI 10.1074/jbc.M700744200; SHENK JC, 2009, J NEUROLOG IN PRESS; Shibasaki T, 1999, BIOCHEM MOL BIOL INT, V47, P569; Sorensen SD, 2003, NEUROPHARMACOLOGY, V44, P699, DOI 10.1016/S0028-3908(03)00053-4; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; Suo ZM, 2004, J NEUROSCI, V24, P3444, DOI 10.1523/JNEUROSCI.4856-03.2004; Theilade J, 2003, BASIC RES CARDIOL, V98, P97, DOI 10.1007/s00395-003-0395-x; Tsai VWW, 2005, NEUROTOX RES, V7, P125, DOI 10.1007/BF03033782; TSUCHIYA M, 1992, EXP BRAIN RES, V89, P87; Ungerer M, 1996, CIRC RES, V79, P455, DOI 10.1161/01.RES.79.3.455; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003; Yoshida N, 2003, EUR J BIOCHEM, V270, P1154, DOI 10.1046/j.1432-1033.2003.03465.x; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039; Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	75	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	MAY	2009	13	5					853	865		10.1111/j.1582-4934.2008.00512.x	http://dx.doi.org/10.1111/j.1582-4934.2008.00512.x			13	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	458AB	19292735	Green Published, Green Accepted			2022-09-04	WOS:000266980300004
J	Cadena, J; Vinaccia, S; Perez, A; Rico, MI; Hinojosa, R; Anaya, JM				Cadena, J; Vinaccia, S; Perez, A; Rico, MI; Hinojosa, R; Anaya, JM			The impact of disease activity on the quality of life, mental health status, and family dysfunction in Colombian patients with rheumatoid arthritis	JCR-JOURNAL OF CLINICAL RHEUMATOLOGY			English	Article						rheumatoid arthritis; quality of life; mental health status; family; disability	SELF-EFFICACY; STRESS; QUESTIONNAIRE; INTERVENTIONS; HELPLESSNESS; DEPRESSION; VALIDATION	This study investigated the relationship between activity of disease, mental health status, quality of life, and family dysfunction in northwestern Colombian patients with rheumatoid arthritis (RA). Seventy-nine patients completed a 2-phase study that included physical examination (objective measurement of disease activity according to adapted American College of Rheumatology criteria) and a pretested questionnaire that sought information on helplessness, disability, depression, anxiety, quality of life, arthritis self-efficacy for pain, and other symptoms, as well as family dysfunction and socioeconomic status. Nineteen patients (24%) had active RA, 48 (61%) had moderately active RA, and 12 (15%) were in remission. Symptoms of depression, helplessness, disability, pain, anxiety, lower quality of life, and self-efficacy were associated with RA activity regardless of age, sex, and duration of the disease. Symptoms of depression were directly correlated with anxiety, helplessness, pain, and disability and inversely correlated with quality of life and self-efficacy. Although family dysfunction was present in 39% of patients, no associations between family dysfunction, activity of RA, mental health variables, socioeconomical status or quality of fife were observed. These results indicate that RA activity significantly influences mental health status and quality of life in this population. Accordingly, a holistic conception of therapy should guide the treatment of patients with RA.	Corp Invest Biol, Unidad Reumatol, Medellin, Colombia; Univ San Buenaventura, Medellin, Colombia; Univ Texas Houston, Brownsville, TX USA; Pontificia Univ Javeriana, Bogota, Colombia; Clin Univ Bolivariana, Medellin, Colombia; Univ Ponticicia Bolivariana, Sch Med, Rheumatol Unit, Medellin, Colombia		Anaya, JM (corresponding author), Corp Invest Biol, Unidad Reumatol, Cra 72-A 78-B-141, Medellin, Colombia.	jmanaya@epm.net.co	Anaya, Juan-Manuel/J-1960-2016; vinaccia, stefano/P-4287-2016	Anaya, Juan-Manuel/0000-0002-6444-1249; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Perez, Adriana/0000-0002-6859-9916; vinaccia, stefano/0000-0001-6899-8573				ABELLOBANFI M, 1994, J RHEUMATOL, V21, P1250; Agarwal SK, 2001, CLIN EXP ALLERGY, V31, P25, DOI 10.1046/j.1365-2222.2001.01005.x; Anaya JM, 2001, SEMIN ARTHRITIS RHEU, V31, P191, DOI 10.1053/sarh.2001.27737; [Anonymous], WORLD HLTH REP 2001; [Anonymous], 2001, WORLD HLTH REPORT 20, P30; ARIAS L, 1994, COLOMBIA MED, V25, P6; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Astin JA, 2002, ARTHRIT RHEUM-ARTHR, V47, P291, DOI 10.1002/art.10416; BALLINAGARCIA FJ, 2002, REV ESP REUMATOL, V29, P56; Barlow JH, 2002, PATIENT EDUC COUNS, V46, P11, DOI 10.1016/S0738-3991(01)00146-X; BUSTAMANTE FAV, 1997, LEY 100 SEGURIDAD SO; Cadena J, 2002, REV COLOMB REUMATOL, V9, P184; Correa PA, 2002, TISSUE ANTIGENS, V59, P436, DOI 10.1034/j.1399-0039.2002.590515.x; Danao LL, 2001, ARTHRIT RHEUM-ARTHR, V45, P167, DOI 10.1002/1529-0131(200104)45:2<167::AID-ANR170>3.0.CO;2-X; de Pineda V. Gutierrez, 1999, ESTRUCTURA FUNCION C, P338; Dekkers JC, 2001, ARTHRIT RHEUM-ARTHR, V45, P307, DOI 10.1002/1529-0131(200108)45:4<307::AID-ART342>3.0.CO;2-0; DEVELLIS BM, 1993, BAILLIERE CLIN RHEUM, V7, P241, DOI 10.1016/S0950-3579(05)80088-3; DEVELLIS RF, 1993, BAILLIERE CLIN RHEUM, V7, P397, DOI 10.1016/S0950-3579(05)80096-2; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Escalante A, 1996, ARTHRITIS RHEUM-US, V39, P93, DOI 10.1002/art.1780390113; Escalante A, 1999, ARTHRIT CARE RES, V12, P341, DOI 10.1002/1529-0131(199910)12:5<341::AID-ART6>3.0.CO;2-P; Escalante A, 2002, ARTHRIT RHEUM-ARTHR, V47, P333, DOI 10.1002/art.10418; Evers AWM, 2001, J CONSULT CLIN PSYCH, V69, P1026, DOI 10.1037//0022-006X.69.6.1026; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; GONZALEZ VM, 1995, ARTHRITIS RHEUM-US, V38, P1429, DOI 10.1002/art.1780381010; JIMENEZ G, VIOLENCIA MEDELLIN E; KRUG HE, 1995, J MUSCULOSKEL MED, V12, P27; le Gallez P, 1993, Nurs Stand, V7, P30; LIVENGOOD JM, 1999, CURR REV PAIN, V3, P1; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; NEWMAN SP, 1993, BAILLIERE CLIN RHEUM, V7, P259, DOI 10.1016/S0950-3579(05)80089-5; NICASSIO PM, 1985, J RHEUMATOL, V12, P462; PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308, DOI 10.1002/art.1780241012; SAS Institute, 2001, SAS SYST WIND VERS 8; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Strand CV, 1997, J RHEUMATOL, V24, P1630; Suurmeijer TPBM, 2001, ARTHRIT RHEUM-ARTHR, V45, P111; Waldrop D, 2001, J COUNS PSYCHOL, V48, P233, DOI 10.1037/0022-0167.48.2.233; Waltz M, 1998, ARTHRIT CARE RES, V11, P356, DOI 10.1002/art.1790110507; Wolfe F, 1994, RHEUMATOID ARTHRITIS; Zautra AJ, 2001, PSYCHOSOM MED, V63, P687, DOI 10.1097/00006842-200107000-00022	42	43	63	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-1608	1536-7355		JCR-J CLIN RHEUMATOL	JCR-J. Clin. Rheumatol.	JUN	2003	9	3					142	150		10.1097/01.RHU.0000073434.59752.f3	http://dx.doi.org/10.1097/01.RHU.0000073434.59752.f3			9	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rheumatology	758QA	17041449				2022-09-04	WOS:000187660600003
J	Ruiz-Garcia, M; Jaramillo, MF; Lopez, JB; Rivillas, Y; Bello, A; Leguizamon, N; Shostell, JM				Ruiz-Garcia, Manuel; Jaramillo, Maria F.; Lopez, Juan B.; Rivillas, Yudrum; Bello, Aurita; Leguizamon, Norberto; Shostell, Joseph M.			Mitochondrial and karyotypic evidence reveals a lack of support for the genus Nasuella (Procyonidae, Carnivora)	JOURNAL OF VERTEBRATE BIOLOGY			English	Article						coatis; karyotypes; mitogenomes; Nasua; Nasuella	SPATIAL AUTOCORRELATION ANALYSIS; COATI NASUA-NARICA; WHITE-NOSED COATIS; GENETIC-STRUCTURE; POPULATION-GENETICS; HOME-RANGE; PRIMATES; PATTERNS; MTDNA; PHYLOGEOGRAPHY	Coatis are traditionally divided into two genera (Nasua and Nasuella). Coatis from the lowlands of the Neotropics are larger (Nasua nasua in South America and Nasua narica in Central America) than those from the highlands in the Andean Cordilleras (Nasuella olivacea and maybe Nasuella meridensis). Some authors have claimed that Nasuella should be included in Nasua but strong data have not been provided to support this statement. We reported an extensive mitochondrial (mt) DNA analysis with 205 specimens with complete mitogenomes. Some N. olivacea were intermixed among haplogroups of N. nasua, some haplotypes of N. narica were intermediate between N. nasua and the most recent haplotypes of the Central American N. narica, and N. narica from southern Central America and northern Colombia were introgressed with mtDNA from N. olivacea. Furthermore, the spatial genetic structure of N. nasua, N. narica, and N. olivacea were practically identical. Additionally, we also show, for first the time, the karyotype of N. olivacea. The chromosome morphology of N. olivacea was un-differentiable from that of N. nasua. These data fail to support the independence of these two genera.	[Ruiz-Garcia, Manuel; Jaramillo, Maria F.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota, DC, Colombia; [Lopez, Juan B.; Rivillas, Yudrum] Univ Nacl Colombia, Lab Genet & Citogenet, Sede Medellin, Medellin, Colombia; [Bello, Aurita; Leguizamon, Norberto] Secretaria Dist Ambiente SDA, Bogota, DC, Colombia; [Shostell, Joseph M.] Univ Minnesota Crookston, Math Sci & Technol Dept, Crookston, MN USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota, DC, Colombia.	mruizgar@yahoo.es; ocmafe@hotmail.com; jblopez@unal.edu.co; ymrivillas@unal.edu.co; aurita.bello@ambientebogota.gov.co; norberto.leguizamon@ambientebogota.gov.co; joseph.shostell@gmail.com		Ruiz-Garcia, Manuel/0000-0003-2820-2950	Pontificia Universidad Javeriana [6839]	Pontificia Universidad Javeriana	Thanks to Dr Diana Alvarez, Pablo Escobar-Armel, Nicolas Lichilin, Luisa Fernanda Castellanos-Mora, Dr. Clara Saldamando, Armando Castellanos, and Jorge Brito for their respective help in obtaining Nasua and Nasuella during the last 20 years. This work was financed by the Project 6839 (Pontificia Universidad Javeriana). Thanks to the Ministerio del Ambiente Ecuatoriano (MAE) in Santo Domingo de Tsachilas and in Coca, to INABIO (Quito, Ecuador), to the Instituto von Humboldt (Colombia), to the Peruvian Ministry of Environment, PRODUCE (Direccion Nacional de Extraccion y Procesamiento Pesquero), Consejo Nacional del Ambiente and the Instituto Nacional de Recursos Naturales (INRENA) from Peru, to the Coleccion Boliviana de Fauna (Dr. Julieta Vargas), to CITES Bolivia, and to the Direccion General de Zoologicos y Vida Silvestre (DGZVS) in Mexico for their role in facilitating the collection of permits in Ecuador, Colombia, Peru, Bolivia, and Mexico. The second author also thanks the many people of diverse Indian tribes in Ecuador (Kichwa, Huaorani, Shuar and Achuar), Colombia (Jaguas, Ticunas, Huitoto, Cocama, Tucano, Nonuya, Yuri and Yucuna), Peru (Bora, Ocaina, Shipigo-Comibo, Capanahua, Angoteros, Orejon, Cocama, Kishuarana and Alamas), and Bolivia (Siriono, Canichana, Cayubaba and Chacobo) for their assistance in obtaining samples of N. nasua, and multiple colonos and peasants in Andean areas of Colombia, Ecuador, Peru, and Bolivia, and multiple Mayan communities and peasants from Honduras, El Salvador, Belize, Guatemala, and southern Mexico for their assistance in obtaining samples of N. narica and Nasuella. Author contributions: M. Ruiz-Garcia designed the research and obtained the major part of the samples of the study. M.F. Jaramillo, A. Bello and N. Leguizamon obtained some samples of Nasuella olivacea. M. Ruiz-Garcia and J.M. Shostell supervised the molecular analyses. M.F. Jaramillo performed laboratory procedures with mtDNA. J.B. Lopez and Y. Rivillas performed the karyotypes M. Ruiz-Garcia performed the statistical analyses and wrote the manuscript with inputs from J.M. Shostell. M. Ruiz-Garcia submitted sequences to GenBank. M.F. Jaramillo, J.B. Lopez, Y. Rivillas, A. Bello, N. Leguizamon and J.M. Shostell revised the manuscript. All authors read and approved the final version of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baskin JA, 2004, J VERTEBR PALEONTOL, V24, P709, DOI 10.1671/0272-4634(2004)024[0709:BAPMCP]2.0.CO;2; Benirschke K., 1966, MAMMAL CHROMOSOMES N, V21, P148; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Biedrzycka A, 2014, BIOL INVASIONS, V16, P1611, DOI 10.1007/s10530-013-0595-8; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; CAMARGO M, 1982, AM J HUM GENET, V34, P757; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cullingham CI, 2008, MOL ECOL, V17, P4874, DOI 10.1111/j.1365-294X.2008.03956.x; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DECKER DM, 1991, P BIOL SOC WASH, V104, P370; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EPPERSON BK, 1993, EVOL BIOL, V27, P95; EPPERSON BK, 1990, GENETICS, V124, P757; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Everitt, 1992, ANAL CONTINGENCY TAB, DOI 10.1201/b15072; Freeland J., 2011, MOL ECOL; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Glatston A., 1994, RED PANDA OLINGOS CO; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Gompper Matthew E., 1995, Mammalian Species, V487, P1; Gompper ME, 1997, J ZOOL, V241, P441; Gompper ME, 1997, ANIM BEHAV, V53, P781, DOI 10.1006/anbe.1996.0344; Gompper ME, 1998, MOL ECOL, V7, P157, DOI 10.1046/j.1365-294x.1998.00325.x; Gonzalez-Maya Jose F., 2015, Small Carnivore Conservation, V52-53, P93; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hass CC, 2002, J MAMMAL, V83, P934, DOI 10.1644/1545-1542(2002)083<0934:HRDOWN>2.0.CO;2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Helgen Kristofer M., 2009, Small Carnivore Conservation, V41, P65; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Hsu T.C., 1970, ATLAS MAMMALIAN CHRO; Hsu T.C., 1966, MAMMAL CHROMOSOMES N, V21, P155; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koepfli KP, 2007, MOL PHYLOGENET EVOL, V43, P1076, DOI 10.1016/j.ympev.2006.10.003; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; LANNING DV, 1976, J MAMMAL, V57, P609, DOI 10.2307/1379318; Lopez J.B., 2002, MODELO EXPT ESTUDIO; MANTEL N, 1967, CANCER RES, V27, P209; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; McFadden KW, 2008, J ZOOL, V276, P176, DOI 10.1111/j.1469-7998.2008.00461.x; McFadden K.W, 2004, THESIS COLUMBIA U NE; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mondolfi E, 1987, FIELDANA ZOOL, V39, P447; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; Nabholz B, 2013, MOL BIOL EVOL, V30, P272, DOI 10.1093/molbev/mss238; Neves-Chaves B.R, 2011, THESIS FEDERAL MINAS; Nigenda-Morales SF, 2019, MOL PHYLOGENET EVOL, V131, P149, DOI 10.1016/j.ympev.2018.11.011; Nowak R.M., 1999, WALKERS MAMMALS WORL; Paquette SR, 2014, EVOL APPL, V7, P734, DOI 10.1111/eva.12161; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rambaut A., 2012, FIGTREE V1 4 3; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Ruiz-Garcia M, 1998, ACTA THERIOL, V43, P39, DOI 10.4098/AT.arch.98-4; Ruiz-Garcia M, 1999, GENET MOL BIOL, V22, P493, DOI 10.1590/S1415-47571999000400006; Ruiz-Garcia M., 2021, THERYA, V12, DOI [10.12933/therya-21-1164, DOI 10.12933/THERYA-21-1164]; Ruiz-Garcia M., 2021, ANIM BIODIV CONSERV, V44, DOI [10.32800/abc.2021.44.0316, DOI 10.32800/ABC.2021.44.0316]; Ruiz-Garcia M, 2020, MAMM BIOL, V100, P521, DOI 10.1007/s42991-020-00050-w; Ruiz-Garcia M, 2019, J MAMMAL, V100, P1631, DOI 10.1093/jmammal/gyz109; Ruiz-Garcia M, 2019, MITOCHONDRIAL DNA A, V30, P525, DOI 10.1080/24701394.2019.1570174; Ruiz-Garcia M, 2018, INT J PRIMATOL, V39, P1068, DOI 10.1007/s10764-018-0062-6; Ruiz-Garcia M, 2017, FOLIA PRIMATOL, V88, P421, DOI 10.1159/000480502; Ruiz-Garcia M, 2014, MOL PHYLOGENET EVOL, V79, P179, DOI 10.1016/j.ympev.2014.05.034; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Silva-Caballero A., 2017, NATURAL RESOURCES, V8, P31; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sneath PHA., 1973, NUMERICAL TAXONOMY; Soibelzon LH, 2013, MOL POPULATION GENET, P509; SOKAL RR, 1986, GENETICS, V114, P259; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, EVOLUTION, V45, P152, DOI [10.2307/2409490, 10.1111/j.1558-5646.1991.tb05274.x]; SOKAL RR, 1983, GENETICS, V105, P219; SOKAL RR, 1989, GENETICS, V121, P845; SOKAL RR, 1987, AM NAT, V129, P122, DOI 10.1086/284625; Spowart G, 1994, Methods Mol Biol, V29, P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Todd N.B., 1966, MAMMAL CHROMOSOMES N, V21, P153; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tsuchiya-Jerep MTN, 2009, THESIS PONTIFICIA U; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Valenzuela D, 2000, J MAMMAL, V81, P810, DOI 10.1644/1545-1542(2000)081&lt;0810:HSHRAA&gt;2.3.CO;2; Verleye D.M., 1987, J INDIANA ACAD SCI, V97, P511; Wurster D.H., 1967, MAMMAL CHROMOSOME NE, V8, P195; WURSTER DH, 1968, CHROMOSOMA, V24, P336, DOI 10.1007/BF00336201; WURSTERHILL DH, 1975, CYTOGENET CELL GENET, V15, P306, DOI 10.1159/000130528	103	0	0	0	1	INST VERTEBRATE BIOLOGY AS CR	BRNO	KVETNA 8, BRNO 603 65, CZECH REPUBLIC	2694-7684			J VERTEBR BIOL	J. Vertebr. Biol.	JAN	2022	71								21040	10.25225/JVB.21040	http://dx.doi.org/10.25225/JVB.21040			25	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	XJ4GB		gold			2022-09-04	WOS:000726747500001
J	Vecino-Ortiz, AI; Congote, JV; Bedoya, SZ; Cucunuba, ZM				Vecino-Ortiz, Andres, I; Congote, Juliana Villanueva; Bedoya, Silvana Zapata; Cucunuba, Zulma M.			Impact of contact tracing on COVID-19 mortality: An impact evaluation using surveillance data from Colombia	PLOS ONE			English	Article								Background Contact tracing is a crucial part of the public health surveillance toolkit. However, it is labor-intensive and costly to carry it out. Some countries have faced challenges implementing contact tracing, and no impact evaluations using empirical data have assessed its impact on COVID-19 mortality. This study assesses the impact of contact tracing in a middle-income country, providing data to support the expansion and optimization of contact tracing strategies to improve infection control. Methods We obtained publicly available data on all confirmed COVID-19 cases in Colombia between March 2 and June 16, 2020. (N = 54,931 cases over 135 days of observation). As suggested by WHO guidelines, we proxied contact tracing performance as the proportion of cases identified through contact tracing out of all cases identified. We calculated the daily proportion of cases identified through contact tracing across 37 geographical units (32 departments and five districts). Further, we used a sequential log-log fixed-effects model to estimate the 21-days, 28-days, 42-days, and 56-days lagged impact of the proportion of cases identified through contact tracing on daily COVID-19 mortality. Both the proportion of cases identified through contact tracing and the daily number of COVID-19 deaths are smoothed using 7-day moving averages. Models control for the prevalence of active cases, second-degree polynomials, and mobility indices. Robustness checks to include supply-side variables were performed. Results We found that a 10 percent increase in the proportion of cases identified through contact tracing is related to COVID-19 mortality reductions between 0.8% and 3.4%. Our models explain between 47%-70% of the variance in mortality. Results are robust to changes of specification and inclusion of supply-side variables. Conclusion Contact tracing is instrumental in containing infectious diseases. Its prioritization as a surveillance strategy will substantially impact reducing deaths while minimizing the impact on the fragile economic systems of lower and middle-income countries. This study provides lessons for other LMIC.	[Vecino-Ortiz, Andres, I] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Congote, Juliana Villanueva] San Ignacio Univ Hosp, Res Off, Bogota, Colombia; [Bedoya, Silvana Zapata] Dept Antioquia Colombia, Planning Dept, Medellin, Colombia; [Cucunuba, Zulma M.] Imperial Coll London, MRC, Ctr Global Infect Dis Anal, London, England; [Cucunuba, Zulma M.] Pontificia Univ Javeriana, Sch Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia		Vecino-Ortiz, AI (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	andres.vecino@gmail.com	Cucunuba, Zulma M/X-5670-2019	Cucunuba, Zulma M/0000-0002-8165-3198				[Anonymous], Does One Size Fit All? Realistic Alternatives for COVID-19 Response in Low-Income Countries; Braithwaite I, 2020, LANCET DIGIT HEALTH, V2, pE607, DOI 10.1016/S2589-7500(20)30184-9; Breeher L, 2020, MAYO CLIN PROC, V95, P1432, DOI 10.1016/j.mayocp.2020.05.008; Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0; Coetzee BJ, 2020, GLOB PUBLIC HEALTH, V15, P1093, DOI 10.1080/17441692.2020.1779331; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; European Centre for Disease Prevention and Control, 2020, RESOURCE ESTIMATION; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gaythorpe K, 2020, REPORT 8 SYMPTOM PRO; Google, 2020, 8000 COMMUNITY COLL; Halpern SD, 2020, JAMA-J AM MED ASSOC, V324, P337, DOI 10.1001/jama.2020.11623; Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Keeling MJ, 2020, J EPIDEMIOL COMMUN H, V74, P861, DOI 10.1136/jech-2020-214051; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5; Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039; Megnin-Viggars O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241473; Ministerio de Salud Publica, 2020, INSTR EL DES LAB CLI; Ministerio de Salud y Proteccion Social, 2020, XCES MORT COL 2020; Ministerio de Salud y Proteccion Social, 2020, ARCGIS DASHB; Pablos-Mendez A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2939; Quilty BJ, 2021, LANCET PUBLIC HEALTH, V6, pE175, DOI 10.1016/S2468-2667(20)30308-X; Rapoport T., 2020, DOING FANDOM LESSONS, DOI [10.17226/25916, DOI 10.17226/25916]; Sanchez Ramos K.J., 2020, IMPACTO EC COVID 19, P1; Silva RDFE, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101667; Tang YJ, 2020, EMERG MICROBES INFEC, V9, P827, DOI 10.1080/22221751.2020.1760146; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; WHO, 2020, CONT TRAC CONT COVID; Wong Vincent, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.322427f4c3cc2b9c1a5b3395e7d20894; World Health Organization, 2014, CONT TRAC OUTBR EB V; World Health Organization, 2015, WHO IMPL MAN CONT TR; World Health Organization, 2020, SURV STRAT COVID 19	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0246987	10.1371/journal.pone.0246987	http://dx.doi.org/10.1371/journal.pone.0246987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY		gold, Green Published, Green Submitted			2022-09-04	WOS:000626604100085
J	Gomez, SA; Martinez-Cajas, JL; Mueses, HF; Alvarado-Llano, B; Galindo, X; Camargo, P; Martinez, E; Torres, JA; Arrivillaga, M				Gomez, S. A.; Martinez-Cajas, J. L.; Mueses, H. F.; Alvarado-Llano, B.; Galindo, X.; Camargo, P.; Martinez, E.; Torres, J. A.; Arrivillaga, M.			The CFIR application on PrEP implementation: facilitators and recommendations by HIV-care clinic administrators in Colombia	JOURNAL OF THE INTERNATIONAL AIDS SOCIETY			English	Meeting Abstract									[Gomez, S. A.; Arrivillaga, M.] Pontificia Univ Javeriana, Cali, Colombia; [Martinez-Cajas, J. L.; Alvarado-Llano, B.; Camargo, P.] Queens Univ, Kingston, ON, Canada; [Mueses, H. F.; Galindo, X.] Corp Lucha El Sida, Cali, Colombia; [Mueses, H. F.; Galindo, X.; Martinez, E.] Red VIH Col, Cali, Colombia; [Martinez, E.] Univ Valle, Cali, Colombia; [Torres, J. A.] Montefiore Med Ctr, New York, NY USA				Arrivillaga, Marcela/L-2786-2016	Arrivillaga, Marcela/0000-0001-5927-3386					0	0	0	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND		1758-2652		J INT AIDS SOC	J. Int. AIDS Soc.	FEB	2021	24			1	SI	PU01.24LB								1	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	QK9ZN					2022-09-04	WOS:000620738900395
J	Castellanos-Perilla, N; Borda, MG; Fernandez-Quilez, A; Aarsland, V; Soennesyn, H; Cano-Gutierrez, CA				Castellanos-Perilla, Nicolas; German Borda, Miguel; Fernandez-Quilez, Alvaro; Aarsland, Vera; Soennesyn, Hogne; Alberto Cano-Gutierrez, Carlos			Factors associated with functional loss among community-dwelling Mexican	BIOMEDICA			English	Article						Aged; public health; pain; activities of daily living	OLDER-PEOPLE; RISK-FACTORS; DISABILITY; DECLINE; HEALTH; ADULTS; PROGRESSION; DEMENTIA; RATES	Introduction: Functional status decline is related to many negative outcomes. Objective: To explore the relation between sociodemographic, medical and psychological factors with the incidence of functional status decline in Mexican older adults. Materials and methods: Data from the 2012 and 2015 waves of the Mexican Health and Aging Study (MHAS) survey was analyzed. Participants with previous functional status decline at baseline were excluded. We assessed functional status decline individually with activities of daily living (ADLs) and instrumental ADLs (IADLs) in an individual way. Results: Age was associated with functional limitation in ADLs. Male sex had an association with limitations for IADLs. A poor financial situation and lower education related to higher limitations for ADLs. Furthermore, pain, comorbidities and depression were found to be independently associated with limitations in ADLs. IADLs limitation was associated with age, poor education, comorbidities, depression as well as cognitive impairment. Conclusions We found that factors such as age, financial status, educational level, pain and the number of comorbidities were associated with the incidence of functional status decline. Pain had a greater association in the 3-year functional ADLs decline incidence when compared with cognitive impairment. Studying functional decline by domains allowed us to find more detailed information in order to identify factors that are susceptible to intervention with the aim to reduce the incidence of functional status decline and dependence.	[Castellanos-Perilla, Nicolas; German Borda, Miguel; Alberto Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Fac Med, Inst Envejecimiento, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [German Borda, Miguel; Fernandez-Quilez, Alvaro; Aarsland, Vera; Soennesyn, Hogne] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [German Borda, Miguel; Fernandez-Quilez, Alvaro] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Fernandez-Quilez, Alvaro] Stavanger Univ Hosp, Stavanger Med Imaging Lab, Stavanger, Norway; [Fernandez-Quilez, Alvaro] Univ Stavanger, Fac Sci & Technol, Stavanger, Norway; [Aarsland, Vera] Semmelweis Univ, Sch Med, Budapest, Hungary; [Alberto Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Unidad Geriatria, Bogota, Colombia		Castellanos-Perilla, N (corresponding author), Pontificia Univ Javeriana, Fac Med, Inst Envejecimiento, Semillero Neurociencias & Envejecimiento, Cra 7 40-62, Bogota, DC, Colombia.	nicolascastellanos@javeriana.edu.co	Fernandez-Quilez, Alvaro/GNH-4964-2022; Borda, Miguel German/AHB-5593-2022; Castellanos, Nicolas/F-2868-2019	Borda, Miguel German/0000-0001-5832-0603; Castellanos, Nicolas/0000-0002-8229-2611; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Fernandez-Quilez, Alvaro/0000-0001-7544-0797	Norwegian government; Pontificia Universidad Javeriana; National Institutes of Health/National Institute on Aging [NIH R01AG018016]; Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Health of Older Minorities training Grant from the National Institute on Aging [T32AG00270]	Norwegian government; Pontificia Universidad Javeriana; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Health of Older Minorities training Grant from the National Institute on Aging	This paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority). Also, supported by the Pontificia Universidad Javeriana. The MHAS was sponsored by the National Institutes of Health/National Institute on Aging (Grant NIH R01AG018016), as well as the Sealy Center on Aging at the University of Texas Medical Branch in Galveston and by the Health of Older Minorities T32AG00270 training Grant from the National Institute on Aging.	Aguilar-Navarro SG, 2007, SALUD PUBLICA MEXICO, V49, P256, DOI 10.1590/S0036-36342007000400005; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Astudillo G Claudia I, 2017, Rev. Univ. Ind. Santander. Salud, V49, P438, DOI 10.18273/revsal.v49n3-2017002; Barry LC, 2011, AM J GERIAT PSYCHIAT, V19, P783, DOI 10.1097/JGP.0b013e3181ff6669; Brito Kyonayra Quezia Duarte, 2015, Rev. Bras. Enferm., V68, P633, DOI 10.1590/0034-7167.2015680409i; Cano-Gutierrez C, 2017, BIOMEDICA, V37, P57, DOI 10.7705/biomedica.v37i1.3197; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Diaz-Venegas C, 2016, DISABIL REHABIL, V38, P2016, DOI 10.3109/09638288.2015.1111435; Diaz-Venegas C, 2015, SALUD PUBLICA MEXICO, V57, pS54; Dunlop DD, 2005, ARTHRITIS RHEUM-US, V52, P1274, DOI 10.1002/art.20968; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; GLOSSER G, 1993, J AM GERIATR SOC, V41, P931, DOI 10.1111/j.1532-5415.1993.tb06758.x; Gomes CD, 2014, ARCH GERONTOL GERIAT, V58, P214, DOI 10.1016/j.archger.2013.10.009; Gomez F, 2017, BROCKLEHURSTS TXB GE, P1017; Gutie Robledo LM, 2012, GER MED FAM, P1; Hoogerduijn JG, 2012, AGE AGEING, V41, P381, DOI 10.1093/ageing/afs015; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Laan W, 2013, MATURITAS, V75, P276, DOI 10.1016/j.maturitas.2013.04.005; Landi F, 2009, J PAIN SYMPTOM MANAG, V38, P350, DOI 10.1016/j.jpainsymman.2008.10.005; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Liu-Seifert H, 2015, J ALZHEIMERS DIS, V43, P949, DOI 10.3233/JAD-140792; Mejia-Arango S, 2015, SALUD PUBLICA MEXICO, V57, pS90; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Reyes-Ortiz CA, 2006, ARCH GERONTOL GERIAT, V42, P21, DOI 10.1016/j.archger.2005.06.006; Saunders P, 2007, AUST J SOC ISSUES, V42, P461, DOI 10.1002/j.1839-4655.2007.tb00072.x; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Storeng SH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018942; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Trigas-Ferrin M, 2011, GALICIA CLIN, V72, P11; United Nations, AG DIS; van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wong R., 2009, INT HDB POPULATION A, P231, DOI 10.1007/978-1-4020-8356-3_11; Wong R, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyu263; 2011, WORLD REP DIS, P1	38	0	0	4	6	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	SEP	2020	40	3								10.7705/biomedica.5380	http://dx.doi.org/10.7705/biomedica.5380			28	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	MC6FH	33030833	gold, Green Published			2022-09-04	WOS:000543379800016
J	Gutierrez, S; Huynh, T; Iwanaga, J; Dumont, AS; Bui, CJ; Tubbs, RS				Gutierrez, Santiago; Huynh, Trong; Iwanaga, Joe; Dumont, Aaron S.; Bui, C. J.; Tubbs, R. Shane			A Review of the History, Anatomy, and Development of the C1 Spinal Nerve	WORLD NEUROSURGERY			English	Review						C1 spinal nerve; Development; Occipital neuralgia; Review; Suboccipital nerve	ACCESSORY NERVE; POSTERIOR ROOT; CLINICAL ANATOMY; HYPOGLOSSAL; CONNECTIONS; GANGLION	The C1 spinal nerve is a fascinating anatomic structure owing to its wide range of variations. Throughout history, understanding of the cranial and spinal nerves has probably influenced the current conception of this nerve among anatomists. Located at the craniocervical junction, the C1 spinal nerve contributes to the motor innervation of deep cervical muscles through the cervical (anterior) and Cruveilhier's (posterior) plexuses. Sensory functions of this nerve are more enigmatic; despite investigations into its dorsal rootlets, a dorsal root ganglion, and the relationships between this nerve and adjacent cranial and spinal nerves, there is still no consensus regarding its true anatomy. In this article, we review the available literature and discuss some of the developmental models that could potentially explain the wide range of variations and functions of the C1 nerve.	[Gutierrez, Santiago] Pontificia Univ Javeriana, Bogota, Colombia; [Huynh, Trong] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Iwanaga, Joe; Dumont, Aaron S.; Tubbs, R. Shane] Tulane Univ, Sch Med, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Tubbs, R. Shane] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Bui, C. J.] Ochsner Med Ctr, Dept Neurosurg, New Orleans, LA USA; [Tubbs, R. Shane] St Georges Univ, Dept Anat Sci, St Georges, Grenada		Iwanaga, J (corresponding author), Tulane Univ, Sch Med, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA.	iwanagajoeca@gmail.com	Gutierrez, Santiago/AAA-7964-2020; Gutiérrez, Santiago/H-6456-2015; Iwanaga, Joe/ABC-7040-2021	Gutierrez, Santiago/0000-0003-1326-8308; Gutiérrez, Santiago/0000-0001-6659-1390; Iwanaga, Joe/0000-0002-8502-7952				[Anonymous], 2015, NEUROANATOMICAL TERM; [Anonymous], NEUROMORFOFISIOLOGIA; [Anonymous], 1962, ANATOMICAL EPONYMS; [Anonymous], 1995, ANATOMA HUMANA; [Anonymous], NEUROANATOMIA; [Anonymous], 1982, ANATOMY SURG HEAD NE; [Anonymous], TRATADO ANATOMIA HUM; [Anonymous], ANAT ANZ; Benninger B, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/476018; Brazis PW, 2011, LOCALIZATION CLIN NE; Campos D., 2012, Journal of Morphological Sciences, V29, P65; Catala M, 2013, HAND CLINIC, V115, P29, DOI 10.1016/B978-0-444-52902-2.00003-5; Cho KH, 2015, CHILD NERV SYST, V31, P95, DOI 10.1007/s00381-014-2546-9; Edwards B, 2018, CUREUS, V10, DOI 10.7759/cureus.2500; Ericsson R, 2013, J ANAT, V222, P67, DOI 10.1111/j.1469-7580.2012.01530.x; HOLLIGER A, 1955, Arch Anat Histol Embryol, V38, P1; Iwanaga J, 2017, WORLD NEUROSURG, V100, P590, DOI 10.1016/j.wneu.2017.01.038; KURATANI S, 1988, AM J ANAT, V182, P155, DOI 10.1002/aja.1001820206; Lake S, 2018, CUREUS, V10, DOI 10.7759/cureus.2933; Lang J., 1993, CLIN ANATOMY CERVICA; LIM TM, 1987, DEVELOPMENT, V100, P525; Offiah CE, 2017, INSIGHTS IMAGING, V8, P29, DOI 10.1007/s13244-016-0530-5; Oh CS, 2002, CLIN ANAT, V15, P267, DOI 10.1002/ca.10026; Orhan M, 2009, SURG RADIOL ANAT, V31, P107, DOI 10.1007/s00276-008-0414-6; OUAKNINE G, 1973, J NEUROSURG, V38, P189, DOI 10.3171/jns.1973.38.2.0189; Shoja MM, 2018, CLIN ANAT, V31, P488, DOI 10.1002/ca.23048; Tada MN, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0006-8; Tubbs RS, 2007, CLIN ANAT, V20, P624, DOI 10.1002/ca.20472; Tubbs RS, 2011, J NEUROSURG, V115, P929, DOI 10.3171/2011.5.JNS102058; Tubbs RS, 2009, J NEUROSURG-SPINE, V10, P390, DOI 10.3171/2008.12.SPINE08661; Tubbs R, 2009, SURG RADIOL ANAT, V31, P173, DOI 10.1007/s00276-008-0422-6; Verberne ME, 1999, ANAT RECORD, V255, P407; Williams, 1995, GRAYS ANATOMY ANATOM	33	4	5	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.12.024	http://dx.doi.org/10.1016/j.wneu.2019.12.024			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	31838236				2022-09-04	WOS:000517784600161
J	Mina-Vargas, AM; McKeown, PC; Flanagan, NS; Debouck, DG; Kilian, A; Hodkinson, TR; Spillane, C				Mina-Vargas, Angela M.; McKeown, Peter C.; Flanagan, Nicola S.; Debouck, Daniel G.; Kilian, Andrzej; Hodkinson, Trevor R.; Spillane, Charles			Origin of year-long bean (Phaseolus dumosus Macfady, Fabaceae) from reticulated hybridization events between multiple Phaseolus species	ANNALS OF BOTANY			English	Article						Phaseolus dumosus; year-long bean; common bean; genetic diversity; secondary gene pool; hybridization; crop wild relative (CWR); reticulate evolution; sympatry; inter-species	BAYESIAN PHYLOGENETIC INFERENCE; SEQUENCE ALIGNMENT; MODEL; DNA; VULGARIS; CONSEQUENCES; POLYANTHUS; JMODELTEST; DIVERSITY; SOFTWARE	Background and Aims Improved understanding of the secondary gene pools of crops is essential for advancing genetic gain in breeding programmes. Common bean, Phaseolus vulgaris, is a staple crop with several wild relatives in its secondary gene pool. The year-long bean, P. dumosus, an important crop in Guatemala, is considered particularly closely related to P. vulgaris and a potential source of novel variation. However, the genetic diversity and relationship to other Phaseolus species of P. dumosus remain unclear. Methods We conducted the first comprehensive investigation of P. dumosus genetic diversity using both nuclear and chloroplast genome markers. Our nuclear marker set included over 700 markers present within the Phaseolus DArT (Diversity Arrays Technology) array, which we applied to P. dumosus and other relatives of P. vulgaris (including every secondary gene pool species: P. acutifolius, P. albescens, P. coccineus and P. costaricensis). Key Results Phaseolus dumosus arose from hybridization of P. vulgaris and P. coccineus, followed by at least two later hybridizations with sympatric congener populations. Existing P. dumosus collections have low genetic diversity. Conclusions The under-utilized crop P. dumosus has a complex hybrid origin. Further sampling in the region in which it arose may uncover additional germplasm for introgressing favourable traits into crops within the P. vulgaris gene pool.	[Mina-Vargas, Angela M.; McKeown, Peter C.; Spillane, Charles] Natl Univ Ireland Galway, Genet & Biotechnol Lab, Plant & AgriBiosci Res Ctr PABC, Aras de Brun 2006,Univ Rd, Galway H91 REW4, Ireland; [Flanagan, Nicola S.] Pontificia Univ Javeriana, Cali, Colombia; [Debouck, Daniel G.] CIAT, Apartado Aereo 6713, Cali, Colombia; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol Pty Ltd, Bldg 3,Level D,Kirinari St, Bruce, ACT 2617, Australia; [Hodkinson, Trevor R.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin 2, Ireland		McKeown, PC; Spillane, C (corresponding author), Natl Univ Ireland Galway, Genet & Biotechnol Lab, Plant & AgriBiosci Res Ctr PABC, Aras de Brun 2006,Univ Rd, Galway H91 REW4, Ireland.	peter.mckeown@nuigalway.ie; charles.spillane@nuigalway.ie	Flanagan, Nicola S./AAN-2272-2020; Mina Vargas, Angela/U-6849-2017; Hodkinson, Trevor/F-6850-2014; Spillane, Charles/H-3786-2013	Flanagan, Nicola S./0000-0002-4909-8710; Mina Vargas, Angela/0000-0002-3913-4247; Kilian, Andrzej/0000-0002-2730-7462; McKeown, Peter/0000-0002-7255-6062; Hodkinson, Trevor/0000-0003-1384-7270; Spillane, Charles/0000-0003-3318-323X	IRCSET Government of Ireland	IRCSET Government of Ireland	This work was supported by an IRCSET Government of Ireland Postgraduate PhD Fellowship to A.M.M.V., under the PhD supervision of C.S.	Afanador L. K., 1993, ANN REP BEAN IMPROV, V36, P10; Akaike H., 1998, SELECTED PAPERS HIRO, P199, DOI 10.1007/978-1-4612-1694-0_15; Angioi SA, 2009, PLANT BIOLOGY, V11, P598, DOI 10.1111/j.1438-8677.2008.00143.x; Baudoin JP, 1997, EUPHYTICA, V96, P115, DOI 10.1023/A:1002954224234; Beebe S., 2013, ECOEFFICIENCY VISION, P117; Brinez B, 2012, MOL BREEDING, V30, P181, DOI 10.1007/s11032-011-9609-3; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEBOUCK D.G., 1999, COMMON BEAN IMPROVEM, P25, DOI DOI 10.1007/978-94-015-9211-6_2; Delgado-Salinas A, 1999, SYST BOT, V24, P438, DOI 10.2307/2419699; Delgado-Salinas A, 2006, SYST BOT, V31, P779, DOI 10.1600/036364406779695960; Desiderio F, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00312; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freytag G.F., 2002, TAXONOMY DISTRIBUTIO; Gepts P., 1991, Common beans: research for crop improvement., P7; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HERNANDEZ-XOLOCOTZI E., 1959, REV SOC MEX HIST NAT, V20, P99; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LLACA V, 1994, THEOR APPL GENET, V88, P646, DOI 10.1007/BF01253966; Maddison W.P., 2011, MESQUITE MODULAR SYS; Mahuku GS, 2002, PLANT DIS, V86, P1383, DOI 10.1094/PDIS.2002.86.12.1383; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McBreen K, 2006, TRENDS PLANT SCI, V11, P398, DOI 10.1016/j.tplants.2006.06.004; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McKinnon G., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P81, DOI 10.1079/9780851999043.0081; MIRANDA-COLIN S, 1967, Agrociencia, V1, P99; Morrison DA, 2011, INTRO PHYLOGENETIC N; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 2000, MOL EVOLUTION PHYLOG; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN SOFTWARE DISS; Perrier X, 2003, GENETIC DIVERSITY CU, P43, DOI DOI 10.1017/S0014479704252152; PINERO D, 1988, EUPHYTICA, V37, P199; Porch TG, 2013, AGRONOMY-BASEL, V3, P433, DOI 10.3390/agronomy3020433; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHMIT V, 1991, ECON BOT, V45, P345, DOI 10.1007/BF02887077; Schmit V, 1992, THESIS; Schmit V, 2014, 2 INT SCI M PHAS BEA; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; SMARTT J, 1973, EUPHYTICA, V22, P424, DOI 10.1007/BF00022657; Spataro G, 2011, THEOR APPL GENET, V122, P1281, DOI 10.1007/s00122-011-1530-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tohme J., 1995, P95; Vriesendorp B, 2005, TAXON, V54, P593, DOI 10.2307/25065417; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WRIGHT S, 1951, ANN EUGENIC, V15, P323	73	5	6	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	OCT	2016	118	5					957	969		10.1093/aob/mcw138	http://dx.doi.org/10.1093/aob/mcw138			13	Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences	EA3GJ	27497241	hybrid, Green Submitted, Green Published			2022-09-04	WOS:000386489600007
J	Tong, SB; Sheet, D; Bhuiyan, S; Diaz, MLZ; Taberne, A				Tong, Shanbao; Sheet, Debdoot; Bhuiyan, Shoaib; Zequera Diaz, Martha Lucia; Taberne, Andrew			BME Trends Around the World	IEEE PULSE			English	Editorial Material									[Tong, Shanbao] Shanghai Jiao Tong Univ, Biomed Engn, Shanghai 200030, Peoples R China; [Sheet, Debdoot] Indian Inst Technol, Elect Engn, Kharagpur 721302, W Bengal, India; [Bhuiyan, Shoaib] Suzuka Univ Med Sci, Med Informat Sci, Suzuku, Japan; [Zequera Diaz, Martha Lucia] Pontificia Univ Javeriana, Elect Engn, Bogota, Colombia; [Taberne, Andrew] Univ Auckland, Engn Sci, Auckland 1, New Zealand		Tong, SB (corresponding author), Shanghai Jiao Tong Univ, Biomed Engn, Shanghai 200030, Peoples R China.		Sheet, Debdoot/W-2548-2019; Zequera-Díaz, Martha Lucía/F-2742-2019	Zequera-Díaz, Martha Lucía/0000-0001-8226-3370					0	0	0	0	6	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2154-2287			IEEE PULSE	IEEE Pulse	JAN-FEB	2015	6	1								10.1109/MPUL.2014.2366899	http://dx.doi.org/10.1109/MPUL.2014.2366899			3	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CE7NM	25757232				2022-09-04	WOS:000352028600001
J	Cepeda, MS; Farrar, JT; Baumgarten, M; Boston, R; Carr, DB; Strom, BL				Cepeda, MS; Farrar, JT; Baumgarten, M; Boston, R; Carr, DB; Strom, BL			Side effects of opioids during short-term administration: Effect of age, gender, and race	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Article							PATIENT-CONTROLLED ANALGESIA; SEX-RELATED DIFFERENCES; ETHNIC-DIFFERENCES; POSTOPERATIVE NAUSEA; CANCER-PATIENTS; MORPHINE; PETHIDINE; PAIN; PHARMACOKINETICS; REQUIREMENTS	Objective: Little is known about risk factors that increase the risk of development of opioid side effects. Our objective was to evaluate the effect of the type of opioid, age, gender, and race on the incidence of side effects from short-term opioid use. Methods. A secondary analysis of a retrospective cohort study in 35 community-based and tertiary hospitals was done: There were 8855 black or white subjects aged 16 years and older. Patients received meperidine (INN, pethidine), morphine, or fentanyl as part of their treatment. Measurements were made to assess the presence of nausea and vomiting and respiratory depression. Results. Of the patients, 26% had nausea and vomiting and 1.5% had respiratory depression after opioid administration. After adjustment for opioid dose, route of administration, age, gender, and race, meperidine produced less nausea and vomiting (odds ratio [OR] = 0.7; 95% confidence interval [CI], 0.5-0.8) and less respiratory depression (OR = 0.6; 95% CI, 0.2-0.9) than morphine. The risk of respiratory depression increased with age. Compared with patients aged between 16 and 45 years, those aged between 61 and 70 years had 2.8 times the risk of development of respiratory depression (95% CI, 1.2-6.6); those aged between 71 and 80 years had 5.4 times the risk (95% CI, 2.4-11.8); and those aged older than 80 years had 8.7 times the risk (95% CI, 3.8-20.0). Men had less nausea and vomiting than women (OR = 0.5; 95% CI, 0.4-0.6). White subjects had more nausea and vomiting than black subjects (OR = 1.4; 95% CI, 1.1-1.7). Conclusions. Meperidine produced fewer side effects than morphine during short-term use. The risk of respiratory depression increases substantially after 60 years of age. Women have nausea and vomiting more often than men. The effect of race deserves further investigation.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Javeriana Univ, Dept Anesthesiol, Bogota, Colombia; Javeriana Univ, Clin Epidemiol Unit, Bogota, Colombia; Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Tufts Univ, New England Med Ctr, Sch Med, Dept Anesthesia, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Sch Med, Dept Med, Boston, MA 02111 USA		Strom, BL (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, 824 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	bstrom@cceb.med.upenn.edu	Baumgarten, Martin/U-8468-2019; Farrar, John/A-1037-2007; Farrar, John T/AAP-4788-2021	Farrar, John/0000-0001-8656-5157; Farrar, John T/0000-0001-8656-5157				AFSHAR M, 1992, ANN PHARMACOTHER, V26, P1595, DOI 10.1177/106002809202601222; AGRESTI A, 1996, INTRO CATEGORICAL DA, P71; Anderson R, 2001, J PAIN SYMPTOM MANAG, V21, P397, DOI 10.1016/S0885-3924(01)00271-8; [Anonymous], [No title captured]; BAHAR M, 1985, ANAESTHESIA, V40, P529; BAILEY PL, 1990, ANESTHESIA, P281; BAILLIE SP, 1989, AGE AGEING, V18, P258, DOI 10.1093/ageing/18.4.258; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; BELLVILL.JW, 1971, J AMER MED ASSOC, V217, P1835, DOI 10.1001/jama.217.13.1835; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Carr D.B., 1998, NEURAL BLOCKADE CLIN, P915; Cepeda MS, 1996, J CLIN ANESTH, V8, P324, DOI 10.1016/0952-8180(96)00042-6; Cepeda MS, 2001, CLIN PHARMACOL THER, V70, P351, DOI 10.1016/S0009-9236(01)45600-1; Cepeda MS, 2002, PAIN, V96, P73, DOI 10.1016/S0304-3959(01)00425-0; CEPEDA MS, 1995, ANESTH ANALG, V80, P1150, DOI 10.1097/00000539-199506000-00014; CEPEDA MS, 2003, IN PRESS ANESTH ANAL; Cicero TJ, 1997, J PHARMACOL EXP THER, V282, P939; Dahan A, 1998, ANESTHESIOLOGY, V88, P903, DOI 10.1097/00000542-199804000-00009; Fanshawe MP, 1999, ANAESTH INTENS CARE, V27, P610, DOI 10.1177/0310057X9902700609; FERRELL BA, 1991, J AM GERIATR SOC, V39, P64, DOI 10.1111/j.1532-5415.1991.tb05908.x; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; Gear RW, 1996, NEUROSCI LETT, V205, P207, DOI 10.1016/0304-3940(96)12402-2; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P253; Herrick IA, 1996, ANAESTHESIA, V51, P356, DOI 10.1111/j.1365-2044.1996.tb07748.x; HOUGHTON IT, 1992, ANAESTH INTENS CARE, V20, P52, DOI 10.1177/0310057X9202000110; HOUGHTON IT, 1993, EUR J DRUG METAB PH, V18, P285, DOI 10.1007/BF03188810; Ioannidis JPA, 1997, J CLIN EPIDEMIOL, V50, P1089, DOI 10.1016/S0895-4356(97)00149-2; Janssen PA, 1984, OPIOIDS ANESTHESIA, P37; Johnson JA, 1997, J PHARM SCI, V86, P1328, DOI 10.1021/js9702168; Junger A, 2001, ANESTH ANALG, V92, P1203, DOI 10.1097/00000539-200105000-00023; KAIKO RF, 1980, CLIN PHARMACOL THER, V28, P823, DOI 10.1038/clpt.1980.241; KAIKO RF, 1983, ANN NEUROL, V13, P180, DOI 10.1002/ana.410130213; KEPLER KL, 1991, PAIN, V45, P87, DOI 10.1016/0304-3959(91)90168-W; LARSSON S, 1995, ACTA ANAESTH SCAND, V39, P539, DOI 10.1111/j.1399-6576.1995.tb04115.x; Lee A, 1997, ANAESTH INTENS CARE, V25, P665, DOI 10.1177/0310057X9702500613; MATTEO RS, 1990, CAN J ANAESTH, V37, P852, DOI 10.1007/BF03006620; MAURER PM, 1993, DRUG SAFETY, V8, P30, DOI 10.2165/00002018-199308010-00005; MCKENZIE R, 1992, J AM ASS NURSE ANEST, V60, P282; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; MOSKOWITZ AS, 1985, BRAIN RES, V361, P46, DOI 10.1016/0006-8993(85)91273-9; MURAKI T, 1986, PSYCHOPHARMACOLOGY, V89, P60; OWEN JA, 1983, CLIN PHARMACOL THER, V34, P364, DOI 10.1038/clpt.1983.180; Payne, 1994, AHCPR PUBLICATION; Plummer JL, 1997, ANESTH ANALG, V84, P794, DOI 10.1097/00000539-199704000-00018; Quigley C., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003447; Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9; Sear J W, 1989, J Clin Anesth, V1, P164, DOI 10.1016/0952-8180(89)90036-6; Sinclair DR, 1999, ANESTHESIOLOGY, V91, P109, DOI 10.1097/00000542-199907000-00018; Stanley G, 1996, BRIT J ANAESTH, V76, P484, DOI 10.1093/bja/76.4.484; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Strom BL, 1996, JAMA-J AM MED ASSOC, V275, P376, DOI 10.1001/jama.275.5.376; Strom BL, 1994, PHARMACOEPIDEM DR S, P449; VANDENBERG AA, 1994, BRIT J CLIN PHARMACO, V38, P533; Wall TL, 1997, ANN INTERN MED, V127, P376, DOI 10.7326/0003-4819-127-5-199709010-00007; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; WOOD AJJ, 1991, CLIN PHARMACOKINET, V20, P350, DOI 10.2165/00003088-199120050-00002; Woodhouse A, 1999, PAIN, V80, P545, DOI 10.1016/S0304-3959(98)00247-4; Woodhouse A, 1996, PAIN, V64, P115, DOI 10.1016/0304-3959(95)00082-8; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; ZHOU HH, 1993, CLIN PHARMACOL THER, V54, P507, DOI 10.1038/clpt.1993.182	60	218	226	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	AUG	2003	74	2					102	112		10.1016/S0009-9236(03)00152-8	http://dx.doi.org/10.1016/S0009-9236(03)00152-8			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	710KJ	12891220				2022-09-04	WOS:000184679100002
J	Orozco, C; Gonzalez-Giraldo, Y; Bonilla, DA; Montalvo-Ortiz, J; Forero, DA				Orozco, Carlos; Gonzalez-Giraldo, Yeimy; Bonilla, Diego A.; Montalvo-Ortiz, Janitza; Forero, Diego A.			AN IN SILICO ANALYSIS OF GENOME-WIDE EXPRESSION AND METHYLATION PROFILES FROM HUMAN AND MOUSE MODELS OF POST-TRAUMATIC STRESS DISORDER IDENTIFY ALTERATIONS IN BRAIN-PLASTICITY MECHANISMS	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	World Congress of Psychiatric Genetics (WCPG)	OCT 11-15, 2021	ELECTR NETWORK						[Orozco, Carlos; Forero, Diego A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy] Univ Antonio Narino, Pontificia Univ Javeriana, Ctr Psychosocial Studies Amer Latina & Caribbean, Bogota, Colombia; [Bonilla, Diego A.] Univ Cordoba, Res Grp Phys Act Sports & Hlth Sci GICAFS, Dynam Business & Sci Soc DBSS Int SAS, Cordoba, Spain; [Montalvo-Ortiz, Janitza] Yale Univ, Sch Med, New Haven, CT 06520 USA				Bonilla, Diego A./I-5769-2019	Bonilla, Diego A./0000-0002-2634-1220					0	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	OCT	2021	51					TH13	E201	E202		10.1016/j.euroneuro.2021.08.188	http://dx.doi.org/10.1016/j.euroneuro.2021.08.188		SEP 2021	2	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	WC1PH		Bronze			2022-09-04	WOS:000704035500351
J	Montana, JDC; Loaiza, AE; Romanelli, GP; De Waele, I; Tobon, YA; Castanoa, JAG				Montana, Jeisson D. Corredor; Loaiza, Alix E.; Romanelli, Gustavo P.; De Waele, Isabelle; Tobon, Yeny A.; Castanoa, Jovanny A. Gomez			INSIGHT INTO THE CONFORMATIONAL SPACE OF N-BENZYL-N-(FURAN-2-YLMETHYL)ACETAMIDE BY NMR SPECTROSCOPY AND DFT CALCULATIONS	QUIMICA NOVA			English	Article						Density Functional Theory; conformational analysis; NMR spectroscopy; green synthesis; amides	NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFTS; INTERNAL-ROTATION; SOLVENT; AMIDES; SPECTRA; ATOMS	In this study, the conformational behavior of N-benzyl-N-(furan-2-ylmethyl) acetamide in chloroform was addressed by using a combined experimental/theoretical strategy using NMR spectroscopy and quantum chemical calculations. The H-1 and C-13 one-dimensional NMR spectra, as well as the two-dimensional HSQC-DEPT and HMBC-DEPT NMR spectra, evinced the presence of a hindered cis(E)-trans(Z) rotational equilibrium in solution. DFT calculations were performed at different theoretical levels using the polarizable continuum model (PCM) and predicted nine (four Z and live E structures) stable conformations. The interconversion dynamics among the different confirmations were established in terms of four different rotational equilibria in CDCl3. The chemical shifts in the H-1 and C-13 NMR spectra of the compound are similar to the values calculated for the two mast abundant conformational equilibria at room temperature, one caused by two Z rotamers and the other by two E rotamers. The compound was also characterized for the first time by FTIR, Raman spectroscopy, and GC/MS spectrometry. Additionally, several acylation methodologies for synthesizing the title compound from N-benzyl-1-(furan-2-yl)methanamine were tested which resulted in high yields (> 90%) under very convenient conditions (10 min, at room temperature).	[Montana, Jeisson D. Corredor; Castanoa, Jovanny A. Gomez] Univ Pedagog & Tecnol Colombia, Fac Ciencias, Escuela Ciencias Quim, Tunja Boyaca 050030, Colombia; [Loaiza, Alix E.] Pontificia Univ Javeriana, Dept Quim, Fac Ciencias, Cra 7 40-62,Edificio Carlos Ortiz, Bogota 110231561, Colombia; [Romanelli, Gustavo P.] Univ Nacl La Plata, Ctr Invest & Desarrollo Ciencias Aplicadas Dr Jor, B1900AJK, Bogota, Colombia; [De Waele, Isabelle; Tobon, Yeny A.] Univ Lille, CNRS, UMR 8516, Lab Spectrochim Infrarouge & Raman, F-59000 Lille, France		Castanoa, JAG (corresponding author), Univ Pedagog & Tecnol Colombia, Fac Ciencias, Escuela Ciencias Quim, Tunja Boyaca 050030, Colombia.	jovanny.gomez@uptc.edu.co	Gómez Castaño, Jovanny A./X-7862-2019; Tobon, Yeny/B-9218-2013	Gómez Castaño, Jovanny A./0000-0002-6654-1315; Tobon, Yeny/0000-0003-1858-8271; De Waele, Isabelle/0000-0002-6222-3926	Universidad Pedagogica y Tecnologica de Colombia (UPTC); Pontificia Universidad Javeriana; Universidad Nacional de La Plata, Argentina; Universite de Lille, France; French Ministere de l'Enseignement Superieur et de la Recherche; Direccion de Investigaciones (DIN) of the UPTC [SGI 2619]	Universidad Pedagogica y Tecnologica de Colombia (UPTC); Pontificia Universidad Javeriana; Universidad Nacional de La Plata, Argentina(National University of La Plata); Universite de Lille, France; French Ministere de l'Enseignement Superieur et de la Recherche; Direccion de Investigaciones (DIN) of the UPTC	The authors would like to acknowledge the financial support provided by the host institutions, i.e., Universidad Pedagogica y Tecnologica de Colombia (UPTC), Pontificia Universidad Javeriana, Universidad Nacional de La Plata, Argentina, and the Universite de Lille, France. J. A.G.C especially like to thank the French Ministere de l'Enseignement Superieur et de la Recherche for his post-doctoral grant developed at the laboratory LASIR (Laboratoire de Spectrochimie Infrarouge et Raman) in France, as well as the Direccion de Investigaciones (DIN) of the UPTC for financial support provided through the project SGI 2619.	Abraham RJ, 2013, MAGN RESON CHEM, V51, P143, DOI 10.1002/mrc.3920; Abraham RJ, 2006, MAGN RESON CHEM, V44, P491, DOI 10.1002/mrc.1747; Austin A, 2012, J CHEM THEORY COMPUT, V8, P4989, DOI 10.1021/ct300778e; Avalos M, 2001, J ORG CHEM, V66, P7275, DOI 10.1021/jo0102361; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Benzi C, 2004, MAGN RESON CHEM, V42, pS57, DOI 10.1002/mrc.1447; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Casabianca LB, 2020, MAGN RESON CHEM, V58, P611, DOI 10.1002/mrc.4994; Coronado JLG, 2007, J PHYS CHEM A, V111, P9724, DOI 10.1021/jp075336a; Da Silva HC, 2020, CHEM PHYS, V528, DOI 10.1016/j.chemphys.2019.110479; Dennington R.D., 2016, GAUSSVIEW 6 0 16; Di Grandi MJ, 2015, SYNTHETIC COMMUN, V45, P2601, DOI 10.1080/00397911.2015.1096943; Fontoura LAM, 2002, J MOL STRUCT, V609, P73, DOI 10.1016/S0022-2860(01)00941-3; Frisch M. J, 2013, GAUSSIAN 09 REVISION; Gilbert K. E., 2020, PCMODEL VERSION 10 0; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; GUTOWSKY HS, 1956, J CHEM PHYS, V25, P1228, DOI 10.1063/1.1743184; Iron MA, 2017, J CHEM THEORY COMPUT, V13, P5798, DOI 10.1021/acs.jctc.7b00772; Jacobi PA, 2001, J AM CHEM SOC, V123, P9307, DOI 10.1021/ja016303q; Kang YK, 2004, J MOL STRUC-THEOCHEM, V676, P171, DOI 10.1016/j.theochem.2004.01.024; Lednecki I, 2007, J MOL STRUCT, V834, P349, DOI 10.1016/j.molstruc.2006.11.017; Lodewyk MW, 2012, J AM CHEM SOC, V134, P18550, DOI 10.1021/ja3089394; Mazzanti A, 2012, WIRES COMPUT MOL SCI, V2, P613, DOI 10.1002/wcms.96; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Nossa D. L., J BIOMED SCI SUBMITT; PETERSSON GA, 1988, J CHEM PHYS, V89, P2193, DOI 10.1063/1.455064; PHILLIPS WD, 1955, J CHEM PHYS, V23, P1363, DOI 10.1063/1.1742298; Ramirez JZ, 2012, J MEX CHEM SOC, V56, P275; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; STEWART WE, 1970, CHEM REV, V70, P517, DOI 10.1021/cr60267a001; Suarez-Castillo OR, 2009, TETRAHEDRON-ASYMMETR, V20, P2374, DOI 10.1016/j.tetasy.2009.09.017; Warren S., 1991, DESIGNING ORGANIC SY, V1st; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303	33	0	0	1	2	SOC BRASILEIRA QUIMICA	SAO PAULO	CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL	0100-4042	1678-7064		QUIM NOVA	Quim. Nova	JAN	2021	44	1					1	14		10.21577/0100-4042.20170639	http://dx.doi.org/10.21577/0100-4042.20170639			14	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	RA1IO		gold			2022-09-04	WOS:000631171400001
J	Sharma, A; Liu, HD; Tobar-Tosse, F; Noll, A; Dakal, TC; Li, HM; Holz, FG; Loeffler, KU; Herwig-Carl, MC				Sharma, Amit; Liu, Hongde; Tobar-Tosse, Fabian; Noll, Angela; Dakal, Tikam Chand; Li, Huamei; Holz, Frank G.; Loeffler, Karin U.; Herwig-Carl, Martina C.			Genome organization in proximity to the BAP1 locus appears to play a pivotal role in a variety of cancers	CANCER SCIENCE			English	Article						cancer; evolution; monosomy 3; repetitive sequence; uveal melanoma	TUMOR-SUPPRESSOR GENE; CELL CARCINOMA; SHORT ARM; UVEAL; DELETIONS; MUTATION; BROWSER; BREAST; ROBO1	Cancer studies primarily focus on the characterization of the key driver genes and the underlying pathways. However, the contribution of other cancer-associated genes located in the genomic neighborhood of the driver genes could help to understand further aspects of cancer progression. Given the frequent involvement of chromosome 3 in multiple human cancers, in particular in the form of the prognostically highly relevant monosomy 3 in uveal melanoma (UM), we investigated the cumulative impact of cancer-associated genes on chromosome 3. Our analysis showed that these genes are enriched with repetitive elements with genes surrounded by distinctive repeats (MIR, hAT-Charlie, ERVL-MaLR, LINE-2, and simple/low complexity) in the promoter being more precisely associated with cancer-related pathways than the ones with major transposable elements (SINE/Alu and LINE-1). Additionally, these genes showed strong intrachromosomal chromatin interactions in 3D nuclear organization. Further investigations revealed a genomic hotspot in the vicinity of BAP1 locus, which is affected in 27 types of different cancers and contains abundant noncoding RNAs that are often expressed in a tissue-specific manner. The cross-species comparison of these cancer-associated genes revealed mostly a shared synteny in closer primates. However, near to the BAP1 locus signs of chromosomal inversions were observed during the course of evolution. To our knowledge, this is the first study to characterize the entire genomic neighborhood of cancer-associated genes located on any single chromosome. Based on our results, we hypothesize that monosomy of chromosome 3 will have important clinical and molecular consequences in the respective diseases and in particular in UM.	[Sharma, Amit; Holz, Frank G.; Loeffler, Karin U.; Herwig-Carl, Martina C.] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany; [Liu, Hongde; Li, Huamei] Southeast Univ, State Key Lab Bioelect, Nanjing, Peoples R China; [Tobar-Tosse, Fabian] Pontificia Univ Javeriana Cali, Cali, Colombia; [Noll, Angela] German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany; [Dakal, Tikam Chand] Mohanlal Sukhadia Univ Udaipur, Dept Biotechnol, Udaipur, Rajasthan, India		Herwig-Carl, MC (corresponding author), Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany.	Martina.Herwig@ukbonn.de	Sharma, Amit/W-4209-2019; Herwig-Carl, Martina/AAI-2618-2019	Sharma, Amit/0000-0002-2216-5389; Herwig-Carl, Martina/0000-0002-5943-7675	German Research Foundation (DFG) [HE 5775/5-1] Funding Source: Medline	German Research Foundation (DFG)(German Research Foundation (DFG))		Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Dekker J, 2017, NATURE, V549, P219, DOI 10.1038/nature23884; Dewey CN, 2011, BRIEF BIOINFORM, V12, P401, DOI 10.1093/bib/bbr040; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ewens KG, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5079-x; Fields Alan P., 2015, Advances in Biological Regulation, V60, P47, DOI 10.1016/j.jbior.2015.10.009; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herwig-Carl MC, 2019, EXP EYE RES, V182, P175, DOI 10.1016/j.exer.2019.04.001; Herwig-Carl MC, 2018, OCUL ONCOL PATHOL, V4, P297, DOI 10.1159/000486370; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; HORSMAN DE, 1990, CANCER GENET CYTOGEN, V45, P249, DOI 10.1016/0165-4608(90)90090-W; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Maerker DA, 2014, BRIT J OPHTHALMOL, V98, P224, DOI 10.1136/bjophthalmol-2013-303814; Melzer C, 2019, GENE CHROMOSOME CANC, V58, P357, DOI 10.1002/gcc.22724; Piva F, 2015, EXPERT REV MOL DIAGN, V15, P1201, DOI 10.1586/14737159.2015.1068122; Prando ED, 2011, EPIGENETICS-US, V6, P1413, DOI 10.4161/epi.6.12.18271; PRESCHER G, 1990, J NATL CANCER I, V82, P1765, DOI 10.1093/jnci/82.22.1765; Sharma A, 2018, CLIN GENET, V93, P952, DOI 10.1111/cge.13136; Sharma A, 2019, CANCERS, V11, DOI 10.3390/cancers11101600; Sharma A, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.601; Sharma A, 2017, NEUROBIOL AGING, V57, DOI 10.1016/j.neurobiolaging.2017.05.021; Sharma A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0112-2; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Tobar-Tosse F, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5196-6; Tschentscher F, 2001, CANCER RES, V61, P3439; Tsend-Ayush E, 2004, GENOMICS, V83, P193, DOI 10.1016/j.ygeno.2003.08.012; Villacis RAR, 2016, TUMOR BIOL, V37, P3145, DOI 10.1007/s13277-015-4145-0; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835	36	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2020	111	4					1385	1391		10.1111/cas.14319	http://dx.doi.org/10.1111/cas.14319			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	LC7XH	31957195	Green Published, gold			2022-09-04	WOS:000525546200033
J	Mora-Plazas, M; Gomez, LF; Miles, DR; Parra, DC; Taillie, LS				Mora-Plazas, Mercedes; Gomez, Luis F.; Miles, Donna R.; Parra, Diana C.; Taillie, L. S.			Nutrition Quality of Packaged Foods in Bogota, Colombia: A Comparison of Two Nutrient Profile Models	NUTRIENTS			English	Article						front-of-package labels; warning labels; labelling; nutrient profile models; Latin America; food policy; sugar-sweetened beverages; junk food	ULTRA-PROCESSED FOODS; CONSUMPTION; WARNINGS; SUGAR	Background: Front-of-package warning labels are an increasingly common policy and have been implemented to inform consumers of the nutritional quality of ultra-processed foods. This study examined the proportion of Colombian products that could be subjected to such regulations. Methods: Two nutrition profile models were compared: the Pan American Health Organization (PAHO) model, and the nutrient profile established under the Chilean food labeling and advertising law (Chilean model). Products (n = 6708) exceeding nutrient criteria based on each model were identified as subject to regulation. Results: A total of 80.2% (PAHO model) to 66.4% (Chilean model) of foods met the criteria for regulation. The categories with the highest proportion of regulated products were meats (97.3% PAHO model; 87.5% Chilean model), sweets (95.6% PAHO) and snacks (Chilean model). The category with the lowest proportions of regulated products were cereals (47.3% PAHO model) and miscellaneous foods and fish/seafood (39.0% and 39.5%, respectively, Chilean model). Conclusions: Under both the PAHO and Chilean nutrient profile models, the majority of packaged foods available in Bogota would be eligible to receive front-of-package warning labels. These results suggest a warning label law could have a major impact on the Colombian food supply, especially in the context of the growing prevalence of diet-related chronic diseases in Colombia.	[Mora-Plazas, Mercedes] Univ Nacl Colombia, Dept Nutr Humana, Carrera 45 26-85, Bogota 11001, Colombia; [Gomez, Luis F.] Pontificia Univ Javeriana, Fac Med, Hosp Univ San Ignacio, 8 Piso, Bogota 110231, Colombia; [Miles, Donna R.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [Parra, Diana C.] Washington Univ, Sch Med, Program Phys Therapy, 4444 Forest Pk Ave, St Louis, MO 63108 USA; [Taillie, L. S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [Taillie, L. S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA		Mora-Plazas, M (corresponding author), Univ Nacl Colombia, Dept Nutr Humana, Carrera 45 26-85, Bogota 11001, Colombia.	mmorap@unal.edu.co; L.gomezg@javeriana.edu.co; drmiles@email.unc.edu; parrad@wustl.edu; taillie@unc.edu	; Parra, Diana/D-7633-2013	Miles, Donna/0000-0001-9490-2096; Parra, Diana/0000-0002-9797-6231; Mora, Mercedes/0000-0001-5396-8726; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012	Bloomberg Philanthropies [5103721]; NIH [P2C HD050924]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002489] Funding Source: NIH RePORTER	Bloomberg Philanthropies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was funded by Bloomberg Philanthropies (Subward number #5103721), and NIH grant to CPC P2C HD050924.	[Anonymous], 2005, ESTR BOG DC EST REL; [Anonymous], REL PREL AN IMP REG; Ares G, 2018, FOOD QUAL PREFER, V65, P40, DOI 10.1016/j.foodqual.2017.12.001; Arrua A, 2017, APPETITE, V116, P139, DOI 10.1016/j.appet.2017.04.012; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; Centurion M., 2019, J NUTR ED BEHAV; Contreras-Manzano A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060737; Correa T, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0781-x; Corvalan C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hernandez A, 2018, REV ESP NUTR HUM DIE, V22, P108, DOI 10.14306/renhyd.22.2.413; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Kakisu E, 2018, INT J FOOD SCI NUTR, V69, P928, DOI 10.1080/09637486.2018.1428537; Kanter R, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001016; Lohner S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0278-x; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492; Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006; OPS/OMS, 2015, AL BEB ULTR AM LAT T, P21; Pan American Health Organization, 2016, NUTR PROF MOD; Pan American Health Organization/World Health Organization, NUTR PROF REP WHO IA; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Popova L, 2019, AM J HEALTH BEHAV, V43, P406, DOI 10.5993/AJHB.43.2.16; Quinio C, 2007, EUR J NUTR, V46, P37, DOI 10.1007/s00394-007-2005-4; Republica de Chile. Ministerio de Salud, 2018, REGL SAN AL; Roberto CA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3185; Shangguan S, 2019, AM J PREV MED, V56, P300, DOI 10.1016/j.amepre.2018.09.024; Stanhope KL, 2018, OBES REV, V19, P1205, DOI 10.1111/obr.12699; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; WHO, 2012, GUID SOD INT AD CHIL; WHO, 2015, GUID SUG INT AD CHIL	32	21	21	2	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	MAY	2019	11	5							1011	10.3390/nu11051011	http://dx.doi.org/10.3390/nu11051011			13	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	IC5PY	31060219	Green Published, Green Submitted, gold			2022-09-04	WOS:000471021600071
J	Rocha, A; Borges, SH; Ovalle, JMR; Barnett, AA				Rocha, Alessandro; Borges, Sergio Henrique; Ruiz Ovalle, Juan Miguel; Barnett, Adrian A.			Collared Forest-Falcon (Micrastur semitorquatus) preying on a squirrel in a fragment of Atlantic Forest with a revision of the predation events for the species	REVISTA BRASILEIRA DE ORNITOLOGIA			English	Article						bird-mammal; hawk diet; interaction; predator-prey; Seasonal Semideciduous Forest	BREEDING-SEASON; RUFICOLLIS; GUATEMALA; BEHAVIOR	We recorded predation on the squirrel Guerlinguetus ingrami by a Collared Forest-Falcon (Micrastur semitorquatus) through camera trapping in a forest fragment of Atlantic Forest in the interior of Sao Paulo state, Brazil. The squirrel was captured while it moved across the forest floor. A compilation from bibliographic and other sources resulted in 68 vertebrate and 03 invertebrate species as prey of the Collared Forest-Falcon, with birds more commonly reported in the diet of the species. The majority of prey (66% of species) did not exceed 300 g, but some prey species (12%) such as guans (Penelope spp.) were heavier than the falcon. The Collared Forest-Falcon could affect the population dynamics of smaller vertebrates in forest fragments of Atlantic Forest due to its flexibility in diet and habitat use, an aspect that deserve a more thorough investigation.	[Rocha, Alessandro] Unesp Rio Claro, LEEC, Ave 24A,1515, BR-13506900 Rio Claro, SP, Brazil; [Rocha, Alessandro; Barnett, Adrian A.] Manaus INPA, Inst Nacl Pesquisas Amazonia, AMRG, Ave Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Borges, Sergio Henrique] Univ Fed Amazonas, Inst Ciencias Biol, Dept Biol, Av Gen Rodrigo O Jordao Ramos 3000, BR-69077000 Manaus, Amazonas, Brazil; [Ruiz Ovalle, Juan Miguel] Pontificia Univ Javeriana, Carrera 7,40, Bogota, Colombia; [Ruiz Ovalle, Juan Miguel] Manaus INPA, Inst Nacl Pesquisas Amazonia, Dept Biodiversidade & Colecoes Zool Aves, Ave Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil; [Barnett, Adrian A.] Roehampton Univ, Ctr Res Evolutionary Anthropol, Holybourne Ave, London SW15 4JD, England		Rocha, A (corresponding author), Unesp Rio Claro, LEEC, Ave 24A,1515, BR-13506900 Rio Claro, SP, Brazil.; Rocha, A (corresponding author), Manaus INPA, Inst Nacl Pesquisas Amazonia, AMRG, Ave Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil.	alessandrorocha.eco@gmail.com		Barnett, Adrian Ashton/0000-0002-8829-2719	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM - Programa Fixam)	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM - Programa Fixam)	We thanks Willian Menq and Jefferson Otavio for the identification of the species and other observations; Dr. Milton Cesar Ribeiro, Landscape Ecology Laboratory (LEEC) - Unesp Rio Claro, Dr. Ramachrisna Teixeira and Mr. Sisinho Paes de Santana, Institute of Astronomy, Geophysics and Atmospheric Sciences of the University of Sao Paulo (IAG-USP) for institutional support. S.H.B. is a grantee of Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM - Programa Fixam).	Alonso C., 1989, Revista Nordestina de Biologia, V6, P105; Antas P. T. Z., 2005, AVES DO PANTANAL; Blanco C. E., 2013, WA1116281 MICRASTUR; Bonvicino CR., 2008, RIO JANEIRO CTR PAN, V2008, p120p; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Carrara L. A., 2007, REV BRAS ORNITOL, V15, P25; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Cunado C., 2014, MICRASTUR SEMITORQUA; del Hoyo J., 1993, HDB BIRDS WORLD V 2, V2; DELHOYO J, 1997, HDB BIRDS WORLD NEW, V2, P310; Ferguson-Lees J., 2001, RAPTORS WORLD; Flores J., 2017, MICRASTUR SEMITORQUA; Guedes N. M. R., 1993, 3 C BRAS ORN PEL UFP; Haemig P. D., 2012, MICRASTUR ECOLOGIA; Hilty S. L., 2002, BIRDS VENEZUELA; Labelle S., 2010, MICRASTUR SEMITORQUA; Martinhao T., 2012, MICRASTUR SEMITORQUA; MAYS NM, 1985, WILSON BULL, V97, P231; Menq W., 2016, MICRASTUR SEMITORQUA; Messias S. M., 2015, WA2027105 MICRASTUR; Olmos F, 2006, REV BRAS ORNITOL, V14, P401; Pontes ARM, 2005, J ZOOL, V266, P55, DOI 10.1017/S095283690500662X; REIS NR, 2015, PRIMATAS BRASIL GUIA; Ribeiro LF, 2010, REV ARVORE, V34, P637, DOI 10.1590/S0100-67622010000400008; ROBINSON SK, 1994, BIOTROPICA, V26, P443, DOI 10.2307/2389239; RYLANDS A B, 1981, Primates, V22, P46, DOI 10.1007/BF02382556; Salles O. C., 2012, WA730811 MICRATUR SE; Salles O. C., 2010, WA207015 MICRATUR SE; Savage JM., 2002, AMPHIBIANS REPTILES; Sigrist T, 2014, GUIA CAMPO AVIFAUNA; Skutch A. F., 1981, PUBLICATIONS NUTTALL, V19, P1; SLUD PAUL, 1964, BULL AMER MUS NATUR HIST, V128, P1; Souza F., 2014, WA1383268 MICRATUR S; Souza F., 2015, WA1713773 MICRASTUR; SUTTON GEORGE MIKSCH, 1942, WILSON BULL, V54, P199; Thorstrom R, 2000, J RAPTOR RES, V34, P196; THORSTROM RK, 1990, CONDOR, V92, P237, DOI 10.2307/1368405; Thorstrom R, 2007, ORNITOL NEOTROP, V18, P395; TRAIL PW, 1987, AUK, V104, P496, DOI 10.2307/4087549; VANNINI J P, 1989, Journal of Raptor Research, V23, P27; Viana I. R., 2012, Revista Brasileira de Biociencias, V10, P171; Vallejos MAV, 2008, REV BRAS ORNITOL, V16, P268; Wehtje W, 2003, J BIOGEOGR, V30, P1593, DOI 10.1046/j.1365-2699.2003.00970.x; West J. N., 1988, THESIS CENTRAL WASHI; WETMORE ALEXANDER, 1965, SMITHSONIAN MISC COLLECT, V150, P1; WILLIS E O, 1983, Revista Brasileira de Biologia, V43, P23	46	2	2	0	6	SOC BRASILEIRA ORNITOLOGIA	VICOSA	C/O ROMULO RIBON, MUSEU ZOOLOGIA JOAO MOOJEN, LADEIRA DOS OPERARIOS 54-204, VICOSA, MG 36570-000, BRAZIL	0103-5657			REV BRAS ORNITOL	Rev. Bras. Ornitol.	DEC	2017	25	4					248	253						6	Ornithology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	GC0GT					2022-09-04	WOS:000429456000004
J	Stiglitz, RS; Fandino, MB				Stiglitz, Ruben S.; Bernal Fandino, Mariana			The Lesion in Argentinian and Colombian Law: A Comparative Approach	REVISTA DE DERECHO PRIVADO			Spanish	Article						Contractual justice; contractual balance; lesion		The lesion intends to sanction the contractual imbalance that occurs during the stage of contract formation. The regulation of this figure should weigh the need for legal certainty in transactions with the importance of equity and contractual justice. Legal systems have chosen different positions face to this challenge, so the comparison of two legal systems such as the Colombian and the Argentine is illustrative to analyze the effectiveness of the lesion in contemporary legal business.	[Stiglitz, Ruben S.] Univ Nacl La Plata, Fac Ciencias Jurid & Sociales, La Plata, Buenos Aires, Argentina; [Stiglitz, Ruben S.] Univ Nacl Buenos Aires, Derecho & Ciencias Sociales, Buenos Aires, DF, Argentina; [Stiglitz, Ruben S.] Univ Nacl Buenos Aires, Fac Derecho & Ciencias Sociales, Buenos Aires, DF, Argentina; [Bernal Fandino, Mariana] Pontificia Univ Javeriana, Bogota, Colombia; [Bernal Fandino, Mariana] Univ Paris II, Derecho Int Privado, Paris, France; [Bernal Fandino, Mariana] Univ Javeriana, Ciencias Jurid, Bogota, Colombia; [Bernal Fandino, Mariana] Univ Sergio Arboleda, Bogota, Colombia		Stiglitz, RS (corresponding author), Univ Nacl La Plata, Fac Ciencias Jurid & Sociales, La Plata, Buenos Aires, Argentina.; Stiglitz, RS (corresponding author), Univ Nacl Buenos Aires, Derecho & Ciencias Sociales, Buenos Aires, DF, Argentina.; Stiglitz, RS (corresponding author), Univ Nacl Buenos Aires, Fac Derecho & Ciencias Sociales, Buenos Aires, DF, Argentina.	rstiglitz@estudiostiglitz.com.ar; mariana.bernal@usa.edu.co						Alterini A. A., 1998, CONTRATOS CIVILES CO, P381; Barbero D., SISTEMA DERECHO PRIV, V1, P529; Bianca M., 1987, DIRITTO CIVILE CONTR, V3, P647; Brebbia R., 1998, CODIGO CIVIL NORMA B, V2B, P615; Chantepie G., LA LESION, V8; Cifuentes Santos, 1986, NEGOCIO JURIDICO; Consejo de Estado, 2001, SA DE LO CONT ADM; de Espanes L.Moisset, 1976, LESION NUEVO ARTICUL, V954, P82; Diez-Picazo L., 1996, FUNDAMENTOS DERECHO, P457; Flour A., LES OBLIGATIONS, V1, P177; Gentili A., 2006, TRATTATO CONTRATTO, Viv, P454; Hinestrosa F., 2015, TRATADO OBLIGACIONES, V11, P1133; Iturraspe J., 1995, CONTRATOS B, Vii, P178; Iturraspe J.Mosset, INTERPRETACION EC CO, P265; Llambias J. J., CODIGO CIVIL ANOTADO, P107; Mendoza A., 2016, C C INT AB COM LEY G; Messineo F., DOCTRINA GEN CONTRAT, V9, P292; Messineo F., 1971, MANUAL DERECHO CIVIL, V11, P441; Mirabelli G., 1987, CONTRATTI GEN, P585; Ordoqui G., 2007, DESEQUILIBRIO CONTRA, P395; Pothier R.J, TRAITE OBLIGATIONS, Vi; Sacco R., 1975, IL CONTRATTO, P362; Stiglitz R. S., 1998, CONTRATOS CIVILES CO, Vi, P299; Tobias J. W., 1996, ALGUNAS PRECISIONES, P438; Vives A.Perez, TEORIA GEN OBLIGACIO, Vi, P200	25	0	0	0	1	UNIV EXTERNADO COLOMBIA	BOGOTA	CALLE 12 NO 1-17 ESTE, BOGOTA, 00000, COLOMBIA	0123-4366	2346-2442		REV DERECH PRIV-U EX	Rev. Derecho Priv.	JUL-DEC	2017		33					137	159		10.18601/01234366.n33.06	http://dx.doi.org/10.18601/01234366.n33.06			23	Law	Emerging Sources Citation Index (ESCI)	Government & Law	FP1LG		Green Submitted, gold			2022-09-04	WOS:000417373900006
J	Angarita, FA; Acuna, SA; Torregrosa, L; Tawil, M; Sanchez, EF; Heilbron, O; Dominguez, LC				Angarita, Fernando A.; Acuna, Sergio A.; Torregrosa, Lilian; Tawil, Mauricio; Sanchez, Elio F.; Heilbron, Oscar; Carlos Dominguez, Luis			Bilateral necrotizing fasciitis of the breast following quadrantectomy	BREAST CANCER			English	Article						Necrotizing fasciitis; Breast; Soft-tissue infections; Negative-pressure wound therapy; Breast cancer	SOFT-TISSUE INFECTIONS; VACUUM-ASSISTED CLOSURE; STERNAL WOUND INFECTIONS; STREPTOCOCCUS-MILLERI; MORTALITY; MANAGEMENT; THERAPY; COMPLEX; SKIN; DETERMINANTS	Necrotizing fasciitis (NF) is a rare and highly lethal soft-tissue infection that involves the skin, subcutaneous tissue, and fascia. Although it can affect any part of the body, the breast is seldom involved. We describe a case of bilateral NF of the breast following elective quadrantectomy, successfully treated with antibiotics, bilateral mastectomy, and a vacuum-assisted wound closure system.	[Angarita, Fernando A.] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON M5G 2M1, Canada; [Acuna, Sergio A.] Mt Sinai Hosp, Peter A Silverman Ctr Int Hlth, Toronto, ON M5G 1X5, Canada; [Torregrosa, Lilian; Tawil, Mauricio; Sanchez, Elio F.; Heilbron, Oscar; Carlos Dominguez, Luis] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Surg, Bogota, Colombia; [Torregrosa, Lilian; Tawil, Mauricio] Ctr Javeriano Oncol, Breast & Soft Tissue Clin, Bogota, Colombia		Angarita, FA (corresponding author), Toronto Gen Res Inst, Div Expt Therapeut, Room 4-425,67 Coll St, Toronto, ON M5G 2M1, Canada.	fernando.angarita@uhnres.utoronto.ca	Acuna, Sergio A./H-7783-2013; Angarita, Fernando A./AAI-9245-2020	Acuna, Sergio A./0000-0002-6266-2136; Angarita, Fernando A./0000-0002-8546-7309; DOMINGUEZ, LUIS/0000-0002-1595-8364; Torregrosa Almonacid, Lilian/0000-0002-5392-7083; Sanchez Cortes, Elio Fabio/0000-0002-3503-8493				Brothers TE, 1998, J AM COLL SURGEONS, V187, P416, DOI 10.1016/S1072-7515(98)00192-6; Cainzos M, 2007, CURR OPIN CRIT CARE, V13, P433, DOI 10.1097/MCC.0b013e32825a6a1b; Chen Y, 2008, ANZ J SURG, V78, P333, DOI 10.1111/j.1445-2197.2008.04467.x; Cheng NC, 2008, SURG TODAY, V38, P1108, DOI 10.1007/s00595-008-3799-2; Childers BJ, 2002, AM SURGEON, V68, P109; Cuschieri J, 2008, SURG INFECT, V9, P559, DOI 10.1089/sur.2008.9952; de Geus HRH, 2005, INTENS CARE MED, V31, P601, DOI 10.1007/s00134-004-2553-5; Deodhar S D, 1985, J Postgrad Med, V31, P170; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; Erba P, 2008, J PLAST RECONSTR AES, V61, P852, DOI 10.1016/j.bjps.2007.10.080; Eugster T, 1997, Swiss Surg, V3, P117; Flandrin A, 2009, BREAST J, V15, P199, DOI 10.1111/j.1524-4741.2009.00697.x; Fleck Tatjana, 2006, Int Wound J, V3, P273, DOI 10.1111/j.1742-481X.2006.00273.x; Gehlen JMLG, 2008, BREAST J, V14, P199, DOI 10.1111/j.1524-4741.2007.00556.x; Hanif MA, 2008, J CLIN ULTRASOUND, V36, P517, DOI 10.1002/jcu.20492; HOCKEN DB, 1985, THORAX, V40, P626, DOI 10.1136/thx.40.8.626; Hsiao GH, 1998, DERMATOL SURG, V24, P243, DOI 10.1111/j.1524-4725.1998.tb04143.x; Huang WS, 2006, ASIAN J SURG, V29, P133; Kendrick AS, 2008, PLAST RECONSTR SURG, V121, p138E, DOI 10.1097/01.prs.0000300196.75587.bf; Keune JD, 2009, BREAST J, V15, P321, DOI 10.1111/j.1524-4741.2009.00731.x; Kuncir EJ, 2003, EMERG MED CLIN N AM, V21, P1075, DOI 10.1016/S0733-8627(03)00089-0; Liao EC, 2007, ANN PLAS SURG, V59, P218, DOI 10.1097/SAP.0b013e31802c148c; Lopez FA, 2006, INFECT DIS CLIN N AM, V20, P759, DOI 10.1016/j.idc.2006.09.006; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Mossa-Basha M, 2007, ULTRASOUND CLIN, V2, P639; Nizami S, 2006, BREAST J, V12, P168, DOI 10.1111/j.1075-122X.2006.00227.x; Olsen RJ, 2010, ANNU REV PATHOL-MECH, V5, P1, DOI 10.1146/annurev-pathol-121808-102135; Ozturk E, 2009, AM J SURG, V197, P660, DOI 10.1016/j.amjsurg.2008.04.018; Phelps JR, 2006, OSTOMY WOUND MANAG, V52, P54; Porta G, 1998, EUR RESPIR J, V12, P357, DOI 10.1183/09031936.98.12020357; Rajakannu M, 2006, BREAST J, V12, P266, DOI 10.1111/j.1075-122X.2006.00253.x; Reiss N, 2007, ANN THORAC SURG, V83, P2246, DOI 10.1016/j.athoracsur.2006.07.077; Rogers RL, 2006, PRIMARY CARE, V33, P697, DOI 10.1016/j.pop.2006.06.005; Salazard B, 2008, J PLAST RECONSTR AES, V61, P302, DOI 10.1016/j.bjps.2007.05.004; Salcido Richard Sal, 2007, Adv Skin Wound Care, V20, P288, DOI 10.1097/01.ASW.0000269317.76380.3b; Sarani B, 2009, J AM COLL SURGEONS, V208, P279, DOI 10.1016/j.jamcollsurg.2008.10.032; Schaffzin DM, 2004, DIS COLON RECTUM, V47, P1745, DOI 10.1007/s10350-004-0633-9; Shah J, 2001, BRIT J PLAST SURG, V54, P67, DOI 10.1054/bjps.2000.3461; Silberstein Jonathan, 2008, Rev Urol, V10, P76; Singh G, 2002, EUR J SURG, V168, P366, DOI 10.1080/11024150260284897; Sjogren J, 2008, INT WOUND J, V5, P216, DOI 10.1111/j.1742-481X.2007.00371.x; Steinstraesser L, 2009, INT J LOW EXTR WOUND, V8, P28, DOI 10.1177/1534734609331991; Stoeckel WT, 2006, BREAST, V15, P610, DOI 10.1016/j.breast.2005.11.006; Velchuru VR, 2006, BREAST J, V12, P72, DOI 10.1111/j.1075-122X.2006.00186.x; Vilar-Compte D, 2004, WORLD J SURG, V28, P242, DOI 10.1007/s00268-003-7193-3; WARD RG, 1991, BRIT J SURG, V78, P488, DOI 10.1002/bjs.1800780431; WONG CA, 1995, THORAX, V50, P1093, DOI 10.1136/thx.50.10.1093; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Wong CH, 2008, PLAST RECONSTR SURG, V122, p151E, DOI 10.1097/PRS.0b013e318186cd92	50	10	10	0	7	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Breast Cancer	JAN	2014	21	1					108	114		10.1007/s12282-010-0219-4	http://dx.doi.org/10.1007/s12282-010-0219-4			7	Oncology; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Obstetrics & Gynecology	277VV	20814771				2022-09-04	WOS:000328848300015
J	Restrepo, CS; Artunduaga, M; Carrillo, JA; Rivera, AL; Ojeda, P; Martinez-Jimenez, S; Manzano, AC; Rossi, SE				Restrepo, Carlos Santiago; Artunduaga, Maddy; Carrillo, Jorge A.; Rivera, Aura L.; Ojeda, Paulina; Martinez-Jimenez, Santiago; Manzano, Ana C.; Rossi, Santiago E.			Silicone Pulmonary Embolism: Report of 10 Cases and Review of the Literature	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						silicone embolism; nonthrombotic pulmonary embolism; fluid silicone injection	RESOLUTION CT FINDINGS; ACUTE PNEUMONITIS; SUBCUTANEOUS INJECTIONS; LIQUID SILICONE; TRANSSEXUAL MEN; FAT-EMBOLISM; LUNG; COMPLICATIONS; AUGMENTATION; FLUIDS	Objective: To assess patient outcome and imaging findings of patients with pulmonary embolism of fluid silicone. Methods: Medical records and imaging examinations of 10 patients with respiratory distress after illicit injection of fluid silicone were reviewed. Population consisted of 8 male (6 male-to-female transsexuals) and 2 female subjects. Results: Average age was 29 years. Most common injection sites were gluteal and trochanteric, Respiratory symptoms developed between 15 minutes and 2 days after silicone injection. Five referred fever, 6 developed adult respiratory distress syndrome, and 2 subsequently died. Alveolar hemorrhage was demonstrated on pathological examination in 6, with silicone vacuoles in the lung parenchyma in 3. Computed tomography demonstrated peripheral ground glass opacities with interlobular septal thickening in all and peripheral airspace disease in 7. Conclusions: Illicit injection of large volumes of fluid silicone for cosmetic purposes is associated with pulmonary embolism and acute alveolar hemorrhage and is associated with a significant mortality,	[Restrepo, Carlos Santiago; Artunduaga, Maddy] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Carrillo, Jorge A.; Rivera, Aura L.; Ojeda, Paulina] Univ Nacl Colombia, Hosp Santa Clara, Bogota, Colombia; [Martinez-Jimenez, Santiago] Duke Univ, Durham, NC USA; [Manzano, Ana C.] Pontificia Univ Javeriana, Bogota, Colombia; [Rossi, Santiago E.] Fdn Dr Enrique Rossi, Buenos Aires, DF, Argentina		Restrepo, CS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Mail Code 7800,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	crestr@gmail.com		Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; Restrepo, Carlos/0000-0002-4722-3741; Artunduaga, Maddy/0000-0003-0338-548X				CAPAN LM, 1983, ANESTHESIOLOGY, V58, P569, DOI 10.1097/00000542-198306000-00018; CELLI B, 1978, AM J MED SCI, V275, P81, DOI 10.1097/00000441-197801000-00009; CHASTRE J, 1987, AM REV RESPIR DIS, V135, P236; CHASTRE J, 1983, NEW ENGL J MED, V308, P764, DOI 10.1056/NEJM198303313081307; CHEN YM, 1993, AM REV RESPIR DIS, V147, P1299, DOI 10.1164/ajrccm/147.5.1299; Chung KY, 2002, YONSEI MED J, V43, P152, DOI 10.3349/ymj.2002.43.2.152; Duffy DM, 2005, DERMATOL SURG, V31, P1530, DOI 10.2310/6350.2005.31238; Duffy DM, 2005, DERMATOL SURG, V31, P1626, DOI 10.2310/6350.2005.31251; Duong T, 1998, CHEST, V113, P1127, DOI 10.1378/chest.113.4.1127; ELLENBOGEN R, 1975, JAMA-J AM MED ASSOC, V234, P308, DOI 10.1001/jama.234.3.308; Ferreira M C, 1975, Br J Plast Surg, V28, P173, DOI 10.1016/0007-1226(75)90124-1; Gurvits GE, 2006, NEW ENGL J MED, V354, P211, DOI 10.1056/NEJMc052625; Hage JJ, 2001, PLAST RECONSTR SURG, V107, P734, DOI 10.1097/00006534-200103000-00013; Jeong YJ, 2007, RADIOGRAPHICS, V27, P617, DOI 10.1148/rg.273065051; Kim CH, 2003, RESPIRATION, V70, P104, DOI 10.1159/000068422; Malagari K, 2003, CHEST, V123, P1196, DOI 10.1378/chest.123.4.1196; MATSUBA T, 1994, INTERNAL MED, V33, P481, DOI 10.2169/internalmedicine.33.481; Narins RS, 2006, PLAST RECONSTR SURG, V118, p77S, DOI 10.1097/01.prs.0000234919.25096.67; RODRIGUEZ MA, 1989, J FORENSIC SCI, V34, P504; Rosioreanu A, 2004, AM J ROENTGENOL, V183, P248, DOI 10.2214/ajr.183.1.1830248; Schmid A, 2005, CHEST, V127, P2276, DOI 10.1378/chest.127.6.2276; Souza CA, 2006, AM J ROENTGENOL, V186, P368, DOI 10.2214/AJR.04.1847; Villa A, 2000, AM J EMERG MED, V18, P336, DOI 10.1016/S0735-6757(00)90132-3	23	43	46	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAR-APR	2009	33	2					233	237		10.1097/RCT.0b013e31817ecb4e	http://dx.doi.org/10.1097/RCT.0b013e31817ecb4e			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	427KB	19346851				2022-09-04	WOS:000264777100013
J	Benincore-Florez, E; El-Azaz, J; Solarte, GA; Rodriguez, A; Reyes, LH; Almeciga-Diaz, CJ; Cardona-Ramirez, C				Benincore-Florez, Eliana; El-Azaz, Jorge; Solarte, Gabriela Alejandra; Rodriguez, Alexander; Reyes, Luis H.; Almeciga-Diaz, Carlos Javier; Cardona-Ramirez, Carolina			Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assay	HELIYON			English	Article						Lysosome; Hunter syndrome; Yeast two-hybrid; Proteomics; Interactome; Lysosome; Hunter syndrome; Yeast two-hybrid; Proteomics; Interactome	PROTEIN-PROTEIN INTERACTION; ENZYME REPLACEMENT THERAPY; ENDOCYTOSIS; EXOCYTOSIS; YOUNGER; FRODOCK; BIOLOGY; CELLS	Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare X-linked recessive disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS), which activates intracellular accumulation of nonmetabolized glycosaminoglycans such as heparan sulfate and dermatan sulfate. This accumulation causes severe damage to several tissues, principally the central nervous system. Previously, we identified 187 IDSprotein interactions in the mouse brain. To validate a subset of these interactions, we selected and cloned the coding regions of 10 candidate genes to perform a targeted yeast two-hybrid assay. The results allowed the identification of the physical interaction of IDS with LSAMP and SYT1. Although the physiological relevance of these complexes is unknown, recent advances allow us to point out that these interactions could be involved in vesicular trafficking of IDS through the interaction with SYT1, as well as to the ability to form a transcytosis module between the cellular components of the blood-brain-barrier (BBB) through its interaction with LSAMP. These results may shed light on the role of IDS on cellular homeostasis and may also contribute to the understanding of MPS II physiopathology and the development of novel therapeutic strategies to transport recombinant IDS through the brain endothelial cells toward the brain parenchyma.	[Benincore-Florez, Eliana; Solarte, Gabriela Alejandra; Rodriguez, Alexander; Almeciga-Diaz, Carlos Javier] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Bogota, Colombia; [El-Azaz, Jorge] Univ Malaga, Dept Biol Mol & Bioquim, Malaga 29071, Spain; [Reyes, Luis H.] Univ Los Andes, Dept Ingn Quim & Alimentos, Grp Diseno Prod & Proc, Bogota, Colombia; [Cardona-Ramirez, Carolina] Univ Ciencias Aplicadas & Ambientales UDCA, Fac Ciencias Salud, Grp Invest Biomed & Genet Humana Aplicada GIBGA, Bogota, Colombia; [El-Azaz, Jorge] Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA		Almeciga-Diaz, CJ (corresponding author), Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Bogota, Colombia.; Cardona-Ramirez, C (corresponding author), Univ Ciencias Aplicadas & Ambientales UDCA, Fac Ciencias Salud, Grp Invest Biomed & Genet Humana Aplicada GIBGA, Bogota, Colombia.	cjalmeciga@javeriana.edu.co; clacardona@udca.edu.co	Reyes, Luis/J-8334-2017	Reyes, Luis/0000-0001-7251-5298	Pontificia Universidad Javeriana [6699, 3964, 5537, 7204]; Grupo de Investigaciones Biomedicas y de Genetica Humana Aplicada GIBGA, Facultad de Ciencias de la Salud, Universidad de Ciencias Aplicadas y Ambientales U.D.C.A, Bogota, Colombia [15402038]; Ministry of Science, Technology and Innovation [FP44842-233-2015]; Faculty of Science of Pontificia Universidad Javeriana; COLCIENCIAS [5174, 120356933205, 5170, 120356933427]	Pontificia Universidad Javeriana; Grupo de Investigaciones Biomedicas y de Genetica Humana Aplicada GIBGA, Facultad de Ciencias de la Salud, Universidad de Ciencias Aplicadas y Ambientales U.D.C.A, Bogota, Colombia; Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Faculty of Science of Pontificia Universidad Javeriana; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by Pontificia Universidad Javeriana (Project ID 6699), Grupo de Investigaciones Biomedicas y de Genetica Humana Aplicada GIBGA, Facultad de Ciencias de la Salud, Universidad de Ciencias Aplicadas y Ambientales U.D.C.A, Bogota, Colombia (Project ID 15402038), the Ministry of Science, Technology and Innovation (Grant No. FP44842-233-2015). EBF received a master's scholarship from Faculty of Science of Pontificia Universidad Javeriana. CJAD was also supported by Pontificia Universidad Javeriana (Grant ID 3964, 5537, and 7204) and COLCIENCIAS (Grant ID 5174, contract No. 120356933205; and Grant ID 5170, contract No. 120356933427).	Andreani J, 2013, BIOINFORMATICS, V29, P1742, DOI 10.1093/bioinformatics/btt260; Antonov AV, 2009, PROTEOMICS, V9, P2740, DOI 10.1002/pmic.200800612; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Cardona C, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01667; Chen CHB, 2008, P NATL ACAD SCI USA, V105, P15908, DOI 10.1073/pnas.0808360105; Cho SY, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0356-0; Chung YK, 2014, GLYCOCONJUGATE J, V31, P309, DOI 10.1007/s10719-014-9523-0; D'Avanzo F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041258; Das Supratik, 2009, V485, P271, DOI 10.1007/978-1-59745-170-3_19; Dong GQ, 2013, BIOINFORMATICS, V29, P3158, DOI 10.1093/bioinformatics/btt560; Fierro H, 1978, Bol Med Hosp Infant Mex, V35, P665; Galletta BJ, 2015, METHOD CELL BIOL, V129, P251, DOI 10.1016/bs.mcb.2015.03.012; Gleitz HFE, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708730; Hoshina H, 2018, MOL GENET METAB, V123, P118, DOI [10.1016/j.yragme.2017.12.428, 10.1016/j.ymgme.2017.12.428]; Hua X, 2019, EBIOMEDICINE, V50, P178, DOI 10.1016/j.ebiom.2019.10.009; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Kubick N, 2018, EVOL BIOINFORM, V14, DOI 10.1177/1176934318775081; Kuroda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050009; Li YC, 2017, NEURON, V93, P616, DOI 10.1016/j.neuron.2016.12.010; MacDougall DD, 2018, J GEN PHYSIOL, V150, P783, DOI 10.1085/jgp.201711944; Maeda M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235829; Marques ARA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221739; Martin-Blondel G, 2015, EUR J IMMUNOL, V45, P3302, DOI 10.1002/eji.201545632; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNamee CJ, 2011, CELL BIOCHEM FUNCT, V29, P114, DOI 10.1002/cbf.1730; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Muenzer J, 2011, GENET MED, V13, P102, DOI 10.1097/GIM.0b013e318206786f; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Muro S, 2012, J CONTROL RELEASE, V164, P125, DOI 10.1016/j.jconrel.2012.05.052; Nathan DG, 2009, GENOME MED, V1, DOI 10.1186/gm114; Neufeld E F, 1980, Birth Defects Orig Artic Ser, V16, P77; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Osaki Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0871-8; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Philips MA, 2015, BRAIN STRUCT FUNCT, V220, P1381, DOI 10.1007/s00429-014-0732-x; Poli EF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.430; Pulgar VM, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01019; Ramirez-Aportela E, 2016, BIOINFORMATICS, V32, P2386, DOI 10.1093/bioinformatics/btw141; Salazar DA, 2016, MOL GENET METAB, V117, P129, DOI 10.1016/j.ymgme.2015.08.001; Salvalaio M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051072; Scarpa M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-72; Schweingruber C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150239; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sohn YB, 2015, MOL GENET METAB, V114, P156, DOI 10.1016/j.ymgme.2014.08.009; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Tomatsu S, 2018, MUCOPOLYSACCHARIDOSE, P165; van Breevoort D, 2014, BLOOD, V123, P3185, DOI 10.1182/blood-2013-10-535831; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Wu Z, 2010, J IMMUNOL, V184, P3191, DOI 10.4049/jimmunol.0803609; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Zapolnik P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115490; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	57	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	MAR	2022	8	3							e09031	10.1016/j.heliyon.2022.e09031	http://dx.doi.org/10.1016/j.heliyon.2022.e09031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1Z1DC	35284671	Green Published			2022-09-04	WOS:000808571700022
J	Shannon, CL; Bartels, SM; Cepeda, M; Castro, S; Cubillos, L; Suarez-Obando, F; Williams, MJ; Restrepo, CG; Uribe, M; Marsch, L; Torrey, WC				Shannon, C. L.; Bartels, S. M.; Cepeda, M.; Castro, S.; Cubillos, L.; Suarez-Obando, F.; Williams, M. J.; Gomez Restrepo, C.; Uribe, M.; Marsch, L.; Torrey, W. C.			Perspectives on the Implementation of Screening and Treatment for Depression and Alcohol Use Disorder in Primary Care in Colombia	COMMUNITY MENTAL HEALTH JOURNAL			English	Article						Depression; Alcohol use disorder; Primary care; Colombia; Qualitative analysis		Depression and alcohol use disorder (AUD) greatly contribute to the burden of disease worldwide, and have large impact on Colombia's population. In this study, a qualitative analysis evaluates the implementation of a technology-supported model for screening, decision support, and digital therapy for depression and AUD in Colombian primary care clinics. Patient, provider, and administrator interviews were conducted, exploring attitudes towards depression and AUD, attitudes towards technology, and implementation successes and challenges. Researchers used qualitative methods to analyze interview themes. Despite stigma around depression and AUD, the model improved provider capacity to diagnose and manage patients, helped patients feel supported, and provided useful prevalence data for administrators. Challenges included limited provider time and questions about sustainability. The implementation facilitated the identification, diagnosis, and care of patients with depression and AUD. There is ongoing need to decrease stigma, create stronger networks of mental health professionals, and transition intervention ownership to the healthcare center.	[Shannon, C. L.; Bartels, S. M.; Cubillos, L.; Marsch, L.; Torrey, W. C.] Dartmouth Coll, Geisel Sch Med, Ctr Technol & Behav Hlth, 46 Centerra Pkwy, Lebanon, NH 03766 USA; [Cepeda, M.; Castro, S.; Suarez-Obando, F.; Gomez Restrepo, C.; Uribe, M.] Pontificia Univ Javeriana, Bogota, Colombia; [Cubillos, L.; Torrey, W. C.] Geisel Sch Med Dartmouth, Dept Psychiat, One Med Ctr Dr, Lebanon, NH USA; [Williams, M. J.] NIMH, Global Mental Hlth Res Program, Off Res Dispar & Global Mental Hlth, Bethesda, MD 20892 USA; [Gomez Restrepo, C.] Hosp Univ San Ignacio, Bogota, Colombia		Shannon, CL (corresponding author), Dartmouth Coll, Geisel Sch Med, Ctr Technol & Behav Hlth, 46 Centerra Pkwy, Lebanon, NH 03766 USA.	chelsea.l.shannon.med@dartmouth.edu; Sophia.M.Bartels@dartmouth.edu; macepeda@javeriana.edu.co; sergio.castro@javeriana.edu.co; Leonardo.Cubillos@hitchcock.org; fernando.suarez@javeriana.edu.co; willimak@mail.nih.gov; cgomez@javeriana.edu.co; miguel.uribe@gmail.com; Lisa.A.Marsch@dartmouth.edu; william.c.torrey@hitchcock.org	Suarez-Obando, Fernando/AAY-3327-2021	Shannon, Chelsea/0000-0002-3179-497X; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Suarez-Obando, Fernando/0000-0001-6336-5347; Cepeda-Gil, Magda/0000-0003-4579-6033; Uribe Restrepo, Jose Miguel/0000-0003-4284-7886	National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) [1U19MH109988]	National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was funded by the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) under Award Number 1U19MH109988 (Multiple Principal Investigators: Lisa A. Marsch, Ph.D. and Carlos GomezRestrepo, MD). The contents are solely the opinion of the authors and do not necessarily represent the views of the NIH or the United States Government.	[Anonymous], WHO WE AR; [Anonymous], 2020, ESTRATEGIA PROMOCION; Chaskel Roberto, 2015, BJPsych Int, V12, P95; Cubillos L, 2021, BJPSYCH BULL, V45, P40, DOI 10.1192/bjb.2020.35; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Evans M, 2020, RETHINK WAY WE DRINK; G?mez-Restrepo, 2015, ENSM; Gu?a de Pr?ctica Cl?nica (GPC), 2013, AB DEP ALC; Gu?a de Pr?ctica Cl?nica (GPC), 2013, EP DEPR TRAST DEPR R; IHME (Institute for Health Metrics and Evaluation), 2020, GBD COMPARE; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Torrey WC, 2020, PSYCHIAT SERV, V71, P678, DOI 10.1176/appi.ps.201900457	13	0	0	1	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853	1573-2789		COMMUNITY MENT HLT J	Community Ment. Health J.	NOV	2021	57	8					1579	1587		10.1007/s10597-021-00781-1	http://dx.doi.org/10.1007/s10597-021-00781-1		MAR 2021	9	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	WK5WV	33665738	Green Accepted			2022-09-04	WOS:000625809300001
J	Tomatsu, S; Yasuda, E; Patel, P; Ruhnke, K; Shimada, T; Mackenzie, WG; Mason, R; Thacker, MM; Theroux, M; Montano, AM; Almeciga-Diaz, CJ; Barrera, LA; Chinen, Y; Sly, WS; Rowan, D; Suzuki, Y; Orii, T				Tomatsu, Shunji; Yasuda, Eriko; Patel, Pravin; Ruhnke, Kristen; Shimada, Tsutomu; Mackenzie, William G.; Mason, Robert; Thacker, Mihir M.; Theroux, Mary; Montano, Adriana M.; Almeciga-Diaz, Carlos J.; Barrera, Luis A.; Chinen, Yasutsugu; Sly, William S.; Rowan, Daniel; Suzuki, Yasuyuki; Orii, Tadao			Morquio A Syndrome: Diagnosis and Current and Future Therapies	PEDIATRIC ENDOCRINOLOGY REVIEWS PER			English	Article						Mucopolysaccharidosis IVA; Enzyme assay; Keratan sulfate; Tandem mass spectrometry; GALNS; Enzyme replacement therapy; Bone marrow transplantation; Pathogenesis; Morquio tissue repository bank	ENZYME-REPLACEMENT THERAPY; MUCOPOLYSACCHARIDOSIS TYPE-II; ADENOASSOCIATED VIRUS VECTORS; GENISTEIN-MEDIATED INHIBITION; STEM-CELL TRANSPLANTATION; KERATAN SULFATE; GLYCOSAMINOGLYCAN SYNTHESIS; GROWTH-INHIBITION; CARCINOMA-CELLS; LOWER-EXTREMITY	Morquio A syndrome is an autosomat recessive disorder, one of 50 lysosomal storage diseases (LSDs), and is caused by the deficiency of N - acetylgalactosamine-6-sulfate sulfatase (GALNS). Deficiency of this enzyme causes specific glycosaminoglycan (GAG) accumulation: keratan sulfate (KS) and chondroitin-6-sulfate (C6S). The majority of KS is produced in the cartilage, therefore, the undegraded substrates accumulate mainly in cartilage and in its extracelluar matrix (ECM), causing direct leads to direct impact on cartilage and bone development and leading to the resultant systemic skeletal spondyloepiphyseal dysplasia. Chondrogenesis,the earliest phase of skeletal formation that leads to cartilage and bone formation is controlled by cellular interactions with the ECM, growth and differentiation factors and other molecules that affect signaling pathways and transcription factors in a temporal-spatial manner. In Morquio A patients, in early childhood or even at birth, the cartilage is disrupted presumably as a result of abnormal chondrogenesis and/or endochondral ossification. The unique clinical features are characterized by a marked short stature, odontoid hypoplasia, protrusion of the chest, kyphoscoliosis, platyspondyly, coxa valga, abnormal gait, and laxity of joints. In spite of many descriptions of the unique clinical manifestations, diagnosis delay still occurs. The pathogenesis of systemic skeletal dysplasia in Morquio A syndrome remains an enigmatic challenge. In this review article, screening, diagnosis, pathogenesis and current and future therapies of Morquio A are discussed.	[Tomatsu, Shunji; Yasuda, Eriko; Patel, Pravin; Ruhnke, Kristen; Shimada, Tsutomu; Mackenzie, William G.; Mason, Robert; Thacker, Mihir M.; Theroux, Mary] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Montano, Adriana M.; Rowan, Daniel] St Louis Univ, Dept Pediat, St Louis, MO 63103 USA; [Almeciga-Diaz, Carlos J.; Barrera, Luis A.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota, Colombia; [Chinen, Yasutsugu] Univ Ryukyus, Fac Med, Dept Pediat, Okinawa, Japan; [Sly, William S.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO USA; [Suzuki, Yasuyuki] Gifu Univ, Med Educ Dev Ctr, Gifu, Japan; [Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan		Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA.	stomatsu@nemours.org	Thacker, Mihir/AAN-6014-2020; Alméciga-Díaz, Carlos J/A-2494-2017; Rowan, Daniel/AAP-8347-2020; Montano, Adriana/AHE-8741-2022	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Rowan, Daniel/0000-0001-7830-2525; Patel, Pravin/0000-0002-7598-6121; Thacker, Mihir/0000-0002-6236-8703	Austrian MPS Society; National MPS Society; International Morquio Organization (Carol Ann Foundation); National Institutes of Health grant [GM34182, P20GM103464, 1R01HD065767-01]; Administrative Department of Science, Technology and Innovation COLCIENCIAS (Colombia) [120356933205 (ID PPTA 5174)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065767] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034182, R37GM034182, P20GM103464] Funding Source: NIH RePORTER	Austrian MPS Society; National MPS Society; International Morquio Organization (Carol Ann Foundation); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Administrative Department of Science, Technology and Innovation COLCIENCIAS (Colombia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Austrian MPS Society, National MPS Society and International Morquio Organization (Carol Ann Foundation). W.S.S. was also supported by National Institutes of Health grant GM34182. S.T. and R.M. were supported by National Institutes of Health grant P20GM103464. S.T. and A.M were supported by National Institutes of Health grant 1R01HD065767-01. CJAD and LAB are supported by The Administrative Department of Science, Technology and Innovation COLCIENCIAS (Colombia) grant 120356933205 (ID PPTA 5174). The content of the article has not been influenced by the sponsors. Editorial assistance to the manuscript was provided by Michelle Stofa at Nemours/Alfred I. duPont Hospital for Children.	Alexander IE, 2008, GENE THER, V15, P831, DOI 10.1038/gt.2008.64; Almeciga-Diaz CJ, 2010, FEBS J, V277, P3608, DOI 10.1111/j.1742-4658.2010.07769.x; Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Borowski A, 2007, J PEDIATR ORTHOPED, V27, P893, DOI 10.1097/bpo.0b013e31815a6007; Buning H, 2003, GENE THER, V10, P1142, DOI 10.1038/sj.gt.3301976; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Chinen Y, 2014, MOLEC GENET METAB RE, V1, P31, DOI 10.1016/j.ymgmr.2013.11.002; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dhawale AA, 2013, J PEDIATR ORTHOP B, V22, P59, DOI 10.1097/BPB.0b013e32835a0e6d; Dhawale AA, 2012, J PEDIATR ORTHOPED, V32, P534, DOI 10.1097/BPO.0b013e318259fe57; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; Fraldi A, 2007, BIOCHEM J, V403, P305, DOI 10.1042/BJ20061783; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Godichaud S, 2006, INT J BIOCHEM CELL B, V38, P629, DOI 10.1016/j.biocel.2005.11.001; Gutierrez MA, 2008, BIOMEDICA, V28, P448; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Harmatz P, 2010, TURKISH J PEDIATR, V52, P443; Hendriksz CJ, 2013, J INHERIT METAB DIS, V36, P309, DOI 10.1007/s10545-012-9459-0; Hintze JP, 2011, BIOMARK INSIGHTS, V6, P69, DOI 10.4137/BMI.S7451; Hughes DG, 1997, NEURORADIOLOGY, V39, P381, DOI 10.1007/s002340050429; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Khanna G, 2007, BONE MARROW TRANSPL, V39, P331, DOI 10.1038/sj.bmt.1705586; Kloska A, 2011, METAB BRAIN DIS, V26, P1, DOI 10.1007/s11011-011-9233-2; Lee LT, 2002, ANTICANCER RES, V22, P1615; Liang L, 2012, ONCOL REP, V28, P999, DOI 10.3892/or.2012.1874; Lim YC, 2011, J SURG ONCOL, V104, P776, DOI 10.1002/jso.21999; LIPSON SJ, 1977, J BONE JOINT SURG AM, V59, P340, DOI 10.2106/00004623-197759030-00008; Loiler SA, 2003, GENE THER, V10, P1551, DOI 10.1038/sj.gt.3302046; Martell LA, 2011, BIOANALYSIS, V3, P1855, DOI [10.4155/BIO.11.172, 10.4155/bio.11.172]; Marucha J, 2011, AM J MED GENET A, V155A, P2257, DOI 10.1002/ajmg.a.34146; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Mizuno H, 2006, MOL CARCINOGEN, V45, P204, DOI 10.1002/mc.20174; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Phromnoi K, 2011, MOL PHARMACOL, V80, P889, DOI 10.1124/mol.111.073676; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Ransford AO, 1996, J BONE JOINT SURG BR, V78B, P307, DOI 10.1302/0301-620X.78B2.0780307; Rowan DJ, 2012, MOL GENET METAB, V107, P161, DOI 10.1016/j.ymgme.2012.07.002; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; STEVENS JM, 1991, J BONE JOINT SURG BR, V73, P851, DOI 10.1302/0301-620X.73B5.1910048; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Tanaka A, 2012, MOL GENET METAB, V107, P513, DOI 10.1016/j.ymgme.2012.09.004; Toietta G, 2001, HUM GENE THER, V12, P2007, DOI 10.1089/104303401753204571; Tolar J, 2008, BONE MARROW TRANSPL, V41, P531, DOI 10.1038/sj.bmt.1705934; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; Tomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2007, MOL GENET METAB, V91, P251, DOI 10.1016/j.ymgme.2007.02.009; Tomatsu S, 2010, J INHERIT METAB DIS, V33, pS35, DOI 10.1007/s10545-009-9013-x; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65, DOI 10.2147/RRED.S37278; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Turbeville S, 2011, MOL GENET METAB, V102, P111, DOI 10.1016/j.ymgme.2010.09.010; Tylki-Szymanska A, 2012, ACTA PAEDIATR, V101, pE42, DOI 10.1111/j.1651-2227.2011.02385.x; Tylki-Szymanska A, 2010, J INHERIT METAB DIS, V33, P151, DOI 10.1007/s10545-010-9059-9; White K, 2008, GENE THER, V15, P443, DOI 10.1038/sj.gt.3303077; Whyte MP, 2011, NEW ENGL J MED, V8, P904	70	43	45	0	2	MEDICAL MEDIA	NETANYA	PO BOX 8214, NETANYA, 4250543, ISRAEL	1565-4753			PEDIATR ENDOCR REV P	Pediatr. Endocrinol. Rev. PER	SEP	2014	12			1			141	151						11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	V41UW	25345096				2022-09-04	WOS:000209572100010
J	Song, JW; Jeong, YJ; Kim, KI; Choi, SJ; Lee, HK; Lee, KN; Manzano, AC				Song, J. W.; Jeong, Y. J.; Kim, K. I.; Choi, S. J.; Lee, H. K.; Lee, K. N.; Manzano, A. C.			Environmental lung diseases: Clinical and imaging findings	CLINICAL RADIOLOGY			English	Review							LEGIONNAIRES-DISEASE; PULMONARY-EDEMA; FEATURES; CT; LEGIONELLA; SPECTRUM; VOLUME; FLUID; WATER	Environmental lung diseases are caused by exposure to adverse environmental conditions, such as atmospheric pressure changes or the ingestion or inhalation of toxic agents. The development of environmental lung diseases depends on the intensity and duration of exposure, the physiological and biological susceptibility of the host, and the toxic effects of the adverse environmental conditions encountered. A combination of clinical features, related exposure history, imaging findings, and a review of previous reports that support an association between exposure and the disease process is required for diagnosis. Crown Copyright (C) 2012 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.	[Song, J. W.] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Radiol, Pusan, South Korea; [Jeong, Y. J.] Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Radiol, Pusan 602739, South Korea; [Jeong, Y. J.] Med Res Inst, Pusan, South Korea; [Kim, K. I.] Pusan Natl Univ, Sch Med, Pusan Natl Univ Yangsan Hosp, Dept Radiol, Yangsan, South Korea; [Kim, K. I.] Med Res Inst, Yangsan, South Korea; [Choi, S. J.] Inje Univ, Coll Med, Busan Paik Hosp, Dept Radiol, Pusan, South Korea; [Lee, H. K.] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med, Pusan, South Korea; [Lee, K. N.] Dong A Univ Hosp, Dept Radiol, Pusan, South Korea; [Manzano, A. C.] Univ San Ignacio, Javeriana Hosp, Pontificia Univ, Dept Radiol, Bogota, Colombia		Jeong, YJ (corresponding author), Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Radiol, 1-10 Ami Dong, Pusan 602739, South Korea.	jeongyj@pusan.ac.kr						Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; BUTLER BD, 1979, J APPL PHYSIOL, V47, P537, DOI 10.1152/jappl.1979.47.3.537; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Gluecker T, 1999, RADIOGRAPHICS, V19, P1507, DOI 10.1148/radiographics.19.6.g99no211507; Hultgren HN, 1997, WILD ENVIRON MED, V8, P218, DOI 10.1580/1080-6032(1997)008[0218:LPIHAP]2.3.CO;2; HULTGREN HN, 1964, CIRCULATION, V29, P393, DOI 10.1161/01.CIR.29.3.393; Idris AH, 2003, RESUSCITATION, V59, P45, DOI 10.1016/j.resuscitation.2003.09.003; KANGARLOO H, 1977, AM J ROENTGENOL, V128, P441, DOI 10.2214/ajr.128.3.441; Kim M, 2008, AM J ROENTGENOL, V190, P907, DOI 10.2214/AJR.07.2766; Kiyan E, 2001, CHEST, V120, P2098, DOI 10.1378/chest.120.6.2098; LEE SH, 1995, RADIOLOGY, V195, P271, DOI 10.1148/radiology.195.1.7892484; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Miller K, 2003, EMERG MED CLIN N AM, V21, P533, DOI 10.1016/S0733-8627(03)00011-7; MODELL JH, 1967, ANN INTERN MED, V67, P68, DOI 10.7326/0003-4819-67-1-68; MODELL JH, 1966, ANESTHESIOLOGY, V27, P33, DOI 10.1097/00000542-196601000-00007; MODELL JH, 1966, ANESTHESIOLOGY, V27, P662, DOI 10.1097/00000542-196609000-00018; MODELL JH, 1976, CHEST, V70, P231, DOI 10.1378/chest.70.2.231; MOORE EH, 1984, RADIOLOGY, V153, P589, DOI 10.1148/radiology.153.3.6387784; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; Silva CIS, 2007, AM J ROENTGENOL, V188, P334, DOI 10.2214/AJR.05.1826; Slade JB, 2001, CHEST, V120, P1686, DOI 10.1378/chest.120.5.1686; STRAUSS RH, 1979, AM REV RESPIR DIS, V119, P1001; TASAKA S, 1995, RESPIRATION, V62, P40; VOCK P, 1991, CHEST, V100, P1306, DOI 10.1378/chest.100.5.1306; WHITE CS, 1992, RADIOL CLIN N AM, V30, P1231; Yagyu H, 2003, INTERNAL MED, V42, P477, DOI 10.2169/internalmedicine.42.477	27	3	4	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0009-9260	1365-229X		CLIN RADIOL	Clin. Radiol.	MAR	2013	68	3					310	316		10.1016/j.crad.2012.07.012	http://dx.doi.org/10.1016/j.crad.2012.07.012			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	094HG	22980721				2022-09-04	WOS:000315253000014
J	Andonova, V; Stoyanova, A; Valencia, C; Juliao-Rossi, J				Andonova, Veneta; Stoyanova, Alexandina; Valencia, Carlos; Juliao-Rossi, Jorge			What can Latin-American entrepreneurs learn from Catalan gazelles?	ACADEMIA-REVISTA LATINOAMERICANA DE ADMINISTRACION			English	Article						Gazelles; High-growth firms; Strategic capabilities; Entrepreneurship; Catalonia; Latin America; Entrepreneurialism; Central America; South America	COMPETITIVE ADVANTAGE; FINANCIAL CONSTRAINTS; FIRM SIZE; GROWTH; INNOVATION; MANAGEMENT; PERFORMANCE; IMPACT	Purpose - The purpose of this paper is to systematize the strategic capabilities of seven surviving industrial Catalan companies which were going through explosive growth in 1999. Design/methodology - We use the comparative case studies method to draw on the common features among the seven in-debt cases we built. We are well aware that the method of comparative case studies does not provide a sufficient base for bold generalizations. However, the qualitative approach adopted here allows for the first in-depth look at the strategies that bring surviving entrepreneurs from explosive growth to a more balanced growth path. Findings - We identify four organizational capabilities as key to the survival of these businesses ten years later: first, ability to prioritize product and market development, including internationalization, over operations; second, ability to reorganize internally and delegate in a timely manner; third, ability to manage innovation and support creativity linked to productivity; and finally, ability to manage economic and financial resources. Social implications - Implications for the culturally proximate and less-studied Latin-American gazelles are presented.	[Andonova, Veneta] Amer Univ Bulgaria, Dept Business, Blagoevgrad, Bulgaria; [Andonova, Veneta; Valencia, Carlos; Juliao-Rossi, Jorge] Univ Los Andes, Sch Management, Bogota, Colombia; [Stoyanova, Alexandina] Univ Barcelona, Dept Econ, Barcelona, Spain; [Valencia, Carlos] Pontificia Univ Javeriana, Dept Business, Bogota, Colombia; [Juliao-Rossi, Jorge] De La Salle Univ, Dept Business, Bogota, Colombia		Andonova, V (corresponding author), Amer Univ Bulgaria, Dept Business, Blagoevgrad, Bulgaria.	vandonova@aubg.bg	Andonova, Veneta/R-2569-2016	Andonova, Veneta/0000-0003-0072-0174				Amat O., 2010, PAPERS EC IND U EMPR, V29; AMIT R, 1993, STRATEGIC MANAGE J, V14, P33, DOI 10.1002/smj.4250140105; Amoros J.R., 2007, GLOBAL ENTREPRENEURS; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Barrett R, 2007, J SMALL BUS ENTERP D, V14, P307, DOI 10.1108/14626000710746727; Beck T, 2006, J BANK FINANC, V30, P2931, DOI 10.1016/j.jbankfin.2006.05.009; Birch David L., 1979, JOB GENERATION UNPUB; Capelleras J., 2009, NUEVAS EMPRESAS AM L; Carpenter RE, 2002, REV ECON STAT, V84, P298, DOI 10.1162/003465302317411541; Chan YE, 2006, J SMALL BUS MANAGE, V44, P426, DOI 10.1111/j.1540-627X.2006.00180.x; Coad A, 2008, RES POLICY, V37, P633, DOI 10.1016/j.respol.2008.01.003; Crespi G., 2010, IDB WORKING PAPER SE; De Wit G., 2008, HIGH GROWTH SMES EVI; Delmar F, 2003, J BUS VENTURING, V18, P189, DOI 10.1016/S0883-9026(02)00080-0; Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Arteaga ME, 2009, ACAD-REV LATINOAM AD, P1; Federico J., 2009, NUEVAS EMPRESAS AM L, P21; FITZGERALD L, 2009, SAGE HDB ORG RES MET; Gibson T., 2011, HIGH IMPACT GAZELLES; Goedhuys Micheline, 2012, Structural Change and Economic Dynamics, V23, P516, DOI 10.1016/j.strueco.2011.01.004; Grundstrom C, 2012, INT J INNOV MANAG, V16, DOI 10.1142/S1363919612400038; Hall BH, 2002, OXFORD REV ECON POL, V18, P35, DOI 10.1093/oxrep/18.1.35; Hernandez J.M., 1999, PAPERS EC IND DEP IN, V12; Holzl W, 2010, ECON BULL, V30, P1016; Klatt L. A., 2006, INT J ENTREPRENEURSH, V10, P21; Kuemmerle W, 2002, J BUS VENTURING, V17, P99, DOI 10.1016/S0883-9026(00)00054-9; Bonilla JCL, 2012, ACAD-REV LATINOAM AD, P31; Lopez-Garcia P., 2009, 0920 BANC ESP; Lunati M., 2008, HIGH GROWTH SMES INN; Merino F, 2012, RES ECON, V66, P349, DOI 10.1016/j.rie.2012.07.001; Miles M.B, 1994, QUALITATIVE DATA ANA; Milesi D., 2007, ESTUDIO COMPARADO EX; Mohr V., 2011, EC MANAGEMENT FINANC, V4, P29; Moreno AM, 2007, ENTREP REGION DEV, V19, P69, DOI 10.1080/08985620601002162; Musso P, 2008, J EVOL ECON, V18, P135, DOI 10.1007/s00191-007-0087-z; Newbert SL, 2008, STRATEGIC MANAGE J, V29, P745, DOI 10.1002/smj.686; Orser BJ, 2000, J SMALL BUS MANAGE, V38, P42; Park C., 2001, REV QUANT FINANCE AC, V16, P33; Parker SC, 2010, SMALL BUS ECON, V35, P203, DOI 10.1007/s11187-009-9250-2; PETERAF MA, 1993, STRATEGIC MANAGE J, V14, P179, DOI 10.1002/smj.4250140303; Pla-Barber J, 2007, INT BUS REV, V16, P275, DOI 10.1016/j.ibusrev.2007.02.005; PORTER ME, 1991, STRATEGIC MANAGE J, V12, P95, DOI 10.1002/smj.4250121008; Rahaman MM, 2011, J BANK FINANC, V35, P709, DOI 10.1016/j.jbankfin.2010.09.005; Sadler-Smith E, 2003, J SMALL BUS MANAGE, V41, P47, DOI 10.1111/1540-627X.00066; Savignac F, 2008, ECON INNOV NEW TECH, V17, P553, DOI 10.1080/10438590701538432; Segarra A., 2009, WORKING PAPERS; Smallbone D., 1995, INT J ENTREPRENEURIA, V1, P44, DOI DOI 10.1108/13552559510100657; Teal E. J., 2003, J DEV ENTREPRENEURSH, V8, P177; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Thakur SP, 1999, J BUS VENTURING, V14, P283, DOI 10.1016/S0883-9026(98)00002-0; Tidd Joe, 1997, MANAGING INNOVATION; Upton N., 2004, FORUM EMPRESARIAL, V9, P24; Vanacker TR, 2010, SMALL BUS ECON, V35, P53, DOI 10.1007/s11187-008-9150-x; Winker P, 1999, SMALL BUS ECON, V12, P169, DOI 10.1023/A:1008035826914; Yin R.K., 2003, CASE STUDY REASERCH; Yin R.K., 2009, CASE STUDY REASERCH	57	4	6	1	30	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1012-8255	2056-5127		ACAD-REV LATINOAM AD	Acad.-Rev. Latinoam. Adm.		2013	26	2					290	317		10.1108/ARLA-06-2013-0069	http://dx.doi.org/10.1108/ARLA-06-2013-0069			28	Business; Management	Social Science Citation Index (SSCI)	Business & Economics	212NG					2022-09-04	WOS:000323989500005
J	Taborda, PA; Acosta-Reyes, JL; Estupinan, A; Barengo, N; Gabriel, R; Mercado, MAB; Gonzalez, NC; Taborda, A				Taborda, P. A.; Acosta-Reyes, J. L.; Estupinan, A.; Barengo, N.; Gabriel, R.; Barrios Mercado, M. A.; Correa Gonzalez, N.; Taborda, A.			SYSTEMATIC REVIEW OF TYPE 2 DIABETES MELLITUS CLINICAL PRACTICE GUIDELINES IN LATIN AMERICA	VALUE IN HEALTH			English	Meeting Abstract									[Taborda, P. A.; Taborda, A.] Sapyens SAS BIC, Bogota, CUN, Colombia; [Acosta-Reyes, J. L.; Estupinan, A.; Barrios Mercado, M. A.] Univ Norte, Barranquilla, Colombia; [Barengo, N.] Florida Int Univ, Miami, FL 33199 USA; [Gabriel, R.] Inst Salud Carlos III, Madrid, Spain; [Correa Gonzalez, N.] Pontificia Univ Javeriana, Bogota, CUN, Colombia										0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	JUL	2022	25	7		SUPPL		HSD71	S492	S492						1	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	3C6US					2022-09-04	WOS:000828757301328
J	Crispi, F; Crovetto, F; Rodriguez-Lopez, M; Sepulveda-Martinez, A; Miranda, J; Gratacos, E				Crispi, Fatima; Crovetto, Francesca; Rodriguez-Lopez, Merida; Sepulveda-Martinez, Alvaro; Miranda, Jezid; Gratacos, Eduard			Postnatal persistence of cardiac remodeling and dysfunction in late fetal growth restriction	MINERVA OBSTETRICS AND GYNECOLOGY			English	Review						Fetal growth retardation; Infant; small for gestational age; Fetal development; Prenatal care; Cardiovascular diseases; Echocardiography	SYSTOLIC BLOOD-PRESSURE; INTRAUTERINE GROWTH; BIRTH-WEIGHT; GESTATIONAL-AGE; PRETERM BIRTH; SWEDISH MEN; DISEASE; RISK; COHORT; GENERATIONS	Fetal growth restriction is one of the most common obstetric complications, affecting 7-10% of all pregnancies. Affected fetuses are exposed to an adverse environment in utero during a critical time of development and may face long-term health consequences such as increased cardiovascular risk in adulthood. Growth restricted fetuses develop remodeled hearts with signs of systolic and diastolic dysfunction. Cardiac adaptations are more evident in early severe cases, but also present in late onset fetal growth restriction. Cardiovascular remodeling persists into postnatal life, from the neonatal period to adolescence, encompassing an increased susceptibility to adult disease. In this review, we summarize the current evidence on cardiovascular programming associated to fetal growth restriction, its postnatal consequences and potential strategies to reduce their cardiovascular risk.	[Crispi, Fatima; Crovetto, Francesca; Rodriguez-Lopez, Merida; Sepulveda-Martinez, Alvaro; Miranda, Jezid; Gratacos, Eduard] Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med BCNat, Ctr Biomed Res Rare Dis CIBER ER,Inst Invest Biom, Inst Clin Ginecol Obstetricia & Neonatol ICGON,Ho, Sabino Arana 1, E-08028 Barcelona, Spain; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana, Secc Cali, Cali, Colombia; [Sepulveda-Martinez, Alvaro] Univ Chile, Dept Obstet & Gynecol, Unit Fetal Med, Hosp Clin, Santiago, Chile; [Miranda, Jezid] Univ Cartagena, Dept Obstet & Gynecol, Grp Invest Cuidado Intens GRICIO, Cartagena, Colombia		Crovetto, F (corresponding author), Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med BCNat, Ctr Biomed Res Rare Dis CIBER ER,Inst Invest Biom, Inst Clin Ginecol Obstetricia & Neonatol ICGON,Ho, Sabino Arana 1, E-08028 Barcelona, Spain.	fcrovetto@sjdhospitalbarcelona.org	Miranda, Jezid/AAG-4747-2021; Sepulveda-Martinez, Alvaro/H-6546-2014; Rodriguez-Lopez, Merida/N-9273-2017	Miranda, Jezid/0000-0003-4198-6534; Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Rodriguez-Lopez, Merida/0000-0001-8245-0811; Gratacos, Eduard/0000-0002-7405-7224	Erasmus + Program of the European Union [2013-0040]; "la Caixa" Foundation [LCF/PR/GN14/10270005]; Instituto de Salud Carlos III [PI14/00226, PI18/00073, PI20/00246]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa"; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR 2017 SGR [1531]	Erasmus + Program of the European Union; "la Caixa" Foundation(La Caixa Foundation); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa"; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR 2017 SGR	This study was funded by a grant from the Erasmus + Program of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. Additionally, the research leading to these results has received funding form "la Caixa" Foundation under grant agreement LCF/PR/GN14/10270005, Dthe Instituto de Salud Carlos III (PI14/00226, PI18/00073, PI20/00246) integrated in the Plan Nacional de I+D+I and funded by the ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa", Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) and AGAUR 2017 SGR grant N. 1531.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Arnott C, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000265; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bjarnegard N, 2013, ULTRASOUND OBST GYN, V41, P177, DOI 10.1002/uog.12314; Brodszki J, 2005, CIRCULATION, V111, P2623, DOI 10.1161/CIRCULATIONAHA.104.490326; Castrillio SM, 2014, MATERN CHILD HLTH J, V18, P2456, DOI 10.1007/s10995-014-1484-1; Comas M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.010; Coutinho R, 1997, AM J EPIDEMIOL, V146, P804; Crispi F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82389-9; Crispi F, 2020, FETAL DIAGN THER, V47, P337, DOI 10.1159/000506047; Crispi F, 2018, EARLY HUM DEV, V126, P23, DOI 10.1016/j.earlhumdev.2018.08.013; Crispi F, 2018, AM J OBSTET GYNECOL, V218, pS869, DOI 10.1016/j.ajog.2017.12.012; Crispi F, 2014, CIRC-CARDIOVASC IMAG, V7, P781, DOI 10.1161/CIRCIMAGING.113.001490; Crispi F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.011; Crispi F, 2012, FETAL DIAGN THER, V32, P47, DOI 10.1159/000338003; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Cruz-Lemini M, 2016, ULTRASOUND OBST GYN, V48, P349, DOI 10.1002/uog.15767; Cruz-Lemini M, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.031; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dejea H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43407-z; Demicheva E, 2014, FETAL DIAGN THER, V36, P143, DOI 10.1159/000353633; Drake AJ, 2010, TRENDS ENDOCRIN MET, V21, P206, DOI 10.1016/j.tem.2009.11.006; European Heart Network, 2008, EUROPEAN CARDIOVASCU; Figueras F, 2018, AM J OBSTET GYNECOL, V218, pS790, DOI 10.1016/j.ajog.2017.12.003; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Garcia-Canadilla P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218192; Garcia-Otero L., 2020, ULTRASOUND OBSTET GY; Garcia-Otero L, 2020, FETAL DIAGN THER, V47, P387, DOI 10.1159/000494838; GENNSER G, 1988, BMJ-BRIT MED J, V296, P1498, DOI 10.1136/bmj.296.6635.1498; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gonzalez-Tendero A, 2017, EUR HEART J-CARD IMG, V18, P732, DOI 10.1093/ehjci/jew314; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Leon DA, 2000, AM J EPIDEMIOL, V152, P597, DOI 10.1093/aje/152.7.597; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARTYN CN, 1995, BRIT HEART J, V73, P116; Miles KL, 2011, J HYPERTENS, V29, P2324, DOI 10.1097/HJH.0b013e32834d0ca1; Miranda J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31832-5; Paules C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78207-3; Perez-Cruz M, 2018, FETAL DIAGN THER, V44, P271, DOI 10.1159/000484315; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rodriguez-Lopez M, 2017, ULTRASOUND OBST GYN, V50, P207, DOI 10.1002/uog.17365; Rodriguez-Lopez M, 2016, PEDIATR RES, V79, P100, DOI 10.1038/pr.2015.182; Sarvari SI, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005270; Sehgal A, 2016, J DEV ORIG HLTH DIS, V7, P626, DOI 10.1017/S2040174416000337; Selling KE, 2006, BJOG-INT J OBSTET GY, V113, P430, DOI 10.1111/j.1471-0528.2006.00872.x; Sepulveda-Martinez A, 2019, ULTRASOUND OBST GYN, V53, P623, DOI 10.1002/uog.20119; Skilton MR, 2012, PEDIATRICS, V129, pE698, DOI 10.1542/peds.2011-2472; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Wikstrom AK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.009	60	2	2	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	2724-606X	2724-6450		MINERVA OBSTET GYNEC	Minerva Obstet. Gynecol.	AUG	2021	73	4					471	481		10.23736/S2724-606X.21.04823-5	http://dx.doi.org/10.23736/S2724-606X.21.04823-5			11	Obstetrics & Gynecology	Emerging Sources Citation Index (ESCI)	Obstetrics & Gynecology	TR8UH	33949826				2022-09-04	WOS:000679234900010
J	Roy, S; Pandit, S; Papia, M; Rahman, MM; Ocampo, JCOR; Razi, MA; Fraile-Jurado, P; Ahmed, N; Hoque, MA; Hasan, MM; Yeasmin, J; Hossain, MS				Roy, Sanjoy; Pandit, Santa; Papia, Mossammat; Rahman, Md Masudur; Ocampo, Jan Christian Otto Rehder; Razi, Mohammad Arfar; Fraile-Jurado, Pablo; Ahmed, Naser; Hoque, Muhammad Al-Amin; Hasan, Md Mehedi; Yeasmin, Jakeya; Hossain, Md Sakhawat			Coastal erosion risk assessment in the dynamic estuary: The Meghna estuary case of Bangladesh coast	INTERNATIONAL JOURNAL OF DISASTER RISK REDUCTION			English	Article						Risk assessment; Coastal hazard; AHP; Hot spot analysis; Meghna estuary	CLIMATE-CHANGE; SEA-LEVEL; VULNERABILITY ASSESSMENT; TROPICAL CYCLONE; STORM SURGES; FUZZY-AHP; IMPACT; ISLAND; GIS; COMMUNITIES	Erosion is one of the predominant hazards in coastal Bangladesh. For implementing effective adaptation and mitigation strategies, assessment of risk to coastal erosion is crucial. This study aimed to assess the levels of risk to coastal erosion in the Meghna estuary, a major erosion-prone area in the coastal region of the country impacted by abrupt changes in hydrological and geomorphological conditions. Using physical, environmental, and socio-economic geospatial data, this is the first attempt in assessing erosion risk and characterizing three main risk components: hazard, vulnerability, and exposure at a regional extent in the estuary. A total of 19 indicators were considered, and statistical methods assisted with the Analytic Hierarchy Process (AHP) were used for the construction of hazard, vulnerability, and exposure indices, which were then integrated to calculate erosion risk comprehensively at the lowermost administrative unit (union) level throughout the study area. The results of hazard and vulnerability analyses depicted 35.72% and 46.69% areas as highly hazard-prone and highly vulnerable to erosion, respectively. Assessment of the exposure index exhibited 42.25% area as highly exposed to coastal erosion in the estuary. Finally, the results quantified different levels of risk as very high (14.91%), high (19.36%), moderate (23.40%), low (23.91%), and very low (18.41%). Among 161 coastal unions, 45 unions were identified as high to very high erosion risk-prone areas, located in the coasts of Bhola, Noakhali, and Barishal districts including their major islands. The validation result confirmed a reasonable level of acceptance of the calculated risk map, despite several data limitations. The geospatial distribution of different risk categories presented in this paper can assist relevant authorities with reliable spatial information in formulating improved erosion risk mitigation policies in the most dynamic estuary of the country.	[Roy, Sanjoy; Razi, Mohammad Arfar] Bengal Inst Architecture Landscapes & Settlements, Unique Oval,45 Kamal Ataturk Ave, Dhaka 1212, Bangladesh; [Pandit, Santa] United Nat Univ, Inst Adv Study Sustainabil, Tokyo, Japan; [Papia, Mossammat; Rahman, Md Masudur; Hasan, Md Mehedi; Yeasmin, Jakeya] Univ Dhaka, Dept Geog & Environm, Dhaka, Bangladesh; [Ocampo, Jan Christian Otto Rehder] Pontificia Univ Javeriana, Dept Biol, Bogota, Colombia; [Fraile-Jurado, Pablo] Univ Seville, Dept Geog Fis & AGR, Seville, Spain; [Ahmed, Naser; Hoque, Muhammad Al-Amin] Jagannath Univ, Dept Geog & Environm, Dhaka, Bangladesh; [Hossain, Md Sakhawat] Jagannath Univ, Dept Zool, Dhaka, Bangladesh		Roy, S (corresponding author), Bengal Inst Architecture Landscapes & Settlements, Unique Oval,45 Kamal Ataturk Ave, Dhaka 1212, Bangladesh.	sroy.du@gmail.com; razs.san@gmail.com; mpapia.du@gmail.com; masud_ra0171@yahoo.com; jan.rehder.ocampo@gmail.com; arfar_razi@yahoo.com; pfraile@us.es; naserbipu.geo2011@gmail.com; shajidgeo34@gmail.com; mehedi.sagor84@gmail.com; jakeyayeasmin89@gmail.com; sakhawat.hossain@zool.jnu.ac.bd	Rahman, Masudur/X-9708-2019	Rahman, Masudur/0000-0002-5079-3606; Razi, Mohammad Arfar/0000-0003-2230-4438; HOSSAIN, MD. SAKHAWAT/0000-0002-8393-9157; Roy, Sanjoy/0000-0002-5699-0758; Ahmed, Naser/0000-0003-2775-0592; Hoque, Muhammad Al-Amin/0000-0001-6845-6176				ADRC, 2005, TOT DIS RISK MAN GOO, P5; Ahmed A, 2018, OCEAN COAST MANAGE, V151, P10, DOI 10.1016/j.ocecoaman.2017.10.030; Ahmed AU, 2006, BANGLADESH CLIMATE C; Ahmed H, 2019, J COASTAL ZONE MANAG, V22, P66; Ahmed S., 1997, RESIDUAL FLOW VOLUME; Al Emran, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-015-0060-z; Alam A, 2020, SCI TOTAL ENVIRON, V704, DOI 10.1016/j.scitotenv.2019.135360; Alam E, 2015, INT J CLIMATOL, V35, P801, DOI 10.1002/joc.4035; Ali A, 1996, WATER AIR SOIL POLL, V92, P171; Ali A, 1999, CLIMATE RES, V12, P109, DOI 10.3354/cr012109; Ali M.A, 2020, SE U J LAW, V3, P2020; [Anonymous], 1996, SEA LEVEL RISE COAST, DOI DOI 10.1007/978-94-015-8719-8_5; [Anonymous], 2004, SURV LAND INFORM SCI; [Anonymous], 2019, ASIA NEWS; [Anonymous], 2016, J ASIATIC SOC BANGLA; Aranguiz R, 2020, INT J DISAST RISK RE, V50, DOI 10.1016/j.ijdrr.2020.101727; Atkinson AL, 2018, COAST ENG, V136, P183, DOI 10.1016/j.coastaleng.2018.03.003; Balasuriya A, 2018, BIODIVERSITY AND CLIMATE CHANGE ADAPTATION IN TROPICAL ISLANDS, P701, DOI 10.1016/B978-0-12-813064-3.00025-9; Bangladesh Bureau of Statistics (BBS),, 2011, PRELIMINARY REPORT; Bangladesh Economic Review, 2019, BANGL EC REV GDP SAV; Bathi JR, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020239; Berberoglu M. I., 2008, THESIS GAZI U I SCI; Birkmann J., 2007, Environmental Hazards, V7, P20, DOI 10.1016/j.envhaz.2007.04.002; Blaikie PM, 1994, RISK NATURAL HAZARDS; Bouwer LM, 2011, B AM METEOROL SOC, V92, P39, DOI 10.1175/2010BAMS3092.1; Brammer H, 2014, CLIM RISK MANAG, V1, P51, DOI 10.1016/j.crm.2013.10.001; Bricheno L., 2018, ECOSYSTEM SERVICES W; Bruno MF, 2020, J MAR SCI ENG, V8, DOI 10.3390/jmse8070531; Bruun P., 1962, AM SOC CIVIL ENG J W, V8, P117, DOI [10.1061/jwheau.0000252, DOI 10.1061/JWHEAU.0000252]; Cabrera JS, 2020, J FLOOD RISK MANAG, V13, DOI 10.1111/jfr3.12607; Cabrera JS, 2019, WATER-SUI, V11, DOI 10.3390/w11112203; Cai F., 2011, 19 INT C GEOINF 24 2, DOI [10.1109/GeoInformatics.2011.5980891, DOI 10.1109/GEOINFORMATICS.2011.5980891]; Cardona OD, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P65; Chen XL, 2017, MARINE GEO-HAZARDS IN CHINA, P269, DOI 10.1016/B978-0-12-812726-1.00007-3; CURRAY JR, 1971, GEOL SOC AM BULL, V82, P563, DOI 10.1130/0016-7606(1971)82[563:GOTBDF]2.0.CO;2; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2000, ANN ASSOC AM GEOGR, V90, P713, DOI 10.1111/0004-5608.00219; Dewan A, 2017, GEOMORPHOLOGY, V276, P257, DOI 10.1016/j.geomorph.2016.10.017; Dolan AH, 2006, J COASTAL RES, P1316; Dou XY, 2018, STOCH ENV RES RISK A, V32, P1131, DOI 10.1007/s00477-017-1429-5; Ehrlich D, 2018, ENVIRON SCI POLICY, V90, P73, DOI 10.1016/j.envsci.2018.10.001; Emran A, 2017, INT J APPL GEOSPAT R, V8, P33, DOI 10.4018/IJAGR.2017040103; Espada R, 2017, INT J DISASTER RESIL, V8, P375, DOI 10.1108/IJDRBE-03-2015-0010; Evans R.L., 2004, OCEANUS MAGAZINE, V43; FAO, 2016, NTR REFERENCE; Fraile-Jurado P, 2013, GEO-MAR LETT, V33, P225, DOI 10.1007/s00367-012-0317-8; FRANK NL, 1971, B AM METEOROL SOC, V52, P438, DOI 10.1175/1520-0477(1971)052<0438:TDTCIH>2.0.CO;2; Gao Y, 2014, J GEOPHYS RES-ATMOS, V119, P5364, DOI 10.1002/2013JD021268; Ghosh MK, 2015, ISPRS J PHOTOGRAMM, V101, P137, DOI 10.1016/j.isprsjprs.2014.12.009; Gornitz VM, 1994, J COASTAL RES, V1, P327; Gupta N, 2013, REMOTE SENS LETT, V4, P1, DOI 10.1080/2150704X.2012.682658; Hagenlocher M, 2018, SCI TOTAL ENVIRON, V631-632, P71, DOI 10.1016/j.scitotenv.2018.03.013; HANSON H, 1993, AMBIO, V22, P188; Haque A., 2018, ECOSYSTEM SERVICES W, P147; Haque A, 2016, INT J DISAST RISK SC, V7, P312, DOI 10.1007/s13753-016-0100-y; HASSAN SMT, 2017, 6 INT C WAT FLOOD MA; Hoque MA, 2021, GEOMAT NAT HAZ RISK, V12, P198, DOI 10.1080/19475705.2020.1867652; Hoque MAA, 2021, SCI TOTAL ENVIRON, V756, DOI 10.1016/j.scitotenv.2020.143600; Hoque MA, 2019, OCEAN COAST MANAGE, V181, DOI 10.1016/j.ocecoaman.2019.104898; Hoque MA, 2019, SCI TOTAL ENVIRON, V692, P10, DOI 10.1016/j.scitotenv.2019.07.132; Hoque MA, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19061302; Hoque MA, 2018, INT J DIGIT EARTH, V11, P246, DOI 10.1080/17538947.2017.1320595; Hoque MA, 2017, OCEAN COAST MANAGE, V146, P109, DOI 10.1016/j.ocecoaman.2017.07.001; Hossain M.M., 2010, THESIS LEIBNIZ U HAN; Huq S., 1996, NATO ASI SERIES SERI, V37, P347, DOI [DOI 10.1007/978-3-642-61086-8, 10.1007/978-3-642-61086-8_14, DOI 10.1007/978-3-642-61086-8_14]; Hussain MA, 2014, IOP C SER EARTH ENV, V20, DOI 10.1088/1755-1315/20/1/012047; Ietto F, 2018, ENVIRON PROCESS, V5, P201, DOI 10.1007/s40710-018-0295-6; Islam F, 2019, NAT HAZARD EARTH SYS, V19, P353, DOI 10.5194/nhess-19-353-2019; Islam M.S, 2015, THESIS BANGLADESH U; Islam MA, 2015, J INDIAN SOC REMOTE, V43, P625, DOI 10.1007/s12524-014-0426-0; Islam MN, 2013, NAT HAZARDS, V69, P2083, DOI 10.1007/s11069-013-0796-6; Islam SN, 2016, SUST WAT RESOUR MAN, V2, P237, DOI 10.1007/s40899-016-0047-6; Islam SMR, 1999, VULNERABILITY AND ADAPTATION TO CLIMATE CHANGE FOR BANGLADESH, P71; Jakobsen F, 2002, ESTUAR COAST SHELF S, V55, P587, DOI 10.1006/ecss.2001.0929; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kabir MA, 2020, REG STUD MAR SCI, V35, DOI 10.1016/j.rsma.2020.101167; Kabir R, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/9654753; Khalil G. M., 1992, Natural Hazards, V6, P11, DOI 10.1007/BF00162096; Khan R.S., 2006, CYCLONE HAZARD BANGL, P86; Krantz M, 1999, COASTAL EROSION ISLA, P27; Leal F.W, 2019, CLIMATE ACTION ENCY; Lee HS, 2013, J GEOPHYS RES-OCEANS, V118, P4273, DOI 10.1002/jgrc.20310; Lin L, 2017, NAT RESOUR MODEL, V30, DOI 10.1111/nrm.12146; Mahmood R., 2020, INT J DISAST RISK RE, V44, P1; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Merlotto A, 2016, J COAST CONSERV, V20, P351, DOI 10.1007/s11852-016-0447-7; MES-II, 2001, HYDR MORPH DYN MEGHN; MoEF (Ministry of Environment and Forests), 2007, BANGL NAT PROGR ACT; Montz BE, 2011, APPL GEOGR, V31, P1, DOI 10.1016/j.apgeog.2010.06.005; Mosadeghi R, 2015, COMPUT ENVIRON URBAN, V49, P54, DOI 10.1016/j.compenvurbsys.2014.10.001; Mujabar PS, 2013, NAT HAZARDS, V69, P1295, DOI 10.1007/s11069-011-9962-x; Multi-purpose Cyclone Shelter Project (MCSP), 1993, MULT PURP CYCL SHELT; Murty T. S., 1992, Natural Hazards, V6, P251, DOI 10.1007/BF00129511; MURTY TS, 1986, PROG OCEANOGR, V16, P195, DOI 10.1016/0079-6611(86)90039-X; National Geospatial-Intelligence Agency, 2005, SHUTTL RAD TOP MISS; Nazeer M, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12050749; Nishat A., 2016, CLIMATE CHANGE CELL; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; ORTIZ CAC, 1994, OCEAN COAST MANAGE, V23, P249; Parvin Gulsan Ara, 2008, Journal of Coastal Conservation, V12, P181, DOI 10.1007/s11852-009-0044-0; Paul SK., 2013, J LIFE EARTH AGRIC S, V41, P1; Pramanik M.A.H., 1988, NAT DEV MAN 3 4 OCT; Prasetya G, 2007, PROTECTION COASTAL E; Quader MA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080831; Quasem M.A., 2001, BANGLADESH DEV STUD, V27, P105; Rahman M, 2019, EARTH SYST ENVIRON, V3, P585, DOI 10.1007/s41748-019-00123-y; Rangel-Buitrago N, 2020, OCEAN COAST MANAGE, V186, DOI 10.1016/j.ocecoaman.2020.105099; Rezaie AM, 2019, EXTREME HYDROCLIMATIC EVENTS AND MULTIVARIATE HAZARDS IN A CHANGING ENVIRONMENT: A REMOTE SENSING APPROACH, P317, DOI 10.1016/B978-0-12-814899-0.00013-4; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Roy S., 2016, PENNSYL GEOGRAPHER, V54, P20, DOI DOI 10.3390/IJGI1010003; Royo ML, 2016, J COASTAL RES, V32, P932, DOI 10.2112/JCOASTRES-D-14-00217.1; Ruane AC, 2013, GLOBAL ENVIRON CHANG, V23, P338, DOI 10.1016/j.gloenvcha.2012.09.001; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Saaty TL., 1980, ANAL HIERARCHY PROCE, P579; Saffarian S, 2020, HUM ECOL RISK ASSESS, V27, P1227, DOI 10.1080/10807039.2020.1816809; Salauddin M., 2018, ANN VALAHIA U TARGO, V18, P1, DOI 10.2478/avutgs-2018-0001; Saleem A, 2020, EARTH SYST ENVIRON, V4, P167, DOI 10.1007/s41748-019-00143-8; Sarwar M.G.M, 2005, THESIS LUND U SWED; Sarwar MGM, 2013, J COAST CONSERV, V17, P515, DOI 10.1007/s11852-013-0251-6; Senevirathna EMTK, 2018, PROCEDIA ENGINEER, V212, P1010, DOI 10.1016/j.proeng.2018.01.130; Singh O. P., 2002, MAR GEODES, V25, P205, DOI DOI 10.1080/01490410290051536; Singh OP, 2002, GLOBAL PLANET CHANGE, V32, P245, DOI 10.1016/S0921-8181(01)00152-7; SIURS, 2009, SPHER IND UN RESP ST; Tasnim KM, 2015, NAT HAZARDS, V75, P1619, DOI 10.1007/s11069-014-1387-x; Tragaki A, 2018, LAND-BASEL, V7, DOI 10.3390/land7020056; Tsoukala VK, 2015, ENVIRON PROCESS, V2, pS55, DOI 10.1007/s40710-015-0096-0; Uddin M.S., 2019, P INT C DIS RISK MAN; Un-SPIDER, 2020, KNOWL PORT SPAC BAS; UNDP, 2010, DIS RISK ASS; UNDRO, 1979, REPORT EXPERT GROUP; Villarroel-Lamb D, 2020, NAT HAZARDS REV, V21, DOI 10.1061/(ASCE)NH.1527-6996.0000388; Wen S., 2019, IOP C SERIES EARTH E; Wijitkosum S, 2019, WATER-SUI, V11, DOI 10.3390/w11050939; World Bank, 2009, IMPLICATIONS CLIMATE; Wu CC, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8121270; Yang X., 1999, JAG, V1, P146, DOI [10.1016/S0303-2434(99)85007-7, DOI 10.1016/S0303-2434(99)85007-7]; Yang XZ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205780; Yi LX, 2014, ENVIRON EARTH SCI, V71, P3109, DOI 10.1007/s12665-013-2689-0; Zhau Zhemg-T., 2018, SUSTAINABILITY-BASEL, V11, P1	139	4	5	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2212-4209			INT J DISAST RISK RE	Int. J. Disaster Risk Reduct.	JUL	2021	61								102364	10.1016/j.ijdrr.2021.102364	http://dx.doi.org/10.1016/j.ijdrr.2021.102364		JUN 2021	20	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geology; Meteorology & Atmospheric Sciences; Water Resources	SV9PU					2022-09-04	WOS:000664151200003
J	Gregorio-Chaviano, O; Repiso, R; Calderon-Rehecho, A; Leon-Marin, J; Jimenez-Contreras, E				Gregorio-Chaviano, Orlando; Repiso, Rafael; Calderon-Rehecho, Antonio; Leon-Marin, Joaquin; Jimenez-Contreras, Evaristo			Dialnet Metrics as a bibliometric evaluation tool: contributions to the analysis of the scientific activity in Social Sciences and Humanities	PROFESIONAL DE LA INFORMACION			Spanish	Article						Dialnet Metrics; Citation indexes; Bibliometrics; Indicators; Scientific evaluation; Rankings; Journals; Institutions; Researchers; Classifications; Collaboration; University libraries; Scientific information; Scholarly information; Academic information; Evaluation; Quality; Impact	JOURNALS; CLASSIFICATION	Within the current panorama of science evaluation, the limitations of citation indexes to study the social sciences and humanities have been the subject of wide debate. To resolve this situation, different products have been created for use in national contexts, since they cover certain aspects not contained in more international indices. An example is the In-RECS family, where an indicator such as the impact factor of Eugene Garfield is defined, but its contribution lies in the ability to evaluate research in Spain by obtaining citation indicators. This paper thus highlights the need to create new products for research evaluation in general, but particularly in the social sciences and humanities. The context in which different alternatives arise and are developed to evaluate existing journals is presented, along with Dialnet Metrics, a citation index developed by the Dialnet Foundation in collaboration with the EC3 Group and dozens of Spanish universities. Based on an analysis of the citations of source journals from different subject areas, Dialnet Metrics provides indicators to evaluate the research impact at different levels. This bibliometric product enables contextualized analysis at the micro (researchers), meso (journals), and macro (areas and universities) levels. Finally, the content, data volumes, and structure of this citation index are described quantitatively.	[Gregorio-Chaviano, Orlando] Pontificia Univ Javeriana, Fac Comunicac & Lenguaje, Dept Ciencia Informac, Transversal 4,42-00,Piso 6 Edif 67, Bogota, Colombia; [Repiso, Rafael] Univ Int La Rioja, Av La Paz 137, Logrono 26006, Spain; [Calderon-Rehecho, Antonio] Univ Complutense Madrid, Biblioteca, Edificio Multiusos,Ciudad Univ,Prof Aranguren S-N, Madrid 28040, Spain; [Leon-Marin, Joaquin] Univ La Rioja, Fdn Dialnet, Barriocepo 10, Logrono 26001, Spain; [Jimenez-Contreras, Evaristo] Univ Granada, Grp Invest EC3, Campus Cartuja S-N, Granada 18011, Spain		Gregorio-Chaviano, O (corresponding author), Pontificia Univ Javeriana, Fac Comunicac & Lenguaje, Dept Ciencia Informac, Transversal 4,42-00,Piso 6 Edif 67, Bogota, Colombia.	ogregorio@javeriana.edu.co; rafael.repiso@gmail.com; acaldero@urm.es; joaquin.leon@unirioja.es; evaristo@ugr.es	Jimenez, Evaristoo/ABF-8182-2021; Gregorio-Chaviano, Orlando/B-5480-2018	Gregorio-Chaviano, Orlando/0000-0002-3064-8639				Abejon-Pena Teresa, 2018, REV ESP DOC CIENT, V41, pE200; Aguado López Eduardo, 2008, Cienc. docencia tecnol., P11; Alperin Juan Pablo, 2017, Rev. Interam. Bibliot, V40, P231, DOI 10.17533/udea.rib.v40n3a04; Charum Jorge, 2004, REV CIENC SOC-VENEZ, V11, P293; Chavarro D, 2018, RES EVALUAT, V27, P106, DOI 10.1093/reseval/rvy001; Córdoba González Saray, 2017, E-Ciencias de la Información, V7, P54, DOI 10.15517/eci.v7i1.25713; Delgado-Lopez-Cozar Emilio, 2005, BIBLIO 3W REV BIBLIO, V10; Delgado-Lopez-Cozar Emilio, 2017, REVISTAS CIENTIFICAS, P73; Dialnet, 2020, DIALN METR DIALN METR; Garfield E, 1999, CAN MED ASSOC J, V161, P979; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Garfield E., 2003, INT J CLIN HLTH PSYC, V3, P363; Toledo EG, 2018, REV ESP DOC CIENT, V41, DOI 10.3989/redc.2018.3.1552; Gimenez-Toledo E, 2015, RELIEVE, V21, DOI 10.7203/relieve.21.1.5160; López López Wilson, 2018, Univ. Psychol., V17, P1; Martinez-Avila D, 2019, ANUARIO THINKEPI, V13, DOI 10.3145/thinkepi.2019.e13-01; Packer Abel-Laerte, 2006, EDICION ELECTRONICA, P191; Rodriguez-Gairin JM, 2011, PROF INFORM, V20, P589, DOI 10.3145/epi.2011.sep.15; Torres-Salinas Daniel, 2016, Anuario ThinkEPI, V10, P237, DOI 10.3145/thinkepi.2016.47; Torres-Salinas D, 2010, PROF INFORM, V19, P675, DOI 10.3145/epi.2010.nov.15; Torres-Salinas D, 2010, PROF INFORM, V19, P201, DOI 10.3145/epi.2010.mar.12; Vasen F, 2017, REV MEX CIENC POLIT, V62, P199, DOI 10.1016/S0185-1918(17)30043-0	22	0	0	5	12	 EDICIONES PROFESIONALES INFORMACION SL-EPI	BARCELONA	MISTRAL, 36, BARCELONA, ALBOLOTE, SPAIN	1386-6710	1699-2407		PROF INFORM	Prof. Inf.	MAY-JUN	2021	30	3							e300318	10.3145/epi.2021.may.18	http://dx.doi.org/10.3145/epi.2021.may.18			12	Communication; Information Science & Library Science	Social Science Citation Index (SSCI)	Communication; Information Science & Library Science	TC1OV		Bronze			2022-09-04	WOS:000668413600022
J	Benfield, AJ; Yu, ZC; Benavides, JC				Benfield, Adam J.; Yu, Zicheng; Benavides, Juan C.			Environmental controls over Holocene carbon accumulation in Distichia muscoides-dominated peatlands in the eastern Andes of Colombia	QUATERNARY SCIENCE REVIEWS			English	Article						Peatlands; Climate change; Paramo; Distichia muscoides; Carbon; Andes	INTERTROPICAL CONVERGENCE ZONE; WESTERN CORDILLERA; TROPICAL ANDES; CLIMATE-CHANGE; SIERRA-NEVADA; SOUTH-AMERICA; PEAT; DYNAMICS; LIMITS; AGE	The long-term carbon (C) and vegetation dynamics of tropical, high-Andean cushion peatlands are poorly understood. Here, we present radiocarbon-dated paleoecological records and modern microclimate data from high-elevation peatlands currently dominated by the cushion plant Distichia muscoides in the paramo (alpine tundra) of the eastern Colombian Andes. Focusing on a well-dated 4300-year-old peat core collected at 4194 m elevation from the Sierra Nevada del Cocuy, we investigated the response of peatland vegetation to hydroclimate changes and environmental controls on C accumulation. In addition, we carried out a regional synthesis of existing C accumulation data from northern Andean peatlands to place our new results in broad geographic and temporal context over the last 17,000 years. Our results show that the current Distichia-dominated peatlands are a recent landscape feature on El Cocuy occurring only during the last similar to 250 years. The Distichia peatlands have extremely high sediment accumulation rates of up to 1 cm yr(-1) and C accumulation rates between 183.7 and 849.5 g C m(-2) yr(-1), decreasing with the elevation of a site. These rates far exceed an expected modern C accumulation rate of 110 g C m(-2) yr(-1), calculated by extrapolating an exponential function from a late Holocene average C accumulation rate of 48.6 g C m(-2) yr(-1) for the northern Andes. This suggests that recent Distichia establishment represents an acceleration of C accumulation at a rate higher than expected from decomposition-related autogenic effects. Before the modern climate warming period, our record indicates that Distichia cushions have only grown intermittently, often after the peatland was flooded with mineral sediments. Mineral sediment deposits at 3290, 2590, 1620, 930, and 860 cal. yr BP correspond with wet intervals from lake-derived records of hydroclimate change in the northern Andes and indicate increases in precipitation and subsequent in-wash of mineral sediments. However, within the last 150 years, mineral sediment deposition has increased in frequency, likely due to warming-induced melting of permanent snow and ice mobilizing exposed fluvio-glacial sediments. Increased mineral nutrients, rising temperatures, and strong diurnal temperature contrast in the tropical mountains may explain the rapid C accumulation rates. Taken together, we show that Andean peatlands have experienced the largest shift in vegetation and C accumulation rates in the last 250 years than at any other time during the last 4000 years. (C) 2020 Elsevier Ltd. All rights reserved.	[Benfield, Adam J.; Yu, Zicheng] Lehigh Univ, Dept Earth & Environm Sci, Bethlehem, PA 18015 USA; [Benfield, Adam J.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Yu, Zicheng] Northeast Normal Univ, Sch Geog Sci, Changchun 130024, Jilin, Peoples R China; [Benavides, Juan C.] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota 11032, Colombia		Yu, ZC (corresponding author), Lehigh Univ, Dept Earth & Environm Sci, Bethlehem, PA 18015 USA.; Benfield, AJ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.; Benavides, JC (corresponding author), Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota 11032, Colombia.	ajbenfield@psu.edu; ziy2@lehigh.edu; jubenavides@javeriana.edu.co		Yu, Zicheng/0000-0003-2358-2712; Benavides, Juan/0000-0002-9694-2195	Lehigh University's Faculty Innovation Grant (FIG); Department of Earth and Environmental Sciences at Lehigh University; Javeriana University	Lehigh University's Faculty Innovation Grant (FIG); Department of Earth and Environmental Sciences at Lehigh University; Javeriana University	We thank A. Perez, C. Pulgarin, D. Cooper, D. Flett, D. Parra Carranza, D. Castro, E. Oyague, E. Avilan, E. Cubley, and V. Amigo for field assistance and discussion, N. Sturchio for 210Pb analysis, R. Booth, J. Stelling, Z. Xia, S. Peters, F. Pazzaglia, and D. Groff for discussion of this work, and D. Charman, and two anonymous reviewers for comments that greatly improved the manuscript. We thank the Parque Nacional Natural el Cocuy for access to the peatlands and for logistical assistance. We acknowledge the Keck-Carbon Cycle AMS facility at the University of California-Irvine for radiocarbon dating, the University of California-Davis Stable Isotope Facility for C and N isotope analysis, and the IDEAM for making climate and hydrological data available from the El Cocuy region. Landsat imagery used in Fig. 1B was downloaded from Earth Explorer (https://earthexplorer.usgs.gov/).This project was supported by Lehigh University's Faculty Innovation Grant (FIG) to Z. Yu and the Department of Earth and Environmental Sciences at Lehigh University. J.C. Benavides acknowledges the support of Javeriana University.	Angel I, 2017, CUAD INVESTIG GEOGR, V43, P571, DOI 10.18172/cig.3202; Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Benavides JC, 2014, MIRES PEAT, V15; Benavides JC, 2014, PLANT ECOL, V215, P937, DOI 10.1007/s11258-014-0346-7; Benavides JC, 2013, J GEOPHYS RES-BIOGEO, V118, P1627, DOI 10.1002/2013JG002419; Benfield A.J., 2019, THESIS; Bird BW, 2018, HOLOCENE, V28, P217, DOI 10.1177/0959683617721324; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Bosman A.F., 1994, HOLOCENE, V4, P233, DOI DOI 10.1177/095968369400400302; Buytaert W, 2006, EARTH-SCI REV, V79, P53, DOI 10.1016/j.earscirev.2006.06.002; Ceballos J.L., 2012, I HIDROLOGIA METEORO; Ceballos JL, 2006, ANN GLACIOL-SER, V43, P194, DOI 10.3189/172756406781812429; CHAMBERS FM, 2011, MIRES PEAT, V0007; Charman D., 2002, Peatlands and environmental change; Chimner RA, 2008, MIRES PEAT, V3, P1; Cleef A. M., 1981, DISSERTATIONES BOT, V61, P1; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Cooper DJ, 2015, ARCT ANTARCT ALP RES, V47, P505, DOI 10.1657/AAAR0014-060; Cooper DJ, 2010, ARCT ANTARCT ALP RES, V42, P19, DOI 10.1657/1938-4246-42.1.19; COOPER MA, 1995, AAPG BULL, V79, P1421; Coronel JS, 2004, ARCH SCI, V57, P85; Cruz FW, 2009, NAT GEOSCI, V2, P210, DOI 10.1038/NGEO444; Dangles O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175814; Dommain R, 2014, QUATERNARY SCI REV, V97, P1, DOI 10.1016/j.quascirev.2014.05.002; Earle LR, 2003, QUATERNARY RES, V59, P2, DOI 10.1016/S0033-5894(02)00011-X; Engel Z, 2014, QUATERNARY SCI REV, V99, P60, DOI 10.1016/j.quascirev.2014.06.019; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; Gallego-Sala AV, 2018, NAT CLIM CHANGE, V8, P907, DOI 10.1038/s41558-018-0271-1; Giraldo-Giraldo MJ, 2018, HOLOCENE, V28, P183, DOI 10.1177/0959683617721330; Gonzales P, 2016, B SOC ARGENT BOT, V51, P123, DOI 10.31055/1851.2372.v51.n1.14422; Gonzalez E.T., 1965, LEIDSE GEOLOGISCHE M, V32, P157; Gorham E, 2007, QUATERNARY SCI REV, V26, P300, DOI 10.1016/j.quascirev.2006.08.008; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hoyos I, 2018, CLIM DYNAM, V50, P971, DOI 10.1007/s00382-017-3653-6; Hribljan JA, 2014, MIRES PEAT, V15; Hribljan JA, 2016, WETL ECOL MANAG, V24, P113, DOI 10.1007/s11273-016-9482-2; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Hughes P.D.M., 2010, MIRES PEAT, V7, P1; Hunt S.J., 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584; Jomelli V, 2017, CUAD INVESTIG GEOGR, V43, P629, DOI 10.18172/cig.3201; Jomelli V, 2014, NATURE, V513, P224, DOI 10.1038/nature13546; Jones MC, 2010, P NATL ACAD SCI USA, V107, P7347, DOI 10.1073/pnas.0911387107; Kuhry P, 1996, ECOLOGY, V77, P271, DOI 10.2307/2265676; KUHRY P, 1988, REV PALAEOBOT PALYNO, V55, P19, DOI 10.1016/0034-6667(88)90053-X; Lahteenoja O, 2009, GLOBAL CHANGE BIOL, V15, P2311, DOI 10.1111/j.1365-2486.2009.01920.x; Ledru MP, 2013, CLIM PAST, V9, P307, DOI 10.5194/cp-9-307-2013; Liu B, 2019, QUATERNARY RES, V92, P14, DOI 10.1017/qua.2018.143; Loisel J., 2012, Biogeosciences, V9, P2737, DOI 10.5194/bg-9-2737-2012; Loisel J, 2014, HOLOCENE, V24, P1028, DOI 10.1177/0959683614538073; Loisel J, 2013, QUATERNARY SCI REV, V69, P125, DOI 10.1016/j.quascirev.2013.02.023; Loisel J, 2013, J GEOPHYS RES-BIOGEO, V118, P41, DOI 10.1029/2012JG001978; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; Morris PJ, 2018, P NATL ACAD SCI USA, V115, P4851, DOI 10.1073/pnas.1717838115; Munoz P, 2017, QUATERNARY SCI REV, V155, P159, DOI 10.1016/j.quascirev.2016.11.021; Notestein FB, 1932, GEOGR REV, V22, P423, DOI 10.2307/208972; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Payne RJ, 2019, QUATERNARY SCI REV, V212, P213, DOI 10.1016/j.quascirev.2019.03.022; Peterson LC, 2006, PALAEOGEOGR PALAEOCL, V234, P97, DOI 10.1016/j.palaeo.2005.10.021; Polissar PJ, 2013, P NATL ACAD SCI USA, V110, P14551, DOI 10.1073/pnas.1219681110; Poveda G, 2001, WATER RESOUR RES, V37, P2169, DOI 10.1029/2000WR900395; Poveda G, 2006, PALAEOGEOGR PALAEOCL, V234, P3, DOI 10.1016/j.palaeo.2005.10.031; Poveda G, 2011, CLIM DYNAM, V36, P2233, DOI 10.1007/s00382-010-0931-y; R Development Core Team, 2008, R LANG ENV STAT COMP; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rundel PW, 1994, TROPICAL ALPINE ENV; Schittek K, 2014, THESIS; SMITH AP, 1987, ANNU REV ECOL SYST, V18, P137, DOI 10.1146/annurev.ecolsys.18.1.137; Snow J. W., 1976, CLIMATES S CENTRAL A, P358; Stansell ND, 2014, QUATERNARY SCI REV, V89, P44, DOI 10.1016/j.quascirev.2014.01.021; Stuiver M., 2020, CALIB; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Treat CC, 2019, P NATL ACAD SCI USA, V116, P4822, DOI 10.1073/pnas.1813305116; VANDERHAMMEN T, 1981, PALAEOGEOGR PALAEOCL, V32, P247; Yu ZC, 2001, ECOL MODEL, V145, P159, DOI 10.1016/S0304-3800(01)00387-8; Yu ZC, 2009, GEOPHYS MONOGR SER, V184, P55, DOI 10.1029/2008GM000822	77	2	2	4	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-3791	1873-457X		QUATERNARY SCI REV	Quat. Sci. Rev.	JAN 1	2021	251								106687	10.1016/j.quascirev.2020.106687	http://dx.doi.org/10.1016/j.quascirev.2020.106687			19	Geography, Physical; Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physical Geography; Geology	PH9RD					2022-09-04	WOS:000600739300004
J	Eadie, A; Vasquez, IC; Liang, XF; Wang, XH; Souders, CL; El Chehouri, J; Hoskote, R; Feswick, A; Cowie, AM; Loughery, JR; Martyniuk, CJ				Eadie, Ashley; Vasquez, Isabel Cristina; Liang, Xuefang; Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Feswick, April; Cowie, Andrew M.; Loughery, Jennifer R.; Martyniuk, Christopher J.			Transcriptome network data in larval zebrafish (Danio rerio) following exposure to the phenylpyrazole fipronil	DATA IN BRIEF			English	Article; Data Paper						Environmental toxicology; Gene network; Neurotoxicity; Pesticide		Fipronil is a phenylpyrazole pesticide that is used in both residential and agricultural applications. Fipronil is detected in run-offand water systems that are near areas in which the pesticide has been applied. The pesticide acts to antagonize gamma aminobutyric acid receptors, leading to overexcitation in the central nervous system. Fipronil has relatively high toxicity to fish, but the mechanisms underlying the toxicity are not well understood in embryonic stages. Zebrafish embryos were exposed to a single concentration of fipronil for 48 h at similar to 3-4 h-post-fertilization. Following a 7-day depuration phase, transcriptome and behavioral analyses were conducted. Transcriptomics identified neural processes as those differentially expressed with different doses of fipronil (0.2 mu g, 200 mu g and 2 mg fipronil/L). Gene networks associated with astrocyte differentiation, myelination, neural tube development, brain stem response, innervation, nerve regeneration, astrocyte differentiation, among other pathways were altered with exposure. In addition, miRNA-related events are disrupted by fipronil exposure and genes associated with primary or pri-miRNA processing were increased in larval fish exposed to the pesticide. These data present putative mechanisms associated with neurological impacts at later ages of zebrafish. This is important because it is not clear how early exposure to pesticides like fipronil affect central nervous system function and organisms later in life. (c) 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)	[Eadie, Ashley; Feswick, April; Cowie, Andrew M.; Loughery, Jennifer R.; Martyniuk, Christopher J.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada; [Vasquez, Isabel Cristina] Pontificia Univ Javeriana, Fac Med, Dept Ciencias Fisiol, Bogota, Colombia; [Liang, Xuefang] Inner Mongolia Univ, Sch Ecol & Environm, Hohhot 010021, Inner Mongolia, Peoples R China; [Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32611 USA; [Wang, Xiaohong; Souders, Christopher L., II; El Chehouri, Jana; Hoskote, Rohit; Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Genet Inst,Interdisciplinary Program Biomed Sci N, Gainesville, FL 32611 USA; [Martyniuk, Christopher J.] Canadian Rivers Inst, St John, NB, Canada		Martyniuk, CJ (corresponding author), Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.; Martyniuk, CJ (corresponding author), Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32611 USA.; Martyniuk, CJ (corresponding author), Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Genet Inst,Interdisciplinary Program Biomed Sci N, Gainesville, FL 32611 USA.; Martyniuk, CJ (corresponding author), Canadian Rivers Inst, St John, NB, Canada.	cmartyn@ufl.edu	Eadie, Ashley/AAH-7415-2019	El Chehouri, Jana/0000-0001-5480-4862; Martyniuk, Christopher J./0000-0003-0921-4796; Vasquez Velez, Isabel Cristina/0000-0003-3744-6383	New Brunswick Research Assistantship Initiative grant from the New Brunswick Innovation Foundation [RAI 2015-080]; Canada Research Chair program; Natural Sciences and Engineering Research Council of Canada [386275-2010]	New Brunswick Research Assistantship Initiative grant from the New Brunswick Innovation Foundation; Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors have no conflict of interest to declare. This research was funded by a New Brunswick Research Assistantship Initiative grant from the New Brunswick Innovation Foundation (RAI 2015-080, CJM), Canada Research Chair program (CJM), and Natural Sciences and Engineering Research Council of Canada Discovery Grant (386275-2010, CJM).	Cowie AM, 2017, J PROTEOMICS, V157, P71, DOI 10.1016/j.jprot.2017.02.003; Eadie A, 2020, COMP BIOCHEM PHYS D, V36, DOI 10.1016/j.cbd.2020.100743; Martyniuk CJ, 2013, NEUROTOXICOLOGY, V34, P105, DOI 10.1016/j.neuro.2012.09.012; Oliveros J. C., 2007, INTERACTIVE TOOL COM	4	2	2	3	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	DEC	2020	33								106413	10.1016/j.dib.2020.106413	http://dx.doi.org/10.1016/j.dib.2020.106413			8	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	PH8JS	33134444	Green Published, gold			2022-09-04	WOS:000600652300080
J	Cardenas, P; Bartels, SM; Cruz, V; Gafaro, L; Uribe-Restrepo, JM; Torrey, WC; Castro, SM; Cubillos, L; Williams, MJ; Marsch, LA; Oviedo-Manrique, DG; Gomez-Restrepo, C				Cardenas, Paula; Bartels, Sophia M.; Cruz, Viviana; Gafaro, Lina; Uribe-Restrepo, Jose M.; Torrey, William C.; Castro, Sergio M.; Cubillos, Leonardo; Williams, Makeda J.; Marsch, Lisa A.; Oviedo-Manrique, Diana Goretty; Gomez-Restrepo, Carlos			Perspectives, Experiences, and Practices in the Use of Digital Information Technologies in the Management of Depression and Alcohol Use Disorder in Health Care Systems in Colombia	QUALITATIVE HEALTH RESEARCH			English	Article						implementation research; qualitative methods; Latin America; Colombia; technology; depression; alcohol; primary health care; qualitative	BARRIERS; INTERNET	Digital information technologies are increasingly used in the treatment of mental health disorders. Through this qualitative study, researchers illuminated perspectives, experiences, and practices among diverse stakeholders in the use of digital information technologies in the management of depression and alcohol use disorders in Colombia. In-depth interviews and focus groups were conducted in five primary care institutions across Colombia. Thematic analysis was used to analyze the data. The use of technology in the treatment of mental health disorders can facilitate the evaluation and diagnosis, treatment, and promotion and prevention of mental health disorders, as well as multiple nonmental health applications in the primary care setting. Potential barriers to the use of technology in this setting include challenges of digital literacy, access to technology, confidentiality, and financing. This study can inform the implementation of digital information technologies in the care of depression and problematic alcohol use within health care systems in Colombia.	[Cardenas, Paula; Cruz, Viviana; Gafaro, Lina; Castro, Sergio M.; Oviedo-Manrique, Diana Goretty; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Sch Med, Dept Epidemiol & Biostat, Bogota, Colombia; [Bartels, Sophia M.; Torrey, William C.; Cubillos, Leonardo; Marsch, Lisa A.] Dartmouth Coll, Geisel Sch Med, Ctr Technol & Behav Hlth, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Uribe-Restrepo, Jose M.; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Sch Med, Dept Psychiat & Mental Hlth, Bogota, Colombia; [Torrey, William C.] Dartmouth Coll, Geisel Sch Med, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Cubillos, Leonardo] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA; [Cubillos, Leonardo; Williams, Makeda J.] NIMH, Global Mental Hlth Effectiveness Res, Ctr Global Mental Hlth Res, Bethesda, MD 20892 USA; [Gomez-Restrepo, Carlos] Hosp Univ San Ignacio, Bogota, Colombia		Bartels, SM (corresponding author), Dartmouth Coll, Geisel Sch Med, Ctr Technol & Behav Hlth, EverGreen Ctr, 46 Centerra Pkwy,Suite 315, Lebanon, NH 03766 USA.	sophiamariebartels@gmail.com		Bartels, Sophia/0000-0002-9431-8735; Castro Diaz, Sergio/0000-0001-6820-8711; Uribe Restrepo, Jose Miguel/0000-0003-4284-7886; Gomez-Restrepo, Carlos/0000-0002-9013-5384	National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) [1U19MH109988]	National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was funded by the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) under Award Number 1U19MH109988 (Multiple Principal Investigators: Lisa A. Marsch, PhD and Carlos Gomez-Restrepo, MD). The contents are solely the opinion of the authors and do not necessarily represent the views of the NIH or the United States Government.	Andreassen HK, 2006, QUAL HEALTH RES, V16, P238, DOI 10.1177/1049732305284667; Arboleda M. A., 2010, ONLINE PSYCHIAT TELE; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Belendez M, 2010, ACCION PSICOL, V7, P17; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Campo-Arias Adalberto, 2014, rev.colomb.psiquiatr., V43, P177, DOI 10.1016/j.rcp.2014.07.003; Chaskel Roberto, 2015, BJPsych Int, V12, P95; Chevalier S., 2018, SHARE INDIVIDUALS WH; Dilkes-Frayne E, 2019, QUAL HEALTH RES, V29, P2010, DOI 10.1177/1049732319838231; Garay Fernández Javier D, 2011, rev.colomb.psiquiatr., V40, P504; Gilgun J.F., 2019, SAGE HDB CURRENT DEV, P107; Gómez-Restrepo Carlos, 2003, rev.colomb.psiquiatr., V32, P130; Guest G.S., 2011, APPL THEMATIC ANAL; Huang YH, 2009, LECT NOTES COMPUT SC, V5614, P361, DOI 10.1007/978-3-642-02707-9_41; Hyler Steven E, 2004, J Psychiatr Pract, V10, P272, DOI 10.1097/00131746-200407000-00011; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Levitt H. M., 2017, QUAL PSYCHOL, V4, P2, DOI [10.1037/qup0000082, DOI 10.1037/QUP0000082]; Marin-Torres V, 2013, ATEN PRIM, V45, P46, DOI 10.1016/j.aprim.2012.09.004; Marsch LA, 2013, J DUAL DIAGN, V9, P101, DOI 10.1080/15504263.2012.750105; McDonald N., 2018, WE ARE SOCIAL; Ministerio de Salud y Proteccion Social, 2012, 10 PUBL HLTH PLAN 20; Ministerio de Tecnologias de la Informacion y las Comunicaciones, 2017, 75 COL US INT YEAR; Ministerio de Telcnologias de la Informacion y las Comunicaciones, 2017, TIC TRIM B DAT 1 TRI; Naslund JA, 2017, LANCET PSYCHIAT, V4, P486, DOI 10.1016/S2215-0366(17)30096-2; National Institute of Mental Health, 2017, TECHN FUT MENT HLTH; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; NVivo, 2018, QUALITATIVE DATA ANA; Pan American Health Organization, 2012, GLOB MENT HLTH DAY D; Pan American Health Organization & World Health Organization, 2016, IMPL GLOB ACT PROGR; Pontificia Universidad Javeriana, 2016, RES MENT HLTH DARTM; Posada-Villa José A., 2004, rev.colomb.psiquiatr., V33, P241; Puerto G. A. S., 2016, REV CUB INFORM CIENC, V27, P271; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Statista Research Department, 2015, INT US PEN COL 2013; Valimaki M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007198.pub2; Vargas I, 2016, HEALTH POLICY PLANN, V31, P736, DOI 10.1093/heapol/czv126; Whitebird RR, 2013, QUAL HEALTH RES, V23, P805, DOI 10.1177/1049732313482399; World Health Organization, 2011, 2010 REP GLOB SIT NO; World Health Organization, 2017, MENT ILLN; World Health Organization, 2004, INV MENT HLTH	40	4	4	2	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	MAY	2020	30	6					906	916	1049732320902460	10.1177/1049732320902460	http://dx.doi.org/10.1177/1049732320902460		FEB 2020	11	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	LF0PQ	32054418	Green Accepted			2022-09-04	WOS:000513404000001
J	De Aquino, JP; Parida, S; Avila-Quintero, VJ; Flores, J; Compton, P; Hickey, T; Gomez, O; Sofuoglu, M				De Aquino, Joao P.; Parida, Suprit; Avila-Quintero, Victor J.; Flores, Jose; Compton, Peggy; Hickey, Thomas; Gomez, Oscar; Sofuoglu, Mehmet			Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies	DRUG AND ALCOHOL DEPENDENCE			English	Review						Opioid addiction; Antinociception; Drug development; Pain tolerance; Opioids	CHRONIC POSTSURGICAL PAIN; PERIOPERATIVE MANAGEMENT; MAINTENANCE PATIENTS; POSTOPERATIVE PAIN; SEARCH STRATEGIES; CROSS-TOLERANT; REMIFENTANIL; SENSITIVITY; MODELS; HYPERALGESIA	Background: Treating acute pain among persons with opioid use disorder (OUD) on opioid agonist therapy (OAT) is complex, and the therapeutic benefits of opioids remain unclear when weighted against their abuse potential and respiratory depressant effects. Methods: We conducted a systematic review of experimental pain studies examining opioid-induced analgesia among persons with OUD on OAT. We searched multiple databases from inception to July 30, 2021. Study quality was assessed by previously established validity measures. Results: Nine studies were identified, with a total of 225 participants, of whom 63% were male, and 37% were female. Six studies included methadone-maintained persons with OUD; four studies included buprenorphinemaintained persons with OUD; and three studies included healthy persons as comparison groups. Either additional doses of OAT or other opioids - morphine, oxycodone, hydromorphone, or remifentanil - were administered. In seven studies, persons with OUD on OAT did not experience analgesia, despite receiving opioid doses up to 20 times greater than those clinically used to treat severe pain among the opioid naive. Conversely, in two studies, high-potency opioids did produce analgesia, albeit with greater abuse potential. Notably, persons with OUD on OAT remained vulnerable to respiratory depression. Conclusions: Although persons with OUD on OAT can derive analgesic effects from opioids, high-potency compounds may be required to achieve clinically significant pain relief. Further, persons with OUD on OAT may remain vulnerable to opioid-induced abuse potential and respiratory depression. Together, these finding have clinical, methodological, and mechanistic implications for the treatment of acute pain in the context of OAT.	[De Aquino, Joao P.; Parida, Suprit; Hickey, Thomas; Sofuoglu, Mehmet] VA Connecticut Healthcare Syst, 950 Campbell Ave,Bldg 36-116A4, West Haven, CT 06516 USA; [De Aquino, Joao P.; Parida, Suprit; Avila-Quintero, Victor J.; Flores, Jose; Sofuoglu, Mehmet] Yale Univ, Sch Med, Dept Psychiat, 300 George St, New Haven, CT 06511 USA; [Compton, Peggy] Univ Penn, Dept Family & Community Hlth, 418 Curie Blvd,Room 402, Philadelphia, PA 19104 USA; [Hickey, Thomas] Yale Univ, Sch Med, Dept Anesthesiol, 333 Cedar St, New Haven, CT 06520 USA; [Gomez, Oscar] Pontificia Univ Javeriana, Fac Med, Dept Physiol Sci, 7th St,46-62, Bogota, Colombia		De Aquino, JP (corresponding author), VA Connecticut Healthcare Syst, 950 Campbell Ave,Bldg 36-116A4, West Haven, CT 06516 USA.	joao.deaquino@yale.edu	Gómez, Oscar/AAG-2646-2020	Gómez, Oscar/0000-0001-5987-013X; Gomez, O/0000-0003-4183-9876				Aasvang E, 2005, BRIT J ANAESTH, V95, P69, DOI 10.1093/bja/aei019; Acampora GA, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19com12810; Agin-Liebes G, 2021, DRUG ALCOHOL DEPEN, V226, DOI 10.1016/j.drugalcdep.2021.108869; Alford DP, 2006, ANN INTERN MED, V144, P127, DOI 10.7326/0003-4819-144-2-200601170-00010; Anderson TA, 2017, ANESTHESIOLOGY, V126, P1180, DOI 10.1097/ALN.0000000000001633; Arendt-Nielsen L, 2007, CURR OPIN INVEST DR, V8, P41; Arout CA, 2015, CNS DRUGS, V29, P465, DOI 10.1007/s40263-015-0255-x; Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2; Athanasos P, 2006, PAIN, V120, P267, DOI 10.1016/j.pain.2005.11.005; Athanasos P, 2019, PAIN MED, V20, P119, DOI 10.1093/pm/pny025; Bryson EO, 2014, CURR OPIN ANESTHESIO, V27, P359, DOI 10.1097/ACO.0000000000000052; Bryson Ethan O, 2010, Anesthesiol Clin, V28, P611, DOI 10.1016/j.anclin.2010.08.005; Buresh M, 2020, J GEN INTERN MED, V35, P3635, DOI 10.1007/s11606-020-06115-3; Burkle H, 1996, ANESTH ANALG, V83, P646, DOI 10.1097/00000539-199609000-00038; Carusone SC, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0285-7; Chang AK, 2013, ANN EMERG MED, V62, P304, DOI 10.1016/j.annemergmed.2013.02.023; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Coluzzi F, 2017, THER CLIN RISK MANAG, V13, P1163, DOI 10.2147/TCRM.S141332; Comelon M, 2016, BRIT J ANAESTH, V116, P524, DOI 10.1093/bja/aev547; Comer S.D., 2018, NEUROSCI BIOBEHAV R; Compton P, 2000, J PAIN SYMPTOM MANAG, V20, P237, DOI 10.1016/S0885-3924(00)00191-3; Compton PA, 2020, CLIN J PAIN, V36, P667, DOI 10.1097/AJP.0000000000000855; Conley KM, 1997, PSYCHOPHARMACOLOGY, V131, P313, DOI 10.1007/s002130050298; Cornett EM, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0783-z; da Cunha Brooke Faria, 2015, Medsurg Nurs, V24, P4; De Aquino J.P., CLIN DRUG INVEST, P1; De Aquino JP, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.12964; Doverty M, 2001, PAIN, V93, P155, DOI 10.1016/S0304-3959(01)00306-2; Eckhardt K, 1998, PAIN, V76, P27, DOI 10.1016/S0304-3959(98)00021-9; Edwards RR, 2016, PAIN MED, V17, P1882, DOI 10.1093/pm/pnw010; Elman I, 2016, NEURON, V89, P11, DOI 10.1016/j.neuron.2015.11.027; Ene KW, 2008, J CLIN NURS, V17, P2042, DOI 10.1111/j.1365-2702.2008.02278.x; Freye Enno, 2005, J Opioid Manag, V1, P162; GLASS PSA, 1993, ANESTH ANALG, V77, P1031; Goel A, 2019, BRIT J ANAESTH, V123, pE333, DOI 10.1016/j.bja.2019.03.044; Greenwald MK, 2014, DRUG ALCOHOL DEPEN, V144, P1, DOI 10.1016/j.drugalcdep.2014.07.035; Haber LA, 2019, J HOSP MED, V14, P633, DOI 10.12788/jhm.3265; Hausner E, 2015, J CLIN EPIDEMIOL, V68, P191, DOI 10.1016/j.jclinepi.2014.09.016; Hausner E, 2016, J CLIN EPIDEMIOL, V77, P118, DOI 10.1016/j.jclinepi.2016.05.002; Hay JL, 2008, EUR J PAIN, V12, P926, DOI 10.1016/j.ejpain.2007.12.012; Huhn AS, 2019, ANESTHESIOLOGY, V130, P131, DOI 10.1097/ALN.0000000000002492; Jonan AB, 2018, PAIN PHYSICIAN, V21, pE1; Kadic AJ, 2016, J CLIN EPIDEMIOL, V74, P119, DOI 10.1016/j.jclinepi.2016.01.002; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Kornfeld H, 2010, AM J THER, V17, P523, DOI 10.1097/MJT.0b013e3181be0804; Koster J., 2004, PUBMED PUBREMINER TO; LEVINE J, 1983, BRAIN RES, V289, P391, DOI 10.1016/0006-8993(83)90049-5; Macintyre PE, 2013, ANAESTH INTENS CARE, V41, P222, DOI 10.1177/0310057X1304100212; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Martinez-Calderon J., 2021, J PAIN; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mercadante S, 1996, ANN ONCOL, V7, P613; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Murnion BP, 2020, PAIN MED, V21, P1188, DOI 10.1093/pm/pnz178; Myers J, 2018, PAIN MED, V19, P1908, DOI 10.1093/pm/pnx277; Nielsen S, 2019, J SUBST ABUSE TREAT, V104, P128, DOI 10.1016/j.jsat.2019.07.002; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Parida S, 2019, EXPERT REV CLIN PHAR, V12, P791, DOI 10.1080/17512433.2019.1635454; Paschkis Z, 2015, AM J NURS, V115, P24, DOI 10.1097/01.NAJ.0000471243.30951.92; Patanwala AE, 2010, ANN PHARMACOTHER, V44, P1800, DOI 10.1345/aph.1P438; Peng PWH, 2005, CAN J ANAESTH, V52, P513, DOI 10.1007/BF03016532; Quaye A.N.-A., 2018, PAIN MED; Quaye A, 2020, PAIN MED, V21, P1955, DOI 10.1093/pm/pnaa020; Reddy KSK, 2012, J RES MED SCI, V17, P587; S. National Library of Medicine, 2021, MESH DEM; Scott LJ, 2005, DRUGS, V65, P1793, DOI 10.2165/00003495-200565130-00007; Smith SM, 2015, J PAIN, V16, P299, DOI 10.1016/j.jpain.2015.01.004; Sofuoglu M., 2019, PSYCHIATRIC RES CLIN, V1, P4, DOI [10.1176/appi.prcp.20180006, DOI 10.1176/APPI.PRCP.20180006]; Stromer W, 2013, EUR J ANAESTH, V30, P55, DOI 10.1097/EJA.0b013e32835b822b; Trafton JA, 2004, DRUG ALCOHOL DEPEN, V73, P23, DOI 10.1016/j.drugalcdep.2003.08.007; WALLENSTEIN SL, 1990, PAIN, V41, P5, DOI 10.1016/0304-3959(90)91102-O; Williams AR, 2019, AM J DRUG ALCOHOL AB, V45, P1, DOI 10.1080/00952990.2018.1546862; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	75	1	1	6	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	NOV 1	2021	228								109097	10.1016/j.drugalcdep.2021.109097	http://dx.doi.org/10.1016/j.drugalcdep.2021.109097		OCT 2021	10	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	WL1TV	34601272				2022-09-04	WOS:000710197200016
J	Gomez, SA; Martinez-Cajas, JL; Mueses, HF; Alvarado-Llano, B; Galindo, X; Camargo, P; Martinez, E; Torres, J; Arrivillaga, M				Gomez, S. A.; Martinez-Cajas, J. L.; Mueses, H. F.; Alvarado-Llano, B.; Galindo, X.; Camargo, P.; Martinez, E.; Torres, J.; Arrivillaga, M.			What do HIV clinic administrators think about PrEP implementation in Colombia? A qualitative CFIR guided study	JOURNAL OF THE INTERNATIONAL AIDS SOCIETY			English	Meeting Abstract									[Gomez, S. A.; Arrivillaga, M.] Pontificia Univ Javeriana, Cali, Colombia; [Martinez-Cajas, J. L.; Alvarado-Llano, B.; Camargo, P.] Queens Univ, Kingston, ON, Canada; [Mueses, H. F.; Galindo, X.] Corp Lucha Sida, Cali, Colombia; [Mueses, H. F.; Galindo, X.; Martinez, E.] Red VIH Col, Cali, Colombia; [Martinez, E.] Univ Valle, Cali, Colombia; [Torres, J.] Montefiore Med Ctr, New York, NY USA				Arrivillaga, Marcela/L-2786-2016	Arrivillaga, Marcela/0000-0001-5927-3386					0	0	0	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND		1758-2652		J INT AIDS SOC	J. Int. AIDS Soc.	FEB	2021	24			1	SI	PE01.60LB								1	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	QK9ZN					2022-09-04	WOS:000620738900164
J	Borda, M; Reyes-Ortiz, CA; Sonnesyn, H; Arsland, D				Borda, M.; Reyes-Ortiz, C. A.; Sonnesyn, H.; Arsland, D.			Disability variation among older adults with dementia	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 02-04, 2019	Portland, OR	Amer Geriatr Soc					[Reyes-Ortiz, C. A.] UTHSC Houston, Internal Med Geriatr Palliat Med, Houston, TX USA; [Borda, M.; Sonnesyn, H.; Arsland, D.] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Borda, M.] Pontificia Univ Javeriana, Sch Med, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Arsland, D.] Kings Coll London, Dept Old Age Psychiat, London, England				Borda, Miguel German/AHB-5593-2022; Borda, Miguel Germán/AAK-9029-2020	Borda, Miguel German/0000-0001-5832-0603; Borda, Miguel Germán/0000-0001-5832-0603					0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2019	67			1	SI	C227	S255	S255						1	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Geriatrics & Gerontology	HR4WU					2022-09-04	WOS:000463149000740
J	Rodriguez, JC; Gomez, D; Pacetti, D; Nunez, O; Gagliardi, R; Frega, NG; Ojeda, ML; Loizzo, MR; Tundis, R; Lucci, P				Rodriguez, Juanita C.; Gomez, Daniela; Pacetti, Deborah; Nunez, Oscar; Gagliardi, Riccardo; Frega, Natale G.; Ojeda, Myriam L.; Loizzo, Monica R.; Tundis, Rosa; Lucci, Paolo			Effects of the Fruit Ripening Stage on Antioxidant Capacity, Total Phenolics, and Polyphenolic Composition of Crude Palm Oil from Interspecific Hybrid Elaeis oleifera x Elaeis guineensis	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						ripening; interspecific hybrid palm; phenols; dietary antioxidants; HPLC-ESI-MS/MS	VIRGIN OLIVE OIL; CULTIVAR; HARVEST; ACID; MATURATION; TESTS; POWER; PEEL; TIME; PULP	In the present study, we assessed for the first time the changes in the antioxidant capacity, total phenolic content, and polyphenolic composition of interspecific hybrid palm oil extracted from Elaeis oleifera X Elaeis guineensis (O X G, Coari X La Me cultivar) during the fruit ripening process 18, 20, 22, and 24 weeks after anthesis. A progressive decrease (p < 0.05) of phenolic content occurred during fruit development together with marked changes in polyphenol profiles. Significant negative correlations were established between antioxidant activity measured by TEAC (R = -0.954; p < 0.05) and ORAC (R = -0.745; p < 0.05) and the fruit ripening stage, while a positive correlation between total phenolic content was found using either the TEAC assay or the ORAC assay. The highest DPPH radical scavenging activity was also obtained with oils extracted at 18 WAA. These results highlight that O X G fruits of early ripeness represent a better source of phenolic compounds and may provide extracts with higher antioxidant activities when hybrid palm oil is aimed to be used as a functional ingredient for the development of food or food products with antioxidant properties.	[Rodriguez, Juanita C.; Gomez, Daniela; Ojeda, Myriam L.] Pontificia Univ Javeriana, Dept Nutr & Biochem, Fac Sci, Bogota, Colombia; [Pacetti, Deborah; Gagliardi, Riccardo; Frega, Natale G.] Polytech Univ Marche, Dept Agr Food & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy; [Nunez, Oscar] Univ Barcelona, Dept Analyt Chem, Marti & Franques 1-11, Barcelona 08028, Spain; [Nunez, Oscar] Univ Barcelona, Res Inst Food Nutr & Food Safety INSA, Barcelona, Spain; [Loizzo, Monica R.; Tundis, Rosa] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [Lucci, Paolo] Univ Udine, Dept Food Sci, Via Sondrio 2-A, I-33100 Udine, Italy		Lucci, P (corresponding author), Univ Udine, Dept Food Sci, Via Sondrio 2-A, I-33100 Udine, Italy.	paololucci2001@yahoo.it	Núñez, Oscar/D-7912-2014; Rodríguez, Juanita Carolina Rodríguez/AAJ-1685-2021; Ojeda-Arredondo, Myriam Lucia/J-8752-2015	Núñez, Oscar/0000-0001-5850-8972; Ojeda-Arredondo, Myriam Lucia/0000-0001-9961-4050; Rodriguez-Rodriguez, Juanita-Carolina/0000-0001-9458-5983	Universidad Pontificia Javeriana (Bogota - Colombia) [5626]; Young Investigator Award from Colciencias, Bogota, Colombia; Spanish Ministry of Economy and Competitiveness [CTQ2012-30836]; Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain) [2014 SGR-539]	Universidad Pontificia Javeriana (Bogota - Colombia); Young Investigator Award from Colciencias, Bogota, Colombia; Spanish Ministry of Economy and Competitiveness(Spanish Government); Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain)	We acknowledge the project "Effect of Fruit Ripening on Fatty Acids Regiodistribution and Glycerides Molecular Species of Oil from Interspecific Hybrid Elaeis oleifera x E. guineensis Grown in Colombia" [project ID 5626 - Universidad Pontificia Javeriana (Bogota - Colombia)] and the Hacienda La Cabana (Bogota - Colombia) for their donation of oil samples. Juanita C. Rodriguez was supported by a Young Investigator Award from Colciencias, Bogota, Colombia. We are also grateful to the Spanish Ministry of Economy and Competitiveness (project CTQ2012-30836) and to the Agency for Administration of University and Research Grants (Generalitat de Catalunya, Spain) (Project 2014 SGR-539). O.N. is a Serra Hunter Fellow, Generalitat de Catalunya, Spain.	Amira E, 2012, J AGR FOOD CHEM, V60, P10896, DOI 10.1021/jf302602v; [Anonymous], 2004, REV PALMAS; Atawodi S. E., 2011, International Journal of Biology, V3, P153; Baccouri O, 2008, FOOD CHEM, V109, P743, DOI 10.1016/j.foodchem.2008.01.034; Beltran G, 2005, FOOD CHEM, V89, P207, DOI 10.1016/j.foodchem.2004.02.027; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bouaziz M, 2004, J AGR FOOD CHEM, V52, P5476, DOI 10.1021/jf0497004; Chakraborty M, 2006, BIOCHEM SYST ECOL, V34, P509, DOI 10.1016/j.bse.2005.11.011; Christodouleas DC, 2014, TALANTA, V130, P233, DOI 10.1016/j.talanta.2014.06.058; D'Angelo S, 2007, J AGR FOOD CHEM, V55, P9977, DOI 10.1021/jf071773a; Dag A, 2011, SCI HORTIC-AMSTERDAM, V127, P358, DOI 10.1016/j.scienta.2010.11.008; DAS NP, 1990, J AM OIL CHEM SOC, V67, P255, DOI 10.1007/BF02540652; Dey G, 2005, J PLANT PHYSIOL, V162, P375, DOI 10.1016/j.jplph.2004.08.006; Eid NMS, 2013, J AGR FOOD CHEM, V61, P2453, DOI 10.1021/jf303951e; el Amira A, 2012, J AGR FOOD CHEM, V60, P10896, DOI DOI 10.1021/JF302602V; Fraga CG, 2014, BBA-GEN SUBJECTS, V1840, P931, DOI 10.1016/j.bbagen.2013.06.030; Franco MN, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.051513; Ghasemnezhad M, 2011, J FUNCT FOODS, V3, P44, DOI 10.1016/j.jff.2011.02.002; Hassimotto NMA, 2005, J AGR FOOD CHEM, V53, P2928, DOI 10.1021/jf047894h; Hormaza P, 2012, SCI AGR, V69, P275, DOI 10.1590/S0103-90162012000400007; Huang CL, 2008, J AM COLL SURGEONS, V207, P407, DOI 10.1016/j.jamcollsurg.2008.02.018; Ilahy R, 2011, J FOOD COMPOS ANAL, V24, P588, DOI 10.1016/j.jfca.2010.11.003; Jaganath I.B., 2010, PLANT PHENOLICS HUMA, V1, P1; Jemai H, 2009, J AGR FOOD CHEM, V57, P2961, DOI 10.1021/jf8034176; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Loizzo MR, 2015, PLANT FOOD HUM NUTR, V70, P331, DOI 10.1007/s11130-015-0498-1; Loizzo MR, 2012, J FOOD COMPOS ANAL, V25, P179, DOI 10.1016/j.jfca.2011.09.002; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; Lucci P, 2016, FOOD FUNCT, V7, P347, DOI [10.1039/C5FO01083G, 10.1039/c5fo01083g]; Lucci P, 2015, EUR J LIPID SCI TECH, V117, P1027, DOI 10.1002/ejlt.201400599; Lucci P, 2015, FOOD CHEM, V167, P475, DOI 10.1016/j.foodchem.2014.06.123; Mennella G, 2012, J AGR FOOD CHEM, V60, P11821, DOI 10.1021/jf3037424; Rincon SM, 2013, IND CROP PROD, V49, P204, DOI 10.1016/j.indcrop.2013.04.035; Minioti KS, 2010, GRASAS ACEITES, V61, P45, DOI 10.3989/gya.010508; MONTEDORO G, 1992, J AGR FOOD CHEM, V40, P1571, DOI 10.1021/jf00021a019; Morello JR, 2004, J AGR FOOD CHEM, V52, P6002, DOI 10.1021/jf035300p; Mozzon M, 2015, J AM OIL CHEM SOC, V92, P717, DOI 10.1007/s11746-015-2628-1; Mozzon M, 2013, FOOD CHEM, V141, P245, DOI 10.1016/j.foodchem.2013.03.016; Neo YP, 2008, INT J FOOD SCI TECH, V43, P1832, DOI 10.1111/j.1365-2621.2008.01717.x; Neo YP, 2010, FOOD CHEM, V122, P353, DOI 10.1016/j.foodchem.2010.02.046; Ninfali P, 2001, J AM OIL CHEM SOC, V78, P243, DOI 10.1007/s11746-001-0252-9; Prada F., 2012, REV PALMAS, V33, P25; Preciado C. A., 2011, CORPOICA CIENC TECNO, V12, P5; Prior R. L., 2013, AM J BIOMEDICAL SCI, V5, P126, DOI DOI 10.5099/AJ130200126; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Prior RL, 2000, J AOAC INT, V83, P950; Puigventos L, 2015, ANAL BIOANAL CHEM, V407, P597, DOI 10.1007/s00216-014-8298-2; Quinones M, 2012, NUTR HOSP, V27, P76, DOI [10.3305/nh.2012.27.1.5418, 10.1590/S0212-16112012000100009]; Rey L., 2004, PALMAS, V25, P39; RIVERA MÉNDEZ YURANY DAYANNA, 2013, Acta biol.Colomb., V18, P465; Roleira FMF, 2015, FOOD CHEM, V183, P235, DOI 10.1016/j.foodchem.2015.03.039; Sanchez CS, 2007, ANAL CHIM ACTA, V593, P103, DOI 10.1016/j.aca.2007.04.037; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Stockham K, 2011, J FOOD COMPOS ANAL, V24, P686, DOI 10.1016/j.jfca.2010.11.007; Van Dyck S., 2004, 3 EUR LIP C EXP OILS; Yoo KM, 2008, FOOD CHEM, V106, P929, DOI 10.1016/j.foodchem.2007.07.006; Yorulmaz A, 2013, J AM OIL CHEM SOC, V90, P647, DOI 10.1007/s11746-013-2210-7; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zambrano J. E., 2004, REV PALMAS, V25, P339; Zujko ME, 2014, INT J FOOD PROP, V17, P86, DOI 10.1080/10942912.2011.614984	60	18	18	1	44	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	FEB 3	2016	64	4					852	859		10.1021/acs.jafc.5b04990	http://dx.doi.org/10.1021/acs.jafc.5b04990			8	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Chemistry; Food Science & Technology	DC9QX	26752619	Green Accepted, Green Submitted			2022-09-04	WOS:000369557200015
J	Ortega-Lara, A; Milani, N; DoNascimiento, C; Villa-Navarro, F; Maldonado-Ocampo, JA				Ortega-Lara, Armando; Milani, Nadia; DoNascimiento, Carlos; Villa-Navarro, Francisco; Alejandro Maldonado-Ocampo, Javier			Two new trans-Andean species of Imparfinis Eigenmann & Norris, 1900 (Siluriformes: Heptapteridae) from Colombia	NEOTROPICAL ICHTHYOLOGY			English	Article						Andes; Imparfinis lineatus; Imparfinis nemacheir; Imparfinis spurrellii; Neotropical catfishes		Two new species of Imparfinis are described from the trans-Andean region of Colombia. Imparfinis timana is diagnosed by having longer anal fin base (12.4-15.5% in SL), in combination with long adipose fin (24.6-31.3% in SL), 5-6 gill rakers on the first ceratobranchial, 42-43 vertebrae and additional measurements. Imparfinis usmai is distinguished by the combination of first ray of dorsal fin longest, but not projected as a long filament, long adipose fin (21.1-27.0% in SL), maxillary barbel exceeding pelvic-fin base, 39-40 vertebrae, upper caudal-fin lobe pointed and longer than lower lobe, lower lobe rounded, 7-8 gill rakers on the first ceratobranchial, as well as additional measurements. Imparfinis timana is only known from rio Guarapas, a small tributary of the upper course of the rio Magdalena. Imparfinis usmai is broadly distributed in the upper basin of rios Cauca and Magdalena, and in the lower Pat a river basin. The restricted distribution of I. nemacheir to trans-Andean drainages (Atrato, Magdalena, and Lago de Maracaibo) is also discussed.	[Ortega-Lara, Armando] Fdn Invest & Desarrollo Sostenible FUNINDES, Bogota, Colombia; [Milani, Nadia] Cent Univ Venezuela, Inst Biomed, Fac Med, Caracas 1041A, Venezuela; [Milani, Nadia] Cent Univ Venezuela, Lab Biosistemat Peces, Inst Zool Trop, Fac Ciencias, Caracas 1041A, Venezuela; [DoNascimiento, Carlos] Univ Carabobo, Dept Biol, Fac Expt Ciencias & Tecnol, Valencia 2005, Venezuela; [Villa-Navarro, Francisco] Univ Tolima, Grp Invest Zool, Fac Ciencias, Ibague, Colombia; [Villa-Navarro, Francisco] Univ Nacl Colombia, Programa Doctorado Ciencias Biol, Inst Ciencias Nat, Fac Ciencias, Bogota, Colombia; [Alejandro Maldonado-Ocampo, Javier] Pontificia Univ Javeriana, Dept Biol, Fac Ciencias, Bogota, Colombia		Ortega-Lara, A (corresponding author), Fdn Invest & Desarrollo Sostenible FUNINDES, Trv 76C 81H-20, Bogota, Colombia.	ictiologo@hotmail.com; nadia.milani@ciens.ucv.ve; cdonascimiento@uc.edu.ve; favilla@ut.edu.co; gymnopez@gmail.com	DoNascimiento, Carlos/W-2661-2019	DoNascimiento, Carlos/0000-0002-8680-7942; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X	US National Science Foundation [NSF DEB-0315963]; Programa de Inventarios of Instituto Alexander von Humboldt; WWF Colombia; Comite Central de Investigaciones of Universidad del Tolima; Laboratorio de Ictiologia of Universidad de Antioquia; Instituto para la Investigacion y la Preservacion del Patrimonio Cultural y Natural del Valle del Cauca - INCIVA; FMNH; ANSP; TWAS-CNPq	US National Science Foundation(National Science Foundation (NSF)); Programa de Inventarios of Instituto Alexander von Humboldt; WWF Colombia; Comite Central de Investigaciones of Universidad del Tolima; Laboratorio de Ictiologia of Universidad de Antioquia; Instituto para la Investigacion y la Preservacion del Patrimonio Cultural y Natural del Valle del Cauca - INCIVA; FMNH; ANSP; TWAS-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The All Catfish Species Inventory Project (NSF DEB-0315963), a five year grant supported by the US National Science Foundation, funded this work through research grants to AOL and JAMO. Additional financial support for field work was provided by Programa de Inventarios of Instituto Alexander von Humboldt; WWF Colombia; Comite Central de Investigaciones of Universidad del Tolima; Laboratorio de Ictiologia of Universidad de Antioquia and Instituto para la Investigacion y la Preservacion del Patrimonio Cultural y Natural del Valle del Cauca - INCIVA. CD received a Visitor Scholarship Grant from FMNH and a Bohlke Memorial Endowment Fund from ANSP to visit ichthyological collections of each respective institution. JAMO is grateful to TWAS-CNPq Postgraduate Fellowships program for support during this project. We thank the following individuals and institutions for hospitality during visits, loans of specimens and other assistance: J. Lundberg, M. Sabaj-Perez and K. Luckenbill (ANSP), K. Swagel, M. A. Rogers, P. Willink and M. Littmann (FMNH); J. Bogota-Gregory (IAvH); J. Mojica, G. Galvis and M. Arce (ICN-MHN); F. Provenzano (MBUCV); D. Taphorn and O. Castillo (MCNG); K. Hartel (MCZ); C. Lasso, O. Lasso-Alcala, K. Gonzalez and J. Hernandez-Acevedo (MHNLS). M. Littmann and the Division of Fishes of FMNH kindly allowed the reproduction of the photograph of the holotype of Nannorhamdia nemacheir, available at All Catfish Species Inventory Image Base website (http://acsi.acnatsci.org/base/index.html). M. Littmann and F. Provenzano critically read a draft of the manuscript and offered valuable suggestions. M. Quiroga-Carmona kindly helped us with the translation from the German of the original description of Imparfinis hasemani. Finally we want to recognize the invaluable contribution of the Biodiversity Heritage Library (http://www.biodiversitylibrary.org/), for making freely available the universal knowledge of biodiversity, allowing us to have direct access to all original descriptions reviewed, dating from late nineteenth and first half of twentieth century's.	Almironi A, 2007, REV SUISSE ZOOL, V114, P817, DOI 10.5962/bhl.part.80416; Bockmann F.A., 1998, THESIS U SAO PAULO S; Bockmann F.A., 2003, CHECK LIST FRESHWATE, P406; BOCKMANN FA, 1994, P BIOL SOC WASH, V107, P760; Bockmann FA, 2008, ZOOTAXA, P1; Bogota-Gregory Juan David, 2006, Biota Colombiana, V7, P55; Bussing W. A., 1970, Contr. Sci., VNo. 196, P1; Dahl G., 1971, PECES NORTE COLOMBIA; Eigenmann C. H., 1922, Memoirs of the Carnegie Museum, V9, P1; EIGENMANN CH, 1916, ANN CARNEGIE MUS, V10, P77; Eigenmann CH, 1900, REV MUS PAULISTA, V4, P349; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Galvis G, 2007, PECES ORINOQUIA COLO; Galvis G., 2007, PECES AMAZONIA COLOM; GALVIS G, 1997, PECES CATATUMBO; Galvis G, 2006, SERIE GUIAS TROPICAL, V5; L?tken C.F., 1875, KONGELIGE DANSKE VID, V5, P1; Lasso C, 2003, MEM FUND LA SALLE CS, V159-169, P105; Lasso C. A., 2005, BIOTA COLOMBIANA, V5, P95; LEVITON AE, 1985, COPEIA, P802; Lundberg J.G., 1986, NOTULAE NATURAE, V463, P1; Maldonado-Ocampo J. A., 2006, BIOTA COLOMBIANA, V7, P141; Maldonado-Ocampo J.A., 2005, PECES ANDES COLOMBIA; Maldonado-Ocampo Javier Alejandro, 2006, Biota Colombiana, V7, P113; Mees G.F., 1974, Zoologische Verh Leiden, VNo. 132, P1; MEES GF, 1989, P K NED AKAD C BIOL, V92, P379; Milani N., 2005, MEM 8 S COL ICT, P55; Mojica Jose Ivan, 2005, Biota Colombiana, V6, P191; Mojica Jose Ivan, 2006, Biota Colombiana, V7, P23; Mojica-C. Jose Ivan, 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P547; Ortega Hernan, 2006, Biota Colombiana, V7, P95; Ortega-Lara A., 2000, PECES CUENCA CAUCA R; Ortega-Lara Armando, 2006, Biota Colombiana, V7, P39; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Ruiz-C. R. I., 2006, Animal Biodiversity and Conservation, V29, P123; Schultz Leonard P., 1944, PROC U S NATION MUS, V94, P173; Silfvergrip A. M., 1996, SYSTEMATIC REVISION; TAYLOR W R, 1985, Cybium, V9, P107; Vari Richard P., 2005, Neotrop. ichthyol., V3, P127, DOI 10.1590/S1679-62252005000200001; Villa-Navarro Francisco Antonio, 2006, Biota Colombiana, V7, P3; Zuanon J, 2006, NEOTROP ICHTHYOL, V4, P107, DOI 10.1590/S1679-62252006000100012	41	6	7	0	5	SOC BRASILEIRA ICTIOLOGIA	SAO PAULO	UNIV SAO PAULO, DEPT FISIOLOGIA-IB, RUA DO MATAO, TRAVESSA 14 N 321, SAO PAULO, SP 05508-900, BRAZIL	1679-6225			NEOTROP ICHTHYOL	Neotrop. Ichthyol.	DEC 26	2011	9	4					777	793		10.1590/S1679-62252011000400009	http://dx.doi.org/10.1590/S1679-62252011000400009			17	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	875XQ		Green Published, gold, Green Submitted			2022-09-04	WOS:000299068900009
J	Jensen, AB; Wynne, C; Ramirez, G; Antje, L; Nina, O; Mehta, A; Wang, H; He, W; Song, Y; Berd, Y; Lombardi, A				Jensen, A. B.; Wynne, C.; Ramirez, G.; Antje, L.; Nina, O.; Mehta, A.; Wang, H.; He, W.; Song, Y.; Berd, Y.; Lombardi, A.			Suppression of bone resorption from odanacatib, a cathepsin K inhibitor, in women with bone metastases from breast cancer, and the effect of concomitant anti-neoplastic treatment on efficacy: a 4-week, double-blind, randomized controlled trial.	CANCER RESEARCH			English	Meeting Abstract	31st Annual San Antonio Breast Cancer Symposium	DEC 10-14, 2008	San Antonio, TX						Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Christchurch Clin Studies Trust, Christchurch, New Zealand; Javeriana Univ, Bogota, Colombia; Johannes Gutenberg Univ Mainz, Mainz, Germany; Azienda Osped Sassari, Sassari, Italy; Merck Res Labs, Rahway, NJ USA										0	0	0	0	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472			CANCER RES	Cancer Res.	JAN 15	2009	69	2					153S	154S						2	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	396HQ					2022-09-04	WOS:000262583200286
J	Vivert, M; Diez, R; Cousineau, M; Cobaleda, DB; Patino, D; Ladoux, P				Vivert, Miguel; Diez, Rafael; Cousineau, Marc; Bernal Cobaleda, Diego; Patino, Diego; Ladoux, Philippe			Real-Time Adaptive Selective Harmonic Elimination for Cascaded Full-Bridge Multilevel Inverter	ENERGIES			English	Article						multilevel inverter; selective harmonic elimination; polynomial transform; newton-raphson method; closed-loop system	MINIMIZATION; THD	Selective Harmonics Elimination is a high-efficiency modulation method for multilevel inverters that allows handling very high voltage applications. It eliminates the most significant harmonics and fixes the desired fundamental component. The main issue of these techniques is the complex process to obtain the appropriate switching-angles, being necessary to calculate them offline, meaning that if some disturbances occur, the system will not be compensated. This article proposes a real-time selective harmonic elimination for a single-phase cascaded multilevel inverter. The control strategy maintains constant the fundamental component of the output voltage while removing its third, fifth, and seventh order harmonics. The switching-angles are dynamically adapted to compensate for variations in the input voltage and the load. This is done by obtaining a virtual dynamic system using Groebner basis, an adaptation of the Newton-Raphson method, and implementing a digital PI controller into the virtual dynamical model. This adaptive modulation technique is validated experimentally in a 200 W, 9-levels Cascaded Full Bridge Inverter, canceling the harmonics and regulating the fundamental components in all the tests. The developed theory can be adapted or extended for any multilevel inverter modulated by selective harmonic elimination.	[Vivert, Miguel] Univ Tecn Norte, Fac Ciencias Aplicada FICA, Carrera Ingn Elect CIELE, Ibarra 100105, Ecuador; [Vivert, Miguel] IKERGUNE AIE, Elgoibar 20870, Spain; [Diez, Rafael; Patino, Diego] Pontificia Univ Javeriana, Dept Elect Engn, Bogota 110231, Colombia; [Cousineau, Marc; Ladoux, Philippe] Univ Toulouse, Dept Elect Elect Energy & Automat, ENSEEIHT Engn Sch, LAPLACE,CNRS,Toulouse INP,UPS, 3 Rue Charles Camichel, F-31071 Toulouse, France; [Bernal Cobaleda, Diego] KU Leuven EnergyVille Diepenbeek, Elect Engn Dept ESAT, B-3001 Genk, Belgium		Vivert, M (corresponding author), Univ Tecn Norte, Fac Ciencias Aplicada FICA, Carrera Ingn Elect CIELE, Ibarra 100105, Ecuador.; Vivert, M (corresponding author), IKERGUNE AIE, Elgoibar 20870, Spain.	mevivert@utn.edu.ec; rdiez@javeriana.edu.co; cousineau@laplace.univ-tlse.fr; diego.bernal@kuleuven.be; patino-d@javeriana.edu.co; philippe.ladoux@laplace.univ-tlse.fr		Vivert, Miguel/0000-0003-2279-2304; LADOUX, Philippe/0000-0002-2697-8707; Diez, Rafael/0000-0002-8107-2844; Bernal Cobaleda, Diego/0000-0001-8771-1128; cousineau, marc/0000-0002-2797-365X	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion" of the Ecuadorian Government (SENESCYT) [8859]	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion" of the Ecuadorian Government (SENESCYT)	The authors would like to thank the "Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion" of the Ecuadorian Government (SENESCYT) that supported this study with the contract no: 8859.	Ahmed M, 2017, IEEE J EM SEL TOP P, V5, P1700, DOI 10.1109/JESTPE.2017.2746760; Alolah A. I., 1988, IEEE Transactions on Power Electronics, V3, P399, DOI 10.1109/63.17960; Cobaleda DB, 2019, INT C POWER ELECT DR; Cousineau M., 2015, P 2015 IEEE ENERGY C, p4343 4350, DOI [10.1109/ECCE.2015.7310274, DOI 10.1109/ECCE.2015.7310274]; Cox D, 1992, IDEALS VARIETIES ALG, DOI [10.1007/978-1-4757-2181-2, DOI 10.1007/978-1-4757-2181-2]; Edpuganti A, 2015, IEEE T IND APPL, V51, P4212, DOI 10.1109/TIA.2015.2437351; Fabre J., 2016, P 2016 INT C EL SYST, P1, DOI [10.1109/ESARS-ITEC.2016.7841371, DOI 10.1109/ESARS-ITEC.2016.7841371]; Fabre J, 2017, IEEE T IND APPL, V53, P5820, DOI 10.1109/TIA.2017.2747498; Fabre J, 2016, IEEE T IND APPL, V52, P1669, DOI 10.1109/TIA.2015.2496109; Haghdar K, 2018, IEEE T IND INFORM, V14, P3124, DOI 10.1109/TII.2018.2790931; Huang QY, 2018, IEEE J EM SEL TOP P, V6, P2192, DOI 10.1109/JESTPE.2018.2817183; Kavousi A, 2012, IEEE T POWER ELECTR, V27, P1689, DOI 10.1109/TPEL.2011.2166124; Lal R., 2017, ALGEBRA 2 LINEAR ALG; Liu Y, 2008, IEEE T IND ELECTRON, V55, P1014, DOI 10.1109/TIE.2007.909072; Liu Y, 2009, IEEE T IND ELECTRON, V56, P2249, DOI 10.1109/TIE.2009.2015360; Luo FL, 2013, ARTECH HOUSE ANTENNA, P137; Negash M.F., 1847, P INT C ELECT ELECT, P1852, DOI [10.1109/ICEEOT.2016.7755008, DOI 10.1109/ICEEOT.2016.7755008]; Proakis J.G., 2006, DIGIT SIGNAL PROCESS, V4th ed.; Routray A, 2019, IEEE T IND INFORM, V15, P4407, DOI 10.1109/TII.2018.2883050; Sahoo SK, 2018, IEEE T POWER ELECTR, V33, P513, DOI 10.1109/TPEL.2017.2669084; Sahu N, 2017, 2017 NATIONAL POWER ELECTRONICS CONFERENCE (NPEC), P325, DOI 10.1109/NPEC.2017.8310479; Sharifzadeh M, 2019, IEEE T POWER ELECTR, V34, P86, DOI 10.1109/TPEL.2018.2812186; Srndovic M, 2018, IEEE T IND APPL, V54, P1532, DOI 10.1109/TIA.2017.2775178; Vivert M., 2019, P PCIM EUR 2019 INT, P1; Yang KH, 2019, IEEE T POWER ELECTR, V34, P8201, DOI 10.1109/TPEL.2018.2881448; Yang KH, 2017, IEEE T POWER ELECTR, V32, P1579, DOI 10.1109/TPEL.2016.2548080; Yang KH, 2016, IEEE T POWER ELECTR, V31, P2742, DOI 10.1109/TPEL.2015.2447555; Yang KH, 2015, IEEE T POWER ELECTR, V30, P6581, DOI 10.1109/TPEL.2014.2388077; Zhao H, 2016, IEEE T POWER ELECTR, V31, P1000, DOI 10.1109/TPEL.2015.2413898	29	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1996-1073		ENERGIES	Energies	MAY	2022	15	9							2995	10.3390/en15092995	http://dx.doi.org/10.3390/en15092995			15	Energy & Fuels	Science Citation Index Expanded (SCI-EXPANDED)	Energy & Fuels	1E6HV		gold			2022-09-04	WOS:000794588100001
J	Guzman, M; Knight, S; Quintero, S; Ramirez, S; Rueda, C; Valencia, F				Guzman, Michell; Knight, Sophia; Quintero, Santiago; Ramirez, Sergio; Rueda, Camilo; Valencia, Frank			Reasoning about distributed information with infinitely many agents	JOURNAL OF LOGICAL AND ALGEBRAIC METHODS IN PROGRAMMING			English	Article						Reasoning about groups; Distributed knowledge; Infinitely many agents; Reasoning about space; Mathematical morphology; Algebraic modeling	COMMON KNOWLEDGE; CORE	Spatial constraint systems (scs) are semantic structures for reasoning about spatial and epistemic information in concurrent systems. We develop the theory of scs to reason about the distributed information of potentially infinite groups. We characterize the notion of distributed information of a group of agents as the infimum of the set of join-preserving functions that represent the spaces of the agents in the group. We provide an alternative characterization of this notion as the greatest family of join-preserving functions that satisfy certain basic properties. For completely distributive lattices, we establish that the distributed information of c amongst a group is the greatest lower bound of all possible combinations of information in the spaces of the agents in the group that derive c. We show compositionality results for these characterizations and conditions under which information that can be obtained by an infinite group can also be obtained by a finite group. Finally, we provide an application to mathematical morphology where dilations, one of its fundamental operations, define an scs on a powerset lattice. We show that distributed information represents a particular dilation in such scs. (C) 2021 Elsevier Inc. All rights reserved.	[Ramirez, Sergio; Rueda, Camilo; Valencia, Frank] Pontificia Univ Javeriana, Dept Elect & Comp Sci, Cali, Colombia; [Valencia, Frank] LIX Ecole Polytech Paris, CNRS, Paris, France; [Knight, Sophia] Univ Minnesota, Duluth, MN 55812 USA; [Guzman, Michell; Quintero, Santiago] LIX Ecole Polytech Paris, Paris, France; [Guzman, Michell] Fortiss Res Inst Free State Bavaria, Munich, Germany		Valencia, F (corresponding author), LIX Ecole Polytech Paris, CNRS, Paris, France.	guzman@fortiss.org; sknight@d.umn.edu; squinter@lix.polytechnique.fr; sergio@javerianacali.edu.co; crueda@javerianacali.edu.co; frank.valencia@lix.polytechnique.fr	; Knight, Sophia/S-2269-2017	Ramirez, Sergio/0000-0003-2879-831X; Knight, Sophia/0000-0001-6203-1505; Quintero, Santiago/0000-0003-4008-5697	ECOS-NORD project FACTS [C19M03]	ECOS-NORD project FACTS	This work has been partially supported by the ECOS-NORD project FACTS (C19M03).	Abramsky S., 1994, HDB LOGIC COMPUTER S, p1s168; Alvim MS, 2019, LECT NOTES COMPUT SC, V11760, P419, DOI 10.1007/978-3-030-31175-9_24; Aristizabal A, 2011, LECT NOTES COMPUT SC, V6604, P138, DOI 10.1007/978-3-642-19805-2_10; Ash R, 2007, BASIC ABSTRACT ALGEB; AUMANN RJ, 1976, ANN STAT, V4, P1236, DOI 10.1214/aos/1176343654; Bellin G, 2014, LOG METH COMPUT SCI, V10, DOI 10.2168/LMCS-10(3:16)2014; Belmonte G, 2019, LECT NOTES COMPUT SC, V11427, P281, DOI 10.1007/978-3-030-17462-0_16; Bergmann G., 1956, J SYMBOLIC LOGIC, V21, P257; Birkhoff G., 1948, LATTICE THEORY; Blackburn P., 2001, MODAL LOGIC; Bloch I, 2007, HANDBOOK OF SPATIAL LOGICS, P857, DOI 10.1007/978-1-4020-5587-4_14; Chagrov A.V., 1997, MODAL LOGIC OXFORD L, V35; Davey B.A., 2002, INTRO LATTICES ORDER, V2nd ed.; DEBOER FS, 1995, THEOR COMPUT SCI, V151, P37, DOI 10.1016/0304-3975(95)00047-Z; DEBREU G, 1963, INT ECON REV, V4, P235, DOI 10.2307/2525306; Dummit DS., 2003, ABSTRACT ALGEBRA; ESTEBAN JM, 1994, ECONOMETRICA, V62, P819, DOI 10.2307/2951734; Fagin Ronald, 1995, REASONING KNOWLEDGE; Frittella S, 2016, J LOGIC COMPUT, V26, P1961, DOI 10.1093/logcom/exu063; Geanakoplos J., 1994, HDB GAME THEORY EC A, V2, P1437; Gierz G., 2003, CONTINUOUS LATTICES; Gilboa I., 1998, TARK, P43; Goldblatt R., 2000, LOG J IGPL, V8, P393, DOI [10.1093/jigpal/8.4.393, DOI 10.1093/JIGPAL/8.4.393]; Gratzer G., 1958, P AM MATH SOC, V9, P722; Guzman M., 2016, OASICS, V52; Guzman M., 30 INT C CONC THEOR; Guzman M., 2018, THEOR COMPUT SCI, V744; guzman maria constanza, 2020, MAPPING SPACES TRANS; Guzman M, 2016, LECT NOTES COMPUT SC, V9965, P214, DOI 10.1007/978-3-319-46750-4_13; Haar S, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL SYMPOSIUM ON PRINCIPLES AND PRACTICE OF DECLARATIVE PROGRAMMING (PPDP 2015), P161, DOI 10.1145/2790449.2790520; Halpern JY, 2004, INFORM COMPUT, V191, P1, DOI 10.1016/j.ic.2004.01.003; HALPERN JY, 1990, J ACM, V37, P549, DOI 10.1145/79147.79161; HALPERN JY, 1987, ANNU REV COMPUT SCI, V2, P37, DOI 10.1146/annurev.cs.02.060187.000345; He W, 2017, THEOR ECON, V12, P771, DOI 10.3982/TE1647; Hendricks V., 2008, STANFORD ENCY PHILOS; HILDENBRAND W, 1970, J ECON THEORY, V2, P161, DOI 10.1016/0022-0531(70)90003-7; Hildenbrand W., 1974, CORE EQUILIBRIA LARG; Hintikka J., 1962, KNOWLEDGE BELIEF; Johnstone P., 1982, CAMBRIDGE STUDIES AD; Jonsson Bjarni, 1951, AM J MATH, V73, P891, DOI [10.2307/2372123, DOI 10.2307/2372123]; Knight S., 2020, IN PRESS; Knight S, 2012, LECT NOTES COMPUT SC, V7454, P317, DOI 10.1007/978-3-642-32940-1_23; Maibaum T.S.E., 1995, HDB LOGIC COMPUTER S, V3; McKinsey JCC, 1944, ANN MATH, V45, P141, DOI 10.2307/1969080; McLean R, 2005, GAME ECON BEHAV, V50, P58, DOI 10.1016/j.geb.2004.06.005; Munkres J.R., 1974, TOPOLOGY 1 COURSE; Najman L., 2013, MATH MORPHOLOGY THEO; Palmigiano A.A., 2013, ARXIV PREPRINT ARXIV; Parikh R, 2007, HANDBOOK OF SPATIAL LOGICS, P299, DOI 10.1007/978-1-4020-5587-4_6; Popkorn S, 1994, 1 STEPS MODAL LOGIC; Quintero S, 2020, LECT NOTES COMPUT SC, V12062, P253, DOI 10.1007/978-3-030-43520-2_16; RONSE C, 1990, SIGNAL PROCESS, V21, P129, DOI 10.1016/0165-1684(90)90046-2; Rueda C, 2004, SOFT COMPUT, V8, P641, DOI 10.1007/S00500-004-0390-7; Rueda C., 2016, J LOG ALGEBRAIC METH; SARASWAT VA, 1990, CONFERENCE RECORD OF THE SEVENTEENTH ANNUAL ACM SYMPOSIUM ON PRINCIPLES OF PROGRAMMING LANGUAGES, P232; SARASWAT VA, 1991, POPL, P333, DOI DOI 10.1145/99583.99627; Schneider R, 2014, ENCYCLOP MATH APPL, V151; SERRA J, 1986, COMPUT VISION GRAPH, V35, P283, DOI 10.1016/0734-189X(86)90002-2; Serra J., 2012, MATH MORPHOLOGY ITS; Valencia F., 2019, EPTCS, V300, P39; van Ditmarsch H., 2015, HDB EPISTEMIC LOGIC; van Ditmarsch H, 2019, SYNTHESE, V196, P2927, DOI 10.1007/s11229-017-1592-8; Vickers S., 1996, TOPOLOGY VIA LOGIC; Zelenyuk V, 2015, EUR J OPER RES, V240, P269, DOI 10.1016/j.ejor.2014.06.038	64	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2208	2352-2216		J LOG ALGEBR METHODS	J. Log. Algebr. Methods Program	JUN	2021	121								100674	10.1016/j.jlamp.2021.100674	http://dx.doi.org/10.1016/j.jlamp.2021.100674		MAR 2021	35	Computer Science, Theory & Methods; Logic	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Science & Technology - Other Topics	SF8RZ					2022-09-04	WOS:000653017200002
J	Restrepo, CS; Gonzalez, TV; Brar, R; Ocazionez, D; Velasco, ML; Lopez, RAR; Arias, L; Baxi, AJ; Carrillo, J				Restrepo, Carlos S.; Gonzalez, Tomas, V; Brar, Rahat; Ocazionez, Daniel; Velasco, Marta Lucia; Reyna Lopez, Rolando A.; Arias, Liliana; Baxi, Ameya J.; Carrillo, Jorge			Thoracic Cardiovascular Complications of Tuberculosis	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						cardiovascular complications; tuberculosis; pericarditis; aortitis; myocarditis; endocarditis		Mycobacterium infection remains a leading cause of morbidity and mortality worldwide. Although rare, thoracic cardiovascular complications are associated with devastating consequences if not promptly diagnosed using computed tomography. Intrapulmonary complications include tuberculous aortitis, Rasmussen aneurysms, involvement of bronchial and nonbronchial systemic arteries, and thromboembolic events. Extrapulmonary complications include pericarditis, myocarditis, endocarditis, involvement of coronary arteries, annular-subvalvular left ventricle aneurysms and mediastinal fibrosis. This article will review these complications and their computed tomography features.	[Restrepo, Carlos S.; Gonzalez, Tomas, V; Baxi, Ameya J.] Univ Texas Hlth San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Brar, Rahat] Fortis Hosp Mohali, Mohali, Punjab, India; [Ocazionez, Daniel] UT Hlth Houston, Houston, TX USA; [Velasco, Marta Lucia] Clin Shaio, Bogota, Colombia; [Reyna Lopez, Rolando A.] Hosp Santo Tomas, Panama City, Panama; [Arias, Liliana] Pontificia Univ Javeriana, Bogota, Colombia; [Carrillo, Jorge] Univ Nacl Colombia, Bogota, Colombia		Baxi, AJ (corresponding author), Univ Texas Hlth San Antonio, 7703 Floyd Curl Dr Mail Code 7800, San Antonio, TX 78229 USA.	baxi@uthscsa.edu	Brar, Rahat/ABC-6720-2021	Brar, Rahat/0000-0002-1814-792X; Gonzalez, Tomas/0000-0003-3518-7832; Restrepo, Carlos/0000-0002-4722-3741				Aebert H, 2003, J THORAC CARDIOV SUR, V125, P411, DOI 10.1067/mtc.2003.130; AI-Jandali F, 2017, INT J MYCOBACT, V6, P111, DOI [10.4103/ijmy.ijmy_9_17, 10.4103/ijmy.ijmy_9_l7]; Al-Nasser I, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-60; BALI HK, 1990, AM HEART J, V120, P703, DOI 10.1016/0002-8703(90)90036-W; BARNARD PJ, 1956, BRIT HEART J, V18, P309; Bertog SC, 2004, J AM COLL CARDIOL, V43, P1445, DOI 10.1016/j.jacc.2003.11.048; Bikdeli B, 2010, THROMB RES, V125, P478, DOI 10.1016/j.thromres.2010.01.014; Bischof Johanna Elisabeth, 2015, Am J Respir Crit Care Med, V192, pe1, DOI 10.1164/rccm.201502-0384IM; Boedefeld RL, 2008, J HEART LUNG TRANSPL, V27, P1176, DOI 10.1016/j.healun.2008.07.009; Brar R., 2010, EUR J RADIOL EXTRA, V74, pE47; Bruzzi JF, 2006, RADIOGRAPHICS, V26, P3, DOI 10.1148/rg.261045726; Bukhary ZA, 2006, ANN SAUDI MED, V26, P56, DOI 10.5144/0256-4947.2006.56; Cantinotti M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-359; CATINELLA FP, 1988, ANN THORAC SURG, V45, P87, DOI 10.1016/S0003-4975(10)62405-8; Chatterjee K, 2015, RESPIR MED CASE REP, V16, P74, DOI 10.1016/j.rmcr.2015.08.003; Chen RFC, 2005, CIRC J, V69, P458, DOI 10.1253/circj.69.458; Cherian G, 2004, ANGIOLOGY, V55, P431, DOI 10.1177/000331970405500410; Cho WC, 2013, J CARDIAC SURG, V28, P563, DOI 10.1111/jocs.12168; COPE AP, 1990, J INFECTION, V21, P293, DOI 10.1016/0163-4453(90)94029-Y; Couture T, 2014, ANN THORAC SURG, V98, P2234, DOI 10.1016/j.athoracsur.2014.08.011; Darwish Y, 1998, ANGIOLOGY, V49, P151, DOI 10.1177/000331979804900208; Delaval L, 2017, J VASC SURG, V66, P209, DOI 10.1016/j.jvs.2016.11.045; Dentan C, 2014, CLIN INFECT DIS, V58, P495, DOI 10.1093/cid/cit780; Dixit Rashmi, 2009, Indian J Radiol Imaging, V19, P57, DOI 10.4103/0971-3026.45347; Do KH, 2001, RADIOGRAPHICS, V21, P387, DOI 10.1148/radiographics.21.2.g01mr06387; du Toit-Prinsloo L, 2016, CARDIOVASC PATHOL, V25, P271, DOI 10.1016/j.carpath.2016.03.003; Glaveckaite S, 2013, EUR HEART J-CARD IMG, V14, P322, DOI 10.1093/ehjci/jes211; Gleason JB, 2016, CHEST, V150, pE99, DOI 10.1016/j.chest.2016.02.655; Golzarian J, 1999, TEX HEART I J, V26, P232; Gowda RM, 2003, ANGIOLOGY, V54, P469, DOI 10.1177/000331970305400411; Grigoratos C, 2014, EUR HEART J-CARD IMG, V15, P522, DOI 10.1093/ehjci/jet250; Gude MJL, 2006, J HEART LUNG TRANSPL, V25, P128, DOI 10.1016/j.healun.2005.07.013; Gulati GS, 2008, CLIN RADIOL, V63, P605, DOI 10.1016/j.crad.2007.09.002; Gupta M, 2013, CAN ASSOC RADIOL J, V64, P61, DOI 10.1016/j.carj.2011.08.002; HAGEMAN JH, 1964, NEW ENGL J MED, V270, P327, DOI 10.1056/NEJM196402132700702; Hashmani S., 2016, BMJ CASE REP, V2016, P1; Hu Y, 2016, CHINESE MED J-PEKING, V129, P2697, DOI 10.4103/0366-6999.193457; Ivkovic S., 2014, EUR RESPIR J, V44, pP2631; Jagia P, 2004, PEDIATR RADIOL, V34, P904, DOI 10.1007/s00247-004-1222-8; Jain AK, 2007, SPINE J, V7, P249, DOI 10.1016/j.spinee.2006.04.021; Jeilan M, 2008, CIRCULATION, V117, P984, DOI 10.1161/CIRCULATIONAHA.107.691766; Kamen L, 1895, BEITR PATHOL, V17, P416; Kandachar P, 2014, ANN THORAC SURG, V98, pE81, DOI 10.1016/j.athoracsur.2014.06.091; KAPOOR OP, 1973, AM HEART J, V86, P334, DOI 10.1016/0002-8703(73)90042-2; Karmakar S, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.81293; Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839; KINARE SG, 1971, CHEST, V60, P613, DOI 10.1378/chest.60.6.613; Kolhari VB., 2013, BMJ CASE REP, V2013, P1; KRISHNASWAMI H, 1984, THORAX, V39, P550, DOI 10.1136/thx.39.7.550; Labrousse L, 2007, J VASC SURG, V46, P786, DOI 10.1016/j.jvs.2007.05.038; LARRIEU AJ, 1980, ANN THORAC SURG, V29, P464, DOI 10.1016/S0003-4975(10)61681-5; 윤지영, 2011, [Journal of the Korean Society of Radiology (JKSR), 대한영상의학회지], V65, P563; Lee S, 2015, INFECT CHEMOTHER, V47, P261, DOI 10.3947/ic.2015.47.4.261; Lin HC, 2015, CIRCULATION, V132, P1154, DOI 10.1161/CIRCULATIONAHA.115.015311; Lin MM, 2012, INTERNAL MED, V51, P1983, DOI 10.2169/internalmedicine.51.7690; Lin YY, 2012, ANN THORAC SURG, V94, P1235, DOI 10.1016/j.athoracsur.2012.05.002; Liu A, 2013, INT J CARDIOL, V167, P640, DOI 10.1016/j.ijcard.2012.08.009; Liu A, 2012, TUBERCULOSIS, V92, P307, DOI 10.1016/j.tube.2012.02.002; Liu TX, 2018, CLIN RESPIR J, V12, P1974, DOI 10.1111/crj.12766; Long R, 1999, CHEST, V115, P522, DOI 10.1378/chest.115.2.522; Loureiro R, 2009, CIRCULATION, V120, pE285, DOI 10.1161/CIRCULATIONAHA.108.782177; Manika K, 2017, RESPIR MED CASE REP, V21, P30, DOI 10.1016/j.rmcr.2017.03.010; Giraldo-Montoya AM, 2018, INT J INFECT DIS, V69, P8, DOI 10.1016/j.ijid.2018.01.023; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; MORAN TJ, 1950, DIS CHEST, V18, P171, DOI 10.1378/chest.18.2.171; Moura C., 2015, BMJ CASE REP, V2015, P1; Mutyaba AK, 2014, J THORAC CARDIOV SUR, V148, P3058, DOI 10.1016/j.jtcvs.2014.07.065; Ojeifo O, 2015, ANN THORAC SURG, V100, pE49, DOI 10.1016/j.athoracsur.2015.03.113; ORTBALS DW, 1979, ARCH INTERN MED, V139, P231, DOI 10.1001/archinte.139.2.231; Ozer N, 2002, J AM SOC ECHOCARDIOG, V15, P756, DOI 10.1067/mje.2002.119846; Pallangyo P., 2017, J MED CASE REPORTS, V11, P1; Panda A, 2017, DIAGN INTERV RADIOL, V23, P307, DOI 10.5152/dir.2017.16454; Pathirana Upul, 2015, BMC Res Notes, V8, P659, DOI 10.1186/s13104-015-1667-x; Pellenc Q, 2016, CIRCULATION, V133, P234, DOI 10.1161/CIRCULATIONAHA.115.018177; Pierret C, 2011, J VASC SURG, V53, P1720, DOI 10.1016/j.jvs.2011.01.063; Rajamannar KV, 2017, RESPIR MED CASE REP, V22, P277, DOI 10.1016/j.rmcr.2017.10.003; Ramakantan R, 1996, RADIOLOGY, V200, P691, DOI 10.1148/radiology.200.3.8756916; Rao VR, 2012, INTERACT CARDIOV TH, V15, P290, DOI 10.1093/icvts/ivs129; Remy-Jardin M, 2004, RADIOLOGY, V233, P741, DOI 10.1148/radiol.2333040031; Ren MY, 2016, EXP THER MED, V11, P2373, DOI 10.3892/etm.2016.3187; Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123; Robson SC, 1996, BRIT J HAEMATOL, V93, P943, DOI 10.1046/j.1365-2141.1996.d01-1722.x; Rodriguez E, 2001, J COMPUT ASSIST TOMO, V25, P577, DOI 10.1097/00004728-200107000-00012; Sass LA, 2016, J PEDIAT INF DIS SOC, V5, P85, DOI 10.1093/jpids/piu087; Seo Dong Ju, 2012, Korean J Thorac Cardiovasc Surg, V45, P408, DOI 10.5090/kjtcs.2012.45.6.408; Shaarawy H, 2018, EGYPT J CHEST DIS TU, V67, P62, DOI 10.4103/ejcdt.ejcdt_12_17; Shaikh Q, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-231; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; STRANG JIG, 1984, CLIN CARDIOL, V7, P667, DOI 10.1002/clc.4960071208; Takawira FF, 2010, ANN THORAC SURG, V90, P644, DOI 10.1016/j.athoracsur.2010.01.070; Turken O, 2002, INT J TUBERC LUNG D, V6, P927; Velayudhan BV, 2016, J THORAC CARDIOV SUR, V152, pE95, DOI 10.1016/j.jtcvs.2016.06.013; Walker CM, 2015, RADIOGRAPHICS, V35, P32, DOI 10.1148/rg.351140089; WALLIS PJW, 1984, THORAX, V39, P155, DOI 10.1136/thx.39.2.155; Wang W, 2013, CLIN IMAG, V37, P580, DOI 10.1016/j.clinimag.2012.09.007; Weigert C., 1882, VIRCHOWS ARCH PATHOL, V88, P307; World Health Organization, 2018, AD NUTR BANGL; Yoon W, 2003, RADIOLOGY, V227, P232, DOI 10.1148/radiol.2271020324; Zhang C, 2007, J THORAC CARDIOV SUR, V133, P836, DOI 10.1016/j.jtcvs.2006.11.023	99	0	0	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2021	45	1					157	165		10.1097/RCT.0000000000001024	http://dx.doi.org/10.1097/RCT.0000000000001024			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	QK9YJ	33475319				2022-09-04	WOS:000620735900025
J	Alba, LH; Diaz, S; Gamboa, O; Poveda, C; Henao, A; Perry, F; Duggan, C; Gil, F; Murillo, R				Alba, Luz Helena; Diaz, Sandra; Gamboa, Oscar; Poveda, Cesar; Henao, Andres; Perry, Fernando; Duggan, Catherine; Gil, Fabian; Murillo, Raul			Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia	PREVENTIVE MEDICINE			English	Article						Sensitivity; Specificity; Mammography; Clinical breast exam; Colombia; Massive screening; Breast neoplasms	RANDOMIZED-TRIAL; BENEFITS; PATIENT; HARMS; WOMEN	Most evidence on breast cancer screening accuracy derives from high income countries. We evaluated screening accuracy and factors related to program implementation in Bogota, Colombia. Between 2008 and 2012 participants underwent clinical breast examination (CBE) and mammography. Positive results underwent histological verification. Adherence to screening protocols was analyzed. Sensitivity, specificity, and predictive values were estimated and adjusted by overdiagnosis. Impact of alternative screening algorithms on follow-up was explored, including combined screening tests and modified coding systems for mammography. In total, 7436 women aged 50-69 were enrolled; 400 discontinued and 1003 non-compliant with screening protocols. 23 cancer cases were diagnosed. Mammography sensitivity and specificity were 78.3% (95% CI 77.3-99.3) and 99.4% (95% CI 99.2-99.6). CBE sensitivity was 39.1% (95% CI 37.9-40.3) and specificity 83.4% (95% CI 82.6-84.3). Parallel mammography and CBE showed the highest sensitivity (95.6%) and combined as serial tests the lowest (positive CBE followed by mammography 13.0%). A simplified coding system for mammography (recall/ no-recall) had 6.3% of positive results and a minor reduction in specificity compared with standard mammography, but reported the best balance between recall rates and screening protocol compliance. Call-backs had high rates of loss-to-follow-up; thus, alternative screening algorithms might help increase screening compliance and follow-up in low and middle income countries, particularly in populations with poor screening history and low access to health services.	[Alba, Luz Helena] Pontificia Univ Javeriana, Dept Prevent & Social Med, Bogota, Colombia; [Diaz, Sandra; Perry, Fernando] Inst Nacl Cancerol, Clin Seno, Bogota, Colombia; [Gamboa, Oscar; Murillo, Raul] Inst Nacl Cancerol, Subdirecc Invest & Salud Publ, Bogota, Colombia; [Poveda, Cesar] Inst Nacl Cancerol, Serv Imaginol, Bogota, Colombia; [Poveda, Cesar] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Henao, Andres] Ctr Enfermedades Mamarias, Radiol, Bogota, Colombia; [Duggan, Catherine] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Gil, Fabian] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Murillo, Raul] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France		Murillo, R (corresponding author), Diagonal 70B 2-14 Este Apto 104, Bogota, Colombia.	murillor@iarc.fr	Murillo, Raúl/AAY-4416-2021; Gil, Fabian/A-3352-2011; Duggan, Catherine/AAE-9777-2020; Duggan, Catherine/F-9414-2015	Gil, Fabian/0000-0001-6444-7248; Duggan, Catherine/0000-0001-7369-4021; Alba Talero, Luz Helena/0000-0002-6186-7842	National Cancer Institute of Colombia [4103620-012]; Susan G. Komen for the Cure [SAC110001]; Secretary of Health of Bogota [Convenio SDS-INC]	National Cancer Institute of Colombia; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Secretary of Health of Bogota [Convenio SDS-INC]	This work was supported by the National Cancer Institute of Colombia [Proyecto inversion nacion 4103620-012); Susan G. Komen for the Cure [Grant number SAC110001], and the Secretary of Health of Bogota [Convenio SDS-INC].	Abulkhair OA, 2010, ANN SAUDI MED, V30, P350, DOI 10.4103/0256-4947.67078; American College of Radiology, 2013, BI RADS FOLL UP OUTC, P229; Baines CJ, 2016, PREV MED, V90, P66, DOI 10.1016/j.ypmed.2016.06.033; Bairati I, 2007, CANCER DETECT PREV, V31, P323, DOI 10.1016/j.cdp.2007.08.001; Balleyguier C, 2007, EUR J RADIOL, V61, P192, DOI 10.1016/j.ejrad.2006.08.033; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Chen Tony Hsiu-Hsi, 2017, Medicine (Baltimore), V96, pe5684, DOI [10.1097/MD.0000000000005684, 10.1097/md.0000000000005684]; Drukteinis JS, 2013, AM J MED, V126, P472, DOI 10.1016/j.amjmed.2012.11.025; Duffy SW, 2006, BREAST J, V12, pS91, DOI 10.1111/j.1075-122X.2006.00207.x; Eusebi P, 2013, CEREBROVASC DIS, V36, P267, DOI 10.1159/000353863; Ferlay J., 2013, GLOBOCAN 2012 V1 0 C; Ghate SV, 2012, AM J ROENTGENOL, V198, P962, DOI 10.2214/AJR.11.6648; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Heywang-Kobrunner SH, 2016, EUR RADIOL, V26, P342, DOI 10.1007/s00330-015-3849-2; International Agency for Research on Cancer, 2016, IARC HDB CANC PREV; Ly A, 2016, J NATL COMPR CANC NE, V14, P527, DOI 10.6004/jnccn.2016.0061; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Mariotto R, 2007, RADIOL MED, V112, P287, DOI 10.1007/s11547-007-0142-8; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Massat NJ, 2016, CANCER EPIDEM BIOMAR, V25, P455, DOI 10.1158/1055-9965.EPI-15-0803; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Murillo R, 2016, INT J CANCER, V138, P705, DOI 10.1002/ijc.29801; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Nelson HD, 2016, SCREENING BREAST CAN; NHS Cancer Screening Programmes, 2003, NHSBSP PUBL, V55; Obenauer S, 2005, EUR RADIOL, V15, P1027, DOI 10.1007/s00330-004-2593-9; Pardo C, 2015, CANC COLOMBIA 2007 2, P1; Prorok PC, 2015, J MED SCREEN, V22, P213, DOI 10.1177/0969141315600003; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Thomas D.B., 2013, BREAST CANC EARLY DE, P378; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465	31	4	5	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	OCT	2018	115						19	25		10.1016/j.ypmed.2018.08.005	http://dx.doi.org/10.1016/j.ypmed.2018.08.005			7	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	GS8ZB	30092313				2022-09-04	WOS:000444003100004
J	Mueller, NT; Pereira, MA; Buitrago-Lopez, A; Rodriguez, DC; Duran, AE; Ruiz, AJ; Rueda-Clausen, CF; Villa-Roel, C				Mueller, Noel T.; Pereira, Mark A.; Buitrago-Lopez, Adriana; Rodriguez, Diana C.; Duran, Alvaro E.; Ruiz, Alvaro J.; Rueda-Clausen, Christian F.; Villa-Roel, Cristina			Socioeconomic Status and Metabolic Syndrome Components in Prepubescent Colombian Children	CIRCULATION			English	Meeting Abstract	Scientific Sessions of the American-Heart-Association on Epidemiology and Prevention/Physical Activity, Nutrition and Metabolism	MAR 19-22, 2013	New Orleans, LA	Amer Heart Assoc		Social Determinants of Health; Lipids; Prevention			[Mueller, Noel T.; Pereira, Mark A.] Univ Minnesota, Minneapolis, MN USA; [Buitrago-Lopez, Adriana] Erasmus Med Cntr, Netherlands Inst Hlth Sci, Rotterdam, Netherlands; [Rodriguez, Diana C.; Duran, Alvaro E.] Fdn Cardiovasc Colombia, Bucaramanga, Colombia; [Ruiz, Alvaro J.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Rueda-Clausen, Christian F.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Villa-Roel, Cristina] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada				Rueda-Clausen, Christian/S-2428-2019; Ruiz, Alvaro/AAD-5422-2019	Rueda-Clausen, Christian/0000-0002-4077-6159; Ruiz, Alvaro/0000-0001-6528-4268					0	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322	1524-4539		CIRCULATION	Circulation	MAR 26	2013	127	12		S		MP49								2	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology	302HW					2022-09-04	WOS:000330596100098
J	Janssen, MA; Bousquet, F; Cardenas, JC; Castillo, D; Worrapimphong, K				Janssen, Marco A.; Bousquet, Francois; Cardenas, Juan-Camilo; Castillo, Daniel; Worrapimphong, Kobchai			Field experiments on irrigation dilemmas	AGRICULTURAL SYSTEMS			English	Article						Field experiments; Irrigation; Common pool resources; Asymmetry; Trust	COMMONS	It is often assumed that irrigation systems require a central authority to solve coordination problems due to the asymmetry in position and influence between those located at the head-end of a system and those located at the tail-end. However, many examples of complex irrigation systems exist that are self-organized without central coordination. Field experiments on asymmetric commons dilemmas are performed with villagers in rural Colombia and Thailand. Our experiments show that there is a dynamic interaction between equality in the use of the common resource, and the level of the contributions to the creation of a common resource. Inequality in the distribution of benefits in one round triggers lower levels of group contributions, reducing efficiency and triggering even more inequality in contributions and distribution of the resource among players. The upstream players act as "stationary bandits". They take more than an equal share of the common resource, but leave sufficient resources for the downstream players to stimulate them to continue their contributions to the public infrastructure. After 10 rounds, players can vote on one of three allocation rules: equal quota, random and rotating access to appropriation of the resource. The rotating access is most often elected. The resource dynamics in the second part of the experiment depend on the rule elected. With the quota rule, the stationary bandit metaphor is less relevant since taking equal shares of the resource is enforced. With the rotation access rule, the players act strategically on the rotating position. They invest more when having the first access to the resource compared to less favorable access. And when they have first access they extract the main part of the common resource. The rotation rule led to a reduction of the performance of the groups. With the random access rule there is no such strategic investment behavior and participants remain investing equal and similar levels as in the first 10 rounds. The experiments show that a necessary condition of irrigation systems to self-organize is the development of norms to allocate fair shares of the water in order to recruit sufficient labor to construct and maintain the physical infrastructure. The different allocation rules do not increase efficiency, but they did increase equality of the earnings. (C) 2012 Elsevier Ltd. All rights reserved.	[Janssen, Marco A.] Arizona State Univ, Sch Human Evolut & Social Change, Ctr Study Inst Divers, Tempe, AZ 85287 USA; [Bousquet, Francois] CIRAD GREEN, Montpellier 5, France; [Cardenas, Juan-Camilo] Univ Los Andes, Dept Econ, Bogota, Colombia; [Castillo, Daniel] Javeriana Univ, Sch Environm & Rural Studies, Bogota, Colombia; [Worrapimphong, Kobchai] Chulalongkorn Univ, Dept Biol, Fac Sci, Bangkok 10330, Thailand		Janssen, MA (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Ctr Study Inst Divers, POB 872402, Tempe, AZ 85287 USA.	Marco.Janssen@asu.edu	Bousquet, Francois/Y-7904-2019; Castillo Brieva, Daniel/C-4104-2015; cardenas, juan-camilo/B-4658-2009; Bousquet, Francois/G-3605-2010	Bousquet, Francois/0000-0002-4552-3724; Castillo Brieva, Daniel/0000-0001-9251-6124; cardenas, juan-camilo/0000-0003-0005-7595; 	National Science Foundation [BCS-0432894]	National Science Foundation(National Science Foundation (NSF))	We acknowledge support from the National Science Foundation (BCS-0432894). We acknowledge comments on earlier version of this manuscript derived from Elinor Ostrom.	Aggarwal RM, 2004, J ENVIRON ECON MANAG, V47, P163, DOI 10.1016/S0095-0696(03)00034-2; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Budescu DV, 2002, J BEHAV DECIS MAKING, V15, P37, DOI 10.1002/bdm.402; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; HUNT RC, 1988, J ANTHROPOL RES, V44, P335, DOI 10.1086/jar.44.4.3630504; Joshi N. N., 2000, Asia-Pacific Journal of Rural Development, V10, P67; Lam W. F., 1998, GOVERNING IRRIGATION; Lansing J., 1991, PRIESTS PROGRAMMERS; OLSON M, 1993, AM POLIT SCI REV, V87, P567, DOI 10.2307/2938736; Olson M, 2000, POWER PROSPERITY; OSTROM E, 1993, J ECON PERSPECT, V7, P93, DOI 10.1257/jep.7.4.93; Ostrom E., 1992, CRAFTING I SELF GOVE; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rapoport A, 1997, INT J GAME THEORY, V26, P113, DOI 10.1007/s001820050021; Richerson Peter J., 2002, DRAMA COMMONS, P403; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Shivakoti G, 2005, ASIAN IRRIGATION TRA; Wittfogel K.A., 1957, ORIENTAL DESPOTISM C	26	42	42	0	24	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-521X	1873-2267		AGR SYST	Agric. Syst.	JUN	2012	109						65	75		10.1016/j.agsy.2012.03.004	http://dx.doi.org/10.1016/j.agsy.2012.03.004			11	Agriculture, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Agriculture	951RR					2022-09-04	WOS:000304738200008
J	Barahona-Correa, JE; Morales, SD; Andrade-Perez, R; Hani, A				Barahona-Correa, Julian E.; Morales, Samuel-David; Andrade-Perez, Rafael; Hani, Albis			Renal Amyloidosis and Crohn Disease	OCHSNER JOURNAL			English	Article						Amyloidosis; Crohn disease; Latin America; renal insufficiency-chronic; tumor necrosis factor-alpha	INFLAMMATORY-BOWEL-DISEASE; SECONDARY SYSTEMIC AMYLOIDOSIS; AA; INFLIXIMAB; FEATURES	Background: Secondary amyloidosis, a rare complication of Crohn disease (CD), is triggered by persistent systemic inflammation. Kidney involvement is the most frequent manifestation and is often characterized by nephrotic syndrome and kidney failure. This complication usually appears in patients with long-standing disease and is associated with increased morbidity and mortality risk. Diagnosis is by microscopic amyloid observation of tissue biopsy, and when the diagnosis is confirmed, the therapeutic objective is disease activity control. Response assessment is challenging because of a lack of reliable biomarkers. Case Report: A 56-year-old male with a long-standing history of CD treated with a tumor necrosis factor-alpha inhibitor presented with an acute elevation of creatinine in association with clinical and laboratory markers of nephrotic syndrome. Kidney biopsy revealed renal amyloidosis. After treatment adjustment, although a stable creatinine was achieved, the patient had persistent impaired glomerular filtration rate. Conclusion: As a systemic chronic inflammatory disorder, CD may present multisystemic morbidity, for which increased awareness among gastroenterologists is warranted. Renal amyloidosis is an infrequent extraintestinal complication of CD that may lead to chronic kidney impairment. Although evidence-based treatment is lacking, disease activity control is pivotal for management.	[Barahona-Correa, Julian E.; Hani, Albis] Pontificia Univ Javeriana, Sch Med, Dept Internal Med, Bogota, Colombia; [Morales, Samuel-David] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Sch Med, Dept Pathol, Bogota, Colombia; [Morales, Samuel-David] Fdn Univ Ciencias Salud, Hosp San Jose, Sch Med, Dept Pathol, Bogota, Colombia; [Andrade-Perez, Rafael] Fdn Santa Fe Bogota, Dept Pathol & Labs, Bogota, Colombia; [Andrade-Perez, Rafael] Univ Los Andes, Sch Med, Bogota, Colombia; [Andrade-Perez, Rafael] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Hani, Albis] Hosp Univ San Ignacio, Gastroenterol Unit, Carrera 7 40-62, Bogota, Colombia		Hani, A (corresponding author), Hosp Univ San Ignacio, Gastroenterol Unit, Carrera 7 40-62, Bogota, Colombia.	albis.hani@javeriana.edu.co						Beji S, 2004, PRESSE MED, V33, P862, DOI 10.1016/S0755-4982(04)98773-8; Bibani N, 2017, J CROHNS COLITIS, V11, pS270; DEBEER FC, 1982, LANCET, V2, P231; Denis MA, 2013, EUR J CLIN INVEST, V43, P292, DOI 10.1111/eci.12045; Elaziz MMA, 2018, ACTA GASTRO-ENT BELG, V81, P381; Fernández-Ávila Daniel G., 2020, Rev.Colomb.Reumatol., V27, P3; Fernandez-Nebro A, 2010, AM J MED, V123, P454, DOI 10.1016/j.amjmed.2009.11.010; Fidalgo C, 2010, BIODRUGS, V24, P15, DOI 10.2165/11586250-000000000-00000; GREENSTEIN AJ, 1992, MEDICINE, V71, P261, DOI 10.1097/00005792-199209000-00001; Arevalo AG, 2011, REV ESP ENFERM DIG, V103, P268; Iizuka M, 2006, GUT, V55, P744, DOI 10.1136/gut.2005.087577; Miyaoka M, 2011, DIGEST ENDOSC, V23, P157, DOI 10.1111/j.1443-1661.2010.01069.x; Papa R, 2018, RHEUM DIS CLIN N AM, V44, P585, DOI 10.1016/j.rdc.2018.06.004; Pukitis A, 2013, J GASTROINTEST LIVER, V22, P333; Romero-Marín Juan David, 2020, Rev.Colomb.Reumatol., V27, P46; Said Y, 2011, J CROHNS COLITIS, V5, P171, DOI 10.1016/j.crohns.2011.01.005; Sattianayagam PT, 2013, DIGEST DIS SCI, V58, P1689, DOI 10.1007/s10620-012-2549-x; SAVERYMUTTU SH, 1986, GUT, V27, P809, DOI 10.1136/gut.27.7.809; Serra I, 2010, J CROHNS COLITIS, V4, P269, DOI 10.1016/j.crohns.2009.11.009; Sharma P, 2017, ANN GASTROENTEROL, V30, P504, DOI 10.20524/aog.2017.0168; Cuquerella JT, 2016, J CROHNS COLITIS, V10, P1245, DOI 10.1093/ecco-jcc/jjw080; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Wester AL, 2001, INFLAMM BOWEL DIS, V7, P295, DOI 10.1097/00054725-200111000-00003	23	0	0	0	0	OCHSNER CLINIC	NEW ORLEANS	1514 JEFFERSON HWY, NEW ORLEANS, LA 70121 USA	1524-5012			OCHSNER J	OCHSNER J.	SEP	2021	21	3					291	295		10.31486/toj.20.0129	http://dx.doi.org/10.31486/toj.20.0129			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UR8LN	34566512	Green Published, gold			2022-09-04	WOS:000696993800015
J	Navarrete, M; Alvarado-Rojas, C; Le Van Quyen, M; Valderrama, M				Navarrete, Miguel; Alvarado-Rojas, Catalina; Le Van Quyen, Michel; Valderrama, Mario			RIPPLELAB: A Comprehensive Application for the Detection, Analysis and Classification of High Frequency Oscillations in Electroencephalographic Signals	PLOS ONE			English	Article							OPEN SOURCE TOOLBOX; HZ; EPILEPSY; TRANSFORM; SOFTWARE; DYNAMICS	High Frequency Oscillations (HFOs) in the brain have been associated with different physiological and pathological processes. In epilepsy, HFOs might reflect a mechanism of epileptic phenomena, serving as a biomarker of epileptogenesis and epileptogenicity. Despite the valuable information provided by HFOs, their correct identification is a challenging task. A comprehensive application, RIPPLELAB, was developed to facilitate the analysis of HFOs. RIPPLELAB provides a wide range of tools for HFOs manual and automatic detection and visual validation; all of them are accessible from an intuitive graphical user interface. Four methods for automated detection-as well as several options for visualization and validation of detected events-were implemented and integrated in the application. Analysis of multiple files and channels is possible, and new options can be added by users. All features and capabilities implemented in RIPPLELAB for automatic detection were tested through the analysis of simulated signals and intracranial EEG recordings from epileptic patients (n = 16; 3,471 analyzed hours). Visual validation was also tested, and detected events were classified into different categories. Unlike other available software packages for EEG analysis, RIPPLELAB uniquely provides the appropriate graphical and algorithmic environment for HFOs detection (visual and automatic) and validation, in such a way that the power of elaborated detection methods are available to a wide range of users (experts and non-experts) through the use of this application. We believe that this open-source tool will facilitate and promote the collaboration between clinical and research centers working on the HFOs field. The tool is available under public license and is accessible through a dedicated web site.	[Navarrete, Miguel; Valderrama, Mario] Univ Los Andes, Dept Biomed Engn, Bogota, Colombia; [Alvarado-Rojas, Catalina; Le Van Quyen, Michel] Hop La Pitie Salpetriere, INSERM UMRS 975, CNRS UPR640, Ctr Rech,Inst Cerveau & Moelle Epiniere CRICM, Paris, France; [Navarrete, Miguel] Univ Los Andes, Dept Elect & Elect Engn, Bogota, Colombia; [Alvarado-Rojas, Catalina] Pontificia Univ Javeriana, Dept Elect Engn, Bogota, Colombia		Valderrama, M (corresponding author), Univ Los Andes, Dept Biomed Engn, Bogota, Colombia.	mvalderr@uniandes.edu.co	Navarrete, Miguel/E-3130-2019; Alvarado-Rojas, Catalina/AAR-8761-2021	Navarrete, Miguel/0000-0002-4903-2156; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Valderrama, Mario/0000-0001-8791-6078	COLCIENCIAS [567]; Likewise	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Likewise	This research was partially supported by COLCIENCIAS (Grant 567), http://www.colciencias.gov.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Likewise, there was no additional external funding received for this study.; We would like to thank Vincent Navarro (Centre de Recherche de L'Institut du Cerveau et de la Moelle Epiniere, Paris, France) for valuable suggestions on the interface design, Samuel Ahn, (Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, USA) and Gerriet Janssen for helpful comments on the manuscript. This research was partially supported by COLCIENCIAS (Grant 567).	Alvarado-Rojas C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04545; Alvarado-Rojas C, 2015, ANN NEUROL, V77, P281, DOI 10.1002/ana.24324; BARNES CW, 1985, IEEE T CIRCUITS SYST, V32, P530, DOI 10.1109/TCS.1985.1085756; Benar CG, 2010, CLIN NEUROPHYSIOL, V121, P301, DOI 10.1016/j.clinph.2009.10.019; Birot G, 2013, J NEUROSCI METH, V213, P236, DOI 10.1016/j.jneumeth.2012.12.013; Blanco JA, 2010, J NEUROPHYSIOL, V104, P2900, DOI 10.1152/jn.01082.2009; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Brazdil M, 2010, EPILEPSY RES, V90, P28, DOI 10.1016/j.eplepsyres.2010.03.003; Burnos S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094381; Chaibi S., 2012, 2012 IEEE International Conference on Emerging Signal Processing Applications, P56, DOI 10.1109/ESPA.2012.6152445; Chatillon CE, 2011, CLIN NEUROPHYSIOL, V122, P1701, DOI [10.1016/j.clinph.2011.02.022, 10.1016/j.clinph.2011.06.006]; Colombet B, 2015, J NEUROSCI METH, V242, P118, DOI 10.1016/j.jneumeth.2015.01.017; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; de la Prida LM, 2015, J CLIN NEUROPHYSIOL, V32, P207, DOI 10.1097/WNP.0000000000000150; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dumpelmann M, 2015, EPILEPSIA, V56, P197, DOI 10.1111/epi.12844; Dumpelmann M, 2012, CLIN NEUROPHYSIOL, V123, P1721, DOI 10.1016/j.clinph.2012.02.072; Egert U, 2002, J NEUROSCI METH, V117, P33, DOI 10.1016/S0165-0270(02)00045-6; Esteller R, 2005, CLIN NEUROPHYSIOL, V116, P517, DOI 10.1016/j.clinph.2004.10.015; Esteller R, 2001, 2001 C P 23 ANN INT, P2; Gardner AB, 2007, CLIN NEUROPHYSIOL, V118, P1134, DOI 10.1016/j.clinph.2006.12.019; Gliske SV, 2016, CLIN NEUROPHYSIOL, V127, P1057, DOI 10.1016/j.clinph.2015.07.016; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Guerrini R, 2013, DESIRE DEV EPILEPSY; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HERRMANN O, 1970, ELECTRON LETT, V6, P329, DOI 10.1049/el:19700232; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; JACKSON LB, 1979, IEEE T CIRCUITS SYST, V26, P149, DOI 10.1109/TCS.1979.1084623; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Le TP, 2004, J SOUND VIB, V277, P73, DOI 10.1016/j.jsv.2003.08.049; Le Van Quyen M, 2006, TRENDS NEUROSCI, V29, P419, DOI 10.1016/j.tins.2006.06.001; Lidierth M, 2009, J NEUROSCI METH, V178, P188, DOI 10.1016/j.jneumeth.2008.11.004; Mallat S., 1999, WAVELET TOUR SIGNAL; Matsumoto A, 2013, J NEUROPHYSIOL, V110, P1958, DOI 10.1152/jn.00341.2013; MORLET J, 1982, GEOPHYSICS, V47, P222, DOI 10.1190/1.1441329; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pail M, 2013, CLIN NEUROPHYSIOL, V124, P1935, DOI 10.1016/j.clinph.2013.03.032; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Xiang J, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00057; Zelmann R, 2010, IEEE ENG MED BIO, P2329, DOI 10.1109/IEMBS.2010.5627464; Zelmann R, 2009, CLIN NEUROPHYSIOL, V120, P1457, DOI 10.1016/j.clinph.2009.05.029; Zijlmans M, 2011, CLIN NEUROPHYSIOL, V122, P664, DOI 10.1016/j.clinph.2010.09.021	50	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158276	10.1371/journal.pone.0158276	http://dx.doi.org/10.1371/journal.pone.0158276			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341033	Green Published, gold, Green Submitted, Green Accepted			2022-09-04	WOS:000378393600046
J	Diaz-Granados, N; Pitzul, KB; Dorado, LM; Wang, F; McDermott, S; Rondon, MB; Posada-Villa, J; Saavedra, J; Torres, Y; Des Meules, M; Stewart, DE				Diaz-Granados, Natalia; Pitzul, Kristen Blythe; Dorado, Linda M.; Wang, Feng; McDermott, Sarah; Rondon, Marta B.; Posada-Villa, Jose; Saavedra, Javier; Torres, Yolanda; Des Meules, Marie; Stewart, Donna E.			Monitoring Gender Equity in Health Using Gender-Sensitive Indicators: A Cross-National Study	JOURNAL OF WOMENS HEALTH			English	Article							PUBLIC-HEALTH; SOCIAL INEQUALITIES; VIOLENCE; SEX; OPPORTUNITIES; PERFORMANCE; CHALLENGES; QUALITY	Background: As gender is known to be a major determinant of health, monitoring gender equity in health systems remains a vital public health priority. Focusing on a low-income (Peru), middle-income (Colombia), and high-income (Canada) country in the Americas, this study aimed to (1) identify and select gender-sensitive health indicators and (2) assess the feasibility of measuring and comparing gender-sensitive health indicators among countries. Methods: Gender-sensitive health indicators were selected by a multidisciplinary group of experts from each country. The most recent gender-sensitive health measures corresponding to selected indicators were identified through electronic databases (CINAHL, PsycINFO, MEDLINE, Embase, LILACS, LIPECS, Latindex, and BIREME) and expert consultation. Data from population-based studies were analyzed when indicator information was unavailable from reports. Results: Twelve of the 17 selected gender-sensitive health indicators were feasible to measure in at least two countries, and 9 of these were comparable among all countries. Indicators that were available were not stratified or adjusted by age, education, marital status, or wealth. The largest between-country difference was maternal mortality, and the largest gender inequity was mortality from homicides. Conclusions: This study shows that gender inequities in health exist in all countries, regardless of income level. Economic development seemed to confer advantages in the availability of such indicators; however, this finding was not consistent and needs to be further explored. Future initiatives should include identifying health system factors and risk factors associated with disparities as well as assessing the cost-effectiveness of including the routine monitoring of gender inequities in health.	[Diaz-Granados, Natalia; Dorado, Linda M.; Stewart, Donna E.] Univ Hlth Network, Womens Hlth Program, Toronto, ON M5G 2C4, Canada; [Pitzul, Kristen Blythe; Wang, Feng; McDermott, Sarah; Des Meules, Marie] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Rondon, Marta B.] Univ Peruana Cayetano Heredia, Lima, Peru; [Posada-Villa, Jose] Univ Javeriana, Bogota, Colombia; [Saavedra, Javier] Inst Nacl Salud Mental, Lima, Peru; [Torres, Yolanda] Univ CES, Medellin, Colombia		Diaz-Granados, N (corresponding author), Univ Hlth Network, Womens Hlth Program, 200 Elizabeth St,EN 7-234, Toronto, ON M5G 2C4, Canada.	natalia.diaz.granados@utoronto.ca	Posada-Villa, José/AAA-2355-2019; Stewart, Donna Eileen E/J-2844-2016	Posada-Villa, José/0000-0001-5840-3118; Stewart, Donna Eileen E/0000-0002-8157-7746; Rondon, Marta/0000-0001-8459-6785; Saavedra, Javier Esteban/0000-0001-8403-5363	Canadian Institute of Health Research [NIG-79774]; Public Health Agency of Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada	This study was funded by a Canadian Institute of Health Research grant NIG-79774 and by the Public Health Agency of Canada.	ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Arah OA, 2003, INT J QUAL HEALTH C, V15, P377, DOI 10.1093/intqhc/mzg049; Barcelo A, 2001, Epidemiol Bull, V22, P1; Beck T., 1999, USING GENDER SENSITI; Beland Yves, 2002, Health Rep, V13, P9; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; COLMAN R, 2003, PROFILE WOMENS HLTH; Davis RM, 1999, BRIT MED J, V318, P889, DOI 10.1136/bmj.318.7188.889; Doyal L, 2003, INT J HEALTH SERV, V33, P569, DOI 10.2190/CWK2-U7R6-VCE0-E47P; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Doyal L, 2000, SOC SCI MED, V51, P931, DOI 10.1016/S0277-9536(00)00072-1; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garfield R, 2004, REV PANAM SALUD PUBL, V16, P266, DOI 10.1590/S1020-49892004001000006; HILTZ A, 2004, 75F0002MIE MIN IND S; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; LIN V, 2003, COMP EVALUATION INDI; Lin V, 2007, INT J PUBLIC HEALTH, V52, pS19, DOI 10.1007/s00038-006-6050-1; Lin V, 2007, INT J PUBLIC HEALTH, V52, pS27, DOI 10.1007/s00038-006-6049-7; Marmot M, 1997, SOC SCI MED, V44, P901, DOI 10.1016/S0277-9536(96)00194-3; Moss NE, 2002, SOC SCI MED, V54, P649, DOI 10.1016/S0277-9536(01)00115-0; *PAN AM HLTH ORG, 2009, GEND HLTH DEV AM BAS; Pan-American Health Organization, 2005, BAS IND GEND EQ AN H; Phillips Susan P, 2005, Int J Equity Health, V4, P11, DOI 10.1186/1475-9276-4-11; Sen G, 2008, Glob Public Health, V3 Suppl 1, P1, DOI 10.1080/17441690801900795; Theobald S, 2005, HEALTH POLICY PLANN, V20, P141, DOI 10.1093/heapol/czi019; *WHO CTR HLTH DEV, 2004, P 4 INT M WOM HLTH G	31	19	19	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	JAN	2011	20	1					145	153		10.1089/jwh.2010.2057	http://dx.doi.org/10.1089/jwh.2010.2057			9	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	709NH	21190425				2022-09-04	WOS:000286446900019
J	Rusticucci, M; Fontan, SG; Abrutzky, R; Bartolomeu, L; Chesini, F; Mantilla, G				Rusticucci, M.; Fontan, S. G.; Abrutzky, R.; Bartolomeu, L.; Chesini, F.; Mantilla, G.			Towards a Latin American Health & Climate Observatory: Seminary on Instrumentation and Methodologies	REVISTA DE SALUD AMBIENTAL			Spanish	Article						health observatory; climate; environmental health; social determinants of health; interdisciplinary	ARGENTINA; EXTREMES	The study of the relationship between health and climate requires articulating various actors and disciplines. This paper presents the experience of the Latin American Seminar on Instruments and Methodologies for a climate and health observatory- held in Buenos Aires in 2019 and supported by the Latin American Center for Interdisciplinary Training (CELFI)-as a linking and training facility referencing the projects that are being carried out in this field throughout Latin American. This paper presents the design, contents, didactic approach and execution of the seminar, as well as its results regarding participation, products and evaluation. Likewise, the methodologies that could allow articulating different disciplines in a process of gainingknowledge about the climate-health relationship are reflected throughout this process. Finally, the main guidelines for this observatory, arising from an exchange with key actors, are set forth herein. The execution of the seminar, the projects presented as the products thereof, the discussions that arose during the exchange, and the need to continue with this work over the following months point out to the importance and necessity of building this observatory for Latin America and the Caribbean in an interdisciplinary way.	[Rusticucci, M.] Univ Buenos Aires, Dept Ciencias Atmosfera & Oceanos, Buenos Aires, DF, Argentina; [Rusticucci, M.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Fontan, S. G.] Univ Nacl La Matanza, Dept Ciencias Salud, San Justo, Argentina; [Abrutzky, R.] Univ Buenos Aires, Inst Invest Gino Germani, Buenos Aires, DF, Argentina; [Bartolomeu, L.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Chesini, F.] Minist Salud Argentina, Buenos Aires, DF, Argentina; [Chesini, F.] Univ Metropolitana Educ & Trabajo, Buenos Aires, DF, Argentina; [Mantilla, G.] Pontificia Univ Javeriana, Sede Bogota, Bogota, Colombia; [Mantilla, G.] Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA		Rusticucci, M (corresponding author), Univ Buenos Aires, Buenos Aires, DF, Argentina.	matilde.rusticucci@gmail.com						Almeira Gustavo, 2016, Meteorologica, V41, P65; [Anonymous], 2013, INT J ENVIRON HEALTH, DOI DOI 10.1504/IJENVH.2013.056977; Rivera JA, 2017, WATER-SUI, V9, DOI 10.3390/w9090652; Asamblea Mundial de la Salud, 2019, ESTR MUND OMS SAL ME; Barcellos C, 2016, REV PANAM SALUD PUBL, V40, P167; Cavalcanti IFA, 2015, J HYDROL, V523, P211, DOI 10.1016/j.jhydrol.2015.01.028; Chesini Francisco, 2019, Rev. argent. salud pública, V10, P28; Chesini F, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00165218, 10.1590/0102-311X00165218]; Penalba OC, 2016, INT J CLIMATOL, V36, P974, DOI 10.1002/joc.4398; Coelho CAS, 2016, CLIM DYNAM, V46, P3737, DOI 10.1007/s00382-015-2800-1; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; CUNHA APMA, 2018, ATMOS SCI LETT, V19, DOI DOI 10.1504/IJENVH.2013.056975; Gattini CH, 2009, IMPLEMENTACION OBSER; Hales S., 2014, QUANTITATIVE RISK AS; Moreno-Banda GL, 2017, SALUD PUBLICA MEXICO, V59, P41, DOI 10.21149/8414; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Mantilla G, 2016, CLIMATE CHANGE HLTH; Mantilla G, 2012, CURSO ANDINO CLIMA S; Pruss-Ustun A., 2016, PREVENTING DIS HLTH; Rodriguez-Morata C, 2018, INT J CLIMATOL, V38, P3388, DOI 10.1002/joc.5507; Rusticucci M, 2017, INT J CLIMATOL, V37, P3003, DOI 10.1002/joc.4895; Street RB, 2019, INT J DISAST RISK RE, V34, P28, DOI 10.1016/j.ijdrr.2018.12.001; WMO, 2011, CLIM KNOWL ACT GLOB	23	0	0	0	0	SOC ESPANOLA SANIDAD AMBIENTAL	MADRID	C LONDRES 17, MADRID, 28028, SPAIN	1577-9572	1697-2791		REV SALUD AMBIENT	Rev. Salud Ambient.		2020	20	2					119	128						10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	PF6FE					2022-09-04	WOS:000599146900004
J	Modreanu, R; Cerquera, SC; Marti, MJ; Rios, J; Sanchez-Gomez, A; Camara, A; Fernandez, M; Compta, Y				Modreanu, Raluca; Catalina Cerquera, Sonia; Jose Marti, Maria; Rios, Jose; Sanchez-Gomez, Almudena; Camara, Ana; Fernandez, Manel; Compta, Yaroslau			Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal tau and A beta as well as dementia-risk in Parkinson's disease	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Parkinson's disease-dementia; CSF A beta; CSF tau; Endophenotypes; Non-motor symptoms; Motor fluctuations	CSF AMYLOID-BETA; PREDICTS COGNITIVE DECLINE; ALPHA-SYNUCLEIN; DE-NOVO; PROGRESSION; BIOMARKERS; LEVODOPA; SUBTYPES; NEUROPATHOLOGY; HETEROGENEITY	Experimental, neuropathological and cerebrospinal fluid (CSF) studies support tau and amyloid-beta (A beta) relevance in Parkinson's disease (PD) related dementia. Lesser motor fluctuations (MFs) and non-motor features have also been related to PD-dementia. Yet, little is known about the association of MFs and non-motor symptoms with CSF tau and A beta in PD. We hypothesized that lesser MFs and non-motor predominance are related to these CSF markers and dementia-risk in PD. We studied 58 PD patients (dementia at baseline, n = 21; dementia at 18-months, n = 35) in whom CSF A beta and tau had been determined with ELISA techniques. MFs and a number of non-motorsymptoms (apathy, anxiety, irritability, depression, visual hallucinations, spatial disorientation, memory complaints) over disease course were dichotomized as absent-mild vs. moderate-severe by retrospective clinical chart review blind to CSF findings. Non-motor predominance was defined as >= 3 non-motor symptoms (after the cohort-median of non-motor symptoms per patient) with >= 2 being moderate-severe and having been present from onset, with all these being more disabling overall than motor features. Cross-sectionally, CSF biomarkers were non-parametrically compared according to dichotomized MFs and non-motor predominance. Longitudinally, dementia was the outcome (dependent variable), CSF markers, MFs and non-motor predominance were the predictors (independent variables), and potential modifiers as age, sex, and memory complaints were the covariates in binary regression models. Absent-mild MFs were associated with higher CSF tau markers and shorter time-to-dementia, while non-motor predominance and decreasing CSF A beta independently increased longitudinal dementia-risk. In summary, absent-mild MFs, non-motor predominance and CSF tau and A beta might define endophenotypes related to the timing or risk of dementia in PD. (C) 2016 Elsevier B.V. All rights reserved.	[Modreanu, Raluca; Catalina Cerquera, Sonia; Jose Marti, Maria; Sanchez-Gomez, Almudena; Camara, Ana; Fernandez, Manel; Compta, Yaroslau] Univ Barcelona, Hosp Clin, ICN,Neurol Serv, IDIBAPS,CIBERNED,Parkinsons Dis & Movement Disord, Barcelona, Catalonia, Spain; [Modreanu, Raluca] Segeberger Kliniken, Neurol Serv, Parkinsons Dis & Movement Disorders Unit, Bad Segeberg, Germany; [Catalina Cerquera, Sonia] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Neurol Unit, Bogota, Colombia; [Rios, Jose] Hosp Clin Barcelona, IDIBAPS, Stat & Methodol Support Unit, UASP, Barcelona, Catalonia, Spain		Compta, Y (corresponding author), Hosp Clin Barcelona, ICN, Neurol Serv, Parkinsons Dis & Movement Disorders Unit, 170 Villarroel, Barcelona 08036, Catalonia, Spain.; Compta, Y (corresponding author), Univ Barcelona, IDIBAPS, CIBERNED, 170 Villarroel, Barcelona 08036, Catalonia, Spain.	ycompta@clinic.cat	Ríos, José/AAZ-2341-2020; Fernandez, Manel/AAC-2447-2020; Compta, Yaroslau/U-8298-2017	Ríos, José/0000-0002-0716-8784; Fernandez, Manel/0000-0002-8558-9920; Compta, Yaroslau/0000-0001-6443-0104; Cerquera, Catalina/0000-0002-3874-0261	"Premio FEP" (Award of the Spanish Federation of Parkinson's Disease); P.I.: Y. Compta [P1041833]; CERCA Programme / Generalitat de Catalunya	"Premio FEP" (Award of the Spanish Federation of Parkinson's Disease); P.I.: Y. Compta; CERCA Programme / Generalitat de Catalunya	The authors are most grateful to all the study participants, as none of this research would have been possible without their generosity. This study was funded through "Premio FEP 2011" (2011 Award of the Spanish Federation of Parkinson's Disease; P.I.: Y. Compta [P1041833]), as well as the CERCA Programme / Generalitat de Catalunya.	Aarsland D, 2005, ANN NEUROL, V58, P773, DOI 10.1002/ana.20635; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Alves G, 2013, J NEUROL NEUROSUR PS, V84, P537, DOI 10.1136/jnnp-2012-303808; Alves G, 2010, J NEUROL NEUROSUR PS, V81, P1080, DOI 10.1136/jnnp.2009.199950; [Anonymous], 2000, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890423349; Buongiorno M, 2017, J ALZHEIMERS DIS, V55, P1261, DOI 10.3233/JAD-160698; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2015, J NEUROL, V262, P294, DOI 10.1007/s00415-014-7560-z; Compta Y, 2013, PARKINSONISM RELAT D, V19, P717, DOI 10.1016/j.parkreldis.2013.03.009; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Erro R, 2012, J NEUROL, V259, P1808, DOI 10.1007/s00415-011-6407-0; Fahn S., 1987, MACMILLAN HLTH CARE, P153; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Larsen JP, 2000, MOVEMENT DISORD, V15, P826, DOI 10.1002/1531-8257(200009)15:5<826::AID-MDS1010>3.0.CO;2-E; Liu CQ, 2015, PARKINSONISM RELAT D, V21, P271, DOI 10.1016/j.parkreldis.2014.12.027; Marras C, 2016, MOVEMENT DISORD, V31, P1095, DOI 10.1002/mds.26510; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Montine TJ, 2010, MOVEMENT DISORD, V25, P2682, DOI 10.1002/mds.23287; Muller MLTM, 2013, MOVEMENT DISORD, V28, P296, DOI 10.1002/mds.25213; Parnetti L, 2016, BIOMARK MED, V10, P35, DOI 10.2217/bmm.15.107; Parnetti L, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00053; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petrie A., 2009, BINARY OUTCOMES LOGI, P88; Santangelo G, 2007, MOVEMENT DISORD, V22, P2418, DOI 10.1002/mds.21746; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Stefani A, 2006, J NEUROL SCI, V251, P124, DOI 10.1016/j.jns.2006.09.014; Stewart T, 2014, AM J PATHOL, V184, P966, DOI 10.1016/j.ajpath.2013.12.007; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Vranova HP, 2012, J NEURAL TRANSM, V119, P353, DOI 10.1007/s00702-011-0708-4; Wenzelburger R, 2002, BRAIN, V125, P871, DOI 10.1093/brain/awf084	41	9	9	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2017	373						223	229		10.1016/j.jns.2016.12.064	http://dx.doi.org/10.1016/j.jns.2016.12.064			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK8US	28131192				2022-09-04	WOS:000394200700054
J	Lopez, MC; Murphy, JJ; Spraggon, JM; Stranlund, JK				Claudia Lopez, Maria; Murphy, James J.; Spraggon, John M.; Stranlund, John K.			COMPARING THE EFFECTIVENESS OF REGULATION AND PRO-SOCIAL EMOTIONS TO ENHANCE COOPERATION: EXPERIMENTAL EVIDENCE FROM FISHING COMMUNITIES IN COLOMBIA	ECONOMIC INQUIRY			English	Article							COLLECTIVE ACTION; ECONOMIC-THEORY; PUBLIC GOOD; PUNISHMENT; EXCHANGE; MONETARY; WORLD; NORMS	This paper presents the results from a series of framed field experiments conducted in fishing communities off the Caribbean coast of Colombia. The goal is to investigate the relative effectiveness of exogenous regulatory pressure and pro-social emotions in promoting cooperative behavior in a public goods context. The random public revelation of an individual's contribution and its consequences for the rest of the group leads to significantly higher public good contributions and social welfare than regulatory pressure, even under regulations that are designed to motivate fully efficient contributions. (JEL C93, H41, Q20, Q28)	[Claudia Lopez, Maria] Pontificia Univ Javeriana Bogota, Sch Environm & Rural Studies, Bogota, Colombia; [Murphy, James J.] Univ Alaska Anchorage, Chair Econ, Dept Econ, Anchorage, AK 99508 USA; [Murphy, James J.; Spraggon, John M.; Stranlund, John K.] Univ Massachusetts, Dept Resource Econ, Amherst, MA 01003 USA		Lopez, MC (corresponding author), Indiana Univ, Bloomington, IN 47408 USA.	mlopez@javeriana.edu.co; murphy@uaa.alaska.edu; john.spraggon@gmail.com; stranlund@resecon.umass.edu						Barr A., 2001, 149 CTR STUD AFR EC; Beckenkamp M., 1999, RESOLVING SOCIAL DIL, P165; Bohnet I, 1999, J ECON BEHAV ORGAN, V38, P43, DOI 10.1016/S0167-2681(98)00121-8; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Davis DD, 1992, EXPT EC; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; Elster J, 1998, J ECON LIT, V36, P47; FALK A, 2001, 59 U ZUR I EMP RES E; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gachter S, 1999, J ECON BEHAV ORGAN, V39, P341, DOI 10.1016/S0167-2681(99)00045-1; Gintis H, 2003, 0207028 SANT FE I; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; HOLLANDER H, 1990, AM ECON REV, V80, P1157; KANDEL E, 1992, J POLIT ECON, V100, P801, DOI 10.1086/261840; Ledyard O., 1995, HDB EXPT EC, V1, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Lewis Helen Block, 1971, SHAME GUILT NEUROSIS; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Noussair C, 2005, ECON INQ, V43, P649, DOI 10.1093/ei/cbi045; Noussair C, 2007, PUBLIC FINANC REV, V35, P176, DOI 10.1177/1091142106290453; Ostmann A, 1998, RATION SOC, V10, P103, DOI 10.1177/104346398010001005; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Rege M, 2004, J PUBLIC ECON, V88, P1625, DOI 10.1016/S0047-2727(03)00021-5; Tangney J. P., 2002, SHAME GUILT; Tangney JP, 1996, J PERS SOC PSYCHOL, V70, P1256, DOI 10.1037/0022-3514.70.6.1256; Velez MA, 2010, ECON INQ, V48, P254, DOI 10.1111/j.1465-7295.2008.00125.x; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	29	43	44	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0095-2583			ECON INQ	Econ. Inq.	JAN	2012	50	1					131	142		10.1111/j.1465-7295.2010.00344.x	http://dx.doi.org/10.1111/j.1465-7295.2010.00344.x			12	Economics	Social Science Citation Index (SSCI)	Business & Economics	872YR		Green Submitted			2022-09-04	WOS:000298847900008
J	Trujillo, AJ; Ortiz, AIV; Gomez, FR; Steinhardt, LC				Trujillo, Antonio J.; Ortiz, Andres Ignacio Vecino; Ruiz Gomez, Fernando; Steinhardt, Laura C.			Health Insurance Doesn't Seem To Discourage Prevention Among Diabetes Patients In Colombia	HEALTH AFFAIRS			English	Article							EPIDEMIOLOGIC TRANSITION; MELLITUS; MANAGEMENT; COUNTRIES; SERVICES; CARE	In the South American nation of Colombia, as elsewhere, patients with type 2 diabetes often avoid care that could prevent their condition from worsening. Availability of health insurance may play a role in explaining this behavior. Some patients with diabetes skip preventive measures because they have insurance and calculate that they can access curative services later in life. Insurers may limit preventive services coverage because they can't be assured of sharing in the eventual savings that emerge when a chronic condition such as diabetes is managed properly. Our analysis of a nationally representative sample of Colombians who have type 2 diabetes and who pay premiums into the country's "contributory" insurance program, found no evidence that insurance influences those individuals to avoid preventive services. The evidence is less clear for those participating in a different, fully subsidized insurance program, who-despite the availability of preventive care-are no more likely to seek preventive visits than are uninsured patients. We propose controlled experiments to identify and measure the true causal effects of insurance on prevention and, more broadly, steps to increase patients' understanding of the benefits of prevention.	[Trujillo, Antonio J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Ortiz, Andres Ignacio Vecino] Univ Washington, Global Hlth Dept, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ruiz Gomez, Fernando] Pontificia Univ Javeriana, Ctr Dev Projects, Bogota, Colombia; [Steinhardt, Laura C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA		Trujillo, AJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	atrujill@jhsph.edu		Vecino-Ortiz, Andres I./0000-0002-8089-2488	Inter-American Development Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Inter-American Development Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by the Inter-American Development Bank. The authors are indebted to Amanda Glassman and Antonio Gluffrida for valuable comments during the development of the project. They also gratefully acknowledge suggestions by Philip Musgrove, Stephen Langel, and three anonymous referees on different versions of this manuscript. The paper benefits from suggestions made by participants in several seminars in the United States and Colombia. Lastly, this work was presented at the Hemispheric Meeting of the Social Protection and Health Network, Improving Chronic Disease Prevention and Management in Latin America and the Caribbean, which was held in Santiago, Chile, October 2010.	Albala C, 1997, REV MED CHILE, V125, P719; Albala C, 1995, PUBLIC HEALTH, V109, P431, DOI 10.1016/S0033-3506(95)80048-4; Arauz A G, 2001, Rev Panam Salud Publica, V9, P145, DOI 10.1590/S1020-49892001000300003; Arredondo A, 2004, DIABETES CARE, V27, P104, DOI 10.2337/diacare.27.1.104; BARCELO A, REV PANAM SALUD PUBL, V10, P300; BELTRAN LG, 2009, EVALUACION PROPUESTA; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; EHRLICH I, 1972, J POLIT ECON, V80, P623, DOI 10.1086/259916; ESLAVA C. JUAN CARLOS, 2002, Rev. salud pública, V4, P1; Gagliardino J J, 2001, Rev Panam Salud Publica, V10, P309, DOI 10.1590/S1020-49892001001100003; Glassman A. L., 2009, FEW MANY 10 YEARS HL; Goetzel RZ, 2009, HEALTH AFFAIR, V28, P37, DOI 10.1377/hlthaff.28.1.37; Kendall DM, 2001, AM J MANAG CARE, V7, pS327; Kenkel DS, 2000, HDB HLTH EC; Klick J, 2007, J LAW ECON, V50, P519, DOI 10.1086/519813; Levy H, 2004, HLTH POLICY UNINSURE, P179; Pagan JA, 2007, HEALTH ECON, V16, P1359, DOI 10.1002/hec.1226; PAULY MV, 1986, J ECON LIT, V24, P629; Peualoza E., 2009, ENCUESTA NACL SALUD; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rubin RJ, 1998, J CLIN ENDOCR METAB, V83, P2635, DOI 10.1210/jc.83.8.2635; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Trujillo AJ, 2004, J POLICY ANAL MANAG, V23, P873, DOI 10.1002/pam.20052; Trujillo AJ, 2003, HEALTH ECON, V12, P231, DOI 10.1002/hec.711	24	19	19	0	6	PROJECT HOPE	BETHESDA	7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA	0278-2715			HEALTH AFFAIR	Health Aff.	DEC	2010	29	12					2180	2188		10.1377/hlthaff.2010.0463	http://dx.doi.org/10.1377/hlthaff.2010.0463			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	690PF	21134918				2022-09-04	WOS:000285016000007
J	Gonzalez-Orozco, CE; Sosa, CC; Thornhill, AH; Laffan, SW				Gonzalez-Orozco, Carlos E.; Sosa, Chrystian C.; Thornhill, Andrew H.; Laffan, Shawn W.			Phylogenetic diversity and conservation of crop wild relatives in Colombia	EVOLUTIONARY APPLICATIONS			English	Article						agriculture; crop wild relatives; evolution; neotropics; phylogenetic diversity; species richness	AGRICULTURAL LAND-USE; SPATIAL PHYLOGENETICS; EVOLUTIONARY HISTORY; GENETIC DIVERSITY; SPECIES RICHNESS; CLIMATE-CHANGE; BIODIVERSITY; PATTERNS; ENDEMISM; FLORA	Crop wild relatives (CWR) are an important agricultural resource as they contain genetic traits not found in cultivated species due to localized adaptation to unique environmental and climatic conditions. Phylogenetic diversity (PD) measures the evolutionary relationship of species using the tree of life. Our knowledge of CWR PD in neotropical regions is in its infancy. We analysed the distribution of CWR PD across Colombia and assessed its conservation status. The areas with the largest concentration of PD were identified as being in the northern part of the central and western Andean mountain ranges and the Pacific region. These centres of high PD were comprised of predominantly short and closely related branches, mostly of species of wild tomatoes and black peppers. In contrast, the CWR PD in the lowland ecosystems of the Amazon and Orinoquia regions had deeply diverging clades predominantly represented by long and distantly related branches (i.e. tuberous roots, grains and cacao). We categorized 50 (52.6%) of the CWR species as 'high priority', 36 as 'medium priority' and nine as 'low priority' for further ex-situ and in situ conservation actions. New areas of high PD and richness with large ex-situ gap collections were identified mainly in the northern part of the Andes of Colombia. We found that 56% of the grid cells with the highest PD values were unprotected. These baseline data could be used to create a comprehensive national strategy of CWR conservation in Colombia.	[Gonzalez-Orozco, Carlos E.] Corp Colombiana Invest Agr AGROSAVIA, Ctr Invest Libertad, Villavicencio, Colombia; [Sosa, Chrystian C.] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Sosa, Chrystian C.] Univ Quindio, Grp Invest Evoluc Ecol & Conservac EECO, Programa Biol, Fac Ciencias Basicas & Tecnol, Armenia, Colombia; [Thornhill, Andrew H.] Univ Adelaide, Environm Inst, Adelaide, SA, Australia; [Thornhill, Andrew H.] State Herbarium South Australia, Bot Gardens & State Herbarium, Dept Environm & Water, Adelaide, SA, Australia; [Laffan, Shawn W.] Univ New South Wales, Earth & Sustainabil Sci Res Ctr, Sch Biol Earth & Environm Sci, Kensington, NSW, Australia		Gonzalez-Orozco, CE (corresponding author), Corp Colombiana Invest Agr Agrosavia, Ctr Invest Libertad, Km 14 Via Villavicencio Puerto Lopez, Bogota, Colombia.	cegonzalez@agrosavia.co	Laffan, Shawn W/A-3761-2008; Sosa, Chrystian/I-6787-2016	Laffan, Shawn W/0000-0002-5996-0570; Sosa, Chrystian/0000-0002-3734-3248; Gonzalez-Orozco, Carlos/0000-0002-4593-9113	Corporacion Colombiana de Investigacion Agropecuaria-Agrosavia	Corporacion Colombiana de Investigacion Agropecuaria-Agrosavia	Corporacion Colombiana de Investigacion Agropecuaria--Agrosavia	Agrosavia, 2014, ESTABLECIMIENTO BASE; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alzate Velásquez Diego Fernando, 2018, Colomb. for., V21, P102, DOI 10.14483/2256201x.11601; Alzate-Velasquez D. F., 2017, REGRAIN METHOD REGRA; Azevedo JAR, 2020, ECOGRAPHY, V43, P328, DOI 10.1111/ecog.04815; Baldwin BG, 2017, AM J BOT, V104, P487, DOI 10.3732/ajb.1600326; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Canas-Gutierrez G. P., 2019, Journal of Plant Breeding and Crop Science, V11, P106, DOI 10.5897/JPBCS2018.0792; Carver D, 2021, ECOGRAPHY, V44, P1000, DOI 10.1111/ecog.05430; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.22, 10.1038/NPLANTS.2016.22]; Chacon J, 2008, MOL PHYLOGENET EVOL, V49, P260, DOI 10.1016/j.ympev.2008.07.015; Couvreur TLP, 2007, SYST BOT, V32, P519, DOI 10.1600/036364407782250526; Crop Wild Relatives Occurrence Data Consortia-CWRODC, 2018, GLOB DAT DIST CROP W, DOI 10.15468/jyrthk; Dagallier LPMJ, 2020, NEW PHYTOL, V225, P2196, DOI 10.1111/nph.16293; Daru BH, 2019, GLOBAL ECOL BIOGEOGR, V28, P757, DOI 10.1111/geb.12888; DEBOUCK DG, 1993, ECON BOT, V47, P408, DOI 10.1007/BF02907356; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Faith DP, 2013, ANN NY ACAD SCI, V1289, P69, DOI 10.1111/nyas.12186; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Freyman WA, 2016, MATRIX MAKER; Garcia-R JC, 2019, ECOGRAPHY, V42, P500, DOI 10.1111/ecog.03783; Global Biodiversity Information Facility, 2019, GBIF OCC, DOI 10.15468/dl.ya4o6u; Gonzalez-Orozco CE, 2021, PHYTOTAXA, V484, P247, DOI [10.11646/phytotaxa.484.3.1, 10.11646/PHYTOTAXA.484.3.1]; Gonzalez-Orozco CE, 2020, GENET RESOUR CROP EV, V67, P2071, DOI 10.1007/s10722-020-00960-1; Gonzalez-Orozco CE, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.106015; Gonzalez-Orozco CE, 2016, NAT CLIM CHANGE, V6, P1110, DOI [10.1038/NCLIMATE3126, 10.1038/nclimate3126]; Gonzalez-Orozco CE, 2015, ECOL EVOL, V5, P5177, DOI 10.1002/ece3.1747; Gumbs R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16410-6; International Union for Conservation of Nature-IUCN, 2012, RESOLUTIONS; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jovovic Z, 2020, REDISCOVERY OF GENETIC AND GENOMIC RESOURCES FOR FUTURE FOOD SECURITY, P25, DOI 10.1007/978-981-15-0156-2_2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kell SP, 2017, CROP SCI, V57, P1042, DOI 10.2135/cropsci2016.10.0873; Khoury CK, 2020, DIVERS DISTRIB, V26, P209, DOI 10.1111/ddi.13008; Khoury CK, 2019, ECOL INDIC, V98, P420, DOI 10.1016/j.ecolind.2018.11.016; Khoury CK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0792; Laffan S.W, 2018, PHYLOGENETIC DIVERSI, P111; Laffan SW, 2016, METHODS ECOL EVOL, V7, P580, DOI 10.1111/2041-210X.12513; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Laffan SW, 2003, J BIOGEOGR, V30, P511, DOI 10.1046/j.1365-2699.2003.00875.x; Laity T, 2015, SCI TOTAL ENVIRON, V534, P131, DOI 10.1016/j.scitotenv.2015.04.113; Lombardo U, 2020, NATURE, V581, P190, DOI 10.1038/s41586-020-2162-7; Maitner BS, 2018, METHODS ECOL EVOL, V9, P373, DOI 10.1111/2041-210X.12861; Velez JM, 2016, GENET RESOUR CROP EV, V63, P47, DOI 10.1007/s10722-015-0234-6; Martin AR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209788; Maxted N, 2015, ECPGR CONCEPT SITU C; Maxted N, 2009, ESTABLISHMENT GLOBAL; Maxted N, 2007, BIOL CONSERV, V140, P142, DOI 10.1016/j.biocon.2007.08.006; Maxted N, 2021, GENET RESOUR CROP EV, V68, P1283, DOI 10.1007/s10722-021-01114-7; Maxted N, 2015, CROP WILD RELATIVES AND CLIMATE CHANGE, P88; Maxted N, 2012, CROP SCI, V52, P774, DOI 10.2135/cropsci2011.08.0415; Mayorga C, 2019, P I CONF MEC EL AUT, P56, DOI 10.1109/ICMEAE.2019.00018; Mienna IM, 2020, J BIOGEOGR, V47, P915, DOI 10.1111/jbi.13789; Miller MA, 2009, CIPRES PORTALS CIPRE; Miller R.E., 2018, N AM CROP WILD RELAT, P167, DOI [10.1007/978-3-319-95101-0_6, DOI 10.1007/978-3-319-95101-0_6]; Mishler B. D., 2010, CONT DEBATES PHILOS, P110; Mishler BD, 2020, J SYST EVOL, V58, P393, DOI 10.1111/jse.12590; Mishler BD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ocampo J., 2010, Diversity, V2, P1158, DOI 10.3390/d2111158; Park DS, 2020, NEW PHYTOL, V227, P1544, DOI 10.1111/nph.16621; Perales H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114657; Perez-Escobar OA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01328; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pironon S, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9091128; Rambaut A, 2009, FIGTREE VERSION 131; Ramirez-Villegas J, 2020, DIVERS DISTRIB, V26, P730, DOI 10.1111/ddi.13046; Rosauer Dan F, 2017, Proc Biol Sci, V284, DOI 10.1098/rspb.2017.0627; Scherson RA, 2017, MOL PHYLOGENET EVOL, V112, P88, DOI 10.1016/j.ympev.2017.04.021; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Sosa V, 2018, J SYST EVOL, V56, P523, DOI 10.1111/jse.12416; Sundaram M, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1887; Thornhill AH, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0435-x; Thornhill AH, 2016, J BIOGEOGR, V43, P2085, DOI 10.1111/jbi.12797; Tolley KA, 2016, BIOL CONSERV, V204, P63, DOI 10.1016/j.biocon.2016.04.006; Turley NE, 2016, ECOLOGY, V97, P2240, DOI 10.1002/ecy.1443; Uchida K, 2019, J APPL ECOL, V56, P1419, DOI 10.1111/1365-2664.13386; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vincent H, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0372-z; Viruel J, 2021, BOT J LINN SOC, V195, P1, DOI 10.1093/botlinnean/boaa064; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Zhang HY, 2017, EVOL APPL, V10, P5, DOI 10.1111/eva.12434; Zhang J, 2015, DIVERS DISTRIB, V21, P1441, DOI 10.1111/ddi.12365	86	1	1	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-4571			EVOL APPL	Evol. Appl.	NOV	2021	14	11					2603	2617		10.1111/eva.13295	http://dx.doi.org/10.1111/eva.13295		SEP 2021	15	Evolutionary Biology	Science Citation Index Expanded (SCI-EXPANDED)	Evolutionary Biology	WX0FR	34815742	gold, Green Published			2022-09-04	WOS:000696225800001
S	Shakour, N; Cabezas, R; Santos, JG; Barreto, GE; Jamialahmadi, T; Hadizadeh, F; Sahebkar, A		Barreto, GE; Sahebkar, A		Shakour, Neda; Cabezas, Ricardo; Gonzalez Santos, Janneth; Barreto, George E.; Jamialahmadi, Tannaz; Hadizadeh, Farzin; Sahebkar, Amirhossein			Curcumin Can Bind and Interact with CRP: An in silico Study	PHARMACOLOGICAL PROPERTIES OF PLANT-DERIVED NATURAL PRODUCTS AND IMPLICATIONS FOR HUMAN HEALTH	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Curcumin; Curcumin derivatives; C-reactive protein; Molecular docking; Molecular dynamic simulation	C-REACTIVE PROTEIN; PROLIFERATION; CANDIDATE; COMPOUND	Curcuminis a polyphenol with anti-inflammatory and antioxidative properties, found primarily in turmeric, a flowering plant of the ginger family. Among its numerous medical uses, curcumin has been used in the management of metabolic syndrome, and inflammatory conditions such as artrhritis, anxiety and hyperlipidemia. In this paper, we used molecular docking tools to assess the affinity of four curcumin derivatives (Curcumin, Cyclocurcumin, Demethoxycurcumin, Bisdemethoxycurcumin) as well as the endogenous ligand phosphorylcholine to C-reactive protein (CRP), a sensitive marker of systemic inflammation. Our results showed that curcumin interacts through H bond with CRP at GLN 150 and ASP 140. Similar H bond interactions were found for each of the four curcumin derivatives with CRP. Moreover, a molecular dynamic simulation were performed to further establish the interaction between CRP and the ligands in atomic details using the Nanoscale Molecular Dynamics (NAMD) and CHARMM27 force field. Importantly, our results suggest the possible interaction between curcumin and curcurmin related molecules with CRP, thus showing an important regulatory function with plausible applications in inflammatory and oxidative processes in diseases.	[Shakour, Neda; Hadizadeh, Farzin] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Razavi Khorasan, Iran; [Cabezas, Ricardo] Univ Antonio Narino, Sch Med, Dept Physiol, Bogota, Colombia; [Gonzalez Santos, Janneth] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Jamialahmadi, Tannaz] Islamic Azad Univ, Dept Food Sci & Technol, Quchan Branch, Quchan, Iran; [Jamialahmadi, Tannaz] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran; [Hadizadeh, Farzin; Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland		Hadizadeh, F (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Razavi Khorasan, Iran.; Hadizadeh, F; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland.	hadizadehf@mums.ac.ir; sahebkara@mums.ac.ir	Santos-Junior, Jair Guilherme/B-1880-2016	Jami, Tannaz/0000-0001-9521-3153				Adibian M, 2019, PHYTOTHER RES, V33, P1374, DOI 10.1002/ptr.6328; Alvarenga L, 2020, CLIN NUTR; [Anonymous], 2014, CHINESE J BIOL; Bagheri H, 2020, BIOFACTORS, V46, P5, DOI 10.1002/biof.1566; Derosa G, 2020, DIABET METAB SYND OB, P13653; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Forouzanfar F, 2020, IUBMB LIFE, V72, P652, DOI 10.1002/iub.2209; Gao XH, 2004, BIOCHEM PHARMACOL, V68, P51, DOI 10.1016/j.bcp.2004.03.015; Ghanaatian N, 2019, J CELL PHYSIOL, V234, P12237, DOI 10.1002/jcp.27965; Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605; Ghasemi F, 2019, NEUROTOX RES, V36, P12, DOI 10.1007/s12640-019-00030-0; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177; Hasanzadeh S, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104921; Iranshahi M, 2009, EUR J CANCER PREV, V18, P412, DOI 10.1097/CEJ.0b013e32832c389e; Lopez-Malo D, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010048; Mohajeri M, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104765; Mollazadeh H, 2019, CRIT REV FOOD SCI, V59, P89, DOI 10.1080/10408398.2017.1358139; Momtazi AA, 2016, MOL DIAGN THER, V20, P335, DOI 10.1007/s40291-016-0202-7; Noorafshan A, 2013, CURR PHARM DESIGN, V19, P2032; Panahi Y, 2018, DRUG RES, V68, P403, DOI 10.1055/s-0044-101752; Panahi Y, 2018, J CELL PHYSIOL, V233, P141, DOI 10.1002/jcp.25756; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; Rauf A, 2018, TRENDS FOOD SCI TECH, V74, P33, DOI 10.1016/j.tifs.2018.01.016; Saberi-Karimian M, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2020.102322; Sadeghian M, 2021, J AFFECT DISORDERS, V278, P627, DOI 10.1016/j.jad.2020.09.091; Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045; Selvam C, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117032; Shinde S, 2014, J THEOR BIOL, V351, P37, DOI 10.1016/j.jtbi.2014.02.017; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Sohilait MR, 2017, BIOINFORMATION, V13, P356, DOI 10.6026/97320630013356; Soleimani V, 2018, PHYTOTHER RES, V32, P985, DOI 10.1002/ptr.6054; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6; Tabrizi R, 2019, PHYTOTHER RES, V33, P253, DOI 10.1002/ptr.6226; Talapatra SN, 2017, INT LETT NAT SCI, P6143; Teymouri M, 2017, BIOFACTORS, V43, P331, DOI 10.1002/biof.1344; Tilak JC, 2004, PHYTOTHER RES, V18, P798, DOI 10.1002/ptr.1553; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YQ, 2018, IMMUNOPHARM IMMUNOT, V40, P476, DOI 10.1080/08923973.2018.1469145; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b	41	4	4	2	6	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-64872-5; 978-3-030-64871-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2021	1308						91	100		10.1007/978-3-030-64872-5_7	http://dx.doi.org/10.1007/978-3-030-64872-5_7	10.1007/978-3-030-64872-5		10	Chemistry, Medicinal; Medicine, Research & Experimental; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Research & Experimental Medicine	BR3MG	33861438				2022-09-04	WOS:000647701200007
J	Angarita, H; Wickel, AJ; Sieber, J; Chavarro, J; Maldonado-Ocampo, JA; Herrera, GA; Delgado, J; Purkey, D				Angarita, Hector; Wickel, Albertus J.; Sieber, Jack; Chavarro, John; Maldonado-Ocampo, Javier A.; Herrera-R., Guido A.; Delgado, Juliana; Purkey, David			Basin-scale impacts of hydropower development on the Mompos Depression wetlands, Colombia	HYDROLOGY AND EARTH SYSTEM SCIENCES			English	Article							MAGDALENA RIVER; HYDROLOGICAL ALTERATIONS; FISH; DAMS; FLOODPLAIN; PATTERNS; TRENDS; CONNECTIVITY; RESERVOIRS; RESOURCES	A number of large hydropower dams are currently under development or in an advanced stage of planning in the Magdalena River basin, Colombia, spelling uncertainty for the Mompos Depression wetlands, one of the largest wetland systems in South America at 3400 km(2). Annual large-scale inundation of floodplains and their associated wetlands regulates water, nutrient, and sediment cycles, which in turn sustain a wealth of ecological processes and ecosystem services, including critical food supplies. In this study, we implemented an integrated approach focused on key attributes of ecologically functional floodplains: (1) hydrologic connectivity between the river and the floodplain, and between upstream and downstream sections; (2) hydrologic variability patterns and their links to local and regional processes; and (3) the spatial scale required to sustain floodplain-associated processes and benefits, like migratory fish biodiversity. The implemented framework provides an explicit quantification of the nonlinear or direct response relationship of those considerations with hydropower development. The proposed framework was used to develop a comparative analysis of the potential effects of the hydropower expansion necessary to meet projected 2050 electricity requirements. As part of this study, we developed an enhancement of the Water Evaluation and Planning system (WEAP) that allows resolution of the floodplains water balance at a medium scale (similar to 1000 to 10 000 km(2)) and evaluation of the potential impacts of upstream water management practices. In the case of the Mompos Depression wetlands, our results indicate that the potential additional impacts of new hydropower infrastructure with respect to baseline conditions can range up to one order of magnitude between scenarios that are comparable in terms of energy capacity. Fragmentation of connectivity corridors between lowland floodplains and upstream spawning habitats and reduction of sediment loads show the greatest impacts, with potential reductions of up to 97.6 and 80 %, respectively, from pre-dam conditions. In some development scenarios, the amount of water regulated and withheld by upstream infrastructure is of similar magnitude to existing fluxes involved in the episodic inundation of the floodplain during dry years and, thus, can also induce substantial changes in floodplain seasonal dynamics of average-to-dry years in some areas of the Mompos Depression.	[Angarita, Hector; Delgado, Juliana] Nature Conservancy, Bogota, Colombia; [Angarita, Hector] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Grp Ecol & Terr, Bogota, Colombia; [Wickel, Albertus J.; Purkey, David] Stockholm Environm Inst US Ctr, Davis, CA USA; [Sieber, Jack] Stockholm Environm Inst US Ctr, Somerville, MA USA; [Chavarro, John] Ctr Invest Ciencias & Recursos GeoAgroAmbientales, Neiva, Colombia; [Maldonado-Ocampo, Javier A.; Herrera-R., Guido A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS,Lab Ictiol, Bogota, Colombia; [Herrera-R., Guido A.] Paul Sabatier Univ, Lab Evolut & Divers Biol EDB, Toulouse, France		Angarita, H (corresponding author), Nature Conservancy, Bogota, Colombia.; Angarita, H (corresponding author), Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Grp Ecol & Terr, Bogota, Colombia.	hangarita@javeriana.edu.co		Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Herrera-R, Guido A/0000-0001-5686-6362	USAID [AID-S14-A-13-00004, AID-514-A-12-00002]; Rio Magdalena Watershed Management Program; "Generacion del Bicentenario" scholarship program - Colombia's Departamento administrativo de ciencia, tecnologia e innovacion - Colciencias	USAID(United States Agency for International Development (USAID)); Rio Magdalena Watershed Management Program; "Generacion del Bicentenario" scholarship program - Colombia's Departamento administrativo de ciencia, tecnologia e innovacion - Colciencias	This work was supported by USAID Cooperative Agreement Award No. AID-S14-A-13-00004 and AID-514-A-12-00002, the Rio Magdalena Watershed Management Program, and "Generacion del Bicentenario" scholarship program funded by Colombia's Departamento administrativo de ciencia, tecnologia e innovacion - Colciencias. The authors would like to thank Anne G. Hereford for her contributions in writing assistance, technical editing, language editing, and proofreading.	Angarita H., 2013, MEM C INT AGUA; [Anonymous], PLAN EXP REF GEN TRA; Antonio Villa-Navarro Francisco, 2014, Biota Colombiana, V15, P111; ARCADIS Nederland BV and JESYCA S. A. S, 2015, PLAN MAESTR FLUV COL; Arias ME, 2014, HYDROL EARTH SYST SC, V18, P5303, DOI 10.5194/hess-18-5303-2014; BAYLEY PB, 1995, BIOSCIENCE, V45, P153, DOI 10.2307/1312554; Carvajal-Quintero JD, 2017, CONSERV LETT, V10, P708, DOI 10.1111/conl.12336; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Cramton P., 2007, P 40 ANN HAW INT C S; Deemer BR, 2016, BIOSCIENCE, V66, P949, DOI 10.1093/biosci/biw117; DENDY FE, 1974, T ASAE, V17, P898; Departamento Nacional de Planeacion, 1979, EST SECT EN EL INV R; DePhilip M., 2013, ECOSYSTEM FLOW RECOM; DHI, 2016, MIKE21; Dutta D, 2013, J HYDROL, V504, P12, DOI 10.1016/j.jhydrol.2013.09.033; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Estrada M., 2015, REV ESTUDIOS PENALES, P1, DOI [10.1109/ ROPEC.2015.7395132, DOI 10.1109/ROPEC.2015.7395132]; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; FAO, 2015, COL PESC CIFR 2014 F; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FitzHugh TW, 2011, RIVER RES APPL, V27, P1192, DOI 10.1002/rra.1417; Fullerton AH, 2010, FRESHWATER BIOL, V55, P2215, DOI 10.1111/j.1365-2427.2010.02448.x; Galvis G, 2007, AQUAT ECOSYST HEALTH, V10, P127, DOI 10.1080/14634980701357640; Gao YX, 2009, J HYDROL, V374, P136, DOI 10.1016/j.jhydrol.2009.06.009; Gill R., 2013, NEW FRONTIER HYDROPO; Grant G.E., 2011, WATER SCI APPL, P203, DOI [10.1029/007ws13, DOI 10.1029/007WS13]; Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; IDEAM, 2010, SIST MORF TERR COL; IDEAM, 2015, OBS SIST INF REC HID; IDEAM IGAC IAvH INVEMAR I. Sinchi & IIAP, 2007, EC CONT COST MAR COL; IDEAM [Institut de Hidrologia Meteorologia y Estudios Ambientales], 2014, EST NAC AG; Isabel Pareja-Carmona Maria, 2014, Biota Colombiana, V15, P54; Jaramillo U., 2015, COLOMBIA ANFIBIA PAI, V1; Jaramillo-Villa U, 2010, J FISH BIOL, V76, P2401, DOI 10.1111/j.1095-8649.2010.02629.x; Jimenez-Segura L. F., 2014, ICTIOFAUNA DESARROLL; LASSO C.A., 2011, SERIE EDITORIAL RECU; Lehner B., 2008, EOS, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Lewin J, 2014, GEOMORPHOLOGY, V215, P83, DOI 10.1016/j.geomorph.2013.02.024; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lopez-Casas S, 2016, J FISH BIOL, V89, P157, DOI 10.1111/jfb.12941; Lopez-Casas Silvia, 2014, Biota Colombiana, V15, P26; Maeck A, 2013, ENVIRON SCI TECHNOL, V47, P8130, DOI 10.1021/es4003907; Maldonado-Ocampo Javier A., 2008, Biota Colombiana, V9, P143; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nardini A, 2016, RESOURCES-BASEL, V5, DOI 10.3390/resources5030022; Opperman J., 2015, POWER RIVERS FINDING; Opperman JJ, 2010, J AM WATER RESOUR AS, V46, P211, DOI 10.1111/j.1752-1688.2010.00426.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piman T, 2016, RIVER RES APPL, V32, P2095, DOI 10.1002/rra.3045; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Posada G. L., 2006, 17 SEM NAC HIDR HIDR, P655; Poveda German, 2011, Climate Dynamics, V36, P2233, DOI 10.1007/s00382-010-0931-y; Poveda G, 1997, J CLIMATE, V10, P2690, DOI 10.1175/1520-0442(1997)010<2690:FBHPIT>2.0.CO;2; Poveda G, 2001, WATER RESOUR RES, V37, P2169, DOI 10.1029/2000WR900395; Restrepo JD, 2006, J HYDROL, V316, P213, DOI 10.1016/j.jhydrol.2005.05.002; Restrepo-López Juan Camilo, 2015, Rev. acad. colomb. cienc. exact. fis. nat., V39, P527, DOI 10.18257/raccefyn.209; Richter BD, 1998, REGUL RIVER, V14, P329; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Ritter J., 2016, OPTIMISATION HYDROPO; Roberts S., 2017, ANUGA OPEN SOURCE HY; Ropke CP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40170; SEI, 2017, WAT EV PLANN WEAP; SMITH DG, 1986, SEDIMENT GEOL, V46, P177, DOI 10.1016/0037-0738(86)90058-8; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P913, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Tanner W. F., 1974, GEOLOGY, V2, P281, DOI [10.1130/0091-7613(1974)2&lt281a:TIFPR&gt2.0.CO;2, DOI 10.1130/0091-7613(1974)2&LT281A:TIFPR&GT2.0.CO;2]; Dang TD, 2016, HYDROL PROCESS, V30, P3824, DOI 10.1002/hyp.10894; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; UPME, 2015, PLAN EN NAC; Verdin KL, 1999, J HYDROL, V218, P1, DOI 10.1016/S0022-1694(99)00011-6; Vogel RM, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005226; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wilkinson SN, 2009, ENVIRON MODELL SOFTW, V24, P489, DOI 10.1016/j.envsoft.2008.09.006; XM, 2005, HIST HIDR COMP EXP M; XM, 2014, INF OP SIN ADM MERC; Yang X, 2014, EVID-BASED COMPL ALT, V2014, P1, DOI DOI 10.1155/2014/187484; Yates D, 2005, WATER INT, V30, P501, DOI 10.1080/02508060508691894; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	84	26	28	2	25	COPERNICUS GESELLSCHAFT MBH	GOTTINGEN	BAHNHOFSALLEE 1E, GOTTINGEN, 37081, GERMANY	1027-5606	1607-7938		HYDROL EARTH SYST SC	Hydrol. Earth Syst. Sci.	MAY 8	2018	22	5					2839	2865		10.5194/hess-22-2839-2018	http://dx.doi.org/10.5194/hess-22-2839-2018			27	Geosciences, Multidisciplinary; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Geology; Water Resources	GF0VK		gold			2022-09-04	WOS:000431649000005
J	Tomatsu, S; Montano, AM; Oikawa, H; Rowan, DJ; Smith, M; Barrera, L; Chinen, Y; Thacker, MM; Mackenzie, WG; Suzuki, Y; Orii, T				Tomatsu, S.; Montano, A. M.; Oikawa, H.; Rowan, Daniel J.; Smith, M.; Barrera, L.; Chinen, Y.; Thacker, M. M.; Mackenzie, W. G.; Suzuki, Y.; Orii, T.			Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review	CURRENT PHARMACEUTICAL BIOTECHNOLOGY			English	Review						Mucopolysaccharidosis IVA; keratan sulfate; GALNS; chondrodysplasia; enzyme replaement therapy; bone marrow transplantation; tandem mass spectrometry	ENZYME-REPLACEMENT THERAPY; LYSOSOMAL STORAGE DISEASES; SULFATASE GALNS GENE; TERM-FOLLOW-UP; N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE; DRUG-DELIVERY; KERATAN-SULFATE; DEFICIENCY; MUTATION; BONE	Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A, is a rare, autosomal recessive disorder caused by a deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate-sulfatase (GALNS), which catalyzes a step in the catabolism of glycosaminoglycans (GAGs), keratan sulfate (KS) and chondroitin-6-sulfate (C6S). It leads to accumulation of the KS and C6S, mainly in bone and cornea, causing a systemic skeletal chondrodysplasia. MPS IVA has a variable age of onset and variable rate of progression. Common presenting features include elevation of urinary and blood KS, marked short stature, hypoplasia of the odontoid process, pectus carinatum, kyphoscoliosis, genu valgum, laxity of joints and corneal clouding; however there is no central nervous system impairment. Generally, MPS IVA patients with a severe form do not survive beyond the third decade of life whereas those patients with an attenuated form may survive over 70 years. There has been no effective therapy for MPS IVA, and care has been palliative. Enzyme replacement therapy (ERT) and hematopoietic stem cell therapy (HSCT) have emerged as a treatment for mucopolysaccharidoses disorders, including Morquio A disease. This review provides an overview of the clinical manifestations, diagnosis and symptomatic management of patients with MPS IVA and describes potential perspectives of ERT and HSCT. The issue of treating very young patients is also discussed.	[Tomatsu, S.; Montano, A. M.; Oikawa, H.; Rowan, Daniel J.] St Louis Univ, Dept Pediat, St Louis, MO 63104 USA; [Smith, M.] Int Morquio Org, Phoenix, AZ USA; [Barrera, L.] Pontificia Univ Javeriana, Inst Study Inborn Errors Metab, Bogota, Colombia; [Chinen, Y.] Univ Ryukyus, Dept Pediat, Fac Med, Okinawa, Japan; [Thacker, M. M.; Mackenzie, W. G.] Alfred I duPont Hosp Children, Wilmington, DE USA; [Suzuki, Y.; Orii, T.] Gifu Univ, Dept Pediat, Gifu, Japan		Tomatsu, S (corresponding author), St Louis Univ, Dept Pediat, Doisy Res Ctr Room 307,1100 S Grand Blvd, St Louis, MO 63104 USA.	tomatsus@slu.edu	Thacker, Mihir/AAN-6014-2020; Rowan, Daniel/AAP-8347-2020; Montano, Adriana/AHE-8741-2022	Rowan, Daniel/0000-0001-7830-2525; Thacker, Mihir/0000-0002-6236-8703				Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; ARBISSER AI, 1977, AM J MED GENET, V1, P195, DOI 10.1002/ajmg.1320010205; BAKER E, 1993, AM J HUM GENET, V52, P96; BIELICKI J, 1991, BIOCHEM J, V279, P515, DOI 10.1042/bj2790515; Brailsford JF, 1929, AM J SURG, V7, P404, DOI DOI 10.1016/S0002-9610(29)90496-7; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; DIFERRANTE N, 1978, SCIENCE, V199, P79, DOI 10.1126/science.199.4324.79; Dullenkopf A, 2002, CAN J ANAESTH, V49, P198, DOI 10.1007/BF03020496; FUJIMOTO A, 1983, AM J MED GENET, V15, P265, DOI 10.1002/ajmg.1320150210; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gutierrez MA, 2008, BIOMEDICA, V28, P448; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; HECHT JT, 1984, AM J MED GENET, V18, P369, DOI 10.1002/ajmg.1320180222; IWAMOTO M, 1990, GRAEF ARCH CLIN EXP, V228, P342, DOI 10.1007/BF00920060; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kanazawa T, 2001, ACTA ORTHOP SCAND, V72, P18, DOI 10.1080/000164701753606635; Kasmann-Kellner B, 1999, OPHTHALMOLOGICA, V213, P200, DOI 10.1159/000027420; Kato Z, 1997, HUM GENET, V101, P97, DOI 10.1007/s004390050594; Khanna G, 2007, BONE MARROW TRANSPL, V39, P331, DOI 10.1038/sj.bmt.1705586; Lim-Melia ER, 2009, PEDIATR ANN, V38, P448, DOI 10.3928/00904481-20090723-09; LOWRY RB, 1990, HUM GENET, V85, P389; Malefijt MCD, 2000, ARCH ORTHOP TRAUM SU, V120, P179, DOI 10.1007/s004020050039; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; MASUNO M, 1993, GENOMICS, V16, P777, DOI 10.1006/geno.1993.1266; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P1450, DOI 10.1016/S0006-291X(74)80446-8; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; Montano AM, 2008, AM J MED GENET A, V146A, P1286, DOI 10.1002/ajmg.a.32281; Montano AM, 2003, HUM GENET, V113, P162, DOI 10.1007/s00439-003-0959-8; Montano AM, 2000, BBA-MOL BASIS DIS, V1500, P323, DOI 10.1016/S0925-4439(99)00119-2; MORQUIO L., 1929, ARCH MED ENFANTS, V32, P129; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; NAKASHIMA Y, 1994, GENOMICS, V20, P99, DOI 10.1006/geno.1994.1132; Nelson J, 1997, HUM GENET, V101, P355, DOI 10.1007/s004390050641; Nelson J, 2003, AM J MED GENET A, V123A, P310, DOI 10.1002/ajmg.a.20314; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI 10.1111/j.1651-2227.2009.01134.x; Oncag G, 2006, ANGLE ORTHOD, V76, P335; Orii T, 1981, CONNECT TISSUE RES, V13, P169; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; RIEDNER ED, 1977, ARCH OTOLARYNGOL, V103, P518, DOI 10.1001/archotol.1977.00780260048003; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; SUKEGAWA K, 1982, J INHERIT METAB DIS, V5, P231, DOI 10.1007/BF02179150; Sukegawa K, 2000, HUM MOL GENET, V9, P1283, DOI 10.1093/hmg/9.9.1283; Tolar J, 2008, BONE MARROW TRANSPL, V41, P531, DOI 10.1038/sj.bmt.1705934; TOMATSU S, 1995, AM J HUM GENET, V57, P556; Tomatsu S, 2005, HUM MUTAT, V26, P500, DOI 10.1002/humu.20257; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2007, MOL GENET METAB, V91, P251, DOI 10.1016/j.ymgme.2007.02.009; Tomatsu S, 2007, MOL GENET METAB, V91, P69, DOI 10.1016/j.ymgme.2007.01.004; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Tomatsu S, 2010, J INHERIT METAB DIS, V33, P141, DOI 10.1007/s10545-009-9036-3; Vellodi A, 1999, J INHERIT METAB DIS, V22, P638, DOI 10.1023/A:1005525931994; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228	68	145	155	0	23	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-2010	1873-4316		CURR PHARM BIOTECHNO	Curr. Pharm. Biotechnol.	JUN	2011	12	6					931	945		10.2174/138920111795542615	http://dx.doi.org/10.2174/138920111795542615			15	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	777QF	21506915				2022-09-04	WOS:000291638000010
J	Barron, K; Omiunu, A; Celidonio, J; Cruz-Mullane, A; Din-Lovinescu, C; Chemas-Velez, MM; Baredes, S; Eloy, JA; Fang, CH				Barron, Kendyl; Omiunu, Ariel; Celidonio, Joseph; Cruz-Mullane, Alexandra; Din-Lovinescu, Corina; Chemas-Velez, Maria Manuela; Baredes, Soly; Eloy, Jean Anderson; Fang, Christina H.			Kaposi Sarcoma of the Larynx: A Systematic Review	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Review; Early Access						Kaposi sarcoma; larynx; AIDS; HIV; human herpesvirus 8; chemotherapy; radiotherapy; surgical management; systematic review	PEGYLATED-LIPOSOMAL DOXORUBICIN; IMMUNE-DEFICIENCY-SYNDROME; UPPER AIRWAY-OBSTRUCTION; INTRALESIONAL VINBLASTINE; DIFFICULT AIRWAY; AIDS; HIV; HEAD; THERAPY; NECK	Objective Kaposi sarcoma (KS) of the larynx is a rare disease with few cases reported in the literature. This study aims to provide a comprehensive review of laryngeal KS, including patient characteristics, treatment, and clinical outcomes. Data Sources PubMed, CINAHL, SCOPUS, and Cochrane Library. Review Methods A systematic review of the published English literature was conducted. An electronic search and bibliographic examination of articles pertaining to laryngeal KS were performed. Demographic data, tumor site, treatment strategies, follow-up, and outcome were analyzed. Results A total 77 cases from 50 articles were included in the review. The mean age was 47.6 years (range, 8-81). There was an 8.6:1 male:female ratio. The most common presenting symptoms were dyspnea (n = 35) and hoarseness (n = 25). Laryngeal KS arose most frequently in the supraglottic region (n = 16). Chemotherapy alone (n = 27) was the most common treatment modality in patients with AIDS-associated KS, and surgical excision alone (n = 7) was most common in patients with other subtypes of KS (eg, classic, transplant associated). Average follow-up was 20.4 months (range, 0.75-120). Most patients with AIDS-associated KS died of other causes (n = 25), but most patients with other subtypes of KS were alive with no evidence of disease at follow-up (n = 13). Conclusion This review contains the largest pool of laryngeal KS cases to date. Long-term outcomes were generally unfavorable, often due to advanced HIV disease at the time of diagnosis.	[Barron, Kendyl; Omiunu, Ariel; Celidonio, Joseph; Cruz-Mullane, Alexandra; Din-Lovinescu, Corina; Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ USA; [Chemas-Velez, Maria Manuela] Pontificia Univ Javeriana, Dept Otolaryngol & Maxillofacial Surg, Bogota, Colombia; [Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Ctr Skull Base & Pituitary Surg, Neurol Inst New Jersey, Newark, NJ USA; [Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Ophthalmol & Visual Sci, Newark, NJ USA; [Eloy, Jean Anderson] St Barnabas Med Ctr RWJBarnabas Hlth, Dept Otolaryngol & Facial Plast Surg, Livingston, NJ USA; [Fang, Christina H.] Montefiore Med Ctr, Albert Einstein Coll Med, Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, 3400 Bainbridge Ave,Med Arts Pavil,Third Floor, Bronx, NY 10467 USA		Fang, CH (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, 3400 Bainbridge Ave,Med Arts Pavil,Third Floor, Bronx, NY 10467 USA.	christina.fang1@gmail.com		Barron, Kendyl/0000-0003-3310-1492; Celidonio, Joseph/0000-0003-4529-5853				AbdullGaffar B, 2018, ANN DIAGN PATHOL, V37, P35, DOI 10.1016/j.anndiagpath.2018.09.007; ABEMAYOR E, 1983, ARCH OTOLARYNGOL, V109, P536; Ablanedo-Terrazas Y., 2015, LARYNGOSCOPE, V125; ABRAMSON AL, 1970, ARCHIV OTOLARYNGOL, V92, P505; Agaimy A, 2018, HEAD NECK PATHOL, V12, P511, DOI 10.1007/s12105-018-0902-x; Alkhuja S, 2001, AIDS PATIENT CARE ST, V15, P293, DOI 10.1089/108729101750279650; Angouridakis N, 2006, EUR ARCH OTO-RHINO-L, V263, P537, DOI 10.1007/s00405-006-0007-0; Ares C, 2005, NAT CLIN PRACT ONCOL, V2, P473, DOI 10.1038/ncponc0294; Beitler AJ, 1996, CHEST, V109, P836, DOI 10.1378/chest.109.3.836; Biricik M, 2019, SAUDI J KIDNEY DIS T, V30, P537, DOI 10.4103/1319-2442.256864; Bishop BN., 2021, KAPOSI SARCOMA; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Bradley PJ, 1999, OTOLARYNG HEAD NECK, V120, P737, DOI 10.1053/hn.1999.v120.a90043; Brambilla L, 2010, BRIT J DERMATOL, V162, P854, DOI 10.1111/j.1365-2133.2009.09601.x; Cabezas-Calderon V, 2020, INT J STD AIDS, V31, P600, DOI 10.1177/0956462420916291; Cesarman E, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0060-9; Chemas-Velez MM., 2020, OTOLARYNGOLOGY CASE, V17, P100237; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; COYAS A, 1983, J LARYNGOL OTOL, V97, P647, DOI 10.1017/S0022215100094755; Dhanasekar Ganapathy, 2006, Ulster Med J, V75, P160; Dispenza F, 2010, B-ENT, V6, P289; EMERY CD, 1986, AM J ROENTGENOL, V147, P919, DOI 10.2214/ajr.147.5.919; Facciola A, 2017, EUR REV MED PHARMACO, V21, P5868, DOI 10.26355/eurrev_201712_14036; Faiq TN., 2013, KIRKUK J MEDICAL SCI, V1, P81; Friedman M, 1996, ANN OTO RHINOL LARYN, V105, P272, DOI 10.1177/000348949610500405; Gasparetto TD, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-18; Geraminejad P, 2002, J AM ACAD DERMATOL, V47, P641, DOI 10.1067/mjd.2002.128383; GNEPP DR, 1984, ANN INTERN MED, V100, P107, DOI 10.7326/0003-4819-100-1-107; GRIDELLI C, 1990, TUMORI, V76, P292, DOI 10.1177/030089169007600318; Guan CS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012530; Hosseinipour MC, 2014, MBIO, V5, DOI 10.1128/mBio.01633-14; Howick J., 2011, EXPLANATION 2011 OXF; Karatayli-Ozgursoy S, 2016, AM J OTOLARYNG, V37, P279, DOI 10.1016/j.amjoto.2016.01.005; Kato H, 2016, INTERNAL MED, V55, P1001, DOI 10.2169/internalmedicine.55.5813; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Krown SE, 2008, NEW ENGL J MED, V358, P535, DOI 10.1056/NEJMc072994; Kucuk I, 2014, J CRANIOFAC SURG, V25, P1105, DOI 10.1097/SCS.0000000000000701; Lawson G, 2010, B-ENT, V6, P285; LEVINE HL, 1986, OTOLARYNG CLIN N AM, V19, P475; LEVY F E, 1990, Ear Nose and Throat Journal, V69, P182; Li J, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, V52, P373; Liao CH, 2003, TRANSPLANTATION, V76, P884, DOI 10.1097/01.TP.0000084182.74269.4D; Lin CH, 1998, J OTOLARYNGOL SOC RE, V33, P256; Liu WH, 2018, SAUDI J KIDNEY DIS T, V29, P426, DOI 10.4103/1319-2442.229298; Liu Z, 2018, HIV MED, V19, P355, DOI 10.1111/hiv.12584; Mani Deepthi, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P279, DOI 10.1177/1545109709341852; Mantilla JG, 2020, HEAD NECK PATHOL, V14, P707, DOI 10.1007/s12105-019-01106-1; Marino D, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009467; Martin-Carbonero L, 2004, AIDS, V18, P1737, DOI 10.1097/01.aids.0000131385.60974.b9; Garcia PM, 2019, ATEN PRIM, V51, P257, DOI 10.1016/j.aprim.2018.04.008; Maurer T, 2007, NEW ENGL J MED, V357, P1352, DOI 10.1056/NEJMc070508; MEDURI GU, 1986, AM J MED, V81, P11, DOI 10.1016/0002-9343(86)90175-0; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; MEYERS AD, 1976, T AM ACAD OPHTHALMOL, V82, P560; Miner JE, 2000, ANESTH ANALG, V90, P1223, DOI 10.1097/00000539-200005000-00043; Mochloulis G, 1996, J LARYNGOL OTOL, V110, P1034, DOI 10.1017/S0022215100135698; Motta S, 2005, OTOLARYNG HEAD NECK, V132, P802, DOI 10.1016/j.otohns.2004.09.105; Ngalamika O, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254177; Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445; Nosyk B, 2014, MED CARE, V52, P362, DOI 10.1097/MLR.0000000000000097; Pantanowitz Liron, 2006, AIDS Read, V16, P194; Pantanowitz L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-190; PATOW CA, 1984, OTOLARYNG HEAD NECK, V92, P713; Qin J, 2017, ADV EXP MED BIOL, V1018, P237, DOI 10.1007/978-981-10-5765-6_15; Radu O, 2013, ARCH PATHOL LAB MED, V137, P289, DOI 10.5858/arpa.2012-0101-RS; Restrepo CS, 2011, SEMIN ULTRASOUND CT, V32, P456, DOI 10.1053/j.sult.2011.03.007; REYNOLDS WA, 1965, MEDICINE, V44, P419, DOI 10.1097/00005792-196509000-00003; Ribeiro C, 2011, J BRONCHOL INTERN PU, V18, P259, DOI 10.1097/LBR.0b013e318222a1b8; ROY T M, 1991, Journal of Emergency Medicine, V9, P23, DOI 10.1016/0736-4679(91)90527-M; Royse KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182750; Schiff NF, 1997, ANN OTO RHINOL LARYN, V106, P563, DOI 10.1177/000348949710600706; Schneider JW, 2017, AM J CLIN DERMATOL, V18, P529, DOI 10.1007/s40257-017-0270-4; Server EA, 2016, CASE REP OTOLARYNGOL, V2016, DOI 10.1155/2016/1818304; Simonart T, 2000, BRIT J DERMATOL, V143, P557, DOI 10.1046/j.1365-2133.2000.03709.x; Sissolak G, 2005, TROP MED INT HEALTH, V10, P981, DOI 10.1111/j.1365-3156.2005.01491.x; STAFFORD ND, 1989, J LARYNGOL OTOL, V103, P379, DOI 10.1017/S0022215100109016; Stebbing J, 2008, AIDS, V22, P551, DOI 10.1097/QAD.0b013e3282f4de5d; Steuer CE, 2017, CA-CANCER J CLIN, V67, P32, DOI 10.3322/caac.21386; Sumarroca A, 2016, EUR ANN OTORHINOLARY, V133, P289, DOI 10.1016/j.anorl.2016.03.003; Taheri S, 2012, IRAN J KIDNEY DIS, V6, P222; Tahir M, 2010, BANGLADESH J MED SCI, V9, P107, DOI 10.3329/bjms.v9i2.5660; TAMI TA, 1995, OTOLARYNG HEAD NECK, V113, P283; Tami TA, 1999, ANN OTO RHINOL LARYN, V108, P214, DOI 10.1177/000348949910800221; Tirelli U, 2001, EUR J CANCER, V37, P1320, DOI 10.1016/S0959-8049(01)00106-X; Torretta S, 2013, TUMORI J, V99, pe208, DOI [10.1177/030089161309900514, 10.1700/1377.15316]; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; Vally F, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022415; Vangipuram R, 2019, INT J DERMATOL, V58, P538, DOI 10.1111/ijd.14080; Vinh D, 2020, JAMA OTOLARYNGOL, V146, P667, DOI 10.1001/jamaoto.2020.0223; Wang Z B, 2017, Zhonghua Bing Li Xue Za Zhi, V46, P760, DOI 10.3760/cma.j.issn.0529-5807.2017.11.005; Watson JR, 2004, J VOICE, V18, P398, DOI 10.1016/j.jvoice.2004.04.007; Weir A, 1997, AIDS, V11, P1895, DOI 10.1097/00002030-199715000-00022; Yarchoan R, 2018, NEW ENGL J MED, V378, P1029, DOI 10.1056/NEJMra1615896; Yip E, 2015, ANAESTHESIA CASES, V3, P26; ZIBRAK JD, 1986, CHEST, V90, P476, DOI 10.1378/chest.90.4.476	95	0	0	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.											01945998221105059	10.1177/01945998221105059	http://dx.doi.org/10.1177/01945998221105059		JUN 2022	13	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	2B0WM	35671149				2022-09-04	WOS:000809915800001
J	Sanabria, C; Florez, D; Piquet, H; Diez, R				Sanabria, Camilo; Florez, David; Piquet, Hubert; Diez, Rafael			Sizing Equations for a Square Voltage Pulse Power Supply for Dielectric Barrier Discharges	IEEE TRANSACTIONS ON POWER ELECTRONICS			English	Article						Discharges (electric); Plasmas; Power supplies; Mathematical models; Inverters; Transformers; Power transformer insulation; Circuit analysis; dielectric barrier discharges (DBD); power supplies; pulsed power systems	RESONANT INVERTER; DBD LAMP; GENERATOR; IDENTIFICATION; EFFICIENCY; EXCILAMPS; UNIPOLAR; DESIGN; MODEL	This article presents an analysis of the full-bridge voltage inverter widely used to supply dielectric barrier discharges. The main contribution of this article is the deduction of the analytical equations for the delivered power, peak voltage, and duration of the discharge as a function of the dc input voltage and of the switching frequency, but also as a function of the parasitic elements of the transformer and the parameters of the DBD load. To date, these equations are not found in the literature and are useful to design a power converter complying with specifications derived from plasma process requirements. The state plane is used to understand the different sub-intervals taking place in an entire switching period. The equations are verified using a simple example of design, which implementation accurately obeys the sizing equations, and provide the expected performances.	[Sanabria, Camilo] Pontificia Univ Javeriana, Bogota 110231, Colombia; [Sanabria, Camilo] Univ Pedag & Tecnol Colombia, Res Grp LIRA, Sogamoso 150003, Colombia; [Sanabria, Camilo; Piquet, Hubert] Univ Toulouse, CNRS, LAPLACE Lab, F-31071 Toulouse, France; [Florez, David] Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota 110221, Colombia; [Diez, Rafael] Pontificia Univ Javeriana, Dept Elect Engn, Bogota 110231, Colombia		Sanabria, C (corresponding author), Pontificia Univ Javeriana, Bogota 110231, Colombia.; Sanabria, C (corresponding author), Univ Pedag & Tecnol Colombia, Res Grp LIRA, Sogamoso 150003, Colombia.	camilo.sanabria@javeriana.edu.co; david.florez@usa.edu.co; hubert.piquet@laplace.univ-tlse.fr; rdiez@javeriana.edu.co	; Piquet, Hubert/D-4396-2013	Florez, David/0000-0002-1666-1247; Piquet, Hubert/0000-0002-3736-2676; Sanabria, Camilo/0000-0002-1102-3211	Minciencias [294-2016]; French-Colombian Cooperation ECOSNord/Minciencias; Departamento de Boyaca Scholarship Program [779]	Minciencias; French-Colombian Cooperation ECOSNord/Minciencias; Departamento de Boyaca Scholarship Program	This work was supported in part by the Minciencias under Contract 294-2016, in part by the French-Colombian Cooperation ECOSNord/Minciencias, and in part by the Departamento de Boyaca Scholarship Program under Grant 779 for the Ph.D. studies of one of the authors. Recommended for publication by Associate Editor M. Ponce-Silva.	Adamovich I, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa76f5; Lopez-Fernandez JA, 2015, IEEE T IND ELECTRON, V62, P2215, DOI 10.1109/TIE.2014.2352601; Bonnin X., 2013, P 15 EUR C POW EL AP, P1; Bonnin X, 2014, IEEE T POWER ELECTR, V29, P4261, DOI 10.1109/TPEL.2013.2295525; Cheron Y, COMMUTATION DOUCE CO; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez R, 2015, IEEE T PLASMA SCI, V43, P452, DOI 10.1109/TPS.2014.2370796; Diop Mame Andallah, 2020, Plasma, V3, P103, DOI 10.3390/plasma3030009; Dragonas FA, 2015, IEEE T IND APPL, V51, P3334, DOI 10.1109/TIA.2015.2409262; Florez D, 2018, IEEE T PLASMA SCI, V46, P140, DOI 10.1109/TPS.2017.2777835; Florez D, 2014, IEEE T IND APPL, V50, P86, DOI 10.1109/TIA.2013.2271216; Gopi S, 2013, INSTRUM SCI TECHNOL, V41, P651, DOI 10.1080/10739149.2013.821657; Hao SQ, 2016, IEEE T POWER ELECTR, V31, P8528, DOI 10.1109/TPEL.2016.2520953; Truong HT, 2021, AIP ADV, V11, DOI 10.1063/5.0033846; Huang SJ, 2014, IEEE INT SYMP CIRC S, P2433, DOI 10.1109/ISCAS.2014.6865664; Jakraktok I, 2018, INT ELECT ENG CONGR; Jin SS, 2021, IEEE T POWER ELECTR, V36, P10852, DOI 10.1109/TPEL.2021.3064957; Kane S.N., 2016, J PHYS C SER, V755, DOI [10.1088/1742-6596/755/1/011001, DOI 10.1088/1742-6596/755/1/011001]; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Kolek J, 2018, 2018 14TH SELECTED ISSUES OF ELECTRICAL ENGINEERING AND ELECTRONICS (WZEE); Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392; Liu SH, 2001, J PHYS D APPL PHYS, V34, P1632, DOI 10.1088/0022-3727/34/11/312; Liu Y, 2019, IEEE T DIELECT EL IN, V26, P476, DOI 10.1109/TDEI.2018.007861; Lomaev MI, 2012, PROG QUANT ELECTRON, V36, P51, DOI 10.1016/j.pquantelec.2012.03.003; Lopez AM, 2013, IEEE T PLASMA SCI, V41, P2335, DOI 10.1109/TPS.2013.2273462; Meisser M, 2011, APPL POWER ELECT CO, P1180, DOI 10.1109/APEC.2011.5744743; Mi Y, 2018, IEEE T PLASMA SCI, V46, P2582, DOI 10.1109/TPS.2018.2841651; Moselhy M, 2003, J PHYS D APPL PHYS, V36, P2922, DOI 10.1088/0022-3727/36/23/009; Neretti G, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8101137; ORUGANTI R, 1985, IEEE T IND APPL, V21, P1453, DOI 10.1109/TIA.1985.349602; Panousis E, 2009, IEEE T DIELECT EL IN, V16, P734, DOI 10.1109/TDEI.2009.5128513; Abkenar PP, 2020, IEEE T POWER ELECTR, V35, P8215, DOI 10.1109/TPEL.2019.2962972; Rueda V, 2018, IEEE IND APPLIC SOC; Rueda V, 2019, IEEE T IND APPL, V55, P6567, DOI 10.1109/TIA.2019.2933519; Samukawa S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/25/253001; Schitz D., KNE ENERGY, V3, P456; Schoenbach KH, 2012, IEEE J QUANTUM ELECT, V48, P768, DOI 10.1109/JQE.2012.2185686; Shao T, 2016, IEEE T PLASMA SCI, V44, P2072, DOI 10.1109/TPS.2016.2537813; Sosnin EA, 2015, INSTRUM EXP TECH+, V58, P309, DOI 10.1134/S0020441215030124; Wang L., 2016, P 6 INT C POW EL SYS, P4; Wang RX, 2021, IEEE T PLASMA SCI, V49, P2210, DOI 10.1109/TPS.2021.3084601; Wang YG, 2018, IEEE T PLASMA SCI, V46, P3340, DOI 10.1109/TPS.2018.2844328; Wang YG, 2017, PLASMA SCI TECHNOL, V19, DOI 10.1088/2058-6272/aa6153; Wang YG, 2016, IEEE T PLASMA SCI, V44, P1933, DOI 10.1109/TPS.2016.2558519; You CQ, 2017, IEEE ENER CONV, P2232, DOI 10.1109/ECCE.2017.8096436; Yuan DK, 2018, OZONE-SCI ENG, V40, P494, DOI 10.1080/01919512.2018.1476127; Zhang XM, 2016, IEEE T PLASMA SCI, V44, P2288, DOI 10.1109/TPS.2016.2601246; Zouaghi A, 2017, IEEE T DIELECT EL IN, V24, P2314, DOI 10.1109/TDEI.2017.006505	48	0	0	2	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8993	1941-0107		IEEE T POWER ELECTR	IEEE Trans. Power Electron.	APR	2022	37	4					4374	4384		10.1109/TPEL.2021.3122934	http://dx.doi.org/10.1109/TPEL.2021.3122934			11	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	XU0JQ					2022-09-04	WOS:000733963100066
J	Velez, N; Bessudo, S; Barragan-Barrera, DC; Ladino, F; Bustamante, P; Luna-Acosta, A				Velez, Natalia; Bessudo, Sandra; Barragan-Barrera, Dalia C.; Ladino, Felipe; Bustamante, Paco; Luna-Acosta, Andrea			Mercury concentrations and trophic relations in sharks of the Pacific Ocean of Colombia	MARINE POLLUTION BULLETIN			English	Article						Sharks; Total mercury; Stable isotopes; Human health risks; Trophic ecology; Colombian Pacific	SCALLOPED HAMMERHEAD SHARK; GULF-OF-CALIFORNIA; SPHYRNA-LEWINI; STABLE-ISOTOPE; FEEDING-HABITS; FISH; FIN; MUSCLE; COAST; GOLD	Sharks are fished for human consumption in Colombia, and fins are exported illegally to international markets. The goal was to identify differences in total mercury (THg) concentrations in fins and muscles of shark species seized in the Buenaventura port (Colombian Pacific), and to assess potential human health risks related to shark consumption. Seven species were considered in this study: Pelagic Thresher (Alopias pelagicus), Pacific Smalltail Shark (Carcharhinus cerdale), Brown Smoothhound (Mustelus henlei), Sicklefin Smoothhound (Mustelus lunulatus), Scalloped Bonnethead (Sphyrna corona), Scalloped Hammerhead (Sphyrna lewini), and Bonnethead Shark (Sphyrna tiburo), and THg was analyzed in shark tissues. 24% muscle samples concentrations were above international recommended limits for human consumption, especially for A. pelagicus and S. lewini. Stable isotopes (delta 13C and delta 15N) analysis showed a foraging overlapping in coastal habitats, where overfishing usually occurs. This study provides useful scientific information to develop management plans for sharks in Colombia and neighboring countries.	[Velez, Natalia; Bessudo, Sandra; Ladino, Felipe] Fdn Malpelo & Otros Ecosistemas Marinos, Parques Nacl Nat Colombia, Carrera 11 87-51, Bogota, Colombia; [Velez, Natalia; Luna-Acosta, Andrea] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Transversal 4 42-00, Bogota, Colombia; [Barragan-Barrera, Dalia C.] Ctr Invest Oceanog & Hidrog Caribe CIOH, Sect Manzanillo Escuela Naval Cadetes Almirante P, Direcc Gen Maritima, Cartagena De Indias, Colombia; [Barragan-Barrera, Dalia C.] Corp Ctr Excellence Marine Sci CEMarin, Carrera 21 35-53, Bogota, Colombia; [Barragan-Barrera, Dalia C.] Fdn Macuat Colombia, Calle 27 79-167, Medellin, Colombia; [Bustamante, Paco] La Rochelle Univ, Littoral Environm & Soc LIENSs, UMR 7266 CNRS, 2 Rue Olympe Gouges, F-17000 La Rochelle, France; [Bustamante, Paco] Inst Univ France IUF, 1 Rue Descartes, F-75005 Paris, France		Velez, N (corresponding author), Fdn Malpelo & Otros Ecosistemas Marinos, Parques Nacl Nat Colombia, Carrera 11 87-51, Bogota, Colombia.; Velez, N (corresponding author), Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Transversal 4 42-00, Bogota, Colombia.	n.velez858@gmail.com	Bustamante, Paco/G-5833-2011; Barragán-Barrera, Dalia C./ABA-2913-2020	Bustamante, Paco/0000-0003-3877-9390; Barragán-Barrera, Dalia C./0000-0003-4023-9908	CPER (Contrat de Projet Etat-Region); FEDER (Fonds Europeen de Developpement Regional); Corporation Center of Excellence in Marine Sciences -CEMarin; IUF (Institut Universitaire de France); Colombian Sciences Ministry [848]	CPER (Contrat de Projet Etat-Region); FEDER (Fonds Europeen de Developpement Regional)(European Commission); Corporation Center of Excellence in Marine Sciences -CEMarin; IUF (Institut Universitaire de France); Colombian Sciences Ministry	We appreciate support of C. Churlaud and M. Brault-Favrou from the Plateforme Analyses Elementaires of the LIENSs laboratory for their support during THg analyses, and G. Guillou from the Plateforme Analyses Isotopiques of the LIENSs laboratory for running stable isotope analyses. Thanks to the CPER (Contrat de Projet Etat-Region) and the FEDER (Fonds Europeen de Developpement Regional) for funding the AMA, and the IRMS of LIENSs laboratory. We thank the Malpelo and Other Marine Ecosystems Foundation, the Unit of National Natural Parks of Colombia, and Fondo Patrimonial Fundacion Malpelo for their support in collecting and providing the samples. The Corporation Center of Excellence in Marine Sciences -CEMarin also supported part of this study (D. Barragan, 2018). Special thanks to Dr. Andrea Paz for her essential help with the statistical analyses using the R platform. The IUF (Institut Universitaire de France) is acknowledged for its support to P. Bustamante as a Senior Member, and the Colombian Sciences Ministry for granting a Postdoctoral Fellowship to D. Barrag ' an through the Francisco Jose de Caldas Fund (Call No 848 of 2019).	Adams DH, 1999, FISH B-NOAA, V97, P372; Angel -Romero P.A., 2018, SC67BE09 INT WHAL CO; Aubail A, 2013, MAR POLLUT BULL, V76, P158, DOI 10.1016/j.marpolbul.2013.09.008; Barcia LG, 2020, MAR POLLUT BULL, V157, DOI 10.1016/j.marpolbul.2020.111281; Barrag an-Barrera D.C., 2019, FORAGING HABITS LEVE, V145, P343; Batschelet E, 1981, CIRCULAR STAT BIOL; Berges-Tiznado ME, 2015, ARCH ENVIRON CON TOX, V69, P440, DOI 10.1007/s00244-015-0226-8; Bessudo S, 2011, ENVIRON BIOL FISH, V91, P165, DOI 10.1007/s10641-011-9769-3; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Bryan G.W., MAR ECOL, V5, P1289; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Cadena-Cardenas L., 2004, THESIS I TECNOLOGICO; Caldas Aristizabal J.P., 2010, PLAN ACCION NACL CON; Castellanos A, 2016, MEM I OSWALDO CRUZ, V111, P59, DOI 10.1590/0074-02760150382; Chouvelon T, 2011, MAR ECOL PROG SER, V433, P107, DOI 10.3354/meps09159; Clarke S.C., 2004, J NORTHWEST ATL FISH, V35, P453; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 1996, B MAR SCI, V58, P353; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E., 2016, IUCN RED LIST THREAT; Cresson P, 2015, SCI TOTAL ENVIRON, V532, P184, DOI 10.1016/j.scitotenv.2015.06.020; Delshad Somayeh Torabi, 2012, Pan-American Journal of Aquatic Sciences, V7, P135; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Environmental Protection Agency, 2011, EXPOSURE FACTORS HDB; Eriksson H, 2015, BIOL CONSERV, V184, P163, DOI 10.1016/j.biocon.2015.01.018; Escobar-Sanchez O, 2010, B ENVIRON CONTAM TOX, V84, P488, DOI 10.1007/s00128-010-9966-3; Escobar-Sanchez O, 2011, BIOL TRACE ELEM RES, V144, P550, DOI 10.1007/s12011-011-9040-y; Estupinan-Montano C, 2017, ACTA ICHTHYOL PISCAT, V47, P357, DOI 10.3750/AIEP/02177; Estupinan-Montano C, 2009, REV BIOL MAR OCEANOG, V44, P379; Estupinan-Montao C., MAR BIODIVERS, V51, P1; Every SL, 2016, J EXP MAR BIOL ECOL, V479, P46, DOI 10.1016/j.jembe.2016.02.011; Fabinyi M, 2014, CONSERV SOC, V12, P218, DOI 10.4103/0972-4923.138423; Falco G, 2006, J AGR FOOD CHEM, V54, P6106, DOI 10.1021/jf0610110; FAO/WHO, 2011, COD COMM CONT FOODS; Navia Andres Felipe, 2016, Univ. Sci., V21, P9, DOI 10.11144/Javenana.SC21-1.feoe; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.2307/3072048; Fontaine M, 2015, MAR BIOL, V162, P207, DOI 10.1007/s00227-014-2587-3; Food and Agriculture Organization (FAO), 2009, STATE WORLD FISHERIE; Fuentes-Gandara F, 2018, ENVIRON GEOCHEM HLTH, V40, P229, DOI 10.1007/s10653-016-9896-z; Galvan-Magana F, 2013, DEEP-SEA RES PT II, V95, P52, DOI 10.1016/j.dsr2.2013.04.002; Güiza Leonardo, 2013, Univ. Sci., V18, P33; Helfman G., 2014, SHARKS ANIMAL ANSWER, P47; Hern andez Betancourt S., 2011, TIBURONES COSTA NORT, V4, P39; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; HISLOP JRG, 1991, J ZOOL, V224, P501, DOI 10.1111/j.1469-7998.1991.tb06039.x; Hussey NE, 2011, LIMNOL OCEANOGR-METH, V9, P524, DOI 10.4319/lom.2011.9.524; Sandoval-Herrera NI, 2016, REG STUD MAR SCI, V3, P254, DOI 10.1016/j.rsma.2015.11.011; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jaiteh VF, 2017, MAR POLICY, V82, P224, DOI 10.1016/j.marpol.2017.03.027; JECFA, 2004, WHO TECHN REP SER, V922, P132; Kim SJ, 2016, MAR POLLUT BULL, V102, P210, DOI 10.1016/j.marpolbul.2015.11.038; Kiszka JJ, 2015, DEEP-SEA RES PT I, V96, P49, DOI 10.1016/j.dsr.2014.11.006; Le Bourg B, 2019, ENVIRON RES, V169, P387, DOI 10.1016/j.envres.2018.11.024; Le Croizier G, 2020, CHEMOSPHERE, V253, DOI 10.1016/j.chemosphere.2020.126645; Leung SSF, 2000, J PAEDIATR CHILD H, V36, P56, DOI 10.1046/j.1440-1754.2000.00441.x; Maggie B., 2004, MMW FORTSCHR MED, V153, P90; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Man YB, 2014, ENVIRON GEOCHEM HLTH, V36, P1015, DOI 10.1007/s10653-014-9598-3; Masse F., 2017, RESPONSIBLE BUSINESS; Matulik AG, 2017, MAR POLLUT BULL, V116, P357, DOI 10.1016/j.marpolbul.2017.01.033; Maya Meneses C.I., 2016, TROPHIC OVERLAP BLUE, V7, P13; Maz-Courrau A, 2012, B ENVIRON CONTAM TOX, V88, P129, DOI 10.1007/s00128-011-0499-1; McKinney MA, 2016, SCI TOTAL ENVIRON, V541, P176, DOI 10.1016/j.scitotenv.2015.09.074; Mohammed A, 2017, MAR POLLUT BULL, V119, P214, DOI 10.1016/j.marpolbul.2017.04.025; Murray J., 1969, 38 TORR RES STAT; Mycock S.G., 2004, IUCN RED LIST THREAT; Nadal M, 2008, HUM ECOL RISK ASSESS, V14, P780, DOI 10.1080/10807030802235235; Nakano H, 2008, SHARKS OPEN OCEAN BI, P140, DOI DOI 10.1002/9781444302516; Nalluri D, 2014, SCI TOTAL ENVIRON, V496, P644, DOI 10.1016/j.scitotenv.2014.04.107; O'Bryhim JR, 2017, ENVIRON POLLUT, V223, P323, DOI 10.1016/j.envpol.2017.01.029; Palacios-Torres Y, 2018, CHEMOSPHERE, V193, P421, DOI 10.1016/j.chemosphere.2017.10.160; Pay an L.F., 2008, 1 ENC COL CONDR; Payne SA, 1999, FISH OCEANOGR, V8, P159, DOI 10.1046/j.1365-2419.1999.00097.x; Perez-Jim enez J., 2016, IUCN RED LIST THREAT; Perez-Jim J., 2016, IUCN RED LIST THREAT; Perez-Valbuena G.J., 2007, EC PACIFICO COLOMBIA, P55; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pethybridge H, 2010, MAR ENVIRON RES, V69, P18, DOI 10.1016/j.marenvres.2009.07.006; Pollom R., 2020, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2020-3.RLTS.T44575A152015479.en; Quintanilla S, 2015, J HERED, V106, P448, DOI 10.1093/jhered/esv050; R Core Team, 2022, R LANG ENV STAT COMP; Rangel BD, 2019, J FISH BIOL, V94, P781, DOI 10.1111/jfb.13958; Rodriguez Ortiz S., 2016, PESCA ILEGAL MARINA, P34; Ross Salazar E., 2019, COMERCIO INT TIBURON, P95; Storelli MM, 2001, ITAL J FOOD SCI, V13, P101; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; The 8 Restaurant, 2017, GRAND LISB; Torres-Rojas Y, 2006, CYBIUM, V30, P85; Tubb D, 2015, EXTRACT IND SOC, V2, P722, DOI 10.1016/j.exis.2015.08.008; US Environmental Protection Agency (USEPA), 1989, HUMAN HLTH EVALUATIO, VI, P154; USEPA, 2000, RISK ASSESSMENT FISH, V2; USEPA, 2010, RISK BASED CONCENTRA; USEPA, 2008, EPA600R06096F NAT CT; Vieira C, 2011, FOOD CHEM TOXICOL, V49, P923, DOI 10.1016/j.fct.2010.12.016; Whitcraft S, 2014, EVIDENCE DECLINES SH; WHO, 2006, PREV DIS HLTH ENV, P4; Winker H, 2019, IUCN RED LIST THREAT; World Gold Council, 2020, GOLD MIN PROD	101	1	1	6	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-326X	1879-3363		MAR POLLUT BULL	Mar. Pollut. Bull.	DEC	2021	173		B						113109	10.1016/j.marpolbul.2021.113109	http://dx.doi.org/10.1016/j.marpolbul.2021.113109		NOV 2021	13	Environmental Sciences; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Marine & Freshwater Biology	WZ2HM	34749115	Green Submitted			2022-09-04	WOS:000719792800015
J	Duran, F; Rocha, C; Salaun, G				Duran, Francisco; Rocha, Camilo; Salaun, Gwen			Resource provisioning strategies for BPMN processes: Specification and analysis using Maude	JOURNAL OF LOGICAL AND ALGEBRAIC METHODS IN PROGRAMMING			English	Article						Business processes; BPMN; Resource provisioning; Rewriting logic; Maude; Simulation-based analysis		Business process optimization is a strategic activity in organizations because of its potential to increase profit margins and reduce operational costs. One of the main challenges in this activity is concerned with the problem of optimizing allocation and sharing of resources. Companies are continuously adjusting their resources to their needs following different strategies. However, the dynamic provisioning strategies are hard to compare. This paper proposes an automatic analysis technique to evaluate and compare the execution time and resource occupancy of a business process relative to a workload and a provisioning strategy. Four different strategies are presented, which are guided by, respectively, recent resource usage, recent resource request, predicted behavior, and a combination of available strategies. Such analysis is performed on models conforming to an extension of BPMN with quantitative information, including resource availability and constraints. Within this framework, the approach is fully mechanized using a formal and executable specification in the Maude rewriting logic framework, which relies on existing techniques and tools for simulating probabilistic and real-time specifications. The paper includes results on the extensive experimentation that has been carried out for validation purposes. (C) 2021 Elsevier Inc. All rights reserved.	[Duran, Francisco] Univ Malaga, ITIS Software, Malaga, Spain; [Rocha, Camilo] Pontificia Univ Javeriana, Cali, Colombia; [Salaun, Gwen] Univ Grenoble Alpes, CNRS, Grenoble INP, LIG,INRIA, F-38000 Grenoble, France		Duran, F (corresponding author), Univ Malaga, ITIS Software, Malaga, Spain.	duran@lcc.uma.es		Duran, Francisco/0000-0001-5864-8094; Rocha, Camilo/0000-0003-4356-7704	Spanish MINECO/FEDER [PGC2018-094905-B-I00]; ECOS-NORD MinCiencias project "FACTS: Foundational Approach to Computation in Today's Society" [C19M03]; J. Andalucia/FEDER [UMA18-FEDERJA-180]	Spanish MINECO/FEDER(Spanish Government); ECOS-NORD MinCiencias project "FACTS: Foundational Approach to Computation in Today's Society"; J. Andalucia/FEDER	We thank both the editor and the reviewers for their careful reading of our work and the comments made, which we found very useful in order to improve the quality and clarity of our article. The first author was partially supported by projects PGC2018-094905-B-I00 (Spanish MINECO/FEDER) and UMA18-FEDERJA-180 (J. Andalucia/FEDER) . The second author was partially supported by the ECOS-NORD MinCiencias C19M03 project "FACTS: Foundational Approach to Computation in Today's Society".	Agha G, 2006, ELECTRON NOTES THEOR, V153, P213, DOI 10.1016/j.entcs.2005.10.040; AlTurki Musab, 2011, Algebra and Coalgebra in Computer Science. Proceedings 4th International Conference, CALCO 2011, P386, DOI 10.1007/978-3-642-22944-2_28; [Anonymous], 2013, 19510 ISOIEC; Bouhoula A, 2000, THEOR COMPUT SCI, V236, P35, DOI 10.1016/S0304-3975(99)00206-6; Combi Carlo, 2018, Business Process Management Forum. BPM Forum 2018. Proceedings. Lecture Notes in Business Information Processing (LNBIP 329), P20, DOI 10.1007/978-3-319-98651-7_2; Di Francescomarino C, 2017, LECT NOTES COMPUT SC, V10445, P252, DOI 10.1007/978-3-319-65000-5_15; Duran Francisco, 2020, Rewriting Logic and Its Applications. 13th International Workshop, WRLA 2020. Revised Selected Papers. Lecture Notes in Computer Science (LNCS 12328), P38, DOI 10.1007/978-3-030-63595-4_3; Duran F, 2019, SCI COMPUT PROGRAM, V183, DOI 10.1016/j.scico.2019.102303; Duran F, 2018, SCI COMPUT PROGRAM, V168, P1, DOI 10.1016/j.scico.2018.08.007; Duran F, 2017, LECT NOTES COMPUT SC, V10319, P219, DOI 10.1007/978-3-319-59746-1_12; Frappaolo C., 2008, BUSINESS PROCESS MAN; Havur G, 2016, LECT NOTES BUSINESS, P3, DOI DOI 10.1007/978-3-319-45468-9; Ihde Sven, 2019, Business Process Management Forum. BPM Forum 2019. Proceedings. Lecture Notes in Business Information Processing (LNBIP 360), P55, DOI 10.1007/978-3-030-26643-1_4; Krishna A., 2017, 13 INT C INT FORM ME, P323; Krishna A, 2019, SCI COMPUT PROGRAM, V170, P1, DOI 10.1016/j.scico.2018.09.007; Leemans SJJ, 2018, SOFTW SYST MODEL, V17, P599, DOI 10.1007/s10270-016-0545-x; Li JQ, 2004, IEEE T SYST MAN CY A, V34, P229, DOI 10.1109/TSMCA.2003.819490; Lincoln P., 2007, ALL MAUDE A HIGH PER, V4350; MESEGUER J, 1992, THEOR COMPUT SCI, V96, P73, DOI 10.1016/0304-3975(92)90182-F; Netjes N., 2005, P CPN, P251; Oliveira CAL, 2012, IEEE T SYST MAN CY A, V42, P669, DOI 10.1109/TSMCA.2011.2170412; Olveczky P. C., 2007, Higher-Order and Symbolic Computation, V20, P161, DOI 10.1007/s10990-007-9001-5; Peters Sander P. F., 2018, Business Process Management Forum. BPM Forum 2018. Proceedings. Lecture Notes in Business Information Processing (LNBIP 329), P159, DOI 10.1007/978-3-319-98651-7_10; Polato M, 2018, COMPUTING, V100, P1005, DOI 10.1007/s00607-018-0593-x; Russell N., 2004, BETA WORKING PAPER S; Schomig A.K., 1995, 116 U WURZBURG WURZB; Sperl S., 2017, 7 INT S DAT DRIV PRO, P128; van der Aalst WMP, 2017, LECT NOTES COMPUT SC, V10445, P59, DOI 10.1007/978-3-319-65000-5_4; Walck C, 2007, SUFPFY9601 U STOCKHO; Xu JJ, 2008, LECT NOTES COMPUT SC, V5240, P228	30	0	0	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2208	2352-2216		J LOG ALGEBR METHODS	J. Log. Algebr. Methods Program	NOV	2021	123								100711	10.1016/j.jlamp.2021.100711	http://dx.doi.org/10.1016/j.jlamp.2021.100711		JUL 2021	27	Computer Science, Theory & Methods; Logic	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Science & Technology - Other Topics	WB4RP		Green Submitted			2022-09-04	WOS:000703561100007
J	Nesbitt, D; Ananian, CD; Stodden, DF; Vezina, J; Florez-Pregonero, A; Ainsworth, B				Nesbitt, Danielle; Ananian, Cheryl Der; Stodden, David F.; Vezina, Jesse; Florez-Pregonero, Alberto; Ainsworth, Barbara			Examining to the Relationship Between Supine-to-Stand, Motor Competence, and Health-Related Fitness in Middle-Aged Women Ages 45-65 Years	JOURNAL OF SPORT & EXERCISE PSYCHOLOGY			English	Meeting Abstract									[Nesbitt, Danielle] Fayetteville State Univ, Fayetteville, NC 28301 USA; [Ananian, Cheryl Der; Vezina, Jesse; Ainsworth, Barbara] Arizona State Univ, Tempe, AZ 85287 USA; [Stodden, David F.] Univ South Carolina, Columbia, SC 29208 USA; [Florez-Pregonero, Alberto] Pontificia Univ Javeriana, Bogota, Colombia				Der Ananian, Cheryl/AAB-6893-2021						0	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0895-2779	1543-2904		J SPORT EXERCISE PSY	J. Sport Exerc. Psychol.	AUG	2020	42			S			S5	S5						1	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	MX3JS					2022-09-04	WOS:000557622200015
J	Dehnavi, S; Sadeghi, M; Johnston, TP; Barreto, G; Shohan, M; Sahebkar, A				Dehnavi, Sajad; Sadeghi, Mahvash; Johnston, Thomas P.; Barreto, George; Shohan, Mojtaba; Sahebkar, Amirhossein			The role of protein SUMOylation in rheumatoid arthritis	JOURNAL OF AUTOIMMUNITY			English	Article						Post-translational modifications; Small ubiquitin-like modifier; Proteins; Rheumatoid arthritis	FIBROBLAST-LIKE SYNOVIOCYTES; POSTTRANSLATIONAL MODIFICATION; M55V POLYMORPHISM; SUMO; UBIQUITIN; IMMUNE; CELLS; INFLAMMATION; MECHANISMS; MIGRATION	Small ubiquitin-like modifier (SUMO) proteins, as a subgroup of post-translational modifiers, act to change the function of proteins. Through their interactions with different targets, immune pathways, and the responses they elicit, can be affected by these SUMO conjugations. Thus, both a change to protein function and involvement in immune pathways has the potential to promote an efficient immune response to either a pathogenic challenge, or the development of an imbalance that could lead to an autoimmune-based disease. Also, a variety of changes such as mutations and polymorphisms can interfere with common functions of these modifications and move an effective immune response in the direction of an autoimmune disease. The present review discusses the general characteristics of SUMO proteins and focuses on their involvement in rheumatoid arthritis as an autoimmune disease.	[Dehnavi, Sajad; Shohan, Mojtaba] Ahvaz Jundishapur Univ Med Sci, Dept Immunol, Fac Med, Ahvaz, Iran; [Sadeghi, Mahvash] Mashhad Univ Med Sci, Dept Immunol, Fac Med, Mashhad, Razavi Khorasan, Iran; [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO 64110 USA; [Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Sadeghi, Mahvash/GQI-2357-2022; Sahebkar, Amirhossein/B-5124-2018; Dehnavi, Sajad/AAX-8123-2021; Shohan, Mojtaba/AHE-0730-2022; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971; Dehnavi, Sajad/0000-0002-8442-0584; Shohan, Mojtaba/0000-0003-4925-2439				Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Adorisio S, 2017, J AUTOIMMUN, V84, P21, DOI 10.1016/j.jaut.2017.09.001; Baier A, 2003, CURR OPIN RHEUMATOL, V15, P274, DOI 10.1097/00002281-200305000-00015; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bhat S, 2014, PROTEOM CLIN APPL, V8, P19, DOI 10.1002/prca.201300068; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chen K, 2017, J AUTOIMMUN, V83, P1, DOI 10.1016/j.jaut.2017.03.008; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Davis LS, 2003, AM J PATHOL, V162, P1399, DOI 10.1016/S0002-9440(10)64272-1; Ding XB, 2017, SCI REP-UK, V7, DOI 10.1038/srep34278; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Doody KM, 2017, EPIGENOMICS-UK, V9, P479, DOI 10.2217/epi-2016-0151; Duarte Joao H, 2016, Nat Rev Rheumatol, V12, P70, DOI 10.1038/nrrheum.2015.182; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Frank S, 2010, ANN RHEUM DIS, V69, DOI 10.1136/ard.2010.129619h; Frank S., 2017, 02 14 SMALL UBIQUITI; Franz JK, 2000, ARTHRITIS RHEUM, V43, P599, DOI 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo DH, 2005, BIOCHEM BIOPH RES CO, V337, P1308, DOI 10.1016/j.bbrc.2005.09.191; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hannoun Z, 2016, CYTOKINE GROWTH F R, V29, P3, DOI 10.1016/j.cytogfr.2016.04.003; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Hendriks IA, 2016, NAT PROTOC, V11, P1630, DOI 10.1038/nprot.2016.082; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hu MM, 2017, CELL MOL IMMUNOL, V14, P331, DOI 10.1038/cmi.2016.66; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Hummel KM, 1998, J RHEUMATOL, V25, P1887; Hwang KW, 2012, DIABETES-METAB RES, V28, P196, DOI 10.1002/dmrr.2273; Hwang KW, 2011, DIABETES-METAB RES, V27, P854, DOI 10.1002/dmrr.1261; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karray EF, 2011, CLIN EXP RHEUMATOL, V29, P751; Klein K., 2018, RHEUMATOID ARTHRITIS, P149; Klein K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4074; Lao MX, 2019, EXP CELL RES, V375, P52, DOI 10.1016/j.yexcr.2018.12.011; Lao MX, 2016, J IMMUNOL, V196, P596, DOI 10.4049/jimmunol.1403254; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li FX, 2014, INFLAMMATION, V37, P1134, DOI 10.1007/s10753-014-9837-x; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037636; Maciejewska-Rodrigues H, 2010, J AUTOIMMUN, V35, P15, DOI 10.1016/j.jaut.2009.12.010; Maroun MC, 2014, IMMUNOL RES, V60, P339, DOI 10.1007/s12026-014-8582-4; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Murphy G, 2005, ANN RHEUM DIS, V64, P44, DOI 10.1136/ard.2005.042465; Okura T, 1996, J IMMUNOL, V157, P4277; Orozco G, 2006, J RHEUMATOL, V33, P1235; Ospelt C, 2008, BEST PRACT RES CL RH, V22, P239, DOI 10.1016/j.berh.2008.01.004; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Quan LD, 2008, EXPERT OPIN THER PAT, V18, P723, DOI 10.1517/13543776.18.7.723; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Shao L, 2016, ADIPOCYTE, V5, P270, DOI 10.1080/21623945.2016.1162358; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Smolen J, 2008, EUR J HEALTH ECON, V8, pS39, DOI 10.1007/s10198-007-0087-9; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Tran CN, 2007, ARTHRITIS RHEUM, V56, P1497, DOI 10.1002/art.22573; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Woo CH, 2010, CURR OPIN PHARMACOL, V10, P146, DOI 10.1016/j.coph.2009.12.001; Yan DY, 2010, GENE, V466, P1, DOI 10.1016/j.gene.2010.07.003; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zou YF, 2010, INT J IMMUNOGENET, V37, P345, DOI 10.1111/j.1744-313X.2010.00931.x	79	7	8	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0896-8411	1095-9157		J AUTOIMMUN	J. Autoimmun.	AUG	2019	102						1	7		10.1016/j.jaut.2019.05.006	http://dx.doi.org/10.1016/j.jaut.2019.05.006			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IN9UU	31078376				2022-09-04	WOS:000479024700001
J	Giatti, S; Garcia-Segura, LM; Barreto, GE; Melcangi, RC				Giatti, Silvia; Garcia-Segura, Luis M.; Barreto, George E.; Melcangi, Roberto C.			Neuroactive steroids, neurosteroidogenesis and sex	PROGRESS IN NEUROBIOLOGY			English	Review						Estradiol; microRNAs; Neuroprotection; Pregnenolone; Progesterone; Steroid receptors; Steroidogenesis; Synaptic plasticity; Testosterone	TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR MODULATORS; SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ESTRADIOL-INDUCED ENHANCEMENT; CEREBROSPINAL-FLUID CONTENT; TRANSLOCATOR PROTEIN TSPO; ACUTE REGULATORY PROTEIN; ADULT-RAT HIPPOCAMPUS; MYELIN BASIC-PROTEIN	The nervous system is a target and a source of steroids. Neuroactive steroids are steroids that target neurons and glial cells. They include hormonal steroids originated in the peripheral glands, steroids locally synthesized by the neurons and glial cells (neurosteroids) and synthetic steroids, some of them used in clinical practice. Here we review the mechanisms of synthesis, metabolism and action of neuroactive steroids, including the role of epigenetic modifications and the mitochondria in their sex specific actions. We examine sex differences in neuroactive steroid levels under physiological conditions and their role in the establishment of sex dimorphic structures in the nervous system and sex differences in its function. In addition, particular attention is paid to neuroactive steroids under pathological conditions, analyzing how pathology alters their levels and their role as neuroprotective factors, considering the influence of sex in both cases.	[Giatti, Silvia; Melcangi, Roberto C.] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Garcia-Segura, Luis M.] CSIC, Inst Cajal, Madrid, Spain; [Garcia-Segura, Luis M.] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia		Melcangi, RC (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	roberto.melcangi@unimi.it	Giatti, Silvia/G-9334-2016; Melcangi, Roberto Cosimo/AAA-6534-2022; Barreto, George E./AAD-7420-2020	Giatti, Silvia/0000-0001-7741-826X; Barreto, George E./0000-0002-6644-1971	MIUR Progetto Eccellenza; Fondazione CARIPLO [Rif.2012-0547]; Colciencias [777-2017, 120377757021]; Ministerio de Economia, Industria y Competitividad (MINECO), Spain [BFU2014-51836-C2-1-R, BFU2017-82754-R]; CIBER de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Fondos Feder	MIUR Progetto Eccellenza(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIPLO(Fondazione Cariplo); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministerio de Economia, Industria y Competitividad (MINECO), Spain; CIBER de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Fondos Feder(European Commission)	This research was supported by grants from MIUR Progetto Eccellenza. We also acknowledge support from Fondazione CARIPLO (Rif.2012-0547), Colciencias (Convocatoria 777-2017, Contract #120377757021), Ministerio de Economia, Industria y Competitividad (MINECO), Spain (grant numbers BFU2014-51836-C2-1-R and BFU2017-82754-R), CIBER de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain and Fondos Feder.	Acaz-Fonseca E., 2015, GLIA; Acaz-Fonseca E, 2017, SCI REP-UK, V7, DOI 10.1038/srep43878; Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385; Albertazzi P, 1998, MATURITAS, V30, P295, DOI 10.1016/S0378-5122(98)00059-0; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Arad M, 2010, NEUROPSYCHOPHARMACOL, V35, P2179, DOI 10.1038/npp.2010.89; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Ayhan S, 2003, MICROSURG, V23, P49, DOI 10.1002/micr.10088; Ayoola C, 2014, PSYCHOPHARMACOLOGY, V231, P3503, DOI 10.1007/s00213-014-3588-0; Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Backstrom T, 2014, PROG NEUROBIOL, V113, P88, DOI 10.1016/j.pneurobio.2013.07.005; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baez-Jurado E., 2017, MOL NEUROBIOL; Bagnard D, 2004, MOL CELL NEUROSCI, V25, P722, DOI 10.1016/j.mcn.2003.12.007; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Balthazart J., 2011, FRONT ENDOCRINOL, V2, P34, DOI DOI 10.3389/FEND0.2011.00034; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Bebo BF, 1999, J IMMUNOL, V162, P35; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Bender RA, 2017, J NEUROSCI, V37, P1532, DOI 10.1523/JNEUROSCI.1532-16.2016; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Berning B, 2001, Climacteric, V4, P120, DOI 10.1080/713605085; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Biamonte F, 2009, NEUROBIOL DIS, V36, P103, DOI 10.1016/j.nbd.2009.07.001; Blanco M. J., 2017, BIOORG MED CHEM LETT; Bourque M, 2016, NEUROENDOCRINOLOGY, V103, P300, DOI 10.1159/000438789; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunton PJ, 2015, J NEUROSCI, V35, P666, DOI 10.1523/JNEUROSCI.5104-13.2015; Cabezas R., 2017, MOL NEUROBIOL; Cagnacci A, 1997, J CLIN ENDOCR METAB, V82, P251, DOI 10.1210/jc.82.1.251; Calabrese D, 2014, J ENDOCRINOL, V221, P1, DOI 10.1530/JOE-13-0541; Calmarza-Font I, 2012, BEHAV BRAIN RES, V227, P287, DOI 10.1016/j.bbr.2011.10.036; Caruso D, 2010, J NEUROENDOCRINOL, V22, P1137, DOI 10.1111/j.1365-2826.2010.02064.x; Caruso D, 2008, J MOL NEUROSCI, V34, P249, DOI 10.1007/s12031-007-9029-3; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Caruso D, 2013, NEUROBIOL AGING, V34, P1080, DOI 10.1016/j.neurobiolaging.2012.10.007; Caruso D, 2010, J NEUROCHEM, V114, P921, DOI 10.1111/j.1471-4159.2010.06825.x; Carver CM, 2013, PSYCHOPHARMACOLOGY, V230, P151, DOI 10.1007/s00213-013-3276-5; Catalano S, 2014, BREAST CANCER RES TR, V146, P273, DOI 10.1007/s10549-014-3017-4; Cattier S., 2001, SYNAPSE, V41, P131; Chavez-Delgado ME, 2005, J BIOMED MATER RES B, V74B, P589, DOI 10.1002/jbm.b.30243; Chehadeh SEH, 2014, AM J PHYSIOL-ENDOC M, V307, pE1009, DOI 10.1152/ajpendo.00364.2014; Chen XM, 2015, NEUROSCI LETT, V606, P194, DOI 10.1016/j.neulet.2015.09.002; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Cho T, 2012, J NEUROENDOCRINOL, V24, P789, DOI 10.1111/j.1365-2826.2011.02272.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Cisternas C. D., 2017, J NEUROENDOCRINOL; Cisternas CD, 2015, MOL CELL ENDOCRINOL, V414, P99, DOI 10.1016/j.mce.2015.07.027; Cline JM, 2007, BIRTH DEFECTS RES B, V80, P147, DOI 10.1002/bdrb.20111; Cohen RE, 2010, BRAIN BEHAV EVOLUT, V76, P279, DOI 10.1159/000322096; Colombo D, 2008, ARZNEIMITTELFORSCH, V58, P86, DOI 10.1055/s-0031-1296473; Colon JM, 2018, EXP NEUROL, V299, P109, DOI 10.1016/j.expneurol.2017.10.006; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dalal M, 1997, J IMMUNOL, V159, P3; Cisternas CD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05658-6; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; De Carvalho D, 2016, NEUROSCIENCE, V313, P36, DOI 10.1016/j.neuroscience.2015.11.026; de Gooyer ME, 2001, MOL CELL ENDOCRINOL, V183, P55, DOI 10.1016/S0303-7207(01)00606-2; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; de Michele F, 2003, NEUROL SCI, V24, P172, DOI 10.1007/s10072-003-0115-1; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Djordjevic J, 2017, NEUROSCIENCE, V361, P81, DOI 10.1016/j.neuroscience.2017.08.006; Dooley MA, 2003, CURR OPIN RHEUMATOL, V15, P99, DOI 10.1097/00002281-200303000-00002; Ebihara K, 2017, BEHAV BRAIN RES, V334, P6, DOI 10.1016/j.bbr.2017.07.019; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; Fester L, 2015, BRAIN RES, V1621, P162, DOI 10.1016/j.brainres.2014.10.033; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Foot M, 2004, DEPRESS ANXIETY, V20, P123, DOI 10.1002/da.20031; Forger N. G., 2017, J NEUROENDOCRINOL; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Frick KM, 2013, J NEUROENDOCRINOL, V25, P1151, DOI 10.1111/jne.12106; Fry JP, 2014, BRIT J PHARMACOL, V171, P5870, DOI 10.1111/bph.12891; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Frye CA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00136; Frye CA, 2009, EPILEPSY BEHAV, V16, P418, DOI 10.1016/j.yebeh.2009.09.008; Gaignard P, 2017, J NEUROENDOCRINOL; Gaignard P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00406; Gaignard P, 2015, ENDOCRINOLOGY, V156, P2893, DOI 10.1210/en.2014-1913; Galanopoulou AS, 2003, NEUROSCI LETT, V342, P201, DOI 10.1016/S0304-3940(03)00282-9; Galea LAM, 2017, NEUROSCI BIOBEHAV R, V76, P363, DOI 10.1016/j.neubiorev.2016.03.024; Gallart-Palau X, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0205-7; Gao XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07091; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garay L, 2014, J NEUROIMMUNOL, V276, P89, DOI 10.1016/j.jneuroim.2014.08.619; Garay L, 2010, HORM MOL BIOL CLIN I, V1, P43, DOI 10.1515/HMBCI.2010.006; Ghorbanpoor S, 2014, ENDOCRINOLOGY, V155, P4341, DOI 10.1210/en.2014-1158; Giatti S., 2017, FRONT NEUROENDOCRINO; Giatti S, 2016, J MOL ENDOCRINOL, V57, pR109, DOI 10.1530/JME-16-0061; Giatti S, 2015, J STEROID BIOCHEM, V153, P127, DOI 10.1016/j.jsbmb.2015.03.002; Giatti S, 2015, NEUROENDOCRINOLOGY, V101, P296, DOI 10.1159/000381064; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Gillies GE, 2004, PHARMACOL BIOCHEM BE, V78, P513, DOI 10.1016/j.pbb.2004.04.022; Gimenez-Llort L, 2008, NEUROIMMUNOMODULAT, V15, P331, DOI 10.1159/000156475; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Guebel DV, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00229; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Hadjimarkou MM, 2018, J STEROID BIOCHEM, V176, P57, DOI 10.1016/j.jsbmb.2017.04.012; Hankin BL, 1999, ANN MED, V31, P372, DOI 10.3109/07853899908998794; Hasirci AS, 2017, ALCOHOL CLIN EXP RES, V41, P299, DOI 10.1111/acer.13300; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hidalgo-Lanussa O., 2017, MOL NEUROBIOL; Hogarth SJ, 2018, BEHAV BRAIN RES, V339, P73, DOI 10.1016/j.bbr.2017.11.019; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; HU ZY, 1987, P NATL ACAD SCI USA, V84, P8215, DOI 10.1073/pnas.84.23.8215; Huppenbauer CB, 2005, J NEUROSCI, V25, P4004, DOI 10.1523/JNEUROSCI.5279-04.2005; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Ingle JN, 2006, BREAST CANCER RES TR, V98, P217, DOI 10.1007/s10549-005-9152-1; Islamov RR, 2002, BRAIN RES, V943, P283, DOI 10.1016/S0006-8993(02)02827-5; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jones KJ, 2001, BRAIN RES REV, V37, P372, DOI 10.1016/S0165-0173(01)00107-2; Josefsson ML, 2010, BREAST, V19, P76, DOI 10.1016/j.breast.2009.12.010; Jover-Mengual T, 2017, J STEROID BIOCHEM, V171, P296, DOI 10.1016/j.jsbmb.2017.05.001; Cambiasso MJ, 2017, J NEUROGENET, V31, P300, DOI 10.1080/01677063.2017.1390572; Karisetty BC, 2017, NEUROSCIENCE, V356, P89, DOI 10.1016/j.neuroscience.2017.05.020; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Kaye W, 2008, PHYSIOL BEHAV, V94, P121, DOI 10.1016/j.physbeh.2007.11.037; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Khalifa ARM, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13125; Khasnavis S, 2013, J BIOL CHEM, V288, P20843, DOI 10.1074/jbc.M112.443556; Kight KE, 2017, J NEUROSCI RES, V95, P345, DOI 10.1002/jnr.23920; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Kloosterboer HJ, 2007, REPROD SCI, V14, P151, DOI 10.1177/1933719106298679; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; Kumar N, 2017, ENDOCRINOLOGY, V158, P170, DOI 10.1210/en.2016-1426; Kumar P, 2014, EUR J PHARMACOL, V723, P38, DOI 10.1016/j.ejphar.2013.11.036; Kumar RC, 2004, NEUROBIOL AGING, V25, P925, DOI 10.1016/j.neurobiolaging.2003.10.011; Kundakovic M, 2015, P NATL ACAD SCI USA, V112, P6807, DOI 10.1073/pnas.1408355111; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lavaque E, 2006, NEUROSCIENCE, V138, P741, DOI 10.1016/j.neuroscience.2005.05.060; Lavaque E, 2006, J NEUROBIOL, V66, P308, DOI 10.1002/neu.20221; LEGOASCOGNE C, 1987, SCIENCE, V237, P1212, DOI 10.1126/science.3306919; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Li R, 2013, MOL NEUROBIOL, V47, P857, DOI 10.1007/s12035-012-8377-3; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Li Y, 2016, J MOL NEUROSCI, V58, P28, DOI 10.1007/s12031-015-0645-z; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; Luchetti S, 2011, NEUROSCIENCE, V191, P6, DOI 10.1016/j.neuroscience.2011.04.010; Luchetti S, 2014, J NEUROPATH EXP NEUR, V73, P123, DOI 10.1097/NEN.0000000000000037; Luchetti S, 2011, NEUROBIOL AGING, V32, P1964, DOI 10.1016/j.neurobiolaging.2009.12.014; Luchetti S, 2010, BRAIN PATHOL, V20, P945, DOI 10.1111/j.1750-3639.2010.00396.x; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; MARTINI L, 1991, J STEROID BIOCHEM, V39, P819, DOI 10.1016/0960-0760(91)90031-Y; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; MASSA R, 1972, J STEROID BIOCHEMIST, V3, P385, DOI 10.1016/0022-4731(72)90085-4; Matsuda KI, 2011, ENDOCRINOLOGY, V152, P2760, DOI 10.1210/en.2011-0193; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Melcangi RC, 2003, PROG NEUROBIOL, V71, P57, DOI 10.1016/j.pneurobio.2003.09.003; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Melcangi RC, 2000, J NEUROCYTOL, V29, P327, DOI 10.1023/A:1007105121765; Melcangi RC, 2000, PROG NEUROBIOL, V60, P291, DOI 10.1016/S0301-0082(99)00028-3; Melcangi RC, 2012, J MOL NEUROSCI, V46, P177, DOI 10.1007/s12031-011-9570-y; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Menger Y, 2010, EPIGENOMICS-UK, V2, P807, DOI [10.2217/epi.10.60, 10.2217/EPI.10.60]; Mensah-Nyagan Ayikoe G, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS169, DOI 10.1016/j.psyneuen.2009.06.004; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Meyer L, 2010, CELL MOL LIFE SCI, V67, P3017, DOI 10.1007/s00018-010-0372-0; Meyer M, 2015, NEUROSCIENCE, V308, P51, DOI 10.1016/j.neuroscience.2015.09.007; Mishra S, 2017, GEN COMP ENDOCR, V241, P80, DOI 10.1016/j.ygcen.2016.04.031; Misiak M, 2010, BBA-BIOENERGETICS, V1797, P1178, DOI 10.1016/j.bbabio.2010.04.009; Mitro N, 2014, J STEROID BIOCHEM, V143, P115, DOI 10.1016/j.jsbmb.2014.02.015; Moon JM, 2013, J CEREBR BLOOD F MET, V33, P1976, DOI 10.1038/jcbfm.2013.157; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Murray EK, 2009, ENDOCRINOLOGY, V150, P4241, DOI 10.1210/en.2009-0458; Murray HE, 2003, NEUROSCIENCE, V116, P213, DOI 10.1016/S0306-4522(02)00578-X; NAFTOLIN F, 1972, ENDOCRINOLOGY, V90, P295, DOI 10.1210/endo-90-1-295; NAFTOLIN F, 1971, J CLIN ENDOCR METAB, V33, P368, DOI 10.1210/jcem-33-2-368; Nagy C, 2015, MOL PSYCHIATR, V20, P320, DOI 10.1038/mp.2014.21; Nelson BS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0321-16.2016; Nieschlag E, 2014, ASIAN J ANDROL, V16, P161, DOI 10.4103/1008-682X.122358; Nugent BM, 2015, NAT NEUROSCI, V18, P690, DOI 10.1038/nn.3988; Nugent BM, 2011, HORM BEHAV, V59, P338, DOI 10.1016/j.yhbeh.2010.08.009; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Owusu C, 2007, BREAST J, V13, P374, DOI 10.1111/j.1524-4741.2007.00445.x; Palaszynski KM, 2004, J NEUROIMMUNOL, V146, P144, DOI 10.1016/j.jneuroim.2003.11.004; Pandey D, 2016, HORM BEHAV, V79, P70, DOI 10.1016/j.yhbeh.2015.09.004; Papadopoulos V, 2017, J NEUROENDOCRINOL; Patte-Mensah C, 2014, PROG NEUROBIOL, V113, P70, DOI 10.1016/j.pneurobio.2013.07.004; Perisic T, 2010, NEUROPSYCHOPHARMACOL, V35, P792, DOI 10.1038/npp.2009.188; Pesaresi M, 2011, NEUROSCIENCE, V199, P401, DOI 10.1016/j.neuroscience.2011.09.013; Pesaresi M, 2011, EXP NEUROL, V228, P215, DOI 10.1016/j.expneurol.2011.01.005; Pesaresi M, 2010, J MOL NEUROSCI, V42, P135, DOI 10.1007/s12031-010-9344-y; Pesaresi M, 2010, HORM BEHAV, V57, P46, DOI 10.1016/j.yhbeh.2009.04.008; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Piaton G, 2011, BRAIN, V134, P1156, DOI 10.1093/brain/awr022; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Platania P, 2005, NEUROBIOL DIS, V20, P461, DOI 10.1016/j.nbd.2005.03.025; Radowicki S, 1988, Ginekol Pol, V59, P705; Rao YS, 2013, ENDOCRINOLOGY, V154, P2795, DOI 10.1210/en.2013-1230; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Reynir Tomas Geirsson, 2004, Acta Obstet Gynecol Scand, V83, P606, DOI 10.1111/j.0001-6349.2004.0523.x; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Rodriguez-Navarro JA, 2008, J NEUROCHEM, V106, P2143, DOI 10.1111/j.1471-4159.2008.05569.x; Rodriguez-Perez AI, 2013, NEUROBIOL DIS, V58, P209, DOI 10.1016/j.nbd.2013.06.004; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Roglio I, 2007, CELL MOL LIFE SCI, V64, P1158, DOI 10.1007/s00018-007-7002-5; Roglio I, 2009, J PERIPHER NERV SYST, V14, P36, DOI 10.1111/j.1529-8027.2009.00204.x; Romano S., 2017, J STEROID BIOCH MOL; Romano S, 2017, J STEROID BIOCHEM, V167, P135, DOI 10.1016/j.jsbmb.2016.11.019; Romeo E, 1998, AM J PSYCHIAT, V155, P910, DOI 10.1176/ajp.155.7.910; Rosario ER, 2011, NEUROBIOL AGING, V32, P604, DOI 10.1016/j.neurobiolaging.2009.04.008; Rosenfeld CS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00632; Ruiz-Palmero I, 2016, SCI REP-UK, V6, DOI 10.1038/srep31891; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rzemieniec J, 2018, MOL CELL ENDOCRINOL, V461, P64, DOI 10.1016/j.mce.2017.08.014; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Sanchez P, 2009, HORM BEHAV, V56, P348, DOI 10.1016/j.yhbeh.2009.07.001; Santillo A, 2017, GEN COMP ENDOCR, V246, P226, DOI 10.1016/j.ygcen.2016.12.012; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Scerbo MJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00188; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Schumacher M, 2008, NEUROCHEM INT, V52, P522, DOI 10.1016/j.neuint.2007.08.022; Schwarz JM, 2010, ENDOCRINOLOGY, V151, P4871, DOI 10.1210/en.2010-0142; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shang AJ, 2015, MOL MED REP, V12, P1693, DOI 10.3892/mmr.2015.3593; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Sitruk-Ware R, 2010, CONTRACEPTION, V82, P410, DOI 10.1016/j.contraception.2010.04.004; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Spence RD, 2012, FRONT NEUROENDOCRIN, V33, P105, DOI 10.1016/j.yfrne.2011.12.001; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stary CM, 2017, MOL CELL NEUROSCI, V82, P118, DOI 10.1016/j.mcn.2017.05.004; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Su LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087867; Su XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144724; Tam H, 2007, GEN COMP ENDOCR, V150, P26, DOI 10.1016/j.ygcen.2006.07.001; Tanzer L, 2004, HORM BEHAV, V45, P339, DOI 10.1016/j.yhbeh.2004.01.002; Tata JR, 2005, EMBO REP, V6, P490, DOI 10.1038/sj.embor.7400444; Taylor LC, 2010, NEUROBIOL DIS, V39, P127, DOI 10.1016/j.nbd.2010.03.016; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Tsunemi T, 2012, PROG NEUROBIOL, V97, P142, DOI 10.1016/j.pneurobio.2011.10.004; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Vega-Vela NE, 2017, MOL NEUROBIOL, V54, P4996, DOI 10.1007/s12035-016-0045-6; Veiga S, 2006, NEUROSCI LETT, V402, P150, DOI 10.1016/j.neulet.2006.03.058; Velazquez-Zamora DA, 2012, HORM BEHAV, V61, P512, DOI 10.1016/j.yhbeh.2012.01.010; Veliskova J, 2006, NEUROSCIENCE, V138, P837, DOI 10.1016/j.neuroscience.2005.07.005; Venis S, 2001, LANCET, V358, P2055, DOI 10.1016/S0140-6736(01)07148-3; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1105, DOI 10.1124/dmd.106.014118; Vierk R, 2014, NEUROSCIENCE, V274, P24, DOI 10.1016/j.neuroscience.2014.05.003; Vierk R, 2012, J NEUROSCI, V32, P8116, DOI 10.1523/JNEUROSCI.5319-11.2012; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; VITA G, 1983, EXP NEUROL, V80, P279, DOI 10.1016/0014-4886(83)90282-0; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Wang JM, 2008, BRAIN RES REV, V57, P398, DOI 10.1016/j.brainresrev.2007.08.010; Wang X, 2017, J NEUROSCI, V37, P3294, DOI 10.1523/JNEUROSCI.2717-16.2017; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Wirth Michelle M, 2011, Front Endocrinol (Lausanne), V2, P19, DOI 10.3389/fendo.2011.00019; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiong XX, 2015, STROKE, V46, P2271, DOI 10.1161/STROKEAHA.115.008897; Yang SH, 2005, CNS NEUROL DISORD-DR, V4, P169, DOI 10.2174/1568007053544174; Yorek MA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1067, DOI 10.1152/ajpendo.00173.2002; YU WHA, 1989, BRAIN RES, V491, P379, DOI 10.1016/0006-8993(89)90075-9; YU WHA, 1982, EXP NEUROL, V77, P129; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019; Zhang XL, 2014, J NEUROCHEM, V128, P344, DOI 10.1111/jnc.12465; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107; Zschocke J, 2005, J BIOL CHEM, V280, P34924, DOI 10.1074/jbc.M502581200; Zup SL, 2014, NEUROSCIENCE, V281, P77, DOI 10.1016/j.neuroscience.2014.09.040	315	44	44	0	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-0082	1873-5118		PROG NEUROBIOL	Prog. Neurobiol.	MAY	2019	176				SI		1	17		10.1016/j.pneurobio.2018.06.007	http://dx.doi.org/10.1016/j.pneurobio.2018.06.007			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV8TN	29981391				2022-09-04	WOS:000466257100001
J	Ramirez-Hernandez, A; Montoya, V; Martinez, A; Perez, JE; Mercado, M; de la Ossa, A; Velez, C; Estrada, G; Correa, MI; Duque, L; Ariza, JS; Henao, C; Valbuena, G; Hidalgo, M				Ramirez-Hernandez, Alejandro; Montoya, Viviana; Martinez, Alejandra; Perez, Jorge E.; Mercado, Marcela; de la Ossa, Alberto; Velez, Carolina; Estrada, Gloria; Correa, Maria I.; Duque, Laura; Ariza, Juan S.; Henao, Cesar; Valbuena, Gustavo; Hidalgo, Marylin			Molecular Detection of Rickettsia felis in Different Flea Species from Caldas, Colombia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							BRAZILIAN SPOTTED-FEVER; CTENOCEPHALIDES-FELIS; SAO-PAULO; BORNE RICKETTSIOSES; XENOPSYLLA-CHEOPIS; MURINE TYPHUS; PREVALENCE; STATE; IDENTIFICATION; SIPHONAPTERA	Rickettsioses caused by Rickettsia felis are an emergent global threat. Historically, the northern region of the province of Caldas in Colombia has reported murine typhus cases, and recently, serological studies confirmed high seroprevalence for both R. felis and R. typhi. In the present study, fleas from seven municipalities were collected from dogs, cats, and mice. DNA was extracted and amplified by polymerase chain reaction (PCR) to identify gltA, ompB, and 17kD genes. Positive samples were sequenced to identify the species of Rickettsia. Of 1,341 fleas, Ctenocephalides felis was the most prevalent (76.7%). Positive PCR results in the three genes were evidenced in C. felis (minimum infection rates; 5.3%), C. canis (9.2%), and Pulex irritans (10.0%). Basic Local Alignment Search Tool (BLAST) analyses of sequences showed high identity values (> 98%) with R. felis, and all were highly related by phylogenetic analyses. This work shows the first detection of R. felis in fleas collected from animals in Colombia.	[Ramirez-Hernandez, Alejandro] Univ Nacl Colombia, Grp Parasitol Vet, Bogota, Colombia; [Montoya, Viviana; Martinez, Alejandra; Mercado, Marcela; Hidalgo, Marylin] Pontificia Univ Javeriana, Grp Enfermedades Infecciosas, Dept Microbiol, Bogota, Colombia; [Perez, Jorge E.] Univ Caldas, Fac Ciencias Salud, Lab Microbiol, Manizales, Colombia; [de la Ossa, Alberto; Velez, Carolina] Direcc Territorial Salud Caldas, Manizales, Colombia; [Estrada, Gloria] Univ Catolica Manizales, Programa Bacteriol, Manizales, Colombia; [Correa, Maria I.; Duque, Laura; Ariza, Juan S.; Henao, Cesar] Univ Caldas, Dept Med Vet & Zootecn, Manizales, Colombia; [Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Grp Enfermedades Infecciosas, Cra 7 43-82, Bogota, Colombia.	aramirezhe@unal.edu.co; pmontoya@javeriana.edu.co; amartinezr@javeriana.edu.co; mmeicado@javeriana.edu.co; tomasossa@hotmail.com; carovelez@hotmail.com; gestrada19@gmail.com; mariaico00@hotmail.com; lalitaduque7@hotmail.com; juanariza1709@hotmail.com; cesar.a.velez@hotmail.com; gvalbuen@utmb.edu; hidalgo.m@javeriana.edu.co	Hidalgo, Marylin/AAF-5736-2019; Hernandez, Alejandro Ramirez/U-1567-2019	Hernandez, Alejandro Ramirez/0000-0001-8689-5930; Estrada-Salazar, Gloria Ines/0000-0002-0006-4026; Henao Galeano, Carlos Mario/0000-0001-6936-9453; Hidalgo, Marylin/0000-0001-8960-0616	Pontificia Universidad Javeriana [PY003532]	Pontificia Universidad Javeriana	This study was supported by Pontificia Universidad Javeriana Grant PY003532.	Abdad Mohammad Yazid, 2011, Emerg Health Threats J, V4, P7168, DOI 10.3402/ehtj.v4i0.7168; Abramowicz KF, 2012, MED VET ENTOMOL, V26, P458, DOI 10.1111/j.1365-2915.2012.01017.x; Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Bermudez CSE, 2011, VET PARASITOL, V177, P134, DOI 10.1016/j.vetpar.2010.11.020; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Blair PJ, 2004, J CLIN MICROBIOL, V42, P4961, DOI 10.1128/JCM.42.11.4961-4967.2004; Cardoso Luciane Daniele, 2006, Cad. Saúde Pública, V22, P495, DOI 10.1590/S0102-311X2006000300004; Eremeeva ME, 2008, EMERG INFECT DIS, V14, P1613, DOI 10.3201/eid1410.080571; Furman D. P., 1982, MANUAL MED ENTOMOLOG, P138; Gehrke FS, 2009, CLIN MICROBIOL INFEC, V15, P267, DOI 10.1111/j.1469-0691.2008.02229.x; Gilles J, 2008, EMERG INFECT DIS, V14, P684, DOI 10.3201/eid1404.071103; Hawley JR, 2007, J FELINE MED SURG, V9, P258, DOI 10.1016/j.jfms.2006.12.005; Hidalgo M, 2008, AM J TROP MED HYG, V78, P321, DOI 10.4269/ajtmh.2008.78.321; Hidalgo M, 2013, VECTOR-BORNE ZOONOT, V13, P289, DOI 10.1089/vbz.2012.1173; Horta MC, 2007, MEM I OSWALDO CRUZ, V102, P793, DOI 10.1590/S0074-02762007000700003; Horta MC, 2006, ANN NY ACAD SCI, V1078, P361, DOI 10.1196/annals.1374.071; Horta MC, 2005, ARQ BRAS MED VET ZOO, V57, P321, DOI 10.1590/S0102-09352005000300008; Hun L, 2011, VECTOR-BORNE ZOONOT, V11, P1395, DOI 10.1089/vbz.2011.0641; Jiang J, 2006, EMERG INFECT DIS, V12, P1281, DOI 10.3201/eid1708.060327; Kamrani A, 2008, CAN J VET RES, V72, P411; Kelly PJ, 2004, EMERG INFECT DIS, V10, P967, DOI 10.3201/eid1005.030986; Labruna MB, 2007, EMERG INFECT DIS, V13, P1794, DOI 10.3201/eid1311.070782; Labruna MB, 2011, REV MVZ CORDOBA, V16, P2435, DOI 10.21897/rmvz.282; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Nava S, 2008, VECTOR-BORNE ZOONOT, V8, P465, DOI 10.1089/vbz.2007.0243; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Oliveira KA, 2008, MEM I OSWALDO CRUZ, V103, P191, DOI 10.1590/S0074-02762008000200011; Oliveira RP, 2002, EMERG INFECT DIS, V8, P317, DOI 10.3201/eid0803.010301; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Reeves WK, 2006, EXP APPL ACAROL, V39, P321, DOI 10.1007/s10493-006-9012-7; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; Stevenson HL, 2005, J MED ENTOMOL, V42, P163, DOI 10.1603/0022-2585(2005)042[0163:DORFIA]2.0.CO;2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI [10.1093/molbev/msm092, 10.1093/molbev/msr121]; Tsai KH, 2009, VECTOR-BORNE ZOONOT, V9, P561, DOI 10.1089/vbz.2008.0076; Venzal JM, 2006, ANN NY ACAD SCI, V1078, P305, DOI 10.1196/annals.1374.056; Wall R., 2001, VET ECTOPARASITES BI; WEBB L, 1990, J CLIN MICROBIOL, V28, P530, DOI 10.1128/JCM.28.3.530-534.1990; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869	44	19	20	1	11	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2013	89	3					453	459		10.4269/ajtmh.12-0698	http://dx.doi.org/10.4269/ajtmh.12-0698			7	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	240XB	23878183	Green Published			2022-09-04	WOS:000326129900009
J	Rivera-Hoyos, CM; Morales-Alvarez, ED; Poveda-Cuevas, SA; Reyes-Guzman, EA; Poutou-Pinales, RA; Reyes-Montano, EA; Pedroza-Rodriguez, AM; Rodriguez-Vazquez, R; Cardozo-Bernal, AM				Rivera-Hoyos, Claudia M.; Morales-Alvarez, Edwin David; Poveda-Cuevas, Sergio Alejandro; Reyes-Guzman, Edwin Alfredo; Poutou-Pinales, Raul A.; Reyes-Montano, Edgar Antonio; Pedroza-Rodriguez, Aura Marina; Rodriguez-Vazquez, Refugio; Cardozo-Bernal, Angela M.			Computational Analysis and Low-Scale Constitutive Expression of Laccases Synthetic Genes GlLCC1 from Ganoderma lucidum and POXA 1B from Pleurotus ostreatus in Pichia pastoris	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRAMETES-VERSICOLOR; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SCORING FUNCTION; MODEL QUALITY; OPTIMIZATION; DEGRADATION; SUBSTRATE	Lacasses are multicopper oxidases that can catalyze aromatic and non-aromatic compounds concomitantly with reduction of molecular oxygen to water. Fungal laccases have generated a growing interest due to their biotechnological potential applications, such as lignocellulosic material delignification, biopulping and biobleaching, wastewater treatment, and transformation of toxic organic pollutants. In this work we selected fungal genes encoding for laccase enzymes GlLCC1 in Ganoderma lucidum and POXA 1B in Pleurotus ostreatus. These genes were optimized for codon use, GC content, and regions generating secondary structures. Laccase proposed computational models, and their interaction with ABTS [2, 2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)] substrate was evaluated by molecular docking. Synthetic genes were cloned under the control of Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase (GAP) constitutive promoter. P. pastoris X-33 was transformed with pGAPZ alpha A-LaccGluc-Stop and pGAPZ alpha A-LaccPost-Stop constructs. Optimization reduced GC content by 47 and 49% for LaccGluc-Stop and LaccPost-Stop genes, respectively. A codon adaptation index of 0.84 was obtained for both genes. 3D structure analysis using SuperPose revealed LaccGluc-Stop is similar to the laccase crystallographic structure 1GYC of Trametes versicolor. Interaction analysis of the 3D models validated through ABTS, demonstrated higher substrate affinity for LaccPost-Stop, in agreement with our experimental results with enzymatic activities of 451.08 +/- 6.46 UL-1 compared to activities of 0.13 +/- 0.028 UL-1 for LaccGluc-Stop. This study demonstrated that G. lucidum GlLCC1 and P. ostreatus POXA 1B gene optimization resulted in constitutive gene expression under GAP promoter and alpha-factor leader in P. pastoris. These are important findings in light of recombinant enzyme expression system utility for environmentally friendly designed expression systems, because of the wide range of substrates that laccases can transform. This contributes to a great gamut of products in diverse settings: industry, clinical and chemical use, and environmental applications.	[Rivera-Hoyos, Claudia M.; Poutou-Pinales, Raul A.; Cardozo-Bernal, Angela M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David; Pedroza-Rodriguez, Aura Marina] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Microbiol Ambiental & Suelos,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David] Univ Caldas, Fac Ciencias Exactas & Nat, Grupo Invest Genet Biodiversidad & Manejo Ecosist, Dept Quim, Manizales Caldas, Colombia; [Poveda-Cuevas, Sergio Alejandro] UPTC, Fac Ciencias Basicas, Escuela Ciencias Biol, Tunja Boyaca, Colombia; [Reyes-Guzman, Edwin Alfredo; Pedroza-Rodriguez, Aura Marina] Univ Nacl Colombia UNAL, Fac Ciencias, Dept Quim, Bogota, DC, Colombia; [Rodriguez-Vazquez, Refugio] IPN, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, Mexico City, DF, Mexico		Poutou-Pinales, RA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia.	rpoutou@javeriana.edu.co; eareyesm@unal.edu.co; apedroza@javeriana.edu.co	Poutou-Piñales, Raúl A./AAF-2962-2019; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/AAX-1132-2021; Rivera-Hoyos, Claudia M./AAF-2954-2019; Marina, Aura/AAF-7657-2019	Poutou-Piñales, Raúl A./0000-0001-8841-2357; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/0000-0002-3087-6674; Reyes Montano, Edgar Antonio/0000-0003-0921-2125; Rivera-Hoyos, Claudia Marcela/0000-0003-0915-8229; Morales-Alvarez, Edwin David/0000-0003-2622-2130	Pontificia Universidad Javeriana, Bogota, D.C. Colombia [00004334, 00004335]; Universidad Nacional de Colombia, Bogota, D.C. Colombia [DIB 12929]	Pontificia Universidad Javeriana, Bogota, D.C. Colombia; Universidad Nacional de Colombia, Bogota, D.C. Colombia	This work was supported by Pontificia Universidad Javeriana, Bogota, D.C. Colombia (Grants 00004334 and 00004335) and by Universidad Nacional de Colombia, Bogota, D.C. Colombia (grant DIB 12929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Barragan CE, 2005, NOVA, V3, P80; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Bleve G, 2008, APPL MICROBIOL BIOT, V79, P731, DOI 10.1007/s00253-008-1479-1; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Cambria MT, 2010, J BIOMOL STRUCT DYN, V27, P501, DOI 10.1080/07391102.2010.10507334; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cordoba-Ruiz HA, 2009, AFR J BIOTECHNOL, V8, P1786; Doran P. M., 1998, PRINCIPIOS INGENIERI; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Fernández Jorge Andrés, 2009, Rev. colomb. biotecnol, V11, P59; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo M, 2006, APPL MICROBIOL BIOT, V71, P848, DOI 10.1007/s00253-005-0210-8; Helles G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-338; Henao-Jaramillo L.M., 2011, INT BIOTECHNOL COLOR, V1, P9; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joo SS, 2008, MOL CELLS, V25, P112; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; Landazuri P, 2009, AFR J BIOTECHNOL, V8, P2871; Loera Corral O., 2006, Advances in agricultural and food biotechnology, P323; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Callaghan J, 2002, J IND MICROBIOL BIOT, V29, P55, DOI 10.1038/sj.jim.7000268; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pedroza AM, 2007, CHEMOSPHERE, V67, P793, DOI 10.1016/j.chemosphere.2006.10.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli A, 2005, APPL MICROBIOL BIOT, V69, P428, DOI 10.1007/s00253-005-0004-z; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Plummer DT, 1981, INTRO BIOQUIMICA PRA; Poutou-Pinales RA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue3-fulltext-8; Poutou-Pinales RA, 2010, AFR J BIOTECHNOL, V9, P2173; Prasad NK, 2011, J MOL MODEL, P1; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Robert V, 2011, CURR GENOMICS, V12, P123, DOI 10.2174/138920211795564340; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Sun J, 2012, MOL BIOL REP, V39, P3807, DOI 10.1007/s11033-011-1158-7; Suresh PS, 2008, J MOL GRAPH MODEL, V26, P845, DOI 10.1016/j.jmgm.2007.05.005; Theerachat M, 2012, BIORESOURCE TECHNOL, V125, P267, DOI 10.1016/j.biortech.2012.07.117; Tinoco R, 2001, LETT APPL MICROBIOL, V32, P331, DOI 10.1046/j.1472-765X.2001.00913.x; Velu C, 2011, J BIOPROCESSING BIOT, V1; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xie HF, 2013, J MICROBIOL BIOTECHN, V23, P864, DOI 10.4014/jmb.1212.12057; Yu GC, 2006, PROCESS BIOCHEM, V41, P1987, DOI 10.1016/j.procbio.2006.04.008	63	28	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116524	10.1371/journal.pone.0116524	http://dx.doi.org/10.1371/journal.pone.0116524			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611746	gold, Green Published, Green Submitted			2022-09-04	WOS:000348562900017
J	Cucunuba, Z; Valencia, C; Florez, C; Leon, C; Castellanos, Y; Cardenas, A; Pavia, P; Hernandez, C; Robinson, A; Cuervo, R; Rios, L; Montilla, M; Villalobos, M; Nicholls, RS; Puerta, C				Cucunuba, Z.; Valencia, C.; Florez, C.; Leon, C.; Castellanos, Y.; Cardenas, A.; Pavia, P.; Hernandez, C.; Robinson, A.; Cuervo, R.; Rios, L.; Montilla, M.; Villalobos, M.; Nicholls, R. S.; Puerta, C.			Pilot program for surveillance of congenital Chagas disease in Colombia 2010-2011	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES			English	Meeting Abstract									[Cucunuba, Z.; Valencia, C.; Florez, C.; Leon, C.; Cardenas, A.; Hernandez, C.; Montilla, M.] Natl Inst Hlth, Bogota, Colombia; [Castellanos, Y.] Univ Ind Santander, Bucaramanga, Colombia; [Pavia, P.; Puerta, C.] Pontificia Univ Javeriana, Bogota, Colombia; [Robinson, A.] Secretaria Salud Arauca, Arauca, Colombia; [Cuervo, R.] Secretaria Salud Boyaca, Tunja, Colombia; [Rios, L.] Secretaria Salud Casanare, Yopal, Colombia; [Villalobos, M.] Secretaria Salud Meta, Villavicencio, Colombia; [Nicholls, R. S.] Pan Amer Hlth Org, Washington Dc, DC USA				Cucunuba, Zulma M./L-4076-2016; Cucunuba, Zulma M/X-5670-2019; Puerta, Concepcion J/AAG-4912-2019	Cucunuba, Zulma M./0000-0002-8165-3198; Cucunuba, Zulma M/0000-0002-8165-3198; 					0	1	2	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1201-9712			INT J INFECT DIS	Int. J. Infect. Dis.	JUN	2012	16			1			E343	E343		10.1016/j.ijid.2012.05.412	http://dx.doi.org/10.1016/j.ijid.2012.05.412			1	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	999YX		gold			2022-09-04	WOS:000308353101398
J	Aschner, P; Buendia, R; Brajkovich, I; Gonzalez, A; Figueredo, R; Juarez, XE; Uriza, F; Gomez, AM; Ponte, CI				Aschner, Pablo; Buendia, Richard; Brajkovich, Imperia; Gonzalez, Antonio; Figueredo, Rafael; Juarez, Xiomara E.; Uriza, Felipe; Maria Gomez, Ana; Ponte, Carlos I.			Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Waist circumference; Visceral adiposity; Latin America; Metabolic syndrome	VISCERAL FAT AREA; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ASSOCIATION; TOMOGRAPHY; ADIPOSITY	Aims: The recent definitions of the metabolic syndrome (MS) recognize the need for ethnic and region-specific waist circumference (WC) cut-offs that identify people with abdominal obesity. We tested WC as a diagnostic tool to identify people with visceral adiposity in Hispanics from the Latin America region. Methods: We used the area of visceral adipose tissue (VAT) >= 100 cm(2) at the level between the 4th and 5th lumbar vertebrae in abdominal CT scans as a marker of visceral adiposity and established the optimal WC threshold for men and women by means of receiver operating characteristic (ROC) curves. Results: 179 men and 278 women from Mexico, El Salvador, Venezuela, Colombia and Paraguay were included. The ROC curves were highly discriminative of excess VAT for men and women (area under the curve 0.9 and 0.8 respectively) and the WC threshold was identified at 94 cm for men and between 90 and 92 cm for women. Conclusion: In men the WC cutoff was equal to that proposed for europids and suggested for US adults who may have strong genetic contribution to insulin resistance such as Hispanics. In women the threshold was significantly higher than previously proposed for South and Central Americans. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Aschner, Pablo; Buendia, Richard; Uriza, Felipe; Maria Gomez, Ana] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Brajkovich, Imperia] Cent Univ Venezuela, Caracas, Venezuela; [Gonzalez, Antonio] Hosp Gen Mexico City, Mexico City, DF, Mexico; [Figueredo, Rafael] Univ Nacl Asuncion, Asuncion, Paraguay; [Juarez, Xiomara E.] Hosp San Juan Dios, San Miguel, El Salvador; [Ponte, Carlos I.] Hosp Dr Domingo Luciani, Caracas, Venezuela		Aschner, P (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia.	paschner@cable.net.co		Uriza Carrasco, Luis Felipe/0000-0002-1923-3934	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	We want to thank Jean-Pierre Despres and Isabelle Lemieux for their expert advise on the measurement of AVAT and Brian Shine for his help with the ROC curves. We also want to thank Doctors Diego Benitez, Alvaro Ruiz and Gloria Lopez for their contribution to the design and recruitment of patients. This study was partially financed by an unrestricted grant from Sanofi-Aventis.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aschner P, 2009, J CLIN HYPERTENS, V11, P769, DOI 10.1111/j.1559-4572.2008.00051.x; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Barbosa Paulo José Bastos, 2006, Arq. Bras. Cardiol., V87, P407, DOI 10.1590/S0066-782X2006001700003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres Jean-Pierre, 1993, Nutrition Research Reviews, V6, P137, DOI 10.1079/NRR19930010; FERLAND M, 1989, BRIT J NUTR, V61, P139, DOI 10.1079/BJN19890104; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kashihara H, 2009, CIRC J, V73, P1881, DOI 10.1253/circj.CJ-09-0183; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Matsushita Y, 2010, DIABETES CARE, V33, P2117, DOI 10.2337/dc10-0120; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Medina-Lezama J, 2010, DIABETES CARE, V33, P1385, DOI 10.2337/dc09-2353; Nagai M, 2008, J ATHEROSCLER THROMB, V15, P193, DOI 10.5551/jat.E566; Ohashi N, 2010, JACC-CARDIOVASC IMAG, V3, P908, DOI 10.1016/j.jcmg.2010.06.014; Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016; Perez Maritza, 2003, Eur J Cardiovasc Prev Rehabil, V10, P328, DOI 10.1097/01.hjr.0000095050.46631.6f; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sanchez-Castillo CP, 2003, OBES RES, V11, P442, DOI 10.1038/oby.2003.60	21	66	96	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2011	93	2					243	247		10.1016/j.diabres.2011.05.002	http://dx.doi.org/10.1016/j.diabres.2011.05.002			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	806QQ	21632141				2022-09-04	WOS:000293825400026
J	Lombardi, B; Loaiza, S; Trujillo, C; Arevalo, A; Vazquez, E; Arango, J; Chirinda, N				Lombardi, Banira; Loaiza, Sandra; Trujillo, Catalina; Arevalo, Ashly; Vazquez, Eduardo; Arango, Jacobo; Chirinda, Ngonidzashe			Greenhouse gas emissions from cattle dung depositions in two Urochloa forage fields with contrasting biological nitrification inhibition (BNI) capacity	GEODERMA			English	Article						Cattle dung; Tropical forages; Static chamber technique; Methane; Nitrous oxide; Emission factor	NITROUS-OXIDE EMISSIONS; BOVINE URINE; PLANTAGO-LANCEOLATA; BRACHIARIA GRASSES; DICYANDIAMIDE DCD; N2O EMISSIONS; SOIL; CH4; MITIGATION; EXCRETA	Grazing-based production systems are a source of soil greenhouse gas (GHG) emissions triggered by excreta depositions. The adoption of Urochloa forages (formerly known as Brachiaria) with biological nitrification inhibition (BNI) capacity is a promising alternative to reduce nitrous oxide (N2O) emissions from excreta patches. However, how this forage affects methane (CH4) or carbon dioxide (CO2) emissions from excreta patches remains unclear. This study investigated the potential effect of soils under two Urochloa forages with contrasting BNI capacity on GHG emissions from cattle dung deposits. Additionally, the N2O and CH4 emission factors (EF) for cattle dung under tropical conditions were determined. Dung from cattle grazing star grass (without BNI) was deposited on both forage plots: Urochloa hybrid cv. Mulato and Urochloa humidicola cv. Tully, with a respectively low and high BNI capacity. Two trials were conducted for GHG monitoring using the static chamber technique. Soil and dung properties and GHG emissions were monitored in trial 1. In trial 2, water was added to simulate rainfall and evaluate GHG emissions under wetter conditions. Our results showed that beneath dung patches, the forage genotype influenced daily CO2 and cumulative CH4 emissions during the driest conditions. However, no significant effect of the forage genotype was found on mitigating N2O emissions from dung. We attribute the absence of a significant BNI effect on N2O emissions to the limited incorporation of dung-N into the soil and rhizosphere where the BNI effect occurs. The average N2O EFs was 0.14%, close to the IPCC 2019 uncertainty range (0.01-0.13% at 95% confidence level). Moreover, CH4 EFs per unit of volatile solid (VS) averaged 0.31 g CH4 kgVS(-1), slightly lower than the 0.6 g CH4 kgVS(-1) developed by the IPCC. This implies the need to invest in studies to develop more region-specific Tier 2 EFs, including farm-level studies with animals consuming Urochloa forages to consider the complete implications of forage selection on animal excreta based GHG emissions.	[Lombardi, Banira] IFAS, CIFICEN, CONICET, UNICE,CICPBA, Tandil, Argentina; [Lombardi, Banira; Loaiza, Sandra; Trujillo, Catalina; Arevalo, Ashly; Vazquez, Eduardo; Arango, Jacobo; Chirinda, Ngonidzashe] Int Ctr Trop Agr CIAT, Cali, Colombia; [Loaiza, Sandra] Pontificia Univ Javeriana, Cali, Colombia; [Vazquez, Eduardo] Univ Bayreuth, Dept Soil Biogeochem & Soil Ecol, Bayreuth, Germany; [Chirinda, Ngonidzashe] Mohammed VI Polytech Univ UM6P, Agr Innovat & Technol Transfer Ctr AITTC, AgroBioSci AgBS, Benguerir, Morocco		Lombardi, B (corresponding author), IFAS, CIFICEN, Pinto 399, RA-7000 Buenos Aires, DF, Argentina.	blombardi@ifas.exa.unicen.edu.ar	Lombardi, Banira/AAB-6564-2022	Lombardi, Banira/0000-0001-5284-3382; Chirinda, Ngonidzashe/0000-0002-4213-6294; Arango, Jacobo/0000-0002-4828-9398	CGIAR Research Program on Climate Change (CRP), Agriculture and Food Security (CCAFS); Global Research Alliance on Agricultural Greenhouse Gases (GRA) through their CLIFF-GRADS programme; CGIAR Fund; Biotechnology and Biological Sciences Research Council project grant RCUK-CIAT Newton Fund -Towards climate-smart forage-based diets for Colombian livestock [BB/R021856/1]; Biological Sciences Research Council project grant Advancing sustainable forage-based livestock production systems in Colombia (CoForLife) [BB/S01893X/1]	CGIAR Research Program on Climate Change (CRP), Agriculture and Food Security (CCAFS); Global Research Alliance on Agricultural Greenhouse Gases (GRA) through their CLIFF-GRADS programme; CGIAR Fund(CGIAR); Biotechnology and Biological Sciences Research Council project grant RCUK-CIAT Newton Fund -Towards climate-smart forage-based diets for Colombian livestock(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biological Sciences Research Council project grant Advancing sustainable forage-based livestock production systems in Colombia (CoForLife)	This research was supported by the CGIAR Research Program on Climate Change (CRP), Agriculture and Food Security (CCAFS) and the Global Research Alliance on Agricultural Greenhouse Gases (GRA) through their CLIFF-GRADS programme. CCAFS is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details, please visit https://ccafs.cgiar.org/donors.Also, this work was conducted as part of the Livestock CRP and with funding from the Biotechnology and Biological Sciences Research Council project grants RCUK-CIAT Newton Fund -Towards climate-smart forage-based diets for Colombian livestock (BB/R021856/1) and Advancing sustainable forage-based livestock production systems in Colombia (CoForLife) (BB/S01893X/1).	Arango J, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00065; Bain WG, 2005, AGR FOREST METEOROL, V131, P225, DOI 10.1016/j.agrformet.2005.06.004; Bowatte S, 2018, GEODERMA, V323, P74, DOI 10.1016/j.geoderma.2018.03.001; Bretas IL, 2020, AGR ECOSYST ENVIRON, V295, DOI 10.1016/j.agee.2020.106896; Buendia L., 2006, IPCC GUIDELINES NATL, V4; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Byrnes RC, 2017, SOIL BIOL BIOCHEM, V107, P156, DOI 10.1016/j.soilbio.2016.12.029; Cai YJ, 2017, EARTH-SCI REV, V171, P44, DOI 10.1016/j.earscirev.2017.05.013; Cardenas LM, 2016, AGR ECOSYST ENVIRON, V235, P229, DOI 10.1016/j.agee.2016.10.025; Cardoso AD, 2019, SOIL TILL RES, V194, DOI 10.1016/j.still.2019.104341; Cardoso AD, 2018, ANIM PROD SCI, V58, P1079, DOI 10.1071/AN15392; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Chirinda N, 2010, AGR ECOSYST ENVIRON, V136, P199, DOI 10.1016/j.agee.2009.11.012; Clough TJ, 2020, J ENVIRON QUAL, V49, P1081, DOI 10.1002/jeq2.20117; Coskun D, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.74; Di Rienzo J.A, 2020, INFOSTAT VERSION 202; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; Edenhofer O., 2014, CLIMATE CHANGE 2014, P922; Evans KS, 2019, RANGELAND ECOL MANAG, V72, P667, DOI 10.1016/j.rama.2019.01.008; FAOSTAT, 2018, STAT FOOD AGR ORG UN; Gardiner CA, 2018, NEW ZEAL J AGR RES, V61, P495, DOI 10.1080/00288233.2017.1411953; Gerber PJ, 2013, ANIMAL, V7, P220, DOI 10.1017/S1751731113000876; Gulledge J, 1998, APPL ENVIRON MICROB, V64, P4291; Hahn J, 2018, BIOL FERT SOILS, V54, P533, DOI 10.1007/s00374-018-1279-4; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Horrocks CA, 2019, SCI TOTAL ENVIRON, V688, P609, DOI 10.1016/j.scitotenv.2019.06.152; Lessa ACR, 2014, AGR ECOSYST ENVIRON, V190, P104, DOI 10.1016/j.agee.2014.01.010; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Lombardi B, 2021, ANIM FEED SCI TECH, V279, DOI 10.1016/j.anifeedsci.2021.115029; Mazzetto AM, 2015, NUTR CYCL AGROECOSYS, V101, P83, DOI 10.1007/s10705-014-9663-4; Mazzetto AM, 2014, SOIL BIOL BIOCHEM, V76, P242, DOI 10.1016/j.soilbio.2014.05.026; Misselbrook TH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115006; Nunez J, 2018, PLANT SOIL, V426, P401, DOI 10.1007/s11104-018-3626-5; Oenema O, 2008, NITROGEN IN THE ENVIRONMENT: SOURCES, PROBLEMS, AND MANAGEMENT, 2ND EDITION, P395, DOI 10.1016/B978-0-12-374347-3.00012-3; Parkin TB, 2012, J ENVIRON QUAL, V41, P705, DOI 10.2134/jeq2011.0394; Parkin T.B., 2010, SAMPLING PROTOCOLS; Paul E.A., 2014, SOIL MICROBIOLOGY EC, P1, DOI [10.1016/B978-0-12-415955-6.00001-3, DOI 10.1016/B978-0-12-415955-6.00001-3]; Pelster DE, 2016, J ENVIRON QUAL, V45, P1531, DOI 10.2134/jeq2016.02.0050; Priano ME, 2014, ANIM FEED SCI TECH, V194, P145, DOI 10.1016/j.anifeedsci.2014.04.011; Rao I., 2011, P 3 INT S FOR BREED, P361; Rivera JE, 2019, AGROFOREST SYST, V93, P915, DOI 10.1007/s10457-018-0187-9; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513, DOI 10.1080/00288233.2004.9513618; Simon PL, 2020, SCI TOTAL ENVIRON, V720, DOI 10.1016/j.scitotenv.2020.137692; Simon PL, 2019, SCI TOTAL ENVIRON, V691, P430, DOI 10.1016/j.scitotenv.2019.07.141; Simon PL, 2018, AGR ECOSYST ENVIRON, V267, P74, DOI 10.1016/j.agee.2018.08.013; Subbarao GV, 2013, ANIMAL, V7, P322, DOI 10.1017/S1751731113000761; Subbarao GV, 2009, P NATL ACAD SCI USA, V106, P17302, DOI 10.1073/pnas.0903694106; Teutscherova N, 2019, BIOL FERT SOILS, V55, P325, DOI 10.1007/s00374-019-01353-y; Tully KL, 2017, J ENVIRON QUAL, V46, P921, DOI 10.2134/jeq2017.01.0040; van der Weerden TJ, 2011, AGR ECOSYST ENVIRON, V141, P426, DOI 10.1016/j.agee.2011.04.007; Vazquez E, 2020, SOIL BIOL BIOCHEM, V151, DOI 10.1016/j.soilbio.2020.108058; Vendramini J. M. B., 2014, Revista Brasileira de Ciencias Agrarias (Agraria), V9, P308; Volpi I, 2017, GEODERMA, V307, P181, DOI 10.1016/j.geoderma.2017.08.018; Wu Q, 2020, BIOL FERT SOILS, V56, P235, DOI 10.1007/s00374-019-01415-1; Zhu YH, 2020, SOIL BIOL BIOCHEM, V140, DOI 10.1016/j.soilbio.2019.107636; Zhu YH, 2018, GLOBAL BIOGEOCHEM CY, V32, P1589, DOI 10.1029/2018GB005949	56	0	0	7	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0016-7061	1872-6259		GEODERMA	Geoderma	JAN 15	2022	406								115516	10.1016/j.geoderma.2021.115516	http://dx.doi.org/10.1016/j.geoderma.2021.115516		OCT 2021	10	Soil Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	WJ2QP	35039687	Green Published, hybrid			2022-09-04	WOS:000708893700012
J	Ceballos-Garzon, A; Garcia-Effron, G; Cordoba, S; Rodriguez, JY; Alvarez-Moreno, C; Le Pape, P; Parra-Giraldo, CM; Morales-Lopez, S				Ceballos-Garzon, Andres; Garcia-Effron, Guillermo; Cordoba, Susana; Rodriguez, Jose Y.; Alvarez-Moreno, Carlos; Le Pape, Patrice; Parra-Giraldo, Claudia Marcela; Morales-Lopez, Soraya			Head-to-head comparison of CLSI, EUCAST, Etest and VITEK (R) 2 results for Candida auris susceptibility testing	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Candida auris; Susceptibility testing; CLSI; EUCAST; Etest	RESISTANCE	The susceptibility of 31 Candida auris clinical isolates was evaluated by four methods, namely the microdilution reference method according to Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines as well as Etest and VITEK (R) 2. Essential agreement between the two reference methods was 90%. Etest showed a better overall agreement with the reference methods (94% and 81% for CLSI and EUCAST, respectively) than VITEK (R) 2 (70% and 72%, respectively). Discrepancies were found for fluconazole (FLC) and amphotericin B. Considering categorical agreement (CDC tentative breakpoints), the majority of isolates were considered FLC-resistant (93.6% and 80.6% by CLSI and EUCAST, respectively). Furthermore, all isolates were considered susceptible to echinocandins by all methods. Susceptibility results should be interpreted with care if the VITEK (R) 2 system is used to guide therapeutic decisions for C. auris infections. (c) 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.	[Ceballos-Garzon, Andres; Le Pape, Patrice] Univ Nantes, Cibles & Medicaments Infect & Canc, IICiMed, EA 1155, F-44000 Nantes, France; [Ceballos-Garzon, Andres; Parra-Giraldo, Claudia Marcela] Univ Javeriana, Unidad Proteom & Micosis Humanas, Grp Enfermedades Infecciosas, Dept Microbiol,Fac Ciencias, Bogota 110231, Colombia; [Garcia-Effron, Guillermo] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, cLab Micol & Diagnost Mol, Caedra Parasitol & Micol,Consejo Nacl Invest Cien, Santa Fe, Argentina; [Cordoba, Susana] Inst Nacl Enfermedades Infecciosas Dr CG Malbran, Dept Micol, Buenos Aires, DF, Argentina; [Rodriguez, Jose Y.] Ctr Invest Microbiol Cesar, CIMCE, Valledupar, Colombia; [Alvarez-Moreno, Carlos] Univ Nacl Colombia, Clin Univ Colombia, Fac Med, Clin Colsanitas, Bogota, Colombia; [Morales-Lopez, Soraya] Univ Popular Cesar, Grp CINBIOS, Programa Microbiologra, Valledupar, Colombia		Parra-Giraldo, CM (corresponding author), Univ Javeriana, Unidad Proteom & Micosis Humanas, Grp Enfermedades Infecciosas, Dept Microbiol,Fac Ciencias, Bogota 110231, Colombia.; Morales-Lopez, S (corresponding author), Univ Popular Cesar, Grp CINBIOS, Programa Microbiologra, Valledupar, Colombia.	Claudia.parra@javeriana.edu.co; sorayaeugeniam@hotmail.com	CEBALLOS, Andres/AAN-8908-2021	CEBALLOS, Andres/0000-0003-2129-1399; Ceballos-Garzon, Andres/0000-0002-0743-6857; alvarez Moreno, carlos Arturo/0000-0001-5419-4494	Pontificia Universidad Javeriana in Bogota, Colombia [20291]; Ministerio de Ciencia y Tecnologia Argentina [PICT-20161985]; Universidad Popular del Cesar; Instituto Nacional de Enfermedades Infecciosas Malbran;  [MINCIENCIAS 807-2018];  [120380763646]	Pontificia Universidad Javeriana in Bogota, Colombia; Ministerio de Ciencia y Tecnologia Argentina; Universidad Popular del Cesar; Instituto Nacional de Enfermedades Infecciosas Malbran; ; 	This work was financed by the Research Vice Presidency of the Pontificia Universidad Javeriana [grant ID 20291] and MINCIENCIAS 807-2018 [Code 120380763646] in Bogota, Colombia to CMPG; the Ministerio de Ciencia y Tecnologia Argentina [grant PICT-20161985] to GGE; the Instituto Nacional de Enfermedades Infecciosas Malbran to SC; and the Universidad Popular del Cesar to SML.	Ademe M, 2020, INFECT DRUG RESIST, V13, P1287, DOI 10.2147/IDR.S249864; Arendrup MC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00485-17, 10.1128/aac.00485-17]; Ceballos-Garzon A, 2020, J FUNGI, V6, DOI 10.3390/jof6020072; Ruiz-Gaitan AC, 2019, INT J ANTIMICROB AG, V53, P541, DOI 10.1016/j.ijantimicag.2019.02.005; Chow NA, 2020, MBIO, V11, DOI 10.1128/mBio.03364-19; Clinical and Laboratory Standards Institute (CLSI), 2002, M27A2 CLSI, V2nd; Cuenca-Estrella M, 2010, J CLIN MICROBIOL, V48, P1782, DOI 10.1128/JCM.02316-09; de Jong AW, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03220-20; Espinel-Ingroff A, 2014, ANTIMICROB AGENTS CH, V58, P2006, DOI 10.1128/AAC.02615-13; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2020, EUCAST DEFINITIVE DO; Forsberg K, 2019, MED MYCOL, V57, P1, DOI 10.1093/mmy/myy054; Knabl L, 2020, EXPERT REV ANTI-INFE, V18, P779, DOI 10.1080/14787210.2020.1760841; Mathur P, 2018, MYCOSES, V61, P674, DOI 10.1111/myc.12790; Morales-Lopez SE, 2017, EMERG INFECT DIS, V23, P162, DOI 10.3201/eid2301.161497; Parra-Giraldo CM, 2018, INT J INFECT DIS, V69, P63, DOI 10.1016/j.ijid.2018.01.034; Pfaller MA, 2014, DIAGN MICR INFEC DIS, V79, P198, DOI 10.1016/j.diagmicrobio.2014.03.004; Rodriguez JY, 2021, CLIN INFECT DIS, V73, pE2836, DOI 10.1093/cid/ciaa1595; Tan YE, 2019, INT J ANTIMICROB AG, V54, P709, DOI 10.1016/j.ijantimicag.2019.09.016; Theill L, 2018, REV IBEROAM MICOL, V35, P110, DOI 10.1016/j.riam.2018.01.003; US Centers for Disease Control and Prevention (CDC), CAND AUR ANT SUSC TE	20	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	APR	2022	59	4							106558	10.1016/j.ijantimicag.2022.106558	http://dx.doi.org/10.1016/j.ijantimicag.2022.106558			5	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	2S0KC	35227828				2022-09-04	WOS:000821489800008
J	Bahrami, A; Barreto, GE; Lombardi, G; Pirro, M; Sahebkar, A				Bahrami, Afsane; Barreto, George E.; Lombardi, Gemma; Pirro, Matteo; Sahebkar, Amirhossein			Emerging roles for high-density lipoproteins in neurodegenerative disorders	BIOFACTORS			English	Review						Alzheimer's disease; apolipoprotein; cholesterol; dementia; HDL; Parkinson's disease	MILD COGNITIVE IMPAIRMENT; LOW HDL CHOLESTEROL; APOLIPOPROTEIN-E POLYMORPHISM; E EPSILON-4 ALLELE; 21-YEAR FOLLOW-UP; AGE-OF-ONSET; ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; CEREBROSPINAL-FLUID; HUNTINGTON-DISEASE	Lipoproteins are the complexes of different lipids and proteins, which are devoted to the transport and clearance of lipids or lipid-related molecules in the circulation. Lipoproteins have been found to play a crucial role in brain function and may influence myelination process. Among lipoproteins, high-density lipoproteins (HDLs) and their major protein component, apoA-I, are directly involved in cholesterol efflux in the brain. It has been suggested that inadequate or dysfunctional brain HDLs may contribute to cerebrovascular dysfunctions, neurodegeneration, or neurovascular instability. HDL deficiency could also promote cognitive decline through impacting on atherosclerotic risk. The focus of this review is to discuss knowledge on HDL dysregulation in neurological disorders. A better understanding on how changes in cellular HDL and apolipoprotein homeostasis affect central nervous system function may provide promising novel avenues for the treatment of specific HDL-related neurological disorders.	[Bahrami, Afsane] Birjand Univ Med Sci, Cellular & Mol Res Ctr, Birjand, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Lombardi, Gemma] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Pirro, Matteo] Univ Perugia, Dept Med, Unit Internal Med, Perugia, Italy; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Barreto, George E./AAD-7420-2020; Pirro, Matteo/AAC-2318-2022; Sahebkar, Amirhossein/B-5124-2018	Barreto, George E./0000-0002-6644-1971; 				Ahmed RM, 2014, NEUROLOGY, V83, P1812, DOI 10.1212/WNL.0000000000000993; Akhmedova SN, 2001, J NEUROL SCI, V184, P179, DOI 10.1016/S0022-510X(01)00439-7; Ancelin ML, 2013, J ALZHEIMERS DIS, V34, P519, DOI 10.3233/JAD-121228; [Anonymous], 2015, DEMENTIA STAT 2015; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Baig SS, 2016, NEURODEGENER DIS MAN, V6, P331, DOI 10.2217/nmt-2016-0008; Banach M, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0169-0; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Baxter LC, 2003, NEUROBIOL AGING, V24, P947, DOI 10.1016/S0197-4580(03)00006-X; Bianconi V, 2018, CURR MED CHEM, V25, P4518, DOI 10.2174/0929867324666171012111603; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Buchanan DD, 2007, NEUROSCI LETT, V411, P185, DOI 10.1016/j.neulet.2006.07.080; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.3.CO;2-C; Camponova P, 2017, CAN J PHYSIOL PHARM, V95, P894, DOI 10.1139/cjpp-2016-0710; Escola-Gil JC, 2009, ATHEROSCLEROSIS, V206, P321, DOI 10.1016/j.atherosclerosis.2008.12.044; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Cassani E, 2013, NUTRITION, V29, P1331, DOI 10.1016/j.nut.2013.04.013; Cereda E, 2012, NEUROLOGY, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Cockerill GW, 2001, CIRCULATION, V103, P108; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Czapski GA, 2012, ACTA NEUROBIOL EXP, V72, P397; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, P1236, DOI 10.1016/j.neurobiolaging.2009.07.015; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Dening Tom, 2015, Nurs Stand, V29, P37, DOI 10.7748/ns.29.37.37.e9405; Dias IHK, 2014, J ALZHEIMERS DIS, V40, P399, DOI 10.3233/JAD-131964; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Du Y, 2015, EXPERT OPIN DRUG DIS, V10, P841, DOI 10.1517/17460441.2015.1051963; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Elias PK, 2005, PSYCHOSOM MED, V67, P24, DOI 10.1097/01.psy.0000151745.67285.c2; Esiri MM, 2001, LANCET, V357, P169; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.3.CO;2-O; Fan QW, 2001, J NEUROCHEM, V76, P391, DOI 10.1046/j.1471-4159.2001.00063.x; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; Federoff M, 2012, NEUROBIOL DIS, V46, P389, DOI 10.1016/j.nbd.2012.02.002; Fellows K, 2015, J LIPID RES, V56, P2010, DOI 10.1194/jlr.M060970; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Ganjali S, 2019, TRENDS ENDOCRIN MET, V30, P12, DOI 10.1016/j.tem.2018.10.004; Ganjali S, 2017, PROG LIPID RES, V67, P16, DOI 10.1016/j.plipres.2017.05.001; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Gatz M, 2010, BEHAV GENET, V40, P768, DOI 10.1007/s10519-010-9407-4; Ghebranious N, 2011, CLIN MED RES, V9, P17, DOI 10.3121/cmr.2010.894; Gregorio ML, 2013, BIOMED RES INT, V2013, P1; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hesse C, 2000, NEUROCHEM RES, V25, P511, DOI 10.1023/A:1007516210548; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; Hottman DA, 2014, NEUROBIOL DIS, V72, P22, DOI 10.1016/j.nbd.2014.07.015; Hu J, 2016, AM J MED SCI, V352, P408, DOI 10.1016/j.amjms.2016.06.014; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kehoe P, 1999, J MED GENET, V36, P108; Khalil A, 2012, MECH AGEING DEV, V133, P20, DOI 10.1016/j.mad.2011.11.008; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Komulainen P, 2007, DEMENT GERIATR COGN, V23, P29, DOI 10.1159/000096636; Kondo I, 1998, BRAIN RES, V806, P271, DOI 10.1016/S0006-8993(98)00586-1; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Kurz MW, 2009, J GERIATR PSYCH NEUR, V22, P166, DOI 10.1177/0891988709332945; Lara VP, 2016, J CLIN LAB ANAL, V30, P374, DOI 10.1002/jcla.21865; Leoni V, 2013, NEUROBIOL DIS, V55, P37, DOI 10.1016/j.nbd.2013.03.013; LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807; Lewis GF, 1996, DIABETES METAB REV, V12, P37, DOI 10.1002/(SICI)1099-0895(199603)12:1&lt;37::AID-DMR154&gt;3.0.CO;2-Q; Li G, 2004, NEUROLOGY, V63, P1624, DOI 10.1212/01.WNL.0000142963.90204.58; Lindh M, 1997, NEUROSCI LETT, V229, P85, DOI 10.1016/S0304-3940(97)00429-1; Liu YZ, 2014, MOL NEUROBIOL, V49, P1043, DOI 10.1007/s12035-013-8579-3; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Luchsinger JA, 2012, ALZ DIS ASSOC DIS, V26, P101, DOI 10.1097/WAD.0b013e318222f0d4; Luchsinger Jose A, 2004, Curr Atheroscler Rep, V6, P261, DOI 10.1007/s11883-004-0056-z; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchesi S, 2003, J CLIN PHARM THER, V28, P419, DOI 10.1046/j.0269-4727.2003.00512.x; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Meyer JS, 2000, NEUROBIOL AGING, V21, P161, DOI 10.1016/S0197-4580(00)00136-6; Michikawa M, 2003, J NEUROSCI RES, V72, P141, DOI 10.1002/jnr.10585; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mineo C, 2013, J LIPID RES, V54, P2315, DOI 10.1194/jlr.R039479; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Olesen OF, 2000, BIOCHEM BIOPH RES CO, V270, P62, DOI 10.1006/bbrc.2000.2372; Pan LR, 2016, BBA-BIOMEMBRANES, V1858, P2401, DOI 10.1016/j.bbamem.2016.03.010; Panas M, 1999, J NEUROL, V246, P574, DOI 10.1007/s004150050406; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Panza F, 2006, BRAIN RES REV, V51, P275, DOI 10.1016/j.brainresrev.2005.11.007; Pasqualini L, 2005, ATHEROSCLEROSIS, V183, P349, DOI 10.1016/j.atherosclerosis.2005.03.030; Paterno R, 2004, CEREBROVASC DIS, V17, P204, DOI 10.1159/000075792; Paulsen JS, 2013, PROG NEUROBIOL, V110, P2, DOI 10.1016/j.pneurobio.2013.08.003; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pirro M, 2004, EUR J CARDIOV PREV R, V11, P497, DOI 10.1097/00149831-200412000-00009; Pirro M, 2018, PROG LIPID RES, V71, P54, DOI 10.1016/j.plipres.2018.06.001; Pirttila T, 1998, NEUROSCI LETT, V249, P21, DOI 10.1016/S0304-3940(98)00381-4; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Pontes-Neto Octavio M, 2012, Eur Neurol Rev, V7, P134; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Pulkes T, 2011, J CLIN NEUROSCI, V18, P1333, DOI 10.1016/j.jocn.2011.01.028; Qiang JK, 2013, ANN NEUROL, V74, P119, DOI 10.1002/ana.23872; Rasmussen KL, 2015, ANN NEUROL, V77, P301, DOI 10.1002/ana.24326; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004; Reid PC, 2007, J CELL MOL MED, V11, P383, DOI 10.1111/j.1582-4934.2007.00054.x; Reitz C, 2005, NEUROLOGY, V64, P1378, DOI 10.1212/01.WNL.0000158274.31318.3C; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Riekse RG, 2004, J AM GERIATR SOC, V52, P1442, DOI 10.1111/j.1532-5415.2004.52405.x; Riwanto M, 2013, J LIPID RES, V54, P3227, DOI 10.1194/jlr.R037762; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Romas SN, 1999, NEUROLOGY, V53, P517, DOI 10.1212/WNL.53.3.517; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Rountree SD, 2007, DEMENT GERIATR COGN, V24, P476, DOI 10.1159/000110800; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P2729, DOI 10.1001/jama.285.21.2729; Sampedro F, 2015, ONCOTARGET, V6, P26663, DOI 10.18632/oncotarget.5185; Sanders AE, 2010, JAMA-J AM MED ASSOC, V303, P150, DOI 10.1001/jama.2009.1988; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scigliano G, 2009, PARKINSONISM RELAT D, V15, P138, DOI 10.1016/j.parkreldis.2008.04.036; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shang JW, 2018, J CLIN NEUROL, V14, P29, DOI 10.3988/jcn.2018.14.1.29; SHARRETT AR, 1994, ARTERIOSCLER THROMB, V14, P1098, DOI 10.1161/01.ATV.14.7.1098; Siddiqi HK, 2015, CURR OPIN CARDIOL, V30, P536, DOI 10.1097/HCO.0000000000000211; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Singh-Manoux A, 2003, J AM GERIATR SOC, V51, P1445, DOI 10.1046/j.1532-5415.2003.51464.x; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Solomon A, 2007, NEUROLOGY, V68, P751, DOI 10.1212/01.wnl.0000256368.57375.b7; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; Sonnino S, 2014, MOL NEUROBIOL, V50, P130, DOI 10.1007/s12035-013-8614-4; Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje; Stukas S, 2014, CELL METAB, V19, P574, DOI 10.1016/j.cmet.2014.01.003; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; SWAN GE, 1992, ARCH NEUROL-CHICAGO, V49, P476, DOI 10.1001/archneur.1992.00530290058012; Tanne D, 1997, STROKE, V28, P83, DOI 10.1161/01.STR.28.1.83; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Tynkkynen J, 2018, ALZHEIMERS DEMENT, V14, P723, DOI 10.1016/j.jalz.2018.01.003; Tynkkynen J, 2016, AGE, V38, P465, DOI 10.1007/s11357-016-9950-x; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Valenza M, 2010, J NEUROSCI, V30, P10844, DOI 10.1523/JNEUROSCI.0917-10.2010; van densKommer TN, 2012, NEUROBIOL AGING, V33; van Exel E, 2002, ANN NEUROL, V51, P716, DOI 10.1002/ana.10220; van Wijk Nick, 2017, Alzheimers Dement (Amst), V8, P139, DOI 10.1016/j.dadm.2017.04.005; Vanhanen M, 2006, NEUROLOGY, V67, P843, DOI 10.1212/01.wnl.0000234037.91185.99; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Ward MA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00029; Warren MW, 2012, J ALZHEIMERS DIS, V29, P151, DOI 10.3233/JAD-2012-111385; Williams-Gray CH, 2009, J NEUROL, V256, P493, DOI 10.1007/s00415-009-0119-8; Wolf H, 2004, ANN NEUROL, V56, P745, DOI 10.1002/ana.20289; Wollmer MA, 2003, NEUROBIOL AGING, V24, P421, DOI 10.1016/S0197-4580(02)00094-5; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Yokoyama S, 2015, NUTRIENTS, V7, P2359, DOI 10.3390/nu7042359; Zanchetti A, 2014, J HYPERTENS, V32, P1741, DOI 10.1097/HJH.0000000000000253; Zhang XP, 2012, ANALYST, V137, P490, DOI 10.1039/c1an15551b; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30741; Zhu Y, 2016, INT J CLIN EXP MED, V9, P15243; ZIMETBAUM P, 1992, ARTERIOSCLER THROMB, V12, P416, DOI 10.1161/01.ATV.12.4.416; Zipfel GJ, 2009, STROKE, V40, pS16, DOI 10.1161/STROKEAHA.108.533174; Zuliani G, 2001, BMC Geriatr, V1, P5, DOI 10.1186/1471-2318-1-5	188	17	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-6433	1872-8081		BIOFACTORS	Biofactors	SEP	2019	45	5					725	739		10.1002/biof.1541	http://dx.doi.org/10.1002/biof.1541		JUL 2019	15	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	JD6CP	31301192				2022-09-04	WOS:000476423500001
J	Delgado-Jojoa, MG; Sanchez-Gilede, JA; Rondon-Quintana, HA; Fernandez-Gomez, WD; Reyes-Lizcano, FA				Delgado-Jojoa, Miguel G.; Sanchez-Gilede, Jessica A.; Rondon-Quintana, Hugo A.; Fernandez-Gomez, Wilmar D.; Reyes-Lizcano, Fredy A.			Influence of four non-conventional additives on the physical, rheological and thermal properties of an asphalt	INGENIERIA E INVESTIGACION			English	Article						modified asphalt; low density polyethylene waste; crumb rubber; Gilsonite; Husil	LABORATORY EVALUATION; PERFORMANCE; CONCRETE; BINDERS; POLYETHYLENE; TEMPERATURE; RESISTANCE; GILSONITE; DESIGN; HMA	This article shows the evaluation of the influence of two polymer wastes (crumb rubber - GCR and low density polyethylene-LDPE), a natural bitumen (Gilsonite - G) and a chemical component (Husil) on the physical, rheological and thermal properties of an asphalt cement (AC 60/70 penetration grade). Over a control asphalt and the modified asphalts were performed: penetration, softening point, ductility, ignition point, rheology (using a dynamic cut rheometer - DSR), Multi Stress Creep and Recovery (MSCR), linear amplitude sweep (LAS), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) tests. The results show that the four additives increase the stiffness and rutting resistance of the asphalts. Additionally, it reports an increase in fatigue cracking resistance when asphalt cement is modified with GCR, G and Husil. The additives give thermal stability to the asphalt cement, providing less mass loss (linked mostly to a less oxidation).	[Delgado-Jojoa, Miguel G.; Sanchez-Gilede, Jessica A.; Reyes-Lizcano, Fredy A.] Pontifica Univ Javeriana, Bogota, Colombia; [Delgado-Jojoa, Miguel G.; Sanchez-Gilede, Jessica A.] Pontifica Univ Javeriana, Sci, Bogota, Colombia; [Rondon-Quintana, Hugo A.] UFPS, Cucuta, Colombia; [Rondon-Quintana, Hugo A.] Univ Los Andes, Sci, Bogota, Colombia; [Rondon-Quintana, Hugo A.; Fernandez-Gomez, Wilmar D.] Univ Los Andes, Engn, Bogota, Colombia; [Rondon-Quintana, Hugo A.; Fernandez-Gomez, Wilmar D.] Univ Distrital Francisco Jose de Caldas, Bogota, Colombia; [Fernandez-Gomez, Wilmar D.] Univ Catolica Colombia, Bogota, Colombia; [Fernandez-Gomez, Wilmar D.] Pontificia Univ Javeriana, Engn, Bogota, Colombia; [Reyes-Lizcano, Fredy A.] Ecole Natl Super Mecan, Sci, Besancon, France; [Reyes-Lizcano, Fredy A.] Ecole Natl Super Mecan, Engn, Besancon, France		Delgado-Jojoa, MG (corresponding author), Pontifica Univ Javeriana, Bogota, Colombia.; Delgado-Jojoa, MG (corresponding author), Pontifica Univ Javeriana, Sci, Bogota, Colombia.	Miguel.delgado@javeriana.edu.co; J.sanchezg@javeriana.edu.co; harondonq@udistrital.edu.co; wfernandez@udistrital.edu.co; fredy.reyes@javeriana.edu.co		Fernandez-Gomez, Wilmar/0000-0001-6339-8050; Rondon-Quintana, Hugo Alexander/0000-0003-2946-9411				Al-Hadidy AI, 2009, J MATER CIVIL ENG, V21, P618, DOI 10.1061/(ASCE)0899-1561(2009)21:10(618); Rondon-Quintana HA, 2016, REV FAC ING-UNIV ANT, P129, DOI 10.17533/udea.redin.n78a17; Ameri M., 2012, TRANSPORT RES, V2, P1; Ameri M, 2011, CONSTR BUILD MATER, V25, P1379, DOI 10.1016/j.conbuildmat.2010.09.005; Anderson K. W., 2008, EVALUATION LONG TERM; Ashish PK, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002106; Babagoli R, 2015, ROAD MATER PAVEMENT, V16, P889, DOI 10.1080/14680629.2015.1042016; Bagampadde U., 2013, INT J PAVEMENT RES T, V6, P217; Bakhshi B, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002116; Cai LC, 2018, CONSTR BUILD MATER, V172, P204, DOI 10.1016/j.conbuildmat.2018.03.187; Lopez WAC, 2016, INGENIERIA-BOGOTA, V21, P7, DOI 10.14483/udistrital.jour.reving.2016.1.a01; Cholewinska M., 2011, STRUCT ENV, V3, P5; Cong PL, 2010, J APPL POLYM SCI, V118, P3678, DOI 10.1002/app.32440; Dong Y., 2011, GEOTECHNICAL SPECIAL, V212, P78, DOI DOI 10.1061/47623(402)10; Esfeh H.K., 2011, INT J CHEM ENG APPL, V2, P168, DOI [10.7763/IJCEA.2011.V2.96, DOI 10.7763/IJCEA.2011.V2.96]; Fang CQ, 2016, CONSTR BUILD MATER, V119, P113, DOI 10.1016/j.conbuildmat.2016.04.099; Fang CQ, 2015, J MATER SCI TECHNOL, V31, P320, DOI 10.1016/j.jmst.2014.04.019; Feng X., 2011, OPEN MAT SCI J, V5, P140, DOI [10.2174/1874088X01105010140, DOI 10.2174/1874088X01105010140]; Feng XJ, 2011, ADV MATER RES-SWITZ, V146-147, P217, DOI 10.4028/www.scientific.net/AMR.146-147.217; Hsu TW, 2011, J MATER CIVIL ENG, V23, P342, DOI 10.1061/(ASCE)MT.1943-5533.0000181; Huang SC, 2008, J MATER CIVIL ENG, V20, P221, DOI 10.1061/(ASCE)0899-1561(2008)20:3(221); Huang Y, 2007, RESOUR CONSERV RECY, V52, P58, DOI 10.1016/j.resconrec.2007.02.002; IDU-Instituto de Desarrollo Urbano, 2002, EST MEJ MEC MEZCL AS; IDU-Instituto de Desarrollo Urbano, 2005, IDU306003; Instituto Nacional de Vias-INVIAS, 2016, EST RED VIAL CRIT TE; Instituto Nacional de Vias-INVIAS, 2013, ESP GEN CONSTR CARR; Jahanian HR, 2017, CONSTR BUILD MATER, V131, P156, DOI 10.1016/j.conbuildmat.2016.11.069; Kaloush KE, 2014, CONSTR BUILD MATER, V67, P258, DOI 10.1016/j.conbuildmat.2014.03.020; Kok BV, 2012, INT J MATER RES, V103, P506, DOI 10.3139/146.110654; Kumar P, 2010, J MATER CIVIL ENG, V22, P978, DOI 10.1061/(ASCE)MT.1943-5533.0000099; Lee SJ, 2008, CONSTR BUILD MATER, V22, P1368, DOI 10.1016/j.conbuildmat.2007.04.010; Lougheed TJ, 1996, J MATER CIVIL ENG, V8, P153, DOI 10.1061/(ASCE)0899-1561(1996)8:3(153); MCQUILLEN JL, 1987, J CONSTR ENG M ASCE, V113, P537, DOI 10.1061/(ASCE)0733-9364(1987)113:4(537); MINTRANSPORTE-Ministerio de Transporte Oficina de Planeacion, 2004, DIAGN SECT TRANSP BO; MINTRANSPORTE-Ministerio de Transporte Oficina de Planeacion, 2004, DIAGN SECT TRANSP; Oliveira JRM, 2013, J CLEAN PROD, V41, P15, DOI 10.1016/j.jclepro.2012.09.047; Othman AM, 2010, J MATER CIVIL ENG, V22, P1019, DOI 10.1061/(ASCE)MT.1943-5533.0000106; Partl MN, 2010, CONSTR BUILD MATER, V24, P283, DOI 10.1016/j.conbuildmat.2009.08.041; Punith VS, 2011, J TEST EVAL, V39, P191, DOI 10.1520/JTE102919; Punith VS, 2011, J MATER CIVIL ENG, V23, P833, DOI 10.1061/(ASCE)MT.1943-5533.0000235; Rondón Quintana Hugo, 2010, Rev. ing. constr., V25, P83; Rondón Quintana Hugo Alexander, 2017, Ing. Desarro., V35, P152, DOI 10.14482/inde.35.1.8947; Quintana HAR, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001339; Rondón Quintana Hugo Alexander, 2014, Tecnura, V18, P97, DOI 10.14483/udistrital.jour.tecnura.2014.DSE1.a09; Rondón Quintana Hugo Alexander, 2012, rev.ing., P12; Saberi KF, 2017, J CLEAN PROD, V165, P1125, DOI 10.1016/j.jclepro.2017.07.079; Said SF, 2013, J TEST EVAL, V41, P602, DOI 10.1520/JTE20120177; Su NY, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002449; Wang C, 2017, CONSTR BUILD MATER, V153, P695, DOI 10.1016/j.conbuildmat.2017.07.151; Widyatmoko I, 2005, ROAD MATER PAVEMENT, V6, P469, DOI 10.3166/rmpd.6.469-483; Xiao FP, 2007, J MATER CIVIL ENG, V19, P475, DOI 10.1061/(ASCE)0899-1561(2007)19:6(475); Yilmaz M, 2017, J MATER CIVIL ENG, V29, DOI 10.1061/(ASCE)MT.1943-5533.0001938; Yilmaz M, 2013, CAN J CIVIL ENG, V40, P27, DOI 10.1139/cjce-2011-0354; Zoorob SE, 2000, CEMENT CONCRETE COMP, V22, P233, DOI 10.1016/S0958-9465(00)00026-3	54	2	2	3	18	UNIV NAC COLOMBIA, FAC INGENIERIA	BOGOTA	CALLE 44, NO 45-67, UNIDAD CAMILO TORRES, BLOQUE B5, OFICINA 401, BOGOTA, 00000, COLOMBIA	0120-5609			ING INVEST	Ing. Invest.	AUG	2018	38	2					18	26		10.15446/ing.investig.v38n2.68638	http://dx.doi.org/10.15446/ing.investig.v38n2.68638			9	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HI0DN		gold, Green Submitted, Green Published			2022-09-04	WOS:000456112400003
J	Avila-Rodriguez, M; Garcia-Segura, LM; Hidalgo-Lanussa, O; Baez, E; Gonzalez, J; Barreto, GE				Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Hidalgo-lanussa, Oscar; Baez, Eliana; Gonzalez, Janneth; Barreto, George E.			Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression	MOLECULAR AND CELLULAR ENDOCRINOLOGY			English	Article						Tibolone; Astrocytes; Glucose deprivation; Mitochondria; ER beta; Neuroglobin	RAT MODEL; BRAIN; 17-BETA-ESTRADIOL; NEURONS; ALPHA; NEUROPROTECTION; OVEREXPRESSION; METABOLITES; PHYSIOLOGY; APOPTOSIS	Tibolone, a synthetic steroid used for the prevention of osteoporosis and the treatment of climacteric symptoms in post-menopausal women, may exert tissue selective estrogenic actions acting on estrogen receptors (ERs). We previously showed that tibolone protects human T98G astroglial cells against glucose deprivation (GD). In this study we have explored whether the protective effect of tibolone on these cells is mediated by ERs. Experimental studies showed that both ER alpha and ER beta were involved in the protection by tibolone on GD cells, being ER beta preferentially involved on these actions over ERa. Tibolone increased viability of GD cells by a mechanism fully blocked by an ER beta antagonist and partially blocked by an ERa antagonist. Furthermore, ER beta inhibition prevented the effect of tibolone on nuclear fragmentation, ROS and mitochondria] membrane potential in GD cells. The protective effect of tibolone was mediated by neuroglobin. Tibolone upregulated neuroglobin in T98G cells and primary mouse astrocytes by a mechanism involving ER beta and neuroglobin silencing prevented the protective action of tibolone on GD cells. In summary, tibolone protects T98G cells by a mechanism involving ER beta and the upregulation of neuroglobin. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Avila-Rodriguez, Marco; Hidalgo-lanussa, Oscar; Baez, Eliana; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Dept Ciencias Clin, Ibague, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barreto, George E.] Univ Cient Sur, Lima, Peru		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./AAD-7420-2020; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./B-5747-2014	Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X; Avila-Rodriguez, Marco/0000-0003-4612-3236	Ministerio de Economia y Competitividad, Spain [4509, 5024, 5619, BFU2014-51836-C2-1-R]; Colciencias Convocatoria 511 Generation del Bicentenario	Ministerio de Economia y Competitividad, Spain; Colciencias Convocatoria 511 Generation del Bicentenario	This work was supported in part by grants PUJ IDs 4509, 5024 to GB and 5619 to JG, by grant BFU2014-51836-C2-1-R from Ministerio de Economia y Competitividad, Spain, to LMGS and Colciencias Convocatoria 511 Generation del Bicentenario to MAR.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Al-Bader MD, 2011, PHYSIOL RES, V60, P951, DOI 10.33549/physiolres.932167; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Bankhead P., 2014, ANAL FLUORESCENCE MI; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Biglia N, 2010, GYNECOL ENDOCRINOL, V26, P804, DOI 10.3109/09513590.2010.495437; Bjorling DE, 2001, UROLOGY, V57, P40, DOI 10.1016/S0090-4295(01)01124-4; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Catley MC, 2008, J PHARMACOL EXP THER, V326, P83, DOI 10.1124/jpet.108.136275; cooperlab, 2016, BACKGR SUBTR OBT TOT; de Joannon AC, 2000, NEUROSCI LETT, V285, P218, DOI 10.1016/S0304-3940(00)01051-X; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Ettinger B, 2007, MATURITAS, V57, P35, DOI 10.1016/j.maturitas.2007.02.008; Falany JL, 2007, J STEROID BIOCHEM, V107, P202, DOI 10.1016/j.jsbmb.2007.03.046; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Fiocchetti M., 2013, 15 EUR C END COP DEN, V32, P693; Fiocchetti M, 2015, J STEROID BIOCHEM, V149, P128, DOI 10.1016/j.jsbmb.2015.02.005; Garcia-Segura LM., FRONT CELL NEUROSCI; Gasque P, 1996, J IMMUNOL, V156, P2247; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Gompel A, 2002, FERTIL STERIL, V78, P351, DOI 10.1016/S0015-0282(02)03203-X; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; [Inc T.F.S. Thermo Fisher], 2015, BAS RT PCR; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu Chao, 2009, Zhonghua Shao Shang Za Zhi, V25, P222; Liu YC, 2015, BRAIN INJURY, V29, P651, DOI 10.3109/02699052.2014.1002004; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Moens L, 2000, NATURE, V407, P461, DOI 10.1038/35035181; Ouyang YB, 2006, CELL STRESS CHAPERON, V11, P180, DOI 10.1379/CSC-182R.1; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Pawlak J, 2005, GLIA, V50, P270, DOI 10.1002/glia.20162; Qiu J, 2008, J NEUROENDOCRINOL, V20, P1310, DOI 10.1111/j.1365-2826.2008.01789.x; Ren CH, 2015, RESTOR NEUROL NEUROS, V33, P369, DOI 10.3233/RNN-140413; Sandhir R, 2014, NEUROSCI LETT, V577, P123, DOI 10.1016/j.neulet.2014.06.005; Shang AJ, 2015, MOL MED REP, V12, P1693, DOI 10.3892/mmr.2015.3593; Spence R. D., 2013, THESIS, P115; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Stark J, 2015, GYNECOL ENDOCRINOL, V31, P31, DOI 10.3109/09513590.2014.943727; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tan HY, 2008, OPT COMMUN, V281, P3013, DOI 10.1016/j.optcom.2008.01.012; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Venis S, 2001, LANCET, V358, P2055, DOI 10.1016/S0140-6736(01)07148-3; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200; Yu Z., 2015, MOL NEUROBIOL; Yu ZL, 2014, NEUROSCIENCE, V270, P158, DOI 10.1016/j.neuroscience.2014.04.013; Yue G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-608; Zhang W, 2006, J SOC GYNECOL INVEST, V13, P459, DOI 10.1016/j.jsgi.2006.05.004	59	50	50	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0303-7207			MOL CELL ENDOCRINOL	Mol. Cell. Endocrinol.	SEP 15	2016	433	C					35	46		10.1016/j.mce.2016.05.024	http://dx.doi.org/10.1016/j.mce.2016.05.024			12	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Endocrinology & Metabolism	DT1JV	27250720				2022-09-04	WOS:000381239100005
J	Bejarano, CA; Diaz, JE; Cifuentes-Lopez, A; Lopez, LV; Jaramillo-Gomez, LM; Buendia-Atencio, C; Velasquez, VPL; Mejia, SM; Loaiza, AE				Bejarano, Carlos A.; Diaz, John E.; Cifuentes-Lopez, Andres; Lopez, Lina, V; Jaramillo-Gomez, Luz M.; Buendia-Atencio, Cristian; Lorett Velasquez, Vaneza Paola; Mejia, Sol M.; Loaiza, Alix E.			Experimental and theoretical study of the mechanism and rate constants of the sequential 5-exo-trig spirocyclization involving vinyl, aryl and N-alkoxyaminyl radicals	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							APPROXIMATE RATE CONSTANTS; CARBON-CENTERED RADICALS; OXIME ETHERS; HYDROGEN-TRANSFER; ALKYL RADICALS; C-H; CYCLIZATIONS; DFT; ABILITIES; ENERGIES	In this research the sequential generation and cyclization of N-alkoxyaminyl radicals to produce 1-azaspiro[4.4]nonane, a prominent scaffold in organic and medicinal chemistry, was studied. Competition experiments in benzene at 80 degrees C with brominated oxime ethers using Bu3SnH as chain transfer and AIBN as the initiator generated vinyl or aryl radicals which were captured by oxime ethers, allowing approximate 5-exo-trig cyclization constants at 4.6 x 10(8) s(-1) and 9.9 x 10(8) s(-1) respectively to be established. Similar results were obtained by kinetic studies using the transition state theory (TST) from ab initio calculations with density functional theory (DFT) using the M06-2X, B3LYP, mPW1PW91 and TPSSh functionals in combination with the 6-311+G(d, p) basis set. Additionally, it was found that the 5-exo-trig cyclization of the N-alkoxyaminyl radical onto C = C double bonds is a reversible process whose constants were determined to be in the range of 6.2 x 10(0) s(-1) and 3.5 x 10(6) s(-1) at 80 degrees C, depending on the nature of the substituents. The calculation of the radical stabilization energy (RSE) shows that the N-alkoxyaminyl radical is a very stable species and its reactivity in the addition on alkenes is governed by its nucleophilic character and the stability of the carbon-centered radical formed after cyclization. The reduction constant of the N-alkoxyaminyl radical with Bu3SnH in the gas phase at 80 degrees C was also estimated to be 3.4 x 10(0) M(-1)s(-1 )through computational calculations. This information facilitates the rational planning of cascades and other methodologies applied to the construction of carbocyclic and aza-heterocyclic compounds.	[Bejarano, Carlos A.; Diaz, John E.; Lopez, Lina, V; Mejia, Sol M.; Loaiza, Alix E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Quim, Bogota 11001000, Colombia; [Bejarano, Carlos A.; Buendia-Atencio, Cristian] Univ Antonio Narino, Fac Ciencias, Dept Quim, Bogota 110231, Colombia; [Cifuentes-Lopez, Andres] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Jaramillo-Gomez, Luz M.] Univ Valle, Fac Ciencias, Dept Quim, Cali 760032, Colombia; [Lorett Velasquez, Vaneza Paola] Univ Mil Nueva Granada, Fac Med & Ciencias Salud, Bogota, Colombia		Mejia, SM; Loaiza, AE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Quim, Bogota 11001000, Colombia.	aloaiza@javeriana.edu.co	; Buendia-Atencio, Cristian/I-6854-2012	Cifuentes Lopez, Andres/0000-0002-7861-0111; Bejarano, Carlos A./0000-0002-3447-8833; Buendia-Atencio, Cristian/0000-0001-6375-3382; Diaz, John/0000-0002-8447-307X	Pontificia Universidad Javeriana; MINCIENCIAS [120365843351, 785]; Universidad Antonio Narino from VCTI [2022025]	Pontificia Universidad Javeriana; MINCIENCIAS; Universidad Antonio Narino from VCTI	The authors thank the Pontificia Universidad Javeriana and MINCIENCIAS Colombia for the financial support through the project 120365843351. Carlos A. Bejarano thanks MINCIENCIAS for the credit scholarship through call number 785 -Doctorado Nacional. Cristian Buendia-Atencio appreciates the funding by the Universidad Antonio Narino from VCTI (Project 2022025). John E. Diaz thanks the Pontificia Universidad Javeriana for the postdoctoral fellowship. V. P. Lorett Velasquez thankful the institution for this product resulting from the academic exercise as a professor at the Universidad Militar Nueva Granada.	Baboul AG, 1999, J CHEM PHYS, V110, P7650, DOI 10.1063/1.478676; BARTLETT PA, 1988, J AM CHEM SOC, V110, P1633, DOI 10.1021/ja00213a052; BECKWITH ALJ, 1986, TETRAHEDRON LETT, V27, P4525, DOI 10.1016/S0040-4039(00)84994-1; BECKWITH ALJ, 1985, TETRAHEDRON, V41, P3925, DOI 10.1016/S0040-4020(01)97174-1; Bejarano CA, 2016, CHEM HETEROCYCL COM+, V52, P177, DOI 10.1007/s10593-016-1857-z; Bhatti B.S., 2006, U.S.A Pat, Patent No. [PCT/US2005/033270, 2005033270]; BOOTH SE, 1994, J CHEM SOC PERK T 1, P3499, DOI 10.1039/p19940003499; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chan B, 2013, J PHYS CHEM A, V117, P3666, DOI 10.1021/jp401248r; Chan B, 2012, J PHYS CHEM A, V116, P4975, DOI 10.1021/jp302542z; Chatgilialoglu C, 1999, ADV ORGANOMET CHEM, V44, P67, DOI 10.1016/S0065-3055(08)60620-6; Cheng GJ, 2015, J AM CHEM SOC, V137, P1706, DOI 10.1021/ja5112749; Coote ML, 2016, TETRAHEDRON, V72, P7749, DOI 10.1016/j.tet.2016.03.015; Coote ML, 2014, PHYS CHEM CHEM PHYS, V16, P8686, DOI 10.1039/c4cp00537f; Coote ML, 2010, PHYS CHEM CHEM PHYS, V12, P9597, DOI 10.1039/c003880f; COREY EJ, 1983, TETRAHEDRON LETT, V24, P2821, DOI 10.1016/S0040-4039(00)88033-8; DANEN WC, 1973, J AM CHEM SOC, V95, P5716, DOI 10.1021/ja00798a045; Elsevier, 2015, ADV FREE RADICAL REA; Enholm E.J., 1990, FREE RADICAL CYCLIZA, V31; Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fallis AG, 1997, TETRAHEDRON, V53, P17543, DOI 10.1016/S0040-4020(97)10060-6; Gansauer A, 2013, BEILSTEIN J ORG CHEM, V9, P1620, DOI 10.3762/bjoc.9.185; Godin F, 2014, ORG CHEM FRONT, V1, P974, DOI 10.1039/c4qo00142g; Godin F, 2013, CHEM-EUR J, V19, P9308, DOI 10.1002/chem.201300377; Godineau E, 2008, J ORG CHEM, V73, P6983, DOI 10.1021/jo801308j; Greger H, 2019, PHYTOCHEM REV, V18, P463, DOI 10.1007/s11101-019-09602-6; Guerrero-Caicedo A, 2019, ACS OMEGA, V4, P21100, DOI 10.1021/acsomega.9b02515; Han A, 2014, J ORG CHEM, V79, P1938, DOI 10.1021/jo402499w; HART DJ, 1988, J AM CHEM SOC, V110, P1631, DOI 10.1021/ja00213a051; Hioe J., 2012, ENCY RADICALS CHEM B; Hioe J, 2015, ORG BIOMOL CHEM, V13, P157, DOI 10.1039/c4ob01656d; Hioe J, 2010, ORG BIOMOL CHEM, V8, P3609, DOI 10.1039/c004166a; Jager CM, 2017, CHEM-EUR J, V23, P953, DOI 10.1002/chem.201604719; Jaramillo-Gomez LM, 2006, TETRAHEDRON LETT, V47, P3909, DOI 10.1016/j.tetlet.2006.03.161; JOHNSTON LJ, 1985, J AM CHEM SOC, V107, P4594, DOI 10.1021/ja00301a062; Kim S, 1997, TETRAHEDRON LETT, V38, P2487, DOI 10.1016/S0040-4039(97)00373-0; KIM S, 1995, TETRAHEDRON LETT, V36, P6069, DOI 10.1016/0040-4039(95)01201-R; Kim S, 2001, CR ACAD SCI II C, V4, P431, DOI 10.1016/S1387-1609(01)01258-0; KRAPCHO AP, 1978, J ORG CHEM, V43, P138, DOI 10.1021/jo00395a032; Li YY, 2020, PHYS CHEM CHEM PHYS, V22, P3290, DOI 10.1039/c9cp05937g; Luo Y.-R, 2007, COMPREHENSIVE HDB CH; Mardirossian N, 2011, PHYS CHEM CHEM PHYS, V13, P19325, DOI 10.1039/c1cp21635j; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Miura Y, 2002, J ORG CHEM, V67, P8764, DOI 10.1021/jo0202785; Miura Y, 2001, J ORG CHEM, V66, P7456, DOI 10.1021/jo0106288; Mohamed S, 2016, ORG BIOMOL CHEM, V14, P2950, DOI 10.1039/c6ob00283h; Mukaida N., 2011, U.S.A Pat, Patent No. [PCT/JP2008/073094, 2008073094]; NAITO T, 1994, TETRAHEDRON LETT, V35, P2205, DOI 10.1016/S0040-4039(00)76797-9; NEWCOMB M, 1993, TETRAHEDRON, V49, P1151, DOI 10.1016/S0040-4020(01)85808-7; Newcomb M., 2012, ENCY RADICALS CHEM B, p107?124, DOI 10.1002/9781119953678.rad007; Perard-Viret J., 2017, ALKALOIDS, V78; Qu HJ, 2020, RSC ADV, V10, P34752, DOI 10.1039/d0ra07638d; Sanchez-Marquez J, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2492-1; SPELLMEYER DC, 1987, J ORG CHEM, V52, P959, DOI 10.1021/jo00382a001; Tauh P, 1999, J ORG CHEM, V64, P6960, DOI 10.1021/jo982017u; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Ullrich T, 2002, J MED CHEM, V45, P4047, DOI 10.1021/jm020916b; Yang ZH, 2020, J ORG CHEM, V85, P6981, DOI 10.1021/acs.joc.0c00296; Zard SZ, 2008, CHEM SOC REV, V37, P1603, DOI 10.1039/b613443m; Zheng C, 2020, ACCOUNTS CHEM RES, V53, P974, DOI 10.1021/acs.accounts.0c00074; Zipse H, 2006, TOP CURR CHEM, V263, P163, DOI 10.1007/128_028; Zyla-Karwowska M, 2018, J ORG CHEM, V83, P5199, DOI 10.1021/acs.joc.8b00630	63	0	0	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.	MAY 26	2022	20	20					4141	4154		10.1039/d2ob00387b	http://dx.doi.org/10.1039/d2ob00387b		APR 2022	14	Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Chemistry	1P4LY	35521783				2022-09-04	WOS:000791984300001
J	Elhawary, MA; Rostom, H; Edwards, B; Caro, A				Elhawary, Mohamed A.; Rostom, Hadir; Edwards, Brian; Caro, Angela			Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety	DRUG SAFETY			English	Editorial Material									[Elhawary, Mohamed A.] Egyptian Minist Hlth & Populat, Cairo, Egypt; [Elhawary, Mohamed A.] Ain Shams Univ, Fac Pharm, Cairo, Egypt; [Rostom, Hadir] Int Soc Pharmacovigilance ISoP, Egypt Chapter, Cairo, Egypt; [Rostom, Hadir] MSA Univ, Fac Pharm, Giza, Egypt; [Edwards, Brian] NDA Regulatory Sci Ltd, Pharmacovigilance & Drug Safety, Surrey, England; [Caro, Angela] Pontificia Univ Javeriana, Bogota, Colombia		Elhawary, MA (corresponding author), Egyptian Minist Hlth & Populat, Cairo, Egypt.; Elhawary, MA (corresponding author), Ain Shams Univ, Fac Pharm, Cairo, Egypt.	mohamedmetwally.alhawary@pharma.asu.edu.eg		Rostom, Hadir/0000-0003-3872-0540; Elhawary, Mohamed A./0000-0002-4043-6867					0	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	FEB	2022	45	2					97	99		10.1007/s40264-021-01145-0	http://dx.doi.org/10.1007/s40264-021-01145-0		JAN 2022	3	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	ZC9NH	35040093	Bronze			2022-09-04	WOS:000743401200001
J	Velez, N; Monteoliva, L; Sanchez-Quitian, ZA; Amador-Garcia, A; Garcia-Rodas, R; Ceballos-Garzon, A; Gil, C; Escandon, P; Zaragoza, O; Parra-Giraldo, CM				Velez, Norida; Monteoliva, Lucia; Sanchez-Quitian, Zilpa-Adriana; Amador-Garcia, Ahinara; Garcia-Rodas, Rocio; Ceballos-Garzon, Andres; Gil, Concha; Escandon, Patricia; Zaragoza, Oscar; Parra-Giraldo, Claudia-Marcela			The Combination of Iron and Copper Increases Pathogenicity and Induces Proteins Related to the Main Virulence Factors in Clinical Isolates of Cryptococcus neoformans var. grubii	JOURNAL OF FUNGI			English	Article						Cryptococcus neoformans; metals; iron; copper; pathogenicity; virulence; proteins	TRANSPORTER-ENCODING GENE; CELL-WALL; YEAST; ADAPTATION; SIDEROPHORES; CAPSULE; MODEL; METABOLISM; PATHWAY; ROLES	In fungi, metals are associated with the expression of virulence factors. However, it is unclear whether the uptake of metals affects their pathogenicity. This study aimed to evaluate the effect of iron/copper in modulating pathogenicity and proteomic response in two clinical isolates of C. neoformans with high and low pathogenicity. Methods: In both isolates, the effect of 50 mu M iron and 500 mu M copper on pathogenicity, capsule induction, and melanin production was evaluated. We then performed a quantitative proteomic analysis of cytoplasmic extracts exposed to that combination. Finally, the effect on pathogenicity by iron and copper was evaluated in eight additional isolates. Results: In both isolates, the combination of iron and copper increased pathogenicity, capsule size, and melanin production. Regarding proteomic data, proteins with increased levels after iron and copper exposure were related to biological processes such as cell stress, vesicular traffic (Ap1, Vps35), cell wall structure (Och1, Ccr4, Gsk3), melanin biosynthesis (Hem15, Mln2), DNA repair (Chk1), protein transport (Mms2), SUMOylation (Uba2), and mitochondrial transport (Atm1). Increased pathogenicity by exposure to metal combination was also confirmed in 90% of the eight isolates. Conclusions: The combination of these metals enhances pathogenicity and increases the abundance of proteins related to the main virulence factors.	[Velez, Norida; Sanchez-Quitian, Zilpa-Adriana; Ceballos-Garzon, Andres; Parra-Giraldo, Claudia-Marcela] Pontificia Univ Javeriana, Unidad Prote & Micosis Humanas, Grp Enfermedades Infecciosas, Fac Ciencias,Dept Microbiol, Bogota 110231, Colombia; [Monteoliva, Lucia; Amador-Garcia, Ahinara; Gil, Concha] Univ Complutense Madrid, Fac Farm, Dept Microbiol & Parasitol, Madrid 28040, Spain; [Garcia-Rodas, Rocio; Zaragoza, Oscar] Inst Salud Carlos III, Natl Ctr Microbiol, Mycol Reference Lab, Carretera Majadahonda Pozuelo, Madrid 28013, Spain; [Ceballos-Garzon, Andres] Univ Nantes, Fac Pharm, Dept Parasitol & Med Mycol, F-44200 Nantes, France; [Escandon, Patricia] Inst Nacl Salud, Grp Microbiol, Bogota 111321, Colombia		Parra-Giraldo, CM (corresponding author), Pontificia Univ Javeriana, Unidad Prote & Micosis Humanas, Grp Enfermedades Infecciosas, Fac Ciencias,Dept Microbiol, Bogota 110231, Colombia.	velez.norida@javeriana.edu.co; luciamon@ucm.es; adrbiology@gmail.com; ahinaram@ucm.es; rocio.rodas@gmail.com; c-ceballos@javeriana.edu.co; conchagil@ucm.es; pescandon@ins.gov.co; ozaragoza@isciii.es; claudia.parra@javeriana.edu.co	Monteoliva, Lucia/G-8720-2015; CEBALLOS, Andres/AAN-8908-2021	Monteoliva, Lucia/0000-0003-4949-0664; CEBALLOS, Andres/0000-0003-2129-1399; Garcia-Rodas, Rocio/0000-0002-3759-2412; Ceballos-Garzon, Andres/0000-0002-0743-6857				Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Bahn YS, 2013, EUKARYOT CELL, V12, P1564, DOI 10.1128/EC.00218-13; Balhara M, 2016, EXPERT OPIN THER TAR, V20, P1477, DOI 10.1080/14728222.2016.1254196; Bose I, 2003, EUKARYOT CELL, V2, P655, DOI 10.1128/EC.2.4.655-663.2003; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; Ceballos-Garzon A, 2022, J ANTIMICROB CHEMOTH, V77, P585, DOI 10.1093/jac/dkab454; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Christin C, 2011, TALANTA, V83, P1209, DOI 10.1016/j.talanta.2010.10.029; Crawford A, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov071; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; Ding C, 2014, MOL MICROBIOL, V93, P10, DOI 10.1111/mmi.12653; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695; Garcia-Santamarina S, 2018, MOL MICROBIOL, V108, P473, DOI 10.1111/mmi.13960; Garcia-Santamarina S, 2017, MBIO, V8, DOI [10.1128/mBio.01742-17, 10.1128/mbio.01742-17]; Grutter C, 2012, ACS CHEM BIOL, V7, P1257, DOI 10.1021/cb300128b; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Havel VE, 2011, EUKARYOT CELL, V10, P895, DOI 10.1128/EC.00006-11; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Helsel ME, 2017, METALLOMICS, V9, P69, DOI [10.1039/c6mt00172f, 10.1039/C6MT00172F]; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Jung KW, 2019, MBIO, V10, DOI [10.1128/mBio.01726-18, 10.1128/mbio.01726-18]; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Jung WH, 2011, FEBS LETT, V585, P3342, DOI 10.1016/j.febslet.2011.09.025; Kauppinen R, 2005, LANCET, V365, P241; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Lee KT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12766; Lee KT, 2014, EUKARYOT CELL, V13, P796, DOI 10.1128/EC.00069-14; Mauch RM, 2013, REV INST MED TROP SP, V55, P117, DOI 10.1590/S0036-46652013000200009; McFadden DC, 2001, MED MYCOL, V39, P19, DOI 10.1080/714031007; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Norwood SJ, 2011, TRAFFIC, V12, P56, DOI 10.1111/j.1600-0854.2010.01124.x; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2010, EUKARYOT CELL, V9, P1193, DOI 10.1128/EC.00098-10; Orsi CF, 2009, FEMS YEAST RES, V9, P301, DOI 10.1111/j.1567-1364.2008.00470.x; Panepinto John C., 2013, Frontiers in Genetics, V4, P302, DOI 10.3389/fgene.2013.00302; Park JN, 2012, J BIOL CHEM, V287, P19501, DOI 10.1074/jbc.M112.354209; Potrykus J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003910; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Sahu MS, 2020, J FUNGI, V6, DOI 10.3390/jof6010032; Sanguinetti M, 2006, INFECT IMMUN, V74, P1352, DOI 10.1128/IAI.74.2.1352-1359.2006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Selvan LDN, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-5; Thak EJ, 2020, MBIO, V11, DOI 10.1128/mBio.00711-20; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; VARTIVARIAN SE, 1993, J INFECT DIS, V167, P186, DOI 10.1093/infdis/167.1.186; Velez N, 2017, MED MYCOL, V55, P794, DOI 10.1093/mmy/myw138; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Zamudio-Arroyo J.M., 2012, REV ESP CIENC QUIM B, V15, P135; Zaragoza O, 2019, VIRULENCE, V10, P490, DOI 10.1080/21505594.2019.1614383; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	60	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2309-608X		J FUNGI	J. Fungi	JAN	2022	8	1							57	10.3390/jof8010057	http://dx.doi.org/10.3390/jof8010057			18	Microbiology; Mycology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology; Mycology	ZD8KP	35049997	gold, Green Published			2022-09-04	WOS:000758444500001
J	Lancheros, MLY; Rai, KM; Balasubramanian, VK; Dampanaboina, L; Mendu, V; Teran, W				Yaya Lancheros, Mary Luz; Rai, Krishan Mohan; Balasubramanian, Vimal Kumar; Dampanaboina, Lavanya; Mendu, Venugopal; Teran, Wilson			De novo transcriptome analysis of white teak (Gmelina arborea Roxb) wood reveals critical genes involved in xylem development and secondary metabolism	BMC GENOMICS			English	Article						RNA-seq; Xylem; Differential gene expression; Wood development	LIGNIN BIOSYNTHESIS; LEAF SENESCENCE; WEB SERVER; ARABIDOPSIS; REGULATORS; LIGNIFICATION; RESPONSES; ALIGNMENT; MEMBERS; COMPLEX	Background Gmelina arborea Roxb is a fast-growing tree species of commercial importance for tropical countries due to multiple industrial uses of its wood. Wood is primarily composed of thick secondary cell walls of xylem cells which imparts the strength to the wood. Identification of the genes involved in the secondary cell wall biosynthesis as well as their cognate regulators is crucial to understand how the production of wood occurs and serves as a starting point for developing breeding strategies to produce varieties with improved wood quality, better paper pulping or new potential uses such as biofuel production. In order to gain knowledge on the molecular mechanisms and gene regulation related with wood development in white teak, a de novo sequencing and transcriptome assembly approach was used employing secondary cell wall synthesizing cells from young white teak trees. Results For generation of transcriptome, RNA-seq reads were assembled into 110,992 transcripts and 49,364 genes were functionally annotated using plant databases; 5071 GO terms and 25,460 SSR markers were identified within xylem transcripts and 10,256 unigenes were assigned to KEGG database in 130 pathways. Among transcription factor families, C2H2, C3H, bLHLH and MYB were the most represented in xylem. Differential gene expression analysis using leaves as a reference was carried out and a total of 20,954 differentially expressed genes were identified including monolignol biosynthetic pathway genes. The differential expression of selected genes (4CL, COMT, CCoAOMT, CCR and NST1) was validated using qPCR. Conclusions We report the very first de novo transcriptome of xylem-related genes in this tropical timber species of commercial importance and constitutes a valuable extension of the publicly available transcriptomic resource aimed at fostering both basic and breeding studies.	[Yaya Lancheros, Mary Luz; Teran, Wilson] Pontificia Univ Javeriana, Dept Biol, Carrera 7 43-82, Bogota 110231, Colombia; [Rai, Krishan Mohan; Balasubramanian, Vimal Kumar; Dampanaboina, Lavanya; Mendu, Venugopal] Texas Tech Univ, Fiber & Biopolymer Res Inst, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; [Rai, Krishan Mohan] Univ Minnesota, Coll Biol Sci, Dept Plant & Microbial Biol, Minneapolis, MN USA; [Balasubramanian, Vimal Kumar] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA		Teran, W (corresponding author), Pontificia Univ Javeriana, Dept Biol, Carrera 7 43-82, Bogota 110231, Colombia.	wteran@javeriana.edu.co	Mohan, Krishan/J-1350-2019	Mohan, Krishan/0000-0003-2647-1436; Teran, Wilson/0000-0002-7597-5190	Pontifical Xavierian University [00565]; Colciencias	Pontifical Xavierian University; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by the Pontifical Xavierian University research grant 00565; MLYL was a recipient of a graduate studies fellowship from Colciencias.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Carpita NC, 2015, J EXP BOT, V66, P4145, DOI 10.1093/jxb/erv090; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chanoca A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00912; Cheng X, 2017, BIOL OPEN, V6, P1602, DOI 10.1242/bio.026997; Colombian Ministry of Environment and Sustainable Development (Ministerio de Ambiente y Desarrollo Sostenible de Colombia), 2013, RES, P1376; Dvorak WS, 2004, NEW FOREST, V28, P111, DOI 10.1023/B:NEFO.0000040940.32574.22; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Galeano E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0599-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui JS, 2020, NEW PHYTOL, V226, P1074, DOI 10.1111/nph.16411; Guillaumie S, 2010, PLANT MOL BIOL, V72, P215, DOI 10.1007/s11103-009-9563-1; Hefer CA, 2015, NEW PHYTOL, V206, P1391, DOI 10.1111/nph.13277; Hinchee M, 2009, IN VITRO CELL DEV-PL, V45, P619, DOI 10.1007/s11627-009-9235-5; Hirano K, 2012, PLANT CELL REP, V31, P91, DOI 10.1007/s00299-011-1142-7; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Jiang AL, 2014, PLANT MOL BIOL REP, V32, P1241, DOI 10.1007/s11105-014-0719-z; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lerouxel O, 2006, CURR OPIN PLANT BIOL, V9, P621, DOI 10.1016/j.pbi.2006.09.009; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li XG, 2010, NEW PHYTOL, V187, P764, DOI 10.1111/j.1469-8137.2010.03333.x; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Lin Y, 2014, J PLANT BIOCHEM BIOT, V23, P199, DOI 10.1007/s13562-013-0202-1; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Malavasi UC, 2016, FLORESTA AMBIENTE, V23, P589, DOI 10.1590/2179-8087.143715; Mendu V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-43; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Moya-Roque R, 2013, REV FOR MESOAM KURU-, V10, P26, DOI 10.18845/rfmk.v10i24.1321; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00965; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Nakano Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00288; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Onyekwelu JC, 2011, TROP FOREST, P109, DOI 10.1007/978-3-642-19986-8_9; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ranade SS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0220-8; Rennie EA, 2012, PLANT PHYSIOL, V159, P1408, DOI 10.1104/pp.112.200964; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Pappas MDR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2322-6; Rojas Andrea, 2012, Agron. colomb., V30, P52; Roshetko JM, 2004, NEW FOREST, V28, P207, DOI 10.1023/B:NEFO.0000040948.53797.c5; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Sanjay Basumatary, 2012, Advances in Applied Science Research, V3, P2745; Shen H, 2013, PLANT CELL, V25, P4342, DOI 10.1105/tpc.113.118828; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Song Y, 2014, MOL PLANT, V7, P1776, DOI 10.1093/mp/ssu109; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang HZ, 2012, IND CROP PROD, V37, P170, DOI 10.1016/j.indcrop.2011.12.014; Wang JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03863-z; Wang JH, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0331-y; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Xie M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01427; Yang JH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00356; Yasodha R, 2018, DNA RES, V25, P409, DOI 10.1093/dnares/dsy013; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoon J, 2015, J INTEGR PLANT BIOL, V57, P902, DOI 10.1111/jipb.12422; Zamyatnin AA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1701, DOI 10.1134/S0006297915130064; Zhang GF, 2021, GCB BIOENERGY, V13, P305, DOI 10.1111/gcbb.12772; Zhang J, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00652; Zhang LD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-153; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zhao D, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz005; Zhao Q, 2013, PLANT CELL, V25, P3976, DOI 10.1105/tpc.113.117770; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Ziebell A, 2016, BIOENERG RES, V9, P691, DOI 10.1007/s12155-016-9713-7	96	0	0	4	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUL 2	2021	22	1							494	10.1186/s12864-021-07777-x	http://dx.doi.org/10.1186/s12864-021-07777-x			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	TG9PW	34215181	gold, Green Published, Green Submitted			2022-09-04	WOS:000671729100001
J	Garcia-Otero, L; Gomez, O; Rodriguez-Lopez, M; Torres, X; Soveral, I; Sepulveda-Martinez, A; Guirado, L; Valenzuela-Alcaraz, B; Lopez, M; Martinez, JM; Gratacos, E; Crispi, F				Garcia-Otero, Laura; Gomez, Olga; Rodriguez-Lopez, Merida; Torres, Ximena; Soveral, Iris; Sepulveda-Martinez, Alvaro; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Lopez, Marta; Maria Martinez, Josep; Gratacos, Eduard; Crispi, Fatima			Nomograms of Fetal Cardiac Dimensions at 18-41 Weeks of Gestation	FETAL DIAGNOSIS AND THERAPY			English	Article						Fetal heart; Congenital heart defects; Nomograms	CROSS-SECTIONAL ECHOCARDIOGRAPHY; CONGENITAL HEART-DISEASE; SCORE REFERENCE RANGES; PRENATAL-DIAGNOSIS; AMERICAN SOCIETY; HUMAN-FETUS; RECOMMENDATIONS; QUANTIFICATION; BIOMETRY	Objective: There is a need for standardized reference values for cardiac dimensions in prenatal life. The objective of the present study was to construct nomograms for fetal cardiac dimensions using a well-defined echocardiographic methodology in a low-risk population. Methods: This is a prospective cohort study including 602 low-risk singleton pregnancies undergoing a standardized fetal echocardiography to accurately assess fetal cardiac, ventricular, and atrial dimensions. Parametric regressions were tested to model each measurement against gestational age from 18 to 41 weeks of gestation. Results: Nomograms were constructed for fetal cardiac dimensions (transverse and longitudinal diameters and areas) of the whole heart, atria, and ventricles, as well as myocardial wall thicknesses. All dimensions showed a progressive increase with gestational age. The best model for most parameters was a second-degree linear polynomial. Fetal cardiac, ventricular, and atrial diameters and areas were successfully obtained in 98.6% of the fetuses, while myocardial wall thicknesses could be obtained in 96.5% of the population. The results showed excellent interobserver and intraobserver reproducibility (intraclass correlation coefficient, ICC > 0.811 and ICC > 0.957, respectively). Conclusions: We provide standardized and comprehensively evaluated reference values for fetal cardiac morphometric parameters across gestation in a low-risk population. These no mograms would enable the early identification of different patterns of fetal cardiac remodeling.	[Garcia-Otero, Laura; Gomez, Olga; Rodriguez-Lopez, Merida; Torres, Ximena; Soveral, Iris; Sepulveda-Martinez, Alvaro; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Lopez, Marta; Maria Martinez, Josep; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Fetal Med Res Ctr, Hosp Clin,Inst Invest Biomed August Pi I Sunyer I, Barcelona, Spain; [Garcia-Otero, Laura; Gomez, Olga; Rodriguez-Lopez, Merida; Torres, Ximena; Soveral, Iris; Sepulveda-Martinez, Alvaro; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Lopez, Marta; Maria Martinez, Josep; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Fetal Med Res Ctr, Hosp St Joan Deu,Inst Invest Biomed August Pi I S, Barcelona, Spain; [Garcia-Otero, Laura; Gomez, Olga; Rodriguez-Lopez, Merida; Torres, Ximena; Soveral, Iris; Sepulveda-Martinez, Alvaro; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Lopez, Marta; Maria Martinez, Josep; Gratacos, Eduard; Crispi, Fatima] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana Secc Cali, Cali, Colombia; [Sepulveda-Martinez, Alvaro] Hosp Clin Univ Chile, Dept Obstet & Gynecol, Fetal Med Unit, Santiago, Chile		Gomez, O (corresponding author), Univ Barcelona, Hosp Clin, BCNatal, Dept Maternal Fetal Med, Sabino Arana 1, ES-08028 Barcelona, Spain.	ogomez@clinic.ub.es	Sepulveda-Martinez, Alvaro/H-6546-2014; Rodriguez-Lopez, Merida/N-9273-2017	Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Rodriguez-Lopez, Merida/0000-0001-8245-0811; Gratacos, Eduard/0000-0002-7405-7224; Garcia-Otero, Laura/0000-0003-2766-5048; Gomez, O/0000-0003-4183-9876; Soveral, Iris/0000-0002-3571-1780	Erasmus+ Programme of the European Union [2013-0040]; "la Caixa" Foundation [LCF/PR/GN14/10270005]; Instituto de Salud Carlos III [PI14/00226, INT16/00168, PI17/00675, PI15/00263, PI15/00130]; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) AGAUR 2017 SGR grant [1531]; Ajut Josep Font (Hospital Clinic de Barcelona, Spain); FI AGAUR [2016FI_B01184]	Erasmus+ Programme of the European Union; "la Caixa" Foundation(La Caixa Foundation); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) AGAUR 2017 SGR grant; Ajut Josep Font (Hospital Clinic de Barcelona, Spain); FI AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This project has been funded with support of the Erasmus+ Programme of the European Union (Framework Agreement No. 2013-0040). This publication reflects the views of the authors only, and the Commission cannot be held responsible for any use that may be made of the information contained therein. Additionally, the research leading to these results has received funding from "la Caixa" Foundation (LCF/PR/GN14/10270005), Instituto de Salud Carlos III (PI14/00226, INT16/00168, PI17/00675, PI15/00263, PI15/00130) integrados en el Plan Nacional de I+D+I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa," Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) AGAUR 2017 SGR grant No. 1531, and Ajut Josep Font (Hospital Clinic de Barcelona, Spain). L.G.-O. received a grant from FI AGAUR (2016FI_B01184).	ALLAN LD, 1982, BRIT HEART J, V47, P573; ALLAN LD, 1981, PRENATAL DIAG, V1, P131, DOI 10.1002/pd.1970010208; Aye CYL, 2018, FETAL DIAGN THER, V44, P18, DOI 10.1159/000477964; BARKER DJP, 1989, LANCET, V2, P577; Byrne FA, 2015, ULTRASOUND OBST GYN, V46, P688, DOI 10.1002/uog.14790; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; Chanthasenanont Athita, 2008, Journal of the Medical Association of Thailand, V91, P1774; CRAWFORD CS, 1982, ANN CLIN LAB SCI, V12, P99; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Firpo C, 2001, AM J CARDIOL, V87, P594, DOI 10.1016/S0002-9149(00)01437-5; Gagnon C, 2016, J AM SOC ECHOCARDIOG, V29, P448, DOI 10.1016/j.echo.2016.01.002; Garcia-Otero L, 2016, AIDS, V30, P1393, DOI 10.1097/QAD.0000000000001066; Gembruch U, 2000, FETAL DIAGN THER, V15, P20, DOI 10.1159/000020970; Gu XY, 2017, J PERINAT MED, V45, P171, DOI 10.1515/jpm-2015-0385; Guirado L, 2018, ULTRASOUND OBST GYN, V51, P349, DOI 10.1002/uog.17456; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hata T, 1997, HUM REPROD, V12, P2286, DOI 10.1093/humrep/12.10.2286; Hernandez-Andrade E, 2017, FETAL DIAGN THER, V42, P161, DOI 10.1159/000477564; Jatavan P, 2018, J MATERN-FETAL NEO M, V31, P946, DOI 10.1080/14767058.2017.1301423; Jatavan P, 2016, J ULTRAS MED, V35, P1481, DOI 10.7863/ultra.15.08017; KLEINMAN CS, 1980, PEDIATRICS, V65, P1059; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lee W, 2010, ULTRASOUND OBST GYN, V35, P28, DOI 10.1002/uog.7483; Li XY, 2015, PRENATAL DIAG, V35, P117, DOI 10.1002/pd.4498; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Luewan S, 2011, ULTRASOUND OBST GYN, V37, P416, DOI 10.1002/uog.8961; McAuliffe FM, 2005, AM J OBSTET GYNECOL, V193, P1253, DOI 10.1016/j.ajog.2005.05.086; Michelfelder E, 2007, ULTRASOUND OBST GYN, V30, P965, DOI 10.1002/uog.5211; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Patchakapat Lawan, 2006, Journal of the Medical Association of Thailand, V89, P748; Pauliks LB, 2015, EXPERT REV CARDIOVAS, V13, P67, DOI 10.1586/14779072.2015.988141; Rodriguez-Lopez M, 2017, ULTRASOUND OBST GYN, V50, P207, DOI 10.1002/uog.17365; Rodriguez-Lopez M, 2016, PEDIATR RES, V79, P100, DOI 10.1038/pr.2015.182; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schneider C, 2005, ULTRASOUND OBST GYN, V26, P599, DOI 10.1002/uog.2597; Shapiro I, 1998, ULTRASOUND OBST GYN, V12, P404, DOI 10.1046/j.1469-0705.1998.12060404.x; SHARLAND GK, 1992, ULTRASOUND OBST GYN, V2, P175, DOI 10.1046/j.1469-0705.1992.02030175.x; Smrcek JM, 2006, J ULTRAS MED, V25, P173, DOI 10.7863/jum.2006.25.2.173; TAN J, 1992, AM J CARDIOL, V70, P1459, DOI 10.1016/0002-9149(92)90300-N; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428	41	20	20	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-3837	1421-9964		FETAL DIAGN THER	Fetal Diagn. Ther.	MAY	2020	47	5					387	398		10.1159/000494838	http://dx.doi.org/10.1159/000494838			12	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	LU6ME	30612128	Green Accepted			2022-09-04	WOS:000537866600006
J	Williams, BA; Grantham, HS; Watson, JEM; Alvarez, SJ; Simmonds, JS; Rogeliz, CA; Da Silva, M; Forero-Medina, G; Etter, A; Nogales, J; Walschburger, T; Hyman, G; Beyer, HL				Williams, Brooke A.; Grantham, Hedley S.; Watson, James E. M.; Alvarez, Silvia J.; Simmonds, Jeremy S.; Rogeliz, Carlos A.; Da Silva, Mayesse; Forero-Medina, German; Etter, Andres; Nogales, Jonathan; Walschburger, Tomas; Hyman, Glenn; Beyer, Hawthorne L.			Minimising the loss of biodiversity and ecosystem services in an intact landscape under risk of rapid agricultural development	ENVIRONMENTAL RESEARCH LETTERS			English	Article						land use planning; trade-offs; multiple objectives; conservation; ecosystem services; biodiversity; agricultural development	LAND-USE; IMPACTS; CONSERVATION; COLOMBIA; MANAGEMENT; GAINS; MODEL	As humanity's demand for resources continues to rise and productive arable lands become increasingly scarce, many of Earth's remaining intact regions are at heightened risk of destruction from agricultural development. In situations where agricultural expansion is inevitable, it is important to manage intact landscape transformation so that impacts on environmental values are minimised. Here, we present a novel, spatially explicit, land use planning framework that addresses the decision making needed to account for different, competing economic-environment objectives (agricultural production value, biodiversity conservation, ecosystem service retention) when land use change is inevitable within an intact landscape. We apply our framework to the globally significant savannahs of the Orinoquia (Colombia), which in a post-conflict era is under increased agricultural development pressure. We show that while negative environmental impacts can be reduced through planning, the total area of land converted to agriculture is the unavoidable principal driver of biodiversity and ecosystem service loss. We therefore identify planning solutions that perform well across all objectives simultaneously, despite trade-offs among them. When 15%, 20%, 30% and 40% of the study area is allowed to be converted to agriculture, on average planning can improve species persistence and ecosystem service retention by up to 16%, 15%, 12%, and 9%, respectively, when compared to agricultural-focused solutions. Development in the region so far has had an unnecessarily large impact on environmental objectives due to a lack of effective land use planning, creating an 'opportunity debt'. Our study provides an evidence base to inform proactive planning and the development of environmentally sensible agricultural development policy and practice in the region. This framework can be used by stakeholders to achieve agriculture expansion goals and maximise economic profit while minimising impacts on the environment in the Orinoquia, or any relatively intact region that is being developed.	[Williams, Brooke A.; Watson, James E. M.; Simmonds, Jeremy S.] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia; [Williams, Brooke A.; Grantham, Hedley S.; Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, New York, NY 10460 USA; [Williams, Brooke A.; Watson, James E. M.] Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia; [Alvarez, Silvia J.; Forero-Medina, German] Wildlife Conservat Soc, Colombia Program, Cali, Colombia; [Rogeliz, Carlos A.; Nogales, Jonathan; Walschburger, Tomas] Nature Conservancy, Calle 67 7-84 Piso 3, Bogota 110231, Colombia; [Da Silva, Mayesse; Hyman, Glenn] Int Ctr Trop Agr, Km 17 Recta Cali Palmira, Valle Del Cauca, Colombia; [Etter, Andres] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Bogota, Colombia; [Hyman, Glenn] Spatial Informat Grp, Cali, Colombia; [Beyer, Hawthorne L.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia		Williams, BA (corresponding author), Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia.; Williams, BA (corresponding author), Wildlife Conservat Soc, Global Conservat Program, New York, NY 10460 USA.; Williams, BA (corresponding author), Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia.	brooke.williams@uq.edu.au	Watson, James E.M./D-8779-2013; Simmonds, Jeremy/AAC-1182-2019; Etter, Andrés/E-1860-2011; Williams, Brooke/AAW-1658-2020; Beyer, Hawthorne/F-8050-2013	Watson, James E.M./0000-0003-4942-1984; Simmonds, Jeremy/0000-0002-1662-5908; Etter, Andrés/0000-0003-0665-9300; Williams, Brooke/0000-0002-0692-7507; DA SILVA, MAYESSE/0000-0002-3734-9586; Alvarez, Silvia/0000-0002-7397-4151; Beyer, Hawthorne/0000-0002-5430-0784	School of Earth and Environmental Sciences at the University of Queensland	School of Earth and Environmental Sciences at the University of Queensland	This study was part of a collaborative SNAPP (Science for Nature and People Partnership) project titled `Land use change in the Orinoquia' between the University of Queensland (UQ), Wildlife Conservation Society (WCS), The Nature Conservancy (TNC) and International Center for Tropical Agriculture (CIAT). We thank two anonymous reviewers for suggestions that improved the manuscript. We also acknowledge the support provided by the School of Earth and Environmental Sciences at the University of Queensland. The authors have no conflicts of interest to declare.	Adams VM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158350; Alkemade R, 2013, P NATL ACAD SCI USA, V110, P20900, DOI 10.1073/pnas.1011013108; Angarita H, 2018, HYDROL EARTH SYST SC, V22, P2839, DOI 10.5194/hess-22-2839-2018; [Anonymous], CUAL SE CREAN SE DES; [Anonymous], 2019, GUROBI OPTIMIZER REF; Armenteras D, 2019, NAT ECOL EVOL, V3, P20, DOI 10.1038/s41559-018-0727-8; Assad ED, 2013, BIOGEOSCIENCES, V10, P6141, DOI 10.5194/bg-10-6141-2013; Baillie J, 2018, SCIENCE, V361, P1051, DOI 10.1126/science.aau1397; Bijl DL, 2017, GLOBAL ENVIRON CHANG, V45, P47, DOI 10.1016/j.gloenvcha.2017.04.003; Boron V., 2012, BIODIVERSIDAD CASANA; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Clark M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6cd5; Dinerstein E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2869; DNP, 2014, DOC CONPES; DNP, 2018, BAS PLAN NAC DES 201; Dudley Nigel, 2017, Biodiversity (Ottawa), V18, P45, DOI 10.1080/14888386.2017.1351892; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Estes LD, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0316; Etter A., 2017, RISK ASSESSMENT COLO; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Forman RTT, 1997, LANDSCAPE URBAN PLAN, V37, P129, DOI 10.1016/S0169-2046(96)00378-7; Gasson RA, 2002, J WORLD PREHIST, V16, P237, DOI 10.1023/A:1020978518142; Gobierno Nacional de Colombia, 2016, AC FIN TERM CONFL CO; Hanasaki N, 2010, J HYDROL, V384, P232, DOI 10.1016/j.jhydrol.2009.09.028; IPBES, 2019, GLOBAL ASSESSMENT RE, DOI 10.5281/zenodo.3831673; Klumpp K, 2009, J ECOL, V97, P876, DOI 10.1111/j.1365-2745.2009.01549.x; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lasso CA, 2010, BIODIVERSIDAD CUENCA; Lopez-Ricaurte L, 2017, BIOL CONSERV, V213, P225, DOI 10.1016/j.biocon.2017.07.009; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; MADR, 2016, MED CUAL SE DEF FRON; Martin TG, 2016, NAT CLIM CHANGE, V6, P122, DOI 10.1038/nclimate2918; Moran-Ordonez A, 2017, CONSERV LETT, V10, P94, DOI 10.1111/conl.12255; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Pardo LE, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-019-44288-y, 1]; Pardo LE, 2018, BIOL CONSERV, V227, P65, DOI 10.1016/j.biocon.2018.08.026; Vargas LEP, 2015, TROP CONSERV SCI, V8, P828, DOI 10.1177/194008291500800317; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2616; Polak T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150107; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Potapov P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600821; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Roucoux KH, 2017, CONSERV BIOL, V31, P1283, DOI 10.1111/cobi.12925; Runting RK, 2019, NAT SUSTAIN, V2, P53, DOI 10.1038/s41893-018-0203-0; Runting RK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7819; Salazar A, 2018, FRONT ECOL ENVIRON, V16, P525, DOI 10.1002/fee.1950; Sanderman J, 2017, P NATL ACAD SCI USA, V114, P9575, DOI 10.1073/pnas.1706103114; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Smith J, 1997, AGR SYST, V54, P501, DOI 10.1016/S0308-521X(96)00088-1; Sommer R, 2018, SOIL CARBON CURRENT; Strassburg BBN, 2019, NAT ECOL EVOL, V3, P62, DOI 10.1038/s41559-018-0743-8; Strassburg BBN, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0099; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Watson JEM, 2017, NATURE, V550, P48, DOI 10.1038/nature24144; Zinn YL, 2005, SOIL TILL RES, V84, P28, DOI 10.1016/j.still.2004.08.007	60	18	19	1	13	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-9326			ENVIRON RES LETT	Environ. Res. Lett.	JAN	2020	15	1							014001	10.1088/1748-9326/ab5ff7	http://dx.doi.org/10.1088/1748-9326/ab5ff7			13	Environmental Sciences; Meteorology & Atmospheric Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	KD5OH		gold, Green Published			2022-09-04	WOS:000507914800001
J	Salas, G; Vega, M; Gonzalez, C; Ossa, JC; Cudina, JN; Caycho-Rodriguez, T; Barboza-Palomino, M; Ventura-Leon, J; Guerra-Labbe, L; Lopez-Lopez, W				Salas, Gonzalo; Vega, Maribel; Gonzalez, Carolina; Cesar Ossa, Julio; Nikola Cudina, Jean; Caycho-Rodriguez, Tomas; Barboza-Palomino, Miguel; Ventura-Leon, Jose; Guerra-Labbe, Luisa; Lopez-Lopez, Wilson			The Fiftieth Anniversary of the Revista Latinoamericana de Psicologia: A Bibliometric Analysis	REVISTA LATINOAMERICANA DE PSICOLOGIA			English	Article						Revista Latinoamericana de Psicologia; bibliometrics; H-Classics; SciMAT	PSYCHOLOGY JOURNALS; COLOMBIAN PSYCHOLOGY; BOOK-REVIEWS; CITATION; INTERNATIONALITY; PUBLICATIONS; ARTICLES; HISTORY; IMPACT; WEB	The aim of this study was to conduct a bibliometric analysis of the Revista Latinoamericana de Psicologia (RLP) journal in commemoration of its fiftieth anniversary in order to discover its evolution as a journal and its scientific production. We extracted a dataset from the Web of Science's principal collection from 1975 to 2017. This contained a total sample of 2,163 scientific documents, which were processed using Excel and SciMat programmes. The bibliometric indicators used were H-Classics, TC2, identification of the most commonly cited authors and journals, and references. We used Lotka's Law to analyse research productivity. Results showed that the content included 48.6% scientific articles and 42.1% book reviews. Spain had the highest number of articles published. Burrhus Skinner, Ruben Ardila, Rogelio Diaz Guerrero, and Albert Bandura were the most commonly cited authors. Analyses revealed certain strengths of and challenges faced by the RLP. Future research should compare these results with journals from other countries. (C) 2019 Fundacion Universitaria Konrad Lorenz.	[Salas, Gonzalo; Vega, Maribel] Univ Catolica Maule, Dept Psicol, Maule, Chile; [Gonzalez, Carolina] Univ Queensland, Brisbane, Qld, Australia; [Cesar Ossa, Julio; Nikola Cudina, Jean] Univ San Buenaventura, San Buenaventura, Colombia; [Caycho-Rodriguez, Tomas; Barboza-Palomino, Miguel; Ventura-Leon, Jose] Univ Privada Norte, Lima, Peru; [Guerra-Labbe, Luisa] Univ Autonoma Chile, Escuela Terapia Ocupac, Providencia, Chile; [Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Bogota, Colombia		Lopez-Lopez, W (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	lopezw@javeriana.edu.co	López López, Wilson/AAV-8032-2021; Gonzalez, Carolina/AAU-6374-2021; Cudina, Jean Nikola/Q-3149-2019; Leon, Jose Luis Ventura/E-4060-2017	López López, Wilson/0000-0002-2964-0402; Gonzalez, Carolina/0000-0002-8157-2056; Cudina, Jean Nikola/0000-0003-4004-7615; Leon, Jose Luis Ventura/0000-0003-2996-4244; Barboza Palomino, Miguel/0000-0001-8045-5491				Acevedo-Triana C, 2018, REV LAT AM PSICOL, V50, P145, DOI 10.14349/rlp.2018.v50.n3.2; Aguado-Lopez E., 2017, REV INTERAM PSICOL, V51, P268; Aguado-Lopez E, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-2.upci; Aguilar-Bustamante M. C., 2018, DIVERSITAS PERSP PSI, V14, P1; Alarcon R., 2010, ESTUDOS PESQUISAS PS, V10, P553; Allik J, 2013, J CROSS CULT PSYCHOL, V44, P657, DOI 10.1177/0022022112461941; Arce R, 2011, REV LAT AM PSICOL, V43, P473; Ardila R, 1998, REV LAT AM PSICOL, V30, P393; Ardila R., 1986, PSICOLOGIA AM LATINA; ARDILA R., 2013, HIST PSICOLOGIA COLO; Avila-Toscano J., 2013, AV PSICOL LATINOAM, V32, P167, DOI [10.12804/apl32.1.2014.12, DOI 10.12804/APL32.1.2014.12]; Banks D, 2018, REV LINGUIST LENGUAS, V13, P31, DOI 10.4995/rlyla.2018.7933; Bapte VD, 2017, DESIDOC J LIB INF TE, V37, P264, DOI 10.14429/djlit.37.4.10712; BRINGMANN WG, 1980, PSYCHOL RES-PSYCH FO, V42, P57, DOI 10.1007/BF00308692; Caso-Niebla J, 2007, REV LAT AM PSICOL, V39, P487; Chiu WT, 2005, SCIENTOMETRICS, V63, P3, DOI 10.1007/s11192-005-0201-7; Cobo MJ, 2012, J AM SOC INF SCI TEC, V63, P1609, DOI 10.1002/asi.22688; Cudina JN., 2017, REV INTERAM PSICOL, V51, P282; Florez L., 2003, LEGADO RUBEN ARDILA; Fradkin Chris, 2017, Paidéia (Ribeirão Preto), V27, P7, DOI 10.1590/1982-43272766201702; Franco-Suarez O, 2017, PSIENCIA-REV LATINOA, V9, DOI 10.5872/psiencia/9.4.22; Fuchs AH, 2012, AM J PSYCHOL, V125, P3; Rodriguez AG, 2018, REV IBEROAM PSICOL E, V13, P33; Gallegos M, 2017, REV LAT AM PSICOL, V49, P1, DOI 10.1016/j.rlp.2017.02.001; GALLEGOS MIGUEL, 2010, Univ. Psychol., V9, P911; Contreras Francisco Ganga, 2015, Idesia, V33, P111, DOI 10.4067/S0718-34292015000400014; GARFIELD E, 1993, J AM SOC INFORM SCI, V44, P298, DOI 10.1002/(SICI)1097-4571(199306)44:5<298::AID-ASI5>3.0.CO;2-A; Garfield E., 1977, ESSAYS INF SCI, V3, P5; GÓMEZ MORALES YURI JACK, 2012, Rev. colomb. psicol., V21, P97; Gorraiz J, 2014, SCIENTOMETRICS, V98, P841, DOI 10.1007/s11192-013-1176-4; Gracia E, 2006, REV LAT AM PSICOL, V38, P327; Fernandez JG, 2010, REV LAT AM PSICOL, V42, P251; Gutierrez G, 2009, REV LAT AM PSICOL, V41, P413; Harper K, 2019, J HIST BEHAV SCI, V55, P139, DOI 10.1002/jhbs.21963; Hartley J, 2017, SCIENTOMETRICS, V112, P655, DOI 10.1007/s11192-017-2256-7; Ho YS, 2016, BRIT J PSYCHOL, V107, P768, DOI 10.1111/bjop.12163; Ho YS, 2016, FUTURE VIROL, V11, P631, DOI 10.2217/fvl-2016-0057; Ho YS, 2012, CHINESE J CHEM ENG, V20, P478, DOI 10.1016/S1004-9541(11)60209-7; Klappenbach H, 2018, PSYCHOL LATIN AM CUR, P27; Li Z, 2008, SCIENTOMETRICS, V75, P97, DOI 10.1007/s11192-007-1838-1; Lila M, 2012, REV LAT AM PSICOL, V44, P99; Liu WS, 2017, SCIENTOMETRICS, V110, P355, DOI 10.1007/s11192-016-2172-2; López López Wilson, 2018, Univ. Psychol., V17, P1; Lopez WL, 1998, REV LAT AM PSICOL, V30, P401; Lopez-Lopez W., 2019, PUBLICACIONES PERIOD; Lopez-Lopez W., 2018, TEACHING PSYCHOL WOR, V4, P53; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; Lotka A. J., 1926, J WASHINGT ACAD SCI, V16, P317, DOI DOI 10.1002/ASI.4630280610; Martinez MA, 2014, SCIENTOMETRICS, V98, P1971, DOI 10.1007/s11192-013-1155-9; Millán Juan David, 2017, Rev. Guillermo Ockham, V15, P5, DOI 10.21500/22563202.3437; Montero I, 2007, INT J CLIN HLTH PSYC, V7, P847; Morgado-Gallardo Katherine, 2018, Suma Psicol., V25, P90, DOI 10.14349/sumapsi.2018.v25.n2.1; Naranjo-Valencia JC, 2016, REV LAT AM PSICOL, V48, P30, DOI 10.1016/j.rlp.2015.09.009; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; Navarrete-Cortes J, 2010, UNIV PSYCHOL, V9, P553, DOI 10.11144/Javeriana.upsy9-2.gpba; Cudina JN, 2016, INFORM SOC-ESTUD, V26, P137; Orduna-Malea E, 2016, PROF INFORM, V25, P485, DOI 10.3145/epi.2016.may.18; Ossa J. C., 2016, REV GUI LLERMO OCKHA, V14, P7, DOI [10.21500/22563202.2720, DOI 10.21500/22563202.2720]; Page, 2013, PSYECOLOGY, V4, P195, DOI [DOI 10.1080/21711976.2013.10773866, 10.1080/21711976.2013.10773866]; Pire R, 2015, COMPENDIUM, V18, P1; Polanco F., 2017, REV INTERAM PSICOL, V51, P297, DOI [10.30849/rip/ijp.v51i3.910, DOI 10.30849/RIP/IJP.V51I3.910]; Polanco-Carrasco R, 2017, TER PSICOL, V35, P81; Ravelo E. L, 2016, ACTA COLOMB PSICOL, V19, P281, DOI DOI 10.14718/ACP.2016.19.2.12; Sáez-Ibáñez Ángeles, 2018, Rev. psicol., V27, P61, DOI 10.5354/0719-0581.2019.52315; Salas Gonzalo, 2017, Rev. Guillermo Ockham, V15, P9, DOI 10.21500/22563202.3495; Salas G, 2018, ACTA COLOMB PSICOL, V21, P13, DOI [10.14718/ACP.2018.21.2.2, 10.14718/acp.2018.21.2.2]; Salas Gonzalo, 2017, Psykhe, V26, P1, DOI 10.7764/psykhe.26.1.1205; Staley TW, 2009, J HIST IDEAS, V70, P259, DOI 10.1353/jhi.0.0040; Garcia-Martinez AT, 2012, UNIV PSYCHOL, V11, P699; Titchener EB, 1921, AM J PSYCHOL, V32, P108, DOI 10.2307/1413478; Tortosa-Perez M, 2019, AN PSICOL-SPAIN, V35, P332, DOI 10.6018/analesps.35.2.332171; Tur-Porcar A, 2018, J PSYCHOL, V152, P199, DOI 10.1080/00223980.2018.1440516; Visca J, 2018, REV ARGENT CLIN PSIC, V27, P478, DOI 10.24205/03276716.2018.1076; Zych I, 2010, UNIV PSYCHOL, V9, P27, DOI 10.11144/Javeriana.upsy9-1.irpm; Zych I, 2009, REV LAT AM PSICOL, V41, P401	75	4	4	5	16	FOUNDATION ADVANCEMENT PSYCHOLOGY	BOGOTA D C	APARTADO AEREO 92621, BOGOTA D C, COLOMBIA	0120-0534			REV LAT AM PSICOL	Rev. Latinoam. Psicol.		2019	51	2					123	135		10.14349/rlp.2019.v51.n2.7	http://dx.doi.org/10.14349/rlp.2019.v51.n2.7			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	KW7NT		gold, Green Published			2022-09-04	WOS:000521372100007
J	Cruz-Rodriguez, N; Combita, AL; Enciso, LJ; Quijano, SM; Pinzon, PL; Lozano, OC; Castillo, JS; Li, L; Bareno, J; Cardozo, C; Solano, J; Herrera, MV; Cudris, J; Zabaleta, J				Cruz-Rodriguez, Nataly; Combita, Alba L.; Enciso, Leonardo J.; Quijano, Sandra M.; Pinzon, Paula L.; Lozano, Olga C.; Castillo, Juan S.; Li, Li; Bareno, Jose; Cardozo, Claudia; Solano, Julio; Herrera, Maria V.; Cudris, Jennifer; Zabaleta, Jovanny			High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH			English	Article						Acute lymphoblastic leukemia; Gene expression profile; Complete remission; Minimal residual disease; Translational research	DOSE-INTENSIVE REGIMEN; CANCER STEM-CELLS; HYPER-CVAD; SELF-RENEWAL; KAPPA-B; CLASSIFICATION; ANCESTRY; CHILDREN; TARGET; RISK	Background: B-Acute lymphoblastic leukemia (B-ALL) represents a hematologic malignancy with poor clinical outcome and low survival rates in adult patients. Remission rates in Hispanic population are almost 30 % lower and Overall Survival (OS) nearly two years inferior than those reported in other ethnic groups. Only 61 % of Colombian adult patients with ALL achieve complete remission (CR), median overall survival is 11.3 months and event -free survival (EFS) is 7.34 months. Identification of prognostic factors is crucial for the application of proper treatment strategies and subsequently for successful outcome. Our goal was to identify a gene expression signature that might correlate with response to therapy and evaluate the utility of these as prognostic tool in hispanic patients. Methods: We included 43 adult patients newly diagnosed with B-ALL. We used microarray analysis in order to identify genes that distinguish poor from good response to treatment using differential gene expression analysis. The expression profile was validated by real-time PCR (RT-PCT). Results: We identified 442 differentially expressed genes between responders and non -responders to induction treatment. Hierarchical analysis according to the expression of a 7-gene signature revealed 2 subsets of patients that differed in their clinical characteristics and outcome. Conclusions: Our study suggests that response to induction treatment and clinical outcome of Hispanic patients can be predicted from the onset of the disease and that gene expression profiles can be used to stratify patient risk adequately and accurately. The present study represents the first that shows the gene expression profiling of B -ALL Colombian adults and its relevance for stratification in the early course of disease.	[Cruz-Rodriguez, Nataly; Combita, Alba L.; Enciso, Leonardo J.; Castillo, Juan S.] Inst Nacl Cancerol, Programa Invest & Innovac Leucemias Agudas & Cron, Bogota, Colombia; [Cruz-Rodriguez, Nataly; Combita, Alba L.; Pinzon, Paula L.; Lozano, Olga C.] Inst Nacl Cancerol, Grp Invest Biol Canc, Calle 1 9-85, Bogota, Colombia; [Cruz-Rodriguez, Nataly] Pontificia Univ Javeriana, Programa Doctorado Ciencias Biol, Bogota, Colombia; [Quijano, Sandra M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Quijano, Sandra M.; Cardozo, Claudia; Solano, Julio; Herrera, Maria V.; Cudris, Jennifer] Hosp Univ San Ignacio, Bogota, Colombia; [Enciso, Leonardo J.] Inst Nacl Cancerol, Grp Hemato Oncol, Bogota, Colombia; [Bareno, Jose] Univ CES, Medellin, Colombia; [Combita, Alba L.] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Zabaleta, Jovanny] Ctr Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Stanley S Scott Canc Ctr, 1700 Tulane Ave,Room 909, New Orleans, LA USA; [Zabaleta, Jovanny] Ctr Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Pediat, 1700 Tulane Ave,Room 909, New Orleans, LA USA		Combita, AL (corresponding author), Inst Nacl Cancerol, Programa Invest & Innovac Leucemias Agudas & Cron, Bogota, Colombia.; Zabaleta, J (corresponding author), Ctr Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Stanley S Scott Canc Ctr, 1700 Tulane Ave,Room 909, New Orleans, LA USA.	acombita@cancer.gov.co; jzabal@lsuhsc.edu	Cruz-Rodriguez, Nataly/P-8177-2016; Quijano, Sandra/AAF-2945-2019; ENCISO, LEONARDO/ABG-2119-2021; bareño silva, jose/ABE-2435-2020; Cardozo-Romero, Claudia Cecilia/R-8704-2016	Cruz-Rodriguez, Nataly/0000-0002-5849-8011; Quijano, Sandra/0000-0003-4452-9291; bareno silva, Jose/0000-0003-2552-3660; Solano Vega, Julio Cesar/0000-0002-5150-3041; Cardozo-Romero, Claudia Cecilia/0000-0002-2739-9619	"Programa de Investigacion e Innovation en Leucemias Agudas y Cronicas (PILAC), Institute National de Cancerologia, Bogota, Colombia" - Departamento administrative de ciencia, tecnologia e innovation, Colciencias, Bogota, Colombia; National Institute of General Medical Sciences (NIGMS) [P20GM103501, P30GM114732, U54GM104940-01]; National Institute on Minority Health and Health Disparities (NIMHD) [P20MD004817, U54MD008176-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501, U54GM104940, P30GM114732] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008176, P20MD004817] Funding Source: NIH RePORTER	"Programa de Investigacion e Innovation en Leucemias Agudas y Cronicas (PILAC), Institute National de Cancerologia, Bogota, Colombia" - Departamento administrative de ciencia, tecnologia e innovation, Colciencias, Bogota, Colombia; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	"Programa de Investigacion e Innovation en Leucemias Agudas y Cronicas (PILAC), Institute National de Cancerologia, Bogota, Colombia" funded by the Departamento administrative de ciencia, tecnologia e innovation, Colciencias, Bogota, Colombia; JZ has been partially supported by grants from the National Institute of General Medical Sciences (NIGMS P20GM103501, P30GM114732, U54GM104940-01), and the National Institute on Minority Health and Health Disparities (NIMHD P20MD004817, U54MD008176-01).	Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Arteaga-Ortiz L, 2008, REV INVEST CLIN, V60, P459; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Both J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115835; Brunning RD, 2003, SEMIN DIAGN PATHOL, V20, P142, DOI 10.1016/S0740-2570(03)00031-5; Chen N, 2014, INT J CLIN EXP PATHO, V7, P716; Clarke PA, 2001, BIOCHEM PHARMACOL, V62, P1311, DOI 10.1016/S0006-2952(01)00785-7; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Combariza JF, 2012, REV COLOMB CANCEROL, V11, P92; Cubillo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059948; Curado MP, 2011, REV PANAM SALUD PUBL, V29, P96, DOI 10.1590/S1020-49892011000200004; D'Andrea FP, 2011, RADIOTHER ONCOL, V99, P373, DOI 10.1016/j.radonc.2011.05.086; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Di KJ, 2007, EXP CELL RES, V313, P3983, DOI 10.1016/j.yexcr.2007.08.023; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerber JM, 2013, ONCOTARGET, V4, P715, DOI 10.18632/oncotarget.990; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Gokbuget N, 2000, HEMATOL ONCOL CLIN N, V14, P1307, DOI 10.1016/S0889-8588(05)70188-X; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gunther EC, 2005, PHARMACOGENOMICS J, V5, P126, DOI 10.1038/sj.tpj.6500300; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hu YN, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-154; Iacobucci I, 2012, CURR HEMATOL MALIG R, V7, P133, DOI 10.1007/s11899-012-0122-5; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; Kantarjian HM, 2000, J CLIN ONCOL, V18, P547, DOI 10.1200/JCO.2000.18.3.547; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-175; Koh H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-36; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; Liu YF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-107; Lopez-Guerra M, 2010, EXPERT OPIN THER TAR, V14, P275, DOI 10.1517/14728221003598930; Lu Q.J.W., 2009, OPEN LEUK J, V2, P1; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Matasar MJ, 2006, LEUKEMIA LYMPHOMA, V47, P2365, DOI 10.1080/10428190600799888; Morris K, 2011, LEUKEMIA LYMPHOMA, V52, P85, DOI 10.3109/10428194.2010.532889; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; RADFORD JE, 1989, J CLIN ONCOL, V7, P58, DOI 10.1200/JCO.1989.7.1.58; Ramos-Peñafiel Christian Omar, 2014, Rev. perú. med. exp. salud publica, V31, P525; Robison LL, 2011, HEMATOL-AM SOC HEMAT, P238, DOI 10.1182/asheducation-2011.1.238; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Rowe JM, 2010, BRIT J HAEMATOL, V150, P389, DOI 10.1111/j.1365-2141.2010.08246.x; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Thomas DA, 2004, BLOOD, V104, P1624, DOI 10.1182/blood-2003-12-4428; Troeger A, 2008, BLOOD, V112, P1028, DOI 10.1182/blood-2007-11-123315; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Vora A, 2014, LANCET ONCOL, V15, P809, DOI 10.1016/S1470-2045(14)70243-8; Walsh KM, 2013, LEUKEMIA, V27, P2416, DOI 10.1038/leu.2013.130; Walsh KM, 2014, AM J HEMATOL, V89, P721, DOI 10.1002/ajh.23727; Workman C., 2002, GENOME BIOL, V3, P0048; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Xu W, 2008, LEUKEMIA RES, V32, P930, DOI 10.1016/j.leukres.2007.10.019; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yin ZQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-49; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang HW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0132-y	68	16	18	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-9966			J EXP CLIN CANC RES	J. Exp. Clin. Cancer Res.	APR 5	2016	35								64	10.1186/s13046-016-0333-z	http://dx.doi.org/10.1186/s13046-016-0333-z			14	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	DI3HC	27044543	Green Published, gold			2022-09-04	WOS:000373388700001
J	Gomez, LF; Mosquera, J; Gomez, OL; Moreno, J; Pinzon, JD; Jacoby, E; Cepeda, M; Parra, DC				Fernando Gomez, Luis; Mosquera, Janeth; Lucia Gomez, Olga; Moreno, Jose; Pinzon, Jose D.; Jacoby, Enrique; Cepeda, Magda; Parra, Diana Celmira			Social conditions and urban environment associated with participation in the Ciclovia program among adults from Cali, Colombia	CADERNOS DE SAUDE PUBLICA			English	Article						Motor Activity; Social Participation; Urban Health	QUALITY-OF-LIFE; PHYSICAL-ACTIVITY LEVELS; HEALTH; BOGOTA; GENDER; POPULATION; PATTERNS; POLICY; RISK	The Ciclovia program (CP) has emerged as an effective initiative to promote active living in urban spaces in Latin America. This study assessed the association between social conditions, the urban environment and participation in the CP among adults living in the city of Cali, Colombia. A cross-sectional study was conducted in 2011 and 2012 among 719 adults aged 18 to 44. Urban environment measures were obtained using Geographic Information Systems. A multilevel logistic regression was used for the analysis. Slightly more than 7% of participants had participated in the CP in the previous four weekends. Being male and having a high school degree were positively associated with participation in the CP. Participation in the CP was positively associated with living in neighborhoods with Ciclovia lanes. In contrast, a negative association was found among those living in neighborhoods with a presence of traffic fatalities. This study provides new insights about a recreational program that has potential health benefits in a region marked by urban inequalities in terms of opportunities for physical activity.	[Fernando Gomez, Luis] Pontificia Univ Javeriana, Fac Med, Bogota 11001000, Distrito Capita, Colombia; [Mosquera, Janeth; Lucia Gomez, Olga; Cepeda, Magda] Univ Valle, Fac Saude Publ, Cali, Colombia; [Moreno, Jose] Univ Rosario, Escuela Med & Ciencias Salud, Bogota, Colombia; [Pinzon, Jose D.] Univ Jorge Tadeo Lozano, Bogota, Colombia; [Jacoby, Enrique] Org Panamer Salud, Washignton, DC USA; [Parra, Diana Celmira] Washington Univ, Sch Med, St Louis, MO USA		Gomez, LF (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Med Prevent & Social, Calle 23,68-59,Interior 18,Apartamento 303, Bogota 11001000, Distrito Capita, Colombia.	luisefe64@yahoo.com	Parra, Diana/D-7633-2013	Parra, Diana/0000-0002-9797-6231; Cepeda-Gil, Magda/0000-0003-4579-6033; Mosquera Becerra, Janeth/0000-0001-9516-7011	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS [110651929042 620449326152, 246-2010]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by a grant from the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS (Project code # 110651929042 620449326152 - Contract # 246-2010). Many individuals contributed to this research and their assistance is acknowledged. We would like to acknowledge the contribution of Maria Cristina Quevedo for the review of the concept of gender rule and Logan Mauney for the English review of the manuscript.	[Anonymous], 2012, ENCUESTA PERCEPCION; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Casaer J, 1999, INT J GEOGR INF SCI, V13, P499, DOI 10.1080/136588199241175; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Chai WW, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-83; Ciclovida Avila D., 2013, TRES DECADAS DEPORTE; Diaz del Castillo A, CICLOVIAS RECREATIVA; del Castillo AD, 2011, TRANSL BEHAV MED, V1, P350, DOI 10.1007/s13142-011-0038-y; Galea S, 2005, SOC SCI MED, V60, P1017, DOI 10.1016/j.socscimed.2004.06.036; Gomez LF, 2015, SOC SCI MED, V131, P18, DOI 10.1016/j.socscimed.2015.02.042; Gomez LF, 2013, QUAL LIFE RES, V22, P2351, DOI 10.1007/s11136-013-0378-9; Gomez LF, 2010, J PHYS ACT HEALTH, V7, pS196, DOI 10.1123/jpah.7.s2.s196; Gomez LF, 2010, AM J PREV MED, V38, P592, DOI 10.1016/j.amepre.2010.02.005; Gómez Luis Fernando, 2004, Cad. Saúde Pública, V20, P1103, DOI 10.1590/S0102-311X2004000400026; Gonzalez S, 2014, BIOMEDICA, V34, P447, DOI [10.7705/biomedica.v34i3.2258, 10.1590/S0120-41572014000300014]; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; KLEINBAUM DG, 2008, APPL REGRESSION ANAL; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Krieger N., 2011, EPIDEMIOLOGY PEOPLES; Lugo A, CAN CICLOVIAS CAN UN; Marquez DX, 2006, ANN BEHAV MED, V31, P138, DOI 10.1207/s15324796abm3102_5; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Monteiro Carlos A., 2003, Rev Panam Salud Publica, V14, P246, DOI 10.1590/S1020-49892003000900005; Montes F, 2012, J URBAN HEALTH, V89, P153, DOI 10.1007/s11524-011-9628-8; Mosquera J, 2013, EVALUACION IMPACTO R; Mosquera J, 2012, J PHYS ACT HEALTH, V9, P776, DOI 10.1123/jpah.9.6.776; Parra D, 2007, INDOOR BUILT ENVIRON, V16, P344, DOI 10.1177/1420326X07080462; Parra DC, 2010, HEALTH PLACE, V16, P1174, DOI 10.1016/j.healthplace.2010.07.008; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978; Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048; Talaei M, 2013, ARYA ATHEROSCLER, V9, P51; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Torres Andrea, 2013, Am J Public Health, V103, pe23, DOI 10.2105/AJPH.2012.301142; UN-Habitat, NEW URB TRANS; Vivas H, 2013, ENS POLIT ECON, V70, P121; Wolin KY, 2007, AM J PREV MED, V32, P490, DOI 10.1016/j.amepre.2007.02.014	39	8	8	1	14	CADERNOS SAUDE PUBLICA	RIO DE JANIERO	RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL	0102-311X	1678-4464		CAD SAUDE PUBLICA	Cad. Saude Publica	NOV	2015	31			1			S257	S266		10.1590/0102-311X00086814	http://dx.doi.org/10.1590/0102-311X00086814			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CY8AS	26648379	gold, Green Published			2022-09-04	WOS:000366631400029
J	Rabinowitz, YS; Galvis, V; Tello, A; Rueda, D; Garcia, JD				Rabinowitz, Yaron S.; Galvis, Virgilio; Tello, Alejandro; Rueda, Daniela; Daniel Garcia, Juan			Genetics vs chronic corneal mechanical trauma in the etiology of keratoconus	EXPERIMENTAL EYE RESEARCH			English	Article						Cornea; Keratoconus; Corneal diseases; Corneal topography; Corneal pachymetry	AUTOSOMAL-DOMINANT KERATOCONUS; DIFFERENTIALLY EXPRESSED GENES; FAMILIAL KERATOCONUS; LYSYL OXIDASE; SEGREGATION ANALYSIS; LINKAGE SCAN; EYE; LOCUS; IDENTIFICATION; MUTATION	Both genetic and environmental factors have been considered to play a role in the etiology keratoconus. Eye rubbing, and more recently eye compression due to sleeping position, have been identified to be highly related to the condition, and are present in a high percentage of patients. Today, the predominant model is that these factors can provide the "second hit" necessary to generate the condition in a genetically susceptible individual. In addition, the extremely high prevalence in Arab populations, where endogamy could play a role, the high concordance rate in monozygotic twins, and the presence of family history of the condition between 5 and 23% of cases, support a genetic influence. Segregation analysis studies suggest that keratoconus is a complex non Mendelian disease. Results from linkage analysis, next generation sequencing studies and genome-wide association studies also have suggested that genetic factors are involved in the condition. Recently, it has been proposed that mechanical trauma (i.e. eye rubbing or eye compression at night), is a sine quanon condition for the onset of keratoconus, and quite possibly its only cause. There are various arguments for and against this hypothesis. Indeed, it is possible, as initially suggested around 55 years ago, that the term "keratoconus" include diverse phenotypically similar conditions, which are actually of different etiology.	[Rabinowitz, Yaron S.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Rabinowitz, Yaron S.] Cornea Genet Eye Inst, Beverly Hills, CA USA; [Rabinowitz, Yaron S.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Galvis, Virgilio; Tello, Alejandro; Rueda, Daniela; Daniel Garcia, Juan] Ctr Oftalmol Virgilio Galvis, Floridablanca, Colombia; [Galvis, Virgilio; Tello, Alejandro] Fdn Oftalmol Santander FOSCAL, Floridablanca, Colombia; [Galvis, Virgilio; Tello, Alejandro] Univ Autonoma Bucaramanga UNAB, Dept Ophthalmol, Bucaramanga, Colombia; [Rueda, Daniela] Pontificia Univ Javeriana, Bogota, Colombia; [Daniel Garcia, Juan] Univ Sabana, Chia, Colombia		Tello, A (corresponding author), FOSCAL Int, Ctr Oftalmol Virgilio Galvis, Calle 157 20-94,Torre C,Consultorio 301 Canaveral, Floridablanca, Santander, Colombia.	atello579@unab.edu.co		Tello, Alejandro/0000-0001-5081-0720; Rueda Latorre, Daniela/0000-0003-4696-0624; Garcia Sanchez, Juan Daniel/0000-0002-5240-4782				Abu-Amero KK, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/641708; Avetisov S E, 2011, Vestn Oftalmol, V127, P3; Avetisov S E, 2015, Vestn Oftalmol, V131, P34, DOI 10.17116/oftalma2015131634-42; Balasubramanian SA, 2013, CLIN EXP OPTOM, V96, P214, DOI 10.1111/cxo.12038; BARBARA J, 2017, KERATOCONUS ESSENTIA, P13, DOI DOI 10.1007/978-3-319-43881-8_3; Bawazeer AM, 2000, BRIT J OPHTHALMOL, V84, P834, DOI 10.1136/bjo.84.8.834; Bisceglia L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/iovs.08-2382; Burdon KP, 2008, HUM GENET, V124, P379, DOI 10.1007/s00439-008-0555-z; Burdon KP, 2013, CLIN EXP OPTOM, V96, P146, DOI 10.1111/cxo.12024; Bykhovskaya Y, 2015, OPHTHALMIC GENET, V36, P244, DOI 10.3109/13816810.2013.848908; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; COPEMAN PWM, 1965, BRIT MED J, V2, P977, DOI 10.1136/bmj.2.5468.977; COYLE JT, 1984, AM J OPHTHALMOL, V97, P527; CULBERTSON WW, 1994, CORNEA, V13, P33, DOI 10.1097/00003226-199401000-00007; Czugala M, 2012, EUR J HUM GENET, V20, P389, DOI 10.1038/ejhg.2011.203; Davidson AE, 2014, EYE, V28, P189, DOI 10.1038/eye.2013.278; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Davidson AE, 2015, INVEST OPHTH VIS SCI, V56, P578, DOI 10.1167/iovs.14-15792; DAVIES GE, 1994, HUM GENET, V93, P443; Dey SK, 2014, MOL CYTOGENET, V7, pP24; DONNENFELD ED, 1991, OPHTHALMOLOGY, V98, P1674; Dua, 2020, J EUCORNEA, V7, P23, DOI DOI 10.1016/J.XJEC.2020.05.002; Dudakova Lubica, 2017, Cornea, V36, pe14, DOI 10.1097/ICO.0000000000001155; Dudakova L, 2013, J NEURAL TRANSM, V120, P977, DOI 10.1007/s00702-013-0993-1; Dudakova L, 2012, EXP EYE RES, V104, P74, DOI 10.1016/j.exer.2012.09.005; Ezra DG, 2010, OPHTHALMOLOGY, V117, P831, DOI 10.1016/j.ophtha.2009.09.029; Fakhraie Ghasem, 2016, J Ophthalmic Vis Res, V11, P319, DOI 10.4103/2008-322X.158896; Ferrari G, 2020, OCUL SURF, V18, P363, DOI 10.1016/j.jtos.2020.03.006; FORSTOT SL, 1988, AM J OPHTHALMOL, V105, P92, DOI 10.1016/0002-9394(88)90130-4; Fullerton J, 2002, HUM GENET, V110, P462, DOI 10.1007/s00439-002-0705-7; Gajecka M, 2009, INVEST OPHTH VIS SCI, V50, P1531, DOI 10.1167/iovs.08-2173; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; GALVIS V, 2017, CORNEA, V36, pE; Gao XY, 2016, HUM MOL GENET, V25, P5035, DOI 10.1093/hmg/ddw319; Gatinel D, 2016, INT J KERAT ECT COR, V5, P6, DOI DOI 10.5005/JP-JOURNALS-10025-1114; Gatinel D., 2018, INT J KERATOCONUS EC, V7, P66, DOI [10.5005/jp-journals-10025-1161, DOI 10.5005/JP-J0URNALS-10025-1161, DOI 10.5005/JP-JOURNALS-10025-1161]; Gatinel D, 2020, CORNEA, V39, pE11, DOI 10.1097/ICO.0000000000002219; Gokhale NS, 2013, INDIAN J OPHTHALMOL, V61, P382, DOI 10.4103/0301-4738.116054; Gomes JAP, 2015, CORNEA, V34, P359, DOI 10.1097/ICO.0000000000000408; Gordon-Shaag A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795738; Gordon-Shaag A, 2013, OPTOMETRY VISION SCI, V90, P448, DOI 10.1097/OPX.0b013e31828da95c; Gorskova E N, 1998, Vestn Oftalmol, V114, P38; GRITZ DC, 1988, AM J OPHTHALMOL, V106, P757, DOI 10.1016/0002-9394(88)90726-X; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Ha NT, 2004, CURR EYE RES, V28, P373, DOI 10.1080/02713680490502201; Hao XD, 2015, OPHTHALMIC GENET, V36, P132, DOI 10.3109/13816810.2015.1005317; Hasanian-Langroudi F, 2015, OPHTHALMIC GENET, V36, P309, DOI 10.3109/13816810.2014.881507; Hashemi H, 2020, CORNEA, V39, P263, DOI 10.1097/ICO.0000000000002150; Hashemi H, 2018, OPHTHAL PHYSL OPT, V38, P447, DOI 10.1111/opo.12448; Hashemi H, 2014, OPHTHAL PHYSL OPT, V34, P519, DOI 10.1111/opo.12147; Heur M, 2008, AM J OPHTHALMOL, V145, P997, DOI 10.1016/j.ajo.2008.01.028; Hughes AE, 2003, INVEST OPHTH VIS SCI, V44, P5063, DOI 10.1167/iovs.03-0399; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutchings H, 2005, J MED GENET, V42, P88, DOI 10.1136/jmg.2004.022103; Ioannidis AS, 2005, AM J OPHTHALMOL, V139, P356, DOI 10.1016/j.ajo.2004.07.044; Jafri B, 2004, CORNEA, V23, P560, DOI 10.1097/01.ico.0000121711.58571.8d; Jaramillo JA, 2011, REV SOC COLOMBIANA O, V44, P129; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; Karolak JA, 2017, EUR J HUM GENET, V25, P73, DOI 10.1038/ejhg.2016.130; KARSERAS AG, 1976, BRIT J OPHTHALMOL, V60, P522, DOI 10.1136/bjo.60.7.522; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Khaled ML, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7803029; Khawaja AP, 2019, JAMA OPHTHALMOL, V137, P1005, DOI 10.1001/jamaophthalmol.2019.2058; Kinori M, 2017, AM J OPHTHALMOL, V177, P144, DOI 10.1016/j.ajo.2017.02.022; Kriszt A, 2014, ACTA OPHTHALMOL, V92, pe562, DOI 10.1111/aos.12389; Lechner J, 2014, HUM MOL GENET, V23, P5527, DOI 10.1093/hmg/ddu253; Li XH, 2006, INVEST OPHTH VIS SCI, V47, P3791, DOI 10.1167/iovs.06-0214; Lindsay RG, 2000, CORNEA, V19, P567, DOI 10.1097/00003226-200007000-00034; Liskova P, 2016, EUR J HUM GENET, V24, P985, DOI 10.1038/ejhg.2015.232; Loukovitis E, 2018, OPHTHALMOL THER, V7, P263, DOI 10.1007/s40123-018-0144-8; Mashor RS, 2011, CAN J OPHTHALMOL, V46, P83, DOI 10.3129/i10-072; McComish BJ, 2020, JAMA OPHTHALMOL, V138, P174, DOI 10.1001/jamaophthalmol.2019.5293; McMonnies Charles W, 2007, Eye Contact Lens, V33, P265, DOI 10.1097/ICL.0b013e31814fb64b; McMonnies CW, 2009, CORNEA, V28, P607, DOI 10.1097/ICO.0b013e318198384f; Millodot M, 2011, OPHTHAL EPIDEMIOL, V18, P91, DOI 10.3109/09286586.2011.560747; Miyake M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7689; Moran S, 2020, CORNEA, V39, P697, DOI 10.1097/ICO.0000000000002283; Najmi H, 2019, INT J OPHTHALMOL-CHI, V12, P1775, DOI 10.18240/ijo.2019.11.17; NESBURN AB, 1995, J REFRACT SURG, V11, P194; Nielsen K, 2006, EXP EYE RES, V82, P201, DOI 10.1016/j.exer.2005.06.009; Nielsen K, 2005, CORNEA, V24, P661, DOI 10.1097/01.ico.0000153556.59407.69; Nielsen K, 2003, INVEST OPHTH VIS SCI, V44, P2466, DOI 10.1167/iovs.02-0671; Nowak DM, 2011, MIDDLE EAST AFR J OP, V18, P2, DOI 10.4103/0974-9233.75876; Owens H, 2003, CORNEA, V22, P122, DOI 10.1097/00003226-200303000-00008; Pearson AR, 2000, EYE, V14, P625, DOI 10.1038/eye.2000.154; Rabinowitz Yaron S, 2003, Ophthalmol Clin North Am, V16, P607, DOI 10.1016/S0896-1549(03)00099-3; RABINOWITZ YS, 1993, OPHTHALMOLOGY, V100, P181; RABINOWITZ YS, 1990, ARCH OPHTHALMOL-CHIC, V108, P365, DOI 10.1001/archopht.1990.01070050063032; RABINOWITZ YS, 1992, CORNEA, V11, P302, DOI 10.1097/00003226-199207000-00005; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; RIDLEY F, 1962, Int Ophthalmol Clin, V2, P687, DOI 10.1097/00004397-196210000-00007; Ridley F, 1961, Br J Ophthalmol, V45, P631, DOI 10.1136/bjo.45.9.631; Rohrbach M, 2013, MOL GENET METAB, V109, P289, DOI 10.1016/j.ymgme.2013.04.014; Schmitt-Bernard CF, 2000, J CATARACT REFR SURG, V26, P1830, DOI 10.1016/S0886-3350(00)00556-3; Shneor E., 2014, INT J KERATOCONUS EC, V3, P9, DOI [DOI 10.5005/JP-JOURNALS-10025-1070, 10.5005/jp-journals-10025-1070]; Steele TM, 2008, CLIN EXP OPHTHALMOL, V36, P824, DOI 10.1111/j.1442-9071.2009.01908.x; Sugar J, 2012, CORNEA, V31, P716, DOI 10.1097/ICO.0b013e31823f8c72; Tang YMG, 2005, GENET MED, V7, P397, DOI 10.1097/01.GIM.0000170772.41860.54; Tuft SJ, 2012, ACTA OPHTHALMOL, V90, pe482, DOI 10.1111/j.1755-3768.2012.02448.x; Tyynismaa H, 2002, INVEST OPHTH VIS SCI, V43, P3160; Valgaeren H, 2018, OPHTHALMIC GENET, V39, P158, DOI 10.1080/13816810.2017.1393831; Valluri S, 1999, AM J OPHTHALMOL, V127, P158, DOI 10.1016/S0002-9394(98)00319-5; Vincent AL, 2014, INVEST OPHTH VIS SCI, V55, P5629, DOI 10.1167/iovs.14-14532; Wang Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.3.CO;2-1; Weed K H, 2006, Cont Lens Anterior Eye, V29, P123, DOI 10.1016/j.clae.2006.03.003; Zadnik K, 2002, CORNEA, V21, P671, DOI 10.1097/00003226-200210000-00008; Zadnik K, 1998, INVEST OPHTH VIS SCI, V39, P2537	107	12	12	0	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JAN	2021	202								108328	10.1016/j.exer.2020.108328	http://dx.doi.org/10.1016/j.exer.2020.108328		JAN 2021	8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	PS8PH	33172608				2022-09-04	WOS:000608185500003
J	Duran, F; Rocha, C; Salaun, G				Duran, Francisco; Rocha, Camilo; Salaun, Gwen			A rewriting logic approach to resource allocation analysis in business process models	SCIENCE OF COMPUTER PROGRAMMING			English	Article						BPMN; Resource allocation; Rewriting logic; Automated verification; Maude	SEMANTICS	This paper presents an approach for the modeling and analysis of resource allocation for business processes. It enables the automatic computation of measures for precisely identifying and optimizing the allocation of resources in business processes, including resource usage over time. The proposed analysis, especially suited to support decision-making strategies, is illustrated with a case study of a parcel ordering and delivery by drones that is developed throughout the paper. The paper comprises an encoding of a significant and expressive subset of the Business Process Model and Notation (BPMN) in rewriting logic, an executable logic of concurrent change that can naturally deal with state and with concurrent computations. The encoding is by itself a formal semantics and interpreter of the BPMN subset that captures all concurrent behavior and thus is used to simulate the concurrent evolution of any business process with a given number of resources and replicas. (C) 2019 Elsevier B.V. All rights reserved.	[Duran, Francisco] Univ Malaga, Malaga, Spain; [Rocha, Camilo] Pontificia Univ Javeriana, Cali, Colombia; [Salaun, Gwen] Univ Grenoble Alpes, CNRS, INRIA, Grenoble INP,LIG, F-38000 Grenoble, France		Rocha, C (corresponding author), Pontificia Univ Javeriana, Cali, Colombia.	camilo.rocha@javerianacali.edu.co		Rocha, Camilo/0000-0003-4356-7704; Duran, Francisco/0000-0001-5864-8094	Spanish MINECO/FEDER [PGC2018-094905-B-100]; FEDER Andalucia [UMA18-FEDERJA-180]; CAPES; Colciencias; INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency" [88881.117603/2016-01]; Capital Semilla 2017 project "SCORES: Stochastic Concurrency in Rewrite-based Probabilistic Models" [020100610]	Spanish MINECO/FEDER; FEDER Andalucia; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency"; Capital Semilla 2017 project "SCORES: Stochastic Concurrency in Rewrite-based Probabilistic Models"	The first author was supported in part by projects PGC2018-094905-B-100 (Spanish MINECO/FEDER) and UMA18-FEDERJA-180 (FEDER Andalucia). The second author has been supported in part by CAPES, Colciencias, and INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency" (Proc. No. 88881.117603/2016-01), and Capital Semilla 2017 project "SCORES: Stochastic Concurrency in Rewrite-based Probabilistic Models" (Proj. No. 020100610).	[Anonymous], 2007, LECT NOTES COMPUTER; [Anonymous], 2014, BEHAVIOUR MODELLING; [Anonymous], 2013, 19510 ISOIEC; Arevalo C, 2016, INFORM SOFTWARE TECH, V77, P17, DOI 10.1016/j.infsof.2016.05.004; Bouhoula A, 2000, THEOR COMPUT SCI, V236, P35, DOI 10.1016/S0304-3975(99)00206-6; Braghetto KR, 2011, LECT NOTES COMPUT SC, V6977, P42, DOI 10.1007/978-3-642-24749-1_5; Bruni Roberto, 2012, Web Services and Formal Methods. 8th International Workshop (WS-FM 2011). Revised Selected Papers, P111, DOI 10.1007/978-3-642-29834-9_9; Capel MI, 2012, IEEE ANNU SOFTW ENG, P100, DOI 10.1109/SEW.2012.17; Christiansen DR, 2011, LECT NOTES COMPUT SC, V6551, P146, DOI 10.1007/978-3-642-19589-1_10; Dijkman RM, 2008, INFORM SOFTWARE TECH, V50, P1281, DOI 10.1016/j.infsof.2008.02.006; Duran Francisco, 2018, Software Technologies: Applications and Foundations. STAF 2018 Collocated Workshops. Revised Selected Papers. Lecture Notes in Computer Science (LNCS 11176), P320, DOI 10.1007/978-3-030-04771-9_24; Duran F., 2018, NOTE RESOURCE ALLOCA; Duran F, 2018, SCI COMPUT PROGRAM, V168, P1, DOI 10.1016/j.scico.2018.08.007; Duran F, 2017, LECT NOTES COMPUT SC, V10319, P219, DOI 10.1007/978-3-319-59746-1_12; Gagne Denis, 2009, 2009 IEEE Conference on Commerce and Enterprise Computing, P361, DOI 10.1109/CEC.2009.71; Krishna Ajay, 2017, Integrated Formal Methods. 13th International Conference, IFM 2017. Proceedings: LNCS 10510, P323, DOI 10.1007/978-3-319-66845-1_21; Li JQ, 2004, IEEE T SYST MAN CY A, V34, P229, DOI 10.1109/TSMCA.2003.819490; Mateescu R., 2014, P CBSE 2014, P159, DOI 10.1145/2602458.2602473; Mendoza LE, 2012, INFORM SOFTWARE TECH, V54, P149, DOI 10.1016/j.infsof.2011.08.004; Morales LEM, 2011, LECT NOTES BUS INF P, V73, P388; MESEGUER J, 1992, THEOR COMPUT SCI, V96, P73, DOI 10.1016/0304-3975(92)90182-F; Netjes N., 2005, P CPN, P251; Object Management Group, 2011, BUSINESS PROCESS MOD; Oliveira C, 2009, IEEE SYS MAN CYBERN, P2824, DOI 10.1109/ICSMC.2009.5346592; Oliveira CAL, 2012, IEEE T SYST MAN CY A, V42, P669, DOI 10.1109/TSMCA.2011.2170412; Olveczky P. C., 2007, Higher-Order and Symbolic Computation, V20, P161, DOI 10.1007/s10990-007-9001-5; Poizat P., 2012, P 27 ANN ACM S APPL, P1927, DOI 10.1145/2245276.2232095; Poizat P, 2017, LECT NOTES COMPUT SC, V10231, P36, DOI 10.1007/978-3-319-57666-4_4; Raedts I., 2007, MSVVEIS, V2007, P126; Schomig A.K., 1995, 116 U WURZB; Sperl S., 2017, 7 INT S DAT DRIV PRO, P128; van der Aalst W., 2016, PROCESS MINING DATA; van der Aalst WMP, 2002, LECT NOTES COMPUT SC, V2480, P45; Walck C., 2007, SUFPFY9601 U STOCKH; Wong PYH, 2008, INT CONF QUAL SOFTW, P126, DOI 10.1109/QSIC.2008.6; Wong PYH, 2009, ELECTRON NOTES THEOR, V229, P59, DOI 10.1016/j.entcs.2009.06.029; Wong PYH, 2008, LECT NOTES COMPUT SC, V5256, P355, DOI 10.1007/978-3-540-88194-0_22	37	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-6423	1872-7964		SCI COMPUT PROGRAM	Sci. Comput. Program.	SEP 1	2019	183								102303	10.1016/j.scico.2019.102303	http://dx.doi.org/10.1016/j.scico.2019.102303			16	Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	JF8DA		Green Submitted			2022-09-04	WOS:000491614000003
J	Singh, N; Halliday, HL; Stevens, TP; Suresh, G; Soll, R; Rojas-Reyes, MX				Singh, Neetu; Halliday, Henry L.; Stevens, Timothy P.; Suresh, Gautham; Soll, Roger; Ximena Rojas-Reyes, Maria			Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review							2 NATURAL SURFACTANTS; PREMATURE-INFANTS; PORACTANT-ALPHA; SURVANTA BERACTANT; TREATMENT REGIMENS; CLINICAL-EFFICACY; PERFUSION INDEX; TRIAL; GUIDELINES; CUROSURF	Background Animal-derived surfactants have been shown to have several advantages over the first generation synthetic surfactants and are the most commonly used surfactant preparations. The animal-derived surfactants in clinical use are minced or lavaged and modified or purified from bovine or porcine lungs. It is unclear whether significant differences in clinical outcome exist among the available bovine (modified minced or lavage) and porcine (minced or lavage) surfactant extracts. Objectives To compare the effect of administration of different animal-derived surfactant extracts on the risk of mortality, chronic lung disease, and other morbidities associated with prematurity in preterm infants at risk for or having respiratory distress syndrome (RDS). Search methods We used the standard search strategy of the Cochrane Neonatal Review group to search the Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 7), MEDLINE via PubMed (1966 to July 31, 2015), EMBASE (1980 to July 31, 2015), and CINAHL (1982 to July 31, 2015). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomized controlled trials and quasi-randomized trials. Selection criteria Randomized or quasi-randomized controlled trials that compared the effect of animal-derived surfactant extract treatment administered to preterm infants at risk for or having RDS to prevent complications of prematurity and mortality. Data collection and analysis Data regarding clinical outcomes were excerpted from the reports of the clinical trials by the review authors. Subgroup analyses were performed based on gestational age, surfactant dosing and schedule, treatment severity and treatment strategy. Data analysis was performed in accordance with the standards of the Cochrane Neonatal Review Group. Main results Sixteen randomized controlled trials were included in the analysis. Bovine lung lavage surfactant extract to modified bovine minced lung surfactant extract: Seven treatment studies and two prevention studies compared bovine lung lavage surfactant extract to modified bovine minced lung surfactant extract. The meta-analysis did not demonstrate any significant differences in death or chronic lung disease in the prevention trials (typical RR 1.02, 95% CI 0.89 to 1.17; typical RD 0.01, 95% CI -0.05 to 0.06; 2 studies and 1123 infants; high quality evidence) or treatment trials (typical RR 0.95, 95% CI 0.86 to 1.06; typical RD -0.02, 95% CI -0.06 to 0.02; 3 studies and 2009 infants; high quality evidence) Modified bovine minced lung surfactant extract compared with porcine minced lung surfactant extract: Nine treatment studies compared modified bovine minced lung surfactant extract to porcine minced lung surfactant extract. Meta-analysis of these trials demonstrate a significant increase in the risk of mortality prior to hospital discharge (typical RR 1.44, 95% CI 1.04 to 2.00; typical RD 0.05, 95% CI 0.01 to 0.10; NNTH 20, 95% CI 10 to 100; 9 studies and 901 infants; moderate quality evidence), death or oxygen requirement at 36 weeks' postmenstrual age (typical RR 1.30, 95% CI 1.04 to 1.64; typical RD 0.11, 95% CI 0.02 to 0.20; NNTH 9, 95% CI 5 to 50; 3 studies and 448 infants; moderate quality evidence), receiving more than one dose of surfactant (typical RR 1.57, 95% CI 1.29 to 1.92; typical RD 0.14, 95% CI 0.08 to 0.20; NNTH 7, 95% CI 5 to 13; 6 studies and 786 infants), and patent ductus arteriosus (PDA) requiring treatment (typical RR 1.86, 95% CI 1.28 to 2.70; typical RD 0.28, 95% CI 0.13 to 0.43; NNTH 4, 95% CI 2 to 8; 3 studies and 137 infants) in infants treated with modified bovine minced lung surfactant extract compared with porcine minced lung surfactant extract. In the subgroup analysis based on initial dose of surfactant, improvement in mortality prior to discharge (typical RR 1.62, 95% CI 1.11 to 2.38; typical RD 0.06, 95% CI 0.01 to 0.11; NNTH 16, 95% CI 9 to 100) and risk of death or oxygen requirement at 36 weeks' postmenstrual age (typical RR 1.39, 95% CI 1.08 to 1.79; typical RD 0.13, 95% 0.03 to 0.23; NNTH 7, 95% CI 4 to 33) was limited to higher initial dose of porcine minced lung surfactant (> 100 mg/kg). Other comparisons: No difference in outcome was noted between bovine lung lavage surfactant extract versus porcine minced lung surfactant extract. There were no studies comparing bovine lung lavage surfactant extract versus porcine lung lavage surfactant; or porcine minced lung surfactant extract versus porcine lung lavage surfactant. Authors' conclusions Significant differences in clinical outcome were noted in the comparison trials of modified minced lung surfactant extract (beractant) compared with porcine minced lung surfactant extract (poractant alfa) including a significant increase in the risk of mortality prior to discharge, death or oxygen requirement at 36 weeks' postmenstrual age, PDA requiring treatment and "receiving > 1 dose of surfactant" in infants treated with modified bovine minced lung surfactant extract compared with porcine minced lung surfactant extract. The difference in these outcomes was limited to studies using a higher initial dose of porcine minced lung surfactant extract. It is uncertain whether the observed differences are from differences in dose or from source of extraction (porcine vs. bovine) because of the lack of dose-equivalent comparison groups with appropriate sample size. No differences in clinical outcomes were observed in comparative trials between bovine lung lavage surfactant and modified bovine minced lung surfactants.	[Singh, Neetu] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03784 USA; [Halliday, Henry L.] Queens Univ, Child Hlth, Belfast, Antrim, North Ireland; [Stevens, Timothy P.] Univ Rochester, Pediat, Rochester, NY USA; [Suresh, Gautham] Dartmouth Hitchcock Med Ctr, Dept Pediat, Neonatal Div, Lebanon, NH 03766 USA; [Soll, Roger] Univ Vermont, Med Ctr, Div Neonatol Perinatal Med, Burlington, VT USA; [Ximena Rojas-Reyes, Maria] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia		Singh, N (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Pediat, 1 Med Ctr Dr, Lebanon, NH 03784 USA.	Neetu.Singh@Hitchcock.org		Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Stevens, Timothy/0000-0002-2959-3925	Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA [HHSN275201100016C]	Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	External sources; Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA.; Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C.	Attar Mohammad A, 2004, J Perinatol, V24, P626, DOI 10.1038/sj.jp.7211160; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Baroutis G, 2003, EUR J PEDIATR, V162, P476, DOI 10.1007/s00431-002-1144-0; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bloom BT, 2005, PEDIATRICS, V116, P392, DOI 10.1542/peds.2004-2783; Bloom BT, 1997, PEDIATRICS, V100, P31, DOI 10.1542/peds.100.1.31; Bozdag S, 2015, AM J PERINAT, V32, P211, DOI 10.1055/s-0034-1389090; Choi CW, 2005, J KOREAN MED SCI, V20, P591, DOI 10.3346/jkms.2005.20.4.591; CHU J, 1967, PEDIATRICS, V40, P709; Dargaville PA, 2011, ARCH DIS CHILD-FETAL, V96, pF243, DOI 10.1136/adc.2010.192518; Dizdar EA, 2012, AM J PERINAT, V29, P95, DOI 10.1055/s-0031-1295648; Engle WA, 2008, PEDIATRICS, V121, P411, DOI 10.1542/peds.2007-3281; ENHORNING G, 1972, PEDIATRICS, V50, P58; Eras Z, 2014, AM J PERINAT, V31, P463, DOI 10.1055/s-0033-1351659; Fujii AM, 2010, J PERINATOL, V30, P665, DOI 10.1038/jp.2010.20; FUJIWARA T, 1980, LANCET, V1, P55; Gharehbaghi MM, 2014, INT J WOMEN HEAL REP, V2, P245, DOI 10.15296/ijwhr.2014.36; Gharehbaghi MM, 2010, INDIAN J PEDIATR, V77, P751, DOI 10.1007/s12098-010-0097-y; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Halahakoon WL, 1999, THESIS; Halliday HL, 2008, J PERINATOL, V28, pS47, DOI 10.1038/jp.2008.50; Hammoud M, 2004, J Matern Fetal Neonatal Med, V15, P167, DOI 10.1080/14767050410001668266; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; Higgins A, 2011, COCHRANE HDB SYSTEMA; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Karadag N, 2014, AM J PERINAT, V31, P1015, DOI 10.1055/s-0034-1370344; Kribs A, 2007, PEDIATR ANESTH, V17, P364, DOI 10.1111/j.1460-9592.2006.02126.x; Lam BCC, 2005, PEDIATR PULM, V39, P64, DOI 10.1002/ppul.20125; Logan J Wells, 2009, Ther Clin Risk Manag, V5, P251; Malloy CA, 2005, ACTA PAEDIATR, V94, P779, DOI 10.1080/08035250510028740; Mercado VV, 2010, ADV THER, V27, P476, DOI 10.1007/s12325-010-0044-3; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pfister RH, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006069.pub3, DOI 10.1002/14651858.CD006069.PUB3]]; Pfister RH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006180.pub2; Proquitte H, 2007, RESP MED, V101, P169, DOI 10.1016/j.rmed.2006.03.033; Ramanathan R, 2004, AM J PERINAT, V21, P109, DOI 10.1055/s-2004-823779; Ramanathan R, 2009, J PERINATOL, V29, pS38, DOI 10.1038/jp.2009.31; Rebello CM, 2014, EINSTEIN-SAO PAULO, V12, P397, DOI 10.1590/S1679-45082014AO3095; Rebello CM, 2009, MULTICENTER RANDOMIZ; ROBILLARD E, 1964, CAN MED ASSOC J, V90, P55; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000510.pub2, DOI 10.1002/14651858.CD000510.PUB2]]; Saeidi R, 2013, IRAN J NEONATOL, V4, P7; Sanchez-Mendiola Melchor, 2005, Gac Med Mex, V141, P267; Sch_unemann H, GRADE HDB GRADING QU; Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836; Singh N, 2011, PEDIATRICS, V128, pE1588, DOI 10.1542/peds.2011-1395; Soll R, 1997, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000511, DOI 10.1002/14651858.CD000511]]; Soll R, 1998, COCHRANE DB SYST REV, DOI [10.1002/14651858. CD001149, DOI 10.1002/14651858.CD001149]]; Soll RF, 1992, SINCLAIR J BRACKEN M, P325; Soll RF, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000144, DOI 10.1002/14651858.CD000144]]; SPEER CP, 1995, ARCH DIS CHILD-FETAL, V72, pF8, DOI 10.1136/fn.72.1.F8; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Terek D, 2015, PEDIATR NEONATOL, V56, P248, DOI 10.1016/j.pedneo.2014.11.004; The Nordic Cochrane Centre, 2018, REVMAN 5 3 US GUID; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Yalaz M, 2004, KLIN PADIATR, V216, P230, DOI 10.1055/s-2004-44899	60	53	56	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2015		12							CD010249	10.1002/14651858.CD010249.pub2	http://dx.doi.org/10.1002/14651858.CD010249.pub2			114	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9QQ	26690260				2022-09-04	WOS:000368145000062
J	Delgado-Machuca, N; Meza-Lazaro, RN; Romero-Napoles, J; Sarmiento-Monroy, CE; Amarillo-Suarez, AR; Bayona-Vasquez, NJ; Zaldivar-Riveron, A				Delgado-Machuca, Natalia; Meza-Lazaro, Rubi N.; Romero-Napoles, Jesus; Sarmiento-Monroy, Carlos E.; Amarillo-Suarez, Angela R.; Bayona-Vasquez, Natalia J.; Zaldivar-Riveron, Alejandro			Genetic structure, species limits and evolution of the parasitoid wasp genus Stenocorse (Braconidae: Doryctinae) based on nuclear 3RAD and mitochondrial data	SYSTEMATIC ENTOMOLOGY			English	Article							RADSEQ LOCI; DELIMITATION; HYMENOPTERA; INFERENCE; BIOGEOGRAPHY; COLEOPTERA; BRUCHIDAE; INSIGHTS; HISTORY; DIVERSIFICATION	Stenocorse (Braconidae: Doryctinae) is an ectoparasitoid wasp genus widely distributed from southern U.S.A. to central Argentina, which is known to attack over 60 bruchine beetle species that feed on a variety of legumes. This genus currently comprises a single described species, S. bruchivora (Crawford, 1910), though it is probably composed of additional, morphologically similar species. In this study we investigated genetic structure, species limits and evolutionary relationships of sampled populations of Stenocorse obtained along its known geographic distribution, with an emphasis on the Mexican territory. For this, we generated DNA sequences from both the mitochondrial (mt) barcoding locus and nuclear genome data obtained with the 3RAD technique. The Bayesian phylogenetic reconstructions based on the two datasets were mostly congruent, both showing clear geographic structure. Four clusters were recovered with nuclear data, which were also congruent with the geographic distribution of the samples and the species delimitation analyses. We delimited six evolutionary lineages with the two data sources, and three additional species were also delimited with the COI locus alone. Stenocorse probably originated during the mid- to early Miocene, and the diversification events that led to its current species distribution probably occurred between the early Pliocene and late Pleistocene. Our species delineation analyses, phylogenetic reconstructions and rearing records suggest that the species of Stenocorse have generalist feeding habits, contrary to what was expected due to host plant specialization of the bruchine species and the cascading effect that this could have in the species diversification of their parasitoids.	[Delgado-Machuca, Natalia; Meza-Lazaro, Rubi N.; Zaldivar-Riveron, Alejandro] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Insectos, 3er Circuito Exterior S-N,AP 70-233, Mexico City 04510, DF, Mexico; [Romero-Napoles, Jesus] Colegio Postgrad, Inst Fitosanidad, Texcoco, Mexico; [Sarmiento-Monroy, Carlos E.] Univ Nacl Colombia, Inst Ciencias Nat, Lab Sistemat & Biol Comparada Insectos, Bogota, Texcoco, Colombia; [Amarillo-Suarez, Angela R.] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, Colombia; [Bayona-Vasquez, Natalia J.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA		Zaldivar-Riveron, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Insectos, 3er Circuito Exterior S-N,AP 70-233, Mexico City 04510, DF, Mexico.	azal-divar@ib.unam.mx		Sarmiento, Carlos E./0000-0003-4012-8108				Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Avise J.C., 2000, PHYLOGEOGRAPHY HIST; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barley AJ, 2018, SYST BIOL, V67, P269, DOI 10.1093/sysbio/syx073; Battey CJ, 2017, MOL PHYLOGENET EVOL, V113, P67, DOI 10.1016/j.ympev.2017.05.006; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Che YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169006; Chifman J, 2015, J THEOR BIOL, V374, P35, DOI 10.1016/j.jtbi.2015.03.006; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crawford J. C., 1910, Proceedings of the Entomological Society of Washington DC, V11; Cronin JT, 2001, ECOL ENTOMOL, V26, P347, DOI 10.1046/j.1365-2311.2001.00332.x; Cruaud A, 2018, PEERJ, V6, DOI 10.7717/peerj.5640; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dedeine F, 2016, MOL PHYLOGENET EVOL, V94, P778, DOI 10.1016/j.ympev.2015.10.020; Deng J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-275; Development Core team R, 2008, R FDN STAT COMP; Drummond AJ, 2002, GENETICS, V161, P1307; Eaton DAR, 2017, SYST BIOL, V66, P399, DOI 10.1093/sysbio/syw092; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eyer PA, 2017, MOL PHYLOGENET EVOL, V115, P128, DOI 10.1016/j.ympev.2017.07.024; Fa J, 1998, DIVERSIDAD BIOL MEXI, P3; Fernandez-Flores S, 2013, MOL ECOL RESOUR, V13, P1146, DOI 10.1111/1755-0998.12102; Ferrari L, 2012, TECTONOPHYSICS, V522, P122, DOI 10.1016/j.tecto.2011.09.018; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forbes AA, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0176-x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.ecolsys.19.1.207; Glenn T.C., 2017, ADAPTERAMA 3 QUADRUP, P1; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall AAG, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0959-2; Hamback Peter A., 2013, BMC Evolutionary Biology, V13, P1; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hime PM, 2016, MOL ECOL, V25, P5959, DOI 10.1111/mec.13883; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jermy T, 2003, OIKOS, V101, P196, DOI 10.1034/j.1600-0706.2003.11918.x; Johnson C.D., 1983, Miscellaneous Publications of the Entomological Society of America, P1; Johnson C. D., 1989, OPERA LILLOANA, V37; JOHNSON CD, 1990, T AM ENTOMOL SOC, V116, P297; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KINGSOLVER J M, 1986, Entomography, V4, P109; Kingsolver J.M., 1988, USDA TECHNICAL B, V63, P1744; KINGSOLVER JM, 1978, USDA TECHNICAL B, V1590; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Korenko S, 2018, INSECT CONSERV DIVER, V11, P587, DOI 10.1111/icad.12307; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; López-Martínez Víctor, 2003, Acta Zool. Mex, P287; Luo A, 2018, SYST BIOL, V67, P830, DOI 10.1093/sysbio/syy011; Maldonado-Sanchez D, 2016, MOL PHYLOGENET EVOL, V99, P76, DOI 10.1016/j.ympev.2016.03.014; MARSH PM, 1968, P ENTOMOL SOC WASH, V70, P101; Marshall CJ, 2000, J BIOGEOGR, V27, P203, DOI 10.1046/j.1365-2699.2000.00388.x; Mastretta-Yanes A, 2015, J BIOGEOGR, V42, P1586, DOI 10.1111/jbi.12546; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Montes C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008959; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pedraza-Lara C, 2015, MOL PHYLOGENET EVOL, V84, P220, DOI 10.1016/j.ympev.2015.01.001; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pritchard JK, 2000, GENETICS, V155, P945; Quicke D. L. J., 1997, PARASITIC WASPS; Quicke DLJ, 2015, BRACONID AND ICHNEUMONID PARASITOID WASPS: BIOLOGY, SYSTEMATICS, EVOLUTION AND ECOLOGY, P1; Rambaut, 2009, FIG TREE; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rannala B, 2017, SYST BIOL, V66, P823, DOI 10.1093/sysbio/syw119; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104008; Rochette NC, 2017, NAT PROTOC, V12, P2640, DOI 10.1038/nprot.2017.123; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Romero J, 2000, T AM ENTOMOL SOC, V126, P221; Romero Nápoles Jesús, 2002, Acta Zool. Mex, P01; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Salas-Lizana R, 2018, ECOL EVOL, V8, P6638, DOI 10.1002/ece3.4147; Schwarzfeld MD, 2015, MOL PHYLOGENET EVOL, V93, P234, DOI 10.1016/j.ympev.2015.08.003; Shenefelt R.D., 1976, P1263; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stahlhut JK, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-2; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Suchan T, 2017, MOL PHYLOGENET EVOL, V114, P189, DOI 10.1016/j.ympev.2017.06.012; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; TEMPLETON AR, 1992, GENETICS, V132, P619; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tripp EA, 2017, ECOL EVOL, V7, P7920, DOI 10.1002/ece3.3274; Tuda M, 2006, MOL ECOL, V15, P3541, DOI 10.1111/j.1365-294X.2006.03030.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Veijalainen A, 2012, P ROY SOC B-BIOL SCI, V279, P4694, DOI 10.1098/rspb.2012.1664; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yu H, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1239-5; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	102	4	5	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6970	1365-3113		SYST ENTOMOL	Syst. Entomol.	JAN	2020	45	1					33	47		10.1111/syen.12373	http://dx.doi.org/10.1111/syen.12373			15	Evolutionary Biology; Entomology	Science Citation Index Expanded (SCI-EXPANDED)	Evolutionary Biology; Entomology	JZ7BV		Bronze			2022-09-04	WOS:000505262100003
J	Conde-Saldana, CC; Albornoz-Garzon, JG; Garcia-Melo, JE; Dergam, JA; Villa-Navarro, FA				Conde-Saldana, Cristhian C.; Albornoz-Garzon, Juan G.; Garcia-Melo, Jorge E.; Dergam, Jorge A.; Villa-Navarro, Francisco A.			A new species of Pimelodella Eigenmann & Eigenmann, 1888 (Siluriformes: Heptapteridae) from the Sierra Nevada de Santa Marta, Colombia	ZOOTAXA			English	Article						Neotropical freshwater fishes; morphology; trans-Andean region; taxonomy	FRESH-WATER FISHES; ANATOMY	A new species of Pimelodella is described from northern coastal drainages of the Sierra Nevada de Santa Marta (SNSM), Colombia. The new species is diagnosed from all trans-Andean congeners by the following unique combination of characters: head length 22.2-23.7% SL, bony interorbital width 17.6-21.6% HL, maxillary barbels length 53.0-68.3% SL, inner mental-barbels length 14.4-20.0% SL, body width 17.6-21.1% SL, dorsal-fin spine length 8.3-13.7% SL, dorsal-fin base 12.3-14.9% SL, pectoral-fin spine length 12.9-14.5% SL, pectoral-fin spine length without dentations on the distal posterior margin 21.6-29.8% in pectoral-fin spine length, maximum depth of dentations in posterior margin of pectoral-fin spine 1.40-1.68 times in the width of the spine at its base, adipose-fin base length 22.8-26.4% SL, caudal-peduncle depth 9.2-10.5% SL, 40 vertebrae, having a conspicuous paired dark brown stripe on the dorsal surface of body, extending from posterior margin of head to caudal-fin insertion and a wide dark brown midlateral stripe present. The isolated occurrence of this new taxon living in allopatry in coastal drainages of the SNSM could have interesting biogeographic implications for dispersal and vicariance processes of the ichthyofauna from northern South America.	[Conde-Saldana, Cristhian C.] IBB UNESP Julio de Mesquita Filho, Dept Morfol, Lab Biol & Genet Peixes, R Prof Dr Antonio Celso Wagner Zanin 250, BR-18618689 Botucatu, SP, Brazil; [Albornoz-Garzon, Juan G.] Inst Invest Recursos Biol Alexander von Humboldt, Villa De Leyva, Boyaca, Colombia; [Albornoz-Garzon, Juan G.; Garcia-Melo, Jorge E.; Villa-Navarro, Francisco A.] Univ Tolima, Fac Ciencias, Dept Biol, Grp Invest Zool, Ibague, Tolima, Colombia; [Garcia-Melo, Jorge E.] Pontificia Univ Javeriana, Ciencias Biol, Unidad Ecol & Sistemat UNESIS, Lab Ictiol, Bogota, Colombia; [Dergam, Jorge A.] Univ Fed Vicosa, Dept Biol Anim, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil; [Garcia-Melo, Jorge E.] Univ Ibague, Fac Ciencias Nat & Matemat, Carrera 22 Calle 67, Ibague 730001, Colombia		Conde-Saldana, CC (corresponding author), IBB UNESP Julio de Mesquita Filho, Dept Morfol, Lab Biol & Genet Peixes, R Prof Dr Antonio Celso Wagner Zanin 250, BR-18618689 Botucatu, SP, Brazil.	ccconde27@gmail.com	García-Melo, Jorge E/AAU-3289-2020	García-Melo, Jorge E/0000-0003-2885-5652; Conde-Saldana, Cristhian/0000-0002-2821-0275	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES); FAPESP [2018/09767-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We are grateful to Mariangeles Arce and Mark H. Sabaj (ANSP), Carlos DoNascimiento (IAvH-P), Ivan Mojica (ICNMHN), Armando Ortega-Lara (IMCN), Ramiro Barriga-Salazar and Francisco Provenzano (MEPN), Pedro Jimenez (CEMZ-P), Claudio Oliveira (LBP), Hernan Ortega (MUSM), Ana Rosa Ramirez and Myrna Lopez (UCR), for the access and loan of specimens in their respective collections. To Arturo Angulo, Gian Carlo Sanchez-Garces and Vanessa Meza-Vargas which provided assistance to obtain loan specimens for comparative material. To Andrew Williston (MCZ) and James Maclaine (BMHN) for sending photographs and radiographs of type material. To Paula Sanchez-Duarte for the photo of the Rio Canas. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES). The first author was funded by FAPESP (grant #2018/09767-6). This manuscript was enriched and improved by the helpful comments from J. W. Armbruster, V. Slobodian and one anonymous reviewer.	Angulo Arturo, 2013, Check List, V9, P987; Ardila-Rodriguez C., 2017, PIMELODELLA FLORIDAB; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bockmann FA, 1998, THESIS U SAO PAULO S; Bockmann FA, 2008, ZOOTAXA, P1; Cardona A, 2011, TERRA NOVA, V23, P26, DOI 10.1111/j.1365-3121.2010.00979.x; Castano-Uribe C., 1999, SIERRAS SERRANIAS CO; Conde-Saldana C. C., 2016, HIST EVOLUTIVA GENER; Dahl G., 1964, INFORM FAUNA ACUATIC; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; DoNascimiento C, 2017, ZOOKEYS, P25, DOI 10.3897/zookeys.708.13897; Eigenmann CH., 1917, MEMOIRS CARNEGIE MUS, V7, P229; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Fricke R, 2019, CATALOG FISHES; Galvis G, 2006, SERIE GUIAS TROPICAL, V5, P548; Garcfa-Aizate Carlos A., 2015, Cuadernos de Investigación UNED, V7, P89; Gunther A.C.L.G., 1860, P ZOOL SOC LOND, V28, P233; Leiva M., 2005, REVISION TAXONOMICA; Lundberg J.G., 1986, NOTULAE NATURAE, V463, P1; LUNDBERG JG, 1991, COPEIA, P190, DOI 10.2307/1446263; Miles C., 1943, ESTUDIO EC ECOLOGICO; Provenzano F, 2017, ZOOTAXA, V4329, P256, DOI 10.11646/zootaxa.4329.3.4; Regan C. T., 1913, Annals & Magazine of Natural History, V12; Regan C. T., 1903, Annals of Natural History, Vxii, P621; Rodriguez-Olarte D, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P243; Roman-valencia C, 2009, REV INVESTIG, V19, P144; Sabaj, 2019, STANDARD SYMBOLIC CO; Schultz Leonard P., 1944, PROC U S NATION MUS, V94, P173; Slobodian V, 2018, J FISH BIOL, V93, P901, DOI 10.1111/jfb.13795; Slobodian V, 2017, ZOOTAXA, V4338, P85, DOI 10.11646/zootaxa.4338.1.4; Steindachner F., 1902, DENKSCHRIFTEN 315 MN, V72, P89; Steindachner F., 1876, MATH NATURWISSENSCHA, V72, P551; Vanscoy T, 2015, P ACAD NAT SCI PHILA, V164, P177, DOI 10.1635/053.164.0107; Villa-Navarro F. A., 2014, SERIE EDITORIAL RECU, P315	34	2	3	0	0	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	SEP 12	2019	4668	4					562	574		10.11646/zootaxa.4668.4.8	http://dx.doi.org/10.11646/zootaxa.4668.4.8			13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	IW8BL	31716611				2022-09-04	WOS:000485217800008
J	Castrillo, AC; Casas, NY; Arevalo, MA; Azcoitia, I; Barreto, GE; Segura, LMG				Crespo Castrillo, A.; Yanguas Casas, N.; Arevalo, M. A.; Azcoitia, I.; Barreto, G. E.; Garcia Segura, L. M.			The synthetic steroid tibolone decreases reactive gliosis and neuronal death after a stab wound injury in the cerebral cortex of female mice.	GLIA			English	Meeting Abstract	14th European Meeting on Glial Cells in Health and Disease (GLIA)	JUL 10-13, 2019	Porto, PORTUGAL						[Crespo Castrillo, A.; Yanguas Casas, N.; Arevalo, M. A.; Garcia Segura, L. M.] Inst Cajal, Funct & Syst Neurobiol, Madrid, Spain; [Yanguas Casas, N.; Arevalo, M. A.; Azcoitia, I.; Garcia Segura, L. M.] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Azcoitia, I.] Univ Complutense, Dept Cell Biol, Fac Biol, Madrid, Spain; [Barreto, G. E.] Pontificia Univ Javeriana, Nutr & Bioquim, Fac Ciencias, Bogota, Colombia				Barreto, George E./AAD-7420-2020; Azcoitia, Iñigo/A-6208-2011	Barreto, George E./0000-0002-6644-1971; Azcoitia, Iñigo/0000-0002-5791-9144					0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2019	67			S1		T14-007A	E521	E522						2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	JW2DC					2022-09-04	WOS:000502867402271
J	Urbina-Cardona, N; Blair, ME; Londono, MC; Loyola, R; Velasquez-Tibata, J; Morales-Devia, H				Urbina-Cardona, Nicolas; Blair, Mary E.; Londono, Maria C.; Loyola, Rafael; Velasquez-Tibata, Jorge; Morales-Devia, Hernan			Species Distribution Modeling in Latin America: A 25-Year Retrospective Review	TROPICAL CONSERVATION SCIENCE			English	Review						bibliometrics; communities of practice; ecological niche models; niche-based models; social network analysis; statistical modeling	R-PACKAGE; POTENTIAL DISTRIBUTIONS; CONSERVATION; BIODIVERSITY; CLIMATE; PLATFORM; SOFTWARE; PREDICT; CENTRALITY; NICHES	Species distribution modeling (SDM) is a booming area of research that has had an exponential increase in use and development in recent years. We performed a search of scientific literature and found 5,533 documents published from 1993 to 2018 using SDM, representing a global network of 4,329 collaborating institutions from 155 countries, with Brazil and Mexico being in the top 10 of the most prolific countries globally. National Autonomous University of Mexico, Chinese Academy of Sciences, University of Kansas, and U.S. Geological Survey are the most prolific institutions worldwide. Latin American institutions (n = 556) participated in 1,000 (18% of global productivity) documents published in collaboration with 591 institutions outside Latin American countries, from which the National Autonomous University of Mexico, Federal University of Goias, Institute of Ecology A.C., National Scientific and Technical Research Council in Argentina, University of Sic, Paulo, and University of Brasilia were the most productive. From this body of literature, the most frequently modeled taxonomic groups were Chordata and Insecta, and the most common realms of application were conservation planning and management, climate change, species conservation, epidemiology, evolutionary biology, and biological invasions. From the 36 modeling methods identified to generate SDMs, MaxEnt is used in 73.5% of the papers, followed by Genetic Algorithm for Rule-Set Prediction (GARP) with 18.7%, and just 7.4% of the papers compared between 3 and 10 modeling methods. In Latin American countries, productivity in SDM research could be improved as the network of collaborations diversifies and connects with other productive countries (such as United Kingdom, China, Spain, Germany, Australia, and France). The scientific collaboration between Latin American countries should be increased, as the most prolific countries (Brazil, Mexico, Argentina, and Colombia) share less than 10% of its productivity. Some of the main challenges for SDM development in Latin America include bridging the gaps from (a) software use to research productivity and (b) translation to decision-making. To address these challenges, we propose to strengthen communities of practice where modelers, species experts, and decision-makers come together to discuss and develop SDM to shift and enhance current paradigms on how science and decision-making are linked.	[Urbina-Cardona, Nicolas] Pontificia Univ Javeriana, Dept Ecol & Terr, Fac Estudios Ambientales & Rurales, Carrera 7 40-62, Bogota, Colombia; [Blair, Mary E.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Londono, Maria C.] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Loyola, Rafael] Univ Fed Goias, Dept Ecol, Conservat Biogeog Lab, Goiania, Go, Brazil; [Loyola, Rafael] Fundacao Brasileira Desenvolvimento Sustentavel, Rio De Janeiro, Brazil; [Velasquez-Tibata, Jorge] Nature Conservancy, NASCA Conservat Program, Bogota, Colombia; [Morales-Devia, Hernan] Pontificia Univ Javeriana, Biblioteca Gen Alfonso Borrero Cabal, Bogota, Colombia		Urbina-Cardona, N (corresponding author), Pontificia Univ Javeriana, Dept Ecol & Terr, Fac Estudios Ambientales & Rurales, Carrera 7 40-62, Bogota, Colombia.	urbina-j@javeriana.edu.co	Morales-Devia, Hernán/O-8683-2016; Urbina-Cardona, J. Nicolas/B-5447-2008; Loyola, Rafael/A-4425-2008; Londono Murcia, Maria Cecilia/J-1327-2017	Morales-Devia, Hernán/0000-0002-8895-7864; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Loyola, Rafael/0000-0001-5323-2735; Velasquez-Tibata, Jorge/0000-0002-7773-7348; Londono Murcia, Maria Cecilia/0000-0002-2317-5503	CNPq [306694/2018-2]; MCTIC/CNPq/FAPEG [465610/2014-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTIC/CNPq/FAPEG	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We thank John Nope and Sergio Cuellar from Direction of Innovation, Vicerectory of Research, Pontificia Universidad Javeriana. R. L. research is funded by CNPq (grant 306694/2018-2). This article is a contribution of the INCT in Ecology, Evolution and Biodiversity Conservation founded by MCTIC/CNPq/FAPEG (grant 465610/2014-5).	Ahmed SE, 2015, DIVERS DISTRIB, V21, P258, DOI 10.1111/ddi.12305; Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Anderson R., 2016, FINAL REPORT TASK GR; Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; [Anonymous], 2017, BIODIVERS INFORM; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Ball I.R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Barbosa FG, 2012, BRAZ J BIOL, V72, P821, DOI 10.1590/S1519-69842012000500007; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brewer MJ, 2016, METHODS ECOL EVOL, V7, P1489, DOI 10.1111/2041-210X.12609; Brocket C., 1990, LAND POWER POVERTY; Brown JL, 2017, PEERJ, V5, DOI 10.7717/peerj.4095; Busby J. R., 1993, PLANT PROTECTION Q, V6, P8; Canovas F, 2016, ECOGRAPHY, V39, P593, DOI 10.1111/ecog.01426; Carl G, 2017, ECOGRAPHY, V40, P675, DOI 10.1111/ecog.02593; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Conservacion Internacional-Colombia & Secretaria Distrital de Ambiente, 2010, 01141 CONS INT COL S; de Queiroz DL, 2013, AUST J ENTOMOL, V52, P20, DOI 10.1111/aen.12001; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Dedman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188955; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Duan RY, 2015, ECOGRAPHY, V38, P108, DOI 10.1111/ecog.01080; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Escobar LE, 2018, ECOL EVOL, V8, P4757, DOI 10.1002/ece3.4014; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, J STAT SOFTW, V23, P1; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Golding N, 2018, METHODS ECOL EVOL, V9, P260, DOI 10.1111/2041-210X.12858; Guillaumot C., 2017, SDMPLAY SPECIES DIST; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huettmann F, 2015, CENTRAL AM BIODIVERS; Humphries GR, 2018, MACHINE LEARNING ECO, P411; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945; Kearney MR, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.6; KNOCHEL P, 1999, PRACT APPR CHEM SER, P1; Koleff P., 2011, PLANEACION CONSERVAC; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Leroy B, 2016, ECOGRAPHY, V39, P599, DOI 10.1111/ecog.01388; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Londono-Murcia M. C., 2011, RANCHERIA RIVER BASI; Loyola R, 2014, DIVERS DISTRIB, V20, P1365, DOI 10.1111/ddi.12252; Loyola RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046257; Manhaes AP, 2018, BIOL CONSERV, V217, P187, DOI 10.1016/j.biocon.2017.11.009; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Mazzoni S, 2015, ECOL INFORM, V30, P215, DOI 10.1016/j.ecoinf.2015.07.001; Meyer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9221; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Ministerio do Meio Ambiente, 2007, PRIOR AR CONS SUST U; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Navarro LM, 2017, CURR OPIN ENV SUST, V29, P158, DOI 10.1016/j.cosust.2018.02.005; Urbina-Cardona JN, 2010, CONSERV BIOL, V24, P1031, DOI 10.1111/j.1523-1739.2009.01432.x; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Ochoa-Ochoa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006878; Ochoa-Ochoa LM, 2016, ECOL MODEL, V320, P372, DOI 10.1016/j.ecolmodel.2015.10.031; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Porter A.L., 2004, TECH MINING EXPLOITI; Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961; Qiao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043327; RANGEL TFL, 2009, BIOENSEMBLES 1 0 SOF; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Redford KH, 2012, CONSERV BIOL, V26, P757, DOI 10.1111/j.1523-1739.2012.01925.x; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Renjifo L. M., 2016, RED BOOK BIRDS COLOM, VII; Rosales J, 2008, CONSERV BIOL, V22, P1409, DOI 10.1111/j.1523-1739.2008.01091.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sales LP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183785; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Scheldeman X., 2010, TRAINING MANUAL SPAT; Schmitt S, 2017, METHODS ECOL EVOL, V8, P1795, DOI 10.1111/2041-210X.12841; SCImago, 2019, SJR SCIMAGO J COUNTR; Search Technology, 2018, VANT TURN INF KNOWL; Soberon J, 2001, FLA ENTOMOL, V84, P486, DOI 10.2307/3496376; Soberon J, 2017, REV MEX BIODIVERS, V88, P437, DOI 10.1016/j.rmb.2017.03.011; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Title PO, 2018, ECOGRAPHY, V41, P291, DOI 10.1111/ecog.02880; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; U. S. Geological Survery, 2018, MIN COMM SUMM 2018, P116; United Nations Environmental Program/ Convention on Biological Diversity, 2016, LIK MIND MEG DIV COU; van Eck N.J., 2013, VOSVIEWER MANUAL; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Vega GC, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.78; Velasquez-Tibata J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214522; Villarroya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107144; Villero D, 2017, BIODIVERS CONSERV, V26, P251, DOI 10.1007/s10531-016-1243-2; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Zwiener VP, 2017, DIVERS DISTRIB, V23, P955, DOI 10.1111/ddi.12588	108	7	10	4	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1940-0829			TROP CONSERV SCI	Trop. Conserv. Sci.	JUN 4	2019	12									10.1177/1940082919854058	http://dx.doi.org/10.1177/1940082919854058			19	Biodiversity Conservation	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation	IF2MA		gold			2022-09-04	WOS:000472910100001
J	Duran, F; Rocha, C; Salaun, G				Duran, Francisco; Rocha, Camilo; Salaun, Gwen			Stochastic analysis of BPMN with time in rewriting logic	SCIENCE OF COMPUTER PROGRAMMING			English	Article						BPMN business processes; Stochastic modeling and analysis; Rewriting logic; Statistical model checking; Maude	BUSINESS PROCESS MODELS; VERIFICATION; SEMANTICS; FRAMEWORK; CHECKING; PATTERNS; SYSTEMS	A business process is a set of structured activities that provide a certain service or product. Business processes can be modeled using the BPMN standard, and several industrial platforms have been developed for supporting their design, modeling, and simulation. This paper presents a rewriting logic executable specification of BPMN with time and extended with probabilities. Duration times and delays for tasks and flows can be specified as stochastic expressions, while probabilities are associated to various forms of branching behavior in gateways. These quantities enable discrete-event simulation and automatic stochastic verification of properties such as expected processing time, expected synchronization time at merge gateways, and domain-specific quantitative assertions. The mechanization of the stochastic analysis tasks is done with Maude's statistical model checker PVeStA. The approach is illustrated with a running example and further experimental results encompass specifications from the literature. (C) 2018 Elsevier B.V. All rights reserved.	[Duran, Francisco] Univ Malaga, Malaga, Spain; [Rocha, Camilo] Pontificia Univ Javeriana, Cali, Colombia; [Salaun, Gwen] Univ Grenoble Alpes, CNRS, Grenoble INP, Inria,LIG, F-38000 Grenoble, France		Duran, F (corresponding author), Univ Malaga, Malaga, Spain.	duran@lcc.uma.es		Rocha, Camilo/0000-0003-4356-7704; Duran, Francisco/0000-0001-5864-8094	Spanish MINECO/FEDER [TIN2014-52034-12]; CAPES; Colciencias; INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency" [88881.117603/2016-01]; Capital Semilla [020100610]	Spanish MINECO/FEDER; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency"; Capital Semilla	The authors would like to thank the anonymous reviewers for their valuable comments on an earlier draft of this paper. The work of F. Duran has been partially supported by Spanish MINECO/FEDER project TIN2014-52034-12. The work of C. Rocha was partially supported by CAPES, Colciencias, and INRIA via the STIC AmSud project "EPIC: EPistemic Interactive Concurrency" (Proc. No 88881.117603/2016-01), and by Capital Semilla 2017, project "SCORES: Stochastic Concurrency in Rewrite-based Probabilistic Models" (Proj. No. 020100610).	Agha G, 2006, ELECTRON NOTES THEOR, V153, P213, DOI 10.1016/j.entcs.2005.10.040; Agha G, 2018, ACM T MODEL COMPUT S, V28, DOI 10.1145/3158668; AlTurki Musab, 2011, Algebra and Coalgebra in Computer Science. Proceedings 4th International Conference, CALCO 2011, P386, DOI 10.1007/978-3-642-22944-2_28; AlTurki M, 2009, ELECTRON NOTES THEOR, V234, P3, DOI 10.1016/j.entcs.2009.02.069; [Anonymous], 2014, BEHAVIOUR MODELLING; [Anonymous], 2013, 19510 ISOIEC; Arevalo C, 2016, INFORM SOFTWARE TECH, V77, P17, DOI 10.1016/j.infsof.2016.05.004; Baier C, 2003, IEEE T SOFTWARE ENG, V29, P524, DOI 10.1109/TSE.2003.1205180; Braghetto KR, 2011, LECT NOTES COMPUT SC, V6977, P42, DOI 10.1007/978-3-642-24749-1_5; Bruni R, 2006, THEOR COMPUT SCI, V360, P386, DOI 10.1016/j.tcs.2006.04.012; Bruni Roberto, 2011, WEB SERVICES FORMAL, P111; Capel MI, 2012, IEEE ANNU SOFTW ENG, P100, DOI 10.1109/SEW.2012.17; Christiansen DR, 2011, LECT NOTES COMPUT SC, V6551, P146, DOI 10.1007/978-3-642-19589-1_10; Clavel M, 2007, LECT NOTES COMPUT SC, V4624, P173; Corradini F, 2017, IEEE INT CONF AUTOM, P217, DOI 10.1109/ASE.2017.8115635; Dijkman RM, 2008, INFORM SOFTWARE TECH, V50, P1281, DOI 10.1016/j.infsof.2008.02.006; Duran F., 2018, P WRLA; Duran F., 2017, NOTE STOCHASTIC ANAL; Duran F, 2017, LECT NOTES COMPUT SC, V10319, P219, DOI 10.1007/978-3-319-59746-1_12; Eckhardt J, 2012, LECT NOTES COMPUT SC, V7212, P78, DOI 10.1007/978-3-642-28872-2_6; EKER S, 2002, ELECT NOTES THEORETI, V71, P115; Gagne Denis, 2009, 2009 IEEE Conference on Commerce and Enterprise Computing, P361, DOI 10.1109/CEC.2009.71; Gruhn V, 2006, ELECTRON NOTES THEOR, V153, P117, DOI 10.1016/j.entcs.2005.10.035; Hansson H., 1994, Formal Aspects of Computing, V6, P512, DOI 10.1007/BF01211866; Herbert L., 2012, 2012 IEEE 14th International Symposium on High-Assurance Systems Engineering (HASE 2012), P98, DOI 10.1109/HASE.2012.29; Kheldoun A, 2015, LECT NOTES COMPUT SC, V9253, P55, DOI 10.1007/978-3-319-23063-4_4; Konrad S, 2005, PROC INT CONF SOFTW, P372; Krishna A., 2017, P IFM 17; Kwiatkowska Marta, 2011, Computer Aided Verification. Proceedings 23rd International Conference, CAV 2011, P585, DOI 10.1007/978-3-642-22110-1_47; Larsen KG, 2014, LECT NOTES COMPUT SC, V8803, P135, DOI 10.1007/978-3-662-45231-8_10; Lincoln P., 2007, ALL MAUDE A HIGH PER, V4350; Mateescu R., 2014, P CBSE 2014, P159, DOI 10.1145/2602458.2602473; Mendoza LE, 2012, INFORM SOFTWARE TECH, V54, P149, DOI 10.1016/j.infsof.2011.08.004; Meseguer J, 2003, LECT NOTES ARTIF INT, V2741, P2; MESEGUER J, 1992, THEOR COMPUT SCI, V96, P73, DOI 10.1016/0304-3975(92)90182-F; Morales L. E. M, 2010, INT C ENT INF SYST, P388; Oliveira C, 2009, IEEE SYS MAN CYBERN, P2824, DOI 10.1109/ICSMC.2009.5346592; Olveczky P. C., 2007, Higher-Order and Symbolic Computation, V20, P161, DOI 10.1007/s10990-007-9001-5; Poizat P., 2012, P 27 ANN ACM S APPL, P1927, DOI 10.1145/2245276.2232095; Poizat P., 2016, INT WORKSH FORM ASP, P36; Raedts I., 2007, MSVVEIS, V2007, P126; Rocha C, 2017, J LOG ALGEBR METHODS, V86, P269, DOI 10.1016/j.jlamp.2016.10.001; Sen K, 2005, LECT NOTES COMPUT SC, V3576, P266; Sun YT, 2011, LECT NOTES COMPUT SC, V7084, P1, DOI 10.1007/978-3-642-25535-9_1; van der Aalst W., 2016, PROCESS MINING DATA; van der Aalst WMP, 2002, LECT NOTES COMPUT SC, V2480, P45; Walck, 2007, HDB STAT DISTRIBUTIO; Wong PYH, 2008, INT CONF QUAL SOFTW, P126, DOI 10.1109/QSIC.2008.6; Wong PYH, 2009, ELECTRON NOTES THEOR, V229, P59, DOI 10.1016/j.entcs.2009.06.029; Wong PYH, 2008, LECT NOTES COMPUT SC, V5256, P355, DOI 10.1007/978-3-540-88194-0_22; Wynn MT, 2009, BUS PROCESS MANAG J, V15, P74, DOI 10.1108/14637150910931479	51	10	10	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6423	1872-7964		SCI COMPUT PROGRAM	Sci. Comput. Program.	DEC 15	2018	168						1	17		10.1016/j.scico.2018.08.007	http://dx.doi.org/10.1016/j.scico.2018.08.007			17	Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	HA6JG		Green Submitted			2022-09-04	WOS:000450385200001
J	Montes-Correa, AC; Jimenez-Bolano, JD; Medina-Rangel, GF; Rivas, GA; Granda-Rodriguez, HD; Saboya-Acosta, LP; Renjifo, JM				Camilo Montes-Correa, Andres; David Jimenez-Bolano, Juan; Fabian Medina-Rangel, Guido; Rivas, Gilson A.; Granda-Rodriguez, Hernan D.; Saboya-Acosta, Liliana P.; Manuel Renjifo, Juan			Geographic distribution and habitat use of Lepidoblepharis miyatai (Squamata: Sphaerodactylidae), with comments on the taxonomic status of the genus in northern Colombia	PHYLLOMEDUSA			English	Article						conservation; Gekkota; Lepidoblepharis sanctaemartae; Sierra Nevada de Santa Marta; substrate use; Tayrona National Park; tropical dry forest	NATIONAL NATURAL PARK; FOREST; HERPETOFAUNA; DIVERSITY; CONSERVATION; ASSEMBLAGES; MAGDALENA; NEGUANJE; LIZARDS; ECOLOGY	We present some ecological and biogeographic data on Lepidoblephoris miyatai, a small and endangered gecko endemic to the northwestern foothills of the Sierra Nevada de Santa Marta (SNSM), 31 years after its description. Based on museum specimens and field observations, we recorded four new localities with confirmed presence of L. miyatai. We calculated the extent of occurrence and altitudinal distribution of this species reaching 21.3 km(2) and from sea level to 360 m respectively. Lepidoblepharis miyatai inhabits plant formations of scrub thorn and tropical deciduous forest. Based on microhabitat data obtained from 88 individuals observed in "Las Tinajas Village" we can state a differential use of three substrates with predominant use of leaf-litter. We consider L. miyatai an endemic species of the northwestern sector of the SNSM with a distribution range limited to the south-west by the occurrence of L. sanctaemartae, and towards the east by a thus far undetermined Lepidoblepharis species (here called Lepidoblepharis cf. sanctaemartae). We do not register sympatry of L miyatai with any other congener. Accordingly, we consider that the recent records of this species in the southeast sector of SNSM are erroneous, given that the specimens cited as L. miyatai of this zone correspond to Lepidoblepharis cf. sanctaemartae. Finally, a reevaluation of the conservation status of L. miyatai is needed, including precise information of its distribution.	[Camilo Montes-Correa, Andres; David Jimenez-Bolano, Juan; Saboya-Acosta, Liliana P.; Manuel Renjifo, Juan] Univ Magdalena, Grp Invest Manejo & Conservac Fauna Flora & Ecosi, Santa Marta, Colombia; [Fabian Medina-Rangel, Guido] Univ Nacl Colombia, Inst Ciencias Nat, Reptiles Grp Biodiversidad & Couservac, Bogota, Colombia; [Fabian Medina-Rangel, Guido] Univ Nacl Colombia, Grp Biodiversidad & Sistemat Mol, Inst Ciencias Nat, Bogota, Colombia; [Rivas, Gilson A.] Univ Zulia, Museo Biol, Fac Expt Ciencias, Maracaibo, Venezuela; [Granda-Rodriguez, Hernan D.] Univ Chile, Fac Ciencias Forestales & Conservac Nat, Programa Postgrado Areas Silvestros & Conservac N, Santiago, Chile; [Granda-Rodriguez, Hernan D.] Univ Magdalena, Fac Ciencias Basicas, Programa Biol, Santa Marta, Colombia; [Saboya-Acosta, Liliana P.] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Programa Doctorado Estudios Ambientales & Rurales, Bogota, DC, Colombia; [Saboya-Acosta, Liliana P.] Zool Soc London, London, England		Montes-Correa, AC (corresponding author), Univ Magdalena, Grp Invest Manejo & Conservac Fauna Flora & Ecosi, Santa Marta, Colombia.	andresc.montes@gmail.com		Montes-Correa, Andres Camilo/0000-0003-3561-0426	EDGE program of Zoological Society of London (ZSL); Fondation Segre; Universidad del Magdalena, Santa Marta, Colombia	EDGE program of Zoological Society of London (ZSL); Fondation Segre; Universidad del Magdalena, Santa Marta, Colombia	This contribution is a result of the project "The small world of Lepidoblepharis miyatai: taxonomic-ecological relationships as conservation tools", financed by by EDGE program of Zoological Society of London (ZSL) and Fondation Segre, and supported by Universidad del Magdalena, Santa Marta, Colombia. We thanks to Juan Carlos Dib for allowing us to make observations in Kalashe Kalabria Reserve, in Las Tinajas Village; to Luz Adriana Velazco for allowing us to make observations in La Iguana Verde Reserve, in Puerto Mosquito; and Carlos "Cayito" Fernandez for allowing us to make observations in La Escuela de la Naturaleza Reserve. Special thanks go to Adolfo del Portillo, Richard Thomas, Adriana Santodomingo, Alina Gamez, Sintana Rojas, Jefferson Villalva, Harold Cuello, Jose Barros, Alexandra Ramirez, Raiza Castaneda, and Oskarly Perez for their field assistance. To German Blanco and the Histology Class 2013-2 at Magdalena University, with whom ACMC met L. miyatai. ACMC and JDJB are grateful with Miguel Gutierrez and Alex Gonzalez for their help with specimen collections in the eastern sector of the SNSM. Thanks to curators of ICN, MHUA, EBRG, MBLUZ, and CBUMAG for allowing us to review their voucher specimens. We are grateful to Myriam Lugo-Rugeles, Abel Batista, and Konrad Mebert for providing additional information about their research. Finally, thanks to Lorena Benitez, Andrea Cotes, Jorge M. Gonzalez, Claudia Koch, William W. Lamar, Junior Larreal, Franziska Leonhardt, and Jose Angel Rincon for their invaluable comments on the manuscript. The collecting activities were legally permitted under Permiso Marco de Recoleccion de Especimenes Number 0255, Universidad Nacional de Colombia-Ministerio del Medio Ambiente y Desarrollo Sostenible.	RUEDA-SOLANO LUÍS ALBERTO, 2010, Acta biol.Colomb., V15, P195; Andersson L.G, 1918, ARK ZOOL, V16, P1; Angarita-M O., 2015, AMPHIB REPTILE CONSE, V8, P33; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; AYALA S C, 1986, Caldasia, V15, P555; AYALA S C, 1986, Caldasia, V15, P649; Barbour T., 1925, Proceedings of the Biological Society of Washington, V38, P101; Batista A, 2015, ZOOTAXA, V3994, P187, DOI 10.11646/zootaxa.3994.2.2; Blanco-Torres Argelina, 2013, Revista Biodiversidad Neotropical, V3, P113; Boulenger G. A, 1888, ANN MAGAZINE NATURAL, V2, P40, DOI DOI 10.1080/00222938809460873; Calderon-Espinosa M. L., 2015, LIBRO ROJO REPTILES, P58; Carbono-Delahoz E, 2010, CALDASIA, V32, P235; Carvajal-Cogollo J.E., 2012, COLOMBIA DIVERSIDAD, P791; Carvajal-Cogollo JE, 2015, BIODIVERS CONSERV, V24, P1109, DOI 10.1007/s10531-014-0845-9; Carvajal-Cogollo JE, 2008, TROP CONSERV SCI, V1, P397, DOI 10.1177/194008290800100407; Colli GR, 2003, J HERPETOL, V37, P694, DOI 10.1670/180-02A; Crump M. L., 1994, MEASURING MONITORING, P84; Cuadros H., 2014, BOSQUE SECO TROPICAL, P74; Medina-Rangel GF, 2011, REV BIOL TROP, V59, P935; Ferrer C. J., 2007, REV ACAD COLOMB CIEN, VXXXI, P139; Hern?ndez-Camacho J., 1992, DIVERSIDAD BIOL IBER, P153; LAMAR WW, 1985, HERPETOLOGICA, V41, P128; Lisboa Carolina M. C. A., 2012, South American Journal of Herpetology, V7, P181; Calderon-Espinosa ML, 2016, ZOOTAXA, V4067, P215, DOI 10.11646/zootaxa.4067.2.6; Lugo-Rugeles M., 1981, B DEP BIOL U NACL CO, V3, P19; Lynch John D., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P237; Montes-Correa Andres, 2015, Revista Biodiversidad Neotropical, V5, P54; Noble G.K., 1921, AM MUS NOVIT, V4, P1; ARMESTO LUIS ORLANDO, 2017, Pap. Avulsos Zool., V57, P491, DOI 10.11606/0031-1049.2017.57.39; Ortega A., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T44579408A44579411.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T44579408A44579411.EN]; PARKER H. W., 1926, ANN AND MAG NAT HIST, V17, P291; Peracca MG, 1897, B MUSEI ZOOLOGIA ANA, V12, P1; Rangel-CH J. O., 2012, COLOMBIA DIVERSIDAD, P67; Rivas Fuenmayor Gilson, 2002, Herpetozoa, V15, P92; Rivero-Blanco C, 2012, ZOOTAXA, P66; Rueda-Almonacid J.V., 2008, SERIE GUIAS TROPICAL, V7, P193; Ruthven A. G, 1916, OCCASIONAL PAPERS MU, P1; Sanchez-Herrera G., 2006, PLAN MANEJO PARQUE N; Vitt LJ, 2007, J HERPETOL, V41, P654, DOI 10.1670/06-279.1; Vitt LJ, 2005, HERPETOL MONOGR, V19, P137, DOI 10.1655/0733-1347(2005)019[0137:SIABWE]2.0.CO;2; Vitt LJ, 1998, J TROP ECOL, V14, P63, DOI 10.1017/S0266467498000066; Werneck FD, 2009, AUSTRAL ECOL, V34, P97, DOI 10.1111/j.1442-9993.2008.01915.x	42	1	1	0	6	UNIV SAO PAULO, ESALQ	PIRACICABA	AVE PADUA DIAS NO 11, PIRACICABA, SP 13418-900, BRAZIL	1519-1397	2316-9079		PHYLLOMEDUSA	Phyllomedusa	JUN	2018	17	1					61	72		10.11606/issn.2316-9079.v17i1p61-72	http://dx.doi.org/10.11606/issn.2316-9079.v17i1p61-72			12	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	GU7OY		Green Submitted, gold			2022-09-04	WOS:000445515400004
J	Giraldo, NA; Bolanos, NI; Cuellar, A; Guzman, F; Uribe, AM; Bedoya, A; Olaya, N; Cucunuba, ZM; Roa, N; Rosas, F; Velasco, V; Puerta, CJ; Gonzalez, JM				Giraldo, Nicolas A.; Bolanos, Natalia I.; Cuellar, Adriana; Guzman, Fanny; Maria Uribe, Ana; Bedoya, Astrid; Olaya, Natalia; Cucunuba, Zulma M.; Roa, Nubia; Rosas, Fernando; Velasco, Victor; Puerta, Concepcion J.; Gonzalez, John M.			Increased CD4(+)/CD8(+) Double-Positive T Cells in Chronic Chagasic Patients	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CRUZI KMP-11 PROTEIN; PERSISTENT EXPANSIONS; LYMPHOCYTES; DISEASE; EPITOPE; BLOOD; GAMMA; IDENTIFICATION; HETEROGENEITY; ACTIVATION	Background: CD4+/CD8+ double positive (DP) T cells have been described in healthy individuals as well as in patients with autoimmune and chronic infectious diseases. In chronic viral infections, this cell subset has effector memory phenotype and displays antigen specificity. No previous studies of double positive T cells in parasite infections have been carried out. Methodology/Principal Findings: Seventeen chronic chagasic patients (7 asymptomatic and 10 symptomatic) and 24 noninfected donors, including 12 healthy and 12 with non-chagasic cardiomyopathy donors were analyzed. Peripheral blood was stained for CD3, CD4, CD8, HLA-DR and CD38, and lymphocytes for intracellular perforin. Antigen specificity was assessed using HLA*A2 tetramers loaded with T. cruzi K1 or influenza virus epitopes. Surface expression of CD107 and intracellular IFN-gamma production were determined in K1-specific DP T cells from 11 chagasic donors. Heart tissue from a chronic chagasic patient was stained for both CD8 and CD4 by immunochemistry. Chagasic patients showed higher frequencies of DP T cells (2.1%+/- 0.9) compared with healthy (1.1%+/- 0.5) and non-chagasic cardiomyopathy (1.2%+/- 0.4) donors. DP T cells from Chagasic patients also expressed more HLA-DR, CD38 and perforin and had higher frequencies of T. cruzi K1-specific cells. IFN-gamma production in K1-specific cells was higher in asymptomatic patients after polyclonal stimulation, while these cells tended to degranulate more in symptomatic donors. Immunochemistry revealed that double positive T cells infiltrate the cardiac tissue of a chagasic donor. Conclusions: Chagasic patients have higher percentages of circulating double positive T cells expressing activation markers, potential effector molecules and greater class I antigenic specificity against T. cruzi. Although K1 tetramer positive DP T cell produced little IFN-gamma, they displayed degranulation activity that was increased in symptomatic patients. Moreover, K1-specific DP T cells can migrate to the heart tissue.	[Giraldo, Nicolas A.; Bolanos, Natalia I.; Gonzalez, John M.] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Fac Ciencias, Grp Inmunobiol Biol & Celular, Bogota, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, NBC, Valparaiso, Chile; [Maria Uribe, Ana; Roa, Nubia] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Olaya, Natalia] Univ Antioquia, Fac Med, Inst Patol, Medellin, Colombia; [Bedoya, Astrid] Univ Antioquia, Fac Med, Grp Infecc Canc, Medellin, Colombia; [Cucunuba, Zulma M.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Rosas, Fernando; Velasco, Victor] Clin Abood Shaio, Bogota, Colombia; [Puerta, Concepcion J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Parasitol Mol, Bogota, Colombia		Giraldo, NA (corresponding author), Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia.	johgonza@uniandes.edu.co	Cucunuba, Zulma M./L-4076-2016; Puerta, Concepcion J/AAG-4912-2019; Zaky, Mohammad/I-3187-2017; Cucunuba, Zulma M/X-5670-2019; Cuellar, Adriana/AAF-2958-2019; Guzman, Fanny fg/K-5592-2013; Giraldo, Nicolas/U-6521-2017	Cucunuba, Zulma M./0000-0002-8165-3198; Zaky, Mohammad/0000-0003-3547-2588; Cucunuba, Zulma M/0000-0002-8165-3198; Guzman, Fanny fg/0000-0003-1537-0904; Giraldo, Nicolas/0000-0002-7452-1103; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Cuellar, Adriana/0000-0003-0834-8442; Mursalin, Adi/0000-0002-1867-0868; Gonzalez, John M./0000-0001-6925-0620	COLCIENCIAS [1203-333-18692]; Vicerrectoria de Investigaciones, Universidad de los Andes, Colombia	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigaciones, Universidad de los Andes, Colombia	This work was supported partially by grants from COLCIENCIAS research project No. 1203-333-18692 (AC, JMG and CJP) and Vicerrectoria de Investigaciones, Universidad de los Andes, Colombia (JMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Bang K, 2001, BRIT J DERMATOL, V144, P1140, DOI 10.1046/j.1365-2133.2001.04223.x; BERRIH S, 1981, CLIN EXP IMMUNOL, V45, P1; BLUE ML, 1986, J IMMUNOL, V137, P1202; BLUE ML, 1985, J IMMUNOL, V134, P2281; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Cuellar A, 2009, IMMUNOL CELL BIOL, V87, P149, DOI 10.1038/icb.2008.76; DACRUZ DAM, 2003, MICROBES INFECT, V5, P825; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Denkers EY, 1997, J IMMUNOL, V159, P1903; Diez H, 2007, PEPTIDES, V28, P1520, DOI 10.1016/j.peptides.2007.06.017; DUTRA WO, 1994, INT IMMUNOL, V6, P499, DOI 10.1093/intimm/6.4.499; Fiuza JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000512; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; Franchin G, 1997, INFECT IMMUN, V65, P2548, DOI 10.1128/IAI.65.7.2548-2554.1997; Gonzalez JM, 2000, PARASITE IMMUNOL, V22, P501, DOI 10.1046/j.1365-3024.2000.00331.x; Guhl F, 2007, MEM I OSWALDO CRUZ, V102, P29, DOI 10.1590/S0074-02762007005000099; Howe R, 2009, JAIDS-J ACQ IMM DEF, V50, P444, DOI 10.1097/QAI.0b013e31819aa8c4; IWATANI Y, 1993, CLIN EXP IMMUNOL, V93, P430, DOI 10.1111/j.1365-2249.1993.tb08196.x; KRETTLI AU, 1976, J IMMUNOL, V116, P755; Kroll-Palhares K, 2008, MEM I OSWALDO CRUZ, V103, P375, DOI 10.1590/S0074-02762008000400011; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; LEITEDEMORAES MC, 1992, IMMUNOLOGY, V77, P95; Mizuki M, 1998, LEUKEMIA, V12, P499, DOI 10.1038/sj.leu.2400978; da Siveira ABM, 2007, HUM PATHOL, V38, P1256, DOI 10.1016/j.humpath.2007.01.020; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; ORTOLANI C, 1993, BIOCHEM BIOPH RES CO, V191, P601, DOI 10.1006/bbrc.1993.1260; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; REED SG, 1988, J IMMUNOL, V140, P4342; REIS DD, 1993, AM J TROP MED HYG, V48, P637, DOI 10.4269/ajtmh.1993.48.637; SALA P, 1993, BLOOD, V82, P1546; Silverio JC, 2010, INT J EXP PATHOL, V91, P72, DOI 10.1111/j.1365-2613.2009.00670.x; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; TONUTTI E, 1994, CLIN IMMUNOL IMMUNOP, V73, P312, DOI 10.1006/clin.1994.1204; Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x; Vitelli-Avelar DM, 2005, SCAND J IMMUNOL, V62, P297, DOI 10.1111/j.1365-3083.2005.01668.x; Weiss L, 1998, J INFECT DIS, V178, P1158, DOI 10.1086/515674; *WHO, 2002, WHO TECHN REP SER, V905, P82; Xie DX, 2009, CELL IMMUNOL, V259, P157, DOI 10.1016/j.cellimm.2009.06.011; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X	45	32	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2011	5	8							e1294	10.1371/journal.pntd.0001294	http://dx.doi.org/10.1371/journal.pntd.0001294			10	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	814TJ	21886854	gold, Green Published, Green Submitted			2022-09-04	WOS:000294479800042
J	Maria, JUA; Mario, CF; Mauricio, HC; Gisset, GPA; Alirio, HRJ; Guillermo, PP; Alejandro, BC				Angela Maria, Jimenez Urrego; Mario, Calero-Florez; Mauricio, Hernandez-Carrillo; Ana Gisset, Gutierrez-Posso; Jorge Alirio, Holguin Ruiz; Guillermo, Perlaza-Pelaez; Alejandro, Botero-Carvajal			A cross-sectional study of the socio-demographic and epidemiological factors associated with childhood cancer in Cali, Colombia*	HELIYON			English	Article						Child mortality; Neoplasms; Adolescent; Child; Preschooler	HEALTH; UNION; CARE	This study investigates the occurrence of childhood cancer between the years 2015 and 2016 in the city of Cali, Colombia, with respect to: a) sociodemographic characteristics, b) type of cancer, c) epidemiological weeks of cancer and d) comparative survival according to health system affiliation by consolidating the records notified to the municipal health secretariat. Statistically significant differences were found between the groups analysed in relation to the variables related to the type of cancer (p 1/4 0.006). With respect to the proportion of cancer mortality between the years 2015???2016 there was no significant change, even though survival increased in the year 2016. The implications for collective health and public policies in Latin America are discussed.	[Angela Maria, Jimenez Urrego] Univ San Buenaventura Cali, Cali, Colombia; [Mario, Calero-Florez] Fdn Univ San Martin Cali, Cali, Colombia; [Mauricio, Hernandez-Carrillo] Univ Valle, Univ Libre, Fdn Univ San Martin, Escuela Nacl Deporte, Cali, Colombia; [Ana Gisset, Gutierrez-Posso] Pontificia Univ Javeriana Cali, Univ Valle, Cali, Colombia; [Jorge Alirio, Holguin Ruiz] Pontificia Univ Javeriana Cali, Dept Publ Hlth & Epidemiol, Municipal Hlth Secretariat Cali, Cali, Colombia; [Guillermo, Perlaza-Pelaez] Univ Libre, Cali, Colombia; [Alejandro, Botero-Carvajal] Univ Santiago Cali, Cali, Colombia; [Angela Maria, Jimenez Urrego; Mario, Calero-Florez; Mauricio, Hernandez-Carrillo; Ana Gisset, Gutierrez-Posso; Jorge Alirio, Holguin Ruiz; Guillermo, Perlaza-Pelaez; Alejandro, Botero-Carvajal] Cali Colombia Municipal Publ Hlth Secretariat, Publ Hlth & Epidemiol Res Grp GISPE, Cali, Colombia		Mauricio, HC (corresponding author), Cali Colombia Municipal Publ Hlth Secretariat, Publ Hlth & Epidemiol Res Grp GISPE, Cali, Colombia.	mauriciohc@gmail.com		HERNANDEZ CARRILLO, MAURICIO/0000-0001-8816-7726; Calero Florez, Mario Fernando/0000-0003-1090-7872; Jimenez, Angela Maria/0000-0002-0100-6741				Alegria P. Moreno, 2018, INFORME EVENTO CANC; [Anonymous], 2012, RESOLUCION 2590 2012; Beltrami Alina, 2022, Cancer Epidemiol, V76, P102082, DOI 10.1016/j.canep.2021.102082; Boehmer U, 2022, CANCER-AM CANCER SOC, V128, P284, DOI 10.1002/cncr.33915; Committee on Quality of Health Care in America and Institute of Medicine, 2001, CROSSING QUALITY CHA; Nagar SD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00241; Departamento Administrativo de Planeacion, 2017, PRESCRIBING INFORM, P1; E.S.E. Instituto Nacional de Cancerologia, 2017, ANAL SIT CANC COL 20; Bravo LE, 2017, REV COLOMB CANCEROL, V21, P83, DOI 10.1016/j.rccan.2017.05.002; Grivas P, 2021, ANN ONCOL, V32, P787, DOI 10.1016/j.annonc.2021.02.024; Gupta S., 2015, DIS CONTROL PRIORITI, V3; Heintzman J, 2021, J AM BOARD FAM MED, V34, P849, DOI 10.3122/jabfm.2021.04.210060; Howard SC, 2018, LANCET ONCOL, V19, pE252, DOI 10.1016/S1470-2045(18)30123-2; International Agency for Research on Cancer, 2019, SERRATED POLYPOSIS; International Agency for Research on Cancer, 2019, PREAMB PRIM INT; Landes SD, 2022, PREV MED, V156, DOI 10.1016/j.ypmed.2022.106985; Minsalud, 2018, OBS NAC CAN ONC COL; Narvaez C., 2012, EDITORIAL PONTIFICIA, V53, P120; Norris ET, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5195-7; Pardo C.C.R., 2015, INCIDENCIA MORTALIDA; Pineros M, 2011, REV PANAM SALUD PUBL, V30, P15; Santos JV, 2020, INT J PUBLIC HEALTH, V65, P175, DOI 10.1007/s00038-020-01335-0; Sisk B.A., 2021, PATIENT EDUC COUNS; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; The International Agency for Research on Cancer, 2018, CANC TOM; Tovar C. José Rafael, 2016, Rev. Cienc. Salud, V14, P315, DOI 10.12804/revsalud14.03.2016.01; Tovar J., 2016, REV CIEN SALUD, V14; Vera A.M., 2012, BIOMEDICA, V32	28	0	0	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	MAY	2022	8	5							e09410	10.1016/j.heliyon.2022.e09410	http://dx.doi.org/10.1016/j.heliyon.2022.e09410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U1OG	35620634	Green Published, gold			2022-09-04	WOS:000805187600019
J	Ceballos-Garzon, A; Monteoliva, L; Gil, C; Alvarez-Moreno, C; Vega-Vela, NE; Engelthaler, DM; Bowers, J; Le Pape, P; Parra-Giraldo, CM				Ceballos-Garzon, Andres; Monteoliva, Lucia; Gil, Concha; Alvarez-Moreno, Carlos; Vega-Vela, Nelson E.; Engelthaler, David M.; Bowers, Jolene; Le Pape, Patrice; Parra-Giraldo, Claudia M.			Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							SOLVENT ACCESSIBILITY; CELL-WALL; TRANSMEMBRANE TOPOLOGY; SECONDARY STRUCTURE; PROTEIN TOPOLOGY; DRUG-RESISTANCE; NUCLEAR IMPORT; FKS MUTATIONS; PREDICTION; ALBICANS	Background Echinocandin resistance represents a great concern, as these drugs are recommended as first-line therapy for invasive candidiasis. Echinocandin resistance is conferred by mutations in FKS genes. Nevertheless, pathways are crucial for enabling tolerance, evolution, and maintenance of resistance. Therefore, understanding the biological processes and proteins involved in the response to caspofungin may provide clues indicating new therapeutic targets. Objectives We determined the resistance mechanism and assessed the proteome response to caspofungin exposure. We then evaluated the phenotypic impact of calcineurin inhibition by FK506 and cephalosporine A (CsA) on caspofungin-resistant Candida glabrata isolates. Methods Twenty-five genes associated with caspofungin resistance were analysed by NGS, followed by studies of the quantitative proteomic response to caspofungin exposure. Then, susceptibility testing of caspofungin in presence of FK506 and CsA was performed. The effects of calcineurin inhibitor/caspofungin combinations on heat stress (40 degrees C), oxidative stress (0.2 and 0.4 mM menadione) and on biofilm formation (polyurethane catheter) were analysed. Finally, a Galleria mellonella model using blastospores (1 x 10(9) cfu/mL) was developed to evaluate the impact of the combinations on larval survival. Results F659-del was found in the FKS2 gene of resistant strains. Proteomics data showed some up-regulated proteins are involved in cell-wall biosynthesis, response to stress and pathogenesis, some of them being members of calmodulin-calcineurin pathway. Therefore, the impact of calmodulin inhibition was explored. Calmodulin inhibition restored caspofungin susceptibility, decreased capacity to respond to stress conditions, and reduced biofilm formation and in vivo pathogenicity. Conclusions Our findings confirm that calmodulin-calcineurin-Crz1 could provide a relevant target in life-threatening invasive candidiasis.	[Ceballos-Garzon, Andres; Vega-Vela, Nelson E.; Parra-Giraldo, Claudia M.] Pontificia Univ Javeriana, Dept Microbiol, Fac Ciencias, Grp Enfermedades Infecciosas,Unidad Prote & Micos, Bogota, DC, Colombia; [Ceballos-Garzon, Andres; Le Pape, Patrice] Nantes Atlantique Univ, Univ Nantes, Fac Pharm, Dept Parasitol & Med Mycol, Nantes, France; [Monteoliva, Lucia; Gil, Concha] Univ Complutense Madrid, Fac Farm, Dept Microbiol & Parasitol, Madrid, Spain; [Gil, Concha] Univ Complutense Madrid, Unidad Prote, Madrid, Spain; [Alvarez-Moreno, Carlos] Univ Nacl Colombia, Fac Med, Dept Internal Med, Bogota, Colombia; [Alvarez-Moreno, Carlos] Clin Colsanitas, Clin Univ Colombia, Bogota, Colombia; [Engelthaler, David M.; Bowers, Jolene] Translat Genom Res Inst, Flagstaff, AZ USA		Parra-Giraldo, CM (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Fac Ciencias, Grp Enfermedades Infecciosas,Unidad Prote & Micos, Bogota, DC, Colombia.	Claudia.parra@javeriana.edu.co	CEBALLOS, Andres/AAN-8908-2021; Monteoliva, Lucia/G-8720-2015	CEBALLOS, Andres/0000-0003-2129-1399; Monteoliva, Lucia/0000-0003-4949-0664; Ceballos-Garzon, Andres/0000-0002-0743-6857	ECOS Nord [C17S01]; Pontificia Universidad Javeriana in Bogota, Colombia [20291]; MINCIENCIAS [807-2018, 120380763646, 715-2018]	ECOS Nord; Pontificia Universidad Javeriana in Bogota, Colombia; MINCIENCIAS	This study was financially supported by ECOS Nord C17S01, the research vice rectory of the Pontificia Universidad Javeriana in Bogota, Colombia ID20291, and MINCIENCIAS 807-2018, Code 120380763646, contract RC No. 715-2018.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Alonso-Monge Rebeca, 2020, Microorganisms, V8, P1867, DOI 10.3390/microorganisms8121867; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Reales-Calderon JA, 2017, J PROTEOME RES, V16, P87, DOI 10.1021/acs.jproteome.6b00605; Bahn YS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004936; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bashir Q, 2020, BIOMOL NMR ASSIGN, V14, P105, DOI 10.1007/s12104-020-09928-9; Beom JY, 2019, J NAT PROD, V82, P2078, DOI 10.1021/acs.jnatprod.9b00144; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; Bruneau JM, 2003, PROTEOMICS, V3, P325, DOI 10.1002/pmic.200390046; Chen L, 2014, J BIOL CHEM, V289, P32339, DOI 10.1074/jbc.M114.582023; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Clinical and Laboratory Standards Institute, 2008, M7A4 CLSI, V4th; CLSI, 2008, M27S3 CLSI; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cuellar-Cruz M, 2008, EUKARYOT CELL, V7, P814, DOI 10.1128/EC.00011-08; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dobson L, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0061-x; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fonseca E, 2014, BIOFOULING, V30, P447, DOI 10.1080/08927014.2014.886108; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08; Garcia-Rubio R, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.702779; Garzon AC, 2020, J ANTIMICROB CHEMOTH, V75, P1187, DOI 10.1093/jac/dkz565; Gil-Bona A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00064; Gomez-Molero E, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov098; Ha SW, 2014, J BIOL CHEM, V289, P2701, DOI 10.1074/jbc.M113.524926; Healey KR, 2018, J FUNGI, V4, DOI 10.3390/jof4030105; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Hofmann K., 1993, BIOL CHEM H-S, V374; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Juvvadi PR, 2017, VIRULENCE, V8, P186, DOI 10.1080/21505594.2016.1201250; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kandasamy R, 2000, FEMS MICROBIOL LETT, V186, P239, DOI 10.1111/j.1574-6968.2000.tb09111.x; Katiyar SK, 2012, ANTIMICROB AGENTS CH, V56, P6304, DOI 10.1128/AAC.00813-12; Kelly J, 2010, MED MYCOL, V48, P598, DOI 10.3109/13693780903405782; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020039; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Le Pape P, 2003, ACTA PARASITOL, V48, P301; Lee Y, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01627-18; Malik A, 2019, BIOINFORMATION, V15, P277, DOI 10.6026/97320630015277; Mazan M, 2008, ANTON LEEUW INT J G, V94, P335, DOI 10.1007/s10482-008-9228-0; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Monteoliva L, 2011, J PROTEOME RES, V10, P502, DOI 10.1021/pr100710g; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Oñate José M., 2019, Infect., V23, P271, DOI 10.22354/in.v23i3.792; Pais P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02045; Pais P, 2016, MOL CELL PROTEOMICS, V15, P57, DOI 10.1074/mcp.M114.045344; Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194; Park HS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005873; Parollo A., 2004, MAXIMUM FEASIBILITY; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perlin DS, 2015, CLIN INFECT DIS, V61, pS612, DOI 10.1093/cid/civ791; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Rodrigues CF, 2018, BIOFOULING, V34, P569, DOI 10.1080/08927014.2018.1472244; Roman E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133476; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Seneviratne CJ, 2010, PROTEOMICS, V10, P1444, DOI 10.1002/pmic.200900611; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Singh-Babak SD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002718; Tieg B, 2013, BBA-GENE REGUL MECH, V1829, P791, DOI 10.1016/j.bbagrm.2012.10.010; Toda M, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss6808a1; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vargas-Casanova Y, 2020, CHEMISTRYSELECT, V5, P7236, DOI 10.1002/slct.202001329; Vasicova P, 2013, TRAFFIC, V14, P176, DOI 10.1111/tra.12025; Vaz C, 2019, J PROTEOME RES, V18, P2139, DOI 10.1021/acs.jproteome.9b00032; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Walker LA, 2013, ANTIMICROB AGENTS CH, V57, P146, DOI 10.1128/AAC.01486-12; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whaley SG, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0554-5; Yu SJ., 2015, FEMS YEAST RES, V15, P1; Zimbeck AJ, 2010, ANTIMICROB AGENTS CH, V54, P5042, DOI 10.1128/AAC.00836-10; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	88	3	3	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	FEB 23	2022	77	3					585	597		10.1093/jac/dkab454	http://dx.doi.org/10.1093/jac/dkab454		DEC 2021	13	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	ZF7PJ	34893830	Green Published, hybrid			2022-09-04	WOS:000759761100009
J	Ghidinelli, M; Luciani, S; Alonso, M; de Mello, M; Cano, A; Murillo, R; Berenguer, BN				Ghidinelli, Massimo; Luciani, Silvana; Alonso, Monica; de Mello, Maeve; Cano, Arely; Murillo, Raul; Berenguer, Bernardo Nuche			Elimination of cervical cancer as a public health problem	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Meeting Abstract									[Ghidinelli, Massimo; Alonso, Monica; Berenguer, Bernardo Nuche] Pan Amer Hlth Org, HIV STI Viral Hepatitis & TB Unit, Washington, DC USA; [Luciani, Silvana] Pan Amer Hlth Org, Noncommunicable Dis Violence & Injury Prevent Uni, Washington, DC USA; [de Mello, Maeve] World Hlth Org, Global HIV STI Hepatitis Programme, Geneva, Switzerland; [Cano, Arely] Int Community Women Living HIV ICW Latina, Managua, Nicaragua; [Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; [Murillo, Raul] Pontif Univ Javeriana, Fac Med, Bogota, Colombia; [Murillo, Raul] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France				Murillo, Raúl/AAY-4416-2021						0	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	JUN	2021	28	SUPPL 1		1			S212	S212						1	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	SQ0CU					2022-09-04	WOS:000660029800631
J	Meli, P; Schweizer, D; Brancalion, PHS; Murcia, C; Guariguata, MR				Meli, Paula; Schweizer, Daniella; Brancalion, Pedro H. S.; Murcia, Carolina; Guariguata, Manuel R.			Multidimensional training among Latin America's restoration professionals	RESTORATION ECOLOGY			English	Article						capacity building; ecological restoration; education; multiple dimensions of restoration; restoration practice; restoration training; social perceptions	ECOLOGICAL RESTORATION; APPLIED NUCLEATION; UNITED-STATES; FOREST; STRAIGHTFORWARD; OPPORTUNITIES; CAPACITY; SCIENCE	The ambitious restoration commitments made by Latin American countries have increased the demand for professionals having multidimensional training in ecological restoration; however, little is known about the kind of training that professionals are currently receiving. Through an online survey, we explored whether restoration professionals in Latin America have been trained on the ecological, socioeconomic, and management dimensions of ecological restoration, and their perceptions of training constraints and curricula needs. Half of the 411 respondents simultaneously work in academia, governments, and nongovernmental organizations, lessening the typical division between the science and practice of restoration, and suggesting the need for stronger multidimensional training to adequately respond to different needs and expectations. Over 80% received formal academic training in fields relevant for restoration and most respondents also reported attending interdisciplinary courses. Training was more focused on the ecological dimension of restoration compared to socioeconomic or management dimensions. Respondents have similar education levels (i.e. most respondents have postgraduate degrees), independently from the organization type in which respondents work, and multidimensionality among organization types was slight. Professionals expressed a need for training opportunities not demanding full-time dedication. Although increasing training opportunities in socioeconomic and management dimensions is needed, we highlight opportunities to reinforce multidimensional training on restoration through organizational and institutional training, and collaborations among organizations.	[Meli, Paula; Schweizer, Daniella; Brancalion, Pedro H. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Forest Sci, BR-13418900 Piracicaba, Brazil; [Meli, Paula] Fdn Int Restaurac Ecosistemas, Madrid 28008, Spain; [Schweizer, Daniella] ETH, Inst Terr Ecosyst, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland; [Murcia, Carolina] Pontificia Univ Javeriana, Dept Nat Sci & Math, Cali 760031, Colombia; [Murcia, Carolina] Univ Florida, Dept Biol, 220 Bartram Hall, Gainesville, FL 32611 USA; [Guariguata, Manuel R.] Ctr Int Forestry Res, Lima 15024, Peru		Meli, P (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Forest Sci, BR-13418900 Piracicaba, Brazil.; Meli, P (corresponding author), Fdn Int Restaurac Ecosistemas, Madrid 28008, Spain.	pmeli@usp.br	, 0000-0001-5390-7552/G-1872-2018; Schweizer, Daniella/G-6991-2012; Brancalion, Pedro/D-6995-2012	, 0000-0001-5390-7552/0000-0001-5390-7552; Brancalion, Pedro/0000-0001-8245-4062	CGIAR Program on Forests, Trees and Agroforestry; United States Agency for International Development (USAID); Department for International Development of the United Kingdom (DFID) through the KNOWFOR Project; FAPESP [2016/00052-9]; National Council for Scientific and Technological Development of Brazil (CNPq) [304817/2015-5]	CGIAR Program on Forests, Trees and Agroforestry(CGIAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Department for International Development of the United Kingdom (DFID) through the KNOWFOR Project; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the CGIAR Program on Forests, Trees and Agroforestry, the United States Agency for International Development (USAID), and the Department for International Development of the United Kingdom (DFID) through the KNOWFOR Project. P.M. acknowledges FAPESP for a postdoctoral grant (2016/00052-9). P.H.S.B. thanks the National Council for Scientific and Technological Development of Brazil (CNPq no. 304817/2015-5). C. Nelson helped us to improve previous versions of this article. We would like to give special thanks to everyone who contributed by answering the questionnaire, and also to all the people that helped to spread it across the region.	[Anonymous], [No title captured]; Armesto JJ, 2008, FRONTIERS ECOLOGY EN, V5, pW1; Aronson J, 2017, ANN MO BOT GARD, V102, P188, DOI 10.3417/2017003; Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Bakker JD, 2011, RESTOR ECOL, V19, P572, DOI 10.1111/j.1526-100X.2011.00799.x; Bloomfield G, 2018, J SUSTAIN FOREST, V37, P157, DOI 10.1080/10549811.2017.1359097; Bonn Challenge, 2018, FOR LANDSC REST; Brancalion PHS, 2016, NAT CONSERVACAO, V14, P1, DOI 10.1016/j.ncon.2016.03.003; Cabin RJ, 2009, RESTORATION ECOLOGY, V18, P783; Calmon M, 2011, RESTOR ECOL, V19, P154, DOI 10.1111/j.1526-100X.2011.00772.x; CBD, 2010, AICH BIOD TARG; Ceccon E, 2017, RESTORATION ECOLOGY, P384; Cirani Claudia Brito Silva, 2015, Avaliação (Campinas), V20, P163, DOI 10.590/S1414-40772015000500011; Djenontin INS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10040906; Gordon J., 2007, 44 AUSTR CTR INT AGR, V44; Guariguata MR, 2010, INT FOREST REV, V12, P418, DOI 10.1505/ifor.12.4.418; Higgs E, 2014, FRONT ECOL ENVIRON, V12, P499, DOI 10.1890/110267; HOBBS RJ, 2007, FDN RESTORATION ECOL; Holl KD, 2018, RESTOR ECOL, V26, P618, DOI 10.1111/rec.12701; Holl KD, 2017, SCIENCE, V355, P455, DOI 10.1126/science.aam5432; IUCN WRI, 2014, GUID REST OPP ASS ME; Kainer KA, 2006, CONSERV BIOL, V20, P3, DOI 10.1111/j.1523-1739.2006.00356.x; Keenleyside KA., 2012, ECOLOGICAL RESTORATI; Lazos-Chavero E, 2016, BIOTROPICA, V48, P900, DOI 10.1111/btp.12391; Lopez-Barrera F, 2017, REV MEX BIODIVERS, V88, P97, DOI 10.1016/j.rmb.2017.10.001; Mcdonald T, 2016, INT STANDARDS PRACTI, VFirst; Meli P, 2017, RESTOR ECOL, V25, P156, DOI 10.1111/rec.12473; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mendez-Toribio M., 2017, REV CIENCIAS AMBIENT, V51, P1, DOI DOI 10.15359/RCA.51-2.1; Murcia C, 2017, DOCUMENTOS OCASIONAL, V170; Murcia C, 2016, CONSERV LETT, V9, P213, DOI 10.1111/conl.12199; Naveh Z, 2005, RESTOR ECOL, V13, P228, DOI 10.1111/j.1526-100X.2005.00028.x; Nelleman C, 2010, DEAD PLANET LIVING P; Nelson CR, 2008, RESTOR ECOL, V16, P225, DOI 10.1111/j.1526-100X.2007.00352.x; Nelson CR, 2017, RESTOR ECOL, V25, P4, DOI 10.1111/rec.12484; Ramirez-Soto A, 2018, RESTOR ECOL, V26, P620, DOI 10.1111/rec.12823; Ramirez-Soto A, 2018, RESTOR ECOL, V26, P206, DOI 10.1111/rec.12660; Rao M, 2014, ENVIRON MANAGE, V53, P715, DOI 10.1007/s00267-014-0235-9; Sanchez-Cuervo AM, 2013, ECOSYSTEMS, V16, P1052, DOI 10.1007/s10021-013-9667-y; Sansevero JBB, 2017, RESTORATION ECOLOGY, V26, P997; Schweizer D, 2018, DOCUMENTOS OCASIONAL, V182; Shackelford N, 2013, RESTOR ECOL, V21, P297, DOI 10.1111/rec.12012; Slusser J.L., 2015, EFFECTIVE FOREST FAR, V57, P31; UNACAR (Universidad Autonoma del Carmen), 2018, MAESTR CIENC REST EC; UNAL (Universidad Nacional Autonoma de Nuevo Leon), 2018, MAESTR REST EC; UNEP, 2016, GEO 6 REG ASS LAT AM; Viani RAG, 2017, TROP CONSERV SCI, V10, DOI 10.1177/1940082917697265	48	13	13	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1061-2971	1526-100X		RESTOR ECOL	Restor. Ecol.	MAY	2019	27	3					477	484		10.1111/rec.12933	http://dx.doi.org/10.1111/rec.12933			8	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	HY7QY					2022-09-04	WOS:000468332300003
J	Perez-Urrutia, N; Mendoza, C; Alvarez-Ricartes, N; Oliveros-Matus, P; Echeverria, F; Grizzell, JA; Barreto, GE; Iarkov, A; Echeverria, V				Perez-Urrutia, Nelson; Mendoza, Cristhian; Alvarez-Ricartes, Nathalie; Oliveros-Matus, Patricia; Echeverria, Florencia; Alex Grizzell, J.; Barreto, George E.; Iarkov, Alexandre; Echeverria, Valentina			Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP plus cells loss induced by restraint stress in mice	EXPERIMENTAL NEUROLOGY			English	Article						Astrocytes; Stress; Cotinine; Depression; Memory	FIBRILLARY ACIDIC PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; COMBAT-RELATED PTSD; ALZHEIMERS-DISEASE; MOUSE MODEL; FLUOXETINE TREATMENT; HUNTINGTONS-DISEASE	Posttraumatic stress disorder (PTSD), chronic psychological stress, and major depressive disorder have been found to be associated with a significant decrease in glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus of rodents. Cotinine is an alkaloid that prevents memory impairment, depressive-like behavior and synaptic loss when co-administered during restraint stress, a model of PTSD and stress-induced depression, in mice. Here, we investigated the effects of post-treatment with intranasal cotinine on depressive- and anxiety like behaviors, visual recognition memory as well as the number and morphology of GFAP+ immunoreactive cells, in the hippocampus and frontal cortex of mice subjected to prolonged restraint stress. The results revealed that in addition to the mood and cognitive impairments, restraint stress induced a significant decrease in the number and arborization of GFAP+ cells in the brain of mice. Intranasal cotinine prevented these stress-derived symptoms and the morphological abnormalities GFAP+ cells in both of these brain regions which are critical to resilience to stress. The significance of these findings for the therapy of PTSD and depression is discussed. (C) 2017 Elsevier Inc. All rights reserved.	[Perez-Urrutia, Nelson; Mendoza, Cristhian; Alvarez-Ricartes, Nathalie; Oliveros-Matus, Patricia; Echeverria, Florencia; Iarkov, Alexandre; Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Alex Grizzell, J.] Univ Tennessee, NeuroNET Res Ctr, Dept Psychol, Knoxville, TN 37996 USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.; Echeverria, Valentina] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA		Iarkov, A; Echeverria, V (corresponding author), Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile.; Echeverria, V (corresponding author), 10,000 Bay Pines Blvd, Bay Pines, FL 33744 USA.	Alexandre.larkov@uss.cl; valentina.echeverria@uss.cl	Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Grizzell, J. Alex/AAF-3845-2019	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Mendoza, Cristhian/0000-0002-5038-0991; Perez Urrutia, Nelson/0000-0001-9009-671X	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile [1150149]	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile	This material is the result of work supported with resources and the use of facilities at the Bay Pines VA Healthcare System. The contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. Also, we thank Dr. William Fray and Dr. Leha Hanson from the Alzheimer's Research Center at Regions Hospital, HealthPartners Research Foundation for providing training and guidance with the implementation of intranasal delivery of drugs to mice. We would also like to thank Drs. Lowell Gaertner and Matthew Cooper from the University of Tennessee for advice on statistical analyses. Funding: This work was supported by the Fondo de Ciencia y Tecnologia (FONDECYT) de Chile, grant 1150149.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Babb T L, 1996, Epilepsy Res Suppl, V12, P343; Balsera B, 2014, EUR J MED CHEM, V86, P724, DOI 10.1016/j.ejmech.2014.09.039; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Bencherif M, 2014, CNS NEUROL DISORD-DR, V13, P836, DOI 10.2174/1871527313666140711094525; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Cobb JA, 2016, NEUROSCIENCE, V316, P209, DOI 10.1016/j.neuroscience.2015.12.044; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Colvonen PJ, 2017, NEUROSCI BIOBEHAV R, V75, P140, DOI 10.1016/j.neubiorev.2017.01.027; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; d'Incamps BL, 2014, J PHYSIOL-LONDON, V592, P4131, DOI 10.1113/jphysiol.2014.273128; Day JR, 1998, J APPL PHYSIOL, V85, P716, DOI 10.1152/jappl.1998.85.2.716; de Aguiar RB, 2013, NEUROPHARMACOLOGY, V71, P292, DOI 10.1016/j.neuropharm.2013.03.032; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Diniz DG, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0111-2; Echeverria V, 2017, CURR MED CHEM, V24, P411, DOI 10.2174/0929867323666161101140908; Echeverria V, 2016, PROG NEUROBIOL, V144, P142, DOI 10.1016/j.pneurobio.2016.01.002; Echeverria V, 2016, CURR PHARM DESIGN, V22, P1324, DOI 10.2174/138161282210160304112511; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Feng DY, 2015, EUR NEUROPSYCHOPHARM, V25, P1287, DOI 10.1016/j.euroneuro.2015.04.020; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Forster D, 2016, NEUROCHEM INT, V94, P57, DOI 10.1016/j.neuint.2016.02.006; Franklin K., 2008, MOUSE BRAIN STEREOTA, V3rd Edn; Fuchs E, 2006, FRONT BIOSCI-LANDMRK, V11, P2746, DOI 10.2741/2004; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gao J, 2014, BIOORG MED CHEM LETT, V24, P1472, DOI 10.1016/j.bmcl.2014.02.008; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Grizzell JA, 2017, PROG NEURO-PSYCHOPH, V78, P75, DOI 10.1016/j.pnpbp.2017.05.010; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Grizzell JA, 2014, NEUROCHEM RES; Guo-Ross SX, 1999, J NEUROCHEM, V73, P1609, DOI 10.1046/j.1471-4159.1999.0731609.x; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Heinrichs SC, 2013, NEUROSCI LETT, V552, P108, DOI 10.1016/j.neulet.2013.07.035; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Iarkov A, 2016, CANCER CHEMOTH PHARM, V78, P1033, DOI 10.1007/s00280-016-3161-0; Imbe H, 2012, NEUROSCIENCE, V223, P209, DOI 10.1016/j.neuroscience.2012.08.007; Jak A.J, 2016, CURR TOP BEHAV NEURO; Javidi H, 2012, INT J OCCUP ENV MED, V3, P2; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Karperien AL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00051; Kim J, 2015, J NEUROCHEM, V134, P927, DOI 10.1111/jnc.13178; KRETZSCHMAR HA, 1985, J NEUROPATH EXP NEUR, V44, P459, DOI 10.1097/00005072-198509000-00002; Laughame J., 2016, J NEUROPSYCHIATR CLI; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lee JD, 2017, BR J PHARM; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; McHugh T, 2012, CLIN PSYCHOL REV, V32, P93, DOI 10.1016/j.cpr.2011.07.013; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Moller HJ, 2015, WORLD J BIOL PSYCHIA, V16, P483, DOI 10.3109/15622975.2014.989261; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naitoh H, 1992, Yakubutsu Seishin Kodo, V12, P105; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; North CS, 2016, ANN CLIN PSYCHIATRY, V28, P197; Orlovsky MA, 2014, BRAIN RES, V1593, P83, DOI 10.1016/j.brainres.2014.09.059; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Patel S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00162; Perrine SA, 2016, BEHAV BRAIN RES, V303, P228, DOI 10.1016/j.bbr.2016.01.056; Pichon Y, 2004, EUR BIOPHYS J BIOPHY, V33, P211, DOI 10.1007/s00249-003-0373-0; Radford RA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00414; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Rotaru TS, 2016, INT J CLIN EXP HYP, V64, P116, DOI 10.1080/00207144.2015.1099406; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Schaaf KPW, 2013, RESUSCITATION, V84, P873, DOI 10.1016/j.resuscitation.2012.11.021; Schaffner AE, 2001, METHODS, V24, P323, DOI 10.1006/meth.2001.1202; Sheynin J, 2016, NEUROSCI LETT; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Szczepanik J, 2016, PSYCHIAT RES-NEUROIM, V254, P67, DOI 10.1016/j.pscychresns.2016.06.005; Terry AV, 2015, J PHARMACOL EXP THER, V352, P405, DOI 10.1124/jpet.114.219881; Trevizol Alisson Paulino, 2016, Trends Psychiatry Psychother., V38, P50, DOI 10.1590/2237-6089-2015-0072; Ugbode C, 2017, BIOCHEM J, V474, P333, DOI 10.1042/BCJ20160505; Verkhratsky A, 2013, FUTUR NEUROL, V8, P149, DOI 10.2217/fnl.12.90; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang L, 2015, PSYCHOPHARMACOLOGY, V232, P4303, DOI 10.1007/s00213-015-4058-z; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; Wildeboer-Andrud KM, 2014, PHARMACOL BIOCHEM BE, V117, P144, DOI 10.1016/j.pbb.2013.12.005; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Xia L, 2013, BEHAV BRAIN RES, V256, P472, DOI 10.1016/j.bbr.2013.08.048; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang SS, 2015, PROG NEURO-PSYCHOPH, V61, P30, DOI 10.1016/j.pnpbp.2015.03.007; Yoon S, 2017, NEUROPSYCHOPHARMACOL, V42, P454, DOI 10.1038/npp.2016.136; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; Zhu X., 2016, DEPRESS ANXIETY	102	19	19	0	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						211	221		10.1016/j.expneurol.2017.06.016	http://dx.doi.org/10.1016/j.expneurol.2017.06.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	28625590				2022-09-04	WOS:000406820900021
J	Serrano-Gomez, SJ; Sanabria-Salas, MAC; Garay, J; Baddoo, MC; Hernandez-Suarez, G; Mejia, JC; Garcia, O; Miele, L; Fejerman, L; Zabaleta, J				Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Garay, Jone; Baddoo, Melody C.; Hernandez-Suarez, Gustavo; Carlos Mejia, Juan; Garcia, Oscar; Miele, Lucio; Fejerman, Laura; Zabaleta, Jovanny			Ancestry as a potential modifier of gene expression in breast tumors from Colombian women	PLOS ONE			English	Article							CANCER INTRINSIC SUBTYPES; GRB7; HER2; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; CLASSIFICATION; IDENTIFICATION; POLYMORPHISMS; ASSOCIATION; MANAGEMENT	Background Hispanic/Latino populations are a genetically admixed and heterogeneous group, with variable fractions of European, Indigenous American and African ancestries. The molecular profile of breast cancer has been widely described in non-Hispanic Whites but equivalent knowledge is lacking in Hispanic/Latinas. We have previously reported that the most prevalent breast cancer intrinsic subtype in Colombian women was Luminal B as defined by St. Gallen 2013 criteria. In this study we explored ancestry-associated differences in molecular profiles of Luminal B tumors among these highly admixed women. Methods We performed whole-transcriptome RNA-seq analysis in 42 Luminal tumors (21 Luminal A and 21 Luminal B) from Colombian women. Genetic ancestry was estimated from a panel of 80 ancestry-informative markers (AIM). We categorized patients according to Luminal subtype and to the proportion of European and Indigenous American ancestry and performed differential expression analysis comparing Luminal B against Luminal A tumors according to the assigned ancestry groups. Results We found 5 genes potentially modulated by genetic ancestry: ERBB2 (log2FC = 2.367, padj<0.01), GRB7 (log2FC = 2.327, padj<0.01), GSDMB (log2FC = 1.723, padj<0.01, MIEN1 (log2FC = 2.195, padj<0.01 and ONECUT2 (log2FC = 2.204, padj<0.01). In the replication set we found a statistical significant association between ERBB2 expression with Indigenous American ancestry (p = 0.02, B = 3.11). This association was not biased by the distribution of HER2+ tumors among the groups analyzed. Conclusions Our results suggest that genetic ancestry in Hispanic/Latina women might modify ERBB2 gene expression in Luminal tumors. Further analyses are needed to confirm these findings and explore their prognostic value.	[Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Hernandez-Suarez, Gustavo] Inst Nacl Cancerol, Grp Invest Biol Canc, Bogota, Colombia; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Programa Doctorado Ciencias Biol, Bogota, Colombia; [Garay, Jone; Zabaleta, Jovanny] LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Baddoo, Melody C.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Carlos Mejia, Juan] Inst Nacl Cancerol, Grp Patol, Bogota, Colombia; [Garcia, Oscar] Inst Nacl Cancerol, Grp Seno & Tejidos Blandos, Bogota, Colombia; [Miele, Lucio] LSUHSC, Dept Genet, New Orleans, LA USA; [Fejerman, Laura] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA; [Zabaleta, Jovanny] LSUHSC, Dept Pediat, New Orleans, LA 70112 USA		Zabaleta, J (corresponding author), LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.; Zabaleta, J (corresponding author), LSUHSC, Dept Pediat, New Orleans, LA 70112 USA.	jzabal@lsuhsc.edu		Fejerman, Laura/0000-0003-3179-1151; Miele, Lucio/0000-0002-5853-7287	National Institute of General Medical Sciences (NIGMS) [P20GM103501, P30GM114732, U54GM104940-01]; National Institute on Minority Health and Health Disparities (NIMHD) [P20MD004817, U54MD008176-01]; NATIONAL CANCER INSTITUTE [P20CA202922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114732] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Colombian National Cancer Institute (C41030610-110 to MCSS). National Cancer Institute (CA 160607 to L.F.). J.Z. has been partially supported by grants from the National Institute of General Medical Sciences (NIGMS, P20GM103501 subproject # 2, P30GM114732, U54GM104940-01) and the National Institute on Minority Health and Health Disparities (NIMHD, P20MD004817, U54MD008176-01).	Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Aronesty E., 2011, EA UTILS COMMAND LIN; Artigalas O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0373-9; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Carey LA, 2006, J AM MED ASS, V295; Chavez-MacGregor M, 2014, CANCER EPIDEM BIOMAR, V23, P316, DOI 10.1158/1055-9965.EPI-13-0929; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; D'Arcy M, 2015, BREAST CANCER RES TR, V152, P437, DOI 10.1007/s10549-015-3474-4; de Ronde JJ, 2010, BREAST CANCER RES TR, V119, P119, DOI 10.1007/s10549-009-0499-6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2013, CANCER RES, V73, P7243, DOI 10.1158/0008-5472.CAN-13-2014; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grunda Jessica M, 2012, BMC Res Notes, V5, P248, DOI 10.1186/1756-0500-5-248; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang X, 2015, CANC MED; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Kpetemey M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0428-8; Kristensen VN, 2005, J STEROID BIOCHEM, V95, P105, DOI 10.1016/j.jsbmb.2005.04.028; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li ZH, 2016, ONCOTARGET, V7, P65024, DOI 10.18632/oncotarget.11344; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Long JR, 2006, CANCER EPIDEM BIOMAR, V15, P2115, DOI 10.1158/1055-9965.EPI-06-0464; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lusa L, 2007, JNCI-J NATL CANCER I, V99, P1715, DOI 10.1093/jnci/djm216; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Pritchard JK, 2000, GENETICS, V155, P945; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Romero A, 2011, AM J PATHOL, V178, P1453, DOI 10.1016/j.ajpath.2010.12.042; Rugo HS, 2008, ANN ONCOL, V19, P16, DOI 10.1093/annonc/mdm282; Serrano-Gomez SJ, 2016, CARCINOGENESIS; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sparano JA, 2009, CLIN CANCER RES, V15, P7693, DOI 10.1158/1078-0432.CCR-09-1450; Staaf J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju386; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stern Mariana C, 2016, Curr Epidemiol Rep, V3, P181, DOI 10.1007/s40471-016-0083-7; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Tao YM, 2014, P NATL ACAD SCI USA, V111, pE4429, DOI 10.1073/pnas.1407139111; Tishchenko I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158259; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1844; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972	66	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183179	10.1371/journal.pone.0183179	http://dx.doi.org/10.1371/journal.pone.0183179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832682	Green Submitted, Green Published, gold			2022-09-04	WOS:000408355800050
J	Toro-Urrego, N; Garcia-Segura, LM; Echeverria, V; Barreto, GE				Toro-Urrego, Nicolas; Garcia-Segura, Luis M.; Echeverria, Valentina; Barreto, George E.			Testosterone Protects Mitochondria! Function and Regulates Neuroglobin Expression in Astrocytic Cells Exposed to Glucose Deprivation	FRONTIERS IN AGING NEUROSCIENCE			English	Article						testosterone; mitochondria; brain; glucose deprivation; neuroglobin; neuroprotection	OXIDATIVE STRESS; MALE RATS; EXPERIMENTAL STROKE; BRAIN-TISSUE; PC12 CELLS; MALE-MICE; IN-VIVO; INJURY; NEURONS; NEUROPROTECTION	Testosterone is a hormone that has been shown to confer neuroprotection from different insults affecting the central nervous system (CNS). Testosterone induces this protection by different mechanisms that include the activation of anti-apoptotic pathways that are directly implicated in neuronal survival. However, little attention has been devoted to its actions on glial cells. In the present study, we have assessed whether testosterone exerts protection in a human astrocyte cell model, the T98G cells. Our results indicate that testosterone improves cell survival and mitochondria' membrane potential and reduces nuclear fragmentation and reactive oxygen species (ROS) generation. These effects were accompanied by a positive regulation of neuroglobin, an oxygen-binding and sensor protein, which may serve as a regulator of ROS and nitrogen reactive species (NOS), and these protective effects of testosterone may be at least in part mediated by estradiol and DHT. In conclusion, these findings suggest that astroglia may mediate some of the protective actions of testosterone in the brain upon pathological conditions.	[Toro-Urrego, Nicolas; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Garcia-Segura, Luis M.] CSIC, Inst Cajal, Madrid, Spain; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barreto, George E.] Univ Cient Sur, Lima, Peru		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Madrid, Spain.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.; Barreto, GE (corresponding author), Univ Cient Sur, Lima, Peru.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./B-5747-2014	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971	Ministerio de Economia y Competividad, Spain [PUJ IDs 5608, 5544, BFU2014-51836-C2-1-R]	Ministerio de Economia y Competividad, Spain	This work was supported in part by grants PUJ IDs 5608 and 5544 to GB, and grant number: BFU2014-51836-C2-1-R from Ministerio de Economia y Competividad, Spain, to LG.	Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Bialek M, 2004, POL J PHARMACOL, V56, P509; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carrier N, 2015, BIOL PSYCHIAT, V78, P259, DOI 10.1016/j.biopsych.2014.12.024; Cheng J, 2009, J CEREBR BLOOD F MET, V29, P486, DOI 10.1038/jcbfm.2008.138; Cherrier M M, 2005, J Endocrinol Invest, V28, P65; Chisu V, 2006, ARCH ITAL BIOL, V144, P63; Christiansen K, 2001, J ENDOCRINOL, V170, P39, DOI 10.1677/joe.0.1700039; de Joannon AC, 2000, NEUROSCI LETT, V285, P218, DOI 10.1016/S0304-3940(00)01051-X; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Fanaei H, 2014, BRAIN RES, V1558, P74, DOI 10.1016/j.brainres.2014.02.028; Gasque P, 1996, J IMMUNOL, V156, P2247; Gold SM, 2006, CURR OPIN INVEST DR, V7, P625; Gurer B, 2015, INJURY, V46, P240, DOI 10.1016/j.injury.2014.11.002; Hartig Sean M, 2013, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1415s102; Hatanaka Y, 2015, BRAIN RES, V1621, P121, DOI 10.1016/j.brainres.2014.12.011; Hioki T, 2014, J MOL NEUROSCI, V52, P531, DOI 10.1007/s12031-013-0108-3; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Khasnavis S, 2013, J BIOL CHEM, V288, P20843, DOI 10.1074/jbc.M112.443556; Korenic A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090697; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WD, 2014, CELL MOL NEUROBIOL, V34, P247, DOI 10.1007/s10571-013-0008-7; Li Zhan-Kui, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P441; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Meydan S, 2010, J CHEM NEUROANAT, V40, P281, DOI 10.1016/j.jchemneu.2010.07.006; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Orlando R, 2007, BRAIN RES, V1165, P21, DOI 10.1016/j.brainres.2007.06.047; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Romero J, 2014, NEUROSCI LETT, V565, P42, DOI 10.1016/j.neulet.2013.10.046; Rosario ER, 2011, NEUROBIOL AGING, V32, P604, DOI 10.1016/j.neurobiolaging.2009.04.008; Son SW, 2016, J NEUROCHEM, V136, P106, DOI 10.1111/jnc.13371; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Szymanski M, 2010, NEUROBIOL AGING, V31, P1835, DOI 10.1016/j.neurobiolaging.2008.10.003; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Tunez I, 2007, LIFE SCI, V80, P1221, DOI 10.1016/j.lfs.2006.12.013; Uchida M, 2009, J CEREBR BLOOD F MET, V29, P1454, DOI 10.1038/jcbfm.2009.60; Vasconsuelo A, 2011, STEROIDS, V76, P1223, DOI 10.1016/j.steroids.2011.08.001; Xiao FY, 2015, LIFE SCI, V133, P45, DOI 10.1016/j.lfs.2015.05.009; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Zhang GL, 2013, BEHAV BRAIN RES, V252, P388, DOI 10.1016/j.bbr.2013.05.063	54	46	46	1	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUN 27	2016	8								152	10.3389/fnagi.2016.00152	http://dx.doi.org/10.3389/fnagi.2016.00152			9	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	DP5KL	27445795	Green Published, gold			2022-09-04	WOS:000378535000001
J	Jurado-Coronel, JC; Avila-Rodriguez, M; Capani, F; Gonzalez, J; Moran, VE; Barreto, GE				Camilo Jurado-Coronel, Juan; Avila-Rodriguez, Marco; Capani, Francisco; Gonzalez, Janneth; Echeverria Moran, Valentina; Barreto, George E.			Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease	CURRENT PHARMACEUTICAL DESIGN			English	Article						Parkinson disease; nicotine; astrocytes; nAChRs; neuroinflammation; neuroprotection; apoptosis	PROTECTS DOPAMINERGIC-NEURONS; FACTOR-KAPPA-B; MEDIATED NEUROPROTECTION; SYNAPTIC PLASTICITY; GROWTH-FACTOR; MOUSE MODEL; D-SERINE; RELEASE; ACTIVATION; INFLAMMATION	Parkinson's disease (PD) is a relatively common disorder of the Central Nervous System (CNS), whose etiology is characterized by a selective and progressive degeneration of dopaminergic neurons, and the presence of Lewy bodies in the pars compacta of the substantia nigra, and gaping dopamine depletion in the striatum. Patients with this disease suffer from tremors, slowness of movements, gait instability, and rigidity. These patients may also present functional disability, reduced quality of life, and rapid cognitive decline. It has been shown that nicotine exerts beneficial effects in patients with PD and in in-vitro and in-vivo models of this disease. Astrocytes are an important component in the immune response associated with PD, and that nicotine might be able to inhibit the inflammation-related apoptosis of these cells, being this a potential strategy for PD treatment. This action of nicotine could be due mainly to activation of alpha 7 nicotinic acetylcholine receptors (alpha 7-nAChRs) expressed in glial cells. However, nicotine administration can protect dopaminergic neurons against degeneration by inhibiting astrocytes activation in the substantia nigra pars compacta (SNpc) and therefore reduce inflammation. Owing to the toxicity and capacity of nicotine to induce addiction, analogues of this substance have been designed and tested in various experimental paradigms, and targeting alpha 7-nAChRs expressed in glial cells may be a novel therapeutic strategy for PD treatment.	[Camilo Jurado-Coronel, Juan; Avila-Rodriguez, Marco; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Capani, Francisco] UBA CONICET, Fac Med, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Marcelo T de Alvear 2270,C1122AAJ, Buenos Aires, DF, Argentina; [Capani, Francisco] UAJFK, Dept Biol, C1197AAR, Buenos Aires, DF, Argentina; [Echeverria Moran, Valentina] Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile; [Echeverria Moran, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Moran, VE (corresponding author), Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile.; Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia.	echeverria.valentina@gmail.com; gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; capani, Francisco/D-9781-2016; Barreto, George E./B-5747-2014; Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Avila-Rodriguez, Marco/0000-0003-4612-3236; Jurado, Juan/0000-0003-4167-8726	PUJ [6435]	PUJ	This work was in part funded by PUJ grants ID #6435 to GEB.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Andersson MS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-87; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bradford ST, 2011, AM J PHYSIOL-HEART C, V300, pH1518, DOI 10.1152/ajpheart.00928.2010; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Chen JD, 2013, GLIA, V61, P178, DOI 10.1002/glia.22425; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dervan AG, 2004, EXP NEUROL, V190, P145, DOI 10.1016/j.expneurol.2004.07.004; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Fratiglioni L, 2000, BEHAV BRAIN RES, V113, P117, DOI 10.1016/S0166-4328(00)00206-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Graham AJ, 2003, J CHEM NEUROANAT, V25, P97, DOI 10.1016/S0891-0618(02)00100-X; Grybko M, 2010, J MOL NEUROSCI, V40, P114, DOI 10.1007/s12031-009-9266-8; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Henneberger C, 2010, NEURON GLIA BIOL, V6, P141, DOI 10.1017/S1740925X10000153; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez-Morales M, 2009, NEUROPHARMACOLOGY, V56, P975, DOI 10.1016/j.neuropharm.2009.01.024; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hong DP, 2009, BBA-PROTEINS PROTEOM, V1794, P282, DOI 10.1016/j.bbapap.2008.09.026; Hu ZJ, 2009, INTERDISCIP SCI, V1, P254, DOI 10.1007/s12539-009-0052-7; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee E, 2014, J NEUROSCI RES, V92, P130, DOI 10.1002/jnr.23307; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li XZ, 2009, NEUROSCI RES, V65, P252, DOI 10.1016/j.neures.2009.07.007; LI ZH, 2013, LIFE SCI J, V10, P1198; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lopez-Hidalgo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049998; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; McNaught KSP, 2000, NEUROSCI LETT, V285, P61, DOI 10.1016/S0304-3940(00)00982-4; Mogi M, 1996, J NEURAL TRANSM, V103, P1077, DOI 10.1007/BF01291792; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Oikawa H, 2005, J NEUROSCI RES, V79, P535, DOI 10.1002/jnr.20398; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Ono K, 2008, NEUROSCIENCE, V154, P994, DOI 10.1016/j.neuroscience.2008.04.028; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Park HJ, 2007, EUR J NEUROSCI, V26, P79, DOI 10.1111/j.1460-9568.2007.05636.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Quik M, 2009, BIOCHEM PHARMACOL, V78, P677, DOI 10.1016/j.bcp.2009.05.003; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Skucas VA, 2011, J NEUROSCI, V31, P6392, DOI 10.1523/JNEUROSCI.6249-10.2011; Son IH, 2008, MOL CELL TOXICOL, V4, P106; Tufekci KU, 2012, ADV PROTEIN CHEM STR, V88, P69, DOI 10.1016/B978-0-12-398314-5.00004-0; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/487450; Villalba RM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00068; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang J, 2012, CHINESE J CHEM, V30, P2813, DOI 10.1002/cjoc.201200952; Wang XL, 2013, J NEUROCHEM, V127, P632, DOI 10.1111/jnc.12436; Ward RJ, 2008, PROG NEUROBIOL, V85, P135, DOI 10.1016/j.pneurobio.2008.03.003; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xiu J, 2005, NEUROCHEM INT, V47, P281, DOI 10.1016/j.neuint.2005.04.023; Yuan HB, 2006, BIOORGAN MED CHEM, V14, P7936, DOI 10.1016/j.bmc.2006.07.049; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	87	28	29	0	16	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	10					1305	1311		10.2174/138161282210160304112133	http://dx.doi.org/10.2174/138161282210160304112133			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG4VZ	26972289				2022-09-04	WOS:000372072500003
J	Zuluaga, MA; Davila, EE; Uriza, LF; Hoyos, MH				Zuluaga, M. A.; Davila, E. E.; Uriza, L. F.; Hernandez Hoyos, M.			Carotid artery segmentation and characterization in 3D computed tomography (CT) images	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Image processing; Vascular segmentation; Characterization; CT image	PLAQUE CHARACTERIZATION; ENDARTERECTOMY; MRI	A method is proposed for vessel segmentation in 3D CT images based in the extraction of the vessel centreline and of vessel contours locally perpendicular to the centerline. The method is divided into three stages: axis extraction, discontinuity detection and contour refinement. Vessel axis is extracted by an extensible skeleton. First, discontinuities between lumen and calcifications are detected. Second, in order to obtain well-defined contours, a contour extraction algorithm is applied using isocontours. A quantitative evaluation is presented. It is done by comparing the extracted contours with contours manually traced by an expert.	[Zuluaga, M. A.; Hernandez Hoyos, M.] Univ Los Andes, Grp Imagine, Grp Ingn Biomed, Bogota, Colombia; [Davila, E. E.] Univ Lyon 1, CNRS, INSA Lyon, CREATIS,LRMN,UMR 5220,Inserm,U630, F-69621 Villeurbanne, France; [Uriza, L. F.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Radiol & Imagenes Diagnost, Bogota, Colombia		Zuluaga, MA (corresponding author), Univ Los Andes, Grp Imagine, Grp Ingn Biomed, Bogota, Colombia.			Hernandez Hoyos, Marcela/0000-0002-9723-5417				Adame IM, 2004, MAGN RESON MATER PHY, V16, P227, DOI 10.1007/s10334-003-0030-8; Biasi GM, 1998, J ENDOVASC SURG, V5, P240, DOI 10.1583/1074-6218(1998)005<0240:CPCUDI>2.0.CO;2; Boldak C., 2003, BIOCYBERN BIOMED, V23, P41; Boskamp T, 2004, RADIOGRAPHICS, V24, P287, DOI 10.1148/rg.241035073; Choudhury RP, 2002, ARTERIOSCL THROM VAS, V22, P1065, DOI 10.1161/01.ATV.0000019735.54479.2F; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Fayad ZA, 2000, ANN NY ACAD SCI, V902, P173; Florez Valencia L, 2004, P INT C COMP VIS GRA, P87; Hennerici M, 2000, CEREBROVASC DIS, V10, P9, DOI 10.1159/000047600; Hoyos MH, 2006, INT J COMPUT ASS RAD, V1, P167, DOI 10.1007/s11548-006-0049-1; Hoyos MH, 2006, INT J COMPUT ASS RAD, V1, P51, DOI 10.1007/s11548-006-0005-0; Lorenz C, 2005, INT CONGR SER, V1281, P230, DOI 10.1016/j.ics.2005.03.249; Reid DB, 1998, J ENDOVASC SURG, V5, P247, DOI 10.1583/1074-6218(1998)005<0247:CPCHTE>2.0.CO;2; Stoitsis J, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2392; Wink O, 2004, IEEE T MED IMAGING, V23, P130, DOI 10.1109/TMI.2003.819920	15	0	0	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	JUN	2007	2			1			S72	S74						3	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	V32ZD					2022-09-04	WOS:000208988200038
J	Camargo, DRB; Amado, ED; Munoz, AP				Bernal Camargo, Diana Rocio; Diaz Amado, Eduardo; Padilla Munoz, Andrea			Ethical Challenges of the Socio-Juridical Research: Review from Good Practices in Published Articles	REVISTA ESTUDIOS SOCIO-JURIDICOS			Spanish	Review						Sociojuridical research; research ethics; publications	JUSTICE	In this article, some considerations and reflections about socio-juridical research are presented from the perspective of the statements and approaches of the human research ethics, as it has developed in the biomedical area. Socio-juridical research is taken as a subtype of social sciences research. As a part of the kind of research required to the advance and development of law, socio-juridical research has its particular theoretical considerations from which we make an approach to the problem of its definition. For the analysis from the research ethics point of view, ten articles presenting results of socio-juridical research were reviewed as a convenience sample, without it being a meta-analysis, taking human research ethics in biomedicine as a departing point. In the articles cited, it was found that in fact this type of research takes into account different ethical guidelines -not formally established- that seek for the respect of the rights of the participants, with the particularities of the socio-legal research and which deserve to be taken into account. The article concludes with some suggestions from the practical and methodological approach in regard to the ethics of socio-juridical research.	[Bernal Camargo, Diana Rocio; Padilla Munoz, Andrea] Univ Rosario, Fac Jurisprudencia, Grp Invest Derechos Humanos, Bogota, Colombia; [Diaz Amado, Eduardo] Univ Los Andes, Literatura, Santiago, Chile; [Diaz Amado, Eduardo] Univ El Bosque, Bioet, Bogota, Colombia; [Diaz Amado, Eduardo] Univ Nacl Colombia, Bogota, Colombia; [Diaz Amado, Eduardo] Pontificia Univ Javeriana, Inst Bioet, Bogota, Colombia; [Padilla Munoz, Andrea] IUKB, Med Europea, Bogota, Colombia		Camargo, DRB (corresponding author), Univ Rosario, Fac Jurisprudencia, Grp Invest Derechos Humanos, Bogota, Colombia.	diana.bernalc@urosario.edu.co; eduardo.diaz@javeriana.edu.co; andrea.padillac@urosario.edu.co						Achio Tacsan M., 2003, REV CIENCIAS SOCIALE, V99, P85; Agar Corbinos Lorenzo, 2004, Acta bioeth., V10, P65, DOI 10.4067/S1726-569X2004000100008; Arango Pajon G. L., 2013, TENDENCIAS ENSENANZA, P217; Arellano Hernandez A., 2005, REDES, V11, P75; Santamaria RA, 2014, REV COLOMB SOCIOL, V37, P49; Botero Uribe D., 1997, TEORIA SOCIAL DERECH; Brown N., 2004, SOCIAL SCI RES ETHIC; Cassell EJ, 2000, HASTINGS CENT REP, V30, P12, DOI 10.2307/3527640; Clare J, 2017, CAN J CRIMINOL CRIM, V59, P143, DOI 10.3138/cjccj.2016.E01; Colciencias, 2012, COM ET ET INV; Miranda MC, 2006, REV COLOMB BIOET, V1, P141; Coronado G., 2006, REV FILOSOFIA U COST, V44, P167; Cortina A., 1995, ETICA SOC CIVIL; Cortina A., 2003, SELECCIONES BIOETICA, V4, P67; Cruz Ordierez M., 2011, CIENCIAS SOCIALES HU, VII, P160; DELOPEZ JO, 2007, REV ESTUDIOS INTERDI, V9, P345; Diaz Amado E., 2005, CUADERNOS DOCTORADO, P71; Famega C, 2017, POLICE Q, V20, P106, DOI 10.1177/1098611116664336; Giraldo Angel J., 2012, OBRAS COMPLETAS JG A; GOODE E, 1996, QUALITATIVE SOCIOLOG, V19, P11, DOI [dx.doi.org/10.1007/BF02393246, DOI 10.1007/BF02393246]; Guba EG., 1994, HDB QUALITATIVE RES, P105; Hicks Jr G. W., 2005, HARV JL PUB POLY, V29, P623; Hosagrahar J., 2005, RES ETHICS SOCIAL SC; Israel M., 2015, RES ETHICS INTEGRITY; McElhattan D, 2017, LAW SOC REV, V51, P669, DOI 10.1111/lasr.12276; Mejía Walker Juan Camilo, 2006, Opin. jurid., V5, P183; Milmaniene M. P., 2013, ETICA INVESTIGACION; Morin C, 2011, SOCIETY, V48, P131, DOI 10.1007/s12115-010-9408-1; Myhill A., 2017, POLIC SOC, P1, DOI DOI 10.1080/10439463.2017.1356299; National Research Council . (Committee on Revisions to the Common Rule for the Protection of Human Subjects in Research in the Behavioral and Social Sciences. Board on Behavioral Cognitive and Sensory Sciences Committee on National Statistics Division of Behavioral and Social Sciences and Education), 2014, PROP REV COMM RUL PR; Nino C., 2013, INTRO ANALISIS DEREC; Nygard RH, 2016, INT SOC WORK, V59, P666, DOI 10.1177/0020872816646815; Pernebo K, 2017, J FAM VIOLENCE, V32, P169, DOI 10.1007/s10896-016-9856-5; Cuevas JP, 2016, ANDAMIOS, V13, P129; Ransome P., 2013, ETHICS VALUES SOCIAL; Rees M., 2012, CODE CONDUCT BEST PR; Ritchie J, 2013, QUALITATIVE RES PRAC, V2; Rowen JR, 2017, LAW SOCIAL INQUIRY, V42, P622; Rueda Martínez Gabriela, 2015, rev.latinoam.bioet., V15, P144; Santi M., 2013, THESIS; Santi María Florencia, 2015, rev.latinoam.bioet., V15, P52; Smith O., 2017, SOCIAL LEGAL STUDIES; Tai MCT, 2012, TZU CHI MED J, V24, P218, DOI 10.1016/j.tcmj.2012.05.003; Tantalean Reynaldo, 2016, DERECHO CAMBIO SOCIA, V13, P1; Turnbull S, 2017, PUNISHM SOC, V19, P135, DOI 10.1177/1462474516660695; VANDOORN J, 2017, INTERNATIONAL REVIEW, V23, P303, DOI DOI 10.1177/0269758017710819; Zito-Guerriero I. C., 2015, REV FAC NAC SALUD PU, V33, pS93, DOI [10.17533/udea.rfnsp.v33s1a17, DOI 10.17533/UDEA.RFNSP.V33S1A17]; [No title captured]	48	0	0	1	2	UNIV ROSARIO, FAC JURISPRUDENCIA	BOGOTA	CARRERA 6 NO 15-18 EDIFICIO JOCKEY CLUB, BOGOTA, DC 00000, COLOMBIA	0124-0579	2145-4531		REV ESTUD SOCIO-JURI	Rev. Estud. Socio-Jurid.	JAN-JUN	2018	20	1					107	131		10.12804/revistas.urosario.edu.co/sociojuridicos/a.6043	http://dx.doi.org/10.12804/revistas.urosario.edu.co/sociojuridicos/a.6043			25	Law; Political Science	Emerging Sources Citation Index (ESCI)	Government & Law	IT1QD		gold, Green Submitted			2022-09-04	WOS:000482620300005
J	Bauer, IE; Galvez, JF; Hamilton, JE; Balanza-Martinez, V; Zunta-Soares, GB; Soares, JC; Meyer, TD				Bauer, Isabelle E.; Galvez, Juan F.; Hamilton, Jane E.; Balanza-Martinez, Vicent; Zunta-Soares, Giovana B.; Soares, Jair C.; Meyer, Thomas D.			Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review	JOURNAL OF PSYCHIATRIC RESEARCH			English	Review						Bipolar disorder; Physical activity; Nutrition; Wellbeing; Psychosocial intervention; Lifestyle intervention	SEVERE MENTAL-ILLNESS; BODY-MASS INDEX; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; MEDICAL BURDEN; I DISORDER; ADULTS; OBESITY; RISK; COMORBIDITY	Background: Bipolar disorder (BD) is a serious mental illness associated with a high risk of medical comorbidities, long-term disability and premature death. This systematic review examined the current literature on therapeutic interventions targeting nutrition, physical activity and wellness in BD and collecting health-related measures such as mood and course of illness. Methods: Scopus (all databases), Pubmed and Ovid Medline were systematically searched with no language or year restrictions, up to June 2015, for studies focusing on lifestyle interventions in BD. Search terms were related to bipolar disorder, nutrition, physical activity, wellbeing, psychosocial interventions and course of illness. We hand searched content pages of Bipolar Disorders and Journal of Affective Disorders and checked references of relevant reviews and dissertations to identify additional papers. Results: After applying inclusion and exclusion criteria to identified hits, this literature search retrieved six papers. Overall findings point towards a beneficial role of lifestyle interventions on mood, weight, blood pressure, lipid profile, physical activity and overall wellbeing. Methodological limitations include small sample size, gender ratio imbalance, inconsistencies in terms of laboratory measures, and lack of randomized controlled trials and absence of follow-up and longitudinal studies to determine the benefits of these factors on clinical and functional outcomes over time Conclusions: Lifestyle interventions in BD targeting nutrition, exercise, wellbeing alongside beliefs, coping strategies and attitudes towards health show promise in reducing the risk of comorbid ailments in BD. There is still a strong need for studies a) developing interventions which are informed by the patient's input and b) examining the effectiveness of such interventions targeting general wellness using well-controlled trials. Published by Elsevier Ltd.	[Bauer, Isabelle E.; Galvez, Juan F.; Hamilton, Jane E.; Zunta-Soares, Giovana B.; Soares, Jair C.; Meyer, Thomas D.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Galvez, Juan F.] Pontificia Univ Javeriana, Sch Med, Dept Psychiat, Bogota, Colombia; [Balanza-Martinez, Vicent] Univ Valencia, Teaching Unit Psychiat, Dept Med, La Fe Univ & Polytech Hosp,CIBERSAM,ISNPR, Valencia, Spain		Meyer, TD (corresponding author), Univ Texas HSC Houston, UT Ctr Excellence Mood Disorders, Biomed & Behav Sci Bldg BBSB,1941 East Rd, Houston, TX 77054 USA.	Thomas.D.Meyer@uth.tmc.edu	Balanzá-Martínez, Vicent/C-3073-2011	Balanzá-Martínez, Vicent/0000-0001-7772-7396; Soares, Jair C./0000-0002-5466-5628	NIMH [R01085667]; John S. Dunn Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085667] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John S. Dunn Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIMH grant R01085667, the John S. Dunn Foundation, and the Pat Rutherford, Jr. Endowed Chair in Psychiatry (UTHealth).	Belanger ME, 2013, SANTE MENT QUE, V38, P103, DOI 10.7202/1019188ar; Booth A, 2016, SYSTEMATIC APPROACHE, V2nd; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Calkin C, 2009, BIPOLAR DISORD, V11, P650, DOI 10.1111/j.1399-5618.2009.00730.x; Cerimele JM, 2014, GEN HOSP PSYCHIAT, V36, P19, DOI 10.1016/j.genhosppsych.2013.09.008; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; Davison KM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-10; Davison KM, 2011, J AM COLL NUTR, V30, P547, DOI 10.1080/07315724.2011.10720001; Depp Colin A, 2008, Dialogues Clin Neurosci, V10, P239; Elmslie JL, 2001, J CLIN PSYCHIAT, V62, P486, DOI 10.4088/JCP.v62n0614; Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112; Fagiolini A, 2008, CNS DRUGS, V22, P655, DOI 10.2165/00023210-200822080-00004; Frank E, 2015, BIPOLAR DISORD, V17, P424, DOI 10.1111/bdi.12283; Galvez JF, 2014, J AFFECT DISORDERS, V168, P306, DOI 10.1016/j.jad.2014.05.054; Gillhoff Kornelia, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09m00906yel; Goldstein TR, 2011, J CHILD ADOL PSYCHOP, V21, P275, DOI 10.1089/cap.2010.0104; Gomes F, 2010, ARQ BRAS CARDIOL, V94, P273, DOI 10.1590/S0066-782X2010000200021; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Hong JH, 2011, PSYCHIAT RES, V190, P110, DOI 10.1016/j.psychres.2011.04.016; Jackson N, 2007, HDB SYSTEMATIC REV H; Janney CA, 2014, J AFFECT DISORDERS, V152, P498, DOI 10.1016/j.jad.2013.09.009; Jewell L, 2015, MENT HEALTH PHYS ACT, V8, P62, DOI 10.1016/j.mhpa.2015.04.001; Kazdin, 2021, SINGLE CASE RES DESI; Kemp DE, 2010, BIPOLAR DISORD, V12, P404, DOI 10.1111/j.1399-5618.2010.00823.x; Kilbourne AM, 2007, BIPOLAR DISORD, V9, P443, DOI 10.1111/j.1399-5618.2007.00386.x; Kilbourne AM, 2013, J CLIN PSYCHIAT, V74, pE655, DOI 10.4088/JCP.12m08082; Kim B, 2009, PSYCHIAT INVEST, V6, P78, DOI 10.4306/pi.2009.6.2.78; McIntyre Roger S, 2005, Ann Clin Psychiatry, V17, P83, DOI 10.1080/10401230590932380; McIntyre RS, 2004, HUM PSYCHOPHARM CLIN, V19, P369, DOI 10.1002/hup.612; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nover C, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-116; Prieto ML, 2014, ACTA PSYCHIAT SCAND, V130, P342, DOI 10.1111/acps.12293; Sarris J, 2015, LANCET PSYCHIAT, V2, P271, DOI 10.1016/S2215-0366(14)00051-0; Sharma AN, 2014, PROG NEURO-PSYCHOPH, V54, P289, DOI 10.1016/j.pnpbp.2014.06.005; Soundy A, 2014, ARCH PSYCHIAT NURS, V28, P135, DOI 10.1016/j.apnu.2013.12.002; Sylvia L.G., 2014, USE TREATMENT SERVIC; Sylvia LG, 2013, INT J BIPOLAR DISORD, V1, DOI 10.1186/2194-7511-1-24; Sylvia LG, 2015, BIPOLAR DISORD, V17, P212, DOI 10.1111/bdi.12243; Sylvia LG, 2013, PSYCHOTHER PSYCHOSOM, V82, P10, DOI 10.1159/000341309; Sylvia LG, 2011, J PSYCHIATR PRACT, V17, P224, DOI 10.1097/01.pra.0000398419.82362.32; Ussher M, 2007, PSYCHIAT SERV, V58, P405, DOI 10.1176/appi.ps.58.3.405; Van Citters AD, 2010, COMMUNITY MENT HLT J, V46, P540, DOI 10.1007/s10597-009-9272-x; Vancampfort D, 2015, PSYCHIAT RES, V228, P100, DOI 10.1016/j.psychres.2015.04.021; Vancampfort D, 2013, J AFFECT DISORDERS, V145, P285, DOI 10.1016/j.jad.2012.07.020	46	43	43	2	46	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	MAR	2016	74						1	7		10.1016/j.jpsychires.2015.12.006	http://dx.doi.org/10.1016/j.jpsychires.2015.12.006			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DE8RS	26724541	Green Accepted			2022-09-04	WOS:000370905000001
J	Rodriguez, MA; Garcia-Segura, LM; Cabezas, R; Torrente, D; Capani, F; Gonzalez, J; Barret, GE				Avila Rodriguez, Marco; Miguel Garcia-Segura, Luis; Cabezas, Ricardo; Torrente, Daniel; Capani, Francisco; Gonzalez, Janneth; Barret, George E.			Tibolone protects T98G cells from glucose deprivation	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Neuroprotection; Estrogenic activity; Metabolic insult; Free radicals	ESTROGEN-RECEPTOR; HYDROGEN-PEROXIDE; BREAST-CANCER; ASTROCYTES; 17-BETA-ESTRADIOL; MECHANISM; NEUROPROTECTION; DYSFUNCTION; EXPRESSION; DAMAGE	The steroidal drug Tibolone is used for the treatment of climacteric symptoms and osteoporosis in post-menopausal women. Although Tibolone has been shown to exert neuroprotective actions after middle cerebral artery occlusion, its specific actions on glial cells have received very little attention. In the present study we have assessed whether Tibolone exerts protective actions in a human astrocyte cell model, the T98G cells, subjected to glucose deprivation. Our findings indicate that Tibolone decreases the effects of glucose deprivation on cell death, nuclear fragmentation, superoxide ion production, mitochondrial membrane potential, cytoplasmic calcium concentration and morphological parameters. These findings suggest that glial cells may participate in the neuroprotective actions of Tibolone in the brain. (C) 2014 Elsevier Ltd. All rights reserved.	[Avila Rodriguez, Marco; Cabezas, Ricardo; Gonzalez, Janneth; Barret, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Torrente, Daniel] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX USA; [Capani, Francisco] UBA CONICET, Fac Med, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal, Buenos Aires, DF, Argentina		Barret, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gsampaio@javeriana.edu.co	capani, Francisco/D-9781-2016; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; GONZALEZ, JANNETH/AAB-9948-2020; Garcia-Segura, Luis M/U-3711-2017	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-4482-256X; Garcia-Segura, Luis M/0000-0002-2450-2916; Avila-Rodriguez, Marco/0000-0003-4612-3236	PUJ [4509, 5024, 5619]; Ministerio de Economia y Competitividad, Spain [BFU2011-30217-C03-01]	PUJ; Ministerio de Economia y Competitividad, Spain	This work was supported in part by grants PUJ IDs 4509, 5024 to GB and 5619 to JG and by grant BFU2011-30217-C03-01 from Ministerio de Economia y Competitividad, Spain to LMGS.	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Aguiar RB, 2007, COMP BIOCHEM PHYS A, V148, pS114, DOI 10.1016/j.cbpa.2007.06.401; Arnold S, 2005, NEUROBIOL DIS, V20, P82, DOI 10.1016/j.nbd.2005.02.002; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Bankhead P., 2013, ANAL FUORESCENCE MIC; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Belenichev O.V., 2012, NEUROCHEM J, V6; Bergeron M, 1996, NEUROL RES, V18, P64, DOI 10.1080/01616412.1996.11740380; Bernardi P., 2007, CALCIUM CELL DEATH M, P592; BRUNO VMG, 1994, J NEUROCHEM, V63, P1398; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; de Joannon AC, 2000, NEUROSCI LETT, V285, P218, DOI 10.1016/S0304-3940(00)01051-X; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dhandapani KM, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-6; Gasque P, 1996, J IMMUNOL, V156, P2247; Giffard R, 2004, J BIOENERG BIOMEMBR, V36, P313, DOI 10.1023/B:JOBB.0000041760.23917.e1; Giffard Rona G, 2002, Curr Opin Anaesthesiol, V15, P495, DOI 10.1097/00001503-200210000-00004; Gompel A, 1999, CONTRACEPT FERTIL S, V27, P368; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Guo JB, 2012, FREE RADICAL BIO MED, V52, P2151, DOI 10.1016/j.freeradbiomed.2012.03.005; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2004, MATURITAS, V49, pS5, DOI 10.1016/j.maturitas.2004.06.022; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Mao X., 2006, J BIOL CHEM, V358, P63; Maudelonde T, 1999, Contracept Fertil Sex, V27, P620; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Ouyang YB, 2006, CELL STRESS CHAPERON, V11, P180, DOI 10.1379/CSC-182R.1; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Presl J, 1991, Cesk Gynekol, V56, P299; Radowicki S, 1988, Ginekol Pol, V59, P705; Raobaikady B, 2005, J STEROID BIOCHEM, V94, P229, DOI 10.1016/j.jsbmb.2005.01.021; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Reynir Tomas G., 2004, ACTA OBSTET GYN SCAN, V83, P606; RYMER J, 1994, OSTEOPOROSIS INT, V4, P314, DOI 10.1007/BF01622189; Sadarangani A, 2005, BIOL RES, V38, P245, DOI 10.4067/S0716-97602005000200014; Simpkins JW, 2008, BRAIN RES REV, V57, P421, DOI 10.1016/j.brainresrev.2007.04.007; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Steckelbroeck S, 2004, MOL PHARMACOL, V66, P1702, DOI 10.1124/mol.104.004515; Swegle JM, 2004, ANN PHARMACOTHER, V38, P874, DOI 10.1345/aph.1D462; Technologies L., 2014, FLUO 4 AM CELL PERME; [田文艳 TIAN Wen-yan], 2009, [第二军医大学学报, Academic Journal of Second Military Medical University], V30, P790; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Xiong JW, 2006, PROC SPIE, V6150, DOI 10.1117/12.676524; Xu LJ, 2003, NEUROL RES, V25, P697, DOI 10.1179/016164103101202183; Xu Y, 2008, J PHARMACOL EXP THER, V327, P402, DOI 10.1124/jpet.108.142372	55	47	47	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	OCT	2014	144		B				294	303		10.1016/j.jsbmb.2014.07.009	http://dx.doi.org/10.1016/j.jsbmb.2014.07.009			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AT8KT	25086299				2022-09-04	WOS:000345183000007
J	Ramirez, CA; Dea-Ayuela, MA; Gutierrez-Blazquez, MD; Bolas-Fernandez, F; Requena, JM; Puerta, CJ				Ramirez, C. A.; Dea-Ayuela, M. A.; Gutierrez-Blazquez, M. D.; Bolas-Fernandez, F.; Requena, J. M.; Puerta, C. J.			Identification of proteins interacting with HSP70 mRNAs in Leishmania braziliensis	JOURNAL OF PROTEOMICS			English	Article						Leishmania braziliensis; HSP70 protein; HSP70 UTRs; mRNA expression regulation; Mass spectrometry; Pull-down	POLY(A) BINDING-PROTEIN; TRANSLATION INITIATION; GENE-EXPRESSION; GENOMIC ORGANIZATION; POSTTRANSCRIPTIONAL REGULATION; 5'-UNTRANSLATED REGION; STAGE-DIFFERENTIATION; PHOSPHATASE 2A; INFANTUM; ELEMENT	HSP70 protein is involved in Leishmania differentiation, apoptosis, antimony-resistance and host-immune response. Therefore, this protein and the regulatory mechanisms of HSP70 gene expression are promising targets for therapeutic intervention against leishmaniasis. The regulation of mRNA expression in trypanosomatids operates mostly through the interaction of trans-acting proteins, and elements located in the untranslated regions of mRNAs. The aim of this work was to identify protein factors interacting specifically with the Leishmania braziliensis IISP70 mRNAs. Thus, the 5' UTR and the two types of 3' UTRs (UTR-I and UTR-II) from L. braziliensis HSP70 genes were used as baits in pull down assays using total protein extracts from parasites cultured at 26 or 35 degrees C. The captured proteins were resolved by two-dimensional gel electrophoresis (2-DE) and identified by mass spectrometry (MS) analysis. As a result, 52 different proteins were identified based on their binding to the L. braziliensis HSP70-mRNAs. As expected, several of the identified proteins were related to RNA metabolism (27%) and translation process (7%). In addition, five hypothetical conserved proteins having motifs related with RNA interaction were also identified (9.6%). Nevertheless, unexpected proteins, apparently unrelated to the mRNA expression, were also identified. The biological significance of these and others L. braziliensis detected proteins, including the HSP70 itself, is discussed. Biological significance For the first time, a riboproteomic analysis of the proteins interacting with the untranslated regions of the heat shock protein 70 (HSP70) mRNA from Leishmania braziliensis was carried out. This work provides new insights related to protein factors putatively involved in the regulation of HSP70 gene expression in L. braziliensis, and thereby, contributes to a better understanding of the parasite biology, and ultimately to the development of novel therapeutic interventions for controlling the important diseases caused by this parasite. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.	[Ramirez, C. A.; Puerta, C. J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Bogota, Colombia; [Ramirez, C. A.; Requena, J. M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Dea-Ayuela, M. A.] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Dept Farm, Valencia 46113, Spain; [Dea-Ayuela, M. A.; Bolas-Fernandez, F.] Univ Complutense, Fac Farm, Dept Parasitol, E-28040 Madrid, Spain; [Gutierrez-Blazquez, M. D.] Univ Complutense Madrid, Unidad Prote, E-28040 Madrid, Spain		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Carrera 7 43-82,Edificio 52,Oficina 608, Bogota, Colombia.	cesar-ramirez@javeriana.edu.co; mda_3000@yahoo.es; dgutierr@farm.ucm.es; francisb@farm.ucm.es; jmrequena@cbm.uam.es; cpuerta@javeriana.edu.co	Requena, Jose M/I-2022-2019; Gutiérrez, Dolores/H-9167-2015; Dea-Ayuela, M. Auxiliadora/ABG-5971-2020; Puerta, Concepcion J/AAG-4912-2019; Dea-Ayuela, M. Auxiliadora/AAA-7021-2019; Bolas Fernandez, Francisco/H-2514-2017	Requena, Jose M/0000-0001-7550-0198; Gutiérrez, Dolores/0000-0002-1792-9727; Dea-Ayuela, M. Auxiliadora/0000-0002-5468-1863; Bolas Fernandez, Francisco/0000-0001-8062-2974; Ramirez, Cesar Augusto/0000-0002-2687-9880; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Colciencias (Colombia) [1203-405-20233]; Ministerio de Ciencia y Tecnologia [BFU2009-08986]; Comunidad Autonoma de Madrid [S2010/BMD-2361]; Fondo de Investigaciones Sanitarias [ISCIII-RETIC RD12/0018/0009-FEDER]; Colciencias, Programa Nacional de Doctorados, convocatoria	Colciencias (Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministerio de Ciencia y Tecnologia(Spanish GovernmentEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Colciencias, Programa Nacional de Doctorados, convocatoria	CJP's lab was supported by Colciencias (Colombia), Research project No. 1203-405-20233. JMR's lab was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2009-08986), Comunidad Autonoma de Madrid (S2010/BMD-2361) and the Fondo de Investigaciones Sanitarias (ISCIII-RETIC RD12/0018/0009-FEDER). CAR was supported by Colciencias, Programa Nacional de Doctorados, convocatoria 2008.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; Barhoumi M, 2006, FEBS J, V273, P5086, DOI 10.1111/j.1742-4658.2006.05506.x; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004; Brochu C, 2004, CELL STRESS CHAPERON, V9, P294, DOI 10.1379/CSC-15R1.1; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; Collingridge PW, 2010, PARASITOLOGY, V137, P1467, DOI 10.1017/S0031182010000259; Cushman I, 2004, J MOL BIOL, V344, P303, DOI 10.1016/j.jmb.2004.09.043; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; da Silva RA, 2006, INT J PARASITOL, V36, P87, DOI 10.1016/j.ijpara.2005.09.005; David M, 2010, RNA, V16, P364, DOI 10.1261/rna.1874710; Dea-Ayuela MA, 2009, INT J MED MICROBIOL, V299, P221, DOI 10.1016/j.ijmm.2008.07.006; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Ding XZ, 1998, FASEB J, V12, P451, DOI 10.1096/fasebj.12.6.451; Drummelsmith J, 2004, J BIOL CHEM, V279, P33273, DOI 10.1074/jbc.M405183200; Folgueira C, 2007, PARASITOLOGY, V134, P369, DOI 10.1017/S0031182006001570; Folgueira C, 2005, J BIOL CHEM, V280, P35172, DOI 10.1074/jbc.M505559200; Folgueira C, 2008, INT MICROBIOL, V11, P81, DOI 10.2436/20.1501.01.47; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gonzalez J, 2003, BIOCHEM J, V374, P647, DOI 10.1042/BJ20030215; Hentze MW, 2010, TRENDS BIOCHEM SCI, V35, P423, DOI 10.1016/j.tibs.2010.05.009; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holzer TR, 2008, MOL BIOCHEM PARASIT, V157, P54, DOI 10.1016/j.molbiopara.2007.10.001; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kilchert C, 2010, MOL BIOL CELL, V21, P2624, DOI 10.1091/mbc.E10-02-0099; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Larreta R, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-3; MARESCA B, 1994, EXPERIENTIA, V50, P1067, DOI 10.1007/BF01923463; Pais SM, 2009, PLANT SIGNAL BEHAV, V4, P1013, DOI 10.4161/psb.4.11.9783; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Mittal N, 2013, MOL BIOCHEM PARASIT, V187, P21, DOI 10.1016/j.molbiopara.2012.11.001; Mittra B, 2004, EUKARYOT CELL, V3, P1185, DOI 10.1128/EC.3.5.1185-1197.2004; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Oddone R, 2009, J CLIN MICROBIOL, V47, P2818, DOI 10.1128/JCM.00645-09; Pacheco A, 2008, PROTEOMICS, V8, P4782, DOI 10.1002/pmic.200800338; Purdy JE, 2005, EXP PARASITOL, V110, P102, DOI 10.1016/j.exppara.2005.02.008; Quijada L, 1997, J BIOL CHEM, V272, P4493, DOI 10.1074/jbc.272.7.4493; Raina P, 2012, MOL CELL BIOCHEM, V359, P135, DOI 10.1007/s11010-011-1007-y; Ramirez CA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-454; Ramirez CA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-166; Requena JM, 2012, STRESS RESPONSE IN MICROBIOLOGY, P323; Requena JM, 2011, FRONT BIOSCI-LANDMRK, V16, P2069, DOI 10.2741/3840; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; SHAPIRA M, 1988, EMBO J, V7, P2895, DOI 10.1002/j.1460-2075.1988.tb03147.x; Singh CR, 2011, NUCLEIC ACIDS RES, V39, P8314, DOI 10.1093/nar/gkr339; Neto JLS, 2007, BIOCHEM BIOPH RES CO, V358, P417, DOI 10.1016/j.bbrc.2007.04.144; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zick A, 2005, NUCLEIC ACIDS RES, V33, P4235, DOI 10.1093/nar/gki742; Zilka A, 2001, J BIOL CHEM, V276, P47922, DOI 10.1074/jbc.M108271200	76	13	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	DEC 6	2013	94						124	137		10.1016/j.jprot.2013.09.008	http://dx.doi.org/10.1016/j.jprot.2013.09.008			14	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	300VZ	24060997	hybrid			2022-09-04	WOS:000330493400009
J	Hidalgo, M; Montoya, V; Martinez, A; Mercado, M; De la Ossa, A; Velez, C; Estrada, G; Perez, JE; Faccini-Martinez, AA; Labruna, MB; Valbuena, G				Hidalgo, Marylin; Montoya, Viviana; Martinez, Alejandra; Mercado, Marcela; De la Ossa, Alberto; Velez, Carolina; Estrada, Gloria; Perez, Jorge E.; Faccini-Martinez, Alvaro A.; Labruna, Marcelo B.; Valbuena, Gustavo			Flea-Borne Rickettsioses in the North of Caldas Province, Colombia	VECTOR-BORNE AND ZOONOTIC DISEASES			English	Article						Colombia; Rickettsia; Rickettsia felis; Fleas; Zoonotic diseases	MURINE TYPHUS; FELIS; INFECTION; POPULATION; ECOLOGY; SPAIN	Rickettsia typhi and R. felis are the etiological agents of murine typhus and flea-borne spotted fever, respectively. Both are emerging acute febrile zoonotic diseases for which fleas are vectors; they also have similar clinical characteristics and global distribution. In 2005, we identified the circulation of murine typhus in 6 towns within the mountainous coffee-growing area north of Caldas, Colombia. We now report the specific seroprevalence against R. typhi and R. felis, and associated risk factors in 7 towns of this province. The combined seroprevalence against the 2 flea-borne rickettsioses is the highest yet reported in the literature: 71.7% (17.8% for R. felis, 25.2% for R. typhi, and 28.7% for both). We also report a prospective analysis of 26 patients with a febrile illness compatible with rickettsioses, including murine typhus; 9 of these patients had a rickettsiosis. This supports our sero-epidemiological results and highlights the diagnostic complexity of febrile syndromes in this region.	[Hidalgo, Marylin; Montoya, Viviana; Martinez, Alejandra; Mercado, Marcela; Faccini-Martinez, Alvaro A.] Pontificia Univ Javeriana, Dept Microbiol, Infect Dis Grp, Bogota, Colombia; [De la Ossa, Alberto; Velez, Carolina] Direcc Terr Salud Caldas, Manizales, Colombia; [Estrada, Gloria] Univ Catolica Manizales, Manizales, Colombia; [Perez, Jorge E.] Univ Caldas, Fac Hlth Sci, Manizales, Colombia; [Labruna, Marcelo B.] Univ Sao Paulo, Fac Vet Med, Sao Paulo, Brazil; [Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Microbiol, Infect Dis Grp, 50 Bldg, Bogota, Colombia.	hidalgo.m@javeriana.edu.co	Hidalgo, Marylin/AAF-5736-2019; Labruna, Marcelo B/B-6241-2013	Labruna, Marcelo B/0000-0002-9675-3132; Faccini-Martinez, Alvaro A./0000-0002-1127-0132; Hidalgo, Marylin/0000-0001-8960-0616; Estrada-Salazar, Gloria Ines/0000-0002-0006-4026	Pontificia Universidad Javeriana [003532]	Pontificia Universidad Javeriana	This research was supported by grant 003532 from Pontificia Universidad Javeriana to M. Hidalgo. The authors thank Andrea Rodriguez Lopez for a preliminary review of the English. The authors thank Becton, Dickinson and Company for the donation of material for sampling.	ALEXIOUDANIEL S, 2002, AM J TROP MED HYG, V66, P76; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bernabeu-Wittel M, 2006, EUR J CLIN MICROBIOL, V25, P375, DOI 10.1007/s10096-006-0147-6; Blacksell SD, 2007, T ROY SOC TROP MED H, V101, P686, DOI 10.1016/j.trstmh.2007.02.015; Bolanos-Rivero M, 2011, INT J INFECT DIS, V15, pE481, DOI 10.1016/j.ijid.2011.03.019; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Forshey BM, 2010, AM J TROP MED HYG, V82, P683, DOI 10.4269/ajtmh.2010.09-0355; Goncalves P, 2005, MEM I O CRUZ, V100, P853; Hidalgo M, 2008, AM J TROP MED HYG, V78, P321, DOI 10.4269/ajtmh.2008.78.321; Hii SF, 2011, VECTOR-BORNE ZOONOT, V11, P1007, DOI 10.1089/vbz.2010.0270; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Lim MY, 2012, EMERG INFECT DIS, V18, P167, DOI 10.3201/eid1801.110996; Lledo L, 2001, EUR J EPIDEMIOL, V17, P927, DOI 10.1023/A:1016248630809; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Nogueras MM, 2006, AM J TROP MED HYG, V74, P123, DOI 10.4269/ajtmh.2006.74.123; Parker TM, 2007, AM J TROP MED HYG, V77, P390, DOI 10.4269/ajtmh.2007.77.390; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; PundaPolic V, 1995, EUR J EPIDEMIOL, V11, P697, DOI 10.1007/BF01720305; Ramirez N, 2007, INVESTIG ANDINA, V9, P5; Raoult D, 2009, RICKETTSIAL DIS, P37; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Renvoise A, 2009, MED MALADIES INFECT, V39, P71, DOI 10.1016/j.medmal.2008.11.003; Suarez R, 2008, RICKETTSIAS COMO AGE, P23; Villar L, 2010, INFECTIO, V14, P22	25	20	24	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-3667	1557-7759		VECTOR-BORNE ZOONOT	Vector-Borne Zoonotic Dis.	MAY	2013	13	5					289	294		10.1089/vbz.2012.1173	http://dx.doi.org/10.1089/vbz.2012.1173			6	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	132LE	23473218	Green Published			2022-09-04	WOS:000318068600002
J	Acevedo, RA; Harmath, P; Mora, JU; Puente, R; Aponte, E				Acevedo, Rafael A.; Harmath, Pedro; Mora, Jose U.; Puente, Raquel; Aponte, Elvis			Shock determination in a two-stage decision-making model: The case of COVID-19 in Colombia	MANAGERIAL AND DECISION ECONOMICS			English	Article							EVOLUTION; CONFLICT	The contributions of this paper are as follows: (a) proposing a two-stage model to study whether an event has temporary or permanent effects on the probability of choosing a good within a market basket that traditional decision theory cannot explain and (b) studying the effects of COVID-19 on consumers' decisions in Colombia. Findings suggest that the pandemic has transitory effects on preferences in the short run. If it lasts longer, it could induce to permanent changes. Thus, this model can be used to analyze the temporary or permanent effects of any event, regardless of its nature or geographical region, on consumer's decision.	[Acevedo, Rafael A.] Creighton Univ, Heider Coll Business, Dept Econ, 2500 Calif Plaza, Omaha, NE 68718 USA; [Acevedo, Rafael A.] Econintech, Barquisimeto, Venezuela; [Harmath, Pedro] Univ Austral, Fac Business Sci, Dept Data Sci, Rosario, Argentina; [Mora, Jose U.] Pontificia Univ Javeriana Cali, Fac Econ & Business Sci, Dept Econ, Santiago De Cali, Colombia; [Puente, Raquel] Univ Navarra, Fac Commun, Dept Mkt & Business Commun, Pamplona, Spain; [Aponte, Elvis] Escuela Super Politecn Litoral, ESPOL, FCNM, Campus Gustavo Galindo Via Perimetral, Guayaquil, Ecuador		Acevedo, RA (corresponding author), Creighton Univ, Heider Coll Business, Dept Econ, 2500 Calif Plaza, Omaha, NE 68718 USA.	rafaelacevedo@creighton.edu	Castro, Raquel Puente/AAF-9266-2019; Castro, Raquel Puente/U-5976-2017; Mora Mora, Jose U./J-5117-2016	Castro, Raquel Puente/0000-0002-8902-1136; Aponte Valladares, Elvis Coromoto/0000-0002-5745-3233; Acevedo, Rafael/0000-0002-1253-0311; Mora Mora, Jose U./0000-0002-5898-4482	Free Market Institute at Texas Tech University	Free Market Institute at Texas Tech University	The authors are indebted to RADDAR and particularly to Doctor Camilo Herrera who was the contact when authors required the data and some information needed for this research. The authors want to thank Dr. Antony Dnes, Editor-in-Chief of the Journal Managerial and Decision Economics, and an anonymous referee for their valuable comments and suggestion to improve our paper. Acevedo thanks the Free Market Institute at Texas Tech University because this research was conducted during his visiting fellowship. Lastly, all errors are the sole responsibility of the authors.	Alchian AA, 1950, J POLIT ECON, V58, P211, DOI 10.1086/256940; Alos-Ferrer C, 2014, J ECON PSYCHOL, V41, P1, DOI 10.1016/j.joep.2013.12.005; Ariely D., 2010, PREDICTABLY IRRATION; Ariely Dan, 2010, UPSIDE IRRATIONALITY; Armstrong T, 2020, J GAMBL STUD, V36, P183, DOI 10.1007/s10899-019-09927-z; Baddeley A.D., 1987, WORKING MEMORY; Barro RJ., 2020, TECHNICAL REPORT; Bauer BW, 2020, PERSPECT PSYCHOL SCI, V15, P44, DOI 10.1177/1745691619866463; BAUMOL WJ, 1964, AM ECON REV, V54, P23; Berdiev AN, 2022, CONTEMP ECON POLICY, V40, P263, DOI 10.1111/coep.12557; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brinca P., 2020, EC SYNOPSIS FEDERAL, P1, DOI DOI 10.20955/ES.2020.31; Brocas I, 2014, J ECON PSYCHOL, V41, P45, DOI 10.1016/j.joep.2013.01.004; Cristofaro M, 2021, INT J ORGAN ANAL, V29, P301, DOI 10.1108/IJOA-01-2020-2010; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Dhar R, 2013, J CONSUM PSYCHOL, V23, P528, DOI 10.1016/j.jcps.2013.02.002; di Mauro B.W., 2020, EC TIME COVID 19, P31; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Gil-Alana L., 2020, ENERGY RES LETT, V1, P13200, DOI [10.46557/001c.13200, DOI 10.46557/001C.13200]; Goel RK, 2021, J POLICY MODEL, V43, P503, DOI 10.1016/j.jpolmod.2021.04.003; Goel RK, 2020, J POLICY MODEL, V43, P298, DOI 10.1016/j.jpolmod.2021.01.003; Kahneman, 2011, THINKING FAST SLOW; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Laibson D, 2001, Q J ECON, V116, P81, DOI 10.1162/003355301556356; Lim WM, 2022, CURR ISSUES TOUR, V25, P1258, DOI 10.1080/13683500.2021.1910218; Ludvigson Sydney C., 2020, W26987 NBER; Maital S., 2020, GLOBAL EC IMPACT COV; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; Mora, 2021, ADV DECISION SCI, V25, P1, DOI [10.47654/v25y2021i1p1-39, DOI 10.47654/V25Y2021I1P1-39]; Rebucci A., 2020, NATL BUREAU EC RES W, DOI [10.3386/w27855, DOI 10.3386/W27855]; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Simon H.A., 1947, ADM BEHAV STUDY DECI; SIMON HA, 1959, AM ECON REV, V49, P253; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Soofi M, 2020, IRAN J PUBLIC HEALTH, V49, P1787, DOI 10.18502/ijph.v49i9.4100; Triggs A., 2020, TRIPLE EC SHOCK COVI; Weibull JW., 1995, EVOLUTIONARY GAME TH; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778	41	0	0	2	4	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	0143-6570	1099-1468		MANAG DECIS ECON	Manag. Decis. Econ.	SEP	2022	43	6					2587	2597		10.1002/mde.3547	http://dx.doi.org/10.1002/mde.3547		JAN 2022	11	Economics; Management	Social Science Citation Index (SSCI)	Business & Economics	3P0GH	35465150	Green Published			2022-09-04	WOS:000738340600001
J	Forero-Becerra, E; Patel, J; Martinez-Diaz, HC; Betancourt-Ruiz, P; Benavides, E; Duran, S; Olaya-Masmela, LA; Bolanos, E; Hidalgo, M; McBride, JW				Forero-Becerra, Elkin; Patel, Jignesh; Martinez-Diaz, Heidy-C; Betancourt-Ruiz, Paola; Benavides, Efrain; Duran, Steven; Olaya-Masmela, Luz-A; Bolanos, Eliana; Hidalgo, Marylin; McBride, Jere W.			Seroprevalence and Genotypic Analysis of Ehrlichia canis Infection in Dogs and Humans in Cauca, Colombia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							IMMUNODIAGNOSIS; AGENT	Ehrlichia canis infections have been reported in humans in Venezuela and Costa Rica. In this study, 506 healthy residents and 114 dogs from four municipalities (Cauca, Colombia) were surveyed and blood samples collected. Antibodies to E. canis in human and canine sera were evaluated using the Tandem repeat protein 19 (TRP19) peptide ELISA and indirect immunofluorescence assay (IFA). Ehrlichia canis TRP19 antibodies were detected in only 1/506 human sera, but the single positive sample was negative by IFA. The majority (75/114; 66%) of dogs surveyed had antibodies to the E. canis TRP19 peptide by ELISA, and eight randomly selected sera were further confirmed by E. canis IFA. Genomic DNA samples obtained from 73 E. canis TRP19 ELISA-positive dog blood samples were examined by PCR targeting the 16S ribosomal ribonucleic acid (rRNA) gene. Ehrlichia canis 16S rRNA was amplified in 30 (41%) of the dogs, and 16 amplicons were selected for DNA sequencing, which confirmed that all were E. canis. A second PCR was performed on the 16 confirmed E. canis 16S rRNA PCR-positive samples to determine the TRP36 genotype by amplifying the trp36 gene. TRP36 PCR amplicon sequencing identified nine dogs infected with the U.S. E. canis TRP36 genotype (56%), one dog with the Brazilian genotype (6%), and six dogs with the Costa Rican genotype (38%). Moreover, these molecular genotype signatures were consistent with serologic analysis using TRP36 genotype-specific peptides. Notably, there was no serologic evidence of E. canis infection in humans, suggesting that E. canis infection in dogs in Cauca is not associated with zoonotic human infection.	[Forero-Becerra, Elkin] Univ Texas Med Branch, Res Training Program, Fogarty Int Ctr Code 1 D43, Galveston, TX USA; [Patel, Jignesh; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Martinez-Diaz, Heidy-C; Betancourt-Ruiz, Paola; Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Benavides, Efrain; Duran, Steven] Univ La Salle, Fac Ciencias Agr, Grp Invest Epidemiol & Salud Publ, Bogota, Colombia; [Olaya-Masmela, Luz-A] Univ Libre Cali, Fac Ciencias La Salud, Programa Med, Sede Valle Lili, Santiago De Cali, Colombia; [Bolanos, Eliana] Secretaria Salud, Dept Cauca, Popayan, Colombia		Forero-Becerra, E (corresponding author), Univ Pedagog & Tecnol Colombia, Fac Ciencias Agr, Grp Invest Med Vet & Zootecnia GIDIMEVETZ, Av Cent Norte 39-115, Tunja 150001, Colombia.	egforerob@unal.edu.co; jgpatel@utmb.edu; h-martinez@javeriana.edu.co; betancourtp@javeriana.edu.co; efbenavides@unisalle.edu.co; sduran26@unisalle.edu.co; adrianaolaya26@gmail.com; eliana.bolanos@cauca.gov.co; hidalgo.m@javeriana.edu.co; jemcbrid@utmb.edu		Martinez-Diaz, Heidy-Carolina/0000-0001-7239-6428; /0000-0003-3706-3542; Benavides, Efrain/0000-0002-8894-5441	Colciencias (Colombia) [120374455209]; Research Training Program of the Fogarty International Center (United States of America) [5D43TW01033104]	Colciencias (Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Research Training Program of the Fogarty International Center (United States of America)	This work was supported by Colciencias (Project No. 120374455209, Colombia) and the Research Training Program of the Fogarty International Center (United States of America) (grant number 5D43TW01033104) .	Aguiar DM, 2013, VET MICROBIOL, V164, P315, DOI 10.1016/j.vetmic.2013.02.015; Aguiar DM, 2016, TICKS TICK-BORNE DIS, V7, P142, DOI 10.1016/j.ttbdis.2015.10.003; Allsopp MTEP, 2005, ANN NY ACAD SCI, V1063, P358, DOI 10.1196/annals.1355.060; ANDERSON BE, 1992, J CLIN MICROBIOL, V30, P775, DOI 10.1128/JCM.30.4.775-780.1992; [Anonymous], 2014, J SPEC OPER MED; Arroyave E, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2019.101367; Botero Alicia Hidrón, 2014, Infect., V18, P158, DOI 10.1016/j.infect.2014.04.001; Bouza-Mora L, 2017, TICKS TICK-BORNE DIS, V8, P36, DOI 10.1016/j.ttbdis.2016.09.012; Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093; Bowser NH, 2018, VET SCI, V5, DOI 10.3390/vetsci5040083; Cardenas AM, 2007, CLIN VACCINE IMMUNOL, V14, P123, DOI 10.1128/CVI.00361-06; Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P64, DOI 10.1590/S0037-86822006000100012; de Aguiar DM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7110528; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Faccini-Martinez AA, 2017, AM J TROP MED HYG, V97, P782, DOI 10.4269/ajtmh.16-0442; Farah J. M., 2012, REV CIENCIAS BIOMEDI, V3, P339; Geiger J, 2018, AM J TROP MED HYG, V99, P297, DOI 10.4269/ajtmh.17-0776; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P9; Guillemi EC, 2015, J MICROBIOL METH, V119, P87, DOI 10.1016/j.mimet.2015.10.009; Ismail N, 2017, CLIN LAB MED, V37, P317, DOI 10.1016/j.cll.2017.01.006; Jones EH, 2018, ZOONOSES PUBLIC HLTH, V65, P74, DOI 10.1111/zph.12369; Jones EK, 1972, B YOUNG U SCI B BIOL, V17, P11; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Luo T, 2009, CLIN VACCINE IMMUNOL, V16, P982, DOI 10.1128/CVI.00048-09; McBride JW, 2007, INFECT IMMUN, V75, P74, DOI 10.1128/IAI.01494-06; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; McBride JW, 2001, J CLIN MICROBIOL, V39, P315, DOI 10.1128/JCM.39.1.315-322.2001; McCown ME, 2014, J SPEC OPER MED, V14, P81; Nava S, 2014, TICKS TICK-BORNE DIS, V5, P252, DOI 10.1016/j.ttbdis.2013.11.004; Ortega C, 2000, REV SCI TECH OIE, V19, P735, DOI 10.20506/rst.19.3.1245; Perez M, 1996, J CLIN MICROBIOL, V34, P2133, DOI 10.1128/JCM.34.9.2133-2139.1996; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Pesapane R, 2019, VET MICROBIOL, V233, P184, DOI 10.1016/j.vetmic.2019.05.002; Pritt BS, 2017, INT J SYST EVOL MICR, V67, P2121, DOI 10.1099/ijsem.0.001896; STANDAERT SM, 1995, NEW ENGL J MED, V333, P420, DOI 10.1056/NEJM199508173330704; Szabo MPJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00027; Vargas-Hernandez G, 2012, VET PARASITOL, V186, P254, DOI 10.1016/j.vetpar.2011.11.011; Zhang X, 2008, CLIN VACCINE IMMUNOL, V15, P1080, DOI 10.1128/CVI.00482-07	38	1	1	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2021	104	5					1771	1776		10.4269/ajtmh.20-0965	http://dx.doi.org/10.4269/ajtmh.20-0965			6	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	SD2MU	33755584	Green Published			2022-09-04	WOS:000651201800036
J	Arbelaez-Cortes, E; Sanchez-Sarria, CE; Ocampo, D; Estela, FA; Garcia-Arroyo, M; MacGregor-Fors, I				Arbelaez-Cortes, Enrique; Sanchez-Sarria, Camilo E.; Ocampo, David; Estela, Felipe A.; Garcia-Arroyo, Michelle; MacGregor-Fors, Ian			EXPERIENCES OF SURVEYING URBAN BIRDS DURING THE ANTHROPAUSE IN COLOMBIA	ORNITOLOGIA NEOTROPICAL			English	Article						Bird surveys; COVID-19 lockdown; Monitoring biodiversity; Urban ecology	DATA-INTENSIVE SCIENCE; CITIZEN SCIENCE	The COVID-19 lockdowns set a singular opportunity to perform scientific research in idle cities. The expected changes in urban ecology led us to conform a community composed of several volunteers which, following standardized protocols, conducted structured bird surveys across Colombia. We describe the process and experience of this initiative, conducted between 30 March and 30 June, 2020, and discuss recommendations to apply to future projects. The volunteer-based survey that we organized began with 93 collaborators in 40 urban centers, but ended with just 45 collaborators from 22 urban centers. Some issues that probably explain the drop in collaborators are commented on. This exercise was successful, gathering over 75,000 bird records of at least 250 bird species.	[Arbelaez-Cortes, Enrique] Univ Ind Santander, Escuela Biol, Grp Estudios Biodiversidad, Bucaramanga, Colombia; [Sanchez-Sarria, Camilo E.; Estela, Felipe A.] Pontificia Univ Javeriana, Dept Ciencias Nat & Matemat, Cali, Colombia; [Sanchez-Sarria, Camilo E.; Garcia-Arroyo, Michelle; MacGregor-Fors, Ian] Inst Ecol AC INECOL, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Sanchez-Sarria, Camilo E.; Garcia-Arroyo, Michelle; MacGregor-Fors, Ian] Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Program, Niemenkatu, Lahti, Finland; [Ocampo, David] Inst Invest Recursos Biol Alexander von Humboldt, Villa De Leyva, Colombia		Arbelaez-Cortes, E (corresponding author), Univ Ind Santander, Escuela Biol, Grp Estudios Biodiversidad, Bucaramanga, Colombia.	enriquearbelaez@gmail.com	MacGregor-Fors, Ian/P-1455-2014	MacGregor-Fors, Ian/0000-0003-3198-7322				Acevedo-Charry O., 2020, LISTA REFERENCIA ESP, DOI [10.15472/qhsz0p, DOI 10.15472/QHSZ0P]; [Anonymous], 2017, AVIAN ECOLOGY LATIN; Arbelaez-Cortes E, 2013, BIODIVERS CONSERV, V22, P2875, DOI 10.1007/s10531-013-0560-y; Asociacion Colombiana de Ornitologia, 2020, LIST REF ESP AV COL, DOI [10.15472/qhsz0p, DOI 10.15472/QHSZ0P]; BirdLife International, 2017, ANN REV 2017; Chandler M, 2017, BIOL CONSERV, V213, P280, DOI 10.1016/j.biocon.2016.09.004; Codazzi Instituto Geografico Agustin, 2008, ATL BAS COL; Consejeria Presidencial para las Regiones, 2020, COR COVID 19 DECR LI; Delgado-V Carlos A, 2013, ing.cienc., V9, P215; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Domroese MC, 2017, BIOL CONSERV, V208, P40, DOI 10.1016/j.biocon.2016.08.020; Dutheil F, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114466; eBird Colombia, 2019, EBIRD COL SIST INF B, DOI [10.15472/zso3xd, DOI 10.15472/ZSO3XD]; Eitzel M.V., 2017, CITIZEN SCI THEORY P, V2, P1, DOI [10.5334/cstp.113, 10.5334/cstp.96]; Gill F, 2018, IOC WORLD BIRD NAMES; Google, 2020, 8000 COMMUNITY COLL; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; MacGregor-Fors I, 2010, ECOL RES, V25, P883, DOI 10.1007/s11284-010-0717-z; Mallapaty S, 2020, NATURE, V580, P176, DOI 10.1038/d41586-020-00965-x; Pollack L, 2017, CURR ZOOL, V63, P205, DOI 10.1093/cz/zox011; Ruktanonchai NW, 2020, SCIENCE, V369, P1465, DOI 10.1126/science.abc5096; Rutz C, 2020, NAT ECOL EVOL, V4, P1156, DOI 10.1038/s41559-020-1237-z; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117; Williams M, 2015, ANTHROPOCENE REV, V2, P196, DOI 10.1177/2053019615591020	26	0	0	1	3	NEOTROPICAL ORNITHOLOGICAL SOC, USGS PATUXENT WILDLIFE RESEARCH CTR	ATHENS	UNIV GEORGIA, WARNELL SCH FOREST RESOURCES, ATHENS, GA 30602-2152 USA	1075-4377			ORNITOL NEOTROP	ORNITOL. NEOTROP.		2021	32						166	169						4	Ornithology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	XN7IZ					2022-09-04	WOS:000729675300001
J	Saheb, M; Fereydouni, N; Nemati, S; Barreto, GE; Johnston, TP; Sahebkar, A				Saheb, Mahsa; Fereydouni, Narges; Nemati, Saeideh; Barreto, George E.; Johnston, Thomas P.; Sahebkar, Amirhossein			Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						bioavailability; chitosan; curcumin; drug delivery; solubility	FATTY LIVER-DISEASE; ORAL DELIVERY; DRUG-DELIVERY; IN-VITRO; COATED NANOPARTICLES; PIPERINE COMBINATION; CHITOSAN/ALGINATE NANOPARTICLES; TRIPOLYPHOSPHATE NANOPARTICLES; POLYCAPROLACTONE NANOPARTICLES; PHYTOSOMAL CURCUMIN	Effective drug delivery is one of the most important issues associated with the administration of therapeutic agents that have low oral bioavailability. Curcumin is an active ingredient in the turmeric plant, which has low oral bioavailability due to its poor aqueous solubility. One strategy that has been considered for enhancing the aqueous solubility, and, thus, its oral bioavailability, is the use of chitosan as a carrier for curcumin. Chitosan is a biodegradable and biocompatible polymer that is relatively water-soluble. Therefore, various studies have sought to improve the aqueous solubility of chitosan. The use of different pharmaceutical excipients and formulation strategies has the potential to improve aqueous solubility, formulation processing, and the overall delivery of hydrophobic drugs. This review focuses on various methods utilized for chitosan-based delivery of curcumin.	[Saheb, Mahsa; Nemati, Saeideh] Islamic Azad Univ Damghan, Dept Basic Sci, Damghan, Iran; [Fereydouni, Narges] Mashhad Univ Med Sci, Fac Med, Dept Modern Sci & Technol, Mashhad, Razavi Khorasan, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO 64110 USA; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Barreto, George E./AAD-7420-2020; Fereydouni, Narges/ABD-8931-2020	Barreto, George E./0000-0002-6644-1971; 				Abdel-Hafez SM, 2018, INT J BIOL MACROMOL, V108, P753, DOI 10.1016/j.ijbiomac.2017.10.170; Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Abruzzo A, 2016, COLLOID SURFACE B, V145, P362, DOI 10.1016/j.colsurfb.2016.05.023; Akhtar F, 2012, BIOTECHNOL ADV, V30, P310, DOI 10.1016/j.biotechadv.2011.05.009; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anitha A, 2014, EUR J PHARM BIOPHARM, V88, P238, DOI 10.1016/j.ejpb.2014.04.017; Anitha A, 2012, J BIOMAT SCI-POLYM E, V23, P1381, DOI 10.1163/092050611X581534; Anitha A, 2011, CARBOHYD POLYM, V84, P1158, DOI 10.1016/j.carbpol.2011.01.005; Anitha A, 2011, CARBOHYD POLYM, V83, P452, DOI 10.1016/j.carbpol.2010.08.008; Baghbani F, 2017, MAT SCI ENG C-MATER, V74, P186, DOI 10.1016/j.msec.2016.11.107; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Bavarsad K., 2018, MOL NEUROBIOLOGY; Bhunchu S, 2016, PHARMAZIE, V71, P691, DOI 10.1691/ph.2016.6105; Bianconi V, 2018, CURR OPIN HEMATOL, V25, P44, DOI 10.1097/MOH.0000000000000389; Chan WH, 2005, ANN NY ACAD SCI, V1042, P372, DOI 10.1196/annals.1338.057; Chaubey P, 2014, EXPERT OPIN DRUG DEL, V11, P1163, DOI 10.1517/17425247.2014.917076; Chen HL, 2012, J LIPOSOME RES, V22, P100, DOI 10.3109/08982104.2011.621127; Chuah LH, 2014, COLLOID SURFACE B, V116, P228, DOI 10.1016/j.colsurfb.2014.01.007; Chuah LH, 2013, PHARM DEV TECHNOL, V18, P591, DOI 10.3109/10837450.2011.640688; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.5114/aoms.2017.69326, 10.1093/nutrit/nux047]; DAI M, 2009, BIOMED RESEARCH INTE, V2009, DOI DOI 10.1155/2009/595126; Duse L, 2017, PHYS STATUS SOLIDI; Esfandiarpour-Boroujeni S, 2017, CARBOHYD POLYM, V168, P14, DOI 10.1016/j.carbpol.2017.03.031; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Garcia-Gonzalez CA, 2011, CARBOHYD POLYM, V86, P1425, DOI 10.1016/j.carbpol.2011.06.066; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Hu LD, 2015, AAPS PHARMSCITECH, V16, P1327, DOI 10.1208/s12249-014-0254-0; Huang YC, 2016, FOOD HYDROCOLLOID, V53, P261, DOI 10.1016/j.foodhyd.2015.02.006; Huang YC, 2011, J CHIN CHEM SOC-TAIP, V58, P779; Jahromi MAM, 2014, IRAN J BIOTECHNOL, V12, P1; Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001; Karewicz A, 2013, COLLOID SURFACE B, V109, P307, DOI 10.1016/j.colsurfb.2013.03.059; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Karri VVSR, 2016, INT J BIOL MACROMOL, V93, P1519, DOI 10.1016/j.ijbiomac.2016.05.038; Kumara JBV, 2017, IET NANOBIOTECHNOL, V11, P96, DOI 10.1049/iet-nbt.2016.0062; Kumirska J, 2011, POLYMERS-BASEL, V3, P1875, DOI 10.3390/polym3041875; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Li JY, 2016, CARBOHYD POLYM, V146, P435, DOI 10.1016/j.carbpol.2016.03.079; Li X, 2012, SCI REP-UK, V2, DOI [10.1038/srep00395, 10.1038/srep00870]; Liu MX, 2016, J MATER CHEM B, V4, P2253, DOI 10.1039/c5tb02725j; Luckanagul JA, 2018, CARBOHYD POLYM, V181, P1119, DOI 10.1016/j.carbpol.2017.11.027; Malesu V.K., 2011, CHITOSAN SODIUM ALGI; Martins AF, 2013, INT J BIOL MACROMOL, V57, P174, DOI 10.1016/j.ijbiomac.2013.03.029; Mazzarino L, 2015, J NANOSCI NANOTECHNO, V15, P781, DOI 10.1166/jnn.2015.9189; Mazzarino L, 2014, J PHARM SCI-US, V103, P3764, DOI 10.1002/jps.24142; Mazzarino L, 2014, MACROMOL BIOSCI, V14, P709, DOI 10.1002/mabi.201300465; Mazzarino L, 2014, J BIOMED NANOTECHNOL, V10, P787, DOI 10.1166/jbn.2014.1768; Mazzarino L, 2012, J COLLOID INTERF SCI, V370, P58, DOI 10.1016/j.jcis.2011.12.063; Mirzaei H, 2017, BIOMED PHARMACOTHER, V85, P102, DOI 10.1016/j.biopha.2016.11.098; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Momtazi AA, 2017, PHARMACOL RES, V120, P157, DOI 10.1016/j.phrs.2017.03.023; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Nasab NA, 2018, ARTIF CELL NANOMED B, V46, P75, DOI 10.1080/21691401.2017.1290648; Norouzi S, 2018, CURR PHARM DESIGN, V24, P171, DOI 10.2174/1381612824666171129203506; Panahi Y, 2018, DRUG RES, V68, P403, DOI 10.1055/s-0044-101752; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006; Panahi Y, 2014, PHYTOTHER RES, V28, P1625, DOI 10.1002/ptr.5174; Parida U.K., 2011, J BIOMATER NANOBIOTE, V2, P414, DOI [10.4236/jbnb.2011.24051, DOI 10.4236/JBNB.2011.24051]; Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003; Pfeiffer E., 2003, STABLE UNSTABLE GLUC, P313; Pirro M, 2004, EUR J CARDIOV PREV R, V11, P497, DOI 10.1097/00149831-200412000-00009; Popat A, 2014, COLLOID SURFACE B, V117, P520, DOI 10.1016/j.colsurfb.2014.03.005; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Ramalingam P, 2015, PHARM RES-DORDR, V32, P389, DOI 10.1007/s11095-014-1469-1; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Rejinold NS, 2011, INT J BIOL MACROMOL, V49, P161, DOI 10.1016/j.ijbiomac.2011.04.008; Rejinold NS, 2011, J COLLOID INTERF SCI, V360, P39, DOI 10.1016/j.jcis.2011.04.006; Sahebkar A, 2016, PAIN MED, V17, P1192, DOI 10.1093/pm/pnv024; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Samrot AV, 2018, INFORM MED UNLOCKED; Shah BR, 2016, FOOD HYDROCOLLOID, V52, P369, DOI 10.1016/j.foodhyd.2015.07.015; Shelma R, 2013, CARBOHYD POLYM, V95, P441, DOI 10.1016/j.carbpol.2013.02.029; Shelma R, 2011, COLLOID SURFACE B, V88, P722, DOI 10.1016/j.colsurfb.2011.08.007; Shelma R, 2010, J MATER SCI-MATER M, V21, P2133, DOI 10.1007/s10856-010-4073-x; Shin GH, 2013, J AGR FOOD CHEM, V61, P11119, DOI 10.1021/jf4035404; Songkroh T, 2015, MACROMOL RES, V23, P53, DOI 10.1007/s13233-015-3006-4; Sorasitthiyanukarna FN, 2018, MAT SCI ENG C-MATER, V93, P178, DOI 10.1016/j.msec.2018.07.069; Subramanian SB, 2014, CARBOHYD POLYM, V114, P170, DOI 10.1016/j.carbpol.2014.07.053; Tan C, 2016, FOOD HYDROCOLLOID, V57, P236, DOI 10.1016/j.foodhyd.2016.01.021; Tanzeela Nisar, 2015, American-Eurasian Journal of Agricultural & Environmental Sciences, V15, P1278; Thomas-Eapen NE, 2009, EXPLORE-NY, V5, P114, DOI 10.1016/j.explore.2008.12.008; Umerska A, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7040046; Vidyalakshmi K, 2004, J MACROMOL SCI PURE, VA41, P1115, DOI 10.1081/MA-200026554; Wan SX, 2012, PHARMAZIE, V67, P525, DOI 10.1691/ph.2012.1124; Wang FZ, 2018, J AGR FOOD CHEM, V66, P2685, DOI 10.1021/acs.jafc.7b05083; Pham XN, 2016, ADV NAT SCI-NANOSCI, V7, DOI 10.1088/2043-6262/7/4/045010; Yadav A, 2012, CHEM-BIOL INTERACT, V199, P49, DOI 10.1016/j.cbi.2012.05.011; Yadavalli T, 2015, J MAGN MAGN MATER, V380, P315, DOI 10.1016/j.jmmm.2014.09.035; Yang CW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-22; Zabihi NA, 2017, CURR PHARM DESIGN, V23, P969, DOI 10.2174/1381612822666161010115235; Zhang JF, 2013, INT J PHARMACEUT, V448, P168, DOI 10.1016/j.ijpharm.2013.03.021; Zhou N, 2013, CARBOHYD POLYM, V94, P420, DOI 10.1016/j.carbpol.2013.01.014	97	20	20	3	81	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	AUG	2019	234	8					12325	12340		10.1002/jcp.28024	http://dx.doi.org/10.1002/jcp.28024			16	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HX2SA	30697728				2022-09-04	WOS:000467240800018
J	Olaya, M; Garrido, M; Hernandez-Losa, J; Sese, M; Ayala-Ramirez, P; Somoza, R; Vargas, MJ; Cajal, SRY				Olaya-C, Mercedes; Garrido, Marta; Hernandez-Losa, Javier; Sese, Marta; Ayala-Ramirez, Paola; Somoza, Rosa; Jimena Vargas, Magda; Ramon y Cajal, Santiago			The umbilical cord, preeclampsia and the VEGF family	INTERNATIONAL JOURNAL OF WOMENS HEALTH			English	Article						preeclampsia; umbilical cord; VEGF; sFLT1; PLGF; stillbirth	PLACENTAL GROWTH-FACTOR; GENE-EXPRESSION; RISK; HYPERTENSION; STATEMENT; RATIO; 1ST	Introduction: The VEGF family has been identified as abnormal in preeclampsia (PE). Hypertensive disorders of pregnancy (HDP) are major contributors to maternal and neonatal morbidity and mortality worldwide; likewise, umbilical cord anatomical abnormalities (UCAA) are linked to poor neonatal outcomes. Based on the relationship described between PE and UCAA and the role of the VEGF family in PE, this study explored VEGF expression in placental and UC tissued from patients with PE and with UCAA. Methods: We performed an observational, analytical study on placentas, comparing protein and mRNA expression in four groups: patients with PE, patients with UC abnormalities, patients with both, and patients with none of them. Using immunohistochemistty, we studied VEGF A, VEGF R1 (FLT1), MMP1, and PLGF. With quantitative reverse transcription polymerase chain reaction we described mRNA expression of PLGF, VEGF and sFLT1, and sFLT1/PLGF ratio. Results: Forty newborns were included. Sixty-seven percent of mothers and 45% of newborns developed no complications. Immunohistochemistry was performed on UC and placental disc paraffin-embedded tissue; in the latter, the mRNA of the VEGF family was also measured. Statistically significant differences were observed among different expressions in both HDP and UCAA groups. Interestingly, the UCAA group exhibited lower levels of sFLT1 and VEGF-A in comparison with other groups, with significant P-value for sFLT1 (P=0000.1). Conclusion: The origin of UCAA abnormalities and their relation with HDP are still unknown. VEGF family alterations could be involved in both. This study provides the first approach related to molecules linked to UCAA.	[Olaya-C, Mercedes] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Med Sch, Inst Human Genet,Dept Pathol, Bogota, Colombia; [Garrido, Marta; Hernandez-Losa, Javier; Sese, Marta; Somoza, Rosa; Ramon y Cajal, Santiago] Vall dHebron Hosp, Pathol Dept, Barcelona, Spain; [Hernandez-Losa, Javier; Sese, Marta; Somoza, Rosa; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Vali dHebron Res Inst VHIR, Translat Mol Pathol, Barcelona, Spain; [Hernandez-Losa, Javier; Sese, Marta; Somoza, Rosa; Ramon y Cajal, Santiago] Spanish Biomed Res Network Ctr Oncol CIBERONC, Barcelona, Spain; [Ayala-Ramirez, Paola] Pontificia Univ Javeriana, Med Sch, Inst Human Genet, Bogota, Colombia; [Jimena Vargas, Magda] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Med Sch, Dept Pathol, Bogota, Colombia		Olaya, M (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Patol, Fac Med, Carrera 7, Bogota 4062, Colombia.	olaya.m@javeriana.edu.co	Ramon y Cajal, Santiago/H-4955-2016; Javier, Hernandez Losa/C-1173-2008; Sese, Marta/AAH-9749-2021; OLAYA-C, MERCEDES/AGC-7209-2022	Ramon y Cajal, Santiago/0000-0002-3867-1390; Javier, Hernandez Losa/0000-0003-1526-3201; Sese, Marta/0000-0003-1473-4833; OLAYA-C, MERCEDES/0000-0002-7147-425X; Somoza, Rosa/0000-0003-4156-6716; Ayala Ramirez, Paola/0000-0002-0141-1149	Pontificia Universidad Javeriana - Hospital Universitario San Ignacio in Bogota, Colombia [PPTA 00008027]; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain [PPTA 00008027]; Fundacion Carolina de Espana; Pontificia Universidad Javeriana - Hospital Universitario San Ignacio in Bogota; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Espana	Pontificia Universidad Javeriana - Hospital Universitario San Ignacio in Bogota, Colombia; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain; Fundacion Carolina de Espana; Pontificia Universidad Javeriana - Hospital Universitario San Ignacio in Bogota; Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Espana	We wish to thank the Fundacion Carolina de Espana, Pontificia Universidad Javeriana -Hospital Universitario San Ignacio in Bogota, and Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Espana for their indispensable support and participation in this study. We also extend our thanks to the parents who participated in this study and to Steven W Bayless for the English language text correction. This study constitutes part of the research project entitled, "Molecular alteration in vascular placental development", (ID PPTA 00008027) financed by the Pontificia Universidad Javeriana - Hospital Universitario San Ignacio in Bogota, Colombia, and the Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Spain.	Aghababaei M, 2014, MOL HUM REPROD, V20, P235, DOI 10.1093/molehr/gat084; Amaral LM, 2015, VASC HEALTH RISK MAN, V11, P403, DOI 10.2147/VHRM.S64798; Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Baergen RN, 2001, PEDIATR DEVEL PATHOL, V4, P144, DOI 10.1007/s100240010135; Benton SJ, 2016, PLACENTA, V42, P1, DOI 10.1016/j.placenta.2016.03.010; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1661, DOI 10.1001/jama.2017.3439; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Binder NK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163096; Black MH, 2016, J HYPERTENS, V34, P728, DOI 10.1097/HJH.0000000000000855; Chang SD, 2011, TAIWAN J OBSTET GYNE, V50, P283, DOI 10.1016/j.tjog.2011.07.005; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Cohen M, 2012, NEUROENDOCRINOL LETT, V33, P406; Collins JH, 2011, SILENT RISK ISSUES H; Conti E, 2013, CYTOKINE GROWTH F R, V24, P411, DOI 10.1016/j.cytogfr.2013.05.008; Duhig KE, 2014, EXPERT REV MOL DIAGN, V14, P403, DOI 10.1586/14737159.2014.908121; Ehrlich L, 2017, HYPERTENS PREGNANCY, V36, P175, DOI 10.1080/10641955.2017.1291673; Ferguson VL, 2009, EUR J OBSTET GYN R B, V144, pS108, DOI 10.1016/j.ejogrb.2009.02.024; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Foo L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0545-1; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Goynumer G, 2008, J PERINAT MED, V36, P523, DOI 10.1515/JPM.2008.087; GRAFE MR, 1994, J NEUROPATH EXP NEUR, V53, P407, DOI 10.1097/00005072-199407000-00013; Gumina DL, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00041; Herzog EM, 2017, PLACENTA, V49, P72, DOI 10.1016/j.placenta.2016.11.014; Kaplan C., 2007, COLOR ATLAS GROSS PL, P119; Kinney MV, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-28; Lee G, 2015, MIDWIFERY, V31, P1127, DOI 10.1016/j.midw.2015.09.005; Li SW, 2014, ASIAN PAC J TROP MED, V7, P663, DOI 10.1016/S1995-7645(14)60112-7; Nasiell J, 2016, J MATERN-FETAL NEO M, V29, P721, DOI 10.3109/14767058.2015.1015984; Olaya-C M, 2015, J Neonatal Perinatal Med, V8, P251, DOI 10.3233/NPM-15915056; Olaya-C M, 2016, J Neonatal Perinatal Med, V9, P49, DOI 10.3233/NPM-16814108; Olaya-C M, 2014, APM, V20, P22; Olaya M, 2018, PEDIATR DEVEL PATHOL, V21, P467, DOI 10.1177/1093526618758204; Olaya M, 2015, EARLY HUM DEV, V91, P291, DOI 10.1016/j.earlhumdev.2015.03.001; Perrone Serafina, 2016, World J Clin Pediatr, V5, P172, DOI 10.5409/wjcp.v5.i2.172; Piccoli GB, 2017, J NEPHROL, V30, P307, DOI 10.1007/s40620-017-0390-1; Redline Raymond W, 2013, Surg Pathol Clin, V6, P153, DOI 10.1016/j.path.2012.11.005; Redline RW, 2000, PEDIATR RES, V47, P721, DOI 10.1203/00006450-200006000-00007; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Robillard PY, 2011, J REPROD IMMUNOL, V89, P104, DOI 10.1016/j.jri.2011.02.003; Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419; Saha T, 2013, INDIAN J BIOCHEM BIO, V50, P462; Saleemuddin A, 2010, PEDIATR DEVEL PATHOL, V13, P459, DOI 10.2350/10-01-0774-OA.1; Shennan AH, 2017, LANCET, V389, P582, DOI 10.1016/S0140-6736(17)30184-8; Sovio U, 2017, HYPERTENSION, V69, P731, DOI 10.1161/HYPERTENSIONAHA.116.08620; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Vrachnis N, 2013, J MATERN-FETAL NEO M, V26, P995, DOI 10.3109/14767058.2013.766694; Wagnew M, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.9716; Weel IC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157584; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	50	5	5	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1411			INT J WOMENS HEALTH	Int. J. Womens Health		2018	10						783	795		10.2147/IJWH.S174734	http://dx.doi.org/10.2147/IJWH.S174734			13	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	HD0VN	30568515	gold, Green Published			2022-09-04	WOS:000452227300003
J	Marin, LS; Rodriguez, AC; Rey-Becerra, E; Piedrahita, H; Barrero, LH; Dennerlein, JT; Johnson, PW				Marin, Luz S.; Rodriguez, Andres C.; Rey-Becerra, Estefany; Piedrahita, Hugo; Barrero, Lope H.; Dennerlein, Jack T.; Johnson, Peter W.			Assessment of Whole-Body Vibration Exposure in Mining Earth-moving Equipment and Other Vehicles Used in Surface Mining	ANNALS OF WORK EXPOSURES AND HEALTH			English	Article						daily exposure metrics; daily vibration action limits; health risk predictions; heavy equipment vehicles; mining vehicle operators; open-pit mine; predominant axis	LOW-BACK-PAIN; HEALTH-RISKS; CITY BUS; OPERATORS; DRIVERS; LOADER	This study characterized whole-body vibration exposures in a set of vehicles that operate in open-pit mines and compared three different daily exposure parameters based on the ISO 2631-1: 1997 and ISO 2631-5: 2004 standards. Full-shift, 6 to 12-hour, continuous whole-body vibration measurements were collected from 11 representative types of vehicles in terms of hours of operation and number of vehicles used. For each type of vehicle, the exposure parameters (A(8), VDV(8), and S-ed (8)) were calculated for each axis (x, y, and z), and in addition, shear or horizontal (Sigma xy) and vector sum (Sigma xyx) whole-body vibration exposure. Findings showed that: (i) substantially higher shear and vector sum whole-body vibration exposures indicated relatively high levels of exposure on the non-predominant axis; (ii) the predominant axis of exposure varied across the different type of vehicles; (iii) there were differences in whole-body vibration exposure parameters regarding the standards-based predictions of potentially adverse health outcomes (the impulsive exposure parameters VDV(8) and S-ed (8) were higher and reduced acceptable vehicle operation times by one-half to two-thirds relative to A(8) exposures); and (iv) based on the predominant exposures and the time to reach daily vibration action limits, the operation of most mining vehicles would be limited to less than 8 hours a day. Differences in whole-body vibration exposure parameters impact the prediction of potentiallyadverse health outcomes and may introduce some uncertainty regarding how to best characterize a vehicle operator's actual exposure.	[Marin, Luz S.] Indiana Univ Penn, Coll Hlth & Human Serv, Dept Safety Sci, 1010 Oakland Ave, Indiana, PA 15705 USA; [Marin, Luz S.; Dennerlein, Jack T.] Northeastern Univ, Dept Phys Therapy Movement & Rehabil Sci, Bouve Coll Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA; [Rodriguez, Andres C.; Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Cr 7 40-62, Bogota, Colombia; [Rey-Becerra, Estefany] Pontificia Univ Javeriana, Dept Civil & Ind Engn, Cl 18 118328, Cali, Colombia; [Piedrahita, Hugo] Hlth & Wellbeing Div, Cerrejon, La Guajira, Colombia; [Johnson, Peter W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Box 357234-4225 Roosevelt Way,NE Suite 100, Seattle, WA 98195 USA		Marin, LS (corresponding author), Indiana Univ Penn, Coll Hlth & Human Serv, Dept Safety Sci, 1010 Oakland Ave, Indiana, PA 15705 USA.; Marin, LS (corresponding author), Northeastern Univ, Dept Phys Therapy Movement & Rehabil Sci, Bouve Coll Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA.	LuzMarin@iup.edu	; Johnson, Peter/C-3046-2011	Dennerlein, Jack/0000-0001-7703-643X; Barrero, Lope/0000-0003-1503-0264; Marin, Luz S./0000-0002-1383-8166; Johnson, Peter/0000-0001-5583-5919	Alpha Foundation for the Improvement of Mine Safety and Health, Inc.; Alpha Foundation [AFC113-3]	Alpha Foundation for the Improvement of Mine Safety and Health, Inc.; Alpha Foundation	We would like to thank the mining personnel who facilitated and supported our data collection efforts; Claudia Arias who assisted with data collection in the field; and Lovenoor Aulck and Jennifer Ibbotson-Brown, for assistance with data programming and analysis. This study was sponsored by the Alpha Foundation for the Improvement of Mine Safety and Health, Inc. (ALPHA FOUNDATION). The views, opinions, and recommendations expressed herein are solely those of the authors and do not imply any endorsement by the ALPHA FOUNDATION, its Directors and staff. Alpha Foundation Grant # AFC113-3.	[Anonymous], 1997, 2631 ISO; Blood RP, 2012, J SAFETY RES, V43, P357, DOI 10.1016/j.jsr.2012.10.006; Bovenzi M, 2006, Med Lav, V97, P535; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; Burgess-Limerick R, 2016, J OCCUP ENVIRON HYG, V13, P339, DOI 10.1080/15459624.2015.1125486; Chaudhary DK, 2015, SAF HEALTH WORK, V6, P268, DOI 10.1016/j.shaw.2015.06.004; Chen JC, 2003, ERGONOMICS, V46, P1075, DOI 10.1080/0014013031000109205; Eger T, 2008, INT J IND ERGONOM, V38, P726, DOI 10.1016/j.ergon.2007.08.012; Eger T., 2006, Occupational Ergonomics, V6, P121; International Organization for Standardization, 2004, MECH VIBRATION SHOCK; Kumar S, 2004, APPL ERGON, V35, P509, DOI 10.1016/j.apergo.2004.06.009; Langer TH, 2015, INT J IND ERGONOM, V47, P79, DOI 10.1016/j.ergon.2015.02.009; Lewis CA, 2012, OCCUP MED-OXFORD, V62, P519, DOI 10.1093/occmed/kqs096; Milosavljevic S, 2012, ANN OCCUP HYG, V56, P10, DOI 10.1093/annhyg/mer068; Milosavljevic S, 2010, APPL ERGON, V41, P530, DOI 10.1016/j.apergo.2009.11.002; Okunribido OO, 2007, APPL ERGON, V38, P29, DOI 10.1016/j.apergo.2006.01.006; Paddan GS, 2002, J SOUND VIB, V253, P195, DOI 10.1006/jsvi.2001.4256; Rehn B, 2005, ANN OCCUP HYG, V49, P267, DOI 10.1093/annhyg/meh077; Skandfer M, 2014, ERGONOMICS, V57, P1541, DOI 10.1080/00140139.2014.904005; Smets MPH, 2010, APPL ERGON, V41, P763, DOI 10.1016/j.apergo.2010.01.002; Thamsuwan O, 2013, INT J IND ERGONOM, V43, P9, DOI 10.1016/j.ergon.2012.10.003; US Bureau of Labor Statistics, 2016, NONF OCC INJ ILLN RE; Vanerkar AP, 2008, ENVIRON MONIT ASSESS, V143, P239, DOI 10.1007/s10661-007-9972-z; Wolfgang R, 2014, APPL ERGON, V45, P1700, DOI 10.1016/j.apergo.2014.05.020; Zhao XJ, 2014, INT J IND ERGONOM, V44, P840, DOI 10.1016/j.ergon.2014.09.006; Zuo L, 2003, J SOUND VIB, V265, P459, DOI 10.1016/S0022-460X(02)01567-5	26	28	28	1	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2398-7308	2398-7316		ANN WORK EXPOS HEAL	Ann. Work Expos. Health	JUL	2017	61	6					669	680		10.1093/annweh/wxx043	http://dx.doi.org/10.1093/annweh/wxx043			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FG6XJ	28637189	hybrid			2022-09-04	WOS:000410541900006
J	Aschner, P; Munoz, OM; Giron, D; Garcia, OM; Fernandez, DG; Casas, LA; Bohorquez, LF; Arango, CM; Carvajal, L; Ramirez, DA; Sarmiento, JG; Colon, CA; Correa, NF; Alarcon, P; Bustamante, A				Aschner M, Pablo; Mauricio Munoz, Oscar, V; Giron C, Diana; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Angela Casas, Luz; Fernanda Bohorquez, Luisa; Maria Arango T, Clara; Carvajal, Liliana; Amanda Ramirez, Doris; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro			Clinical Practice Guideline for Treatment of Type 2 Diabetes Mellitus: Initial Treatment	UNIVERSITAS MEDICA			Spanish	Article						type 2 diabetes mellitus; metformin; primary treatment; clinical practice guidelines	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; PHYSICAL-ACTIVITY; COMBINATION THERAPY; GLYCEMIC CONTROL; METAANALYSIS; METFORMIN; MONOTHERAPY; ROSIGLITAZONE; RISK; DIET	Introduction: Today, metformin is widely accepted as standard initial pharmacologic treatment for diabetes mellitus type 2 (DMT2). However, it is controversial if in some groups of patients, the treatment can be initiated only with life style changes, or if there are groups who should begin with combined therapy since the beginning. Aim: To define the effect of intensive strategies for change of diet or exercise, and the effect of combined therapy with metformin and a second oral antidiabetic, as initial treatment in patients with newly DMT2. Methods: A clinical practice guide has been developed following the broad outline of the methodological guide from the Colombian Ministry of Health and Social Welfare. with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. Conclusions: In patients with recently diagnosed DMT2, initial treatment with lifestyle changes only is not recommended. However, it is recommended that lifestyles changes must begin simultaneously with metformin, including the components of a Mediterranean diet and aerobic exercise. In patients with recently diagnosed DMT2 and HbA1c levels >8%, it is recommended to administer a combined therapy from the beginning with metformin and another oral antidiabetic medication. The DPP4 inhibitor is recommended.	[Aschner M, Pablo; Mauricio Munoz, Oscar, V; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Hosp Univ San Ignacio, Bogota, Colombia; [Aschner M, Pablo; Mauricio Munoz, Oscar, V; Giron C, Diana; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Pontificia Univ Javeriana, Bogota, Colombia; [Angela Casas, Luz] Univ Valle, Cali, Colombia; [Fernanda Bohorquez, Luisa; Amanda Ramirez, Doris] Univ Nacl Colombia, Bogota, Colombia; [Maria Arango T, Clara] Univ Antioquia, Medellin, Colombia; [Carvajal, Liliana] Asociac Colombiana Diabet, Bogota, Colombia		Munoz, OM (corresponding author), Hosp Univ San Ignacio, Bogota, Colombia.; Munoz, OM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	o.munoz@javeriana.edu.co	Girón, Diana/ABC-1451-2021; Muñoz, Oscar/Q-2906-2019	Muñoz, Oscar/0000-0001-5401-0018				Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; Asociacion Latinoamericana de Diabetes, 2013, REV ALAD; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2013, CAN J DIABETES, V37, pS1, DOI DOI 10.1016/J.JCJD.2013.01.009; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ferwana M, 2013, DIABETIC MED, V30, P1026, DOI 10.1111/dme.12144; Franz MJ, 2010, J AM DIET ASSOC, V110, P1852, DOI 10.1016/j.jada.2010.09.014; Garber AJ, 2002, DIABETES OBES METAB, V4, P201, DOI 10.1046/j.1463-1326.2002.00211.x; Giacco R., 2013, Current Nutrition Reports, V2, P174; Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Guerrero Giraldo JE., 2014, MODELO SEGURIDAD ATE, P34; Handelsman Y, 2011, DIABETES CARE, P1; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Kadowaki T, 2014, DIABETES OBES METAB, V16, P418, DOI [10.1111/dom.12235, 10.1111/dom.12233]; Lincoff A, 2014, JAMA-J AM MED ASSOC, V298, P1180; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; National Collaborating Centre for Chronic Conditions, 2008, TYP 2 DIAB NAT CLIN; Nield L, 2009, COCHRANE DB SYST REV, P1; Nielsen PJ, 2006, DIABETES RES CLIN PR, V74, P111, DOI 10.1016/j.diabres.2006.03.033; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Perez A, 2009, CURR MED RES OPIN, V25, P2915, DOI 10.1185/03007990903350011; Rosenstock J, 2006, DIABETES OBES METAB, V8, P650, DOI 10.1111/j.1463-1326.2006.00659.x; Rosenstock J, 2006, DIABETES OBES METAB, V8, P49, DOI 10.1111/j.1463-1326.2005.00541.x; Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600; Sigal RJ, 2013, CAN J DIABETES, V37, pS40, DOI 10.1016/j.jcjd.2013.01.018; Sluik D, 2012, ARCH INTERN MED, V172, P1285, DOI 10.1001/archinternmed.2012.3130; THOMAS D, 2009, COCHRANE DB SYST REV, V21; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; Umpierre D, 2014, JAMA-J AM MED ASSOC, V305, P1790; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wu D, 2014, DIABETES OBES METAB, V16, P30, DOI 10.1111/dom.12174; Yang B, 2011, ASIA PAC J CLIN NUTR, V20, P593; Zhang F, 2013, ENDOCRINE, V44, P648, DOI 10.1007/s12020-013-9970-6; Zinman B, 2011, AM J MED, V124, pS3, DOI 10.1016/j.amjmed.2010.11.003	39	0	0	1	4	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.		2017	58	4								10.11144/Javeriana.umed58-4.dmmi	http://dx.doi.org/10.11144/Javeriana.umed58-4.dmmi			13	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FV6HC		gold, Green Submitted			2022-09-04	WOS:000424681100003
J	Cerdo, T; Ruiz, A; Acuna, I; Nieto-Ruiz, A; Dieguez, E; Sepulveda-Valbuena, N; Escudero-Marin, M; Garcia-Santos, JA; Garcia-Ricobaraza, M; Herrmann, F; Moreno-Munoz, JA; De Castellar, R; Jimenez, J; Suarez, A; Campoy, C				Cerdo, Tomas; Ruiz, Alicia; Acuna, Inmaculada; Nieto-Ruiz, Ana; Dieguez, Estefania; Sepulveda-Valbuena, Natalia; Escudero-Marin, Mireia; Antonio Garcia-Santos, Jose; Garcia-Ricobaraza, Maria; Herrmann, Florian; Antonio Moreno-Munoz, Jose; De Castellar, Roser; Jimenez, Jesus; Suarez, Antonio; Campoy, Cristina			A synbiotics, long chain polyunsaturated fatty acids, and milk fat globule membranes supplemented formula modulates microbiota maturation and neurodevelopment	CLINICAL NUTRITION			English	Article						Infant formula; Gut microbiota; Enterotypes; Neurodevelopment	RANDOMIZED CONTROLLED-TRIAL; GUT MICROBIOME; EARLY-LIFE; INFANT; GROWTH; RECOMMENDATIONS; ENTEROTYPES; NUTRITION; AGE	Background & aims: The critical window of concurrent developmental paths of the nervous system and gut microbiota in infancy provides an opportunity for nutritional interventions with potential health benefits later in life. Methods: We compared the dynamics of gut microbiota maturation and explored its association with neurodevelopment at 12 months and 4 years of age in 170 full-term healthy infants fed a standard formula (SF) or a new formula (EF) based on standard formula supplemented with synbiotics, long chain polyunsaturated fatty acids (LC-PUFA) and bovine milk fat globule membranes (MFGM), including a breastfed reference group (BF). Results: Using Dirichlet Multinomial Modelling, we characterized three microbial enterotypes (Mixed, anaerobic and aerobic profile; Bact, Bacteroides-dominant; Firm, Firmicutes-enriched) and identified a new enterotype dominated by an unidentified genus within Lachnospiraceae (U_Lach). Enterotypes were associated with age (Mixed with baseline, U_Lach with month 6, Bact and Firm with months 12 and 18). Trajectories or timely enterotype shifts in each infant were not random but strongly associated with type of feeding. Trajectories in SF shifted from initial Mixed to U_Lach, Bact or Firm at month. Microbiota maturation in EF split into a fast trajectory as in SF, and a slow trajectory with Mixed to U_Lach, Bact or Firm transitions at months 12 or 18, as in BF. EF infants with slow trajectories were more often in-home reared and born by vaginal delivery to mothers with pre-pregnancy lean BMI. At 12 months of age, language and expressive language scores were significantly higher in EF infants with fast trajectories than in BF. Neurodevelopmental outcomes were similar between EF infants with slow trajectories and BF at 12 months and 4 years of age.	[Cerdo, Tomas; Nieto-Ruiz, Ana; Dieguez, Estefania; Escudero-Marin, Mireia; Antonio Garcia-Santos, Jose; Garcia-Ricobaraza, Maria; Herrmann, Florian; Campoy, Cristina] Univ Granada, Sch Med, Dept Paediat, Granada, Spain; [Cerdo, Tomas; Nieto-Ruiz, Ana; Dieguez, Estefania; Sepulveda-Valbuena, Natalia; Escudero-Marin, Mireia; Antonio Garcia-Santos, Jose; Garcia-Ricobaraza, Maria; Herrmann, Florian; Campoy, Cristina] Univ Granada, EURISTIKOS Excellence Ctr Paediat Res, Biomed Res Ctr, Granada, Spain; [Cerdo, Tomas; Escudero-Marin, Mireia; Campoy, Cristina] Neurociences Inst Doctor Oloriz, Hlth Sci Technol Pk, Granada, Spain; [Ruiz, Alicia; Acuna, Inmaculada; Suarez, Antonio] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Ruiz, Alicia; Acuna, Inmaculada; Suarez, Antonio] Univ Granada, Biomed Res Ctr, Nutr & Food Technol Inst Jose Mataix, Granada, Spain; [Nieto-Ruiz, Ana; Antonio Garcia-Santos, Jose; Garcia-Ricobaraza, Maria; Campoy, Cristina] Inst Invest Biosanitaria Granada IBS GRANADA, Hlth Sci Technol Pk, Granada, Spain; [Antonio Moreno-Munoz, Jose; De Castellar, Roser; Jimenez, Jesus] Ordesa Labs SL, Barcelona, Spain; [Campoy, Cristina] Inst Hlth Carlos III, Granadas Node, Spanish Network Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Cerdo, Tomas] Maimonides Inst Res Biomed Cordoba IMBIC, Cordoba, Spain; [Ruiz, Alicia] Univ Edinburgh, Ctr Inflammat Res, Queens Med Inst, Edinburgh, Midlothian, Scotland; [Sepulveda-Valbuena, Natalia] Pontificia Univ Javeriana, Nutr & Biochem Dept, Sch Sci, Bogota, Colombia		Suarez, A (corresponding author), Univ Granada, Nutr & Food Technol Inst Jose Mataix, Biomed Res Ctr, Lab 119,Avd Conocimiento Sn, Armilla 18016, Spain.	asuarez@ugr.es	Moreno-Munoz, J.A./AAG-2230-2020	Moreno-Munoz, J.A./0000-0003-2172-7412; Dieguez, Estefania/0000-0001-7715-3345; Acuna, Inmaculada/0000-0002-1265-770X; Nieto Ruiz, Ana/0000-0002-4303-6228; Sepulveda-Valbuena, Natalia/0000-0002-1900-6475; RUIZ-RODRIGUEZ, ALICIA/0000-0001-6464-0996; Herrmann, Florian/0000-0002-3383-0874				Acuna Inmaculada, 2021, Nutrients, V13, P1673, DOI 10.3390/nu13051673; Aguinaga G, 2005, PLON R PRUEBA LENGUA; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Auestad N, 2001, PEDIATRICS, V108, P372, DOI 10.1542/peds.108.2.372; Avershina E, 2016, ENVIRON MICROBIOL, V18, P2226, DOI 10.1111/1462-2920.13248; Bazanella M, 2017, AM J CLIN NUTR, V106, P1274, DOI 10.3945/ajcn.117.157529; Biddle AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077599; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Borewicz K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38268-x; Brink LR, 2020, J NUTR BIOCHEM, V85, DOI 10.1016/j.jnutbio.2020.108465; Carlson AL, 2018, BIOL PSYCHIAT, V83, P148, DOI 10.1016/j.biopsych.2017.06.021; Cerdo T, 2019, CURR OPIN CLIN NUTR, V22, P434, DOI 10.1097/MCO.0000000000000606; Cerdo T, 2018, ENVIRON MICROBIOL, V20, P2160, DOI 10.1111/1462-2920.14235; Cerdo T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111247; Cerdo T, 2016, TRENDS FOOD SCI TECH, V57, P273, DOI 10.1016/j.tifs.2016.08.007; Christian LM, 2015, BRAIN BEHAV IMMUN, V45, P118, DOI 10.1016/j.bbi.2014.10.018; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Derrien M, 2019, TRENDS MICROBIOL, V27, P997, DOI 10.1016/j.tim.2019.08.001; Fouhy F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09252-4; Fu YW, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/8879227; Galazzo G, 2020, GASTROENTEROLOGY, V158, P1584, DOI 10.1053/j.gastro.2020.01.024; Ho NT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06473-x; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Ismail FY, 2017, EUR J PAEDIATR NEURO, V21, P23, DOI 10.1016/j.ejpn.2016.07.007; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koletzko B, 2005, J PEDIATR GASTR NUTR, V41, P584, DOI 10.1097/01.mpg.0000187817.38836.42; Koletzko B, 2014, ANN NUTR METAB, V65, P49, DOI 10.1159/000365767; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Larsson MW, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00297; Maga EA, 2013, GUT MICROBES, V4, P136, DOI 10.4161/gmic.23188; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Moeller AH, 2017, P NATL ACAD SCI USA, V114, P13768, DOI 10.1073/pnas.1700122114; Nieto-Ruiz Ana, 2020, Nutrients, V12, P3825, DOI 10.3390/nu12123825; Nieto-Ruiz A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020535; Nieto-Ruiz A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102456; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Ruiz A, 2017, ENVIRON MICROBIOL, V19, P1536, DOI 10.1111/1462-2920.13713; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Lorenzo IS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030602; Salminen S, INFANT FORMULA SUPPL, DOI [10.3390/nu12071952, DOI 10.3390/NU12071952]; Sepulveda-Valbuena N, 2021, BRIT J NUTR, V126, P1809, DOI 10.1017/S000711452100057X; Skott E, 2020, BRAIN BEHAV IMMUN, V89, P9, DOI 10.1016/j.bbi.2020.05.056; Sordillo JE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0905; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295; Tognini P, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00025; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Vieira-Silva S, 2020, NATURE, V581, P310, DOI 10.1038/s41586-020-2269-x; Walfisch A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003259; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	58	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	AUG	2022	41	8					1697	1711		10.1016/j.clnu.2022.05.013	http://dx.doi.org/10.1016/j.clnu.2022.05.013			15	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	2T3MI	35777109	hybrid			2022-09-04	WOS:000822382600010
J	Baquero, MPR; Parcerisas, C; Seger, KD; Perazio, C; Acosta, NB; Mesa, F; Luna-Acosta, A; Botteldooren, D; Debusschere, E				Rey Baquero, Maria Paula; Parcerisas, Clea; Seger, Kerri D.; Perazio, Christina; Botero Acosta, Natalia; Mesa, Felipe; Luna-Acosta, Andrea; Botteldooren, Dick; Debusschere, Elisabeth			Comparison of Two Soundscapes: An Opportunity to Assess the Dominance of Biophony Versus Anthropophony	OCEANOGRAPHY			English	Editorial Material									[Rey Baquero, Maria Paula; Luna-Acosta, Andrea] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, Colombia; [Parcerisas, Clea; Debusschere, Elisabeth] Flanders Marine Inst, Oostende, Belgium; [Parcerisas, Clea; Botteldooren, Dick] Univ Ghent, WAVES Dept, Ghent, Belgium; [Seger, Kerri D.] Appl Ocean Sci, Seattle, WA USA; [Seger, Kerri D.; Perazio, Christina; Botero Acosta, Natalia] Fdn Macuat Colombia, Medellin, Antioquia, Colombia; [Perazio, Christina] SUNY Buffalo, Evolut Ecol & Behav Program, Neural & Cognit Plast Lab, Buffalo, NY USA; [Mesa, Felipe] Expedic Tribuga, Bogota, Colombia		Baquero, MPR (corresponding author), Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, Colombia.; Parcerisas, C (corresponding author), Flanders Marine Inst, Oostende, Belgium.; Parcerisas, C (corresponding author), Univ Ghent, WAVES Dept, Ghent, Belgium.	rey_m@javeriana.edu.co; clea.parcerisas@vliz.be		Debusschere, Elisabeth/0000-0002-5595-0295				Duarte CM, 2021, SCIENCE, V371, P583, DOI 10.1126/science.aba4658; Merchant ND, 2013, J ACOUST SOC AM, V133, pEL262, DOI 10.1121/1.4794934; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Rey-Baquero MP, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.623724; Wilford DC, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.672336	5	1	1	0	0	OCEANOGRAPHY SOC	ROCKVILLE	P.O. BOX 1931, ROCKVILLE, MD USA	1042-8275			OCEANOGRAPHY	Oceanography	DEC	2021	34	4					62	+		10.5670/oceanog.2021.supplement.02-24	http://dx.doi.org/10.5670/oceanog.2021.supplement.02-24			5	Oceanography	Science Citation Index Expanded (SCI-EXPANDED)	Oceanography	ZT7TY		Green Published, gold			2022-09-04	WOS:000769355300010
J	Rundfeldt, LC; Maggioni, MA; Coker, RH; Gunga, HC; Riveros-Rivera, A; Schalt, A; Steinach, M				Rundfeldt, Lea C.; Maggioni, Martina A.; Coker, Robert H.; Gunga, Hanns-Christian; Riveros-Rivera, Alain; Schalt, Adriane; Steinach, Mathias			Cardiac Autonomic Modulations and Psychological Correlates in the Yukon Arctic Ultra: The Longest and the Coldest Ultramarathon	FRONTIERS IN PHYSIOLOGY			English	Article						cold; exercise performance; extreme environments; fatigue; heart rate variability; mood; subarctic ultramarathon; ultra-endurance	HEART-RATE-VARIABILITY; PERCEIVED EXERTION; SLEEP-DEPRIVATION; NERVOUS-SYSTEM; MOOD STATES; PARASYMPATHETIC ACTIVITY; COGNITIVE PERFORMANCE; PHYSICAL PERFORMANCE; TRAINING ADAPTATION; PACING STRATEGY	Studies on human physical performance in extreme environments have effectively approached the investigation of adaptation mechanisms and their physiological limits. As scientific interest in the interplay between physiological and psychological aspects of performance is growing, we aimed to investigate cardiac autonomic control, by means of heart rate variability, and psychological correlates, in competitors of a subarctic ultramarathon, taking place over a 690 km course (temperatures between +5 and -47 degrees C). At baseline (PRE), after 277 km (D1), 383 km (D2), and post-race (POST, 690 km), heart rate (HR) recordings (supine, 15min), psychometric measurements (Profile of Mood States/POMS, Borg fatigue, and Karolinska Sleepiness Scale scores both upon arrival and departure) were obtained in 16 competitors (12 men, 4 women, 38.6 +/- 9.5 years). As not all participants reached the finish line, comparison of finishers (FIN, n = 10) and non-finishers (NON, n = 6), allowed differential assessment of performance. Resting HR increased overall significantly at D1 (FIN + 15.9; NON + 14.0 bpm), due to a significant decrease in parasympathetic drive. This decrease was in FIN only partially recovered toward POST. In FIN only, baseline HR was negatively correlated with mean velocity [r-0.63 (P.04)] and parasympathetic drive [pNN50+: r -0.67 (P.03)], a lower HR and a higher vagal tone predicting a better performance. Moreover, in FIN, a persistent increase of the long-term self-similarity coefficient, assessed by detrended fluctuation analysis (DFA alpha 2), was retrieved, possibly due to higher alertness. As for psychometrics, at D1, POMS Vigor decreased (FIN: -7.0; NON: -3.8), while Fatigue augmented (FIN: +6.9; NON: +5.0). Sleepiness increased only in NON, while Borg scales did not exhibit changes. Baseline comparison of mood states with normative data for athletes displayed significantly higher positive mood in our athletes. Results show that: the race conditions induced early decreases in parasympathetic drive; the extent of vagal withdrawal, associated to the timing of its recovery, is crucial for success; pre-competition lower resting HR predicts a better performance; psychological profile is reliably depicted by POMS, but not by Borg fatigue scales. Therefore, assessment of heart rate variability and psychological profile may monitor and partly predict performance in long-duration ultramarathon in extreme cold environment.	[Rundfeldt, Lea C.; Maggioni, Martina A.; Gunga, Hanns-Christian; Riveros-Rivera, Alain; Schalt, Adriane; Steinach, Mathias] Charite, Inst Physiol, Ctr Space Med & Extreme Environm Berlin, Berlin, Germany; [Maggioni, Martina A.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Coker, Robert H.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Riveros-Rivera, Alain] Pontificia Univ Javeriana, Dept Physiol Sci, Bogota, Colombia		Rundfeldt, LC (corresponding author), Charite, Inst Physiol, Ctr Space Med & Extreme Environm Berlin, Berlin, Germany.	lea-christiane.rundfeldt@charite.de	Maggioni, Martina Anna/P-1351-2019; Maggioni, Martina Anna A/M-2931-2016; Coker, Robert H/Q-4767-2018	Maggioni, Martina Anna/0000-0002-6319-8566; Maggioni, Martina Anna A/0000-0002-6319-8566; Riveros-Rivera, Alain/0000-0002-0011-0758; Coker, Robert/0000-0002-1037-9339	DLR grant [50WB1330]	DLR grant(Helmholtz AssociationGerman Aerospace Centre (DLR))	This investigation was partly supported by the DLR grant 50WB1330.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Anglem N, 2008, WILD ENVIRON MED, V19, P30, DOI 10.1580/07-WEME-OR-091.1; Atlaoui D, 2007, INT J SPORTS MED, V28, P394, DOI 10.1055/s-2006-924490; Bellenger CR, 2017, EUR J APPL PHYSIOL, V117, P541, DOI 10.1007/s00421-017-3549-5; Bellenger CR, 2016, SPORTS MED, V46, P1461, DOI 10.1007/s40279-016-0484-2; Bellenger CR, 2016, INT J SPORT PHYSIOL, V11, P685, DOI 10.1123/ijspp.2015-0495; BIGGER JT, 1988, AM J CARDIOL, V61, P208, DOI 10.1016/0002-9149(88)90917-4; Bisschoff CA, 2016, J SPORT SCI MED, V15, P658; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bossi AH, 2017, INT J SPORT PHYSIOL, V12, P590, DOI 10.1123/ijspp.2016-0237; Bricout VA, 2010, AUTON NEUROSCI-BASIC, V154, P112, DOI 10.1016/j.autneu.2009.12.001; Buchheit M, 2015, INT J SPORTS MED, V36, P351, DOI 10.1055/s-0034-1385882; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Buchheit M, 2010, EUR J APPL PHYSIOL, V108, P1153, DOI 10.1007/s00421-009-1317-x; Camm AJ, 1996, CIRCULATION, V93, P1043; Castiglioni P, 2011, J PHYSIOL-LONDON, V589, P355, DOI 10.1113/jphysiol.2010.196428; Blasquez JCC, 2009, PSICOTHEMA, V21, P531; Coker RH, 2017, MED SCI SPORT EXER, V49, P357, DOI 10.1249/MSS.0000000000001095; Comotto S, 2015, J SPORT MED PHYS FIT, V55, P361; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; da Silva DF, 2014, EUR J SPORT SCI, V14, P443, DOI 10.1080/17461391.2013.832802; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Dettoni JL, 2012, J APPL PHYSIOL, V113, P232, DOI 10.1152/japplphysiol.01604.2011; EWING DJ, 1984, BRIT HEART J, V52, P396; Farrace S, 2003, INT J PSYCHOPHYSIOL, V49, P17, DOI 10.1016/S0167-8760(03)00074-6; Flatt AA, 2017, J SPORT MED PHYS FIT, V57, P907, DOI 10.23736/S0022-4707.16.06322-2; Flatt AA, 2017, J STRENGTH COND RES, V31, P531, DOI 10.1519/JSC.0000000000001482; Foulds HJA, 2014, EUR J SPORT SCI, V14, P686, DOI 10.1080/17461391.2014.884169; Freitas VH, 2014, J SPORT SCI MED, V13, P571; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Glos M, 2014, PHYSIOL BEHAV, V125, P45, DOI 10.1016/j.physbeh.2013.11.011; Gratze G, 2005, J APPL PHYSIOL, V99, P1728, DOI 10.1152/japplphysiol.00487.2005; Gunga H.C., 2014, HUMAN PHYSL EXTREME; Harinath K, 2005, WILD ENVIRON MED, V16, P81, DOI 10.1580/PR30-04.1; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hedelin R, 2000, MED SCI SPORT EXER, V32, P1480, DOI 10.1097/00005768-200008000-00017; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; Ivanov PC, 1999, EUROPHYS LETT, V48, P594, DOI 10.1209/epl/i1999-00525-0; Johnston RD, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0015-y; Joslin J, 2014, CLIN J SPORT MED, V24, P245, DOI 10.1097/JSM.0000000000000019; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kalin K, 2012, OPEN ACCESS J SPORTS, V3, P131, DOI 10.2147/OAJSM.S36808; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kentta G, 1998, SPORTS MED, V26, P1; Kiviniemi AM, 2014, SCAND J MED SCI SPOR, V24, pE77, DOI 10.1111/sms.12114; Kobayashi I, 2016, PHYSIOL BEHAV, V164, P11, DOI 10.1016/j.physbeh.2016.05.005; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Souza GGL, 2013, STRESS, V16, P377, DOI 10.3109/10253890.2013.767326; Leti T, 2013, AUTON NEUROSCI-BASIC, V173, P14, DOI 10.1016/j.autneu.2012.10.007; Lucini D, 2017, INT J CARDIOL, V240, P307, DOI 10.1016/j.ijcard.2017.05.001; Manzi V, 2009, AM J PHYSIOL-HEART C, V296, pH1733, DOI 10.1152/ajpheart.00054.2009; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Martinmaki K, 2008, EUR J APPL PHYSIOL, V102, P353, DOI 10.1007/s00421-007-0594-5; Maughan RJ, 2007, SPORTS MED, V37, P396, DOI 10.2165/00007256-200737040-00032; McNair D.M., 1971, MANUAL PROFILE MOOD; Merati G, 2015, EUR J APPL PHYSIOL, V115, P825, DOI 10.1007/s00421-014-3064-x; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Mrakic-Sposta S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141780; Nuissier F, 2007, EUR J APPL PHYSIOL, V99, P615, DOI 10.1007/s00421-006-0385-4; Parry D, 2011, BRIT J SPORT MED, V45, P1088, DOI 10.1136/bjsm.2010.072637; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Penttila J., 2003, Autonomic & Autacoid Pharmacology, V23, P173, DOI 10.1046/j.1474-8673.2003.00293.x; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Plews DJ, 2013, INT J SPORT PHYSIOL, V8, P688, DOI 10.1123/ijspp.8.6.688; Plews DJ, 2013, SPORTS MED, V43, P773, DOI 10.1007/s40279-013-0071-8; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Ramirez G, 1999, AVIAT SPACE ENVIR MD, V70, P73; Renfree A, 2016, EUR J SPORT SCI, V16, P409, DOI 10.1080/17461391.2015.1041061; Sakuragi Sokichi, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P159, DOI 10.2114/jpa.21.159; Sallinen M, 2008, CHRONOBIOL INT, V25, P279, DOI 10.1080/07420520802107106; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Saw AE, 2016, BRIT J SPORT MED, V50, P281, DOI 10.1136/bjsports-2015-094758; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Schmitt LHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075956; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Scott JM, 2009, MED SCI SPORT EXER, V41, P25, DOI 10.1249/MSS.0b013e31818313ff; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Sgoifo A, 2015, STRESS, V18, P343, DOI 10.3109/10253890.2015.1045868; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Siegl A, 2017, INT J SPORTS MED, V38, P675, DOI 10.1055/s-0043-110226; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Spangler DP, 2015, INT J PSYCHOPHYSIOL, V96, P95, DOI 10.1016/j.ijpsycho.2015.03.002; Stanley J, 2015, INT J SPORT PHYSIOL, V10, P528, DOI 10.1123/ijspp.2014-0196; Stein PK, 2012, SLEEP MED REV, V16, P47, DOI 10.1016/j.smrv.2011.02.005; Suzuki S, 2006, J STRENGTH COND RES, V20, P36; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Taralov ZZ, 2015, FOLIA MED PLOVDIV, V57, P173, DOI [DOI 10.1515/F0LMED-2015-0036, 10.1515/folmed-2015-0036]; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Terry PC, 2000, J APPL SPORT PSYCHOL, V12, P93, DOI 10.1080/10413200008404215; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thorpe RT, 2016, INT J SPORT PHYSIOL, V11, P947, DOI 10.1123/ijspp.2015-0490; Tobaldini E, 2014, ARCH ITAL BIOL, V152, P103, DOI 10.12871/000298292014235; Tonacci A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00201; Waldeck Miriam R, 2003, J Sports Sci Med, V2, P133; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Wuthrich TU, 2015, MED SCI SPORT EXER, V47, P519, DOI 10.1249/MSS.0000000000000449	97	11	11	0	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	FEB 12	2018	9								35	10.3389/fphys.2018.00035	http://dx.doi.org/10.3389/fphys.2018.00035			18	Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physiology	FV7VK	29483874	Green Published, gold			2022-09-04	WOS:000424793300001
J	Ottenbacher, AJ; Snih, SA; Bindawas, SM; Markides, KS; Graham, JE; Samper-Ternent, R; Raji, M; Ottenbacher, KJ				Ottenbacher, Allison J.; Snih, Soham Al; Bindawas, Saad M.; Markides, Kyriakos S.; Graham, James E.; Samper-Ternent, Rafael; Raji, Mukaila; Ottenbacher, Kenneth J.			Role of Physical Activity in Reducing Cognitive Decline in Older Mexican-American Adults	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						aging; cognition; Hispanic Americans; minority health	MINI-MENTAL-STATE; ACTIVITY SCALE; ELDERLY PASE; MORTALITY; EXERCISE; MEMORY	The effect of physical activity on cognitive function in older adults from minority and disadvantaged populations is not well understood. This study examined the longitudinal association between physical activity and cognition in older Mexican Americans. The study methodology included a prospective cohort with longitudinal analysis of data from the Hispanic Established Populations for the Epidemiologic Study of the Elderly. General linear mixed models were used to assess the associations and interactions between physical activity and cognitive function over 14years. Community-based assessments were performed in participants' homes. Physical activity was recorded for 1,669 older Mexican Americans using the Physical Activity Scale for the Elderly. Cognition was measured using the Mini-Mental State Examination (MMSE) and separated into memory and nonmemory components. A statistically significant positive association was observed between levels of physical activity and cognitive function after adjusting for age, sex, marital status, education, and comorbid health conditions. There was a statistically significant difference in MMSE scores over time between participants in the third (=0.11, standard error (SE)=0.05) and fourth (=0.10, SE=0.2) quartiles of physical activity and those in the first. The protective effect of physical activity on cognitive decline was evident for the memory component of the MMSE but not the nonmemory component after adjusting for covariates. Greater physical activity at baseline was associated with less cognitive decline over 14years in older Mexican Americans. The reduction in cognitive decline appeared to be related to the memory components of cognitive function.	[Ottenbacher, Allison J.] NCI, NIH, Bethesda, MD 20892 USA; [Snih, Soham Al; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Sealy Ctr Aging, Sch Hlth Profess, Galveston, TX 77555 USA; [Bindawas, Saad M.] King Saud Univ, Coll Appl Med Sci, Dept Rehabil Sci, Riyadh, Saudi Arabia; [Markides, Kyriakos S.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Samper-Ternent, Rafael] Univ Javeriana, Hosp San Ignacio, Bogota, Colombia; [Raji, Mukaila] Univ Texas Med Branch, Div Geriatr, Dept Internal Med, Galveston, TX 77555 USA		Ottenbacher, KJ (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	kottenba@utmb.edu	Snih, Soham Al/ABC-2882-2020; Samper-Ternent, Rafael Antonio/C-1453-2012	Samper-Ternent, Rafael Antonio/0000-0002-2250-9401; Ottenbacher, Kenneth/0000-0001-5990-3982; Ottenbacher, Allison/0000-0002-8974-5580; Al Snih, Soham/0000-0002-0681-4641	NIH; Department of Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, R01AG010939, R01AG017638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funding agencies (NIH and Department of Education) had no input into study design, results, or interpretation of findings. Thus, the opinions and conclusions included in this paper are the authors' and have not been reviewed or endorsed by NIH or the Department of Education.	Angevaren M, 2010, ANN EPIDEMIOL, V20, P473, DOI 10.1016/j.annepidem.2010.03.007; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Centers for Disease Control and Prevention, 2011, BEH RISK FACT SURV S; Chad KE, 2005, MED SCI SPORT EXER, V37, P1774, DOI 10.1249/01.mss.0000181303.51937.9c; Chang YK, 2013, PSYCHOPHYSIOLOGY, V50, P1174, DOI 10.1111/psyp.12089; Cousins JM, 2010, BONE, V47, P205, DOI 10.1016/j.bone.2010.05.003; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Eggermont LHP, 2009, J AM GERIATR SOC, V57, P1750, DOI 10.1111/j.1532-5415.2009.02441.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Janney CA, 2010, J AM GERIATR SOC, V58, P1128, DOI 10.1111/j.1532-5415.2010.02861.x; Kerr J, 2013, J AM GERIATR SOC, V61, P1927, DOI 10.1111/jgs.12524; Krarup LH, 2008, NEUROLOGY, V71, P1313, DOI 10.1212/01.wnl.0000327667.48013.9f; Lindwall M., 2012, J AGING RES; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Neighbors CJ, 2008, AM J PUBLIC HEALTH, V98, P1460, DOI 10.2105/AJPH.2006.096982; Newson RS, 2005, J GERONTOL B-PSYCHOL, V60, pP113, DOI 10.1093/geronb/60.3.P113; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Ottenbacher AJ, 2012, J AM GERIATR SOC, V60, P1085, DOI 10.1111/j.1532-5415.2012.03995.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Tanigawa T, 2014, GERIATR GERONTOL INT, V14, P758, DOI 10.1111/ggi.12159; UHLMANN RF, 1991, J AM GERIATR SOC, V39, P876, DOI 10.1111/j.1532-5415.1991.tb04454.x; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	10	10	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	SEP	2014	62	9					1786	1791		10.1111/jgs.12978	http://dx.doi.org/10.1111/jgs.12978			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	AQ3VZ	25112531	Green Accepted			2022-09-04	WOS:000342722900023
J	Gutierrez, MJ; Zhu, JJ; Rodriguez-Martinez, CE; Nino, CL; Nino, G				Gutierrez, Maria J.; Zhu, Junjia; Rodriguez-Martinez, Carlos E.; Nino, Cesar L.; Nino, Gustavo			Nocturnal phenotypical features of obstructive sleep apnea (OSA) in asthmatic children	PEDIATRIC PULMONOLOGY			English	Article						asthma; OSA phenotype; OSAS; REM-related OSA; REM sleep	POSITIVE AIRWAY PRESSURE; REM-SLEEP; YOUNG-CHILDREN; RISK; ASSOCIATION; MOTONEURONS; HYPOXEMIA; DISEASE; GENDER; IMPACT	Background Asthma and obstructive sleep apnea (OSA) often coexists during childhood. To delineate this clinical association, we investigated the phenotypical features of OSA in asthmatic children. Specifically, we hypothesized that asthmatic children have a distinct OSA phenotype that involves a higher prevalence of Rapid-Eye-Movement (REM)-related breathing abnormalities relative to children with OSA alone. Methods We conducted a retrospective cross-sectional analysis of 141 children aged 2-12 years with OSA diagnosed by polysomnography (PSG) in our sleep center. Outcomes included PSG parameters, maximal %SaO2 REM desaturations and prevalence of REM-related OSA. Multivariate linear regression model or logistic regression model was built to study the joint effect of asthma and OSA parameters with control for potential confounders (significance level P<0.05). Results Baseline respiratory parameters, obstructive apnea-hypopnea index (OAHI) severity, and oxygenation during NREM sleep were unaffected by the presence of asthma in children with OSA. In contrast, maximal %SaO2 REM desaturation, REM-OAHI and prevalence of REM-related OSA in children with moderate-severe OSA were significantly increased in asthmatic children with OSA compared to subjects with OSA alone. Multivariate analysis revealed that the association between asthma and REM-related OSA parameters is independent of asthma control, BMI, age, and gender. The presence of REM-related OSA in asthmatics was unaffected by rhinitis or atopic status. Conclusion These results demonstrate that asthma is associated with REM-related breathing abnormalities in children with moderate-severe OSA. The link between asthma and REM-related OSA is independent of asthma control and obesity. Further research is needed to delineate the REM-sleep biological mechanisms that modulate the phenotypical expression of OSA in asthmatic children. Pediatr Pulmonol. 2013; 48:592-600. (c) 2012 Wiley Periodicals, Inc.	[Gutierrez, Maria J.] Penn State Univ, Coll Med, Div Pulm Allergy & Immunol & Crit Care Med, Hershey, PA 17033 USA; [Gutierrez, Maria J.; Nino, Gustavo] Penn State Univ, Coll Med, Penn State Sleep Res & Treatment Ctr, Hershey, PA 17033 USA; [Zhu, Junjia] Penn State Univ, Div Biostat & Bioinformat, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Rodriguez-Martinez, Carlos E.] Univ Nacl Colombia, Sch Med, Dept Pediat, Bogota, Colombia; [Rodriguez-Martinez, Carlos E.] Univ El Bosque, Sch Med, Bogota, Colombia; [Rodriguez-Martinez, Carlos E.] Mil Hosp Colombia, Res Unit, Bogota, Colombia; [Nino, Cesar L.] Javeriana Univ, Dept Elect Engn, Bogota, Colombia; [Nino, Gustavo] Penn State Univ, Coll Med, Dept Pediat, Div Pediat Pulmonol, Hershey, PA 17033 USA		Nino, G (corresponding author), Penn State Univ, Penn State Hershey Childrens Hosp, Div Pediat Pulm & Sleep Med, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	gninobarrera@hmc.psu.edu	Gutierrez, Maria/AAK-2528-2021	Gutierrez, Maria Jimena/0000-0001-5494-5841				Alkhalil M, 2008, ANN ALLERG ASTHMA IM, V101, P350, DOI 10.1016/S1081-1206(10)60309-2; American Thoracic Society, 1996, AM J RESP CRIT CARE, V153, P866; Arens R, 2010, PAEDIATR RESPIR REV, V11, P24, DOI 10.1016/j.prrv.2009.10.003; Ballard RD, 1999, CHRONOBIOL INT, V16, P565, DOI 10.3109/07420529908998729; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2011, J ALLERGY CLIN IMMUN, V127, P1082, DOI 10.1016/j.jaci.2011.01.024; CATTERALL JR, 1982, LANCET, V1, P301; CATTERALL JR, 1985, J APPL PHYSIOL, V59, P1698, DOI 10.1152/jappl.1985.59.6.1698; CHAN CS, 1988, AM REV RESPIR DIS, V137, P1502, DOI 10.1164/ajrccm/137.6.1502; Ciftci TU, 2005, RESP MED, V99, P529, DOI 10.1016/j.rmed.2004.10.011; Espana RA, 2004, SLEEP, V27, P811; Fenik VB, 2005, AM J RESP CRIT CARE, V172, P1322, DOI 10.1164/rccm.200412-1750OC; FLETCHER EC, 1990, LUNG, V168, P751, DOI 10.1007/BF02718204; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; GUILLEMINAULT C, 1988, EUR RESPIR J, V1, P902; Gupta RS, 2009, PEDIATRICS, V123, pS193, DOI 10.1542/peds.2008-2233J; Haba-Rubio J, 2005, CHEST, V128, P3350, DOI 10.1378/chest.128.5.3350; Haxhiu MA, 2005, J APPL PHYSIOL, V98, P1961, DOI 10.1152/japplphysiol.01340.2004; Haxhiu MA, 2003, FRONT BIOSCI-LANDMRK, V8, pD946, DOI 10.2741/1099; Haxhiu MA, 2008, ADV EXP MED BIOL, V605, P469; Iber C, 2007, AASM MANUAL SCORING, V1st; Kheirandish-Gozal L, 2011, PEDIATR PULM, V46, P913, DOI 10.1002/ppul.21451; Koo BB, 2008, CHEST, V134, P1156, DOI 10.1378/chest.08-1311; Kubin L, 1998, NEWS PHYSIOL SCI, V13, P91; Lafond C, 2007, EUR RESPIR J, V29, P307, DOI 10.1183/09031936.00059706; Marcus C L, 1996, Semin Pediatr Neurol, V3, P23, DOI 10.1016/S1071-9091(96)80025-8; Mokhlesi B, 2012, SLEEP, V35, P5, DOI 10.5665/sleep.1570; Ogden Cynthia L, 2004, Md Med, V5, P19; Oksenberg A, 2010, J CLIN SLEEP MED, V6, P343; PACK AI, 1990, PROG CLIN BIOL RES, V345, P177; Ramagopal M, 2009, J ASTHMA, V46, P895, DOI 10.3109/02770900903229636; Resta O, 2005, RESP MED, V99, P91, DOI 10.1016/j.rmed.2004.05.014; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; SHAPIRO CM, 1986, BRIT MED J, V292, P1161, DOI 10.1136/bmj.292.6529.1161; Steier J, 2008, EUR RESPIR J, V32, P1479, DOI 10.1183/09031936.00018808; Teodorescu M, 2010, CHEST, V138, P543, DOI 10.1378/chest.09-3066; Teodorescu M, 2009, CHEST, V135, P1125, DOI 10.1378/chest.08-1273; WHITE JES, 1995, THORAX, V50, P376, DOI 10.1136/thx.50.4.376; Wilson CG, 2007, J APPL PHYSIOL, V103, P2095, DOI 10.1152/japplphysiol.01182.2006; Yigla M, 2003, J ASTHMA, V40, P865, DOI 10.1081/JAS-120023577	40	26	26	1	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863			PEDIATR PULM	Pediatr. Pulmonol.	JUN	2013	48	6					592	600		10.1002/ppul.22713	http://dx.doi.org/10.1002/ppul.22713			9	Pediatrics; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Respiratory System	152HQ	23203921				2022-09-04	WOS:000319523000010
J	Crespo-Castrillo, A; Yanguas-Casas, N; Arevalo, MA; Azcoitia, I; Barreto, GE; Garcia-Segura, LM				Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Barreto, George E.; Garcia-Segura, Luis M.			The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Microglia; Neuroinflammation; Neuroprotection; Steroid receptors; Brain trauma	TRAUMATIC BRAIN-INJURY; CORTICAL PERICONTUSIONAL ZONE; RECEPTOR MODULATORS DECREASE; PROGRAMMED CELL-DEATH; ESTROGEN-RECEPTOR; MICROGLIAL ACTIVATION; ANDROGEN RECEPTORS; OXIDATIVE STRESS; UP-REGULATION; ESTRADIOL	Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.	[Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Garcia-Segura, Luis M.] Inst Cajal, CSIC, Madrid, Spain; [Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Garcia-Segura, Luis M.] Inst Salud Carlos III, CIBERFES, Madrid, Spain; [Azcoitia, Inigo] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia		Garcia-Segura, LM (corresponding author), Inst Cajal, CSIC, Madrid, Spain.; Garcia-Segura, LM (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid, Spain.; Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gsampaio@javeriana.edu.co; lmgs@cajal.csic.es	Arevalo, Maria-Angeles/J-7000-2014; Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Azcoitia, Iñigo/A-6208-2011; Casás, Natalia Yanguas/AAB-6704-2019	Arevalo, Maria-Angeles/0000-0002-4303-9576; Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Azcoitia, Iñigo/0000-0002-5791-9144; Casás, Natalia Yanguas/0000-0003-4368-0176	Ministerio de Economia, Industria y Competitividad (MINECO), Spain [BFU2014-51836-C2-1-R, BFU2017-82754-R]; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES); Instituto de Salud Carlos III, Madrid, Spain; Fondos Feder	Ministerio de Economia, Industria y Competitividad (MINECO), Spain; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Fondos Feder(European Commission)	This work was supported by grants from Ministerio de Economia, Industria y Competitividad (MINECO), Spain (grant numbers BFU2014-51836-C2-1-R and BFU2017-82754-R), Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), and Instituto de Salud Carlos III, Madrid, Spain and Fondos Feder.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; de Aguiar RB, 2006, PHARMACOL BIOCHEM BE, V85, P689, DOI 10.1016/j.pbb.2006.10.023; Chuffa LGD, 2017, STEROIDS, V118, P93, DOI 10.1016/j.steroids.2016.12.011; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DonCarlos LL, 2006, NEUROSCIENCE, V138, P801, DOI 10.1016/j.neuroscience.2005.06.020; Escande A, 2009, J STEROID BIOCHEM, V116, P8, DOI 10.1016/j.jsbmb.2009.03.008; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Finley SK, 1999, J NEUROBIOL, V40, P446; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Genazzani AR, 2006, MENOPAUSE, V13, P57, DOI 10.1097/01.gme.0000191372.79052.d3; Gibbs RB, 2002, NEUROSCIENCE, V113, P907, DOI 10.1016/S0306-4522(02)00239-7; Goc J, 2014, EUR J NEUROSCI, V39, P2151, DOI 10.1111/ejn.12548; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hatton WJ, 1999, J COMP NEUROL, V409, P169; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Howard CV, 1998, THREE DIMENSIONAL ME; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li CY, 2015, MOL MED REP, V12, P4410, DOI 10.3892/mmr.2015.3942; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Paxinos G, 2001, THE MOUSE BRAIN IN S; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Perez-Alvarez MJ, 2015, MOL NEUROBIOL, V52, P1690, DOI 10.1007/s12035-014-8963-7; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Petrone AB, 2014, AGING DIS, V5, P340, DOI 10.14336/AD.2014.0500340; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020; Qiu J, 2008, J NEUROENDOCRINOL, V20, P1310, DOI 10.1111/j.1365-2826.2008.01789.x; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Sierra A., 2007, GLIA, V55, P412, DOI [10. 1002/glia. 20468 17203473, DOI 10.1002/glia.22867]; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Simoncini T, 2004, J CLIN ENDOCR METAB, V89, P4594, DOI 10.1210/jc.2003-032189; Simoncini T, 2000, MOL CELL ENDOCRINOL, V162, P87, DOI 10.1016/S0303-7207(00)00206-9; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Thakkar R, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12484; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vergouwen MDI, 2000, BRAIN RES, V878, P88, DOI 10.1016/S0006-8993(00)02713-X; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1105, DOI 10.1124/dmd.106.014118; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	98	21	21	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2018	55	11					8651	8667		10.1007/s12035-018-1008-x	http://dx.doi.org/10.1007/s12035-018-1008-x			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU7ID	29582398	Green Submitted			2022-09-04	WOS:000445493600033
J	Villamizar, O; Chambers, CB; Mo, YY; Torry, DS; Hofstrand, R; Riberdy, JM; Persons, DA; Wilber, A				Villamizar, Olga; Chambers, Christopher B.; Mo, Yin-Yuan; Torry, Donald S.; Hofstrand, Reese; Riberdy, Janice M.; Persons, Derek A.; Wilber, Andrew			Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death	BLOOD CELLS MOLECULES AND DISEASES			English	Article						Erythropoiesis; Long noncoding RNA; Saf; Apoptosis; Fas	NF-KAPPA-B; STEM-CELL; TRANSCRIPTION FACTORS; NORMAL ERYTHROPOIESIS; VENTRICULAR MYOCYTES; GENE-EXPRESSION; DISTINCT STAGES; APOPTOSIS; PROTEINS; LEUKEMIA	Long noncoding RNAs (IncRNAs) interact with other RNAs, DNA and/or proteins to regulate gene expression during development. Erythropoiesis is one developmental process that is tightly controlled throughout life to ensure accurate red blood cell production and oxygen transport to tissues. Thus, homeostasis is critical and maintained by competitive outcomes of pro- and anti-apoptotic pathways. LncRNAs are expressed during blood development; however, specific functions are largely undefined. Here, a culture model of human erythropoiesis revealed that lncRNA Fas-antisense 1 (Fas-AS1 or Sat) was induced during differentiation through the activity of essential erythroid transcription factors GATA-1 and KLF1. Saf was also negatively regulated by NF-kappa B, where decreasing NF-kappa B activity levels tracked with increasing transcription of Saf. Furthermore, Saf over-expression in erythroblasts derived from CD34(+) hematopoietic stem/progenitor cells of healthy donors reduced surface levels of Fas and conferred protection against Fas-mediated cell death signals. These studies reveal a novel IncRNA-regulated mechanism that modulates a critical cell death program during human erythropoiesis. (C) 2016 Elsevier Inc. All rights reserved.	[Villamizar, Olga; Chambers, Christopher B.; Mo, Yin-Yuan; Torry, Donald S.; Hofstrand, Reese; Wilber, Andrew] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, 825 North Rutledge,Room 2633, Springfield, IL USA; [Torry, Donald S.; Wilber, Andrew] SIU, Simmons Canc Inst, Springfield, IL USA; [Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Inst Canc, Jackson, MS 39216 USA; [Riberdy, Janice M.; Persons, Derek A.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Villamizar, Olga] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia		Wilber, A (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, 825 North Rutledge,Room 2633, Springfield, IL USA.	awilber@siumed.edu	Mo, Yin-Yuan/R-8255-2019; Wilber, Andrew/I-9259-2019	Wilber, Andrew/0000-0002-8457-599X; Hofstrand, Reese/0000-0002-5080-2066	Medical Innovators Grant from the Doris Duke Charitable Foundation [2010037]; National Center for Research Resources [S10RR025674]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025674] Funding Source: NIH RePORTER	Medical Innovators Grant from the Doris Duke Charitable Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the flow cytometry laboratory of Melissa Roberts for expertise in flow cytometry and cell sorting. This work was supported by a Medical Innovators Grant from the Doris Duke Charitable Foundation (Award Number 2010037) (D.A.P. and A.W.). The Southern Illinois University School of Medicine flow cytometry equipment was supported by Award Number S10RR025674 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baratti MO, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-30; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; De Datta D., 2013, PLOS ONE, V8; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fernando TR, 2015, MOL CANCER RES, V13, P839, DOI 10.1158/1541-7786.MCR-15-0006-T; Garzon R, 2014, P NATL ACAD SCI USA, V111, P18679, DOI 10.1073/pnas.1422050112; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo G, 2015, ONCOGENE, V34, P1768, DOI 10.1038/onc.2014.131; Guo GJ, 2014, FEBS LETT, V588, P1780, DOI 10.1016/j.febslet.2014.03.038; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Liu JJ, 2003, J BIOL CHEM, V278, P19534, DOI 10.1074/jbc.M212278200; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paralkar VR, 2014, BLOOD, V123, P1927, DOI 10.1182/blood-2013-12-544494; Paralkar VR, 2013, BLOOD, V121, P4842, DOI 10.1182/blood-2013-03-456111; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sae-ung N, 2005, EUR J HAEMATOL, V74, P315, DOI 10.1111/j.1600-0609.2004.00400.x; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Sun JN, 2014, NUCLEIC ACIDS RES, V42, P9588, DOI 10.1093/nar/gku549; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Ulirsch JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004890; Villamizar O., 2016, ONCOTARGET, V5, P7329; Villamizar O., DATA IN BRIEF SUBMIT; Wagner LA, 2007, BLOOD, V109, P5191, DOI 10.1182/blood-2006-06-027987; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Wilber A, 2010, BLOOD, V115, P3033, DOI 10.1182/blood-2009-08-240556; Yan MD, 2005, HUM MOL GENET, V14, P1465, DOI 10.1093/hmg/ddi156; ZABEL U, 1991, J BIOL CHEM, V266, P252; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P4129, DOI 10.1093/nar/gkt093	64	13	15	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	MAY	2016	58						57	66		10.1016/j.bcmd.2016.03.002	http://dx.doi.org/10.1016/j.bcmd.2016.03.002			10	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	DJ9CW	27067490				2022-09-04	WOS:000374512600011
J	Alves, OC; Srygley, RB; Riveros, AJ; Barbosa, MA; Esquivel, DMS; Wajnberg, E				Alves, Odivaldo C.; Srygley, Robert B.; Riveros, Andre J.; Barbosa, Marcia A.; Esquivel, Darci M. S.; Wajnberg, Eliane			Magnetic anisotropy and organization of nanoparticles in heads and antennae of neotropical leaf-cutter ants, Atta colombica	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Article						magnetic characterization; magnetic sensor; spatial orientation; homing	IRON-OXIDE NANOPARTICLES; FIELD; MAGNETORECEPTION; ORIENTATION; RESONANCE; DETECT; SCANS; BIRDS; BEES	Oriented magnetic nanoparticles have been suggested as a good candidate for a magnetic sensor in ants. Behavioural evidence for a magnetic compass in neotropical leaf-cutter ants, Atta colombica (Formicidae: Attini), motivated a study of the arrangement of magnetic particles in the ants' four major body parts by measuring the angular dependence of the ferromagnetic resonance spectra at room temperature. Spectra of the thoraces and those of the abdomens showed no significant angular dependence, while those of the antennae and those of the heads exhibited a periodic dependence relative to the magnetic field. Fitting of the angular dependence of the resonant field resulted in an unexpected magnetic anisotropy with uniaxial symmetry. High values of the first order anisotropy constant were observed for the magnetic material in antennae (-2.9 x 10(5) erg cm(-3)) and heads (-1 x 10(6) erg cm(-3)) as compared to body parts of other social insects. In addition, the magnitude of the anisotropy in the heads was comparable to that observed in magnetite nanoparticles of 4-5 nm diameter. For the antennae, the mean angle of the particles' easy magnetization axis (EA) was estimated to be 41 degrees relative to the straightened antenna's long axis. For the heads, EA was approximately 60 degrees relative to the head's axis running from midway between the spines to the clypeus. These physical characteristics indicate organized magnetic nanoparticles with a potential for directional sensitivity, which is an important feature of magnetic compasses.	[Alves, Odivaldo C.] Univ Fed Fluminense, Inst Quim, Dept Fis Quim, BR-24020150 Niteroi, RJ, Brazil; [Barbosa, Marcia A.; Esquivel, Darci M. S.; Wajnberg, Eliane] Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, RJ, Brazil; [Srygley, Robert B.] USDA ARS, Northern Plains Agr Res Lab, Sidney, MT 59270 USA; [Srygley, Robert B.] Smithsonian Trop Res Inst, Balboa, Panama; [Riveros, Andre J.] Pontificia Univ Javeriana, Fac Med, Dept Ciencias Fisiol, Bogota, Colombia		Alves, OC (corresponding author), Univ Fed Fluminense, Inst Quim, Dept Fis Quim, Outeiro Sao Joao Batista S-N, BR-24020150 Niteroi, RJ, Brazil.	elianew@cbpf.br	Alves, Odivaldo Cambraia/Z-3260-2019	Alves, Odivaldo Cambraia/0000-0003-4300-3407; Riveros, Andre J./0000-0001-7928-1885	Centro Brasileiro de Pesquisas Fisicas (CBPF) of the Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); National Geographic Society Committee for Research and Exploration; US Department of Agriculture; Smithsonian Tropical Research Institute; National Science Foundation	Centro Brasileiro de Pesquisas Fisicas (CBPF) of the Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); National Geographic Society Committee for Research and Exploration(National Geographic Society); US Department of Agriculture(United States Department of Agriculture (USDA)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); National Science Foundation(National Science Foundation (NSF))	We thank the Autoridad Nacional del Ambiente (ANAM) of the Republic of Panama for permission to export ants to Brazil for physical analysis. This project was supported in part by Centro Brasileiro de Pesquisas Fisicas (CBPF) of the Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), the National Geographic Society Committee for Research and Exploration, the US Department of Agriculture and the Smithsonian Tropical Research Institute. AJR received support from National Science Foundation.	Abracado LG, 2008, J MAGN MAGN MATER, V320, pE204, DOI 10.1016/j.jmmm.2008.02.048; Alves OC, 2009, MAGNETIC MATERIALS: RESEARCH, TECHNOLOGY AND APPLICATIONS, P297; Banerjee S.K., 1985, FERRIMAGNETIC PROPER, P17, DOI [10.1007/978-1-4613-0313-8_2, DOI 10.1007/978-1-4613-0313-8_2]; Banks AN, 2003, ETHOLOGY, V109, P835, DOI 10.1046/j.0179-1613.2003.00927.x; Brik A.B., 2003, MINERAL J UKRAINE, V25, P16; Cao CQ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006855; Chambarelli LL, 2008, J MAGN MAGN MATER, V320, pE207, DOI 10.1016/j.jmmm.2008.02.049; Charilaou M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869092; Charilaou M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658387; Charilaou M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3581103; de Oliveira JF, 2010, J R SOC INTERFACE, V7, P143, DOI 10.1098/rsif.2009.0102; ESOUIVEL DMS, 1986, J EXP BIOL, V121, P153; Esquivel DMS, 2014, NATURWISSENSCHAFTEN, V101, P245, DOI 10.1007/s00114-014-1147-5; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Gould J.L., 2012, NATURES COMPASS MYST; Gould JL, 2008, CURR BIOL, V18, pR482, DOI 10.1016/j.cub.2008.03.052; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Goya GF, 2004, J METASTAB NANOCRYST, V20-21, P673, DOI 10.4028/www.scientific.net/JMNM.20-21.673; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Li HY, 2009, J MAGN MAGN MATER, V321, P175, DOI 10.1016/j.jmmm.2008.08.082; Lohmann KJ, 2012, CURR OPIN NEUROBIOL, V22, P336, DOI 10.1016/j.conb.2011.11.005; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Noginov MM, 2008, J MAGN MAGN MATER, V320, P2228, DOI 10.1016/j.jmmm.2008.04.154; Riveros AJ, 2008, ANIM BEHAV, V75, P1273, DOI 10.1016/j.anbehav.2007.09.030; Riveros A.J., 2010, ENCY ANIMAL BEHAV, V2, P305; Riveros AJ, 2014, BEHAV ECOL SOCIOBIOL, V68, P55, DOI 10.1007/s00265-013-1621-7; SCHIFF H, 1991, COMP BIOCHEM PHYS A, V100, P975, DOI 10.1016/0300-9629(91)90325-7; Shikazumi S, 1977, MAGNETOCRYSTALLIEN A; Ugolini A, 2006, J COMP PHYSIOL A, V192, P45, DOI 10.1007/s00359-005-0046-9; Wajnberg E, 2005, BIOMETALS, V18, P595, DOI 10.1007/s10534-005-2995-4; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; WEIR MP, 1985, BIOCHIM BIOPHYS ACTA, V828, P298, DOI 10.1016/0167-4838(85)90311-5; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wirth R., 2003, ECOLOGICAL STUDIES, V164	37	6	6	1	46	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	OCT 29	2014	47	43							435401	10.1088/0022-3727/47/43/435401	http://dx.doi.org/10.1088/0022-3727/47/43/435401			7	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	AQ9EN					2022-09-04	WOS:000343150500021
J	Cortes-Urrea, C; Bueno-Gutierrez, F; Solarte, M; Guevara-Burbano, M; Tobar-Tosse, F; Velez-Varela, PE; Bonilla, JC; Barreto, G; Velasco-Medina, J; Moreno, PA; De las Rivas, J				Cortes-Urrea, Carolina; Bueno-Gutierrez, Fernando; Solarte, Melissa; Guevara-Burbano, Miguel; Tobar-Tosse, Fabian; Velez-Varela, Patricia E.; Carlos Bonilla, Juan; Barreto, Guillermo; Velasco-Medina, Jaime; Moreno, Pedro A.; De las Rivas, Javier			Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations	BIOMOLECULES			English	Article; Proceedings Paper	10th International Conference on Bioinformatics (SolBio)	OCT 28-30, 2019	Montevideo, URUGUAY			breast cancer; cancer genomics; genetic variant; whole exome sequencing; SNPs; differential expression; RNA-seq; bioinformatics; Limma-Voom; DESeq2	ESTROGEN-RECEPTOR STATUS; MESSENGER-RNA DECAY; SURVIVAL; VARIANTS; SUBTYPES; PATHWAY; BINDING; KINASE; ALPHA	Cancer is one of the leading causes of mortality worldwide. Breast cancer is the most frequent cancer in women, and in recent years it has become a serious public health problem in Colombia. The development of large-scale omic techniques allows simultaneous analysis of all active genes in tumor cells versus normal cells, providing new ways to discover the drivers of malignant transformations. Whole exome sequencing (WES) was obtained to provide a deep view of the mutational genomic profile in a set of cancer samples from Southwest Colombian women. WES was performed on 52 tumor samples from patients diagnosed with invasive breast cancer, which in most cases (33/52) were ductal luminal breast carcinomas (IDC-LM-BRCA). Global variant call was calculated, and six different algorithms were applied to filter out false positives and identify pathogenic variants. To compare and expand the somatic tumor variants found in the Colombian cohort, exome mutations and genome-wide expression alterations were detected in a larger set of tumor samples of the same breast cancer subtype from TCGA (that included DNA-seq and RNA-seq data). Genes with significant changes in both the mutational and expression profiles were identified, providing a set of genes and mutations associated with the etiology of ductal luminal breast cancer. This set included 19 single mutations identified as tumor driver mutations in 17 genes. Some of the genes (ATM, ERBB3, ESR1, TP53) are well-known cancer genes, while others (CBLB, PRPF8) presented driver mutations that had not been reported before. In the case of the CBLB gene, several mutations were identified in TCGA IDC-LM-BRCA samples associated with overexpression of this gene and repression of tumor suppressive activity of TGF-beta pathway.	[Cortes-Urrea, Carolina; Bueno-Gutierrez, Fernando; De las Rivas, Javier] CSIC, Salamanca 37007, Spain; [Cortes-Urrea, Carolina; Bueno-Gutierrez, Fernando; De las Rivas, Javier] Univ Salamanca USAL, Salamanca 37007, Spain; [Cortes-Urrea, Carolina; Solarte, Melissa; Barreto, Guillermo] Univ Valle, Dept Biol, Human Mol Genet Lab, Cali 25360, Colombia; [Guevara-Burbano, Miguel; Moreno, Pedro A.] Univ Valle, Sch Syst Engn & Computat, Cali 25360, Colombia; [Tobar-Tosse, Fabian] Pontificia Univ Javeriana Cali, Dept Basic Hlth Sci, Cali 110321, Colombia; [Velez-Varela, Patricia E.] Univ Cauca, Dept Biol, Popayan 190003, Colombia; [Carlos Bonilla, Juan] Imbanaco Med Ctr, Cali 760042, Colombia; [Velasco-Medina, Jaime] Univ Valle, Sch Elect & Elect Engn, Cali 25360, Colombia		De las Rivas, J (corresponding author), CSIC, Salamanca 37007, Spain.; De las Rivas, J (corresponding author), Univ Salamanca USAL, Salamanca 37007, Spain.	karourrea64@gmail.com; fernando.bueno.gutierrez@usal.es; melissa.solarte.cadavid@correounivalle.edu.co; miguel.guevara@correounivalle.edu.co; tfabiant@gmail.com; pvelez@unicauca.edu.co; juancarlos.bonilla.asistente@imbanaco.com.co; guillermo.barreto@correounivalle.edu.co; jaime.velasco@correounivalle.edu.co; pedro.moreno@correounivalle.edu.co; jrivas@usal.es	De Las Rivas, Javier/G-5936-2014; Tobar-Tosse, Fabian/P-1710-2014	De Las Rivas, Javier/0000-0002-0984-9946; Tobar-Tosse, Fabian/0000-0001-5334-4286; VELEZ VARELA, PATRICIA EUGENIA/0000-0003-3470-8704; Velasco-Medina, Jaime/0000-0003-4091-1055; Barreto, Guillermo/0000-0003-2568-2629; Moreno Tovar, Pedro Antonio/0000-0001-9154-7009; Cortes Urrea, Carolina/0000-0002-7668-6884	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (FIS-ISCIII, Spanish Ministry of Health) [PI18/00591]; FEDER program of the European Union; Sistema de Regalias del Valle del Cauca, Colombia [BPIN 2013000100297]	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (FIS-ISCIII, Spanish Ministry of Health); FEDER program of the European Union(European Commission); Sistema de Regalias del Valle del Cauca, Colombia	This research was funded by Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (FIS-ISCIII, Spanish Ministry of Health, project reference PI18/00591) where J.D.L.R. was the PI. The work within this project was also co-funded by the FEDER program of the European Union. The project on breast cancer from Colombia patients was funded by Sistema de Regalias del Valle del Cauca, Colombia (reference BPIN 2013000100297).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ainscough BJ, 2016, NAT METHODS, V13, P806, DOI 10.1038/nmeth.4000; Alonso-Lopez D, 2016, NUCLEIC ACIDS RES, V44, pW529, DOI 10.1093/nar/gkw363; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Barnes DM, 2004, ENDOCR-RELAT CANCER, V11, P85, DOI 10.1677/erc.0.0110085; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boon KL, 2006, RNA, V12, P198, DOI 10.1261/rna.2281306; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chakraborty S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9836256; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Conley AB, 2017, G3-GENES GENOM GENET, V7, P3435, DOI 10.1534/g3.117.1118; Cortes C, 2019, HERED CANCER CLIN PR, V17, DOI 10.1186/s13053-019-0120-x; Dai XF, 2015, AM J CANCER RES, V5, P2929; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; Fujiwara S, 2014, BREAST CANCER-TOKYO, V21, P472, DOI 10.1007/s12282-012-0415-5; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Kang JM, 2012, ONCOGENE, V31, P5123, DOI 10.1038/onc.2012.18; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lei Jonathan T, 2019, J Cancer Metastasis Treat, V5, DOI 10.20517/2394-4722.2019.12; Lever J, 2019, NAT METHODS, V16, P505, DOI 10.1038/s41592-019-0422-y; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Mularoni L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0994-0; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Neelamraju Y, 2018, RNA BIOL, V15, P115, DOI 10.1080/15476286.2017.1391436; Norris ET, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5195-7; Pardo C, 2018, COLOMB MEDICA, V49, P102, DOI 10.25100/cm.v49i1.2840; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Popp MW, 2018, CURR OPIN GENET DEV, V48, P44, DOI 10.1016/j.gde.2017.10.007; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; Repana D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1612-0; Rhana P, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176011, 10.1590/1414-431x20176011]; Ring AE, 2004, BRIT J CANCER, V91, P2012, DOI 10.1038/sj.bjc.6602235; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schroeder MP, 2014, BIOINFORMATICS, V30, pI549, DOI 10.1093/bioinformatics/btu467; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sharma GN, 2010, J ADV PHARM TECHNOL, V1, P109; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Silva Tiago C, 2016, F1000Res, V5, P1542, DOI 10.12688/f1000research.8923.2; Sun YQ, 2016, CARCINOGENESIS, V37, P163, DOI 10.1093/carcin/bgv170; Sun YS, 2017, INT J BIOL SCI, V13, P1387, DOI 10.7150/ijbs.21635; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Toy W, 2017, CANCER DISCOV, V7, P277, DOI 10.1158/2159-8290.CD-15-1523; Urbach D, 2012, TRENDS GENET, V28, P538, DOI 10.1016/j.tig.2012.07.001; Villa E, 2019, CANCERS, V11, DOI 10.3390/cancers11050688; Wang S, 2010, ONCOGENE, V29, P4225, DOI 10.1038/onc.2010.180; Wilkerson MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku489; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Zaidi Z, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-4191	66	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	MAY	2020	10	5							698	10.3390/biom10050698	http://dx.doi.org/10.3390/biom10050698			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	ME9ZV	32365829	Green Published, gold			2022-09-04	WOS:000545013700035
J	Ali, A; Dai, D; Akhtar, K; Teng, M; Yan, Z; Urbina-Cardona, N; Mullerova, J; Zhou, ZX				Ali, Ashfaq; Dai, Dong; Akhtar, Kashif; Teng, Mingjun; Yan, Zhaogui; Urbina-Cardona, Nicolas; Mullerova, Jana; Zhou, Zhixiang			Response of understory vegetation, tree regeneration, and soil quality to manipulated stand density in a Pinus massoniana plantation	GLOBAL ECOLOGY AND CONSERVATION			English	Article						Forest plantations; Stand density; Natural regeneration; Soil properties; Ground vegetation	SPECIES RICHNESS; TABULAEFORMIS PLANTATIONS; NATURAL REGENERATION; FOREST COMMUNITY; GARHWAL HIMALAYA; DIVERSITY; BIODIVERSITY; TEMPERATE; CHRONOSEQUENCE; LANDSCAPE	Tree density affects species diversity in forest plantations. Understory species diversity, tree regeneration, and soil physicochemical characteristics were assessed under three planting densities of Pinus massoniana in Taizishan Mountains, Hubei, China. There was a higher degree of shrub and herb species diversity in lower density stands. Total species richness was higher for herbs (n = 42) than for shrubs (n = 30) but the two groups exhibited a similar pattern with greater species richness at lower stand density. Changes in community structure and composition were more frequent in high density stands. Community structure in low and medium density stands was more similar to one another than to high stand densities for both herbs and shrubs. The regeneration status of tree species was more abundant in low and medium density stands. Low and medium density stands had significantly more favorable chemical properties such as soil organic matter, total phosphorus, available phosphorus, and nitrogen, as well as on physical soil properties such as non-capillary pores and minimum water holding capacity. Lower planting density was beneficial with regard to natural regeneration, plant species diversity, and soil quality. Reducing tree density of existing high-density P. massoniana plantations can promote both understory plant species diversity and tree regeneration to sustain forest ecosystem services. (c) 2019 The Authors. Published by Elsevier B.V.	[Ali, Ashfaq; Dai, Dong; Teng, Mingjun; Yan, Zhaogui; Zhou, Zhixiang] Huazhong Agr Univ, Coll Hort & Forestry Sci, Hubei Engn Technol Res Ctr Forestry Informat, Wuhan, Hubei, Peoples R China; [Akhtar, Kashif] Zhejiang Univ, Coll Agr & Biotechnol, Inst Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Urbina-Cardona, Nicolas] Pontificia Univ Javeriana, Fac Rural & Environm Studies, Ecol & Terr Dept, Bogota, Colombia; [Mullerova, Jana] Czech Acad Sci, Inst Bot, Dept GIS & Remote Sensing, Pruhonice, Czech Republic; [Dai, Dong] East China Normal Univ, Tiantong Forest Ecosyst Natl Observat & Res Stn, Sch Ecol & Environm Sci, Alberta Joint Lab Biodivers Study, Shanghai, Peoples R China		Zhou, ZX (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, 1 Shizishan, Wuhan 430070, Hubei, Peoples R China.	whzhouzx@mail.hzau.edu.cn	Mullerova, Jana/A-7915-2012; Urbina-Cardona, J. Nicolas/B-5447-2008	Mullerova, Jana/0000-0001-7331-3479; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Ali, Ashfaq/0000-0003-0419-9478; Dai, Dong/0000-0003-2291-3487	National Key R&D Programof China [2017YFC0505603, 2016YFD0600201]; Major Scientific and Technical Innovation Project of Hubei Province [2018ABA074]; Long-term Track Research Program of Forest Ecological Station in Three Gorges Reservoir Region (Zigui) of the Yangtze River, China	National Key R&D Programof China; Major Scientific and Technical Innovation Project of Hubei Province; Long-term Track Research Program of Forest Ecological Station in Three Gorges Reservoir Region (Zigui) of the Yangtze River, China	This workwas sponsored by the National Key R&D Programof China (Grant number 2017YFC0505603, 2016YFD0600201), the Major Scientific and Technical Innovation Project of Hubei Province (Grant number 2018ABA074) and the Long-term Track Research Program of Forest Ecological Station in Three Gorges Reservoir Region (Zigui) of the Yangtze River, China. We are thankful to the funding agencies for providing funds for this research.	Abe M, 2008, ECOL RES, V23, P681, DOI 10.1007/s11284-007-0428-2; Adam R, 2013, COMMUNITY ECOL, V14, P101, DOI 10.1556/ComEc.14.2013.1.11; Ahmad A, 2018, LAND USE POLICY, V78, P781, DOI 10.1016/j.landusepol.2018.07.009; Ali A, 2019, FORESTS, V10, DOI 10.3390/f10080645; Anderson M, 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Archer JK, 2007, J TORREY BOT SOC, V134, P489, DOI 10.3159/07-RA-013.1; Aubin I, 2008, BIOL CONSERV, V141, P2461, DOI 10.1016/j.biocon.2008.07.007; Ballabha Radha, 2013, Forest Science and Practice, V15, P89, DOI 10.1007/s11632-013-0205-y; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Sansevero JBB, 2017, NEW FOREST, V48, P573, DOI 10.1007/s11056-017-9586-4; Bermudez AM, 2007, ANN FOREST SCI, V64, P109, DOI 10.1051/forest:2006094; Sansevero JBB, 2011, RESTOR ECOL, V19, P379, DOI 10.1111/j.1526-100X.2009.00556.x; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Cao SX, 2011, EARTH-SCI REV, V104, P240, DOI 10.1016/j.earscirev.2010.11.002; Chen D, 2019, SCI TOTAL ENVIRON, V657, P1568, DOI 10.1016/j.scitotenv.2018.12.099; Chen YM, 2014, ECOL ENG, V73, P238, DOI 10.1016/j.ecoleng.2014.09.055; Cheng XR, 2017, FORESTS, V8, DOI 10.3390/f8060198; Chirino E, 2006, CATENA, V65, P19, DOI 10.1016/j.catena.2005.09.003; Clarke KP, 2015, PRIMER V7 USER MANUA, P300; Coll L, 2011, EUR J FOREST RES, V130, P55, DOI 10.1007/s10342-010-0395-y; Czerepko J, 2004, FOREST ECOL MANAG, V202, P119, DOI 10.1016/j.foreco.2004.07.033; Dirks I, 2010, GLOBAL CHANGE BIOL, V16, P2799, DOI 10.1111/j.1365-2486.2010.02172.x; Duan RY, 2009, RUSS J ECOL+, V40, P501, DOI 10.1134/S106741360907008X; Dzwonko Z, 2002, BIOL CONSERV, V106, P389, DOI 10.1016/S0006-3207(01)00266-X; Goldman RL, 2008, BIODIVERS CONSERV, V17, P1765, DOI 10.1007/s10531-008-9383-7; Hebert F, 2016, FORESTS, V7, DOI 10.3390/f7110276; Henkin Z., 1998, END OF SEASON SOIL W, P317; Jiao JY, 2012, RESTOR ECOL, V20, P240, DOI 10.1111/j.1526-100X.2010.00756.x; Justine MF, 2015, FORESTS, V6, P3665, DOI 10.3390/f6103665; Kaeser MJ, 2008, NORTH J APPL FOR, V25, P38, DOI 10.1093/njaf/25.1.38; Lal R., 2004, PRINCIPLES SOIL PHYS, DOI DOI 10.1016/j.still.2014.04.003; Langer ER, 2008, FOREST ECOL MANAG, V256, P949, DOI 10.1016/j.foreco.2008.05.052; Latham P, 2002, TREE PHYSIOL, V22, P137, DOI 10.1093/treephys/22.2-3.137; Lima TA, 2013, FOREST ECOL MANAG, V295, P77, DOI 10.1016/j.foreco.2013.01.006; Liu TY, 2015, APPL VEG SCI, V18, P591, DOI 10.1111/avsc.12178; Lu JingXian, 2010, J NW A F U, V38, P49; [鲁绍伟 LU Shaowei], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P144; Matias L, 2011, GLOBAL CHANGE BIOL, V17, P1646, DOI 10.1111/j.1365-2486.2010.02338.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Payn T, 2015, FOREST ECOL MANAG, V352, P57, DOI 10.1016/j.foreco.2015.06.021; Perez-Ramos IM, 2008, FOREST ECOL MANAG, V255, P3242, DOI 10.1016/j.foreco.2008.01.069; Rahman Md Habibur, 2011, Journal of Forestry Research (Harbin), V22, P551, DOI 10.1007/s11676-011-0198-0; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; Sardans J., 2004, INCREASING DROUGHT D, P367; Saxena A.K., 1998, VEGETATIO, V56, P61, DOI [10.1007/s00442-004-1788-8, DOI 10.1007/S00442-004-1788-8]; Selkimaki M, 2012, EUR J FOREST RES, V131, P727, DOI 10.1007/s10342-011-0545-x; Sharma CM, 2016, J SUSTAIN FOREST, V35, P119, DOI 10.1080/10549811.2015.1118387; singh sushma, 2016, Journal of Asia-Pacific Biodiversity, V9, P293; Sitzia T, 2012, FOREST ECOL MANAG, V270, P232, DOI 10.1016/j.foreco.2012.01.032; Somerfield PJ, 2013, J EXP MAR BIOL ECOL, V449, P261, DOI 10.1016/j.jembe.2013.10.002; Soucy M, 2012, CAN J FOREST RES, V42, P1669, DOI [10.1139/x2012-107, 10.1139/X2012-107]; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; von Oheimb G, 2009, BIODIVERS CONSERV, V18, P271, DOI 10.1007/s10531-008-9475-4; Wang YQ, 2012, SURV GEOPHYS, V33, P311, DOI 10.1007/s10712-011-9154-y; Wei X, 2018, FORESTS, V9, DOI 10.3390/f9030124; Whigham DE, 2004, ANNU REV ECOL EVOL S, V35, P583, DOI 10.1146/annurev.ecolsys.35.021103.105708; Wilson DS, 2007, FOREST ECOL MANAG, V246, P123, DOI 10.1016/j.foreco.2007.03.052; Xu CH, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061874; Xue L, 2014, FORESTS, V5, P2947, DOI 10.3390/f5122947	62	18	20	14	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2351-9894			GLOB ECOL CONSERV	Glob. Ecol. Conserv.	OCT	2019	20								e00775	10.1016/j.gecco.2019.e00775	http://dx.doi.org/10.1016/j.gecco.2019.e00775			15	Biodiversity Conservation; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	JP4HB		gold			2022-09-04	WOS:000498226800075
J	Keshavarzi, Z; Shakeri, F; Barreto, GE; Bibak, B; Sathyapalan, T; Sahebkar, A				Keshavarzi, Zakieh; Shakeri, Farzaneh; Barreto, George E.; Bibak, Bahram; Sathyapalan, Thozhukat; Sahebkar, Amirhossein			Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited	BIOFACTORS			English	Review						brain; medicinal plants; signaling mechanisms; TBI; trauma	KOREAN RED GINSENG; CHRONIC CEREBRAL HYPOPERFUSION; CARTHAMUS-TINCTORIUS L.; DA CHUANXIONG FORMULA; NITRIC-OXIDE SYNTHASE; JAMZAD ESSENTIAL OIL; FATTY LIVER-DISEASE; BARK ESSENTIAL OIL; NIGELLA-SATIVA; ANTIINFLAMMATORY ACTIVITY	Traumatic brain injury (TBI) is the most prevalent health problem affecting all age groups, and leads to many secondary problems in other organs especially kidneys, gastrointestinal tract, and heart function. In this review, the search terms were TBI, fluid percussion injury, cold injury, weight drop impact acceleration injury, lateral fluid percussion, cortical impact injury, and blast injury. Studies with Actaea racemosa, Artemisia annua, Aframomum melegueta, Carthamus tinctorius, Cinnamomum zeylanicum, Crocus sativus, Cnidium monnieri, Curcuma longa, Gastrodia elata, Malva sylvestris, Da Chuanxiong Formula, Erigeron breviscapus, Panax ginseng, Salvia tomentosa, Satureja khuzistanica, Nigella sativa, Drynaria fortune, Dracaena cochinchinensis, Polygonum cuspidatum, Rosmarinus officinalis, Rheum tanguticum, Centella asiatica, and Curcuma zedoaria show a significant decrease in neuronal injury by different mechanisms such as increasing superoxide dismutase and catalase activities, suppressing nuclear factor kappa B (NF-kappa B), interleukin 1 (IL-1), glial fibrillary acidic protein, and IL-6 expression. The aim of this study was to evaluate the neuroprotective effects of medicinal plants in central nervous system pathologies by reviewing the available literature.	[Keshavarzi, Zakieh; Shakeri, Farzaneh; Bibak, Bahram] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran; [Keshavarzi, Zakieh; Bibak, Bahram] North Khorasan Univ Med Sci, Sch Med, Dept Physiol, Bojnurd, Iran; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sathyapalan, Thozhukat] Univ Hull, Hull York Med Sch, Dept Acad Diabet Endocrinol & Metab, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Dept Med Biotechnol, Sch Med, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Sathyapalan, Thozhukat/J-5212-2012; Sahebkar, Amirhossein/B-5124-2018; Barreto, George E./AAD-7420-2020; Keshavarzi, Zakieh/ABG-4268-2020	Sathyapalan, Thozhukat/0000-0003-3544-2231; Barreto, George E./0000-0002-6644-1971; 				Abbasloo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31866; Abdel-Fattah AFM, 2000, EUR J PHARMACOL, V400, P89, DOI 10.1016/S0014-2999(00)00340-X; Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; ACTAURRAHMAN, 1985, HETEROCYCLES, V23, P953; Advani U., 2011, INT J PHARM PHARM SC, V3, P154; Akhtar M, 2012, J PHARM BIOALLIED SC, V4, P70, DOI 10.4103/0975-7406.92740; Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309; Amanlou M, 2005, J PHARM PHARM SCI, V8, P102; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2017, BOT MED WOMENS HLTH; Ansari A.K., 1989, PHYTOCHEMISTRY, V27, P377; AQEL MB, 1991, J ETHNOPHARMACOL, V33, P57, DOI 10.1016/0378-8741(91)90161-6; ATTAURRAHMAN, 1995, TETRAHEDRON LETT, V36, P1993, DOI 10.1016/0040-4039(95)00210-4; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Bano F, 2014, PAK J PHARM SCI, V27, P1547; Bhakuni RS, 2001, CURR SCI INDIA, V80, P35; Boskabady MH, 2007, FUND CLIN PHARMACOL, V21, P559, DOI 10.1111/j.1472-8206.2007.00509.x; Boskabady MH, 2016, PHYTOTHER RES, V30, P1072, DOI 10.1002/ptr.5622; Cao F, 2015, CAN J PHYSIOL PHARM, V93, P485, DOI 10.1139/cjpp-2014-0465; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Chen X, 2011, CARBOHYD POLYM, V86, P1300, DOI 10.1016/j.carbpol.2011.06.029; Chen Yao, 2003, Zhong Yao Cai, V26, P870; Chericoni S, 2005, J AGR FOOD CHEM, V53, P4762, DOI 10.1021/jf050183e; Chevallier A., 1996, ENCY MED PLANTS; Chiou WF, 2010, BRIT J PHARMACOL, V161, P321, DOI 10.1111/j.1476-5381.2010.00823.x; Choy CS, 2008, J ETHNOPHARMACOL, V115, P455, DOI 10.1016/j.jep.2007.10.012; Coon JT, 2002, DRUG SAFETY, V25, P323, DOI 10.2165/00002018-200225050-00003; Dincer C, 2013, TURK J AGRIC FOR, V37, P561, DOI 10.3906/tar-1211-72; Duan RT, 2016, PHYTOCHEM LETT, V18, P197, DOI 10.1016/j.phytol.2016.10.013; Efferth T, 2017, SEMINARS CANC BIOL; El-Dakhakhny M, 1963, PLANTA MED, V11, P465, DOI DOI 10.1055/S-0028-1100266; Emongor V., 2010, Asian Journal of Plant Sciences, V9, P299; Engeu PO, 2015, AFR HEALTH SCI, V15, P828, DOI 10.4314/ahs.v15i3.17; Er M, 2013, ENVIRON MONIT ASSESS, V185, P5193, DOI 10.1007/s10661-012-2935-z; Fan Hui-Ting, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2545; Fan JY, 2014, MOLECULES, V19, P10650, DOI 10.3390/molecules190710650; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Foster S, 1990, FIELD GUIDE MED PLAN, p[xii, 366]; Fu PK, 2016, IRAN J BASIC MED SCI, V19, P1368, DOI 10.22038/ijbms.2016.7925; Galal AM, 1996, INT J PHARMACOGN, V34, P64, DOI 10.1076/phbi.34.1.64.13172; Gbolade AA, 2009, J ETHNOPHARMACOL, V121, P135, DOI 10.1016/j.jep.2008.10.013; Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c; Ghazanfari G, 2006, TOXICOL MECH METHOD, V16, P365, DOI 10.1080/15376520600620125; Ghiringhelli F, 2012, ANTI-CANCER AGENT ME, V12, P852, DOI 10.2174/187152012802650048; Ghosh T, 2015, 3 BIOTECH, V5, P939, DOI 10.1007/s13205-015-0296-3; Gohil KJ, 2010, INDIAN J PHARM SCI, V72, P546, DOI 10.4103/0250-474X.78519; Gu HJ, 2009, J ENZYM INHIB MED CH, V24, P136, DOI [10.1080/14756360801936399, 10.1080/14756360801936399 ]; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Gupta R.P. S., 2003, INDIAN J TRADIT KNOW, V2, P375; Hajhashemi V, 2000, J ETHNOPHARMACOL, V71, P187, DOI 10.1016/S0378-8741(99)00209-3; Hamdi OAA, 2015, REC NAT PROD, V9, P349; Han SY, 2009, PHYTOMEDICINE, V16, P694, DOI 10.1016/j.phymed.2009.02.019; Han XS, 2017, PHYTOTHER RES, V31, P1034, DOI 10.1002/ptr.5822; HAUSEN BM, 1993, CONTACT DERMATITIS, V29, P175, DOI 10.1111/j.1600-0536.1993.tb03532.x; Haznedaroglu MZ, 2001, FITOTERAPIA, V72, P829, DOI 10.1016/S0367-326X(01)00335-5; He B, 2012, NEUROSCI LETT, V526, P106, DOI 10.1016/j.neulet.2012.08.022; He L, 2006, STEROIDS, V71, P476, DOI 10.1016/j.steroids.2006.01.006; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Him-Che Y., 1985, HDB CHINESE HERBS FO, V1, pS219; Hiramatsu M, 2009, NEUROCHEM RES, V34, P795, DOI 10.1007/s11064-008-9884-5; Hong M, 2016, J GINSENG RES, V40, P203, DOI 10.1016/j.jgr.2015.07.006; Hosseinzadeh H, 2004, PHYTOMEDICINE, V11, P56, DOI 10.1078/0944-7113-00376; Hosseinzadeh H, 2009, PHYTOTHER RES, V23, P768, DOI 10.1002/ptr.2597; HOU JP, 1977, COMP MED EAST WEST, V5, P123, DOI 10.1142/S0147291777000209; Hsieh CL, 2005, AM J CHINESE MED, V33, P599, DOI 10.1142/S0192415X0500320X; Hu BY, 2014, J ETHNOPHARMACOL, V155, P1243, DOI 10.1016/j.jep.2014.07.009; Hu WH, 2018, PHYTOMEDICINE, V42, P135, DOI 10.1016/j.phymed.2018.03.029; HUHTANEN CN, 1980, J FOOD PROTECT, V43, P195, DOI 10.4315/0362-028X-43.3.195; Hussein A., 2012, J MED ACT PLANTS, V1, P6, DOI [10.7275/R5CR5R84, DOI 10.7275/R5CR5R84]; Hwang SM, 2009, AM J CHINESE MED, V37, P395, DOI 10.1142/S0192415X09006916; Ikegbunam M., 2016, American Journal of Plant Sciences, V7, P118, DOI 10.4236/ajps.2016.71013; Ilic NM, 2014, J AGR FOOD CHEM, V62, P10452, DOI 10.1021/jf5026086; INATANI R, 1983, AGR BIOL CHEM TOKYO, V47, P521, DOI 10.1080/00021369.1983.10865682; Iranshahi M, 2009, EUR J CANCER PREV, V18, P412, DOI 10.1097/CEJ.0b013e32832c389e; Jang J, 2015, EVID-BASED COMPL ALT, V2015, P1; Jayanthi M., 2012, IJRRMS, V2, P1; Jazmi AF, 2015, INDONESIAN J CANC CH, V6, P105, DOI DOI 10.14499/INDONESIANJCANCHEMOPREV6ISS3PP105-9; Ji HJ, 2010, EUR J PHARMACOL, V636, P96, DOI 10.1016/j.ejphar.2010.03.038; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Jung JH, 2013, J GINSENG RES, V37, P167, DOI 10.5142/jgr.2013.37.167; Kachur K, 2016, EXPERT REV ANTI-INFE, V14, P81, DOI 10.1586/14787210.2016.1118345; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Keshavarzi Z, 2015, J PHARM BIOALLIED SC, V7, P75, DOI 10.4103/0975-7406.149815; Keshavarzi Z, 2012, IRAN J BASIC MED SCI, V15, P1102; Keshavarzi Z, 2011, IRAN J BASIC MED SCI, V14, P231; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Kim BW, 2012, J ETHNOPHARMACOL, V139, P549, DOI 10.1016/j.jep.2011.11.048; Kim HG, 2011, FOOD CHEM TOXICOL, V49, P2229, DOI 10.1016/j.fct.2011.06.020; Kim WS, 2015, KOREAN J PHYSIOL PHA, V19, P21, DOI 10.4196/kjpp.2015.19.1.21; Kokwaro JO., 1976, MED PLANTS E AFRICA; Kumar A., 2015, NATURAL PRODUCTS CHE, V3, P167; Kumar A, 2014, INFLAMMOPHARMACOLOGY, V22, P155, DOI 10.1007/s10787-013-0187-3; Kumar MHV, 2002, J ETHNOPHARMACOL, V79, P253, DOI 10.1016/S0378-8741(01)00394-4; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawal B. A. S., 2007, IJP - International Journal of Pharmacology, V3, P311; Lee MH, 2011, J GINSENG RES, V35, P429, DOI 10.5142/jgr.2011.35.4.429; Li M, 2006, WORLD SCI TECHNOL MO, V8, P34; Li X, 2011, INT J MOL SCI, V12, P7265, DOI 10.3390/ijms12107265; Li XJ, 2017, NEUROPSYCH DIS TREAT, V13, P1733, DOI 10.2147/NDT.S139362; Li ZZ, 2017, AM J TRANSL RES, V9, P5653; Lin YW, 2010, J NAT MED-TOKYO, V64, P146, DOI 10.1007/s11418-009-0387-8; Liu H, 2003, FITOTERAPIA, V74, P387, DOI 10.1016/S0367-326X(03)00068-6; Liu L, 2011, BRAIN RES, V1382, P147, DOI 10.1016/j.brainres.2011.01.051; Liu ZF, 2004, TOXICOLOGY, V203, P139, DOI 10.1016/j.tox.2004.06.007; Liu ZK, 2018, J ETHNOPHARMACOL, V217, P11, DOI 10.1016/j.jep.2018.02.004; Liu ZK, 2017, J ETHNOPHARMACOL, V196, P20, DOI 10.1016/j.jep.2016.12.014; Loo WTY, 2004, LIFE SCI, V76, P191, DOI 10.1016/j.lfs.2004.06.021; Luszczki JJ, 2009, EUR J PHARMACOL, V607, P107, DOI 10.1016/j.ejphar.2009.02.022; Majdalawieh AF, 2015, INT IMMUNOPHARMACOL, V28, P295, DOI 10.1016/j.intimp.2015.06.023; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mastejohn C, 2007, J AM COLL CARDIOL, V49, P1825, DOI 10.1016/j.jacc.2007.04.001; Meng XG, 2018, TRANSL NEUROSCI, V9, P33, DOI 10.1515/tnsci-2018-0007; Michaelsen FW, 2015, PHYTOMEDICINE, V22, P1223, DOI 10.1016/j.phymed.2015.11.001; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; Mohamed A.E.A., 2017, THESIS; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Mondal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116566; Ng CF, 2016, J ETHNOPHARMACOL, V185, P87, DOI 10.1016/j.jep.2016.03.018; Niphade SR, 2009, PHARM BIOL, V47, P1168, DOI 10.3109/13880200903019234; Noori S, 2004, INT IMMUNOPHARMACOL, V4, P1301, DOI 10.1016/j.intimp.2004.05.003; Okoli C. O., 2007, Journal of Herbs, Spices & Medicinal Plants, V13, P11, DOI 10.1300/J044v13n01_02; Onoja SO, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/159343; Ozcan MM, 2008, INT J FOOD SCI NUTR, V59, P691, DOI 10.1080/09637480701777944; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Park JH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040738; Paul D, 2016, INV J SCI, V4, P1; Pittella F, 2009, INT J MOL SCI, V10, P3713, DOI 10.3390/ijms10093713; Qin HL, 2017, MED SCI MONITOR, V23, P6099, DOI 10.12659/MSM.905429; Rafatullah S, 1995, INT J PHARMACOGN, V33, P311, DOI 10.3109/13880209509065384; Rahman M. M., 2012, International Food Research Journal, V19, P589; Ranasinghe L, 2002, LETT APPL MICROBIOL, V35, P208, DOI 10.1046/j.1472-765X.2002.01165.x; Ranasinghe P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-275; Rathore R, 2002, ASIAN J ANIM VET ADV, V9, P65; Ren RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22135; Rios JL, 1996, PHYTOTHER RES, V10, P189, DOI 10.1002/(SICI)1099-1573(199605)10:3&lt;189::AID-PTR754&gt;3.0.CO;2-C; Sadeghnia HR, 2008, J PHARM PHARM SCI, V11, P1; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Sawmiller D, 2014, INT J MOL SCI, V15, P895, DOI 10.3390/ijms15010895; Schafer G, 2014, ANTI-CANCER AGENT ME, V14, P233, DOI 10.2174/18715206113136660370; Sefidkon F, 2000, J ESSENT OIL RES, V12, P427, DOI 10.1080/10412905.2000.9699556; Seyedemadi P, 2016, IRAN J PHARM RES, V15, P875; Shaikh A.M., 2015, INT J PHARM TECH RES, V8, P88; Shakeri F, 2018, PHARMACOL REP, V70, P981, DOI 10.1016/j.pharep.2018.04.007; Shakeri F, 2017, IRAN J BASIC MED SCI, V20, P155, DOI 10.22038/ijbms.2017.8241; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Siddiqui BS, 2007, J ASIAN NAT PROD RES, V9, P407, DOI 10.1080/10286020600782454; SIMON JE, 1990, ADVANCES IN NEW CROPS, P522; Singh P, 2013, FOOD BIOSCI, V3, P42, DOI 10.1016/j.fbio.2013.06.002; Smith MJ, 2013, TOXICOLOGY, V308, P146, DOI 10.1016/j.tox.2013.03.017; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; Stuart G, 1984, CHINESE MAT MED; Sung WS, 2008, BIOL PHARM BULL, V31, P139, DOI 10.1248/bpb.31.139; Sunilkumar, 1998, Indian J Exp Biol, V36, P569; Szymczak G, 2015, NAT PROD RES, V29, P1149, DOI 10.1080/14786419.2014.980254; Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524; TARANTILIS PA, 1995, J CHROMATOGR A, V699, P107, DOI 10.1016/0021-9673(95)00044-N; Thong-asa W, 2018, AVICENNA J PHYTOMEDI, V8, P210; Ullah HMA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-346; Ulukanli Z, 2013, MED CHEM RES, V22, P832, DOI 10.1007/s00044-012-0075-1; Umukoro S., 2005, NIG J HLTH BIOMED SC, V4, P35, DOI [10.4314/njhbs.v4i1.11535, DOI 10.4314/NJHBS.V4I1.11535]; Umukoro S, 2007, J ETHNOPHARMACOL, V109, P501, DOI 10.1016/j.jep.2006.08.025; Vakili A, 2014, J STROKE CEREBROVASC, V23, P106, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.008; Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643; Vosough-Ghanbari S, 2010, EVID-BASED COMPL ALT, V7, P465, DOI 10.1093/ecam/nen018; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/425369; Wang M, 2008, AM J CHINESE MED, V36, P1199, DOI 10.1142/S0192415X08006521; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Wang WZ, 2012, J ETHNOPHARMACOL, V142, P300, DOI 10.1016/j.jep.2012.04.031; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Wang Y, 2018, MICROB PATHOGENESIS, V116, P26, DOI 10.1016/j.micpath.2018.01.009; Wang Zhi-peng, 2003, Zhongguo Zhongyao Zazhi, V28, P974; Winterhoff H, 2003, MATURITAS, V44, pS51, DOI 10.1016/S0378-5122(02)00348-1; Wong RWK, 2006, PHYTOTHER RES, V20, P313, DOI 10.1002/ptr.1842; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xia Lei, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1671; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Xin N, 2011, J ETHNOPHARMACOL, V135, P510, DOI 10.1016/j.jep.2011.03.063; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JQ, 2015, WOUND REPAIR REGEN, V23, P565, DOI 10.1111/wrr.12314; Xu JH, 2015, CHINESE MED J-PEKING, V128, P1376, DOI 10.4103/0366-6999.156795; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; YAMASAKI T, 1994, PHYTOTHER RES, V8, P408, DOI 10.1002/ptr.2650080706; Yulug B, 2018, CNS NEUROL DISORD-DR, V17, P439, DOI 10.2174/1871527317666180501110918; Zahoor A, 2012, REC NAT PROD, V6, P376; Zeng JP, 2017, INT J CLIN EXP MED, V10, P15213; Zhang JC, 2016, BIOMED RES-INDIA, V27, P1240; Zhang ZF, 2008, YAKUGAKU ZASSHI, V128, P805, DOI 10.1248/yakushi.128.805; Zheng CJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/680756; Zheng Q.A., 2005, NAT PROD RES DEV, V17, P84; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zimecki M, 2009, Z NATURFORSCH C, V64, P361; Zou Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-92	208	19	21	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-6433	1872-8081		BIOFACTORS	Biofactors	JUL	2019	45	4					517	535		10.1002/biof.1516	http://dx.doi.org/10.1002/biof.1516			19	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	IP8HT	31206893	Green Accepted			2022-09-04	WOS:000480288200003
J	Resque, AGL; Coudel, E; Piketty, MG; Cialdella, N; Sa, T; Piraux, M; Assis, W; Le Page, C				Resque, Antonio Gabriel L.; Coudel, Emilie; Piketty, Marie-Gabrielle; Cialdella, Nathalie; Sa, Tatiana; Piraux, Marc; Assis, William; Le Page, Christophe			Agrobiodiversity and Public Food Procurement Programs in Brazil: Influence of Local Stakeholders in Configuring Green Mediated Markets	SUSTAINABILITY			English	Article						agroecological transition; agrobiodiversity; ecosystem services; public food procurement programs; mediated markets	ECOSYSTEM SERVICES; PLANT DIVERSITY; BIODIVERSITY; SECURITY	The last few years have seen the emergence of different initiatives designed to promote the biodiversification of agroecosystems as a counterpoint to the global expansion of homogenized industrial agriculture. In Brazil, two food procurement programs demonstrate the potential to promote discussions related to this agroecological transition: the National School Meal Program (Programa Nacional de Alimentacao Escolar, PNAE) and the Food Procurement Program (Programa de Aquisicao de Alimentos, PAA). The objectives of this paper are to analyze: (a) how these procurement programs currently integrate agrobiodiversity (crops and cropping systems) according to the local context; (b) the main challenges that key stakeholders perceive for the adoption of biodiverse systems; and (c) the extent to which the key stakeholders involved in these programs associate agrobiodiversity with the provision of ecosystem services. We carried out this research in 2017 in two contrasting municipalities in the eastern part of the Brazilian Amazon, Paragominas and Irituia. Our research shows that these programs have included up to 42 species in Irituia and 32 species in Paragominas. Perennial crop species are the most common type of culture in Irituia (up to 50%), while vegetables are the most common in Paragominas (up to 47%). Although in both municipalities stakeholders identify a large number of ecosystem services (up to 17), services mentioned in Irituia were more closely related to agrobiodiversity. Stakeholders indirectly associated with the programs have a broader view of ecosystem services. We conclude that these procurement programs can be useful tools to promote the biodiversification of local production systems, but their potential may depend on involving institutions not directly associated with their administration. Additionally, despite the observed differences in production context, providing more ecosystem services appears to be a compelling motivation for promoting changes in agroecosystems.	[Resque, Antonio Gabriel L.] Univ Fed Rural Amazonia, Campus Paragominas, BR-68625000 Paragominas, Brazil; [Coudel, Emilie] Univ Brasilia, Ctr Desenvolvimento Sustentavel, UPR Green Cirad, Campus Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil; [Piketty, Marie-Gabrielle] Pontif Univ Javeriana, UPR Green Cirad, A 4-38,Cl 42 42, Bogota, Colombia; [Cialdella, Nathalie] Embrapa Amazonia Oriental, UMR Innovat Cirad, BR-66095903 Belem, Para, Brazil; [Sa, Tatiana] Embrapa Amazonia Oriental, UMR Tetis Cirad, BR-66095903 Belem, Para, Brazil; [Piraux, Marc] Embrapa Amazonia Oriental, BR-66095903 Belem, Para, Brazil; [Assis, William] Univ Fed Para, Inst Amazon Agr Familiares INEAF, BR-66075110 Belem, Para, Brazil; [Le Page, Christophe] CIRAD, UPR GREEN, F-34398 Montpellier, France		Resque, AGL (corresponding author), Univ Fed Rural Amazonia, Campus Paragominas, BR-68625000 Paragominas, Brazil.	gabriel.resque@ufra.edu.br; emilie.coudel@cirad.fr; marie-gabrielle.piketty@cirad.fr; nathalie.cialdella@cirad.fr; tatiana.sa@embrapa.br; marc.piraux@cirad.fr; williamassis@ufpa.br; christophe.le_page@cirad.fr	Coudel, Emilie S./M-1900-2016; Le Page, Christophe/E-6856-2010	Le Page, Christophe/0000-0002-1920-0091; Santos Assis, William/0000-0002-9525-7153; Coudel, Emilie/0000-0001-8272-8051	research project "STRADIV-System approach for the TRAnsition to bio-DIVersified agroecosystems" - Agropolis Fondation [1504-003]; research project "Refloramaz-Forest restoration by family farmers in the Eastern Amazon" - Agropolis Fondation through the "Investissements d'avenir" programme (Labex Agro) [1503-011, ANR-10-LABX-0001-01]; research project "IDEA-institutionalization of agroecologies - ANR-French Research Agency, generic call for projects 2015	research project "STRADIV-System approach for the TRAnsition to bio-DIVersified agroecosystems" - Agropolis Fondation; research project "Refloramaz-Forest restoration by family farmers in the Eastern Amazon" - Agropolis Fondation through the "Investissements d'avenir" programme (Labex Agro)(French National Research Agency (ANR)); research project "IDEA-institutionalization of agroecologies - ANR-French Research Agency, generic call for projects 2015(French National Research Agency (ANR))	This study was supported by the research project "STRADIV-System approach for the TRAnsition to bio-DIVersified agroecosystems", financed by Agropolis Fondation under the reference 1504-003; by the research project "Refloramaz-Forest restoration by family farmers in the Eastern Amazon", financed by Agropolis Fondation under the reference ID 1503-011 through the "Investissements d'avenir" programme (Labex Agro: ANR-10-LABX-0001-01) ", and by Embrapa (SEG 03.15.12.004.00.00); and by the research project "IDEA-institutionalization of agroecologies, financed by the ANR-French Research Agency, generic call for projects 2015. We are grateful for the many contributions of a number of local actors both in Paragominas and Irituia. Special thanks for the contribution of Fellipe Barbosa, who created the map.	Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; Alves L., 2014, EMBRAPA AMAZONIA ORI; [Anonymous], 2017, CENS AGR; Barnaud C, 2018, ECOL SOC, V23, DOI 10.5751/ES-09848-230115; BARRETEAU O, 2010, MODELISATION ACCOMPA; Boerner J, 2007, ECOL ECON, V64, P356, DOI 10.1016/j.ecolecon.2007.03.001; Buckley J, 2013, J HUNGER ENVIRON NUT, V8, P397, DOI 10.1080/19320248.2013.816988; Cerdan CR, 2012, AGR SYST, V110, P119, DOI 10.1016/j.agsy.2012.03.014; Cialdella N., 2014, REV TIERS MONDE, V1, DOI [10.3917/rtm.220.0121, DOI 10.3917/RTM.220.0121]; CLEMENT CR, 2007, RECURSOS GENETICOS V, P00511; Coq-Huelva D, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101920; Costa F, 2001, DESAFIO SUSTENTABILI, P289; COSTA RC, 2013, SUSTENTABILIDADE DEB, V4, P99; Duru M, 2015, AGRON SUSTAIN DEV, V35, P1237, DOI 10.1007/s13593-015-0318-x; FAO, 1998, STAT WORLDS PLANT GE; Food and Agriculture Organization (FAO) of the United Nations, 2007, STATE IND REPORT CUL; Gillespie G., 2007, REMAKING N AM FOOD S, P65; Gliessman S. R., 2001, AGROECOLOGIA PROCESS; Griffon M, 2009, POUR, P117; Grisa C., 2015, POLITICAS PUBLICAS D, P155; Guerra J, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.248; Hespanhol Rosângela Aparecida de Medeiros, 2013, Soc. nat., V25, P469; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Le Clec'h S, 2016, ECOL INDIC, V69, P508, DOI 10.1016/j.ecolind.2016.05.021; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Ma M., 2005, ECOSYSTEMS HUMAN WEL; Major J, 2005, ECON BOT, V59, P77, DOI 10.1663/0013-0001(2005)059[0077:IOMOOF]2.0.CO;2; MATTOS L, 2010, AMAZONICA, V0002, P00220; Mattos L., 2010, DECISOES USOS TERRA; Meynard JM, 2017, OCL OILS FAT CROP LI, V24, DOI 10.1051/ocl/2017021; Nijaki LK, 2012, INT J PUBLIC SECT MA, V25, P133, DOI 10.1108/09513551211223785; Olivera J. A., 2009, P IEEE 69 VEH TECHN, P1, DOI 10.1109/VETECS.2009.5073905; Ostrom E, 2011, POLICY STUD J, V39, P7, DOI 10.1111/j.1541-0072.2010.00394.x; Padoch C, 2010, BIOTROPICA, V42, P550, DOI 10.1111/j.1744-7429.2010.00681.x; PAILLE P., 1996, REV ASS RECHERCHE QU, V15, P179; Palomo I, 2016, ADV ECOL RES, V54, P245, DOI 10.1016/bs.aecr.2015.09.003; Petersen P., 2009, AGR FAMILIAR CAMPONE; Piketty MG, 2015, FORESTS, V6, P1516, DOI 10.3390/f6051516; PIRAUX M., 2012, ESTUDOS SOC AGR RIO, V20, P5; de Assis SCR, 2017, CIENC SAUDE COLETIVA, V22, P617, DOI 10.1590/1413-81232017222.02292015; Sambuichi RHR, 2014, POLITICAS AGROAMBIEN, P75; Sampaio G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030612; SANTILLI Juliana, 2012, AGROBIODIVERSITY LAW; Smale M, 2004, GENET RESOUR CROP EV, V51, P121, DOI 10.1023/B:GRES.0000020678.82581.76; SPINELLI Maria Angélica dos Santos, 2002, Rev. Nutr., V15, P105; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Tittonell P, 2012, FIELD CROP RES, V132, P168, DOI 10.1016/j.fcr.2011.12.011; Toledo V.M., 2008, MEMORIA BIOCULTURAL, V3; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Viana C, 2016, ENVIRON POLICY GOV, V26, P337, DOI 10.1002/eet.1720; Wilson MH, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8060574; Wittman H, 2017, REG ENVIRON CHANGE, V17, P1291, DOI 10.1007/s10113-016-1045-9; Wood D, 2011, AGROBIODIVERSITY MANAGEMENT FOR FOOD SECURITY: A CRITICAL REVIEW, P150, DOI 10.1079/9781845937614.0150; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	75	7	7	2	19	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	MAR 1	2019	11	5							1425	10.3390/su11051425	http://dx.doi.org/10.3390/su11051425			22	Green & Sustainable Science & Technology; Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics; Environmental Sciences & Ecology	HQ8GA		Green Published, Green Submitted, gold			2022-09-04	WOS:000462661000209
J	Liu, N; Tobon, LE; Zhao, YM; Tang, YF; Liu, QH				Liu, Na; Eduardo Tobon, Luis; Zhao, Yanmin; Tang, Yifa; Liu, Qing Huo			Mixed Spectral-Element Method for 3-D Maxwell's Eigenvalue Problem	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Anisotropic cavity; divergence-free condition; Maxwell eigenvalues; spectral-element method (SEM); spurious modes	FINITE-ELEMENTS; SPURIOUS MODES; WAVE-GUIDE; APPROXIMATION; EQUATIONS; CAVITIES	A high-order 3-D mixed spectral-element method (SEM) based on Gauss-Lobatto-Legendre polynomials in the mixed finite-element framework is proposed to remove the spurious eigenmodes in the numerical solution of the vector Maxwell eigenvalue problem with inhomogeneous, lossy isotropic, and anisotropic media. In order to suppress all zero and nonzero spurious modes that exist in the conventional finite-element and higher order SEMs, the proposed method not only employs the mixed-order curl-conforming vector basis functions for the electric field intensity, but also includes the divergence-free condition given by Gauss' law in a weak form. Several numerical examples are given to verify that the mixed SEM is free of any spurious eigenmodes and has spectral accuracy with analytic eigenvectors.	[Liu, Na] Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China; [Eduardo Tobon, Luis] Pontificia Univ Javeriana, Dept Elect & Comp Sci, Cali 760031, Colombia; [Zhao, Yanmin] Xuchang Univ, Sch Math & Stat, Xuchang 461000, Peoples R China; [Tang, Yifa] Chinese Acad Sci, State Key Lab Sci & Engn Comp LSEC, ICMSEC, Acad Math & Syst Sci, Beijing 100190, Peoples R China; [Liu, Qing Huo] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA		Liu, N (corresponding author), Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China.	liuna@xmu.edu.cn; letobon@javeri-anacali.edu.co; zhaoym@lsec.cc.ac.cn; tyf@lsec.cc.ac.cn; qhliu@duke.edu	Liu, Qing Huo/AFR-9899-2022; Liu, Qing Huo/AFO-6814-2022; TOBON, LUIS E/N-4459-2016	Liu, Qing Huo/0000-0001-5286-4423; Liu, Qing Huo/0000-0001-5286-4423; TOBON, LUIS E/0000-0003-2500-0982	National Natural Science Foundation of China [11371357, 11101381, 41390453]; Fujian Province Natural Science Foundation [2013J05060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China under Grant 11371357, Grant 11101381, and Grant 41390453, and by the Fujian Province Natural Science Foundation under Grant 2013J05060.	ADAM S, 1997, 275 ETH ZUR I SCI CO; Arbenz P, 1998, LECT NOTES COMPUT SC, V1470, P771; Balanis C. A., 2012, ADV ENG ELECTROMAGNE, V2nd; BESPALOV AN, 1988, SOV J NUMER ANAL MAT, V3, P163; Boffi D, 2010, ACTA NUMER, V19, P1, DOI 10.1017/S0962492910000012; Brenner SC, 2009, J SCI COMPUT, V40, P51, DOI 10.1007/s10915-008-9266-9; Cai GX, 2012, IEEE PHOTONICS J, V4, P844, DOI 10.1109/JPHOT.2012.2198914; Cendes Z. J., 1986, DEV NEW METHODS PRED; Cohen G., 2001, HIGHER ORDER NUMERIC; COSTABEL M, 1990, MATH METHOD APPL SCI, V12, P365, DOI 10.1002/mma.1670120406; Costabel M, 2005, MATH MOD METH APPL S, V15, P575, DOI 10.1142/S0218202505000480; Costabel M, 1999, MATH METHOD APPL SCI, V22, P243, DOI 10.1002/(SICI)1099-1476(199902)22:3<243::AID-MMA37>3.3.CO;2-S; Costabel M, 2000, ARCH RATION MECH AN, V151, P221, DOI 10.1007/s002050050197; Graglia RD, 2004, IEEE T ANTENN PROPAG, V52, P1672, DOI 10.1109/TAP.2004.831292; KIKUCHI F, 1987, COMPUT METHOD APPL M, V64, P509; Lee JH, 2006, IEEE T MICROW THEORY, V54, P437, DOI 10.1109/TMTT.2005.860502; LEVILLAIN V, 1992, MATH COMPUT, V58, P11, DOI 10.2307/2153017; Liu N., 2014, COMMUN COMP IN PRESS; Liu N, 2013, IEEE ANTENNAS PROP, P1646, DOI 10.1109/APS.2013.6711482; Luo M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056702; Luo M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026705; Monk P., 2003, FINITE ELEMENT MAXWE; MUR G, 1994, IEEE T MAGN, V30, P3552, DOI 10.1109/20.312706; NEDELEC JC, 1980, NUMER MATH, V35, P315, DOI 10.1007/BF01396415; NEDELEC JC, 1986, NUMER MATH, V50, P57, DOI 10.1007/BF01389668; Pantic-Tanner Z, 1998, IEEE T MICROW THEORY, V46, P178, DOI 10.1109/22.660984; Peverini OA, 2011, IEEE T MICROW THEORY, V59, P1685, DOI 10.1109/TMTT.2011.2144991; RAHMAN BMA, 1984, IEEE T MICROW THEORY, V32, P922, DOI 10.1109/TMTT.1984.1132789; Silvester P., 1969, ALTA FREQ, V38, P313; SUN D, 1995, IEEE ANTENNAS PROPAG, V37, P12, DOI 10.1109/74.475860; Trefethen L.N, 1997, NUMERICAL LINEAR ALG; Venkatarayalu NV, 2006, IEEE T MICROW THEORY, V54, P3019, DOI 10.1109/TMTT.2006.877057; Venkatarayalu NV, 2011, ASIA PACIF MICROWAVE, P1949; Venkatarayalu NV, 2010, INT J NUMER MODEL EL, V23, P231, DOI 10.1002/jnm.741; WINKLER JR, 1984, J COMPUT PHYS, V56, P1, DOI 10.1016/0021-9991(84)90079-2	35	28	29	4	24	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	FEB	2015	63	2	1				317	325		10.1109/TMTT.2014.2387839	http://dx.doi.org/10.1109/TMTT.2014.2387839			9	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CB4UI					2022-09-04	WOS:000349623300001
J	Lesmes, ACZ; Garcia, MA; Viviescas, MA; Stuhmer, W; Posada, ML; Camacho, M				Zapata Lesmes, A. C.; Garcia, M. A.; Viviescas, M. A.; Stuehmer, W.; Posada, M. L.; Camacho, M.			Lb_0210 has an osmotic effect in Leishmania, essential for differentiation and replication in macrophages.	MOLECULAR BIOLOGY OF THE CELL			English	Meeting Abstract	ASCB/IFCB Meeting	DEC 06-10, 2014	Philadelphia, PA	Amer Soc Cell Biol, Int Federat Cell Biol					[Zapata Lesmes, A. C.] La Salle Univ, Ciencias Basicas, Bogota, DC, Colombia; [Zapata Lesmes, A. C.] Pontificia Univ Javeriana, Fac Ciencias, Bogota, DC, Colombia; [Zapata Lesmes, A. C.; Garcia, M. A.; Viviescas, M. A.; Posada, M. L.; Camacho, M.] Ctr Int Fis, Bogota, DC, Colombia; [Garcia, M. A.] Univ Nacl Colombia, Fac Med, Bogota, DC, Colombia; [Garcia, M. A.] Univ Rosario, Fac Med, Bogota, DC, Colombia; [Viviescas, M. A.] Univ Nacl Colombia, Fac Ciencias, Bogota, DC, Colombia; [Stuehmer, W.] Max Planck Inst Expt Med, Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Camacho, M.] Univ Nacl Colombia, Biol, Bogota, DC, Colombia				Stuehmer, Walter/A-2176-2009						0	0	0	0	2	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	DEC	2014	25					P2366								1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cell Biology	CE8LP					2022-09-04	WOS:000352094105395
J	Gomez, L; Jacoby, E; Ibarra, L; Lucumi, D; Hernandez, A; Parra, D; Florindo, A; Hallal, P				Gomez, Luis; Jacoby, Enrique; Ibarra, Lorena; Lucumi, Diego; Hernandez, Alexandra; Parra, Diana; Florindo, Alex; Hallal, Pedro			Sponsorship of physical activity programs by the sweetened beverages industry: public health or public relations?	REVISTA DE SAUDE PUBLICA			Portuguese	Article						Nutririon; Public Health; Physical Activity; Soft Drinks; Soft Drinks Industries; Conflict of interest	FOOD; CONSUMPTION; CHILDREN	The growing evidence on the association between consumption of sugar-sweetened beverages, obesity and other chronic diseases has highlighted the need to implement policy actions that go beyond programs exclusively focused on individual responsibility. In order to protect their commercial goals in Latin America, the sugar-sweetened beverage industry practices intense lobbying at high government levels in several countries across the region. This strategy is accompanied by corporate social responsibility programs that fund initiatives promoting physical activity. These efforts, although appearing altruistic, are intended to improve the industry's public image and increase political influence in order to block regulations counter to their interests. If this industry wants to contribute to human well being, as it has publicly stated, it should avoid blocking legislative actions intended to regulate the marketing, advertising and sale of their products.	[Gomez, Luis; Ibarra, Lorena; Lucumi, Diego] Fdn FES Social, Div Salud, Bogota, Dist Capital, Colombia; [Gomez, Luis] Pontificia Univ Javeriana, Fac Med, Bogota, Dist Capital, Colombia; [Jacoby, Enrique] Org Panamer Salud, Asesoria Reg Nutr, Washington, DC USA; [Hernandez, Alexandra] Univ Rosario, Dept Medio Univ, Bogota, Dist Capital, Colombia; [Parra, Diana] Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Florindo, Alex] Univ Sao Paulo USP Leste, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Hallal, Pedro] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil		Gomez, L (corresponding author), Calle 23 68-59, Bogota 1015, Dist Capital, Colombia.	luisefe64@yahoo.com	Florindo, Alex Antonio/K-1870-2013; Hallal, Pedro C/A-3249-2011; Parra, Diana C/D-7633-2013	Florindo, Alex Antonio/0000-0002-4429-0826; Hallal, Pedro C/0000-0003-1470-6461; Parra, Diana C/0000-0002-9797-6231; Lucumi Cuesta, Diego Ivan/0000-0003-1834-7937; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012				Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Gomes FS, 2009, PUBLIC HEALTH NUTR, V12, P1024, DOI 10.1017/S1368980009005941; Hawkes C, 2010, AM J PREV MED, V38, P457, DOI 10.1016/j.amepre.2010.01.011; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666; Pomeranz JL, 2010, J LAW MED ETHICS, V38, P98, DOI 10.1111/j.1748-720X.2010.00470.x; Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	10	19	23	0	33	REVISTA DE SAUDE PUBLICA	SAO PAULO	FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO, BRAZIL	0034-8910			REV SAUDE PUBL	Rev. Saude Publica	APR	2011	45	2					423	427		10.1590/S0034-89102011005000001	http://dx.doi.org/10.1590/S0034-89102011005000001			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	735AK	21225220	Green Submitted, gold, Green Published			2022-09-04	WOS:000288385500022
J	Hossain, MF; Uddin, MS; Uddin, GMS; Sumsuzzman, DM; Islam, MS; Barreto, GE; Mathew, B; Ashraf, GM				Hossain, Md Farhad; Uddin, Md Sahab; Uddin, G. M. Sala; Sumsuzzman, Dewan Md; Islam, Md Siddiqul; Barreto, George E.; Mathew, Bijo; Ashraf, Ghulam Md			Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology	MOLECULAR NEUROBIOLOGY			English	Article						Melatonin; Alzheimer's disease; Amyloid beta; Neurofibrillary tangles; Circadian rhythm	AMYLOID-BETA-PEPTIDE; ADULT HIPPOCAMPAL NEUROGENESIS; NITRIC-OXIDE SYNTHASE; HUMAN PINEAL-GLAND; ALLEVIATES OXIDATIVE STRESS; PAIRED HELICAL FILAMENTS; TRANSGENIC MOUSE MODEL; CLOCK GENE-EXPRESSION; PROTEIN-KINASE-C; PRECURSOR PROTEIN	Melatonin, a pineal gland synthesized neurohormone is known as a multifunctioning pleiotropic agent which has a wide range of neuroprotective role in manifold age-related neurodegenerative disorders especially Alzheimer's diseases (AD). AD is a devastating neurodegenerative disorder and common form of dementia which is defined by abnormal and excessive accumulation of several toxic peptides including amyloid beta (A beta) plaques and neurofibrillary tangles (NFTs). The Alzheimer's dementia relates to atrophic changes in the brain resulting in loss of memory, cognitive dysfunction, and impairments of the synapses. Aging, circadian disruption, A beta accumulation, and tau hyperphosphorylation are the utmost risk factor regarding AD pathology. To date, there is no exact treatment against AD progression. In this regard, melatonin plays a crucial role for the inhibition of circadian disruption by controlling clock genes and also attenuates A beta accumulation and tau hyperphosphorylation by regulating glycogen synthase kinase-3 (GSK3) and cyclin-dependent kinase-5 (CDK5) signaling pathway. In this review, we highlight the possible mechanism of AD etiology and how melatonin influences neurogenesis by attenuating circadian disruption, A beta formation, as well as tau hyperphosphorylation. Furthermore, we also find out and summarize the neuroprotective roles of melatonin by the blockage of A beta production, A beta oligomerization and fibrillation, tau hyperphosphorylation, synaptic dysfunction, oxidative stress, and neuronal death during AD progression.	[Hossain, Md Farhad] Inje Univ, Dept Phys Therapy, Grad Sch, Gimhae, South Korea; [Uddin, Md Sahab; Uddin, G. M. Sala; Islam, Md Siddiqul] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Uddin, Md Sahab] Pharmakon Neurosci Res Network, Dhaka, Bangladesh; [Sumsuzzman, Dewan Md] Inje Univ, Dept Rehabil Sci, Grad Sch, Gimhae, South Korea; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Mathew, Bijo] Ahalia Sch Pharm, Dept Pharmaceut Chem, Div Drug Design, Palakkad, India; [Mathew, Bijo] Ahalia Sch Pharm, Dept Pharmaceut Chem, Med Chem Res Lab, Palakkad, India; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia		Uddin, MS (corresponding author), Southeast Univ, Dept Pharm, Dhaka, Bangladesh.; Uddin, MS (corresponding author), Pharmakon Neurosci Res Network, Dhaka, Bangladesh.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.	msu-neuropharma@hotmail.com; ashraf.gm@gmail.com	Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Sumsuzzman, Dewan Md./N-7052-2016; Uddin, Md. Sahab/Q-2315-2015	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Sumsuzzman, Dewan Md./0000-0002-4468-1202; Hossain, Md. Farhad/0000-0002-8641-4911; Uddin, Md. Sahab/0000-0002-0805-7840				Agrawal R, 2008, BEHAV BRAIN RES, V189, P381, DOI 10.1016/j.bbr.2008.01.015; Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; AncoliIsrael S, 1997, SLEEP, V20, P18; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; [Anonymous], POL BRIEF REV 135 MI; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Anuthakoengkun Areeya, 2014, Journal of the Medical Association of Thailand, V97, pS116; Arendt J, 1997, J BIOL RHYTHM, V12, P604, DOI 10.1177/074873049701200616; ARMSTRONG SM, 1991, MED HYPOTHESES, V34, P300, DOI 10.1016/0306-9877(91)90046-2; Asayama Kentaro, 2003, Journal of Nippon Medical School, V70, P334; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Bazoti FN, 2005, J MASS SPECTROM, V40, P182, DOI 10.1002/jms.738; Beal MF, 2000, ANN NY ACAD SCI, V924, P164; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Begum MM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/1562038; Benleulmi-Chaachoua A, 2016, J PINEAL RES, V60, P95, DOI 10.1111/jpi.12294; Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x; Benot S, 1998, J PINEAL RES, V25, P1, DOI 10.1111/j.1600-079X.1998.tb00378.x; Bhat RV, 2002, NEUROSIGNALS, V11, P251, DOI 10.1159/000067423; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bilici D, 2002, PHARMACOL RES, V46, P133, DOI 10.1016/S1043-6618(02)00089-0; Bonanni E, 2005, J SLEEP RES, V14, P311, DOI 10.1111/j.1365-2869.2005.00462.x; Bonilla E, 2002, EXP GERONTOL, V37, P629, DOI 10.1016/S0531-5565(01)00229-7; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Brusco LI, 2000, NEUROENDOCRINOL LETT, V21, P39; Brusco LI, 1999, BIOL SIGNAL RECEPT, V8, P126; Brusco LI, 1998, J PINEAL RES, V25, P260, DOI 10.1111/j.1600-079X.1998.tb00396.x; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cardinali DP, 2010, CURR NEUROPHARMACOL, V8, P218, DOI 10.2174/157015910792246209; Cardinali DP, 1997, J PINEAL RES, V23, P32, DOI 10.1111/j.1600-079X.1997.tb00332.x; Cardinali DP, 2002, NEUROENDOCRINOL LETT, V23, P20; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Carrillo-Vico A, 2013, INT J MOL SCI, V14, P8638, DOI 10.3390/ijms14048638; Chang HM, 2009, J PINEAL RES, V47, P211, DOI 10.1111/j.1600-079X.2009.00704.x; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chetsawang B, 2004, NEUROSCI LETT, V371, P205, DOI 10.1016/j.neulet.2004.08.068; Chung SY, 2003, J PINEAL RES, V34, P95, DOI 10.1034/j.1600-079X.2003.00010.x; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Corpas R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12515; Corrales A, 2014, J PINEAL RES, V56, P51, DOI 10.1111/jpi.12097; Costa EJX, 1995, J PINEAL RES, V19, P123, DOI 10.1111/j.1600-079X.1995.tb00180.x; Cristofol R, 2012, J PINEAL RES, V52, P271, DOI 10.1111/j.1600-079X.2011.00939.x; De Butte M, 2007, NEUROBIOL AGING, V28, P306, DOI 10.1016/j.neurobiolaging.2005.12.004; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Deng YQ, 2005, ACTA PHARMACOL SIN, V26, P519, DOI 10.1111/j.1745-7254.2005.00102.x; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dominguez-Alonso A, 2012, J PINEAL RES, V52, P427, DOI 10.1111/j.1600-079X.2011.00957.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Duffy JF, 2007, NEUROBIOL AGING, V28, P799, DOI 10.1016/j.neurobiolaging.2006.03.005; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Feng Z, 2006, FREE RADICAL BIO MED, V40, P101, DOI 10.1016/j.freeradbiomed.2005.08.014; Feng Z, 2005, FREE RADICAL BIO MED, V39, P195, DOI 10.1016/j.freeradbiomed.2005.03.007; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Ghosal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011866; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Gong YH, 2018, J PHARM PHARMACOL, V70, P70, DOI 10.1111/jphp.12830; Grandy J.K., 2013, J NEUROL NEUROPHYSIO, V4, P1, DOI DOI 10.4172/2155-9562.1000148; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Guenther AL, 2005, J PINEAL RES, V39, P251, DOI 10.1111/j.1600-079X.2005.00242.x; Guermonprez L, 2001, MOL PHARMACOL, V60, P838; Guerrero-Munoz MJ, 2014, BIOCHEM PHARMACOL, V88, P468, DOI 10.1016/j.bcp.2013.12.023; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Harada J, 1999, BRAIN RES, V842, P311, DOI 10.1016/S0006-8993(99)01808-9; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090; HAUGH RM, 1983, ARCH NEUROL-CHICAGO, V40, P560, DOI 10.1001/archneur.1983.04050080060011; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; He HW, 2010, CURR NEUROPHARMACOL, V8, P211, DOI 10.2174/157015910792246137; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Herljevic M, 2005, EXP GERONTOL, V40, P237, DOI 10.1016/j.exger.2004.12.001; HOFMAN MA, 1995, NEUROBIOL AGING, V16, P965, DOI 10.1016/0197-4580(95)02016-0; Hong Y, 2010, J PINEAL RES, V49, P201, DOI 10.1111/j.1600-079X.2010.00786.x; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hoppe JB, 2010, J PINEAL RES, V48, P230, DOI 10.1111/j.1600-079X.2010.00747.x; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Hull M, 1996, ANN NY ACAD SCI, V777, P205, DOI 10.1111/j.1749-6632.1996.tb34420.x; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Ikeno T, 2015, HIPPOCAMPUS, V25, P142, DOI 10.1002/hipo.22358; Fernandez-Bachiller MI, 2009, CHEMMEDCHEM, V4, P828, DOI 10.1002/cmdc.200800414; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jang MH, 2005, NEUROSCI LETT, V380, P26, DOI 10.1016/j.neulet.2005.01.003; Jenwitheesuk A, 2014, INT J MOL SCI, V15, P16848, DOI 10.3390/ijms150916848; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kim JS, 2014, J NEURAL TRANSM, V121, P1233, DOI 10.1007/s00702-014-1208-0; Kolker DE, 2003, J BIOL RHYTHM, V18, P159, DOI 10.1177/0748730403251802; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kunz D, 2004, PHARMACOPSYCHIATRY, V37, P139, DOI 10.1055/s-2004-827167; Lacoste B, 2015, J PINEAL RES, V58, P397, DOI 10.1111/jpi.12224; Lahiri DK, 1999, ANN NY ACAD SCI, V893, P325, DOI 10.1111/j.1749-6632.1999.tb07847.x; Lahiri DK, 2004, J PINEAL RES, V36, P224, DOI 10.1111/j.1600-079X.2004.00121.x; Lau WWI, 2012, J PINEAL RES, V52, P477, DOI 10.1111/j.1600-079X.2011.00965.x; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Leon J, 2006, J NEUROCHEM, V98, P2023, DOI 10.1111/j.1471-4159.2006.04029.x; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li XH, 2002, BIPOLAR DISORD, V4, P137, DOI 10.1034/j.1399-5618.2002.40201.x; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Ling X, 1999, ACTA PHARMACOL SIN, V20, P409; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Liu D, 2015, CELL DEATH DIFFER, V22, P583, DOI 10.1038/cdd.2014.195; Liu DD, 2013, BRAIN RES BULL, V93, P10, DOI 10.1016/j.brainresbull.2012.12.003; Liu JB, 2013, J PINEAL RES, V54, P222, DOI 10.1111/jpi.12023; Liu RY, 2000, J NEUROPATH EXP NEUR, V59, P314, DOI 10.1093/jnen/59.4.314; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Liu XZ, 2014, FREE RADICAL BIO MED, V68, P234, DOI 10.1016/j.freeradbiomed.2013.12.012; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Luo Y., 2006, OXIDATIVE STRESS AGE; MAESTRONI GJM, 1989, INT J IMMUNOPHARMACO, V11, P333, DOI 10.1016/0192-0561(89)90078-7; Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459; Mahlberg R, 2004, J CLIN PSYCHOPHARM, V24, P456, DOI 10.1097/01.jcp.0000132443.12607.fd; Mallidis C, 2007, HUM REPROD, V22, P2169, DOI 10.1093/humrep/dem156; Martinez-Canabal Alonso, 2014, Front Neurosci, V8, P147, DOI 10.3389/fnins.2014.00147; MASANA MI, 2001, SCI STKE, V107, P39, DOI DOI 10.1126/stke.2001.107.pe39; Masilamoni JG, 2008, FREE RADICAL RES, V42, P661, DOI 10.1080/10715760802277388; Matsubara E, 2003, J NEUROCHEM, V85, P1101, DOI 10.1046/j.1471-4159.2003.01654.x; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203; McCurry SM, 2000, SLEEP MED REV, V4, P603, DOI 10.1053/smrv.2000.0127; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Medeiros R, 2011, CNS NEUROSCI THER, V17, P514, DOI 10.1111/j.1755-5949.2010.00177.x; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Mishima K, 1999, BIOL PSYCHIAT, V45, P417, DOI 10.1016/S0006-3223(97)00510-6; Mishima K, 2001, J CLIN ENDOCR METAB, V86, P129, DOI 10.1210/jc.86.1.129; MOE KE, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00145.x; Moreira PI, 2006, NEUROLOGY, V66, pS97, DOI 10.1212/01.wnl.0000192307.15103.83; Moriya T, 2007, J PINEAL RES, V42, P411, DOI 10.1111/j.1600-079X.2007.00435.x; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; O'Neal-Moffitt G, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0027-6; Oh S, 2014, BIOFACTORS, V40, P586, DOI 10.1002/biof.1185; Ohashi Y, 1999, BIOL PSYCHIAT, V45, P1646, DOI 10.1016/S0006-3223(98)00255-8; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Olivier G, 2001, J PINEAL RES, V31, P320, DOI 10.1034/j.1600-079X.2001.310406.x; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pandi-Perumal S.R., 2007, MELATONIN MOL THERAP; Paouri E, 2017, J NEUROSCI, V37, P5155, DOI 10.1523/JNEUROSCI.2484-16.2017; Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185; Pappolla MA, 1997, J NEUROSCI, V17, P1683; Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018; Payne Judith K, 2006, Semin Oncol Nurs, V22, P31, DOI 10.1016/j.soncn.2005.10.005; Peng CX, 2013, NEUROBIOL AGING, V34, P1555, DOI 10.1016/j.neurobiolaging.2012.12.010; Perini G, 2002, J EXP MED, V195, P907, DOI 10.1084/jem.20011797; Pevet Paul, 2002, Dialogues Clin Neurosci, V4, P57; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; PIERPAOLI W, 1991, ANN NY ACAD SCI, V621, P291; Poeggeler B, 2001, BIOCHEMISTRY-US, V40, P14995, DOI 10.1021/bi0114269; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Ramirez-Rodriguez G, 2012, NEUROSCI LETT, V530, P53, DOI 10.1016/j.neulet.2012.09.045; Ramirez-Rodriguez G, 2009, NEUROPSYCHOPHARMACOL, V34, P2180, DOI 10.1038/npp.2009.46; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; REITER RJ, 1995, EXP GERONTOL, V30, P199, DOI 10.1016/0531-5565(94)00045-5; Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x; Reiter RJ, 2002, J PINEAL RES, V33, P61, DOI 10.1034/j.1600-079X.2002.2e001.x; REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x; Rennie K, 2009, J PINEAL RES, V47, P313, DOI 10.1111/j.1600-079X.2009.00716.x; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x; Rudnitskaya EA, 2015, J ALZHEIMERS DIS, V47, P103, DOI 10.3233/JAD-150161; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sarlak G, 2013, J PHARMACOL SCI, V123, P9, DOI 10.1254/jphs.13R01SR; Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x; SAYLER A, 1969, NEUROENDOCRINOLOGY, V5, P322, DOI 10.1159/000121892; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Semenova NV, 2018, CHRONOBIOL INT, V35, P1066, DOI 10.1080/07420528.2018.1456447; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Shen YX, 2007, ARCH MED RES, V38, P284, DOI 10.1016/j.arcmed.2006.10.007; Shen YX, 2002, J PINEAL RES, V32, P85, DOI 10.1034/j.1600-079x.2002.1819.x; Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x; Shi C, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00005; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shochat T, 2000, J SLEEP RES, V9, P373, DOI 10.1046/j.1365-2869.2000.00221.x; Shukla M, 2017, CURR NEUROPHARMACOL, V15, P1010, DOI 10.2174/1570159X15666170313123454; Shukla M, 2015, J PINEAL RES, V58, P151, DOI 10.1111/jpi.12200; Simonneaux V, 2004, MOL BRAIN RES, V120, P164, DOI 10.1016/j.molbrainres.2003.10.019; SKENE DJ, 1990, BRAIN RES, V528, P170, DOI 10.1016/0006-8993(90)90214-V; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; Skene DJ, 2003, J NEUROENDOCRINOL, V15, P438, DOI 10.1046/j.1365-2826.2003.01006.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Song H, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0007-x; Song WH, 1997, J MOL NEUROSCI, V9, P75, DOI 10.1007/BF02736852; Sotthibundhu A, 2010, J PINEAL RES, V49, P291, DOI 10.1111/j.1600-079X.2010.00794.x; Spuch C, 2010, NEUROTOX RES, V17, P421, DOI 10.1007/s12640-009-9121-2; Srinivasan V, 2010, BRAIN RES BULL, V81, P362, DOI 10.1016/j.brainresbull.2009.12.001; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; STOKKAN KA, 1994, J PINEAL RES, V16, P33, DOI 10.1111/j.1600-079X.1994.tb00079.x; STRAUSS S, 1992, LAB INVEST, V66, P223; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; SUGDEN D, 1983, J PHARMACOL EXP THER, V227, P587; Swaab, 2003, HUMAN HYPOTHALAMUS B; Swaab DF, 1987, PROG BRAIN RES <D>, V72, P301; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; SWAAB DF, 1992, BRAIN RES, V590, P239, DOI 10.1016/0006-8993(92)91101-J; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Takuma K, 2005, J PHARMACOL SCI, V97, P312, DOI 10.1254/jphs.CPJ04006X; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2010, CURR NEUROPHARMACOL, V8, P162, DOI 10.2174/157015910792246263; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Thiffault C, 2005, MITOCHONDRION, V5, P109, DOI 10.1016/j.mito.2004.12.002; Thomas JN, 1997, J PINEAL RES, V23, P123, DOI 10.1111/j.1600-079X.1997.tb00344.x; Thomas L, 2002, J PINEAL RES, V33, P218, DOI 10.1034/j.1600-079X.2002.02921.x; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tocharus C, 2014, NEUROSCIENCE, V275, P314, DOI 10.1016/j.neuroscience.2014.06.026; Trimmer PA, 2004, NEUROBIOL DIS, V15, P29, DOI 10.1016/j.nbd.2003.09.011; Uchida K, 1996, BRAIN RES, V717, P154, DOI 10.1016/0006-8993(96)00086-8; Uddin M.S., 2016, ADV ALZHEIMERS DIS, V5, P87, DOI [10.4236/aad.2016.53007, DOI 10.4236/AAD.2016.53007]; Uddin M.S., 2016, AM J PSYCHIAT NEUROS, V4, P26, DOI DOI 10.11648/J.AJPN.20160402.12; Uddin M.S., 2016, J ALZHEIMERS DIS PAR, V6, P1, DOI [10.4172/2161-0460.1000245, DOI 10.4172/2161-0460.1000245]; Uddin MS, 2019, NEUROTOX RES, V36, P583, DOI 10.1007/s12640-019-00047-5; Uddin MS, 2019, MOL NEUROBIOL, V56, P4925, DOI 10.1007/s12035-018-1420-2; Uddin MS, 2019, J CELL PHYSIOL, V234, P8094, DOI 10.1002/jcp.27588; Uddin Md Sahab, 2019, Psychogeriatrics, V19, P87, DOI 10.1111/psyg.12368; Uddin MS, 2019, MOL NEUROBIOL, V56, P2450, DOI 10.1007/s12035-018-1237-z; Uddin MS, 2018, ANN NEUROSCI, V25, P25, DOI 10.1159/000481812; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; Uddin MS, 2016, ANN NEUROSCI, V23, P218, DOI 10.1159/000449482; Uddin MS., 2016, J NEUROLOGY NEUROSCI, V7, P1, DOI DOI 10.21767/2171-6625.1000126; Uddin MS, 2018, HDB RES CRITICAL EXA, DOI [10.4018/978-1-5225-5282-6, DOI 10.4018/978-1-5225-5282-6]; Uddin MS, 2017, J INTELLECT DISABILI, V5, P137, DOI DOI 10.6000/2292-2598.2017.05.04.6; UECK M, 1977, ARCH HISTOL JAPON, V40, P261, DOI 10.1679/aohc1950.40.Supplement_261; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Wakatsuki A, 2001, J PINEAL RES, V30, P22, DOI 10.1034/j.1600-079X.2001.300103.x; Walker DG, 2002, BRAIN RES, V926, P69, DOI 10.1016/S0006-8993(01)03298-X; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wang J, 2010, BBA-PROTEINS PROTEOM, V1804, P1690, DOI 10.1016/j.bbapap.2009.11.015; Wang JZ, 2006, ACTA PHARMACOL SIN, V27, P41, DOI 10.1111/j.1745-7254.2006.00260.x; Wang L, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12429; Wang XC, 2008, NEUROCHEM RES, V33, P1138, DOI 10.1007/s11064-007-9563-y; Wang Xiao-Chuan, 2005, Shengli Xuebao, V57, P7; Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Wu YH, 2003, J CLIN ENDOCR METAB, V88, P5898, DOI 10.1210/jc.2003-030833; Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x; Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002; Wu YH, 2006, J COMP NEUROL, V499, P897, DOI 10.1002/cne.21152; Wu YH, 2006, FASEB J, V20, P1874, DOI 10.1096/fj.05-4446fje; Xue FX, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00049; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Yan SD, 2000, BBA-MOL BASIS DIS, V1502, P145, DOI 10.1016/S0925-4439(00)00041-7; Yang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/108486; Yon JH, 2006, NEUROBIOL DIS, V21, P522, DOI 10.1016/j.nbd.2005.08.011; Yonei Y, 2010, EFFECTS MELATONIN BA; Yoo DY, 2012, J PINEAL RES, V52, P21, DOI 10.1111/j.1600-079X.2011.00912.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yuan TF, 2015, STEM CELL REV REP, V11, P706, DOI 10.1007/s12015-015-9603-y; Zhang L, 1997, BIOCHEM BIOPH RES CO, V235, P845, DOI 10.1006/bbrc.1997.6698; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; Zhang YC, 2004, ACTA PHARMACOL SIN, V25, P447; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200; Zhou JN, 1999, MICROSC RES TECHNIQ, V44, P36, DOI 10.1002/(SICI)1097-0029(19990101)44:1<36::AID-JEMT5>3.0.CO;2-F; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zhou JN, 2003, J PINEAL RES, V35, P125, DOI 10.1034/j.1600-079X.2003.00065.x; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273; Zhu LQ, 2004, J PINEAL RES, V37, P71, DOI 10.1111/j.1600-079X.2004.00136.x	303	70	71	3	37	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2019	56	12					8255	8276		10.1007/s12035-019-01660-3	http://dx.doi.org/10.1007/s12035-019-01660-3			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JK5CI	31209782				2022-09-04	WOS:000494860800023
J	Lizcano-Sandoval, LD; Marulanda-Gomez, A; Lopez-Victoria, M; Rodriguez-Ramirez, A				Lizcano-Sandoval, Luis D.; Marulanda-Gomez, Angela; Lopez-Victoria, Mateo; Rodriguez-Ramirez, Alberto			Climate Change and Atlantic Multidecadal Oscillation as Drivers of Recent Declines in Coral Growth Rates in the Southwestern Caribbean	FRONTIERS IN MARINE SCIENCE			English	Article						coral growth parameters; Atlantic Multi-decadal Oscillation; ocean acidification; coral reefs; Orbicella faveolata; Serrana Atoll	SEA-SURFACE TEMPERATURE; MASSIVE PORITES; NORTH-ATLANTIC; MONTASTRAEA-ANNULARIS; SKELETAL EXTENSION; CARBON-DIOXIDE; RIVER RUNOFF; CALCIFICATION; DENSITY; REEFS	Historical records of growth rates of the key Caribbean reef framework-building coral Orbicella faveolata can be fundamental not only to understand how these organisms respond to environmental changes but also to infer future responses of reef ecosystems in a changing world. While coral growth rates have been widely documented throughout the Caribbean, the drivers of coral growth variability remain poorly understood. Here, we provide a record spanning 53 years (1963-2015) of the coral growth parameters for five O. faveolata core samples collected at Serrana Atoll, inside the Seaflower Biosphere Reserve, Colombian Caribbean. Coral cores were extracted from reefs isolated from direct anthropogenic impacts, and growth estimations (skeletal density, linear extension, and calcification rates) were derived using computerized tomography. Master records of coral growth parameters were evaluated to identify long-term trends and to relate growth responses with sea surface temperature (SST), the Atlantic Multi-decadal Oscillation (AMO), North Atlantic Oscillation (NAO) and Southern Oscillation indexes, aragonite saturation state (Omega(arag)), and degree heating months (DHM). We found significant negative relationships between density and mean SST, maximum SST, AMO, and DHM. Moreover, density showed significant positive correlations with NAO and Omega(arag). Extension rate did not show significant correlations with any environmental variable. However, there were significant negative correlations between calcification and maximum SST, AMO, and DHM. Trends of coral growth indicated a significant reduction in density and calcification over time, which were best explained by changes in Omega(arag). Inter-annual declines in calcification and density up to 25% (relative to historical mean) were associated to the impacts of previously recorded mass bleaching events (1998, 2005, and 2010). Our study provides further evidence that AMO and Omega(arag) are important drivers affecting coral growth rates in the Southwestern Caribbean. Therefore, we suggest upcoming variations of AMO and future trajectories of Omega(arag) in the Anthropocene could have a substantial influence on future disturbances, ecological process and responses of the Caribbean reefs.	[Lizcano-Sandoval, Luis D.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Puerto Morelos, Mexico; [Lizcano-Sandoval, Luis D.; Marulanda-Gomez, Angela; Lopez-Victoria, Mateo] Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia; [Rodriguez-Ramirez, Alberto] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Lizcano-Sandoval, Luis D.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Marulanda-Gomez, Angela] Univ Amsterdam, Dept Freshwater & Marine Ecol, IBED, Amsterdam, Netherlands; [Rodriguez-Ramirez, Alberto] Univ Queensland, Sch Biol Sci, Marine Palaeoecol Lab, St Lucia, Qld, Australia		Lopez-Victoria, M (corresponding author), Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia.	malov@javerianacali.edu.co	Lizcano-Sandoval, Luis/AAV-4127-2020	Lizcano-Sandoval, Luis/0000-0003-2312-1836; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Marulanda Gomez, Angela Maria/0000-0002-9760-0779	Pontificia Universidad Javeriana Cali; Administrative Department of Science, Technology and Innovation (Colciencias) under the Colombia-BIO program [341-2016]	Pontificia Universidad Javeriana Cali; Administrative Department of Science, Technology and Innovation (Colciencias) under the Colombia-BIO program(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was funded by the Pontificia Universidad Javeriana Cali. The field trip was conducted during the Seaflower Scientific Expedition-Serrana 2016, supported by the Colombian Government, under the leadership of the Colombian Oceans' Commission (CCO), and with logistic support from the Colombian Navy. Additional funding was provided by the Administrative Department of Science, Technology and Innovation (Colciencias), under the Colombia-BIO program (Agreement 341-2016, between Universidad de los Andes and Comision Colombiana del Oceano).	Albright R, 2018, NATURE, V555, P516, DOI 10.1038/nature25968; Anderson M, 2008, PERMANOVA PRIMER GUI; Anderson M.J., 2003, DISTLM FORWARD FORTR; Barnes DJ, 1996, GLOBAL CHANGE BIOL, V2, P569, DOI 10.1111/j.1365-2486.1996.tb00068.x; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carricart-Ganivet JP, 2007, MAR BIOL, V153, P1, DOI 10.1007/s00227-007-0780-3; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Carricart-Ganivet JP, 2001, B MAR SCI, V68, P133; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V344, P67, DOI 10.1016/j.jembe.2006.12.018; Carricart-Ganivet JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032859; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/NCLIMATE1577, 10.1038/nclimate1577]; Castillo KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014615; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Cruz-Pinon G, 2003, MAR BIOL, V143, P491, DOI 10.1007/s00227-003-1127-3; D'Olivo JP, 2013, CORAL REEFS, V32, P999, DOI 10.1007/s00338-013-1071-8; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DODGE RE, 1984, B MAR SCI, V34, P288; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fantazzini P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8785; Vasquez-Bedoya LF, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002313; Frajka-Williams E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11046-x; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Gischler E, 2005, PALAIOS, V20, P159, DOI 10.2110/palo.2004.p04-09; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Grove CA, 2013, CLIM PAST, V9, P641, DOI 10.5194/cp-9-641-2013; Guzman HM, 2008, AMBIO, V37, P342, DOI 10.1579/07-A-372.1; Helmle Kevin P., 2011, P958; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Hetzinger S, 2008, GEOLOGY, V36, P11, DOI 10.1130/G24321A.1; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Klower M, 2014, EARTH PLANET SC LETT, V406, P1, DOI 10.1016/j.epsl.2014.09.001; Kwiatkowski L, 2013, NAT GEOSCI, V6, P362, DOI [10.1038/NGEO1780, 10.1038/ngeo1780]; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liu G., 2006, P 10 INT COR REEF S; Lough JM, 2014, BIOL BULL-US, V226, P187, DOI 10.1086/BBLv226n3p187; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Lough JM, 2008, MAR ECOL PROG SER, V373, P257, DOI 10.3354/meps07398; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; LOUGH JM, 1992, J EXP MAR BIOL ECOL, V155, P1, DOI 10.1016/0022-0981(92)90024-5; Manzello DP, 2015, MAR ECOL PROG SER, V521, P81, DOI 10.3354/meps11085; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Meissner KJ, 2012, CORAL REEFS, V31, P309, DOI 10.1007/s00338-011-0866-8; Mollica NR, 2018, P NATL ACAD SCI USA, V115, P1754, DOI 10.1073/pnas.1712806115; Page NJ, 2017, ENERG ENVIRON-UK, V28, P330, DOI 10.1177/0958305X16686488; Pandolfi JM, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P13, DOI 10.1007/978-94-007-0114-4_2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P2161, DOI 10.1175/1520-0493(1987)115<2161:AEOTTS>2.0.CO;2; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Tambutte E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8368; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Tanzil JT, 2013, GLOBAL CHANGE BIOL, V19, P3011, DOI 10.1111/gcb.12279; van Woesik R, 2013, PEERJ, V1, DOI 10.7717/peerj.208; VANVEGHEL MLJ, 1995, B MAR SCI, V56, P902; Yan H, 2011, NAT GEOSCI, V4, P611, DOI 10.1038/ngeo1231; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	67	2	2	3	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-7745		FRONT MAR SCI	Front. Mar. Sci.	FEB 8	2019	6								38	10.3389/fmars.2019.00038	http://dx.doi.org/10.3389/fmars.2019.00038			10	Environmental Sciences; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Marine & Freshwater Biology	HQ8HJ		gold			2022-09-04	WOS:000462664800001
J	Ruiz-Garcia, M; Escobar-Armel, P; de Thoisy, B; Martinez-Aguero, M; Pinedo-Castro, M; Shostell, JM				Ruiz-Garcia, Manuel; Escobar-Armel, Pablo; de Thoisy, Benoit; Martinez-Aguero, Maria; Pinedo-Castro, Myreya; Shostell, Josep Mark			Biodiversity in the Amazon: Origin Hypotheses, Intrinsic Capacity of Species Colonization, and Comparative Phylogeography of River Otters (Lontra longicaudis and Pteronura brasiliensis, Mustelidae, Carnivora) and Pink River Dolphin (Inia sp., Iniidae, Cetacea)	JOURNAL OF MAMMALIAN EVOLUTION			English	Article						Lontra; Pteronura; Inia; Mitochondrial markers; Amazon biodiversity; Systematics; Phylogeny	NEOTROPICAL RAIN-FOREST; POPULATION-GENETICS; GIANT OTTER; HISTORICAL BIOGEOGRAPHY; MOLECULAR SYSTEMATICS; EVOLUTIONARY HISTORY; AREA RELATIONSHIPS; PHOCOENA-PHOCOENA; RAW DISTRIBUTIONS; WESTERN AMAZONIA	We sequenced mitochondrial genes of otter (Lontra longicaudis and Pteronura brasiliensis) and dolphin (Inia sp.) species to provide new systematics data and to test hypotheses that offer explanations as to the Amazon's biodiversity. Four of the 11 hypotheses tested --Paleogeography (PH), Recent Lagoon (RLH), Hydrogeological Recent Change (HRCH), and Refugia (RH)-- support the evolution of these three species. As part of this comparative phylogenetic study, we also considered the degree of water dependence of each species. For the least water dependent of the three species, L. longicaudis, only HRCH and RH had an influence on genetic structure, although it was relatively minor. For the more water dependent otter species, P. brasiliensis, our analyses stressed the significance of a single PH event along with two lesser important PH events. However, its gene diversification basically occurred during the Pleistocene and our analyses did detect a relatively small influence of HRCH and RH. For the completely water dependent species, Inia, we detected two significant PH events. Its genetic structure was considerably more developed than in either otter species, although the Pleistocene was a very important period of genetic diversification for the pink river dolphins (HRCH and RLH). Each species has ancestors with different geographical origins and genomes with different capacities to colonize-making it difficult to rely on a generalized hypothesis to understand the origins of the Amazon's extremely rich biodiversity.	[Ruiz-Garcia, Manuel; Escobar-Armel, Pablo; Martinez-Aguero, Maria; Pinedo-Castro, Myreya] Pontificia Univ Javeriana, Fac Ciencias, Lab Genet Poblac Mol & Biol Evolut, Unidad Genet,Dept Biol, Cra 7A 43-82, Bogota, DC, Colombia; [de Thoisy, Benoit] Assoc Kwata, Cayenne, French Guiana; [de Thoisy, Benoit] Inst Pasteur, Cayenne, French Guiana; [Martinez-Aguero, Maria] Univ Rosario, Fac Ciencias Nat & Matemat, Biol, Bogota, DC, Colombia; [Shostell, Josep Mark] Univ Minnesota Crookston, Dept Math Sci & Technol, Crookston, MN 56716 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Lab Genet Poblac Mol & Biol Evolut, Unidad Genet,Dept Biol, Cra 7A 43-82, Bogota, DC, Colombia.	mruizgar@yahoo.es	Castro, Myreya Pinedo/AAF-8450-2019; Ruiz-Garcia, Manuel/AAF-8191-2019	de thoisy, benoit/0000-0002-8420-5112; Ruiz-Garcia, Manuel/0000-0003-2820-2950	Fondo para la Accion Ambiental (US-Aid) [120108-E0102141]; Colciencias [1203-09-11239]	Fondo para la Accion Ambiental (US-Aid); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Economic resources to carry out this study were obtained from Colciencias (Grant 1203-09-11239; Geographical population structure and genetic diversity of two river dolphin species, Inia boliviensis and Inia geoffrensis, using molecular markers) and the Fondo para la Accion Ambiental (US-Aid) (120108-E0102141; Structure and Genetic Conservation of river dolphins, Inia and Sotalia, in the Amazon and Orinoco basins). Many thanks go to Dr. Diana Alvarez (Colombia), Luisa Castellanos (Colombia), Ariel Rodriguez (Colombia), Esteban Payan (Colombia), Carlos Vergara (Colombia), Maria Fernanda Gomez (Colombia), Nathali Romero (Colombia), Mariana Escovar (La Paz, Bolivia), Juanito, and Angelito (Iquitos, Peru), and to Isaias, and his sons (Requena, Peru), who participated in the capture of the pink river dolphins herein studied. Also, diverse Peruvian Indian communities collaborated with our pink river dolphin and otter captures throughout the Peruvian rivers (Bora, Ocaina, Shipigo-Comibo, Capanahua, Angoteros, Orejon, Cocama, Kishuarana, and Alamas) and also to diverse Bolivian communities, who helped to capture dolphins and otters throughout the Mamore river and other Bolivian Amazon tributaries (Siriono, Canichana, Cayubaba and Chacobo). Dr. Fernando Trujillo (Omacha Foundation) gently offered some dolphin samples from the Colombian Orinoco, and Amazon. Additional thanks go to Hugo Galvez (Iquitos, Peru), and Armando Castellanos (Quito, Ecuador) to collaborate in collection permits in both countries. Similarly, many thanks go to the Bolivian, Peruvian and Ecuadorian Ministry of Environment, to the Direccion General de Biodiversidad and CITES from Bolivia, PRODUCE, Direccion Nacional de Extraccion and Procesamiento Pesquero and to the Instituto Nacional de Recursos Naturales (INRENA) from Peru for their role in facilitating the obtainment of the collection permits. Special thanks goes to the Coleccion Boliviana de Fauna (Dr. Julieta Vargas) in La Paz (Bolivia). Thanks also to the Fundacion Sociedad Portuaria de Santa Marta (Colombia) for its logistical support.	AbSaber AN, 1982, BIOL DIVERSIFICATION, P41; Aleixo A, 2007, J ORNITHOL, V148, pS443, DOI 10.1007/s10336-007-0168-7; Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P436, DOI 10.1016/j.ympev.2014.09.004; Almeida R, 2007, REMOTE SENS ENVIRON, V110, P387, DOI 10.1016/j.rse.2007.03.005; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; ASHLEY MV, 1995, INT J PRIMATOL, V16, P793, DOI 10.1007/BF02735720; ASSUMPCAO M, 1988, GEOPHYS J INT, V92, P253, DOI 10.1111/j.1365-246X.1988.tb01138.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Avise John C., 1994, pi; AYRES J. M., 1986, THESIS; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banguera-Hinestroza E, 2002, J HERED, V93, P312, DOI 10.1093/jhered/93.5.312; Bates JM, 2004, J ORNITHOL, V145, P199, DOI 10.1007/s10336-004-0039-4; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Behling H, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P335; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Best Robin C., 1993, Mammalian Species, V426, P1; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Caballero S, 2007, MAR MAMMAL SCI, V23, P358, DOI 10.1111/j.1748-7692.2007.00110.x; Caballero S, 2015, J HERED, V106, P469, DOI 10.1093/jhered/esv049; Cabrera A., 1957, ZOOLOGIA, V4, P1; Campbell K.E. Jr, 1990, P33; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cella-Ribeiro A, 2013, PEIXES RIO MADEIRA, P47; COLINVAUX P, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P473; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; Croizat L, 1976, BIBLIOTECA ACAD CIEN, V15; Cunha HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028297; Degen B., 1998, Forest Genetics, V5, P191; Degen B, 2001, J HERED, V92, P447, DOI 10.1093/jhered/92.5.447; DEJONG CGV, 1972, LIFE SCI CONTRIBUTIO, V80, P1; DEMUIZON C, 1983, CR ACAD SCI III-VIE, V296, P625; Dobzhansky T., 1971, ECOLOGICAL GENETICS, P109, DOI DOI 10.1007/978-1-4757-0432-7_6; Dominguez C, 1998, COLOMBIA ORINOCO, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duckworth, 1973, TROPICAL FOREST ECOS, P255; Dumont JF, 1996, TECTONOPHYSICS, V259, P137, DOI 10.1016/0040-1951(95)00200-6; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; Edwards AMC, 1970, AMAZONIANA, V2, P245; Eisenberg J. F., 1989, MAMMALS NEOTROPICS N, V1; EMSLEY M. G., 1965, ZOOLOGICA [NEW YORK], V50, P191; Endler J.A., 1982, P641; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Espurt N, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P89; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRAILEY C D, 1988, Acta Amazonica, V18, P119; Garcia DM., 2007, Braz. J. Biol., V67, P819, DOI 10.1590/S1519-69842007000500004; GRABERT H, 1984, Z SAUGETIERKD, V49, P334; GRABERT H, 1984, AMAZONIANA, V8, P365; Gravena W, 2015, BIOL J LINN SOC, V114, P764, DOI 10.1111/bij.12463; Gravena W, 2014, CONSERV GENET, V15, P619, DOI 10.1007/s10592-014-0565-4; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; Guerrero Javier, 1997, P15; Haffer J., 1982, P6; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Haffer J., 1987, BIOGEOGRAPHY QUATERN, P1; Haffer J., 1974, PUBLICATION NUTTALL, V14; Haffer J, 1993, BIOGEOGRAPHICA, V69, P15; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harris CJ, 1968, OTTERS STUDY RECENT; Hartl D.L., 2006, PRINCIPLES POPULATIO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedrick PW., 2005, GENETICS POPULATIONS, V4th ed; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hollatz C, 2011, BIOL J LINN SOC, V102, P812, DOI 10.1111/j.1095-8312.2011.01616.x; Hooghiemstra H, 1998, EARTH-SCI REV, V44, P147, DOI 10.1016/S0012-8252(98)00027-0; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klammer G., 1984, AMAZON LIMNOLOGY LAN, P47; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Lavergne A, 2010, AM J PRIMATOL, V72, P242, DOI 10.1002/ajp.20773; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima C, 1997, GEOPHYS J INT, V130, P112, DOI 10.1111/j.1365-246X.1997.tb00991.x; Lomolino M., 2006, BIOGEOGRAPHY, P1; Lovejoy NR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P405; Lundberg John G., 1998, P13; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Macdonald S., 1990, P11; Mago-Leccia, 1972, REV DEF NAT, V1, P5; Manly BF., 1997, RANDOMIZATION BOOTST; MANTEL N, 1967, CANCER RES, V27, P209; Marroig G, 1997, J COMP BIOL, V2, P103; MARSHALL LG, 1985, GREAT AM BIOTIC INTE, P49, DOI DOI 10.1007/978-1-4684-9181-4_3; Martin AR, 2004, CAN J ZOOL, V82, P1307, DOI 10.1139/Z04-109; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Morell V, 1996, SCIENCE, V273, P1496; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nores M, 2004, GLOBAL ECOL BIOGEOGR, V13, P149, DOI 10.1111/j.1466-882X.2004.00076.x; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Palumbi SR., 1991, SIMPLE FOOLS GUIDE P; Patton JL, 1998, ENDLESS FORMS, P202; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Pickles RSA, 2011, MOL PHYLOGENET EVOL, V61, P616, DOI 10.1016/j.ympev.2011.08.017; Pilleri G, 1977, INVESTIGATIONS CETAC, P11; PINDELL JL, 1998, SEPM SPECIAL PUBLICA, V58, P45, DOI DOI 10.2110/PEC.98.58.0045; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Prance GT, 1996, PHILOS T R SOC B, V351, P823, DOI 10.1098/rstb.1996.0077; Prance GT, 1985, AMAZONIA KEY ENV; Prance GT, 1982, BIOL DIVERSIFICATION, P137; Prevosti FJ, 2008, J VERTEBR PALEONTOL, V28, P1171, DOI 10.1671/0272-4634-28.4.1171; Prum R.O., 1988, P2562; Pyenson ND, 2015, PEERJ, V3, DOI 10.7717/peerj.1227; Racheli L, 2004, BIOL J LINN SOC, V82, P345, DOI 10.1111/j.1095-8312.2004.00363.x; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; Rheingantz ML, 2014, TROP CONSERV SCI, V7, P224; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; Roddaz M, 2006, J S AM EARTH SCI, V20, P351, DOI 10.1016/j.jsames.2005.11.004; Roddaz M, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P61; Nogueira ACR, 2013, J S AM EARTH SCI, V46, P89, DOI 10.1016/j.jsames.2013.05.004; Ron SR, 2000, BIOL J LINN SOC, V71, P379, DOI 10.1111/j.1095-8312.2000.tb01265.x; ROSEL PE, 1995, CAN J FISH AQUAT SCI, V52, P1210, DOI 10.1139/f95-118; Rosenbaum G, 2005, EARTH PLANET SC LETT, V239, P18, DOI 10.1016/j.epsl.2005.08.003; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Rossetti DF, 2007, CATENA, V70, P253, DOI 10.1016/j.catena.2006.08.009; Roy Michael S., 1997, P325, DOI 10.1016/B978-012498315-1/50018-2; Ruiz-Garcia M, 2010, MOL PHYLOGENET EVOL, V57, P1049, DOI 10.1016/j.ympev.2010.09.002; Ruiz-Garcia M., 2007, Animal Biodiversity and Conservation, V30, P115; RUIZ-GARCIA M, 2008, POPULATION GENETICS, P177; Ruiz-Garcia M, 2006, ACTA THERIOL, V51, P411, DOI 10.1007/BF03195188; Ruiz-Garcia M, 2016, MITOCHONDRIAL DNA A, V27, P2334, DOI 10.3109/19401736.2015.1022766; Ruiz-Garcia M, 2014, MOL PHYLOGENET EVOL, V79, P179, DOI 10.1016/j.ympev.2014.05.034; Ruiz-Garcia M, 2012, FOLIA PRIMATOL, V83, P100, DOI 10.1159/000342832; Ruiz-Garcia M, 2012, AM J PRIMATOL, V74, P366, DOI 10.1002/ajp.20940; Ruiz-Garcia M, 2010, WILDL PROT DESTR EXT, P161; Ruiz-Garcia M, 2010, WILDL PROT DESTR EXT, P131; SAMBROCK J, 1989, MOL CLONING LAB MANU; SANDERS HL, 1969, BROOKHAVEN SYM BIOL, P71; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Soibelzon LH, 2005, J S AM EARTH SCI, V20, P105, DOI 10.1016/j.jsames.2005.07.005; Sombroeck WG, 1966, AMAZON SOILS; Stern K.M., 1970, AMAZONIANA, V2, P401; Sternberg HO, 1975, AMAZON RIVER BRAZIL, P1; Streiff R, 1998, MOL ECOL, V7, P317, DOI 10.1046/j.1365-294X.1998.00360.x; Terborgh J., 1992, DIVERSITY TROPICAL R; Trinca CS., 2007, Braz. J. Biol., V67, P813, DOI 10.1590/S1519-69842007000500003; Trinca CS, 2012, J HERED, V103, P479, DOI 10.1093/jhered/ess001; Tuomisto Hanna, 1992, Acta Amazonica, V22, P353; Van der Hammen T, 1975, J BIOGEOGR, V1, P3; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vanzolini P.E, 1992, ESTUD AV-SAO PAULO, V6, P41, DOI DOI 10.1590/S0103-40141992000200003; Vanzolini PE., 1970, ZOOLOGIA SISTEMATICA, P1; Vendramin GG, 1999, MOL ECOL, V8, P1117, DOI 10.1046/j.1365-294x.1999.00666.x; Von Ihering, 1927, GESCH ATLANTISCHEN O; Wallace, 1852, P ZOOL SOC LOND, V20, P107, DOI [10.1080/037454809494374, DOI 10.1080/037454809494374]; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JY, 1996, CAN J FISH AQUAT SCI, V53, P1632, DOI 10.1139/cjfas-53-7-1632; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.1093/sysbio/46.4.622; Weber LI, 2009, IHERINGIA SER ZOOL, V99, P5, DOI 10.1590/S0073-47212009000100001; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Whithmore RT, 1987, MONOGRAPY BIOGEOGRAP, V3; Wilkinson MJ, 2006, J S AM EARTH SCI, V21, P151, DOI 10.1016/j.jsarnes.2005.08.002; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	186	6	7	1	46	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1064-7554	1573-7055		J MAMM EVOL	J. Mamm. Evol.	JUN	2018	25	2					213	240		10.1007/s10914-016-9375-4	http://dx.doi.org/10.1007/s10914-016-9375-4			28	Evolutionary Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Evolutionary Biology; Zoology	GF1EQ					2022-09-04	WOS:000431676400005
J	Martin-Jimenez, CA; Garcia-Vega, A; Cabezas, R; Aliev, G; Echeverria, V; Gonzalez, J; Barreto, GE				Martin-Jimenez, Cynthia A.; Garcia-Vega, Angela; Cabezas, Ricardo; Aliev, Gjumrakch; Echeverria, Valentina; Gonzalez, Janneth; Barreto, George E.			Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases	PROGRESS IN NEUROBIOLOGY			English	Review						Endoplasmic reticulum; ER stress; Astrocytes; Obesity; Neurodegenerative diseases	UNFOLDED-PROTEIN RESPONSE; INDUCED ER STRESS; AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL QUALITY-CONTROL; AMYLOID PRECURSOR PROTEIN; OXYGEN SPECIES PRODUCTION; TOLL-LIKE RECEPTORS; INDUCED CELL-DEATH; BETA/NF-KAPPA-B; ALZHEIMERS-DISEASE	Endoplasmic reticulum (ER) is a subcellular organelle involved in protein folding and processing. ER stress constitutes a cellular process characterized by accumulation of misfolded proteins, impaired lipid metabolism and induction of inflammatory responses. ER stress has been suggested to be involved in several human pathologies, including neurodegenerative diseases and obesity. Different studies have shown that both neurodegenerative diseases and obesity trigger similar cellular responses to ER stress. Moreover, both diseases are assessed in astrocytes as evidences suggest these cells as key regulators of brain homeostasis. However, the exact contributions to the effects of ER stress in astrocytes in the various neurodegenerative diseases and its relation with obesity are not well known. Here, we discuss recent advances in the understanding of molecular mechanisms that regulate ER stress-related disorders in astrocytes such as obesity and neurodegeneration. Moreover, we outline the correlation between the activated proteins of the unfolded protein response (UPR) in these pathological conditions in order to identify possible therapeutic targets for ER stress in astrocytes. We show that ER stress in astrocytes, shares UPR activation pathways during both obesity and neurodegenerative diseases, demonstrating that UPR related proteins like ER chaperone GRP 78/Bip, PERK pathway and other exogenous molecules ameliorate UPR response and promote neuroprotection. (C) 2017 Elsevier Ltd. All rights reserved.	[Martin-Jimenez, Cynthia A.; Garcia-Vega, Angela; Cabezas, Ricardo; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Inst Inc, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./AAD-7420-2020; martin, cynthia/AAC-6016-2021; Aliev, Gjumrakch/AAE-7734-2020; Valentina Echeverria Moran, BCh/E-7765-2013	GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Valentina Echeverria Moran, BCh/0000-0003-2393-5418				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aburasayn H, 2016, AM J PHYSIOL-ENDOC M, V311, pE423, DOI 10.1152/ajpendo.00133.2016; Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Agostinis P., 2016, ENDOPLASMIC RETICULU; Alberdi E, 2013, AGING CELL, V12, P292, DOI 10.1111/acel.12054; Alberts B., 2002, MOL BIOL CELL, DOI [10.1038/oby.2007.197, DOI 10.1038/OBY.2007.197]; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baker MJ, 2014, BRIT J PHARMACOL, V171, P1870, DOI 10.1111/bph.12430; Bales KR, 2010, NEUROPHARMACOLOGY, V59, P295, DOI 10.1016/j.neuropharm.2010.01.005; Barbero-Camps E, 2014, AM J PATHOL, V184, P2066, DOI 10.1016/j.ajpath.2014.03.014; Barreto GE, 2016, PROG NEUROBIOL, V144, P1, DOI 10.1016/j.pneurobio.2016.09.001; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; BASSERI S, 2012, BIOCH RES INT, DOI DOI 10.1007/S12975-013-0282-1; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Benavides A, 2005, GLIA, V52, P261, DOI 10.1002/glia.20242; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boden G, 2009, DIABETES, V58, P518, DOI 10.2337/db08-1746; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Buckman LB, 2015, MOL METAB, V4, P58, DOI 10.1016/j.molmet.2014.10.001; Bujisic B, 2017, NAT IMMUNOL, V18, P479, DOI 10.1038/ni.3725; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Cali T, 2011, BIOFACTORS, V37, P228, DOI 10.1002/biof.159; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Cho H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-9; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Contreras C., 2016, DIABETES, V65; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Copanaki E, 2007, BBA-MOL CELL RES, V1773, P157, DOI 10.1016/j.bbamcr.2006.10.002; Costa RO, 2013, MOL CELL NEUROSCI, V52, P1, DOI 10.1016/j.mcn.2012.09.005; Cui W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059921; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.1471-4159.2003.01590.x; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS217, DOI 10.3233/JAD-2012-111728; Degasperi GR, 2009, METABOLISM, V58, P1087, DOI 10.1016/j.metabol.2009.04.002; Deslauriers A.M., 2011, J IMMUNOL; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014; Duran-Aniotz C., 2017, ACTA NEUROPATHOL, P1; Duthie A, 2011, QJM-INT J MED, V104, P913, DOI 10.1093/qjmed/hcr118; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007; Fucho R, 2017, FASEB J, V31, P1263, DOI 10.1096/fj.201601156R; Garcia-Caceres C, 2012, MOL METAB, V1, P37, DOI 10.1016/j.molmet.2012.07.001; Garcia-Caceres C, 2013, ENDOCRIN METAB CLIN, V42, P57, DOI 10.1016/j.ecl.2012.11.003; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gasiorowski K., 2017, MOL NEUROBIOL; Glab J.A., 2017, CELL DEATH DIFFERENT; Glenner GG, 2012, BIOCHEM BIOPH RES CO, V425, P534, DOI 10.1016/j.bbrc.2012.08.020; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gonzalez-Barosso MMRE, 2009, CURR CHEM BIOL, V3, P180, DOI [10.1079/PNS2003336, DOI 10.2174/187231309788166451]; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gorbatyuk MS, 2013, J GENET SYNDR GENE T, V4; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Gregor M. F., 2011, INFLAMMATORY MECH OB; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; GROOP LC, 1992, AM J PHYSIOL, V263, pE79, DOI 10.1152/ajpendo.1992.263.1.E79; Gu LZ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-109; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Hager L, 2012, J BIOL CHEM, V287, P20755, DOI 10.1074/jbc.M112.340919; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamdy Osama, 2005, Curr Diab Rep, V5, P317, DOI 10.1007/s11892-005-0086-0; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Honda T, 1999, J NEUROCHEM, V72, P255, DOI 10.1046/j.1471-4159.1999.0720255.x; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hori O, 1996, J NEUROCHEM, V66, P973; Horimoto S, 2013, J BIOL CHEM, V288, P31517, DOI 10.1074/jbc.M113.476010; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsuchou H, 2009, BRAIN, V132, P889, DOI 10.1093/brain/awp029; Cornejo VH, 2013, SEMIN IMMUNOPATHOL, V35, P277, DOI 10.1007/s00281-013-0373-9; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Iglesias J., 2016, MOL NEUROBIOL; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jaronen M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00402; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karaskov E., 2011, ENDOCRINOLOGY; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Kaus A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00448; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Khadir A, 2016, METABOLISM, V65, P1409, DOI 10.1016/j.metabol.2016.06.004; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kogel D, 2012, NEUROBIOL AGING, V33, P2200, DOI 10.1016/j.neurobiolaging.2011.06.012; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Koss DJ, 2017, BEHAV PHARMACOL, V28, P161, DOI 10.1097/FBP.0000000000000299; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Kuang XH, 2010, NEUROCHEM INT, V57, P738, DOI 10.1016/j.neuint.2010.08.010; Kume T, 2017, BIOL PHARM BULL, V40, P553, DOI 10.1248/bpb.b17-00091; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee JH, 2010, EXP MOL MED, V42, P386, DOI 10.3858/emm.2010.42.5.040; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Levytskyy RM, 2016, J NEUROIMMUNE PHARM, V11, P629, DOI 10.1007/s11481-016-9683-8; Lew QJ, 2011, NUCLEIC ACIDS RES, V39, P429, DOI 10.1093/nar/gkq785; Li JJ, 2008, MOL NUTR FOOD RES, V52, P631, DOI 10.1002/mnfr.200700399; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lindholm D, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00048; Liu ZC, 2012, J ALZHEIMERS DIS, V29, P727, DOI 10.3233/JAD-2012-111898; Liu Z, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-71; Logica T, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/tnagi.2016.00116, 10.3389/fnagi.2016.00116]; Luce K, 2010, ADV EXP MED BIOL, V694, P108; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Ma T, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt260; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Maly DJ, 2014, NAT CHEM BIOL, V10, P892, DOI 10.1038/nchembio.1664; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marwarha G, 2016, CELL SIGNAL, V28, P1789, DOI 10.1016/j.cellsig.2016.08.012; Massaro M, 2002, THROMB HAEMOSTASIS, V88, P335; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; Matsuzaka T, 2016, J DIABETES INVEST, V7, P677, DOI 10.1111/jdi.12497; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McFadden JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115642; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Mekahli D., 2011, COLD SPRING HARB PER, V3; Mignard V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.226; Mitsuda T, 2007, BIOCHEM BIOPH RES CO, V352, P722, DOI 10.1016/j.bbrc.2006.11.075; Moore K, 2015, MOL BIOL CELL, V26, P2873, DOI 10.1091/mbc.E15-02-0074; Moreno JA, 2015, NEUROCHEM RES, V40, P329, DOI 10.1007/s11064-014-1405-0; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paillamanque J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158518; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Parkinson's Disease Foundation (PDF), 2016, STAT PARK; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Prasad VVTS, 2008, NEUROCHEM INT, V53, P220, DOI 10.1016/j.neuint.2008.07.002; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Prince M., 2015, WORLD ALZHEIMER REPO, V17, P2016; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Raghubir R, 2011, METHOD ENZYMOL, V489, P259, DOI 10.1016/B978-0-12-385116-1.00015-7; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Redinger Richard N, 2007, Gastroenterol Hepatol (N Y), V3, P856; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Riboni Laura, 2002, Cerebellum, V1, P129, DOI 10.1080/147342202753671268; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Rojas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113929; Romero J, 2014, NEUROSCI LETT, V565, P42, DOI 10.1016/j.neulet.2013.10.046; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Samavedam UKSRL, 2016, J IMMUNOL, V196; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Sato Y, 2014, J DIABETES INVEST, V5, P19, DOI 10.1111/jdi.12124; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schaffer JE, 2016, J LIPID RES, V57, P1327, DOI 10.1194/jlr.E069880; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Seyb KI, 2006, J MOL NEUROSCI, V28, P111, DOI 10.1385/JMN:28:2:111; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shen J, 2004, NEURON, V44, P575, DOI 10.1016/j.neuron.2004.11.008; Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Spiegel A, 2005, NAT NEUROSCI, V8, P552, DOI 10.1038/nn0505-552; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Steiner H, 2001, NEUROBIOL DIS, V8, P717, DOI 10.1006/nbdi.2001.0405; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Thaler J.P., 2012, J CLIN INVEST; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thon M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07096; Tsoi P.S., 2017, COLD SPRING HARB LAB; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Vlug AS, 2005, EUR J NEUROSCI, V22, P1881, DOI 10.1111/j.1460-9568.2005.04389.x; Voos W, 2016, ESSAYS BIOCHEM, V60, P213, DOI 10.1042/EBC20160009; Wang CC, 2009, J CELL BIOCHEM, V107, P933, DOI 10.1002/jcb.22196; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wate R, 2005, ACTA NEUROPATHOL, V110, P557, DOI 10.1007/s00401-005-1080-y; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Williams LM, 2012, P NUTR SOC, V71, P521, DOI 10.1017/S002966511200078X; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu L, 2010, HORM METAB RES, V42, P643, DOI 10.1055/s-0030-1255034; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuste JE, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00322; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	293	34	35	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-0082	1873-5118		PROG NEUROBIOL	Prog. Neurobiol.	NOV	2017	158						45	68		10.1016/j.pneurobio.2017.08.001	http://dx.doi.org/10.1016/j.pneurobio.2017.08.001			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FN1WK	28802884				2022-09-04	WOS:000415781700003
J	Trakatelli, M; Barkitzi, K; Apap, C; Majewski, S; De Vries, E				Trakatelli, M.; Barkitzi, K.; Apap, C.; Majewski, S.; De Vries, E.		EPIDERM Grp	Skin cancer risk in outdoor workers: a European multicenter case-control study	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							ULTRAVIOLET-RADIATION; SUN PROTECTION; OCCUPATIONAL-EXPOSURE; PREVENTION; IMPACT; EPIDEMIOLOGY; METAANALYSIS; BEHAVIORS; LIGHT	BackgroundExposure to ultraviolet radiation (UVR) is the most important external risk factor for skin cancer. Outdoor workers, who are exposed to high ambient UVR levels are at increased risk. ObjectiveTo compare outdoor with indoor workers in terms of: (i) skin cancer risk factors, and (ii) risk of developing skin cancer. MethodsUsing descriptive methods and a large multicenter European case-control study, we compared risk factor patterns between outdoor (N=1416) and indoor workers (N=1863). Risk of developing basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma and actinic keratosis (AK) were analysed by type of work using multivariate logistic regression models, for three categories of work: indoor; farming/construction; other outdoor work. ResultsAlthough skin phototype was equally distributed by type of work, significantly less outdoor than indoor workers used sunscreen in their own country (44.3% vs. 60.2%), but had more outdoor hobbies (66.2% vs. 58.2%). Outdoor workers had lower educational levels, and felt less confident in understanding medical information and filling medical forms (all P<0.001). Outdoor workers had more signs of photodamage (78.1% vs. 65.5%) and among the skin cancer patients, 37.7% of outdoor workers vs. 28.6% of indoor workers had 2 skin cancers diagnosed during their lifetime.Multivariate logistic regression models showed significantly increased risk of outdoor vs. indoor work for AK (ORother outdoor=1.55, ORfarming/construction=2.58), SCC (ORother outdoor=1.32, ORfarming/construction=2.77) and BCC (ORother outdoor=1.53, ORfarming/construction=1.83). No significant associations were found for melanoma. The risk of all types of skin cancer and AK was significantly increased for workers with 5years of outdoor work. ConclusionsOutdoor workers had more risk behaviour with similar constitutional skin cancer risk factors: more UV exposure (both occupational and leisure) and less sunscreen use and lower health literacy. This results in higher exposure, more photodamage and an increased risk of developing AK, BCC and SCC.	[Trakatelli, M.] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Dermatol, GR-54006 Thessaloniki, Greece; [Trakatelli, M.] St Pierre Hosp, Dept Dermatol, Brussels, Belgium; [Barkitzi, K.] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Apap, C.] Sir Paul Boffa Hosp, Dept Dermatol, Floriana, Malta; [Majewski, S.] Med Univ Warsaw, Dept Dermatol & Venerol, Warsaw, Poland; [De Vries, E.] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia		Trakatelli, M (corresponding author), Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Dermatol, GR-54006 Thessaloniki, Greece.; Trakatelli, M (corresponding author), St Pierre Hosp, Dept Dermatol, Brussels, Belgium.	mtrakatelli@hotmail.com	de Vries, Esther/A-6603-2009; MAGNONI, Cristina/F-5367-2017	de Vries, Esther/0000-0002-5560-2258; MAGNONI, Cristina/0000-0002-6081-4925; Apalla, Zoe/0000-0002-9255-8196; Coebergh, Jan Willem/0000-0002-2419-3930; Moreno-Ramirez, David/0000-0002-1301-7974	European Commission's Executive Agency for Health and Consumers EPIDERM project [PHEA 2007-A/100994 HI]; Leo Pharma	European Commission's Executive Agency for Health and Consumers EPIDERM project; Leo Pharma(LEO Pharma)	This publication is based on data from the EPIDERM project which was funded by the European Commission's Executive Agency for Health and Consumers EPIDERM project: PHEA 2007-A/100994 HI. M. Trakatelli and E. de Vries have received a grant from Leo Pharma specifically for their time dedicated to study the association of skin cancer and outdoor occupation.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Batra T., 2010, INT J ENV SCI, V2, P73; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; BORLAND RM, 1991, MED J AUSTRALIA, V154, P686, DOI 10.5694/j.1326-5377.1991.tb121261.x; de Vries E, 2012, BRIT J DERMATOL, V167, P1, DOI 10.1111/j.1365-2133.2012.11081.x; Diepgen TL, 2012, BRIT J DERMATOL, V167, P76, DOI 10.1111/j.1365-2133.2012.11090.x; European Union, 2009, OFFICIAL J EUROPEAN, P12; Fartasch M, 2012, DTSCH ARZTEBL INT, V109, P715, DOI 10.3238/arztebl.2012.0715; Fransen M, 2012, MED J AUSTRALIA, V197, P565, DOI 10.5694/mja12.10654; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Geller AC, 2001, PREV MED, V33, P155, DOI 10.1006/pmed.2001.0870; Glanz K, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-22; Hammond V, 2008, HEALTH PROMOT J AUST, V19, P97, DOI 10.1071/HE08097; *IARC, 1992, IARC MON EV CARC RIS, P316; Janda M, 2014, J OCCUP HEALTH, V56, P62, DOI 10.1539/joh.13-0179-OA; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Madgwick P, 2011, OCCUP MED-OXFORD, V61, P430, DOI 10.1093/occmed/kqr054; McCool JP, 2009, J OCCUP HEALTH, V51, P404, DOI 10.1539/joh.L9030; McDaid C, 2010, SUN PROTECTION RESOU; Mudigonda T, 2010, J NATL COMPR CANC NE, V8, P888, DOI 10.6004/jnccn.2010.0066; Mullan PB, 1996, J RURAL HEALTH, V12, P311, DOI 10.1111/j.1748-0361.1996.tb00820.x; Nahar VK, 2013, DERMAT RES PRACT, V2013, DOI 10.1155/2013/496913; Oldenburg M, 2013, EUR J DERMATOL, V23, P663, DOI 10.1684/ejd.2013.2142; Reinau D, 2013, BRIT J DERMATOL, V168, P928, DOI 10.1111/bjd.12160; Schmitt J, 2011, BRIT J DERMATOL, V164, P291, DOI 10.1111/j.1365-2133.2010.10118.x; Schmitt J, 2010, J DTSCH DERMATOL GES, V8, P250, DOI 10.1111/j.1610-0387.2009.07260.x; Traianou A, 2012, BRIT J DERMATOL, V167, P36, DOI 10.1111/j.1365-2133.2012.11085.x; Trakatelli M, 2007, BRIT J DERMATOL, V156, P1, DOI 10.1111/j.1365-2133.2007.07861.x; Woolley T, 2002, J OCCUP ENVIRON MED, V44, P847, DOI 10.1097/00043764-200209000-00007; Woolley T, 2008, AM J HEALTH BEHAV, V32, P201; World Health Organization, SKIN CANC; Young C, 2009, OCCUP MED-OXFORD, V59, P82, DOI 10.1093/occmed/kqn170	32	56	57	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	APR	2016	30			3	SI		5	11		10.1111/jdv.13603	http://dx.doi.org/10.1111/jdv.13603			7	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	DH6HQ	26995016				2022-09-04	WOS:000372892000002
J	Aschner, P; Ruiz, A; Balkau, B; Massien, C; Haffner, SM				Aschner, Pablo; Ruiz, Alvaro; Balkau, Beverley; Massien, Christine; Haffner, Steven M.		Latin Amer Caribbean Int Day Evalu	Association of Abdominal Adiposity With Diabetes and Cardiovascular Disease in Latin America	JOURNAL OF CLINICAL HYPERTENSION			English	Article							WAIST CIRCUMFERENCE; INTERNATIONAL DAY; PRIMARY-CARE; OBESITY; RISK; MELLITUS; MORTALITY; MEN	The authors explored whether the waist circumference (WC) cutoffs currently proposed to define abdominal obesity (AO) are associated with diabetes and cardiovascular disease (CVD) in Latin America. Primary care physicians in 12 countries were randomly chosen to measure WC and body mass index and record the presence of diabetes and CVD in all consecutive adult patients, consulting them on 2 prespecified half-days. Overall, 70% of 9719 men, and 76% of 18,526 women had AO. Diabetes was reported in 10% of men and 9% of women and CVD in 9% of men and 7% of women. AO was significantly related with diabetes (age-adjusted odds ratio, 1.63 for men and 2.86 for women) and with CVD (odds ratio, 1.41 for men and 1.62 for women). Obesity was also significantly related with diabetes and CVD. Strikingly, abdominal adiposity was very frequent in women with normal body mass index, suggesting that an evidence-based definition of abdominal adiposity in Latin America is needed.	[Aschner, Pablo; Ruiz, Alvaro] Javeriana Univ, Sch Med, Bogota, Colombia; [Balkau, Beverley] Univ Paris 11, INSERM, U780 IFR79, F-91405 Orsay, France; [Massien, Christine] Sanofi Aventis, Paris, France; [Haffner, Steven M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA		Aschner, P (corresponding author), Hosp Univ San Ignacio Piso 7, Carrera 7 40-62, Bogota, Colombia.	paschner@cable.net.co	Ruiz, Alvaro/AAD-5422-2019	Ruiz, Alvaro/0000-0001-6528-4268				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], DIABETES ATLAS; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; BERDASCO A, 2002, REV CUBANA ALIMENT N, V16, P48; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Caterson ID, 2004, CIRCULATION, V110, pE476, DOI 10.1161/01.CIR.0000140114.83145.59; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Leite CC, 2002, METABOLISM, V51, P1034, DOI 10.1053/meta.2002.34035; Perez Maritza, 2003, Eur J Cardiovasc Prev Rehabil, V10, P328, DOI 10.1097/01.hjr.0000095050.46631.6f; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Sanchez-Castillo CP, 2003, OBES RES, V11, P442, DOI 10.1038/oby.2003.60; Seidell Jaap C., 2001, American Journal of Clinical Nutrition, V73, P123; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; *WHO W PAC REG IAS, 2000, AS PAC PERSP RED OB; Wittchen HU, 2006, EUR HEART J SUPPL, V8, pB26, DOI 10.1093/eurheartj/sul005; 2007, HLTH STAT AM	25	21	25	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-6175	1751-7176		J CLIN HYPERTENS	J. Clin. Hypertens.	DEC	2009	11	12					769	774		10.1111/j.1559-4572.2008.00051.x	http://dx.doi.org/10.1111/j.1559-4572.2008.00051.x			6	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	524FR	20021540	Green Published, Bronze			2022-09-04	WOS:000272129700014
J	Cano, C; Gutierrez, LM; Marin, PP; Martinez, FM; Pelaez, M; Manas, LR; Vega, E; Zuniga, C				Cano, C; Gutierrez, LM; Marin, PP; Martinez, FM; Pelaez, M; Manas, LR; Vega, E; Zuniga, C			Proposed minimum contents for medical school programs in geriatric medicine in Latin America	REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH			Spanish	Article						education; medical; undergraduate; geriatrics; Latin America		In the developing countries of the world, an aging of the population in general is occurring at the same time that the life expectancy of older adults is increasing. The results of this double aging process are especially striking for health care services because of the concurrent epidemiologic transition, which has led to infectious diseases being replaced by noninfectious, habitually chronic diseases that occur predominantly in older age. In these circumstances, older adults begin to predominate among the patients whom physicians in Latin America now serve and in the near future, older adults will constitute the immense majority of those patients. To respond to this situation, the training of professionals responsible for providing care to older adults should be improved, and the preparation of specialists in geriatric medicine should be enhanced both quantitatively and qualitatively. Future doctors should have the knowledge, abilities, and attitudes to enable them to appropriately serve this population segment. With these aims in mind, structures and procedures should be established that make it possible to impart the specific contents of geriatric medicine during medical school not only as a part of the traditional vertical teaching of the core curriculum of geriatric medicine, but also through the horizontal teaching of some of the material in other subjects. This article discusses why, with what objectives, with what contents, with what procedures, and with what staffing and materials the training of professionals in geriatric medicine should be carried out, and why it is time to give priority to this undertaking. Putting into place the measures proposed in this article should facilitate the incorporation of this subject-matter into the curricula of the medical schools of Latin America.	Pontifica Univ Javeriana, Fac Med, Bogota, Colombia; Inst Nacl Ciencias Med & Nutr Salvador, Mexico City, DF, Mexico; Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; Hosp Nacl Geriatr Raul Blanco Cervantes, San Jose, Costa Rica; Org Panamer Salud, Washington, DC USA; Soc Espanola Med Geriatr, Madrid, Spain; Hosp Univ Calixto Garcia, Ctr Iberomaer Tercera Edad, Havana, Cuba; Univ Autonoma Baja California, Fac Med, Tijuana, Baja California, Mexico		Cano, C (corresponding author), C Juan Duque 29, Madrid 28005, Spain.	lrodriguezmanas@mi.madritel.es		Cano-Gutierrez, Carlos/0000-0001-5680-7880; Rodriguez-Manas, Leocadio/0000-0002-6551-1333				*AM GER SOC, 2002, GER REV SYLL; ARRIETA JL, 2001, BASES ATENCION SANIT, P229; CANO C, 1996, REV ASOC COLOMB GERO, V10, P79; Duque G, 2003, J AM GERIATR SOC, V51, P544, DOI 10.1046/j.1532-5415.2003.51166.x; Harden RM, 2000, MED TEACH, V22, P334; HARDEN RM, 1995, MED TEACH, V17, P125, DOI 10.3109/01421599509008301; LANGSLEY DG, 1991, JAMA-J AM MED ASSOC, V266, P977, DOI 10.1001/jama.266.7.977; MARIN PP, 1999, PROGRAMA PREGRADO GE; MCGOVERN PG, 1992, JAMA-J AM MED ASSOC, V268, P753; McNicoll G, 2002, WORLD POPULATION AGE, P483; *ORG PAN SAL, 2002, SAL ENV; *ORG PAN SAL, 2002, SAL AM, P188; PALAEZ M, 2001, AGING CULTURE HLTH S, P145; Palloni A, 2002, INT J EPIDEMIOL, V31, P762, DOI 10.1093/ije/31.4.762; *PONT U JAV FAC ME, 2005, PROGR GER SANT FE BO; TALLIS R, 2003, BROCKLEHURSTS TXB GE; WHO Group., 2002, RES UNIVERSAL HLTH C	17	8	13	0	2	PAN AMER HEALTH ORGANIZATION	WASHINGTON	525 23RD ST NW, WASHINGTON, DC 20037 USA	1020-4989			REV PANAM SALUD PUBL	Rev. Panam. Salud Publica	MAY-JUN	2005	17	5-6					429	437		10.1590/S1020-49892005000500015	http://dx.doi.org/10.1590/S1020-49892005000500015			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	942HP	16053653	gold			2022-09-04	WOS:000230273800015
J	Ruiz-Garcia, M; Campos, HA; Alvarez, D; Kajon, A; Diaz, S				Ruiz-Garcia, M; Campos, HA; Alvarez, D; Kajon, A; Diaz, S			Coat gene profiles of several cat populations in Cuba, Costa Rica, Colombia, Paraguay, Chile and Argentina, and possible genetic origins of these cat populations	RUSSIAN JOURNAL OF GENETICS			English	Article							MUTANT ALLELE FREQUENCIES; DOMESTIC CAT; UNITED-KINGDOM; FELIS-CATUS; SELECTION; REGRESSION	Until the present moment, only a scarce number of Latin American domestic cat populations have been studied from a population genetic standpoint. For this reason, the cat populations of La Havana (Cuba), San Jose (Costa Rica), Bogota and lbague (Colombia), Asuncion (Paraguay), Santiago (Chile) and Buenos Aires (Argentina) were sampled for several coat genes. The results obtained were as follows: (1) there was a strong genetic resemblence between several Hispanic American cat populations (especially, those of Buenos Aires, San Jose and the two Colombian populations studied) and those from South Western United States (California, Texas and Colorado), which adds suport to the suspicion that these populations probably have a common origin; (2) The cat population of Santiago (Chile), contrarily to the other Hispanic American populations studied, showed a strong genetic resemblance with some Anglo North American populations; and (3) The l (long hair) and d (dilution) alleles showed systematic higher frequencies in the Hispanic American populations than those observed in Spain. Although the Hispanic American populations were not identical to the current Spanish populations (with the exception of Asuncion), this historic genetic experiment was very different to that found for the British populations and their overseas colonies.	Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Bioquim Biol & Genet Poblac Mol,Unidad Genet, Bogota, DC, Colombia; CIGEEM, Tarragona, Spain; Univ Nacl Colombia, Dept Biol, Bogota, DC, Colombia; Federat Int Feline, Buenos Aires, DF, Argentina; Univ Georgia, Dept Genet, Athens, GA 30602 USA; IFAL, Ctr Control Biol, Havana, Cuba; Ctr Nacl Invest Cient, Ctr Prod Nat, Lab Mutagenesis, Havana, Cuba		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Bioquim Biol & Genet Poblac Mol,Unidad Genet, Cra 7A 43-82, Bogota, DC, Colombia.	mruiz@javercol.javeriana.edu.co	Alvarez, Diana/AAF-8172-2019; Ruiz-Garcia, Manuel/AAF-8191-2019	Alvarez, Diana/0000-0001-6700-8101; Ruiz-Garcia, Manuel/0000-0003-2820-2950				BLUMENBERG B, 1977, THEOR APPL GENET, V49, P243, DOI 10.1007/BF00274479; BLUMENBERG B, 1986, GENETICA, V68, P81, DOI 10.1007/BF02424403; BLUMENBERG B, 1980, GENETICA, V54, P17, DOI 10.1007/BF00122403; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; *COMM STAND GEN NO, 1968, J HERED, V59, P39; EVERITT BS, 1979, BIOMETRICS, V35, P169, DOI 10.2307/2529943; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISHER JR, 1988, HISTORIA, P49; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GARCIA MR, 1990, GENETICA, V82, P209, DOI 10.1007/BF00056364; GARCIA MR, 1990, GENETICA, V82, P215, DOI 10.1007/BF00056365; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; KAJON A, 1992, J HERED, V83, P148, DOI 10.1093/oxfordjournals.jhered.a111177; KLEIN K, 1988, J HERED, V79, P389, DOI 10.1093/oxfordjournals.jhered.a110535; LLOYD AT, 1989, DOMESTIC CAT GENE FR; LLOYD J, 1981, LEARN DISABILITY Q, V4, P203, DOI 10.2307/1511005; MANTEL N, 1967, CANCER RES, V27, P209; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; PONTIER D, 1995, OIKOS, V73, P299, DOI 10.2307/3545954; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; PREVOSTI A, 1974, PUBLICACIONS U BARCE, P109; ROBINSON R, 1969, THEOR APPL GENET, V39, P326, DOI 10.1007/BF00281914; Robinson R., 1980, Carnivore Genetics Newsletter, V4, P46; ROBINSON R, 1981, GENETICA, V55, P41, DOI 10.1007/BF00134003; ROBINSON R, 1987, THEOR APPL GENET, V74, P579, DOI 10.1007/BF00288855; ROBINSON R, 1972, THEOR APPL GENET, V42, P293, DOI 10.1007/BF00277721; ROBINSON R, 1977, GENETICS CAT BREEDER; RUIZ M, 1988, Genetica Iberica, V40, P157; Ruiz-Garcia M., 1995, Miscellania Zoologica (Barcelona), V18, P169; RUIZ-GARCIA M, 1991, Evolucion Biologica (Bogota), V5, P227; Ruiz-Garcia M, 2000, J HERED, V91, P49, DOI 10.1093/jhered/91.1.49; RUIZGARCIA M, 1993, J HERED, V84, P173, DOI 10.1093/oxfordjournals.jhered.a111312; RUIZGARCIA M, 1994, GENET SEL EVOL, V26, P39, DOI 10.1051/gse:19940104; RuizGarcia M, 1997, J GENET, V76, P1, DOI 10.1007/BF02931765; RuizGarcia M, 1997, BRAZ J GENET, V20, P215; RUIZGARCIA M, 2000, UNPUB OIKOS; RUIZGARCIA M, 2000, UNPUB J HERED, V91; RUIZGARCIA M, 1991, EVOL BIOL, V4, P307; RUIZGARCIA M, 1990, EVOL BIOL, V4, P189; RUIZGARCIA M, 1989, C GENE J, V6, P1; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sneath PHA., 1973, NUMERICAL TAXONOMY; Todd N. B., 1974, Carnivore Genetics Newsletter, V2, P230; TODD NB, 1984, J HERED, V75, P495, DOI 10.1093/oxfordjournals.jhered.a109994; TODD NB, 1977, SCI AM, V237, P100, DOI 10.1038/scientificamerican1177-100; TODD NB, 1978, CARNIVORE, V1, P52; TODD NB, 1976, J HERED, V67, P368, DOI 10.1093/oxfordjournals.jhered.a108754; TODD NB, 1969, J HERED, V60, P273, DOI 10.1093/oxfordjournals.jhered.a107992; TODD NB, 1976, CARNIVORE GENET NEWS, V3, P388; Vinogradov AE, 1997, HEREDITAS, V126, P95, DOI 10.1111/j.1601-5223.1997.00095.x; Watanabe M.A., 1981, CARNIVORE GENETICS NEWSLETTER, V4, P168; WATANABE MA, 1984, THESIS U SAO PAULO B; WRIGHT M, 1982, GATO	53	4	5	0	1	PLEIADES PUBLISHING INC	NEW YORK	PLEIADES HOUSE, 7 W 54 ST, NEW YORK,  NY, UNITED STATES	1022-7954	1608-3369		RUSS J GENET+	Russ. J. Genet.	FEB	2002	38	2					165	180		10.1023/A:1014334111142	http://dx.doi.org/10.1023/A:1014334111142			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533CU					2022-09-04	WOS:000174512500010
J	Calderon-Martinez, V; Delgado-Ospina, J; Ramirez-Navas, JS; Florez-Lopez, E; Valdes-Restrepo, MP; Grande-Tovar, CD; Chaves-Lopez, C				Calderon-Martinez, Vanessa; Delgado-Ospina, Johannes; Sebastian Ramirez-Navas, Juan; Florez-Lopez, Edwin; Piedad Valdes-Restrepo, Magda; David Grande-Tovar, Carlos; Chaves-Lopez, Clemencia			Effect of Pretreatment with Low-Frequency Ultrasound on Quality Parameters in Gulupa (Passiflora edulis Sims) Pulp	APPLIED SCIENCES-BASEL			English	Article						antioxidant capacity; biomolecules; conservation; postharvest; pulp; shelf life	HIGH-INTENSITY ULTRASOUND; ASCORBIC-ACID CONTENT; POWER ULTRASOUND; ORANGE JUICE; FUNCTIONAL-PROPERTIES; ANTIOXIDANT CAPACITY; MICROBIAL QUALITY; ESCHERICHIA-COLI; FRUIT JUICES; PEAR JUICE	Featured Application Ultrasound treatment offers a new strategy to improve and extend the shelf life in minimally processed fresh fruit. The Gulupa (Passiflora edulis f. edulis Sims) is an expression of South America's tropics' biodiversity, and a source of B vitamins and amino acids. It is a climacteric export fruit for which it is necessary to incorporate emerging technologies for its conservation and transport. This work investigated the effect of ultrasound on gulupa pulp and verified the stability of the characters of interest in the shelf life of 20 days. Six treatments and a control sample were used, evaluated in triplicate, and varied in frequency (30 and 40 kHz) with an exposure time of 10, 20, and 30 min. A statistical analysis of unidirectional variances and Dunnett's test was used. It was found that the ultrasound treatments did not affect the pH or the titratable acidity. Soluble solid results presented a significant increase (p < 0.05) (from 13.4 to 14.8% w/v) in the antioxidant capacity (from 1.13 to 1.54 mu mol Trolox Equivalent (TE)/g by the ABTS center dot+ (2,2 '-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) Cationic Radical Assay and from 3.3 to 3.7 mu mol TE/g by the DPPH center dot (2,2-diphenyl-1-picrilhydrazil) Radical Scavenging Assay). During the shelf life, ascorbic acid was the parameter that varied most (p < 0.05). It decreased from 42.7 to 21.6 mg ascorbic acid/100 g of pulp in the control sample. However, a smaller decrease was observed (23.8-24.5 mg ascorbic acid/100 g of pulp) in the 40 kHz treatments. The smallest global color difference (Delta E) for the control was found in the 40 kHz treatment at 30 min through the entire shelf life (day 0 to 20). Ultrasound treatment offers a new strategy to improve and extend the shelf life of chilled gulupa pulp.	[Calderon-Martinez, Vanessa; Florez-Lopez, Edwin] Univ Santiago Cali, Grp Invest Quim & Biotecnol QUIBIO, Calle 5 62-00, Cali 760035, Colombia; [Delgado-Ospina, Johannes] Univ San Buenaventura Cali, Fac Ingn, Grp Invest Biotecnol, Carrera 122 6-65, Cali 760032, Colombia; [Delgado-Ospina, Johannes; Chaves-Lopez, Clemencia] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Via R Balzarini 1, I-64100 Teramo, Italy; [Sebastian Ramirez-Navas, Juan] Univ Valle, Escuela Ingn Alimentos, Grp Invest Proc Agroalimentarios & Biotecnol GIPA, Cali 760032, Colombia; [Sebastian Ramirez-Navas, Juan] Pontificia Univ Javeriana Cali, Fac Hlth Sci, Food & Nutr Dept, CL 18 118-250,AA 26239, Cali 760031, Colombia; [Piedad Valdes-Restrepo, Magda] Univ Nacl Abierta & Distancia, Fac Basic Sci Technol & Engn, Res Grp Biot, Palmira 763531, Colombia; [David Grande-Tovar, Carlos] Univ Atlantico, Grp Invest Fotoquim & Fotobiol, Carrera 30 8-49, Puerto Colombia 081008, Colombia		Delgado-Ospina, J (corresponding author), Univ San Buenaventura Cali, Fac Ingn, Grp Invest Biotecnol, Carrera 122 6-65, Cali 760032, Colombia.; Delgado-Ospina, J (corresponding author), Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Via R Balzarini 1, I-64100 Teramo, Italy.; Grande-Tovar, CD (corresponding author), Univ Atlantico, Grp Invest Fotoquim & Fotobiol, Carrera 30 8-49, Puerto Colombia 081008, Colombia.	vanessa.calderon00@usc.edu.co; jdelgado1@usbcali.edu.co; juan.sebastian.ramirez@correounivalle.edu.co; edwin.florez00@usc.edu.co; magda.valdes@unad.edu.co; carlosgrande@mail.uniatlantico.edu.co; cchaveslopez@unite.it	Ramírez-Navas, Juan Sebastián/N-8026-2013	Ramírez-Navas, Juan Sebastián/0000-0002-6731-2784; Florez Lopez, Edwin/0000-0001-6312-7568; Delgado Ospina, Johannes/0000-0001-8095-4741; Grande Tovar, Carlos David/0000-0002-6243-4571				Abdullah N, 2014, AGRIC AGRIC SCI PROC, V2, P320, DOI 10.1016/j.aaspro.2014.11.045; Abid M, 2013, ULTRASON SONOCHEM, V20, P1182, DOI 10.1016/j.ultsonch.2013.02.010; Acevedo MF, 2018, GLOB FOOD SECUR-AGR, V16, P127, DOI 10.1016/j.gfs.2018.01.001; Adekunte AO, 2010, FOOD CHEM, V122, P500, DOI 10.1016/j.foodchem.2010.01.026; Adiamo OQ, 2018, FOOD CHEM, V245, P79, DOI 10.1016/j.foodchem.2017.10.090; Aguilar K, 2017, ULTRASON SONOCHEM, V37, P375, DOI 10.1016/j.ultsonch.2017.01.029; Aguirre OM, 2006, INTERCIENCIA, V31, P728; [Anonymous], 2012, 54682012 ICONTEC NTC; Bevilacqua A, 2015, LWT-FOOD SCI TECHNOL, V64, P616, DOI 10.1016/j.lwt.2015.06.038; Bhargava N, 2021, ULTRASON SONOCHEM, V70, DOI 10.1016/j.ultsonch.2020.105293; Bhat R, 2011, ULTRASON SONOCHEM, V18, P1295, DOI 10.1016/j.ultsonch.2011.04.002; Bhavya ML, 2019, ULTRASON SONOCHEM, V57, P108, DOI 10.1016/j.ultsonch.2019.05.002; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Cheng XF, 2015, ULTRASON SONOCHEM, V27, P576, DOI 10.1016/j.ultsonch.2015.04.015; Choi MH, 2002, FOOD RES INT, V35, P753, DOI 10.1016/S0963-9969(02)00071-6; Colucci D, 2018, FOOD RES INT, V106, P580, DOI 10.1016/j.foodres.2018.01.022; Cortes C, 2008, FOOD CONTROL, V19, P151, DOI 10.1016/j.foodcont.2007.03.001; Dai C, 2016, DRY TECHNOL, V34, P1196, DOI 10.1080/07373937.2015.1100203; de la Fuente-Blanco S, 2006, ULTRASONICS, V44, pE523, DOI 10.1016/j.ultras.2006.05.181; Cruz-Cansino ND, 2016, BRAZ J MICROBIOL, V47, P431, DOI 10.1016/j.bjm.2016.01.014; Alarcon-Rojo AD, 2019, ULTRASON SONOCHEM, V55, P369, DOI 10.1016/j.ultsonch.2018.09.016; Desai V, 2008, CHEM ENG J, V140, P483, DOI 10.1016/j.cej.2007.11.030; Dhawan K, 2004, J ETHNOPHARMACOL, V94, P1, DOI 10.1016/j.jep.2004.02.023; Ordonez-Santos LE, 2017, FOOD CHEM, V233, P96, DOI 10.1016/j.foodchem.2017.04.114; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Fan K, 2019, ULTRASON SONOCHEM, V54, P162, DOI 10.1016/j.ultsonch.2019.02.003; Firouz MS, 2019, ULTRASON SONOCHEM, V57, P73, DOI 10.1016/j.ultsonch.2019.05.014; Fonteles TV, 2012, FOOD RES INT, V48, P41, DOI 10.1016/j.foodres.2012.02.013; Franco G., 2013, Agronomia, V21, P48; Franco Germán, 2014, Rev Cubana Plant Med, V19, P154; Gani A, 2016, LWT-FOOD SCI TECHNOL, V66, P496, DOI 10.1016/j.lwt.2015.10.067; Gomez-Lopez VM, 2017, ACTA ALIMENT HUNG, V46, P470, DOI 10.1556/066.2017.46.4.10; Grande-Tovar CD, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920180140; Horwitz W., 2000, OFFICIAL METHODS ANA, V17th; Jalilzadeh A, 2018, J DAIRY SCI, V101, P5809, DOI 10.3168/jds.2017-14352; Jambrak AR, 2018, ULTRASONICS, V83, P3, DOI 10.1016/j.ultras.2017.02.011; Khandpur P, 2015, ULTRASON SONOCHEM, V27, P125, DOI 10.1016/j.ultsonch.2015.05.008; Kowalski SJ, 2017, DRY TECHNOL, V35, P939, DOI 10.1080/07373937.2016.1239631; Lee HS, 2003, LEBENSM-WISS TECHNOL, V36, P153, DOI 10.1016/S0023-6438(02)00087-7; Li YT, 2005, ULTRASON SONOCHEM, V12, P183, DOI 10.1016/j.ultsonch.2003.10.011; Jimenez AM, 2011, FOOD RES INT, V44, P1912, DOI 10.1016/j.foodres.2010.11.007; Merone D, 2020, J FOOD ENG, V283, DOI 10.1016/j.jfoodeng.2020.110031; Franco MN, 2014, FOOD CHEM, V163, P289, DOI 10.1016/j.foodchem.2014.04.091; Norena Triana M.E., 2020, CADENA PASIFLORAS IN; Pertuzatti PB, 2015, LWT-FOOD SCI TECHNOL, V64, P259, DOI 10.1016/j.lwt.2015.05.031; Pinzón Ingrid Mónica del Pilar, 2007, Agron. colomb., V25, P83; Pilevar Z, 2019, TRENDS FOOD SCI TECH, V91, P248, DOI 10.1016/j.tifs.2019.07.020; Piljac-Zegarac J, 2009, FOOD CHEM, V113, P394, DOI 10.1016/j.foodchem.2008.07.048; Piyasena P, 2003, INT J FOOD MICROBIOL, V87, P207, DOI 10.1016/s0168-1605(03)00075-8; dos Reis LCR, 2018, FOOD RES INT, V106, P481, DOI 10.1016/j.foodres.2018.01.019; Ren F, 2018, LWT-FOOD SCI TECHNOL, V87, P102, DOI 10.1016/j.lwt.2017.08.053; Rodriguez O, 2018, J SCI FOOD AGR, V98, P1660, DOI 10.1002/jsfa.8673; Saeeduddin M, 2015, LWT-FOOD SCI TECHNOL, V64, P452, DOI 10.1016/j.lwt.2015.05.005; Sandi D, 2004, BRAZ ARCH BIOL TECHN, V47, P233, DOI 10.1590/S1516-89132004000200011; Saravanan S., 2014, FOOD SCI HUMAN WELLN, V3, DOI [DOI 10.1016/J.FSHW.2014.05.001, 10.1016/j.fshw.2014.05.001]; Sasikala V., 2011, Journal of Applied Pharmaceutical Science, V1, P89; Tanner D., 2016, IMPACTS STORAGE FOOD, P1, DOI 10.1016/b978-0-08-100596-5.03479-x; Tiwari BK, 2009, J FOOD ENG, V93, P166, DOI 10.1016/j.jfoodeng.2009.01.027; Tomadoni B, 2017, J FOOD PROCESS ENG, V40, DOI 10.1111/jfpe.12533; Valero M, 2007, J FOOD ENG, V80, P509, DOI 10.1016/j.jfoodeng.2006.06.009; Villa-Rodriguez JA, 2011, FOOD RES INT, V44, P1231, DOI 10.1016/j.foodres.2010.11.012; Walkling-Ribeiro M, 2009, FOOD BIOPROD PROCESS, V87, P102, DOI 10.1016/j.fbp.2008.08.001; Wang J, 2019, LWT-FOOD SCI TECHNOL, V107, P299, DOI 10.1016/j.lwt.2019.03.024; Wang J, 2019, FOOD CONTROL, V96, P128, DOI 10.1016/j.foodcont.2018.09.007; Wyckhuys K., 2012, TECNOLOGIA CULTIVO G, V1st; Yildiz G, 2019, J FOOD PROCESS ENG, V42, DOI 10.1111/jfpe.13223; Zhang LH, 2020, FOOD CHEM, V303, DOI 10.1016/j.foodchem.2019.125386; Zinoviadou KG, 2015, FOOD RES INT, V77, P743, DOI 10.1016/j.foodres.2015.05.032; Zlabur JS, 2019, ULTRASON SONOCHEM, V56, P372, DOI 10.1016/j.ultsonch.2019.04.034	69	0	0	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	FEB	2021	11	4							1734	10.3390/app11041734	http://dx.doi.org/10.3390/app11041734			15	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	RB5JJ		gold			2022-09-04	WOS:000632146700001
J	Diaz-Cardenas, C; Rojas, LY; Fiorentino, S; Cala, MP; Diaz, JI; Ramos, FA; Armengaud, J; Restrepo, S; Baena, S				Diaz-Cardenas, Carolina; Yinneth Rojas, Laura; Fiorentino, Susana; Cala, Monica P.; Diaz, Jorge, I; Ramos, Freddy A.; Armengaud, Jean; Restrepo, Silvia; Baena, Sandra			Bioactive Potential of Extracts of Labrenzia aggregata Strain USBA 371, a Halophilic Bacterium Isolated from a Terrestrial Source	MOLECULES			English	Article						Labrenzia aggregata USBA 371; cytotoxic activities; bioactive natural products; saline natural products; secondary metabolism; genome annotation; NMR characterization	DIKETOPIPERAZINE DERIVATIVES; ANTICANCER ACTIVITY; CYCLIC DIPEPTIDES; SP NOV.; CELL	Previous studies revealed the potential of Labrenzia aggregata USBA 371 to produce cytotoxic metabolites. This study explores its metabolic diversity and compounds involved in its cytotoxic activity. Extracts from the extracellular fraction of strain USBA 371 showed high levels of cytotoxic activity associated with the production of diketopiperazines (DKPs). We purified two compounds and a mixture of two other compounds from this fraction. Their structures were characterized by 1D and 2D nuclear magnetic resonance (NMR). The purified compounds were evaluated for additional cytotoxic activities. Compound 1 (cyclo (l-Pro-l-Tyr)) showed cytotoxicity to the following cancer cell lines: breast cancer 4T1 (IC50 57.09 +/- 2.11 mu M), 4T1H17 (IC50 40.38 +/- 1.94), MCF-7 (IC50 87.74 +/- 2.32 mu M), murine melanoma B16 (IC50 80.87 +/- 3.67), human uterus sarcoma MES-SA/Dx5 P-pg (-) (IC50 291.32 +/- 5.64) and MES-SA/Dx5 P-pg (+) (IC50 225.28 +/- 1.23), and murine colon MCA 38 (IC50 29.85 +/- 1.55). In order to elucidate the biosynthetic route of the production of DKPs and other secondary metabolites, we sequenced the genome of L. aggregata USBA 371. We found no evidence for biosynthetic pathways associated with cyclodipeptide synthases (CDPSs) or non-ribosomal peptides (NRPS), but based on proteogenomic analysis we suggest that they are produced by proteolytic enzymes. This is the first report in which the cytotoxic effect of cyclo (l-Pro-l-Tyr) produced by an organism of the genus Labrenzia has been evaluated against several cancer cell lines.	[Diaz-Cardenas, Carolina; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, POB 56710, Bogota, DC, Colombia; [Yinneth Rojas, Laura; Fiorentino, Susana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, POB 56710, Bogota, DC, Colombia; [Cala, Monica P.] Univ los Andes, Vicepresidency Res & Creat, Metabol Core Facil MetCore, Cra 1 18A-12, Bogota 111711, DC, Colombia; [Diaz, Jorge, I] Univ los Andes, Vicepresidency Res & Creat, Cra 1 18A-12, Bogota 111711, DC, Colombia; [Ramos, Freddy A.] Univ Nacl Colombia, Fac Ciencias, Dept Quim, Sede Bogota, Carrera 30 45-03, Bogota 110111, DC, Colombia; [Armengaud, Jean] Univ Paris Saclay, Dept Medicaments & Technol Sante DMTS, SPI, INRAE,CEA, F-30200 Bagnols Sur Ceze, France; [Restrepo, Silvia] Univ los Andes, Chem Engn Dept, Cra 1 18A-12, Bogota 111711, DC, Colombia		Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento & Biotecnol Ambiental, POB 56710, Bogota, DC, Colombia.	diazcardenascaro@gmail.com; rojasl.a@javeriana.edu.co; susana.fiorentino@javeriana.edu.co; mp.cala10@uniandes.edu.co; ji.diaz1@uniandes.edu.co; faramosr@unal.edu.co; jean.armengaud@cea.fr; srestrep@uniandes.edu.co; baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019	Rojas Fonseca, Laura Yinneth/0000-0001-6584-8123; ARMENGAUD, Jean/0000-0003-1589-445X	Ministry of Sciences [RC 0016-2013]; Pontificia Universidad Javeriana; Universidad de los Andes; MAVDT contract [0104]	Ministry of Sciences; Pontificia Universidad Javeriana; Universidad de los Andes; MAVDT contract	This research was funded by the Ministry of Sciences (Formerly Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia (Grand Colciencias-Contract RC 0016-2013), Pontificia Universidad Javeriana and Universidad de los Andes. It was done under MAVDT contract No. 0104.	Adams LS, 2006, EVID-BASED COMPL ALT, V3, P117, DOI 10.1093/ecam/nel001; Alshaibani MM, 2017, J MICROBIOL BIOTECHN, V27, P1249, DOI 10.4014/jmb.1608.08032; Azab A, 2016, MOLECULES, V21, DOI 10.3390/molecules21101321; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biebl H, 2007, INT J SYST EVOL MICR, V57, P1095, DOI 10.1099/ijs.0.64821-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borthwick AD, 2017, CRIT REV FOOD SCI, V57, P718, DOI 10.1080/10408398.2014.911142; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Camacho M, 2016, INT J SYST EVOL MICR, V66, P5173, DOI 10.1099/ijsem.0.001492; Chen L, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7851251; Chen L, 2010, WORLD J MICROB BIOT, V26, P879, DOI 10.1007/s11274-009-0247-4; Deharo E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S5; Diaz-Cardenas C, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0527-6; Fdhila F, 2003, J NAT PROD, V66, P1299, DOI 10.1021/np030233e; de la Fuente AG, 2018, J PHARMACEUT BIOMED, V154, P138, DOI 10.1016/j.jpba.2018.02.046; Gomes NGM, 2019, MAR DRUGS, V17, DOI 10.3390/md17100551; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Hartmann EM, 2014, METHODS MOL BIOL, V1197, P275, DOI 10.1007/978-1-4939-1261-2_16; Holden MTG, 1999, MOL MICROBIOL, V33, P1254, DOI 10.1046/j.1365-2958.1999.01577.x; Iimura K, 2017, TOXINS, V9, DOI 10.3390/toxins9070219; Kacar D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02561; Kang H, 2016, BIOORG MED CHEM LETT, V26, P1873, DOI 10.1016/j.bmcl.2016.03.030; Karthikeyan P, 2013, SAUDI J BIOL SCI, V20, P205, DOI 10.1016/j.sjbs.2013.02.002; Klein G, 2016, NANOTOXICOLOGY, V10, P1555, DOI 10.1080/17435390.2016.1244299; Kumar N, 2013, WORLD J MICROB BIOT, V29, P355, DOI 10.1007/s11274-012-1189-9; Kumar SN, 2012, J APPL MICROBIOL, V113, P914, DOI 10.1111/j.1365-2672.2012.05385.x; Kwak MK, 2013, J MICROBIOL, V51, P836, DOI 10.1007/s12275-013-3521-y; Lasso P, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735419848047; Lautru S, 2002, CHEM BIOL, V9, P1355, DOI 10.1016/S1074-5521(02)00285-5; Lin YJ, 2019, PHYTOMEDICINE, V58, DOI 10.1016/j.phymed.2019.152893; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Mazguene S, 2018, EXTREMOPHILES, V22, P259, DOI 10.1007/s00792-017-0994-3; Mishra AK, 2017, MOLECULES, V22, DOI 10.3390/molecules22101796; Moghaddam JA, 2018, MAR DRUGS, V16, DOI 10.3390/md16100369; Mukherjee S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18; Palaniappan K, 2020, NUCLEIC ACIDS RES, V48, pD422, DOI 10.1093/nar/gkz932; Prieto K, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0214-2; Quadri I, 2016, MICROBIOL RES, V186, P119, DOI 10.1016/j.micres.2016.04.003; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rodrigues GN, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00132-18; Sandoval TA, 2016, AM J CHINESE MED, V44, P1693, DOI 10.1142/S0192415X16500956; Schleissner C, 2017, J NAT PROD, V80, P2170, DOI 10.1021/acs.jnatprod.7b00408; Sharma AR, 2019, J ANTIBIOT, V72, P634, DOI 10.1038/s41429-019-0192-x; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; Sinha S, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5762-6; Skinnider MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4435-1; Skinnider MA, 2017, NUCLEIC ACIDS RES, V45, pW49, DOI 10.1093/nar/gkx320; STIERLE AC, 1988, P NATL ACAD SCI USA, V85, P8008, DOI 10.1073/pnas.85.21.8008; Tang XX, 2019, MAR DRUGS, V17, DOI 10.3390/md17090509; Tommonaro G, 2012, MICROB ECOL, V63, P490, DOI 10.1007/s00248-011-9980-y; van der Merwe E, 2008, PEPTIDES, V29, P1305, DOI 10.1016/j.peptides.2008.03.010; Vazquez-Rivera D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/197608; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Yao TT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06411-x; Yonezawa K, 2011, CHEM PHARM BULL, V59, P106, DOI 10.1248/cpb.59.106; Yuan HD, 2017, MOLECULES, V22, DOI 10.3390/molecules22071135	56	1	1	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	JUN	2020	25	11							2546	10.3390/molecules25112546	http://dx.doi.org/10.3390/molecules25112546			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	MR8RU	32486092	Green Published, gold			2022-09-04	WOS:000553858800083
J	Janssen, MA; Bousquet, F; Cardenas, JC; Castillo, D; Worrapimphong, K				Janssen, Marco A.; Bousquet, Francois; Cardenas, Juan-Camilo; Castillo, Daniel; Worrapimphong, Kobchai			Breaking the elected rules in a field experiment on forestry resources	ECOLOGICAL ECONOMICS			English	Article						Common pool resources; Dynamic games; Forestry; Field experiments; Rule compliance	SOCIAL-ECOLOGICAL SYSTEMS; CROWDING-OUT; COMMONS; COOPERATION; LAB; INSTITUTIONS; GOVERNANCE	Harvesting from common resources has been studied through experimental work in the laboratory and in the field. In this paper we report on a dynamic commons experiment, representing a forest, performed with different types of communities of resource users in Thailand and Colombia, as well as student participants. We find that all groups overharvest the resource in the first part of the experiment and that there is no statistical difference between the various types of groups. In the second part of the experiment, participants appropriate the common resource after one of three possible regulations is elected and implemented. There is less overharvesting after the rules are implemented, but there is a significant amount of rule breaking. The surprising finding is that Colombian villagers break the rules of the games more often than other groups, and even more so when they have more trust in members of the community. This observation can be explained by the distrust in externally proposed regulations due to the institutional and cultural context. (C) 2013 Elsevier B.V. All rights reserved.	[Janssen, Marco A.] Arizona State Univ, Ctr Study Inst Divers, Tempe, AZ 85287 USA; [Bousquet, Francois] CIRAD GREEN, Montpellier 5, France; [Cardenas, Juan-Camilo] Univ Los Andes, Dept Econ, Bogota, Colombia; [Castillo, Daniel] Univ Javeriana, Res Grp Inst & Rural Dev, Sch Environm & Rural Studies, Bogota, Colombia; [Worrapimphong, Kobchai] Chulalongkorn Univ, Dept Biol, Fac Sci, Bangkok 10330, Thailand		Janssen, MA (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, POB 872402, Tempe, AZ 85287 USA.	Marco.Janssen@asu.edu	Castillo Brieva, Daniel/C-4104-2015; cardenas, juan-camilo/B-4658-2009; Bousquet, Francois/Y-7904-2019; Bousquet, Francois/G-3605-2010	Castillo Brieva, Daniel/0000-0001-9251-6124; cardenas, juan-camilo/0000-0003-0005-7595; Bousquet, Francois/0000-0002-4552-3724; 	National Science Foundation [BCS-0432894]	National Science Foundation(National Science Foundation (NSF))	We would like to acknowledge the support provided by the National Science Foundation (BCS-0432894) as well as our appreciation for comments on an earlier version of this manuscript by Elinor Ostrom, five anonymous reviewers and editing support by Jennifer Fraser.	[Anonymous], 1990, GOVERNING COMMONS; Cardenas J.C., 2001, ENVIRON RESOUR ECON, V48, P451; Cardenas J.C., HDB EXPT EC ENV; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Cardenas JC, 2004, FOREST POLICY ECON, V6, P229, DOI 10.1016/j.forpol.2004.03.006; Castillo D, 2011, ECOL ECON, V70, P1609, DOI 10.1016/j.ecolecon.2011.05.011; Herr A, 1997, GAME ECON BEHAV, V19, P77, DOI 10.1006/game.1997.0541; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Janssen MA, 2008, RATION SOC, V20, P371, DOI 10.1177/1043463108096786; Janssen MA, 2007, SOC NATUR RESOUR, V20, P307, DOI 10.1080/08941920601161320; Janssen MA, 2012, AGR SYST, V109, P65, DOI 10.1016/j.agsy.2012.03.004; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Oses-Eraso N, 2008, ENVIRON RESOUR ECON, V40, P529, DOI 10.1007/s10640-007-9168-6; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E, 2006, J ECON BEHAV ORGAN, V61, P149, DOI 10.1016/j.jebo.2005.02.008; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Prediger S, 2011, ECOL ECON, V70, P1599, DOI 10.1016/j.ecolecon.2010.08.017; Rodriguez-Sickert C, 2008, J ECON BEHAV ORGAN, V67, P215, DOI 10.1016/j.jebo.2007.06.004; Rucha Ghate, 2013, Economic and Political Weekly, V48, P59; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Schlager E., 1994, LAND ECON, V70, P293; Titmuss Richard, 1970, GIFT RELATIONSHIP HU; Transparency International, 2012, CORR PERC IND; Travers H, 2011, ECOL ECON, V71, P151, DOI 10.1016/j.ecolecon.2011.08.020; Vollan B, 2008, ECOL ECON, V67, P560, DOI 10.1016/j.ecolecon.2008.01.015; Voors M, 2012, ECON LETT, V114, P308, DOI 10.1016/j.econlet.2011.10.016	26	18	19	0	36	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	JUN	2013	90						132	139		10.1016/j.ecolecon.2013.03.012	http://dx.doi.org/10.1016/j.ecolecon.2013.03.012			8	Ecology; Economics; Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Business & Economics	170FQ		Green Published			2022-09-04	WOS:000320836200014
J	Goyes, C; Ferrari, M; Armellini, C; Chiasera, A; Jestin, Y; Righini, GC; Fonthal, F; Solarte, E				Goyes, Clara; Ferrari, Maurizio; Armellini, Cristina; Chiasera, Alessandro; Jestin, Yoann; Righini, Giancarlo C.; Fonthal, Faruk; Solarte, Efrain			CO2 laser annealing on erbium-activated glass-ceramic waveguides for photonics	OPTICAL MATERIALS			English	Article; Proceedings Paper	2nd International Workshop on Photoluminescence in Rare Earths - Photonic Materials and Devices	MAY 24-25, 2007	Trento, ITALY			Planar waveguides; CO2 laser annealing; Erbium; Sol-gel	SCATTERING LOSS REDUCTION; FILM OPTICAL-WAVEGUIDES	Silica-based sol-gel waveguides activated by Er3+ ions are one of the most important materials for integratedoptics devices. In this paper, we present an alternative method combining sol-gel route and CO2 laser annealing for planar optical waveguides processing. The effects of pulsed and continuous CO2 laser irradiation on the optical and spectroscopic properties of SiO2-ZrO2 and SiO2-HfO2 planar waveguides are evaluated and the thermal conventional annealing effects for these systems are reported for comparison. All the planar waveguides, doped with 0.5 and 5 mol% Er3+, were prepared by sol-gel route using dip-coating deposition on v-SiO2 substrates. An increase of the refractive index of approximately 0.04 at 1.5 mu m has been observed on 70SiO(2)-30HfO(2) planar waveguide after continuous CO2 laser annealing. A similar refractive-index variation was detected in all SiO2-ZrO2 planar waveguides after CO2 laser irradiation. We have observed, moreover, that continuous CO2 laser annealing can lead to waveguides with a lower attenuation coefficient with respect to the attenuation coefficient measured for thermal annealed waveguides. Upon excitation at 514.5 nm continuous-wave laser light, on the irradiated sample. the shape is found to be almost independent on the time and irradiation power with CW laser annealing but a decrease of the FWHM of approximately 46-12 nm has been observed on planar waveguides after pulsed laser annealing. Before and after conventional thermal annealing, the I-4(13/2) level decay curves present a single-exponential profile with a lifetime of 4.0 and 5.7 ms, respectively, but the lifetime increases up to 7.0 ms, after pulsed laser annealing treatment. X-ray diffraction and optical spectroscopy showed that after an adapted pulsed CO2 laser annealing, the resulting materials showed a crystalline environment. (C) 2008 Published by Elsevier B.V.	[Goyes, Clara] Univ Autonoma Occidente, Dept Ciencias Basicas Ingn, Grp Mat Avanzados Micro & Nanotecnol, Cali, Colombia; [Goyes, Clara; Ferrari, Maurizio; Armellini, Cristina; Chiasera, Alessandro; Jestin, Yoann] CNR, IFN, CSMFO Grp, I-38050 Trento, Italy; [Righini, Giancarlo C.] CNR, DMD, I-00185 Rome, Italy; [Righini, Giancarlo C.] CNR, Ist Fis Applicata Nello Carrara, I-50019 Sesto Fiorentino, Italy; [Fonthal, Faruk] Univ Autonoma Occidente, Grp Mat Avanzados Micro & Nanotecnol, Dept Automat & Elect, Cali, Colombia; [Solarte, Efrain] Univ Valle, Grp Opt Cuant, Santiago Cali, Colombia		Goyes, C (corresponding author), Pontificia Univ Javeriana, Fac Ingn, Dept Ciencias Ingn & Prod, Cali, Colombia.	cgoyes@javerianacali.edu.co	Righini, Giancarlo C./AAQ-1041-2020; Chiasera, Alessandro/A-9164-2013; Chiasera, Alessandro/R-5484-2019; Ferrari, Maurizio/H-3362-2011; Rico, Faruk Fonthal/F-8314-2016	Righini, Giancarlo C./0000-0002-6081-6971; Chiasera, Alessandro/0000-0002-7981-6584; Chiasera, Alessandro/0000-0002-7981-6584; Ferrari, Maurizio/0000-0003-3723-5957; Rico, Faruk Fonthal/0000-0002-9331-0491; Solarte, Efrain/0000-0003-4606-0925; Goyes, Clara/0000-0001-5913-1564; Jestin, Yoann/0000-0002-5546-625X				Almeida RM, 1997, PROC SPIE, V3136, P296, DOI 10.1117/12.284127; DUTTA S, 1980, APPL PHYS LETT, V37, P512, DOI 10.1063/1.91994; DUTTA S, 1981, J APPL PHYS, V52, P3873, DOI 10.1063/1.329854; DUTTA S, 1981, APPL PHYS LETT, V39, P206, DOI 10.1063/1.92680; DUTTA S, 1982, IEEE J QUANTUM ELECT, V18, P800, DOI 10.1109/JQE.1982.1071579; Duverger C, 1998, PHILOS MAG B, V77, P363, DOI 10.1080/13642819808204963; JESTIN Y, 2006, 5 WORKSH IT SOL GEL; JESTIN Y, 2006, SPIE, V6183; Kik PG, 1998, MRS BULL, V23, P48, DOI 10.1557/S0883769400030268; Tosello C, 1999, PHILOS MAG B, V79, P2103, DOI 10.1080/13642819908223099; Zevin M, 1997, OPT MATER, V8, P37, DOI 10.1016/S0925-3467(97)00026-8	11	16	16	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467			OPT MATER	Opt. Mater.	JUL	2009	31	9					1310	1314		10.1016/j.optmat.2008.10.005	http://dx.doi.org/10.1016/j.optmat.2008.10.005			5	Materials Science, Multidisciplinary; Optics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Materials Science; Optics	468RI					2022-09-04	WOS:000267837200011
J	Jaimes, MC; Rojas, OL; Kunkel, EJ; Lazarus, NH; Soler, D; Butcher, EC; Bass, D; Angel, J; Franco, MA; Greenberg, HB				Jaimes, MC; Rojas, OL; Kunkel, EJ; Lazarus, NH; Soler, D; Butcher, EC; Bass, D; Angel, J; Franco, MA; Greenberg, HB			Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children	JOURNAL OF VIROLOGY			English	Article							INTESTINAL HOMING RECEPTOR; ANTIBODY-SECRETING CELLS; HUMAN PLASMA-CELLS; LYMPHOCYTE HOMEOSTASIS; CUTTING EDGE; T-CELLS; MEMORY; EXPRESSION; IMMUNITY; PROTEIN	We have previously studied B cells, from people and mice, that express rotavirus-specific surface immunoglobulin (RV-sIg) by flow cytometry with recombinant virus-like particles that contain green fluorescent protein. In the present study we characterized circulating B cells with RV-sIg in children with acute and convalescent infection. During acute infection, circulating RV-sIgD(-) B cells are predominantly large, CD38(high), CD27(high), CD138(+/-), CCR6(-), alpha4beta7(+), CCR9(+), CCR10(+), cutaneous lymphocyte antigen-negative (CLA(-)), L-selectin(int/-), and sIgM(+), sIgG(-), sIgA(+/-) lymphocytes. This phenotype likely corresponds to gut-targeted plasma cells and plasmablasts. During convalescence the phenotype switches to small and large lymphocytes, CD38(int/-), CD27(int/-), CCR6(+), alpha4beta7(+/-) CCR9(+/-) and CCR10(-) most likely representing RV specific memory B cells with both gut and systemic trafficking profiles. Of note, during acute RV infection both total and RV-specific murine IgM and IgA antibody-secreting cells migrate efficiently to CCL28 (the CCR10 ligand) and to a lesser extent to CCL25 (the CCR9 ligand). Our results show that CCR10 and CCR9 can be expressed on IgM as well as IgA antibody-secreting cells in response to acute intestinal infection, likely helping target these cells to the gut. However, these intestinal infection-induced plasmablasts lack the CIA homing receptor for skin, consistent with mechanisms of differential CCR10 participation in skin T versus intestinal plasma cell homing. Interestingly, RV memory cells generally lack CCR9 and CCR10 and instead express CCR6, which may enable recruitment to diverse epithellial sites of inflammation.	VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA USA; Stanford Univ, Sch Med, Lab Immunol & Vasc Biol, Dept Pathol, Stanford, CA USA; Stanford Univ, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, Stanford, CA USA; Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; Millennium Pharmaceut Inc, Inflammat Dept, Cambridge, MA USA		Greenberg, HB (corresponding author), VA Palo Alto Hlth Care Syst, 3801 Miranda Ave,MC154C, Palo Alto, CA 94304 USA.	harry.greenberg@stanford.edu	CORTES, Manuel Antonio FRANCO/M-7517-2014; Angel, Juana/O-2908-2014	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Angel, Juana/0000-0001-6623-5337; greenberg, harry/0000-0002-2128-9080	NHLBI NIH HHS [P50 HL067674, P01 HL067674, HL 67674] Funding Source: Medline; NIAID NIH HHS [R37 AI047822, R01 AI021362, R01 AI 21362-20, R21 AI047822, AI 47822, R01 AI047822] Funding Source: Medline; NIDDK NIH HHS [DK 56339, P30 DK056339] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067674, P50HL067674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047822, R01AI021362, R21AI047822, R37AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; Blutt SE, 2002, J IMMUNOL, V168, P5716, DOI 10.4049/jimmunol.168.11.5716; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Brown KA, 2000, J INFECT DIS, V182, P1039, DOI 10.1086/315808; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; COULSON BS, 1992, J CLIN MICROBIOL, V30, P1678, DOI 10.1128/JCM.30.7.1678-1684.1992; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Franco MA, 2001, VIROLOGY, V281, P153, DOI 10.1006/viro.2001.0830; Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805; Gonzalez AM, 2003, VIROLOGY, V305, P93, DOI 10.1006/viro.2002.1708; Horst A, 2002, CLIN EXP IMMUNOL, V130, P370, DOI 10.1046/j.1365-2249.2002.02025.x; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kantele A, 1997, J IMMUNOL, V158, P574; Kantele A, 1999, VACCINE, V17, P229, DOI 10.1016/S0264-410X(98)00193-5; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lakew M, 1997, J IMMUNOL METHODS, V203, P193, DOI 10.1016/S0022-1759(97)00030-6; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Williams MB, 1998, J IMMUNOL, V161, P4227; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	39	52	56	0	7	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2004	78	20					10967	10976		10.1128/JVI.78.20.10967-10976.2004	http://dx.doi.org/10.1128/JVI.78.20.10967-10976.2004			10	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	858YO	15452217	Green Published			2022-09-04	WOS:000224229000014
J	Sharma, A; Liu, HD; Tobar-Tosse, F; Dakal, TC; Ludwig, M; Holz, FG; Loeffler, KU; Wullner, U; Herwig-Carl, MC				Sharma, Amit; Liu, Hongde; Tobar-Tosse, Fabian; Dakal, Tikam Chand; Ludwig, Michael; Holz, Frank G.; Loeffler, Karin U.; Wuellner, Ullrich; Herwig-Carl, Martina C.			Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cancer; neurodegenerative diseases; ubiquitin carboxyl-terminal hydrolases (UCHs); Parkinson's disease; BAP1; alpha-synuclein	PGP-9.5; PATHWAY	Emerging evidence suggests an inverse association between cancer and neurodegenerative diseases (NDD). Although phenotypically different, both diseases display a significant imbalance in the ubiquitination/deubiquitination processes. Therefore, we particularly investigated the expression of ubiquitin C-terminal hydrolases (UCHs: UCH-L1, UCH-L3, UCH-L5 and BAP1), a subfamily of deubiquitinating enzymes (DUBs), using publically available datasets (GTEx, TCGA) and observed altered expression of UCH-L1, UCH-L3, UCH-L5 in 17 cancer types. Interestingly, UCH-L1 (known to be enriched in neurons and interacting with the Parkinson's disease-associated protein alpha-synuclein) appeared to be a prognostic indicator of unfavorable outcome in endometrial and urothelial cancer, while increased expression of UCH-L3 and UCH-L5 was associated with poor survival in liver and thyroid cancer, respectively. In normal tissues, UCH-L1 was found to be strongly expressed in the cerebral cortex and hypothalamus, while UCH-L3 expression was somewhat higher in the testis. The occurrence of mutation rates in UCHs also suggests that BAP1 and UCH-L5 may play a more dominant role in cancers than UCH-L1 and UCH-L3. We also characterized the functional context and configuration of the repeat elements in the promoter of DUBs genes and found that UCHs are highly discriminatory for catabolic function and are mainly enriched with LINE/CR1 repeats. Regarding the thesis of an inverse association between cancer and NDD, we observed that among all DUBs, UCHs are the one most involved in both entities. Considering a putative therapeutic potential based on presumed common mechanisms, it will be useful to determine whether other DUBs can compensate for the loss of UCH activity under physiological conditions. However, experimental evidence is required to substantiate this argument.	[Sharma, Amit; Holz, Frank G.; Loeffler, Karin U.; Herwig-Carl, Martina C.] Univ Hosp Bonn, Dept Ophthalmol, D-53127 Bonn, Germany; [Liu, Hongde] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China; [Tobar-Tosse, Fabian] Pontificia Univ Javeriana Cali, Dept Basic Hlth Sci, Cali 760031, Colombia; [Dakal, Tikam Chand] Mohanlal Sukhadia Univ, Dept Biotechnol, Udaipur 313001, Rajasthan, India; [Ludwig, Michael] Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Wuellner, Ullrich] Univ Hosp Bonn, Dept Neurol, D-53127 Bonn, Germany; [Wuellner, Ullrich] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany		Herwig-Carl, MC (corresponding author), Univ Hosp Bonn, Dept Ophthalmol, D-53127 Bonn, Germany.	Amit.Sharma@ukbonn.de; liuhongde@seu.edu.cn; ftobar@javerianacaliedu.co; tikam260707@gmail.com; mludwig@uni-bonn.de; Frank.Holz@ukbonn.de; Karinloeffler@uni-bonn.de; ullrich.wuellner@ukbonn.de; Martina.Herwig@ukbonn.de	Sharma, Amit/W-4209-2019; Herwig-Carl, Martina/AAI-2618-2019; Tobar-Tosse, Fabian/P-1710-2014	Sharma, Amit/0000-0002-2216-5389; Herwig-Carl, Martina/0000-0002-5943-7675; Wullner, Ullrich/0000-0002-3132-0790; Tobar-Tosse, Fabian/0000-0001-5334-4286; Liu, Hongde/0000-0001-8768-764X	German Research Foundation (DFG) [HE 5775/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG; HE 5775/5-1).	Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; BONFANTI L, 1992, J COMP NEUROL, V322, P35, DOI 10.1002/cne.903220104; Durcan TM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00046; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Healy DG, 2006, ANN NEUROL, V59, P627, DOI 10.1002/ana.20757; Herwig-Carl MC, 2019, EXP EYE RES, V182, P175, DOI 10.1016/j.exer.2019.04.001; Houck Alexander L, 2018, Curr Aging Sci, V11, P77, DOI 10.2174/1874609811666180223154436; Hurst-Kennedy J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/123706; Ibanez K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004173; Jamil MA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00508; Kelly M, 2018, CLIN IMMUNOL, V197, P6, DOI 10.1016/j.clim.2018.08.011; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu HM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000733; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Melzer C, 2019, GENE CHROMOSOME CANC, V58, P357, DOI 10.1002/gcc.22724; Nakajima J, 2002, J CATARACT REFR SURG, V28, P2035, DOI 10.1016/S0886-3350(02)01420-7; Poondla N, 2019, BMB REP, V52, P181, DOI 10.5483/BMBRep.2019.52.3.048; Sharma A, 2020, CANCER SCI, V111, P1385, DOI 10.1111/cas.14319; Sharma A, 2019, CANCERS, V11, DOI 10.3390/cancers11101600; Sharma A, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.601; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zhang MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07298; Zhong JL, 2012, INT J MOL MED, V30, P430, DOI 10.3892/ijmm.2012.1012	24	8	9	1	11	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2020	21	11							3910	10.3390/ijms21113910	http://dx.doi.org/10.3390/ijms21113910			9	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	MC6ND	32486284	Green Published, gold			2022-09-04	WOS:000543400300172
J	Sanches, LFS; Mejia, NAA; Castano, ELA; Muriel, FAZ; Arias, LFB				Sanchez Sanches, Luis Fernando; Alzate Mejia, Nicolas Alberto; Arbelaez Castano, Enrique Leon; Zapata Muriel, Fernando Antonio; Benitez Arias, Luis Fernando			Towards the interdisciplinary construction of an anthropology of pain in franciscan perspective	REVISTA PERSEITAS			Spanish	Article						Anthropology of pain; Humanism; Interdisciplinarity; Pain; Sense; Suffering; Saint Francis of Assisi		The general purpose of the research work, which is presented below, is intended to conduct a systematic study around the sense of pain in an interdisciplinary perspective, in order to make approaches to a new vision that favors the meaning and meaning of pain by presenting the validity and validity of the evangelical sense of the latter in Francis of Assisi, through a hermeneutical study and documentary analysis. Discussion: Pain makes us aware of our existence in the world of individuality, limits and corporeality. Every human being has ever experienced pain, so it is said that it is something inherent and intrinsic to the human condition, even if you don't want to, don't look for it, you want to run away or evade it, despite being in some cases something inevitable. The method to follow is the documentary, guided by hermeneutics, in order to congregate the different truths constructed from the different disciplines that go to the study of this topic Conclusion: pain cannot be reduced to a neurological or organic fact exclusively. Human pain requires an interdisciplinary treatment, if what is sought is to provide for an integral view, recognizing the contribution of multiple epistemological intentions and human sciences that come to the study of pain.	[Sanchez Sanches, Luis Fernando] Univ San Buenaventura, Educ & Desarrollo Human, Bogota, Colombia; [Sanchez Sanches, Luis Fernando; Alzate Mejia, Nicolas Alberto; Arbelaez Castano, Enrique Leon; Zapata Muriel, Fernando Antonio] Grp Invest Gidpad, Linea Invest Antropol Educ Format, Medellin, Colombia; [Alzate Mejia, Nicolas Alberto] Inst Catolico Paris, Teol Comparada Grandes Relig, Paris, France; [Alzate Mejia, Nicolas Alberto] Univ Javeriana, Bioet, Bogota, Colombia; [Alzate Mejia, Nicolas Alberto] Univ San Buenaventura, Bogota, Colombia; [Arbelaez Castano, Enrique Leon; Zapata Muriel, Fernando Antonio] Univ San Buenaventura, Psicol, Bogota, Colombia; [Zapata Muriel, Fernando Antonio] Univ Pontificia Bolivariana, Teol, Medellin, Colombia; [Benitez Arias, Luis Fernando] Pontificia Univ Antonianum Roma, Filosofia, Rome, Italy; [Benitez Arias, Luis Fernando] Inst Catolico Paris, Paris, France; [Benitez Arias, Luis Fernando] Univ Sorbona, Paris, France; [Benitez Arias, Luis Fernando] Pensamiento Medieval & Franciscano, Paris, France		Sanches, LFS (corresponding author), Univ San Buenaventura, Educ & Desarrollo Human, Bogota, Colombia.; Sanches, LFS (corresponding author), Grp Invest Gidpad, Linea Invest Antropol Educ Format, Medellin, Colombia.	luis.sanchez@usbmed.edu.co; nicolas.alzate@usbmed.edu.co; fartbelaezj@une.net.co; zafernando331@gmail.com; lbenitezarias@hotmail.com						Alzate N., 2019, RIQUEZA CONCEPTO POB, P66; Ardila R., 1978, PSICOLOGIA FISIOLOGI; Berdiaev N., 1955, ESCLAVITUD LIBERTAD; Colombo G., 1999, ENFERMEDAD TIEMPO VA; de Asis San Francisco, 1980, SAN FRANC AS ESCR BI; Ellis A., 1980, RAZON EMOCION PSICOT; Esser K, 2002, SCRITTI S FRANCESCO; Fernandez H., 2001, CUADERNOS FRANCISCAN, V1, P189; Forthomme B., 2010, SELECCIONES FRANCISC, P381; Franciscanos.org, 2018, CEL VID 2 SAN FRANC, P26; Iammarrone G., 2012, SELECCIONES FRANCISC, P27; Jasper K., 1978, CLARIFICAZIONE ESSIS; Le Breton David, 2002, ANTROPOLOGIA CUERPO; Morgan C. T., 1968, PSICOLOGIA FISIOLOGI; Mota R., 1983, DOCUMENTOS FRANCISCA; Pablo II Juan, 1984, CARTA APOSTOLICA SAL; Young J., 2001, COGNITIVE THERAPY PE	17	0	0	0	1	FUNDACION UNIV LUIS AMIGO	MEDELLIN	TRANSVERSAL 51 A, MEDELLIN, 67B 90, COLOMBIA	2346-1780			REV PERSEITAS	Rev. Perseitas		2020	8						275	294		10.21501/23461780.3606	http://dx.doi.org/10.21501/23461780.3606			20	Humanities, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Arts & Humanities - Other Topics	NH4TN		Green Submitted, gold			2022-09-04	WOS:000564664400023
J	Arnold, M; de Vries, E; Whiteman, DC; Jemal, A; Bray, F; Parkin, DM; Soerjomataram, I				Arnold, Melina; de Vries, Esther; Whiteman, David C.; Jemal, Ahmedin; Bray, Freddie; Parkin, Donald Maxwell; Soerjomataram, Isabelle			Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012	INTERNATIONAL JOURNAL OF CANCER			English	Article						cancer incidence; melanoma; global; UV radiation; population attributable fraction	MALIGNANT-MELANOMA; THIN MELANOMAS; UNITED-STATES; CANCER; EXPOSURE; TRENDS; SKIN; SURVIVAL; EUROPE; EPIDEMIOLOGY	Ultraviolet radiation (UVR) is a strong and ubiquitous risk factor for cutaneous melanoma, emitted naturally by the sun but also artificial sources. To shed light on the potential impact of interventions seeking to reduce exposure to UVR in both high and low risk populations, we quantified the number of cutaneous melanomas attributable to UVR worldwide. Population attributable fractions and numbers of new melanoma cases in adults due to ambient UVR were calculated by age and sex for 153 countries by comparing the current melanoma burden with historical data, i.e., the melanoma burden observed in a population with minimal exposure to UVR. Secondary analyses were performed using contemporary melanoma incidence rates in dark-skinned African populations with low UVR susceptibility as reference. Globally, an estimated 168,000 new melanoma cases were attributable to excess UVR in 2012, corresponding to 75.7% of all new melanoma cases and 1.2% of all new cancer cases. This burden was concentrated in very highly developed countries with 149,000 attributable cases and was most pronounced in Oceania, where 96% of all melanomas (representing 9.3% of the total cancer burden) were attributable to excess UVR. There would be approximately 151,000 fewer melanoma cases worldwide were incidence rates in every population equivalent to those observed in selected low-risk (dark-skinned, heavily pigmented) reference populations. These findings underline the need for public health action, an increasing awareness of melanoma and its risk factors, and the need to promote changes in behavior that decrease sun exposure at all ages.	[Arnold, Melina; Bray, Freddie; Soerjomataram, Isabelle] Int Agcy Res Canc, Sect Canc Surveillance, 150 Cours Albert Thomas, F-69372 Lyon 08, France; [de Vries, Esther] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Canc Control Grp, Brisbane, Qld, Australia; [Jemal, Ahmedin] Amer Canc Soc, NW, Atlanta, GA 30329 USA; [Parkin, Donald Maxwell] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England		Arnold, M (corresponding author), Int Agcy Res Canc, Sect Canc Surveillance, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	arnoldm@iarc.fr	Whiteman, David C/P-2728-2014; Arnold, Melina/AAO-9525-2020; de Vries, Esther/A-6603-2009; Arnold, Melina/L-9331-2015	Whiteman, David C/0000-0003-2563-9559; de Vries, Esther/0000-0002-5560-2258; Bray, Freddie/0000-0002-3248-7787; Parkin, Donald Maxwell/0000-0002-3229-1784; Arnold, Melina/0000-0003-1700-6831	National Health and Medical Research Council of Australia [APP1058522]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Grant sponsor: National Health and Medical Research Council of Australia (for D.C.W.); Grant number: APP1058522	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; [Anonymous], 2013, GLOBOCAN 2012 CANC I; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Arnold M, 2014, J EUR ACAD DERMATOL, V28, P1170, DOI 10.1111/jdv.12236; Baade P, 2012, INT J CANCER, V130, P170, DOI 10.1002/ijc.25996; BONIOL M, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E4757; Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609; Brunssen A, 2017, J AM ACAD DERMATOL, V76, P129, DOI 10.1016/j.jaad.2016.07.045; Chokunonga E, 2016, INT J CANCER, V138, P1416, DOI 10.1002/ijc.29883; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; de Vries E, 2012, BRIT J DERMATOL, V167, P53, DOI 10.1111/j.1365-2133.2012.11087.x; de Vries E, 2017, INT J CANCER, V140, P2070, DOI 10.1002/ijc.30638; de Vries E, 2016, CANCER EPIDEMIOL, V45, pS13, DOI 10.1016/j.canep.2016.09.014; Durbec F, 2012, BRIT J DERMATOL, V166, P727, DOI 10.1111/j.1365-2133.2011.10772.x; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Fajuyigbe D, 2018, FASEB J, DOI [10.1096/fj.201701472R, DOI 10.1096/EJ.201701472R]; Ferlay J, 2013, GLOBOCAN; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forman D., 2013, CANC INCIDENCE 5 CON, VX; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Garsaud P, 1998, AM J EPIDEMIOL, V147, P66; Glazer AM, 2016, JAMA DERMATOL, DOI [10.1001/jamadermatol.2016.4512, DOI 10.1001/JAMADERMATO11016.4512]; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Green AC, 2011, PROG BIOPHYS MOL BIO, V107, P349, DOI 10.1016/j.pbiomolbio.2011.08.010; Greinert R, 2015, CANCER EPIDEMIOL, V39, pS75, DOI 10.1016/j.canep.2014.12.014; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100; Laaksonen MA, 2010, AM J EPIDEMIOL, V171, P837, DOI 10.1093/aje/kwp457; Lindholm C, 2004, CANCER-AM CANCER SOC, V101, P2067, DOI 10.1002/cncr.20602; MacKie RM, 2007, BRIT J CANCER, V96, P1772, DOI 10.1038/sj.bjc.6603801; National Cancer Registry, 2011, CANC S AFR 2011; Olsen CM, 2015, AUST NZ J PUBL HEAL, V39, P471, DOI 10.1111/1753-6405.12470; Parkin DM, 2011, BRIT J CANCER, V105, pS66, DOI 10.1038/bjc.2011.486; Purdue MP, 2005, CANCER EPIDEM BIOMAR, V14, P2015, DOI 10.1158/1055-9965.EPI-05-0097; Sankaranarayanan R., 2011, CANC SURVIVAL AFRICA; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21332, 10.3322/caac.21708, 10.3322/caac.21551]; UNDP, 2013, RIS S HUM PROGR DIV; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Leest RJT, 2015, EUR J CANCER, V51, P2833, DOI 10.1016/j.ejca.2015.09.008; Waldmann A, 2012, BRIT J CANCER, V106, P970, DOI 10.1038/bjc.2012.22; Wang Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2747-6; Watson M, 2016, PREV MED, V91, P294, DOI 10.1016/j.ypmed.2016.08.032; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Whiteman DC, 2015, J INVEST DERMATOL, V135, P1190, DOI 10.1038/jid.2014.452; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	47	61	61	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7136	1097-0215		INT J CANCER	Int. J. Cancer	SEP 15	2018	143	6					1305	1314		10.1002/ijc.31527	http://dx.doi.org/10.1002/ijc.31527			10	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	GP7ZH	29659012				2022-09-04	WOS:000441128700004
J	Vommaro, P; Alvarado, SV				Vommaro, Pablo; Victoria Alvarado, Sara			Transformations and new searches in youth studies: a look from Colombia	ENCRUCIJADAS-REVISTA CRITICA DE CIENCIAS SOCIALES			Spanish	Editorial Material									[Vommaro, Pablo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Victoria Alvarado, Sara] Univ Catolica Sao Paulo, Ciencias Sociales Ninez & Juventud, Sao Paulo, Brazil; [Victoria Alvarado, Sara] Univ Manizales, CINDE, CLACSO, COLEF, Manizales, Colombia; [Victoria Alvarado, Sara] Pontificia Univ Javeriana Bogota, Psicol, Bogota, Colombia; [Victoria Alvarado, Sara] Univ Manizales CINDE, Ctr Estudios Avanzados Ninez & Juventud, Manizales, Colombia; [Victoria Alvarado, Sara] CLACSO, Red Iberoamer Postgrad Infancia & Juventud, Buenos Aires, DF, Argentina; [Victoria Alvarado, Sara] Escuela Int Posgrad Infancia & Juventud, Com Acad, Programa Postdoctoral Invest Ciencias Sociales Ni, Buenos Aires, DF, Argentina; [Victoria Alvarado, Sara] Grp Trabajo CLACSO Juventudes & Infancias, Buenos Aires, DF, Argentina		Vommaro, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.							Munoz G, 1995, QUE SIGNIFICA TENER	1	0	0	0	0	ASOC CONTUBERNIO	SALAMANCA	UNIV SALAMANCA, CAMPUS MIGUEL UNAMUNO, SALAMANCA, 37007, MEXICO	2174-7148	2174-6753		ENCRUCIJADAS	Encrucijadas		2018	15								e1502					15	Social Issues	Emerging Sources Citation Index (ESCI)	Social Issues	GH3IQ					2022-09-04	WOS:000433296400005
J	Cespedes, C; Duran, P; Uribe, C; Chahin, S; Lema, A; Coll, M				Cespedes, Camila; Duran, Paola; Uribe, Carolina; Chahin, Silvia; Lema, Adriana; Coll, Mauricio			Thyroid abscess. A case series and literature review	ENDOCRINOLOGIA Y NUTRICION			English	Review						Acute suppurative thyroiditis; Thyroid abscess; Pyriform sinus fistula		Thyroid abscess is rare in children but the presence of previous thyroid disease, and congenital remnants such as a pyriform sinus fistula, are predisposing factors. The classical presentation consists of fever, cervical pain and a painful mass. The diagnosis is confirmed through clinical findings, and by diagnostic imaging (ultrasound and computerized axial tomography). A barium swallow must be performed in order to detect a fistula and to consider surgical drain. We present the cases of thyroid abscess in five patients who were admitted in four medical centers (Fundacion Cardioinfantil, Hospital Universitario San Ignacio, Clinica infantil de Colsubsidio and Hospital de la Misericordia) in Bogota, Colombia between 2000 and 2010. (C) 2012 SEEN. Published by Elsevier Espana, S.L. All rights reserved.	[Cespedes, Camila] Univ Javeriana, Hosp Univ San Ignacio, Dept Pediat, Unidad Endocrinol Pediat, Bogota, Colombia; [Duran, Paola; Chahin, Silvia] Univ Rosario, Dept Pediat, Fdn Cardioinfantil, Unidad Endocrinol Pediat, Bogota, Colombia; [Uribe, Carolina] Fdn Univ Ciencias Salud, Dept Pediat, Bogota, Colombia; [Lema, Adriana] Clin Infantil Colsubsidio, Unidad Endocrinol Pediat, Bogota, Colombia; [Coll, Mauricio] Univ Nacl Colombia, Fdn Hosp Misericordia, Unidad Endocrinol Pediat, Dept Pediat, Bogota, Colombia		Cespedes, C (corresponding author), Univ Javeriana, Hosp Univ San Ignacio, Dept Pediat, Unidad Endocrinol Pediat, Bogota, Colombia.	ccespedes@javeriana.edu.co		Cespedes Salazar, Camila/0000-0002-7856-7213				Agarwal A, 1998, THYROID, V8, P399, DOI 10.1089/thy.1998.8.399; Astl J, 2003, INT J PEDIATR OTORHI, V67, P1375, DOI 10.1016/j.ijporl.2003.07.002; BarZiv J, 1996, AM J ROENTGENOL, V167, P1569, DOI 10.2214/ajr.167.6.8956599; Chen Ching Yuan, 2011, Am J Otolaryngol, V32, P253, DOI 10.1016/j.amjoto.2010.02.006; de Boeck K, 2000, PEDIATR INFECT DIS J, V19, P903; GODIN MS, 1990, LARYNGOSCOPE, V100, P174; Grobl F, 2009, REV CHIL PEDIAT, V8; Herndon MD, 2007, AM SURGEON, V73, P725; Houghton DJ, 1998, CLIN ENDOCRINOL, V48, P521, DOI 10.1046/j.1365-2265.1998.00378.x; Jordan JA, 1998, ARCH OTOLARYNGOL, V124, P1021, DOI 10.1001/archotol.124.9.1021; Kawanaka M, 1994, Ann Nucl Med, V8, P159; Meier DA, 1996, J NUCL MED, V37, P1745; Minhas SS, 2001, J LARYNGOL OTOL, V115, P1029; Nicollas R, 1998, INT J PEDIATR OTORHI, V44, P5, DOI 10.1016/S0165-5876(98)00023-8; Ogale S B, 2002, Indian Pediatr, V39, P1156; Paes JE, 2010, THYROID, V20, P247, DOI 10.1089/thy.2008.0146; Park SW, 2000, AM J NEURORADIOL, V21, P817; Parmar Hemant, 2002, Australas Radiol, V46, P186, DOI 10.1046/j.1440-1673.2001.01033.x; Prasad TRS, 2007, PEDIATR SURG INT, V23, P779, DOI 10.1007/s00383-007-1939-1; RICH EJ, 1987, PEDIATR INFECT DIS J, V6, P936, DOI 10.1097/00006454-198710000-00017; Shrime M, 2003, INT J PEDIATR OTORHI, V67, P1227, DOI 10.1016/j.ijporl.2003.07.015; Smith SL, 2008, PEDIATR EMERG CARE, V24, P764, DOI 10.1097/PEC.0b013e31818c286a; SZEGO PL, 1970, CAN MED ASSOC J, V103, P631; TAKAI S, 1979, LANCET, V1, P751	24	6	6	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1575-0922	1579-2021		ENDOCRINOL NUTR	Endocrinol. Nutr.	APR	2013	60	4					190	196		10.1016/j.endonu.2012.09.001	http://dx.doi.org/10.1016/j.endonu.2012.09.001			7	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	V43XQ	23177094				2022-09-04	WOS:000209714500005
J	Trujillo, AJ; Vecino-Ortiz, AI; Gomez, FR; Steinhardt, LC				Trujillo, A. J.; Vecino-Ortiz, A., I; Ruiz Gomez, F.; Steinhardt, L. C.			IMPROVING HEALTH INSURANCE AND PREVENTIVE EFFORT AMONG DIABETIC PATIENTS: THE COLOMBIAN EXPERIENCE	VALUE IN HEALTH			English	Meeting Abstract									[Trujillo, A. J.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Vecino-Ortiz, A., I] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ruiz Gomez, F.] Univ Javeriana, Bogota, DC, Colombia; [Steinhardt, L. C.] Ctr Dis Control, Atlanta, GA 30333 USA				Vecino-Ortiz, Andres I./R-4022-2019	Vecino-Ortiz, Andres I./0000-0002-8089-2488					0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015			VALUE HEALTH	Value Health	MAY	2011	14	3					A100	A100		10.1016/j.jval.2011.02.559	http://dx.doi.org/10.1016/j.jval.2011.02.559			1	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	876JY		Bronze			2022-09-04	WOS:000299105000524
J	Weller, A; Rozin, A; Goldstein, A; Charpak, N; Ruiz-Pelaez, JG; de Calume, ZF; Charpak, Y; Sack, J				Weller, A; Rozin, A; Goldstein, A; Charpak, N; Ruiz-Pelaez, JG; de Calume, ZF; Charpak, Y; Sack, J			Longitudinal assessment of pituitary-thyroid axis and adrenal function in preterm infants raised by 'kangaroo mother care'	HORMONE RESEARCH			English	Article						touch; skin-to-skin-contact; thyroxine; 17 alpha-hydroxy-progesterone; thyroxine-stimulating hormone; premature infants	BIRTH-WEIGHT INFANTS; 17-ALPHA-HYDROXYPROGESTERONE LEVELS; 21-HYDROXYLASE DEFICIENCY; CONTROLLED TRIAL; HYPERPLASIA	Objective: To assess whether complete kangaroo mother care (KMC), a skin-to-skin contact intervention, would affect longitudinal/developmental patterns of hormonal change. Method. An open randomized controlled trial was conducted in a large tertiary care hospital, comparing KMC and traditional care for newborn infants weighing less than 2,001 g. Eighty-seven healthy preterm (<37 weeks gestational age) infants from this study provided three blood-spot samples on filter paper: at randomization (postnatal age 1-5 days), 2 weeks later, and at calculated term (41 weeks gestational age). They met a number of additional inclusion criteria including discharge from the hospital within the first postnatal week. The levels of 17&alpha;-hydroxy-progesterone (17-OHP), thyroxine-stimulating hormone (TSH) and thyroxine (T-4) were assessed by radioimmunoassay. Birth weight (<1,800 or greater than or equal to1,800g) and prenatal maternal corticosteroid treatment were taken into account in the analysis. Interventions: Complete KMC includes early discharge, positioning the infant on the parent's chest in an upright position, 24 h/day in skin-to-skin contact, and breast-feeding. In the traditional care group, infants were discharged according to routine hospital practice. Results: Levels of 17-OHP and TSH decreased significantly from eligibility to calculated term while T-4 levels did not change significantly over time. Most importantly, overall, treatment (KMC) did not interact with the pattern of physiological change. Conclusions: Maturation of the pituitary-thyroid axis and adrenal function is apparently not compromised by KMC, at least in healthy preterm infants. Copyright (C) 2002 S. Karger AG, Basel.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; ISS World Lab, Programme Madre Canguro, Santa Fe Bogota, Colombia; Univ Javeriana, Fac Med, Unidad Epidemiol Clin, Santa Fe Bogota, Colombia; EVAL Inst, Paris, France; Chaim Sheba Med Ctr, Dept Pediat, IL-52621 Tel Hashomer, Israel; Sackler Sch Med, IL-52621 Tel Hashomer, Israel		Weller, A (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.		Weller, Aron/AAU-3074-2020	Weller, Aron/0000-0002-0663-4384; Goldstein, Abraham/0000-0002-9349-0621; charpak, nathalie/0000-0001-6697-5837; Ruiz Pelaez, Juan Gabriel/0000-0003-3088-5834				ACOLET D, 1993, ARCH DIS CHILD-FETAL, V68, P29, DOI 10.1136/adc.68.1_Spec_No.29; Anderson G C, 1991, J Perinatol, V11, P216; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; BERRY J, 1986, ANN CLIN BIOCHEM, V23, P546, DOI 10.1177/000456328602300510; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; CHARPAK N, 1994, PEDIATRICS, V94, P804; Charpak Nathalie, 1996, Current Opinion in Pediatrics, V8, P108, DOI 10.1097/00008480-199604000-00004; ELDAR D, 1991, HORM RES, V34, P219; FISHER DA, 1969, J CLIN INVEST, V48, P1670, DOI 10.1172/JCI106132; KUHN CM, 1991, J PEDIATR-US, V119, P434, DOI 10.1016/S0022-3476(05)82059-1; Linder N, 1999, ARCH DIS CHILD-FETAL, V81, pF175, DOI 10.1136/fn.81.3.F175; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; PACHIAROTTI A, 1988, J ENDOCRINOL INVEST, V11, P515; PANG S, 1977, J CLIN ENDOCR METAB, V45, P1003, DOI 10.1210/jcem-45-5-1003; Sack J, 1997, HORM RES, V48, P115, DOI 10.1159/000185500; Sapolsky RM, 1997, SCIENCE, V277, P1620, DOI 10.1126/science.277.5332.1620; Shimon I, 1995, HORM RES, V44, P247, DOI 10.1159/000184636; SLOAN NL, 1994, LANCET, V344, P782, DOI 10.1016/S0140-6736(94)92341-8; Tessier R, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e17; THOMPSON R, 1989, J PEDIATR-US, V114, P400, DOI 10.1016/S0022-3476(89)80557-8; TRAVERT G, 1985, CLIN CHEM, V31, P1829; WHITELAW A, 1985, LANCET, V1, P1206; Winer B.J., 1971, STAT PRINCIPALS EXPT, V2nd	23	9	10	0	14	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163			HORM RES	Horm. Res.		2002	57	1-2					22	26		10.1159/000057942	http://dx.doi.org/10.1159/000057942			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	551LH	12006715				2022-09-04	WOS:000175562800004
J	Buitrago, EM; Onate, JM; Garcia-Goez, JF; Alvarez, J; Lenis, W; Sanudo, LM; Rubiano, LC				Martinez Buitrago, Ernesto; Millan Onate, Jose; Fernando Garcia-Goez, Jose; Alvarez, Jorge; Lenis, William; Marina Sanudo, Luz; Consuelo Rubiano, Luisa			HLA-B*57:01 allele prevalence in treatment-Naive HIV-infected patients from Colombia	BMC INFECTIOUS DISEASES			English	Article						Abacavir; Antiretroviral therapy; HLA-B*57; 01; HIV infection; Hypersensitivity; Pharmacogenetics; Cross-sectional study	ABACAVIR HYPERSENSITIVITY REACTIONS; RISK-FACTOR-ANALYSIS; PHARMACOGENETICS; FREQUENCY; ASSOCIATION; TRANSLATION	Background The HLA-B*57:01 allele is associated with a hypersensitivity reaction to abacavir. Due to the lack of knowledge of HLA-B*57:01 prevalence in Colombia, routine screening is not performed and is not recommended by the national guidelines. We aimed to determine the prevalence of HLA-B*57:01 in HIV population from Colombia. Methods This cross-sectional study included naive HIV-infected adults from 13 cities of the country. The presence of HLA-B*57:01 was determined by using SSP-PCR in blood samples. Prevalence rates were stratified by sex, race, and region of origin. Results HLA-B*57:01 allele prevalence in Colombian HIV-infected individuals was 2.7%. When stratifying for the race, the prevalence was 4% for whites, 2.6% for other race (mainly mestizo), and 1.9% for Afro-Colombians. The prevalence varied from 0% up to 11.4% depending on the department of origin. The highest prevalence rates were found in Caldas (11.4%), Antioquia (5%), Risaralda (4.8%), and Valle del Cauca (4.3%). When distributed by country zones, the central, with a racial predominance of Caucasians and mestizos, was the highest (6.0%, 0R = 4.1, CI 1.2-12.8, p = 0,016). Conclusions The overall prevalence of HLA-B*57:01 in Colombia was lower than the reported rates for other Latin American countries such as Brazil, Costa Rica, and Argentina, but similar in comparison to Chile and Mexico. The diversity in the racial and ethnic heritage shown in our data supports the recommendation to implement routine screening for the HLA-B*57:01 allele before initiation of abacavir-containing antiretroviral therapy in the Colombian HIV management guidelines.	[Martinez Buitrago, Ernesto; Millan Onate, Jose; Fernando Garcia-Goez, Jose; Alvarez, Jorge; Lenis, William; Marina Sanudo, Luz; Consuelo Rubiano, Luisa] Fundac Red VIH Valle Cauca REVIVA, Cali, Colombia; [Martinez Buitrago, Ernesto; Alvarez, Jorge] Univ Valle, Cali, Colombia; [Millan Onate, Jose] Ctr Med Imbanaco, Cali, Colombia; [Fernando Garcia-Goez, Jose] Hosp Univ Fdn Valle Lili, Cali, Colombia; [Lenis, William] Recuperar SA IPS, Cali, Colombia; [Consuelo Rubiano, Luisa] Pontificia Univ Javeriana Cali, Cali, Colombia; [Fernando Garcia-Goez, Jose] Univ Icesi, Cali, Colombia		Buitrago, EM (corresponding author), Fundac Red VIH Valle Cauca REVIVA, Cali, Colombia.; Buitrago, EM (corresponding author), Univ Valle, Cali, Colombia.	emarbui@gmail.com			ViiV Healthcare	ViiV Healthcare	An unrestricted grant provided the funding for this research from ViiV Healthcare to Fundacion Red de VIH del Valle del Cauca (REVIVA), Cali, Colombia. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PROSP HLA B57 01 SCR; Arrieta-Bolanos E, 2014, HUM IMMUNOL, V75, P1092, DOI 10.1016/j.humimm.2014.09.011; Baniasadi, 2016, PREVALENCE HLA B 57, P5; Carolino Fabricia, 2017, Porto Biomed J, V2, P59, DOI 10.1016/j.pbj.2016.12.004; Clay PG, 2002, CLIN THER, V24, P1502, DOI 10.1016/S0149-2918(02)80057-1; Crovella S, 2011, CLINICS, V66, P1485, DOI 10.1590/S1807-59322011000800030; Cuenta de Alto Costo, 2016, B SIT VIH COL; Cutrell AG, 2004, ANN PHARMACOTHER, V38, P2171, DOI 10.1345/aph.1E202; De Araujo C, 2014, OPEN J GENET, V4, P56; Department of Health and Human Services, PAN ANT GUID AD AD G; Easterbrook P J, 2003, HIV Med, V4, P321, DOI 10.1046/j.1468-1293.2003.00166.x; European AIDS Clinical Society, 2018, EUR AIDS CLIN SOC GU; Guo YL, 2013, SCI CHINA LIFE SCI, V56, P119, DOI 10.1007/s11427-013-4438-8; Hammond E, 2007, TISSUE ANTIGENS, V70, P58, DOI 10.1111/j.1399-0039.2007.00840.x; Hammond E, 2007, ANTIVIR THER, V12, P1027; Hanratty D. M., 1988, COLOMBIA COUNTRY STU; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hughes CA, 2008, ANN PHARMACOTHER, V42, P1520, DOI 10.1345/aph.1K522c; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Martin AM, 2005, TISSUE ANTIGENS, V65, P571, DOI 10.1111/j.1399-0039.2005.00401.x; Martin MA, 2012, CLIN PHARMACOL THER, V91, P734, DOI 10.1038/clpt.2011.355; Ministry of Health and Social Protection, 2014, EV BAS CLIN PRACT GU; Moragas M, 2015, TISSUE ANTIGENS, V86, P28, DOI 10.1111/tan.12575; Orkin C, 2010, PHARMACOGENET GENOM, V20, P307, DOI 10.1097/FPC.0b013e3283390666; Phillips E, 2009, MOL DIAGN THER, V13, P1, DOI 10.2165/01250444-200913010-00001; Phillips GD, 2006, BEYOND THE EPIC: THE LIFE AND FILMS OF DAVID LEAN, P3; Poggi H, 2010, BRAZ J INFECT DIS, V14, P510, DOI 10.1590/S1413-86702010000500015; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Sanchez-Giron F, 2011, PHARMACOGENOMICS, V12, P809, DOI [10.2217/pgs.11.31, 10.2217/PGS.11.31]; Small CB, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2331-y; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Sun HY, 2007, J ANTIMICROB CHEMOTH, V60, P599, DOI 10.1093/jac/dkm243; Symonds W, 2002, CLIN THER, V24, P565, DOI 10.1016/S0149-2918(02)85132-3; Zucman D, 2007, JAIDS-J ACQ IMM DEF, V45, P1, DOI 10.1097/QAI.0b013e318046ea31	36	4	4	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2334		BMC INFECT DIS	BMC Infect. Dis.	SEP 9	2019	19	1							793	10.1186/s12879-019-4415-3	http://dx.doi.org/10.1186/s12879-019-4415-3			8	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	IW4YT	31500584	Green Submitted, Green Published, gold			2022-09-04	WOS:000484986400001
J	Stevens, LF; Arango-Lasprilla, JC; Deng, XY; Schaaf, KW; Aragon, CJD; Quijano, MC; Kreutzer, J				Stevens, Lillian Flores; Carlos Arango-Lasprilla, Juan; Deng, Xiaoyan; Schaaf, Kathryn Wilder; De los Reyes Aragon, Carlos Jose; Cristina Quijano, Maria; Kreutzer, Jeffrey			Factors associated with depression and burden in Spanish speaking caregivers of individuals with traumatic brain injury	NEUROREHABILITATION			English	Article						Caregivers; depression; burden	TREATING FAMILIES; HEALTH; PREDICTORS; DISTRESS; CARERS; NEEDS; TBI; REHABILITATION; PERSPECTIVE; VALIDATION	Objective: To determine which factors are highly associated with burden and depression in a group of caregivers of persons with Traumatic Brain Injury (TBI) in Colombia, South America. Design: Prospective. Participants: Fifty-one pairs of individuals with TBI and their caregivers from two major cities in Colombia completed a comprehensive psychosocial evaluation that included information related to patient and caregiver sociodemographic factors, patient factors, and caregiver estimation of patient neurobehavioral functioning. Outcome measures: Caregiver burden (Zarit Burden Interview) and caregiver depression (PHQ-9). Results: Generalized linear models revealed that patient language problems and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver burden. Caregiver socioeconomic status and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver depression. These variables were then selected as candidates for the multiple regression models, which were fit separately for caregiver depression and burden, and revealed that caregivers' perception of patient depression was the only factor associated with both caregiver burden and depression. Conclusion: Caregivers' perception of patient depression was the single best predictor of both caregiver burden and depression. Implications for treatment based on these preliminary findings are discussed.	[Stevens, Lillian Flores] Hunter Holmes McGuire VAMC, Richmond, VA 23249 USA; [Schaaf, Kathryn Wilder; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain; [Deng, Xiaoyan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [De los Reyes Aragon, Carlos Jose] Univ Norte, Dept Psychol, Barranquilla, Colombia; [Cristina Quijano, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia		Stevens, LF (corresponding author), Hunter Holmes McGuire VAMC, 1201 Broad Rock Blvd,116-B, Richmond, VA 23249 USA.	Lillian.Stevens@va.gov	De los Reyes Aragon, Carlos Jose/P-3516-2019; De los Reyes Aragon, Carlos Jose CDA/E-2585-2015	De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635; De los Reyes Aragon, Carlos Jose CDA/0000-0003-4472-0635; Quijano Martinez, Maria Cristina/0000-0003-3548-1628				Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Anez Luis M, 2005, J Psychiatr Pract, V11, P221; Beck AT., 1979, COGNITIVE THERAPY DE; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Centers for Disease Control and Prevention (CDC), MAN PEOPL HAV TBI; Cuellar I, 1995, J COMMUNITY PSYCHOL, V23, P339, DOI 10.1002/1520-6629(199510)23:4<339::AID-JCOP2290230406>3.0.CO;2-7; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; DEPOMPEI R, 1994, TOP LANG DISORD, V15, P68, DOI 10.1097/00011363-199411000-00007; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hayes S, 2005, PRACTICAL GUIDE ACCE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karlikay G, 2005, INTERNET J NEUROL, V4, P2; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Livingston MG., 1990, REHABILITATION ADULT, P225; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOL, V6, P338; Marwitz JH., 1999, NEUROBEHAVIORAL FUNC; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MILLER B, 1991, J HEALTH SOC BEHAV, V32, P165, DOI 10.2307/2137150; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Pereira F., 2007, AVANCES PSIQUIATRIA, V8, P153; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Sander AM, 2007, NEUROREHABILITATION, V22, P9; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; TEASDALE G, 1974, LANCET, V2, P81; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	15	16	1	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	31	4					443	452		10.3233/NRE-2012-00815	http://dx.doi.org/10.3233/NRE-2012-00815			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	052GV	23232169				2022-09-04	WOS:000312186600014
J	Orozco, CA; Gonzalez-Giraldo, Y; Bonilla, DA; Forero, DA				Orozco, Carlos A.; Gonzalez-Giraldo, Yeimy; Bonilla, Diego A.; Forero, Diego A.			An in silico analysis of genome-wide expression profiles of the effects of exhaustive exercise identifies heat shock proteins as the key players	META GENE			English	Article						Physiological adaptation; Systems biology; Bioinformatics; Blood cells; Transcriptomics	PHYSICAL-ACTIVITY; GENE-EXPRESSION; MUSCLE; ADAPTATIONS; HEALTH; BDNF	Physical exercise induces important system disturbances in the human body in a dose-response manner. Meta analyses of genome-wide expression studies (GWES) might contribute to identify gene expression patterns and to a better understanding of the molecular mechanisms behind the complexity of adaptations to exercise, under a systems biology approach. Here, we aimed to analyze available data for human GWES that have evaluated the effect of exhaustive exercise in peripheral blood mononuclear cells (PBMC) and white blood cells (WBC). Three primary datasets retrieved from the NCBI Gene Expression Omnibus were meta-analyzed using a random effects model in the NetworkAnalyst software. After identifying nine differentially expressed genes (DEGs), we performed functional enrichment analyses to extract relevant biological information. A protein-protein interactions network on DEGs was built to evaluate the associated regulatory pathways. We found that five upregulated genes were members of the heat shock protein family, one of the top stress-response groups of genes. The enrichment analysis revealed key roles of the DEGs on the cellular adaptations to exercise-induced stress (i.e., temperature stimulus, topologically-incorrect and unfolded proteins). Our comparison analysis of DEG signatures found in blood cells with the expression pattern on muscle skeletal tissue showed some common genes. Thus, novel DEGs that might serve as hormetic mediators to exercise-induced adaptations were identified. Further experimental research is needed to validate these findings.	[Orozco, Carlos A.; Forero, Diego A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Hlth & Sport Sci Res Grp, Bogota, Colombia; [Orozco, Carlos A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Profess Program Surg Instrumentat, Bogota, Colombia; [Orozco, Carlos A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Profess Program Optometry, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy] Univ Antonio Narino, Ctr Psychosocial Studies Amer Latina & Caribbean, Bogota, Colombia; [Bonilla, Diego A.] Dynam Business & Sci Soc DBSS Int SAS, Res Div, Bogota, Colombia; [Bonilla, Diego A.] Univ Cordoba, Res Grp Phys Act Sports & Hlth Sci GICAFS, Monteria, Colombia; [Bonilla, Diego A.] Univ Basque Country, Joxe Mari Korta Res Ctr, kDNA Genom, Donostia San Sebastian 20018, Spain; [Forero, Diego A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Profess Program Resp Therapy, Bogota, Colombia		Orozco, CA (corresponding author), Fdn Univ Area Andina, Sch Hlth & Sport Sci, Hlth & Sport Sci Res Grp, Bogota, Colombia.	corozco35@areandina.edu.co	González-Giraldo, Yeimy/Q-5652-2018; Bonilla, Diego A./I-5769-2019	González-Giraldo, Yeimy/0000-0002-2527-218X; Bonilla, Diego A./0000-0002-2634-1220; Orozco Castano, Carlos Alberto/0000-0002-7256-0942				Abbasi A, 2014, BRAIN BEHAV IMMUN, V39, P130, DOI 10.1016/j.bbi.2013.10.023; Amar D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23579-x; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; Bonilla DA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010103; Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Calabrese EJ, 2021, PHARMACOL RES, V167, DOI 10.1016/j.phrs.2021.105526; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Cuthbert Rebecca L, 2019, Temperature (Austin), V6, P77, DOI 10.1080/23328940.2018.1555414; da Rocha AL, 2019, CYTOKINE, V119, P57, DOI 10.1016/j.cyto.2019.02.016; Dattilo S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0046-8; de Freitas Marcelo Conrado, 2017, World J Methodol, V7, P46, DOI 10.5662/wjm.v7.i2.46; de Sousa CV, 2017, SPORTS MED, V47, P277, DOI 10.1007/s40279-016-0566-1; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Farshbaf MJ, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.649929; Flockhart M, 2021, CELL METAB, V33, P957, DOI 10.1016/j.cmet.2021.02.017; Forero DA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006922; Gillum T, 2013, INT J ENDOCRINOL MET, V11, DOI 10.5812/ijem.8739; Goncalves C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073574; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Guan JY, 2018, CELL STRESS CHAPERON, V23, P1193, DOI 10.1007/s12192-018-0925-y; Henstridge DC, 2016, J APPL PHYSIOL, V120, P683, DOI 10.1152/japplphysiol.00811.2015; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia RX, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1175-2; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Kostek MC, 2007, PHYSIOL GENOMICS, V31, P42, DOI 10.1152/physiolgenomics.00151.2006; Kruger K, 2019, J APPL PHYSIOL, V126, P916, DOI 10.1152/japplphysiol.01052.2018; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Landen S, 2019, EPIGENETICS-US, V14, P523, DOI 10.1080/15592294.2019.1603961; Li Y, 2021, ANN PALLIAT MED, V10, P2638, DOI 10.21037/apm-20-1661; Lin XF, 2019, J REHABIL MED, V51, P473, DOI 10.2340/16501977-2560; Locke M, 2000, CELL STRESS CHAPERON, V5, P45, DOI 10.1379/1466-1268(2000)005<0045:HSTFAA>2.0.CO;2; MacNeil LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010695; Makhnovskii PA, 2021, INT J MOL SCI, V22, P1208, DOI 10.3390/ijms22031208; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; Natelson BH, 1996, INT J SPORTS MED, V17, P299, DOI 10.1055/s-2007-972850; Noble EG, 2008, APPL PHYSIOL NUTR ME, V33, P1050, DOI 10.1139/H08-069; Noble EG, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/836519; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n71; Pang RQ, 2019, J ALZHEIMERS DIS, V72, P83, DOI 10.3233/JAD-190328; Pillon NJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13869-w; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; REICHSMAN F, 1991, EUR J APPL PHYSIOL O, V62, P245, DOI 10.1007/BF00571547; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Seeland I, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005380; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Stubbs B, 2017, PSYCHIAT RES, V249, P102, DOI 10.1016/j.psychres.2016.12.020; Sun Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8381242; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Suzuki K, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050401; Topolska-Wos AM, 2016, BBA-GEN SUBJECTS, V1860, P79, DOI 10.1016/j.bbagen.2015.10.012; Vieira JG, 2022, SPORTS MED, V52, P1103, DOI 10.1007/s40279-021-01602-x; Wang SY, 2020, J ALZHEIMERS DIS, V76, P799, DOI 10.3233/JAD-200406; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Zhang F, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000024930; Zheng H., 2016, NEUROBIOL; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240; Ziegler GC, 2020, J CELL PHYSIOL, V235, P9021, DOI 10.1002/jcp.29753; Zieker D, 2005, PHYSIOL GENOMICS, V23, P287, DOI 10.1152/physiolgenomics.00096.2005	65	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-5400		META GENE	Meta Gene	FEB	2022	31								101012	10.1016/j.mgene.2022.101012	http://dx.doi.org/10.1016/j.mgene.2022.101012			7	Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Genetics & Heredity	1B9NJ					2022-09-04	WOS:000792756700005
J	Cruz-Sanabria, F; Reyes, PA; Trivino-Martinez, C; Garcia-Garcia, M; Carmassi, C; Pardo, R; Matallana, DLL				Cruz-Sanabria, Francy; Reyes, Pablo Alexander; Trivino-Martinez, Cristian; Garcia-Garcia, Milena; Carmassi, Claudia; Pardo, Rodrigo; Matallana, Diana L. L.			Exploring Signatures of Neurodegeneration in Early-Onset Older-Age Bipolar Disorder and Behavioral Variant Frontotemporal Dementia	FRONTIERS IN NEUROLOGY			English	Article						neurodegeneration; structural connectivity; surface-based morphometry; diffusion tensor imaging; neuropsychology; frontotemporal dementia; early-onset older-age bipolar disorder	DEEP BRAIN-STIMULATION; LOBAR DEGENERATION SPECTRUM; WHITE-MATTER INTEGRITY; EXECUTIVE FUNCTIONS; CORTICAL THICKNESS; ANATOMICAL CONNECTIVITY; COGNITIVE PERFORMANCES; DIAGNOSTIC CHALLENGE; LONGITUDINAL COURSE; GRAY-MATTER	Introduction: Older-age bipolar disorder (OABD) may involve neurocognitive decline and behavioral disturbances that could share features with the behavioral variant of frontotemporal dementia (bvFTD), making the differential diagnosis difficult in cases of suspected dementia. Objective: To compare the neuropsychological profile, brain morphometry, and structural connectivity patterns between patients diagnosed with bvFTD, patients classified as OABD with an early onset of the disease (EO-OABD), and healthy controls (HC). Methods: bvFTD patients (n = 25, age: 66 +/- 7, female: 64%, disease duration: 6 +/- 4 years), EO-OABD patients (n = 17, age: 65 +/- 9, female: 71%, disease duration: 38 +/- 8 years), and HC (n = 28, age: 62 +/- 7, female: 64%) were evaluated through neuropsychological tests concerning attention, memory, executive function, praxis, and language. Brain morphometry was analyzed through surface-based morphometry (SBM), while structural brain connectivity was assessed through diffusion tensor imaging (DTI). Results: Both bvFTD and EO-OABD patients showed lower performance in neuropsychological tests of attention, verbal fluency, working memory, verbal memory, and praxis than HC. Comparisons between EO-OABD and bvFTD showed differences limited to cognitive flexibility delayed recall and intrusion errors in the memory test. SBM analysis demonstrated that several frontal, temporal, and parietal regions were altered in both bvFTD and EO-OABD compared to HC. In contrast, comparisons between bvFTD and EO-OABD evidenced differences exclusively in the right temporal pole and the left entorhinal cortex. DTI analysis showed alterations in association and projection fibers in both EO-OABD and bvFTD patients compared to HC. Commissural fibers were found to be particularly affected in EO-OABD. The middle cerebellar peduncle and the pontine crossing tract were exclusively altered in bvFTD. There were no significant differences in DTI analysis between EO-OABD and bvFTD. Discussion: EO-OABD and bvFTD may share an overlap in cognitive, brain morphometry, and structural connectivity profiles that could reflect common underlying mechanisms, even though the etiology of each disease can be different and multifactorial.	[Cruz-Sanabria, Francy] Univ Pisa, Dept Translat Res New Surg & Med Technol, Pisa, Italy; [Cruz-Sanabria, Francy; Pardo, Rodrigo] Univ Nacl Colombia, Inst Genet, Neurosci Res Grp, Bogota, Colombia; [Reyes, Pablo Alexander; Garcia-Garcia, Milena; Matallana, Diana L. L.] Pontificia Univ Javeriana, Dept Psychiat, PhD Program Neurosci, Bogota, Colombia; [Reyes, Pablo Alexander] Hosp Univ San Ignacio, Radiol Dept, Bogota, Colombia; [Trivino-Martinez, Cristian; Matallana, Diana L. L.] Pontificia Univ Javeriana, Aging Inst, Sch Med, Psychiat Dept, Bogota, Colombia; [Garcia-Garcia, Milena] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Carmassi, Claudia] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Matallana, Diana L. L.] Hosp Univ Fdn Santa Fe, Mental Hlth Dept, Bogota, Colombia; [Matallana, Diana L. L.] Hosp Univ San Ignacio, Intellectus, Memory & Cognit Clin, Bogota, Colombia		Cruz-Sanabria, F (corresponding author), Univ Pisa, Dept Translat Res New Surg & Med Technol, Pisa, Italy.; Cruz-Sanabria, F (corresponding author), Univ Nacl Colombia, Inst Genet, Neurosci Res Grp, Bogota, Colombia.	francy.cruzsanabria@phd.unipi.it	; Reyes, Pablo Alexander/N-6695-2017	Cruz-Sanabria, Francy/0000-0001-5807-6399; Reyes, Pablo Alexander/0000-0001-6705-7157	Department of Science, Technology, and Innovation (Colciencias) of Colombia	Department of Science, Technology, and Innovation (Colciencias) of Colombia	Funding. This study was partially supported by a grant from the Department of Science, Technology, and Innovation (Colciencias) of Colombia, the Pontificia Universidad Javeriana, and the Hospital Universitario San Ignacio (Grants 697-2014 and 345-2011).	Abe C, 2016, J PSYCHIATR NEUROSCI, V41, P240, DOI 10.1503/jpn.150093; Achalia R, 2020, PSYCHIAT RES-NEUROIM, V302, DOI 10.1016/j.pscychresns.2020.111110; Agosta F, 2012, CORTEX, V48, P389, DOI 10.1016/j.cortex.2011.04.012; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Altshuler LL, 2008, PSYCHIAT RES, V157, P289, DOI 10.1016/j.psychres.2007.01.001; Ambrosi E, 2013, J AFFECT DISORDERS, V150, P610, DOI 10.1016/j.jad.2013.02.023; Argyropoulos GD, 2021, PROG NEURO-PSYCHOPH, V104, DOI 10.1016/j.pnpbp.2020.110034; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashtari M, 2012, DEV MED CHILD NEUROL, V54, P6, DOI 10.1111/j.1469-8749.2011.04122.x; Baez S, 2019, NEUROPSYCHOLOGIA, V126, P159, DOI 10.1016/j.neuropsychologia.2017.02.012; Baez S, 2014, PSYCHIAT RES, V216, P269, DOI 10.1016/j.psychres.2014.01.020; Barbosa IG, 2012, J AFFECT DISORDERS, V137, P151, DOI 10.1016/j.jad.2011.12.034; Bauer IE, 2014, J PSYCHIATR RES, V56, P18, DOI 10.1016/j.jpsychires.2014.04.017; Bellani M, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00021; Bellani M, 2009, BIOCHEM SOC T, V37, P1096, DOI 10.1042/BST0371096; Bernal B., 2009, WEB BASED INTERACTIV; Bertoux Maxime, 2013, Alzheimers Dement, V9, pS84, DOI 10.1016/j.jalz.2012.09.010; Bora E, 2017, PSYCHOL MED, V47, P2753, DOI 10.1017/S0033291717001490; Borges Saulo Queiroz, 2019, Dement. neuropsychol., V13, P475, DOI 10.1590/1980-57642018dn13-040016; Braw Y, 2013, PSYCHIAT RES, V210, P842, DOI 10.1016/j.psychres.2013.01.003; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Cerami C, 2015, J NEUROL SCI, V351, P72, DOI 10.1016/j.jns.2015.02.039; Cerami C, 2013, NEUROL SCI, V34, P1267, DOI 10.1007/s10072-013-1317-9; Cerami C, 2011, J ALZHEIMERS DIS, V27, P791, DOI 10.3233/JAD-2011-110788; Chen GM, 2019, J AFFECT DISORDERS, V243, P441, DOI 10.1016/j.jad.2018.09.076; Chen Y, 2019, NEUROPSYCHOL REV, V29, P450, DOI 10.1007/s11065-019-09414-7; Chen Y, 2018, ANN NEUROL, V84, P98, DOI 10.1002/ana.25271; Crespi C., 2014, NEUROLOGY, V82; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Daianu M, 2016, BRAIN IMAGING BEHAV, V10, P1038, DOI 10.1007/s11682-015-9458-5; de Haan EHF, 2020, NEUROPSYCHOL REV, V30, P224, DOI 10.1007/s11065-020-09439-3; Delaloye C, 2011, INT J GERIATR PSYCH, V26, P1309, DOI 10.1002/gps.2683; Delvecchio G, 2019, AUST NZ J PSYCHIAT, V53, P413, DOI 10.1177/0004867418815976; DEVANAND DP, 1992, ARCH NEUROL-CHICAGO, V49, P371, DOI 10.1001/archneur.1992.00530280051022; Diniz BS, 2017, AM J GERIAT PSYCHIAT, V25, P357, DOI 10.1016/j.jagp.2016.11.014; Dols Annemiek, 2016, Neuropsychiatr Dis Treat, V12, P2207, DOI 10.2147/NDT.S99229; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Floris G, 2013, J NEUROL, V260, P1155, DOI 10.1007/s00415-013-6833-2; Frey BN, 2008, EUR NEUROPSYCHOPHARM, V18, P717, DOI 10.1016/j.euroneuro.2008.04.015; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Galimberti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032164; Gaser C, 2016, HBM, V2016, P336; Gildengers AG, 2010, BIPOLAR DISORD, V12, P851, DOI 10.1111/j.1399-5618.2010.00877.x; Gildengers AG, 2009, BIPOLAR DISORD, V11, P744, DOI 10.1111/j.1399-5618.2009.00739.x; Glasser MF, 2016, NAT NEUROSCI, V19, P1175, DOI 10.1038/nn.4361; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Heng S, 2010, J NEURAL TRANSM, V117, P639, DOI 10.1007/s00702-010-0368-9; Herlin B, 2021, J CHEM NEUROANAT, V113, DOI 10.1016/j.jchemneu.2021.101925; Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73; Hodges JR, 2018, J ALZHEIMERS DIS, V62, P1467, DOI 10.3233/JAD-171087; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Huttlova J, 2014, CEREBELLUM, V13, P415, DOI 10.1007/s12311-014-0550-y; Jiskoot LC, 2018, ANN CLIN TRANSL NEUR, V5, P1025, DOI 10.1002/acn3.601; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Josephs KA, 2013, BRAIN, V136, P455, DOI 10.1093/brain/aws324; Kessing LV, 2010, BIPOLAR DISORD, V12, P87, DOI 10.1111/j.1399-5618.2009.00788.x; Kittel-Schneider S, 2014, J AFFECT DISORDERS, V157, P87, DOI 10.1016/j.jad.2014.01.006; Kril JJ, 2005, J NEUROL SCI, V232, P83, DOI 10.1016/j.jns.2005.02.003; Kurz A, 2014, MATURITAS, V79, P216, DOI 10.1016/j.maturitas.2014.07.001; Lam BYK, 2014, HUM BRAIN MAPP, V35, P3547, DOI 10.1002/hbm.22420; Lebert F, 2008, ENCEPHALE, V34, P606, DOI 10.1016/j.encep.2007.12.007; Leow A, 2013, BIOL PSYCHIAT, V73, P183, DOI 10.1016/j.biopsych.2012.09.014; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Lim CS, 2013, NEUROSCI BIOBEHAV R, V37, P418, DOI 10.1016/j.neubiorev.2013.01.003; Lin FC, 2011, J AFFECT DISORDERS, V131, P299, DOI 10.1016/j.jad.2010.12.018; Linke J, 2013, BIOL PSYCHIAT, V74, P908, DOI 10.1016/j.biopsych.2013.04.010; Luders E, 2006, NEUROIMAGE, V29, P1224, DOI 10.1016/j.neuroimage.2005.08.049; Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468; Maletic V, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00098; Martino DJ, 2008, J AFFECT DISORDERS, V109, P149, DOI 10.1016/j.jad.2007.12.232; Martino DJ, 2013, J AFFECT DISORDERS, V147, P345, DOI 10.1016/j.jad.2012.11.037; Masouy A, 2011, PSYCHOGERIATRICS, V11, P60, DOI 10.1111/j.1479-8301.2010.00348.x; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McMonagle P., 2016, HODGESFRONTOTEMPORAL, P15; Meisler MH, 2013, BIPOLAR DISORD, V15, P326, DOI 10.1111/bdi.12063; Mendez MF, 2020, J NEUROPSYCH CLIN N, V32, P376, DOI 10.1176/appi.neuropsych.20010003; Miki Y, 2020, NEUROPATH APPL NEURO, V46, P296, DOI 10.1111/nan.12582; Monji A, 2014, J NEUROPSYCH CLIN N, V26, pE35, DOI 10.1176/appi.neuropsych.13020031; Moorhead TWJ, 2007, BIOL PSYCHIAT, V62, P894, DOI 10.1016/j.biopsych.2007.03.005; Nascimento C, 2019, PROG NEURO-PSYCHOPH, V93, P269, DOI 10.1016/j.pnpbp.2019.04.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nicastro N, 2020, J ALZHEIMERS DIS, V76, P331, DOI 10.3233/JAD-200246; Nigro Salvatore, 2021, Brain Sci, V11, DOI 10.3390/brainsci11020192; Niida R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00522; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; Panman JL, 2019, NEUROBIOL AGING, V76, P115, DOI 10.1016/j.neurobiolaging.2018.12.017; Papazacharias A, 2017, J ALZHEIMERS DIS, V55, P973, DOI 10.3233/JAD-160860; Pavlovic Aleksandar, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.09.2010.3303; Pennington C, 2011, J ALZHEIMERS DIS, V24, P261, DOI 10.3233/JAD-2011-101668; Perry A, 2019, MOL PSYCHIATR, V24, P1296, DOI 10.1038/s41380-018-0267-2; Poletti M, 2013, NEUROL SCI, V34, P1893, DOI 10.1007/s10072-013-1400-2; Poletti S, 2015, J AFFECT DISORDERS, V174, P342, DOI 10.1016/j.jad.2014.12.030; Post RM, 2012, J PSYCHIATR RES, V46, P561, DOI 10.1016/j.jpsychires.2012.02.004; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47; Rascovsky K, 2013, INT REV PSYCHIATR, V25, P145, DOI 10.3109/09540261.2013.763341; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rizzo LB, 2014, NEUROSCI BIOBEHAV R, V42, P157, DOI 10.1016/j.neubiorev.2014.02.004; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Roca M, 2013, NEUROPSYCHOLOGIA, V51, P725, DOI 10.1016/j.neuropsychologia.2013.01.008; Rubino E, 2017, AMYOTROPH LAT SCL FR, V18, P624, DOI 10.1080/21678421.2017.1339716; Sajatovic M, 2015, BIPOLAR DISORD, V17, P689, DOI 10.1111/bdi.12331; Samame C, 2014, J AFFECT DISORDERS, V164, P130, DOI 10.1016/j.jad.2014.04.028; Sanchez-Moreno J, 2009, PSYCHOTHER PSYCHOSOM, V78, P285, DOI 10.1159/000228249; Savitz JB, 2014, NEUROSCI BIOBEHAV R, V42, P132, DOI 10.1016/j.neubiorev.2014.02.008; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Sheelakumari R, 2020, BRAIN IMAGING BEHAV, V14, P2004, DOI 10.1007/s11682-019-00150-3; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spreen O, 2006, COMPENDIUM NEUROPSYC, V3rd ed.; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Strejilevich SA, 2015, J AFFECT DISORDERS, V175, P396, DOI 10.1016/j.jad.2015.01.018; Tadayonnejad R, 2014, J GERIATR PSYCH NEUR, V27, P5, DOI 10.1177/0891988713516539; Takehara-Nishiuchi K, 2014, NEUROSCI RES, V84, P27, DOI 10.1016/j.neures.2014.02.012; Torgerson CM, 2013, BRAIN IMAGING BEHAV, V7, P129, DOI 10.1007/s11682-012-9202-3; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tsolaki E, 2021, HUM BRAIN MAPP, V42, P2005, DOI 10.1002/hbm.25341; Van den Stock J, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101770; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Vijverberg EGB, 2017, J CLIN PSYCHIAT, V78, pE1197, DOI 10.4088/JCP.16m11078; Volz LJ, 2017, BRAIN, V140, P2051, DOI 10.1093/brain/awx139; Voogd J, 2012, CEREBELLUM PRECEREBE, P471; Vorspan F, 2012, FUNCT NEUROL, V27, P193; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wechsler D., 1958, MEASUREMENT APPRAISA, DOI [10.1037/11167-000, DOI 10.1037/11167-000]; Woolley JD, 2011, J CLIN PSYCHIAT, V72, P126, DOI 10.4088/JCP.10m06382oli; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yotter RA, 2011, HUM BRAIN MAPP, V32, P1109, DOI 10.1002/hbm.21095; Young RC, 2006, J AFFECT DISORDERS, V92, P125, DOI 10.1016/j.jad.2005.12.042	136	0	0	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 3	2021	12								713388	10.3389/fneur.2021.713388	http://dx.doi.org/10.3389/fneur.2021.713388			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UR6CZ	34539558	Green Published, gold			2022-09-04	WOS:000696836400001
J	Anaya-Isaza, A; Mera-Jimenez, L; Cabrera-Chavarro, JM; Guachi-Guachi, L; Peluffo-Ordonez, D; Rios-Patino, JI				Anaya-Isaza, Andres; Mera-Jimenez, Leonel; Cabrera-Chavarro, Johan Manuel; Guachi-Guachi, Lorena; Peluffo-Ordonez, Diego; Rios-Patino, Jorge Ivan			Comparison of Current Deep Convolutional Neural Networks for the Segmentation of Breast Masses in Mammograms	IEEE ACCESS			English	Article						Breast cancer; Cancer; Task analysis; Lesions; Image segmentation; Tools; Medical diagnostic imaging; Artificial intelligence; biomedical imaging; cancer; image segmentation; machine learning; mammography; medical diagnostic imaging	ARTIFICIAL-INTELLIGENCE; CANCER STATISTICS; U-NET; MORTALITY; BENIGN; UPDATE	Breast cancer causes approximately 684,996 deaths worldwide, making it the leading cause of female cancer mortality. However, these figures can be reduced with early diagnosis through mammographic imaging, allowing for the timely and effective treatment of this disease. To establish the best tools for contributing to the automatic diagnosis of breast cancer, different deep learning (DL) architectures were compared in terms of breast lesion segmentation, lesion type classification, and degree of suspicion of malignancy tests. The tasks were completed with state-of-the-art architectures and backbones. Initially, during segmentation, the base UNet, Visual Geometry Group 19 (VGG19), InceptionResNetV2, EfficientNet, MobileNetv2, ResNet, ResNeXt, MultiResUNet, linkNet-VGG19, DenseNet, SEResNet and SeResNeXt architectures were compared, where "Res" denotes a residual network. In addition, training was performed with 5 of the most advanced loss functions and validated by the Dice coefficient, sensitivity, and specificity. The proposed models achieved Dice values above 90%, with the EfficientNet architecture achieving 94.75% and 99% accuracy on the two tasks. Subsequently, classification was addressed with the ResNet50V2, VGG19, InceptionResNetV2, DenseNet121, InceptionV3, Xception and EfficientNetB7 networks. The proposed models achieved 96.97% and 97.73% accuracy through the VGG19 and ResNet50V2 networks on the lesion classification and degree of suspicion tasks, respectively. All three tasks were addressed with open-access databases, including the Digital Database for Screening Mammography (DDSM), the Mammographic Image Analysis Society (MIAS) database, and INbreast.	[Anaya-Isaza, Andres] Pontificia Univ Javeriana, Fac Engn, Bogota 410001, Colombia; [Anaya-Isaza, Andres; Mera-Jimenez, Leonel; Cabrera-Chavarro, Johan Manuel] INDIGO Res, Bogota 410010, Colombia; [Mera-Jimenez, Leonel] Univ Antioquia, Fac Engn, Medellin 050010, Colombia; [Cabrera-Chavarro, Johan Manuel] Univ Surcolombiana, Fac Engn, Neiva 410010, Colombia; [Guachi-Guachi, Lorena] Univ Int Ecuador, Dept Mechatron, Quito 170411, Ecuador; [Peluffo-Ordonez, Diego] Mohammed VI Polytech Univ, Modeling Simulat & Data Anal MSDA Res Program, Ben Guerin 47963, Morocco; [Rios-Patino, Jorge Ivan] Univ Tecnol Pereira, Fac Engn, Pereira 666003, Colombia		Mera-Jimenez, L (corresponding author), INDIGO Res, Bogota 410010, Colombia.; Mera-Jimenez, L (corresponding author), Univ Antioquia, Fac Engn, Medellin 050010, Colombia.	leonel.mera@udea.edu.co	Peluffo-Ordóñez, Diego Hernán/ABF-7707-2021	Peluffo-Ordóñez, Diego Hernán/0000-0002-9045-6997; Guachi Guachi, Lorena de los Angeles/0000-0002-8951-8150; Mera, Leonel/0000-0002-1825-4370	Research Division of INDIGO Technologies	Research Division of INDIGO Technologies	This work was supported by the Research Division of INDIGO Technologies (https://indigo.tech/).	Abdelhafiz D, 2019, ACM-BCB'19: PROCEEDINGS OF THE 10TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY AND HEALTH INFORMATICS, P475, DOI 10.1145/3307339.3342157; Abdelhafiz D, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3521-y; Abdelrahman L, 2021, COMPUT BIOL MED, V131, DOI 10.1016/j.compbiomed.2021.104248; Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; American Cancer Society, 2019, BREAST CANC RISK PRE; American Cancer Society, 2019, BREAST CANC EARL DET; American Cancer Society, 2020, BREAST CANC FACTS FI; American Cancer Society, 2017, BREAST CANC WHAT IS; American Society of Clinical Oncology (ASCO), 2021, BREAST CANC STAT; Anttila S, 2020, OCCUPATIONAL CANCERS, 2 EDITION, P1, DOI 10.1007/978-3-030-30766-0; Taghanaki SA, 2021, ARTIF INTELL REV, V54, P137, DOI 10.1007/s10462-020-09854-1; Balali GI., 2020, OPEN ACCESS LIB J, V7, P1, DOI DOI 10.4236/OALIB.1106866; Bali A, 2015, INT C ADV COMPUT COM, P113, DOI 10.1109/ACCT.2015.63; Barragan-Montero A, 2021, PHYS MEDICA, V83, P242, DOI 10.1016/j.ejmp.2021.04.016; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaurasia A, 2017, 2017 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING (VCIP); Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; DEMOOR T, 2018, P 14 INT WORKSH BREA, P23, DOI DOI 10.1117/12.2318326; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; Duffy SW, 2020, LANCET ONCOL, V21, P1165, DOI 10.1016/S1470-2045(20)30398-3; Dwarapureddi B. K, THERANOSTIC PRECISIO, V2021, P71, DOI [10.1016/B978-0-12-822009-2.00004-2, DOI 10.1016/B978-0-12-822009-2.00004-2]; Gao YM, 2019, AM J ROENTGENOL, V212, P300, DOI 10.2214/AJR.18.20392; Gill J, 2019, INT J IMAGE GRAPH, V19, DOI 10.1142/S021946781950013X; He K., 2016, PROC CVPR IEEE, DOI DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hosny A, 2018, NAT REV CANCER, V18, P500, DOI 10.1038/s41568-018-0016-5; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/TPAMI.2019.2913372, 10.1109/CVPR.2018.00745]; Ibrahim A, 2020, BREAST, V49, P267, DOI 10.1016/j.breast.2019.12.007; Ibtehaz N, 2020, NEURAL NETWORKS, V121, P74, DOI 10.1016/j.neunet.2019.08.025; Jadon Shruti, 2020, P115; Jafari SH, 2018, J CELL PHYSIOL, V233, P5200, DOI 10.1002/jcp.26379; Jones LD, 2018, BONE JOINT RES, V7, P223, DOI 10.1302/2046-3758.73.BJR-2017-0147.R1; Kamil M.Y., 2019, INT J INTELL ENG SYS, V12, P22, DOI 10.22266/ijies2019.0228.03; Kaminska M, 2015, MENOPAUSE REV, V14, P196, DOI 10.5114/pm.2015.54346; Katzen J, 2018, CLIN IMAG, V52, P305, DOI 10.1016/j.clinimag.2018.08.014; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee RS, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.177; Li SY, 2019, IEEE ACCESS, V7, P59037, DOI 10.1109/ACCESS.2019.2914873; Lin TY, 2020, IEEE T PATTERN ANAL, V42, P318, DOI 10.1109/TPAMI.2018.2858826; Lindsay GW, 2021, J COGNITIVE NEUROSCI, V33, P2017, DOI 10.1162/jocn_a_01544; Ma YD, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P743; Meisner ALW, 2008, MED CLIN N AM, V92, P1115, DOI 10.1016/j.mcna.2008.04.003; MONOSTORI Z, 1991, SURG GYNECOL OBSTET, V173, P438; Moo TA, 2018, PET CLIN, V13, P339, DOI 10.1016/j.cpet.2018.02.006; Moreira IC, 2012, ACAD RADIOL, V19, P236, DOI 10.1016/j.acra.2011.09.014; Norgeot B, 2019, NAT MED, V25, P14, DOI 10.1038/s41591-018-0320-3; Paez D, 2020, CLIN TRANSL IMAGING, V8, P51, DOI 10.1007/s40336-020-00359-z; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; RamBihariLal Shrivastava S., 2013, AJPHR, V1, P135, DOI [10.12691/ajphr-1-6-2, DOI 10.12691/AJPHR-1-6-2]; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sadeghi Bahram, 2021, Health and Technology, V11, P99, DOI 10.1007/s12553-020-00506-6; Salama D, 2015, COMP STUDY MED IMAGI; Salama WM, 2021, ALEX ENG J, V60, P4701, DOI 10.1016/j.aej.2021.03.048; Salehi SSM, 2017, LECT NOTES COMPUT SC, V10541, P379, DOI 10.1007/978-3-319-67389-9_44; Salih AM, 2018, 2018 1ST ANNUAL INTERNATIONAL CONFERENCE ON INFORMATION AND SCIENCES (AICIS 2018), P40, DOI 10.1109/AiCIS.2018.00020; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Simonyan K., 2014, ARXIV; SUCKLING J, 1994, INT CONGR SER, V1069, P375; Sudre CH, 2017, LECT NOTES COMPUT SC, V10553, P240, DOI 10.1007/978-3-319-67558-9_28; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tan M., 2019, P 36 INT C MACH LEAR, P10691; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; WINSBERG F, 1967, RADIOLOGY, V89, P211, DOI 10.1148/89.2.211; Winters S, 2017, PROG MOL BIOL TRANSL, V151, P1, DOI 10.1016/bs.pmbts.2017.07.002; World Health Organization (WHO), 2020, BREAST CANC NOW MOST; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Zhou, 2017, P INT APPL COMP EL S, P1, DOI DOI 10.1109/ICSPCC.2017.8242445; Zhu WT, 2018, I S BIOMED IMAGING, P847, DOI 10.1109/ISBI.2018.8363704; Zhu Y, 2017, IEEE IMAGE PROC, P790, DOI 10.1109/ICIP.2017.8296389	72	2	2	4	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						152206	152225		10.1109/ACCESS.2021.3127862	http://dx.doi.org/10.1109/ACCESS.2021.3127862			20	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	XA2UM		gold			2022-09-04	WOS:000720508700001
J	Aschner, P; Sethi, B; Gomez-Peralta, F; Landgraf, W; Loizeau, V; Dain, MP; Pilorget, V; Comlekci, A				Aschner, Pablo; Sethi, Bipin; Gomez-Peralta, Fernando; Landgraf, Wolfgang; Loizeau, Virginie; Dain, Marie-Paule; Pilorget, Valerie; Comlekci, Abdurrahman			Insulin glargine compared with premixed insulin for management of insulin-naive type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						GALAPAGOS; Hypoglycemia; Insulin glargine; Premixed insulin; Type 2 diabetes	BASAL INSULIN; THERAPY; REGIMENS; MELLITUS; GLUCOSE	Aims: Demonstrate superiority of insulin glargine (+/- glulisine) strategy versus premixed insulin strategy for percentage of patients reaching HbA1c <7% (<53 mmol/mol) at study end without any documented symptomatic hypoglycemia (bloof glucose [BG] <= 3.1 mmol/L) in type 2 diabetes (T2DM) patients failing oral agents. Methods: This 24-week, open-label, multinational trial randomized patients to glargine OD or premix OD or BID, continuing metformin +/- insulin secretagogue (IS). Second premix injection could be added any time; glulisine could be added with main meal in glargine OD patients with HbA1c >= 7% and fasting blood glucose (FBG) <7 mmol/L at week 12. IS was stopped with any second injection. Insulin titration targeted FBG <= 5.6 mmol/L. Results: Modified intent-to-treat population comprised 923 patients (glargine, 462; premix, 461). Baseline characteristics were similar (mean 12DM duration: 9 years; HbA1c: 8.7% (72 mmol/mol); FBG: 10.4 mmol/L). Primary endpoint was achieved by 332% of glargine (+/- glulisine) and 31.4% of premix patients. Superiority was not demonstrated, but non-inferiority was (pre-specified margin: 25% of premix rate). More patients using premix achieved target (52.6% vs. 43.2%, p = 0.005); symptomatic hypoglycemia was less with glargine (1.17 vs. 2.93 events/patient-year). Conclusions: Glargine (+/- glulisine) and premix strategies resulted in similar percentages of well-controlled patients without hypoglycemia, with more patients achieving target HbA1c with premix whereas overall symptomatic hypoglycemia was less with glargine. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license	[Aschner, Pablo] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota 110231, Colombia; [Sethi, Bipin] CARE Hosp, Hyderabad, Andhra Pradesh, India; [Gomez-Peralta, Fernando] Hosp Gen Segovia, Endocrinol & Nutr Unit, Segovia, Spain; [Landgraf, Wolfgang] Sanofi, Frankfurt, Germany; [Loizeau, Virginie] Lincoln, Boulogne, France; [Dain, Marie-Paule; Pilorget, Valerie] Sanofi, Paris, France; [Comlekci, Abdurrahman] Dokuz Eylul Univ, Sch Med, Div Endocrinol & Metab, Izmir, Turkey		Aschner, P (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Carrera 7 40-62, Bogota 110231, Colombia.	paschner@cable.net.co; sethibipin54@gmail.com; fgomezperalta@gmail.com; wolfgang.landgraf@sanofi.com; Virginie.Loizeau-prest@sanofi.com; dainmariepaule@yahoo.fr; Valerie.pilorget@sanofi.com; drcomlekci@hotmail.com	Gomez-Peralta, Fernando/J-8249-2019; Landgraf, Wolfgang/AAD-2624-2019	Gomez-Peralta, Fernando/0000-0003-0106-0091; Landgraf, Wolfgang/0000-0001-5321-7164	Sanofi	Sanofi	This study was funded by Sanofi. Editorial support was provided by Tom Claus, PhD, of PPSI (a PAREXEL company) and was funded by Sanofi.	Davidson MB, 2011, ENDOCR PRACT, V17, P395, DOI 10.4158/EP10323.OR; Giugliano D, 2011, DIABETES RES CLIN PR, V92, P1, DOI 10.1016/j.diabres.2010.08.006; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Janka HU, 2005, DIABETES CARE, V28, P254, DOI 10.2337/diacare.28.2.254; Lankisch MR, 2008, DIABETES OBES METAB, V10, P1178, DOI 10.1111/j.1463-1326.2008.00967.x; Lasserson DS, 2009, DIABETOLOGIA, V52, P1990, DOI 10.1007/s00125-009-1468-7; Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015; Owens DR, 2011, DIABETES OBES METAB, V13, P1020, DOI 10.1111/j.1463-1326.2011.01459.x; Pontiroli AE, 2012, DIABETES OBES METAB, V14, P433, DOI 10.1111/j.1463-1326.2011.01543.x; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2014, DIABETES OBES METAB, V16, P396, DOI 10.1111/dom.12225; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0	16	26	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	AUG	2015	29	6					838	845		10.1016/j.jdiacomp.2015.04.003	http://dx.doi.org/10.1016/j.jdiacomp.2015.04.003			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CO0CK	25981123	hybrid			2022-09-04	WOS:000358817500018
